id|nct_id|organization|name|phone|email|extension
22319872|NCT01330134|University of Chicago|John P. Kress, MD|773-702-1000|jkress@medicine.bsd.uchicago.edu|
22319873|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu|
22289251|NCT00479687|Bioventus LLC|Regulatory and Clinical Affairs|18003964325|CT.gov@bioventusglobal.com|
22289252|NCT01264705|UT Southwestern Medical Center|Adam Yopp, MD|214-648-5870|adam.yopp@utsouthwestern.edu|
22289253|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu|
22289254|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22289255|NCT02840799|University of Pennsylvania|Hannah Maynard|215-662-7580|hannah.maynard@pennmedicine.upenn.edu|
22289256|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu|
22289257|NCT04990804|Vanderbilt University Medical Center|Research Coordinator|615-936-7107|kennadie.long@vumc.org|
22289258|NCT04202419|Miami Dermatology and Laser Institute|Dr. Jill Waibel|(305) 615-2393|info@miamidermlaser.com|
22319874|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu|
22319875|NCT03441334|Texas Woman's University|Hui-Ting Goh, Assistant Professor|2146897723|HGoh1@twu.edu|
22319876|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012||
22319877|NCT04946825|University of Vermont|Elias Klemperer, PhD|802-656-1641|elias.klemperer@med.uvm.edu|
22319878|NCT00682448|Rush University Medical Center|Stephanie Cavanaugh, MD||Stephanie_Cavanaugh@rush.edu|
22319879|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22319880|NCT04050670|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22319881|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu|
22273926|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22273927|NCT01334086|Princess Margaret Cancer Centre|Dr. Karen Yee, Hematology and Medical Oncology Site Group Lead|416-946-4501|Karen.Yee@uhn.ca|4495
22273928|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com|
22289259|NCT02642315|University of Missouri Columbia|Pradeep Sahota MD|573-882-6402|sahotap@missouri.edu|
22289260|NCT02687191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289261|NCT01349049|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22289262|NCT03887702|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
22289263|NCT01643772|Mundipharma (China) Pharmaceutical Co.Ltd|Ms. Dan Zhu, Clinical operation and quality lead of the study|+8610 6563 6891|dan.zhu@mundipharma.com.cn|
22289264|NCT03860818|Ralph H. Johnson VA Healthcare System|Dr. David J. Taber|843.789.6624|David.Taber2@va.gov|
22289265|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22289266|NCT03436082|Yale School of Medicine|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
22289267|NCT02917642|University of São Paulo|Dr. Ericka T. Pinheiro|551126488293|erickapinheiro@usp.br|
22289268|NCT01864603|University of California, San Francisco|Tamara Clark|628-206-8790|Tamara.Clark@ucsf.edu|
22289269|NCT02423902|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22289270|NCT02136069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22289271|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22289272|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304488|NCT04034238|National cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
22304489|NCT04822298|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22304490|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu|
22304491|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22304492|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com|
22304493|NCT02092987|Columbia University Medical Center|Jose Luchsinger|212-305-4730|jal94@cumc.columbia.edu|
22304494|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300||
22304495|NCT02967016|Rutgers SUNJ|Dr. Antonio Gonzalez|4133869415|ajantoni@gmail.com|
22304496|NCT02068729|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
22304497|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|ROrlowski@mdanderson.org|
22304498|NCT03487666|Georgetown University|Candace Mainor, MD|202-444-2223|Candace.Mainor@gunet.georgetown.edu|
22304499|NCT03201757|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
22304500|NCT05967442|Advocate Christ Medical Center|Marc McDowell|708684800|marc.mcdowell@aah.org|
22304501|NCT03930186|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22304502|NCT04569240|Cleveland Clinc|Andrea Parianos|216-445-8354|debsa@ccf.org|
22304503|NCT04365413|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Lacey McNally|405-325-0789|lacey-mcnally@ouhsc.edu|
22304504|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304505|NCT01244763|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22304506|NCT03330119|Main Line Health System|Dr. Norman Brest|484-476-2325|brestn@mlhs.org|
22304507|NCT05205941|MMV|Benoit Bestgen|+41797651868|bestgenb@mmv.org|
22304508|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com|
22304509|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304510|NCT02664220|McGovern Medical School, University of Texas Health Sciences Center at Houston|Dr. Kuojen Tsao|713-500-7300|Kuojen.Tsao@uth.tmc.edu|
22273929|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
22304511|NCT03311854|Sobi AG|Veronica Asnaghi, MD|+41 61 201 13 20|veronica.asnaghi@sobi.com|
22319882|NCT02553265|NYU Langone Health|Horacio C Kaufmann, MD|212-263-7225|Horacio.Kaufmann@nyulangone.org|
22258613|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580||
22289273|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org|
22289274|NCT04154189|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22289275|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
22289276|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu|
22289277|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22289278|NCT02722499|Medical College of Wisconsin|Jennifer A. Campbell|414-955-8829|jacampbell@mcw.edu|
22289279|NCT04999852|Indiana University|Clarissa Tokash|(812) 855-7686|catokash@iu.edu|
22289280|NCT05626322|Pfizer Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289281|NCT04758637|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22289282|NCT03610269|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22304512|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org|
22304513|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
22304514|NCT03566680|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22304515|NCT03189134|Boston Children's Hospital|Aditya K. Kaza, MD|617-355-7932|aditya.kaza@cardio.chboston.org|
22304516|NCT04227340|St. Jude Children's Research Hospital|Belinda Mandrell, PhD, RN|(901) 595-4209|belinda.mandrell@stjude.org|
22304517|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org|
22304518|NCT04003974|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22304519|NCT02400307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22304520|NCT03248440|Senju USA, Inc.|Takahiro Ogawa, PhD|+1 818 719 7190|ogawataka@senju-usa.com|
22304521|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22304522|NCT04081298|Fred Hutchinson Cancer Center|Heather Greenlee|206-667-4502|hgreenlee@fredhutch.org|
22304523|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304524|NCT00525057|UT MD Anderson Cancer Center|Patrick Lin, MD/Professor, Orthopaedic Oncology|(713) 745-0088|plin@mdanderson.org|
22304525|NCT03389893|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
22304526|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22304527|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu|
22304528|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
22304529|NCT04305236|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22304530|NCT02308501|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
22304531|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304532|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu|
22304533|NCT02186938|MUSC|Dr Hand|843-792-5442|handw@musc.edu|
22304534|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
22304535|NCT02034435|Vanderbilt University Medical Center|Dr. James M. Luther, MD|(615) 936-3420|james.luther@vumc.org|
22319883|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org|
22319884|NCT02053909|Boca Raton Regional Hospital|Dr. Alexander Kulik|561-955-6300|alex_kulik@yahoo.com|
22258614|NCT02661126|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258615|NCT01513551|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304536|NCT03862482|Université de Montréal|Dr. Aldo Joseph Camarda|514-343-7124|aj.camarda@umontreal.ca|
22304537|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
22304538|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22304539|NCT02839681|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
22304540|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com|
22304541|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22304542|NCT02165124|Johns Hopkins Univesity|Dr. Clifford Weiss|4106141046|cweiss@jhmi.edu|
22304543|NCT03100838|USFDA|Dr. Minori Kinjo|240-40269118|minori.kinjo@fda.hhs.gov|
22304544|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22304545|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu|
22304546|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22304547|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22304548|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22304549|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055|dhumes@cytopherx.com|302
22304550|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304551|NCT04504916|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289283|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu|
22304552|NCT03057834|Wake Forest University School of Medicine|Candace Parker-Autry, MD|336-716-3779|candace.parkerautry@wfusm.edu|
22304553|NCT01638468|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
22319885|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22289284|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com|
22289285|NCT05019521|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22289286|NCT02721966|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
22319886|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22319887|NCT02767323|Duke University|Dr. Lysianne Beynel|9193386273|lysianne.beynel@gmail.com|
22319888|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319889|NCT03523728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22319890|NCT02023242|Ivantis, Inc.|Richard Hope|949-333-1310|rhope@ivantisinc.com|
22319891|NCT02528370|Hospital Galdakao-Usansolo|Dr Cristobal Esteban|0034 94 400 7000|cristobal.estebangonzalez@osakidetza.eus|7002
22319892|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
22289287|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22319893|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com|
22319894|NCT01809132|UTexas Southwestern Medical Center|Dr. Mack C. Mitchell|2146485036|mack.mitchell@utsouthwestern.edu|
22319895|NCT04854434|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22319896|NCT03349775|Beth Israel Deaconness Medical Center|Dr. Jennifer Ho|617-735-4102|jho@bidmc.harvard.edu|
22319897|NCT04479436|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
22319898|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl|
22319899|NCT02428855|Massachusetts General Hospital|Dr. Bruce Giantonio|617-724-4000|BGIANTONIO@mgh.harvard.edu|
22319900|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu|
22319901|NCT03334409|Mayo Clinic, Rochester|Lance Pagliaro, M.D.|(507)293-0566|Pagliaro.lance@mayo.edu|
22319902|NCT01364623|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
22319903|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
22319904|NCT00718549|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22319905|NCT01303965|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22319906|NCT03633526|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
22319907|NCT05417607|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
22319908|NCT02871778|Parion Sciences|Karl Donn|919 313 1185|kdonn@parion.com|
22319909|NCT02653300|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
22319910|NCT00888381|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22319911|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu|
22319912|NCT04166383|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
22319913|NCT03044886|Department of Stomatology, Beijing Chao-yang Hospital, Capital Medical University|Dr. Wang Zuomin|+86-010-85231492|wzuomin@sina.cn|
22319914|NCT01560923|Masonic Cancer Center, University of Minnesota|Dr.Gautam Jha|612-624-5373|jhaxx014@umn.edu|
22319915|NCT03785678|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22319916|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319917|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22289288|NCT02840461|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22319918|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
22319919|NCT02684279|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22258616|NCT02917447|VA Puget Sound Health Care System|Keren Lehavot, PhD|206-277-1511|keren.lehavot@va.gov|
22258617|NCT02038634|Medical College of Wisconsin|Karen Gonzalez|414-955-3221|kgonzalez@mcw.edu|
22258618|NCT01706198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289289|NCT03217071|University of California, San Francisco|Dr. Sue Yom, MD, PhD|(415) 353-9893|Sue.Yom@ucsf.edu|
22289290|NCT04163016|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22289291|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org|
22289292|NCT04301193|University of Maryland|Division Chief of Obstetric Anesthesiology|(410) 328-4229|bkodali@som.umaryland.edu|
22289293|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
22289294|NCT04983680|Massachusetts General Hospital/Harvard Medical School|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
22289295|NCT04434937|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22289296|NCT02633059|Mayo Clinic|Dr. Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
22289297|NCT04193189|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22289298|NCT04549545|Aerin Medical|Tien Dang Sr. Clinical Affairs Manager|669-256-6596|tdang@aerinmedical.com|
22319920|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22319921|NCT01479829|Loyola University Medical Center|Dr. Angelos Halaris|708-216-3272|ahalaris@luc.edu|
22273930|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il|
22273931|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu|
22273932|NCT03110354|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22273933|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu|
22273934|NCT03429348|University of Arizona|Jeff Burgess, MD., MS, MPH, Assoc Dean of Research|520-626-4918|jburgess@email.arizona.edu|
22319922|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org|
22319923|NCT01444456|Amgen Inc.|Study Director|866-572-6436||
22304554|NCT00003509|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22304555|NCT03803774|National Cancer Institute|Dr. Vassiliki Saloura|240-760-6352|vassiliki.saloura@nih.gov|
22319924|NCT05868811|Children's Mercy Hospital|Dr. Kai Ling Kong|5157712880|kkong@cmh.edu|
22319925|NCT01932242|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22319926|NCT02142738|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319927|NCT02615470|Auburn University|Salisa Westrick|3348448314|westrsc@auburn.edu|
22319928|NCT03713034|Yale University|Tyra Pendergrass Boomer|(203) 737-6101|tyra.pendergrass@yale.edu|
22319929|NCT03042780|H Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
22319930|NCT02000596|University of Maryland Greenebaum Comprehensive Cancer Center|Kate Tkaczuk|410-328-7394|ktkaczuk@umm.edu|
22319931|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu|
22319932|NCT02982590|HOSPITAL UNIVERSITI SAINS MALAYSIA|DR W YUS HANIFF W ISA|09-767 3000|wyhaniff@usm.my|
22319933|NCT04196803|Vanderbilt University Medical Center|Dr. Qi Dai|615)936-0707|qi.dai@vanderbilt.edu|
22319934|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22319935|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com|
22319936|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300||
22319937|NCT02650999|University of Pennsylvania, Clinical Research Unit|Ellen Napier, Nurse Pracitioner|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
22319938|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22319939|NCT01756040|University of Maryland Baltimore|Rose Marie Viscardi, M.D.|410-328-6003|rviscard@som.umaryland.edu|
22319940|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu|
22319941|NCT04774250|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
22319942|NCT00986544|"Department of Surgery, Hospital P. Colombo, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy"|Marcello Picchio|+39696102228|marcellopicchio@libero.it|
22319943|NCT01871220|University of Iowa College of Dentistry|Dr. Christopher Barwacz|3193843002|chris-barwacz@uiowa.edu|
22319944|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com|
22319945|NCT04872348|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22258619|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319946|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22319947|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
22319948|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535|pine3.tw@yahoo.com.tw|2174
22319949|NCT05111041|Duke University|Devon Noonan, Ph.D.|919-684-3786|devon.noonan@duke.edu|
22319950|NCT04912245|Wake Forest University Health Sciences|Tele Voice|336.716.8028|jgabbard@wakehealth.edu|
22319951|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319952|NCT03945591|NYU Langone Health|Ahmad Al-Homsi|6465017621|Samer.Al-Homsi@nyulangone.org|
22319953|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22319954|NCT00210184|Institut Bergonie|Pr Marianne Fonck|+33556333333||
22319955|NCT03198520|Solvay® Dental 360|Tim Shary Compliance and Product Specialist|770-772-8665|Tim.shary@solvay.com|
22319956|NCT01338415|Actelion Pharmaceuticals Ltd|Principal Clinical Scientist||ClinicalTrialDisclosure@its.jnj.com|
22319957|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22319958|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319959|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22258620|NCT03220230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258621|NCT04229303|Zambon SpA|Arnd Mueller, MD|+39 02 665241|clinicaltrials@zambongroup.com|
22258622|NCT03572933|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22258623|NCT01764854|Ardelyx, Inc.|Chief Development Officer|617 513-4929|drosenbaum@ardelyx.com|
22258624|NCT03273387|Department of Cardiology and Vascular Medicine, Universitas Indonesia|dr. Bambang WIdyantoro, FIHA, PhD|+628128164299|bambang_ui@yahoo.com|
22258625|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258626|NCT04480463|SamChunDang Pharm. Co. Ltd.|Byung Jhip Ha, Director of Bio Research Center|+82-31-869-7327|scd411clinical@scd.co.kr|
22258627|NCT02231710|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
22258628|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org|
22258629|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu|
22258630|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu|
22258631|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
22258632|NCT00981253|Duke Health|Dr. James A. Blumenthal|919-684-3828|james.blumenthal@duke.edu|
22258633|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22258634|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22304556|NCT03749460|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
22304557|NCT04343222|University of Wisconsin - Madison|Maxwell Wingelaar|231-233-6051|mwingelaar@uwhealth.org|
22319960|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22304558|NCT03077620|Washington University in St Louis School of Medicine|Dr. Brendan Lucey|314-747-3805|luceyb@wustl.edu|
22289299|NCT03036215|HealthPartners Institute|James Fricton, DDS, Senior Research Investigator|6126191678|james.r.fricton@healthpartners.com|
22304559|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22258635|NCT00730522|Catalyst Pharmaceuticals|Chief Scientific Officer|305-420-3200|gingenito@catalystpharma.com|
22258636|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258637|NCT01977092|Public Health Institute|Elizabeth Mahoney|(818)310-2684|lmahoney@bhrsca.org|
22258638|NCT01958281|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22258639|NCT03038113|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258640|NCT02784106|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22273935|NCT01198002|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289300|NCT04075812|The Ohio State University|Marcia Bockbrader MD PhD|6142933127|bockbrader.13@osu.edu|
22258641|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
22258642|NCT02927847|Duke University|Maggie M Sweitzer, PhD|919-668-0094|maggie.sweitzer@duke.edu|
22258643|NCT00553540|Cleveland Clinic Florida|Dr. David Westerdahl|954-659-5422|westerd@ccf.org|5422
22258644|NCT02004704|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22258645|NCT01755858|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22258646|NCT03882047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258647|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com|
22258648|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22273936|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl|
22273937|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com|
22289301|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
22289302|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22289303|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com|
22289304|NCT03983317|TheraNova, LLC|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
22289305|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22319961|NCT00233363|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22319962|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689|leejiyoung0616@gmail.com|667
22319963|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu|
22319964|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
22319965|NCT05215262|Mount Sinai Adolescent Health Center|Sarah Wood, MD, MSHP|(332) 227-4355|Sarah.Wood@mountsinai.org|
22319966|NCT00866749|The University of Texas MD Anderson Cancer Center|Michael Andreeff MD./Professor|713-792-7261|mandreeff@mdanderson.org|
22289306|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158||
22319967|NCT04880447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304560|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu|
22319968|NCT01353508|Novartis|Study Director|862-778-1873||
22304561|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304562|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22319969|NCT00646906|University of Pennsylvania|Tilo Grosser, MD|215-573-7600|tilo@pennmedicine.upenn.edu|
22319970|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk|
22319971|NCT02137122|University of Florida|Adam Woods|352-294-5842|ajwoods@phhp.ufl.edu|
22319972|NCT04534491|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22319973|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
22319974|NCT03331861|Columbia University Irving Medical Center|Barry Fine, MD|212-305-5755|bmf2002@cumc.columbia.edu|
22258600|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258601|NCT04049552|UT Health San Antonio|Dean L Kellogg Jr.|210-617-5311|kelloggd@uthscsa.edu|
22258602|NCT03360656|CoolTech|Director of Clinical Operations|2036856352|channan@cooltechcorp.com|
22258603|NCT00738920|University at Buffalo, SUNY|Dr. Jeffrey Lackner|716-898-5671|lackner@buffalo.edu|
22258604|NCT03821324|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22258605|NCT05113901|Rush University Medical Center|Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a D|3124322468|anne.debenedetti@rushortho.com|
22258606|NCT04147611|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
22258607|NCT01799213|Veterans Health Administration, West Haven, CT|Lisa G. Suter, MD|2039325711|lisa.suter@va.gov; lisa.suter@yale.edu|
22258608|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
22258609|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22258610|NCT04385199|Henry Ford Health System|Dr Geneva Tatem|313-916-2431|gtatem1@hfhs.org|
22258611|NCT02557672|Mayo Clinic|Gregory A. Nuttall, M.D.|(507) 255-3298|gnuttall@mayo.edu|
22258612|NCT03705169|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22319975|NCT02945150|Massachusetts General Hospital|Dr. Raymond Chung|617-724-7562|Chung.Raymond@mgh.harvard.edu|
22319976|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22319977|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319978|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319979|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu|
22319980|NCT02678416|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22319981|NCT01848353|University of Oklahoma Health Sciences Center|Kevin Short, PhD, Associate Professor|(405) 271-8001|kevin-short@ouhsc.edu|43094
22319982|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com|
22319983|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200|h0711@ms13.hinet.net|3846
22319984|NCT02017379|Texas Tech University Health Sciences Center at El Paso|Research Compliance Officer|915-215-4814|jackie.roberts@ttuhsc.edu|
22319985|NCT01727765|University of Portsmouth|Dr Mitch Lomax|02392845297|mitch.lomax@port.ac.uk|
22319986|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr|
22319987|NCT02289352|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22319988|NCT03606980|Children's Hospital of the King's Daughters|Dana Reesman, PT, DPT|757-668-4894|dana.reesman@chkd.org|
22258649|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu|
22258650|NCT03124797|Masimo|Tala Harake||studies@masimo.com|
22258651|NCT03596918|AMC Statistical and Data Analysis Center|Dr. Jeannette Y. Lee|(501) 526-6712|jylee@uams.edu|
22258652|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628||
22258653|NCT00297479|UT MD Anderson Cancer Center|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
22273938|NCT03353792|Associate Professor of Medicine|Raimund Herzog, MD, MHS|(877) 925-3637|raimund.herzog@yale.edu|
22258654|NCT03263819|Vanderbilt University Medical Center|Dr.Cyndya A. Shibao|6159364584|cyndya.shibao@vumc.org|
22289307|NCT01717053|Duke University|Dr. Bridget Koontz|919-668-5213|bridget.koontz@duke.edu|
22289308|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300||
22258655|NCT03563027|Crescenz Veterans Affairs Medical Center|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
22258656|NCT00386724|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22258657|NCT00686920|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22258658|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258659|NCT02752256|University of Iowa Hospitals and Clinics|Brett Faine|319-384-6800|brett-faine@uiowa.edu|
22258660|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
22258661|NCT02087046|Abbott|Clinical Research Scientist|972-309-8000|mike.frassica@abbott.com|
22258662|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu|
22258663|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333||
22258664|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu|
22258665|NCT04726514|Berendo Scientific, LLC|Eric Kezirian|4152358706|eric.kezirian@gmail.com|
22289309|NCT04681352|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22258666|NCT02077192|Rigel Pharmaceuticals, Inc.|Director of Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
22258667|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu|
22258668|NCT01571635|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22258669|NCT02005354|Plymouth Hospitals NHS Trust|Dr David Tucker|01752 432595|david.tucker1@nhs.net|
22258670|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk|
22258671|NCT01201356|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22258672|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com|
22273939|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu|
22273940|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22273941|NCT02452047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273942|NCT02787499|Massachusetts General Hospital/Harvard Medical School|Mark Siedner|6177264686|msiedner@mgh.harvard.edu|
22289310|NCT04432727|Tactile Medical|Michelle Wetherby|612-230-4576|mwetherby@tactilemedical.com|
22289311|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu|
22273943|NCT02185417|Boston VAHCS|Dr. Sarah Leatherman|857-364-4201|sarah.leatherman@va.gov|
22273944|NCT02147613|Arizona State University - Downtown Phoenix Campus|Siddhartha S. Angadi, PhD., FACSM|6028272254|sangadi@asu.edu|
22273945|NCT03131167|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22289312|NCT00792571|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
22304563|NCT01385280|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22304564|NCT01207908|Cincinnati Children's Hospital Medical Center|Dr. Meilan Rutter|513-636-4744|meilan.rutter@cchmc.org|
22258673|NCT02173301|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
22258674|NCT01585831|University of Colorado Denver|Nicole Tartaglia, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22258675|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu|
22258676|NCT04079842|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22258677|NCT02904200|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22258678|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu|
22258679|NCT04444752|Head of Clinical Operations US|Malinda Longphre|+15105203361|Mlongphre@connectpharm.com|
22258680|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22258681|NCT00433381|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22258682|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
22258683|NCT04582266|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22304565|NCT01893320|The University of Texas MD Anderson Cancer Center|Naval Daver MD, Associate Professor|713-794-4392|NDaver@mdanderson.org|
22304566|NCT05406791|University of Illinois at Chicago|Colleen Stiles-Shields, PhD|312-413-1128|ecss@uic.edu|
22258684|NCT03015142|Philips|Rami Nachabe|+1-513-926-1486|rami.nachabe@philips.com|
22258685|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22258686|NCT01466686|Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Medicine|Kristin Redmond, MD|4109556980|kjanson3@jhmi.edu|
22258687|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300|hhenney@acorda.com|5138
22258688|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22258689|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
22258690|NCT02449291|Acacia Pharma Ltd|Gabriel Fox|01-223919764|gabrielfox@acaciapharma.com|
22258691|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
22273946|NCT04553666|University of Rochester Medical Center|Dr. Nikesha Gilmore, Assistant Professor|1-585-275-1275|nikesha_gilmore@urmc.rochester.edu|
22273947|NCT05439421|Wake Forest University Health Sciences|Erin L. Sutfin, PhD|336.713.5282|esutfin@wakehealth.edu|
22273948|NCT01167569|Rutgers RWJMS|Alan Spotnitz, MD|732-235-9806|spotnitz@rwjms.rutgers.edu|
22273949|NCT03843372|Sleep Center, Chang Gung Memorial Hospital, Keelung, Taiwan|Dr. Chung-Chieh Yu|886+22432-9292|terminatorchieh@yahoo.com.tw|2658
22258692|NCT02462421|University of Maryland School of Medicine|Dr. Simeon Taylor (Professor of Medicine)|410-706-6439|staylor2@som.umaryland.edu|
22258693|NCT02891200|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
22258694|NCT01339910|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22258695|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu|
22258696|NCT00810732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258697|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22258698|NCT05117099|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
22258699|NCT01155583|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Jason Valent|+1 216-445-7238|VALENTJ3@ccf.org|
22258700|NCT05085613|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|301-712-8357|cweiger2@jhmi.edu|
22258701|NCT01413399|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
22258702|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu|
22258703|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258704|NCT00602030|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
22258705|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu|
22258706|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22258707|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410||
22258708|NCT01534975|Los Angeles Biomedical Research Institute|Matthew Budoff|3102224107|mbudoff@labiomed.org|310
22258709|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590||
22258710|NCT02151461|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
22258711|NCT02168270|University of Nebraska Medical Center|Dr. Nicole Shonka|402-559-5166|nshonka@unmc.edu|
22258712|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu|
22258713|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com|
22258714|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu|
22258715|NCT02191579|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22258716|NCT02862535|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22258717|NCT02280356|Memorial Sloan Kettering Cancer Center|Dr. Marisa Kollmeier, MD|212-639-3952|KollmeiM@mskcc.org|
22258718|NCT02611206|University of Minnesota|Kathryn Cullen|612-625-3403|rega0026@umn.edu|
22273950|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu|
22258719|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
22258720|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
22258721|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258722|NCT02524106|University of California San Francisco|Priscilla Hsue, PI|415-206-8257|priscilla.hsue@ucsf.edu|
22258723|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22258724|NCT03493698|Spring Bank Pharmaceuticals, Inc.|Don Mitchell, Vice President, Operations & Corporate Development|(508) 689-9737|dmitchell@springbankpharm.com|
22258725|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22304567|NCT01789203|Methodist Hospital|Samir Patel|267-808-0577|spatel2@houstonmethodist.org|
22258726|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273951|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu|
22258727|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com|
22258728|NCT03443869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258729|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22258730|NCT00299728|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22258731|NCT03654209|Indiana University|Clinical Research Coordinator|317-948-0724|rlahr@iu.edu|
22258732|NCT04071626|University Hospitals Cleveland Medical Center|Dr. Trevor Jenkins|(216)844-1229|Trevor.Jenkins@UHhospitals.org|
22258733|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258734|NCT02033876|Mayo Clinic|Dr. Michael Camilleri|507-284-2687|camilleri.michael@mayo.edu|
22273952|NCT00597818|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22273953|NCT04176939|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273954|NCT02157519|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
22273955|NCT01656395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273956|NCT03871153|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22273957|NCT02318849|University of Hawaii|Cheryl Albright, PhD, Prinicipal Investigator|808-956-9716|cherylal@hawaii.edu|
22273958|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
22273959|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22289313|NCT02600819|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22289314|NCT02631590|Moffitt Cancer Center|Richard Kim, MD, Principal Investigator|813-745-1277|Richard.Kim@moffitt.org|
22289315|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289316|NCT04857320|LANGFORD RESEARCH INSTITUTE|Managing Director|5614296429|KKirby@Langfordresearch.org|150
22289317|NCT03790696|Washington University School of Medicine|Jennifer Harper / Clinical Research Coordinator|314-286-2697|jenniferharper@wustl.edu|
22289318|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu|
22258735|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
22258736|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
22258737|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22258738|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258739|NCT04582409|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22258740|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22258741|NCT02046369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22273960|NCT03225170|NHGRI|Dr. Lori Erby|301-443-2635|lori.erby@nih.gov|
22273961|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
22273962|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org|
22273963|NCT03107208|"University of Colorado Denver | Anschutz"|Rebecca Ohman, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22273964|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273965|NCT01168921|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
22273966|NCT00971867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials.@bms.com|
22273967|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com|
22273968|NCT00905424|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22273969|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu|
22273970|NCT00379899|Amgen Inc.|Study Director|866-572-6436||
22273971|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com|
22273972|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22273973|NCT01156805|Hospital General de Granollers|Dr. Esteve Llargues|938425000|ellargues@fhag.es|2675
22273974|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com|
22273975|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu|
22273976|NCT04786691|University of Arkansas for Medical Sciences|Jessica Yeh|(501) 686-6114|jyeh@uams.edu|
22273977|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22273978|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu|
22273979|NCT04001803|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273980|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22273981|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu|
22273982|NCT02541409|Johns Hopkins University Bloomberg School of Public Health|Dr. Shruti Mehta|443-287-3837|smehta@jhu.edu|
22273983|NCT00520039|West Virginia School of Osteopathic Medicine|Dr. Karen Steele|(304)667-4255|ksteele@osteo.wvsom.edu|
22273984|NCT02472262|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manarymj@wustl.edu|
22273985|NCT02329327|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22273986|NCT03560869|University of Delaware|William B. Farquhar|302-831-6178|wbf@udel.edu|
22273987|NCT02493517|Ipsen|Medical Director, Oncology||clinical.trials@ipsen.com|
22273988|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com|
22273989|NCT03718429|University of Florida|Dominick Angiolillo, MD,PhD|904-244-3378|dominick.angiolillo@jax.ufl.edu|
22273990|NCT05404711|University of Pittsburgh School of Medicine|Mary Ellen Vajravelu, MD,MSHP|412-692-6533|vajravelume@upmc.edu|
22273991|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org|
22273992|NCT02346877|Amgen Inc.|Study Director|866-572-6436||
22273993|NCT01545141|Roswell Park Cancer Institute|Kris Attwood|716-845-2300|Kristopher.attwood@roswellpark.org|
22273994|NCT02049983|Levita Magnetics International Corp|Alberto Rodriguez-Navarro, MD|6506557625|info@levita.com|
22273995|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu|
22273996|NCT02481050|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22273997|NCT04159714|Mayo Clinic|Dr. Robert Hyde|507-255-4137|Hyde.Robert1@mayo.edu|
22273998|NCT01548599|University of California, San Francisco|Sheri Weiser|(415) 314-0665|Sheri.Weiser@ucsf.edu|
22273999|NCT02188160|Kala Pharmaceuticals, Inc.|VP, Clinical Development|781-996-5252|results002@kalarx.com|
22274000|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100||
22274001|NCT02674503|Birmingham VA - GRECC Director; Professor at UAB|Dr. Alayne Markland|205-558-7067|alayne.markland@va.gov|
22274002|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu|
22274003|NCT03638128|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22274004|NCT03163446|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
22289319|NCT04896086|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22289320|NCT02249832|Feinstein Institutes for Medical Research|Bruce T. Volpe, MD|(516) 562-3384|bvolpe1@northwell.edu|
22289321|NCT03848182|Montefiore Medical Center; 1695 Eastchester Road|Dr. Jennifer Chuy, Co-Investigator, Assistant Professor (Oncology)|718-405-8505|jchuy@montefiore.org|
22289322|NCT03291964|Oregon Health and Science university|David Sheridan Assistant Prof|5034941691|sheridda@ohsu.edu|
22289323|NCT02936648|Department of Veterans Affairs, CHOIR and BridgeQUERI|Vera Yakovchenko|781.687.3374|vera.yakovchenko@va.gov|
22289324|NCT02914301|George Washington University School of Medicine & Health Sciences- Department of Emergency Medicine|Dr. Andrew C. Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
22289325|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22289326|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org|
22289327|NCT00481091|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22289328|NCT04294680|Campbell Clinic|Principal Investigator|9017595522|tbrolin@campbellclinic.com|
22289329|NCT03010488|New York State Psychiatric Institute|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
22289330|NCT02078960|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22304568|NCT02403674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22289331|NCT03565328|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
22289332|NCT04605991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289333|NCT01743859|University of Colorado|Dr. Daniel Pollyea||daniel.pollyea@ucdenver.edu|
22289334|NCT01056302|Department of Veterans Affairs|Dr. Rebeka Silva|415-221-4810|rebeka.silva@va.gov|22784
22289335|NCT04881942|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22289336|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140|jrichard@mcmaster.ca|27811
22289337|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn|
22289338|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22289339|NCT03328208|Hypnalgesics, LLC|Elvira V. Lang, MD, CEO|6177349087|drevlang@comforttalk.com|
22289340|NCT00947193|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22289341|NCT04364984|Medical Practice Prof D.Ivanov|Prof Dmytro Ivanov|0504448788|drivanovdd@gmail.com|+38
22289342|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu|
22289343|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
22289344|NCT01652534|Northwestern University|Dr. Tanya Simuni|312-503-2970|tsimuni@nm.org|
22289345|NCT02722304|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22289346|NCT03656380|University of North Carolina at Chapel Hill|Lindsay Cortright, MA|919-445-4911|lindsay_cortright@med.unc.edu|
22289347|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289348|NCT02920242|Novartis Pharmaceuticals|Study Director|862-778-1873|novartisemail@novartis.com|
22289349|NCT03021343|Khalidi Hospital & Medical Center|Dr. Ramzi Tabbalat|00962795535522|ramzi_md@yahoo.com|
22289350|NCT02028208|Allerdern (dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|7208
22289351|NCT04995419|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
22289352|NCT02948088|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22289353|NCT00634101|Johnson & Johnson Vision|DIR CLINICAL NEW PRODUCT DEVELOPMENT|1-800-843-2020|KMoody1@its.jnj.com|
22289354|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org|
22304569|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22319989|NCT01196533|Morristowm Memorial Hospital|Dr. Frank Smart|973-214-2601|frank.smart@atlantichealth.org|
22274005|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org|
22274006|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org|
22274007|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274008|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
22274009|NCT01094288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22289355|NCT03776812|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22274010|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22274011|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org|
22274012|NCT04152200|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22274013|NCT04969289|Columbia University|Lauren Chernick, MD, MSc|212-305-9825|lc2243@columbia.edu|
22289356|NCT02879812|Emory University|Dr. Rachel Patzer|404-727-6047|rpatzer@emory.edu|
22289357|NCT04693767|Penumbra Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
22289358|NCT05522153|Virtua Medical Group, PA|Sean McMillan|908-812-7542|smcmillan@virtua.org|
22289359|NCT02082119|Humanitas Cancer Center|Dr. Marta Scorsetti|+390282248524|marta.scorsetti@hunimed.eu|
22289360|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
22289361|NCT01368562|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22289362|NCT04216264|Duke University|Dr. Charles Wood|919-620-4772|charles.wood@duke.edu|
22289363|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu|
22289364|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22289365|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu|
22289366|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi|
22289367|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611|janis.daly@neurology.ufl.edu|5223
22289368|NCT02867384|Dana-Farber Cancer Institute|Corey Cutler, MD|6176323470|corey_cutler@dfci.harvard.edu|
22289369|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu|
22289370|NCT02105961|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22289371|NCT01976091|Sarepta Therapeutics, Inc|Medical Information|1-800-690-2003|SareptAlly@sarepta.com|
22289372|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22289373|NCT02566369|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
22289374|NCT01092117|Endologix|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
22289375|NCT04380519|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
22289376|NCT04173494|Sierra Oncology LLC - a GSK company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22289377|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com|
22289378|NCT02283827|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22289379|NCT00526071|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22289380|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov|
22289381|NCT03898557|University of Pennsylvania|Alison M. Buttenheim, PhD MBA|215.573.5314|abutt@nursing.upenn.edu|
22289382|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu|
22304570|NCT03019458|Sunshine Care Foundation|Dr. Patrick Acuna|+63 947 959-1851|patrick_acuna@hotmail.com|
22304571|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu|
22304572|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304573|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com|
22304574|NCT02271594|BD|Dr. Ken Strauss|32475380454|kenneth.strauss@bd.com|
22304575|NCT02521259|Seoul National University Bundang Hospital|Dr. YEA JI LEE|+821086307701|ladydaisy82@naver.com|
22274014|NCT02699996|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
22304576|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu|
22304577|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
22304578|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu|
22274015|NCT04069715|KGK Science Inc.|Malkanthi Evans (Ph.D.), Chief Scientific officer|5194389374|mevans@kgkscience.com|239
22274016|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org|
22274017|NCT02486692|Ralph H. Johnson VAMC|Anouk Grubaugh|843-532-6672|grubaugh@musc.edu|
22274018|NCT02063672|Lutonix|Heidi Ronhovde|7634632900|heidi.ronhovde@crbard.com|
22274019|NCT00313729|UCSF Neuro-Oncology|Susan Chang MD|415-353-2966|Susan.Chang@ucsf.edu|
22274020|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22274021|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com|
22274022|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937||
22274023|NCT01657617|University of Kentucky|Ronald McGarry|859 323 6486|rcmcga2@email.uky.edu|
22274024|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca|
22274025|NCT02169505|UT MD Anderson Cancer Center|Ahmed,Sairah,MD / Stem Cell Transplantation|713-792-7734|sahmed3@mdanderson.org|
22274026|NCT01248455|National Cancer Institute|Dr. Dickran Kazandijian|301-480-0532|kazandjiandg@mail.nih.gov|
22274027|NCT02735980|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274028|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com|
22274029|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com|
22274030|NCT01783743|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22274031|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22274032|NCT02654639|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
22289383|NCT05300763|Johnson & Johnson Vision Care, Inc.|John R. Buch, Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
22289384|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289385|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org|
22289386|NCT01409811|City of Hope|Carolyn Behrendt, Ph.D.|626-218-1148|cbehrendt@coh.org|
22289387|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289388|NCT03051178|University of Florida|Dr. Aysegul Gunduz|3522736877|agunduz@bme.ufl.edu|
22289389|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22304579|NCT03835546|Fundació Lluita contra la SIDA|Jose A. Muñoz-Moreno|+34 93 497 84 14|jmunoz@flsida.org|
22289390|NCT03111628|JohnsHopkinsU|Sarbjit S. Saini|410550-2129|ssaini@jhmi.edu|
22304580|NCT02435901|Northwell Health System Cohen Children's Medical Center of NY|Indira Sahdev, MD|7184703460|isahdev@northwell.edu|
22289391|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22289392|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22289393|NCT04476797|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
22289394|NCT02395081|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-8264|jr33@partners.org|
22289395|NCT01583296|Ferkauf Graduate School of Psychology, Yeshiva University|Jonathan M. Feldman|6465924508|jonathan.feldman@einstein.yu.edu|
22289396|NCT01063283|Inova|Michael Maitland, MD, PhD|571-472-4724|Michael.Maitland@inova.org|
22304581|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22289397|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180|alejandro.interian@va.gov|4617
22304582|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu|
22304583|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com|
22304584|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com|
22304585|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com|
22274033|NCT04821063|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 6443 2575|m.caserini@italfarmacogroup.com|
22304586|NCT00180674|Imperial College London|Prof Mark Thursz|+44 (0)20 3312 1903|m.thursz@imperial.ac.uk|
22274034|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22274035|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22274036|NCT05635045|Columbia University Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
22274037|NCT05044429|GWUniversity|Principal Investigator|202-823-4259|eheinz@mfa.gwu.edu|
22274038|NCT02937623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274039|NCT03675360|Tulane University School of Public Health and Tropical Medicine|Dr. Kirsten Dorans, Assistant Professor, Department of Epidemiology|15049880883|kdorans@tulane.edu|
22274040|NCT02533934|University of California San Francisco|Rodney Rogers|+14155951226|Rodney.Rogers@ucsf.edu|
22274041|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274042|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu|
22274043|NCT04396626|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274044|NCT02111174|Johns Hopkins SKCCC|Thomas Smith, M.D.|410-955-2091|tsmit136@jhmi.edu|
22274045|NCT01657162|Radius Health, Inc.|Radius Head of Clinical Operations|(617) 551-4700||
22274046|NCT02600923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274047|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274048|NCT03758157|Wello, Inc.|Alan C. Heller|469-522-5200|allen.heller@welloinc.com|
22274049|NCT04157088|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22304587|NCT03302910|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
22304588|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu|
22304589|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov|
22304590|NCT02949518|Hospital for Special Surgery|Dr. Ellen Soffin|212-606-1206|soffine@hss.edu|
22304591|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com|
22304592|NCT03560141|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22304593|NCT02223689|Medline Industries, Inc.|Lori Rotolo|8476434640|lrotolo@medline.com|
22304594|NCT05677867|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274050|NCT02421419|Penn State Milton S. Hershey Medical Center|Kenneth Taylor, M.D.|(717) 531-5638|ktaylor2@pennstatehealth.psu.edu|
22274051|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu|
22274052|NCT01747499|Washington University School of Medicine|Mark A. Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
22274053|NCT01676701|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274054|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
22304595|NCT01521949|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
22274055|NCT05117112|UAMS|David Church|5015265769|dchurch@uams.edu|
22304596|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com|
22304597|NCT02851511|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
22274056|NCT02227784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274057|NCT04058028|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22289398|NCT02504216|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22289399|NCT00223080|Department of Disease Control, Ministry of Public Health|Dr. Supachai Rerks-Ngarm|66-2-590-3006|supachai@health.moph.go.th|
22304598|NCT02988375|Henry Ford Health|Dr. Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
22289400|NCT02598583|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22289401|NCT03237286|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22289402|NCT03193593|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
22289403|NCT02792829|Eisai Inc.|Eisai Medical Research Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22289404|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22289405|NCT04473469|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
22289406|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22289407|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22289408|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100|john_bellone@brown.edu|6168
22274058|NCT01705977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22289409|NCT03523988|University of Washington|Lead Investigator|4254668544|akeith@uw.edu|
22304599|NCT04004208|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22304600|NCT01902901|Kaiser Permanente Center for Health Research|Katrina Goddard|503-335-6353|katrina.ab.goddard@kpchr.org|
22304601|NCT01528124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274059|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411|Santanu.Datta@va.gov|7580
22274060|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu|
22274061|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu|
22274062|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22274063|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu|
22304602|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22304603|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu|
22304604|NCT02118714|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22304605|NCT01328587|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
22304606|NCT02071095|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22304607|NCT03023332|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
22274064|NCT05607576|Cincinnati Children's Hospital Medical Center|Deborah Elder; Associate Professor|5136364744|Deborah.Elder@cchmc.org|
22304608|NCT02412761|The University of Texas Health Science Center at Houston|Joyce P. Samuel, MD, MS|(713) 500-5670|Joyce.P.Samuel@uth.tmc.edu|
22304609|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289410|NCT03433040|University of South Florida|Wendy Duncan, QA/QI Research Compliance Manager|8139747454|wduncan3@usf.edu|
22289411|NCT02527421|Prosoft Clinical|Robert Babilon President|484 320 2068|b.babilon@prosoftclinical.com|
22289412|NCT04200352|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22289413|NCT02541604|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22289414|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
22304610|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org|
22304611|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611|ntester@phhp.ufl.edu|7507
22304612|NCT06096181|Cedars-Sinai Medical Center|Glenn Tan, MD|310-423-5841|Glenn.Tan@cshs.org|
22304613|NCT02240680|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304614|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl|
22304615|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300||
22304616|NCT05968482|Amzell BV|Chief Executive Officer|+31235560460|amzell-disclosure@amzell.com|
22304617|NCT02559817|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22304618|NCT02687919|University of Iowa|Amanda Irish||amanda.k.irish@gmail.com|
22304619|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu|
22304620|NCT01653847|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
22304621|NCT02554513|VASLCHCS|Dr. Shannon Mauszycki|801-582-1565|shannon.mauszycki@utah.edu|
22304622|NCT02303574|AstraZeneca|Bengt Larsson|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22304623|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu|
22304624|NCT05590910|UT Health San Antonio-Faculty; Texas Woman's University-Student|Jorgie Ann Contreras|2107235319|contrerasj6@uthscsa.edu|
22304625|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu|
22274065|NCT00870467|Abbott|Global Medical Services|800-633-9110||
22274066|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22274067|NCT03430856|Biocon Research limited|Dr. Subramanian L|080-28082808|subramanian.l101@biocon.com|1323
22304626|NCT04796935|Elevate Clinical Consulting|Keri Urwin|919-247-8845|kurwin@elevateclinicalconsulting.com|
22319990|NCT04458103|Massachusetts General Hospital|David D'Alessandro|617-726-8841|DADALESSANDRO@mgh.harvard.edu|
22289415|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289416|NCT02373683|Case Western Reserve University|Katherine Slain|12168443310|katherine.slain@uhhospitals.org|
22304627|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
22319991|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
22274068|NCT00962078|Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany|Dr. Rainer Gloeckl|+49 8652 931630|rgloeckl@schoen-klinik.de|
22274069|NCT02357459|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22274070|NCT03246347|Wake Forest|Danielle Boselli|2017903385|danielle.boselli@atriumhealth.edu|
22274071|NCT00916578|UT MD Anderson Cancer Center|Woodward,Wendy,M.D., PH.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
22274072|NCT04350593|Saint Luke's Hospital of Kansas City|DARE-19 Global Project Manager|816-932-9858|DARE-19@saint-lukes.org|
22274073|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
22274074|NCT02611882|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|2264
22274075|NCT01389232|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22274076|NCT01317940|Children's Hospital Los Angeles|Dr. Etan Orgel|3233612672|eorgel@chla.usc.edu|
22274077|NCT04678284|Hennepin Healthcare|Dr. Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22274078|NCT02371616|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274079|NCT02576899|VISN 1 MIRECC|Megan M. Kelly, Ph.D.|781-687-3317|Megan.Kelly1@va.gov|
22274080|NCT01921517|University of Pennsylvania Perelman School of Medicine|Felix W. Wehrli, Principal Investigator|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
22289417|NCT05220436|South London & Maudsley NHS Foundation Trust|Dr Emilie Bourke|07702686322|emilie.bourke@slam.nhs.uk|
22289418|NCT01737502|Mayo Clinic in Florida|Yanyan Lou, MD|904-953-0315|lou.yanyan@mayo.edu|
22289419|NCT05307965|John Radcliffe Hospital|Giovanni Luigi De Maria|+441865228364|GiovanniLuigi.DeMaria@ouh.nhs.uk|
22289420|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
22289421|NCT00912197|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22289422|NCT00756613|VA|Tamara Paine|7082028387|tamara.paine@va.gov|25785
22304628|NCT03782727|Cardiff and Vale University Health Board|Dr Rachel Abbott|02920743181|rachel.abbott@wales.nhs.uk|
22304629|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304630|NCT00051311|National Cancer Institute|Dr. Ronald Gress|240-760-6167|Ronald_Gress@nih.gov|
22304631|NCT04170023|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22304632|NCT04990440|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22304633|NCT03712098|SUNY Buffalo|Rebecca Ashare|7168296273|rlashare@buffalo.edu|
22304634|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|6060
22304635|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304636|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
22304637|NCT02537444|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22304638|NCT03836664|University of Kansas Medical Center|Dr Dipika Aggarwal, Clinical Assistant Professor|9139459926|daggarwal@kumc.edu|
22304639|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com|
22304640|NCT03825393|Tokat State Hospital|Dr.Sevil Okan|5308211797|doctorsevil@yahoo.com|
22304641|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu|
22304642|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu|
22304643|NCT03278028|Aclaris Therapeutics|Executive Director, Clinical Operations|+1(484) 329-2144|jschnyder@aclaristx.com|
22304644|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov|
22304645|NCT03890120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22304646|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
22304647|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu|
22274081|NCT03205150|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22274082|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590||
22274083|NCT03028142|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
22274084|NCT00001322|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22274085|NCT00116688|Amgen Inc.|Study Director|866-572-6436||
22274086|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22274087|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
22274088|NCT03593200|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22274089|NCT01298700|Allergan, Inc|Michael Robinson, MD|714-246-4500|clinicaltrials@allergan.com|
22274090|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu|
22274091|NCT04006145|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
22274092|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu|
22274093|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
22274094|NCT02812186|Stony Brook University|Dr. Ruchir Gupta|917-443-1263|gupta2005@yahoo.com|
22274095|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012||
22274096|NCT02169440|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22274097|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22274098|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22274099|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22274100|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22274101|NCT01162343|Vanderbilt University Medical Center|Dr. Jin Han, MD|615-936-0253|jin.h.han@vanderbilt.edu|
22304648|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu|
22304649|NCT02478359|Kaiser Permanente|Huong Q2 Nguyen, Research Scientist|626-564-3935|huong.q2.nguyen@kp.org|
22304650|NCT00905060|University of California, Davis|Dr. Orin Bloch, MD||obloch@ucdavis.edu|
22304651|NCT03293485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304652|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com|
22304653|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
22304654|NCT03633903|Laureate Institute for Brain Research|Namik Kirlic, PhD|918-502-5747|nkirlic@laureateinstitute.org|
22304655|NCT02987829|Tracon Pharmaceuticals Inc.|Charles Theuer, MD PhD|8585500780|ctheuer@traconpharma.com|
22304656|NCT03379233|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22304657|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304658|NCT02531438|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
22304659|NCT01813422|Amgen Inc.|Study Director|866-572-6436||
22304660|NCT02874846|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22304661|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22319992|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu|
22319993|NCT03945357|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
22274102|NCT02771275|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22274103|NCT05556148|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22274104|NCT03191799|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22274105|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22274106|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
22274107|NCT02631941|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
22274108|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu|
22274109|NCT03506048|Emory University|Dr. Taofeek Owonikoko|412-647-9975|owonikokotk2@upmc.edu|
22274110|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274111|NCT04073303|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22289423|NCT03304249|University of Kansas Medical Center|Megan Olalde|913-588-2042|molalde@kumc.edu|
22289424|NCT03801044|Sisli Hamidiye Etfal Training and Research Hospital|Mustafa Sevinc|00905309291239|musevinc@hotmail.com|
22289425|NCT04901715|University of North Carolina at Chapel Hill|Kelli Sullivan, MPH|919-962-9786|kelli_sullivan@med.unc.edu|
22289426|NCT05036733|University of Michigan|Yvonne J Huang MD|734-936-5047|yvjhuang@med.umich.edu|
22289427|NCT02285439|Children's Hospital Los Angeles|Dr. Nathan Robison|323.361.2121|mek162@chla.usc.edu|
22304662|NCT01845636|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22304663|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu|
22304664|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
22304665|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu|
22304666|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com|
22304667|NCT04992442|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22304668|NCT00162942|Otsuka America Pharmaceutical, Inc|Tao Wang|240-683-3213|tao.wang@otsuka-us.com|
22304669|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304670|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu|
22304671|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22304672|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22304673|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22304674|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za|
22304675|NCT02953548|GW Research Ltd|Medical Enquires|+44 01223 238170; 1877886281|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22304676|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu|
22304677|NCT03610633|Medical University of South Carolina|Laura Lohnes|843-792-7709|lohnes@musc.edu|
22304678|NCT03453385|Medical University of South Carolina (MUSC)|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
22304679|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
22304680|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com|
22304681|NCT02929108|Washington University School of Medicine|Debra Oliver, Ph.D.|314-747-5361|oliverd@wustl.edu|
22304682|NCT01027871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304683|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304684|NCT05489224|CELLTRION, Inc.|Head of Clinical Planning Department 3|+82-32-850-4167|jeehye.suh@celltrion.com|
22304685|NCT04887285|Northwestern University|Steven P. Cohen|312-695-2500|steven.cohen@northwestern.edu|
22304686|NCT04640571|University of Maryland, Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
22319994|NCT01561495|AbramsonCC Radiation Oncolocy|Susan Prendergast, RN|215-662-4267|susan.prendergast@pennmedicine.upenn.edu|
22319995|NCT04666350|PATH|Chris F Ockenhouse, MD, PhD|+1 (202) 716-5849|cockenhouse@path.org|
22289428|NCT03390114|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
22274112|NCT01867008|Cochlear Americas|Clinical Project Manager|303-264-2340|knix@cochlear.com|
22274113|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com|
22274114|NCT03143101|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
22274115|NCT05227118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274116|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121|fwchaie@vghks.gov.tw|8233
22274117|NCT03727841|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
22274118|NCT03126786|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22289429|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com|
22289430|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu|
22289431|NCT02609113|Wake Forest Baptist Health|Vanessa Baute, MD|336-716-8140|vbaute@wakehealth.edu|
22304687|NCT06268301|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22304688|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu|
22304689|NCT00832780|University of New Mexico Comprehensive Cancer Center|Ben Liem, MD|505-272-0086|BLiem@salud.unm.edu|
22304690|NCT05705167|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22304691|NCT05768945|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22304692|NCT03658811|Toyos Clinic|Dillon O'Brien|6153274015|dobrien@toyosclinic.com|6
22304693|NCT04209790|Geisinger|Regulatory Project Manager|570-214-2462|khassanzadeh@geisinger.edu|
22304694|NCT04060680|Medtronic|Drew Turk, Clinical Research Specialist|7633580375|drew.turk@medtronic.com|
22304695|NCT04482855|University of Pennsylvania School of Nursing|Dr. Jie Deng|2155734729|jiedeng@nursing.upenn.edu|
22304696|NCT02044419|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
22304697|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22304698|NCT03173248|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33155726000|scientificinformation@servier.com|
22304699|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304700|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov|
22304701|NCT03015740|M D Anderson Cancer Center|Dr. Pavlos Msaouel|713-563-4585|PMsaouel@mdanderson.org|
22304702|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22304703|NCT05927480|HealthPartners Institute|Sandy Vang, Director of Research Administration at Regions Hospital|1-651-254-6961|sandy.x.vang@healthpartners.com|
22304704|NCT05194735|Alaunos Therapeutics, Inc.|Jaymes Holland|6502732627|jholland@alaunos.com|
22304705|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com|
22304706|NCT02624778|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274119|NCT01601496|Getinge Group|Elizabeth Bulger|603 880 1433 ext 5368|Elizabeth.Bulger@getinge.com|
22274120|NCT03243305|Evofem, Inc.|Chief Medical Officer|858 550 1900|kculwell@evofem.com|
22274121|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu|
22274122|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu|
22274123|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22274124|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
22274125|NCT04552132|Saint Louis University|Dr. David Bingham|208-851-0618|davidbingham1623@gmail.com|
22274126|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
22274127|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22274128|NCT04865029|Tulane University|Franck Mauvais-Jarvis|504-259-1139|fmauvais@tulane.edu|
22274129|NCT04907214|Vanderbilt University Medical Center|Dr. Mona Mashayekhi|615-936-1760|mona.mashayekhi@vumc.org|
22274130|NCT05616013|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274131|NCT05067972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274132|NCT02981914|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|karrisont@nrgoncology.org|
22274133|NCT04391842|Medical Pain Consultants|Dr. Ralph Ortiz|(607) 844-9979|drortizmpc@gmail.com|
22274134|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22274135|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
22274136|NCT01691378|Rocky Mountain MIRECC|Lisa Brenner|720-723-6488|lisa.brenner@va.gov|
22274137|NCT02951312|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22274138|NCT04877990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22274139|NCT04235504|Medtronic Diabetes|Javier Castaneda|+31 433566566|javier.castaneda@medtronic.com|
22274140|NCT01514383|Medline Industries, Inc|Ed Drower, Clinical Project Director|847-643-3874|edrower@medline.com|
22274141|NCT04888494|Northwestern University|A. Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
22289432|NCT00147069|Imperial College London|Professor Louise Donnelly|+44 (0)20 7594 7895|l.donnelly@imperial.ac.uk|
22289433|NCT04458090|University of Colorado Anschutz Medical Campus|Dr. Channing Tate, Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
22289434|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22319996|NCT02374021|Brigham and Women's Hospital|Dr. Daniel Solomon|617-732-5356|dsolomon@bwh.harvard.edu|
22289435|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu|
22319997|NCT00732251|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
22274142|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
22274143|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772||
22304707|NCT05541497|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
22274144|NCT04940156|Oxford University Hospitals NHS Trust|Dr Richard Varini|01865220256|richard.varini@ouh.nhs.uk|
22304708|NCT04091672|AVITA Medical|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
22304709|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22304710|NCT05296629|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
22274145|NCT02864069|UCSD|Dr. Amy Jak|8586423742|ajak@ucsd.edu|
22274146|NCT03652818|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
22304711|NCT01796665|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22304712|NCT02600429|clinical operation|Director of clinical operation||swkang@regentreellc.com|
22304713|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu|
22304714|NCT02491411|SKCCC at JHU|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
22304715|NCT01955382|NIAID/NIH|Dr. Rick M. Fairhurst, Principal Investigator|301-761-5077|rfairhurst@niaid.nih.gov|
22304716|NCT04610684|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
22304717|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org|
22304718|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304719|NCT04672460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquires@pfizer.com|
22304720|NCT03575962|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22304721|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012||
22304722|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22304723|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304724|NCT04940390|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
22304725|NCT02949271|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
22304726|NCT05458102|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22304727|NCT05642000|University of California San Diego|Rebecca Fielding-Miller|8583810603|rfieldingmiller@health.ucsd.edu|
22304728|NCT05336123|Brown University|Dr. Lauren Weinstock|401-455-6304|Lauren_Weinstock@brown.edu|
22304729|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu|
22304730|NCT02373813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22304731|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22304732|NCT02357758|London Health Sciences Centre|Dr. Sumit Dave|519.685.8439|Sumit.Dave@lhsc.on.ca|
22304733|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22304734|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
22319998|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com|
22304735|NCT02703532|Emory University|Sarah Blanton, PT, DPT, NCS, FNAP|404-712-2222|sblanto@emory.edu|
22319999|NCT01007032|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304736|NCT03738241|Baylor College of Medicine|Hana El Sahly, MD, FIDSA|713-798-2058|hana.elsahly@bcm.edu|
22320000|NCT02285920|University of Pennsylvania|Laura M. Dember, MD|215-573-5264|ldember@pennmedicine.upenn.edu|
22320001|NCT01825057|Yale School of Medicine|Steve Martino|203-932-5711|steve.martino@yale.edu|7418
22320002|NCT01688596|Penn State Milton S. Hershey Medical Center|Dr. Matthew F. Davies, M.D.|7175310003|mdavies@hmc.psu.edu|283519
22320003|NCT02716675|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22320004|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu|
22320005|NCT02015442|Imperial College London|Prof Gary Frost|020 7594 0959|g.frost@imperial.ac.uk|
22320006|NCT01172197|NHS Tayside|Dr G McLeod|+44 1382 7974440848|g.a.mcleod@dundee.ac.uk|
22320007|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org|
22320008|NCT01380730|Amgen Inc.|Study Director|866-572-6436||
22320009|NCT05686928|Galderma|Thu Q. Nguyen, PhD|8179615495|thu.nguyen@galderma.com|
22320010|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320011|NCT01994382|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22274147|NCT04789304|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22274148|NCT02067858|University of Pittsburgh|Karen Holeva|412-623-1275|holevakd@upmc.edu|
22274149|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com|
22274150|NCT01959113|University of California, San Diego|Director of Clinical Trials Unit|858-657-8390|dermstudies@ucsd.edu|
22274151|NCT05310877|The Miriam Hospital|Emily Gathright, PhD|401-793-8271|Emily.Gathright@lifespan.org|
22304737|NCT03169361|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320012|NCT04667377|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320013|NCT03861936|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22320014|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548||
22304738|NCT02263885|InSightec|Nadir Alikacem, PhD|214-630-2000|nadira@insightec.com|
22304739|NCT04446975|UNMC|Dr. Karsten Bartels|(402) 559-4081|anesthesiology.research@unmc.edu|
22304740|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22320015|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org|
22304741|NCT00278564|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
22320016|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu|
22320017|NCT01670539|West Virginia University|Georgia L Narsavage|304-293-6729|gnarsavage@hsc.wvu.edu|
22320018|NCT04353596|Medizinische Universität Innsbruck/ Medical University Innsbruck|Prof. Dr. Axel Bauer|0043 512 504 25621|Axel.Bauer@i-med.ac.at|
22320019|NCT02783443|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
22320020|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22320021|NCT05418673|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22320022|NCT02665052|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Susan S. Conroy|(410) 637-3213|susan.conroy@va.gov|
22274152|NCT01868646|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22274153|NCT01831427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22274154|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov|
22274155|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22274156|NCT01854697|AbbVie|Global Medical Information|800-633-9110||
22274157|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
22320023|NCT02234284|University of California San Francisco|Dr. David Thom|415-206-2278|David.Thom@UCSF.edu|
22320024|NCT03923556|University of Colorado School of Medicine|Dr. Ana Fernandez-Bustamante|720-848-6744|ana.fernandez-bustamante@cuanschutz.edu|
22320025|NCT01986920|Aclaris Therapeutics|Christopher Powala, Chief Operating Officer|484-324-7933|cpowala@aclaristx.com|
22320026|NCT01690897|University of British Columbia|Dr. Lori Brotto|604 875 4111|Lori.Brotto@vch.ca|68901
22320027|NCT03023059|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
22274158|NCT01171898|Aragon Pharmaceuticals, Inc.|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22320028|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com|
22320029|NCT00873366|Mayo Clinic|Dr. Matthew P. Goetz|507-284-2511|goetz.matthew@mayo.edu|
22320030|NCT01576172|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
22320031|NCT03496324|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22274159|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
22274160|NCT03769649|InMode|Maria Shusterman|855.411.2639|marias@inmodemd.com|
22274161|NCT03322293|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
22274162|NCT01421498|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22274163|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22274164|NCT03059914|Loma Linda University Health|Sarat Ummethala|909 558 4983|saratdoc@yahoo.com|
22274165|NCT01607658|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
22274166|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
22274167|NCT03933449|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274168|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
22274169|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu|
22274170|NCT02858401|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22274171|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22274172|NCT01307956|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
22274173|NCT01418339|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22274174|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22274175|NCT02869789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22274176|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22320032|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22304742|NCT02783482|Green Cross Corporation|Clinical Project Manager|82 31 260 9472|sungsil.lee@gccorp.com|
22320033|NCT01614821|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22304743|NCT01341080|Rush University Medical Center|Deborah A Hall MD PhD|312-563-2900|Deborah_A_Hall@rush.edu|
22320034|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22320035|NCT01033552|University of Minnesota, Masonic Cancer Center|Dr. Jakub Tolar|(612) 626-5654|tolar003@umn.edu|
22320036|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com|
22320037|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424|el_heber@live.concordia.ca|2199
22320038|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
22320039|NCT04366050|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
22320040|NCT02613884|Kate Farms|Vanessa Millovich|3522634409|vannanole@gmail.com|
22320041|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu|
22320042|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22320043|NCT02844920|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
22320044|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320045|NCT00528580|University of Chicago|Millie Maleckar|773-702-1472|mmalecka@bsd.uchicago.edu|
22274177|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22274178|NCT01529606|UTHSC|Professor|901-448-2369|lhong2@uthsc.edu|
22274179|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22274180|NCT04742673|Vanderbilt University Medical Center|Christopher Hughes|615-322-5000|christopher.hughes@vumc.org|
22274181|NCT02233530|University of Ibadan, Ibadan, Nigeria|Dr Adesola Ogunniyi|+2348038094173|aogunniyi892@gmail.com|
22258742|NCT03120520|Bausch Health Americas, Inc|Clinical Operations Director|908-927-0873|lindsey.mathew@bauschhealth.com|
22320046|NCT03024970|CooperVision, Inc.|Myhanh Nguyen, OD, FAAO|925-730-6716|mnguyen@coopervision.com|
22274182|NCT04074265|University of California, Los Angeles|Rachel Thompson|8472200324|rathompson@mednet.ucla.edu|
22274183|NCT02577640|Ohio State University|Casey McClurkin|614-293-6255|casey.mclurkin@osumc.edu|
22274184|NCT04585919|Harvard TH Chan School of Public Health|James Daly|617-384-8915|jdaly@hsph.harvard.edu|
22274185|NCT03519009|Johns Hopkins University|Professor|4436176051|ksilverm@jhmi.edu|
22274186|NCT06290089|Scandinavian Biopharma Holding AB / Etvax|Head of Clinical Development|004684705600|info@scandinavianbiopharma.se|
22274187|NCT05209880|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|6175257771|kouchi@bwh.harvard.edu|
22320047|NCT02518997|Stanford University|Melissa Scala|650-723-5711|mscala@stanford.edu|
22274188|NCT03834493|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289436|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885|efung@mail.cho.org|4939
22289437|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22304744|NCT00480441|Treatment Research Center|Dr. Marina Goldman, Principle Study Investigator|215 222 3200|marinag@mail.med.upenn.edu|104
22289438|NCT03093662|Brooke Army Medical Center|Dr. Derek Brown|2109160808|Derek.J.Brown1.mil@mail.mil|
22304745|NCT01417000|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
22304746|NCT01657682|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22274189|NCT04003103|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289439|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22304747|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com|
22274190|NCT05017272|Q2i LLC Telephone: 646-660-2151 Email: sjenkins@q2i-group.com|Steve Jenkins|646-660-2151|sjenkins@q2i-group.com|
22304748|NCT02284464|Hospital Regional Universitario de Málaga|Dr. Domingo Hernandez|951291174|domingohernandez@gmail.com|
22289440|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com|
22304749|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
22304750|NCT04653051|Zimmer Biomet|Georgia Tsapara|+41 79 94 54936|georgia.tsapara@zimmerbiomet.com|
22304751|NCT03748771|University of California San Diego|Dr. Rakesh Bhattacharjee|858-966-5846|rlbhattacharjee@ucsd.edu|
22304752|NCT01318811|Vanderbilt_Univeristy MC|Dr. Thomas Golper|615-322-5914|thomas.golper@vumc.org|
22304753|NCT00811187|Montefiore Medical Center|Research Program Administrator|718-405-8526|fheitor@montefiore.org|
22304754|NCT02825043|University of Oklahoma Health Sciences Center Dept. of Medicine|Clinical Trials Manager|(405)271-6651|research@ouhsc.edu|
22304755|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu|
22320048|NCT00131469|OHSU|Eric Orwoll|15034940225|orwoll@ohsu.edu|
22320049|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22258743|NCT03927781|University of Missouri|Dr Katie Murray|573-884-8768|murraykat@health.missouri.edu|
22258744|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
22274191|NCT05796791|Medical University of South Carolina|Emily Amador|916-279-6481|emmcamador@gmail.com|
22274192|NCT03437694|University of North Texas Health Science Center|Crystal Hodge|8177350131|crystal.hodge@unthsc.edu|
22274193|NCT04144322|University of Michigan|Dr. Tae-Ju Oh|7346473320|taejuoh@umich.edu|
22289441|NCT03387111|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22289442|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu|
22274194|NCT02277028|now at Northwestern University, Department of PM&R|Mary Ellen Stoykov|312-503-3106|mstoykov@sralab.org|
22289443|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22289444|NCT00727441|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22274195|NCT02718911|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274196|NCT04817332|University of Dundee, UK|Professor James D Chalmers|01382660111|jchalmers@dundee.ac.uk|
22289445|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de|
22320050|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu|
22320051|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu|
22320052|NCT02361944|Vanderbilt University|Frederic T. BIllings IV|6159368487|frederic.t.billings@vumc.org|
22274197|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org|
22289446|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289447|NCT02810444|Biotest AG|Dr. med. Andrea Wartenbrg-Demand|+49 6103 801|andrea.wartenberg-demand@biotest.com|0
22304756|NCT00083174|Canadian Cancer Trials Group|Senior Biostatistician|613-533-6430|dtu@ctg.queensu.ca|
22304757|NCT00329303|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22289448|NCT04643158|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22320053|NCT03123250|PROCEPT BioRobotics Corporation|Angela Lee|650-232-7215|a.lee@procept-biorobotics.com|
22320054|NCT01772004|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22320055|NCT03591354|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22320056|NCT01688856|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
22320057|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
22320058|NCT02032550|University of Pennsylvania|Ravishankar Jayadevappa|215-898-3798|jravi@pennmedicine.upenn.edu|
22258745|NCT04345471|Mochida Pharmaceutical Company, Ltd.|Director of Clinical Research Department|+81332256331|clinical.trials.contact@mochida.co.jp|
22320059|NCT05144113|Spaulding Rehabilitation Hospital|Dr. J.Andrew Taylor|616-758-5503|jandrew_taylor@hms.harvard.edu|
22258746|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220|dfehlings@hollandbloorview.ca|3586
22320060|NCT03422679|Cellestia Biotech AG|Maria Bobadilla, Chief Development Officer|+41616332957|maria.bobadilla@cellestia.com|
22320061|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258747|NCT01710306|Department of Veteran's Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
22320062|NCT02431897|University of Texas Southwestern Medical Center Dallas|Dr. David D. Rahn|12146486430|david.rahn@utsouthwestern.edu|
22320063|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br|
22320064|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22320065|NCT01499953|University Hospital Dresden, Centre for Vascular Medicine|PD Dr. med. Jan Beyer-Westendorf|+49-351-4582899|Jan.Beyer@uniklinikum-dresden.de|
22320066|NCT03007979|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22320067|NCT03734016|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22320068|NCT02715466|B. Braun Melsungen AG|Study Manager|00495661/71|studies@bbraun.com|0
22320069|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320070|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320071|NCT02273726|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|064study@fibrogen.com|
22320072|NCT01979835|principal investigator|Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
22320073|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org|
22320074|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
22320075|NCT01744353|Brown Oncology Research Group|Helena Lau|4018633000|helena_lau@brown.edu|
22320076|NCT03697720|NorthShore University HealthSystem|Kevin Hellman, Research Associate Professor|847-570-2622|khellman@northshore.org|
22320077|NCT05907213|University of Pittsburgh, UPMC Department of Anesthesiology & Perioperative Medicine|Dr. Katherine Grace Lim, Chief of the Division of OB & Women's Anesthesiology|412-641-1778|limkg2@upmc.edu|
22320078|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590||
22320079|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
22320080|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com|
22320081|NCT02414399|University of Washington|Dr. Patricia Pavlinac|206 616-8326|ppav@uw.edu|
22320082|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com|
22320083|NCT03688880|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22320084|NCT01183143|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22320085|NCT05745675|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22320086|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258748|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258749|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22258750|NCT01759537|NYU College of Dentistry|Ismael Khouly|212-998-9800|iek3@nyu.edu|
22274198|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org|
22274199|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu|
22274200|NCT01435759|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22274201|NCT00427908|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274202|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274203|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22274204|NCT02115607|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
22274205|NCT03377270|Northwestern University|Dr. Bonnie Martin-Harris|847-467-0407|bonnie.martinharris@northwestern.edu|
22274206|NCT04863872|Kaiser Permanente Washington Health Research Institute|James Ralston, MD, MPH|206-287-2076|James.D.Ralston@kp.org|
22274207|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274208|NCT02155699|Northwestern University|Dr. Vijay A Mittal|847-467-3880|vijay.mittal@northwestern.edu|
22274209|NCT05547386|Mayo Clinic|Geoffrey Johnson, M.D., Ph.D.|507-284-4104|johnson.geoffrey@mayo.edu|
22274210|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu|
22274211|NCT00952315|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
22274212|NCT02573259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274213|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org|
22274214|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274215|NCT01815502|MUSC|Dr. Andrew M Atz|843-876-1698|atzam@musc.edu|
22274216|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258751|NCT01015612|Medtronic|Dr Deama Amr (PhD)|+61 2 9857 9157|deama.amr@medtronic.com|
22289449|NCT04329806|Vanderbilt University Medical Center|Dr. Alfredo Gamboa|615 875 1003|alfredo.gamboa@vumc.org|
22289450|NCT02197078|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289451|NCT00622440|University of California, San Francisco|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu|
22258752|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu|
22289452|NCT02223377|Department of Anesthesia, McMaster University, Canada|Dr. Thuvaraha Vanniyasingam|(905) 525-9140|tvanniya@stjosham.on.ca|21736
22289453|NCT04726969|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22304758|NCT02444143|University of Illinois at Chicago|Dr. Patricia West-Thielke|312-996-5695|pwest@uic.edu|
22304759|NCT03582137|University of Colorado|Maureen Leehey, MD|3037248288|maureen.leehey@cuanschutz.edu|
22258753|NCT02248285|BioFire Diagnostics|Director of Clinical Affairs|8017366354|kevin.bourzac@biofiredx.com|
22304760|NCT04582045|HealthPartners Institute|Linda M. Loes|952-967-7862|linda.m.loes@healthpartners.com|
22258754|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
22304761|NCT03704298|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22258755|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22258756|NCT04136626|Massachusetts General Hospital|Dr. Sabine Wilhelm, Chief of Psychology|617-724-6146|swilhelm@mgh.harvard.edu|
22258757|NCT03974152|Eastern Virginia Medical School|Dr. Paul Harrell|757-446-6047|harrelpt@evms.edu|
22258758|NCT02049359|Campbell University|Jennifer Smith|2522439800|jsmith@cfhcnc.org|224
22304762|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com|
22258759|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300||
22258760|NCT01975090|Novate Medical|Gordon Crowley|+353 91 750 030|gordon.crowley@novate.ie|
22258761|NCT02410252|Partners Connected Health Innovations|Amanda Centi|6177242158|acenti@partners.org|
22258762|NCT00820235|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22258763|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22258764|NCT03877055|Memorial Sloan Kettering Cancer Center|Dr. Gilles Salles, MD, PhD|646-608-4153|SallesG@mskcc.org|
22258765|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000|charlene.hafer-macko@va.gov|5451
22258766|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu|
22258767|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu|
22258768|NCT01411267|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22258769|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br|
22258770|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org|
22258771|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
22258772|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com|
22258773|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22258774|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
22258775|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
22258776|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22258777|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de|
22258778|NCT03222141|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
22258779|NCT03421652|Karmanos Cancer Institute|Nitin Vaishampayan, MD|313-576-9624|nvaisham@med.wayne.edu|
22258780|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
22304763|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258781|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307||
22258782|NCT00827359|Beth Israel Deaconess Medical Center|Rupal Bhatt|6177352060|rbhatt@bidmc.harvard.edu|
22258783|NCT02436135|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22258784|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
22258785|NCT02345486|Vanderbilt University Medical Center|Dr. Matthew Semler|615-322-3412|matthew.w.semler@vumc.org|
22258786|NCT03412019|Tufts Medical Center|Dan Drzymalski, MD|617 636 4526|ddrzymalski@tuftsmedicalcenter.org|
22258787|NCT03979677|Vanderbilt University Medical Center|Richard A. Roberts, Ph.D.|6153227384|richard.a.roberts@vanderbilt.edu|
22258788|NCT00415532|Amgen Inc.|Study Director|866-572-6436||
22258789|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22258790|NCT01952574|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22258791|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu|
22258792|NCT01107535|Abbott|Global Medical Services|1-800-633-9110||
22258793|NCT03567057|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22304764|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com|
22304765|NCT04794062|Good Samaritan Hospital, TriHealth|Leonid Khokhlov, MD|5138858974|leonkhokhlov@gmail.com|
22304766|NCT04515797|Massachusetts General Hospital|Dr. Raymond Chung|6177247562|Chung.Raymond@mgh.harvard.edu|
22304767|NCT02820051|UANL|Dr. Julio E. González-Aguirre|82204444|jeglza111@gmail.com|229
22258794|NCT01271933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274217|NCT05254340|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
22258795|NCT01620983|Virginia Commonwealth University|Dr. Daniel L. Riddle|804-828-0234|dlriddle@vcu.edu|
22274218|NCT01817075|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22258796|NCT02777931|Aevi Genomic Medicine|Garry A Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22258797|NCT03156270|Dept. of Otolaryngology-Head and Neck Surgery, The Ohio State University|Kai Zhao, PhD.|614-293-3857|zhao.1949@osu.edu|
22258798|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22258799|NCT00362401|Aarhus University Hospital, Skejby|Dr. Thais A. Pedersen, primary investigator|+45 8949 5484|thais.a.pedersen@ki.au.dk|
22258800|NCT01783730|AbbVie|Global Medical Services|800-633-9110||
22258801|NCT01841359|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173092635|MaryElizabeth.Patti@joslin.harvard.edu|
22258802|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu|
22258803|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu|
22258804|NCT03764059|Peking University Hospital of Stomatology|Xiaoyan Wang|010-82195525|wangxiaoyanpx@163.com|
22258805|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu|
22258806|NCT01752920|Basilea Pharmaceutica International Ltd.|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22304768|NCT02774213|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
22304769|NCT04883346|Section on Growth and Obesity, NICHD, NIH|Jack A. Yanovski, MD, PhD|301-496-0858|yanovskj@mail.nih.gov|
22304770|NCT01670500|DFCI|Project Manager|617-632-2257|CTOPM@dfci.harvard.edu|
22304771|NCT04955626|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
22304772|NCT03473756|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22304773|NCT03714022|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22304774|NCT05121675|Perelman School of Medicine|Dr. Heather Nuske|2153495537|Heather.Nuske@Pennmedicine.upenn.edu|
22304775|NCT03864133|Wake Forest University Health Sciences|Keith Walter, MD|336-716-3937|kwalter@wakehealth.edu|
22320087|NCT04042740|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22304776|NCT02668432|University of Texas Health San Antonio|Bethany Kalich, PharmD|210-883-1177|kalich@uiwtx.edu|
22304777|NCT02487446|Novartis Pharmaceuticals|Study Director|862-778-1873||
22320088|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320089|NCT04024228|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22320090|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600|clemens.vonschacky@med.uni-muenchen.de|2165
22320091|NCT04968041|Florida State University|Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
22304778|NCT02234310|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22304779|NCT03289455|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
22304780|NCT04951479|UPMC|Anish Ghodadra, MD|4126470104|ghodadraa@upmc.edu|
22304781|NCT03706690|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22304782|NCT05617040|Barinthus Biotherapeutics|Chief Medical Officer|+44 1865 818808|enquiries@barinthusbio.com|
22320092|NCT04490395|Duke University|Jennifer Plumb Vilardaga, PhD|919-668-6123|jennifer.plumb.vilardaga@duke.edu|
22320093|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22320094|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22320095|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
22320096|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
22320097|NCT01861028|Conformis|Director of Clinical and Technical Research|781-345-9103|sumesh.zingde@conformis.com|
22320098|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu|
22320099|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
22320100|NCT02807480|Laureate Institute for Brain Research|Robin Aupperle|918-502-5744|raupperle@laureateinstitute.org|
22320101|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org|
22320102|NCT02369848|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
22320103|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320104|NCT00257725|New York State Psychiatric Institute|Laurence Greenhill, MD|212-543-5340|GREENHIL@nyspi.columbia.edu|
22320105|NCT01858532|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22320106|NCT00514514|Novartis|Study Director|862-778-8300||
22320107|NCT02829307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320108|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th|
22258807|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22258808|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu|
22274219|NCT04157517|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320109|NCT01021956|STEBA Biotech|Bertrand Gaillac International Project Leader|+33 9 74 19 79 05|b.gaillac@stebabiotech.com|
22320110|NCT02081534|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22320111|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org|
22320112|NCT03947983|The University of Texas Austin|Kavita Radhakrishnan|5124717936|kradhakrishnan@mail.nur.utexas.edu|
22274220|NCT03574974|Yale University|Ilan Harpaz-Rotem Professor|203-937-4760|ilan.harpaz-rotem@yale.edu|
22274221|NCT06236113|North Memorial Health Robbinsdale Hospital|Michaela A West, MD, PhD|763-581-3704|Michaela.West@NorthMemorial.com|
22289454|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22320113|NCT05506956|Johns Hopkins University|Kristen Murray, Program Manager|410-614-6707|kmeckel2@jhmi.edu|
22289455|NCT06026124|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
22320114|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk|
22320115|NCT01841749|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22320116|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com|
22320117|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320118|NCT04746833|VA Connecticut Healthcare System|Dr. Brent A. Moore|2034352243|brent.moore@yale.edu|
22320119|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267||
22320120|NCT02357134|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22320121|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com|
22320122|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org|
22320123|NCT03593850|Universidad del Rosario|Dr. Juan Sebastian Martin Saavedra|2672200532|juans.martin@urosario.edu.co|
22320124|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22320125|NCT04130633|Johns Hopkins University School of Medicine|C. Austin Zamarripa, PhD|410-550-6969|czamarr2@jh.edu|
22320126|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22320127|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300|david.aron@va.gov|5702
22320128|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov|
22320129|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320130|NCT01161043|Medtronic Diabetes|Suiying Huang|8185763319|suiying.huang@medtronic.com|
22320131|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu|
22320132|NCT03496220|Angulus|Dr. Perry Dubin|‪(917) 426-5911‬|perry@angulus.us|
22320133|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22320134|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov|
22320135|NCT04754802|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
22320136|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320137|NCT00324753|Center for Health Equity Research and Promotion (VAPHS)|Maria K. Mor|(412) 360-2240|maria.mor@va.gov|
22320138|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320139|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com|
22320140|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu|
22320141|NCT02463071|AstraZeneca|Torbjorn Lundstrom, MD, PhD|+46 31 706 4100|torbjorn.lundstrom@astrazeneca.com|
22320142|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22320143|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com|
22320144|NCT04029961|Medical College of Wisconsin|John LaDisa|414-288-6739|jladisa@mcw.edu|
22320145|NCT03086265|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
22320146|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826|mespelan@wakehealth.edu|336
22320147|NCT04310085|Medicines for Malaria Venture|Dr Stephan Chalon|+41 22 555 0379|chalons@mmv.org|
22320148|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100|tluhl2@uky.edu|80858
22320149|NCT03184077|Virginia Commonwealth University|Lindsay Morrell, MD|410-823-1120|lmorrellmcv@gmail.com|
22320150|NCT04136184|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22320151|NCT03318978|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
22320152|NCT02322125|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
22320153|NCT03427047|Medacta USA|Rena Mandino, Director, Clinical Research|352-359-3581|rmandino@medacta.us.com|
22320154|NCT04096274|Boise State University|Dr. Nathaniel Williams|2084263145|natewilliams@boisestate.edu|
22320155|NCT05030454|Washington University School of Medicine|Pamela Samson, M.D., MPHS|314-747-1786|psamson@wustl.edu|
22320156|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
22258809|NCT00771901|Washington University School of Medicine in Saint Louis, Missouri|Samuel Klein, M.D.|314-362-8708|sklein@wustl.edu|
22258810|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in|
22258811|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258812|NCT01855126|Rensselaer Polytechnic Institute|Mariana Figueiro|(518)687-7142|figuem@rpi.edu|
22258813|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com|
22258814|NCT01298596|University of Washington|Dr. Michael H. Chung|‭(206) 302-8361‬|mhchung@uw.edu|
22258815|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22258816|NCT03740100|MD Anderson Cancer Center|Dr. Faye Johnson|7137922121|fmjohns@mdanderson.org|
22274222|NCT01900847|University of Arizona|Jaiva Larsen|5039396612|jlarsen@aemrc.arizona.edu|
22320157|NCT05092919|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
22320158|NCT01490684|King Abdulaziz Medical City|Dr Hasan Al-Dorzi|966535888632|aldorzih@yahoo.com|
22274223|NCT01395810|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22258817|NCT02340156|SynerGene Therapeutics, Inc.|Senior Consultant|301-706-1509|clinicaltrial@synergeneus.com|
22258818|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
22258819|NCT00254397|University of Texas MD Anderson Cancer Center|Patrick Hwu, MD / Professor, Melanoma Medical Oncology|713-792-2921|phwu@mdanderson.org|
22258820|NCT01386879|University of Missouri Columbia|Boris Mraovic|573-882-2568|mraovicb@health.missouri.edu|
22258821|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22258822|NCT04578548|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
22258823|NCT01956279|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
22258824|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com|
22258825|NCT02224456|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258826|NCT01241461|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22258827|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu|
22258828|NCT02247479|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
22258829|NCT03740698|Imperial College London|Prof Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
22258830|NCT02625766|University of Maryland Medical Center|Research Administrator|4103289579|NO'Hara@som.umaryland.edu|
22258831|NCT01467063|Nemours Children's Health System|Dominique Darmaun|904-697-3674|Ddarmaun@nemours.org|
22258832|NCT02802514|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258833|NCT01045499|Columbia University|Jeffrey Zitsman, MD|212-305-8862|jlz2@cumc.columbia.edu|
22258834|NCT05216978|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭617-525-7472‬|hermioni_amonoo@dfci.harvard.edu|
22258835|NCT02429869|University of California, San Francisco|Rodney Rogers|415-514-6454|Rodney.Rogers@ucsf.edu|
22258836|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
22258837|NCT03467412|Follicum AB|CEO Jan Alenfall|+46 (0)70 931 51 15|jan.alenfall@follicum.com|
22258838|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov|
22258839|NCT00557882|MedStar Washington Hospital Center|Andrew Sokol, MD|2028776526|andrew.i.sokol@medstar.net|
22258840|NCT03043274|University of Kentucky|Dr. Khaled M. Ziada|8593236036|khaled.ziada@uky.edu|
22258841|NCT03433001|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22258842|NCT01299038|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
22258843|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
22258844|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22258845|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585|jill.bormann@va.gov|x2378
22258846|NCT04467697|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
22274224|NCT05814419|UCHealth|Gary J Luckasen, MD|970-624-1680|gary.luckasen@uchealth.org|
22274225|NCT00830219|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22258847|NCT03907280|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258848|NCT03843957|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
22274226|NCT01130272|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22258849|NCT04690413|NOWDiagnostics|Beth Cobb|479-966-4531|beth.cobb@nowdx.com|
22258850|NCT02637076|CAMH|Dr. Stephen Kish|416-535-8501|stephen.kish@utoronto.ca|36256
22258851|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu|
22258852|NCT03487796|Rhode Island Hospital|Larry K. Brown, MD|(401) 793-8808|lkbrown@lifespan.org|
22258853|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258854|NCT03581474|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
22258855|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258856|NCT02588573|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22258857|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22258858|NCT04604184|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258859|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu|
22258860|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu|
22258861|NCT03734237|USUHS|Timothy Burgess, MD, MPH|(301) 295-9792|timothy.burgess@usuhs.edu|
22258862|NCT02711956|Zenith Epigenetics Ltd|Zenith Study Team|(415) 470-5600|ZEN003694-002@zenithepigenetics.com|
22258863|NCT01844583|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22258864|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22258865|NCT03513497|University of North Carolina at Chapel Hill|Julie Marchesan, DDS, PhD|919-537-3853|julie_marchesan@unc.edu|
22258866|NCT01412541|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
22258867|NCT03294538|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22258868|NCT03295643|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
22258869|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov|
22258870|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488|andra.thomas@capsovision.com|117
22258871|NCT04394754|Yale University|Francis Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
22258872|NCT00718159|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258873|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274227|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22274228|NCT03041441|Duke University Dept of Radiology|Research Coordiantor|(919) 684-7732|christopher.vallanat@duke.edu|
22274229|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu|
22274230|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
22274231|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274232|NCT04773223|University Clinical Centre of Serbia|Petar Zlatanovic|+381644961020|petar91goldy@gmail.com|
22274233|NCT00896493|Stanford University Medical Center|Wen-Kai Weng, Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22274234|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274235|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com|
22258874|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar|
22258875|NCT02040766|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22289456|NCT03023813|Cleveland Clinic|Glen Taksler PhD|216-445-7499|taksleg@ccf.org|
22258876|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com|
22258877|NCT03944486|Imperial College London|Research Integrity Officer|+44 (0)20 7594 1872|e.magnusson@imperial.ac.uk|
22258878|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258879|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22274236|NCT04539964|SetPoint Medical|VP of Clinical Affairs|661.750.6140|info@setpointmedical.com|
22258880|NCT05085964|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
22258881|NCT01821625|UT Southwestern Medical Center at Dallas|William M Lee, MD|214 645 6111|william.lee@utsouthwestern.edu|
22274237|NCT01674725|AbbVie|Global Medical Information|800-633-9110||
22274238|NCT03102762|Cairo University|Dr. Hussein Ghanem, Directer of this clinical trial|01001176111|hmhghanem@gmail.com|
22274239|NCT02709746|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22274240|NCT03074695|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
22274241|NCT00902577|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
22274242|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu|
22274243|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22274244|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu|
22274245|NCT03836586|University of Florida|Dr. Ellen Terry|352-273-6441|elterry@ufl.edu|
22274246|NCT04456686|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274247|NCT02532036|University of Oxford|Professor Helen McShane|+44 (0)1865 617606|helen.mcshane@ndm.ox.ac.uk|
22289457|NCT03710083|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
22289458|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22289459|NCT02283762|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
22289460|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289461|NCT02416622|AGTC|Dr. Matt Feinsod|386-462-2204|mfeinsod@agtc.com|7202
22289462|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca|
22289463|NCT01594528|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
22289464|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu|
22289465|NCT02813577|Becton Dickinson|Anna Lovas|763-445-2385|anna.lovas@bd.com|
22289466|NCT01976741|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22289467|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289468|NCT00078897|University of Arizona|Dr. Elizabeth Jacobs|(520) 626-0341|jacobse@email.arizona.edu|
22289469|NCT01620216|OHSU|Dr. Stephen Spurgeon|5034948950|spurgeos@ohsu.edu|
22289470|NCT03865381|Verily Life Sciences|Head of Clinical Science|(650) 253-0000|info@verily.com|
22289471|NCT02622178|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22289472|NCT02873377|University of Miami|Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
22289473|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22289474|NCT04421027|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22289475|NCT06019611|Mayo Clinic|Dr. Kristin Zhao, Director of the Assistive and Restorative Technologies Laboratory|507-284-8942|zhao.kristin@mayo.edu|
22289476|NCT02219659|MemorialCare Long Beach|Division of Pulmonary and Critical Care|(562) 933-2000|mtanios@yahoo.com|
22289477|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22289478|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu|
22289479|NCT03892967|Mayo Clinic|Andrea L. Cheville, MD|507-284-1402|Cheville.Andrea@mayo.edu|
22289480|NCT04917757|University Hospital Würzburg|Prof Dr. Martin Fassnacht|4993120139021|fassnacht_m@ukw.de|
22289481|NCT05767749|Weill Cornell Medicine|Dr. Kira Minkis|(646) 962-3376|kim9036@med.cornell.edu|
22289482|NCT03568461|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22289483|NCT05603312|MeiraGTx, LLC|Program Manager|646-860-7982|patients@meiragtx.com|
22289484|NCT03387085|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22289485|NCT04540510|Nuvance Health (formerly Western Connecticut Health Network)|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
22289486|NCT02848729|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22289487|NCT03390101|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
22289488|NCT04838977|University of Utah|Heather Keenan|8015877567|heather.keenan@hsc.utah.edu|
22289489|NCT00353470|Albert Einstein College of Medicine|Barbara Milrod, M.D., PI|212-595-0806|bmilrod@montefiore.org|
22289490|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343||
22289491|NCT03583385|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22289492|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu|
22289493|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289494|NCT02934503|NYU Langone|Dr. Joshua Sabari|212-731-6363|Joshua.Sabari@nyulangone.org|
22289495|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289496|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289497|NCT04027608|University at Buffalo|Jennifer Temple, Principle Investigator|7168295593|jltemple@buffalo.edu|
22289498|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu|
22289499|NCT04248491|Beaumont Health|Director Urology Research|2485511488|bernadette.zwaans@Corewellhealth.org|
22289500|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22289501|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22289502|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com|
22289503|NCT02910505|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22289504|NCT02474069|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22289505|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289506|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121|sfsun.tw@yahoo.com.tw|4210
22289507|NCT01474018|Baylor Endocrine Center|Dr. Erin D. Roe|214-820-3466|edr@roemd.com|
22289508|NCT03801031|University of Iowa|David Bender, MD|319-356-2015|david-bender@uiowa.edu|
22289509|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22289510|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
22289511|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org|
22289512|NCT04625517|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
22289513|NCT02925416|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
22289514|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
22289515|NCT03962504|National Center for PTSD at VA Boston Healthcare System|Dr. Denise Sloan|857-364-6333|denise.sloan@va.gov|
22289516|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22289517|NCT02268175|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mary_taplin@dfci.harvard.edu|
22289518|NCT04080167|St. Jude Children's Research Hospital|Jane Hankins, MD|(901) 595-4974|jane.hankins@stjude.org|
22289519|NCT02100696|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22289520|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
22289521|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be|
22289522|NCT03566485|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22289523|NCT05110872|Fralin Biomedical Research Institute at Virginia Tech Carilion|Dr. Freitas-Lemos|540-526-2106|rflemos@vtc.vt.edu|
22289524|NCT04059159|Spinal Singularity|Derek Herrera|949-436-7974|dherrera@urodevmedical.com|
22320159|NCT02248259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289525|NCT04518358|Guiding Technologies Corp.|John Nosek|609-605-9273|john.nosek@guidingtechnologies.com|
22274248|NCT03722576|Mayo Clinic|Elizabeth J. Carey, M.D.|480-342-1094|Carey.Elizabeth@mayo.edu|
22274249|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu|
22274250|NCT02059239|Weill Cornell Medicine|Dr. Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
22274251|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net|
22274252|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org|
22274253|NCT02204917|Children's Hospital of Philadelphia|Dr. Kassa Darge, MD, PhD, Radiologist-in-Chief|267-425-7110|DARGE@email.chop.edu|
22274254|NCT02048722|Northwestern University|Mary Mulcahy, MD|312 695 4440|m-mulcahy@northwestern.edu|
22289526|NCT02797613|Memorial University|Peter Daley|7097250240|pkd336@mun.ca|
22274255|NCT01039467|Fuwai Hospital|Dr. Shu Zhang|861088398833|zsfuwai@vip.163.com|
22274256|NCT03575702|R-Pharm|Georgiy Sharvadze, Medical Advisor|0074959567937|sharvadze@rpharm.ru|1175
22289527|NCT03849118|Telix Pharmaceuticals (Innovations) Pty Ltd|Dr. Kavita Vadali, Sr. Clinical Project Manager|+1 919-924-8887|kavita.vadali@telixpharma.com|
22289528|NCT02282514|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22289529|NCT03043105|Peking Union Medical College Hospital|Dr. Jian Li|86-010-69155027|lijian@pumch.cn|
22289530|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu|
22289531|NCT01668589|Amgen Inc.|Study Director|866-572-6436||
22274257|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22274258|NCT02127658|Indiana University|Dr. Paul Musey|(317) 880-3900|pmusey@iu.edu|
22289532|NCT02954172|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
22274259|NCT05559905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289533|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000||
22289534|NCT02302339|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
22289535|NCT03564678|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
22304783|NCT02711826|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22304784|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com|
22304785|NCT02169219|Massachusetts General Hospital, Division of Rheumatology|Dr. John Stone|617-643-2140|adfernandes@mgh.harvard.edu|
22304786|NCT02886936|University of Pennsylvania|Jessica Kenia, Research Coordinator|215-893-2678|jessica.kenia@pennmedicine.upenn.edu|
22304787|NCT02507219|Laureate Institute for Brain Research|Dr. Martin Paulus|918-502-5120|mpaulus@laureateinstitute.org|
22304788|NCT04562779|Denver Health & Hospital Authority|Dr. Dale Terasaki|303-602-6922|dale.terasaki@dhha.org|
22304789|NCT02788656|Brigham and Women's Hospital|Akshay Desai|617-732-7046|adesai@bwh.harvard.edu|
22304790|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com|
22304791|NCT03929302|UT Southwestern Medical center|Namrata Das|2146082836|Namrata.Das@utsouthwestern.edu|
22304792|NCT03815916|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
22304793|NCT04454567|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
22304794|NCT03748264|Philips|Jeff Jasko|4125423651|Jeff.Jasko@philips.com|
22304795|NCT02757885|Emory University|Professor of Pediatrics, Dr. Suhag H. Parikh|4047853240|suhag.parikh@emory.edu|
22304796|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22289536|NCT04420325|UZ Leuven|Lennert Minten|+32496397568|lennert.minten@gmail.com|
22289537|NCT01827956|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22289538|NCT04393454|Albert Einstein College of Medicine|Dr. Chaoyuan Kuang|718-430-3516|chaoyuan.kuang@einsteinmed.edu|
22289539|NCT02752165|University of Rochester|Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22289540|NCT01120964|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
22289541|NCT01003769|Mayo Clinic|Asher Alban Chanan-Khan, M.D.|(716) 845-3221|chanan-khan.asher@mayo.edu|
22289542|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org|
22289543|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu|
22289544|NCT05064358|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22289545|NCT04022499|Denver Health and Hospital Authority|Rocio Pereira, Medical Director, Community Integrated Health Care|303-436-6000|rocio.pereira@dhha.org|
22289546|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu|
22289547|NCT04976192|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22304797|NCT02459964|UT MD Anderson Cancer Center|Sai-Ching J. Yeung, MD, Professor, Emergency Medicine|(713) 745-9911|syeung@mdanderson.org|
22304798|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318||
22304799|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
22304800|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com|
22289548|NCT02621151|NYU Langone Health|Minas Economides, MD|2127315413|minas.economides@nyulangone.org|
22320160|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
22304801|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
22320161|NCT01180478|CROES|J. de la Rosette, chairman CROES|+31 20 5666030|info@croesoffice.org|
22320162|NCT02709694|Hospital for Special Surgery|Dr. Lisa Mandl|(212) 774-2960|mandll@hss.edu|
22304802|NCT04170764|TriHealth|Dr. Emily Aldrich|513-463-4300|Emily_Aldrich@trihealth.com|
22289549|NCT04073225|Johns Hopkins University|Michelle Carlson|(410) 790-8205|mcarlso2@jhu.edu|
22289550|NCT05407064|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
22289551|NCT05186805|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22289552|NCT04238819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289553|NCT02529553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289554|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323-442-1478|athero@usc.edu|
22289555|NCT03760718|Oregon Health & Science University|Brandon Togioka, MD|503-494-4572|togioka@ohsu.edu|
22304803|NCT01598025|Memorial Sloan Kettering Cancer Center|Dr. Richard O'Reilly, MD|646-888-2157|oreillyr@mskcc.org|
22320163|NCT01979159|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@va.gov|1363
22289556|NCT03704389|Northwestern University|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
22304804|NCT04531540|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22304805|NCT02688621|University of Vermont|Doris Ogden|802-656-1960|doris.ogden@uvm.edu|
22320164|NCT03281668|University of North Carolina at Chapel Hill/Thurston Arthritis Research Center|Yvonne Golightly, PhD|919-966-0566|golight@email.unc.edu|
22289557|NCT00924027|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
22274260|NCT05276973|NRG Oncology|Helen Huang on behalf of Wei Deng, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
22289558|NCT04236141|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22289559|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com|
22289560|NCT05480111|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
22289561|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu|
22289562|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
22289563|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu|
22304806|NCT01501929|University of Texas Southwestern|Wanpen Vongpatanasin|2146482103|Wanpen.Vongpatanasin@UTSouthwestern.edu|
22320165|NCT01543152|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
22289564|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov|
22289565|NCT02160899|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22289566|NCT04129151|Dana-Farber Cancer Institute|David S Shulman, MD|617-632-6670|david_shulman@dfci.harvard.edu|
22304807|NCT02359838|Dana-Farber Cancer Institute|Gregory A. Abel|617-632-2304|gregory_abel@dfci.harvard.edu|
22289567|NCT04473235|Universidade Federal de Minas Gerais|Elisa de Paula França Resende|+55 31 3307 9417|elisa.resende@gbhi.org|
22289568|NCT02726542|Massachusetts General Hospital|Takara Stanley, MD|617-726-5312|tstanley@mgh.harvard.edu|
22289569|NCT01945710|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22289570|NCT02730195|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
22320166|NCT02114164|OhioHealth|Dr. Oscar Martinez|(614) 544-8104|oscar.martinez@ohiohealth.com|
22304808|NCT03239210|NYU Langone Health|Nicolette Recchia|845-398-6563|nicolette.recchia@nyulangone.org|
22304809|NCT01575860|Abramson Cancer Center of the University of Pennsylvania|Jakub Svoboda, MD. Study Principal Investigator|855-216-0098|PennCancerTrials@emergingmed.com|
22304810|NCT01996644|Washington University|Cheri Levinson|5023456483|cherialevinson@wustl.edu|
22304811|NCT04760444|University of Michigan School of Social Work|Dr. Jaclynn Hawkins|(734) 647-4072|jachawk@umich.edu|
22320167|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569|Clinical-Trials@grunenthal.com|3223
22304812|NCT05349864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304813|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22320168|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org|
22320169|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu|
22304814|NCT02223793|University of Oslo|Karianne Svendsen|+4795026445|karianne.svendsen@medisin.uio.no|
22304815|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com|
22304816|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
22304817|NCT02321540|UT MD Anderson Cancer Center|Dr. John V. Heymach, Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
22304818|NCT03606460|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22304819|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org|
22304820|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org|
22304821|NCT05142228|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
22304822|NCT04541186|89bio, Inc.|Entrigue Study Team|1-415-432-9270|Ct.gov_SHTG@89bio.com|
22304823|NCT01873287|Children's Hospital of Eastern Ontario|Dr. Roger Zemek|613-737-7600|rzemek@cheo.on.ca|
22320170|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu|
22320171|NCT03374995|Wake Forest University Health Sciences|Principal investigator|336-716-5440|kwinkfie@wakehealth.edu|
22320172|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu|
22320173|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au|
22320174|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22274261|NCT03180736|EMN|Sarah Lonergan, Trial lead|+44 7767565020|sarah.lonergan@emn.life|
22320175|NCT04013789|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22320176|NCT03319407|Mayo Clinic|Robert L. McClain, M.D.|904-956-1728|Mcclain.Robert@mayo.edu|
22320177|NCT01488279|Frist Clinic Endocrinology|Dr. Annis Marney|615-403-8398|annis.marney@hcahealthcare.com|
22320178|NCT00914927|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22320179|NCT04784897|Innovation Pharmaceuticals Inc.|Senior Vice President, Clinical Sciences|978-921-4125|info@ipharminc.com|
22320180|NCT01846728|University of Colorado Anschutz Medical Campus|Edward Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
22320181|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
22320182|NCT01490814|Medtronic|Ralf Meyer|+49215981490|ralf.meyer@medtronic.com|
22274262|NCT03258593|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
22274263|NCT06228703|Rush University|Jie Li|3125634643|Jie_Li@rush.edu|
22274264|NCT01447888|Allina Health|John Mrachek, MD|612-871-7639|John.Mrachek@allina.com|
22274265|NCT02036931|Zimmer Biomet|Oliver Marti|+41 79 576 31 98|oliver.marti1@zimmerbiomet.com|
22274266|NCT05457257|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22274267|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com|
22274268|NCT01062893|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-8278|ppan@wakehealth.edu|
22274269|NCT02131064|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22274270|NCT02554760|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22274271|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu|
22274272|NCT04458675|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
22320183|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22320184|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501|srikala.sridhar@uhn.ca|2662
22320185|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22320186|NCT01314963|Stanford Univeristy Medical Center|Craig Levin, PhD; Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine)|650-736-0449|cslevin@stanford.edu|
22274273|NCT01579513|Medical University of South Carolina|Eric Graham, MD|843-792-9570|grahamem@musc.edu|
22274274|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu|
22274275|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu|
22274276|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22274277|NCT04344301|Dartmouth College|Dr. Paul Barr|+1-603-653-0863|paul.j.barr@dartmouth.edu|
22320187|NCT03769246|Columbia University Medical Center|Dr. Anna-Christina Bevelaqua|(212) 342-0085|ab3302@cumc.columbia.edu|
22274278|NCT00072410|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22274279|NCT03160716|Q-Med AB|Reception|+46184749000|reception.seupp@galderma.com|
22320188|NCT00889226|CMC|Dr. Hoyoung Sohn|82-2-222-2222|abc@snu.ac.kr|3333
22320189|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22320190|NCT01921751|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22274280|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
22274281|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org|
22320191|NCT03962738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274282|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu|
22274283|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net|
22274284|NCT03311945|Hospital Clinic of Barcelona|Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
22320192|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262|hugosc@ohsu.edu|52338
22320193|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com|
22320194|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22320195|NCT02941926|Novartis Pharmaceuticals|Study director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22320196|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org|
22320197|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn|
22320198|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22320199|NCT03700320|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22320200|NCT04305275|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22320201|NCT00995475|University of Dundee|Professor Brian J Lipworth|+44 1382 383188|b.j.lipworth@dundee.ac.uk|
22320202|NCT00199836|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22320203|NCT03061175|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne, Associate Director, Population Science|732-235-6759|mannesl@cinj.rutgers.edu|
22320204|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
22320205|NCT01692691|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22320206|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov|
22320207|NCT02456662|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5367|sarah_betstadt@urmc.rochester.edu|
22274285|NCT03839394|Duke University|Nwora Lance Okeke, MD, MPH|919-684-2579|lance.okeke@duke.edu|
22274286|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com|
22320208|NCT00982007|Luitpold Pharmaceuticals, Inc.|Mark A. Falone|610-650-4200|mfalone@luitpold.com|
22320209|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
22320210|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22320211|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
22320212|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com|
22320213|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu|
22320214|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu|
22320215|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com|
22320216|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu|
22320217|NCT02811549|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
22320218|NCT05293743|The Hospital for Sick Children|Dr. Maryse Bouchard|4168137654|maryse.bouchard@sickkids.ca|224522
22320219|NCT01771055|University of Louisville|Dr. Jason Smith|502-852-5675|josmit19@louisville.edu|
22274287|NCT04000438|Dilafor AB|Gunvor Ekman-Ordeberg|+467060833111|gunvor.ekman-ordeberg@dilafor.com|
22274288|NCT00223665|University of Washington|Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
22274289|NCT00418028|GEICAM (Grupo Español de Investigación en Cancer de Mama)|The Oncologist 2015;20:1-2 http://www.theoncologist.com/ Scientific Director and CEO|+34916592870|geicam@geicam.org|
22274290|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com|
22274291|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net|
22274292|NCT04376515|University of California, Irvine|Dr. Dominic Ugarte|949-508-0135|dugarte@hs.uci.edu|
22274293|NCT04369833|Pusan national university hospital|Dr. Sang Soo Kim|+82-51-240-7837|drsskim7@gmail.com|
22274294|NCT06729177|University of Tennessee, Knoxville|Leala Holcomb|415-307-6410|lholcom5@utk.edu|
22274295|NCT04579380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274296|NCT04113694|Medtronic Diabetes|Emma Pham, MSHS (Clinical Study Manager)|818 576 4878|emma.pham@medtronic.com|
22274297|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22274298|NCT05630196|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22274299|NCT03438266|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22320220|NCT04391036|University of Pittsburgh Medical School|Dr. Leslie Meyn|412-641-4233|meynla@mwri.magee.edu|
22274300|NCT03973996|Ohio State University|Dr. Richard Bruno|8603358494|bruno.27@osu.edu|
22274301|NCT04070989|JnJ MedTech|Mary Panozzo|+15744049398|MPanozzo@its.jnj.com|
22274302|NCT06088784|HPI, Inc.|Sr. Director, Clinical Development Operations|301-738-3980|mary.bearkland@hanall.com|
22274303|NCT03635333|Yale University School of Medicine|Danielle Davis|2039747607|danielle.davis@yale.edu|
22320221|NCT01889238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320222|NCT04887155|UCLA Semel Institute|Marc Weintraub|3108251300|mjweintraub@mednet.ucla.edu|
22320223|NCT05314712|Center for American Indian and Rural Health Equity|Vernon Grant|406-531-9310|vernon.grant@montana.edu|
22320224|NCT01200238|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22274304|NCT05556616|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22274305|NCT03256578|Leiden University Medical Center|Dr. Arjan te Pas|+31 71 5265839|a.b.te_pas@lumc.nl|
22274306|NCT05428436|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22274307|NCT03964207|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274308|NCT05252858|UPMC|Amy Monroe|412-623-6382|monroeal@upmc.edu|
22274309|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|GabrielFox@acaciapharma.com|
22320225|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22320226|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22320227|NCT03548285|University of Texas Southwestern Medical Center|David Sher, MD|214-645-8525|david.sher@utsouthwestern.edu|
22320228|NCT00667823|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22320229|NCT05834348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22320230|NCT04360551|University of Hawaii at Manoa John A Burns School of Medicine|Cecilia M. Shikuma MD|808 692-1328|shikuma@hawaii.edu|
22274310|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov|
22274311|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22274312|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu|
22274313|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300||
22274314|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000||
22274315|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22274316|NCT02643693|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
22274317|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com|
22274318|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org|
22274319|NCT03250689|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274320|NCT00685815|Luitpold Pharmaceuticals, Inc.|Angie Butcher|610-650-4200|abutcher@lpicrd.com|
22274321|NCT03669549|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
22274322|NCT04023578|Ossur Iceland ehf|Kristleifur Kristleifsson|6641112|kkristjansson@ossur.com|+354
22274323|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org|
22274324|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu|
22274325|NCT02674516|Nanyang Technological University|Dr. Olivia Choy|(65) 65921522|oliviachoy@ntu.edu.sg|
22274326|NCT01064479|UT MD Anderson Cancer Center|Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6980|xle1@mdanderson.org|
22320231|NCT05338515|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22274327|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320232|NCT03496012|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22320233|NCT03138538|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22320234|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com|
22320235|NCT03650842|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-5817|Joseph.Tobias@nationwidechildrens.org|
22320236|NCT02232802|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22320237|NCT00634634|Cancer Institute of New Jersey|Dr. Deborah Toppmeyer|732-235-5203|toppmede@cinj.rutgers.edu|
22320238|NCT00885703|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22320239|NCT00346073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320240|NCT02204150|Mass General Hospital|Gary Tearney|617-724-2979|gtearney@partners.org|
22320241|NCT02053168|BD Interventional - Surgery|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
22320242|NCT02687542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320243|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22320244|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22320245|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it|
22320246|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22320247|NCT01227187|George Washington University|Lakhmir Chawla|202-715-4752|lchawla@mfa.gwu.edu|
22320248|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
22320249|NCT01566773|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22320250|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
22274328|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274329|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu|
22289571|NCT00745849|University of Texas Southwestern|Ganesh Shanmugam, MD|9797036112|ganesh01@yahoo.com|
22274330|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com|
22274331|NCT02425306|University of Virginia|Craig Slingluff, MD, Professor of Surgery|434-924-9311|cls8h@virginia.edu|
22274332|NCT05696392|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22274333|NCT02783898|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
22289572|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22274334|NCT02638974|University of Manchester|Dr Kerry Gutridge, Trial Manager|0161-306-7931|kerry.gutridge@manchester.ac.uk|
22320251|NCT02187471|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22274335|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu|
22274336|NCT02903446|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Angelo Gaffo, MD; Associate Professor|205-996-6086|agaffo@uab.edu|
22274337|NCT03389620|Duke University|Timothy J. Amrhein, M.D.|919-684-1909|timothy.amrhein@duke.edu|
22274338|NCT02201342|Mezzion Pharmaceuticals|Won Geun Kim|3128980292|wg.kim@mezzion.com|
22274339|NCT04782180|University of Miami|Hansel Tookes, Professor of Medicine|305-689-7030|hetookes@miami.edu|
22274340|NCT05852353|Stanford University|Kathleen Kan, MD|(650) 497-8000|kkan@stanford.edu|
22320252|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu|
22274341|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org|
22274342|NCT06077773|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22274343|NCT03834506|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22274344|NCT04577794|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22274345|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320253|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu|
22320254|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org|
22320255|NCT01735279|Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros, São Paulo , Brazil|Md PhD José Carlos F. Galduróz|+55 11 2149 0000|galduroz@unifesp.br|
22320256|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22320257|NCT02210065|U.T. MD Anderson Cancer Center|Dr. Betul Oran / Associate Professor, Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
22320258|NCT03634397|Penn State College of Medicine|Dr Candice Maenza|7175310003|cmaenza@pennstatehealth.psu.edu|283146
22320259|NCT04748653|University of California San Francisco|Alison El Ayadi, Associate Professor|415-476-5877|alison.elayadi@ucsf.edu|
22320260|NCT02446314|The University of Reading|Prof Claire Williams|0118 378 7540|claire.williams@reading.ac.uk|
22320261|NCT00326209|Bausch Health Americas, Inc.|Director of Clinical Operations||lindsey.mathew@bauschhealth.com|
22320262|NCT02138617|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
22320263|NCT02902081|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22320264|NCT01671111|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22320265|NCT04792567|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22320266|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org|
22320267|NCT00113074|University of Iowa|Mark Vander Weg|319-338-0581|mark-vanderweg@uiowa.edu|7717
22320268|NCT03680911|University of Miami|Roy R. Casiano, MD|305-243-5290|rcasiano@med.miami.edu|
22320269|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
22320270|NCT04556136|Madigan Army Medical Center|Dr. Mary McCarthy|253-968-3695|mary.s.mccarthy1.civ@health.mil|
22320271|NCT01507779|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22320272|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com|
22320273|NCT03492554|Apple|Health Technology Clinical Operations|1-866-905-5303|htclinicalquestions@apple.com|
22320274|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300||
22320275|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320276|NCT04340557|Sharp HealthCare|Matthew Geriak, PharmD|858-939-3717|matthew.geriak@sharp.com|
22320277|NCT01221727|Amgen Inc.|Study Director|866-572-6436||
22320278|NCT02566577|Emory University|Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
22320279|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300||
22320280|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
22320281|NCT02179671|AstraZeneca|Phillip Dennis|1 + 301-398-5549|Phillip.Dennis@astrazeneca.com|
22320282|NCT01775735|Boston Scientific|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
22320283|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com|
22320284|NCT01034540|Biofortis Clinical Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
22320285|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu|
22320286|NCT01721876|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320287|NCT03805750|University of California San Diego|F.B. Nahab MD|858-822-6683|fnahab@health.ucsd.edu|
22320288|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22274346|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu|
22320289|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22274347|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794|icro.meattini@unifi.it|7719
22274348|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274349|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22274350|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
22274351|NCT05770713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274352|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu|
22274353|NCT02895295|Stanford University|Dr. M. Kate Bundorf|6507250067|bundorf@stanford.edu|
22274354|NCT02532283|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22274355|NCT03811821|Mayo Clinic|Adil Bharucha, M.B.B.S., M.D.|507-266-6931|bharucha.adil@mayo.edu|
22274356|NCT03433898|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274357|NCT03574038|Study's principal investigator|Dr. Mersedeh Bahr-Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
22274358|NCT05069259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274359|NCT01496976|Moffitt Cancer Center|Celeste M. Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
22274360|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274361|NCT00870727|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
22274362|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu|
22274363|NCT01968421|Peking Union Medical College Hospital|Dr. Jinming Gao, Director of Clinical Trials|8610691550549|gjinming@yahoo.com|
22274364|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org|
22274365|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com|
22289573|NCT05111301|Tandem Diabetes Care|Supervisor, Clinical Operations|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
22274366|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509||
22274367|NCT02779491|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22274368|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274369|NCT03362944|Frohlich Lab - University of North Carolina at Chapel HIll|Trevor McPherson|919-966-4755|trevor_mcpherson@med.unc.edu|
22274370|NCT02915835|University of Michigan|Dr. Cathie Spino|7346155469|spino@umich.edu|
22274371|NCT02456727|Albert Einstein College of Medicine|Diane McKee|718-430-2952|Diane.Mckee@einstein.yu.edu|
22274372|NCT01319565|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
22274373|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779||
22274374|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com|
22274375|NCT02974868|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274376|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22274377|NCT01663402|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
22274378|NCT02265965|University of California, San Francisco|Jennifer Lucero, MD|415-476-5535|jennifer.lucero@ucsf.edu|
22274379|NCT05953363|Becton, Dickinson and Company|Gloria Viti/Clinical Project Manager|00393452237718|gloria.viti@bd.com|
22274380|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org|
22274381|NCT03387267|Nestlé Health Science|Kemuel Reyes|(908) 333-9379|Kemuel.Reyes@us.nestle.com|
22274382|NCT04195594|TRCGEN+ (managed by Trans Russian Co)|Nikolaos Tzenios|+447583902071|Nicolas@trccolleges.com|
22274383|NCT03077893|Regenesis Biomedical|Heather M Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
22274384|NCT04464707|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22274385|NCT04613518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22274386|NCT04831138|UT Southwestern Medical Center|Dr. Ananth Madhuranthakam|214-648-7737|ananth.madhuranthakam@utsouthwestern.edu|
22274387|NCT04663685|UBC/Arthritis Research Canada|Ellen Wang|2266980999|ewang@arthritisresearch.ca|
22274388|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu|
22274389|NCT04202497|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22274390|NCT05590377|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22289574|NCT01754727|AbbVie|Global Medical Information|800-633-9110||
22289575|NCT02785770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289576|NCT03968939|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22289577|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22289578|NCT05367492|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
22289579|NCT00265148|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289580|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu|
22289581|NCT04780919|Charles University, 2nd Faculty of Medicine|Jakub Katolicky|+420 739 081 676|jakub@katolicky.eu|
22320290|NCT02844816|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
22289582|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289583|NCT03539549|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22320291|NCT04376827|Janssen Research & Development, LLC|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22320292|NCT04701138|University of North Carolina at Chapel Hill|Saame Shaikh, PhD|919-843-4348|shaikhsa@email.unc.edu|
22320293|NCT01798589|Dermatology Specialists|Joseph Fowler, MD|502-583-7546|fowlerjoe@msn.com|
22289584|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu|
22289585|NCT01652469|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
22289586|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
22289587|NCT03760731|Rocky Mountain Regional VA Medical Center|Lauren Michelle Borges, PhD|303-916-0128|lauren.borges2@va.gov|
22289588|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com|
22289589|NCT01970358|Dana-Farber Cancer Institute|Patrick Ott, MD PhD|6176325990|patrick_ott@dfci.harvard.edu|
22289590|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl|
22289591|NCT04075734|Rutgers Cancer Institute of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
22289592|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org|
22289593|NCT02433080|University College London|Dr Anne Lanceley|+442076796807|a.lanceley@ucl.ac.uk|
22289594|NCT03462511|Columbia University School of Nursing|Arlene Smaldone, PhD, RN|212-342-3048|ams130@columbia.edu|
22289595|NCT02625909|The Kirby Institute|Pip Marks, Clinical Trials Manager|+61 2 9385 0886|pmarks@kirby.unsw.edu.au|
22289596|NCT02367833|Penn State University|Dr. Mary Jane De Souza|8148630045|mjd34@psu.edu|
22289597|NCT03001817|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22289598|NCT03855059|University of Arizona/Deptartment of Anesthesiology|Peter Lichtenthal, MD|5206267221|plich@arizona.edu|
22289599|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com|
22289600|NCT02067676|Enteric Disease Department, Naval Medical Research Center|Ramiro Gutierrez, MD|301-319-3193|ramiro.l.gutierrez.mil@mail.mil|
22289601|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
22289602|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org|
22289603|NCT04296448|Johns Hopkins University Department o Peidaitrics Division of Pediatric Emergency Medicne|Dr. Therese Canares|(410) 955-6146‬|therese.canares@jhmi.edu|
22289604|NCT01640834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289605|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200||5888
22289606|NCT03601117|Stanford University|Dr Nolan Williams|(650)800-6920|nolanw@stanford.edu|
22289607|NCT05422638|VA San Diego Healthcare System|Ariel J Lang, PhD, MPH|858-552-8585|ariel.lang@va.gov|5953
22289608|NCT04016623|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22289609|NCT04695977|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22289610|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com|
22289611|NCT03278067|GlaxoSmithKline|GSK Response Center|866-435-7343|emily.p.lu@gsk.com|
22289612|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22289613|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu|
22289614|NCT03844945|Aerie Pharmaceuticals Ireland Limited, Japan Branch|Clinical Research, Japan|+81-3-6860-8410|JapanCS208@aeriepharma.com|
22289615|NCT04518995|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22289616|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com|
22289617|NCT01816711|Aarhus University Hospital|Mette Abildgaard Pedersen|31411180|meabpe@rm.dk|
22289618|NCT01303003|Steward St. Elizabeth's Medical Center|Meghan Cashman, IRB Manager|617-789-2804|meghan.cashman@steward.org|2804
22289619|NCT05011279|Dana-Farber Cancer Institute|Catherine Marinac|617-632-4703|CatherineR_Marinac@dfci.harvard.edu|
22289620|NCT01088048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22289621|NCT04978454|Duke University Medical Center|Christopher Woods|919-684-7916|chris.woods@duke.edu|
22289622|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289623|NCT01343693|Zimmer Biomet Spine|Zimmer Biomet Spine Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
22289624|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
22289625|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289626|NCT01667419|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22289627|NCT03364270|Cedars-Sinai Medical Center|Balaji Tamarappoo, MD|3104232219|Balaji.Tamarappoo@cshs.org|
22289628|NCT03869216|Xavier University of Louisiana|Margarita Echeverri, Professor of Social and Behavioral Sciences|504-520-6719|mechever@xula.edu|
22289629|NCT03646123|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289630|NCT04915950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22289631|NCT03860259|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
22289632|NCT02280408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289633|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289634|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22289635|NCT01519869|University of Kentucky|Rachel Miller|859-323-2169|raware00@uky.edu|
22289636|NCT02209532|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
22289637|NCT03563183|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22289638|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590||
22289639|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
22289640|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343||
22289641|NCT02164461|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|Sheeri@advaxis.com|
22289642|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu|
22289643|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289644|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu|
22289645|NCT06011759|VA Ann Arbor Health Care System|Paul Pfeiffer, MD, MS, Corresponding Principal Investigator|N/A|paul.pfeiffer@va.gov|
22289646|NCT04927364|VA Palo Alto Healthcare System|Claudia Padula|650-849-1211|padula@stanford.edu|
22289647|NCT05487196|UPMC Magee Women's Hospital|Dr. Grace Lim, MD, MSc|412-641-1778|limkg2@upmc.edu|
22289648|NCT05188053|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|507-266-5895|schouten.gabriel@mayo.edu|
22289649|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu|
22289650|NCT01761240|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22289651|NCT06013176|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
22289652|NCT05126225|University of California Los Angeles, Joe. C Wen School of Nursing|Dr. Wei-Ti Chen|310-206-8539|wchen@sonnet.ucla.edu|
22289653|NCT05321784|OHSU Knight Cancer Institute|Khoa Nguyen|503-418-9314|nguyekho@ohsu.edu|
22289654|NCT02355184|CytoDyn|Joseph Meidling|(360) 980-8524|jmeidling@cytodyn.com|
22289655|NCT06173063|Rockfield Medical Devices Ltd.|Edel Keaveney, Senior Research Manager|(+353) (0)91 763 000|edel@rockfieldmd.com|
22289656|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov|
22289657|NCT03254459|Insys Therapeutics, Inc.|Director, Clinical Development|4805003105|gdecastro@insysrx.com|
22289658|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net|
22289659|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com|
22289660|NCT04565327|University of California, San Francisco|Dr. Zhen Wang, MD|(415) 476-3767|Zheng.Wang@ucsf.edu|
22289661|NCT01511055|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
22289662|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22289663|NCT04590248|AstraZeneca Clinical Study Information Centre|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
22258882|NCT03559010|HRA Pharma|Christine VENARD|33 1 84 13 92 44|c.venard@hra-pharma.com|
22258883|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22258884|NCT01829295|F.I. Proctor Foundation, UCSF|Dr. Nisha Acharya|4154768131|Nisha.Acharya@ucsf.edu|
22258885|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com|
22258886|NCT02629965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258887|NCT03331965|Duke University Medical Center|Dr. James Ronald|919.684.7299|james.ronald@duke.edu|
22274391|NCT02499146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274392|NCT04325828|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22274393|NCT05115630|University of Texas MD Anderson Cancer Center|Jeremy Ramdial, MD./ Stem Cell Transplantation Department|713-745-0146|JLRamdial@mdanderson.org|
22274394|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu|
22274395|NCT02287038|Ralph H. Johnson VA Medical Center|Dr. Zhewu Wang|8437897949|zhewu.wang@va.gov|
22274396|NCT02713178|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22274397|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu|
22274398|NCT02864732|University of Pittsburgh|Research Assistant|412 4822283|mza7@pitt.edu|
22274399|NCT02667301|StratejikYG|Murat Haluk Ozkul|0905327777842|kbbhaluk@gmail.com|
22274400|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com|
22274401|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300||
22274402|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289664|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22258888|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121|b.dauser@hotmail.com|5098
22258889|NCT03387059|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22258890|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22258891|NCT00528437|NYU Langone|Dr. Sharon Gardner|212-263-9913|Sharon.Gardner@nyulangone.org|
22258892|NCT00634283|Laboratory of Brain, Behavior, and Pharmacology at UCLA|Director of the Laboratory of Brain|310-825-0207|info@brain.ucla.edu|
22258893|NCT03501550|Cocrystal Pharma Inc|Luz Pascual|9083611678|lpascual@cocrystalpharma.com|
22258894|NCT01743677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258895|NCT05028751|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
22258896|NCT03092089|University of Alberta Hospital|Dr Kevin Bainey|780-407-2176|Kevin.Bainey@albertahealthservices.ca|
22258897|NCT03586830|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22258898|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov|
22258899|NCT04192799|The Dartmouth Institute for Health Policy & Clinical Practice|Stephanie Acquilano, Research Project Director|603-646-5937|stephanie.acquilano@dartmouth.edu|
22258900|NCT00628745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258901|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov|
22258902|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com|
22258903|NCT02034799|Ethicon, Inc|Senior Director of Ethicon Clinical R&D|(908) 218-2492|jbatill2@its.jnj.com|
22258904|NCT03827213|Montefiore Medical Center|Elilary Medilla Medrano|(718) 920-4316|emontill@montefiore.org|
22258905|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu|
22258906|NCT03381248|Avanos Medical|David Curd|470-448-5178|david.curd@avanos.com|
22258907|NCT01717898|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
22258908|NCT05188521|Mayo Clinic|Dr. Aaron R. Mangold, Principal Investigator|480-301-9196|mangold.aaron@mayo.edu|
22258909|NCT01341639|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258910|NCT01590433|Beth Israel Deaconess Medical Center|Jody Dushay|617-667-9344|jdushay@bidmc.harvard.edu|
22258911|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22258912|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com|
22258913|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258914|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
22258915|NCT02961920|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82324603624|jjchoi2@gilhospital.com|
22258916|NCT02243020|MicroTransponder Inc.|VP Clinical Affairs|5123714160|brent@microtransponder.com|
22258917|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22258918|NCT03551730|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22258919|NCT01038557|Oregon Health & Science University|Dr. Martin A. Schreiber|503-494-8324|schreibm@ohsu.edu|
22258920|NCT02363010|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
22258921|NCT03347695|Fujian Medical University Union Hospital|Dr. Liangwan Chen|861335825333|chenliangwan@tom.com|
22258922|NCT00996866|Winthrop-University Hospital|John Aloia, MD|516-663-2442|jaloia@winthrop.org|
22258923|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us|
22258924|NCT04633837|American Health Network|Brian Badman|317-208-3866|bbadman@gmail.com|
22258925|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu|
22258926|NCT04527471|Verona Pharma|Margot MacDonald-berko|833-417-0262|margot.macdonald-berko@veronapharma.com|
22258927|NCT05432271|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
22258928|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com|
22258929|NCT03158298|Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany|Dr. Benjamin Schleenvoigt|+49 3641 9 32 46|benjamin.schleenvoigt@med.uni-jena.de|70
22258930|NCT02884206|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22258931|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22258932|NCT01492582|University of Alabama at Birmingham|Dr. Wendy Landier, Deputy Director, Institute for Cancer Outcomes and Survivorship|(205) 638-2120|wlandier@peds.uab.edu|
22258933|NCT01628120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258934|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org|
22258935|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22258936|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org|
22258937|NCT02232074|Boston Medical Center|Tracy Battaglia|617.638.8036|tracy.battaglia@bmc.org|
22258938|NCT01927757|Amgen Inc.|Study Director|866-572-6436||
22258939|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu|
22258940|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
22258941|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22258942|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22304824|NCT00303303|Carolinas Medical Center|William Kerns II MD Program Directorm Medical Toxicology|704-355-5297|rkerns@carolinas.org|
22258943|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22289665|NCT02891070|Baxter Healtcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22274403|NCT04414787|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
22274404|NCT05093933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22274405|NCT04112368|University of Illinois Chicago|Tory Eisenlohr-Moul|859-317-0503|temo@uic.edu|
22274406|NCT05027815|University of California, San Francisco|Jonathan Esensten MD, PhD|415-502-3785|Jonathan.Esensten@ucsf.edu|
22274407|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org|
22274408|NCT04802161|University of North Carolina, Lineberger Comprehensive Cancer Center|Dr. Joshua F. Zeidner|919-962-5164|Joshua_Zeidner@med.unc.edu|
22274409|NCT02997163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274410|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu|
22274411|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300||
22274412|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300||
22274413|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org|
22274414|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22274415|NCT02308046|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
22274416|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22274417|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr|
22274418|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com|
22274419|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
22274420|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274421|NCT01996371|OhioU|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22274422|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422|leonardo.fabbri@unimore.it|4227
22274423|NCT03342001|University of Maryland School of Medicine|Dr. Kashif Munir|443-682-6873|kmunir@som.umaryland.edu|
22274424|NCT01384877|BC Cancer|Dr. Philippa Hawley|604-877-6000|phawley@bccancer.bc.ca|67-2752
22274425|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu|
22274426|NCT01930539|University of Nebraska Medical Center|Lynn Mack|402-559-6276|lmack@unmc.edu|
22274427|NCT01548404|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22274428|NCT04040439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274429|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com|
22274430|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org|
22274431|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274432|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
22274433|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274434|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov|
22274435|NCT01235065|R Adams Cowley Shock Trauma Center|Dale Yeatts, Principal Investigator|443-909-0648|djyeatts@gmail.com|
22274436|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22274437|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov|
22274438|NCT03426345|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22274439|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu|
22274440|NCT00192114|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274441|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22274442|NCT03885908|Memorial Sloan Kettering Cancer Center|Dr. Armin Shahrokni, MD, MPH|646-888-3651|shahroka@mskcc.org|
22274443|NCT03817606|Riverside Medical Center|Cynthia Koehn, Clinical Research Nurse|815-933-1671|ckoehn@rhc.net|
22274444|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu|
22274445|NCT03194334|University Ghent|Prof. Wim Derave|+32/9/2646326|wim.derave@ugent.be|
22274446|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
22274447|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22274448|NCT00072384|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22274449|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org|
22274450|NCT06058390|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274451|NCT03292016|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22274452|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu|
22274453|NCT05518539|Newsom Eye|T Hunter Newsom|813-908-2020|hunter@newsomeye.net|
22274454|NCT01218542|Emory University|Dr. Hui-Kuo Shu|404-778-2161|hgshu@emory.edu|
22274455|NCT03589807|Emory Children's Center|Evan J. Anderson, MD|404-727-5642|evanderson@emory.edu|
22274456|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com|
22274457|NCT04195061|Massachusetts General Hospital|Melanie S. Haines, MD|617-726-3870|mshaines@mgh.harvard.edu|
22274458|NCT00249834|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22274459|NCT01787006|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22289666|NCT02704143|Changhai Hospital affiliated to Navy Medical University|Dr. Huojun Zhang|86-021-31162207|chyyzhj@163.com|
22289667|NCT02516969|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
22289668|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
22289669|NCT02551991|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
22289670|NCT05525078|Medical University of South Carolina|Tracy Smith, PhD|843 792 5164|smithtra@musc.edu|
22289671|NCT02507960|University of Maryland Medical Center|Elizabeth Nichols|4103287586|enichols1@umm.edu|
22289672|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289673|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22289674|NCT04491604|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
22289675|NCT04126278|NYU Langone Health|Mehul Shah|616-501-7223|Mehul.Shah@nyulangone.org|
22289676|NCT03029988|Navidea Biopharmaceuticals|Bonnie Abbruzzese Senior Director|614.793.7500|babbruzzese@navidea.com|147
22289677|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22289678|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu|
22289679|NCT04657666|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22289680|NCT05043142|Yuria-Pharm|Tetiana Sprynsian|+380665134849|Tetiana.Sprynsian.pm@pharmaxi.com.ua|
22289681|NCT02386189|Iowa City VA Health Care System|Dr. Carolyn Turvey|319 358 9501|carolyn.turvey@va.gov|7714
22289682|NCT03120351|ClevelandCF|Bruce Vrooman|216-444-2200|vroomab@ccf.org|
22289683|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
22289684|NCT04931888|Yale University|Julia Rosenberg, MD MHS|2037777411|julia.rosenberg@yale.edu|
22289685|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu|
22289686|NCT04693052|Northwestern University|Dr. Jeffrey Rado, MD,MPH,FAPA|312-695-5060|jeffrey.rado@nm.org|
22289687|NCT02969408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22289688|NCT02350478|Medical University of Graz|Assoz.-Prof. Dr. Harald Sourij|+43316385|ha.sourij@medunigraz.at|81310
22289689|NCT03330002|Essential Medical, a wholly owned subsidiary of Teleflex, Inc.|Darra Bigelow, Clinical Trials Manager|610-331-7299|darra.bigelow@teleflex.com|
22289690|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|101
22289691|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
22289692|NCT02745145|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22289693|NCT04036292|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22289694|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com|
22289695|NCT04413617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289696|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it|
22289697|NCT03152929|Spectrum Health|Marianne Melnik|616-486-6333|marianne.melnik@corewellhealth.org|
22289698|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289699|NCT01703754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22289700|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22289701|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com|
22289702|NCT02447302|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22289703|NCT03686007|City of Hope Medical Center|Dr. Virginia Sun|626-359-8111|VSun@coh.org|
22289704|NCT06057727|University of Pennsylvania|Dr. Shivan Mehta|2679726027|shivan.mehta@pennmedicine.upenn.edu|
22289705|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22289706|NCT04449263|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256402964|javega2@coopervision.com|
22289707|NCT01742286|Study Director|Study Director|862-778-8300|novartis.email@novartis.com|
22289708|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22289709|NCT04198714|MetroHealth Medical Center|Dr. Jeffrey Mangel|216-778-5595|jmangel@metrohealth.org|
22289710|NCT02578095|Viking Therapeutics, Inc|Scott Stubbe, Vice President Clinical Operations|8587044685|sstubbe@vikingtherapeutics.com|
22289711|NCT01925131|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|amoseley@fredhutch.org|
22289712|NCT05091567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22289713|NCT01217307|University Medical Center Groningen|Dr. I.C.C. van der Horst||i.c.c.van.der.horst@umcg.nl|
22289714|NCT03054129|Dr. İsmail Atabek Physical Therapy and Rehabilitation Center|Ertan Şahinoğlu, PT, PhD|+90 5326478653|ertan.sahinoglu@hotmail.com|
22289715|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22289716|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu|
22258944|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22258945|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22258946|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22258947|NCT03083483|Duke University|Hannah Palmer|919-613-7665|hlp14@duke.edu|
22258948|NCT02710071|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
22258949|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
22258950|NCT05487456|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22320294|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
22289717|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000|ferenc.karpati@karolinska.se|81656
22289718|NCT03320824|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22289719|NCT00109590|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22289720|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500|nicholas.higdon@biomet.com|3047
22289721|NCT02438358|Lumicell|Jorge Ferrer, Ph.D.|617-571-0592|jmferrer@lumicell.com|
22289722|NCT00490529|Stanford University|Ronald Levy|650-725-6452|levy@stanford.edu|
22289723|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com|
22289724|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
22289725|NCT04672954|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289726|NCT02165839|Stanford University|Oxana Palesh, Associate Professor of Psychiatry and Behavioral Sciences|(650) 725-7011|oxana.palesh@stanford.edu|
22289727|NCT03861988|Stanford University|Boris Heifets, MD, PhD|(650) 497-8057|bheifets@stanford.edu|
22289728|NCT02617485|Mabion S.A.|Adam Tuszyner|+48504441105|a.tuszyner@mabion.eu|
22289729|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22289730|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
22289731|NCT00669409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289732|NCT03101111|Themis Bioscience|Christiane Thomasser|01 236 7151|christiane.thomasser@themisbio.com|
22289733|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org|
22289734|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu|
22289735|NCT01874340|Novartis|Study Director|862-778-8300||
22289736|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU|
22289737|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
22289738|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu|
22289739|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org|
22304825|NCT00058058|American College of Radiology Imaging Network|Senior Director of Protocol Management||Donna Hartfeil <dhartfeil@acr.org>|
22304826|NCT03085017|Loma Linda University Health Care|David G. Rabkin, MD FACS|909-558-4354|drabkin@llu.edu|
22289740|NCT03241030|Baylor College of Medicine|Nidhi Singh, MD|832-824-2771|nidhi.singh@bcm.edu|
22289741|NCT02864862|The University of Texas Health Science Center at Houston|Chun-Teh Lee|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
22289742|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22289743|NCT01523275|University of California, San Francisco|Jolie Chang|415-353-2203|jolie.chang@ucsf.edu|
22289744|NCT03263702|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
22289745|NCT03598114|Washington University School of Medicine|Sarah Moreland-Russell, Ph.D., MPH|314-935-8382|smoreland-russell@wustl.edu|
22289746|NCT02527200|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22289747|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304827|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu|
22289748|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289749|NCT02204124|Washington University School of Medicine|William Hawkins, M.D.|314-286-0702|hawkinsw@wustl.edu|
22304828|NCT03570255|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22289750|NCT00444678|NYU Langone Health|Deirdre Cohen, MD|212-731-5656|Deirdre.Cohen@nyulangone.org|
22289751|NCT02453347|Audie L. Murphy Veterans Administration Hospital|Dr. Carlos Jaramillo|210-617-5300|jaramilloc3@uthscsa.edu|15773
22289752|NCT02597478|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22289753|NCT02747433|MGH Institute of Health Professions|Susan Fasoli, ScD OTR/L, Associate Professor|617-643-4777|sfasoli@mghihp.edu|
22304829|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu|
22289754|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22289755|NCT00796978|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Cynthia Owusu|+1 216-844-7670|cynthia.owusu@uhhospitals.org|
22289756|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22289757|NCT02834793|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22289758|NCT02364336|NIDDK|Dr. Marc Ghany|301-402-5115|mg228m@nih.gov|
22289759|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com|
22289760|NCT03319745|The University of Texas MD Anderson Cancer Center|Dr. Neema Navai|(713) 792-3250|nnavai@mdanderson.org|
22289761|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22289762|NCT01317550|MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|713-563-2300|zliao@mdanderson.org|
22289763|NCT03179202|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
22289764|NCT03255629|Joslin Diabetes Center|Mary Elizabeth Patti, MD|(617) 309-2635|MaryElizabeth.Patti@joslin.harvard.edu|
22289765|NCT04540198|Baylor Scott & White Health Research Institute|Dr. Alan Stevens|254-215-9885|alan.stevens@bswhealth.org|
22289766|NCT02779556|University of Arkansas for Medical Sciences|Kristie Hadden, PhD/Associate Professor|501-993-3178|KBHADDEN@uams.edu|
22289767|NCT03236662|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
22304830|NCT02680756|Shield Therapeutics|Jackie Mitchell MA DPhil|0044 752 565 6885|jmitchell@shieldtx.com|
22289768|NCT03110770|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22289769|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555|hbissada@ottawahospital.on.ca|78042
22289770|NCT01086358|Cleveland Clinic Foundation|Jennifer Kriegler, MD|216-444-8265|krieglj@ccf.org|
22289771|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org|
22289772|NCT02888119|NYU Langone Health|Dr. Ravinder Regatte|(212) 263-4857|Ravinder.Regatte@nyulangone.org|
22289773|NCT01996839|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22289774|NCT05246514|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22289775|NCT01802073|Stanford University|Dr. Kenneth Cox|(650) 723-5070|KCox@stanfordchildrens.org|
22289776|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com|
22289777|NCT01980589|Amgen, Inc.|Study Director|866-572-6436||
22289778|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22289779|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22289780|NCT01805791|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
22289781|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu|
22289782|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
22289783|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289784|NCT04145219|ALK-Abelló A/S|Vice President, Clinical Operations Strategy|+45 4574 7576|clinicaltrials@alk.net|
22289785|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446|rose@motusgi.com|104
22289786|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800|Albiruni.Razak@uhn.ca|5371
22289787|NCT02902484|UT Southwestern Medical Center|Dr. Salwan Al Mutar|214-648-4008|salwan.almutar@utsouthwestern.edu|
22289788|NCT05854784|CLINUVEL UK LTD|Director, Global Clinical Affairs|+4401372860765|mail@clinuvel.com|
22289789|NCT05871450|German University of Health and Sports|Wolfgang Ruf|+49 (030) 577 97 37 370|wolfgang.ruf@dhgs-hochschule.de|
22289790|NCT01031836|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22289791|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9933
22289792|NCT01888432|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22289793|NCT03159260|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
22289794|NCT01856218|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
22289795|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289796|NCT01794338|Carolinas HelathCare System|Research Director|704-355-3168|Amy.Lincourt@carolinashealthcare.org|
22289797|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
22289798|NCT01282463|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289799|NCT02051933|CarolinasHS|Christine Churchill|704-355-6947|christine.churchill@carolinashealthcare.org|
22289800|NCT01954927|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
22289801|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu|
22289802|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22289803|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22289804|NCT02123251|University of Hawaii, Center on Disability Studies|Dr. Chuan Chinn|8089565379|chuanc@hawaii.edu|
22289805|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777||
22289806|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
22289807|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22289808|NCT02338882|University of Plymouth|Dr Phillip Buckhurst|01752 588884|phillip.buckhurst@plymouth.ac.uk|
22289809|NCT02184455|DeCell Technolpogies Inc.|Dr. Paul F. Gratzer, CSO|902-223-2179|pfgratzer@decelltechnologies.com|
22289810|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu|
22289811|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22289812|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22289813|NCT03206788|Kansas University Medical Center|Dr. Matthias Salathe|913 588 6045|msalathe@kumc.edu|
22289814|NCT02082340|American University of Armenia|Dr. Harutyunyan||aharutyunyan@aua.am|
22289815|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590||
22289816|NCT01625260|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22289817|NCT05573386|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
22289818|NCT03899805|Dana Farber Cancer Institute|Suzanne George MD, PI|6176326826|suzanne_george@dfci.harvard.edu|
22289819|NCT04195893|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22289820|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu|
22289821|NCT02291016|University of Tennessee Graduate School of Medicine|Clinical Trials Coordinator|865-305-7975|jferris@utmck.edu|
22289822|NCT00577798|University of Nebraska Medical Center|Thomas Porter, MD|+1 (402) 559-8150|trporter@unmc.edu|
22289823|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22289824|NCT01776307|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
22289825|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22289826|NCT05037578|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
22289827|NCT03672097|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22289828|NCT01459497|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214-645-7603|puneeth.iyengar@utsouthwestern.edu|
22289829|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|: 60094
22289830|NCT02872935|University of Iowa|Dr. Kokila Thenuwara|319-384-5876|kokila-thenuwara@uiowa.edu|
22289831|NCT03530124|Duke University|Dr. Rachel Greenberg|919 668 4725|rachel.greenberg@duke.edu|
22289832|NCT05343624|University Hospitals Cleveland Medical Center|Dr. Tanureet Arora|(440)892-6424|Tanureet.Arora@UHhospitals.org|
22289833|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
22289834|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com|
22289835|NCT02751385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289836|NCT02791763|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|7343
22289837|NCT05334212|University Hospitals Cleveland Medical Center|Dr. Gabriel Smith|(440)827-5088|Gabriel.Smith@UHhospitals.org|
22289838|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289839|NCT01456897|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
22289840|NCT04535453|Janssen Vaccines & Prevention B.V.|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22304831|NCT02374957|Wake Forest University Health Sciences|Dr. Matthew Edwards|336-716-9343|medwards@wakehealth.edu|
22304832|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org|
22289841|NCT02878798|Virginia Commonwealth University|Dr. A. Gordon Smith|801-828-9869|gordon.smith@vcuhealth.org|
22304833|NCT03532178|UCaliforniaSF|Dr. Chanhung Lee|4154762131|chanhung.lee@ucsf.edu|
22304834|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de|
22304835|NCT02724787|James A. Haley Veterans' Hospital|Dr. Shannon Miles|813-972-2000|shannon.miles@va.gov|6728
22304836|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org|
22304837|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304838|NCT00562965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304839|NCT00761774|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22304840|NCT01648283|Washington University School of Medicine|Evan D. Kharasch, MD, PhD|314-362-8796|kharasch@wustl.edu|
22304841|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
22304842|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu|
22304843|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org|
22304844|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954||
22304845|NCT01253200|Boston Scientific|Timothy Meyer; Director of Clinical Trials|651 581 3425|Timothy.meyer@bsci.com|
22304846|NCT02049437|University Hospitals Cleveland Medical Center|Marijke Frederix, PhD|(216) 844-0383|marijke.frederix@UHhospitals.org|
22304847|NCT02706626|Criterium, Inc.|Tom Stinchcombe|9196819509|Thomas.stinchcombe@duke.edu|
22304848|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk|
22304849|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22304850|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22304851|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu|
22304852|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304853|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
22304854|NCT05302791|University of Montana|Dustin Slivka|406-243-2389|dustin.slivka@umontana.edu|
22304855|NCT03663712|Duke University|Dan G. Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
22304856|NCT04956692|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22304857|NCT03541603|Tenax Therapeutics, Inc.|Stuart Rich, MD; Chief Medical Officer|919 855 2100|s.rich@tenaxthera.com|
22304858|NCT02099539|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22304859|NCT05812794|The University of Texas Health Science Center at Houston|Stuart Mason Fraser, MD|713-500-7142|Stuart.M.Fraser@uth.tmc.edu|
22304860|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org|
22304861|NCT02148718|AbbVie|Global Medical Services|800-633-9110||
22304862|NCT04447820|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22304863|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304864|NCT03888365|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
22304865|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22304866|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22304867|NCT02655692|Yale University|John Krystal|203.785.6396|john.krystal@yale.edu|
22304868|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au|
22304869|NCT04978363|University of Iowa|Molly Pacha|319-290-7596|molly-pacha@uiowa.edu|
22304870|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22304871|NCT01876043|Institut Bergonié|Dr Antoine ITALIANO|+33556333333|a.italiano@bordeaux.unicancer.fr|
22304872|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu|
22304873|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22289842|NCT02762370|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22289843|NCT00268853|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
22289844|NCT03632954|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
22289845|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289846|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
22289847|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22289848|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
22289849|NCT02445794|Retrotope, Inc|Frederic Heerinckx/VP Clinical Operations|650-437-0700|frederic@retrotope.com|109
22289850|NCT01388985|Institute of Tropical Medicine Antwerp|Dr. Patrick Soentjens|+32 3 247 66 41|psoentjens@itg.be|
22289851|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289852|NCT03761368|Medical University of Łódź|Karolina Stokfisz|+48422014260|stokfisz.karolina@gmail.com|
22289853|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22289854|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677|yachunwang@tcmbio.com|733
22289855|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu|
22289856|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289857|NCT02560025|Massachusetts General Hospital|Amir Fathi, MD|617-724-1124|AFATHI@mgh.harvard.edu|
22289858|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22289859|NCT03800420|Clinical Trials_inquiries|Clinical Trials_inquiries|+82-31-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
22289860|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com|
22289861|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289862|NCT02745080|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22289863|NCT05073432|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22289864|NCT01881828|Jaeb Center for Health Research|Kellee Miller|15310 Amberly Drive|t1dstats@jaeb.org|
22289865|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu|
22289866|NCT00829504|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22289867|NCT04507373|UT Southwestern Medical Center|Dr. Zahid Ahmad|214/648-2377|ZAHID.AHMAD@UTSouthwestern.edu|
22289868|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov|
22289869|NCT02506985|University of Kentucky|Susan Smyth|859-323-2274|susansmyth@uky.edu|
22289870|NCT03745820|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22289871|NCT03619811|UCSD|Clinical Research Coordinator|858-246-5236|mgreytak@ucsd.edu|
22289872|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com|
22289873|NCT01790243|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
22289874|NCT04250077|We The Village|Jane Macky, CEO|9176844267|jane@wethevillage.co|
22289875|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
22289876|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com|
22289877|NCT00591318|New York State Psychiatric Institute|Brian Fallon|646-774-8052|brian.fallon@nyspi.columbia.edu|
22289878|NCT00647270|Abbott|Global Medical Services|800-633-9110||
22289879|NCT03615040|University of Leicester|Professor Chris Brightling|+44 116 250 2704|ceb17@le.ac.uk|
22289880|NCT02420015|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
22289881|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com|
22289882|NCT01743001|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
22289883|NCT03194737|Teleflex/NeoTract|Emily Friedland, Director, Global Clinical Operations|925.387.6014|emily.friedland@teleflex.com|
22289884|NCT02657408|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289885|NCT01403948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289886|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289887|NCT05498701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289888|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com|
22289889|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003|eoimagosie@iroko.com|3182
22289890|NCT02184572|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289891|NCT03764293|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yongli Xie|18581831003|yongli.xie@hengrui.com|
22289892|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com|
22289893|NCT02495038|Yonsei University Wonju college of medicine|Dr. Wooyoung Park|563664250|wongulung28@gmail.com|971
22289894|NCT05051631|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615-875-5649|lucy.b.spalluto@vumc.org|
22289895|NCT03679754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22289896|NCT00964171|Institut Bergonié|Dr Marianne Fonck|05.56.33.32.42|m.fonck@bordeaux.unicancer.fr|
22289897|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22289898|NCT04615832|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7882
22289899|NCT03179319|Brown University|Katie Biello|401-863-3082|katie_biello@brown.edu|
22289900|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300||
22289901|NCT03117140|Univesity of Iowa Hospitals and Clinics|Melinda Seering|3193561616|melinda-seering@uiowa.edu|
22289902|NCT02640508|UT Health San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
22289903|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de|
22289904|NCT04534686|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
22289905|NCT03179605|Prosoft Clinical|Robert Babilon President|4843202068|b.babilon@prosoftclinical.com|
22289906|NCT00635999|Penn State University|Michelle G. Newman|814-863-1148|mgn1@psu.edu|
22289907|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22289908|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu|
22289909|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
22289910|NCT02636361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289911|NCT02695420|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22289912|NCT02448641|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
22289913|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com|
22289914|NCT02929407|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22289915|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123||
22289916|NCT03037580|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
22289917|NCT02036853|Cook Children's Health Care System|Director of Research Operations|682-885-2103|CookChildrensResearch@cookchildrens.org|
22289918|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22289919|NCT04530136|Pharming Technologies BV|Anurag Relan, MD|0031 (0)71 5247400|a.relan@pharming.com|
22289920|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22289921|NCT02692391|Ohio State University|Georgios Papachristou, MD PhD|6142836255|georgios.papachristou@osumc.edu|
22289922|NCT02917122|National Cheng Kung University|Dr. Kao Chin Chen|+886-6-2353535|andchen@mail.ncku.edu.tw|5213
22289923|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu|
22289924|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu|
22289925|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu|
22289926|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com|
22289927|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22289928|NCT05564052|Janssen Research & Development, LLC|Sr. Director Clinical Sciences Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22289929|NCT01224145|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22289930|NCT05283031|Imperial College Ophthalmology Research Group|Jamie Spofforth|020 3312 6666|Jamiespofforth@nhs.net|
22289931|NCT03818035|Janssen Research & Development LLC|GUIDE-Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22289932|NCT03718091|Massachusetts Genera Hospital|Gregory M Cote MD PhD|6177244000|gcote@partners.org|
22289933|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu|
22289934|NCT03338959|University of Washington|Lee Cranmer, MD, PhD, Sarcoma Program Director|206-606-7439|ldcranme@fredhutch.org|
22289935|NCT04434846|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
22289936|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672||
22289937|NCT00281658|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22289938|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
22289939|NCT03680742|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
22289940|NCT01248104|Loma Linda University Medical Center|Dr. Jason Gatling|909-558-4475|jgatling@llu.edu|44475
22289941|NCT02894502|University of Rome Tor vergata, Rome, Italy|Dr. Ercole Vellone|+393387491811|ercole.vellone@uniroma2.it|
22289942|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
22289943|NCT01710137|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
22289944|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com|
22289945|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
22289946|NCT01324518|Orion Global Clinical Operations|Clinical Study Director||jutta.hanninen@orionpharma.com|
22289947|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623||
22289948|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22289949|NCT04620213|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22289950|NCT03700684|University of Massachusetts Amherst|Kelly Richardson|413-545-2007|krichardson@umass.edu|
22289951|NCT04144127|Emory University|Dr. Felipe Lobelo|(770) 488-5737|felipelobelo@emory.edu|
22289952|NCT01767142|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22289953|NCT03317405|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22289954|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22289955|NCT01999517|Mount Sinai Medical Center|Gervasio Lamas, MD|305-674-2162|gervasiolamas@gmail.com|
22289956|NCT04093024|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289957|NCT03145818|Providence VA Medical Center|James Rudolph, MD, Principal Investigator|401-273-7100|James.Rudolph@va.gov|6406
22304874|NCT02685293|Pearl Therapeutics Inc.|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22304875|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22289958|NCT03236155|Rush University Medical Center|Anne DeBenedetti, CRC|3124322468|anne.debenedetti@rushortho.com|
22289959|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289960|NCT03052426|West Virginia University|Dr. Brandy Brown|304-293-1955|bkenned2@hsc.wvu.edu|
22289961|NCT05387434|University of Kansas Medical Center|Dr. Anna Gorczyca|913-588-9077|agorczyca@kumc.edu|
22289962|NCT04233918|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22289963|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com|
22289964|NCT00865280|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22289965|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22289966|NCT02371941|The University of Tennessee Health Science Center|Dr. Jay Lieberman|901-287-7337|jlieber1@uthsc.edu|
22289967|NCT01472718|Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana,|Marco De Carlo, MD, PHD|+39 050995326|marcodecarlo@gmail.com|
22289968|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu|
22289969|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
22289970|NCT03091348|Men|Abraham Morgentaler|617-277-5000|research@menshealthboston.com|
22289971|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
22289972|NCT02087423|AstraZeneca|Phillip Dennis, MD, PhD|+1 301 398-5549|ClinicalTrialTransparency@astrazeneca.com|
22289973|NCT03574181|Boston Medial Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
22289974|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com|
22289975|NCT01980485|Penn State University|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
22289976|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com|
22289977|NCT02633020|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22289978|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu|
22289979|NCT05661851|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|(347) 903-5029|njoshi30@its.jnj.com|
22289980|NCT02152956|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22289981|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu|
22289982|NCT03753789|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22289983|NCT01012089|University of Oklahoma College of Pharmacy|Teresa Lewis Pharm D|405-271-2859|Teresa-Lewis@ouhsc.edu|
22289984|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu|
22289985|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com|
22289986|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22289987|NCT02654769|Teva Pharmaceuticals Inc., USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
22289988|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu|
22289989|NCT02055118|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22289990|NCT03098615|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
22289991|NCT02281383|Memorial Sloan Kettering Cancer Center|Dr. Harry Herr, MD|646-422-4411|herrh@MSKCC.ORG|
22289992|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu|
22289993|NCT04270370|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289994|NCT01324141|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22289995|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu|
22289996|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22289997|NCT04189224|Johnson & Johnson Vision Care, Inc.|Thomas R Karkkainen.|1-800-843-2020|tkarkkai@its.jnj.com|
22289998|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22289999|NCT03483922|HKG Epitherapeutics|David Cheishvili|5142601972|david.cheishvili@hkgepitherapeutics.com|
22290000|NCT04313647|Ruijin Hospital , Shanghai Jiao Tong University School of Medicine|Dr. Qu|(+86)2164370045|jmqu0906@163.com|
22290001|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822||9493
22290002|NCT02933671|Duke University|W. Michael Bullock, MD, PhD|919-668-2024|william.bullock@duke.edu|
22290003|NCT00830869|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22290004|NCT00507728|UT MD Anderson Cancer Center|Paul M Cinciripini, MD, Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
22290005|NCT04601454|Medtronic|DTM-LE Clinical Research Study Team|763-514-4000|rs.scsresearch@medtronic.com|
22290006|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu|
22290007|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org|
22290008|NCT01250496|Rush University Medical Center|Dr. Rami Doukky; Director of Nuclear Cardiology|312-942-4655|rami_doukky@rush.edu|
22290009|NCT00802113|Columbia University|Prakash Satwani, MD|(212) 305-0223|ps2087@cumc.columbia.edu|
22290010|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
22290011|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22290012|NCT01332799|University of Iowa|Dr. Roberto Kalil|319-355-6564|roberto-kalil@uiowa.edu|
22290013|NCT03467152|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22290014|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22290015|NCT04583709|Geisinger Heart Institute|Pugazhendhi Vijayaraman|5708085444|pvijayaraman1@geisinger.edu|
22290016|NCT01236547|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22290017|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com|
22290018|NCT04140227|Bausch and Lomb|Johnson Varughese VP Clinical Services|908-927-1162|johnson.varughese@bausch.com|
22290019|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com|
22290020|NCT04022733|Ajou University|Associate professor in Anesthesiology Department|82-31-2195689|beye98@aumc.ac.kr|
22290021|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu|
22290022|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
22290023|NCT04224688|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22290024|NCT03083990|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
22290025|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290026|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22290027|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com|
22290028|NCT02709538|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22290029|NCT05099263|Aerin Medical|Anais Laborde, Sr. Director of Clinical Operations|6505189624|alaborde@aerinmedical.com|
22290030|NCT00835211|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22290031|NCT02343549|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22290032|NCT03087617|Imbio, Inc|Director of Engineering|612520360|laurenkeith@imbio.com|2142
22290033|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
22290034|NCT02160041|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|novartis.email@novartis.com|
22290035|NCT04450381|Masimo Corporation|Vikram Ramakanth|949-297-7000|clincalresearchdept@masimo.com|
22290036|NCT03899467|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+8651262639938|PR@kintor.com.cn|
22290037|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu|
22290038|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22290039|NCT04343235|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
22290040|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411|kelleym@duke.edu|7326
22290041|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22290042|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290043|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290044|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22290045|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22290046|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22290047|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu|
22290048|NCT02969655|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290049|NCT00597597|Rush University Medical Center|Ruta Rao|312-942-3324|ruta_d_rao@rush.edu|
22290050|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290051|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu|
22290052|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
22290053|NCT02703337|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290054|NCT03508908|Aurum Institute|Dr. Eduard Sanders|254723593762|ESanders@auruminstitute.org|
22290055|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu|
22290056|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
22290057|NCT02758184|Duke University|Sergio Mendoza Lattes, M.D.|919-684-2023|sergio.mendoza@duke.edu|
22290058|NCT01584440|Avanir Pharmaceuticals, Inc.|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
22290059|NCT04237116|Novartis Pharma GmbH|Study Director|(862) 778-8300|novartis.email@novartis.com|
22290060|NCT03212144|Columbia University|Dr. Richard Sloan|6467748947|rps7@columbia.edu|
22290061|NCT00899431|The University of Texas MD Anderson Cancer Center|Dr. Issa F. Khouri, MD/Professor, Stem Cell Transplantation|713- 745-0049|ikhouri@mdanderson.org|
22290062|NCT05225805|Nabriva Therapeutics US, Inc.|Christine Guico-Pabia, MD, MBA, MPH|610-981-2874|christine.guico-pabia@nabriva.com|
22290063|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
22290064|NCT01821560|University of Pennsylvania|Dr. Teresa R. Franklin|215-746-1883|teresafr@pennmedicine.upenn.edu|
22290065|NCT01338298|Maryland Psychiatric Research Center|AnnMarie Kearns, MS|4104066854|akearns@som.umaryland.edu|
22290066|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333||
22290067|NCT05477108|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-94 79|information.center@astrazeneca.com|
22290068|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com|
22290069|NCT05688670|Duke University Medical Center|Lisa Einhorn, M.D.|(919) 668-4000|lisa.einhorn@duke.edu|
22290070|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22290071|NCT04941443|Boston Medical Center, Department of Anesthesiology|Rachel Achu, MD|(617) 414-2000|rachel.achu@bmc.org|
22290072|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22290073|NCT03897439|University of Kanas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
22290074|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22290075|NCT04586387|Virginia Commonwealth University|Carrie Peterson|804 827 5270|clpeterson@vcu.edu|
22290076|NCT02047344|Golden Biotechnology Corp.|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
22304876|NCT03302156|UW School of Medicine and Public Health|Elizabeth Sadowski, MD|608-263-9028|esadowski@uwhealth.org|
22290077|NCT00361634|Amgen Inc.|Study Director|866-572-6436||
22290078|NCT05315908|University of California San Diego|Dr. Jesse Nodora|(858) 822-3686|jnodora@health.ucsd.edu|
22290079|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp|
22290080|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
22290081|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290082|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu|
22290083|NCT04074161|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22290084|NCT02317744|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
22290085|NCT03595228|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422|medical.information_us@bavarian-nordic.com|8274
22290086|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
22290087|NCT03232333|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
22290088|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu|
22290089|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810|david.pennington2@va.gov|4504
22290090|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22290091|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290092|NCT01214057|The University of Texas Health Science Center at Houston|Davide Cattano, MD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
22290093|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22290094|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22290095|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
22290096|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22290097|NCT02673541|Dartmouth-Hitchcock Medical Center|Dr Jeffrey Adler|603-650-5261|Jeffrey.m.adler@hitchcock.org|
22290098|NCT05408637|Massachusetts General Hospital and Harvard Medical School|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
22290099|NCT04975438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290100|NCT02693132|University of Colorado Denver|Seth Creasy|720-848-6477|seth.creasy@ucdenver.edu|
22290101|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
22290102|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu|
22290103|NCT05405257|Baylor College of Medicine|Keren Machol|7137987359|machol@bcm.edu|
22290104|NCT02246413|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
22290105|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu|
22290106|NCT03116152|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22290107|NCT02413151|University of Lisbon|Maria Helena Santa-Clara Pombo Rodrigues|00351917377277|santaclara@fmh.ulisboa.pt|
22290108|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
22290109|NCT03500224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22290110|NCT00335764|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-3657|jfisher@jhmi.edu|
22304877|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu|
22304878|NCT03635112|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22304879|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov|
22304880|NCT01950260|Mayo Clinic|Dr. Marius N. Stan|507-284-2463|stan.marius@mayo.edu|
22304881|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr|
22304882|NCT03283553|Johns Hopkins University|Research Program Manager|410-614-7910|dechava1@jhu.edu|
22304883|NCT03686683|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
22304884|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984||
22304885|NCT05124899|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22304886|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu|
22304887|NCT03432533|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22304888|NCT03587194|Psoriasis Treatment Center of Central New Jersey|Ashley Reed|6094434500|ashley.reed@schweigerderm.com|
22304889|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304890|NCT00797225|AbbVie|Global Medical Services|800-633-9110||
22304891|NCT02408965|UCSF|Jennifer Kerns|4152068715|Jennifer.kerns@ucsf.edu|
22304892|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
22304893|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com|
22304894|NCT03419780|University of Pennsylvania|Dr Rebecca Hamm|215-662-6913|rebecca.feldmanhamm@pennmedicine.upenn.edu|
22304895|NCT01605136|Clinuvel Inc.|Dr. Dennis Wright|646 527 7310|Dennis.Wright@clinuvel.com|170
22304896|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22304897|NCT04833855|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22290111|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290112|NCT00145977|The University of Chicago|Tamara Vokes, MD|773-702-1465|tvokes@medicine.bsd.uchicago.edu|
22290113|NCT03435783|Brown University School of Public Health|Tyler Wray|401-863-6659|tyler_wray@brown.edu|
22304898|NCT02806336|Baltimore VA Geriatric Research Education and Clinical Center|Dr. Leslie Katzel|4106057248|leslie.katzel@va.gov|
22304899|NCT03682536|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22290114|NCT02645019|Nationwide Children's Hospital|Mineto Kamada|6147224200|mineto.kamata@gmail.com|
22290115|NCT01573052|VA Salt Lake City Medical Center|Dr. Christopher Stock|801-582-1565|christopher.stock@va.gov|1172
22290116|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22290117|NCT02717832|University of Michigan|Dr. Jeffrey Horowitz|734-647-1076|jeffhoro@umich.edu|
22290118|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290119|NCT01818752|Amgen Inc.|Study Director|866-572-6436||
22290120|NCT04629066|Duke Clinical Research Institute|Marjan Cobbaert|919-668-9740|mr157@duke.edu|
22290121|NCT03911102|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22290122|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590||
22290123|NCT02369172|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22290124|NCT02872285|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
22290125|NCT02970942|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22290126|NCT00508196|University of Dundee|DR Anna Maria Choy|01382 383482|a.choy@dundee.ac.uk|
22290127|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22290128|NCT03374202|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22290129|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22290130|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290131|NCT02793856|West China Hospital, Sichuan University|You Lu|+862885423571|283494287@qq.com|
22290132|NCT03630770|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
22290133|NCT02558829|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
22290134|NCT02248688|Dayton Interventional Radiology-Research|Mubin Syed, MD|937-215-0878|mubinsyed@aol.com|
22290135|NCT00955201|Edward Hines Jr. VA Hospital|Evan Stubbs|708-202-3507|evan.stubbs@va.gov|
22290136|NCT02737891|Saniona A/S|Kim Krogsgaard|20148384|kim.krogsgaard@saniona.com|0045
22290137|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee|
22290138|NCT01988584|The University of Texas Health Science Center at Houston|Charles S. Cox, MD, Professor|713-500-7300|charles.s.cox@uth.tmc.edu|
22290139|NCT01816945|Yale University|Megan Smith Associate Professor|203 764 8655|megan.smith@yale.edu|
22290140|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22290141|NCT04973436|Duke University School of Medicine|Tamara Somers, PhD|9194163408|tamara.somers@duke.edu|
22290142|NCT00275340|University of Toronto|Monica Parry, RN, PhD, CCN(C)||parrym@kgh.kari.net|
22290143|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org|
22290144|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22290145|NCT02365480|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22290146|NCT01034670|Stanford University|Shai Friedland, MD|(650) 617-2732|shaif@stanford.edu|
22290147|NCT04762719|Mayo Clinic|Madhusudan (Madhu) Grover, M.B.B.S.|507-293-2698|Grover.Madhusudan@mayo.edu|
22290148|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590||
22290149|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu|
22290150|NCT01099449|Mayo Clinic|Charles Loprinzi, M.D.|(507) 284-3731|cloprinzi@mayo.edu|
22290151|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com|
22290152|NCT01798849|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22290153|NCT02395172|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22290154|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282|ulrike.weber@od-os.com|100
22290155|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com|
22290156|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com|
22290157|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22290158|NCT00475982|VA Medical Center Greater Los Angeles Healthcare System|William Aronson, MD|3102683446|waronson@ucla.edu|
22290159|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu|
22290160|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org|
22290161|NCT02778113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22290162|NCT02410343|Teva Branded Pharmaceutical Products|Director of Clinical Trials|215-591-3000|Public_CTD@tevapharm.com|
22290163|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu|
22290164|NCT02663934|Washington University in St. Louis|Brittany Nelson, Senior Clinical Research Coordinator|314-747-8425|bmnelson@wustl.edu|
22290165|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229||
22290166|NCT00271505|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
22290167|NCT04556383|GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB004, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22290168|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu|
22290169|NCT02720042|Becton, Dickinson and Company|Sandra van Guldener|+31 6 46900840|sandra.vanguldener@bd.com|
22290170|NCT03704636|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22290171|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
22290172|NCT04784442|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22290173|NCT00509145|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22290174|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22290175|NCT01994889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290176|NCT01748240|academic group|Groupe Francophone des Myelodysplasies|+ 33 (0)1 71 20 70 59|fatiha.chermat@aphp.fr|
22290177|NCT02037555|Grifols Therapeutics, LLC|Miquel Barceló, PhD|+34 935.712.368|Miquel.Barcelo@grifols.com|
22304900|NCT04824131|HPTN Statistical & Data Management Center|HPTN Statistical Manager|1206-667-4004|HPTN-Data-Access@scharp.org|
22304901|NCT03643965|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
22304902|NCT04536025|University of Colorado|Dr. Chelsey Anderson|12069926861|chelsey.anderson@cuanschutz.edu|
22304903|NCT03008122|Saint Louis University|Sarah George, MD|314-977-9035|sarah.george@health.slu.edu|
22304904|NCT04159896|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
22304905|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
22304906|NCT01222247|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
22304907|NCT02338609|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
22304908|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304909|NCT02655653|Montefiore Medical Centr|Dr. Jonathan Leff|7189205409|jleff@montefiore.org|
22304910|NCT03298113|3M Healthcare Business Group|Nancy Klinger, Clinical Manager|651 736|nmklinger@mmm.com|5825
22304911|NCT04736056|Duke University|Hannah Fisher, PhD|919-416-3471|hannah.fisher@duke.edu|
22304912|NCT04529538|PATH|Chris Gast, Ph.D.|206-285-3500|cgast@path.org|
22304913|NCT03669042|Artivion, Inc.|Karen Sylvester|7704193355|karen.sylvester@artivion.com|
22304914|NCT02223182|DBV Technologies|Pharis Mohideen, MD Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
22304915|NCT03552978|San Francisco Veterans Affairs Medical Center|Ellen Herbst, MD|415-221-4810|Ellen.Herbst@va.gov|24926
22304916|NCT03437668|UCaliforniaLA|Stephen R Marder|3102670221|smarder@mednet.ucla.edu|
22304917|NCT03298815|University of Utah|Catherine Lee, MD|206-667-4922|Catherine.Lee@hci.utah.edu|
22290178|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com|
22290179|NCT02259088|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22290180|NCT00932828|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22290181|NCT03060551|Department of Plastic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea|Suk-Ho Moon|821090803527|nasuko@catholic.ac.kr|
22290182|NCT03562988|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|609-806-1200|annahita.ghassemi@churchdwight.com|
22290183|NCT02453672|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
22290184|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu|
22290185|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au|
22290186|NCT04166240|VAORD|Hardeep Singh|713 7948515|hardeep.singh@va.gov|
22290187|NCT03698591|Duke University|Dr. Kevin LaBar, PhD.|(919)668-2424|klabar@duke.edu|
22290188|NCT03009396|Redhill Biopharma|Reza Fathi, Sn. VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
22290189|NCT00548652|VANebraska|Cyrus Desouza|4023468800|cyrus.desouza@va.gov|5506
22290190|NCT00610480|UT Southwestern Medical Center|Peter Chen|214-648-3837|peter.chen@utsouthwestern.edu|
22290191|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu|
22290192|NCT02660983|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22290193|NCT04410133|Blue Earth Diagnostics|Head of Research and Development|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
22290194|NCT02902146|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
22290195|NCT03376295|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290196|NCT00893815|Henry Jackson Foundation|Infectious Diseases Clinical Research Program||contactus@idcrp.org|
22290197|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
22290198|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22290199|NCT04180540|Emory University|Michael lloyd|404-712-4063|mlloyd@emory.edu|
22290200|NCT06457204|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22290201|NCT01457352|Sun Pharma Advanced Research Company Limited|SPARC|912266455645|Clinical.Trials@Sparcmail.com|
22290202|NCT02712047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290203|NCT03865316|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
22290204|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22290205|NCT01371032|Cedars Sinai Medical Center|Dr. Roya Yumul, MD, PhD|310-423-1682|Roya.Yumul@cshs.org|
22290206|NCT03381742|Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China|Dr. Yue Li|86-451-85555673|ly99ly@vip.163.com|
22290207|NCT03035487|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
22290208|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com|
22304918|NCT04996069|Tufts University School of Dental Medicine|Mabi Singh|6176363931|mabi_l.singh@tufts.edu|
22304919|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu|
22304920|NCT04739423|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
22304921|NCT02538679|Cedars Sinai Medical center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
22304922|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|groman@appliedstats.com|847
22304923|NCT02451423|University of California, San Francsico|Dr. Lawrence Fong, MD|(415) 514-3160|lawrence.fong@ucsf.edu|
22290209|NCT02908490|University of Pittsburgh|Kimberly P. Liang, MD, MS|412-586-3550|liangkp@upmc.edu|
22290210|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com|
22290211|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290212|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329||
22290213|NCT00576680|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
22290214|NCT01836276|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
22290215|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719|g.young@visioncare.co.uk|207
22290216|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22290217|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov|
22290218|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com|
22290219|NCT02208063|Cumberland Pharmaceuticals Inc.|Senior Director of Clinical and Regulatory Affairs|615-255-0068|ahaeberle@cumberlandpharma.com|
22290220|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22290221|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290222|NCT02366091|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
22290223|NCT05194579|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290224|NCT02338232|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22290225|NCT03890666|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22290226|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
22290227|NCT02331095|The Ohio State University|Dr. Tzu-Fei Wang|614-366-8366|tzufeiwang@gmail.com|
22290228|NCT03495856|University of North Carolina School of Medicine|Carrie Brintz|919-445-6109|carrie_brintz@med.unc.edu|
22290229|NCT02122783|MossRehab|Mukul Talaty|2156636682|mctalaty@einstein.edu|
22290230|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22290231|NCT04987788|Icahn School of Medicine at Mount Sinai|Sarah Miller|(212) 824-7783|sarah.miller@mssm.edu|
22290232|NCT02010151|Seoul National University Hospital|Dr. Sun Young Lee|+82-10-9269-2376|sy2376@gmail.com|
22290233|NCT02213133|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22290234|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290235|NCT03180619|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22290236|NCT02743611|Bellicum|Contact for Clinical Trials|(832) 384-1100|clinicaltrials@bellicum.com|
22290237|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22290238|NCT01989208|Sulfagenix|President and CEO|1-318-349-3851|tgiordano@sulfagenix.com|
22290239|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
22290240|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22290241|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22290242|NCT03567343|The University of Arizona|Dr Michael Grandner|15206266346|grandner@email.arizona.edu|
22290243|NCT00574236|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
22290244|NCT00852371|Makerere University Kampala|Nankabirwa Joaniter|+256772676429|jnankabirwa@yahoo.co.uk|
22290245|NCT02744040|Fred Hutchinson Cancer Research Center|Ann C Duerr, MD, PhD, MPH, Member|206-667-7938|aduerr@fredhutch.org|
22290246|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290247|NCT03456882|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Elisabetta Pupillo|+390239014605|elisabetta.pupillo@marionegri.it|
22290248|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov|
22290249|NCT02083861|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
22290250|NCT02509026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290251|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22290252|NCT00167219|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan, MD|+1 612-626-2961|macmi002@umn.edu|
22290253|NCT04947085|Maimonides Medical Center|Sergey Motov|718-283-6000|smotov@maimo.org|
22304924|NCT04019561|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22304925|NCT05781490|Lument AB|Dr Jan Marsal|+46709822008|jan.marsal@med.lu.se|
22304926|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org|
22304927|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
22304928|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
22304929|NCT03212365|University of Utah|Christopher Pannucci, MD|801 581 2121|christopher.pannucci@hsc.utah.edu|
22304930|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300||
22304931|NCT03005288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22304932|NCT04011033|BeijingYouan Hospital|Lu Jun|+86-010-83997153|lujun98@ccmu.edu.cn|
22258951|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov|
22304933|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org|
22304934|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org|
22274460|NCT02688933|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22290254|NCT00243841|Indiana University|Amy Miller Research Manager|317 944 1242|amym@iu.edu|
22304935|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net|
22304936|NCT03658629|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22304937|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304938|NCT03323151|ECOG-ACRIN Statistical Center|Opeyemi Jegede, Statistician|617-582-7613|ojegede@ds.dfci.harvard.edu|
22304939|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304940|NCT03253653|San Diego State University Research Foundation|Dr. Nada Kassem|619-370-7488|Nkassem@sdsu.edu|
22304941|NCT01489176|University of Nebraska Medical Center|Thomas R Porter|402-559-5156|trporter@unmc.edu|
22304942|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300||
22304943|NCT02857283|UNC Center for Environmental Medicine, Asthma and Lung Biology|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
22304944|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22304945|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304946|NCT00961805|Federal University of Sao Paulo|Andreia S Baptista, PT|551155764239|deiasalvador1@yahoo.com.br|
22304947|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22304948|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22304949|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304950|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300||
22304951|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304952|NCT05080192|University of Pennsylvania|Seavmeiyin Kun|215-917-0115|seavmeiyin.kun@pennmedicine.upenn.edu|
22304953|NCT01743729|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22304954|NCT05074498|Truebinding, Inc|Dongxu Sun|650-847-1117|info@truebinding.com|
22304955|NCT04094064|University of Virginia Center for Diabetes Technology|Dr. Meaghan Stumpf|(434) 982-4351|MMS5CF@hscmail.mcc.virginia.edu|
22304956|NCT01306331|Evofem|Clinical Operations|858-550-1900|clinicaloperations@evofem.com|
22304957|NCT03614130|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22304958|NCT03371108|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
22304959|NCT05805059|Coopervision|Jose A. Vega,OD,MSc,FAAO, PhD|925-621-3761|jvega2@coopervision.com|
22304960|NCT00172185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22290255|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290256|NCT04303195|Neurogastrx|Chief Scientific Officer|17817304040|info@neurogastrx.com|
22290257|NCT06221826|Pharmasoft|Meshcherskiy Y.E., Medical director|+7(495)626-47-55|meshcherskiy_y@pharmasoft.ru|140
22290258|NCT00773604|University of California, San Francisco|Jill Ostrem|415-353-7885|Jill.Ostrem@ucsf.edu|
22290259|NCT01601652|UC Davis|Arthur J de Lorimier, Director of Pediatric Gastroenterology|916-734-3112|adelorimier@ucdavis.edu|
22304961|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com|
22304962|NCT04188288|Yale University|Kathleen Garrison, PhD|203-737-6232|kathleen.garrison@yale.edu|
22304963|NCT02790606|C.R. Bard|Talar Saber, Clinical Project Manager|480-379-2839|talar.saber@crbard.com|
22290260|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com|
22290261|NCT04219085|Yale University|Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
22290262|NCT04469998|AxeroVision, Inc.|Dr. Houman Hemmati|+1 (310) 600-4123|houman@axerovision.com|
22290263|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com|
22290264|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu|
22290265|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org|
22290266|NCT03425253|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22290267|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org|
22290268|NCT04614324|Aerin Medical|Anais Laborde Sr. Director of Clinical Affairs|650-518-9624|alaborde@aerinmedical.com|
22304964|NCT02735915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22304965|NCT05328973|M.D. Anderson Cancer Center|Neil Bailard, MD|713-597-1687|nbailard@mdanderson.org|
22304966|NCT04669249|PRO Health Group|Dr. Steven Proctor|305-814-7762|sproctor@prohealthgroup.net|
22304967|NCT03127358|Albert Einstein College of Medicine|Julia Arnsten, MD|718-920-6641|jarnsten@montefiore.org|
22304968|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300||
22304969|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304970|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu|
22304971|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304972|NCT04565249|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
22304973|NCT02022462|University of Southern California|Dr. John Brekke|213-740-0297|brekke@usc.edu|
22304974|NCT03613129|Bateman Horne Center|Lucinda Bateman, MD|(801) 359-7400|LBateman@batemanhornecenter.org|
22304975|NCT02334306|MedImmune, LLC|Gabor Illei|+1 240 558 0038 118|information.center@astrazenea.com|
22304976|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22304977|NCT02390557|Massachusetts General Hospital, Mongan Institute for Health Policy|Lisa I. Iezzoni, MD, MSc|6176430657|liezzoni@mgh.harvard.edu|
22304978|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu|
22290269|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu|
22290270|NCT04174365|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22304979|NCT02002819|UCLA Mary S. Easton Center for Alzheimer's Disease Research|Dr. Keith Vossel|310-794-3665,|neuroeaston@mednet.ucla.edu|
22304980|NCT02446223|Cosmetic Laser Dermatology/West Dermatology Research|Clinical Research Coordinator|858 657 1004|IGuiha@CLderm.com|
22304981|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com|
22290271|NCT03472547|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
22290272|NCT05141448|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|614-531-6781|anixon1@its.jnj.com|
22304982|NCT03006341|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304983|NCT04337489|Imperial College London|Fahad Iqbal|020 3312 6666|f.iqbal@imperial.ac.uk|
22304984|NCT02950545|University of Virginia|Principal Investigator|434-924-8021|djc4f@virginia.edu|
22304985|NCT04296942|National Cancer Institute|Dr. Fatima H. Karzai|301-480-7174|fatima.karzai@nih.gov|
22304986|NCT03255941|FHI 360|Mario Chen|919 544 7040|mchen@fhi360.org|11399
22304987|NCT02865434|Navidea Biopharmaceuticals|Bonnie Abbruzzzese|6147937500|babbruzzese@navidea.com|
22304988|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22304989|NCT01528709|Lynn Heart and Vascular Institute, Boca Raton Regional Hospital|Dr. Alexander Kulik|5619556300|alex_kulik@yahoo.com|
22304990|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com|
22304991|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu|
22304992|NCT01008748|UT MD Anderson Cancer Center - Clinical Research Operations|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
22304993|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org|
22304994|NCT03251378|HUTCHMED International|William Schelman, MD, PhD|973-306-4490|albertof@hutch-med.com|+1
22304995|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323|Mitchell.Goldman@astrazeneca.com|+1
22304996|NCT05780047|Million Marker Wellness, Inc.|Carol Kwiatkowski, VP of Research|510-305-5690|carol@millionmarker.com|
22304997|NCT03109015|Duke University|Michael Harrison, MD|919-668-8108|michael.harrison@duke.edu|
22304998|NCT03194776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22304999|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
22305000|NCT00764868|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305001|NCT02698436|JNJWorldwide|Lisa Fitzgerald|+1 908-904-6235|lfitzge6@its.jnj.com|
22305002|NCT00665561|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305003|NCT04949399|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305004|NCT01515319|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
22305005|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com|
22305006|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22305007|NCT05397470|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22305008|NCT01919619|M D Anderson Cancer Center|Issa Khouri, MD / Stem Cell Transplantation Department|713-792-8750|ikhouri@mdanderson.org|
22305009|NCT02738840|Abbott|Robyn A Capobianco|+1 512 934 3941|robyn.capobianco@abbott.com|
22305010|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov|
22305011|NCT02162446|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22305012|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22305013|NCT01311648|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22305014|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22305015|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net|
22305016|NCT03618095|Boston Scientific|Amy Maurer|800-876-9960|amy.maurer@bsci.com|
22305017|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22290273|NCT04627285|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22290274|NCT03658876|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
22290275|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22290276|NCT04096482|Emory University|Joshua M Levy|(404) 778-3381|joshua.levy2@emory.edu|
22290277|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
22290278|NCT03137069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22290279|NCT03225859|Minneapolis VA Medical Center|Shannon Kehle-Forbes, PhD|612-467-4772|Shannon.Kehle-Forbes@va.gov|
22290280|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290281|NCT02434471|Duke University|Mustafa R. Bashir, M.D.|919-684-7366|mustafa.bashir@duke.edu|
22290282|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
22290283|NCT00369629|Northwestern University|Barbara Pro||barbara.pro@nm.org|
22290284|NCT04839562|Massachusetts General Hospital|Dr. Craig Surman|6176808489|csurman@partners.org|
22290285|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org|
22290286|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
22290287|NCT02907892|University of Minnesota|Dr. Rachel Vogel|6513345982|isak0023@umn.edu|
22290288|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com|
22290289|NCT01964755|University of Miami|Juan C. Ramos MD|305-243-1326|jramos2@med.miami.edu|
22305018|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com|
22290290|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com|
22290291|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590||
22290292|NCT03135119|Penn State College of Medicine|Dr. Brian Allen|7175314100|ballen1@pennstatehealth.psu.edu|
22305019|NCT05526911|TB Alliance|Antonio Lombardi|917.601.0024|antonio.lombardi-consultant@tballiance.org|
22305020|NCT05025449|Emory University|Laura Oh, MD|404-778-1709|laura.oh@emory.edu|
22305021|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu|
22305022|NCT03379740|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22290293|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22305023|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
22305024|NCT02333630|Nationwide Children's Hospital|David Stukus, MD|614 722-4808|david.stukus@nationwidechildrens.org|
22305025|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22290294|NCT02766582|Medical College of Wisconsin|D. Denise Uyar|414-805-6606|duyar@mcw.edu|
22290295|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
22290296|NCT03032380|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22290297|NCT02937584|AstraZeneca|Stephan Stenglein, MD|+46 (0)31 776 1000|stephan.stenglein@astrazeneca.com|
22290298|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se|
22290299|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22290300|NCT00796445|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290301|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22290302|NCT04136444|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22290303|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22290304|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22290305|NCT02350764|Memorial Sloan Kettering Cancer Center|Dr. Adam Schoenfeld, MD|646-608-4042|schoenfa@mskcc.org|
22290306|NCT01433289|Baylor|Supriya Parikh|832-824-2589|supriya.parikh@bcm.edu|
22290307|NCT04132804|Massachusetts General Hospital|Dr. Kyle Staller|617-726-5565|kstaller@mgh.harvard.edu|
22290308|NCT02535572|Medical University of South Carolina|Morgan Dancy|843-876-5141|maddoxm@musc.edu|
22290309|NCT03163017|The University of Texas Health Science Center at Houston|Joshua Gary, MD|713-486-6500|Joshua.L.Gary@uth.tmc.edu|
22290310|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22290311|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
22290312|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22290313|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca|
22290314|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org|
22290315|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com|
22290316|NCT02674204|Cedars-Sinai Medical Center|Marc Goodman, PhD|310-423-6188|Marc.Goodman@cshs.org|
22290317|NCT02646371|LimmaTech Biologics AG|Director of Clinical Trials|+41 44 733 8585|info@lmtbio.com|
22290318|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu|
22290319|NCT01536392|UT MD Anderson Cancer Center|Michael Frumovitz, Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
22290320|NCT02874144|Northwestern|Anju Peters|3126950513|anju.peters@northwestern.edu|
22290321|NCT02369744|Albert Einstein Medical Center|Kamran Mohiuddin; Director ED Clinical Research|2154562313|MOHIUDDK@EISNTEIN.EDU|
22290322|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com|
22290323|NCT02975557|Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22290324|NCT04525885|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290325|NCT02756806|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22290326|NCT03158285|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22290327|NCT03753113|Tabriz University of Medical Sciences|Dr. Farid Masoud|+989036859062|faridmasoud@gmail.com|
22290328|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22290329|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514||
22290330|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22290331|NCT02057081|VISN 5 Mental Illness Research, Education, and Clinical Center|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22290332|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com|
22305026|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22305027|NCT02347943|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
22305028|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
22305029|NCT01492309|UPenn|Deborah Kim, MD|6107261020|drkim@upenn.edu|
22305030|NCT02596906|Center for BrainHealth, The university of Texas at Dallas|Dr. Namrata Das|9728833266|Namrata.Das@utdallas.edu|
22305031|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22305032|NCT03441360|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22305033|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22305034|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22290333|NCT00978757|Francisco C. Bonofiglio|MD|541149590200|francisco.bonofiglio@hospitalitaliano.org.ar|4949
22290334|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com|
22305035|NCT04038099|UT Southwestern Medical Center|Christina Hicks, MS, APRN, WHNP-BC, FAUNA|2146453848|christy.hicks@utsouthwestern.edu|
22290335|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22290336|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk|
22305036|NCT01237678|ImmunoGen Inc.|Dr. Richard Bates, Sr. Manager, Publications|781 895 0196|Richard.Bates@immunogen.com|
22290337|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305037|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931|anne-monique.nuyt@recherche-ste-justine.qc.ca|3971
22290338|NCT00946153|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22290339|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de|
22290340|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305038|NCT01982760|Case School of Medicine|Dr. Bahman Guyuron|440-461-7999|bguyuron@guyuron.com|
22305039|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu|
22290341|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22290342|NCT04160975|Harvard University|Dr. Marcella Alsan|617-496-1770|marcella_alsan@hks.harvard.edu|
22290343|NCT04002908|Ariadne Labs|Katherine Semrau|6177805311|ksemrau@ariadnelabs.org|
22290344|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
22290345|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290346|NCT04359901|VA Boston Healthcare System|Westyn Branch-Elliman, MD, MMSc|857-203-5116|westyn.branch-elliman@va.gov|
22290347|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290348|NCT05601544|Johnson & Johnson Vision Care, Inc. (JJVC)|Senior Principal Research Optometrist|904-608-7238|jbuch@its.jnj.com|
22290349|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu|
22290350|NCT02537015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22290351|NCT03524729|VA|Dr. Sangeorzan|206-516-3261|bruce.sangeorzan@va.gov|
22290352|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22290353|NCT02626624|CarboFix Orthopedics Ltd.|Dvir Sherpsky, Director of Clinical Trials|+972-54-770-9920|dvir@carbo-fix.com|
22290354|NCT04084561|Center for Asian Health, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
22290355|NCT02695160|Sangamo Therapeutics|Medical Monitor|+1 510 307 7266|clinicaltrials@sangamo.com|
22290356|NCT02043899|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22290357|NCT02720107|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22290358|NCT01949337|Memorial Sloan-Kettering Cancer Center|Michael J. Morris, MD|646-422-4469|morrism@mskcc.org|
22290359|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu|
22290360|NCT03699475|Bellicum|Contact for Clinical Trial Information|(832) 384-1100|clinicaltrials@bellicum.com|
22290361|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu|
22290362|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22290363|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU|
22290364|NCT02267317|University of Texas Health San Antonio|Hanyu Liang|210-617-5300|liangh0@uthscsa.edu|15197
22290365|NCT03595618|Galapagos NV|Galapagos Medical Information|+32 15342900|medicalinfo@glpg.com|
22290366|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
22305040|NCT03163992|Samsung Medical Center|Jeeyun Lee|8223410-1779|jyunlee@skku.edu|
22305041|NCT02954055|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
22305042|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22305043|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22305044|NCT03750656|University of Kansas Medical Center|Dr. David Duchene|(913) 588-8721|dduchene@kumc.edu|
22305045|NCT03713645|Temple University Hospital, Inc.|Adam Diamond, PharmD, BCPS, FAST|215-280-8041|adam.diamond@tuhs.temple.edu|
22305046|NCT03050294|Wake Forest Baptist Health|Steven R. Feldman|336-716-7740|sfeldman@wakehealth.edu|
22305047|NCT04438785|Grupo Hospitalario Quironsalud|Francisco Jesus Gonzalez|0034645014593|fgonzasan@gmail.com|
22305048|NCT04831775|The University of Texas at Austin|Dr. Heather Cuevas|5124226059|hcuevas@mail.nur.utexas.edu|
22305049|NCT02027935|University of Texas MD Anderson Cancer Center|Dr. Adi Diab|(713) 745-7336|adiab@mdanderson.org|
22305050|NCT03115346|VA Hospital|Dr. Mark Eid|502-295-8961|mark.a.eid01@gmail.com|
22305051|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com|
22305052|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com|
22305053|NCT04873817|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Devyani.Nanduri@abbott.com|
22305054|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us|
22305055|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu|
22305056|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu|
22305057|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org|
22305058|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu|
22305059|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097||
22305060|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305061|NCT02337361|Public Health Institute/Alcohol Research Group|Madhabika B. Nayak|510-898-5849|mnayak@arg.org|
22305062|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu|
22305063|NCT03073005|Northwestern University|Dr. Jeffrey H Barsuk|312-926-5924|jbarsuk@nm.org|
22305064|NCT02230579|Medicines for Malaria Venture|Dr Cristina Donini - Associate Director|00 41 22 555 03 12|doninic@mmv.org|
22305065|NCT01734811|Inmunotek|Medical Director|916 510 010|mcasanovas@inmunotek.com|
22305066|NCT00062868|Baylor College of Medicine|Dr. Helen E. Heslop|832-824-4662|hheslop@bcm.edu|
22305067|NCT02427646|LHSC|Dr. Mandar Jog|519-685-8500|mandar.jog@lhsc.on.ca|76708
22305068|NCT03824236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22305069|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th|
22305070|NCT01786343|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
22305071|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305072|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
22305073|NCT04580407|Director|Study|+1-877-825-3327|TrialDisclosures@takeda.com|
22305074|NCT03230006|Center for Anxiety and Related Disorders, Boston University|Dr. Todd Farchione|6173539610|tfarchio@bu.edu|
22305075|NCT01974687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305076|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305077|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov|
22305078|NCT04880161|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
22274461|NCT04252625|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22274462|NCT03509467|Moffitt Cancer Center|Peter Kanetsky, PhD, MPH|813-745-3988|Peter.Kanetsky@moffitt.org|
22274463|NCT04379921|Stanford University|Corinna Zygourakis, MD|(650) 723-6469|corinnaz@stanford.edu|
22274464|NCT04275973|University of Wisconsin - Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
22274465|NCT06110754|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
22274466|NCT03383874|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22290367|NCT00422084|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
22290368|NCT01410344|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22290369|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290370|NCT03996369|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22290371|NCT01579812|UPMC Hillman Cancer Center|Dr. Ronald Buckanovich, MD, PhD|412-641-4721|buckanovichrj@mwri.magee.edu|
22290372|NCT00653432|Anika Therapeutics, Inc.|Kara Mezger, Exec Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22290373|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22290374|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22290375|NCT02353143|Menarini Ricerche|Director of Clinical Sciences|003905556809990|acapriati@menarini-ricerche.it|
22290376|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
22290377|NCT04740905|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22305079|NCT00901485|Royal Brompton Hospital|Miss Julia Kelly|+44 2073528121|j.kelly@rbht.nhs.uk|4183
22290378|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu|
22290379|NCT03077087|Regions Hospital|Joshua S Rosenzweig / Study Coordinator|651-254-3351|joshua.s.rosenzweig@healthpartners.com|
22290380|NCT01989468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22305080|NCT04207255|Medical University of South Carolina|Alan Brisendine|(843) 792-9007|brisend@musc.edu|
22290381|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22290382|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it|
22290383|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
22290384|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu|
22305081|NCT00256308|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
22290385|NCT01950013|Indiana University, Dept of Speech & Hearing Sci|Larry Humes|812-855-3507|humes@indiana.edu|
22305082|NCT01419717|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22305083|NCT02165605|UT Southwestern Medical Center|Sarmistha Sen|214-645-1477|Sarmistha.Sen@UTSouthwestern.edu|
22290386|NCT00993226|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22290387|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com|
22305084|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu|
22290388|NCT01765218|University of California, Davis|Kristin Hoffman, MD|916-205-2755|krhoffman@ucdavis.edu|
22290389|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22290390|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
22290391|NCT02929498|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274467|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov|
22305085|NCT03766438|Mayo Clnic|Mark Wieland, MD, MPH|507-284-1195|wieland.mark@mayo.edu|
22290392|NCT03353233|Duke University Medical Center|W. Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
22290393|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg|
22290394|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org|
22290395|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir|
22305086|NCT04048135|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-002@89bio.com|
22290396|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22305087|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22305088|NCT02485964|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22290397|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov|
22305089|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305090|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22290398|NCT02973438|University of Miami|Mark S. Nash, Ph.D.|3052433628|mnash@med.miami.edu|
22290399|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
22290400|NCT03255083|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22290401|NCT05009979|National Cancer Institute|Dr. Esther Mena Gonzalez|240-760-6111|esther.menagonzalez@nih.gov|
22290402|NCT05286749|UW School of Medicine and Public Health|Tana Chongsuwat, MD, MPH|224-260-1666|tana.chongsuwat@fammed.wisc.edu|
22290403|NCT02957968|Virginia Commonwealth University Massey Cancer Center|Massey CTO Breast Team|804-628-6430|masseyctbrst@vcu.edu|
22290404|NCT00678743|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
22290405|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22290406|NCT02616146|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290407|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22290408|NCT01340872|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22290409|NCT03521102|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|bfriedm@montefiore.org|
22290410|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br|
22290411|NCT03039621|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22290412|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
22290413|NCT03254108|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22290414|NCT01771809|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22290415|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com|
22290416|NCT03930264|Nova Laboratories Limited|Dr Hussain Mulla|+44 (0)116 223 0100|hussain.mulla@novalabs.co.uk|
22290417|NCT02600871|University of Texas Health San Antonio|Dr. Adriana Segura Olson|2152649796|adriana.s.olson@gmail.com|
22290418|NCT02930980|Medtronic EMEA RCC|Valentina Amori, Medical Writer|+39 06 32814236|valentina.amori@medtronic.com|
22290419|NCT02361476|Rigshospitalet|Mogens Ydemann, MD|+45 35455620|mogens@ydemann.dk|
22290420|NCT01246466|AtriCure|Vice President, Clinical Affairs and Biometrics|1-513-644-8192|nndikintum@atricure.com|
22290421|NCT00911443|R&D Department - Sigma-Tau SpA|Roberto Camerini|+390691393562|roberto.camerini@sigma-tau.it|
22290422|NCT01142089|Cosmo Technologies Ltd.|Richard Jones|+35318170370|RJones@cosmopharma.com|
22290423|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk|
22305091|NCT02501629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22305092|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22305093|NCT03120676|Memorial Sloan Kettering Cancer Center|Dr. Anas Younes, MD|212-639-5059|younesa@mskcc.org|
22305094|NCT02933320|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22305095|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305096|NCT04878172|Cynosure|Jamie Trimper|9788776342|jamie.trimper@cynosure.com|
22305097|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
22290424|NCT01974765|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
22290425|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org|
22290426|NCT01489111|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22290427|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org|
22290428|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com|
22290429|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22290430|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290431|NCT02870933|National Cardiovascular Center Harapan Kita|Tri Wisesa Soetisna, M.D, MHA, PhD|+62215684093|tricts2000@yahoo.com|
22290432|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu|
22290433|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22290434|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
22290435|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
22290436|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir|
22290437|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com|
22290438|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22290439|NCT03005873|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
22290440|NCT04585009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290441|NCT02871882|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
22290442|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
22305098|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22290443|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu|
22290444|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com|
22290445|NCT04618770|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
22290446|NCT01733212|New York Methodist Hospital|Sandip Darji|718/780-3779|darji_sandip2005@yahoo.com|
22290447|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935||
22290448|NCT01252667|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22290449|NCT04644315|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22290450|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
22290451|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu|
22290452|NCT04497038|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22290453|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com|
22290454|NCT04493892|Columbia University|Jasmine A. McDonald|12123053586|jam2319@cumc.columbia.edu|
22290455|NCT02577887|Abbott (previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim@abbott.com|
22290456|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
22290457|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu|
22290458|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu|
22290459|NCT03816709|North Dakota State University|Kara Gange, Associate Professor|701-231-5777|kara.gange@ndsu.edu|
22290460|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
22290461|NCT03774823|Venus Concept Ltd.|Director, Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22290462|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290463|NCT00568633|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation)|650-725-8950|rlowsky@stanford.edu|
22290464|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22290465|NCT00977080|Abbott|Global Medical Services|800-633-9110||
22290466|NCT02080819|Virginia Commonwealth University|Dr. Liangsuo Ma|8048282871|liangsuo.ma@vcuhealth.org|
22290467|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com|
22290468|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290469|NCT03148691|Aclaris Therapeutics|Executive Director, Clinical Operations|4843247933|jschnyder@aclaristx.com|
22290470|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu|
22290471|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551|juraj.koska@va.gov|7685
22290472|NCT05092360|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
22305099|NCT03681691|Wake Forest University Health Science|Christina Hugenschmidt, PhD|336.713.4190|chugensc@wakehealth.edu|
22305100|NCT02534896|SPARC|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
22305101|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305102|NCT00269399|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
22305103|NCT03439124|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
22305104|NCT04353037|UnitedHealth Group R&D / Optum Labs|Mike Lahm, Director Data Science|302-379-0209|MichaelLahm@uhg.com|
22305105|NCT02749045|University of Pittsburgh Medical Center|Prem Soman, MD, PhD|412 647 3435|somanp@upmc.edu|
22305106|NCT00463151|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22305107|NCT05349084|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
22305108|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
22305109|NCT03688542|Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
22305110|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305111|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305112|NCT02341534|BIOTRONIK SE & Co. KG|Sascha Mrosk, Senior Clinical Project Manager|15168901308|sascha.mrosk@biotronik.com|0049
22305113|NCT03398356|Wroclaw Medical University|Dr Edyta Sutkowska|+48/503077016|edytasutkowska@yahoo.com|
22305114|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
22305115|NCT04034121|Elixir Medical|Candace Elek, Executive Vice President, Clinical Research|408-636-2020|celek@elixirmedical.com|
22305116|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330|bellis@durrievision.com|7255
22305117|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305118|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22305119|NCT02096003|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
22305120|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
22305121|NCT01112735|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|734-646-8214|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22305122|NCT03999944|FRESCA Medical|Vice President, RA/CA/QA|949-542-3535|mlmooney@frescamed.com|
22305123|NCT00884611|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
22305124|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu|
22305125|NCT01941316|Cancer Research and Biostatistics|Director of Quality and Regulatory Compliance|206-839-1782|lisau@crab.org|
22305126|NCT02775435|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22305127|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305128|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com|
22305129|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305130|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
22305131|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu|
22305132|NCT04555044|Organization: Baxter Healthcare|Name/Official Title: Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22305133|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu|
22258952|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22258953|NCT05431153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258954|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258955|NCT03341507|Iuliu Hatieganu University of Medicine and Pharmacy- Cluj Napoca Romania|Dr Ioan Florin Marchis|+40757065205|marchis.ioan@umfcluj.ro|0757065205
22258956|NCT03352427|University of Michigan|Carl Koschmann, MD|734-615-2736|ckoschma@umich.edu|
22258957|NCT00989261|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22258958|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258959|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
22258960|NCT01224210|Tufts Medical Center|Ioana Preston MD|617-636-7609|ipreston@tuftsmedicalcenter.org|
22258961|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22258962|NCT03151499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258963|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22258964|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261||
22258965|NCT03687125|Mundipharma Research Limited|Terry Nichols|(0044)1223424444|terry.nichols@mundipharma-rd.eu|
22258966|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org|
22258967|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org|
22258968|NCT00490061|Stanford University|Quynh Le|650-498-5032|qle@stanford.edu|6506370734
22258969|NCT01982383|Medical Faculty Associates|Nicole Swanson|202-741-2437|nswanson@mfa.gwu.edu|
22258970|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu|
22258971|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
22258972|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu|
22258973|NCT02746263|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22258974|NCT02536378|Silk Road Medical, Inc.|Ric Ruedy, Executive VP, Clinical, Regulatory and Quality Affairs|408-585-2112|ric@silkroadmed.com|
22258975|NCT02418910|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
22258976|NCT02472977|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Clinical.Trials@bms.com|Clinical.Trials@bms.com|
22258977|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org|
22258978|NCT01644890|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
22258979|NCT04942379|UMass Chan Medical School|Dr. Michelle Trivedi|7744418086|Michelle.Trivedi3@umassmed.edu|
22258980|NCT01413204|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22258981|NCT03287050|University of Michigan|Zachery Reichert|764-3066|zreiche@med.umich.edu|
22258982|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22258983|NCT02497391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258984|NCT02452060|NYU Langone Medical Center|Jing Wang|212-460-0176|jing.wang@nyulangone.org|
22258985|NCT03031899|The Oxford Dental college|Dr. Anisha Yaji|9480718531|dr.anishayaji@gmail.com|
22258986|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22258987|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616|katie.bush@integralife.com|267
22258988|NCT04682444|Farmak|Clinical Enquiry Manager|+ 38 (067) 464-28-27|Farmak-Clinical-Affairs@regenold.com|
22290473|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22290474|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290475|NCT04531462|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290476|NCT05338671|University of Washington|Avina Paranjpe|206-543-5044|avina@uw.edu|
22290477|NCT03859973|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290478|NCT03085914|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22290479|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290480|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th|
22290481|NCT03874429|Laboratoires Thea|Corentin Le Camus|0680382020|corentin.lecamus@theapharma.com|+33
22290482|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22290483|NCT03642132|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290484|NCT03560518|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22290485|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22290486|NCT02307253|Fondazione Policlino Universitario A Gemelli IRCCS|Dr Alberto Larghi|0630156580|alberto.larghi@yahoo.it|
22290487|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22290488|NCT04121078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22290489|NCT00430183|Memorial Sloan-Kettering Cancer Center|James A. Eastham, MD|646-422-4390|easthamj@mskcc.org|
22290490|NCT02946931|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290491|NCT03492840|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
22290492|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
22290493|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099|schinzel@vasopharm.de|115
22290494|NCT03531632|MacroGenics, Inc.|Stephen Eck, M.D., Chief Medical Officer|301 251-5172|ecks@macrogenics.com|
22290495|NCT03051620|Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark|Anne Sophie Sølling|+45 78 45 54 75|annesoel@rm.dk|
22290496|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk|
22290497|NCT01534182|Novartis|Study Director|+1 (862) 778-8300||
22290498|NCT02412488|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
22290499|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com|
22290500|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
22290501|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu|
22290502|NCT01462253|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22290503|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22290504|NCT01616693|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22290505|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290506|NCT02925338|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290507|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290508|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu|
22290509|NCT01008423|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22290510|NCT02878057|Department of Breast Oncology, Peking University Cancer Hospital and Institute|Dr. Huiping Li|86-10-88196739|huipingli2012@hotmail.com|
22290511|NCT02034409|VA Salt Lake City Health Care System|Daniel Clegg, MD|801-582-1565|daniel.clegg@va.gov|
22290512|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu|
22290513|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu|
22290514|NCT04255394|Zimmer Biomet|Linda Meijer|+31627933741|linda.meijer@zimmerbiomet.com|
22290515|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
22290516|NCT03512457|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
22290517|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org|
22290518|NCT02465099|Ethicon Inc|Jason Waggoner|(513) 337-8130|jwaggon1@its.jnj.com|
22290519|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600||
22290520|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22290521|NCT03602560|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
22290522|NCT00222131|Texas Tech|Jerzy Sarosiek, MD, PhD, AGAF, FACG|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
22290523|NCT04784065|Baylor College of Medicine|Dr. Grace Lo, Associate Professor of Medicine|713-791-1414|ghlo@bcm.edu|227804
22290524|NCT00645450|Manchester VA Medical Center|Dr. Scott P. Orr|603-624-4366|scott.orr@va.gov|6565
22290525|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22290526|NCT01182844|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
22290527|NCT01379508|Novartis|Clinical Disclosure Office|862-778-8300||
22290528|NCT00833664|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22290529|NCT03952039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22290530|NCT02055365|Icahn School of Medicine at Mount Sinai|Brad Rosenberg, MD, PhD||brad.rosenberg@mssm.edu|
22290531|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr|
22290532|NCT02656680|University of Connecticut|Dr. Sherry Pagoto|8604868979|sherry.pagoto@uconn.edu|
22290533|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Christopher R Flowers,Chair, Lymphoma-Myeloma|713- 745-6095|crflowers@mdanderson.org|
22290534|NCT01143389|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
22290535|NCT04966910|University of Washington|Michael Pullmann|206-685-0408|pullmann@uw.edu|
22290536|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com|
22290537|NCT04175509|Aultman Hospital|Dr. Michaela Beynon|2488218826|michaelabeynon@gmail.com|
22290538|NCT01757691|Novartis|Study Director|862-778-8300||
22290539|NCT02641483|VAORD|Dennis Bourbeau|2167913800|dennis.bourbeau@va.gov|
22290540|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290541|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22290542|NCT00528970|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22290543|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br|
22290544|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
22290545|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org|
22290546|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
22290547|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com|
22290548|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk|
22290549|NCT00177047|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
22290550|NCT00052442|Memorial Sloan-Kettering Cancer Center|Owen A. O'Connor, MD, PhD|212-639-8889|oo2130@columbia.edu|
22290551|NCT02661178|Drugs for Neglected Diseases initiative|Sophie Delhomme|+41229069230|sdelhomme@dndi.org|
22290552|NCT02278471|UT southwestern|Dr. Thomas J Wang|6159361717|thomas.wang@UTsouthwestern.edu|
22290553|NCT04391049|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22290554|NCT02855541|University of Colorado Boulder|James Peterman, PhD|303-735-0358|james.peterman@colorado.edu|
22290555|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290556|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067||
22290557|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov|
22290558|NCT02204761|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22290559|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290560|NCT01215916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290561|NCT02788279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22290562|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov|
22290563|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22290564|NCT00740376|Corin|Global Regulatory Affairs and Clinical Director|+44 (0)1285 659866||
22290565|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu|
22290566|NCT05168501|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22290567|NCT01133990|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22290568|NCT05277337|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22290569|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22290570|NCT02683746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290571|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk|
22290572|NCT04987944|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290573|NCT00606047|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8920|pbeaule@toh.ca|
22290574|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu|
22290575|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu|
22290576|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290577|NCT03339297|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
22290578|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu|
22290579|NCT03726996|Yale University|Yong-Hui Jiang, MD, PhD|203-785-2660|yong-hui.jiang@yale.edu|
22290580|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com|
22290581|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290582|NCT03207438|University of Saskatchewan|Evyn Peters|13068441312|evyn.peters@usask.ca|
22290583|NCT03241368|Medtronic GIH|Amanda Wenisch, Clinical Resaerch Coordinator / Study Manager|1-206-225-4025|amanda.m.wenisch@medtronic.com|
22290584|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290585|NCT03316911|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
22290586|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu|
22290587|NCT01566214|Iowa City VA Health Care System|Mark Vander Weg|319-338-0581|mark.vanderweg@va.gov|7717
22290588|NCT04620798|Indiana University Bloomington School of Public Health|Molly Rosenberg, MPH, PhD|(812) 856-2509|rosenmol@indiana.edu|
22290589|NCT01023477|Inova Health Care|Kirsten Edmiston, MD|703-850-9555|Kirsten.edmiston@inova.org|
22290590|NCT04821362|Ege University|Dr. Sercan Yalçınlı|+90 505 537 41 01|sercan.yalcinli@ege.edu.tr|
22290591|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22290592|NCT03222492|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22290593|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org|
22290594|NCT02486627|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
22290595|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011|christof.schmeer@pfmmedical.com|41
22290596|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com|
22290597|NCT02112045|Washington University School of Medicine|Meagan Jacoby, M.D., Ph.D.|314-454-8304|mjacoby@wustl.edu|
22290598|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22290599|NCT03554486|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
22290600|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu|
22290601|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
22290602|NCT02431260|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22290603|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
22290604|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290605|NCT01059929|University of Chicago|John Kress|773-702-6790|jkress@medicine.bsd.uchicago.edu|
22290606|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu|
22290607|NCT01375075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290608|NCT00620503|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22290609|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301|johannes.rieger@med.uni-frankfurt.de|87711
22290610|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu|
22290611|NCT03050775|Mayo Clinic|Jean M. Guyer, DNP|507-255-5716|guyer.jean@mayo.edu|
22290612|NCT03603509|Mayo Clinic|Richard Kennedy, PhD|507-284-0708|Kennedy.Rick@mayo.edu|
22290613|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com|
22290614|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22290615|NCT00504582|UT MD Anderson Cancer Center|Dr. Paul F Mansfield, Professor, Surgical Oncology|(713) 794-5499|pmansfie@mdanderson.org|
22290616|NCT02716896|University of Texas Health San Antonio|Dharam Kaushik|210-567-5676|kaushik@uthscsa.edu|
22290617|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22290618|NCT02404532|Otsuka Pharmaceutical Development & Commercialization, Inc|Tim Peters-Strickland|800 562-3974||
22290619|NCT02484859|Recep Tayyip Erdoğan Üniversitesi|Dr. Başar Erdivanlı|04642130491|berdivanli@gmail.com|2128
22290620|NCT02564432|Department of Veterans Affairs|James Peter Beck|801-231-6309|james.beck@hsc.utah.edu|
22290621|NCT02415842|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290622|NCT01909791|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
22290623|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
22290624|NCT04240678|UC Davis Medical Center|Eric Chak|916-734-3751|echak@ucdavis.edu|
22290625|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu|
22290626|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22258989|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000|hsieh.yuhsi@msa.hinet.net|5241
22290627|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu|
22258990|NCT03705351|Providence Health & Services|Chiayi Chen / Director of PBSI and WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22258991|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
22258992|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456|kmjmay@gmail.com|2141
22258993|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu|
22258994|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com|
22258995|NCT02180061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258996|NCT02557945|New York State Psychiatric Institute|Scott Small, MD|212-305-1269|sas68@cumc.columbia.edu|
22258997|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com|
22258998|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu|
22258999|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290628|NCT01002820|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22290629|NCT02478398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290630|NCT01031420|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
22290631|NCT00813176|University of Iowa|Dr Javier H Campos|3193567208|javier-campos@uiowa.edu|
22290632|NCT02013141|Cumberland Pharmaceuticals Inc|Clinical Scientist|615-255-0068|bgibson@cumberlandpharma.com|229
22290633|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com|
22290634|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com|
22290635|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org|
22290636|NCT01568528|Emory University|Dr. Erica Duncan|404-321-6111|eduncan@emory.edu|
22290637|NCT00618098|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22290638|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
22290639|NCT01512667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290640|NCT01883856|University of Virginia|Peter A. Netland, MD, PhD|4349821086|pan9c@virginia.edu|
22290641|NCT02775240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22290642|NCT01544088|VA Boston Healthcare System|Denise Sloan, Ph.D.|(857) 364-6333|denise.sloan@va.gov|
22290643|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500|kzandinejad@partners.org|34769
22290644|NCT05395091|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
22290645|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22290646|NCT02992197|The University of Vermont College of Medicine|Benjamin Lee|8026567748|blee7@uvm.edu|
22290647|NCT04114617|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
22290648|NCT03192358|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
22290649|NCT01915303|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22290650|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290651|NCT02509117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22290652|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290653|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22290654|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
22290655|NCT01251536|UZ Leuven|Prof Dr Eric Van Cutsem|003216344218|eric.vancutsem@uzleuven.be|
22290656|NCT05396599|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
22290657|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22290658|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290659|NCT03467685|UPMC Dermatology|Dr. Rashek Kazi|5167105208|kazir@upmc.edu|
22290660|NCT00796523|University of Toledo|Jonna M. McRury, M.D.|419-389-1118|jmcrury@aol.com|
22290661|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu|
22290662|NCT03288142|Northwestern University Feinberg School of Medicine|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
22290663|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290664|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22290665|NCT01294098|Washington University School of Medicine|Lauren Westlund|314-454-5345|davislauren@wustl.edu|
22290666|NCT02390791|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22290667|NCT00384111|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
22290668|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi|
22290669|NCT01551420|Providence VA Medical Center|Linda Resnik, Research Career Scientist|401-273-7100|Linda.Resnik@va.gov|2368
22290670|NCT03612856|Aronora, Inc.|Christina U. Lorentz|503-964-0250|christina.lorentz@aronorabio.com|
22290671|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016|ozgur@udel.edu|3663
22290672|NCT04463069|Hong Kong Baptist University|Dr. Yang Gao|+852 3411 3082|gaoyang@hkbu.edu.hk|
22290673|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22290674|NCT03073733|jCyte, Inc.|Robert Beathard|9492430687|rob.beathard@jcyte.com|
22290675|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org|
22290676|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290677|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu|
22290678|NCT03708393|Seno Medical|Shaan Schaeffer VP of Clinical Operations|610-698-3259|sschaeffer@senomedical.com|
22290679|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu|
22290680|NCT02276027|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22290681|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com|
22290682|NCT01264081|National Cancer Institute|Dr. Udo Rudloff'|301-496-3098|rudloff@nih.gov|
22290683|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
22290684|NCT02320903|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|grants@ebpi.org|
22290685|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590||
22259000|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu|
22259001|NCT03256968|Universtiy of Alabama at Birmingham|Steven Rowe|205-975-9776|srowe@uabmc.edi|
22290686|NCT03386253|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22290687|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305134|NCT04654351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22290688|NCT03493815|The Pennsylvania State Univ College of Medicine, The Milton S. Hershey Medical Center|Stephanie Estes, M.D.|717-531-8478|sestes@pennstatehealth.psu.edu|
22290689|NCT03811093|Vidantis Technologies, Inc|Thomas A. Namynanik - Consultant to invisa-RED Technologies|404 915-5938|andyn997@vidantis.com|
22290690|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu|
22290691|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu|
22290692|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu|
22290693|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au|
22290694|NCT03188042|NYU Langone Health|Joel Schuman, MD, FACS|929-455-5030|Joel.Schuman@nyu.edu|
22290695|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22290696|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22290697|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22290698|NCT03616223|Frequency Therapeutics|Carl LeBel, PhD, CDO|781-315-4600|clinicaltrialsinformation@frequencytx.com|
22290699|NCT03739242|A. Menarini Industrie Farmaceutiche Riunite SrL|Dr Paolo Fabrizzi Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22290700|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov|
22290701|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22290702|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290703|NCT03086967|Atrium Health|Dr. Susan Bliss|(704)562-4860|Susan.Bliss@atriumhealth.org|
22259002|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu|
22290704|NCT01556347|Tim Icenogle MD PLLC|Timothy B Icenogle MD|509-220-1900|timicenogle@comcast.net|
22290705|NCT02531971|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22290706|NCT02230527|Cleveland Clinic|Joseph Campbell, MD|216-444-9836|campbej10@ccf.org|
22290707|NCT01752036|SKCCC|Terrence Caldwell|443-287-1889|caldwte@jhmi.edu|
22290708|NCT01011478|NSABP Foundation|Director, Department of Regulatory Affairs|412-339-5300||
22290709|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com|
22290710|NCT04418661|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22290711|NCT03337490|Mayne Pharma LLC|Associate Director, Clinical Operations|9195737948|phoevos.hughes@maynepharma.com|
22290712|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22305135|NCT04088188|MD Anderson|Shubham Pant|832-803-5306|spant@mdanderson.org|
22305136|NCT03686384|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22305137|NCT02783950|University of Michigan|Todd Morgan, MD|734-647-8902|tomorgan@med.umich.edu|
22305138|NCT01767909|Wake Forest School of Medicine|Suzanne Craft, PhD, Project Director for Clinical Trial|(336) 713-8830|suzcraft@wakehealth.edu|
22305139|NCT04348370|Texas A&M University College of Medicine|Jeffrey D. Cirillo|979-436-0343|jdcirillo@tamu.edu|
22305140|NCT03163511|Vertex Pharmaceuticals, Inc|Gautham Marigowda|617-961-0568|gautham_marigowda@vrtx.com|
22305141|NCT01740557|M D Anderson Cancer Center|Dr. Rodabe Amaria M.D.|(713) 792-2921|rnamaria@mdanderson.org|
22305142|NCT02320253|MGH Diabetes Center|Dr. Deborah J. Wexler|617-726-8767|dwexler@mgh.harvard.edu|
22305143|NCT05174065|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22305144|NCT03507309|Imperial College Healthcare NHS Trust|Dr Amit Kaura|020 3312 6666|amit.kaura@nhs.net|
22305145|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com|
22305146|NCT01190176|GlaxoSmithKline|GSK Response Center|866-435-7343|pr266560@gsk.com|
22305147|NCT02909101|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
22305148|NCT01221181|Columbia University Medical Center|Andrew Bomback, MD, MPH|212-305-0320|asb68@cumc.columbia.edu|
22305149|NCT02466516|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22259003|NCT03532009|Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22259004|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22259005|NCT01602614|University of Alabama at Birmingham|David Kimberlin, MD|205 934-2424|Dkimberlin@peds.uab.edu|
22259006|NCT02866175|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22259007|NCT01584609|Penumbra, Inc.|Michaella Corso|(510) 748-3200|mcorso@penumbrainc.com|
22259008|NCT01694485|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22259009|NCT02907203|W. L. Gore and Associates|Rizwan Afzal|6236404888|rafzal@wlgore.com|
22259010|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com|
22259011|NCT02750306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259012|NCT02422290|New York State Psychiatric Institute|Pablo H. Goldberg, MD|646-774-6318|Pablo.Goldberg@nyspi.columbia.edu|
22259013|NCT04071951|Cedars-Sinai Medical Center|Joshua Pevnick|310.423.4683|pevnickj@cshs.org|
22259014|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
22259015|NCT02227849|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22305150|NCT04358549|FUJIFILM Pharmaceuticals U.S.A., Inc.|Clinical Research Manager|No phone at site|fphucontact@fujifilm.com|
22259016|NCT02950753|UMCSouthernNevada|Dr. Tony Zitek|702-383-7885|zitek10@gmail.com|3
22259017|NCT00457665|UTSouthwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
22259018|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22290713|NCT03442868|Texas Woman's University|Hui-Ting Goh|2146897723|HGoh1@twu.edu|
22305151|NCT03712930|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22290714|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301|eickholz@med.uni-frankfurt.de|5642
22290715|NCT03271983|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22290716|NCT02921061|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
22290717|NCT02599051|Cleveland Clinic Florida|G W Davila|9546595559|davilag@ccf.org|
22290718|NCT02596750|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
22290719|NCT02108262|CSLBehring|Trial Registration Coordinator|610-878-4000|clinicaltrials@cslbehring.com|
22290720|NCT02700334|INSTITUTO DE TERAPUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22290721|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22290722|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu|
22290723|NCT04449029|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22290724|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22290725|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu|
22290726|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu|
22290727|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu|
22290728|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800|jxj24@case.edu|2947
22290729|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
22290730|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290731|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com|
22290732|NCT03417713|Hamilton General Hospital|Dr. Theodore Rapanos|905-521-2100|rapanost@mcmaster.ca|44652
22290733|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org|
22290734|NCT02730793|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
22290735|NCT02365233|University of Texas Medical Branch|Nicola Abate, MD - Professor and Director of Endocrinology Division|409 772 1922|niabate@utmb.edu|
22290736|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu|
22290737|NCT00160667|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22290738|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com|
22290739|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com|
22290740|NCT03259620|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22290741|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com|
22290742|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290743|NCT01055067|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22290744|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr|
22290745|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu|
22290746|NCT03224598|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
22290747|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu|
22290748|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com|
22290749|NCT03328182|Hollister Incorporated|Director Global Clinical Affairs|8476802837|stacy.haddad@hollister.com|
22290750|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22290751|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
22290752|NCT00874614|Progenics Pharmaceuticals, Inc|Jessica D Jensen, MPH|646-975-2513|jjensen@progenics.com|
22290753|NCT00137839|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
22290754|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz|
22290755|NCT03860935|Eidos Therapeutics, Inc., a BridgeBio Company|VP, Clinical Operations|415-887-1471|info@bridgebio.com|
22290756|NCT00266851|Wisconsin Resaerch & Education Network|Dr. David Hahn|608-234-3212|dlhahn@wisc.edu|
22290757|NCT03361176|Maryland Laser Skin and Vein|Robert A. Weiss, MD|4106662839|cmyers@mdlsv.com|
22290758|NCT04461600|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
22290759|NCT01661088|University of Michigan Rogel Cancer Center|Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
22290760|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu|
22290761|NCT04456673|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22290762|NCT02160002|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
22290763|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135|jesfandiari@chembio.com|112
22290764|NCT04395001|Wake Forest School of Medicine|Dennis C. Ang|3367058701|dang@wakehealth.edu|
22290765|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com|
22290766|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
22290767|NCT05508074|InFlectis Bioscience|Beatrice Lejeune|+33 668919060|beatricelejeune@inflectisbioscience.com|
22290768|NCT02142387|Laboratory of Emergency Medical Services, Seoul National University Hospital Biomedical Research Institute|Dr. Gwan Jin Park|82-10-7477-3293|pkj83531@naver.com|
22290769|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22259019|NCT02535000|Serviço de Anestesiologia de Joinville|Antonio Bedin|+554734331666|abjoimailbox-ct@yahoo.com|
22290770|NCT02984943|David Grant Medical Center, Travis Air Force Base|Dr. Michelle Sit|707-423-3875|michelle.t.sit.mil@mail.mil|
22290771|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
22290772|NCT02282345|UT MD Anderson Cancer Center|Dr. Jennifer Litton,VP, Clinical Research, VP Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
22290773|NCT02296138|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290774|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
22290775|NCT02692651|University of Michigan|Krishna Rao|734 615-9730|krirao@med.umich.edu|
22290776|NCT03490981|VA Center for Integrated Healthcare|Dr. Gregory P. Beehler, Associate Director of Research|716-862-7934|gregory.beehler@va.gov|
22290777|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22290778|NCT02324543|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22274468|NCT05502302|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
22290779|NCT01860846|AbbVie|Global Medical Services|800-633-9110||
22290780|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
22290781|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290782|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22290783|NCT01525901|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
22290784|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974||
22290785|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
22290786|NCT03396952|University of California, San Francisco|Dr. Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
22290787|NCT04345367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290788|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca|
22290789|NCT03208985|HRA Pharma|Christine VENARD|+33184139244|c.venard@hra-pharma.com|
22290790|NCT00439738|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
22290791|NCT03774719|Washington University in Saint Louis|Gonzalo Matzumura|3143627211|g.matzumuraumemoto@wustl.edu|
22290792|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22290793|NCT00781885|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
22290794|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu|
22290795|NCT03836001|Stanford University|Albert Chiou|(650) 721-8418|achiou@stanford.edu|
22290796|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22290797|NCT01978938|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
22290798|NCT02694757|11 Health|Michael Seres|+16572660570|michael@11health.com|
22290799|NCT02650921|Galderma Research & Development, LLC|Assoc Director of Clinical Operations|817-961-5000|courtney.maguire@galderma.com|
22290800|NCT01087788|Cares|UCB|+1877 822||9493
22290801|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
22290802|NCT01806662|Rockefeller University|James Krueger|2123278333|gilleap@mail.rockefeller.edu|
22290803|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu|
22290804|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22290805|NCT02285062|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22290806|NCT00545129|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290807|NCT03678870|Vanderbilt University Medical Center|Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology|(615) 343-7869‬|sarah.osmundson@vumc.org|
22290808|NCT03127098|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22290809|NCT03104816|USCalifornia|Eugenia Ayrian|8186363161|eayrian@med.usc.edu|
22290810|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290811|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22290812|NCT00883688|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Multicenter coordinating for Collaborative Ependymoma Research Network Study (CERN)||CR_Study_Registration@mdanderson.org|
22290813|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22290814|NCT04896229|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22290815|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22290816|NCT01958489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290817|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
22290818|NCT00045942|Novartis|Study Director|862-778-8300||
22290819|NCT04575597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22290820|NCT01280201|Group for Neuroendocrine Tumors (GETNE)|Dr. Enrique Grande (Hospital Universitario Ramón y Cajal)|931780742|getne@getne.org|201
22290821|NCT02095132|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22305152|NCT02909439|Stony Brook Medicine|Ramon Abola, Clinical Associate Professor|631-444-2975|ramon.abola@stonybrookmedicine.edu|
22305153|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305154|NCT01062126|Abbott (Previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim1@abbott.com|
22305155|NCT03837028|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
22305156|NCT00646451|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
22305157|NCT03784963|The University of Chicago|Dr. Ann Nguyen, MD|773-702-9396|anguyen3@medicine.bsd.uchicago.edu|
22290822|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at|
22290823|NCT04905498|University of Kansas Medical Center|Amanda S. Bruce|4014990576|abruce2@kumc.edu|
22290824|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290825|NCT01268579|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
22290826|NCT03312751|Swedish Orphan Biovitrum AG|Radmila Kanceva, MD, Medicine Development Lead|+41 793048899|Radmila.Kanceva@sobi.com|
22290827|NCT05463198|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
22290828|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22290829|NCT00420641|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290830|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com|
22290831|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300|cheolhee.lim@dong-wha.co.kr|551
22290832|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be|
22290833|NCT02815280|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22290834|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu|
22290835|NCT01944839|Ophthotech|Denise Teuber||denise.teuber@ophthotech.com|
22290836|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk|
22290837|NCT05093790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22290838|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22290839|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290840|NCT00641316|University of Alabama at Birmingham|Nicolaas Geurs, DDS,MS|2059344506|ngeurs@uab.edu|
22290841|NCT05027971|Boston Scientific|Winnie Chen|952-930-6000|FlexivaPulseRegistry@bsci.com|
22290842|NCT02025556|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22290843|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
22290844|NCT02582684|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22290845|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290846|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
22290847|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22290848|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca|
22290849|NCT02437110|National Institutes of Health|Dr. Avi Nath|301-496-1561|natha@mail.nih.gov|
22290850|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300||
22290851|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu|
22290852|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22290853|NCT01479426|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jong-Kwan Park, MD|82-63-276-8284|rain@chonbuk.ac.kr|
22290854|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com|
22290855|NCT01306929|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22290856|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000|lfowler@shrinenet.org|6249
22290857|NCT03041129|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
22290858|NCT03608150|Luminopia, Inc.|VP of Clinical Development|9788067080|endri@luminopia.com|
22290859|NCT04355728|University of Miami|Camillo Ricordi|305-243-6913|ricordi@miami.edu|
22290860|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||RColeman@mdanderson.org|
22290861|NCT01872325|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
22290862|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov|
22290863|NCT01390064|University of Arkansas for Medical Sciences|Dr. Laura Hutchins|5016868274|hutchinslauraf@uams.edu|
22290864|NCT04850781|Johns Hopkins University|Kali Thomas|(410) 955-4766|kali.thomas@jhu.edu|
22290865|NCT00608569|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22290866|NCT03011892|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22290867|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
22290868|NCT03381729|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22290869|NCT04456153|UT Southwestern Medical Center|Dr. Mamta K. Jain|2140648-9914|mamta.jain@utsouthwestern.edu|
22290870|NCT03758755|Inova Health System|Dr. Edward Chang|571-472-0464|edward.chang@inova.org|
22290871|NCT03848871|Skin Sciences, PLLC|Maureen McAllister|5024519000|mmdermresearch@yahoo.com|
22290872|NCT02000908|University of Minnesota|Peter Argenta MD|612-626-3111|argenta@umn.edu|
22290873|NCT02312687|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22290874|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org|
22290875|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com|
22259020|NCT04317781|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-794-4422|qbashir@mdanderson.org|
22259021|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com|
22290876|NCT00729846|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
22290877|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu|
22290878|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
22290879|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
22274469|NCT00791219|Mayne Pharma|Stuart Mudge, VP Scientific Affairs|+613 8614 7704|stuart.mudge@maynepharma.com|
22290880|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22290881|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu|
22290882|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil|
22290883|NCT05347147|Executive Director Invex Australia|Tom Duthy|+61 (08) 6382 0137|tduthy@invextherapeutics.com|
22290884|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22290885|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu|
22290886|NCT02677324|DFCI|Jorge J. Castillo|617-632-2681|jorgej_Castillo@dfci.harvard.edu|
22290887|NCT01895361|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22290888|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22290889|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22290890|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com|
22290891|NCT02239120|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290892|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu|
22290893|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22290894|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org|
22290895|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org|
22290896|NCT00603642|Amgen Inc.|Study Director|866-572-6436||
22290897|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22290898|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu|
22290899|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20|wim.decleer@janpalfijngent.be|092248851
22290900|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22290901|NCT01624870|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|maarten.hollander@medtronic.com|
22290902|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com|
22290903|NCT02548728|University of North Carolina at Chapel Hill|Cort Pedersen, MD|919-923-3284|cort_pedersen@med.unc.edu|
22290904|NCT04672252|NYU Langone Health|Michael J. Alaia, MD|(646) 501-7223|Michael.Alaia@nyulangone.org|
22290905|NCT05478681|The University of Texas Health Science Center at Houston|Kendra M Anderson, PhD|713-486-0513|Kendra.M.Anderson@uth.tmc.edu|
22290906|NCT01911910|Queen Mary University London/ Barts Health NHS Trsut|Dr Mohammed Khanji|020 7363 8079|m.khanji@qmul.ac.uk|
22290907|NCT03735238|Baylor College of Medicine|Jasvinder Singh, MD, MPH; Senior Faculty and Chief of Immunology, Allergy, and Rheumatology|713.798.1365|jasvinder.md@gmail.com|
22290908|NCT02660138|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
22290909|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22290910|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu|
22290911|NCT02438475|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
22290912|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu|
22290913|NCT04475198|SiteOne Therapeutics|John Mulcahy|+1 (650) 392-0419|john.mulcahy@site1therapeutics.com|
22290914|NCT02489422|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
22290915|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22290916|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com|
22290917|NCT04604132|Basilea Pharmaceutica International Ltd, Allschwil|Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
22290918|NCT00952380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290919|NCT03235180|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
22290920|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu|
22290921|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22290922|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290923|NCT03007888|Impax Laboratories, LLC|Pamela Fitzpatrick, Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
22290924|NCT03493932|Emory University|Edjah K. Nduom, MD, FAANS|404-778-5770|edjah.k.nduom@emory.edu|
22290925|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22290926|NCT04658940|Acutus Medical|Karen Stephens, Director Clinical Affairs|442-232-6080|karen.stephens@acutus.com|
22290927|NCT03471624|Stanford University|Mindie H Nguyen, Professor of Medicine, GI & Hepatology, Liver Transplant|650-498-6084|mindiehn@stanford.edu|
22290928|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290929|NCT00300430|Abbott|Medical Information Specialist|800-633-9110||
22290930|NCT03579602|Blaze Bioscience|Dr. Kristi Harrington|206-535-8144|Clinical.trials@blazebioscience.com|
22290931|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22290932|NCT00495040|UT MD Anderson Cancer Center|Chang,Joe Y.,M.D. / Radiation Oncology|713-563-2337|jychang@mdanderson.org|
22290933|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu|
22290934|NCT04157673|University at Buffalo|Leonard H. Epstein, PhD|7168293400|lhenet@buffalo.edu|
22290935|NCT02452931|Tolmar, Inc.|Vice President of Clinical Development|970-212-4500|info@tolmar.com|
22290936|NCT02282293|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
22290937|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22290938|NCT01894568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290939|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org|
22290940|NCT04545944|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
22290941|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
22290942|NCT01514370|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22290943|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu|
22290944|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290945|NCT01439815|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
22290946|NCT03353740|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|
22290947|NCT01484288|CVRx|Vice President, Global Clinical Research|763-416-2876|egalle@cvrx.com|
22290948|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu|
22290949|NCT03207035|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
22290950|NCT03976648|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22290951|NCT03645434|AstraZeneca AB|AstraZeneca AB|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
22290952|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22290953|NCT02076425|Early Emotional Development Program at Washington University School of Medicine|Dr. Joan Luby|3142862730|lubyj@wustl.edu|
22290954|NCT02880956|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22290955|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
22290956|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov|
22290957|NCT03718299|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trials@sunpharma.com|5689
22290958|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu|
22290959|NCT04389970|University of Alabama at Birmingham|Brooks Wingo|2059345982|bcwingo@uab.edu|
22290960|NCT03123185|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290961|NCT02153476|Allegro Ophthalmics, LLC|Director of Clinical Research|949-444-5722|lkarageozian@allegroeye.com|
22290962|NCT03702244|Heartflow Inc|Director, Clinical Operations|877-478-3569|whuey@heartflow.com|
22290963|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22290964|NCT00880464|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
22290965|NCT04369924|University of Miami|Amanda Jensen-Doss|3052848332|ajensendoss@miami.edu|
22290966|NCT01431209|University of Nebraska Medical Center|Dr. Julie M. Vose|402-559-3848|jmvose@unmc.edu|
22290967|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu|
22290968|NCT03828370|Klein Buendel Inc.-|Dr. W. Gill Woodall, Ph. D.|5053829796|gwoodall@kleinbuendel.com|
22290969|NCT01209832|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22290970|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22290971|NCT04964193|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
22290972|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu|
22290973|NCT01982968|University of California, San Francisco|Harold Collard, MD|415 4761000|Harold.Collard@ucsf.edu|
22290974|NCT00625703|University of Texas Southwestern Medical Center|Lus Stella Muniz, MD|214-648-3111|irb@utsouthwestern.edu|
22290975|NCT06400251|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22290976|NCT02217527|Univ of Pittsburgh|Dr. Kenneth A. Perkins, Prof of Psychiatry|412-246-5395|perkinska@upmc.edu|
22290977|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
22290978|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu|
22290979|NCT06390839|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22290980|NCT01495676|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22305158|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com|
22305159|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305160|NCT04867902|Massachusetts General Hospital|Dr. Emily Feig|617-724-9140|efeig@mgh.harvard.edu|
22305161|NCT05355116|University of Winchester|Dr James Belsey|(+44) 07799040556|KneeResearch@pm.me|
22305162|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu|
22305163|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305164|NCT02004613|Cleveland Clinic Foundation|Dr. Alparslan Turan|216-445-9857|turana@ccf.org|
22305165|NCT02321748|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22305166|NCT03255018|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22305167|NCT01688973|City of Hope National Medical Center|Przemyslaw W. Twardowski, MD|626-256-4673|ptwardowski@coh.org|68218
22305168|NCT01702896|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22305169|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22305170|NCT03710564|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22305171|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@ucsf.edu|
22305172|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22305173|NCT00647348|University of London|Professor Jeremy Chataway, Chief Investigator|07974752295|j.chataway@ucl.ac.uk|
22305174|NCT04880070|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22305175|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu|
22305176|NCT03382821|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
22305177|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu|
22305178|NCT00875641|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305179|NCT04500821|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
22305180|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu|
22305181|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305182|NCT01511250|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22305183|NCT04668144|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904244206|francesco.franchi@jax.ufl.edu|
22305184|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22305185|NCT03441984|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22305186|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305187|NCT04001114|University of Maryland|Britta Hahn, Ph.D.|410-402-6112|bhahn@som.umaryland.edu|
22305188|NCT04436029|Cartesian Therapeutics|Chief Medical Officer|(301) 348-8698|trials@cartesiantx.com|
22305189|NCT02696785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22305190|NCT03486197|University of Washington/Fred Hutch Cancer Center Proton Therapy|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22305191|NCT01016353|KCI|Senior Director, Global Clinical Development|(210) 255-5595|jane.hart@kci1.com|
22305192|NCT04863898|RTI International|Laura Nyblade, Fellow|202-728-1961|lnyblade@rti.org|
22305193|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122|alaptook@wihri.org|47421
22305194|NCT00877851|Queen's University, Belfast|Prof Michelle McKinley|+44(0)2890632685|m.mckinley@qub.ac.uk|
22305195|NCT03285711|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22305196|NCT02431533|Pharmabiotix, Inc|Mark Cobb|214-327-4712|cobbcoinc@aol.com|
22305197|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866|vlorenzo.germanstrias@gencat.cat|8443
22305198|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
22305199|NCT02982928|Nationwide Children's Hospital|Ahsan Syed, MD|614-722-4200|Ahsan.Syed@nationwidechildrens.org|
22305200|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305201|NCT00318656|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305202|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu|
22305203|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305204|NCT05051540|University of Miami|Hadar Lev-Tov, MD|305-243-1953|hlevtov@med.miami.edu|
22305205|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22305206|NCT02956967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305207|NCT02963597|Albert Einstein Healthcare Network|Dr Sunil Sharma|2154566950|sharmasu@einstein.edu|
22305208|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22305209|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305210|NCT03568162|Ichnos Sciences SA|Ichnos Sciences Clinical Trials Administrator|315-583-1249|clinicaltrials@ichnossciences.com|
22305211|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305212|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu|
22305213|NCT00938340|Penn State University|Penny Kris-Etherton||pmk3@psu.edu|
22305214|NCT04783415|City of Hope Medical Center|Dr. Alexey Danilov|626-359-8111|adanilov@coh.org|
22274470|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org|
22305215|NCT04816526|Cartesian Therapeutics|Dr. Milos Miljkovic, Chief Medical Officer|4436335855|milos@cartesiantx.com|
22305216|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22259022|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22259023|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com|
22259024|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov|
22290981|NCT06054269|CDC|Perrine Marcenac|6782830242|pmarcenac@cdc.gov|
22290982|NCT01738477|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290983|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org|
22290984|NCT02720094|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22290985|NCT02055638|Azevan Pharmaceuticals, Inc.|Dr. Neal Simon, CEO|(610) 419-1057|ngsimon@azevan.com|
22290986|NCT01431638|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22290987|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343||
22290988|NCT04876690|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22290989|NCT02971033|Edward Hines Jr. Veterans Administration Hospital|Susan L. Uprichard|(336) 402-1086|susan.uprichard@va.gov|
22290990|NCT03400956|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22290991|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22290992|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu|
22290993|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290994|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290995|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br|
22290996|NCT01700439|Edwards Lifesciences, LLC|Jennifer Currin, Senior VP of Medical and Clinical Affairs, Surgical Structural Heart|949-250-2500|Jennifer_Currin@edwards.com|
22290997|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743||
22290998|NCT01892384|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22290999|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com|
22291000|NCT03445156|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22291001|NCT00053898|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22291002|NCT03705273|Vanderbilt University School of Medicine|Donald H. Arnold, MD, MPH|16155790516|don.arnold@vumc.org|
22291003|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291004|NCT03985878|Sarepta Therapeutics, Inc.|Medical Director|1-888-SAREPTA (1-888-727-3782)|SareptAlly@sarepta.com|
22291005|NCT02889562|Sanford Health|Todd Chapin PharmD|701-417-2351|todd.chapin@sanfordhealth.org|
22291006|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com|
22291007|NCT02162576|Propeller Health|Dr. Meredith Barrett|415-409-9258|meredith.barrett@propellerhealth.com|
22291008|NCT04054947|White River Junction VA Medical Center|Dr. Brian Shiner|802-295-9363|brian.shiner@va.gov|6070
22291009|NCT01606878|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22291010|NCT03720652|University of North Carolina at Chapel Hill|Philip D. Sloane, MD, MPH|+1 (919) 966-4439|philip_sloane@med.unc.edu|
22291011|NCT03068091|University of Missouri|Talissa Altes|573 882 1026|ALTEST@HEALTH.MISSOURI.EDU|
22291012|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu|
22291013|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu|
22291014|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
22291015|NCT02654717|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759900|srinivassidgiddi@drreddys.com|
22291016|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22291017|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22291018|NCT02491359|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22291019|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22291020|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291021|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291022|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||clinicaltrialtransparency@astrazeneca.com|
22291023|NCT03565367|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
22291024|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com|
22291025|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22291026|NCT02873585|University of North Carolina at Chapel Hill|Angela Broome, DDS, MS|9195373160|abroome@unc.edu|
22291027|NCT01611454|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute|786-596-3505|raulh@baptisthealth.net|
22291028|NCT01275339|Washington University School of Medicine|Brian R. Lindman, MD|615-936-5949|brlindman@wustl.edu|
22291029|NCT01555957|University of Rochester|Sanjiv Amin|585-273-2696|sanjiv_amin@urmc.rochester.edu|
22259025|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259026|NCT01943461|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22259027|NCT02175966|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22259028|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464||
22259029|NCT03361956|Janssen Sciences Ireland UC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22291030|NCT01198158|Georgetown University Hospital|George Philips MBBS, MD, MPH, FACP|202-444-2198|George.K.Philips@gunet.georgetown.edu|
22291031|NCT03023046|University of Washington|Ryan Cassaday, MD|2066061202|cassaday@seattlecca.org|
22291032|NCT05478174|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
22291033|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu|
22291034|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
22291035|NCT03390842|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
22291036|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22291037|NCT05954143|Bolt Biotherapeutics, Inc.|Director of Clinical Development Operations|1-650-434-8640|clinicaltrials@boltbio.com|
22291038|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22291039|NCT05028361|Duke Human Vaccine Institute|Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
22291040|NCT01993836|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
22291041|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22291042|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22291043|NCT02288377|FFCD|Karine Le Malicot|+ 33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22291044|NCT01887743|Children's Mercy Kansas City|Valentina Shakhnovich, MD|816-302-3068|vshakhnovich@cmh.edu|
22291045|NCT01925989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22291046|NCT05072470|Sonova USCS|Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
22291047|NCT02496676|National Institute of Allergy and Infectious Diseases|Ravell Aumaitre, Juan|+1 301 761 6669|juan.ravell@nih.gov|
22291048|NCT03459690|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-634- 2721|bsubrama@bidmc.harvard.edu|
22291049|NCT02963831|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
22291050|NCT02538783|UPenn|Catherine Reale|215-746-4009|catherine.reale@uphs.upenn.edu|
22291051|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291052|NCT02536404|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22291053|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22291054|NCT04381988|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@MSKCC.ORG|
22291055|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291056|NCT03485495|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22291057|NCT03915860|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22291058|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22291059|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22291060|NCT04559529|Vanderbilt University Medical Center|Stephan Heckers, MD; Principal Investigator|6153222665|stephan.heckers@vumc.org|
22291061|NCT01009281|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22291062|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov|
22291063|NCT00579436|University of Kentucky|Phillip Kern|859 323 4933|pake2222@uky.edu|
22291064|NCT03901456|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
22291065|NCT05318183|The Ohio State University|Richard Bruno|614.292.5522|bruno.27@osu.edu|
22291066|NCT04098224|ART MEDICAL|Mrs. Shirly Steinlauf|972-54-5804242|Shirly@artmedical.com|
22291067|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
22291068|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu|
22291069|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu|
22291070|NCT02589600|University of Pittsburgh|Susan Greenspan|4126922477|greenspn@pitt.edu|
22291071|NCT03709576|Penn State Cancer Institute|Michelle Stojanovic|7175310003|mstojanovic1@pennstatehealth.psu.edu|287412
22291072|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov|
22291073|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
22291074|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22291075|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800|ihizoh@web.de|71773
22291076|NCT00890045|Houston Methodist Hospital|George M. Nassar M.D.|713-790-1963|georgemnassar@gmail.com|
22291077|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org|
22291078|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22291079|NCT02520089|Universidad Autonoma de Nuevo Leon|Dr. Carlos Alberto Acosta-Olivo|+528183476698|dr.carlosacosta@gmail.com|
22291080|NCT01634191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22291081|NCT01981551|National Cancer Institute|Dr. Geraldine H O'Sullivan Coyne|240-781-3371|osullivancoyngh@nci.nih.gov|
22291082|NCT05486416|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
22291083|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291084|NCT01252732|Melinta Therapeutics, Inc.|Karen Fusaro|6098270956|kfusaro@melinta.com|
22291085|NCT04085367|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22291086|NCT04133064|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
22291087|NCT03274999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22291088|NCT00130442|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
22291089|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu|
22291090|NCT01527357|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22291091|NCT02233946|Boston Children's Hospital|Dr. Sion Kim Harris|8572184304|sion.harris@childrens.harvard.edu|
22291092|NCT00910247|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22291093|NCT02927067|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22291094|NCT02292784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22291095|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org|
22291096|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org|
22291097|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org|
22291098|NCT03384693|University of California, San Francisco|Dr. Christine Higham|415-476-2188|christine.higham@ucsf.edu|
22291099|NCT03387150|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22291100|NCT04006119|Alaunos Therapeutics, Inc|Jaymes Holland, Clinical Consultant|6502732627|jholland@alaunos.com|
22291101|NCT02919969|Dana Farber Cancer Institute|James Cleary|617-632-6073|james_cleary@dfci.harvard.edu|
22291102|NCT03621475|University of Vermont|Renee Stapleton, MD, PhD|(802) 656-7975|renee.stapleton@med.uvm.edu|
22291103|NCT04179409|Abigail Wexner Research Institute, Nationwide Children's Hospital|Dr. Kevin Flanigan, Center for Gene Therapy Director|614-722-5615|kevin.flanigan@nationwidechildrens.org|
22291104|NCT02057042|VA Center for Clinical Managment Research|Paul Pfeiffer|7348453649|paul.pfeiffer@va.gov|
22291105|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22291106|NCT02616601|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22291107|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22291108|NCT02713256|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22291109|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
22291110|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov|
22291111|NCT01397825|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22291112|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22291113|NCT01931670|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22291114|NCT01689909|Medical College of Georgia; Augusta University|William Vaughn McCall|706-721-6719|WMCCALL@augusta.edu|
22305217|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr|
22305218|NCT02753530|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22305219|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305220|NCT03590743|Mayo Clinic|Robert D. McBane, II M.D.|507-266-3964|mcbane.robert@mayo.edu|
22305221|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22305222|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22305223|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
22305224|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com|
22305225|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org|
22305226|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
22305227|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22305228|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305229|NCT02912195|Alameda Health System|Andrew Herring|510 437-8356|aherring@alamedahealthsystem.org|
22305230|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305231|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305232|NCT03647475|Medtronic Coronary/Renal Denervation (C/RDN)|Cecile Mahoney, Sr. Clinical Research Specialist|763-505-1057|cecile.c.mahoney@medtronic.com|
22305233|NCT04577183|RedDress Medical|Clinical Trial Manager|1-800-674-9615|alon@reddress.co.il|
22305234|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk|
22305235|NCT01168401|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
22305236|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
22305237|NCT03049111|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
22305238|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au|
22305239|NCT01801930|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22305240|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu|
22305241|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org|
22305242|NCT02072226|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22305243|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305244|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de|
22305245|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
22259030|NCT03760510|Vanderbilt University Medical Center|Janna Landsperger|6153223412|janna.landsperger@vumc.org|
22259031|NCT03198988|ART MEDICAL|Mrs Shirly Steinlauf|972-54-5804242|shirly@artmedical.com|
22259032|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
22259033|NCT04147715|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22305246|NCT00908947|BD/Bard|Talar Saber, Senior Project Manager, Clinical Affairs|1.480.379.2839|Talar.Saber@crbard.com|
22305247|NCT04371536|Baylor College of Medicine|Dr. Jacquelyn Powers|832-824-7330|jmpowers@txch.org|
22305248|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es|
22305249|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu|
22305250|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com|
22305251|NCT03101592|David Geffen School of Medicine at UCLA|Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine|310 825-7225|rhoffman@mednet.ucla.edu|
22305252|NCT01970943|Massachusetts General Hospital|Dr David Borsook, study PI|6172817135|david.borsook@childrens.harvard.edu|
22305253|NCT02397889|Icahn School of Medicine at Mount Sinai|Adriana Feder|212-659-9279|adriana.feder@mssm.edu|
22305254|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305255|NCT03178201|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
22305256|NCT02347917|Sumitomo Dainippon Pharmaceutical|Clinical Research (Oncology)|e-mail only|cc@ds-pharma.co.jp|
22305257|NCT00883350|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
22305258|NCT04639947|Duke Eye Center|Dr. Sanjay Asrani|+1 919 684 8656|sanjay.asrani@duke.edu|
22305259|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
22305260|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300|tcaggiano@acorda.com|5150
22305261|NCT03424239|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|ewyu@mgh.harvard.edu|
22305262|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
22305263|NCT03697460|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-6479|Mangold.Aaron@mayo.edu|
22305264|NCT03369951|Northwestern University of Feinberg School of Medicine|Richard G. Wunderink, MD|312-695-1878|r-wunderink@northwestern.edu|
22305265|NCT03677375|Masimo|Tala Harake|9492977000|studies@masimo.com|
22305266|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22305267|NCT01324882|UConn Health Center|Joseph Anderson|8022959362|joseph.anderson@dartmouth.edu|6003
22305268|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22305269|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org|
22305270|NCT02376933|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22305271|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305272|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22305273|NCT01555762|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22305274|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com|
22305275|NCT03663101|Ipsen Innovation SAS|Medical Director|see email|clinical.trials@ipsen.com|
22305276|NCT05579886|CooperVision Inc.|José A. Vega OD, MSc, FAAO, PhD|19256213761|javega@coopervision.com|
22305277|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693||
22305278|NCT02931396|University of Pittsburgh|Alicia Koontz|4128223700|akoontz@pitt.edu|
22305279|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr|
22305280|NCT01866917|Montefiore Medical Center|Ja Hyun Shin|718-920-5157|JASHIN@montefiore.org|
22305281|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk|
22305282|NCT02530151|Northwestern University|Michael Terry, MD|312-472-6488|mterry@nm.org|
22305283|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366||
22305284|NCT01374490|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22305285|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22305286|NCT03396835|Masimo Corporation|Tala Harake|949-297-7137|studies@masimo.com|
22305287|NCT03467724|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
22305288|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu|
22305289|NCT02049866|Columbia University|Mariana Bucovsky|212-305-7225|mb3523@cumc.columbia.edu|
22305290|NCT03700658|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22305291|NCT02145182|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22305292|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org|
22305293|NCT02775617|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
22305294|NCT03404609|Stanford University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22305295|NCT02219490|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305296|NCT01454362|Queen Mary University of London|Dr Hayden McRobbie|0207 882 7260|researchamendments@bartsandthelondon.nhs.uk|
22305297|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com|
22305298|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305299|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com|
22305300|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305301|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274471|NCT03459625|Loma Linda University|Cameron Leigh Neece|909 558 4000|cneece@llu.edu|
22305302|NCT03360422|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
22305303|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291115|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291116|NCT04352127|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22291117|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov|
22291118|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291119|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu|
22291120|NCT04179890|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291121|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com|
22291122|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262|salintho@ohsu.edu|54394
22291123|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22291124|NCT04535167|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291125|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
22291126|NCT02579928|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
22291127|NCT02352922|Center for Advanced Gynecology, PLLC|Dr. Kenneth I Barron|5088876896|kenneth.barron.md@gmail.com|
22291128|NCT04300751|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
22291129|NCT05033002|Duke University School of Nursing|Michael Relf, Ph.D.|919-684-9219|michael.relf@duke.edu|
22291130|NCT06312462|Jiangsu Institute of Parasitic Diseases|Dr. Huang Yuzheng|19941716698|huangyuzheng@jipd.com|
22291131|NCT04656275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291132|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu|
22291133|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22291134|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22291135|NCT05765227|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22291136|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com|
22291137|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000|michelle.prisco@va.gov|56235
22291138|NCT01721577|Rush University Medical Center|Crista Brawley|312-563-2312|crista_brawley@rush.edu|
22291139|NCT03723603|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
22291140|NCT01055496|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291141|NCT00584740|Novartis|Study Director|862-778-8300||
22291142|NCT02830438|AlbertEHN|Mario Naranjo-Tovar|2157965542|mario.edu6@hotmail.com|
22291143|NCT02158364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22291144|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com|
22291145|NCT03734705|Stanford University|Katie Fracalanza, PhD|408-769-0589|kfracalanza@stanford.edu|
22291146|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291147|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu|
22291148|NCT02805504|Loma Linda University Health|Duane Baldwin, MD Director of Urologic Research|909 558 4196|dbaldwin@llu.edu|
22291149|NCT01230125|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22291150|NCT01589770|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|michael.stein@vanderbilt.edu|
22291151|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
22291152|NCT00819793|Abbott|Poornima Sood||psood@sjm.com|
22291153|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com|
22291154|NCT02581839|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
22291155|NCT04711837|Haisco USA Pharmaceutical Inc.|Yu-Ling Lai Senior Director Clinical Operations|1 732-26-4759|Yuling.lai@Haisco-usa.com|
22291156|NCT03021564|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Maxime Leloup|+33 (0)5 46 45 66 09|maxime.leloup@ght-atlantique17.fr|
22291157|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com|
22291158|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu|
22291159|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22291160|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22291161|NCT00278915|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22291162|NCT05214573|Mayo Clinic|Rozalina McCoy, M.D., M.S.|507-538-7955|mccoy.rozalina@mayo.edu|
22291163|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717||
22291164|NCT04148872|University of Wisconsin - Madison|Scott Chaiet, MD|608-263-0192|chaiet@surgery.wisc.edu|
22291165|NCT02103153|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22291166|NCT02081248|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22291167|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu|
22291168|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22291169|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com|
22291170|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22291171|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org|
22291172|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu|
22291173|NCT02155946|VA Ann Arbor|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
22291174|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
22259034|NCT00235833|Abbott|Medical Information Specialist|800-633-9110||
22259035|NCT01288833|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
22259036|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com|
22259037|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu|
22291175|NCT00244842|Aurinia Pharmaceuticals Inc.|Robert Huizinga|250-708-4322|rhuizinga@auriniapharma.com|
22291176|NCT03042702|Innovation Pharmaceuticals|Arthur P. Bertolino MD, PhD, MBA|9789214125|abertolino@IPharmInc.com|
22291177|NCT01992159|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22291178|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22291179|NCT03754972|Medical Metrics, Inc|Trevor Grieco|713-850-7500|tgrieco@medicalmetrics.com|247
22291180|NCT02311582|Washington University School of Medicine|Milan G. Chheda, M.D.|314-747-2712|mchheda@wustl.edu|
22291181|NCT05822531|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
22291182|NCT03404960|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22291183|NCT03544775|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22291184|NCT06460493|Verona Pharma|Clinical Development|844-341-9901|clinicaltrials@veronapharma.com|
22291185|NCT05204381|University of North Carollina at Chapel Hill|Zachary Stewart|919-966-9929|zachary_stewart@med.unc.edu|
22291186|NCT02607514|Massachusetts General Hospital|Maren Nyer|6072796290|mnyer@partners.org|
22291187|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291188|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291189|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22291190|NCT02987660|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22291191|NCT05247398|University of Minnesota|Corey McGee|612-626-5645|mcge0062@umn.edu|
22291192|NCT05171816|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291193|NCT02937571|Memorial Sloan Kettering Cancer Center|Dr. Neha Korde, MD|646-608-3708|korden@mskcc.org|
22291194|NCT04902326|University of Michigan Medical School|Jeffrey Kullgren|734-845-3613|jkullgre@med.umich.edu|
22291195|NCT03513848|University of California, Irvine|Alyson Zalta|949-824-3409|azalta@uci.edu|
22291196|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu|
22291197|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291198|NCT01857310|NICHD|Dr. Enrique Schisterman|3014356893|schistee@mail.nih.gov|
22291199|NCT02360605|LSUShreveport|Dr. Connie Arnold|318-675-4324|carnol@lsuhsc.edu|
22291200|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu|
22291201|NCT02757950|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
22291202|NCT05442775|Cytokinetics|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
22291203|NCT04739865|COMPASS Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
22291204|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu|
22291205|NCT03681288|PROVIDENCE VAMC/ BROWN UNIVERSITY|Erica Eaton, Ph.D.|14012737100|erica_eaton@brown.edu|13428
22291206|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov|
22291207|NCT03720392|Massachusetts General Hospital|Zachariah DeFilipp, MD|617-643-3944|ZDEFILIPP@MGH.HARVARD.EDU|
22291208|NCT02216812|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
22291209|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22291210|NCT03036800|University of Leicester|Prof Melanie Davies|0116 258 6481|melanie.davies@uhl-tr.nhs.uk|
22291211|NCT01986933|Chugai Pharmaceutical|Clinical trials information||clinical-trials@chugai-pharm.co.jp|
22291212|NCT01077154|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22291213|NCT04030026|Trevi Therapeutics, Inc.|Thomas Sciascia, MD, Chief Scientific Officer|203-304-2499|info@trevitherapeutics.com|
22291214|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22291215|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22291216|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22291217|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22291218|NCT05744258|UZ Brussel|prof. dr. Sebastien Kindt|+32 2 477 60 11|sebastien.kindt@uzbrussel.be|
22291219|NCT06372782|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22291220|NCT06432088|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22291221|NCT07123272|University of Michigan|Anna Kratz|734-647-5982|alkratz@med.umich.edu|
22291222|NCT06447688|Medicalpark Hospital|Sefa SURAL|+90 532 565 0160|sesural@hotmail.com|
22291223|NCT04285580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22291224|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com|
22291225|NCT02935543|Univ. of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22291226|NCT04948866|University of North Carolina at Chapel Hill|Kathryn Wessell, MPH|919-966-2939|kwessell@email.unc.edu|
22259038|NCT03867383|Stanford University|Dr. Jessica Ansari|760-845-0328|jansari@stanford.edu|
22291227|NCT02316548|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
22259039|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu|
22291228|NCT02415855|University of Alberta|Dr. Kenneth Butcher|780-407-4366|ken.butcher@ualberta.ca|
22291229|NCT02642744|University of Pennsylvania|Laura Stein|215-662-6214|laura.stein@pennmedicine.upenn.edu|
22291230|NCT03422627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22305304|NCT02616263|Washington University in St. Louis, School of Medicine, Program in Physical Therapy|Dr. Mary Hastings, Professor|3142107108|hastingsmk@wustl.edu|
22305305|NCT04807517|Massachusetts General Hospital Lurie Center for Autism|Lurie Center Research Manager|781-860-1711|luriecenterresearch@mgh.org|
22305306|NCT01859195|The Miriam Hospital|Principal Investigator|401-793-4775 or 401-793-8180|scu-uvin@lifespan.org; kate.guthrie@lifespan.org|
22305307|NCT03569813|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
22305308|NCT02939183|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22305309|NCT05015478|Icahn School Of Medicine at Mount Sinai|Mariana Figueiro PhD|212-241-6500|Mariana.Figueiro@mountsinai.org|
22305310|NCT04939428|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22305311|NCT05096117|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|3014430788|falkde@mail.nih.gov|
22305312|NCT04319094|Mass General Hospital|Dr. Jin hui Joo|410-724-5317|jhjoo@mgh.harvard.edu|
22305313|NCT04081545|Virginia Mason Medical Center|Christine Oryhan|206-223-6980|christine.oryhan@virginiamason.org|
22305314|NCT03057132|Cancer Treatment Centers of America|Joseph Rudolph, BSN, RN, CWOCN, DWC|(215) 537-4678|Joe.Rudolph@ctca-hope.com|
22305315|NCT00654238|Abramson Cancer Center at the University of Pennsylvania|Dr. Marcia Brose|215-746-6344|brosem@mail.med.upenn.edu|
22305316|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
22305317|NCT03905135|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22305318|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu|
22305319|NCT04523181|Golden Biotechnology Corporation|Dr. Howard Cheng|+886228086006|howard@goldenbiotech.com|826
22305320|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408||
22305321|NCT01649427|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
22305322|NCT02735187|Philips Light & Health|Dr. Joerg Liebmann|+ 49-(0)1733715907|joerg.liebmann@philips.com|
22305323|NCT02138916|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
22305324|NCT01913340|University of California San Francisco|Yvonne Wu, MD MPH||wuy@ucsf.edu|
22305325|NCT05010304|University of Texas Southwestern|Dr Timothy Chow|2144569093|timothy.chow@utsouthwestern.edu|
22305326|NCT05750745|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22305327|NCT05064761|Galderma Research and Development, LLC (GLLC)|Clinical Project Manager|+1 817-961-5000|aestheticclinicaltrials@galderma.com|
22305328|NCT05096884|Hackensack Meridian Health|Jana Tancredi|5519962353|Jana.Tancredi@hmhn.org|
22305329|NCT02482233|Royal Columbian Hospital / University of British Columbia|Dr. Susan Ming Lee|604-520-4253|susanlee.anesthesia@gmail.com|
22305330|NCT04888585|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305331|NCT04927975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305332|NCT03822351|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22305333|NCT02237079|Tulane University|Dr. Franck Mauvais-Jarvis|504-988-5990|fmauvais@tulane.edu|
22305334|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161|amendizabal@emmes.com|221
22305335|NCT05550337|Teva Pharmaceuticals, Inc.|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22305336|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22305337|NCT02178436|Karmanos Cancer Institute|Mohammed Najeeb Al Hallak M.D.|313-576-8718|alhallakm@karmanos.org|
22305338|NCT02266329|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
22305339|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
22305340|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
22305341|NCT02926937|Lexicon Pharmaceuticals, Inc,|Medical Affairs|338-6064|medical-information@lexpharma.com|(510)
22305342|NCT01559090|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22305343|NCT04985383|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
22305344|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262|gabrielle.saunders@va.gov|56210
22305345|NCT03499600|George Mason University|Dr. Amanda Sanchez|703-993-1354|asanch49@gmu.edu|
22305346|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305347|NCT00445692|Fred Hutch Cancer Research Center|Leona A. Holmberg, MD, PhD|206-667-6447|lholmber@fredhutch.org|
22305348|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22305349|NCT03971357|Price Vision Group|Marianne Price|317-814-2990|mprice@cornea.org|
22305350|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com|
22305351|NCT03860077|Brown University|Dr. Rachel Cassidy|4018636621|rachel_cassidy@brown.edu|
22305352|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
22305353|NCT02147990|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22305354|NCT01779375|George Washington University Biostatistics Center|Sharon Edelstein|3018819260|sharone@bsc.gwu.edu|
22305355|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil|
22305356|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl|
22305357|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22305358|NCT01772719|University of Louisville, James Graham Brown Cancer Center|James Graham Brown Cancer Center, Clinical Trials|502-562-3429|ctobcc@louisville.edu|
22305359|NCT00477412|UT MD Anderson Cancer Center|Michael Wang, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
22305360|NCT01560949|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|(713) 792-2828|gvaradha@mdanderson.org|
22305361|NCT03181724|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
22305362|NCT03032159|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
22305363|NCT05460663|University of New Mexico, College of Nursing|Stephen H. A. Hernandez, PhD, RN, FAAN|505-272-0756|shhernandez@salud.unm.edu|
22305364|NCT00681811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305365|NCT03896230|Hackensack Meridian Health|Gabrielle L. Procopio, Pharm.D., BCPS|551-996-4368|Gabrielle.Procopio@hmhn.org|
22305366|NCT02613897|University of Texas Health San Antonio|Yuejuan Qin|210-617-5300|qiny@uthscsa.edu|
22305367|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305368|NCT00828919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305369|NCT05567159|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22305370|NCT04155424|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22305371|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284-2511|sinicrope.frank@mayo.edu|
22305372|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu|
22305373|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
22305374|NCT02030028|University of Pittsburgh|Dr. Dana Ascherman (Principal Investigator)|14123838123|DAscher@pitt.edu|
22305375|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590||
22305376|NCT02891629|EyeFree Assisting Communication|Or Retzkin, CEO|+972526490093|or@eyecontrol.co.il|
22305377|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
22305378|NCT00817635|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22305379|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
22305380|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
22305381|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22305382|NCT03107611|Mylan Pharmaceuticals Pvt Ltd|Prasanna C Ganapathi, Clinical Sciences Program Lead|+91 9148448200|PrasannaC.Ganapathi@mylan.in|
22305383|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305384|NCT01720446|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22305385|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22305386|NCT04176458|Northwestern University|Daniel Ganger, MD|3126954496|daniel.ganger@nm.org|
22305387|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22305388|NCT00601848|University of Pennsylvania|Keith A Cengel, MD, PhD|(215) 615-5312|cengel@pennmedicine.upenn.edu|
22305389|NCT03999554|FluGen|Pamuk Bilsel, CSO|6084426562|pbilsel@flugen.com|
22305390|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611|aaron.eagan@va.gov|4973
22305391|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu|
22305392|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com|
22305393|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22305394|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org|
22305395|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com|
22305396|NCT02060279|Nemours Children's Specialty Care|Dr. Amanda Lochrie|904-697-3698|alochrie@nemours.org|
22305397|NCT05457842|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22305398|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu|
22305399|NCT03124108|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
22305400|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com|
22305401|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu|
22305402|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22305403|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu|
22305404|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305405|NCT03586167|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22305406|NCT03058783|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22305407|NCT03537651|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22305408|NCT00295867|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu|
22305409|NCT05487703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305410|NCT02403323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22305411|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org|
22305412|NCT00952718|ChangGungMH|Dr. Liaw MY|+8867317123|myliaw1@yahoo.com.tw|8199
22305413|NCT03582956|Yale University|Michelle Van Name|2037855831|michelle.vanname@yale.edu|
22305414|NCT03885596|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
22305415|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305416|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22305417|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu|
22305418|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu|
22305419|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291231|NCT04251156|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22291232|NCT03675321|Medical College of Wisconsin|Clinical Research Manager|4142666131|ksiegel@mcw.edu|
22291233|NCT05293392|Nemours Children's Health|Thao-Ly Phan, MD, MPH|302-331-7342|thaoly.phan@nemours.org|
22291234|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com|
22291235|NCT04656899|Washington State University Elson S. Floyd College of Medicine, Analytics and PsychoPharmacology Laboratory (APPL)|Dr. Crystal Smith (backup: Dr. Sterling M. McPherson)|(509) 368-6876|crystal.lederhos@wsu.edu|
22291236|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291237|NCT01848782|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
22291238|NCT01479985|Washington University in St. Louis|Dr. Tessa Madden, MD, MPH|314-747-6495|maddent@wudosis.wustl.edu|
22291239|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22291240|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu|
22291241|NCT01933789|University of Washington|Dr. J. Randall Curtis|206-744-3356|jrc@uw.edu|
22291242|NCT03398278|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
22291243|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu|
22291244|NCT03102190|Massachusetts Eye and Ear Infirmary|Project Manager, Clinical Trials|617-573-6981|elizabeth_grimm@meei.harvard.edu|
22291245|NCT03562767|Emory University|Dr. Ambar Kulshreshtha|(404) 686-2410|akulshr@emory.edu|
22291246|NCT02004288|Sestre milosrdnice University Hospital Center Vinogradska 29, Zagreb, Croatia|Orjena Žaja, MD MSc PhD primarius Ass Prof Pediatrics, Pediatric gastroenterologist|P:+38513787342 M:+3859937872|Orjena Žaja <orjenazf@yahoo.com>|
22291247|NCT02518464|Columbia University Medical Center|Robert Sommer, MD|212-305-7060|rs2463@cumc.columbia.edu|
22291248|NCT03761797|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291249|NCT00266877|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22291250|NCT01254942|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
22291251|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
22291252|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu|
22291253|NCT04231981|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22291254|NCT02581943|Wake Forest Baptist Comprehensive Cancer Center|Assistant Director of Clinical Research Operations|336-713-6913|mebrown@wakehealth.edu|
22291255|NCT01470989|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22291256|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
22291257|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu|
22291258|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22291259|NCT03783702|Stanford University School of Medicine|Noel Ayoub|3109407055|nfa@stanford.edu|
22291260|NCT02119676|Incyte Corporation|Study Director|855 463-3463||
22291261|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22291262|NCT00989573|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22291263|NCT05038904|Johns Hopkins University School of Medicine|Melanie C. Dispenza, MD, PhD|410-550-2301|mdispen1@jhmi.edu|
22291264|NCT03473548|Washington University|Dr. David Leonard|314-454-6162|dsleonard@wustl.edu|
22291265|NCT03351101|Bausch Health|Study Director|+1 (585) 338-6399|Robert.Steffen@bausch.com|
22291266|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org|
22291267|NCT02207946|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22291268|NCT02829944|Duke University Medical Center|Emily Barney|9709031869|ezb2@duke.edu|
22291269|NCT05856760|Travere Therapeutics, Inc.|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
22291270|NCT04675151|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22291271|NCT04035486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291272|NCT01730937|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22291273|NCT03947684|UT southwestern medical center|Dr. Yasin Dhaher|2146450064|yasin.dhaher@utsouthwestern.edu|
22291274|NCT06661954|University of Alabama at Birmingham|Rachel Cowan, PhD|205-934-5034|recowan@uabmc.edu|
22291275|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu|
22291276|NCT05772702|Pulvinar Neuro|Dr. Christopher Walker|8043173403|chris.walker@pulvinarneuro.com|
22305420|NCT00235495|University of Miami|Dr. Myron D. Ginsberg|305-243-6103|MGinsberg@med.miami.edu|
22305421|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
22305422|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711|jennifer.soares@va.gov|83240
22305423|NCT02806895|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22305424|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com|
22305425|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
22305426|NCT02784704|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
22305427|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305428|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com|
22305429|NCT04794179|University of Utah Healthcare|Richard Gurgel MD, PI|801-585-1626|Richard.Gurgel@hsc.utah.edu|
22305430|NCT01110174|PI has left the institution, all efforts to locate PI have been exhausted.|PI has left the institution, all efforts to locate PI have been exhausted.||steve.martinez@ucdmc.ucdavis.edu|
22305431|NCT03781804|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|267-521-0565|John.Messina@optinose.com|
22305432|NCT04678830|CytoDyn Inc.|Bernie Cunningham, PhD|(360) 980-8524|bcunningham@cytodyn.com|
22305433|NCT06044948|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|8884513937|alcon.medinfo@alcon.com|
22305434|NCT03788291|University of Rochester|Paul Barr, MD|585-273-3258|paul_barr@urmc.rochester.edu|
22305435|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305436|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22305437|NCT01333514|Rush University Medical Center|Chung-Kay Koh|8475305230|chungkay@gmail.com|
22305438|NCT00836810|University of Bristol|Professor John Kirwan|+44 117 342 2904|John.Kirwan@Bristol.ac.uk|
22305439|NCT04257058|Emory University|Dr. Jordan Marchak|404-727-2293|jgillel@emory.edu|
22305440|NCT03227757|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
22305441|NCT05570006|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305442|NCT03888144|Cleveland Clinic foundation|Dr Sriharan Sivalingam|2162130159|SIVALIS@ccf.org|
22305443|NCT01144468|University Health Network|Dr. Angela Cheung|416-340-4841|jscher@uhnresearch.ca|
22305444|NCT02960659|NIDDK|Dr. Stephanie Chung|301-402-2122|stephanie.chung@nih.gov|
22305445|NCT04476472|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22305446|NCT03919955|Brigham and Women's Hospital|Scott Sands|8579280341|scottysands@gmail.com|
22305447|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org|
22305448|NCT04199728|Penn State College of Medicine|Dr. Scott Bunce|215-510-8295|sbunce@pennstatehealth.psu.edu|
22305449|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com|
22305450|NCT02703714|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
22305451|NCT05333263|Mayo Clinic|Kenton Kaufman, Ph.D|507-284-2262|Kaufman.Kenton@mayo.edu|
22305452|NCT02749968|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
22305453|NCT03068468|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22305454|NCT02085356|University of Miami Miller School of Medicine|Violeta Rodriguez|3052432188|vjrodriguez@med.miami.edu|
22305455|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305456|NCT03140176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305457|NCT02234128|Lung Bioengineering Inc.|Michael Roberts, Director Regulatory Affairs|2406502261|mroberts@lungbioengineering.com|
22305458|NCT03179787|Otsuka Pharmaceutical Co., Ltd.|Section Chief of Pharmacovigilance|+81-3-6717-1400|Sugimoto.Yuna@otsuka.jp|
22305459|NCT03181958|Children's Hospital of Chongqing Medical University|Dr.Yuan Shi|+86 23 68757731|shiyuan@hospital.cqmu.edu.cn|
22305460|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305461|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org|
22305462|NCT03106025|Loma Linda University Medical Center|Dr. Stephanie Tseeng|9095584000|ttseeng@llu.edu|
22305463|NCT03557385|Duke Clinical Research Institute|Marjan Cobbaert|9196995638|mr157@duke.edu|
22305464|NCT02236559|McGovern Medical School at The University of Texas Health Science Center at Houston|Dr. Pratik Doshi, MD||pratik.b.doshi@uth.tmc.edu|
22305465|NCT02263508|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22305466|NCT04148937|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22305467|NCT01149681|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22305468|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22305469|NCT01803646|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
22305470|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com|
22305471|NCT02993471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22305472|NCT02047461|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
22305473|NCT04974489|University of North Carolina, Chapel Hill|M. Justin Byron, PhD|(919)966-3292|jbyron@unc.edu|
22305474|NCT05674370|Mayo Clinic|Dr. Matthew Binicker|507-284-3697|binnicker.matthew@mayo.edu|
22305475|NCT02020018|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7066|schaff.hartzell@mayo.edu|
22305476|NCT04044664|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22305477|NCT02005666|Cadila Healthcare Limited|Mr Anuj K Saini|02717623666|Anuj.Saini@zyduscadila.com|314
22305478|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov|
22305479|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu|
22305480|NCT00831792|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-7734|PCORN@MDANDERSON.ORG|
22305481|NCT03736785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22305482|NCT02974010|NeuroRx|Martin Brecher|+1 484 254 6134|mbrecher@neurorxpharma.com|
22305483|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22305484|NCT03256344|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22305485|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu|
22305486|NCT04163458|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22305487|NCT03852433|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22305488|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
22305489|NCT01113515|NovaLead Pharma Pvt. Ltd.|Supreet Deshpande|+91-866-965-6660|supreet@novaleadpharma.com|12
22305490|NCT02929069|Yale University|John Pachankis, PhD|(203) 785-3710|john.pachankis@yale.edu|
22305491|NCT02708862|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
22305492|NCT03717194|Seoul National University Bundang Hospital|Soo Lim|+82-31-787-7035|limsoo@snu.ac.kr|
22305493|NCT03102242|Mayo Clinic|Helen J. Ross, MD|4803018000|Ross.Helen@mayo.edu|
22305494|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
22305495|NCT02639429|The University of Texas Health Science Center at Houston|Mesk Alrais, MD|(713) 566-5735|Mesk.A.Alrais@uth.tmc.edu|
22305496|NCT03425539|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
22305497|NCT02040844|Circassia Ltd|VP Clinical Operations|+44 1865 405560|info@circassia.com|
22305498|NCT00946192|Massachusetts General Hospital and Harvard Medical School|Madhu Misra, MD; Chief, Pediatric Endocrine|6177245602|mmisra@mgh.harvard.edu|
22305499|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300||
22305500|NCT02014558|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22305501|NCT05273801|Shirley Ryan AbilityLab|Dr. Miriam Rafferty|3122387233|mrafferty@sralab.org|
22305502|NCT03719677|Wayne State University|Heather Fritz|313-664-2627|Heather.fritz@wayne.edu|
22305503|NCT03059992|SCYNEXIS, Inc.|Dr. David Angulo, SCYNEXIS CEO|201-884-5471|david.angulo@scynexis.com|
22305504|NCT04159506|VA Connecticut Healthcare System|Steve Martino, Ph.D.|203-932-5718|Steve.Martino@va.gov|7418
22305505|NCT00147043|Imperial College London|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
22305506|NCT05968079|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22305507|NCT01875250|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
22305508|NCT04057196|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
22305509|NCT02555449|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22259040|NCT02330081|Terumo BCT|Beth Crump|+1 303 231-4606|beth.crump@terumobct.com|
22305510|NCT03895034|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22259041|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22291277|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291278|NCT05710185|Brigham and Women's Hospital|Director of Clinical Trials, Brigham and Women's Hospital Department of Dermatology|617-732-5500|amostaghimi@mgb.org|
22291279|NCT03269552|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
22291280|NCT01343823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22291281|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22291282|NCT03468543|Lyndra|Andrew Bellinger, MD, PhD|857-302-7878|abellinger@lyndra.com|
22291283|NCT04972630|Medical University of South Carolina|Dr. Suparna Qanungo|(843) 876-1125|qanungo@musc.edu|
22291284|NCT02651714|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22291285|NCT04214288|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291286|NCT03469570|Edwards Lifesciences|Edwards Critical Care Clinical Affairs|(949) 250-7169|afmidestudy@edwards.com|
22291287|NCT02455557|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22291288|NCT02278341|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22291289|NCT01129024|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22291290|NCT02409914|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
22291291|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org|
22291292|NCT02047318|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22291293|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu|
22291294|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com|
22291295|NCT02554279|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22291296|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu|
22291297|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291298|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu|
22291299|NCT04761627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22291300|NCT01634178|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22291301|NCT01117792|Boston Scientific|Tom Stoltz, Clinical Trial Manager|1-800-227-3422|thomas.stoltz@bsci.com|
22291302|NCT05867342|Stanford University|Peter H. Hwang, MD|(650) 725-6500|hwangph@stanford.edu|
22291303|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
22291304|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012||
22291305|NCT02524977|University of Cincinnati Health|VP Research UC Health|513-558-6937|christopher.lindsell@uc.edu|
22291306|NCT01903525|Scottish Rite for Children|Dr. Shane Miller|469-515-7222|shane.miller@tsrh.org|
22291307|NCT04365257|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Chetan Bettegowda|4109558620|cbetteg1@jhmi.edu|
22291308|NCT03935399|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
22291309|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu|
22291310|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22305511|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590||
22291311|NCT02915874|University of Iowa|Jess G Fiedorowicz, MD, PhD|319-384-9267|jess-fiedorowicz@uiowa.edu|
22291312|NCT03103061|Medical University of South Carolina|Hunter Gray, Program Coordinator|843-876-3185|grayhu@musc.edu|
22305512|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com|
22305513|NCT05365633|University of Oklahoma|Dr. Julia McQuoid|405-271-8001|julia-mcquoid@ouhsc.edu|1
22305514|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu|
22305515|NCT03196167|Yale University|Amit Bardia|2038436469|amit.bardia@yale.edu|
22305516|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
22305517|NCT02008292|Yale University|Dr. Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
22305518|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu|
22305519|NCT03667547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305520|NCT03223883|University of Iowa Carver College of Medicine|Dr. Diana Jalal|319-356-3500|diana-jalal@uiowa.edu|
22305521|NCT05298111|Universiti Sultan Zainal Abidin|Ms Ong Ying Qian|+60142186195|oyq0109@gmail.com|
22305522|NCT04866407|Rutgers RWJMS|Dr Sydney Asselstine|6469403587|sydneyasselstine@gmail.com|
22305523|NCT03079375|OdenseUH|Lene V. Ravn-Nielsen clinical pharmacist|+4523467925|lene.ravn-nielsen@rsyd.dk|
22305524|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu|
22305525|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22305526|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305527|NCT03783533|University of Washington|Dr. Jessica Jenness|206-616-7967|jennessj@uw.edu|
22305528|NCT03615001|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
22305529|NCT02001623|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
22305530|NCT03669354|Southern California University Of Health Sciences|Anupama Kizhakkeveettil|(562) 475-5158|anu@scuhs.edu|
22305531|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu|
22305532|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu|
22305533|NCT02628093|Weill Cornell Medicine|Koianka Trencheva|646-9622342|kivanova@med.cornell.edu|
22305534|NCT02786771|Partners Connected Health Innovation|Odeta Dyrmishi - Acting Project Manager|6177243605|odyrmishi@partners.org|
22305535|NCT02702921|Ethicon Endo Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
22305536|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22305537|NCT01107626|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22305538|NCT04381494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22305539|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu|
22305540|NCT01760291|Boston Scientific|Director of Clinical Trials|18002273422|peter.maurer@bsci.com|
22305541|NCT02715258|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22305542|NCT02052648|Lumos Pharma Corporation|Lumos Pharma, Inc.|515-598-2921|clinical.trials@lumos-pharma.com|
22305543|NCT04310579|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22305544|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com|
22305545|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22305546|NCT01117480|AbbVie|Global Medical Information|800-633-9110||
22305547|NCT04208243|Children's Hospital Colorado|Dr. Jennifer Raybin|720-777-3407|jennifer.raybin@childrenscolorado.org|
22305548|NCT02955069|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22305549|NCT04083976|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305550|NCT03721016|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22305551|NCT03357341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22305552|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
22305553|NCT01908634|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
22305554|NCT01524536|National Institute of Allergy and Infectious Diseases|Paneez Khoury|+1 301 402 3773|khouryp@niaid.nih.gov|
22305555|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
22305556|NCT01876511|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22305557|NCT02131324|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
22305558|NCT05790408|Northwestern University|Angelo P. Tanna|3129088152|atanna@northwestern.edu|
22305559|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22305560|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu|
22305561|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu|
22305562|NCT03533036|UCLA|Dr. Aparna Sridhar, Associate Clinical Professor|3107947274|asridhar@mednet.ucla.edu|
22305563|NCT04582877|Zurich Medical|Charles Chan|(612) 889-9412|cchan@zurichmed.com|
22305564|NCT01134575|The University of Texas MD Anderson Cancer Center|Hagop M. Kantarnian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
22305565|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621|mary.sevick@nyumc.org|646
22305566|NCT01982643|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
22305567|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259042|NCT02707432|University of North Carolina at Chapel Hill|Stephanie Hoover, PhD|919-966-1649|stephanie_hoover@med.unc.edu|
22291313|NCT02301611|Lumabridge, LLC|Marsha Greene|(484) 319-1117|mgreene@lumabridge.com|
22291314|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org|
22291315|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
22291316|NCT04973137|Prothena Biosciences Limited|Katelyn Diffin|650-837-8550|AFFIRM-ALClinicalTrials@prothena.com|
22291317|NCT01351896|The Ohio State University Comprehensive Cancer Center|Dr. Kerry Rogers|614-293-3873|Kerry.Rogers@osumc.edu|
22291318|NCT04391569|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22291319|NCT04641221|Butler Hospital|Lisa Uebelacker, PhD|401-455-6381|luebelacker@butler.org|
22305568|NCT04930822|Gaylord Hospital|Dr. Henry Hrdlicka|2032842864|hhrdlicka@gaylord.org|
22305569|NCT03921528|Scholar Rock|Clinical Trials Coordinator|833-724-7625|clinicaltrials@scholarrock.com|
22305570|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22305571|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22305572|NCT03284411|Medtronic|SCS Dosing Clinical Research Study Team|800-633-8766|rs.scsdosing@medtronic.com|
22305573|NCT02232178|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22305574|NCT02162667|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22305575|NCT01956669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22305576|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22305577|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu|
22305578|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com|
22305579|NCT05419557|Inova Health System|Dr. Elyssa Wood|5714728649|elyssa.wood@inova.org|
22305580|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org|
22305581|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305582|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu|
22305583|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305584|NCT05257798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305585|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22305586|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com|
22305587|NCT03102710|Massachusetts General Hospital, Harvard Medical School|Jian Kong, Principal Investigator|617-726-7893|jkong2@mgh.harvard.edu|
22305588|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com|
22305589|NCT04304534|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22305590|NCT04012853|WJB Dorn VA Medical Center|Dr. X. Michelle Androulakis Chief of Neurology|803-776-4000|xiao.androulakis@va.gov|4077
22305591|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org|
22305592|NCT01695317|St. olavs Hospital|Dr. knut Hagen|95401579|knut.hagen@stolav.no|
22305593|NCT00003656|Weill Cornell Medical College|Sharon Singh|(646) 962-9340|shs4011@med.cornell.edu|
22305594|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com|
22305595|NCT03055767|"University of California, Irvine | Dept. of Anesthesiology & Perioperative Care"|Shalini Shah, MD|(949) 824-7246|ssshah1@hs.uci.edu|
22305596|NCT02228408|New York University Medical Center|David Charytan|(646) 501-9086|david.charytan@nyulangone.org|
22305597|NCT02759731|National Cancer Institute|Dr. Steven Pavletic|240-760-6174|pavletis@mail.nih.gov|
22305598|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu|
22305599|NCT04969822|Vitrolife A/S|Mr. Jørgen Berntsen|+4551542005|jberntsen@vitrolife.com|
22305600|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org|
22305601|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
22305602|NCT00957229|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
22305603|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22305604|NCT04580303|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
22305605|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com|
22305606|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22305607|NCT02427737|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant sponsoring site-PIs); CEO|617 734 9087|drevlang@ComfortTalk.com|
22305608|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418||
22305609|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
22305610|NCT03095508|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
22305611|NCT02317705|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
22305612|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22305613|NCT01674569|Tyrogenex, Inc|Sr Vice President, Development|240-403-7153|Dan@tyrogenex.com|
22305614|NCT02430181|Eiger BioPharmaceuticals, Inc|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22305615|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22291320|NCT01903252|Tillotts Pharma AG|Dr. Robert Hofmann, MD PhD|+4161 935 27 14|robert.hofmann@tillotts.com|
22305616|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com|
22305617|NCT01878890|Institut Bergonié|Dr Guilhem Roubaud|33 5 56 33 33 33|g.roubaud@bordeaux.unicancer.fr|
22305618|NCT04054661|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
22305619|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu|
22305620|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22305621|NCT02846415|School of Nursing, The Hong Kong Polytechnic University|Dr Daphne Cheung|+852 27664534|cheungdaphne@polyu.edu.hk|
22305622|NCT03404843|Colorado State University|Frank Dinenno|970-491-3203|frank.dinenno@colostate.edu|
22305623|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22305624|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305625|NCT04490148|Penn State College of Medicine|Dr. Andrew Geronimo|717 531 0003|ageronimo@pennstatehealth.psu.edu|282576
22305626|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22305627|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305628|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com|
22305629|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
22305630|NCT01636206|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305631|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174||
22305632|NCT02595398|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22305633|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305634|NCT05576051|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305635|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040||2917
22305636|NCT03601507|University of Arizona Cancer Center|Ricklie Julian, MD|520-694-2873|rickliej@arizona.edu|
22305637|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
22305638|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu|
22305639|NCT03381274|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22305640|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623||
22305641|NCT03168438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22305642|NCT04432974|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Dr. Massimiliano Paltenghi|(+39) 3487046844|massimiliano.paltenghi@spedalicivili.brescia.it|
22305643|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351||
22305644|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300||
22305645|NCT03598790|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22305646|NCT03297112|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
22305647|NCT03410992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22305648|NCT04018066|Rutgers, The State University of New Jersey|Dr. Diana Roopchand, Study Investigator|8489320248|roopchand@sebs.rutgers.edu|
22305649|NCT03568318|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305650|NCT05245669|Alkem Laboratories Limited|Dr. Akhilesh Sharma|+91- 9701346369|akhilesh.sharma@alkem.com|
22305651|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu|
22305652|NCT04988295|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305653|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org|
22305654|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu|
22305655|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
22305656|NCT01693614|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22305657|NCT04618471|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22305658|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22305659|NCT05197049|Janssen-Cilag International NV|Senior Medical Leader IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305660|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590||
22305661|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305662|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305663|NCT00828672|UZ Leuven|Prof. Dr. Eric Van Cutsem|+32 16 34 42 18|Eric.VanCutsem@uzleuven.be|
22305664|NCT04889118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22305665|NCT00073957|Beth Israel Deaconess Medical Center|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
22305666|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu|
22259043|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259044|NCT03775681|UT MD Anderson Cancer Center|Katherine Hagan, Associate Professor, Anesthesiology & PeriOper Med|(713) 794-5945|khagan@mdanderson.org|
22259045|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com|
22259046|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259047|NCT02196506|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22259048|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
22259049|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259050|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22259051|NCT03507439|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22259052|NCT00874757|University of Nebraska Medical Center|Timothy R McGuire|402-651-2496|trmcguir@unmc.edu|
22259053|NCT00974142|University of Pittsburgh Medical Center|Michael Donahoe MD|412-648-9636|donahoem@upmc.edu|
22259054|NCT01486407|Teleflex|Tatiana Puga||tatiana.puga@teleflex.com|
22259055|NCT03698669|Boston University|Michael Stein, MD|617 358 1956|mdstein@bu.edu|
22259056|NCT03346538|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22259057|NCT03369756|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
22259058|NCT04014959|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22259059|NCT05286528|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259060|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
22259061|NCT02220920|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259062|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov|
22259063|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu|
22259064|NCT02811861|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22259065|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com|
22259066|NCT04081337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22259067|NCT06624072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259068|NCT05076422|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259069|NCT00416520|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259070|NCT01387737|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259071|NCT02642627|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
22259072|NCT00707954|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259073|NCT04326257|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
22259074|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22259075|NCT04630626|NuVasive, Inc.|Nicole Czaplewski, Manager Clinical Affairs|308-660-2021|nczaplewski@nuvasive.com|
22259076|NCT06509100|University of North Carolina at Chapel Hill|David Rauscher|828-405-0588|david_rauscher@med.unc.edu|
22259077|NCT02207309|Ludwigs-Maximilians-Universtity of Munich|Lars Lindner|0049894400|Lars.Lindner@med.uni-muenchen.de|74768
22259078|NCT05002569|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22259079|NCT06076681|TenNor Therapeutics (Suzhou) Limited.|TenNor Medical Information|0512-86861979|info@tennorx.com|
22259080|NCT02971956|Dana-Farber Cancer Institute|Peter C. Enzinger MD|(877) 442-3324|Peter_Enzinger@dfci.harvard.edu|
22259081|NCT04041570|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22259082|NCT05211336|National Cancer Institute|Dr. Rahul Lakhotia|240-858.7242|rahul.lakhotia@nih.gov|
22259083|NCT02337829|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
22259084|NCT01418352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22259085|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259086|NCT05332626|Poznan University of Life Sciences|Iskandar Harahap|+48618486330|iskandar.harahap@up.poznan.pl|
22259087|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22259088|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
22259089|NCT01214603|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259090|NCT00542386|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259091|NCT01507896|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22259092|NCT00621179|Colorado Center for Reproductive Medicine|Eric Surrey|303-788-8300|esurrey@colocrm.com|
22291321|NCT02067975|Maryland Psychiatric Research Center|Sam Kane-Gerard|410-402-6120|SGerard@som.umaryland.edu|
22291322|NCT01138917|AVITA Medical|Director of Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
22291323|NCT02819908|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
22291324|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu|
22291325|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22291326|NCT01924429|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Newcorn|212-659-8775|Jeffrey.newcorn@mssm.edu|
22291327|NCT06165627|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22305667|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov|
22259093|NCT01110681|Q-Med AB|Head of Medical Affairs|+ 46 (0)18 4749000|reception.SEUPP@galderma.com|
22259094|NCT03503474|University of Leeds|Professor Mark Wilcox|+441133926818|mark.wilcox@nhs.net|
22259095|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133||
22259096|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
22259097|NCT04029090|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml.JP@ml.tanabe-pharma.com|
22259098|NCT00506441|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259099|NCT00501046|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259100|NCT05056727|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22259101|NCT02622113|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259102|NCT03404180|Malcom Randall VAMC/University of Florida|Jose R. Soberon, Jr., MD|352-376-1611|jose.soberon@va.gov|10-3581
22259103|NCT03289208|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22259104|NCT05245682|Emory University|Nicole Schmitt|404-778-0278|nicole.cherie.schmitt@emory.edu|
22259105|NCT01840605|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259106|NCT05308472|Disc Medicine|CMO|(617) 674-9274|clinicaltrials@discmedicine.com|
22305668|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305669|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305670|NCT03879642|Nemours Children's Health-Jacksonville|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
22305671|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com|
22305672|NCT02701361|Duke University Health System|Christopher Cox|9196817232|christopher.cox@duke.edu|
22305673|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com|
22305674|NCT04469218|Lineus Medical|CEO|844-546-3728|vance@lineusmed.com|
22305675|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no|
22305676|NCT04154943|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22305677|NCT02121418|University of Washington|Dr. Pamela Becker|206-606-7273|pbecker@u.washington.edu|
22305678|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305679|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
22305680|NCT00591838|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4633|clifford.robinson@wustl.edu|
22305681|NCT03761784|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22305682|NCT01549652|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
22305683|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305684|NCT02512042|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22305685|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu|
22305686|NCT03320096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22305687|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889||
22305688|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22305689|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com|
22305690|NCT04109118|Boston Medical Center and BU School of Medicine|Tae Woo Park, MD|617-414-1906|taewoo.park@bmc.org|
22305691|NCT01830842|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|MAddicott@uams.edu|501
22305692|NCT03235349|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22305693|NCT03394027|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
22305694|NCT05905302|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
22305695|NCT05887323|Abbott|Director of Clinical Research|9725269673|kwangdeok.lee@abbott.com|
22305696|NCT02824432|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22259107|NCT03469271|Mayo Clinic|Aminah Jatoi, M.D.|507-266-0984|huyber.christine@mayo.edu|
22259108|NCT05021133|UMass Chan Medical School|Mayuko Ito Fukunaga|5088561975|mayuko.itofukunaga@umassmed.edu|
22259109|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274472|NCT04037358|Johns Hopkins University School of Medicine|Dr. Ana P. Kiess|443-287-7528|akiess1@jhmi.edu|
22305697|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300||
22291328|NCT01445886|Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Keelung, Taiwan|Yin-Ku Lin|886-2-2431-3131|lin1266@adm.cgmh.org.tw|2127
22291329|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com|
22259110|NCT04326842|The First Affiliated Hospital of Harbin Medical University|Dr. Hong Zhang|+86 0451-85553952|2315186458@qq.com|
22259111|NCT04535583|Geisel School of Medicine at Dartmouth|Dr. Lisa A. Marsch|603-646-7092|lisa.a.marsch@dartmouth.edu|
22259112|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22259113|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov|
22259114|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org|
22259115|NCT03035227|Kansas City Heart Rhythm Institute|Dr. Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
22259116|NCT02100956|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
22259117|NCT03529955|Tulane University|Carole Bitar, MD, FAAD|202-642-8122|cbitar@tulane.edu|
22259118|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
22259119|NCT03289234|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22259120|NCT03016078|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22259121|NCT04526899|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22259122|NCT01259869|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22259123|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22259124|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22259125|NCT05245617|Orthofix s.r.l.|Clinical Affairs Operations team|+39 045 6719000|clinicalaffairs@orthofix.it|
22259126|NCT00795665|University of California Davis|Analyst|916-734-8053|nlogihara@ucdavis.eduu|
22259127|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca|
22259128|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22259129|NCT03425331|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
22259130|NCT03433274|Abbott|Kayla Dellefratte, Senior Manager Clinical Project Management|+16692149748|kayla.dellefratte@abbott.com|
22259131|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22259132|NCT04864405|The Ottawa Hospital Cancer Centre|Marie-France Savard, MD|613-737-7700|msavard@toh.ca|70170
22259133|NCT04969939|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22259134|NCT03843359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259135|NCT03075527|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
22259136|NCT02811432|London Sch Hygiene & Trop Medicine -|Professor Joy Lawn|+44 (0)20 7636 8636|joy.lawn@lshtm.ac.uk|
22259137|NCT02667067|NuVasive, Inc.|Nicole Czaplewski|308-660-2021|nczaplewski@nuvasive.com|
22259138|NCT05359003|Wake Forest University School of Medicine|Halley Alexander, MD, MS, FACNS|336-716-6898|halley.alexander@advocatehealth.org|
22259139|NCT06230848|Loyola University Chicago|Dr. Thao Griffith|464-220-9825|tgriffith1@luc.edu|
22259140|NCT06202521|Senhwa Biosciences|Becky Lin, Project Manager of Clinical Department|+886-2-8911-9856|beckylin@senhwabio.com|
22259141|NCT06064617|The Ohio State University|Ann Morrison|614-247-0010|morrison.421@osu.edu|
22259142|NCT02717611|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22259143|NCT04980378|Globus Medical|Jessica Fulwider, Lead Clinical Project Manager|703-772-1455|jfulwider@globusmedical.com|
22259144|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259145|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org|
22259146|NCT05182606|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
22259147|NCT01357356|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22259148|NCT02669264|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22259149|NCT00500682|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259150|NCT01680159|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259151|NCT00772382|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259152|NCT01512849|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259153|NCT05576012|Lipum AB|Peter Hovstadius, Chief Medical Officer|0046708893335|peter.hovstadius@lipum.se|
22259154|NCT00821821|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259155|NCT06268730|University of North Carolina at Chapel Hill|Keri Heilman, PhD|913-802-2168|keri_heilman@med.unc.edu|
22259156|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22259157|NCT03731182|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259158|NCT01711021|Noven Pharmaceuticals, Inc.|Study Director|(305) 253-5099|ClinicalTrials@noven.com|
22259159|NCT02442856|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
22259160|NCT01769209|Stanford University Medical Center|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
22259161|NCT02833415|University of Texas Southwestern Medical Center|Ian J. Neeland MD|214-645-1267|ian.neeland@utsouthwestern.edu|
22291330|NCT02964078|Moffitt Cancer Center|Jad Chahoud MD, MPH|813-745-6926|Jad.Chahoud@moffitt.org|
22291331|NCT04268823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22291332|NCT05313009|Medical University of South Carolina|Alan Brisendine|843-792-9007|brisend@musc.edu|
22291333|NCT02186301|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
22305698|NCT05822440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22305699|NCT02081391|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|Clinical-Trials@grunenthal.com|3223
22305700|NCT03184428|Eyestylianides ophthalmology center|Christoforos Stylianides|0035725320244|Info@eyestylianides.com|
22305701|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22305702|NCT00980538|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER EST PRODUCTS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305703|NCT05663866|Janssen Research & Development LLC|Senior Medical Director Global Medical Affair Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305704|NCT03720990|University of Nebraska Medical Center|William Rizzo|402-559-2560|wrizzo@unmc.edu|
22305705|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org|
22305706|NCT03518112|The University of Texas MD Anderson Cancer Center|Dr. Elias Joseph Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
22305707|NCT05546515|Johns Hopkins School if Medicine|Jennifer Ellis|4105506346|jellis36@jhmi.edu|
22305708|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu|
22305709|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu|
22305710|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22305711|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov|
22305712|NCT05650333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Centre|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305713|NCT02873754|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
22305714|NCT01981850|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22305715|NCT03495713|Abramson Cancer Center at Penn Medicine|John P. Plastaras, MD, PhD|855-216-0098|PennCancerTrials@emergingmed.com|
22305716|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com|
22305717|NCT02979899|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22305718|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
22305719|NCT02059980|University of Wisconsin-Milwaukee|Dr. Han Joo Lee|414-229-5858|leehj@uwm.edu|
22305720|NCT01321606|William S. Middleton Memorial Veterans Affairs Medical Center|Dr. Nasia Sardar|608-256-1901|nasia.safdar@va.gov|17800
22305721|NCT03412747|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22305722|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu|
22305723|NCT03610698|Northwestern University|Project Manager|3125035247|amanda.summers@northwestern.edu|
22305724|NCT04982575|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22305725|NCT05483933|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22305726|NCT03038022|Madrigal Pharmaceuticals, Inc.|Thomas Hare|267-268-7800|thare@madrigalpharma.com|
22305727|NCT04798521|Oregon Health & Science University|Dr. P. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22305728|NCT01467427|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22305729|NCT04925752|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22305730|NCT04269200|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22305731|NCT04181827|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305732|NCT03887936|Michael E. DeBakey VA Medical Center|Dr, Reina Villareal|314-313-4550|reina.villareal@bcm.edu|
22305733|NCT06269367|University of Michigan|Chandramouli Krishnan|(734) 936-4031|mouli@umich.edu|
22305734|NCT03331250|Massachusetts General Hospital|Gregory Cote, MD, PhD|617-726-8748|GCOTE@mgh.harvard.edu|
22305735|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com|
22305736|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
22305737|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org|
22305738|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org|
22305739|NCT05824351|Duke University|Amy Barto, MD|919-684-1817|amy.barto@duke.edu|
22305740|NCT02137850|Novo Nordisk A/S|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
22305741|NCT02912260|Madrigal Pharmaceuticals, Inc.|Thomas Hare|267-268-7800|thare@madrigalpharma.com|
22305742|NCT05005429|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22305743|NCT01311713|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22305744|NCT04549051|Albert Einstein College of Medicine|Sayed Wahezi, M.D.|718-920-7246|swahezi@montefiore.org|
22305745|NCT03878446|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22305746|NCT05803720|RAND|Dr. Lu Dong|3103930411|ldong@rand.org|7494
22305747|NCT03370133|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22305748|NCT06688370|Pierre Fabre Médicament|Aurore Puglisi Mouton|+335679463982|aurore.puglisi.mouton@pierre-fabre.com|
22305749|NCT02501811|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
22305750|NCT04804605|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22305751|NCT05323630|West End Plastic Surgery|Paul G. Ruff, MD|202-785-4187|drruff@westendplasticsurgery.com|
22305752|NCT00567879|Novartis|Study Director|862-778-8300||
22305753|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
22305754|NCT00151996|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305755|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
22305756|NCT02899000|Galderma Laboratories, LP|Dr. Jean Philippe York, Medical Affairs Manager|1-817-961-5468|jp.york@galderma.com|
22305757|NCT02220478|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
22305758|NCT02156687|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22305759|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305760|NCT03546907|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22305761|NCT04033432|Northwestern University|Maha Hussain, MD|312-908-5487|mhussain@northwestern.edu|
22305762|NCT03110458|Sensorion|Director of Regulatory Affairs|+33 4 67 20 77 30|contact@sensorion-pharma.com|
22305763|NCT03131206|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
22305764|NCT04936035|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22305765|NCT03745794|UT MD Anderson Cancer Center|Dr. Ching-Wei D. Tzeng, MD/Associate Professor, Surgical Oncology|(713) 792-0386|cdtzeng@mdanderson.org|
22305766|NCT05827926|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22305767|NCT04131933|Ottawa Hospital Research Institute|Dr. Mark Clemons|+1-613-737-7700|mclemons@toh.ca|70170
22305768|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org|
22305769|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu|
22305770|NCT04588480|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22305771|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000|steven.woolson@va.gov|66101
22305772|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
22305773|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22305774|NCT04511650|EyePoint Pharmaceuticals, Inc.|Dario Paggiarino, MD|8589670016|dpaggiarino@eyepointpharma.com|
22305775|NCT02982213|Northwestern University|Feyce Peralta, MD|312-472-3585|feyce.peralta@northwestern.edu|
22305776|NCT01992354|GE Healthcare|John Strohmeyer|+1 609 865 7423|john.strohmeyer@ge.com|
22305777|NCT03247543|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22305778|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu|
22305779|NCT01253226|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305780|NCT04210024|University of Kentucky|Dr. Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
22305781|NCT04075266|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22305782|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com|
22305783|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com|
22305784|NCT04858425|First Wave BioPharma|VP, Regulatory, QA & Compliance|19194491484|AChandler@FirstWaveBio.com|
22305785|NCT03473743|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305786|NCT02864992|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22305787|NCT05457491|Mayo Clinic|Saranya P. Wyles, M.D., Ph.D.|507-284-5475|Wyles.Saranya@mayo.edu|
22305788|NCT04536077|Washington University School of Medicine|Roheena Z. Panni, M.D.|314-362-7046|roheenazpanni@wustl.edu|
22305789|NCT04948333|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22305790|NCT05191797|University of Washington|Rafael Santana-Davila|2066062190|rafaelsd@uw.edu|
22305791|NCT03805295|Massachusetts General Hospital|Dr. Rachel Whooten|6176434585|rwhooten@mgh.harvard.edu|
22305792|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org|
22305793|NCT00928200|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22305794|NCT04305912|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22305795|NCT02908620|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
22305796|NCT04548622|Yale University Department of Psychiatry|Dr. Philip R. Corlett PhD|(203) 974-7866|philip.corlett@yale.edu|
22305797|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100|peter.friedmann@va.gov|6240
22305798|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45|sboveda@clinique-pasteur.com|8819
22305799|NCT00555581|Hospital for Special Surgery|Robert F. Spiera|212-774-2048|spierar@hss.edu|
22305800|NCT05365386|Novoxel Ltd|Dr. Ifat Klein|+972.52-6009860|ifat@novoxel.com|
22305801|NCT04538664|Janssen Research & Development|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305802|NCT03681678|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@corewellhealth.org|
22305803|NCT00331162|Wake Forest University Health Sciences|Dr. Alan Farney|336-716-6510|afarney@wakehealth.edu|
22305804|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305805|NCT02141074|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22305806|NCT03563053|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
22305807|NCT03536884|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22305808|NCT03722446|University of Michigan - Department of Anesthesiology|Dr. Carlo Pancaro|617-435-5403|cpancaro@med.umich.edu|
22305809|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305810|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22305811|NCT04540835|Baskent University|Leyla Kerimova Köse|+905378986689|lkerimova@baskent.edu.tr|
22305812|NCT01838200|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22305813|NCT03105336|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22305814|NCT03451851|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305815|NCT04969991|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
22305816|NCT05208359|Loyola University Chicago|Sungha Kang|7735082712|skang@luc.edu|
22305817|NCT03645031|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
22305818|NCT04622527|Mayo Clinic|Dr. Ivana Croghan|507-284-2511|gimresearchstudies@mayo.edu|
22305819|NCT01090024|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305820|NCT04460898|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305821|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
22305822|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22305823|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu|
22305824|NCT02689349|Envoy Medical Corp.|Elizabeth Anderson, Ph.D.|(1) 651-788-3017|landerson@envoymedical.com|
22305825|NCT02930343|JIPMER|Dr Pooja Belani|8940482248|drpoojabelani@gmail.com|
22305826|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22305827|NCT01729819|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22305828|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305829|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22305830|NCT02987543|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22305831|NCT03224299|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
22305832|NCT03646669|Icahn School of Medicine at Mount Sinai|Maria Peralta|212-274-7571|Maria.peralta@mountsinai.org|
22305833|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
22305834|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu|
22305835|NCT03720210|Mayo Clinic|Marius N. Stan, M.D.|507-266-3769|Stan.Marius@mayo.edu|
22305836|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22305837|NCT02274493|UT MD Anderson Cancer Center|Dr. Jesse C Selber / Professor, Plastic Surgery|713-794-1297|jcselber@mdanderson.org|
22305838|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
22305839|NCT04008836|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22305840|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456|louice1070@gmail.com|62131
22305841|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca|
22305842|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22305843|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM|
22305844|NCT05252871|Western University of Health Sciences|Frank Spors|9097063883|fspors@westernu.edu|
22305845|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22305846|NCT03861169|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|818-687-3310|trodriguez@sightsciences.com|
22305847|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
22305848|NCT03523962|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
22305849|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305850|NCT03727854|Seoul National University Hospital|Professor|82-2-2072-2217|ymchomd@snu.ac.kr|
22305851|NCT01081145|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305852|NCT03593070|Rush University College of Nursing|Dr. Olimpia Paun|3129426996|olimpia_paun@rush.edu|
22305853|NCT03643211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305854|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com|
22305855|NCT06078774|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
22305856|NCT04164563|Brigham and Women's Hospital|Dr. Jeremy T. Smith|6177325322|jsmith42@bwh.harvard.edu|
22305857|NCT03431350|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22320295|NCT02722863|Korea Otsuka Pharmaceutical Co.,Ltd.|Huiyeong,Shim/Associate CTM for LPS & ISS|02-3287-9220|hyshim@otsuka.co.kr|
22320296|NCT05745662|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22320297|NCT01490450|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22320298|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300||
22320299|NCT03600142|University of Utah|Dr. Melissa Watt|8015817201|melissa.watt@hsc.utah.edu|
22320300|NCT03887533|National Institute of Child Health and Human Development (NICHD)|Dr. Forbes Porter|301-435-4432|fdporter@mail.nih.gov|
22305858|NCT04540822|CHD Vendée|Stéphanie BREHU|06 88 39 85 17|stephanie.brehu@ght85.fr|+33
22320301|NCT04639973|Baylor College of Medicine|Cara Buskmiller, MD|832-824-1000|cara.buskmiller@bcm.edu|
22320302|NCT00636675|University of North Carolina Chapel HIll|Ruth A. Anderson|919-966-8785|rutha@email.unc.edu|
22320303|NCT03785925|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22320304|NCT02318667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259162|NCT03036579|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
22259163|NCT02352337|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22259164|NCT04488575|Evelo Biosciences Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22259165|NCT02458638|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22259166|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com|
22259167|NCT03495648|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
22259168|NCT02324972|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 604-629-9223|clinical@aqxpharma.com|
22259169|NCT02236338|Virginia Commonwealth University|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
22259170|NCT02401542|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
22259171|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259172|NCT02398188|Neothetics, Inc.|Neothetics Clinical|858-550-1900||
22291334|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu|
22291335|NCT05128929|Stanford University School of Medicine|Roham Zamanian, MD|650-725-5495|zamanian@stanford.edu|
22291336|NCT03553836|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22291337|NCT00807027|GREEN CROSS CELL|CRA of Clinical Trial|82-2-2101-0665|a1pole@greencrosscell.com|665
22291338|NCT05660850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22291339|NCT02604017|AbbVie|Global Medical Services|800-633-9110||
22291340|NCT05820997|Mayo Clinic|Dr. John Stauffer|904-953-2000|stauffer.john@mayo.edu|
22291341|NCT05048082|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
22291342|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu|
22291343|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se|
22291344|NCT02777749|Columbia University Medical Center|Dr. Matthew Grosso|2123058193|mgrosso13@gmail.com|
22291345|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org|
22291346|NCT02497976|IC Study LLC|Philip C. Bosch, MD|760 743-3135|pboschmd@gmail.com|
22291347|NCT01410552|LivaNova|Scientific Communication manager|33146013082|Anne.rousseauplasse@sorin.com|
22291348|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291349|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com|
22291350|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22291351|NCT02483533|Neothetics|Director of Clinical Trials|8585501900||
22291352|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
22291353|NCT00768469|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22291354|NCT05040971|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22291355|NCT05622604|Pray.com|Breanne Laird, PhD|9095574002|breanne.laird@pray.com|
22291356|NCT01293799|Dept. of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden|Susanne Ljungman prof. emer. Director of the study|+46-(0)31-3421000|susanne.ljungman@vgregion.se|28579
22291357|NCT02891603|Moffitt Cancer Center|Joseph Pidala, MD, PhD|813-745-2556|Joseph.Pidala@moffitt.org|
22291358|NCT04702802|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22291359|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22291360|NCT02283177|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22291361|NCT03044574|Pirogov Russian National Researching Medical University|Dr. Kirill Lobastov, Associated professor at the Department of General Surgery and Radiology|+7-985-211-63-31|lobastov_kv@hotmail.com|
22291362|NCT01233518|Heartflow, Inc.|Whitney Huey|650.257.6697|whuey@heartflow.com|
22291363|NCT02635646|University of Guanajuato|Dr. Rodolfo Guardado-Mendoza||guardamen@gmail.com|
22291364|NCT02995369|Montefiore Medical Center|Nuntiya Kakanantadilok|718-405-8057|nkakanan@montefiore.org|
22291365|NCT02387476|FRESCA Medical|Robert Lahaderne|949-542-3535|rlahaderne@frescamed.com|
22291366|NCT03769376|"University of Colorado Denver | Anschutz"|Kerri Font, DDS, MS|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22291367|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291368|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22291369|NCT03910387|Emory University|Dr. Olumide Gbolahan|404-778-1900|ogbolah@emory.edu|
22291370|NCT03122301|Northwestern Medicine|David Walega, MD|13129271345|d-walega@northwestern.edu|
22291371|NCT04466228|University of California, San Francisco|Wan-Yu Hsu|+14153531140|wanyuhsu3@gmail.com|
22291372|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
22291373|NCT06340763|Abbott|Vinuta Rau|(408)845-0864|vinuta.rau@abbott.com|
22291374|NCT02751931|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
22291375|NCT04090411|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22291376|NCT03615508|Denver Health|Dr. Ifantides|303-602-0156|cristos.ifantides@dhha.org|
22291377|NCT02233478|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|61987
22291378|NCT03624517|Medical University of South Carolina|Dr. Don Rockey|(843) 792-6982|rockey@musc.edu|
22291379|NCT04155567|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22291380|NCT03764033|San Francisco VA Health Care System|Shira Maguen, PhD|415-221-4810|Shira.Maguen@va.gov|22511
22259173|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
22291381|NCT04594369|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
22291382|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com|
22291383|NCT03875235|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291384|NCT05592223|Fred Hutchinson Cancer Center|Dr. Elizabeth Chandler Church|2066676982|cchurch2@fredhutch.org|
22291385|NCT02477696|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291386|NCT02104739|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|(713) 500-6641|Absalon.D.Gutierrez@uth.tmc.edu|
22291387|NCT05618782|Levicept|Iwona Bombelka|0000000000|info@levicept.com|
22291388|NCT02003365|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22291389|NCT03070444|Folktandvården Gävleborg AB|Anke Krämer|+4625155680|anke.kramer@regiongavleborg.se|
22291390|NCT01373489|Medical College of Wisconsin|Jennifer Campbell|4149558829|jacampbell@mcw.edu|
22291391|NCT02582255|FIDEC|Ricardo Rüttimann|+13058540075|rruttimann@fidec-online.org|
22291392|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22291393|NCT04050371|UCSF|Robert Grant|415-323-6658|robert.grant@ucsf.edu|
22291394|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org|
22291395|NCT04247620|Baylor College of Medicine|Dr. Marisa Hilliard|8328247209|mehillia@bcm.edu|
22291396|NCT02670343|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Christina Wang, MDAssociate Director UCLA Clinical and Translational Science Institute|1-310-222-1888|wang@labiomed.org|
22291397|NCT04078178|MGH|Kayla McEachern|617-643-5265|kmceachern2@mgh.harvard.edu|
22291398|NCT04617795|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22291399|NCT04850313|University of Arkansas for Medical Sciences|Dr. David Warner|501-686-5822|DBwarner@uams.edu|
22291400|NCT04999982|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Andrea Spencer|3122273402|aspencer@luriechildrens.org|
22291401|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu|
22291402|NCT03505671|Wake Forest Baptist Comprehensive Cancer Center|Nancy Avis, PhD|336-713-5440|navis@wakehealth.edu|
22291403|NCT02038829|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22291404|NCT04393298|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22291405|NCT05381454|University of Texas Southwestern Medical Center|Theodoros Kelesidis|2146488979|Theodoros.Kelesidis@UTSouthwestern.edu|
22291406|NCT04633460|Hospital of the University of Pennsylvania|Payman Zamani|(215) 662-4000|payman.zamani@pennmedicine.upenn.edu|
22291407|NCT05283928|The University of Texas Health Science Center at Houston|Popi Stylianou, DDS,MS|713-486-4048|Popi.Stylianou@uth.tmc.edu|
22291408|NCT04911426|Texas Christian University Institute of Behavioral Research|Dr.Jennifer Pankow|8172577226|j.pankow@tcu.edu|6475
22291409|NCT02339376|Beth Israel Deaconess Medical Center|Bernard S. Chang, M.D.|617-632-8930|bchang@bidmc.harvard.edu|
22291410|NCT01315236|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
22291411|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn|
22291412|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com|
22291413|NCT03964337|Duke University|Michael Harrison, M.D.|919-668-8108|michael.harrison@duke.edu|
22291414|NCT03160859|Veterans Administration Greater Los Angeles Healthcare System|Felix W. Leung, M.D, Staff Gastroenterologist|818-891-7711|felix.leung@va.gov|32520
22291415|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22291416|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de|
22291417|NCT04779216|Massachusetts General Hospital|Karen Miller, MD|6177263870|kkmiller@mgh.harvard.edu|
22291418|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666|dkh2@queensu.ca|4847
22291419|NCT02674854|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22291420|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu|
22291421|NCT00745615|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22291422|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu|
22291423|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291424|NCT03114059|Dietrich-Bonhoeffer-Klinikum|Ahmed Medra|+49 395 775 13483|a.medra@live.com|
22291425|NCT01464723|University of California San Diego Shiley Eye Center|Dr. Stuart Brown|(858) 822-2585858-246-0814|sibrown@ucsd.edu|
22291426|NCT01683825|Brigham and Women's Hospital|Sharmila Dorbala, Director Nuclear Cardiology|617-732-6290|sdorbala@bwh.harvard.edu|
22291427|NCT05700747|MGH Institute of Health Professions|Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
22291428|NCT03326206|Brigham and Women's Hospital|Dr. Sonya Shin|617-872-0310|sshin@bwh.harvard.edu|
22291429|NCT01958827|AbbVie|Global Medical Information|800-633-9110||
22291430|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22291431|NCT03587727|University of Colorado|Yesenia Garcia Reyes|720-777-6984|Yesenia.GarciaReyes@childrenscolorado.org|
22291432|NCT05987709|University of Arizona|Gloria D. Coronado, PhD - Professor, Associate Director Population Sciences, Cancer Center|520-626-0023|gdcoronado@arizona.edu|
22291433|NCT05797974|University of Florida|Dr. Jana Sacco|904-244-7418|Jana.Sacco@jax.ufl.edu|
22291434|NCT06359314|Northwestern University Feinberg School of Medicine|Elizabeth L. Addington, PhD|3125033808|elizabeth.addington@northwestern.edu|
22291435|NCT04770753|Agios Pharmaceuticals, Inc .|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
22291436|NCT04562480|Mayo Clinic|Safia K. Ahmed, MD|507-284-2511|ahmed.safia@mayo.edu|
22291438|NCT05281510|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22291439|NCT05905250|The George Washington University|Carla Berg|202-994-0168|carlaberg@gwu.edu|
22291442|NCT04001829|ECOG-ACRIN Biostatistics Center|Study statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22291443|NCT05859698|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
22291444|NCT05900999|Marquette University|Robert A. Scheidt, PhD|414-288-6124|robert.scheidt@marquette.edu|
22291448|NCT05388058|Mayo Clinic|Dr. Stacy D. D'Andre|507-284-2511|dandre.stacy@mayo.edu|
22291449|NCT03807661|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
22291451|NCT03064152|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
22291452|NCT06415305|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22291453|NCT04527549|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22291454|NCT04103346|University of Michigan|Geoff Barnes|734-763-0047|gbarnes@med.umich.edu|
22291455|NCT05380180|University of Illinois Urbana-Champaign|Wendy Rogers|2173001470|wendyr@illinois.edu|
22291456|NCT04831216|University of Arkansas for Medical Sciences|Krista Langston|479-713-8000|KNLangston@uams.edu|
22291457|NCT02969837|University of Chicago|Member of the Biostatistics Lab|773.702.2453|slee@health.bsd.uchicago.edu|
22291460|NCT03470441|Faraday Pharmaceuticals, Inc|Clinical Trials Manager|206-492-5310|info@faradaypharma.com|
22291463|NCT05411367|Seikagaku Corporation|General Manager, Clinical Development Department|+81-3-5220-8593|reply@seikagaku.co.jp|
22291465|NCT02032823|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291468|NCT02411448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22291471|NCT06066697|University of Pittsburgh|Ana Radovic MD, MSc|412 692 7227|anr94@pitt.edu|
22291472|NCT03096418|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
22291473|NCT02616562|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22291474|NCT05470036|University of California, San Diego|Rana McKay, MD|(858) 822-5354|CancerCTO@health.ucsd.edu|
22291475|NCT04770779|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
22291477|NCT03692052|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
22291478|NCT02656706|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-300|BrUOG@BROWN.EDU|
22291480|NCT05076266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22291481|NCT05169567|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22291482|NCT05545735|University of Miami|Dr. Jonathan Meizoso|305-585-1178|jpmeizoso@med.miami.edu|
22291483|NCT04576455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291484|NCT04449055|The University of Iowa College of Public Health|Dr. Ryan Carnahan|3193841556|ryan-carnahan@uiowa.edu|
22291489|NCT06596005|Hangzhou PhecdaMed Co., Ltd.|Director of Clinical Trials|+86 18626868383|dong.liu@phecdamed.com|
22291490|NCT02445391|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22291497|NCT03961555|Synermore Biologics Co., Ltd.|Ariel Chuang / Director|+886 22659 0988|achuang@synermore.com|
22291498|NCT06837116|Prince of Songkla university|Tawin Khaimook|+66846912946|tawin.khaimook@gmail.com|
22259174|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu|
22259175|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu|
22259176|NCT05034731|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
22259177|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
22259178|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259179|NCT03267030|NOPHO|Dr Birgitte Klug Albertsen|+45 20224643|biralber@rm.dk|
22259180|NCT00696709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259181|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22259182|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22259183|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22259184|NCT02668302|Collin County ENT|Keith E Matheny, MD (Principal Investigator)|(972) 596-4005|kmatheny618@gmail.com|
22259185|NCT05576987|Afyonkarahisar Health Science University|Dr. Cahide ÇEVİK|+90 505 518 92 44|cahide.cevik@afsu.edu.tr|
22259186|NCT02948426|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navemed.nci.nih.gov|
22259187|NCT02619682|Fred Hutchinson Cancer Care Center|Dr Leona A Holmberg|206-667-6447|lholmber@fredhutch.org|
22259188|NCT01861522|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259189|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22259190|NCT01995058|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22259191|NCT03664544|Tanabe Pharma Europe Ltd|General Information|Please e-mail|Regulatory.eu@mb.tanabe-pharma.com|
22259192|NCT03611309|Stanford University|Karl Lorenz, MD MSHS|650-498-9822|kalorenz@stanford.edu|
22259193|NCT04128696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259194|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org|
22259195|NCT03280537|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259196|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de|
22259197|NCT03083132|University of Arkansas for Medical Sciences|Dr. Tuhin Virmani|501-686-7235|tvirmani@uams.edu|
22259198|NCT03118739|AstraZeneca R&D|Fredrik Erlandsson, Global Clinical Lead|+46317762365|Fredrik.Erlandsson@astrazeneca.com|
22274473|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22291500|NCT05222555|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22291501|NCT06560632|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22291502|NCT03516942|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22291503|NCT06472869|Massachusetts General Hospital|Nancy Rigotti, Study PI|6177243548|nrigotti@mgh.harvard.edu|
22305859|NCT00635817|Abbott|Global Medical Services|800-633-9110||
22305860|NCT04341298|Avulux|Dr. Charles Posternack, President|833-288-5890|cposternack@avulux.com|
22305861|NCT04487080|Janssen Research & Development|Global Medical Head Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305862|NCT04415333|North Carolina A&T State University|Marc Cook, PhD|336-285-3547|mdcook@ncat.edu|
22305863|NCT03354390|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator|301-451-7128|childsr@nhlbi.nih.gov|
22305864|NCT03523702|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
22305865|NCT03944512|The Ohio State University|Maged M. Costantine, MD|614-293-9036|maged.costantine@osumc.edu|
22305866|NCT02126878|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22305867|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590||
22305868|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu|
22305869|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu|
22305870|NCT02962674|seleon gmbh|Annegret Genger|+49 175 934 91 83|Annegret.Genger@seleon.de|
22305871|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com|
22305872|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554||
22305873|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22305874|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com|
22305875|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22305876|NCT02814643|AstraZeneca|Mitchell Goldman MD, PhD|+1 610 457 5585|Mitchell.Goldman@astrazeneca.com|
22305877|NCT02504619|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
22305878|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
22305879|NCT01883492|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22305880|NCT00796068|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206-667-5925|fmilano@fredhutch.org|
22305881|NCT02378714|Northwestern University|Dr. Brian Hitsman|312-504-5834|b-hitsman@northwestern.edu|
22305882|NCT04020718|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@mgh.harvard.edu|
22305883|NCT01281813|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305884|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org|
22259199|NCT02995837|University of Miami|Ignacio Tapia, MD|3052439885|itapia@miami.edu|
22305885|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305886|NCT03673124|The GOG Foundation, Inc.|Brian Slomovitz, MD|1-215-854-0770|bslomovitz@gog.org|
22274474|NCT06831344|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22305887|NCT02174562|Thomas Jefferson University|Barry Rovner, MD|215-503-1243|Barry.Rovner@Jefferson.edu|
22305888|NCT03336450|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305889|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22305890|NCT03608670|Medtronic Cardiac Rhythm Management|CRM Clinical Research|+1 800 328 2518|rs.medtronicCRMtrials@medtronic.com|
22305891|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22305892|NCT03636451|University of California, San Diego|Sheila Mody|8583294464|smody@health.ucsd.edu|
22305893|NCT02155829|USUHS|Dr. David M. Benedek|(301) 295-3294|david.benedek@usuhs.edu|
22305894|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22305895|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu|
22305896|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22305897|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org|
22305898|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22305899|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22305900|NCT02087306|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22305901|NCT02736799|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
22305902|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305903|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305904|NCT02596035|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22305905|NCT02526680|Wills Eye Hospital Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22305906|NCT03395353|Shionogi|Corporate Communications Department|+81-6-6209-7885|shionogiclintrials-admin@shionogi.co.jp|
22305907|NCT03301220|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22305908|NCT03981549|The Emmes Company, LLC|Principal Investigator of the TRUST Data Coordinating Center|301-251-1161|trust@emmes.com|
22305909|NCT05012644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305910|NCT04845620|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22305911|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343||
22305912|NCT03425643|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22305913|NCT04133363|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS, MS, Interim Dean, Principal Investigator|205-9344506|ngeurs@uab.edu|
22305914|NCT05150210|Intuitive|Anna Virk|1 480-676-3938|SP.Thoracic@intusurg.com|
22305915|NCT07214922|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22305916|NCT00726596|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
22305917|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22305918|NCT02743078|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
22305919|NCT01549314|Massachusetts General Hospital Endocrine Unit|Dr. Melissa Putman|857-218-5017|msputman@partners.org|
22305920|NCT02425449|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
22305921|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com|
22305922|NCT03265210|Weill Cornell Medicine|Dimitris Kiosses, PhD|914-997-4381|dkiosses@med.cornell.edu|
22305923|NCT04002973|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22305924|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com|
22305925|NCT03768856|Cleveland Clinic, Case Comprehensive Cancer Center|Dr Shlomo Koyfman|1-800-223-2273|TaussigResearch@ccf.org|
22305926|NCT02620761|Medical College of Wisconsin|Jeffrey Segar|14143377702|jsegar@mcw.edu|
22305927|NCT02614560|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22305928|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22305929|NCT00549848|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
22305930|NCT05193318|Metrohealth Hospital System (formerly employee of Medical University of South Carolina)|Eric Dobson, MD (principal nvestigator)|513-504-2091|edobson@metrohealth.org|
22305931|NCT03670602|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22305932|NCT03201809|UC Davis|Dr. Granger Wong, Chief and Professor of Plastic Surgery|(916) 734-7289|gwong@ucdavis.edu|
22305933|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22305934|NCT03383887|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22305935|NCT00300456|Abbott|Medical Information Specialist|800-633-9110||
22305936|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
22305937|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116||
22305938|NCT02377362|GLWL Research Inc|Study Director||choruspharma@lists.lilly.com|
22305939|NCT02718118|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
22305940|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu|
22305941|NCT01919697|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22305942|NCT04107805|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305943|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com|
22305944|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22305945|NCT01234532|University of Maryland, Baltimore|Katherine Tkaczuk, M.D.|410-328-2565|ktkaczuk@umm.edu|
22305946|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com|
22291505|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22291506|NCT05959200|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22291507|NCT05803603|University of Maryland School of Social Work|Jay Unick|410-706-3735|junick@ssw.umaryland.edu|
22291508|NCT04950608|Dana-Farber Cancer Institute|Dr. Yvan Beaussant|617-582-9318|patresearch@dfci.harvard.edu|
22291509|NCT04104438|University of California Los Angeles|Dr. Fady Kaldas|310-825-1037|fkaldas@mednet.ucla.edu|
22291510|NCT05001347|I-Mab Biopharma|VP of Clinical Development|240-745-6330|us.info@imabbio.com|
22291511|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110||
22291512|NCT03977454|Yale School of Medicine: Anesthesiology|Jinlei Li, MD, PhD|(203) 785-2802|jinlei.li@yale.edu|
22291513|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22291514|NCT00518973|UCSD Eating Disorders Treatment and Research Center|Walter H. Kaye|858-534-3951|wkaye@ucsd.edu|
22291515|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu|
22291516|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291517|NCT01565499|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22291518|NCT01923168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22291519|NCT04193410|Maastricht University|Marla Hahnraths, MSc|3882184|mth.hahnraths@maastrichtuniversity.nl|0031
22291520|NCT03896659|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22291521|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
22291522|NCT00773838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291523|NCT02421198|University of Arizona|Dr. Melanie D Hingle|520-621-3087|hinglem@email.arizona.edu|
22291524|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22291525|NCT02522871|TransMedics|Laura Damme|978-552-0910|LDamme@TransMedics.com|
22291526|NCT02398227|University of Akron|Dawn M Johnson, Ph.d|3309722505|johnsod@uakron.edu|
22291527|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22291528|NCT02793622|University of California, San Francisco|Grant Dorsey, MD|628-206-4680|grant.dorsey@ucsf.edu|
22291529|NCT03149848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22291530|NCT01486810|New York Psychiatric Institute|Dr. John Mariani|646-774-8181|John.mariani@nyspi.columbia.edu|
22291531|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu|
22291532|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977|tkinlock@friendsresearch.org|224
22291533|NCT02274038|University of Pennsylvania Perelman School of Medicine|Dr. Sharyn Katz, Principal Investigator|215-662-4000|sharyn.katz@pennmedicine.upenn.edu|
22291534|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org|
22291535|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22291536|NCT04856865|Alladapt Immunotherapeutics|Chief Medical Officer|650-420-3900|info@alladapt.com|
22291537|NCT01602666|Children's Oncology Group|Results Reporting Coordinator|626 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22291538|NCT05458648|CathVision ApS|Clinical Research Manager|0702097102|kpf@cathvision.com|
22291539|NCT03666676|University of Rochester|Dr. Laurel H. Carney|585-276-3948|Laurel_Carney@URMC.Rochester.edu|
22291540|NCT03610555|University of Texas - Medical Branch|Ajay Israni, MD, MS - Division Chief - Transplant & General Nephrology|409 772 2473|akisrani@utmb.edu|
22291541|NCT01892722|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22291542|NCT02275910|Eisai Co., Ltd.|Eisai Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22291543|NCT05217927|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291544|NCT04509739|University of Washington|Christina Zhao|206-221-6415|zhaotc@uw.edu|
22291545|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291546|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291547|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22291548|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr|
22291549|NCT03052764|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22291550|NCT01314911|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D|301-451-9881|jbeigel@niaid.nih.gov|
22291551|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22291552|NCT03150485|Johnson & Johnson Vision|Thomas Karkkainen - SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
22291553|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp|
22291554|NCT01695005|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22291555|NCT00472459|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22291556|NCT04478123|Memorial Sloan Kettering Cancer Center|Dr. Michael Scordo, MD|646-608-3771|scordom@mskcc.org|
22291557|NCT00588952|Yale University|Ismene Petrakis|203-932-5711|Ismene.petrakis@yale.edu|2244
22291558|NCT01490723|U.T. MD Anderson Cancer Center|Issa F. Khouri, M.D., Stem Cell Transplantation|(713) 745-0049|ikhouri@mdanderson.org|
22291559|NCT01362595|Feinstein Institutes for Medical Research|Dr. Adrianna Vlachos|516-562-1504|avlachos@northwell.edu|
22305947|NCT01833832|National Cancer Institute|Dr. Jeremy Davis|240-760-6229|jeremy.davis@nih.gov|
22305948|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu|
22305949|NCT02057718|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22291560|NCT02448680|LFB USA, Inc.|Kerry Biron, Director US Clinical Operations|508-370-5166|kerry.biron@lfb-usa.com|
22291561|NCT01739400|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22291562|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680||
22291563|NCT03350984|University of Guanajuato|Dra. Paulina Crespo Morfin|+52 4431300112|pb.crespomorfin@outlook.es|
22291564|NCT04198818|Haihe Biopharma Co., Ltd|Medical Officer|86-(021)-20568888|fugen.li@haihepharma.com|8988
22291565|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291566|NCT04533880|NYU Langone Health|Larry Chen|(646) 501-7200|Larry.Chen@nyulangone.org|
22291567|NCT04243421|Medical University of Białystok|Małgorzata Pietruska|+48606461092|mpietruska@wp.pl|
22291568|NCT02284178|University of Central Florida|Mary Lou Sole|407-823-5496|mary.sole@ucf.edu|
22291569|NCT01741012|Wayne State University School of Medicine|Dr. J. Patricia Dhar, MD, Principal Investigator|313-577-6011|pdhar@med.wayne.edu|
22291570|NCT04123665|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22291571|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300||
22291572|NCT04396496|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22291573|NCT01711879|University of Colorado School of Medicine|Rachel Gerle|720-848-2020|rachel.gerle@ucdenver.edu|
22291574|NCT02260531|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
22291575|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
22291576|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org|
22291577|NCT02464917|Memorial Health Systems|Michael Nageotte, MD|562-933-2748|mnageotte@memorialcare.org|
22291578|NCT01466179|Amgen Inc.|Study Director|866-572-6436||
22291579|NCT03410823|University of Maryland School of Medicine|Denise Orwig|410-706-2406|dorwig@som.umaryland.edu|
22291580|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu|
22291581|NCT03707184|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|8012136110|sam.mitchell@hci.utah.edu|
22291582|NCT04704154|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22291583|NCT03220438|University of Maryland Baltimore|Dr Laura Rowland|410-402-6073|lrowland@som.umaryland.edu|
22291584|NCT04062123|University of Pittsburgh|Keith Vogt, MD, PhD|4126473147|vogtkm@upmc.edu|
22291585|NCT04190680|Maastricht University|Marla Hahnraths, MSc|433882184|mth.hahnraths@maastrichtuniversity.nl|0031
22291586|NCT03780400|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22291587|NCT01850602|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22291588|NCT03115580|Icahn School of Medicine at Mount Sinai|Annapoorna S. Kini, MD|212-241-4181|annapoorna.kini@mountsinai.org|
22291589|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291590|NCT03452527|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22291591|NCT00476047|Fred Hutchinson Cancer Research Ctr|Mazyar Shadman, MD|2066675467|mshadman@fredhutch.org|
22291592|NCT02502006|University of Pennsylvania|Katherine N. Theken, PharmD, PhD|2158987470|ktheken@upenn.edu|
22291593|NCT04738318|Vanderbilt University Medical Center|Dr. Jed Maslow|615-936-7846|jed.i.maslow@vumc.org|
22291594|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca|
22291595|NCT04151667|Moffitt Cancer Center|Dr. Rachid Baz|813-745-3163|Rachid.Baz@moffitt.org|
22291596|NCT04445792|Duke Clinical Research Institute|Kady-Ann Steen-Burrell, Ph.D.|919-668-8300|kady.ann.steen.burrell@duke.edu|
22291597|NCT03375788|Massachusetts General Hospital|Dr. Takara Stanley|617-724-9109|tstanley@mgh.harvard.edu|
22291598|NCT05443594|Boston Scientific|Thomas Stoltz|651-582-4000|Thomas.Stoltz@bsci.com|
22291599|NCT04369053|Freenome|Director of Clinical Development|(650)446-6630|medicalaffairs@freenome.com|
22291600|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu|
22291601|NCT02395016|Biotech Pharmaceutical Co., Ltd.|Director of Clinical Trials|010-51571020|lucy_he@biotechplc.com|8753
22291602|NCT01547780|National Institute of Mental Health|Robert Innis|+1 301 594 1368|innisr@mail.nih.gov|
22305950|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu|
22305951|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
22305952|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov|
22305953|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov|
22305954|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305955|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu|
22305956|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org|
22305957|NCT03237936|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
22305958|NCT03068611|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22305959|NCT04379713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305960|NCT04567888|Twill|Eliane M. Boucher, PhD (Sr Director of Research Strategy)|(800) 264-6428|eliane@twill.health|
22305961|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22305962|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22305963|NCT00383188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22305964|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu|
22305965|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com|
22305966|NCT01224678|University of Vermont|Marie E. Wood, M.D|802-656-5452|marie.wood@uvm.edu|
22305967|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262|Marjorie.Leek@va.gov|54525
22305968|NCT03028363|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22305969|NCT02104765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22305970|NCT04771273|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22305971|NCT05196737|Medical University of South Carolina|Gretchen Seif, PT, DPT, MHS, OCS, FAAOMPT|(843) 792-9345|seif@musc.edu|
22305972|NCT02357784|Northwestern University|Dr. Margaret Mueller|13124723874|mgmueller@nm.org|
22305973|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22305974|NCT02698241|Medtronic CRHF Clinical Research|Joe Hobbs Clinical Research Specialist|800-633-8766|joe.hobbs@medtronic.com|
22305975|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com|
22305976|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
22305977|NCT02987335|Albert Einstein College of Medicine|Dr Meredith Hawkins|718.430.3186|meredith.hawkins@einsteinmed.org|
22305978|NCT01670110|Mayo Clinic|Marie C. Hogan, M.D., Ph.D.|507-284-3479|Hogan.Marie@mayo.edu|
22305979|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu|
22305980|NCT03693742|BC Cancer - Vancouver|Study Manager|(604) 877-6000,|hsaprunoff@bccancer.bc.ca|
22305981|NCT02685033|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22305982|NCT00603447|Amgen, Inc.|Study Director|866-572-6436||
22305983|NCT00798265|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22305984|NCT04411082|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
22291603|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net|
22291604|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu|
22291605|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291606|NCT01288976|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
22291607|NCT03560739|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22291608|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com|
22291609|NCT03183778|NYU Langone Health|David Goldfarb, MD|212-263-0744|David.Goldfarb@nyulangone.org|
22291610|NCT05386823|HighField BioPharmaceuticals Corporation|Dr. Yuhong Xu|+86-571-86961869|yhxu@hf-biopharm.com|
22291611|NCT03007407|NSABP Foundation|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
22291612|NCT03228420|Nevro Corp.|Donald Middlebrook|(650) 433-2218|don.middlebrook@nevro.com|
22291613|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22291614|NCT00792077|UT MD Anderson Cancer Center|Sriram Yennu, MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22291615|NCT04626310|University of Massachusetts Amherst|Katherine Dixon-Gordon, PhD|413-545-0226|katiedg@umass.edu|
22291616|NCT03239665|Rutgers University Center for Health Outcomes, Policy, & Economics|Laura T. Pizzi, PharmD, MPH|8484456825|laura.pizzi@rutgers.edu|
22291617|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu|
22291619|NCT01853618|National Cancer Institute|Dr. Tim F. Greten|(301) 451-4723|tim.greten@nih.gov|
22291620|NCT01658813|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22291621|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291622|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291623|NCT04777331|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22305985|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
22305986|NCT02804594|University of California San Francisco|Emmanuelle Waubant, MD|415 514 2468|Emmanuelle.Waubant@ucsf.edu|
22291624|NCT01401959|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22291625|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com|
22291626|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463||
22291627|NCT03020446|University of Toledo|Munier Nazzal, MD|419-383-3576|Munier.Nazzal@utoledo.edu|
22291628|NCT02300727|Aurora Health Care - Bay Area Medical Center|Dhimant Patel, MD|920-288-4123|dhimant.patel@aurora.org|
22291629|NCT05494632|Washington University School of Medicine|Jill B Firszt, PhD|314-362-4760|firsztj@wustl.edu|
22291630|NCT06982937|Jerzy Kukuczka Academy of Physical Education|Katarzyna Sadowska|32 207 5189|komisjabioetyczna@awf.katowice.pl|
22291631|NCT07086378|Cedars Sinai Medical Center|Dr. Robert Wong|3104231682|Robert.Wong@cshs.org|
22291632|NCT02625389|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22291633|NCT06785857|Xiamen Tongan District Xiangping Street Community Health Service Center|Miaoqian Huang|15880248915|hmiaoqian@163.com|
22291634|NCT02621398|Cancer Institute of New Jersey|Salma Jabbour, MD|732-235-8675|jabbousk@cinj.rutgers.edu|
22291635|NCT05952401|Washington University School of Medicine|Li-Shiun Chen, M.D., MPH, ScD|314-362-3932|li-shiun@wustl.edu|
22291636|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590||
22291637|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590||
22291638|NCT01483690|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
22291639|NCT02239224|aTyR Pharma|Gennyne Walker|858 731 8389|clinicaltrials@atyrpharma.com|
22291640|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu|
22291641|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com|
22291642|NCT03028350|Cumberland Pharmaceuticals|Senior Clinical Scientist|6154257644|bgibson@cumberlandpharma.com|
22291643|NCT02090075|Los Angeles Biomedical Research Institute at Harbo|Dr Matthew Budoff|3102224107|mbudoff@labiomed.org|
22291644|NCT04565236|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22291645|NCT05454657|Massachusetts General Hospital / Harvard Medical School|Dr. David Eddie|6176439194|deddie@mgh.harvard.edu|
22291646|NCT00740246|Luitpold Pharmaceuticals, Inc.|Mark A Falone|610-650-4200|mfalone@americanregent.com|844
22291647|NCT01041495|SUNY Upstate MEdical Univ|thomas schwartz|3154643166|schwartt@upstate.edu|
22291648|NCT03584373|Montefiore Medical Center|Dr. Kara Watts, Associate Professor, Department of Urology|718-920-4531|kwatts@montefiore.org|
22291649|NCT01060345|University of Chicago|Nora Jaskowiak, MD|773-702-2048|njaskowi@surgery.bsd.uchicago.edu|
22291650|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
22291651|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291652|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com|
22291653|NCT01778179|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|doris@hexsel.com.br|
22291654|NCT04163822|CHCMU|no sponsor, PI: Yuan Shi|13508320283|shiyuan@hospital.cqmu.edu.cn|
22291655|NCT03282565|University of Michigan|Dr. Riann Palmieri-Smith|734-615-3154|riannp@umich.edu|
22291656|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291657|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com|
22291658|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org|
22291659|NCT03116347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22305987|NCT03538041|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22305988|NCT00094809|Amgen Inc.|Study Director|866-572-6436||
22305989|NCT04889664|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-585-4661|adriana.feder@mssm.edu|
22305990|NCT04181632|Nemours Children's Health System (North Florida/JAX)|Jennifer Pfieffer|904 383 0414|jennifer.pfieffer@nemours.org|
22305991|NCT02699970|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
22305992|NCT02469064|Universidad del Valle|Dr Lina Marcela Sandoval Moreno|316 478 0808|linamarce48@gmail.com|
22305993|NCT03408860|University of Kentucky|Shannon Sauer-Zavala|858-218-4082|ssz@uky.edu|
22305994|NCT01596751|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
22305995|NCT03748433|Imperial College London|Professor Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
22305996|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343||
22305997|NCT05372094|Sonova US|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22305998|NCT02046616|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22305999|NCT03760419|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
22306000|NCT02957539|VA Puget Sound Health Care System|Paul Hebert|2062774165|paul.hebert2@va.gov|
22306001|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org|
22306002|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu|
22306003|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu|
22306004|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu|
22306005|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
22291660|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22291661|NCT04966741|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22291662|NCT03835728|UT Southwestern, Dept of Neurology|Dr. Steven Vernino|214-645-8800|steven.vernino@utsouthwestern.edu|
22291663|NCT05764265|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22291664|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291665|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22291666|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
22291667|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
22291668|NCT02009384|University of Louisville|Jason Chesney|502-562-3429||
22291669|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22291670|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu|
22291671|NCT01244490|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22291672|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov|
22291673|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br|
22291674|NCT02414139|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22291675|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md|
22306006|NCT02925195|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22259200|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22259201|NCT01893138|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22259202|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22259203|NCT05771545|Hebrew University of Jerusalem|Adam Rose|+972-55-500-1040|adam.rose@mail.huji.ac.il|
22259204|NCT03996005|Hôpitaux Universitaires de Strasbourg|Dr TRICARD Thibault|03 69 55 04 61|thibault.tricard@chru-strasbourg.fr|
22259205|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca|
22259206|NCT04274192|University of Arkansas for Medical Sciences|Dr. Sherry Courtney|501-364-1028|SECourtney@uams.edu|
22259207|NCT07174544|College of Nursing, The Catholic University of Korea|Hyunjoo Na, Associate professor, PI|+82-2-3147-8442|hjna@catholic.ac.kr|
22259208|NCT03419234|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22259209|NCT05918952|Duke University School of Nursing|Dr. Schenita Randolph|919-684-3786|schenita.randolph@duke.edu|
22259210|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
22259211|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22259212|NCT01907087|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
22259213|NCT01919190|Pacira Pharmaceuticals, Inc.|Paci|1-855-793-9727|MedInfo@pacira.com|
22259214|NCT03355742|Clinical Affairs, Abbott Vascular|Siok Hwee Tan, PhD, Principal Clinical Research Scientist|+1 408-845-3581|siokhwee.tan@abbott.com|
22259215|NCT04064229|ivWatch, LLC|Jason Naramore|1-855-489-2824|jason.naramore@ivwatch.com|7019
22259216|NCT02207621|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22259217|NCT02623959|UT MD Anderson Cancer Center|Ost,David,M.D. / DOST@MDANDERSON.ORG|713-745-8775|DOst@mdanderson.org|
22259218|NCT00135707|Dept of Obstetrics and Gynecology, University of Pittsburgh|Dr. James Roberts|412-641-1427|RSIJMR@mwri.magee.edu|
22274475|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274476|NCT02873689|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22274477|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590||
22274478|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch|
22274479|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
22274480|NCT02337764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22274481|NCT02990000|University of Massachusetts Amherst|Dr. Michael J. Constantino|4135451388|mconstantino@psych.umass.edu|
22274482|NCT03653741|Weill Cornell Medical College|David Chuang, MD|212-746-5519|dtc9002@med.cornell.edu|
22274483|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com|
22274484|NCT01949545|Amgen, Inc.|Study Director|866-572-6436||
22274485|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com|
22274486|NCT03268343|Achieve Life Sciences|Daniel Cain, Senior Director Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22274487|NCT02810418|National Cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
22274488|NCT03103503|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
22274489|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org|
22274490|NCT05088772|University of Toronto|Dr. Connor Brenna|416 340 3598|connor.brenna@mail.utoronto.ca|
22274491|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org|
22274492|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22274493|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
22274494|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu|
22274495|NCT04161391|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22274496|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net|
22274497|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu|
22274498|NCT02860988|University of Kentucky|Dr. Joseph Calvert|(859) 323-5771|joe.calvert@uky.edu|
22274499|NCT01739335|Bronx VA Medical Center|Dr. Julia Golier; Chief of Psychiatry|718-584-9000|julia.golier@va.gov|6587
22274500|NCT03657069|Stanford University|Dung Nguyen, MD, PharmD, FACS|(650) 498-6004|nguyendh@stanford.edu|
22274501|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22274502|NCT00883181|Amgen Inc.|Study Director|866-572-6436||
22274503|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274504|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351||
22274505|NCT03238417|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|818-891-7711|elizabeth.yano@va.gov|36031
22274506|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22274507|NCT02914834|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
22274508|NCT03060473|University of Texas Medical Branch|Dr. Nkechinyere Emezienna|4097476651|nkemezie@utmb.edu|
22274509|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306007|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590||
22306008|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22259219|NCT01681030|Ethicon, Inc|Richard Kocharian, MD, PhD|+1-908-218-2013|rkochar1@its.jnj.com|
22274510|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22259220|NCT00635778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259221|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
22259222|NCT04903288|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22259223|NCT02909140|Wilmer Eye Institute|Dr. Fasika Woreta|(410) 955-5650|fworeta1@jhmi.edu|
22259224|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com|
22259225|NCT02627742|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22259226|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com|
22259227|NCT03291509|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22259228|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787|gwen.mcmillin@aruplab.com|2671
22259229|NCT01645306|advanceCOR GmbH|Prof. Dr. Götz Münch, CRP & CEO|+4989200020410|muench@advancecor.com|
22259230|NCT03445195|Entasis Therapeutics|Chief Medical Officer|781-810-8940|Enquiries@entasistx.com|
22259231|NCT02584140|UCSD Medical Center, Antiviral Research Center|Jill Blumenthal, MD|(619) 471-3913|jblumenthal@health.ucsd.edu|
22259232|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu|
22291676|NCT03324581|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22291677|NCT04473482|University of Michigan|Jessica Mellinger|734-232-0284|jmelling@umich.edu|
22291678|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22259233|NCT01338636|Brigham and Women's Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org|
22259234|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999|ahmedmkotp@hotmail.com|+20
22259235|NCT03172780|Mylan Pharmaceuticals Pvt Ltd.|Dr. Prasanna C Ganapathi, Associate Vice President, Global Clinical Sciences|08066728952|PrasannaC.Ganapathi@mylan.in|28952
22259236|NCT01689974|New York University School of Medicine|Sylvia Formenti, MD|646.962.4073|formenti@med.cornell.edu|
22259237|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259238|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
22259239|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550|mwalker@vectoroncology.com|1759
22259240|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
22259241|NCT02659202|Mayo Clinic|Dr. Bruce Johnson|507-284-4375|johnson.bruce@mayo.edu|
22259242|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
22259243|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
22259244|NCT03937466|Wake Forest University School of Medicine|Nancy Avis, PhD|336-716-6974|navis@wakehealth.edu|
22259245|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
22259246|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700|wgarcia@silanes.com.mx|3785
22259247|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu|
22259248|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
22259249|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712-1993|abchapm@emory.edu|
22259250|NCT00543439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259251|NCT02354378|Boston Children's Hospital|Keira Mason, MD|6173552339|keira.mason@childrens.harvard.edu|
22259252|NCT03264066|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22259253|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com|
22259254|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400|kyle.possmato@va.gov|53551
22259255|NCT02922959|University of Cincinnati Addiction Sciences Division|Theresa Winhusen|5135858292|winhust@ucmail.uc.edu|
22259256|NCT03187080|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
22259257|NCT03872700|Montefiore Medical Center|Dr. Benjamin W Friedman|718-920-6626|befriedm@montefiore.org|
22259258|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu|
22259259|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22259260|NCT00722111|VAHSRD|Dr. JoAnne Robbins|608-256-1901|bert.landreth@va.gov|11697
22259261|NCT02826603|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22259262|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259263|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com|
22259264|NCT03558997|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22259265|NCT03944785|Supernus Pharmacueticals|Gianpiera Ceresoli-Borroni|301-838-2521|gceresoliborroni@supernus.com|
22259266|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg|
22259267|NCT03123549|NuVasive, Inc.|Jessica Fulwider|7037721455|jfulwider@nuvasive.com|
22259268|NCT01170260|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
22259269|NCT04567615|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22259270|NCT04317053|NYU Langone Health|Kelly Doran, MD, MHS|212-263-5850|Kelly.Doran@nyulangone.org|
22259271|NCT01022112|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22291679|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
22259272|NCT04680052|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22259273|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu|
22306009|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
22306010|NCT03781336|National Institutes of Health|Psychologist|3014027360|amelir@mail.nih.gov|
22306011|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com|
22306012|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306013|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486|nancy.suchman@yale.edu|7430
22306014|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu|
22306015|NCT00639002|Incyte Corporation|Study Director|855 463-3463||
22306016|NCT03098966|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22306017|NCT05325853|American Genomics, LLC|Dr. Martin Uram|973-885-3447|aschupp@cmcturnkey.com|
22306018|NCT01839877|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22306019|NCT02509585|Cardinal Health|LaTosha Eligon|913-661-3896|latosha.eligon@cardinalhealth.com|
22306020|NCT04979988|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306021|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22306022|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
22306023|NCT04495634|University of North Carolina at Chapel Hill|Doreen Steed, R.T. (R)(M)|919-966-0188|doreen_steed@med.unc.edu|
22306024|NCT04391309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22306025|NCT02781584|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22306026|NCT00967369|UT MD Anderson Cancer Center|Dr. Michelle A Fanale / Associate Professor, Lymphoma/Myeloma|713-792-2860|MFANALE@MDANDERSON.ORG|
22306027|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
22306028|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca|
22306029|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300||
22306030|NCT03328949|Shockwave Medical, Inc.|Beaux Alexander, Vice President of Clinical Affairs|510-279-4262 ext. 145|balexander@shockwavemedical.com|
22306031|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
22306032|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu|
22306033|NCT04776213|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22306034|NCT03392532|Alcon, A Novartis Division|CDMA Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22306035|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
22306036|NCT01838551|Strongbridge Biopharma|Chief Medical Officer|14845890392|f.cohen@strongbridgebio.com|
22306037|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
22306038|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22306039|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589||
22306040|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu|
22306041|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22306042|NCT02555631|Albert Einstein College of Medicine|Dr. Elizabeth Walker|718-430-3242|elizabeth.walker@einstein.yu.edu|
22306043|NCT03906968|MUSC|Dr. Zachary M. Soler|(843) 792-3531|solerz@musc.edu|
22306044|NCT04181307|NYU Langone Health|Andrea B. Troxel, ScD|646-501-3654|andrea.troxel@nyulangone.org|
22306045|NCT02299336|Retina Consultants of Houston|Dr. Charles C. Wykoff|7135243434|ccwmd@houstonretina.com|
22306046|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com|
22306047|NCT02013037|Cedars Sinai Smidt Heart Institute|Dr. Jignesh Patel|310-248-8300|jignesh.patel@cshs.org|
22306048|NCT02465359|University of South Florida|Tuan H. Vu, MD|813-974-9413|tvu6@usf.edu|
22291680|NCT00727532|Northwestern University|Results Entry Administrator|312-695-1301|croqualityassurance@northwestern.edu|
22291681|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp|
22291682|NCT04647890|Certa Therapeutics Pty Ltd|Prof Darren Kelly, CEO|+61 3 9657 0700|dkelly@certatherapeutics.com|
22291683|NCT03687970|Washington University|Simon Haroutounian, PhD. Assistant Professor,|314-286-1715|simon.haroutounian@wustl.edu|
22291684|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22291685|NCT01848041|RVL Pharmaceuticals|Sr. Director, Clinical Development|908-809-1423|mvelasco@osmotica.com|
22291686|NCT06374394|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22291687|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22291688|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245||
22291689|NCT00847171|Johns Hopkins University|Dr. Leisha Emens||emensle@jhmi.edu|
22291690|NCT01981759|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
22291691|NCT01994590|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-2830|PCorn@mdanderson.org|
22291692|NCT00255801|Memorial Sloan Kettering Cancer Center|Dr. David Straus|212-639-8365|strausd@mskcc.org|
22291693|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300||
22291694|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291695|NCT01966692|Unversity of Florida|Dr Yuanyuan Jiao|(407) 313-7014|yyjiao@cop.ufl.edu|
22259274|NCT00759148|Alcon Research, Ltd.|Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22306049|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu|
22306050|NCT03141788|3M|Elaine Egging|651-737-0263|eegging@mmm.com|
22306051|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br|
22306052|NCT02812966|Advocate Aurora Research Institute|Director, Clinical Trials Research Cardiovascular and Multiple Specialties|708-860-7792|laura.wrona@aah.org|
22274511|NCT02730962|University of Minnesota|Dr. Alexander Khoruts|612-624-2101|khoru001@umn.edu|
22274512|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca|
22291696|NCT03581786|Shanghai Junshi Bioscience Co., Ltd.|Xiaojun Wang|86-021-50796193|xiaojun_wang@junshipharma.com|
22291697|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu|
22291698|NCT02469038|University of Chicago|Melanie Norstrom|773-702-1991|mnorstrom@medicine.bsd.uchicago.edu|
22291699|NCT03435640|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22291700|NCT01347307|Mercy Research|Lead Regulatory Coordinator - Investigator Initiated Trials|314-251-8827|michelle.mcfarland@mercy.net|
22291701|NCT01955980|PARI Pharma|Friedrich Gruber|+4989742846|friedrich.gruber@pari.com|10
22291702|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com|
22291703|NCT03954041|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22291704|NCT01896479|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22291705|NCT05403866|Lumosa Therapeutics Co., Ltd.|Sabrina Yeh|+886 2 26557918|sabrina_yeh@lumosa.com.tw|5735
22291706|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu|
22291707|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291708|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org|
22291709|NCT03127956|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22291710|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22291711|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
22291712|NCT02953509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22291713|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu|
22291714|NCT02325791|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22291715|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291716|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291717|NCT02128100|University of Louisville|Dr. Neal Dunlap|502-561-2700|neal.dunlap@louisville.edu|
22291718|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22291719|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22291720|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com|
22291721|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
22291722|NCT03523000|University Hospitals Cleveland Medical Center|Dr. Salim Hayek|216-844-2685|salim.hayek@uhhospitals.org|
22291723|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22291724|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22291725|NCT03993379|CytomX Therapeutics|Lawrence Lu|(650) 515-3185|clinicaltrials@cytomx.com|
22291726|NCT02380690|VA ORD|Robert O'Brien|2024435741|Robert.O'Brien2@va.gov|
22291727|NCT02361346|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
22291728|NCT04461509|Cedars-Sinai Medical Center|Laura Sarmiento|310-423-4295|Laura.sarmiento@cshs.org|
22291729|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu|
22320305|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22291730|NCT02483429|Johns Hopkins University|David E. Newman-Toker|443-287-9593|toker@jhu.edu|
22291731|NCT03576274|Johns Hopkins School of Nursing|Dr.Nada Lukkahatai,|410-614-5297|nada.lukkahatai@jhu.edu|
22291732|NCT02314364|Massachusetts General Hospital|Henning Willers, MD|617-726-5184|hwillers@mgh.harvard.edu|
22291733|NCT04854642|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22291734|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com|
22291735|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com|
22291736|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22291737|NCT03442764|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22291738|NCT01801072|University of Michigan|Dr. Aditya Pandey, Chair, Department of Neurosurgery|734-936-7010|adityap@umich.edu|
22291739|NCT03693170|Pierre Fabre Medicament|Isabelle Klauck, MD|+33149108018|isabelle.klauck@pierre-fabre.com|
22291740|NCT04444895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22291741|NCT03034200|Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Peter Anderson|216-308-2706|andersp@ccf.org|
22291742|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291743|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com|
22291744|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22291745|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22291746|NCT04534465|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22291747|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov|
22291748|NCT03347188|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22291749|NCT02266914|The Ohio State University Wexner Medical Center|Tamara McMath, MPH|614-293-8082|tamara.mcmath@osumc.edu|
22291750|NCT04177355|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22291751|NCT03139604|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22291752|NCT04148911|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22291753|NCT02477423|Neonatology, Department of Pediatrics, University of Chicago|Dr. Christina S. Kim|773-702-6210|christinakim13@gmail.com|
22291754|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22291755|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com|
22291756|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411||5509
22291757|NCT04543409|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22291758|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br|
22291759|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291760|NCT04499599|L-Nutra, Inc.|Dr. Min Wei|323.791.2426|mwei@l-nutra.com|
22291761|NCT00121173|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
22291762|NCT01754909|Baltimore VAMC|Dr Eric Cohen|410 605 7000|eric.cohen@va.gov|5/7182
22291763|NCT02195011|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22291764|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu|
22291765|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291766|NCT01466595|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22291767|NCT02313454|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22291768|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
22291769|NCT03418571|Ablynx NV|Medical Monitor|+32 9 262 00 00|clinicaltrials@ablynx.com|
22291770|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291771|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com|
22291772|NCT01439347|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
22291773|NCT03595774|Indiana University Purdue University Indianapolis|Dr. Andrew R. Coggan|3172740656|acoggan@iu.edu|
22291774|NCT03882008|University of Washington|Bobby Kwanghoon Han|206-685-9950|hank4@uw.edu|
22291775|NCT04831788|University of Novi Sad, Faculty of Medicine|Prof. Vladimir Petrovic|+381648028800|vladimir.petrovic@izjzv.org.rs|
22291776|NCT04115644|UT Southwestern Medical Center|Dr. Michael Khazzam|214/645-8917|michael.khazzam@utsouthwestern.edu|
22291777|NCT03519386|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22291778|NCT05714644|Massachusetts General Hospital|Jennifer Haas, MD|6176434266|jennifer.haas@mgh.harvard.edu|
22291779|NCT02783469|University of Dundee|Professor Blair H. Smith|01382383795|b.h.smith@dundee.ac.uk|
22291780|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22291781|NCT03101267|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22291782|NCT04068896|NGM Biopharmaceuticals|VP Clinical Operations|(650)243-5555|ngm120@ngmbio.com|
22291783|NCT05780268|University of Minnesota|Birgit Grund|612- 626-8622|birgit@ccbr.umn.edu|
22306053|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu|
22291784|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259275|NCT01073020|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 1966|mary.elizabeth.patti@joslin.harvard.edu|
22259276|NCT04642950|Nobel Pharma Co. Ltd.|Information Desk|+81-3-6670-3800|taniguchi.masaki@nobelpharma.co.jp|
22259277|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com|
22259278|NCT05780541|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22259279|NCT03329027|Vibrantgastro|Clinical trials manager|046663322|service@vibrantgastro.com|
22259280|NCT04089982|Duke University|James M. Davis, MD|919-668-5055|james.m.davis@duke.edu|
22259281|NCT03889756|Yale University|Dr. Michael Bloch|203 7374809|michael.bloch@yale.edu|
22259282|NCT02761980|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259283|NCT02929979|VA Palo Alto Healthcare System|Adrienne Heinz|9196306847|adrienneheinz@gmail.com|
22259284|NCT02848599|University Hospital Osijek, Croatia|Dr. Gordana Kristek|+385915115746|gordanaldrmed@yahoo.com|
22259285|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa|
22259286|NCT02337933|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22259287|NCT00100165|University of Colorado, Denver|Dr. Robert Freedman|303 724-4940|robert.freedman@ucdenver.edu|
22259288|NCT02850068|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22259289|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22259290|NCT03996603|University of Alabama at Birmingham|Kyle Norris, MD Principal Investigator|(205) 934-1704|kyleparkernorris@gmail.com|
22259291|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es|
22259292|NCT00755326|University of Maryland Center for Integrative Medicine|Brian M. Berman|410706-6181|bberman@som.umaryland.edu|
22259293|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22259294|NCT02385526|Cyberonics, Inc.|Peter Sears, Clinical Project Manager|(281) 228-7597|peter.sears@cyberonics.com|
22259295|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965|michael.hotze@straumann.com|1235
22259296|NCT01595009|Novartis Pharmaceuticals|Study Director|862-778-1873||
22259297|NCT00506909|UCSD|David Feifel||dfeifel@kadimanp.com|
22259298|NCT03463525|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22259299|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu|
22291785|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22291786|NCT03442400|Cleveland Clinic|Samir Kapadia, MD|216-444-6735|kapadis@ccf.org|
22291787|NCT02068768|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
22291788|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu|
22291789|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629||
22291790|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov|
22291791|NCT04644783|University of Michigan|Mohamad El Zaatari|734-647-2954|mohamade@med.umich.edu|
22291792|NCT02290431|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22291793|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org|
22291794|NCT03455764|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
22291795|NCT05161689|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
22291796|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com|
22291797|NCT03437512|University of Michigan|Emily O. Garnett, PhD, CCC-SLP|734-232-3371|emilyog@med.umich.edu|
22291798|NCT02417844|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291799|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu|
22291800|NCT03332771|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
22291801|NCT02876640|University of Wisconsin - Madison|Lisa Barroilhet, MD, MS|608-264-3204|barroilhet@wisc.edu|
22291802|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
22291803|NCT03718871|Weill Cornell Medicine|Dr. Radhika Sundararajan|(646) 962-4654|ras9199@med.cornell.edu|
22291804|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22291805|NCT02423109|CooperVision|Myhanh Nguyen, OD|9257306716|mnguyen@coopervision.com|
22291806|NCT03868124|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22291807|NCT02742246|Yale University School of Medicine|Dr. Brian Kiluk, Associate Professor of Psychiatry|203-737-1544|Brian.kiluk@yale.edu|
22291808|NCT03489551|University of Iowa|Michelle Weckmann|319-384-7538|michelle-weckmann@uiowa.edu|
22291809|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291810|NCT00585559|Vanderbilt University Medical Center|Dr. Matthew Fusco|615-322-1054|matthew.r.fusco@vumc.org|
22291811|NCT04111939|RTI International|Charles Knott|9195416294|cknott@rti.org|
22291812|NCT03535571|KGK Science Inc.|Dr. Mal Evans|519-438-9374|mevans@kgkscience.com|
22291813|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu|
22291814|NCT04218123|Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina|Habib Rizk, MD, MSc|8438760112|rizkh@musc.edu|
22291815|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com|
22259300|NCT03758365|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22306054|NCT02577523|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director||laurence@neuroderm.com|
22306055|NCT03597100|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
22291816|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22291817|NCT03727373|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22306056|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu|
22306057|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
22306058|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
22259301|NCT02623829|Icahn School of Medicine at Mount Sinai|Dr. Daniel Bernstein|212-731-3311|daniel.bernstein@mountsinai.org|
22259302|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259303|NCT03119064|Brown University Oncology Research Group|Heinrich Elinzano, MD|401-863-3000|BrUOG@BROWN.EDU|
22259304|NCT01333033|Alliance for Clinical Trials in Oncology|Karyn Goodman, M.D.|(212) 639-3983|goodmank@mskcc.org|
22259305|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22259306|NCT01842958|Straumann USA, LLC|Kelly Jork|978-747-2533|kelly.jork@straumann.com|
22259307|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22259308|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com|
22259309|NCT03465891|Memorial Sloan Kettering Cancer Center|Dr. Lia Palomba|646-608-3711|palombam@mskcc.org|
22259310|NCT02737306|CytoDyn|Joseph Meidling Executive Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22259311|NCT03361423|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
22259312|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22259313|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org|
22259314|NCT01166568|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
22259315|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070||
22259316|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com|
22259317|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu|
22259318|NCT01934296|University of California San Francisco|Dr. Sarah Wang, Director of Clinical Research|416-353-7885|Sarah.Wang@ucsf.edu|
22259319|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com|
22259320|NCT02015793|AbbVie|Global Medical Services|800-633-9110||
22259321|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22259322|NCT01076166|Abbott|Global Medical Services|1-800-633-9110||
22259323|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22259324|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103|janne.jokinen@helsinki.fi|+358
22259325|NCT02462070|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22259326|NCT00321711|Amgen Inc.|Study Director|866-572-6436||
22259327|NCT03979209|Rush UMC|Bobby Tajudeen, MD|312-942-6100|Bobby_Tajudeen@rush.edu|
22259328|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
22259329|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br|
22259330|NCT04749524|Intelligent Hearing Systems Corp|Dr. Rafael E. Delgado|305-668-6102|redelgado@ihsys.com|
22259331|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124|ehl4@georgetown.edu|202
22259332|NCT01193517|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-792-2828|moverman@mdanderson.org|
22259333|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22259334|NCT01841606|UBC Department of Anesthesia - BC Women's Hospital|Mr. James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
22259335|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu|
22291818|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org|
22306059|NCT03557333|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
22306060|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org|
22306061|NCT00742573|New York State Psychiatric Institute|Mark Olfson, MD, MPH|646-774-6413|mark.olfson@nyspi.columbia.edu|
22306062|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl|
22306063|NCT03036735|Steward Health Care|Dr Peter Catalano|617-789-5004|peter.catalano@steward.org|5004
22259336|NCT03065283|Department of Physical Therapy|Prof. Dr. Pedro Lima|558533668091|pedrolima@ufc.br|
22291819|NCT03577171|Assembly Biosciences|Linda Baher, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
22291820|NCT03823378|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22291821|NCT03190369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22291822|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22291823|NCT03742440|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22291824|NCT03436810|Mahidol University|Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|
22306064|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000|christopher.erbes@va.gov|2125
22306065|NCT01563354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22306066|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22306067|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org|
22291825|NCT04081233|The University of Texas Health Science Center at Houston|David E. Meyer, MD, MS, FACS|713-500-7244|David.E.Meyer@uth.tmc.edu|
22259337|NCT02525029|University of Minnesota, Masonic Cancer Center|Dr. Shernan Holtan, MD|(612) 626-5654|sgholtan@umn.edu|
22259338|NCT02638090|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|Jhanelle.Gray@Moffitt.org|
22259339|NCT05440097|AstraZeneca|Clinical project manager|18500554074|jiayu.ye@astrazeneca.com|
22259340|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22259341|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org|
22259342|NCT05590585|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22259343|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu|
22259344|NCT03617692|University of Colorado Boulder|Angela Bryan, PhD|3034929549|Angela.Bryan@Colorado.EDU|
22259345|NCT04161144|Medical University of South Carolina|Dr. Michael Saladin|8437925306|saladinm@musc.edu|
22259346|NCT04828161|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22259347|NCT03093454|Duke Health|Scott Hollenbeck, MD|919-681-5079|scott.hollenbeck@duke.edu|
22259348|NCT02524379|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22259349|NCT01884025|Central Arkansas Veterans Healthcare System|Dr. Kristen Viverito|501-257-1699|KRISTEN.VIVERITO@VA.GOV|
22259350|NCT05380635|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22259351|NCT02854436|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259352|NCT01700621|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22259353|NCT03588390|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259354|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259355|NCT02985151|Dermatology SLUCare Physician Group|Research Manager/Coordinator|314 977-1794|rhonda.lebbing@health.slu.edu|
22259356|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22259357|NCT04992052|Northwell Health System|Nancy Dengler, Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
22259358|NCT05425966|University of California San Francisco|Lauren Haack, PhD|415-502-8060|lauren.haack@ucsf.edu|
22259359|NCT04756141|Mayo Clinic|Adrian G. Dumitrascu, M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
22259360|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu|
22259361|NCT02843074|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22259362|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259363|NCT01186978|Duke University Health System|Assistant Research Practice Manager (ARPM) for Clinical Trials|919-668-5211|Jennifer.Mewshaw@duke.edu|
22259364|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22259365|NCT04281485|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259366|NCT04317599|Pierre Fabre|Project leader|+33(0)1 49 10 81 84|farida.beghdad@pierre-fabre.com|
22259367|NCT04738279|NorthShore University HealthSystem|Nirav Shah, MD, MPH|(847) 570-1236|nshah2@northshore.org|
22259368|NCT01072331|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259369|NCT00891878|Mayo Clinic|Aminah Jatoi, M.D|(507) 284-5352|jatoi.aminah@mayo.edu|
22259370|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu|
22259371|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
22259372|NCT04616417|University of Illinois at Chiago|Principal Investigor|312-355-3245|Sana.Salih@bsd.uchicago.edu|
22259373|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com|
22259374|NCT02427607|Eisai Co., Ltd.|Hidetaka Hiramatsu|+81-3-3817-5245|esi_medinfo@eisai.com|
22259375|NCT03211416|Roswell Park Comprehensive Cancer Center|Kris Attwood|8772757724|Kris.Attwood@roswellpark.org|
22259376|NCT01789320|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22259377|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org|
22259378|NCT03199274|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|john.eisenbrey@jefferson.edu|
22259379|NCT02407756|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22259380|NCT02387814|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259381|NCT03621085|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
22259382|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com|
22259383|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22291826|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22259384|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259385|NCT03896490|Queen's University Belfast|Dr Oliver Perra|+44289097|o.perra@qub.ac.uk|2313
22259386|NCT02743442|Fondation Ophtalmologique A. de Rothschild|Dr Amélie Yavchitz (deputy head of the clinical research unit)|+33148036454|ayavchitz@for.paris|
22291827|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com|
22306068|NCT04897737|UCLA|Dr. Dvora Joseph Davey, PI|310-701-1526|dvoradavey@ucla.edu|
22259387|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org|
22259388|NCT00385541|Columbia University|Dr. Pamela Flood|201-370-3933|pflood@stanford.edu|
22259389|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com|
22259390|NCT02154529|Kadmon Corporation|Associate Vice President, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
22259391|NCT02081599|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22291828|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22291829|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org|
22291830|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22291831|NCT01298193|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22291832|NCT01975831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22291833|NCT02925793|DS Biopharma|Study Director|+35312933590|regulatory.dsbiopharma@dsbiopharma.com|
22291834|NCT03794882|University of Wisconsin-Madison|Dr Kristin Bevil|6082638100|kbevil@wisc.edu|
22291835|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
22274513|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300||
22306069|NCT05334758|BioTeke USA|Chang Turkmani|202-679-2112|chang@themegaco.com|
22306070|NCT00478335|University of Colorado Denver|Melissa Cadnapaphornchai, MD|720776263|melissa.cadnapaphornchai@ucdenver.edu|
22306071|NCT04059237|Stanford University|Catherine Benedict, PhD|650-498-9111|cbenedict@stanford.edu|
22306072|NCT02050308|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
22306073|NCT03058991|Boston University Charles River Campus|Dr. Michael Otto|617-353-9610|mwotto@bu.edu|
22306074|NCT01988233|University of Illinois Chicago|Dr. David X. Marquez|3129961209|marquezd@uic.edu|
22306075|NCT03525119|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22306076|NCT05046132|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22306077|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300||
22306078|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22306079|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22306080|NCT03888755|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22306081|NCT02903836|Wockhardt|Dr Manishkumar D Shah|02226534444|manish.shah@wockhardt.com|6893
22306082|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
22306083|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu|
22306084|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu|
22306085|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
22306086|NCT03038399|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
22306087|NCT00770965|Novartis|Study Director|862-778-8300||
22306088|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590||
22306089|NCT00414648|Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati|Francis X. McCormack, MD|513-558-4831|mccormfx@ucmail.uc.edu|
22306090|NCT02371746|Envisia Therapeutics, Inc.|Kristin Blackwell, Consultant, Regulatory Affairs & Quality Assurance|919-219-6448|kristin.blackwell@envtx.com|
22306091|NCT00754936|Weill Cornell Medicine|George S Alexopoulos|914-997-5767|gsalexop@med.cornell.edu|
22306092|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu|
22306093|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
22306094|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
22306095|NCT04364269|Vifor Pharma, Inc.|CSL Vifor|+41 588 518 000|VIT2763-THAL-201.study@viforpharma.com|
22306096|NCT04173572|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
22306097|NCT01490580|NICU, CHI Créteil|Dr Xavier Durrmeyer|+33145175433|xavier.durrmeyer@chicreteil.fr|
22306098|NCT04615299|John Dingell VA Medical Center|Dr Padmavathi Patel|313-576 2731|Padmavathi.Patel@va.gov|
22306099|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu|
22306100|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22306101|NCT03478696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306102|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
22306103|NCT04673851|University of North Carolina at Chapel Hill|Bryan Stiles, MA|919-590-5811|stilesb@unc.edu|
22306104|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306105|NCT00117663|Group Health Research Institute|Diana Buist PhD, Principal Investigator|206-287-2931|buist.d@ghc.org|
22306106|NCT01104415|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22306107|NCT04286529|Mayo Clinic|Rajiv Kumar, MD|507-284-0020|rkumar@mayo.edu|
22306108|NCT02914522|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22306109|NCT03098030|United Therapeutics Corporation|Program Manager, Oncology|919-485-8350|kmaher@unither.com|
22306110|NCT03368001|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|615-936-0280|blythe.corbett@vumc.org|
22306111|NCT03612804|VA Puget Sound Health Care System|Steven B Zeliadt|206-277-4175|Steven.Zeliadt@va.gov|
22306112|NCT05484726|Fatima Memorial Hospital Shadman Lahore|Assistant Professor Dr Rafia Gul|00923064620027|docrafiagul@gmail.com|
22306113|NCT03105128|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22306114|NCT04550039|Shirley Ryan AbilityLab|Katherine Enzler, Physical Therapist|312-238-2941|kenzler@sralab.org|
22306115|NCT05826431|UW Medicine Multiple Sclerosis Center|Dr. Kevin Alschuler, Director of Rehabilitation Research|206-668-8413|kalschul@uw.edu|
22306116|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu|
22306117|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22306118|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com|
22306119|NCT04222959|San Diego State University Research Foundation|Elizabeth Reed|508-212-1517|ereed@sdsu.edu|
22306120|NCT04026620|University of North Carolina at Chapel Hill|Julie Hasken, PhD|704-250-5000|julie_hasken@unc.edu|
22306121|NCT03254394|Washington University in St Louis|Simon Haroutounian, PhD. Associate Professor|3132861715|sharout@wustl.edu|
22306122|NCT04248829|Yuhan Corporation|Dongmin Kim|+82-2-828-0523|clinicaltrials@yuhan.co.kr|
22306123|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22306124|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com|
22306125|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22306126|NCT04670822|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
22306127|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br|
22291836|NCT03475875|Johnson & Johnson Vision|John Buch - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
22291837|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
22291838|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22291839|NCT00256282|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
22291840|NCT02431247|Janssen Sciences Ireland UC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22291841|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22259392|NCT00782431|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22259393|NCT01806688|Agriculture and Agri-Food Canada|Dr. Heather Blewett|204 237-2954|hblewett@sbrc.ca|
22259394|NCT02146430|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|+1 (908) 992-6400|CTRinfo@DSI.com|
22259395|NCT03093324|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22259396|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
22259397|NCT05342753|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
22259398|NCT00836927|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259399|NCT02518230|Children's Mercy Hospital|Winston Manimtim|816-234-3000|wmmanimtim@cmh.edu|
22259400|NCT04583579|Lexitas Pharma Services|Dr. Andrew Pucker|9205792900|andrewpucker@hotmail.com|
22259401|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259402|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu|
22259403|NCT04700449|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
22259404|NCT06041646|BioXcel Therapeutics|SVP Clinical and Medical Affairs|(203) 530-5000|DKostic@Bioxceltherapeutics.com|
22259405|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
22259406|NCT03209570|Insight Therapeutics, LLC|H. Edward Davidson, PharmD, MPH|7576246040|EDavidson@inther.com|
22259407|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr|
22259408|NCT02173704|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259409|NCT03901963|Janssen Research & Development|Director Clinical Research Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259410|NCT04956666|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22259411|NCT02909673|UT Health Houston|Melanie Thiel|713-818-6281|melanie.thiel@uth.tmc.edu|
22259412|NCT02869646|Tibor Rubin VA Medical Center|Michael Hollifield, M.D.|562 826-8000|michael.hollifield@va.gov|4324
22259413|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it|
22259414|NCT03349333|Mundipharma(China) Co.,Ltd|clinical study manager|8610-65636856|guodong.lu@mundipharma.com.cn|
22259415|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22259416|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu|
22259417|NCT02752776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22259418|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu|
22259419|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22259420|NCT02116803|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259421|NCT03213210|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22259422|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259423|NCT04128007|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22259424|NCT02755545|Galderma|Director, Medical Affairs and Clinical Development|8179615325|matthew.meckfessel@galderma.com|
22259425|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22259426|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259427|NCT04371419|Massachusetts Institute of Technology|Pierre-Luc Vautrey|(617) 258-7013|vautrey@mit.edu|
22259428|NCT02931565|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22259429|NCT02110706|Yale School of Medicine|Dr. Richard Nowak, MD,MS|203-785-4085|richard.nowak@yale.edu|
22259430|NCT04177810|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
22259431|NCT03521999|Ralph H. Johnson VA Medical Center|Research Coordinator|843-301-9917|sarah.szafranski@va.gov|
22259432|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
22259433|NCT04182204|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22259434|NCT03933202|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151725200|service@emdgroup.com|+49
22259435|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22259436|NCT05105711|University of North Carolina at Chapel Hill|Melissa Gilkey, PhD|919-966-8650|gilkey@email.unc.edu|
22259437|NCT01348542|Penn State University College of Medicine|Alexandros Vgontzas|717 531-7278|vgontzas@pennstatehealth.psu.edu|
22259438|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259439|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22259440|NCT01411995|Washington University School of Medicine|Dr Colleen McNicholas|314-747-1331|mcnicholasc@wudosis.wustl.edu|
22259441|NCT05658523|Murdoch Childrens Research Institute|Kathryn Bright|+61 3 99366656|kathryn.bright@mcri.edu.au|
22259442|NCT03212170|UW Carbone Cancer Center|Dr. Amy Fowler, MD, PhD|608-262-9186|afowler@wisc.edu|
22259443|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org|
22259444|NCT06052202|ISA Associates, Inc.|Samantha Leaf, PhD|7037390883|sleaf@isagroup.com|
22259445|NCT00628212|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259446|NCT02482571|University of Minnesota|Silvia Mangia, PhD|6126254920|mangia@umn.edu|
22274514|NCT02446691|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
22291842|NCT03631355|NYU Langone Health Orthopedic Hospital|Dr. Michael J. Alaia|6465017223|michael.alaia@nyulangone.org|
22291843|NCT02810340|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22259447|NCT06016725|School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University|Dr. Jessica Krok-Schoen, Associate Professor|8133686470|Jessica.krok@osumc.edu|
22259448|NCT06394973|Laboratoires Théa|Clinical Affairs Director|+33473981436|Corentin.LECAMUS@theapharma.com|
22291844|NCT01723696|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
22291845|NCT05074173|Tulane University School of Medicine|Keith Ferdinand|504-988-5492|kferdina@tulane.edu|
22291846|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
22291847|NCT04721067|Indiana University|Dr. Samir K. Gupta|3172747926|sgupta1@iu.edu|
22291848|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it|
22291849|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22291850|NCT01030783|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|617-588-1960|Clinical@aveooncology.com|
22291851|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu|
22291852|NCT04480424|Scientific Innovation Office (SIO) Clinical Program Leader/Director Bioscience Clinical & Pharmacovigilance|Rhonda Griffin|+1 919 316 6693|Rhonda.griffin@grifols.com|
22291853|NCT04894916|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22291854|NCT01897714|Oncopeptides AB|Eva Nordström|+4686152040|trials@oncopeptides.com|
22291855|NCT04233034|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
22291856|NCT05828095|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22291857|NCT03206073|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
22291858|NCT05523323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291859|NCT05654441|University of North Carolina at Chapel Hill|Keely Muscatell, PhD|919-843-5467|kmuscatell@unc.edu|
22291860|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
22291861|NCT02428608|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22291862|NCT00397943|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291863|NCT05007717|University of Washington|Data Analyst|7347809402|wenwenj@uw.edu|
22291864|NCT01117051|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22291865|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu|
22291866|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22291867|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu|
22306128|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
22259449|NCT04071769|Duke University|Robert M. Tighe, MD|919-684-4894|robert.tighe@duke.edu|
22259450|NCT01890707|Northwestern University|Shireen Ahmad MD|312-472-3585|sahmad@northwestern.edu|
22259451|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255||2078
22259452|NCT03495869|Virginia Commonwealth University|Lori Keyser-Marcus, PhD|(804) 828-4164|lori.keysermarcus@vcuhealth.org|
22259453|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22259454|NCT03312530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22259455|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22259456|NCT00093964|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22259457|NCT02489318|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259458|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com|
22259459|NCT03679741|Johnson & Johnson Vision Care|John Buch, O.D., M.S. Sr. Prinicpal Research Optometrist|904 443-1707|JBUCH@its.jnj.com|
22259460|NCT00650936|Abbott|Maren Wagner, Clinical Program Director|7517565585|maren.wagner@abbott.com|
22259461|NCT02035137|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
22259462|NCT01215942|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259463|NCT03305055|Johns Hopkins University|James A. Fauerbach|410-550-0890|jfauerb1@jhmi.edu|
22259464|NCT04471935|Flint Rehabilitation Devices|Ian Russell|3392232676|irussell@flintrehab.com|
22259465|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
22259466|NCT01399736|Maasstad Hospital|Dr.Pieter Smits|+31102913322|SmitsP@maasstadziekenhuis.nl|
22259467|NCT03500484|Yale University / Yale School of Medicine|Ania Jastreboff, MD, PhD|203 737 1932|ania.jastreboff@yale.edu|
22259468|NCT02795104|The Ohio State University Comprehensive Cancer Center|Ryan Baltic|614-293-4121|ryan.baltic@osumc.edu|
22259469|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22259470|NCT02296775|Dr. Reddy's Laboratories Ltd, Biologics Survey No. 47, Bachupally Village, Bachupally Mandal, Medchal Malkajgiri District Telangana, India - 500 090|Dr. Ankit Ranpura, MD (Associate Director- Clinical Development)|040 4464 4000|ankitr@drreddys.com|
22259471|NCT01654380|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259472|NCT03335371|vTv Therapeutics LLC|Study Director|336-841-0300|clinicaltrials@vtvtherapeutics.com|
22259473|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu|
22259474|NCT06331156|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259475|NCT05845645|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22259476|NCT06375499|Laboratoires Théa|Corentin LE CAMUS|0033 473989604|Corentin.LECAMUS@theapharma.com|
22259477|NCT04571242|SGX Medical|VP of Clinical Affairs|818-527-2710|clinical@sgxmedical.com|
22259478|NCT00998881|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259479|NCT02649231|University of Exeter|Professor Celia Morgan|01392 724649|Celia.Morgan@exeter.ac.uk|
22259480|NCT02531022|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
22259481|NCT02970669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22259482|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259483|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
22259484|NCT02611752|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
22259485|NCT03495986|University of Miami Miller School of Medicine|Dr. Eduard Tiozzo|3052431633|etiozzo@miami.edu|
22259486|NCT05476679|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|972-8-9126941|racheli@raziel-therapy.com|
22259487|NCT01214330|Mike O'Callaghan Military Medical Center|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
22259488|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22259489|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu|
22259490|NCT01636297|Cleveland Clinic|Dr. Jay Alberts|216-445-3222|albertj@ccf.org|
22259491|NCT01498484|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
22259492|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22259493|NCT00814320|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22259494|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
22259495|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu|
22259496|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320306|NCT01101438|Canadian Cancer Trials Group|Professor Bingshu Chen|+16135336000|bechen@ctg.queensu.ca|77703
22259497|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22259498|NCT01483872|UCSD|Saima Aslam|858 657 7463|saslam@ucsd.edu|
22259499|NCT05550532|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259500|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu|
22259501|NCT02780661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259502|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180|tjaebl@lsuhsc.edu|419
22259503|NCT04820842|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22259504|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259505|NCT01296932|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259506|NCT04579926|Klein Buendel, Inc.|Julia Berteletti|3035654321|jberteletti@kleinbuendel.com|
22259507|NCT02918162|Columbia University|Gulam Manji, MD, PhD|212-305-7115|gam2140@cumc.columbia.edu|
22259508|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org|
22259509|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com|
22259510|NCT02655237|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22259511|NCT02227862|Mylan Inc.|David Gillogly, Head of Global Clinical Operations|+1 (724) 4856581|david.gillogly@mylan.com|
22259512|NCT05014204|Endogenex|Chris Sorli, CMO|(763) 251-6820|csorli@endogenex.com|
22259513|NCT02959775|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22259514|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22259515|NCT02893267|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3559|rwilson@metrohealth.org|
22259516|NCT03748641|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259517|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259518|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259519|NCT04104646|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22259520|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu|
22259521|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22259522|NCT03387098|Immunitybio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22259523|NCT00278512|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
22259524|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu|
22259525|NCT02292238|Weill Cornell Med/ Burke Neurological Institute|Gary E Gibson, Professor of Neuroscience|9145972291|ggibson@med.cornell.edu|
22259526|NCT04000009|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22259527|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu|
22259528|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org|
22259529|NCT02829918|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@Moffitt.org|
22259530|NCT03520283|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
22259531|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22274515|NCT03924323|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22274516|NCT03903172|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
22274517|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274518|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu|
22274519|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22274520|NCT01474486|Phoenix VA Health Care System|Diane J. Parrington|602-277-5551|diane.parrington@va.gov|7532
22274521|NCT01255163|National Institute on Aging (NIA/NIH)|Dimitrios Kapogiannis, Clinical Investigator|410-350-3953|kapogiannisd@mail.nih.gov|
22274522|NCT04219189|Virginia Commonwealth University|Dr. Caroline Cobb|(804) 827-3562|cobbco@vcu.edu|
22274523|NCT02495389|Loyola University Chicago|Alan Wolfe, Ph.D.|708-216-5814|awolfe@luc.edu|
22274524|NCT01924533|AstraZeneca|Gershon Locker Global Clinical Lead (GCL)||gershon.locker@astrazeneca.com|
22274525|NCT05817669|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
22274526|NCT04233879|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274527|NCT03918811|Hospitalsantojanni|Professor Mauro Andreu|+541168788298|mfandreu@gmail.com|
22274528|NCT03585270|Idorsia Pharmaceutical Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
22274529|NCT02184208|Boston Children's Hospital|Brian Kendall Walsh|617-919-3692|brian.walsh@childrens.harvard.edu|
22274530|NCT01802385|University of Minnesota|Joshua Rhein|612-624-1966|joshua.rhein@gmail.com|
22274531|NCT02756910|Peking Union Medical College Hospital|Lijian Pei|＋86 10 69152020|hazelbeijing@vip.163.com|
22274532|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
22274533|NCT03904693|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22274534|NCT03041636|The University of Texas MD Anderson Cancer Center|Zeev Extrov MD./Professor|713-794-1675|zestrov@mdanderson.org|
22274535|NCT05002972|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
22274536|NCT01664091|Dana-Farber Cancer Institute|Julia Wong, MD|617-632-3591|JWONG@LROC.HARVARD.EDU|
22291868|NCT03355664|Mahidol Oxford Tropical Medicine Research Unit (MORU)|Thomas Peto|(+66) 802 187 460|tom@tropmedres.ac|
22291869|NCT02145507|Haemonetics (trial sponsor)|Adrian Orr, Clinical Research Director|781.356.9647|aorr@haemonetics.com|
22259532|NCT01103505|Notal Vision|Grace Chang, MD, PhD|571-719-6416|Grace.Chang@NotalVision.com|
22291870|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
22291871|NCT02821910|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22291872|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22291873|NCT00900601|Oslo University Hospital|Thomas Kibsgård|99030831|kibsgard@gmail.com|+47
22291874|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371|simiao.wu@ed.ac.uk|26371
22291875|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22291876|NCT03583073|Brown U|Anthony Spirito|4013692435|anthony_spirito@brown.edu|
22291877|NCT02045303|Texas Health Resources Presbyterian Hospital of Dallas|Lisley Viana, Physical Therapist|214-345-4334|lisleyviana@texashealth.org|
22291878|NCT01856023|Clinigen|Head of Medical Affairs|8323263256|nancy.gregory@clinigengroup.com|
22291879|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
22291880|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291881|NCT03004248|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
22291882|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22291883|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu|
22291884|NCT03945175|NYU Langone Health|Terry Leon|646 754 4837|terry.leon@nyulangone.org|
22291885|NCT00870233|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi ME|212-639-5016|chid@mskcc.org|
22291886|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com|
22291887|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it|
22291888|NCT00236951|Luitpold Pharmaceuticals|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
22291889|NCT02942576|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22291890|NCT00769483|UT MD Anderson Cancer Center|Milind Javle, MD/Professor, GI Medical Oncology|713-792-2828|mjavle@mdanderson.org|
22291891|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com|
22291892|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22291893|NCT01958112|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
22291894|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu|
22291895|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com|
22291896|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu|
22291897|NCT01285960|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22291898|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868|ayseparlakgumus@yahoo.de|2102
22291899|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917||
22291900|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu|
22291901|NCT01017575|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
22291902|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com|
22291903|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu|
22291904|NCT03014492|Cincinanti Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
22291905|NCT04705363|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
22291906|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu|
22291907|NCT02730208|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22291908|NCT04490239|University of Mississippi|Dr. Joshua Sharp|662-915-1758|jsharp@olemiss.edu|
22291909|NCT00413166|The University of Texas (UT) MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, Professor, Leukemia|7137927734|fravandi@mdanderson.org|
22291910|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com|
22291911|NCT00439465|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603-650-6432|Kenneth.R.Meehan@hitchcock.org|
22291912|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu|
22291913|NCT02021656|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22291914|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu|
22291915|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu|
22291916|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu|
22291917|NCT05985980|Istanbul Medeniyet University|Mehmet Agirbasli MD|+902166065200|agirbasli@gmail.com|
22291918|NCT02793128|UroGen Pharma Ltd.|Madlen Malinowski|6467689533|madlen.malinowski@urogen.com|
22291919|NCT02359851|Vanderbilt-Ingram Cancer Center|Principal Investigator|615-936-7423|douglas.b.johnson@vanderbilt.edu|
22291920|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590||
22259533|NCT02255513|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22291921|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22259534|NCT02041702|Abbott (formerly St. Jude Medical)|Clinical Project Leader Asia|0085229967605|lyim@sjm.com|
22259535|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu|
22259536|NCT03730103|The Cleveland Clinic|Lynn Borzi, Research Administrator|216-445-3158|borzil@ccf.org|
22259537|NCT02789111|University of Virginia Department of Aneshtesiology|Bhiken Naik MD|434-924-2283|BIN4N@hscmail.mcc.virginia.edu|
22259538|NCT02308111|Intercept Pharmaceuticals, Inc.|Medical Information|+1 884-782-4278|medinfo@interceptpharma.com|
22259539|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil|
22259540|NCT03271528|Boston Medical Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
22259541|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259542|NCT03977584|Hoffmann-La Roche|BN40199|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22259543|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu|
22259544|NCT02257736|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259545|NCT04234568|University of Kentucky|Dr. Susanne Arnold|859-323-8043|susanne.arnold@uky.edu|
22259546|NCT03071406|Moffitt Cancer Center|Sungjune Kim, MD, PhD|813-745-1898|sungjune.kim@moffitt.org|
22259547|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
22259548|NCT03390504|Janssen Research & Development, LLC|SR DIRECTOR ONCOLOGY CDTL|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259549|NCT05431686|Children's National Hospital|Dr. Jody Grundman|2024762121|jgrundman@childrensnational.org|
22259550|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22259551|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22259552|NCT06454604|Center for Youth Social Emotional Wellness - Graduate School of Applied and Professional Psychology|Dr. Joshua Langberg|(848) 445-2000|jl3079@gsapp.rutgers.edu|
22259553|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org|
22259554|NCT02938494|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22259555|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414|lilian.dindo@bcm.edu|10296
22259556|NCT01736553|The Ohio State Unviersity Wexner Medical Center|Dr. Stephen Kolb|614-366-9050|stephen.kolb@osumc.edu|
22259557|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259558|NCT04555525|Skin Sciences, PLLC|Senen Pena|502-451-9000|spdermresearch@yahoo.com|
22259559|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22259560|NCT03482713|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-80-672-6372|ClinicalTrialsDisclosure@merck.com|
22259561|NCT03626857|University of Michigan|Riann Palmieri-Smith, PhD, ATC|734-615-3154|riannp@umich.edu|
22259562|NCT01301833|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22259563|NCT02178709|IndianaU|Dr. Amikar Sehdev|(317) 274-0339|asehdev@iupui.edu|
22259564|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu|
22259565|NCT02192905|University of Massachusetts Medical School|Sherry Pagoto, Professor|508-856-5159|study@umassmed.edu|
22259566|NCT05218655|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22259567|NCT02228382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259568|NCT02337465|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ping Xia|1-866-223-8100|TaussigResearch@ccf.org|
22259569|NCT02396381|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22259570|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org|
22259571|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
22259572|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259573|NCT04652453|Department of Internal Medicine: Yale School of Medicine|Lauren Ferrante, MD, MHS|(203) 785-3207|lauren.ferrante@yale.edu|
22259574|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu|
22259575|NCT04033445|Janssen Research & Development, LLC|Medical Director IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259576|NCT00585780|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
22259577|NCT02985957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
22259578|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org|
22259579|NCT02978326|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22259580|NCT02024087|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22291922|NCT04340063|Edward Hines Jr. VA|Dr. Keith Gordon|(312) 503-3339|keith.gordon2@va.gov|
22259581|NCT02365597|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259582|NCT04309474|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22259583|NCT04670068|UNC Lineberger Comprehensive Cancer Center|Kelly Hoye, MS, CCRP Study coordinator - Clinical Immunotherapy Program|919-445-9676|khoye@email.unc.edu|
22259584|NCT02974153|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22259585|NCT02521948|Essential Medical, Inc|Director of Operations|610-557-1009|todd@essmedclosure.com|
22291923|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22291924|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu|
22291925|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com|
22259586|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
22291926|NCT05824741|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
22259587|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22259588|NCT00673790|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22259589|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu|
22259590|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir|
22259591|NCT04471428|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22259592|NCT03504852|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22259593|NCT03290079|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-5553|jonathan.strosberg@moffitt.org|
22259594|NCT03850509|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22259595|NCT02666430|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22259596|NCT03922477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259597|NCT05202093|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
22291927|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22291928|NCT03642327|University of Maryland School of Medicine|Howard Dubowitz, MD, Professor of Pediatrics|4107066144|hdubowitz@som.umaryland.edu|
22291929|NCT05063318|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit|0034918466000|clinicaltrials@pharmamar.com|
22291930|NCT03287635|Toyos Clinic|Dr.|9137064408|mtoyos@toyosclinic.com|
22291931|NCT01847001|Columbia University Medical Center|Dr. Kevin Kalinsky|212-305-1925|cancerclinicaltrials@cumc.columbia.edu|
22291932|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
22291933|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org|
22291934|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk|
22291935|NCT00920829|Medical University of South Carolina|Dr. Raymond Anton|843-792-1226|antonr@musc.edu|
22291936|NCT03875118|National Taipei University of Nursing Health and Sciences|Director of Nursing Department|886-2-28227101|tsaejyy@ntunhs.edu.tw|3118
22291937|NCT02237911|University of Pittsburgh|Dr. Sara Piva|(412) 383-6712|spiva@pitt.edu|
22291938|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590||
22291939|NCT03468985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22291940|NCT03981822|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22291941|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my|
22291942|NCT04521777|UT MD Anderson Cancer Center|An T Ngo-Huang, Assistant Professor, Rehabilitation Medicine|(713) 745-2327|ango2@mdanderson.org|
22291943|NCT06053463|The Ohio State University College of Optometry|Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
22291944|NCT01617148|Cleveland Clinic Foundation|Dr. Rishi Singh|330-888-4000|singhr@ccf.org|
22291945|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
22291946|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040|vhalpern@fhi360.org|11390
22291947|NCT02960997|Stanford University|Joyce Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
22291948|NCT03463031|Glenmark Pharmaceuticals Ltd|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22291949|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22291950|NCT00055224|National Institute of Mental Health|Dr Maryland Pao|(301) 435 5770|paom@mail.nih.gov|
22291951|NCT01677312|Center for Interventional Endoscopy, Florida Hospital|Dr. Shyam Varadarajulu, MD|407-303-2570|svaradarajulu@yahoo.com|
22291952|NCT04291001|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
22291953|NCT02376829|Align Technology Inc|Sherri Wilson-Lopes|408-470-1032|swilson@aligntech.com|
22291954|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012||
22291955|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu|
22291956|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
22291957|NCT00701376|Cleveland Clinic|Brian Parker, MD|216-444-9950|parkerb1@ccf.org|
22291958|NCT02663687|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22291959|NCT03189381|Indiana University (IU)|Dr. Kevin Shiue|317 944 2524|kshiue@iupui.edu|
22291960|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com|
22291961|NCT04025710|BIOTRONIK SE & Co.KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22291962|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu|
22291963|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291964|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net|
22291965|NCT05308290|Stanford University|Charles Brown, MD PhD|6504983512|chbrown@stanford.edu|
22291966|NCT02117427|Aevi Genomic Medicine|Garry A Neil|610-254-4208|garry.neil@aevigenomics.com|
22291967|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22291968|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22291969|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
22291970|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22291971|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22291972|NCT04533685|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22291973|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22291974|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22291975|NCT02750215|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-726-8033|RHEIST@PARTNERS.ORG|
22291976|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp|
22291977|NCT02945787|Moffitt Cancer Center|Thomas H. Brandon PhD|813 745-1750|Thomas.Brandon@moffitt.org|
22259598|NCT01618305|Westat|Lauren Laimon, Project Manager|240-453-2987|laurenlaimon@westat.com|
22259599|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22291978|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259600|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com|
22259601|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22259602|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
22259603|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259604|NCT01693783|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
22259605|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22259606|NCT06611410|CooperVision|Lee Hall|+19256604365|LHall@coopervision.com|
22259607|NCT01402908|Medigen Biotechnology Corp.|Clinical Research Manager|886-2-77361234|Doyce.Chen@medigen.com.tw|
22259608|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu|
22259609|NCT01797471|University of Miami|Jean L. Wright MD|305-243-5965|jwright3@med.miami.edu|
22259610|NCT01691859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259611|NCT00862979|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22259612|NCT05568225|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22259613|NCT02405325|UCSD|Loki Natarajan|8588224763|lnatarajan@ucsd.edu|
22259614|NCT01027143|Duke University Medical Center|Jason Lang, MD|919-684-9590|jason.lang@duke.edu|
22259615|NCT03493126|The Ohio State University|Dr. Andrew Hundley|614-293-4647|andrew.hundley@osumc.edu|
22259616|NCT01095003|Institut de Recherche Pierre Fabre|Karim Keddad|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
22259617|NCT02637557|Ironwood Pharmaceuticals, Inc.|IW-3718-202 Study Chair|1 (617) 621-7722|Info@ironwoodpharma.com|
22259618|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518||
22259619|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
22259620|NCT03738332|University of Pennsylvania|Dr. Jie Deng|215-573-2393|jiedeng@nursing.upenn.edu|
22259621|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
22259622|NCT02336737|Endomag|Clinical Develoment Director|+44 7851 247439|mwomack@endomag.com|
22259623|NCT03197064|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
22259624|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501|jose.trigo@camh.ca|30021
22259625|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu|
22259626|NCT00287118|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22259627|NCT02324465|Vanderbilt University Medical Center|Doug Hester|6153439419|doug.hester@vanderbilt.edu|
22259628|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259629|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259630|NCT04543136|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
22259631|NCT02901899|Northwestern University|Daniela Matei, MD|312.472.4684|daniela.matei@northwestern.edu|
22259632|NCT00546390|University of Alb erta|Dr B Finegan|7809701302|bfinegan@ualberta.ca|780
22259633|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
22259634|NCT04684524|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22259635|NCT05120570|Masonic Cancer Center|Punita Grover, MBBS|(612) 273-8383|groverp@umn.edu|
22259636|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu|
22259637|NCT05876091|Roswell Park Comprehensive Cancer Center|Brian Fix|716-845-2300|Brian.Fix@roswellpark.org|
22259638|NCT03402893|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22259639|NCT03466411|J&J Innovative Medicine|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259640|NCT03462719|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22259641|NCT04799158|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT|medicalinformation@phathompharma.com|7426
22259642|NCT00319956|University of Kentucky Medical Center|Dr. Hubert O. Ballard|859-323-1496|hoball2@uky.edu|
22259643|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22259644|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22259645|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
22259646|NCT04041609|Lyra Therapeutics|Lyra Clinical|617-393-4600|lyraclinical@lyratx.com|
22259647|NCT01446913|Yale University School of medicine|Henry Klar Yaggi, MD (PI)|203-785-4163|henry.yaggi@yale.edu|
22259648|NCT01576588|Vilnius University Hospital Santaros Klinikos|Regina Pileckyte, investigator|+370 5 2501384|regina.pileckyte@santa.lt|
22259649|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22259650|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org|
22259651|NCT02626949|Icahn School of Medicine at Mount Sinai|Jeffrey Weiss, PhD, MS|212-824-7575|Jeffrey.Weiss@mountsinai.org|
22274537|NCT02240667|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274538|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
22274539|NCT03569397|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
22274540|NCT01076543|University of Chicago|Dr. Sonali Smith, Professor of Medicine|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
22274541|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179||
22274542|NCT01534273|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259652|NCT00601484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259653|NCT02928848|University of Pennsylvania|Dr. H. Branch Coslett|2156623606|hbc@pennmedicine.upenn.edu|
22259654|NCT00969332|UCLA|Dr. Kara L. Calkins|310-825-9330|KCalkins@mednet.ucla.edu|
22259655|NCT03828461|Stanford University|Carolyn Rodriguez, MD, PhD|650-723-4095|cr2163@stanford.edu|
22259656|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590||
22259657|NCT04523142|Novaliq GmbH|Sonja Krösser|+49 6221 50259|info@novaliq.com|0
22259658|NCT00663871|University of Pittsburgh, Heart and Vascular Institute|Matthew F. Muldoon, MD, MPH|412-624-8798|mfm10@pitt.edu|
22259659|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu|
22259660|NCT03123822|UAB|Katherine Weise|2059752020|kweise@uab.edu|
22259661|NCT03095352|University of California, San Francisco|Dr. Laura Huppert, MD|(415) 476-1000|Laura.Huppert@ucsf.edu|
22259662|NCT01050231|University of California Irvine|Dr David Reinkensmeyer|(949) 824-5218|dreinken@uci.edu|
22259663|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22259664|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
22259665|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com|
22259666|NCT03708211|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22259667|NCT00097695|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22259668|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22259669|NCT05328375|Columbia University Irving Medical Center|Dr. Andrea T. Duran, Assistant Professor of Medical Sciences|212.342.4491|atd2127@cumc.columbia.edu|
22259670|NCT05856123|Mayo Clinic|Deanna Covelli|480-342-5284|covelli.deanna@mayo.edu|
22259671|NCT04849845|MannKind Corporation|Johanna Ulloa|818-661-5000|contact@mannkindcorp.com|
22259672|NCT05514119|Mayo Clinic|Channa Jayasekera, M.D.|480-342-1095|jayasekera.channa@mayo.edu|
22259673|NCT02946385|GlaxoSmithKline|GSK Response Center|866-435-7343|anand.n.harpalani@gsk.com|
22259674|NCT04849988|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
22259675|NCT03185065|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
22259676|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es|
22259677|NCT00590395|Cedars Sinai Medical Center|Alan Waxman, M.D.|310-423-8000|Alan.Waxman@cshs.org|
22291979|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net|
22259678|NCT02708290|ImagiRation LLC|Dr. Andrey Vyshedskiy, Founder|6174338577|vysha@bu.edu|
22259679|NCT03229252|Spyryx Biosciences|Dr. Rob Tarran|919-966-7052|rtarran@spyryxbio.com|
22259680|NCT00278200|Johns Hopkins University|Richard Ambinder, MD, PhD|4109558839|rambind1@jhmi.edu|
22259681|NCT00974493|Oxford University Hospitals NHS Trust|Matthew Scarborough|07872436461|matthew.scarborough@ouh.nhs.uk|
22259682|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu|
22259683|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22259684|NCT02688400|Arthrolab inc.|Dr.Jean-Pierre Pelletier|+1 (514) 992-4939|dr@jppelletier.ca|
22259685|NCT02767388|University of Nebraska Medical Center|David Anderson|402-559-6870|david.anderson@unmc.edu|
22259686|NCT03467477|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22291980|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
22306129|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu|
22259687|NCT03068273|Scripps Health|Athena Philis-Tsimikas|858-678-7077|philis-tsimikas.athena@scrippshealth.org|
22259688|NCT03901573|NeoImmuneTech,INC|Alex Oh|301-337-2283|aho@neoimmunetech.com|
22306130|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu|
22306131|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com|
22306132|NCT02787694|University of Alabama at Birmingham|David A. Brown, PT, PhD|205-975-2788|dbrownpt@uab.edu|
22306133|NCT02525796|Brigham and Women's Hospital|Anand Vaidya|16177325666|anandvaidya@bwh.harvard.edu|
22306134|NCT01199783|Herz- und Diabeteszentrum NRW|PD Dr. Bernd Stratmann|+495731973768|bstratmann@hdz-nrw.de|
22306135|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org|
22306136|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996|nodari@med.unibs.it|587
22306137|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22306138|NCT03624413|Emory University|Brian C. Zanoni, MD|404-727-0284|brian.christopher.zanoni@emory.edu|
22306139|NCT02729701|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
22306140|NCT02477670|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|SDube@avanir.com|
22306141|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259689|NCT03519256|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22259690|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22259691|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
22259692|NCT04637997|University Hospital Erlangen, Vascular Surgery|Dr. med. Antje Mükke|+4991318532968|antje.muekke@uk-erlangen.de|
22259693|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
22259694|NCT02309099|University of North Carolina at Chapel Hill|Dr. Meredith Rooth|919-966-5251|meredith_rooth@med.unc.edu|
22259695|NCT01545076|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22259696|NCT02624843|South Florida Family Health & Research|Elisabeth Rivera|3053870051|elisabeth@sffhrc.com|
22259697|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259698|NCT01031537|Division of Occupational Health and Safety, NIH|Dr. James M. Schmitt|301-496-4411|james_schmitt@nih.gov|
22259699|NCT03238677|Syracuse University|Jonathan Preston|3154433143|jopresto@syr.edu|
22259700|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu|
22259701|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22259702|NCT03194464|VA Northern California Health Care System|Dr. Carolynn Patten (Principal Investigator)|916.724.5029|carolynn.patten@va.gov|
22259703|NCT03594123|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22259704|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22259705|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org|
22259706|NCT02129348|New York State Psychiatric Institute|Davangere Devanand, MD|646.774.8656|dpd3@cumc.columbia.edu|
22259707|NCT02549495|Brigham and Women's Hospital|Daniel Palazuelos, MD, MPH|617-521-3381|dpalazuelos@bwh.harvard.edu|
22306142|NCT02810080|ZOLL|Nathan Burkhart|763.367.0462|nburkhart@zoll.com|
22306143|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22306144|NCT00816751|UC San Diego Health|Jessica M. Kingston, MD|858-249-1204|jkingston@ucsd.edu|
22306145|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
22306146|NCT05174013|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306147|NCT02034916|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306148|NCT01772420|Albert Einstein College of Medicine|Dr. Amit K. Verma|718-430-8761|amit.verma@einsteinmed.edu|
22306149|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org|
22306150|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306151|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306152|NCT05097573|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22306153|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu|
22306154|NCT02507336|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
22306155|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306156|NCT04420195|NYU Langone Health|Tyler C Lewis|646-501-4222|Tyler.lewis@nyulangone.org|
22306157|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu|
22306158|NCT04842604|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22306159|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22306160|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu|
22306161|NCT02503202|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306162|NCT03951649|UAB|Rachel Sinkey|(205) 934-5611|rsinkey@uabmc.edu|
22259708|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu|
22291981|NCT01952470|Alfred Health|Benjamin James Tarrant|+61404455658|b.tarrant@alfred.org.au|
22291982|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org|
22291983|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu|
22291984|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com|
22291985|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22291986|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22291987|NCT05419999|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6700|straud@uthscsa.edu|
22291988|NCT02782923|NYU Langone Madison Avenue Orthopaedics|Yong H. Kim, MD|212-427-3986|Yong.Kim@nyulangone.org|
22291989|NCT02418156|Aziyo Biolgics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
22291990|NCT03368118|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
22291991|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22291992|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590||
22291993|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu|
22291994|NCT03436563|M D Anderson Cancer Center|Dr. Van Morris|713-792-2828|vkmorris@mdanderson.org|
22291995|NCT02882074|Cleveland Clinic|Dr. Marta Kelava|2162133218|kelavam@ccf.org|
22291996|NCT03682809|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22291997|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com|
22306163|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu|
22291998|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu|
22291999|NCT01869725|University of Iowa|M. Sue O'Dorisio, MD, PhD|319-335-7234|sue-odorisio@uiowa.edu|
22292000|NCT03416374|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22292001|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
22292002|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org|
22292003|NCT01251744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292004|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu|
22292005|NCT01323946|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292006|NCT05078138|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@health.mil|
22292007|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22292008|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300||
22292009|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com|
22292010|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22292011|NCT03533686|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
22292012|NCT02632838|School of Nursing, Rutgers, the State University of New Jersey|Dr. Peijia Zha|7327637412|peijiaz@sn.rutgers.edu|
22306164|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306165|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO|jayne.prats@themedco.com|1510
22292013|NCT02797054|University of Colorado|Julie A Maertens|303-724-7319|julie.maertens@ucdenver.edu|
22292014|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu|
22292015|NCT03221764|University of Louisville|Dr. Victor van Berkel|502-588-7600|victor.vanberkel@ulp.org|
22259709|NCT03276975|Duke University Medical Center|Timothy J. Amrhein, MD|9196841909|timothy.amrhein@duke.edu|
22259710|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259711|NCT03111147|William Beaumont Hospitals|Pamela Sloan, Clinical Research Manager|248-551-6059|pamela.sloan@corewellhealth.org|
22259712|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu|
22259713|NCT02779855|Moffitt Cancer Center|Hatem Soliman, MD|813-745-4985|hatem.soliman@moffitt.org|
22259714|NCT06310005|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259715|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22259716|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
22259717|NCT02581345|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
22259718|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com|
22259719|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22259720|NCT02258256|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22259721|NCT03392974|BioMarin Pharmaceutical Inc.|Medical Manager, Clinical Science|415-996-2917|divya.reddy@bmrn.com|
22259722|NCT03012477|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22259723|NCT02819362|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22259724|NCT05456529|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22259725|NCT02518113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22259726|NCT02710123|SUNY Buffalo|John Leddy MD|7162043200|leddy@buffalo.edu|
22259727|NCT02433665|Duke University Medical Center|Dr. Daniele Marin|919.684.7709|daniele.marin@duke.edu|
22259728|NCT02456532|Henry Ford Health System|Timothy Roehrs|13138026681|troehrs1@hfhs.org|
22259729|NCT02750761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259730|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22259731|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259732|NCT03256799|UAB|Steven M. Rowe|205-975-9776|smrowe@uab.edu|
22259733|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22306166|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com|
22259734|NCT02374918|University of Arizona|"Dr. William Scott Killgore"|(520) 621-0605|killgore@psychiatry.arizona.edu|
22259735|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu|
22259736|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259737|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com|
22259738|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22259739|NCT02362594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259740|NCT03803943|Northwestern University|Megan Roberts|(847) 491-3066|megan.y.roberts@northwestern.edu|
22259741|NCT02922868|Wake Forest|Dr Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
22259742|NCT01781286|University of Missouri|Dr. Heather Leidy|(573) 882-4288|leidyh@health.missouri.edu|
22259743|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
22306167|NCT04089488|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22306168|NCT02148133|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22306169|NCT03808883|Case Western Reserve University|Sarah Fulton, MA, RA, Begun Center, Jack, Joseph and Morton Mandel School of Applied Social Science|216-368-0429|sarah.fulton@case.edu|
22306170|NCT04628572|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306171|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu|
22306172|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22306173|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306174|NCT04365400|Afimmune|Study Director|+3532946380|info@afimmune.com|
22306175|NCT00612586|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306176|NCT02613364|University of Rochester Medical Center|Dr. Karen Mustian, Study PI|585-275-0557|karen_mustian@urmc.rochester.edu|
22306177|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com|
22306178|NCT01235949|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306179|NCT03743246|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22306180|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22306181|NCT02534350|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22306182|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu|
22306183|NCT00716144|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306184|NCT01568918|Mayo Clinic|Michelle Clarke, M.D.|(507) 284-5317|Clarke.Michelle@mayo.edu|
22306185|NCT04301986|UNC Center for Esophageal Diseases & Swallowing|Ariel E. Watts, Assistant Director of Clinical Trial Operations|919-962-7316|ariel_watts@med.unc.edu|
22259744|NCT03365375|Indiana University|Paul Musey|317-880-3900|pmusey@iu.edu|
22259745|NCT02187042|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259746|NCT05343156|Oculis SA|Bastian Dehmel, Chief Development Officer|0041 21 711 39 70|bastian.dehmel@culis.com|
22259747|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com|
22259748|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu|
22292016|NCT02721979|University of Washington|Dr. Michael Schweizer|(206) 606-6252|schweize@uw.edu|
22292017|NCT02398409|VHA|Dr. Virginia (Daggett) Wilder|307-675-3659|virginia.wilder@va.gov|
22292018|NCT03370289|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22292019|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22292020|NCT02140775|New York State Psychiatric Institute|Dr. Martin McElhiney|646.774.8035|mcelhin@nyspi.columbia.edu|
22292021|NCT03696927|Abilitech Medical|Director of Clinical and Product Management|833.225.3123|info@abilitechmedical.com|
22292022|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu|
22292023|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com|
22292024|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu|
22292025|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu|
22292026|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292027|NCT04812080|University of California Davis|Dr. Moon Chen|916-734-1191|mschenjr@ucdavis.edu|
22292028|NCT04811573|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22292029|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22292030|NCT06309407|Oregon Health and Science University|Dr. Sandy Christiansen|2038092318|chrissan@ohsu.edu|
22292031|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
22292032|NCT04650854|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22292033|NCT01987401|Department of Veterans Affairs, Office of Research and Development|Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program|2067642773|nicholas.smith@va.gov|
22292034|NCT04859114|Medical College of Wisconsin|Mir A Basir|4142666820|mbasir@mcw.edu|
22292035|NCT02376283|The Royal Wolverhampton NHS Trust|Prof James Cotton|01902307999|jamescotton@nhs.net|
22292036|NCT02378025|Veterans Affairs Palo Alto Healthcare System|Dr. Peter Bayley|650 493-5000|peter.bayley@va.gov|
22292037|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22292038|NCT02495103|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
22292039|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu|
22292040|NCT04867434|Raziel Therapeutics|Dr. Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
22292041|NCT01982331|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22292042|NCT03500679|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22292043|NCT04186481|Smith+Nephew, Inc.|Alison Walker, Regional Operation Manager ANZ|+61 466 322 200|Alison.walker@smith-nephew.com|
22292044|NCT00744471|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292045|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22292046|NCT04706416|Valley Baptist Medical Center|Dr. Ameer Hassan|973-303-8146|ameerehassan@gmail.com|
22292047|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu|
22292048|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com|
22292049|NCT01616082|Translational Research Institute for Metabolism and Diabetes|Dr. Steven R. Smith|407-303-7115|steven.r.smith.md@flhosp.org|
22292050|NCT05281601|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292051|NCT03737851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22292052|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
22292053|NCT03496571|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22292054|NCT05223335|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
22292055|NCT04638673|Medical University of South Carolina|Dr. Mark S. George|843-876-5142|georgem@musc.edu|
22292056|NCT03119701|Faron Pharmaceuticals Ltd|Chief Medical Officer|+3584005529411|medical@faron.com|
22292057|NCT02691962|Becton Dickinson and Company|Dawn Heimer|+1-401-825-8681|Dawn.Heimer@bd.com|
22292058|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org|
22292059|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu|
22292060|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
22292061|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213|thanyasang@yahoo.com|7150
22292062|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu|
22292063|NCT03187756|Perlmutter Cancer Center, NYU Langone Health|David Kaminetzky, MD|212-731-5855|David.Kaminetzky@nyulangone.org|
22292064|NCT04090957|Estetra SRL|Clinical Study Leader|+3243254451|clinical.trials@estetra.com|
22320307|NCT05335356|Biocon Biologics Limited|Dr Sarika D|080 2808|Sarika.Deodhar@biocon.com|5302
22259749|NCT03019965|CISMexico|Dr. Yazmín Fuentes|55276900|yazmin_fuentes@hotmail.com|22462
22292065|NCT01909453|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292066|NCT03172910|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
22292067|NCT04088656|University of Washingtion|Carmen Hazim|4042451459|chazim@uw.edu|
22292068|NCT02247531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22292069|NCT03092024|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
22292070|NCT04879225|Wake Forest University School of Medicine|Emily Harwood|8284067599|eaharwoo@wakehealth.edu|
22292071|NCT02285283|The University of Texas Health Science Center at Houston|Amber U. Luong, MD, PhD|713-486-5000|Amber.U.Luong@uth.tmc.edu|
22292072|NCT02661711|Moorfields Eye Hospital|Tumelo Kaminskas|02072533411|moorfields.resadmin@nhs.net|2036
22292073|NCT01337687|Montefiore Medical Center, Albert Einstein College of Medicine|Casara Jean Ferretti|3472499694|cferrett@montefiore.org|
22292074|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22292075|NCT04457973|University of Arizona|Dr. Hyochol Ahn|520-626-1769|hbrian@arizona.edu|
22292076|NCT01810432|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292077|NCT00214500|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22292078|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22292079|NCT03170232|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292080|NCT00147251|MedStar Research Institute|Barbara V Howard|301-560-7305|barbara.v.howard@medstar.net|
22292081|NCT02537574|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22292082|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445||
22292083|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
22292084|NCT03343067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22292085|NCT00542451|Dana Farber Cancer Institute|SARA TOLANEY, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
22292086|NCT01287078|National Heart Lung and Blood Institute|Dr Richard Childs|301-451-7128|childsr@nhlbi.nih.gov|
22292087|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
22292088|NCT05153473|CHU de Poitiers|Dr Louis Etienne GAYET|+33(0)5.49.44.44.92|Louis-Etienne.GAYET@chu-poitiers.fr|
22292089|NCT01828515|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22292090|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu|
22292091|NCT05014490|"PrJSC Pharmaceutical Firm Darnytsia"|Andrii Doroshenko, PhD, MD|+38 044 207 73 53|a.doroshenko@darnytsia.ua|
22292092|NCT00245583|Icahn School of Medicine at Mount Sinai|Dr. Heather Berlin|212-241-4761|heather.berlin@mssm.edu|
22292093|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com|
22292094|NCT02017171|Joslin Diabetes Center|Dr. Alessandro Doria (Sponsor and PI of the study)|617-319-0970|alessandro.doria@joslin.harvard.edu|
22292095|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266||
22292096|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it|
22292097|NCT02139800|Children's Hospital of Philadelphia (CHOP)|Dr. Haresh Kirpalani|215-590-2455|kirpalanih@email.chop.edu|
22292098|NCT01172275|Yale University|Dr. Michael H. Bloch|203-737-4809|michael.bloch@yale.edu|
22292099|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357|markgmidei@gmail.com|410
22292100|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov|
22292101|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22292102|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22292103|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org|
22292104|NCT04437368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22292105|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600|eric.winquist@lhsc.on.ca|53243
22292106|NCT04271280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22292107|NCT00495131|National Taiwan University Hospital|Chen-Hua Liu, MD|886223123456|jacque_liu@mail2000.com.tw|63572
22292108|NCT03224546|University of Kentucky|William W. Stoops|859-257-5383|william.stoops@uky.edu|
22292109|NCT02034422|Salt Lake City VAMC|Joel Trinity, PhD|801-582-1565|joel.trinity@va.gov|1794
22292110|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu|
22292111|NCT04223232|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
22292112|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu|
22292113|NCT04616027|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292114|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL|
22292115|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
22292116|NCT00901927|The University of Texas (UT) MD Anderson Cancer Center|Nathan Fowler/Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
22306186|NCT02341625|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22306187|NCT03396913|Lumenis|Yair Manor, Clinical Director|+972-52-3763416|yair.manor@lumenis.com|
22306188|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu|
22306189|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590||
22306190|NCT03772964|University of Pittsburgh|Dr. Brian Zuckerbraun|(412) 647-3065|zuckerbraunbs@upmc.edu|
22306191|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000|Matthew.Boden@va.gov|27529
22306192|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org|
22306193|NCT01278862|3M HCBG Clinical Operations|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
22306194|NCT04520165|CHU-Uliege|Dr Florence Schleich|003243667881|fschleich@chuliege.be|
22306195|NCT02952261|Shanghai Pulmonary Hospital affiliated to Tongji university|Dr. Chang Chen|+86 13816869003|chenthoracic@163.com|
22306196|NCT05233085|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22306197|NCT03284957|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22306198|NCT01613118|Travere Therapeutics, Inc.|Jula Inrig, MD|1-445-529-6312|Jula.Inrig@travere.com|
22306199|NCT03169244|University of North Carolina at Chapel Hill|James C. Garbutt, MD|919-445-0205|jc_garbutt@med.unc.edu|
22306200|NCT00178399|University of Rochester|Michael Milano|585-273-4096|michael_milano@urmc.rochester.edu|
22306201|NCT02631148|Brigham and Women's Hosptial|Dr. Ciaran McMullan|617 732 5500|mcmullcj@gmail.com|
22306202|NCT03686813|Duke University|Richard Moon, M.D.|919-684-8762|richard.moon@duke.edu|
22306203|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
22259750|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22259751|NCT01491620|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22259752|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
22306204|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com|
22306205|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22306206|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com|
22306207|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22306208|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org|
22306209|NCT04035668|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22306210|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
22306211|NCT02385669|University of Virginia|Craig L. Slingluff, Jr. MD|434-924-9311|cls8h@virginia.edu|
22306212|NCT00004124|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|(206) 667-4623|ctangen@fredhutch.org|
22306213|NCT02937831|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22306214|NCT03426228|Fakih IVF|Dr. Ayla Coussa|+971501403866|A.coussa@warwick.ac.uk|
22306215|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22306216|NCT02200523|Cleveland Medical Devices|Sarah Weimer|216-791-6720|sweimer@clevemed.com|
22306217|NCT04763044|Procter & Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22306218|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com|
22306219|NCT03262935|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
22306220|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu|
22306221|NCT03557008|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22306222|NCT00701896|Ohio State University|Dr. Philip Diaz|6142934925|diaz.3@osu.edu|
22306223|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306224|NCT02224924|Memorial Sloan Kettering Cancer Center|Dr. Amgad Moussa MD|212-639-3690|moussaa@mskcc.org|
22306225|NCT00590707|Johns Hopkins|frederick Sieber|410-550-0942|fsieber1@jhmi.edu|
22306226|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306227|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22306228|NCT01329328|University of Verona|Prof. Carlo Zancanaro|+390458027155|carlo.zancanaro@univr.it|
22306229|NCT02242773|University of Miami|Sanoj Punnen, MD|+1 (305) 2436596|s.punnen@med.miami.edu|
22306230|NCT04439799|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-6596|Ramasamy@miami.edu|
22306231|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306232|NCT05565391|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306233|NCT04296227|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
22306234|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306235|NCT01891968|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD|713-745-3428|CR_Study_Registration@mdanderson.org|
22306236|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
22259753|NCT01569451|University of Colorado|Stefan Sillau|303-724-8657|stefan.sillau@ucdenver.edu|
22259754|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
22306237|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu|
22306238|NCT03399370|The Medicines Company|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
22306239|NCT01161498|Amgen, Inc.|Study Director|866-572-6436||
22259755|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259756|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu|
22259757|NCT03552757|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22259758|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351||
22259759|NCT02192099|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22259760|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259761|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu|
22259762|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22259763|NCT02334059|Penn State Health Anesthesiology and Perioperative Medicine|Sanjib D Adhikary|717-531-6597|sadhikary1@pennstatehealth.psu.edu|
22259764|NCT02019940|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
22259765|NCT01598701|University of Texas Health Science Center at Houston|Carlos Artime, MD|713-500-6200|Carlos.Artime@uth.tmc.edu|
22259766|NCT01862328|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22259767|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu|
22259768|NCT00440596|Kent State University|Joel Hughes|330-672-7721|jhughes1@kent.edu|
22259769|NCT01592799|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259770|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22259771|NCT02486796|Midwestern Regional Medical Center, Inc.|Director of ClinicalResearch|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
22259772|NCT02114307|Imperial College London|Dr Tristan Lane|02033117317|tristan.lane@imperial.ac.uk|
22259773|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22259774|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259775|NCT00630565|University of Minnesota, Masonic Cancer Center|Dr. Daniel Weisdorf, MD|+1 612-624-3101|weisd001@umn.edu|
22259776|NCT03384745|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22259777|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu|
22259778|NCT02984683|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|option 6
22259779|NCT03131999|Medical University of South Carolina|Charlton Strange, MD|843-792-3174|strangec@musc.edu|
22259780|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290|mlongphre@orieltherapeutics.com|114
22259781|NCT04634409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22259782|NCT02683187|Duke University Medical Center|Dr. David D'Alessio|919-684-5778|david.d'alessio@duke.edu|
22259783|NCT05665595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22259784|NCT01768858|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22259785|NCT02122796|Allina Health|Director of Integrative Health Reseach Center|612-262-2354|jeffery.dusek@allina.com|
22259786|NCT01581970|Masonic Cancer Center, University of Minnesota|Dr. Gautam Jha|612-624-5373|jhaxx014@umn.edu|
22259787|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22259788|NCT03471078|Dova|VP of Global Drug Development|9193387864|clinical@dova.com|
22259789|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259790|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it|
22259791|NCT05381948|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
22259792|NCT04471207|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
22259793|NCT06046482|The University of Texas MD Anderson Cancer Center|Renata Ferrarotto, MD|(713) 745-6774|rferrarotto@mdanderson.org|
22259794|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22259795|NCT03702621|Indiana University|Dr. Yar Luan Yeap|317-274-0275|yyeap@iupui.edu|
22259796|NCT02402166|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22259797|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259798|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org|
22259799|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu|
22259800|NCT02433678|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
22259801|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22259802|NCT02684578|University of California, San Francisco|Dr. Jay Stewart|628-206-3123|jay.stewart@ucsf.edu|
22259803|NCT01505530|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259804|NCT03622658|Kinevant Sciences Inc. on behalf of Kinevant Science GmbH|Dr. Simon Lowry, Chief Medical Officer|646-495-5368|simon.lowry@roivant.com|
22259805|NCT03104205|Dartmouth-Hitchcock|John A. Batsis|6036505000|john.a.batsis@hitchcock.org|
22259806|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
22259807|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com|
22259808|NCT00625807|Massachusetts General Hospital|Sara Lazar|617-724-2256|slazar@mgh.harvard.edu|
22259809|NCT03267264|Becton Dickinson|Michael Gibney|201-847-6170|michael_gibney@bd.com|
22259810|NCT01802879|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22259811|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22259812|NCT01933295|Henry Ford Health|Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
22259813|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
22259814|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012||
22274543|NCT01619865|University of Iowa Holden Comprehensive Cancer Center|Sue O'Dorisio, MD, PhD|319-356-7873|sue-odorisio@uiowa.edu|
22274544|NCT03586050|ETHICON|Jaclyn Calia Stanziola|908-808-6380|jcalia@its.jnj.com|
22274545|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
22306240|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu|
22306241|NCT05819190|Pharmndev Experts|Dr Bernard Gout Organization|+41798659000|Email:bgout@pharmndev.ch|
22306242|NCT03310983|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
22306243|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
22306244|NCT03468920|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22306245|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306246|NCT03523091|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@beaumont.org|
22306247|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs - Urology||clinicaltrials@us.astellas.com|
22306248|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22306249|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22306250|NCT02885311|Northwell Health|Dr. Jonathan Morgenstern|(516) 837-1694|jmorgenste@northwell.edu|
22306251|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca|
22306252|NCT03863834|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
22306253|NCT02685488|University of Arizona|Dr. John J.B. Allen|(520) 621-7448|john.jb.allen@arizona.edu|
22306254|NCT04436120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306255|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306256|NCT03386929|Worldwide Innovative Network (WIN) Association|Fanny Wunder, Project Manager|0033604090029|fanny.wunder@winconsortium.org|
22306257|NCT03538054|The University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
22306258|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG|
22306259|NCT02351180|Washington University in St. Louis|Ramsey Hachem, MD|3144548766|rhachem@wustl.edu|
22306260|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22306261|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22306262|NCT03545984|Cleveland Clinic|Dr. Maged Argalious|+12164452064|ARGALIM@ccf.org|
22306263|NCT03418324|Cedars-Sinai Medical Center|Edwin Posadas, MD|310-423-7600|Edwin.Posadas@cshs.org|
22306264|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200||
22306265|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22306266|NCT03121950|The Ohio State University|Deb Kegelmeyer|614-293-0214|kegelmeyer.1@osu.edu|
22306267|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306268|NCT05147233|OCULIS Operations SàrI|Sharon Klier, M.D., M.S., M.P.H, Chief Development Officer|+41 21 711 3970|info@oculis.com|
22306269|NCT04513522|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22306271|NCT04517864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306272|NCT04541303|Univ of Mo|Brianna Castillo MD|813-765-1619|briannacastillo.md@gmail.com|
22306273|NCT04722003|Emory University Vaccine and Treatment Evaluation Unit (VTEU)|Varun K. Phadke, MD|404-712-9046|varun.phadke@emory.edu|
22306274|NCT03351075|KU Leuven|Prof. An De Groef|+32 16 342 171|an.degroef@kuleuven.be|
22259815|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu|
22306275|NCT05219253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259816|NCT01946165|UT MD Anderson Cancer Center|Christopher J. Logothetis M.D. / Genitourinary Medical Oncology|713-792-2830|clogothe@mdanderson.org|
22259817|NCT01901055|University of Pittsburgh|Eileen R. Chasens, PhD, Professor of Nursing|412-624-9380|chasense@pitt.edu|
22259818|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306276|NCT03086369|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22306277|NCT03544515|Columbia University College of Dental Medicine|Philip Y. Kang, DDS|212-342-5244|pyk2104@cumc.columbia.edu|
22306278|NCT02630719|Truman Medical Center|Sean Gratton MD|816-404-5275|sean.gratton@tmemed.org|
22306279|NCT04218110|Eurofins EVIC|Commercial Manager|+40 213357090|luciachirita@eurofins.com|
22306280|NCT02698891|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-3800|nlin@partners.org|
22306281|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
22306282|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu|
22306283|NCT01867216|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306284|NCT03020745|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306285|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu|
22306286|NCT02452918|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
22306287|NCT02513238|Rigshospitalet|Principal Investigator, Mesrix|26276374|c.gronhoj@gmail.com|
22306288|NCT03622580|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306289|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22306290|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com|
22306291|NCT03959241|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22306292|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22259819|NCT02983448|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|405-271-4742|stavros-stavrakis@ouhsc.edu|37507
22306293|NCT03939819|Emory University|Dr. Elizabeth Hechenbleikner|404-778-3712|elizabeth.hechenbleikner@emory.edu|
22306294|NCT03987451|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22306295|NCT03368937|University of Virginia|Sue Brown|434-982-0206|sab2f@virginia.edu|
22306296|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259820|NCT04582396|Columbia University|Dr. Sachin Agarwal|2123421335|sa2512@cumc.columbia.edu|
22259821|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
22259822|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930|yjchen@tmu.edu.tw|2543
22259823|NCT01586741|Karolinska University Hospital|D. Peter Emanuelsson|+46851770000|peter.emanuelsson@sll.se|
22259824|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259825|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu|
22259826|NCT01325207|Northwestern University|Jeffrey Raizer, MD||Jeffrey.Raizer@nm.org|
22259827|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22259828|NCT01254409|Promedior, Inc.|Dr. Bernt van den Blink|781-538-4203|bvandenblink@promedior.com|
22259829|NCT03309449|SUNY Upstate Medical University|William Eggleston|315-464-8906|egglestw@upstate.edu|
22259830|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu|
22259831|NCT02356471|Wake Forest University Health Sciences|Dr. Clancy Clark|336-716-7207|cjclark@wakehealth.edu|
22259832|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu|
22259833|NCT02114697|Emory University|John Oshinski PhD|404-727-5894|jnoshin@emory.edu|
22259834|NCT03312257|Ohio State University|Jeffrey Walline|614-247-6840|walline.1@osu.edu|
22259835|NCT04558554|Fred Hutchinson Cancer Center|Katrina Ortblad|206.667.7267|kortblad@fredhutch.org|
22259836|NCT02660242|Jaeb Center for Health Research|Stephanie DuBose|813.975.8690|sdubose@jaeb.org|
22259837|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22259838|NCT04087395|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
22259839|NCT02796664|Asan Medical Center|Dr. Dae Chul Suh|+82-2-3010-4366|dcsuh@amc.seoul.kr|
22259840|NCT02246478|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22259841|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu|
22259842|NCT01626079|Abbott|Sripad Bellary|4088458114|sripad.bellary@abbott.com|
22259843|NCT01709032|Children's Hospital of Philadelphia|Janet Kwiatkowski, MD|215-590-3437|kwiatkowski@email.chop.edu|
22259844|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22259845|NCT02566135|Medical College, Baroda.|Dr Aditi Amrutlal Dhimar|09825334605|dhimaraditi@yahoo.in|
22259846|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22259847|NCT00429923|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
22259848|NCT01265784|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
22259849|NCT03644095|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22259850|NCT03740165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22259851|NCT03049618|University of Southern California|Victoria Soto|323-865-3441|victoria.soto@med.usc.edu|
22259852|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259853|NCT03387033|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
22259854|NCT02785913|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22259855|NCT03717064|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22259856|NCT01298570|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22259857|NCT01929109|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22259858|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
22259859|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu|
22259860|NCT03724149|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
22259861|NCT02180711|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22259862|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu|
22259863|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22259864|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306297|NCT03253913|University of Cincinnati|Nishant Gupta, MD|5135584831|nishant.gupta@uc.edu|
22259865|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com|
22259866|NCT05920161|Yale School of Medicine|Elizabeth Goldfarb, PhD|203-737-6365|elizabeth.goldfarb@yale.edu|
22259867|NCT02742090|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22306298|NCT02194933|Otsuka Data Transparency Organization|Global Clinical Development||DT-inquiry@otsuka.jp|
22306299|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com|
22306300|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org|
22306301|NCT02807493|University of Minnesota|James Gambucci|612-625-7448|gambu001@umn.edu|
22306302|NCT05190419|UNION therapeutics A/S|UNION therapeutics A/S|+4561777435|clinicaltrials@uniontherapeutics.com|
22306303|NCT02020616|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306304|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu|
22306305|NCT05019729|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22306306|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu|
22306307|NCT03008915|Columbia University|Dr. Carrie Pistenmaa|212-342-4162|"cp2346@atcumc.columbia.edu"|
22306308|NCT04318444|Columbia University|Jon T. Giles, MD|212-305-6327|jtg2122@cumc.columbia.edu|
22306309|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22306310|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22306311|NCT04173962|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-4640|james.murrough@mssm.edu|
22306312|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306313|NCT02289560|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-630-9900|nadira@insightec.com|
22306314|NCT02908464|Beth Israel Deaconess Medical Center|Brian O'Gara, MD, MPH|617-754-3189|bpogara@bidmc.harvard.edu|
22306315|NCT01264718|Medica Research Institute|Dr. Glenn Flores, Distinguished Chair of Health Policy Research|952-992-3367|Glenn.Flores@medica.com|
22306316|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org|
22306317|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com|
22306318|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22306319|NCT00387465|SKCCC|John Wrangle, MD|843-792-7789|wrangle@musc.edu|
22306320|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu|
22306321|NCT02754479|DuPage Medical Group|Kelly Stankiewicz, MD FAAD|(630) 547-5040|kjstanki@gmail.com|
22306322|NCT03183518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306323|NCT02132702|Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen|Carsten Bach Baunsgaard|1111111111|carsten.bach.baunsgaard@regionh.dk|
22306324|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
22259868|NCT02303548|Asan Medical Center|Director of Clinical Trials|8230103350|wonpia73@naver.com|
22259869|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
22259870|NCT02016300|Stanford University|Jason Dragoo, MD|650-721-3430|jdragoo@stanford.edu|
22259871|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu|
22259872|NCT05301751|Allgenesis Biotherapeutics Inc.|Tan Nguyen, Vice President of R&D|+886-2-87871232|tan.nguyen@allgenesis.com|105
22259873|NCT04815863|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
22259874|NCT06165744|Alcon Research, LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22259875|NCT01546987|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22259876|NCT02270736|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22259877|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259878|NCT02134756|University of South Florida|Marcus Kilpatrick|(813) 362-6696|mkilpatrick@usf.edu|
22259879|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu|
22259880|NCT06132919|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2therapeutics.com|
22259881|NCT02132247|IBSA Pharma Inc.|Christopher Jones, Ph.D.|(202) 753-6475|chris.jones@ibsapharma.com|7005
22259882|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu|
22259883|NCT04908748|Teikoku Seiyaku Co.,Ltd.|Hirofumi Fujiwara|+81362649123|hirofumi-fujiwara@teiyaku.co.jp|
22259884|NCT04373434|Emory University|Michelle C. Kegler, MPH, DrPH|404-712-9957|mkegler@emory.edu|
22259885|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
22259886|NCT02446132|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|clinicaltransparency@otsuka-us.com|
22259887|NCT03444038|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22259888|NCT00231868|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8082|DYKUO@montefiore.org|
22259889|NCT02354586|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259890|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259891|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com|
22259892|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259893|NCT01424722|Abbott Medical Devices|Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22259894|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259895|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22259896|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22259897|NCT00939653|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22259898|NCT01556009|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
22259899|NCT03879239|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
22259900|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259901|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22259902|NCT04763876|William Beaumont Army Medical Center Department of Emergency Medicine|Nathaniel James Turner|915-742-6228|nathaniel.j.turner3.mil@mail.mil|
22259903|NCT03179345|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22259904|NCT02585700|Clinical Center of Serbia-Clinic for Infectious and Tropical Diseases|Dr. Goran Stevanovic|+381 64 1703059|goran_ste@yahoo.com|
22259905|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22259906|NCT00290745|Duke University and Duke Cancer Institute|Dr. E. Shelly Hwang, MD, MPH|(919) 684-6849|shelley.hwang@duke.edu|
22259907|NCT02226796|University of Minnesota Duluth|Sharyl Samargia-Grivette|218-726-8347|samargia@d.umn.edu|
22259908|NCT02511236|University of Miami Miller School of Medicine|David J. Lee|305-243-9680|dlee@med.miami.edu|
22259909|NCT02224391|UT MD Anderson Cancer Center|Dr. Jason Robinson, PHD- Associate Professor, Behavioral Science|(713) 792-0919|jdrobinson@mdanderson.org|
22259910|NCT02492958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259911|NCT03522948|Boston University|Tibor Palfai|617-353-9345|palfai@bu.edu|
22259912|NCT03718455|Mayo Clinic|Genevieve A. Woodard, M.D., Ph.D.|507-538-3945|Woodard.Genevieve@mayo.edu|
22259913|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu|
22259914|NCT01948505|Pacific Neuroscience Institute|Dr. Walavan Sivakumar|424-212-5361|walavan.sivakumar@gmail.com|
22259915|NCT00424489|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
22259916|NCT01984242|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22259917|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259918|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
22259919|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
22259920|NCT02348385|Yale|Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
22259921|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu|
22259922|NCT02115646|MGH Wellman Center|Kachiu Lee, MD|4018303128|klee52@partners.org|
22259923|NCT01089647|University of Cincinnati|Dr. Ann Romaker|513-475-7500|romakean@ucmail.uc.edu|
22259924|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov|
22274546|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
22292117|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org|
22259925|NCT02001558|University of Alabama at Birmingham|Yuying Chen, MD, PhD|205-934-3329|yuyingchen@uabmc.edu|
22259926|NCT04117607|ICON CRU|Dr. Dennis Ruff, Senior Medical Director|210-283-4572|Dennis.Ruff@iconplc.com|
22259927|NCT02327195|The Ohio State University Wexner Medical Center|Nicoleta Stoicea|614-293-3559|nicoleta.stoicea@osumc.edu|
22259928|NCT04026126|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
22259929|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu|
22259930|NCT02073643|Rush University Medical Center|Brad Appelhans, PhD|312-942-3477|brad_appelhans@rush.edu|
22259931|NCT02532010|Weill Cornell Medicine|Dr. Sangmin Lee|646-962-2700|sal9053@med.cornell.edu|
22259932|NCT04333095|Baylor Scott & White Research Institute|Sarah Hale, Project Manager|469-814-4845|Sarah.Hale@BSWHealth.org|
22259933|NCT02364557|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22259934|NCT04347239|CytoDyn Inc.|Bernie Cunningham, PhD, MRPharmS; VP Operations|5164060197|bcunningham@cytodyn.com|
22259935|NCT06052566|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22259936|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com|
22259937|NCT00788957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22259938|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
22259939|NCT00966953|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22259940|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259941|NCT02841709|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
22259942|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259943|NCT00788125|City of Hope National Medical Center|Dr. Judith Sato|626-218-5430|jsato@coh.org|
22259944|NCT03165058|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
22259945|NCT03252964|Savvysherpa, Inc.|Jared Jones, PhD|7635493540|JaredJones@savvysherpa.com|8116
22259946|NCT04526210|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22259947|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu|
22259948|NCT02637232|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
22306325|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306326|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org|
22306327|NCT05052983|Galderma Research & Development|Sponsor|(817) 961-5000|clinical.studies@galderma.com|
22306328|NCT04493242|Direct Biologics, LLC|Dr. Amy Lightner|512-354-7124|alightner@directbiologics.com|
22306329|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22306330|NCT03175172|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
22306331|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22306332|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623||
22306333|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
22306334|NCT02496702|Technical University of Denmark, Center for Playware|Jari Due Jessen|+45 45 25 39 29|jdje@elektro.dtu.dk|
22306335|NCT02694835|Alcon, A Novartis Division|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22306336|NCT00446550|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
22306337|NCT02983617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22306338|NCT02860286|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
22306339|NCT02027558|VA Greater Los Angeles Healthcare System|Cathy Alessi, MD|818-891-7711|Cathy.Alessi@va.gov|39311
22306340|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|
22306341|NCT04238429|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
22306342|NCT02694978|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22306343|NCT03848910|Hearing CRC Melbourne|Professor Robert Cowan|+61 3 9035 5347|r.cowan@unimelb.edu.au|
22306344|NCT03675581|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306345|NCT00807144|Imperial College Healthcare NHS Trust|Adam McLean|+44 020 8383 5164|adammclean@nhs.net|
22306346|NCT00989937|UCSD|David Feifel||dfeifel@kadimanp.com|
22306347|NCT02567656|Rhizen Pharmaceuticals S.A.|Prajak Barde MD|+41 32 580 0113|pjb@rhizen.com|
22306348|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu|
22306349|NCT01616654|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22306350|NCT02057692|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22306351|NCT03923491|Brown University School of Public Health|Dr. Alison Tovar|401-863-7327|alison_tovar@brown.edu|
22306352|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|100
22306353|NCT02633358|China Medical University Hospital, Taichung, Taiwan|Dr. Da-Long Chen, director of cardiac intensive care unit|0952122027|my686chen@gmail.com|
22306354|NCT03823300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306355|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu|
22306356|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22306357|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
22259949|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu|
22306358|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
22292118|NCT02239627|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22292119|NCT00484718|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292120|NCT01702571|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22292121|NCT03004443|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
22292122|NCT00828854|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
22292123|NCT04221230|Neumora Therapeutics, Inc.|Study Contact|+1- (857) 760-0900|clinicaltrials@neumoratx.com|
22292124|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com|
22292125|NCT03425019|The University of Texas Health Science Center at Houston|Hyochol Ahn|(713) 500-2179|hahn@fsu.edu|
22292126|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292127|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22292128|NCT04350606|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292129|NCT01753739|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22292130|NCT05211284|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22292131|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400|mohammad.amin2@va.gov|2469
22292132|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com|
22292133|NCT02595996|Columbia University Irving Medical Center|June K. Wu, MD|212-342-3704|jw92@cumc.columbia.edu|
22292134|NCT00395538|Rho, Inc|Robert James|(919) 595-6468|robert_james@rhoworld.com|
22292135|NCT05140382|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292136|NCT04070144|Injeq|Chief Scientific Officer|+358405805944‬|info@injeq.com|
22292137|NCT01397201|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292138|NCT00122278|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22292139|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr|
22292140|NCT03861611|Montefiore Medical Center|Eddie Irizarry, MD|718-904-2104|eddiriza@montefiore.org|
22292141|NCT02598960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22292142|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de|
22292143|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22292144|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com|
22292145|NCT03402659|EIP Pharma|Jennifer Conway, Associate Director of Clinical Development|(617) 744-4400|jconway@eippharma.com|
22292146|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22292147|NCT03403374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22292148|NCT02128828|University of Hawaii|Dr. Cecilia Shikuma|808 692-1328|shikuma@hawaii.edu|
22292149|NCT03257696|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Camille Bonnin|+0546455050|camille.bonnin@ght-atlantique17.fr|
22292150|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com|
22292151|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509||
22292152|NCT03646643|University of Pennsylvania|Dr. Saman Nazarian|215-615-5220|Saman.Nazarian@pennmedicine.upenn.edu|
22292153|NCT02806973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292154|NCT02840240|Cleveland Clinic|Fabio Rodriguez|216444-9950|rodrigf3@ccf.org|
22292155|NCT04209426|Medextens SARL|Frederic C Daoud, M.D., M.Sc., Epidemiologist-Biostatistician|+33964281703|fcdaoud@medextens.com|
22292156|NCT04060862|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22292157|NCT03051646|Columbia University Medical Center|Victoria M. Leavitt|212 342 1351|vl2337@cumc.columbia.edu|
22292158|NCT04824365|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
22292159|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22306359|NCT05694065|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Fenghua Ding|+00 86 21 64370045|ruijindfh@126.com|
22306360|NCT01087762|Cares|UCB|+1887822||9493
22306361|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
22306362|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu|
22292160|NCT03739840|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22292161|NCT02788474|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22259950|NCT00458848|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22259951|NCT05097326|Stanford University|Principal Investigator|(650) 497-5175|gynresearch@stanford.edu|
22259952|NCT03480425|University of Saskatchewan|Dr. William P. McKay|306 250 5344|bill.mckay@usask.ca|
22274547|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com|
22306363|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306364|NCT02393716|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
22306365|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306366|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306367|NCT01565928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306368|NCT05340244|GE Healthcare|Tracy Grzendzielewski|414-218-6167|tracy.grzendzielewski@ge.com|
22306369|NCT03264248|University of Pittsburgh|Dr. Jonathan Pearlman|412-822-3685|jlp46@pitt.edu|
22306370|NCT03621761|University of Michigan|Tiffany Braley|734-232-1147|tbraley@med.umich.edu|
22306371|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov|
22306372|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411|kwatkins@rand.org|6509
22306373|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300||
22306374|NCT03673943|RadioMedix Inc|Ebrahim Delpassand|7134999733|edelpassand@radiomedix.com|
22306375|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp|
22306376|NCT02441036|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22306377|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306378|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov|
22306379|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
22306380|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22306381|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306382|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com|
22306383|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22306384|NCT02716324|The Children's Hospital of Philadelphia|James Guevara, MD MPH|2155901130|guevara@email.chop.edu|
22259953|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu|
22259954|NCT02753842|Emory University|Aaron Siegler|404-712-9733|asiegle@emory.edu|
22259955|NCT05216081|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
22259956|NCT02473640|Synthetic Biologics Inc.|Michael Kaleko, M.D.|(240) 238-3862|mkaleko@syntheticbiologics.com|
22259957|NCT03292653|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22259958|NCT04720664|Georgetown University|Nadia Ashai, MD|202-444-2223|nadia.ashai@medstar.net|
22259959|NCT02841774|Northwestern University|Dr. Matthew Feinstein|3126643278|matthewjfeinstein@northwestern.edu|
22259960|NCT03103100|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
22259961|NCT02606500|University medical centre Ljubljana|Professor Eda Vrtacnik Bokal|+38615226060|eda.bokal@guest.arnes.si|
22259962|NCT02773836|European Network for Smoking and Tobacco Prevention|Dr Constantine Vardavas|+306937281680|vardavas@tobcontrol.eu|
22259963|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22259964|NCT02720510|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22274548|NCT02998151|Cincinnati Children's Hospital Medical Center|Dr. Craig Erickson|513-636-0523|craig.erickson@cchmc.org|
22274549|NCT05047536|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22306385|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu|
22259965|NCT02460159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259966|NCT00084084|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22259967|NCT02106065|VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
22306386|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22306387|NCT04347954|Stanford University|Jayakar Nayak, MD, PhD|(650) 723-5281|jnayak@stanford.edu|
22306388|NCT03257813|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|3001 4200|ricardo.llamas@sophia.com.mx|1059
22306389|NCT02878330|MedImmune, LLC|M. Pamela Griffin|+1 301-398-4059|information.center@astrazeneca.com|
22306390|NCT04246762|R-Pharm|Marina Beloukhova, Scientific advisor|0074959567937|beloukhova@rpharm.ru|2129
22306391|NCT03615924|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22306392|NCT01989910|Taipei Veterans General Hospital|Dr. WEN-WEI KU|+886228751997|stephaneku@gmail.com|
22306393|NCT02954848|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22306394|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu|
22306395|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
22306396|NCT03299816|Johns Hopkins University School of Medicine|Deidra C. Crews, MD, ScM|410-502-0518|dcrews1@jhmi.edu|
22306397|NCT01184508|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306398|NCT02969863|MGH|Courtney Balliro, BS RN CDE|617-726-1242|cballiro@partners.org|
22306399|NCT02053363|Rady Children's Hospital|Michael P Kelly|858-576-1700|mkelly5@rchsd.org|223750
22306400|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org|
22306401|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22306402|NCT04349150|Massachusetts General Hospital|Daniel C. Chung, MD|6177263544|chung.daniel@mgh.harvard.edu|
22306403|NCT05382104|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22306404|NCT01493778|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22306405|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306406|NCT03210402|Medtronic Inc|Mike Bennett, Clinical Study Manger|262-362-1956|mike.s.bennett@medtronic.com|
22306407|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu|
22306408|NCT03215927|University of Pittsburgh|Rohit Aggarwal|4123838123|aggarwalr@upmc.edu|
22306409|NCT03779048|University of Pennsylvania|Dr. Jena Tronieri|2157465045|jena.tronieri@pennmedicine.upenn.edu|
22306410|NCT05328297|Janssen Research & Development|Senior Director Clinical Sciences Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22306411|NCT01286272|Alliance for Clinical Trials in Oncology|Kristie A. Blum, MD|614-293-8858|kristie.blum@osumc.edu|
22306412|NCT02945332|Texas Tech University|Dr. Nikhil Dhurandhar|806 834-6446|nikhil.dhurandhar@ttu.edu|
22306413|NCT03979365|Mayo Clinic|Mark Stegall, M.D.|507-266-4505|stegall.mark@mayo.edu|
22306414|NCT04496960|National Institute of Dental and Craniofacial Research|Dr. Blake Warner|+1 301 500 8063|blake.warner@nih.gov|
22306415|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu|
22306416|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov|
22306417|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu|
22306418|NCT03245580|Parkview Mirro Research Center|Christina Zelt RN|2602664153|christina.zelt@parkview.com|
22306419|NCT05855655|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
22306420|NCT01613716|Cleveland Clinic Foundation|Sunil K. Srivastava, MD|216-636-2286|srivass2@ccf.org|
22306421|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22306422|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
22306423|NCT04580160|Vesper Medical|Joseph C. Griffin, III|4848926340|Jgriffin@vespermedical.com|
22306424|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493||
22306425|NCT02296424|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
22306426|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22306427|NCT02680457|Instituto de Terapéutica Experimental y Clínica, Universidad de Guadalajara|Dr. Manuel González Ortiz|+52 3310585200|uiec@prodigy.net.mx|34212
22306428|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
22306429|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu|
22306430|NCT03176654|Loma Linda University Health|Everett Lohman, PhD. Professor||elohman@llu.edu|83171
22306431|NCT03287622|University of Michigan|Dr. Terri Voepel-Lewis|734-646-6803|terriv@umich.edu|
22306432|NCT05882812|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
22259968|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org|
22259969|NCT02465567|Pearl Therapeutics Inc|Pearl Therapeutics Inc|1-877-240-9479|information.center@astrazeneca.com|
22259970|NCT01085344|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
22259971|NCT01807637|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|15015267773|msmennemeier@uams.edu|
22259972|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012||
22259973|NCT05723822|RxFunction|Clinical Research Specialist|612-358-2141|Yvonne.Rumsey@rxfunction.com|
22274550|NCT00350545|Stanford University|David B. Miklos|650 725-4959|dmiklos@stanford.edu|650
22306433|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org|
22306434|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
22306435|NCT03804918|Imperial College London|Dr Gehan Soosaipillai|+44 20 3312 6666|gsoosaip@ic.ac.uk|7651
22306436|NCT02314117|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22306437|NCT05641311|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22306438|NCT00909363|Weill Cornell Medicine|Dr james B Bussel|917-291-5091|jbussel@med.cornell.edu|
22306439|NCT03280836|Penn State University|Dr. Kathleen Sturgeon|7175314530|kms99@psu.edu|284676
22306440|NCT04141917|University of Washington|Dr. Helen Chu|206-685-8702|helenchu@uw.edu|
22306441|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306442|NCT02476890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306443|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
22306444|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu|
22306445|NCT03515304|Johns Hopkins University - Baltimore, MD|Dr. Thorsten Leucker|4105020469|tleucke1@jhmi.edu|
22306446|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22306447|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu|
22306448|NCT02861937|Krishnadevaraya college of dental sciences|Dr. Rudrakshi C|080-28467083|drrudrakshi@rediffmail.com|
22306449|NCT03684265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306450|NCT02705586|VA Portland Health Care System|Dr. Amie Hiller|503 721 1091|peterami@ohsu.edu|
22259974|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22259975|NCT04582539|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22259976|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu|
22259977|NCT03978403|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
22259978|NCT05030753|Univeristy of Virginia|Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
22292162|NCT03555435|National Center for PTSD|Eve Carlson|6504935000|eve.carlson@va.gov|24058
22292163|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr|
22292164|NCT02694523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22292165|NCT04489732|University of Wisconsin Carbone Cancer Center|Randy Kimple, MD, PhD, FASTRO|608-263-5361|rkimple@humonc.wisc.edu|
22292166|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu|
22292167|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22292168|NCT02962765|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22292169|NCT02169284|University of Wisconsin Carbone Cancer Center|Dr. Tracy Downs|608-263-9534|downs@urology.wisc.edu|
22292170|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu|
22306451|NCT02808338|Philips|Clinical Operations Manager|14125423669|jeremy.powers@philips.com|
22306452|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292171|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu|
22292172|NCT02964507|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292173|NCT04341662|University of Birmingham|Dr Adam Devall|+447971823452|a.j.devall@bham.ac.uk|
22292174|NCT02675231|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22306453|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012||
22306454|NCT02000817|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306455|NCT03383146|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22306456|NCT01317420|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306457|NCT05686421|Wills Eye Hospital|Joel Schuman, MD FACS|215-928-3197|JSchuman@willseye.org|
22306458|NCT04210180|Rose Research Center|Jed E. Rose, Ph.D.|9193282345|jed.rose@roseresearchcenter.com|
22306459|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306460|NCT04663802|University of Pennsylvania|Dr. Meeta Prasad Kerlin (PI)|215-746-0446|prasadm@pennmedicine.upenn.edu|
22259979|NCT03277183|NFSGVA|Dr. Mark Segal|3523761611|mark.segal@va.gov|104496
22306461|NCT00539292|The Hospital for Sick Children|Dr Jacob C Langer|416-813-7340|jacob.langer@sickkids.ca|
22306462|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
22292175|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22292176|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22292177|NCT03309046|MemphisVAMC|Dr. Linda Olivia Nichols|901 523-8990|linda.nichols@va.gov|5082
22306463|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292178|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22292179|NCT02764190|Seattle Children's Research Institute|Cari McCarty|206-884-8243|Carolyn.McCarty@seattlechildrens.org|
22292180|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22292181|NCT03488927|University of Nebraska-Lincoln|Katie Edwards|402-472-2223|katie.edwards@unl.edu|
22306464|NCT02205307|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
22259980|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org|
22259981|NCT03072459|Smith & Nephew, Inc.|Salima Reddy|817-916-2233|salima.reddy@smith-nephew.com|
22259982|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343||
22259983|NCT02579096|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
22259984|NCT03177603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22259985|NCT02097121|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22259986|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300||
22259987|NCT03595657|CStone Pharmaceuticals|Zhang Wenyun|+86 021-60333416|CstoneRA@cstonepharma.com|
22259988|NCT01066052|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22259989|NCT03184441|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
22259990|NCT01200394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22259991|NCT04107493|ResMed|maureen crocker|+1 8588366653|maureen.crocker@resmed.com|
22259992|NCT01835145|Alliance for Clinical Trials in Oncology|Jason J. Luke, M.D.||jluke@medicine.bsd.uchicago.edu|
22259993|NCT02729896|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22259994|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov|
22259995|NCT04094870|University of North Carolina at Chapel Hill|Elizabeth Stringer, MD, MSc|919-966-1601|elizabeth_stringer@med.unc.edu|
22259996|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no|
22259997|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
22259998|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu|
22259999|NCT01592370|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22260000|NCT02742181|University Hospitals Cleveland Medical Center|Sharon Stein|(216)844-2873|Sharon.Stein@UHhospitals.org|
22260001|NCT02739984|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22260002|NCT02785172|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22260003|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com|
22260004|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
22292182|NCT03497676|Family Health International (FHI 360)|IMPAACT ClinicalTrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22306465|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
22306466|NCT02041104|Mlinotest d. d.|Ana Velikonja|0038651321785|anaa.velikonja@gmail.com|
22306467|NCT06269640|National Heart Lung and Blood Institute|Robert Lederman, M.D.|301.402.6769|lederman@nih.gov|
22306468|NCT02974634|University of Pennsylvania|Dr. Robert Krouse|215-615-4573|robert.krouse@pennmedicine.upenn.edu|
22306469|NCT05011396|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
22306470|NCT04668339|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22306471|NCT02986178|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
22306472|NCT03253848|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22306473|NCT06331403|Massachusetts General Hospital|Lucy Finkelstein-Fox, PhD|617-726-6300|lfinkelsteinfox@mgh.harvard.edu|
22306474|NCT05758415|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22306475|NCT03622593|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306476|NCT01037530|Hull University Teaching Hospitals NHS Trust|Judith Long|01482 311918|judith.long3@nhs.net|
22306477|NCT01393119|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
22306478|NCT04860258|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22306479|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com|
22306480|NCT01580293|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22306481|NCT01134562|Amgen, Inc|Study Director|866-572-6436||
22306482|NCT01324453|Minneapolis Heart Institute Foundation|Jane Fox|6128636289|jane.fox@allina.com|
22306483|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu|
22306484|NCT01400776|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22306485|NCT03387319|Emory University|Kimberly R Jacob Arriola, PhD, MPH|404-727-2600|kjacoba@emory.edu|
22306486|NCT03192046|UtexasSouthwestern|Staci Shearin|214-648-6564|staci.shearin@utsouthwestern.edu|
22306487|NCT03557658|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22306488|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306489|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu|
22260005|NCT04947579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22260006|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu|
22306490|NCT01901276|Columbia University Medical Center|Daniel Freedberg, MD, MS|212-305-1021|def2004@cumc.columbia.edu|
22260007|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22292183|NCT01782833|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
22292184|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
22292185|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22292186|NCT02211638|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22292187|NCT02658097|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223 8100|TaussigResearch@ccf.org|
22292188|NCT03120624|Mayo Clinic|Jamie N Bakkum-Gamez MD|507-284-2511|bakkum.jamie@mayo.edu|
22292189|NCT06120777|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22292190|NCT01711372|CogCubed|Dr Monika Roots, Chief Medical Officer|6173082009|monika@cogcubed.com|
22292191|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
22292192|NCT01659658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22292193|NCT01927341|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292194|NCT00970073|Cleveland Clinic|Bijan Eghtesad|2164029954|eghtesb@ccf.org|
22260008|NCT03538756|RxFunction, Inc.|Lars Oddsson, PhD|612-358-2140|loddsson@rxfunction.com|
22260009|NCT00752856|UCSD|Sheldon Morris|8583364088|shmorris@ucsd.edu|
22260010|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
22260011|NCT02688608|Stanford Medicine at Stanford University|Saad A Khan, MD|650-507-5624|Saad.A.Khan@stanford.edu|
22260012|NCT02346201|Johns Hopkins School of Public Health|Jennifer Jones, Research Coordinator|44377086812|jejones@jhu.edu|
22260013|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac|
22260014|NCT05200858|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22260015|NCT03363581|Imperial College London|Prof Carel le Roux|07970719453|carel.leroux@nhs.net|
22260016|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300||
22260017|NCT02448771|Dana-Farber Cancer Institute|Rinath Jeselsohn|617.632.6887|rinath_jeselsohn@dfci.harvard.edu|
22260018|NCT03457909|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
22260019|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22260020|NCT02051309|Yale School of Medicine|Sherry McKee PhD|2037373529|sherry.mckee@yale.edu|
22260021|NCT01669538|University of Pennsylvania|Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
22260022|NCT03581448|Florida Atlantic University|Dr. Erik Engeberg|5612970530|eengeberg@fau.edu|
22260023|NCT01076972|Abbott|Global Medical Services|800-633-9110||
22260024|NCT03900624|Johns Hopkins All Children's Hospital|Dr. Anthony Sochet|7277672912|Anthony.Sochet@jhmi.edu|
22260025|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu|
22260026|NCT02999178|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260027|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22260028|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu|
22260029|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com|
22260030|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22260031|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22260032|NCT02924038|University of California, San Francisco|Dr. Nicholas Butowski, MD|415-353-7500|Nicholas.Butowski@ucsf.edu|
22260033|NCT02395822|University of Minnesota Masonic Cancer Center|Yumna Akhtar - Ct.gov Manager|612-624-6313|akhta012@umn.edu|
22260034|NCT00153803|Dartmouth-Hitchcock Medical Center|Clinical Research Office||Cancer.Research.Nurse@Dartmouth.edu|
22260035|NCT05343715|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
22260036|NCT04347291|Vanderbilt University Medical Center|Dr. Lindsay Mayberry|615-875-5821|lindsay.mayberry@vumc.org|
22260037|NCT03311646|Medical University of South Carolina|Dr. Tracy Smith|843-792-5164|smithtra@musc.edu|
22292195|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22306491|NCT05575375|The Miriam Hospital|Emily Gathright|4017938271|emily.gathright@brownhealth.org|
22306492|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca|
22292196|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22260038|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22292197|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22260039|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260040|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260041|NCT05227820|The Regenesis Project|Chief Research Coordinator|(989) 245-9205|jharoon@theneuroassociates.com|
22260042|NCT02892500|Sanford Health|Christie Ellison|605-312-6030|christie.ellison@sanfordhealth.org|
22260043|NCT03104322|patientMpower|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
22260044|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22260045|NCT03331042|Sequential Medicine Ltd|Thomas Dahl|617-818-2735|tadahl@outlook.com|
22260046|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855||
22260047|NCT03499964|Urotronic, Inc|Vice President of Clinical Affairs|763-285-7489|info@urotronic.com|
22260048|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260049|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com|
22260050|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov|
22260051|NCT00927810|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22260052|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260053|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu|
22260054|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22260055|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260056|NCT04894994|RAPT Therapeutics|William Ho|650-489-9037|bill.ho@RAPT.com|
22260057|NCT04552704|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22260058|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it|
22260059|NCT03845933|Evergreen General Hospital|Dr Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
22306493|NCT03482011|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260060|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu|
22260061|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu|
22260062|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22260063|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260064|NCT03641742|Columbia University Irving Medical Center|Dr. Christine Kim Garcia|2123058203|ckg2116@cumc.columbia.edu|
22260065|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org|
22260066|NCT03066999|PUR Clinic|Dr Sijo Parekattil|3525368761|sijo@orlandohealth.com|
22260067|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu|
22260068|NCT04068142|UAMS|Dr Michael Wilson|501-686-7000|MPWilson@uams.edu|
22260069|NCT01139164|Medical University of South Carolina|Dr. Robert K Stuart|843-792-4271|stuartrk@musc.edu|
22260070|NCT01790568|University of Michigan Comprehensive Cancer Center|Dr. Pavan Reddy, M.D.|734-936-8785|reddypr@umich.edu|
22260071|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22260072|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
22260073|NCT02994056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22260074|NCT02969499|University of British Columbia|Dr. Simon Woo|604-520-4662|simon.woo@fraserhealth.ca|
22260075|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu|
22260076|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com|
22260077|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408||
22292198|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
22292199|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292200|NCT00695578|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
22292201|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22292202|NCT00089284|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
22292203|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu|
22306494|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu|
22306495|NCT02533167|Wake Forest Health Sciences|Ashley Tonidandel, MD|336-718-8278|atonidan@wakehealth.edu|
22306496|NCT04707313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22260078|NCT02625545|NeoTract/Teleflex|Emily Hergenreter, Sr. Director of Clinical Affairs|650-793-5570|Emily.Hergenreter@Teleflex.com|
22260079|NCT01346410|Mercy|Dr Kathy Baglan|3144345886|kathy.baglan@mercy.net|
22260080|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
22260081|NCT05905783|Acelyrin Inc.|Clinical Trials Information Desk|(650) 231 6625|info@alumis.com|
22260082|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22260083|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu|
22260084|NCT02739542|UT Southwestern Medical Center|Darin T. Okuda, M.D.|214-645-8800|darin.okuda@utsouthwestern.edu|
22260085|NCT03008460|Ipsen|Ipsen Medical Director|use email|clinical.trials@ipsen.com|
22260086|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22306497|NCT02459899|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22292204|NCT02611960|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306498|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433|ofra.levy-hacham@sol-gel.com|3802
22306499|NCT03586544|The Ohio State University|Dharini Bhammar|614-866-9467|dharini.bhammar@osumc.edu|
22306500|NCT02165761|W.L. Gore and Associates, Inc.|Suzy Palmer, CCRP|928-864-3670|supalmer@wlgore.com|
22292205|NCT02395666|Beat Childhood Cancer|Dr. Giselle Sholler|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
22292206|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22306501|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22292207|NCT04839146|Radboudumc|Benjamin Mordmüller (Principal investigator)|+31 (0)24 3619499|benjamin.mordmueller@radboudumc.nl|
22292208|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22306502|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu|
22292209|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
22292210|NCT04131556|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22306503|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
22306504|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com|
22320308|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22260087|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu|
22260088|NCT04272801|University of Virginia|Dr. Shayna Showalter|434-956-8032|snl2t@uvahealth.org|
22260089|NCT02456909|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
22260090|NCT02130466|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260091|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22260092|NCT04529109|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
22260093|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
22260094|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22260095|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
22260096|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22260097|NCT01611090|Janssen Research & Development, LLC|Medical Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22260098|NCT03968224|UIM Enfermedades Endocrinas. Hospital de Especialidades Centro Médico Nacional Siglo XXI|Aldo Ferreira Hermosillo|+(52)15556276900|aferreira@endocrinologia.org.mx|21913
22260099|NCT05771428|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22292211|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22306505|NCT02885350|Helsinki University Central hospital/Women's hospital/anaesthesia|Dr Antti Vaananen|358504271850|antti.vaananen@hus.fi|
22260100|NCT04025229|UNC Lineberger Comprehensive Cancer Center|Luz Andrea Cuaboy|1-919-843-1177|luz_cuaboy@med.unc.edu|
22260101|NCT03815942|University of Oxford|Dr Mark Tuthil|01865 227042|mark.tuthill@oncology.ox.ac.uk|
22260102|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
22260103|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22260104|NCT03601637|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22260105|NCT00038675|University of Texas (UT) MD Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
22260106|NCT02322047|Veterans Affairs Puget Sound Health Care System|Tracy Simpson, PhD|206-277-3337|tracy.simpson@va.gov|
22260107|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu|
22260108|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260109|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22260110|NCT03239522|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260111|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org|
22260112|NCT04557124|VA Connecticut Healthcare System|Joanna Fiszdon, Principal Investigator|203-932-5711|Joanna.fiszdon@va.gov|
22260113|NCT00001849|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
22260114|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260115|NCT02428699|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260116|NCT03127137|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22260117|NCT04424407|Stanford University|Andrea Goldstein-Piekarski, PhD|650-721-4780|agoldpie@stanford.edu|
22260118|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu|
22260119|NCT03992196|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22260120|NCT01880073|Center for Reproductive Medicine|Dr. Steven Spandorfer|646-962-3638|sdspando@med.cornell.edu|
22260121|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260122|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22260123|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22260124|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
22260125|NCT00243932|Columbia University|Hiroshi Mitsumoto, MD|2123052940|hm264@cumc.columbia.edu|
22260126|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu|
22260127|NCT01458405|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
22260128|NCT01931033|Massachusetts General Hospital|Gagan Joshi, MD|617-726-1541|gjoshi@mgh.harvard.edu|
22260129|NCT01362998|University Hospitals of Cleveland|Evan Goodman, principal investigator|2168445300|evan.goodman@uhhospitals.org|
22260130|NCT02497781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260131|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260132|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22260133|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22260134|NCT00806156|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
22260135|NCT01095510|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22260136|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com|
22260137|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
22260138|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu|
22260139|NCT00600925|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22260140|NCT01307098|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22260141|NCT03977051|Imperial College London|Dawn Goodall|+44 (0) 203 313 4268|dawn.goodall1@nhs.net|
22260142|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22260143|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es|
22260144|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com|
22260145|NCT00864097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260146|NCT04457310|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
22260147|NCT02349893|Olympus Europa SE & Co. KG|Dr Samuel Faran|0049 1607168798|samuel.faran@olympus.com|
22260148|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov|
22306506|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
22306507|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
22306508|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
22306509|NCT01837641|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22306510|NCT02930590|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
22260149|NCT02899338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306511|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306512|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306513|NCT00290706|Northwestern University|Leo Gordon|312-695-4520|l-gordon@northwestern.edu|
22306514|NCT04884737|UCLA School of Nursing|Barbara Bates-Jensen, PhD, RN, FAAN|626-437-8543|batesjen@sonnet.ucla.edu|
22306515|NCT04066738|Oxford University Hospitals NHS Foundation Trust|Prof. Tim Betts|01865 220256|ep.doctors@ouh.nhs.uk|
22260150|NCT06179108|LB Pharmaceuticals Inc|Leslie Callahan, Head, Clinical Operations|9086556884|leslie@lbpharma.us|
22260151|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
22260152|NCT05233163|Columbia University Irving Medical Center|Ani Nalbandian, MD|646-906-2255|an2558@cumc.columbia.edu|
22260153|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22260154|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
22260155|NCT02665143|Yale School of Medicine|Thomas Prebet, MD, PhD|(203) 200-4363|thomas.prebet@yale.edu|
22260156|NCT00979732|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
22260157|NCT02780687|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260158|NCT03356821|UMC Utrecht, The Netherlands|Prof. M.J.N.L. Benders, MD, PhD, neonatologist|+31 88 755 5555|m.benders@umcutrecht.nl|
22306516|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org|
22260159|NCT00414765|Novartis Pharmaceuticals|Study Director|18627788300|Novartis.email@novartis.com|
22260160|NCT04354012|Wake Forest|Research Administrative Coordinator|336-716-2903|irichard@wakehealth.edu|
22260161|NCT05694013|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22260162|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300||
22260163|NCT04817891|University of Michigan|Dr. Benjamin Hampstead|734-936-6185|bhampste@med.umich.edu|
22260164|NCT03982433|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
22260165|NCT03076255|Thomas Jefferson University|Voichita Bar-Ad, MD|215-955-6702|Voichita.BarAd@jefferson.edu|
22260166|NCT04533646|University of Pittsburgh Medical Center|Associate Professor of Medicine|4125869700|ullalj@upmc.edu|
22260167|NCT04256421|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22260168|NCT02445456|Oxford University Hospitals NHS Foundation Trust|Miss Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
22260169|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@dhs.lacounty.gov|
22260170|NCT02446626|National Institute of Allergy and Infectious Diseases|Marques, Adriana|+1 301 435 7668|amarques@niaid.nih.gov|
22260171|NCT02696070|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
22260172|NCT02424188|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22260173|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com|
22260174|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com|
22260175|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590||
22260176|NCT04885296|Johnson & Johnson Vision Care, Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-608-7238|jbuch@its.jnj.com|
22260177|NCT00433147|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@Alexion.com|
22260178|NCT02683083|Camel-IDS|Tony Lahoutte|0032 24799360|tony.lahoutte@camel-ids.com|
22260179|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu|
22260180|NCT04510857|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
22260181|NCT01059500|indiana university school of medicine|jeffrey kline|317 880 3869|jefkline@iu.edu|
22260182|NCT01124149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22260183|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22260184|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260185|NCT03272139|Department of Anesthesiology, Critical Care & Pain Management|Dr. David Kim|212-606-1206|kimd@hss.edu|
22260186|NCT05518487|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22260187|NCT00543309|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, M.D., M.P.H.|312 227 1551|jmcostello@luriechildrens.org|
22260188|NCT04084483|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22260189|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org|
22260190|NCT05014412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260191|NCT02353169|British Columbia Children's Hospital Research Institute|Simon D. Whyte|604-875-2711|swhyte@cw.bc.ca|
22260192|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22260193|NCT05295953|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
22260194|NCT04559854|Oregon State University|Jessica Gorman|541-737-2323|Jessica.Gorman@oregonstate.edu|
22260195|NCT04981912|UCSD|Michael Choi|8585341765|mychoi@ucsd.edu|
22260196|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu|
22260197|NCT05630547|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22260198|NCT05049460|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
22260199|NCT05065502|VA Ann Arbor Health Care System|Jeremy Sussman, MD, MS, Corresponding Principal Investigator|N/A|Jeremy.Sussman@va.gov|
22260200|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300||
22260201|NCT03441581|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22260202|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22260203|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22260204|NCT04028843|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
22260205|NCT03580343|Washington University in St. Louis|Lynn Hassman, Assistant Professor and Study PI|3142730341|lhassman@wustl.edu|
22260206|NCT02099461|Amgen Inc.|Study Director|866-572-6436||
22260207|NCT01867242|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
22260208|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260209|NCT04803357|university of Washington Diabetes Institute|Dr, Nicole Ehrhardt|2404479566|nehrhard@uw.edu|
22260210|NCT05932654|Biosion, Inc.|Kathy Zhang|+86 18801904945|kathy.zhang@biosion.com|
22260211|NCT02879643|Therapeutic Advances in Childhood Leukemia and Lymphoma|Ellynore Florendo, CCRP|323-361-3022|eflorendo@chla.usc.edu|
22260212|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870||
22260213|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260214|NCT02339909|Imperial College London|Colin Bicknell|02078866666|colin.bicknell@imperial.ac.uk|6072
22260215|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu|
22260216|NCT02576990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260217|NCT00936390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22260218|NCT02093689|Omeros Corporation|Medical Monitor|206-676-5000|info@omeros.com|
22260219|NCT00475020|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-745-3055|UPOPAT@MDANDERSON.ORG|
22260220|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22260221|NCT03481309|University of North Carolina at Chapel Hill|Dr. Sangtae Ahn|9195233127|sangtae_ahn@med.unc.edu|
22260222|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk|
22260223|NCT03309956|Columbia University|Leonardo Liberman, MD|212-305-8509|ll202@cumc.columbia.edu|
22260224|NCT02768298|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@@novartis.com|
22260225|NCT03365947|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400|info@arrowheadpharma.com|
22260226|NCT02518685|BAROnova, Inc|Lian Cunningham, MD, PhD|650.638.9796|lcunningham@baronova.com|22
22260227|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260228|NCT05109234|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22260229|NCT00336024|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
22260230|NCT03533946|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22260231|NCT05067504|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22260232|NCT03805438|Duke University|Riley Landreth, DO|919-684-8111|riley.landreth@duke.edu|
22260233|NCT02684344|University of Rochester|Edward Messing|585 - 275 - 0998|edward_messing@urmc.rochester.edu|
22260234|NCT03469297|MicroOptx|VP of Clinical|888-591-2784|info@microoptx.com|
22260235|NCT02086188|EvergreenHealth|Theodore Brown, MD|4258995350|TRBrown@evergreenhealthcare.org|
22260236|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000|EBayever@merrimack.com|7676
22260237|NCT02248597|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-4761|krike@wakehealth.edu|
22260238|NCT02777528|WL Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
22260239|NCT02127281|Cleveland Clinic|Alison K. Klika, MS, Research Manager, Department of Orthopaedic Surgery|(216) 444-4954|klikaa@ccf.org|
22292212|NCT05314478|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|01517064553|tristan.payne@liverpoolft.nhs.uk|
22292213|NCT00145600|St. Jude Children's Research Hospital|Jamie Flerlage, MD|1-866-278-5833|info@stjude.org|
22292214|NCT00842764|Department of Otolaryngology/UCI|Brian J Wong, MD, PhD|7144565753|bjwong@uci.edu|
22292215|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org|
22292216|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
22292217|NCT03090412|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-6269|Chong.Wang@roswellpark.org|
22292218|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu|
22292219|NCT01684020|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22292220|NCT03583164|F2G Ltd|Daniela Zinzi|43 664 3582281|dzinzi@f2g.com|
22292221|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
22292222|NCT01880047|Weill Cornell Medicine|Sujit Sheth|2126463400|shethsu@med.cornell.edu|
22292223|NCT02869438|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
22292224|NCT01601431|Baylor College of Medicine|Mohamed Othman, M.D.|713 798 0947|mohamed.othman@bcm.edu|
22292225|NCT05323656|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
22292226|NCT03880461|Kaiser Permanente Northern California|Monique Hedderson, Ph.D.|925-520-0785|monique.m.hedderson@kp.org|
22292227|NCT04847622|Research Organisation King's Cross (KC) Ltd.|Toni Sobande, Clinical Project Manager|447494 795 982|toni.sobande@rokcservices.com|
22292228|NCT03953183|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22292229|NCT03839082|University of California Los Angeles|Monica Tincopa|310 825-2631|mtincopa@mednet.ucla.edu|
22292230|NCT00645710|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22292231|NCT03367247|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harard.edu|
22292232|NCT01115803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292233|NCT03063203|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
22292234|NCT02273739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22292235|NCT04718103|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292236|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22292237|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com|
22260240|NCT03718234|University of Minnesota|Kyriakie Sarafoglou|6126245965|saraf010@umn.edu|
22292238|NCT02393690|Academic and Community Cancer Research United (ACCRU)|Alan Ho, M.D.|212-639-7202|hoa@mskcc.org|
22260241|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com|
22260242|NCT01108094|Stanford University Medical Center|Jean Tang MD PhD, Associate Professor of Dermatology|650-723-6316|tangy@stanford.edu|
22260243|NCT01759277|University of California San Diego|Brian Ilfeld|858-822-2171|bilfeld@ucsd.edu|
22260244|NCT05037097|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22260245|NCT02918877|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|617-549-2974|bpogara@bidmc.harvard.edu|
22260246|NCT05346055|Weill Cornell Medical College|Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
22260247|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu|
22306517|NCT03768206|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
22260248|NCT02564263|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306518|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260249|NCT02906709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260250|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu|
22260251|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu|
22306519|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu|
22306520|NCT02551055|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22260252|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu|
22260253|NCT03204526|UC Davis Health|Kiarash Shahlaie, MD, PhD, FAANS, Bronte Professor of Neurological Surgery|916-734-6342|krshahlaie@ucdavis.edu|
22260254|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
22306521|NCT02666742|Kansas City Heart Rhythm Institute|Donita Atkins|913-253-3064|Donita.Atkins@hcahealthcare.com|
22260255|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com|
22260256|NCT01626664|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
22260257|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22260258|NCT00728949|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306522|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
22260259|NCT02747615|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22260260|NCT03209882|University of Texas at Arlington|Fenghua Tian|8178075271|fenghua.tian@gmail.com|
22260261|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260262|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
22260263|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil|
22260264|NCT00048048|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22306523|NCT02106442|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22260265|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com|
22260266|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu|
22260267|NCT02194998|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22306524|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
22260268|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org|
22260269|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22260270|NCT01345019|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22260271|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260272|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com|
22306525|NCT03172624|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
22306526|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300||
22260273|NCT05194839|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
22306527|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com|
22260274|NCT03433430|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22260275|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu|
22260276|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu|
22260277|NCT03629925|Innovent Biologics (Suzhou) Co., Ltd|YiBo|+86 13382419112|jessica.yi@innoventbio.com|
22260278|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
22260279|NCT00497796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22260280|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com|
22260281|NCT01856309|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Associate Director, Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22260282|NCT00220337|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22260283|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306528|NCT02064959|The University of Texas Health Science Center at Houston|Georgene W. Hergenroeder, Ph.D., Associate Professor|713-500-6230|lisa.h.schmitt@uth.tmc.edu|
22306529|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net|
22306530|NCT02711839|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
22306531|NCT03290248|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22260284|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com|
22260285|NCT03661528|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22260286|NCT03249584|MedtronicNeuro|Eric Grovender|763-514-4000|eric.a.grovender@medtronic.com|
22260287|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22260288|NCT03696225|VA Portland Health Care System|Dr. Maya E. O'Neil, Principal Investigator|503-220-8262|Maya.Oneil@va.gov|54522
22260289|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700|ctu@npeu.ox.ac.uk|89728
22260290|NCT03130699|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
22260291|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22260292|NCT04534283|IndianaU|Dr. Anita Turk|(317) 274-0335|aaturk@iu.edu|
22260293|NCT05956665|Vanderbilt University School of Nursing|Jennifer Kim, DNP, GNP-BC|615-936-0739|jennifer.kim@vanderbilt.edu|
22260294|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org|
22260295|NCT03257462|Spruce Biosciences, Inc.|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
22260296|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
22260297|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260298|NCT03682900|Oregon Research Behavioral Intervention Strategies, Inc.|Judy A. Andrews, Senior Scientist|541-484-2123|Judy.Andrews@Influentsin.com|
22260299|NCT06354270|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22260300|NCT05097989|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22260301|NCT02809183|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
22260302|NCT02933866|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22260303|NCT00918567|SUNY Buffalo|James Waxmonsky M.D.|305 348 3258|jwaxmons@fiu.edu|
22260304|NCT02698800|Columbia University Medical Center|Dr. Ari Shechter, Principal Investigator|212-342-4487|as4874@cumc.columbia.edu|
22260305|NCT05275998|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
22260306|NCT01936948|White River Junction VA Medical Center|Heiko Pohl|802-295-9363|heiko.pohl@va.gov|5591
22260307|NCT01988922|Washington University in St. Louis School of Medicine|Dr. Lesley K Rao|3143690683|raol@wustl.edu|
22260308|NCT02327130|Isomark, LLC|Dr. Daniel Butz, Chief Scientific Officer|(608) 561-1895|daniel.butz@isomark.com|
22260309|NCT00493831|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
22260310|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587|dralemar@uol.com.br|55 +
22260311|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22260312|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu|
22260313|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22260314|NCT03348423|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
22260315|NCT00373217|University of Virginia|Craig Slingluff MD, Professor of Surgery|4349249311|cls8h@virginia.edu|
22260316|NCT00934934|CERU Queens University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
22260317|NCT04349917|University of North Carolina at Chapel Hill|Jessica R. Cohen, PhD|(919) 843-3753|jrcohen@unc.edu|
22260318|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org|
22260319|NCT05086835|McLean Hospital|Dr. Roger Weiss|617-855-2242|rweiss@mclean.harvard.edu|
22260320|NCT04486066|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|tracy.simpson@va.gov|
22260321|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22260322|NCT01532141|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22260323|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747|sassmann@neriscience.com|548
22260324|NCT00088829|Georgetown University Medical Center|Claudine Isaacs, MD|202-444-3677|isaacsc@georgetown.edu|
22260325|NCT02532764|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
22260326|NCT02215161|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
22260327|NCT02252562|Dartmouth-Hitchcock Medical Center|Matthew D. Koff, MD Staff Physician, Anesthesiology|(603) 650-5922|Matthew.D.Koff@hitchcock.org|
22260328|NCT02735174|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
22260329|NCT02148302|SerenaGroup|Thomas E. Serena, MD|617-945-5225|serena@serenagroups.com|
22306532|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
22306533|NCT05674136|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22306534|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22306535|NCT02383472|Boston Children's Hospital|Dr. William Meehan|781-216-1328|William.Meehan@childrens.harvard.edu|
22306536|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306537|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org|
22320309|NCT00709111|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22306538|NCT04424641|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
22306539|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu|
22306540|NCT01171625|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22260330|NCT00525590|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22260331|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
22260332|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
22260333|NCT03830164|UT MD Anderson Cancer Center|Dr. Chad Tang, Associate Professor, Radiation Oncology Department|(713) 745-7179|ctang1@mdanderson.org|
22260334|NCT04099888|PCI Biotech AS|Chief Executive Officer|(+47) 67 11 54 00|post@pcibiotech.no|
22260335|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov|
22260336|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
22260337|NCT01050647|Stanford University|Dr. Anna Girsen|6507255720|agirsen@stanford.edu|
22260338|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22260339|NCT04276883|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22260340|NCT01929642|Boling Center for Developmental Disabilities|Dr. Tanjala Gipson|901-448-6512|sbarden@uthsc.edu|
22260341|NCT02458469|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
22260342|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov|
22260343|NCT02603952|MedImmune, LLC|Raburn Mallory|301-398-4095|information.center@astrazeneca.com|
22260344|NCT02789033|Universidad de Guadalajara|PhD. Leonel García Benavides|+52 (33) 20 00 23 00|drleonelgb@hotmail.com|64096
22260345|NCT05215951|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22260346|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net|
22260347|NCT00958243|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22260348|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
22260349|NCT03587207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260350|NCT03283709|University of Kentucky|Hiroko Nagaoka|859-257-2101|h.nagaoka@uky.edu|
22260351|NCT00534703|Imperial College London|Dr Alexander Lyon|+442075943409|a.lyon@imperial.ac.uk|
22260352|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu|
22260353|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com|
22260354|NCT03339349|University of Utah|Daniel Jones|801-581-2121|daniel.jones2@gmail.com|
22260355|NCT04591626|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260356|NCT02494713|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22260357|NCT00615784|abramsoncc, University of Pennsylvania|Harjeet Sembhi, research program director|215-220-9688|harjeet.sembhi@pennmedicine.upenn.edu|
22260358|NCT02003183|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Gary Small|3108250291|gsmall@mednet.ucla.edu|
22260359|NCT03676803|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD|310-206-1987|zli@medent.ucla.edu|
22260360|NCT03104738|The Ohio State University|Ana Mavarez-Martinez, PostDoctoral Reseacher|614-293-3559|ana.mavarezmartinez@osumc.edu|
22260361|NCT00841100|University of Miami|Judy Schaechter|305-243-3993|JSchaech@med.miami.edu|
22260362|NCT03338972|Fred Hutchinson Cancer Center|Dr. Damian Green|2066675398|dgreen@fredhutch.org|
22260363|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22260364|NCT02589171|The University of Texas Health Science Center at Houston|Associate Professor|(713) 500-7277|Shinil.K.Shah@uth.tmc.edu|
22260365|NCT02719522|Medtronic Neurovascular|Claudia Campo|0039 0224137325|claudia.campo@medtronic.com|
22260366|NCT06096168|SERF|Sponsor|0472056010|clinical@serf.fr|
22260367|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260368|NCT04603937|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
22260369|NCT02585258|Amsterdam UMC, Vrije Universiteit|Prof Maarten Boers|+3120-4444474|eb@amsterdamumc.nl|
22260370|NCT05125952|Duke University School of Medicine|Elias Pratt|919-684-8111|elias.pratt@duke.edu|
22260371|NCT03946449|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
22260372|NCT02848326|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22260373|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com|
22260374|NCT00890981|Amgen Inc.|Study Director|866-572-6436||
22260375|NCT00479258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22260376|NCT02087514|Columbia University Medical Center|Dr. Eldad Hod|(212) 342-5648|eh2217@cumc.columbia.edu|
22260377|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200||
22260378|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
22306541|NCT03854253|Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia|Dr. Stanislav Sapozhnikov|+79091919191|stas_ss@bk.ru|
22306542|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu|
22306543|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22306544|NCT01307267|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306545|NCT02568644|Universidade Federal de Minas Gerias|Dr. Antonio Lucio Teixeira||altexr@gmail.com|
22306546|NCT04956575|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22306547|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu|
22306548|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000|harperricharda@uams.edu|2616
22320310|NCT02865018|Icahn School of Medicine at Mount Sinai, Corrine Goldsmith Dickinson Center for MS|Ilana Katz Sand|212-241-6854|ilana.katzsand@mssm.edu|
22320311|NCT04747834|Regulatory Pathways Group, Inc.|Gretchen Neumann|19494667124|gneumann@regulatorypathways.com|
22306549|NCT05526248|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22320312|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com|
22306550|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu|
22306551|NCT01733238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320313|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22306552|NCT02203630|Vanderbilt University Medical Center|Raj Keriwala|615-322-3412||
22260379|NCT03290326|BIDMC|Principal Investigator - Emiliano Santarnecchi|617-667-0326|esantarn@bidmc.harvard.edu|
22260380|NCT01042522|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22260381|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com|
22260382|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
22260383|NCT00745420|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22260384|NCT01367275|University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
22260385|NCT02774798|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
22260386|NCT03765502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260387|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com|
22260388|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411|susan.hastings@va.gov|4033
22260389|NCT03831048|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
22260390|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22260391|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it|
22260392|NCT01996033|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
22260393|NCT04818242|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22306553|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch|
22306554|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306555|NCT03608839|State University of Campinas (UNICAMP)|Dr Rodrigo Pessoa Cavalcanti Lira|551935217396|alayf@hotmail.com|7396
22306556|NCT02425111|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22306557|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu|
22306558|NCT00739141|Memorial Sloan Kettering Cancer Center|Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
22306559|NCT02739035|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|5072665895|schouten.gabriel@mayo.edu|
22306560|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu|
22306561|NCT04446117|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22306562|NCT03165175|Naval Health Research Center|Suzanne Hurtado|619-553-7806|suzanne.l.hurtado.civ@mail.mil|
22306563|NCT06315907|Pennington Biomedical Research Center|Professor|+1 (225) 763-2585|corby.martin@pbrc.edu|
22306564|NCT05673720|Florida State University|Geraldine Martorella, Hyochol Ahn|850-645-9758|gmartorella@fsu.edu|
22306565|NCT00630786|Amgen Inc.|Study Director|866-572-6436||
22306566|NCT02770248|Alcon, A Novartis Division|Field Medical, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
22306567|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
22306568|NCT03264456|University of Alabama at Birmingham|Samuel Galgano|2059341388|samuelgalgano@uabmc.edu|
22320314|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org|
22260394|NCT02896361|Abbott Neuromodulation|Filippo Agnesi, PhD|972-526-4860|filippo.agnesi@abbott.com|
22260395|NCT03831451|University of Michigan|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
22260396|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22260397|NCT02143102|Elucid Bioimaging|Andrew J. Buckler|978-468-0508|andrew.buckler@elucidbio.com|
22260398|NCT03027661|University of Tennessee Health and Science Center|Elaine Todd, Director of Sponsored Programs - Contracts and research agreements|9014483303|ElaineTodd@uthsc.edu|
22260399|NCT03164772|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22260400|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387|frances.weaver@va.gov|25866
22260401|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
22260402|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com|
22260403|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22260404|NCT01682083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22260405|NCT02731157|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
22260406|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22260407|NCT03657160|Takeda|Study Director|+1-877-825-3327|medinfoUS@takeda.com|
22260408|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com|
22260409|NCT02732210|Amgen Inc.|Study Director|866-572-6436||
22260410|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260411|NCT01876706|NeoTract|Monica Ransom Director of Clinical Operations|4159648770|Monica.Ransom@Teleflex.com|
22260412|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com|
22292239|NCT05298306|Lateral Pharma|Dr Stuart Mudge|+61424588904|sm@lateral-pharma.com|
22260413|NCT02191891|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260414|NCT02339233|University of Lousiville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
22260415|NCT03099538|Mayo Clinic|Aaron R. Mangold, MD|480-301-4256|mangold.aaron@mayo.edu|
22260416|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com|
22260417|NCT02724800|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|Adam.Bramoweth@va.gov|
22260418|NCT02468778|Abbott Vascular|Sandeep Pingle, Principal Clinical Scientist|408-845-2111|Sandeep.pingle1@abbott.com|
22260419|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu|
22260420|NCT03912337|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22292240|NCT01482351|George Mason University|Dr. Kathy C. Richards|(703) 946-3725|kricha11@gmu.edu|
22292241|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov|
22292242|NCT05080660|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22292243|NCT00237185|Novartis|Study Director|862-778-8300||
22292244|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org|
22292245|NCT01977937|OHSU|Dr Elizabeth Pedigo|5039705211|pedigo@ohsu.edu|
22292246|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org|
22292247|NCT03194490|Loma Linda University|Dr. Everett Lohman III|(909) 558-4632|elohman@llu.edu|83171
22292248|NCT03911843|Azienda Ospedaliero-Universitaria di Novara, Italy|Dr. Francesco Cadario, Head of the Pediatric Diabetology service|+39 347 226 6507|francesco.cadario@gmail.com|
22292249|NCT02819518|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22292250|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292251|NCT04808999|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22292252|NCT02153710|University of Washington|Diane Kendall|2066160537|dkendall@uw.edu|
22292253|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292254|NCT04597918|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292255|NCT00990938|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22292256|NCT04041700|Cochlear|Johan Blechert|+46766498632|jblechert@cochlear.com|
22292257|NCT05419908|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22292258|NCT00423722|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD / Professor|713-792-6085|ebruera@mdanderson.org|
22292259|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22292260|NCT00414271|Johns Hopkins Singapore|Prof Alex Chang|+65 68802220|alexchang@imc.jhmi.edu|
22292261|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com|
22292262|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22292263|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov|
22292264|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292265|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22292266|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu|
22260421|NCT01041781|Fox Chase Cancer Center|Martin J. Edelman, M.D.|(215) 728-4790|martin.edelman@fccc.edu|
22292267|NCT04622735|Unither Pharmaceuticals|Non Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22260422|NCT03978624|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22260423|NCT04646109|Afyonkarahisar Health Sciences University|Prof. Dr. Nurullah Okumuş|+90 532 4372406|drnuri@hotmail.com|
22306569|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346|arockich@uky.edu|246
22306570|NCT06119113|Başakşehir Çam Ve Sakura Şehir Hastanesi|Dr.Ayşenur Çalış Özbayram|+905549707052|draysenurcalis@gmail.com|
22306571|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org|
22306572|NCT05136443|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
22306573|NCT02221219|University of Kentucky|Research Protocol Manager/Clinical/UKHC|(859) 257-1000|hong.huang@uky.edu|
22306574|NCT00326924|Ottawa Hospital Research Institute|Dean Fergusson, Senior Scientist|613-737-8480|dafergusson@ohri.ca|
22306575|NCT01786564|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
22306576|NCT03034915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306577|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
22306578|NCT03861767|UPMC|Matthew D. Neal, MD FACS|412-647-1158|nealm2@upmc.edu|
22306579|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|Jeffrey.Skolnik@tetralogicpharma.com|141
22306580|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu|
22306581|NCT01145885|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306582|NCT05299606|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22306583|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu|
22306584|NCT03460756|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22306585|NCT04333758|Tan Tock Seng Hospital Pte Ltd|Ms Lim Chien Joo|9035249|Chien_Joo_LIM@ttsh.com.sg|
22306586|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306587|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu|
22306588|NCT02326649|UCSD|Christopher Davis|8589665855|cdavis@rchsd.org|5668
22306589|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu|
22306590|NCT02950558|University of Cincinnati|Jun-Ming Zhang, MD, MSc|5135582427|jun-ming.zhang@uc.edu|
22306591|NCT00717626|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
22306592|NCT04001517|EIP Pharma|Dr. John Alam|6176698426|johnjalam@gmail.com|
22306593|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
22306594|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22306595|NCT03920215|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22306596|NCT01576523|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22306597|NCT03506880|The Pennsylvania State University|Dr. Rob Turrisi|814-865-7808|rturrisi@psu.edu|
22306598|NCT02547922|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22306599|NCT02709655|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22306600|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
22306601|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22306602|NCT03687892|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
22306603|NCT01591733|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
22306604|NCT04470193|University of Utah|Flory Nkoy, MD, MS, MPH|801-662-3660|flory.nkoy@hsc.utah.edu|
22306605|NCT02517307|Oregon Health & Science University|Melanie Gillingham, PhD|503-494-1682|gillingm@ohsu.edu|
22306606|NCT00843882|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22306607|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306608|NCT01582269|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22306609|NCT03360396|Boston Scientific Corporation|Jessica Stockwell|612-618-1136|Jessie.Stockwell@bsci.com|
22306610|NCT02486588|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
22306611|NCT00546871|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22306612|NCT04036058|Wm. S. Middleton Memorial VA Hospital|Linda McKinley|608-256-1901|linda.mckinley2@va.gov|
22306613|NCT06001177|Kanyos Bio, Inc.|Study Director|+1-857-320-6607|clinicaltrials@anokion.com|
22306614|NCT03593876|University of Pittsburgh|Dr. Elizabeth Skidmore|(412) 383-6617|skidmore@pitt.edu|
22306615|NCT05309668|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22306616|NCT02696707|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
22306617|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com|
22306618|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22306619|NCT03941912|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22306620|NCT05764161|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22306621|NCT01241435|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306622|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22306623|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22306624|NCT03145480|Northwell Health|Jacqueline Barrientos, MD|516-470-4050|jbarrientos@northwell.edu|
22306625|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu|
22306626|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22306627|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu|
22306628|NCT03466788|Centre François Baclesse|Jean-Michel Grellard|0231455002|jm.grellard@baclesse.unicancer.fr|
22306629|NCT02798835|Department of Anesthesia and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.|Dr. Steven Lee|6048754111|steven.lee2@vch.ca|61534
22306630|NCT03320434|Ora, Inc|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
22320315|NCT04223843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306631|NCT03024606|Saint Louis University|Research Nurse|314-977-2090|jathompson@slu.edu|
22320316|NCT03901105|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22306632|NCT01996917|Columbia University|Christine Rohde, MD|212-342-3707|chr2111@cumc.columbia.edu|
22306633|NCT01595061|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
22306634|NCT03189589|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306635|NCT03194958|Washington University in St. Louis|Matthew Kreuter|314-935-3701|mkreuter@wustl.edu|
22306636|NCT00356265|University of Michigan|Crystal Gadegbeku||crystal.Gadebeku@tuhs.temple.edu|
22320317|NCT01519934|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22320318|NCT00922480|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
22306637|NCT02498769|Duke University Health System|Dr. Joseph P Mathew Professor of Anesthesiology and Chairman Department of Anesthesiology|919-681-6646|joseph.mathew@duke.edu|
22306638|NCT01118338|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22320319|NCT03442036|University of California San Diego|John J. Finneran IV, MD|4083073004|jfinneran@ucsd.edu|
22320320|NCT02161575|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22320321|NCT01970488|Amgen Inc.|Study Director|866-572-6436||
22320322|NCT05525689|Northwestern University|Dr. David Mohr|312-503-1403|d-mohr@northwestern.edu|
22320323|NCT01231659|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22306639|NCT05241691|Orthofix srl|Clinical Program Manager|0456719000|danielacangiano@orthofix.it|
22320324|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu|
22306640|NCT00588770|ECOG-ACRIN Cancer Reserch Group Statistical Office|Study statistician|6176323012|eatrials@jimmy.harvard.edu|
22320325|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU|
22320326|NCT03716050|Wake Forest Baptist Health|Ivo Pestana|336-716-4171|ipestana@wakehealth.edu|
22320327|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se|
22320328|NCT02243865|Chordate|Dr Jan-Åke Åkesson|+46 8 40015586|info@chordate.com|
22320329|NCT03654976|ALK-Abelló A/S|Senior Director Global Clinical Development|0045 45747576|clinicaltrials@alk.net|
22320330|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320331|NCT01235793|Cedars-Sinai Medical Center|Yuliya Linhares, MD|310-423-4646|Yuliya.Linhares@cshs.org|
22320332|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22320333|NCT05093322|HUTCHMED Limited|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
22320334|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu|
22320335|NCT03880032|Johns Hopkins Bloomberg School of Public Health|Pamela Surkan|4105027396|psurkan@jhu.edu|
22320336|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
22320337|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org|
22320338|NCT01770912|University of Florida|Charles G. Widmer, Associate Professor|352-273-5696|widmer@dental.ufl.edu|
22320339|NCT03613662|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|6503866709|cambrose@scilexpharma.com|
22320340|NCT03250832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320341|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu|
22320342|NCT03142438|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
22320343|NCT04411628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22320344|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306641|NCT04697628|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306642|NCT03388632|National Cancer Institute|Dr. Jiran Ahmed|240-781-4042|jibran.ahmed@nih.gov|
22320345|NCT03982342|Nationwide Children's Hospital|Carl Backes, MD|1-614-355-6729|Carl.Backes@nationwidechildrens.org|
22320346|NCT02774616|Biotronik SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22320347|NCT01817751|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center CTO Operations Managers|877-4627739|ctoclinops@vcu.edu|
22320348|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22320349|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org|
22320350|NCT01984164|Emory University|Dr. Hajjar|404-712-2036|ihabhajjar@emory.edu|
22320351|NCT02219321|University of Texas Southwestern Medical Center|Enas Kandil|214-648|Enas.Kandil@UTSouthwestern.edu|9374
22320352|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22320353|NCT04743921|University of Alabama at Birmingham Department of Orthopaedic Surgery|Dr. Amit Momaya|205-975-2663|amomaya@uabmc.edu|
22320354|NCT03057613|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Shlomo Koyfman|1-866-223-8100|TaussigResearch@ccf.org|
22320355|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
22320356|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org|
22292268|NCT03288454|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
22292269|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22260424|NCT06176768|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260425|NCT03571048|University of Colorado School of Medicine|Elizabeth Thomas, MD|303-724-9083|elizabeth.thomas@cuanschutz.edu|
22292270|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22292271|NCT04157621|MUSC|Vanessa Hinson|843-876-0829|hinsonvk@musc.edu|
22292272|NCT03960554|Columbia University Irving Medical Center|Thomas L. Nickolas MD|212-305-5020|tln2001@cumc.columbia.edu|
22292273|NCT02545075|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22292274|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
22292275|NCT02563990|University of Miami|Andres Missair|3055857037|amissair@miami.edu|
22292276|NCT02751788|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22292277|NCT00735254|Arizona Dermatology and Cosmetic|Edward Galiczynski, MD|(602) 277-1449|egaliczynski@arizonaderm.com|
22292278|NCT06400979|University of California, Davis Medical Center|Carolyn Mofidi, RN-BC, BSN, MS-L|(916) 734-3333|cmofidi@ucdavis.edu|
22292279|NCT04865640|"Medical Products Group | Analog Devices Inc."|Tony Akl|781-937-1665|tony.akl@analog.com|
22292280|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu|
22292281|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200|alemuggeri@hotmail.com.ar|2020
22292282|NCT01417936|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22292283|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com|
22292284|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292285|NCT06207435|University of Pennsylvania|Dr. Farouk Dako|2673091241|farouk.dako@pennmedicine.upenn.edu|
22292286|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org|
22292287|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu|
22292288|NCT01680887|Perelman School of Medicine|Kyle Kampman|215 746 2764|kampman@pennmedicine.upenn.edu|
22292289|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
22292290|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu|
22292291|NCT02536833|Samumed|Christopher Swearingen, PhD, VP of Clinical Outcomes and Analytics|858.926.2952|chris@samumed.com|
22292292|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111|joe.nocera2@va.gov|6354
22292293|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org|
22292294|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu|
22292295|NCT02766465|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22292296|NCT01907100|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292297|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22292298|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu|
22292299|NCT02059005|Treatment Research Institute|Adam Brooks, PhD|215-399-0980|abrooks@tresearch.org|128
22292300|NCT02865343|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
22292301|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca|
22292302|NCT00843726|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22292303|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22292304|NCT03374631|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
22292305|NCT03640559|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|189
22292306|NCT01436162|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22292307|NCT02567552|IVI Barcelona|Evelin Lara Molina|+34 93 531 63 00|Evelin.Lara@ivi.es|27503
22292308|NCT02745210|Loma LInda University Medical Center|Brenda Bartnik Olson|1-909-558-4000|BBartnik@llu.edu|85216
22292309|NCT05032859|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22292310|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300||
22292311|NCT04669535|UMass Chan Medical School|Dr. Terence Flotte|508-856-8992|terry.flotte@umassmed.edu|
22292312|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501|bernard.lefoll@camh.ca|34772
22292313|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co|
22292314|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292315|NCT04382755|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
22292316|NCT02900560|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|026@trioncology.org|
22292317|NCT03173534|Cleveland Clinic|Samir Kapadia, MD Chairman Cardiovascular Medicine|216 444-6735|KAPADIS@ccf.org|
22292318|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu|
22292319|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
22292320|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com|
22292321|NCT03670836|Columbia University Medical center|Rachana Gavara|914-356-2730|rg2460@cumc.columbia.edu|
22260426|NCT02672553|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
22292322|NCT02981940|Dana-Farber Cancer Institute|Eudocia Q Lee, MD MPH|617.632.2166|eudocia_lee@dfci.harvard.edu|
22292323|NCT02160782|Mirum Pharmaceuticals|Mirum Clinical Trials|1 650-667-4085|medinfo@mirumpharma.com|
22320357|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu|
22320358|NCT01292798|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
22320359|NCT04633174|Dartmouth-Hitchcock Medical Center|Dr. Nicholas Daniel, Staff Physician, Emergency Services|(603) 650-7254|Nicholas.Daniel@hitchcock.org|
22320360|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com|
22320361|NCT06156215|University of California San Francisco|Dr Melanie Molina|512.294.4366|melanie.molina@ucsf.edu|
22260427|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org|
22260428|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
22260429|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com|
22260430|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260431|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu|
22260432|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22260433|NCT01333527|Research Associate|Anelise Silveira|780-492-2398|anelise.silveira@ahs.ca|
22260434|NCT01993875|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22260435|NCT04183231|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-2516831|drmilgrom@silverarrest.com|
22260436|NCT02519322|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
22260437|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22274551|NCT01794702|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD./Associate Professor|713-745-6080|njain@mdanderson.org|
22274552|NCT01655901|CHEO Research Institute|Dr. Jean-Philippe Chaput|613-737-7600|jpchaput@cheo.on.ca|3683
22292324|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu|
22292325|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
22292326|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com|
22292327|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22292328|NCT04382391|Allegheny Health Network (AHN)|Tariq Cheema, MD, Vice President and Medical Director AHN Research Institute|412-321-3344|tariq.cheema@ahn.org|
22292329|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444||2303
22292330|NCT02171065|Lund University|Principal Investigator: David Erlinge, MD, PhD|+46-733746165|david.erlinge@gmail.com|
22292331|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp|
22292332|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu|
22292333|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org|
22292334|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu|
22292335|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu|
22292336|NCT03061097|Microbiome Health Research Institute|Majdi Osman, MD, MPH|617-575-2201|majdi@openbiome.org|
22292337|NCT03956056|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
22292338|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292339|NCT00547196|City of Hope|Dr. Anna Pawlowska, MD|626-359-8111|apawlowska@coh.org|
22292340|NCT04882501|InovaHCS|Principal Investigator Inova Fair Oaks Hospital|703 391-4892|Laura.McNicholl@inova.org|
22292341|NCT05015530|BG ClinicalS|Dr Bernard Gout|+33 (0)561 531 944|b.gout@bgclinicals.com|
22292342|NCT04629508|1-855-463-3463|Study Director|1-855-463-3463|medinfo@incyte.com|
22292343|NCT04073368|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
22292344|NCT03026088|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22292345|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
22292346|NCT00950911|Amgen Inc.|Study Director|866-572-6436||
22292347|NCT02600351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22292348|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
22292349|NCT02106910|University of North Carolina at Chapel Hill|Nicholas J. Shaheen, MD|919-966-7655|nicholas_shaheen@med.unc.edu|
22292350|NCT02521766|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22292351|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
22292352|NCT04087213|DEKA Research|Clinical Research Manager|(603) 669-5139|clinical@dekaresearch.com|
22292353|NCT03126370|University of Colorado Anschutz Medical Campus|Jennifer Kiser, PharmD, PhD|3037246131|jennifer.kiser@cuanschutz.edu|
22292354|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
22292355|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org|
22292356|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292357|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu|
22292358|NCT02652767|GenSight Biologics|Magali Taiel CMO|1 76 21 72 26|mtaiel@gensight-biologics.com|0033
22292359|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu|
22292360|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com|
22292361|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
22274553|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22274554|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org|
22260438|NCT02937701|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22260439|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22260440|NCT01101022|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22260441|NCT03075761|The University of Texas Southwestern Medical Center|Ayesha Zia, MD|214-456-7000|Ayesha.Zia@UTSouthwestern.edu|
22260442|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22260443|NCT00581139|University of California, Irvine|Dr. Zeev Kain|714-480-0039|zkain@uci.edu|
22260444|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22260445|NCT01941095|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22260446|NCT01721681|Bio Products Laboratory Ltd|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
22260447|NCT04455633|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
22260448|NCT01648166|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
22260449|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22260450|NCT03527745|Swiss Tropical and Public Health Institute|Jennifer Keiser, PhD|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
22260451|NCT03344510|Perelman School of Medicine at the University of Pennsylvania|Dr. Joseph Sobanko|215.360.0909|joseph.sobanko@uphs.upenn.edu|
22260452|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260453|NCT04015232|Lambda Therapeutic Research Ltd.|Dr. Adarsh Kumar Garg, M.B.B.S. Principal Investigator|+91-79-40202020|adarshgarg@lambda-cro.com|
22260454|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu|
22260455|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260456|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22260457|NCT01029353|Vanderbilt University Medical Center|Martin L Blakely, MD|615-936-7211|martin.blakely@vumc.org|
22260458|NCT01453075|VA ORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|1251
22260459|NCT04538170|Department of Anaesthesiology and Intensive Care Medicine, Eberhard-Karls-University,Tuebingen, Germany|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
22260460|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
22260461|NCT03002597|Children's Hospital of Pittsburgh UPMC|Dr. Kanwal Nischal|4126928940|nischalkk@upmc.edu|
22260462|NCT02932878|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22260463|NCT03503578|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22260464|NCT01918397|Boston University School of Public Health|Charles R Horsburgh, MD|617-414-1282|rhorsbu@bu.edu|
22260465|NCT00959660|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
22260466|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22292362|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com|
22260467|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292363|NCT03091777|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
22260468|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu|
22260469|NCT03828734|University of North Carolina at Chapel Hill|Justin Riddle, PhD|919-966-4755|justin_riddle@med.unc.edu|
22260470|NCT00437658|AbbVie|Global Medical Services|800-633-9110||
22260471|NCT03952143|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260472|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123|rachel.vicars@fphcare.co.nz|7759
22260473|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260474|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu|
22260475|NCT02942264|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
22260476|NCT01328093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260477|NCT04421508|Bellerophon Therapeutics|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
22260478|NCT03980483|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260479|NCT05150964|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22260480|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22260481|NCT02597998|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260482|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz|
22260483|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22260484|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu|
22260485|NCT02921737|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22260486|NCT03883906|Cincinnati Children's Hospital Medical Center|Michael Grimley, MD|513-803-3218|Michael.Grimley@cchmc.org|
22260487|NCT02649387|Mayo Clinic|Asher Alban Chanan Khan|904-953-0450|Chanan-Khan.Asher@mayo.edu|
22260488|NCT01334827|The Miriam Hospital|Dr Kate Guthrie, Co-Investigator, Project MIST Lead Investigator|401-793-8180|kate.guthrie@lifespan.org|
22260489|NCT00924326|National Cancer Institute|Steven Rosenberg, M.D., Ph.D.|240-858.3080|sar@nih.gov|
22260490|NCT02412228|Brown University Oncology Research Group|John Reagan, MD|401-863-3000|BrUOG@Brown.edu|
22260491|NCT03561883|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
22260492|NCT02385097|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22260493|NCT02942966|Philips Image Guided Therapy|Nicolas Aguirre|(612) 297-6655|nicolas.aguirre@philips.com|
22292364|NCT00089674|Amgen Inc.|Study Director|866-572-6436||
22292365|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com|
22292366|NCT01490788|Tonix Pharmaceuticals, Inc.|Greg Sullivan, MD||greg.sullivan@tonixpharma.com|
22260494|NCT03118466|Massachusetts General Hospital|Andrew Brunner MD|6177241124|abrunner@mgh.harvard.edu|
22260495|NCT02365207|University of Texas Health San Antonio|Robert Svatek|210-567-5676|svatek@uthscsa.edu|
22260496|NCT03006978|Sight Sciences|Jaime Dickerson|(877) 266-1144|jdickerson@sightsciences.com|
22260497|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
22260498|NCT01395030|The Queen's Medical Center|Program Director for PET Research|808-691-5466|skwee@queens.org|
22260499|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com|
22260500|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si|
22260501|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22292367|NCT01476644|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22292368|NCT04105543|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|(608) 262-4961|jybruce@medicine.wisc.edu|
22292369|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu|
22292370|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292371|NCT01267656|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22292372|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu|
22292373|NCT02676466|University of Florida|ENRGISE Coordinating Center Project Manager|352-294-5800|ENGISEACC@aging.ufl.edu|
22292374|NCT01016561|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
22292375|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292376|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu|
22292377|NCT02520661|UW School of Medicine and Public Health|Manish N. Shah, MD, MPH|608-263-6690|mnshah@medicine.wisc.edu|
22292378|NCT06352060|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-934-4300|dlakkireddy@gmail.com|
22292379|NCT04192370|Brigham and Women's Hospital|Joji Suzuki, MD|617-455-7981|Jsuzuki2@bwh.harvard.edu|
22292380|NCT01414608|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|gedeonl@nrgoncology.org|
22292381|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22292382|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743||
22292383|NCT02301988|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22292384|NCT02891161|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22292385|NCT03309150|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22292386|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com|
22292387|NCT01931202|New York State Psychiatric Institute|Bret R. Rutherford|6467748660|bret.rutherford@nyspi.columbia.edu|
22260502|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
22260503|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
22260504|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua|
22260505|NCT03218592|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|9199969998|akashuba@unc.edu|
22260506|NCT02098993|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
22260507|NCT02888171|University of Alabama at Birmingham|Orlando M. Gutierrez, MD|205-996-2736|ogutierrez@uabmc.edu|
22260508|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com|
22260509|NCT02817841|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
22260510|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
22260511|NCT04188106|Rose Research Center|Perry Willette, MD|919.908.0945|perry.willette@roseresearchcenter.com|
22260512|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22260513|NCT03514420|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22260514|NCT01746017|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260515|NCT04742283|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22260516|NCT02424097|UCSF - School of Dentistry|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
22260517|NCT01675622|Mundipharma (China) phamaceutical CO. LTD|Director of R&D|0086-10-65636800||
22260518|NCT04032977|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|clinicaltrials@prolleniumus.com|
22260519|NCT02158572|Agile Therapeutics|Michelle Previtera, Associate Director of Clinical Development|609-683-1880|mprevitera@agiletherapeutics.com|
22292388|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
22292389|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org|
22292390|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu|
22260520|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300||
22292391|NCT02775903|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22292392|NCT04468321|Yale University|Joseph Ross, MD, MHS|2037852987|joseph.ross@yale.edu|
22260521|NCT02606708|New York University School of Medicine|Carmen Perez, MD|212 731 5003|carmen.perez@nyumc.org|
22292393|NCT03237871|Johns Hopkins Bloomberg School of Public Health|Principal Investigator|410-955-3537|ljennin6@jhu.edu|
22292394|NCT03552965|University of Arkansas for Medical Sciences|Rashad Perry|501-686-8274|Rperry3@uams.edu|
22292395|NCT05108922|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292396|NCT05036369|VibrantGastro|Clinical trials manager|+972 046663322|service@vibrantgastro.com|
22292397|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil|
22292398|NCT01564914|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
22292399|NCT02793921|University of Pittsburgh|Dr. Catherine Bender, Principal Investigator|412-624-3594|cbe100@pitt.edu|
22292400|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22292401|NCT03906461|Abbott|Clinical Research Scientist|16517563101|laura.zitellaverbick@abbott.com|
22292402|NCT04925271|Thomas Jefferson University|Anand Kumar, Associate Professor of Medicine|215-955-8900|anand.kumar@jefferson.edu|
22292403|NCT01795638|University of Cincinnati Medical Center|Barbara Isemann|513-584-5060|barbara.isemann@uchealth.com|
22292404|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com|
22292405|NCT03714620|Trinity Health, Loyola University Medical Center, Stritch School of Medicine|Shannon Lovett, MD, Associate Professor of Emergency Medicine|7082168705|slovett@lumc.edu|
22292406|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300||
22292407|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
22292408|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu|
22292409|NCT00293215|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22292410|NCT02213042|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22292411|NCT02007512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292412|NCT04735536|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
22292413|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org|
22292414|NCT05402020|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292415|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22292416|NCT05619523|University of Maryland, College Park|Dr. Melanie Killen|(301) 405-3176|mkillen@umd.edu|
22292417|NCT04505540|University of Vermont|Dr. Scott Mackey, PhD|8028478767|msmackey@uvm.edu|
22292418|NCT03686514|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22292419|NCT05342532|Icahn School of Medicine at Mount Sinai|Gres Karim|212-241-2499|gres.karim@mountsinai.org|
22292420|NCT02808871|Baylor College of Medicine|Ivan O. Rosas, MD|617-510-9910|Ivan.Rosas@bcm.edu|
22292421|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
22292422|NCT00805948|Medtronic, Inc|Michael McGuffey, Clinical Research Director|707-591-7126|michael.mcguffey@medtronic.com|
22292423|NCT03180684|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22292424|NCT04007198|Equillium|Clinical Operations|8582401200|clinicaltrials@equilliumbio.com|
22260522|NCT00840632|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260523|NCT05017480|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
22260524|NCT02311361|National Cancer Institute|Dr. Tim Greten|240-760-6114|tim.greten@nih.gov|
22260525|NCT04927013|Emory University|Yue Guan, PhD|404-712-1671|yue.guan@emory.edu|
22260526|NCT05628675|King's College London/South London and Maudsley NHS|Dr Rebecca Cockburn|02032288800|rebecca.cockburn@kcl.ac.uk|
22260527|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com|
22260528|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net|
22260529|NCT02028715|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
22260530|NCT01492361|Amarin Pharma, Inc.|Dr. Alexander Giaquinto, Executive Director, Regulatory Affairs|908-326-1324|alex.giaquinto@amarincorp.com|
22260531|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22260532|NCT04083859|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
22260533|NCT01595503|University of Michigan|stephan taylor|7349364955|sftaylor@umich.edu|
22260534|NCT02091882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22260535|NCT01315249|Novartis|Study Director|41 61 324 1111||
22260536|NCT03655106|William Beaumont Hospitals|Amit Bahl, MD|2488982245|amit.bahl@beaumont.edu|
22260537|NCT03227445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260538|NCT01991470|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22260539|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22260540|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
22260541|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
22260542|NCT03472365|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Medical Director: Linna Wang|+86-13581990612|linna.wang@hengrui.com|
22260543|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu|
22260544|NCT01629381|University of Padua|Dr. Giuseppe Camporese|049 8212882|giuseppe.camporese@aopd.veneto.it|+39
22260545|NCT02158494|University of Wisconsin - Madison|Mitchell Tyler|608-262-5112|metyler1@wisc.edu|
22260546|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com|
22260547|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu|
22260548|NCT02688556|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|clinical.trials@sparcmail.com|
22260549|NCT02545998|Oxshott Medical Practice|Dr Sarah Glynne|01372 844000|sarah.glynne@nhs.net|
22260550|NCT00472290|Amgen Inc.|Study Director|866-572-6436||
22260551|NCT00777829|UCSD|Dr. Sara C. Mednick|8586423192|mednicks@uci.edu|
22260552|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
22260553|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000|mark.korsten@va.gov|6753
22260554|NCT04567342|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22260555|NCT01226797|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260556|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260557|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22260558|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22260559|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org|
22260560|NCT05214560|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
22260561|NCT01968382|Virginia Commonwealth University|Stephanie Taylor MSN, RN|804-828-9311|stephanie.taylor@vcuhealth.org|
22260562|NCT00878995|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
22292425|NCT02495233|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22292426|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu|
22292427|NCT03660488|University of Southern California|Jeffrey D Klausner MD MPH, Clinical Professor of Population and Public Health Sciences|4158768901|jdklausner@med.usc.edu|
22292428|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22260563|NCT03629249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22260564|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu|
22260565|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
22260566|NCT03633721|Albert Einstein College of Medicine|Dr. Anjali Sharma|7185152593|anjali.sharma@einsteinmed.edu|
22260567|NCT03054103|Wake Forest University Health Sciences|Dr. Timothy Harwood|3367164498|tharwood@wakehealth.edu|
22260568|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com|
22260569|NCT02343120|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22260570|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org|
22260571|NCT02134522|Yale University|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
22260572|NCT02914795|Medical University of Grazt|Assoc. Prof. Dr. Dirk von Lewinski|+43 316 385|dirk.von-lewinski@medunigraz.at|80684
22260573|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com|
22260574|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260575|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372||
22260576|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu|
22260577|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400|dzimmerman@toh.on.ca|82534
22292429|NCT04263454|University of Alabama at Birmingham|Jarred Younger|205-975-5821|youngerlab@uab.edu|
22260578|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com|
22260579|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22260580|NCT03422653|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22260581|NCT02880761|Continuous Quality Improvement Experts Congress of Changping District|Director of Continuous Quality Improvement Experts Congress of Changping District|+861069006549|zhangdongliang@pkuih.edu.cn|1069006789
22260582|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22260583|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com|
22260584|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22260585|NCT03538587|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
22260586|NCT02831569|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260587|NCT00954915|MacroGenics, Inc.|Teplizumab Program Manager||info@macrogenics.com|
22260588|NCT01287013|National Institutes of Health|Bradford Wood, MD|(301) 496-7739|bwood@nih.gov|
22260589|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743||
22260590|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22260591|NCT01900730|UT MD Anderson Cancer Center|Dr. Wendy Woodward, PHD/ Professor, Radiation Oncology Department|713-563-8481|wwoodward@mdanderson.org|
22260592|NCT02109042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260593|NCT03203447|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22260594|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088||
22260595|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
22260596|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org|
22260597|NCT02962934|University of Queensland Center for Clinical Research|Professor Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
22260598|NCT01471093|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22260599|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22260600|NCT02475954|Rutgers - Robert Wood Johnson Medical School|Roseanne D. Dobkin|732-235-4051|dobkinro@rutgers.edu|
22260601|NCT03656783|Brigham and Women's Hospital|Marcelo Di Carli, MD|6177326290|mdicarli@bwh.harvard.edu|
22260602|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260603|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300||
22260604|NCT04622709|University of North Carolina, Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
22260605|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300||
22260606|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000|kenneth.boockvar@va.gov|3807
22260607|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu|
22260608|NCT04006171|Near East University|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
22260609|NCT03049488|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
22260610|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116||
22260611|NCT01939197|AbbVie|Global Medical Services|800-633-9110||
22260612|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu|
22260613|NCT02849652|University of Pennsylvania|Dr. Robert Schnoll|2157467143|schnoll@pennmedicine.upenn.edu|
22260614|NCT01641445|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
22260615|NCT04977336|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22260616|NCT04538040|Gilead Sciences|Lisa Sterman, MD, MPH|415-407-8434|Lisa.Sterman@Gilead.com|
22260617|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
22260618|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu|
22260619|NCT01353495|Wright Medical Technology, Inc.|Jonette Hodge, MSN, RN, CCRP, Director, Medical Affairs|8002387188|jonette.hodge@wmt.com|4747
22260620|NCT02480764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22260621|NCT03117569|Viral Hepatitis Clinical Research Program Kirby Institute|Clinical Trials Manager|+61 9385 0900|pmarks@kirby.unsw.edu.au|
22260622|NCT02457832|Associate Professor of Medicine Emory University School of Medicine, Department of Medicine, Division of Geriatrics and Gerontology; Research Health Scientist Atlanta VA Health Care System, Center for Visual and Neurocognitive Rehabilitation|Madeleine E. Hackney, Ph.D.|404-315-4100|mehackn@emory.edu, madeleine.hackney@va.gov|373141
22260623|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com|
22260624|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260625|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com|
22260626|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu|
22260627|NCT03991494|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22292430|NCT01231347|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22292431|NCT01460368|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292432|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22292433|NCT01212107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292434|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22292435|NCT04181320|Mölnlycke|Vice President Corporate Clinical & Medical Affairs CMO & RQA|+46317223045|jane.clark@molnlycke.com|
22292436|NCT04398316|Hennepin County Medical Center, Department of Emergency Medicine|Elliott Chinn, DO|612-873-3508|elliott.chinn@hcmed.org|
22292437|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org|
22260628|NCT05277389|Arizona State University|Claire Honeycutt, Associate Professor|4809658453|claire.honeycutt@asu.edu|
22260629|NCT02467621|Copenhagen University Hospital Rigshospitalet, Dept. of Intensive Care 4131|Dr. Morten Hylander Møller|22555343|mortenhylander@gmail.com|+45
22260630|NCT03086356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260631|NCT03144687|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22260632|NCT02514174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260633|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22260634|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu|
22260635|NCT01894178|Baylor College of Medicine|Dr. Lee Chang|713-873-4321|lcchang@bcm.edu|
22260636|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22260637|NCT02920996|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
22260638|NCT01402947|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22260639|NCT00591630|University of Texas MD Anderson Cancer Center|Issa F. Khouri, MD / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
22260640|NCT02218164|H. Lee Moffitt Cancer Center and Research Institute|Dr. Christine Chung|813-745-5061|christine.chung@moffitt.org|
22260641|NCT02419690|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
22320362|NCT04631796|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22320363|NCT01463670|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun MD|646-608-3718|hassounh@mskcc.org|
22320364|NCT03029715|Menoufia Univeristy|Dr Ezzeldin Ibrahim|0021006303178|ezzeldin7@yahoo.com|
22320365|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu|
22320366|NCT00520884|University of Pennsylvania, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism|Anne Cappola, M.D., Sc.M.|215-573-5359|ACappola@mail.med.upen.edu|
22320367|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu|
22320368|NCT00457015|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22320369|NCT03670953|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
22320370|NCT04179734|Imperial College London|Professor Waljit S. Dhillo, Principal Investigator|00442075943487|w.dhillo@imperial.ac.uk|
22320371|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22320372|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov|
22320373|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu|
22320374|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com|
22320375|NCT04467424|University Hospital of Split|Dr. Ana Nevescanin Biliskov, pediatric anesthesiologist|00385912508001|anevescanin@gmail.com|
22320376|NCT02877693|Abbott|Grant Kim, Director Clinical Programs|818-493-3147|grant.kim1@abbott.com|
22320377|NCT02809131|Vanderbilt University Medical Center|Christopher R. Ellis, MD, FACC, FHRS|(615)-936-2523|Christopher.ellis@vumc.org|
22320378|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320379|NCT05368961|Cleveland Clinic|Michelle Levay, Nurse Research Manager|216-445-4749|levaym@ccf.org|54749
22320380|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
22320381|NCT05714982|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
22320382|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22320383|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
22320384|NCT00357214|Tufts University|Bess Dawson-Hughes|617 556 3066|bess.dawson-hughes@tufts.edu|6175100519
22320385|NCT01687179|Brigham and Women's Hospital|Elizabeth P. Henske, MD|857-307-0782|ehenske@bwh.harvard.edu|
22320386|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
22320387|NCT00971178|Department of Anaesthesiology, the University of Hong Kong|Clinical Assistant Professor|852-22553303|cheucw@hku.hk|
22260642|NCT01471522|NYU Langone Health|Anna Naumova|212.263.6927|Anna.Naumova@nyulangone.org|
22260643|NCT02405195|Västra Götalandsregionen|Lukas Lannemyr|46313428860|lukas.lannemyr@vgregion.se|
22260644|NCT01432171|Dana-Farber Cancer Institute|Dr. Andrew Norden, M.D., M.P.H. - Lead Principal Investigator|617-632-2166|anorden@partners.org|
22260645|NCT02863575|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260646|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
22260647|NCT01248247|UT MD Anderson Cancer Center|Dr. Marcelo Vailati Negrao, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 614-4938|mvnegrao@mdanderson.org|
22260648|NCT03597256|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22260649|NCT02943447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22260650|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu|
22260651|NCT01794039|Mayo Clinic|Shaji K. Kumar, M.D.|(507) 284-2017|kumar.shaji@mayo.edu|
22260652|NCT02562378|Medica Scientia Innovation Research (MEDSIR)|Scientific director|+34 93 221 41 35|trialsregister.medsir@medsir.org|
22260653|NCT04503603|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22260654|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com|
22260655|NCT01104025|Cincinnati Children's Hospital Medical Center|Michael Jordan, MD|513-803-9063|Michael.Jordan@cchmc.org|
22260656|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260657|NCT01804270|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
22260658|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu|
22260659|NCT02334722|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
22260660|NCT03988803|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260661|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22260662|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu|
22260663|NCT01666730|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. David Bajor|1-800-641-2422|CTUReferral@UHhospitals.org|
22260664|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com|
22260665|NCT03138330|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
22260666|NCT02087904|AbbVie|Global Medical Services|AbbVie|abbvieclinicaltrials@abbvie.com|
22260667|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22260668|NCT01327963|EndoGastric Solutions|Adrian Lobontiu, Chief Medical Officer|1 650-474-9259|alobontiu@endogastricsolutions.com|
22260669|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260670|NCT02178722|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22260671|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu|
22260672|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu|
22260673|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22260674|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260675|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260676|NCT04056182|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frances.levin@nyspi.columbia.edu|
22260677|NCT02107092|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22260678|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22260679|NCT02828917|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22260680|NCT04213326|Exact Sciences|Adriann Kern|4843563027|akern@exactsciences.com|
22260681|NCT01954264|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260682|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu|
22260683|NCT03325426|UCSF|Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
22260684|NCT01173692|UT MD Anderson Cancer Center|Brandon Gunn, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2562|gbgunn@mdanderson.org|
22260685|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu|
22260686|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22260687|NCT04826809|Mayo Clinic|Dr. Janielle R. Nordell|507-594-4700|Nordell.Janielle@mayo.edu|
22260688|NCT02359305|Nationwide Children's Hospital - Dept. of Anesthesiology & Pain Medicine|Dr. Arlyne Thung|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
22292438|NCT05466448|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
22292439|NCT00445978|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22292440|NCT03112590|Moffitt Cancer Center|Hyo S. Han, MD|813-745-4933|Hyo.Han@moffitt.org|
22292441|NCT02436681|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
22292442|NCT02103218|UNC Greensboro|Lisa Goble Director Office of Research Integrity|336-256-1173|lagoble@uncg.edu|
22292443|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300||
22292444|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com|
22292445|NCT02443519|Yeshiva University & Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|elizabeth.seng@yu.edu|
22274555|NCT02579629|Emory University|Katherine Egan|404-727-8463|kfegan@emory.edu|
22274556|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil|
22292446|NCT03861702|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22260689|NCT01941030|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22260690|NCT04448678|University of Utah|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
22292447|NCT03635788|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22292448|NCT05595382|Rutgers University Associate Professor|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
22292449|NCT03722173|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292450|NCT04571515|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Susanne Vogt|+49 (0) 172 19 20 321|susanne.vogt@viatris.com|
22292451|NCT04128579|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
22292452|NCT06624449|University of Cincinnati|Fahad Alanezi|5138845844|alanezfz@mail.uc.edu|
22292453|NCT05098938|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22292454|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch|
22292455|NCT02570074|University of Illinois at Chicago|Keith A. Rodvold, PharmD, FCCP, FIDSA|312-996-3341|kar@uic.edu|
22292456|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com|
22292457|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22292458|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292459|NCT01134315|AbbVie|Global Medical Services|800-633-9110||
22292460|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu|
22292461|NCT04587271|University of Kentucky|Dr. Suzanna Attia|859-323-6211|suzanna.attia@uky.edu|
22292462|NCT02360111|Memorial Sloan Kettering Cancer Center|Dr. Ann Jakubowski, Ph.D., MD|212-639-5013|jakubowa@mskcc.org|
22292463|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22292464|NCT01933217|Children's Hospital Medical Center, Cincinnati|Brad Kurowski, MD, MS|513-803-3655|brad.kurowski@cchmc.org|
22292465|NCT01669096|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292466|NCT02861131|Oregon Health & Science University|Brandon Togioka|5034944572|togioka@ohsu.edu|
22292467|NCT03923738|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22292468|NCT05246397|University of Washington|Andrew Bowdle MD, PhD, FASE|206-979-0477|bowdle@u.washington.edu|
22292469|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
22292470|NCT03875768|Duke University|Gary G. Bennett, PhD|919-684-4510|gary.bennett@duke.edu|
22292471|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292472|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu|
22292473|NCT04327674|Department of Respiratory Diseases and Allergy. Aarhus University Hospital. Denmark.|Søren Helbo Skaarup|28911869|soeska@rm.dk|
22292474|NCT00723398|Milton S. Hershey Medical Center|Dr. Andrea Manni|717-531-8395|amanni@pennstatehealth.psu.edu|
22292475|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300||
22292476|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22292477|NCT03719586|NIAID/NIH|Dr. Richard T. Davey, Jr., M.D., U.S. study PI|301-496-8029|rdavey@niaid.nih.gov|
22292478|NCT02791594|Abramson Cancer Center|Dr. Michael Farwell|215-662-7750|michael.farwell@pennmedicine.upenn.edu|
22292479|NCT02310321|Astellas Pharma Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22292480|NCT04950166|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
22292481|NCT01698905|Novartis|Study Director|862-778-8300|novartis.email@novartis.com|
22292482|NCT05896748|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292483|NCT03207555|The University of Texas MD Anderson|Jan Burger, MD/Professor|713-563-1487|jaburger@mdanderson.org|
22292484|NCT06138145|University of Pennsylvania|Dr. Kevin B. Johnson|215-573-5885|Kevin.Johnson1@Pennmedicine.upenn.edu|
22292485|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
22292486|NCT03862040|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22292487|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22292488|NCT04508140|Highlight Therapeutics S.L.|Marisol Quintero|+34 961 10 99 55|mquintero@highlighttherapeutics.com|
22292489|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22292490|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
22292491|NCT01200862|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
22292492|NCT02456103|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22292493|NCT01465191|Columbia University|Richard Smiley, MD|212-342-2742|rms7@cumc.columbia.edu|
22292494|NCT03614975|University of Pittsburgh, Department of Family Medicine|Richard Zimmerman, MD|412-383-2354|zimmrk@upmc.edu|
22292495|NCT01390220|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
22292496|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292497|NCT03059446|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22292498|NCT02992132|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22292499|NCT02448810|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22292500|NCT00136604|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292501|NCT04795622|Merz Aesthetics|Public Disclosure Manager|+49 69 1503|Aesthetic.Trials@merz.com|1
22260691|NCT05067647|Ethicon Endo-Surgery, Inc.|MEDICAL DIRECTOR LCM Compliance|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22260692|NCT04166032|Cleveland Clinic|Kimberly Jenkins, Research Administrator|216-445-4791|jenkink@ccf.org|
22260693|NCT02781727|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22260694|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu|
22260695|NCT03069937|Medical University of South Carolina|Principal Investigator|843-792-4271|gourdith@musc.edu|
22260696|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu|
22260697|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr|
22260698|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
22260699|NCT04190693|Imcyse SA|Jean Van Rampelbergh|+3243251100|j.vanrampelbergh@imcyse.com|
22260700|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu|
22260701|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch|
22260702|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il|
22260703|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org|
22260704|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22260705|NCT02380183|Montefiore Medical Center|Dr. Amaresh Vydynathan|718-920-4316|avydynathan@montefiore.org|
22260706|NCT01411332|University of Miami|Alan Pollack MD, PhD|305-243-4916|apollack@med.miami.edu|
22260707|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590||
22260708|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
22260709|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu|
22260710|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch|
22260711|NCT02653664|University of Washington|Dr. Mark Jensen|206-543-3185|mjensen@uw.edu|
22260712|NCT04657770|UCLA|Steve Cramer|424-522-7273|SCCramer@mednet.ucla.edu|
22260713|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22260714|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22260715|NCT02055963|UT MD Anderson Cancer Center|Dr. Juan P. Cata, MD-Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
22260716|NCT04915755|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260717|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
22260718|NCT00727571|Amgen Inc.|Study Director|866-572-6436||
22260719|NCT03247556|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22260720|NCT02031978|USDA Food and Nutrition Service|Courtney Paolicelli|7036054370|Courtney.Paolicelli2@usda.gov|
22260721|NCT03334825|New York City Department of Health and Mental Hygiene|Dr. Ellen Wiewel|347-396-7653|ewiewel@health.nyc.gov|
22260722|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22260723|NCT03921294|Indiana Hemophilia & Thrombosis Center|Kat Molitor|3178710011|kmolitor@ihtc.org|
22260724|NCT00978822|Albany Medical Center|Panayiotis Varelas|2488739855|varelap@amc.edu|
22260725|NCT05087524|University of Wisconsin - Madison|Dr. Ellen Wald|(608) 263-8558|erwald@pediatrics.wisc.edu|
22260726|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22260727|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22260728|NCT02495857|Teva Pharmaceuticals Inc. USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
22260729|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|001
22260730|NCT02006160|UBMD Neurology|Dr. Ralph Benedict|7163230556|benedict@buffalo.edu|
22260731|NCT04257474|Moffitt Cancer Center|Susan T. Vadaparampil, PhD, MPH|813-745-1997|Susan.Vadaparampil@moffitt.org|
22260732|NCT04407806|William Beaumont Hospital|Dr. Graham Krasan, Pediatric Infectious Disease Specialist|248-551-0046|graham.krasan@beaumont.org|
22260733|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu|
22260734|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu|
22260735|NCT04605094|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22260736|NCT02724462|Fred Hutchinson Cancer Research Center|Dr. Jonathan Bricker|206-667-5077|jbricker@fredhutch.org|
22260737|NCT00469417|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22260738|NCT00979303|Children's Hospital Boston|Christina Miyake|832-826-5650|cymiyake@bcm.edu|
22260739|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org|
22260740|NCT02188303|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260741|NCT02589808|Imperial College|Petros Nihoyannopoulos|020 3311 3311|p.nihoyannopoulos@imperial.ac.uk|
22260742|NCT04206332|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22260743|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111|elham.emami@umontreal.ca|6053
22260744|NCT05612724|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
22260745|NCT03112863|UC Davis Dermatology|Iryna Rybak|916-551-2636|irybak@ucdavis.edu|
22260746|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260747|NCT04000815|Dr.Ali Cenk Ozay|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
22260748|NCT00239577|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260749|NCT02631772|Medical University of South Carolina|Dr. Derek Dubay|843-792-3368|dubay@musc.edu|
22306643|NCT05455476|VA Center of Excellence for Suicide Prevention|Lisham Ashrafioun|585-430-2026|Lisham.ashrafioun@va.gov|
22260750|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu|
22260751|NCT02968992|Johns Hopkins University|Jeremy D. Waltson, MD|410-550-1003|jwalston@jhmi.edu|
22260752|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu|
22260753|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22260754|NCT02017964|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22260755|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
22292502|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org|
22292503|NCT02354482|University of Kentucky|Jessica Clouser|8593230284|jess.clouser@uky.edu|
22292504|NCT03963401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292505|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22292506|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
22292507|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu|
22292508|NCT01610271|Baylor College of Medicine|Rabih Darouiche, MD|713.799.5088|sdself@gmail.com|
22292509|NCT01638819|Sutter Health|Michael Chez, MD|(916) 773-8711|ChezM@sutterhealth.org|
22292510|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov|
22292511|NCT02038452|Keele University|Dr Edward Roddy|01782 734715|e.roddy@keele.ac.uk|
22292512|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
22292513|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22292514|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com|
22292515|NCT01302379|University of San Diego, California|Ruth Patterson|8585349235|repatterson@ucsd.edu|
22292516|NCT01842815|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22292517|NCT01626495|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22292518|NCT00304239|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22292519|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292520|NCT05430022|University of Southern California|Dr. Jessica Schwartzman, Assistant Professor|3232075910|jstrendlab@gmail.com|
22292521|NCT05521906|University of Nebraska-Lincoln, Department of Educational Psychology/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
22292522|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22292523|NCT01828320|University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22292524|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
22292525|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22260756|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22260757|NCT04091971|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
22260758|NCT01391793|UPMC Children's Hospital of Pittsburgh|Nader Shaikh, MD, MPH|412-692-8111|nader.shaikh@chp.edu|
22260759|NCT01015625|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
22260760|NCT05439252|University of Bath|Dr Oliver Perkin|01225384356|o.j.perkin@bath.ac.uk|
22260761|NCT05600322|Photocure ASA|Clinical Director|+4722062210|research@photocure.com|
22260762|NCT00150462|Amgen, Inc.|Study Director|866-572-6436||
22260763|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu|
22260764|NCT03107091|BioVie|Penelope Markham|17035989972|pmarkham@biovieinc.com|
22260765|NCT02332863|University of Colorado - Anschutz Medical Campus|Dr. Sachin Wani|720-848-2786|sachin.wani@cuanschutz.edu|
22260766|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260767|NCT01449630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260768|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22260769|NCT03340727|RTI International|Abhik Das|301-770-8214|adas@rti.org|
22260770|NCT00874237|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
22260771|NCT03205553|University of Arkansas for Medical Sciences|Dr. Patrick Bonasso|(501) 364-2943|PCBonasso@uams.edu|
22260772|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org|
22260773|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
22260774|NCT01541891|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medical Director|+52 (33)30014200|leopoldo.baiza@sophia.com.mx|
22260775|NCT03447262|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22260776|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov|
22260777|NCT03478397|CEDES|Dr. Silvina Arrossi|541148651007|silviarrossi2020@gmail.com|
22260778|NCT05327491|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22260779|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22260780|NCT02535611|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
22260781|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22260782|NCT01126736|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22260783|NCT05194722|Washington University School of Medicine|Abby Cheng, MD, PI|314-747-2823|chengal@wustl.edu|
22260784|NCT02202850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22260785|NCT01873586|SeaSpine|Director Clinical Affairs||tish.mikoczi@seaspine.com|
22260786|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com|
22260787|NCT00669942|Novartis|Study Director|862-778-8300||
22260788|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260789|NCT02703948|Galderma R&D, LLC|US A&C Clinical Operations|8179615111|courtney.maguire@galderma.com|
22260790|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22260791|NCT03522675|NeXtGen Biologics, Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
22260792|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu|
22260793|NCT02674477|Johns Hopkins University|Dr. Alexis Hammond|410-550-0045|ahammon9@jhmi.edu|
22260794|NCT04005859|Atrium Health|Dr. Kevin Kasten|704-355-1813|kevin.kasten@atriumhealth.org|
22260795|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu|
22260796|NCT01789905|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260797|NCT02336165|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22260798|NCT00450190|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22260799|NCT03959683|INDIANA UNI SCHOOL OF MEDICINE|Erica Sahm|317-274-3560|esahm@iuhealth.org|
22260800|NCT03002077|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22260801|NCT02495467|Richmond Pharmacology Limited|Dr Jorg Taubel|020 8664 5200|j.taubel@richmondpharmacology.com|
22260802|NCT00834756|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260803|NCT04365153|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
22260804|NCT03287310|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22260805|NCT03611608|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22260806|NCT04625114|University Hospital Ghent|Dr Marie-Angélique De Scheerder|+32 9 33 21349|marie-angelique.descheerder@uzgent.be|
22260807|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr|
22260808|NCT02461771|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22260809|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590||
22260810|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22260811|NCT02980978|Minneapolis Heart Institute Foundation|Population Health Program Manager|612-863-4222|gbenson@mhif.org|
22260812|NCT03048500|Northwestern University|Young Chae, MD|312-695-1301|young.chae@northwestern.edu|
22292526|NCT02260440|UPMC Hillman Cancer Center|Anuradha Krishnamurthy, MD|412-623-3283|krishnamurthya2@upmc.edu|
22260813|NCT01479439|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
22292527|NCT02349061|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22260814|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net|
22260815|NCT02597101|Allegheny Health Network|Dr. Nick Giannoukakis|412-359-6394|nick.giannoukakis@ahn.org|
22260816|NCT02079766|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22260817|NCT03252353|Chiasma|Asi Haviv, VP Clinical development|972-8-939-3888|Asi@chiasmapharma.com|
22260818|NCT01884740|Weill Cornell Medicine|Jeffery Greenfield, MD PhD|212-746-2363|jpgreenf@med.cornell.edu|
22260819|NCT01313416|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
22260820|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262|hugosc@ohsu.edu|52338
22260821|NCT03018249|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22260822|NCT04881968|The Dartmouth Institute|Dr. Amber Barnato|603-646-5237|amber.barnato@dartmouth.edu|
22260823|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov|
22260824|NCT03929393|University of Minnesota|Brent Leininger|(612) 626-6477|lein0122@umn.edu|
22260825|NCT01320696|Resilience Inc.|Wael El-Amin, M.D.|(240)885-1221|Wael.el-amin@resilience.com|
22260826|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu|
22260827|NCT03883607|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
22260828|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
22260829|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org|
22260830|NCT03929367|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
22260831|NCT00515203|Amgen Inc.|Study Director|866-572-6436||
22260832|NCT01937390|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260833|NCT02216071|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
22260834|NCT03544138|Preceptis Medical|Steve Anderson|612-327-4795|steve@preceptismedical.com|
22292528|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu|
22260835|NCT01706536|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22320388|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260836|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803|risius@uke.uni-hamburg.de|4142
22260837|NCT04753437|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22260838|NCT01096290|University of South Alabama|Jack DiPalma, MD|251-660-5555|jdipalma@health.southalabama.edu|
22260839|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000|lynn.snow@va.gov|2260
22260840|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22260841|NCT02228174|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
22260842|NCT02682602|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
22260843|NCT03567174|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
22260844|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22260845|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300||
22260846|NCT04298918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22260847|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org|
22260848|NCT05376319|Mayo Clinic|Ulrich Specks, M.D.|507-284-2494|specks.ulrich@mayo.edu|
22260849|NCT01340495|Massachusetts General Hospital|Shannon MacDonald, MD|617-643-7250|SMACDONALD@mgh.harvard.edu|
22260850|NCT03497897|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@novartis.com|
22260851|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633||215
22260852|NCT02627924|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22260853|NCT00667862|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22260854|NCT03979079|Institut Bergonié|Dr Carine Bellera|33 0 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
22260855|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu|
22260856|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu|
22260857|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu|
22260858|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260859|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu|
22260860|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu|
22260861|NCT02128997|UPENN|Valerie Riis|2154989099|valerie.armendariz@uphs.upenn.edu|215
22260862|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu|
22260863|NCT00840099|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260864|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
22260865|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22260866|NCT05038293|University of Washington Department of Periodontics|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
22260867|NCT02163837|Chu St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@stpierre-bru.be|
22260868|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260869|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177|Yaelr@enzymotec.com|144
22260870|NCT02339558|Prince of Wales Hospital|Brigette B.Y. Ma|(852) 26321042|brigette@clo.cuhk.edu.hk|
22260871|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22260872|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599||
22260873|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
22260874|NCT04466111|SGX Medical|VP of Clinical|818-527-2710|clinical@sgxmedical.com|
22260875|NCT02829268|Washington University School of Medicine, Department of Medicine, Division of Endocrinology|Fumihiko Urano, MD, PhD|314-362-8683|urano@wustl.edu|
22260876|NCT02016612|Bengtson Center|Dr Bradley Bengtson|616 588 8880|drb@bengtsoncenter.com|
22292529|NCT01397162|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292530|NCT02339285|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
22292531|NCT02053051|Imperial College London|Prof Nick Oliver|02075941862|nick.oliver@imerial.ac.uk|
22292532|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22292533|NCT02367131|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292534|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu|
22292535|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu|
22292536|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu|
22292537|NCT03326726|Medline Industries|Sr. Regulatory Affairs Specialist|847-643-3515|aminarcik@medline.com|
22292538|NCT02754557|Emory University|Negar Fani, PhD|404-712-0354|nfani@emory.edu|
22292539|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu|
22292540|NCT04465162|UT MD Anderson Cancer Center|Dr. Bouthaina S Dabaja, MD-Professor, Radiation Oncology Department|(713) 563-2406|bdabaja@mdanderson.org|
22292541|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504||
22292542|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22292543|NCT01550471|Allegheny Health Network|Deborah Gentile, Principal Investigator|412-359-4099|dgentile@wpahs.org|
22260877|NCT03021538|Cleveland Clinic|Michael Tong, M. D.|216-445-0807|tongz@ccf.org|
22260878|NCT03553823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22260879|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22260880|NCT03450070|Johnson & Johnson Consumer Inc.|Heather Smith|908-874-1235|HSmith21@its.jnj.com|
22292544|NCT02556203|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22306644|NCT06218251|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
22260881|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu|
22260882|NCT02910037|The University of California, San Francisco|Dr. Charles Chiu|(415) 514-8219|charles.chiu@ucsf.edu|
22260883|NCT04753710|Sintetica SA|Roberta Bianchi|0041 91 640 42 50|rbianchi@sintetica.com|
22260884|NCT00813293|Beth Israel Deasoness Medical Center|Andrea Bullock MD, MPH||abullock@bidmc.harvard.edu|
22260885|NCT02794974|HELIOS Medical Center Schwerin, Germany|Ronald Seidel|+49 385 5204251|ronald.seidel@helios-kliniken.de|
22260886|NCT02870920|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22260887|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22260888|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260889|NCT03752528|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
22260890|NCT01981720|Protalix Ltd.|Sari Alon MSc|+972-4-9028100|sari@protalix.com|215
22260891|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
22260892|NCT02549092|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22260893|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260894|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu|
22292545|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22292546|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
22292547|NCT02180165|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292548|NCT01359007|University of Oklahoma|Ingrid Block - CTO Directo|405-271-8777|ingrid-block@ouhsc.edu|
22292549|NCT02943460|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22292550|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22292551|NCT04171765|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22274557|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509||
22260895|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu|
22260896|NCT01376167|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260897|NCT00656305|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22260898|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com|
22260899|NCT02642835|Medway NHS Foundation Trust|Professor Jonaathan Duckett -Consultant Urogynaecologist|01634|jraduckett@hotmail.com|835154
22260900|NCT01546545|Pennington Biomedical Research Center|Jeffrey Gimble, MD, PhD|225-763-3000|doctors@pbrc.edu|
22260901|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22260902|NCT02543554|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wustl.edu|
22260903|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu|
22260904|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22260905|NCT03221374|Carnegie Mellon University|Dr. Bin He|412-268-9857|bhe1@andrew.cmu.edu|
22260906|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu|
22260907|NCT03361228|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22260908|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu|
22260909|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com|
22260910|NCT03693430|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22260911|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22260912|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu|
22260913|NCT02930005|The University of Texas Health Science Center at Houston|Dr. Olaoluwa O. Okusaga|(713) 741-3952|Olaoluwa.O.Okusaga@uth.tmc.edu|
22260914|NCT02373098|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email.@novartis.com|
22260915|NCT00870870|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22260916|NCT01874756|Indiana University|Dr. Alan Breier|3178808495|abreier@iupui.edu|
22260917|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260918|NCT03151057|Northwell Health Cancer Institute|Dr. Douglas Gladstone|(516) 734-8900|msteve35@jhmi.edu|
22260919|NCT00304083|SARC|Research Project Manager|734-930-7600|sarc@sarctrials.org|
22260920|NCT03966365|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22260921|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22260922|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22260923|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260924|NCT01247701|Baylor College of Medicine/Texas Children's Hospital|Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
22260925|NCT04166630|Emory University|Randi Smith|404-251-8914|randi.smith@emory.edu|
22260926|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934|nancy.braverman@mcgill.ca|23404
22260927|NCT02822235|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22260928|NCT00829530|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260929|NCT00840866|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22260930|NCT01038856|University of Oklahoma|Research Regulatory Specialist III|405-271-8777|sharon-ross@ouhsc.edu|48394
22260931|NCT04638153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260932|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org|
22260933|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22260934|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600|jjoffrion@kvph.com|3410
22260935|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22306645|NCT00147277|Medtronic Italia S.p.A.|Laura Manotta|003902241371|laura.manotta@medtronic.com|
22260936|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu|
22260937|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr|
22260938|NCT00625443|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22260939|NCT02015390|Texas Medical Branch, University of, Galveston|Study PI|409-747-5760|zgugala@utmb.edu|
22260940|NCT03136380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260941|NCT01661686|Erasmus University Medical Center|Dr. V.M.C.W. Spaander|0031 10 703 5643|v.spaander@erasmusmc.nl|
22260942|NCT00784823|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
22260943|NCT01720264|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22260944|NCT02728102|The Emmes Company|Adam Mendizabal, PhD|301-284-1798|amendizabal@emmes.com|
22260945|NCT04869787|Cincinnati Children's Hospital Medical Center|Dr. Stuart L.Goldstein|513-636-4837|stuart.goldstein@cchmc.org|
22260946|NCT03834870|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
22260947|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260948|NCT01544127|Canandaigu VA Medical Center|Dr. Peter Britton|585-393-7926|peter.britton@va.gov|
22260949|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu|
22260950|NCT02914600|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
22260951|NCT02377947|Abbott|Dr. Shubhangi Desai|+91 22 7175 7408|shubhangi.desai@abbott.com|
22260952|NCT02996682|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22260953|NCT02457520|SPIL|Clinical Trials|912266455645|Clinical.Trials@sparcmail.com|
22260954|NCT02605395|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260955|NCT02763865|Medical University of South Carolina|Gonzalo REvuelta|843-792-7262|revuelta@musc.edu|
22260956|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22260957|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org|
22320389|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu|
22260958|NCT03687736|Q-Med AB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22260959|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
22260960|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343||
22260961|NCT02514122|University of Saskatchewan|Dr. William P. McKay|1 306 655 1202|bill.mckay@usask.ca|
22260962|NCT03541941|Cleveland Clinic Foundation|Dr. Michael Rosen|216-445-3441|rosenm@ccf.org|
22260963|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320390|NCT01816061|DCVAMC|Dr.Joel Scholten|2027458000|joel.scholten@va.gov|55099
22320391|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu|
22320392|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260964|NCT03115177|Rush University Medical Center|Dr. Allison Rao|608-445-0545|allison.rao@gmail.com|
22260965|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
22260966|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu|
22260967|NCT03506386|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22292552|NCT03633617|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22292553|NCT02540226|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|212-606-1206|JulesElyseeK@HSS.EDU|
22292554|NCT00809354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292555|NCT04396665|University of Oviedo|Vicerrectorado de investigación|+34985104190|viceinvestigacion@uniovi.es|
22292556|NCT04137224|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22292557|NCT01669928|Imperial College London|Professor Neil Poulter|+44 20 7594 3446|n.poulter@imperial.ac.uk|
22292558|NCT02437383|University of North Carolina at Chapel Hill|Dr. Inna E. Tchivileva|1 919 537 3291|inna_tchivileva@unc.edu|
22292559|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292560|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200|jihong@cgmh.org.tw|2600
22292561|NCT04137627|Universitas Indonesia|Dr. dr. Diani Kartini, Sp.B-K(Onk)|+628122684919|d.kartini@gmail.com|
22292562|NCT05085730|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22292563|NCT01400815|22nd Century Group, Inc.|Karen Delaney|716-270-1523|kdelaney@xxiicentury.com|
22292564|NCT02234986|CASI Pharmaceuticals, Inc.|Dr. Alexander Zukiwski|+1 240 864 2888|alexz@casipharmaceuticals.com|
22292565|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343||
22320393|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22274558|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu|
22292566|NCT04010539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306646|NCT00997386|University of Arizona Cancer Center|Program Coordinator|52-626-0301|aselegue@email.arizona.edu|
22274559|NCT02737358|Medical University of South Carolina|Erin A. McClure, Ph.D.|843-792-7192|mccluree@musc.edu|
22306647|NCT03492177|Actelion Pharmaceuticals Ltd|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22274560|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22274561|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
22306648|NCT01713946|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22274562|NCT02124824|VAMC SLC|Scott Capps|8015821565|Scott.Capps@hsc.utah.edu|
22306649|NCT05959655|Bright Uro|Brittany Carter|9492025689|brittany@brighturo.com|
22306650|NCT05555082|University of Linkoping, Department of Health, Medicine and Care|Peter Johansson|460700896548|peter.b.johansson@liu.se|
22306651|NCT05672030|Brigham and Women's Hospital, Allergy and Clinical Immunology|Tanya M. Laidlaw, MD, Associate Professor of Medicine|6177329850|tlaidlaw@partners.org|
22274563|NCT02659501|Loma Linda University, Department of Plastic Surgery|Saba Motakef, Resident Physican|714-925-8932|smotakef@llu.edu|
22274564|NCT03636256|US Biotest, Inc.|Dr. Gere diZerega|805.595.1300|gere.dizerega@usbiotest.com|
22274565|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274566|NCT03845894|Wake Forest School of Medicine|Jonathan Doug Jaffe DO|336-716-4498|jjaffe@wakehealth.edu|
22320394|NCT01898689|UC San Diego|Dr. Brian Ilfeld|(858) 444-5949|bilfeld@ucsd.edu|
22274567|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu|
22274568|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com|
22274569|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu|
22274570|NCT03108482|Esteve Pharmaceuticals, S.A.|Dr. Neus Gascon|+34934446000|ngascon@esteve.com|
22274571|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu|
22274572|NCT00289211|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22274573|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
22274574|NCT00898937|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
22274575|NCT03504917|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WN39434|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22274576|NCT03863353|University of Michigan|Dr. Terri Voepel-Lewis|734-6466803|terriv@umich.edu|
22274577|NCT00966433|Wake Forest University Health Sciences|Dr. Thomas Templeton, MD|336-716-4285|ttemplet@wakehealth.edu|
22274578|NCT04079790|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274579|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
22320395|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
22274580|NCT03810183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22274581|NCT04683640|University of Florida|Yenisel Cruz-Almeida|(352) 294-5845|cryeni@ufl.edu|
22274582|NCT04275336|Children's Hospital of Fudan University|Ms.Yu Zhuowen|18017591126|yzw100@126.com|
22274583|NCT03055936|Orion Corporation, Orion Pharma|Clinical Study Director|+358104264184|clinicaltrials@orionpharma.com|
22274584|NCT04664205|University of North Carolina at Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
22274585|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru|
22274586|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
22274587|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22274588|NCT05057221|University of Michigan|Lena M. Napolitano MD|734-615-4775|lenan@med.umich.edu|
22274589|NCT05401565|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22274590|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com|
22274591|NCT03976752|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22274592|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu|
22274593|NCT02153918|National Cancer Institute|Dr. Peter Pinto|301-496-6353|pintop@nih.gov|
22274594|NCT03327324|NYU Langone Health|Joshua Chodosh, MD, MSHS|(212) 263-6768|Joshua.Chodosh@nyulangone.org|
22274595|NCT01791985|Imperial College London|Michael Seckl|+44 (0)20 3311 1421|m.seckl@imperial.ac.uk|
22274596|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22320396|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952||
22260968|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu|
22260969|NCT05615935|National Taiwan University|Dr. Piao-Yi Chiou|02-2312-3456|piaoyi@ntu.edu.tw|288427
22260970|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22260971|NCT02567968|University of Chicago|Aaron Fox, PhD|7737020021|aaronfox@uchicago.edu|
22260972|NCT04510285|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
22260973|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22260974|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
22260975|NCT03005522|Banner University Medical Center|Dr Noah Tolby|520-694-8888|ntolby@aemrc.arizona.edu|
22260976|NCT03639311|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22260977|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22260978|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22292567|NCT02028871|University of Illinois at Chicago|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22292568|NCT05708586|University of Michigan|Dr. Noelle Whyte|734 936-5780|whyteno@umich.edu|
22292569|NCT02314143|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292570|NCT01289457|The University of Texas M D Anderson Cancer Center|Jabbour,Elias Joseph, M.D./Associate Professor|713-792-4764|CR_Study_Registration@mdanderson.org|
22292571|NCT00179127|Vanderbilt University Medical Center|Sheila McMorrow|615-343-8332||
22292572|NCT03194503|The Children's Hospital of Philadelphia|Dr. Akira Nishisaki|267-426-0665|NISHISAKI@email.chop.edu|
22292573|NCT00457366|USC|Dr George Simpson|7604687106|gsimpson@usc.edu|
22292574|NCT04231318|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22292575|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292576|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net|
22292577|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300||
22292578|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
22292579|NCT02337738|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22292580|NCT02322021|Eisai Medical Information|Eisai Ltd.|+1-888-274-2378|esi_medinfo@eisai.com|
22292581|NCT01934972|The Ohio State University|Nicholas Breitborde, PhD|614-685-6052|nicholas.breitborde@osumc.edu|
22292582|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22292583|NCT02979197|Kitov Pharma Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
22292584|NCT02949700|Baylor College of Medicine|Dr. Vlad Sandulache|713-798-7218|Vlad.Sandulache@bcm.edu|
22292585|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
22292586|NCT03148275|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22292587|NCT03803683|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
22292588|NCT01507298|Imperial College London|Dr. Richard Mark Kwasnicki|07851759471|rmk107@ic.ac.uk|
22292589|NCT01920555|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
22292590|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu|
22292591|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292592|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr|
22292593|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu|
22292594|NCT02841189|Indiana University|Nicole Horn MD|317-944-9981|nhorn@iupui.edu|
22292595|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292596|NCT01006369|Rutgers Cancer Institute of New Jersey|Elizabeth Poplin MD|732-235-7620|poplinea@cinj.rutgers.edu|
22292597|NCT04806503|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22292598|NCT03589469|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22292599|NCT02219438|UCSD|Dr Brian Ilfeld|(619) 543-5560|bilfeld@ucsd.edu|
22292600|NCT05061966|University of Pensylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22292601|NCT03793556|Sofar Spa|Dr Francesca Baldan|0039 02 909362|francesca.baldan@sofarfarm.it|1
22292602|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93|wim.vangrunderbeek@cyberonics.com|312
22292603|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com|
22292604|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17|ruckes@izks-mainz.de|9919
22292605|NCT02413372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22292606|NCT03584100|Stanford University|Jeffrey Yao|650-723-5643|jyao@stanford.edu|
22292607|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602|rprasad@chori.org|7602
22292608|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
22292609|NCT02781779|Kansas City Heart Rhythm Institute|Donita Atkins|816-651-1969|donita.atkins@hcahealthcare.com|
22292610|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca|
22292611|NCT03053271|Millendo Therapeutics|Clinical Trial Information|+1 734 845-9000|millendo@millendo.com|
22292612|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org|
22292613|NCT02654314|Yale Center for Analytical Sciences|Jesse S Reynolds|(203) 785-5445|jesse.reynolds@yale.edu|
22292614|NCT03161093|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22292615|NCT00570765|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22292616|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22292617|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292618|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch|
22292619|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400|hector.garcia@upaep.mx|7466
22292620|NCT01954342|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
22292621|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22292622|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22292623|NCT03845543|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
22292624|NCT04242173|Moffitt Cancer Center|Christine Chung|1-813-745-5061|Christine.Chung@moffitt.org|
22292625|NCT03789214|The Johns Hopkins University School of Medicine|Andrew S. Huhn, Ph.D.|410-550-1971|ahuhn1@jhu.edu|
22292626|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504|markus.stuehlinger@uki.at|81 320
22292627|NCT01912963|Dana-Farber Cancer Institute|Rachel Freeman MD|617.632.3000|Rachel_Freedman@dfci.harvard.edu|
22292628|NCT03139318|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22292629|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22292630|NCT03530800|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
22292631|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22292632|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22292633|NCT01721473|VA San Diego Healthcare System|Arthur Brody|8585528585|arthur.brody@va.gov|
22292634|NCT02080637|Duke University|Kevin Hill, M.D.|919-668-8305|kevin.hill@duke.edu|
22292635|NCT01483807|VA SALT LAKE CITY HEALTHCARE SYSTEM|Dr. Julie Wambaugh|8015821565|julie.wambaugh@health.utah.eduj|1363
22292636|NCT03438383|Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross Hospital, Athens, Greece|Dr. Konstantinos Roditis, Study Chair|+306976686951|roditis.k@gmail.com|
22292637|NCT02435069|Nemours Children's Clinic|Kimberly S. Jarczyk, PhD, C-PNP|9044611730|jarczykks@gmail.com|
22292638|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com|
22292639|NCT02030938|Sofregen|Clinical Project Manager|4029991564|fjawed@sofregen.com|
22292640|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca|
22292641|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
22292642|NCT03954132|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22306652|NCT03602911|West Virginia University|Rusha Patel, MD|4052717559|Rusha-Patel@ouhsc.edu|
22306653|NCT02098343|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22306654|NCT05515562|Wake Forest University Health Sciences|John Williamson, PharmD|336.713.3431|johnwill@wakehealth.edu|
22306655|NCT02188420|University of Minnesota|Kate Frost|612-626-0637||
22306656|NCT05644444|Reckitt Benckiser Health Limited|Clinical Study Manager|+44 (0)1482 326151|ClinicalRequests@reckitt.com|
22306657|NCT03215095|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22306658|NCT03723616|Duke University|Isaac Lipkus Reiner, Ph.D.|919-668-2348|isaac.lipkus@duke.edu|
22306659|NCT03142841|North Florida South Georgia Veterans Health System|Dr. Ivette Magaly Freytes|352-376-1611|ivette.freytes@va.gov|102012
22306660|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com|
22306661|NCT02639286|NIDDK|Dr. Rebecca Brown|301-594-0609|rebecca.brown@nih.gov|
22306662|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk|
22306663|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
22306664|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
22306665|NCT03648762|VA Pittsburgh Healthcare System|Daniel E. Forman, MD|(412) 360-2917|Daniel.Forman@va.gov|
22306666|NCT02135679|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
22306667|NCT04112069|Mass. General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22306668|NCT01662336|AbbVie (prior Sponsor Abbott)|Global Medical Services|800-633-9110||
22306669|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
22306670|NCT04396860|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22306671|NCT03454529|Karmanos Cancer Institute|Michael Simon,MD|313. 576-8727|simonm@karmanos.org|
22306672|NCT01402531|UCSD|Department of Surgery|(858) 657-5291||
22306673|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306674|NCT04147897|University of Washington|Dror Ben-Zeev, Professor|206-685-9655|dbenzeev@uw.edu|
22260979|NCT01853553|University of Colorado|Dr. Michel Chonchol|303-724-7796|Michel.Chonchol@ucdenver.edu|
22260980|NCT03097783|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22260981|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu|
22260982|NCT04320849|Duke University Medical Center|Dr. Jonathan Piccini|919-668-8049|jonathan.piccini@duke.edu|
22260983|NCT02287675|Kettering Health Network|Dr. Arash Kardan|937-395-8611|arash.kardan@ketteringhealth.org|
22260984|NCT03135834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320397|NCT02101515|George Washington University School of Medicine and Health Sciences|Alexis Gimovsky, MD|2027412603|agimovsk@mfa.gwu.edu|
22260985|NCT02268500|University of Minnesota|Orly Vardeny, Associate Professor of Medicine|612.467.4586|ovardeny@umn.edu|
22260986|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
22260987|NCT01312922|ANeuroTech|Dr. E. Buntinx, MD|+32 (0) 473 861 079|erik.buntinx@aneurotech.com|
22260988|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22260989|NCT02421952|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
22260990|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com|
22260991|NCT03486990|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22260992|NCT03262012|AstraZeneca|Paul M. Dorinsky, MD|1-877-240-9479|information.center@astrazeneca.com|
22260993|NCT03187002|Stanford University|Research Manager|6507211567|fpresearch@stanford.edu|
22260994|NCT02801877|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
22260995|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de|
22260996|NCT03325114|University of Rochester|Carrie Dykes|15852750736|carrie_dykes@urmc.rochester.edu|
22260997|NCT05665426|Zhejiang Chhinese Medicial University|Siyi Zheng|+86159 9008 8547|zsy980714@gmail.com|
22260998|NCT03857919|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|18186873310|trodriguez@sightsciences.com|
22260999|NCT04934722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261000|NCT06358820|Gaozhou People's Hospital|Shanshan Deng|13927596600|276531255@qq.com|
22261001|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22261002|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22306675|NCT05019144|Medical University of South Carolina|Dr. Aaron P. Lesher|843-408-6782|leshera@musc.edu|
22261003|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261004|NCT01948258|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
22261005|NCT00834535|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261006|NCT04408586|Mayo Clinic|Andres J. Acosta, M.D., Ph.D.|507-266-6931|Acosta.Andres@mayo.edu|
22261007|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu|
22261008|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov|
22261009|NCT03547622|Yale University|Theresa Babuscio Data Manager|203 737 5430|theresa.babuscio@yale.edu|
22261010|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22261011|NCT01900691|Cook Research Incorporated|Alan Saunders, MDR, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22261012|NCT01954394|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22261013|NCT00909610|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261014|NCT01026623|Memorial Sloan Kettering Cancer Center|Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
22261015|NCT02422264|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22261016|NCT03021018|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22261017|NCT01032083|Imperial College London|Professor Thomas Barnes||t.r.barnes@imperial.ac.uk|
22261018|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22261019|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu|
22261020|NCT03342157|Advocate Aurora Health|Dr. Bradley Gose|414-385-2590|bradley.gose@aah.org|
22261021|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
22261022|NCT03612960|Pennsylvania State University|Dr. Andrea Hobkirk|7175310003|ahobkirk@pennstatehealth.psu.edu|286415
22261023|NCT00834249|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261024|NCT00834743|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261025|NCT01534663|University Hospital Jena|Christian Schulze, MD, PhD|03641-9 32 41 04|christian.schulze@med.uni-jena.de|
22261026|NCT01643707|Medtronic|Sr Clinical Research Program Manager|+1 (651) 308 3608|jennifer.tinsley@medtronic.com|
22261027|NCT04112823|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22261028|NCT01693523|UT MD Anderson Cancer Center|Dr. David Fogelman/ Associate Professor, GI Medical Oncology|832-710-7754|dfogelman@mdanderson.org|
22261029|NCT03049215|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
22261030|NCT03603314|Sensorion|Director of Regulatory Affairs|+33467207720|contact@sensorion-pharma.com|
22261031|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300||
22261032|NCT02379247|University of Kansas Medical Center|Dr. Priyanka Sharma|9135886079|psharma2@kumc.edu|
22261033|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com|
22261034|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com|
22261035|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu|
22306676|NCT04177394|Abbott|Melody Dong|4086434617|melody.dong@abbott.com|
22261036|NCT02193880|University of Alabama at Birmingham|Tiffany D Hill|205-996-8023|tiffanydhill@uabmc.edu|
22261037|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
22261038|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov|
22306677|NCT02115282|ECOG-ACRIN Cancer Research Group|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
22306678|NCT00256243|Chao Family Comprehensive Cancer Center|Dr. Rita Mehta|(714) 456-5153|rsmehta@uci.edu|
22306679|NCT06129045|Black Hills State University|Ashley Pfeiffer|6053815370|ashley.pfeiffer@bhsu.edu|
22306680|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22306681|NCT04970342|National Advanced Driving Simulator, University of Iowa|Timothy Brown, Ph.D.|3193354785|timothy-l-brown@uiowa.edu|
22306682|NCT05797155|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
22306683|NCT03617263|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22306684|NCT02763124|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
22306685|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22306686|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu|
22306687|NCT01350804|Novartis|Study Director|862-778-8300||
22306688|NCT05793112|Massachusetts General Hospital|Dr. Qian Yuan|6172435466|QYUAN@mgh.harvard.edu|
22306689|NCT05850520|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22306690|NCT01170026|Department of Psychiatry and Human Behavior, The Alpert Medical School of Brown University|Dr. Anthony Spirito|401-369-2435|anthony_spirito@brown.edu|
22306691|NCT03889925|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
22306692|NCT05777785|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
22306693|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22261039|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu|
22261040|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com|
22261041|NCT01182415|Massachusetts General Hospital|Dr. Yi-Bin Chen|617-726-0187|YCHEN6@PARTNERS.ORG|
22261042|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22261043|NCT04121364|RevBio|Dr. Alan Pollack|9145226972|apollack@revbio.com|
22261044|NCT05452798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22261045|NCT02587962|Medivir AB|Chief Medical Officer|+46854683100|info@medivir.com|
22261046|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22261047|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261048|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
22261049|NCT02076022|University of Pittsburgh Plastic Surgery|Patsy Simon|412-648-9207|simopa@upmc.edu|
22261050|NCT01972204|Mirai Iryo Research Center|Tomoko Machida (Director)|81-3-3263-4801|machida@mirai-iryo.com|
22261051|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261052|NCT02024646|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
22261053|NCT01844375|Faculty of Medicine siriraj Hospital|Dr.Mingkwan Wongyingsinn|6624197995|mingkwan.won@mahidol.ac.th|
22261054|NCT03627091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22261055|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261056|NCT02729714|EvergreenHealth Medical Center|Dr. Daniel Burdick|4258993108|djburdick@evergreenhealthcare.org|
22261057|NCT01863745|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22261058|NCT01157091|City of Hope|Dr. Sumanta Pal|626-359-8111|SPal@coh.org|
22261059|NCT03865654|Dana-Farber Cancer Institute|Rachel Freedman, M.D., M.P.H.|617-632-3800|rafreedman@partners.org|
22261060|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261061|NCT05093205|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261062|NCT02519491|University of Ottawa Heart Institute|Dr. Benjamin Hibbert, Cardiologist|613-696-7000|bhibbert@ottawaheart.ca|
22261063|NCT03660839|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22261064|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com|
22261065|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743||
22261066|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org|
22261067|NCT03897088|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
22261068|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
22261069|NCT02865122|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098600|Miki@elganpharma.com|
22261070|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261071|NCT01819597|Cedars-Sinai Medical Center|Nestor Gonzalez, MD. Professor of Neurosurgery|310 423 0783|nestor.gonzalez@cshs.org|
22261072|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261073|NCT04089735|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
22261074|NCT02337218|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22261075|NCT04123548|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22261076|NCT00851877|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
22261077|NCT02440711|University of Washington|Dr. Brian Hafner|206-685-0214|bhafner@uw.edu|
22261078|NCT04129346|Northwestern University Feinberg School of Medicine|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
22261079|NCT05755282|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
22261080|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu|
22261081|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22261082|NCT03025880|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22261083|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu|
22306694|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22306695|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22261084|NCT01185548|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22261085|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623||
22261086|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22261087|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22261088|NCT02770820|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22261089|NCT00312663|WRAIR|James Cummings, MD|301-319-9312|james.cummings@us.army.mil|
22261090|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22261091|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500|Sundar.Natarajan@va.gov|3287
22261092|NCT02661295|NYU Langone Health|Candace Grant, MD|516-663-0333|candace.grant@nyulangone.org|9054
22261093|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22261094|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22261095|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261096|NCT02726581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22261097|NCT02841033|Boston Medical Center|Vaishali Sanchorawala, MD|617-638-8213|vaishali.sanchorawala@bmc.org|
22261098|NCT03195491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22261099|NCT03496623|United Therapeutics|United Therapeutics Global Medical Information|240-821-1881|304perfectstudy@lungbiotechnology.com|
22261100|NCT02543203|The Ohio State University Nisonger Center|Dr. Jill Ann Hollway|614-688-3848|Jill.Hollway@osumc.edu|
22261101|NCT04786184|Columbia University|Annamaria Norweg, PhD|212-305-1651|amn2212@cumc.columbia.edu|
22261102|NCT02255097|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261103|NCT03956862|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB001, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22261104|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48|clinicaltrials@ucb.com|15 15
22261105|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088|kelvintam@h.tmu.edu.tw|8860
22261106|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
22261107|NCT03965091|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22261108|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22261109|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22261110|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22261111|NCT02979353|Vanderbilt University Medical Center|Sandra F Simmons, PhD, Principle Investigator|615-343-6729|sandra.simmons@vumc.org|
22261112|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22261113|NCT04185909|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22261114|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
22261115|NCT03435081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261116|NCT02601560|MedImmune, LLC|Richard George, MD, Director, Clinical Development|+1-301-398-5681|information.center@astrazeneca.com|
22261117|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
22261118|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22261119|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22292643|NCT03170856|Boston Children's Hospital|Dr. William Meehan|781-216-1328|william.meehan@childrens.harvard.edu|
22292644|NCT00932737|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292645|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22292646|NCT05156073|Johns Hopkins University School of Medicine|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
22292647|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22292648|NCT02780609|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-1856|Taiga.Nishihori@moffitt.org|
22292649|NCT03763318|Equillium|Clinical Operations|858-240-1200|clinicaltrials@equilliumbio.com|
22292650|NCT05597020|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
22292651|NCT05736224|Yale University Department of Dermatology|Kacie Carlson, Physician Assistant|203 785 7432|Kacie.carlson@yale.edu|
22292652|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292653|NCT04526509|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292654|NCT02452697|Duke University|Cristina Gasparetto, MD|919-668-1000|cristina.gasparetto@duke.edu|
22292655|NCT02422940|Acorda Therapeutics|Holy Roberts, Executive Medical Director - Medical Affairs|914-326-5224|hroberts@acorda.com|
22292656|NCT01554397|UCSD Moores Cancer Center|Dr. Loren Mell|858-246-4071|lmell@health.ucsd.edu|
22292657|NCT04493333|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|iwen@uams.edu|24024
22292658|NCT02791399|VA Portland Health Care System|Benjamin Morasco, PhD|5032208262|benjamin.morasco@va.gov|
22292659|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu|
22261120|NCT04384978|DreamFace Technologies, LLC|President and CEO|7202015694|mmahoor@dreamfacetech.com|
22261121|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22261122|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu|
22261123|NCT03125200|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22261124|NCT03154658|University of Texas Southwestern|Anthony Machi M.D.|2146486400|anthony.machi@utsouthwestern.edu|
22261125|NCT02629094|National Institute of Allergy and Infectious Diseases|Hadigan, Colleen|+1 301 594 5754|hadiganc@mail.nih.gov|
22261126|NCT03041025|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306696|NCT05636332|Philips|Tiffani Bowers|724-989-3072|tiffani.bowers@philips.com|
22306697|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
22306698|NCT04603924|Robert Homolka|Sr. Vice President Clinical Operations|8572991035|bob.homolka@neurobopharma.com|
22306699|NCT03762668|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22306700|NCT02164240|DFCI|Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
22306701|NCT00768664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306702|NCT02544152|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22306703|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
22306704|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306705|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22306706|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306707|NCT03573518|Botanix Pharmaceuticals|Head of Development|+1 445 300 3403|trials@botanixpharma.com|
22306708|NCT00779870|Imperial College London|Prof Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22306709|NCT02334436|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22306710|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu|
22306711|NCT04483856|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
22261127|NCT02963259|Abbott|Erika Ross|+19725268207|Erika.ross@abbott.com|
22261128|NCT02131129|IndianaU|Dr. Michael Francis|317-880-8495|mmfranci@iupui.edu|
22261129|NCT00539071|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
22261130|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu|
22261131|NCT02110277|UConn Health|Dr.Molly Brewer|860-679-2100||
22261132|NCT00396279|Amgen Inc.|Study Director|866-572-6436||
22261133|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu|
22261134|NCT00830206|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261135|NCT00905346|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261136|NCT03585790|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
22261137|NCT00773422|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
22261138|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu|
22261139|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22261140|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
22261141|NCT00829673|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261142|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
22261143|NCT04089917|Department of Interventional Neuroradiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Mariano Espinosa de Rueda|+34 968 36 96 42|mm.espinosa@gmail.com|
22261144|NCT02473718|University of Texas Southwestern Medical Center|Catherine Chen|214-648-9095|catherine.chen@utsouthwestern.edu|
22261145|NCT04088760|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD|(513) 803-1139|Rebecca.Marsh@cchmc.org|
22261146|NCT03257722|Augusta University|Asha Nayak, MD|706-721-2505|anayak@augusta.edu|
22292660|NCT02206048|UT MD Anderson Cancer Center|Dr. Kathleen M. Schmeler, MD|713-745-3518|kschmele@mdanderson.org|
22292661|NCT02925923|University of Alabama at Birmingham|Leah Pogwizd|(205) 996-4410|leahpogwizd@uabmc.edu|
22292662|NCT00282412|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
22292663|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com|
22292664|NCT03911713|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22292665|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu|
22292666|NCT02203071|University of Missouri|Research Project Analyst|573-882-7583|jonesvicki@health.missouri.edu|
22292667|NCT01845818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22292668|NCT02595970|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|Novartis.email@novartis.com|
22292669|NCT02572388|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|adrian.hill@ndm.ox.ac.uk|
22306712|NCT00494442|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22261147|NCT00376623|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292670|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov|
22306713|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu|
22306714|NCT03593213|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22306715|NCT03184558|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
22306716|NCT03109795|University of Iowa|Professor|319-335-9487|gary-pierce@uiowa.edu|
22306717|NCT00317226|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22306718|NCT00566527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306719|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22306720|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22306721|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22306722|NCT00664430|Abbott|Global Medical Services|800-633-9110||
22306724|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306725|NCT03070483|Loyola University Chicago|Dr. Holly Kramer|7083279039|hkramer@lumc.edu|
22306726|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com|
22306727|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
22306728|NCT04789330|University of California, San Francisco|Matthieu LEGRAND MD, PhD|415-885-7388|matthieu.legrand@ucsf.edu|
22306729|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22306730|NCT02611037|Moffit Cancer Center|Bela Kis, MD, PhD|813-745-8425|Bela.Kis@Moffitt.org|
22261148|NCT02331394|Jewish General Hospita;|Goulnar Kasymjanova|514-340-8222|gkasymja@jgh.mcgill.ca|24312
22261149|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351||
22261150|NCT04459585|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22261151|NCT02098876|Northeast Georgia Health System|Habib Samady|770-297-3549|Habib.Samady@nghs.com|
22320398|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22261152|NCT02566239|Oregon Health & Science University|Dr. Jeffrey Kaye|503 494 6695|kaye@ohsu.edu|
22261153|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx|
22261154|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22261155|NCT02459951|Albert Einstein Healthcare Network|Nathaniel Mayer MD|215 663 6681|nmayer@einstein.edu|
22261156|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22261157|NCT04239872|University of Michigan School of Dentistry|Dr. Livia Tenuta|734-763-3703|litenuta@umich.edu|
22261158|NCT00783367|University of Pennsylvania, Clinical Research Unit, Lymphoma Group|Ellen Napier, CRNP|215.279.1972|Ellen.Napier@pennmedicine.upenn.edu|
22261159|NCT01010542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261160|NCT01808794|Tufts University|Associate Vice Provost for Research Administration & Development|617-627-7000|tss@tufts.edu|
22261161|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
22306731|NCT05841680|Florida International University|Jeremy Pettit|3053481671|jpettit@fiu.edu|
22306732|NCT03785782|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22306733|NCT04817670|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
22306734|NCT04951310|University of Pennsylvania|Dr. Katherine Milkman|215-573-9646|bcfg@wharton.upenn.edu|
22306735|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306736|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22306737|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl|
22306738|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
22306739|NCT02731755|University of Reading|Prof Jeremy Spencer|+44(0) 1183788724|j.p.e.spencer@reading.ac.uk|
22306740|NCT02320123|UT Southwestern Medical Center|Dr. Ramona Rhodes|214-648-9012|ramona.rhodes@utsouthwestern.edu|
22306741|NCT04480827|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|972.3.693.8448|yossigs@galmedpharma.com|
22306742|NCT01292252|University of California, San Francisco|Shane Burch, MD|415-353-4487|Shane.Burch@ucsf.edu|
22306743|NCT02207972|Mount Sinai West|Dr Barbara Orlando MD and PI|2125236915|barbara.orlando@mountsinai.org|
22306744|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu|
22306745|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306746|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu|
22306747|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com|
22306748|NCT05876949|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
22306749|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
22320399|NCT03086057|Brown University|Dr. Katie Biello|401-863-3082|katie_biello@brown.edu|
22261162|NCT03025945|Arizona Eye Consultants|Sean McCafferty, MD|520-327-3487|sjmccafferty66@hotmail.com|
22261163|NCT02819323|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22306750|NCT02369484|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
22306751|NCT02178241|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22320400|NCT02887404|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
22292671|NCT02202837|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292672|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
22292673|NCT02006888|IconBioscience|Howard Franklin|2153961332|hfranklin@iconbioscience.com|215
22292674|NCT03485391|Ralph H. Johnson VA Health Care System|Stephanie Hart|843-577-5011|Stephanie.Hart4@va.gov|205103
22292675|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu|
22292676|NCT03089320|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
22292677|NCT00231842|Montefiore Medical Center|Mark Einstein, MD, MS|718-405-8082|meinstei@montefiore.org|
22292678|NCT02422303|University of Texas Health Science Center San Antonio|Bonnie Gillis|210-567-4500|gillis@uthscsa.edu|
22292679|NCT03481907|George Washington University|Dr. Adam Friedman|214 235 7381|ajfriedman@mfa.gwu.edu|
22292680|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300||
22292681|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
22292682|NCT02468232|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22292683|NCT01973569|Contact for Clinical Trial Information|Daiichi Sanyko|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
22292684|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22292685|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22292686|NCT01237821|Penn State Hershey Medical Center|Diane Thiboutot|717-531-1513|dthiboutot@pennstatehealth.psu.edu|
22292687|NCT02710396|Columbia University Herbert Irving Comprehensive Cancer Center|Catherine Shu|212 305 3997|cas2145@cumc.columbia.edu|
22292688|NCT04612790|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292689|NCT00785928|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292690|NCT04644003|STALICLA SA|Eric Painbeni, PhD - Head of Clinical Operations|+41 (0)79 918 33 16|clinical@stalicla.com|
22292691|NCT05027464|Veterans Affairs San Francisco HCS|Nicole McCamish|415-221-4810|nicole.mccamish@va.gov|24284
22292692|NCT03764007|University of California, San Francisco|Dr. Thomas A. Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
22292693|NCT02923427|DorkuzEU|Anaesthesiology and Intensive Care, Sule Ozbilgin|905055252901|ozbilginsule@gmail.com|
22292694|NCT01420653|AFT Pharmaceuticals Ltd.|Jennifer Zhang|+ 64 9 488 0232|jenniferz@aftpharm.com|710
22292695|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22292696|NCT03611010|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Development|6155642188|imaciasperez@cumberlandpharma.com|
22292697|NCT01924988|Georgetown University Medical Center|James B. Spies MD MPH|202-444-3450|spiesj@gunet.georgetown.edu|
22292698|NCT03572244|University of Iowa|Dr. Chris Barwacz|3193843002|chris-barwacz@uiowa.edu|
22292699|NCT05021081|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, O.D., M.S., F.A.A.O.|1-800-843-2020|jbuch@its.jnj.com|
22292700|NCT01967433|University of Oklahoma Health Sciences Center and VAMC, Oklahoma City|Salman Nusrat|4052715428|salman-nusrat@ouhsc.edu|
22292701|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com|
22292702|NCT03028103|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
22292703|NCT03257371|University of Missouri|Dr. James Cook|573-882-7189|cookjl@health.missouri.edu|
22292704|NCT03387683|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22292705|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22292706|NCT00566501|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22292707|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22292708|NCT05095454|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
22292709|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu|
22292710|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292711|NCT00853073|Wills Eye Hospital|Marlene R. Moster, MD|215-928-3123|marlenemoster@gmail.com|
22292712|NCT01999114|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stephen.harris@pharma.com|
22292713|NCT03840174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292714|NCT02409810|The Ohio State University|Judy Opalek Director, Research Administration|6147789696|judy.opalek@osumc.edu|
22292715|NCT01008150|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
22292716|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu|
22292717|NCT03420625|Karolinska University Hospital|Dr. Paul Ackermann|+46 8 517 700 00|paul.ackermann@sll.se|717 34
22292718|NCT01649609|Columbia University Medical Center|Sumit Mohan, MD|2123053273|sm2206@cumc.columbia.edu|
22292719|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil|
22292720|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22292721|NCT01810588|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
22292722|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22292723|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22292724|NCT02787551|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22292725|NCT03799211|NYU Langone Health|Mia Minen, MD, MPH|212-263-7744|Mia.Minen@nyulangone.org|
22292726|NCT00764491|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|651-256-8503|Rgriffith@spineology.com|
22292727|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org|
22292728|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov|
22306752|NCT06258785|Endeavor Health|Dr. Claudia Paya Ten|847-570-4729|claudia.payaten@endeavorhealth.org|
22261164|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca|
22261165|NCT01675765|Aduro Biotech, Inc.|Corporate Communications|510-848-4400|press@aduro.com|
22261166|NCT02420210|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22261167|NCT04060147|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22261168|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu|
22261169|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
22261170|NCT03204539|UC Davis|Dr. Jonathan Ducore|916-734-3461|jmducore@ucdavis.edu|
22261171|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22261172|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu|
22261173|NCT02008565|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22261174|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com|
22261175|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu|
22261176|NCT00537979|Abbott|Global Medical Services|800-633-9110||
22261177|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
22261178|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22261179|NCT03555305|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261180|NCT00925054|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
22261181|NCT04544787|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
22261182|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu|
22261183|NCT03031847|UPMC Presbyterian Hospital|Eric Pasquantonio|4126478210|pasquantonioej@upmc.edu|
22261184|NCT04841317|Stanford University|Paul J. Wang, MD|(650) 723-7111|Paul.J.Wang@stanford.edu|
22261185|NCT04916548|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22261186|NCT02100228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261187|NCT00214422|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphausen@nih.gov|
22261188|NCT01964092|University of Oslo|Silje Endresen Reme|22845236|s.e.reme@psykologi.uio.no|+47
22261189|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu|
22261190|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov|
22261191|NCT00854100|Allergan, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22261192|NCT02744352|University of Pennsylvania|Anmol Madaan, Clinical Research Coordinator|2156623778|Anmol.Madaan@Pennmedicine.Upenn.edu|
22261193|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu|
22261194|NCT02242201|Mayo Clinic|Dr. Rebecca L. Johnson|507-266-2049|Johnson.Rebecca1@mayo.edu|
22261195|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22261196|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
22261197|NCT02298322|Zeltiq Aesthetics, Inc. an Allergan Affiliate|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22261198|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22261199|NCT03880266|Dermira, Inc|Jordan Adajar|650-421-2919|jordan.adajar@dermira.com|
22261200|NCT02186821|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22261201|NCT05472038|BioNTech clinical trials patient information|BioNTech SE|6131 90840|patients@biontech.de|
22261202|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu|
22261203|NCT01529060|Baylor|Alyssa Tran, BS|832-822-4264|alyssat@bcm.edu|
22261204|NCT03785548|TriHealth Inc.|Tiffanie Tam, Md|513-463-4300|Tiffanie_Tam@trihealth.com|
22261205|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com|
22261206|NCT01033565|University of Nebraska|Howard Needelman MD|402-559-4097|hneedelm@unmc.edu|
22261207|NCT01199848|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
22261208|NCT01832259|Huntsman Cancer Institute / University of Utah|Josiah Lyn Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
22261209|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
22261210|NCT03351335|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22261211|NCT02996591|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
22261212|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu|
22261213|NCT01439880|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22261214|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22261215|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22261216|NCT01980771|State University of New York, Downstate Medical Center|Tracey Wilson, Principal Investigator|718 270 2105|Tracey.Wilson@downstate.edu|
22261217|NCT03199872|RhoVac ApS|Steven Glazer, MD|+4525674434|sgl@rhovac.com|
22306753|NCT03718767|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
22306754|NCT02658240|UT Southwestern Medical Center|Irina Gasanova|4694191997|Irina.Gasanova@UTSouthwestern.edu|
22306755|NCT03691428|Yale|Dr. Joan Monin|203785-2895|joan.monin@yale.edu|
22261218|NCT03450057|General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine|Prof. Evangelos Terpos|+302102162540|eterpos@med.uoa.gr|
22261219|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov|
22306756|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
22320401|NCT02132884|Fox Chase Cancer Center|Dr. Hossein Borghaei|215-2141515|Hossein.Borghaei@fccc.edu|
22320402|NCT01092143|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320403|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509|michael.nauck@rub.de|6332
22320404|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22320405|NCT03098836|Duke University Medical Center|Daniel George, MD|(919) 668-8108|daniel.george@duke.edu|
22320406|NCT03986866|University of Arkansas for Medical Sciences|Johnathan Goree, MD|(501) 686-8818|JHGoree@uams.edu|
22320407|NCT01500525|Capital Institute of Pediatrics|Ling Cao，MD,Pulmonologist, Professor|86-13910610319|caoling9919@163.com|
22320408|NCT01660451|Bayer|Therapeutic Area Head|+1-888-8422937|clinical-trials-contact@bayer.com|
22320409|NCT04688775|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22320410|NCT03407651|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22320411|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de|
22320412|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320413|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org|
22320414|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu|
22320415|NCT01977820|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
22320416|NCT00698997|University California Davis|Dr. Sally Rogers|916-703-0264|sjrogers@ucdavis.edu|
22320417|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu|
22320418|NCT03491007|Durham VA Healthcare Center|Susan O'Loughlin|919-286-0411|susan.o'loughlin@va.gov|
22320419|NCT05082376|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22320420|NCT02568475|Florida Atlantic University|Ruth M. Tappen, Principal Investigator|561-297-2613|rtappen@health.fau.edu|
22320421|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
22320422|NCT02504554|Arizona State University|James Adams|480 965 3316|jim.adams@asu.edu|
22261220|NCT03214952|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22261221|NCT00829790|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261222|NCT03935880|University of Wisconsin - Madison|Andrew Brooks|248-953-9777|abrooks2@uwhealth.org|
22261223|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org|
22261224|NCT04247282|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22261225|NCT02865850|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22261226|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar|
22261227|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu|
22261228|NCT01263704|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261229|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22261230|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
22261231|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com|
22261232|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22261233|NCT04627038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261234|NCT02325531|Kaiser Permanente Center for Health Research|Rachel Gold|5033352400|rachel.gold@kpchr.org|
22261235|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261236|NCT03861845|Florida International University|Dr. Jaclyn Schwartz|305-348-3106|jschwart@fiu.edu|
22261237|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22261238|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
22261239|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com|
22261240|NCT05428020|Rush University Medical Center|Anne DeBenedetti, Director of Research, Adult Reconstruction|3124322468|anne.debenedetti@rushortho.com|
22261241|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22261242|NCT03502148|Privo Technologies|Dr. Manijeh Goldberg|9785872322|mgoldberg@privotechnologies.com|
22261243|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
22261244|NCT03999684|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
22261245|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22261246|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com|
22261247|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu|
22261248|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22261249|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu|
22261250|NCT02711852|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22261251|NCT02431494|Nova Southeastern University|Sue Breno|9542621447|sb1382@nova.edu|
22261252|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300|dsquillacote@acorda.com|5367
22292729|NCT03139279|Department of Anesthesiology, SUNY Downstate Medical Center|Dennis Dimaculangan, MD|718-270-3765|dennis.dimaculangan@downstate.edu|
22320423|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
22292730|NCT01224665|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
22292731|NCT02027376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22292732|NCT01565642|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
22292733|NCT03171051|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22292734|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu|
22292735|NCT01528033|Witten/Herdecke University|Dörthe Seidel|00492219895731|Doerthe.Seidel@uni-wh.de|
22292736|NCT02856698|Hospital Universitario de Canarias|Alberto Dominguez Rodriguez. MD, PhD, FESC|+34 922678000|adrvdg@hotmail.com|
22292737|NCT02898116|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22292738|NCT02130024|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22261253|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000||
22261254|NCT02612337|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22261255|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300||
22261256|NCT03616106|University of Colorado College of Nursing|Samantha Stonbraker, Assistant Professor|720-880-8194|Samantha.Stonbraker@Cuanschutz.edu|
22261257|NCT01880593|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
22261258|NCT02779543|Weill Cornell Medical College|Dr. Ana Krieger|6469629316|ack2003@med.cornell.edu|
22261259|NCT02372630|State University of NY at Buffalo|Paresh Dandona, B.Sc., M.B. B.S., D.Phil., F.R.C.P|71653518520|dandona@buffalo.edu|
22261260|NCT05275205|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
22261261|NCT03962348|Columbia University Irving Medical Center|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
22261262|NCT03243630|Yale University|Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22261263|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
22261264|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22261265|NCT02648880|University of Colorado|Ryan Marker|3037240819|ryan.marker@cuanschutz.edu|
22261266|NCT03707912|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22261267|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk|
22261268|NCT02350647|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
22261269|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk|
22261270|NCT06090461|Currax Pharmaceuticals LLC|SVP, Chief Medical Officer|708.834.8254|mkyle@curraxpharma.com|
22261271|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr|
22261272|NCT03235739|Cleveland Clinic|Alparslan Turan, MD|216-4459857|turana@ccf.org|
22261273|NCT02847650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261274|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
22261275|NCT03797872|University of Oxford|Professor Laura Coates|+447870257823|laura.coates@ndorms.ox.ac.uk|
22261276|NCT03818581|Massachusetts General Hospital|Dr. John Winkelman|617-643-9101|jwwinkelman@mgh.harvard.edu|
22261277|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051||
22261278|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com|
22261279|NCT01466166|Horizon Pharma Rheumatology LLC|Jeffery Nieves, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
22261280|NCT02262377|Boston Medical Center|Paula Gardiner|414-6267|Paula.GardinerMD@gmail.com|617
22261281|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084|Marjorie.Leek@va.gov|7293
22261282|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com|
22320424|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org|
22261283|NCT01591785|Icahn School of Medicine at Mount Sinai|Gary Goldenberg, MD|212-241-6500|garygoldenbergmd@gmail.com|
22261284|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22261285|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
22261286|NCT02393417|Nielsen BioSciences Inc.|David Burney, PhD, MBA|858-571-2726|david@nielsenbio.com|
22261287|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu|
22261288|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com|
22261289|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261290|NCT02563561|Spectrum Pharmaceuticals, Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22261291|NCT03769896|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
22261292|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com|
22261293|NCT03122535|University of Utah|Elizabeth Nuttall|8012133461|elizabeth.nuttall@hsc.utah.edu|
22261294|NCT02646124|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22261295|NCT05025345|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
22261296|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22261297|NCT03154047|Prothena Biosciences|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
22261298|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com|
22261299|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
22292739|NCT03029702|University of Pittsburgh|Maisa Feghali|412 641 1000|feghalim@upmc.edu|
22261300|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22261301|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu|
22261302|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com|
22261303|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org|
22261304|NCT04567186|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO, Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22261305|NCT02924883|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261306|NCT00904345|University of Michigan Rogel Cancer Center|Shruti Jolly, M.D.|734-936-4302|shrutij@med.umich.edu|
22261307|NCT02481830|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
22261308|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306757|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261309|NCT02294253|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22306758|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306759|NCT04589689|Stanford University|Jessie Wong, PhD|6507361517|wongjj@stanford.edu|
22306760|NCT03193619|Becton, Dickinson, and Company|Anna Lovas|952-239-0548|anna.lovas@bd.com|
22306761|NCT01254019|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306762|NCT03061474|University of California, Irvine|Dr. Joshua Grill|(949) 824-5905|jgrill@uci.edu|
22306763|NCT03963583|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
22306764|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22306765|NCT01391130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22306766|NCT01665092|Univeristy of Mississippi Medical Center|Alan Jones|601-384-5586|aejones@umc.edu|
22306767|NCT04153435|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
22306768|NCT03520413|Durham Veterans Affairs Medical Center|Matthew Crowley, MD|919-286-0411|matthew.crowley@va.gov|
22306769|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
22306770|NCT02880241|Medicines for Malaria Venture (MMV)|Dr Stephan Duparc, Chief Medical Officer|+41 22 555 0351|duparcs@mmv.org|
22306771|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22306772|NCT05283395|Alcon Research, LLC|Scientific Advisor, Clinical R&D|1-888-451-3937|alcon.medinfo@alcon.com|
22306773|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr|
22306774|NCT03401112|Imara Inc.|Imara Clinical Operations|617-206-2020|info@imaratx.com|
22306775|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22306776|NCT03475316|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
22306777|NCT02476409|University of North Carolina at Chapel Hill|Amanda Lee|919-843-9936|akg72@med.unc.edu|
22306778|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171|courtney.hall@va.gov|7518
22306779|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000|william.bauman@va.gov|5428
22306780|NCT02971488|Hospital Universitario Infanta Leonor|Pablo Ryan|0034616832148|pablo.ryan@salud.madrid.org|
22306781|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org|
22306782|NCT03293498|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22306783|NCT04975308|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22306784|NCT03654768|SWOG Statistics and Data Management Center|Leukemia Committe Statistician|2066674623|amoseley@fredhutch.org|
22306785|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
22306786|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22306787|NCT02950896|Washington University School of Medicine|Heather McKenzie|3142862628|heather.mckenzie@wustl.edu|
22306788|NCT00748410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306789|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22306790|NCT02601170|Tri-service general hospital|Dr. Tsung-Ying Li|886-2-87927166|doc31141@gmail.com|
22306791|NCT02994654|AVITA Medical|VP Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
22306792|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov|
22306793|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr|
22306794|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22306795|NCT04178941|Children's Hospital of Philadelphia|Chris Bonafide, MD, MSCE|267-426-2901|bonafide@chop.edu|
22306796|NCT03995069|Ralph H. Johnson VA Health Care System|Principal Investigator|8434671373|NaJin.Seo@va.gov|
22306797|NCT02582593|University of Florida|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
22320425|NCT02592018|UCSF Department of Dermatology|Dr. Wilson Liao|415-476-4701|wilson.liao@ucsf.edu|
22320426|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|216
22320427|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
22320428|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com|
22320429|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu|
22320430|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320431|NCT03337542|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22320432|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu|
22320433|NCT03372928|US Army Research Institute of Environmental Medicine|Jess Gwin|508-206-2300|jessica.a.gwin.ctr@mail.mil|
22320434|NCT03828292|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320435|NCT04198623|UCSF Fresno/Community Cancer Institute|Mohammed Sani Bukari MD, Associate clinical professor|3473019055|Mohammed.Bukari@ucsf.edu|
22320436|NCT02481921|Providence VA Medical Center|Dr. Wen-Chih Wu|401-273-7100|wen-chih.wu@va.gov|16237
22320437|NCT04456764|University of Pittsburgh|P. Daniel Patterson|412-647-3078|pdp3@pitt.edu|
22320438|NCT03116997|Memorial Sloan Kettering Cancer Center|Dr. German Echeverry, MD|212-639-8865|echeverg@mskcc.org|
22320439|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu|
22320440|NCT03227471|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22320441|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
22320442|NCT00675922|University of Texas Medical Branch|Tina Mack-Moshay, ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
22320443|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320444|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22320445|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
22320446|NCT03197493|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
22320447|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22320448|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320449|NCT02236520|Vanderbilt University Medical Center|Alp Ikizler|(615) 343-7592|alp.ikizler@vumc.org|
22320450|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320451|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22320452|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com|
22320453|NCT00867789|Children's Mercy Hospital|Dr. Joan Giovanni|8162343430|gegiovanni@cmh.edu|
22320454|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22320455|NCT03677596|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320456|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320457|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320458|NCT03329911|Bio-Thera Solutions Ltd.|Yufeng Zhang|+86 2038251386|yfzhang@bio-thera.com|
22320459|NCT02475070|Lund University|Dr Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
22320460|NCT03668600|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22320461|NCT01925573|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
22320462|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu|
22320463|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22320464|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300||
22320465|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22320466|NCT04109222|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22320467|NCT02577406|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22261310|NCT02714062|VIVUS|Sr. Director, Clinical Research|650-934-5200||
22320468|NCT05143489|Maimonides Medical Center|Director of Research Administraton|7182836896|alikourezos@maimo.org|
22320469|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
22320470|NCT00702754|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
22320471|NCT01353196|VA Medical Center VA Maryland Health Care System, Baltimore, MD|Brajesh K. Lal, MD|410-605-7000|blal@som.umaryland.edu|
22320472|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
22320473|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22320474|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22320475|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com|
22320476|NCT02901574|Johns Hopkins University School of Medicine|Rajani Sebastian, PhD|410-502-5012|rsebast3@jhmi.edu|
22320477|NCT01751399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320478|NCT02790138|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320479|NCT03199040|Washington University School of Medicine|Williams Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
22261311|NCT02682784|Medical University of South Carolina|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
22320480|NCT01786603|University of Kansas Medical Center|Dr. Richard Barohn|913-945-9944|rbarohn@kumc.edu|
22261312|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu|
22261313|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov|
22261314|NCT03181594|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22261315|NCT02017223|University of Southern California|Donna Spruijt-Metz, MFA PhD|310-577-6248|dmetz@usc.edu|
22261316|NCT02834663|Wonkwang University Hospital|Dr. Seung Joon Lee|010-5004-8165|eunilsa@hanmail.net|
22261317|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org|
22261318|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261319|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22261320|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
22261321|NCT00838630|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261322|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu|
22261323|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22261324|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
22261325|NCT04263649|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
22261326|NCT02057458|Augusta University|Ryan Harris, PhD|7067215998|ryharris@augusta.edu|
22261327|NCT05244421|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22261328|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100|papaioannou@hhsc.ca|77715
22261329|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22261330|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22261331|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22261332|NCT02352259|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
22261333|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22261334|NCT03459807|University of California, San Francisco|Dr. Chi-yuan Hsu|415-476-2172|chi-yuan.hsu@ucsf.edu|
22261335|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu|
22261336|NCT02563808|University of Pennsylvania Hospital|Lee Fleisher|2156623738|lee.fleisher@uphs.upenn.edu|
22274597|NCT04406714|University of North Carolina Lineberger Comprehensive Cancer Center|Alexis Moore|+1 919-962-5409|alexis.moore@unc.edu|
22274598|NCT04536701|Ohio State University|Dr. Karen Rose|614-292-4844|rose.1482@osu.edu|
22274599|NCT01946204|Janssen Research & Development, LLC|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22274600|NCT03797898|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
22274601|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274602|NCT03217591|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
22274603|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu|
22274604|NCT05324306|Medical University of South Carolina|Dr. Konrad Rajab|843-792-1414|tkrajab@uams.edu|
22274605|NCT02421354|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD. Professor|713-745-3429|sverstov@mdanderson.org|
22292740|NCT03817879|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
22261337|NCT02392000|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley|781-687-2273|karen.quigley@va.gov|
22274606|NCT03301636|Lumos Pharma Inc. (Formerly NewLink Genetics)|Lumos Pharma|515-598-2921|clinical.trials@lumos-pharma.com|
22292741|NCT03265665|University of Illinois at Chicago|Dr. Sharmilee Nyenhuis|3124131655|snyenhui@uic.edu|
22320481|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
22320482|NCT03770091|UPMC|John Fowler|412-605-3245|fowlerjr@upmc.edu|
22320483|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22320484|NCT04702737|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22320485|NCT01908972|Seoul National University College of Medicine|Prof. Tae Hyun Choi|82-10-5595-5829|psthchoi@snu.ac.kr|
22320486|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320487|NCT02109562|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22320488|NCT03023930|Yale University|Dr. Gail D'Onofrio|(203) 785-7059|gail.donofrio@yale.edu|
22320489|NCT03598647|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
22320490|NCT01675635|Mundipharma (China) pharmaceutical Co, LTD.|Ms. Dan Zhu, Clinical operation and quality lead of the study|0086-10-65636800|medical.mcpc@mundipharma.com.cn|
22320491|NCT00262522|Abbott|Global Medical Services|800-633-9110||
22320492|NCT04722042|University of North Carolina at Chapel Hill|Margaret Dillon, AuD, PhD|919-966-5251|mdillon@med.unc.edu|
22320493|NCT02454140|University of California, San Diego|Dr. James D. Murphy|(858) 822-6040|j2murphy@health.ucsd.edu|
22320494|NCT05359679|Kaiser Permanente Washington|Lorella Palazzo PhD|206-287-2900|lorella.g.palazzo@kp.org|
22320495|NCT01877915|Janssen Research & Development, LLC|SENIOR DIRECTOR, CLINICAL LEADER CV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22320496|NCT02247245|University of Leeds|Dr Haqeel Jamil|0113 343 3241|haqeel.jamil@nhs.net|
22320497|NCT05314517|Kinevant|Study Director|(+1) 646-494-6491|kinevant.resolve-lung@kinevant.com|
22320498|NCT04714073|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320499|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
22320500|NCT02710136|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22320501|NCT02269787|Department of Veterans Affairs|Dr. Christine Timko, Research Career Scientist|6504935000|Christine.Timko@va.gov|23336
22320502|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22320503|NCT03366298|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22320504|NCT05050318|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22320505|NCT04183790|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22320506|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320507|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22320508|NCT02833974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320509|NCT04419610|Imperial College|Dr David Owen|07575089144|d.owen@imperial.ac.uk|
22320510|NCT01439282|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22320511|NCT03370536|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|(212) 241-7114|vivek.reddy@mountsinai.org|
22320512|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889||
22320513|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22320514|NCT04814342|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22320515|NCT03807349|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
22320516|NCT00111800|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320517|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22320518|NCT02752035|Astellas Pharma Global Development, Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22320519|NCT04630171|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22320520|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22320521|NCT05500274|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
22320522|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
22320523|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
22320524|NCT03000179|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22320525|NCT03269435|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22320526|NCT03959332|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22320527|NCT00073528|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22320528|NCT02937194|The University of Hong Kong|Prof Wong, May Chun Mei|852-28590422|mcmwong@hku.hk|
22261338|NCT00833937|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261339|NCT01985308|Wave Neuroscience, Inc.|Mazaya Soundra, Clinical Trials Manager|9492292869|mazaya@waveneuro.com|
22320529|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu|
22320530|NCT04037748|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22261340|NCT04115293|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22320531|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22320532|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu|
22320533|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22320534|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org|
22320535|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
22320536|NCT03519867|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320537|NCT01846624|Stanford University Medical Center|David Joseph Iberri, MD; Clinical Assistant Professor (Hematology)|650-498-6000|diberri@stanford.edu|
22320538|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com|
22320539|NCT03472924|Oregon State University|Marc Norcross, PhD, ATC|541-737-6788|marc.norcross@oregonstate.edu|
22320540|NCT00617539|University of California San Francisco|Michelle Melisko, MD|415-353-7070|Michelle.Melisko@ucsf.edu|
22320541|NCT02546765|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|6176320706
22320542|NCT02426476|Columbia VA Health Care System, Virginia Commonwealth University, University of South Carolina|James Burch, MS, PhD, Professor|803-404-1552|burch@mailbox.sc.edu|
22320543|NCT04425720|Montefiore Medical Center|Dr. Jonathan Leff|7189204316|jleff@montefiore.org|
22320544|NCT04814823|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22320545|NCT04272892|University of Oxford|Dr Melanie Fleming|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
22261341|NCT02674152|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320546|NCT06557122|Encoll Corp|Dr. Subramanian Gunasekaran, PhD|+1 (510) 396-8581|guna@encoll.com|
22320547|NCT05318937|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
22261342|NCT03772522|MAP Centre for Urban Health Solutions, Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|ThulienN@mcmaster.ca|
22261343|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu|
22320548|NCT05678257|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
22261344|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012||
22320549|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320550|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22320551|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22320552|NCT05470465|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
22320553|NCT03912376|Memorial Sloan Kettering Cancer Center|Dr. Michelle Bradbury, MD, PhD|917-294-4585|bradburm@MSKCC.ORG|
22320554|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22320555|NCT04702451|Volta Medical|Paola Milpied|+33768025499|paola.milpied@volta-medical.com|
22320556|NCT00430482|Boston University Charles River Campus|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
22320557|NCT04338516|UT Health San Antonio (UTHSA), San Antonio, Texas|Angela Palaiologou-Gallis , DDS., MS|210-450 8736|PalaiologouA@uthscsa.edu|
22320558|NCT04347226|Columbia University|Mark N. Stein, MD|917-658-2771|mns2146@cumc.columbia.edu|
22320559|NCT04259411|Abbott Structural Heart|Janani Aiyer/ Clinical Scientist II|+1(669)287-4507|Janani.aiyer@abbott.com|
22320560|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org|
22320561|NCT00449670|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320562|NCT03743311|AO Servier|Olga Linnik|+7 495 9370700|olga.linnik@servier.com|
22320563|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
22320564|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org|
22320565|NCT02966509|Stanford University and VA Palo Alto Health Care System|Dr. Manali Patel|650-723-4000|manalip@stanford.edu|
22320566|NCT02982954|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22320567|NCT02603120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22320568|NCT05102344|University of California, Irvine|Sabrina E.B. Schuck, Ph.D.|9495335465|sabrina@uci.edu|
22320569|NCT03810781|Syracuse VA Medical Center|Dr. Richard Servatius|315-744-3370|richard.servatius@va.gov|
22261345|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
22320570|NCT05152927|University of California, San Francisco|Dr. Quan-Yang Duh, MD|(415) 221-4810|quan-yang.duh@ucsf.edu|
22320571|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262|shannoja@ohsu.edu|54868
22320572|NCT04252859|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
22320573|NCT05807464|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22320574|NCT04451161|University of Washington|Dr. Aaron Lyon|(206) 221-8604|lyona@uw.edu|
22320575|NCT03596866|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320576|NCT04770532|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22261346|NCT00210223|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22261347|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261348|NCT02096211|Johnson & Johnson MedTech|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
22261349|NCT03649841|University of Washington|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22261350|NCT03618147|Kuwait Society of Allergy & Clinical Immunology|Kuwait Society of Allergy & Clinical Immunology|0096524636478|walherz@hsc.edu.kw|
22261351|NCT02883452|Celltrion, Inc.|SungHyun Kim|+82 32 850 5778|sunghyun.kim@celltrion.com|
22261352|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000|kmusikatavorn@yahoo.com|4553-5
22261353|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
22306798|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com|
22306799|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22261354|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17|al-nawas@mkg.klinik.uni-mainz.de|3083
22306800|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22261355|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org|
22261356|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
22306801|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com|
22261357|NCT02477202|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@MSKCC.ORG|
22261358|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl|
22261359|NCT02699866|Institut Straumann AG|Dr. Michael McCaskey, Team Leader Clinical Research|+41619651741|michael.mccaskey@straumann.com|
22261360|NCT01837654|Assaf Harofhe MC|Dr. Kobi Stav|972-8-9779409|stavkobi@yahoo.com.au|
22261361|NCT05169710|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
22261362|NCT04107675|Zambon SpA|Ferdinando Ceravolo, MD|02 665241|ferdinando.ceravolo@zambongroup.com|
22261363|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu|
22261364|NCT02399917|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
22261365|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22261366|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261367|NCT02158663|James A. Haley VA Hospital|F. Andrew Kozel|(813) 972-2000|FRANK.KOZEL@VA.GOV|
22261368|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
22261369|NCT03197883|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22306802|NCT02616900|eSight Corporation|Rob Hilkes|613 276-4145|rhilkes@eSightcorp.com|
22306803|NCT04425863|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
22306804|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22306805|NCT02448446|South Coast Retina Center|Dr. Julie Gasperini|5629847024|jgasperini@gmail.com|
22306806|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22306807|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
22306808|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22306809|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu|
22306810|NCT02200770|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22306811|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org|
22306812|NCT04925765|University of Pittsburgh Medical Center|Dr. Katherine Grace Lim|4126411777|limkg2@upmc.edu|
22306813|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org|
22306814|NCT02555215|Biogen|Medical Director, Overall Study Officials|866-633-4636|clinicaltrials@biogen.com|
22306815|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306816|NCT02204982|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22306817|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org|
22306818|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org|
22306819|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306820|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22306821|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org|
22306822|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306823|NCT01943916|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
22306824|NCT00919763|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
22306825|NCT05323734|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22261370|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22261371|NCT03273153|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22261372|NCT02409355|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22320577|NCT02703090|Boston Children's Hospital|Dr. Barry Kussman|617-355-6225|barry.kussman@childrens.harvard.edu|
22261373|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov|
22261374|NCT00838539|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22261375|NCT01908205|Holland Bloorview Kids Rehabilitation Hospital|Lisa Genore|416-425-6220|lgenore@hollandbloorview.ca|6443
22261376|NCT05323396|University of North Carolina at Chapel Hill|Melisa Reimer-McAtee, MD|265 175 5056|melissa_reimer-mcatee@med.unc.edu|
22261377|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937|medinfo@alconlabs.com|817.568.67
22261378|NCT03458871|The University of Texas Health Science Center at Houston|Dr. Argyrios Stampas|713-797-5938|argyrios.stampas@uth.tmc.edu|
22261379|NCT03420300|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-223123456|jacque_liu@mail2000.com.tw|63572
22261380|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu|
22261381|NCT00584922|University of Oklahoma Health Science Center|Sunny Po, MD, PhD|405-271-9696|Sunny-Po@ouhsc.edu|
22261382|NCT01944930|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
22261383|NCT04234997|The University of Texas Health Science Center at Houston|Robert Suchting, MD|713-486-2521|Robert.Suchting@uth.tmc.edu|
22320578|NCT02512809|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|joseph.tobias@nationwidechildrens.org|
22320579|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320580|NCT03437564|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22320581|NCT00243386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22320582|NCT00133991|Johns Hopkins University|Yvette Kasamon, MD||ykasamon@jhmi.edu|
22320583|NCT01953575|Mayo Clinic|David A. Katzka|507-284-4824|Katzka.David@mayo.edu|
22320584|NCT04995055|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
22320585|NCT03418129|Duke University|Eric Elbogen, Ph.D.|919-684-9983|eric.elbogen@duke.edu|
22320586|NCT02087956|University of Rochester|Dr. Ellen Poleshuck|585-275-3138|ellen_poleshuck@urmc.rochester.edu|
22320587|NCT01378858|Albert Einstein College of Medicine|Shadi Nahvi, MD, MS|718 920 5379|snahvi@montefiore.org|
22320588|NCT02664272|Smith & Nephew, Inc.|Vice President of Medical Affairs|+41 41 7662222|luca.orlandini@smith-nephew.com|
22320589|NCT03073980|Massachusetts General Hospital|John C. Petrozza, M.D.|617-726-8868|jpetrozza@mgh.harvard.edu|
22320590|NCT04810689|USCalifornia|Darcy Spicer|3238653904|DSPICER@USC.EDU|
22320591|NCT01940471|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22320592|NCT04695392|UPENN|Martha A.Q. Curley, RN, PhD|2155739449|curley@nursing.upenn.edu|
22320593|NCT04261504|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
22320594|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu|
22320595|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com|
22320596|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320597|NCT01202279|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
22320598|NCT03574753|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22320599|NCT01379469|Washington University School of Medicine|David Rudnick MD, PhD- Associate Professor|314-286-2832|rudnick_d@wustl.edu|
22320600|NCT00807742|Brown University|Damaris Rohsenow, Ph.D.|401-863-6648|damaris_rohsenow@brown.edu|
22320601|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320602|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu|
22320603|NCT03159091|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22320604|NCT02667418|Hines VA|Dr. Stuart Johnson|708--202-8387|Stuart.Johnson2@va.gov|257772
22320605|NCT02044133|Centre hospitalier départemental Vendée|Dr Yves BLEHER|0251446572|yves.bleher@ght85.fr|
22320606|NCT04085523|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
22320607|NCT02046096|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22320608|NCT03520959|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320609|NCT04969276|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22320610|NCT05599672|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
22320611|NCT05097144|CooperVision Inc.|José A. Vega OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22320612|NCT00418665|Amgen Inc.|Study Director|866-572-6436||
22320613|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320614|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22320615|NCT02786134|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6290|mdicarli@bwh.harvard.edu|
22320616|NCT03996980|Universidad de Sevilla|Dr. Manuel Pabón-Carrasco|954 350 997|mpabon2@us.es|+34
22320617|NCT00583024|University of Iowa/Holden Comprehensive Cancer Center|David Lubaroff, PhD|(319) 335-8423|david-lubaroff@uiowa.edu|
22320618|NCT00766038|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
22320619|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu|
22320620|NCT03703882|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
22320621|NCT02013180|Catalca Ilyas Cokay State Hospital|Dr. Mustafa Zafer Temiz|+90 212 787 19 12|dr_mustafazafertemiz@hotmail.com|1178
22261384|NCT03500692|Abbott|Sripad Bellary|6503531726|sripad.bellary@abbott.com|
22292742|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu|
22292743|NCT03150160|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
22292744|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu|
22292745|NCT01680965|Moffitt Cancer Center|Joseph Pidala, M.D., PhD|813-745-2069|Joseph.Pidala@moffitt.org|
22292746|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu|
22261385|NCT02305758|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22261386|NCT01051570|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath M.D.|313-576-8717|vaishamu@karmanos.org|
22261387|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22261388|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22261389|NCT05593965|University of North Carolina at Chapel Hill|Justin Riddle, PhD|(919) 966-4584|justin_riddle@med.unc.edu|
22261390|NCT02272777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22261391|NCT04732195|Emory University|Dr. Lokesh Guglani|404-712-2324|lokesh.guglani@emory.edu|
22261392|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com|
22261393|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261394|NCT02445339|NYU Langone Health|Ryan P. McCormack, MD|212-562-6561|Ryan.McCormack@nyulangone.org|
22261395|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873||
22261396|NCT03206177|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
22261397|NCT03020641|Ramon y Cajal University Hospital|Characterization of changes in peritoneal cells gene expression after standard versus low pressure l|610 312962|aserranor@salud.madrid.org|+34
22261398|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22261399|NCT03238781|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22261400|NCT03161405|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22261401|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
22261402|NCT02039908|Florida International University|William E. Pelham, Jr., Ph.D.|305-348-0477|wpelham@fiu.edu|
22261403|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22261404|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu|
22261405|NCT02571907|Cook Research Incorporated|Alan Saunders, MS, Senior Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22261406|NCT03071575|Centers for Disease Control and Prevention|Dr. Takudzwa SAYI|404-718-3797|prp2@cdc.gov|
22261407|NCT03666026|UCLA|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
22261408|NCT00218257|University of Minnesota|Dr. Sheila Specker|612-273-9806|speck001@umn.edu|
22261409|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22261410|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22261411|NCT02517294|Nemours|Dr Katrin Post-Martens|904-330-9942|Katrin.Post-Martens@nemours.org|
22261412|NCT02267187|University of Pittsburgh|Patsy Simon|412-648-9207|simonpa@upmc.edu|
22261413|NCT02392286|Yale|Dr. Loren Laine|203-785-7312|loren.laine@yale.edu|
22261414|NCT04210557|Yale University|Dr. Philip Corlett|203 974 7866|belieflab@yale.edu|
22261415|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22261416|NCT00834067|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261417|NCT00418561|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22261418|NCT01796171|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
22261419|NCT00829309|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22292747|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com|
22292748|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22261420|NCT01083693|Abbott|Global Medical Services|1-800-633-9110||
22261421|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
22261422|NCT01707420|University of Colorado|Thomas Notides|720-777-6005|thomas.notides@childrenscolorado.org|
22261423|NCT03699020|University of California San Diego|Maile Young Karris|1-619-543-5039|m1young@health.ucsd.edu|
22261424|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com|
22261425|NCT04860804|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
22261426|NCT03020615|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
22261427|NCT00089661|Amgen Inc.|Study Director|866-572-6436||
22261428|NCT02760368|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
22261429|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu||
22261430|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261431|NCT01602419|Octapharma AG|Sigurd Knaub/SVP CR&D Haematology|+41 55 4512141|Sigurd.Knaub@octapharma.com|
22261432|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300||
22261433|NCT03645785|Albany Medical Center|Vikas Bhatt|5182623341|bhattv@amc.edu|
22261434|NCT03620747|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22261435|NCT02129426|University of Louisville|John W. Berkenbosch|502-852-3720|john.berkenbosch@louisville.edu|
22261436|NCT00850174|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261437|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22261438|NCT04533594|JOHNS HOPKINS HOSPITAL|Dulce M. Cruz-Oliver, MD|4109558305|dcruzoli@jhmi.edu|
22261439|NCT02757105|RedHill Biopharma Ltd.|Dr. Terry F. Plasse|972-(0)3-541-3131|terry@redhillbio.com|
22261440|NCT02355886|University of Washington|George Schade|2065986190|grschade@uw.edu|
22261441|NCT03500341|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22261442|NCT02937870|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22261443|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567|marc.schulze@uwaterloo.ca|36590
22261444|NCT03017885|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261445|NCT04503174|Tandem Diabetes Care|Clinical Affairs|877-801-6901|clinicalaffairs@tandemdiabetes.com|
22261446|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu|
22261447|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu|
22261448|NCT02107300|Medical University of South Carolina|Chitra Lal|(843) 792-7776|lalch@musc.edu|
22261449|NCT00836056|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261450|NCT03226522|Axsome Therapeutics|Study Director|212-332-5061|cstreicher@axsome.com|
22261451|NCT01001208|Amgen Inc.|Study Director|866-572-6436||
22261452|NCT02648347|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22261453|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22261454|NCT03546842|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261455|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22261456|NCT02739997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261457|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22261458|NCT03380845|MGH|Dr. Sandeep Saluja|6466621084|sandeep.s.saluja@gmail.com|
22261459|NCT04419311|Aksaray University Training and Research Hospital|Dr. Erdem Aras Sezgin|+905057777697|sezginmd@hotmail.com|
22261460|NCT01921062|University Medical Center Groningen|Dieuwke Broekstra, PhD; postdoctoral researcher|0031503613531|d.c.broekstra@umcg.nl|
22261461|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
22261462|NCT03686033|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22261463|NCT00925119|University of Maryland|Dr. Amber Beitelshees|410-706-0118|abeitels@medicine.umaryland.edu|
22261464|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu|
22261465|NCT05528588|UT Southwestern Medical Center|Ambarish Pandey, Principal Investigator|2146200286|Ambarish.pandey@utsouthwestern.edu|
22261466|NCT00913627|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261467|NCT03254420|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22261468|NCT02089997|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22261469|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org|
22261470|NCT00017953|Wake Forest School of Medicine|Dr. Mark Espeland, Principal Investigator|336-922-2072|mespelan@wakehealth.edu|
22261471|NCT02374853|University of Alberta|Dr. John Mullen|780-902-6327|jmullen@ualberta.ca|
22261472|NCT05844553|Imperial College London, National Heart & Lung Institute and RBH|Prof. Omar Usmani|02073518053|o.usmani@imperial.ac.uk|
22261473|NCT03681470|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
22292749|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com|
22261474|NCT00762307|Zeltiq Aesthetics|Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22261475|NCT02335658|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22292750|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22261476|NCT01594047|Fondazione IRCCS Istituto nazionale dei Tumori|Tognoli Emiliano MD|+39 0223902282|Emiliano.Tognoli@istitutotumori.mi.it|
22261477|NCT04149964|William Beaumont Hospitals|Mitchell Shecter, DO|2487629363|mitchell.shecter@corewellhealth.org|
22261478|NCT02851992|Zimmer Biomet|Lisette Smid, Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
22261479|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com|
22261480|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261481|NCT01754597|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22261482|NCT03447353|National Advanced Driving Simulator, University of Iowa|Timothy Brown|3193354785|timothy-l-brown@uiowa.edu|
22261483|NCT02175095|Asan Medical Center|Yong Sang Hong, M.D., Ph.D.|+82-2-3010-3227|yshong@amc.seoul.kr|
22261484|NCT02635750|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261485|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org|
22261486|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22261487|NCT04196907|Masimo Corporation|Vikram Ramakanth|949-297-7000|clinicalresearchdept@masimo.com|
22261488|NCT02642653|University of California Davis|Dr. Randi Hagerman|9167030247|rjhagerman@ucdavis.edu|
22261489|NCT03909607|Maimonides Medical Center|Sergey Motov MD|718-283-8693|smotov@maimonidesmed.org|
22261490|NCT02875392|Taipei Municipal Wanfang Hospital|Ming-Shun Wu|+886229307930|vw1017@gmail.com|
22261491|NCT04974684|IKEM Prague|Dr. Zuzana Tucanova|+420 776292211|zuzana.tucanova@ikem.cz|
22261492|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com|
22261493|NCT03155425|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Clinical Operation Director: Chenglei Qiao|+86-18036618600|chenglei.qiao@hengrui.com|
22261494|NCT02713425|Mayo Clinic|Stephen P. Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
22261495|NCT03874715|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22261496|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu|
22261497|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22261498|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us|
22261499|NCT03161158|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49 6172 609 93488|Jennifer.Braun@fmc-ag.com|
22261500|NCT01379222|Medtronic|Thushari Alahapperuma|763.526.8119|thushari.r.alahapperuma@medtronic.com|
22261501|NCT03616535|NYU Grossman School of Medicine and Langone Health|Dr. Mara McAdams DeMarco|1-646-987-1358|mara.mcadamsdemarco@nyulangone.org|
22261502|NCT03591458|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
22261503|NCT00834418|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261504|NCT01705574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22261505|NCT00777023|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
22261506|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR|
22261507|NCT02678286|Recro Pharma|Randall Mack|484-35-2470|rmack@recropharma.com|2406
22261508|NCT04274686|University of New Mexico|Dr. Neal Gerstein|505-272-2610|ngerstein@salud.unm.edu|
22261509|NCT04111965|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22261510|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu|
22261511|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22261512|NCT05704426|Hackensack Meridian Health|Sameer Jamal, MD|15519962997|Sameer.Jamal@hmhn.org|
22261513|NCT02077465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22261514|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22261515|NCT01827163|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
22261516|NCT03375463|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261517|NCT03075553|Mayo Clinic|Stephen M Ansell MD PhD|507/284-2511|ansell.stephen@mayo.edu|
22261518|NCT04920929|Access Vascular Inc.|Brian Hanley|1-781-538-6594|bhanley@accessvascularinc.com|101
22261519|NCT01745120|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22261520|NCT04314362|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
22261521|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it|
22261522|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu|
22261523|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu|
22261524|NCT02909907|Cleveland Clinic Foundation|Hubert H Fernandez|2164451108|FERNANH@ccf.org|
22261525|NCT01513174|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22261526|NCT02413320|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
22261527|NCT01900626|University of Wisconsin School of Medicine and Public Health|Benjamin J. Walker, MD|608/262-8858|bjwalker2@wisc.edu|
22261528|NCT03617523|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22261529|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
22261530|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000|honyenwu@gmail.com|1164
22261531|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no|
22261532|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22261533|NCT02576938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261534|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22261535|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22261536|NCT03749252|Guerbet|Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22261537|NCT03098394|University of Maryland School of Medicine|Richard Gentry Wilkerson|4103285555|gwilkerson@som.umaryland.edu|
22261538|NCT04408794|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22261539|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261540|NCT01518972|VA Puget Sound Health Care System|Tracy L. Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
22261541|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261542|NCT04022954|Abbott|Principal Scientist Clinical Research|1 202 253 5981|eric.horvath@abbott.com|
22261543|NCT03637764|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22261544|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22261545|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac|
22261546|NCT03138967|UT MD Anderson Cancer Center|Dr. Farzin Goravanchi / Anesthesiology & Perioperative Medicine|713-291-1163|fgoravan@mdanderson.org|
22261547|NCT04604275|University of Miami|Amanda Fifi|305-243-3166|amandacfifi@gmail.com|
22261548|NCT04405570|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
22261549|NCT04499963|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
22261550|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org|
22261551|NCT03117296|Henry Ford Hospital|Adele Myszenski, PT, DPT|313-916-1334|amyszen1@hfhs.org|
22261552|NCT02601625|AstraZeneca AB|Anifrolumab Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22261553|NCT00838279|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261554|NCT04608188|University of South Carolina|Robert Weaver|8037775605|weaverrg@mailbox.sc.edu|
22261555|NCT03286465|The University of Texas Health Science Center at Houston|Javier Barreda Garcia, MD|713-500-6838|Javier.BarredaGarcia@uth.tmc.edu|
22261556|NCT03586726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22261557|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22261558|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22292751|NCT02486302|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292752|NCT03789396|University of Colorado|Adit Ginde, MD, MPH|720-848-6777|ADIT.GINDE@CUANSCHUTZ.EDU|
22292753|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292754|NCT01601860|University of São Paulo|Dra. Alessandra Cristina Marcolin|+55(16)36022813|dralemar@uol.com.br|
22292755|NCT02104752|VA Greater Los Angeles Healthcare System/UCLA|Jonathan K. Wynn, Ph.D.|(310) 478-3711|jkwynn@ucla.edu|44957
22292756|NCT02899299|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22292757|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22292758|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu|
22292759|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22292760|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292761|NCT03423641|Kaiser Permanente|Elizabeth McGlynn, Ph.D.|6265643807|Elizabeth.A.Mcglynn@kp.org|
22292762|NCT04540497|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22292763|NCT05274815|AstraZeneca|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
22292764|NCT04416633|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292765|NCT03914326|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22292766|NCT03323502|Indiana University School of Nursing|Dr. Susan Hickman|317-274-0032|hickman@iu.edu|
22306826|NCT01595321|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
22306827|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu|
22306828|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22306829|NCT04795752|Sight Sciences, Inc|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22306830|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623||
22292767|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
22261559|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu|
22292768|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292769|NCT02239354|ViaCyte|Corporate Communications|858-207-0500|info@viacyte.com|
22261560|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu|
22261561|NCT02281084|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22261562|NCT02957942|University of Minnesota|Mo Chen|612-624-5220|mchen@umn.edu|
22261563|NCT03110003|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
22261564|NCT02655679|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22261565|NCT03801707|The Ohio State University|Brenda Cuson|614-293-6883|Brenda.Cuson@osumc.edu|
22261566|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22261567|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
22261568|NCT00834717|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261569|NCT01660243|Toray Industries, Inc|Clinical Trials Information Desk||clinical-trials.toray.mb@mail.toray|
22261570|NCT04299087|University of Florida|Dr. David Vaillancourt|(352) 294 - 1770|vcourt@ufl.edu|
22261571|NCT03025087|Duke University|Joseph Mathew, MD|919-681-6646|joseph.mathew@duke.edu|
22261572|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22261573|NCT00795821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22261574|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com|
22261575|NCT03821675|Baylor College of Medicine|Prof. Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
22261576|NCT01415232|UPittsburgh'|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu|
22261577|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
22292770|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22292771|NCT04066647|Cedars Sinai Medical Center|Kacey Haptonstall|424-315-4489|kacey.haptonstall@cshs.org|
22292772|NCT04172623|Yale School of Medicine|Krysten Bold, PhD|2039747603|krysten.bold@yale.edu|
22292773|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu|
22292774|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22292775|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org|
22292776|NCT00408629|Abbott|Global Medical Services|800-633-9110||
22292777|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292778|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov|
22292779|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22292780|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu|
22292781|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292782|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu|
22292783|NCT01784848|HCor|Dr Carlos Schiavon|1130536611|schiavon.ca@gmail.com|8201
22292784|NCT02607930|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22292785|NCT03198078|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22292786|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22292787|NCT01676727|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|Maarten.Hollander@medtronic.com|
22292788|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu|
22292789|NCT03140254|Becton Dickinson|Erin Zook|201-847-5351|erin.zook@bd.com|
22292790|NCT02517866|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22292791|NCT03114488|University of Minnesota|Elias Boroda|763-498-4176|borod002@umn.edu|
22292792|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315|sergio.salerno@unipa.it|2315
22292793|NCT03711266|Michigan Medicine|Rebecca Sripada|734-222-7432|rekaufma@med.umich.edu|
22292794|NCT02175628|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|9199664997|rad_research@med.unc.edu|
22292795|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22292796|NCT04558281|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22292797|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292798|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
22292799|NCT00749515|St. Jude Children's Research Hospital|Ellis Neufeld, MD, PhD|901-595-7509|ellis.neufeld@stjude.org|
22292800|NCT01393301|Massachusetts General Hospital|Dr. Conall O'Cleirigh, PI|(617) 643-0385|cocleirigh@mgh.harvard.edu|
22292801|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu|
22292802|NCT03342963|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22292803|NCT01309165|Sunnybrook Research Institute|Dr. Sara McEwen|4162266780|sara.mcewen@sunnybrook.ca|7957
22292804|NCT01739309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292805|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu|
22292806|NCT05012657|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
22292807|NCT04810481|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
22292808|NCT01318642|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
22261578|NCT03570749|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22261579|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174||
22320622|NCT01535573|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD, Professor and Director of Center For Neurobehavioral Research On Addictions||Joy.M.Schmitz@uth.tmc.edu|
22320623|NCT02263079|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22320624|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu|
22320625|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com|
22320626|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu|
22320627|NCT01761292|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22320628|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22320629|NCT03332498|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@moffitt.org|
22320630|NCT03577730|University of Michigan|Phillip Vlisides|734-936-4280|pvliside@umich.edu|
22320631|NCT02538016|Boston Children's Hospital|Alyssia Venna|617-919-6352|Alyssia.Venna@childrens.harvard.edu|
22320632|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu|
22320633|NCT06098248|VPIX Medical, Inc|Min-Jae Jeong|82425350676|clinical@vpixmedical.com|
22320634|NCT05611671|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22320635|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300||
22320636|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu|
22320637|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu|
22320638|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320639|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22320640|NCT03810911|Richard L. Roudebush Veterans Affairs Medical Center|Dr. Rajiv Agarwal MD MS|(317) 988-2241|ragarwal@iu.edu|
22320641|NCT05374525|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320642|NCT04738474|University of Washington|Jill Steiner|2062218240|jills8@uw.edu|
22320643|NCT02445651|Thomas Jefferson University|Andrew Newberg, M.D.|215-503-3423|Andrew.Newberg@jefferson.edu|
22320644|NCT01349101|Thomas Jefferson University|Dr. John Wagner|215-955-8874|JLW102@jefferson.edu|
22320645|NCT00454857|Amgen Inc.|Study Director|866-572-6436||
22261580|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
22320646|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu|
22320647|NCT01785459|Carolinas Medical Center|Dr. Sean Fox|704-355-3181|Sean.Fox@atriumhealth.org|
22320648|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org|
22261581|NCT03086460|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22261582|NCT02545283|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WO29519|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22261583|NCT02436005|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22261584|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu|
22261585|NCT00905606|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261586|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu|
22261587|NCT02659150|Massachusetts General Hospital|Ahmed Tawakol, MD|617-724-3699|atawakol@mgh.harvard.edu|
22261588|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
22261589|NCT02902211|University of Nebraskat at Omaha|Sara Myers|402-554-3246|samyers@unomaha.edu|
22261590|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com|
22261591|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261592|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22261593|NCT00571064|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22261594|NCT02701556|Valeant Pharmaceuticals|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
22261595|NCT02363803|Washington University in St. Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
22261596|NCT03140631|Michigan Medicine|Dr. Hakan Oral|734-936-8214|oralh@med.umich.edu|
22261597|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
22261598|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22261599|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org|
22320649|NCT04707157|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22320650|NCT04232553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22320651|NCT02969915|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
22320652|NCT03625687|Massachusetts General Hospital|Raymond Chung, MD|6177247562|Chung.Raymond@mgh.harvard.edu|
22320653|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com|
22320654|NCT04206605|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320655|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22320656|NCT04580446|UT Southwestern Medical Center|Dr. Dominic Moon|214-645-8525|Dominic.Moon@UTSouthwestern.edu|
22320657|NCT01651351|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22320658|NCT02225080|Integra LifeSciences Corporation|Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
22320659|NCT00003702|NRG Oncology|Angela M. Kuras on behalf of Virginia Filiaci|7168455702|kurasa@nrgoncology.org|
22320660|NCT00585611|UW-Madison at time of study|Nancy Sweitzer||nancysweitzer@shc.arizona.edu|
22261600|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu|
22261601|NCT03872128|Yale University|Nia Fogelman|(917)861-9865|nia.fogelman@yale.edu|
22261602|NCT00958334|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22261603|NCT03702608|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22261604|NCT03285594|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22261605|NCT00834431|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261606|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu|
22261607|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org|
22261608|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22261609|NCT03733444|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22261610|NCT01913405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22261611|NCT04400890|formerly of Mount Carmel Health Systems|Marvin McCreary, MD|614-526-8492|Marvin.McCreary+RCT@gmail.com|
22261612|NCT03925532|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22261613|NCT02258074|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|216-444-9938|gassmaj@ccf.org|
22261614|NCT05446870|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22261615|NCT03444090|Evergreen General Hospital, Taoyuan, Taiwan|Dr. Chi-Liang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
22292809|NCT03649867|NHS Tayside - Dundee Adult Psychological Therapies Service|Dr Lucie Bartoskova|00441382346556|lucie.bartoskova@nhs.net|
22292810|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com|
22292811|NCT03538431|Massachusetts General Hospital|Dr. Joseph Biederman|6177261743|biederman@helix.mgh.harvard.edu|
22292812|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22292813|NCT05394350|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292814|NCT02024555|Vanderbilt University Medical Center|Wonder Drake, MD|(615) 322-2035|wonder.drake@vumc.org|
22292815|NCT02887859|Humacyte Inc.|Dr. Shamik Parikh, MD, CMO|919-313-9633|sparikh@humacyte.com|
22292816|NCT00492050|UT MD Anderson Cancer Center|Sheeba Thomas, MD-Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
22292817|NCT04246372|Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz|Joaquin Espinosa|303-724-7389|joaquin.espinosa@cuanschutz.edu|
22292818|NCT04339140|Beth Israel Deaconess Medical Center|Dr. Rushad Patell|617-667-7000|rpatell@bidmc.harvard.edu|
22292819|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22292820|NCT03673046|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
22292821|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu|
22292822|NCT02614092|VISN 21 MIRECC, VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
22292823|NCT00392015|United States Military Malaria Vaccine Program Naval Medical Research Center|Dr. Judith Epstein|301-252-9026|judith.epstein@med.navy.mil|
22292824|NCT03693300|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292825|NCT02742441|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22292826|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292827|NCT03538678|University of Pittsburgh|Kar-Hai Chu|412-692-2578|chuk@pitt.edu|
22292828|NCT01824342|Amgen Inc.|Study Director|866-572-6436||
22292829|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292830|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22292831|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu|
22292832|NCT06132659|University of Michigan|Dr. Stefanie Russman Block|734-232-0373|srblo@umich.edu|
22292833|NCT03615326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22292834|NCT03794583|United Therapeutics|United Therapeutics Global Medical Information|1-240-821-1881|305PerfectOLEStudy@lungbiotechnology.com|
22292835|NCT02497612|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22306831|NCT00800605|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22292836|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343||
22292837|NCT03153956|NYU Langone Health|Dennis A. Cardone, DO|+1 646 501 7223|Dennis.Cardone@nyulangone.org|
22292838|NCT02477839|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22292839|NCT02268955|Maricopa Integrated Health System|Dan Quan, DO|602-344-5058|dany_quan@dmgaz.org|
22292840|NCT01439568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292841|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22292842|NCT00149734|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22292843|NCT00437320|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22292844|NCT01950169|Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden|Dr. Lena Flodin|Mobile: 0701910300|lena.flodin@sll.se|
22292845|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22292846|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22292847|NCT02410551|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
22306832|NCT04923724|Washington University School of Medicine|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
22261616|NCT01615198|Novartis|Study Director|862-778-8300||
22261617|NCT01686438|Crescenz VA Medical Center|Dr. Samuel T. Kuna|215-823-4400|Samuel.Kuna@va.gov|
22261618|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22261619|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu|
22261620|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
22261621|NCT03335761|Medtronic|Mylène Champs (Sr Clinical Research Specialist)|+17635261627|mylene.champs@medtronic.com|
22261622|NCT00214097|University of Wisconsin|Diana Trask|608-263-9528|trask@humonc.wisc.edu|
22261623|NCT02308475|Medical University of South Carolina|Brian Jacobs - Program Assistant|843-876-4922|jacobsbr@musc.edu|
22261624|NCT02009163|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22261625|NCT02453386|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
22261626|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
22261627|NCT00833586|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261628|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
22261629|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu|
22261630|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22261631|NCT02155465|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
22261632|NCT03373162|University of California, Irvine|Dr. Craig Stark, Professor|949-824-4201|cestark@uci.edu|
22261633|NCT03122457|Icahn School of Medicine at Mount Sinai|Dr. Anjali Vekaria|212-241-3288|anjali.shroff@mssm.edu|
22261634|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br|
22261635|NCT03769025|Perelman School of Medicine|Kyle M Kampman MD Principal Investigator|215 746 2764|kampman@pennmedicine.upenn.edu|
22261636|NCT03374176|Centro Universitario de Tonalá, Universidad de Guadalajara|Dr. Arieh Roldán Mercado Sesma|+52 (33) 20 00 23 00|arieh.mercado@academicos.udg.mx|6400
22261637|NCT02911701|University of New Mexico, Division of Maternal-Fetal Medicine|Dr. Nathan Blue|505-272-6309|nblue1297@gmail.com|
22261638|NCT00852696|Cleveland Clinic Florida|Cecilia Calvo|954-659-5637|calvoc@ccf.org|
22261639|NCT04659603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22261640|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
22261641|NCT04646213|Virginia Commonwealth University|Dr. Ashlee Loughan|804-828-4178|ashlee.loughan@vcuhealth.org|
22261642|NCT02441309|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
22261643|NCT02658084|University of Miami|Dr. Reshma Mahtani|954-698-3639|rmahtani@miami.edu|
22261644|NCT03290781|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22261645|NCT04494867|Attune Medical|Erik Kulstad, MD|+1-708-651-0736|ekulstad@gmail.com|
22261646|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261647|NCT02538523|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22261648|NCT02820350|SeaStar Medical|Eric Schlorff, CEO|844-427-8100|eric@seastarmed.com|
22261649|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261650|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com|
22261651|NCT02328040|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22261652|NCT03697109|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22261653|NCT05244447|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
22261654|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22261655|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261656|NCT00835991|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261657|NCT02149420|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22261658|NCT04278560|Hebrew SeniorLife|On-Yee Lo|6179715331|AmyLo@hsl.harvrd.edu|
22261659|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu|
22261660|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu|
22261661|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184||
22261662|NCT01531894|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22261663|NCT04347018|University at Buffalo|Mohammed Al-Zainal|7168292845|malzaina@buffalo.edu|
22261664|NCT03040362|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261665|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22261666|NCT03635320|Johnson & Johnson Medical (Shanghai) Ltd.|Jie, Zhou|+86 18600551010|JZHOU138@its.jnj.com|
22261667|NCT01558635|Medtronic, Bakken Research Center, Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen, Sr Clinical Research Manager|+31653227763|ber.kleijnen@medtronic.com|
22261668|NCT02322593|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22261669|NCT03868891|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
22292848|NCT05469113|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22292849|NCT05447897|General Internal Medicine, University of Colorado School of|Dr. Gina Kruse, PI|303-724-4811|gina.kruse@cuanschutz.edu|
22292850|NCT04553679|University of Southern California|Marika Demers, PhD, OT, post-doctoral research fellow|13234421196|demers@pt.usc.edu|
22292851|NCT04926077|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
22292852|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261670|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
22292853|NCT02905149|Instituto de Investigación Sanitaria La Fe|Maria Cortell|961246611|investigacion_clinica@iislafe.es|
22261671|NCT04994535|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22261672|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com|
22261673|NCT04808362|Peptomyc|Dr Niewel|+34932543450|mniewel@peptomyc.com|8684
22261674|NCT02246920|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22261675|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu|
22261676|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net|
22261677|NCT03247972|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
22261678|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22261679|NCT00834340|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261680|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261681|NCT05956925|University of Nevada, Las Vegas|Dieu-My Tran (PI)|17028953371|dieu-my.tran@unlv.edu|
22261682|NCT02689505|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261683|NCT04108858|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran, MD. PhD.|(832) 829-4307|sdamodaran@mdanderson.org|
22261684|NCT03663179|University of Pennsylvania|Leah Bernardo|2157467162|lleah@pennmedicine.upenn.edu|
22261685|NCT01940341|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22261686|NCT01935934|University Health Network - Princess Margaret Cancer Centre|Dr. Neesha Dhani|416-946-4501|neesha.dhani@uhn.ca|2361
22261687|NCT01289262|DrLutfiKirdarTRH|DR CEM TURAN|00905323513423|cemturan@gmail.com|
22261688|NCT03359356|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
22261689|NCT03792477|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261690|NCT01681745|Pacira Cryotech, Inc.|Kent Jones/ Sr. Director Quality and Medical Affairs|(510)933-1513|kent.jones@pacira.com|
22261691|NCT05239754|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22261692|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300||
22261693|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261694|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org|
22261695|NCT03134222|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22261696|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi|
22261697|NCT00906165|UCL Eastman Dental lnstitute University College London|Professor N Donos|+4420 3456 1075|n.donos@eastman.ucl.ac.uk|
22261698|NCT03482882|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22261699|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu|
22261700|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org|
22261701|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu|
22261702|NCT05341622|University of Pennsylvania|Shivan Mehta|215-898-9807|shivan.mehta@pennmedicine.upenn.edu|
22261703|NCT04611789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261704|NCT05152576|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22261705|NCT00859430|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261706|NCT02286739|Stryker|Kevin Barga|201 831 5073|kevin.barga@stryker.com|
22261707|NCT00834795|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261708|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com|
22261709|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu|
22261710|NCT04726345|Columbia University|Ezra J. Margolin, MD|212-305-0114|ejm2182@cumc.columbia.edu|
22261711|NCT02718326|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22261712|NCT06195579|University of Lincoln|Dr Nima Moghaddam|01522882000|nmoghaddam@lincoln.ac.uk|
22261713|NCT00761813|University of Minnesota|Principal Investigator|612.273.8000|swion001@umn.edu|
22261714|NCT03049748|Johns Hopkins University (Former Faculty at University of Michigan)|Dr. Jesus Casida|3132047665|jcasida1@jhu.edu|
22261715|NCT01735994|Pennington Biomedical Research Center|Dr. Tiffany Stewart, Director, Behavior Technology Laboratory|2257632554|tiffany.stewart@pbrc.edu|
22261716|NCT04162899|ReistoneBiopharma|Roger Liu, Medical Director|8613917512446|roger.liu@reistonebio.com|
22261717|NCT01011413|University of New South Wales|Sean Emery|02 9385 0900|semery@kirby.unsw.edu.au|
22261718|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
22261719|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp|
22261720|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu|
22292854|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com|
22274607|NCT03528551|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22292855|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca|
22292856|NCT01708161|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22292857|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
22292858|NCT01986140|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22292859|NCT02759354|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292860|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22261721|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22261722|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974||
22261723|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651|chenjm10@126.com|86
22261724|NCT03437265|Norgine|Lucy Clayton|+441895826669|LClayton@norgine.com|
22261725|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org|
22261726|NCT02362997|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|philippe_armand@dfci.harvard.edu|
22261727|NCT03410862|Cleveland Clinic|Jeff Negrey Study Coordinator|2166365504|negreyj2@ccf.org|
22261728|NCT02600403|Wills Eye Hospital|Michael Waisbourd|2159283000|MWaisbourd@willseye.org|
22261729|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22261730|NCT03302780|University of Texas McGovern Medical School - Houston|Sheng Li, MD, PhD|7137977125|sheng.li@uth.tmc.edu|713
22261731|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu|
22261732|NCT02911792|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD - Chief Diabetes Division - Medicine|210 567 6706|defronzo@uthscsa.edu|
22261733|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org|
22261734|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu|
22261735|NCT02926677|Stanford University|Hilit Kletter|650-723-5511|hkletter@stanford.edu|
22261736|NCT00840073|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261737|NCT04267276|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261738|NCT01788423|Indiana University, Department of Speech and Hearing Sci|Larry E. Humes|812-855-3507|humes@indiana.edu|
22261739|NCT00835263|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261740|NCT03249454|The University of Texas Health Science Center at Houston|Radha Korupolu, MD, MS|713-797-6976|Radha.Korupolu@uth.tmc.edu|
22261741|NCT03856320|William S. Middleton VA Hospital|Dr. Luke Funk|608-256-1901|Luke.Funk@va.gov|17899
22261742|NCT03987191|University of Colorado Anschutz Medical Campus|Dr. Viral Shah, Principal Investigator|303-724-8186|viral.shah@cuanschutz.edu|
22261743|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261744|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu|
22261745|NCT03669861|Massachusetts General Hospital|DRAI Director of Clinical Trials|6176920668|JHSTONE@mgh.harvard.edu|
22261746|NCT02760927|Hollister Incorporated|Stacy Haddad, Director Global Clinical Affairs|+1.847.680.2837|stacy.haddad@hollister.com|
22274608|NCT01789047|Rush University Medical Center|Director of Clinical Research|312 942 8002|Teresa_Chmura@rush.edu|
22274609|NCT02700048|University of Minnesota|Amir Moheet|6126249990|mohee002@umn.edu|
22274610|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274611|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu|
22274612|NCT02668640|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22274613|NCT02530437|University of Texas MD Anderson Cancer Center|Dr. Jaffer Ajani|(713) 792-2828|jajani@mdanderson.org|
22274614|NCT04541355|University of California, San Francisco|Dr. Hyunseok Kang, MD|(888) 689-8273|hyunseok.kang@ucsf.edu|
22274615|NCT06034457|Cleveland Clinic|Dr. Leslie Heinberg, Vice Chair for Psychology, Department of Psychiatry and Psychology|216 445-1986|heinbel@ccf.org|
22274616|NCT04344028|University of Wisconsin - Madison|Dr. C. Shawn Green|(608) 263-4868|csgreen2@wisc.edu|
22274617|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com|
22274618|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22274619|NCT05163392|UCSF|Sylvie Baudart|415-203-4027|sylvie.baudart@ucsf.edu|
22274620|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu|
22274621|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
22274622|NCT04059250|University of California San Francisco|Dr. Peter Rechmann|4155143225|Peter.Rechmann@ucsf.edu|
22274623|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
22274624|NCT03631641|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.Hays@osumc.edu|
22274625|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu|
22274626|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu|
22292861|NCT03616171|Emory University|Ashley Coombe, PhD|404-712-9313|ashley.coombe@emory.edu|
22274627|NCT02337491|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
22274628|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
22274629|NCT01432951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274630|NCT02900352|Virginia Commonwealth University|Dr. Albert Arias|8048285793|albert.arias@vcuhealth.org|
22274631|NCT03785028|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
22274632|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22274633|NCT01206465|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
22274634|NCT03712280|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22274635|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22274636|NCT04896216|University of Minnesota|Kumi Smith|612.301.3051|smi00831@umn.edu|
22320661|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274637|NCT04753034|Aditum Bio|VP, Clinical Operations|(510) 227-2102|Chris.resburg@aditumbio.com|
22274638|NCT01122173|Auris Health, Inc.|Emir Deljkich/Sr. Director, Clinical Affairs|650-397-2677|emir.deljkich@aurisrobotics.com|
22274639|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22261747|NCT03169062|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22261748|NCT03256695|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22261749|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
22261750|NCT03359863|University of California at San Francisco|Aida Venado, MD, MAS|4153532577|aida.venado@ucsf.edu|
22261751|NCT03450850|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
22261752|NCT02964039|Ralph H. Johnson VAMC / MUSC|Jesse Dean|8437929566|deaje@musc.edu|
22261753|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261754|NCT02089685|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261755|NCT01341730|The Catholic University of Korea|Dr. Eun Ho Choo|82-10-8500-4569|cmcchu@catholic.ac.kr|
22261756|NCT04887415|University of Florida|Emily K. Plowman, Ph.D. CCC-SLP|(352)273-8632|eplowman@ufl.edu|
22261757|NCT00840411|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261758|NCT01424293|Maimonides Medical Center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22261759|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu|
22261760|NCT03233724|National Cancer Institute|Dr. David S. Schrump|240-760-6239|david_schrump@nih.gov|
22320662|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261761|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
22261762|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com|
22261763|NCT01911676|Yale University|Christina Luddy|203-932-5711|christina.luddy@yale.edu|4549
22261764|NCT05178927|UF Health Proton Therapy Institute|Dr. Perry Johnson|904-588-1253|PBJohnson@floridaproton.org|
22261765|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu|
22261766|NCT03670017|Washington University School of Medicine|Grant Bochicchio, Harry Edison Professor of Surgery, Chief of Acute and Critical Care Surgery|314-362-9347|gbochicchio@wustl.edu|
22261767|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990|pettynathanm@uams.edu|2461
22261768|NCT03173547|Therapeutics, Inc.|Clinical Project Manager|858-571-1800|ClinicalResearch@therapeuticsinc.com|
22261769|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22261770|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
22261771|NCT04044521|University of Wisconsin-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
22261772|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
22261773|NCT01258933|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|wwierda@mdanderson.org|
22261774|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
22261775|NCT02608177|Kidney Research Institute, University of Washington|Dr. Ian de Boer, Associate Director|2067444029|IDeBoer@Nephrology.washington.edu|
22261776|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22261777|NCT06907719|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22261778|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com|
22261779|NCT05265624|University of Utah Moran Eye Center|Paul Bernstein, Principal Investigator|801-585-7231|Paul.Bernstein@hsc.utah.edu|
22261780|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov|
22292862|NCT01833546|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22292863|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292864|NCT02963935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22292865|NCT03911154|University of Pennsylvania|Dr. David Dinges|215-898-9665|dinges@pennmedicine.upenn.edu|
22292866|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711|felix.leung@va.gov|9403
22292867|NCT01822496|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22292868|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22292869|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292870|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292871|NCT04502979|University of North Carolina at Chapel Hill|Eric A Hodges, PhD, FNC-BC, FAAN|919-966-0534|eahodges@email.unc.edu|
22292872|NCT01881373|University of Hawaii|Rachel Novotny|808-956-3848|novotny@hawaii.edu|
22292873|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22292874|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
22292875|NCT02906332|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22292876|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu|
22292877|NCT02046902|Saint Luke's Mid America Heart Institute|Carole Decker|(816) 932-5440|c1decker@saint-lukes.org|
22292878|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu|
22292879|NCT02734433|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22261781|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22261782|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22261783|NCT02798458|Massachusetts General Hospital|Dr. Braden Kuo and Dr. Claire-Zar-Kessler|617-724-6038|bkuo@mgh.harvard.edu, czarkessler@mgh.harvard.edu|
22261784|NCT04035187|University of Maryland Baltimore|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22261785|NCT03423654|VA|April Maa|4043216111|april.maa2@va.gov|206817
22261786|NCT04310345|Vanderbilt School of Nursing|Dr. Mary Jo Gilmer|6153430938|maryjo.gilmer@vanderbilt.edu|
22261787|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
22261788|NCT01402050|Phoenix Perinatal Associates - Mednax|Ana Braescu|602-614-0488|ana_braescu@mednax.com|
22261789|NCT03581097|Ospedale Regionale di Bellinzona e Valli (ORBV)|Dr. med. Andrea Saporito, Vice-Chair Department of Anesthesia|091/811.91.11|andrea.saporito@eoc.ch|
22261790|NCT03220958|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22261791|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu|
22261792|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261793|NCT05700383|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
22261794|NCT03032172|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261795|NCT02925884|Pacific University|Yu-Chi Tai|503-352-2289|ytai@pacificu.edu|
22261796|NCT04516434|Duke University Medical Center|Cindy Amundsen, MD|919-401-1000|cindy.amundsen@duke.edu|
22261797|NCT06144424|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22261798|NCT00834522|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261799|NCT03165994|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
22261800|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com|
22261801|NCT02598089|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
22261802|NCT02303405|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22261803|NCT04757298|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
22261804|NCT03600805|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22261805|NCT04512781|Vapotherm|Amy Bergeski|570-351-6966|Abergeski@vtherm.com|
22261806|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu|
22261807|NCT00804856|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261808|NCT02557035|Helsinn Healthcare SA|Daniel Voisin|+41 91 985 2121|daniel.voisin@helsinn.com|
22261809|NCT03343535|TransMedics, Inc.|VP, Clinical Affairs|978-552-0900|ldamme@transmedics.com|
22261810|NCT00834132|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261811|NCT03415308|Duke Center for Research to Advance Healthcare Equity|Alesha Majors|919-660-7545|alesha.majors@duke.edu|
22261812|NCT00835484|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261813|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu|
22261814|NCT04383587|Mayo Clinic|Mark A. Parkulo, MD|9049532000|parkulo.mark@mayo.edu|
22261815|NCT03123094|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261816|NCT04859517|INVIVYD, Inc.|Study Inquiry|17818190080|ClinicalTrials@invivyd.com|
22261817|NCT04238754|Johns Hopkins Univeristy|Cecilia Bergeria|410-550-1979|cberge21@jhmi.edu|
22261818|NCT03517085|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22261819|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com|
22261820|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22261821|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu|
22261822|NCT02645409|Indiana University|Courtney Dhondt, Clinical Research Nurse|317-274-1791|cgerler@iu.edu|
22261823|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu|
22261824|NCT03552393|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22261825|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org|
22261826|NCT05646251|Geisinger|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|
22261827|NCT00465270|Abbott|Dr. Laura O'Brien||laura.obrien@abbott.com|
22261828|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org|
22261829|NCT02530905|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
22261830|NCT01231906|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22261831|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261832|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800|patriciasosab@hotmail.com|31828
22261833|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22261834|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261835|NCT04322500|University of Molise|Prof. Ciro Costagliola|+39 0874 404861/ 0874 404896|ciro.costagliola@unimol.it|
22261836|NCT03873272|Columbia University Irving Medical Center|Melissa Accordino, MD|646-317-4692|mkg2134@cumc.columbia.edu|
22261837|NCT03761173|Inari Medical, Now Part of Stryker|Ashleigh Willson|925-330-3446|Ashleigh.Willson@Stryker.com|
22261838|NCT03429712|Duke University Medical Center|Daniele Marin|919-684-2711|daniele.marin@duke.edu|
22274640|NCT04076917|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|800-547-0394|crystal.miller@biotronik.com|
22261839|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306833|NCT04345913|Washington University in St. Louis School of Medicine|Nusayba Bagegni|3142733022|nbagegni@wustl.edu|
22261840|NCT02740413|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306834|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu|
22306835|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261841|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-2828|SKopetz@mdanderson.org|
22261842|NCT01718301|Infetious disesases|Dr Josep Mallolas Masferrer|932275400|jmallolas@clinic.ub.es|3312
22261843|NCT05780788|UConn Health - Department of Orthodontics|Dr. Flavio Uribe (Study principal investigator)|8606792550|furibe@uchc.edu|
22261844|NCT00199901|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22261845|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu|
22261846|NCT05776901|University of California, Irvine|Dr. Melissa Pinto, Associate Professor, Sue & Bill Gross School of Nursing|949-824-9272|mdpinto@uci.edu|
22261847|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu|
22261848|NCT04517604|Edward Hines Jr., VA Hospital|Dr. Amy Herrold|708-202-5867|amy.herrold@va.gov|
22261849|NCT04336332|Cancer Institute of New Jersey|Dr. Sabiha Hussain|+1 732-718-3253|hussaisa@rwjms.rutgers.edu|
22261850|NCT01440465|Centre François Baclesse|Alexandra LECONTE|0231455002|a.leconte@baclesse.unicancer.fr|
22261851|NCT02225106|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732-|Ramon.Diaz-Arrastia@uphs.upenn.edu|
22261852|NCT01958294|Silk Road Medical, Inc.|Ric Ruedy, Exec VP, Clinical Affairs|408-585-2112|ric@silkroadmed.com|
22261853|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079|cmpglc@unife.it|+39
22261854|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685|gdiefen@harthosp.org|5-7396
22261855|NCT06137781|Royal United Hospitals Bath NHS Foundation Trust|Alec Snow|07793554479|alec.snow@nhs.net|
22261856|NCT05932134|Linkou Chang Gung Memorial Hospital|M.D|+886-3-3281200|pitiful1984@gmail.com|8467
22261857|NCT05292963|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22261858|NCT06284525|Northern Arizona University|Principal investigator|928-523-1787|Zachary.Lerner@nau.edu|
22261859|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com|
22261860|NCT04523168|Mayo Clinic|Dr. Amir Lerman|507-255-2446|lerman.amir@mayo.edu|
22274641|NCT04210986|Vice President of Operations|Suzanne Liv Page|970-401-8770|spage@sprivail.org|
22274642|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
22274643|NCT05222880|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen|(904)254-0152|TKarkkai@its.jnj.com|
22274644|NCT02886923|Johnson & Johnson Vision|Ross Franklin - PRINCIPAL RESEARCH OPTOMETRIST|904 4431768|RFrankl1@its.jnj.com|
22274645|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22274646|NCT02984982|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22274647|NCT02144701|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22274648|NCT04232839|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274649|NCT03902613|Columbia University Irving Medical Center|Dr. Martin Lan|646 774 7610|martin.lan@nyspi.columbia.edu|
22274650|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
22274651|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de|
22274652|NCT04622969|University of South Carolina|Director, Office of Research Compliance|8037777095|lisaj@mailbox.sc.edu|
22274653|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000||
22274654|NCT04249427|Duke University|David Jang, MD|919-613-6407|david.jang@duke.edu|
22274655|NCT02589145|UT MD Anderson Cancer Center|Dr. Yago Nieto/Professor, Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
22274656|NCT03724357|University of Maryland, Baltimore|Marcelo Sztein, MD|410-706-5328|msztein@som.umaryland.edu|
22261861|NCT05058430|Saliwell Ltd.|Dr. Andy Wolff|+972508801852|awolff@saliwell.com|
22274657|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl|
22261862|NCT01515891|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22274658|NCT02849080|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22261863|NCT02768701|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22261864|NCT00540995|City of Hope Medical Center|Dr. Anthony Stein|626-359-8111||
22274659|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20|info@valneva.com|0
22274660|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
22274661|NCT01819727|BioMarin Pharmaceutical Inc.|Principal Scientist I, Clinical Sciences|415-506-6348|dlounsbury@bmrn.com|
22306836|NCT00433199|Abbott|Global Medical Services|800-633-91110||
22306837|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306838|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com|
22306839|NCT03072953|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22306840|NCT01625013|University of California, San Francisco|Anthony Luke, MD|4155146120|Anthony.Luke@ucsf.edu|
22306841|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
22306842|NCT03603717|Department of Veterans Affairs, Center of Excellence for Suicide Prevention|Wilfred Pigeon, PhD|(585) 393-7918|wilfred.pigeon2@va.gov|
22320663|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu|
22320664|NCT02047253|University of Alabama at Birmingham|Pam Dixon, RN, BSN, OCN|205-975-9875|pamdixon@uab.edu|
22320665|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
22320666|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22320667|NCT00832520|UNM Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
22320668|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22320669|NCT01177683|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22320670|NCT06347731|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
22320671|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873||
22320672|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
22320673|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com|
22320674|NCT04551677|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22320675|NCT04066491|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22261865|NCT05014828|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22261866|NCT03382925|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
22292880|NCT03882788|Research Office|Clinical Trials Manager|650-724-1720|clinicaltrials-gov@stanford.edu|
22261867|NCT02682238|Botanix Pharmaceuticals|Anthony Robinson, MS, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22261868|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org|
22261869|NCT04665375|University Health Network|Sharon Walmsley|416-340-5077|sharon.walmsley@uhn.ca|
22261870|NCT03270462|"University of Colorado Denver | Anschutz"|Larry Chan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22261871|NCT05763147|BD China|MA manager of Clinical Trial|0086 21 2325 4853|justina.zhu@bd.com|
22261872|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261873|NCT01891994|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
22261874|NCT02115347|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261875|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com|
22261876|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22261877|NCT02849457|University of Alabama at Birmingham|E. Martina Bebin M.D., M.P.A.|205-975-2890|ebebin@uabmc.edu|
22261878|NCT02599558|Mayo Clinic|Jeffrey A. Alexander, M.D.|507+284-0474|Alexander.Jeffrey14@mayo.edu|
22261879|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
22261880|NCT01778010|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
22261881|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu|
22261882|NCT02159183|ZMK University of Bern, Clinic of Periodontology|Prof. Dr. med. dent., Dr. h.c., M.S. Anton Sculean|004131 632 25 72|anton.sculean@zmk.unibe.ch|77
22261883|NCT02154672|Yale University School of Medicine|Dr. Preston Sprenkle|2037852815|preston.sprenkle@yale.edu|
22261884|NCT02558491|University of Virginia Center for Diabetes Technology|Daniel R. Chernavvsky, MD|434-982-0602|mc7m@virginia.edu|
22261885|NCT03259139|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22261886|NCT02825680|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|Laura.Damschroder@va.gov|
22261887|NCT05630885|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22261888|NCT03419403|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22261889|NCT02068820|Florida Hospital Gynecologic Oncology|Robert W. Holloway|407-303-2400|robhollowaymd@gmail.com|
22292881|NCT03698331|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22292882|NCT06033521|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292883|NCT04916769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292884|NCT04941456|Gaylord Hospital, Inc.|Dr. Henry Hrdlicka|203-284-2864|hhrdlicka@gaylord.org|
22292885|NCT03806491|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
22292886|NCT05628103|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|smb_clinicaltranspa@otsuka-us.com|
22292887|NCT04840888|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292888|NCT02718300|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22292889|NCT05741528|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|SMB_ClinicalTranspa@otsuka-us.com|
22292890|NCT04063384|University of Texas at Austin|Dr. Elizabeth Lippard|512-495-5216|elizabeth.lippard@austin.utexas.edu|
22292891|NCT01743131|Boston Children's Hospital|Dr. Leslie Kean|404-376-0187|leslie.kean@childrens.harvard.edu|
22292892|NCT03894046|Entasis Therapeutics|Dr. David Altarac - Chief Medical Officer|+1 781 810 0120|david.altarac@entasistx.com|
22292893|NCT03270644|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22292894|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov|
22292895|NCT02476201|Abbott Medical|Pilar Santamaria|+34 917 278 964|pilar.santamaria@abbott.com|
22292896|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov|
22306843|NCT03505099|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22306844|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr|
22306845|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306846|NCT04584099|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22261890|NCT02354339|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uice@prodigy.net.mx|34212
22261891|NCT03084471|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22261892|NCT03435835|Purdue University/Indiana University|Dr. Bruno Roseguini|7654962612|brosegui@purdue.edu|
22261893|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
22306847|NCT05314634|National Taiwan Normal University|Ruei-Hong Li|+886988163220|rueihongli@gmail.com|
22306848|NCT03439891|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
22306849|NCT05470868|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22306850|NCT00585052|University of Iowa|Raymond Hohl, MD|319-335-6564|rhohl@pennstatehealth.psu.edu|
22306851|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu|
22306852|NCT02613871|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22261894|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com|
22261895|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22261896|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu|
22261897|NCT03682653|UCSF FI Proctor|Dr. Thomas Lietman|(414) 476-1442|tom.lietman@ucsf.edu|
22306853|NCT02527148|Stryker South Pacific|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
22306854|NCT02918279|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22261898|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22261899|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261900|NCT04870606|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+86- 512 6263 9938|PR@kintor.com.cn|
22261901|NCT02566850|Ekso Bionics|Katherine Strausser PhD|(510) 529-2529|kstrausser@eksobionics.com|
22261902|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261903|NCT04377087|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
22261904|NCT02028221|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
22261905|NCT01881763|Northwell Health|Georgios Petrides, MD, PI|718-470-8569|gpetride@northwell.edu|
22261906|NCT03098485|Washington University in St. Louis School of Medicine|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
22261907|NCT04200833|Medical University of Graz|PD MD Andrea Skrabl-Baumgartner|+43 316 385|andrea.skrabl-baumgartner@medunigraz.at|111
22261908|NCT06298396|Cochlear Limited|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22261909|NCT00836004|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261910|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu|
22261911|NCT02718963|Seoul National University Bundang Hospital, Seoul National University College of Medicine|Ju Seok Ryu|82-31-787-7739|jseok337@snu.ac.kr|
22261912|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu|
22261913|NCT00836472|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261914|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22261915|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu|
22261916|NCT05239195|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
22261917|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000||
22261918|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com|
22261919|NCT03246503|BiliCam, LLC|James Taylor|2064194923|uncjat@google.com|
22261920|NCT01370317|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22261921|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673|pfrankel@och.org|65265
22261922|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu|
22261923|NCT03673670|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
22261924|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
22261925|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu|
22261926|NCT02294786|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22261927|NCT05373173|Vanderbilt University Medical Center|Zachary Warren, Ph.D.|615-875-3085|zachary.e.warren@vumc.org|
22261928|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22261929|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca|
22261930|NCT03406156|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22261931|NCT05479058|Galapagos N.V.|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22261932|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
22261933|NCT02738086|University of Colorado Denver|Cory L. Christiansen|303-724-9101|cory.christiansen@cuanschutz.edu|
22261934|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu|
22261935|NCT01757392|Nielsen Biosciences, Inc|David Burney|858-571-2726|david@nielsenbio.com|
22261936|NCT01218672|Boston Scientific Corporation|Teresa Takle-Flach, Director, Clinical Operations|(952)930-6000|teresa.takle-flach@bsci.com|
22261937|NCT03703791|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22261938|NCT01552317|University of Oxford|Principal Investigator|+441865287794|chris.ocallaghan@ndm.ox.ac.uk|
22261939|NCT00841698|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261940|NCT00838136|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22261941|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com|
22261942|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at|
22261943|NCT04078022|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Dr. Wilbur Chen|410-706-5328|wchen@som.umaryland.edu|
22261944|NCT01250912|University of Maryland, Baltimore|Dr. Timm-Michael Dickfeld|410-328-7801|tdickfel@som.umaryland.edu|
22261945|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22261946|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261947|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22261948|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22261949|NCT06185088|University of Michigan|Meghan Arnold|734-936-8978|meghanar@med.umich.edu|
22261950|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22261951|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org|
22261952|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu|
22261953|NCT01878292|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22261954|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22261955|NCT05168735|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22261956|NCT01668602|Emory University|Trisha Kesar, PT, PhD|404-712-5803|trisha.m.kesar@emory.edu|
22261957|NCT00322439|Amgen Inc.|Study Director|866-572-6436||
22261958|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com|
22261959|NCT00415363|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22261960|NCT02152163|Delray Medical Center|Russell Weisz, MD|561-213-9371|rdweisz@gmail.com|
22261961|NCT03123471|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22261962|NCT01641380|Johns Hopkins University School of Medicine|Maria Trent, MD, MPH, Principal Investigator|443-287-8945|mtrent2@jhmi.edu|
22261963|NCT02358538|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22261964|NCT01686477|ImperialC|Luke Mills|+447989748017|l.mills@imperial.ac.uk|
22261965|NCT01863030|University of Kentucky Medical Center|Scott Roth M.D.|859-323-6346|sroth@uky.edu|240
22261966|NCT06999265|University of Michigan at Ann Arbor|Tim Bruns|(734) 647-8727|bruns@umich.edu|
22261967|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
22261968|NCT04189848|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22261969|NCT01588236|Jiangsu Kanion Pharmaceutical Co. Ltd|Weiyi Liu, MD|3016533500|liuweiyi65@hotmail.com|
22261970|NCT02430480|National Cancer Institute|Dr. Fatima Karzai|301-480-7174|karzaifh@mail.nih.gov|
22261971|NCT01030133|Medical University of South Carolina|Dr. Jeffery J Borckardt|843.792.3127|borckardt@musc.edu|
22261972|NCT01097577|US Air Force|Julie Meek, Clinical Pharmacist|210-808-2200|julie.m.meek.mil@mail.mil|
22261973|NCT03190005|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22261974|NCT04493684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22261975|NCT04825275|Penn State College of Medicine|Alireza Mansouri, MD|717-763-2559|connect@mansourimd.com|
22261976|NCT05635019|University of Pennsylvania and Johns Hopkins University|Ariana Chao|443-287-6223|ariana.chao@jhu.edu|
22261977|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu|
22261978|NCT05710718|Becton, Dickinson and Company|Director Clinical Affairs and Medical Affairs Strategy|551-225-1164|Kirsten.Hammitt@bd.com|
22261979|NCT04372238|Brown University School of Public Health|Brandon DL Marshall, PhD|4018636427|brandon_marshall@brown.edu|
22261980|NCT02591420|Data Coordinating and Analysis Center, HJF Global Infectious Diseases|Dr. Glenna Schluck|3015003824|gschluck@global-id.org|
22261981|NCT04241458|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261982|NCT05005442|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22261983|NCT03696160|Research Organisation (KC) Ltd|Project Manager|+44 (0) 7508 439711|LAPTOP@rokcservices.com|
22261984|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org|
22261985|NCT05604170|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22261986|NCT05056376|Johns Hopkins University, School of Medicine|Nestoras Mathioudakis, MD MHS|667-306-8085|nmathio1@jhmi.edu|
22261987|NCT04742491|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22261988|NCT03317899|Thomas Jefferson University|Dolores Grosso|848-256-5751|dag104@jefferson.edu|
22261989|NCT00446966|Carient Heart and Vascular|Dr Chirag Sandesara|7033358750|csandesara@carient.org|
22261990|NCT01440803|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
22261991|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org|
22261992|NCT03502811|Abbott|Nadia Bouhdi|32-479-94-10-37|nadia.bouhdi@abbott.com|
22306855|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22306856|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343||
22261993|NCT03913377|Johnson & Johnson Vision Care|Elizabeth Dow, PRINCIPAL RESEARCH OPTOMETRIST|+1800-843-2020|edow1@its.jnj.com|
22320676|NCT05166226|Pennington Biomedical Research Center|Dr. Corby Martin|+1 (225) 763-2585|corby.martin@pbrc.edu|
22261994|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu|
22261995|NCT02197416|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261996|NCT03689400|Rehabilitation and Exercise Science Laboratory (RESlab), Department of Business Economics, Health and Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Landquart, Switzerland|Giannina Bianchi|00418 300 01 78|giannina.dias@supsi.ch|
22261997|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22261998|NCT03128723|JnJ Worldwide|Gboyega Adenaike|908-874-1214|aadenaike@its.jnj.com|
22261999|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262000|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262001|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22262002|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
22262003|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
22262004|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22262005|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22262006|NCT01776190|University of Texas Southwestern Medical Center|Benjamin Chong, MD|214-645-2400|ben.chong@utsouthwestern.edu|
22262007|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300|paupperle@acorda.com|5263
22262008|NCT01907607|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
22262009|NCT01505933|Penn State Health Milton S. Hershey Medical Center|Dr. Uma R Parekh, MBBS, DNB, FRCA, FFARCSI|717531-4264|uparekh@pennstatehealth.psu.edu|
22262010|NCT05919823|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22262011|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262012|NCT04614168|University of Edinburgh|Prof. Shareen Forbes|0131 242 6740|shareen.forbes@ed.ac.uk|
22262013|NCT02777580|KU Leuven|Prof Frans Van de Werf|003216342111|frans.vandewerf@kuleuven.be|
22262014|NCT02321098|Galderma|Farzaneh Sidou Clinical Project Manager|04 93 95 70 51|farzaneh.sidou@galderma.com|33
22262015|NCT00840476|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262016|NCT00908128|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262017|NCT03261167|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262018|NCT00835146|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262019|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org|
22262020|NCT03199963|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
22262021|NCT01144494|University of Nebraska Medical Center|Carol Toris|402-559-1852|ctoris@unmc.edu|
22262022|NCT04813354|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262023|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
22262024|NCT05454956|Tarsus Pharmaceuticals, Inc.|Kavita Dhamdhere, Vice President of Clinical Development|650-223-4062|kdhamdhere@tarsusrx.com|
22262025|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22262026|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743||
22262027|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262028|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu|
22262029|NCT00835692|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262030|NCT03644550|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
22262031|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov|
22262032|NCT04688658|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22262033|NCT04970810|University of Chicago|Jacqueline Kanoon|773-834-3419|kanoon@bsd.uchicago.edu|
22262034|NCT04851184|George Washington University|Karen Goodman|202-994-0705|karengoodman@gwu.edu|
22262035|NCT04534010|Stanford University|Arash Momeni, MD, FACS|(650) 723-6189|amomeni@stanford.edu|
22262036|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
22292897|NCT04046055|University of Iowa|Dr. Craig D. Workman|319-467-0746|craig-workman@uiowa.edu|
22320677|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org|
22320678|NCT01538628|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22320679|NCT01357577|VA National Center for PTSD|Jessica L. Hamblen, PhD|8022965132|jessica.hamblen@va.gov|
22262037|NCT02776774|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
22262038|NCT02651272|Bosotn Medical Center|Elizabeth Klings, MD|617-638-7480|elizabeth.klings@bmc.org|
22262039|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501|sean.kidd@camh.ca|6295
22262040|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262041|NCT04349267|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22262042|NCT04618211|Pharvaris Netherlands B.V.|Pharvaris Clinical|31 712036410|clinical@pharvaris.com|
22262043|NCT06107725|Maimonides Medical Center|Dr. QingL Tony Wang|718.283.7670|qwang@maimo.org|
22262044|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262045|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262046|NCT03930732|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22262047|NCT04708028|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
22262048|NCT05797961|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
22262049|NCT03279250|UT MD Anderson Cancer Center|Dr. Christopher Logothetis, MD-Professor, Genitourinary Medical Oncology|(713) 563-7210|clogothe@mdanderson.org|
22262050|NCT02913924|New York State Psychiatric Institute|John Mariani MD|646-774-8181|john.mariani@nyspi.columbia.edu|
22262051|NCT04128761|Virginia Tech|Stephen LaConte|5405262008|slaconte@vtc.vt.edu|
22262052|NCT06539676|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+4631 3763191|freja.freedman@dentsplysirona.com|
22262053|NCT03393208|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22262054|NCT04405765|University of Texas Southwestern Medical Center|Tara Kristof - research coordinator|214-648-9007|tara.kristof@utsouthwestern.edu|
22262055|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262056|NCT00207090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22262057|NCT01370811|Quest Research Institute|Aaron L. Ellenbogen, OD, MPH|+1 248 644 7770|aellenbogen@comcast.net|
22262058|NCT03480763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262059|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22262060|NCT01647828|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
22262061|NCT01718873|National Cancer Institute, IRCCS, G. Pascale Foundation|Antonio Avallone, Dierctor of Experimental Abdominal Medcial Oncology|+390815903629|a.avallone@istitutotumori.na.it|
22262062|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu|
22262063|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org|
22262064|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22262065|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22262066|NCT00830024|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262067|NCT02554890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22262068|NCT00834275|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262069|NCT03649477|Levo Therapeutics|Vice President of Clinical Development|1-847-901-9260|contactus@levotx.com|
22262070|NCT04544410|Spruce Biosciences|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
22262071|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it|
22262072|NCT03331289|UTexas_SanAntonio|Ralph A DeFronzo|2105676691|defronzo@uthscsa.edu|
22262073|NCT04037969|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22262074|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
22262075|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22262076|NCT03121586|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
22262077|NCT06381102|University of Miami|Marlon Wong, Associate Professor of Clinical|3052842670|mwong2@miami.edu|
22262078|NCT03119025|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD Study Principal Investigator|383-236-03-29|ct_lab@mail.ru; ostanin62@mail.ru|+7
22262079|NCT02832063|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22262080|NCT03733730|Alcon Research, LLC|Sr. Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22262081|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500|sschwabe@supernus.com|2527
22262082|NCT00835575|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262083|NCT01988376|Far Eastern Memorial Hospital|Hsiao, Sheng-Mou|(02)89667000|smhsiao2@gmail.com|1424
22262084|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu|
22262085|NCT00859521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22320680|NCT05493280|UT Southwestern|Lead Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22274662|NCT02569892|Stanford University School of Medicine|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
22274663|NCT01533116|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22274664|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22274665|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22274666|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22274667|NCT04460326|Boston Medical Center|Sara M Alexanian, MD|617-638-8545|sara.alexanian@bmc.org|
22274668|NCT00577317|NRG Oncology|Linda Gedeon for Helen Huang, MS.|716-845-1169|Linda.gedeon@roswellpark.org|
22274669|NCT03372798|Oxford University Hospitals NHS Foundation Trust|Dr Tim Betts|0044 01865 220256|ep.doctors@ouh.nhs.uk|
22274670|NCT01831895|Vascular Dynamics|VP Clinical Affairs|949-942-1640|clinical@vasculardynamics.com|
22274671|NCT04794751|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
22274672|NCT02360488|UCLA|Steve Cramer|424-522-7273|sccramer@mednet.ucla.edu|
22274673|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk|
22274674|NCT02283658|Mayo Clinic|Gerardo Colon-Otero, M.D.|(904) 953-2000|gcolonotero@mayo.edu|
22274675|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu|
22274676|NCT01835912|BrockU|Panagiota Klentrou|19056885550|nklentrou@brocku.ca|4538
22274677|NCT03608826|Medtronic|Nicole Wood|8006338766|nicole.wood@medtronic.com|
22274678|NCT02084511|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274679|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au|
22274680|NCT02236000|NSABP Foundation, Inc.|Judy Langer, Director of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
22274681|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22274682|NCT03204643|Atrium Health|Dr. Jason Roberge|704-355-0268|Jason.Roberge@AtriumHealth.org|
22274683|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com|
22274684|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22274685|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org|
22274686|NCT03644017|Merit Medical Systems, Inc.|Casey Holland, Senior Director Clinical Operations|+1 (617) 842-0251|casey.holland@merit.com|
22274687|NCT02175225|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-632-8913|mselim@bidmc.harvard.edu|
22274688|NCT03106077|UT MD Anderson Cancer Center|Stacy Moulder, Professor, Breast Medical Oncology|(713) 792-2817|smoulder@mdanderson.org|
22274689|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org|
22274690|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
22274691|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com|
22274692|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22274693|NCT03810456|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
22306857|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu|
22306858|NCT01641198|Université de Montréal|Dr. Aldo-Joseph Camarda|(514) 343-7124|aj.camarda@umontreal.ca|
22306859|NCT01396837|RedDress|Saron Sirota, Clinical Team Leader|+972-54-5800765|sharon@reddress.co.il|
22306860|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22306861|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22306862|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com|
22306863|NCT03260140|VA Puget Sound Health Care Sysem|Margaret P. Collins|206.764.2085|margaret.collins@va.gov|
22306864|NCT01755949|Mayo Clinic|Joseph L. Blackshear, Principal Investigator|904-953-7279|blackshear.joseph@mayo.edu|
22306865|NCT01059877|QuietMind Foundation|Marvin Berman, PhD|610.940.0488|marvinberman@quietmindfdn.org|
22306866|NCT04598321|Brown University Oncology Research Group (BrUOG)|Assistant Director|401-863-3000|BrUOG@brown.edu|
22306867|NCT00640250|Institute of Clinical Research, Department of Dermoto Venerology and Allergy Center|Evy Paulsen, MD|+45 65 41 27 08||
22306868|NCT02957136|Duke University Health System|Christopher Polage|919-668-5008|christopher.polage@duke.edu|
22306869|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu|
22306870|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22306871|NCT01444417|Amgen Inc.|Study Director|866-572-6436||
22306872|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22306873|NCT02423291|"Institute of Hematology L. e A. Seràgnoli, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy"|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it|
22262086|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22262087|NCT02125461|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22262088|NCT02305732|Cerus|Carol Moore, Senior VP Regulatory Affairs & Quality|925-288-6361|cmoore@cerus.com|
22262089|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com|
22262090|NCT02645253|AstraZeneca AB|AZD7594 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22306874|NCT04018924|Emoled|Duccio Rossi Degl'Innocenti|+39 0550751981|d.rossi@emoled.com|
22320681|NCT06689527|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
22320682|NCT04890314|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-6363|jch9011@med.cornell.edu|
22262091|NCT03170219|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-668-5590|rachel.e.olson@duke.edu|
22262092|NCT03552484|Rush University Medical Center|Jori Fleisher, MD MSCE|3125632900|jori_fleisher@rush.edu|
22306875|NCT01124734|Penn State Cancer Institute|Joseph Drabick, MD|717 531 5059|jdrabick@pennstatehealth.psu.edu|
22262093|NCT02241551|University of Pittsburgh Cancer Institute|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22262094|NCT03499353|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262095|NCT02741687|Emory University|Maya Fayfman, MD|404-778-1664|maya.fayfman@emory.edu|
22262096|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu|
22262097|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu|
22262098|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com|
22262099|NCT02663349|Minneapolis VA Health Care System|Tasha Nienow, PhD|612-467-1004|tasha.nienow@va.gov|
22262100|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu|
22262101|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867||
22262102|NCT02751424|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262103|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725||
22262104|NCT01175135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262105|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com|
22262106|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330||
22262107|NCT02927639|Children's Hospital of Philadelphia|Tara Kaushal, MD|6177322603|tara.kaushal@joslin.harvard.edu|
22262108|NCT03534193|Hackensack Meridian Health|Steven Ghanny, MD|5519965329|steven.ghanny@hmhn.org|
22262109|NCT02699463|ResMed Ltd|Dr Alison Wimms|+61 8884 1123|alison.wimms@resmed.com|
22262110|NCT02488239|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
22262111|NCT05283148|University of California Davis Comprehensive Cancer Center|Oyebimpe Adesina, MD, MS|9167035166|adesina@ucdavis.edu|
22262112|NCT04414930|UCSD|Neal R. Swerdlow, M.D., Ph.D.|6194719455|nswerdlow@health.ucsd.edu|
22262113|NCT05470699|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
22262114|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu|
22262115|NCT03325881|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22262116|NCT03676634|California Department of Public Health|Stephen S. Arnon, M.D., M.P.H., Chief, Infant Botulism Treatment and Prevention Program|510-231-7600|Stephen.Arnon@cdph.ca.gov|
22262117|NCT02294981|UCSF Psoriasis and Skin Treatment Center|Tina Bhutani|4159147618|psoriasis@ucsf.edu|
22262118|NCT00829712|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262119|NCT06682403|University of Pennsylvania|Dr. Mucio Kit Delgado|2157468256|mucio.delgado@pennmedicine.upenn.edu|
22262120|NCT03926052|Yale University School of Medicine|Dr. Carlos Grilo|2037857210|carlos.grilo@yale.edu|
22262121|NCT03466866|Thomas Jefferson University|Barry Rovner,MD|215-503-1243|Barry.Rovner@Jefferson.edu|
22262122|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com|
22262123|NCT04134091|Lipocine Inc|Senior Director of Clinical Development|801-994-7383|admin@lipocine.com|
22262124|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se|
22262125|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk|
22262126|NCT00909753|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262127|NCT00835536|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262128|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu|
22262129|NCT03077451|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22262130|NCT03527485|Yale School of Medicine|Gustavo A. Angarita, MD, MHS|(203) 974-7536|gustavo.angarita@yale.edu|
22262131|NCT05980286|University of California, San Francisco|Julene Johnson, Professor|415-476-1106|Julene.Johnson@ucsf.edu|
22292898|NCT03534362|Saint Louis University|Joe D Brunworth, MD|314-577-8884|joe.brunworth@health.slu.edu|
22292899|NCT02633501|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22292900|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu|
22292901|NCT01104155|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
22292902|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292903|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493||
22292904|NCT05055128|Cinclus Pharma Holding AB|Kajsa Larsson, MD, PhD|+46 70 675 01 28|kajsa.larsson@cincluspharma.com|
22292905|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
22292906|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181|chenhao_316@aliyun.com|8405
22292907|NCT00299182|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7966|CR_Study_Registration@mdanderson.org|
22292908|NCT04102956|Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.|Xiaoyun Liu PhD|+8613191887318|audrey-l@163.com|
22292909|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
22292910|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292911|NCT03643159|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22306876|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22306877|NCT02214160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22306878|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com|
22306879|NCT01063972|University of Kansas Medical Center|Sharon Fitzgerald, MPH|913-588-3488|sfitzgerald@kumc.edu|
22274694|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
22274695|NCT03408899|Johns Hopkins University|Craig Hendrix, MD|4109559707|chendrix@jhmi.edu|
22274696|NCT01248416|Nemours Children's Clinic|Dr. Nelly Mauras|904-697-3674|nmauras@nemours.org|
22274697|NCT04745351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22274698|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274699|NCT03499795|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22274700|NCT02265510|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22274701|NCT02530385|Massachusetts General Hospital Endocrine Unit|Dr. Elaine Yu|617-726-6723|ewyu@mgh.harvard.edu|
22274702|NCT00116142|Dana Farber Cancer Institute|Anthony D'Amico|617.732.6310|ADAMICO@LROC.HARVARD.EDU|
22274703|NCT03093181|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274704|NCT02378662|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22274705|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22274706|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22274707|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274708|NCT01253161|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-6585|Jonathan.Strosberg@moffitt.org|
22274709|NCT03871556|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22274710|NCT03101020|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Lucas Villalta Santos|+5515998197899|lucasvillalta.s@gmail.com|
22274711|NCT05412134|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
22274712|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
22274713|NCT03167242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22274714|NCT03444584|MedImmune, LLC|Armando Flor|+1-301-398-1955|information.center@astrazeneca.com|
22274715|NCT03786380|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22274716|NCT02414698|Montefiore Medical Center|Sayed E Wahezi, MD|7189207246|swahezi@montefiore.org|
22274717|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22306880|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com|
22306881|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22306882|NCT04221828|US Biotest, Inc.|Gere S. diZerega, MD|18055951300|gere.dizerega@usbiotest.com|
22306883|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22306884|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
22306885|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
22306886|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000|jm.wecht@va.gov|3122
22306887|NCT00392054|Population Health Research Institute|Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC, FHRS|905-527-4322|Carlos.Morillo@phri.ca|40311
22306888|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22306889|NCT02115139|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
22306890|NCT04740164|The University of Texas MD Anderson Cancer Center|Dr. Katherine Hagan|(713) 794-5945|khagan@mdanderson.org|
22306891|NCT05216510|Tonix Pharmaceuticals|Herb Harris, MD, PhD|(862) 904-0355|herb.harris@tonixpharma.com|
22306892|NCT05444244|University of Wisconsin School of Medicine and Public Health|Andrea Gilmore-Bykovskyi|6082623057|algilmore@wisc.edu|
22306893|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22306894|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com|
22306895|NCT01568073|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22306896|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu|
22306897|NCT00305695|NRG Oncology|Linda Gedeon on behalf of James Kauderer, MA, BS|716-845-1169|linda.gedeon@roswellpark.org|
22306898|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu|
22306899|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306900|NCT03619226|Coloplast A/S|Julie Schnipper, Medical Writer|49111257|dkjuls@coloplast.com|
22306901|NCT04786457|University of Maryland, Baltimore, Center for Vaccine Development and Global Health|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
22306902|NCT02763319|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22306903|NCT04926181|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
22306904|NCT00840177|SWOG Statistical Center|S0919 Statistician|2066674623|amoseley@fredhutch.org|
22306905|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu|
22306906|NCT00722046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306907|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
22306908|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
22306909|NCT01668940|The Hospital for Sick Children|Dr Shinya Ito, Principal Investigator|4168135776|shinya.ito@sickkids.ca|205776
22274718|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274719|NCT01342354|The University of Chicago|Dr. Stanley Liauw|(773) 702-0817|Stanley.Liauw@uchospitals.edu|
22306910|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590||
22274720|NCT02956382|Seattle Cancer Care Alliance|Chaitra Ujjani, MD|(206) 606-1955|ujjani@uw.edu|
22262132|NCT04827394|University of Oklahoma Health Sciences Center|Birju Shah, MD|405-271-5215|birju-shah@ouhsc.edu|42167
22262133|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262134|NCT06041256|Aurion Biotech, Inc.|Study director|+1-857-639-4143|clinicalaffairs@aurionbiotech.com|
22262135|NCT03578809|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22262136|NCT03599193|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22262137|NCT00835705|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262138|NCT01116739|University of Colorado Denver|Patricia A. Braun|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22262139|NCT05090839|University of Miami|Dr. Roger McIntosh|3052435166|r.mcintosh@miami.edu|
22262140|NCT04039022|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22262141|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22262142|NCT03256227|Minneapolis VA Health Care System|Laura Meis, PhD|612-467-4516|laura.meis@va.gov|
22262143|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22262144|NCT00834964|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262145|NCT02826694|The University of North Carolina at Chapel Hill|Dr. Cynthia M. Powell|9199667646|powellcm@med.unc.edu|
22262146|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590||
22262147|NCT03606174|Mirati Therapeutics|Director, Clinical Operations|858-381-5289|LatvenL@Mirati.com|
22262148|NCT00491738|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22262149|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
22262150|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262151|NCT01572662|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
22262152|NCT03364192|VA Center for Integrated Healthcare|Emily M. Johnson, Ph.D., PI|315-425-4400|Emily.Johnson1@va.gov|53487
22262153|NCT04692155|UAB|Amitkumar Mehta|2059968400|amitkumarmehta@uabmc.edu|
22262154|NCT04547192|KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH|Dr Adam Gyedu|+233248228838|drgyedu@gmail.com|
22262155|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com|
22262156|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934|de_tran@hotmail.com|43261
22262157|NCT00935012|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262158|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22262159|NCT04626414|Shield Therapeutics|Jackie Mitchell|+44 (0) 191 511 8500|jackie.mitchell@shieldtx.com|
22262160|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu|
22262161|NCT03283982|Cleveland Clinic Foundation|Dr. Ajita Prabhu|2164444790|prabhua@ccf.org|
22262162|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw|
22262163|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com|
22262164|NCT00911274|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262165|NCT04603495|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22262166|NCT03275623|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
22262167|NCT01983969|UT MD Anderson Cancer Center|Nieto, Yago / Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
22262168|NCT03719040|Abbott|Dr. Kwangdeok Lee|9725269673|kwangdeok.lee@abbott.com|
22262169|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262170|NCT02709018|University of California San Diego|Murray B. Stein MD, MPH|858-534-6451|mstein@health.ucsd.edu|
22262171|NCT04589650|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22262172|NCT00950989|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22262173|NCT03804983|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22262174|NCT03600376|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
22262175|NCT02067611|Techfields|Dr. Chongxi Yu|571 276 5371|chongxiyu@hotmail.com|
22262176|NCT00796562|Johns Hopkins University|Heather Symons, MD|4105029961|hsymons2@jhmi.edu|
22262177|NCT05655520|Supernus Pharmaceuticals, Inc.|Gianpiera Ceresoli-Borroni PhD|3018382521|gceresoliborroni@supernus.com|
22262178|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com|
22262179|NCT02664961|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
22262180|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456|patty.jt@gmail.com|67587
22262181|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22262182|NCT05248204|Solventum US LLC|Paula Myhre|6513948069|pemyhre1@solventum.com|
22262183|NCT03100344|Galderma|Kenny Frazier|817-961-5120|Kenny.frazier@galderma.com|
22262184|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com|
22262185|NCT01963728|Inova Health Care System|Anne Whitney Brown, MD Principal Investigator|703.776.3067|anne.brown@inova.org|
22262186|NCT04375514|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
22306911|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306912|NCT00373386|Research Institute at Nationwide Children's hospital|Robert P. Hoffman MD|614-722-4425|robert.hoffman@nationwidechildrens.org|
22306913|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22320683|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22320684|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22320685|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu|
22320686|NCT01444742|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|CR_Study_Registration@mdanderson.org|
22320687|NCT03179891|Aquestive Therapeutics|Director of Clinical Operations|908-941-1900|clinicaltrials@aquestive.com|
22320688|NCT02159729|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
22320689|NCT02636582|UT MD Anderson Cancer Center|Dr. Isabelle Bedrosian, MD, Professor, Breast Surgical Oncology|(713) 563-1872|ibedrosian@mdanderson.org|
22320690|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181|aztrial_results_posting@astrazeneca.com|5895
22320691|NCT00067028|The University of Texas M. D. Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
22320692|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
22320693|NCT05895552|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22320694|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
22320695|NCT01843842|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
22320696|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu|
22320697|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu|
22320698|NCT03782402|CUIMC|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
22320699|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu|
22320700|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu|
22320701|NCT02018822|University of Rochester|Hans Malmstrom|585-275-5087|hans_malmstrom@urmc.rochester.edu|
22320702|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320703|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu|
22320704|NCT05032612|The University of Texas Health Science Center at Houston|Timothy Kirkpatrick, DDS|713-486-4227|timothy.c.kirkpatrick@uth.tmc.edu|
22320705|NCT02184195|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|information.center@astrazeneca.com|
22320706|NCT00589420|Abramson Cancer Center|Ravi Amaravadi|2156622222|ravi.amaravadi@pennmedicine.upenn.edu|
22320707|NCT00841568|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22320708|NCT03002155|University of Washington (affiliation)|Sara Morgan, PhD|651-229-1719|sjmorgan@uw.edu|
22320709|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu|
22320710|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22320711|NCT04311216|University of Liverpool|Dr Fraser Philp|01517942000|f.philp@liverpool.ac.uk|
22320712|NCT01412554|Oslo University Hospital Ullevål, Norway|MD PhD Tonje Amb Aksnes|+22119101|tonjeaksnes@hotmail.com|47
22320713|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|
22320714|NCT04118270|University of Massachusetts Medical School|Alok Kapoor|917-856-4538|alok.kapoor@umassmed.edu|
22320715|NCT03302975|Univeristy of British Columbia|Chris Napier|604-721-1310|chris.napier@ubc.ca|
22320716|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
22320717|NCT03834519|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|Clinicaltrialsdisclosure@msd.com|
22292912|NCT03467048|Cleveland Clinic|Dr. Kurt Ruetzler|216-445-8105|ruetzlk@ccf.org|
22292913|NCT04308304|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22292914|NCT03318900|M D Anderson Cancer Center|Amir A. Jazaeri, MD|713-792-2921|aajazaeri@mdanderson.org|
22262187|NCT04406194|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
22262188|NCT02888756|Erasmus MC|Dr R.A. Gruters|+31 10 7032100|r.gruters@erasmusmc.nl|
22262189|NCT03264092|Texas Tech University Health Sciences Center|Dr. Antonio Mendoza Ladd|9152154678|antonio.mendoza-ladd@ttuhsc.edu|
22262190|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com|
22262191|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com|
22292915|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22262192|NCT03206749|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22262193|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu|
22262194|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
22262195|NCT03497130|Department of Dermatology at Johns Hopkins University|Dr. Anna Chien|410-502-7546|achien3@jhmi.edu|
22262196|NCT00418938|Amgen Inc.|Study Director|866-572-6436||
22274721|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com|
22292916|NCT03945266|Pennsylvania State University|Dr. Abigail Pauley|814-863-7354|amp34@psu.edu|
22292917|NCT03750461|Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH Geisel School of Medicine, Hanover, NH|Matthew Z. Wilson, MD MSc FACS FASCRS|(603) 650-8113|Matthew.Z.Wilson@hitchcock.org|
22292918|NCT03242824|Mayo Clinic|Nadia N. Laack, MD, MS|507/284-2511|Laack.Nadia@mayo.edu|
22292919|NCT04432272|Beaumont Hospitals|Matthew Sims, MD|248-551-0027|matthew.sims@beaumont.org|
22292920|NCT03772678|Arch Biopartners Inc.|Richard Muruve|(647) 428-7031|info@archbiopartners.com|
22274722|NCT02314728|Montefiore Medical Center|Kafui A. Demasio, MD, MPH, Maternal Fetal Medicine, Dept of Obstetrics/Gynecology and Women's Health|718-920-2767|kdemasio@montefiore.org|
22274723|NCT02343224|Emory University|Dolly Aguilera MD|404-785-3515|Dolly.Aguilera@choa.org|
22292921|NCT03805646|University of California Los Angeles|Dr. Catherine Juillard|310-267-9609|cjuillard@mednet.ucla.edu|
22292922|NCT02682420|BD Peripheral Intervention|Courtney Rothwell, Clinical Project Manager|602-830-5544|courtney.rothwell@bd.com|
22292923|NCT04452344|Rutgers University School of Dental Medicine|Cecile A. Feldman, DMD|973-972-4634|feldman@rutgers.edu|
22292924|NCT05171777|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22292925|NCT02364713|Mayo Clinic|Evanthia Galanis|507-266-0584|galanis.evanthia@mayo.edu|
22292926|NCT04686786|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22306914|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu|
22306915|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com|
22274724|NCT03118934|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
22274725|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu|
22274726|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743||
22274727|NCT04467515|Precirix|Jonathan Delara, Clinical Trial Manager|+1 (512) 589-2114|jonathan.delara@precirix.com|
22274728|NCT03886272|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274729|NCT03014206|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274730|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com|
22274731|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274732|NCT03177148|University of Michigan|Mx. Emerson Delacroix|734-764-2014|emmed@med.umich.edu|
22274733|NCT02456194|NSHA|Ross Leighton|1-902-473-4035|Ross.Leighton@nshealth.ca|
22274734|NCT02408198|King's College London|Dr Amy Hardy|0207 848 0033|amy.hardy@kcl.ac.uk|
22274735|NCT02848664|James Madison University|Dr. Erin Kamarunas|540-568-8846|kamaruee@jmu.edu|
22274736|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22274737|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000|dr@jppelletier.ca|26666
22274738|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274739|NCT03139552|University of Colorado Anschutz Health and Wellness Center|John C. Peters, PhD|303-724-9160|john.c.peters@ucdenver.edu|
22274740|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu|
22274741|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
22274742|NCT00780975|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22274743|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343||
22274744|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22274745|NCT03044314|Duke University Medical Center|Richard Krasuski|919-681-6195|richard.krasuski@duke.edu|
22274746|NCT03122171|Rutgers-New Jersey Medical School|Alice Chu, MD|(973) 972-2076|chual@njms.rutgers.edu|
22274747|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22274748|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274749|NCT03234465|Oragenics, Inc.|Dr. Alan Jolyn|+ 1 813-286-7900|info@oragenics.com|
22274750|NCT02743364|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22292927|NCT03448653|Centre Hospitalier Départemental Vendée|Dr. Vincent MACE|0251446572|vincent.mace@ght85.fr|+33
22306916|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528||
22306917|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22292928|NCT04191187|Moffitt Cancer Center|Dr. Nelli Bejanyan|813-745-6008|Nelli.Bejanyan@moffitt.org|
22262197|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262198|NCT04428307|Duke University|Wendy Prudhomme-O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
22262199|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com|
22262200|NCT02314403|Massachusetts General Hospital|Tatsuo Kawai, MD PhD|617-726-0289|tkawai@mgh.harvard.edu|
22262201|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22262202|NCT04667338|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22262203|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu|
22262204|NCT05604209|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
22262205|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org|
22262206|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com|
22262207|NCT02911025|Brigham and Women's Hospital|Dr. Milena Pavlova|6174772129|mpavlova@bwh.harvard.edu|
22262208|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22262209|NCT02597049|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22262210|NCT04050735|Brown University|Dr. Mollie Monnig|401-863-3491|mollie_monnig@brown.edu|
22262211|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com|
22262212|NCT06647173|Emory University|Dr. Aaron Siegler|404-712-9733|asiegle@emory.edu|
22262213|NCT02923349|Incyte Corporation Call Centre|Incyte Biosciences International Sàrl|8554633463|RA@incyte.com|
22262214|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262215|NCT02751827|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22262216|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220|eanagnostou@hollandbloorview.ca|6005
22262217|NCT01841554|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22262218|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com|
22262219|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22262220|NCT00312897|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
22262221|NCT01278953|Abbott|Lori Rusch, Ph.D.|651-756-2668|lori.rusch@abbott.com|
22262222|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0|bettina.ammentorp@daiichi-sankyo.eu|585
22262223|NCT06336356|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22262224|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22262225|NCT05350137|Tongji Hospital affiliated Tongji Medical College of Huazhong University of Science and Technology|Dr. Wei Ping|+8613437101581|247046170@qq.com|
22262226|NCT05871151|University of Alabama at Birmingham|Alexandra Evancho|(205)975-5221|amelgin@uab.edu|
22292929|NCT02719327|Madison Veterans Affairs Geriatrics Research, Education & Clinical Center (GRECC)|Cynthia Carlsson, MD, MS; Professor of Medicine (Geriatrics)|608-280-7000|cynthia.carlsson@va.gov|
22306918|NCT01571596|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22306919|NCT03344536|Memorial Sloan Kettering Cancer Center|Dr. Komal Jhaveri MD|646-888-5145|jhaverik@mskcc.org|
22306920|NCT01437605|Moffitt Cancer Center|Dr. Nikhil Khushalani|813-745-3437|Nikhil.Khushalani@Moffitt.org|
22306921|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu|
22306922|NCT03795194|Phoenix Children's|Research Coordinator|6029331858|zhunteman@phoenixchildrens.com|
22306923|NCT01647581|VA|Linda Feagins|214-587-1603|linda.feagins@austin.utexas.edu|
22306924|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
22306925|NCT01078116|Abbott|Global Medical Services|1-800-633-9110||
22306926|NCT02499159|Inova Health System|Devon Collins|703-776-4096|Devon.Collins@inova.org|
22306927|NCT02242487|Acorda Therapeutics|Dr. Charles Oh, Senior Vice President - Clinical Development|914-326-5455|coh@acorda.com|
22306928|NCT03644849|Saint Louis University|Dr. Ramona Behshad|314-977-9721|ramona.behshad@health.slu.edu|
22306929|NCT02564744|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22306930|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22306931|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org|
22306932|NCT02771899|Columbia University Medical Center|Dr. Lawrence Lenke|2129324410|ll2989@columbia.edu|
22306933|NCT03835819|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
22292930|NCT04340193|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22292931|NCT03924869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22292932|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com|
22292933|NCT03001882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22292934|NCT03708770|Becton Dickinson (BPV)|Courtney Rothwell|480.350.6037|courtney.rothwell@bd.com|
22292935|NCT05268055|UMass Chan Medical School|Melissa L. Anderson, PhD|508-856-5820|melissa.anderson@umassmed.edu|
22320718|NCT04506086|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22320719|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu|
22320720|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22320721|NCT01181076|Oslo University Hospital|Kristin Skaarud|4723070000|kskaarud@ous-hf.no|
22320722|NCT02324075|Stanford University|Prof. Stephen P. Luby, MD|+1-650-723-4129|sluby@stanford.edu|
22320723|NCT05937165|Hebrew SeniorLife, Marcus Institute of Aging, Harvard Medical School|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22320724|NCT06608368|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22320725|NCT03977974|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22320726|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com|
22320727|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
22320728|NCT02530528|MicroBioTest|Dr. MH Bashir|7039250100|muhammad.bashir@microbac.com|
22320729|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22320730|NCT01183559|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|215 728-3135|Igor.Astsaturov@fccc.edu|
22320731|NCT02701868|Pennington Biomedical Research Center|Abby Altazan|2257632801|Abby.Altazan@pbrc.edu|
22320732|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu|
22320733|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22320734|NCT01999465|University of Michigan|Dr. Lynda Yang|7349365017|bpclinic@umich.edu|
22320735|NCT02554019|Biotest AG|Dr. Peter Röttgen|+496103801|peter.roettgen@biotest.com|803
22320736|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345|ssanatani@cw.bc.ca|7955
22320737|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816|ashley.h.shoemaker@vanderbilt.edu|615
22320738|NCT01308008|VA GRECC|Neil Alexander MD|734-845-3048|nalexand@umich.edu|
22320739|NCT02325219|Janssen Pharmaceutical K.K., Japan|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22320740|NCT02187172|University of Pennsylvania|Dr. Joel Gelfand|215-662-3514|joel.gelfand@pennmedicine.upenn.edu|
22320741|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320742|NCT01523496|University Hospitals Cleveland Medical Center|Dr Grace McComsey|216-844-2739|Grace.McComsey@UHhospitals.org|
22320743|NCT02181816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22320744|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com|
22262227|NCT03215706|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22262228|NCT02433977|University of Pittsburgh|Stacy Gelhaus Wendell|412-648-1351|gstacy@pitt.edu|
22262229|NCT03114891|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22262230|NCT03506633|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22262231|NCT02324335|Innovation Pharmaceuticals Inc.|Arthur P. Bertolino MD, PhD, MBA|978.921.4125|abertolino@IPharmInc.com|
22262232|NCT02973269|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22320745|NCT02830880|Emory University|David Schuster, MD|(404) 712-4859|dschust@emory.edu|
22320746|NCT05400213|University of Texas Health Science Center at San Antonio|Brian Mealeey, DDS, MS|210-450-8736|mealey@uthscsa.edu|
22262233|NCT03247686|Resolve Therapeutics LLC|James Posada|208 727 7010|jp@resolvebio.com|
22274751|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu|
22274752|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22274753|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274754|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22274755|NCT02845674|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
22306934|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306935|NCT02888080|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22306936|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22306937|NCT01296191|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
22274756|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590||
22274757|NCT02139397|Beat Childhood Cancer|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
22274758|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22274759|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com|
22274760|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
22274761|NCT02033759|Mercy Integrative Medicine|Sarah Stolker, MSPT, CLT-LANA|13145402858|sarah@stolker.com|
22274762|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu|
22274763|NCT04853043|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22274764|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu|
22274765|NCT04265261|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22274766|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu|
22274767|NCT03895801|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
22274768|NCT02466399|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
22274769|NCT02669849|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22274770|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org|
22274771|NCT03736967|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22274772|NCT02369653|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22274773|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274774|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com|
22274775|NCT01603602|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@Allergan.com|
22274776|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com|
22274777|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu|
22274778|NCT04748718|Northern Vermont University|Dr. Eleanor Beltz|802-635-1329|Eleanor.Beltz@NorthernVermont.edu|
22274779|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
22274780|NCT02090881|Imperial College Healthcare NHS Trust|Dr Mohammed Aslam|02083831000|m.aslam@imperial.ac.uk|1541
22274781|NCT01118299|Abbott|Sripad Bellary|408845814|sripad.bellary@abbott.com|
22274782|NCT01935089|The Wistar Institute|Luis J. Montaner|+1 (215) 898-9143|montaner@wistar.org|
22274783|NCT02932943|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22274784|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu|
22274785|NCT02665117|UT Southwestern Medical Center|Dr. Wanpen Vongpatanasin|214-648-9078|wanpen.vongpatanasin@utsouthwestern.edu|
22274786|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu|
22274787|NCT05379920|University at Buffalo|Haley Chizuk|7162043200|haleychi@buffalo.edu|2188
22274788|NCT01267279|Spokane Joint Replacement Center|Principal Investigator|509-466-6393|dfscott@mac.com|
22274789|NCT03530293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22274790|NCT01997125|The Ohio State University|Marcia Bockbrader MD PhD|6142937604|bockbrader.13@osu.edu|
22274791|NCT03482024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274792|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com|
22274793|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu|
22274794|NCT02147626|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|6175258264|jr33@partners.org|
22274795|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com|
22274796|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274797|NCT01038687|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22274798|NCT02783911|LomaLindaU|Dr. Jung-Wei Chen, Program director|9095584690|jwchen@llu.edu|85909
22274799|NCT02616783|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22274800|NCT05214118|Virginia Commonwealth University|Dr. Caitlin E. Martin|(804) 628-7023|caitlin.martin@vcuhealth.org|
22274801|NCT03080935|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22274802|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22306938|NCT03737240|University of Miami Miller School of Medicine|Dr. Rodolfo Galindo|305-243-7707|Rodolfo.galindo@miami.edu|
22274803|NCT03974282|Virginia Commonwealth University|David Chester|8048287624|dschester@vcu.edu|
22274804|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu|
22274805|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274806|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu|
22320747|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
22320748|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com|
22320749|NCT00871845|Allegheny Singer Research Institute|Hossam Kandil||Hossam.KANDIL@ahn.org|
22320750|NCT01035099|Weill Cornell Medicine|Rodriq Stubbs|646-962-3276|res2011@med.cornell.edu|
22320751|NCT02605187|Stanford University School of Medicine|Dr. Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
22320752|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320753|NCT02969187|Cleveland Clinic|Dr. Philip R. Schauer|216-444-4794|schauep@ccf.org|
22320754|NCT04075721|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22320755|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22320756|NCT01376778|The George Washington University Biostatistics Center|Dr. Rebecca Clifton, MFMU Principal Investigator|301-881-9260|rclifton@bsc.gwu.edu|
22320757|NCT03374189|St. Vincent's Hospital|Dr. Hee Youn Kim|82-31-249-7473|khyoun10589@gmail.com|
22320758|NCT03201458|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22320759|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com|
22320760|NCT04490863|Masimo Corporation|Vikram Ramakanth|949-297-7000|ClinicalResearchDept@masimo.com|
22320761|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org|
22320762|NCT00916149|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
22320763|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22320764|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com|
22320765|NCT02662036|Washington University School of Medicine|Terence Myckatyn, M.D.|314-996-8800|myckatyn@wustl.edu|
22320766|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320767|NCT05998148|Lundquist Institute for Biomedical Innovation|Jonathan Wu|6268227769|wu.jonathan.g@gmail.com|
22320768|NCT03497806|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
22320769|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22320770|NCT03473652|Centre François Baclesse|Alexandra LECONTE|0231455002|a.leconte@baclesse.unicancer.fr|
22320771|NCT05248295|MGH IHP|Lauryn Zipse|6176433245|lzipse@mghihp.edu|
22320772|NCT04490018|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22320773|NCT01839396|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
22320774|NCT03996876|University of California, San Francisco|Aoife O'Donovan, Associate Professor of Psychiatry|4152214810|aoife.odonovan@ucsf.edu|x24959
22320775|NCT00121108|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22320776|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
22320777|NCT02122198|University of Colorado Denver|Kerry Hildreth, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22320778|NCT04090580|"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Vasco de Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, 14080, CDMX, Mexico. Department of endocrinology and lipid metabolism"|Miguel Ángel Gómez Sámano|+52 1 55 59939816|miguel.gomezs@incmnsz.mx|
22320779|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22320780|NCT03080883|Mayo Clinic|Dr. Robert McBane|(507)266-3964|mcbane.robert@mayo.edu|
22320781|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
22320782|NCT04342871|UNC Lineberger|Eliza Park|919-966-3494|leeza_park@med.unc.edu|
22320783|NCT03382665|Zimmer Biomet|Fabrizio Lucchini, Clinical Jr.Project Lead|0041798575924|Fabrizio.Lucchini@zimmerbiomet.com|
22320784|NCT04002037|UMissourri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22320785|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu|
22320786|NCT00750698|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
22320787|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22320788|NCT04766021|Indiana University|Dr. Blair Johnson|8128558699|bj33@indiana.edu|
22320789|NCT03289650|Northwestern University|Lorenzo Gallon|312 695 4457|l-gallon@northwestern.edu|
22320790|NCT02634151|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
22320791|NCT03709654|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
22320792|NCT06243198|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22320793|NCT04172714|Emory University|Nima Kokabi, MD|(404) 778-4747|nima.kokabi@emory.edu|
22320794|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com|
22320795|NCT01230242|MaineHealth|Clinicaltrials.gov Administrator|207.396.8228|llemire@mmc.org|
22320796|NCT02256540|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau|303-724-1914|kerrie.moreau@cuanschutz.edu|
22262234|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262235|NCT00830258|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262236|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org|
22262237|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu|
22320797|NCT03923426|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrialsgov_Inquiries@Pfizer.com|
22320798|NCT01761084|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
22320799|NCT00940589|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
22320800|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu|
22262238|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com|
22274807|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22274808|NCT00606307|Italfarmaco S.p.A.|Tiziano Oldoni, MD|+39 02 6443|t.oldoni@italfarmaco.com|2540
22274809|NCT03368807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274810|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu|
22274811|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22274812|NCT03781726|University of Pennsylvania|Peter Reese|215-573-8070|Peter.Reese@pennmedicine.upenn.edu|
22274813|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274814|NCT03669588|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22274815|NCT01721447|University of Utah Division of Cardiovascular Medicine|Dr. Brent Wilson|801-585-2341|brent.wilson@hsc.utah.edu|
22274816|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274817|NCT02949947|UT MD Anderson Cancer Center|Saroj Vadhan,Clinical Professor, Cytokine & Supportive Oncology|(713) 792-7966|svadhanr@mdanderson.org|
22274818|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22274819|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22274820|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274821|NCT02247466|Department of Anaesthesiology, Herlev Hospital, University of Copenhagen|Roar Borregaard Medici, MD, Research Assistant|+4526390068|roar.borregaard.medici.01@regionh.dk|
22274822|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22274823|NCT01100502|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22274824|NCT04386902|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
22274825|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com|
22274826|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu|
22274827|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22274828|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
22274829|NCT04347408|Queen's University Belfast|Dr Thomas Waterfield|028 9024 5133|t.waterfield@qub.ac.uk|
22274830|NCT04356937|Massachusetts General Hospital|DRAI Director of Clinical Trials|617-726-7938|JHSTONE@mgh.harvard.edu|
22274831|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu|
22274832|NCT00060606|George Washington University Biostatistics Center|Dr. Elizabeth A Thom|301-881-9260|e_thom@bsc.gwu.edu|8035
22274833|NCT04821830|University of Michigan|Dr. Roger Albin|734-936-9115|ralbin@med.umich.edu|
22274834|NCT02557399|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274835|NCT00960804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274836|NCT02007720|Novartis Pharma AG|Study Director|+41613241111|novartis.email@novartis.com|
22274837|NCT01702909|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22274838|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22274839|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899|skanji@toh.on.ca|78159
22274840|NCT02100124|Penn State College of Medicine|Dr. Cynthia Chuang|7175318161|CChuang@psu.edu|
22274841|NCT04350827|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
22274842|NCT07116759|University of Pennsylvania|Rodney Wiersma, PhD|773-623-9820|Rodney.Wiersma@pennmedicine.upenn.edu|
22274843|NCT02097732|University of Michigan Comprehensive Cancer Center|Dr. Christopher Lao, MD, MPH|(734) 936-4498|clao@med.umich.edu|
22274844|NCT04166214|NYU Langone Health - Hansjörg Wyss Department of Plastic Surgery|Mary E. Northridge, PhD, MPH, Director of Dental Research|347-377-4342|Mary.Northridge@nyulangone.org|
22274845|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu|
22274846|NCT02034006|Novartis Pharmaceuticals|Study Director|862-778-8300||
22274847|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274848|NCT02470741|University of California, San Francisco|Lisa Abinanti, Project Director|415-353-9978|lisa.abinanti@ucsf.edu|
22274849|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590||
22274850|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22274851|NCT01898078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22274852|NCT03813108|Radboud university medical center|Matthew McCall, MD, PhD|+3124 3615363|Matthew.mccall@Radboudumc.nl|
22274853|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu|
22274854|NCT03630393|OhioHealth|Dr. Ryan Hedgepeth|614-788-2870|ryan.hedgepeth@ohiohealth.com|
22274855|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu|
22292936|NCT03507400|Practice for Neurology and Ludwigs-Maximilians-Universitiy Munich|Dr. Monika Empl|+4989500598710|dr.empl@dr-empl-neurologie.de|
22292937|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu|
22292938|NCT04905082|City of Hope|Stacy W. Gray, MD. AM.|626-715-4425|stagray@coh.org|
22292939|NCT04026711|University of Vermont|Anne Dixon, Professor of Medicine|802 847 0000|anne.dixon@uvmhealth.org|
22292940|NCT05985395|University of Nebraska Medical Center|Windy Alonso|814-577-2941|windy.alonso@unmc.edu|
22292941|NCT04823650|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22292942|NCT02875132|The Chinese University of Hong Kong|Dr. Herbert Ho Fung LOONG|35052166|h_loong@clo.cuhk.edu.hk|
22274856|NCT04635839|University of California, Los Angeles|Dr. Thalia Mok|310-794-7274|tmok@mednet.ucla.edu|
22274857|NCT02870868|Vanderbilt University Medical Center|Alfredo Gamboa|(615) 322-5000|alfredo.gamboa@vumc.org|
22262239|NCT02997176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262240|NCT05511935|KDH Research & Communication Inc.|President|4043958711|kholtz@kdhrc.com|
22262241|NCT04523480|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|3052434562|ramasamy@miami.edu|
22262242|NCT04102345|HealthPartners Neuroscience Research|Bhavani Kashyap, MBBS, PhD|651-495-6358|bhavani.x.kashyap@healthpartners.com|
22262243|NCT02722239|Biocard Research LLC|Nadiya Rizvanova|+74993088278|n.rizvanova@biocard.com|
22262244|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22262245|NCT04145635|Procyrion, Inc.|Rubi Reyes-Fuentez, Clinical Research Associate II|-|rubi@procyrion.com|
22262246|NCT01662960|Albert Einstein Healthcare Network|Dr. Steven Jax|215-870-0196|stevenandrewjax@gmail.com|
22262247|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
22262248|NCT02727192|Oslo University Hospital|Professor Lars Gullestad|+4797644772|lars.gullestad@medisin.uio.no|
22262249|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu|
22262250|NCT05497557|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22262251|NCT02920476|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22262252|NCT04590027|University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
22262253|NCT01384591|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8126|melmoore@utmb.edu|
22262254|NCT01959672|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
22262255|NCT02392195|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
22262256|NCT00907907|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262257|NCT04089553|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22262258|NCT04342663|Washington University School of Medicine|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22262259|NCT03366792|NYU Langone Health - Perlmutter Cancer Center|Samir S. Taneja, MD|(212) 263-6301|Samir.Taneja@nyulangone.org|
22262260|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262261|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org|
22262262|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
22262263|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu|
22262264|NCT00841542|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262265|NCT04345653|JFK University Medical Center - Hackensack Meridian Health|Dr. Jawad Kirmani|7327745805|jawad.kirmani@hmhn.org|
22262266|NCT03214588|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22262267|NCT03734861|Connecticut Children's Medical Center, Asthma Center|Dr. Jessica Hollenbach, PhD|860-837-5333|jhollenbach@connecticutchildrens.org|
22262268|NCT04631562|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22262269|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467|spss@snuh.org|9
22262270|NCT03503318|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22262271|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com|
22274858|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343||
22306939|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu|
22306940|NCT02512965|Canadian Cancer Trials Group|Dr. Keyue Ding|16135336430|kding@ctg.queensu.ca|77705
22306941|NCT04303156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306942|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu|
22306943|NCT05001945|Mineralys Therapeutics|David Rodman, MD Chief Medical Officer|1-888-378-6240|drodman@mineralystx.com|
22306944|NCT02570711|Acerta Pharma, LLC|Priti Patel, MD, Vice President - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22306945|NCT04283552|Washington University School of Medicine|Richard L. Wahl, M.D.|314-362-7100|rwahl@wustl.edu|
22306946|NCT01369498|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22306947|NCT00545077|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22306948|NCT01852071|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
22306949|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu|
22306950|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
22306951|NCT02755116|Icahn School of Medicine at Mount Sinai|Dr. Jaime B. Hyman|212-241-7473|Jaime.hyman@mountsinai.org|
22306952|NCT00958633|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|yatham@mail.ubc.ca|
22306953|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu|
22306954|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
22306955|NCT01576952|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22306956|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU|
22306957|NCT01597258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306958|NCT04789408|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22306959|NCT03073941|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
22306960|NCT04250883|Radboud umc|Dr. Michiel Warle|024-3613808|michielwarle@radboudumc.nl|
22306961|NCT03936660|Duke Clinical Research Institute|Chris Granger, MD|9196688700|christopher.granger@duke.edu|
22320801|NCT02860676|University of California, San Diego|Michael Choi, MD|858-534-1765|mychoi@ucsd.edu|
22320802|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22320803|NCT02953340|Spectrum Pharmaceuticals Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22320804|NCT01977599|UCL|Dr Robert Kerrison, Senior Research Fellow|02076798268|Robert.kerrison.13@ucl.ac.uk|
22320805|NCT02700412|University of Alabama at Birmingham|Dr. Jerzy Szaflarski, MD, PhD|205-934-3866|jszaflarski@uabmc.edu|
22306962|NCT00925587|Amgen Inc.|Study Director|866-572-6436||
22306963|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22306964|NCT01599793|University of Chicago|Russell Szmulewitz, MD|773-702-7609|rszmulew@medicine.bsd.uchicago.edu|
22306965|NCT02966275|MGH|Courtney Balliro BS, RN, CDE|617-726-1242|cballiro@partners.org|
22306966|NCT03122236|University of Florida|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
22306967|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
22306968|NCT04530149|Maimonides Medical Center|Research Administration Director|7182836896|alikourezos@maimo.org|
22306969|NCT00538759|Minneapolis Heart Institute Foundation|Lisa Tindell, Director of Clinical Operations|6128633816|Lisa.Tindell@allina.com|
22306970|NCT02675244|Icahn School of Medicine at Mount Sinai|Annetine Gelijns|212-659-9567|annetine.gelijns@mountsinai.org|
22306971|NCT04040296|Yale University|Abinet Aklilu|203-737-1787|abinet.aklilu@yale.edu|
22306972|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22306973|NCT02652442|James H Quillen VAMC|Research Health Science Specialist|(423) 926-1171|courtney.hall@va.gov|7518
22306974|NCT02252042|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306975|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu|
22306976|NCT02593149|Pursuit Vascular, Inc.|Laurie Lynch, PhD|6124249006|llynch@pursuitvascular.com|
22306977|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com|
22306978|NCT00749749|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|Innocoll|484-406-5211|ctucker@innocoll.com|
22306979|NCT02663297|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22262272|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org|
22262273|NCT02139826|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
22262274|NCT01457196|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22262275|NCT03498560|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22262276|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu|
22262277|NCT00112437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262278|NCT00659828|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
22262279|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com|
22262280|NCT03703258|University of Washington School of Medicine|Dr. Emily R. Dworkin|206-221-6932|edworkin@uw.edu|
22262281|NCT01125163|UTexas_Houston|Dr. Kathleen A. Kennedy|713-500-6708|Kathleen.A.Kennedy@uth.tmc.edu|
22262282|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu|
22262283|NCT03218787|Abbott|Lijuan Jenn Wang, Advisor, Clinical Affairs|01-408-8453133|Lijuan.wang1@abbott.com|
22262284|NCT02896296|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
22262285|NCT02463487|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22262286|NCT01120028|University of Oxford|Prof Peter Friend|01865223872|ccc@ctsu.ox.ac.uk|
22262287|NCT03250117|Titan Pharmaceuticals, Inc.|Kate Beebe DeVarney, PhD|650-244-4990|medinfo@titanpharm.com|
22262288|NCT04063878|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+46 31 376 44 11|marie.ahlson@dentsplysirona.com|
22262289|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262290|NCT04633564|Mylan GmbH|Keri Vaughan, Senior Director|+215.280.2846|keri.vaughan@viatris.com|
22262291|NCT01279486|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
22262292|NCT04198363|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22262293|NCT05344118|Nationwide Children's Hospital|Dr. Joseph D Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
22262294|NCT03442322|University of Pittsburgh|Natalie Leland|(412) 383-3405|NEL24@pitt.edu|
22262295|NCT01885949|MGH Cancer Center|Dr. Dror Michaelson|6177244000|dmichaelson1@mgh.harvard.edu|
22262296|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262297|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22262298|NCT03669250|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
22306980|NCT01636687|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|Novartis.email@novartis.com|
22262299|NCT00828321|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262300|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262301|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262302|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540||
22262303|NCT05523895|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2289|medicalinformation@acadia-pharm.com|
22262304|NCT03674892|Tufts Medical Center|Pedram Hamrah, MD|617-636-5720|pedram.hamrah@tuftsmedicine.org|
22262305|NCT05099380|Johnson & Johnson Vision Care, Inc.|John R. Buch-Sr. Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
22262306|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu|
22262307|NCT03276754|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306981|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu|
22306982|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22306983|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov|
22306984|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306985|NCT01039688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22306986|NCT02594735|GWU Myositis Center|Dr. Rodolfo Curiel|202-741-2488|rcuriel@gwu.edu|
22306987|NCT04567407|Boston Children's Hospital|Roland Brusseau MD|857-218-4814|roland.brusseau@childrens.harvard.edu|
22306988|NCT03844269|Akili Interactive Labs, Inc.|Minny Suh|857-254-4444|minny@akiliinteractive.com|
22306989|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22306990|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067||
22306991|NCT00101010|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Alma Rodriguez, MD, Lymphoma||CR_Study_Registration@mdanderson.org|
22306992|NCT03698708|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
22306993|NCT00908830|University of Michigan Health System|Linda Stuckey, Pharm.D|734-936-8129|lindastu@med.umich.edu|
22306994|NCT03897348|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22306995|NCT04054635|University of Manitoba|Dr. Robert J. Schroth|204-977-7764|robert.schroth@umanitoba.ca|
22306996|NCT00364013|Amgen Inc.|Study Director|866-572-6436||
22306997|NCT00891930|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
22306998|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22306999|NCT03873337|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
22307000|NCT03040661|Inova Heart and Vascular Institute|Vineet Kumar|(703) 289-9400|vineet.kumar@inova.org|
22307001|NCT01574807|Division of Endodontics|Dr. John Nusstein|614-292-3596|nusstein.1@osu.ed|
22307002|NCT00835770|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22307003|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22307004|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22307005|NCT00149838|MUSC|Mark S. George, MD, Professor|8438700368|georgem@musc.edu|
22307006|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu|
22307007|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22307008|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kutzschn@uw.edu|6-3568
22307009|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22307010|NCT02202499|H. Lee Moffitt Cancer Center and Research Institute|Dr. Thomas Brandon|813-745-1750|thomas.brandon@moffitt.org|
22307011|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327|rlaguna@venoushealth.com|104
22307012|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
22307013|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org|
22307014|NCT05082935|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
22307015|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
22307016|NCT04530747|Pennington Biomedical Research Center|Prachi Singh|12257633151|prachi.singh@pbrc.edu|
22307017|NCT03292913|RTI International Institute|Megan Lewis|206-268-3613|melewis@rti.org|
22307018|NCT03950622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307019|NCT03977935|Changhai Hospital|Investigator of Clinical Trials|15021569528|1372971347@qq.com|
22307020|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22307021|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk|
22307022|NCT03531840|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
22307023|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu|
22307024|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
22307025|NCT02928224|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307026|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22307027|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
22307028|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com|
22262308|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu|
22262309|NCT05041361|University of California, San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
22262310|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu|
22262311|NCT03679598|University of Alabama at Birmingham|Dr. James Wells|2059345555|LungHealth@uabmc.edu|
22262312|NCT03605342|VA Connecticut Healthcare System|Dr Ismene Petrakis|203-932-5711|Ismene.Petrakis@va.gov|1-2244
22262313|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu|
22262314|NCT02842853|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22262315|NCT01798264|Intarcia|Michelle Braon|510-782-7800||
22262316|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se|
22262317|NCT03317444|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
22262318|NCT02518945|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22262319|NCT00918645|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
22262320|NCT05133180|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22262321|NCT04723693|Oxford university Hospitals NHS Foundation Trust|Simon Fletcher|01865 225316|simon.fletcher@ouh.nhs.uk|
22262322|NCT02157974|University of Colorado Anschutz Medical Campus|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
22262323|NCT04188392|Baylor College of Medicine|Melissa B Jones, MD|713-791-1414|melissa.jones2@bcm.edu|24747
22262324|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au|
22307029|NCT03302741|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22307030|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov|
22307031|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307032|NCT04411056|The Guthrie Clinic|Praneet Madabhushi MD|5708874882|praneeth.madabhushi@guthrie.org|
22307033|NCT04623008|Ohio State University College of Nursing|Mei-Wei Chang, PhD|614-247-7211|chang.1572@osu.edu|
22307034|NCT03702842|University of Florida|Emily J Fox, Research Associate Professor|352-273-6085|ejfox@phhp.ufl.edu|
22307035|NCT03568422|Canadian Cancer Trials Group|Pierre-Olivier Gaudreau|6135336430|p-ogaudreau@ctg.queensu.ca|
22307036|NCT02631603|LMU/ Haunersches Kinderspital|Prof. Dr. med. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
22307037|NCT03122886|Mayo Clinic|Aminah Jatoi, MD|507/284-2511|Jatoi.Aminah@mayo.edu|
22307038|NCT02460900|NIH|National Heart, Lung and Blood Institute--Josh Fessel|3018275514|josh.fessel@nih.gov|
22307039|NCT05985044|Johns Hopkins University School of Nursing|Dr.Binu Koirala|707-225-2166|bkoiral1@jhu.edu|
22307040|NCT04888637|University of Arkansas for Medical Sciences (UAMS)|University of Arkansas for Medical Sciences (UAMS)|501-526-6876|ORRAClinicalTrials-govadmin@uams.edu|
22307041|NCT04163328|UAB|Dr. Kelly K. Nichols|205-975-9935|nicholsk@uab.edu|
22307042|NCT02279095|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22307043|NCT05938413|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
22307044|NCT03312907|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307045|NCT04688450|Massachusetts General Hospital|Dr. Andrew Tomas Reisner|617-726-2241|areisner@mgh.harvard.edu|
22307046|NCT04498052|University of Utah|Kensaku Kawamoto, MD, PhD, MHS / Associate Chief Medical Information Officer|801-581-4080|kensaku.kawamoto@utah.edu|
22307047|NCT02576574|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22307048|NCT03481777|Aarhus University Hospital|Dr. Rolf Blauenfeldt|0045 78450000|rolfblau@rm.dk|
22307049|NCT03189524|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22307050|NCT04879524|Queen Mary University of London|P Chaichanavichkij|020 7882 8752|p.chaichanavichkij@qmul.ac.uk|
22307051|NCT01780298|Philip Morris Products S.A.|Julia HOENG, PhD|+41 (58) 242 2214|clinicaltrials.pmi@pmi.com|
22307052|NCT03718065|Medical University of South Carolina|Dr. Constance Guille|843-792-6489|guille@musc.edu|
22307053|NCT05286385|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61294286555|cltd-prs-admin@cochlear.com|
22307054|NCT04046848|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22307055|NCT05930782|MMV Medicines for Malaria Venture|Dr Anne Claire Marrast|+41 22 555 03 00|marrasta@mmv.org|
22307056|NCT03613740|University of Guadalajara|PhD. Karina G. Pérez Rubio|+52 1 3310585200|karina.prubio@academicos.udg.mx|
22307057|NCT01693120|Medtronic AF Solutions|Bob Hokanson, Clinical Research Manager|763.526.2811|robert.hokanson@medtronic.com|
22307058|NCT01741363|Department of Internal Medicine, National Taiwan University Hospita|Han-Mo CHIU|+886-2-23123456|hanmochiu@ntu.edu.tw|63354
22307059|NCT03803605|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-2537|cynthia_gay@med.unc.edu|
22307060|NCT02300298|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307061|NCT02407249|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
22307062|NCT01391832|University of Texas at Dallas|Dr. John Hart, Jr.|972-883-4853|jill.ritter@utdallas.edu|
22307063|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp|
22307064|NCT03345901|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22307065|NCT04252586|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22307066|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307067|NCT02748317|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
22307068|NCT03452189|NYU Langone Health|Dr. Jerome Lowenstein|+1 212 263 5635|Jerome.Lowenstein@nyulangone.org|
22307069|NCT02724592|University of Greifswald|Dr. Mohammad Alkilzy|0049-17623399340|alkilzym@uni-greifswald.de|
22274859|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
22274860|NCT03312738|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22274861|NCT01130844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22274862|NCT02305316|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22274863|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org|
22274864|NCT00612235|Beth Israel Deaconess Medical Center|Andrew G. Herzog M.D., M.Sc.|781-431-0277|aherzog@bidmc.harvard.edu|
22274865|NCT00547339|University of Texas Southwestern Medical Center Dallas|Dr. Robert Timmerman|214-645-8525|Robert.Timmerman@UTSouthwestern.edu|
22274866|NCT02426684|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
22274867|NCT03587636|University of Minnesota|James Flaherty|612-625-7675|jflahert@umn.edu|
22274868|NCT04452045|University of California, San Francisco|Lauren Asarnow|(415) 353-2273|lauren.asarnow@ucsf.edu|
22274869|NCT04236284|The University of Texas Health Science Center at Houston|Melba Hernandez Tejada, PhD, DHA|7134862729|Melba.A.HernandezTejada@uth.tmc.edu|
22274870|NCT02271451|Cincinnati Children's Hospital|Dr. Gregory Myer|513-636-4366|gregory.myer@cchmc.org|
22274871|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu|
22274872|NCT03073486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274873|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu|
22274874|NCT02280252|NYU Langone Health|Dr. Nelly Huppert|(212) 731-5003|Nelly.Huppert@nyulangone.org|
22274875|NCT01079780|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22274876|NCT01178294|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22274877|NCT02783066|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
22274878|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22274879|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu|
22274880|NCT01663623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274881|NCT02251275|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22274882|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700||
22274883|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu|
22274884|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274885|NCT02834975|University of Miami|Abdulrahman Sinno, MD|+1 (305) 2432233|ak.sinno@med.miami.edu|
22274886|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu|
22274887|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274888|NCT02037893|Pernix Therapeutics|Senior Director, Medical and Scientific Affairs|8007932145|egould@pernixtx.com|
22274889|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22274890|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu|
22274891|NCT00381628|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
22274892|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22274893|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274894|NCT01677741|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22292943|NCT06350474|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
22274895|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
22274896|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu|
22274897|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22274898|NCT01926028|NovaDigm Therapeutics, Inc.|Chief Scientific Officer|2676405189|john_hennessey@novadigm.net|
22274899|NCT04539275|Palo Alto Cooperative Studies Program Coordinating Center|Lisa Zehm, Project Manager|(650)493-5000|lisa.zehm@va.gov|28805
22274900|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22274901|NCT04596319|Armata Pharmaceuticals, Inc.|Mina Pastagia, MD|(310) 665-2928|mpastagia@armatapharma.com|
22274902|NCT00900562|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22274903|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu|
22274904|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22274905|NCT03181308|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
22274906|NCT03248297|University of Alabama at Birmingham|Alan Tita, MD|205-934-5612|atita@uab.edu|
22274907|NCT02051296|VA HCS Palo Alto|Dr Catherine Curtin|650-493-5000|ccurtin@stanford.edu|
22292944|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu|
22292945|NCT01191333|Director, VISN21 MIRECC, Department of Veterans Affairs|Jerome Yesavage, MD|650-852-3287|Jerome.Yesavage@va.gov|
22292946|NCT02699697|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Doris.R.Brown@advocatehealth.org|
22292947|NCT02362035|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292948|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
22292949|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22292950|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au|
22292951|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu|
22307070|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307071|NCT05262738|University of Texas at Austin, Dell Medical School|Alexander Saucedo, MD|210-845-7571|alexander.saucedo@ascension.org|
22307072|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
22307073|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov|
22307074|NCT01424397|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307075|NCT01149369|Johns Hopkins Data Coordinating Center|Katherine Yates|443-287-0082|kyates1@jhu.edu|
22307076|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22307077|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22307078|NCT04676334|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22307079|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990|barlogiebart@uams.edu|2420
22307080|NCT01972724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22307081|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org|
22307082|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu|
22307083|NCT01546753|University of Arkansas for Medical Sciences|Dr. Stacie Jones|(501) 364-1060|JonesStacieM@uams.edu|
22262325|NCT00807495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262326|NCT01631552|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22262327|NCT00463684|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22262328|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu|
22262329|NCT03629054|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262330|NCT03808376|Senseonics|Vice President, Clinical Sciences|301-515-7260|katherine.tweden@senseonics.com|
22262331|NCT02462837|Southern Illinois University School of Medicine|Dr. Danuta Dynda|217-545-7443|ddynda@siumed.edu|
22262332|NCT04029545|Prollenium Medical Technologies|Director Clinical Affairs|19055081469|clinicaltrials@prolleniumus.com|
22262333|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
22262334|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300|hhenney@acorda.com|5138
22262335|NCT02992067|Zhejiang Cancer Hospital|Yu Xingfei|057188122001|yuxf1177@zjcc.org.cn|+86
22262336|NCT02679729|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
22262337|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262338|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com|
22262339|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com|
22262340|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300||
22262341|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu|
22262342|NCT02177617|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22262343|NCT02845336|Johns Hopkins University|Timothy J McCulley, MD|4105503000|tmccull5@jhmi.edu|
22262344|NCT03488108|Mayo Clinic|Alison J. Bruce, M.B., Ch.B|904-953-6412|Bruce.Alison@mayo.edu|
22262345|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org|
22262346|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu|
22262347|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com|
22262348|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com|
22262349|NCT04404725|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22262350|NCT01075516|Department of Cardiology, San Filippo Neri Hospital - Rome|Dr. Renato P. Ricci||renatopietroricci@tin.it|
22262351|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307084|NCT02933944|Targovax|Chief Medical Officer|+ 47 21398810|contact@targovax.com|
22307085|NCT01102231|IFCT|Communications Officer|+33156811045|contact@ifct.fr|
22307086|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22262352|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu|
22262353|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu|
22262354|NCT01825798|Holland Bloorview Kids Rehabilition Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
22262355|NCT04171115|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22307087|NCT01236560|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22307088|NCT01195883|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|DS@OR.org|
22307089|NCT01576484|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22307090|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu|
22307091|NCT04470375|University of South Dakota|Dr. Kory Zimney|16056586373|kory.zimney@usd.edu|
22307092|NCT05714696|Florida State University College of Medicine|Dr. Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
22307093|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org|
22262356|NCT01559363|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22262357|NCT00834873|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262358|NCT05327777|Thomas Jefferson University Hospital|Research Resident|516-547-7676|ryan.lamm@jefferson.edu|
22307094|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu|
22262359|NCT01653704|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
22262360|NCT03966911|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
22262361|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262362|NCT01899053|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262363|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22262364|NCT02584608|Indiana Univerity School of Medicine|Micheal Econs|317-274-1339|mecons@iu.edu|
22262365|NCT03500094|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22262366|NCT01891357|on behalf of Westdeutsche Studiengruppe GmbH|Anja Braschoss, Consultant Clinical Research and Medical Writing|0049-176-82119153|anja.braschoss@wsg-online.com|
22262367|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
22262368|NCT01251393|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
22262369|NCT01541215|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22262370|NCT03232736|University of Colorado Anschutz Medical Campus|William Cornwell|16142961686|william.cornwell@ucdenver.edu|
22262371|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
22262372|NCT02316223|Icahn School of Medicine at Mount Sinai|Dr. Alex Federman|212-824-7565|alex.federman@mountsinai.org|
22262373|NCT01275664|NRG Oncology|Linda Gedeon for Helen Huang, MS|716-845-1169|lgedeon@gogstats.org|
22262374|NCT03234907|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22262375|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it|
22262376|NCT02986139|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22262377|NCT02583048|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22262378|NCT02155257|Wake Forest University Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
22262379|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org|
22262380|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
22262381|NCT02985749|Massachusetts General Hospital|Gagan Joshi, MD|617-724-1541|gjoshi@mgh.harvard.edu|
22262382|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
22262383|NCT01993186|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22262384|NCT03390257|SF Otolaryngology|Dr. Jacob Johnson|4153625443|jjohnson@sfotomed.com|
22262385|NCT02451696|NYU Langone|Dr. Orrin Devinsky|646-558-0800|od4@nyu.edu|
22262386|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu|
22262387|NCT01557751|University of Pittsburgh Medical Center (UPMC)|Dr. Jacques Chelly, MD, PHD MBA|412-623-6382|chelje@anes.upmc.edu|
22262388|NCT02752074|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22262389|NCT00840216|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262390|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com|
22262391|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org|
22262392|NCT03682601|GTO Pharma|Clinical Trial Coordinator|9175436934|akhmea01@gmail.com|
22262393|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu|
22262394|NCT04474405|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22262395|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22262396|NCT03446768|University of California, San Diego, La Jolla, CA|Carl Stepnowsky, PhD|858-642-1240|cstepnowsky@health.ucsd.edu|
22262397|NCT02511535|Med Uni Wien, Institut für Spezifische Prophylaxe und Tropenmedizin|Erika Garner-Spitzer, PhD|0043 1 40160|erika.garner-spitzer@meduniwien.ac.at|38255
22262398|NCT01604941|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22262399|NCT01410227|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22262400|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22262401|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu|
22262402|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262403|NCT03131895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262404|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262405|NCT03556618|University of California, Los Angeles|Dr. Elizabeth Barnert, Principal Investigator, Associate Professor|(310) 206-1483|ebarnert@mednet.ucla.edu|
22262406|NCT02213263|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262407|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
22262408|NCT05752721|NYU Langone Health|Pasquale Rummo|646-501-3371|Pasquale.Rummo@nyulangone.org|
22262409|NCT00263588|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22262410|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22262411|NCT02287480|Geneva University Hospitals|Prof. Claire-Anne Siegrist|0041 22 379 5778|claire-anne.siegrist@unige.ch|
22262412|NCT02622386|University of Michigan|Johann Gudjonsson|(734) 615-4508|johanng@med.umich.edu|
22262413|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com|
22262414|NCT05274763|Emory University|Dr. Jennifer Mascaro|404-727-4301|jmascar@emory.edu|
22292952|NCT02585843|Columbia University|A. Reshad Garan|(917) 374-3346|arg2024@cumc.columbia.edu|
22292953|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
22292954|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu|
22262415|NCT02960295|Kaiser Permanente Southern California|Steven Jacobsen MD, PhD. Director, Department of Research and Evaluation|626-564-3470|Steven.J.Jacobsen@nsmtp.kp.org|
22292955|NCT01604408|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22292956|NCT03711318|NYS Psychiatric Institute|Dr. Adam Bisaga, study PI|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22292957|NCT02509481|Colorado State University|Dr. Brian D. Foy, Professor|970-491-3470|Brian.Foy@colostate.edu|
22307095|NCT04090190|Mass General Brigham|Vatche Minassian, MD, MPH|(617) 732-4838|vminassian@bwh.harvard.edu|
22307096|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu|
22307097|NCT03512756|Tyme, Inc.|Study Director|617-674-9069|Maria.Loushin@TymeInc.com|
22307098|NCT01212991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307099|NCT04520061|Mass General Hospital|Lisa Morse|617-724-2000|lgmorse@partners.org|
22307100|NCT03133182|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22307101|NCT03314753|Medtronic|Study Project Manager (CSM)|00491742122|petra.kremer@medtronic.com|081
22307102|NCT01285999|Cardiovascular Institute and Fu Wai Hospital|Dr. Runlin Gao|+861068314466|gaorunlin@citmd.com|
22307103|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969|Doug.Scharre@osumc.edu|
22307104|NCT03190174|Sarcoma Oncology Research Center|Erlinda M. Gordon, MD/Principal Investigator|310-552-9999|egordon@sarcomaoncology.com|
22307105|NCT04714320|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22307106|NCT04755660|National Taipei University of Nursing and Health Sciences|Dr. Tingru Lin|886-2-28227101|tingru@ntunhs.edu.tw|3150
22307107|NCT02879162|Canadian Cancer Trials Group|Dr. Janet Dancey|6135336000|jdancey@ctg.queensu.ca|75606
22307108|NCT05672667|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22307109|NCT04524390|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
22307110|NCT03873779|Zeltiq|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22307111|NCT02581215|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22307112|NCT04270526|Mount Auburn Hospital|William Winkelman|617-354-5452|william.winkelman@mah.harvard.edu|
22307113|NCT04279574|Solventum US LLC|Paula Myhre|6513842714|pemyhre1@solventum.com|
22307114|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
22307115|NCT03631433|OSU|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
22307116|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@gmail.com|838
22307117|NCT02597920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307118|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307119|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu|
22307120|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org|
22307121|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22292958|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov|
22307122|NCT03036813|Global Blood Therapeutics|Margaret Tonda, PharmD, Sr. Director, Clinical Science|(650) 741-7761|mtonda@gbt.com|
22307123|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22307124|NCT04762875|Ensoma|Elizabeth Hook|617-766-3917|ehook@ensoma.com|
22307125|NCT02943590|MassGH|Tomas Neilan|617726200|tneilan@partners.org|
22307126|NCT05946551|Emory University|Tiffany Walker, MD Assistant Professor|404-778-1621|tiffany.austin.walker@emory.edu|
22307127|NCT05061693|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22307128|NCT03823911|Institute of Human Virology, University of Maryland School of Medicine|Dr. Poonam Mathur|410-706-4745|pmathur@ihv.umaryland.edu|
22307129|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22307130|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22307131|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu|
22307132|NCT04009577|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22307133|NCT01832480|Tulane University School of Public Health and Tropical Medicine|Patricia Kissinger, Ph.D.|504-988-7320|kissing@tulane.edu|
22307134|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22307135|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
22307136|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu|
22320806|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org|
22274908|NCT03044418|University of Pecs|Dr. Timea Bocskai|+36 72 507374|timokeri@gmail.com|
22274909|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov|
22292959|NCT04040244|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
22292960|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22292961|NCT03945214|University of California San Francisco|Dr. Rachel Radin|845-641-9569|rachel.radin@ucsf.edu|
22292962|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu|
22292963|NCT02480920|Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey|Volkan Emren||vemren@hotmail.com|
22292964|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
22320807|NCT04416555|Cleveland Clinic|Dr. Sabry Ayad|216.476.7052|Saayad@ccf.org|
22274910|NCT03613493|University of Miami|Dr. Susan Morgan|7654094919|semorgan@miami.edu|
22274911|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22307137|NCT04305405|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22320808|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu|
22320809|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
22320810|NCT01923285|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
22320811|NCT04512040|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
22320812|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
22320813|NCT03462576|Exalenz Bioscience|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737513|avrahamh@exalenz.com|
22320814|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
22320815|NCT01496131|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22320816|NCT04784182|Auburn University|Drew Frugé|3348448433|adf0003@auburn.edu|
22320817|NCT01441037|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
22320818|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320819|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22320820|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300||
22320821|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com|
22320822|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
22320823|NCT02997735|Children's Hospital of Philadelphia|Brian Jenssen, MD MSHP|215-554-4390|JenssenB@email.chop.edu|
22320824|NCT01087775|San Francisco VA Medical Center|Dr. Karen Seal|4152214810|Karen.Seal@va.gov|24852
22320825|NCT03096730|Tianjin Medical University General Hospita|Dr. Guolin Wang|13002211205|1464322162@qq.com|
22320826|NCT00825162|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22320827|NCT03113656|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22320828|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu|
22320829|NCT01279850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320830|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320831|NCT01252745|Acerus Pharmaceuticals Corporation|Vice President|(416) 679-0776|nbryson@aceruspharma.com|
22320832|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu|
22320833|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22320834|NCT00432042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320835|NCT03497585|Pennine Acute NHS Trust|Dr Deborah Antcliff|0161 7242168|Deborah.Antcliff@pat.nhs.uk|
22320836|NCT01744665|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22320837|NCT02321930|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
22320838|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com|
22320839|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22320840|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22320841|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
22320842|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com|
22320843|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com|
22262416|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320844|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com|
22320845|NCT02580409|Spaulding Rehabilitation Hospital|Dr. Jonathan Bean|617 952 6813|jfbean@mgh.harvard.edu|
22320846|NCT04649255|Sirtex Medical|Janet Bell|+ 888-474-7839|jbell@sirtex.com|
22262417|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
22320847|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262418|NCT00847535|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22262419|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22262420|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu|
22262421|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu|
22262422|NCT02471807|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
22262423|NCT02811003|Smith+Nephew, Inc.|Samantha Andrews|978.971.8990|samantha.andrews@smith-nephew.com|
22262424|NCT02055547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262425|NCT01456221|Coordinacion de Investigacion en Salud, Mexico|Dr. Mardia Guadalupe Lopez Alarcon||marsau2@prodigy.net.mx|
22262426|NCT01608906|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22262427|NCT01986647|University of Pittsburgh|Jennifer S. Brach, PhD, PT|412-383-6533|jbrach@pitt.edu|
22262428|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org|
22262429|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22262430|NCT02611323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22262431|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22262432|NCT01345539|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
22262433|NCT04693429|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22262434|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
22262435|NCT02011945|Bristol-Myers squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
22262436|NCT03531827|National Cancer Institute|Dr. Ravi Madan|301.480-7168|madanr@mail.nih.gov|
22262437|NCT03944057|Antengene Corporation|Shimin Sun|+8613701803117|jasmine.sun@antengene.com|
22262438|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22262439|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889||
22262440|NCT03930849|Department of Veterans Affairs|Carolyn Turvey, Ph.D.|319 338 0581|Carolyn.Turvey@va.gov|637714
22262441|NCT02488109|University of California, San Francisco, Department of Pediatrics|Andrea Garber, PhD, RD|415-514-2180|andrea.garber@ucsf.edu|
22262442|NCT05259852|Case Western Reserve University|Jin Kim-Mozeleski|216-368-6793|jin.kim-mozeleski@case.edu|
22262443|NCT03969641|Duke University|Dr. Geeta Swamy|919.681.5220|geeta.swamy@duke.edu|
22262444|NCT05157048|University of Pennsylvania|Victoria Constantine|215-746-4069|vmcl@pennmedicine.upenn.edu|
22262445|NCT01006967|Geisel School of Medicine at Dartmouth|Jon D. Lurie, MD, MS|603 653-3575|jon.d.lurie@dartmouth.edu|
22262446|NCT02633241|Boston Children's Hospital|Joseph P. Cravero|617-355-4292|Joseph.Cravero@childrens.harvard.edu|
22262447|NCT02906813|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262448|NCT00754052|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22262449|NCT02466087|University of Vermont|Emily Tarleton, MS, RD|802-847-4730|emily.tarleton@uvm.edu|
22262450|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu|
22262451|NCT02658019|University of Miami|Lynn G. Feun, MD|305-243-6606|lfeun@med.miami.edu|
22262452|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22262453|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22262454|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com|
22262455|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
22262456|NCT02651987|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
22262457|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262458|NCT02725515|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|
22262459|NCT02015832|European Cardiovascular Research Institute|Dr. Ernest Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
22262460|NCT02297230|New York University School of Medicine|Sylvia Formenti|646.962.4073|lao2003@med.cornell.edu|
22262461|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22262462|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22262463|NCT03428750|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22262464|NCT01919112|Beth Israel Deaconess Medical Center|Sandeep Kumar, MD|617-632-8917|skumar@bidmc.harvard.edu|
22262465|NCT02944617|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22262466|NCT00835666|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262467|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262468|NCT04194801|CStone Pharmaceuticals|Hua Hu|+86 021-60333416|CstoneRA@cstonepharma.com|
22262469|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262470|NCT00506831|Stanford University|Lorinda Chung|650-493-5000|shauwei@stanford.edu|62042
22262471|NCT02464657|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, MD/Professor|(713)745-0394|fravandi@mdanderson.org|
22262472|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu|
22262473|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com|
22262474|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu|
22262475|NCT04002648|IRCCSSRaffaele|Prof. Michele De Bonis|+390226437102|debonis.michele@hsr.it|
22262476|NCT04313751|University of North Carolina at Chapel Hill|Yamnia Cortes, PhD, MPH, RN|319-335-1131|yamnia-cortes@uiowa.edu|
22274912|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22274913|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300||
22274914|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu|
22274915|NCT02497469|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22274916|NCT03558516|Department of Anesthesiology, Faculty of medicine, Siriaj hospital, Mahidol University|Assoc. Prof. Manee Raksakietisak|+66814880620|manee95@hotmail.com|
22274917|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22274918|NCT02065557|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22274919|NCT03144232|Stanford University|Gregory Sahlem|650-724-0444|gsahlem@stanford.edu|
22274920|NCT04081688|Cancer Institute of New Jersey Rutgers|Dr. Jabbour|732-757-9840|jabbousk@cinj.rutgers.edu|
22274921|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22274922|NCT02737722|Lakewood Amedex|Chief Medical Officer|941 928 7774|poconnor@lakewoodamedex.com|
22274923|NCT02449434|King's College London|Prof David Bartlett|02071887462|david.bartlett@kcl.ac.uk|
22274924|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22307138|NCT00206375|Texas Children's Hospital, Baylor College of Medicine|Dr. MJ Redondo (designated by the institution to enter results)|832-822-1019|redondo@bcm.edu|
22307139|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu|
22307140|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov|
22307141|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu|
22307142|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22307143|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307144|NCT03473340|University of Michigan|VIbha Lama|734-936-5010|vlama@med.umich.edu|
22307145|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22307146|NCT01420549|Aché Laboratórios Farmacêuticos S. A.|Antonio Carlos Amedeo Vattimo|+55 11 26088111|antonio.vattimo@ache.com.br|
22307147|NCT03394885|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|angeles.secord@duke.edu|
22307148|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu|
22307149|NCT04980755|University of Plymouth|Dr Joseph Lanario|01752 764403|joseph.lanario@plymouth.ac.uk|
22307150|NCT01351272|Universitätsklinikum Würzburg|Prof. Dr. M. Herrmann|093120176650|Herrmann_m@ukw.de|
22307151|NCT03949335|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|ethoma39@its.jnj.com|
22307152|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com|
22307153|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
22307154|NCT02531113|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
22307155|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu|
22307156|NCT02270645|University of Miami|Keyvan Nouri|3052433380|knouri@med.miami.edu|
22307157|NCT03149991|Massachusetts General Hospital|Dr. Rebecca Hock|617-872-3711|rhock@mgh.harvard.edu|
22307158|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22307159|NCT04120454|The Ohio State University Comprehensive Cancer Center|Dr. Asrar Alahmadi|614-293-6786|Asrar.Alahmadi@osumc.edu|
22307160|NCT04928001|Montana State University|Dr. Katey T. Franklin|406-570-6056|katey.franklin@montana.edu|
22307161|NCT04153565|Merck Sharp& Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307162|NCT03827304|Sheffield Hallam University|Ivan Phelan|+44 114 225 6955|i.phelan@shu.ac.uk|
22307163|NCT02541565|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
22307164|NCT03113617|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
22307165|NCT01950780|Columbia University Dept of Dermatology|Director of Clinical Research Dermatology|2123056953|jc299@cumc.columbia.edu|
22307166|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu|
22307167|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu|
22307168|NCT00858117|Northwestern University|Olga Frankfurt, MD|312 695 6180|o-frankfurt@northwestern.edu|
22307169|NCT02647905|Senseonics|Vice President, Clinical Sciences|3015157260|katherine.tweden@senseonics.com|
22307170|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567|cawoods@uwaterloo.ca|36547
22307171|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22307172|NCT02601820|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-260-4062|donna_evon@med.unc.edu|
22307173|NCT02765100|Weill Cornell Medicine|James H Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
22307174|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22307175|NCT03733028|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
22307176|NCT04532528|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307177|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22307178|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org|
22274925|NCT02662569|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22274926|NCT03154086|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22274927|NCT00514618|MemorialCare Health Services LBMC|Lorna Camfield, Research Compliance Analyst|714-377-3227|lcamfield@memorialcare.org|
22274928|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com|
22274929|NCT03148262|UT Southwestern Medical Center|Dr. Christina Riccio|214-590-7284|Christina.Riccio@UTSouthwestern.edu|
22274930|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com|
22274931|NCT04710004|Emory University|Dr. Robert Gross|404-727-2354|rgross@emory.edu|
22307179|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
22307180|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22307181|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org|
22307182|NCT03401190|CalciMedica, Inc.|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
22307183|NCT01061151|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22307184|NCT03740009|UNC School of Medicine|Crystal Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
22307185|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22274932|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
22274933|NCT01183923|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
22274934|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu|
22274935|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22274936|NCT02785939|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22274937|NCT04465422|Taipei City Hospital|Shu Chun Lee|+886 2 27263141|A1057@tpech.gov.tw|1004
22274938|NCT02668003|University of Aberdeen|Professor Gary Macfarlane|01224 437 143|g.j.macfarlane@abdn.ac.uk|
22274939|NCT01787552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22274940|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu|
22274941|NCT02443623|Emergent Biosolutions Inc.|Clinical Development Representative|(204) 275-4196|ctgov@ebsi.com|
22274942|NCT02465450|Corbus Pharmaceuticals|Ajay Aggarwal, MD|781-250-9176|aaggarwal@corbuspharma.com|
22274943|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343||
22274944|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu|
22274945|NCT04456920|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22274946|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500|TKarkkai@its.jnj.com|3402
22274947|NCT03072186|Ohio State University Wexner Medical Center|Dr. Daniel Prevedello, MD|(614) 293-7190|Daniel.Prevedello@osumc.edu|
22274948|NCT02709317|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
22274949|NCT01604785|Oregon Health & Science University|David Sheridan|503 494-8311|sheridda@ohsu.edu|
22274950|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com|
22274951|NCT01307813|University Hospitals Cleveland Medical Center|Jeffrey Marks, MD - General Surgeon|216-983-4930|Jeffrey.Marks@uhhospitals.org|
22274952|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22274953|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777||
22274954|NCT04798027|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22274955|NCT01439035|Massachusetts General Hospital|Dr. Gary Tearney PI|617-724-2979|gtearney@partners.org|
22274956|NCT04054544|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22274957|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu|
22274958|NCT03087058|Vifor Pharma, Inc.|EMERALD Clinical Study Team|+41 588 518 000|EMERALD.study@viforpharma.com|
22274959|NCT02753881|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
22274960|NCT05158140|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22274961|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com|
22274962|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net|
22274963|NCT01814007|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22274964|NCT01274351|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22274965|NCT03415152|Abbott Laboratories|Irina Solnyshkina|+7 (495) 258-42 80|irina.solnyshkina@abbott.com|
22274966|NCT05471505|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274967|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com|
22274968|NCT03861039|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274969|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu|
22274970|NCT03427892|UTexasSouthwestern|Dr. E. Sherwood Brown|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
22274971|NCT02934178|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22274972|NCT04323592|University of Trieste|Prof. Marco Confalonieri|+393356895168|mconfalonieri@units.it|4667
22274973|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22274974|NCT02340676|Dana-Farber Cancer Institute|Dr. John Koreth, MBBS, DPhil|(617) 632-2949|John_Koreth@dfci.harvard.edu|
22307186|NCT03926039|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
22307187|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu|
22320848|NCT03723707|NYU Langone Health|Mauricio Arcila-Mesa|646-501-4660|Mauricio.arcila-mesa@nyulangone.org|
22274975|NCT03944616|University of California, Irvine|Dr. Andrew Odegaard|949-824-8544|aodegaar@hs.uci.edu|
22307188|NCT02869334|Nathan Kline Institute|Dr. Daniel Javitt|8453986534|javitt@nki.rfmh.org|
22320849|NCT04682405|Washington University School of Medicine|Keith Stockerl-Goldstein, M.D.|314-747-7859|ksgoldstein@wustl.edu|
22320850|NCT05030012|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
22320851|NCT03357731|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22320852|NCT01773109|University of Pennsylvania (Abramson Cancer Center)|Dr. Charu Aggarwal|2156624000|charu.aggarwal@pennmedicine.upenn.edu|
22320853|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|EJonasch@mdanderson.org|
22320854|NCT01733472|Region Skane|Andreas Harsten|46708870567|andreas.harsten@skane.se|
22320855|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320856|NCT04325542|Medical Mission Institute|Dr Christa Kasang||christa.kasang@medmissio.de|
22320857|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22262477|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com|
22320858|NCT01849874|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320859|NCT02347098|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
22262478|NCT05780463|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22262479|NCT00835614|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22320860|NCT04640272|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
22262480|NCT04077645|University of Illinois Urbana Champaign|Dr. Sean P Mullen|217-244-4502|spmullen@illinois.edu|
22262481|NCT02280863|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
22262482|NCT02903407|Duke University|Angela Lowenstern|919-684-0111|angela.sandelin@duke.edu|
22262483|NCT03158727|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262484|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
22262485|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk|
22262486|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
22262487|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300||
22262488|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu|
22262489|NCT02351700|Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center|Andrew S. Little, MD|602-406-3181|neuropub@dignityhealth.org|
22262490|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu|
22262491|NCT00472212|The Ohio State University College of Optometry|Marjean Kulp|614-688-3336|kulp.6@osu.edu|
22262492|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300||
22262493|NCT05143801|University of New Mexico|Dr. Christine Mermier|5052772664|cmermier@unm.edu|
22262494|NCT01252953|Nuffield Department of Population Health, University of Oxford|Prof Martin Landray|+44 (0)1865 743743|martin.landray@ndph.ox.ac.uk|
22262495|NCT01007994|Northwell|Christine Sethna|7184703423|csethna@northwell.edu|
22262496|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp|
22262497|NCT03393754|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
22262498|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262499|NCT01851772|Xoft, Inc.|Crystal Leonard, CCRP|9375038588|cleonard@icadmed.com|
22262500|NCT04739735|Faculty of dentistry, Alexandria University, Egypt|Dr. Rodaina Helmy|00201100001193|rodaina.helmy@alexu.edu.eg|
22262501|NCT03272685|University of Minnesota|Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
22262502|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org|
22262503|NCT02272803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22262504|NCT03124758|Masimo|Tala Harake||studies@masimo.com|
22262505|NCT03067987|University of Miami|Ranjith Ramasamy|3052434873|ramasamy@miami.edu|
22262506|NCT03733145|Atrium Health Wake Forest Baptist|Rohesh J. Fernando, MD|336.716.2712|rfernan@wakehealth.edu|
22262507|NCT00829764|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262508|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
22262509|NCT03102879|Universidad de los Andes|Claudia Brizuela|56 2 26181166|clau@cibrizuela.com|
22262510|NCT02244554|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22262511|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
22262512|NCT00385736|Abbott|Global Medical Services|800-633-9110||
22262513|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu|
22262514|NCT02837913|Cedars-Sinai Medical Center|Dr. Mark Zakowski|310-423-5841|mark.zakowski@cshs.org|
22262515|NCT06078501|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22262516|NCT03602339|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22262517|NCT04224753|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22262518|NCT03209505|University of Houston College of Optometry|Eric Ritchey, OD, PhD|713-743-1933|erritche@central.uh.edu|
22262519|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu|
22262520|NCT00829452|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262521|NCT02615249|Allerderm (dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smartpractice.com|7208
22262522|NCT02911909|University of Missouri|Ennio Rizzo|573-882-7615|eardvb@health.missouri.edu|
22262523|NCT03053245|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
22262524|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22320861|NCT04673292|Johns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University School of Nursing|Jacky Jennings,PhD, MPH; Shruti Mehta, PhD, MPH; Jason Farley, PhD, MPH, ANP-BC, FAAN|410-550-4132|jennings@jhmi.edu; smehta@jhu.edu; jfarley1@jhu.edu|
22320862|NCT02535715|University of Texas Health San Antonio|Curtis Triplitt, PharmD|210-358-7228|triplitt@uthscsa.edu|
22320863|NCT04353284|Yale School of Medicine|Geoffrey Chupp, MD Professor of Medicine (Pulmonary); Director, Yale Center for Asthma and Airways D|(203) 785-3627|geoffrey.chupp@yale.edu|
22320864|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com|
22320865|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu|
22320866|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com|
22320867|NCT03451786|Carl Zeiss|Michael Bonilla|+1 925-557-4100|michael.bonilla@zeiss.com|
22320868|NCT03719690|Kura Oncology, Inc.|Clinical Operations|617-588-3755|KO-TIP-007@kuraoncology.com|
22320869|NCT03129321|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
22320870|NCT03070470|U.S. Food and Drug Administration|Jose Vicente, PhD|301-796-8442|Jose.VicenteRuiz@fda.hhs.gov|
22320871|NCT02576444|Yale School of Medicine: Medical Oncology|Joseph Paul Eder, MD|(203) 737-6980|joseph.eder@yale.edu|
22320872|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22320873|NCT03503877|University of California, San Francisco|Mitchell Rosen|415-353-7475|Mitchell.Rosen@ucsf.edu|
22320874|NCT03370120|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22320875|NCT03672370|Zimmer Biomet|Clinical Project Lead, Sandra Rosser|+41 (0)58 854 84 09|sandra.rosser@zimmerbiomet.com|
22320876|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300||
22320877|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22320878|NCT04712110|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320879|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22320880|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22320881|NCT03962101|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22320882|NCT05879107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320883|NCT03901079|BSC|Chenchen FAN|+861085216427|chenchen.fan@bsci.com|
22262525|NCT05098743|Vanderbilt University|Dr. Christa Hartch, PI|203-979-2044|christahartch@me.com|
22262526|NCT04060251|Brigham Health|Dr. Wolfgang Fitz|617-732-9501|wfitz@bwh.harvard.edu|
22262527|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22262528|NCT01807026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262529|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262530|NCT01151618|Philips Respironics|Bob Romano, Biomedical Engineer|724-387-7781|bob.romano@philips.com|
22262531|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu|
22262532|NCT02047305|Medtronic MITG-RGI|Senior Director of Clinical Affairs|303-581-7064|Tumordirectedtherapiesclinical@Medtronic.com|
22262533|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
22262534|NCT02701101|Bruin Biometrics|Vignesh Iyer|3102689494|viyer@bruinbiometrics.com|
22262535|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
22262536|NCT00474188|Celgene Corporation|Robert Kinght, M.D.|908-673-9749|rknight@celgene.com|
22262537|NCT05412121|University of Michigan|Anne Murphy|734-936-5566|aemurph@med.umich.edu|
22262538|NCT03541252|Bispebjerg Hospital|Dr. Emily Wenande, MD, PhD|+4540505590|emily.cathrine.wenande@regionh.dk|
22262539|NCT03349632|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22262540|NCT01962298|Antwerp University Hospital|Dr Tom Schepens|003238213265|tom.schepens@uza.be|
22262541|NCT01576705|Institut Jérôme Lejeune|Dr Clotilde Mircher|00 33 1 56 58 63 00|clotilde.mircher@institutlejeune.org|
22262542|NCT03727139|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22262543|NCT00566722|Abbott|Global Medical Services|800-633-9110||
22262544|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org|
22262545|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
22262546|NCT03573544|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
22262547|NCT03329209|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22262548|NCT04364191|University of Pennsylvania|Miranda McPhillips|215-898-8281|mvarr@nursing.upenn.edu|
22262549|NCT03105297|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262550|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov|
22262551|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu|
22262552|NCT03846193|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22262553|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22262554|NCT03961204|Merck Healthcare KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
22262555|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
22262556|NCT03111381|Yale Urology|Jamil Syed|2037852815|Jamil.syed@yale.edu|
22262557|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
22262558|NCT05740098|University of Vermont|Stephen T. Higgins, PhD., P.I.|802-656-9615|stephen.higgins@uvm.edu|
22262559|NCT02452463|Roswell Park|CTRP/CT.gov Registry Coordnator|716-845-1073|KIM.BROSIUS@ROSWELLPARK.ORG|
22262560|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320884|NCT04607148|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22320885|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com|
22320886|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
22320887|NCT03029143|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320888|NCT02588976|Triemli City Hospital|Director Clinical Trial|+41 44 416 25 52|christoph.hofer@triemli.stzh.ch|
22320889|NCT04744207|Gesynta Pharma AB|Study Director|+46 73 386 4246|ctg@gesynta.se|
22320890|NCT04041284|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22292965|NCT02640716|Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China|Dr. Yi Tang|+86 10 83199456|tangyi@xwhosp.org|
22292966|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu|
22292967|NCT04429243|WL Gore|Charee Robe|9288644048|crobe@wlgore.com|
22292968|NCT04102098|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292969|NCT06448078|Ege University|Gizem Kececi Ozgur|+90 506 678 71 28|gizem.kececi.1991@gmail.com|
22292970|NCT03150173|Montefiore Medical Center|Dr. Aaron D. Fox, Professor, General Internal Medicine|718-920-7173|adfox@montefiore.org|
22292971|NCT00799812|BD|Erin Zook|847-362-9047|erin.zook@bd.com|
22292972|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
22292973|NCT03277690|Cortendo AB|Xeris Medical Director|+1 610-254-9200|LOGICS@cortendo.com|
22292974|NCT02396251|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
22292975|NCT02853344|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
22292976|NCT05055453|Sonova|Jean Anne Schnittker, Research Audiologist|+41 58 928 01 01|jeananne.schnittker@sonova.com|
22292977|NCT01209923|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
22292978|NCT04836312|University of Pennsylvania|Alexander Fanaroff, MD|215-615-7674|alexander.fanaroff@pennmedicine.upenn.edu|
22292979|NCT03860597|University of California, San Diego|Neal Swerdlow, M.D., Ph.D.|(619) 543-6270|nswerdlow@ucsd.edu|
22292980|NCT03648827|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22292981|NCT02955797|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22292982|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu|
22292983|NCT03131453|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22292984|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22292985|NCT04043728|Rush University Medical Center|Dr. Amanda Mathew|13125631273|amanda_mathew@rush.edu|
22292986|NCT02840721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22292987|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu|
22292988|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu|
22292989|NCT05535972|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22292990|NCT02649894|Becton Dickinson|Dawn Heimer|2018476800|dawn.heimer@bd.com|
22292991|NCT04590963|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22292992|NCT01736124|James J. Peters Veterans Affairs Medical Center|Dr. Jeremy Silverman|718-584-9000|jeremy.silverman@va.gov; jeremy.silverman@mssm.edu|1700
22292993|NCT06007664|University of Michigan|Noah J. Webster|734-936-3075|njwebs@umich.edu|
22292994|NCT04176705|Wake Forest University Health Sciences|John Bailey, MD|(336) 716-8002|jkbailey@wakehealth.edu|
22292995|NCT02628769|Imperial College London|Louise Donnelly|+44 02075947895|l.donnelly@imperial.ac.uk|
22292996|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org|
22292997|NCT03727425|Auris Health, Inc.|Scott Rehage|9256832590|scott.rehage@aurishealth.com|
22292998|NCT05274165|Sonova USCS|Senior Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
22292999|NCT02127723|Q-Med AB|Q-Med AB|+46 18 474 9000|medicalinfo.q-med@alderma.com|
22293000|NCT03950791|Stanford University School of Medicine|Maisa Ziadni, PhD|(650) 724-9143|mzaidni@stanford.edu|
22293001|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
22293002|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu|
22293003|NCT03428932|Nemours Children's Health|Nelly Mauras, MD|904-697-3674|Nelly.Mauras@nemours.org|
22293004|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293005|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623||
22293006|NCT03948698|Elizabeth Glaser Pediatric AIDS Foundation|Shirin Kakayeva|2404377929|skakayeva@pedaids.org|
22293007|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu|
22293008|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov|
22293009|NCT01805440|Department of Psychiatry|Douglas Kondo, MD|801-583-2500|doug.kondo@hsc.utah.edu|
22293010|NCT02903355|Southern Illinois University School of Medicine|Gary Fifer, MSHI|217-545-7823|gfifer@siumed.edu|
22293011|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22262561|NCT02589067|The Lundquist Institute at Harbor-UCLA|Dr. Loren G. Miller|310-222-3775|lmiller@lundquist.org|
22262562|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org|
22262563|NCT01131260|The George Washington University Biostatistics Center|Rebecca Clifton, Ph.D.|301-881-9260|rclifton@bsc.gwu.edu|
22262564|NCT03544216|Marshall B. Ketchum University (The Ohio State University during study data collection)|Erin Rueff, OD, PhD|7654145644|em.rueff@gmail.com|
22262565|NCT01935674|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
22293012|NCT04176497|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-966-4432|Melahat_Canter@med.unc.edu|
22293013|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
22293014|NCT04667481|University of Washington|Dr. Kerryn Reding, Study Principal Investigator|206-221-1571|kreding@uw.edu|
22293015|NCT04195906|Sanifit Therapeutics S. A.|Peter Szecsödy|+41588529079|clinicaltrials@cslbehring.com|
22293016|NCT03708562|Becton Dickinson (BPV)|Courtney Rothwell|480-350-6037|courtney.rothwell@bd.com|
22293017|NCT00691301|Gynecologic Oncology Group|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22293018|NCT02642029|McLean Hospital|Ann Shinn, MD|617-855-3053|akshinn@partners.org|
22293019|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu|
22293020|NCT00463580|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
22293021|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22293022|NCT01788046|Amgen Inc.|Study Director|866-572-6436||
22293023|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540||
22293024|NCT05143541|Kantonsspital St. Gallen|Dr. André E. Dutly|071 494 9944|andre.dutly@kssg.ch|
22293025|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org|
22293026|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu|
22293027|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no|
22293028|NCT02038881|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22293029|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300||
22293030|NCT02357979|University of California at San Francisco|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
22262566|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293031|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293032|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch|
22293033|NCT03449901|Washington University School of Medicine|Mia Weiss, M.D.|314-362-5737|m.c.weiss@wustl.edu|
22293034|NCT03594435|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
22293035|NCT03755791|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22293036|NCT03599635|University of Minnesota|Jason Habeck|612-624-9990|habe0073@umn.edu|
22293037|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
22293038|NCT02394548|Massachusetts General Hospital|Dr. Henning Willers|617-726-5184|hwillers@mgh.harvard.edu|
22293039|NCT03605212|Menarini Group|Angela Capriati, MD PhD - Corporate Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
22293040|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22293041|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22293042|NCT02083081|Mayo Clinic|Christi Patten PhD|507-538-7370|patten.christi@mayo.edu|
22293043|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu|
22293044|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu|
22262567|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com|
22262568|NCT00860938|University Hospital Basel, Switzerland|Jörg D. Leuppi, MD PhD, principle investigator|+41-61-2654294|jleuppi@uhbs.ch|
22262569|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
22262570|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
22262571|NCT04594252|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22262572|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu|
22262573|NCT01691430|Yale University|Dr. Manisha Juthani-Mehta|(203)785-4140|manisha.juthani@yale.edu|
22262574|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu|
22262575|NCT02756949|World Bank|Ms Marelize Gorgens|0012024730547|mgorgens@worldbank.org|
22262576|NCT01086228|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22262577|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu|
22262578|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com|
22262579|NCT03087786|Niconovum USA|Dr. Abraham Varghese|336-741-2315|varghea@rjrt.com|
22262580|NCT04661202|National Cheng Kung University|Dr. Kuan-Yin Lin|06-2353535|10802003@gs.ncku.edu.tw|6737
22262581|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com|
22262582|NCT02132910|DVCIPM|Chester Buckenmaier|301-816-4710|cbuckenmaier@dvcipm.org|
22262583|NCT04158687|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22262584|NCT02856594|Massachusetts General Hospital|Dr, Oluwaseun Johson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22262585|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk|
22262586|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com|
22262587|NCT02906917|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22262588|NCT00687739|University of Colorado Anschutz Medical Campus|Wendy M Kohrt, PhD|3037241913|wendy.kohrt@ucdenver.edu|
22262589|NCT02542462|Cincinnati Childrens Hospital Medical Center|Nancy Back RN MPH|513-636-2479|Nancy.Back@cchmc.org|
22262590|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu|
22262591|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262592|NCT03827395|Emory University|Evan J. Anderson, MD|404-727-1746|evanderson@emory.edu|
22262593|NCT01537887|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262594|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422|catriona.steele@uhn.ca|7603
22262595|NCT00538031|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22262596|NCT02450539|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22293045|NCT02263131|The Catholic University of Korea, Seoul St. Mary's Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr|
22274976|NCT01287936|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
22274977|NCT02420639|Department of Anesthesiology & Intensive Care Medicine, Dnipropetrovsk Medical Academy|Alexander Tsarev|+38 057 701 52 00|tsarev03@rambler.ru|
22274978|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22274979|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22274980|NCT02683109|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22274981|NCT00368251|UCB|UCB Cares|+1877 822||9493
22274982|NCT03617588|Theragnostics Ltd|Director of Clinical Operations|+44 330 606 7437|archie.hale@theragnostics.com|
22274983|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu|
22274984|NCT03563222|Fresenius Kabi Germany|Jean-Marc Lohse, PhD|+49 6172|jean-marc.lohse@fresenius-kabi.com|4911
22274985|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com|
22274986|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274987|NCT02300610|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jingsong Zhang|813-745-3973|jingsong.zhang@moffitt.org|
22274988|NCT05052580|Duke Clinical Research Institute|Tara Mann, PhD, RN|(919) 668-5111|schoolSETstudy@duke.edu|
22274989|NCT02515227|University of Virginia|Craig Slingluff, MD|434 924-9311|cls8h@uvahealth.org|
22274990|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22274991|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com|
22274992|NCT03316105|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
22274993|NCT00447083|Wake Forest University Health Sciences|Steve feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
22274994|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu|
22274995|NCT03451071|University of Alabama at Birmingham|Haller Smith|205-934-4986|hjsmith@uabmc.edu|
22274996|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org|
22274997|NCT03363906|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22274998|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22274999|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu|
22275000|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com|
22275001|NCT02714153|Yale School of Medicine|Jude Clancy, MD Associate Professor Term; Director, Lead Management Program|(203) 785-4126|jude.clancy@yale.edu|
22275002|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22275003|NCT01901185|Amgen Inc.|Study Director|866-572-6436||
22275004|NCT02318264|SUNY Upstate Medical|Michelle Dolphin, Associate Professor|315 464 6917|dolphinm@upstate.edu|
22275005|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org|
22275006|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22293046|NCT03109847|Thomas Jefferson University|Joseph Curry, MD|215-503-6828|joseph.curry@jefferson.edu|
22293047|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22307189|NCT01414738|UT Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|ROBERT.TIMMERMAN@UTSouthwestern.edu|
22293048|NCT01672736|University Health Network - Princess Margaret Cancer Centre|Dr. Suzanne Trudel|416-946-4501|Suzanne.Trudel@uhn.ca|4566
22293049|NCT04209348|The University of Tennessee, Knoxville|Dr. Samantha Ehrlich|510 299 8747|sehrlic1@utk.edu|
22293050|NCT02927262|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22293051|NCT02913612|Duke Clinical Research Institute|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
22293052|NCT04251273|Truth Initiative|Amanda L. Graham, PhD, Principal Investigator|(202) 525-6473‬|vapestudy@truthinitiative.org|
22307190|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org|
22307191|NCT03756571|Seattle Children's Research Institute|Kristie Bjornson, PT, PhD|206-884-2066|Kristie.bjornson@seattlechildrens.org|
22307192|NCT02379819|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22307193|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307194|NCT03752151|Medtronic, Plc|Dana Wigert, Sr Prin Clinical Research Specialist|+17635262802|dana.wigert@medtronic.com|
22307195|NCT04056624|East Carolina University, Department of Public Health|Stephanie Jilcott Pitts|252-744-5572|jilcotts@ecu.edu|
22307196|NCT03224390|Duke University|Dr. Eric Green|9196817289|eric.green@duke.edu|
22307197|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
22307198|NCT00703820|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
22289169|NCT03695367|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22289170|NCT02469870|Trifoia|Dr. Jordan Pennefather|1-877-874-3642|jordanp@trifoia.com|
22289171|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590||
22289172|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289173|NCT02685267|PCCTC|Jake Vinson|646-422-4383|vinsonj@mskcc.org|
22289174|NCT01865552|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
22289175|NCT01027806|School of Medicine, University of Missouri Health|Leila Kheirandish-Gozal, M.D., M.Sc.|(573) 884-3229|gozall@health.missouri.edu|
22289176|NCT03079102|Baylor College of Medicine|Cameron Dezfulian|832-826-6210|cameron.dezfulian@bcm.edu|
22289177|NCT02923921|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289178|NCT03083873|Iovance|Sr. Medical Director, Rana Fiaz|661-645-3572|rana.fiaz@iovance.com|
22293053|NCT04402060|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22293054|NCT00936611|Dana-Farber Cancer Institute|Irene Ghobrial|6176324101|irene_ghobrial@dfci.harvard.edu|
22293055|NCT02497300|University of Alabama at Birmingham|Eric Judd|205 934-9509|ejudd@uab.edu|
22293056|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com|
22293057|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu|
22293058|NCT02282358|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
22293059|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu|
22293060|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu|
22293061|NCT03780543|Assembly BioSciences Inc.|Chief Development Officer|415-855-3006|manderson@assemblybio.com|
22262597|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu|
22262598|NCT03060486|AOU Careggi|Riccardo Pace, DMD|00390557945608|riccardo.pace@unifi.it|
22262599|NCT03358147|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22262600|NCT05143047|Vanderbilt University Medical Center|Alison Carroll, MD, MPH|615-875-5025|alison.carroll@vumc.org|
22262601|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262602|NCT03236311|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22262603|NCT00669162|University of Kansas Cancer Center|Xinglei Shen, MD|913-588-3600|ctnursenav@kumc.edu|
22262604|NCT02704091|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
22262605|NCT02412852|TheraVasc Inc.|Tony Giordano|3183493851|tgiordano@theravasc.com|
22293062|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org|
22293063|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu|
22293064|NCT02000180|St. Michael's|Dr. Samir C. Grover|4168645628|samir.grover@utoronto.ca|
22293065|NCT02728596|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|karnold@fredhutch.org|
22293066|NCT04430738|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293067|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293068|NCT04102189|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22293069|NCT03319173|Bristlecone Health, Inc.|Dr. Kelly J. Gibas|763-913-4600|kelly-gibas@bethel.edu|
22293070|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088||
22293071|NCT01543698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293072|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293073|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22293074|NCT05439941|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22293075|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu|
22293076|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
22293077|NCT02336373|Baylor College of Medicine|Vivien Sheehan, MD, PhD|(832) 824-4459|vxsheeha@txch.org|
22293078|NCT03095885|Allena Pharmaceuticals, Inc|Allena Medical Affairs|6174674577|AllenaMedInfo@allenapharma.com|
22293079|NCT02160535|University of Washington|Dr. Sylvia Lucas, MD, PhD|206-598-9260|lucass@uw.edu|
22293080|NCT04798781|Cedars-Sinai Medical Center|Andrew Hendifar, MD, MPH|3104232217|andrew.hendifar@cshs.org|
22293081|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu|
22293082|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293083|NCT02024529|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22293084|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22293085|NCT02122458|VA Pittsburgh Healthcare System|Sheila R. Pratt, Ph.D.|412-979-3157|Sheila.Pratt@va.gov|
22293086|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org|
22293087|NCT02833350|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22293088|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22320891|NCT03455491|PHARMENTERPRISES LLC|CEO Vladimir Nebolsin|+7 (985) 728-75-72|ph@pharmenterprises.ru|
22262606|NCT01051349|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22262607|NCT05485662|UT Health San Antonio|Bennett Amaechi, BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
22262608|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu|
22262609|NCT02336074|Imperial College London|Professor Sarah Fidler|004420331|s.fidler@imperial.ac.uk|26790
22262610|NCT05604014|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
22262611|NCT01266902|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22262612|NCT02121184|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
22293089|NCT03643575|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22320892|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22293090|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org|
22293091|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590||
22293092|NCT00843531|University of California, San Francisco|Emily Bergsland, MD|(415) 514-6520|Emily.Bergsland@ucsf.edu|
22293093|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22293094|NCT04081324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22320893|NCT00455689|Brigham & Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
22320894|NCT02016820|Columbia University|Daniel E. Freedberg, MD, MS||def2004@cumc.columbia.edu|
22320895|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22320896|NCT02973087|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320897|NCT03710486|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22320898|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22320899|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
22320900|NCT02437864|University of New Mexico Health Sciences Center (HSC)|Dr. Codruta Soneru|5052722610|csoneru@salud.unm.edu|
22320901|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com|
22320902|NCT03803059|Crown Laboratories, Inc|Thomas Hitchcock, PhD.|8883723982|THitchcock@crownlaboratories.com|
22320903|NCT02904915|The University of Texas Health Science Center at Houston|Pamela D. Berens, MD|713-500-6471|Pamela.D.Berens@uth.tmc.edu|
22320904|NCT03067571|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD/Professor|713-563-1586|gborthak@mdanderson.org|
22320905|NCT04857996|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
22320906|NCT02988661|Emory University|Cristina Drenkard, MD, PhD|404-251-8901|cdrenka@emory.edu|
22320907|NCT04050982|Stanford University|Linda Ottoboni|(650) 498-5914|LOttoboni@stanfordhealthcare.org|
22320908|NCT04138017|University of Virginia|Eric McVey, Clinical Research Coordinator|434.243.5382|eric.mcvey@uvahealth.org|
22320909|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu|
22262613|NCT00840203|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262614|NCT03349567|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel-livorsi@uiowa.edu|
22262615|NCT04567329|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22262616|NCT00495222|Ethicon Endo-Surgery|Susan Knippenberg|513 337-3452|sknippen@its.jnj.com|
22262617|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22262618|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262619|NCT00834405|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262620|NCT00840281|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262621|NCT00076622|University of Pennsylvania|Joel Streim||Joel.Streim@uphs.upenn.edu|
22262622|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22262623|NCT00875524|Sanofi Pasteur SA|Medical Director||Contact-US@sanofi.com|
22262624|NCT03082586|Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr tingfeng Chen|86-021-37798364|tingfeng138138@163.com|
22262625|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000|soetikno@earthlink.net|64800
22262626|NCT03867838|Stanford University|Cole Simpson|4049077708|cole.simpson@stanford.edu|
22262627|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu|
22262628|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
22293095|NCT01076231|University of Pennsylvania|Dr. Jacob Shabason|215-662-3998|susan.mazzoni@uphs.upenn.edu|
22320910|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com|
22320911|NCT02562924|University of Vermont Medical Center|Dr. Daniel Gerges|8028474535|daniel.gerges@uvmhealth.org|
22262629|NCT02442687|Duke University|Dr. Manal F. Abdelmalek|919-684-8356|manal.abdelmalek@duke.edu|
22320912|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320913|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
22320914|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org|
22262630|NCT00819169|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22262631|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com|
22262632|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au|
22262633|NCT02637141|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22293096|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293097|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu|
22293098|NCT01904058|Mirum|Study Physician|1-650-667-4085|medinfo@mirumpharma.com|
22293099|NCT04041375|Michael E. DeBakey VAMC|Dr. Natalie E. Hundt|713-791-1414|natalie.hundt@va.gov|10315
22293100|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu|
22293101|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu|
22320915|NCT03557281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22320916|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com|
22320917|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071|trinidadtp@yahoo.com.ph|2281
22320918|NCT04036708|Michigan State University|Michael J Boivin|1-517-884-0281|boivin@msu.edu|
22320919|NCT02918864|Rush University Medical Center|Dr. Latha Valluripalli Soorya|(312) 942-6238|latha_soorya@rush.edu|
22320920|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu|
22320921|NCT02104583|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22320922|NCT04203745|Candela Medical|Dr. Konika Patel Schallen|508-358-0357|konikap@candelamedical.com|
22320923|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
22320924|NCT03448068|Mayo Clinic|Dr. Andrew W. Gorlin|480-342-2446|Gorlin.Andrew@mayo.edu|
22320925|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au|
22320926|NCT02833922|Institute for Reproductive Health|Dr. Victoria Jennings|2026871392|Victoria.Jennings@georgetown.edu|
22320927|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
22320928|NCT05433571|Johnson & Johnson Vision Care (JJVC)|Ross Franklin|1-800-843-2020|RFRANKL1@its.jnj.com|
22320929|NCT04329702|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
22320930|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22320931|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
22320932|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22320933|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
22293102|NCT02404220|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22293103|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22293104|NCT05835323|Johnson & Johnson MedTech Surgery|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22293105|NCT04981392|UMass Chan Medical School|Kimberly Fisher, MD|5088561975|kimberly.fisher2@umassmed.edu|
22293106|NCT04856891|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22293107|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
22293108|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
22293109|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22320934|NCT01918007|National and Kapodistrian University of Athens School of Medicine and Aghia Sophia Children's Hospital, Athens, Greece|Dr. Athanasios Kaditis, Head, Division of Pediatric Pulmonology, First Department of Pediatrics|+302132013000|akaditis@med.uoa.gr|
22262634|NCT03031795|OhioHealth|John O. Elliott PhD, MPH Research Specialist Medical Education|614-566-3643|john.elliott@ohiohealth.com|
22262635|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000||
22262636|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
22262637|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262638|NCT00562718|UT Southwestern Medical Center|ann spangler|(214) 648-3111|ResearchRegistry@utsouthwestern.edu|
22293110|NCT02507973|The R Adams Cowley Shock Trauma Center|Dr Deborah Stein|410-328-3495|dstein@umm.edu|
22293111|NCT02711345|Novartis Pharma AG|Study Director|862 778-8300|Novartis.email@novartis.com|
22293112|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22293113|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22293114|NCT04357782|Central Virginia VA Health Care System|Dr. Brian Davis|804-675-5000|Brian.Davis5@va.gov|
22293115|NCT01786148|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
22293116|NCT00338104|Northwestern University|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
22293117|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293118|NCT02362269|University of Wisconsin|Dr. Corinne D. Engleman|(608) 265-5491|cengelman@wisc.edu|
22293119|NCT03841448|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22293120|NCT04068610|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22293121|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501|amit.oza@uhn.ca|2818
22293122|NCT02586064|Providence VA Medical Center|Dr. Tracie Shea|401-273-7100|MaryTracie.Shea@va.gov|6248
22293123|NCT04815031|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293124|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293125|NCT03594994|Washington University|Joseph Beals|314-362-8199|bealsjw@wustl.edu|
22293126|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22293127|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22293128|NCT03672643|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293129|NCT03401489|San Francisco VA Medical Center|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
22293130|NCT01950390|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22293131|NCT06462014|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22293132|NCT02975336|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22293133|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00|clinic@croalliance.com|510
22293134|NCT02008318|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22293135|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293136|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
22293137|NCT04021771|Thomas Jefferson University|Dr. Kristin Rising|215-503-5507|Kristin.Rising@jefferson.edu|
22293138|NCT03019575|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293139|NCT03792191|Mansoura University|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
22293140|NCT02927327|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
22293141|NCT01856907|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5278|karen.elkind-hirsch@womans.org|
22293142|NCT01436396|Sanofi Pasteur|Director||Contact-US@sanofi.com|
22293143|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22293144|NCT04674644|Suleyman Demirel University|Dr Esra Oz|05326788040|esrakaraagac@sdu.edu.tr|
22293145|NCT03469934|AnaptysBio, Inc|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22293146|NCT05280782|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
22293147|NCT01024231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22293148|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org|
22293149|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu|
22293150|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu|
22293151|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
22293152|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22293153|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293154|NCT04295772|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293155|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
22262639|NCT04025021|MetroHealth Medical Center|Stephanie Merlino Barr|216-778-3269|SMERLINO@METROHEALTH.ORG|
22262640|NCT01663896|St. Jude Medical|Sr. Manager, Global Clinical Affairs|651-756-5585|mwagner2@sjm.com|
22262641|NCT00842309|Massachusetts General Hospital|Dr. Hilary Weingarden|617-643-6206|hilary_weingarden@mgh.harvard.edu|
22262642|NCT02670551|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22262643|NCT04476277|National Heart, Lung, and Blood Institute (NHLBI)|Mathew Hsieh, M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
22262644|NCT00849797|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262645|NCT02153645|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|908-809-1357|gwagner@osmotica.ccom|
22262646|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275007|NCT02330341|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22293156|NCT02345226|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22262647|NCT01675596|Edwards Lifesciences|Tenley Koepnick||tenley.koepnick@edwards.com|
22293157|NCT04141046|University of North Carolina at Chapel Hill|Saira Sheikh, MD|919-966-0545|szsheikh@email.unc.edu|
22262648|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu|
22262649|NCT01730846|Yale School of Medicine|Sherry McKee, PhD|203-737-3529|sherry.mckee@yale.edu|
22262650|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us|
22262651|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu|
22307199|NCT02283749|Brown University Oncology Research Group (BrUOG)|Kayla Rosati|14018633000|kayla_rosati@brown.edu|
22307200|NCT02639910|MorphoSys AG|Peter Kelemen MD, PhD - Director, Clinical Program Leader|+498989927|peter.kelemen@morphosys.com|26856
22307201|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22307202|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu|
22307203|NCT03451721|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
22307204|NCT03689920|Boston Scientific|Director of Clinical Sciences|661-949-4350|roshini.jain@bsci.com|
22307205|NCT03903822|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307206|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
22307207|NCT01796236|Ear Nose Throat, University Medical Center Utrecht, Utrecht|Professor Robert Stokroos|0031 8875 56644|R.J.Stokroos@umcutrecht.nl|
22307208|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22307209|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22307210|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
22307211|NCT05274217|University of Washington|Teresa Evans-Campbell|206-543-6075|tecamp@uw.edu|
22307212|NCT01542229|Charleston VAMC|Dr. Anouk L. Grubaugh|843-789-5853|grubaugh@musc.edu|
22307213|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22307214|NCT02414204|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Timmy Lee|205-934-3589|txlee@uab.edu|
22307215|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22307216|NCT02674750|Curis, Inc.|Reinhard von Roemeling, M.D., Senior Vice President, Clinical Development|617-503-6500|rvonroemeling@curis.com|
22307217|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509||
22307218|NCT01764464|University of Rochester|John Markman|585-276-3616|john_markman@urmc.rochester.edu|
22307219|NCT04578496|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
22307220|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307221|NCT03632941|Duke University|Michael Morse, M.D.|919-681-3480|michael.morse@duke.edu|
22307222|NCT02237417|Otsuka|Wilt, Timothy|240.683.3095|timothy.wilt@otsuka-us.com|
22307223|NCT04156581|Hospital for Special Surgery|Dr. Justas Lauzadis|212-774-2946|lauzadisj@hss.edu|
22307224|NCT05165485|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22307225|NCT03237481|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22307226|NCT02991807|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
22307227|NCT02566902|University of California - San Diego|Mike Gardiner, MD|8589668036|magardiner@ucsd.edu|
22307228|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711|william.becker4@va.gov|2247
22307229|NCT02411084|ADIENNE S.A|Renata Palmieri|+41.91.210.47.22|renata.palmieri@adienne.com|
22307230|NCT02374463|Baltimore VA Medical Center|Leslie Katzel, MD, PhD|410-605-7248|leslie.katzel@va.gov|
22307231|NCT03538717|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307232|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu|
22307233|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557||
22307234|NCT04723394|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22307235|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org|
22307236|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
22307237|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22307238|NCT01839331|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
22307239|NCT03076515|Theranica Bio-Electronics Ltd|Dagan Harris|+972723909755|daganh@theranica.com|
22307240|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22307241|NCT01943799|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22307242|NCT04594759|Medical University of South Carolina|Dr. Samantha Karlin|(843)- 714-0146|karlin@musc.edu|
22307243|NCT03811574|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22307244|NCT03639558|University of Nottingham/Psychiatric Hospital of the Cross|Dr. Joseph Dib|07748668553|joseph.elie.dib@gmail.com|
22307245|NCT03485950|UT MD Anderson Cancer Center|Issam Raad,MD - Chair, Infectious Diseases|(713) 792-7943|iraad@mdanderson.org|
22307246|NCT03764475|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22307247|NCT03994705|Cartesian Therapeutics|Dr. Vera Sarkodie Medical Director,|617-231-8085|vera.sarkodie@cartesiantx.com|
22307248|NCT06243796|Nakhon Phanom hospital|Dr.Kriengkrai Prasert|+6642199222|gpsiam28@gmail.com|1091
22307249|NCT03144674|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22307250|NCT05510245|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307251|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac|
22262652|NCT01968031|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22320935|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22320936|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320937|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22320938|NCT02614859|Fox Chase Cancer Center|Dr. Daniel Geynisman|215-728-3889|Daniel.Geynisman@fccc.edu|
22320939|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22320940|NCT00290342|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320941|NCT03341975|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343430|mmiller@cmh.edu|
22320942|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22320943|NCT02242578|The University of Texas at Austin|Robert J Buchanan, MD|512-324-7991|robertbuchanan@utexas.edu|
22320944|NCT01793142|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22320945|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
22320946|NCT02121262|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22320947|NCT02829138|University of Guelph|Dr. David M Mutch|+1-519-824-4120|dmutch@uoguelph.ca|53322
22320948|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org|
22320949|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu|
22320950|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com|
22320951|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977||
22320952|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com|
22320953|NCT02230384|University of Pittsburgh|K.N. Roy Chengappa, MD / Principal Investigator|412-246-5006|chengappakn@upmc.edu|412
22320954|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org|
22320955|NCT05376215|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22320956|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
22320957|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22320958|NCT02651584|Braeburn Pharmaceuticals|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
22320959|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22320960|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22320961|NCT00047060|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
22320962|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu|
22320963|NCT00353834|Joslin Diabetes Center|Edward S. Horton, MD|6173091995|edward.horton@joslin.harvard.edu|
22320964|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu|
22320965|NCT02941705|Cedar Sinai|Russell Haber|(310) 967-8322|Russell.Haber@CSHS.org|
22320966|NCT04402970|University of Missouri|Dr. Zach Holliday|5738829072|hollidayz@health.missouri.edu|
22320967|NCT01840579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320968|NCT03499509|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
22320969|NCT04018794|University of California, San Francisco|Dr. Melissa Dvorsky|4154767167|melissa.dvorsky@ucsf.edu|
22320970|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
22320971|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu|
22320972|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300||
22320973|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320974|NCT04013529|Corporal Michael J. Crescenz VA Medical Center|Manik Chhabra|(215) 823-5800|manik.chhabra@va.gov|
22320975|NCT05419128|CHESS - University of Wisconsin--Madison|Kasey Thompson|608-590-7821|kfwagner@wisc.edu|
22320976|NCT01671423|Einstein Medical Center|Scott Goldstein|2154561836|goldstes@einstein.edu|
22320977|NCT04093843|West Virginia University|Amelia Adcock, MD|304-598-6127|akadcock@hsc.wvu.edu|
22320978|NCT02971631|University of Cambridge|Mr Geoffrey Roberts|01223767176|geoffroberts@cantab.net|
22320979|NCT02581202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22320980|NCT05885737|CSL Behring|Clinical Study Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22320981|NCT00609791|City of Hope|Dr. Mina Sedrak|6263598111|msedrak@coh.org|
22320982|NCT04218201|NYU Langone Health|Rebecca Stone|646-754-5322|Rebecca.Stone@nyulangone.org|
22320983|NCT04129528|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22320984|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu|
22262653|NCT00840879|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262654|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22262655|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org|
22262656|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu|
22262657|NCT02219009|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22262658|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
22262659|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22275008|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu|
22320985|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22320986|NCT03118232|University of California, Irvine|Dr. Susan Huang|714-456-5047|sshuang@hs.uci.edu|
22262660|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22320987|NCT03303950|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22320988|NCT02933034|Stanford University|Phillip C. Yang|(650) 498-8008|phillip@stanford.edu|
22320989|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu|
22320990|NCT04773106|Implandata Ophthalmic Products GmbH|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22320991|NCT02387359|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
22320992|NCT00291447|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22320993|NCT02819635|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22320994|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
22320995|NCT01140451|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22320996|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu|
22320997|NCT04206020|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
22275009|NCT03306199|Cardiovascular Institute of the South|Research Team Leader|(985) 873-5613|Deanna.Benoit@cardio.com|
22320998|NCT02888093|University of Iowa Hospitals and Clinics|Dr. Joseph Kowalski|3193561616|joseph-kowalski@uiowa.edu|
22320999|NCT04962022|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321000|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22321001|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22321002|NCT02055820|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22262661|NCT02664415|MHRP|Biostatistician|3015003715|spinyakorns@hivresearch.org|
22262662|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22262663|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22262664|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155||
22262665|NCT03544242|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
22262666|NCT04408924|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22262667|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com|
22262668|NCT02218541|University of North Carolina at Chapel Hill|Gidgetta Jenkins|919-537-3968|gidget_jenkins@unc.edu|
22262669|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com|
22275010|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
22321003|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321004|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321005|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|225
22275011|NCT03555149|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22275012|NCT02965924|Mayo Clinic|Arthur J. Sit, MD|507-284-2787|Sit.Arthur@mayo.edu|
22275013|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil|
22275014|NCT02667639|Monitor CRO|Murat Özdemir|902122341260|murato@monitorcro.com|
22275015|NCT01692119|ABDA, Department of Medicine|Dr. Martin Schulz|+49 30 40004-514|arzneimittel@abda.de|
22275016|NCT04656652|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
22275017|NCT02722967|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22275018|NCT04142242|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22307252|NCT01198028|MD Anderson Cancer Center|Dr. Bonnie Glisson, MD,Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|bglisson@mdanderson.org|
22307253|NCT01186198|Abbott Medical Devices|Jessie Coe|224 668 5360|Jessie.coe@abbott.com|
22307254|NCT01395758|ArQule, Inc.|Brian Schwartz, MD Chief Medical Officer|781-994-0300|ClinicalTrials@arqule.com|
22307255|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu|
22307256|NCT01759771|Ralph H. Johnson Veterans Affairs Medical Center|Stephen J. Savage, MD, Chief Section of Urology|843 789 7330|savages@musc.edu|
22307257|NCT03631550|Neurolief Ltd.|Michal Kedar-Datel|+972-52-6659806|michal.kedar-datel@neurolief.com|
22307258|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22307259|NCT04515641|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307260|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu|
22307261|NCT01415349|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22307262|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22307263|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu|
22307264|NCT01429350|Penumbra, Inc.|Michaella Corso|510-995-2079|mcorso@penumbrainc.com|
22307265|NCT00700336|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
22307266|NCT03762213|Arkansas Children's Hospital|Dr. Saumya V Joshi|501-364-4619|svjoshi@uams.edu|
22307267|NCT02918071|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
22307268|NCT01029587|Johns Hopkins University|Benjamin Philosophe|443-287-7178|bphilosophe@jhmi.edu|
22307269|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu|
22307270|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org|
22307271|NCT04585191|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|5108213969|Richard.W.Grant@kp.org|
22307272|NCT03783026|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22307273|NCT04814186|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307274|NCT03342027|University of Chicago|Dr. Seth Himelhoch|773-834-4314|seth.himelhoch@bsd.uchicago.edu|
22307275|NCT03602612|National Cancer Institute|Dr. James Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22307276|NCT06336629|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22307277|NCT03960463|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22307278|NCT04043455|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22307279|NCT03422276|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
22321006|NCT01437852|Stratatech Corporation, a Mallinckrodt Company|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
22321007|NCT03548935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22321008|NCT04677959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22321009|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22321010|NCT01074190|Northwerstern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22321011|NCT00397813|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22321012|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321013|NCT02919436|Maine Medical Center|Dr. Anand Rughani|207-885-0011|arughani@mmc.org|
22321014|NCT01389752|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321015|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321016|NCT01576549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321017|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300|ablight@acorda.com|102
22321018|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321019|NCT02830776|Formerly - Tulane University Department of Dermatology. Currently - Suzanne Bruce and Associates, PA|Megan Couvillion, MD, FAAD|504-473-2915|megan.couvillion@gmail.com|
22321020|NCT03339206|University of North Carolina at Chapel Hill|Adam O. Goldstein|984-974-0210|adam_goldstein@med.unc.edu|
22321021|NCT02668874|University of Iowa College of Dentistry|Director of Clinical Research|319-467-1398|dentistry-research@uiowa.edu|
22275019|NCT00773357|Yale School of Medicine|Sherry McKee|2037373529|sherry.mckee@yale.edu|
22275020|NCT00846053|Washington University|Thomas Ferkol, MD|314 454 6000||
22275021|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402||
22275022|NCT05597865|Washington University in St. Louis|Rachel Brathwaite|3147282869|rachel.brathwaite@yahoo.com|
22307280|NCT05194917|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Dr. Adrienne Johnson|608-262-8673|aljohnson43@ctri.wisc.edu|
22262670|NCT01981044|Allergan Medical|Marcio Torre, M.D., M.A., Medical Monitor|805-683-6761|torre_marcio@allergan.com|
22262671|NCT03809000|American College of Radiology|Wendy Seiferheld|2155743208|wseiferheld@acr.org|
22262672|NCT02998541|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22262673|NCT03540160|Menlo Therapeutics, Inc.|Iain Stuart, PhD|1-800-775-7936|Iain.Stuart@foamix.com|
22262674|NCT01944722|Becton, Dickinson and Company|Clinical Study Manager|410-316-4000|BDClinicalTrials@bd.com|
22262675|NCT01923740|Abbott Vascular|Siok Hwee Tan|+1 408-845-3581|siokhwee.tan@abbott.com|
22262676|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr|
22262677|NCT03345420|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22293158|NCT01848704|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
22262678|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp|
22262679|NCT01439620|Massachusetts General Hospital|Gary Tearney, MD|Optical Frequency Domain Imagi|gtearney@partners.org|
22262680|NCT03056144|The Hong Kong Polytechnic University|Dr Tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
22262681|NCT01694563|Atricure Inc.|Nfii K. Ndikintum, PhD, MBA / VP, Clinical Affairs and Biometrics|513-644-8192|NNdikintum@atricure.com|
22262682|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com|
22293159|NCT02503410|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
22262683|NCT00836758|University of Florida|Richard B. Berry, MD|352-262-1575|sleep_doc@msn.com|
22262684|NCT03616379|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
22293160|NCT03386474|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22262685|NCT00979147|Minneapolis VAMC|Terence Gioe M.D.|612-467-1780|tjgioe@gmail.com|
22262686|NCT02674711|Brooke Army Medical Center|Dr Dan Rhon|210-916-3303|daniel.i.rhon.ctr@mail.mil|
22262687|NCT02933060|Cooper University Health System|Dr. Christopher Jones|856-342-2627|jones-christopher@cooperhealth.edu|
22262688|NCT01945580|Boston Scientific|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22262689|NCT02045108|The Mind Research Network|Dr. Eric Claus|505-272-5028|eclaus@mrn.org|
22262690|NCT02463981|UESTC|Prof. Keith Kendrick|+86028-61830811|k.kendrick.uestc@gmail.com|
22262691|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22262692|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262693|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
22262694|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com|
22293161|NCT01498978|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
22293162|NCT03488355|Memorial University of Newfoundland|Dr. Peter Daley|7097772089|pkd336@mun.ca|
22293163|NCT00066729|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22293164|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
22262695|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
22262696|NCT04848688|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22262697|NCT03306277|AveXis, Inc|US Medical Information|833-828-3947|medinfo@avexis.com|
22262698|NCT04306952|Northwestern University|Jennifer Mundt PhD|312-503-2846|jennifer.mundt@nm.org|
22262699|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu|
22262700|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22262701|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22262702|NCT03885934|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262703|NCT02227238|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262704|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262705|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22262706|NCT02905435|PolyNovo Biomaterials Pty Ltd|Tim Barker, PhD|+61386814054|tim.b@polynovo.com|
22262707|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
22262708|NCT02377349|GlaxoSmithKline|GSK Response Center|866-435-7343|en736091@gsk.com|
22262709|NCT03486938|agenebio|Richard Mohs|317-997-3241|richard.mohs@agenebio.com|
22262710|NCT03504020|Medtronic CRM Clincial Research|CRM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22262711|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com|
22262712|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu|
22262713|NCT04541173|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22262714|NCT03985657|Johns Hopkins University|Mudiaga Sowho|4105506264|msowho1@jhmi.edu|
22262715|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22262716|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu|
22262717|NCT02235870|Obalon Therapeutics, Inc.|Amy VandenBerg, Vice-President, Clinical Affairs and Regulatory Affairs|760.795.6551|avandenberg@obalon.com|
22262718|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
22293165|NCT00200161|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
22262719|NCT05248399|The University of Texas Health Science Center at Houston|Maria E Fernandez Esquer, PhD|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
22262720|NCT03614728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262721|NCT02818894|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
22262722|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com|
22293166|NCT03896165|Ohio State University College of Nursing|Assistant Professor|614-292-5684|thrane.2@osu.edu|
22262723|NCT02837237|KBP Biosciences Co., Ltd.|Vincent J. Benn|2677996545|vince.benn@kbpbiosciences.com|
22262724|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22262725|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org|
22262726|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org|
22262727|NCT04203823|Medtronic|Clinical Study Manager|8185765849|carrie.corrigan@medtronic.com|
22262728|NCT03684928|CooperVision,Inc.|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
22262729|NCT03193021|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
22293167|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22293168|NCT02919696|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
22262730|NCT02286466|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
22262731|NCT00835081|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262732|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu|
22262733|NCT04573309|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22262734|NCT02300987|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
22262735|NCT04211766|Fred Hutchinson Cancer Center|Dr. Johanna Lampe|(206) 667-6580|JLampe@fredhutch.org|
22262736|NCT05330975|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22262737|NCT03574363|KBP Biosciences USA, Inc.|Kimberly Miller|4847644862|kimberly.miller@kbpbiosciences.com|
22262738|NCT05267106|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22262739|NCT04165824|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22293169|NCT03181893|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262740|NCT04986072|University of Rochester Medical Center|Dr. Paulo Lizano MD, PhD|(201) 776-6708|lizanopl@gmail.com|
22293170|NCT04128371|National Institute of Allergy and Infectious Diseases|Dr. Paneez Khoury|+1 301 402 3673|paneez.khoury@nih.gov|
22262741|NCT03199885|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22293171|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
22262742|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
22262743|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262744|NCT02890992|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22262745|NCT01496118|Sarah Cannon Development Innovations, LLC|Dr. Jesus Berdeja|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22293172|NCT03021304|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262746|NCT00841659|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22293173|NCT02308189|Ohio University|Brian Clark, PhD|740-593-2354|clarkb2@ohio.edu|
22262747|NCT03810703|University of Chicago|Dave Arndt|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22307281|NCT04922021|LEO Pharma A/S|Disclosure Specialist|+4544945888|disclosure@leo-pharma.com|
22262748|NCT03499873|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22307282|NCT05786391|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
22262749|NCT04608448|UT Health San Antonio|Ellen Kraig, PhD|210-567-3818|kraig@uthscsa.edu|
22262750|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22307283|NCT03817684|Tetra Therapeutics|CEO|616-224-0084|info@tetratherapeutics.com|
22262751|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
22262752|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482||
22262753|NCT01370863|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22262754|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu|
22262755|NCT04431518|Indiana University School of Medicine|Samir K. Gupta|3172747926|sgupta1@iu.edu|
22262756|NCT05004649|University of Pennsylvania|Dr. David Brainard|215-573-7579|brainard@psych.upenn.edu|
22262757|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22262758|NCT01852799|Shanghai Changzheng Hospital|Jian Hou, PhD|86021-63610109-73221|houjian@medmail.com.cn|
22262759|NCT02385708|Vanderbilt University Medical Center|Steven Klintworth|615-936-3298|steven.klintworth@vumc.org|
22262760|NCT02436200|Imperial College London|Professor Alun Davies, Professor of Vascular Surgery|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
22262761|NCT02761915|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22262762|NCT03276559|Weill Cornell Medicine|Hillary Winoker|646-962-7143|hiw4002@med.cornell.edu|
22262763|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu|
22275023|NCT02027025|Sun Pharma Advanced Research Company Limited|Mudgal Kothekar|912266455645|mudgal.kothekar@sparcmail.com|
22262764|NCT02654145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22262765|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22307284|NCT05686408|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22262766|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22262767|NCT06475729|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22262768|NCT03515044|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22262769|NCT03922750|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22262770|NCT03366428|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22262771|NCT00804973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262772|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262773|NCT02166606|Boston Scientific|Dipl.-Ing. (FH) Jens Goetzke|+49171|jens.goetzke@bsci.com|5426813
22262774|NCT01958476|Tufts Medical Center Floating Hospital for Children|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
22262775|NCT01971645|Nationwide Children's Hospital|Giorgio Veneziano, MD|6147224200|Giorgio.Veneziano@nationwidechildrens.org|
22262776|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org|
22262777|NCT02943096|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
22262778|NCT03868631|Point Loma Nazarene University|Dr. Heidi Lynch|619-806-3306|hlynch@pointloma.edu|
22262779|NCT03867760|University of Washington Bothell|Dr. Linda Eaton|4253523645|lineaton@uw.edu|
22262780|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu|
22262781|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org|
22262782|NCT04236596|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
22262783|NCT05984290|Bausch & Lomb Incorporated|Director, Medical Affairs, Vision Care R&D|585-413-6397|marjorie.rah@bausch.com|
22262784|NCT02588339|Moffitt Cancer Center|Lia E. Perez, MD|813-745-3665|Lia.Perez@moffitt.org|
22262785|NCT02966340|UW Madison|John J. Curtin|608-262-0387|jjcurtin@wisc.edu|
22262786|NCT03395197|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262787|NCT02560051|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22262788|NCT03123874|Cornell University|Sarah Reyes|208-921-4967|smr296@cornell.edu|
22262789|NCT02308241|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
22262790|NCT03609944|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
22262791|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
22262792|NCT02578641|Tessa Therapeutics|Khong-Bee Kang, Senior Manager Clinical Development|+65 6978 6594|kangkhongbee@tessacell.com|
22262793|NCT02889393|University of Miami|Dr. D. Dante Yeh|3055851178|dxy154@med.miami.edu|
22262794|NCT02655224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22262795|NCT03036930|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22262796|NCT06102174|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262797|NCT04227899|Abbott|Karine Ruster|(408) 845-0764|karine.piard-ruster@abbott.com|
22262798|NCT05151471|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22262799|NCT04230174|Massachusetts General Hospital|Caterina Mainero|6177247746|cmainero@mgh.harvard.edu|
22262800|NCT04998136|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22262801|NCT04259632|University of Minnesota|Niki Oldenberg|612-625-8781|olden019@umn.edu|
22262802|NCT05280301|Dartmouth-Hitchcock|Dr Nicholas Daniel|603-650-5000|Nicholas.Daniel@hitchcock.org|
22262803|NCT03292458|Massachusetts Eye and Ear|Prof. Kristina Simonyan|617-573-6016|kristina_simonyan@meei.harvard.edu|
22262804|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262805|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu|
22262806|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22262807|NCT01741545|Bristol Myers Squibb|Bristol Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22262808|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22262809|NCT03820258|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22262810|NCT04179396|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22262811|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22262812|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu|
22262813|NCT02276885|NYU Langone Health|Naamit Gerber, MD|2127316338|Naamit.Gerber@nyulangone.org|
22262814|NCT04569032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262815|NCT05908162|Republican center of Hygiene, Epidemiology and Public Health|Head of laboratory Fomina E.G.|+375173740417|feg1@tut.by|
22262816|NCT03837626|University of Missouri|Camila Manrique, MD|573-882-2554|manriquec@missouri.edu|
22262817|NCT03599362|NYU Langone Health|Fraustina Hsu|6467547124|Fraustina.Hsu@nyulangone.org|
22262818|NCT03707587|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scott.norberg@nih.gov|
22262819|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262820|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MPH/Clinical Professor, General Oncology|(713) 563-9905|mfisch@mdanderson.org|
22262821|NCT00958724|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22275024|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22262822|NCT04442503|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22275025|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
22262823|NCT02484807|Centre for pulmonary hypertension of the Thoraxclinic at the University Hospital Heidelberg|Professor Dr. med. Ekkehard Grünig|+4962213968053|ekkehard.gruenig@med.uni-heidelberg.de|
22262824|NCT05034874|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|intervexion@gmail.com|
22262825|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
22262826|NCT05278858|University Hospitals Cleveland Medical Center|Dr. Sonal Shah, Director of Pediatric Dermatology|216-286-7285|Sonal.Shah@UHhospitals.org|
22262827|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493||
22262828|NCT03101358|US Biotest, Inc.|Gere diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
22262829|NCT02640235|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22262830|NCT02426918|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22262831|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262832|NCT02420353|Hopsital For Special Surgery and University of Michigan|Dr. Christopher Mendias|212-249-2373|mendiasc@hss.edu|
22262833|NCT00503867|Sirtex Medical|Medical Director|011 61 2 9964 8470|dcade@sirtex.com|
22262834|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22262835|NCT05616728|Enanta Pharmaceuticals, Inc.|Justin Aubin|857-760-0591|jaubin@enanta.com|
22262836|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu|
22262837|NCT02016235|Mayo Clinic|John C. Lieske, M.D.|507-266-7960|Lieske.John@mayo.edu|
22262838|NCT05032807|King's College London|Dr Edward Chesney|+44 (0)20 7848 0728|edward.chesney@kcl.ac.uk|
22262839|NCT03790137|Massachusetts General Hospital|Dr. Elizabeth Thiele|6177266540|ethiele@mgh.harvard.edu|
22262840|NCT05203146|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
22262841|NCT05468320|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22262842|NCT03921554|Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
22262843|NCT04440592|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22262844|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
22262845|NCT02957331|UCHealth|Thomas J. Schroeppel, MD, MS|719 365 2422|thomas.schroeppel@uchealth.org|
22262846|NCT05568615|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22262847|NCT00565851|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22262848|NCT03291067|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please e-mail|information.US@mb.tanabe-pharma.com|
22262849|NCT05587530|Columbia University|Lisa B. Dixon, MD, MPH|646 774 8420|Lisa.Dixon@nyspi.columbia.edu|
22262850|NCT05079620|UConn Health|Brandon Oto|18606792000|oto.brandon@gmail.com|3881
22262851|NCT06437626|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47-55|pharmasoft@pharmasoft.ru|140
22262852|NCT03388008|Washington University in St. Louis|Ramsey Hachem, MD|(314) 454-7953|Rhachem@wustl.edu|
22262853|NCT01520987|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22262854|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22262855|NCT04768296|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22262856|NCT01863186|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22262857|NCT02664545|Miach Orthopaedics|Rita Paparazzo|1-800-590-6995 x107|rpaparazzo@miachortho.com|
22262858|NCT00255346|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Department Chair|713-792-7026|hkantarjian@mdanderson.org|
22262859|NCT04965181|Georgia State University|Claire Spears|404-413-9335|cspears@gsu.edu|
22262860|NCT04758780|Institut de cancérologie de l'Ouest|Dr Caroline ROUSSEAU|+33 240679900|caroline.rousseau@ico.unicancer.fr|
22262861|NCT04402489|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please E-mail|information.US@mb.tanabe-pharma.com|
22262862|NCT03192891|Brigham and Women's Hospital|Raymond Y. Kwong, MD MPH|8573071960|rykwong@bwh.harvard.edu|
22262863|NCT05223868|Janssen Research and Development, LLC|Global Medical Head Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22262864|NCT05029687|Rutgers University|Sara Heinert, PhD, MPH|732-235-7872|sara.heinert@rutgers.edu|
22262865|NCT04230304|Mayo Clinic|Sikander Ailawadhi|904-953-2000|Ailawadhi.Sikander@mayo.edu|
22262866|NCT05740371|Tanabe Pharma GmbH|Clinical Trials, Information Desk|Please email|regulatorycontact.DE@mb.tanabe-pharma.com|
22262867|NCT05112809|Mayo Clinic|Michael Cevette, Ph.D.|480-301-4380|mcevette@mayo.edu|
22262868|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu|
22262869|NCT02854800|West Virginia University|Dr. Melissa Blank|304-293-8341|Melissa.Blank@mail.wvu.edu|
22262870|NCT05673005|Mass General Brigham Department of Urology|Martin Kathrins, MD|617-732-6227|mkathrins@bwh.harvard.edu|
22262871|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262872|NCT05014438|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22262873|NCT02627963|AVEO Pharmaceuticals, Inc.|AVEO Clinical Trial Office|857-400-0101|Clinical@aveooncology.com|
22262874|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22262875|NCT05562011|Wake Forest University School of Medicine|Timothy Harwood, M.D.|336.716.8830|tharwood@wakehealth.edu|
22262876|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com|
22262877|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu|
22262878|NCT03068780|Amryt Research Limited|Janet Boylan|+3531518|Janet.boylan@amrytpharma.com|0200
22262879|NCT04540094|University of Edinburgh|Prof Alasdair Gray|0131 242 1340|alasdair.gray@ed.ac.uk|
22262880|NCT04411680|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
22307285|NCT05233098|Boston Scientific|Jessie Stockwell, Sr. Clinical Trial Specialist|6126181136|jessie.stockwell@bsci.com|
22262881|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu|
22307286|NCT04201834|University of Rochester|Ruth Schneider, MD|585-341-7500|Ruth_schneider@urmc.rochester.edu|
22307287|NCT04941287|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22307288|NCT03591770|Boston Medical Center|Sharmeel K. Wasan, MD|(617) 638-6116|sharmeel.wasan@bmc.org|
22307289|NCT01998984|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22262882|NCT02974907|ReGenTree, LLC|Shinwook Kang|609-649-5505|swkang@regentreellc.com|
22307290|NCT02652260|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307291|NCT04300647|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22307292|NCT05056246|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22307293|NCT05386238|Rush University Medical Center|Melissa Crane|312-563-0269|melissa_m_crane@rush.edu|
22307294|NCT04907474|Eyenovia, Inc.|Michael Rowe|833-393-6684|mmrowe@eyenovia.com|
22307295|NCT02476695|Wuxi HISKY Medical Technologies Co., Ltd.|Peng Lu|13816688340|yixuebu@fibrotouch.com|
22307296|NCT05055778|University of Virginia|Kara P. Wiseman, MPH, PhD|434-243-8126|kara.wiseman@virginia.edu|
22307297|NCT05857644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307298|NCT01353313|University of New Mexico Health Sciences|Kristi Watterberg|505-272-8609|kwatterberg@salud.unm.edu|
22307299|NCT03079024|University of Minnesota|Melissa Fisher|(612) 273-9812|mafisher@umn.edu|
22262883|NCT05109104|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22262884|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22262885|NCT02372006|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262886|NCT03504085|UC San Diego|Erik Groessl, PhD|858-642-6347|egroessl@ucsd.edu|
22262887|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com|
22262888|NCT04133311|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22262889|NCT00834561|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22262890|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22262891|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn|
22262892|NCT00672984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22262893|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22262894|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600|robert.huizinga@isotechnika.com|223
22307300|NCT01631214|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22307301|NCT03575052|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|58-261|medicalinformation@acadia-pharm.com|2897
22307302|NCT03717415|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
22307303|NCT01622868|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22307304|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org|
22307305|NCT03285763|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22307306|NCT03624972|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22307307|NCT03112174|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22307308|NCT04425629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22307309|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22307310|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307311|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22307312|NCT04987021|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22307313|NCT04259450|Affimed GmbH|Clinical Operations|+49 62216530770|trials@affimed.com|
22307314|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com|
22307315|NCT03390296|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
22307316|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org|
22307317|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22307318|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu|
22307319|NCT02584829|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22307320|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu|
22307321|NCT03628885|Indiana University|Dr. Gregory Zimet|3172748812|gzimet@iu.edu|
22307322|NCT01537419|Center for Family Intervention Science, Drexel University|Guy Diamond, Ph.D.|215-571-3420|gd342@drexel.edu|
22307323|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov|
22307324|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu|
22307325|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804||
22307326|NCT03074331|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22307327|NCT00741455|Dartmouth-Hitchcock Medical Center|Darcie Findley|603-650-4595|darcie.l.findley@hitchcock.org|
22307328|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307329|NCT03283371|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22262895|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu|
22262896|NCT00835588|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22307330|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
22262897|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk|
22307331|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com|
22262898|NCT03255980|Helsinn Healthcare SA|Dr. Fabio Macchi|0041919852121|fabio.macchi@helsinn.com|
22262899|NCT01597791|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.eud|
22262900|NCT02611362|Rhode Island Hospital|Dr. Larry K. Brown|(401) 793-8808|lkbrown@lifespan.org|
22262901|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518|medtronicCRMtrials@medtronic.com|62736
22262902|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org|
22262903|NCT02229084|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
22262904|NCT05128058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262905|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com|
22307332|NCT02561702|University of Rochester|David Herrmann|585-275-4568|david_herrmann@urmc.rochester.edu|
22307333|NCT04086966|University of Alabama at Birmingham|April Riddle|(205)934-6504|ariddle@uabmc.edu|
22307334|NCT03233633|Connecticut Hospice|Jim Prota, Director of Pharmacy|203-848-0660|jprota@hospice.com|
22307335|NCT02708108|Childrens Hospital Los Angeles|Dr Etan Orgel|13233612121|eorgel@chla.usc.edu|
22307336|NCT05360901|Brigham and Women's Hospital|Jessica M. Lipschitz|617-732-6548|jlipschitz@bwh.harvard.edu|
22307337|NCT04556981|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22307338|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu|
22307339|NCT05113771|Denovo Biopharma|Julie Doostzadeh, Executive Director|858-799-1021|jdoostzadeh@denovobiopharma.com|709
22307340|NCT02574455|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22307341|NCT00995150|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
22307342|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22307343|NCT02788773|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22307344|NCT05505045|University of Missouri|Anna Boone, PhD|573-882-7023|booneae@umsystem.edu|
22307345|NCT01643070|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
22307346|NCT02975505|University of California, San Francisco Division of Nephrology|Dr. Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
22307347|NCT05540535|New York University|Liraz Arie|3478661117|la1816@nyu.edu|
22307348|NCT04104321|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|0543314054|yossigs@galmedpharma.com|
22307349|NCT04842500|Vanderbilt University|Dr. Joseph Lambert|615-343-0824|joseph.m.lambert@vanderbilt.edu|
22307350|NCT02980276|University of Galway|Professor Fidelma Dunne|+35391492117|fidelma.f.dunne@universityofgalway.ie|
22307351|NCT04354337|University of Washington|Weichao Yuwen|2536924478|wyuwen@uw.edu|
22307352|NCT04139668|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|33111
22307353|NCT02824029|Karmanos Cancer Institute|Dr. Dipenkumar Modi, MD|313-576-8782|modid@karmanos.org|
22307354|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de|
22307355|NCT04512482|Indiana University School of Dentistry, Department of Orthodontics|Kelton T. Stewart, Department Chair|317-278-1087|keltstew@iu.edu|
22307356|NCT05119855|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307357|NCT02115828|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
22293174|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
22293175|NCT03308786|Case Western Reserve University|Michael M. Lederman MD|2168448786|MXL6@CASE.EDU|
22262906|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com|
22262907|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com|
22262908|NCT01745094|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512 Ext:|motoko.ida@astellas.com|
22262909|NCT01170715|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
22262910|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351||
22262911|NCT02083809|University of Hawaii|Dr.|8082036500|whrc@ucera.org|
22262912|NCT05665387|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22262913|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov|
22262914|NCT00006436|National Cancer Institute|Dr. Max Gordon|240-858-7151|max.gordon@nih.gov|
22262915|NCT00939523|Cedars-Sinai Medical Center|Odelia Cooper|310-423-4774|coopero@cshs.org|
22262916|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu|
22262917|NCT05194202|Children's Mercy Hospital|Dr. Kimberly Randell|816-302-3503|karandell@cmh.edu|
22262918|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22262919|NCT03086135|Radboud University Medical center, Nijmegen|Professor Emmanuel Mylanus|+31 24 361 49 34|Emmanuel.Mylanus@radboudumc.nl|
22262920|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22262921|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262922|NCT02710214|University of California, San Francisco|Dr. Riley Bove|415-595-2795|riley.bove@ucsf.edu|
22262923|NCT02832167|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22262924|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu|
22262925|NCT04590781|Xencor, Inc|Benjamin Thompson, MD, PhD|858-480-3133|bthompson@xencor.com|433
22262926|NCT04313296|Pen Bay Medical Center|Caroline Knight|207-301-8959|caroline.knight@mainehealth.org|
22262927|NCT00820599|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22262928|NCT03686215|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
22262929|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22262930|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525|tcraig@psu.edu|1
22262931|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu|
22262932|NCT01134198|new york state psychiatric institute|wilfrid raby, md|212-923-3031|wilfrid.raby@nyspi.columbia.edu|
22262933|NCT05353036|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
22262934|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22262935|NCT04707846|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
22262936|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org|
22262937|NCT03988608|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22262938|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524|sradovick@jhmi.edu|7733073353
22262939|NCT01134549|Amgen, Inc|Study Director|866-572-6436||
22262940|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com|
22262941|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu|
22275026|NCT03883386|University of Michigan Medical School|Professor Kelly Walkovich|734-647-2893|kwalkovi@med.umich.edu|
22293176|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293177|NCT01999868|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22293178|NCT00289016|Amgen, Inc.|Study Director|866-572-6436||
22293179|NCT03553927|Imperial College London|Channa Jayasena|02083833242|c.jayasena@imperial.ac.uk|
22293180|NCT02717273|University of Virginia|Robert Sawyer|4349821632|rws2k@virginia.edu|
22293181|NCT04294277|EAU Research Foundation|Dr. Wim Witjes|31263890677|w.witjes@uroweb.org|
22293182|NCT03350620|Vyluma, Inc|VP of Clinical Development|9083677400|info@vyluma.com|
22293183|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu|
22307358|NCT05848817|Mann Eye Institute|Phillip Brunson|1-713-580-2500|brunsonphillip@gmail.com|
22307359|NCT04977700|Klein Buendel, Inc.|Julia Berteletti|303-565-4321|jberteletti@kleinbuendel.com|
22307360|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300||
22307361|NCT05489484|Guna S.p.a.|Vincenzo Miranda (Clinical Research Manager); Kamilia Laarej (TSU&CRA)|02 280.18.(358)-(359)|v.miranda@guna.it; k.laarej@guna.it|
22307362|NCT02529995|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+44 1625 231825|Yuri.Rukazenkov@astrazeneca.com|
22307363|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
22307364|NCT05132478|UW School of Medicine and Public Health|Corrine Voils, PhD|(608) 262-9636|voils@surgery.wisc.edu|
22307365|NCT02549170|Shire|Study Director|+18668425335|ClinicalTransparency@shire.com|
22307366|NCT02988817|Genmab A/S|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
22307367|NCT04204993|Imperial College London|Professor Chris Chiu|+44 (0)20 8383 2301|c.chiu@imperial.ac.uk|
22307368|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22307369|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22307370|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262942|NCT02483416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262943|NCT04808908|University of Minnesota|Kevin Escandón|612-626-9344|escan012@umn.edu|
22262944|NCT03387462|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628-217-7479|susan.buchbinder@sfdph.org|
22293184|NCT03366012|Columbia University|Julian Abrams, MD, MPH|212-305-1909|ja660@cumc.columbia.edu|
22262945|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
22262946|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu|
22262947|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158||
22262948|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com|
22262949|NCT04684485|Sun Pharmaceutical Industries Limited|Head Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22293185|NCT03774082|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
22321022|NCT03300674|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
22321023|NCT02716987|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22321024|NCT01553188|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
22321025|NCT02445625|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
22321026|NCT05289570|Duke University|Ian Welsby, MD|919-681-6752|ian.welsby@duke.edu|
22321027|NCT01024010|Mayo Clinic|Tait D. Shanafelt, M.D.||shanafelt.tait@mayo.edu|
22321028|NCT00841789|Seattle Childrens hospital|Michael A Portman|2069871014|michael.portman@seattlechildrens.org|
22321029|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
22321030|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es|
22321031|NCT03317795|Mayo Clinic|Dr. Shannon K. Laughlin-Tommaso|507-538-5783|LaughlinTommaso.Shannon@mayo.edu|
22321032|NCT00886600|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22321033|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
22321034|NCT03917823|University of California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@health.ucsd.edu|
22321035|NCT01732809|Brazilian Center for Studies in Dermatology|Scientific Coordinator|+55 51 30262633|cientifico@cbed.org.br|
22321036|NCT02424253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22321037|NCT00473343|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22321038|NCT04126083|Mayo Clinic|W. Michael Hooten, M.D.|507-266-9672|Hooten.William@mayo.edu|
22321039|NCT03471975|Ajou University School of Medicine|Jihoon Hwang|+821093103304|kironojh@gmail.com|
22321040|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk|
22321041|NCT02577146|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
22321042|NCT02258451|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22321043|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com|
22321044|NCT05815719|Instituto Bernabeu|Juan Carlos Castillo|+34965154000|jcastillo@institutobernabeu.com|
22321045|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22262950|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293186|NCT05938920|InSilico Medicine Hong Kong Limited|Yujin Tian|+86-21-50831718|Insilico-Clinicaltrial@insilico.ai|
22293187|NCT01251861|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22293188|NCT03423082|University of Pittsburgh|Nghi C. Nguyen, MD, PhD|412-647-0104|nguyennc@upmc.edu|
22293189|NCT01816074|Dept of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
22293190|NCT03643796|University of Arkansas for Medical Sciences|Mohamed Abdeldayem|2244279747|Maabdeldayem@uams.edu|
22293191|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu|
22293192|NCT03355365|Tisch MS Research Center of New York|Saud Sadiq|212-265-8070|ssadiq@tischms.org|
22293193|NCT00320931|University of Maryland, Baltimore|Vasken Dilsizian, MD|410-328-6890|vdilsizian@umm.edu|
22293194|NCT05203289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293195|NCT02234570|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22293196|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu|
22293197|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu|
22293198|NCT02056639|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
22293199|NCT03509883|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22293200|NCT03650556|Abbott Medical|Amber Miller|(612) 413-7236|amber.miller@abbott.com|
22293201|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org|
22293202|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu|
22293203|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com|
22293204|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22293205|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361||
22293206|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
22293207|NCT03656107|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
22321046|NCT02958007|VA Maryland Healthcare System|Anjana Muralidharan|443-421-6275|anjana.muralidharan2@va.gov|
22321047|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th|
22262951|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22262952|NCT03405363|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262953|NCT00630253|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
22262954|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org|
22262955|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262956|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu|
22262957|NCT04610580|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22262958|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu|
22262959|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22262960|NCT04116957|University of Missouri|Jung Hyup Kim|5738840354|kijung@missouri.edu|
22262961|NCT01942135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262962|NCT01499043|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22275027|NCT01326871|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22275028|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22275029|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275030|NCT01589315|Medical University of South Carolina|Mark S. George, MD|1843876 5142|georgem@musc.edu|
22275031|NCT02147301|University of California, San Francisco|Curt Johanson|415-353-2310|curt.johanson@ucsf.edu|
22275032|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
22275033|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000|jamalira@tums.ac.ir|411
22275034|NCT01200329|UT MD Anderson Cancer Center|Yago Nieto/Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
22275035|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov|
22275036|NCT02230891|Michael E DeBakey Veterans Affairs Hospital|Vijay Nambi|713-794-7300|vijay.nambi@va.gov|
22275037|NCT03400449|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22275038|NCT03642990|University of Iowa|Donna L. Hammond, Ph.D Professor|319-335-9595|donna-hammond@uiowa.edu|
22275039|NCT02858908|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
22275040|NCT04865588|Icahn School of Medicine at Mount Sinai|Director of The Zena and Michael A. Wiener Cardiovascular Institute|(212) 241-4021|samin.sharma@mountsinai.org|
22262963|NCT06588530|Rutgers University|Dr. Robert Laumbach|1-848-445-6084|laumbach@eohsi.rutgers.edu|
22262964|NCT01596127|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22275041|NCT05994963|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275042|NCT04158219|Hennepin Healthcare|Dr. Andrew Busch|6128736681|andrew.busch@hcmed.org|
22275043|NCT00929838|Medical College of Wisconsin|Jennifer Campbell|414-955-8829|jacampbell@mcw.edu|
22262965|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu|
22293208|NCT04517500|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
22262966|NCT00438633|Massachusetts General Hospital|Dr. Neal Chen|6177264700|nchen1@partners.org|
22262967|NCT04569084|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22293209|NCT00986830|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22262968|NCT03196284|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22293210|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com|
22293211|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org|
22262969|NCT05471349|University of Wisconsin - Madison|Mark Zehner|608-262-7568|mark.zehner@wisc.edu|
22293212|NCT02391701|Hospital Clínico Universitario de Santiago|Dr. María del Mar Calvo Malvar|34 981950395|mariadelmar.calvo.malvar@sergas.es|
22262970|NCT02233751|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22293213|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org|
22293214|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
22293215|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca|
22293216|NCT01522248|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22293217|NCT01360593|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor, MPH, CCRP|412-647-5554|stadtermanbm@upmc.edu|
22293218|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22293219|NCT01332331|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293220|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
22293221|NCT00694707|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
22293222|NCT03096483|GE Healthcare|Beth Heckel|2623127269|beth.heckel@ge.com|
22293223|NCT03417804|Centro Hospitalar do Porto|Dr. Simão Esteves|+351222077549|simao.esteves@me.com|
22293224|NCT00369707|Northwestern University|Leo Gordon, MD|312-695-4520|l-gordon@northwestern.edu|
22293225|NCT05224141|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22293226|NCT02046733|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|STIMULI@etop-eu.org|
22262971|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu|
22293227|NCT04562792|Children's Mercy|Dr. Alan Gamis|816-302-6808|agamis@cmh.edu|
22293228|NCT02956070|Universidade Federal Fluminense|Dr. Luiz Augusto Poubel|55 21 981113344|luizpoubel@id.uff.br|
22293229|NCT02390908|Hunter College|Dr. Tyrel J. Starks|212-772-5550|tstarks@hunter.cuny.edu|
22293230|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
22293231|NCT04515394|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22293232|NCT00199875|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22293233|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com|
22293234|NCT01691898|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22293235|NCT01013350|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22293236|NCT02019277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22293237|NCT03725852|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22293238|NCT03557853|MSD Pharmaceuticals LLC|Vladimir Achikyan|+74959167100|vladimir.achikyan@merck.com|
22293239|NCT04048122|Washington University School of Medicine|Dr. Erin Foster|314-286-1638|erfoster@wustl.edu|
22262972|NCT04577404|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22262973|NCT02860000|Mayo Clinic|Dr Tufia C Haddad|507-284-2511|Haddad.Tufia@mayo.edu|
22262974|NCT03922490|Hospital for Special Surgery|Jessica Rios|212-774-7321|riosj@hss.edu|
22307371|NCT03029598|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
22307372|NCT01610297|Novartis|Study Director|862-778-8300||
22307373|NCT03051165|Emory University|Raj Dedhia, MD, MS|(404) 778-3381|raj.dedhia@emory.edu|
22307374|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca|
22307375|NCT03231358|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
22307376|NCT03684044|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22307377|NCT03703336|POLYVAC|Nguyen Thuy Huong, Ph.D, Vice Director|+84 912514309|huong72us@yahoo.com|
22307378|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22307379|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22307380|NCT00533910|Hunter Holmes McGuire VAMC|Jasmohan Bajaj|804 675 5802|jasmohan@gmail.com|
22307381|NCT04629950|Department of Dermatology, Weill Cornell Medicine|Dr. Richard D. Granstein|(646) 962-7546|rdgranst@med.cornell.edu|
22307383|NCT03049969|NYU Langone Health|Leigh Charvet, MD|9294555141|Leigh.Charvet@nyulangone.org|
22307384|NCT02568683|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22307385|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu|
22307386|NCT01561989|Roswell Park Cancer Institute|Dr. Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
22275044|NCT02374320|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
22293240|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu|
22293241|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22262975|NCT04729101|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
22262976|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262977|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu|
22262978|NCT04556734|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22262979|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com|
22262980|NCT01813435|Jessa Ziekenhuis, Hasselt, Belgium|Dr. Pascal Vranckx|+32 11 30 9589|pascal.vranckx@jessazh.be|
22262981|NCT01435824|The Hospital for Sick Children|Dr. Shinya Ito|416-813-5776|shinya.ito@sickkids.ca|205776
22262982|NCT03028896|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|31
22262983|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov|
22262984|NCT01765751|Palmer College of Chiropractic|Maruti R. Gudavalli, PhD|563-884-5260|gudavalli_r@palmer.edu|
22262985|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22262986|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22262987|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22262988|NCT04956289|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
22262989|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22262990|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22262991|NCT02898740|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
22262992|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22262993|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu|
22262994|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu|
22262995|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22262996|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22262997|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22262998|NCT03538795|University of Alabama of Birmingham|Gitendra Uswatte|205-975-5089|guswatte@uab.edu|
22262999|NCT02460835|University of Michigan Rogel Cancer Center|Dr. Theodore Lawrence|734-647-9955|tsl@umich.edu|
22263000|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca|
22263001|NCT02318550|Lancaster General Health|Project Manager|7175447395|Tawnya.Vernon@pennmedicine.upenn.edu|
22263002|NCT02951195|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22263003|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
22263004|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu|
22263005|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com|
22263006|NCT04421625|INSTITUT DE CANCEROLOGIE DE L'OUEST|DR FREDERIC BIGOT|02 41 35 27 00|frederic.bigot@ico.unicancer.fr|+33
22263007|NCT04462198|Pipeline Therapeutics, Inc.|Stephen Huhn, MD|858-333-5280|SHuhn@pipeline-tx.com|
22263008|NCT02786953|Vanderbilt University Medical Center|Sarah S Jaser|6153436775|sarah.jaser@vumc.org|
22275045|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22263009|NCT01897077|Johns Hopkins School of Medicine|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
22275046|NCT00535613|University of Wisconsin|Cari Meyer|(608) 265-5980|cmeyer@wisc.edu|
22275047|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275048|NCT02160626|Aclaris Therapeutics Inc.|Judith Schnyder|+1-484-329-2144|jschnyder@aclaristx.com|
22275049|NCT04239924|BerbeeWalsh Department of Emergency Medicine|Dr. Manish Shah|608-263-9174|mnshah@medicine.wisc.edu|
22275050|NCT04194814|University of Sheffield|Dr Simon Danby|0114 2268515|s.danby@sheffield.ac.uk|
22275051|NCT03255187|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
22293242|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293243|NCT02215096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293244|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22293245|NCT01787331|University of California, San Francisco|Rahul Aggarwal, MD|877-827-3222|cancertrials@ucsf.edu|
22293246|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu|
22293247|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293248|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
22293249|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
22293250|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22293251|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu|
22293252|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com|
22293253|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22293254|NCT00150709|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22293255|NCT04092582|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22293256|NCT03689114|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Giorgia Giussani|0239014604|giorgia.giussani@marionegri.it|
22321048|NCT00218491|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
22321049|NCT03927105|Hoosier Cancer Research Network|Adelai Neal|317-921-2053|aneal@hoosiercancer.org|
22321050|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com|
22321051|NCT01870401|Becton Dickinson|Lisa Erickson|763-463-2897|Lisa.Erickson@bd.com|
22275052|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22275053|NCT01075048|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22275054|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu|
22293257|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr|
22293258|NCT03019185|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22293259|NCT03930680|University of Arkansas for Medical Sciences|Hui-Ming Chang, MD, MPH|501-686-7575|hchang@uams.edu|
22293260|NCT02764333|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner, MD|848-225-6530|konnerj@MSKCC.ORG|
22293261|NCT04075279|Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health|Dr. Tyler Quinn|412-386-4450|yhh7@cdc.gov|
22293262|NCT00608972|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
22293263|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
22293264|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu|
22293265|NCT00333177|University of California, Los Angeles|Keith H. Nuechterlein, Ph.D., Principal Investigator|(310) 825-0036|keithn@ucla.edu|
22293266|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
22293267|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281|bduke@ChildPsychopharmacologyInstitute.org|2
22293268|NCT03917459|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22293269|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
22293270|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293271|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
22293272|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22293273|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp|
22293274|NCT03273543|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22293275|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk|
22293276|NCT03228433|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22293277|NCT03055156|Stanford University|Dr. Seiji Nishino|650-725-8602|nishino@stanford.edu|
22293278|NCT03626168|The University of Alabama|Dr. Amy Ellis, principal investigator|205-348-8128|aellis@ches.ua.edu|
22293279|NCT01419626|Johnson & Johnson Consumer and Personal Products Worldwide|DIRECTOR ORAL HEALTH, MEDICAL AFFAIR & CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22293280|NCT02737397|Clinilabs, Inc|Magdy Shenouda, MD|201-417-7765|Jackie@sen-jam.com|
22293281|NCT03569033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293282|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu|
22293283|NCT04738734|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory, and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
22293284|NCT04093414|Beaumont Hospitals|Diedre Brunk|248-898-5580|Diedre.Brunk@beaumont.org|
22293285|NCT03452228|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22293286|NCT03212690|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293287|NCT03998566|Boston Scientific|Jeya Satheesh|6124490870|jeya.satheesh@bsci.com|
22275055|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
22293288|NCT03208127|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|chung.raymond@mgh.harvard.edu|
22293289|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org|
22293290|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22293291|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22293292|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu|
22293293|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
22293294|NCT01346969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293295|NCT01967173|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
22293296|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com|
22293297|NCT03225599|Northwell Health|Administrative Director, Clinical Research|(516) 881-7064|dcannone1@northwell.edu|
22293298|NCT03666624|University of Washington|Karen Fredriksen Goldsen|206-543-5722|fredrikk@uw.edu|
22293299|NCT05213481|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22293300|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg|
22293301|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293302|NCT00423514|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
22293303|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293304|NCT02128932|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22293305|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com|
22293306|NCT03685123|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
22293307|NCT01254630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293308|NCT02959983|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22293309|NCT03221270|University of North Carolina at Chapel Hill|Rachel Force, PhD|984-974-6239|rachel_force@med.unc.edu|
22293310|NCT03439657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293311|NCT03353246|Duke University Medical Center|Michael Haglund, M.D., Ph.D.|919-684-6936|haglu001@mc.duke.edu|
22293312|NCT02925117|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22293313|NCT04032652|NorthShore University HealthSystem|Asst Director Research Compliance|2243647975|rpulido@northshore.org|
22293314|NCT02663908|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22293315|NCT02004522|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22293316|NCT03175978|IGF Oncology, LLC|Hugh McTavish|651-207-8270|hmctavish@igfoncology.com|
22293317|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
22293318|NCT02764697|Tampa Bay Uveitis Center, LLC|Dr. Grace Levy Clarke|855 798 8393|grace@tampabayuveitis.com|
22293319|NCT01892865|Michael E. DeBakey VAMC|Panos Kougias MD MSc|713.794.7700|panagiotis.kougias@va.gov|
22293320|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov|
22293321|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il|
22293322|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22293323|NCT03320057|University of California San Francisco|Shelly Kaller|510-986-8945|shelly.kaller@ucsf.edu|
22293324|NCT06956170|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293325|NCT02323113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22293326|NCT00690274|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
22293327|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|2158709177|tom.chmielewski@jazzpharma.com|
22293328|NCT02280304|Michael E. DeBakey VA Medical Center|Dr. Mary Newsome|713-791-1414|mary.newsome@va.gov|25947
22293329|NCT04805541|Akdeniz University|Prof.Dr. Ahmet Burak Bilgin|5465473336|gozdrburakbilgin@gmail.com|
22293330|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
22293331|NCT01935791|Imperial College London|Dr Chioma Izzi-Engbeaya|02075942454|c.izzi@imperial.ac.uk|
22293332|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22293333|NCT05154578|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
22293334|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
22293335|NCT02980783|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22293336|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu|
22293337|NCT05047770|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293338|NCT01772160|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293339|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22293340|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22293341|NCT03441269|Maimonides Medical Center|Sergey Motov, MD|718-283-8693|alikourezos@maimonidesmed.org|
22293342|NCT01540838|University of Helsinki, Children´s Hospital, Helsinki University Hospital|Dr. Okko Savonius, PhD candidate|+358456731185|okko.savonius@helsinki.fi|
22293343|NCT02130570|Brigham and Women's Hospital|Dr. Jeffrey L Schnipper, MD, MPH, FHM|617-732-7063|jschnipper@partners.org|
22293344|NCT05294640|Moyes Eye Center|Meleha Ahmad|401-523-5911|meleha.ahmad@gmail.com|
22293345|NCT04460937|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
22293346|NCT03225573|AIn Shams University|Professor Ali Gamal Zohni|+2 01004931448|zohniali@gmail.com|
22321052|NCT02289222|University of Maryland Greenebaum Comprehensive Cancer Center|Ashraf Badros M.B.Ch.B|410-328-1230|Abadros@umm.edu|
22321053|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321054|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22321055|NCT01351389|Brown University, Center for Alcohol and Addiction Studies|Dr. Peter Monti|(401) 863-6661|peter_monti@brown.edu|
22321056|NCT04839978|Emory University|Kelli Komro, PhD|404-727-8742|kkomro@emory.edu|
22321057|NCT03045861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22321058|NCT03551509|Cleveland Clinic|Dr. Gregory Gilot|786 566-9176|gilotg@ccf.org|
22321059|NCT01902966|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD, Professor, Gynecologic Oncology & Reproductive Medicine|713-745-0307|lramonde@mdanderson.org|
22321060|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw|
22321061|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321062|NCT02868242|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22321063|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu|
22321064|NCT02152085|University of Colorado Boulder|Roger Enoka|3034927232|enoka@colorado.edu|
22321065|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321066|NCT01324232|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
22321067|NCT02513329|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22321068|NCT05440539|Houston Methodist Hospital|Dr. Emily Rutledge|713-441-5800|erut@me.com|
22321069|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com|
22321070|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321071|NCT05626270|Erchonia Corporation|Travis Sammons|864-531-0064|tsammons@erchonia.com|
22321072|NCT03078075|UT Southwestern Medical Center|Dr. Madhukar Trivedi|214/648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
22321073|NCT02841397|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
22321074|NCT02324920|BIOTRONIK Italiy|Daniele Giacopelli|+39 3491712305|daniele.giacopelli@biotronik.com|
22321075|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com|
22321076|NCT02004262|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
22321077|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu|
22321078|NCT03703102|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
22321079|NCT00876187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321080|NCT04331795|University of Chicago, Department of Medicine Section of Rheumatology|Dr. Pankti Reid|773-702-6119|pankti.reid@uchospitals.edu|
22321081|NCT03200366|Indiana University|Susan M. Rawl, PhD, RN, FAAHB, FAAN|317-278-2217|srawl@iu.edu|
22321082|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
22293347|NCT02808650|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22293348|NCT03072732|ZOLL|Project Manager|14127216444|moszm@yahoo.com|
22293349|NCT02484287|University of Oklahoma Health Science Center|Blair Apple|4052714658|Blair-Apple@ouhsc.edu|1
22293350|NCT04889222|Masimo Corporation|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
22293351|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org|
22293352|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com|
22293353|NCT01485393|MGH|Dr. Johnson-Akeju|6177247200|ojohnsonakeju@partners.org|
22293354|NCT01561378|Montefiore Medical Center|Daniel Ceusters|718-920-2956|dceuster@montefiore.org|
22293355|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org|
22293356|NCT04545554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22293357|NCT02639546|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22293358|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net|
22293359|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010|mschult1@its.jnj.com|8787
22293360|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293361|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com|
22293362|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300||
22293363|NCT02713204|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22293364|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
22293365|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22293366|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293367|NCT04569253|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22293368|NCT01927627|Case Comprehensive Cancer Cent|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
22293369|NCT02635776|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22293370|NCT00660673|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22293371|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu|
22293372|NCT03505190|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321083|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293373|NCT03476278|Derince Eğitim Ve Araştırma Hastanesi|Dr. Hande Aytuluk|5336515650|handegrbz@gmail.com|
22293374|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919||
22293375|NCT01903031|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22293376|NCT01811225|University of Minnesota|Dr. Sharon Allen|612-624-2446|allen001@umn.edu|
22293377|NCT03000569|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22263010|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263011|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22263012|NCT04281472|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
22263013|NCT03334734|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
22263014|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com|
22263015|NCT05053360|Inova Health System|Jaimee Robinson, Labor and delivery Clinical Nurse Educator|7038586028|jaimee.robinson@inova.org|
22263016|NCT04697173|Virginia Commonwealth University|Nikki Miller Ferguson MD|804-828-4080|nikki.millerferguson@vcuhealth.org|
22263017|NCT05533411|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22263018|NCT03277248|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22263019|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
22263020|NCT01949532|Amgen, Inc.|Study Director|866-572-6436||
22263021|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org|
22263022|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
22263023|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org|
22263024|NCT03617419|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
22263025|NCT01211262|Immunocore, LLC|Chris Holland, Executive Director Head of Biostatistics|1-267-589-9204|chris.holland2@immunocore.com|
22263026|NCT02248714|6thShanghaiJiaotongU|Dr. Yuqian Bao|(021)64369181|byq522@163.com|
22263027|NCT01277510|Amgen Inc.|Study Director|866-572-6436||
22263028|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263029|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com|
22263030|NCT02119936|UNC Chapel Hill|Holly Krohn|919-445-0218|holly_krohn@med.unc.edu|
22263031|NCT00570128|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22263032|NCT04091945|Lumosa Therapeutics Co., Ltd.|Sabrina Yeh|+886 2 26557918|sabrina_yeh@lumosa.com.tw|5735
22263033|NCT02161705|Johns Hopkins University School of Medicine|Dr. Pathik Aravind|4437879385|paravin1@jhmi.edu|
22263034|NCT03555695|Rush University Medical Center|Dr. Jori Fleisher|312-563-2900|jori_fleisher@rush.edu|
22263035|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com|
22263036|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com|
22263037|NCT03820947|Medtronic|Wendy Moeyersons, Clinical Research Specialist|+32486313172|wendy.moeyersons@medtronic.com|
22263038|NCT02940522|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22263039|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22263040|NCT01639664|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Guido Bertolini|035 4535 313|guido.bertolini@marionegri.it|
22263041|NCT05135273|Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH|Dr. David Cook|240.627.3066|david.cook@nih.gov|
22263042|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
22263043|NCT04264819|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22263044|NCT02400463|University of Michigan Rogel Cancer Center|Ryan Wilcox|734-615-1482|rywilcox@umich.edu|
22263045|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22263046|NCT02569541|Arrevus, Inc.|Carl Kraus, MD (CEO)|9193665503|ckraus@arrevus.com|
22263047|NCT03460990|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22263048|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263049|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22293378|NCT02298023|, Seoul National University Hospital|Dr. Sun G. Chung|+82-2-2072-2560|chung60611@gmail.com|
22293379|NCT04010695|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
22321084|NCT05074251|UCLA|Dr. Dvora Joseph Davey|310-701-1526|dvoradavey@ucla.edu|
22321085|NCT05112536|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22321086|NCT03571646|Medtronic|Geraldine Kelly|+353 879840223|geraldine.kelly@medtronic.com|
22321087|NCT03972969|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22321088|NCT04718974|Infectious Diseases Institute, College of Health Sciences, Makerere University|Dr. Agnes Bwanika Naggirinya|+256752521570|anaggirinya@idi.co.ug|
22321089|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321090|NCT04081363|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22321091|NCT02409290|MRC CTU at UCL, University College London, London UK|Dr Ruth Goodall|+44 2076704728|r.goodall@ucl.ac.uk|
22321092|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org|
22321093|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22321094|NCT02182687|Lahey Hospital & Medical Center|Julia Roache|781-744-3055|julia.roache@lahey.org|
22321095|NCT02327052|Hospital São Rafael|Dr. Milena Botelho Pereira Soares|+557132816455|milenabpsoares@gmail.com|
22321096|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
22321097|NCT04251910|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22321098|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz|
22321099|NCT03831971|Clinical Center|Masur, Henry|+1 301 496 9320|hmasur@cc.nih.gov|
22321100|NCT03451084|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
22321101|NCT00573989|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
22321102|NCT04544475|NYU Langone Health|Lila Nachtigall|2122636361|Lila.Nachtigall@nyulangone.org|
22321103|NCT01765920|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22321104|NCT03223428|TerSera Therapeutics LLC|Noran Osman, PharmD, MHS, Associate Director, External Research and Medical|+1-224-754-4605|nosman@tersera.com|
22321105|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22263050|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com|
22263051|NCT03480685|Avinger, Inc.|Thomas Lawson, PhD|650-241-7030|tlawson@avinger.com|
22263052|NCT02846883|Roudebush VA Medical Center|Michael P. Murphy, MD|317-988-4049|mipmurph@iupui.edu|
22263053|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com|
22263054|NCT01550367|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22263055|NCT04492397|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
22263056|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22263057|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22263058|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22263059|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org|
22263060|NCT02435433|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@Lilly.com|
22263061|NCT01243151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263062|NCT03119662|GE Healthcare|Francois Tranquart, M.D., Ph.D.|00-44-1494-543037|francois.tranquart@ge.com|
22263063|NCT02817828|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
22263064|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22263065|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com|
22263066|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263067|NCT02383706|Duke University Medical Center|Dr Jennifer Dominguez|(919) 668-2024|jennifer.dominguez@dm.duke.edu|
22263068|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat|
22263069|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22263070|NCT03343639|Chief Scientific Officer|Paul Kwon|650-486-1416|pkwon@menlotx.com|
22263071|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
22263072|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263073|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
22263074|NCT02587143|Servicio de Urgencias, Hospital de Basurto, Bilbao, España|Dr. Ballesteros-Peña|(+34)946012804|sendoa.ballesteros@ehu.eus|
22263075|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22263076|NCT00981799|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
22321106|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22275056|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu|
22275057|NCT04596293|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|031-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
22275058|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22275059|NCT01258374|Hospital Clinic|Dr. Josep Mallolas Masferrer|00 44 93 227 54 00|mallolas@clinic.cat|3312
22275060|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu|
22263077|NCT01586039|Brigham and Women's Hospital|Dr. Steven W. Lockley|617-732-4977|slockley@hms.harvard.edu|
22263078|NCT04436198|Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22263079|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp|
22263080|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu|
22263081|NCT01753362|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
22263082|NCT04535986|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
22263083|NCT01632306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263084|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262|CHUNGKA@OHSU.EDU|51091
22263085|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br|
22263086|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu|
22263087|NCT03141151|Vanderbilt University Medical Center|William Heerman, MD MPH|615-322-7080|bill.heerman@vumc.org|
22263088|NCT01885897|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
22263089|NCT04561115|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
22263090|NCT00743145|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
22275061|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net|
22275062|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu|
22275063|NCT01507350|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22275064|NCT02863666|University of Buffalo|Brooke Lerner PHD,|716.390.3509|lerner@buffalo.edu|
22275065|NCT03946059|University of California San Diego|Dr. Jyoti Mishra|8582322855|jymishra@ucsd.edu|
22275066|NCT00266708|Montefiore Medical Center|Maria Coco, MD|718-920-4136|mcoco@montefiore.org|
22275067|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22275068|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu|
22275069|NCT02741284|Washington University in St Louis|Dr Nandini Raghuraman|314 362 7300|nraghuraman@wustl.edu|
22293380|NCT02002832|Sumitomo Pharma (Suzhou) Co., Ltd.|Chief Medical Officer|+86-10-57322070|luo@dsmpharm.com.cn|
22293381|NCT03329508|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
22293382|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu|
22263091|NCT02179190|Medtronic Plc|Senior Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
22263092|NCT01670097|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22263093|NCT02311894|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22263094|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263095|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org|
22263096|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com|
22263097|NCT04736537|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
22263098|NCT04049097|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22263099|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov|
22263100|NCT01874535|Kaohsiung Chang Gung Memorial Hospital, Taiwan|Dr. Seng-Kee Chuah and Dr. Wei-Chen Tai|886-975056007|chuahsk@seed.net.tw|
22263101|NCT01816230|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
22263102|NCT02616380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22263103|NCT05065619|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22263104|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
22263105|NCT05315713|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22263106|NCT00421304|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22263107|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22263108|NCT00919711|Amgen Inc.|Study Director|866-572-6436||
22293383|NCT04122534|Montana State University|Dr. Kelly E. Knight|303-819-6997|kelly.knight3@montana.edu|
22293384|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
22293385|NCT01790932|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|nlin@partners.org|
22293386|NCT03572972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275070|NCT04319224|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
22275071|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22275072|NCT03261401|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22275073|NCT01516216|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
22293387|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
22263109|NCT03694197|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22263110|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp|
22263111|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu|
22263112|NCT04980456|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22263113|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org|
22263114|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu|
22263115|NCT04284553|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22263116|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu|
22263117|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org|
22263118|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it|
22263119|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263120|NCT02415387|Center for Biostatistics, The Ohio State University|Juan Peng|614-293-5869|juan.peng@osumc.edu|
22263121|NCT01891812|Columbia University Irving Medical Center|Dr. Daniel Tsze, Professor of Pediatrics|212 305 9825|dst2141@cumc.columbia.edu|
22263122|NCT02733627|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263123|NCT02246764|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22263124|NCT05393271|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263125|NCT02048813|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22263126|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22263127|NCT05293106|Weill Cornell Medicine|Marianne Nellis, MD|2127463056|man9026@med.cornell.edu|
22263128|NCT03314857|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22263129|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263130|NCT03237156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22263131|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22263132|NCT02754492|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22263133|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263134|NCT04542694|A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation|Academician Dmitry Pushkar|+7495-609-67-00|dmitry.pushkar@gmail.com|
22263135|NCT03490916|UMass Medical School|Principal Investigator|4136279111|vincent.kan08@gmail.com|
22263136|NCT04633642|Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain|Dr. Francisco Javier Álvaro Afonso|913-941-502|alvaro@ucm.es|+34
22263137|NCT05387408|Washington University|Dr. Ann Marie Dale, Principal Investigator|3144548470|amdale@wustl.edu|
22263138|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410|t.roesch@uke.de|50098
22263139|NCT01207752|Southern California College of Optometry at MBKU|Jerry Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
22263140|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263141|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22263142|NCT01617096|International Partnership for Microbicides|Dr John Steytler|+27218602300|jsteytler@ipmglobal.org|
22263143|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263144|NCT01532908|MassBiologics|Director of Clinical Affairs|617-474-3000|Mblclinicaldirector@Umassmed.edu|
22263145|NCT01196390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22263146|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com|
22263147|NCT03480022|Woman's Hospital|Director of Research|12252315278|karen.elkind-hirsch@womans.org|
22263148|NCT00881569|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22263149|NCT03660787|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|1150
22263150|NCT02623218|AOMA Graduate School of Integrative Medicine|Dr. John Finnell|512-492-3057|jfinnell@aoma.edu|
22263151|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org|
22263152|NCT04207333|University of North Carolina at Chapel Hill|Lee Stoner, PhD, MPH|919-962-0534|stonerl@unc.edu|
22263153|NCT00537095|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22263154|NCT01970592|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
22263155|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu|
22263156|NCT03980522|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22263157|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org|
22263158|NCT01091363|University of Massachusetts Medical School|Dr. Sun S Kim|201-388-2656|sun.kim@umb.edu|
22263159|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22263160|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
22263161|NCT04892147|Duke University|Guy G. Potter, PhD|919-668-1269|guy.potter@duke.edu|
22263162|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22263163|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu|
22263164|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
22263165|NCT01044433|Abramson Cancer Center|Dr. Corey Langer|215-615-5121|Corey.Langer@uphs.upenn.edu|
22275074|NCT03098979|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22321107|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22321108|NCT02031770|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@ucdenver.edu|
22321109|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk|
22321110|NCT01947816|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22321111|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org|
22321112|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu|
22321113|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org|
22321114|NCT03631732|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22321115|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22263166|NCT05263505|Washington University School of Medicine|Dr. Michael Paley, Director of the Ocular Rheumatology Clinic|314-273-7556|paleym@wustl.edu|
22321116|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com|
22321117|NCT02255409|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22263167|NCT00826241|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|gilbertmr@nih.gov|
22263168|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu|
22263169|NCT03786770|Revance Therapeutics, Inc.|Domenico Vitarella, Sr. Director, Clinical Development|510-742-3400|dvitarella@revance.com|
22263170|NCT02243579|Fred Hutchinson Cancer Research Center|Asa Davis|206-667-5300|akdavis@fredhutch.org|
22263171|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300||
22263172|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263173|NCT03505151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263174|NCT04194151|Hospital Central de la Defensa Gomez Ulla|Dr. Paula Agostina VULLO|+34681054151|agosvullo@hotmail.com|
22263175|NCT03018925|Institut d'Investigació Biomèdica de Girona - Hosp Univ Dr Josep Trueta|MD PhD X Aldeguer|34972940200|xaldeguer.girona.ics@gencat.cat; abahi@idibgi.org|2401
22263176|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263177|NCT02535923|Department of Veterans Affairs|Elizabeth A Klingaman PhD|410-259-7810|elizabeth.klingaman@va.gov|
22263178|NCT04388787|Virginia Commonwealth University|Olivier Rolin, MD, PhD|(804) 828-4230|olivier.rolin@vcuhealth.org|
22263179|NCT01723202|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-366-5068|Bhvana.konda@osumc.edu|
22263180|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu|
22263181|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org|
22263182|NCT04662710|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22263183|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com|
22263184|NCT02722616|Johns Hopkins, East Baltimore|Dr. Amol Narang|410-913-3395|anarang2@jhmi.edu|
22263185|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263186|NCT04489303|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
22263187|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov|
22263188|NCT01453153|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22263189|NCT01196117|Medical College of Wisconsin|B. Tucker Woodson|414-805-7667|bwoodson@mcw.edu|
22263190|NCT03547635|Integra LifeSciences|Jessica Knowlton, Sr Mgr, Clinical Research & PMCF Strategy|609-325-0111|jessica.knowlton@integralife.com|
22263191|NCT03243396|Duke University|Kathryn Whetten, PhD, MPH|919-613-5313|k.whetten@duke.edu|
22263192|NCT03687242|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
22263193|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com|
22263194|NCT02473393|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22263195|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu|
22263196|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22263197|NCT00397254|Clinvest|M.E. Beach|417-841-3618|mbeach@clinvest.com|
22263198|NCT05633862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22263199|NCT00152451|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22263200|NCT00897676|The Children's Hospital of Philadelphia|Diva DeLeon, MD|267-426-5529|deleon@email.chop.edu|
22263201|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu|
22263202|NCT01728636|Northwestern University|Luanne Carabini MD|312-695-0061|l-carabini@northwestern.edu|
22263203|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com|
22263204|NCT04473326|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
22263205|NCT02046122|Duke University|Anthony Sung, MD|919-668-1002|anthony.sung@duke.edu|
22263206|NCT04090658|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263207|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
22263208|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
22263209|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil|
22263210|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu|
22263211|NCT04164758|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22321118|NCT00135668|Duke University Medical Center|Scott Schulman, MD|919-681-4877|schul003@mc.duke.edu|
22321119|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22321120|NCT02290873|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
22321121|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22321122|NCT03715153|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr. Pierre-François PENELAUD|+ 33 1 55 72 68 58|pierre-francois.penelaud@servier.com|
22275075|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300||
22275076|NCT02419807|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Stephen Grobmyer|1-866-223-8100|TaussigResearch@ccf.org|
22275077|NCT03860753|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
22275078|NCT01499511|Imperial College London|Professor Peter Sever|02075941100|p.sever@imperial.ac.uk|
22275079|NCT01006629|Abbott|Global Medical Services|800-633-9110||
22275080|NCT03424304|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22275081|NCT00998946|Spectrum Pharmaceuticals, Inc|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22275082|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22275083|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu|
22275084|NCT04459338|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
22275085|NCT03157089|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275086|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu|
22275087|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275088|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22275089|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22275090|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org|
22275091|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu|
22275092|NCT01829347|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
22275093|NCT03435055|University of Michigan|Richard Harris|734-998-6996|reharris@umich.edu|
22275094|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu|
22275095|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com|
22275096|NCT03703895|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
22275097|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22275098|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22275099|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu|
22275100|NCT05998967|VA San Diego HCS|Ariel J Lang, PhD, MPH|(858) 552-8585|ariel.lang@va.gov|
22275101|NCT03502798|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22275102|NCT05169905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275103|NCT00062166|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22275104|NCT01791595|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22275105|NCT06119854|CityUNYSPH|Denis Nash|3473316554|denis.nash@sph.cuny.edu|
22275106|NCT06494761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22275107|NCT04865289|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22275108|NCT03104374|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22275109|NCT03210714|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22275110|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu|
22275111|NCT04158648|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22275112|NCT04609514|Duke University|Roger Vilardaga Viera, PhD|919-684-3441|roger.vilardaga@duke.edu|
22275113|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275114|NCT02816723|VA Northern California Health Care System|Juliana Baldo|925-372-4649|Juliana.Baldo@VA.gov|
22275115|NCT02643875|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
22275116|NCT02873975|Dana-Farber Cancer Institute|Geoffrey Shapiro M.D., PhDDana-Farber Cancer Institute|617-632-6594|Geoffrey_Shapiro@dfci.harvard.edu|
22275117|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22275118|NCT03638323|Groupe Hospitalier de la Rochelle Ré Aunis|Marie-Laure Vignaud, neuropsychologist|+33 (0)5 46 45 63 70|marie-laure.vignaud@ght-atlantique17.fr|
22275119|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
22275120|NCT01502085|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22275121|NCT05399680|Cordis|Rajesh Nathan|(908) 528-3931|rajesh.nathan@cordis.com|
22275122|NCT02936999|Inova Health Services|Regulatory Research Coordinator|(571) 472-0239|elizabeth.gebregeorgis@inova.org|
22275123|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com|
22275124|NCT03737994|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22275125|NCT01373164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275126|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22275127|NCT01605903|Massachusetts Eye and Ear Infirmar|Gillian Diercks, MD, MPH|617-573-3190|gillian_diercks@meei.harvard.edu|
22293388|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov|
22293389|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321123|NCT03116698|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759910|srinivassidgiddi@drreddys.com|
22321124|NCT03021499|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22321125|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov|
22321126|NCT00820950|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22321127|NCT01066364|UCSD|Rohit Loomba, MD|858-246-2201|roloomba@ucsd.edu|
22321128|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22321129|NCT03615183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321130|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22321131|NCT03187769|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
22321132|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu|
22321133|NCT03402607|Duke University Health System|Linda Kaltenbach|919-681-6804|Linda.Kaltenbach@duke.edu|
22321134|NCT02037295|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Jonathan Krakoff, M.D.|(602) 200-5217|jkrakoff@mail.nih.gov|
22321135|NCT03077347|University of CA Davis Health|Tiffany T . Norris|916-703-9193|ttnorris@ucdavis.edu|
22321136|NCT01981590|Medtronic Bakken Research Center|Lilian Kornet, Prin.Scientist|+31433566710|lilian.kornet@medtronic.com|
22321137|NCT02770547|Purdue University|Bruno Roseguini, Assistant Professor|(765) 496-2612|brosegui@purdue.edu|
22321138|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
22321139|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012||
22321140|NCT03134599|CooperVision|Jose Vega, O.D., MSc., FAAO|9252516213761|javega@coopervision.com|
22321141|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22321142|NCT02311153|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD||justin.h.turner@vanderbilt.edu|
22321143|NCT01967628|University of Iowa|Dr. Alicia Gerke|319-356-1869|alicia-gerke@uiowa.edu|
22321144|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu|
22321145|NCT01379274|Rush University Medical Center|Dr. Jamile Shammo|312-CANCER-1|jamile_shammo@rush.edu|
22321146|NCT03287219|Cosmo Technologies Ltd|R&D Manager||rjones@cosmopharma.com|
22321147|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu|
22321148|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321149|NCT01118351|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
22321150|NCT00518154|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán|Dr. Carlos Aguilar Salinas, Director of Ethics in Human Research Committee|5554870900|carlos.aguilars@incmnsz.mx|4524
22321151|NCT03345108|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275128|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov|
22275129|NCT03055013|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22275130|NCT03177395|Pharmacology, Therapeutics and Toxicology Unit, Centre for Cardiovascular Science, University of Edinburgh, UK|Dr James Dear|+44(0)131 242 9214|james.dear@ed.ac.uk|
22275131|NCT02765035|Otto Bock Healthcare GmbH|Director of Clinical Research and Services Vienna|+4315233786733|Milana.Mileusnic@Ottobock.com|
22293390|NCT04721171|Medical College of Wisconsin|Thangam Venkatesan|262-226-9632|tvenkate22@gmail.com|
22293391|NCT01771952|University of Virginia, Kinesiology|Joe Hart|4349246187|jmh3zf@virginia.edu|
22293392|NCT01402011|University of British Columbia Department of family practice|Dr. Helene Bertrand, M.D., CCFP, LM|604-985-5381|dr.hbertrand@gmail.com|
22293393|NCT02612129|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22293394|NCT02557295|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
22293395|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22293396|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731||
22293397|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22293398|NCT04449861|Jilin Cancer Hospital|Ying Cheng, MD|NA|jl.cheng@163.com|
22293399|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012||
22293400|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22293401|NCT03487549|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22293402|NCT01925534|Tufts Medical Center|Dr. Nicholas Hill|(617) 636-6377|nhill@tuftsmedicalcenter.org|
22293403|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293404|NCT03642457|Icahn School of Medicine at Mount Sinai|Poonam Pai|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
22293405|NCT02609204|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22293406|NCT03689530|University of Michigan|Michele Heisler|(734) 845-3504|mheisler@med.umich.edu|
22293407|NCT01392443|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22293408|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22275132|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org|
22275133|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22275134|NCT04418947|University of Pennsylvania|Dr. Anne Cappola|2155735359|acappola@pennmedicine.upenn.edu|
22275135|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
22275136|NCT03937778|National Center for Complementary and Integrative Health|Chesler, Alexander|+1 301 594 1049|alexander.chesler@nih.gov|
22275137|NCT03261999|Foresee Pharmaceuticals Co., Ltd|John Mao|+886 2-7750-0188|john.mao@foreseepharma.com|
22293409|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com|
22293410|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22293411|NCT02515825|AUM Cardiovascular|Marie Johnson, PhD|612.799.2511|mariej@aumcv.com|
22293412|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22293413|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com|
22293414|NCT01925677|University of Maryland, Baltimore|Dr. Rolf Barth|4103286020|rnbarth@som.umaryland.edu|4103286020
22293415|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22263212|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com|
22263213|NCT03259165|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
22263214|NCT03732833|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22263215|NCT05068661|Duke University School of Medicine|Dr. Ashraf Habib|9196682024|habib001@mc.duke.edu|
22263216|NCT01567527|Otsuka Pharmaceutical Development & Commercialization, Inc.|Joan Amatniek, Senior Director, Global Clinical Development|(609) 512-4464|joan.amatniek@otsuka-us.com|
22263217|NCT02004691|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22263218|NCT01726803|University of Utah|Julie Fritz|801-581-6861|julie.fritz@hsc.utah.edu|
22263219|NCT02805517|Loma Linda University Health|Dr. Duane Baldwin|909-588-4000|dbaldwin@llu.edu|44196
22263220|NCT03407729|Case Western Reserve University|Dr. Michael J. Decker|2163682467|mjd6@case.edu|
22263221|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com|
22263222|NCT04387617|Mayo Clinic|Karen L. Stern, M.D.|480-342-3868|Stern.Karen@mayo.edu|
22293416|NCT04015336|National Cancer Institute|Dr. Scott Norberg, D.O.|301-275-9668|scott.norberg@nih.gov|
22293417|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org|
22263223|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org|
22263224|NCT01863433|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22263225|NCT03950674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263226|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
22293418|NCT01603355|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
22293419|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22275138|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
22293420|NCT03921073|Moffitt Cancer Center|Dr. John Mullinax|813-745-1867|John.Mullinax@moffitt.org|
22293421|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22293422|NCT05981391|The University of Texas Health Science Center at San Antonio|Dr. John Moring|210-562-6716|moringj@uthscsa.edu|
22293423|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu|
22293424|NCT02653872|AstraZeneca AB|AZD7986 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22293425|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293426|NCT04873700|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22293427|NCT01281137|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
22293428|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
22293429|NCT03608254|The University of Alabama|Dr. Amy Ellis|2053488128|aellis@ches.ua.edu|
22293430|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293431|NCT03540030|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
22293432|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com|
22293433|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22293434|NCT03451578|Duke Eye Center|Dr. Sharon Fekrat|919-681-3937|sharon.fekrat@duke.edu|
22293435|NCT04729621|Teva Pharmaceuticals|US Medical Affairs|1-888-483-8279|usmedinfo@tevapharm.com|
22307387|NCT04110743|University of California Davis|Dr. Lorenzo Nardo|916-731-9004|lnardo@ucdavis.edu|
22307388|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22307389|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
22307390|NCT02665988|Houston Methodist Hospital|Dr. Alok Madan|832-930-1662|amadan@houstonmethodist.org|
22307391|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org|
22307392|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22307393|NCT01763970|SKCCC at Johns Hopkins|Matthew Ladra,MD|(202) 537-4788|mladra@jhmi.edu|
22307394|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com|
22307395|NCT05368831|NorthSea Therapeutics BV|CLIENT TO PROVIDE|31 035760 65 05|info@northseatherapeutics.com|
22307396|NCT05330234|Imperial College London|Mr Gianpaolo Fusari|--|g.fusari@imperial.ac.uk|
22307397|NCT03565315|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22307398|NCT03887650|Hartford Hospital|Dr. Kevin Finkel|860-972-1778|Kevin.Finkel@hhchealth.org|
22307399|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22307400|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
22307401|NCT04200365|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
22307402|NCT03942042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307403|NCT02101190|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22307404|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307405|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22307406|NCT02808585|PhaseBio|Dr. John Lee, Chief Medical Officer|6109816500|john.lee@PhaseBio.com|
22307407|NCT01849055|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307408|NCT01199575|University of California, San Diego|Thomas Kipps, MD PhD|858-534-5400|tkipps@ucsd.edu|
22307409|NCT00933400|American College of Radiology|Communications Director|215-574-3150|nfredericks@acr.org|
22307410|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov|
22307411|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114|stephen.borst@va.gov|5033
22307412|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu|
22307413|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
22307414|NCT01819883|Massachusetts General Hospital|Karen Miller|617-726-3870|KKMiller@MGH.Harvard.edu|
22307415|NCT02409667|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22307416|NCT01925339|University of Michigan|Dr. Hom-Lay Wang|734-763-3383|homlay@umich.edu|
22307417|NCT06630390|University of Rochester Medical Center|Mark Oldham|585-275-3592|mark_oldham@urmc.rochester.edu|
22307418|NCT03025789|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41795431713|ovalverde@dndi.org|
22307419|NCT03554265|University of Texas Medical Branch|Randall Urban, MD|409-772-5476|rurban@utmb.edu|
22307420|NCT02723955|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307421|NCT03657212|University of California, Irvine|Dr Sara Mednick|8589457904|mednicks@uci.edu|
22307422|NCT04999085|University of North Carolina Lineberger Comprehensive Cancer Center|Christopher E. Jensen, MD, MSCR|+1 984-987-1072|cejensen@med.unc.edu|
22307423|NCT05057897|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22307424|NCT04751526|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22293436|NCT03943160|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22293437|NCT02850601|BWH|Dr. Herve Sroussi|617 5256864|hsroussi@bwh.harvard.edu|
22263227|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263228|NCT03428945|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@yale.edu|
22263229|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22263230|NCT03231345|University Medical Center of Southern Nevada|Dr. Zitek|702-383-7885|zitek10@gmail.com|
22263231|NCT04841967|University of Illinois Chicago|Patricia Hershberger|3129961305|phersh@uic.edu|
22321152|NCT02192827|Johns Hopkins all childrens hospital|Meghan Martin|9417373107|mmart163@jhmi.edu|
22321153|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org|
22321154|NCT02459795|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22321155|NCT03259074|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22321156|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu|
22321157|NCT01722604|Bausch & Lomb|Daniel Donatello|(585) 338-5306|Daniel.Donatello@bausch.com|
22321158|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu|
22321159|NCT02017327|Laboratoires Thea|Director of medical operation|+473985089|J.auger@laboratoires-thea.fr|
22321160|NCT02153528|Institute of Tropical Medicine Antwerp|Clinical Trials Unit ITM|0032 32470778|jbuyze@itg.be|
22321161|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu|
22321162|NCT01298752|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22321163|NCT06290206|University of Utah|Kaila Christini, MsPH, MS|801-587-4565|Kaila.Christini@hci.utah.edu|
22321164|NCT00336973|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22321165|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321166|NCT03998046|Northwestern University|Ronald Ackermann, MD, MPH|(312)-503-3232|r.ackermann@northwestern.edu|
22321167|NCT02431572|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
22321168|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22321169|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22321170|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321171|NCT03610724|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22321172|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22321173|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com|
22321174|NCT03054922|Nationwide Children's Hospital|David P. Martin, MD|614-722-4200|david.martin@nationwidechildrens.org|
22321175|NCT01699542|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
22321176|NCT05513625|AiCuris Anti-infective Cures AG|Information Desk|+4920231763|info@aicuris.com|0
22321177|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu|
22321178|NCT02943564|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22321179|NCT00932360|University of Iowa|Dana Dailey|319-335-7149|dana-dailey@uiowa.edu|
22321180|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22321181|NCT00917150|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22321182|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu|
22321183|NCT04143009|University of North Carolina at Chapel Hill|Brian Wells Pence, PhD|+1 919-966-7446|bpence@unc.edu|
22321184|NCT03704142|University of Massachusetts Amherst Dept. of Communication Disorders|Dr. Karen Helfer|413-545-4014|khelfer@comdis.umass.edu|
22321185|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
22321186|NCT00781911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321187|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321188|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22321189|NCT03924752|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
22321190|NCT02012621|University of Colorado-AMC|Dr. Jose Castillo-Mancilla|303-724-4934|jose.castillo-mancilla@cuanschutz.edu|
22321191|NCT01445821|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22321192|NCT01624662|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
22321193|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov|
22321194|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu|
22321195|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu|
22321196|NCT01423851|NS Pharma, Inc.|Medical Affairs|201-986-3860|trialinfo@nspharma.com|+1
22321197|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu|
22321198|NCT03787472|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22321199|NCT02227693|Eisai Inc.|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
22321200|NCT01611974|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22321201|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org|
22321202|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22321203|NCT03699007|Stanford University Medical School|Dr. Laura Simons|(650) 736-0838|lesimons@stanford.edu|
22263232|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22263233|NCT02289820|MedImmune LLC|Judith Falloon, MD, FACP, FIDSA, Senior Director, Clinical Development|+1-301-398-4010|information.center@astrazeneca.com|
22321204|NCT01709435|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22321205|NCT01780662|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22293438|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu|
22293439|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22293440|NCT05004077|University of Kentucky|Dr. Kevin Hatton|859-218-0365|kevin.hatton@uky.edu|
22293441|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com|
22293442|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293443|NCT00134030|MRC Clinical Trials Unit at UCL|Prof Matt Sydes||mrcctu.euramos@ucl.ac.uk|
22293444|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293445|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22293446|NCT00601198|University of Cincinnati|Alison Kastl, Director of Clinical Trials|813-584-0436|kastla@ucmail.uc.edu|
22293447|NCT02358681|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
22293448|NCT02059408|University of California, San Francisco|Carmen Peralta, Professor of Medicine|415-221-4810|carmenalicia.peralta@ucsf.edu|23678
22275139|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040||2917
22275140|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
22275141|NCT02879032|Bangabandhu Sheikh Mujib Medical University|Dr. Md. Mashiul Alam|+8801724490475|mashiull@gmail.com|
22275142|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com|
22275143|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22275144|NCT01027845|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275145|NCT01281306|Novartis|Study Director|862-778-8300||
22275146|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200|kranzler_h@mail.trc.upenn.edu|137
22275147|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000||
22275148|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22275149|NCT03466346|University of California San Francisco|Susan Meffert MD, MPH; Professor of Psychiatry; MPI|4158765455|susan.meffert@ucsf.edu|
22275150|NCT03072550|DeviceFarm|Jeffrey N Roe|925-895-1584|jeffnroe1@devicefarmtech.com|
22275151|NCT02410629|University of California Irvine|Dr An Do|(714) 456-2332|and@uci.edu|
22293449|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com|
22293450|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com|
22293451|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu|
22293452|NCT04223973|Medtrum France|Mrs Melanie MARMOUNIER-WILHLEM- Commercial DIrector|+33620591224|melanie.marmounier@medtrum.com|
22293453|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu|
22293454|NCT04266769|LightForce Orthodontics|Kelsey Fafara|7329775646|kelsey@lightforceortho.com|
22293455|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300||
22293456|NCT03630042|Oxford University Hospital NHS Trust|Jaimal Kothari|NA|Jaimal.Kothari@ouh.nhs.uk|
22293457|NCT00394147|University of Maryland|Dr. Ranee Mehra|410-328-7904|rmehra@umd.edu|
22293458|NCT02423772|Queen's University of Belfast|Kevin Vowles|+44 (0)28 9097 5445|k.vowles@qub.ac.uk|
22293459|NCT01193842|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
22293460|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com|
22293461|NCT06238362|SleepRes|Bernard Hete|+1 615-921-2406|bhete@sleepres.com|
22293462|NCT02637622|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
22293463|NCT04638400|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
22293464|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
22293465|NCT01995825|U of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22293466|NCT01367002|Yale School of Medicine|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
22293467|NCT03243071|NYU Langoen Health|Girardin Jean-Louis, PhD|646-501-3431|Girardin.Jean-Louis@nyulangone.org|
22293468|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22293469|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu|
22293470|NCT02840097|University of California, Davis|Daniel Nishijima, Study Co-PI|916.734.3884|dnishijima@ucdavis.edu|
22293471|NCT03094169|Formation Biologics|Sandra Sinclair|8326221699|sandra@forbius.com|
22293472|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22293473|NCT02758132|University of Hawaii Cancer Center|Stacy Mercado|8084404561|smercado@cc.hawaii.edu|
22293474|NCT05350410|Alzheimer's Disease Cooperative Study|Sara Moukarzel, PhD, Program Manager|(858) 432-8828|smoukarzel@health.ucsd.edu|
22293475|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22293476|NCT03750955|University of Washington|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
22293477|NCT02050841|Octapharma|Michael Eppolito|2016041155|michael.eppolito@octapharma.com|
22293478|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
22293479|NCT01479478|Stanford University|Dr. Natali Aziz, MD|650-725-5720|mfmresearch@stanford.edu|
22293480|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org|
22293481|NCT02432742|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22293482|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org|
22293483|NCT00689078|ORA|Paul Gomes|9786858900|pgomes@oraclinical.com|
22293484|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com|
22263234|NCT02005276|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
22263235|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
22263236|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300||
22263237|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu|
22263238|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263239|NCT01912807|University of Saskatchewan|Andrea Vasquez Camargo|306 7660444|a.vasquez@usask.ca|
22263240|NCT04750239|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
22263241|NCT02179788|University of Cincinnati|Dr. Laurie Nommsen-Rivers|513-558-0461|laurie.rivers@uc.edu|
22263242|NCT00834613|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22263243|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22263244|NCT00840840|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22263245|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22263246|NCT04584983|The University of Texas Health Science Center at Houston|Lindsay F Holzapfel, MD, MS|713-500-6422|Lindsay.N.Fleig@uth.tmc.edu|
22263247|NCT02061358|Emergent BioSolutions|Clinical Development Representative||ctgov@ebsi.com|
22263248|NCT03093025|Taisho Pharmaceutical R&D Inc.|Taisho Pharmaceutical R&D Inc. Study Director|800-602-0203|ClinicalTrials@taisho-rd.com|
22263249|NCT01800838|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Elma Baron|216-368-4971|elma.baron@uhhospitals.org|
22263250|NCT05186415|Nemours Children's Hospital, Delaware|Shannon Nees, MD|302-651-6600|shannon.nees@nemours.org|
22263251|NCT03403439|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263252|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov|
22263253|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu|
22263254|NCT05113563|NYSPI|Diana Martinez|646-771-7774|dm437@cumc.columbia.edu|
22263255|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com|
22263256|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263257|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
22263258|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22263259|NCT05061992|University of Michigan|Dr. Elliot Tapper|734-647-9252|etapper@med.umich.edu|
22263260|NCT01833754|Amgen Inc.|Study Director|866-572-6436||
22263261|NCT02153723|Montefiore Medical Center|Aleksandra Djukic|718 920 4378|adjukic@montefiore.org|
22263262|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org|
22263263|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu|
22263264|NCT03033134|Boston Scientific Japan|Yutaka Gomi|+81.3.6853.7500|Yutaka.Gomi@bsci.com|
22263265|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au|
22263266|NCT02509260|Cleveland Clinic Foundation|Dr. David Liska|1-216-444-9219|liskad@ccf.org|
22263267|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
22263268|NCT00964353|University of Chicago|Dr David Meltzer|773-702-0836|dmeltzer@medicine.bsd.uchicago.edu|
22263269|NCT01876953|City of Hope Medical Center|Ahmed Aribi|626-359-8111|aaribi@coh.org|
22263270|NCT05996198|NYU Langone Health|Heidi Schambra, MD|212-598-6000|Heidi.Schambra@nyulangone.org|
22263271|NCT03542344|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263272|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu|
22307426|NCT04656925|Washington State University|Abigail Bowen|(425) 736-1354|abigail.bowen@wsu.edu|
22307427|NCT04540913|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
22307428|NCT04440176|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307429|NCT04188379|argenx BV|Regulatory Manager|+32 9 310 3400|regulatory@argenx.com|
22307430|NCT05288283|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22307431|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22307432|NCT01164098|University of Miami|George W. Burke, M.D.|3053555315|gburke@med.miami.edu|
22307433|NCT03990649|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22307434|NCT03050814|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|julius.strauss@nih.gov|
22307435|NCT04759833|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22307436|NCT00508924|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307437|NCT00630058|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307438|NCT04079972|Dongguk University|Dr.NaNa Keum|+82 10-6793-6654|nak212@mail.harvard.edu|
22307439|NCT02168400|University of Minnesota|Jazmin Camchong|(612) 625-3330|camch002@umn.edu|
22263273|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
22289179|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
22293485|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22293486|NCT01030536|MedImmune LLC, Milstein Building, Granta Park, Cambridge, CB21 6GH, United Kingdom|Edward Bradley, MD|+44 (0)1223 895997||
22293487|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu|
22293488|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293489|NCT03345914|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22293490|NCT01550731|Veterans Administration|Dr. Rebecca Sudore|(415) 221-4810|Rebecca.Sudore@va.gov|23475
22293491|NCT02601027|Stanford University|Gordon Kwanlyp Lee, Professor of Surgery (Plastic and Reconstructive Surgery)|650-723-5824|glee@stanford.edu|
22293492|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu|
22293493|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22263274|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu|
22293494|NCT02577549|Wake Forest University|Dr. Stephen Messier|336-758-5849|messier@wfu.edu|
22307440|NCT02706717|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22263275|NCT01358877|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263276|NCT02518139|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22263277|NCT02429583|The Rockefeller University|Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
22263278|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22263279|NCT02564016|Medical University of South Carolina|Laura L Roberts MD, Assistant Professor|843 792 2322|roberll@musc.edu|
22263280|NCT00751023|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
22263281|NCT01742208|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22263282|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu|
22263283|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com|
22263284|NCT02707276|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
22263285|NCT03448692|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263286|NCT03711396|University of Colorado School of Medicine|Dr. Hillary D. Lum|303-724-1911|hillary.lum@cuanschutz.edu|
22263287|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263288|NCT01801917|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22263289|NCT01924364|University of Pittsburgh Plastic Surgery|Danielle Minteer|412-383-4804|minteerdm@upmc.edu|
22263290|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623||
22263291|NCT03919695|San Diego State University|Assist. Vice President Research Support Services|619-594-5938|rgulizia@sdsu.edu|
22263292|NCT01706263|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263293|NCT02416934|West Virginia University Department of Orthopaedics|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
22263294|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263295|NCT03061903|Columbia University|Roshan P. Shah, MD|212-305-8193|rs3464@cumc.columbia.edu|
22263296|NCT03490227|Pennington Biomedical Research Center|Dr. Leanne Redman|225-763-0947|leanne.redman@pbrc.edu|
22263297|NCT02614196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22263298|NCT01539239|Ivantis|Richard Hope|949-333-1310|rhope@ivantisinc.com|
22263299|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com|
22263300|NCT02282722|Dana-Farber Cancer Institute|Dr. Deb Schrag|617-582-8301|deb_schrag@dfci.harvard.edu|
22263301|NCT00633022|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275152|NCT00087178|NRG Oncololgy|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22275153|NCT03451045|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
22275154|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22275155|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275156|NCT03040726|The University of Texas MD Anderson Cancer Center|Dr. David Hui|(713) 792-6258|dhui@mdanderson.org|
22275157|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
22275158|NCT05063448|Colorado State University|Dr. Stephanie Rayburn|970-988-6306|Stephanie.Rayburn@colostate.edu|
22275159|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
22275160|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be|
22275161|NCT03641508|University of Iowa|Dr. Ericka Lawler|3193563943|ericka-lawler@uiowa.edu|
22275162|NCT00094445|University of Texas (UT) MD Anderson Cancer Center|Vivek Subbiah, MD / Assistant Professor, Investigational Cancer Therapeutics|713-563-0393|CR_Study_Registration@mdanderson.org|
22275163|NCT02717195|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22275164|NCT02078817|University of Minnesota|Katherine Cullen|612-273-9732|rega0026@umn.edu|
22275165|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282|m.shedden@staff.uni-marburg.de|3657
22275166|NCT01773928|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22307441|NCT03833661|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22307442|NCT02121002|Amneal Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amneal.com|
22307443|NCT02590432|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22263302|NCT00987480|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
22263303|NCT03382041|The University of Alabama at Birmingham (UAB)|Dr. Clay Spitler|205-934-6413|caspitler@uabmc.edu|
22263304|NCT00789776|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22263305|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22263306|NCT01337596|Eli Lilly Company|Chief Medical Officer|1-800-545-5979||
22263307|NCT04640194|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263308|NCT02946255|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22263309|NCT03201003|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22263310|NCT01994980|Denver Health|Dr Fredric Pieracci|303-436-4029|Fredric.Pieracci@dhha.org|
22263311|NCT03646162|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
22263312|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300||
22263313|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
22263314|NCT04771286|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263315|NCT06891729|Next Life Sciences|Darlene Walley|415-407-5229|darlene.walley@nextlifesciences.org|
22263316|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600||
22263317|NCT05377489|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|
22263318|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com|
22263319|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn|
22263320|NCT05590039|Cynosure|Jamie Trimper|(201) 479-9612|jamie.trimper@cynosure.com|
22263321|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263322|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263323|NCT02031237|University of Michigan Comprehensive Cancer Center|Dr. Yue Cao|(734) 936-8695|yuecao@umich.edu|
22263324|NCT02293460|LFB Biotechnologies|Clinical trial information desk|0033169827010|supportqcm@lfb.fr|
22263325|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com|
22263326|NCT04225260|Galderma Research & Development|Galderma Research & Development|817-961-5000|clinical.studies@galderma.com|
22263327|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22263328|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22263329|NCT02805309|Hebrew SeniorLife Marcus Institute for Aging Research|Dr. Dae Hyun Kim, Associate Scientist|617-632-5362|daehyunkim@hsl.harvard.edu|
22263330|NCT01636934|UT MD Anderson Cancer Center|Zhongxing Liao, MD/ Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
22263331|NCT03239496|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
22263332|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu|
22263333|NCT02339415|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
22307444|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22307445|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu|
22307446|NCT04788641|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22307447|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com|
22307448|NCT04247074|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
22307449|NCT03951805|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22307450|NCT03337399|Massachusetts General Hospital/Harvard Medical School|Jennifer Temel|617-724-4000|jtemel@mgh.harvard.edu|
22307451|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu|
22307452|NCT02528188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307453|NCT02299375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307454|NCT03799783|University Hospital Padova|Angela Amigoni, MD|339 8333765|Angela.amigoni@aopd.veneto.it|++39
22307455|NCT03226899|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
22307456|NCT02047981|UCSF F.I. Proctor Foundation|Ying Lin|4155144709|ying.lin@ucsf.edu|
22307457|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307458|NCT03276871|Cleveland Clinic|Aldo Fafaj|2162195943|fafaja@ccf.org|
22307459|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307460|NCT02178098|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22307461|NCT02701257|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
22307462|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307463|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu|
22307464|NCT01205048|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22307465|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl|
22307466|NCT02515305|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22307467|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu|
22307468|NCT02960204|Histogen Inc.|Mark Hubka, Executive Director, Medical Affairs|858-526-3109|mhubka@histogen.com|
22307469|NCT03087708|VA Long Beach Health Care System|Dr. Pankaj Gupta|562-826-8000|pankaj.gupta@va.gov|
22307470|NCT01827787|Dana-Farber Cancer Institute|Dr. Erica Mayer|617-632-2335|Erica_Mayer@dfci.harvard.edu|
22263334|NCT03035890|WVCTSI|Tara Riddle|304-581-1829|tlr0011@hsc.wvu.edu|
22307471|NCT02769858|University of Michigan|Dr. Leslie Swanson|734-239-2248|LMSwan@med.umich.edu|
22307472|NCT04939246|Miami Cancer Institute at Baptist Health, Inc.|Director, Concept Development & Data Management|(786) 527-9546|mciresearchconceptandprotocoldev@baptisthealth.net|
22321206|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu|
22321207|NCT03975920|The Restful Jaw Company, LLC|Dr. Eric Schiffman|(651)338-3344|schif001@umn.edu|
22321208|NCT03882970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22321209|NCT02863809|Massachusetts Eye and Ear|Odeta Dyrmishi & Joseph Ciolino|7742745014|Odeta_Dyrmishi@meei.harvard.edu; Joseph_Ciolino@meei.harvard.edu|
22321210|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22321211|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22321212|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321213|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net|
22321214|NCT04839380|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22321215|NCT00713427|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
22321216|NCT01923129|Cedars Sinai Medical Center|Dr. Phillip Fleshner|(310) 289-9224|Phillip.Fleshner@cshs.org|
22321217|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu|
22321218|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com|
22321219|NCT02189213|RFMH|Amir Levine|646 481 2566|amir.levine@nyspi.columbia.edu|
22321220|NCT03775421|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22321221|NCT02445807|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
22321222|NCT01227044|Yale School of Medicine|Dr. Lynn Fiellin|203-737-3347|lynn.fiellin@yale.edu|
22321223|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu|
22321224|NCT04247061|Boston University|Director of Center for Behavioral Science Research|6173583358|belindab@bu.edu|
22321225|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu|
22321226|NCT01997411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321227|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp|
22321228|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com|
22321229|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org|
22321230|NCT02870309|Grifols Therapeutics LLC|Susan Sorrells|919-316-6582|susan.sorrells@grifols.com|
22321231|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22321232|NCT04901481|TheraNova, LLC|Director of Clinical|4159268616|clinicalstudy@theranova.com|
22321233|NCT02739620|University of Vermont|Michael J. Toth|802-656-7989|michael.toth@med.uvm.edu|
22321234|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com|
22321235|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com|
22321236|NCT02218242|University of Kentucky|Angela Mahan|859 257 4488|angela.mahan@uky.edu|
22321237|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22321238|NCT04341441|Henry Ford Health System|John McKinnon, MD, MSc|313-916-8828|jmckinn3@hfhs.org|
22321239|NCT02039375|Johns Hopkins University School of Medicine|Victor C. Urrutia, MD|4109552228|vurruti1@jhmi.edu|
22321240|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62736
22321241|NCT03891264|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@partners.org|
22321242|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com|
22321243|NCT03765138|Columbia University Medical Center/New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|Yuval.Neria@nyspi.columbia.edu|
22321244|NCT05003622|Pierre Fabre Medicament|Jean Claude Vedovato|+33 609828746|jean.claude.vedovato@pierre-fabre.com|
22263335|NCT00003404|Dartmouth Hitchcock Medical Center|Richard J. Barth Jr., MD|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
22263336|NCT04578132|An organization designated by the Sponsor|A person designated by the Sponsor|+34934344412|investigacion@mfar.net|
22263337|NCT05480800|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263338|NCT04632641|Aurora Health Care|Dr. Mahmoud Ali|(262) 948-6630|mahmoud.ali@aah.org|
22263339|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
22263340|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu|
22263341|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
22263342|NCT01802216|University of California, San Francisco|Dr. Vanessa Grubbs|415-206-5649|Vanessa.Grubbs@ucsf.edu|
22263343|NCT02459418|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
22263344|NCT03978598|UNM Obstetrics & Gynecology|Family Planning Research Team|505-205-4118|HSC-FamilyPlanningResearch@salud.unm.edu|
22263345|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400||
22263346|NCT02814708|Biomedizinische Forschung & Bio-Produkte AG|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
22263347|NCT02786719|Baylor College of Medicine|Sarah Whittle, MD MS|8328241471|whittle@bcm.edu|
22263348|NCT03303417|University of Nottingham|Robin Spiller|0115 823 1090|robin.spiller@nottingham.ac.uk|
22263349|NCT02697617|Indiana University School of Medicine|Dr. Sharon Moe|317 278 2868|smoe@iu.edu|
22263350|NCT01578317|NIH|John Tsang|301-496-0304|tsangjs@mail.nih.gov|
22321245|NCT01692275|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|LONG_C@palmer.edu|
22321246|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com|
22263351|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22321247|NCT03921021|Weill Cornell Medicine|Manish Shah, MD|(646) 962-6200|mas9313@med.cornell.edu|
22307473|NCT01853748|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22307474|NCT06050083|University of Washington|Dr. Mark Jensen, PhD, Principal Investigator|+1 206 543-3185|mjensen@uw.edu|
22307475|NCT00780416|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307476|NCT02916706|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22307477|NCT03845829|Department of Vascular Surgery, Shanghai Ninth People's Hospital|Kaichuang Ye|+86-021-2327166|ykaichuang@163.com|
22307478|NCT03088813|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
22307479|NCT02152137|Mayo Clinic|Robert C. Smallridge, M.D.|904-953-2392|smallridge.robert@mayo.edu|
22307480|NCT04878354|ALK-Abelló A/S|Senior Director, Clinical Data Science|+4545747576|clinicaltrials@alk.net|
22307481|NCT03599648|University of Oregon|Dr. Laura Lee McIntyre|541-346-7452|llmcinty@uoregon.edu|
22307482|NCT03363854|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
22307483|NCT02217904|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307484|NCT00977691|National Heart Lung and Blood Institute|Courtney Fitzhugh, MD, Investigator|+1 301 402 6496|courtney.fitzhugh@nih.gov|
22307485|NCT01903811|SWOG Statistical Center|S1304 Statistician|2066674623|rachaels@crab.org|
22307486|NCT05613205|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307487|NCT02118961|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml.JP@ml.tanabe-pharma.com/clinicaldevelopment@mail.biken.or.jp|
22307488|NCT03103321|Mayo Clinic|Jon C. Tilburt, MD|5072661105|tilburt.jon@mayo.edu|
22307489|NCT03043599|H Lee Moffitt Cancer Center & Research Institute|Bradford Perez, MD|813-745-8234|Bradford.Perez@moffitt.org|
22307490|NCT05332340|Biozeus Biopharmaceutical S.A.|Joaquim Herzog de Oliveira Knox|+55 (21) 25239089|joaquim.knox@biozeus.com.br|
22307491|NCT03602014|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22307492|NCT05406258|Shirley Ryan AbilityLab|Dr. Megan O'Brien, PhD|312-238-2289|mobrien02@sralab.org|
22263352|NCT02315261|Faculty of Medicine Siriraj Hospital|Dr.Mingkwan Wongyingsinn|66824197995|minkcheerful@hotmail.com|81
22263353|NCT05661344|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263354|NCT05212948|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22263355|NCT05347693|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22263356|NCT03167606|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
22263357|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300||
22263358|NCT01884844|Department of Psychiatry, Universtity of Massachusetts|Director of the Bipolar Disorders Specialty Clinic|508-334-5052|wendy.marsh@umassmemorial.org|
22263359|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu|
22263360|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
22263361|NCT01755975|Memorial Sloan Kettering Cancer Center|Dr. Steven Horwitz, MD|646-608-2680|horwitzs@mskcc.org|
22263362|NCT03653026|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22263363|NCT05560555|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263364|NCT02104817|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22263365|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22263366|NCT01312181|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
22263367|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat|
22263368|NCT02167594|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22263369|NCT02340780|Canadian Cancer Trials Group|Bingshu Chen|613-533-2430|bchen@ctg.queensu.ca|
22263370|NCT03433703|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22263371|NCT03971578|Intelligent Hearing Systems|Dr. Rafael E. Delgado, Director of Research & Development|305-668-6102|redelgado@ihsys.com|
22263372|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263373|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263374|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com|
22263375|NCT02985398|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22263376|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu|
22263377|NCT04768114|Washington University School of Medicine|Alex T. Ramsey, Ph.D.|314-362-5370|aramsey@wustl.edu|
22307493|NCT02992925|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com, clinicaldevelopment@mail.biken.or.jp|
22307494|NCT05678998|Werewolf Therapeutics|Werewolf Study Director|617-675-1865|clinicaltrials@werewolftx.com|
22307495|NCT05773313|Mayo Clinic|Nathan Delafield, M.D.|480-574-1920|Delafield.Nathan@mayo.edu|
22307496|NCT05137236|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22263378|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com|
22263379|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307497|NCT01534494|New York University Grossman School of Medicine|Michael Bogenschutz|5059999325|Michael.Bogenschutz@nyulangone.org|
22307498|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307499|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com|
22307500|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il|
22307501|NCT02880137|Mayo Clinic|Dr. Jonathan Johnson|507-255-7013|johnson.jonathan@mayo.edu|
22307502|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
22307503|NCT04071756|Dana-Farber Cancer Institute|Nicole LeBoeuf, MD, MPH|617-632-6571|nicole_leboeuf@dfci.harvard.edu|
22307504|NCT03567252|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
22307505|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com|
22307506|NCT01939899|Millennium Pharmaceuticals, Inc.|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
22307507|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu|
22307508|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22307509|NCT02015520|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22307510|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu|
22307511|NCT03285542|Cleveland Clinic|Viktor Krebs|216-445-3843|krebsv@ccf.org|
22307512|NCT01854385|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
22307513|NCT02932579|University of Rochester Eastman Institute for Oral Health|Yanfang Ren, Professor|5852735588|yanfang_ren@urmc.rochester.edu|
22307514|NCT04059042|University of Kansas Medical Center|Dr. Rebecca Lepping|913-588-0287|rlepping@kumc.edu|
22307515|NCT00335036|Children's National|Charles Berul, MD|202-476-5710|cberul@childrensnational.org|
22307516|NCT00415519|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307517|NCT04163718|Moffitt Cancer Center|Javier Pinilla, MD, PhD|813-745-8212|javier.pinilla@moffitt.org|
22307518|NCT05608564|School Of Dental Medicine, University Of Belgrade, Department of Periodontology and Oral Medicine|Assistant Professor Dr. Iva Milinkovic|+381642041811|iva.milinkovic@gmail.com|
22307519|NCT01985334|Novartis Pharmaceuticals|Study Director|862-778-8300||
22307520|NCT00093015|Amgen Inc.|Study Director|866-572-6436||
22307521|NCT04872738|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|617-724-0127|cbrunelle@mgh.harvard.edu|
22307522|NCT04191499|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22307523|NCT03501264|University of Pittsburgh, Graduate School of Public Health|James Egan|412-624-2255|jee48@pitt.edu|
22307524|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307525|NCT02253537|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22307526|NCT05524454|Varian Medical Systems|Sean Davidson|437-991-8294|sean.davidson@varian.com|
22307527|NCT05999435|Laurent Pharmaceuticals Inc.|Vice President Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
22307528|NCT05082116|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22307529|NCT01468584|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307530|NCT03811535|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22307531|NCT05364684|Massachusetts General Hospital|Dr. Laura E. Dichtel|6177263870|ldichtel@mgh.harvard.edu|
22307532|NCT00781274|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307533|NCT05675046|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
22307534|NCT00603954|CHU de Liège|Dr. Frédéric Baron|003243667201|f.baron@ulg.ac.be|
22307535|NCT04705480|Charleston Area Medical Center|Nancy Duvall|304-388-3653|nancy.duvall@vandaliahealth.org|
22307536|NCT04970654|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22307537|NCT03350542|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
22307538|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22307539|NCT01996605|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
22307540|NCT03546608|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22307541|NCT04992390|P1vital Products Ltd|Dr Amy Beckenstrom|+44(0)1865 522 030|abeckenstrom@p1vital.com|
22307542|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
22307543|NCT03358875|BeiGene|Study Director|1-877-828-5568|Clinicaltrials@beigene.com|
22307544|NCT06375421|Vanderbilt University Medical Center|Dr. Emily Morrow|6153228392|emily.morrow@vumc.org|
22307545|NCT03702725|Dana Farber Cancer Institute|Dr. Jacob P. Laubach|617-632-4218|jacobp_laubach@dfci.harvard.edu|
22321248|NCT04473690|KBio Inc|Katrina Whelan|2706893345|katrinaw@KBio.com|
22321249|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743||
22263380|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com|
22321250|NCT02899689|UTMB|Antonio F Saad|4097720982|afsaad@utmb.edu|
22321251|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu|
22307546|NCT06839378|Tsinghua Changgung Hospital|Yan Li, Director of the Department of Peritoneal Oncology|+86 18612709123|lya03816@btch.edu.cn|
22307547|NCT05760313|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22307548|NCT00956007|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22307549|NCT05228470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321252|NCT01439555|UMass Medical School|Elizabeth DeGrush, DO|508-334-1000|elizabeth.degrush@umassmemorial.org|
22263381|NCT03828539|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22263382|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it|
22263383|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu|
22263384|NCT05467540|AORN Cardarelli|Dr. Prof. Mario Muto|+39800019774|mutomar2@gmail.com|
22263385|NCT04315272|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
22263386|NCT06107036|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22263387|NCT00804999|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
22263388|NCT01841736|UCSF Helen Diller Family Comprehensive Cancer Center|Emily Bergsland, M.D.|415-353-9888|emily.bergsland@ucsf.edu|
22263389|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu|
22263390|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22263391|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22263392|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu|
22263393|NCT02824640|Prisma Health|Megan Groome|864-382-1023|megan.groome@primsahealth.org|
22263394|NCT01504711|Barbara Ann Karmanos Cancer Institute|Dr. Philip A. Philip, M.D., Ph.D., F.R.C.P|(313)576-8624|philipp@karmanos.org|
22263395|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu|
22263396|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263397|NCT01775722|University of California, Irvine. Beckamn Laser Institute|J Stuart Nelson|9498247997|jsnelson@uci.edu|
22263398|NCT04501094|National Cancer Institute|Dr. Andrea B. Apolo|301-480-0536|andrea.apolo@nih.gov|
22263399|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22263400|NCT05693805|BUCA School of Medicine, Psychiatry; Boston Veterans Administration|Barbara L Niles, PhD|857-364-4128|barbara.niles@va.gov|
22263401|NCT02943993|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22307550|NCT03885037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307551|NCT01492686|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307552|NCT05428332|Stanford University|Allen Seo|9254939732|allenseo@stanford.edu|
22307553|NCT03314987|University of Louisville|Dr. Timothy O'Toole Associate Professor|15024190808|tim.otoole@louisville.edu|
22307554|NCT05552963|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22307555|NCT06511076|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22307556|NCT05529979|quantum surgical|MESSNER Laetitia, Chief Clinical officer|0448194050|clinical.department@quantumsurgical.com|
22307557|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
22307558|NCT03403413|Loui9s Stokes Cleveland VAMC|Dr. Stephen Selkirk|440-552-0493|stephen.selkirk@va.gov|
22307559|NCT02924064|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22307560|NCT05054725|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-01@revmed.com|
22307561|NCT03674411|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|(612) 626-5654|macmi002@umn.edu|
22307562|NCT04982315|Kaiser Permanente Washington|Andrea Cook, PhD - Principal Investigator|206-287-4257|andrea.j.cook@kp.org|
22307563|NCT00780910|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307564|NCT01753557|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307565|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu|
22307566|NCT05018910|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
22307567|NCT02346526|Massachusetts General Hospital|Philip Saylor, MD|617-724-5197|psaylor@mgh.harvard.edu|
22307568|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307569|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu|
22307570|NCT00861692|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307571|NCT06429163|Saint-Petersburg State University|Nikita S. Kharlov|+7 926 283-93-77|nikita.kharlov@gmail.com|
22307572|NCT04929483|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-122@89bio.com|
22307573|NCT01626885|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307574|NCT05914519|faculty of medicine sohag university|Ahmed Sabri mahmoud|201061691091|sabriahmed188@gmail.com|
22307575|NCT04395222|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
22307576|NCT04083781|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22307577|NCT01143337|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307578|NCT01466192|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307579|NCT05600283|Mayo Clinic|Dr. Kathy MacLaughlin|507-266-4648|maclaughlin.kathy@mayo.edu|
22307580|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623||
22307581|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu|
22307582|NCT02468128|Lumosa Theapeutics|Director of clinical Division|+886 2 26557918|June_Kuo@lumosa.com.tw|5702
22307583|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
22307584|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr|
22307585|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu|
22307586|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu|
22263402|NCT02510261|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22263403|NCT05431777|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22263404|NCT02003222|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22263405|NCT03760003|ABIVAX|Fabio Cataldi|+33 (0) 1 53 83 08 41|clinicaltrials@abivax.com|
22263406|NCT04941768|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22263407|NCT01737619|M.D. Anderson Cancer Center|Pamela Soliman, MD|713-745-2352|psoliman@mdanderson.org|
22263408|NCT03302078|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263409|NCT01886872|Ohio State University|Jennifer Woyach, MD|614-685-5667|jennifer.woyach@osumc.edu|
22263410|NCT05148299|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|medical.info@sobi.com|
22263411|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447|ravit@motusgi.com|203
22263412|NCT01957150|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263413|NCT01856192|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22263414|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012||
22263415|NCT03422068|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263416|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de|
22263417|NCT01841073|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22263418|NCT02858037|International Partnership for Microbicides|Dr John Steytler|+27 21 860 2300|jsteytler@ipmglobal.org|
22263419|NCT04404907|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
22307587|NCT02321514|Abbott|Karine Miquel, PhD|+32 479 600 107|karine.miquel@abbott.com|
22307588|NCT00621296|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307589|NCT04166058|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22307590|NCT02998528|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22307591|NCT00591214|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307592|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22307593|NCT03359889|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307594|NCT01753570|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307595|NCT05308316|Masonic Cancer Center|Dr. Irina Stepanov|612-624-4998|stepa011@umn.edu|
22307596|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu|
22307597|NCT03188692|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com, clinicaldevelopment@mail.biken.or.jp|
22307598|NCT03997916|University Hospitals Cleveland Medical Center|Eric Yeh, MD|216-844-1867|eric.yeh@uhhospitals.org|
22307599|NCT03671811|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
22307600|NCT04220229|City of Hope|Lee Cranmer, MD, PhD|626-256-4673|lcranmer@coh.org|
22307601|NCT06938230|University of Miami|Dr. Lisa Gwynn|305-243-3440|LGwynn@med.miami.edu|
22307602|NCT05096819|Oxford University Hospitals|Dr Elizabeth Orchard|01865 741166|elizabeth.orchard@ouh.nhs.uk|
22307603|NCT03324984|Montefiore Medical Center|Dr. Elilary Montilla Medrano|929-263-3302|emontill@montefiore.org|
22307604|NCT04541043|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
22307605|NCT04898023|University of Missouri Healthcare|Ryan Camden|(575) 882-4141|camdenr@health.missouri.edu|
22307606|NCT01563341|Mayo Clinic|Ryan J. Uitti, MD|904-953-2000|uitti.ryan@mayo.edu|
22307607|NCT04337372|University of Florida|Lisa Scott|352-273-2125|lscott@ufl.edu|
22307608|NCT03494504|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22307609|NCT04832360|University of Georgia|Dr. Michelle vanDellen|706-542-8991|mvd@uga.edu|
22307610|NCT05273723|Northwell Health|Karina Davidson|(516) 562-3467|kdavidson2@northwell.edu|
22307611|NCT03584516|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22307612|NCT04500301|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
22307613|NCT05846646|ImmuneSensor Therapeutics, Inc.|Patrick Widhelm, Senior Director Clinical Operations and Project Management|830-730-8176|pwidhelm@immunesensor.com|
22307614|NCT00003042|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22307615|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22307616|NCT02014129|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307617|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com|
22307618|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307619|NCT02461628|Duke University|Wendy O'Meara, PhD|16099103091|wpo@duke.edu|
22307620|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
22307621|NCT03399604|Liquidia Technologies|Chief Medical Offier|919-328-4400|safety@liquidia.com|
22307622|NCT02462759|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22307623|NCT00570700|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22307624|NCT02410018|IMBiotechnologies Ltd|President|780-945-6609|mstewart@tbwifi.ca|
22321253|NCT03310450|Universitas Negeri Semarang|Mahalul Azam|+628122853982|mahalul.azam@mail.unnes.ac.id|
22307625|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org|
22321254|NCT01290874|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
22307626|NCT02088853|Göteborgs University|Professor Lars Fandriks|+46313424123|lars.fandriks@gastro.gu.se|
22307627|NCT02131597|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/ Professor|713-745-3428|ggarciam@mdanderson.org|
22307628|NCT03351699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307629|NCT04704284|Mayo Clinic|Julie Guerin, M.D.|507-293-3698|Guerin.Julie@mayo.edu|
22263420|NCT01653405|Rand Corporation|Dr. Adam Rose|617-338-2059|arose@rand.org|8672
22263421|NCT03174158|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@partners.org|
22263422|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com|
22263423|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu|
22263424|NCT04320745|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22263425|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com|
22263426|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22263427|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110||
22263428|NCT01181596|University of California - San Diego|Jae Kim, MD|619-543-3759|neojae@ucsd.edu|
22263429|NCT01176981|Hospital for Sick Children|Dr. Abha Gupta|14168137744|abha.gupta@sickkids.ca|
22263430|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu|
22263431|NCT01685008|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
22263432|NCT01321177|Northwell Health|Patricia Marcy|347-439-8035|pmarcy@northwell.edu|
22263433|NCT03720704|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
22263434|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263435|NCT02340962|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7020|lwchang@taigenbiotech.com|1227
22263436|NCT04994431|UMass Memorial Health Care|Feiran Lou|5083348996|feiran.lou@umassmemorial.org|
22263437|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400|ogarrieta@gmail.com|832
22263438|NCT01341405|CrystalGenomics, Inc|Sang-Yoon Lee, M.D.|82-31-628-2871|sang-yoon.lee@cgxinc.com|
22263439|NCT02760433|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
22263440|NCT02151149|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22263441|NCT04721145|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
22263442|NCT05653362|Indiana University School of Medicine|Claire Edelman|3176509107|ceedelma@iu.edu|
22263443|NCT03419962|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263444|NCT03439085|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, Chief Patient Experience Ofc, Ofc of Chief Operating Officer|(713) 792-9599|mfrumovitz@mdanderson.org|
22263445|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22263446|NCT04720547|Wayne State University|Dr. Abdulghani Sankari|313-576-3548|atarbich@med.wayne.edu|
22263447|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org|
22263448|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263449|NCT03833427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22263450|NCT00176891|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|(612) 626-2313|orcha001@umn.edu|
22263451|NCT01499160|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22263452|NCT01438476|UT MD Anderson Cancer Center|Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology|713- 792-2022|jvauthey@mdanderson.org|
22263453|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22263454|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22263455|NCT03294317|Medtronic CRM Clinical|Nonye Harcourt|6122421785|nonye.o.harcourt@medtronic.com|
22263456|NCT03847974|LIB Therapeutics|Evan A Stein MD PhD FACC|18596533141|estein@libtherapeutics.com|
22263457|NCT02911935|Washington University School of Medicine.|Dr. Avraham Beigelman|314-454-2694|beigelmana@wustl.edu|
22263458|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263459|NCT04979858|Georgia Institute of Technology|Dr. Sundaresan Jayaraman|404.894.2461|sundaresan.jayaraman@gatech.edu|
22263460|NCT04253236|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22263461|NCT01896505|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22263462|NCT02063217|Washington University School of Medicine|Dr. Brendan Lucey|314-362-4342|luceyb@wustl.edu|
22263463|NCT04291508|Massachsetts General Hospital|PETAL Network Coordinatine Center PI, B. Taylor Thompson, MD|617 872-2882|tthompson1@mgh.harvard.edu|
22263464|NCT03566238|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
22263465|NCT02710591|EspeRare Fondation|Florence Porte-Thomé|22 794 4004|porte.florence@esperare.org|+41
22263466|NCT04235660|Indiana University School of Medicine|Paul Haste|317-944-5005|phaste@iu.edu|
22263467|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22263468|NCT00089973|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263469|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu|
22263470|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200|clingchen@gmail.com|3846
22263471|NCT04592419|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
22307630|NCT05644730|Ideal Medical Technologies|Dr. Leon DeJournett/Chief Medical Officer|8283379960|leondej@idealmedtech.com|
22263472|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com|
22275167|NCT02370511|Mayo Clinic|Dr. Mayra Guerrero|507-255-1267|Guerrero.Mayra@mayo.edu|
22275168|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22293495|NCT02248701|North Florida/South Georgia Veterans Health System|Joshua Yarrow, MS, PhD|(352) 548-6477|Joshua.Yarrow@va.gov|
22293496|NCT02218320|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|919 966-9998|akashuba@unc.edu|
22293497|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu|
22293498|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22293499|NCT03758443|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22293500|NCT03080454|Feinstein Institute for Medical Research at Northwell Health|Bruce Volpe|516-562-3384|bvolpe1@northwell.edu|
22293501|NCT02747875|Children's National Hospital|Dr. Andrew Waberski, Assistant Professor|2024762025|awabersk@childrensnational.org|
22293502|NCT03863197|KU Leuven|Dr. Britta Hanssen|+3216341295|britta.hanssen@kuleuven.be|
22293503|NCT01781975|University of South Florida|Melissa Parker|8133969378|MELISSA.PARKER@EPI.USF.EDU|
22293504|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293505|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942||
22293506|NCT04545060|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22293507|NCT02846324|Global Blood Therapeutics|Nick Vlahakis|1 650 8228756|nvlahakis@gbt.com|
22293508|NCT04206800|Boston IVF|Kristin Rooney|781-434-6470|krooney@bostonivf.com|
22293509|NCT00579878|University of Nebraska Medical Center|James O'Dell|402 559-7288|jrodell@unmc.edu|
22293510|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22293511|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov|
22293512|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu|
22293513|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590||
22293514|NCT02564497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22293515|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293516|NCT03113071|Fox Chase Cancer Center|Dr. Henry Fung|215-728-2674|Henry.Fung@tuhs.temple.edu|
22293517|NCT02012283|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
22293518|NCT02369016|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22293519|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22293520|NCT04203797|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22293521|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22293522|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu|
22293523|NCT03360747|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22293524|NCT02484690|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22293525|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22293526|NCT03105479|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22293527|NCT02569671|Institut Straumann|Mustapha El Amrani|0041619651741|mustapha.elamrani@straumann.com|
22293528|NCT01757535|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinica.Trials@bms.com|
22293529|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov|
22293530|NCT04508335|Reia, LLC|Chief Medical Officer|603 715-7017|paul@reiahealth.com|
22293531|NCT03730012|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22293532|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333||
22293533|NCT03811028|Sobi|Global Communication|+4686972000|info@sobi.com|
22293534|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu|
22293535|NCT03539081|University of Iowa|Marshall Holland, MD|205-934-2654|mtholland@uabmc.edu|
22293536|NCT03695250|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22293537|NCT00990236|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|traumare@ohsu.edu|
22307631|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22307632|NCT03930420|University of Washington|Margaret Hannon, PhD|206-616-7859|peggyh@uw.edu|
22307633|NCT05609032|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
22307634|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu|
22307635|NCT00567489|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22307636|NCT04661410|The WELL Center|Dr. Adrienne Juarascio|443-801-8093|asj32@drexel.edu|
22307637|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com|
22307638|NCT03635151|University of Cincinnati College of Nursing|Tamilyn Bakas|513-558-2254|tamilyn.bakas@uc.edu|
22307639|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu|
22307640|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com|
22307641|NCT00331136|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22275169|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org|
22293538|NCT02555683|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22293539|NCT03554746|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
22293540|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org|
22275170|NCT03092752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275171|NCT03684408|University of Missouri|Megha Garg MD|573-882-1026|gargmeg@health.missouri.edu|
22275172|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22275173|NCT03882918|Ovid Therapeutics Inc|Julia Tsai, PhD|(203) 623-1996|jtsai@ovidrx.com|
22275174|NCT06996301|Doc Lab Inc|Roel Chavez|971 570-4008|roel@doclabinc.com|
22275175|NCT04030598|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22275176|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com|
22275177|NCT01419535|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
22275178|NCT02543840|VA Boston Healthcare System- Center for Healthcare Organization and Implementation Research|Dr. Mark S. Bauer, MD|857-364-6380|mark.bauer@va.gov|
22275179|NCT03114150|The University of Iowa|Dr. Michelle Voss, Study Principal Investigator|319-335-2057|michelle-voss@uiowa.edu|
22275180|NCT02659865|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275181|NCT02325414|Northwestern University|Dr. Thomas Schnitzer|312-503-4043|tjs@northwestern.edu|
22275182|NCT04817189|Helsinn|Alessandro Alonzi, Medical Advisor|+41793262091|Alessandro.Alonzi@helsinn.com|
22275183|NCT02775851|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
22293541|NCT04622306|Sagami|Mr Grant R Burt|+33 607 54 52 41|grantburt@sagami-europe.com|
22293542|NCT03289858|University of Massachusetts, Worcester|Eric Swart|503-880-7125|eric.swart@umassmemorial.org|
22293543|NCT04269707|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
22275184|NCT06125964|University of Southern California|Genevieve Dunton (Principal Investigator)|323-442-8224|dunton@usc.edu|
22275185|NCT04006457|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275186|NCT03370172|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22275187|NCT05918055|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22275188|NCT02194465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275189|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275190|NCT02058095|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
22275191|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22275192|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22275193|NCT01983930|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
22275194|NCT01454284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275195|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca|
22275196|NCT02842866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22275197|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be|
22275198|NCT03248037|Cornea Research Foundation of America|Marianne Price|3178142990|mprice@cornea.org|
22275199|NCT03720119|Sofar|Dr Laura Patrucco|+39 02909362|laura.patrucco@sofarfarm.it|1
22275200|NCT02897349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275201|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr|
22293544|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
22293545|NCT01896102|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22293546|NCT02673138|Yale Pediatric Diabetes|Neha S. Patel, DO|203-764-6747|neha.patel@yale.edu|
22293547|NCT04289623|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22293548|NCT03719612|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
22293549|NCT05091047|Erchonia Corporation|Clinical Affairs Manager|888.242.0571|tsammons@erchonia.com|
22293550|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com|
22293551|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu|
22293552|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293553|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
22293554|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088||
22293555|NCT04424888|Pendulum Therapeutics|James Bullard, PhD, Chief Technical Officer|(844) 912-2256|james.bullard@pendulum.co|
22293556|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu|
22293557|NCT00493025|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Rosalyn Juergens, MD.|410-908-7829|rjuerge1@jhmi.edu|
22293558|NCT03779711|Mayo Clinic|Clint Hagen|(507) 577-1764|hagen.clint@mayo.edu|
22293559|NCT01457573|Houston Methodist Hosptial System|Timothy Boone, MD, PhD, Principal Investigator|713-441-6455|tboone3@houstonmethodist.org|
22293560|NCT03881670|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
22293561|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov|
22293562|NCT02939079|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
22293563|NCT01609231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293564|NCT00973674|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
22293565|NCT01440452|Johns Hopkins Hospital|Daniel Becker|4108284629|db@inirehab.com|
22275202|NCT03113955|Zhongda Hospital Southeast University|Dr. Gaojun Teng|13805171500|gjteng@vip.sina.com|+86
22293566|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com|
22293567|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22293568|NCT03783975|University of Maryland Baltimore|Dr. Amber Beitelshees|410-706-0118|abeitels@som.umaryland.edu|
22275203|NCT01708603|Bausch Health|Study Director|510-259-5284||
22275204|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu|
22275205|NCT03817528|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-5340|marlene.carlson@nyspi.columbia.edu|
22275206|NCT03895086|Maison de la Recherche en Santé|Mr Thomas RULLEAU|6 35 55 03 35|thomas.rulleau@chu-nantes.fr|+33
22275207|NCT01192815|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
22275208|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov|
22275209|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu|
22275210|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu|
22275211|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22275212|NCT04287816|Ohio State University|Dr. Richard Bruno|6142925522|bruno.27@osu.edu|
22275213|NCT03025035|Cedars-Sinai Medical Center|Yuan Yuan, MD, PhD|3108888680|yuan.yuan@cshs.org|
22275214|NCT05892341|ConvaTec Inc.|Cristin Taylor, Senior Director, Medical Affairs, Advanced Wound Care|1-800-422-8811|cristin.taylor@convatec.com|
22275215|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu|
22275216|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
22275217|NCT04264208|Stanford University|Andrei Iagaru, MD|(650) 725-4711|aiagaru@stanford.edu|
22275218|NCT01123655|Memphis VAMC|Arnold E. Postlethwaite,MD Principal Investigator|901 448 5774|apostlet@uthsc.edu|
22275219|NCT04373031|Providence Portland Medical Center|Dr. David Page|503-215-1979|canrsrchstudies@providence.org|
22275220|NCT05469438|University Hospitals Cleveland Medical Center (Case Western Reserve University)|Kylie Phillips (Clinical Research Regulatory Specialist III)|(440)328-7964|kylie.phillips@uhhospitals.org|
22275221|NCT02368132|Corporal Michael J Crescenz VA Medical Center|Dr. Shahrzad Mavandadi|215.823.5211|shahrzad.mavandadi@va.gov|
22275222|NCT02475369|BIDMC|Caitlin Barrett|617-667-8266|cbarret5@bidmc.harvard.edu|
22275223|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22275224|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu|
22275225|NCT03329885|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|clinical.trials@bms.com|
22275226|NCT01991795|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22275227|NCT04004000|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22275228|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22275229|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu|
22275230|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22275231|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net|
22307642|NCT02692417|University of Michigan|Dr. Tim Bruns|(734) 647-8727|bruns@umich.edu|
22307643|NCT02020252|University of Chicago Medicine|Toni M Cipriano|574-339-0652|tcipriano@uchicago.edu|
22307644|NCT02793154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307645|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu|
22307646|NCT04426500|Icahn School of Medicine at Mount Sinai|Dr. Reza Mehrazin|(212) 241-4812|reza.mehrazin@mountsinai.org|
22307647|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu|
22307648|NCT04578106|Hospital Clínic de Barcelona|Dr. Tomas Pascual|932275400|topascual@clinic.cat|
22307649|NCT06678178|Johns Hopkins Bloomberg School of Public Health|Julia Wolfson|213-359-2915|jwolfso7@jhu.edu|
22307650|NCT04690556|Lupin|Study Director: Lupin|020-66749100|chiragshah@lupin.com|49068
22307651|NCT06729073|AMZELL BV|Delpy|+31235560460|amzell-disclosure@amzell.com|
22307652|NCT03891758|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com, clinicaldevelopment@mail.biken.or.jp|
22307653|NCT07074171|The University of Texas Health Science Center at Houston|Belinda M Reininger, DrPH|956-755-0654|Belinda.M.Reininger@uth.tmc.edu|
22307654|NCT04434729|Boston Children's Hospital|Dr. Darren Orbach|617-355-5012|darren.orbach@childrens.harvard.edu|
22307655|NCT00975819|Children's Hospital of Philadelphia|Denise M. Adams, M.D.|2674253010|adamsdm@chop.edu|
22307656|NCT01968109|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22307657|NCT06954883|Assuit university|Ahmed Kamel Abdel Naser|01061553007|a.k.soliman@hotmail.com|
22307658|NCT04316676|Emory University|Carlo De Cecco, MD, PhD|404-712-7968|carlo.dececco@emory.edu|
22307659|NCT04917588|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
22307660|NCT04919590|Truth Initiative|Dr. Amanda Graham|202-525-6473‬|vapestudy@truthinitiative.org|
22307661|NCT04192747|Elixir Medical Corporation|Tina Cordaro, Sr. Director, Clinical Trials|585-360-7270|tcordaro@ElixirMedical.com|
22307662|NCT04310735|The Pennsylvania State University|Stephen Wilson|8148656219|sjw42@psu.edu|
22307663|NCT03012841|Medtronic|Mary Sauline, Clinical Research Specialist|440-596-3529|mary.k.sauline@medtronic.com|
22307664|NCT05696080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307665|NCT03398200|University of Rochester|Omar Aljitawi, MD|(585) 275-4099|Omar_Aljitawi@URMC.Rochester.edu|
22307666|NCT04065048|Case Western Reserve University|Abigail Raffner Basson, Principal Investigator & Study Coordinator|2163276003|axb860@case.edu|
22307667|NCT03397108|The Hospital for Sick Children|Dr. Shinya Ito|4168135776|shinya.ito@sickkids.ca|
22307668|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com|
22275232|NCT01141608|UT Southwestern Medical Center|Dr. Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
22307669|NCT04607044|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22293569|NCT01581710|CHA UNIVERSITY|Dr. HAN, MAN YONG|82-31-780-6262|drmesh@gmail.com|
22293570|NCT02605304|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22293571|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu|
22293572|NCT03638622|Massachusetts General Hospital, Boston|Tayyaba Hasan|617-726-6996|thasan@mgh.harvard.edu|
22293573|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700|ggoss@ottawahospital.on.ca|56708
22293574|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22293575|NCT03273270|Medical University of South Carolina|Gonzalo Revuelta|7927262|revuelta@musc.edu|
22293576|NCT03822182|AHNI Orthopedics|Brian Badman|3178328800|bbadman@gmail.com|
22293577|NCT01484275|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22293578|NCT04154930|Galderma|Clinical Project Manager|817-961-5655|aestheticclinicaltrials@galderma.com|
22293579|NCT00515411|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22293580|NCT04584970|University of North Carolina at Chapel Hill|Jacob Nelson|704-677-3801|jacob14@live.unc.edu|
22293581|NCT03113916|Kaiser Permanente Center for Health Research|Nangel Lindberg|503 528 3961|Nangel.M.Lindberg@kpchr.org|
22293582|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22293583|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
22293584|NCT01758523|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
22293585|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
22293586|NCT01533077|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22293587|NCT02130297|Icahn School of Medicine at Mount Sinai|Dr. Hooman Khorasani|347-574-8500|hooman.khorasani@mountsinai.org|
22293588|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
22293589|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
22293590|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22293591|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
22293592|NCT01602120|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
22293593|NCT01435603|Northwestern University|Research Project Manager|312-503-3359|emily.anderson1@northwestern.edu|
22293594|NCT01611155|Mayo Clinic|Charles L. Loprinzi, MD|507-284-3731|cloprinzi@mayo.edu|
22293595|NCT04502433|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22293596|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu|
22293597|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com|
22293598|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22293599|NCT02556554|Regents of the University of Colorado|Sarit Polsky, MD, MPH|3037248575|sarit.polsky@ucdenver.edu|
22293600|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293601|NCT00880997|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
22293602|NCT00678080|UT Health|Dr. Jerrie Refuerzo, M.D.|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
22293603|NCT03569618|University of California, San Francisco|Riley Bove, MD MSc|415.502.7209|riley.bove@ucsf.edu|
22293604|NCT04439201|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22293605|NCT05136690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321255|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22263473|NCT04241133|Montana State University|Dr. Carmen Byker Shanks|406-994-1952|cbykershanks@montana.edu|
22263474|NCT01503333|Michigan State University College of Nursing|Dr. Lorraine Robbins|517-353-3011|Lorraine.Robbins@hc.msu.edu|
22263475|NCT02877017|Boston Children's Hospital|Alisa Khan, MD, MPH|6173552565|alisa.khan@childrens.harvard.edu|
22263476|NCT04254198|University of New Mexico Health Sciences|Janet Page-Reeves|505-272-1694|JPage-Reeves@salud.unm.edu|
22263477|NCT02152982|Mayo Clinic|Jann N. Sarkaria, MD|507-284-8227|Sarkaria.jann@mayo.edu|
22263478|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com|
22263479|NCT04968925|Johnson & Johnson Vision Care, Inc. (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
22263480|NCT03408730|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
22263481|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
22263482|NCT00835796|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22263483|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263484|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
22263485|NCT02327325|Health Services Research & Development, Durham VA Healthcare System|Kelli Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
22263486|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org|
22263487|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263488|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr|
22263489|NCT00695110|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
22275233|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
22275234|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385|elisabeth.mahla@medunigraz.at|13027
22275235|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com|
22275236|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org|
22275237|NCT03824561|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22275238|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275239|NCT02764801|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|John.Eisenbrey@jefferson.edu|
22275240|NCT03658980|Hiroshima University|Zara Khair|+8801715342168|zara.oikee@gmail.com|
22275241|NCT05117060|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22275242|NCT03141359|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22275243|NCT03675308|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22275244|NCT05722522|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22275245|NCT00863122|Johns Hopkins School of Medicine|Jaishri Blakeley|410-955-6827|jblakel3@jhmi.edu|
22275246|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22275247|NCT04953338|Pfizer Ltd|John Nesnas|01304 616161|john.nesnas@pfizer.com|
22275248|NCT01721798|FHI 360|Catherine Todd|+1-919-544-7040|ctodd@fhi360.org|
22275249|NCT00961064|National Heart Lung and Blood Institute|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
22275250|NCT01408641|FDA|Bernard Fischer, M.D.|240-402-4511|Bernard.Fischer@fda.hhs.gov|
22275251|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu|
22275252|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov|
22275253|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22275254|NCT03979313|Astrazeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22275255|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777||
22275256|NCT03183908|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
22275257|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu|
22275258|NCT02019069|Stanford University|Rondeep Singh Brar|(650) 498-6000|rbrar@stanford.edu|
22275259|NCT01588509|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22275260|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu|
22307670|NCT05403801|Dana Farber Cancer Institute|Desiree Azizoddin|(617) 632-3000|desiree_azizoddin@dfci.harvard.edu|
22275261|NCT01944423|Univeristy of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
22275262|NCT01712178|AbbVie|Global Medical Services|800-633-9110||
22275263|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
22275264|NCT00204737|University of Wisconsin - Madison|Catherine Johnson|608-280-7084|catherine.johnson2@va.gov|
22275265|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275266|NCT04796415|Indiana University School of Nursing|Yvonne Lu, PhD, RN, FGSA, FAAN, Professor, Science of Nursing Care Department|3172782042|yuelu@iu.edu|
22275267|NCT04232137|Vanderbilt University Medical Center|Dr. Tobias Limperg|(615) 343-6710|tobias.limperg@vumc.org|
22275268|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
22275269|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu|
22307671|NCT05307783|Merit Medical|Vicky Brunk|(385) 766-9152|vicky.brunk@merit.com|
22307672|NCT04883645|Medical University of South Carolina|Dr. Angela J. Yoon|8437924496|yoona@musc.edu|
22275270|NCT02701634|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22275271|NCT01206764|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22275272|NCT04494646|NYU Langone Health|Sripal Bangalore, MD, MHA|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
22275273|NCT02456896|AIIMS, Bhubaneswar, India|Dr. Rituparna Maiti|9438884191|rituparnamaiti@gmail.com|
22275274|NCT00997893|University of Illinois at Chicago|Dr. Pauline Maki|312 996-6941|pmaki1@uic.edu|
22275275|NCT03620162|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275276|NCT02767531|UT Southwestern Medical Center|Abhimanyu Garg, MD|2146482895|abhimanyu.garg@utsouthwestern.edu|
22275277|NCT04009837|University of Delaware|Dr. Gregory Hicks, PT, PhD, FAPTA, FGSA|(302) 831-2690|ghicks@udel.edu|
22275278|NCT05569174|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
22275279|NCT00112957|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22275280|NCT02182804|Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.|Dr. Piyapan Prueksapanich|6622564000|mpkus1@gmail.com|81001
22275281|NCT03134768|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
22275282|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com|
22275283|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22275284|NCT02309359|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
22275285|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com|
22275286|NCT06129149|The Ohio State University|Christine Kimpel|614-247-1195|kimpel.28@osu.edu|
22307673|NCT06194214|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307674|NCT04847999|University of British Columbia|Dr Jonathan Little|2508786893|jonathan.little@ubc.ca|
22275287|NCT04649359|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275288|NCT03307174|University of California San Francisco|Paul Su|415-885-7246|paul.su@Ucsf.edu|
22263490|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742|suman-rathbun@ouhsc.edu|44773
22263491|NCT03388502|Rush University Medical Center|Dr Philip Louie|2539069256|louie.philip@gmail.com|
22263492|NCT02919111|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|22648
22263493|NCT01118026|Alliance for Clinical Trials in Oncology|Ann S. LaCasce, MD|617-632-5959|alacasce@partners.org|
22263494|NCT04675775|University of Michigan|Elliot Tapper|734-647-9252|etapper@med.umich.edu|
22263495|NCT02970552|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joni@email.unc.edu|
22263496|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263497|NCT02419924|Mayo Clinic|Dr. Amy Foxx-Orenstein|480-301-6990|foxx-orenstein.amy@mayo.edu|
22263498|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org|
22263499|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com|
22263500|NCT02780167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263501|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
22263502|NCT02315066|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263503|NCT01067521|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|001-215-591-3000|info.era-clinical@teva.de|
22263504|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
22263505|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov|
22263506|NCT02667951|School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan|Dr. Yea-Ing L. Shyu|+886-3-211 8800|yeaing@mail.cgu.edu.tw|5275
22263507|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22263508|NCT04142658|Artivion|Melissa Thalin, Director, New Indications|770-419-3355|melissa.thalin@artivion.com|
22263509|NCT01781234|University of Illinois College of Pharmacy|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22263510|NCT02413008|ITF Research Pharma SLU|Concepción Nieto Magro|0034916572323|concepcion@itfsp.com|
22263511|NCT02287636|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22263512|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com|
22263513|NCT03538262|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
22263514|NCT01685216|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22263515|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu|
22263516|NCT02466386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22263517|NCT05317195|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22263518|NCT03259789|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22263519|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
22263520|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22263521|NCT03718039|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22263522|NCT02922582|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22263523|NCT04718129|Vanderbilt University|Principal Investigator|615-330-5605|jgarber.vanderbilt@gmail.com|
22263524|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263525|NCT03346902|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|9493796569
22263526|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22263527|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu|
22263528|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com|
22263529|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu|
22263530|NCT03297541|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
22263531|NCT02528409|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22263532|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
22263533|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22263534|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be|
22263535|NCT02061280|Nemours Children's Specialty Care|Kathryn Blake, Pharm.D.|9046865047|kathryn.blake@nemours.org|904
22263536|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu|
22263537|NCT00493792|Mayo Clinic, Rochester, MN|Emilee Andersen, M.A., Clinical Research Coordinator|507-266-9807|andersen.emilee@mayo.edu|
22263538|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu|
22263539|NCT02076776|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
22263540|NCT02426541|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22263541|NCT00745134|M D Anderson Cancer Center|Dr. Jillian Gunther|832-710-7864|JGunther@mdanderson.org|
22263542|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org|
22263543|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org|
22263544|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
22307675|NCT02488863|University o fFlorida|Eric Weber|352-273-7802|ebweber@ufl.edu|
22307676|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22263545|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
22263546|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com|
22307677|NCT04300231|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|317-274-0275|yyeap@iupui.edu|
22307678|NCT00448240|Henry Ford Health System|Tiffany Pearce, Director of Clinical Trials|313-575-8046|tpearce1@hfhs.org|
22307679|NCT04431050|Imperial|Joan Nanan|+44 (0)20 7594 9000|j.nanan@imperial.ac.uk|
22307680|NCT03504423|Cornerstone Pharmaceuticals Inc.|Sanjeev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
22307681|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu|
22307682|NCT03128359|City of Hope Medical Center|Dr. Monzr M.Al Malki, MD|6263598111|malmalki@coh.org|
22263547|NCT02674633|Akili Interactive Labs|Kathryn Jenkins|8572543399|kjenkins@akiliinteractive.com|
22263548|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22263549|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu|
22263550|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu|
22263551|NCT02788513|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263552|NCT04178096|VA Pittsburgh Healthcare System|Dr. Shari Rogal|412 360 6177|shari.rogal@va.gov|
22263553|NCT03230487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263554|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu|
22263555|NCT04443569|Massachusetts General Hospital|Christopher Arkfeld|4029803860|carkfeld@mgh.harvard.edu|
22263556|NCT03211039|Rady Children's Institute for Genomic Medicine|Dr. Stephen F. Kingsmore|816 854 0882|skingsmore@rchsd.org|
22263557|NCT01933919|AbbVie|Global Medical Services|800-633-9110||
22263558|NCT01961882|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22263559|NCT01901848|Durham Veterans Health Care System|Eric Dedert, Ph.D.|919-384-8582|eric.dedert@va.gov|4055
22263560|NCT02575339|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22263561|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu|
22263562|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22263563|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu|
22263564|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257||
22263565|NCT05552261|Dompé Farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinicaltrials@dompe.com|
22263566|NCT04269993|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
22263567|NCT04886063|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
22263568|NCT01628549|Allergan|Thearpeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22263569|NCT04116658|Enterome|Jan Fagerberg|+33175772785|info@enterome.com|
22263570|NCT05584553|Zimmer Biomet|Dr Nesma Bayrich|+41793001484|nesma.bayrich@zimmerbiomet.com|
22263571|NCT03807440|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263572|NCT02451358|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
22263573|NCT06128525|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22263574|NCT00960414|UCSF Osher Center for Integrative Medicine|Rick Hecht, MD|4153739743|rick.hecht@ucsf.edu|
22263575|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com|
22263576|NCT03414034|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
22263577|NCT02725645|Universidade Fernando Pessoa|Sandra Beatriz Pereira Rodrigues||sandrar@ufp.edu.pt|
22263578|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22263579|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com|
22263580|NCT03702816|Cleveland Clinic|Aaron Ritter, MD|17024836000|rittera@ccf.org|
22263581|NCT04194008|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|0542220121|daganh@theranica.com|
22263582|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu|
22263583|NCT02522780|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22263584|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263585|NCT01517867|Johns Hopkins University|Deborah Gross|410-614-5311|debgross@jhu.edu|
22263586|NCT02095340|University of Houston|Andres G Viana, Ph.D., Associate Professor|832-842-0234|agviana@uh.edu|
22263587|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263588|NCT01183884|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22263589|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com|
22263590|NCT01598896|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
22263591|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22263592|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263593|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu|
22263594|NCT04553406|SperoTherapeutics|Dr. Jon Bruss|(+1) 269-352-3766|jbruss@sperotherapeutics.com|
22263595|NCT03370510|Yale Child Study Center|Dr. Pamela Ventola|(203) 737-4378|ventolalab@yale.edu|
22263596|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com|
22263597|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
22307683|NCT02006758|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
22263598|NCT01756885|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
22263599|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22263600|NCT05718648|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263601|NCT04814459|Oakland University|Dr. Sara Arena|2483648682|arena@oakland.edu|
22263602|NCT01841060|Institut Bergonie|Pr Simone Mathoulin-Pélissier|33556333333|s.mathoulin@bordeaux.unicancer.fr|
22263603|NCT05258630|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22263604|NCT03431337|Albany Medical College|Dr. Paul Sorum|518-262-7500|sorump@amc.edu|
22307684|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22307685|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com|
22307686|NCT02101281|Dompé|Flavio Mantelli, MD, PhD|+39 513138|info@dompe.it|
22307687|NCT05052996|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22307688|NCT01695954|NYU School of Medicine|Carlos Malvestutto, MD, MPH|212-263-3570|carlos.malvestutto@nyumc.org|
22307689|NCT02290613|Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital|Prof. Dr. med. E. Grünig|+49 6221 396|ekkehard.gruenig@med.uni-heidelberg.de|8053
22307690|NCT02372253|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Anath Shalev, MD|205-996-4777|shalev@uab.edu|
22307691|NCT03201562|Presbyopia Therapies, LLC|Jerry Horn, MD|(847)-772-8885|visionxcl@icloud.com|
22307692|NCT01803555|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22307693|NCT03294499|Imperial College Healthcare NHS Trust|Dr Farai Nyatsanza|n/a|farai.nyatsanza@nhs.net|
22307694|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307695|NCT00780234|Rocky Mountain Regional VA Medical Center|Robert L. Keith, MD|720-857-5120|robert.keith@ucdenver.edu|
22307696|NCT03892564|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22307697|NCT04019444|The Hope Clinic of the Emory Vaccine Center|Varun K. Phadke, MD|404-712-9046|vphadke@emory.edu|
22307698|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu|
22307699|NCT00497198|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307700|NCT00424463|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307701|NCT04242940|Oticon Medical|Manager of Clinical Affairs|609-366-0424|studyinfo@oticonmedical.com|
22307702|NCT03570892|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
22307703|NCT05028582|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22307704|NCT04474314|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
22307705|NCT03899792|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307706|NCT00330681|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22307707|NCT03954184|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|todd.molfenter@wisc.edu|
22307708|NCT06382064|The Ohio State University College of Optometry|Dr. Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
22307709|NCT03460236|Stanford University|Christine Hoang, Clinical Research Coordinator|650-721-7630|c1hoang@stanford.edu|
22307710|NCT04869982|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307711|NCT04608045|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
22307712|NCT05833789|Vanderbilt University Medical Center|Michael McGill|615-322-0128|michael.g.mcgill@vumc.org|
22307713|NCT02473250|Columbia University Irving Medical Center|Martin Lan MD PhD|646 774 7610|martin.lan@nyspi.columbia.edu|
22307714|NCT05215847|Aardvark Therapeutics|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
22307715|NCT03830177|Northwestern University|Lucy Bilaver, PhD|312-503-5618|l-bilaver@northwestern.edu|
22307716|NCT02960230|University of California, San Francisco|Dr. Sabine Mueller, MD PhD|(415) 502-1600|Sabine.Mueller@ucsf.edu|
22307717|NCT03401853|University of Washington|Stephen Smith, MD|(206) 606-6546|ssmith50@fredhutch.org|
22307718|NCT03625323|Immutep|Immutep CMO|+ 49 30 88716843|regulatoryaffairs@immutep.com|
22307719|NCT06023082|Citruslabs|Patrick Renner|(805) 292-0714|hello@citruslabs.com|
22307720|NCT05986565|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|
22307721|NCT00670046|UTHSCSA|Ron Rodriguez, MD, PhD|2105675643|rodriguezr32@uthscsa.edu|
22307722|NCT06146374|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
22321256|NCT04194528|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
22263605|NCT02419573|Unviersity of Texas Health Science Center at Houston|Henry E. Wang, MD, MS|713-500-7878|henry.e.wang@uth.tmc.edu|
22263606|NCT05838456|The University of Texas Health Science Center at Houston|Sunil A. Sheth, MD|713-500-7897|Sunil.A.Sheth@uth.tmc.edu|
22263607|NCT04167618|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
22263608|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu|
22263609|NCT02994394|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22263610|NCT03619876|Columbia University|Laura Geraldino-Pardilla, MD|212-305-4308|lbg2124@cumc.columbia.edu|
22263611|NCT05707403|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263612|NCT04982445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263613|NCT00763555|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22263614|NCT00493064|PaloAltoMF|Renee Kaneshiro, study coordinator|650-853-4744|kaneshr@pamf.org|
22263615|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263616|NCT02916693|Johns Hopkins University|Dr. Arthur L. Burnett|410-614-3986|aburnet1@jhmi.edu|
22263617|NCT05383170|Cytovation ASA|CEO|+4747718809|contact@cytovation.com|
22263618|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22275289|NCT05911841|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275290|NCT05595369|Duke University|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
22307723|NCT02058108|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22307724|NCT01154192|UC San Diego School of Medicine|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
22307725|NCT01376700|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22307726|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov|
22307727|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu|
22307728|NCT06027229|UW School of Medicine and Public Health|Dr. Freddy Caldera, DO, PhD, MS|(608) 263-1995|fcaldera@medicine.wisc.edu|
22307729|NCT04630301|Johns Hopkins University|Dr. Jeffrey Thiboutot|410-502-2533|jthibou1@jhmi.edu|
22307730|NCT06459401|Boston University|Ashlyn Aiello|617-500-3645|ajma@bu.edu|
22307731|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668|david.sciberras@emdserono.com|5248
22307732|NCT02740231|Bone Therapeutics|Dr Olivier Godeaux Medical Officer|+32 71 12 10 00|jta.koa1@bonetherapeutics.com|
22307733|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307734|NCT04110054|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22307735|NCT03693937|Sensus Healthcare|Isabelle Raymond|561-922-5808|iraymond@sensushealthcare.com|
22307736|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307737|NCT03988023|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22307738|NCT03655262|UCLA|Michelle Craske, Ph. D|(310) 825 8403|mcraske@mednet.ucla.edu|
22307739|NCT03733119|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
22307740|NCT01188369|Aarhus University Hospital|Dr. Peter Juhl-Olsen|+4578451199|peter.juhl-olsen@ki.au.dk|
22307741|NCT02554786|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22307742|NCT01828554|University of Madison Carbone Cancer Center|Kari B. Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
22307743|NCT02395978|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
22307744|NCT03032406|University of Pennsylvania|Dr Angela DeMichele|2156624000|angela.demichele@pennmedicine.upenn.edu|
22307745|NCT04583423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22307746|NCT03330795|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
22307747|NCT05575076|Cassava Sciences|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
22307748|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu|
22307749|NCT02214550|NorthShore University HealthSystem|Dr. Frank Tu|8475702520|ftu@northshore.org|
22307750|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232||
22307751|NCT03447249|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22307752|NCT02376790|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22307753|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307754|NCT02238483|AstraZeneca|Ziad Taib|+46 708 46 73 56|ziad.taib@astrazeneca.com|
22307755|NCT02538341|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis|205-975-2176|jrcurtis@uabmc.edu|
22307756|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22307757|NCT00132964|Hospital for Sick Children|Kathy Boutis|4168138982|kathy.boutis@sickkids.ca|
22307758|NCT02382744|Department of Anesthesia, St. Paul's Hospital/Providence Health Care|Dr. Stephan Schwarz, Director of Research|(604) 806-8337|stephan.schwarz@ubc.ca|
22307759|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com|
22307760|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu|
22307761|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu|
22307762|NCT00031694|Montefiore Medical Center-New York cancer Consortium|Joseph Sparano|718-405-8404|jsparano@montefiore.org|
22307763|NCT03010631|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22307764|NCT01538719|Boston University School of Medicine|Eric A Stratton, Sr. Clinical Research Manager|6174142507|eas@bu.edu|
22307765|NCT01985542|Helsinki University Hospital|Dr. Sanna Salmi|+358505431421|sanna.salmi@helsinki.fi|
22307766|NCT01255670|Helsinki University Central Hospital|Dr. Karin Blomgren|+358504271579|karin.blomgren@hus.fi|
22307767|NCT03664960|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22307768|NCT03640949|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
22307769|NCT03807778|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22307770|NCT03582722|Emory University|Michele Marcus, PhD, MPH|404-727-8010|mmarcus@emory.edu|
22307771|NCT01701986|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, MD, PhD/ Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
22307772|NCT02576509|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22307773|NCT05873062|Autifony Therapeutics Ltd|Head of Clinical Project Management|+447909228562|Alice.Sharman@autifony.com|
22307774|NCT06546657|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
22307775|NCT01216176|University of Miami|Joyce Slingerland MD PhD FCRP(C)|305-243-7265|jslingerland@med.miami.edu|
22307776|NCT04847479|University of Pennsylvania|Robert Gross|215-898-2437|grossr@pennmedicine.upenn.edu|
22275291|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307777|NCT03725722|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22307778|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22307779|NCT04592198|Xiamen LP Pharmaceutical Co.,Ltd|Matthew H Nieder|(415) 516-9498|matthew@lppharma.com|
22321257|NCT04867473|Stanford University|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
22321258|NCT00616122|University of California, San Francisco|Hope S. Rugo|877-827-3222|clinicaltrials@ucsf.edu|
22321259|NCT03921424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321260|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22321261|NCT01246583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321262|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22293606|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293607|NCT01453361|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22293608|NCT01752985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22293609|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293610|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22293611|NCT02025621|Duke Clinical Research Institute|Rajendra Mehta, MD Study Principal Investigator|919-668-8971|raj.mehta@dm.duke.edu|
22293612|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22293613|NCT02373852|Gardia Medical Ltd|Dr Vardit Segal|972-52-4579178|vardit@gardiamedical.com|
22293614|NCT01897454|NYU Langone|Dr. Jennifer Chuy|646-501-0194|jennifer.chuy@nyulangone.org|
22293615|NCT02958293|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22293616|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293617|NCT01560403|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22293618|NCT00539656|Johns Hopkins University School of Medicine|Allen Chen, MD,PhD,MHS|410-614-4434|chenal@jhmi.edu|
22293619|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22293620|NCT04019288|M.D. Anderson Cancer Center|Amir A Jazaeri|713-745-1613|aajazaeri@mdanderson.org|
22293621|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22293622|NCT04538430|University of Utah|Shellie Cunningham|801-587-5488|shellie.cunningham@hsc.utah.edu|
22293623|NCT01112358|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22293624|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU|
22293625|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
22293626|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
22293627|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22293628|NCT03372096|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22293629|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov|
22293630|NCT03513328|University of Florida|Biljana Horn, MD|352-273-9121|biljana.horn@ufl.edu|
22293631|NCT01803204|USP|Cristina Sousa|+5511996017972|crissousa@usp.br|
22293632|NCT01548651|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22293633|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400|ClinicalTrialTransparency@astrazeneca.com|429
22293634|NCT03260881|University of Miami Miller School of Medicine|Dr Gianluca Iacobellis MD PhD Professor of Medicine|3052433636|giacobellis@med.miami.edu|
22293635|NCT04755790|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
22293636|NCT02763462|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22293637|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu|
22293638|NCT03473171|The University of Texas Health Science Center at Houston|James M. Stark, MD|713-500-5650|James.M.Stark@uth.tmc.edu|
22293639|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com|
22293640|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293641|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com|
22293642|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293643|NCT04138810|University of Pennsylvania, Department of Urogynecology|Dr. Lily Arya|215-662-4147|larya@pennmedicine.upenn.edu|
22293644|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu|
22293645|NCT03641339|National Institutes of Health|Matthew J. Memoli, MD, MS|301-443-5971|memolim@niaid.nih.gov|
22293646|NCT02329080|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
22293647|NCT03285984|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293648|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org|
22293649|NCT02509767|Planned Parenthood Federation of America|Julia Kohn|2122614636|julia.kohn@ppfa.org|
22293650|NCT02319837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293651|NCT02435147|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
22293652|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
22293653|NCT00839852|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
22293654|NCT03082261|Abbott|Robyn Capobianco|+15129343941|robyn.capobianco@abbott.com|
22293655|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu|
22293656|NCT01961362|National Jewish Health|Dr. Jeffrey J. Swigris|303-398-1621|swigrisj@njhealth.org|
22293657|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com|
22307780|NCT03481660|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
22307781|NCT04278586|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6056|zschuman@cha.harvard.edu|
22307782|NCT04076293|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|8224100377|jiyeon.kang@hanmi.co.kr|
22307783|NCT05075408|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
22307784|NCT03651895|Imperial College|Farne Hugo|+44 (0)20 7589 5111|h.farne@imperial.ac.uk|
22307785|NCT04527146|UPenn|Rachel Paul, Genetic Counselor|215-490-5816|rachel.paul3@pennmedicine.upenn.edu|
22307786|NCT05510232|Hospital for Special Surgery|Dr. Peter Fabricant|(212) 606-1996|fabricantstaff@hss.edu|
22307787|NCT02380612|AVITA Medical|VP Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
22307788|NCT02721381|Michigan State University|Dr. Brooke Ingersoll|517-930-2275|ingers19@msu.edu|
22307789|NCT05166135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307790|NCT04468776|CPMCRI|Dr. Katie Stone|(510) 427-4562|katie.Stone@ucsf.edu|
22307791|NCT05687903|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22307792|NCT04855760|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
22307793|NCT03890913|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22307794|NCT04840199|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22307795|NCT02879448|Abbott Medical|Jordan Anderson, Clinical Scientist|651 756 3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
22307796|NCT03433339|Lindner Center of HOPE/ University of Cincinnati Department of Psychiatry and Behavioral Neurosciences|Dr. Francisco Romo-Nava|513-536-0725|romofo@ucmail.uc.edu|
22307797|NCT04970407|Ipsen Innovation|Laurent Pons/Clinical Pharmacology Director|see email|clinical.trials@ipsen.com|
22307798|NCT01898494|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22307799|NCT05540002|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
22307800|NCT02819843|Memorial Sloan Kettering Cancer Center|Dr. Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
22307801|NCT04732494|BeiGene, Ltd.|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22307802|NCT03055858|Abbott Laboratories|Ebony Kargbo|612-209-8185|Ebony.Kargbo@abbott.com|
22307803|NCT02728557|University of Haifa|Prof. Sigal Zilcha-Mano|972-4-8249047|sigalzil@gmail.com|
22307804|NCT03416010|The Ohio State University|Dr. Bernadette Melnyk|6142924844|melnyk.15@osu.edu|
22307805|NCT03948763|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307806|NCT06629454|University of Pennsylvania|Doraid Jarrar|2156627878|doraid.jarrar@pennmedicine.upenn.edu|
22307807|NCT05136404|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22307808|NCT02793687|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
22307809|NCT05568004|Ege University Faculty of Medicine Sport Medicine Department|Dr. Yunus Emre Meydanal|905068046512|yemremeydanal@gmail.com|
22307810|NCT02553642|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4718|funts@mskcc.org|
22307811|NCT03755141|Korea university Guro hospital|In Hae Park|+82-2-2626-3172|parkih@korea.ac.kr|
22307812|NCT01820260|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22307813|NCT05444192|University of Central Lancashire|Dr Graham Chapman|01772894949|gchapman2@uclan.ac.uk|
22307814|NCT04522713|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
22307815|NCT04848974|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD/Professor|713-563-3534|tkadia@mdanderson.org|
22307816|NCT04424927|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22307817|NCT03727061|Roswell Park Compressive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|adrienne.groman@roswellpark.org|
22307818|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
22307819|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22307820|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu|
22307821|NCT02134951|New York State Psychiatric Institute|Marlene Carlson|646-774-8436|mc157@columbia.edu|
22307822|NCT01046136|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
22307823|NCT05623345|Acelyrin Inc.|Clinical Trials Information Desk|+18054564393|clinicaltrials@acelyrin.com|
22307824|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
22307825|NCT04149002|Duke University|Sarahn M. Wheeler, MD|(919) 684-6327|sarahn.wheeler@duke.edu|
22307826|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
22307827|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu|
22307828|NCT02539225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307829|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de|
22307830|NCT00212134|Stanford University School of Medicine|Scott R Lambert, MD, Study Chairman|650-498-4242|lambert7@stanford.edu|
22307831|NCT03101371|University of Colorado, Anshcutz Medical Campus|Saketh Guntupalli, MD|303-724-2033|saketh.guntupalli@cuanschutz.edu|
22307832|NCT01553058|University of Pennsylvania|Suzette Baez VanderBeek, MPH|215-662-3514|suzettev@upenn.edu|
22307833|NCT01094184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22307834|NCT02318134|First Affiliated Hospital of Nanchang University|Dr. Ling Ding|15279196058|2495802456@qq.com|
22307835|NCT03988842|Cedars-Sinai Medical Center|Victor Tapson|919-971-6441|Victor.Tapson@cshs.org|
22307836|NCT04766034|NYU Langone Health|Pasquale Rummo, MPH, PhD|914-316-5907|Pasquale.rummo@nyulangone.org|
22307837|NCT01976312|Novartis|Study Director|862-778-8300||
22307838|NCT02556138|Mayo Clinic|Dr. Kymberly Watt|507-266-1686|Watt.Kymberly@mayo.edu|
22307839|NCT03939312|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22307840|NCT04881175|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22307841|NCT01609218|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307842|NCT02807779|University of California, San Francisco|Warren Gasper, MD|415-353-4366|warren.gasper@ucsf.edu|
22307843|NCT02791230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307844|NCT05769595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307845|NCT04605198|University of California, Los Angeles|Dr. Dana Rose Garfin, Associate Professor|415-407-9498|dgarfin@ucla.edu|
22307846|NCT05307978|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22307847|NCT03416023|OstomyCure AS|Johan Järte|+46 706 524 532|jjaerte@ostomycure.com|
22307848|NCT02837510|University of Pennsylvaina|James Loughead PhD|215-746-6827|loughead@pennmedicine.upenn.edu|
22307849|NCT01727518|Ludwig Boltzmann Institute for Lung Health|Dr Robab Breyer-Kohansal|+436505398439|Robab.Breyer-Kohansal@lunghealth.lbg.ac.at|
22307850|NCT05419505|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22307851|NCT05683392|Tandem Diabetes Care, Inc|Supervisor, Clinical Affairs|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
22307852|NCT02780388|Viela Bio|Viela Bio Clinical Operations|+1 240-558-0038|ClinicalTrials@VielaBio.com|
22307853|NCT04881162|Silk Road Medical|Heather Smith|763-335-5160|hsmith@silkroadmed.com|
22307854|NCT03857620|University of Texas MD Anderson Cancer Center|George J. Chang, MD, MS|713-563-1875|gchang@mdanderson.org|
22307855|NCT04118452|University of California, Los Angeles & Kaiser Permanente School of Medicine|Dr. Paul Chung, Professor and Principal Investigator|626-710-0389|paul.j.chung@kp.org|
22307856|NCT01718743|University of Texas M D Anderson Cancer Center|Dr. Krina Patel|(713) 792-6662|kpatel1@mdanderson.org|
22307857|NCT05145257|Citruslabs|Patrick Renner|4242450284|hello@citruslabs.com|
22307858|NCT04995484|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307859|NCT05178810|Ferrer|Clinical Operations Head|+34 649 442 389|nalbareda@ferrer.com|
22307860|NCT06072404|University of Palermo|Prof. Olga Di Fede|00393294030298|olga.difede@unipa.it|
22307861|NCT04868110|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
22307862|NCT05271903|University of Utah|Melissa Watt|801-587-2100|melissa.watt@hsc.utah.edu|
22307863|NCT02386553|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22307864|NCT04752163|The University of MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
22307865|NCT05384730|University of Southampton|Dr Samantha Meredith|0238120|s.j.meredith@soton.ac.uk|4656
22307866|NCT02664558|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22307867|NCT01619410|University of Pennsylvania|Michael Z. David/Assistant Professor|215-662-6932|michdav@pennmedicine.upenn.edu|
22307868|NCT03405714|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22307869|NCT00194714|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
22307870|NCT02885636|Mayo Clinic|Dr. Barry Borlaug|507-284-8846|borlaug.barry@mayo.edu|
22307871|NCT03921866|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307872|NCT01363492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22307873|NCT03794024|Cleveland Clinic|Robert Bolash|216-444-3134|bolashr@ccf.org|
22307874|NCT05187442|National Taiwan University|PIAO-YI CHIOU, doctoral|+886-2-23123456|piaoyi@ntu.edu.tw|288427
22307875|NCT06061081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307876|NCT05782231|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
22307877|NCT02252172|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22307878|NCT03830866|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22307879|NCT01426412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22307880|NCT03014453|Shengjing Hospital of China Medical University|Dr. Shucheng Zhang|862496615|zhangshucheng76@126.com|57911
22307881|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu|
22307882|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343||
22307883|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu|
22307884|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu|
22307885|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22307886|NCT04154384|Emory University|Mara L. Schenker|404-778-1550|mara.schenker@emory.edu|
22307887|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22307888|NCT04732338|Hackensack Meridian Health|Alphonsa Thomas, DO|7328364504|Alphonsa.Thomas@hmhn.org|
22307889|NCT00001277|NIDDK|Dr. Smita Jha|301-827-1930|smita.jha@nih.gov|
22307890|NCT03161327|Saint Louis University|Dr. Keith Pereira|314-268-5782|keith.pereira@health.slu.edu|
22307891|NCT03750968|University of Utah John A. Moran Eye Center|Paul Bernstein, MD, PhD|801-581-4069|Paul.Bernstein@hsc.utah.edu|
22307892|NCT04484935|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22307893|NCT04767698|Johns Hopkins University, School of Medicine|Dimitrios Ladakis|410-614-1522|dladaki1@jhmi.edu|
22307894|NCT00088413|National Cancer Institute|Dr. James Gulley|301-480-8870|james_gulley@nih.gov|
22307895|NCT02759016|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307896|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu|
22307897|NCT04048382|San Diego State University|Dr. Aaron J. Blashill|6195942245|ajblashill@sdsu.edu|
22307898|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
22321263|NCT02330978|University São Paulo|Jayter Silva de Paula, MD, PhD|55 16 3602-2499|jspaula@fmrp.usp.br|
22321264|NCT05264740|McMaster University|Dr. Laura Anderson|N/a|ln.anderson@mcmaster.ca|
22321265|NCT02813551|The University of Texas Health Science Center at Houston|Oscar Andres Viteri Molina, MD|(713) 500-6412|Oscar.A.ViteriMolina@uth.tmc.edu|
22321266|NCT00102960|Perinatal HIV Research Unit, Johannesburg and Children's Infectious Diseases Clinical Research Unit, Cape Town all in South Africa|Dr Avy Violari and Prof Mark Cotton|27 11 989 9702/27 21 938 4219|violari@mweb.co.za|9702/4219
22321267|NCT02901925|Dartmouth-Hitchcock|Dr. David Roberts|603-650-|David.W.Roberts@dartmouth.edu|
22321268|NCT03040999|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22321269|NCT05121480|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22321270|NCT02366611|University of Michigan, School of Dentistry|Alexandre DaSilva|7346153807|adasilva@umich.edu|
22321271|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495|adavidoff@stemcellthera.com|226
22321272|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321273|NCT02831673|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22321274|NCT02356562|AbbVie|Global Medical Services|800-633-9110||
22321275|NCT00150592|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22321276|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321277|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu|
22321278|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22321279|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22321280|NCT00665457|University of Nebraska Medical Center|Elizabeth Reed, M.D.|402-559-5388|ereed@unmc.edu|
22321281|NCT02145741|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321282|NCT03776175|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321283|NCT01496885|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22321284|NCT03273166|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22321285|NCT01294670|Memorial Sloan Kettering Cancer Center|Tanya Trippett, MD|1-833-MSK-KIDS|trippet@mskcc.org|
22307899|NCT00352976|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2961|macmi002@umn.edu|
22307900|NCT03498196|Baylor College of Medicine|Jennifer M. Taylor, MD, MPH|713-797-7670|Jennifer.Taylor@bcm.edu|
22307901|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org|
22307902|NCT02119650|Incyte Corporation|Study Director|855 463-3463||
22307903|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
22275292|NCT03431584|Centre Hospitalier Departemental Vendée|Dr. Grégoire CORMIER|251446197|gregoire.cormier@ght85.fr|+33
22307904|NCT03481816|National Cancer Institute|Dr. Marijo Bilusic|240-760-6064|marijo.bilusic@nih.gov|
22307905|NCT02730871|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22307906|NCT05368558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22307907|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307908|NCT01304277|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22307909|NCT03757949|SWOG|Danika Lew|206-667-2272|dlew@fredhutch.org|
22307910|NCT05094141|UT Southwestern Medical Center|Dr. Sarah Rebstock|214-456-8106|sarah.rebstock@utsouthwestern.edu|
22307911|NCT05134337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307912|NCT04923347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22307913|NCT03398148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22307914|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|9173
22307915|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22307916|NCT06241794|Hitit University faculty of medicine|Guvenc Dogan|06342193000|guvencdogan@gmail.com|
22307917|NCT03661359|University of Toledo|Heather Klepacz, M.D, Principle Investigator|419-383-6754|heather.klepacz@utoledo.edu|
22307918|NCT03089125|Massachusetts General Hospital|Joseph A. Greer, Ph.D.|617-643-2143|jgreer2@mgh.harvard.edu|
22307919|NCT00186992|St. Jude Children's Research Hospital|Matthew Krasin, MD|(901) 595-3226|matthew.krasin@stjude.org|
22307920|NCT03683069|Brigham and Women's Hospital|Gordon H. Williams, Professor of Medicine|617-223-1611|gwilliams@bwh.harvard.edu|
22307921|NCT01489813|Emory University|Omer Kucuk|404-778-4729|okucuk@emory.edu|
22307922|NCT05644002|Rutgers, the State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
22307923|NCT04499950|SKCCC|Jennifer Sheng|410-614-0762|jsheng7@jhmi.edu|
22307924|NCT06180967|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22307925|NCT05756075|Radboudumc|Drs. D. de Graaf|+31243613450|debbie.degraaf@radboudumc.nl|
22307926|NCT03821844|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
22321286|NCT03808077|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Rieth, MD|212-639-5737|riethe@mskcc.org|
22321287|NCT02412787|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22289035|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov|
22307927|NCT05104697|Emma Pendleton Bradley Hospital|Dr. Kristen Benito|401-432-1054|kbenito@lifespan.org|
22307928|NCT03913195|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
22275293|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr|
22275294|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22275295|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com|
22275296|NCT03512652|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Erich Hohenauer|+41 81 300 01 75|erich.hohenauer@supsi.ch|
22275297|NCT05462821|Jaeb Center for Health Research - Pediatric Eye Disease Investigator Group|Victoria Woodard, Publications Manager|813-975-8690|pedigpublications@jaeb.org|
22275298|NCT05079321|Centre for Ocular Research and Education|Lyndon Jones|(519) 888-4567|lwjones@uwaterloo.ca|35030
22275299|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22275300|NCT02003144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22275301|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net|
22275302|NCT02344316|UCSF Pediatric Headache Program|Amy Gelfand, MD|415-885-7832|Amy.Gelfand@ucsf.edu|
22275303|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22275304|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000|Bob.Edson@va.gov|22250
22275305|NCT00666237|University of Miami|Steven Gedde, MD|305-326-6435|sgedde@med.miami.edu|
22275306|NCT05366725|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 06151725200|service@emdgroup.com|
22275307|NCT02839707|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22275308|NCT01778413|Hospital Clínic de Barcelona|Dr. Esteban Martinez|932275400|estebanm@clinic.cat|
22275309|NCT05507437|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22275310|NCT06583096|University of Michigan|Adam Horwitz|(734) 764-0231|ahor@med.umich.edu|
22275311|NCT05172609|University of Pennsylvania|Dr. Emily Becker-Haimes|215-573-5614|emily.haimes@pennmedicine.upenn.edu|
22275312|NCT04771754|Chelsea and Westminster Hospital NHS Foundation Trust|Dr Ruth Byrne|02033152560|ruthbyrne@nhs.net|
22275313|NCT05610605|University of Cadiz|Cristina Casals|956016216|cristina.casals@uca.es|
22275314|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
22275315|NCT00042289|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22275316|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org|
22275317|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org|
22275318|NCT03150043|UTMB|Katherine Jelliffe|2146635394|katherine.emilie@gmail.com|
22275319|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov|
22275320|NCT03042546|Harboview|research coordinator|206.744.4406|bagel@uw.edu|
22275321|NCT03588624|Sight Sciences|VP Medical and Clinical Affairs|(877) 266-1144|info@sightsciences.com|
22275322|NCT04460885|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22275323|NCT05001620|University of Maryland School of Nursing|Dr. Joan G. Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
22275324|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22275325|NCT05282823|Boston Scientific|Clinical Trial Manager|+6564188833|jamie.kwek@bsci.com|
22275326|NCT05352815|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22275327|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com|
22275328|NCT05144945|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22275329|NCT06290180|Cambridge Health Alliance|Heather Gray|(617) 575-5612|hgray@cha.harvard.edu|
22275330|NCT06831786|prince of songkla university|Sarunyou Chusri|+66897340446|sarunyouchusri@hotmail.com|
22275331|NCT00534469|City of Hope Medical Center|Dr. Anthony Stein|626-5375748|AStein@coh.org|
22275332|NCT02592824|Linköping University Hospital|Dr Jonas Holm|+46101034498|jonas.holm@regionostergotland.se|
22275333|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275334|NCT02391337|University of Birmingham|Prof. Dipak Kotecha|+44 (0) 7974 115676|d.kotecha@bham.ac.uk|
22275335|NCT04182958|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22275336|NCT02855268|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22275337|NCT04002791|Apex Heart Institute|Chairman|011 91 9824030576|theheartworld@gmail.com|
22275338|NCT00465517|Marinus Pharmaceuticals, Inc.|Marinus|(484) 801-4670|clinicaltrials@marinuspharma.com|
22275339|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca|
22275340|NCT02326064|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|0251446161|guillaume.ducarme@ght85.fr|
22275341|NCT00111761|Amgen Inc.|Study Director|866-572-6436||
22293658|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org|
22293659|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca|
22293660|NCT00784641|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22293661|NCT02640573|Baylor College of Medicine|Vivien Sheehan|832 824 4459|vsheehan@bcm.edu|
22293662|NCT01206166|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
22293663|NCT02716805|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22293664|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22307929|NCT03899961|Oslo University Hospital|Leiv Arne Rosseland|92204274|lrossela@ous-hf.no|+47
22307930|NCT05107401|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
22307931|NCT03569176|Stanford University|Dr. Dennis P. Wall|650-497-9214|dpwall@stanford.edu|
22307932|NCT03229811|Fresenius Medical Care|Dr. Amaka Eneanya|267-769-5455|amakaeneanya@gmail.com|
22307933|NCT04093362|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
22307934|NCT05265312|Johns Hopkins University School of Medicine|Dr. Eva Tseng|410-583-2774|etseng3@jhmi.edu|
22307935|NCT05952076|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22307936|NCT03289039|Dana-Farber Cancer Institute|Jose Pablo Leone, MD|617-632-3800|josep_leone@dfci.harvard.edu|
22307937|NCT04586920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22307938|NCT04761302|University of Puerto Rico: Department of Orthopedic Surgery|Dr. Hans Hess|787-365-5755|hans.hess1@upr.edu|
22307939|NCT00753987|SickKids|Felix Ratjen|4168137500|felix.ratjen@sickkids.ca|
22307940|NCT04905407|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
22307941|NCT04899115|University of Michigan|Patricia Bloom, MD|734-647-5944|ppbloom@med.umich.edu|
22307942|NCT00150813|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22307943|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu|
22307944|NCT03446157|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|919-445-4208|Melahat_Canter@med.unc.edu|
22307945|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de|
22307946|NCT05050682|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307947|NCT04452318|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22307948|NCT03928522|Washington University|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
22307949|NCT02638337|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22307950|NCT03771352|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22307951|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22307952|NCT03380390|Aclaris Therapeutics|Dr. David Gordon|484-540-6273|dgordon@aclaristx.com|
22307953|NCT06647238|Atrium Health|Lyndsi Roland|828-434-5434|lyndsi.roland@advocatehealth.org|
22307954|NCT05494788|Cardiol Therapeutics Inc.|Andrea B. Parker, MSc., PhD, Senior Director of Clinical Operations|+1 289 9100862|andrea.parker@cardiolrx.com|
22307955|NCT01771731|University of California San Francisco|Donald I. Abrams, MD|415-476-4082|Donald.Abrams@ucsf.edu|444
22307956|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012||
22307957|NCT00073749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307958|NCT02272816|Centre for Experimental Cancer Medicine, Barts Cancer Institute, QMUL|Project Lead|02078828277|bci-carpet@qmul.ac.uk|
22307959|NCT02672033|Jonsson Comprehensieve Cancer Center|Dr. Percy Lee|310 825-9771|percylee@mednet.ucla.edu|
22307960|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com|
22307961|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de|
22307962|NCT04095104|University of Colorado School of Medicine|Jaime Moore, MD MPH|303-724-8419|jaime.moore@cuanschutz.edu|
22307963|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22307964|NCT05321069|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22307965|NCT03547999|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22307966|NCT05048186|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22307967|NCT02412748|Rush University College of Nursing|Dr. Wrenetha Julion, Professor|3129426272|Wrenetha_A_Julion@rush.edu|
22307968|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000||
22307969|NCT04218266|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22307970|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu|
22307971|NCT00065260|NIH NHLBI|Dr. Bhavisha Patel|301.402.3477|bhavisha.patel@nih.gov|
22307972|NCT00879060|Tufts Medical Center|Martin Maron, MD|(617) 636-8066|mmaron@tuftsmedicalcenter.org|
22307973|NCT04011631|SMART Clinical Products|Ellie Coumans|+31 (0)6 53 82 70 16|e.coumans@smartclinicalproducts.com|
22307974|NCT04820686|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
22307975|NCT01424670|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22307976|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
22307977|NCT01494922|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307978|NCT04377308|The University of Toledo Department of Psychiatry|Cheryl McCullumsmith, M.D., Ph.D.|419-383-5669|cheryl.mccullumsmith@utoledo.edu|
22307979|NCT05123742|Rutgers School of Dental Medicine|Cecile A. Feldman, DMD, MBA|9739724634|feldman@sdm.rutgers.edu|
22307980|NCT00972439|USC/Norris Comprehensive Cancer Center|Celeste Pearce, Ph.D.|323 865 0437|cpearce@usc.edu|
22307981|NCT02150967|QED Therapeutics, Inc.|David van Veenhuyzen, Vice President, Clinical Development|1 650 391-9740|david.vanveenhuyzen@bridgebio.com|103
22307982|NCT02891915|Vanderbilt Vaccine Research Program|Dr. C. Buddy Creech|615-343-0332|buddy.creech@vanderbilt.edu|
22307983|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128||
22307984|NCT01037985|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22307985|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22307986|NCT05239182|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22263619|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22263620|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263621|NCT02618382|Dignity Health Research Institute|Lisa Arnold, Clinical Research Operations Manager|602-406-9593|lisa.arnold@arrowneuro.org|
22263622|NCT03223909|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22293665|NCT04288752|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
22293666|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com|
22293667|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com|
22293668|NCT03576495|Brigham and Women's Hospital|Dr. Douglas S. Smink|617-983-7260|dsmink@bwh.harvard.edu|
22293669|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com|
22293670|NCT05306977|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
22293671|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk|
22293672|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com|
22293673|NCT02058693|Collaborative Behavioral Health|Michael Topel PsyD|847-922-3253|michaeltopel@gmail.com|
22293674|NCT03558087|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22293675|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu|
22293676|NCT03855228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293677|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org|
22293678|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300||
22293679|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca|
22293680|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22293681|NCT02468674|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22293682|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22293683|NCT01650844|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
22293684|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293685|NCT01687998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22293686|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu|
22293687|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu|
22293688|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22293689|NCT02785432|UT Southwestern|Jason Zafereo|146481002|jason.zafereo@utsouthwestern.edu|146481002
22293690|NCT02432729|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|christelle.haziza@pmi.com|
22293691|NCT03663816|University of Florica|Sharareh Sharififar|352-273-7410|sharareh75@phhp.ufl.edu|
22293692|NCT00871260|The University of Chicago|Dr. Amit Patel|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
22293693|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22293694|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu|
22293695|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu|
22293696|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il|
22293697|NCT00934089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293698|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov|
22293699|NCT01337700|Montefiore Medical Center, Albert Eins|Eric Hollander, MD|7189204287|eholland@montefiore.org|
22293700|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22293701|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
22293702|NCT01434667|Brigham and Women's Hospital|Kurt Christensen, PhD|(617) 264-5883|kchristensen@bwh.harvard.edu|
22293703|NCT02647203|University of Talca|Dr. Rodrigo Giacaman|+56712201546|giacaman@utalca.cl|2654
22293704|NCT02034110|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22293705|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623||
22293706|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com|
22293707|NCT01948947|VA San Diego Healthcare System|Valerie Metzger Smith, Study Coordinator|858-750-0274|valerie.metzgersmith@va.gov|
22293708|NCT03535844|National University of Singapore|Dr. Kim Jung Eun|+6565161136|fstkje@nus.edu.sg|
22293709|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22293710|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu|
22293711|NCT02835820|University of Alabama at Birmingham|Shannon Morrison|12059967841|samorris@uab.edu|
22293712|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22293713|NCT05096221|Sarepta Therapeutics Inc.|Sarepta Therapeutics Inc.|1-888-727-3782|SareptAlly@sarepta.com|
22293714|NCT02911857|Novartis Pharmaceuticals|Study Director|862-778-1873|Novartis.email@novartis.com|
22293715|NCT02061774|TTUHSC CRI|Cathy Lovett|806-743-4222|cathy.lovett@ttuhsc.edu|
22293716|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22293717|NCT03417219|VA Palo Alto Health Care System|Dr. Blake Scanlon|6504935000|blake.scanlon@va.gov|65316
22293718|NCT02581787|Stanford University|Maximilian Diehn, MD, PhD|(650) 721-1550|diehn@stanford.edu|
22275342|NCT03084237|Shanghai Henlius Biotech|Head of Clinical Development|+86 021-33395800|contact@henlius.com|
22275343|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com|
22275344|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22275345|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22275346|NCT04458922|National Cancer Institute|Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
22275347|NCT05432232|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
22275348|NCT02867592|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22275349|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com|
22293719|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu|
22293720|NCT02264639|Apellis Pharmaceuticals, Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22293721|NCT02727842|Cochlear Americas|Kimberly Nix, Clinical Project Manager|303-264-2340|knix@cochlear.com|
22293722|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22293723|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22293724|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293725|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org|
22293726|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22293727|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22293728|NCT01749631|AbbVie|Global Medical Information|800-633-9110||
22293729|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org|
22293730|NCT00003487|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22293731|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com|
22293732|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22307987|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22307988|NCT04428112|UCSF|Dr. Veronica Yank|415-476-9654|veronica.yank@ucsf.edu|
22307989|NCT04708509|The Ottawa Hospital|Dr. Andrew Seely|613-737-8899|aseely@toh.ca|74052
22307990|NCT04870645|M D Anderson Cancer Center|Jason Johnson, MD|713-792-8443|jasonjohnson@mdanderson.org|
22307991|NCT04924062|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22307992|NCT05768373|Solventum|Helen Han|6517856568|mhan3@solventum.com|
22307993|NCT05478525|Glyscend Therapeutics|Ashish Nimgaonkar, MD|6175483513|ashish.nimgaonkar@gmail.com|
22307994|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22307995|NCT01991977|Mayo Clinic|Nadia N. Laack, MD|507/284-2511|Laack.Nadia@mayo.edu|
22307996|NCT03433469|University of California, San Francisco|Dr. Collin M. Blakely, MD, PhD|(415) 502-6959|collin.blakely@ucsf.edu|
22307997|NCT04038957|Sumitomo Pharma America Inc|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22307998|NCT04799197|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22307999|NCT02605837|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22308000|NCT03845465|Vanderbilt University Medical Center|Sarah Jaser, PhD|6153436775|sarah.jaser@vumc.org|
22308001|NCT04491968|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman, Associate Professor|7322358569|cooperna@rwjms.rutgers.edu|
22308002|NCT02428192|DFCI|Dr. Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
22308003|NCT05656911|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22308004|NCT03547908|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22321288|NCT03246958|Dana Farber Cancer Institute (DFCI)|Dr. Kartik Sehgal|617-632-3090|kartik_sehgal@dfci.harvard.edu|
22263623|NCT05932810|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22263624|NCT02046317|The University of Texas Health Science Center at Houston|Carlos J Roldan, MD|713-745-7246|Carlos.J.Roldan@uth.tmc.edu|
22263625|NCT03287687|University of Iowa|Dr. Warren Bishop, Professor of Pediatrics|319 356 2977|warren-bishop@uiowa.edu|
22263626|NCT02988882|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22263627|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu|
22263628|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238||
22263629|NCT00974350|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22263630|NCT01344018|EORTC (European Organisation for Research and Treatment of Cancer)|EORTC HEADQUARTERS|+32 2 774 16 11|eortc@eortc.be|
22263631|NCT02351167|Washington University School of Medicine|Li-Shiun Chen, M.D.|314-362-3932|li-shiun@wustl.edu|
22263632|NCT04010227|Indiana University|Dr. Catherine Mosher|3172746769|cemosher@iupui.edu|
22263633|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22263634|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org|
22263635|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
22263636|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263637|NCT02308696|Univ. WI Madison|Amy Amessoudji|608-263-2621|amessoudji@surgery.wisc.edu|
22263638|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu|
22263639|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu|
22263640|NCT02914457|Medtronic Bakken Research Center|Richard Cornelussen|+31433566651|richard.cornelussen@medtronic.com|
22263641|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
22293733|NCT00843856|Imperial College NHS Trust|Dr Megan Griffith|02083835272|megan.griffith1@nhs.net|
22293734|NCT03104543|Fred Hutchinson Cancer Center|Dr. Eric Chow|206-667-7724|ericchow@uw.edu|
22293735|NCT03698409|SUNY Upstate medical University|Assistant Profressor|3154644243|zidan@upstate.edu|
22293736|NCT02993757|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22293737|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org|
22293738|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch|
22293739|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22293740|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22293741|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com|
22293742|NCT02015754|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22293743|NCT02229383|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22293744|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu|
22293745|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org|
22293746|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu|
22293747|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu|
22293748|NCT05764408|Prisma Health|Dr. Melissa Wise|8644551600|melissa.wise2@prismahealth.org|
22293749|NCT04659928|The University of Texas Health Science Center at Houston|Claudia Ruiz Brisuela, DDS|713-486-4138|Claudia.RuizBrisuela@uth.tmc.edu|
22293750|NCT06934993|Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine|Dr. Abdulgani Orhun YENİGÜN|+90 05346214600|orhunyenigun@gmail.com|
22293751|NCT01218113|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293752|NCT02823431|Duke Biomedical Engineering|Warren Grill PhD|(919) 660-5276|warren.grill@duke.edu|
22293753|NCT00544466|City of Hope Medical Center|Dr. Jeffrey Wong, MD|6263598111|JWong@coh.org|
22293754|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293755|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
22293756|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il|
22293757|NCT03281577|Takeda|Medical Director|+1-877-825-3327|takedadisclosures@takeda.com|
22293758|NCT01644565|Enteric Diseases Department, Naval Medical Research Center|Ramiro L. Gutierrez, MD, MPH|301-319-3193|ramiro.gutierrez@med.navy.mil|
22293759|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
22293760|NCT01594281|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@novartis.com|
22293761|NCT03542474|Northwestern University|Dr. Daniel Corcos|312-908-6792|daniel.corcos@northwestern.edu|
22293762|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu|
22293763|NCT01193530|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Medicine|713-792-6085|rdev@mdanderson.org|
22293764|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22293765|NCT01945281|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293766|NCT02577978|Northwestern Medicine|David W Manning|3124726023|David.Manning@nm.org|
22293767|NCT05074667|Stanford University|Sejal Shah, MD|650-498-7351|sshah2@stanford.edu|
22293768|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000|ngentile@temple.edu|8402
22293769|NCT02478632|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293770|NCT01867424|National Cancer Institute|Dr. Ismail Baris Turkbey|301-443-2315|turkbey@nih.gov|
22293771|NCT04645953|Alexza Pharmaceuticals Inc.|Dan Myers, PhD, VP Product & R&D|(650) 210-6164|dmyers@alexza.com|
22293772|NCT04613375|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293773|NCT03783949|UZLeuven|Ellen Reynders, SC|+3216342996|ellen.reynders@uzleuven.be|
22293774|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22293775|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623||
22293776|NCT01705730|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22293777|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293778|NCT05673889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293779|NCT04891978|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22293780|NCT01776840|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22293781|NCT05338216|Northeastern University|Dr. Erin Meier|1 (617) 373-7438|e.meier@northeastern.edu|
22293782|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
22293783|NCT02589405|Galderma R&D|Stephanie Leclerc|492386706|stephanie.leclerc@galderma.com|+33
22293784|NCT04208997|Vanderbilt University Medical Center|Dr Giovanni Davogustto|6159361720|giovanni.e.davogustto@vumc.org|
22321289|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22321290|NCT04086823|Raziel Therapeutics|Racheli Gueta , Director of Clinical trials|97289124670|racheli@raziel-therapy.com|
22263642|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca|
22293785|NCT02693119|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-(617) 600-6888|jim.carr@stealthbt.com|
22293786|NCT01719783|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22293787|NCT01350492|William S. Middleton Memorial Veterans Hospital|Aaron J. Stegner, Ph.D.|608-262-1290|aaron.stegner@va.gov|
22293788|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov|
22275350|NCT03699748|Stanford University|Dr. Manali Patel|6504859462|manalip@stanford.edu|
22275351|NCT03818854|University of California San Francisco|Dr. Michael Matthay|415-476-1079|michael.matthay@ucsf.edu|
22275352|NCT01222299|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22275353|NCT02866643|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
22275354|NCT01420536|Araraquara Dental School -Universidade Estadual Paulista (Sao Paulo State University)|Prof. Marco Antonio Compagnoni|+55-16-3331-6411|compagno@foar.unesp.br|
22275355|NCT04711005|Duke University School of Medicine|Michelle Mack|919 613 1107|michelle.mack@duke.edu|
22308005|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22308006|NCT03236441|UT Southwestern Medical Center|Oladipupo Olafiranye, MD, MS|2148572923|oladipupo.olafiranye@utsouthwestern.edu|
22308007|NCT04059354|University of Wisconsin - Madison, Waisman Center|Houri K. Vorperian, PhD, Senior Scientist Emerita|608-213-3257|vorperian@waisman.wisc.edu|
22308008|NCT02349412|Massachusetts General Hospital Cancer Center|Jennifer Temel, MD|(617) 724-0453|jtemel@partners.org|
22308009|NCT00567398|Vantive|Clinical Trials Disclosure Group|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22308010|NCT03517553|University of Iowa|Dr Bradley S. Dixon|319-356-1626|bradley-dixon@uiowa.edu|
22275356|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308011|NCT03271151|Anesthesiology Critical Care & Pain Management|Dr. Jacques Yadeau|2127742224|Yadeauj@hss.edu|
22263643|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411|angela.kirby@va.gov|5526
22293789|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888|clinical.research@medapharma.de|01
22263644|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov|
22263645|NCT04254809|Southeast Louisiana Veterans Health Care System|Joseph Boffa, PhD|504-507-2000|joseph.boffa@va.gov|67372
22263646|NCT02972515|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
22263647|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22263648|NCT04531527|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22263649|NCT01266603|U T MD Anderson Cancer Center|Dr. Michael A Davies, BA,MD,PHD/Melanoma Medical Oncology|713-792-3454|MDavies@mdanderson.org|
22263650|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net|
22263651|NCT02725411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263652|NCT04307849|NYU Langone Health|Marie Brault, PhD|210-276-9012|Marie.Brault@nyulangone.org|
22263653|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu|
22263654|NCT02654015|Icahn School of Medicine at Mount Sinai|Samantha St. Elin|(212) 241-1497|samantha.stelin@mountsinai.org|
22263655|NCT02846233|University of California San Francisco, Fresno Medical Education Program|SOE NAING|5593239236|snaing@fresno.ucsf.edu|
22263656|NCT02418754|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22263657|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu|
22263658|NCT04784637|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
22263659|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com|
22263660|NCT02762994|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
22263661|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu|
22263662|NCT05103657|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263663|NCT02020967|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
22263664|NCT01104090|The University of Texas Health Science Center at Houston|Davide Cattano, MD, PhD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
22263665|NCT02387762|Acerta Pharma|Ahmed Hamdy, MD, VP of Early Development|650-591-2800|a.hamdy@acerta-pharma.com|145
22263666|NCT04203667|Interscope, Inc.|Alexis James, Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
22263667|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu|
22263668|NCT02132650|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
22263669|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22275357|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545|girayesra@hotmail.com|6515
22293790|NCT03800173|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22293791|NCT02149719|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22293792|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293793|NCT02127710|AstraZeneca|Senior Medical Director, Savolitinib||ClinicalTrialTransparency@astrazeneca.com|
22293794|NCT04718961|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22293795|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293796|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22293797|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293798|NCT03763175|MAST Program|Director of Clinical Trials|(310) 423-0617|GroupMedicineMAST@cshs.org|
22293799|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22293800|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343||
22293801|NCT05248867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22293802|NCT03704467|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22293803|NCT03128411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293804|NCT00345839|Amgen Inc.|Study Director|866-572-6436||
22293805|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000|Yannick.Tousignant-Laflamme@USherbrooke.ca|72912
22293806|NCT03928353|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
22293807|NCT04547712|Medtronic Neuromodulation|Helen Berrier|763-526-8178|helen.berrier@medtronic.com|
22293808|NCT05544734|Weill Cornell Medicine|Dr Shari Lipner|6469623376|shl9032@med.cornell.edu|
22293809|NCT02989714|University of Michigan Rogel Cancer Center|Ajjai Alva, MD|734-936-0091|ajjai@umich.edu|
22293810|NCT03298867|Horizon Pharma USA, Inc.|Suzy Hammel|866-479-6742|clinicaltrials@horizontherapeutics.com|
22293811|NCT02963649|Medtronic|Giulia Gatta, Clinical Study Manager|+310629467793|giulia.gatta@medtronic.com|
22293812|NCT05263895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293813|NCT03749447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22293814|NCT04096963|Boston Scientific Corperation|Associate Clinical Trial Manager|+861085742971|yifan.zhao@bsci.com|
22293815|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22293816|NCT02550106|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
22293817|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator||clinicaltrials@regeneron.com|
22293818|NCT04218695|BIDMC|Dr. Zachary Fricker|6176321070|zfricker@bidmc.harvard.edu|
22293819|NCT03166735|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263670|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263671|NCT02614898|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
22263672|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300||
22308012|NCT02201108|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22308013|NCT03535727|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, M.D.|443-287-0002|Dle@jhmi.edu|
22308014|NCT03055377|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22308015|NCT04143061|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22308016|NCT02287311|Baylor College of Medicine|Dr. Rayne Rouce|832-824-4647|rouce@bcm.edu|
22308017|NCT02991534|VA Greater Los Angeles Healthcare System|Dr. Bevanne Bean-Mayberry|818-891-7711|bevanne.bean-mayberry@va.gov|36009
22308018|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
22308019|NCT04048681|Beth Israel Deaconess Medical Center|Dr. Olivia Farr|6176678636|ofarr@bidmc.harvard.edu|
22308020|NCT04579250|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22308021|NCT02919449|Vyriad|Alice Bexon MD Chief Medical Officer|+1-617-417-7300|alice.bexon@bexonclinical.com|
22308022|NCT01881412|Rhode Island Hospital and Brown University|Dr. Aris Garro|401-480-8682|arisgarro1@gmail.com|
22308023|NCT03144518|University of Nottingham|Dr Kieran Ayling|+44 1158466908|kieran.ayling@nottingham.ac.uk|
22308024|NCT02374307|OsloMet - Oslo Metropolitan University|Maria Bjerk|+4767236683|maria.bjerk@oslomet.no|
22263673|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22263674|NCT03493919|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263675|NCT04428645|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
22263676|NCT00243152|Boston Children's Hospital|Dr. David Borsook|617-281-7135|david.borsook@childrens.harvard.edu|
22263677|NCT02710240|University of Pennsylvania|Marie Kerr, Project Manager|215-829-6720|marie.kerr@pennmedicine.upenn.edu|
22263678|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263679|NCT02812771|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22263680|NCT02014441|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22263681|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br|
22263682|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org|
22263683|NCT02576717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22263684|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22263685|NCT00114231|Memorial Sloan Kettering Cancer Center|Julio Garcia-Aguilar, MD|212-639-5506|garciaaj@mskcc.org|
22263686|NCT02156154|Cleveland Clinic|Alparslan Turan, MD|216-445-0998|turana@ccf.org|
22263687|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com|
22263688|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca|
22263689|NCT03330236|Yale University|Lingzhong Meng, MD|(203) 785-2198|lingzhong.meng@yale.edu|
22263690|NCT01191476|Abbott|Global Medical Services|800-633-9110||
22263691|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov|
22263692|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu|
22263693|NCT00928226|Stanford University|Scott Soltys, Associate Professor of Radiation Oncology|65072441569|sgsoltys@stanford.edu|
22263694|NCT03765996|Dr. İsmail Atabek Physiotherapy and Rehabilitation Center|Ertan Şahinoğlu|+90 532 647 86 53|ertan.sahinoglu@hotmail.com|
22263695|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22263696|NCT00955552|Eurofarma Laboratórios|Eurofarma Laboratórios|08007043876||
22263697|NCT02940730|University of Colorado|Dr. Tyree Kiser|3037242883|ty.kiser@ucdenver.edu|
22263698|NCT02960438|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22263699|NCT01522950|University of Minnesota|Jay N. Cohn, M.D., Professor of Medicine|612.625.5646|cohnx001@umn.edu|
22263700|NCT01795079|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mhg.harvard.edu|
22263701|NCT03519282|CooperVision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|MNguyen@coopervision.com|
22263702|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22263703|NCT03449199|Teijin America, Inc.|President|1-415-887-9742|clinical-trials-contact@teijinpo.com|
22263704|NCT03307564|SKCCC @ Johns Hopkins|Amol Narang. MD|410-955-7390|anarang2@jhmi.edu|
22263705|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720|rdickson@nanospectra.com|216
22263706|NCT02744755|Hexal AG/Sandoz Inc.|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
22263707|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
22263708|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22263709|NCT04523324|Centers for Disease Control and Prevention|Dr. Ashley Fowlkes|4046394830|afowlkes@cdc.gov|
22263710|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340|nmoser@cmcc.ca|319
22263711|NCT04364737|NYU Langone Health|Mila B. Ortigoza, MD, PhD|646-634-7803|Mila.Ortigoza@nyulangone.org|
22263712|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22263713|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263714|NCT03440424|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22275358|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu|
22275359|NCT05965752|Duke University|Daniel Laskowitz, MD|919-684-0056|daniel.laskowitz@duke.edu|
22275360|NCT05619471|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
22275361|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300||
22275362|NCT02634177|Genomind|Chief Medical Officer|267-989-3461|dkrause@genomind.com|
22275363|NCT02634710|Froedtert and the Medical college of Wisconsin|Ciani Ellison, MD|414-805-4400|cellison@mcw.edu|
22275364|NCT04530630|Weill Cornell Medicine|Catherine Small, MD|212-746-9803|cbs9003@med.cornell.edu|
22275365|NCT00850642|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275366|NCT06128954|Orphalan SA|Carla Bennett|07918380893|carla.bennett@orphalan.com|
22275367|NCT05335161|Purdue University|Bruno Tesini Roseguini|7654962612|brosegui@purdue.edu|
22275368|NCT05352763|Cassava Sciences|Project Manager|5125013180|closedstudyinfo@cassavasciences.com|
22275369|NCT01288430|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22275370|NCT02555254|CHU Nantes|Jean-Baptiste Lascarrou|+33251446572|jeanbaptiste.lascarrou@chu-nantes.fr|
22275371|NCT00788671|UT MD Anderson Cancer Center|Dr. Shannon N. Westin, MD, Associate Professor, Gyn Onc & Reproductive Med|(713) 794-4314|swestin@mdanderson.org|
22275372|NCT04780659|Karolinska University Hospital|Soo Aleman Sponsor representative|+46 72595 7225|soo.aleman@regionstockholm.se|
22275373|NCT03729362|Amicus Therapeutics, Inc.|Patient advocacy|001 6096622000|clinicaltrials@amicusrx.com|
22275374|NCT03405870|University of Florida College of Medicine|Dr. Faheem Guirgis, MD|352-733-1469|fguirgis@ufl.edu|
22275375|NCT02987868|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
22275376|NCT02807259|Karnataka Health Promotion Trust|Prakash Javalkar|+91 80 4040 0200|prakashj@khpt.org|
22275377|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu|
22275378|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275379|NCT04588259|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22275380|NCT01673386|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22275381|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22275382|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org|
22275383|NCT02688803|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
22275384|NCT04476043|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22275385|NCT02100631|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research||dcassie@ebsi.com|
22275386|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
22275387|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590||
22275388|NCT03427411|National Cancer Institute|Dr. Julius Strauss|240-858-3999|julius.strauss@nih.gov|
22275389|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
22275390|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org|
22275391|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com|
22275392|NCT02156258|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22275393|NCT03738696|University of Alabama at Birmingham, Department of Orthopaedics|Dr. Amit Momaya|205-930-8339|amomaya@uabmc.edu|
22275394|NCT02631057|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275395|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com|
22275396|NCT04757636|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
22275397|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22275398|NCT02606253|Lipscomb University College of Pharmacy|Dr. Zachary Cox, Associate Professor|6159667163|zac.cox@lipscomb.edu|
22275399|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22275400|NCT03426878|Kaiser Permanente Center for Health Research|Joanna Bulkley, PhD|5033352400|joanna.e.bulkley@kpchr.org|
22275401|NCT03704064|University of Florida|Dr. Rebecca Pearl, Assistant Professor|352-294-5405|rebecca.pearl@ufl.edu|
22275402|NCT05033041|Northwestern University|Paul C. Fitzgerald,RN,BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22275403|NCT06469372|Columbia University Irving Medical Center|Timothy J. Poterucha, MD|(212) 932-4537|tp2558@cumc.columbia.edu|
22293820|NCT01543958|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22293821|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
22293822|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
22293823|NCT00681083|Fisher & Paykel Healthcare|Hansinie Laing|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|8601
22293824|NCT01819831|Loma Linda University Health|Gary Yang, Professor, Chair of Radiation Medicine|909 558 4444|gyang@llu.edu|
22293825|NCT01513343|Baylor College of Medicine|Dr. Sheryl O. Hughes, Associate Professor|713-798-7017|shughes@bcm.edu|
22293826|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22293827|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu|
22293828|NCT02165215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22293829|NCT01877265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22293830|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
22293831|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu|
22275404|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22275405|NCT01067586|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
22275406|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com|
22275407|NCT01451372|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22275408|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com|
22275409|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
22275410|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
22275411|NCT01434511|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22275412|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
22275413|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012||
22275414|NCT04062227|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|Bhavani.X.Kashyap@HealthPartners.com|
22275415|NCT04682301|Fred Hutchinson Cancer Center|Madison Snidarich, Clinical Research Coordinator|2066674589|msnidari@fredhutch.org|
22275416|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22275417|NCT06015490|Virginia Polytechnic Institute and State University|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
22275418|NCT02642042|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
22275419|NCT04108468|Leeds Teaching Hospital Trust|Professor Helena Marzo-Ortega|+44 (0) 113 392 4848|H.Marzo-Ortega@leeds.ac.uk|
22275420|NCT03260023|Transgene|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
22275421|NCT03506061|Emory University|Eric Sorscher, MD|205-612-1327|esorscher@emory.edu|
22275422|NCT05035407|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scoot.norberg@nih.gov|
22275423|NCT04220021|University of Florida|Laura P.W. Ranum, PhD|(352) 294-5209|ranum@ufl.edu|
22275424|NCT04386785|Venclose|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
22275425|NCT06121609|Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Scien|aijun xu|+8618627784217|ajxu@tjh.tjmu.edu.cn|
22275426|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
22275427|NCT04935879|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22275428|NCT03054428|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22275429|NCT01652690|Amgen Inc.|Study Director|866-572-6436||
22275430|NCT03880474|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
22275431|NCT03225287|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22275432|NCT03036267|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
22275433|NCT06070610|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22275434|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
22275435|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com|
22275436|NCT05019430|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
22275437|NCT05032183|The Univeristy of Texas MD Anderson Cancer Center|Ghayas Issa MD./Associate Professor|713-745-6798|GCIssa@mdanderson.org|
22275438|NCT03834961|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22275439|NCT05539131|Yongin Severance Hospital|Woo Jung Kim|01092827943|woojungkim@yuhs.ac|
22275440|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com|
22275441|NCT01648764|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275442|NCT03801252|University of Oklahoma Health Sciences Center|Dr. Stephanie Pierce|(405) 271-8787|stephanie-pierce@ouhsc.edu|
22275443|NCT02443077|University of California|Dr. Charalambos Andreadis|415-353-8363|candreadis@medicine.ucsf.edu|
22275444|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22275445|NCT01027949|United Therapeutics|Louis Holdstock, PhD|919-425-8866|lholdstock@unither.com|
22275446|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
22275447|NCT03315949|College of Medicine, The Catholic University of Korea|Dr. Tae-Geun Gweon|82 32 340 2228|gweontae@naver.com|
22275448|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22275449|NCT02805998|UCSF|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
22275450|NCT01107015|University of Maryland, Baltimore|Cindy Geppi|4107062406||
22275451|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040|wkatabam@its.jnj.com|22025
22275452|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22275453|NCT01208051|University of Chicago|Chih-Yi Liao, MD|(773) 702-6241|andyliao@medicine.bsd.uchicago.edu|
22275454|NCT02349386|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
22275455|NCT00973973|AbbVie|Global Medical Services|800-633-9110||
22275456|NCT02471339|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
22275457|NCT06057064|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22275458|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu|
22275459|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu|
22293832|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
22263715|NCT01190930|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22263716|NCT02407171|Yale School of Medicine|Allison Campbell, MD/PhD: Assistant Professor of Clinical Therapeutic Radiology|(203) 863-3700|allison.campbell@yale.edu|
22308025|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22263717|NCT05070754|Medical University of South Carolina|Dr. Lara Wine Lee|(843) 792-3021|winelee@musc.edu|
22263718|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22263719|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org|
22263720|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
22263721|NCT02958319|Servicio de Reumatología del Hospital Universitario|David Vega-Morales MD|52 81 80485210|drdavidvega@yahoo.com.mx|
22263722|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263723|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com|
22308026|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22263724|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22263725|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22263726|NCT03937791|National Cancer Institute|Scott Norberg, D.O.|301-275-9668|scott.norberg@mail.nih.gov|
22263727|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com|
22263728|NCT01819064|Women and Children's Hospital of Buffalo, State University of New York at Buffalo|Dr. Jerrold Lerman|7168787701|jlerman@buffalo.edu|
22263729|NCT04155840|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
22263730|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22263731|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22263732|NCT04079452|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
22263733|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
22263734|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org|
22308027|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske||clinicaltrials@horizonpharma.com|
22263735|NCT03496298|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22308028|NCT00448669|National Institutes of Health|Dr. Michael Thigpen|1-240-669-2877|michael.thigpen@nih.gov|
22308029|NCT04287985|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
22308030|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
22263736|NCT01658995|Mayo Clinic|Petra M. Casey, M.D.|507-266-9873|Casey.Petra@mayo.edu|
22263737|NCT00676494|Pathway Medical Technologies, Inc.|Kevin Peters/Director of Clinical Affairs|425-636-4053|petersk@pathwaymedical.com|
22263738|NCT02608476|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22263739|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22263740|NCT05862844|School of Medicine, Virginia Commonwealth University|Asmaa Namoos|804-628-4754|Asmaa.Namoos@vcuhealth.org|
22263741|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com|
22263742|NCT04106817|WCCT Global|Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
22263743|NCT02260635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263744|NCT03310619|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22263745|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
22263746|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22263747|NCT03604549|Penn State Health Milton S. Hershey Medical Center|Richard S. Legro, M.D., Principal Investigator|717-531-6210|rsl1@psu.edu|
22308031|NCT02789020|University of Florida|David Vaillancourt|3522941770|vcourt@ufl.edu|
22308032|NCT01691079|University of California, San Francisco|Mona Luke-Zeitoun, MD||lukezeitounm@peds.ucsf.edu|
22308033|NCT04238247|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Michelle Macy|312-227-6676|mmacy@luriechildrens.org|
22263748|NCT04660032|University of Michigan|Dr. Jourdan Triebwasser|734-764-1406|jtriebwa@med.umich.edu|
22263749|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590||
22263750|NCT02767947|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
22263751|NCT03224520|University of Massachusetts Medical School|Rajani Sadasivam|508-856-8923|rajani.sadasivam@umassmed.edu|
22308034|NCT05512962|Oxular Limited|Friedrich Asmus, MD|'+1 631 292 1207|friedrich.asmus@oxular.com|
22308035|NCT04315181|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
22308036|NCT01948661|E.O. Ospedali Galliera|Andrea DeCensi|010563|andrea.decensi@galliera.it|4501
22308037|NCT02886286|University Hospitals Cleveland Medical Center|Salim M. Hayek, MD, PhD|2168442685|salim.hayek@uhhospitals.org|
22263752|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com|
22263753|NCT00756717|Loyola University Medical Center|Dr. Kathy Albain|708-327-3102|KALBAIN@lumc.edu|
22263754|NCT03573336|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22263755|NCT03108820|University of Wisconsin School of Medicine and Public Health|Dr. Ben Zarzaur|(608) 265-9574|zarzaur@surgery.wisc.edu|
22263756|NCT03298880|University of Exeter, Royal Devon and Exeter Hospital|Dr Andrew Appelboam, Isabel FitzGerald|07515688294|andy.appelboam@nhs.net ; if223@exeter.ac.uk|
22263757|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org|
22263758|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22308038|NCT01127373|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
22275460|NCT02736617|Oregon Health and Sciences University, Knight Cancer Institute|Dr. Stephen E. Spurgeon, Associate Professor of Medicine|503-494-8950|spurgeos@ohsu.edu|
22275461|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125||
22275462|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300||
22275463|NCT02911116|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22275464|NCT01240694|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22275465|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22275466|NCT02110693|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|276
22275467|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com|
22275468|NCT01881425|InnFocus, Inc. (a Santen Company)|Sharon Herbert, Director of Global Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22275469|NCT00397579|University of Texas Southwestern Medical Center at Dallas|Clinical Research Office|214-648-7097|studyfinder@utsouthwestern.edu|
22275470|NCT02524119|UT Southwestern Medical Center|Dr. Muhammad Beg|2146484180|Muhammad.Beg@UTSouthwestern.edu|
22275471|NCT02054156|Seattle Children's Hospital|Margaret Kloster|2068847862|margaret.kloster@seattlechildrens.org|
22275472|NCT04154956|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22275473|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693||
22275474|NCT04424901|UConnHealth|Ellen Ciesielski|860-679-6004|eciesielski@uchc.edu|
22293833|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22293834|NCT01539694|Bausch Health|Study Director||robert.steffen@bausch.com|
22293835|NCT04401423|Columbia University Irving Medical Center|Dr. Jeanine D'Armiento / Principal Investigator|212-305-3745|jmd12@cumc.columbia.edu|
22293836|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22293837|NCT04678661|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
22293838|NCT02643381|UT-Southwestern Medical Center|Gerald Matchett|214-648-6400|gerald.matchett@utsouthwestern.edu|
22293839|NCT03039283|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
22293840|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22293841|NCT02193867|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22293842|NCT03639935|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22293843|NCT02924571|NYU Langone Health|Themistocles Protopsaltis|646-501-7200|themistocles.protopsaltis@nyulangone.org|
22293844|NCT00864721|Ocala Oncology, Ocala, FL, USA|Dr. Craig Reynolds|352-732-4032|Craig.Reynolds@USOncology.com|
22293845|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com|
22293846|NCT01921387|Seattle Cancer Care Alliance|Ajay Kumar Gopal, MD, Director of Clinical Research|(206) 606-2037|agopal@uw.edu.org|
22293847|NCT01773733|"FEDERAL STATE BUDGETARY INSTITUTION ENDOCRINOLOGY RESEARCH CENTRE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"|Prof. Ivan I . Dedov, Director of the Endocrinology Research Centre|+7 499 124 4300|dedov@endocrincentr.ru|
22293848|NCT01315665|Riley Hospital for Children|James Chmiel|317-948-7180|jfchmiel@iu.edu|
22293849|NCT00261807|U. of Maryland Medical Systems, R Adams Cowley Shock Trauma Center|Dr. Manjari Joshi|410-328-3656|mjoshi@som.umaryland.edu|
22293850|NCT03992014|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293851|NCT03416946|Orthopaedic Innovation Centre|Trevor Gascoyne|204-926-1235|tgascoyne@orthoinno.com|
22293852|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
22293853|NCT01439633|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
22293854|NCT01081678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22293855|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu|
22293856|NCT00900237|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22293857|NCT01619423|PledPharma AB|Stefan Carlsson, MD, PhD, Chief Medical Officer|+46 8 679 72 10|stefan.carlsson@pledpharma.se|
22293858|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov|
22293859|NCT04159571|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
22293860|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org|
22293861|NCT03478657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22293862|NCT02590003|Yale University|Rogerio C. Lilenbaum, MD, Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow|(203) 200-5864|rogerio.lilenbaum@yale.edu|
22293863|NCT03733470|University of Iowa|Eric Hoffman, PhD|319-365-1381|eric-hoffman@uiowa.edu|
22293864|NCT02983825|University of Pennsylvania|Nicolas Bamat, MD MSCE|2155904010|bamatn@email.chop.edu|
22293865|NCT02989545|Shaare Zedek Medical Center|Dr. Dan Livovsky|+972525622398|danlivo@szmc.org.il|
22293866|NCT04457336|Spruce Biosciences|Dina Ayala-Jones, Associate Director, Clinical Development Operations|424.558.1211|djones@sprucebio.com|
22293867|NCT01554683|Beth Israel Deaconess Medical Center|Dr. Daniel Press|617-667-4074|dpress@bidmc.harvard.edu|
22293868|NCT02506465|Medi-Tate / Olympus|Sivan Baker|+97247701839|sivan.baker@olympus.com|
22293869|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu|
22293870|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
22293871|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
22293872|NCT03993132|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22293873|NCT00239590|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
22293874|NCT02169479|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22263759|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800|naveed.siddiqui@uhn.ca|5270
22263760|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
22263761|NCT03168906|Tufts Medical Center|Jaime Chisholm|617-636-5409|jchisholm1@tuftsmedicalcenter.org|
22263762|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300||
22263763|NCT01621906|Memorial Sloan Kettering Cancer Center|Dr. Andrew Seidman, MD|646-888-4559|seidmana@MSKCC.ORG|
22263764|NCT04231409|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
22263765|NCT02839798|Butler Hospital|Dr. Linda Carpenter|401-455-6349|Linda_Carpenter_MD@brown.edu|
22263766|NCT03180528|Stanford University|Kavita Yang Sarin|(650) 723-6316|ksarin@stanford.edu|
22263767|NCT02447887|Fox Chase Cancer Center|Dr. Daniel M. Geynisman|215-728-3889|daniel.geynisman@fccc.edu|
22263768|NCT03429049|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
22263769|NCT04703855|Abbott|Carlo Gazzola|+3227746811|carlo.gazzola@abbott.com|
22263770|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca|
22263771|NCT04412057|Avalo Therapeutics, Inc.|Scott White, MD|484-763-3080|swhite@avalotx.com|
22263772|NCT02457819|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22263773|NCT06217796|Eyenovia|Greg M. Bennett, VP, Clinical Program Strategy and Development|833-393-6684|gbennett@eyenovia.com|5
22263774|NCT02740920|Canadian Cancer Trials Group|Janet Dancey|613-533-2430|jdancey@ctg.queensu.ca|
22263775|NCT01064531|Smith & Nephew, Inc|Tracey Brengola, MS|978-749-1491|Tracey.brengola@smith-nephew.com|
22263776|NCT00513617|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
22263777|NCT03136406|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22263778|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu|
22263779|NCT00906373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263780|NCT03346850|The University of Texas Health Science Center at Houston|Raymond Parlar-Chun, MD|713-500-5666|Raymond.L.Chun@uth.tmc.edu|
22263781|NCT02418455|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22263782|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
22263783|NCT02001051|National Cancer Institute|Dr. Dhaval Patel|301-827-4989|pateldt@nih.gov|
22263784|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22263785|NCT04205162|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22263786|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
22263787|NCT05181800|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22263788|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22263789|NCT00779402|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22263790|NCT01519947|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22263791|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu|
22263792|NCT01992016|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
22263793|NCT01186016|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
22263794|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu|
22263795|NCT03750695|Duke University|Dr. William Todd Cade|919-660-9825|todd.cade@duke.edu|
22263796|NCT03173560|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22263797|NCT02174276|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22263798|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu|
22263799|NCT02661022|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|877-332-7967|clinicaltrials@menarinistemline.com|
22263800|NCT02525263|CTI|Dr William S Aronstein|5135989290|baronstein@ctifacts.com|
22263801|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263802|NCT04480307|GeNeuro SA|David Leppert, Study director|225524800|dl@geneuro.com|+41
22293875|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
22293876|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl|
22293877|NCT03407625|University of Texas Southwestern Medical Center|Emily Adhikari, MD|214-648-7825|emily.adhikari@utsouthwestern.edu|
22293878|NCT03351933|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22293879|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22293880|NCT02151110|MedImmune LLC|David Howe, MBChB, MD, MRCOG|+44 (0) 1223 895980|information.center@astrazenea.com|
22293881|NCT01999179|Versiti|Dr Lisa Baumann Kreuziger|414-937-6826|lisakreuziger@versiti.org|
22293882|NCT01146665|University of Alberta|Dr. Amanda Newton|780-248-5581|an6@ualberta.ca|
22293883|NCT02403986|Q-Med AB|Cecilia Skoglund, Manager Study strategy and publications|46 18 474 9000|cecilia.skoglund@galderma.com|
22293884|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22293885|NCT00001880|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
22293886|NCT02639065|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22293887|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu|
22263803|NCT00609154|Albert Einstein College of Medicine|Dr. Daniel Stein|718-430-2237|daniel.stein@einsteinmed.edu|
22263804|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu|
22321291|NCT01650636|University of Miami|Dr. Michael Antoni|305-284-5466|mantoni@miami.edu|
22263805|NCT00434837|Rhode Island Hospital|Dr. Braden C. Fleming|401-316-4737|braden_fleming@brown.edu|
22263806|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
22263807|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com|
22263808|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu|
22263809|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22263810|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu|
22263811|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
22263812|NCT05467982|Dartmouth-Hitchcock|Sarah Pratt, PhD-Contact PI|603-496-2665|sarah.i.pratt@dartmouth.edu|
22263813|NCT00176930|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
22263814|NCT03507686|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22263815|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263816|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca|
22263817|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263818|NCT04728620|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22321292|NCT01560780|VA North Texas Healthcare System|Shuaib Abdullah|214-857-1458|shuaib.abdullah@va.gov|
22321293|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com|
22321294|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000|laurafleider@hotmail.com|8582
22321295|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22321296|NCT01500278|Cares|UCB|+1877 822||9493
22321297|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu|
22321298|NCT01157364|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22321299|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321300|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu|
22321301|NCT02370875|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22321302|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423|alarias@uchc.edu|4423
22321303|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22321304|NCT02631525|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
22321305|NCT03292809|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
22321306|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22321307|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393||
22321308|NCT00689572|University of Virginia|Nassima Ait-Daoud Tiouririne, M.D.|(434)243-0570|nat7b@virginia.edu|
22321309|NCT03303794|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
22321310|NCT02813694|Nabriva Therapeutics US, Inc|Jennifer Schranz, M.D., Chief Medical Officer|610 981 2842|jennifer.schranz@nabriva.com|
22321311|NCT04474795|Washington University In St. Louis School of Medicine|Cynthia Herrick, MD, MPHS|3147470278|herrickc@wustl.edu|
22321312|NCT02980224|Brace Consulting Group Inc.|Jeremy Brace, President|7274582823|jbrace@braceconsultinggroup.com|
22321313|NCT00879645|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22321314|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321315|NCT03042715|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
22321316|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22321317|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr|
22321318|NCT02700997|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
22321319|NCT04770389|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22263819|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org|
22263820|NCT04084990|Washington University in St. Louis|Alexander Hincker, Associate Professor of Anesthesiology|3143231312|hinckera@wustl.edu|
22263821|NCT03185741|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22263822|NCT00749658|University of Minnesota|Marc Mooney PhD||moon0078@umn.edu|
22263823|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22263824|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
22263825|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263826|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu|
22263827|NCT03840382|Rhode Island Hospital|Dr. Larry Brown|+1 (401) 793-8808|lkbrown@lifespan.org|
22263828|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743||
22263829|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs|
22263830|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263831|NCT04773600|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22263832|NCT04974736|Massachusetts General Hospital|Jonathan P. WInickoff|(617) 726-2728|jwinickoff@mgh.harvard.edu|
22321320|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300||
22321321|NCT04514523|Yale School of Medicine|Dr. Kasia Lipska|203-737-4853|kasia.lipska@yale.edu|
22275475|NCT04810962|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
22275476|NCT01348269|University Hospital Wuerzburg - Department of Orthopaedics (Clinical Study Unit)|Dr. Lothar Seefried|+499318033590|l-seefried.klh@uni-wuerzburg.de|
22275477|NCT00805532|VA Portland Health Care System|Amy W. Wagner, Ph.D.|(503) 220-8262|amy.wagner@va.gov|33365
22275478|NCT01859741|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
22275479|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca|
22275480|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456|lebai@ntu.edu.tw|63352
22275481|NCT00920816|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275482|NCT03185208|University of Pittsburgh|Ariel Gildengers, M.D.|412-246-6002|ariel.gildengers@pitt.edu|
22275483|NCT03834350|University of Chicago|Dr. Valerie Press|773-702-5170|vpress@bsd.uchicago.edu|
22275484|NCT02567422|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22275485|NCT02765165|Proximagen, LLC|Chief Medical Officer|952-658-7440|tcmeng@proximagen.com|
22308039|NCT01066026|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|55 51 30262633|cientifico@cbed.org.br|
22275486|NCT02511717|Lawson Health Institute|Dr Blayne Welk|5196466000|lawson@lawsonsresearch.com|
22275487|NCT02382939|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22275488|NCT02026297|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
22275489|NCT01189266|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22275490|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275491|NCT05824026|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
22308040|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308041|NCT02371395|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
22308042|NCT01101451|NRG Oncology|Helen Huang on behalf of Wei Deng Ph.D.|7168452318|huangh@nrgoncology.org|
22308043|NCT00136435|Dana Farber Cancer Institute|Dr. Dan DeAngelo|617-582-8410|Daniel_Deangelo@dfci.harvard.edu|
22308044|NCT03148496|The University of Texas Health Science Center at Houston|Julie Holihan, MD|713-500-7188|Julie.L.Holihan@uth.tmc.edu|
22308045|NCT00390299|Mayo Clinic|Evanthia Galanis, M.D.|+1 (507) 266-0584|Galanis.Evanthia@mayo.edu|
22308046|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
22308047|NCT02965846|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
22308048|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com|
22308049|NCT02794480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308050|NCT01070069|Endologix|Elisa Hebb|949-598-4628|ehebb@endologix.com|
22308051|NCT03101930|Vanderbilt University Medical Center|Dr. James M. Luther, MD MSCI (Principal Investigator)|(615) 936-3420|james.luther@vumc.org|
22308052|NCT02814838|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22308053|NCT01747486|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
22308054|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308055|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308056|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22308057|NCT05158153|University of California, San Francisco|Dr. Ian McCoy|415-476-2172|ian.mccoy@ucsf.edu|
22308058|NCT05928624|Columbia University|Giuseppe Cullaro, MD MAS|8454067438|gc2576@cumc.columbia.edu|
22308059|NCT03638427|Stanford University|Paul Blumenthal, MD|(650) 725-6035|gynresearch@stanford.edu|
22308060|NCT04402294|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22308061|NCT04459416|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng, MD, PhD|646-608-8556|dengg@MSKCC.ORG|
22308062|NCT03744312|Columbia University|Patrick J. Lao, PhD|212-305-9079|pjl2133@cumc.columbia.edu|
22308063|NCT04955717|USC|Dr. Jeffrey D. Klausner|415-876-8901|jdklausner@med.usc.edu|
22308064|NCT03888989|Stanford University|Philip Grant|650-521-3540|pmgrant@stanford.edu|
22308065|NCT03611153|Mayo Clinic|Dr. Barry A. Borlaug|507-255-2200|borlaug.barry@mayo.edu|
22308066|NCT05338086|mAbxience Research S.L.|Susana Millan , PhD|(+34) 917.711.500|Susana.Millan@mabxience.com|
22308067|NCT03424811|University of Pennsylvania|Tanja Kral|(215) 573-7512|tkral@nursing.upenn.edu|
22308068|NCT03805594|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|Rahul.Aggarwal@ucsf.edu|
22308069|NCT05931861|Laboratoires Théa|Clinical Affairs Director|0473981436|Corentin.LECAMUS@theapharma.com|
22308070|NCT05141903|Prolacta Bioscience|Dr. David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
22308071|NCT03467542|Terumo Neuro|Robert Gash|714-247-8000|robert.gash@microvention.com|
22308072|NCT05387447|University of Nebraska Medical Center|Marcia Shade|402-559-6641|marcia.shade@unmc.edu|
22308073|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22308074|NCT04178733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22308075|NCT03679611|Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network|Dr. Jean Wong, MD, FRCPC.|416-603-5800|tojean.wong@uhn.ca|3635
22308076|NCT05126862|University of Virginia School of Nursing|Jessie Gibson, PhD, RN|434-924-0107|js6zn@virginia.edu|
22308077|NCT03655132|VA Bedford Healthcare System|Dr. Erin D. Reilly|781-724-4191|Erin.Reilly@va.gov|
22308078|NCT04119284|Nemours Hospital for Children|Suken Shah, MD, Orthopedics Department Chair|3025472557|suken.shah@nemours.org|
22308079|NCT02651324|Albany medical center|Farzana Afroze|518-262-4300|afrozef@amc.edu|
22308080|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br|
22321322|NCT03817775|• Department of Anaesthesia and Intensive Care, American Hospital of Paris|Dr Gilles BOCCARA|+33 1 46 41 25 25|gilles.boccara@ahparis.org|
22321323|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321324|NCT04048616|Tufts University and Tufts Medical Center|Lisa Ceglia, MD MS|(617) 636-8171|lisa.ceglia@tuftsmedicine.org|
22321325|NCT03099187|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22321326|NCT03885089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321327|NCT03349099|Cleveland Clinic|Manoj Monga MD|216-445-8678|mongam@ccf.org|
22321328|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu|
22321329|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173|karenand@rm.dk|0045
22321330|NCT04869345|Cornell University|Dr. Anthony Ong|6072559993|anthony.ong@cornell.edu|
22321331|NCT01500759|ResMed Germany Inc|Medical Affairs CRS|089990100|ClinicalResearch&Strategy@ResMed.com|
22321332|NCT00528021|Boston Scientific Corporation|Jessie Stockwell|612-618-1136|jessie.stockwell@bsci.com|
22321333|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu|
22321334|NCT05054114|SPP Pharmaclon Ltd.|Julia Isakova|81079055353311|isakova@pharmaclon.ru|
22321335|NCT01779024|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
22321336|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th|
22321337|NCT03077685|NanOlogy, LLC|Mark Mitchell|8179004074|Mark.Mitchell@dfb.com|
22321338|NCT02116777|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22321339|NCT03770260|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22321340|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22321341|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com|
22321342|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
22321343|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu|
22321344|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu|
22321345|NCT03955133|Swansea University|Professor Sue Jordan|+44 (0) 1792518541|s.e.jordan@swansea.ac.uk|
22321346|NCT02135692|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22321347|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu|
22321348|NCT01097746|UT MD Anderson Cancer Center|Dr. Anil K. Sood, MD/Professor, Gyn Onc & Reproductive Med|(713) 745-5266|asood@mdanderson.org|
22321349|NCT01514682|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
22321350|NCT00769002|Hackensack University Medical Center|Dr. David Schwartz|551-996-2000|DSchwartz@hackensackumc.org|
22321351|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22321352|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321353|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22321354|NCT00001379|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
22321355|NCT03405259|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22321356|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22321357|NCT03958552|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
22321358|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22321359|NCT00607386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22321360|NCT02671136|Loma Linda University Health|Ahmed Khocht|909 558 4000|akhocht@llu.edu|
22321361|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321362|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org|
22321363|NCT02970292|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261-2897|medicalinformation@acadia-pharm.com|
22321364|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu|
22321365|NCT02511730|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22321366|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org|
22321367|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321368|NCT04486950|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22321369|NCT02821715|Theranexus|Chief medical officer|+33680026779|werner.rein@theranexus.fr|
22263833|NCT01923311|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22263834|NCT02304406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263835|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu|
22263836|NCT04129944|Unity Biotechnology, Inc.|Chief Medical Officer|650-416-1192|Clinicaltrials@unitybiotechnology.com|
22263837|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org|
22321370|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321371|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com|
22321372|NCT02374099|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22321373|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351||
22321374|NCT04294719|Centre for Addiction and Mental Health|Courtney Brennan|4165358501|courtney.brennan@camh.ca|
22321375|NCT01714687|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
22321376|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22321377|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu|
22321378|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu|
22321379|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22321380|NCT02911922|Weill Cornell Medicine - New York Presbyterian Hospital|Josephine Kang, M.D. Ph.D.|212-746-3607|jok9106@med.cornell.edu|
22321381|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321382|NCT06080451|University of Michigan|Dr. David Flood|734-647-2892|dcflood@umich.edu|
22321383|NCT01210690|UCB|UCB Cares|+1 877 822 9493||
22263838|NCT02717078|University of Minnesota|Anne Bantle|612-625-8673|endofixer@umn.edu|
22263839|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com|
22321384|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321385|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22321386|NCT01076049|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
22293888|NCT05147428|UMass Chan Medical School|Jerry H. Gurwitz, MD|508-856-3085|jerry.gurwitz@umassmed.edu|
22321387|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22321388|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321389|NCT04294901|VA Boston Healthcare System|Amy Linsky, MD, MSc|857-364-2760|amy.linsky@va.gov|
22321390|NCT01733628|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22293889|NCT03128047|Hackensack Meridian Health|Jeanette Haugh|5519963457|Jeanette.haugh@hmhn.org|
22293890|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22321391|NCT02589496|Samsung Medical Center|Jeeyun Lee|82234101779|jyunlee@skku.edu|
22293891|NCT02385045|Imperial College London|Professor Julian Teare|02033126666|j.teare@ic.ac.uk|
22293892|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org|
22293893|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com|
22293894|NCT01235351|TIMI Study Group|Jessica L. Mega, MD, MPH|6172780145|jmega@partners.org|
22321392|NCT01934556|Palmetto Retina Center, LLC|John F. Payne, MD|(803) 931-0077|jpayne@palmettoretina.com|
22293895|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com|
22293896|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu|
22321393|NCT03471065|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22293897|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22321394|NCT02909985|University of New Mexico|L. Olivia Hopkins|(505) 925-7769|LHopkins@salud.unm.edu|
22293898|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
22321395|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22293899|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22321396|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com|
22293900|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
22293901|NCT02980601|Wake Forest Baptist Health|Joseph Molnar|336-716-4171|jmolnar@wakehealth.edu|
22321397|NCT02495844|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22293902|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
22321398|NCT03678402|The Ohio State University Wexner Medical Center|Dr. Tammy Moore|6142937847|tammy.moore@osumc.edu|
22321399|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22293903|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com|
22321400|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22321401|NCT01594853|Kennedy Krieger Institute|Kathleen Zackowski|443-923-2716|zackowski@kennedykrieger.org|
22321402|NCT03124823|Masimo|Tala Harake||studies@masimo.com|
22293904|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321403|NCT05396742|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22321404|NCT04677712|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
22293905|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22321405|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu|
22293906|NCT00799383|Baylor College of Medicine|Chadi Calarge, MD|832-824-4764|chadi.calarge@bcm.edu|
22293907|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22293908|NCT01259128|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22321406|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22293909|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314|gkatzonis.tasos@gmail.com|0030
22293910|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu|
22293911|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com|
22293912|NCT03486223|Vanderbilt University Medical Center|Dr. James M Luther|6153223353|james.luther@vumc.org|
22293913|NCT01023620|UT Southwestern Medical Center|Dr. Michael Limerick|214-590-0611|Michael.Limerick@UTSouthwestern.edu|
22293914|NCT02417831|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293915|NCT05166824|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22321407|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at|
22321408|NCT05525533|University of California, San Francisco|Jenny Liu|6503800762|jenny.liu2@ucsf.edu|
22321409|NCT01032915|Novartis|Study Director|862-778-8300||
22321410|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155||
22321411|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111|gwen.lawrence@nhs.net|8362
22321412|NCT02915523|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
22263840|NCT04403399|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
22263841|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com|
22308081|NCT05919082|LEO Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22293916|NCT03068130|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22293917|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz|
22293918|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
22293919|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org|
22293920|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn|
22293921|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu|
22293922|NCT03741062|University of Manitoba|Dr. Brian Wiens|613-809-4501|wiensb3@myumanitoba.ca|
22293923|NCT02527161|Stryker SP|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
22293924|NCT02609828|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293925|NCT01517711|University of Cincinnati College of Medicine|Dr. Thomas Geracioti, Principle Investigator|513-748-9825|thomas.geracioti@uc.edu|
22293926|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293927|NCT01979445|The Medicines Company|Global Health Science Center, The Medicines Company|1-888-977-6326|medical.information@themedco.com|
22293928|NCT03068455|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22293929|NCT05379231|National Centre for Audiology|Dr. Susan Scollie|519 661-2111|scollie@nca.uwo.ca|88948
22293930|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com|
22293931|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu|
22293932|NCT00702689|National Institute of Arthritis and Musculoskeletal and Skin Diseases|Edward Cowen, M.D.|301-827-2328|cowene@mail.nih.gov|
22293933|NCT01986907|Novartis Pharmaceuticals|Study Director|+41613241111|trialandresults.registries@novartis.com|
22293934|NCT02805972|University of California San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
22293935|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu|
22293936|NCT00939640|University of Michigan|Dr. Scott Hummel|734-998-7991|scothumm@med.umich.edu|
22293937|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it|
22293938|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com|
22293939|NCT01706978|The Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|78377
22293940|NCT00306189|Amgen Inc.|Study Director|866-572-6436||
22293941|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu|
22293942|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22293943|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22308082|NCT05439603|Ancora Bio, Inc dba EmbarkNeuro|Chief Medical Officer|610 871-4891|info@embarkneuro.com|
22308083|NCT03854578|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308084|NCT05461131|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
22308085|NCT03896516|National Institute on Drug Abuse (NIDA)|Dr Lorenzo Leggio, M.D., Ph.D.|1-667-312-5188|lorenzo.leggio@nih.gov|
22308086|NCT03739450|UT Southwestern Medical Center|Dr. Shannon Juengst|8328480674|Shannon.Juengst@UTSouthwestern.edu|
22293944|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22293945|NCT02653183|Universitair Ziekenhuis Gent|Prof. Dr. Hilde Beele|+32 9 332 21 11|Hilde.Beele@uzgent.be|
22293946|NCT00939770|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22293947|NCT04665856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22293948|NCT03386448|The Taub Group|Neal Taub MD|7044429805|nealtaub@gmail.com|
22293949|NCT02564796|UC San Diego|Dr. David Werho|(858) 966-5855|dwerho@rchsd.org|
22293950|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22293951|NCT01586065|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
22293952|NCT02450591|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
22293953|NCT02538029|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
22293954|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com|
22293955|NCT03483740|University of Toronto|Andrew Eaton|4169788895|andrew.eaton@utoronto.ca|
22293956|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu|
22293957|NCT02383498|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22293958|NCT01703039|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
22293959|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22293960|NCT02342327|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22293961|NCT01700725|University of Wisconsin - Madison|David Rabago, MD|608-843-0850|david.rabago@fammed.wisc.edu|
22293962|NCT05996718|Georgia State University|Candace L. Kemp|404-413-5216|ckemp@gsu.edu|
22293963|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu|
22293964|NCT04840615|National Cancer Institute|Dr. Raffit Hassan|240760-6232|rh276q@nih.gov|
22293965|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu|
22308087|NCT05968495|Pearl Plastic Surgery|Christopher Nichols, MD|360-878-9300|cnichols@pearlplasticsurgery.com|
22293966|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com|
22263842|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22293967|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu|
22263843|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22263844|NCT03710590|Virginia Commonwealth University|Dr. Alison Breland|804 628 2300|abbrelan@vcu.edu|
22263845|NCT02488824|VAORD|Dr John Handrakis|(718) 584-9000|John.Handrakis@va.gov|5439
22263846|NCT01976728|Ferring Pharmaceuticals|Clinical Development Support|+1 833-548-1402|DK0-Disclosure@ferring.com|
22263847|NCT02356211|TVHS GRECC, Nashville TN|James S. Powers MD, Clinical Associate Director, GRECC|615-873-8032|james.powers2@va.gov|
22321413|NCT02797808|University of Minnesota|Dr. Gail Bernstein|612-625-1632|berns001@umn.edu|
22293968|NCT02200211|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22321414|NCT04338815|University of Nebraska-Omaha|Philippe Malcolm|617-487-1148|pmalcolm@unomaha.edu|
22293969|NCT02501473|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263848|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
22263849|NCT01563237|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22263850|NCT02211014|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
22263851|NCT04057248|Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)|Dr. Alan Schorr|2157501691|abs@sugardoc.com|
22263852|NCT03180801|SEEK|Dr Olga Pleguezuelos|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
22321415|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
22263853|NCT04735068|University of Pennsylvania|Melissa Volpe|215-220-9703|melissa.volpe@Pennmedicine.upenn.edu|
22263854|NCT03173170|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22263855|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263856|NCT05966090|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22321416|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
22263857|NCT00367016|University of California-Davis, Department of Dermatology|Fu-Tong Liu, M.D., Ph.D.|916-734-6556|fliu@ucdavis.edu|
22293970|NCT02954237|Abbott|Jordan Anderson, Clinical Scientist|651-756-3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
22293971|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu|
22293972|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
22293973|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu|
22293974|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22293975|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
22263858|NCT01734694|Augusta University|Jose Vazquez|(706) 723-0105|JVAZQUEZ@augusta.edu|
22263859|NCT01303068|University of New Mexico|Hengameh Raissy|5052725484|hraissy@salud.unm.edu|
22263860|NCT03585959|Medtronic|Katie Bayliss|(763) 647-5547|katie.j.bayliss@medtronic.com|
22263861|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263862|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22263863|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263864|NCT03843125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22263865|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
22263866|NCT02359864|William Beaumont Hospital|Dr. James Fontanesi, Professor of Neurosurgery, Director of Radiation Oncology|947-521-8121|james.fontanesi@beaumont.org|
22263867|NCT03460899|Medical University of Graz|Assoc.-Prof. Harald Sourij, MD|0043 316 385|ha.sourij@medunigraz.at|81310
22263868|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu|
22263869|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu|
22263870|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu|
22263871|NCT02907073|Mayo Clinic|Dr. Timothy R. DeGrado|507-293-3793|DeGrado.Timothy@mayo.edu|
22263872|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu|
22263873|NCT03316976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22263874|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu|
22263875|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov|
22263876|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu|
22263877|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22263878|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
22263879|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22293976|NCT01001377|Amgen Inc.|Study Director|866-572-6436||
22293977|NCT04343261|Saint Francis Hospital and Medical Center|Latha Dulipsingh, MD|860-714-4402|Latha.Dulipsingh@trinityhealthofne.org|
22321417|NCT03524339|Cleveland Clinic|Graham Chapman|440-312-2229|gchapman5@gmail.com|
22293978|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
22293979|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22321418|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22321419|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918||
22293980|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org|
22321420|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22321421|NCT05051904|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22293981|NCT04600375|University of Arkansas for Medical Sciences|Dr. Vivian Shi|5015266994|VYShi@uams.edu|
22293982|NCT03330288|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22293983|NCT04447794|University of Alaska Anchorage|Dr. Patrick Dulin|(907) 786-1653|pldulin@alaska.edu|
22293984|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111|office@jsw-lifesciences.com|310
22293985|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com|
22321422|NCT01242267|Hackensack Meridan Health|Joshua Zenreich|5519964248|Joshua.Zenreich@hmhn.org|
22293986|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com|
22293987|NCT03463512|Abbott|Suntje Sander|+495116750|suntje.sander@abbott.com|3254
22293988|NCT04203498|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22293989|NCT01202565|AbbVie|Global Medical Services|800-633-9110||
22293990|NCT00334958|Eisai Medical Services|Eisai Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22293991|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net|
22293992|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
22293993|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov|
22293994|NCT02762578|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22293995|NCT01090492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22293996|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22293997|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com|
22293998|NCT02718157|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
22293999|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294000|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294001|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca|
22294002|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22294003|NCT00941005|University of Wisconsin - Madison|Jeffrey Larson, MD|(608) 417-6175|larsonjef@surgery.wisc.edu|
22294004|NCT03583697|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 792-756-5104|alice.huntsmanlabed@bmrn.com|
22294005|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22294006|NCT02929667|University of Iowa|Dr. Rup Sainju|319-356-4337|rup-sainju@uiowa.edu|
22294007|NCT00404235|Mayo Clinic|Svetomir N. Markovic, MD, Ph.D|(507) 284-1370|markovic.svetomir@mayo.edu|
22294008|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com|
22294009|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482||
22294010|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22294011|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294012|NCT02610725|Massachusetts General Hospital|Louisa G. Sylvia, Ph.D.|617-643-4804|lsylvia2@mgh.harvard.edu|
22294013|NCT04094883|University of North Carolina at Chapel Hill|Joseph Duncan, MD, PhD|919-966-2536|joseph_duncan@med.unc.edu|
22294014|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com|
22294015|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
22294016|NCT02914119|Herlev Hospital, research unit, anesthesia|Dr. JLD Thomsen|004538633863|prs@demants.dk|
22294017|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com|
22294018|NCT03100500|Novartis Pharmaceuticals|Director|862-778-8300|novartis.email@novartis.com|
22294019|NCT02352974|4Pharma AB|Åsa Carlsheimer|+4672244516|asa.carlsheimer@4pharma.com|
22294020|NCT05570500|Ain Shams University|Dr. Omar Alaa Taqa|01001454416|o.a.taqa@hotmail.com|
22294021|NCT01095731|Columbia University Irving Medical Center|E. Sander Connolly Jr., MD|212-305-0376|esc5@cumc.columbia.edu|
22294022|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu|
22294023|NCT02302807|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294024|NCT03261973|Massachusetts General Hospital|Grace Ha|617-643-1697|gha2@mgh.harvard.edu|
22294025|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294026|NCT03000283|Allina Health|Dr. Jesse Corry|651-241-6550|Jesse.Corry@allina.com|
22294027|NCT03802227|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
22294028|NCT04731363|Cleveland Clinic Foundation|Dr. Stanley Hazen, MD|216-444-9426|hazens@ccf.org|
22294029|NCT04147221|Center for Anti Infective Research and Development|Dr. Joseph L. Kuti|860-972-3612|joseph.kuti@hhchealth.org|
22294030|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk|
22294031|NCT03192462|Baylor College of Medicine|Dr. Benjamin Musher|(713)798-3750|blmusher@bcm.edu|
22294032|NCT03187197|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294033|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22294034|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG|
22321423|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
22275492|NCT02366871|University of Colorado, Anschutz Medical Campus|Dr. Saketh Guntupalli|303-724-2033|saketh.guntupalli@cuanschutz.edu|
22294035|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org|
22294036|NCT02519036|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22294037|NCT03576976|New York State Psychiatric Institute|Dr. Alice Medalia|646-774-8482|am2938@cumc.columbia.edu|
22294038|NCT00300391|UPittsburgh|Barb Early, RN, BSN, CCRC|(412) 647-9745|earlybj@upmc.edu|
22263880|NCT03904550|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
22294039|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com|
22294040|NCT01270516|University of Kentucky|Emily Bradford, Clinical Trial Compliance Administrator|859) 323-2973|emily.bradford@uky.edu|
22263881|NCT03401918|Stanford University|Ruth Bunker Lathi|(650) 498-7911|clinicaltrials-gov@stanford.edu|
22294041|NCT02732119|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22294042|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com|
22294043|NCT02585960|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22294044|NCT02683161|Johns Hopkins University|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
22294045|NCT06333613|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|osova@its.jnj.com|
22294046|NCT01847274|GSK|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22294047|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org|
22263882|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22294048|NCT02059395|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
22294049|NCT00134082|Johns Hopkins University|Richard Ambinder, MD|4109558839|rambind1@jhmi.edu|
22294050|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com|
22294051|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22263883|NCT00685750|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263884|NCT03222037|Johnson & Johnson Vision Care, INC.|Chantal Coles-Brennan -PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
22294052|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu|
22294053|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu|
22294054|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com|
22294055|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu|
22294056|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
22263885|NCT04974580|Ohio State University College of Public Health|Dr. Elizabeth G. Klein|614-292-5424|klein.232@osu.edu|
22294057|NCT00695409|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
22263886|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294058|NCT02249585|Seoul National University Hospital|Dr Kook Hyun Lee, MD, PhD|82-2-2072-2467|leekh@snu.ac.kr|
22263887|NCT02539368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263888|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu|
22263889|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22263890|NCT03558139|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22263891|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com|
22263892|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov|
22263893|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG|
22294059|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu|
22294060|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU|
22294061|NCT01158157|Cangene Corporation|Christine Hall, Ph.D. Director Clinical|204-275-4248|chall@ebsi.com|
22294062|NCT02340975|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
22294063|NCT04003012|CAMC Institute of Academic Medicine|Dr. Stephanie Thompson|304-388-9911|stethompson@camc.org|
22294064|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22294065|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu|
22294066|NCT03948581|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22294067|NCT03173313|ZOLL Circulation, Inc.|Vice President of Clinical Affairs|(408) 541-2140|jcreech@zoll.com|
22294068|NCT01876420|Medtronic|Terry Noel|763-526-0309||
22294069|NCT04461210|University at Buffalo|Director of the Clinical and Translational Science Institute|7168884850|vmbarnab@buffalo.edu|
22294070|NCT02498132|University of Kansas|Professor Carl Lejuez|240-535-0467|clejuez@ku.edu|
22294071|NCT00730405|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294072|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294073|NCT02106975|Virginia Commonwealth University School of Medicine|Alpha A Fowler, III, MD|804-828-9071|alpha.fowler@vcuhealth.org|
22294074|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
22294075|NCT03546062|"Università degli studi della Campania luigi Vanvitelli"|Raffaele Marfella|+390815665110|raffaele.marfella@unicampania.it|
22263894|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22263895|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk|
22263896|NCT03689894|Dartmouth Hitchcock Medical Center|Director of Clinical Research|2167129120|sean.hobson@hitchcock.org|
22263897|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
22294076|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
22294077|NCT02572401|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
22294078|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294079|NCT00223262|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146456950|sherwood.brown@utsouthwestern.edu|
22294080|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22263898|NCT00709306|Fox Chase Cancer Center|Carolyn Heckman, PhD|215-214-3962|carolyn.heckman@fccc.edu|
22294081|NCT02243696|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
22263899|NCT01839695|Medtronic Vascular|Taryn Dellaripa, Principal Clinical Research Specialist|541-301-3181|taryn.dellaripa@medtronic.com|
22294082|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294083|NCT02935842|University Hospital Basel|Prof. Peter Fuhr|0041 61 265|peter.fuhr@usb.ch|41 66
22294084|NCT02774954|USCalifornia|Ricky Bluthenthal|3234428236|rbluthen@usc.edu|
22294085|NCT01201850|Children's Hospital Colorado|Margaret Macy, MD|720-777-5877|margaret.macy@childrenscolorado.org|
22294086|NCT04066023|Zosano Pharma Corporation|Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
22294087|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22294088|NCT03338010|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294089|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294090|NCT00293033|Meda Pharmaceuticals Inc.|Larry Gever, PharmD, Director, Medical Affairs|732-564-2400|larry.gever@meda.us|
22294091|NCT00837811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294092|NCT03835780|Centre for Musculoskeletal Research|Maya H Buch|+441613066000|maya.buch@manchester.ac.uk|
22294093|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu|
22263900|NCT02056652|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
22263901|NCT04511208|CCF|Daniel Sessler, MD|216-444-4900|sseslerd@ccf.org|
22263902|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300||
22263903|NCT04547036|Dept. Ophthalmology at Paracelsus Medical University Salzburg|PD Dr. Markus Lenzhofer PhD FEBO|+43 57255|m.lenzhofer@salk.at|24201
22263904|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com|
22263905|NCT03253094|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
22263906|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263907|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu|
22263908|NCT02625974|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22263909|NCT03941834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263910|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100|wen-chih.wu@va.gov|6237
22263911|NCT01124695|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22263912|NCT01119807|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
22263913|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300||
22263914|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22263915|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu|
22263916|NCT02265341|Mayo Clinic|Mitesh J. Borad, MD|480/301-8335|Borad.Mitesh@mayo.edu|
22263917|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263918|NCT03036839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22263919|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263920|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu|
22263921|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22263922|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu|
22263923|NCT03244475|VA San Diego Health System|Dr. Mingxiong Huang|858-534-1254|mingxiong.huang@va.gov|
22263924|NCT02548312|BMJ|Dr Sara Schroter|02073836744|sschroter@bmj.com|
22263925|NCT03170388|Bausch Health Americas, Inc|Study Director|5102595284|aloncaric@bauschhealth.com|
22263926|NCT02285634|Mayo Clinic|Dr. Tobias Kummer|507 255 4732|vanmeter.derek@mayo.edu|
22263927|NCT03764735|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
22263928|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263929|NCT01685073|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
22263930|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu|
22294094|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|
22294095|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu|
22294096|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu|
22294097|NCT01811654|NYU Langone Health|Dennis Cardone, DO|212-460-0176|ariel.aponte@nyumc.org|
22294098|NCT01898806|Columbia University|Grace Ulerio|212-305-6953|gu2102@cumc.columbia.edu|
22294099|NCT03003390|Yale University|Dr. E. Vincent S Faustino|203-785-4651|vince.faustino@yale.edu|
22294100|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294101|NCT00940225|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22294102|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294103|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu|
22294104|NCT03311724|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294105|NCT01433991|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22263931|NCT01049412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22263932|NCT00804141|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22294106|NCT02955602|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
22263933|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411|hayden.bosworth@va.gov|6936
22294107|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249|ron.zimmerman@plxpharma.com|205
22263934|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315|markku.h.vaarala@ppshp.fi|2840
22294108|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294109|NCT02734940|Virginia Commonwealth University|Dr. Jessica Potter|(804) 828-2755|jessica.potter@vcuhealth.org|
22263935|NCT03235479|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22294110|NCT02551757|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
22263936|NCT04090879|Brown University|Jennifer W. Tidey|4018636418|jennifer_tidey@brown.edu|
22263937|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu|
22263938|NCT03110380|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22294111|NCT04666051|Menoufia Univeristy|M. Ashraf BAlbaa|+20482224216|mohamed.balbaa@med.menofia.edu.eg|
22294112|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
22263939|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org|
22263940|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu|
22294113|NCT03229278|Cancer Institute of New Jersey Rutgers|Dr. Biren Saraiya - Associate Professor of Medicine Medical Director, Office of Human Research Servi|732-235-5773|saraiybi@cinj.rutgers.edu|
22294114|NCT00980057|Medtronic, Inc|Adaptive CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|
22263941|NCT03417739|Dana Farber Cancer Institute|Elizabeth Buchbinder, MD|617-632-5055|Elizabeth_buchbinder@dfci.harvard.edu|
22294115|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756|nelsons@utad.pt|+351
22294116|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu|
22294117|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com|
22294118|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com|
22294119|NCT04160195|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22294120|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu|
22294121|NCT03766581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22294122|NCT03716024|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22294123|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
22294124|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca|
22294125|NCT05275400|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294126|NCT04566302|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
22294127|NCT01651039|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
22294128|NCT03727230|Guangzhou Blood Center|Director of Clinical Trials|+86-20 83595049|fuyongshui1969@yahoo.com|
22294129|NCT03600818|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22294130|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org|
22294131|NCT02837328|University of Minnesota|Pamela Lutsey, PhD MPH|612-624-5812|lutsey@umn.edu|
22294132|NCT02124083|National Institute of Child Health and Human Development|Porter, Forbes|+1 301 435 4432|fdporter@mail.nih.gov|
22294133|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590||
22294134|NCT04377620|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22294135|NCT04930965|Tulane University|Erin Peacock|504-988-1075|epeacoc@tulane.edu|
22294136|NCT05209360|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22294137|NCT03355820|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22294138|NCT04189081|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22294139|NCT00044083|Office of the Clinical Director-NIMH-NIH-HHS|Jose A. Apud|3015946561|apudj@mail.nih.gov|
22294140|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com|
22294141|NCT03758066|Dimagi, Inc.|Y. Xian Ho|617-649-2214|yho@dimagi.com|63
22294142|NCT00332163|Amgen Inc.|Study Director|866-572-6436||
22294143|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
22294144|NCT02000583|University of Kansas Medical Center|Jeffrey M. Burns MD|913-588-0555|jburns2@kumc.edu|
22294145|NCT03706079|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22294146|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294147|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22294148|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
22294149|NCT02284516|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22294150|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
22294151|NCT01306942|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22294152|NCT03988088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294153|NCT03344796|Northwestern Univ|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
22294154|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294155|NCT02412618|VCU Medical Center|Dr. Frances Casey|804-828-7877|frances.casey@vcuhealth.org|
22294156|NCT02516046|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22263942|NCT05889039|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
22294157|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300||
22294158|NCT03137537|Dana Farber Cancer Institute|Dr. Anju Nohria|6175257052|anohria@partners.org|
22294159|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu|
22294160|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
22294161|NCT02465515|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22294162|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu|
22308088|NCT03737058|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
22308089|NCT03984695|KUMCRI|Jaime Caldwell|913-588-1261|spa@kumc.edu|
22263943|NCT02795676|Protalix Ltd.|Sari Alon, MSc|+972-4-9028100|sari@protalix.com|215
22263944|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
22263945|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV|
22263946|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22263947|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300||
22263948|NCT02994290|Yale University|Dr. Sangini Sheth|203-785-5545|Sangini.Sheth@yale.edu|
22263949|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com|
22263950|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov|
22263951|NCT02997722|University of Mississippi Medical Center|Allen Richert, MD|(601) 984-4820|arichert@umc.edu|
22263952|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn|
22263953|NCT04381481|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-962-5907|mghall@unc.edu|
22263954|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22263955|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763|a.wexler@online.no|0074
22263956|NCT03430011|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22263957|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
22263958|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22263959|NCT04126343|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22263960|NCT01235442|Amgen Inc.|Study Director|866-572-6436||
22263961|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
22263962|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov|
22263963|NCT01701973|Vanderbilt University Medical Center|Dr. Jessica Devin|6159361665|jessica.devin@vanderbilt.edu|
22263964|NCT02663882|Yeshiva University|Dr. Andrea Weinberger|(646) 592-4474|andrea.weinberger@yu.edu|
22263965|NCT03712124|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22263966|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780|ctheuer@traconpharma.com|233
22263967|NCT01290237|Boston Children's Hospital|Dr. Alicia Demirjian||alicia.demirjian@post.harvard.edu|
22263968|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu|
22263969|NCT02941523|Noxopharm Limited|Clinical Manager|+61 499005049|marinella.messina@noxopharm.com|
22263970|NCT04330157|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
22263971|NCT04314843|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22263972|NCT00869440|PAION UK Ltd|Trial Information||reg_paion@paion.com|
22263973|NCT01899326|Albert Einstein College of Medicine|Dr. Amit Verma|718-430-4091|amit.verma@einsteinmed.edu|
22263974|NCT03581188|The University of Sydney, Australia|Associate Professor Katy Bell|+61 415 764 321|katy.bell@sydney.edu.au|
22263975|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org|
22263976|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
22263977|NCT01989676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263978|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585|tmoellerbertram@ucsd.edu|3123
22263979|NCT03907241|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22263980|NCT02190279|National Cancer Institute|Dr. Maria Liza Lindenberg|240-760-6109|liza.lindenberg@nih.gov|
22263981|NCT02688387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263982|NCT02938442|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
22263983|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22263984|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766||
22263985|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263986|NCT04100096|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800 562-3974|clinicaltransparency@otsuka-us.com|
22263987|NCT01684215|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22263988|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343||
22263989|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
22263990|NCT03785145|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22263991|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu|
22263992|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22263993|NCT04025684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22263994|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22294163|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22294164|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121|mi.ho@msa.hinet.net|2063
22321424|NCT00794677|Children's Hospital Oakland Research Institute|Ronald M Krauss|510.450.7912|rkrauss@chori.org|
22321425|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
22321426|NCT03350217|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
22263995|NCT01239472|Hospital e Maternidade Marieta Konder Bornhausen|Dr Andre Barreto Pereira|+55 47 984482826|andrebarper@yahoo.com.br|
22263996|NCT03662308|SPINAL CORD DAMAGE RESEARCH CENTER|Dr. John Handrakis|718.584.9000|john.handrakis@va.gov|3129
22263997|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22263998|NCT02695719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22263999|NCT01163084|UT MD Anderson Cancer Center|Logothetis, Christopher, M.D. / Genitourinary Medical Oncology|7137922830|clogothe@mdanderson.org|
22264000|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22264001|NCT01714739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
22264002|NCT02250651|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22264003|NCT01903564|University of Wisconsin-Madison|Ronald Wakai, Ph.D.|6082654988|rtwakai@wisc.edu|
22264004|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org|
22264005|NCT01466036|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
22264006|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577|wendy@teclabsinc.com|338
22264007|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com|
22264008|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22264009|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com|
22264010|NCT02913131|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
22264011|NCT01493596|Catalyst Pharmaceutical Partners, Inc.|Douglas Winship, Vice President of Regulatory Operations|305 529-2522|dwinship@catalystpharma.com|12
22264012|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22264013|NCT02630316|United Therapeutics|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22264014|NCT02508116|University of Pennsylvania School of Medicine|Sony Tuteja, PharmD, MS|215-573-7834|sonyt@pennmedicine.upenn.edu|
22264015|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu|
22264016|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623||
22264017|NCT04234464|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22264018|NCT03635983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22264019|NCT03604432|Corewell Health|Dr. Charles Willekes|616-459-7258|Charles.Willekes@corewellhealth.org|
22264020|NCT02578745|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
22264021|NCT00330460|Amgen Inc.|Study Director|866-572-6436||
22264022|NCT01857973|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22264023|NCT04458467|UC San Diego|John Finneran|(619) 543-2202|jfinneran@health.ucsd.edu|
22264024|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca|
22264025|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu|
22264026|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
22264027|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22264028|NCT03718117|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264029|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22264030|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264031|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com|
22264032|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu|
22264033|NCT03257254|Boston Scientific|Timothy Keo|425-599-3814|Timothy.Keo@bsci.com|
22264034|NCT02219308|University of California, San Diego|Dr. Sheila Mody|858-249-1205|smody@ucsd.edu|
22264035|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk|
22264036|NCT03169816|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@columbia.edu|
22264037|NCT04149535|Boston Scientific|Sarah Zanon - Director Clinical Trials, Interventional Cardiology|+41798407006|sarah.zanon@bsci.com|
22264038|NCT00966381|UNC Greensboro|Cheryl Lovelady|336 256-0310|cheryl_lovelady@uncg.edu|
22264039|NCT01915940|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22264040|NCT03686150|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
22264041|NCT02443324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22264042|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com|
22264043|NCT03346070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264044|NCT03404401|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22264045|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264046|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl|
22264047|NCT04894084|Coloplast A/S|Medical Affairs Project Manager|+4549111341|dkteaa@coloplast.com|
22264048|NCT02551679|Hemostemix|Dr. Fraser Henderson|2022978858|fhenderson@hemostemix.com|
22264049|NCT01573533|Mayo Clinic|Fernando C. Fervenza, M.D., Ph.D.|507-266-1045|Fervenza.Fernando@mayo.edu|
22308090|NCT04549168|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22308091|NCT05519228|ZimmerBio|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
22308092|NCT05535257|Mayo Clinic Florida|Suzanne Langley OTR/L|9044724288|langley.suzanne@mayo.edu|
22308093|NCT04864912|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22308094|NCT06320964|University of California, San Francisco|Nadia Diamond-Smith, PhD, MS|(415) 502-5800|nadia.diamond-smith@ucsf.edu|
22308095|NCT04469036|UC Davis Health|Raynald Dizon|9167344736|rodizon@ucdavis.edu|
22264050|NCT03122587|University of North Carolina at Chapel Hill|Stacey Daughters, PhD|9199629924|daughter@unc.edu|
22264051|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22264052|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264053|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
22264054|NCT00880087|University of Utah|Dr. Rich Holubkov, Professor of Pediatrics|807-587-3326|richard.holubkov@hsc.utah.edu|
22264055|NCT01002794|Oslo University Hospital|Professor May Arna Risberg|+4741312776|marisb@ous-hf.no|
22264056|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
22264057|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803||
22264058|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu|
22264059|NCT02147587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264060|NCT03068949|University of Rochester|Dr. Angela Branche|5852750526|angela_branche@urmc.rochester.edu|
22264061|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk|
22264062|NCT02531594|Cincinnati Children's Hospital Medical Center|Dr. Melinda Mahabee-Gittens|513-636-7966|melinda.mahabee-gittens@cchmc.org|
22264063|NCT03636386|Universidad Andrés Bello|Professor Hernán Andrés de la Barra Ortiz|+56984706322|quiropraxiayequilibrio@gmail.com|
22264064|NCT02255487|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
22264065|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22264066|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22264067|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu|
22264068|NCT03170869|University of Colorado|Dr. Thor Johnson|720-848-1765|thor.johnson@ucdenver.edu|
22264069|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com|
22264070|NCT00983528|UC San Diego|MCC Clinical Trials Office|(858) 534-5417|tkipps@ucsd.edu|
22264071|NCT04763278|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
22264072|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com|
22264073|NCT03073811|Durham VA Health Care System|Kathryn Starr, PhD, RD; Research Health Scientist|919-660-7571|kathryn.starr2@va.gov|
22264074|NCT00551616|HRA Pharma|Henri Mathé|+33140331130|medical2914@hra-pharma.com|
22264075|NCT02808819|AstraZeneca|AstraZeneca Information Center|+1 8002369933|information.center@astrazeneca.com|
22264076|NCT03297294|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264077|NCT02692482|Istituto Ortopedico Rizzoli|Cristiana Forni|0516366694|cristiana.forni@ior.it|0039
22264078|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300|jetnoyer@ssrehab.com|838
22264079|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22264080|NCT00133679|University of California, San Francisco|Roberta Keller, MD|(415) 476-1888|roberta.keller@ucsf.edu|
22264081|NCT00925756|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
22264082|NCT03314662|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22264083|NCT01393457|The University of Texas Health Science Center at Houston|Charles Green, PhD|713-500-6402|charles.green@uth.tmc.edu|
22264084|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264085|NCT04405739|Ridgeback Biotherapeutics|Wendy Painter, MD, MPH|786-687-2495|EIDD2801@ridgebackbio.com|
22264086|NCT05766787|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22264087|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu|
22264088|NCT01867606|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-4918|jatoi.aminah@mayo.edu|
22264089|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22264090|NCT01917968|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22264091|NCT03623035|Wake Forest Baptist Health|Christopher Edwards|3367168222|chedward@wakehealth.edu|
22264092|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351||
22264093|NCT03922139|UW School of Medicine and Public Health|Michael Suer, MD|608-265-3207|suer@rehab.wisc.edu|
22264094|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22264095|NCT02248662|Dana-Farber Cancer Institute|Rinaa Punglia, MD|617-582-8759|rinaa_punglia@dfci.harvard.edu|
22264096|NCT01835548|Neos Tx|Carolyn Sikes, PhD|972-408-1300|csikes@neostx.com|1255
22264097|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
22264098|NCT02490800|Basilea Pharmaceutica International Ltd, Allschwil|Thomas Kaindl, MD|+41 61 567 15 24|thomas.kaindl@basilea.com|
22264099|NCT03365791|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264100|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300||
22264101|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22264102|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22264103|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr|
22321427|NCT03362970|University of Calgary|Stephen Freedman|403-955-7740|stephen.freedman@ahs.ca|
22275493|NCT03530696|George Washington Cancer Center|Dr. Pavani Chalasani|(202) 741-2277|pavani.chalasani@email.gwu.edu|
22275494|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu|
22275495|NCT02841046|Guangzhou Panyu central Hospital|Dr. Yang Lin|+8615915721012|salinyangyl@163.com|
22264104|NCT02843659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22275496|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275497|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu|
22275498|NCT04759131|Bioverativ Therapeutics Inc. (a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22275499|NCT03207399|Duke University Medical Center|Dr. Omar Mohamedaly|919-684-4589|omar.mohamedaly@duke.edu|
22275500|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov|
22275501|NCT04513366|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
22275502|NCT03344757|University of Miami|Dr. Frank Penedo|305-284-4290|fpenedo@miami.edu|
22275503|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22275504|NCT03043053|Massachusetts General Hospital|Elizabeth A. Lawson, MD, MMSc|617-726-3870|ealawson@mgh.harvard.edu|
22275505|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu|
22275506|NCT02139540|Washington University|Principal Investigator|7737022544||
22275507|NCT03533751|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22275508|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22275509|NCT03454555|RTI International|Dr. Lauren McCormack|919-541-6277|lmac@rti.org|
22275510|NCT05493111|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22275511|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300||
22275512|NCT03265964|VA Salt Lake City Health Care System, VISN 19 Rocky Mountain MIRECC for Veteran Suicide Prevention|Dr. Douglas Kondo|801-587-1549|douglas.kondo@va.gov|
22275513|NCT00890162|National Institute of Allergy and Infectious Diseases|Carter, Melody|+1 301 496 8772|mc396j@nih.gov|
22275514|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22275515|NCT01649765|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308096|NCT03606642|HonorHealth Research Institute|Joanne Saczynski, MSN, RN, ACRP-CP|480-323-1046|jsaczynski@honorhealth.com|
22308097|NCT04437433|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22308098|NCT02808676|Lawson Health Research Institute|Dr. Manuel Montero-Odasso|519-685-4292|manuel.monteroodasso@sjhc.london.on.ca|42179
22308099|NCT01549899|University of Arizona|Daniel J. Taylor, Ph.D.|5206219289|danieljtaylor@arizona.edu|
22308100|NCT04711135|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22308101|NCT02191085|University of Calgary|Dr. Sachin Pendharkar|403-210-8617|sachin.pendharkar@ucalgary.ca|
22264105|NCT03203642|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22308102|NCT03578536|Minneapolis VA Health Care System|Andrew Hansen, PhD|612-467-2910|Andrew.Hansen2@va.gov|
22308103|NCT02538900|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22308104|NCT03732820|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22308105|NCT04436107|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22308106|NCT04004325|FORMA Therapeutics, Inc.|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22264106|NCT02175368|Ivoclar Vivadent AG|Dr. Erik Braziulis||erik.braziulis@ivoclarvivadent.com|
22264107|NCT02875028|Medical University of Vienna|Bernd Jilma|+4314040029910|bernd.jilma@meduniwien.ac.at|
22264108|NCT05068284|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264109|NCT02760264|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
22264110|NCT05918822|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22264111|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22264112|NCT03250299|Basilea Pharmaceutica International Ltd (Basilea)|Thomas Kaindl, MD, Global Medical Director|+41615671505|thomas.kaindl@basilea.com|
22264113|NCT02948257|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|408-470-7119|Terry_Alverson@cardivamedical.com|
22308107|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308108|NCT05751785|The Geneva Foundation|Ms. Elizabeth Metzger, Senior Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
22308109|NCT00274469|AstraZeneca|Jasmine Lichfield|07585404954|jasmine.lichfield@astrazeneca.com|
22308110|NCT03338816|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22308111|NCT04950127|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308112|NCT01711632|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
22308113|NCT03517969|Dana Farber Cancer Institute|Dr. Atish D Choudhury|617-6326328|atish_choudhury@dfci.harvard.edu|
22308114|NCT03271489|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22308115|NCT02860130|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22308116|NCT02633267|University of Michigan|Dr. Joseph Himle|(734) 615-0611|himlej@umich.edu|
22308117|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22308118|NCT02713126|Mayo Clinic|Dr. Barry Borlaug|507-255-1051|borlaug.barry@mayo.edu|
22264114|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org|
22308119|NCT05450458|RodillaActiva Medical Center|Dr. Julio Carlos Vélez de Lachica|5215518338063|activeknee@gmail.com|
22308120|NCT02671435|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22264115|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22264116|NCT03008837|VAORD|Dr. Anna Woodbury|404-321-6111|anna.woodbury@va.gov|
22264117|NCT03325972|NYU Langone Health|Lisa Doan, MD|212.201.1004|Lisa.Doan@nyulangone.org|
22264118|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22264119|NCT00794417|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22264120|NCT02956616|Montefiore Medical Center|Peter S. Bernstein, MD, MPH|718-904-2767|pbernste@montefiore.org|
22264121|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22264122|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com|
22264123|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
22264124|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22264125|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
22264126|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se|
22308121|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
22264127|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu|
22264128|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121|wcchen@vghks.gov.tw|2139
22264129|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22264130|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu|
22264131|NCT04975321|University of Washington|Mariella Garcia|2065431740|mgarciaf@uw.edu|
22264132|NCT01280617|Lahey Hospital & Medical Ctr|Mary Ann Simpson, Ph.D|781-744-2500|Mary.a.Simpson@Lahey.org|
22264133|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br|
22264134|NCT02225665|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
22264135|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22264136|NCT03852524|Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22264137|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu|
22264138|NCT03488030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22264139|NCT02973321|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|
22264140|NCT05045469|CGMH|Dr. HuanHsuan Hsu|0978839349|10356017a@cgmh.org.tw|
22264141|NCT01845116|Atrium Health Levine Children's Hospital|Ricardo A. Caicedo, MD|704-381-8840|ricardo.caicedo@atriumhealth.org|
22264142|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264143|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743||
22264144|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264145|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748|pujithaw@yahoo.com|170
22264146|NCT00707434|UT MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22264147|NCT05212883|Duke University|Saira Siddiqui, M.P.H.|919-688-8464|saira.siddiqui@duke.edu|
22264148|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264149|NCT00614822|Christiana Care Health System|Dr. Michael Guarino|302 366 1200|mguarino@cbg.org|
22264150|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22264151|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22264152|NCT03476317|Children's Hospital of Philadelphia|Lindsey Albenberg, DO|267-426-0139|albenbergl@chop.edu|
22264153|NCT03649412|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22264154|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu|
22264155|NCT02865395|George Washington University|Dr. Patrick Mufarrij|2027154000|pmufarrij@gmail.com|
22264156|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22308122|NCT04128319|Xenikos|Eric van Hooren, Chief Development Officer|+31 6 109 345 84|e.vanhooren@xenikos.com|
22308123|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22308124|NCT02467166|University of California, San Diego Health System|Gregory K. Feld, MD, Director CCEP|(858) 246-2972|gfeld@health.ucsd.edu|
22308125|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22308126|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu|
22308127|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22308128|NCT02910713|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22308129|NCT04430634|Nerudia|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
22308130|NCT03859869|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22308131|NCT04442126|Numab Therapeutics AG|Josephine Adams|00447712295851|j.adams@numab.com|
22308132|NCT06450405|University of California, San Diego|Antoni Duleba|858-657-7000|aduleba@health.ucsd.edu|
22308133|NCT03767517|University of Alabama at Birmingham|Dr. Ronit Elk|205-996-1702|relk@uabmc.edu|
22308134|NCT04994509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22308135|NCT03152786|Wake Forest School of Medicine|Ashok Hemal, MD|336-716-5694|ahemal@wakehealth.edu|
22264157|NCT04364763|Renibus Therapeutics|Stacey Ruiz|682-285-1711|sruiz@renibus.com|
22264158|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
22264159|NCT01839838|Hospital of the University of Pennsylvania|Gary Freedman, MD|215-615-6767|Gary.freedman@pennmedicine.upenn.edu|
22308136|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294165|NCT02885012|Medical University of South Carolina|John Terrill Huggins|(843) 792-2296|hugginjt@musc.edu|
22275516|NCT02469233|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22275517|NCT04889040|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22275518|NCT03837847|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
22275519|NCT03726476|University of New Mexico Health Sciences Center|Cassandra Darley|505-967-8428|cjdarley@salud.unm.edu|
22275520|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979||
22275521|NCT02832037|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275522|NCT01038765|Radboud University Medical Centre|Anne E.M. Speckens|0031243610449|a.speckens@psy.umcn.nl|
22294166|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
22294167|NCT01918774|Richard L. Roudebush VA Medical Center|Marina Kukla|317-988-3330|marina.kukla2@va.gov|
22294168|NCT01619982|Stanford University|Chandra Ramamoothy|650-723-5728|chandrar@stanford.edu|
22294169|NCT03000439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294170|NCT01308060|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22294171|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu|
22294172|NCT01749137|Rhythm Pharmaceuticals, Inc|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22294173|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
22294174|NCT04980040|Takeda|Medical Director|+1 877-825-3327|trialdisclosures@takeda.com|
22294175|NCT03130257|Kaiser Permanente Washington Health Research Institute|Beverly B. Green, MD, MPH|206-287-2997|Bev.B.Green@kp.org|
22294176|NCT01508650|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-2227|dkitzman@wakehealth.edu|
22294177|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca|
22294178|NCT01976338|Novartis|Study Director|862-778-8300||
22294179|NCT01373242|University of North Carolina at Chapel Hill|Edwin Kim, MD; Director UNC Food Allergy Initiative|919-537-3193|edwinkim@email.unc.edu|
22294180|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294181|NCT00705484|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294182|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22294183|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
22294184|NCT00977860|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
22294185|NCT00851747|Loyola Medical Center|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedical.org|
22294186|NCT04353271|University of South Alabama|Office of Research Complaince|2514607573|swhite@southalabama.edu|
22294187|NCT02499783|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22294188|NCT02228460|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22294189|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294190|NCT03675477|ReistoneBiopharma|Roger Liu, Medical Director|+8613917512446|roger.liu@reistonebio.com|
22294191|NCT00119106|CDC|Dr. Michael Martin|662 580 0669|ZND9@CDC.GOV|
22294192|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org|
22294193|NCT01010061|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294194|NCT03066804|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22294195|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
22294196|NCT03050554|UC San Diego Moores Cancer Center|Dr. Andrew Sharabi|858-534-4808|ansharabi@health.ucsd.edu|
22321428|NCT03681119|NYU Langone Health|Abraham Brody, PhD, RN, FAAN|212-992-7341|Abraham.Brody@nyulangone.org|
22294197|NCT03982368|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22294198|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22294199|NCT03570697|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22294200|NCT01849783|University of Iowa|Margarida Magalhaes-Silverman, MD|319-384-9156|margarida-silverman@uiowa.edu|
22294201|NCT02571777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22294202|NCT03652012|University of Arizona|Dr Ying-hui Chou|5206217447|yinghuichou@arizona.edu|
22294203|NCT01288235|Massachusetts General, Hospital|Torunn I. Yock, MD|6177262000|tyock@mgh.harvard.edu|
22294204|NCT05393895|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22294205|NCT03190915|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22294206|NCT02713373|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@RoswellPark.org|
22294207|NCT04789499|Washington University in Saint Louis|Research Statistician|3143621077|kallogjerid@wustl.edu|
22294208|NCT01194466|Mount Mercy University/The University of Iowa|Dr. Jen Lee|3193231623|jlee@mtmercy.edu|
22294209|NCT02933606|Bionomics Limited|VP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
22294210|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org|
22294211|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
22294212|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
22275523|NCT04383132|Şehit Prof. Dr. İlhan Varank Eğitim Ve Araştırma Hastanesi|Dr. Beslen Göksoy|05349530112|beslengoksoy@gmail.com|
22275524|NCT03901300|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
22294213|NCT02021773|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22294214|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com|
22321429|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi|
22294215|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
22294216|NCT03408483|UAB|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22321430|NCT01797575|The University of Texas Health Science Center at Houston|Jair C Soares, MD|713-486-2627|jair.c.soares@uth.tmc.edu|
22321431|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu|
22321432|NCT03761615|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
22294217|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321433|NCT02941627|Oticon Medical|Clinical Research Director|+33 4 93 95 18 18|mhoe@oticonmedical.com|
22321434|NCT00563186|University of Calgary|Dr. John Conly|403-944-8090|John.Conly@albertahealthservices.ca|
22294218|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22294219|NCT01899261|Montefiore Medical Center and Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
22321435|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
22264160|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com|
22264161|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu|
22264162|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
22264163|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22264164|NCT05633082|CooperVision Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22264165|NCT02169791|Northside Hospital|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22264166|NCT04936594|University of Kentucky|Dr. Gopalkumar Rakesh|859-562-2348|gopalkumar.rakesh@uky.edu|
22264167|NCT02221817|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22264168|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264169|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22264170|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu|
22264171|NCT01818518|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
22264172|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu|
22264173|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22264174|NCT02449473|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22264175|NCT01301482|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22264176|NCT03326986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264177|NCT04039919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22264178|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743||
22264179|NCT03460158|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
22264180|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22264181|NCT03095118|Mayo Clinic|Dr. Fernando C. Fervenza|507-266-1045|Fervenza.Fernando@mayo.edu|
22264182|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300||
22264183|NCT01321437|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22264184|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu|
22264185|NCT01966809|Medical College of Wisconsin|Dr. Harry T. Whelan|414-266-7516|hwhelan@mcw.edu|
22264186|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com|
22264187|NCT03420768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22264188|NCT02075606|Ipsen|Medical Director|00441753627777|clinical.trials@ipsen.com|
22264189|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov|
22264190|NCT02969876|Massachusetts General Hospital|Dr. Andrew Nierenberg|6175122641|anierenberg@mgh.harvard.edu|
22264191|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br|
22264192|NCT02681406|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
22264193|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com|
22264194|NCT04019054|UCLA Psychiatry|Dr. Michael K. Leuchter|3108906943|mkleuchter@mednet.ucla.edu|
22264195|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264196|NCT05070390|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264197|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
22264198|NCT02412722|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22264199|NCT01083680|AbbVie|Global Medical Information|800-633-9110||
22294220|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22294221|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22264200|NCT03877926|Emergent BioSolutions Inc.|Bojan Drobic, Director, Clinical Research|204 275 4196|bdrobic@ebsi.com|
22264201|NCT03546647|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@central.uh.edu|
22264202|NCT02400476|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
22264203|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862|damusk@bu.edu|617
22264204|NCT00003531|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22294222|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
22294223|NCT01817530|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264205|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711|mohini.ranganathan@yale.edu|2546
22264206|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
22264207|NCT02621463|University of Utah|Dr. Kai Kuck, PhD|8012051010|kai.kuck@hsc.utah.edu|
22264208|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22264209|NCT00810888|Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center|Dr Jane Khoury, Professor of Pediatrics|513-636-2690|jane.khoury@cchmc.org|
22264210|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
22264211|NCT02927834|Loma Linda University|Dr. Kristin Seiberling|9095582002|kseiberling@llu.edu|
22264212|NCT04925713|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
22264213|NCT03812991|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22264214|NCT03942211|Janssen Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22264215|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org|
22264216|NCT01148225|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264217|NCT04798482|Boston Children's Hospital|Keira Mason MD|617-355-5775|keira.mason@childrens.harvard.edu|
22264218|NCT03496987|Yale University School of Medicine|Jonathan Puchalski, MD|2037375699|jonathan.puchalski@yale.edu|
22264219|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067|lsm16@cumc.columbia.edu|646
22264220|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264221|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264222|NCT02919826|Queen's University|Dr. Muhammad Ayub|613-549-7944|ma84@queensu.ca|
22264223|NCT00925301|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22264224|NCT03043560|Icahn School of Medicine at Mount Sinai|Dr, James Murrough|212-585-4640|james.murrough@mssm.edu|
22264225|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22264226|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
22264227|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22264228|NCT04232540|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
22264229|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264230|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215|douglas-dannaway@ouhsc.edu|42048
22264231|NCT03234608|Portland State University|Dr. Christina Nicolaidis|503-725-9603|nicol22@pdx.edu|
22264232|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264233|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu|
22264234|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264235|NCT02774850|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
22264236|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
22264237|NCT02339090|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
22264238|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu|
22264239|NCT05427045|UArkansas|Dr. Santos-Horta|507-250-5880|ESantoshorta@uams.edu|
22264240|NCT02521181|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|(216) 444-9938|gassmaj@ccf.org|
22264241|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu|
22264242|NCT03183141|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
22264243|NCT04052698|Octapharma|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22264244|NCT06442410|Medtronic|Thanh Tran|7278082652|thanh.tran2@medtronic.com|
22264245|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu|
22264246|NCT04947150|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
22264247|NCT02953678|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22264248|NCT02966184|Norton Healthcare|Tristan Murray, PharmD|5026295571|tristan.murray@nortonhealthcare.org|
22264249|NCT03535857|University of Pittsburgh|Dr, Gnankang Sarah Napoe|412-641-7850|napoegs@upmc.edu|
22264250|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu|
22264251|NCT03632135|Cordgenics|Pier Paolo Claudio, MD, Chief Scientific Officer|6064657226|claudio@cordgenics.com|
22264252|NCT02928536|Istituto di Ricerche Farmacologiche Mario Negri|Silvano Gallus, head of the Laboratory of Lifestyle Epidemiology|0039023901|silvano.gallus@marionegri.it|4657
22294224|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22294225|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov|
22294226|NCT02657369|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22294227|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22294228|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org|
22308137|NCT02163447|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
22264253|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22264254|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20|wim.decleer@janpalfijngent.be|09/2248851
22294229|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com|
22294230|NCT01785069|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22275525|NCT04727749|University of Saskatchewan|Dr. Colleen Dell|306-966-5912|Colleen.Dell@usask.ca|
22275526|NCT02378181|Public Health Management Corporation|Adam C. Brooks, Ph.D.|215-399-0636|abrooks@tri.phmc.org|
22275527|NCT03988647|Stanford University|Susan J Knox, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
22275528|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com|
22275529|NCT04167462|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22275530|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275531|NCT00142415|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22275532|NCT04342169|University of Utah School of Medicine Division of Infectious Diseases|Dr. Adam Spivak|8015871964|adam.spivak@hsc.utah.edu|
22275533|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275534|NCT02674659|Harapan Kita National Cardiovascular Center|Bambang Dwiputra, MD, FIHA|0215684093|bambangdwiputra@gmail.com|
22275535|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22275536|NCT02013414|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
22275537|NCT04497883|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22275538|NCT03692949|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275539|NCT06309394|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22275540|NCT04431206|Wake Forest University School of Medicine|Dr. James Eisenach|3367164182|james.eisenach@advocatehealth.org|
22275541|NCT03197129|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972-2-6776135|fuxavia@gmail.com|
22294231|NCT03288129|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22294232|NCT05853185|Liaquat University of Medical and Health Sciences|Dr. Sarang Suresh|03154044802|hotchandanisarang@gmail.com|
22294233|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com|
22294234|NCT02777333|University of Oxford|Mr P Garfjeld Roberts|01865 227374|patrick.garfjeldroberts@ndorms.ox.ac.uk|
22294235|NCT04543838|UPMC|Parthasarathy Thirumala, MD|412-648-4208|thirumalapd@upmc.edu|
22294236|NCT02761252|Menarini International Operations Luxembourg SA|Medical Director|+352 2649761|aconte@menarini.lu|
22294237|NCT03305575|Tufts Medical Center|Alaa Basura, MD|6176365000|abasura@tuftsmedicalcenter.org|6208
22294238|NCT01758432|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22294239|NCT02871297|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22294240|NCT02966028|Sanifit|SVP Clinical Development Operations|18582815976|Claire.Padgett@sanifit.com|
22294241|NCT04115839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22294242|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com|
22294243|NCT02151591|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Lisa Fucito|203-200-1470|Lisa.fucito@yale.edu|
22294244|NCT01342796|Novartis Vaccines and Diagnostics|Posting Director||Novartis.email@novartis.com|
22294245|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197||
22294246|NCT01396148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294247|NCT02536040|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22294248|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22294249|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22294250|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
22294251|NCT03095066|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22294252|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu|
22294253|NCT05988619|Pomona College|Dr. Benjamin Rosenberg|408-458-5375|benjamin.rosenberg@pomona.edu|
22294254|NCT04538261|AdventHealth Orlando|D. Ashley Hill, MD|407-303-1444|Ashley.Hill.MD@AdventHealth.com|
22294255|NCT00726232|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22294256|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22294257|NCT02864498|DS Biopharma|Study Director|+353 1 2933590|regulatory.dsbiopharma@DSBiopharma.com|
22294258|NCT00790985|Primus Pharmaceuticals|Robert Levy, MD., Director of Clinical Development|480-483-1410|Rlevy@primusrx.com|
22294259|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22294260|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294261|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22294262|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu|
22294263|NCT00764738|Retina Macula Institute|Dr. Ron Gallemore||rongallemoremd@gmail.com|
22294264|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
22294265|NCT02650856|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
22294266|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
22294267|NCT02478775|University of Colorado School of Medicine|Dr. Alex Polotsky|303-704-8221|ALEX.POLOTSKY@CUANSCHUTZ.EDU|
22294268|NCT03851705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22294269|NCT03095612|University of Texas Southwestern Medical Center|Dr. David Gerber|214-648-4180|david.gerber@utsouthwestern.edu|
22275542|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22275543|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu|
22275544|NCT04848480|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22294270|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294271|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22294272|NCT03617185|University of Michigan|Brian Callaghan, MD|7349367183|Bcallagh@med.umich.edu|
22294273|NCT04672993|Coloplast|Senior Scientific Manager Marianne Raff Dambæk|004549112562|dkmr@coloplast.com|
22294274|NCT01387932|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
22294275|NCT01964430|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22321436|NCT01265550|Dallas VA Medical Center|Stuart Spechler||sjspechler@aol.com|
22321437|NCT01929408|Fred Hutchinson Cancer Research Center|Mohamed Sorror, MD, MSc|(206) 667-6298|msorror@fredhutch.org|
22321438|NCT04377711|Covis Pharma|Clinical Trial Interest|1-877-374 -4177|CTInterest@covispharma.com|
22321439|NCT02079987|University of Florida|Donna L. Carden, MD, MPH|352-265-5911|dcarden@ufl.edu|
22264255|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com|
22264256|NCT01333072|MUSouthCarolina|C. Lindsay DeVane, Pharm.D.|8432701818|devaneL@musc.edu|
22264257|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22264258|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
22264259|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22264260|NCT03920280|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22264261|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22264262|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com|
22264263|NCT04220775|M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
22264264|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu|
22264265|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22264266|NCT01679054|The Chinese University of Hong Kong|Vivian Lee|+85239438012|vivianlee@cuhk.edu.hk|
22264267|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264268|NCT00084799|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22264269|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977|mgordon@friendsresearch.org|251
22264270|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443|p.bettica@italfarmaco.com|2584
22264271|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu|
22264272|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22264273|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
22264274|NCT04449341|Carl R Darnall Army Medical Center|Matthew Perdue|(254) 553-4653|matthewperdue94@gmail.com|
22264275|NCT04499482|Pennington Biomedical Research Center|Dr. Candida Rebello|2252882411|Candida.Rebello@pbrc.edu|
22264276|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
22264277|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264278|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22264279|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu|
22264280|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22264281|NCT03573817|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22264282|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org|
22264283|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594|hermanns@diabetes-zentrum.de|553
22264284|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org|
22264285|NCT01719562|Wake Forest University|Project Manager|+1(336) 758-3728|jvolpini@wakehealth.edu|
22264286|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22264287|NCT04155073|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22264288|NCT02240186|Mayo Clinic|Dr. Kenton Kaufman, Principal Investigator|507-284-2262|kaufman.kenton@mayo.edu|
22264289|NCT03554317|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Mark Markowski|410-614-0567|mmarko12@jhmi.edu|
22264290|NCT04061577|UCLA|Dr. Mersedeh Bahr Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
22264291|NCT02487082|Stony Brook Medicine Dept. of Neurology|Ruth A. Reinsel Ph.D., Clinical Research Associate II|(631) 638-2087|ruth.reinsel@stonybrookmedicine.edu|
22264292|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510||
22264293|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org|
22264294|NCT03139240|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22264295|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org|
22264296|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu|
22264297|NCT00467987|State University of NY at Buffalo|Paresh Dandona|17165351852|dandona@buffalo.edu|
22264298|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov|
22264299|NCT02776553|University of Arkansas for Medical Sciences|Arny A. Ferrando, Ph.D.|501-526-5711|aferrando@uams.edu|
22264300|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org|
22264301|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300||
22294276|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22294277|NCT02571075|Womack Army Medical Center|Anthony Plunkett|910-643-2324|anthony.r.plunkett.civ@mail.mil|
22294278|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu|
22294279|NCT04092439|Pennington Biomedical Research Center|Tim Allerton, Ph.D.|225-763-2940|timothy.allerton@pbrc.edu|
22294280|NCT02197520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294281|NCT00913497|Corewell Health|Esther Peariso|6164860358|esther.peariso@corewellhealth.org|
22294282|NCT03208244|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|Chung.Raymond@mgh.harvard.edu|
22294283|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
22294284|NCT04431453|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22294285|NCT03385564|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294286|NCT01146834|Weill Cornell Medicine|Ruben Niesvizky, MD|646-962-9376|run9001@med.cornell.edu|
22294287|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120||
22294288|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
22294289|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22294290|NCT03724032|University of Michigan|Jacqueline Dobson|734-763-8469|contactHOPE@umich.edu|
22294291|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no|
22294292|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu|
22294293|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
22294294|NCT02605824|UCSF Airway Clinical Research Center|Fahy Research Manager|415-514-1539|ariana.baum@ucsf.edu|
22294295|NCT04875195|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
22294296|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com|
22294297|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com|
22294298|NCT03715530|University of Iowa|Dr. Mark Santillan|319-356-3180|mark-santillan@uiowa.edu|
22264302|NCT03827018|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22264303|NCT02898103|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
22264304|NCT01998243|Hospital severo ochoa|Dr Luis Ramon Rabago Torre|34914818000|lrabagot@gmail.com|8326
22264305|NCT05197829|University of Massachusetts Chan Medical School|Mark O'Connor|508-334-1000|mark.oconnor2@umassmed.edu|
22264306|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22264307|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22264308|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com|
22264309|NCT04569786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264310|NCT05022563|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264311|NCT02646917|Crown Laboratories, Inc.|Thomas Hitchcock, PhD|8883723982|THitchcock@crownlaboratories.com|
22264312|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
22264313|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264314|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu|
22264315|NCT01351350|Takeda|Medical Director, Clinical Science|+1-866-835-2233|trialdisclosures@takeda.com|
22264316|NCT04647383|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22264317|NCT03746002|University of Maryland School of Pharmacy|Brent Reed|410-706-1452|breed@rx.umaryland.edu|
22264318|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net|
22264319|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22264320|NCT02938013|Johns Hopkins University School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
22264321|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu|
22264322|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300||
22264323|NCT02376257|Boston UCRC|Michael Otto, PhD|617-353-9610|mwotto@bu.edu|
22264324|NCT02260258|BIDMC|Mike Donnino|6177542882|mdonnino@bidmc.harvard.edu|
22264325|NCT01644149|PharmaJet, Inc.|Marilyn Dysart, Clinical Affairs Manager|720-214-9399|marilyn.dysart@pharmajet.com|
22264326|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22264327|NCT03693950|BIOCAD|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext. 930|linkova@biocad.ru|
22264328|NCT04230876|Amptify|Chris Cardinal|3143999940|Chris@amptify.com|
22264329|NCT04350008|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22264330|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22264331|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
22264332|NCT04243096|Boston University|Deepak Kumar, PT, PhD|617-358-3037|kumard@bu.edu|
22264333|NCT02792218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264334|NCT00248170|Novartis|Study Director|862-778-8300||
22264335|NCT03123783|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
22264336|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com|
22264337|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
22264338|NCT02280226|University of Bonn|Dr. Jonas Doerner|017632817006|jonas.doerner@ukb.uni-bonn.de|
22275545|NCT05219162|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22275546|NCT04428151|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22275547|NCT02187783|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22275548|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22275549|NCT02908347|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
22275550|NCT05816070|IVIEW Therapeutics Inc.|Bo Liang, PhD|609 773 8580|info@iviewinc.com|
22275551|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
22275552|NCT04622345|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22275553|NCT05516758|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22275554|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca|
22275555|NCT00402831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275556|NCT02792504|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275557|NCT01535924|The Ohio State University|Dr. Beth Christian|614-293-7807|Beth.Christian@osumc.edu|
22275558|NCT02814526|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
22264339|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
22264340|NCT00749411|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275559|NCT02485860|Centre Hospitalier Departemental Vendée|Dr. Emeric ABET|02 51 44 61 48|emeric.abet@ght85.fr|+33
22275560|NCT03540771|Albert Einstein Healthcare Network|Manisha Verma, MD, MPH. Director, Research|2154561026|Manisha.Verma@jefferson.edu|
22275561|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275562|NCT03836053|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22275563|NCT03846479|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
22264341|NCT03694808|University Hospitals Cleveland Medical Center|Dr. David Canaday|216-368-5537|dxc44@case.edu|
22264342|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org|
22264343|NCT02070757|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264344|NCT04086641|University of Washington|Conrad Slater|5409318478|conslate13@gmail.com|
22264345|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
22308138|NCT01939275|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
22264346|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264347|NCT02429375|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz, MD|\646-608-3726|moskowia@mskcc.org|
22308139|NCT02597946|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308140|NCT05161715|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22308141|NCT03379168|University of New Mexico Health Sciences Center|Dustin Richter, MD; Vice Chair of Research|505-272-4107|DLRichter@salud.unm.edu|
22308142|NCT04690673|Helsinki and Uusimaa Hospital District, Pain clinic|Dr Johanna Kujala|+358400780411|johanna.kujala@helsinki.fi|
22308143|NCT03743636|Northwestern University|Mary M. McDermott, MD|312-503-6419|mdm608@northwestern.edu|
22308144|NCT05485922|Coloplast, Clinical strategies|Medical Writer|+4549112057|dkmhla@coloplast.com|
22308145|NCT04823611|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22308146|NCT05038566|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
22321440|NCT02613936|University of New Mexico|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
22321441|NCT02076997|Baylor College of Medicine|Dr. Jennifer Foster|832-824-4646|jhfoster@texaschildrens.org|
22321442|NCT02533063|University of Wisconsin|Diane Krueger|6082656410|dckruege@wisc.edu|
22321443|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321444|NCT03873714|Medtronic Neurovascular|Director, Global Clinical Research|949.837.3700|rs.advance@medtronic.com|
22321445|NCT01970501|Arca biopharma Inc.|Dr. Michael Bristow|7209412100|Michael.Bristow@arcabio.com|
22321446|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321447|NCT00845650|Emergent Product Development Gaithersburg, Inc.|Study Director||clinicalstudies@ebsi.com|
22321448|NCT01811875|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 20 8957 2200|medinfo@bpl.co.uk|
22321449|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
22321450|NCT03115567|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
22321451|NCT01326546|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
22321452|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu|
22321453|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22321454|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22264348|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525|saliu@vghtc.gov.tw|5409
22321455|NCT01548339|University Hospital Lausanne|Prof. N. Demartines||demartines@chuv.ch|
22294299|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
22294300|NCT02151383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22294301|NCT03338998|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22294302|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu|
22294303|NCT04706091|Massachusetts General Hospital|John W Winkelman, MD PhD|617-724-7426|jwwinkelman@mgh.harvard.edu|
22294304|NCT03329573|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22294305|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
22294306|NCT05405309|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22294307|NCT05695209|Indiana University|Principal Investigator|317-278-3154|mmatthia@iu.edu|
22321456|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov|
22321457|NCT03693625|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22321458|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110||
22321459|NCT02457637|Renji Hospital, Shanghai Jiao Tong University School of Medical|Professor Hai Li , Director of Clinical Trials|+86-13818525494|haili＿17@126.cpm|
22321460|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22294308|NCT03069378|Memorial Sloan Kettering Cancer Center|Dr. Ciara Kelly, MD|646-888-4312|Kellyc1@mskcc.org|
22321461|NCT01979536|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22294309|NCT01397708|Alaunos Therapeutics, Inc|Jaymes Holland Clinical Consultant|6502732627|jholland@alaunos.com|
22294310|NCT04997304|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
22264349|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu|
22294311|NCT05231954|Indiana University|Katrina Coppedge|317-278-1602|kcoppedg@iu.edu|
22321462|NCT02408471|Smith+Nephew, Inc.|Belinda Larson, Director, Global Clinical Strategy (Trauma)||belinda.larson@smith-nephew.com|
22294312|NCT05947643|Washington University, Department of Otolaryngology - Head and Neck Surgery|Dorina Kallogjeri, Assoc.Professor of Otolaryngology|314-362-1077|kallgjerid@wustl.edu|
22321463|NCT05038020|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
22264350|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu|
22264351|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu|
22264352|NCT04862156|OrganOx|Katerina de Metz|19713442167|katerina.demetz@organox.com|
22264353|NCT01570283|Center for Cell and Gene Therapy|Dr. Helen Heslop|832-824-4662|heheslop@txch.org|
22264354|NCT01833533|AbbVie|Global Medical Information|800-633-9110||
22264355|NCT02017860|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264356|NCT00256776|EBMT|Clinical Study Unit|+31(0)715265005|ebmtcsu@lumc.nl|
22264357|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
22264358|NCT04136951|Columbia University|Maxim Topaz, PhD, Elizabeth Standish Gill Associate Professor of Nursing|6462760460|mt3315@cumc.columbia.edu|
22264359|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr|
22264360|NCT04668274|Marshall A. Hayward, Ph.D., Jupiter Orphan Therapeutics Inc.|David Wyatt|305-547-5857|david.wyatt@syneoshealth.com|
22264361|NCT03767062|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
22264362|NCT00444821|Medtronic|Kristel Wittebols|707-591-3275|kristel.wittebols@medtronic.com|
22264363|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov|
22264364|NCT02326363|Medical University of South Carolina|Nathaniel L Baker|843-792-5028|bakern@musc.edu|
22264365|NCT01832402|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
22264366|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22264367|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573|mgruneb@nyspi.columbia.edu|646
22264368|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu|
22264369|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22294313|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294314|NCT01340885|Oregon Health & Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
22294315|NCT04249583|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
22294316|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu|
22294317|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com|
22294318|NCT02370160|Masonic Cancer Center at University of Minnesota|Dr. Veronika Bachanova|612-625-8287|pham0179@umn.edu|
22294319|NCT04487730|Weill Cornell Medicine|Dr. Nili Solomonov|212-746-5886|nis2051@med.cornell.edu|
22294320|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22294321|NCT03291808|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
22294322|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463||
22294323|NCT03875885|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0677|radellin@wakehealth.edu|
22294324|NCT03364023|Medtronic Neurovascular Clinical Affairs|Medtronic Neurovascular Clinical Affairs|9498373700|rs.nvclinicalprospr-sea@medtronic.com|
22294325|NCT02891850|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22264370|NCT00895037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294326|NCT02957305|Dep. of Obstetrics and Gynecology, Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brazil|Ricardo Francalacci Savaris|+5551997781966|rsavaris@hpca.edu.br|
22264371|NCT02063087|Mayo Clinic|Dr. Erik Hess|507-255-6501|hess.erik@mayo.edu|
22321464|NCT05472012|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
22264372|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264373|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu|
22264374|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu|
22264375|NCT01930175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264376|NCT02820740|Monteris Medical|Clinical Program Manager|763-401-1727|medicalaffairs@monteris.com|
22264377|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu|
22264378|NCT04965389|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22264379|NCT03903159|University of Minnesota|Amy Krentzman|612-625-2312|akrentzm@umn.edu|
22264380|NCT02732691|JenaValve Technologies Inc.|Vinny Podichetty, Vice President: Clinical & Med Affairs|949-767-2110|podichetty@jenavalve.com|1050
22264381|NCT03770078|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
22264382|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300||
22264383|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca|
22264384|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com|
22264385|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu|
22264386|NCT02568007|Medical College of Wisconsin|Praveen Goday|4142663690|pgoday@mcw.edu|
22264387|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu|
22264388|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264389|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
22264390|NCT03450629|Sun Pharma Advanced Research Company Limited|Head, Clinical Developmnt|912266455645|clinical.trials@sparcmail.com|
22264391|NCT03366194|Esthetic Education LLC|Study Coordinator|(480) 656-2251|Support@skinstylus.com|
22264392|NCT02093923|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22264393|NCT03438006|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22264394|NCT01181531|Amgen Inc.|Study Director|866-572-6436||
22264395|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22264396|NCT00955721|University of Miami|Peter J. Hosein MD|3052433462|phosein@miami.edu|
22264397|NCT03512002|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
22264398|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu|
22264399|NCT02408445|University of Colorado|Dr. Shanlee Davis|720-777-6073|shanlee.davis@childrenscolorado.org|
22264400|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590||
22264401|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22264402|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22264403|NCT04034355|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46 732344698|kristina.sjoblom@egetis.com|
22264404|NCT04678817|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
22264405|NCT00380757|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22264406|NCT03064438|Accuitis, Inc.|Chief Science Officer|678-812-1492|info@accuitis.com|
22264407|NCT01937351|Avinger|Thomas Lawson|650.241.7030|tlawson@avinger.com|
22264408|NCT01961687|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
22264409|NCT03707041|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
22264410|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu|
22264411|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com|
22264412|NCT02999984|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
22264413|NCT02631837|Imelda ziekenhuis Bonheiden|Dr Jan Baekelandt|+ 32 15 505208|jan.baekelandt@imelda.be|
22264414|NCT00784524|Masonic Cancer Center, University of Minnesota|Dr. Douglas Yee|612-626-8487|yeexx006@umn.edu|
22264415|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743||
22264416|NCT02310789|Stanford University|Jeff Wine, PhD|650-725-2462|wine@stanford.edu|
22264417|NCT02277704|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
22264418|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu|
22264419|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
22264420|NCT01252719|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
22264421|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp|
22264422|NCT02813421|Children's Hospital Los Angeles|Dr. Jessica Ferris|323-361-4606|jeferris@chla.usc.edu|
22264423|NCT03135899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264424|NCT04373551|University of Alabama at Birmingham|Dr. Mirjam-Colette Kempf|205-934-9333|MKempf@uab.edu|
22264425|NCT02914236|Aerin Medical, Inc.|Scott Wolf, M.D., Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
22264426|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org|
22264427|NCT00441350|Menarini Group|Angela Capriati, MD PhD - Global Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
22264428|NCT03438539|University of Kentucky|Craig Rush, Ph.D.|859-257-5388|crush2@uky.edu|
22264429|NCT00385788|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22264430|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu|
22264431|NCT03614494|The University of Hong Kong|Dr Raymond Li|+852 22554517|raymondli@hku.hk|
22264432|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
22264433|NCT02129647|NYU Langone|Theodore Nicolaides|212-263-9959|Theodore.Nicolaides@nyualangone.org|
22264434|NCT00918463|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
22264435|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
22264436|NCT02834806|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22264437|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22264438|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org|
22264439|NCT01004042|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
22264440|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu|
22264441|NCT02772562|Medical University of South Carolina|Dr. Michael Lilly|843-792-4271|lillym@musc.edu|
22264442|NCT03478865|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
22264443|NCT03336242|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22264444|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22308147|NCT05535062|Neuronetics|Neha Goyal|763-528-1599|neha.goyal@neurostar.com|
22308148|NCT02226341|Columbia University|Anca Askanase MD, MPH|212 305 0856|ada20@cumc.columbia.edu|
22308149|NCT05194969|University of North Carolina at Chapel Hill|Christopher J. Sayed, MD|984-974-3900|christopher_sayed@med.unc.edu|
22308150|NCT05996744|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22308151|NCT04850807|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
22308152|NCT03739996|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Cent|ACTGCT.gov@fstrf.org|
22308153|NCT05783219|University of Louisville Medical Center|Rodger Rothenberger|(502) 588-7660|Rodger.rothenberger@louisville.edu|
22308154|NCT05653856|Curium|Darcy Denner|314-506-3511|Solar@curiumpharma.com|
22308155|NCT04737772|RVO Health|Helena Berlin|702-620-4965|hberlin@rvohealth.com|
22264445|NCT02296853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22308156|NCT02549339|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22308157|NCT02728076|Froedtert and the Medical college of Wisconsin|Adam Currey, MD|414-805-4462|acurrey@mcw.edu|
22264446|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu|
22264447|NCT01352182|Cincinnati Children's Hospital Medical Center|Jennifer Kaplan|513-636-4259|jennifer.kaplan@cchmc.org|
22264448|NCT02039063|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
22264449|NCT02740179|Massachusetts General Hospital|Dr. Steven K. Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
22264450|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu|
22264451|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
22264452|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com|
22264453|NCT03851588|University of Cape Town|Prof Gary Maartens|214066008|gary.maartens@uct.ac.za|+27
22264454|NCT00613730|Amgen Inc.|Study Director|866-572-6436||
22264455|NCT01192399|Alexion Pharmaceuticals, Inc|Alexion Pharmaceuticals, Inc||clinicaltrials@alexion.com|
22264456|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu|
22264457|NCT03060759|Massachusetts General Hospital|Farrah J. Mateen, MD, PhD, Associate Professor of Neurology|617-724-8653|fmateen@mgh.harvard.edu|
22264458|NCT02244424|Michigan State University, College of Nursing|Dr. Mildred A. Horodynski|(517) 355-6744|millie@msu.edu; silkk@msu.edu|
22264459|NCT02377063|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD - Principal Investigator|310-206-1987|zli@mednet.ucla.edu|
22264460|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu|
22264461|NCT02723773|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22264462|NCT05168774|Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynch@chop.edu|
22264463|NCT05368012|Hospital for Special Surgery|MIDCAB (Mid-Calf Block) for foot surgery: A pilot study|646-797-8948|popovicm@hss.edu|
22264464|NCT02124902|Washington University School of Medicine|Foluso Ademuyiwa, M.D., MPH|314-362-7201|bisiademuyiwa@wustl.edu|
22264465|NCT01314118|Janssen Services, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22264466|NCT01794572|Institut de Cancérologie de l'Ouest|Pr Stéphane SUPIOT|(+33) 2406799 00|stephane.supiot@ico.unicancer.fr|
22264467|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22264468|NCT04815850|University of Leicester|Dr Matthew Graham-Brown|01162588043|mgb23@le.ac.uk|
22264469|NCT03185182|Lund University|Professor Håkan Axelson|+46 046 2226434|hakan.axelson@med.lu.se|
22264470|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22264471|NCT03407612|Jameson Crane Sports Medicine Institute|Maria Munsch|614-293-3600|maria.munsch@osumc.edu|
22264472|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22264473|NCT01552369|University of Pittsburgh - Medicine - Infectious Diseases|Nina Singh, MD|412-360-1688|nis5@pitt.edu|
22264474|NCT03341546|NHS Tayside|Mark Worrall|01382632177|markworrall@nhs.net|
22264475|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org|
22264476|NCT03050697|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22264477|NCT00440466|J&J PRD|Peter Bowers|908-927-2116||
22275564|NCT02332707|Merck Sharp & Dohme Corp.|Senior VIce President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275565|NCT01473134|Clinical Affairs Associate Director|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
22275566|NCT03643848|Florida International University|Dana L. McMakin, PhD, ABPP|305-348-0042|dmcmakin@fiu.edu|
22275567|NCT04761822|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22275568|NCT05423743|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22275569|NCT06217380|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22275570|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org|
22275571|NCT02612857|Idera|Senior Development Operations Director|877-888-6550|clinicaltrials@iderapharma.com|2
22275572|NCT03556683|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
22275573|NCT02018107|Brigham & Women's Hospital INC|Paul Shyn, MD|6177326304|PSHYN@BWH.HARVARD.EDU|
22275574|NCT03286504|Weill Cornell Medicine|Dr. Daniel Fitzgerald|646-962-8140|dwf2001@med.cornell.edu|
22275575|NCT01890577|Amgen Inc.|Study Director|866-572-6436||
22264478|NCT02997657|Brown University School of Public Health|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22275576|NCT02730130|Memorial Sloan Kettering Cancer Center|Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
22275577|NCT00141921|Amgen Inc.|Study Director|866-572-6436||
22275578|NCT03320369|Northwestern University|Nirmala Gonsalves|312-695-4054|n-gonzalves@northwestern.edu|
22275579|NCT03813654|Brigham and Women's Hospital|Jeanne F. Duffy, Principal Investigator|617-732-7995|jduffy@bwh.harvard.edu|
22275580|NCT03104413|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22275581|NCT02721069|Neurelis, Inc.|Cyndi Guerra|9736156258|cguerra@neurelis.com|
22275582|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22275583|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634||
22264479|NCT01223235|Memorial Sloan Kettering Cancer Center|Dr. Paul Sabbatini, MD|212-639-4016|sabbatip@mskcc.org|
22264480|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu|
22264481|NCT03756883|Teva Pharmaceuticals, USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22264482|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22264483|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu|
22264484|NCT03005067|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22264485|NCT03233958|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
22264486|NCT02593396|UNIVERSITY MALAYA|Dr. Anne Yee|+60379492068|annyee17@um.edu.my|
22264487|NCT03093272|Dana-Farber Cancer Institute|Lauren Harshman, MD|617-632-2429|laurenc_harshman@dfci.harvard.edu|
22264488|NCT00103038|Oregon Health and Science University|Gerda Teglassy, MD|5034945626|tothg@ohsu.edu|
22264489|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com|
22264490|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
22264491|NCT05445843|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22264492|NCT03453840|University of California San Francisco|Liusheng Huang (Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
22264493|NCT05307679|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22264494|NCT03581214|Washington University in St Louis|Nandini Raghuraman|3144548181|nraghuraman@wustl.edu|
22264495|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
22264496|NCT02310763|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264497|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
22264498|NCT01731886|Columbia University|Suzanne Lentzsch, MD, PhD, Professor of Medicine|646-317-4840|sl3440@cumc.columbia.edu|
22264499|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22264500|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
22264501|NCT03396874|University of Michigan|Morand Piert|734-936-5385|mpiert@med.umich.edu|
22264502|NCT03417830|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22264503|NCT02563769|Temple University Episcopal Hospital|Yaminah Carter Research Coordinator|2678097602|yaminah.carter@tuhs.temple.edu|
22264504|NCT04072315|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
22264505|NCT02598895|University of Washington/Fred Hutchinson Cancer Center|Dr. Heather Cheng|206-606-7416|hhcheng@uw.edu|
22264506|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org|
22264507|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu|
22264508|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22264509|NCT02083926|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
22264510|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22264511|NCT00842530|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
22264512|NCT02939950|Bausch Health Americas, Inc.|Director of Clinical Operations|(585) 338-5306|Daniel.Donatello@bausch.com|
22275584|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294327|NCT03797014|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel Chua|14107065704|jchua@ihv.umaryland.edu|
22275585|NCT00171249|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22275586|NCT01426581|University of Chicago|Valerie G. Press, MD, MPH|73-702-5170|vpress@medicine.bsd.uchicago.edu|
22275587|NCT02783690|Mayo Clinic|Robert Mutter, M.D.|507-284-2511|mutter.robert@mayo.edu|
22264513|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264514|NCT04117945|Mayo Clinic|Daniel H. Ahn, D.O.|(480) 342-4800|Ahn.Daniel@mayo.edu|
22264515|NCT01769274|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264516|NCT00402025|Amgen, Inc.|Study Director|866-572-6436||
22264517|NCT02767934|University of Washington|Dr. Ryan Cassaday|206-606-1202|cassaday@seattlecca.org|
22264518|NCT02409329|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
22264519|NCT03391115|University of Colorado, College of Nursing|Heather Coats, PhD, APRN-BC, PI|303-724-3740|heather.coats@cuanschutz.edu|
22264520|NCT04290494|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264521|NCT02369354|Duke University School of Medicine|Dr. L. Ebony Boulware|919-613-2099|ebony.boulware@duke.edu|
22264522|NCT03200535|Kaiser Permanente Colorado|Dr. Emily Schroeder|303-636-2478|emily.b.schroeder@kp.org|
22264523|NCT03291041|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
22264524|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22264525|NCT01451996|University of Chicago|Anup Malani, J.D., Ph.D|773-702-9602|amalani@uchicago.edu|
22264526|NCT04184999|SR Cornea Consultants|Dr. Sanjay Rao|8476685498|sanjaynraomd@gmail.com|
22264527|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264528|NCT02985879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264529|NCT03377023|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|jhanelle.gray@moffitt.org|
22264530|NCT03940703|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22264531|NCT04079712|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22264532|NCT02658487|Vanderbilt University Medical Center|Stephen Strickland, MD|(615) 936-8422|stephen.strickland@vumc.org|
22264533|NCT03815240|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
22264534|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com|
22264535|NCT01885182|Mundipharma (China) Pharmaceutical Co. LTD|Clinical study manager|0086-10-65636800|Wei.Zhu@mundipharma.com.cn|6900
22264536|NCT00682617|Oregon Health & Science University|Dr. Nels Carlson|(503) 494-6420|carlsonn@ohsu.edu|
22264537|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22264538|NCT04507126|MGH|Research Operations Director|617-724-1992|jgerber2@mgh.harvard.edu|
22264539|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264540|NCT04213209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22264541|NCT02065713|Instituto Medicina Molecular|Elsa Vieira-Sousa|00351 217999544|elsa-sousa@hotmail.com|47221
22264542|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu|
22264543|NCT02459665|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
22264544|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com|
22264545|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org|
22264546|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611||
22264547|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com|
22264548|NCT02164734|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@amc.edu|
22264549|NCT03465748|Illinois College of Optometry|Dr. Yi Pang|3129497287|YPang@ico.edu|
22264550|NCT02596321|Abbott|Therapeutic Area Clinical Director|+31294477008|dmitri.kazei@abbott.com|
22264551|NCT03923699|Washington University School of Medicine|Thomas Kannampallil|(314) 273-7801|thomas.k@wustl.edu|
22264552|NCT04578886|University of Alabama at Birmingham, Department of Anesthesiology and Perioperative Medicine|Dr. Andrew B. Barker, MD|205-934-6007|abbarker@uabmc.edu|
22264553|NCT03851796|Virginia Commonwealth University|Dr. Melanie K Bean|804-527-4756|melanie.bean@vcuhealth.org|
22275588|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Celeste Claudy - Study Lead|763-514-0130|celeste.m.claudy@medtronic.com|
22264554|NCT05560763|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
22264555|NCT02560779|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|
22264556|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264557|NCT03347838|Rocky Mountain Regional VA Medical Center / University of Colorado School of Medicine|Robert Keith, MD|720-857-5120|robert.keith@cuanschutz.edu|
22264558|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
22275589|NCT04585893|UNC Lineberger Comprehensive Cancer Center|Matthew S Painschab|919-966-4431|matthew_painschab@med.unc.edu|
22275590|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu|
22275591|NCT06178991|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
22275592|NCT01526408|House Institute Foundation|Mahta Marefat|(213) 770-1808|mmarefat@hifla.org|
22275593|NCT07000981|Inonu University|Asst. Prof. Gürkan ÖZDEN|+90 505 715 62 65|gurkan.ozden@inonu.edu.tr|
22275594|NCT05706610|Cincinnati Children's Hospital Medical Center|Dr. Meghan McGrady|513-803-8044|meghan.mcgrady@cchmc.org|
22275595|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org|
22275596|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
22275597|NCT02394769|Massachusetts General Hospital|Andrew T. Chan, MD, MPH|(617) 726-3212|achan@partners.org|
22275598|NCT03082729|University of Pennsylvania|Joel Gelfand, MD, MSCE|215-662-2737|joel.gelfand@pennmedicine.upenn.edu|
22275599|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22275600|NCT04066374|Cleveland Clinic|Yuki Kuramochi, BSN, RN|216-445-4063|kuramoy@ccf.org|
22275601|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275602|NCT03608163|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-430-2903|meredith.hawkins@einsteinmed.edu|
22275603|NCT03914612|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22275604|NCT04320888|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22275605|NCT03353220|Columbia University|Sharon Wardlaw, MD|212-305-3725|sw22@cumc.columbia.edu|
22275606|NCT03586479|University of Kansas|Rebecca Swinburne Romine|7857668612|swin0024@ku.edu|
22275607|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22275608|NCT06649409|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
22275609|NCT03857256|Montreal Heart Institute|Dr Jean-Claude Tardif|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
22275610|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22275611|NCT04240314|Nationwide Children's Hospital|Megan Waldrop, Sponsor-Investigator|614-722-2231|megan.waldrop@nationwidechildrens.org|
22275612|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711|albert.arias@va.gov|8155
22275613|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22275614|NCT02700841|University of Nebraska Medical Center|IIT Office|402-559-4596|IITOffice@unmc.edu|
22275615|NCT02233413|Massachusetts General Hospital|Dr. Rajiv Gupta|617-726-0369|rgupta1@mgh.harvard.edu|
22275616|NCT01799889|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22275617|NCT06633965|Center for Diabetes Technology|Dr. Marc Breton|434-982-6484|mb6nt@virginia.edu|
22275618|NCT04213261|Castle Creek Biosciences|Associate VP of Clinical Trials|16506901024|rblumenthal@castlecreekbio.com|
22275619|NCT02385318|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22275620|NCT00300053|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
22275621|NCT02472405|University of Miami|Keyvan Nouri MD|305-243-3380|KNouri@med.miami.edu|
22275622|NCT03095287|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22275623|NCT02594111|VA NY Harbor Healthcare System|Dr. Binita Shah|212-686-7500|binita.shah@va.gov|
22275624|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275625|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com|
22275626|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22308158|NCT05054374|Memorial Sloan Kettering Cancer Center|Dr. Ezra Rosen, MD, PhD|646-888-6955|rosene1@mskcc.org|
22275627|NCT04601506|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
22264559|NCT01929395|Dartmouth Hitchcock Medical Center|Dr Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
22308159|NCT05415410|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
22264560|NCT01980342|Johns Hopkins University School of Medicine|Jenny Robinson, MD MP FACOG|4105500337|mailto:jrobin87@jhmi.edu|
22264561|NCT00484419|Daiichi Sankyo Inc.|John Raia, Director, Professional Affairs|973-630-2683|jraia@dsus.com|
22264562|NCT03604341|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22264563|NCT01829113|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22264564|NCT01740791|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22264565|NCT02674386|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264566|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com|
22264567|NCT02462486|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
22264568|NCT04706507|Fred Hutch Cancer Center|Dr. Michael J. Boeckh|2066676706|mboeckh@fredhutch.org|
22264569|NCT04625673|University of Pennsylvania|Regulatory Lead|215.573.7101|psom-ind-ide@pobox.upenn.edu|
22264570|NCT02127073|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
22264571|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22264572|NCT03648879|National Cancer Institute|Dr. Jeremy L. Davis|240-760-6229|jeremy.davis@nih.gov|
22264573|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org|
22264574|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
22264575|NCT04099641|OncXerna Therapeutics, Inc.|CDO, OncXerna Therapeutics, Inc.|(781) 907-7810|medical@oncxerna.com|
22264576|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu|
22264577|NCT02470091|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22264578|NCT01523587|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264579|NCT02709486|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264580|NCT00489281|Johns Hopkins University|F Javier Bolanos Meade, MD|4106146398|fbolano2@jhmi.edu|
22264581|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov|
22264582|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22264583|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264584|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn|
22264585|NCT02549573|US WorldMeds|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
22264586|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu|
22264587|NCT02610816|Cincinnati Childrens Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|Marc.Rothenberg@cchmc.org|
22264588|NCT02919813|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22264589|NCT02691741|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22264590|NCT03465436|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22264591|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu|
22264592|NCT02697773|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264593|NCT00613834|The Ohio State University|Dr. Michelle Isley|614-293-4203|Michelle.Isley@osumc.edu|
22264594|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu|
22264595|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22264596|NCT03660241|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264597|NCT06141824|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264598|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu|
22264599|NCT03919448|Laboratorios Richmond|Regulatory Affairs Department|(+54 11) 5555 - 1600|info@richmondlab.com|
22264600|NCT01440010|Medical Faculty Mannheim, Heidelberg University|PD Dr. med. Elena Sperk|+496213838624|elena.sperk@medma.uni-heidelberg.de|
22264601|NCT02473783|Tri-Service General Hospital, National Defense Medical center|Dr. Chin-bin Yeh|886-2-87923311|chinbinyeh@gmail.com|17387
22264602|NCT01891305|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
22264603|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org|
22275628|NCT00867932|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.||ClinicalTrials@Alexion.com|
22275629|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com|
22275630|NCT02127671|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22275631|NCT02394275|St. Joseph's Healthcare Hamilton, ON|Dr. Marek Smieja|905 521 6021|smiejam@mcmaster.ca|
22275632|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22275633|NCT02471183|Actelion Pharmaceuticals Ltd|Global Post approval studies Director||lperchen@its.jnj.com|
22275634|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
22275635|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275636|NCT02328105|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22275637|NCT06094647|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|919-962-1401|kelsey_ludwig@med.unc.edu|
22275638|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org|
22275639|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275640|NCT05350423|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|Mantu.Gupta@mountsinai.org|
22275641|NCT02097277|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
22275642|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com|
22275643|NCT04398966|University of North Carolina at Chapel Hill|Markeela Lipscomb|919-843-3670|markeela_lipscomb@med.unc.edu|
22275644|NCT02081807|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275645|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com|
22275646|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275647|NCT02326883|Kaiser Permanente Washington Health Research Institute|Gregory Simon, Investigator|206-287-2979|gregory.e.simon@kp.org|
22275648|NCT01385176|Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy, France|Principal Investigator of the Study, Prof. Faiez Zannad|+33 3 83 15 73 22|f.zannad@chu-nancy.fr|
22275649|NCT01056536|Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
22275650|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22275651|NCT05853120|Emory University|Colleen Kelley|404-712-1823|scolleen.kelley@emory.edu|
22275652|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300||
22275653|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275654|NCT02373865|GWT-TUD GmbH, Study center Prof. Hanefeld|Prof. Dr. Markolf Hanefeld|+49 351 44005|Markolf.Hanefeld@gwtonline.de|82
22275655|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275656|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
22275657|NCT02921256|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5261|langerj@nrgoncology.org|
22275658|NCT03507790|Cogntion Therapeutics Inc|Dr. Anthony Caggiano|914-221-6730|acaggiano@cogrx.com|
22264604|NCT01612884|Indiana University School of Medicine|Rolf Kreutz, MD|3179620500|rkreutz@iu.edu|
22264605|NCT03265288|Laurent Pharmaceuticals Inc.|Dr Jean-Marie Houle, VP Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
22264606|NCT02790034|Newron Pharmaceuticals S.p.A.|Ravi Anand MD, Chief Medical Officer|+41 793741364|regulatoryaffairs@newron.com|
22264607|NCT01057381|Baylor College of Medicine|Olutoyin A. Olutoye, M.D., M.Sc.|(832) 824-5800|oao@bcm.edu|
22275659|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
22275660|NCT03415178|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22275661|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300||
22275662|NCT02781324|Children's Hospital Colorado|Eun Kim, Spine Research Assistant|720-777-8026|eun.kim@childrenscolorado.org|
22275663|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu|
22264608|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22264609|NCT04051463|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
22264610|NCT04943159|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22264611|NCT03316573|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617-632-6633|edjacobsen@partners.org|
22264612|NCT04075890|UCLA|Reza Tadayon Nejad|3102066389|rtadayonnejad@mednet.ucla.edu|
22264613|NCT04976621|Corporal Michael J. Crescenz VA Medical Center|Helene Moriarty, PhD, RN|610-519-5735|helene.moriarty@va.gov|
22264614|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu|
22264615|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
22264616|NCT05611996|Massachusetts General Hospital|Dr. Jin Hui Joo|6177245317|jhjoo@mgh.harvard.edu|
22264617|NCT03053583|Anesthesiology|Jerrold Lerman MD|716-323-6570|jlerman@buffalo.edu|
22264618|NCT04479475|Johns Hopkins University|Haneefa Saleem, PhD, MPH|443-287-5130|haneefa.saleem@jhu.edu|
22264619|NCT05363683|University of Nebraska Medical Center|Elizabeth Wellsandt|402-559-4309|elizabeth.wellsandt@unmc.edu|
22264620|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22264621|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com|
22264622|NCT06972251|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|allison.lewinski@va.gov|
22275664|NCT05020015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22275665|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275666|NCT02515253|University of Portsmouth|Dr Emma Sharland||emma.sharland@port.ac.uk|
22275667|NCT00320086|University of New Mexico|Aaron Jacobs, MD|(505)272-5551|Ajacobs@salud.unm.edu|
22275668|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com|
22275669|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com|
22275670|NCT02566005|Mount Sinai Health Systems|Dr. Zainab Al-Ibraheemi||Zainab.Al-ibraheemi@mountsinai.org|
22275671|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov|
22275672|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275673|NCT03345004|Diamyd Medical AB|Director of Clinical Development|+46 (0) 8 661 00 26|clinicaltrials@diamyd.com|
22275674|NCT04706221|Zynex Monitoring Solutions|Donald Gregg|(800) 495-6670|dgregg@zynex.com|3802
22275675|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22275676|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org|
22275677|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22275678|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
22275679|NCT01541748|Coloplast|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
22275680|NCT03340883|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
22275681|NCT01675778|Jacobi Medical Center|Dr. Shujun Xia|718-918-5800|shujun.xia@nbhn.net|
22275682|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22275683|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu|
22275684|NCT03473197|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
22275685|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net|
22275686|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu|
22275687|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
22275688|NCT01114555|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak, MD|212-639-7623|modaks@mskcc.org|
22275689|NCT04773795|Nitinotes Ltd.|Ravit Peled- Director of clinical operations|0526145354|ravit@nitinotesurgical.com|
22275690|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22275691|NCT03329989|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22275692|NCT01283386|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22275693|NCT02469857|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
22275694|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22275695|NCT01531153|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
22275696|NCT03416179|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275697|NCT00879658|Novartis Pharmaceuticals|Study Director||Novartis.email@novartis.com|
22275698|NCT03279952|Penn State College of Medicine|Raman Baweja, MD|7175318521|rbaweja@pennstatehealth.psu.edu|
22275699|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com|
22275700|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net|
22275701|NCT02421939|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22264623|NCT05575063|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
22275702|NCT05881733|Erasmus MC|Dr. Sing-Chien Yap|+31650031551|s.c.yap@erasmusmc.nl|
22275703|NCT04773028|Kartal Kosuyolu Hihg Speciality Training and Research Hospital|Dr.Ahmet Zengin|+905365022173|dr.zenginahmet@gmail.com|
22275704|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275705|NCT02966834|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275706|NCT03513952|Fred Hutchinson Cancer Center|Cancer Immunotherapy Trials Network Trial Manager|514-718-2858|citn@fredhutch.org|
22275707|NCT03133676|Calibr, a Division of Scripps Research|Study Director|(858) 242 1000|KA34ph1@scripps.edu|
22275708|NCT01925417|Rebiotix|Sarah Mische PhD, Associate Director of Clinical Research|6512122839|smische@rebiotix.com|
22275709|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
22308160|NCT02365766|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22308161|NCT05166811|University of Utah|Dr. Michael D. Johnson|(801) 935-0503|mike.johnson@hsc.utah.edu|
22264624|NCT00949988|UCSD Moores Cancer Center|Kimberly Aguilar, Clinical Trials Manager|858-534-5201|k1aguilar@ucsd.edu|
22264625|NCT04625062|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
22264626|NCT02654587|OSE Immunotherapeutics|Chief Medical Officer Immuno-Oncology|+33 2 28 29 10 10|contact@ose-immuno.com|
22264627|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22264628|NCT02269631|Emory Unioversity|Hartman, Terry Professor, SPH Epidemiology|404-727-8713|terryl.johnson.hartman@emory.edu|
22264629|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264630|NCT01682148|Ipsen|Medical Director, Neurology|clinicaltrials@ipsen.com|clinicaltrials@ipsen.com|
22264631|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22264632|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com|
22275710|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr|
22275711|NCT04739800|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22275712|NCT05227677|Nagase Diagnostics Co.,Ltd.|Takuji Kohzuma|09080045463|takuji.kohzuma@nagase.co.jp|
22275713|NCT03573297|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22275714|NCT04084015|Massachusetts General Hospital|Dr. David D'Alessandro|617-726-8841|DADALESSANDRO@MGH.HARVARD.EDU|
22275715|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
22275716|NCT02696798|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275717|NCT04880850|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22275718|NCT04091451|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275719|NCT03074500|Marmara University School of Medicine|Gulseren Derya Akyuz|+90 216 657 06 06|girayesra@hotmail.com|1628
22275720|NCT06023563|Indiana University|Dr. Georgia Frey, Faculty, Department of Kinesiology|(812) 855-1262|gfrey@iu.edu|
22275721|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com|
22275722|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275723|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22275724|NCT01928849|Duke University Department of Anesthesiology|Thomas Buchheit, MD Division Chief, Pain Medicine|9196811924|Thomas.Buchheit@duke.edu|
22275725|NCT03483103|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22275726|NCT02475213|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22275727|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org|
22275728|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu|
22275729|NCT02411643|Northwestern University|Stephanie Rangel|3125035942|stephanie.rangel@northwestern.edu|
22275730|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org|
22275731|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu|
22275732|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22275733|NCT02196831|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@mgh.harvard.edu|
22275734|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu|
22275735|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680|fitzgb@shands.ufl.edu|87829
22275736|NCT03822416|University of Minnesota|Harry Lando, PhD|612-624-1877|lando001@umn.edu|
22275737|NCT04666298|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22275738|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu|
22275739|NCT01303419|GE Healthcare|Jean-Paul Antonini|+33 130709703|Jean-Paul.antonini@ge.com|
22275740|NCT06438601|CooperVision, Inc.|Jose A. Vega, OD, MSc, PhD|925-621-3761|javega@coopervision.com|
22275741|NCT03329001|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275742|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu|
22308162|NCT04058626|Imperial College London/ Imperial College Healthcare NHS Trust|Mr Pasha Normahani|020 3312 6666|p.normahani@imperial.ac.uk|switch
22275743|NCT02178956|Sumitomo Dainippon Pharma Oncology|Marilyn Fontaine|617-674-8556|mfontaine@bostonbiomedical.com|
22275744|NCT03769493|Brown University|Ethan Moitra, Ph.D.|4014441949|ethan_moitra@brown.edu|
22275745|NCT02709369|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
22275746|NCT01341470|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275747|NCT03282097|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
22275748|NCT01732211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275749|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu|
22275750|NCT00957359|NYU Langone Health|Stephen Ross, MD|212-263-7264|Stephen.Ross@nyulangone.org|
22275751|NCT03034967|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275752|NCT04613453|Yale University|Brooke Rivera|203-974-2241|Brooke.rivera@yale.edu|
22275753|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu|
22275754|NCT05258721|Arcadia Consumer Healthcare, Inc.|Jai Shewale|504-913-4344|jshewale@arcadiach.com|
22275755|NCT04512924|Medical University of South Carolina|Dr. Brantlee Broome|843-792-3370|broomeb@musc.edu|
22275756|NCT05291689|Morphic Therapeutic Inc.|Head of Clinical Development|781-996-0955|clinicaltrials@morphictx.com|
22275757|NCT01931098|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@nih.gov|
22275758|NCT02612155|Duke University|Dr. Kim Fisher, Ph.D., FNP-BC|919-681-4913|kimberley.fisher@duke.edu|
22275759|NCT04235374|University of Maryland|Barbara Resnick|410 706 5178|resnick@umaryland.edu|
22275760|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22275761|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22275762|NCT04530344|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22275763|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22275764|NCT01933594|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22275765|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22275766|NCT03869268|The University of Sheffield|Dr William Parker|01142266159|w.parker@sheffield.ac.uk|
22275767|NCT05457855|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22275768|NCT05352399|Yale School of Medicine|Cameron Gettel|717-228-7759|cameron.gettel@yale.edu|
22275769|NCT04478266|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22275770|NCT04058717|Penn State College of Medicine|Nicolle Krebs|7175315673|nkrebs@pennstatehealth.psu.edu|
22275771|NCT03836066|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22275772|NCT02799602|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22275773|NCT06006208|Thomas Jefferson University|Associate Professor|3059784358|moritayoshihisa2016@gmail.com|
22275774|NCT05430204|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
22275775|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22275776|NCT01850641|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22275777|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275778|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
22275779|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22275780|NCT03907488|SWOG|Hongli Li|206-667-6077|hongli@fredhutch.org|
22275781|NCT03456245|Harvard TH Chan School of Public Health|Dr. David Bloom|6174320650|dbloom@hsph.harvard.edu|
22275782|NCT03321721|St. Louis University School of Medicine|Dr. Trevor L. Tredway|314-577-5630|trevor.tredway@health.slu.edu|
22275783|NCT07169032|First Affiliated Hospital of Jinan University|LI ZHEN ZHONG|+8613711706774|nicolezlz@foxmail.com|
22289036|NCT01614392|Jean Mayer USDA HNRCA, Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
22289037|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22289038|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu|
22289039|NCT03534180|City of Hope|Dr. Jasmine Zain, MD|6263598111|jazain@coh.org|
22289040|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22289041|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551|charles.oh@va.gov|1-5127
22289042|NCT01237899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289043|NCT00790088|Medtronic Int. Trading SaRL|Dr Odile Carrette|+41218038119|odile.osullivan@medtronic.com|
22289044|NCT02910986|Mayo Clinic|Celine M. Vachon, Ph.D.|507 293-3247|Vachon.Celine@mayo.edu|
22289045|NCT04902924|Rehabilitation and Exercise Science Laboratory (RESlab), University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Vanessa Wellauer|0041 81 300 01 78|vanessa.wellauer@supsi.ch|
22308163|NCT04791709|University of Miami|Dr. Daniel Jimenez|305-243-2776|dej18@miami.edu|
22308164|NCT02724956|UT MD Anderson Cancer Center|Carin Hagberg, MD/Chief Academic Officer, CAO Office|713-792-5888|chagberg@mdanderson.org|
22264633|NCT01099631|Masonic Cancer Center, University of Minnesota|Daniel Saltzman|612 626 4214|saltz002@umn.edu|
22264634|NCT04844021|Northwestern University|Dr. Rinad Beidas|312-503-0546|rinad.beidas@northwestern.edu|
22264635|NCT02389101|Turku Univesrity Hospital, Turku, Finland|Heikki Minn, MD|+35823130000|heikki.minn@utu.fi|30149
22264636|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org|
22264637|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu|
22264638|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu|
22264639|NCT02377921|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22264640|NCT02443545|Chiesi Canada Corp.|Fernando Tricta, MD|1-800-854-3534|f.tricta@chiesi.com|7049
22264641|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com|
22264642|NCT02139124|Purdue Pharma|Dr Lance Payne|1-800-384-5349|Lance.Payne@purdue.ca|
22264643|NCT02642237|Radboud university medical centre|Matthijs Kox|+31243653881|matthijs.kox@radboudumc.nl|
22264644|NCT04121091|Unit of Biological and Precision Psychiatry|Dr Daniel Lindqvist|+4646173885|daniel.lindqvist@med.lu.se|
22264645|NCT03821272|University of Arkansas for Medical Sciences|Mayumi Nakagawa, M.D., Ph.D.|(501) 686-8635|MNakagawa@uams.edu|
22264646|NCT05904769|Mayo Clinic|Guru Kowlgi M.B.B.S., M.S.|507-422-0549|Kowlgi.NarayanGurukripa@mayo.edu|
22264647|NCT04266041|Dartmouth-Hitchcock Medical Center|Dr. Yinchen Song|603-650-5104|yinchen.song@hitchcock.org|
22264648|NCT05626803|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
22264649|NCT04974619|Moffitt Cancer Center|Dr. Shannon Christy|813-745-8840|Shannon.Christy@moffitt.org|
22264650|NCT01688466|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22264651|NCT03310957|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22264652|NCT05529511|University Hospitals of Derby and Burton NHS Foundation Trust|Hayley Carter|01332254631|hayley.carter1@nhs.net|
22264653|NCT03740113|Univeristy of Virginia|Dr. Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
22264654|NCT02516410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22264655|NCT04051684|Montefiore Medical Center|Dr. Karina Gritsenko|718-920-7246|kgritsen@montefiore.org|
22264656|NCT04146363|Eli Lilly and Company|Chief Medical officer|800-549-5929|ClinicalTrials.gov@lilly.com|
22264657|NCT02676284|Zambon S.A.U.|Antonio Esteras, MD|+34 93 544 64 00|antonio.esteras@zambongroup.com|
22264658|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22264659|NCT04776746|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22264660|NCT05017974|University of California, San Francisco|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
22264661|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264662|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu|
22264663|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu|
22264664|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22264665|NCT03647046|University of Rochester|Study Coordinator|(585) 276-6922|keratoconusstudy@gmail.com|
22264666|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com|
22264667|NCT03575871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264668|NCT05444556|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22264669|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu|
22264670|NCT02791893|Mount Sinai Beth Israel, New York, NY|Dr. Benjamin Natelson|212-844-6768|Benjamin.Natelson@mountsinai.org|
22264671|NCT03738020|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22264672|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300||
22264673|NCT04060719|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264674|NCT04319159|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
22264675|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22264676|NCT02100319|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22264677|NCT00971737|Johns Hopkins University|Leisha Emens, MD, PhD||emensle@jhmi.edu|
22264678|NCT02589522|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22264679|NCT03422198|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22264680|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu|
22264681|NCT05224544|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
22264682|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org|
22264683|NCT01341587|University of Maryland Baltimore|*Administrator, Division of Gerontology|4107062406|cquinn@som.umaryland.edu|
22264684|NCT03208673|Allergan|Medical Director|714-246-4500|CTRegistration@allergan.com|
22264685|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org|
22264686|NCT03891329|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22264687|NCT03176784|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
22264688|NCT02990806|Nichi-Iko Pharmaceutical Co., Ltd|Hiroshi Anekawa|+81-3-6262-1564|hiroshi-anekawa@nichiiko.co.jp|
22264689|NCT04403763|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264690|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
22264691|NCT01376310|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264692|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu|
22264693|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu|
22264694|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu|
22264695|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com|
22264696|NCT01615887|SUNY University at Buffalo|Ralph Benedict|716-323-0556|benedict@buffalo.edu|
22264697|NCT00604201|National Heart Lung and Blood Institute|Childs, William|+1 301 451 7128|childsr@nhlbi.nih.gov|
22264698|NCT02463799|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-8341|eantona1@jhmi.edu|
22264699|NCT00631852|Southern Illinois University School of Medicine|Director of Oncology Clinical Trials|217-545-8000|krobinson@siumed.edu|
22264700|NCT02416011|Moffitt Cancer Center|Dr. Thomas Bradon|(813) 745-1750|Thomas.Brandon@moffitt.org|
22264701|NCT02080832|VCU|F. Gerard Moeller, M.D.|804-828-4134|frederick.moeller@vcuhealth.org|
22264702|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411|marx0001@mc.duke.edu|7426
22264703|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
22264704|NCT03069417|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
22264705|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322|andrea.petznick@seri.com.sg|4512
22264706|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org|
22264707|NCT03360539|Harvard University|Dr. Margaret McConnell|6174321232|mmcconne@hsph.harvard.edu|
22264708|NCT03545191|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
22264709|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22264710|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22264711|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
22264712|NCT03919162|Vivoryon Therapeutics N.V.|Study Director|0049 34555599|clinics@vivoryon.com|00
22264713|NCT03078478|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22264714|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22264715|NCT00965055|UCSD|Ori Ben-Yehuda|9179697273|obenyehuda@ucsd.edu|
22264716|NCT03182751|Mayo Clinic|Dr. Brandon Yuan|507-255-6112|Yuan.Brandon@mayo.edu|
22264717|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264718|NCT03861481|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22264719|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com|
22264720|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu|
22264721|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com|
22264722|NCT03768726|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264723|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22264724|NCT02148913|Corewell Health|Esther Peariso|616-486-0358|esther.peariso@corewellhealth.org|
22264725|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028|john.carlquist@imail.org|74707
22308165|NCT01532388|Karolinska Institutet|Dr Kristina Sinadinovic|+46812345735|kristina.sinadinovic@socialstyrelsen.se|
22264726|NCT01360866|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|609 524 6788|clinicaltransparency@otsuka-us.com|
22264727|NCT05016622|Montefiore Medical Center|Dr. Balazs Halmos|718-405-8404|bahalmos@montefiore.org|
22264728|NCT02678442|Mayo Clinic|Dr. Michael B. Wallace|904-953-2222|wallace.michael@mayo.edu|
22264729|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
22264730|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu|
22264731|NCT05506358|The University of British Columbia|Pranav Shrestha|6507893270|pranav.shrestha@alumni.ubc.ca|
22264732|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com|
22264733|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
22264734|NCT03301532|University of Texas Southwestern Medical Center|Dr. Juan Pascual|214-648-3550|juan.pascual@utsouthwestern.edu|
22264735|NCT04939519|Huntsman Cancer Institute at University of Utah|Dr. David Wetter|801-213-6178|david.wetter@hci.utah.edu|
22264736|NCT01744093|Weill Cornell Medicine|Mei Wang, BS, CCRP|646-962-2672|mew2001@med.cornell.edu|
22264737|NCT02006628|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22264738|NCT00834652|Washington University School of Medicine|Patrick J. Lustman, Ph.D.|3142861320|lustmanp@psychiatry.wustl.edu|
22264739|NCT03578237|University of California San Diego|Program Manager|(858) 220-5714|baabdullah@health.ucsd.edu|
22264740|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com|
22264741|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu|
22264742|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil|
22264743|NCT03050203|Istituto Ortopedico Rizzoli|Cristiana Forni|0039516366|cristiana.forni@ior.it|694
22264744|NCT03998436|Novalead Pharma Pvt. Ltd.|Supreet K. Deshpande|7066233033|supreet@novaleadpharma.com|
22264745|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu|
22264746|NCT05206448|University of Iowa|Rachel Mejia, DO|319-356-3143|rachel-mejia@uiowa.edu|
22264747|NCT04323098|BioMarin Pharmaceutical Inc.|Tara M Robinson, MD, PhD, Senior Medical Director, Late-Stage Clinical Development|415-455-7931|tara.robinson@bmrn.com|
22264748|NCT01122316|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
22264749|NCT04572243|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22308166|NCT03385629|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
22308167|NCT03926819|Hillhurst Bio|President and CEO|858 232 9495|admin@hillhurstbio.com|
22308168|NCT04600752|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308169|NCT04431726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22308170|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22308171|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22308172|NCT04349072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22275784|NCT04356833|Royal Free London NHS Foundation Trust|Professor Pratima Chowdary|0207 794 0500|p.chowdary@nhs.net|35921
22275785|NCT04809974|Massachusetts General Hospital|Edmarie Guzmán-Vélez|6176436107|eguzman-velez@mgh.harvard.edu|
22275786|NCT04338581|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22275787|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275788|NCT00770809|University of North Carolina - Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu|
22275789|NCT03834168|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|2059754720|parora@uabmc.edu|
22275790|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu|
22275791|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com|
22275792|NCT01898130|Northwestern University|Priya Kumthekar, MD|312-503-1818|p-kumthekar@northwestern.edu|
22275793|NCT04115059|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22275794|NCT04491994|Pak Emirates Military Hospital (PEMH) Rawalpindi|Sultan Mehmood Kamran|+923008501100|sultanmajoka79@hotmail.com|
22275795|NCT03589703|Johns Hopkins University|Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN|410-614-5297|nada.lukkahatai@jhu.edu|
22275796|NCT02234180|Memorial Sloan-Kettering Cancer Center|Yelena Y. Janjigian MD|646-888-4186|janjigiy@mskcc.org|
22275797|NCT03575364|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
22275798|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22275799|NCT01033136|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
22275800|NCT05383209|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
22294328|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22294329|NCT03903874|University of Alabama at Birmingham|Dr. Dori Pekmezi|205-975-8061|dpekmezi@uab.edu|
22294330|NCT02356575|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao, MD, MSCE|646-888-0866|maoj@mskcc.org|
22294331|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294332|NCT01509950|Stanford University|Research Operations Manager|6507255720|agirsen@stanford.edu|
22308173|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org|
22308174|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308175|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org|
22308176|NCT05480943|VA Sierra Nevada Healthcare System|Elisabeth Mates, MD,PhD, Principal investigator|775-786-7200|Elisabeth.Mates@va.gov|5273
22308177|NCT04999592|MaineHealth Maine Medical Center - Portland|David J. Gagnon, PharmD - Principal Investigator|207-662-0111|dgagnon@mmc.org|
22308178|NCT03069313|Cleveland Clinic Florida|Zeina Nahleh, MD (previoulsy PI at Texas Tech university HSC-EP)|9546595840|nahlehz@ccf.org|
22308179|NCT03912831|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22308180|NCT03242148|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
22308181|NCT04623775|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22308182|NCT06377358|University of Malaga|José Rioja Villodres|(+34) 952 137 278|jose.rioja@uma.es|
22308183|NCT06024174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22308184|NCT05005221|University of Michigan|Manjunath Pai|734/647-0006|amitpai@med.umich.edu|
22308185|NCT02525692|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22308186|NCT02396199|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22308187|NCT05794763|Stanford University|Dr. Eric Stice|6507237885|estice@stanford.edu|
22308188|NCT04112316|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
22308189|NCT04455035|The University of Texas Health Science Center at Houston|Brett Chiquet, DDS, PhD, Associate Professor|7135008220|Brett.T.Chiquet@uth.tmc.edu|
22275801|NCT01369433|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22294333|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu|
22294334|NCT02820753|Northwestern University|Stephanie Batio|312-503-4684|stephanie.batio@northwestern.edu|
22294335|NCT01652703|Amgen Inc.|Study Director|866-572-6436||
22294336|NCT03555591|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22294337|NCT02728050|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
22294338|NCT02380677|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
22294339|NCT05035550|Michigan State University|Dr. Jason Moser|517-355-2159|jmoser@msu.edu|
22294340|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com|
22294341|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22294342|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294343|NCT03052725|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22294344|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294345|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22294346|NCT04213079|Icahn School of Medicine at Mount Sinai|Sergei Yakushin|212-241-9349|sergei.yakushin@mssm.edu|
22294347|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294348|NCT02123121|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
22294349|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org|
22294350|NCT03858309|Oregon Health & Science University (OHSU)|Selda Yildiz, PhD|(503) 494-7219|yildiz@ohsu.edu|
22321465|NCT03416153|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22294351|NCT01812174|Artivion, INC|Erica Troup , Clinical Project Manager|706-409-5974|erica.troup@artivion.com|
22294352|NCT02621060|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22321466|NCT05159648|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
22294353|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321467|NCT03468855|Aclaris Therapeutics, Inc.|David Gordon|484-540-6296|Clintrials@aclaristx.com|
22264750|NCT03847194|Seattle Children's Research Institute|Joyce Yi-Frazier|2068841456|joyce.yi-frazier@seattlechildrens.org|
22264751|NCT05472116|University of Minnesota|Jonathan Strutt|(314) 578-8045|strutt@umn.edu|
22264752|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22264753|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu|
22264754|NCT04179019|Brigham and Women's Hospital|Anand Vaidya|6177325666|anandvaidya@bwh.harvard.edu|
22264755|NCT00408564|Medical University of South Carolina|Kate Anderton, MPH, CCRP|843-792-2708|anderton@musc.edu|
22264756|NCT05307887|Imperial College NHS Foundation Trust|Dr Thomas Sewell|02033122152|thomas.sewell2@nhs.net|
22264757|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu|
22264758|NCT03179163|Penn State|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
22264759|NCT04400760|The University of the West Indies, St. Augustine|Dr. Naveen Seecheran|18687537686|nseecheran@gmail.com|
22264760|NCT02746627|Vanderbilt University Medical Center|Sarah Jaser, PhD|615-343-6775|sarah.jaser@vanderbilt.edu|
22264761|NCT02858726|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22264762|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu|
22264763|NCT01972035|University of Minnesota|Henry Balfour, MD|612-625-3998|balfo001@umn.edu|
22264764|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22264765|NCT02508259|University of California, San Diego School of Medicine|Dr. Robert K. Naviaux, MD, PhD|619-543-2904|naviaux@ucsd.edu|
22264766|NCT04553913|Atrium Health Wake Forest Baptist|Seiha Kim, DO|336-716-4498|sekim@wakehealth.edu|
22264767|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22264768|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org|
22264769|NCT06400745|Alcon Research, LLC|Director Clinical Trial Management, Surgical IOL|1-888-451-3937|alcon.medinfo@alcon.com|
22264770|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
22294354|NCT05469178|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
22264771|NCT05478252|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22294355|NCT00968513|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
22294356|NCT03292562|The University of Texas Health Science Center at Houston|Amir Khan, MD|713-500-5519|Amir.M.Khan@uth.tmc.edu|
22294357|NCT05466682|NYU Langone Health|Mia T Minen, MD|212-263-7744|mia.minen@nyulangone.org|
22294358|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
22294359|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru|
22294360|NCT02856035|Department of Veterans Affairs, N Fl/S Georgia VA Medical Center|Dr. Janis J Daly|216 402 8940|jjd17@case.edu|
22294361|NCT02846714|Huntsman Cancer Institute University of Utah|Dr. Yelena Wu|8012135653|yelena.wu@utah.edu|
22294362|NCT03087643|University of Verona|Dr. Massimo Venturelli|00390458415114|massimo.venturelli@univr.it|
22294363|NCT02083783|Tris Pharma, Inc.|Antonio Pardo MD|732-823-4755|apardo@trispharma.com|
22294364|NCT04528732|Washington University in St. Louis|Dr. Proscovia Nabunya|3149359087|nabunyap@wustl.edu|
22294365|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com|
22294366|NCT01804465|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
22294367|NCT04338074|University of Alabama at Birmingham|Dr. Timothy J Ness|205-975-9643|tness@uabmc.edu|
22294368|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu|
22294369|NCT02051686|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22294370|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
22294371|NCT02405780|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|0044 1896 668 173|Clinical-Trials@fk-b.com|
22294372|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351||
22294373|NCT00668707|The Centre for Health Innovation|Mark Legacy, Clinical Trial Coordinator|613-792-1222|mlegacy@thechi.ca|1
22294374|NCT01996852|Case Comprehensive Cancer Center|Dr. Amy Zhang|+1 216-368-0968|amy.zhang@case.edu|
22264772|NCT04846881|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264773|NCT04560998|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22264774|NCT04862949|CHA Bundang Medical Center|Hong Jae Chon|82-31-780-3928|minidoctor@cha.ac.kr|
22264775|NCT02332980|Mayo Clinic|Wei Ding|5072845096|Ding.Wei@mayo.edu|
22264776|NCT03714555|HonorHealth|Gayle Jameson, MSN, ACNP-BC, AOCN|480-323-1364|clinicaltrials@honorhealth.com|
22264777|NCT05599269|Ivoclar Vivadent AG|Dr. med. dent. Ronny Watzke|+423 235 3401|Ronny.Watzke@ivoclar.com|
22264778|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22264779|NCT01010126|Mayo Clinic|Henry Pitot, M.D.|(507) 284-2511|pitot.henry@mayo.edu|
22264780|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264781|NCT04495283|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
22264782|NCT05218109|University of Florida|Sarah Bottari, M.S.|(352) 273-6455|sbottari@ufl.edu|
22294375|NCT02494297|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
22294376|NCT03846804|Indiana University School of Medicine|James Wood, MD|317-944-7260|woodjb@iu.edu|
22264783|NCT01959490|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
22294377|NCT05438888|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294378|NCT04698187|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22294379|NCT02993146|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22294380|NCT04362072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294381|NCT04524689|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22294382|NCT01133522|Amgen Inc.|Study Director|866-572-6436||
22294383|NCT03128424|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
22294384|NCT01354977|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einstein.yu.edu|2903
22294385|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22294386|NCT04869644|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
22294387|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com|
22294388|NCT05255068|The University of Iowa|Wen Liu|3193557104|wen-liu-1@uiowa.edu|
22294389|NCT00680862|VHA|Henry Anaya|310-478-3711|henry.anaya@va.gov|48488
22294390|NCT03156543|University of Michigan Medical School|Bethany Ruffino|734 615-0768|bruffino@med.umich.edu|
22294391|NCT02397278|Stanford University|Michael Fadell II|3037241111|mfadell@stanford.edu|
22264784|NCT04859699|University of Washington|Linda K. Ko|+1 206 707-5624|lindako@uw.edu|
22264785|NCT04718545|Goteborg University|Dr Olivier Carcuac|317863124|olivier.carcuac@gu.se|+46
22264786|NCT04843566|Weill Cornell Medicine|Jim Hu|2127463418|jch9011@med.cornell.edu|
22264787|NCT03341000|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
22264788|NCT02287909|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
22264789|NCT04718194|Yale|Dr. Dani Chiaramonte|3479310195|danielle.chiaramonte@yale.edu|
22264790|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22264791|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
22294392|NCT03444961|Cleveland Clinic|Dr. Aleksandra Rachitskaya|216-445-9519|rachita@ccf.org|
22294393|NCT02601469|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22275802|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22294394|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu|
22294395|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22294396|NCT01315678|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
22294397|NCT02471430|Massachusetts General Hospital|Mathias Lichterfeld|617-726-2000|mlichterfeld@mgh.harvard.edu|
22294398|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351||
22294399|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22294400|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22294401|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu|
22294402|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu|
22294403|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
22294404|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org|
22294405|NCT03719885|Penn Medicine|Research Coordinator|215-662-9393|jonathan.lilley@pennmedicine.upenn.edu|
22294406|NCT03644212|Maimonides Medical Center|Sara Meeder|7182837253|smeeder@maimonidesmed.org|
22294407|NCT02155608|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22294408|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com|
22294409|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org|
22294410|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu|
22294411|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
22294412|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br|
22294413|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294414|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com|
22294415|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org|
22294416|NCT03487276|InflaRx N.V.|Dr. Korinna Pilz, MD, MSc|+49 89 414 189 78 00|Korinna.Pilz@InflaRx.de|
22294417|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22294418|NCT03616600|Hong Kong Polytechnic University|Dr. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
22294419|NCT03984994|University of Maryland|Dr. Steven J. Prior|301-405-2483|sprior@umd.edu|
22294420|NCT05873257|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
22294421|NCT03010176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294422|NCT04220866|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294423|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com|
22294424|NCT03210376|UT MD Anderson Cancer Center|Dr. Wendell H. Williams III / Anesthesiology & Perioperative Medicine|713-563-0034|WHWilliams@mdanderson.org|
22294425|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22294426|NCT03478930|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294427|NCT04950998|University of Southern California|Dr. Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
22294428|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu|
22294429|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000|steve.woodward@va.gov|22111
22294430|NCT00555971|Cleveland Clinic|David M. Lang|216-444-6933|langd@ccf.org|
22294431|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com|
22294432|NCT02573311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294433|NCT05683249|Neurocentria Inc.|Clinical Development|925-954-4868|info@neurocentria.com|
22294434|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
22294435|NCT03834441|MGH|Margaret Samuels-Kalow|617-726-8340|msamuels-kalow@partners.org|
22294436|NCT02256631|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22294437|NCT01427972|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294438|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22294439|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com|
22294440|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov|
22294441|NCT04967443|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294442|NCT04502693|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22294443|NCT02784431|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
22294444|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org|
22294445|NCT04404361|CTI BioPharma Corp.|John Volpone|206-351-7663|jvolpone@ctibiopharma.com|
22294446|NCT00217594|NHLBI, NIH|Chris Hourigan MD|301-451-0257|hourigancs@mail.nih.gov|
22294447|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302|mintzero@musc.edu|2834
22294448|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22294449|NCT01949506|Froedtert and the Medical college of Wisconsin|Meena Bedi, MD|414-805-4400|mbedi@mcw.edu|
22294450|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22294451|NCT03307967|Yale University|Christina Lazar, Project Director|203-932-5711|christina.lazar@yale.edu|4833
22264792|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu|
22294452|NCT02915016|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22294453|NCT02578316|Eisai Inc.|Eisai Medical Services|888-||
22264793|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
22264794|NCT02698865|DePuy Synthes|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22264795|NCT03715998|Quantum Genomics|Dr Bruno Besse|+33 1 85 34 77 73|bruno.besse@quantum-genomics.com|
22264796|NCT01386684|AbbVie|Global Medical Services|800-633-9110||
22264797|NCT02130583|Alpert Brown Medical School|Shirley Yen, Ph.D., Principal Investigator|4014441915|Shirley_Yen_PhD@Brown.edu|
22264798|NCT02149290|ZOLL LifeVest|VP of Medical Affairs|412-968-3333|stevens@zoll.com|14400
22264799|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu|
22264800|NCT02694549|CaveoMed GmbH|Albertus M. Scheule, MD, PhD, MBA|+49(0)7071-53982-10|albertus.scheule@caveomed.com|
22264801|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22264802|NCT02113189|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|2146481559|karen.mccain@utsouthwestern.edu|
22264803|NCT03623620|Massachusetts General Hospital, Center for Women's Mental Health|Lee Cohen, MD|617-724-8020|lcohen2@mgh.harvard.edu|
22264804|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300||
22264805|NCT03702049|University of California, Irvine, Sue & Bill Gross School of Nursing|Adeline M Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
22275803|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org|
22264806|NCT02954159|Medical College Of Wisconsin|Andres Yarur, MD; Principal Investigator|414-955-6858|ayarur@mcw.edu|
22264807|NCT03438396|Genmab A/S|Ibrahima Soumaoro|+1 609 430 2481|clinicaltrials@genmab.com|
22264808|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22264809|NCT03028740|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22264810|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com|
22264811|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264812|NCT02566993|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 918466000|clinicaltrials@pharmamar.com|
22264813|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
22264814|NCT01790113|Arthrex|Clinical Affairs Manager|2392161894|melissa.hirschberg@arthrex.com|
22264815|NCT03451006|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
22264816|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu|
22264817|NCT02278718|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
22264818|NCT04440449|University of Texas Health San Antonio|Rozmin Jiwani|210-450-8498|jiwani@uthscsa.edu|
22264819|NCT02547766|University of Utah|Associate Director of Clinical Trials|801-581-5318|heather.thiesset@hsc.utah.edu|
22264820|NCT03212794|Brigham and Women's Hospital|Joji Suzuki, MD|617-732-5752|Jsuzuki2@bwh.harvard.edu|
22264821|NCT04317313|Second Affiliated Hospital, School of Medicine, Zhejiang University|Dr. Xiaohui Zhang|+86-571-87767188|zhanghui4127@zju.edu.cn|
22264822|NCT01763918|Amgen Inc.|Study Director|866-572-6436||
22264823|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264824|NCT01553747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22264825|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com|
22275804|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu|
22294454|NCT02166905|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|chong.wang@roswellpark.org|
22294455|NCT02617628|University of Pennsylvania Office of Research Services|W. Stuart Watson|215-573-6707|wswatson@upenn.edu|
22294456|NCT02065375|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22294457|NCT03432897|Brown Oncology Research Group|BrUOG|4018633000|BrUOG@Brown.edu|
22294458|NCT03278873|MeiraGTx|Program Manager|0044 (0)20 3866 4320|ocularinfo@meiragtx.com|
22294459|NCT05243641|M D Anderson Cancer Center|Rachel M. Layman, MD|713) 745-8401|rlayman@mdanderson.org|
22294460|NCT04785677|Florida State University|Stephen Tripodi|850-645-1572|stripodi@fsu.edu|
22294461|NCT05169437|Tempus AI, Inc|Virginia Rhodes, MD|(800) 976-5448|support@tempus.com|
22294462|NCT01886794|University of Texas Medical Branch|Kathleen L. Vincent, M.D.|409-772-2610|klvincen@utmb.edu|
22294463|NCT00895232|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
22294464|NCT02159560|Beth Israel Deaconess Medical Center|Philip Hess|6176673112|phess@bidmc.harvard.edu|
22294465|NCT05372419|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22294466|NCT02801331|University of Pittsburgh School of Medicine|Elisabeth B Salisbury, PhD|14122465378|salisburye2@upmc.edu|
22294467|NCT02443987|Gloucestershire Hospitals NHS Foundation Trust|Dr Sharan Athwal|0300 422 2222|sharan.athwal@glos.nhs.uk|
22294468|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net|
22294469|NCT02513394|Dana-Farber Cancer Institute|Erica L. Mayer, MD, MPH|617-632-3800|emayer@partners.org|
22294470|NCT02161731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294471|NCT03633695|AcuFocus, Inc.|Magda Michna, PhD., Chief Global Clinical, Medical and Regulatory Affairs Officer|(949) 585-9511|mmichna@acufocus.com|
22294472|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294473|NCT05426902|Duke University|Amanda Eudy, MSPH, Ph.D.|919-681-1811|amanda.eudy@duke.edu|
22294474|NCT03217175|MGH Diabetes Research Center|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22294475|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu|
22294476|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com|
22264826|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu|
22275805|NCT01101100|Valeant Pharmaceuticals International|Lindsey Mathew|908|lindsey.mathew@valeant.com|
22264827|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu|
22264828|NCT03253744|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
22294477|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu|
22294478|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org|
22294479|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294480|NCT00975650|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
22294481|NCT03739593|Aerie Pharmaceuticals, Inc|Kevin Kerr, Director of Clinical Development|(949) 526-8701|kkerr@aeriepharma.com|
22294482|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294483|NCT02713347|VA|Dr. David Bekelman|7207236388|david.bekelman@va.gov|
22294484|NCT03250845|UZ Leuven|Datamanager|+3216346880|jonas.vanham@uzleuven.be|
22294485|NCT01402492|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
22294486|NCT04866225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294487|NCT02019693|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
22308190|NCT03217565|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22308191|NCT04247542|Acurx Pharmaceuticals, Inc.|Robert J DeLuccia|914-949-3898|rjdeluccia@acurxpharma.com|
22308192|NCT03438188|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
22308193|NCT06066541|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22308194|NCT04533022|Vicore Pharma AB|Chief medical officer Bertil Lindmark|+46 707661505|info@vicorepharma.com|
22308195|NCT03897686|RCBIOFORM|Julia Melentyeva Commercial Director|+7 (495) 223-70-95|md@bioform.ru|
22308196|NCT05415436|The University of Toledo Medical Center|Kristi Baker BSN, RN|4193836223|kristi.baker@utoledo.edu|
22308197|NCT04030130|Medical University of South Carolina|Evan Graboyes, MD, MPH|843-792-0719|graboyes@musc.edu|
22308198|NCT04505774|University of Pittsburgh|Dr. Stephen Wisniewski|412-383-4696|stevewis@pitt.edu|
22308199|NCT05386355|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
22308200|NCT04788537|University of Pennsylvania|Edward S Brodkin, MD|1-215-746-0118|ebrodkin@pennmedicine.upenn.edu|
22308201|NCT03157167|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
22308202|NCT02643667|Washington University School of Medicine|Dr. Russell K. Pachynski|314-286-2341|rkpachynski@wustl.edu|
22308203|NCT03263026|DeNovo Biopharma|Gracielli Hage-Kautz, Associate Director Clinical Operations|858-799-1021|gkautz@denovobiopharma.com|746
22308204|NCT03775109|Imperial College, London|Professor Mark Thursz|+44 (0) 203 3126454|m.thursz@imperial.ac.uk|
22308205|NCT05691452|Vanderbilt University School of Nursing|Dr. Chorong Park|6153436075|chorong.park@vanderbilt.edu|
22308206|NCT04712994|University of Washington|Anjuli Wagner|9784602331|anjuliw@uw.edu|
22308207|NCT01938547|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22308208|NCT03564600|University of Pittsburgh School of Medicine|Professor Debra K. Weiner, M.D.|4124016811|dweiner@pitt.edu|
22264829|NCT06279871|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22264830|NCT04744155|Children's Mercy Kansas City|Melissa K. Miller MD|8162343430|mmiller@cmh.edu|
22264831|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
22264832|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22264833|NCT04776954|University of Minnesota|Michael Todd|6126264551|mmtodd@umn.edu|
22264834|NCT02339740|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22264835|NCT01807117|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Raj Paspulati|1-800-641-2422|Raj.Paspulati@UHhospitals.org|
22264836|NCT04070287|Saint Louis University|Dr. Juliet Iwelunmor|2405280123|juliet.iwelunmor@slu.edu|
22264837|NCT02777918|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22264838|NCT01343095|Wake Forest Baptist Health|Matthew C. Miles|336-716-7765|mmiles@wakehealth.edu|
22264839|NCT02510014|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
22264840|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com|
22264841|NCT01949116|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22264842|NCT03399318|University of Rochester|Professor Gretchen L. Birbeck|+ 1(517) 505-0283|gretchen_birbeck@urmc.rochester.edu|
22264843|NCT04209335|University of Salford|ISOMETRIC CORE MUSCLE ENDURANCE IN HEALTHY ACTIVE AND NON-ACTIVE WORKING AGE POPULATIONS|07488550768|H.Holmberg@edu.salford.ac.uk|
22294488|NCT03822078|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22294489|NCT05973981|RAND|William Shadel|412-683-2300|shadel@rand.org|4489
22275806|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
22275807|NCT01532089|Duke University|Thomas E. Stinchcombe, M.D.|507/284-4565|thomas.stinchcombe@duke.edu|
22275808|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275809|NCT03149770|University of Minnesota|Anjali Kumar|612-301-7040|studydiabetes@umn.edu|
22275810|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
22275811|NCT01104766|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
22275812|NCT04057235|Integrity Implants Inc|Lauren Kamer, Senior Director of Regulatory and Clinical Affairs|+1.561.529.3861|lkamer@integrityimplants.com|
22275813|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22275814|NCT03225482|VA San Diego Healthcare System|Elizabeth Twamley, PhD|858-642-3848|Elizabeth.Twamley@va.gov|
22275815|NCT05452239|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22275816|NCT03965923|Fred Hutchinson Cancer Center|Daniel Szydlo|2066677451|dszydlo@fredhutch.org|
22275817|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22275818|NCT03916926|Case Western Reserve University|Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
22275819|NCT05473039|SEID|Ana Gavilán|+34 630928812|agavilan@lab-seid.com|
22275820|NCT04291131|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
22275821|NCT05850494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22275822|NCT03806296|University of Pittsburgh School of Medicine|Brant Hasler, PhD|412-246-6413|haslerbp@upmc.edu|
22275823|NCT03350919|University of Rochester|Steven E. Feldon, MD|585-273-1050|Steven_Feldon@urmc.rochester.edu|
22275824|NCT03136198|Indiana University|Peter S. Pang|317-880-3900|ppang@iu.edu|
22275825|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com|
22275826|NCT03116230|Stanford University|Thomas Andriacchi|650-|tandriac@stanford.edu|
22275827|NCT02763566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275828|NCT04896385|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22275829|NCT05233761|Defined Research Institute|Paul Muchowski|415-413-8666|paul.muchowski@definedresearch.org|
22275830|NCT04612400|The University of Arkansas for Medical Sciences|Katie Rose Hisrch, Ph.D.|5015265708|krhirsch@uams.edu|
22275831|NCT03314935|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22275832|NCT05252702|Abbott Medical Devices, Cardiac Rhythm Management|Nicole Harbert, Director of Clinical Research|972-526-4841|nicole.harbert@abbott.com|
22275833|NCT02657551|Dana-Farber Cancer Institute|Kartik Seghal|000-000-0000|Kartik_Sehgal@dfci.harvard.edu|
22275834|NCT02251821|Fred Hutchinson Cancer Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
22275835|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275836|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org|
22275837|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275838|NCT03229499|Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine|Dr. Steven M Kawut, MD, MS|646-352-1654|kawut@upenn.edu|
22275839|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu|
22275840|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu|
22275841|NCT01484340|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|443-287-2969|jgolub@jhmi.edu|
22275842|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com|
22275843|NCT01010763|Zimmer Biomet G.K.|Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22275844|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu|
22275845|NCT00858988|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454-2178|manary@kids.wustl.edu|
22275846|NCT02525523|Atlantic Pharmaceuticals|Dr Chris Dunk, Director of Clinical Development|+44 1799 513391|chris.dunk@atlantichc.com|
22275847|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22275848|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22275849|NCT03261193|UPMC|Nicholas Schott, MD|412-692-4503|schottnj@upmc.edu|
22275850|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu|
22275851|NCT05032196|Wave Life Sciences USA, Inc|Medical Director, MD|+1 617-949-2900|info@wavelifesci.com|
22275852|NCT00857389|UT MD Anderson Cancer Center|Kris M Mahadeo, Associate Professor, Pediatrics - Patient Care|(713) 792-2873|kmmahadeo@mdanderson.org|
22275853|NCT00001305|National Institute of Child Health and Human Development|Marini, Joan|+1 301 594 3418|marinij@mail.nih.gov|
22275854|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu|
22275855|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu|
22275856|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22275857|NCT03823131|University of California, San Francisco|Dr Chase Heaton, MD|(415) 502-1889|Chase.Heaton@ucsf.edu|
22294490|NCT02002091|Algiers' university -1- Benyoucef Benkhedda, Faculty of Medicine Meherzi, Algiers.|Dr Wafia- Nadia Nibouche-Hattab|+213771810932|wani16000@yahoo.fr|
22294491|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu|
22294492|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22275858|NCT01953237|University of Maryland, Baltimore|Julie Kreyenbuhl|410-637-1864|jkreyenb@som.umaryland.edu|
22275859|NCT03517137|EORTC|Catherine Fortpied|+32 2 774 1681|catherine.fortpied@eortc.org|
22294493|NCT03685968|The University of Texas Health Science Center at Houston (UTHealth)|Elizabeth M. Gendel|+1 (713) 500-3587|Elizabeth.M.Gendel@uth.tmc.edu|
22294494|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22264844|NCT04632706|MedinCell S.A.|Joel Richard - Chief Development Officer|00336984590|joel.richard@medincell.com|99
22264845|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it|
22264846|NCT04079127|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22264847|NCT01855048|Organization:Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
22264848|NCT02994355|University of Washington|Dr. R. Scott McClelland|+206-543-4278|mcclell@uw.edu|
22294495|NCT03965039|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22264849|NCT03050918|Vanderbilt University Medical Center|Maame Yaa Yiadom|615-936-0087|maya.yiadom@vumc.org|
22264850|NCT02972502|OhioHealth Research Institute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
22264851|NCT03832738|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22264852|NCT03852459|Aponia Labs|Kenneth Corroon|917-574-5335|kcorroon@aponialabs.com|
22264853|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22264854|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu|
22264855|NCT05486065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22264856|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22264857|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com|
22264858|NCT03755336|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
22264859|NCT04583163|Hackensack Meridian Health|Tania Zielonka|5519964452|tania.zielonka@hmhn.org|
22264860|NCT03943537|McLean Hospital|Virginie-Anne Chouinard|617-855-3034|vchouinard@mclean.harvard.edu|
22264861|NCT03860207|Y-mAbs Therapeutics|Joris Wilms|+45 7026 1414|clinicaltrials@ymabs.com|
22264862|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22264863|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu|
22264864|NCT05506930|Medical University of South Carolina|Natalie Barnett|(843) 792-5454|barnettn@musc.edu|
22264865|NCT02786277|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
22264866|NCT01013649|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22264867|NCT01647958|EndoGastric Solutions|Adrian Lobontiu|650-474-9259|alobontiu@endogastricsolutions.com|
22264868|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov|
22264869|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com|
22264870|NCT01398059|University of Prince Edward Island|Dr. Travis Saunders|902-566-0641|trsaunders@upei.ca|
22264871|NCT01207440|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22264872|NCT01592721|UTexas_SanAntonio|Anand B. Karnad, MD|2104501365|regulatoryaffairs@uthscsa.edu|
22264873|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu|
22264874|NCT01408563|Massachusetts General Hospital|Dr. Zachariah DeFilipp|617-643-3944|ZDEFILIPP@mgh.harvard.edu|
22264875|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org|
22264876|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu|
22264877|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu|
22264878|NCT03111914|Duke University|Dr. Daniele Marin|919-684-7366|daniele.marin@duke.edu|
22264879|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343||
22264880|NCT04109313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22264881|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu|
22264882|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22264883|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422||
22264884|NCT04271735|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
22264885|NCT04268316|Stanford University|Margot Paul|415-625-3127|mdpaul@stanford.edu|
22264886|NCT00746018|Memorial Sloan Kettering Cancer Center|Nadeem Abu-Rustum, M.D.|212-639-7051|abu-rusn@mskcc.org|
22294496|NCT03322631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294497|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu|
22264887|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22264888|NCT02132637|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294498|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu|
22294499|NCT00602797|University of Nebraska Medical Center|Apar Ganti|402-559-5622|aganti@unmc.edu|
22294500|NCT03943147|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22294501|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294502|NCT00418457|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
22294503|NCT02267083|Gem Pharmaceuticals, LLC|Elizabeth Moore, Regulatory Affairs Agent|8583532019|elizabethmoore109@comcast.net|
22294504|NCT03736447|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22264889|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu|
22264890|NCT00922272|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22264891|NCT03197558|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
22264892|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu|
22264893|NCT02581163|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22264894|NCT03394755|Cellphire Therapeutics, Inc.|Mike Fitzpatrick, PhD|240-268-2470|mfitzpatrick@cellphire.com|
22264895|NCT03533374|Aarhus University Hospital|Professor Sandor Beniczky|+4526981536|sbz@filadelfia.dk|
22264896|NCT03633448|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22264897|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu|
22264898|NCT02384941|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22264899|NCT06005597|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22264900|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com|
22264901|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22264902|NCT00977431|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22264903|NCT01652976|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22264904|NCT05528861|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22264905|NCT01602172|VA Pittsburgh Healthcare System|Lauren M. Broyles, PhD, RN|412-360-2269|Lauren.Broyles@va.gov|
22264906|NCT03739138|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22264907|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu|
22264908|NCT01803269|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22264909|NCT03069677|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@uphs.upenn.edu|
22264910|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22264911|NCT04740931|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22264912|NCT04475250|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
22264913|NCT02696031|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
22264914|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil|
22264915|NCT00063882|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22264916|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
22264917|NCT04588688|University of Michigan|Tobias Else|734-936-1319|telse@med.umich.edu|
22264918|NCT01813071|PATH|Jennifer O'Reilly|202-540-4510|joreilly@path.org|
22264919|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu|
22264920|NCT02537873|Virginia Commonwealth University|F. Gerard Moeller, M.D.|804-628-7788|lmbobb@vcu.edu|
22264921|NCT02442271|AbbVie|Global Medical Services|800 633-9110||
22264922|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu|
22264923|NCT03657108|Icahn School of Medicine at Mount Sinai|Ketan Badani|(212) 241-3919|ketan.badani@mountsinai.org|
22264924|NCT00831623|LomaLindaU|Dr. Jason Slater|909-558-4243|jaslater@llu.edu|
22264925|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu|
22264926|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590||
22264927|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22264928|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com|
22264929|NCT02149121|Celltrion, Inc.|SungYoung Lee|+82 32 850 6532|SungYoung.Lee@celltrion.com|
22264930|NCT04464993|Arizona State University|Matthew P Buman, PhD, Director & Professor|602-496-8617|mbuman@asu.edu|
22264931|NCT07106489|Universidad Nacional de Colombia|Leidy Tatiana Reyes Vega|+573016971711|ltreyesv@unal.edu.co|
22264932|NCT00603291|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22264933|NCT02177136|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22264934|NCT02054130|MedImmune, LLC|Fred Reid|+44 (0) 203 749 6512|information.center@astrazeneca.com|
22264935|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu|
22264936|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
22264937|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com|
22294505|NCT02619175|Loewenstein Rehabilitation Hospital|Mrs. Shirley Handelzalts|972-9-7709010|peregshir@gmail.com|
22294506|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu|
22294507|NCT02644135|UHCMC|Dr. Robert Salata|2168443293|robert.salata@uhhospitals.org|
22294508|NCT02795832|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22294509|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com|
22294510|NCT02695329|Zimmer Biomet G.K.|Clinical Affairs Senior Manager|+81-6402-6777|takahito.nakai@zimmerbiomet.com|
22294511|NCT01382212|AbbVie|Global Medical Information|800-633-9110||
22294512|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22294513|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov|
22294514|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no|
22294515|NCT03547583|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22294516|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294517|NCT00382252|Institut Bergonie|Dr Françoise Bonichon||F.Bonichon@bordeaux.unicancer.fr|
22294518|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22294519|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu|
22264938|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com|
22264939|NCT04132336|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22264940|NCT02488330|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22264941|NCT02493777|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22264942|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com|
22264943|NCT01705236|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22264944|NCT02224573|Greenwich Biosciences|Medical Enquiries|1-833-424-6724|medinfo@greenwichbiosciences.com|
22264945|NCT02546362|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
22264946|NCT02025010|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
22264947|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu|
22264948|NCT01570348|FHCRC|Dr. George Georges|(206) 667-6886|ggeorges@fredhutch.org|
22264949|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22264950|NCT02660528|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
22264951|NCT04355663|Third Faculty of Medicine, Charles University|PhDr. Kamila Řasová, Ph.D.|+420604511416|kamila.rasova@gmail.com|
22264952|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22264953|NCT03529461|Bristol Hospital|Makram Gedeon, MD|8605853339|mgedeon@bristolhospital.org|
22264954|NCT02787408|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
22264955|NCT02003911|Mount Sinai Kravis Children's Hospital|Dr. Lindsey Douglas|2122416500|lindsey.douglas@mssm.edu|
22264956|NCT05444543|University Hospitals Cleveland Medical Center|Dr. Thomas Sferra|(216)844-1765|Thomas.Sferra@UHhospitals.org|
22264957|NCT03808740|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
22264958|NCT02408120|Emory University|Dr. Priyathama Vellanki|404-251-8957|priyathama.vellanki@emory.edu|
22264959|NCT01010750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22264960|NCT00466726|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22264961|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22264962|NCT02096588|SKCCC SOM Onc Breast and Ovarian Cancer|Dr. Karen Smith ; Clinical Associate|2026606500|ksmith60@jhmi.edu|
22264963|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22264964|NCT02743728|University of Minnesota|Dr. Bernadette Gillick|612-626-5898|gillick@umn.edu|
22264965|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu|
22264966|NCT02854059|Hansa Biopharma AB|Elisabeth Sonesson (Director Clinical Operations)|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
22264967|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
22264968|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22264969|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu|
22264970|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com|
22264971|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca|
22264972|NCT03401073|BIDMC|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
22264973|NCT01470612|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264974|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22264975|NCT05012865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264976|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu|
22264977|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22264978|NCT03438227|Brown University|Dr. Methodius Tuuli|401-430-1575|MTuuli@wihri.org|
22264979|NCT03977701|San Diego State University|Dr Jessica Barlow, Principal Investigator|6195943807|jbarlow@sdsu.edu|
22264980|NCT02429934|University of California at Los Angeles|Dr. Bevra Hahn|8184869745|bhahn@mednet.ucla.edu|8184869745
22264981|NCT00293202|University of California, Davis|George Kaysen MD PhD|916-734-3774|gakaysen@ucdavis.edu|
22264982|NCT01606852|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
22264983|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22264984|NCT03166124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22264985|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22264986|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22264987|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu|
22264988|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
22264989|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov|
22264990|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu|
22264991|NCT04459715|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22264992|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121|pihsu@isca.vghks.gov.tw|8233
22321468|NCT01908101|Seattle Cancer Care Alliance|Stefanie Parker|206-889-0917|parkers@seattlecca.org|
22264993|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it|
22264994|NCT04141696|National Institute of Nursing Research (NINR)|Dr. Leorey Saligan, PhD.|+1 301 451 1685|saliganl@mail.nih.gov|
22264995|NCT03959527|GARDP|Dr Alison Luckey|+41 22 559 05 39|aluckey@gardp.org|
22264996|NCT06029959|University of Washington|Sandeep Khot, MD|206-744-3251|skhot@uw.edu|
22264997|NCT06357286|Cornell University|Heather Schofield|6172334775|hws44@cornell.edu|
22294520|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu|
22294521|NCT01269463|Rhodes Pharmaceuticals L.P.|Inder Chaudhary, PhD|401-262-9272|inder.chaudhary@rhodespharma.com|
22294522|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu|
22294523|NCT02657915|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22294524|NCT02612727|Minnesota Medical Research Foundation (now Hennepin Healthcare) and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
22294525|NCT05670236|Cleveland Clinic Foundation|Dr. Patrick Corrigan|216-618-9932|corrigd4@ccf.org|
22294526|NCT04518306|George Medicines Pty Limited|Anthony Rodgers (Principal Investigator)|+44 7983 578 290|arodgers@georgeinstitute.org|
22294527|NCT03268954|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22294528|NCT05358444|Johns Hopkins University Schoo of Medicine|Maya Venkataramani MD, MPH|4109559869|mvenkat2@jh.edu|
22321469|NCT01394939|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
22264998|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
22264999|NCT02960893|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22265000|NCT03692312|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
22265001|NCT04963569|NHS Lothian/University of Edinburgh|Dr John (Jack) Cafferkey|0|j.cafferkey@ed.ac.uk|
22265002|NCT02631876|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22265003|NCT04285567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265004|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22265005|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net|
22265006|NCT02091141|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22265007|NCT02246439|RedHill Biopharma Ltd.|Dr. Terry Plasse|+972-(0)3-541-3131|terry@redhillbio.com|
22265008|NCT05713552|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22265009|NCT03439852|University of Hawaii at Manoa, Office of Research Studies|Sharleen Andreshak|808 356 5762|sfa2@hawaii.edu|
22265010|NCT04551911|OPKO Health Inc|OPKO Health Inc|305-575-4100|contact@opko.com|
22265011|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22265012|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
22265013|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu|
22265014|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
22265015|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22265016|NCT02072148|Icahn School of Medicine at Mount Sinai|Dr. Raymond L Chai|(212) 844-8775|Raymond.Chai@mountsinai.org|
22265017|NCT02466230|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
22265018|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22265019|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265020|NCT03656874|HealthPartners Institute|Dr. D. Brad Rindal|952.967.5026|D.Brad.Rindal@HealthPartners.com|
22265021|NCT01206816|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265022|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265023|NCT02528123|London Vision Clinic|Prof Dan Z Reinstein|02072214005|dzr@londonvisionclinic.com|
22265024|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22265025|NCT02274844|University of Wisconsin-Madison|Susan Andreae|608-265-8195|sandreae@wisc.edu|
22265026|NCT00506129|University of Texas (UT) MD Anderson Cancer Center|Chitra M. Hosing, Professor, Stem Cell Transplantation|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
22265027|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000|Steven.Shiff@actavis.com|8077
22265028|NCT04295135|Indiana University|Dr. Christopher A. Harle|317 278 3245|charle@iu.edu|
22265029|NCT02923674|Wake Forest School of Medicine|Barbara Nicklas, MD|336-713-8569|bnicklas@wakehealth.edu|
22265030|NCT04539886|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
22265031|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com|
22265032|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
22265033|NCT03463993|University of Zimbabwe|Dr Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
22265034|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu|
22321470|NCT03379662|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22321471|NCT02068547|Washington University St. Louis|Wilson Z. Ray, MD|314-362-9959|rayz@wustl.edu|
22321472|NCT03657043|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22321473|NCT00880893|Sanofi Pasteur|Director||Contact-US@sanofi.com|
22321474|NCT04365465|UPMC Magee-Womens Hospital|Dr. Grace Lim, MD, MSc|412-641-2179|limkg2@upmc.edu|
22321475|NCT01736579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22321476|NCT01995071|AbbVie|Global Medical Services|800-633-9110||
22321477|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu|
22321478|NCT01979523|Memorial Sloan Kettering Cancer Center|Dr. Alexander Shoushtari|646-888-4161|shoushta@mskcc.org|
22321479|NCT03657368|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
22321480|NCT04762537|New York Psychiatric Institute|Kenzie Potter|2535920386|kenzie.potter@nyspi.columbia.edu|
22321481|NCT03378076|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22321482|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22321483|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu|
22321484|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265035|NCT03360916|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
22321485|NCT02239939|WFSM|Dr. Barbara Nicklas|3367138569|bnicklas@wakehealth.edu|
22321486|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu|
22321487|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
22265036|NCT01825889|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22321488|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com|
22321489|NCT03470493|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
22321490|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com|
22265037|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com|
22265038|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22321491|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
22265039|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22321492|NCT00493870|US Oncology Research|Taqi Mohammad|281-863-6439|taqi.mohammad@mckesson.com|
22321493|NCT03605680|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22265040|NCT02071953|University of Pennslyvania|Ricardo Walter|215-898-9164|walterr@dental.upenn.edu|
22321494|NCT05594173|University Health Network|Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
22321495|NCT01692964|Rapid Pathogen Screening, Inc.|Robert Sambursky, MD|941-556-1853|rob.sambursky@lumosdiagnostics.com|
22308209|NCT06190678|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22265041|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu|
22321496|NCT02181829|Memorial Sloan Kettering Cancer Center|Suzanne Wolden, MD|212-639-5148|woldens@MSKCC.ORG|
22265042|NCT02447926|Northwestern University|Dr. Josh Levitsky|312-695-4837|j-levitsky@northwestern.edu|
22321497|NCT03865706|Columbia University|Daniel E. Freedberg, MD, MS|857-998-9370|def2004@cumc.columbia.edu|
22321498|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca|
22321499|NCT02646982|University of Texas Southwestern|Ihab Hajjar, MD|214-645-9533|ihabhajjar@emory.edu|
22321500|NCT01877187|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
22321501|NCT01685463|Medical University of south Carolina|Dr. Xingbao Li|8437925729|lixi@musc.edu|
22321502|NCT00919100|MMJ Labs|Dr. Amy Baxter|877-805-2899|abaxter@mmjlabs.com|106
22321503|NCT03221751|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
22321504|NCT00919503|Fred Hutchinson Cancer Research Center|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
22308210|NCT05320432|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22308211|NCT04286282|University of Minnesota|Sarah Lofgren|612-624-9996|Lofg0020@umn.edu|
22308212|NCT01226979|SKCCC at Johns Hopkinis|Amol Narang, MD|(410) 955-7390|anarang2@jhmi.edu|
22308213|NCT01894061|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. David Peereboom|1-866-223-8100|TaussigResearch@ccf.org|
22308214|NCT02278562|VA TN Valley Healthcare System|Alp Ikizler MD|615-322-5000|alp.ikizler@vanderbilt.edu|
22308215|NCT04638998|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
22308216|NCT03713086|CureVac|CureVac SE|+49 (0) 697680587-0|clinicaltrials@curevac.com|
22308217|NCT02784509|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22308218|NCT05374837|Rutgers School of Public Health|Shauna Downs|973-972-7212|sd1081@sph.rutgers.edu|
22308219|NCT03841669|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
22308220|NCT05406921|AMGA|Elizabeth Ciemins, PhD, SVP Research|4062813275|eciemins@amga.org|
22308221|NCT04299009|Pittsburgh VA Healthcare System|Isabella Soreca|412 3606815|Isabella.Soreca@va.gov|
22308222|NCT04831281|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
22308223|NCT02249949|Georgetown University|Michael J. Pishvaian, MD, PhD|202-444-2144|pishvaim@georgetown.edu|
22308224|NCT04414644|University of Pennsylvania|Kelly Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
22321505|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org|
22321506|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22321507|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22294529|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com|
22294530|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org|
22294531|NCT03820986|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22294532|NCT02284126|Columbia University Irving Medical Center|Dr. E. Sander Connolly Jr.|2123054118|esc5@cumc.columbia.edu|
22294533|NCT03480646|Constellation, Inc.|Clinical Program Lead|1-844-667-1992|medinfo@morphosys.com|
22294534|NCT01638546|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
22265043|NCT00430950|Daiichi Sankyo|Global Clinical Leader|908-992-6400|DataSharing@dsi.com|
22265044|NCT00869024|University of Minnesota|Dr. Ganesh Raveendran|612-626-4283|ravee001@umn.edu|
22265045|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265046|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22294535|NCT05766423|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
22294536|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22294537|NCT01651195|Helsinki University Central Hospital|Prof. Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
22294538|NCT02417974|Boston Medical Center and BU School of Medicine|Alan Moss, MD, PhD|617-638-6116|alan.moss@bmc.org|
22294539|NCT01892293|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
22294540|NCT04988646|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
22265047|NCT00775684|University of Pennsylvania|Professor of Medicine, Director of Translational Research Program|215 746-0025|rickels@pennmedicine.upenn.edu|
22265048|NCT02728752|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22265049|NCT02025751|Evoke Pharma|Chief Medical Officer|8589457189|mcarlson@evokepharma.com|
22265050|NCT03345394|Federal University of Sao Paulo|Dr. André Miguel|+55 11 965884111|aqcmiguel@gmail.com|
22265051|NCT02687360|Columbia Univeristy|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
22265052|NCT00653991|Annenberg School for Communication and Journalism, University of Southern California|Professor Lynn Carol Miller|310-874-3402|lmiller@usc.edu|
22265053|NCT01568866|Amgen Inc.|Study Director|866-572-6436||
22265054|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265055|NCT03864042|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265056|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu|
22265057|NCT04527328|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
22265058|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835||
22265059|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22265060|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310||
22265061|NCT03487848|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22265062|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265063|NCT04189445|Taiho Oncology, Inc|Taiho Oncology, Inc|609-250-7336|clinicaltrialinfo@taihooncology.com|
22265064|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012||
22265065|NCT05142566|Essential Medical LLC (a subsidary of Teleflex, Inc.)|Darra Bigelow, Sr. Manager, Clinical Operations|610-331-7299|darra.bigelow@teleflex.com|
22265066|NCT04556552|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
22265067|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265068|NCT03012672|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
22265069|NCT03805100|Xbrane Biopharma AB|Clinical Affairs|+46 85-590 56 00|xbregistry@xbrane.com|
22265070|NCT03474432|Jesse Brown VAMC|Dr. Mladen Vidovich, study PI|312-996-6730|miv@uic.edu|
22265071|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265072|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405||
22265073|NCT03247517|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22265074|NCT03310411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22265075|NCT03573505|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22265076|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com|
22294541|NCT03602482|Pennsylvania State University College of Medicine|Dr. Amanda J. Miller|7175317676|aross1@pennstatehealth.psu.edu|
22294542|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com|
22294543|NCT02114814|The Ohio State University|Dr. Jie Hu|6146880394|hu.1348@osu.edu|
22294544|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu|
22294545|NCT05276401|Lakewood Amedex|Dr. Adam Ruskin|941-225-2514|ARuskin@LakewoodAmedex.com|
22294546|NCT04617509|Gesynta Pharma AB|Charlotte Edenius|+46733864246|charlotte.edenius@gesynta.se|
22294547|NCT00441883|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22294548|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu|
22294549|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22294550|NCT03143894|Johns Hopkins University|Tracy Vannorsdall, PhD|410-502-3701|TVannor1@jhmi.edu|
22294551|NCT02170298|UC Davis|Julie B Schweitzer|916-703-0294|jschweitzer@UCDAVIS.EDU|
22265077|NCT01385306|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22265078|NCT02145026|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22265079|NCT01421342|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Gary R. Johnson, MS|(203) 932-5711|gary.johnson4@va.gov|3774
22294552|NCT03809117|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
22275860|NCT01186770|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22275861|NCT02441283|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22275862|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com|
22275863|NCT02472353|Avera|Stacy Kehoe|605.322.3082|Stacy.Kehoe@avera.org|
22275864|NCT00688597|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
22275865|NCT01995201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22275866|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22275867|NCT06001866|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
22275868|NCT04703192|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22275869|NCT04797169|Icahn School of Medicine at Mount Sinai|Thomas B Hildebrandt, Psy.D.|(212) 659-8673|tom.hildebrandt@mssm.edu|
22275870|NCT04725188|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22275871|NCT02236364|University of Toledo|Basil Akpunonu, MD|419-383-4909|Basil.Akpunonu@utoledo.edu|
22275872|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu|
22275873|NCT03839641|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
22275874|NCT03981055|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
22275875|NCT05653843|Boston Scientific|Andrea Burbage, Principal Clinical Trial Manager|7812544679|andrea.burbage@bsci.com|
22275876|NCT04325386|University of Maryland, Baltimore|Dr Deanna L. Kelly, PharmD, BCPP|410-402-6861|dlkelly@som.umaryland.edu|
22275877|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org|
22275878|NCT03188822|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
22275879|NCT04537299|Mayo Clinic|Brandon Verdoorn, M.D.|507-266-6201|Verdoorn.Brandon@mayo.edu|
22275880|NCT00392041|Princeton University|Lesley Allen, Ph.D.|609-924-9213|lesleyaallen@gmail.com|
22275881|NCT04297917|Vaccitech Plc|Tom Evan, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
22275882|NCT04279483|University of Pennsylvania|Emily Falk|215-573-9901|emilybfalk@falklab.org|
22275883|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366||
22275884|NCT04800627|UT MD Anderson Cancer Center|Dr. Michael Overman,MD- Assoc VP, CN Research, SVP, Cancer NW Clin & Acad Dev|(713) 792-2828|moverman@mdanderson.org|
22275885|NCT04926233|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275886|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu|
22275887|NCT04153864|Sinai Health System (Canada)|Dr. Daisy R Singla|416-535-8501|daisy.singla@utoronto.ca|39423
22275888|NCT06442800|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-445-1310|mghall@unc.edu|
22275889|NCT03834688|Dana-Farber Cancer Institute|Opeyemi Jegede, Statistician|(617) 582-7613|ojegede@ds.dfci.harvard.edu|
22275890|NCT03331341|University of Washington|Dr. Ryan Lynch, Associate Professor|206-606-1739|rclynch@uw.edu|
22275891|NCT04717557|Duke University|Dr. Richard Moon|919-684-8762|richard.moon@duke.edu|9199065651
22275892|NCT06354257|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22275893|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu|
22275894|NCT02401230|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22275895|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686|msiedner@mgh.harvard.edu|917
22275896|NCT00964782|Milton S. Hershey Medical Center|Compliance Specialist|7175310003|clinicaltrials.gov@pennstatehealth.psu.edu|287544
22275897|NCT02630030|Emory University|Dr. Jeffrey Olson|404-778-5770|jolson@emory.edu|
22294553|NCT05048784|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22294554|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111|b.brew@unsw.edu.au|4100
22294555|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net|
22294556|NCT02853604|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
22294557|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org|
22294558|NCT02269241|Exeltis|Dr. Enrico Colli, Chief Scientific Officer|+34917711500|enrico.colli@exeltis.com|
22294559|NCT03020160|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294560|NCT02270957|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405 822 2336|joan-merrill@omrf.org|
22294561|NCT03291054|Northwell|Richard Carvajal, MD|516-734-8900|rcarvajal2@northwell.edu|
22294562|NCT04251169|SOLTI|Sara Cano|34 664 449 862|info@gruposolti.org|
22294563|NCT02535312|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22294564|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
22294565|NCT03897465|Lohmann & Rauscher GmbH & Co. KG|Dr Daria Trofimenko, Senior Manager Clinical Regulatory Affairs|+49 (0) 2631 99 6385|Daria.Trofimenko@de.LRMed.com|
22294566|NCT00847379|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22294567|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22294568|NCT04390191|Icahn School of Medicine at Mount Sinai|Dr. Neomi Shah|212-241-6286|neomi.shah@mssm.edu|
22294569|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711|mcdavis@mednet.ucla.edu|49234
22294570|NCT03978832|Indivior Inc|PERSERIS Medicines Development Lead and Head Global Clinical Operations and Development|804 379-1090|regan.fong@indivior.com|
22294571|NCT00003499|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22275898|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov|
22294572|NCT01744574|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
22294573|NCT02042183|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-844-2830|clinicaltrials@mnk.com|5
22308225|NCT02097420|Abbott|Vinny Podichetty, Clinical Program Director|+1 779-209-9425|vinny.podichetty@abbott.com|
22308226|NCT05106257|Rush University Medical Center|Amanda R. Mathew, PhD|(312 563-1273|amanda_mathew@rush.edu|
22308227|NCT05691309|Children's Hospital of Philadelphia|Dr. Kevin Downes|215-590-4024|downeskj@chop.edu|
22308228|NCT01707030|Department of Veterans Affairs|Dr. Micheal Cucciare|501-257-1068|Michael.Cucciare@va.gov|
22308229|NCT04301778|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng, MD PhD|646-239-3110|Lzheng6@jhmi.edu|
22308230|NCT04263311|NYU Langone Health|Jennifer Zanowiak|(646) 501-3502|Jennifer.Zanowiak@nyulangone.org|
22308231|NCT03580369|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
22308232|NCT03448458|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
22308233|NCT05511467|Medical University of South Carolina|Principal Investigator|(843) 792-3435|heisek@musc.edu|
22308234|NCT03819686|Emory University|Dr. Kimberly Jacob Arriola|404)-727-2600|kjacoba@emory.edu|
22308235|NCT06143670|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22308236|NCT04563793|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22308237|NCT00837369|University of Nebraska Medical Center|Thomas Porter|402-559-5151|trporter@unmc.edu|
22308238|NCT03625882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308239|NCT05058391|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308240|NCT02790931|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
22308241|NCT03697070|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22308242|NCT03833245|University of Utah|Gerald Cochran, PhD|801-213-0799|jerry.cochran@hsc.utah.edu|
22308243|NCT03347383|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
22308244|NCT04030169|Lykos Therapeutics|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|877-627-7722|trialdata@lykospbc.com|
22308245|NCT04842643|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308246|NCT03484702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22308247|NCT02840474|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
22265080|NCT03052322|Fresenius Kabi Swiss BioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
22308248|NCT05114460|New York State Psychiatric Institute|Jermaine Jones PhD: Research Scientist/Associate Professor|646 774-6113|jermaine.jones@nyspi.columbia.edu|
22308249|NCT03262779|Yale School of Medicine|Scott Gettinger, MD|(203) 200-5864|scott.gettinger@yale.edu|
22308250|NCT05059262|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
22308251|NCT02312960|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22308252|NCT03131648|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
22308253|NCT02724878|Dana-Farber Cancer Institute|Toni Choueiri|617-632-5456|toni_choueiri@dfci.harvard.edu|
22308254|NCT04820855|University of New Mexico Health Sciences Center|Dr. Angela Dao|5059678428|angela.dao@gmail.com|
22308255|NCT04838262|The University of Texas at Arlington|Dr. Jody Greaney|8172727891|jody.greaney@uta.edu|
22308256|NCT02927769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22321508|NCT03504410|Cornerstone Pharmaceuticals Inc|Sanejev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
22308257|NCT04179149|Ponce Research Institute, Ponce Health Sciences University|Dr. Idhaliz Flores|787-840-2575|iflores@psm.edu|2206
22308258|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp|
22308259|NCT05524233|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22308260|NCT05272852|BostonScientific|Karin Froidcourt|+0032471636566|Karin.Froidcourt@bsci.com|
22308261|NCT02307565|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22308262|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308263|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308264|NCT06064916|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22308265|NCT03295734|UAB|Thomas W. Buford, PhD|205-996-3008|twbuford@gmail.com|
22308266|NCT05633407|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22308267|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu|
22308268|NCT04838613|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22308269|NCT04757610|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
22308270|NCT03113422|Dana-Farber Cancer Institute|Mr Opeyemi Jegede|(617) 582-7613|ojegede@jimmy.harvard.edu|
22308271|NCT06207058|Tricore|Medical Director|505-938-8461|michael.crossey@tricore.org|
22321509|NCT02798536|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
22321510|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343||
22321511|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu|
22321512|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321513|NCT05515250|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
22321514|NCT03015259|KINDEVA DRUG DELIVERY|Lester Harrison, PhD|6122714814|lester.harrison@kindevadd.com|
22321515|NCT05284760|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308272|NCT06155721|Badalona Serveis Assistencials|Jose Ferrer Costa|+34 937407482|jfcosta@bsa.cat|
22308273|NCT00593489|Lawson Research Institute|Dr. Stewart Harris|519 858-5028|sharris1@uwo.ca|
22308274|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org|
22308275|NCT03432858|WellSpan Health|Clinical Research Associate|(717) 851-7634|cbush@wellspan.org|
22275899|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com|
22275900|NCT01047319|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22275901|NCT03100747|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
22275902|NCT04376567|University of Arizona|Tze-Woei Tan|3234426835|tze-woei.tan@med.usc.edu; ttan@arizona.edu|
22275903|NCT05759338|Wake Forest University Health Sciences|Amy McMichael|704-355-2000|Amy.Mcmichael@Advocatehealth.org|
22275904|NCT04611126|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
22275905|NCT05260008|Allay Therapeutics, Inc|Study Director|669-679-5081|clinicaltrialsinfo@allaytx.com|
22275906|NCT03308669|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22275907|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu|
22275908|NCT02546570|National Center for PTSD|Dr. Lauren Sippel|802-295-9363|lauren.m.sippel@dartmouth.edu|6082
22275909|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
22275910|NCT04817410|Rutgers New Jersey Medical School|Ethan Cowan|917-447-4964|ethan.cowan@rutgers.edu|
22275911|NCT03595748|Albert Einstein College of Medicine|Dr. Ladan Golestaneh|718-920-5442|lgolesta@montefiore.org|
22275912|NCT02328014|Acerta Pharma|Global Clinical Lead|1-877-240-9497|information.center@astrazeneca.com|
22275913|NCT03166709|Center for Suicide Prevention and Recovery, University of Washington|Dr. Katherine Anne Comtois|206-744-1752|uwcspar@uw.edu|
22275914|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no|
22275915|NCT04175639|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
22275916|NCT04070703|Oregon Research Institute|Fuzhong Li|5414842123|fuzhongl@ori.org|
22275917|NCT03481049|Washington State University|Michael G. McDonell|509-368-6967|mmcdonell@wsu.edu|
22275918|NCT05028569|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22275919|NCT04609553|Rutgers University|Manuel Jimenez, MD, MS|732-235-9300|jimenema@rwjms.rutgers.edu|
22275920|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov|
22275921|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
22275922|NCT03829475|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
22275923|NCT03841513|TMC|Dr Tsung Mou|6176365890|tmou@tuftsmedicalcenter.org|
22275924|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22275925|NCT02362451|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22275926|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org|
22275927|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com|
22275928|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22275929|NCT01234116|Henry Ford Health Sytem|Indira Brar, MD|313-916-2565|ibrar1@hfhs.org|
22275930|NCT02226159|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
22275931|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu|
22275932|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es|
22275933|NCT01925794|CeloNova BioSciences Inc.|Mark Barakat, MD|(210) 489-4004|mbarakat@celonova.com|
22275934|NCT01901562|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
22275935|NCT03126110|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22275936|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22275937|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu|
22275938|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu|
22275939|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22275940|NCT03837704|Philip Morris Products S.A.|Global Head Clinical Development & Operations|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22275941|NCT06181799|I.M. Sechenov First Moscow State Medical University (Sechenov University)|Basheer Abdullah Marzoog|+7(996) 960 28 20|marzug@mail.ru|
22275942|NCT01771107|Emmes Company|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
22294574|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn|
22294575|NCT02256189|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
22294576|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22294577|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
22294578|NCT03722966|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|
22294579|NCT03132220|University of Colorado School of Medicine|Dr. Meredith Mealer|303-724-6857|Meredith.Mealer@cuanschutz.edu|
22294580|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org|
22294581|NCT05820685|The University of Texas Health Science Center at Houston|John Harvin, MD, FACS|713-500-7244|John.Harvin@uth.tmc.edu|
22294582|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22294583|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855||
22294584|NCT03647033|National University Hospital|Dr. David Chen|+6594550281|david_chen@nuhs.edu.sg|
22275943|NCT03805841|Rain Oncology Inc.|Chief Medical Officer|(510) 953-5559|info@rainoncology.com|
22294585|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org|
22275944|NCT02141555|University of California, San Diego|Dr. Sheila Mody||smody@ucsd.edu|
22275945|NCT03621592|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
22275946|NCT04812015|Wayne State University|Danielle Taylor, PhD|6166486793|dtaylo@med.wayne.edu|
22275947|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
22275948|NCT02512419|Brown University|Dr. Bess Marcus|401-863-9858|bess_marcus@brown.edu|
22275949|NCT03980223|University of California, San Francisco|Anne Luetkemeyer|415-502-5753|annie.luetkemeyer@ucsf.edu|
22275950|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590||
22275951|NCT02460289|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22275952|NCT02916927|Alameda Health Systemt - Highland Hospital|Dr. Andrew Herring|(510) 437-4564|aherring@alamedahealthsystem.org|
22275953|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22275954|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu|
22275955|NCT02587936|UT Southwestern Medical Center|Miguel A Vazquez|214-648-8884|Miguel.Vazquez@UTSouthwestern.edu|
22275956|NCT03479905|UTexasSouthwestern|Christina Riccio|214-590-7284|Christina.Riccio@utsouthwestern.edu|
22275957|NCT05203185|NYU Langone Health|Safiya Richardson, MD, MPH|212-263-8313|Safiya.Richardson@nyulangone.org|
22275958|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343||
22275959|NCT01859091|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22275960|NCT06481579|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22275961|NCT04584788|Masimo Corporation|Cristina Johnson|(949) 297-7576|clinicalresearchdept@masimo.com|
22275962|NCT03311555|Duke University|Andrew Armstrong, MD|919-668-8797|andrew.armstrong@duke.edu|
22275963|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org|
22275964|NCT04284774|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22275965|NCT04390750|New York University|Bei Wu|12129925951|bw75@nyu.edu|
22275966|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22275967|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743||
22275968|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
22275969|NCT00674297|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
22275970|NCT00458835|Covis Pharma|Clinical Trials Interest|1-877-374 -4177|CTInterest@covispharma.com|
22275971|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
22275972|NCT02199496|NIAID - LCIM|Fuss, Ivan|+1 301 496 9663|ifuss@niaid.nih.gov|
22275973|NCT04190225|Brown University|Dr. Shira Dunsiger, Biostatistician|401-863-6747|shira_dunsiger@brown.edu|
22275974|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com|
22275975|NCT01732783|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22275976|NCT02239328|Washington University|Dr. Benjamin Kozower|314-362-8089|kozower@wustl.edu|
22275977|NCT01989975|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22275978|NCT04429971|Rutgers New Jersey Medical School|Ethan Cowan, MD, MS, FACEP|917-447-4964|ethan.cowan@rutgers.edu|
22275979|NCT03331562|Translational Genomics Research Institute (TGen) An Affiliate of City of Hope|Derek Cridebring, PhD. Director, Molecular Medicine Division|6023438629|dcridebring@tgen.org|
22321516|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com|
22321517|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es|
22321518|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu|
22321519|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343||
22321520|NCT02898259|Clevleland|Dr. Brian Hill|1-866-223-8100|TaussigResearch@ccf.org|
22321521|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl|
22321522|NCT02681172|Piramal Imaging|Dr. Juergen Hirschfeld, Head of GRA & PV|+49 30461124615|Juergen.Hirschfeld@piramal.com|
22321523|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321524|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22321525|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321526|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br|
22321527|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu|
22321528|NCT02595723|UT Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
22321529|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275980|NCT01088789|SKCCC Johns Hopkins Medical Institution|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
22321530|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com|
22321531|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com|
22275981|NCT03718000|University of Georgia|Dr. Jamie Cooper, Associate Professor|706-542-4903|jamie.cooper@uga.edu|
22275982|NCT01866592|University of Pennsylvania|Suzette Baez VanderBeek, MPH|2156623514|suzette.baezvanderbeek@uphs.upenn.edu|
22289046|NCT04141839|University of Arizona|Mary Koss|5204818610|mpk@arizona.edu|
22289047|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
22289048|NCT03682770|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22289049|NCT00774566|Stardtisches Klinikum Karlsruhe, Medizinische Klinik IV|Dr. Armin Luik|0049-721974|armin.luik@klinikum-karlsruhe.de|2901
22289050|NCT04896073|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22265081|NCT05065983|Emergent BioSolutions|Dr. Sufia Muhammad|346-732-7331|muhammads@ebsi.com|
22308276|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu|
22308277|NCT04277936|Vanderbilt University Medical Center|Stephan Heckers|6159222665|stephan.heckers@vumc.org|
22265082|NCT03261960|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22265083|NCT04505293|Duke University|Anthony 'Tony' T. Fuller, MD, MScGH|919-613-1813|anthony.fuller@duke.edu|
22265084|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22265085|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265086|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22265087|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22265088|NCT02494817|University of Hawaii|Jason W. Mitchell, PhD, MPH|8082196729|jasonmit@hawaii.edu|
22265089|NCT00706381|NIDDK|Kong Chen, Ph.D.|301-451-1636|chenkong@niddk.nih.gov|
22265090|NCT05420012|University of Utah|Josef Stehlik|801-585-9797|josef.stehlik@hsc.utah.edu|
22265091|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu|
22265092|NCT00867048|University of Minnesota|Birgit Grund|612-624-8076|birgit@umn.edu|
22308278|NCT02057939|Duke University|Andrew Armstrong, MD ScM|919-668-4615|andrew.armstrong@duke.edu|
22308279|NCT03169894|Avalo Therapeutics, Inc.|Garry Neil, MD|908-720-2691|gneil@avalotx.com|
22308280|NCT03527160|Cincinnati Children's Hospital Medical Center|Dr. Stuart Goldstein|513-636-2209|stuart.goldstein@cchmc.org|
22308281|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov|
22308282|NCT01721291|Imperial College London|Dr Omar Usmani|+440(0) 207351 8051|o.usmani@imperial.ac.uk|
22308283|NCT00084552|Fox Chase Cancer Center|Eric Horwitz|215-728-2995|Eric.Horwitz@fccc.edu|
22308284|NCT05239039|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308285|NCT03690206|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
22308286|NCT04774380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22308287|NCT03978637|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22308288|NCT01959698|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22308289|NCT05343390|University of North Carolina at Chapel Hill|Nora E. Rosenberg, PhD|(919) 966-3761|nrosenbe@email.unc.edu|
22308290|NCT05806788|UT Health San Antonio|Dr. Lisa Smith Kilpela|210-450-8121|kilpela@uthscsa.edu|
22308291|NCT00739648|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
22308292|NCT05110495|University of Oxford|Dr Simon Lord|01865 227212|simon.lord@oncology.ox.ac.uk|
22308293|NCT04173663|Vanderbilt University Medical Center|Julie Lounds Taylor, PhD, principal investigator|615-343-5659|julie.l.taylor@vumc.org|
22308294|NCT03604263|Medtronic CRHF|Krestyn Thomas|6123236613|krestyn.j.thomas@medtronic.com|
22308295|NCT03931291|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22308296|NCT04847544|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22308297|NCT04716634|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22308298|NCT04833777|University of Saskatchewan|Dr. David Sauder|306-955-9800|sauderdave@gmail.com|
22308299|NCT03636503|Dana-Farber Cancer Institute|Caron Jacobson, MD|617-632-6404|caron_jacobson@dfci.harvard.edu|
22308300|NCT03089398|Icahn School of Medicine at Mount Sinai|Dr. Emilia Bagiella|212-659-9580|emilia.bagiella@mountsinai.org|
22308301|NCT00579124|Children's Hospital of Philadelphia|Patricia Hankins|215 590 5168|hankinsp@chop.edu|
22308302|NCT03818191|Mayo Clinic|Victor Karpyak, MD, PhD|(507)284-8891|karpyak.victor@mayo.edu|
22308303|NCT05418296|Mentia|Dr Mandy Salomon|4156326872|mandy@mentia.me|
22308304|NCT04703322|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22308305|NCT04419168|University of Pittsburgh|Dr. Charles Jonassaint|412-586-9850|cjonassaint@pitt.edu|
22308306|NCT04640961|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22308307|NCT05595629|Women & Infants Hospital of Rhode Island|Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|
22308308|NCT05009251|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
22308309|NCT04204278|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22308310|NCT01582711|CDC|Andrey Borisov, MD, MPH, Study Director|(404) 639-3311|pha5@cdc.gov|
22308311|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22308312|NCT05249439|Imperial College London|Professor Tricia Tan|44 207 594 9048|t.tan@imperial.ac.uk|
22308313|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu|
22308314|NCT04453592|FIFA|Dr Andreas Serner|+41796253899|andreas.serner@fifa.org|
22308315|NCT05061095|Lineberger Comprehensive Cancer Center|Dr. Daniel Richardson|(919) 966-4432|daniel_richardson@med.unc.edu|
22308316|NCT02384317|ChemoCentryx|Study Director|650-210-2900|medinfo@amgen.com|
22308317|NCT04245501|University of Denver|Michelle Rozenman, Ph.D., Director, BRAVE Lab & Associate Professor, Department of Psychology|303-871-6448|michelle.rozenman@du.edu|
22308318|NCT04140708|Vanderbilt University Medical Center|Dr. Daniel Claassen|615-322-6103|daniel.claassen@vumc.org|
22308319|NCT05337748|University of Pretoria|Professor De Wet Swanepoel|+27827824009|dewet.swanepoel@up.ac.za|
22308320|NCT04638309|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22308321|NCT02506959|The University of Texas MD Anderson Cancer Center|Yago Nieto, MD / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderosn.org|
22308322|NCT03610490|M D Anderson Cancer Center|Amir A Jazaeri, MD|713-792-8578|aajazaeri@mdanderson.org|
22275983|NCT00626236|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22321532|NCT00385255|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321533|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161|tclemons@emmes.com|212
22321534|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321535|NCT03339921|MOMH|Amanda Crawford|7026533583|amanda.j.rawford.ctr@health.mil|
22321536|NCT03436862|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22321537|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com|
22321538|NCT02692495|MEBO Research|Irene Gabashvili, Scientific Director|(408) 341-9355|irene.gabashvili@meboresearch.org|
22275984|NCT05522751|University of California San Francisco|Khaled Moussawi|415-502-6343|khaled.moussawi@ucsf.edu|
22275985|NCT06487390|University of Alabama at Birmingham|Dr. Lynn Matthews|2059348148|lynnmatthews@uabmc.edu|
22275986|NCT04044690|CSL Behring|Study Director|16108784697|clinicaltrials@cslbehring.com|
22275987|NCT01325441|Sumitomo Pharma Oncology|Tegan Nguyen|6176748745|tegan.nguyen@oncology.sumitomo-pharma.com|
22275988|NCT01582451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22275989|NCT03318341|MUSC|Na Jin Seo, PhD|8437920084|seon@musc.edu|
22275990|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22275991|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590||
22275992|NCT01838876|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22275993|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22275994|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu|
22275995|NCT06525727|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
22275996|NCT03881371|Zambon S.p.A|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
22275997|NCT02508389|Galera Therapeutics, Inc.|Kara Terry|610-725-1500|kterry@galeratx.com|
22275998|NCT01869374|New York State Psychiatric Institute|Stefan Rowny, MD|(646) 774-5417|stefan.rowny@nyspi.columbia.edu|
22275999|NCT05376358|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
22276000|NCT04225832|RAND|Laura Bogart, PhD|3103830411|lbogart@rand.org|7281
22276001|NCT00311168|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
22276002|NCT05472142|University of Kentucky|Mary E. Lacy, PhD, Study PI|8595621126|mary.lacy@uky.edu|
22276003|NCT02452190|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22276004|NCT06001021|University of Gujrat|Dr. Sameera Shafiq (Lecturer, M. Phil, QAU; Ph.D., UOG)|923345116648|sameera.shafiq@uog.edu.pk|
22276005|NCT04341636|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
22276006|NCT03112603|Call Center|Incyte Corporation|1.855.463.3463|medinfo@incyte.com|
22276007|NCT02278354|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22276008|NCT00562328|Mayo Clinic|Timothy G. Call, M.D.|507-266-4671|Call.Timothy@mayo.edu|
22276009|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276010|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu|
22276011|NCT05845619|University of California San Francisco|Pamela Murnane|4155021000|pamela.murnane@ucsf.edu|
22321539|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043||
22276012|NCT02595892|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos, MD, PhD|617-632-5269|panagiotis_konstantinopoulos@dfci.harvard.edu|
22276013|NCT04967222|Icahn School of Medicine at Mount Sinai|Dr. Harold W Koenigsberg|(718) 584-9000|harold.koenigsberg@mssm.edu|
22276014|NCT02629159|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22276015|NCT05722015|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22276016|NCT02685735|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22276017|NCT04133909|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276018|NCT05020743|Vigil Neuro|VP, Clinical & Medical Sciences|+18572280538|jchavez@vigilneuro.com|
22276019|NCT02003924|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276020|NCT02340949|MFAR Clinical Research|Pau Doñate Macian|0034934344412|investigacion@mfar.net|
22276021|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22276022|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu|
22276023|NCT02354118|TriHealth|Rachel Baker, Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22276024|NCT02774889|University of Wisconsin-Madison|Associate Research Specialist|6082631105|wpalmer3@wisc.edu|
22276025|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22276026|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com|
22276027|NCT05166876|Clear Creek Bio, Inc.|Vikram Sheel Kumar|(617) 765-2252|kumar@clearcreekbio.com|
22276028|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743||
22321540|NCT02461550|Memorial Sloan Kettering Cancer Center|Dr. Stephen Solomon|212-639-5012|solomons@mskcc.org|
22321541|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257|clintriage.rdg@boehringer-ingelheim.com|Option 4
22321542|NCT00401375|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22276029|NCT04901624|University of Southern California|Dr. Jason Doctor|213.821.8142|jdoctor@usc.edu|
22321543|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr|
22276030|NCT03654417|Duke University|Dr. Laura Havrilesky|(919) 684-0188|laura.havrilesky@duke.edu|
22276031|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276032|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu|
22276033|NCT04685811|Weill Cornell Medical College|Dr. Juana Martinez Zuloaga|212-746-6000|jum4005@med.cornell.edu|
22276034|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu|
22276035|NCT02811159|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22276036|NCT04603066|Washington University in St Louis|Simon Haroutounian|3132861715|sharout@wustl.edu|
22276037|NCT04409002|Massachusetts General Hospital|Theodore Hong, MD|617-726-6050|TSHONG1@mgh.harvard.edu|
22276038|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca|
22276039|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276040|NCT01756235|AbbVie|Global Medical Information|800-633-9110||
22276041|NCT05658887|University of Iowa Hospitals and Clinics|Dr. Colin Johnson|3193561616|colin-johnson@uiowa.edu|
22276042|NCT04635345|Barts Health NHS Trust|Jessica Gaddie|020 7480 4737|j.gaddie1@nhs.net|
22276043|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org|
22276044|NCT02327078|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22276045|NCT04940221|Christiana Care Health System|Heather Bittner Fagan, MD MPH|302 320 4110|hbittner-fagan@christianacare.org|
22276046|NCT04092777|Massachusetts General Hospital|Dr. Margarita Alegria|617-724-1237|malegria@mgh.harvard.edu|
22276047|NCT05219552|University of California School of Nursing|Dr. Emily Tuthill|2078411983|emily.g.tuthill@gmail.com|
22276048|NCT03330197|Alaunos Therapeutics|Jaymes Holland|650 273-2627|jholland@alaunos.com|
22276049|NCT03765073|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276050|NCT05561400|University of Minnesota|Sharyl Samargia-Grivette|218-726-8347|samargia@umn.edu|
22276051|NCT01670006|Cochlear|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22276052|NCT02802228|Cumberland Pharmaceuticals|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
22276053|NCT05984030|UNC Institute for Global Health and Infectious Diseases|Sarah Rutstein, MD, PhD|919-966-2537|sarah_rutstein@med.unc.edu|
22276054|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741|mcummins@amarbio.com|14
22276055|NCT03073759|Johns Hopkins University|Mohammad Khoshnoodi|410-955-5460|mkhoshn1@jhmi.edu|
22276056|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk|
22276057|NCT05007925|Shockwave Medical|Denise Winn|410-991-9311|dwinn@its.jnj.com|
22276058|NCT05495997|Yale School of Medicine|Sule Tinaz|203-737-6158|sule.tinaz@yale.edu|
22276059|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22276060|NCT00261040|The Ottawa Hospital - Ottawa Hospital Research Institute|Dr Paul Kim|613-737-8920|pkim@toh.ca|
22276061|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1||
22276062|NCT00984399|Memorial Sloan Kettering Cancer Center|Dr. Shari Goldfarb, MD|646-888-5080|goldfars@mskcc.org|
22276063|NCT05049122|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22276064|NCT04357795|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
22276065|NCT01723774|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22276066|NCT01910441|Novartis|Study Director|862-778-8200||
22276067|NCT02964182|MD Anderson Cancer Center|Jason Robinson, PhD|713-792-2265|nicotinestudy@mdanderson.org|
22276068|NCT03636477|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22276069|NCT05807477|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22276070|NCT02382380|Loyola University Medical Center|Ari Goldberg, M.D.|708-216-2229|argoldberg@lumc.edu|
22276071|NCT01295944|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
22276072|NCT03785366|Sebela Women's Health|Elizabeth Gray|760.593.8383|Elizabeth.Gray@sebelapharma.com|
22276073|NCT05168800|Dartmouth College|Glyn Elwyn|(603) 646-5623|glynelwyn@gmail.com|
22276074|NCT03240874|Northwestern University|Lynn Yee, MD, MPH|312-472-4685|lynn.yee@northwestern.edu|
22289051|NCT02304367|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
22289052|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu|
22289053|NCT03417154|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|(612) 626-5654|maaka001@umn.edu|
22289054|NCT02637037|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22289055|NCT04853017|Elicio Therapeutics, Inc.|Study Director|(857) 209-0050|info@elicio.com|
22289056|NCT00074490|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
22289057|NCT06404021|University of Calabria|Antonio Curcio|+390984681889|antonio.curcio.cardio@unical.it|
22289058|NCT02981446|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22289059|NCT04411667|Sharp HealthCare|Matthew Geriak, PharmD / Research Pharmacist|8589393717|matthew.geriak@sharp.com|
22289060|NCT03239106|Washington University School of Medicine|Brian Kim, Associate Professor of Medicine|314-273-1376|briankim@wustl.edu|
22289061|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu|
22289062|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com|
22289063|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289064|NCT02991040|Prollenium Medical Technologies Inc.|Mr. Ario Khoshbin|+1 (905) 508-1469|ario@prollenium.com|
22289139|NCT01543633|Neuroscience Statistics Research Laboratory, Massachusetts General Hospital|Dr. Emery N. Brown|(617) 726-8786|enb@neurostat.mit.edu|
22276075|NCT04958707|University of Medicine and Pharmacy at Ho Chi Minh City|Dr. Nguyen Tran To Tran|+84 979635889|nguyentrantotran@ump.edu.vn|
22276076|NCT02489539|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
22276077|NCT04279522|Neurolief Ltd.|Yaron Gruper, Director of Clinical affairs|+972-544330712|Yaron.Gruper@neurolief.com|
22276078|NCT04383223|Emory University|Dr. Sophia Hussen|404-727-2446|sophia.ahmed.hussen@emory.edu|
22276079|NCT05360056|The Ohio State University|Dr. Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
22276080|NCT02783274|Johnson & Johnson MedTech|Kirstin Cosgrove|+1 574 4049398|kcosgro1@its.jnj.com|
22276081|NCT05277207|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
22276082|NCT05567172|Boston Scientific|Nilou Zilinek|5086836127|nilou.zilinek@bsci.com|
22276083|NCT05484778|IstanbulU|Aysen Elif YILMAZ|+905059466301|aysen.elif4@gmail.com|
22276084|NCT02246777|Alcon, A Novartis Division|Associate, Medical Group 1, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
22276085|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com|
22276086|NCT04707469|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22276087|NCT04115098|The University of Texas Health Science Center at Houston|Mark C. Hwang, MD|(713) 500-6597|Mark.C.Hwang@uth.tmc.edu|
22276088|NCT04635423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22276089|NCT05556057|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.Korupolu@uth.tmc.edu|
22276090|NCT04431960|University of Connecticut|Ock K. Chun|18604866275|ock.chun@uconn.edu|
22276091|NCT03133156|Joslin Diabetes Center|Laura Simpson|617-735-3924|laura.simpson@joslin.harvard.edu|
22276092|NCT05748626|Northwestern University|Paul C. Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22276093|NCT04798768|Boston Scientific|Julie West|651-582-4721|Julie.West@bsci.com|
22276094|NCT03488524|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
22276095|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu|
22276096|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333||
22276097|NCT02390284|University of Miami|Dr. Vittorio Porciatti|3053266050|vporciatti@med.miami.edu|
22276098|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
22276099|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu|
22276100|NCT01977846|Foundation Fighting Blindness|Chief Scientific Officer|410-423-0600|info@FightBlindness.org|
22276101|NCT02517658|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
22276102|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
22276103|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
22276104|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22276105|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22276106|NCT00356590|Amgen Inc.|Study Director|866-572-6436||
22294586|NCT04862585|Ohio State University|Mike Berger, PharmD|614-366-0556|michael.berger@osumc.edu|
22294587|NCT05288062|Mayo Clinic|Wilson I. Gonsalves, MD|507-266-5947|Gonsalves.Wilson@mayo.edu|
22294588|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov|
22294589|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22294590|NCT05229406|Center for Healthy Minds, University of Wisconsin - Madison|Simon B. Goldberg, PhD|608-265-8986|sbgoldberg@wisc.edu|
22294591|NCT01930123|Duke University|Brian J. Soher, Ph.D.|919-684-7350|brian.soher@duke.edu|
22294592|NCT02899793|Yale University School of Medicine|Dr. Alessandro Santin|203-737-4450|alessandro.santin@yale.edu|
22294593|NCT01805154|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22294594|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294595|NCT03310021|Portola Pharmaceuticals|Head of Clinical Development|6502767153|ClinicalTrials@Portola.com|
22294596|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22294597|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu|
22294598|NCT03953820|Aquestive Therapeutics|Denis Scheper, Director of Portfolio Management and Clinical Operations|(908)941-1887|denis.scheper@aquestive.com|
22294599|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680|acapriati@menarini-ricerche.it|9933
22294600|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294601|NCT02771093|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22308323|NCT04541706|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308324|NCT05974046|Clinical Development|Global Director|(804) 594-4488|trialdisclosure@indivior.com|
22308325|NCT03436745|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
22308326|NCT03661840|University of Colorado Hospital|Elissa Kolva, MD|7208488090|elissa.kolva@va.gov|
22308327|NCT05849051|UNC Lineberger Comprehensive Cancer Center|Adam O Goldstein|919-270-6491|AOG@med.unc.edu|
22308328|NCT05873751|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308329|NCT01772472|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22308330|NCT02697136|Abionyx Pharma|Constance Peyrottes|+33673045380|cpeyrottes@abionyx.com|
22276107|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
22276108|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu|
22276109|NCT04919161|Gaylord Hospital Inc.|Dr. Henry C. Hrdlicka, Research Coordinator|203-284-2864|hhrdlicka@gaylord.org|
22308331|NCT04391894|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22265093|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22265094|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk|
22265095|NCT01155778|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22265096|NCT01901874|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22265097|NCT03078582|Ra Pharmaceuticals, Inc|Sponsor Ra Pharmaceuticals, Inc.|+1 617 401 4060|trials@rapharma.com|
22265098|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350|robert.winker@hera.co.at|45666
22265099|NCT02519621|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22265100|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
22265101|NCT03676751|UCSF FI Proctor|Pr Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
22265102|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65|shahram.attarian@ap-hm.fr|79
22265103|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22265104|NCT04722601|University of Chicago|Dr. Sonali Smith|855-702-8222|smsmith@bsd.uchicago.edu|
22265105|NCT02181296|University of Pennsylvania|Dr. Nabil M Elkassabany|(215) 662-3793|Nabil.Elkassabany@uphs.upenn.edu|
22265106|NCT03020719|Seattle Children's Hospital|Arthur Baines|2068841431|Arthur.Baines@seattlechildrens.org|
22265107|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu|
22265108|NCT02340221|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265109|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22265110|NCT03499119|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22265111|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu|
22265112|NCT04143243|Baylor College of Medicine|Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
22265113|NCT02655016|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265114|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
22265115|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22265116|NCT02522403|Universidad Autonoma de Nuevo Leon|Carlos Acosta-Olivo|528183467798|dr.carlosacosta@gmail.com|
22265117|NCT01553279|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265118|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu|
22308332|NCT01889199|University of California, Los Angeles|Daniel A. Dumesic, MD|310-794-5542|DDumesic@mednet.ucla.edu|
22308333|NCT02323321|TransMedics Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
22308334|NCT00446225|Fundación GECP|Eva Pereira|+34934302006|epereira@gecp.org|
22308335|NCT05741489|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22308336|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es|
22308337|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22308338|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22308339|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
22308340|NCT04854096|NS Pharma, Inc.|Medical Affairs|+1-201-986-3860|trialinfo@nspharma.com|
22308341|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
22308342|NCT03930342|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
22308343|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22308344|NCT02742519|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22308345|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu|
22308346|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com|
22308347|NCT01091168|INSTITUT DE RECHERCHE PIERRE FABRE|Dr Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
22308348|NCT05792423|MGH|Anthony Samir|6176432009|asamir@mgh.harvard.edu|
22308349|NCT04572750|VA Palo Alto Health Care System|Keith Humphreys, PhD|(650) 493-5000|keith.humphreys@va.gov|
22308350|NCT06240091|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
22308351|NCT04052516|NorthSea Therapeutics BV|Chief Scientific Officer|31 035760 65 05|info@northseatherapeutics.com|
22308352|NCT03747484|Fred Hutchinson Cancer Center|Joshua Veatch|206.667.5108|jveatch@fredhutch.org|
22308353|NCT05549726|UCSF|Tamara Clark|415-517-3444|tamara.clark@ucsf.edu|
22308354|NCT02387853|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22308355|NCT03744936|Mayo Clinic|Dr. Victor Montori|507-284-1920|montori.victor@gmail.com|
22308356|NCT04272619|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|kristen.sorice@fccc.edu|
22308357|NCT05062265|Atlantic Orthopaedic|Dr. Ashley Suttmiller|7573213300|suttmilera@atlanticortho.com|6283
22308358|NCT04172441|Zealand Pharma A/S|Charlotte Teglman Schiøler|+45 5060 3722|cschioler@zealandpharma.com|
22308359|NCT04236856|Corindus|Clinical Scientist|6173012445|hamid.rai@siemens-healthineers.com|
22308360|NCT03101904|Bangor Univeristy|Dr Jamie Hugo Macdonald|+44 1248 38|j.h.macdonald@bangor.ac.uk|3272
22308361|NCT04538417|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
22308362|NCT05693610|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
22308363|NCT01180634|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22308364|NCT02662062|ANZUP|Dr Anthony Uccellini - ANZUP Research fellow|61 2 9046 8954|trials@anzup.org.au|
22308365|NCT04356027|Abbott|Tarn Teraphongphom, Principal Clinical Research Scientist|+1 (408) 931-0504|tarn.teraphongphom@abbott.com|
22308366|NCT02910583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22265119|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu|
22265120|NCT02588950|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22265121|NCT01936519|Penn State Milton S Hershey Medical Center|Dr Zakiyah Kadry|717 531 5921|zkadry@pennstatehealth.psu.edu|
22265122|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22265123|NCT02072824|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265124|NCT01859130|Zimmer Biomet|Clinical Research Specialist|5745497606|tim.swanson@zimmerbiomet.com|
22265125|NCT03949244|Icahn School of Medicine at Mount Sinai|Harriet Lloyd|212-979-4672|hlloyd@nyee.edu|
22265126|NCT03835325|Eurofarma Laboratórios S.A|Sandra Rodrigues|1150908600|sandra.rodrigues@eurofarma.com.br|8417
22265127|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu|
22265128|NCT01370213|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
22265129|NCT01227655|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22265130|NCT00038649|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-794-5783|CR_Study_Registration@mdanderson.org|
22265131|NCT03395639|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22265132|NCT00942331|Memorial Sloan-Kettering Cancer Center|Jonathan Rosenberg, MD|646-422-4461|rosenbj1@mskcc.org|
22265133|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22265134|NCT02994251|Yale University|Dr. Todd Schlachter|203-785-5885|todd.schlachter@yale.edu|
22265135|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300||
22265136|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com|
22265137|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22265138|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com|
22265139|NCT00594620|The University of Kansas|Jeffrey Holzbeierlein, MD, FACS|913-945-8239|jholzbeierlein@kumc.edu|
22265140|NCT01338987|National Cancer Institute|Dr. Christopher Kanakry|240-760-6171|christopher.kanakry@nih.gov|
22265141|NCT03844789|University of Virginia Center for Diabetes Technology|Marc Breton|434-982-6484|mb6nt@virginia.edu|
22265142|NCT03856593|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22265143|NCT02595008|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22265144|NCT03407118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22308367|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
22308368|NCT02193958|FUJIFILM Pharmaceuticals U.S.A, Inc.|Vice President of Clinical Operations|(617) 945-3763|fphucontact@fujifilm.com|
22308369|NCT03414814|Seoul National University Hospital|Ji-Sook Kim|821025866440|kbj3075814@snu.ac.kr|
22308370|NCT03161379|Sidney Kimmel Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
22308371|NCT05021640|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22308372|NCT02207062|University of Washington|Dr. Ajay Gopal, Professor|206-606-2037|agopal@uw.edu|
22308373|NCT03779204|Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|naomi.thulien@unityhealth.to|
22308374|NCT04539574|M.D. Anderson Cancer Center|Max Wintermark, MD|713-792-0845|mwintermark@mdanderson.org|
22308375|NCT03315754|Memorial Sloan Kettering Cancer Center, New York, NY, USA|Jonathan Coleman, MD|+1-646-422-4432|colemanj@mskcc.org|
22308376|NCT02954341|CHU de Lille - Institut Coeur Poumon|Dr Pascal De Groote|33 (0)3 20 44 50 38|Pascal.DEGROOTE@chu-lille.fr|
22308377|NCT05227209|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
22308378|NCT05633953|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
22308379|NCT05695989|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22308380|NCT05493787|Geisinger|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
22308381|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22308382|NCT03526861|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22308383|NCT05327101|Abbott Medical Devices|Stephanie Delgado|818-493-3285|stephanie.delgado1@abbott.com|
22308384|NCT03940963|Axogen|Stacy Arnold, VP of Product Development and Clinical Research|770-833-2570|sarnold@axogeninc.com|
22308385|NCT05323084|Pennington Biomedical Research Institute|Prachi Singh|15072068331|prachi.singh@pbrc.edu|
22308386|NCT01261312|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-560-2913|harold.keer@astx.com|
22308387|NCT04294225|Mayo Clinic|Tufia C Haddad MD|507/284-2511|Haddad.Tufia@mayo.edu|
22308388|NCT02790502|Department of Agriculture, Environmental and Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
22308389|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org|
22308390|NCT04812535|InflaRx GmbH|Dr. Camilla Chong, CMO|+49 3641-508-180|camilla.chong@inflarx.com|
22308391|NCT03336333|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22308392|NCT02589275|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22308393|NCT04401800|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22308394|NCT04927065|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22308395|NCT05751382|Dentsply Sirona Implants and Consumables|AnnaKarin Lungren Dr.|0046 702 666 492|annakarin.lundgren@dentsplysirona.com|
22308396|NCT05671029|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22308397|NCT03846505|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers, Lab Manager|8437925807|sellersst@musc.edu|
22308398|NCT04621266|The University of Hong Kong|Dr Kris Lok|39176690|krislok@hku.hk|
22308399|NCT05767437|University of Valencia|Jose casaña Granell|677361782|jose.casana@uv.es|
22308400|NCT02085421|University of Minnesota|Caroline Demro|(612) 625-3330|schi0599@umn.edu|
22308401|NCT04021602|University of Kansas Medical Center|Lisette T. Jacobson, Ph.D., MPA, M.A., Associate Professor, Obstetrics and Gynecology|316-293-3484|ljacobson@kumc.edu|
22308402|NCT02689284|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
22308403|NCT05592418|AIM ImmunoTech Inc.|Diane Young|352-448-7797|diane.young@aimimmuno.com|
22265145|NCT02046525|Washington University in St. Louis|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
22265146|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
22265147|NCT02689063|AFT Pharmaceuticals|Jennifer Zhang -Project Manager|+ 64 9 488 0232|jenniferz@aftpharm.com|710
22265148|NCT01797484|University Heart Centre Hamburg Eppendorf|Dr. Tjark F. Schwemer|+49 40 7410|t.schwemer@uke.de|56800
22265149|NCT01933464|UCSD Dermatology Clincal Trials|Dermatology Clinical Trial Manager|(858)657-8390|dermstudies@ucsd.edu|
22265150|NCT04017754|Aalborg University Hospital, Gynecologic and Obstetric department|Caroline Nørgaard-Pedersen|+45 41120267|carolinenp94@gmail.com|
22265151|NCT03508687|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@med.umich.edu|
22265152|NCT02999477|Dana-Farber Cancer Institute|Adrienne Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
22265153|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285|avaidya1@partners.org|617
22265154|NCT01846273|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22265155|NCT02939014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22265156|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265157|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265158|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu|
22265159|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
22265160|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265161|NCT02220725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22265162|NCT03351231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22265163|NCT03052972|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22265164|NCT00103402|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
22265165|NCT02333487|H. LUndbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22265166|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com|
22265167|NCT01111019|Merck Healthcare, a business of Merck KGaA|Merck KGaA Communication Center|+49 6151 72 5200|service@merckgroup.com|
22265168|NCT03168321|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22265169|NCT02013375|University of Illinois at Chicago|Dr Damiano Rondelli|312-996-6179|drond@uic.edu|
22265170|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu|
22265171|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265172|NCT01902628|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22265173|NCT04385277|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22265174|NCT04905290|Medtronic|James Burrell, Senior Statistician|18006338766|burrej3@medtronic.com|
22265175|NCT03303625|Janssen Vaccines and Prevention B.V.|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265176|NCT05392907|INAIL|Ing. Emanuele Gruppioni|+39 051 6936 609|e.gruppioni@inail.it|
22265177|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22265178|NCT01108666|University of Pennsylvania|Dr. Abigail Berman|215-615-3659|Abigail.Berman@uphs.upenn.edu|
22265179|NCT01884311|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
22265180|NCT02858492|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265181|NCT02944383|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
22265182|NCT04425538|Neely Center for Clinical Research, Tufts Medical Center|Director of Clinical Trials|617-636-5000|ncccr@tuftsmedicalcenter.org|3264
22265183|NCT01995266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22265184|NCT03853148|Medical University of South Carolina|Teresa Kelechi, Associate Dean for Research and PhD Studies|843-792-4602|kelechtj@musc.edu|
22265185|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu|
22265186|NCT04029311|Tohoku University|Dr. Yasue Tanaka|+81227178396|yasue.tanaka.b3@tohoku.ac.jp|
22265187|NCT03623386|Yale School of Medicine|Sule Tinaz, MD, PhD: Associate Professor of Neurology|(877) 925-3637|sule.tinaz@yale.edu|
22265188|NCT01996943|University of California, San Francisco|Dr. Gregory Marcus|(415) 353-2554|Greg.Marcus@ucsf.edu|
22265189|NCT02802449|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
22265190|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
22265191|NCT05855616|Marques de Valdecilla University Hospital|Raquel Pelayo Alonso, Head Nurse of Nephrology, RN|+34 649443488|raquel.pelayo@scsalud.es|
22265192|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22276110|NCT02175758|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22276111|NCT02489773|Asahi Kasei Pharma Corporation|Takuji Kohzuma PhD|+81-3-3296-3617|kouzuma.tb@om.asahi-kasei.co.jp|
22308404|NCT03822845|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
22308405|NCT02386371|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22308406|NCT04450342|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22308407|NCT05481320|UC Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
22308408|NCT02923180|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Emmanuel Antonarakis|410-502-8341|eantona1@jhmi.edu|
22308409|NCT05198310|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22308410|NCT04116736|Johnson & Johnson Vision Care (JJVC)|Graeme Young|+44(0) 1252 718719|g.young@visioncare.co.uk|
22308411|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com|
22308412|NCT03526354|UMass Chan Medical School|Dr. Xiaoduo Fan|5088566463|xiaoduo.fan@umassmed.edu|
22308413|NCT06041139|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22308414|NCT03941860|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22308415|NCT04093752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22308416|NCT05386069|Prisma Health|Manager OBGYN Research|864-455-1510|patti.parker@prismahealth.org|
22308417|NCT00753090|Zimmer Biomet|Lisette Smid|0623956378|lisette.smid@zimmerbiomet.com|
22308418|NCT05574426|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
22308419|NCT04521478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308420|NCT04578912|University of Minnesota|Christine Conelea|(612) 261-3127|cconelea@umn.edu|
22308421|NCT06311084|Imperial College London|Dr Martina Di Simplicio|0208 383 4162|m.di-simplicio@imperial.ac.uk|
22308422|NCT04725240|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22308423|NCT04600323|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|jessica.kendrick@cuanschutz.edu|
22308424|NCT03222128|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
22308425|NCT02829814|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
22308426|NCT05449795|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22308427|NCT03393975|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308428|NCT04501861|Cleveland Clinic Foundation|Dr. Mariya Geube|216-444-2779|Geubem@ccf.org|
22308429|NCT04234698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308430|NCT01007591|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22308431|NCT03016169|Abbott|Karine Miquel, Associate Director of Project Management|+32 479 600 107|karine.miquel@abbott.com|
22308432|NCT04060355|Emory University, School of Nursing|Kenneth Hepburn, PhD|404-712-9286|khepbur@emory.edu|
22308433|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org|
22308434|NCT02496780|University of Minnesota|Antoinette Moran|612-624-5409|moran001@umn.edu|
22308435|NCT04421378|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22308436|NCT04258709|University of Pittsburgh|Dr. Jill Demirci|412-648-9236|JVR5@pitt.edu|
22308437|NCT02592330|Massachusetts Eye and Ear|Michael Cheung, MS, CCRP (Clinical Research Project Manager)|617-573-6981|mcheung0@meei.harvard.edu|
22308438|NCT03090152|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|2126061036|JulesElyseeK@HSS.EDU|
22308439|NCT03958955|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22308440|NCT04673929|The Royal Marsden Hospital|Professor Vinidh Paleri|02078082732|vinidh.paleri@rmh.nhs.uk|
22308441|NCT04638829|Sobi,Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
22308442|NCT05150860|San Diego State University|Assistant Vice President for Research Support Services|(619) 594-5938|rgulizia@sdsu.edu|
22308443|NCT02807636|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22308444|NCT05082909|Imperial College London|Dr Timothy Rawson|07891750151|antibiotic.research@imperial.ac.uk|
22308445|NCT04088630|Wake Forest University School of Medicine|Carol Kittel, Senior Biostatistician|336-399-3832|c.kittel@wakehealth.edu|
22308446|NCT03164980|NOGGO e.V.|Jasmin Yamamoto|+49 30 4036865 32|jasmin.yamamoto@noggo.de|
22308447|NCT03175029|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
22308448|NCT03381261|Weill Cornell Medicine|Dr. Lisa Gfrerer|646.962.4250|lig4013@med.cornell.edu|
22308449|NCT05634226|Children's Hospital of Pittsburgh|Dr. Tarek Alsaied|5136521226|tarek.alsaied84@gmail.com|
22308450|NCT05324124|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22308451|NCT04969419|Momentum Data Ltd|Dr Andrew McGovern|+44 7531221970|andy.mcgovern@momentumdata.co.uk|
22308452|NCT04089371|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22308453|NCT03453619|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22308454|NCT04382898|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22308455|NCT05229120|Henry Ford Health|Julia Felton, PhD|704-995-7832|jfelton4@hfhs.org|
22308456|NCT05134350|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22308457|NCT03932682|Seqirus|Clinical Trial Disclosure Manager|+1 855 358 8966|seqirus.clinicaltrials@seqirus.com|
22308458|NCT04321031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321544|NCT03152019|Hospices Civils de Lyon|Dr Dupuis Girod|427856522|sophie.dupuis-girod@chu-lyon.fr|+33
22321545|NCT04703075|Johns Hopkins University School of Medicine|Maria Beatriz Kohler, Senior Research Nurse|4104048921|bkohler@jhmi.edu|
22321546|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22321547|NCT03449095|University of Illinois at Urbana-Champaign|Dr. Catharine Fairbairn|215-300-5850|cfairbai@illinois.edu|
22321548|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com|
22321549|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov|
22321550|NCT03036293|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22321551|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu|
22321552|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22321553|NCT01408147|Cal Poly|Suzanne Phelan|805 756 2087|sphelan@calpoly.edu|
22321554|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22321555|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22321556|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu|
22321557|NCT03311711|Emory University|Mi-Kyung Song, PhD|404-727-3134|mi-kyung.song@emory.edu|
22321558|NCT02229552|SUNY Buffalo|Leonard H Epstein|716-826-3400|ckk@buffalo.edu|
22321559|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300||
22321560|NCT02586675|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
22321561|NCT03186677|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22321562|NCT02730884|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD/Professor|713-794-5783|jcortes@mdanderson.org|
22321563|NCT03354754|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22321564|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694|cristiana.forni@ior.it|0039
22321565|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu|
22321566|NCT03860961|NRG Oncology|Wendy Seiferheld|(215) 574-3208|seiferheldw@nrgoncology.org|
22321567|NCT03189446|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
22321568|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22321569|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
22321570|NCT05634577|M D Anderson Cancer Center|Mouhammed Habra, MD|713-792-2841|mahabra@mdanderson.org|
22321571|NCT03468309|VA Puget Sound Health Care System|Dr. Amanda E. Wood; Clinical Research Psychologist, VA PSHCS|253-583-1652|amanda.wood@va.gov|71652
22321572|NCT03239574|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22321573|NCT01515787|Memorial Sloan Kettering Cancer Center|Dr.Deborah Schrag|617-416-5194|schragd@mskcc.org|
22321574|NCT02631200|Queen's University Belfast|Dr Peter O'Halloran|02890972490|p.ohalloran@qub.ac.uk|
22321575|NCT03174132|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
22321576|NCT02340585|Stryker|Stacy Phung|678 469 2428|stacy.phung@stryker.com|
22321577|NCT02669017|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22321578|NCT04091087|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321579|NCT04152161|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22321580|NCT03621280|Cortendo AB|Valentina Conoscenti, MD|1-877-937-4737|OPTICS@cortendo.com|
22321581|NCT03363321|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321582|NCT00915681|Meda Pharma GmbH & Co KG (A Viatris company)|Baerbel Fingerhut|+49 6172 888|baerbel.fingerhut@viatris.com|1419
22321583|NCT02918773|Emory University|Andi L Shane MD/MPH/MSc|404-727-9880|ashane@emory.edu|
22321584|NCT02559687|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321585|NCT01780831|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22321586|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22321587|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
22321588|NCT00876993|Johns Hopkins All Children's Hospital|Stacie Stapleton|727-767-4176|stacie.stapleton@jhmi.edu|
22321589|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org|
22321590|NCT01784861|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@wustl.edu|
22321591|NCT02599961|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22321592|NCT01857869|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321593|NCT03341962|Immunic AG|Andreas Muehler, MD|004989|Andreas.Muehler@imux.com|20804770
22321594|NCT01142401|Icahn School of Medicine at Mount Sinai|Joseph Sparano, MD|212-241-3300|joseph.sparano@mssm.edu|
22321595|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org|
22321596|NCT03016325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22321597|NCT02728830|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
22321598|NCT01152021|Department of Anesthesia, Perioperative and Pain Medicine|Rachel Dabek|857-218-5413|rachel.dabek@childrens.harvard.edu|
22321599|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu|
22321600|NCT04288154|Mayo Clinic|Amir Lerman, M.D.|507-255-2398|lerman.amir@mayo.edu|
22321601|NCT03711500|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|6467746738|Joshua.Kantrowitz@nyspi.columbia.edu|
22321602|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321603|NCT01902290|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22321604|NCT00774345|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@BMS.com|
22321605|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com|
22276112|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22294602|NCT01128842|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22294603|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22294604|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org|
22294605|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov|
22294606|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22294607|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294608|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov|
22294609|NCT03396367|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
22294610|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
22294611|NCT01411774|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
22294612|NCT03808545|University of Alabama at Birmingham|Brooks Wingo, Associate Professor|2059345982|bcwingo@uab.edu|
22294613|NCT03292588|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22294614|NCT03808493|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22294615|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org|
22294616|NCT05526716|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClincalTrialsDisclosure@msd.com|
22308459|NCT04237298|NUMalaysia|Dr Asma Ashari, Orthodontist and Senior Lecturer, Principal Investigator|+60192228440|asmaashari@ukm.edu.my|
22308460|NCT04950192|Philips IGTD|Rashmi Ram, Director of Clinical Development|719-464-6326|rashmi.ram@philips.com|
22308461|NCT05285618|University of California, Santa Barbara|Michael Beyeler|(805) 893-4321|mbeyeler@ucsb.edu|
22308462|NCT04251299|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
22308463|NCT04556656|Prilenia|Prilenia|+972 775558|info@prilenia.com|
22308464|NCT05536440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308465|NCT03094663|Hospital for Special Surgery, Anesthesiology|Dr. David Kim|2126061036|kimd@hss.edu|
22308466|NCT01566695|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22308467|NCT04882449|Bodyport Inc.|Dorothy Kwok, Head of Clinical Operations|669-240-3077|dorothy@bodyport.com|
22308468|NCT01416831|Earle A. Chiles Research Institute, Providence Cancer Institute|Brendan Curti, M.D.|503-215-6588|brendan.curti@providence.org|
22308469|NCT05470400|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22308470|NCT05956002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308471|NCT04784559|PharmaMar|Clinical Development Virology Business Unit|+34 918466000|virologytrials@pharmamar.com|
22294617|NCT02552199|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22321606|NCT01015768|Southern California College of Optometry|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@scco.edu|
22321607|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
22321608|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321609|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org|
22321610|NCT01556425|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22321611|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu|
22321612|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300||
22321613|NCT00490451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22321614|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu|
22321615|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321616|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111||
22265193|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com|
22265194|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
22265195|NCT01280409|University of Texas Health Science Center at Houston|Dr Jerrie Refuerzo|713.500.7780|Jerrie.S.Refuerzo@uth.tmc.edu|
22265196|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com|
22265197|NCT03275766|University of Bern, University Hospital of Psychiatry, Bern|Prof. Sebastian Walther|+41 632 8979|sebastian.walther@upd.unibe.ch|
22265198|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com|
22265199|NCT03001219|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265200|NCT01797835|RAND|Dr. Elizabeth D'Amico|3103930411|damico@rand.org|6487
22265201|NCT01403064|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22265202|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
22265203|NCT02669940|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22265204|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
22265205|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250||
22265206|NCT04408599|NextCure, Inc|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
22265207|NCT02163486|DorkuzEU|Bahar Kuvaki|902324122836|ozbilginsule@gmail.com|
22265208|NCT01249365|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265209|NCT03579966|Catalyst Pharmaceuticals, Inc.|Gary Ingenito, MD, Chief Medical Officer|3054203200|gingenito@catalystpharma.com|
22265210|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com|
22265211|NCT03484117|Massachusetts General Hospital|Dr. Julie Levison, PI|617-724-4698|jlevison@partners.org|
22265212|NCT03041324|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
22265213|NCT03551496|Boston Scientific|Dana Hromyak|1 216-526-8534|Dana.Hromyak@bsci.com|
22265214|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22265215|NCT02303041|Stanford University|Anne Lynn S. Chang/ Associate Professor of Dermatology|650-723-6316|alschang@stanford.edu|
22265216|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265217|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk|
22265218|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com|
22265219|NCT01553201|National Institute of Neurological Disorders & Stroke|Barbara Karp, MD|301-496-0150|karpb@ninds.nih.gov|
22265220|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22265221|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22265222|NCT01347866|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265223|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22265224|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com|
22265225|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22265226|NCT02674061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265227|NCT03182582|Stanford University|Geoffrey C. Gurtner, MD|650-736-2776|ggurtner@stanford.edu|
22265228|NCT03334721|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
22265229|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se|
22265230|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22265231|NCT02932228|VA Palo Alto Health Care System|Dr Donna Zulman|650-493-5000|Donna.Zulman@va.gov|29113
22265232|NCT04062448|Janssen Pharmaceutical K.K.|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265233|NCT05140954|Departments of Global Health and Epidemiology, University of Washington|Kenneth K. Mugwanya, MBChB, MS, PhD|+1 206 520-3800|mugwanya@uw.edu|
22265234|NCT03340064|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22265235|NCT00856973|Sunovion|CNS Medical Director|866-503-6357||
22265236|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
22265237|NCT02751359|University of California Los Angeles|Dr. Ziva Cooper, Principal Investigator|310-206-9942|zcooper@mednet.ucla.edu|
22265238|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22265239|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22265240|NCT02400671|University of Washington|Dr. Keshet Ronen|206-685-4363|keshet@uw.edu|
22308472|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300||
22308473|NCT03665597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22308474|NCT05516147|Hopeful Aging|Michael Skrajner|440-477-7881|mike@hopefulaging.com|
22308475|NCT02874534|University of North Carolina at Chapel Hill|Gabriel S. Dichter, PhD|9194450132|dichter@med.unc.edu|
22308476|NCT02926911|Duke university|Dr. Shelley Hwang|919-668-6688|shelley.hwang@duke.edu|
22308477|NCT02317783|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah|
22308478|NCT03361748|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22308479|NCT02318901|WRMC|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22308480|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22294618|NCT04932096|Oregon Health & Science University|Dr. Cydni Williams|5034945522|willicyd@ohsu.edu|
22294619|NCT01438957|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294620|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com|
22294621|NCT03902574|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22294622|NCT00846430|Corewell Health|Dr. Albert Cornelius|616-391-2086|albert.cornelius@helendevoschildrens.org|
22294623|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
22294624|NCT04592874|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
22294625|NCT00314093|University of Texas Southwestern Medical Center|Dr. Ellen Vitetta|214-648-1200|ELLEN.VITETTA@UTSouthwestern.edu|
22294626|NCT02101060|Salem VA Medical Center|Dr. Krisann Oursler|540-982-2463|krisann.oursler@va.gov|4981
22294627|NCT03784729|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22294628|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300||
22294629|NCT02244606|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
22294630|NCT02348606|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22294631|NCT02321800|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22308481|NCT00901901|BAYER|Therapeutic Area Head|(+)1-888-84-22937|clinical-trials-contact@bayer.com|
22308482|NCT03811366|Hospital das clínicas- Faculdade de Medicina da Universidade São Paulo|Dra Joyce Hisae Yamamoto|41988263757|vmsakata@yahoo.com.br|
22308483|NCT03748342|UT Southwestern Medical Center|Dr. Tiffany Moon|469/419-5790|Tiffany.Moon@UTSouthwestern.edu|
22308484|NCT04774237|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
22308485|NCT02520063|UAB|Erica Stringer-Reasor|2059759375|esreasor@uabmc.edu|
22308486|NCT03264131|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22308487|NCT02485834|Weill Medical College of Cornell University|Manish A. Shah MD|646-962-6200|mas9313@med.cornell.edu|
22308488|NCT05902793|The Second Affiliated Hospital of Zhejiang University School of Medicine|Dr. Zhijun Pan|0571-87783777|zepzj@163.com|
22308489|NCT05121740|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|91 846 60 00|virologytrials@pharmamar.com; clinicaltrials@pharmamar.com|
22308490|NCT06391177|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22308491|NCT04311996|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
22308492|NCT02630823|Washington University School of Medicine|Premal Thaker, M.D., MSc.|314-362-1740|thakerp@wustl.edu|
22308493|NCT05159583|University of California, Berekeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22308494|NCT03676582|Sheffield Teaching Hospitals NHS Trust|Lise Sproson|07753827428|Lise.Sproson@nihr.ac.uk|
22308495|NCT04280445|Trent Doctorate in Clinical Psychology Programme, University of Nottingham, UK|Dr Daniell De Boos|+44 (0)115 84 67523|danielle.deboos@nottingham.ac.uk|
22308496|NCT03328702|University of California, Davis|Dr. Peter Belafsky|8582053366|pcbelafsky@ucdavis.edu|
22308497|NCT05993078|Tianjin Medical University General Hospital|Jiayue Ding|18518347837|sjnkzz2@163.com|
22308498|NCT04674358|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22308499|NCT03158805|Lindner Center of HOPE|Susan McElroy|5135360700|susan.mcelroy@lindnercenter.org|
22308500|NCT05382936|Stemline|Carlos Garay, M.D.|877-332-7967|clinicaltrials@menarinistemline.com|
22308501|NCT03703700|Center for Reproductive Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Dr. Dongzi Yang|8602081332233|yangdz@mail.sysu.edu.cn|
22308502|NCT02682316|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
22308503|NCT03394846|University of South Carolina|Robert Glenn Weaver|8037775605|weaverrg@mailbox.sc.edu|
22308504|NCT05543746|University of North Carolina at Chapel Hill|Rachel Kozik|919-590-0813|rachel_kozik@med.unc.edu|
22308505|NCT04630262|DePuy Synthes|Kelly Francher, Staff Clinical Research Scientist|574-241-6581|kfranche@its.jnj.com|
22308506|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com|
22308507|NCT04975880|Quanta Dialysis Technologies|Dr. Paul Komenda|(204) 510-5219|paul.komenda@quantadt.com|
22308508|NCT03692676|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308509|NCT03692611|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
22308510|NCT03988634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22308511|NCT04049747|Imperial College London|Ms Puja Jadav|020 7594 7773|p.jadav@imperial.ac.uk|
22294632|NCT03012165|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22308512|NCT04092387|University of Vermont|Stephen T. Higgins, PhD|802-735-6267|stephen.higgins@uvm.edu|
22308513|NCT03205800|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
22321617|NCT00853671|Massachusetts General Hospital|Dr. Brian B. Ghoshhajra|617-726-3745|bghoshhajra@partners.org|
22321618|NCT01848184|Medtronic|Michelle DiSalvo|774 284 6089|michelle.v.disalvo@medtronic.com|
22321619|NCT02587650|University of California, San Francisco|Dr. Adil Daud|(415) 353-7392|Adil.Daud@ucsf.edu|
22321620|NCT04099251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22321621|NCT04311502|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22321622|NCT04874194|The university of Texas MD Anderson Cancer Center|Courtney DiNardo MD, Professor|713-794-1141|cdinardo@mdanderson.org|
22294633|NCT00982878|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22294634|NCT03284398|Fresenius Kabi Deutschland, GmbH|Prof. Dr. med. Martin Westphal|+49 6172 686-7348|martin.westphal@fresenius-kabi.com|
22294635|NCT02227758|St Jude Medical/Abbott|Clinical Study Director||rdiaz@sjm.com|
22321623|NCT05032157|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22294636|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590||
22294637|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401|max.dieterich@uni-rostock.de|4500
22294638|NCT04605484|AlloVir, Inc.|Richard Riese|617-433-2605|rriese@allovir.com|
22294639|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu|
22321624|NCT03451773|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|rudloffu@mail.nih.gov|
22321625|NCT02627495|Spaulding Rehabilitation Hospital|Prof. Felipe Fregni|+1 (617) 935-2743|Fregni.Felipe@mgh.harvard.edu|
22321626|NCT02543528|Johnson & Johnson Vision|Elizabeth Dow -PRINCIPAL RESEARCH OPTOMETRIST|904-443-1061|edow1@its.jnj.com|
22321627|NCT02049944|Memorial Care|Dr. Morgan Swank|5624808460|morganswankmd@gmail.com|
22321628|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu|
22321629|NCT03936387|BOSTON CHILDREN'S HOSPITAL|ROLAND BRUSSEAU MD|6173557737|roland.brusseau@childrens.harvard.edu|
22321630|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321631|NCT01339559|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22321632|NCT00971945|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22321633|NCT03354663|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
22321634|NCT03691974|Regeneron Pharmaceuticals, Inc|Study Director|844-734-6643|clinicaltrials@regeneron.com|
22321635|NCT03962439|University of Texas at Dallas|Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
22321636|NCT00746252|University of Marylland, Baltimore|Gloria M. Reeves, M.D.|410-706-3522|greeves@psych.umaryland.edu|
22321637|NCT01049035|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22321638|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
22321639|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com|
22321640|NCT03548051|Hope Clinic of the Emory Vaccine Center|Nadine Rouphael|404-377-3719|nroupha@emory.edu|10
22265241|NCT03687658|Stanford University|Russell Poldrack, PhD|(650) 497-8488|poldrack@stanford.edu|
22294640|NCT04171531|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
22308514|NCT04083235|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22308515|NCT03047928|CCIT-DK|Prof. MD, Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|+45
22308516|NCT02729311|University of California, San Francisco|Deborah Barnes, PhD|415-221-4810|Deborah.Barnes@ucsf.edu|4221
22308517|NCT05034952|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22308518|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
22308519|NCT04950660|Children's Mercy Kansas City|Anne Stuedemann MSN, RN, CPNP|8162343693|astuedemann@cmh.edu|
22308520|NCT03761537|LEO Pharma A/S|Disclosure|44 94 58 88|disclosure@leo-pharma.com|+45
22308521|NCT04783935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22308522|NCT05275842|Medical University of South Carolina|Cristina Lopez|843-792-2945|lopezcm@musc.edu|
22308523|NCT05273749|Tonix Pharmaceuticals|Gregory Sullivan, MD|8629040355|greg.sullivan@tonixpharma.com|
22308524|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22308525|NCT03420833|Mayo Clinic|Dr. Yong-Mei Cha|507-255-0774|ycha@mayo.edu|
22308526|NCT05687916|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308527|NCT03338790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22308528|NCT02380885|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
22308529|NCT04588298|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22308530|NCT02281955|University of North Carolina at Chapel Hill|Dr. Colette Shen|984-974-0400|cjshen@email.unc.edu|
22308531|NCT03892616|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308532|NCT04177823|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308533|NCT03683719|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22308534|NCT05081583|Washington State University|Dr. Mary Paine|5093587759|mary.paine@wsu.edu|
22308535|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org|
22308536|NCT03924986|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22308537|NCT04922502|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
22308538|NCT05147155|University of Thessaly|Research Committee - Special Account for Research Grants University of Thessaly|+306971894688|raniakotsiou@gmail.com|
22308539|NCT03699709|University of Washington School of Public Health Department of Epidemiology|Dr. Amanda Fretts|2065431065|amfretts@uw.edu|
22308540|NCT02907099|The University of Texas MD Anderson Cancer Center|Brandon Smaglo, MD|(713) 745-8763|bgsmaglo@mdanderson.org|
22294641|NCT04124757|LUMC|Martijn Boon MD PhD|003171522301|m.boon@lumc.nl|
22294642|NCT05537883|Wake Forest University Health Sciences|Selwan Barbat, MD|704-355-2000|Selwan.Barbat@atriumhealth.org|
22294643|NCT03366337|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22294644|NCT00769392|Lahey Clinic|Gregory Blaha, MD|781-744-2580|christine.gould@lahey.org|
22294645|NCT02296320|MedImmune, LLC|Hasan S. Jafri|301-398-4431|information.center@astrazeneca.com|
22294646|NCT03282682|Comenius University in Bratislava|Doc. Mgr. Milan Sedliak, PhD.|+421918340671|milan.sedliak@uniba.sk|
22294647|NCT04026308|UAMS|Michael Wilson|501-686-8729|MPWilson@uams.edu|
22294648|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu|
22294649|NCT01697566|M.D. Anderson Cancer Center|Karen H. Lu, MD|713-745-8902|khlu@mdanderson.org|
22294650|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com|
22265242|NCT04397445|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22294651|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
22294652|NCT04518293|George Medicines Pty Limited|Anthony Rogers (Principal Investigator)|+44-7983 578 290|arodgers@georgeinstitute.org|
22294653|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com|
22294654|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22294655|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294656|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
22294657|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294658|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22294659|NCT04087096|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|EWYU@mgh.harvard.edu|
22294660|NCT02334358|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22294661|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000|ddodge@llu.edu|48500
22294662|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22294663|NCT04545385|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22294664|NCT01919606|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22294665|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22294666|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22294667|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22294668|NCT05399641|Scynexis|David Angulo|201-884-5471|david.angulo@scynexis.com|
22321641|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu|
22321642|NCT03874377|Children's National Medical Center|Dr. Sarah Hornack|202-895-3860|shornack@childrensnational.org|
22321643|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
22321644|NCT00812214|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|617-744-1310|Spierings@MedVadis.com|
22321645|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com|
22321646|NCT03325673|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22321647|NCT02684981|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321648|NCT03598166|VA|Anika Zaman|6464190648|anika.zaman@nyulangone.org|
22321649|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22321650|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org|
22321651|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321652|NCT01602692|University of Wisconsin - Madison|Dr. Venkat Rao|(608) 263-1223|rao@surgery.wisc.edu|
22321653|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22321654|NCT03847987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321655|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com|
22321656|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22321657|NCT01695473|University of California, San Francisco|Dr. Won Kim, MD|877-827-3222|Won.Kim@ucsf.edu|
22321658|NCT03548558|University of Southern California|Dr. Jill Luoto|+1-213-764-1581|jluoto@usc.edu|
22321659|NCT04852848|University of Oregon|Anne Marie Mauricio, Research Associate Professor|602-920-7459|amariem@uoregon.edu|
22294669|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294670|NCT03334539|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
22321660|NCT03799458|University of New Mexico Health Sciences Center|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
22321661|NCT04175626|Biotronik, Inc|Crystal Miller|1 800-547-0394|crystal.miller@biotronik.com|
22321662|NCT03494881|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
22321663|NCT01709149|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22321664|NCT03509350|Emory University|Jon Sevransky MD, MHS|404-778-5734|jonathan.sevransky@emoryhealthcare.org|
22265243|NCT03921151|Virginia Commonwealth University|Liangsuo Ma, PhD|(804) 828-2871|liangsuo.ma@vcuhealth.org|
22294671|NCT02457260|University of Pittsburgh|Daniel E. Forman - Chief of a section of Geriatrics Cardiology|412-864-2507|formand@pitt.edu|
22294672|NCT03706456|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22321665|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22321666|NCT04951037|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
22294673|NCT04523220|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22294674|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22321667|NCT05630937|Nerviano Medical Sciences S.r.l.|Alberto Ocana|39 0331 58 1111|DL-Clinicaltrials@nervianoms.com|
22321668|NCT02429414|UT MD Anderson Cancer Center|Jagtar S Heir, Professor, Anesthesiology & PeriOper Med|(713) 745-3793|jsheir@mdanderson.org|
22321669|NCT03245450|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22294675|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22294676|NCT02517567|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22294677|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu|
22294678|NCT04659161|Karuna Therapeutics, Inc.|Inder Kaul, VP Clinical Development|1-888-783-0380|medinfo@karunatx.com|
22294679|NCT01929343|UT Southwestern Medical Center|Josh Becker|2146485277|joshua.becker@utsouthwestern.edu|
22294680|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu|
22294681|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294682|NCT02615145|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22294683|NCT02320669|Seattle Childrens hospital|Michael A Portman|206-987-1014|michael.portman@seattlechildrens.org|
22294684|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408||
22294685|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org|
22294686|NCT01257087|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22294687|NCT01600638|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22294688|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org|
22294689|NCT03648983|Montefiore Medical Center|Lisa Wiechmann||lwiechma@montefiore.org|
22294690|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
22294691|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu|
22294692|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com|
22294693|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
22294694|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294695|NCT03825315|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22294696|NCT02038023|AUERBACH HEMATOLOGY ONCOLOGY ASSOC|Dr Michael AUERBACH|410-780-4050|MAUERBACHMD@ABHEMONC.COM|
22294697|NCT00583778|MetroHealth Medical Center|Dr. Rita Cydulka|216-778-7800|rcydulka@gmail.com|
22294698|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu|
22294699|NCT03489720|Vanderbilt University Medical Center|Dr. Uma Shastri|615-936-3198|uma.shastri@vumc.org|
22294700|NCT02511184|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294701|NCT01806545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22294702|NCT00884312|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22294703|NCT01148940|Albert Einstein College of Medicine|Dr. Henny Billett|718-430-2186|hbillett@montefiore.org|
22294704|NCT02442869|University of Nevada, Reno|Dr. Jacqueline Pistorello|775-784-4648|pistorel@unr.edu|
22294705|NCT03521934|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22294706|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300||
22294707|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22294708|NCT02335294|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22294709|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
22294710|NCT00960778|Medical University of South Carolina|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
22294711|NCT03508921|Vanderbilt Medical Center|Melissa Kaufman, MD, PhD Professor of Urology|615-322-3807|melissa.kaufman@vumc.org|
22294712|NCT01833520|UT MD Anderson Cancer Center|Vivek Subbiah,Associate Professor, Invest. Cancer Therapeutics|(713) 563-0393|vsubbiah@mdanderson.org|
22294713|NCT02010840|The Hog Kong Polytechnic University|Vivian Ngai|2766|vivian.ngai@polyu.edu.hk|6775
22294714|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22294715|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
22294716|NCT04028700|University of North Carollina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.karafin@unchealth.unc.edu|
22294717|NCT04182763|Oregon Health & Science University|Allison Gregory, MS CGC, Project Manager|503-494-4344|gregorya@ohsu.edu|
22294718|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch|
22294719|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22294720|NCT03348956|Dartmouth Hitchcock Medical Center|Victoria Lawson|(603) 650-5104|victoria.h.lawson@hitchcock.org|
22294721|NCT02551731|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22294722|NCT03680105|Reven Pharmaceuticals|Head, Global Clinical Affairs|13036691336|kristina.cabala@reven.com|
22294723|NCT03814356|Massachusetts General Hospital|Brian L. Edlow, M.D.|617-724-6352|bedlow@mgh.harvard.edu|
22294724|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu|
22321670|NCT01849172|Guang'an Men Hospital, China Academy of Chinese Medical Sciences|Dr.Zhishun Liu|+86 01088002331|liuzhishun@aliyun.com|
22321671|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22265244|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22294725|NCT01727297|Medtronic, Inc.|Medtronic Cardiac Rhythm and Heart Failure clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
22294726|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu|
22294727|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
22294728|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il|
22294729|NCT05228132|Becton Dickinson|Joshua Black, Clinical Project Manager|520-599-6124|joshua.black@bd.com|
22294730|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294731|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com|
22294732|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22294733|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486|rene.thyrian@dzne.de|7592
22294734|NCT04891874|Shanghai Eastern Hepatobiliary Surgery Hospital|Dr. SHI Changying|+86-021-81887735|nona-peach@hotmail.com|
22294735|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
22294736|NCT04456959|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294737|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22294738|NCT04584645|Evidation Health|Director, Enterprise Research Design|650-389-9550|results@evidation.com|
22294739|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
22294740|NCT03473977|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
22294741|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu|
22294742|NCT03845985|UMass Chan Medical School|Melissa L. Anderson, Associate Professor of Psychiatry|508-856-5820|melissa.anderson@umassmed.edu|
22294743|NCT02756013|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Peter Rose|+1 216-444-6601|ROSEP@ccf.org|
22294744|NCT03926169|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22294745|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22294746|NCT04974697|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
22294747|NCT03889444|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22294748|NCT03302234|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294749|NCT04112784|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22294750|NCT00221403|Ohio State Medical Center/Nationwide Children's Hospital|Robert Kowatch, MD, PhD|(614) 355-2872|Robert.Kowatch@nationwidechildrens.org|
22294751|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22294752|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
22294753|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
22294754|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr|
22294755|NCT03129178|University of Portsmouth|Dr Anthony Shepherd|02392 84|ant.shepherd@port.ac.uk|5289
22294756|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org|
22294757|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de|
22294758|NCT02549937|HUTCHMED Limited|Martin Benes|+1.973.306|martinb@hutch-med.com|4490
22294759|NCT01893632|NYSPI|john mariani, md|646-774-6140|john.mariani@nyspi.columbia.edu|
22294760|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22294761|NCT00317356|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22294762|NCT04342897|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294763|NCT05519540|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22294764|NCT02674529|University of Pittsburgh|Project Research Coordinator|412-376-3913|neppacham@upmc.edu|
22294765|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22294766|NCT02141282|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22294767|NCT02566083|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
22294768|NCT00963547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294769|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
22294770|NCT03761277|Medtronic Neuromodulation Clinical Research|Pain Therapies Clinical Research Director|763-514-4000|rs.embracetdd@medtronic.com|
22294771|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22294772|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22294773|NCT04532164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22294774|NCT02483520|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588-1673|Kwilliams1@kumc.edu|
22294775|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22294776|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com|
22294777|NCT02033694|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
22294778|NCT02111772|University of Virginia|Dr. Peter W. Heymann|434-242-8209|pwh5a@virginia.edu|
22294779|NCT00743340|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22294780|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu|
22294781|NCT01987505|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22294782|NCT01425281|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
22308541|NCT05569252|Daiichi Sankyo|Contact for Clinical Trial Information|9089926400|CTRinfo_us@daiichisankyo.com|
22308542|NCT02949362|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22276113|NCT00584285|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
22308543|NCT05268302|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
22308544|NCT02811679|Massachusetts General Hospital|Jeffrey Barnes, MD, PhD|6177244000|JABARNES@mgh.harvard.edu|
22308545|NCT06365086|University of Texas at Austin|Sara Hussain, PhD|5122322686|sara.hussain@austin.utexas.edu|
22308546|NCT05611073|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22308547|NCT05319860|University of Miami|Dr. Debbie Anglade|305-284-2388|d.anglade@miami.edu|
22308548|NCT04314895|NanOlogy, LLC|Mark Mitchell|8179004074|mark.mitchell@dfb.com|
22308549|NCT05113966|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22308550|NCT02815813|Dartmouth-Hitchcock|Dr. Kelly Aschbrenner|603-440-7722|kelly.a.aschbrenner@dartmouth.edu|
22308551|NCT02187003|Biossil Inc.|Head of Regulatory|978-245-7397|debora@biossil.ai|
22308552|NCT01525966|City of Hope Medical Center|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
22308553|NCT03648840|Indiana University - Indianapolis|Dr. Martin H. Plawecki, MD, PhD|317 944 8164|mplaweck@iu.edu|
22308554|NCT05063994|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
22308555|NCT04868227|University of Edinburgh|Professor Malcolm Dunlop|+44 (0) 131 651 8602|malcolm.dunlop@ed.ac.uk|
22308556|NCT04490915|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22308557|NCT03149315|Johns Hopkins University School of Medicine|Melanie Dispenza, MD, PhD|410-550-1815|mdispen1@jhmi.edu|
22308558|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|1-862-778-8300|Novartis.email@novartis.com|
22308559|NCT03376321|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22308560|NCT02995434|University of British Columbia|Dr. Bernie Garrett|604 822 7443|bernie.garrett@ubc.ca|
22308561|NCT05680675|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
22308562|NCT03400059|Chordate Medical AB|Dr Jan Hermansson|+46 8 400 115 86|jan.hermansson@chordate.com|
22308563|NCT04150718|University of Pennsylvania|Dr. Jennifer Goldschmied|215-573-2774|jrgolds2@pennmedicine.upenn.edu|
22308564|NCT02437318|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22308565|NCT05086016|Renata Medical|Dali Alarian|8553184988|dali@renatamedical.com|6
22308566|NCT06074523|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
22308567|NCT03818659|University of California, San Francisco|Dr. Mark Pletcher|415-514-8008|mark.pletcher@ucsf.edu|
22308568|NCT02900924|Veryan Medical|Nick Yeo|+441403258984|nick.yeo@veryanmed.com|
22308569|NCT02897531|Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital|Sung-Bum Kang, MD, PhD|+82-031-787-7093|kangsb@snubh.org|
22308570|NCT04382404|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
22308571|NCT05102409|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22308572|NCT03662607|Spectrum Health|Dr. Ryan Madder|6163916660|stephen.orey@corewellhealth.org|
22308573|NCT05868772|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
22308574|NCT03406871|NationalCCHE,JAPAN|Dr.Kohei Shitara|+81-4-7133-1111|regonivo_core@east.ncc.go.jp|
22308575|NCT05102591|University of Calgary/Alberta Health Services|Dr. Serena Orr|403-955-7728|serena.orr@albertahealthservices.ca|
22276114|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22308576|NCT05784662|University at Buffalo, School of Social Work|Patricia Logan-Greene|7166451533|pblogang@buffalo.edu|
22308577|NCT04739956|Imperial College Healthcare NHS Trust|Dr Margaret Pikovsky|+447870276373|m.pikovsky@nhs.net|
22308578|NCT02386722|Cantonal Hospital Baselland|Dr. Claudia Gregoriano|+41619253765|claudia.gregoriano@ksbl.ch|
22308579|NCT03519581|University of California, Davis Eye Center|Clinical Research Supervisor|916 734-6303|dcmacias@ucdavis.edu|
22308580|NCT05694286|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
22308581|NCT03110315|EvergreenHealth Research|Theodore Brown|4258995385|trbrown@evergreenhealthcare.org|
22308582|NCT01781468|Mayo Clinic Arizona|Alyx B. Porter Umphrey, M.D.|480-301-4062|Porter.alyx@mayo.edu|
22308583|NCT05371652|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308584|NCT05256706|Emory University|Dr. Arshed Quyyumi|404-712-2741|aquyyum@emory.edu|
22308585|NCT05009004|Environment and Health Group|Patricia Weitzman|6174555976|pat.weitzman@ehgcambridge.com|
22308586|NCT04410042|St. Jude Children's Research Hospital|Michael D. Neel, MD|901-259-1600|mneel@orthosouth.org|
22308587|NCT03898986|Stanford University|Philip Grant, MD|6507239001|pmgrant@stanford.edu|
22308588|NCT01494662|Dana-Farber Cancer Institute|Rachel Freedman, MD|617-632-3800|Rachel_Freedman@dfci.harvard.edu|
22308589|NCT04322643|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|866-223-8100|TaussigResearch@ccf.org|
22308590|NCT05329493|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
22308591|NCT05486078|Guna S.p.a|Dr. Vincenzo Miranda, Clinical Research & Scientific Service Manager|02 280.18.(358)|v.miranda@guna.it|
22308592|NCT03302494|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22308593|NCT05134233|Fralin Biomedical Research Institute at VTC|Jessica Florig|540-526-2261|jnw@vtc.vt.edu|
22308594|NCT03978871|University of Illinois, Urbana-Champaign|Dr. Karen Rudolph|217-333-8624|krudolph@illinois.edu|
22308595|NCT05710107|Medical University of South Carolina|Ellen Johnson|843-792-2322|hayell@musc.edu|
22308596|NCT04166773|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22308597|NCT04072822|Indiana University School of Medicine|Samer Gawrieh, MD|(317) 278-9326|sgawrieh@iu.edu|
22276115|NCT03755076|Albert Einstein Healthcare Network|Dr. Shailesh Kantak|562-385-7111|skantak@ranchoresearch.org|
22321672|NCT02706873|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22321673|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553|jmiller@somnatherapeutics.com|102
22321674|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
22294783|NCT01749514|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321675|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
22321676|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321677|NCT00797732|Dana-Farber Cancer Institute|Weidong Lu, PhD, MB, Lic.Ac.|617.632.4350|weidong_lu@dfci.harvard.edu|
22321678|NCT03948178|Orion Corporation|Head of Compliance and UK Study Management, Clinical Operations|+441159487100|clinicaltrials@orionpharma.com|
22321679|NCT03196076|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22321680|NCT02424526|Sacramento State|Katrin Mattern-Baxter, PT, DPT|19162785766|kbaxter@csus.edu|
22294784|NCT02509156|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
22321681|NCT04400474|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
22321682|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu|
22321683|NCT02873936|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22294785|NCT05131646|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
22321684|NCT02054897|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22321685|NCT02069899|Sobi AG|Radmila Kanceva/Senior Medical Director Immunology|+ 41 22 551 91 63|Radmila.Kanceva@sobi.com|
22321686|NCT01119248|Rutgers/New Jersey Medical School|Anuradha Patel, MD Director of Pediatric Anesthesiology|973 972-1886|patelan@njms.rutgers.edu|
22294786|NCT02128113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22294787|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com|
22294788|NCT03765918|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22294789|NCT04202965|Protagonist Therapeutics, Inc|Clinical Study Director|1-888-899-1543|ptgxclintrials@ptgx-inc.com|
22294790|NCT02969369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltraildisclosure@sunovion.com|
22294791|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir|
22294792|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
22294793|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
22294794|NCT04380116|Yale University|Dr. Frank Buono|2037795799|frank.buono@yale.edu|
22294795|NCT01746745|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294796|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu|
22294797|NCT05883449|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
22294798|NCT04171050|University of California, Los Angeles|Tamara Grisales, MD|310-983-1023|tgrisales@mednet.ucla.edu|
22294799|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22294800|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294801|NCT03170401|University of Washingtion|Dr. Grant E O'Keefe|206-744-8016|gokeefe@uw.edu|
22294802|NCT05451225|Columbia University|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
22294803|NCT04746963|AsclepiX Therapeutics|Dr A Shojaei|800-572-3545|info@asclepix.com|
22294804|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22294805|NCT01496612|NIH/NINDS|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
22294806|NCT02518750|St. Jude Children's Research Hospital|Sima Jeha, MD|901-595-3901|sima.jeha@stjude.org|
22294807|NCT03129100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294808|NCT03789474|ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RISHIKESH,UTTARAKHAND,INDIA.|Dr M KESARI|7093005219|kesyellow@yahoo.com|
22294809|NCT03708328|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22294810|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de|
22294811|NCT00496808|UT MD Anderson Cancer Center|Raphael E Pollock,PHD/Professor Emeritus, Surgical Oncology|(713) 792-6928|CR_Study_Registration@mdanderson.org|
22294812|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22294813|NCT02010775|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22294814|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com|
22294815|NCT03936985|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
22294816|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22294817|NCT03123913|University of Rochester Medical Center|Chad Heatwole, MD, MS-CI|585-275-7867|dystrophy_registry@urmc.rochester.edu|
22321687|NCT01550562|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22321688|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu|
22321689|NCT01553136|Yale University|Stephanie Samples O'Malley, PhD, Professor of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu|
22321690|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22294818|NCT02984709|Vanderbilt University Medical Center|Sarah Jaser|615-343-6775|sarah.jaser@vanderblit.edu|
22294819|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22294820|NCT01737697|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22321691|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr|
22294821|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org|
22294822|NCT01866930|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22294823|NCT02579239|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22294824|NCT02288897|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|865-769-4011|wachter@pvct.com|23
22294825|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300||
22294826|NCT02854631|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22294827|NCT03930797|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22294828|NCT01962896|University of Texas Southwestern Medical Center|Theodore Laetsch, MD|214-648-5475|ted.laetsch@utsouthwestern.edu|
22294829|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu|
22308598|NCT03269136|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265245|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
22265246|NCT03760250|University of Pennsylvania|Jenny Wei|2153165151|jenny.wei@pennmedicine.upenn.edu|
22265247|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu|
22265248|NCT03733210|Stanford Medicine at Stanford University|Yu-Jin Lee, MD, MS|650-725-4711|yujinlee@stanford.edu|
22265249|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265250|NCT03728634|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22265251|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265252|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22265253|NCT01338649|Massachusetts General Hospital|Aleksandar Videnovic|855-644-6387|avidenovic@mgh.harvard.edu|
22265254|NCT04688931|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
22265255|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
22265256|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399||
22265257|NCT02034058|Stryker Neurovascular|Alice Lin, Clinical Program Manager|510 413 2673|alice.lin@stryker.com|
22265258|NCT03840616|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
22265259|NCT03949803|Universidad de Murcia|Prof. Marta Garaulet Aza|+34868889478|garaulet@um.es|
22265260|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265261|NCT04493320|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
22265262|NCT03251963|University of Utah|Christopher Pannucci|801 581 2121|christopher.pannucci@hsc.utah.edu|
22265263|NCT00616941|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22265264|NCT02044796|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
22265265|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com|
22265266|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu|
22265267|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265268|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22265269|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu|
22265270|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200|siupo.sit@penumbrainc.com|221
22265271|NCT01732874|Nationwide Childrens Hospital|Dr. Christina J. Valentine MD,MS,RD|(614) 722-2000|Christina.Valentine@nationwidechildrens.org|
22265272|NCT03709823|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22265273|NCT02737332|SPARC|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
22265274|NCT00688376|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22265275|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov|
22276116|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil|
22276117|NCT02550795|Gil hospital|Dr. Youn Yi Jo|82324603636|endless37@gilhospital.com|
22308599|NCT04799704|UZ Leuven|Heleen Delbeke, MD|003216342229|heleen.delbeke@uzleuven.be|
22308600|NCT03983018|Örebro University|Prof Susanne Bejerot|+46701655102|susanne.bejerot@oru.se|
22308601|NCT02515773|University of Cincinnati|Casey Moore|513-558-6307|casey.moore@uc.edu|
22308602|NCT04918823|BostonSight|Dr. Daniel Brocks|7817267337|dbrocks@bostonsight.org|
22308603|NCT04072380|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
22308604|NCT01552473|The University of Texas at Dallas, Center for BrainHealth|Dr. Daniel Krawczyk, Primary Investigator|214-905-3007|dck061000@utdallas.edu|
22308605|NCT03468218|Emory University|Dr. Nabil Saba|404-778-1900|nfsaba@emory.edu|
22308606|NCT03033576|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
22308607|NCT03719443|Parexel International|Principal Investigator|(781) 487-9900|info@parexel.com|
22308608|NCT03526874|Children's Hospital of Philadelphia|Dr. Christina Szperka|12155901719|szperka@chop.edu|
22308609|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22308610|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308611|NCT03447470|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
22308612|NCT05328648|University of North Carolina at Chapel Hill|Emilia Goland, MMSc|919-966-2017|emilia_goland@unc.edu|
22276118|NCT02225587|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294830|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589|aztrial_results_posting@astrazeneca.com|4589
22308613|NCT01361711|Northwestern University|Shuo Ma, MD, PhD|312-908-5250|shuo-ma@northwestern.edu|
22276119|NCT06026813|UT Southwestern Medical Center|Dr. Peter Crisologo|214/648-7284|Peter.Crisologo@UTSouthwestern.edu|
22276120|NCT03483584|The Chinese University of Hong Kong|Prof. Grace Lui|+852 35051716|gracelui@cuhk.edu.hk|
22276121|NCT02879695|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22276122|NCT04063163|ShanghaiHenliusBiotech|Fan Zhang|021-33395800*6334|Fan_Zhang2@henlius.com|
22276123|NCT02572167|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22276124|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu|
22276125|NCT04435626|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22276126|NCT04426656|University of North Carolina at Chapel Hill|Chunyan Li, MSc|919-966-6695|chunyli@live.unc.edu|
22276127|NCT06407375|University Hospital Zurich|Dr. Toni Rabadi|043 254 41 10|radiologie@usz.ch|
22276128|NCT00619528|Northwestern University|Joseph Leventhal MD, PhD|312-695-0427|jleventh@nm.org|
22276129|NCT05248386|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|000
22276130|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com|
22276131|NCT01149083|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22276132|NCT03275168|Johns Hopkins University|Dr Maria Trent|4109552910|mtrent2@jhu.edu|
22276133|NCT03036254|Icahn School of Medicine at Mount Sinai|Dr. Mary Sano|(212) 659-8838|mary.sano@mssm.edu|
22276134|NCT00278408|Saarland University Medical School|Dr. Viola Poeschel|+4968411615014|dshnhl@uks.eu|
22276135|NCT03033355|houston methodist Hospital|Dr. Rose Khavari|713-363-9154|rkhavari@houstonmethodist.org|
22276136|NCT03013751|Mezzion Pharmaceuticals, Inc|Director of Clinical Operatons|3128980292|wg.kim@mezzion.com|
22276137|NCT02213003|Diabetes Research Institute/University of Miami|Rodolfo Alejandro, MD|305-243-3389|Ralejand@med.miami.edu|
22276138|NCT01802281|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
22276139|NCT05523297|Toronto General Hospital|Dr Keyvan Karkouti|(416) 340-8597|keyvan.karkouti@uhn.ca|
22276140|NCT05965427|Research Organization (KC) Ltd|MASH1 Clinical Project Manager|+44 (0) 7494 795 982|mash1@rokcservices.com|
22276141|NCT03168672|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
22321692|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu|
22276142|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012||
22276143|NCT04556097|McLean Hospital|Dr. Brent Forester|617-855-3622|bforester@mclean.harvard.edu|
22321693|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276144|NCT05436613|University of East Lonson|Professor Cynthia Fu|020 8223 4119|c.fu@uel.ac.uk|
22276145|NCT03771716|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
22276146|NCT05317546|Medical University of South Carolina|Dr. Lindsay Squeglia|843-792-5454|squegli@musc.edu|
22276147|NCT02290184|University of California San Francisco|Melinda Sarmiento Bender, PhD, RN|415 502 5668|melinda.bender@ucsf.edu|
22276148|NCT02530541|BSL|C. Beausoleil|406-587-5735|cbeausoleil@biosciencelabs.com|
22276149|NCT02353780|University of Pittsburgh|Larry Moreland, MD|412-648-4098|lwm5@pitt.edu|
22276150|NCT02402062|MFAR Clinical Research|Federico Nepote|0034934344412|investigacion@mfar.net|102
22276151|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu|
22276152|NCT02555878|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22276153|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276154|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22276155|NCT02335944|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22276156|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es|
22276157|NCT03160170|University of Miami Miller School of Medicine|Ian Cote|305-256-4492|Icote@med.miami.edu|
22276158|NCT06081829|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22321694|NCT03315871|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
22321695|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22321696|NCT02532231|The University of Texas MD Anderson Cancer Center|Tapan Mahendra Kadia, MD/Professor|713-563-3534|tkadia@mdanderson.org|
22321697|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276159|NCT04835441|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22276160|NCT05666245|Center for Vaccine Development and Global Health (CVD)|Wilbur Chen, MD, MS|410-706-5328|wilbur.chen@som.umaryland.edu|
22276161|NCT03421561|Philips|Nicolas Aguirre|612-297-6655|nicolas.aguirre@philips.com|
22276162|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000|phil.peyton@austinhealth.org.au|5704
22276163|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu|
22276164|NCT02293499|University of Rochester School of Nursing|Hyekyun Rhee PhD, RN, FAAN|585-276-3775|Hyekyun_Rhee@urmc.rochester.edu|
22276165|NCT03915067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22321698|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321699|NCT04623242|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
22321700|NCT03300466|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22321701|NCT02921971|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22321702|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276166|NCT03317496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276167|NCT02693418|Evofem Biosciences|Kelly Culwell, MD, MPH, FACOG|858-550-1900|kculwell@evofem.com|225
22276168|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov|
22265276|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu|
22294831|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294832|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu|
22294833|NCT03727347|Aerin Medical, Inc.|Anais Laborde|(650) 518-9624|alaborde@aerinmedical.com|
22294834|NCT04292743|Lombardi Comprehensive Cancer Center|Marcus Noel|202-444-2223|Marcus.S.Noel@gunet.georgetown.edu|
22294835|NCT05330702|University of Iowa|Shaoping Zhang|(319) 335-7386|shaoping-zhang@uiowa.edu|
22294836|NCT02881554|University of Washington|Dr. Smith Apisarnthanarax, Principal Investigator|+1 206 598-4100|apisarn@uw.edu|
22294837|NCT01852110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22294838|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org|
22294839|NCT02298803|Diabetes Centre, Royal Prince Alfred Hospital|Dr Ted Wu|61295155888|ted.wu@sswahs.nsw.gov.au|
22294840|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu|
22294841|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773|marilee-monnot@ouhsc.edu|5773
22294842|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com|
22308614|NCT02596126|Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P (CNIC)|Antonio J Quesada, PhD|+34 914531200|aquesada@cnic.es|(#1163)
22308615|NCT03717506|Gage Development Company|Gage Development Clinical Trials|1-847-999-0600|clinicalinfo@capstonedevservices.com|
22265277|NCT01517659|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22265278|NCT02792959|Institute Bergonie|Dr. Anne Laure Cazeau, Coordinating Investigator|0556337860|A.Cazeau@bordeaux.unicancer.fr|
22265279|NCT03201250|Vanderbilt University Medical Center|Muhamed Baljevic, MD|615-936-8422|muhamed.baljevic@vumc.org|
22265280|NCT00894738|Washington University School of Medicine|Dr. Ginger Nicol|(314) 362-2461|nicolg@psychiatry.wustl.edu|
22265281|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22265282|NCT02335983|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22265283|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22308616|NCT04889755|Boston University|Associate Professor|(617) 358-4296|kalong@bu.edu|
22265284|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu|
22265285|NCT04465630|SIght Sciences, Inc|Kavita Dhamdhere, MD|877-266-1144|kdhamdhere@sightsciences.com|
22265286|NCT02356003|University of Calgary|Frank MacMaster|403-955-2784|fmacmast@ucalgary.ca|
22265287|NCT01912274|Helsinn HealthcareSA|Edwin de Wit - Head of Clinical development|+ 41 919852121|info-HHC@helsinn.com|
22265288|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22265289|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at|
22265290|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265291|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000|ngregori@med.miami.edu|3081
22265292|NCT01708590|Bausch Health|Study Director|510-259-5284||
22265293|NCT05070546|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265294|NCT02643355|Hennepin Healthcare|Dr. Marc Martel|612-873-7448|Edresearch@hcmed.org|
22265295|NCT02697240|Children's National Medical Center|Suvankar Majumdar|2024763800|smajumdar@childrensnational.org|
22265296|NCT05080426|Purdue University|Dr. Ellen Ernst Kossek|(765) 494-6852|ekossek@purdue.edu|
22265297|NCT04988152|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22265298|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca|
22265299|NCT04982874|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
22265300|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
22265301|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu|
22265302|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265303|NCT02477774|University of California, San Francisco|Rahul Seth, MD|415-353-9500|Rahul.Seth@ucsf.edu|
22265304|NCT02214420|Scripps Clinic|Dr. Paul Pockros|(858) 554-8879|Pockros.paul@scrippshealth.org|
22265305|NCT03295318|Serum Institute of India Pvt. Ltd.|Abhijeet Dharmadhikari|+91-20-26602855|abhijeet.dharmadhikari@seruminstitute.com|2855
22265306|NCT04319718|University of Pittsburgh|Dr. Leslie Meyn, Research Assistant Professor|412-641-4233|meynla@mwri.magee.edu|
22265307|NCT02664363|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
22265308|NCT03955471|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265309|NCT01030341|Johns Hopkins Data Coordinating Center|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
22265310|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com|
22265311|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu|
22265312|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22265313|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
22265314|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com|
22308617|NCT02471638|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
22265315|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22294843|NCT04882540|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22294844|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343||
22308618|NCT01328262|Haukeland University Hospital|Elin Opheim Netland|+4755976050|elin.opheim.netland@helse-bergen.no|
22308619|NCT05529966|Stanford University|Robert T. Chang, MD|650-725-5743|christyr@stanford.edu|
22308620|NCT04024813|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22308621|NCT04034251|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|blakelyam@nih.gov|
22308622|NCT04419389|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22308623|NCT05493423|Hemotek Medical Inc|Chief Scientific Officer|7074942895|patrick@hemotekmedical.com|
22276169|NCT00704353|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22308624|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu|
22276170|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276171|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22265316|NCT03882528|Walter Reed Army Institute of Research|Dr. James Moon, Principal Investigator|301-319-9176|James.e.moon.mil@mail.mil|
22276172|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com|
22276173|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22276174|NCT02782468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22276175|NCT02887586|Clinical Cancer Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences|Hebin|13520253895|hebinbj68@163.com|
22276176|NCT05350202|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22276177|NCT04364646|Center for Sleep and Circadian Rhythms, AHWFB|Katherine M. Sharkey, MD, PhD|336-716-4657|katherine.sharkey@advocatehealth.org|
22276178|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org|
22276179|NCT01525589|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
22276180|NCT02924376|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22276181|NCT03608033|Omeros|Skylar Liles|206-676-5000|ctinfo@omeros.com|
22276182|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org|
22276183|NCT05253807|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22276184|NCT04735367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276185|NCT02360579|Iovance Biotherapeutics|Rana Fiaz, Executive Medical Director|661-645-3572|rana.fiaz@iovance.com|
22276186|NCT05423756|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22276187|NCT06455111|Boston University School of Medicine Endocrinology, Diabetes, Nutrition & Weight Management|Nicole L Spartano, PhD|315-415-2040|spartano@bu.edu|
22276188|NCT03682848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276189|NCT06910332|Acıbadem University, Department of Physiotherapy and Rehabilitation|Ali Ömer ACAR|+90 216 500 44 44|aliomer.acar@acibadem.edu.tr|3578
22265317|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu|
22276190|NCT06910202|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas Lemos|5405262106|rflemos@vtc.vt.edu|
22276191|NCT02145390|University of Miami|Adrian Ishkanian MD|305-243-4200|aishkanian@miami.edu|
22276192|NCT06231511|Shirley Ryan Abilitylab|Sara Prokup PT, DPT|312-238-1355|sprokup@sralab.org|
22276193|NCT05370326|Yale School of Medicine|Melissa B. Weimer, DO, MCR, DFASAM|(203) 859-2962|melissa.weimer@yale.edu|
22276194|NCT02880176|Fox Chase Cancer Center|Dr. Marshall Strother|555-555-5555|m12912988@gmail.com|
22276195|NCT02606305|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22308625|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com|
22308626|NCT06093659|Imperial Brands PLC|Tasnim Abusalem|+44 (0) 117 332 2343|tasnim.abusalem@impbrands.com|
22265318|NCT00418301|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22265319|NCT04032158|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@merckgroup.com|
22265320|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
22265321|NCT01796912|Imperiwal College London|Dudley Pennell|+44 (0)20 3811 6871|d.pennell@imperial.ac.uk|
22265322|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com|
22265323|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22265324|NCT04325204|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
22265325|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com|
22265326|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
22265327|NCT04710979|University of Minnesota|Dr. Daheia J. Barr-Anderson|240-475-2806|barra027@umn.edu|
22265328|NCT03535675|Johns Hopkins University|Channing Paller; M.D.|4109558239|cpaller1@jhmi.edu|
22276196|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500|d.rampton@qmul.ac.uk|7885
22276197|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
22276198|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org|
22276199|NCT02008370|Maimonides Medical Center|Dr G Trunfio|718-283-6000|gtrunfio@maimonidesmed.org|
22276200|NCT00662259|University of California San Diego|Gregory G. Brown|858-246-0607|gbrown@ucsd.edu|
22276201|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22276202|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918||
22308627|NCT03281291|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308628|NCT00512070|VA Puget Sound Health Care System|Amanda Wood, PhD|253-583-1652|amanda.wood@va.gov|
22276203|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com|
22321703|NCT00648375|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
22321704|NCT02721355|Immunology Research Institute in Gifu|Dr. Van Sa Nguyen|+819068053288|nguyen@ew-nutrition.co.jp|
22321705|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu|
22321706|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org|
22265329|NCT03426137|University of Maryland School of Nursing|Research Coordinator|410-706-5975|NRSCollocaLab@umaryland.edu|
22265330|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com|
22265331|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22265332|NCT03667014|UCSF|Tina Bhutani|4153537800|tina.bhutani@ucsf.edu|
22265333|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu|
22265334|NCT03537274|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265335|NCT04421586|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
22265336|NCT02963441|IDx LLC|IDx President, Dr. Michael Abramoff|319-248-5620|info@eyediagnosis.net|
22265337|NCT04920916|University of Virginia Health System|William Petri|434-305-9633|wap3g@virginia.edu|
22265338|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com|
22265339|NCT04392583|Smith+Nephew, Inc|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
22265340|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265341|NCT02620150|University of Pennsylvania|Chelsea Voytek|215-746-3711|chelseav@pennmedicine.upenn.edu|
22265342|NCT02878486|University of Kansas|Amber Watts, PhD|785-864-2604|amberwatts@ku.edu|
22265343|NCT03052959|Unity Health Toronto|Dr. Aisha Lofters|4163236400|aisha.lofters@utoronto.ca|3832
22265344|NCT02397408|University of California, Los Angeles|Albert J. Chang, MD, PhD|(310) 82509771|ajchang@mednet.ucla.edu|
22265345|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265346|NCT03736928|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22265347|NCT03096847|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22265348|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22265349|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265350|NCT02931045|1st Chair and Department of Cardiology, Medical University of Warsaw|Aleksandra Gasecka, MD, PhD|+48225991951|alesandra.gasecka@wum.edu.pl|
22265351|NCT03978091|ARLG - Albany College of Pharmacy and Health Sciences|Thomas Lodise, PharmD, PhD|1 (518) 694-7292|Thomas.Lodise@acphs.edu|
22265352|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22265353|NCT04700280|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22265354|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300||
22265355|NCT02093221|Grifols Therapeutics LLC|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
22265356|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110||
22265357|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
22265358|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu|
22265359|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265360|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265361|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22265362|NCT04764630|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22265363|NCT03097588|Department of Pharmacy Services, Oregon health & Science University Hospital|Joseph Bubalo, PharmD (Oncology Clinical Pharmacy Specialist)|5034948007|bubaloj@ohsu.edu|
22265364|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265365|NCT02037165|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265366|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com|
22265367|NCT04932941|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
22265368|NCT02206620|Oregon Health & Science University|Dr. Martina Mancini|5034182602|mancinim@ohsu.edu|
22265369|NCT05816200|Federal University of Rio Grande do Norte|PhD Cristianne Kalinne Santos Medeiros|+55(84)3342-2341|cristiannekalinne@gmail.com|
22265370|NCT02394730|University of New South Wales|Sean Emery, Chief Principal Investigator|+61 2 9385 0897|s.emery@unsw.edu.au|
22265371|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org|
22265372|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu|
22265373|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu|
22265374|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
22265375|NCT03510182|University of Michigan|Carol Persad|734-615-8112|cpersad@umich.edu|
22265376|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22265377|NCT03747601|BIDMC|Daniel Press, MD Chief of Cognitive Neurology Unit|617-667-4074|dpress@bidmc.harvard.edu|
22265378|NCT02221037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265379|NCT01461226|University of Antwerp/Antwerp University Hospital|dr. Luc bruyndonckx|003238213000|luc.bruyndonckx@uza.be|
22265380|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265381|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu|
22265382|NCT03827564|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22321707|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com|
22321708|NCT01968460|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
22321709|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252||5252
22276204|NCT01724190|Nationwide Childrens Hospital|Kathryn Obrynba|6147224425|kathryn.obrynba@nationwidechidrens.org|
22276205|NCT02636283|University of Minnesota|Otto Sanchez|615-833-9867'|sanc0050@umn.edu|
22276206|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu|
22276207|NCT02111980|UC San Diego School of Medicine|Dr. Ulrika Birgersdotter-Green|858-657-5310|ubgreen@ucsd.edu|
22321710|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
22321711|NCT03491384|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|CUChange@Colorado.edu|
22321712|NCT01484626|Loyola University Medical Center|Scott Smith, M.D., Ph.D.|708-327-3142|ssmith8@lumc.edu|
22321713|NCT01777152|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22321714|NCT03446885|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
22321715|NCT04283123|Washington University School of Medicine in St. Louis|Susan Stark, PhD, OTR/L, FAOTA|(314)273-4114|sstark@wustl.edu|
22321716|NCT04442230|Altimmune, Inc.|Sarah K. Browne, MD/Senior Director, Clinical Development|240-654-1450|sbrowne@altimmune.com|
22321717|NCT01903837|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22321718|NCT03759665|IntraBio Ltd.|Taylor Fields, Chief Product Development Officer|+44 8081|tfields@intrabio.com|641283
22321719|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488|einata@protalix.com|137
22321720|NCT05098041|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22321721|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321722|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr|
22265383|NCT02238626|MediciNova, Inc.|Director, Scientific Affairs|8583444535|makhay@medicinova.com|
22265384|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com|
22265385|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22265386|NCT02920918|Virginia Commonwealth University|Salvatore Carbone|804 628 3980|scarbone@vcu.edu|
22265387|NCT01969448|Washington University School of Medicine|Marissa J. Tenebaum, M.D.|314-996-8800|tenenbaumm@wustl.edu|
22265388|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22265389|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22265390|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
22265391|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
22265392|NCT03309007|UNewMexico|MArk Burge|5052724658|mburge@salud.unm.edu|
22265393|NCT02963311|The Medicines Company|Frank Bosley, Vice-President, Regulatory Operaions|9732906016|frank.bosley@themedco.com|
22265394|NCT01691820|GlaxoSmithKline|GSK Response Center|866-435-7343|biliana.v.nestorova@gsk.com|
22265395|NCT03426566|Wroclaw Medical University|Dr Sutkowska Edyta|0048503077016|edytasutkowska@yahoo.com|
22265396|NCT01911897|Vascular Dynamics|Director, Clinical Operations|9492317602|lgreen@vasculardynamics.com|
22265397|NCT04442490|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22265398|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111|rosss0128@bellsouth.net|6817
22265399|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org|
22265400|NCT02836496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265401|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22265402|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org|
22265403|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu|
22265404|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265405|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22265406|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com|
22265407|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
22265408|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
22265409|NCT01524679|IZKS of the University Medical Center of the Johannes Gutenberg University Mainz|Christian Ruckes|+49 6131 17|ruckes@izks-mainz.de|9919
22265410|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com|
22265411|NCT03801265|University of Pittsburgh|Sharad Khetarpal, MD|4126235020|khetarpalsk@upmc.edu|
22265412|NCT04078126|AstraZeneca AB|AstraZeneca AB|877-240-9479|information.center@astrazeneca.com|1
22265413|NCT03056157|VA Boston Healthcare System|Dr. Brett Litz|(617)5849314|brett.litz@va.gov, litzb@bu.edu|
22265414|NCT03321630|NYU Langone Health|Paul Oberstein|2127316120|paul.oberstein@nyulangone.org|
22265415|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org|
22265416|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265417|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org|
22265418|NCT04168190|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276208|NCT02696616|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265419|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com|
22265420|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu|
22308629|NCT04956861|University of Colorado|Christopher DeSouza Ph.D.|303-492-2988|desouzac@colorado.edu|
22308630|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
22308631|NCT03070184|The University of Alabama at Birmingham|Nehal Vekariya, MS - Clinical Research Coordinator III|2059347173|nvekariya@uabmc.edu|
22308632|NCT05097430|Centre for Addiction and Mental Health (CAMH)|Dr. Paul Shuper|416-535-8501|paul.shuper@camh.ca|34097
22308633|NCT05862870|UConn Health|Mark D. Litt, PhD|860-679-4680|Litt@uchc.edu|
22308634|NCT04080531|Emory University|Craig C. Hofmeister, MD, MPH|404-778-0519|craig.hofmeister@emory.edu|
22308635|NCT02543281|Cleveland Clinic, Lerner Research Institute|Larisa Tereshchenko|2164442445|tereshl@ccf.org|
22308636|NCT03143153|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22308637|NCT05448651|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|917-499-0789|sumathi.sivapalasingam@upstreambio.com|
22308638|NCT02736409|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22308639|NCT01415154|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
22308640|NCT02038569|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22308641|NCT02891096|Swiss Paraplegic Research|Dr Gabi Mueller|+41419395563|gabi.mueller@paraplegie.ch|
22308642|NCT00170573|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
22308643|NCT03972813|University of Michigan|Abram Wagner|7347632330|awag@umich.edu|
22308644|NCT03498651|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
22308645|NCT03763708|Medtronic Neuromodulation|SCS Research Study Team|800-633-8766|rs.scsresearch@medtronic.com|
22308646|NCT05200247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308647|NCT04951492|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
22308648|NCT03332017|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22308649|NCT05134636|University of Pennsylvania|Ronac Mamtani|215-662-7606|ronac.mamtani@pennmedicine.upenn.edu|
22308650|NCT05165108|IndianaU|Thomas Nowak, MD|3179484272|tvnowak@iu.edu|
22308651|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22308652|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308653|NCT02682342|Medical College of Wisconsin|Michael E. Widlansky, MD|414-955-6708|mwidlans@mcw.edu|
22308654|NCT04302493|Johns Hopkins School of Medicine|Elisabeth B. Marsh, MD|410-550-8703|ebmarsh@jhmi.edu|
22308655|NCT02243709|Brown University|Prof. Carolina Haass-Koffler|4155191385|carolina_haass-koffler@brown.edu|
22308656|NCT04750473|Emory University/Winship Cancer Institute|Dr. David Schuster|404-712-4859|dschust@emory.edu|
22308657|NCT05178316|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22308658|NCT04347161|University of Pennsylvania|Katharine A Rendle, PhD,MSW,MPH|215-349-5442|Katharine.Rendle@pennmedicine.upenn.edu|
22308659|NCT04610892|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22308660|NCT01413100|Fred Hutchinson Cancer Center|Dr. Leona Holmberg|206-667-6447|lholmb@fredhutch.org|
22308661|NCT05369403|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22308662|NCT03792256|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22308663|NCT02203552|The Ohio State University Comprehensive Cancer Center|Dr. Bhuvaneswari Ramaswamy|614-293-7484|Bhuvaneswari.Ramaswamy@osumc.edu|
22308664|NCT01748448|UZLeuven|Prof. Dr. M. Garmyn|0032 16 33 79 50|marjan.garmyn@uzleuven.be|
22308665|NCT02226276|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22308666|NCT03562377|LEO Pharma A/S|Disclosure|+45|disclosure@leo-pharma.com|44945888
22308667|NCT04562649|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
22308668|NCT05368103|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22308669|NCT05817708|Senhwa Biosciences, Inc.|Gina Huang|+886-2-89119856|ginahuang@senhwabio.com|111
22308670|NCT04650087|Duke University Medical Center|Dr. Thomas Ortel|919-684-5350|thomas.ortel@duke.edu|3
22308671|NCT03001414|Northern Therapeutics, Inc.|Duncan Stewart, Clinical Trial Medical Consultant|613-737-8899|djstewart@toh.ca|76686
22308672|NCT03272373|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
22308673|NCT04663087|University of Alabama at Birmingham|Dr. Jan Jansen|205-975-3030|jjansen@uabmc.edu|
22308674|NCT03818711|Vanderbilt University Medical Center|Senior ClinicalTrials.gov Administrator|615-322-3581|natalie.dilts@vumc.org|
22308675|NCT02913872|University of Leicester|Dr Erol Gaillard|+44116 252 3261|eag15@le.ac.uk|
22308676|NCT03920111|University of Liverpool|Dr Lance Turtle|01517957554|lance.turtle@liverpool.ac.uk|
22308677|NCT05177848|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|(540)526-2106|rflemos@vtc.vt.edu|
22308678|NCT06414213|Appalachian State University|Dr. Jared Skinner|828-262-2512|skinnerjw@appstate.edu|
22308679|NCT03720795|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
22308680|NCT05386758|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22308681|NCT01573442|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-4565|cloprinzi@mayo.edu|
22308682|NCT03649659|University of Michigan|Dr. Margherita Fontana|734-763-3988|mfontan@umich.edu|
22308683|NCT04763265|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
22308684|NCT04510974|James J Peters VA Medical Center|Dr. Caitlyn Peters|9733243588|cpeters@kesslerfoundation.org|
22308685|NCT04418466|Delpor, Inc.|Eesha Gupta|415-289-1770|eesha.gupta@delpor.com|
22308686|NCT05908344|The Pennsylvania State University|Dr. Anne-Marie Chang|814-863-5226|amchang@psu.edu|
22308687|NCT05590312|Düzce University Faculty of Medicine|Assistant Professor Özlem Ersoy Karka|+905337293978|drozlemersoy@gmail.com|
22265421|NCT04765384|Janssen Vaccines & Prevention B.V.|Vice President Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265422|NCT00987389|McMaster University, Hamilton, Ontario|Dr. Michael Walsh|905-522-1155|lastwalsh1975@gmail.com|34055
22265423|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22265424|NCT02992418|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22265425|NCT00289536|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22265426|NCT03246126|NYU Langone Health|Thomas Maldonado|212-263-7311|Thomas.Maldonado@nyulangone.org|
22265427|NCT02468570|BioMarin Pharmaceutical Inc.|Karen Gu/Director, BioStatistics|650-829-4017|kgu@bmrn.com|
22265428|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265429|NCT05297578|Vaxcyte|Vice President of Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
22265430|NCT03127644|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22265431|NCT04972123|University of Wisconsin - Madison Cardiovascular Medicine|Mohamed H. Hamdan, MD, MBA|608-263-4856|mhamdan@medicine.wisc.edu|
22265432|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099|dan@b-alert.com|x6040
22265433|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu|
22265434|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com|
22265435|NCT00928707|Italfarmaco SpA|Carlo Bianchini, MD|+39 02 6443 2540|c.bianchini@italfarmaco.com|
22265436|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623||
22265437|NCT02140411|Novartis Pharmaceuticals|Study Director|862-778-1873||
22265438|NCT03584724|Eye Pharma|Elena Meloni|7862187339|elena.meloni@eyepharma.com|
22265439|NCT03981419|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22308688|NCT05308004|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
22308689|NCT04267172|Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford.|Professor Jonathan Rees|01865737540|jonathan.rees@ndorms.ox.ac.uk|
22308690|NCT04552223|University of Miami|Jose Lutzky MD|+1 (305) 6896500|jose.lutzky@med.miami.edu|
22308691|NCT04856163|RAND|Dr. Lori Uscher-Pines|703-413-1100|luscherp@rand.org|
22308692|NCT04406441|Geisinger Health System|Dr. Lisa Bailey-Davis|570-214-9625|ldbaileydavis@geisinger.edu|
22308693|NCT05816551|Institute for Exercise and Environmental Medicine|Craig Crandall, PhD, Primary Investigator|214-345-4623|craigcrandall@texashealth.org|
22308694|NCT04353661|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22308695|NCT03973320|Hospital for Special Surgery, Anesthesiology|Dr. Jiabin Liu|2126061036|liuji@hss.edu|
22308696|NCT02111798|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
22308697|NCT04363515|Hennepin Healthcare Research Institute|Dr. Allyson Hart|612-873-6998|allyson.hart@hcmed.org|
22308698|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de|
22308699|NCT05247489|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22308700|NCT03126019|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22308701|NCT05551195|Woebot Health|Kate Martin|(415) 209-5642|kate@woebothealth.com|
22308702|NCT05722704|Gulf Medical University|Dr. Rania Zaarour|+971 6 7431333|dr.rania@gmu.ac.ae|4184
22308703|NCT06069713|Wake Forest University Health Sciences|Olivia Horton MSW, MPH|000.000.0000|ohorton@wakehealth.edu|
22308704|NCT04323137|Geisinger Health|Amir Goren, PhD|570-214-4395|agoren@geisinger.edu|
22308705|NCT05563246|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22308706|NCT05215314|University of Wisconsin-Madison|Daniel Grupe|608-263-7572|grupe@wisc.edu|
22308707|NCT04179500|TB Alliance|Antonio Lombardi|917-601-0024|Antonio.Lombardi-Consultant@tballiance.org|
22308708|NCT03138512|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22308709|NCT04682106|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22308710|NCT05470517|Johns Hopkins All Children's Hospital|Nicole M. Chandler, MD|727-767-4170|nicole.chandler@jhmi.edu|
22308711|NCT04106583|Penumbra, Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
22308712|NCT03992274|Columbia University|Kathrine Meyers, DrPH, MPP, MSc|2123046110|kam2157@cumc.columbia.edu|
22308713|NCT06064955|Ohio State University|Karen O. Moss|(614) 688-3100|Moss.391@osu.edu|
22308714|NCT04005716|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22308715|NCT02783300|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308716|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
22308717|NCT04511286|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
22308718|NCT03378570|University of Iowa Hospitals & Clinics|Dr. Nicholas Trapp|(319) 467-8188|nicholas-trapp@uiowa.edu|
22308719|NCT04241068|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22308720|NCT03843151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22308721|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com|
22308722|NCT03443323|Children's Hospital of Philadelphia|Dr. Thomas J. Power|215-590-7447|power@chop.edu|
22308723|NCT03151616|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22308724|NCT05391893|SpectrumLakeland|Rachelle Pichot; Clinical Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
22308725|NCT04492007|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan PhD|919-966-8450|xianming@email.unc.edu|
22308726|NCT03463824|Virginia Commonwealth University|Dr. James Thomas|740-591-1563|jthomas32@vcu.edu|
22265440|NCT01330459|Oregon Health and Science University|Alison Edelman, MD, Assistant Professor|(503) 494-3666|edelmana@ohsu.edu|
22265441|NCT03562559|Vancouver General Hospital|Marcus Tholin|604-875-4111|marcus.tholin@vch.ca|
22321723|NCT02432235|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22321724|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22321725|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
22321726|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr|
22321727|NCT02500628|Woodinville Psychiatric Associates|Jon Berner MD PhD|425-481-0429|jonbernermd@gmail.com|
22321728|NCT01471457|University of New Mexico|Kate Meriwether|5052495967|meriwet2@salud.unm.edu|
22321729|NCT04352439|Duke University|Dr. Brittany Davidson|+1 919 684 0188|brittany.davidson@duke.edu|
22321730|NCT02228590|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|clinicaltrialdisclosure@sunovion.com|
22321731|NCT02111993|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
22321732|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
22321733|NCT04074928|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22321734|NCT05182554|MIT|LISA HO|5106505455|lisaho@mit.edu|
22321735|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22321736|NCT02185404|University of South Florida|Kyle B. Reed|813-974-2385|kylereed@usf.edu|
22321737|NCT01505634|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321738|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22321739|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu|
22321740|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu|
22321741|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321742|NCT04249687|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
22321743|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22321744|NCT04472429|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22321745|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22321746|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu|
22321747|NCT03461757|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22321748|NCT03861559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321749|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320|kpalma@piedmontpharma.com|202
22321750|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com|
22321751|NCT02500121|Hoosier Cancer Research Network|Clinical Trials Results Coordinator|317-634-5842|aneal@hoosiercancer.org|21
22321752|NCT03730116|Sevier|Mrdical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|1389
22321753|NCT00106171|Johns Hopkins University|Dr. Joseph Margolick|410-955-1436|jmargoli@jhsph.edu|
22321754|NCT01836783|University of Alabama at Birmingham|Maninder Kaur, BDS, MPH, MS, Principal Investigator|205-9344506|maninder@uab.edu|
22321755|NCT04011280|Pacific Treatment and Research Center|Dr. Benjamin McKenna|858-534-8817|bmckenna@health.ucsd.edu|
22321756|NCT04942925|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22321757|NCT03649061|UZLeuven|Prof. Dr. Patrick Verschueren|+3216342541|patrick.verschueren@uzleuven.be|
22321758|NCT03221738|Massachusetts General Hospital|Anna Schwartzberg|617-724-7161|aschwartzberg@mgh.harvard.edu|
22321759|NCT02124564|Cares|UCB|+1844599|UCBCares@ucb.comTokyo|2273
22321760|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321761|NCT04489888|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321762|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626|juan.figueroa@ttuhsc.edu|235
22321763|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int|
22321764|NCT02380716|W. L. Gore & Associates|Greg Miller|623-234-5910|gmiller@wlgore.com|
22321765|NCT02867995|Boston Medical Center|Dr. Manishi Desai|671-414-8806|Manishi.Desai@bmc.org|
22321766|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn|
22321767|NCT06706245|Brown University Health|Joshua Kemp, Assistant Professor|4014321466|joshua_kemp@brown.edu|
22321768|NCT04999267|Duke University - Duke Human Vaccine Institute|Chip Walter|919 620 5346|chip.walter@duke.edu|
22321769|NCT05131204|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22321770|NCT04373369|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5817|danielmorgensztern@wustl.edu|
22321771|NCT02469090|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22321772|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
22321773|NCT00539695|Texas Children's Hospital|Dr. Rayne Rouce|832-824-4716|rouce@bcm.edu|
22321774|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu|
22321775|NCT03823391|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22321776|NCT05882318|Valencia Technologies|Dylan Beyer|+1 (661) 775-1414|dbeyer@valenciatechnologies.com|
22321777|NCT05030311|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22321778|NCT03042468|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
22321779|NCT01485627|UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE|Ronald Epstein MD|5855069484|ronald_epstein@urmc.rochester.edu|
22321780|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321781|NCT06117319|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22321782|NCT00290433|The University of Texas (UT) MD Anderson Cancer Center|Christopher Flowers/Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
22265442|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
22265443|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org|
22265444|NCT02623348|University of California, San Francisco|Anoop Sheshadri|415-221-4810|anoop.sheshadri@ucsf.edu|22576
22265445|NCT02272634|Yungjin Pharm. Co., Ltd.|Director of Clinical Trials|82-2-2041-8318|mhlee2017@yungjin.co.kr|
22265446|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org|
22265447|NCT04647721|Merz Aesthetics|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22265448|NCT04380090|Cleveland Clinic Lutheran Hospital|Kathleen Gonzalez|2162174226|gonzalk2@ccf.org|
22265449|NCT01974440|Janssen Research & Development, LLC|Executive Medial Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265450|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de|
22265451|NCT02005887|International Breast Cancer Study Group|Meredith M. Regan|+1 617-632-3012|mregan@jimmy.harvard.edu|
22265452|NCT02684201|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1077|lef44@pitt.edu|
22265453|NCT02749292|Massachusetts General Hospital- Vasculitis and Glomerulonephritis Center|John L Niles|617-726-4132|JLNILES@mgh.harvard.edu|
22265454|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265455|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265456|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu|
22265457|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265458|NCT03629028|Principal investigator of the research|Şafak Yılmaz Baran, MD|+903224586868|safakyilmazbaran@gmail.com|
22265459|NCT03323723|Rinovum Subsidiary 2, LLC.|Clinical Development Manager|7242418932|hwhitelam@rinovum.com|
22265460|NCT03828448|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22265461|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22265462|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265463|NCT03123861|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
22265464|NCT03935464|University of California San Francisco|Dr. Monica Gandhi|415 260 6709|monica.gandhi@ucsf.edu|
22265465|NCT05011123|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22265466|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de|
22265467|NCT01933113|Allegheny Health Network|Donald Whiting, MD|412-359-6200|donald.whiting@ahn.org|
22265468|NCT02297438|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265469|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22265470|NCT00915928|Odense University Hospital, Odense, Denmark|Frantz Rom Poulsen, Professor, consultant|0045 65413600|frantz.r.poulsen@rsyd.dk|
22265471|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org|
22265472|NCT00937378|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22265473|NCT02440022|Becton Dickinson (BD)|Heidi Ronhovde|480-597-8579|Heidi.Ronhovde@bd.com|
22265474|NCT03758404|MeiraGTx|Program Manager|020 3866 4320|CNGA3@meiragtx.com|
22265475|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu|
22265476|NCT02358343|Center for Biomedical Statistics, University of Washington|Tessa Rue, Biostatistician|206-543-4246|ruet@uw.edu|
22265477|NCT00281671|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, MD MPH|312 227 1551|jmcostello@luriechildrens.org|
22265478|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22265479|NCT04322149|Eledon Pharmaceuticals|Laura Batterman|949-874-3487|lbatterman@eledon.com|
22265480|NCT02135653|University of Pennsylvania|Dr. Neha Vapiwala|(215) 662-2337|Neha.Vapiwala@pennmedicine.upenn.edu|
22265481|NCT01700049|Mayo Clinic|Dr. Scott Fosko|904-953-2303|fosko.scott@mayo.edu|
22265482|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265483|NCT03402555|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
22265484|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in|
22265485|NCT03084367|Philips (Volcano)|Becky Inderbitzen, Global Director, Clinical Development|+1.858.764.1336|becky.inderbitzen@philips.com|
22265486|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22265487|NCT00569530|University of California, San Francisco|Roberta R. Keller, MD|415-514-3192|roberta.keller@ucsf.edu|
22265488|NCT05339334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265489|NCT02358135|Keck School of Medicine of University of Southern California|April W. Armstrong, MD, MPH; Associate Dean of Clinical Research|323-865-3871|april.armstrong@med.usc.edu|
22265490|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343||
22265491|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22265492|NCT00912093|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22265493|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu|
22265494|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22265495|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org|
22265496|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com|
22265497|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu|
22265498|NCT03300544|M D Anderson Cancer Center|Arvind Dasari|(713) 792-2828|adasari@mdanderson.org|
22265499|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com|
22276209|NCT03086343|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22321783|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org|
22321784|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
22321785|NCT02264990|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22276210|NCT04900272|Northwestern University Feinberg School of Medicine|Katherine O'Brien|314-747-5361|obrien.k@wustl.edu|
22321786|NCT04749459|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22321787|NCT03031301|Vibrantgastro|clinical trial manager|046663322|service@vibrantgastro.com|
22321788|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321789|NCT03326843|Dova Pharmaceuticals|Associate Director, Clinical Operations|919-338-7864|clinical@dova.com|
22321790|NCT03824808|University of Missouri|Dr Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
22321791|NCT02275338|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22321792|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22321793|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com|
22321794|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800|bcoleman@mtsinai.on.ca|4538
22321795|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu|
22321796|NCT03603496|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-3548|nrigotti@partners.org|
22321797|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
22321798|NCT04639583|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
22321799|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22321800|NCT03594227|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22321801|NCT03389854|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
22321802|NCT00109707|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22321803|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22321804|NCT00586209|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
22321805|NCT02018627|Massachusetts General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22321806|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22321807|NCT01179009|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
22321808|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590||
22321809|NCT02937818|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22321810|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com|
22321811|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com|
22321812|NCT02249143|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
22321813|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com|
22321814|NCT03028870|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
22321815|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
22321816|NCT01967537|Principal Investigator|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22321817|NCT03124771|Masimo|Tala Harake||studies@masimo.com|
22321818|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com|
22321819|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu|
22321820|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil|402-552-6005|ckratoch@unmc.ed|
22321821|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov|
22321822|NCT00456989|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|ctobcc@louisville.edu|
22321823|NCT03829657|Theravance Biopharma Ireland Limited|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
22321824|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
22276211|NCT01716195|University of California Davis|Dr. Megan Daly|916-734-5428|medaly@ucdavis.edu|
22276212|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300||
22276213|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22276214|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com|
22276215|NCT01970371|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
22321825|NCT02159703|University of Pennsylvania|Alexander Lin, MD|(215) 662-3198|alexander.lin@uphs.upenn.edu|
22321826|NCT04418076|Associate Director Domestic Projects|Natalie Kil|203.737.2883|natalie.kil@yale.edu|
22276216|NCT01481779|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276217|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au|
22276218|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu|
22321827|NCT02549209|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
22321828|NCT01344876|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
22321829|NCT05107765|The University of Texas Health Science Center of Houston|Jin H Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
22276219|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321830|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321831|NCT04527185|Yale School of Medicine|Terril Verplaetse|203-737-6496|terril.verplaetse@yale.edu|
22321832|NCT03368170|Integrative Research Laboratories AB|Joakim Tedroff/Chief Medical Officer|+ 46 707 601691|joakim.tedroff@irlab.se|
22321833|NCT03047980|Kennedy Krieger Institute|Research Assistant|443-923-9569|vedmurthyp@kennedykrieger.org|3-9569
22321834|NCT02164981|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
22321835|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22321836|NCT01761266|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22321837|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22321838|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012||
22321839|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu|
22294845|NCT02430311|Astrazeneca|Gershon Locker|+1 773 868 0184|Gershon.Locker@astrazeneca.com|
22276220|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
22276221|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22276222|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com|
22276223|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|wallacea@anesthesia.ucsf.edu|3732
22276224|NCT04398134|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
22276225|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu|
22276226|NCT04882800|Sonova US|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
22321840|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22321841|NCT01975922|Vanderbilt University|Ann Kaiser|615-322-8163|ann.kaiser@vanderbilt.edu|
22321842|NCT03257267|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22321843|NCT03445000|ETOP IBCSG Partners Foundation|Heidi Roschitzki-Voser|+41 31 511 94 00|ALERT-lung@etop.ibcsg.org|
22276227|NCT03093844|University of Colorado|Dr. Jonathan Gutman|303-724-9562|JONATHAN.GUTMAN@CUANSCHUTZ.EDU|
22276228|NCT04225039|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22276229|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu|
22276230|NCT01964404|Dartmouth Hitchcock|Dr. Mary F. Brunette|603-646-7019|Mary.F.Brunette@Hitchcock.org|
22276231|NCT04046471|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-1687|jdonnelly2@kumc.edu|
22276232|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org|
22276233|NCT06239610|Parkview Health System|Jan Powers PhD, RN, CCNS, CCRN, CNRN, NE-BC, FCCM|260-266-7761|jan.powers@parkview.com|
22276234|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org|
22276235|NCT02830087|Wake Forest University Health Sciences|Maxwell Langfit, MD||mlangfit@wakehealth.edu|
22276236|NCT02916771|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@DFCI.Harvard.edu|
22276237|NCT02337686|UT MD Anderson Cancer Center|Dr. Vinaykumar Puduvalli, MD-Chair, Neuro-Oncology|(713) 745-2343|vpuduval@mdanderson.org|
22276238|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276239|NCT05977868|West Virginia University|Dr. Joy J. Juskowich|304-293-3306|jjuskowi@hsc.wvu.edu|3
22276240|NCT00876395|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22276241|NCT04385888|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
22276242|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org|
22276243|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu|
22276244|NCT01199614|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
22276245|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22276246|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu|
22276247|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com|
22276248|NCT02536794|Northwestern University|Ami Shah, MD|312 503 5488|amishah@northwestern.edu|
22276249|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22276250|NCT01201863|Craig Hospital|Don Gerber, PsyD|303-789-8478|dgerber@craighospital.org|
22276251|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276252|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276253|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
22276254|NCT03439514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276255|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070|j.w.c.alffenaar@umcg.nl|40378
22276256|NCT03418675|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
22276257|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22276258|NCT02447029|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22276259|NCT03802110|Boston Scientific Cardiac Rhythm Management|Stephen J. Hahn, PhD|1-800-227-3422|stephen.hahn@bsci.com|
22294846|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com|
22294847|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu|
22321844|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22276260|NCT06420232|University of Texas Medical Branch, Galveston|Heather Celkis, OTR, PPOTD|409-|hdcelkis@UTMB.EDU|
22294848|NCT02113592|Kaiser Permanente Washington Health Research Institute|Lynn DeBar, PhD, MPH, Principal Investigator|206-287-2900|lynn.debar@kp.org|
22321845|NCT03409744|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22321846|NCT04872101|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22321847|NCT05804877|Chung Shan Medical University|Dr. Yun-Ling Chen|+886958226869|yunling.annie@gmail.com|
22321848|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22321849|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22294849|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22321850|NCT02475681|Acerta Clinical Trials|Study Director|18882929613|acertamc@dlss.com|
22321851|NCT02323698|Spaulding Rehabilitation Hospital|Dr. Randy D Trumbower, PI|(617) 952-6953|randy.trumbower@mgh.harvard.edu|
22321852|NCT01262365|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22294850|NCT03684811|Forma Therapeutics, Inc.|Medical Affairs|(617) 679-1970|medicalinformation@formatherapeutics.com|
22294851|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22294852|NCT03848650|Columbia University|Manish Parikh, MD|212-326-8532|map2224@cumc.columbia.edu|
22294853|NCT02950025|Washington University School of Medicine|Michael C. Roach, M.D.|314-747-1786|roachm@wustl.edu|
22294854|NCT00869206|Christiana Care Health System|Andrew L. Himelstein, MD|(302) 366-1200|ahimelstein@cbg.org|
22294855|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22294856|NCT04016285|University of Kentucky Department of Orthopaedic Surgery & Sports Medicine|Dr. Stephen Duncan|859-218-3084|stephen.duncan@uky.edu|
22294857|NCT03462082|University of Rochester|Karlo J Lizarraga, MD, MS / Assistant Professor of Neurology|585-341-7500|karlo.lizarraga@gmail.com|
22294858|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu|
22294859|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu|
22294860|NCT03729960|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
22294861|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
22294862|NCT02708121|Department of Health Education and Behavior, College of Health and Human Performance, University of Florida|Dr. Megan McVay|(352)294-7029|megan.mcvay@ufl.edu|
22294863|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org|
22294864|NCT03266107|Relievant Medsystems Inc.|VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|280
22294865|NCT01898611|University of Pennsylvania|Anne Cappola, MD|215-573-5359|acappola@mail.med.upenn.edu|
22294866|NCT02548650|University of Florida College of Medicine - Jacksonville|Dominick J Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
22294867|NCT01191801|Sunesis Pharmaceuticals, Inc|Judy Fox, Chief Scientific Officer|(650) 266-3736|jfox@sunesis.com|
22294868|NCT04394286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22294869|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de|
22294870|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22294871|NCT03018704|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
22294872|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294873|NCT01110434|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
22294874|NCT04448171|Mayo Clinic|John Occhino, M.D., M.S.|507-538-5883|Occhino.John@mayo.edu|
22294875|NCT02088047|University of Arkansas for Medical Sciences|Betholyn Gentry|(501) 603-1010|bfgenry@uams.edu|
22294876|NCT01667029|Massachusetts General Hospital|Dr. Brian Wainger|617-726-8810|Brian.Wainger@mgh.harvard.edu|
22294877|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu|
22294878|NCT01417234|KCI|VP, Global Clinical Development|12102555595|jane.hart@acelity.com|
22294879|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
22294880|NCT01537393|CaseWestern|Dr. Jonathan Lass|2168448368|Jonathan.Lass@UHhospitals.org|
22294881|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22294882|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu|
22294883|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294884|NCT01891695|University of Virginia|Paul Read, MD|434-924-5191|pwr3u@hscmail.mcc.virginia.edu|
22294885|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn|
22294886|NCT01197560|Celgene|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22294887|NCT00585247|University of Ccalifornia, Irvine. Beckman Laser Institute|Dr. Kristen Kelly|949.824.7997|kmkelly@uci.edu|
22294888|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com|
22294889|NCT01487200|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22294890|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300||
22294891|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22294892|NCT03791489|Stryker ENT|Pr. Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22294893|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com|
22321853|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294894|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org|
22294895|NCT02521870|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
22294896|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22294897|NCT04051008|SUNY Buffalo|Stephanie Anzman-Frasca|17168296692|safrasca@buffalo.edu|
22321854|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu|
22321855|NCT03126760|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22321856|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu|
22321857|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321858|NCT02605642|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321859|NCT02762513|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
22321860|NCT02165384|Preceptis Medical|CEO|6123274795|steve@preceptismedical.com|
22321861|NCT02111564|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22321862|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22321863|NCT03438045|NYU Grossman School of Medicine|Mary E. Northridge, PhD, MPH, Director of Dental Research|(347) 377-4342|Mary.Northridge@nyulangone.org|
22321864|NCT05362526|University of Florida|Ashleigh Wehy, MD|9042449440|amweyh@gmail.com|
22321865|NCT01707472|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22321866|NCT03522324|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|lcb@colorado.edu|
22321867|NCT03704194|Washington university in St.louis|Brittany Minor|314-273-4118|bminor@wustl.edu|
22321868|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321869|NCT02396732|University of Miami|Kenneth Proctor|305-585-1178|kproctor@med.miami.edu|
22321870|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov|
22321871|NCT04986202|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22321872|NCT03340610|Southeast Retina Center|Dr. Dennis Marcus|706650061|dmarcus@southeastretina.com|
22321873|NCT02698735|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
22321874|NCT05526833|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
22321875|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org|
22321876|NCT03806127|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22321877|NCT02163434|University at Buffalo|Dr. Thomas Guttuso, Jr.|7169326080|tguttuso@gmail.com|
22321878|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com|
22321879|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
22321880|NCT05726318|University of Pittsburgh|Megan Bradley, MD|412-641-3189|bradleym4@upmc.edu|
22321881|NCT04302727|University of North Carolina at Chapel Hill|Thomas Keyserling, MD|984-974-4462|thomas_keyserling@med.unc.edu|
22321882|NCT05980299|Miami University|Dr. Katherine Abbott|513-529-0869|abbottkm@miamioh.edu|
22321883|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br|
22321884|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu|
22321885|NCT02128230|University of Arkansas for Medical Sciences|Frits Van Rhee, MD|501-526-2873|vanrheefrits@uams.edu|
22321886|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321887|NCT01662895|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-63208913|mselim@bidmc.harvard.edu|
22321888|NCT01441063|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
22321889|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22321890|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
22321891|NCT02482675|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22321892|NCT04668352|Adicet Bio|Nick Harvey|857-315-5528|nharvey@adicetbio.com|
22321893|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com|
22321894|NCT01888640|University of Iowa|Dr. Kathleen A. Sluka|319-335-9791|kathleen-sluka@uiowa.edu|
22276261|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276262|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590||
22276263|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311||
22276264|NCT05075200|Sunnybrook Health Sciences Centre|Dr. Angela Jerath|416-480-4864|angela.jerath@sunnybrook.ca|
22276265|NCT02903914|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
22321895|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
22321896|NCT00684788|Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22321897|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22321898|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
22321899|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za|
22321900|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com|
22321901|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22321902|NCT03496428|Implantology Institute|Prof. Dr. Duarte Marques|+351217 210 980|d.marques@institutoimplantologia.com|
22321903|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu|
22321904|NCT01294579|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22321905|NCT02788747|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
22321906|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996|nodari@med.unibs.it|587
22321907|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321908|NCT00784654|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22276266|NCT04443452|University of Nottingham|Professor Ana Valdes|0115823114|ana.valdes@nottingham.ac.uk|
22276267|NCT03487445|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
22276268|NCT01963234|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
22276269|NCT00373672|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
22276270|NCT04132050|Kissei Pharmaceutical Co., Ltd.|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
22276271|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200|loyulun@hotmail.com|5108
22276272|NCT06480032|Rehman Medical Institute|Dr.Iftikhar qayum|+92 91 5838 333|iftikhar.qayum@rmi.edu.pk|4708
22276273|NCT04336943|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
22276274|NCT02406612|Essential Medical|Sam Nardone|6105571009|sam@essmedclosure.com|
22276275|NCT03424148|Cutera|Margout Doucette|415-656-9612|mdoucette@cutera.com|
22276276|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov|
22276277|NCT03483012|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22276278|NCT02900976|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22276279|NCT03884374|University of Florida|Eric Weber|352-273-7802|ebweber@ufl.edu|
22276280|NCT05708924|Masonic Cancer Center|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
22276281|NCT03611946|Johns Hopkins CIR|Dr Anna Durbin|410-955-7283|adurbin1@jhu.edu|
22276282|NCT03496129|University of Louisville|Dr. Martha Bickford|502-852-3527|martha.bickford@louisville.edu|
22276283|NCT02872714|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22276284|NCT06717399|Saint Joseph's University|Nabila Enam|2155967348|nenam@sju.edu|
22276285|NCT03043573|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
22276286|NCT03580928|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
22276287|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu|
22276288|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
22276289|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com|
22276290|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu|
22276291|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088||
22276292|NCT01797185|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
22276293|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22276294|NCT01115231|Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA|Baerbel Rohrer, PhD; VA Research Scientist|843-792-5086|rohrer@musc.edu|
22276295|NCT03071744|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
22276296|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
22276297|NCT02115386|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22276298|NCT02493855|AbbVie|Global Medical Services|800-633-9110||
22276299|NCT02299167|Dammam University|Roshdi R. Al-Metwalli|+966 50 289 3485|rmetwalli@iau.edu.sa|
22276300|NCT03600428|Vanderbilt University Medical Center|C. Buddy Creech, MD, MPH|6153430332|buddy.creech@vumc.org|
22276301|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276302|NCT02162433|Massachusetts Eye and Ear|Dr. Makara Cayer|617-573-3380|makara_cayer@meei.harvard.edu|
22276303|NCT06540170|National Healthcare Group Polyclinics|Senior Wound Nurse Clinician|64966611|julia_zhu@nhgp.com.sg|
22276304|NCT04868682|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 891-7711|cathy.alessi@va.gov|39311
22276305|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu|
22276306|NCT03880565|University of Minnesota|Demetri Yannopoulos, MD|612-626-2935|yanno001@umn.edu|
22276307|NCT02202616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22276308|NCT04803279|Oticon Medical|Nicole Amichetti, PhD, MS, Manager of Clinical Affairs|6093660424|nitc@oticonmedical.com|
22276309|NCT04327271|University of Washington|Caryl Feldacker|+1-314-600-6743|cfeld@uw.edu|
22276310|NCT05142774|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22308727|NCT04229992|Vanderbilt University Medical Center|Dr. Martha Shrubsole, Dr. Qi Dai|(615)936-0707|Martha.shrubsole@vanderbilt.edu, qi.dai@vanderbilt.edu|
22308728|NCT03770273|National Institute of Allergy and Infectious Diseases|Hirsh Komarow|+1 301 594 2197|komarowh@niaid.nih.gov|
22308729|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22308730|NCT04169373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22308731|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com|
22308732|NCT03907397|Icahn School of Medicine at Mount Sinai|Dr. Scott Sicherer|212-241-5548|scott.sicherer@mssm.edu|
22308733|NCT04760678|Insitute of Tropical Medicine|Carolien Hoof|0470102562|choof@itg.be|
22308734|NCT05570175|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
22308735|NCT01458782|University Hospital North Norway|Dr.Ann Kristin Hansen|+4777669763|ann.kristin.hansen@unn.no|
22308736|NCT04864691|Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.|Feng Gao|13581936066|gaofengletter@sina.com|
22308737|NCT03675282|Weill Cornell Medicine|Carly Skudin; Research Program Manager|212-746-2003|cas4010@med.cornell.edu|
22308738|NCT03427580|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
22308739|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com|
22308740|NCT03232138|University of Pittsburgh Cancer Institute|Jian-Min Yuan M.D., Ph.D.|412-864-7889|yuanj@upmc.edu|
22276311|NCT02320175|Boston Children's Hospital|Isabella Liss, Patient and Family Centered I-PASS SCORE Study Coordinator|857-218-3229|isabella.liss@childrens.harvard.edu|
22276312|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22265500|NCT01593696|National Cancer Institute|Dr. Nirali N. Shah|240-760-6199|shahnn@nih.gov|
22265501|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu|
22265502|NCT04049617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22265503|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22265504|NCT03402750|University of Miami|Brian McCabe|305-248-1530|bmccabe@miami.edu|
22265505|NCT02981303|HiberCell|Chief Medical Officer|651.675.0300|CMO@hibercell.com|
22265506|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265507|NCT02701413|Northwestern University|Dr. Christina Lewicky-Gaupp|312-472-3874|christina.lewickygaupp@nm.org|
22265508|NCT02138136|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-556-3314|clinicaltrials@mnk.com|
22265509|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu|
22265510|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265511|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265512|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331|daniel.santamina@guelphhumber.ca|6065
22265513|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265514|NCT03003949|University of North Carolina at Chapel Hill|Susan Girdler, PhD|919-590-0813|rachel_kozik@med.unc.edu|
22265515|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22265516|NCT02205983|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
22265517|NCT01640873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265518|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
22265519|NCT02458092|US Army Medical Research Unit - Kenya|Nekoye Otsyula|254-722-239-828|notsyula@wrp-ksm.org|
22265520|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr|
22265521|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
22265522|NCT03431974|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
22265523|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com|
22265524|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265525|NCT03329079|University of Nebraska Medical Center|Kevin Kupzyk|402-552-7262|kkupzyk@unmc.edu|
22265526|NCT02494102|Penn State Health Milton S. Hershey Medical Center|Zyad J. Carr, M.D., FASA|717-531-8521|zcarr@pennstatehealth.psu.edu|
22265527|NCT05069155|University of Pennsylvania|Clinical research coordinator|7574471579|aileen.oon@pennmedicine.upenn.edu|
22265528|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu|
22265529|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265530|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu|
22265531|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632|winnieyeo@cuhk.edu.hk|2118
22265532|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265533|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu|
22265534|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com|
22265535|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265536|NCT03407430|University of North Carolina Medical Center|Dr. Benyam Muluneh|919-966-3213|benyam.muluneh@unchealth.unc.edu|
22265537|NCT03218163|SKCCC|Dr. Philip Imus|4109558873|pimus1@jhmi.edu|
22265538|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265539|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22265540|NCT05882279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22265541|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu|
22265542|NCT03083821|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22265543|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu|
22265544|NCT05742347|Medline Industries, LP|Julie J. Finley|(800) 33-5463|jjfinely@medline.com|
22265545|NCT04221789|IECS|Dr Fernando Rubinstein|01147778767|frubinstein@iecs.org.ar|
22265546|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org|
22265547|NCT04394351|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22265548|NCT03653507|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22265549|NCT05205772|University of North Carolina at Chapel Hill|Miriam Sklerov, MD, MS|984-974-4401|miri@email.unc.edu|
22265550|NCT01288053|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
22265551|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22265552|NCT03696953|Marquette University, College of Nursing|Dr. Lisa Hanson|1-414-288-3841|lisa.hanson@marquette.edu|
22265553|NCT03502707|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265554|NCT04092894|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|7814750572|bsubrama@bidmc.harvard.edu|
22265555|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
22265556|NCT02935686|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22308741|NCT03992339|Antengene Corporation|Yumei Tang|18301318100|yumei.tang@antengene.com|
22265557|NCT02579161|Northwell Health|Dr. Zeph Okeke|516-734-8500|zokeke@northwell.edu|
22265558|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012||
22265559|NCT02766374|Rutgers - Robert Wood Johnson Medical School|Paul M. Lehrer, PhD|(732) 235-4413|lehrer@rutgers.edu|
22265560|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org|
22265561|NCT00679926|Oklahoma State University Center for Health Sciences|Johnny Stephens|918-382-3527|johnny.stephens@okstate.edu|
22265562|NCT03996148|Cooper University Hospital|Ludmil Mitrev|(800) 826-6737|mitrev-ludmil@cooperhealth.edu|
22265563|NCT01951885|Case Comprehensive Cancer Center|Betty Hamilton MD|866-223-8100|TaussigResearch@ccf.org|
22265564|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265565|NCT03188718|University of Colorado Denver|Michelle Sobremonte-King, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22265566|NCT03716076|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
22265567|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265568|NCT05227300|Indiana University School of Dentistry|Dr. Kenneth Spolnik|317-274-7280|kspolnik@iu.edu|
22265569|NCT02075671|The George Washington University, Medical Faculty Associates|Dermatology Research Fellow|202-741-2632|knelson@mfa.gwu.edu|
22265570|NCT02534844|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22265571|NCT01971970|Erasmus University Medical Centre - Sophia Childrens Hospital|Professor J.C. Escher|+31107036076|j.escher@erasmusmc.nl|
22265572|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com|
22265573|NCT01831765|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22265574|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov|
22265575|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22265576|NCT04561375|Cleveland Clinic|Dr. Daniel Sessler|2168702620|ds@ccf.org|
22265577|NCT00706511|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
22265578|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com|
22265579|NCT03272464|Massachusetts General Hospital|David M. Miller, MD, PhD|617-726-2667|dmiller4@mgh.harvard.edu|
22265580|NCT02116608|University of Colorado Denver|Jeremy Prager, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22265581|NCT03456583|Hologic|Muhammad Waqas|5088267183|Muhammad.Waqas@hologic.com|
22265582|NCT01775865|University of Iowa|Gary Pierce|319-335-9487|gary-pierce@uiowa.edu|
22265583|NCT01169532|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
22265584|NCT00117325|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265585|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com|
22265586|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
22265587|NCT02266134|Kaiser Permanente Washington Health Research Institute|Dr. Cara C. Lewis|206-422-4076|Cara.C.Lewis@kp.org|
22265588|NCT02666352|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265589|NCT04771403|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
22265590|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300||
22265591|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com|
22265592|NCT04795908|West Virginia University|Jessica Frey|304-598-6127|jessica.frey@hsc.wvu.edu|
22265593|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265594|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
22265595|NCT03670264|Children's Hospital of Philadelphia|Dr. Brian Jenssen|215-554-4390|jenssenb@chop.edu|
22265596|NCT02327741|shiraz university of medical sciences|Professor|009836250352|kojurij@yahoo.com|
22265597|NCT02257541|Memorial Sloan Kettering Cancer Center|Dr. William Tap, MD|646-888-4163|tapw@mskcc.org|
22265598|NCT02365870|Johns Hopkins University School of Medicine|Dr. Gregory Pontone|(410) 502 - 0477|gpontone@jhmi.edu|
22265599|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com|
22265600|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22265601|NCT00686582|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22265602|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
22265603|NCT02707861|TaiMed Biologics USA Corp.|Manager - Clinical Operations|713-478-2927|bbell@taimedbio.com|
22265604|NCT02150759|Inje University, Haeundae paik hospital|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
22265605|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22265606|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
22265607|NCT03322384|University of California, Davis|Analyst|9167348053|nlogihara@ucdavis.edu|
22265608|NCT03736213|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
22265609|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com|
22265610|NCT03512262|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
22265611|NCT02287493|University Medical Center Hamburg-Eppendorf|Dr. Christina König|+49 040 7410 -0|ch.koenig@uke.de|
22265612|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22308742|NCT03853746|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
22308743|NCT03555448|Washington University|R. Delos Santos|3143628351|delossantos@wustl.edu|
22265613|NCT04018664|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22294898|NCT02862171|International Partnership for Microbicides|Dr John Steytler|+27 21 8602300|jsteytler@ipmglobal.org|
22294899|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil|
22294900|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu|
22294901|NCT04212650|Steadman Philippon Research Institute|Suzanne Liv Page, JD|970-401-8770|spage@sprivail.org|
22294902|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com|
22294903|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
22294904|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
22294905|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294906|NCT03919799|Kadmon (A Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22294907|NCT02142959|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22294908|NCT02970422|McGill University|Emilie Michalovic, Ph.D. Candidate|514-941-6450|emilie.michalovic@mail.mcgill.ca|
22294909|NCT04936256|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
22294910|NCT03547687|Oregon Health Science University|Dr. Julia Durrant|503-494-0353|durrantj@ohsu.edu|
22294911|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
22294912|NCT02959307|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
22294913|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu|
22294914|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294915|NCT05980182|Virginia Commonwealth University|Dr. Maria Thomson|804-628-2640|mthomson2@vcu.edu|
22294916|NCT02136810|Yale School of Medicine|Dr. Robert Schonberger, PI|203-785-2802|robert.schonberger@yale.edu|
22294917|NCT05284656|Al-Azhar University|Amira Reda Muhammad|0106 822 0389|amira.reda89@hotmail.com|
22294918|NCT04334902|Heuron|Yoomi Kim_Clinical Research Team Leader|01035173212|yoomi_kim@iheuron.com|
22294919|NCT04419714|Wesper/Tatch|Amir Reuvent|5754482824|amir@wesper.co|
22294920|NCT04023526|OncoVerity|Clay Smith, MD Chief Medical Officer|7204981136|csmith@oncoverity.com|
22294921|NCT01955733|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294922|NCT02267811|Biolux Research, Ltd.|Dr. Peter Brawn|6046690674|p.brawn@bioluxresearch.com|
22294923|NCT00602953|UT Southwestern Medical Center, Dallas, TX|Dr. ILDIKO LINGVAY|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22294924|NCT04567225|The Cleveland Clinic Foundation|Dr. Mohammed Al-Jaghbeer|216-476-7983|ALJAGHM@ccf.org|
22294925|NCT02324569|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22308744|NCT05326776|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
22294926|NCT02016560|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22294927|NCT03758274|University of Rochester|Kenneth R. Conner|585-275-1211|kenneth_conner@urmc.rochester.edu|
22294928|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294929|NCT02422511|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
22294930|NCT02961751|University of California, Los Angeles|Jeffrey D. Klausner, MD, MPH|310-267-0409|jdklausner@mednet.ucla.edu|
22294931|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22294932|NCT02804932|University of Iowa|Dr. Darren Casey|13193841009|darren-casey@uiowa.edu|
22294933|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org|
22294934|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22294935|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk|
22294936|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu|
22308745|NCT04952909|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
22308746|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
22308747|NCT04359108|Johns Hopkins Applied Physics Laboratory|Seth Billings|240-228-7462|seth.billings@jhuapl.edu|
22308748|NCT06393088|IR Technology LLC|Consulting Director of Clinical Trials|404 915-5938|andyn@invisaredtech.com|
22308749|NCT04176965|BVI medical|Rebecca McQuaid|+353871212615|RMcQuaid@bvimedical.com|
22308750|NCT03903146|University of Kentucky|Dr. Ana Maria Linares, PI|8593234726|am.linares@uky.edu|
22308751|NCT05434078|Baylor College of Medicine|Dr. Bijan Najafi|+1 (424) 467-7127|bijan.najafi@bcm.edu|
22308752|NCT03652688|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
22308753|NCT05179837|Washington University School of Medicine|Vladimir Kushnir, M.D.|314-362-3685|vkushnir@wustl.edu|
22308754|NCT00554788|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22308755|NCT05026320|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22308756|NCT05093478|The University of Texas Health Science Center at Houston|Kunal R Shetty, MD|713-486-5000|Kunal.R.Shetty@uth.tmc.edu|
22308757|NCT05191472|University of California, San Francisco|Dr. Alfred Chung, MD|(415) 476-1000|Alfred.Chung@ucsf.edu|
22308758|NCT03197662|Montefiore Medical Center|Dr. Eric Hollander|718-839-7516|eholland@montefiore.org|
22308759|NCT03721952|University of Washington|Dr. Ruth Engelberg|206-744-9523|rengel@uw.edu|
22308760|NCT03364647|University of Kentucky|Brian Noehren|859-323-1100|b.noehren@uky.edu|
22308761|NCT03476460|Hospital Universitario Ramón y Cajal, IRYCIS|Coordinator of Research Support Unit, Internal Medicine Dept.|0034913369082|martin.fabregate@salud.madrid.org|
22308762|NCT05332366|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22308763|NCT04624633|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|617-632-4894|Jennifer_Brown@dfci.harvard.edu|
22276313|NCT03954535|Columbia University School of Social Work|Dr. Traci Schwinn|212-851-2280|tms40@columbia.edu|
22276314|NCT04871074|UW School of Medicine and Public Health|Barbara Bendlin, PhD, MA|(608) 265-2483|bbb@medicine.wisc.edu|
22276315|NCT06011798|Unity Biotechnology, Inc.|Anirvan Ghosh|-|anirvan.ghosh@unitybiotechnology.com|
22276316|NCT03506477|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
22276317|NCT03462680|Charlie Norwood VAMC|Dr. Chandramohan Wakade|706-733-0188|chandramohan.wakade@va.gov|2379
22276318|NCT02516241|AstraZeneca|Medical Science Director|1-877-240-9479|information.center@astrazeneca.com|
22276319|NCT04164979|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
22276320|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com|
22276321|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22276322|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com|
22276323|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu|
22276324|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22276325|NCT04950686|innovation Research and Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
22276326|NCT07021443|UZ Brussel|Prof. dr. Hendrik Reynaert|+32 2 477 68 11|hendrik.reynaert@uzbrussel.be|
22276327|NCT04262219|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22276328|NCT05061888|Pennington Biomedical Research Center|Corby Martin|225-763-2585|corby.martin@pbrc.edu|
22276329|NCT02266576|Stanford University|Jan J. Vasquez|408-858-4457|jan.vasquez@stanford.edu|
22276330|NCT01440920|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22276331|NCT02906618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276332|NCT05463055|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
22276333|NCT04766333|Rutgers University|Shawna V. Hudson|848-932-0215|hudsonsh@rutgers.edu|
22276334|NCT03234881|VA Connecticut Healthcare System|Robin Masheb, PhD|203-932-5711|Robin.Masheb@va.gov|3954
22276335|NCT03807843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276336|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu|
22276337|NCT02734667|Stanford University|Dr. Korey Hood|6504976899|kkhood@stanford.edu|
22276338|NCT05177094|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22276339|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22276340|NCT03014362|Walter Reed National Military Medical Center|Christopher E Hines, MD|301-319-8122|christopher.e.hines.civ@mail.mil|
22276341|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu|
22276342|NCT05276804|Atrium Health|Gregory T. Scarola|704 355-5379|gregory.scarola@advocatehealth.org|
22276343|NCT02827708|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22276344|NCT02199574|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22276345|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22276346|NCT05059080|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22276347|NCT01047501|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
22276348|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22276349|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495|elaine.mcwhirter@hrcc.on.ca|67559
22276350|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
22276351|NCT03683901|MetroHealth Rehabilitation Institute|Dr. Victoria Whitehair|216-778-4414|vwhitehair@metrohealth.org|
22276352|NCT05696847|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22276353|NCT05513950|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22276354|NCT05561140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276355|NCT00221104|Translational Research Informatics Center, Kobe, Hyogo|Director of Medical Statistics Division|+81-78-303-9108|kagimura@tri-kobe.org|
22276356|NCT02989389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22276357|NCT01666652|WRAIR|Robin Nielsen, RN|301-319-9063|trials.clinical@amedd.army.mil|
22276358|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org|
22276359|NCT01132755|Memorial Sloan Kettering Cancer Center|Dr. Peter Kingham MD|212-639-5260|kinghamt@mskcc.org|
22276360|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov|
22276361|NCT04057365|Massachusetts General Hospital|Joseph Franses, MD, PhD|617-724-4000|JFRANSES@MGH.HARVARD.EDU|
22276362|NCT01063114|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
22276363|NCT03409367|Oregon Health & Science University|Director of Clinical Trials|503-764-8544|michaell@ohsu.edu|
22276364|NCT04598828|Atrium Health Wake Forest Baptist|Project Manager|336-713-8793|richarlette.hightower@advocatehealth.org|
22276365|NCT02676973|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
22276366|NCT02580604|University of Colorado Anschutz Medical Campus|Dr. Sarah Wherry|303-724-1927|sarah.wherry@cuanschutz.edu|
22276367|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
22276368|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276369|NCT03279458|University of Mississippi Medical Center|Dr. Madhankumar Sathyamoorthy, Principal Investigator|6018157066|msathyamoorthy@umc.edu|
22294937|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com|
22321909|NCT02864368|Duke University Medical Center|Principal Investigator|(919) 684-5301|dukebrain1@duke.edu|
22294938|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu|
22321910|NCT03676010|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Dr Carine Bellera|+33 (0)5 56 33 33 33|c.bellera@bordeaux.unicancer.fr|4495
22321911|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
22321912|NCT04205409|University of Washington|Dr. Andrew Cowan|2066067348|ajcowan@fredhutch.org|
22321913|NCT01430455|Depression Evaluation Service (New York State Psychiatric Institute)|Jonathan W. Stewart|646-774-8070|jws6@nyspi.columbia.edu|
22265614|NCT03188666|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22265615|NCT02068092|Houston Methodist Neal Cancer Center|Jenny Chang|713.790.3333|ccresearch@houstonmethodist.org|
22294939|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22294940|NCT04113304|Wayne State University|"Dr. Kathleen Lucy McGoron"|313.664.2500|Lucy.K.McGoron@wayne.edu|
22294941|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it|
22294942|NCT04159025|Washington University School of Medicine|Alexander Chen, M.D.|314-454-8764|chenac@wustl.edu|
22294943|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu|
22294944|NCT02899988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22294945|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22294946|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22294947|NCT03454581|Federal University of Rio Grande do Sul|PhD Manoela Domingues Martins|55-51-33085011|manomartins@gmail.com|
22294948|NCT03138889|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22294949|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu|
22294950|NCT00411645|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22294951|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22294952|NCT02289690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22294953|NCT02376361|Albany Medical College|Loay Salman, MD|518-262-5176|SalmanL@amc.edu|
22265616|NCT03299088|U of California Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
22265617|NCT02128217|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22265618|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
22265619|NCT05071313|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265620|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265621|NCT03107026|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22265622|NCT01183221|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
22265623|NCT04763564|University of North Carolina at Chapel Hill|Hans Herfarth, MD, PhD|9199666806|hherf@med.unc.edu|
22265624|NCT02470390|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22265625|NCT03596151|Antiviral Research Center, University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
22265626|NCT01700036|University of Michigan Cancer Center|Dr. Pavan Reddy, MD|734-936-8785|reddypr@umich.edu|
22265627|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22265628|NCT02444793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265629|NCT01685411|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22265630|NCT02504671|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265631|NCT00210249|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22265632|NCT04280705|Organization:NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22265633|NCT03576183|Valneva Austria GmbH|Head Global Medical Affairs|20620|info@valneva.com|0
22265634|NCT03222583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22265635|NCT02518919|Children's Hospital of Michigan|Dr. Nirupama Kannikeswaran, Associate Professor of Pediatrics and Emergency Medicine|313-745-5260|nkannike@dmc.org|
22265636|NCT04498403|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265637|NCT03986138|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 (0)6 80 24 93 34|frantz.hebert@guerbet.com|
22265638|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
22265639|NCT03062228|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
22265640|NCT02910674|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303.724.6713|satish.garg@ucdenver.edu|
22265641|NCT03182244|Astellas Pharma Inc|Clinical Transparency|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22265642|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22321914|NCT05061719|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22265643|NCT03186781|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22265644|NCT04709835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265645|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22265646|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il|
22265647|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu|
22294954|NCT04166435|Yale University|Dr. Michael Cecchini|(203) 737-3472|michael.cecchini@yale.edu|
22321915|NCT03473145|UC San Diego|Sheri Hartman|(858) 534-9235|sjhartman@health.ucsd.edu|
22321916|NCT04417699|OHSU Knight-Legacy Health Cancer Collaborative|Dr. Hagen Kennecke|971-262-9600|kennecke@ohsu.edu|
22321917|NCT02600507|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22321918|NCT05048719|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22321919|NCT04541004|ALK-Abelló A/S|David Hal Mollerup, Senior Director|+45 45747576|ClinicalTrials@alk.net|
22321920|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22321921|NCT02025426|Duke University, School of Medicine, Department of Anesthesiology|Dr. Ashraf Habib|(919) 681-4544|ashraf.habib@duke.edu|
22321922|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321923|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
22265648|NCT01289665|AdventHealth|Dr. Ashley Hill|407-303-1444|Ashley.Hill.MD@adventhealth.com|
22265649|NCT03347422|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22321924|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu|
22321925|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
22321926|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu|
22265650|NCT03161964|University of Utah|Dr. Anu Sharma|(801) 581-7761|Anu.Sharma@hsc.utah.edu|
22265651|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu|
22265652|NCT02181426|Medical University of South Carolina, Department of Anesthesia and Perioperative Medicine|Research Coordinator for Anesthesia and Perioperative Medicine|843-792-2322|joneswr@musc.edu|
22265653|NCT00622466|The University of Texas Southwestern Medical Center|Dr. Barbara Haley|214-648-4180|barbara.haley@utsouthwestern.edu|
22265654|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com|
22265655|NCT02633488|University of Virginia|Eugene J. Barrett MD PhD|434-924-1263|ejb8x@virginia.edu|
22265656|NCT00119067|CDC|Jennifer G Wright||jgwright@cdc.gov|
22265657|NCT02713386|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|716-845-1300|purdyc@nrgoncology.org|2296
22265658|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
22265659|NCT01383135|Stanford University|Andrei Iagaru, MD|6507362859|aiagaru@stanford.edu|
22265660|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
22265661|NCT04941521|The University of Texas Health Science at Houston|Joy M Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
22265662|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com|
22265663|NCT03397771|Ixaltis|Chief Development Officer|33457260076|svanberg@ixaltis.com|
22265664|NCT02669758|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22265665|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22265666|NCT00631449|University of California, San Francisco|Steven Deeks, MD|415-476-4082|Steven.Deeks@ucsf.edu|404
22265667|NCT03393806|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265668|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
22265669|NCT02605993|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22265670|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618|r.cosentini@gmail.com|3618
22265671|NCT03493386|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265672|NCT04146116|University of Wisconsin, Madison|Dr. Marin Schweizer|6082631545|mschweizer@medicine.wisc.edu|
22265673|NCT04645264|Rush University Medical Center|Kern Singh, MD|(312) 432-2435|kern.singh@rushortho.com|
22265674|NCT03468075|University of Iowa, Holden Comprehensive Cancer Center|Clinical Assistant Professor|319-384-9497|varun-monga@uiowa.edu|
22265675|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com|
22265676|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22265677|NCT04620135|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs|+1 908-947-3551|msenchyna@aeriepharma.com|
22265678|NCT04740320|Imperial College London|Clinical Project Manager|+442083831284|polly.fox@imperial.ac.uk|
22265679|NCT01442688|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22265680|NCT00762437|AbbVie|Sally Hallas, RN|209-294-5571|sally.hallas@abbvie.com|
22265681|NCT04480021|University of Washington|Dr. Amritha Bhat|206-543-3117|amritha@uw.edu|
22265682|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265683|NCT03979820|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22265684|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu|
22265685|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
22265686|NCT02130882|National Institute of Allergy and Infectious Diseases, NIH|Dr. Amy Klion|301-435-8903|aklion@nih.gov|
22265687|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22265688|NCT00548171|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265689|NCT04453202|Janssen Vaccines & Prevention B.V.|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265690|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
22265691|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au|
22265692|NCT01355159|Ottawa Hospital Research Institute|Dr. Mark Walker|6137378899|mwalker@ohri.ca|76655
22265693|NCT03276221|Massachusetts General Hospital|Randi M. Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
22276370|NCT01428245|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
22276371|NCT02875080|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22276372|NCT03018938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22276373|NCT02013427|Northwestern University|Apkar Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
22276374|NCT04550936|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276375|NCT02141113|Rochester Center for Behavioral Medicine|Joel L. Young, MD|2486088800|jyoung@rcbm.net|
22276376|NCT05635370|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22276377|NCT00357565|Masonic Cancer Center|Christen Ebens, MD, MPH|(612) 626-2961|ebens012@umn.edu|
22276378|NCT03069989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276379|NCT05291975|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
22276380|NCT02626611|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
22276381|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org|
22276382|NCT01127061|University of Michigan School of Medicine|Dr. Sara Saberi, MD, MS|734-764-4500|saberis@med.umich.edu|
22276383|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
22276384|NCT03921541|Immedica Pharma AB|Vice President, Head of Global Integrated Evidence / Global Head of Genetic and Metabolic Diseases|+46 8 533 39 500|Clinical@immedica.com|
22276385|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22276386|NCT02798952|GlaxoSmithKline|GSK Response Center|866-435-7343|eg763112@gsk.com|
22276387|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu|
22276388|NCT04928339|University of Wisconsin - Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
22276389|NCT04633447|Janssen Research & Development, LLC|Manager Clinical Science Translational|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22276390|NCT04333498|New York State Psychiatric Institute/ HIV Center|Research Program Manager|646-774-6904|christopher.ferraris@nyspi.columbia.edu|
22276391|NCT01565694|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|310715455050|astellas.resultsdisclosure@astellas.com|
22276392|NCT03690544|Mayo Clinic|Alison J. Bruce, M.B., Ch.B.|904-953-6402|Bruce.Alison@mayo.edu|
22276393|NCT05399771|Atrium Health Wake Forest Baptist|Nicole Levi|336-716-4171|nlevi@wakehealth.edu|
22276394|NCT05416203|Department of Veteran Affairs|Dr. Nicholas Allan|8502740567|nicholas.allan@va.gov|
22276395|NCT01692015|Imperial College London|professor Claire Shovlin|+44 (0)20 7589 5111|c.shovlin@imperial.ac.uk|
22276396|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22276397|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org|
22276398|NCT04529980|Children's Health Children's Medical Center|Dr. Mayra Garcia, DNP, APRN, PCNS-BC, EBP-C|12144567990|Mayra.Garcia@childrens.com|
22276399|NCT03235414|Cincinnati Children's Hospital Medical Center; Department of Radiology|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
22276400|NCT02397837|Brigham and Women's Hospital|Dr. Katherine Burdick|617-732-5789|kburdick1@bwh.harvard.edu|
22276401|NCT04764604|University College London Hospitals NHS Foundation Trust|Brian Saccente-Kennedy, Speech and Language Therapist|+44 20 3456 5180|brian.saccente-kennedy@nhs.net|
22276402|NCT04772547|University of Florida|Dr. Carolina B. Maciel|(352) 273-5550|carolina.maciel@ufl.edu|
22276403|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca|
22276404|NCT02409901|University of Illinois Chicago|Shyreen Kamal, Director of Clinical Research|2068830173|shyreen@uic.edu|
22276405|NCT00263562|Baylor College of Medicine|Andrea T. Cruz, MD, MPh|832-824-5582|acruz@bcm.edu|
22276406|NCT04602000|Celltrion, Inc|Yun Ju Bae / Head of Clinical Planning 1 Department|+82 32 850 4160|YunJu.Bae@celltrion.com|
22276407|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu|
22276408|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276409|NCT03562507|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Cancer Center Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22276410|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com|
22276411|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu|
22276412|NCT03097315|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22276413|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22276414|NCT00367458|National Cancer Institute|Frank Maldarelli|301-435-8019|fmalli@mail.nih.gov|
22276415|NCT02556788|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
22276416|NCT02948400|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
22276417|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276418|NCT04837521|Duke University|Dr. Andrada Neacsiu|+1 919 684 6714|andrada.neacsiu@duke.edu|
22276419|NCT05221866|University of Nebraska Medical Center|Karsten Bartels|402-559-4081|anesthesiology.research@unmc.edu|
22276420|NCT05955378|Shirley Ryan AbilityLab|Arun Jayaraman|312-238-6875|ajayaraman@sralab.org|
22276421|NCT05774977|University of Pennsylvania Perelman School of Medicine|Dr. Mathias Basner, MD, PhD, MScEpi|215-573-5866|basner@pennmedicine.upenn.edu|
22276422|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
22276423|NCT04470427|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22276424|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22276425|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu|
22321927|NCT04312009|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
22265694|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22265695|NCT02615171|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
22265696|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22265697|NCT03554603|Memorial University|Peter Daley MD MSc|7097772089|pkd336@mun.ca|
22265698|NCT03110601|Stimgenics|VP of Clinical Affairs|309-662-4321|clinicalSG@stimgenics.com|217
22265699|NCT02384850|GSO Global Clinical Research B.V., EBC Amsterdam, Keizersgracht 62-64, 1015 CS Amsterdam|Dr. Anne L. Kranich|+49 40 44 19 54 60|kranich@gsoglobal.com|
22265700|NCT02312063|Kansai Electric Power Medical Research Institute|Dr. Daisuke Yabe|+81-6-6458-5821|ydaisuke-kyoto@umin.ac.jp|
22265701|NCT05730556|Mayo Clinic|Amaal Starling, M.D.|715-537-1345|Starling.Amaal@mayo.edu|
22265702|NCT02788045|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265703|NCT03190213|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22265704|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600|cohen@cheo.on.ca|2497
22265705|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
22265706|NCT02326337|AOTI Ltd.|Dr. Mike Griffiths (Medical Director)|+1(760) 431 4700|mike.griffiths@aotinc.net|
22265707|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265708|NCT02369900|Beth Israel Deaconess Medical Center|Michael N. Cocchi MD|617-754-2388|mcocchi@bidmc.harvard.edu|
22265709|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590||
22265710|NCT02244918|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
22265711|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599||
22265712|NCT02227147|Dompé|Flavio Mantelli, MD, PhD|02 583831|info@dompe.com|
22265713|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu|
22265714|NCT03514641|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
22265715|NCT01345175|Memorial Sloan Kettering Cancer Center|Dr. Philip Paty, MD|212-639-6703|patyp@MSKCC.ORG|
22265716|NCT03688282|TheraNova|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
22265717|NCT04112173|University of Delaware|Jeremy Crenshaw, Ph.D.|302-831-4795|crenshaw@udel.edu|
22265718|NCT01561430|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265719|NCT01736241|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265720|NCT04234984|Department of Anaesthesiology & Pain Medicine, Maastricht University Medical Centre, Postbus 5800, 6202 AZ Maastricht, The Netherlands.|Prof. Dr. Jan Van Zundert|(+32) 475687657|jan.van.zundert@mumc.nl|
22265721|NCT04796779|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22265722|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com|
22265723|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22265724|NCT02570113|Ablative Solutions Inc|Kate Rumrill|+1 (650) 688-9743|krumrill@ablativesolutions.com|
22265725|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22265726|NCT02746471|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
22265727|NCT02564211|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265728|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22265729|NCT01659866|Northwestern University|Dr. Anthony Schaeffer|312-908-1615|ajschaeffer@northwestern.edu|
22265730|NCT01908816|Novartis Pharmaceuticals|Study Director|862-778-8300||
22308764|NCT05565092|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22265731|NCT02618408|Supernus|Gianpiera Ceresoli-Borroni, PhD, Director of Clinical Research|301-838-2521|gceresoliborroni@supernus.com|
22265732|NCT04870138|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|919-843-6893|mmhobbs@med.unc.edu|
22265733|NCT05183217|University of Wisconsin - Madison|Heidi Brown|619-695-4714|heidi.w.brown@kp.org|
22265734|NCT01663935|University of Wisconsin, Madison|Dr Michael Struck|608 263-6429|mcstruck@wisc.edu|
22265735|NCT03914950|Medical University of Graz, Department of Radiology, Division of Nuclear Medicine|Dr. Susanne Stanzel|+43-316-385-81789|susanne.stanzel@medunigraz.at|
22265736|NCT03365752|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
22265737|NCT03167723|Atrium Health Wake Forest|Bradley Thomas MD|704-355-3176|bradley.thomas@atriumhealth.org|
22265738|NCT04040322|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
22265739|NCT02524730|Stryker|Britta von den Brincken, Sr. Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
22265740|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
22265741|NCT01772758|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
22265742|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414|lilian.dindo@bcm.edu|10296
22265743|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu|
22265744|NCT04536935|University of Washington|Morgan Johnson|715-416-1493|mjohn23@uw.edu|
22265745|NCT03678285|University of Wyoming|Dr. Evan Johnson|307-766-5282|ejohns54@uwyo.edu|
22265746|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22265747|NCT02731326|Columbia University|Suzanne Bakken, PhD, RN|212-305-1278|sbh22@columbia.edu|
22308765|NCT01902173|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
22308766|NCT05480124|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
22265748|NCT02849938|Billings Clinic|Patricia M Notario, MD|406-238-2143|pnotario@billingsclinic.org|
22265749|NCT04480710|Hepion Pharmaceuticals Inc|Clinical Operations|732-902-4016|jgreytok@hepionpharma.com|
22276426|NCT02324153|Johns Hopkins University School of Medicine|Karin Neufeld MD MPH: PI of Trial|410-550-0197|kneufel2@jhmi.edu|
22294955|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu|
22294956|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22294957|NCT00187369|Sunnybrook Health Sciences Center|Dr Jon Barrett||jon.barrett@sunnybrook.ca|
22294958|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22294959|NCT03167411|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22294960|NCT01053221|University of Wisconsin-Madison|William Burlingham, PhD|6082630119|burlingham@surgery.wisc.edu|
22294961|NCT00420927|Abbott|Global Medical Services|1-800-633-9110||
22294962|NCT01025752|VA Connecticut Healthcare System|Dr. Alicia Heapy|203-932-5711|alicia.heapy@va.gov|2299
22294963|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22294964|NCT02701400|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
22294965|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590||
22294966|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343||
22294967|NCT05201703|University of Florida - Jacksonville|Dr. Katherine Zarroli|3025615456|katherine.zarroli@jax.ufl.edu|
22294968|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org|
22294969|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov|
22294970|NCT02132130|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22294971|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com|
22294972|NCT04656691|UnitedHealth Group/Optum Labs|Tracy Ziolek , Vice President, Human Research Affairs|215-868-3114|tracy_ziolek@uhg.com|
22294973|NCT03779724|Aksaray University Training and Research Hospital|The principal investigator|905555289493|mlk.aykut@gmail.com|
22294974|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300||
22294975|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com|
22294976|NCT04600921|Department of Internal Medicine, Division of Cardiology, Medical University of Graz|Dr. Dirk von Lewinski|+4331638580684|dirk.von-lewinski@medunigraz.at|
22294977|NCT03734055|University of Rochester|Dr. Edith Williams|5856020802|edith_williams@urmc.rochester.edu|
22294978|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu|
22294979|NCT05425745|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22294980|NCT02700815|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294981|NCT02470234|Rhodes Pharmaceuticals L.P.|Dr. Akwete Adjei|401-262-9408|akwete.adjei@rhodespharma.com|
22294982|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu|
22294983|NCT02144233|University of Santiago de Compostela. A Coruña. SPAIN|Professor Urbano Santana Penín|+34647344093|urbano.santana@usc.es|
22294984|NCT02299479|Boston Children's Hospital|Garry Steil, PhD|617 355-6000|Garry.Steil@childrens.harvard.edu|
22294985|NCT03909295|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22294986|NCT02785354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22294987|NCT03312933|Brigham and Women's Hospital|Dr. Jeremy T. Smith|(617) 983-7295|jsmith42@bwh.harvard.edu|
22294988|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22294989|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br|
22294990|NCT01752907|Amgen Inc.|Study Director|866-572-6436||
22265750|NCT02994940|UC Davis Anesthesiology & Pain Medicine|Richard L. Applegate II MD|916-734-5028|rapplegate@ucdavis.edu|
22265751|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22265752|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com|
22265753|NCT04300010|UW School of Medicine and Public Health|Eric Cotter, MD|920.362.9221|ecotter@uwhealth.org|
22265754|NCT02331368|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
22265755|NCT02987959|Fox Chase Cancer Center|Protocol Developer|215-728-4097|ryan.romasko@fccc.edu|
22265756|NCT02302859|The University of Texas (UT) MD Anderson Cancer Center|Dr. Lorna McNeill, MPH,PHD/ Chair, Health Disparities Research|713- 563-1103|lmcneill@mdanderson.org|
22265757|NCT02654860|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22265758|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22265759|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu|
22265760|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22265761|NCT02989168|Global Blood Therapeutics|Nick Vlahakis|16508228756|nvlahakis@gbt.com|
22265762|NCT03456960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22265763|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265764|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943||
22265765|NCT02811263|University of California, San Francisco|Yvonne W. Wu, MD, MPH|(415) 353-2400|Yvonne.Wu@ucsf.edu|
22265766|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22265767|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu|
22265768|NCT03071094|Transgene|Associate Medical Director|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
22294991|NCT03098550|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22265769|NCT01412372|University of Utah|Dr. Ashok Tuteja|801-581-5679|Ashok.Tuteja@hsc.utah.edu|
22294992|NCT02255604|Aarhus Universitets Hospital|Hans Jürgen Hoffmann|7845000|Hans.Jurgen.Hoffmann@ki.au.dk|
22294993|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu|
22308767|NCT04550468|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
22308768|NCT03640312|Washington University in St. Louis|Guhan Iyer|3147479487|guhaniyer@wustl.edu|
22308769|NCT03536754|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
22308770|NCT04891224|Advocate Health Care|Ramona Donovan, Research Project Manager|847-723-5792|ramona.donovan@aah.org|
22308771|NCT03382652|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
22308772|NCT05455086|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22308773|NCT05492318|Italfarmaco SpA|Dr. Paolo Bettica, MD|+39 02 64431 (centralino)|p.bettica@italfarmacogroup.com|
22308774|NCT05008835|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22265770|NCT02876575|Medtronic|Melody LaBeau, Director of Clinical Operations|7635262931|melody.a.labeau@medtronic.com|
22265771|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
22265772|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265773|NCT03544879|UC San Diego|Dr. Erik Groessl|858-642-6347|egroessl@ucsd.edu|
22265774|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935||
22265775|NCT04969861|Nektar Therapeutics|Study Director|415-482-5300|StudyInquiry@nektar.com|
22265776|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
22265777|NCT03548064|University of Maryland|Wilbur H. Chen, MD, MS|410-706-1188|wchen@som.umaryland.edu|
22265778|NCT06218823|University of Wisconsin Center for Tobacco Research and Intervention|Associate Director of Research|6082628673|demccarthy@ctri.wisc.edu|
22265779|NCT04732221|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265780|NCT03611543|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs, BSH|(508) 263-8935|ClinicalResearch@Hologic.com|
22265781|NCT06077487|University of California, San Francisco|Dr. Brian Anderson|(415) 476-1000|Brian.Anderson@ucsf.edu|
22265782|NCT05101486|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265783|NCT04791969|University of California San Francisco|Glenn-Milo Santos|(415) 476-1435|glenn-milo.santos@ucsf.edu|
22265784|NCT05538065|Brigham and Women's Hospital|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
22265785|NCT04002063|VHAPTH|Judith A. Callan PhD, RN|412-628-1534|judith.callan@va.gov|
22265786|NCT03047473|Clinique Neuro-Outaouais|Dr Francois Jacques|819-777-2500|francois.jacques@neuro-outaouais.ca|217
22265787|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22265788|NCT04305587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265789|NCT02492880|Boston Scientific|Director of Clincial Sciences|855-213-9890|BSNClinicalTrials@bsci.com|
22265790|NCT02381626|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Leng, MD, MPH|646-888-8057|lengj@mskcc.org|
22265791|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22265792|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265793|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com|
22265794|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org|
22265795|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
22265796|NCT03398070|Massachusetts General Hospital|David Perez|6177262000|dlperez@partners.org|
22265797|NCT04711902|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22265798|NCT03786718|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22265799|NCT03244644|Rebiotix inc, a Ferring Company|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
22265800|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22265801|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
22265802|NCT04208958|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
22265803|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22265804|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145:||149-157
22265805|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
22265806|NCT05472662|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22294994|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700||
22294995|NCT02990910|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com|
22294996|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-563-7232|ejonasch@mdanderson.org|
22294997|NCT02064868|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22294998|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22265807|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu|
22265808|NCT03893565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265809|NCT03870477|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
22265810|NCT01708629|Bausch Health|Study Director|510-259-5284||
22265811|NCT04558918|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22265812|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265813|NCT05961215|Cedars-Sinai Medical Center|Robert Vescio, MD|3104231825|robert.vescio@cshs.org|
22265814|NCT01394952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|www.ClinicalTrials.gov@lilly.com|
22265815|NCT01986010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265816|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu|
22265817|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265818|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org|
22265819|NCT04740814|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22265820|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr|
22265821|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808|Michael.D.April@post.harvard.edu|210
22265822|NCT01948986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265823|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu|
22265824|NCT04126213|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22265825|NCT02853370|U.O.C. Haematology - A.O.U. Policlinico Paolo Giaccone, Palermo (Italy)|Dr. Emilio Iannitto|+39 091 6554415|emilio.iannitto@gmail.com|
22265826|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22265827|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com|
22265828|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654|jennifer.stinson@sickkids.ca|304514
22265829|NCT03283761|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
22265830|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com|
22276427|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22294999|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22295000|NCT00603993|Abbott|Global Medical Services|1-800-633-9110||
22295001|NCT04180488|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22295002|NCT03506815|The Ottawa Hospital|Dr. Marc Carrier|613-737-8899|mcarrier@toh.ca|73034
22295003|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
22295004|NCT01804296|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
22295005|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295006|NCT03562481|University of North Carolina at Chapel Hill|Jessica Lee, DDS, MPH, PhD|9195373955|jessica_lee@unc.edu|
22295007|NCT02056782|Cantex|CBertrand|954-315-3660|cbertrand@cantex.com|
22295008|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22295009|NCT04271605|National Taiwan University BioMedical Park Hospital Chu-Tung Campus|Chirn-Bin Chang|0972654906|G03776@hch.gov.tw|
22295010|NCT02485301|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295011|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170|roxchan@comcast.net|734
22295012|NCT03991715|University of North Carolina at Chapel Hill|Kelly Evenson, PhD|(919) 966-1967|kelly_evenson@unc.edu|
22295013|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295014|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22295015|NCT03342690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295016|NCT02634684|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
22295017|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
22295018|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020|jjaffe@antarespharma.com|324
22295019|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu|
22265831|NCT01898650|Washington University School of Medicine|Gary Skolnick|13144544005|gskolnic@wustl.edu|
22265832|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org|
22265833|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265834|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22295020|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
22265835|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com|
22265836|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
22265837|NCT02581007|Northside Hospital|Dr. Melhem Solh|404-255-1930|msolh@bmtga.com|
22265838|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
22265839|NCT03923530|NF South Ga VAMC|Dr. Anthony Bavry|352-548-4726|anthony.bavry@va.gov|
22265840|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
22265841|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265842|NCT04135196|Worcester Polytechnic Institute|Dr. Karen Troy|1-(508)-831-5000|ktroy@wpi.edu|6093
22265843|NCT03212521|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22265844|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org|
22265845|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265846|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22265847|NCT01946191|University of Utah|Dr. Molly Conroy|801-581-8310|Molly.Conroy@hsc.utah.edu|
22265848|NCT01083810|Abbott|Global Medical Services|1-800-633-9110||
22265849|NCT04048343|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22265850|NCT04941729|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22265851|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623||
22265852|NCT03845296|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22265853|NCT05424042|Wake Forest University School of Medicine|Cynthia Stowe|336-716-0686|cynthia.stowe@advocatehealth.org|
22265854|NCT05091307|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265855|NCT05104073|Penn State College of Medicine|Ian Paul, MD|7175318006|ipaul@pennstatehealth.psu.edu|
22265856|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22265857|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22265858|NCT01367665|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265859|NCT02752906|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22265860|NCT03283319|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
22265861|NCT04820530|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22265862|NCT05984186|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
22276428|NCT01913353|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22265863|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com|
22265864|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu|
22265865|NCT02551432|Seoul National University Hospital|Bhumsuk Keam|82+10-3231-2208|bhumsuk@snu.ac.kr|
22265866|NCT01823497|Medical College of Wisconsin|Keri R. Hainsworth|414-266-6306|khainswo@mcw.edu|
22276429|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276430|NCT04017962|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou, MD|212-639-6483|papanicg@mskcc.org|
22276431|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22276432|NCT05172570|Indiana Univeristy School of Medicine|Randomized prospective study comparing variable Gabapentin dosages for postoperative analgesia follo|317-274-0275|yyeap@iupui.edu|
22308775|NCT04876118|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22308776|NCT03964350|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22308777|NCT02379156|James J. Peters VA Medical Center|John P. Handrakis|718-584-9000|John.Handrakis@va.gov|3129
22308778|NCT04593472|Johns Hopkins Bloomberg School of Public Heath|Dr. Jennifer Wolff|4105020458|jwolff2@jhu.edu|
22308779|NCT05098795|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
22308780|NCT05264376|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
22308781|NCT04927637|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
22308782|NCT02754882|Samsung Bioepis Co., Ltd|Director of Clinical Trials|031-8061-1096|sbregistry@samsung.com|
22308783|NCT01212029|National Institute of Child Health and Human Development|Dr. Amir Gandjbakhche|2402742949|gandjbaa@mail.nih.gov|
22276433|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22308784|NCT02671903|Imperial College London|Dr Zachary I Whinnett|+44 (0)20 7594 5735|z.whinnett@imperial.ac.uk|
22308785|NCT04806594|Relife Srl|Clinical Trial Coordinator|055 56809345|sdipalma@relifecompany.it|
22308786|NCT04390048|University of Miami|Brian Arwari|305-284-5418|b.arwari@umiami.edu|
22308787|NCT03673111|Imperial College London|Professor Tricia Tan|020 8383 8038|t.tan@imperial.ac.uk|
22308788|NCT04768569|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
22308789|NCT05473234|UCSF FI Proctor|Dr. Catherine E. Oldenburg|415-502-8843|catherine.oldenburg@ucsf.edu|
22308790|NCT03792555|Crinetics Pharmaceuticals Inc.|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
22308791|NCT05593510|UT Southwestern Medical Center|Kelseanna Hollis-Hansen|214-645-7676|kelseanna.hollis-hansen@utsouthwestern.edu|
22308792|NCT04485039|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
22308793|NCT05481216|Research Organization (KC) Ltd|HIV COCO Project Manager|+44 (0) 7494 795 982|hivcoco@rokcservices.com|
22308794|NCT03535272|Centers for Disease Control and Prevention|Kristina Angelo|404-718-4876|kangelo@cdc.gov|
22321928|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000|peter.hauser2@va.gov|2629
22265867|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22276434|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276435|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com|
22276436|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov|
22276437|NCT04298853|Indiana University School of Medicine|Anna Thomas, MD|317-944-9392|aeschwar@iu.edu|
22276438|NCT04882709|Sonova Canada Inc.|Dr. Jinyu Qian|6472624826|jinyu.qian@sonova.com|
22276439|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu|
22276440|NCT02068794|Mayo Clinic|Evanthia Galanis MD|(507) 284-2511|galanis.evanthia@mayo.edu|
22276441|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu|
22265868|NCT04492020|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22276442|NCT03928327|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22276443|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com|
22276444|NCT05607043|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
22276445|NCT01846871|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
22276446|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com|
22276447|NCT05427916|Icahn School of Medicine at Mount Sinai|John C Lantis II|(212) 523-4797|John.Lantis@mountsinai.org|
22276448|NCT04757584|Weill Cornell Medicine|Maryam Hyder|646-962-5904|mah4022@med.cornell.edu|
22276449|NCT00081458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22276450|NCT03384966|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
22276451|NCT04790201|University of North Carolina at Chapel Hill|Bradley Gaynes, MD, MPH|(919) 445-0214|bradley_gaynes@med.unc.edu|
22276452|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22276453|NCT03637374|Johns Hopkins University|Dr. James H. Black, III|(410) 955-5165|jhblack@jhmi.edu|
22276454|NCT03780387|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
22276455|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
22276456|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22276457|NCT06069609|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
22276458|NCT03925220|Tufts University|Dr. Margie Skeer|8579191262|margie.skeer@tufts.edu|
22265869|NCT03412396|The University of Texas MD Anderson Cancer Center|Dr. John Davis|(713) 792-3250|johndavis@mdanderson.org|
22265870|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265871|NCT03614897|Transcend Medical Group|Alicia Harbison|5708874882|aliciajeanbrown@gmail.com|
22265872|NCT02109419|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
22265873|NCT04715932|Montreal Heart Institute|Dr Jocelyn Dupuis (Principal Investigator)|514 376-3330|jocelyn.dupuis@icm-mhi.org|3477
22265874|NCT03560986|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22265875|NCT00655876|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22265876|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22265877|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov|
22265878|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265879|NCT02067468|Universidad de Antioquia|Dr Gloria I Sanchez|+57 (4) 219 6062|sanchezg@une.net.co|
22265880|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22265881|NCT04645966|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265882|NCT04257552|University of Pittsburgh, Magee Womens Research Institute|Dr. Katherine Himes|(412) 641-1805|himekp@upmc.edu|
22265883|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu|
22265884|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com|
22265885|NCT04729309|Hoffmann - LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22265886|NCT01059539|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
22265887|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22265888|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22265889|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu|
22265890|NCT04091659|University of Pennsylvania|Nicholas A. Giordano, PhD RN|(215) 898-8281|ngio@upen.edu|
22265891|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
22265892|NCT02176408|NYU Langone Health|Kristin Szuhany|6467545161|kristin.szuhany@nyulangone.org|
22265893|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508|jbcollins@swmail.sw.org|0612
22265894|NCT00375830|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|650-725-4711|aiagaru@stanford.edu|
22265895|NCT03756506|Prevent-Plus|Jeff Elbl|314-606-5046|jeff.elbl@prevent-plus.com|
22265896|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22265897|NCT01739348|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265898|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov|
22265899|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22276459|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295021|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
22295022|NCT02495168|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22295023|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org|
22295024|NCT03247530|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22295025|NCT03042533|harborview medical center|julie agel|206.744.4113|bagel@uw.edu|
22295026|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org|
22295027|NCT04786990|Supernus Pharmaceuticals|Joseph T. Hull, PhD|240-403-5324|jhull@supernus.com|
22295028|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
22295029|NCT02812160|Spatz FGIA Inc.|Jeffrey Brooks MD|1-516-303-0613|jeff@spatzmedical.net|
22308795|NCT01744782|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22308796|NCT01747863|Research Institute of the McGill University Health Center|Dr. Guilherme Sant'Anna|(514) 412-4400|guilherme.santanna@mcgill.ca|23489
22308797|NCT02120456|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22308798|NCT05192200|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308799|NCT03623321|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22308800|NCT01999075|CHEO Research Institute|Dr. Sherri Katz (Principal Investigator)|613-737-7600|skatz@cheo.on.ca|2956
22308801|NCT04750525|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22308802|NCT05521308|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
22308803|NCT05337943|University of Pennsylvania|Dr. Lea Ann Matura|2157468819|matura@nursing.upenn.edu|
22308804|NCT04406857|University of Kentucky|Dr. Charles Kunos|859-323-6486|Charles.Kunos@uky.edu|
22308805|NCT05948670|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
22308806|NCT00390793|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./ Professor|713-745-0394|fravandi@mdanderson.org|
22308807|NCT03056040|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22308808|NCT04142788|University of Glasgow|Prof John Cleland|0141 330 7774|john.cleland@glasgow.ac.uk|
22308809|NCT05260684|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308810|NCT02035787|University of North Carolina Lineberger Comprehensive Cancer Center|Lauren Higgins|919- 966-4432|lqhiggin@ad.unc.edu|
22308811|NCT05392192|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22308812|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu|
22308813|NCT05229146|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
22308814|NCT05028634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22265900|NCT03362112|Nanjing First Hospital|Ma Jianhua|8625-52887092|majianhua196503@126.com|
22308815|NCT01997840|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22308816|NCT03850678|University of Nebraska-Lincoln|Marc Brennan|4024723132|marc.brennan@unl.edu|
22308817|NCT05523154|Mayo Clinic|Dr. Marina Walther-Antonio|(507) - 284-2282|waltherantonio.marina@mayo.edu|
22308818|NCT04640298|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22308819|NCT04487145|University of Califronia San Francisco|Liusheng Huang(Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
22308820|NCT05311384|University of Alabama at Birmingham|Sarah dos Anjos|205.934.7323|smanjos@uab.edu|
22308821|NCT02933970|University at Buffalo|Andrew Talal|7168884737|AHTALAL@BUFFALO.EDU|
22308822|NCT03300648|Michigan State University|Terrie E. Taylor|5178988467|ttmalawi@msu.edu|
22308823|NCT02724631|Children's Hospital of Philadelphia|Sharon Y Irving|215 590-1000|irvings@chop.edu|
22308824|NCT05076708|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
22321929|NCT01637142|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22265901|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265902|NCT00790335|Washington University in St. Louis|Dr. Suresh Vedantham, Principal Investigator|3143622900|vedanthams@mir.wustl.edu|314
22265903|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22265904|NCT02421224|University of California, San Francisco|Dr. Justin S. White|415-476-8045|justin.white@ucsf.edu|
22265905|NCT02695537|University of Alabama at Birmingham|Dr. Martina Bebin, MD|205-934-3866|ebebin@uab.edu|
22265906|NCT04015908|University of Utah|Dr. Jeffrey D. Swenson|801-581-6393|jeff.swenson@hsc.utah.edu|
22265907|NCT02792699|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22265908|NCT01715571|Johns Hopkins University School of Medicine|Arthur Burnett, MD|410-614-3986|aburnet1@jhmi.edu|
22265909|NCT04420273|Northwestern University Feinberg School of Medicine|Dr. June Robinson|3129433703|june-robinson@northwestern.edu|
22265910|NCT01687972|Johns Hopkins Univesity School of Medicine|Janice Henderson, MD Assistant Professor|443-287-2783|jhender7@jhmi.edu|
22265911|NCT02944071|BSC International Medical Trading (Shanghai) Co., Ltd|Junyang Bai|+13671646036|junyang.bai@bsci.com|
22265913|NCT03569228|Department of Veterans Affairs|Candice Quinn, Principal Investigator|919-922-8046|candice.quinn@va.gov|
22265914|NCT05442866|MedStar Health Research Institute|Dr. Hunter Groninger|202-877-7445|hunter.groninger@medstar.net|
22265915|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
22295030|NCT03305653|Children's Hospital Colorado|Dr. Calies Menard-Katcher|720-777-2318|calies.menard-katcher@childrenscolorado.org|
22265916|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu|
22265917|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343||
22265918|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22265919|NCT02317614|Western Michigan University|Dr. Anthony DeFulio|269-387-4459|anthony.defulio@wmich.edu|
22265920|NCT03285308|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22265921|NCT02283983|Centre Hospitalier Départemental Vendée|Dr. Frank PRIOU|0251446161|frank.priou@ght85.fr|+33
22265922|NCT03275064|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22265923|NCT02829294|Eosera Inc|Joseph Griffin PhD|8447327929|info@eosera.com|
22265924|NCT03055650|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
22265925|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265926|NCT05308368|NC State University|Nitin Sharma|9195130787|nsharm23@ncsu.edu|
22265927|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22265928|NCT04305496|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22265929|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
22265930|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22265931|NCT02523196|University of Colorado Denver|Dr. Amanda Wieland|720-848-2291|amanda.wieland@cuanschutz.edu|
22265932|NCT01733147|Mayo Clinic|Dr. Prasad Iyer|507-293-7911|iyer.Prasad@mayo.edu|
22265933|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22265934|NCT03176459|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22265935|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694|cristiana.forni@ior.it|0039
22265936|NCT03190330|Johnson & Johnson Private Limited|Sr. Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265937|NCT02081209|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22265938|NCT02370329|Mayo Clinic Arizona|Jeanne M. Palmer, MD|480/342-8000|palmer.jeanne@mayo.edu|
22265939|NCT04616430|Atossagenetics|Dr. Steven Quay|206.419.4873|steven.quay@atossainc.com|
22265940|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
22265941|NCT02700386|University of Colorado, Denver|Christine Fisher, MD, MPH|720-848-0154|christine.fisher@cuanschutz.edu|
22265942|NCT06378749|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|4013602985|kevers@prochange.com|
22265943|NCT04347122|KUMC|Kyle Sweeney, MD|913886100|ksweeney2@kumc.edu|
22265944|NCT03510598|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
22265945|NCT06262191|Northern Arizona University|PI|928-523-1787|zachary.lerner@nau.edu|
22265946|NCT05327816|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265947|NCT01972919|Medical College of Wisconsin|Beth Erickson, MD|414-805-4462|BErickson@mcw.edu|
22265948|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
22265949|NCT05367336|Corewell Health Lakeland|Rachelle Pichot; Clinical Research Specialist|240-389-7340|rachelle.pichot@corewellhealth.org|
22265950|NCT00658658|Amgen Inc.|Study Director|866-572-6436||
22265951|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu|
22265952|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu|
22265953|NCT04663295|Medtronic MiniMed|Senior Statistician|+18185764034|dz.dai@medtronic.com|
22265954|NCT00554190|Carbylan BioSurgery Inc.|Marcee Maroney, VP Clinical Affairs|650 855 6774|mmaroney@carbylan.com|
22265955|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22265956|NCT05958888|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
22265957|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300||
22265958|NCT04594707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265959|NCT04585789|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265960|NCT05083585|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265961|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22265962|NCT03469336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22265963|NCT01090921|BVARI|Nikhil C. Munshi, M.D.|857-203-6172|nikhil_munshi@dfci.harvard.edu|
22265964|NCT02628743|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22265965|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com|
22265966|NCT02740699|National Heart, Lung, and Blood Institute at the National Institutes of Health|Dr. Marcus Chen|301.496.0077|chenmy@nhlbi.nih.gov|
22265967|NCT02393248|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22308825|NCT02908477|Mayo Clinic|Katharine Price M.D.|507-284-6139|Price.Katharine@mayo.edu|
22265968|NCT02585934|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
22265969|NCT02958982|Rhizen Pharmaceuticals S.A.|Dr. Prajak Barde|+41 32 580 0113|pjb@rhizen.com|
22308826|NCT03095274|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
22308827|NCT04115540|Stanford University|Michael Eisenberg MD|650-723-3391|meisenb@stanford.edu|
22308828|NCT05590403|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308829|NCT05305235|University of North Carolina at Chapel Hill|Nicole Short, PhD|702-895-3305|nicole.short@unlv.edu|
22308830|NCT04717492|UAB Lung Health Center|Mark Dransfield|205-934-5425|mdransfield@uabmc.edu|
22321930|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu|
22321931|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22321932|NCT02354703|University of Maryland School of Medicine|Dr. David Gorelick|410-408-6806|dgorelick@som.umaryland.edu|
22321933|NCT02848079|Yale University|Dr. Jeremy Kortmansky|1 (203) 407-8002|jeremy.kortmansky@yale.edu|
22321934|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22321935|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov|
22321936|NCT03269344|Henry Ford Cancer Institute|Dr. Andrew Cook|3135568400|acook11@hfhs.org|
22265970|NCT01749995|General Hospital Groeninge, Kortrijk, Belgium|Dr. Philip Debruyne|+32 056 63 39 00|philip.debruyne@azgroeninge.be|
22265971|NCT01359969|Pharming Technologies BV|Anurag Relan, MD, VP Clinical Research & Medical Affairs|+31 715247400|a.relan@pharming.com|
22265972|NCT02174419|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22265973|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22265974|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22265975|NCT01857271|Albert Einstein Cancer Center|Dr. Haiying Cheng|718-405-8404|hcheng@montefiore.org|
22265976|NCT01853930|Jesse Brown VA Medical Center|Dr. Janet P. Szlyk, PhD|312-997-3644|janet.szlyk@va.gov|
22265977|NCT03825341|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
22265978|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22265979|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu|
22265980|NCT01460901|Children's Mercy Hospitals and Clinics|Dr. Gary Douglas Myers|8163026817|gdmyers@cmh.edu|7-6817
22265981|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22265982|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
22265983|NCT00997204|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22265984|NCT02737748|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
22265985|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590||
22265986|NCT05779943|Emory University|Dr. David Schuster|4047781900|dschust@emory.edu|
22265987|NCT05084963|Revolo Biotherapeutics|Chief Medical Officer|(888) 599-7431|clinicaltrials@revolobio.com|
22265988|NCT06354998|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22265989|NCT03819049|Janssen Research & Development, LLC|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22265990|NCT00762931|electroCore LLC|Clinical Affairs electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
22265991|NCT02440568|University of Illinois at Chicago|Dr. John Quigley|312-413-1300|seanq@uic.edu|
22265992|NCT00673244|Department of Anesthesiology and Critical Care Medicine, George Washington University|Lakhmir S. Chawla|202-994-7903|minkchawla@gmail.com|
22265993|NCT03796039|University of New Brunswick|Dr. Danielle Bouchard|(506) 443-3908|dboucha1@unb.ca|
22265994|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu|
22265995|NCT04314414|Boston Medical Center|Sabrina A Assoumou, MD MPH|(617) 414-5282|sabrina.assoumou@bmc.org|
22265996|NCT01157897|WRAIR|Donna Tosh|301-319-9332|donna.m.tosh.ctr@mail.mil|
22265997|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu|
22265998|NCT01795105|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
22265999|NCT01270724|Nationwide Children's Hospital|Megan Blue|614-722-3686|megan.blue@nationwidechildrens.org|
22266000|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22266001|NCT02562482|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Grace Chen, Deputy Chief, Clinical Trials Program, Vaccine Research Center|240-669-2809|grace.chen@nih.gov|
22266002|NCT02876926|Brown University School of Public Health|Dr. Tyler Wray|401-863-6659|tyler_wray@brown.edu|
22266003|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com|
22266004|NCT05896202|University of Miami|Marlon L. Wong|3052842670|mwong2@miami.edu|
22266005|NCT04154150|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22266006|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org|
22266007|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266008|NCT02041091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22266009|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com|
22266010|NCT02991430|Scion NeuroStim, LLC|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
22266011|NCT03970837|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266012|NCT02132754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266013|NCT02304991|University of North Carolina School of Medicine|Edwin Kim, MD, MS|919-962-4960|edwinkim@email.unc.edu|
22266014|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de|
22266015|NCT00578669|UT Austin School of Nursing|Dr. Richard A. Brown|512-471-8584|brown2@utmail.utexas.edu|
22266016|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
22266017|NCT04625426|Tan Tock Seng Hospital|George Glass, Nurse Researcher|+65 6903-5440|glass_george_frederick@ttsh.com.sg|
22266018|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu|
22266019|NCT01573169|Stroke Unit and Division of Internal and Cardiovascular Medicine University of Perugia, Santa Maria della Misericordia Hospital|Dr. Maurizio Paciaroni|+390755786424|maurizio.paciaroni@unipg.it|
22308831|NCT03766009|University of Wisconsin School of Medicine and Public Health|Heather B. Neuman, MD, MS|608-265-5852|neuman@surgery.wisc.edu|
22308832|NCT01106209|University of Utah - Pediatrics|Christian Con Yost, MD|801-518-7052|christian.yost@u2m2.utah.edu|
22308833|NCT02487056|Cardiovascular Academy Society|Dr. Mehdi Zoghi|3904001|mehdi_zoghi@hotmail.com|
22308834|NCT05071807|Penn State University|DCH Lab|8148638056|dchlab@psu.edu|
22266020|NCT04555720|Duke University Medical Center|Kyle Mitchell, MD|919-668-2879|kyle.mitchell@duke.edu|
22266021|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22266022|NCT02283294|University of South Florida|David Rose, MD|813-259-8577|drose1@usf.edu|
22266023|NCT02799095|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
22266024|NCT04994483|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
22266025|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22266026|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
22266027|NCT03954834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22266028|NCT02903030|Nisonger Center|Dr. L. Eugene Arnold, MD, MED. Professor Emeritus College of Medicine|614-685-6701|l.arnold@osumc.edu|
22266029|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr|
22266030|NCT04773301|Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Agustín Díaz Álvarez|0034 923291353|adiazal@saludcastillayleon.es|
22266031|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
22266032|NCT03700385|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|kschneider@farapulse.com|
22266033|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22266034|NCT03047629|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|l.larson@enterininc.com|
22266035|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22266036|NCT04590040|UT Health San Antonio|Bennett Amaechi BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
22266037|NCT01531439|Children's Mercy Hospital|Dr Ben Pieters|816-234-3464|bjpieters@cmh.edu|
22266038|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu|
22266039|NCT02813265|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results006@kalarx.com|
22266040|NCT03376061|Population Health Research Institute|Research assistant|19055212100|Austin.Browne@phri.ca|40582
22266041|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com|
22266042|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300||
22266043|NCT04247100|Virginia Commonwealth University|Gisela Chelimsky, MD|804-628-4859|gisela.chelimsky@vcuhealth.org|
22266044|NCT01806571|Mayo Clinic|Aref Al-Kali, M.D.|(507) 538-0591|alkali.aref@mayo.edu|
22266045|NCT02771795|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22266046|NCT02198183|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
22266047|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
22266048|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22266049|NCT02906930|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22266050|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22266051|NCT03537599|The Ohio State University Comprehensive Cancer Center|Dr. Sumithira Vasu|614-293-9869|Sumithira.Vasu@osumc.edu|
22266052|NCT03544424|University of Manchester|Dr Joanne Taylor|0161 306 6000|joanne.taylor-2@manchester.ac.uk|
22266053|NCT02603393|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22266054|NCT04283500|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
22266055|NCT03599271|Intersect ENT|Andrew Campbell PhD, MPH Clinical Affairs Director|6506412100|acampbell@intersectent.com|
22266056|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22266057|NCT03682224|Southern Illinois University School of Medicine|Sowmy Thuppal, Research Assistant Professor|217-545-2320|sthuppal83@siumed.edu|
22266058|NCT03875859|Stanford University|Kavita Yang Sarin|650-804-2899|ksarin@stanford.edu|
22266059|NCT04540406|Notitia Biotechnologies|Clinical Research Associate|732-230-3175|ciarra.williams@notitiabio.com|
22266060|NCT04053465|University at Buffalo|Dr. Riana Pryor|7168295456|rpryor@buffalo.edu|
22266061|NCT02085135|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22266062|NCT02971735|Linkou Chang Gung Memorial Hospital|Dr. Li-Ang Lee|886 33281200|5738@cgmh.org.tw|3972
22266063|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084||
22266064|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266065|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
22266066|NCT03149445|Saniona A/S|Janus Schreiber Larsen|+457070 5225|janus.larsen@saniona.com|
22266067|NCT02699060|IMSechenovMMA|MD, PhD Ivashkin Vladimir Trofimovich|+79252667987|motility_2013@mail.ru|
22266068|NCT04916444|University of Florida Norman Fixel Institute for Neurological Diseases|Dr. Jun Yu|352-294-5400|jun.yu@neurology.ufl.edu|
22266069|NCT05005312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266070|NCT03769714|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
22266071|NCT06077149|University of Rochester|Ann Falsey, MD|585-922-4339|Ann_Falsey@URMC.Rochester.edu|
22266072|NCT04658095|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
22308835|NCT03729999|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
22266073|NCT01441947|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-643-5415|sisakoff@partners.org|
22266074|NCT02143973|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22266075|NCT02970318|Astrazeneca Clinical Trial|Study Director|1-888-292-9613|information.center@astrazeneca.com|
22266076|NCT03384654|Janssen-Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22266077|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu|
22266078|NCT00816361|MedImmune LLC|Susan Perez MD, MSc|+1 301-398-2827|information.center@astrazeneca.com|
22266079|NCT02500641|A. Menarini Industrie Farmaceutiche Riunite SrL|Post-Registration Clinical Trial Responsible|+39 055 5680459|pfabrizzi@menarini.it|
22266080|NCT01763684|Zimmer Biomet|Linda Meijer, Clinical Operations Manager|+31786292935|linda.meijer@zimmerbiomet.com|
22266081|NCT02196701|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22266082|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22266083|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266084|NCT04058249|Stanford University|Protocol Director|650-800-6920|brainstimulationstudy@stanford.edu|
22266085|NCT04181723|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
22266086|NCT03496610|Duke University|Hector F. Martinez-Wilson, MD, PhD|919-681-6437|hector.martinez-wilson@duke.edu|
22266087|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266088|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu|
22266089|NCT04669691|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22266090|NCT04156620|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22266091|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch|
22266092|NCT03082664|University of Chicago|Dr. Maritza G. Gonzalez|7737026118|mggonzalez@bsd.uchicago.edu|
22266093|NCT01970865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266094|NCT01629966|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22266095|NCT01150890|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22266096|NCT03118570|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22266097|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22266098|NCT04430855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22266099|NCT03801382|Philips Research|Clinical product lead|+31646802217|daisy.van.minde@philips.com|
22266100|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22266101|NCT01531738|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22266102|NCT02351544|The Ohio State University|Dr. Jeffrey Janis|(614) 293-8566|jeffrey.janis@osumc.edu|
22266103|NCT02011386|Rigshospitalet, Denmark|Professor Mikkel Østergaard, MD, PhD, DMSc|+45 38633014|mo@dadlnet.dk|
22266104|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu|
22266105|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300||
22266106|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22266107|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22266108|NCT03972163|UMass Chan Medical School|Dr. Jennifer Tjia, Principal Investigator|774-455-3538|jennifer.tjia@umassmed.edu|
22266109|NCT01265433|Sellas Life Sciences|Dr. Dragan Cicic|646-200-5278|info@sellaslife.com|
22266110|NCT01212588|IndianaU|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
22266111|NCT02885181|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22266112|NCT02651259|Family Health International (FHI 360|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22266113|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22266114|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org|
22266115|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu|
22266116|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22266117|NCT04562155|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22266118|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com|
22266119|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu|
22266120|NCT01025453|Memorial Sloan Kettering Cancer Center|Dr. Eric Sherman, MD|646-888-4234|shermane@mskcc.org|
22266121|NCT05594264|University of Delaware|Dr. Yendelela Cuffee|(302) 831-1302|ylcuffee@udel.edu|
22266122|NCT03490760|Miami Cancer Institute at Baptist Health, Inc.|Michael Chuong, M.D.|(786) 596-2000|michaelchu@baptisthealth.net|
22266123|NCT04005352|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22266124|NCT03303196|Children's Hospital of Philadelphia|Lauren Mitteer|267-426-9915|MitteerL@email.chop.edu|
22266125|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu|
22266126|NCT00176423|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
22266127|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com|
22266128|NCT03597529|Director, Child and Adolescent Headache Program, UCSF Benioff Children's Hospitals|Dr. Amy A. Gelfand|415-502-1914|Amy.Gelfand@ucsf.edu|
22266129|NCT01755767|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22308836|NCT05369533|University of California, Los Angeles|Steven Cramer|424-522-7874|SCCramer@mednet.ucla.edu|
22308837|NCT04526704|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22308838|NCT04924660|Vanderbilt University Medical Center|Sean P. Collins, MD|615-343-8010|vcc@vumc.org|
22308839|NCT02105766|National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)|Matthew Hsieh M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
22266130|NCT03196635|GE Healthcare|Sara Lam|262-548-2369|sara.j.lam@ge.com|
22266131|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266132|NCT02865460|Miami VA Healthcare System|Nancy Klimas, MD|305-575-7000|nancy.klimas@va.gov|1-4800
22266133|NCT00901576|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22266134|NCT01696279|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22276460|NCT03188185|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22266135|NCT00171951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22266136|NCT05788289|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
22266137|NCT03490344|Memorial Sloan Kettering Cancer Center|Dr. Sham Mailankody, MBBS|646-608-3712|mailanks@mskcc.org|
22266138|NCT04154631|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22266139|NCT05187013|George Washington University|Ramin Asgary|(202) 994-6803|raminasgary1@gwu.edu|
22266140|NCT04823975|Huntsman Cancer Institute|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
22266141|NCT05407714|BSC International Medical Trading (Shanghai) Co., Ltd|Associate Clinical Trial Manager|+13671646036|junyang.bai@bsci.com|
22266142|NCT01568320|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22266143|NCT03233230|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22266144|NCT04159935|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22266145|NCT02927366|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22266146|NCT02472223|Washington University School of Medicine|Mae Gordon|3143623716|gordon.mae@wustl.edu|
22266147|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG|
22266148|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@emmes.com|221
22266149|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
22266150|NCT02910063|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22266151|NCT03750292|University of Rochester|Daniel Croft|(585) 275-4861|daniel_croft@urmc.rochester.edu|
22266152|NCT03334617|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22266153|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org|
22266154|NCT03657342|Zambon SpA|Enrica Bucchioni, MD, PhD, Global Clinical Development Senior Director|+3902665241|clinicaltrials@zambongroup.com|
22266155|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
22266156|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
22276461|NCT03301714|Kornber School of Dentistry|Dr. Marisol Tellez Merchan|2177071773|marisol@temple.edu|
22276462|NCT04465955|NGM Biopharmaceuticals|VP, Clinical Operations|(650)243-5555|ngm282@ngmbio.com|
22276463|NCT04738487|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22276464|NCT00632359|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22276465|NCT04253626|Stanford University|Deirdre J. Lyell, MD|(650) 498-4069|dlyell@stanford.edu|
22276466|NCT03599713|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22276467|NCT05578872|Anaveon AG|Medical Director, MD|+41615218383|anaveonclinicaltrials@anaveon.com|
22295031|NCT02846779|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22276468|NCT04941898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22276469|NCT03641924|Corporal Michael J. Crescenz VAMC|Dr. James Cobb Scott|2158235800|James.Scott2de50a@va.gov|207138
22295032|NCT03159624|University of Alabama at Birmingham|Dr. Brad Woodworth|205-801-7858|bwoodworth@uabmc.edu|
22295033|NCT01154764|Asan Medical Center|Hyeong-Seok Lim MD, Ph.D|+82 2 3010 4613|mdihs@amc.seoul.kr|
22295034|NCT05353985|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22295035|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497||
22295036|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com|
22308840|NCT03557697|NYU Langone Health|Lu Hu|646 501 3438|lu.hu@nyulangone.org|
22308841|NCT03547869|UTDallas|Sven Vanneste|n/a|sven.vanneste@utdallas.edu|
22308842|NCT05409183|Tufts Medical Center|James Udelson, MD|(617) 636-8066|James.Udelson@tuftsmedicine.org|
22308843|NCT02274662|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
22295037|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org|
22295038|NCT04221009|James A Haley Veterans' Hospital|Dr. Marc A Silva|813-972-2000|marc.silva1@va.gov|5613
22295039|NCT00793598|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22295040|NCT02762266|Stanford University|Erqi Pollom, MD|(650) 498-0484|erqiliu@stanford.edu|
22308844|NCT02936752|Yale School of Medicine|Amer Zeidan, MBBS|(203) 200-4363|amer.zeidan@yale.edu|
22308845|NCT03241459|Surmodics|Kimberly Hawkinson|952-500-7563|khawkinson@surmodics.com|
22276470|NCT01022580|University of California, San Francisco|Roberta A Ballard, MD|415-476-4193|roberta.ballard@ucsf.edu|
22266157|NCT03201211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295041|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu|
22308846|NCT05805865|Loma Linda University Health|Professor, Director of Student Research|909 558 5118|sorankwon@llu.edu|
22266158|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266159|NCT03401450|NYU Langone|Dr. Prianka Desai|212-263-5072|prianka.desai@nyulangone.org|
22266160|NCT00228423|University Of Ottawa Heart Institute|Dr. Marc Ruel||mruel@ottawaheart.ca|
22266161|NCT04682730|University of Pittsburgh|Dr. Deborah Polk, PhD|14126488656|dpolk@pitt.edu|
22266162|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org|
22266163|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293||
22266164|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu|
22266165|NCT01709838|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22266166|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266167|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22266168|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785||
22266169|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch|
22266170|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
22266171|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org|
22266172|NCT06219278|Candela|Katherine Coleman|508-358-7400|katherinec@candelamedical.com|28533
22266173|NCT03867097|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
22266174|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22266175|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
22266176|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
22266177|NCT03907462|University of California, San Diego|Dr. Job Godino|6195152344|jobg@fhcsd.org|2344
22266178|NCT01745211|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22266179|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22266180|NCT00658515|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22266181|NCT01555671|Prof.Dr.Cemil Tascioglu City Hospital|Orhan SAHIN|+90 532 240 00 12|drorhansahin@gmail.com|
22266182|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266183|NCT04003896|Penn State Health|Dr. Nelson Yee|7175310003|nyee@pennstatehealth.psu.edu|280677
22266184|NCT02026687|Dept of anaesthesia, Linköping University Hospital, Sweden|Dr Lena Nilsson|0046101030000|lena.nilsson@regionostergotland.se|
22266185|NCT03929757|Janssen Vaccines & Prevention B.V.|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22266186|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22266187|NCT00806286|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22266188|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com|
22266189|NCT04713553|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22266190|NCT01199471|Abbott|Global Medical Services|800-633-9110||
22266191|NCT03151408|Helsinn Healthcare SA|Francesco Scarci|+41 (0)91 985 1946|francesco.scarci@helsinn.com|
22266192|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22266193|NCT03400943|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22266194|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22266195|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu|
22266196|NCT02045147|University of Nebraska Medical Center|Lani Zimmerman|402-472-3847|lzimmerm@unmc.edu|
22266197|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012||
22266198|NCT01045135|Akershus University Hospital|Dr.Jette Stær-Jensen, Dr. Franziska Siafarikas|+47-6796000|jett@ahus.no|
22266199|NCT01392625|ISCI / University of Miami Miller School of Medicine|Joshua M. Hare, MD|305-243-5579|JHare@med.miami.edu|
22276471|NCT03439839|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22276472|NCT03720847|University of North Carolina at Chapel Hill|Tory Eisenlohr-Moul|859-317-0503|moul@med.unc.edu|
22276473|NCT01500096|Johns Hokpins University|Adriana Andrade|410-955-7287|aandrade@jhmi.edu|
22276474|NCT05124184|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
22276475|NCT03033901|James A. Haley Veterans' Hospital|Risa Richardson, PhD|813-972-2000|Risa.Richardson@va.gov|5309
22276476|NCT03096353|National Center for Complementary and Integrative Health|Catherine Bushnell|+1 301 496 2222|mary.bushnell@nih.gov|
22276477|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu|
22276478|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22308847|NCT05582746|University of Kansas Medical Center|Dr. Jason E Glenn|9135880076|jglenn4@kumc.edu|
22308848|NCT04495894|Emory University|Viraj Master, MD, PhD|404-778-4898|vmaster@emory.edu|
22308849|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22308850|NCT02432404|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
22308851|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22308852|NCT05184192|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo|314-362-8641|piccirj@wustl.edu|
22276479|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276480|NCT02506036|Johns Hopkins University School of Medicine|Dr. Argye Hillis|410-614-2381|argye@jhmi.edu|
22276481|NCT04119336|Massachusetts General Hospital|Andrew Yee, MD|617-724-4000|AYEE1@mgh.harvard.edu|
22308853|NCT05538754|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
22276482|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000|evialola@hotmail.com|1405
22276483|NCT01733888|DMG Dental Material Gesellschaft|Manager Clinical Research|+494084006|clinicalresearch@mtcompanies.com|0
22276484|NCT02383173|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22276485|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937||
22276486|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276487|NCT04871113|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276488|NCT02143778|Exalenz Bisocience|Clinical Trial Manager|97289737500|avrahamh@exalenz.com|
22276489|NCT05630755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22276490|NCT04502524|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
22276491|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu|
22276492|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22276493|NCT02836769|Sunnybrook Research Institute|Dr. Sara McEwen|416-226-6780|sara.mcewen@sunnybrook.ca|7957
22276494|NCT04339972|Medical University of South Carolina|Dr. Mark George or Dr. Bashar Badran|843-792-6076|georgem@musc.edu|
22276495|NCT00565864|Oregon Health & Science University|Dr. Mary Samuels|5034945242|samuelsm@ohsu.edu|
22276496|NCT02403271|Pharmacyclics LLC, An AbbVie Company|Thorsten Graef|(408) 215-3127|tgraef@pcyc.com|
22276497|NCT02522845|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
22276498|NCT02112552|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
22276499|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu|
22276500|NCT04285411|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
22276501|NCT03349515|Medical University of South Carolina|Dr. Michelle Rovner|843-792-2322|rovner@musc.edu|
22276502|NCT04055519|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22276503|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com|
22276504|NCT01403584|Universitätsklinik, Essen|Prof. Helmut Teschler|0201 433 4001|teschlerh@t-online.de|
22276505|NCT02965456|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
22276506|NCT05073315|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22276507|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
22276508|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org|
22276509|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22276510|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
22276511|NCT02393755|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22276512|NCT05324371|Boston Scientific|Nilou Zilinek|508-683-6127|nilou.zilinek@bsci.com|
22276513|NCT02723331|University of Colorado Hospital|Wells Messersmith, MD|303-724-0747|wells.messersmith@cuanschutz.edu|
22276514|NCT04069520|Emory University|Dr. Kim Barber Foss|404-544-1306|kim.barberfoss@emory.edu|
22276515|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com|
22276516|NCT04822194|Rice University|Bryan Denny|713-348-8257|bryan.denny@rice.edu|
22276517|NCT05182125|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22276518|NCT04057768|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
22276519|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com|
22276520|NCT02085551|Penumbra, Inc.|Michaella Corso|+1 510-995-2079|mcorso@penumbrainc.com|
22276521|NCT02965833|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
22276522|NCT03370302|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22276523|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
22276524|NCT03976375|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22276525|NCT04818112|University of Arizona|Dr. Aleeca Bell|5206260575|aleecab@arizona.edu|
22276526|NCT03091439|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22276527|NCT03122106|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
22276528|NCT00640289|Children's Hospital of Orange County|Clinical Trial Coordinator||KBirschbach@choc.org|
22276529|NCT04507321|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276530|NCT03550209|Nationwide Children's Hospital|Dr. Sarah Keim|1-800-792-8401|sarah.keim@nationwidechildrens.org|52849
22276531|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu|
22276532|NCT06170827|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@GSK.com|
22276533|NCT06048068|Columbia University Irving Medical Center|Dr. Sachin Agarwal, MD MPH|212-305-7236|sa2512@cumc.columbia.edu|
22276534|NCT05643794|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22276535|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com|
22308854|NCT03703492|UW School of Medicine and Public Health|Amy Fowler, MD, PhD|608-262-2122|afowler@uwhealth.org|
22308855|NCT04810650|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
22276536|NCT02927145|University of Oxford|Dr Angela Minassian|0044 01865611425|angela.minassian@ndm.ox.ac.uk|
22276537|NCT03298061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276538|NCT05027282|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22276539|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22276540|NCT00886236|Medical University of South Carolina|Larry Field|843-876-5744|field@musc.edu|
22276541|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276542|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu|
22276543|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
22276544|NCT01946802|Seoul National University Hospital|Pf. Gil Joon Suh|82-2-2072-2196|suhgil@snu.ac.kr|
22276545|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu|
22276546|NCT02541903|UAB|Dr. Lisle Nabell, MD, Professor|(205) 934-3061|lnabell@uabmc.edu|
22276547|NCT02969018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276548|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276549|NCT05762679|Johns Hopkins school of medicine|Dr. Preeti Raghavan|9174889626|praghavan@jhmi.edu|
22276550|NCT03759184|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
22276551|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov|
22276552|NCT04795323|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22276553|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22276554|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276555|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
22276556|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
22276557|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu|
22276558|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22276559|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22276560|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22276561|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu|
22276562|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
22276563|NCT02513563|Moffitt Cancer Center|Jhanelle E. Gray, MD|813-745-2677|Jhanelle.Gray@moffitt.org|
22276564|NCT00317369|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22276565|NCT03491917|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22276566|NCT01684592|Battelle|Dr. Victoria Coleman-Cowger|4103722748|colemancowger@battelle.org|
22276567|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu|
22276568|NCT06086340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276569|NCT01767415|Weill Cornell Medicine|Anita Ou|646-962-8188|ano2014@med.cornell.edu|
22276570|NCT03998462|North Florida/South Georgia VA Healthcare System|Dr. Dawn Schiehser, Ph.D.|352-376-1611|Dawn.Schiehser@va.gov|107538
22276571|NCT05710224|Instituto Butantan|Fernanda Castro Boulos - Diretoria Médica, Centro de Ensaios Clínicos e Farmacovigilância|+55 11 3723-6797|fernanda.boulos@fundacaobutantan.org.br|
22276572|NCT05893823|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini|0516366418|francescocastagnini@hotmail.it|+39
22276573|NCT03369223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22276574|NCT04615507|Johnson & Johns Vision Care Inc.|Thomas Karkkainen- Sr. Research Principal Optometrist|1-800-843-2020|tkarkkai@its.jnj.com|
22276575|NCT03407482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22276576|NCT01648959|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22276577|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
22276578|NCT05887401|University of North Carolina at Chapel Hill|Dr. Erin Coffman|9195254677|erin.coffman@advocatehealth.org|
22276579|NCT03290768|Savvysherpa, LLC|Jared Jones|763-549-3540|JaredJones@savvysherpa.com|8116
22276580|NCT04050605|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22276581|NCT03579771|Robert H. Lurie Comprehensive Cancer Center of Northwestern University Clinical Cancer Center|Shishir Maithel, MD|312-908-5250|shishir.maithel@nm.org|
22276582|NCT02369458|Washington University School of Medicine|Peter Oppelt, M.D.|636-916-9922|poppelt@wustl.edu|
22276583|NCT03853798|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
22276584|NCT02743494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22276585|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it|
22276586|NCT06904404|Wolfe Eye Clinic|Edward Hu|(319) 362-8032|ehu@wolfe.com|
22276587|NCT06400914|CooperVision, Inc.|Jose A. Vega, OD, MSc, FAAO|925-621-3761|javega@coopervision.com|
22276588|NCT06937346|Karaganda Medical University|Amirbekova Mariyam Sayatovna|+77472224951|Amirbekova31081998@gmail.com|
22276589|NCT02850406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276590|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22276591|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
22276592|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802||
22276593|NCT02014103|University of Cincinnati|Rita Alloway|513.558.1568|rita.alloway@uc.edu|
22276594|NCT05638737|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22276595|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com|
22276596|NCT01373229|Duke University Medical Center|Danielle Brander, MD|919-286-6897|danielle.brander@duke.edu|
22276597|NCT04439175|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22321937|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22276598|NCT03128086|HOSPITAL UNIVERSITARIO GENERAL DE CASTELLÓN, SPAIN. CONSELLERIA SANITAT|DR. ALBERTO BELENGUER-MUNCHARAZ|964 72 50 00|belengueralberto8@gmail.com|
22276599|NCT05417113|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-4743|christina.jeng@Mountsinai.org|
22321938|NCT04478708|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22321939|NCT01869114|Thomas Jefferson University|Margaret T Kasner, MD|215-955-3202|Margaret.Kasner@jefferson.edu|
22276600|NCT01847209|Brigham and Women's Hospital|Dr. Raphael Bueno|617-732-8148|rbueno@partners.org|
22276601|NCT00729586|NRG Oncology|Angela Kuras on behalf of Virginia Filiaci|716-845-5702|kurasa@nrgoncology.org|
22276602|NCT01858948|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
22276603|NCT02513199|Icahn School of Medicine at Mount Sinai|Michael Buckstein|212-241-7502|michael.buckstein@mountsinai.org|
22276604|NCT03712852|Università degli studi G. D'ANNUNZIO|Prof. Michele Paolantonio|3395204073|mpaolantonio@unich.it|
22276605|NCT01956942|Ophthalmology Department The George Washington University|Dr. David Belyea|2027412800|dbelyea@mfa.gwu.edu|
22276606|NCT04307394|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|brandon_gaudiano@brown.edu|
22276607|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
22276608|NCT01166945|University of Wisconsin School of Medicine and Public Health|Ellen Wald, MD|608-263-8558|erwald@pediatrics.wisc.edu|
22295042|NCT00345345|National Heart Lung and Blood Institute|Stefan F Cordes, Principal Investigator, M.D., Ph.D.|+1 240 383 6460|stefan.cordes@nih.gov|
22295043|NCT01113983|Edwards Lifesciences|Shin Sakai, PhD||shin_sakai@edwards.com|
22295044|NCT02373202|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22295045|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22295046|NCT03010254|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22295047|NCT02715076|Department of outcomes research Cleveland Ohio|Dr. Daniel I. Sessler||ds@or.org|
22295048|NCT01404325|Novartis Pharmaceuticals|Study Director|8627788300||
22295049|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com|
22295050|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org|
22295051|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295052|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22295053|NCT02893514|NYU Langone Health|Jennifer McNeely, MD, MS|(646) 501-3551|Jennifer.McNeely@nyulangone.org|
22295054|NCT02989194|Visterra|Chief Medical Officer|617-498-1070|clinicaltrials@visterrainc.com|
22295055|NCT00711711|HECVSanté|Pr. Claude Pichonnaz|++41213168126|claude.pichonnaz@hesav.ch|
22295056|NCT04160091|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22295057|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu|
22295058|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu|
22295059|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295060|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com|
22295061|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu|
22295062|NCT04492618|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-4256|Mangold.Aaron@mayo.edu|
22295063|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de|
22295064|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
22295065|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com|
22295066|NCT01635101|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22295067|NCT02569723|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22295068|NCT01327885|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22295069|NCT03975790|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295070|NCT03232801|University of Pittsburgh|Holly Thomas|412-586-9836|thomashn@upmc.edu|
22295071|NCT03824912|Encube Ethicals Pvt Ltd|Dr. Lalatendu Panigrahi, Chief Scientific Officer|+91-22-6264-7002|lalatendu.p@encubeethicals.com|
22295072|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu|
22295073|NCT03836612|St Thomas' Hospital, London|Dr Peter Irving|020 7188 7188|peter.irving@gstt.nhs.uk|
22295074|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295075|NCT01414114|Amgen, Inc|Study Director|866-572-6436||
22295076|NCT00865124|Brigham and Women's Hospital|Gail K. Adler|617-732-5661|gadler@partners.org|
22295077|NCT02743520|University of Miami, Miller School of Medicine|Alberto Ramos, MD, MSPH, FAASM|305-243-8393|a.ramos1@med.miami.edu|
22295078|NCT04648631|University of Miami|Hadar Lev-Tov, MD|305-689-2646|hlevtov@med.miami.edu|
22295079|NCT01573572|Bausch Health|Study Manager|908-242-8287|sandra.narain@bauschhealth.com|
22295080|NCT02461563|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295081|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu|
22295082|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com|
22295083|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22321940|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org|
22295084|NCT02794883|Northwestern University, Feinberg School of Medicine|Karan Dixit, MD|312-503-4724|karan.dixit@northwestern.edu|
22266200|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22266201|NCT06017479|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti Rahardjo, Sp.U(K), PhD|+62 816-825-226|harrinaerlianti@gmail.com|
22266202|NCT00936897|Amgen Inc.|Study Director|866-572-6436||
22266203|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300||
22266204|NCT04058067|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22266205|NCT02287818|TWi Biotechnology Inc.|JingYi Lee|886-2-26571788|jingyi.lee@twibiotech.com|201
22266206|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com|
22266207|NCT04628793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266208|NCT02315430|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22266209|NCT00613886|University of California, Irvine|Chris Nishi Clinical Trials Coordinator|949-824-3238|cnishi@uci.edu|
22266210|NCT05502081|Mansoura University Hospital|Dr. Ahmed Hosny|+2001554658010|ahmedony26@gmail.com|+200115584
22266211|NCT00462124|BioProtect|Galit Itzhaki|+972-9-7731929|galit@bioprotect.co.il|
22266212|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266213|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22266214|NCT03200912|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8259|USMedInfo@tevapharm.com|
22266215|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com|
22266216|NCT03421730|Vectura Limited|Gary Burgess, MD|+44 (0)1249 667700|clinical.enquiries@vectura.com|
22266217|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org|
22266218|NCT00258128|Joslin Diabetes Center|Allison B. Goldfine, MD|617-309-2400|allison.goldfine@joslin.harvard.edu|
22266219|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
22266220|NCT02238795|Jena University Hospital, Center for Clinical Studies|Prof. Dr. Frank M. Brunkhorst|+49 3641 939|frank.brunkhorst@med.uni-jena.de|6687
22266221|NCT02174432|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22266222|NCT01096368|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22266223|NCT02373189|Rush University Medical Center|John Burns|13129420379|john_burns@rush.edu|
22266224|NCT02151877|Advocate Health Care|Chawki Elzein, MD, FACS|7086843029|chawki.elzein@advocatehealth.com|
22266225|NCT02012348|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(585)-657-8390|dermstudies@ucsd.edu|
22266226|NCT03095638|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266227|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
22266228|NCT03347006|Queen Mary University of London|Professor Jesmond Dalli|+442078828263|j.dalli@qmul.ac.uk|
22266229|NCT01158573|University of Michigan|Michael Coffey M.D.|734-936-6267|coffeym@umich.edu|
22266230|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22266231|NCT02980874|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22266232|NCT02450526|Ipsen|Medical Director||clinical.trials@ipsen.com|
22266233|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123|philipp.novak@ebewe.com|733
22266234|NCT05161806|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22266235|NCT00855803|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
22266236|NCT00809159|Novartis|Study Director|862-778-8300||
22266237|NCT01576874|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22266238|NCT01174082|UT MD Anderson Cancer Center|Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
22266239|NCT03918109|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22266240|NCT01045174|University Hospitals Cleveland Medical Center|Dr. Jerri Rose|216-844-7147|jerri.rose@uhhospitals.org|
22266241|NCT01997229|Alexion Pharmaceuticals, Inc.|Jing-Jing Wang, MD|+1 (475) 230-2596|JingJing.Wang@alexion.com|
22266242|NCT03050060|University of Washington|Dr. Ramesh Rengan, Department Chair|206-598-4100|rengan@uw.edu|
22266243|NCT04568031|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22266244|NCT02304458|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22266245|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu|
22266246|NCT04874636|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22266247|NCT01362127|Karolinska Institutet|Fredrik Klevebro|+46858580000|fredrik.klevebro@ki.se|11111
22266248|NCT04188301|Washington University in St. Louis|Dr. Gary Weil|3144547787|gary.j.weil@wustl.edu|
22266249|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov|
22266250|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22295085|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295086|NCT01906008|UT MD Anderson Cancer Center|Dr. James Yao, MD, Director of GI Medical Oncology|(713) 792-2828|jyao@mdanderson.org|
22295087|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com|
22295088|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22295089|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673|rnakamura@coh.org|65285
22295090|NCT04216017|University of Washington|Dr. Jonah Hebert-Davies|2067443466|jdavies2@uw.edu|
22295091|NCT03223246|Massachusetts General Hospital|Dr. Margaret Samuels-Kalow|6177262000|msamuels-kalow@mgh.harvard.edu|
22276609|NCT03228914|The University of Texas Health Science Center at Houston|William C. Yao, MD|713-500-5410|william.c.yao@uth.tmc.edu|
22276610|NCT02453048|ILIAD Biotechnologies|Ken Solovay|9543360777|ken@iliadbio.com|
22276611|NCT02346916|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
22276612|NCT03380572|Imperial College London|Mr R Aggarwal|02033126840|r.aggarwal@ic.ac.uk|
22276613|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276614|NCT03677401|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
22276615|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276616|NCT02810327|Medical University of South Carolina|Kimberly Brown Foil|843-792-6474|foilk@musc.edu|
22276617|NCT06262607|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
22276618|NCT00574951|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
22276619|NCT05161936|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22276620|NCT01692756|Univerisity of Kentucky|Cale Jacobs, ATC, PhD|8592183065|Kycartilagedoc@gmail.com|
22276621|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu|
22276622|NCT04925934|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22276623|NCT03144635|Kyushu University Hospital|Dr. Eiichi Ogawa / Assistant Professor|81926425909|eogawa@gim.med.kyushu-u.ac.jp|
22276624|NCT04425018|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
22295092|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com|
22295093|NCT02268084|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
22295094|NCT05227027|University of California, San Francisco|Dr. Justin White, Associate Professor|415-476-8045|justin.white@ucsf.edu|
22295095|NCT03552198|KCL|Dr D D'Antoni|NA|donatella.d'antoni@kcl.ac.uk|
22295096|NCT06149247|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22295097|NCT03735433|The Ohio State University|Kara Rood, MD|614-293-8515|Kara.Rood@osumc.edu|
22295098|NCT01767155|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
22295099|NCT03725098|Biom'up|William Spotnitz, MD, MBA|351-514-5009|w.spotnitz@biomup.com|
22295100|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
22295101|NCT01756898|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22295102|NCT01500694|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22295103|NCT02837783|Ironwood Pharmaceuticals, Inc.|Lara Lane|(617) 621-7722|llane@ironwoodpharma.com|
22295104|NCT04774328|Concentric Analgesics|Carrie Khouri, Associate Director of Clinical Operations|1-415-484-7921|ckhouri@concentricanalgesics.com|
22308856|NCT05089734|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22308857|NCT05194514|Cedars-Sinai|Fardad Esmailian|310-248-7132|fardad.esmailian@cshs.org|
22308858|NCT03270956|ProKidney|to be determined|n/a|info@prokidney.com|
22308859|NCT06283173|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
22308860|NCT04873401|New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
22308861|NCT03457142|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22308862|NCT04060654|Indivior Inc|Sunita Shinde|804 379-1090|sunita.shinde@indivior.com|
22308863|NCT03707951|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22308864|NCT04887129|University of Rochester|John Foxe, Phd|585 - 275 - 2591|John_foxe@urmc.rochester.edu|
22308865|NCT04294290|Duke University|Joanne Kurtzberg, MD|919-668-1119|joanne.kurtzberg@duke.edu|
22308866|NCT04533347|Fast-Track Drugs and Biologics, LLC|Bernadette Tock|240-401-8634|btock@fasttrackresearch.com|
22308867|NCT05520190|University of Rochester|Aileen Aldalur|(585) 371-6125|aileen_aldalur@urmc.rochester.edu|
22308868|NCT04606069|University of Maryland Medical Center|Dr. Christine Lau, MD, MBA, Department of Surgery, Surgeon-in-Chief|410-328-8407|CLLau@som.umaryland.edu|
22308869|NCT04059770|Universidade Federal de Ciências da Saúde de Porto Alegre|Professor Alessandro C. Pasqualotto|5551999951614|pasqualotto@ufcspa.edu.br|
22308870|NCT04896476|Sonavex|Katy Feeny, Director of Clinical Affairs|443-862-2024|KFEENY@SONAVEX.COM|
22308871|NCT03476187|ZOLL|Nicole Bianco|4129683333|NBianco@zoll.com|14410
22308872|NCT04977947|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
22308873|NCT02921230|Boston Scientific|Andrew Campbell|763-494-2722|Andrew.Campbell@bsci.com|
22308874|NCT03445988|Stanford University|Beth Darnall, PhD|N/A|bdarnall@stanford.edu|
22308875|NCT05875142|We The Village, Inc.|Jane Macky, PI/CEO|91768344267|jane@wethevillage.co|
22308876|NCT04274764|University of Michigan|Paula Anne Newman-Casey|734 763-6967|panewman@med.umich.edu|
22308877|NCT05424549|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
22308878|NCT03662698|University of Colorado Hospital|Jamie Studts|303-724-2284|jamie.studts@cuanschutz.edu|
22308879|NCT05268393|Children's National Hospital|Dr. Eleanor Mackey|202-476-5307|emackey@childrensnational.org|
22308880|NCT03396926|University of California, San Francisco|Dr.Chloe Atreya, MD, PhD|(415) 353-9888|chloe.atreya@ucsf.edu|
22308881|NCT01728857|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22276625|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru|
22295105|NCT01900704|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22308882|NCT01396278|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295106|NCT02465216|IDRI|Dr. Corey Casper|2063810883|corey.casper@idri.org|
22295107|NCT04748120|Cleveland Clinic Foundation|Dr. Clayton Petro|216-444-3501|petroc@ccf.org|
22295108|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it|
22308883|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
22308884|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22308885|NCT04727554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22308886|NCT05763823|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22308887|NCT03778112|Rush University Medical Center|Dian Wang, MD|(708) 660-3476|Dian_Wang@rush.edu|
22308888|NCT05079789|University Hospital Tuebingen|Dr. Anja Schork|+49 707129 83172|Anja.Schork@med.uni-tuebingen.de|
22308889|NCT03891667|Lyme Research Center New York State Psychiatric Institute, New York, New York, United States, 10032|Dr. Brian A. Fallon|646-774-8052|baf1@cumc.columbia.edu|
22308890|NCT05659537|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22308891|NCT04971395|Xentria, Inc.|Tom Matthews, Director of Clinical Research|224.443.4615|tmatthews@xentria.com|
22308892|NCT04456517|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
22308893|NCT06213194|Ibn Haldun University|Dr. Dilruba Sönmez|905365646640|dilrubasonmez@gmail.com|
22308894|NCT02100813|LEO Pharma A/S|Clinical Trial Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22308895|NCT01963793|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22308896|NCT03575897|University of Alabama at Birmingham|Dr. Ariel Salas|205-934-4680|asalas@peds.uab.edu|
22308897|NCT03762915|University of Minnesota|Michelle Arnette|6126243457|marnett@umn.edu|
22308898|NCT03150810|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22308899|NCT03158714|Auburn University|Francesca Adler-Baeder|334-844-4151|adlerfr@auburn.edu|
22308900|NCT02737436|University of Iowa|Dr Lane Strathearn|2193849464|lane-strathearn@uiowa.edu|
22308901|NCT03936322|UNIVERSITY OF MIAMI|Rodrigo Ruano MD PhD|(305) 585-5610|rodrigoruano@hotmail.com|
22308902|NCT01160211|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22308903|NCT05551637|National Institute of Nutrient|Dr. Nguyen Song Tu|0912322602|nguyensongtu@gmail.com|
22308904|NCT04721912|University of New Mexico|Katrina Nardini, CNM, WHNP-BC, MPH|505-205-4118|hsc-familyplanningresearch@salud.unm.edu|
22308905|NCT02734290|Providence Portland Medical Center|Dr. David B. Page|5032156588|david.page2@providence.org|
22308906|NCT01814501|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-3873|John.Hays@osumc.edu|
22308907|NCT03829410|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
22308908|NCT03158129|MD Anderson Cancer Center|Tina Cascone, MD|713-792-6363|tcascone@mdanderson.org|
22308909|NCT05051124|NYU Langone Health|Jessica Gjonaj|646-501-3663|Jessica.gjonaj@nyulangone.org|
22308910|NCT04782973|Massachusetts General Hospital|Kaavya Paruchuri, MD|617-726-1843|kparuchuri@mgh.harvard.edu|
22308911|NCT04676022|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22308912|NCT02235909|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
22308913|NCT05894577|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
22308914|NCT03793972|UAntwerpen|Stefan Morreel|003232658721|stefan.morreel@uantwerpen.be|
22308915|NCT03274310|Columbia University Vagelos College of Physicians and Surgeons|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22308916|NCT03443388|University of Pennsylvania|Michael Gelfand, MD, PhD|215 662 3606|epilepsytrials@pennmedicine.upenn.edu|
22308917|NCT05916664|RSV Opco 5, Inc. (dba Kinto)|Joseph T Chung|(857) 600-2273|joe@kinto.care|
22308918|NCT04064164|University of Kansas School of Nursing|Kristine Williams|7859797879|kwilliams1@kumc.edu|
22308919|NCT05184894|Mayo Clinic|Erin Barreto, PharmD, MS|507-284-2511|barreto.erin@mayo.edu|
22308920|NCT06165146|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22266251|NCT04271020|NeoTract, Inc.|Emily Friedland, Director, Global Clinical Affairs|1-610-331-7299|emily.friedland@teleflex.com|
22266252|NCT02582866|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22266253|NCT03567382|University of North Carolina at Chapel Hill|Peyton Thompson, MD, MSCR|919-445-0854|peyton_thompson@med.unc.edu|
22266254|NCT02175576|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
22266255|NCT03564444|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
22308921|NCT05746455|Columbia University|Dr. Alice Saperstein|646-774-8464|ams2334@cumc.columbia.edu|
22266256|NCT03246646|CMC VA Medical Center|Steven L. Sayers|(215) 823-5196|steven.sayers@va.gov|
22266257|NCT02569112|Venus Concept Ltd.|Dr. Yoni Iger|8889070115|yoni@venusconcept.com|
22266258|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org|
22266259|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266260|NCT03480386|Mayo Clinic|Roberto P. Benzo, MD|507-284-0561|Benzo.Roberto@mayo.edu|
22266261|NCT02201290|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22308922|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
22308923|NCT03307343|West Virginia University|Bethany Barone Gibbs|304-581-1779|bethany.gibbs@hsc.wvu.edu|
22308924|NCT03477968|Diagnostica STAGO S.A.S|Nathalie THUILLIER|+33 146 882 167|nathalie.thuillier@stago.com|
22308925|NCT06190340|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
22308926|NCT06469138|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
22266262|NCT04639713|Novoxel Ltd|Ifat Klein|972-52-6009860|ifat@novoxel.com|
22266263|NCT01580813|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22276626|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22276627|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu|
22321941|NCT04681170|Amryt Pharmaceuticals DAC|Head of Clinical Operations|+35315180200|janet.boylan@amrytpharma.com|
22276628|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca|
22276629|NCT02641834|Department of Experimental and Clinical Medicine, University of Florence, Italy|Prof. Francesco Sofi|+390557949429|francescosofi@gmail.com|
22276630|NCT00657605|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
22276631|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276632|NCT05128942|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
22276633|NCT05942040|Rutgers University|Dr. Elizabeth Luth, Principal Investigator|6465120670|eluth@rwjms.rutgers.edu|
22276634|NCT03442569|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22276635|NCT06461455|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22276636|NCT06142383|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22276637|NCT05838664|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22276638|NCT03010501|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22276639|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov|
22276640|NCT02347787|University of Pennsylvania School of Medicine|Lindsey Norton|215-573-9961|lindsey.turr@uphs.upenn.edu|
22276641|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu|
22276642|NCT02260622|Ottawa Hospital Research Institute|Penny Phillips|613-737-8899|pphillips@ohri.ca|
22276643|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com|
22276644|NCT00308685|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22276645|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321942|NCT06414512|University of Minnesota|David Boulware|612-624-9996|idim@umn.edu|
22321943|NCT01394081|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|Lori.Davis@va.gov|3819
22321944|NCT01407926|McMaster University|Maureen Markle-Reid, Associate Professor and Canada Research Chair, School of Nursing|905-525-9140|mreid@mcmaster.ca|22306
22321945|NCT02468648|NIDDK|Marc Ghany, MD, MHSc|301-402-5115|marcg@intra.niddk.nih.gov|
22321946|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321947|NCT03963544|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trial Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22321948|NCT04232696|Neuspera Clinical Research|Mark Vollmer|612-281-4875|mark.vollmer@neuspera.com|
22321949|NCT00488982|University of California, San Francisco|Dr. Rahul Aggarwal|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
22321950|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22321951|NCT02754726|HonorHealth Research Institute|Erkut Borazanci, MD MS|4803231350|clinicaltrials@honorhealth.com|
22321952|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22321953|NCT01272999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22321954|NCT02952222|Boston Children's Hospital|Dr. Keira Mason|(617) 355-7737|keira.mason@childrens.harvard.edu|
22321955|NCT04852120|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22321956|NCT05215600|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
22321957|NCT03461445|UC Davis Health|Associate Professor of Medicine|916-734-5141|lxchen@ucdavis.edu|
22321958|NCT02872311|Marshfield Clinic Research Institute|Project Manager|715-389-5088|king.jennifer@marshfieldresearch.org|
22321959|NCT05617911|Gaylord Hospital|John Corbett|203-294-3224|jcorbett@gaylord.org|
22321960|NCT03557359|Columbia University|Fabio Iwamoto|212-342-0571|fi2146@cumc.columbia.edu|
22321961|NCT04868903|The University of Chicago|David Meltzer, MD, PhD|7737020836|dmeltzer@bsd.uchicago.edu|
22321962|NCT03975647|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22321963|NCT03735667|Boston Scientific|Sarah Zanon|+41 79 840 7006|sarah.zanon@bsci.com|
22321964|NCT03092726|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22321965|NCT02523040|Dana-Farber Cancer Institute|Eric Jacobsen, MD|857-215-1405|eric_jacobsen@dfci.harvard.edu|
22321966|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
22321967|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22321968|NCT05048342|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22321969|NCT04418765|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22321970|NCT02164422|Yale School of Medicine|Dr. Sherry McKee|2037373529|sherry.mckee@yale.edu|
22321971|NCT03345472|Medtronic Restorative Therapies Group, Spinal Cord Stimulation|Stacie Hallaway/Senior Clinical Research Specialist|763-526-3844|RS.VectorsPM@medtronic.com|
22321972|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22321973|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22321974|NCT04607733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22321975|NCT02296242|BioMed Valley Discoveries|Dean Welsch, PhD|8163898831|dwelsch@biomed-valley.com|
22321976|NCT02501265|Duke University School of Medicine|Dr. James Davis|919-668-5055|james.m.davis@duke.edu|
22321977|NCT02365714|Medstar Georgetown University Hospital|Sonali Rudra, M.D.|202-444-3320|sonali.rudra@gunet.georgetown.edu|
22321978|NCT03504397|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22321979|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org|
22321980|NCT02443883|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22321981|NCT02199080|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Antoine Milhem|+33546455050|antoine.milhem@ch-larochelle.fr|
22321982|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300||
22321983|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22321984|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org|
22321985|NCT03099707|Brigham and Women's Hospital|Ingrid T. Katz|617-525-8194|ikatz2@bwh.harvard.edu|
22321986|NCT03167073|Washington University of St Louis (where research was conducted). Now at Brown University|Dr. Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|47447
22321987|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22321988|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22321989|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22321990|NCT02866279|Montefiore Medical Center|Erika Levi|7184058200|elevi@montefiore.org|
22266264|NCT03589768|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@medicine.umaryland.edu|
22266265|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com|
22266266|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com|
22266267|NCT04241315|On Target Laboratories, Inc.|Tommy Lee|214-289-6422|tlee@ontargetlabs.com|
22266268|NCT03047330|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
22266269|NCT05773794|North Carolina A&T State University|Dr. Shengmin Sang|7042505710|ssang@ncat.edu|
22266270|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266271|NCT02487303|Medical University of South Carolina|Sylvia Wilson|8437921414|wilsosh@musc.edu|
22266272|NCT01392963|Seton Family of Hospitals|Katherine Sebastian|512-324-9999|krsebastian@seton.org|89612
22266273|NCT03783039|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
22266274|NCT02006693|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22266275|NCT01119508|UT MD Anderson Cancer Center|Dr. Sapna P. Patel, Assistant Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22266276|NCT01955837|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22266277|NCT00837473|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22266278|NCT02563106|Synthetic Biologics|Michael Kaleko, MD|(240) 238-3862|mkaleko@syntheticbiologics.com|
22266279|NCT02338193|Woman's Hospital|Dr Karen Elkind-Hirsch, Director of Research|225 231-5278|karen.elkind-hirsch@womans.org|
22266280|NCT04689867|University of Michigan|Lindsay Bornheimer|(734) 615-2915|bornheim@umich.edu|
22266281|NCT02240030|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
22266282|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22266283|NCT01735955|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22266284|NCT03317834|Smith+Nephew, Inc.|Helena Kyriakou|+1 8186995700|Helena.Kyriakou@smith-nephew.com|
22266285|NCT05084716|RAND|Laura Bogart|3103930411|lbogart@rand.org|
22266286|NCT03839823|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22266287|NCT01716715|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22266288|NCT04228783|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22266289|NCT00626392|Abbott|Medical Information Specialist|800-633-9110||
22266290|NCT03327792|Yale University|Dr. Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
22266291|NCT04576923|Indiana University|Samer Gawrieh, MD|317-278-9326|sgawrieh@iu.edu|
22266292|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov|
22266293|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu|
22266294|NCT03151811|Oncopeptides AB|Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22266295|NCT03002571|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22266296|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
22266297|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22266298|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com|
22266299|NCT04839692|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
22276646|NCT02583269|Wake Forest University Health Sciences|Study Nurse|336-713-7748|saverill@wakehealth.edu|
22276647|NCT03656133|Moffitt Cancer Center|Jimmy Caudell, MD, PhD|813-745-8226|jimmy.caudell@moffitt.org|
22276648|NCT03244189|Duke University|Charles D. Scales Jr, MD MSHS FACS|919-684-1999|chuck.scales@duke.edu|
22276649|NCT03393013|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22276650|NCT03860584|Ohio State University|Richard Bruno|8603358494|bruno.27@osu.edu|
22276651|NCT05800145|Wake Forest University Health Sciences|Deepak Palakshappa, MD|3367161795|dpalaksh@wakehealth.edu|
22276652|NCT02813447|Duke University Medical Center|Neil MacIntyre|919 681 2720|macin001@mc.duke.edu|
22276653|NCT04167670|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|Please email|medicalinformation@phathompharma.com|
22276654|NCT04827446|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22276655|NCT05399485|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276656|NCT02955394|University of Colorado Hospital|Anthony Elias|720-848-0300|anthony.elias@cuasnchutz.edi|
22276657|NCT03554473|National Cancer Institute|Dr. Anish Thomas|2407607343|anish.thomas@nih.gov|
22276658|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|
22276659|NCT04706403|UMass Chan Medical School|Dr. Kimberly Fisher|(508)8561975|Kimberly.Fisher@umassmemorial.org|
22276660|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu|
22276661|NCT05206604|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276662|NCT03735498|Massachusetts General Hospital|Dr. Deborah Forst|617-724-8770|dforst@partners.org|
22276663|NCT00160615|Cares|UCB|+1844 599||2273
22276664|NCT06059066|Houston Methodist Hospital|Julu Benoy|(713) 441-6455|jbenoy@houstonmethodist.org|
22276665|NCT05225727|The University of Texas Health Science Center at Houston|Melissa Peskin, PhD|713-500-9759|melissa.f.peskin@uth.tmc.edu|
22276666|NCT03928704|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22276667|NCT01631188|Rutgers University|Enrique Pantin, MD|7328900640|pantinej@rwmjs.rutgers.edu|
22276668|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu|
22276669|NCT05416515|Mayo Clinic|Peter Amadio, M.D.|507-538-1296|pamadio@mayo.edu|
22276670|NCT04575324|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
22276671|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22276672|NCT00943904|University of California, Riverside|Dr. Karen Noblett|(951) 827-7581|karen.noblett@ucr.edu|
22276673|NCT02582632|AbbVie|Global Medical Services|800-633-9110||
22276674|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org|
22276675|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276676|NCT02323334|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276677|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276678|NCT01617967|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|1-877-256-9526|medinfo@alnylam.com|
22276679|NCT04764539|iTherapy, LLC|Lois Brady, CEO|9258120037|lois@itherapyllc.com|
22276680|NCT00416949|SKCCC|George Sgouros|4106140116|gsgouros@jhmi.edu|
22276681|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
22276682|NCT03520569|University of Virginia|Eugene Barrett|434-924-1263|EJB8X@VIRGINIA.EDU|
22276683|NCT01178411|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276684|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu|
22276685|NCT00714272|eXcorLab GmbH|Dr. Horst-Dieter Lemke|+49-6022-812648|horstdieter.lemke@excorlab.de|
22276686|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22276687|NCT04368910|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22276688|NCT02265744|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22276689|NCT00923702|International Agency for Research on Cancer|Dr Partha Basu|+3347273|basup@iarc.fr|8167
22276690|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu|
22276691|NCT02249793|Upenn|Dr. Carsten Skarke|215-573-0673|cskarke@pennmedicine.upenn.edu|
22276692|NCT05950906|Calibr-Skaggs|Director of Clinical Operations|(858) 242-1000|abrooks@scripps.edu|
22276693|NCT02448043|Department of Ophthalmology, Northwestern University Feinberg School of Medicine|Dr. David J. Palmer|3126958150|dpalmermd@comcast.net|
22276694|NCT02635035|NYU Langone Health|Terry Leon|1 646 754 4841|Terry.Leon@nyulangone.org|
22276695|NCT04913636|Procter & Gamble|Clinical Trial Manager|513-622-4601|conde.e.1@pg.com|
22276696|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu|
22276697|NCT05399355|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
22295109|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22295110|NCT02927080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276698|NCT02337946|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22276699|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22276700|NCT02949934|University of Colorado School of Medicine|Joseph P. Schacht, Ph.D.|(303) 724-3773|joseph.schacht@cuanschutz.edu|
22308927|NCT04114877|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
22308928|NCT04471038|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sab.bio|
22308929|NCT04709783|University of Florida|Chiung-ju (CJ) Liu|352-273-6496|c.liu1@phhp.ufl.edu|
22308930|NCT05609760|Universidad de concepción|Rosa Figueroa I, Associate Professor|+56412204247|rosa.figueroa@biomedica.udec.cl|
22308931|NCT05179395|James A Haley Veterans' Hospital and Clinics|Dr. Jeffrey Heckman|813.972.2000|jeffrey.t.heckman@va.gov|7506
22308932|NCT06132867|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308933|NCT04222660|Iowa City VA Healthcare System|Dr. Mark Yorek|13193380581|mark.yorek@va.gov|637696
22308934|NCT04648033|University of Oxford|Professor Geoff Higgins|01865 617311|geoffrey.higgins@oncology.ox.ac.uk|
22308935|NCT03509116|Guy's & St Thomas' NHS Foundation Trust|Dr Alastair Duncan|02071882010|alastair.duncan@gstt.nhs.uk|
22308936|NCT05228730|Murdoch Children's Research Institute|Ms Kathryn Bright|+61 3 99366656|kathrynbright@mcri.edu.au|
22308937|NCT04318548|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22308938|NCT02651428|CorMedix Inc.|Head of Clinical Operations|908-517-9500|lmasson@cormedix.com|
22308939|NCT03366649|Emory University|Dr. Robert Guyton|404 686-4499|rguyton@emory.edu|
22308940|NCT01785719|Cornell University|Marla Lujan, PhD|(607) 255-3153|mel245@cornell.edu|
22308941|NCT05417009|Queen Mary University of London|Professor Gareth Ackland|02035940348|g.ackland@qmul.ac.uk|
22266300|NCT03511326|Galderma R&D SNC|CTA Coordinator|+33 0493 95 70 85|cta.coordinator@galderma.com|
22308942|NCT01333969|Hospital for Special Surgery|Dr. Stavros Memtsoudis|646-797-8522|MemtsoudisS@hss.edu|8522
22308943|NCT06020534|Erasmus Medical Center|Drs. Yitian Fang|+31 645680154|y.fang.1@erasmusmc.nl|
22308944|NCT04029688|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22308945|NCT03436290|Vanderbilt University Medical Center|Myrick Shinall, principal investigator|615-343-5613|ricky.shinall@vumc.org|
22308946|NCT00583349|Columiba University Medical Center|Dr. James McKiernan, John K. Lattimer Professor and Chair of Department of Urology|212-342-3976|jmm23@cumc.columbia.edu|
22308947|NCT01264406|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
22308948|NCT02924272|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22308949|NCT04682587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308950|NCT05087693|UNiversity of BRitish COlumbia|Michael Koehle|8229331|michael.koehle@ubc.ca|
22308951|NCT02884011|Rush University Medical Center|Joshua DeMott|312-947-0226|joshua_demott@rush.edu|
22308952|NCT00506519|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
22308953|NCT01186367|Memorial Sloan Kettering Cancer Center|Dr. Jessica Scott, PhD|646-888-8093|scottj1@mskcc.org|
22308954|NCT02975882|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22308955|NCT05116787|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22308956|NCT05275231|Emory University|Dr. Megha K. Shah|404-778-6944|mkshah@emory.edu|
22308957|NCT02919683|Dana-Farber Cancer Institute|Jonathan Schoenfeld, M.D. M.P.H.|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
22308958|NCT06181006|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22308959|NCT03867500|Mayo Clinic|Michael D. Jensen, M.D.|507-255-6515|jensen@mayo.edu|
22308960|NCT06205407|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22308961|NCT06491433|Department of Cardiology at Gangnam Severance hospital|Byoung Kwon Lee|+82-10-2721-8813|CARDIOBK@yuhs.ac|
22308962|NCT04572399|Cedars-Sinai|Melissa Hampton|3104230617|Melissa.Hampton@cshs.org|
22308963|NCT04749615|Hospital for Special Surgery|Justas Lauzadis, PhD|212-774-2946|lauzadisj@hss.edu|
22308964|NCT03611491|CROMA - PHARMA|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
22308965|NCT05796583|University of California San Diego|Professor of Anesthesiology|(858) 220-5714|bilfeld@health.ucsd.edu|
22308966|NCT05746494|University of Texas at Dallas|Dr. Linlin Fan|+(853) 8822 4226|linlin.fan@utdallas.edu; linlinfan@um.edu.mo|
22308967|NCT03153410|SKCCC Johns Hopkins Medical Institution|Ana De Jesus-Acosta, MD|443-287-0411|adejesu1@jhmi.edu|
22308968|NCT03408340|Emory University|Justin B. Long, MD, Associate Professor|404-785-6670|justin.bradley.long@emory.edu|
22308969|NCT04806451|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22308970|NCT05292365|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
22308971|NCT05282173|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22308972|NCT06398886|Istanbul Nisantasi Universitesi|Metin Çınaroğlu|009053247320|metincinaroglu@gmail.com|
22308973|NCT05891353|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
22308974|NCT01463423|Stanford University|Maximilian Diehn, MD, PhD|650-725-4783|diehn@stanford.edu|
22308975|NCT03134196|NYU Langone Health|Elisabeth Cohen, MD|9294552412|Elisabeth.Cohen@nyulangone.org|
22308976|NCT00875277|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22308977|NCT03800108|Cleveland Clinic|Dr. Darlene Floden|216-444-1298|flodend@ccf.org|
22321991|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu|
22321992|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com|
22321993|NCT01678144|Medtentia International Ltd Oy|Olli Keränen / CEO|+358 50 3567090|ok@medtentia.com|
22321994|NCT01885000|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22266301|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22308978|NCT04541147|Duke University|Eileen M. Raynor, MD|919-613-4573|eileen.raynor@duke.edu|
22266302|NCT03247816|Shield TX (UK) Limited|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22321995|NCT02792842|Asahi Kasei Pharma Corporation|Contact for Clinical Trial Information|+81-3-6699-3600|ct-info@om.asahi-kasei.co.jp|
22295111|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
22321996|NCT03716869|MS Hershey MC|Deepa Sekhar, Associate Professor of Pediatrics, Executive Director Penn State PRO Wellness|7175310003|dsekhar@pennstatehealth.psu.edu|281334
22321997|NCT03756038|University of Pittsburgh|Dr. Maria Pacella|412-647-3183|pacellam@upmc.edu|
22321998|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org|
22321999|NCT05801809|Spaulding Rehabilitation Hospital|Felipe Fregni, PI|6179526158|fregni.felipe@mgh.harvard.edu|
22322000|NCT05289830|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Jordan Winter|216-844-5777|Jordan.winter@uhhospitals.org|
22322001|NCT01046825|St. Jude Children's Research Hospital|Raul Ribeiro, MD|901-595-3694|raul.ribeiro@stjude.org|
22322002|NCT03382847|NYU LANGONE TRANSPLANT INSTITUTE|Dr. Bonnie Lonze|2122638365|Bonnie.Lonze@nyumc.org|
22322003|NCT00577993|UT MD Anderson Cancer Center|Nathan Fowler,MD, Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
22266303|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu|
22266304|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com|
22266305|NCT01439009|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
22266306|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22266307|NCT02955758|Stanford University|Dr. Joel W. Neal|(650) 498-6000|jwneal@stanford.edu|
22266308|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu|
22266309|NCT02704403|GENFIT|Carol Addy, MD MMSc|+01 6179536469|clinicaltrial@genfit.com|
22266310|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22266311|NCT01844856|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
22266312|NCT03340207|VA Western NY Healthcare System|Dr. Nader D. Nader|716-862-8707|nnader@buffalo.edu|
22266313|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300||
22266314|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk|
22266315|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266316|NCT02677714|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22266317|NCT02922738|University of Vermont|Marianne Burke|802-236-0075|marianne.burke@uvm.edu|
22266318|NCT02914210|Duke Clinical Research Institute|Janet Bettger, ScD|919-613-0379|janet.bettger@duke.edu|
22266319|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22266320|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266321|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu|
22266322|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424|swatisattavan@gmail.com|91
22266323|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22266324|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767||
22266325|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com|
22266326|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266327|NCT02640053|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
22266328|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu|
22276701|NCT04544267|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22276702|NCT04536038|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
22276703|NCT04530526|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22276704|NCT03770455|Tulane University School of Medicine|Jodi L. Layton, MD|504-988-6121|jlayton@tulane.edu|
22276705|NCT03686488|Moffitt Cancer Center|Dae Won Kim, MD|813-745-1277|daewon.kim@moffitt.org|
22276706|NCT03971422|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22276707|NCT01658878|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22276708|NCT03083379|University of Virginia Health System|Daniel D. Rowley, MSc, RRT-ACCS, FAARC|434-465-7235|ddr8a@virginia.edu|
22276709|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22276710|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com|
22276711|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
22276712|NCT03695094|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
22276713|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22276714|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22276715|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu|
22276716|NCT03927157|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22276717|NCT02965716|SWOG Data Management Center|Melanoma Committee Statistician|206-667-4623|jmoon@fredhutch.org|
22276718|NCT04022694|University of Pennsylvania|Deputy Director of PEACH Lab|2158987093|thepeachlab@gmail.com|
22276719|NCT02691663|Campbell University|Snezana Petrovic, MD, PhD, FASN|(910) 893-1751|spetrovic@campbell.edu|
22276720|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22266329|NCT02754856|University of Texas M D Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
22266330|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111|RSpielberger@coh.org|65298
22276721|NCT03158688|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22276722|NCT02942407|Duke Universitey|Christopher Granger, MD|919-668-8900|christopher.granger@duke.edu|
22276723|NCT05887908|Clinical Development Department|Meiji Seika Pharma Clinical Trial Administrator|(+81) 3-3273-3745|clinical-trials@meiji.com|
22276724|NCT03928743|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22276725|NCT03576846|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
22276726|NCT03325439|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22276727|NCT02315625|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@nih.gov|
22276728|NCT06132386|Johns Hopkins University|Grant Principal Investigator|410-375-4418|chendrix@jhmi.edu|
22276729|NCT02762604|Albert Einstein College of Medicine|Dr. Helena Blumen|7184303810|helena.blumen@einsteinmed.edu|
22276730|NCT06061952|University Hospitals Cleveland Medical Center|Martha Sajatovic, MD|216-844-2808|martha.sajatovic@UHHospitals.org|
22276731|NCT01405911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276732|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22276733|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011|martin.descarreaux@uqtr.ca|3791
22276734|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276735|NCT04937387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276736|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276737|NCT00153842|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|Cancer.Research.Nurse@Dartmouth.edu|
22276738|NCT03734809|The Chinese University of Hong Kong|Dr. Edwin Pun HUI|3505 2145|p_hui@clo.cuhk.edu.hk|
22276739|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com|
22276740|NCT03514017|Moffitt Cancer Center|Julio Chavez, MD, MS|813-745-4294|julio.c.chavez@moffitt.org|
22276741|NCT06901544|Ain Shams University, Faculty of Medicine|Osama Khalil|01010000903|Osama.Ahmed.Ahmed.Salem.Khalil@med.asu.edu.eg|
22276742|NCT02787291|Abbott CAHF CRM|Dr. Adam Cline- Clinical Scientist|818-493-2025|adam.cline@abbott.com|
22276743|NCT01807520|Novartis Pharmaceuticals|Study Director|862-778-8300||
22276744|NCT01258855|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22276745|NCT02405208|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22276746|NCT03600350|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD, PhD|(608) 263-4198|dm3@medicine.wisc.edu|
22276747|NCT02400736|Tuscaloosa VA Medical Center|Lori L. Davis, M.D.|205-554-2000|Lori.Davis@va.gov|1-3819
22276748|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com|
22276749|NCT00552058|UCB|Study Director|+1 877 822 9493||
22276750|NCT01779362|George Washington University Biostatistics Center|Sharon Edelstein, Lead Research Scientist|301-881-9260|sharone@bsc.gwu.edu|
22276751|NCT02985710|Massachusetts General Hospital|PI|6177260580|akaraa@mgh.harvard.edu|
22276752|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com|
22276753|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com|
22276754|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276755|NCT05558410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22276756|NCT02313272|Moffitt Cancer Center|Peter Forsyth, MD|813-745-3063|peter.forsyth@moffitt.org|
22276757|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22276758|NCT03446573|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276759|NCT02639559|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
22276760|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22276761|NCT03142750|Children's Hospital Colorado|Pediatric Surgery Research Fellow|720-777-5371|youngmeeyoungmee@gmail.com|
22276762|NCT02120079|Tufts Medical Center|Dr. Pedram Hamrah|617-636-5321|phamrah@tuftsmedicalcenter.org|
22276763|NCT04268979|Moffitt Cancer Center|Margaret Byrne, Ph.D.|813-745-5569|Margaret.Byrne@moffitt.org|
22276764|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
22322004|NCT02217566|Janssen Research & Development, LLC|Regional Medical Affairs Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22276765|NCT06413797|University of North Carolina at Chapel Hill, School of Medicine, Department of Family Medicine, and Lineberger Comprehensive Cancer Center|Leah Ranney, PhD, MA, Research Professor and Director of the Tobacco Prevention and Evaluation Progr|984-974-4888|leah_ranney@unc.edu|
22276766|NCT03914703|Zimmer Biomet|Jarrod Hunnicutt, Clinical Affairs Manager|574-453-7834|jarrod.hunnicutt@zimmerbiomet.com|
22276767|NCT04828486|Mayo Clinic|Nguyen H Tran MD MPH|507-284-2511|Tran.Nguyen@mayo.edu|
22276768|NCT06204887|Recep Tayyip Erdogan University|Dr. Ahter Şanal Çıkman|05069293341|ahter.sanalcikman@erdogan.edu.tr|
22276769|NCT04056468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22276770|NCT03833167|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22322005|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322006|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22322007|NCT02064387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276771|NCT06428591|Tandem Diabetes Care|Manager, Clinical Affairs|8583666900|clinicalaffairs@tandemdiabetes.com|
22322008|NCT03099486|Fox Chase Cancer Center|Dr. Namrata Vijayvergia|215-214-4283|Namrata.Vijayvergia@fccc.edu|
22276772|NCT02227199|University of Washington|Dr. Ajay Gopal|26-606-2037|agopal@uw.edu|
22322009|NCT03950973|University of Michigan School of Public Health, Department of Health Behavior & Health Education|Minal R. Patel, Ph.D, M.P.H|(734) 763-0087|minalrp@umch.edu|
22276773|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu|
22266331|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu|
22266332|NCT03541980|Newark Beth Israel Medical Center|Dr Cena Tejani|973 926 7337|ctejani5@gmail.com|
22266333|NCT03477903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22266334|NCT02819050|Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center|Virender Rehan|3102221965|vrehan@labiomed.org|
22266335|NCT06281171|dfusion Inc.|Lane Edwards, MPH, Project Director|8314402192|Lane.edwards@dfusioninc.com|
22266336|NCT01822275|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
22308979|NCT02222155|ChemoCentryx|Study Director|650-210-2900||
22308980|NCT04683744|Indiana University|Dr. Peter H. Schwartz|317-278-4037|phschwar@iu.edu|
22308981|NCT01798498|Croma Pharma|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
22308982|NCT05136417|Mayo Clinic|Dr. Mohamad Alkhouli|507-255-2502|Alkhouli.Mohamad@mayo.edu|
22308983|NCT04026555|Icahn School of Medicine at Mount Sinai|Dr. Matthew Levin|212-241-8382|matthew.levin@mssm.edu|
22308984|NCT04150900|University of Maryland, Baltimore|Dr. Ranee Mehra|410-328-4059|umgccregulatory@umm.edu|
22308985|NCT04592549|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22266337|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22266338|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
22266339|NCT03258853|Massachusetts General Hospital|Dr. Melissa Putman|617-726-1847|msputman@mgh.harvard.edu|
22266340|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
22266341|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22266342|NCT04036799|Hospital for Sick Children|Seema Mital, Staff Cardiologist|416-813-7418|seema.mital@sickkids.ca|
22266343|NCT04240392|Yale School of Medicine|Ariadna Forray, MD|203-785-2618|ariadna.forray@yale.edu|
22266344|NCT03785600|VA Portland Health Care System|Jonathan Elliott|503-220-8262|jonathan.elliott@va.gov|53874
22266345|NCT02185690|Princess Margaret Cancer Centre, University Health Network|Dr. Natasha Leighl, Sponsor-Investigator, Division of Medical Oncology|416-946-4645|natasha.leighl@uhn.ca|
22266346|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22266347|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com|
22266348|NCT04345601|Baylor College of Medicine|Dr. Laquisa Hill|713-441-1450|LaQuisa.Hill@bcm.edu|
22266349|NCT04086407|Sleep Systems|Director of Operations|978-835-7036|e.lyons@sleepsystems-llc.com|
22266350|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22266351|NCT01908907|Sanford Health|Lora Black, Senior Director of Clinical Research|605-328-1368|lora.black@sanfordhealth.org|
22266352|NCT04975191|Rutgers University|Dr. Danielle Dick|732-235-5607|Danielle.M.Dick@rutgers.edu|
22266353|NCT04684238|Sedana Medical AB|Ida Sverud|+46 8 124 052 00|medinfo@sedanamedical.com|
22266354|NCT02711878|Emory university|Dr. Eun Ok IM|404-712-9805|eun.ok.im@emory.edu|
22266355|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266356|NCT01996449|UT Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|Wanpen.Vongpatanasin@UTSouthwestern.edu|
22266357|NCT04176406|Duke University|Dr. Lawrence G. Appelbaum|919-613-7664|greg@duke.edu|
22266358|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22266359|NCT01724489|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
22266360|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu|
22266361|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22266362|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com|
22266363|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu|
22266364|NCT04314648|RAND|Dr. Allison Ober|3103930411|ober@rand.org|6639
22266365|NCT02740114|UT MD Anderson Cancer Center|Pedro Ramirez, MD /Professor, Gyn Onc & Reproductive Med|713-745-5498|peramire@mdanderson.org|
22266366|NCT02861014|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22266367|NCT02201212|Dana Farber Cancer Institute|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
22266368|NCT04623086|University of Washington|Arthi Thirumalai|206-221-0521|arthidoc@uw.edu|
22266369|NCT03464630|Georgia State University|Dr. Kathleen Baggett|404-413-1571|kbaggett@gsu.edu|
22266370|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22266371|NCT03007238|City of Hope Medical Center|Dr. Amandeep Salhotra|626-359-8111|asalhotra@coh.org|
22266372|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org|
22308986|NCT06429319|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
22266373|NCT04524364|Biosense Webster, Inc.|Associate Director - Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22266374|NCT02309138|University of Pittsburgh|Director of Center for Research on Health Care Data Center|412-692-2023|dcenter@pitt.edu|
22266375|NCT03904264|Department of Veterans Affairs|Tara Zaugg, AuD / CRH REC Consultant, VISN 20 and REC ICC Clinical Lead, VISN 20|208-422-1000|tara.zaugg@va.gov|
22266376|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052|anohria@partners.org|617
22266377|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743||
22266378|NCT00380744|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22266379|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu|
22266380|NCT01497808|University of Pennsylvania|Dr. Amit Maity|(215) 615-6767|maity@uphs.upenn.edu|
22266381|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200|hyli38@adm.cgmh.org.tw|3967
22308987|NCT04295798|Hebrew SeniorLife|Junhong Zhou|617-971-5346|JunhongZhou@hsl.harvard.edu|
22266382|NCT02467478|GW MFA|Sabyasachi Sen|3014616676|ssen1@gwu.edu|
22308988|NCT04650269|University of Miami Miller School of Medicine|Hansel Tookes|3056897030|hetookes@miami.edu|
22266383|NCT02763826|Medical University or SC|Scott Hutchison, Manager of COBRE Research Operations|843-792-2712|hutchis@musc.edu|
22266384|NCT01559389|Loyola University Medical Center|Elizabeth Mueller, MD|708-216-2180|emuelle@lumc.edu|
22266385|NCT02871492|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22266386|NCT04546724|Valn|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
22266387|NCT03583086|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22266388|NCT04113785|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
22266389|NCT00435812|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22266390|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22266391|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu|
22266392|NCT03201445|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22266393|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266394|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
22266395|NCT00724048|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22266396|NCT04874155|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
22266397|NCT03735316|Mayo Clinic|James A. Nelson, M.B.B.S.|480-342-1800|Nelson.James1@mayo.edu|
22266398|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266399|NCT02329847|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22266400|NCT05330468|Abbott|Director, Clinical Programs Structural Interventions & Cardiac Surgery|(651)-202-8362|ryan.palmer@abbott.com|
22266401|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22266402|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
22266403|NCT02828241|Dr. Reddy's Laboratories|Katherine D'Angelo|609-282-1400|kdangelo@drreddys.com|
22266404|NCT04572893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22266405|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org|
22266406|NCT05034276|University of Utah|Eric Garland|801-581-3826|eric.garland@socwk.utah.edu|
22266407|NCT02103270|The Sean N. Parker Center for Allergy Research at Stanford|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|9544465645|andresap@stanford.edu|
22266408|NCT03316378|University of Iowa, Department of Physical Therapy & Rehabilitation Science|Ruth Chimenti, Assistant Professor|319-335-9791|ruth-chimenti@uiowa.edu|
22266409|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743||
22266410|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694|cristiana.forni@ior.it|0039
22266411|NCT03276780|University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology|Dr. Karen Cropsey|205-975-4204|kcropsey@uabmc.edu|
22266412|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu|
22266413|NCT02683265|Rhodes Pharmaceuticals L.P.|Inder Chaudhary|401-262-9272|inder.chaudhary@rhodespharma.com|
22266414|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22266415|NCT03365011|Washington University School of Medicine in St. Louis|Jay F. Piccirillo, MD, FACS|(314) 362-8641|piccirij@wustl.edu|
22266416|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
22266417|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu|
22266418|NCT03395405|Northwestern University Feinberg School of Medicine|Michael G Ison|3126954186|mgison@northwestern.edu|
22266419|NCT03722589|Centers for Disease Control and Prevention|Fatimah Dawood, Medical Officer|404-639-0431|hgj0@cdc.gov|
22266420|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu|
22266421|NCT04308226|Division of General Internal Medicine, Massachusetts General Hospital|Travis Baggett, MD, MPH|617-643-9314|tbaggett@mgh.harvard.edu|
22266422|NCT05307510|The University of Toledo|Laura Schmelzer|419-530-5068|laura.schmelzer@utoledo.edu|
22266423|NCT05264129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22266424|NCT00761657|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22266425|NCT04648696|Wake Forest University Health Sciences|John Williamson, PhD|336.713.3431|johnwill@wakehealth.edu|
22266426|NCT03593538|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
22266427|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22266428|NCT03035929|Vanderbilt University Medical Center|Grace Henderson, Study Coordinator|615-936-5356|grace.henderson@vumc.org|
22266429|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
22266430|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr|
22266431|NCT01564537|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22266432|NCT00573378|University of Michigan Rogel Cancer Center|Dale L. Bixby, MD|734-936-4991|dbixby@med.umich.edu|
22266433|NCT03964649|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266434|NCT02784444|Cirius Therapeutics Inc.|Jules Lee|8583336274|jlee@ciriustx.com|514
22266435|NCT05119348|Desmond Tutu Health Foundation|Dr. Philip Smith|+27216501895|Philip.Smith@hiv-research.org.za|
22266436|NCT01664130|Case Comprehensive Cancer Center|Kevin Stephans MD|216-445-8285|stephak@ccf.org|
22266437|NCT02679235|University of Sherbrooke|Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22266438|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22322010|NCT02436876|Microbion Corporation|Brett Baker, President and Chief Innovation Officer|4065991190|bbaker@microbioncorp.com|
22322011|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22322012|NCT01290692|Saint Lukes Hospital KC, Missouri and Washington University School of Medicine, St.Louis Missouri|Michael E. Salacz,MD and David Tran,MD, PH.D|9134922221|gwood@tvaxbiomedical.com|
22322013|NCT02780648|IndianaU|Dr. Robert Miller|317-944-1317|millro@iu.edu|
22322014|NCT00265538|Iowa City VA Health Care System|Dr. Peter Kaboli|319-338-0581|Peter.kaboli@va.gov|
22322015|NCT03557892|University of Florence Medical School and AOU Careggi|Dr Ilaria Dicembrini|+393387861041|Ilaria.dicembrini@unifi.it|
22322016|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22322017|NCT02685709|Amryt|Asi Haviv, VP Clinical development|972 8 9393888|Asi@amrytpharma.com|
22322018|NCT03127384|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22322019|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
22322020|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
22322021|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu|
22322022|NCT04417894|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22322023|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu|
22322024|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu|
22322025|NCT04036968|Johns Hopkins University School of Medicine|Kelly Dunn, Professor|410-550-2254|kdunn9@jhmi.edu|
22322026|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322027|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22322028|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se|
22322029|NCT03074474|TELA Bio|Neal Overbeck|484-802-9570|noverbeck@telabio.com|
22322030|NCT02189850|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22322031|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585|Julie.Wetherell@va.gov|2752
22322032|NCT03441178|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
22322033|NCT04817111|Children's Hospital of Philadelphia|Dr. Shana McCormack|215-590-3174|mccormacks1@email.chop.edu|
22322034|NCT00713583|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22322035|NCT05073458|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22322036|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
22322037|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com|
22266439|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br|
22266440|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266441|NCT03146962|Weill Cornell Medicine|Dr. Manish Shah, Sponsor-Investigator|646-962-6200|mas9313@med.cornell.edu|
22266442|NCT02383810|Helsinn Healthcare SA|Director of Clinical Division|+41 91 9852121|info@helsinn.com|
22266443|NCT02105558|The University of Texas Health Science Center at Houston|Madhumani Rupasinghe, MD|(713) 500-6200|Madhumani.Rupasinghe@uth.tmc.edu|
22266444|NCT01635283|Jonsson Comprehensieve Cancer Center|Dr. Robert Prins|310-825-7647|rprins@mednet.ucla.edu|
22266445|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com|
22266446|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22266447|NCT04516759|St George Street Capital|Mike Johnson, Managing Director|+447768335460|mike@sgscapital.org|
22266448|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
22266449|NCT01551030|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@MSKCC.ORG|
22266450|NCT03416829|Massachusetts General Hospital|Jarrad H Van Stan|617-643-8410|jvanstan@mghihp.edu|
22266451|NCT02351271|Ziemer Ophthalmic Systems AG|Sarah Moyle|970 308 9199|sarah.moyle@ziemergroup.com|
22266452|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org|
22266453|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22266454|NCT03769207|Stanford University|Marco Perez, Associate Professor of Medicine|(650) 723-9363|mvperez@stanford.edu|
22266455|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266456|NCT02774642|San Diego VA Healthcare System|Dr. Peter Colvonen|858-552-8585|peter.colvonen@va.gov|2468
22266457|NCT03835221|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22266458|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22266459|NCT02288182|gwd consult · contract research|Dr. Manfred Klasser|+49 (6108) 8256520|manfred.klasser@gwd-consult.de|
22266460|NCT01088802|Johns Hopkins Medicine|Harry Quon, MD|410-502-3877|hquon2@jhmi.edu|
22266461|NCT04619992|Hollister Incorporated|Director of Global Clinical Affairs|+1 224-206-2857|sara.wegener@hollister.com|
22266462|NCT03582826|MEBO Research|Maria De la Torre, Executive Director|786 228-6880|maria.delatorre@meboresearch.org|
22266463|NCT00499174|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
22266464|NCT01214915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22276774|NCT03003962|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22322038|NCT05913232|D. Western Therapeutics Institute, Inc.|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
22322039|NCT05103332|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22322040|NCT04428476|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
22295112|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
22266465|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu|
22266466|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
22266467|NCT02519738|University of Michigan|Ron Hirschl|734 764-6482|rhirschl@med.umich.edu|
22266468|NCT00469911|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-0183|groplerr@mir.wustl.edu|
22266469|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com|
22266470|NCT04180163|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22266471|NCT04730349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22266472|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu|
22266473|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
22266474|NCT03753763|Zambon S.p.A.|Director of Clinical Trial - Charlotte Keywood, MD|+39 02 665241|charlotte.keywood@zambongroup.com|
22266475|NCT01104779|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
22295113|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300||
22266476|NCT02342639|University of Kansas Medical Center|Dr. Jason Stubbs|9135886074|jstubbs@kumc.edu|
22266477|NCT01246063|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@wustl.edu|
22266478|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933||
22266479|NCT03558061|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22266480|NCT03483363|The University of Texas Health Science Center at Houston|Nagi Demian, MDDS|(713) 500-5082|Nagi.Demian@uth.tmc.edu|
22266481|NCT01372774|Mayo Clinic|Paul D. Brown, M.D.|(713) 563-2415|brown.paul@mayo.edu|
22266482|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266483|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22266484|NCT03936101|Columbia University|Jessica L Giordano, CGC|516-521-5604|jlg2197@cumc.columbia.edu|
22266485|NCT04324073|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|+33(0)1.42.34.89.87|raphael.porcher@aphp.fr|
22266486|NCT03665441|Erytech Pharma Inc|Anu Gupta, Senior Study Team Lead|7327424937|anu.gupta@erytech.com|
22266487|NCT03610516|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22266488|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu|
22266489|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22266490|NCT02657928|Mayo Clinic|Gerardo Colon-Otero, MD|904/953-2000|gcolonotero@mayo.edu|
22266491|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu|
22266492|NCT02500043|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22266493|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu|
22266494|NCT01403051|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22266495|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
22266496|NCT03134248|CooperVision|Jose A.Vega OD MSc., FAAO|9256213761|javega@coopervision.com|
22266497|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl|
22266498|NCT02932306|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
22266499|NCT05776862|University of Miami|Mark Nash, PhD|305-243-3628|mnash@med.miami.edu|
22266500|NCT02448706|Northwestern University|Pamela Souza|8474912433|p-souza@northwestern.edu|
22266501|NCT02065700|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22266502|NCT02315196|Cancer Institute of New Jersey|Deborah L Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
22266503|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es|
22266504|NCT03262038|University of Michigan|Elizabeth Putnam|734-763-2435|eread@umich.edu|
22266505|NCT04933968|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
22266506|NCT04732624|University of Washington/Nepal cleft and burn center|Dr. Raslina Shrestha|+977 9849978888|raslinas@uw.edu|
22266507|NCT02278055|Memorial Sloan Kettering Cancer Center|Dr. Michael Morris, MD|646-422-4469|morrism@MSKCC.ORG|
22266508|NCT01934335|Holden Comprehensive Cancer Center|Ronald Weigel, MD, PhD|319-353-7474|ronald-weigel@uiowa.edu|
22266509|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca|
22266510|NCT02137486|cardiovascular section|taipei city hospital Ren-Ai branch|0088627093600|chenyuehchung.tw@yahoo.com.tw|3741
22266511|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff|
22276775|NCT05179603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22295114|NCT02670083|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295115|NCT02825992|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|763-331-4344|steven.mcquillan@acutus.com|
22295116|NCT05620563|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22295117|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22295118|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu|
22295119|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295120|NCT02573350|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22295121|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov|
22276776|NCT05937373|Wake Forest University Health Sciences|Susan R. Vishneski, MD|336-306-0778|svishnes@wakehealth.edu|
22276777|NCT01750073|University of Nebraska Medical Center|Amulya C Yellala|402-559-5388|amulya.yellala@unmc.edu|
22276778|NCT04337021|Cprl. Michael J. Crescenz VA Medical Center|Dr. Amy Helstrom|215-823-4164|amy.helstrom@va.gov|
22276779|NCT06375655|University Hospitals Cleveland Medical Center|Dr. Furman|216-844-3971|Lydia.Furman@UHhospitals.org|
22276780|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22276781|NCT00567580|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22276782|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276783|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276784|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il|
22276785|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu|
22276786|NCT04621760|University of California, San-Francisco|Dr. Dominika Seidman|(415) 353-2119|Dominika.Seidman@ucsf.edu|
22276787|NCT05141357|HUYABIO International|Chief Medical Officer|(858) 798-8800|Glee@huyabio.com|
22322041|NCT02043548|University of Pittsburgh|Chester Oddis, MD|412-383-8861|cvo5@pitt.edu|
22276788|NCT01028560|Jacobi Medical Center / Albert Einstein College of Medicine|Gabriele de Vos, M.D.|7184152809|gabriele.de-vos@einstein.yu.edu|
22276789|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu|
22276790|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110||
22276791|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22276792|NCT02029443|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22276793|NCT03123588|Incyte Corporation|Call Center|1.855.463.3463|medinfo@incyte.com|
22276794|NCT04740567|Vanderbilt University Medical Center|Jin H. Han|615-936-0253|jin.h.han@vumc.org|
22276795|NCT02063724|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Czerniecki|813-745-7575|brian.czerniecki@moffitt.org|
22276796|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276797|NCT02697422|VA Puget Sound Health Care System|Dr. Karin Nelson|(206)277-4507|karin.nelson@va.gov|
22276798|NCT02991521|Medical City Arlington, 3301 Matlock Rd, Arlington, TX 76015|Danielle A Pigneri, MD, FACS|(502) 387-3117|dpigneri@gmail.com|
22322042|NCT01425008|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22266512|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu|
22276799|NCT02068599|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22276800|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org|
22276801|NCT03019588|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276802|NCT00366535|Symptoms Biology Unit, DIR, NINR, NIH|Leorey Saligan, Chief|301-451-1685|saliganl@mail.nih.gov|
22276803|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590||
22276804|NCT02958527|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276805|NCT03573700|St. Jude Children's Research Hospital|Aimee Talleur, MD|8662785833|referralinfo@stjude.org|
22276806|NCT06042855|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
22276807|NCT05901467|Massachusetts General Hospital|Stephanie Seminara|617-726-1309|MGHKisspeptinResearch@partners.org|
22276808|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@isca.vghks.gov.tw|8233
22276809|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171|sherri.smith@va.gov|7569
22276810|NCT02939781|Great Ormond Street Hospital NHS Trust|Dr Samiran Ray|4420274059200|samiran.ray@gosh.nhs.uk|8213
22276811|NCT06100250|University of Michigan|Dr. Akshay Sharma|734-647-0151|akshaydr@umich.edu|
22266513|NCT02876757|ICES Western|Blayne Welk|5196466000|blayne.welk@sjhc.london.on.ca|
22266514|NCT03016975|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22266515|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22266516|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22266517|NCT02910011|University of Florida|Dr. Anna DeBenedetto|352 594 1500|adebenedetto@dermatology.ufl.edu|
22266518|NCT00838435|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22266519|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266520|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266521|NCT01147107|University of Hawaii at Manoa John A Burns School of Medicine|Dr. Cecilia Shikuma|8086921328|shikuma@hawaii.edu|
22266522|NCT04435184|Johns Hopkins University - Baltimore, MD|Dr. Charles Lowenstein|4105020391|clowens1@jhmi.edu|
22266523|NCT04693416|University of Tennessee Health Science Center|Karen Derefinko, PhD|901-448-2526|kderefin@uthsc.edu|
22266524|NCT02290223|Kaiser NCAL Division of Research|Monique Does, Project Manager|510-891-3612|monique.does@kp.org|
22266525|NCT05293639|Johnson & Johnson MedTech|Reecha Sharma|949.789.3919|rshar120@its.jnj.com|
22266526|NCT02143648|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22266527|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com|
22266528|NCT01695863|Aurora Gastroenterology, West Allis WI|Maqsood Khan MD FACG|414-328-8750|mkhangi@yahoo.com|
22266529|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22322043|NCT03359759|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22266530|NCT00589329|MetroHealth Medical CEnter|Larraine Presley|216-778-8927|lpresley@metrohealth.org|
22276812|NCT03159195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276813|NCT05259033|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22276814|NCT05537571|Silence Therapeutics plc|Global Regulatory|+442034576900|global-regulatory@silence-therapeutics.com|
22276815|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276816|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
22276817|NCT02530242|UCSF Benioff's Children's Hospital Oakland|Ashutosh Lal, MD||Ashutosh.Lal@ucsf.edu|
22276818|NCT00283959|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22276819|NCT03837938|Dompé Farmaceutici SpA|Mauro P Ferrari, Pharm D|+39 02 583831|clinical.trials@dompe.com|
22276820|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com|
22276821|NCT05865886|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22276822|NCT06394323|University of North Carolina at Chapel Hill|Lauren Hill, PhD|919-966-5771|hilllm@ad.unc.edu|
22276823|NCT05136430|Brown University|Cara M. Murphy, Ph.D.|4018636519|murphybrownlab@brown.edu|
22308989|NCT04091750|Georgetown University|Geoffrey T. Gibney, MD|202-444-2223|Geoffrey.T.Gibney@gunet.georgetown.edu|
22308990|NCT02919306|Janssen Vaccines and Prevention BV|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22308991|NCT04293055|The Miriam Hospital|Dr. Jacqueline Hayes|401-793-8917|jhayes3@lifespan.org|
22308992|NCT02649842|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|1+ 714-247-8429|djanaki1@its.jnj.com|
22308993|NCT04625283|Vanderbilt University Medical Center|Dr. Britany Martin|+1 (615)322-8476|britany.l.raymond@vumc.org|
22308994|NCT01824394|Biosense Webster, Inc.|Megan Holden|(949) 923-4700|mholden8@its.jnj.com|
22308995|NCT02619838|Duke University|Mark Easley, M.D.|919-660-5066|mark.e.easley@duke.edu|
22308996|NCT01715285|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22308997|NCT05020249|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22308998|NCT05364671|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22308999|NCT04015167|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22309000|NCT05794243|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309001|NCT05733975|Duke Univerisity Medical Center|Dr. Monica Lemmon|919-668-0477|monica.lemmon@duke.edu|
22309002|NCT03637660|University of Alabama at Birmingham|Edward W. Hook, III|205-932-4204|ehooks@uabmc.edu|
22309003|NCT05297864|University of Oklahoma Health Sciences Center|James Battiste, MD|405-271-8777|James-Battiste@ouhsc.edu|
22309004|NCT05093829|University of Maryland School of Medicine|Wilbur H. Chen, M.D., M.S., FACP, FIDSA|410-706-5328|wchen@som.umaryland.edu|
22309005|NCT02727699|Actinogen Medical Limited|Director of Drug Development & Strategy|+61289647401|info@actinogen.com.au|
22309006|NCT05065658|Medical University of Graz|Dr. Juergen Prattes|004331638530046|juergen.prattes@medunigraz.at|
22309007|NCT01926496|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
22309008|NCT02677298|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22309009|NCT03210272|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309010|NCT03611621|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
22309011|NCT05441579|Nationwide Children's Hospital|Dr. Vanessa Olbrecht|614-722-4200|vanessa.olbrecht@nationwidechildrens.org|
22309012|NCT03064217|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
22309013|NCT02143726|Memorial Sloan-Kettering Cancer Center|Eric J. Sherman, M.D.|646-888-4234|shermane@mskcc.org|
22309014|NCT03812679|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22309015|NCT05653427|Janssen Research & Development, LLC|Global Medical Head Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309016|NCT04574024|Rutgers, The State University of New Jersey|Suhayl Dhib-Jalbut|732-235-7335|jalbutsu@rwjms.rutgers.edu|
22309017|NCT03524118|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22309018|NCT03483610|University of Rochester|Research Administrator|585-274-1509|peter_macdowell@urmc.rochester.edu|
22309019|NCT01437709|Memorial Sloan Kettering Cancer Center|Dr. Paul Hamlin, MD|646-608-1667|hamlinp@mskcc.org|
22309020|NCT03916042|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22309021|NCT05533359|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
22309022|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22309023|NCT02761057|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
22309024|NCT04971681|Indiana University|Dr. Martin H. Plawecki, MD, PhD|3179486550|mplaweck@iu.edu|
22309025|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
22309026|NCT03798093|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
22309027|NCT04376502|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
22309028|NCT04111536|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
22309029|NCT04547920|Avation Medical|Clinical Operations Project Manager|(614) 591-4201|customercare@avation.com|
22309030|NCT06037369|Chang Gung University, Taiwan|Yen-Fan Chin|032118800|yenfan@mail.cgu.edu.tw|5189
22309031|NCT04209465|Black Diamond Therapeutics, Inc.|Medical Monitor|617-401-8444|ClinicalTrials@bdtx.com|
22276824|NCT01501513|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
22276825|NCT02740582|University of California, San Franciso|Jennifer Mitchell, PhD|510-985-3522|jennifer.mitchell@ucsf.edu|
22276826|NCT05675020|Florida State University|Rachel Sharp|850-865-4443|rls14c@fsu.edu|
22266531|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com|
22266532|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org|
22266533|NCT01671332|University of Wisconsin|Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
22266534|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com|
22266535|NCT02722148|University of North Carolina at Chapel Hill|Dr. Evan S. Dellon|(919) 966-2513|evan_dellon@med.unc.edu|
22266536|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22266537|NCT01458106|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22266538|NCT01425723|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
22266539|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266540|NCT03982199|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22266541|NCT03433755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22266542|NCT06913153|Tianjin Medical University|Zhenqiang Song, M.S., Associate Professor and Master's Supervisor|8622-18602276218|Zsong@tmu.edu.cn|
22266543|NCT05065567|SpectrumLakeland|Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
22266544|NCT05323123|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
22266545|NCT05529472|Abbott Vascular|Ikuko Kishimoto, Principal Clinical Scientist|651.756.4878|ikuko.kishimoto@abbott.com|
22266546|NCT02886624|Hôpital Saint Antoine|Prof. Karine Lacombe|+33 1 49 28 24 38|karine.lacombe2@aphp.fr|
22266547|NCT03796598|Richmond VA Medical center|Jasmohan Bajaj|8046755802|jasmohan.bajaj@va.gov|
22266548|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22266549|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
22266550|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu|
22266551|NCT02929056|Prisma Health|Dr. Thomas Oliver|864-454-8272|Tom.Oliver@prismahealth.org|
22266552|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22266553|NCT02420912|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD/Associate Professor|713-745-6080|njain@mdanderson.org|
22266554|NCT02245412|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22266555|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266556|NCT01917916|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266557|NCT01650584|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22266558|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu|
22266559|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu|
22266560|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
22266561|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu|
22266562|NCT05424679|Johns Hopkins Center for Indigenous Health|Dr. Emily Haroz|(410) 449-0051|eharoz1@jhu.edu|
22266563|NCT03758716|Oneness Biotech Co., Ltd.|NienYi Chen PhD|+886 2 2655 8687|nienyichen@onenessbio.com.tw|613
22266564|NCT03156504|Mayo Clinic|Dr. Jennifer Vande Voort|507-255-6782|VandeVoort.Jennifer@mayo.edu|
22266565|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
22266566|NCT05048329|NorthShore university HealthSystem|Nirav S Shah|847-570-3542|nshah@northshore.org|
22266567|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com|
22266568|NCT02618759|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22266569|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org|
22266570|NCT03301649|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22266571|NCT03559400|University of California, San Francisco|David Shearer, MD, MPH, Associate Professor|628-206-8812|david.shearer@ucsf.edu|
22266572|NCT03323437|Weill Cornell Medicine|Dr. Dikoma C. Shungu|212-746-2481|dcs7001@med.cornell.edu|
22266573|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266574|NCT04505956|Vanderbilt University Medical Center - Department of Urology|Nicole Miller, M.D.|(615) 322-3807|nicole.miller@vumc.org|
22266575|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org|
22266576|NCT02656069|Xeris Pharamaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
22266577|NCT03257865|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22266578|NCT03857750|Rigshospitalet|Dr. Matias Vested|+4524464955|matiasvested@gmail.com|
22266579|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266580|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22266581|NCT01377987|Brigham and Women's Hospital|Dr. Scott Sands|617 278 0911|sasands@bwh.harvard.edu|
22266582|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266583|NCT00469144|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22266584|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266585|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266586|NCT02227446|METRC|Susan Collins|4105028966|scolli21@jhu.edu|
22266587|NCT03369197|The Johns Hopkins University|Dr. Laeben Lester|410-955-7519|llester4@jhmi.edu|
22295122|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
22295123|NCT02309489|King's College London, UK|Dr Marina Daniele|020 7836 5454|marina.daniele@kcl.ac.uk|
22295124|NCT02547649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295125|NCT04326231|Cognoa|Senior Director of Clinical Research|4082076659|minda.seal@cognoa.com|
22295126|NCT03303079|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22322044|NCT04818593|NYU Langone Health|Rani Fritz, DO, PhD, FACOG|718-935-9766|rani.fritz@nyulangone.org|
22322045|NCT02600494|Intra-Cellular Therapies, Inc.|Vice President, Clinical Development|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22322046|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22295127|NCT03454997|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22295128|NCT05259696|Palleon Pharmaceuticals|Palleon Clinical Development|857-285-5900|clinical@palleonpharma.com|
22295129|NCT03857243|UTSW|Timea Hodics, M.D.|(240)-423-2741|Timea.Hodics@UTSouthwestern.edu|
22295130|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
22295131|NCT00586001|Boston University Charles River Campus|Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
22295132|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
22295133|NCT01830972|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
22295134|NCT02117648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295135|NCT01815515|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
22295136|NCT05025241|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
22295137|NCT02670837|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
22295138|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu|
22295139|NCT02266225|University of Waterloo|Dr. Lora Giangregorio|519-888-4567|lora.giangregorio@uwaterloo.ca|36357
22295140|NCT03856164|University of Texas Southwestern|Dr. Olutoyosi Ogunkua|2145578873|olutoyosi.ogunkua@utsouthwestern.edu|
22295141|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300||
22295142|NCT03782272|PATH|Gwen Ambler, Clinical Research Officer|+1-206-285-3500|gambler@path.org|
22295143|NCT05860647|HealthPartners Institute Neuroscience Research Center|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
22295144|NCT02532972|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736981|Daniel_Lee@meei.harvard.edu|
22295145|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
22295146|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295147|NCT02603419|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295148|NCT02925494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22295149|NCT02845453|Boston Medical Center|Amy Yule, MD|617-414-1936|amy.yule@bmc.org|
22295150|NCT02911753|University of Arizona|David O. Garcia, PhD, FACSM|520-626-4641|davidogarcia@email.arizona.edu|
22295151|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org|
22295152|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
22295153|NCT02007109|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
22295154|NCT03572062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295155|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22295156|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org|
22295157|NCT03978520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22295158|NCT02760069|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April.mil@mail.mil|
22295159|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu|
22295160|NCT00600483|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22295161|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com|
22295162|NCT02343627|Taro Pharmaceuticals U.S.A. Inc|Senior Director, Clinical|+1 914-345-900|Natalie.Yantovskiy@Taro.com|
22295163|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22295164|NCT03031678|MED-EL Corporation|Allison Racey|1-888-633-3524|research.us@medel.com|
22295165|NCT03694821|UConn Health|Director of Outcomes, Research & Quality|860-679-4932|mcote@uchc.edu|
22295166|NCT02421315|New York State Psychiatric Institute|Dr. Rachel Marsh|646-774-5774|rachel.marsh@nyspi.columbia.edu|
22295167|NCT01317030|Bausch & Lomb Incorporated|Robert Steffen, O.D., M.S.|585-338-6399|Robert.Steffen@bausch.com|
22295168|NCT05109442|Affimed GmbH|Clinical Operations|+49 621 56003-0|trials@affimed.com|
22295169|NCT03898362|VA Pittsburgh Healthcare System|Dr. Brad Dicianno|412-822-3700|brad.dicianno@va.gov|
22295170|NCT05542576|Amydis, Inc.|Matthew Lehman|6463317899|matt.lehman@amydis.com|
22295171|NCT03278613|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22295172|NCT01405456|Massachusetts General Hospital|Dr. Steven K. Grinspoon|6177249109|sgrinspoon@mgh.harvard.edu|
22295173|NCT02299297|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
22295174|NCT05475236|Veterans Health Administration|Dr. Clayton Swanson|3523761611|clayton.swanson@va.gov|107583
22295175|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295176|NCT03631472|Gala Therapeutics|James Stambaugh SVP of Clinical Affairs|4087186834|jstambaugh@galatherapeutics.com|
22295177|NCT02154490|SWOG Statistics & Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22322047|NCT07071129|Stanford University|Jeffrey Goldberg, MD, PhD|(650) 723-6137|eye-chair-office@stanford.edu|
22322048|NCT05429073|Regulus Therapeutics|Kristen Gillotti, Senior Director Clinical Operations|203-313-8185|kgillotti@regulusrx.com|
22322049|NCT04179175|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22322050|NCT01696435|Massachusetts General Hospital|Dr. Olivia Okereke/Study Principal Investigator|(617) 726-2000|olivia.okereke@mgh.harvard.edu|
22322051|NCT03215030|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22322052|NCT02896595|Virginia Commonwealth University Health Department of Anesthesiology|Praveen Prasanna|804-828-2207|praveen.prasanna@vcuhealth.org|
22322053|NCT01745146|Moss Rehabilitation Research Institute|Dr. Tessa Hart, PhD|215-663-6153|thart@einstein.edu|
22322054|NCT04316585|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22322055|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322056|NCT03195517|University of Perugia - Italy|Dr. Rita Lombardini|+39 075 578 4027|rita.lombardini@unipg.it|
22322057|NCT02770326|Memorial Sloan Kettering Cancer Center|Dr. Robin Mendelsohn, MD|212-639-8286|mendelsr@mskcc.org|
22322058|NCT03118297|WashingtonU|Intervention To End Recurrent Unscheduled bleeding Trial (INTERRUPT): A randomized-controlled trial|3143228697|rachelezig@gmail.com|
22322059|NCT02363686|University of Colorado|Carrie Higgins|7205603037|carrie.higgins@cuanschutz.edu|
22322060|NCT02507011|University of Minnesota|Thenappan Thenappan, MD|612-625-2191|cvheart@umn.edu|
22322061|NCT01121393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322062|NCT02615743|Children's Hospital of Philadelphia|Dr. Chen Kenyon, Faculty PolicyLab and Assistant Professor University of Pennsylvania|267-426-6339|kenyonc@email.chop.edu|
22322063|NCT03988335|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
22322064|NCT03215771|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
22322065|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322066|NCT02703311|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22322067|NCT04906980|Janssen Research & Development, LLC|GLOBAL MEDICAL LEADER RESPIRATORY INFEC|+12153252489|ClinicalTrialDisclosure@its.jnj.com|
22322068|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22322069|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org|
22322070|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
22322071|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22322072|NCT02987621|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22322073|NCT02508194|MedImmune, LLC|Judith Falloon, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
22322074|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
22322075|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22322076|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com|
22322077|NCT01632566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22322078|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22322079|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu|
22322080|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu|
22322081|NCT02772432|Mass General Hospital|Elyse Park|6177246836|epark@mgh.harvard.edu|
22322082|NCT03208231|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22322083|NCT03205995|Omeros Corporation|Dr. Andreas Grauer|206-676-5000|ctinfo@omeros.com|
22322084|NCT03321097|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
22322085|NCT03892746|Cleveland Clinic|Ela Plow, Associate Professor|216-445-4589|plowe2@ccf.org|
22322086|NCT03977467|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
22322087|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322088|NCT05721482|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
22322089|NCT01627899|LifeScan Scotland|Mike Grady|+44 01463 721000|MGRADY@its.jnj.com|
22322090|NCT03627403|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22266588|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov|
22322091|NCT03485820|Washington University in St. Louis|Susy Stark|3142734114|sstark@wustl.edu|
22266589|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu|
22266590|NCT02901548|Moffitt Cancer Center|Jingsong Zhang, MD, PhD|813-745-6926|Jingsong.Zhang@moffitt.org|
22266591|NCT03336528|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22266592|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
22266593|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu|
22266594|NCT03065218|MedStar Health Research Institute|Dr. Douglas Van Nostrand|202-877-0300|douglasvannostrand@gmail.com|
22266595|NCT02655666|Medtronic Minimed|Willam Lv|86-21-20325454|william.lv@medtronic.com|
22266596|NCT00895414|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
22266597|NCT03203564|Isofol Medical AB|Chief Medical Officer|+46 (0)707646500|karin.ganlov@isofolmedical.com|
22322092|NCT04289116|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
22266598|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000||
22276827|NCT03787212|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, OD - Principal Research Optometrist|904 443 3449|CColesb@its.jnj.com|
22276828|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu|
22322093|NCT04042103|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22322094|NCT04209855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22322095|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com|
22322096|NCT02289950|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
22322097|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322098|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov|
22276829|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu|
22276830|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu|
22276831|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493||
22276832|NCT05788328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276833|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300||
22322099|NCT03711578|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
22322100|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com|
22322101|NCT01471782|Amgen, Inc|Study Director|866-572-6436||
22322102|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu|
22322103|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322104|NCT04428424|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322105|NCT01411085|Geisel School of Medicine at Dartmouth|Alan I Green, MD|603-650-7549|alan.i.green@dartmouth.edu|
22322106|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22322107|NCT03809611|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22322108|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22322109|NCT04671615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322110|NCT03124563|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
22322111|NCT04745689|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22322112|NCT03790683|Sidney Kimmel Medical College, Thomas Jefferson University and Hospitals|Marc C. Torjman, Ph.D.|(215) 955-5275|Marc.Torjman@Jefferson.edu|
22322113|NCT05979207|Medicines for Malaria Venture|Director, Program Leadership and Strategy|+41 22 555 03 00|info@mmv.org|
22322114|NCT00825565|Northwestern University|Stephanie Rangel|312-503-5942|stephanie.rangel@northwestern.edu|
22322115|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
22322116|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342||
22322117|NCT00661271|Johns Hopkins School of Medicine|Erica Sibinga|410-550-4134|esibinga@jhmi.edu|
22322118|NCT00953758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322119|NCT03987854|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
22322120|NCT00706030|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22322121|NCT05779072|Coopervision|Paul Chamberlain|9257306754|pchamberlain@coopervision.com|
22322122|NCT03870555|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22276834|NCT02197104|Rush University Medical Center|Dr. Deborah A Hall|312-563-2900|Movementdisorder@rush.edu|
22322123|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu|
22322124|NCT03847610|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
22322125|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
22322126|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu|
22322127|NCT01445769|Incyte Corporation|Study Director|855 463-3463||
22322128|NCT01276236|University of California, San Francisco|Dr. Toby Maurer, MD|(628) 206-8680|Toby.Maurer@ucsf.edu|
22322129|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22322130|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
22322131|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org|
22322132|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu|
22322133|NCT03440814|Soleno Therapeutics, Inc.|C601 Project Manager|650-353-2051|C601ProjectManager@soleno.life|
22322134|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22322135|NCT02692209|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22322136|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22322137|NCT02759172|Michigan State University|Dr. Jennifer Johnson|810-730-6121|jjohns@msu.edu|
22322138|NCT02573155|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22322139|NCT01681433|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22322140|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu|
22322141|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu|
22322142|NCT06245551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22322143|NCT04947800|Dartmouth-Hitchcock|james stahl|6036502000|james.e.stahl@hitchcock.org|
22322144|NCT02158091|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
22322145|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu|
22322146|NCT06232317|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
22322147|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322148|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com|
22322149|NCT03194373|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
22322150|NCT04518462|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9729|MedInfo@Pacira.com|
22322151|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu|
22322152|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com|
22322153|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322154|NCT05568888|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
22266599|NCT02458287|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22266600|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
22266601|NCT02365558|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22266602|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22266603|NCT03375294|Palo Alto Veterans Affairs|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22266604|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com|
22266605|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu|
22266606|NCT00418821|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22266607|NCT02823652|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22266608|NCT04428333|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266609|NCT04853992|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22266610|NCT02269163|Prometic Biotherapeutics Inc|Director, External Biologics|438-802-3497|clinical@prometic.com|
22266611|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu|
22266612|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22266613|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com|
22266614|NCT01784055|NeoChord, Inc.|Lori E Adels, PhD|1-952-698-7804|ladels@neochord.com|
22266615|NCT00402116|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22266616|NCT02135614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22266617|NCT03634475|Panoptes Pharma|Study Director|+43 664 851 5865|ssperl@kiorapharma.com|
22266618|NCT00554606|Novartis|Study Director|+41613241111|Novartis.email@novartis.com|
22266619|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu|
22266620|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
22266621|NCT02242045|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22266622|NCT00749892|UT MD Anderson Cancer Center|Dr. Arlene O. Siefker-Radtke,Professor, Genitourinary Medical Oncology|(713) 792-2830|asiefker@mdanderson.org|
22295178|NCT01129609|Medtronic|Rianna Rapson|763-526-2170|rianna.k.rapson@medtronic.com|
22322155|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22266623|NCT00089024|University of Nebraska Medical Center|Jean L Grem|402-552-3233|jgrem@unmc.edu|
22322156|NCT03784079|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266624|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22276835|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov|
22276836|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
22266625|NCT04040192|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276837|NCT01875237|UT MD Anderson Cancer Center|Champlin,Richard,M.D. / Stem Cell Transplantation|713-792-8750|rchampli@mdanderson.org|
22266626|NCT03207243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266627|NCT03196219|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
22266628|NCT04074616|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|713-797-5938|argyrios.stampas@uth.tmc.edu|
22266629|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215|douglas-dannaway@ouhsc.edu|42048
22266630|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu|
22266631|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266632|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22266633|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu|
22266634|NCT02960490|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22266635|NCT01900561|Department of Veterans Affairs|Dr. Sarah Hawley|734-936-8816|sarahawl@umich.edu|
22266636|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22266637|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
22266638|NCT04893018|Cancer Immunotherapy Trials Network|Clinical Trial Manager|206-667-2541|citn.core.reg@hvtn.org|
22266639|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
22266640|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org|
22266641|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
22266642|NCT02842073|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
22266643|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266644|NCT00385008|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266645|NCT02047734|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22266646|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22266647|NCT03100123|Ottawa Hospital Research Institute|Dr. Leslie Skeith|403-944-5246|laskeith@ucalgary.ca|
22266648|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266649|NCT04411914|Temple University|Mary Morrison, MD, MS|215=707=4037|mary.morrison@temple.edu|
22266650|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu|
22266651|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp|
22266652|NCT02010645|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
22266653|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu|
22266654|NCT04106661|Husson University|William Lindblad, Director of Research and Scholarship|20-7992-1958|lindbladw@husson.edu|
22266655|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no|
22266656|NCT03280381|PATH|Dr. Patricia S. Coffey|206-302-4704|pcoffey@path.org|
22266657|NCT03503864|Sun Yat-sen Memorial Hospital|Dr Yang Li|02081332045|drliyang@126.com|
22266658|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22266659|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu|
22266660|NCT02087189|BIOTRONIK SE & Co. KG|Mathias Freudigmann, Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|1248
22266661|NCT00478426|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2082|amit.oza@uhn.ca|
22266662|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266663|NCT04630158|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22322157|NCT05036083|M.D. Anderson Cancer Center|Olena Weaver|713-471-3613|ooweaver@mdanderson.org|
22322158|NCT01844986|AstraZeneca|Elizabeth Lowe|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22322159|NCT07170488|University of Pittsburgh|Martina Anto-Ocrah|4123352862|maa509@pitt.edu|
22322160|NCT02396589|Washington University in St. Louis School of Medicine|Dr. Susan Stark|3142734114|sstark@wustl.edu|
22322161|NCT04381650|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22322162|NCT03963531|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22322163|NCT05593016|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
22322164|NCT05416138|University of Minnesota|Alexander Opitz|612-624-1094|aopitz@umn.edu|
22322165|NCT04705051|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322166|NCT03686397|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22322167|NCT03075085|University of Arkansas for Medical Sciences|Dr. Taren Swindle|870-236-0997|tswindle@uams.edu|
22322168|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
22322169|NCT00598975|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
22322170|NCT02388568|The University of Pennsylvania's Center for Weight and Eating Disorders|Dr. Jena Shaw Tronieri|215-746-5045|jena.tronieri@pennmedicine.upenn.edu|
22266664|NCT05162014|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266665|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu|
22266666|NCT03136965|University of Wisconsin School of Medicine and Public Health|Kenneth Lee, MD, MBA|(608) 263-9387|klee2@uwhealth.org|
22266667|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com|
22266668|NCT01210612|University of Toledo Health Science Campus|Phillip Gribble|(419) 530-2691|pgribbl@UTNet.UToledo.Edu|
22266669|NCT02752087|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22266670|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu|
22266671|NCT01943994|Sheppard Pratt|Dr. Matthew W. Johnson|443 862 0461|mjohnson3@sheppardpratt.org|
22266672|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu|
22266673|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22295179|NCT02692716|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22266674|NCT03713619|Novarts Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22266675|NCT03553576|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22266676|NCT02552212|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22266677|NCT03020589|University of North Carolina at Chapel Hill|Robert Dupuis, PharmD|919-966-6194|re_dupuis@unc.edu|
22266678|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250||
22266679|NCT03866902|University of Miami|Hudson Santos|3052845812|hsantos@miami.edu|
22266680|NCT03613727|Virginia Commonwealth University|BMT- CIT Team|804-628-6430|masseybmt@vcu.edu|
22266681|NCT02092467|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266682|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266683|NCT02392351|Boston Scientific|Clinical Trial Manager|970-294-4082|nicole.kilburn@bsci.com|
22266684|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266685|NCT02293863|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22266686|NCT03155945|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22266687|NCT02013674|ISCI / University of Miami Miller School of Medicine|Marietsy pujol / Senior Regulatory Specialist|305-243-7273|mpujol@med.miami.edu|
22266688|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551||
22295180|NCT03709771|Vanderbilt University Medical Center|Emily Shardelow|615-875-8949|emily.m.shardelow@vumc.org|
22295181|NCT00536601|Roswell Park Cancer Institute|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
22295182|NCT02904512|Veterans Affairs Medical Center|Dr. Ilias (Elias) Spanakis|(617) 319-9731|ispanakis@som.umaryland.edu|
22295183|NCT03828357|Abbott|Grant Kim, Director Clinical Programs|8184933147|grant.kim1@abbott.com|
22295184|NCT03219294|Maine Medical Center|Research Coordinator|2076622862|richaj3@mmc.org|
22295185|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
22295186|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295187|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu|
22295188|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
22295189|NCT02692703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22295190|NCT01077856|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295191|NCT02533427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22295192|NCT01979016|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22295193|NCT00938639|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22295194|NCT01354951|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
22295195|NCT00484874|Dana-Farber Cancer Institute|Heather Jacene, MD|617-632-3767|hjacene@partners.org|
22295196|NCT02706691|University of Chicago Comprehensive Cancer Center|Technical Director|773-702-0819|pccc_regulatory@bsd.uchicago.edu|
22295197|NCT05374434|Lumendo|Mark Bispinghoff|+41 44 589 68 02|mark.bispinghoff@lumendo.ch|
22295198|NCT02602496|University of Nebraska Lincoln|Dr. Devin Rose|402-472-2802|drose3@unl.edu|
22295199|NCT00171730|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22266689|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
22266690|NCT03383523|Drugs for Neglected Diseases Initiative|Jean Yves Gillon|+41229069232|jygillon@dndi.org|
22295200|NCT01985867|The Medical University of Warsaw|Katarzyna Wojtyniak|+48 22 317 94 21|wojtyniakkasia@gmail.com|
22295201|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22295202|NCT03546192|Sanofi Pasteur Inc.|Medical Director|800-633-1610 ext 1#|RegistryContactUs@sanofipasteur.com|
22295203|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245||
22295204|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu|
22295205|NCT02648178|The Koop Institute at Dartmouth, Geisel School of Medicine|Dr James Sargent|603-653-9025|James.D.Sargent@dartmouth.edu|
22295206|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22295207|NCT01465997|Cares|UCB|+1844 599||2273
22295208|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
22295209|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
22295210|NCT02397785|Cleveland Clinic Foundation|Erica Magelky, Principal Investigator|713-628-5357|magelke@ccf.org|
22295211|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22295212|NCT02756689|UAB|Lorie Harper, MD|205-934-5611|lmharper@uabmc.edu|
22276838|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com|
22276839|NCT05278065|Brown University|Alexander Sokolovsky|401-863-6629|alexander_sokolovsky@brown.edu|
22276840|NCT01793909|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
22276841|NCT01279187|University of Michigan|Jill Bashutski||jillbashutski@gmail.com|
22295213|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22295214|NCT00911053|Oregon Health and Science University|OHSU IRB|5034948849|irb@ohsu.edu|
22295215|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov|
22295216|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22295217|NCT01288469|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22295218|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com|
22295219|NCT00582166|University of Wisconsin Carbone Cancer Center|Lymphoma/Myeloma Disease Oriented Team|608-265-3794|barnstable@wisc.edu|
22295220|NCT04488068|VA San Diego Healthcare System|Mahadevan Rajasekaran, Ph.D.|8585528585|Mahadevan.Rajasekaran@VA.gov|7114
22295221|NCT01606436|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295222|NCT02859454|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@nih.gov|
22295223|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com|
22295224|NCT02245308|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
22295225|NCT02452398|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22295226|NCT00748033|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
22295227|NCT03334448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22295228|NCT02326025|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22295229|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu|
22295230|NCT02013791|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22295231|NCT03798483|Oxford University hospital foundation trust|Colin Forde|+441865221540|Colin.Forde@ouh.nhs.uk|
22295232|NCT02643082|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|650-305-2600|creisner@pearltherapeutics.com|
22295233|NCT02289417|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22295234|NCT02725710|Duke University|Jeremy M. Weber|919-681-4561|jeremy.m.weber@duke.edu|
22295235|NCT02505867|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
22295236|NCT01782222|UCB|UCB Cares|+1 877 822 9493||
22295237|NCT03200860|University Medical Center Groningen - Department of Cardiology|Prof. dr. A.A. Voors|0031503616161|a.a.voors@umcg.nl|
22276842|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000|Rodney.Vanderploeg@va.gov|6728
22295238|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000||
22322171|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu|
22322172|NCT03160560|Center for Dental Research, Loma Linda University|Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research|909-558-8069||
22322173|NCT00403260|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22322174|NCT03676257|Institut Bergonié|Carine Bellera|+33556330495|C.Bellera@bordeaux.unicancer.FR|
22322175|NCT04699539|Changhai Hos|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
22322176|NCT01241708|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22322177|NCT05159557|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22322178|NCT04137887|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322179|NCT02040298|UCSF|Tracy Tran, BA|415-353-2707|tracy.tran@ucsf.edu|
22322180|NCT01790503|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22322181|NCT04183335|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322182|NCT00049673|Canadian Cancer Trials Group|Director of Clinical Trials|613-533-6340|jdancey@ctg.queensu.ca|
22322183|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322184|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
22322185|NCT03733392|Abbott|Emily Jesser, Ph.D.|763-954-1350|emily.jesser@abbott.com|
22322186|NCT02740478|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
22322187|NCT03312517|Henry Ford Sleep Research Center|Christopher Drake, PhD|248-344-6672|cdrake1@hfhs.org|
22322188|NCT01934140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322189|NCT02168686|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
22322190|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22266691|NCT03408639|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|Anjidani.N@orchidpharmed.com|
22266692|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu|
22266693|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22266694|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300|hhenney@acorda.com|5138
22266695|NCT01924754|University of California, San Francisco|Dr. Joel Palefsky, MD|(415) 476-8885|Joel.Palefsy@ucsf.edu|
22266696|NCT03132155|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22266697|NCT04320823|Haemonetics Corporation|Jan Hartmann, MD, Vice President of Medical Affairs and Clinical Development|(781) 348 7396|Jan.Hartmann@haemonetics.com|
22266698|NCT03120325|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
22266699|NCT02925403|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|vaccinetrials@ndm.ox.ac.uk|
22266700|NCT02899195|PrECOG|Dr. Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
22266701|NCT04778904|Barinthus Biotherapeutics|Chief Medical Officer|+44 (0) 1865 818 808|clinicaltrials@barinthusbio.com|
22266702|NCT03452137|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22266703|NCT02856802|Upsher-Smith Laboratories, LLC|Clinical Operations|(763) 315-2000|uslinfo@upsher-smith.com|
22266704|NCT03772717|Emory University|Sumit Verma, MD|404-785-9893|sumit.verma@emory.edu|
22266705|NCT04138043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266706|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu|
22266707|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
22266708|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22266709|NCT02755649|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22266710|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22266711|NCT02089659|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266712|NCT02126826|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266713|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22266714|NCT03092219|Teoxane SA|Clinical Project Manager|+41(0) 22 344 96 36|m.chenet@teoxane.com|
22266715|NCT05289869|The Ohio State University|Heather Frey, MD, MSCI|614-688-6798|Heather.Frey@osumc.edu|
22266716|NCT01613768|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
22322191|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22322192|NCT00200850|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
22322193|NCT02392013|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
22322194|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
22322195|NCT02814565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22322196|NCT01414257|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322197|NCT01978093|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322198|NCT03371225|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526154|fregni.felipe@mgh.harvard.edu|
22322199|NCT03124784|Masimo Corporation|Tala Harake|949-297-7000|studies@masimo.com|
22322200|NCT04580290|Xiros Ltd|Tracey Oxley|07810337555|Tracey.Oxley@xiros.co.uk|
22322201|NCT02450487|Bauru School of Dentistry University of Sao Paulo|Dr. Adriana Calvo|+551432358200|birinjela@yahoo.com.br|
22309032|NCT05603143|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22322202|NCT05587296|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22322203|NCT03560752|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
22322204|NCT02847624|Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd|Investigator in charge|+81-6-6943-7722|komaniwa.satoshi@otsuka.jp|
22322205|NCT04735653|University of Michigan Medical School|Dr. Paula Anne Newman-Casey|734-763-6967|panewman@med.umich.edu|
22322206|NCT03142321|Washington University School of Medicine GI Division|Dr. Parakkal Deepak|3143623201|nixd@wustl.edu|
22322207|NCT04589988|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
22322208|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
22322209|NCT03033745|CSL Behring|Trial Registration Coordinator|610 878-4000|clinicaltrials@cslbehring.com|
22322210|NCT00703664|Massey Cancer Center, Virginia Commonwealth University|Dr. Beata Holkova|804-628-2581|bholkova@mcvh-vcu.edu|
22266717|NCT02928055|MetroHealth Medical Center|Richard Wilson, MD|216-778-4414|rwilson@metrohealth.org|
22266718|NCT05013008|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22266719|NCT02094417|Kyowa Kirin Korea Co. Ltd.,|Clinical Development Team, Clinical Development Department|82221912918|kyungmo.lee.m6@kyowakirin.com|
22266720|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk|
22266721|NCT01443728|Columbia University|Gary Brittenham, MD|212-305-7005|gmb31@cumc.columbia.edu|
22266722|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266723|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22266724|NCT03022084|VA RR&D National Center for Rehabilitative Auditory Research|Dr. James Henry|503-220-8262|James.Henry@va.gov|
22266725|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com|
22266726|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
22266727|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266728|NCT02119819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22266729|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22309033|NCT05647304|REGEnLIFE|Guillaume Blivet|+33434481535|gblivet@regenlife.com|
22309034|NCT04171999|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
22309035|NCT03993509|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
22309036|NCT04505904|University of Arizona|Brian Arizmendi|9168473623|arizmendi@email.arizona.edu|
22309037|NCT03629990|Medical University of South Carolina|Brian Sherman, Ph.D.|843-792-8174|shermanb@musc.edu|
22309038|NCT04277442|The Ohio State University|Dr. Alice Mims|(614) 293-3196|Alice.Mims@osumc.edu|
22276843|NCT02070991|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22266730|NCT04497948|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22266731|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu|
22266732|NCT05384171|VA Boston Healthcare system|Dr. Dawne Vogt|857-364-5976|dawne.vogt@va.gov|
22266733|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com|
22266734|NCT04611529|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22276844|NCT04999020|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22266735|NCT02121392|University of Chicago Medical Center|Dr. Hue Luu|773-702-6937|hluu@bsd.uchicago.edu|
22266736|NCT03138590|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
22266737|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org|
22266738|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov|
22309039|NCT03092518|National Cancer Institute|Dr. Jeremy Davis|2408583731|jeremy.davis@nih.gov|
22276845|NCT05706701|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
22266739|NCT02564887|University of Pittsburgh|Christine Harrison, Clinical Research Coordinator|412-647-9665|harrisonta@upmc.edu|
22266740|NCT03150407|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
22266741|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu|
22295239|NCT02818569|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|617-724-7200|ojohnsonakeju@partners.org|
22295240|NCT03844646|Stanford University|Sun H. Kim, MD, MS|650-723-8284|sunhkim@stanford.edu|
22295241|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com|
22295242|NCT03158116|UCSF Benioff Children's Hospital Oakland|Rachna Wadia, MD|844-724-4140|rawadia@mail.cho.org|
22295243|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov|
22295244|NCT02634320|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
22295245|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295246|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se|
22295247|NCT04208698|CinDome Pharma, Inc.|Director of Clinical Trials|844-531-1834|info@cinrx.com|
22266742|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22266743|NCT02648932|University of Chicago|Hongtao Liu|773-834-0589|hliu2@medicine.bsd.uchicago.edu|
22266744|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22266745|NCT03106987|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
22266746|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu|
22266747|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100|althagekarena@uams.edu|5859
22266748|NCT04482387|Cambridge University Hospitals NHS Foundation Trust|Stephen Kelleher|01223217418|research@addenbrookes.nhs.uk|
22266749|NCT01739699|Northshore University Healthsystem, Evanston Hospital|Dr. Steven Greenberg|8475702760|sbgreenb@gmail.com|
22266750|NCT02114385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22266751|NCT03495921|Gradalis, Inc.|Clinical and Regulatory Operations|(214) 442-8100|info@gradalisinc.com|
22266752|NCT04520009|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5724|tor.d.tosteson@dartmouth.edu|
22266753|NCT02460679|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22266754|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu|
22266755|NCT03366207|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22266756|NCT01651793|University of Georgia|Dr. Patrick J. O'Connor|706-542-4382|poconnor@uga.edu|
22266757|NCT02130622|Dartmouth-Hitchcock|Gastroenterology Research Team Lead|603-653-9033|Jessica.I.Chevalier@hitchcock.org|
22276846|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295248|NCT03655691|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
22295249|NCT04557371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309040|NCT02301910|SuperGene LLC|Markin Sergey|(495) 287-98-07|info@supergene.ru|+7
22309041|NCT01824537|McGill University|Eduardo L Franco|514-398-6032|eduardo.franco@mcgill.ca|
22309042|NCT02547987|Baylor College of Medicine|Mothaffar Rimawi, M.D.|713-798-1311|rimawi@bcm.edu|
22309043|NCT04282148|Abbott|Ikuko Kishimoto, Principal Research Scientist|480-482-8279|ikuko.kishimoto@abbott.com|
22309044|NCT01743807|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22309045|NCT04096040|ZOLL Medical|Director of Scientific Affairs|4129683333|nbianco@zoll.com|14410
22309046|NCT04044768|Adaptimmune|Clinical Trials Management|+1 (215) 825 9260|clinicaltrials@adaptimmune.com|
22309047|NCT01814813|Mayo Clinic|Ian Parney, MD, PhD|507-284-8167|Parney.Ian@mayo.edu|
22309048|NCT03808818|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22309049|NCT03858634|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22322211|NCT03728309|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22322212|NCT03403205|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22322213|NCT03104725|National Institutes of Health/NINDS|Dr. David Goldstein|301-496-2103|goldsteind@ninds.nih.gov|
22322214|NCT05130463|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22322215|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
22322216|NCT02065154|UAB|Omer Jamy|205-934-9294|omerjamy@uabmc.edu|
22322217|NCT03652662|MUSC|Sarah Miller, PhD, RN|8427921692|millesar@musc.edu|
22322218|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540||
22322219|NCT02751502|NYU Langone Health|Renat Sukhov, MD|347-377-5138|Renat.Sukhov@nyulangone.org|
22322220|NCT02695628|Stanford University|Rajesh Shah|650-723-0728|rajshah@stanford.edu|
22322221|NCT02678390|Research Centre on Aging|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22322222|NCT03499028|Cleveland Clinic|Anabelle Visperas|216-444-2416|vispera@ccf.org|
22322223|NCT02925156|Loyola University Chicago|Amy Luke, Ph.D.|(464) 220-9243|aluke@luc.edu|
22322224|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22322225|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22322226|NCT06485479|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
22322227|NCT06142643|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
22322228|NCT04982250|Fred Hutchinson Cancer Center|Katrina F Ortblad, ScD, MPH|2066677267|kortblad@fredhutch.org|
22266758|NCT01994850|University of Pennsylvania Abramson Cancer Center|Jakub Svoboda, MD|855-216-0098|PennCancerTrials@emergingmed.com|
22266759|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
22266760|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
22266761|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22266762|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22266763|NCT04581330|UT Southwestern Medical Center|Dr. Heather Goff|2146484229|heather.goff@utsouthwestern.edu|
22266764|NCT06154200|SCCO at MBKU|Dr. Jerry Paugh, Professor Emeritus|7144497487|jpaugh@ketchum.edu|
22266765|NCT03898908|Grupo Español Multidisciplinar en Melanoma (GEM)|GEM Technical Secretary|0034934344412|secretaria@groupgem.es|
22266766|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22266767|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu|
22266768|NCT00345943|New York State Psychiatric Institute|Dr. Rachel Marsh|6467745774|rachel.marsh@nyspi.columbia.edu|
22266769|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com|
22266770|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22266771|NCT02533375|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22266772|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22295250|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
22322229|NCT04685876|University of Texas, Houston|Dr. Alparslan Turan|713-500-6279|Mehmet.A.Turan@uth.tmc.edu|
22266773|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22322230|NCT03845582|Alkeus Pharmaceuticals, Inc.|Meena Venugopal|877-255-7476|mvenugopal@alkeus.com|
22322231|NCT02028455|Seattle Children's Therapeutics|Dr. Colleen Annesley|206-987-7122|ICC-PLAT@seattlechildrens.org|
22276847|NCT00634972|University of South Alabama|Fabien Eyal, MD|251-415-1055|feyal@health.southalabama.edu|
22276848|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22276849|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr|
22276850|NCT03948386|Thomas Jefferson University|Eric S Schwenk, MD|215-955-6161|eric.schwenk@jefferson.edu|
22276851|NCT03296345|Valley Children's Hospital|Jonathan Bryan Cooper-Sood, MD|559-353-3000|coopersoodj@usacs.com|
22276852|NCT02487485|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
22276853|NCT06038643|McGill University|Maiya R. Geddes|514-398-8751|maiya.geddes@mcgill.ca|
22276854|NCT03573882|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276855|NCT02691572|Department of Anesthesia and Surgical Intensive Care, Mansoura University Hospitals, Mansoura, Egypt.|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
22276856|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22276857|NCT01947933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22276858|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu|
22276859|NCT02475837|Stanford University|Ken Mahaffey MD|650.723.3096|kmahaf@stanford.edu|
22276860|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
22276861|NCT04136366|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22276862|NCT04439123|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22276863|NCT03677206|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
22276864|NCT02593864|Stanford University|Constance Chu, MD|650-723-5643|chucr@stanford.edu|
22276865|NCT01181479|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22276866|NCT02213575|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
22276867|NCT02114684|CAPRISA|Mrs Nonhlanhla Yende-Zuma|0027312604392|Nonhlanhla.Yende@caprisa.org|
22276868|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22276869|NCT03828383|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22276870|NCT03345095|EORTC|Dr. Thierry Gorlia|+32 2 7741652|thierry.gorlia@eortc.org|
22276871|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22276872|NCT06991803|Recep Tayyip Erdoğan University, Faculty of Dentistry, Department of Endodontics|Medine Çiçek|5442745525|medinecicekk@hotmail.com|+90
22276873|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22276874|NCT06875115|Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Ying-Hsu Juan, M.D. Principal Investigator|+886-5-2648000|ddjjaa@tcts.seed.net.tw|
22276875|NCT06922760|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
22276876|NCT06923033|Moffitt Cancer Center|Dr. Christine Vinci, Ph.D.|813-745-5421|Christine.Vinci@Moffitt.org|
22276877|NCT02564978|National Institutes of Health|Tiarnan Keenan, MD, PhD, Principal Investigator, NEI|301-451-6330|tiarnan.keenan@nih.gov|
22276878|NCT03166631|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22276879|NCT03022630|Vanderbilt University Medical Center|Dr. Cheryl Gatto|6153432252|cheryl.l.gatto.1@vumc.org|
22276880|NCT00382070|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22276881|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu|
22276882|NCT01629563|PregLem|Dr Pablo Arriagada|0041228840355|info@preglem.com|
22276883|NCT04290676|EyePoint Pharmaceuticals|Dario Paggiarino, MD|(617) 610-3411|dpaggiarino@eyepointpharma.com|
22276884|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012||
22276885|NCT03761914|Sellas Life Sciences|Dr Dragan Cicic, Chief Development Officer|646-200-5278|info@sellaslife.com|
22276886|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
22276887|NCT02370394|Butler Hospital/Women and Infants Hospital|Caron Zlotnick, Ph.D.|(401) 455-6529|CZlotnick@Butler.org|
22276888|NCT03017261|Think Surgical|Valentina Campanelli|510-249-2314|vcampanelli@thinksurgical.com|
22276889|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
22276890|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22276891|NCT02313597|Services Institute of Medical Sciences|Dr, Shabbar Hussain Changazi|923059700111|shabbarchangazi246@gmail.com|
22276892|NCT01263379|Abeona Therapeutics|Chief Medical Officer|(216) 282-8150|clinicalresults@abeonatherapeutics.com|
22276893|NCT04132466|Kestra Medical Technologies, Inc.|Laura Gustavson|14255264759|laura.gustavson@kestramedical.com|
22276894|NCT05890586|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22276895|NCT02545127|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22295251|NCT01428453|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295252|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22295253|NCT04216329|National Cancer Institute|Dr. Kevin A. Camphausen|240-760-6205|camphauk@mail.nih.gov|
22295254|NCT03918447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22295255|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu|
22295256|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295257|NCT05355805|Acelyrin|Donald Betah|(805) 419-3805|Donald.Betah@acelyrin.com|
22295258|NCT00534430|Department of Hematology, City of Hope|Anthony Stein, MD, Clinical Professor|626-537-5748|astein@coh.org|
22295259|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com|
22276896|NCT01952678|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22276897|NCT03202550|Johns Hopkins University|Katrina Thaler|410-550-8506|kstouff3@jhmi.edu|
22309050|NCT06181760|Island Pharmaceuticals|David Foster, CEO|510-393-6523|dfoster@islandpharmaceuticals.com|
22295260|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295261|NCT04317066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22295262|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22295263|NCT02014597|Baylor College of Medicine|Dr. Benjamin Frankfort|713-798-3453|benjamin.frankfort@bcm.edu|
22266774|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu|
22266775|NCT03102606|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
22266776|NCT03996447|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22266777|NCT05849454|Center for Behavioral Cardiovascular Health|Nadia Liyanage-Don|917-280-3776|nal2151@cumc.columbia.edu|
22266778|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
22266779|NCT02896712|The University of Texas Health Science Center at Houston|Joy Schmitz, PhD|713-486-2867|joy.m.schmitz@uth.tmc.edu|
22266780|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu|
22266781|NCT03888066|Vifor Pharma, Inc.|DIAMOND Clinical Study Team|+41 588 518 000|Diamond_Information@viforpharma.com|
22266782|NCT03278626|NYU Langone Health - Perlmutter Cancer Center|Jennifer Wu, MD|212-263-3809|Jennifer.Wu@nyulangone.org|
22266783|NCT02856555|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22266784|NCT03333941|AVITA Medical|VP Clinical Research|661-367-9710|clinicaltrial@avitamedical.com|
22266785|NCT04971187|M D Anderson Cancer Center|Dr. Xiuning Le|(713) 792-6980|xle1@mdanderson.org|
22266786|NCT00547586|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22266787|NCT04981717|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22266788|NCT02207634|Amgen Inc.|Study Director|866-572-6436||
22266789|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22266790|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|608-265-5949|demccarthy@wisc.edu|
22266791|NCT00974922|UCHC|Dr. William White|860-679-2104|wwhite@uchc.edu|
22266792|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org|
22322232|NCT07099521|South China Normal University|Dr. Yuanyuan Wang|+86 13076729124|angelayuanyuanwang@gmail.com|
22322233|NCT02326805|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
22322234|NCT03591380|University of Wisconsin - Madison|David Foley, MD|608-263-2527|foley@surgery.wisc.edu|
22322235|NCT02615990|University of Kentucky|Lisa Fryman|859 323 2060|lisa.fryman@uky.edu|
22322236|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322237|NCT04401267|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
22322238|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090||
22322239|NCT02066792|Institute for Mental Health Research and Department of Psychology, The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
22322240|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com|
22322241|NCT02889796|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22322242|NCT04294459|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322243|NCT02787863|Samara State Medical University, Institute of Sera and Vaccines RAS|Professor Andrei Dmitrievich Protasov, Professor Mikhail Petrovich Kostinov|+79277444126|crosss82@mail.ru|
22322244|NCT02479802|Grifols Bioscience Industrial Group|Miquel Barcelo, PhD|+34 935.712.368|Miquel.Barcelo@Grifols.com|
22322245|NCT02421887|NICHD|Esther Eisenberg, NICHD Project Scientist|301-496-6516|esther.eisenberg@nih.gov|
22322246|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr|
22322247|NCT02162732|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
22322248|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu|
22322249|NCT03757988|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
22322250|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org|
22322251|NCT04269395|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
22322252|NCT04161495|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22322253|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu|
22322254|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org|
22322255|NCT02926209|GI View Ltd.|CEO, Dr. Tal Simchony|+97235753199|tal@giview.com|
22322256|NCT00429858|University of California, San Francisco|Dr. Andrew Ko, MD|(415) 353-7286|Andrew.Ko@ucsf.edu|
22322257|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22322258|NCT01764633|Amgen Inc.|Study Director|866-572-6436||
22322259|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100|petrelli@hhsc.ca|75162
22322260|NCT04142983|GCAM / Biomat USA - Grifols|Center Medical Director|956-729-7677|laredomedical@gcamplasma.com|
22322261|NCT04781816|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322262|NCT02123485|Department of Affective Disorder, Aarhus University Hospital, Denmark|Dr Poul Erik Buchholtz|21474299|Buchholtz.Hansen@ps.rm.dk|
22322263|NCT03545906|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22322264|NCT04372927|University of Washington School of Medicine|Dr. Jing Zeng|206-598-4115|jzeng13@uw.edu|
22322265|NCT03423342|University of Washington|Dr. Kevin O'Brien, Study PI|206-529-7802|cardiac@uw.edu|
22322266|NCT00883246|Medtronic|Clinical Program Manager|763-398-7000|michael.p.swierzewski@medtronic.com|
22322267|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22322268|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
22322269|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu|
22322270|NCT00662792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322271|NCT01999582|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22266793|NCT03831711|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22322272|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22322273|NCT00236977|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22322274|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu|
22322275|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de|
22322276|NCT02342015|University of Padova|Marcello Rattazzi|+300498211867|marcello.rattazzi@unipd.it|
22322277|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
22322278|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
22322279|NCT01849770|University of Washington|Michael D. Weiss, MD|206-598-7688|mdweiss@uw.edu|
22322280|NCT01639872|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5054|mary.f.brunette@hitchcock.org|
22322281|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org|
22322282|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu|
22322283|NCT03861143|NImmune Biopharma, Inc.|Clinical Development|(540) 218-2262|info@nimmunebio.com|
22322284|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com|
22266794|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266795|NCT02640482|AbbVie|Global Medical Services|800-633-9110||
22266796|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322285|NCT05853380|Mindset Medical|Jeremy Markovich|8583055323|jeremy@mindsetmedical.com|
22266797|NCT00113763|Amgen Inc.|Study Director|866-572-6436||
22266798|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322286|NCT04338009|University of Pennsylvania|Dr. Jordana Cohen|215-662-4000|jco@pennmedicine.upenn.edu|
22322287|NCT03963011|Children's Mercy Hospital|Erin Opfer, DO|816-324-3273|ekopfer@cmh.edu|
22322288|NCT04153188|Candela Corporation|Medical Director|+1 904 6549629|konikap@candelamedical.com|
22322289|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
22322290|NCT04899232|University of Miami|Enrique Ginzburg, MD|305-585-1178|eginzbur@med.miami.edu|
22322291|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300||
22322292|NCT02926950|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22322293|NCT02553460|Lucile Packard Children's Hospital|Tanja A. Gruber, MD, PhD|(650) 723-5535|tagruber@stanford.edu|
22322294|NCT02392429|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22322295|NCT03266016|Children's Hospital Los Angeles|Dr. Robinder Khemani, MD. Medical Staff/USC Faculty|3233612376|rkhemani@chla.usc.edu|
22322296|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22322297|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com|
22322298|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu|
22322299|NCT02257580|Hospital for Special Surgery|Colson Zucker, Research Coordinator|6467146029|zuckerc@hss.edu|
22322300|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp|
22322301|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22322302|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu|
22322303|NCT05036681|The University of Texas MD Anderson Cancer Center|Dr. Siqing Fu|(713) 792-4318|siqingfu@mdanderson.org|
22322304|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org|
22322305|NCT02787850|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director of Clinical, Regulatory and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22322306|NCT03718143|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
22322307|NCT02322710|Mylan Medical SAS|Rafik NAMANE MD.|0033146258607|rafik.namane@mylan.com|
22322308|NCT04161131|Stanford University|Molly Tanenbaum|650-725-3955|mollyt@stanford.edu|
22322309|NCT05064059|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22322310|NCT03905863|Serena Group Inc|Dr Thomas Serena|671-945-5225|serena@serenagroups.com|
22322311|NCT02803164|Mayo Clinic|Dr. Mathew Thomas|904-953-2000|thomas.mathew@mayo.edu|
22322312|NCT04415073|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD|+1-781-419-1400|kmadigan@syndax.com|
22322313|NCT01191697|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|(877) 442-3342|peter_enzinger@dfci.harvard.edu|
22322314|NCT01411345|University of Miami|Matthew Abramowitz MD|305-243-4200|mabramowitz@med.miami.edu|
22322315|NCT05702515|Duke University|Deborah Hutch Allen|919-681-4719|hutch.allen@duke.edu|
22322316|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
22322317|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu|
22322318|NCT02397473|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22322319|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22266799|NCT03743415|University of Arizona College of Nursing|Terry Badger, PhD|520-626-6058|tbadger@arizona.edu|
22322320|NCT02298933|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
22322321|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com|
22322322|NCT01790048|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454 2178|manarymj@wustl.edu|
22322323|NCT05159596|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22322324|NCT01415752|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22266800|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu|
22266801|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com|
22266802|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266803|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266804|NCT03781037|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
22266805|NCT02186834|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
22266806|NCT04581369|Indiana University|Eric Orman|317-278-1630|esorman@iu.edu|
22266807|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com|
22266808|NCT04746794|University of Washington|Faith Beers|206-543-1733|fabeers@uw.edu|
22266809|NCT04867174|University of Southern California|Professor Mireille Jacobson|(213) 740-5156|mireillj@usc.edu|
22266810|NCT00856375|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
22266811|NCT04414345|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22266812|NCT02538965|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosur|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22266813|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com|
22266814|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu|
22266815|NCT05084924|University of North Carolina at Chapel Hill|Justin Riddle, PhD|850-644-9869|justin_riddle@med.unc.edu|
22266816|NCT03774407|Texas Tech|Dr Mirla Avila|8322448072|mirla.avila@ttuhsc.edu|
22266817|NCT00182325|Department of Family Medicine, McMaster University|Dr. Heather Waters|(905) 575-6782|watersh@mcmaster.ca|
22266818|NCT03225001|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
22266819|NCT01420965|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
22266820|NCT02015065|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
22266821|NCT02895100|Protagonist Therapeutics, Inc|Director Clinical Development|(+1) 888-899-1543|ptgxclintrials@ptgx-inc.com|
22266822|NCT03322930|Retina Foundation of the Southwest|Dr. David Birch|214-363-3911|dbirch@retinafoundation.org|105
22266823|NCT03344861|on behalf of Concordia Laboratories Inc.|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
22266824|NCT04642365|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22266825|NCT02728843|Chiesi Canada Corp.|Caroline Fradette, PhD|1-800-854-3534|c.fradette@chiesi.com|7014
22266826|NCT03185013|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22266827|NCT02575976|Federal University of Minas Gerais|Professor Raquel Britto|+55 31 99970-4527|r3britto@gmail.com|
22266828|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
22266829|NCT01024686|U.S. Military Malaria Vaccine Program (USMMVP)|Dr. Michele Spring|301-319-9307||
22266830|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22266831|NCT01104792|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com,|
22266832|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22295264|NCT01780636|UC Irvine|Karen Noblett|714-456-6807|knoblett@uci.edu|
22295265|NCT02279173|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22295266|NCT01938378|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
22295267|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22295268|NCT01571427|Oregon Health & Science University|Dr. Hiroko Dodge|(503) 494-6695|dodgeh@ohsu.edu|
22295269|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu|
22295270|NCT03585504|Medical University of South Carolina|Dr. Angela Dempsey|843-762-4500|dempsear@musc.edu|
22295271|NCT02743806|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22295272|NCT00660530|University of Illinois College of Pharmacy|Dr. Alan Lau|(312) 996-0894|alanlau@uic.edu|
22295273|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295274|NCT01622699|Isala|Dr J Bekhof|0384247492|j.bekhof@isala.nl|+31
22295275|NCT02461355|Burke Neurological Institute|Tomoko Kitago, MD|914-368-3169|tok7002@med.cornell.edu|
22295276|NCT04429061|University of Alabama at Birmingham|Dr Carolyn Bolton|966841034|Carolyn.Bolton@cidrz.org|
22295277|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov|
22295278|NCT03590041|University of Colorado Anschutz medical Campus|Dr. Bethany Kwan|303-724-5153|bethany.kwan@cuanschutz.edu|
22295279|NCT04118166|Stanford Medicine at Stanford University|Maria Ahern|650-725-6413|mahern@stanford.edu|
22295280|NCT03519932|CooperVision Inc.|Jose A.Vega OD, MSc., FAAO|9256213761|javega@coopervision.com|
22295281|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com|
22295282|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com|
22295283|NCT01493570|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295284|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org|
22295285|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu|
22295286|NCT02772081|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22295287|NCT03267186|Stanford University|Andrew R. Rezvani, MD|650-725-4077|arezvani@stanford.edu|
22295288|NCT01214356|MUSC|Vanessa Diaz, MD MSCR|8438762923|diazva@musc.edu|
22295289|NCT03950167|UFUK UNIVERSITY|DR MÜGE KESKİN|+905333522090|mugekeskin1@hotmail.com|
22295290|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22295291|NCT02368431|VA Connecticut Healthcare System West Haven Campus, West Haven, CT|Dr Albert Arias|804-828-5793|albert.arias@vcuhealth.org|
22295292|NCT03124875|LimFlow Inc.|Cecilia Petrella|(888) 478-7705|cpetrella@limflow.com|101
22295293|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org|
22295294|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
22295295|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu|
22266833|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
22295296|NCT04677374|University of North Carolina at Chapel Hill|Mitch Matoga, MD, MS|00265 1 755056|mmatoga@email.unc.edu|
22295297|NCT04247581|Apple|Health Tech Clinical Operations|866-905-5303|htclinicalquestions@apple.com|
22295298|NCT00372112|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295299|NCT04649060|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22309051|NCT05838313|University of South Florida Morsani College of Medicine, Department of Obstetrics and Gynecology|Anjali Kaimal, MD, MAS|(813) 259-8680|akaimal@usf.edu|
22309052|NCT04518917|Washington University in St. LOuis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
22266834|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
22266835|NCT03040323|Indiana University Department of Radiology|Jordan Swensson ,MD|317-944-1831|jswensso@iupui.edu|
22266836|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com|
22266837|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22266838|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
22266839|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
22266840|NCT00658021|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22266841|NCT01806506|Department of General, Transplant and Liver Surgery, Medical University of Warsaw|Piotr Kalinowski|0048 22 599 2546|kalip@o2.pl|
22266842|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
22309053|NCT04537715|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22266843|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22309054|NCT04938492|University of Rochester|Dr. Lisham Ashrafioun|585-430-2026|lisham_ashrafioun@urmc.rochester.edu|
22309055|NCT03865498|Columbia University|Sunmoo Yoon|+1 212 300 7081|sy2102@cumc.columbia.edu|
22266844|NCT05819203|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
22266845|NCT02906566|Stanford University|Dr. Anne L. Chang|650-721-7195|alschang@stanford.edu|
22266846|NCT02952898|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
22309056|NCT05084508|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309057|NCT04137289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309058|NCT04531280|Brigham and Women's Hospital|Dr. David Levine|6177328925|dmlevine@bwh.harvard.edu|
22309059|NCT03994653|Imperial College London|Dr James Flanagan|44 2075942127|j.flanagan@imperial.ac.uk|
22309060|NCT03931174|Northwestern University|Sara Becker|312-503-4203|sara.becker@northwestern.edu|
22309061|NCT05386030|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22309062|NCT05228457|University of Pennsylvania|Walid Makhoul|215-573-2409|walid.makhoul@pennmedicine.upenn.edu|
22309063|NCT04382664|Ultimovacs ASA|Øivind Foss, Head of Clinical Operation|97008357|oivind.foss@ultimovacs.com|
22309064|NCT04528173|The Children's Hospital of Philadelphia|Tori Nicole Sutherland MD MPH|443-631-5032|sutherlant@chop.edu|
22309065|NCT03213691|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22309066|NCT03161028|VA Portland Medical Center|Dr. Rebecca Spain|503-346-0768|rebecca.spain@va.gov|
22309067|NCT02862210|Brown University|Edward Huey, MD|401-455-6403|edward_huey@brown.edu|
22309068|NCT03492216|University of California, San Francisco (UCSF)|Dr. Gabriel Chamie|415-476-4082|gabriel.chamie@ucsf.edu|445
22309069|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de|
22309070|NCT02587403|RTI Surgical|Jennifer Johnson, Senior Clinical Manager|386-418-8888|jljohnson@rtix.com|
22309071|NCT01799265|Bluebird Consulting|Melinda Swanson|6123084500|melinda@bluebirddevice.com|
22309072|NCT03134092|University of Pennsylvania Perelman School of Medicine|Dr. Zachary Meisel|215-746-5618|zfm@pennmedicine.upenn.edu|
22309073|NCT05704543|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
22309074|NCT02938377|University of Alabama at Birmingham|Karen Cropsey, Psy.D|(205) 975-4204|kcropsey@uab.edu|
22309075|NCT04830800|PATH|Dr. Thang Tran Cong, Medical office|84-913301883|thangtran@path.org|
22309076|NCT04285515|Intra-Cellular Therapies, Inc.|Susan Kozauer, MD|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22309077|NCT03396588|University of Kentucky|Dr. Henrietta Bada|8593231019|henrietta.bada@uky.edu|
22309078|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22266847|NCT04844762|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22266848|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
22266849|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22266850|NCT02802631|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
22266851|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22266852|NCT02968849|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22266853|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com|
22266854|NCT02203331|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22266855|NCT02542605|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22266856|NCT02125721|NYU Langone Health|David Goldfarb|212 263 0744|David.Goldfarb@nyulangone.org|
22266857|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22266858|NCT00704730|Exelixis, Inc|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22266859|NCT05292183|Dartmouth-Hitchcock Medical Center|Dr. Krzysztof Bujarski|603 650 5104|krzysztof.a.bujarski@hitchcock.org|
22266860|NCT05833139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266861|NCT03128060|University of Southern California|Susan Enguidanos|(213) 740-9822|enguidan@usc.edu|
22266862|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22309079|NCT01388777|UT MD Anderson Cancer Center|Hwang, Rosa, M.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
22322325|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com|
22322326|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22322327|NCT01496066|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
22322328|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322329|NCT00253630|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22322330|NCT01239160|Tactile Medical|Director of Clinical Research|612-540-5267|astone@tactilemedical.com|
22322331|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com|
22322332|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22322333|NCT02475655|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22322334|NCT00643994|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
22322335|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
22322336|NCT01568606|Ahmanson-UCLA Cardiomyopathy Center|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
22322337|NCT04016311|The University of Texas at Austin, School of Nursing|Gayle M. Timmerman PhD, Professor|5124719087|gtimmerman@mail.utexas.edu|
22322338|NCT04311086|Medtronic|Sara Dinkins SPYRAL DYSTAL Global Study Manager|303-840-4034|rs.spyraldystal@medtronic.com|
22322339|NCT04029519|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|, clinicaltrials@prolleniumus.com|
22322340|NCT02706730|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22322341|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29|seraina.mengiardi@unibas.ch|0041
22322342|NCT02499029|MUSC|Sudie Back, PhD|843-792-9383|backs@musc.edu|
22322343|NCT04823949|The Medical University of South Carolina|Dr. Matthew Finneran|(843) 792-4500|finneram@musc.edu|
22322344|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322345|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322346|NCT00441545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22322347|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com|
22322348|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22322349|NCT03326141|University of Minnesota|Siobhan McMahon|612-625-3225|skmcmaho@umn.edu|
22322350|NCT01891331|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
22266863|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22266864|NCT04021238|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22266865|NCT02260570|Department of Veterans Affairs|Andrew Kayser, MD PhD|925-372-2000|Andrew.Kayser@va.gov|
22266866|NCT04034927|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22266867|NCT03956355|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22266868|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22266869|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22266870|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu|
22266871|NCT05177718|Vumc|Natalizumab and chronic Blood Brain Barrier Breakdown|6159360060|francesca.r.bagnato@VUMC.ORG|
22266872|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu|
22266873|NCT05204082|Mayo Clinic|Michael E. Nemergut, M.D., Ph.D.|507-255-7976|Nemergut.Michael@mayo.edu|
22266874|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
22266875|NCT03578549|Univeristy of Michigan|Dr. Darya Dabiri|4198821017|daryad@umich.edu|
22266876|NCT02794597|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
22266877|NCT04141930|University of Washington|Research Coordinator|2066165859|jheimo@uw.edu|
22266878|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr|
22266879|NCT02597127|The Medicine's Company|Global Health Science Center|1-888-997-6326|Medical.Information@themedco.com|
22266880|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300||
22266881|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu|
22266882|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
22266883|NCT04204057|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
22266884|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930|hsumigni@yahoo.com.tw|2508
22266885|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu|
22266886|NCT04797221|Veterans Health Administration|Joseph Simonetti|7207236491|joseph.simonetti@va.gov|
22266887|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com|
22266888|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
22266889|NCT00486031|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
22266890|NCT05320887|Wake Forest School of Medicine|Darcy Lockhart, Project Manager I|3367166182|alaverdi@wakehealth.edu|
22276898|NCT03309605|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
22322351|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
22322352|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
22266891|NCT02463357|University of Colorado Denver|Robert Roach||clinicalresearchsupportcenter@ucdenver.edu|
22266892|NCT02620579|University of Florida|Dr. Samuel S. Wu|3522945910|samwu@biostat.ufl.edu|
22276899|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu|
22276900|NCT02082483|Kidney Transplant Research|Dr. John Gill|6046822344|jgill@providencehealth.bc.ca|64706
22276901|NCT00422461|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276902|NCT02181621|Smith & Nephew, Inc.|Matthew Christensen|+1-303-249-5812|Matthew.Christensen@smith-nephew.com|
22276903|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
22276904|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22276905|NCT04027946|National Cancer Institute|Dr. Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
22276906|NCT05938010|Scripps Optometric Group|Dr Jay Mashouf|1-858-530-2800|jaymashouf@gmail.com|
22276907|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu|
22276908|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
22276909|NCT02707744|Imperial College|Yura Mareev|+79166364410|mareev84@gmail.com|
22276910|NCT01562444|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276911|NCT02331407|Columbia University|Dr. Tomoko Kitago|212-305-8389|tk2229@columbia.edu|
22276912|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl|
22276913|NCT03055195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22276914|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu|
22276915|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org|
22276916|NCT00421733|Abbott|Global Medical Services|800-633-9110||
22276917|NCT00790933|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22276918|NCT03395990|Duke University Medical Center|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
22276919|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
22276920|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com|
22276921|NCT04017910|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
22276922|NCT03050489|First State Pavlov Medical University|Nikolay Bunenkov|+7-950-028-17-40|bunenkov2006@gmail.com|
22276923|NCT04565288|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
22276924|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu|
22276925|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22276926|NCT01524705|University of Washington|Jeffrey L Probstfield, MD|206-616-0292|jeffprob@uw.edu|
22276927|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661|Rachel.mcardle@va.gov|17479
22276928|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
22276929|NCT04285684|Ketamine Research Foundation|Philip E Wolfson, MD|415-550-1700|ketamine.research@gmail.com|
22276930|NCT02573467|Novartis Pharmaceuticals|Study Director|862-778-8300||
22276931|NCT01829165|Stanford University|Amit Etkin, MD, PhD|(650) 725-5736|aetkin@stanford.edu|
22276932|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
22276933|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com|
22276934|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu|
22276935|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084|echaconas@usa.edu|1275
22276936|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org|
22276937|NCT02296801|NSABP Foundation Inc|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
22276938|NCT00625378|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22276939|NCT04018001|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22276940|NCT02609633|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22276941|NCT02320292|Mayo Clinic|Dr. Thomas E Witzig|507-266-4994|witzig.thomas@mayo.edu|
22295300|NCT03033394|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
22295301|NCT02927431|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295302|NCT02246660|Northwestern University|Dr. Mary McDermott|312-503-6419|mdm608@northwestern.edu|
22295303|NCT04952402|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22295304|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295305|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu|
22295306|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22295307|NCT01860651|Hvidovre University Hospital|Dr. Katrine Carlsen|26180513|katrinec@gmail.com|0045
22295308|NCT02695498|Atrium Health Wake Forest Baptist|Rebecca Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
22295309|NCT03944954|University of Kentucky|Dr. Michael J Wesley|8593230579|michael.wesley@uky.edu|
22295310|NCT05564429|National Institute of Mental Health (NIMH)|Dr Robert Innis|301-594-1368|robert.innis@nih.gov|
22295311|NCT03235154|Community Research Initiative of New England|Amy E. Colson, MD|6175021700|acolson@crine.org|
22295312|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu|
22309080|NCT05351554|Kinevant|Study Director|Please email|kinevant.resolve-heart@kinevant.com|
22276942|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22276943|NCT02583477|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22276944|NCT05507450|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22276945|NCT05436288|Kiora Pharmaceuticals, Inc.|Eric Daniels|858-353-0469|edaniels@kiorapharma.com|
22266893|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266894|NCT03168334|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22276946|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu|
22276947|NCT03767894|Columbia University|Dr. Joel Stein|(212) 305-4818|js1165@columbia.edu|
22276948|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276949|NCT04149353|North Carolina State University|David Lalush|919-513-7671|dslalush@ncsu.edu|
22276950|NCT01871727|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22276951|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22276952|NCT04249778|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22276953|NCT03233217|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22276954|NCT00500890|UT MD Anderson Cancer Center|Dr. Richard Gorlick, MD/Division Head, Pediatrics Administration|713- 563-2516|rgorlick@mdanderson.org|
22276955|NCT06818708|University of California San Diego|Baharin Abdullah|+1 858-220-5714|baabdullah@health.ucsd.edu|
22276956|NCT01729091|The University of Texas MD Anderson Cancer Center|Samer Srour, MD / Stem Cell Transplantation|713-794-4354|SSrour@mdanderson.org|
22276957|NCT04971837|Colorado State University|Dr. Christopher Bell, Director, Laboratory of Integrative Physiology|(970) 491-7522|Christopher.Bell@colostate.edu|
22276958|NCT04289298|Weill Cornell Medical College|Dr. Patricia Marino, PhD|914-997-8691|pam2029@med.cornell.edu|
22276959|NCT01734928|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22276960|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu|
22276961|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22276962|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org|
22276963|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg|
22276964|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com|
22276965|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22276966|NCT01158404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22276967|NCT02056288|Baylor College of Medicine|Chris D. Glover, MD, MBA, Principal Investigator|832-824-5800|cdglover@texaschildrens.org|
22276968|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu|
22266895|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu|
22266896|NCT01778634|University of Maryland|Rose Marie Viscardi, M.D.|410-706-1913|rviscard@som.umaryland.edu|
22266897|NCT02661217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22266898|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22266899|NCT03907657|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|melahat.garipagaoglu@gmail.com|
22266900|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
22266901|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu|
22266902|NCT02892149|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22266903|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
22266904|NCT02165735|University of Rochester|Dr. Kevin Fiscella, PI|5853244563|kevin_fiscella@urmc.rochester.edu|
22266905|NCT03066258|Regenxbio Inc.|Sherri Van Everen, PharmD/ Vice President of Clinical Development|240.552.8181|svaneveren@regenxbio.com|
22266906|NCT02784795|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22266907|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012||
22266908|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22266909|NCT01654315|The Ohio State University|Dr. Stephen Page|614-292-5490|STEPHEN.PAGE@OSUMC.EDU|614
22266910|NCT02054338|Institut de Recherche Pierre Fabre|Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
22266911|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu|
22266912|NCT02950818|University of Michigan School of Public Health|Cathleen Connell|734-647-3189|cathleen@umich.edu|
22266913|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
22266914|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
22266915|NCT03276078|AstraZeneca PLC|Dr Sami Daoud|1-877-240-9479|Information.centre@astrazeneca.com|
22266916|NCT02785952|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22309081|NCT05030233|The Ohio State University College of Nursing|Marliese D. Nist|614-247-5781|nist.10@osu.edu|
22266917|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22266918|NCT01758588|Weill Cornell Medicine|Assistant Director of Leukemia and BMT Clinical Trials|646-962-9305|ell2028@med.cornell.edu|
22266919|NCT03565679|Medline Industries, Inc|Kara Cassady|847-643-3809|kcassady@medline.com|
22266920|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266921|NCT00401986|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|(412) 716-0717|grubbm@bsci.com|
22266922|NCT02478320|M D Anderson Cancer Center|Dr. David Hong|(713) 563-5844|dshong@mdanderson.org|
22266923|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu|
22266924|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com|
22266925|NCT03104400|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22266926|NCT02968602|Maryland Psychiatric Research Center|Heidi J Wehring|410-402-6854|hwehring@som.umaryland.edu|
22266927|NCT00129389|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22309082|NCT05251909|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22266928|NCT02495259|Emory University|Dr. Igor Zhukov|404-268-1404|izhukov@live.com|
22266929|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266930|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300|jslaski@ssrehab.com|838
22266931|NCT02814890|Huashan Hospital, Fudan University, Shanghai|Dr. Jun Zhang|0086-021-52887694|snapzhang@aliyun.com|
22266932|NCT02794246|Univ. of Pennsylvania|Emerging Med|855-216-0098|penncancertrials@emergingmed.com|
22266933|NCT04602546|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
22266934|NCT02156167|Cochlear|Christiane D'hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com|
22309083|NCT04671446|Queen Mary University of London|Dr Myles Lewis, Dr Paul Pfeffer|+4420 7882 5555|myles.lewis@qmul.ac.uk; p.pfeffer@qmul.ac.uk|
22266935|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com|
22266936|NCT03551821|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
22266937|NCT03300843|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|steven-rosenberg@nih.gov|
22266938|NCT05676814|Wake Forest University Health Sciences|Scott Coleman, DO|336-716-2712|srcolema@wakehealth.edu|
22266939|NCT01753297|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
22266940|NCT02533180|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22266941|NCT03904108|Stony Brook University|Dr. Roger Keresztes|631-638-1000|roger.keresztes@stonybrookmedicine.edu|
22266942|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu|
22266943|NCT02646761|University of Pittsburgh|Dr. James J. Irrgang|(412) 383-9865|jirrgang@pitt.edu|
22266944|NCT02441660|UT Health San Antonio|Michelle Trbovich|210-617-5300|TrbovichM@uthscsa.edu|18192
22266945|NCT00794339|ACR|Donna Hartfeil|215-717-2765|dhartfeil@acr.org|
22266946|NCT04082338|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
22266947|NCT02934191|Children's Hospital of Philadelphia|Dr. John Germiller|215-590-3440|germiller@email.chop.edu|
22266948|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22266949|NCT03509857|Montefiore MC|Dr. Aravind Pothula|9178015577|apothula@montefiore.org|
22266950|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
22322353|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22322354|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com|
22322355|NCT01707693|University of Arkansas for Medical Sciences|Leanne L. Lefler, PhD, APN, RN Principal Investigator|5012961939|LeflerLeanne@uams.edu|
22322356|NCT04336995|VUMC|Ken Monahan|6153222318|ken.monahan@vanderbilt.edu|
22322357|NCT03115151|UT Southwestern Medical Center|Dr. Enas Kandil|214/648-9374|Enas.Kandil@UTSouthwestern.edu|
22322358|NCT04600895|Appili Therapeutics Inc|Prasann Bavaniya, MS-BioTech|902-442-4655|pbavaniya@appilitherapeutics.com|5
22322359|NCT01543087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322360|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22322361|NCT02682901|Eastern Virginia Medical School|Henri Parson|7574467976|parsonhk@evms.edu|
22322362|NCT03713944|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22322363|NCT01787916|CHU de Quebec|Weisnagel|4185254444|john.weisnagel@crchul.ulaval.ca|47035
22309084|NCT04145466|Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich|Christoph Hoechsmann|+49 (89) 289 - 24492|christoph.hoechsmann@tum.de|
22309085|NCT02140554|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22309086|NCT02289209|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22309087|NCT03953508|University of Oklahoma Health Sciences Center|Amy Cohn, PhD|4052711903|amy-cohn@ouhsc.edu|
22309088|NCT03771417|Louisiana State University|Brian A. Irving, PhD|12255787179|brianairving@lsu.edu|
22309089|NCT03016754|ZOLL|Nicole Bianco|4129683333|nbianco@zoll.com|14410
22309090|NCT04185298|Saint John's Cancer Institute|Dr. Jennifer Bramen|310-525-0865|jennifer.bramen@providence.org|
22266951|NCT01399658|Dana-Farber Cancer Institute|Martin King, MD|617-732-4332|Martin_King@dfci.harvard.edu|
22266952|NCT02279108|CHU Saint-Etienne|Pr Céline CHAULEUR|04 77 82 86 11|celine.chauleur@chu-st-etienne.fr|+33
22266953|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu|
22266954|NCT04315506|Duke University|Devon Noonan|919-684-3786|devon.noonan@duke.edu|
22266955|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com|
22266956|NCT03094637|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero MD/Professor|713-745-3428|ggarciam@mdanderson.org|
22266957|NCT02756208|Institute of Human Virology|Dr. Mohammad Sajadi|410-7061779|msajadi@ihv.umaryland.edu|
22266958|NCT03485365|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22266959|NCT03332979|Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London|Dr Kirsten Moore|020 7679 9488|kirsten.moore@ucl.ac.uk|
22266960|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22266961|NCT03661697|University of Miami|Lisa D Grunebaum MD|3052433223|lgrunebaum@med.miami.edu|
22266962|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com|
22266963|NCT04988087|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22266964|NCT02613182|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
22266965|NCT03968978|AstraZeneca|Global Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
22266966|NCT00863772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266967|NCT05278650|Duke University|Eleanor McConnell, Ph.D.|919-684-9229|eleanor.mcconnell@duke.edu|
22266968|NCT05038800|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22266969|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu|
22266970|NCT04080544|The University of Texas at Dallas|Dr. Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
22266971|NCT04967508|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22266972|NCT02494180|Kwong Wah Hospital|Dr SF Lai|85223322311|lsf087@ha.org.hk|
22266973|NCT04400682|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
22266974|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266975|NCT03597464|Aurinia Pharmaceuticals|Clinical Trials Information|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22266976|NCT04328961|University of Washington|Ruanne Barnabas|206 520 3800|rbarnaba@uw.edu|
22266977|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov|
22266978|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it|
22266979|NCT03316547|Washington University|Roberta Pineda|314-286-1304|bobbi.pineda@chan.usc.edu|
22266980|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com|
22266981|NCT04172597|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
22266982|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr|
22266983|NCT02952586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266984|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
22266985|NCT00492778|NRG Oncology|Linda Gedeon for Danielle Enserro, PhD.|7168451169|gedeonl@nrgoncology.org|
22266986|NCT03751007|Precigen Actobio T1D, LLC|Sven Blomme|+3292771177|sblomme@actobio.com|
22266987|NCT00841828|Department of Medical Oncology, Hospital Universitario Virgen de la Victoria|Dr. Emilio Alba||emilioalbac@gmail.com|
22266988|NCT03717012|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22266989|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309091|NCT01606215|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
22266990|NCT04414618|RedHill Biopharma Ltd.|Vered Katz Ben-Yair|+13474144462|vered@redhillbio.com|
22266991|NCT00658879|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22266992|NCT02640690|Atlanta VA Health Care System|Dr. Ursula Kelly|4047272715|ukelly@emory.edu|
22266993|NCT01645787|Columbia University|Claudia A. Chiriboga, MD, MPH|(212) 305-8549|cac3@columbia.edu|
22266994|NCT02559180|Cleveland Clinic Foundation|Rishi P Singh|772-223-5945|singhr@ccf.org|13014
22266995|NCT02806024|University of Washington|Mallory Kremer|206.616.5258|mkremer@uw.edu|
22266996|NCT01098474|GlaxoSmithKline|GSK Response Center|866-435-7343||
22266997|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22266998|NCT01598194|UT MD Anderson Cancer Center|Weston,Brian,MD / Gastroenterology Hepatology & Nutrition|713-792-7734|BWESTON@MDANDERSON.ORG|
22266999|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22267000|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22276969|NCT02400580|University of Pittsburgh Medical Center|Dr. Noah Rindos|(412) 641-8769|rindosnb@upmc.edu|
22276970|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300||
22309092|NCT04316871|Assiut University|Dr Muhammad Shawqi|01100671067|m.shawqi@med.au.edu.eg|+20
22309093|NCT01842542|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
22309094|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com|
22309095|NCT05505292|SUNY College of Optometry|Danielle Iacono|2129385936|diacono@sunyopt.edu|
22309096|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com|
22309097|NCT02100891|Fred Hutchinson Cancer Center|Monica Thakar, MD - Professor of Pediatrics|206-667-5000|isioc@fredhutch.org|
22309098|NCT03959696|Massachusetts General Hospital|Karen Sepucha|617-724-3350|ksepucha@mgh.harvard.edu|
22309099|NCT03474679|Janssen Pharmaceutical K.K.|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22322364|NCT03850912|Dana-Farber Cancer Institute|Michael Hassett|617-726-5200|michael_hassett@dfci.harvard.edu|
22276971|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837||
22322365|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22322366|NCT04397094|Faculty of Dentistry Ain Shams University|Dr. Mariem Wassel|+2 0064871416|mariem.wassel@dent.asu.edu.eg|
22322367|NCT02665286|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22322368|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org|
22322369|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295313|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org|
22295314|NCT00276744|SKCCC|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22295315|NCT01294267|Icahn School of Medicine at Mount Sinai, Helmsley Electrophysiology Center|Vivek Y. Reddy, MD|212-241-7114|vivek.reddy@mountsinai.org|
22295316|NCT03809052|Galecto BIotech|Dr Bertil Lindmark, Chief Medical Officer|+45 70 70 52 10|info@galecto.com|
22295317|NCT02071914|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22295318|NCT01307397|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295319|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org|
22295320|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org|
22295321|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac|
22295322|NCT03667924|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
22295323|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
22295324|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com|
22295325|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295326|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org|
22295327|NCT04232124|Vanderbilt University Medical Center|David G. Harrison|6158753049|david.g.harrison@vumc.org|
22295328|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk|
22295329|NCT02771990|Providence Veterans Affairs Medical Center|Benjamin Greenberg|4012737100|benjamin.greenberg@va.gov|
22295330|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22295331|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net|
22295332|NCT01164956|Dana-Farber Cancer Institute|Christina K. Ullrich, MD, MPH|617.632.4997|Christina_Ullrich@dfci.harvard.edu|
22295333|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295334|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com|
22295335|NCT00967798|Emory University|Arlene Stecenko, MD|404-712-2657|astecen@emory.edu|
22295336|NCT02425046|Center for Children's Healthy Lifestyles & Nutrition - Children's Mercy Hospital|Dr. Helena Laroche|(816) 234-9251|hhlaroche@cmh.edu|
22295337|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr|
22295338|NCT02782780|San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@va.gov|24386
22295339|NCT01413191|UT MD Anderson Cancer Center|Dr. Sapna Patel, MD - Associate Professor, Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
22295340|NCT03654651|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
22295341|NCT05040386|University of Alabama at Birmingham|Anand Iyer, MD, MSPH|2059341968|aiyer@uabmc.edu|
22295342|NCT03045328|Stanford University|Steven Edward Coutre, Professor of Medicine (Hematology)|650-498-6000|coutre@stanford.edu|
22295343|NCT04615923|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22295344|NCT03395886|Zhongshan Hospital, Fundan university|Mr Zhe Luo|64041990|ec@zs-hospital.sh.cn|
22295345|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324||
22295346|NCT02310464|OBI Pharma, Inc.|Chen-En Tsai, MD, PhD|886 2 27866589|chenentsai@obipharma.com|215
22295347|NCT02618434|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22295348|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca|
22295349|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu|
22295350|NCT02289898|Mereo BioPharma Group Plc.|John, Lewicki, Chief Scientific Officer|+44333023300|John.Lewicki@mereobiopharma.com|
22295351|NCT04626297|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22295352|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22295353|NCT03434275|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
22295354|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu|
22295355|NCT02598076|Yale Comprehensive Epilepsy Center, Department of Neurology, Yale Univseristy School of Medicine|Benjamin Tolchin, MD, MS|347-721-8491|benjamin.tolchin@yale.edu|
22295356|NCT02005445|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6375|daniel.gottlieb@va.gov|
22295357|NCT00010374|Synapse Biomedical, Inc.|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
22295358|NCT01669915|Brigham and Women's Hospital;181 Longwood Ave; Boston, MA 02115|Jae Hee Kang|617-525-2022|nhjhk@channing.harvard.edu|
22295359|NCT03530098|Stanford University|Safwan S Halabi, MD|(650) 721-2850|safwan.halabi@stanford.edu|
22322370|NCT03790280|University of California, Los Angeles (UCLA)|Angela Martinez, Research Manager|310-206-7630|angelamartinez@mednet.ucla.edu|
22322371|NCT00915343|Shire|Study Physician|1866-842-5335|clinicaltransparency@shire.com|
22322372|NCT02406781|Institut Bergonie|Pr Antoine Italiano|0524071947|a.italiano@bordeaux.unicancer.fr|
22276972|NCT01433978|Eisai Call Center|Eisai Inc.|888-422-4743||
22276973|NCT03281538|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22276974|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU|
22276975|NCT04233580|University of Texas Southwestern Medical Center|Tara Kristof|214-648-8602|tara.kristof@utsouthwestern.edu|
22276976|NCT03954938|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
22276977|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22276978|NCT02565186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22276979|NCT00617903|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22276980|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276981|NCT04676646|AstraZeneca|Global Clinical Lead|18772409479|information.center@astrazeneca.com|
22276982|NCT04270760|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22276983|NCT05156125|Oppilan Pharma Ltd|Clinical Trial Contact|+1(888)-411-5176|clinicaltrials@ventyxbio.com|108
22276984|NCT03670628|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-4562|ramasamy@miami.edu|
22276985|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161|amendizabal@emmes.com|221
22276986|NCT02993302|Dr. Cipto Mangunkusumo Hospital|Dyah Purnamasari|62213907703|dyah_p_irawan@yahoo.com|
22276987|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu|
22276988|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343||
22276989|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22276990|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22276991|NCT03338023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22276992|NCT04996264|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
22276993|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22276994|NCT02030418|Abbott Cardiac Rhythm Management|Nicole Harbert, Director Clinical Research|972-526-4841|nicole.harbert@abbott.com|
22276995|NCT03412890|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22276996|NCT05254210|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22276997|NCT03838874|Mayo Clinic|Dr. Matthew Abdel|507-538-1296|Abdel.Matthew@mayo.edu|
22276998|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300||
22276999|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277000|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22277001|NCT03753542|Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi|Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi|0345-2506790|nomiwg@gmail.com|
22277002|NCT04514458|Yale University|Tariq Ahmad|203-843-1667|tariq.ahmad@yale.edu|
22277003|NCT04180696|Medtronic, Bakken Research Center B.V.|Lidwien Vainer|+31610419653|lidwien.vainer@medtronic.com|
22277004|NCT05866367|HealthPartners Institute Neuroscience Research|Clinical Research Coordinator|651-495-6363|ClinicalTrials@HealthPartners.com|
22277005|NCT04210375|Salubris Biotherapeutics, Inc|SVP, Clinical Development|16176459160|amanda.mcewen@salubrisbio.com|
22277006|NCT04906421|Sagimet Biosciences, Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
22277007|NCT05752487|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22277008|NCT03585543|Medical University of South Carolina College of Nursing|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
22277009|NCT04124965|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22277010|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu|
22277011|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22277012|NCT04625972|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22277013|NCT05591755|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22277014|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277015|NCT01346683|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22277016|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com|
22277017|NCT00504309|Penn State University|Ann Skulas-Ray|814-863-0856|aus164@psu.edu|
22277018|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22277019|NCT05067270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22277020|NCT03630354|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
22277021|NCT00983957|Bristol-Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22277022|NCT01560416|Dana-Farber Cancer Institute|Nancy Lin|617-632-2335|Nancy_Lin@dfci.harvard.edu|
22277023|NCT05894564|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22277024|NCT02169401|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
22295360|NCT00533845|Maimonides Medical center|Danny A Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22295361|NCT05989815|Federal University of São Carlos (UFSCar)|Italo Amaral de Oliveira, Principal Investigator|+55 19 99719-0361|italoao@estudante.ufscar.br|
22295362|NCT04583891|University of Virginia|Philip Chow|9146453458|pic2u@virginia.edu|
22295363|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295364|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
22295365|NCT02407704|University of Pittsburgh|Dr. Kirk Erickson|412-624-4533|kiericks@pitt.edu|
22309100|NCT03452579|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
22309101|NCT05490459|Element Science, Inc.|Chief Medical Officer|4158726500|zubin@elementsci.com|
22309102|NCT05604508|RAND|William Shadel|4126832300|shadel@rand.org|4489
22309103|NCT05337306|GogyUp|Ned Zimmerman-Bence, Co-Founder|6124605358|ned.zb@gogyup.com|
22309104|NCT04858321|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
22309105|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22309106|NCT03885518|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22309107|NCT05328362|Dartmouth College|Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
22309108|NCT02573493|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
22309109|NCT04863378|Oregon Heatlh & Science University|Raina Croff, PhD Study investigator/ KL2 trainee|503-494-2367|croff@ohsu.edu|
22309110|NCT04149704|Dana-Farber Cancer Institute|Jennifer Snaman|617632-5548|jennifer_snaman@dfci.harvard.edu|
22309111|NCT05832996|University of Iowa|Douglas Jin, MD|319-356-3185|Douglas-Jin@uiowa.edu|
22309112|NCT03629678|The Ohio State University|Dr Robert Cronin|6146889220|robert.cronin@osumc.edu|
22309113|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
22309114|NCT06215430|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22309115|NCT02433613|Medtronic GmbH|Dr. Ralf Meyer|01755810431|ralf.meyer@medtronic.com|
22309116|NCT04632992|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22309117|NCT02677805|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22309118|NCT02291302|Boston Children's Hospital|Wanda Phipatanakul, MD. MS.|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
22309119|NCT04350463|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22309120|NCT04652700|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309121|NCT04187833|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|James Isaacs, MD|1-866-223-8100|TaussigResearch@ccf.org|
22309122|NCT01898754|University of Washington|Professor Lisa Frenkel|+1 206 987-5140|lfrenkel@uw.edu|
22309123|NCT03097549|Umeå University|Towe Wadensten|0046907865000|towe.wadensten@umu.se|
22309124|NCT02146378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309125|NCT06215521|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22309126|NCT05089019|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22309127|NCT04925986|Yale School of Medicine|Sarah Goldberg, MD, MPH: Associate Professor of Internal Medicine (Medical Oncology)|(203) 200-5864|sarah.goldberg@yale.edu|
22309128|NCT05415722|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
22309129|NCT03524612|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22309130|NCT01414400|Stanford University School of Medicine|Subhas Banerjee|650-723-2623|sbanerje@stanford.edu|
22309131|NCT05457647|Studio Italiano di Oftalmologia|Dr. Marco Lombardo, Study Director|+393313438300|studiolombardo@visioeng.it|
22309132|NCT04623671|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
22309133|NCT03448107|NYU Dentistry|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
22309134|NCT04025554|National Institutes of Health|Dr. Daniel S. Reich|301-496-1801|reichds@ninds.nih.gov|
22309135|NCT03115476|LEO Pharma|Clinical Trial Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22309136|NCT01802788|Abbott|Vinny Podichetty, Clinical Program Director|779-209-9425|vinny.podichetty@abbott.com|
22309137|NCT03509402|"University of Campania Luigi Vanvitelli"|Prof. Marco Annunziata|0815665515|marco.annunziata@unicampania.it|0039
22309138|NCT04700163|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
22309139|NCT03270501|Department of Rheumatology, Gent University Hospital|Professor Dirk Elewaut|+32 9 332 22 30|reumatologie@uzgent.be|
22309140|NCT01648023|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
22309141|NCT04158804|Massachusetts General Hospital|Michael K. Mansour, MD, Ph.D.|617-726-6726|mkmansour@mgb.org|
22309142|NCT01986712|St. Luke's University Health Network|Neil Belman|484-503-4673|neil.belman@sluhn.org|
22309143|NCT00764751|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22309144|NCT01623167|National Heart Lung and Blood Institute (NHLBI)|Neal S. Young, M.D, NIH Principal Investigator|301-496-5093|youngns@nhlbi.nih.gov|
22309145|NCT05296525|Gamida Cell|Associate director, Clinical Operations|+972556660324|aurelie@gamida-cell.com|
22309146|NCT02918890|Columbia University|Dr. Andrew M. Gordon|212.678.3332|ag275@columbia.edu|
22309147|NCT04204265|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22309148|NCT02465268|University of Florida|Duane Mitchell, MD, PhD|352-273-9000|duane.mitchell@neurosurgery.ufl.edu|
22322373|NCT03505021|Orion Corporation|Director, Clinical Operations|358104261|clinicaltrials@orionpharma.com|
22322374|NCT05280756|University of Pittsburgh Medical Center|Dr. Alexandre Paim Diaz|(412) 624-1000|paimdiaza@upmc.edu|
22322375|NCT00939198|George Washington University|Dr. David Diemert|2029942909|ddiemert@gwu.edu|
22322376|NCT01299766|Thomas Jefferson University|Robin Casten|215-503-1250|robin.casten@jefferson.edu|
22322377|NCT04002310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22322378|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22322379|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22267001|NCT00442962|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22267002|NCT04238650|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
22267003|NCT03348163|The University of Texas Health Science Center at Houston|Jordan Elizabeth Lake, MD, Associate Professor|(713) 500-6759|Jordan.E.Lake@uth.tmc.edu|
22267004|NCT02585778|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22267005|NCT03617783|Maryland Psychiatric Research Center|Dr. Robert Buchanan|410-402-7876|rwbuchanan@som.umaryland.edu|
22267006|NCT05246670|Geisinger Medical Center|Mellar P. Davis, MD, FCCP, FAAHPM|570-271-7383|mdavis2@geisinger.edu|
22267007|NCT02281422|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22267008|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267009|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com|
22267010|NCT03682107|Cincinnati Children's Hospital|Dr. Grant Paulsen|513-636-4578|Grant.Paulsen@cchmc.org|
22267011|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000|Ratidzo.Danha@uhcw.nhs.uk|25871
22267012|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu|
22267013|NCT04152291|Wihuri Research Institute|Professor Katariina Öörni|+358 40 7023711|kati.oorni@wri.fi|
22267014|NCT03597295|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22267015|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267016|NCT05124691|Instituto de Salud Global de Barcelona - ISGLOBAL|Jose Muñoz|+34608774071|jose.munoz@isglobal.org|
22267017|NCT05211726|University of Delaware|Christopher Martens|302-831-7270|cmartens@udel.edu|
22267018|NCT01890434|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22267019|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu|
22267020|NCT01038297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267021|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com|
22267022|NCT01898221|Houston Methodist Hospital, Dept of Cardiology|Miguel Valderrabano, MD|713 441 5231|MValderrabano@houstonmethodist.org|
22267023|NCT04791514|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
22267024|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267025|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
22267026|NCT02288156|UZ Leuven|Prof. Dr. Hellings|016336340|nkogh@uzleuven.be|
22267027|NCT05147324|University of North Carolina at Chapel Hill|Angelica Cristello Sarteau|919-445-1191|angcri@live.unc.edu|
22267028|NCT02714426|University of Florida|Michael Marsiske, Ph.D.|352.273.5097|marsiske@phhp.ufl.edu|
22267029|NCT01727726|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22267030|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22267031|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777||
22267032|NCT03149757|University of Minnesota|Keith Horvath|619-594-3346|khorvath@sdsu.edu|
22267033|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com|
22267034|NCT02391987|Mayo Clinic|Charles J. Bruce|904-953-7227|bruce.charles@mayo.edu|
22267035|NCT00896480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22309149|NCT02876588|Columbia University|Dr. Jason Adelman|646-317-4803|adelman.jason@columbia.edu|
22309150|NCT02547363|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22309151|NCT04364048|Hoosier Cancer Research Network|Andrew Benson|317-921-2050|abenson@hoosiercancer.org|
22309152|NCT03322267|National Taiwan University Hospital|Dr Chih-Hung Hsu|+886-23123456|chihhunghsu@ntu.edu.tw|
22309153|NCT03046251|Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA.|Dr. Bianca Weinstock-Guttman|716-829-4415|bw8@buffalo.edu|
22309154|NCT03084536|Washington University School of Medicine|Ryan C. Guffey, M.D.|314-286-2883|rguffey@wustl.edu|
22309155|NCT04836195|Pacylex Pharmaceuticals|VP Operations|1 (888) 580-4483|ryan.heit@pacylex.com|
22309156|NCT04986501|Sunbio|Min-Jung Ahn|+82-31-423-5467|mjahn@sunbio.com|
22309157|NCT05302596|State University of NY at Buffalo|Husam Ghanim|7168818924|ghanim@buffalo.edu|
22309158|NCT03450980|Schepens Eye Research Institute of Mass Eye & Ear, Harvard Medical School, Boston, MA, USA|Gang Luo|(617) 573-4177|gang_luo@MEEI.HARVARD.EDU|
22309159|NCT06212804|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
22309160|NCT03491969|Zhongshan hospital, Fudan University|Dr. Hanchuan Chen|18459111985|chenhanchuan66@126.com|
22309161|NCT03287817|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
22309162|NCT00636077|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22309163|NCT04130438|Stanford University|Jennifer A. Tremmel, MD, MS|(650) 723-0180|nocad_study@stanford.edu|
22309164|NCT03499821|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|
22309165|NCT03338933|VA Portland Health Care System|Dr. William Hoffman|503-220-8262|hoffmaw@ohsu.edu|56214
22309166|NCT01084876|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22309167|NCT04515576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309168|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22309169|NCT04256941|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran|713-792-2817|sdamodaran@mdanderson.org|
22309170|NCT04622943|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
22309171|NCT05717907|Mahidol university|Pattamon Leelachaikul|+66863019830|pattamonl@hotmail.com|
22309172|NCT05546749|Albert Einstein College of Medicine|Hector Perez|7189205756|heperez@montefiore.org|
22295366|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu|
22295367|NCT02496611|University of Minnesota|Aaron Kelly PhD|6126253492|kelly105@umn.edu|
22267036|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu|
22267037|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22267038|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov|
22267039|NCT03014180|Microport CRM|Director of Scientific Communication|0677164209|anne.rousseauplasse@crm.microport.com|
22267040|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu|
22267041|NCT02297698|LumaBridge|Dr. George Peoples|210 557 4291|gpeoples@lumabridge.com|
22267042|NCT02212379|Inserm, Sorbonne Universite, IPLESP|Dr Lambert Assoumou|0142164280|lambert.assoumou@iplesp.upmc.fr|
22267043|NCT04784533|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22267044|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
22267045|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu|
22267046|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org|
22267047|NCT02777073|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
22267048|NCT03844386|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
22267049|NCT02682927|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22267050|NCT03462459|University of Wisconsin-Madison|Nasia Safdar, Professor|608-265-1545|ns2@medicine.wisc.edu|
22267051|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr|
22267052|NCT01177059|Janssen-Cilag Pty Ltd, Australia|Executive Director Medical & Scientific|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22267053|NCT04051619|Brown University|Carolina Haass-Koffler, PharmD, PhD (PI)|4155191385|carolina_haass-koffler@brown.edu|
22267054|NCT05938621|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
22267055|NCT05573763|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
22267056|NCT03975491|Pennington Biomedical Research Center|Dr. Justin Brown|2257632715|Justin.Brown@pbrc.edu|
22267057|NCT04582149|Emory University|Ofer Sadan, MD, PhD|470-480-6956|ofer.sadan@emory.edu|
22267058|NCT03922529|University of Pittsburgh|Daniel Forman, MD|412-360-2411|formand@pitt.edu|
22267059|NCT02731638|University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|+1 415 502 2666|jennifer.rose-nussbaumer@ucsf.edu|
22267060|NCT04158245|Tulane University|Brian Lewis|504-988-6300|blewis@tulane.edu|
22267061|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU|
22267062|NCT02465398|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
22267063|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com|
22267064|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it|
22267065|NCT03624920|Theranexus|Chief Medical Officer|+33680026779|werner.rein@theranexus.fr|
22267066|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com|
22267067|NCT03760185|Denver Health and Hospital Authority|Dr Cristos Ifantides|303-436-4949|Cristos.Ifantides@dhha.org|
22267068|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
22267069|NCT00866879|Northwestern University|Lorenzo Gallon, MD|3126954457|l-gallon@northwestern.edu|
22267070|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22267071|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22267072|NCT02954991|Mirati Therapeutics|Clinical Operations Director|858-381-5289|LatvenL@Mirati.com|
22267073|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22267074|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu|
22267075|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
22267076|NCT01582152|The University of Texas (UT) MD Anderson Cancer Center|Dr. Alfred Yung, Clinical Professor, Neuro-Oncology|713-792-7734|wyung@mdanderson.org|
22267077|NCT03055624|UCSD|Andrew Picel MD|619-543-3436|apicel@stanford.edu|
22267078|NCT03834142|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
22267079|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net|
22267080|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22267081|NCT02652611|U Maryland|Haley Demyanovich|4107063935|hdemyanovich@som.umaryland.edu|
22267082|NCT01275729|University of Chicago|Dr. Jay L Koyner|773-702-4842|jkoyner@uchicago.edu|
22267083|NCT03577301|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
22267084|NCT02252406|University of Florida, Jacksonville|Gladys Velarde, MD|904-244-2060|gladys.velarde@jax.ufl.edu|
22267085|NCT03545893|University of Pennsylvania|Arden McAllister, Research Program Manager|215-662-3532|arden.mcallister@pennmedicine.upenn.edu|
22267086|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA|
22267087|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267088|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267089|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22295368|NCT02850965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277025|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22277026|NCT03150797|UCSF|Dr. Amy Gelfand|415-502-1914|amy.gelfand@ucsf.edu|
22267090|NCT04974749|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22277027|NCT04229381|The Ohio State University Comprehensive Cancer Center|Dr. Carolyn Presley|614-293-9424|Carolyn.Presley@osumc.edu|
22277028|NCT03684057|Brown University|Dr. Judson Brewer|401-863-2826|judson.brewer@brown.edu|
22277029|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com|
22277030|NCT03422718|University of Michigan|Principal Investigator|734-615-2766|mdome@umich.edu|
22277031|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613||
22277032|NCT01629862|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
22277033|NCT03197935|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22277034|NCT03593629|Jomo Kenyatta University of Agriculture and Technology and University of Washington|Kenneth Ngure|+254722362219|kngure@uw.edu|
22277035|NCT03315689|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22277036|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu|
22277037|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com|
22277038|NCT03073109|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277039|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se|
22277040|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au|
22277041|NCT03387046|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22277042|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620||
22277043|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277044|NCT02568423|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22277045|NCT03794544|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22277046|NCT02550210|Dartmouth Hitchcock Medical Center|Dr. Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
22277047|NCT02502383|University of New Mexico Health Sciences|Alberta Kong|505-272-5551|AKong@salud.unm.edu|
22277048|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org|
22277049|NCT02979054|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
22277050|NCT00875667|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|8882601599|ClinicalTrialDisclosure@Celgene.com|
22277051|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
22277052|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com|
22277053|NCT01676350|WellSpan York Hospital|Brent Becker|717-851-2223|bbecker2@wellspan.org|
22277054|NCT03300336|HSRD ADAPT|S. Nicole Hastings|919-286-6936|susan.hastings@va.gov|
22322380|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org|
22322381|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22322382|NCT02944448|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22277055|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262|Frederick.Gallun@va.gov|57472
22277056|NCT02384460|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22277057|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu|
22277058|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp|
22277059|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com|
22277060|NCT03270241|Johns Hopkins Medicine Dermatology Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
22277061|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22277062|NCT02933476|Stanford School of Medicine|Raumin Neuville|6507236709|raumin@stanford.edu|
22277063|NCT03896217|UCL Institute of Neurology|Prof. Richard Nicholas|0208 383 0675|richard.nicholas3@nhs.net|
22277064|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu|
22277065|NCT01399099|Neodyne Biosciences|Sr. Director of R&D|510-456-4128|jjackson@neodynebio.com|128
22295369|NCT02784275|NovMetaPharma Co., Ltd|Peter Lee|+82 (0)2 538 1893|Peter@NovMeta.com|
22322383|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111||
22322384|NCT03037281|University of Leicester|Dr Christopher Hebbes|0116 252 2522|christopher.hebbes@le.ac.uk|
22267091|NCT01520870|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
22267092|NCT02289456|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22267093|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu|
22267094|NCT00796107|Hoffmann-La Roche, Ltd.|Study Director|888-662-6728 (U.S.)|global-roche-genentech-trials@gene.com|
22267095|NCT04902014|Colorado State University|Dr. Kayla Nuss|9705814824|kayla.nuss@colostate.edu|
22267096|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22267097|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu|
22267098|NCT02797171|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22277066|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22277067|NCT01668537|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22322385|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22295370|NCT01462097|University of Maryland School of Medicine|Stephen Seliger, MD MS|410-605-7000|sseliger@som.umaryland.edu|x55231
22295371|NCT03178903|Butler Hospital|Ana M. Abrantes, Ph.D.|4014556440|Ana_Abrantes@Brown.edu|
22295372|NCT00230607|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22295373|NCT03672747|Boys Town National Research Hospital|Tony Wilson|531-355-8909|tony.w.wilson@gmail.com|
22295374|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org|
22295375|NCT03228537|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
22295376|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com|
22295377|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu|
22295378|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
22295379|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22295380|NCT03358290|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22295381|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com|
22295382|NCT04102020|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
22295383|NCT04853225|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295384|NCT03789318|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
22295385|NCT00733408|University of Washington|Jennifer Specht, MD, Associate Professor|(206) 606-1000|jspecht@uw.edu|
22267099|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org|
22267100|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
22267101|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu|
22267102|NCT00606632|Heidelberg Pharma AG (former Wilex AG)|Head of R&D||info@hdpharma.com|
22267103|NCT03908437|University of Pennsylvania, Dpt of Psychiatry, Perelman School of Medicine|Dr. David Metzger, Research Professor, Director of HIV Prevention Research Unit|215-746-7355|dsm@pennmedicine.upenn.edu|
22267104|NCT03633825|Harvard University|Principal Investigator|617-496-4484|jaroszewski@fas.harvard.edu|
22267105|NCT04841577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22267106|NCT03287843|Ege University Hospital|Erhan Akgun,MD, Proffessor|+902323905050|z.erhan.akgun@ege.edu.tr|
22267107|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267108|NCT03456453|University of Kentucky|Michele Staton|859-312-8245|mstaton@uky.edu|
22267109|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267110|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com|
22267111|NCT04856930|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22267112|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267113|NCT04933383|Aquilon Pharmaceuticals SA|Clinical Operations|003242292800|clinops@aquilonpharma.com|
22267114|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22267115|NCT01125371|Johns Hopkins University|Dr. Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
22267116|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com|
22267117|NCT01625988|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267118|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com|
22267119|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267120|NCT01297985|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
22267121|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu|
22267122|NCT02032680|VA, University of Pittsburgh|Dr. Armando Rotondi|412-360-2494|ArmandoRotondi1@gmail.com|
22267123|NCT03086486|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
22267124|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22267125|NCT03593395|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22267126|NCT03713632|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22267127|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22267128|NCT01375946|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22267129|NCT02370238|Dompé Farmaceutici SpA|Dr Pier Adelchi Ruffini, MD|+39 02 583831|info@dompe.it|
22267130|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267131|NCT02652949|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
22267132|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991|henken@ufl.edu|205
22267133|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk|
22295386|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu|
22295387|NCT04346537|Boston Scientific|Gena Kantor|1-800-227-3422|gena.kantor@bsci.com|
22295388|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org|
22267134|NCT04052334|Moffitt Cancer Center|John E. Mullinax, MD, FACS|813-745-4673|John.Mullinax@moffitt.org|
22267135|NCT05831774|Houston Methodist Hospital|Haley Goble|713-441-3930|hmgoble@houstonmethodist.org|
22267136|NCT03985852|University of Utah|Dr. Kimberly Kaphingst|801-213-5724|kim.kaphingst@hci.utah.edu|
22267137|NCT03837743|DURECT Corporation|Executive Director of Regulatory Affairs|408-777-1829|jill.burns@durect.com|
22267138|NCT05199090|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22267139|NCT04868968|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
22267140|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu|
22267141|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22267142|NCT03431493|Johns Hopkins University|Ann Parker, MD, PhD|443-287-2616|aparke36@jhu.edu|
22267143|NCT02686138|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22267144|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com|
22267145|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu|
22267146|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca|
22267147|NCT03423186|Swedish Orphan Biovitrum AB|Anders Bröijersén, Medical Director|+46 8 697 20 00|anders.broijersen@sobi.com|
22267148|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr|
22267149|NCT02881840|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
22277068|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu|
22295389|NCT00531232|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22295390|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
22295391|NCT03641651|Zurich University of applied sciences|Prof. Dr. Markus Wirz|+41 58 934|markus.wirz@zhaw.ch|6321
22295392|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295393|NCT01991067|Medical University of Vienna, Department of Medicine I, Division of Infectious Diseases|Assoc. Prof. Dr. Christina Bahrs|+4314040044400|christina.a.forstner@meduniwien.ac.at|
22295394|NCT03134989|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|
22295395|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com|
22295396|NCT00127712|Purdue University|James E. Tisdale|317-613-2315|jtisdale@iupui.edu|306
22295397|NCT03055260|University of Minenesota|Russel Giveans|5042314007|russell.giveans@gmail.com|
22295398|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
22295399|NCT02781051|UT Southwestern Medical Center|Chad Rethorst, Associate Professor|2146480153|chad.rethorst@utsouthwestern.edu|
22295400|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
22295401|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu|
22295402|NCT02775162|OrganOx Ltd|Robert Bovy, VP of Regulatory Affairs, North America|608-556-4429|robert.bovy@organox.com|
22295403|NCT02051608|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295404|NCT00142584|Viatris Inc|M. Rachel Kirker, PhD, Director, Clinical Oversight & Inspection Readiness|724-485-6170|rachel.kirker@viatris.com|
22295405|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22295406|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com|
22295407|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com|
22295408|NCT04577118|iotaMotion, Inc|Laura Chenier|442-325-4171|lchenier@iotamotion.com|
22295409|NCT00356369|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295410|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295411|NCT02278250|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22295412|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
22295413|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu|
22295414|NCT04294472|Vera Therapeutics Inc.|Isabel Gorham, Director of Clinical Operations|(910)200-0532|isabel.gorham@veratx.com|
22295415|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295416|NCT01957644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295417|NCT04044716|Atrium Health Wake Forest Baptist|Dr. Carolyn Huffman|336.713.4018|cshuffma@wakehealth.edu|
22295418|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com|
22295419|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com|
22295420|NCT03636061|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22295421|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22295422|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
22309173|NCT03869866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22309174|NCT06181227|Aviceda Therapeutics|David Callanan|817-312-9258|dcallanan@avicedarx.com|
22309175|NCT05543915|NYU Langone Health|Guiseppina Pilloni|646-501-9274|giuseppina.pilloni@nyulangone.org|
22309176|NCT02577835|Italian Institute of Telemedicine|Stefano Omboni|00390331984176|stefano.omboni@iitelemed.org|
22309177|NCT04342494|University of Michigan|Amy Bohnert|(734) 936-4280|amybohne@med.umich.edu|
22309178|NCT03736720|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
22309179|NCT05119023|MGH-Institute of Health Professions|Sofia Vallila Rohter, Project Principle Investigator|617-724-3824|svallilarohter@mghihp.edu|
22309180|NCT03194217|BenevolentAI|Administrator|+44 20 3781 9360|LondonAdmin@benevolent.ai|
22309181|NCT02962895|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22309182|NCT03659734|Stanford University|Dr. Jennifer Hah|650-723-4000|map_pain_study@stanford.edu|
22267150|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277069|NCT02216851|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22277070|NCT02122952|AveXis, Inc.|Doug Feltner, MD|833-828-3947|medinfo@avexis.com|
22277071|NCT02336503|Botanix Pharmaceuticals|Vice President, Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
22277072|NCT01659541|MetroHealth Medical Center|Anthony F. DiMarco, MD|216-778-3906|afd3@case.edu|
22277073|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
22277074|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu|
22277075|NCT04185246|Trust Biosonics, Inc.|Charly Kang|+886-3-668-4965|charlykang@trust-biosonics.com|211
22277076|NCT05877586|Duke University|Cristina C. Hendrix, DNS, GNP, FAAN|919-684-9358|cristina.hendrix@duke.edu|
22277077|NCT02184156|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22277078|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com|
22277079|NCT02405962|The Hong Kong Polytechnic University|Dr. Yim Wah Mak|(852) 2766-6421|yw.mak@polyu.edu.hk|
22277080|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22277081|NCT03969420|Sumitomo Pharma Oncology, Inc|Reyna Bishop|512-363-8755|reyna.bishop@oncology.Sumitomo-Pharma.com|
22277082|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov|
22277083|NCT03694652|University of New Mexico|Dr. Tracie Collins|505-272-4979|tccollins@salud.unm.edu|
22277084|NCT03158311|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22277085|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22277086|NCT00724503|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
22277087|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu|
22277088|NCT01186419|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22277089|NCT03812328|Tetherex Pharmaceuticals|Jonathan Stocker, Ph.D.|855-222-0722|jstocker@tetherex.com|
22277090|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22277091|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22277092|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22277093|NCT04073407|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
22277094|NCT07085845|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
22277095|NCT03989570|Minia university|Dr. Hassan Elshorbagy|1204427271|Hassan.Hetta@mu.edu.eg|0020
22277096|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
22277097|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111|azafari@emory.edu|4019
22277098|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu|
22277099|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org|
22277100|NCT01964560|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22277101|NCT03676725|AlkaliDx|Lynn Feldman|16178791670|lynn@alkalidx.com|
22277102|NCT05696158|Mahana Therapeutics|Kathryn Jenkins|17742666693|kathryn@mahanatherapeutics.com|
22277103|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com|
22277104|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org|
22277105|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com|
22277106|NCT03791060|Beth Israel Deaconess Medical Center|Co-Director Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS)|6176675834|mporter3@bidmc.harvard.edu|
22277107|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
22277108|NCT01717859|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
22277109|NCT04389671|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
22277110|NCT02734147|Christiana Care Health Services|Jamie Rosini, Pharm D|302-733-6364|jrosini@christianacare.org|
22277111|NCT02213107|University of Rochester|Chunkit Fung, MD|585 - 275 - 5823|chunkit_fung@urmc.rochester.edu|
22277112|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org|
22277113|NCT03034928|Alcon, A Novartis Division|Sr CDMA Project Lead, GCRA - Vision Care|1-888-451-3937|Alcon.medinfo@alcon.com|
22277114|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22277115|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
22277116|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22277117|NCT03362957|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22277118|NCT04246476|Washington University in St. LOuis|Gammon Earhart|3142861407|earhartg@wustl.edu|
22309183|NCT04509674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277119|NCT04308694|Duke University|William John, Ph.D.|919-681-7291|william.john@duke.edu|
22277120|NCT02181738|Bristol Myers Squibb|Bristol Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22277121|NCT01968317|Obstetrics and Gynecology Hospital of Fudan University|Xiaojun Chen|33189900|xiaojunchen2013@sina.com|
22277122|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com|
22277123|NCT05064800|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277124|NCT02508207|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22309184|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com|
22277125|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22277126|NCT00183391|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey H Newcorn|212-659-8705|jeffrey.newcorn@mssm.edu|
22277127|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22277128|NCT04584554|Duke University School of Nursing|Tolu Oyesanya, PI of study|919-684-5292|tolu.oyesanya@duke.edu|
22277129|NCT02904356|Baylor College of Medicine|Sameer Sheth, MD, PhD|713-798-4696|sasheth@bcm.edu|
22277130|NCT01222351|Columbia University|Yaakov Stern|212-342-1350|ys11@columbia.edu|
22277131|NCT03983109|Flat Medical Co., Ltd|LI YU LIN|+886 25672959|liyulin@flatmedical.com|16
22277132|NCT02021318|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
22277133|NCT01068249|UT MD Anderson Cancer Center|Dr. Pamela Soliman,Professor, Gyn Onc & Reproductive Med|(713) 745-2352|psoliman@mdanderson.org|
22309185|NCT03676764|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
22277134|NCT01740427|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277135|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com|
22277136|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
22277137|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
22277138|NCT02641353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22277139|NCT02547935|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22277140|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277141|NCT03020888|Endomag|Dr Matthew Womack|+44 7851 247439|mwomack@endomag.com|
22277142|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu|
22277143|NCT03461861|Medical College of Wisconsin|Dr. Yang Wang|4149555473|yangwang@mcw.edu|
22277144|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22277145|NCT01937117|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Jenna Canzoniero, MD|410-955-8983|jcanzon1@jhmi.edu|
22277146|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
22277147|NCT01407367|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-382-4822|jfink@som.umaryland.edu|
22277148|NCT01271855|Northwestern University|Kimberly Kenton MD, MS|312-472-3874|kkenton@nm.org|
22277149|NCT03018730|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
22277150|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu|
22277151|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22277152|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22277153|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov|
22277154|NCT03882801|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22277155|NCT01567085|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc. (Sponsor)||clinicaltrials@alexion.com|
22277156|NCT04193176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22277157|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800|Said.Ibrahim2@va.gov|7163
22277158|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277159|NCT05715346|Levation Pharma|Houman Hemmati, M.D., Ph.D.|424 274 2642|info@levationpharma.com|
22277160|NCT03537729|Grand Valley State University|Dr. Rebecca Davis|616.331.3079|davirebe@gvsu.edu|
22277161|NCT03404167|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
22277162|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
22277163|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300||
22277164|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
22277165|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277166|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277167|NCT01297244|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22277168|NCT01348698|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22277169|NCT02595749|USC Dept. of Preventive Medicine|Matthew Kirkpatrick|3234428221|mgkirkpa@usc.edu|
22277170|NCT00546273|UTE. Fund. Inst. Germans Trias i Pujol|Cristina Vilaplana, MD|+34 93 497 86 81|cvilaplana@gmail.com|
22277171|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
22277172|NCT03558672|Tactile Medical|Director of Clinical Research|612.540.5267|astone@tactilemedical.com|
22277173|NCT03607695|University of Washington|Valerie E. Kelly, PT, PhD|206-598-5350|vekelly@uw.edu|
22277174|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22277175|NCT02016885|Dermira Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22277176|NCT01215240|University of Alberta|Dr. Lindsay Ryerson|780 407 3396|ryerson@ualberta.ca|780
22277177|NCT03926598|Research Scientist|Jiten Chhabra|4048942000|jiten@imtc.gatech.edu|
22277178|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk|
22277179|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu|
22277180|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org|
22277181|NCT04366583|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Dr. Huay-Min Wang|+886-7-3422121|hmwang@vghks.gov.tw|2075
22277182|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277183|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
22277184|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov|
22295423|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com|
22295424|NCT04973826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295425|NCT01835587|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22295426|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu|
22295427|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
22295428|NCT03310775|Kyunghee university hospital, Seoul, South Korea|Dr. Miae Oh|82-10-8929-5048|miae612@naver.com|
22295429|NCT01648205|University of Rochester|Wojciech Zareba, MD, PhD|5852755391|wojciech_zareba@urmc.rochester.edu|
22295430|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com|
22295431|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22295432|NCT02260921|Myoscience|Director of Clinical|5109331541||
22295433|NCT03501069|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22295434|NCT02999854|Kiadis Pharma Netherlands B.V|Klaudia Traudtner, MD. Head of Safety and Pharmacovigilance.|+31 (0)20 240 52 50|k.traudtner@kiadis.com|
22295435|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu|
22309186|NCT04461405|Oregon Health & Science University|Dr. Deborah Cohen|503-781-8795|cohendj@ohsu.edu|
22309187|NCT05682937|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
22309188|NCT04660201|University of Maryland School of Medicine|James Campbell, MD|410-706-5328|Jcampbel@som.umaryland.edu|
22309189|NCT04719390|Partnership to End Addiction|Dr. Sarah Dauber|212-841-5270|sdauber@toendaddiction.org|
22309190|NCT06190691|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22309191|NCT05130762|Becton, Dickinson and Company|Stephan Hofmann|+49 160 105 3421|Stephan.Hofmann@bd.com|
22309192|NCT04633122|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
22309193|NCT03241745|Memorial Sloan Kettering Cancer Center|Dr. Claire Friedman, MD|646-888-4247|friedmac@mskcc.org|
22309194|NCT04019873|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309195|NCT02305277|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22309196|NCT05467345|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22309197|NCT03896789|University of Washington|Dr. Monica S. Vavilala|206-744-7235|vavilala@uw.edu|
22309198|NCT05851573|University of Central Florida|Dr. Deena Schwen Blackett|407-823-0909|deena.blackett@ucf.edu|
22309199|NCT03916510|University of Oxford|CEDAR Trial Manager, Oncology Clinical Trials Office (OCTO)|01865 617085|octo-CEDAR@oncology.ox.ac.uk|
22309200|NCT05087992|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309201|NCT04473222|University of Oregon|Ariel Williamson|971-352-4004|arielaw@uoregon.edu|
22309202|NCT02839161|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
22309203|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com|
22309204|NCT02319759|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309205|NCT05006872|Health Research Institute of the Balearic Islands|Dra. Rocío Zamanillo Campos|+34 971175883|rocio.zamanillo@ssib.es|
22309206|NCT04332926|Virginia Commonwealth University|Caroline Cobb, PhD, PI|804-828-8687|cobbco@vcu.edu|
22309207|NCT05783102|Case Western Reserve University|Kylie Meyer|216-368-1928|knm77@case.edu|
22309208|NCT05362487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309209|NCT04973254|Boston Medical Center|Laura Fletcher, LCSW MSW MPH|857-225-5183|laura.fletcher@bmc.org|
22309210|NCT05170009|Weill Cornell Medicine|Dr. Mirella Salvatore|(646) 318-8506|mis2053@med.cornell.edu|
22309211|NCT04629716|Florida State University|Nicole Ennis, PhD|850-644-2334|nicole.ennis@med.fsu.edu|
22309212|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu|
22309213|NCT04543357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309214|NCT04980248|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22309215|NCT05257486|Xoft, Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
22309216|NCT04542317|University of California, Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
22309217|NCT05590962|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
22309218|NCT03848065|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22309219|NCT03854214|Kennedy Krieger Institute|Ann S. Choe, Ph.D.|443-923-9500|choea@kennedykrieger.org|
22309220|NCT04564742|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22322386|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309221|NCT04131686|Boryung|Ji-Yeon Kim|82-2-708-8128|jiyeonkim@boryung.co.kr|
22309222|NCT03313076|University of North Carolina at Chapel Hill|Matt Mauck, MD, PhD|919-966-5136|matt_mauck@med.unc.edu|
22309223|NCT05869383|Sriwijaya University|Nur Riviati|+6281377671384|eviqodir@yahoo.com|
22309224|NCT04473430|University of Miami|Dr. Rodolfo Galindo|305-284-3781|rodolfo.galindo@miami.edu|
22309225|NCT02535338|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22309226|NCT06264986|Blanquerna Institute - Universitat Ramon Llull|Olivia Coope|+447882461097|oliviacharlottec@blanquerna.url.edu|
22309227|NCT04478643|ASST SPEDALI CIVILI - UNIVERSITY OF BRESCIA|Dr. Magda Mensi|+390303995784|magda.mensi@unibs.it|
22309228|NCT04349371|Columbia University|Anca Askanase, MD|212-305-0856|ada20@cumc.columbia.edu|
22309229|NCT05270408|UT Southwestern Medical Center|Dr Christian LoBue|2146485265|Christian.LoBue@utsouthwestern.edu|
22295436|NCT03064451|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
22295437|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22295438|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu|
22295439|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu|
22295440|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22295441|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22295442|NCT03032705|Tufts University School of Dental Medicine|Dr Gerard Kugel|(617) 636-0870|Gerard.Kugel@tufts.edu|
22295443|NCT03482440|University of Iowa|Anna Stanhewicz|3194671732|anna-stanhewicz@uiowa.edu|
22295444|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22295445|NCT04818840|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22295446|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org|
22295447|NCT01730833|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22295448|NCT04847557|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22295449|NCT01325584|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
22295450|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu|
22295451|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333|tubercle@gmail.com|2582
22295452|NCT02345850|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22295453|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org|
22295454|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22295455|NCT02801942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295456|NCT02450903|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22295457|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22295458|NCT01313767|Clinical Development Team of Medytox Inc.|Medytox Inc.|82-70-8666-6911|hgpark@medytox.com|
22295459|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu|
22295460|NCT00232817|Columbia University|Dr. Pamela Flood|201-370-3933|pamelaflood181@gmail.com|
22295461|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca|
22295462|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
22295463|NCT04273217|AbViro LLC|Urban Ramstedt|617-818-8112|urban.ramstedt@abviro.com|
22295464|NCT04532099|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22295465|NCT05492942|Boston Medical Center, Internal Medicine|Emily Hurstak, MD MPH|(617) 414 5951|emily.hurstak@bmc.org|
22295466|NCT02506153|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22295467|NCT03103919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22295468|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
22295469|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295470|NCT02959944|Pharmacyclics, LLC|Justin Wahlstrom MD|669-215-7210|jwahlstrom@pcyc.com|
22295471|NCT03454893|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
22295472|NCT04876274|School of Pharmacy, Taipei Medical University|Professor Hsiang-Yin Chen|(02)2736-1661|shawn@tmu.edu.tw|6175
22295473|NCT02606604|Stony Brook University|Lori Hochman|631-444-1193|lori.hochman@stonybrook.edu|
22295474|NCT03070782|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22295475|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
22295476|NCT03527966|Virtua Health Inc.|Jillian Hoopes|856-761-3904|jhoopes@virtua.org|
22295477|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org|
22295478|NCT02288559|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
22295479|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed|
22295480|NCT02709785|Saint Louis University|D. Douglas Miley|314-977-8381|ddouglas.miley@health.slu.edu|
22295481|NCT02135146|University of Colorado|Nick Naughton, Professional Research Assistant|3037200833|nick.naughton@cuanschutz.edu|
22295482|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org|
22295483|NCT00810407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295484|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295485|NCT03472469|The University of Texas Health Science Center at Houston|John A. Harvin, MD|(713) 500-7244|John.Harvin@uth.tmc.edu|
22295486|NCT02320149|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22295487|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
22295488|NCT04356690|Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center|John Mark Sloan, MD|617-638-7002|mark.sloan@bmc.org|
22295489|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22295490|NCT06073119|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22295491|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu|
22295492|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22295493|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
22295494|NCT02036294|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
22295495|NCT02408315|Indiana University School of Medicine|Dr. David M. Haas|317-880-3949|dahaas@iu.edu|
22277185|NCT02284854|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22277186|NCT03611062|University of Massachusetts Lowell|Dr. Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
22277187|NCT02018887|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22277188|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22277189|NCT01623752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277190|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810|jennifer.hlavin@va.gov|26624
22277191|NCT05987540|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22277192|NCT04053452|Duke University|Natalia Gonzalez, MD|919-684-5422|natalia.gonzalez@duke.edu|
22277193|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22277194|NCT02959892|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22277195|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262|linda.humphrey@va.gov|57176
22277196|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org|
22277197|NCT03099863|MetroHealth Medical Center|Dr. Jeffrey Mangel|2167784444|jmangel@metrohealth.org|
22277198|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
22277199|NCT04433975|University of Michigan Medical School|Dr. Mark Ilgen|734-845-3646|marki@med.umich.edu|
22277200|NCT04882215|University of Glasgow|Professor Jonathan Evans|0141 330 3299|Jonathan.Evans@glasgow.ac.uk|
22277201|NCT06083493|University of Michigan|Zirui Huang|734-615-2875|huangzu@med.umich.edu|
22277202|NCT03911687|Columbia University|Sarah Collins Rossetti, PhD|2123056605|sac2125@cumc.columbia.edu|
22277203|NCT04392635|Stanford University|Study Team|650-723-6189|smeyer27@stanford.edu|
22277204|NCT04402957|Arch Biopartners Inc.|Richard Muruve|647-428-7031|rm@archbiopartners.com|
22277205|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu|
22277206|NCT01851369|National Cancer Institute|Dr. Alice P.Chen|2407813320|chenali@mail.nih.gov|
22277207|NCT02502071|University of Colorado School of Medicine|Dr. Petter Bjornstad, Assistant Professor|7207774659|petter.bjornstad@childrenscolorado.org|
22277208|NCT02460380|Maimonides Medical Center|Mohamad Irani|3472862167|mohamad.irani@hotmail.com|
22277209|NCT02618187|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|617-945-9626|mtrucksis@serestherapeutics.com|
22277210|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com|
22277211|NCT00063999|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-545-8321|lgedeon@gogstats.org|
22277212|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22277213|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu|
22277214|NCT01895647|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|886-975837711|jeff01@mmh.org.tw|
22277215|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org|
22277216|NCT01482286|Pennington Biomedical Research Center|Dr. Joshua R. Sparks|2257632928|joshua.sparks@pbrc.edu|
22277217|NCT05610267|Integra LifeSciences|Dr. Dennis Adam Young|443 766 2569|dennis.young@integralife.com|
22277218|NCT03055507|University of Washington, Department of Otolaryngology - Head & Neck Surgery|Dr. Greg Davis, Director of Rhinology and Skull Base|(206) 598-4022|GEDavis@uw.edu|B
22277219|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com|
22277220|NCT04560309|Nationcal Cardiovascular Center Harapan Kita|I Made Adi Parmana, M.D.|+62 812-4601-212|adiparmana13@gmail.com|
22277221|NCT05085405|University of Michigan|Dr. Jacob E Kurlander, MD, MS|734-647-9252|jkurland@umich.edu|
22277222|NCT01860404|Children's Hospital of Philadelphia|Dr. Daniel Corwin|215-327-2306|corwind@chop.edu|
22277223|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu|
22277224|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22277225|NCT04689009|EMOLED SRL|Dr. Rossi Degl'Innocenti Duccio, Clinical Affairs Manager|+390550751960|d.rossi@emoled.com|
22277226|NCT02187055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277227|NCT04159480|University of Colorado, Anschutz Medical Campus|Lisa Brenner|7208481980|lisa.2.brenner@cuanschutz.edu|
22277228|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277229|NCT01030900|National Cancer Institute|Dr. Wyndham Wilson|(240) 760-6092|wilsonw@mail.nih.gov|
22277230|NCT00441896|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
22277231|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277232|NCT03334175|UCSF|Meghana Gadgil|4153537922|meghana.gadgil@ucsf.edu|
22277233|NCT03277274|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22277234|NCT03651609|Institute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, Slovenia|Gregor|+38631226546|gregor.omejec@kclj.si|
22277235|NCT01793129|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
22277236|NCT04128215|University of Florida|Dr. Demetra Christou|3522941715|ddchristou@ufl.edu|
22277237|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg|
22277238|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22322387|NCT01282073|Kyungpook National University Hospital|Sun-Hee Park|+82532005547|sh-park@knu.ac.kr|
22322388|NCT04288570|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22322389|NCT05227690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22277239|NCT03532490|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
22277240|NCT03548415|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22277241|NCT04605588|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
22322390|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org|
22322391|NCT02634580|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22322392|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22322393|NCT02908880|Essential Medical, Inc.|Sam Nardone|6105571009|sam@essmedclosure.com|
22322394|NCT03521505|Chang-Gung Memorial Hospital|Dr Ting-Yu Lin|886 3281200|yuebaoyuebao@gmail.com|8467
22322395|NCT02653768|Center to Accelerate Discovery and Practice Transformation, Durham VA|Kelli Allen, Associate Director|919-286-0411|kelli.allen@va.gov|177090
22322396|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu|
22267151|NCT02520297|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22267152|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu|
22267153|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22267154|NCT01885195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267155|NCT02803229|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@cumc.columbia.edu|
22267156|NCT03390426|Duke University Medical Center|William Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
22267157|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267158|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr|
22267159|NCT03301623|Cedars-Sinai Medical Center|Brennan Spiegel|310-423-6467|brennan.spiegel@cshs.org|
22267160|NCT02516553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267161|NCT01203020|WV Cancer Institute|Abraham Kanate|3049065228|tlr0011@hsc.wvu.edu|
22267162|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267163|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22267164|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22267165|NCT03862755|Shanghai Pulmonary Hospital|Dr. Lei Shen|86-21-65115006|sh_leisen@126.com|2054
22267166|NCT04123561|Taiwan Liposome Company|Dr. Tien-Tzu Tai|+886 2 2655 7377|tttai@tlcbio.com|801
22267167|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br|
22267168|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
22267169|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com|
22267170|NCT00708227|Nemours Children's Specialty Care|Kathryn Blake|9046973806|kathryn.blake@nemours.org|
22267171|NCT04007991|Emalex Biosciences, Inc.|Clinical contact|7150562|dkim@emalexbiosciences.com|1847
22267172|NCT03764618|Rigel Pharmaceuticals, Inc.|Executive Director, Global Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
22267173|NCT03654599|Arizona State University|Dr. Sunny Kim|602-496-6789|Sunny.Kim@asu.edu|
22267174|NCT03739645|Johns Hopkins University|Fred Lenz|443.287.1609|flenz1@jhmi.edu|
22267175|NCT01290302|Luitpold Pharmaceutical, Inc|Marsha Simon|631-772-3507|msimon@lpicrd.com|61807
22267176|NCT04514679|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5274|tor.d.tosteson@dartmouth.edu|
22267177|NCT03816878|Johns Hopkins University Center for Immunization Research|Kawsar Talaat|410-336-9164|ktalaat1@jhu.edu|
22267178|NCT03355469|Rutgers University|Dr. Steven Malin|848-932-705|steven.malin@rutgers.edu|
22267179|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22267180|NCT05612685|UCLA|Kristen Choi, Associate Professor|3107947493|krchoi@ucla.edu|
22267181|NCT03659929|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|1-800-461-7449|david.sequeira@azurity.com|
22267182|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com|
22267183|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267184|NCT04825912|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
22267185|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
22267186|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov|
22267187|NCT01808547|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22267188|NCT01009814|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22322397|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456|jacque_liu@mail2000.com.tw|63572
22267189|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu|
22267190|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22322398|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22322399|NCT01970176|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
22322400|NCT01491178|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322401|NCT05689047|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22322402|NCT01604512|Memorial Sloan Kettering Cancer Center|Dr. Robert Young, MD|212-639-8196|youngr@mskcc.org|
22277242|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu|
22277243|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu|
22277244|NCT02741193|NYU Langone Health|Anli Liu|9294552340|Anli.Liu@nyulangone.org|
22277245|NCT02320825|Memorial Sloan Kettering Cancer Center|Dr. Ilya Laufer, MD|212-639-2368|lauferi@mskcc.org|
22277246|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
22277247|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277248|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu|
22277249|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
22277250|NCT03055221|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22322403|NCT03132636|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22322404|NCT03470129|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22322406|NCT03083886|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22322407|NCT00857727|Mount Sinai St. Luke's|Dr. Jinu Kim|212-523-6121|JiKim@chpnet.org|
22322408|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov|
22322409|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322410|NCT03655756|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
22322411|NCT03529773|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277251|NCT01243424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277252|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22277253|NCT01093885|University of Pennsylvania Health System|Dr. Chris Derk|215-662-2792|chris.derk@uphs.upenn.edu|
22277254|NCT01030575|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
22277255|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov|
22277256|NCT01346709|European Society of anaesthesiology|Brigitte Leva, Research Team Leader|+3222109414|research@esahq.org|
22277257|NCT02365064|Sleep and Human Health Institute|Dr. Barry Krakow|(505) 9987204|bkrakow@sleeptreatment.com|
22277258|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22277259|NCT03737032|University of Pittsburgh Medical Center, Department of Psychiatry|Dr. Erika Forbes|412-383-5438|forbese@upmc.edu|
22277260|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295496|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
22295497|NCT01907815|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD, Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22295498|NCT03327649|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|14052714742|stavros-stavrakis@ouhsc.edu|
22295499|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
22295500|NCT00514540|University of Texas MD Anderson Cancer Center|Lisa Pruitt, Quality Assurance Specialist|713-792-0411|LPruitt@mdanderson.org|
22295501|NCT04468204|Department of Otolaryngology - Head and Neck Surgery|Director of Clinical Research|(843)792-1356|nguyensh@musc.edu|
22295502|NCT01996982|Ascension Seton|Research Enterprise Staff|512-3247991|ra@seton.org|
22295503|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22295504|NCT01348347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295505|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22295506|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295507|NCT03198234|Stanford|Rajni Agarwal, MD|650-725-9250|rajnia@stanford.edu|
22295508|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245||
22295509|NCT04285879|Connecticut Children's|Adam P. Weaver, PT, DPT|860-284-0246|Aweaver@connecticutchildrens.org|
22295510|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu|
22295511|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22295512|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu|
22295513|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22295514|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500|DTURNER2@its.jnj.com|3479
22295515|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22322412|NCT03066102|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
22322413|NCT03237065|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22322414|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
22295516|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com|
22277261|NCT00397046|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22277262|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277263|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
22277264|NCT04535362|Yale School of Medicine|Mehmet Sofuoglu, MD, PhD: Professor of Psychiatry; Director of VA New England Mental Illness Researc|(203) 937-4809|mehmet.sofuoglu@yale.edu|
22277265|NCT04863807|Imperial College Healthcare NHS Trust|Dr Alex Wickham|+4420233121248|alex.wickham@nhs.net|
22277266|NCT02421510|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22277267|NCT03203512|University of Reading|Professor Parveen Yaqoob|+443787113|p.yaqoob@reading.ac.uk|
22277268|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu|
22277269|NCT02053584|Wolfson Medical Center|Dr. Julio Weinstein|972-3-5028371|vainstein@wolfson.health.gov.il|
22277270|NCT00508300|lausanne university hospital|martin hübner|+41795561506|martin.hubner@chuv.ch|
22277271|NCT02728726|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22277272|NCT04098302|UConn Health|Jonathan Covault Study PI|860-679-7560|jocovault@uchc.edu|
22277273|NCT05061706|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22277274|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22277275|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22277276|NCT04219774|Duke University|David Hasan, MD, MSc|919-684-7777|david.hasan@duke.edu|
22277277|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22277278|NCT02371252|Mahidol University|Dr. Aasis Unnanuntana|+66836871159|uaasis@gmail.com|
22277279|NCT04477486|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22277280|NCT02636322|University of Texas M D Anderson Cancer Center|Dr. Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
22277281|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22277282|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu|
22277283|NCT03712618|National Institutes of Health, Clinical Center (NIH CC)|Dr. Willy Flegel|+1 301 594 7401|bill.flegel@nih.gov|
22277284|NCT04957082|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
22277285|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu|
22277286|NCT03335267|Weill Cornell Medical College|Dr. Ellen K. Ritchie|646-962-2700|ritchie@med.cornell.edu|
22277287|NCT05938816|Oregon Health and Science University|Josh Kaplan, PhD|503) 494-8311|kaplajos@ohsu.edu|
22277288|NCT01254877|JohnHopkinsU|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
22277289|NCT01774370|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277290|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22277291|NCT04243837|PureTech Health, Inc|Director of Clinical Trials|6034982261|ckorth@puretechhealth.com|
22277292|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com|
22277293|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net|
22277294|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
22277295|NCT01666314|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22277296|NCT02512445|UCSD|Dr. Sonya Norman|858-518-8266|snorman@ucsd.edu|
22277297|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com|
22277298|NCT03462563|Ethicon SARL|Richard Kocharian|+1 609 6423787|rkochar1@its.jnj.com|
22277299|NCT05089357|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22277300|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277301|NCT04796207|University of Arizona|Floyd H. Chilton|520-621-5327|fchilton@arizona.edu|
22277302|NCT02759458|Rush University Medical Center|Nikhil Verma, MD|(312) 563-2214|nikhil.verma@rushortho.com|
22277303|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300||
22277304|NCT04739709|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
22277305|NCT04203056|University of California, Los Angeles|Kenneth Subotnik, PhD|3108250334|ksubotnik@mednet.ucla.edu|
22322415|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca|
22277307|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22277308|NCT01751685|University of California, San Francisco|Wendy Katzman, PT|415-353-7598|Wendy.Katzman@ucsf.edu|
22277309|NCT02193152|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5737|danielmorgensztern@wustl.edu|
22277310|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu|
22277311|NCT03888274|Tivic Health Systems|Blake Gurfein|5615737652|blake.gurfein@tivichealth.com|
22277312|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
22277313|NCT01882829|Icahn School of Medicine at Mount Sinai|Dr. James W Murrough|212-241-7574|james.murrough@mssm.edu|
22322416|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
22322417|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
22277314|NCT03312114|University of Texas Southwestern Medical Center|Phase II trial of Concurrent Anti-PD-L1 and SAbR for Patients with Persistent or Recurrent Epithelia|(214) 645-7296|kevin.albuquerque@utsouthwestern.edu|
22295517|NCT03194698|Mayo Clinic|Joanne F. Shen, M.D.|480-301-8085|Shen.Joanne@mayo.edu|
22277315|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570|mwalker@vectoroncology.com|1759
22277316|NCT06358144|Wake Forest University Health Sciences|Beth Reboussin, PhD|336-713-5213|brebouss@wakehealth.edu|
22277317|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org|
22295518|NCT01937559|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
22322418|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590||
22322419|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com|
22322420|NCT02574637|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22322421|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu|
22322422|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr|
22322423|NCT00699907|University of Arizona|Dr. Setsuko K. Chambers|520-626-0950|schamber@uacc.arizona.edu|
22322424|NCT02161211|University of Minnesota|Matt Kushner, Ph.D.|612-625-7546|kushn001@umn.edu|
22322425|NCT01307930|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
22322426|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu|
22322427|NCT03138876|Mayo Clinic|Dr. William O. Tatum|904-953-2498|tatum.william@mayo.edu|
22322428|NCT03889639|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322429|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322430|NCT02556255|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
22322431|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082|dhavlir@php.ucsf.edu|400
22322432|NCT00465595|Johns Hopkins University School of Medicine|Roland R. Griffiths, Ph.D., Principal Investigator|4105500034|rgriff@jhmi.edu|
22277318|NCT04668599|The MetroHealth|Vidya Krishnan|2167784527|vkrishnan@metrohealth.org|
22322433|NCT03506295|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-3412|fabien.maldonado@vumc.org|
22322434|NCT01834729|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
22322435|NCT01665118|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22322436|NCT04673786|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
22322437|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322438|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322439|NCT01298492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22322440|NCT02340663|University of Michigan|Dr. Geoffrey Gerstner|734-763-7717|geger@umich.edu|
22322441|NCT02902120|Institute of Human Virology, University of Maryland School of Medicine|Lydia Tang|410-706-6567|LydiaTang@ihv.umaryland.edu|
22322442|NCT04926779|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6462718593|jstega@optonline.net|
22322443|NCT01353703|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322444|NCT03298022|AltruBio|Vice President of Clinical Operations|17142150224|simona.reed@altrubio.com|
22322445|NCT03694925|Cleveland Clinic Arthroplasty Research Group|Alison Klika|4123017914|klikaa@ccf.org|
22322446|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil|
22322447|NCT04116112|University of Cincinnati|Dr. Eva A. Mistry|513-558-1291|mistryea@ucmail.uc.edu|
22322448|NCT03087955|Drugs for Neglected Diseases|Sandra Rembry, PharmD|+41229077734|srembry@dndi.org|
22322449|NCT04484285|University of Florida|Eric Porges, Associate Profressor|(352) 294-5838|eporges@ufl.edu|
22277319|NCT03403517|Rigshospitalet|Kristin steinthorsdottir|004531666112|kjs@dadlnet.dk|
22322450|NCT06272370|DARTNet Institute|Wilson Pace, MD|800-434-0278|Wilson.pace@dartnet.info|12
22277320|NCT04634903|Stony Brook University|Dr. Jessica Schleider|917-439-1872|jessica.schleider@stonybrook.edu|
22277321|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org|
22277322|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277323|NCT03254147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277324|NCT01723839|John Theurer Cancer Center at Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22277325|NCT02527265|MannKind Corporation|Clinical Development|844.323.7399|mapp@mannkindcorp.com|
22322451|NCT02192931|University of Utah|Danielle Boxer|801-587-1549|danielle.boxer@utah.edu|
22322452|NCT06523491|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
22322453|NCT02527707|Eiger BioPharmaceuticals, Inc.|SVP Clinical Development|1-650-272-6138|info@eigerbio.com|
22322454|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com|
22322455|NCT03695913|University of Michigan|Spring Stonebraker|734-649-0219|sprstone@med.umich.edu|
22322456|NCT02303431|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22322457|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22322458|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu|
22322459|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk|
22322460|NCT03968419|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22322461|NCT02968810|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22322462|NCT03179085|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
22322463|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322464|NCT02894840|Mahidol university|Prof.Punnee Pitisuttithum|662 6435599|punnee.pit@mahidol.ac.th|
22277326|NCT01748552|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22322465|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22322466|NCT03660878|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22322467|NCT05499559|Arthro Therapeutics/Joint Academy|Study Director|+46708971677|leif@jointacademy.com|
22309230|NCT04338061|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22267191|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com|
22267192|NCT00180661|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22267193|NCT02923232|Pacific University|Dr. Shun-nan Yang|5033522852|shunnan.yang@pacificu.edu|
22267194|NCT01977417|University of Iowa|Gary Pierce, PhD|319-335-9487|gary-pierce@uiowa.edu|
22267195|NCT02906358|The University of Texas Health Science Center at San Antonio|Barbara J Turner|210-562-5551|turner@uthscsa.edu|
22267196|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22267197|NCT03112642|RutgersSUNJ|William R Grubb MD|7327426528|wrgrubb@aol.com|
22267198|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22267199|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22267200|NCT04152863|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267201|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de|
22267202|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267203|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu|
22267204|NCT02995408|Massachusetts General Hospital|Karen Kuhlthau, PhD Researcher|6177242842|kkuhlthau@partners.org|
22267205|NCT04237272|Medical University of South Carolina|Dr. Tracy Smith|843 792 5164|smithtra@musc.edu|
22267206|NCT05445492|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
22267207|NCT03474874|NeXtGen Biologics Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
22267208|NCT04289363|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
22295519|NCT01853826|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295520|NCT02152696|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
22295521|NCT04812964|VA Greater Los Angeles Healthcare System|Dr. Jonathan Jacobs|310-478-3711|jonathan.jacobs2@va.gov|
22295522|NCT00289315|Pennington Biomedical Research Center|Lori Steib|(225) 252-5030|Lori.Steib@pbrc.edu|
22295523|NCT02758899|Washington University|Wilson Z. Ray|314-747-6145|rayz@wustl.edu|
22295524|NCT01909154|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
22295525|NCT04779489|UT Southwestern Medical Center|Dr. Solomon Woldu|214-648-9558|solomon.woldu@utsouthwestern.edu|
22295526|NCT05126901|Shield TX (UK) Ltd.|Clinical Operations, Shield TX (UK) Ltd.|+44 (0) 191 511 8500|info@shieldtherapeutics.com|
22295527|NCT00710710|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295528|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com|
22295529|NCT01529346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295530|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22295531|NCT04867850|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
22295532|NCT02282020|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
22295533|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org|
22295534|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300||
22295535|NCT02673489|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22295536|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov|
22295537|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
22295538|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org|
22295539|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22322468|NCT05022641|University of Michigan|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
22277327|NCT01386645|VA Puget Sound Hlthcare System|Kristina Utzschneider|206-277-3568|kutzschn@uw.edu|6-3568
22277328|NCT02930941|University of California, Davis Medical Center|Aimee Moulin, MD|916-703-6110|akmoulin@ucdavis.edu|
22277329|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300||
22277330|NCT03794323|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277331|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
22277332|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu|
22277333|NCT01034527|Mayo Clinic|Dr. Timothy Hewett|513-636-5971|hewett.timothy@mayo.edu|
22277334|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org|
22277335|NCT02164721|University of Rochester|Valentina Kutyifa MD, PhD|585-275-2676|valentina.kutyifa@heart.rochester.edu|
22277336|NCT02391584|Entellus Medical|Clinical Affairs Manager|7634631595|rschacherer@entellusmedical.com|
22277337|NCT04621786|University of New Mexico|Dr. Chris Abbott|5052720406|cabbott@salud.unm.edu|
22295540|NCT02328755|University of Michigan|John Magenau|734 936-8785|johnmage@med.umich.edu|
22295541|NCT00311623|Duke University|Andrew Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
22295542|NCT03998189|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-4550|aohlmans@wakehealth.edu|
22295543|NCT04983264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295544|NCT05081011|Stanford University|Ashwin K Nayak, MD|(650) 725-5071|aknayak@stanford.edu|
22295545|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295546|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu|
22295547|NCT01980914|Gerontology Research Unit|Boris Feldman|6048755115|boris.feldman@vch.ca|
22295548|NCT05247866|Children's Hospital of Philadelphia|Jonathan Spergel|2155902549|spergel@chop.edu|
22295549|NCT04994522|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22295550|NCT04463719|University of Florida|Naykky Singh Ospina|(352) 273-8655|naykky.singhospina@medicine.ufl.edu|
22295551|NCT03315208|Massachusetts General Hospital/Harvard Medical School|Dr. Kate Bentley|617-724-7741|kbentley@mgh.harvard.edu|
22295552|NCT02746874|Northwestern University|David Walega, MD|312-695-0061|d-walega@northwestern.edu|
22295553|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com|
22295554|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22295555|NCT06185374|NYU Langone Health|Peter Liang, MD|(212) 686-7500|peter.liang@nyulangone.org|5745
22295556|NCT06133348|University of Alabama at Birmingham Cancer Center|Gabrielle Rocque, MD, MSPH|205-996-9281|grocque@uabmc.edu|
22295557|NCT00003644|NRG Oncology|Linda Gedeon, Christopher Purdy on behalf of Mark Brady, PhD|(716) 845-1169|lgedeon@gogstats.org|
22295558|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu|
22295559|NCT03545165|Weill Cornell Medicine|Scott Tagawa MD, Principal Investigator|646-962-2072|guonc@med.cornell.edu|
22295560|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
22295561|NCT02493621|MUSC|Sylvia Wilson|8437922322|wilsosh@musc.edu|
22295562|NCT01370174|University of Maryland|Dr. Vicki Gray Principal Investigator|4107063778|vicki.gray@som.umaryland.edu|
22295563|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com|
22309231|NCT03631784|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309232|NCT03482557|Beth Israel Deaconess MEdical Center|Marc Mccall|617-418-9216|mmccall1@bidmc.harvard.edu|
22309233|NCT05002608|Massachusetts General Hospital|Elyse R. Park|6177246836|epark@mgh.harvard.edu|
22309234|NCT05044793|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22309235|NCT04764448|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22309236|NCT04728347|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22309237|NCT02702102|Columbia University|William Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
22309238|NCT05835336|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
22309239|NCT02561247|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22309240|NCT04908722|Janssen Vaccines & Prevention B.V.|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309241|NCT06321809|Hacettepe University|Assoc.Prof. Duygu Ayhan Baser|+90-505-664-5210|dr.duyguayhan@gmail.com|
22267209|NCT03790657|Malcom Randall VA Medical Center|David Clark|3523761611|david.clark1@va.gov|105244
22267210|NCT03126435|SynCore Biotechnology Co., Ltd.|Albert Lin, Ph.D./Special Assistant to GM|+886-2-2760-3688|JWLin@syncorebio.com|2308
22267211|NCT03971474|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22267212|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org|
22267213|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267214|NCT01807065|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22267215|NCT03450473|Washington University School of Medicine in St. Louis|Dr. Grant Bochicchio|314-362-9347|gbochicchio@wustl.edu|
22267216|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629||
22267217|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu|
22267218|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267219|NCT00462904|University of Texas Southwestern Medical Center|Joseph Minei|214-648-3917|joseph.minei@utsouthwestern.edu|
22267220|NCT02664181|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223-8100|TaussigResearch@ccf.org|
22295564|NCT06316973|Clear Scientific|Piercen Oliver|617-621-8500|poliver@clearsci.com|
22295565|NCT03078647|Candela Corporation|Director of Clinical Marketing|(949) 599-7646|doranr@candelamedical.com|
22295566|NCT04997161|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22295567|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295568|NCT04502589|Virginia Commonwealth University|Albert Arias, M.D.|(804) 828-5793|albert.arias@vcuhealth.org|
22295569|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22295570|NCT02730455|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22295571|NCT02733367|Diurnal|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
22295572|NCT02532933|University Of Denver|Kevin Shelburne|3039021249|kevin.shelburne@du.edu|
22295573|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300||
22295574|NCT02988843|Masonic Cancer Center, University of Minnesota|Dr. Shilpa Gupta|612 624 0123|guptash@umn.edu|
22295575|NCT05582889|University of New Mexico|Dr. Cindy Blair|5059257907|CiBlair@salud.unm.edu|
22295576|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov|
22295577|NCT02170051|Professor of Psychiatry, UC San Diego|Elizabeth W Twamley, PhD|858-642-3848|etwamley@health.ucsd.edu|
22295578|NCT04551092|Quantum Applied Science & Research, QUASAR Inc.|Gayle Guy|858 412 1839|gayle@quasarusa.com|
22267221|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr|
22267222|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22267223|NCT03668808|Sansum Diabetes Research Institute|Wendy C Bevier|8056827638|wbevier@sansum.org|207
22267224|NCT03606343|Cincinnati Children's Hospital Medical Center|Leanne Tamm, Principal Investigator|513-803-3176|leanne.tamm@cchmc.org|
22267225|NCT02125877|Novartis|Study Director|862-778-8300||
22267226|NCT04223752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22267227|NCT01822366|University of Washington|Dr. Shannon Dorsey|(206) 543-4527|dorsey2@uw.edu|
22267228|NCT03489109|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@nih.gov|
22267229|NCT02552732|Fisher and Paykel Healthcare|Dr Stanislav Tatkov|09 5740100|stanislav.tatkov@fphcare.co.nz|
22295579|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu|
22295580|NCT01712490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22267230|NCT01178216|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|3102488186|noriko.ammerman@cshs.org|
22267231|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22295581|NCT02423876|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
22295582|NCT01966900|Imperial College London|Dr Tom Cole|+44(0)2033136198|t.cole@imperial.ac.uk|
22295583|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu|
22295584|NCT03748758|Novus Therapeutics|Clinical Director|949-679-1110|study002@novustherapeutics.com|
22295585|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr|
22295586|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu|
22295587|NCT02503735|Massachusetts General Hospital|Dr. Meghan Sise|617-726-5050|MSise@partners.org|
22295588|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com|
22295589|NCT02860169|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295590|NCT01782495|AbbVie|Global Medical Services|800-633-9110||
22295591|NCT03057431|Inselspital, Bern University Hospital, Bern, Switzerland|Prof. Daniel Fuster|++41316323144|daniel.fuster@insel.ch|
22295592|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22295593|NCT01962207|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309242|NCT03123848|Janssen Pharmaceutical K.K.|Director, IDV Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309243|NCT01369355|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309244|NCT02436096|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22309245|NCT03131154|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22309246|NCT06424236|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
22309247|NCT04213872|ASU/PVHMC|Dr. Francisco Munoz|909-753-8391|fmunoz007@verizon.net|
22309248|NCT03339713|Janssen Research & Development, LLC|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309249|NCT05403827|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22309250|NCT01959425|Biosense Webster Inc.|Stephanie Lyke|(949) 285-7966|SLyke@its.jnj.com|
22309251|NCT05597085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22322469|NCT03881007|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
22267232|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu|
22267233|NCT04642404|University of Texas Health Science Center at San Antonio|Vanessa Chrepa, DDS|210-459-3601|vanessa.chrepa@rutgers.edu|
22267234|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343||
22309252|NCT01987895|Actelion Pharmaceuticals Ltd|Clinical Trial disclosure Desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22267235|NCT03473015|Oxford Heart Centre, Oxford University Hospitals, Oxford, United Kingdom|Professor Adrian Banning|1865 228934|adrian.banning@ouh.nhs.uk|+44
22267236|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22267237|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
22267238|NCT04487067|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22267239|NCT04324021|Swedish Orphan Biovitrum|Henrick Andersson, Director of Statistical Science|+46760011816|henrik.andersson@sobi.com|
22267240|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu|
22277338|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU|
22277339|NCT04821245|Benaroya Research Institute|Joseph M. Neal, MD|206-223-6980|Joseph.Neal@virginiamason.org|
22309253|NCT02979327|Mayo Clinic|Anna Svatikova, M.D., Ph.D.|507-284-3685|Svatikova.Anna@mayo.edu|
22309254|NCT04002830|Shaare Zedek Medical Center|Majdolen Istaiti|972526659995|joleenist@szmc.org.il|
22309255|NCT03628924|Janssen Research & Development, LLC|Product development portfolio leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309256|NCT05368402|Dompé Farmaceutici SpA|Clinical Development & Operations|+30 902 583831|clinicaltrials@dompe.com|
22309257|NCT01753414|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22309258|NCT03913702|University of Texas Medical Branch Galveston|Dr. Jeremy Somerson|409-747-5701|jesomers@utmb.edu|
22309259|NCT05499377|Virginia Commonwealth University|Augustus Whiet|(804) 828-8892|whiteam25@vcu.edu|
22309260|NCT03001713|Kaiser Permanente Center for Health Research|Rachel Gold, PhD MPH|503-335-2400|rachel.gold@kpchr.org|
22309261|NCT03544281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309262|NCT02547233|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22309263|NCT05235750|University of Arkansas for Medical Sciences|Dr. Mei Bai|501-603-1900|MBai@uams.edu|
22309264|NCT06019559|Kallyope Inc|Clinical Director|917-336-3279|contactus@kallyope.com|
22309265|NCT05986682|Duke University School of Medicine|Dr. Thomas W. LeBlanc|919-668-2115|thomas.leblanc@duke.edu|
22309266|NCT03603600|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bausch.com|
22309267|NCT03344094|University of Chicago|anthony t reder|773-702-6204|areder@neurology.bsd.uchicago.edu|
22309268|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22309269|NCT00670358|Mayo Clinic|Dr. Grzegorz Nowakowski|507-284-5096|Nowakowski.Grzegorz@mayo.edu|
22309270|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
22309271|NCT03496168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22309272|NCT02396134|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
22309273|NCT05543629|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@BMS.com|
22309274|NCT04568603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309275|NCT05194540|Leo Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22309276|NCT04573517|University of Texas Medical Branch|Dr. Marissa Berry|402-772-4099|majberry@utmb.edu|
22309277|NCT04137367|University of Oslo|Nils Inge Landrø|+4795038479|n.i.landro@psykologi.uio.no|
22309278|NCT05144009|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22309279|NCT04710498|Stanford University|Dr. Vasu Divi|650-725-5968|vdivi@stanford.edu|
22309280|NCT02690558|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22309281|NCT05448105|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
22309282|NCT05331053|Penn State University|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
22309283|NCT02815566|University Health Network|Dr. Sharon Walmsley|416-340-3871|sharon.walmsley@uhn.ca|
22309284|NCT03374787|Oticon Medical|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
22309285|NCT04492722|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22309286|NCT04074759|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22309287|NCT03752203|Children's Hospital Colorado|Dr. Todd Hankinson|7207776100|todd.hankinson@childrenscolorado.org|
22309288|NCT06180954|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309289|NCT05329220|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
22309290|NCT05651308|Weill Cornell Medicine|Lisa M. Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
22309291|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com|
22309292|NCT05445427|Mayo Clinic|Dr. Ryan T. Hurt, MD, PhD|507-284-4461|hurt.ryan@mayo.edu|
22309293|NCT04313972|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
22309294|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309295|NCT04447469|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22309296|NCT05201079|Mikrobiomik Healthcare Company S.L.|Olaia Aurtenetxe Saez|+34 944 540 166|ensayosclinicos@mikrobiomik.net|
22309297|NCT03569631|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22309298|NCT05281562|Prisma Health|J. Benjamin Jackson|803-296-9610|benjamin.jackson@prismahealth.org|
22277340|NCT01840163|University of Michigan|Dr. Sarah Hawley|734-936-8816|sarahawl@med.umich.edu|
22267241|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267242|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com|
22267243|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
22267244|NCT01326923|LSU Health Shreveport|J.K. Miller|318 8131406|jmil12@lsuhsc.edu|
22277341|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org|
22277342|NCT03992482|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22277343|NCT03636269|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22277344|NCT04250363|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22267245|NCT03371459|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
22267246|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com|
22267247|NCT02593682|University of California, San Francisco|Dr. Andrew Goddard|(317) 274-3960|agoddard@fresno.ucsf.edu|
22267248|NCT02906241|Wayne State University/Karmanos Cancer Institute|Susan Eggly, PhD|313-576-8260|egglys@karmanos.org|
22267249|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co|
22267250|NCT01653912|Novartis Pharma AG|Study Director|+41 613241111||
22267251|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267252|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org|
22267253|NCT04559347|The Guthrie Clinic|Poovendran Saththasivam MD|5708874882|Poovendran.Saththasivam@guthrie.org|
22267254|NCT02653625|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22267255|NCT03965689|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22267256|NCT02969382|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|CLINICALTRIALDISCLOSURE@SUNOVION.COM|
22267257|NCT00478062|Johns Hopkins Sidney Kimmel Cancer Center|Yvette Kasamon|4109135018|ykasamon@jhmi.edu|
22267258|NCT02090725|Dartmouth-Hitchcock|Jeffrey A. Cohen, MD|603-650-4211|jeffrey.a.cohen@hitchcock.org|
22267259|NCT01214655|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267260|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22267261|NCT00221338|University of California San Francisco|Clinical Research Coordinator|4154769489|Christopher.Tang2@ucsf.edu|
22267262|NCT05256134|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22277345|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22277346|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com|
22277347|NCT02852434|Stanford University Division of Family Planning Services and Research|Stanford University, Department of OB/GYN|6507211562|familyplanningresearch@stanford.edu|
22277348|NCT05075772|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277349|NCT03774810|University of Pennsylvania|Michael L. Perlis, PHD|215-746-3577|mperlis@upenn.edu|
22277350|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277351|NCT01145222|PAION UK Ltd|Trial Information||reg_paion@paion.com|
22277352|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
22295594|NCT01535053|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-845-1169|lgedeon@gogstats.org|
22277353|NCT01698008|University of Nebraska Medical Center|Whitney Goldner|402-559-3579|wgoldner@unmc.edu|
22277354|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
22277355|NCT03994120|National Institutes of Health/NINDS|Dr. Eric Wasserman|301-495-0151|wassermanne@ninds.nih.gov|
22277356|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il|
22277357|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22277358|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22277359|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501|Daniela.Lobo@camh.ca|36568
22277360|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu|
22277361|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu|
22277362|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22277363|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu|
22277364|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277365|NCT04299425|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
22277366|NCT01431573|NYSPI|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
22295595|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
22295596|NCT03653637|James J. Peters VA Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
22295597|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu|
22295598|NCT02068443|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22295599|NCT03879655|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22295600|NCT02723084|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22277367|NCT04865978|Inova Schar Heart and Vascular|Dr. Palak Shah|703-776-2213|palak.shah@inova.org|
22277368|NCT05587998|AstraZeneca|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22277369|NCT04263532|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22277370|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22322470|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu|
22267263|NCT03870880|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
22267264|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267265|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590||
22267266|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012||
22267267|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org|
22267268|NCT02229474|Northumbria Healthcare NHS Foundation Trust|Professor Richard Walker|+441912932709|richard.walker@nhct.nhs.uk|
22267269|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
22267270|NCT02439970|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22267271|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267272|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com|
22267273|NCT01569295|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|ClinicalTrialDisclosures@gilead.com|
22267274|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22267275|NCT01895777|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|8002430127|clintriage.rdg@boehringer-ingelheim.com|
22267276|NCT00955929|Memorial Sloan Kettering Cancer Center|John Mulhall, MD|646-888-6024|mulhalj1@mskcc.org|
22267277|NCT02064296|University of Michigan|Richard Harris|734-998-6996|reharris@med.umich.edu|
22267278|NCT02526667|Evic Romania|Dr. Olsavszky|40 21 335 70 90|research@evic.ro|
22267279|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22267280|NCT04149821|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
22267281|NCT02481206|Zoll|Director of Clinical Affairs|724-968-3333|mosz@zoll.com|
22267282|NCT05061420|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22267283|NCT01406444|Massachusetts General Hospital|Dr. Karen Klahr Miller|6177263870|kkmiller@mgh.harvard.org|
22267284|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267285|NCT03138655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22267286|NCT02495623|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
22267287|NCT04759768|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
22267288|NCT02996487|Beaumont Hospitals|Maureen Cooney|248 551-0099|maureen.cooney@corewellhealth.org|
22267289|NCT02800642|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22267290|NCT02027428|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22267291|NCT02859142|University of Chicago|Andrea King, Ph.D.|7737026181|aking@yoda.bsd.uchicago.edu|
22267292|NCT03340974|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
22267293|NCT01307748|Oregon Health & Science University|Irina Chamine|503.577.6211|fonareva@ohsu.edu|
22267294|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr|
22267295|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu|
22267296|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652||10118
22267297|NCT03010683|2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital|Dr Ignatios Ikonomidis|+30 6944805732|ignoik@gmail.com|
22267298|NCT05299528|Vanderbilt University Medical Center|Daniel Larach, MD|(615) 322-6033|daniel.larach@vumc.org|
22267299|NCT04877457|Yale University|Erin Longbrake, MD|203-287-6100|erin.longbrake@yale.edu|
22277371|NCT00483509|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
22322471|NCT02971202|Vanderbilt University Medical Center|Justin M. Gregory MD MSCI|615-875-9669|justin.m.gregory.1@vumc.org|
22322472|NCT03472560|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22322473|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com|
22322474|NCT04669678|University of Alabama at Birmingham|Rena C Patel|2059348145|renapatel@uabmc.edu|
22322475|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu|
22322476|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu|
22322477|NCT05425563|Dartmouth College|Dr. Tor Wager, professor|603-646-2196|tor@dartmouth.edu|
22322478|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974||
22322479|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org|
22322480|NCT00584233|University of California Davis|Dr. John Boone|(916) 849-3580|jmboone@ucdavis.edu|
22322481|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322482|NCT02222714|Cedars-Sinai Medical Center|Patrick Lyden, MD, FAAN, FAHA|(310) 423-5166|Patrick.Lyden@cshs.org|
22322483|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu|
22322484|NCT04537208|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322485|NCT03286842|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22322486|NCT02261727|The George Institute for Global Health|Prof Christine Jenkins|+61280524300|christine.jenkins@sydney.edu.au|
22322487|NCT03178487|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22322488|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|215-928-3092|research@midatlanticretina.com|
22322489|NCT06219577|Scripps Optometric Group|Dr Jay Mashouf|18585302800|jaymashouf@gmail.com|
22322490|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322491|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22267300|NCT02211417|Dignity Sciences Ltd|Study Director|+353 1 2933590|dsbiopharma.regulatory@dsbiopharma.com|
22267301|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22267302|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267303|NCT04697069|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22267304|NCT05180227|James J Peters VA Medical Center|Dr. Jill Maria Wecht|(718) 584-9000|JM.Wecht@va.gov|3122
22267305|NCT02924727|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22267306|NCT04614246|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22267307|NCT02185053|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22267308|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com|
22267309|NCT03006302|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
22267310|NCT02521376|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22267311|NCT00338728|UT MD Anderson Cancer Center|Dr. Arun,Banu,M.D. / Breast Medical Oncology|713-792-2817|barun@mdanderson.org|
22267312|NCT03859765|Duke University|Sarah A Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
22267313|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Dr. Robert Nelson|(602) 200-5205|rnelson@phx.niddk.nih.gov|
22267314|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu|
22267315|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267316|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267317|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com|
22267318|NCT03245827|Saint Louis University|Sandeep Dhindsa|716-977-4911|sandeep.dhindsa@health.slu.edu|
22267319|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu|
22267320|NCT05314816|Medical College of Wisconsin|Dr. Kelly Graff|414-266-4123|kegraff@mcw.edu|
22267321|NCT04042376|Janssen Research & Development, LLC|Executive Medical Director Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22267322|NCT02551666|Virginia Tech|Professor Michael L. Madigan, PhD|540-231-3543|mlm@vt.edu|
22267323|NCT05422625|William Beaumont University Hospital|Jennifer Giordano RN BSN/ Clinical Research Manager|248-551-3517|Jennifer.Giordano@corewellhealth.org|
22267324|NCT04140032|UCLA Fielding School of Public Health|Dr. Burt Cowgill|310-794-3569|bcowgill@ucla.edu|
22267325|NCT01059786|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
22267326|NCT04205812|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22267327|NCT00371033|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
22267328|NCT02514447|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22267329|NCT05351164|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
22267330|NCT02905240|Zimmer Biomet|Jennifer Woodell-May, Research Associate Director|5742651885|jennifer.woodell-may@zimmerbiomet.com|
22267331|NCT05789576|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22267332|NCT03130777|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22267333|NCT03367572|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22267334|NCT05929651|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22267335|NCT05026177|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
22267336|NCT06831760|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22267337|NCT05109611|SaNOtize R&D Corp|Chief Science Officer|778-899-0607|chris@sanotize.com|
22267338|NCT05064384|Boston Scientific|Karen Noblett, MD, Chief Medical Officer|559-250-8082|karen.noblett@bsci.com|
22267339|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by|
22267340|NCT03203850|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22267341|NCT02717455|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
22267342|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu|
22267343|NCT04721808|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267344|NCT01728844|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22267345|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22267346|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22267347|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov|
22267348|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com|
22267349|NCT01602068|Eyegate Pharmaceuticals, Inc.|Lisa Brandano|781-398-3806|lbrandano@eyegatepharma.com|
22267350|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
22267351|NCT05244122|BrighamHospital|Jeremy Wolfe, Principle Investigator|617-851-1166|jwolfe@bwh.harvard.edu|
22267352|NCT03860974|University of California, San Diego|Brian Ilfeld|8582493660|bilfeld@health.ucsd.edu|
22267353|NCT05377749|University of North Carolina Lineberger Comprehensive Cancer Center|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
22295601|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22295602|NCT00139399|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
22295603|NCT04067544|University of Utah College of Nursing|Lisa Taylor-Swanson|801.585.5486|lisa.taylor-swanson@nurs.utah.edu|
22322492|NCT02161562|Novartis Pharmaceuticals|Study Director|862-778-8300||
22295604|NCT01320085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295605|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252||5252
22295606|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22322493|NCT03856255|NYU Langone Health|Mark Pochapin, MD|212-263-9177|Mark.Pochapin@nyulangone.org|
22295607|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295608|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org|
22295609|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov|
22295610|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu|
22295611|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca|
22295612|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
22295613|NCT01475331|Milton S. Hershey Medical Center|Dr. Matthew T. Moyer|717-531-3694|mmoyer@pennstatehealth.psu.edu|
22295614|NCT00462761|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22295615|NCT02877082|Emory University/Winship Cancer Institute|Zaid Al-Kadhimi, MD|404-778-1900|zalkadh@emory.edu|
22295616|NCT01843751|University of Wisconsin|Randall Brown|608-263-6558|rtbrown@wisc.edu|
22295617|NCT04309656|TB Alliance|Erica Egizi|917-696-4984|erica.egizi@tballiance.org|
22295618|NCT03720470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295619|NCT01988103|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22295620|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
22295621|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22295622|NCT02451839|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22295623|NCT05682326|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295624|NCT01402544|Univeristy of California, San Diego|Dr. Henry Ferreyra|858-822-7982|hferreyra@ucsd.edu|
22295625|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295626|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295627|NCT02734238|Pennington Biomedical Research Center|Jennifer C. Rood|225-763-2524|jennifer.rood@pbrc.edu|
22295628|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295629|NCT02935088|Abbott Vascular|Tarn Teraphongphom, Sr. Clinical Scientist|408-9310504|tarn.teraphongphom@abbott.com|
22295630|NCT04545866|University of Alabama at Birmingham|Namasivayam Ambalavanan MD|2059344680|nambalav@uabmc.edu|
22295631|NCT02311933|Alliance for Clinical Trials in Oncology|Matthew P. Goetz, MD|: 507-284-2511|goetz.matthew@mayo.edu|
22295632|NCT02436356|Vanderbilt University Medical Center|Jeffry S. Nyman, Ph.D.|615-936-6296|jeffry.s.nyman@vumc.org|
22295633|NCT02875860|Baylor College of Medicine|Dr. Michael Belfort|832-826-7375|belfort@bcm.edu|
22295634|NCT03287804|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
22295635|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com|
22322494|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org|
22322495|NCT05325775|Acer Therapeutics Inc ( a wholly owned subsidiary of Zevra Therapeutics Inc|Chief Medical Officer|844-902-6100|aquartel@zevra.com|
22322496|NCT00197054|Kombewa Clinic, US Army Medical Research Unit, Kisumo Kenya|LTC Mark Polhemus MD, MC|877-379-3788|GSKClinicalSupportHD@gsk.com|
22322497|NCT01163786|Northwestern University|Clinical Trials at Northwestern University|312-695-6180|cancertrials@northwestern.edu|
22267354|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu|
22267355|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu|
22267356|NCT05992623|Inova Schar Heart and Vascular|Brett D. Atwater MD|9192390127|brett.atwater@inova.org|
22267357|NCT03395288|Washington University|Jerry Lowder, MD|314-362-0063|lowderj@wustl.edu|
22267358|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267359|NCT02753920|Northwell Health|Marjorie Pilkinton|5166225114|mlpilk@gmail.com|
22267360|NCT03437031|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
22267361|NCT01434810|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
22267362|NCT04036838|ARJ Medical, Inc.|President|813-855-1557|info@gulfcoastscientific.com|
22267363|NCT02794870|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22267364|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019|dneglia@ifc.cnr.it|2019
22267365|NCT01608061|Functional Neuromodulation|Todd Langevin|7636071214|todd@fxneuromod.com|
22267366|NCT06376682|quantum surgical|MESSNER Laetitia, Chief Clinical officer|+33 (0) 4 48 19 40 50|clinical.department@quantumsurgical.com|
22267367|NCT05560386|Icahn School of Medicine at Mount Sinai|Nita Vangeepuram|917-478-2106|nita.vangeepuram@mssm.edu|
22267368|NCT02540083|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
22267369|NCT02301390|Icahn School of Medicine at Mount Sinai|Betsy Ellsworth, Research Program Director|212-824-8902|betsy.ellsworth@mountsinai.org|
22267370|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu|
22267371|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu|
22267372|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org|
22267373|NCT03001453|American Hip Institute|Dr. Benjamin Domb|630-455-7130|drdomb@americanhipinstitute.org|
22295636|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22295637|NCT04483011|Bioenergy Life Science, Inc.|Alex Xue, Chief Technology Officer|763-746-0032|alex.xue@bioenergyls.com|3924
22295638|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu|
22277372|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22277373|NCT03095976|Indiana University School of Dentistry|Dr. Yusuke Hamada|317-274-5121|yuhamada@iupui.edu|
22277374|NCT01078545|Abbott|Global Medical Services|1-800-633-9110||
22277375|NCT02864914|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22277376|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22277377|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22277378|NCT02555098|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22309299|NCT05746299|University of Pennsylvania|Anna Schapiro|215-898-0482|aschapir@sas.upenn.edu|
22277379|NCT03501277|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22277380|NCT04097223|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277381|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov|
22277382|NCT01873833|USC Norris Comprehensive Cancer Center|Victoria Soto, Regulatory Administrator|323-865-0432|Victoria.Soto@med.usc.edu|
22277383|NCT01968785|Medstar Health Research Institute|Megan Rowland|2028772959|megan.e.rowland@medstar.net|
22277384|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277385|NCT03343886|Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain.|José Luis Ayuso Mateos||joseluis.ayuso@uam.es|
22277386|NCT03193307|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277387|NCT01727154|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
22277388|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22277389|NCT03927716|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22277390|NCT04115228|Nine Continents Medical, Inc.|Peter Jacobson|6128105810|PETERJACOBSON777@YAHOO.COM|
22277391|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22277392|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com|
22277393|NCT02186171|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22277394|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277395|NCT00574353|Memorial Sloan Kettering Cancer Center|Dr. John Humm, PhD|212-639-7367|hummj@MSKCC.ORG|
22277396|NCT06025695|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22277397|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277398|NCT05762744|University of Maryland School of Medicine|Simeon Taylor, MD, PhD (Professor of Medicine0|4107066439|staylor2@som.umaryland.edu|
22277399|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22277400|NCT02507284|Azevan Pharmaceuticals, Inc.|Neal Simon, PhD|(610) 419-1057|ngsimon@azevan.com|
22277401|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277402|NCT02799290|Tampere University Hospital|Ilkka Kaartinen|505687096|ilkka.kaartinen@pshp.fi|
22309300|NCT01652196|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.hay@osumc.edu|
22277403|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22277404|NCT01990352|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
22277405|NCT01502072|UT MD Anderson Cancer Center|Roy F. Chemaly, MD,MPH- Professor, Infectious Diseases|(713) 745-1116|rfchemaly@mdanderson.org|
22277406|NCT01531803|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
22277407|NCT03646188|Medicus Pharma|Dr. Huma Qamar, MD., Chief Scientific Officer|610- 540-7515|hqamar@medicuspharma.com|106
22277408|NCT02773537|Medical University of South Carolina|Dr. Eric Bolin|843-792-2322|bolin@musc.edu|
22277409|NCT03188705|University of Maryland School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
22277410|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu|
22277411|NCT03156621|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844 734 6643|clinicaltrials@regeneron.com|
22277412|NCT04985682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22277413|NCT01694186|Eyepoint Pharmacueticals|Clinical Affairs|6179726204|fleonin@eyepointpharma.com|
22277414|NCT03016403|Latino Research and Policy Center, University of Colorado Denver|Evelinn Borrayo, Associate Director|303-724-0884|Evelinn.Borrayo@cuanschutz.edu|
22267374|NCT02481869|University of Missouri|Dr. James Cook|5738827615|cookjl@health.missouri.edu|
22277415|NCT00799864|Janssen R&D BE|Director 1 Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22277416|NCT00225758|Dartmouth-Hitchcock Medical Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
22267375|NCT02292940|Northern California Kaiser Permanente, Division of Research|Mary Reed, DrPH|510-891-3808|Mary.E.Reed@kp.org|
22267376|NCT03277066|Noven Pharmaceuticals, Inc.|Gunnar Klauss, MD|1-551-233-2656|gklauss@noven.com|
22267377|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu|
22267378|NCT03154125|FHI 360|Vera Halpern, M.D., Director of Clinical Development|+1 (919) 321-3331|VHalpern@fhi360.org|3117
22267379|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22267380|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com|
22267381|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343||
22309301|NCT04524442|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22277417|NCT00576407|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
22277418|NCT04641975|Astellas Pharma Global Development Inc|Clinical Trial Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22277419|NCT02350998|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22277420|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu|
22277421|NCT01657500|Case Western Reserve Univ and University Hospitals Case Medical Center|Jonathan Lass MD|2168445893|jonathan.lass@uhhospitals.org|
22277422|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
22277423|NCT00756444|Amgen Inc.|Study Director|866-572-6436||
22277424|NCT05574764|Duke University|Emily M. D'Agostino, DPH, MS, MEd, MA|646-853-1223|emily.m.dagostino@duke.edu|
22277425|NCT03528577|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
22277426|NCT03892915|RAND Corporation|Glenn Wagner|310-393-0411|gwagner@rand.org|7695
22277427|NCT03364686|University of Pittsburgh|Darrell J. Triulzi, MD|412-209-7304|triudj@upmc.edu|
22277428|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu|
22277429|NCT02201628|King's College Hospital NHS Foundation Trust|Dr Emily Haberman|07890549924|emilysaffer@gmail.com|
22277430|NCT02957123|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD|+7 (383) 236-03-29|ostanin62@mail.ru|
22277431|NCT00449007|Perelman School of Medicine, University of Pennsylvania|Maria A. Oquendo, M.D., Ph.D.|215-662-2818|moquendo@pennmedicine.upenn.edu|
22277432|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu|
22277433|NCT03566550|University of Nottingham|Professor Alan Smyth|01158230612|alan.smyth@nottingham.ac.uk|
22277434|NCT02614768|Medical University of Graz|Mader, Julia, Assoz. Dr.med.univ.|0043316385|julia.mader@medunigraz.at|12383
22277435|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000|turana@ccf.org|9857
22277436|NCT03518203|Cincinnati Children's Hospital Medical Center|Sonata Jodele, MD|(513) 636-5917|Sonata.Jodele@cchmc.org|
22277437|NCT02829957|Indiana University|Dr. Jeffrey Kline|317-880-3869|jefkline@iu.edu|
22277438|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu|
22277439|NCT03511066|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
22277440|NCT04146909|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
22277441|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851|gluca.botto@gmail.com|+39
22277442|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov|
22277443|NCT05001165|VA Greater Los Angeles|Boback Ziaeian|310-478-3711|boback.ziaeian@va.gov|
22277444|NCT03467945|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22277445|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu|
22277446|NCT06171399|Wake Forest University School of Medicine|Dr. Beth Reboussin|336-713-5213|brebouss@wakehealth.edu|
22277447|NCT02821793|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22267382|NCT03345771|NYU Langone Health|Ran Schwarzkopf MD MSc|(646)-501-7300|ran.schwarzkopf@nyulangone.org|
22267383|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22267384|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
22267385|NCT02288325|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22267386|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu|
22267387|NCT03607487|Incyte Corporation|Incyte Corporation Call Center|1-855-463-3463|medinfo@incyte.com|
22267388|NCT04759703|Massachusetts General Hospital|John W. Winkelman, MD, PhD|6176436026|JWWINKELMAN@MGH.HARVARD.EDU|
22267389|NCT06101264|University of Connecticut School of Medicine|Prabhath Mannam|8607092371|pmannam@uchc.edu|
22267390|NCT03617458|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
22267391|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org|
22267392|NCT04186845|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
22267393|NCT03151304|Helsinn Healthcare|Francesco Scarci, Clinical Operations Manager|+41 (0)91 985 2121|francesco.scarci@helsinn.com|
22267394|NCT00337181|Thai Ministry of Public Health|Supachai Rerks-Ngarm|6629659571|supachai@health.moph.go.th|
22267395|NCT04036110|University of North Carolina at Chapel Hill|Jia-Rong Wu, PhD, RN|859-323-4712|jiarong.wu2@uky.edu|
22267396|NCT04252092|Eksen Sağlık ve Rehabilitasyon|PT,Cansu Hayıroğlu|+905378405948|cansu5309@gmail.com|
22267397|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
22267398|NCT02676765|Virginia Commonwealth University|Dr. Brant Ward|804-828-1941|brant.ward@vcuhealth.org|
22267399|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com|
22267400|NCT03452943|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22267401|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22267402|NCT01107197|"Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera Maggiore della Carità"|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it|
22267403|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu|
22267404|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267405|NCT00447993|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22267406|NCT03532373|Stanford University|Robin Kamal|650-721-7629|rnkamal@stanford.edu|
22267407|NCT04380961|Janssen Research & Development, LLC|Director 1 Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22277448|NCT03336866|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
22277449|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov|
22277450|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu|
22277451|NCT03651336|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22277452|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22277453|NCT03378336|University of Pennsylvania|Dr. Alexis Ogdie-Beatty|215-614-2454|alexis.ogdie@pennmedicine.upenn.edu|
22277454|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22277455|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372||
22277456|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277457|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277458|NCT03601052|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
22277459|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277460|NCT00105508|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
22277461|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277462|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org|
22277463|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu|
22277464|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu|
22277465|NCT01049828|Washington University in St. Louis|Dr. Andre Wineland|314-362-5296|winelanda@ent.wustl.edu|
22277466|NCT02015104|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
22277467|NCT03011372|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22277468|NCT03572218|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Pearl|215-746-5129|rpearl@pennmedicine.upenn.edu|
22277469|NCT00853047|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22277470|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu|
22277471|NCT06765889|A*STAR|Alessandro Sparacio|80728247|Alessandro_Sparacio@sics.a-star.edu.sg|
22277472|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com|
22277473|NCT01926509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277474|NCT02730169|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
22277475|NCT03004183|Houston Methodist Cancer Center|Jenny C Chang, MD|713-441-0629|ccresearch@houstonmethodist.org|
22277476|NCT03885206|Landsforeningen for hjerte- og lungesyke|Senior Consultant|0047 95706313|irene.steinsvik@lhl.no|
22277477|NCT03076164|Memorial Sloan Kettering Cancer Center|Dr. Helene Yu, MD|646-608-3912|YuH@mskcc.org|
22277478|NCT02698787|Cochlear|Naomi Croghan|+13032642131|ncroghan@cochlear.com|
22277479|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu|
22277480|NCT02935036|Taro Pharmaceuticals U.S.A., Inc.|Manager, Clinical Research|9143459001|Businessdevelopment@taro.com|
22277481|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu|
22277482|NCT02004275|Levine Cancer Institute|Peter Voorhees|980-442-5219|peter.voorhees@carolinashealthcare.org|
22277483|NCT02533674|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22277484|NCT03606213|University of California, San Francisco (UCSF)|Professor of Medicine|14154761000|Steven.Deeks@ucsf.edu|
22277485|NCT04315961|Johns Hopkins University School of Medicine|Dustin Lee|410-550-4035|dlee214@jhmi.edu|
22277486|NCT01749293|University of Illinois|Dr. Pritesh Patel|312-996-5762|prpatel8@uic.edu|
22277487|NCT03008213|UCSD|Eric Roeland, MD|858- 534-7079|eroeland@ucsd.edu|
22277488|NCT01908699|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
22277489|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22277490|NCT02242903|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277491|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
22277492|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com|
22277493|NCT03021005|Johns Hopkins University|Dr. Yu-Hsiang Hsieh|410-735-6413|yhsieh1@jhmi.edu|
22277494|NCT03917901|University of Houston|Brooke Kauffman|(713) 743-8056|bkauffma@central.uh.edu|
22277495|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu|
22277496|NCT03074643|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
22277497|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277498|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org|
22277499|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
22309302|NCT04719832|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22309303|NCT04324359|Surface Ophthalmics Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
22309304|NCT05526430|Icahn School of Medicine at Mount Sinai|Jessica L Ables|(212) 241-2774|jessica.ables@mssm.edu|
22309305|NCT03085810|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22309306|NCT02601313|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22309307|NCT05239455|Terumo BCT, Inc|Erin Goodhue, DO, MPH, Director, Clinical Affairs|614-400-4638|Erin.Goodhue@TerumoBCT.com|
22309308|NCT02272998|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.roychowdhury@osumc.edu|
22309309|NCT03701763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22277500|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org|
22277501|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
22277502|NCT03142334|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277503|NCT01217047|Kennedy Krieger Institute|Daniel Becker, M.D.|888-923-9222|dbecke13@jhu.edu|
22277504|NCT03835117|Autism Discovery & Treatment Foundation|Richard E Frye|844-ADTF-Research|DrFrye@AutismDiscovery.org|1
22277505|NCT04072432|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
22277506|NCT03225989|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
22277507|NCT02043847|University of Illinois at Chicago|Dr. Rondelli|312-996-6179|drond@uic.edu|
22277508|NCT03093870|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
22295639|NCT01025791|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295640|NCT02979522|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22295641|NCT02237950|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22295642|NCT01896531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22267408|NCT04803305|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295643|NCT05185089|NeRRe Therapeutics Ltd|CMO|+44 (0)1438 906960|info@nerretherapeutics.com|
22295644|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295645|NCT02733991|Medtronic Diabetes EMEA|Ohad Cohen M.D., Medical Affairs Director|+972 54 321 1108|ohad.cohen@medtronic.com|
22295646|NCT03483051|University of Pennsylvania|Dr. Julio Chirinos|215-200-7779|juliochi@pennmedicine.upenn.edu|
22295647|NCT02956486|Eisai Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22295648|NCT01905384|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
22295649|NCT01485770|Jazz Pharmaceuticals|Director, Disclosure & Transparency|(215) 970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22295650|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu|
22295651|NCT02485574|Chung-Ang University hospital|Kwang-Sup Song|+82-1037616503|ksong70@cau.ac.kr|
22295652|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com|
22295653|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22295654|NCT02704975|United States Army|Rob Halle|910-689-8887|robhalle@gmail.com|
22295655|NCT02403154|Indiana University|Krista Brown, Clinical Research Coordinator|317-963-1944|brownkm@indiana.edu|
22295656|NCT00003492|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22295657|NCT04152603|Seattle Children's Research Institute|Professor Stephanie Kraft|20688471022068841191|stephanie.kraft@seattlechildrens.org|
22295658|NCT01958320|University of California San Francisco|Ronald Clyman, MD PI|415-443-9305|clymanr@peds.ucsf.edu|
22295659|NCT03049280|Intuitive Surgical|Intuitive Surgical Clinical Affairs|408-523-2100|sylvie.akiel-fu@intusurg.com|
22295660|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22295661|NCT01516346|University of Pennsylvania|Julio Chirinos, MD, PhD|215-573-6606|julio.chirinos@pennmedicine.upenn.edu|
22295662|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
22295663|NCT02032810|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nikhil I. Khushalani|813-745-3437|nikhil.khushalani@moffitt.org|
22295664|NCT01927367|QEII Health Sciences Centre, Halifax, Nova Scotia|Dr. Jafna L Cox|(902) 473-7811|jafna.cox@dal.ca|
22295665|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu|
22295666|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743||
22267409|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22267410|NCT02121652|University at Buffalo School of Nursing|Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
22267411|NCT01090414|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22267412|NCT04342819|The University of the West Indies|Naveen Seecheran, Senior Lecturer|18687537686|Naveen.Seecheran@sta.uwi.edu|
22267413|NCT01965860|Ghent University|Prof. Dr. Isabelle Van Herzeele|93325108|isabelle.vanherzeele@ugent.be|+32
22267414|NCT00769379|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22267415|NCT03203681|University of Miami|Dr. Ranjith Ramasamy|3052433670|ramasamy@miami.edu|
22267416|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22267417|NCT03901092|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22267418|NCT04347993|Hackensack Meridian Health|Joshua Zenreich|5519965900|joshua.zenreich@hmhn.org|
22267419|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22267420|NCT04138823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267421|NCT04868500|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22267422|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org|
22267423|NCT02466685|Northwestern University|Mahdi Arshadi|3123839950|mahdi.arshadi@northwestern.edu|
22267424|NCT02565511|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22267425|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22267426|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov|
22267427|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov|
22277509|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22277510|NCT02298491|UMaryland|Horea Rus|410-706-3170|hrus@som.umaryland.edu|
22277511|NCT02318277|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22277512|NCT02006654|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22277513|NCT04193527|GE Healthcare Ltd.|Yongqing Tang, MD, PhD|21 38774044|Yongqing.Tang@ge.com|+86
22277514|NCT03808909|University of New Mexico, Health Sciences Center|Pilar Sanjuan|505/272-7055|psanjuan@salud.unm.edu|
22277515|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu|
22277516|NCT00676689|Edwards Lifesciences|Sharanjeet Dhanjal|949-250-2083|sharanjeet_dhanjal@edwards.com|
22277517|NCT01827943|Institut Bergonie|Dr Nadine Houede, oncologist|05.56.33.33.33|nadine.HOUEDE@chu-nimes.fr|
22295667|NCT02743871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295668|NCT01973166|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22295669|NCT03171415|Raziel Therapeutics|Racheli Gueta - Clinical Trials Manager|972-8-9126941|racheli@raziel-therapy.com|
22295670|NCT02848651|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22295671|NCT04140292|Cleveland Clinic Foundation|Maytin, Edward, V|1-866-223-8100|taussigresearch@ccf.org|
22267428|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu|
22267429|NCT03097991|University of South Florida|Dr. James McHale|7278734848|jmchale@usf.edu|
22267430|NCT01755091|University of Illinois at Chicago|David W. Carley, PhD|312-996-3827|dwcarley@uic.edu|
22267431|NCT03307226|Washington University in St. Louis|Dr. Fred Ssewamala|3149358521|fms1@wustl.edu|
22267432|NCT01199146|University of California, San Francisco|Charles Ryan, MD|415-353-9279|charles.ryan@ucsf.edu|
22267433|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267434|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267435|NCT03516513|University of Washington|Michael Pullmann|6158304563|pullmann@uw.edu|
22267436|NCT02593110|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22267437|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22267438|NCT03071276|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
22267439|NCT03022916|UAB|Director of Clinical Trials, UAB Dermatology|2055029960|Lmroop@uabmc.edu|
22267440|NCT05794503|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
22267441|NCT03052127|Aura Biosciences|Uma Chandrasekaran, Director, Clinical Development Scientist|706-294-3454|UChandrasekaran@aurabiosciences.com|
22267442|NCT03694327|MyDigitalStudy|Alankar Gupta, VP, Medical Affairs & Clinical Development|862-485-9279|agupta@clicktherapeutics.com|
22267443|NCT01464931|Amgen Inc.|Study Director|866-572-6436||
22267444|NCT02936180|McGill University|Ines Colmegna, MD|514-934-1934|ines.colmegna@mcgill.ca|35639
22267445|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu|
22267446|NCT03648853|UCalifornia San Francisco|Pekka Talke|415 306 3602|pekka.talke@ucsf.edu|
22267447|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org|
22267448|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612||
22267449|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu|
22267450|NCT03017612|Ms.|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
22267451|NCT03131544|Prostate Laser Center, PLLC|Dr. Ara Karamanian, Medical Director of the Prostate Program|(713) 904-4014|drkaramanian@halodx.com|
22267452|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com|
22267453|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com|
22267454|NCT06360081|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267455|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
22267456|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
22267457|NCT02447744|MGH|Dr. Sara Lazar|617-724-7108|slazar@mgh.harvard.edu|
22267458|NCT00306995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22267459|NCT06419907|University of Liverpool|Gemma Lewis|01744 646668|gemma.lewis@liverpool.ac.uk|
22267460|NCT03573830|BC Children's Hospital Research Institute|Dr. Mariana Brussoni|(604) 875-3712|mbrussoni@bcchr.ubc.ca|
22267461|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267462|NCT03525886|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22267463|NCT03284723|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267464|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov|
22267465|NCT05239611|University of Kansas Medical Center|Joel Mermis|913-588-6045|jmermis@kumc.edu|
22267466|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org|
22267467|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22267468|NCT01368497|University of Pittsburgh|Dr. Steven Belle|412-624-3758|belle@edc.pitt.edu|
22267469|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550||
22267470|NCT05021900|Rhizen Pharmaceuticals AG|Dr. Prajak Barde|+919820503970|pjb@rhizen.com|
22267471|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277518|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
22277519|NCT01487161|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22295672|NCT00667004|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22295673|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277520|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu|
22277521|NCT00663351|Smith & Nephew, Inc.|Rachael Winter, Director, Global Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
22277522|NCT02366130|UT MD Anderson Cancer Center|Dr. Naoto T Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
22277523|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
22277524|NCT03113136|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22277525|NCT03587857|UCSF|Dr. Parya Saberi|415-502-1000 ext. 17171|parya.saberi@ucsf.edu|
22277526|NCT03677180|Henry Ford Hospital|Dr. Mir Babar Basir|313-916-2896|mbasir1@hfhs.org|
22277527|NCT04786600|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22277528|NCT01266083|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
22277529|NCT02675452|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22277530|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277531|NCT04595370|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22277532|NCT03520387|VA Puget Sound Health Care System Seattle Division, Seattle, WA|Pradeep Suri, MD|206-764-2673|Pradeep.Suri@va.gov|
22277533|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277534|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22277535|NCT04267328|HealthPartners Institute - Neuroscience|Clinical Research Coodinator|651-495-6360|clincialtrials@HealthPartners.com|
22277536|NCT04913675|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22277537|NCT05660538|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22277538|NCT04648241|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277539|NCT02489045|Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
22277540|NCT02970812|Family Medicine Clinic, Pusan National University Yangsan Hospital|Sang Yeoup Lee|3601442|saylee@pnu.edu|55
22277541|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com|
22277542|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22277543|NCT05181657|University of California, San Diego|Dr. Steffanie Strathdee|858-822-1952|sstrathdee@health.ucsd.edu|
22277544|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org|
22277545|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277546|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
22277547|NCT03339453|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22277548|NCT02903381|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|irene_ghobrial@dfci.harvard.edu|
22277549|NCT02278237|University of Chicago|Valerie G. Press, MD, MPH|773-702-5170|vpress@medicine.bsd.uchicago.edu|
22277550|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
22277551|NCT03632720|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22277552|NCT01300065|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22277553|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299||
22277554|NCT03834883|Purdue University|James E. Tisdale, PharmD|317-880-5418|jtisdale@purdue.edu|
22277555|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22277556|NCT03738215|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22277557|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22277558|NCT03211858|Trial Transparency Team|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22277559|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22277560|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743||
22277561|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22277562|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
22277563|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295674|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22295675|NCT02480114|Vanderbilt University Medical Center|Derek Smith, DDS, PhD|6159367423|derek.k.smith@vumc.org|
22295676|NCT02081690|Actelion Pharmaeuticals Ltd.|Clinical Trial Disclosure Manager||clinical-trials-disclosure@actelion.com|
22295677|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
22295678|NCT00959842|Professor|Dr. Greg Shearer|814-867-3040|gcs13@psu.edu|
22295679|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22295680|NCT03204981|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
22295681|NCT04203238|Pennington Biomedical Research Center|Dr. Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
22295682|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000||
22277564|NCT02457546|Ethicon, Inc.|Richard Kocharian, MD, PhD|1-908-218-2013|rkochar1@its.jnj.com|
22295683|NCT04244786|New York State Psychiatric Institute|Jeffrey Miller|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
22309310|NCT02618577|Universitätsklinikum Hamburg-Eppendorf|Prof. Dr. Paulus Kirchhof|+49 (0)40 7410-52438|p.kirchhof@uke.de|
22277565|NCT04250675|Purdue University|Bruno Roseguini|7654906284|brosegui@purdue.edu|
22295684|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org|
22309311|NCT05192109|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
22277566|NCT03939494|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
22277567|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com|
22277568|NCT04914000|Moffitt Cancer Center|Dr. Ursula Martinez|813-745-1754|Ursula.Martinez@moffitt.org|
22277569|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org|
22277570|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com|
22277571|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au|
22277572|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
22277573|NCT00948935|Abramson Cancer Center|Bruce Giantonio|(215) 615-5858|bruce.giantonio@uphs.upenn.edu|
22277574|NCT04032327|Walter Reed National Military Medical Center|Katherine L Dengler, MD|301-400-2468|katherine.l.dengler.mil@mail.mil|
22277575|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu|
22277576|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch|
22277577|NCT03302936|Icahn School of Medicine at Mount Sinai|Annacecilia Peacher-Holderied|2104887216|apeacher4@gmail.com|
22277578|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277579|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
22277580|NCT00564070|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|(305) 284-2818|ssafren@miami.edu|
22277581|NCT03374956|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
22277582|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be|
22277583|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu|
22277584|NCT02067156|University of California, San Diego Moores Cancer Center|Dr. David Piccioni|858-657-7000|dpiccioni@ucsd.edu|
22277585|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org|
22277586|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
22277587|NCT00835042|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22277588|NCT04635280|Air Liquide|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
22277589|NCT02453191|University of Iowa, Holden Comprehensive Cancer Cente|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
22277590|NCT02571244|Federal University of Juiz de Fora/Brazil|Dr. Erica Cruvinel|55-32-99174-8855|ericacruvinel@gmail.com|
22277591|NCT00185900|Stanford University|Dr. Anna Girsen|(650) 725-5720|agirsen@stanford.edu|
22277592|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu|
22277593|NCT02134028|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22277594|NCT02719366|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22277595|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
22277596|NCT03722030|University of Wisconsin - Madison|Dr. Lisa Cadmus-Bertram|608-262-1167|lisa.bertram@wisc.edu|
22277597|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu|
22277598|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277599|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com|
22277600|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
22277601|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
22277602|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu|
22277603|NCT04501445|Rush University Medical Center|Jared A Greenberg|312-942-6744|jared_greenberg@rush.edu|
22277604|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it|
22277605|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com|
22277606|NCT04518410|ACTG Network Coordinating Center, DLH|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22277607|NCT05737745|Virginia Tech Carilion Clinic|Shannon Armbruster MD, MPH|540-581-0160|sdarmbruster@carilionclinic.org|
22277608|NCT02569242|Ono Pharmaceutical Co. Ltd|Medical Information Center|ー|clinical_trial@ono.co.jp|
22277609|NCT02057666|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22277610|NCT05661734|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22277611|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
22277612|NCT01348490|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22277613|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org|
22277614|NCT04002557|Imperial College London|Ms Ann-Eneli Allas|07508775892|anastassija@hotmail.com|
22277615|NCT06173648|State Univeristy of Paulista Júlio de Mesquita Filho, School of Dentistry at Araraquara|Dr. Renato de Toledo Leonardo|+55-16-3301-6391|rleonard@foar.unesp.br|
22277616|NCT02487199|AbbVie|Global Medical Services|800-633-9110||
22277617|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22309312|NCT02975375|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22309313|NCT04489771|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309314|NCT04711447|University of Manitoba|Dr. Trisha Scribbans|(204) 272-1699|trisha.scribbans@umanitoba.ca|
22309315|NCT05292872|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22309316|NCT02561585|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22277618|NCT04826731|Ankara Sanatoryum Training and Research Hospital|Dr. Kerem Ensarioğlu|905426142727|kerem.ensarioglu@gmail.com|
22267472|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com|
22267473|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
22267474|NCT03182933|University of Wisconsin|Laura Zitur - research program manager|6082638118|lzitur@wisc.edu|
22267475|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
22267476|NCT02099786|VA RR&D National Center for Rehabilitative Auditory Research|Dr. Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
22267477|NCT03052751|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22267478|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com|
22267479|NCT03071692|Kowa Research Institute, Inc.|Director, Clinical Operations|1 (919) 433-1600|CTGResults@KowaUS.com|
22267480|NCT01427608|Weill Cornell Medicine|Dr. George S. Alexopoulos|(914) 997-5767|gsalexop@med.cornell.edu|
22267481|NCT01439581|Henry Ford Health System|Robert Behrendt|313-874-9537|Rbehren9@hfhs.org|
22267482|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
22267483|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267484|NCT03514966|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
22267485|NCT02862730|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
22267486|NCT03022370|SAMRC|Dr Andrew Gibbs|+27(0)312034899|andrew.gibbs@mrc.ac.za|
22267487|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk|
22267488|NCT01526655|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
22267489|NCT04753216|Northwestern University Feinberg School of Medicine|Daniela Matei, MD|312-472-4684|daniela.matei@northwestern.edu|
22267490|NCT02142608|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director X-Ray and Ultrasound|609-514-2262|marialuigia.storto@diag.bracco.com|
22267491|NCT02001987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22267492|NCT01894087|University of Michigan|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
22267493|NCT03044028|Cleveland Clinic|Carlos Higuera|954-659-5430|higuerc@ccf.org|
22267494|NCT01275846|Detroit Medical Center, Detroit, MI|Ileana L. Piña, MD, MPH, FAHA, FACC|216-225-7385|ilppina@aol.com|
22267495|NCT03571828|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22267496|NCT02411916|Queens Hospital Center|Dr. Aleksandr Fuks|718 883-4035|fuksal@nychhc.org|
22267497|NCT02232984|Boston Scientific|Eszter Pais|6515825307|eszter.pais@bsci.com|
22267498|NCT04020887|Washington University School of Medicine|Thaddeus Budelier|314-273-8646|thaddeus.budelier@wustl.edu|
22267499|NCT01884337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22267500|NCT02455518|Albany Medical College|Dr. Andrew Chang|2125555555|achang3@yahoo.com|
22267501|NCT02508935|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22267502|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
22267503|NCT02683421|Navidea Biopharmaceuticals|Bonnie C. Abbruzzese, MS, RD|614-822-2327|babbruzzese@navidea.com|
22267504|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267505|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267506|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,|
22267507|NCT02969044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22267508|NCT03714919|Nationwide Children's Hospital|Arlyne Thung, MD|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
22267509|NCT03548337|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267510|NCT04502212|GE Research|Diane Minas|(518)698-3959|minas@ge.com|
22267511|NCT04460560|University of Pennsylvania|K. Rajender Reddy, MD|215-662-4311|ReddyR@pennmedicine.upenn.edu|
22267512|NCT02359994|Artivion|Priya Patel|678-290-4358|priya.patel@artivion.com|
22267513|NCT01320150|Rush University Medical Center|Dr. Robert McCarthy|(312) 563-0448|Robert_J_McCarthy@rush.edu|
22267514|NCT02430038|Imperial College|Professor Christoph Lees|02083831000|christoph.lees@nhs.net|
22267515|NCT00489827|Dept Cardiothoracic Surgery, Linköping University Hospital, SE58185 Linköping, Sweden|Rolf Svedjeholm|+46101034825|rolf.svedjeholm@regionostergotland.se|
22267516|NCT02766283|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
22267517|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com|
22267518|NCT02448368|Ardea Biosciences, Inc.|Jesse Hall, MD|(858) 652-6672|JHall@ardeabio.com|
22267519|NCT01632280|Beth Israel Deaconess Medical Center|Dr. Miguel Alonso-Alonso|617-667-0240|malonso@bidmc.harvard.edu|
22267520|NCT03086551|University of Waterloo, Waterloo, Ontario, Canada|Sean K Meehan, PhD|5198884567|skmeehan@uwaterloo.ca|39278
22267521|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu|
22267522|NCT05410964|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
22267523|NCT03736031|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|915-215-5103|elp-obgynresearch@ttuhsc.edu|
22267524|NCT00451178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267525|NCT05680740|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22267526|NCT02586688|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
22267527|NCT04856917|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22267528|NCT05168202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22295685|NCT05024058|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22277619|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com|
22277620|NCT02933151|Dialysis Clinic, Inc. /Tufts Medical Center|Dr. Daniel Weiner|6176365070|dweiner@tuftsmedicalcenter.org|
22277621|NCT02596893|Celgene Corporation|Anne Mcclain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22277622|NCT03280615|Institute of Nutrition and Food Technology University of Chile|Dr. Francisco Perez Bravo, Director|+5629781411|fperez@inta.uchile.cl|
22277623|NCT03052257|Durham VA Medical Center, Durham, NC|Dr. Kelly Muir|919-286-0411|Kelly.Muir@va.gov|174035
22277624|NCT03137407|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22277625|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22277626|NCT01530256|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22277627|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22277628|NCT03408808|NHS Grampian|Miss Katharine Hamlin|0845 456 6000|katharine.hamlin@nhs.scot|56755
22277629|NCT04432298|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1346|jcharpentier@fibrogen.com|
22277630|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22277631|NCT02451007|Pharma Mar, S.A.|Clinical Development Department of PharmaMar's Oncology Business Unit|+34 91 846 60 00|clinicaltrials@pharmamar.com|
22277632|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22277633|NCT02062008|University of California San Francisco|miguel hernandez pampaloni|4153531886|miguel.pampaloni@ucsf.edu|
22277634|NCT04334681|Principal investigator|Dr. Alpaslan Şahin|0332310500|drasahin@gmail.com|50510
22277635|NCT02327143|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277636|NCT02123511|Mayo Clinic|Michele Halyard, M.D.; Robert Foote, M.D.|480-301-4567|mhalyard@mayo.edu; foote.robert@mayo.edu|
22277637|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22277638|NCT02551809|United Neuroscience|Responsible Medical Officer|+(353) 1 524 0397|info@unitedneuroscience.com|
22277639|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22277640|NCT02462057|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
22277641|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22277642|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22277643|NCT04498273|University of Pittsburgh|Dr. Frank Sciurba|412-648-6494|sciurbafc@upmc.edu|
22277644|NCT03615534|Al-Kindy College of Medicine, ////university of Baghdad|Lewai Sharki Abdulaziz|750 659 0024|lewaisharki@kmc.uobaghdad.edu.iq|+964
22277645|NCT05688657|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|jvega2@coopervision.com|
22277646|NCT05345405|University of Washington|Principal Investigator|206-503-3287|edworkin@uw.edu|
22277647|NCT04189588|TerSera Therapeutics Inc.|Executive Director Clinical Development|888 600 8116|jnorth@tersera.com|
22277648|NCT02944461|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22277649|NCT02193347|Duke University|Katy Peters, M.D., Ph.D.|919-684-6173|katherine.peters@duke.edu|
22277650|NCT03757715|UAB|Dr. Jessica W. Grayson|205-801-7801|jgrayson@uabmc.edu|
22277651|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277652|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277653|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22277654|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22277655|NCT03473301|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
22277656|NCT05529173|Rutgers - NJ Medical School|Dr. Dennis Grech|973 972-5007|grechde@njms.rutgers.edu|
22277657|NCT05965323|University of Washington|Linda K Ko, PhD, Principal Investigator|2062568261|lindako@uw.edu|
22277658|NCT03760081|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22277659|NCT04034056|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22277660|NCT04135352|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22295686|NCT02734810|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
22295687|NCT02507505|University of Pennsylvania Perelman School of Medicine|Mark D. Neuman, MD, MSc (Principal Investigator)|215-746-7468|mark.neuman@uphs.upenn.edu|
22295688|NCT00931762|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22295689|NCT03510884|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22295690|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295691|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22295692|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295693|NCT02892760|The University of Texas Health Science Center at Houston|Gerard Francisco, MD|713-797-7636|Gerard.E.Francisco@uth.tmc.edu|
22295694|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu|
22295695|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu|
22309317|NCT03059030|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
22309318|NCT06516705|National Tainan Junior College of Nursing|Mei-Chuan Huang|886-0956646992|mayhuang@ntin.edu.tw|
22309319|NCT05579899|Evommune|Eugene Bauer, M.D., Chief Medical Officer|310-721-3364|eugene.bauer@evommune.com|
22277661|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277662|NCT02807181|Sirtex|Director, Clinical Research Operations|+1-888-474-7839|info-us@sirtex.com|
22267529|NCT04483583|University of Florida|Dominick J Angiolillo|904-244-2636|dominick.angiolillo@jax.ufl.edu|
22267530|NCT04011722|Abbott|Nels Engblom|3198533946|nels.engblom1@abbott.com|
22267531|NCT06389396|Coloplast A/S|Julie Schnipper, Medical Writer|004549111257|dkjuls@coloplast.com|
22267532|NCT05626231|Boston College School of Social Work|Dr. Maggi Price, PI|541-556-5016|priceml@bc.edu|
22267533|NCT06195930|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22267534|NCT02487966|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
22267535|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu|
22267536|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
22267537|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
22267538|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu|
22267539|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267540|NCT06184399|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22267541|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22267542|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
22267543|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu|
22267544|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22267545|NCT01473407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267546|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22267547|NCT05223920|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
22267548|NCT04071405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267549|NCT05044195|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22267550|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267551|NCT03685344|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|
22267552|NCT02276807|VA Center for Integrated Healthcare|Dr. Jennifer Funderburk|315-425-4400|Jennifer.Funderburk@va.gov|54703
22267553|NCT00261950|Amgen Inc.|Study Director|866-572-6436||
22267554|NCT03288714|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
22267555|NCT02819284|Kala Pharmaceuticals, Inc.|VP Clinical Development|(781) 996-5252|Results007@kalarx.com|
22267556|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu|
22267557|NCT05584189|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
22267558|NCT02789137|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267559|NCT00445432|Abbott|Global Medical Services|800-633-9110||
22267560|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu|
22267561|NCT04080739|University of Alabama at Birmingham|Dr. Anthony Morlandt|205-996-2799|morlandt@uab.edu|
22267562|NCT00799058|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22267563|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu|
22267564|NCT03417778|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22267565|NCT02088697|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22267566|NCT03408171|Geisinger Medical Center|David L. Diehl, MD|570-214-2411|dldiehl@geisinger.edu|
22267567|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267568|NCT01232452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267569|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000||
22267570|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22267571|NCT03594071|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
22267572|NCT05219448|University of Washington|Dr. Donald L. Chi|206-616-4332|dchi@uw.edu|
22267573|NCT01750190|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|060study@fibrogen.com|
22267574|NCT02287922|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
22267575|NCT05387889|State University of New York at Buffalo School of Nursing|Dr. Tania Von Visger|7168292201|Taniavon@buffalo.edu|
22267576|NCT01472692|UCSD|Department of Medicine|(858) 552-8585||
22267577|NCT03762239|Barcelona Institute for Global Health (ISGlobal)|Dr. Xavier Basagaña|(+34) 93 214 7306|xavier.basagana@isglobal.org|
22267578|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267579|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu|
22267580|NCT03295630|Hull University Teaching Hospitals NHS Trust|Dr. Jayne Anderson|01482 875875|jayne.anderson@hey.nhs.uk|5099
22267581|NCT03910673|Duke Vaccine and Trials Unit|Emmanuel Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
22267582|NCT03168022|Tonix Pharmaceuticals|Gregory Sullivan, MD||greg.sullivan@tonixpharma.com|
22267583|NCT03091179|Stanford University|Vladimir Nekhendzy|650-498-4055|nek@stanford.edu|
22267584|NCT02171195|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
22267585|NCT03730207|Medtronic|Jane Zhang|86+18612318110|jane.zhang7@medtronic.com|
22267586|NCT04650204|Mayo Clinic|William Tatum, D.O.|507 284-2511|Tatum.William@mayo.edu|
22267587|NCT03164616|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22267588|NCT04768686|Hanmi Pharm. Co., Ltd.|Young Su (Bobby) Noh|82-2-410-9277|63forever@hanmi.co.kr|
22267589|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu|
22322498|NCT02272686|UT MD Anderson Cancer Center|Issa F. Khouri, MD, Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
22295696|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com|
22295697|NCT02902965|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
22322499|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu|
22322500|NCT02582957|University of Colorado|Dr. Richard Albert|303-602-5011|RICHARD.ALBERT@cuanschutz.edu|
22322501|NCT03021642|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22322502|NCT01192347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22322503|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
22322504|NCT02474082|Novartis Pharmaceuticals|Study Director|862 -778- 8300||
22322505|NCT03452371|Boston Medical Center/ Boston University Schools of Medicine and Public Health|Karen Lasser|617-414-6688|karen.lasser@bmc.org|
22322506|NCT04317274|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22322507|NCT00430508|Daiichi Sankyo|James McCarthy / Director Regulatory Operations|732-590-3430|jmccarthy@dsus.com|
22322508|NCT01675960|Children's of Minnesota|Scott Schwantes|(612)813-7888|sschwantes@gillettechildrens.com|
22322509|NCT04173429|Qilu Hospital of Shandong University|Professor Gao Yanjing|18560086087|gaoyanjing@sdu.edu.cn|
22322510|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl|
22322511|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22322512|NCT03403192|Wake Forest Health Science|Benjamin Morris, MD|336.716.6533|bmorris@wakehealth.edu|
22322513|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
22322514|NCT04849780|Johnson & Johnson Vision Care, Inc.|John R. Buch, OD, MS, FAAO|1-800-846-2020|jbuch@its.jnj.com|
22322515|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22322516|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu|
22267590|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267591|NCT02350816|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22267592|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com|
22267593|NCT04787627|Össur Iceland ehf.|Laurine Roussillon|+354 822 1812|lroussillon@ossur.com|
22267594|NCT00548093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267595|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca|
22267596|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548||
22267597|NCT04842292|University of Kentucky|Brittany Bissell|8593239308|bdbi223@uky.edu|
22267598|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22267599|NCT02374138|Children's Research Institute|Stephen Teach, MD, MPH|202 476 5134|steach@childrensnational.org|
22267600|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22267601|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22267602|NCT02933255|National Cancer Institute|Dr. James L. Gulley|301-480-716|gulleyj@mail.nih.gov|
22267603|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu|
22267604|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu|
22267605|NCT02215967|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22267606|NCT03207867|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22267607|NCT02603146|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22267608|NCT05221320|Biomed Valley Discoveries|Deborah Knoerzer, Director Translational Sciences|6368876429|dknoerzer@biomed-valley.com|
22267609|NCT06473519|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22267611|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu|
22267612|NCT03729596|MacroGenics, Inc.|Stephen L. Eck, MD|301-251-5172|info@macrogenics.com|
22267613|NCT03713593|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22267614|NCT05849259|Massachusetts General Hospital|Dr. Christine S Ritchie|415-672-1780|csritchie@mgh.harvard.edu|
22267615|NCT03560037|University of California Davis|Christopher L. Bowlus, MD|916-734-8851|clbowlus@health.ucdavis.edu|
22267616|NCT03620708|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
22267617|NCT02498613|Yale School of Medicine|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
22267618|NCT05126693|KU Leuven|Prof. dr. Kaat Desloovere|+32 486 40 13 73|kaat.desloovere@kuleuven.be|
22267619|NCT04761926|Oticon Medical|Nicole Amichetti, PhD|6093660424|nitc@oticonmedical.com|
22267620|NCT01013077|Southern California College of Optometry|William Ridder|714-449-7494|wridder@scco.edu|
22267621|NCT03631199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22267622|NCT03690388|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22267623|NCT03041311|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22267624|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322517|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
22322518|NCT06488157|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
22267625|NCT01720225|The University of Texas MD Anderson Cancer Center|Elias Joseph MD./Professor|713-792-4764|ejabbour@mdanderson.org|
22277663|NCT02777190|Penn State Milton S. Hershey Medical Center|Dr. Jaimey Pauli|717-531-8142|jpauli@pennstatehealth.psu.edu|5
22277664|NCT01452789|Thomas Jefferson University|Walter Kraft|215 955 9077|walter.kraft@jefferson.edu|
22277665|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
22277666|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu|
22277667|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp|
22322519|NCT03365778|Wills Eye Hospital|Clinical Research Coordinator|215-928-3213|jtran@willseye.org|
22322520|NCT03033875|Emory University|Dr. Kenneth Hepburn|404-712-9286|khepbur@emory.edu|
22322521|NCT03595553|Summit Therapeutics|Katie Tran|408 677 6503|Katie.Tran@Summitplc.com|
22322522|NCT03467958|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22322523|NCT02286947|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
22322524|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
22277668|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22277669|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000||
22277670|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu|
22295698|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295699|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com|
22295700|NCT02259582|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
22295701|NCT01969240|Mayo Clinic|Dr. Erik Hess|507-284-7221|hess.erik@mayo.edu|
22295702|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496|lifezig@photozig.com|3
22295703|NCT02653391|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22295704|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295705|NCT02452346|Weill Cornell Medicine|Dr. Sangmin Lee, MD|646-962-2700|sal9053@med.cornell.edu|
22295706|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu|
22295707|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300||
22295708|NCT03263442|University of North Carolina - Chapel Hill|Zev Nakamura|984-974-3829|zev_nakamura@med.unc.edu|
22295709|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088||
22295710|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295711|NCT05584176|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
22295712|NCT03635957|Horizon Therapeutics Ireland DAC|Paul Peloso, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22295713|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295714|NCT00826020|University of Nebraska Medical Center|David Mercer|402-559-6955|dmercer@unmc.edu|
22295715|NCT01525550|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295716|NCT02493608|Texas Tech Health Sciences Center|Chadley Copeland|8067434752|chadley.copeland@ttuhsc.edu|
22295717|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
22277671|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22295718|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu|
22295719|NCT01141907|Johns Hopkins University|Dr. Cheryl Dennison|443-287-4174|cdennis4@jhu.edu|
22295720|NCT04585022|Copenhagen University Hospital Hvidovre, Orthopaedic Department|MD Peter Nyby Hersnaes|+45 40104845|pnhersnaes@gmail.com|
22277672|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu|
22277673|NCT04000724|Friends Research Institute, Inc.|Cathy Reback|3234631601|reback@friendsresearch.org|
22277674|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567|cawoods@uwaterloo.ca|36547
22277675|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu|
22277676|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
22277677|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22277678|NCT01905267|University of Illinois at Chicago|Rachel Jacobs|3124139178|rjacobs@psych.uic.edu|312
22277679|NCT03438656|University of Washington|Assistant Professor|414-331-4871|jennessj@uw.edu|
22277680|NCT03335566|GE Healthcare|Francois Tranquart, M.D, PhD|011-44-1494-543037|francois.tranquart@ge.com|
22295721|NCT03045887|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295722|NCT03414424|Bronx VA Medical Center|Noam Y. Harel|718-584-9000|Noam.harel@va.gov|1742
22295723|NCT01846507|Nationwide Children's Hospital|Sarah O'Brien, MD|614-722-3070|sarah.obrien@nationwidechildrens.org|
22295724|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu|
22295725|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
22322525|NCT04520113|Johns Hopkins Bloomberg School of Public Health|Dr. Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
22322526|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322527|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
22322528|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu|
22322529|NCT03551743|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22295726|NCT02536196|Keystone Heart|Pauliina Margolis - CMO|813.530.8200|pauliina.margolis@keystoneheart.com|
22295727|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22322530|NCT02317562|LFB|Clinical Information Desk|0033169827010|supportqcm@lfb.fr|
22322531|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com|
22309320|NCT05373862|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22267626|NCT02604407|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22267627|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
22267628|NCT04019626|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
22267629|NCT02964312|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22267630|NCT02779166|Northwestern Univeristy Department of Orthopaedic Surgery|Dr. Michael Terry|312-926-4444||
22267631|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267632|NCT02969421|Duke University Medical Center|Tashima Lambert, MD|484-201-9332|dr.tlambert@gmail.com|
22267633|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu|
22267634|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov|
22267635|NCT03280264|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
22267636|NCT05273411|University of British Columbia|Jonathan Little, PhD|2508079876|jonathan.little@ubc.ca|
22267637|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu|
22267638|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267639|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org|
22267640|NCT02738138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22267641|NCT03127514|Amylyx Pharmaceuticals|Amylyx Pharmaceuticals, Head of Clinical R&D|(617) 682-0917|medinfo@amylyx.com|
22267642|NCT00295893|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22267643|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22267644|NCT02665221|MS Comprehensive Care Center NYU Langone Health|Shannon Haas|646 501 7504|Shannon.Haas@nyumc.org|
22267645|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000|kristin.phillips3@va.gov|6721
22267646|NCT05024747|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22267647|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com|
22267648|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300||
22267649|NCT01960257|University of California, San Diego|Dr. Sara H. Browne|619 543 8080|shbrowne@health.ucsd.edu|
22309321|NCT04059484|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22309322|NCT04292223|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22309323|NCT00753545|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22309324|NCT05453773|Ohio State University Comprehensive Cancer Center|Marielle Brinkman|614-688-3226|brinkman.224@osu.edu|
22309325|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov|
22309326|NCT02485938|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
22309327|NCT03839940|Mayo Clinic|Dr. Kathryn J. Ruddy|507-293-1732|ruddy.kathryn@mayo.edu|
22309328|NCT00470704|Dana-Farber Cancer Institute|Nancy Lin|6176322335|Nancy_Lin@dfci.harvard.edu|
22309329|NCT05210608|University of Colorado-Boulder|Anahi Collado, Assistant Research Professor|3037354140|anco7407@colorado.edu|
22309330|NCT04963270|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22309331|NCT04802967|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22309332|NCT01857245|Prisma Health|Dr. Claire Stam - Director, Addiction Medicine Center|(864) 979-6749|claire.stam@prismahealth.org|
22267650|NCT01942993|Icahn School of Medicine at Mount Sinai|Dr. Philip A Friedlander|212-824-8584|philip.friedlander@mssm.edu|
22267651|NCT02143128|Dept of Anaesthesia and Intensive Care, Akershus University Hospital, Norway|Dr Vladimir Kuklin|98838024|vkuklin@me.com|0047
22267652|NCT02906670|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
22267653|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu|
22267654|NCT03749330|Children's Hospital of Philadelphia|Jennifer Walter, MD, PhD, MS Associate Professor of Pediatrics|215-590-1000|walterj1@chop.edu|
22267655|NCT02038010|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
22267656|NCT05027308|Takeda|Study Director|1-877-825-3327|TrialDisclosures@takeda.com|
22309333|NCT03122847|Aarhus University Hospital|Dr. Torben Harsløf|+4578455470|torbhars@rm.dk|
22277681|NCT04223687|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
22277682|NCT04217057|Washington University School of Medicine|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
22277683|NCT02945046|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22322532|NCT03434977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22277684|NCT02468700|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22277685|NCT03907579|Dartmouth-Hitchcock Norris Cotton Cancer Center|Director of Community Education and Prevention|603-653-9960|nccc.community.outreach@dartmouth.edu|
22277686|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
22277687|NCT03319654|Antwerp University Hospital, Belgium|Dr. Alessa Sugihara|00328213684|alessa.sugihara@uza.be|
22277688|NCT03259308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22277689|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu|
22277690|NCT01807104|VOA Research Foundation|Dr. William P. Barrett, MD|425-656-5060|wpbarrett@comcast.net|3063
22277691|NCT03389750|New York State Psychiatric Institute|Jermaine Jones|646 774-6113|jermaine.jones@nyspi.columbia.edu|
22277692|NCT04902144|University of Washington|Dr. Marianne Dubard-Gault|206-606-6990|mdg2019@uw.edu|
22277693|NCT03361072|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
22277694|NCT06868667|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22277695|NCT04857281|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22322533|NCT01145066|Wake Forest University Health Sciences|Dr. Michael Seeds|3367169811|mseeds@wakehealth.edu|
22322534|NCT03920670|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22322535|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org|
22322536|NCT02363478|"Academic Department of Gastroenterology, LAIKON General Hospital"|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk|
22322537|NCT00930059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322538|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu|
22322539|NCT03303911|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22322540|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322541|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22322542|NCT03064763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22322543|NCT02594644|UC Davis Department of Dermatology|Tatyana Petukhova MD||tpetukhova@ucdavis.edu|
22322544|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu|
22322545|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca|
22322546|NCT01815229|Washington University School of Medicine|Dr. Carlos Puyo|314-747-1709|cpuyo@wustl.edu|
22277696|NCT01251965|The University of Texas (UT) MD Anderson Cancer Center|Srdan Verstovsek, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22277697|NCT01027754|Albert Einstein College of Medicine/Montefiore Medical Center|Dr. Shadi Nahvi|718 920 5379|SNAHVI@montefiore.org|
22277698|NCT02529488|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22277699|NCT05033561|FIDEC Corporation|Ricardo Rüttimann|+5491161188536|rruttimann@fidec-online.org|
22322547|NCT04033367|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322548|NCT02723201|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
22322549|NCT03193398|BlackThorn Therapeutics, Inc.|Jane Tiller, MD; Study Director|(415) 548-5313|jane.tiller@blackthornrx.com|
22322550|NCT02415712|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22322551|NCT03005054|Mallinckrodt|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
22322552|NCT01537211|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22322553|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com|
22322554|NCT01394705|Boston Children's Hospial|Tracy Curran|617355-5445|tracy.curran@cardio.chboston.org|
22322555|NCT01573273|MUSC|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
22322556|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com|
22322557|NCT01757717|Memorial Sloan Kettering Cancer Center|Josh Yamada, MD|212-639-2950|yamadaj@mskcc.org|
22322558|NCT02624492|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322559|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555||
22267657|NCT02144714|Samsung Bioepis|Samsung Bioepis|+82 31 8061 4534|sbregistry@samsung.com|
22267658|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz|
22267659|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267660|NCT03908125|Senseonics, Inc.|Sr. Director of Clinical Operations|301-407-2946|Kathleen.Davis@senseonics.com|
22267661|NCT02262325|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
22267662|NCT02815995|The University of Texas MD Anderson Cancer Center|Dr. Neeta Somaiah|(713) 792-3626|nsomaiah@mdanderson.org|
22267663|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu|
22267664|NCT01288807|UCSD|Tobias Moeller-Bertram (PI)|7603211315|moellerbertram@yahoo.com|
22267665|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22322560|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
22322561|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22322562|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com|
22322563|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22322564|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com|
22322565|NCT02082678|UT Southwestern|E. Sherwood Brown. MD, PhD, MBA|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
22322566|NCT02882633|University of Pennsylvania|Ignacio Badiola|215-893-7251|Ignacio.Badiola@uphs.upenn.edu|
22322567|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22322568|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
22322569|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
22322570|NCT01920711|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22322571|NCT03891901|Emory University|Dr. Cynthia Giver|404-778-5806|cgiver@emory.edu|
22322572|NCT03436615|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
22322573|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu|
22322574|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
22322575|NCT04949841|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22322576|NCT04820309|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22322577|NCT06033079|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
22322578|NCT03430921|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22322579|NCT04202679|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322580|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322581|NCT03864653|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D. [Research Scientist]|(323) 463-1601|jfletcher@friendsresearch.org|126
22322582|NCT01984268|Dartmouth-Hitchcock Medical Center|Director, Office of Research Operations|(603) 650-6340|Barbara.A.Moskalenko@hitchcock.org|
22322583|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22322584|NCT00898560|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22322585|NCT01327157|Master-Pos graduação em Otorrinolaringologia|Dra Rosana de Queiroz Costa|55___11___98579-8799|rosanaqueiroz@msn.com|
22322586|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net|
22322587|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com|
22267666|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22267667|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu|
22267668|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
22267669|NCT03852537|Mayo Clinic|Hemang Yadav, MBBS, MS|507-266-3958|Yadav.Hemang@mayo.edu|
22267670|NCT05534061|University of Oregon|Anne Marie Mauricio, PhD|602-920-7459|amariem@uoregon.edu|
22267671|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22267672|NCT02673775|Rutgers, the State University of New Jersey|Andrew Gow, PhD|848-445-4612|gow@pharmacy.rutgers.edu|
22267673|NCT02016183|Takeda|Medical Director|1-877-825-3327|trialdisclosures@takeda.com|
22267674|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22267675|NCT01776632|San Diego State University|Elva Arredondo|(619) 594-3481|earredon@sdsu.edu|
22267676|NCT02286843|Memorial Sloan Kettering Cancer Center|Dr. Gary Ulaner, MD, PhD|212-639-7373|carrasj1@mskcc.org|
22267677|NCT02536846|McLean Hospital|Dr. Dost Öngür|617-855-3922|dongur@partners.org|
22267678|NCT04388553|Tuen Mun Hospital|Anyon Chan|24680000|Ca663@ha.org.hk|+852
22267679|NCT04604795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22267680|NCT02864355|The Medical University of South Carolina|George Guldan, MD|843-876-5744|guldan@musc.edu|
22267681|NCT02716727|University of North Carolina at Chapel Hill|Sumitha Ahmed, DDS|919-537-3946|sumitha_ahmed@unc.edu|
22267682|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22267683|NCT00839254|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267684|NCT04597632|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22267685|NCT01823835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22322588|NCT00429585|Boston Medical Center|Paul Tornetta, MD|617-414-6295|paul.tornetta@bmc.org|
22322589|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322590|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000|jeremy.rietschel@va.gov|3233
22322591|NCT03376477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Syed Abbas Ali, MD- Assistant Professor- Division of Hematologic Malignancies|4432877104|sali35@jhmi.edu|
22322592|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu|
22267686|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
22267687|NCT04895982|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
22267688|NCT02213289|University of Chicago|Daniel Catenacci, MD|2-1000|dcatenac@bsd.uchicago.edu|
22267689|NCT02687529|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22267690|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu|
22267691|NCT06075277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22267692|NCT05355532|Privolzhsky Research Medical University|Ilya Pochinka, MD|+79030561932|pochinka4@yandex.ru|
22267693|NCT03325101|Mayo Clinic|Matthew Block, MD, PhD|507-266-7446|Block.Matthew@mayo.edu|
22267694|NCT03184571|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
22277700|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu|
22267695|NCT05579782|Medical College of Wisconsin|Tracy Wang, MD|414-955-1459|tswang@mcw.edu|
22267696|NCT03300817|Mayo Clinic|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
22267697|NCT03122730|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
22277701|NCT03453515|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
22277702|NCT01557244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277703|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277704|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov|
22277705|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277706|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org|
22277707|NCT01897896|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22277708|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
22277709|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22277710|NCT00548691|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22277711|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com|
22277712|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22267698|NCT05061134|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22267699|NCT03999996|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22267700|NCT03765788|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22267701|NCT00001521|Clinical Center|Merke, Deborah|+1 301 496 0718|dmerke@nih.gov|
22277713|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org|
22277714|NCT02180672|The Children's Hospital of Philadelphia|Ignacio Tapia, MD, Principal Investigator, Associate Professor|(267) 426-5842|tapia@chop.edu|
22277715|NCT03777176|Zealand Pharma|Sune Birch|+45 5060 3864|SBirch@zealandpharma.com|
22277716|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22277717|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
22277718|NCT03850431|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|5032208262|alan.teo@va.gov|52461
22277719|NCT04046952|Long Beach VA Healthcare System|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|12876
22295728|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu|
22295729|NCT01585194|MD Anderson Cancer Center|Dr. Sapna P. Patel/Associate Professor, Melanoma Medical Oncology|713-792-2921|sppatel@mdanderson.org|
22295730|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu|
22295731|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22295732|NCT04446377|AI Therapeutics|Peter R. Young/Chief Scientific Officer|203-458-7100|pyoung@ai-thera.com|
22295733|NCT01733407|Massachusetts General Hospital|Dr. Florian Eichler|617-643-3799|Feichler@partners.org|
22295734|NCT04903626|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22295735|NCT02642952|Ramón y Cajal University Hospital|Dr. Andrés Reyes Valdivia|0034 629586239|cauzaza@hotmail.com|
22295736|NCT06112756|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22295737|NCT03060629|Janssen Vaccines & Prevention B.V|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22295738|NCT01862874|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295739|NCT03681405|Wake Forest Baptist Comprehensive Cancer Center|Meg O'Mara|336-716-9055|megreen@wakehealth.edu|
22322593|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com|
22322594|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
22267702|NCT03176134|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22267703|NCT03915652|Brigham and Women's Hospital|Dr. Candace Feldman|6175251035|cfeldman@bwh.harvard.edu|
22267704|NCT05736861|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22267705|NCT03410056|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22295740|NCT05740644|Zynex Monitoring Solutions|Clinical Team|888-386-4185|clinical@zynexmonitoring.com|
22295741|NCT02056340|Beth Israel Deaconess Medical Center|Dr Maureeen Chase, Assistant professor of Emergency Medicine|6177542298|mchase1@bidmc.harvard.edu|
22295742|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22295743|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22295744|NCT01031069|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295745|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se|
22277720|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu|
22295746|NCT05286281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295747|NCT03578367|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22295748|NCT01705288|Masonic Cancer Center at University of Minnesota|Dr. Peter Argenta|612-626-6283|argenta@umn.edu|
22295749|NCT02835274|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
22295750|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr|
22295751|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu|
22295752|NCT00587561|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|2039325711|joanna.fiszdon@va.gov|2231
22295753|NCT05661942|Advocate Health|Michael Cirone, MD|7086841710|michael.cirone@aah.org|
22295754|NCT02960776|Columbia University Irving Medical Center|Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
22295755|NCT03274687|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22295756|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com|
22295757|NCT01572909|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22295758|NCT01199289|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22295759|NCT02636868|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9477|psimmons@windtreetx.com|
22295760|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu|
22295761|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu|
22295762|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673|AStein@coh.org|82405
22295763|NCT03626714|Auritec|Sarjan Shah|9092109715|sshah@auritecpharma.com|
22295764|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
22295765|NCT03182829|DOASENSE GmbH|Harenberg, Job Prof Dr.|+496221825|j.harenberg@doasense.de|9785
22295766|NCT03316131|AstraZeneca RD, Gothenburg|Fredrik Erlandsson|1-877-240-9479|information.center@astrazeneca.com|
22295767|NCT02664441|Seattle Children's Hospital|Christian L. Roth, MD|206-987-5428|christian.roth@seattlechildrens.org|
22295768|NCT02560584|Regional Hospitals & Family Health Centers|Dr. J. Stephen Jones|+1-216-442-5060|joness7@cff.org|
22295769|NCT05608005|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22295770|NCT03518073|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22295771|NCT03045081|University of Washington|Dale J. Langford, PhD; Research Assistant Professor|2066160158|dalejwl@uw.edu|
22295772|NCT03804879|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22295773|NCT02436889|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
22295774|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22295775|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295776|NCT02169739|University of California Los Angeles|Latisha Sharma, MD|310-794-6379|lali@mednet.ucla.edu|
22295777|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com|
22295778|NCT03683758|Mountain Health and Performance|Dr. Matthew Wentzell|6043566986|drwentzell@mountainhp.ca|
22295779|NCT05584644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295780|NCT00303498|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295781|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22295782|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu|
22295783|NCT04984993|Futura Medical Development Ltd.|Andrew Graham, Senior Clinical Project Manager|+44 1483 685682|Andy.Graham@futuramedical.com|
22295784|NCT01110707|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22295785|NCT00159250|Imperial College London|Francesco Muntoni|+44 02075941872|f.muntoni@ucl.ac.uk|
22295786|NCT03179995|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22295787|NCT03108027|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22295788|NCT02426892|UT MD Anderson Cancer Center|Dr. Renata Ferrarotto,MD, Associate Professor, Thoracic-Head & Neck Med Onc|(713) 745-6774|rferrarotto@mdanderson.org|
22295789|NCT03178773|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
22295790|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org|
22295791|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org|
22295792|NCT04458909|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22309334|NCT03560609|NYU Langone Health|Jamika Singleton-Garvin|(212) 263-2573|jamika.singleton-garvin@nyulangone.org|
22309335|NCT04636528|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
22309336|NCT05540665|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22309337|NCT03462030|Johns Hopkins University|Dr. Robert Wood|410-955-5883|rwood@jhmi.edu|
22309338|NCT03381196|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309339|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com|
22309340|NCT03371381|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309341|NCT04098263|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
22309342|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com|
22309343|NCT05780437|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22309344|NCT03309306|Department of Agricultural, Environmental & Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
22277721|NCT03760640|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22277722|NCT05463705|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@mgb.org|
22309345|NCT03461276|Araclon Biotech, S.L.|Maria Pascual Lucas|+34976796562|mpascual@araclon.com|
22277723|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org|
22277724|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu|
22309346|NCT05530603|University of South Dakota|Soonhee Roh|6053571593|Soonhee.Roh@usd.edu|
22309347|NCT02619994|Seoul National University|Dr. Prof. JJ Yim|82-02-1588-5700|yimjj@snu.ac.kr|
22309348|NCT02043678|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22309349|NCT04406623|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22309350|NCT05827094|University of Washington School of Nursing|Associate Professor|2068493301|ozasl@uw.edu|
22309351|NCT04307355|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|najafi.bijan@gmail.com|
22309352|NCT04065841|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22309353|NCT03298477|Endologix LLC|Tammy Stiver, Manager, Clinical Affairs|+15136731452|tstiver@endologix.com|
22309354|NCT02809443|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
22277725|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343||
22309355|NCT01420237|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|Kevin.Barga@stryker.com|
22309356|NCT05269667|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22277726|NCT03596983|NYU Langone Health|Susan Malone, PhD, RN|212 992-7047|Susan.Malone@nyulangone.org|
22277727|NCT03071965|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22277728|NCT02346370|Halozyme, Inc.|Halozyme Study Information|1-844-855-4256|medinfo@halozyme.com|
22277729|NCT06399471|Georgia Institute of Technology|Kinsey Herrin, MSPO, C/LPO, FAAOP, Senior Research Scientist|470-578-7600|kinsey.herrin@gatech.edu|
22277730|NCT02662582|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22277731|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu|
22277732|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu|
22277733|NCT00965991|University of New Mexico|Lisa Moore|5052727028|hkhawaja@salud.unm.edu|
22277734|NCT01362270|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|underwos@ohsu.edu|
22277735|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277736|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22277737|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300||
22277738|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277739|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com|
22277740|NCT03063164|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22277741|NCT03733483|University of Colorado, Anschutz Medical Campus|Christine Swanson, MD, MCR, Assistant Professor|(303)724-0073|christine.swanson@cuanschutz.edu|
22277742|NCT01928576|Johns Hopkins|Amber Michalik|667-306-8336|amichal2@jhmi.edu|
22277743|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277744|NCT01927861|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22277745|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277746|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22277747|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com|
22277748|NCT02191397|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277749|NCT03124602|Masimo|Tala Harake|9492977459|studies@masimo.com|
22277750|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca|
22277751|NCT03856177|University of New Mexico|Dr. James F. Cavanagh|4158670303|jcavanagh@unm.edu|
22277752|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu|
22277753|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk|
22309357|NCT03768505|MEI Pharma|Richard Ghalie, MD CMO|858 898 0956|rghalie@meipharma.com|
22309358|NCT05022329|University Health Network|Kevin Yau|416 480 4592|Kevin.Yau@uhn.ca|
22309359|NCT05246280|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
22309360|NCT02861300|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. David Bajor|(216) 286-4414|david.bajor@uhhospitals.org|
22309361|NCT05038878|Icahn School of Medicine at Mount Sinai|Dr. Alice C. Levine|(212) 241-3422|alice.levine@mountsinai.org|
22309362|NCT05459857|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
22309363|NCT03133546|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
22295793|NCT00268996|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277754|NCT03888482|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22277755|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277756|NCT00846482|Montefiore Medical Center|Dr. Sanjay Goel|718-405-8404|sgoel@montefiore.org|
22277757|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22277758|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22277759|NCT02402036|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
22277760|NCT01312675|B. Braun Medical Inc.|Dr. Diana Velencia, Associate Director of Clinical Affairs|610-596-2875|diana.valencia@bbraunusa.com|
22277761|NCT04679818|Cleveland Clinic|Kurt Ruetzler|216 636-0561|ruetzlk@ccf.org|
22277762|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22295794|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
22295795|NCT02545101|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
22295796|NCT03325075|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22295797|NCT00422591|UT MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD|713-792-7734|CR_Study_Registration@mdanderson.org|
22295798|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu|
22295799|NCT02455531|Carelon Research|Dr. Felicia Trachtenberg|Felicia.Trachtenberg@carelon.c|Felicia.Trachtenberg@carelon.com|
22295800|NCT01414075|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22295801|NCT03847233|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
22295802|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu|
22295803|NCT01064713|University of Texas (UT) MD Anderson Cancer Center|Agop Y. Bedikian, MD/Professor||CR_Study_Registration@mdanderson.org|
22295804|NCT03498300|Faculty of Medicine Siriraj Hospital, Mahidol University|Dr. Nalat Sompagdee|+6687-008-7100|pear_nalat@hotmail.com|
22295805|NCT04851314|UC Irvine Health|Dr. Robert Ryan Field|7145065703|fieldr@uci.edu|
22295806|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22295807|NCT03266094|Medtronic|Melody LaBeau, Director of Clinical Operations|763.526.2931|melody.a.labeau@medtronic.com|
22295808|NCT00147199|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22295809|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
22295810|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22295811|NCT03241342|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22295812|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca|
22295813|NCT01537029|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
22295814|NCT03036072|Maine Medical Center|Alexa Craig, MD|207-396-6920|craiga@mmc.org|
22295815|NCT03334903|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177325500|wfitz@bwh.harvard.edu|
22295816|NCT04202354|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
22295817|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov|
22295818|NCT01024296|Stanford University|Bilal M Shafi, MD|(215) 738-0400|bmshafi@stanford.edu|
22295819|NCT03867981|The Miriam Hospital|Principal Investigator|401-793-8966|junick@lifespan.org|
22295820|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295821|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295822|NCT01706003|UT Southwestern Medical Center|Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology|2146483517|Deborah.Friedman@utsouthwestern.edu|
22295823|NCT02261714|Targovax ASA|Chief Medical Officer|004721398810|contact@targovax.com|
22295824|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22295825|NCT03480750|National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University|Dr. Yu-Fang Huang|886 6 2353535|yufangh@mail.ncku.edu.tw|5221
22295826|NCT03889158|University of Illinois at Chicago|Dr. Elizabeth Lefferts|312-996-9607|eschro7@uic.edu|
22295827|NCT03040466|UCSF|Dr. Thomas Chi|415-476-1611|tom.chi@ucsf.edu;manint.usawachintachit@ucsf.edu|
22295828|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu|
22295829|NCT00453921|Dartmouth Hitchcock Medical Center|Dr. Laura Flashman|6036505824|Laura.A.Flashman@hitchcock.org|
22295830|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22295831|NCT02232425|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
22295832|NCT03060447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22295833|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22309364|NCT02993159|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22277763|NCT02205359|CRM|Janelle van Wel|+3166 273 886 62|janelle.van.wel@medtronic.com|
22309365|NCT05034328|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
22309366|NCT04992520|PATH|Patricia Njuguna/Senior Medical Officer|+254 20 3877177|pnjuguna@path.org|
22277764|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
22309367|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309368|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22309369|NCT02268461|University of Minnesota|Kate Frost|612-626-4913|jahnke.k.131@gmail.com|
22309370|NCT05216315|University of Valencia|Dr Juan C Melendez|+34 963983844|melendez@uv.es|
22277765|NCT00480025|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277766|NCT03681093|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22277767|NCT04566510|UCSF|Dr. Grant Dorsey|628-206-4680|grant.dorsey@ucsf.edu|
22277768|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu|
22277769|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
22277770|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300||
22277771|NCT03635996|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
22277772|NCT02821000|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277773|NCT05058456|Shockwave Medical|Kavita Arjungi|1-510-279-4262|karjungi@shockwavemedical.com|
22277774|NCT02802865|University of Iowa|Dr. Rachel Mejia|319-356-3143|rachel-mejia@uiowa.edu|
22277775|NCT01862029|National Institute of Health, NHLBI, Laboratory of Obesity and Aging Research|Jay H. Chung, Ph.D, MD|301-496-3075|chungj@nhlbi.nih.gov|
22277776|NCT03931785|Ironwood Pharmaceuticals, Inc.|Wilmin Bartolini, Ph.D.|617.621.8314|wbartolini@ironwoodpharma.com|
22277777|NCT01832038|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22277778|NCT03810365|School of Nursing, University at Buffalo|Dr Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
22277779|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590||
22277780|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com|
22277781|NCT01585207|Icahn School of Medicine at Mount Sinai|Dr. Barbara J. Coffey|212-659-1663|Barbara.coffey@mssm.edu|
22277782|NCT02695771|Corewell Health|Dr. Brian Lane|616-267-7333|brian.lane@corewellhealth.org|
22277783|NCT03574389|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277784|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22277785|NCT05084885|Centre for Addiction and Mental Health|Dr. Nigel Turner|416-535-8501|nigel.turner@camh.ca|36063
22277786|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com|
22277787|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu|
22277788|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com|
22277789|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277790|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22277791|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277792|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
22277793|NCT04045145|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22277794|NCT02771145|Alcon, A Novartis Division|Sr. Clinical Project Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22277795|NCT00276380|Ipsen|Medical Director||clinical.trials@ipsen.com|
22277796|NCT03654326|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22277797|NCT05287685|Florida International University|Shayl Griffith, PhD|305-348-9891|shagriff@fiu.edu|
22277798|NCT04829214|Otonomy, Inc.|Medical Information|+1 844-686-4636|medinfo@otonomy.com|
22277799|NCT04008069|Stanford University, School of Medicine, Immunology & Rheumatology|Dr. Matthew C. Baker, Principal Investigator|650- 498-4528|mbake13@stanford.edu|
22277800|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22277801|NCT04543786|University of Pittsburgh|Lee Fisher|412-383-1329|lef44@pitt.edu|
22277802|NCT04601493|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
22277803|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22277804|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu|
22277805|NCT02965976|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22277806|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org|
22277807|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648||
22277808|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
22277809|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22277810|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277811|NCT01796470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22277812|NCT05370209|Circius Pharma AB|Maria Carlsson|+46 (0) 31-81 84 00|RAQA@circiuspharma.com|
22277813|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org|
22277814|NCT01378273|University of Washington|Sandra Juul MD, PhD|2062216814|sjuul@uw.edu|
22277815|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com|
22277816|NCT04818086|Virginia Commonwealth University|Dr. Frederick Gerald Moeller|804-828-4134|fgmoeller@vcu.edu|
22277817|NCT02882178|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
22277818|NCT04128228|Department of Psychiatry, Yale University School of Medicine|Dongju Seo|475-441-3457|dongju.seo@yale.edu|
22277819|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22277820|NCT03760666|Clear Creek Bio, Inc.|Vice President, Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
22277821|NCT02129556|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
22309371|NCT05808257|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|mantu.gupta@mountsinai.org|
22309372|NCT04568486|University of Kentucky|Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
22295834|NCT01601626|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22295835|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295836|NCT01230801|BioMarin Pharmaceutical Inc.|Manager, Clinical Operations|415-455-7448|Slava.Titov@bmrn.com|
22295837|NCT03318315|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@som.umaryland.edu|
22295838|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com|
22295839|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu|
22295840|NCT01930747|az sint jan brugge|jan mulier|0032486729203|jan.mulier@azsintjan.be|
22295841|NCT04249310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295842|NCT02617511|University of Manitoba|Dr. Stephen Cornish|204-474-9981|Stephen.Cornish@umanitoba.ca|
22295843|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com|
22295844|NCT04127331|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
22295845|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu|
22295846|NCT02457910|Vanderbilt University Medical Center|Vandana Abramson, MD|(615)936-8422|vandana.abramson@vumc.org|
22295847|NCT02994979|The New Jewish Home|Dr. Kenneth Boockvar|212-870-5062|kenneth.boockvar@mssm.edu|
22295848|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org|
22295849|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22295850|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22295851|NCT01267812|City of Hope|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
22295852|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22295853|NCT03445650|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22295854|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22295855|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
22295856|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu|
22295857|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us|
22295858|NCT00818662|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22295859|NCT03021265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295860|NCT01106898|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
22295861|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu|
22295862|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
22295863|NCT01846611|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22295864|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org|
22295865|NCT01614067|University of California, San Francisco|Mitchell Rosen, MD|415-353-7475||
22295866|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu|
22295867|NCT04049123|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@llilly.com|
22295868|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623||
22295869|NCT02671422|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22295870|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu|
22295871|NCT02111850|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
22295872|NCT03061331|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22295873|NCT02625259|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22295874|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu|
22295875|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
22295876|NCT04772755|Duke University|Emmanuel B Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
22295877|NCT00195676|Abbott|Global Medical Services|800-633-9110||
22295878|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net|
22295879|NCT03761147|Hebrew Univeristy|Anna Shaphir|+972 50 716 7309|shaphira@hadassah.org.il|
22295880|NCT04080297|Chief Exceutive Officer|Rob Crombie|+61 3 9657 0731|rcrombie@queoncology.com|
22295881|NCT02744391|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
22295882|NCT05838742|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295883|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295884|NCT03851302|Bronx Veterans Medical Research Foundation|Principal Investigator|718-584-9000 x1742|NOAM.HAREL@VA.GOV|
22295885|NCT02703909|University of Missouri - Columbia|Terri G. Monk, MD, Principal Investigator|(573)-882-2568|monkt@health.missouri.edu|
22295886|NCT03220217|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
22267706|NCT01250210|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22267707|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22309373|NCT04042233|Houston Methodist Hospital|Thomas Sullivan|2817254460|tsullivan@houstonmethodist.org|
22295887|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com|
22295888|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org|
22295889|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu|
22295890|NCT02355691|UNC Orthopaedics|Scott Eskildsen, MD|(919) 966-9166|seskilds@unch.unc.edu|
22309374|NCT03986931|University of Iowa|Dr. Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
22267708|NCT02762929|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22267709|NCT02656303|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22267710|NCT02871011|SaNOtize Research & Development Corp.|Dr Chris Miller|778-899-0607|chris@sanotize.com|
22267711|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au|
22267712|NCT04909853|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267713|NCT03397589|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
22267714|NCT03242408|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
22267715|NCT01783990|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
22267716|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862|gabrielle.saunders@va.gov|56210
22267717|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com|
22267718|NCT03718832|MIT Sloan School of Management|Joseph doyle|6174523761|jjdoyle@mit.edu|
22267719|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
22267720|NCT01996241|London School of Hygiene and Tropical Medicine|Dr Tara Beattie|0044 (0)2079272613|tara.beattie@lshtm.ac.uk|
22267721|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161|tclemons@emmes.com|10212
22267722|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu|
22267723|NCT04882241|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicalTrialsDisclosure@msd.com|
22267724|NCT02543944|University of Arkansas for Medical Sciences|Dr. Alison H. Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22267725|NCT03639779|University of Central Florida College of Medicine|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
22267726|NCT02932462|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22309375|NCT04907851|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
22309376|NCT05562401|UColima|Fabian Rojas Larios|3121206804|frojas@ucol.mx|
22309377|NCT00704262|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22309378|NCT05312008|Indiana University|Dr. Ann E.K. Kosobud|3172740087|akosobud@iu.edu|
22309379|NCT00324805|ECOG-ACRIN Statistical Center|Study Statistician|617-632-3012||
22309380|NCT05698875|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
22309381|NCT05792085|University of Pennsylvania|Lauren Eberly|2676244449|Lauren.Eberly@pennmedicine.upenn.edu|
22309382|NCT05757453|NXTech|Principal Investigator for Study 31380|7814721140|external+studyinvestigator@nxtech.co|
22309383|NCT03819153|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22309384|NCT04283149|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
22309385|NCT04898673|Cochlear Limited|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22309386|NCT04797897|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
22309387|NCT05966870|Indiana University|Nana Gletsu Miller|812-8557643|ngletsum@indiana.edu|
22267727|NCT02413229|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22267728|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com|
22267729|NCT04584684|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|847-702-0988|ljacox@live.unc.edu|
22267730|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu|
22267731|NCT02955212|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22267732|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu|
22267733|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262|james.henry@va.gov|57466
22267734|NCT02454933|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22267735|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599||
22267736|NCT04362670|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22267737|NCT02071225|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22267738|NCT04090125|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22267739|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22267740|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu|
22267741|NCT03440840|Nova Southeastern University|Raymond L Ownby, MD, PhD|954-262-1481|ro71@nova.edu|
22267742|NCT04720053|Mayo Clinic|Dr. Sanjeev Nanda|507-284-9919|GIMRESEARCHSTUDIES@Mayo.edu|
22267743|NCT03519087|The Ohio State University|Dr. Stephanie Di Stasi|614-685-9779|stephanie.distasi@osumc.edu|
22267744|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br|
22267745|NCT04805515|Rutgers Center for Tobacco Studies|Andrea Villanti|732 235 9585|andrea.villanti@rutgers.edu|
22267746|NCT04807400|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22267747|NCT04194645|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267748|NCT03656744|HighTide Therapeutics|Chief Medical Officer|314-791-0593|adibisceglie@hightidetx.com|
22267749|NCT03076775|University of North Carolina at Chapel Hill|Ashley Battarbee, MD, MSCR|205-975-2361|anbattarbee@uabmc.edu|
22277822|NCT03721367|Baylor College of Medicine|Dr. Lindsay Burrage|832-822-4280|burrage@bcm.edu|
22309388|NCT05778695|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
22267750|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22309389|NCT03058289|Intensity Therapeutics|Lewis Bender|2032217377|LBender@intensityTherapeutics.com|
22309390|NCT03128021|University of Pittsburgh|Rachel Berta|4128607406|goodra@upmc.edu|
22309391|NCT04731818|Eastern Virginia Medical School|Andrea Thurman MD, Principal Investigator|7574465808|thurmaar@evms.edu|
22309392|NCT04049643|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
22309393|NCT05623228|Private practice|Dr. Stavroula Rakitzi|6989766935|srakitzi@gmail.com|
22309394|NCT04752657|Framingham Heart Study, Boston University|Joanne M Murabito, MD ScM|508-935-3461|murabito@bu.edu|
22309395|NCT05123118|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
22267751|NCT00940316|Northwestern University|Dr. Al Benson|(312) 695-0184|albenson@nm.org|
22267752|NCT02290405|National Jewish Health|Bryan Simmons|303-398-1850|SimmonsB@NJHealth.org|
22267753|NCT00996489|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22267754|NCT03142191|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22267755|NCT03112473|Department of Rehabilitation Science, The Hong Kong Polytechnic University|Prof. Shamay Ng|27664889|shamay.ng@polyu.edu.hk|
22267756|NCT01130493|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|(908) 307-2234|Kaihong.Jiang@amneal.com|
22267757|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu|
22267758|NCT03541317|University of Michigan|Amy M Kilbourne|734-845-3452|amykilbo@umich.edu|
22267759|NCT00879086|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
22267760|NCT04728802|Applied Biology, Inc.|Dr. John McCoy|+1 (949)387-4526|johnm@appliedbiology.com|
22267761|NCT02517463|The University of Hong Kong|Dr. Raymond Li|+852 22553914|raymondli@hku.hk|
22267762|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com|
22267763|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22267764|NCT01590277|VA Connecticut Healthcare System|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@va.gov|2594
22267765|NCT04386616|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22267766|NCT01377012|Novartis|Study Director|862-778-8300||
22267767|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net|
22267768|NCT01958073|Kaiser Permanente San Diego|Dr. Kimberly Ferrante|6199801439|klf0409@gmail.com|
22309396|NCT04437615|Olympus Corporation|Jeremy Bolt, Global GI Lead|5085798495|jeremy.bolt@olympus.com|
22309397|NCT04828005|Opiant Pharmaceuticals|Clinical Director|+1 804 379 1090|PatientSafetyNA@Indivior.com|
22309398|NCT05456360|The University of Texas MD Anderson Cancer Center|Dr. Vijaya Gottumukkala|(713) 794-1398|vgottumukkala@mdanderson.org|
22309399|NCT02014649|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
22309400|NCT02675751|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan Ph.D.|+1 408-273-4081|skasthur@its.jnj.com|
22309401|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com|
22309402|NCT05260112|University of Pennsylvania|Lily Arya, MD|267-785-8024|larya@pennmedicine.upenn.edu|
22309403|NCT04341896|New York University|Rhiannon Reed|205-999-3360|rjd1125@uab.edu|
22309404|NCT02268253|Stemline Therapeutics, Inc.|Ira Gupta, MD|1-877-332-7967|clinicaltrials@menarinistemline.com|
22309405|NCT05714761|Icahn School of Medicine at Mount Sinai|Dr. Grenye O'Malley|212-241-7173|omallg01@mssm.edu|
22267769|NCT02972892|GE Healthcare|Research Program Integrator|262-290-6037|meghan.terry@ge.com|
22267770|NCT05022212|University of California, San Francisco|Dr Anke Hemmerling, Co-Investigator|4154765878|anke.hemmerling@ucsf.edu|
22267771|NCT02905032|Mayo Clinci|Peter A. Noseworthy, M.D.|507-255-2446|Noseworthy.Peter@mayo.edu|
22267772|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org|
22267773|NCT03503669|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
22267774|NCT04793711|Primus Pharmaceuticals, Inc.|Clinical Project Manager|4802506689|msanstead@primusrx.com|
22267775|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267776|NCT04182490|Lumen Bioscience, Inc.|Senior Medical Director|206-899-1904|trials@lumen.bio|
22267777|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com|
22267778|NCT01221207|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22267779|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22267780|NCT00074308|Abramson Cancer Center of the University of Pennsylvania|Jane Daly|215-662-2812|jane@mail.med.upenn.edu|
22267781|NCT00934024|MUSC|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
22267782|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu|
22267783|NCT04108299|NYU Langone Health|Lu Hu|646-501-3438|lu.hu@nyulangone.org|
22267784|NCT05262387|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22267785|NCT02045446|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214/645-7603|puneeth.iyengar@utsouthwestern.edu|
22267786|NCT05274178|Phonak Audiology Research Center|Principle Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
22267787|NCT02515331|Novartis Pharmaceuticals|Study Director|862-778-8300|novartisemail@novartis.com|
22267788|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300||
22267789|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu|
22267790|NCT00567008|UPenn|Jennifer Plebani|2152223200|jplebani@mail.med.upenn.edu|152
22267791|NCT00758524|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22267792|NCT04176250|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22267793|NCT04688671|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
22267794|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com|
22267795|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk|
22309406|NCT05672069|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
22322595|NCT03631706|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22322596|NCT03196180|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
22322597|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322598|NCT02554929|The Hospital for Sick Children|Dr. Suneeta Monga|416-813-8954|suneeta.monga@sickkids.ca|
22322599|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org|
22295891|NCT04396990|Vance Thompson Vision|Keeley Boever|6053613937|keeley.boever@vancethompsonvision.com|
22295892|NCT02880189|Mayo Clinic|Dr. Barham K. Abu Dayyeh|507-284-1825|AbuDayyeh.Barham@mayo.edu|
22295893|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295894|NCT02338960|AMAG Pharmaceuticals|Medical Information|1-877-411-2510||
22295895|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22295896|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu|
22295897|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
22295898|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300||
22295899|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net|
22295900|NCT02865187|Wright State University|Steven R Lindheim|858-740-1083|doclalalindheim@gmail.com|
22295901|NCT04267133|University of Rochester|Jean-Philippe Couderc, PhD|585-275-1096|heartjpc@heart.rochester.edu|
22295902|NCT02968563|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22295903|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
22295904|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
22295905|NCT05319795|University Health Network|Professor Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
22295906|NCT03566823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22295907|NCT01909479|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22295908|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22295909|NCT03557151|Nemours Children's Hospital, Delaware|Melissa A. Alderfer, Ph.D., Center Director & Principal Research Scientist|302-651-6522|melissa.alderfer@nemours.org|
22295910|NCT02810392|Wake Forest School of Medicine|Cheryl Bushnell, MD|336-713-2983|cbushnel@wakehealth.edu|
22295911|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22295912|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22295913|NCT03035409|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22295914|NCT00923598|University of California San Diego|Dr. Brian Ilfeld, Professor of Anesthesiology, In Residence|(858) 444-5949|bilfeld@ucsd.edu|
22295915|NCT03383198|Prisma Health|Dr. William R. Hand|864.522.3707|William.Hand@prismahealth.org|
22295916|NCT00927784|Mount Sinai School of Medicine|Deborah Ascheim, MD, Principal Investigator, Data Coordinating Center|212-659-9567|deborah.ascheim@mssm.edu|
22295917|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22295918|NCT06079320|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295919|NCT02196558|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22295920|NCT02947997|Massachusetts General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
22295921|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu|
22295922|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
22295923|NCT03128892|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22295924|NCT02727751|Ardelyx|Chief Development Officer|5107451752|drosenbaum@ardelyx.com|
22295925|NCT00368355|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
22295926|NCT04899921|Dana-Farber Cancer Institute|Senior Physician|6176326836|ann_silk@dfci.harvard.edu|
22295927|NCT04061915|New York University|S. Raquel Ramos|212-992-5994|TheHOTIEStudy@gmail.com|
22295928|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org|
22295929|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com|
22295930|NCT03473808|Medical University of South Carolina|Amanda Vatinno|8437924840|vatinno@musc.edu|
22295931|NCT01706081|Memorial Sloan Kettering Cancer Center|Dr. Ting Bao MD|646-888-0865|baot@mskcc.org|
22295932|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
22295933|NCT03715764|Region Västra Götaland, Närhälsan|PhD-student, Chan-Mei Ho-Henriksson|+46709892821|chan-mei.ho@vgregion.se|
22295934|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com|
22295935|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22295936|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org|
22322600|NCT04660643|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22322601|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|48517
22322602|NCT05162066|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22322603|NCT01220414|University of Wisconsin-Madison|Kelli F. Koltyn|608 262-4234|kelli.koltyn@wisc.edu|
22322604|NCT00445887|NRG Oncology|Linda Gedeon for James Kauderer, MA|716-845-1169|lgedeon@gogstats.org|
22267796|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov|
22267797|NCT03164538|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
22322605|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300||
22322606|NCT00623831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22322607|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com|
22322608|NCT00066690|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, Head Trial Activities/Deputy Director|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
22322609|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu|
22322610|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu|
22322611|NCT02939131|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22295937|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22295938|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
22295939|NCT02059057|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|kristi.winterfeldt@bsci.com|
22295940|NCT06092710|CAndreRenard|CEDRIC GARCION|+33661817274|cedric.garcion.osteo@gmail.com|
22295941|NCT05119569|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295942|NCT03909178|Massachusetts General Hospital|Dr. Scott Martin|(617) 726-7500|sdmartin@partners.org|
22295943|NCT02623439|University of California, San Diego|Michelle Padilla|(858) 822-5354|CancerCTO@health.ucsd.edu|
22295944|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org|
22295945|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200|nancy.ruiz@meda.us|2390
22295946|NCT02200445|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
22295947|NCT04484142|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22295948|NCT03700671|University of Central Lancashire|Stefan Birkett Lecturer in Exercise Science|01772 893325|sbirkett4@uclan.ac.uk|
22295949|NCT05371509|Mayo Clinic|Umesh Goswami, M.B.B.S., M.D.|480-342-1137|goswami.umesh@mayo.edu|
22295950|NCT01083368|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
22295951|NCT06253806|Washington University, Department of Otolaryngology - Head and Neck Surgery|Nyssa Farrell, MD|314-273-2490|nyssafarrell@wustl.edu|
22295952|NCT04405037|Cleveland Clinic Foundation|Dr. Scott Steele|216-444-4715|steeles3@ccf.org|
22295953|NCT04434092|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22295954|NCT02554812|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295955|NCT02879305|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295956|NCT03730948|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22295957|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
22295958|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
22295959|NCT03025542|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22267798|NCT02765256|University of Pennsylvania|Lindsey Albenberg, DO|267-426-0139|albenbergl@email.chop.edu|
22267799|NCT02263963|Spectrum Health|Dr. Nezar Jrebi|507-271-8284|jrebi.nezar@hotmail.com|
22267800|NCT03282916|Columbia University Irving Medical Center|Dr. Davangere P Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22267801|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu|
22267802|NCT03354598|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22267803|NCT05934396|University of North Carolina at Chapel Hill|Marisa Marraccini, PhD|919-843-5099|mmarracc@unc.edu|
22267804|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267805|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org|
22267806|NCT04912232|Dartmouth Health|Norman A. Paradis|(603) 650-7254|Norman.A.Paradis@hitchcock.org|
22295960|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22295961|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22295962|NCT04538066|Synaptogenix, Inc.|Chief Medical Officer|973 242-0005|atuchman@synaptogen.com|
22295963|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22295964|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca|
22295965|NCT02057198|Duke University Medical Center|Daniel Sexton, M.D.|919-684-4596|sexto002@mc.duke.edu|
22295966|NCT03878745|Becton Dickinson|Michael Gibney|201-847-6170|Michael.gibney@bd.com|
22295967|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22295968|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com|
22295969|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22295970|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
22295971|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu|
22295972|NCT00665353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22295973|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu|
22295974|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu|
22295975|NCT02632552|U.S. Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research (CHOIR)|Timothy P. Hogan, PhD,|508-244-2303|Timothy.Hogan@VA.gov|
22295976|NCT01516957|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
22295977|NCT02074631|University of Minnesota, Masonic Cancer Center|Dr. Kyriakie Sarafoglou|(612) 624-5965|saraf010@umn.edu|
22295978|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu|
22322612|NCT03569202|Finnsusp Ltd.|Dr. Jarmo Laihia, Manager of Clinical & Formulation Development|358 50 377 1212|jarmo.laihia@piiloset.fi|
22322613|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org|
22322614|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322615|NCT02450578|Medicines for Malaria Venture|Jörg Möhrle|+41 22 555 0330|moehrlej@mmv.org|
22322616|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com|
22322617|NCT02167945|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22322618|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322619|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322620|NCT02623335|University of Wisconsin, Madison|Gretchen Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
22322621|NCT01463098|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22322622|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22277823|NCT01800058|Hospital Universitario de La Princesa|Almudena Zapatero, MD PhD|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
22277824|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22277825|NCT03772340|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
22277826|NCT05330429|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22277827|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov|
22277828|NCT02931539|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22277829|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com|
22277830|NCT06097273|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22277831|NCT03020082|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
22277832|NCT03181009|The Sean N. Parker Center for Allergy and Asthma Research at Stanford University|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|650 - 521 - 7237|andresap@stanford.edu|
22277833|NCT02562040|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
22277834|NCT03435107|Academic Research Office, Clinical Trial Center, Asan Medical Center|Project manager|82-2-3010-7187|jiyun.an@amc.seoul.kr|
22277835|NCT04804709|Columbia University Irving Medical Center|Cheng-Chia Wu, MD, PhD|646-317-3033|cw2666@cumc.columbia.edu|
22277836|NCT04359680|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22277837|NCT02722330|ENT Department, Royal Hallamshire Hospital, Sheffield|Professor Jaydip Ray|+44 (0)114 271 1900|jaydip.Ray@sth.nhs.uk|
22277838|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22277839|NCT03142451|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22277840|NCT05333965|CooperVision|Jose A. Vega, OD, MSc, FAAO|9256213761|jvega2@coopervision.com|
22277841|NCT03048019|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
22277842|NCT01730729|Northwestern University|Cesar Santa-Maria, MD|312-695-6180|cancertrials@northwestern.edu|
22277843|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com|
22277844|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br|
22277845|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu|
22277846|NCT02595437|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22277847|NCT02925143|Herlev Hospital|Dr. Jakob Thomsen|004538683868|dr.j@demants.dk|
22277848|NCT01879826|University of California San Francisco|Cynthia Kim|(415)353-1328|cynthia.kim@ucsf.edu|
22295979|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu|
22295980|NCT02377466|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22295981|NCT00495170|UT MD Anderson Cancer Center|Dr. Joe Chang / Professor, Radiation Oncology Department|713-563-2337|jychang@mdanderson.org|
22295982|NCT04210310|NYU Langone Health - Preston Robert Tisch Center for Men's Health|Lawrence Newman, MD|646-754-2000|Lawrence.Newman@nyulangone.org|
22295983|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295984|NCT00697203|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22295985|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110||
22295986|NCT03063476|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vanderbilt.edu|
22295987|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22295988|NCT00598663|University Children's Hospital Vrazov trg 1 SI-1525 Ljubljana, Slovenia|Tadej Battelino|+386 1 522 50 50|tadej.battelino@mf.uni-lj.si|
22295989|NCT00732615|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22295990|NCT03254927|Celldex Therapeutics|Chief Medical Officer|844-723-9363|info@celldex.com|
22295991|NCT01341964|Population Health Reseach Institute, Hamilton, ON, Canada|Lynda Hill|905-297-3479|Lynda.Hill@phri.ca|40323
22295992|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22295993|NCT01516424|Shang Hai Mental health center|Dr.HuafangLi|13641625395|lhlh_5@163.com|
22322623|NCT01262976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322624|NCT01528787|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22322625|NCT03534427|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22322626|NCT04409873|University of California San Francisco|Dr. Stuart A. Gansky and Dr. Sepideh Banava|415-502-8094; 415-630-0094|stuart.gansky@ucsf.edu ; sepideh.banava@ucsf.edu|
22277849|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au|
22322627|NCT03433781|NYU Langone|Perla Arriola|347-630-0311|perla.arriola@nyulangone.org|
22322628|NCT02400255|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22322629|NCT02568046|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22322630|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322631|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com|
22322632|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322633|NCT03439033|Weill Cornell Medical College|Dr. Kritika Subramanian|212-746-6000|krs9089@nyp.org|
22322634|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22322635|NCT03261531|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
22322636|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
22322637|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
22322638|NCT03285243|Baylor college of Medicine|Adam Adler|832-8245800|Adam.adler@bcm.edu|
22322639|NCT03175549|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22322640|NCT02435849|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22277850|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu|
22277851|NCT02150863|Massachusetts General Hospital|Elizabeth Morehouse, Clinical Research Coordinator|617-724-2168|emorehouse@partners.org|
22277852|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu|
22277853|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22277854|NCT03492385|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
22277855|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753||
22277856|NCT02314247|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22277857|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu|
22277858|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se|
22277859|NCT02261532|Taiho Pharmaceutical co., ltd.|Clinical Trial Registration Contact|+81-3-3293-2113|toiawase@taiho.co.jp|
22277860|NCT01775410|Avinger, Inc.|Director of Clinical Trials|650 241 7030|tlawson@avinger.com|
22277861|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277862|NCT01340170|Dentsply Sirona Implants|Manager of Global Clinical Reseach|+46313763500|clinicalresearchmolndal@dentsplysirona.com|
22277863|NCT03878602|Ospedale Buon Consiglio Fatebenefratelli|Dr.Giuseppe De Bernardo|3357441303|pinodebtin@gmail.com|+39
22277864|NCT02633527|Supernus|Joseph Hull, PhD, Director Clinical Research|240-403-5324|jhull@supernus.com|
22277865|NCT06091956|Mayo Clinic|Aaron Mangold, M.D.|480-301-6169|Mangold.Aaron@mayo.edu|
22277866|NCT00742157|University of Nebraska Medical Center|Fedja Rochling, MD|402-559-3652|frochling@unmc.edu|
22277867|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590||
22277868|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277869|NCT01950039|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 2635|mary.elizabeth.patti@joslin.harvard.edu|
22277870|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277871|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor|713-792-2828|akaseb@mdanderson.org|
22277872|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu|
22277873|NCT02844075|Yonsei University|Byoung Chul Cho|+82 2 2228 4190|cbc1971@yuhs.ac|
22277874|NCT03163264|VA New York Harbor Manhattan|Dr. Melanie Jay|212-686-7500|melanie.jay@va.gov|5097
22277875|NCT02614066|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22277876|NCT04565756|Exonate|Loic Lhuillier|+44 (0)1223 734716|loic.lhuillier@exonate.com|
22277877|NCT04274218|US Department of Veterans Affairs|Matthew Major|3125035731|matthew.major2@va.gov|
22277878|NCT00968968|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22277879|NCT04401293|System Director - Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Affiliation: Northwell Health|Alex Spyropoulos, MD|(212) 434-6776|aspyropoul@northwell.edu|
22277880|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277881|NCT03679884|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
22277882|NCT03274661|Miami Cancer Institute at Baptist Health, Inc.|Dr. John Diaz, Principal Investigator|(786) 527-8284|johnpd@baptisthealth.net|
22277883|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com|
22309407|NCT05213390|Newcastle University|Prof Edward Meinert|191 208 6000|edward.meinert@newcastle.ac.uk|
22309408|NCT03333590|Abigail Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-355-2947|kevin.flanigan@nationwidechildrens.org|
22309409|NCT06238609|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22309410|NCT04997148|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22309411|NCT03031470|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22322641|NCT02486757|Massachusetts General Hospital|Dr. Natalie Shaw||natalie.shaw@nih.gov|
22277884|NCT00308282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22277885|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se|
22277886|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22277887|NCT03782103|Zurex Pharma|Andrew Morgan Exec. VP RA/QA Clinical|16082175239|amorgan1@charter.net|
22277888|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
22277889|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org|
22277890|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com|
22277891|NCT03315559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22277892|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277893|NCT03478787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22277894|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
22277895|NCT02792257|Johns Hopkins University|Dr. Paul Rosenberg|4105509883|prosenb9@jhmi.edu|
22277896|NCT02189629|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
22277897|NCT02766478|Emory University|Dr. Jessica Alvarez|404-727-1390|jessica.alvarez@emory.edu|
22277898|NCT01093573|Case Comprehensive Cancer Center|Brenda Cooper MD|(216) 844-3213|Brenda.cooper@uhhospitals.org|
22277899|NCT05626686|Coloplast|Zenia Størling, Senior Director of Clinical Strategies|+4549111869|dkzenst@coloplast.com|
22277900|NCT00682435|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22277901|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343||
22277902|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com|
22277903|NCT02946996|Medical University of South Carolina|Tricia Bentz CTO Administrative Director|8437921415|adraleta@musc.edu|
22277904|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu|
22277905|NCT03289741|Memorial Sloan Kettering Cancer Center|Dr. Nitya Raj, MD|646-888-4849|rajn@mskcc.org|
22277906|NCT04967417|Samsung Medical Center|Myung-Ju Ahn|+82-2-3410-3438|silkahn@skku.edu|
22277907|NCT02318979|Denver Research Institute|Judith Jung, DRI Executive Director|303-501-0540|Judith.Jung@dri-va.org|
22277908|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277909|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277910|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|713-792-2830|PHBrown@mdanderson.org|
22277911|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com|
22277912|NCT06896734|Eminence Clinical Research, Inc.|Nick Leppo|719-400-7464|nleppo@ecr-inc.com|
22277913|NCT05670756|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
22277914|NCT04681885|Sunstar Americas, Inc.|Toru Saito|1-847-794-4271|toru.saito@us.sunstar.com|
22277915|NCT03508440|University of Missouri|Rebecca Schneider, Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
22277916|NCT01197300|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22277917|NCT04526925|Rush University|Jie Li|3125634643|jie_li@rush.edu|
22277918|NCT02113878|Dana Farber Cancer Institute|Glenn J. Hanna, MD|617.632.6799|GJHanna@partners.org|
22277919|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22277920|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu|
22277921|NCT04565353|Behavior Change for Good initiative|Dr. Joseph Kay|2157466609|jskay@wharton.upenn.edu|
22277922|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk|
22277923|NCT02743312|San Francisco State University|Dr. Diane Allen|4153386837|ddallen@sfsu.edu|
22277924|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu|
22277925|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22277926|NCT03400787|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22277927|NCT03912805|Clinical Research Management Group|Patrick Murphy|(866) 337-1868|p.murphy@crmg-usa.com|
22277928|NCT02402907|Icahn School of Medicine at Mount Sinai|Dr. Joanne Stone|212-241-5681|joanne.stone@mssm.edu|
22277929|NCT02685436|Manicure university children hospital|Dr.Ahmed Zaki|0201008335567|drahmedmd17@yahoo.com|
22277930|NCT02837952|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277931|NCT01959919|Pfizer Clinical Trial.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrails.gov_Inquiries@Pfizer.com|
22277932|NCT03439072|Xeris Pharmaceuticals, Inc.|Martin J. Cummins|312-736-1624|mcummins@xerispharma.com|
22277933|NCT02923167|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@mgh.harvard.edu|
22277934|NCT02003898|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22277935|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com|
22277936|NCT03436420|Emory University|Miriam Vos, MD|404-727-9930|mvos@emory.edu|
22277937|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br|
22277938|NCT02605967|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22277939|NCT03627468|Botanix Pharmaceuticals|Anthony Robinson, MS, MBA, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22277940|NCT02134808|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
22277941|NCT01475825|Kastle Therapeutics, LLC|Medical Information|1-800-745-4447|medinfo@genzyme.com|
22277942|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
22277943|NCT01903733|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22277944|NCT04792970|Duke University Medical Center|Scott Shofer|(919) 668-2402|scott.shofer@duke.edu|
22277945|NCT03721107|4D pharma plc|Programme Development Director|+4401138950130|clinicaltrials@4dpharmaplc.com|
22277946|NCT02214628|Ophthotech Corp.|Keith Westby|732-824-7474|keith.westby@ophthotech.com|
22277947|NCT03000751|University of California San Francisco|Rebecca Smith-Bindman, MD|415-353-4946|rebecca.smith-bindman@ucsf.edu|
22277948|NCT02991859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309412|NCT01593917|Abbott Medical Devices, Structural Heart Divison|Clinical Scientist, Tissue Heart Valves|+1 651-756-2320|Roland.MaudeGriffin@Abbott.com|
22309413|NCT03435614|MUHC-RIMUHC|Marc Perreault|514-343-6111|marc.perreault@umontreal.ca|3788
22309414|NCT02852330|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
22309415|NCT02683447|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
22309416|NCT04663737|Senhwa Biosciences, Inc.|Kacy Huang, Director of Clinical Department|+886-2-8911-9856|kacyhuang@senhwabio.com|214
22309417|NCT04016662|Jaeb Center for Health Research|Robert Henderson|(813) 975-8690|Rhenderson@jaeb.org|
22309418|NCT03021096|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
22277949|NCT02268305|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22277950|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743||
22277951|NCT03888287|Hackensack Meridian Health|Hooman Azmi, MD|201-342-2550|hooman.azmi@hmhn.org|
22277952|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277953|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org|
22277954|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor|713-792-2573|mgroves@mdanderson.org|
22277955|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
22277956|NCT05094102|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS|(608) 262-2025|neuman@surgery.wisc.edu|
22277957|NCT05652140|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
22277958|NCT03375164|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
22277959|NCT02598973|Crescenz VA Medical Center|James Morley|215-823-5934|james.morley@va.gov|
22277960|NCT06048705|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22277961|NCT02413346|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22277962|NCT02403778|Univesity Colorado Ansshutz Medical Campus|Martin McCarter|303-724-2728|martin.mccarter@ucdenver.edu|
22322642|NCT02793232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322643|NCT04438174|University of Utah|Dr. Giavonni Lewis|801-581-3050|giavonni.lewis@hsc.utah.edu|
22322644|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org|
22277963|NCT02978508|Mayne Pharma LLC|Associate Director, Clinical Operations|919 573 7948|phoevos.hughes@maynepharma.com|
22277964|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
22277965|NCT02427672|Nanyang Technological University|Dr. Olivia Choy|(65)65921522|oliviachoy@ntu.edu.sg|
22277966|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
22277967|NCT02687165|New York State Psychiatric Institute|Alla Landa PhD|6467746717|AL2898@cumc.columbia.edu|
22277968|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com|
22277969|NCT04349098|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22277970|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca|
22277971|NCT04921800|Northwestern University|Shuai Xu|312-695-3721|stevexu@northwestern.edu|
22277972|NCT02151604|Oxford University Hospitals NHS Foundation Trust|Avianna Laws, Clinical Research Operations Manager|01865 (2)26221|avianna.laws@ouh.nhs.uk|
22295994|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org|
22277973|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300||
22277974|NCT01395537|Case Comprehensive Cancer Center|David Adelstein MD|216-444-9310|adelstd@ccf.org|
22295995|NCT01333059|Cook Children's Medical Center|Javier Gelvez, MD||Javier.Gelvez@cookchildrens.org|
22295996|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org|
22295997|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
22295998|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22295999|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu|
22296000|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com|
22296001|NCT02049957|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22296002|NCT04447755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22296003|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu|
22296004|NCT05392998|Clínica Rementería|Dr. Inés Contreras|34913083838|contreras@clinicarementeria.es|
22296005|NCT03721276|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
22296006|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp|
22277975|NCT04495478|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296007|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
22296008|NCT01340898|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296009|NCT04900220|West Virginia University|Dr. Shafic Sraj - Associate Professor|304-293-3007|shafic.sraj@hsc.wvu.edu|
22296010|NCT03428360|Aquestive Therapeutics|Clinical Project Manager|9089411896|cbuan@aquestive.com|
22296011|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296012|NCT00734903|VA BOSTON|Lisa Najavits, PhD|617-299-1620|lisa.najavits@va.gov; najavits@bu.edu|
22296013|NCT04868890|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
22296014|NCT04474704|The Ohio State University|Maged Costantine, MD|614-293-2222|Maged.Costantine@osumc.edu|
22296015|NCT02669433|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
22296016|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111|pcgriff@emory.edu|7138
22296017|NCT04570150|UCSD|Dr. Rodney Gabriel|6194710670|ragabriel@health.ucsd.edu|
22296018|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr|
22296019|NCT01850524|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22296020|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com|
22296021|NCT04059094|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22277976|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22322645|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
22322646|NCT03984305|Global Kinetics Corporation|Director of Clinical Affairs|612.240.2437|karen.krygier@globalkineticscorp.com|
22322647|NCT02883244|Sunstar Americas, Inc.|Senior Manager of R&D|8477944276|akane.takemura@us.sunstar.com|
22322648|NCT01099969|The University of Texas Health Science Center at Houston|Dr. Davide Cattano|713.500.6235|davide.cattano@uth.tmc.edu|
22322649|NCT03650192|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22322650|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu|
22322651|NCT03726164|University College London|Prof Derek Hausenloy|+6584053767|d.hausenloy@ucl.ac.uk|
22322652|NCT03979274|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22322653|NCT02301403|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22322654|NCT02302963|University of Virginia Center for Diabetes Technology|Director|434-924-5592|bpk2u@virginia.edu|
22322655|NCT03528512|William Beaumont Hospitals|Dr. Margaret Menoch|2489897289|margaret.menoch@beaumont.edu|
22322656|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com|
22322657|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca|
22322658|NCT03064841|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322659|NCT00573794|AbbVie|Global Medical Services|800-633-9110||
22322660|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org|
22322661|NCT00632853|Mayo Clinic|Dr. Steven Schild|480-301-9692|sschild@mayo.edu|
22322662|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu|
22296022|NCT03457129|University of Arizona, College of Medicine Phoenix|Stephanie Marsh, MPH, CCRC|602-255-7552|slmarsh@arizona.edu|
22296023|NCT03649750|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22296024|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22296025|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
22296026|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com|
22296027|NCT03195088|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296028|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com|
22296029|NCT06029673|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
22296030|NCT00180414|Boston Scientific|Jens Goetzke|+32 2 41|jens.goetzke@bsci.com|67011
22296031|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22296032|NCT01852942|University of Minnesota|Timothy Schacker, MD|612-626-6577|olso7966@umn.edu|
22296033|NCT02315755|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296034|NCT04693507|Antev Ltd|Carol MacLean|+447525177617|cmaclean@antev.co.uk|
22296035|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
22296036|NCT02642614|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296037|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22296038|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
22296039|NCT02366845|University of Colorado|Dr. Marc Moss|303-724-6080|marc.moss@cuanschutz.edu|
22296040|NCT04708886|Northwestern University Feinberg School of Medicine|Thomas Schnitzer|3125032315|tjs@northwestern.edu|
22296041|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu|
22296042|NCT01729754|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22296043|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22296044|NCT05022784|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296045|NCT03020407|Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+6626494000|kmusikatavorn@yahoo.com|83058
22296046|NCT02699554|University of Washington|Katherine Steele|206-685-2390|kmsteele@uw.edu|
22296047|NCT00788151|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
22296048|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296049|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
22296050|NCT01394523|Nationwide Children's Hospital|Tarun Bhalla, MD|6147224200|Tarun.Bhalla@nationwidechildrens.org|
22296051|NCT00594997|Brigham and Women's Hospital|Nancy Shadick|617-732-5266|nshadick@partners.org|
22296052|NCT00583804|MetroHealth Medical Center|Principal Investigator|2169573683|ue.fes.clinicaltrials@gmail.com|
22296053|NCT02389998|Boston Children's Hospital|Dr Samuel Nurko|6173556055|samuel.nurko@childrens.harvard.edu|
22296054|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu|
22296055|NCT04741074|Geisinger|Alexander Chang|570-271-8026|achang@geisinger.edu|
22322663|NCT01407094|University of Texas Southwestern Medical Center|Dr. Madhukar H. Trivedi|214-648-0188|madhukar.trivedi@UTSouthwestern.edu|
22322664|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
22322665|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu|
22277977|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296056|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
22296057|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22322666|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu|
22322667|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22322668|NCT04556617|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
22322669|NCT05165654|BIDMC|Dr. Paulo Lizano|202-776-6708|lizanopl@gmail.com|
22322670|NCT03512418|Brigham and Women's Hospital|Peter Chai|617-732-5640|pchai@bwh.harvard.edu|
22322671|NCT05902364|Alcon Research, LLC|Clinical Project Lead, Dry Eye|1-888-451-3937|alcon.medinfo@alcon.com|
22322672|NCT02270242|Icahn School of Medicine at Mount Sinai|Dr. Roxana Mehran|212-659-9691|roxana.mehran@mountsinai.org|
22322673|NCT01841333|University of Colorado|Dr. Daniel Pollyea|720-848-8084|DANIEL.POLLYEA@cuanschutz.edu|
22322674|NCT05442853|Malcom Randall VA Medical Center|Andrew J. Franck|3523761611|Andrew.Franck@va.gov|105771
22322675|NCT04024501|AstraZeneca|AstraZeneca information Centre|1-877-240-9479|information.center@astrazeneca.com|
22322676|NCT04187092|University of Virginia|Joe M Hart|434.243.0256|jmh3zf@virginia.edu|
22322677|NCT02707770|Imperial college healthcare NHS trust|vijay padmanaban|02033122349|vijay.padmanaban@nhs.net|
22322678|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
22322679|NCT03068325|New York State Psychiatric Institute|Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
22322680|NCT03720899|University of Alabama at Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uab.edu|
22322681|NCT01445535|National Cancer Institute|Dr. Wyndham Wilson|240-760-6092|wyndham_wilson@nih.gov|
22322682|NCT03216382|Ryerson University|Dr. Naomi Koerner|416-979-5000|naomi.koerner@ryerson.ca|ext. 5521
22322683|NCT05130008|Massachusetts General Hospital|Dr. Jocelyn Carter|617 724 9000|jcarter0@mgh.harvard.edu|
22322684|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
22322685|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800|rretnakaran@mtsinai.on.ca|3941
22322686|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322687|NCT00454779|Amgen Inc.|Study Director|866-572-6436||
22322688|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22322689|NCT01337973|VA Ann Arbor|Stephen Chermack, Ph.D.|734 845-5046|chermack@umich.edu|
22322690|NCT03634800|Weill Cornell Medicine|Dr. Himanshu Nagar|212-746-3704|hnagar@med.cornell.edu|
22296058|NCT00778700|Incyte Organization|Study Director|1-855-463-3463|medinfo@incyte.com|
22322691|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com|
22322692|NCT03244033|University of Illinois at Chicago|Dr. Saul Weiner|312-355-1700|sweiner@uic.edu|
22322693|NCT04428411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322694|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com|
22322695|NCT02918019|Hoffmann-La Roche|Medical Comunications|1-800-821-8590|genentech@druginfo.com|
22296059|NCT04155632|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
22267807|NCT05724589|Institute of Dermatology, Thailand|Dr. Supawee Phanmamuang|6623545222|dewsupawee@gmail.com|
22267808|NCT02435524|London School of Hygiene & Tropical Medicine|Dr Veronique Filippi|+44 (0)20 7927 2874|veronique.filippi@lshtm.ac.uk|
22267809|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267810|NCT04700137|St. Luke's Health System|Dr. Anna K. Radin|208/381-8460|radina@slhs.org|
22267811|NCT01411527|Rigshospitalet|Anders Juul|+45 3545 5085|Anders.Juul@regionh.dk|
22267812|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu|
22267813|NCT03449446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22267814|NCT02159079|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22267815|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de|
22267816|NCT03048552|Columbia University/New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
22267817|NCT03785327|The University of Texas at Dallas|Dr. Noah Sasson|972-883-2541|nsasson@utdallas.edu|
22267818|NCT03180645|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22267819|NCT04208750|Indiana University|Dr. Dawn Meyer|812-855-0559|meyerd@indiana.edu|
22267820|NCT02201277|University of California, San Francisco, Interventional Radiology|Maureen Kohi, MD|(415) 353-1300|maureen.kohi@ucsf.edu|
22267821|NCT02730663|Taewoong Medical Co., Ltd.|JiYoung Ahn/Assistant manager|+82-70-4649-1624|sarahahn@stent.net|628
22267822|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22267823|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu|
22267824|NCT02163057|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22267825|NCT03126448|Indiana University Health|Dr. Roman Natoli|713-516-8973|rnatoli@IUHealth.org|
22267826|NCT02254265|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
22267827|NCT01547390|University of South Florida|Dr. Anthony Odibo|813-259-0828|aodibo@health.usf.edu|
22267828|NCT04182334|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
22267829|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
22267830|NCT02698033|Massachusetts General Hospital|Wayne Shreffler|6177266147|wshreffler@mgh.harvard.edu|
22277978|NCT03178942|Encube Ethicals Pvt ltd|GM-Strategy & Commercial|+91-22-6228-8000|Pratik.K@EncubeEthicals.com|8003
22322696|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu|
22296060|NCT03274440|Columbia University/New York State Psychiatric Institute|Dr. Reilly Kayser|6467748118|reilly.kayser@nyspi.columbia.edu|
22322697|NCT03555266|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
22322698|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22322699|NCT03370770|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322700|NCT03419078|Imperial College Healthcare NHS Trust|Julie Beckerson|02033131922|julie.beckerson@nhs.net|
22322701|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095|geraldine.gebhart@bordet.be|+32
22322702|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu|
22322703|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22322704|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322705|NCT01158521|Cleveland Clinic|Dr. Brian Rini|(216) 444-9567|rinib2@ccf.org|
22322706|NCT00566930|UQTR|Martin Descarreaux|819 376-5011|martin.descarreaux@uqtr.ca|3077
22322707|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322708|NCT02194439|IndianaU|Sophie Paczesny|317-278-5487|sophpacz@iu.edu|
22322709|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
22322710|NCT03076983|Drägerwerk AG & Co. KGaA|Mr. Robin Hüwel|+49 451 882 6830|ClinicalAffairs@draeger.com|
22322711|NCT02979431|Ablynx NV|Medical Monitor|+32 (0)9262 00 00|clinicaltrials@ablynx.com|
22322712|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322713|NCT02435914|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22322714|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
22322715|NCT03522441|Catawba|Zaidoon A. Al-Zubaidy|1-980-242-3977|Zaidoon@catawbaresearch.com|
22322716|NCT01405053|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22322717|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com|
22322718|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu|
22322719|NCT04063371|The Ohio State University|Dr. Douglas Scharre|614-293-4969|Doug.Scharre@osumc.edu|
22322720|NCT02642094|University of Texas Health Science Center|LUZHE SUN, Ph.D.|210-567-5746|sunl@uthscsa.edu|
22322721|NCT01818726|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22322722|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
22322723|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
22322724|NCT03550066|Kaiser Permanente Northern California|Dr. Susan D. Brown|5108913544|susan.d.brown@kp.org|
22322725|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22322726|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322727|NCT05574062|MedtronicD|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
22322728|NCT03042936|UTHSC|Joan Han|9012876408|jhan14@uthsc.edu|
22322729|NCT05702736|Ege University|Dr. Merve UGURYOL UNAL|+902323115545|merve.uguryol.unal@ege.edu.tr|
22322730|NCT01172652|VA Palo Alto Health Care System|Dr. Trisha Suppes, MD PhD|(650) 493-5000|tsuppes@va.gov|67576
22322731|NCT03502993|Imperial College London|Dr J Herberg|0207 594 3900|j.herberg@imperial.ac.uk|
22322732|NCT01119456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22322733|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com|
22322734|NCT03382574|UT MD Anderson Cancer Center|Dr. Powel Brown, Chair, Clinical Cancer Prevention|(713) 745-3672|phbrown@mdanderson.org|
22322735|NCT04811716|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22277979|NCT03645681|W. L. Gore & Associates|Bre Lester|480-698-6670|blester@wlgore.com|
22277980|NCT02376010|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
22277981|NCT01428635|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD./Professor|713-563-1586|GBorthak@mdanderson.org|
22277982|NCT04280783|Emory University|Dr. Jacob Kariuki|4047272353|jacob.kariuki@emory.edu|
22277983|NCT05170061|SUNYBuffalo|Joseph Izzo MD|7168985625|jizzo@buffalo.edu|
22277984|NCT03443401|USouthDakota|Kory Zimney, PhD|6056586373|kory.zimney@usd.edu|
22277985|NCT02363283|UT MD Anderson Cancer Center|Dr. Sapna Pradyuman Patel,MD/ Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
22277986|NCT02257138|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani|713-745-0394|fravandi@mdanderson.org|
22277987|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu|
22277988|NCT00385515|Mucosal Therapeutics, LLC|Eward G. Fey, PhD|857-228-1100||
22277989|NCT03676270|Institut Bergonié|Pr Antoine Italiano|335 56333333|a.italiano@bordeaux.unicancer.fr|
22277990|NCT04110145|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22277991|NCT05401409|Westmead Hospital and Westmead Institute for Medical Research|Prof Gopala Rangan|8627 3000|g.rangan@sydney.edu.au|
22277992|NCT04392362|University of Pretoria|Dr. Amanda Makhubela|0722746091|neurosurgeon76@gmail.com|
22277993|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
22277994|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org|
22277995|NCT02918630|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|(713) 486-2796|Jin.Ho.Yoon@uth.tmc.edu|
22296061|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22322736|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com|
22322737|NCT03355300|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22277996|NCT03160573|University Health Resources Group|Sushma Nachnani, MS, PhD|(310) 645-8576|sushnach@yahoo.com|
22277997|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com|
22277998|NCT02389738|Johns Hopkins/NIH|Principal Investigator|4109558837|sjacks78@jhmi.edu|
22277999|NCT02715856|UT MD Anderson Cancer Center|Dr. Robert Satcher, Associate Professor, Orthopaedic Oncology|(713) 794-5242|rlsatcher@mdanderson.org|
22278000|NCT02336555|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278001|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300||
22278002|NCT03446690|University of Alabama at Birmingham|Chung How Kau|205-934-1289|ckau@uab.edu|
22278003|NCT03682367|UC Davis Health|Arnaud Bewley|9167342704|abewley@ucdavis.edu|
22278004|NCT05166902|CooperVision|Jose A Vega, OD, MSc, FAAO|9256213761|javega2@coopervision.com|
22278005|NCT00612768|SmartPractice|Kathy Shannon|602-225-0595|kshannon@smarthealth.com|7208
22278006|NCT03704922|University of North Carolina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.Karafin@unchealth.unc.edu|
22278007|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu|
22278008|NCT03093246|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
22278009|NCT04157738|Emory University|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
22278010|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
22278011|NCT02244957|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|
22278012|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278013|NCT03232892|University of California, San Francisco|Dr. Collin Blakely, MD PhD.|(415) 502-6959|Collin.Blakely@ucsf.edu|
22278014|NCT02090894|Indiana University School of Medicine|Dr. Ally-Khan Somani|317-944-7744|somania@iupui.edu|
22278015|NCT03111108|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278016|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu|
22278017|NCT04691115|AnaMar AB|Chief Medical Officer|+46 (0)46-275 60 00|info@anamar.com|
22278018|NCT01514279|School of Medicine, Case Western Reserve University|Dr. Elaine Borawski, PhD|216)368-1024|exb11@case.edu|
22278019|NCT00830336|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278020|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22278021|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu|
22278022|NCT00835549|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278023|NCT04526158|Minneapolis VAMC|Dr. Diana Burgess|612-567-1591|diana.burgess@va.gov|
22278024|NCT00677040|Essentia Health|Ken Dornfeld|218 786-1311|kenneth.dornfeld@essentiahealth.org|
22278025|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com|
22278026|NCT05071027|Montefiore Medical Center|Dr. David Altschul, Department of Neurosurgery|718-920-7498|daltschu@montefiore.org|
22278027|NCT04576481|Children's Hospital of Philadelphia|James Guevara, MD MPH|215-590-1130|guevara@chop.edu|
22278028|NCT04463914|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22296062|NCT02402309|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22322738|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322739|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu|
22322740|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
22322741|NCT01877083|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22322742|NCT02851173|University of Texas at Austin|Andreana Haley|512-232-0863|haley@austin.utexas.edu|
22322743|NCT00684957|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
22322744|NCT04341948|SPR|Clinical Affairs|216-378-9106|support@SPRPainRelief.com|
22322745|NCT03406897|University of Miami, Diabetes Research Institute|Dr. David Baidal|305-243-7740|dbaidal@med.miami.edu|
22322746|NCT05900115|innovation Research & Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
22322747|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322748|NCT02152345|Columbia University Irving Medical Center|Dr. Mark A. Hardy|(212) 305-5502|mah1@cumc.columbia.edu|
22322749|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org|
22322750|NCT02324270|Teva Pharmaceuticals USA, Inc|Senior Director, Global Gx Clinical R&D- PD/CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22322751|NCT03521791|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22322752|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565|ashok.tuteja@va.gov|4019
22322753|NCT03786432|William Beaumont University Hospital|Grace San Agustin|248 551 6679|grace.sanagustin@beaumont.org|
22322754|NCT03038308|Columbia University|Gabrielle Page-Wilson, MD|212-305-3725|gp2287@cumc.columbia.edu|
22322755|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22322756|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322757|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322758|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22322759|NCT04793399|ZERO LMC|Valentín García|91 336 86 86|jvalentingg@gmail.com|
22296063|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu|
22296064|NCT02621242|University of Washington|Dr. Joanne Stekler|206-744-8312|jstekler@uw.edu|
22322760|NCT03054363|University of Colorado Hospital|Elena Shagisultanova, MD, PhD|7208480300|elena.shagisultanova@cuanschutz.edu|
22322761|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110||
22322762|NCT04391959|Azura Ophthalmics|Chief Medical Officer|17145598435|charles.bosworth@azuraophthalmics.com|
22322763|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
22322764|NCT04866290|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
22322765|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com|
22322766|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu|
22278029|NCT05463952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22278030|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu|
22278031|NCT02739828|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22278032|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22278033|NCT03180138|Johns Hopkins University|Sanjay K Jain|4105028241|sjain5@jhmi.edu|
22278034|NCT03719300|Anchiano Therapeutics, Israel Ltd.1 Kendall Square, Building 1400, Suite 105 Cambridge, MA 02139|David Kerstein, M.D.,Chief Medical Officer|857-259-4626|David.Kerstein@anchiano.com|
22278035|NCT04191733|DePuy Orthopaedics|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278036|NCT02349477|Medical University of South Carolina|Dr. Michaela Hoffman|8437927758|HoffmaMi@musc.edu|
22278037|NCT02202577|Virginia Commonwealth University Health System|Edward H Springel, MD|804-828-8468|edward.springel@vcuhealth.org|
22278038|NCT01714063|Department of Pediatrics UAMS/COM|Ariel Perlinkski MT||berlinskiariel@uams.edu|
22296065|NCT04344314|Becton, Dickinson and Company|Christopher Rini, Associate Director Translational and Clinical Sciences Center of Excellence|+1 984 389 1186|christopher.rini@bd.com|
22296066|NCT02611778|bioeq GmbH|Head of Clinical Development|+498024463330|columbus@bioeq.com|
22296067|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu|
22296068|NCT04008030|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22296069|NCT02972554|University of North Carolina at Chapel Hill|Dr. Keely A. Muscatell|919-843-9113|kmuscatell@unc.edu|
22296070|NCT03756688|Mayo Clinic|Dr. Landon Trost|507-202-1995|landontrost@gmail.com|
22296071|NCT02574247|University of Illinois at Urbana-Champaign|Dr. Ian Mertes|217-300-4756|imertes@illinois.edu|
22296072|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
22296073|NCT06273124|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
22322767|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343||
22322768|NCT03793439|Oregon Health & Science University|Dr. Marcia Friedman|5034948637|friedmam@ohsu.edu|
22322769|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322770|NCT03588741|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22322771|NCT02288247|Astellas Pharma Europe Ltd. (APEL)|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
22322772|NCT02817087|Houston Methodist Neurological Institute|David Chiu, M.D.|713-441-5801|dmccane@houstonmethodist.org|
22322773|NCT04871711|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22322774|NCT01665144|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22322775|NCT02420873|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/ Associate Professor|713-794-4392|ndaver@mdanderson.org|
22322776|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org|
22322777|NCT01478854|Johns Hopkins University School of Medicine|Kristin Redmond, MD|410-955-6980|kjanson3@jhmi.edu|
22322778|NCT01972074|Massachusetts General Hospital|Gagan Joshi, MD|(617) 724-1541|joshi.gagan@mgh.harvard.edu|
22322779|NCT02319044|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
22322780|NCT02105415|Mayo Clinic|Dr. Nathan Smischney|507-255-4305|smischney.nathan@mayo.edu|
22278039|NCT01646216|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
22296074|NCT03336853|AOUCareggi|Dr. Riccardo Pace|+390557945608|riccardo.pace@unifi.it|
22296075|NCT01528254|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296076|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
22296077|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org|
22296078|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com|
22296079|NCT03626623|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
22296080|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu|
22296081|NCT01190878|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22296082|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22296083|NCT02998840|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22296084|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296085|NCT02530554|Evic Romania|Dr. R Olsavszky|40 21 335 70 91|evicromania@evic.ro|
22296086|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296087|NCT03564145|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22296088|NCT02607033|Baltimore VA Hosptial|Odessa Addison|4106057000|odessa.addison@va.gov|55393
22296089|NCT04219891|Alcon Research, LLC|Clinical Projects Director, Surgical|8884513937|alcon.medinfo@alcon.com|
22296090|NCT00410761|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22309419|NCT03216057|Hospital Infantil de Mexico Federico Gomez|Blanca Estela Del Rio Navarro|+525552289917|leijamjj@gmail.com|2444
22309420|NCT05126433|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22309421|NCT03907878|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22309422|NCT04625686|Cincinnati Children's Hospital Medical Center|Rosalie Hemphill LSW|5044940883|rosalie.hemphill@cchmc.org|
22309423|NCT03904147|Abbott|Natalie Richardson, Senior Clinical Project Manager|651-756-3842|natalie.richardson@abbott.com|
22309424|NCT04910152|The Ohio State University Comprehensive Cancer Center|Dr. Hannah Choe|614-293-3196|Hannah.choe@osumc.edu|
22309425|NCT03468868|Shepherd Center, Atlanta, GA|Deborah Backus, PT, PhD|404-352-2020|deborah.backus@shepherd.org|
22309426|NCT05399459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309427|NCT03625167|Charité - Universitätsmedizin Berlin|Monira El Genedy-Kalyoncu|+49 30 450 529 434|monira.el-genedy@charite.de|
22309428|NCT05583578|University of Florida|Dr. Clayton Swanson|3522735919|clayton.swanson@ufl.edu|
22309429|NCT05877976|NYU Langone Health|Lita Anglin|212-263-2519|Lita.anglin@nyulangone.org|
22309430|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O'Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com|
22322781|NCT02558374|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22322782|NCT03687502|Children's Mercy Hospital|Dr. Tolulope Oyetunji|816-234-3575|taoyetunji@cmh.edu|
22322783|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22322784|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu|
22322785|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu|
22322786|NCT01211600|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
22322787|NCT02887521|Mayo Clinic|Roberto Benzo, MD, MSc|(507) 284-0561|benzo.roberto@mayo.edu|
22322788|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com|
22322789|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322790|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu|
22322791|NCT03110900|University of Arkansas for Medical Sciences|Michael Wilson, M.D.|(501) 686-5515|mpwilso1@outlook.com|
22322792|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22322793|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu|
22322794|NCT03048422|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22322795|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu|
22322796|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
22322797|NCT04247425|Oregon Health & Science University|Lara Davis, MD|5034948423|davisla@ohsu.edu|
22322798|NCT02247193|The University of Texas Health Science Center at Houston|Matthew R. Greives, MD|713-500-7275|Matthew.R.Greives@uth.tmc.edu|
22322799|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22322800|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711|richard.hoffman2@va.gov|5318
22322801|NCT02320487|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322802|NCT03344003|Octapharma AG|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22322803|NCT05027932|Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH|Luca Giurgea|301-538-5235|Luca.giurgea@nih.gov|
22322804|NCT02949128|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22322805|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155|Gregory.Sullivan@TonixPharma.com|117
22322806|NCT00880750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22322807|NCT03242954|Indiana University School of Nursing|Amy Knopf|206-356-9430|asknopf@iu.edu|
22322808|NCT04690699|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
22322809|NCT02265913|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22322810|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org|
22322811|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com|
22322812|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22322813|NCT00925600|Amgen Inc.|Study Director|866-572-6436||
22322814|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
22309431|NCT05825755|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|val-hic@humanitcare.com|
22322815|NCT04785612|hVIVO|Alex Mann|+44(0)7738321671|a.mann@hvivo.com|
22322816|NCT00127127|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22322817|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com|
22322818|NCT03652909|Ascending Hearing Technologies, LLC|Christina Runge|2623523478|chrunge@mcw.edu|
22322819|NCT01059448|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22322820|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org|
22322821|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22267831|NCT04917861|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22267832|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623||
22267833|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu|
22267834|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22267835|NCT05192889|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
22278040|NCT02369159|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22278041|NCT00563316|Amgen Inc.|Study Director|866-572-6436||
22278042|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
22278043|NCT03511209|VA Greater Los Angeles Healthcare System|Constance H. Fung, MD, MSHS|818-891-7711|Constance.Fung@va.gov|39311
22278044|NCT02628145|University of Rhode Island|Matthew Delmonico|4018745440|delmonico@uri.edu|
22278045|NCT02757963|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278046|NCT03769467|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
22278047|NCT01887600|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
22278048|NCT03688139|Weill Medical College of Cornell University|Dr. Jennifer N. Bress|914-997-8683|jeb2061@med.cornell.edu|
22278049|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590||
22278050|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org|
22278051|NCT01943825|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22278052|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278053|NCT03378635|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
22278054|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu|
22278055|NCT03377127|Beaumont Health|Dr. Alexandra Halalau|2485513481|alexandra.halalau@beaumont.org|
22278056|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
22278057|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu|
22278058|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22309432|NCT04103580|Washington University|Kyle Pitzer: Study Statistical Data Analyst|314-747-5361|kyleapitzer@wustl.edu|
22309433|NCT04145440|HI-Bio, A Biogen Company|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22309434|NCT02749006|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|l.yatham@ubc.ca|
22309435|NCT04752709|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
22309436|NCT00576979|Department of Hematology and Hematopoietic Cell Transplantation, City of Hope|Anthony Stein, MD, corresponding author|626-256-4673|astein@coh.org|62405
22309437|NCT04248725|University of Washington|Dawn Ehde, PhD|206-591-3780|ehde@uw.edu|
22309438|NCT03697096|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22309439|NCT04893239|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
22309440|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de|
22309441|NCT05977530|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
22309442|NCT05496231|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309443|NCT05692960|The University of Tennessee, Knoxville|Noël Arring, DNP, PhD, RN|865-974-1988|narring@utk.edu|
22309444|NCT02675777|Kaiser Permanente Washington Health Research Institute|Katharine Bradley, MD, MPH|206-948-1933|katharine.a.bradley@kp.org|
22309445|NCT00167674|University of Washington|Grace John-Stewart|206 948 9357|gjohn@uw.edu|
22309446|NCT00691002|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22309447|NCT05940194|PATH|Dr. Thang Tran Cong, Medical office|+84913301883|thangtran@path.org|
22309448|NCT05493072|Imperial College NHS Healthcare Trust|Calandra Feather|07977185577|calandra.feather@nhs.net|
22309449|NCT04971031|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22309450|NCT04642820|University of Chicago|Harriet de Wit, Principal Investigator|773-702-1234|hdew@uchicago.edu|
22309451|NCT04568434|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22309452|NCT04567238|Duke University School of Medicine|Angela Kirby|9198247729|angela.kirby@duke.edu|
22309453|NCT04164888|CiVi Biopharma, Inc.|Chief, Clinical Development|484-674-5456|chuck.shear@civibiopharma.com|
22309454|NCT04081103|Amber Ophthalmics|Director of Clinical Trials|858-539-3418|clinical@Amberophthalmics.com|
22309455|NCT03365882|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
22309456|NCT03023410|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
22309457|NCT04799899|Massachusetts General Hopsital|Dr. Christina Luberto|617-643-9453|CLUBERTO@mgh.harvard.edu|
22309458|NCT05459688|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22278059|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278060|NCT05346640|Cionic|Rebecca Webster, Clinical Operations Manager|9257886649|rebecca@cionic.com|
22278061|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278062|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22278063|NCT04132427|Arizona State University|James B. Adams|480 965-3316|jim.adams@asu.edu|
22278064|NCT03927846|Wake Forest Health Sciences|Dennis Ang, Primary Investigator|336-705-8701|dang@wakehealth.edu|
22278065|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22278066|NCT03061214|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22309459|NCT04475679|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22309460|NCT03379675|Janssen Research and Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309461|NCT02817776|Biosense Webster Inc|Kendra McInnis|+1 949 322-8010|kmcinnis@its.jnj.com|
22309462|NCT05349500|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22309463|NCT06504862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322822|NCT03593915|Sumitomo Oncology|Holly Beever|210-365-9014|holly.beever@oncology.sumitomo-pharma.com|
22322823|NCT05512949|St. Louis University|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
22322824|NCT01583179|University of Wisconsin-Madison|Melanie Donnelly|720-848-0000|melanie.donnelly@ucdenver.edu|
22322825|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu|
22322826|NCT02002975|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22322827|NCT03988907|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22322828|NCT02810964|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22322829|NCT03523351|Memorial Sloan Kettering Cancer Center|Dr. Divya Yerramilli, MD|646-449-1931|yerramid@mskcc.org|
22322830|NCT03609619|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22322831|NCT00688909|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22322832|NCT03065179|UT Southwestern Medical Center|Dr. Hans Hammers|214/645-7445|Hans.Hammers@UTSouthwestern.edu|
22322833|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu|
22322834|NCT04656990|University of South Carolina|Director, USC Office of Research Compliance|803 777-6670|lisaj@mailbox.sc.edu|
22322835|NCT03244059|University of Alabama at Birmingham|Mark Dransfield MD|205-934-5425|mdransfield@uabmc.edu|
22322836|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu|
22322837|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111||
22322838|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22322839|NCT01044966|Medical University of South Carolina|Dr. Bruce Frankel|8437922052|frankel@musc.edu|
22322840|NCT01705691|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
22322841|NCT02658448|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22322842|NCT03106779|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22322843|NCT04233229|Air Liquide Santé International|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
22322844|NCT04652804|Johns Hopkins Bloomberg School of Public Health|Shruti H. Mehta|443-287-3837|smehta@jhu.edu|
22322845|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil|
22322846|NCT04093531|University of Rochester|Ummara Shah, MD|585-275-1643|ummara_shah@urmc.rochester.edu|
22267836|NCT04467840|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
22267837|NCT04408183|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
22267838|NCT06418529|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267839|NCT06082843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267840|NCT02732730|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22267841|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267842|NCT03989102|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
22267843|NCT04054765|play4REAL XR Lab at the Yale School of Medicine|Dr. Kimberly Hieftje|2037872402|kimberly.hieftje@yale.edu|
22267844|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22267845|NCT01907490|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22267846|NCT04544241|Charles R. Drew University of Medicine & Science|Sharon Cobb|323-568-3329|sharoncobb1@cdrewu.edu|
22267847|NCT02719184|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22267848|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
22267849|NCT04428034|UT Health San Antonio|Kylie Meyer, PhD|210-450-5386|meyerk1@uthscsa.edu|
22267850|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22267851|NCT02556801|HAL Allergy|Andrey Larionov, MD, Head of Clinical Development|+31881959189|alarionov@hal-allergy.com|
22267852|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267853|NCT03983980|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22267854|NCT01121250|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
22267855|NCT01525329|Cleveland Clinic|Dr. Edward Maytin|216-445-6676|maytine@ccf.org|
22267856|NCT00780338|RAND|Matthew Chinman|412 683-2300|chinman@rand.org|4287
22267857|NCT02676882|Massachusetts General Hospital Center for Women's Mental Health|Dr. Marlene Freeman|617-643-6403|mfreeman@partners.org|
22267858|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22267859|NCT03104192|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
22267860|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396||
22267861|NCT00815880|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
22267862|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267863|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267864|NCT02500589|Durahm VA Health Care System|Jennifer Gierisch|919-286-0411|jennifer.gierisch@va.gov; j.gierisch@duke.edu|176936
22267865|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22267866|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300||
22267867|NCT03885661|University of Pennsylvania|John Millar, PhD|215-898-0638|jsmillar@pennmedicine.upenn.edu|
22322847|NCT03665285|NextCure, Inc.|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
22296091|NCT02659709|Wills Eye Hospital, Glaucoma Service|Dr. Jonathan S. Myers|215-928-3197|jmyers@willseye.org|
22296092|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22296093|NCT00773292|Imperial College London|Graham P Taylor|0207 594 3910|g.p.taylor@imperial.ac.uk|
22296094|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22322848|NCT01235962|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22322849|NCT03543410|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22322850|NCT01580397|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22322851|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22322852|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22322853|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22322854|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
22322855|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000|kbwood@stanford.edu|+1
22322856|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com|
22322857|NCT03604445|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22267868|NCT05064397|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22322858|NCT02154425|Cares|UCB|+1877 822||9493
22322859|NCT05787847|University of Vermont|Dr. Richard Rawson|‭+1 (310) 951-9091‬|richard.rawson@uvm.edu|
22322860|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu|
22322861|NCT06468059|Kennesaw State University|Mark Geil|(470) 578-4805|mgeil@kennesaw.edu|
22322862|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
22322863|NCT02199197|Huntsman Cancer Institute Research Compliance Office|Data Manager|801-585-0601|compliance@hci.utah.edu|
22322864|NCT02551159|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22322865|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22322866|NCT06098729|Yale University|Garrett Ash|2034443079|garrett.ash@yale.edu|
22322867|NCT02129660|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22322868|NCT01890421|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
22322869|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
22322870|NCT02067039|CDC|Robin MacGowan|404-639-1920|rmacgowan@cdc.gov|
22322871|NCT00742469|Valeant Pharmaceuticals|Valeant Pharmaceuticals|(866) 246-8245||
22322872|NCT02026063|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD|281-863-3000|plapuerta@lexpharma.com|
22322873|NCT01879345|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22322874|NCT03657459|Cleveland Clinic|Nancy M. Albert PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
22322875|NCT05499520|University of Pennsylvania|Andy Tan|2157466546|andy.tan@asc.upenn.edu|
22322876|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322877|NCT00840827|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
22322878|NCT00358657|Fred Hutchinson Cancer Research Center|Dr. Kanwaldeep Mallhi|206-667-2014|kmallhi@fredhutch.org|
22322879|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22322880|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu|
22322881|NCT02614079|University of Toledo Medical Center|Joseph Atallah, MD|419-383-6699|joseph.atallah@utoledo.edu|
22322882|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
22322883|NCT04451330|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22322884|NCT05099640|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22322885|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org|
22322886|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu|
22267869|NCT02607046|Department of Veterans Affairs|Dr. Steven Prior|410-605-7000|steven.prior@va.gov|54129
22267870|NCT02324582|Southern Illinois University School of Medicine|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
22267871|NCT04309617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267872|NCT06372210|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22267873|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422||
22267874|NCT04660331|Fred Hutchinson Cancer Center|Dr. Parth Shah|2066676120|pshah@fredhutch.org|
22267875|NCT02463773|University of Minnesota|Roy Cho, MD|612-626-2637|choxx548@umn.edu|
22296095|NCT03540147|University of Texas at Austin|Hirofumi Tanaka|5122324801|htanaka@austin.utexas.edu|
22296096|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22296097|NCT02345811|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22296098|NCT02522286|Palo Alto Medical Foundation Research Institute|Dr. Ming Tai-Seale|650-853-4779|Tai-SealeM@pamfri.org|
22296099|NCT03633487|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22296100|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322887|NCT02516670|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Channing Paller Associate Professor Urologic Oncology|4109558239|cpaller1@jhmi.edu|
22296101|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500|ddawson@research.baycrest.org|2136
22278067|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22278068|NCT02371889|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-746-1943|kranzler@pennmedicine.upenn.edu|
22278069|NCT05130281|Weill Cornell Medicine|Maddy Schier|(646) 289-5271|mas4019@med.cornell.edu|720
22278070|NCT06844812|mazhar osman mental and nervous diseases hospital|Dr. Enes Faruk ALTUNKILIÇ|+905077362191|enesfarukaltunkilic@gmail.com|
22278071|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com|
22278072|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22278073|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22278074|NCT05069415|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
22278075|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22278076|NCT03701074|University of South Alabama|Ramachandra Bhat|2514151055|rbhat@health.southalabama.edu; rambhat79@gmail.com|
22278077|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22278078|NCT01661595|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
22278079|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com|
22278080|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
22278081|NCT05538728|Galderma Research and Development, LLC|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
22278082|NCT02593630|University of New England|Peter S. Millard, MD, Phd|2072992131|pmillard@mac.com|207
22278083|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278084|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22278085|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278086|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22278087|NCT01772693|Insightec|Nadir Alikacem, Ph.D., VP Clinical Research|214-630-2000|nadira@insightec.com|
22278088|NCT01633112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22278089|NCT04629157|Alder Hey Children's NHS Foundation Trust|Miss Rachel Harwood|0151 228 4811|rachel.harwood@alderhey.nhs.uk|
22278090|NCT02872142|Grifols Bioscience Industrial Group|Michael Woodward|+34 938008784|michael.woodward@grifols.com|
22278091|NCT04019704|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22278092|NCT01550965|AbbVie|Global Medical Information|800-633-9110||
22278093|NCT02317042|University of Western Australia|Prof Nigel McArdle & Prof Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
22278094|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22278095|NCT02118831|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
22278096|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu|
22278097|NCT02624687|University of Pittsburgh|Bethany Barone Gibbs|4123834002|bbarone@pitt.edu|412
22278098|NCT02811419|University of California San Francisco|Trilokesh Kidambi|909-973-0629|tkgastromd@gmail.com|
22278099|NCT00867334|George Mason University|Emanuel Petricoin|571-830-4166|epetrico@gmu.edu|
22278100|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org|
22278101|NCT01437189|ZhejiangU|Bo Wang|87784711|wangke1121@163.com|
22278102|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
22278103|NCT04893811|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278104|NCT03268499|The Chinese University of Hong Kong|Simon Chun Ho Yu|+852 35051035|simonyu@cuhk.edu.hk|
22278105|NCT04064567|University of Arkansas for Medical Sciences|Director, Research Programs|501-686-6427|hkhorton@uams.edu|
22278106|NCT03168529|Wayne State University|Phillip Levy, MD|3135771214|plevy@med.wayne.edu|
22278107|NCT03464461|University of Missouri|Dr. Matthew Robinson|573 884-4400|robinsonmt@health.missouri.edu|
22278108|NCT05524948|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22278109|NCT05155085|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22278110|NCT03460704|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clinicaltrials@zambongroup.com|
22278111|NCT02913326|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278112|NCT01767857|Janssen Research & Development, LLC|Product Development Portfolio Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278113|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22278114|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
22278115|NCT00967499|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22278116|NCT02899754|Philadelphia VA Medical Center (CMCVAMC), Philadelphia, PA|Dr. Marilyn M Schapira, Senior Investigator, Center for Health Equity Research & Promotion (CHERP)|215 898 2022|mschap@pennmedicine.upenn.edu|
22278117|NCT04818229|Connect Biopharma|Dr. Chin Lee, MD Chief Medial Officer|+1 650 676 9617|clee@connectpharm.com|
22278118|NCT04082364|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22278119|NCT03186378|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22278120|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com|
22278121|NCT03247673|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
22278122|NCT03000166|University of Wisconsin-Milwaukee|Jeanne M. Erickson, PhD, RN|414-229-6920|ericksoj@uwm.edu|
22278123|NCT04409418|William Beaumont Hospitals|Dr. Amit Bahl|248 898-9111|amit.bahl@corewellhealth.org|
22278124|NCT02971137|VA Connecticut Healthcare System|Dr. Lori A. Bastian|203-932-5711|lori.bastian@va.gov|2655
22322888|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22322889|NCT03075163|UC Davis Anesthesiology & Pain Medicine|Neal Fleming, MD, PhD|916 734-5046|nwfleming@ucdavis.edu|
22322890|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22322891|NCT01214044|Oregon Health & Science University and VA Portland Health Care System|Jonathan Emens, M.D.|503-220-8262|emensj@ohsu.edu|58490
22322892|NCT04698525|Medicine Faculty, Universidad Autónoma de San Luis Potosi|Ildefonso Rodriguez-Leyva MD, PhD|4442043016|ildefonso.rodriguez@uaslp.mx|
22322893|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22322894|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov|
22322895|NCT03157531|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
22322896|NCT03450083|Johns Hopkins University School of Medicine|Jody Tversky, MD|410-550-8017|hoddin1@jhmi.edu|
22322897|NCT03640832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22322898|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com|
22322899|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com|
22322900|NCT02211261|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22322901|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22322902|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu|
22322903|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161|sudapunrin@gmail.com|125
22322904|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org|
22322905|NCT02175680|CytoDyn Inc.|Joseph Meidling, Sr. Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22322906|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net|
22322907|NCT03969888|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22322908|NCT00535925|University of Campania|Prof. Ferdinando Carlo Sasso. MD, PhD|+39-081-5665010|ferdinandocarlo.sasso@unicampania.it|
22322909|NCT04062214|Yale University|Marc Rosen, MD|2039325711|marc.rosen@yale.edu|12112
22322910|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colonemeric@va.gov|6777
22322911|NCT00464178|Hackensack University Medical Center|Dr. David Siegel|551-996-2000|DSiegel@hackensackumc.org|
22322912|NCT02052557|Des Moines University|Grants and Contracts Manager|5152711657|mlyon@dmu.edu|
22278125|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
22278126|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22278127|NCT04755231|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22278128|NCT04754399|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22278129|NCT01331330|Abbott Medical Devices|Devyani Nanduri|+1 510-561-4328|devyani.nanduri@abbott.com|
22278130|NCT05259722|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22278131|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22278132|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
22278133|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278134|NCT02069184|Montefiore Medical Center|Jeffrey Bernstein|718-920-4317|JBernste@montefiore.org|
22278135|NCT03406975|Mayo Clinic|Dr. Barham Abu Dayyeh|507-266-4347|AbuDayyeh.Barham@mayo.edu|
22278136|NCT03111732|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
22278137|NCT03072875|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|research@ebpi.org|83
22278138|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654|patricia.parkin@sickkids.ca|301544
22278139|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22278140|NCT03726879|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22278141|NCT02496156|Nemours Children's Health System|Vicky Funanage, PhD, Operational Vice President for Research|302-651-6819|vfunanag@nemours.org|
22278142|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22278143|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278144|NCT03249558|Massachusetts General Hospital|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
22278145|NCT02656173|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
22278146|NCT05177328|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22296102|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22278147|NCT03449147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
22278148|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278149|NCT02043860|UIC Cancer Center Clinical Trials Office|Annette Kinsella, RN, CCRC, QA Education Specialist|312-996-5931|annettek@uic.edu|
22278150|NCT03338686|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059344506|rva@uab.edu|
22278151|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu|
22296103|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu|
22309464|NCT05949788|ShenzhenBMCHH|Dr. Jun Luo|015818671195|luojun-78@163.com|
22278152|NCT00088699|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22309465|NCT01574274|Dana-Farber Cancer Institute|Dr. Lewis Silverman|16176326191|lewis_silverman@dfci.harvard.edu|
22309466|NCT04881903|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
22309467|NCT01363388|ChemoCentryx|Study Director|650-210-2900||
22309468|NCT05477095|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
22309469|NCT02191618|Sequent Medical, Inc|Director, Clinical Operations|714-247-8000|anne.hurley@microvention.com|
22309470|NCT04215146|Oncolytics Biotech Inc.|Chief Medical Officer|(403) 670-7377|info@oncolyticsbiotech.com|
22309471|NCT01943409|Toronto General Hospital|Scientific Associate|4163405159|kschweng@uhnresearch.ca|
22309472|NCT02489903|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
22309473|NCT04413708|Duke University|Sara LeGrand|919-438-0448|sara.legrand@duke.edu|
22309474|NCT04599062|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
22309475|NCT06044090|University of Pittsburgh|Gabriella Alvarez, PhD|412-624-4500|gabyalvarez@pitt.edu|
22309476|NCT04520191|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
22309477|NCT05135650|Fred Hutch/University of Washington Cancer Consortium|Dr. Alpana Waghmare (Study Principal Investigator)|206-667-7329|awaghmar@fredhutch.org|
22309478|NCT06103188|Jordan University Hospital|Dr Omar Ismail|+962791301329|omar.moh.isml@gmail.com|
22309479|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22278153|NCT05520333|RTI International|Nisha Gottfredson O'Shea|9192481826|nishaoshea@rti.org|
22309480|NCT02969707|Stanford University|Dr. David Spiegel|650-723-6421|dspiegel@stanford.edu|
22309481|NCT05283304|UT Southwestern Medical Center|Madhukar Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
22309482|NCT06074172|Colorado State University Pueblo|Dr. Moussa Diawara|719-549-2813|Moussa.Diawara@csupueblo.edu|
22309483|NCT03020199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22309484|NCT04314713|Pharmaron|Paolo DePetrillo|240-673-0500|paolo.depetrillo@pharmaron.com|1731
22309485|NCT05038137|Medical University of South Carolina|Dr. Karanchi|(843) 792-2529|karanchi@musc.edu|
22309486|NCT02714257|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
22309487|NCT04700176|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22309488|NCT04111874|University of Pennsylvania|Dr. Andrew Guzick|215-573-3708|andrew.guzick@pennmedicine.upenn.edu|
22278154|NCT02290574|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
22278155|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22278156|NCT02904265|Mayo Clinic|Dr. Katherine Nickels|5072660774|nickels.katherine@mayo.edu|
22278157|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com|
22278158|NCT01509404|Medical University of South Carolina|James Fleming|843-792-0312|fleminj@musc.edu|
22278159|NCT00185614|Stanford University School of Medicine|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22278160|NCT04255381|Yale University|Dr. Stuart Weinzimer|203-785-5831|stuart.weinzimer@yale.edu|
22278161|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu|
22278162|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu|
22278163|NCT03829514|Medical University of South Carolina|Misti Leyva|endo office|leyva@musc.edu|
22278164|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com|
22278165|NCT01034657|Novartis|Study Director|862-778-8300||
22278166|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk|
22278167|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu|
22278168|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org|
22278169|NCT02790736|NY State Psychiatric Institute|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
22278170|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu|
22278171|NCT03992872|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_NA@bavarian-nordic.com|
22278172|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov|
22278173|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com|
22278174|NCT00889005|New York Langone Medical Center Department of Psychiatry|Arieh Y. Shalev, M.D.|6467544782|arieh.shalev@nyumc.org|
22278175|NCT04556006|Kilis 7 Aralık University|Dr. Uğur Doğan|+903488139301|63ugurdogan@gmail.com|
22278176|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22278177|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
22278178|NCT05122143|Altamira Medica Ltd.|Thomas Meyer|0041 61 201 13|ra@altamiramedica.com|50
22278179|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it|
22278180|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com|
22278181|NCT03766906|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
22278182|NCT00836901|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22309489|NCT05495555|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
22309490|NCT04436276|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278183|NCT01220687|OUHSC College of Medicine, Pediatrics, Neonatal-Perinatal Medicine|Krishnamurhty Sekar, MD, Professor of Pediatrics|405-271-5215|kris-sekar@ouhsc.edu|
22278184|NCT01047540|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22278185|NCT04250207|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22278186|NCT02772302|Massachusetts General Hospital|Brian Edlow|6177246352|bedlow@mgh.harvard.edu|
22278187|NCT03032484|University of Texas Health San Antonio|Andrew Brenner, MD|210-562-4090|brennera@uthscsa.edu|
22278188|NCT05263791|MacKay Memorial Hospital|Chien-Chung Huang|02-25433535|titanh@gmail.com|3009
22278189|NCT03689179|University of Utah|Rebecca Utz|801 699 5685|rebecca.utz@utah.edu|
22278190|NCT04581629|Calcilytix Therapeutics, Inc., a BridgeBio company|Medical Information|650.600.3610|MedInfo@bridgebio.com|
22278191|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com|
22278192|NCT03329131|University of Texas Health Science Center in San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
22278193|NCT05261490|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278194|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu|
22278195|NCT04135443|dfusion, Inc|Tamara Kuhn, Vice President and Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
22278196|NCT01335685|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22278197|NCT02554474|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
22278198|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com|
22278199|NCT03211832|Prevention Research Center, Brown School, Washington University in St. Louis|Ross Brownson|3149350121|rbrownson@wustl.edu|
22278200|NCT02770365|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
22278201|NCT03777020|University of Maryland School of Nursing|Dr. Erika Friedmann|410 706 0659|friedmann@umaryland.edu|
22278202|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22278203|NCT03138382|UCSD|Dr Paul McGeoch|858-232-3312|pdmcgeoch@ucsd.edu|
22278204|NCT04003389|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22278205|NCT02364271|Chinese University of Hong Kong|Professor Timothy Rainer|00 852 2632 1034|thrainer@cuhk.edu.hk|
22278206|NCT01512251|University of California, San Francisco|Alain Algazi|(415) 353-7552|alain.algazi@ucsf.edu|
22278207|NCT02514746|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
22278208|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
22278209|NCT01375140|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
22278210|NCT04003142|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22278211|NCT04806373|Memorial Healthcare System|Mark Block, Chief, Division of Thoracic Surgery|9542651125|mblock@mhs.net|
22278212|NCT03382873|Indiana University|Dr. Carla Miller (current affiliation)|812-855-1608|ckm1@iu.edu|
22278213|NCT03624036|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22278214|NCT02470377|University of Minnesota|Yoon-Hee Cha|612-301-2738|ycha@umn.edu|
22278215|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu|
22278216|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22278217|NCT01185366|UT MD Anderson Cancer Center|Amado Zurita-Saavedra,Associate Professor, Genitourinary Medical Oncology|(713) 563-6966|azurita@mdanderson.org|
22278218|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com|
22278219|NCT02539394|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@hss.edu|
22278220|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555|skilty@ottawahospital.on.ca|18514
22278221|NCT03425188|Respicardia, Inc.|Tim Meyer, VP Clinical Affairs|952-540-4479|tmeyer@respicardia.com|
22278222|NCT02301793|Johns Hopkins Medical Institutions|Elliott R Haut M.D, PhD, Associate Professor of Surgery, Anesthesiology &Critical Care Medicine|410-502-3122|ehaut1@jhmi.edu|
22278223|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com|
22278224|NCT01941628|Dept. of Anaesthesiology and Intensive Medicine, General University Hospital in Prague|Assoc. Prof. Jan Blaha, MD, PhD|+420 224962243|jan.blaha@lf1.cuni.cz|
22296104|NCT03525574|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22296105|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it|
22296106|NCT02929823|PPD|Joseph Pollard|+1 910 558 4428|joseph.pollard@ppdi.com|
22296107|NCT03227029|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22296108|NCT01291173|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22296109|NCT05855005|Northwestern University|Kendra Marks|2069991423|kendra.marks@northwestern.edu|
22278225|NCT00834587|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278226|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu|
22296110|NCT06119529|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22296111|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22296112|NCT02728895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22296113|NCT02769247|Walter Reed National Military Medical Center|Dr. Shana Miles|318 456 6389|shana.m.miles2.mil@mail.mil|
22296114|NCT04788953|Brigham and Women's Hospital|Dr. Kirsi-Marja Zitting|617-525-8339|kzitting@bwh.harvard.edu|
22296115|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22296116|NCT04473937|Massachusetts General Hospital|Chirayu Patel, MD|617-724-9627|CPATEL@MGH.HARVARD.EDU|
22296117|NCT01086540|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22296118|NCT02707991|Johns Hopkins University|Laura Starbird|9787587909|Lstarbi1@jhu.edu|
22296119|NCT02049307|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
22296120|NCT02659631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296121|NCT05407675|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22296122|NCT02612428|Vital Therapies, Inc.|Robert Ashley, Chief Technical Officer|001 858-673-6840|rashley@vitaltherapies.com|
22296123|NCT00742001|Terumo BCT|Marty Huntington / Sr Mgr Global Clinical Affairs|+1 (303) 231-4849|Marty.Huntington@terumobct.com|
22296124|NCT03035708|National Institute on Alcohol Abuse and Alcoholism|Health Scientist Administrator|301-443-0788|falkde@mail.nih.gov|
22296125|NCT01928329|C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)|Kevan Herold, MD|(203) 785-6507|kevan.herold@yale.edu|
22296126|NCT01496313|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22296127|NCT00535990|UCSD|Dr. Jonathan Li|6618603471|jzl023@health.ucsd.edu|
22296128|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com|
22296129|NCT05167734|Mayo Clinic|Matthew Warner, M.D.|507-422-1714|Warner.Matthew@mayo.edu|
22296130|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu|
22296131|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590||
22296132|NCT00171223|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296133|NCT02064166|Brigham & Women's Hospital|Peter Novak, MD PhD|617-732-8896|pnovak2@bwh.harvard.edu|
22296134|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
22296135|NCT03742037|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
22296136|NCT04128267|Vanderbilt-Ingram Cancer Center|Teresa Melton|(615) 936-7423|teresa.melton@vumc.org|
22296137|NCT05020990|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
22296138|NCT01183897|Memorial Sloan Kettering Cancer Center|Brian Kushner MD|212-639-6793|kushnerb@mskcc.org|
22296139|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu|
22296140|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22296141|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296142|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com|
22296143|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca|
22296144|NCT00309842|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
22296145|NCT01865539|Canandaigua VA Medical Center|Dr. Paul Dougherty, PI|585-463-2673|paul.dougherty@va.gov|
22296146|NCT02335099|University of Virginia|Emaad Abdel-Rahman, MD|434-924-5820|ea6n@virginia.edu|
22296147|NCT01472081|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22296148|NCT04702997|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22296149|NCT03915496|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296150|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com|
22296151|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
22296152|NCT03694171|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22296153|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com|
22296154|NCT03712904|Thomas Jefferson University|Wenyin Shi, MD, PhD|(215) 955-6702|wenyin.shi@jefferson.edu|
22296155|NCT03745937|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
22296156|NCT02710890|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22296157|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296158|NCT02356783|Hospital for Special Surgery|Robert Griffin, MD, PhD|212-774-2944|griffinr@hss.edu|
22296159|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22296160|NCT05359666|Irrimax Corporation|Director of Clinical Trials|770-807-3355|cs@irrisept.com|
22296161|NCT00202644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22296162|NCT00602576|University of Pennsylvania|Dr. Ravi Amaravadi|2157965159|ravi.amaravadi@pennmedicine.upenn.edu|
22296163|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu|
22296164|NCT03232281|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22296165|NCT01403246|GIMEMA|Alfonso Piciocchi|+393203671224|a.piciocchi@gimema.it|
22296166|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
22296167|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
22296168|NCT05333900|University of Minnesota|Alexander Khoruts|612-624-2101|khoru001@umn.edu|
22296169|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
22296170|NCT03724812|Abbott|Angelic Roach|+1 651 756 3379|angelic.roach@abbott.com|
22296171|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu|
22296172|NCT03642210|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
22296173|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601|michellecao2007@gmail.com|
22296174|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296175|NCT03742154|MUSC|Lisa Coles Program Coordinator|843-876-2291|colesl@musc.edu|
22296176|NCT02278263|Ko Awatea|Dr Marinus Stowers|+64 276 0044|msto062@aucklanduni.ac.nz|2219
22296177|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi|
22278227|NCT01657942|Insightec|Nadir Alikacem|214-630-9900|nadira@insightec.com|
22278228|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22278229|NCT04129398|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278230|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu|
22278231|NCT03413995|Johns Hopkins University|Mark Markowski, MD|410-614-0567|mmarko12@jhmi.edu|
22278232|NCT02735642|Yale University School of Nursing|Ann Kurth|N/A|ann.kurth@yale.edu|
22278233|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
22278234|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22278235|NCT02310269|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
22278236|NCT00839930|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278237|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
22278238|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu|
22278239|NCT04103814|Rush University Medical cEnter|Dr E Bailey Terhune|8018249805|bailey.terhune@rushortho.com|
22278240|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22278241|NCT02800785|University of Washington|Erin Fannon|206-685-9770|ecarney@uw.edu|
22278242|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22278243|NCT02395627|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|Pamela.Munster@ucsf.edu|
22278244|NCT03253627|New York University Meyers College of Nursing|John Merriman, PhD, RN|212-998-5375|john.merriman@nyu.edu|
22278245|NCT04710303|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22278246|NCT04717479|University of Michigan|Sarah Yon|734-763-0412|shlim@umich.edu|
22278247|NCT04629521|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22278248|NCT03163667|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22278249|NCT00979407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278250|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22278251|NCT02940223|UT MD Anderson Cancer Center|Sriram Yennu,Professor, MD- Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22278252|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu|
22278253|NCT03189433|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
22278254|NCT03769116|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
22278255|NCT04743206|University of Florida|Silvia Delgado Villalta|7185684198|silviadelgado@ufl.edu|
22278256|NCT05810597|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22278257|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com|
22278258|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu|
22278259|NCT02214212|University of Washington|Jeanne Hoffman|2062216511|jeanneh@u.washington.edu|
22278260|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
22278261|NCT04903093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278262|NCT03213405|Pontificia Universidad Católica de Chile|Dr. Alexis Kalergis|+56223541924|akalergis@bio.puc.cl|
22278263|NCT03657407|University of Maryland Medical Center|Anna Reinert, MD|6029089960|anna.reinert@gmail.com|
22278264|NCT00622843|Infectious Disease Clinical Research Program, Uniformed Services University and HJF|Dr. Brian Agan, Deputy Science Director|240-694-2946|bagan@idcrp.org|
22278265|NCT03926247|University of New Mexico|Dr. Jessica Goodkind|505-277-2501|jgoodkin@unm.edu|
22278266|NCT05226884|Clinical Research Coordinator|Diana Hill|713-526-1600|diana.hill@berkeleyeye.com|
22278267|NCT01390584|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22278268|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22278269|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
22278270|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu|
22278271|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu|
22278272|NCT02268851|Dana-Farber Cancer Institute|Matthew Davids, MD, MMSc|617-632-6331|matthew_davids@dfci.harvard.edu|
22278273|NCT02184442|Edwards Life Sciences|Tenley Koepnick|949-250-6504|Tenley_Koepnick@Edwards.com|
22278274|NCT02691494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22278275|NCT04634331|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
22278276|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org|
22278277|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com|
22278278|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22278279|NCT02916433|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
22278280|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278281|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com|
22278282|NCT06003829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278283|NCT03878069|Chiesi Canada Corp.|Anna Rozova, MD, Clinical Program Leader|1-800-854-3534|a.rozova@chiesi.com|7038
22278284|NCT03810495|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
22278285|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu|
22278286|NCT02536339|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22278287|NCT03759379|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22278288|NCT04924608|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22278289|NCT05415215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22278290|NCT03727022|Biosplice Therapeutics|Christopher Swearingen, PhD, VP of Biometrics|858.926.2900|info@biosplice.com|
22278291|NCT05550818|Virginia Tech|Dr. Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
22278292|NCT02797522|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22278293|NCT03031912|CIRN|Dr. Joanne Langley - Coordinating Investigator|902-470-8762|joanne.langley@dal.ca|
22278294|NCT04659876|SBU Gazi Yaşargil Training and Research Hospital|Osman Uzundere|+905330206362|osmanuzundere@gmail.com|
22278295|NCT04097743|University of Oklahoma|Dokyoung Sophia You, PhD|9186603923|dokyoung-you@ou.edu|
22278296|NCT05659329|Stryker|Britta von den Brincken|+491638999202|britta.vondenbrincken@stryker.com|
22278297|NCT02932410|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278298|NCT04975230|Case Western Reserve University|Stephanie Griggs|404-544-9915|stephanie.griggs2@emory.edu|
22278299|NCT04557735|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22278300|NCT05562934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22278301|NCT05365217|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22278303|NCT03997383|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22278304|NCT05473767|University of Pittsburgh|Janet M Catov, PhD MS|412-641-6217|catovjm@mwri.magee.edu|
22278305|NCT01971593|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
22278306|NCT05159869|Johns Hopkins University|Natalie G. Regier, PhD, FGSA|410-502-6876|nregier1@jhu.edu|
22278307|NCT05451329|VivaVision Biotech, Inc.|Xiao-Yan (Joanne) Li, M.D.|(858) 692-9752|joanne.li@vivavisionbio.com|
22278308|NCT02731079|William Beaumont Army Medical Center|Eric Ahnfeldt|915-742-4442|eric.p.ahnfeldt.mil@health.mil|
22278309|NCT03019406|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22278310|NCT02556736|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22296178|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il|
22296179|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk|
22296180|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22296181|NCT03777007|Stanford University|Derek F. Amanatullah|(650) 723-2257|dfa@stanford.edu|
22296182|NCT01266460|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22296183|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu|
22296184|NCT05811234|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
22296185|NCT02710045|University of Tasmania|Katie Flanagan|+61 3 6777 4081|katie.flanagan@ths.tas.gov.au|
22296186|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com|
22278311|NCT04857060|Tufts Medical Center|Dr. Michael Paasche-Orlow|617-636-1029|michael.paasche-orlow@tuftsmedicine.org|
22278312|NCT01302834|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22278313|NCT05528510|Janssen Research & Development, LLC|Senior Medical Leader Pediatrics Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278314|NCT02586857|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22278315|NCT01856478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278316|NCT05032820|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|
22278317|NCT04108208|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278318|NCT04936308|Janssen Research & Development, LLC|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278319|NCT04770272|Palleos healthcare GmbH|"Palleos | CRO Germany"|+496119501900|info@palleos.com|
22278320|NCT02363946|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|6263043400||
22278321|NCT03030261|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
22278322|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278323|NCT05213624|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278324|NCT01602380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22278325|NCT04522947|University of Nebraska-Lincoln|Timothy Nelson|4024727707|tnelson3@unl.edu|
22278326|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22278327|NCT00912873|University California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22278328|NCT04691492|University at Buffalo|Jennifer Read, PhD.|(716) 645-0193|jpread@buffalo.edu|
22278329|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu|
22278330|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu|
22278331|NCT03369704|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22278332|NCT06401551|Alcon Research, LLC|Director Clinical Trial Management, Surgical IOL|1-888-451-3937|alcon.medinfo@alcon.com|
22278333|NCT04028960|HealthPartners Institute dba International Diabetes Center|Anders Carlson, MD|952-993-1927|Anders.L.Carlson@HealthPartners.Com|
22278334|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22278335|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu|
22278336|NCT02037984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278337|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov|
22278338|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
22278339|NCT04350866|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|adam.bramoweth@va.gov|
22278340|NCT04693715|Revalesio Corporation|Clinical Operations|253-922-2600|contact@revalesio.com|
22278341|NCT06433908|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278342|NCT04403880|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22278343|NCT04138277|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
22278344|NCT03768414|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
22278345|NCT04130425|Mayo Clinic|Stephanie Kannas, OTR/L, OTD, CHT|507-284-8841|kannas.stephanie@mayo.edu|
22278346|NCT00124306|University of Pennsylvania|J. Richard Landis, PhD|215-5734922|hultman@upenn.edu|
22278347|NCT03267498|University of California, San Francisco|Dr. Sue Yom, MD PhD, MAS|(415) 353-9893|Sue.Yom@ucsf.edu|
22278348|NCT04153149|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22278349|NCT06151418|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22278350|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
22278351|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22296187|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu|
22296188|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296189|NCT00857220|Sunovion|CNS Medical Director|866-503-6357||
22296190|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22296191|NCT03611790|BioMDg, CRO for VITAL Study|Sigi Caron, President and CEO at BioMDg|(831) 346-6970|sigi@biomdg.com|
22296192|NCT03187262|Dana-Farber Cancer Institute|Dr. Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22296193|NCT00278109|Indiana University School of Medicine|Richard Zellars MD|3179444505|rzellars@iu.edu|
22296194|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
22296195|NCT03706053|UVA Health|Dr. Alex Kadl|434-243-4851|AK5SC@uvahealth.org|
22296196|NCT04339296|Health Systems Evaluation & Evidence - Alberta Health Services|Research and Evaluation Coordinator|4036489255|armghan.ahmad@albertahealthservices.ca|
22296197|NCT03424265|University of Arkansas for Medical Sciences|Scott Schutzler, R.N.|501-526-5734|seschutzler@uams.edu|
22296198|NCT00453544|UC San Diego|Dr. Barton Palmer|858-246-0765|bpalmer@ucsd.edu|
22296199|NCT01558752|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8899|pbeaule@toh.ca|73265
22296200|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22296201|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22296202|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278352|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012||
22278353|NCT02553473|Sørlandet hospital HF|Anne Marit Solheim, MD|0047 38 07 39 10|anne.marit.solheim@sshf.no|
22278354|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22278355|NCT03956082|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|DAVID.LEVINE@MERCY.NET|
22278356|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org|
22278357|NCT03318393|UT Southwestern Medical Center|Lakshmi Raman|214-456-6222|lakshmi.raman@utsw.edu|
22278358|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22278359|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com|
22278360|NCT00752219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278361|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu|
22278362|NCT03533491|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
22278363|NCT05201495|Element Science, Inc.|Chief Medical Officer|(415) 872-6500|zubin@elementsci.com|
22278364|NCT05702047|Florida State University|Director, Cardiovascular and Applied Physiology Laboratory|8506441828|jwatso@fsu.edu|
22278365|NCT05418426|Daré Bioscience, Inc.|Jessica Hatheway, VP of Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22278366|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu|
22278367|NCT02360085|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22278368|NCT03255200|Mainstay Medical|Director, Clinical Affairs|877 702-8488|clinical@mainstaymedical.com|
22278369|NCT03829683|Virginia Commonwealth University|Arun J Sanyal, MD|804-828-4060|arun.sanyal@vcuhealth.org|
22278370|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org|
22278371|NCT02412982|UC Health - University of Cincinnati Medical Center|Molly Droege, PharmD|513-584-2126|molly.droege@uchealth.com|
22278372|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22278373|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22278374|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22278375|NCT04379271|Immunic AG|Silke Kropp, Specialist Regulatory Operations & Systems|+49|Silke.Kropp@imux.com|1626774453
22278376|NCT03301415|The University of Alabama at Birmingham|David W. Kimberlin, MD|205-934-5316|dkimberlin@peds.uab.edu|
22278377|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22278378|NCT02544763|GW Research Ltd|Medical Enquiries|+1 833 424 6724|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
22278379|NCT02097225|Massachusetts General Hospital|Ryan Sullivan, MD|617-643-3614|RSULLIVAN7@PARTNERS.ORG|
22278380|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu|
22278381|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa|
22278382|NCT02528305|University of Striling|Dr Niels Vollaard|+441786466488|n.vollaard@stir.ac.uk|
22278383|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu|
22278384|NCT00322218|Spectrum Pharmaceuticals,Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
22278385|NCT04136288|Mayo Clinic|Chandler Chapman, DHSc, MPH, Senior Clinical Research Coordinator|9049538681|Chapman.Chandler@mayo.edu|
22278386|NCT02842242|MyoKardia Inc.|Dr. Amy Sehnert|650-741-7798|asehnert@myokardia.com|
22278387|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov|
22278388|NCT03404375|UTMB Galveston|Antonio Saad|4097721571|afsaad@utmb.edu|
22278389|NCT07072793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22278390|NCT03596645|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278391|NCT04725513|Spaulding Rehabilitation Hospital|Adam Tenforde, MD|6179526800|atenforde@mgh.harvard.edu|
22278392|NCT04101331|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
22278393|NCT04616196|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22278394|NCT02078869|TCART|Robert F Casper, PI|416-972-0777|casper@lunenfeld.ca|
22278395|NCT06790303|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278396|NCT03026777|LSUHSC New Orleans|Dr. David Janz|504-913-5006|djanz@lsuhsc.edu|
22278397|NCT02579759|Pharnext|Susanne Dorn|+33 (0)1 41 09 22 30|contact@pharnext.com|
22278398|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
22278399|NCT02943499|Brown University|Dr. Judson Brewer|401-863-2826|judson_brewer@brown.edu|
22278400|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22278401|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555|dmanuel@ohri.ca|19108
22278402|NCT03283241|AddBio AB|Ulf Sewerin, CEO|+46708797988|ulf.sewerin@addbio.se|
22278403|NCT00666263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22278404|NCT02439957|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22278405|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org|
22278406|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300||
22278407|NCT05898178|Maribor University Medical Centr|Borut Kovačič||Borut.KOVACIC@ukc-mb.si|0038631211
22278408|NCT02853136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278409|NCT00841815|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278410|NCT04169009|University of Colorado Anschutz Medical Campus|Adriana Weinberg MD|303-724-4480|adriana.weinberg@cuanschutz.edu|
22278411|NCT04889950|Novoxel Ltd|Ifat Klein|972-6009860|ifat@novoxel.com|
22278412|NCT02517918|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22278413|NCT02758626|NYU Langone Health, Comprehensive Epilepsy Center|Orrin Devinsky, MD|6465580803|Orrin.Devinsky@nyulangone.org|
22278414|NCT02732145|Ginekološka poliklinika Dr. Vesna Harni|Dr. Vesna Harni|0038512923648|vesnaharni@gmail.com|
22278415|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22278416|NCT01687595|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
22278417|NCT04204902|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22278418|NCT02096354|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|858-229-1062|boronsky@epicentrx.com|
22278419|NCT03715829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278420|NCT05273437|University of California San Diego|Dr. Eric Hekler|8584299370|ehekler@health.ucsd.edu|
22278421|NCT03647137|Department of Veteran Affairs|Dr. Nicolaas Bohnen|7347697100|nicolaas.bohnen@va.gov|
22278422|NCT03579719|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22278423|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu|
22278424|NCT03900650|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
22278425|NCT00829868|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278426|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22278427|NCT01603368|University of Linköping|Thomas Abrahamsson, MD PhD|+46.10.1030000|thomas.abrahamsson@liu.se|
22278428|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu|
22278429|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu|
22278430|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
22278431|NCT04525183|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-362-2334|alexi_wright@dfci.harvard.edu|
22278432|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
22278433|NCT05014919|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22278434|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973||
22278435|NCT01469156|Southeast Retina Center|Dr. Dennis Marcus|706-650-0061|dmarcus@southeastretina.com|
22278436|NCT01813227|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22278437|NCT04126174|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
22278438|NCT03773562|Mayo Clinic|Dr. Todd Schwedt|480-342-2695|schwedt.todd@mayo.edu|
22278439|NCT05305651|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278440|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com|
22278441|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu|
22278442|NCT01854762|Fundação Bahiana de Infectologia / Universidade Federal da Bahia|Dr. Carlos Brites|5571992329552|crbrites@gmail.com|
22278443|NCT05078112|Duke University|Sujay Kansagra, MD|919-668-0477|sujay.kansagra@duke.edu|
22278444|NCT05021224|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
22278445|NCT03996395|Baylor College of Medicine|Nancy E. Moran, PhD|713-798-0520|nancy.moran@bcm.edu|
22278446|NCT01924065|Akdeniz Sifa Konyaalti Medical Center|Mehmet Ozaydin|905533354243|mehmetozaydin@hotmail.com|
22278447|NCT05375929|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278448|NCT03555994|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22278449|NCT03973489|VA Portland Health Care System|William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
22278450|NCT04573881|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
22278451|NCT03379870|The Children's Cochlear Implant Center at UNC|Lisa Park, AuD|919-419-1449|lisa_park@med.unc.edu|
22278452|NCT00003645|UT MD Anderson Cancer Center|Dr. Curtis A. Pettaway, M.D.- Professor, Urology|713-792-7734|cpettawa@mdanderson.org|
22278453|NCT01373281|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
22278454|NCT03502681|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22278455|NCT02254291|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22278456|NCT05796245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278457|NCT03436732|National Cancer Institute|Dr. Raffit Hassan|240-760-6322|rh276q@nih.gov|
22278458|NCT04622267|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
22278459|NCT03257657|University of Colorado|Darcy Thompson, Associate Professor|303 724 7471|darcy.thompson@ucdenver.edu|
22278460|NCT02801578|The University of Texas MD Anderson Cancer Center|Prithviraj Bose, MD./Associate Professor|713-792-7747|PBose@mdanderson.org|
22278461|NCT02971839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22278462|NCT00668642|Northshore University Healthsystem|Dr. Daniel Shevrin|847-570-2515|Dshevrin@northshore.org|
22278463|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278464|NCT04642976|University of Pennsylvania|Timothy Markman|215-615-4332|timothy.markman@pennmedicine.upenn.edu|
22278465|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22278466|NCT03226691|National Heart Lung and Blood Institute|John Tisdale|+1 301 402 6497|johntis@nhlbi.nih.gov|
22278467|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com|
22309491|NCT05534789|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278468|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no|
22278469|NCT00278161|Johns Hopkins University|Lode Swinnen, MD|4106146398|lswinne1@jhmi.edu|
22278470|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278471|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22278472|NCT03242434|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278473|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org|
22278474|NCT01592747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22278475|NCT03680521|Mirati Therapeutics|Sr. Clinical Operations Trial Manager|858-332-3540|hallinm@mirati.com|
22278476|NCT01935947|Johns Hopkins University|Gary Rosner|410-955-4884|grosner1@jhmi.edu|
22278477|NCT02327169|Takeda|Takeda Study Registration Call Center|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22278478|NCT03787615|The Pennsylvania State University|Dr. David Conroy|814-863-3451|conroy@psu.edu|
22278479|NCT01704157|Pacira Bioscience, Inc.|Pacira MedInfo|1-855-793-9729|MedInfo@Pacira.com|
22278480|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org|
22278481|NCT04102514|University of Kansas Medical Center|Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22278482|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu|
22278483|NCT03876808|University of Missouri - Columbia|Dr. Boris Mraovic, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
22278484|NCT00456365|PKD Research Group, University of Colorado Anschutz Medical Campus|Melissa Cadnapaphornchai, MD|3037241690|pkd@ucdenver.edu|
22278485|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu|
22278486|NCT03566732|University of Bergen|Professor Dagny F. Haugen|+4747606633|dagny.haugen@uib.no|
22278487|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch|
22278488|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org|
22278489|NCT02951481|Fundación de investigación Hospital Universitario 12 de Octubre|MD, PhD José María Aguado García|913908000|jaguadog1@gmail.com|4632
22278490|NCT01051661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278491|NCT05007639|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22278492|NCT02852005|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22278493|NCT01922895|U.T. Southwestern Medical Center|Mack C. Mitchell, MD|2146485036|mack.mitchell@utsouthwestern.edu|
22278494|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278495|NCT05781685|UT Southwestern Medical Center|Chance Ryan Strenth|337-274-7647|chance.strenth@utsouthwestern.edu|
22278496|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22278497|NCT05142306|Emergent BioSolutions Canada Inc|Mila Mirceta, PhD, Senior Scientist, Clinical Research|204-275-4074|mircetam@ebsi.com|
22278498|NCT04079920|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278499|NCT03760068|Sr. Director Global Clinical Operations, General Medicine|Keri L. Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22278500|NCT05430919|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22278501|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
22278502|NCT05181085|NorthSea Therapeutics BV|Michelle Yokley|31 035760 65 05|info@northseatherapeutics.com|
22278503|NCT03784300|Cassava Sciences|Michael R Marsman, PharmD|5125822173|mmarsman@cassavasciences.com|
22278504|NCT02614248|Genesis Medical Center|Michelle Martin, RN|562-421-7743|MartinMi@genesishealth.com|
22278505|NCT03204812|UT MD Anderson Cancer Center|Dr. Sumit Subudhi, PhD-Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|sksubudhi@mdanderson.org|
22278506|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22278507|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278508|NCT04650893|University of Nebraska Medical Center|Peter Danielson|402-559-1703|peter.danielson@unmc.edu|
22278509|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22278510|NCT04091438|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22278511|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu|
22278512|NCT04105725|Medical University of South Carolina|Dr. Kathryn Gex|(843) 876-2084|soltisk@musc.edu|
22278513|NCT02370693|Northwestern University|Manu Jain, MD|312-503-4242|m-jain@northwestern.edu|
22278514|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp|
22278515|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22278516|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22278517|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22278518|NCT04778709|NYU College of Dentistry|Aikaterini Georgantza|212-998-9986|ag4222@nyu.edu|
22278519|NCT03058952|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
22278520|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu|
22309492|NCT03029884|University of California, San Francisco|Prasad Shirvalkar MD, PhD - Principal Investigator|415-885-7246|Prasad.Shirvalkar@ucsf.edu|
22309493|NCT03656510|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309494|NCT05322044|Imperial College London|Dr Louise Fleming|02073528121|l.fleming@imperial.ac.uk|2938
22309495|NCT01710488|Fadoi Foundation|Antonella Valerio|0248005140|antonella.valerio@fadoi.org|
22309496|NCT03728790|Columbia University|Dr. Leslie Moroz|646-532-8208|lm3000@cumc.columbia.edu|
22309497|NCT03852472|Chemocentryx|Study Director|650-210-2900|medinfo@amgen.com|
22278521|NCT02296476|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278522|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG|
22278523|NCT03369158|Medacta International|Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
22296203|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com|
22296204|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
22296205|NCT02663674|Duke Clinical Vaccine Unit|Emmanuel Walter, M.D., M.P.H.|919-620-5346|walte002@mc.duke.edu|
22296206|NCT02811445|Tufts University HNRCA|Michael Lustgarten|617-556-3399|Michael.Lustgarten@tufts.edu|
22296207|NCT01386554|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22296208|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22296209|NCT04166513|Medical College of Wisconsin|Sara Pillay|414-955-4482|Sapillay@mcw.edu|
22296210|NCT05286307|NYU Langone Health|Eric J Strauss, MD|646 501-7223|Eric.Strauss@nyulangone.org|
22296211|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org|
22296212|NCT04568590|Wake Forest University School of Medicine|Elizabeth Halvorson, MD, MS|336-716-4999|ehalvors@wakehealth.edu|
22296213|NCT02489344|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22296214|NCT01132482|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|Taylor-CousarJ@NJHealth.org|
22296215|NCT04499781|NYU Langone Health|Ann-Margaret Navarra, PhD, CPNP-PC|631-638-0859|amd363@nyu.edu|
22296216|NCT03019107|Liberate Medical|Angus Mclachlan|+1 (833) 203-4663|info@liberatemedical.com|
22278524|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu|
22278525|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590||
22278526|NCT04378153|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
22278527|NCT03345550|University of Michigan|Frederick Korley|734 647-0261|korley@med.umich.edu|
22278528|NCT02085980|The Christ Hospital - Cincinnati, OH|Dr. Mickey Karram|(513) 463-2500|mickey.karram@thechristhospital.com|
22278529|NCT03895476|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
22278530|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278531|NCT03014089|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22278532|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu|
22278533|NCT00734032|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278534|NCT03562156|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
22278535|NCT03468998|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059341125|rva@uab.edu|
22278536|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22278537|NCT02296099|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
22278538|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com|
22278539|NCT03412591|Penn State College of Medicine|Dr. Scott Bunce|2155108295|sbunce@pennstatehealth.psu.edu|
22278540|NCT02272985|University Medical Center Groningen|Dr. C.F.M. Franssen|+0031(0)50 3616161|c.f.m.franssen@umcg.nl|
22278541|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com|
22278542|NCT02489279|Think Now, Inc.|Dr. Gregory V. Simpson|4156016522|greg@think-now.com|
22278543|NCT03440411|Fondazione EMN Italy Onlus|Fondazione EMN Italy Onlus|+39 011 0243236|clinicaltrialoffice@emnitaly.org|
22278544|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22278545|NCT03707821|Johnson & Johnson VIsion|John Buch OD, MS, FAAO Sr. Principal Research Optometrist|9044431707|JBUCH@its.jnj.com|
22278546|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22278547|NCT03673176|Stanford University|Joseph Shrager, MD|(650) 721-2086|shrager@stanford.edu|
22278548|NCT02378480|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
22278549|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22278550|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com|
22278551|NCT03802916|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
22278552|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org|
22278553|NCT01285102|Fox Chase Cancer Center|Dr. Efrat Dotan|215-214-4283|Efrat.Dotan@fccc.edu|
22278554|NCT02157610|Moffitt Cancer Center|Jennifer Vidrine, PhD, MS|813-745-8764|jennifer.vidrine@moffitt.org|
22278555|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
22278556|NCT02697448|Medical University of South Carolina|George Guldan|(843) 792-2322|guldan@musc.edu|
22278557|NCT05473715|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
22278558|NCT02743221|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr Patrick Therasse|+33 1 55 72 43 47|patrick.therasse@servier.com|
22296217|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu|
22296218|NCT04318990|Baylor Scott and White Resarch Institute|Sarah Hale|469-814-4845|sarah.hale@bswhealth.org|
22296219|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333|pintakorn@yahoo.com|2301
22296220|NCT04105998|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22296221|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696|karen-beckman@ouhsc.edu|37536
22296222|NCT04232670|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
22296223|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22278559|NCT04547556|UMC Utrecht|Dr Cristina Prat Aymerich|+31631118128|c.prataymerich-2@umcutrecht.nl|
22278560|NCT01946880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22278561|NCT02609503|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22278562|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161|rujeles@javeriana.edu.co|2240
22278563|NCT01969409|University of Alabama at Birmingham|Steven R. Duncan, MD|(205) 934-5017|duncsr19@uab.edu|
22278564|NCT02799043|Abbott|Anne Sarver, PhD|1-651-756-3813|anne.sarver@abbott.com|
22296224|NCT03632655|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-9600|jch9011@med.cornell.edu|
22296225|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22296226|NCT02073279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22296227|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22296228|NCT05074693|University of Houston|Michael Zvolensky, Ph.D.|713-743-8056|mjzvolen@Central.UH.EDU|
22296229|NCT03338062|IndianaU|Dr. Ryan Rhome|(317) 944-1367|rrhome@iu.edu|
22296230|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com|
22267876|NCT00111241|Monash University|Prof Susan Davis|+61399030827|susan.davis@monash.edu|
22267877|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267878|NCT04977479|National Institute of Allergy and Infectious Diseases|Pamela Frischmeyer-Guerrerio|301-402-9782|pamela.guerrerio@nih.gov|
22267879|NCT04536376|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@MAYO.EDU|
22267880|NCT01191450|Eurofarma Laboratórios S.A|Eurofarma Laboratórios S.A|50 11 5090-8415|fernanda.martinez@eurofarma.com.br|
22267881|NCT05287230|University of South Carolina|Dr. Monique Brown|8037775057|brownm68@mailbox.sc.edu|
22267882|NCT02360215|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22267883|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu|
22267884|NCT04515147|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22267885|NCT04123405|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22267886|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22267887|NCT00545714|Hoffmann-La Roche|Medical Communications|800--821--8590|global-roche-genentech-trials@gene.com|
22267888|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com|
22267889|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu|
22267890|NCT01202175|Univeristy of California, San Diego|Joachim H. Ix, MD, MAS|858-552-7528|joeix@ucsd.edu|
22267891|NCT04747470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22267892|NCT02790437|Hansa Biopharma AB|Elisabeth Sonesson, Director Clinical Operations|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
22267893|NCT03805386|Mayo Clinic Arizona|Principal Investigator, Dr Johnny Yi|14803420612|yi.johnny@mayo.edu|
22267894|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
22267895|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22267896|NCT02414958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267897|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org|
22267898|NCT04542057|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
22267899|NCT03624192|AVITA Medical|VP, Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
22267900|NCT01640249|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22267901|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22267902|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22267903|NCT00100828|SKCCC at Johns Hopkins|Arlene Forastiere|410-955-9818|af@jhmi.edu|
22267904|NCT04583735|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22267905|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
22267906|NCT01215136|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22267907|NCT03757819|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22267908|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22267909|NCT05824754|University of Michigan|Inbal Billie Nahum-Shani|7346609626|inbal@umich.edu|
22267910|NCT04421131|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
22267911|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com|
22267912|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343||
22267913|NCT00838526|Eisai Inc.|Eisai Medical Information, Eisai|+1 888 274 2378|esi_medinfo@eisai.com|
22267914|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu|
22267915|NCT04338022|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22267916|NCT00786409|University of Chicago|Linda Wagner-Weinter, MD|773-702-2245|lww@uchicago.edu|
22267917|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org|
22267918|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267919|NCT00115076|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
22267920|NCT02273388|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267921|NCT04331808|Hopital Hotel Dieu (AP-HP)|Dr Raphael Porcher|+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
22278565|NCT04642079|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278566|NCT03813121|Wake Forest University School of Medicine|Dr. Merideth Addicott|336-716-7792|maddicot@wakehealth.edu|
22278567|NCT02226653|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22278568|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278569|NCT03131479|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22278570|NCT04439903|University of Virginia Center for Diabetes Technology|Patricio Colmegna, PhD|434-924-5592|pc2jx@virginia.edu|
22278571|NCT01111552|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22278572|NCT05135754|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
22296231|NCT04340362|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22296232|NCT01689701|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
22296233|NCT02417701|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
22296234|NCT02375113|The University of Texas at San Antonio|Dr. Meizi He|2104585416|meizi.he@utsa.edu|
22296235|NCT01214629|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22296236|NCT03107754|University of Hawaii|Dr. Reni Soon|808-983-6000|rsoon@hawaii.edu|
22296237|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300||
22296238|NCT01953120|UCLA|Dr. Suphamai Bunnapradist|3107948516|bunnapradist@mednet.ucla.edu|
22296239|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22296240|NCT01857232|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875149|GabrielFox@acaciapharma.com|149
22296241|NCT02733588|Joslin Diabetes Center|Mary-Elizabeth Patti, MD|617-309-2665|mary.elizabeth.patti@joslin.harvard.edu|
22296242|NCT04387435|University of California, Los Angeles|Olujimi Ajijola, MD, Phd|310-206-2235|oajijola@mednet.ucla.edu|
22296243|NCT03305822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22296244|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22296245|NCT02573857|Medicines for Malaria Venture|Dr Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
22296246|NCT04501666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22296247|NCT00642941|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
22296248|NCT01991457|University of Alabama at Birmingham|Dr. Omer Jamy|2059349294|omerjamy@uabmc.edu|
22296249|NCT03051607|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
22296250|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
22296251|NCT03338855|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22296252|NCT03965533|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22296253|NCT03605303|Johnson & Johnson Vision Care Inc.|Brian Pall OD, MS, FAAO - Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
22296254|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org|
22296255|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu|
22296256|NCT02626520|Essentia Health|Dr. Bret Friday|218-786-3625|bret.friday@essentiahealth.org|
22267922|NCT02445963|Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC)|Christopher Duplessis, MD|301-319-9047|Christopher.a.duplessis.mil@mail.mil|
22267923|NCT02421055|Imperial College London|Dr Nicholas Penney|020 7589 5111|n.penney@imperial.ac.uk|
22278573|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com|
22278574|NCT04309500|University of Michigan|Annalise M. Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
22278575|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22278576|NCT02679274|University of Texas Medical Branch|Dr. Edgar L. Dillon|409 772 8701|eldillon@utmb.edu|
22278577|NCT04548219|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22278578|NCT03193437|Georgetown University|Chul Kim, MD|(202) 444-2223|Chul.Kim@gunet.georgetown.edu|
22278579|NCT04976855|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
22278580|NCT02038036|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296257|NCT03143569|WASHINGTON UNIVERSITY|Thomas J Graetz|3147474155|graetzt@wustl.edu|
22296258|NCT02472795|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
22296259|NCT04616547|Markey Cancer Center|Dr. Zin Myint|866-340-4488|zin.myint@uky.edu|
22267924|NCT01957176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22267925|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
22267926|NCT03172494|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22267927|NCT04233073|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22267928|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267929|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590||
22267930|NCT04589663|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22278581|NCT02397720|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
22278582|NCT02605616|University of Virginia|Dr. Rita Basu|434-924-5183|rb4vd@virginia.edu|
22296260|NCT03676218|Institut Bergonié, Bordeaux Comprehensive Cancer Center|Carine Bellera, PhD|+33 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
22296261|NCT05636098|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22296262|NCT04318080|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22309498|NCT06457802|Vanderbilt University School of Nursing|Dr. Shelagh Mulvaney, PhD|6153221198|shelagh.mulvaney@vanderbilt.edu|
22278583|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org|
22278584|NCT02657356|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22309499|NCT03896867|University of Minnesota|Benjamin Kloesel|612-301-1245|bkleosel@umn.edu|
22278585|NCT00834574|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278586|NCT03768336|Massachusetts General Hospital/Harvard Medical Schoool|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
22278587|NCT02278003|Memorial Sloan Kettering Cancer Center|Dr. Eric Kelhoffer, MD|212-639-8781|kelhoffe@mskcc.org|
22278588|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22278589|NCT00313560|Sidney Kimmel Comprehensive Cancer Center|Dr. Amol Narang|410-502-3823|anarang2@jhmi.edu|
22278590|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278591|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22322913|NCT04506294|Children's Hospital of Philadelphia|Nancy Kassam-Adams, PhD (Principal Investigator)|215-590-3118|adamsn@chop.edu|
22278592|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com|
22278593|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov|
22278594|NCT02301897|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22278595|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623||
22278596|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567|kdumble@uwaterloo.ca|32694
22278597|NCT02684461|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|gmelahat@med.unc.edu|
22278598|NCT03663582|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22278599|NCT02069847|Mayo Clinic|Michael B. Wallace|507-953-2221|wallace.michael@mayo.edu|
22278600|NCT04189484|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
22278601|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300||
22278602|NCT04507763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278603|NCT03322566|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22278604|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org|
22278605|NCT03177798|Vanderbilt University Medical Center|Dr. Jorge L. Gamboa|615-343-4176|jorge.gamboa@vumc.org|
22278606|NCT00425555|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22278607|NCT05763381|The Geneva Foundation|Elizabeth Metzger, Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
22278608|NCT01847014|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani|6508086586|scott.tsurutani@actelion.com|
22278609|NCT05498870|Medical University of South Carolina|Carey Brewbaker|843-792-2322|brewbake@musc.edu|
22278610|NCT06045273|Johns Hopkins Center for Indigenous Health|Dr. Victoria O'Keefe|410-955-6931|vokeefe3@jhu.edu|
22278611|NCT02592863|University of Missouri|Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
22278612|NCT02947048|Yamo Pharmaceuticals|Tracy Fischer|8596855862|tfischer@yamopharma.com|
22278613|NCT03658304|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22278614|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22278615|NCT04661839|Emergent BioSolutions Canada Inc.|Clinical Development Representative|204-275-4074|ctgov@ebsi.com|
22278616|NCT03895372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278617|NCT03685149|University of Rochester|Dr. Wojciech Zareba|585-275-5391|wojciech_zareba@urmc.rochester.edu|
22278618|NCT06301815|University of Winchester|Amelia Shaw|01962 717478|a.shaw2.18@unimail.winchester.ac.uk|
22278619|NCT02951819|Janssen Scientific Affairs|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22278620|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22278621|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
22278622|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22278623|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
22278624|NCT03232567|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|sholland@altimmune.com|40
22278625|NCT02655601|BioMimetix JV, LLC|Sara Penchev|610-308-6640|sara.penchev@bmxpharma.com|
22278626|NCT05837481|Massachusetts General Hospital|Chien Yi Maximilian Png, MD|617-726-5308|cypng@mgh.harvard.edu|
22278627|NCT02014376|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22278628|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
22309500|NCT04084288|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|
22309501|NCT03974178|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41229069239/+41795431713|ovalverde@dndi.org|
22309502|NCT04880863|NeoTX Therapeutics Ltd.|Dr. Ilana Lorber, VP of Clinical Operations|+972-3-912-5853|ilanal@neotx.com|213
22309503|NCT03899259|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22309504|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309505|NCT05670587|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309506|NCT03738852|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
22278629|NCT04011241|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22278630|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22278631|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267931|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623||
22267932|NCT02764151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267933|NCT00736632|Washington University in St. Louis|Dr. Carlos Bernal-Mizrachi|314-362-0947|cbernal@wustl.edu|
22296263|NCT06308822|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22296264|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296265|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no|
22296266|NCT03055000|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
22296267|NCT04734652|CAPRISA|Dr Anushka Naidoo|031 655 0668|anushka.naidoo@caprisa.org|0669
22296268|NCT05027438|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD (Principal Investigator)|(412) 360-2806|adam.bramoweth@va.gov|
22296269|NCT04729127|University of Pennsylvania|Melanie Pellecchia|215-746-1950|melanie.pellecchia@pennmedicine.upenn.edu|
22296270|NCT02807350|Jaeb Center for Health Research|Raymond Kraker, Coordinating Center Director|(813)-975-8690|rkraker@jaeb.org|
22296271|NCT03662542|Janssen Research & Development, LLC|Head of Gastroenterology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22296272|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22296273|NCT01217060|UT MD Anderson Cancer Center|Steven H. Lin, Associate Professor, Radiation Oncology Department|(713) 563-8490|shlin@mdanderson.org|
22296274|NCT03388138|Johnson & Johnson Vision Care, Inc.|Brian Pall O.D, MS, FAAO|1-800-843-2020|bpall@its.jnj.com|
22296275|NCT01528072|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
22296276|NCT02996864|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22296277|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448|anita.sc@brac.net|3719
22296278|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org|
22296279|NCT02436759|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|9088091423|mvelasco@osmotica.com|
22296280|NCT04014075|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22296281|NCT01912287|NYU Langone Health|Naomi Simon|646-754-4507|Naomi.Simon@nyulangone.org|
22296282|NCT02631850|University of Massachusetts Lowell|Lynne Gauthier|9789345383|lynne_gauthier@uml.edu|
22296283|NCT04600414|University of Washington|John Fortney, Professor|2066856955|fortneyj@uw.edu|
22296284|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org|
22296285|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org|
22296286|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296287|NCT01471106|M D Anderson Cancer Center|Dr. Arun K. Banu|(713) 792-2817|barun@mdanderson.org|
22296288|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
22296289|NCT01879332|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22296290|NCT03087760|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
22296291|NCT01505868|UT MD Anderson Cancer Center|Paul Corn, MD PHD- Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
22296292|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu|
22296293|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
22296294|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296295|NCT01895855|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
22296296|NCT03559257|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296297|NCT00706407|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
22296298|NCT03630120|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
22296299|NCT03251079|Senseonics, Incorporated|Katherine Tweden, PhD|651.335.2205|Katherine.Tweden@senseonics.com|
22296300|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
22296301|NCT01519960|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|61 6878333|global.trial_information@roche.com|
22296302|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu|
22296303|NCT02658357|Braeburn|Christine Kampf|6104678728|ckampf@braeburnrx.com|
22296304|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com|
22296305|NCT02654483|Stanford University|Irene Bailey, CRC|650-721-7149|baileyhi@stanford.edu|
22296306|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240|aliya_jiwani@meei.harvard.edu|4240
22296307|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
22296308|NCT02014844|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22296309|NCT02953314|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22296310|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111|David.Ready@va.gov|7082
22296311|NCT00492115|UCSD|Dr. Sonia Ancoli-Israel|858 822 7710|sancoliisrael@ucsd.edu|
22296312|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22296313|NCT03194555|Allodynic Therapeutics, Inc.|Dr. Annette Toledano, Sponsor-Investigator|+13058956808|annette.toledano@allodynic.com|
22296314|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000|sierra.gower@va.gov|5946
22296315|NCT03831347|Butler Hospital|Dr. Lisa Uebelacker|401-455-6200|LUebelacker@butler.org|
22296316|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu|
22296317|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22296318|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22296319|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
22296320|NCT03255382|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22296321|NCT02221284|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22296322|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110||
22296323|NCT03251508|UNC Food Allergy Initiative|Edwin Kim, MD, MS|919-537-3193|edwinkim@email.unc.edu|
22296324|NCT00101907|Amgen Inc.|Study Director|866-572-6436||
22296325|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296326|NCT00471848|European Group for Blood and Marrow Transplantation|Prof. Judith Marsh|+31 (0)71 5265005|a.j.barrois@lumc.nl|
22296327|NCT01556581|Madigan Army Medical Center|Dr. Dan Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
22296328|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
22296329|NCT01474876|AbbVie|Global Medical Information|800-633-9110||
22296330|NCT02291055|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
22296331|NCT04035161|Becton Dickinson|Erin Zook, PhD|224-358-5019|erin.zook@bd.com|
22296332|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk|
22296333|NCT00631566|Infectious Disease Clinical Research Program, USUHS and HJF|Dr. Brian Agan, Deputy Science Director|301-816-8446|bagan@idcrp.org|
22296334|NCT03839212|University of Miami|Daniel E. Jimenez, Ph.D., Associate Professor|3052432776|dej18@miami.edu|
22296335|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500|matsuda@medicinova.com|132
22296336|NCT04640519|Columbia University|Imama Naqvi, MD|646-426-3876|ian2108@cumc.columbia.edu|
22296337|NCT03479307|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
22296338|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org|
22296339|NCT02113956|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-5858|michele@innovativepublichealth.org|801
22296340|NCT02467465|Universidad Complutense de Madrid|Miguel Suárez Varela|+34913941518|misuarezvarela@gmail.com|
22296341|NCT01499563|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinialTrials@itci-inc.com|
22296342|NCT03658538|Johns Hopkins University|Dr. Nadia Hansel|410-955-3841|nhansel1@jhmi.edu|
22296343|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu|
22296344|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@bwh.harvard.edu|
22296345|NCT02926924|University of Michigan|Rakesh Patel|734 615-2002|rakeshpa@med.umich.edu|
22296346|NCT02410382|University of Arizona|Dr. Sun K. Yi|(520) 694-7236|sunkyi@email.arizona.edu|
22296347|NCT04916600|Wayne State University School of Medicine|Dr. Mark Greenwald, Professor|3139933965|mgreen@med.wayne.edu|
22296348|NCT03303404|University of Texas at Austin|Brandon Fico|512-471-8594|bfico@utexas.edu|
22296349|NCT04146545|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
22296350|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk|
22296351|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22296352|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296353|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu|
22296354|NCT01959542|Brigham and Women's Hospital/Dana-farber Cancer Institute|Dr. Fiona Fennessy|617 632 4891|ffennessy@bwh.harvard.edu|
22296355|NCT03050619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296356|NCT04762680|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22296357|NCT01879228|University of Pennsylvannia|Paola Alvarado|215-746-2081|paola.alvarado@pennmedicine.upenn.edu|
22267934|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22267935|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22267936|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267937|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267938|NCT02729909|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22267939|NCT03220854|Virginia Commonwealth University Massey Cancer Center|Alfredo I Urdaneta|(804) 828-0450|MasseyRadOnc@vcu.edu|
22267940|NCT04779879|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22267941|NCT05101343|Winthrop University|Compliance Coordinator|8033232460|smithmr@winthrop.edu|
22267942|NCT02854527|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22267943|NCT01959295|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22267944|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com|
22267945|NCT01128179|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22267946|NCT01682811|Medical College of Wisconsin|Harry T. Whelan MD, Bleser Professor of Neurology|414-266-7544|hwhelan@mcw.edu|
22267947|NCT01004744|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
22267948|NCT03475992|MVG Industries|Luc Duchesne|0033169298156|luc.duchesne@mvg-world.com|
22267949|NCT02694328|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22267950|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu|
22267951|NCT05954988|Rein Therapeutics, Inc.|Shawna Evans|1 (737) 802-1989|info@reintx.com|
22267952|NCT06146361|The University of Texas Health Science Center at Houston|Maria E. Fernandez-Esquer, PhD|713-500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
22267953|NCT04952922|The Royal Marsden NHS Foundation Trust|Dr Grainne Brady|0000000000000|grainne.brady@rmh.nhs.uk|
22278632|NCT02871440|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
22278633|NCT02420314|University of Iowa|Dr. Muhammad Furqan|319-356-1616|muhammad-furqan@uiowa.edu|
22278634|NCT02251041|UZLeuven|Diethard Monbaliu|+32 16 348727|diethard.monbaliu@uzleuven.be|
22278635|NCT01046669|Spectral Diagnostics Inc.|Debra Foster, VP Clinical Development|4166263233|dfoster@spectraldx.com|2001
22278636|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22278637|NCT02915601|University of Colorado Anschutz Medical Campus|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@cuanschutz.edu|
22278638|NCT01848457|The Children's Hospital of Philadelphia|Frank Balis, MD|2674265414|balisf@email.chop.edu|
22278639|NCT03975660|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
22278640|NCT02181413|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22278641|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu|
22278642|NCT02298946|National Cancer Institute|Dr. Tim F. Greten|301-451-4723|gretentf@mail.nih.gov|
22278643|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300||
22278644|NCT03034044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278645|NCT02412436|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22278646|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22278647|NCT04603560|Brigham and Women's Hospital|Nancy Haff, MD, MPH|617-278-0930|nhaff@mgb.org|
22278648|NCT04732468|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22278649|NCT03514134|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
22278650|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22278651|NCT04976777|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22278652|NCT05654181|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278653|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu|
22278654|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu|
22278655|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com|
22296358|NCT02584504|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22278656|NCT02956473|Dana-Farber/Brigham Cancer Center|Dr. Tari King|617-582-8292|tking7@bwh.harvard.edu|
22278657|NCT03033784|The University of Toledo|Elissar Andari, PhD|419-383-5227|elissar.andari@Utoledo.edu|
22278658|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278659|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
22278660|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22278661|NCT04033640|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
22278662|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22278663|NCT01599286|Children's National Hospital|Robert McCarter|202-476-3140|RMcCarte@childrensnational.org|
22278664|NCT02263547|University of South Florida, COM Neurology|Assistant Director of Research|8139746378|aaungst@health.usf.edu|
22278665|NCT02332928|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center Cancer Prevention & Control Team|877-462-7739|masseycpc@vcu.edu|
22278666|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22278667|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22278668|NCT01052779|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22278669|NCT03580044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278670|NCT03524157|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22278671|NCT02743962|University of Bradford|Hilary Pape|01274 236228|hpape@bradford.ac.uk|
22278672|NCT04805593|Alcon Research, LLC|Clinical Projects Director, Surgical|18884513937|alcon.medinfo@alcon.com|
22278673|NCT01661283|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22278674|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278675|NCT06582732|Glaukos Corporation|Study Director|714-478-2287|ldoan@glaukos.com|
22278676|NCT03931330|Medical College of Wisconsin|Gisela Chelimsky, MD|414-266-3690|gchelimsky@mcw.edu|
22278677|NCT03412929|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
22278678|NCT04330859|University of Virginia Children's Hospital|Santina Zanelli|4349242697|sz5d@virginia.edu|
22278679|NCT04897568|University of Colorado|Dan Mattlock|(303)724-9941|daniel.matlock@cuanschutz.edu|
22278680|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278681|NCT02135133|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(877) 442-3324|Jennifer_Brown@dfci.harvard.edu|
22296359|NCT02432846|Immunicum Aktiebolag (AB)|Chief Medical Officer|+46 (0)8 732 84 00|info@immunicum.com|
22296360|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618||
22296361|NCT01998633|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22296362|NCT03992781|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296363|NCT01996826|Mass. Eye and Ear|Reza Dana, M.D., M. Sc, MPH|6175734331|Reza_Dana@meei.harvard.edu|
22296364|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com|
22278682|NCT03408262|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
22278683|NCT03607500|University of Michigan|Abhijit Naik|734-763-0990|abhinaik@med.umich.edu|
22278684|NCT03312543|Johnson & Johnson Consumer Inc.|Sidney Hornby|908-874-2756|SHornby@its.jnj.com|
22296365|NCT02734979|Stanford University|Dr. Stanley G Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine|650-725-7571|rockson@stanford.edu|
22278685|NCT04507269|Brii Biosciences Limited|Clinical Research|86 10 6299 8808|clinicaltrials@briibio.com|
22278686|NCT05852340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278687|NCT02120261|The University of Texas Health Science Center at Houston|Carlos J. Roldan, MD||Carlos.J.Roldan@uth.tmc.edu|
22278688|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu|
22278689|NCT04197583|Boston Scientific|Director, Clinical Operations|5133058628|teresa.takle-flach@bsci.com|
22278690|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493||
22278691|NCT03637348|Cornea Research Foundation of America|Marianne Price, PhD|3178142990|mprice@cornea.org|
22278692|NCT03285893|University of Minnesota|Joni Jensen|612-624-5178|jense010@umn.edu|
22278693|NCT04042311|Hull University Teaching Hospitals NHS Trust|Dr Sean Pymer|01482 674643|s.pymer@nhs.net|
22278694|NCT04134936|MorphoSys|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
22278695|NCT03518060|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278696|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278697|NCT03630679|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
22278698|NCT03538808|University of Alabama at Birmingham|Samantha Schiavon|9515509388|sschiavon@uabmc.edu|
22278699|NCT03709472|University of Miami|Victoria Mitrani|3052849139|vmitrani@miami.edu|
22278700|NCT03506360|Mayo Clinic|Yi Lin|5072845096|Lin.Yi@mayo.edu|
22278701|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk|
22278702|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org|
22278703|NCT05697380|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
22278704|NCT05293314|Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University，Shanghai, China|Jin-Fu Xu|008621 65115006|jfxu@tongji.edu.cn|
22278705|NCT00934180|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278706|NCT02613507|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22278707|NCT05572567|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22278708|NCT02620865|Karmanos Cancer Institute|Dr. Anthony Shields|313-576-8735|shieldsa@karmanos.org|
22278709|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu|
22278710|NCT05528445|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
22278711|NCT02471144|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22278712|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
22278713|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com|
22296366|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530||
22278714|NCT03977155|Boston Pharmaceuticals, Inc.|Craig Basson|(617) 655-9681|clinicaltrials@bostonpharmaceuticals.com|
22278715|NCT00936936|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, PhD. / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
22278716|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu|
22278717|NCT04073056|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat|212-523-2500|AliNima.Shariat@mountsinai.org|
22278718|NCT04717258|University of York|Sarah Cockaiyne|01904321736|sarah.cockayne@york.ac.uk|
22278719|NCT03440385|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22278720|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov|
22278721|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22278722|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu|
22278723|NCT02374255|Icahn School of Medicine at Mount Sinai|Radhi Yagnik|212-659-5933|radhi.yagnik@mountsinai.org|
22278724|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com|
22278725|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22278726|NCT01943227|UC Davis Medical Center|Neal Fleming, MD, PhD|916-734-5046|nwfleming@ucdavis.edu|
22278727|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22278728|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22278729|NCT01731782|Cleveland Clinic Florida Region|Dr. Conor Delaney|954-659-6001|DELANEC@ccf.org|
22278730|NCT03427619|University of Iowa|Dr. Richard Smith|319-356-2177|richard-smith@uiowa.edu|
22278731|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636||
22278732|NCT00127439|University of Louisville|Andrea L. Behrman, PhD, PT|502-582-7451|andreabehrman@catholichealth.net|
22278733|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu|
22278734|NCT06034340|Emory University|Dr. Eric Felner -Professor of Pediatrics|404-785-0935|efelner@emory.edu|
22278735|NCT01055028|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
22278736|NCT00361712|Rabin Medical Center|Dr Leonid Edilman|972-9376850|leidelman@clalit.org.il|
22278737|NCT04989218|The University of Alabama at Birmingham|Dr. Mehmet Akce, Associate Professor|2059342992|makce@uabmc.edu|
22278738|NCT02919618|Washington University|Dr. Phillip Cuculich|314-454-7698|pcuculic@wustl.edu|
22278739|NCT03528902|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
22278740|NCT03411044|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
22278741|NCT04620668|University of New Brunswick|Luke MacNeill|506-648-5500|luke.macneill@unb.ca|
22278742|NCT03896633|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22278743|NCT04047355|New York State Institute for Basic Research|J. Helen Yoo, Ph.D.|718-494-5295|jhelen.yoo@opwdd.ny.gov|
22278744|NCT01722643|Dartmouth-Hitchcock|Dr. Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
22278745|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.edu.br|
22278746|NCT04581395|IU school of Medicine, Department of Anesthesiology|Dr. Leighan Bye, Assistant Professor of Clinical Anesthesia|317-274-0275|lbye@iu.edu|
22296367|NCT03164928|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22296368|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422||
22296369|NCT04631029|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22296370|NCT01463644|McMaster University|Dr. Parameswaran Nair|905-522-1155|parames@mcmaster.ca|34934
22296371|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743||
22296372|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264|perrytamarat@uams.edu|43264
22296373|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com|
22296374|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com|
22296375|NCT02118012|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Christopher Koh, M.D.|(301) 443-9402|kohchris@mail.nih.gov|
22296376|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com|
22296377|NCT03329690|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22296378|NCT02290106|Massachusetts General Hospital|Takara Stanley, MD|6177249109|tstanley@mgh.harvard.edu|
22296379|NCT01422772|Helixmith Co., Ltd.|Jinsub Lee PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22296380|NCT02315170|Raj K M|Raj K Maturi MD|3178171414|maturi.md@midwesteye.com|
22296381|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22296382|NCT01980355|Spectrum Health|G. Paul Wright, MD|6162678540|paul.wright@spectrumhealth.org|
22296383|NCT02172742|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22296384|NCT00450333|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22296385|NCT01519414|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|(614) 293-6196|Paul.Monk@osumc.edu|
22322914|NCT02838407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322915|NCT02986230|HealthPartners Institute|Dr. Tom Elliott|218-525-7268|elliottt793@gmail.com|
22322916|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22322917|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22322918|NCT03618056|Fred Hutchinson Cancer Research Center|Jessica Andriesen|206-667-5812|jandries@fredhutch.org|
22322919|NCT04033419|University of North Carolina at Chapel Hill, Department of Psychiatry|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
22296386|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br|
22296387|NCT03855280|Medexus Pharma|Julissa Leon|3125483125|julissa.leon@medexus.com|
22296388|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590||
22322920|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22309507|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
22267954|NCT04075487|VA Maryland Health Care System, Geriatric Research, Education, and Clinical Center|Dr. Beth Hogans, M.D., Ph.D., Neurologist|410-605-7000|beth.hogans@va.gov|
22267955|NCT05411991|University Hospital Brussels - Vrije Universiteit Brussel|Prof. Dr. Frederik H. Verbrugge|024749657|frederik.verbrugge@uzbrussel.be|+32
22267956|NCT04653454|Mayo Clinic|Adrian Dumitrascu M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
22267957|NCT05473182|Grand Valley State Univeristy College of Health Professions|Dr. Lisa K. Kenyon|616-331-5653|kenyonli@gvsu.edu|
22267958|NCT05525520|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22267959|NCT05878093|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22309508|NCT04649476|Hospital of Stomatology, Wuhan university|Gang Chen, MD|+86 02787686215|geraldchan@whu.edu.cn|
22309509|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com|
22267960|NCT02721732|The University of Texas MD Anderson Cancer Center|Dr. Aung Naing|(713) 563-3885|anaing@mdanderson.org|
22267961|NCT06227052|Queen's Medical Center|Catherine Rault|808-686-4690|crault@hawaii.edu|
22309510|NCT04223505|University of Ottawa Heart Institute|Dr. Benjamin Chow|6136966786|bchow@ottawaheart.ca|
22267962|NCT04479852|Sirtsei Pharmaceuticals|Greg Rigdon, PhD|+1 919-949-6862|grigdon@arrivobio.com|
22267963|NCT04589247|Johns Hopkins University|Ranh Voong, MD|4105506597|kvoong1@jhmi.edu|
22267964|NCT04100018|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22267965|NCT02848001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22309511|NCT04508309|PATH|Niranjan Bhat, MD|206 302 4843|nbhat@path.org|
22267966|NCT04358081|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22267967|NCT06379048|Çam and Sakura City Hospital|Dr. Emre Kar|+90 (0212) 909 60 00|emre.kar@sbu.edu.tr|11250
22267968|NCT00725283|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267969|NCT03103087|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22267970|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org|
22267971|NCT03283566|Cleveland Clinic Foundation, Department of Endocroine and Metabolism|EMI Research Director|216 445-3757|jenkink@ccf.org|
22309512|NCT05482698|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2theraprutics.com|
22267972|NCT02760004|UMass Chan Medical School / UMass Memorial Health|Nancy Byatt, Tenured Professor of Psychiatry, ObGyn, and Population & Quantitative Health Sciences|508.856.5812|Nancy.Byatt@umassmemorial.org|
22278747|NCT00356187|Denver Health and Hospital Authority|Elizabeth Kingsley, Senior Grants Analyst|3036027061|elizabeth.kingsley@dhha.org|
22278748|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org|
22278749|NCT00815633|Icahn School of Medicine at Mount Sinai|Dr. Joshua Zeichner||joshzeichner@gmail.com|
22278750|NCT04248153|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
22278751|NCT02259231|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22278752|NCT03238196|Vanderbilt-Ingram Cancer Center|Brent Rexer, MD, PhD, Assistant Professor|615-322-4967|brent.rexer@vumc.org|
22278753|NCT05081843|University of Pittsburgh School of Public Health|Dr. Jaime Sidani|412-383-0733|jes107@pitt.edu|
22278754|NCT04629196|NYU Langone Health|David Hudesman, MD|646-501-9327|David.Hudesman@nyulangone.org|
22309513|NCT01674140|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|jmiao@fredhutch.org|
22278755|NCT03792737|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
22278756|NCT00835354|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278757|NCT02061085|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22278758|NCT05487378|APR Applied Pharma Research s.a.|Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
22278759|NCT05472870|Shanghai Jiaotong University School of Medicine Xinhua Hospital|Fei Li|18930830950|feili@shsmu.edu.cn|
22278760|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu|
22267973|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22267974|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22309514|NCT02305888|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22309515|NCT05139810|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22278761|NCT02414841|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
22267975|NCT04004481|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
22267976|NCT03889886|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
22322921|NCT03564626|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
22267977|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22322922|NCT01116544|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
22322923|NCT05168267|University of Wisconsin Madison - Incarceration and Mental Health Lab|Michael Koenigs|(608) 263-1679|mrkoenigs@wisc.edu|
22322924|NCT02937350|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22278762|NCT03053362|Brain and Cognition Discovery Foundation|Dr. Roger McIntyre|(416) 943-6284|rogermcintyre28@gmail.com|
22278763|NCT03918031|University of Houston|Brooke Kauffman|(713) 743-8056|byredmond@central.uh.edu|
22278764|NCT03164356|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
22278765|NCT05339659|Kaiser Permanente|Dr. Jennifer McClure|206-287-2737|jennifer.b.mcclure@kp.org|
22322925|NCT02419508|Alcon, A Novartis Division|Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22267978|NCT03901313|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22267979|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com|
22267980|NCT02423200|EIP Pharma|John Alam|617-945-0794|jalam@eippharma.com|
22267981|NCT04937881|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
22267982|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22267983|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de|
22267984|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org|
22267985|NCT02321111|University of Texas Health San Antonio|Laurie Che Kelly|210-617-5300|che@uthscsa.edu|14731
22267986|NCT00218387|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
22296389|NCT02738450|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
22267987|NCT01400477|University of Colorado|Dr. Robert Freedman|393 724 1000|robert.freedman@ucdenver.edu|
22296390|NCT03204305|Johns Hopkins School of Medicine|Dr. Elise M. Weerts, PhD, Professor|443-550-2781|eweerts@jhmi.edu|
22296391|NCT03439670|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
22296392|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
22296393|NCT02951156|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296394|NCT03388294|University of North Carolina at Chapel Hill|Linda R. Watson, EdD|919-966-1007|lwatson@med.unc.edu|
22296395|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22296396|NCT01092182|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|roschewskimj@nih.gov|
22296397|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296398|NCT01166178|Novartis|Study Director|41 61 324 1111||
22296399|NCT04948450|National Geriatric Hospital|Dr Nguyen Xuan Thanh|0983277646|xuanthanhbmlk@hmu.edu.vn|
22296400|NCT03930446|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22267988|NCT03934541|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22267989|NCT04408729|Massachusetts General Hospital|Jessica Haberer, MD, MS|617-724-0351|jhaberer@mgb.org|
22267990|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22267991|NCT04620746|Johns Hopkins University School of Medicine|Jonathan Zenilman|410-550-9080|jzenilm1@jh.edu|
22309516|NCT03800654|VA San Diego Healthcare System|Dr. Matthew Herbert|858-642-1411|Matthew.Herbert2@va.gov|
22267992|NCT04584502|Geisel School of Medicine|Sarah Lord, Ph.D.|6036467089|sarah.e.lord@dartmouth.edu|
22309517|NCT03459729|Froedtert and the Medical college of Wisconsin|Stuart Wong, MD|414-805-4600|swong@mcw.edu|
22267993|NCT02777372|The Johns Hopkins University School of Medicine|Liisa Hantsoo, Ph.D.|410-502-2334|LHantso1@jh.edu|
22267994|NCT05767905|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22267995|NCT05807828|1. Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou 2. Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-AUTh|Eustathios Kenanidis - Assistant Professor of Orthopaedic Surgery & Traumatology|6973693693|ekenanidis@auth.gr|
22267996|NCT03104855|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22267997|NCT03897634|Northwestern University|Kendra Marks|847-467-0897|kendra.marks@northwestern.edu|
22267998|NCT03404674|PATH|Rahsan Erdem|202-540-4546|rerdem@path.org|
22267999|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com|
22268000|NCT01903798|SCIRE|Executive Director, Southern California Institute for Research and Education|562-826-8000|Sabry.Eassa@va.gov|5747
22268001|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk|
22309518|NCT06182033|Crane Center for Early Childhood Research and Policy at The Ohio State University|Dr. Laura Justice|614-247-7488|justice.57@osu.edu|
22268002|NCT02635984|AU Medical Center / University of Georgia College of Pharmacy|Dr. Amber Clemmons, Clinical Pharmacist - BMT/Hematology & Clinical Associate Professor|706-721-6493|aclemmons@augusta.edu|
22309519|NCT05476328|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22268003|NCT03135015|Housey Healthcare ULC|Project Manager|2486637000|info@housey.com|
22268004|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org|
22268005|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
22268006|NCT03518008|Alcon Research|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22309520|NCT02626533|Hospital for Special Surgery, Anesthesiology|Dr. Meghan Kirksey|2126061036|KirkseyM@hss.edu|
22268007|NCT02501928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268008|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22296401|NCT01762631|Pennington Biomedical Research Center|Leanne Redman, PhD|2257630947|leanne.redman@pbrc.edu|
22296402|NCT03141281|Florida State University|Dr. Neil Charness|850-644-6686|charness@psy.fsu.edu|
22296403|NCT00657241|SUNYBuffalo|Joseph L. Izzo Jr. M.D.|716-898-5625|jizzo@buffalo.edu|
22296404|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com|
22296405|NCT02738151|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22296406|NCT03333044|NYU Langone Health|Shinu Mammen|646-501-3484|shinu.mammen@nyulangone.org|
22296407|NCT01892371|The University of Texas MD Anderson Cancer Center|Yesid Alvarado MD./Associate Professor|713-794-4364|yalvarado@mdanderson.org|
22296408|NCT02893878|GlaxoSmithKline|GSK Response Center|866-435-7343||
22309521|NCT02151981|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22309522|NCT03847311|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
22296409|NCT04007094|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22296410|NCT02921776|The Ohio State University|Mary Beth Happ, PhD, RN|614-292-8336|happ.3@osu.edu|
22296411|NCT05247229|Department of Medicine, Division of Occupational, Environmental, and Climate Medicine, University of California|Matthew O. Gribble|‭(949) 350-6134‬|matt.gribble@ucsf.edu|
22296412|NCT01928524|Odense University Hospital|Per Pfeiffer|+45-26283844|per.pfeiffer@rsyd.dk|
22296413|NCT01239368|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
22296414|NCT02145039|University of Minnesota Cancer Center|Dr. Claudio Brunstein|612-625-8942|bruns072@umn.edu|
22296415|NCT03181399|Weill Cornell Medicine|Dr. Juan Pascual|(212) 746-3278|jup9003@med.cornell.edu|
22296416|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu|
22296417|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
22296418|NCT01921179|San Francisco VA HCS|Dr Tatjana Novakovic-Agopian|415-753-3888|tatjana.novakovic-agopian@va.gov|
22296419|NCT01002755|The University of Texas M D Anderson Cancer Center|Ferrajoli,Alessandra M.D.|713-792-2063|aferrajo@mdanderson.org|
22296420|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl|
22296421|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296422|NCT06145542|Zhejiang University|Dr. Xiao Tan|18651218270|xiao.tan@zju.edu.cn|
22296423|NCT02603809|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 19 77|clinical-trials-disclosure@idorsia.com|
22296424|NCT02953990|Virginia Commonwealth University School of Nursing|Patricia Kinser, PI|804-828-0724|kinserpa@vcu.edu|
22296425|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22296426|NCT01254227|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296427|NCT02750592|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
22296428|NCT02981342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296429|NCT03970733|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
22296430|NCT02341807|Spark Therapeutics|Clinical Director|1-866-647-7275|clinicaltrials@sparktx.com|
22296431|NCT02784821|University of Florida|Dr. Josef Neu|352-733-0111|neuj@peds.ufl.edu|
22296432|NCT02794103|Université de Montréal|Dr. Sylvie Le May, Professor & Researcher|514 345-4931|sylvie.lemay@umontreal.ca|4938
22296433|NCT00112502|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Chair Ad Interim, Neuro-Oncology|713-745-3072|jdegroot@mdanderson.org|
22296434|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22296435|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22296436|NCT02608268|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296437|NCT02994732|Biomed Valley Discoveries|Associate Director of Translational Sciences|636-887-6429|Dknoerzer@biomed-valley.com|
22296438|NCT03684512|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22296439|NCT03202264|McMaster University|Dr. Dee Mangin|905-525-9140|mangind@mcmaster.ca|21219
22296440|NCT02094716|Mylan Pharmaceuticals Pvt Ltd|Clinical Sciences Program Lead||prasannac.ganapathi@mylan.in|
22296441|NCT02430337|Georgia State University|Shannon Self Brown, PhD|404-413-1283|sselfbrown@gsu.edu|
22296442|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22296443|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22296444|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com|
22296445|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com|
22296446|NCT03839511|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
22296447|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123||
22296448|NCT00775931|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22296449|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu|
22296450|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com|
22296451|NCT03814746|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22296452|NCT05089682|Mayo Clinic|Dr. Gregory A. Worrell|507-538-4880|Worrell.Gregory@mayo.edu|
22296453|NCT02631954|INHA UNIVERSITY HOSPITAL|Sang-Heon Cho, Ph.D.|82-32-890-1122|shcho123@inha.ac.kr|
22296454|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22296455|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com|
22296456|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it|
22296457|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22296458|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200|a22141@adm.cgmh.org.tw|8969
22296459|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351||
22296460|NCT02809677|UT Southwestern Medical Center|Dr. E. Sherwood Brown|24-645-6950|sherwood.brown@utsouthwestern.edu|
22296461|NCT03971188|Washington University in St. Louis|Dr. Charles Goldfarb|(314) 362-3768|goldfarbc@wustl.edu|
22296462|NCT05172544|Najít Technologies, Inc.|Dr. Ian Amanna|9717273569|iamanna@najittech.com|
22296463|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
22296464|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu|
22296465|NCT00561080|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296466|NCT02295995|Durham VA HCS|Dr. Katherine S. Hall|919-286-0411|katherine.hall@duke.edu|6734
22278766|NCT03648372|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22278767|NCT05964166|Nationwide Children's Hospital|Dr. Joseph Tobias|6147224200|Joseph.Tobias@nationwidechildrens.org|
22278768|NCT03744637|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278769|NCT03134209|NYU Langone Health|Ran Schwarzkopf, MD|646-356-9405|Ran.Schwarzkopf@nyulangone.org|
22278770|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com|
22278771|NCT03332056|University of Washington|Jonathan Harper|2065988279|jdharper@uw.edu|
22278772|NCT01798225|Medical University of South Carolina|Renata Leite|843-792-3908|leiter@musc.edu|
22278773|NCT03360344|Loma Linda University|Donnamarie Krause|7347642243|donnamarie.krause@gmail.com|
22278774|NCT01145183|Baylor College of Medicine|Thomas Kosten, MD|713 798 8628|kosten@bcm.edu|
22278775|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206|kevin_fiscella@urmc.rochester.edu|205
22278776|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com|
22278777|NCT03840967|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22278778|NCT01765400|University of Nebraska Medical Center|Paul P Dobesh|402-559-3982|pdobesh@unmc.edu|
22278779|NCT04881058|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22278780|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com|
22278781|NCT05012579|Cala Health|Alex Kent|267-973-4180|alex.kent@calahealth.com|
22278782|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com|
22278783|NCT04484857|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-096Study@fibrogen.com|
22278784|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com|
22278785|NCT04507204|Purdue Pharma L.P.|Jaromir Mikl, PhD MSPH|800-745-7445|jaromir.mikl@pharma.com|7277
22278786|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278787|NCT00895921|Veterans Medical Research Foundation|Jonathan M. Meyer, MD|858-964-0777|jmmeyer@ucsd.edu|
22278788|NCT01905540|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22278789|NCT03729609|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22278790|NCT04700800|Mayo Clinic|Lori Roust|(602) 543-4254|Roust.Lori@mayo.edu|
22278791|NCT04770285|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22278792|NCT00645658|VA Palo Alto Health Care System|Jonathan Myers|6504503440|drj993@aol.com|
22278793|NCT04258631|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
22278794|NCT04481685|University of Kansas Medical Center|Gregory Gan, MD PhD|913 588 5881|ggan@kumc.edu|
22278795|NCT02527512|Boston Children's Hospital|Lauren Hutchinson, Clinical Research Manager|6179191632|lauren.hutchinson@childrens.harvard.edu|
22278796|NCT02457065|Dartmouth-Hitchcock Medical Center|Michael S Chapman, MD|(603) 650-5000|Michael.Shane.Chapman@hitchcock.org|
22278797|NCT01362790|National Cancer Institute|Dr. Raffit Hassan|301-451-8742|raffit_hassan@nih.gov|
22278798|NCT03038087|SENSE Diagnostics, Inc.|Joe Korfhagen|844-373-6730|jkorfhagen@senseneuro.com|
22278799|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu|
22278800|NCT01969214|Analyze & Realize|Felix Alt|+49 30 4000 8194|FAlt@a-r.com|
22278801|NCT01435356|EAU Research Foundation|Wim P.J. Witjes, MD, PhD Scientific and Clinical Research Director|+31 26 389 0677|w.witjes@uroweb.org|
22278802|NCT02796651|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22278803|NCT05360784|Bausch and Lomb|Johnson Varughese|908-927-1162|johnson.varughese@bausch.com|
22278804|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22278805|NCT03485157|MIMEDX|Chief Medical Officer|(770) 651-9100|CTInquiries@mimedx.com|
22278806|NCT04918771|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22278807|NCT02971163|Mount Sinai Medical Center|Dr. Marc A. Probst|212-824-8094|marc.probst@mssm.edu|
22278808|NCT01849276|Northwestern University|Dr. Jessica Altman|312-503-1761|J-altman@northwestern.edu|
22278809|NCT02702999|The University of Texas Health Science Center at Houston|Olaide Azizat Ashimi Balogun, MD|(713) 500-6412|Olaide.A.Ashimi@uth.tmc.edu|
22278810|NCT02657343|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22278811|NCT04104477|University of Florida|Jennifer Nichols, Ph.D.|352-294-8803|jnichols@ufl.edu|
22278812|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org|
22278813|NCT04910165|Saint Luke's University Health Network|Dr. Chinenye Nwachuku|6096101054|chinenye.nwachuku@sluhn.org|
22278814|NCT01813357|Monash University and Alfred Health|Dr Janine Trevillyan|03 90762000|janine.trevillyan@monash.edu|
22278815|NCT01799135|Dana Farber Cancer Institute|Raymond H. Mak|617.632.3591|RMAK@PARTNERS.ORG|
22278816|NCT02678377|Northwestern University|Dr. Kimberly Kenton|3124723874|kkenton@nm.org|
22278817|NCT01441492|Baylor College of Medicine|Amy McElhany, Clinical Research Manager|7137981016|pancreas@bcm.edu|
22278818|NCT03135067|University of Pennsylvania|Dr. Harsha Thirumurthy|215-746-0410|hthirumu@upenn.edu|
22278819|NCT03863574|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22278820|NCT05070819|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
22278821|NCT02607722|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22296467|NCT03158051|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|608-417-4224|khoppe2@wisc.edu|
22296468|NCT04262232|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
22296469|NCT02005250|Odense Universitetshospital, afd.M|Prof. Steen Bonnema|+4527339180|steen.bonnema@rsyd.dk|
22278822|NCT04347538|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD|615-343-8848|justin.h.turner@vumc.org|
22268009|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
22309523|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com|
22309524|NCT01922050|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22268010|NCT03737357|Institut Straumann|Anaïs Robert, Clinical Trial Leader|+41799258750|anais.robert@straumann.com|
22278823|NCT02871219|The University of Texas MD Anderson Cancer Center|Jason Westin, MD|(713) 792-3750|jwestin@mdanderson.org|
22268011|NCT01526057|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268012|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22268013|NCT04201197|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22278824|NCT04938427|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22268014|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
22268015|NCT02860546|Taiho Oncology, Inc.|Taiho|844-878-2446|medicalinformation@taihooncology.com|
22309525|NCT05645757|DynPort Vaccine Company, a GDIT Company|George Saviolakis|301-835-4101|George.Saviolakis@gdit.com|
22268016|NCT02466321|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
22268017|NCT01855828|Yale University|Lajos Pusztai, MD, DPhil|203-737-6858|lajos.pusztai@yale.edu|
22268018|NCT03649347|Stress, Trauma, and Anxiety Research Clinic (STARC) at Wayne State University|Kathleen Gorski, Research Coordinator|313-577-9202|kathleen.gorski2@med.wayne.edu|
22278825|NCT04906512|Ruijin Hospital|Dr. Hongping Qu|021-64370045|rjhcrc@126.com|
22309526|NCT03463044|INOTREM SA|Executive VP Research and Medical Sciences, INOTREM SA|30 62 86 51|jjg@inotrem.com|+33 (0)6
22268019|NCT05275920|NYU Langone Health|Amrita Mukhopadhyay, MD|212-263-7751|amrita.mukhopadhyay@nyulangone.org|
22268020|NCT02614274|University of Missouri|James L. Cook, Director of Research|573-884-4689|cookjl@health.missouri.edu|
22268021|NCT05655546|Scripps Research|Julia Moore Vogel|8587842275|immunocare@scripps.edu|
22268022|NCT03493685|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
22268023|NCT04452669|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
22268024|NCT02218463|University of Missouri-Kansas City School of Medicine|Dr. Tazim Dowlut-McElroy, M.D., M.S.|816-404-5150|tdowlut@cmh.edu|
22268025|NCT03700125|Barts Health NHS Trust|Dr Simon Finney|02073777000|simon.finney2@nhs.net|
22268026|NCT04576507|New York State Psychiatric Institute|Caroline A. Arout, Ph.D.|646-774-6167|caroline.arout@nyspi.columbia.edu|
22268027|NCT00413699|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278826|NCT01950520|NIDDK|Kong Chen, PhD, MSCI|301-451-1636|chenkong@niddk.nih.gov|
22278827|NCT01107496|Supernus Pharmaceuticals, Inc.|Jonathan Rubin, MD, Senior Vice President and Chief Medical Officer|240-403-5710|jrubin@supernus.com|
22278828|NCT03559556|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214-645-7637|robert.timmerman@utsouthwestern.edu|
22278829|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com|
22278830|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com|
22278831|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22278832|NCT04090749|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
22278833|NCT03510715|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22278834|NCT04262479|NTNU|Ingrid K Hals|+47 73412207|ingrid.hals@ntnu.no|
22278835|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com|
22278836|NCT02399228|University of Texas Health Science Center at San Antonio|Dr. Ying Li, M.D., Ph.D.|210-450-1719|liy8@uthscsa.edu|
22278837|NCT02457793|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22278838|NCT04316143|BIAL - Portela & Ca, SA|Responsible of Clinical Research & Operations|+351229866100|clinical.trials@bial.com|
22278839|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu|
22278840|NCT03396445|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22268028|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com|
22278841|NCT02964377|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
22278842|NCT04123704|Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center|Dr. C. Kent Osborne|713-798-1640|kosborne@bcm.edu|
22278843|NCT00836706|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278844|NCT02989857|Servier Pharmaceuticals LLC|Medical Affairs|888-788-1735|clinical.trial.management@servier.com|
22278845|NCT01992757|University of Pennsylvania Hospital|Rupa Chowdary|215-615-4105|rupa.chowdary@uphs.upenn.edu|
22278846|NCT02682056|Emory University|Eric Felner MD|404-727-7651|efelner@emory.edu|
22278847|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com|
22278848|NCT01882816|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
22278849|NCT02541591|ZOL Genk|Koen Ameloot|0485685969|koen.ameloot@zol.be|
22278850|NCT01344356|Mercy Research|Mercy Research Manager - Regulatory Operations|314-251-8827|michelle.bryant@mercy.net|
22278851|NCT05157360|Department of Surgery, University of Kansas School of Medicine-Wichita|Dr. Thomas Resch|316-268-5990|tresch@wsspa.com|
22278852|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu|
22268029|NCT01051310|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
22268030|NCT05989672|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268031|NCT03511105|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278853|NCT02965781|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
22268032|NCT02810457|Centus Biotherapeutics Limited|Clinical Trial Information|+353 1 609 7100|Clinical-Trial@centusbio.com|
22322926|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322927|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov|
22322928|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk|
22322929|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu|
22322930|NCT03219866|Wake Forest Health Science|Jill Ohar, MD|336-716-1210|johar@wakehealth.edu|
22322931|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22322932|NCT04698629|University of Washington|Dr. Judith Tsui|206-744-1835|tsuij@uw.edu|
22322933|NCT01821300|The Children's Hopsital of Philadelphia|Dr. Andrea Kelly|215590-3174|kellya@email.chop.edu|
22322934|NCT04663945|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|PT.studies@cuanschutz.edu|
22322935|NCT06228586|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22322936|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605|holloran@slu.edu|1
22322937|NCT03267004|University of Tennessee|Hollie Raynor|865-974-6259|hraynor@utk.edu|
22322938|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr|
22322939|NCT05556525|Mayo Clinic|Dr. Sebastian Fernandez-Bussy|904-953-6320|Fernandez-Bussy.Sebastian@mayo.edu|
22322940|NCT03694392|Kaiser Permanente Vaccine Study Center|Amber Hsiao Hyman, Senior Research Project Manger|510-267-7517|Amber.Hyman@kp.org|
22322941|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300||
22322942|NCT01891643|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22322943|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459|asinghal@partners.org|4
22322944|NCT04047797|MD Anderson Cancer Center|Hun J Lee, MD|713-792-2860|hunlee@mdanderson.org|
22322945|NCT01430442|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22322946|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu|
22322947|NCT03562663|Moss Rehabilitation Research Institute|Dylan Edwards|(215) 663-6411|EdwardDy@einstein.edu|
22322948|NCT00947531|EVERNeuro Pharma|Head of R&D|+43 7665 20555|stefan.winter@everpharma.com|0
22322949|NCT03856944|Gainesville Eye Associates|Clayton Blehm, MD|770-532-4444|claytonblehm@gmail.com|
22322950|NCT01773421|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22322951|NCT02327260|University of Missouri, Kansas City|Dr. Kym Bennett|816-235-6370|bennettkk@umkc.edu|
22322952|NCT03502330|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
22322953|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540|jjasien.ganyresearch@gmail.com|371
22322954|NCT01496157|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
22322955|NCT02804763|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22322956|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
22278854|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu|
22322957|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343||
22322958|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22322959|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22322960|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22322961|NCT02863848|Universitat Rovira i virgili|Dr. Joaquin Escribano|+ 34 977 759364|joaquin.escribano@urv.cat|
22322962|NCT02088385|Changi General Hospital|Dr Andrew Kwek Boon Eu|6788 8833|andrew_kwek@cgh.com.sg|
22322963|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu|
22322964|NCT03980938|EIP Pharma, Inc|Jennifer Conway|(617) 744-4400|jconway@eippharma.com|
22322965|NCT03580616|Dartmouth-Hitchcock Medical Center|Dr. Elijah Stommel|6036505104|elijah.w.stommel@hitchcock.org|
22268033|NCT01962103|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22268034|NCT02750618|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22268035|NCT03456102|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
22268036|NCT03077737|Northwestern University|Dr. Brian Hitsman, PhD|312-503-2074|b-hitsman@northwestern.edu|
22278855|NCT02829996|Inotek Pharmaceuticals Corp.|Roni Cohen|781-676-2100|rcohen@inotekpharma.com|
22278856|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278857|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com|
22278858|NCT03901430|University of New Mexico|Julia Hess|5052724462|jmhess@unm.edu|
22278859|NCT01697709|NYSPI|john mariani. MD|212-923-3031|John.mariani@nyspi.columbia.edu|
22278860|NCT02390076|Minneapolis VA Health Care System|Seth Disner|3105605990|disne014@umn.edu|
22268037|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com|
22268038|NCT04055740|University of Chicago|Dr. Andrew Beaser|(888) 824-0200|abeaser@bsd.uchicago.edu|
22268039|NCT01277783|Medtronic Bakken Research Center B.V.|Mireille van Ginneken, Principal Clinical Research Specialist|+31433566801|mireille.vanginneken@medronic.com|
22268040|NCT03347110|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22278861|NCT00600340|CECOG|MD. Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
22322966|NCT03706365|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22268041|NCT01321879|UT MD Anderson Cancer Center|Dr. Issam I. Raad/ Chair, Infectious Diseases|713- 792-7943|iraad@mdanderson.org|
22322967|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22322968|NCT00006227|NRG Oncology|Christopher Purdy on behalf of Mark Brady PhD|(716)845-1300|purdyc@nrgoncology.org|2296
22322969|NCT04557384|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22268042|NCT02687451|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22296470|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu|
22296471|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu|
22296472|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu|
22296473|NCT03628703|Cincinnati Children's Hospital Medical Center|Steve W. Wu, M.D.|513-636-4222|steve.wu@cchmc.org|
22296474|NCT04350788|UNC-CH School of Nursing|Biostatistician|919-966-7181|peiran@live.unc.edu|
22296475|NCT04537234|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22296476|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
22296477|NCT02070744|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22296478|NCT03084081|Cleveland Clinic|Miriam Cremer, M.D.|216-213-6460|cremerm@ccf.org|
22296479|NCT07114198|Inonu|Assistant Professor Merve Bilmez Selen|5457673089|merve.selen@inonu.edu.tr|
22296480|NCT01698463|University of Waterloo|Dr. Lora Giangregorio|(519) 888-4567|lmgiangr@uwaterloo.ca|36357
22296481|NCT04709575|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22296482|NCT02967692|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22296483|NCT06063603|Mayo Clinic|Andrea L. Cheville, MD|507-284-2511|cheville.andrea@mayo.edu|
22296484|NCT04447417|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22296485|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org|
22296486|NCT02155738|University of Pittsburgh|Halina Zyczynski|412-641-1440|hzyczynski@mail.magee.edu|
22296487|NCT01230931|The University of Texas Health Science Center at Houston|Catherine G. Ambrose, PhD||Catherine.G.Ambrose@uth.tmc.edu|
22296488|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296489|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu|
22296490|NCT02189473|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22296491|NCT03928847|University of California at San Francisco|Harold A. Chapman, M.D.|415-514-1210|hal.chapman@ucsf.edu|
22296492|NCT02385266|Northwestern University|Camila Bonin Pinto, PhD|3125033971|camila.pinto@northwestern.edu|
22296493|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu|
22296494|NCT02082210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296495|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu|
22296496|NCT03493828|New York Methodist Hospital|Dr Joel Yarmush|(718) 780-3279|joelyarmush@gmail.com|
22296497|NCT03460587|UCLA|Steven C. Cramer, MD|424-522-7273|sccramer@mednet.ucla.edu|
22296498|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296499|NCT04322396|Gentofte Hospital|Prof. Jens-Ulrik Stæhr Jensen, MD PHD|+4538673057|jens.ulrik.jensen@regionh.dk|
22296500|NCT01686841|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
22296501|NCT02066467|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
22296502|NCT04259762|University of New Mexico Health Sciences Center|Dr. Shiraz Mishra|505-925-6085|smishra@unm.edu|
22296503|NCT03453684|"University of Colorado Denver | Anschutz"|Melissa Brooks-Peterson, MD|30372411111|clinicalresearchsupportcenter@ucdenver.edu|
22296504|NCT00706979|Medical University of South Carolina'|Matthew J. Carpenter|843-792-3974|carpente@musc.edu|
22296505|NCT00470574|Memorial Sloan Kettering Cancer Center|Teresa Gilewski, MD|(212) 639-2000|gilewskt@mskcc.org|
22296506|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22268043|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com|
22268044|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268045|NCT03472014|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22268046|NCT03652051|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
22268047|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300||
22268048|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
22268049|NCT02394600|Kingston General Hospital|Dr. Anne Ellis|613-548-2336|ellisa@kgh.kari.net|
22268050|NCT02569801|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268051|NCT00776035|Washington University School of Medicine|Linda R. Peterson, MD, Professor of Medicine and Radiology|314-362-4577|lpeterso@wustl.edu|
22268052|NCT03442751|Glaukos|Valerie Smith|9493679600|VSmith@glaukos.com|
22268053|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
22268054|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu|
22268055|NCT00890617|Barbara Ann Karmanos Cancer Institute|Dr. Frank A. Baciewicz|(313) 993-0580|FBaciewi@dmc.org; baciewic@karmanos.org|
22268056|NCT01870778|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22268057|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org|
22268058|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu|
22268059|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696|my686chen@gmail.com|1205
22268060|NCT04429945|James A Haley Veterans Hospital|Dr. Christopher Fowler|619-647-4470|christopher.fowler3@va.gov|
22268061|NCT04870710|BIDMC|Dr. Paulo Lizano|617-754-1227|plizano@bidmc.harvard.edu|
22268062|NCT01329900|UT MD Anderson Cancer Center|Issa F Khouri, M.D. / Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
22268063|NCT01866098|Connecticut Mental Health Center|Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7500|cenk.tek@yale.edu|
22278862|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu|
22278863|NCT00725985|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22278864|NCT02546323|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22278865|NCT04476784|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22278866|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22278867|NCT02997085|Baylor Scott & White Research Institute|Dr. Mark Powers|2148652409|Mark.Powers1@bswhealth.org|
22278868|NCT00863304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278869|NCT00952692|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
22278870|NCT01182350|Dana-Farber Cancer Institute|Karen Wright|617.632.6740|KarenD_Wright@dfci.harvard.edu|
22278871|NCT04023487|University of Southern California|Beth Pyatak|323-442-2615|beth.pyatak@chan.usc.edu|
22278872|NCT00605189|KCI, an Acelity Company|Senior Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
22278873|NCT03898180|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22278874|NCT04503616|NYU Langone Health|Kelli Cole, NP|646-501-4848|Kelli.Cole@NYULangone.org|
22278875|NCT05030766|University of Miami|Dr. Taghrid Asfar|+1 (901) 371-7229|tasfar@miami.edu|
22278876|NCT03093415|Oregon Health and Sciences University|Andrew Seaman, MD|1 (971) 271 - 6102|seaman@ohsu.edu|
22278877|NCT03559530|Unversidade de Sao Paulo|Dr Priscila Rosalba Domingos de Oliveira|551126616900|priscila.rosalba@hc.fm.usp.br|
22278878|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22278879|NCT02958865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278880|NCT01309230|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
22278881|NCT02661815|Dana-Farber Cancer Insitute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
22278882|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22278883|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net|
22278884|NCT01648322|Generon (shanghai) corporation|Chief Medical Officer|8621-61760866|tangt@generonbiomed.com|
22278885|NCT04380142|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22278886|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu|
22278887|NCT04875533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
22278888|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu|
22278889|NCT02904096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22278890|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174||
22278891|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22278892|NCT03633058|Vanderbilt University Medical Center|Jeffrey L. Neul, MD, PhD, Principal Investigator|615-322-8242|jeffrey.l.neul@vumc.org|
22278893|NCT02757768|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22278894|NCT00835367|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278895|NCT00835172|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22278896|NCT04734210|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
22278897|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com|
22278898|NCT05296824|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
22278899|NCT04023045|Orthocare Innovations, LLC|Sarah Chang|425-771-0797|schang@orthocareinnovations.com|1007
22278900|NCT03373435|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
22278901|NCT00553254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278902|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu|
22278903|NCT02314923|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22278904|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org|
22278905|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de|
22278906|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu|
22278907|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com|
22278908|NCT02507934|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22278909|NCT03766399|AstraZeneca Clinical Study Information Center|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
22278910|NCT03331354|VA North Texas Health Care System|James LePage|214-857-0240|james.lepage@va.gov|
22278911|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu|
22296507|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296508|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300||
22296509|NCT02914769|UFRN|Draulio Barros de Araujo|+5584991225987|draulio@neuro.ufrn.br|
22296510|NCT02337907|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296511|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com|
22296512|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22296513|NCT02738333|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22296514|NCT00949325|Johns Hopkins University|David M. Loeb, M.D., Ph.D.|410-502-7247|loebda@jhmi.edu|
22322970|NCT02932787|Sheffield Hallam University|Martin Lamb|01142552782|m.lamb@shu.ac.uk|
22322971|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com|
22322972|NCT01505894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22322973|NCT03222427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22296515|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
22322974|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22322975|NCT01989221|TempleU|Dr. Henry Parkman|2157072498|henry.parkman@temple.edu|
22322976|NCT00059202|Mayo Clinic|Dr. Keith Lindor|507-284-2511||
22322977|NCT03378479|UZ Leuven|Prof. Dr. Joost Wauters - Intensivist|016344275|joost.wauters@uzleuven.be|
22322978|NCT04088409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22322979|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22296516|NCT03033511|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22296517|NCT03311659|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22296518|NCT04327388|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22296519|NCT04829318|Janssen-Cilag Limited|Director Global Medical Affairs Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22296520|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu|
22296521|NCT04053023|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22296522|NCT03447990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22296523|NCT02084147|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22296524|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22296525|NCT00862446|Vanderbilt University Medical Center|William Walsh|615-322-3476|bill.walsh@vumc.org|
22296526|NCT05104567|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22296527|NCT01464346|Medtronic Diabetes Clinical Research|Pamela Haworth||pamela.c.haworth@medtronic.com|
22296528|NCT03999892|Johns Hopkins|Gail Daumit|410 614 6460|gduamit@jhmi.edu|
22296529|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com|
22296530|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com|
22296531|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch|
22296532|NCT04056195|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
22296533|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de|
22296534|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296535|NCT01876485|Department of Veterans Affairs|Dr. LeChauncy Woodard|(713) 440-4441|woodard.lechauncy@va.gov|
22296536|NCT05734443|Virginia Tech|Michael Madigan|5402313543|mlm@vt.edu|
22296537|NCT03279692|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
22296538|NCT05986019|Medical University of South Carolina|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
22296539|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
22296540|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22296541|NCT02588833|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22296542|NCT04709341|Medical University of South Carolina|Samuel Bidwell- Research Manager|843-792-2305|bidwells@musc.edu|
22296543|NCT03649711|University of Arkansas for Medical Sciences|Dr. Nishank Jain, Associate Professor of Medicine|5016865295|njain2@uams.edu|
22296544|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org|
22296545|NCT04994444|Brown University|Dr. Patricia Cioe|4018636638|patricia_cioe@brown.edu|
22296546|NCT02117999|Studio Italiano di Oftalmologia|Marco Lombardo|+39 331 34 38 300|mlombardo@visioeng.it|
22322980|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300||
22296547|NCT01331148|Carolinas Healthcare System|Ifeyinwa Osunkwo, MD, MPH, Principal Investigator|980 442 5001|ify.osunkwo@carolinashealthcare.org|
22296548|NCT04439253|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22296549|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
22296550|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu|
22296551|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com|
22296552|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22296553|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org|
22322981|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
22322982|NCT01688050|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22322983|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22322984|NCT02876887|Northwestern University|Mary McDermott, MD, Jeremiah Stamler Professor|1 312 503 6419|mdm608@northwester.edu|6419
22322985|NCT03887299|University of Texas Medical Branch Galveston|Antonio F Saad|4097476646|afsaad@utmb.edu|
22322986|NCT03473561|Abbott Laboratories|Suntje Sander, PhD|0049 - 511 - 6750 3254|suntje.sander@abbott.com|
22322987|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22322988|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
22268064|NCT04239027|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22268065|NCT03629080|Hookipa Biotech GmbH|Hookipa Front Desk|+43 1 890 63 60 0|office@hookipapharma.com|
22309527|NCT05576155|University of Iowa|Kelsey Schwartz|319-467-3096|kelsey-schwartz@uiowa.edu|
22268066|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu|
22309528|NCT04515849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22268067|NCT03417687|Polarean|Laura Sutton|919-206-7900|lsutton@polarean.com|121
22268068|NCT01876446|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22309529|NCT03272217|Hoosier Cancer Research Network|Fauzia Sharmin|317-634-5842|fsharmin@hoosiercancer.org|75
22268069|NCT02108912|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
22268070|NCT05329259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268071|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
22278912|NCT05889468|Duke University Medical Center|Brenna L. Hughes, MD, MSc|919-684-8111|brenna.hughes@duke.edu|
22278913|NCT05468918|Sonova USCS|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22278914|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org|
22309530|NCT05095779|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
22309531|NCT04078191|Navidea|Michael Blue, MD|6145714313|mblue@navidea.com|
22278915|NCT01153516|University of Texas Southwestern at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22278916|NCT05112640|University of Texas Medical Branch|Brett Goldman|9542632359|brettryangoldman@gmail.com|
22278917|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br|
22278918|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22278919|NCT05022719|Medtronic|Melanie Crystal|774-245-8756|melanie.crystal@medtronic.com|
22278920|NCT01605097|BC Cancer|Dr Juanita Crook|250 712 3958|jcrook@bccancer.bc.ca|
22278921|NCT05006495|Seoul National University Hospital|Researcher of Clinical Trials|+821049051485|junhiya@snu.ac.kr|
22278922|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu|
22278923|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org|
22268072|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu|
22278924|NCT02284893|AstraZeneca|Katarina Fridman|+46(31)7762040|katarina.fridman@astrazeneca.com|62040
22309532|NCT05693935|Teva Branded Pharmaceutical Products R&D LLC|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22268073|NCT01808573|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|424-248-6500|clinicaltrials@pumabiotechnology.com|
22278925|NCT05807945|ABC Medical Center|Angel Cruz Miranda|5516647121|cruz.angel@aol.com|
22278926|NCT03038620|UT Southwestern Medical Center|Dr. Parag Joshi|2146458000|parag.joshi@utsouthwestern.edu|
22268074|NCT02487225|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-7474|Vege.Santhi@mayo.edu|
22278927|NCT04992065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22278928|NCT00539500|University of Texas MD Anderson Cancer Center|Laura L. Worth, MD / Professor, Pediatrics|713-792-6620|CR_Study_Registration@mdanderson.org|
22278929|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22278930|NCT02011542|University of Utah, Dept. of Gastroenterology|Dr. Ashok Tuteja|801-581-5679|ashok.tuteja@hsc.utah.edu|
22268075|NCT01523002|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|
22278931|NCT03261505|Massachusetts General Hospital|Prof. Jian Kong|16179620978|kongj@nmr.mgh.harvard.edu|
22278932|NCT03988205|Froedtert and the Medical college of Wisconsin|Laura Michaelis, MD|414-805-6700|lmichaelis@mcw.edu|
22268076|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22268077|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22278933|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22278934|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22278935|NCT03213509|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
22278936|NCT04562090|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
22278937|NCT00847730|KCI|VP, Global Clinical Affairs|2102555595|jane.hart@kci1.com|
22278938|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
22309533|NCT05544695|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+49 6172 888|christine.kolb@viatris.com|2511
22268078|NCT03953612|Yale School of Medicine|Verica Milivojevic, PhD|203-737-5201|verica.milivojevic@yale.edu|
22278939|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277||
22268079|NCT03485352|Federal University of Uberlandia|Mrs Cibele Crispim|55 34 3218-2084|cibelecrispim@gmail.com|
22268080|NCT02084160|Exalenz|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|
22278940|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554||
22278941|NCT05196776|Temple University Hospital|Ryan Gibbons|2157075522|ryan.gibbons@tuhs.temple.edu|
22278942|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu|
22278943|NCT01722669|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617-667-9299|jzwicker@bidmc.harvard.edu|
22309534|NCT04216563|The University of MD Anderson Cancer Center|Ghayas Issa MD, Associate Professor|7133205722|GCIssa@mdanderson.org|
22278944|NCT01344226|Discover Vision Centers|Melissa Morrison Toyos|8164781230|mtoyos@discovervision.com|
22278945|NCT05677347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22278946|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu|
22278947|NCT03909971|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278948|NCT03140969|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
22278949|NCT04727151|Triumvira Immunologics|Maria Apostolopoulou, Clinical Scientist|518-892-8426|mapostolopoulou@triumvira.com|
22278950|NCT01587196|University of Pennsylvania|Daniel Langleben, MD|215-760-7067|langlebe@pennmedicine.upenn.edu|
22278951|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org|
22278952|NCT03546439|Saint Luke's Hospital of Kansas City|Sanjaya Gupta, MD|8169311883|sgupta@saint-lukes.org|
22278953|NCT03612570|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
22278954|NCT02476448|Cleveland Clinic Florida|Dr. Eric Hurtado|954-659-5559|hurtade@ccf.org|
22296554|NCT00192504|MedImmune, LLC|Genevieve A. Losonsky, MD/VP Clinical Development|301-398-0000|losonskyG@medimmune.com|
22296555|NCT02974296|Columbia University|DR. Marta Moreno-Ortega|9142187311|mm4355@cumc.columbia.edu|
22296556|NCT00542919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296557|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296558|NCT05123222|Center for Immunization Research|Anna Durbin|667-306-9772|adurbin1@jhu.edu|
22296559|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com|
22296560|NCT03927612|Indiana University School of Medicine|Clinical Research Specialist|317-274-8670|vrlab@iupui.edu|
22296561|NCT03020823|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
22296562|NCT03739112|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22296563|NCT03492099|Johns Hopkins University School of Medicine|Dr. Sophie Lanzkron|4105028642|slanzkr@jhmi.edu|
22296564|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu|
22296565|NCT01948739|Rice University|Marcia K. O'Malley, PhD|(713) 348-3545|omalley@rice.edu|
22296566|NCT03054857|King Chulalongkorn Memorial Hospital|Dr.Yada Thongsuk|+66817738629|thongsuk.y@hotmail.com|
22296567|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300||
22296568|NCT02529137|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
22296569|NCT04855643|The University of Texas Health Science Center at Houston|Antonio L. Teixeira, MD, PhD, MSc|713-486-2555|Antonio.L.Teixeira@uth.tmc.edu|
22296570|NCT02731729|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22296571|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22296572|NCT01660711|NorthShore University/University of Chicago|Dr Robert Marsh|847-5702112|rmarsh@northshore.org|
22296573|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22296574|NCT01442363|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
22296575|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu|
22296576|NCT02357901|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22296577|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
22296578|NCT02759120|Weill Cornell Medicine|Elizabeth Peters|646-962-2742|elp2018@med.cornell.edu|
22296579|NCT04302389|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
22296580|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com|
22296581|NCT04461015|Mayo Clinic|Adrian Vella|507-255-6515|vella.adrian@mayo.edu|
22296582|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
22296583|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu|
22296584|NCT02293655|Cincinnati Children's Hospital Medical Center|Tanya Froehlich, MD|5136361154|tanya.froehlich@cchmc.org|
22296585|NCT02004028|Verastem Oncology|Clinical Trials|+1-781-292-4204|clinicaltrials@verastem.com|
22296586|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22296587|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU|
22296588|NCT03002012|University of Minnesota|David Boulware|612-624-1966|boulw001@umn.edu|
22296589|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr|
22296590|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22296591|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22296592|NCT05413369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22296593|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu|
22296594|NCT01679002|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22296595|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304|amanda.isula@terumomedical.com|5549
22296596|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296597|NCT03141242|University of Colorado|Hillary Lum, MD, PhD|3037241911|hillary.lum@cuanschutz.edu|
22296598|NCT02409459|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610.650.4200|mfalone@luitpold.com|844
22296599|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu|
22296600|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
22296601|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com|
22296602|NCT01176266|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22296603|NCT01179477|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22268081|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk|
22296604|NCT00189228|University of New Mexico Health Sciences Center|Dr. Mark Schuyler|5059254197|mschuyler@salud.unm.edu|
22296605|NCT02730299|Gamida Cell|Associate Director, Clinical Operations|+972-073-2064774|aurelie@gamida-cell.com|
22296606|NCT03755414|Washington University School of Medicine|Dr. Ramzi Abboud|314-454-8304|rabboud@wustl.edu|
22268082|NCT00852202|Allergan Sales LLC|Therapeutic Area Head,|877-277-8566|IR-CTRegistration@allergan.com|
22296607|NCT02153112|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22296608|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111||
22268083|NCT03691727|University of Iowa|David Hasan|319-384-8669|david-hasan@uiowa.edu|
22268084|NCT02552121|Genmab A/S|Genmab|7020 2728|clinicaltrials@genmab.com|+45
22296609|NCT04351087|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
22296610|NCT03519347|NYU Langone Health|David M Charytan, MD, MSc|646-501-9086|david.charytan@nyulangone.org|
22296611|NCT01412021|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22296612|NCT02448654|Yale University|Elise E. DeVito, Ph.D./ Associate Research Scientist|203-737-4882|elise.devito@yale.edu|
22296613|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590||
22296614|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu|
22296615|NCT01522365|Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 (0)31 376 30 00|clinicalresearchmolndal@dentsplysirona.com|
22296616|NCT02404285|Next Science|Matt Myntti PHD, President|9046474161|mmyntti@nextscience.org|
22268085|NCT03629184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268086|NCT01263938|University of Pennsylvania School of Medicine|Dr. Ronald Collman|215-898-0193|collmanr@pennmedicine.upenn.edu|
22268087|NCT01982955|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22268088|NCT03051672|Dana-Farber Cancer Institute|Dr. Sara Tolaney|6176323800|sara_tolaney@dfci.harvard.edu|
22268089|NCT02548143|LFB USA|Kerry Biron, Director US Clinical Operations|508.370.5166|kerry.biron@lfb-usa.com|
22268090|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268091|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu|
22268092|NCT07112885|Istanbul University, Department of Orthopedics and Traumatology|Mehmet Yağız Yenigün, MD (Principal Investigator)|+905544383142|mehmet.yenigun@istanbul.edu.tr|
22268093|NCT03825939|NYU Langone|Dr. Jan Koenig|516-678-2232|Jan.Koenig@nyulangone.org|
22268094|NCT04179838|Northwestern University|Thorsten Kahnt|3125032896|thorsten.kahnt@northwestern.edu|
22268095|NCT02763046|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22268096|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
22268097|NCT03411031|Moffitt Cancer Center|Dr. Melissa Alsina|813-745-7202|Melissa.Alsina@moffitt.org|
22268098|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com|
22268099|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529||
22296617|NCT02466555|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
22296618|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu|
22296619|NCT02865915|Millendo Therapeutics US, Inc.|Director of Clinical Operations|734-845-9000|millendo@millendo.com|
22296620|NCT03578081|University of Alabama at Birmingham|Dr Rudolph M. Navari|205-975-2833|rnavari@uabmc.edu|
22296621|NCT06002958|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|(919) 962-1401|kelsey_ludwig@med.unc.edu|
22296622|NCT05760300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22296623|NCT03752307|University of New Mexico|Corey Ford, M.D., Ph.D.|505-925-4124|cford@salud.unm.edu|
22296624|NCT05477875|University of Florida Oaks Eye Center|Yujia Zhou|3522652020|yzhou1996@ufl.edu|
22296625|NCT03989440|ReNetX Bio, Inc.|George D. Maynard, Ph.D., Study Director|2032088925|info@renetx.com|
22296626|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22268100|NCT02826486|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
22268101|NCT01103180|University of Chicago|Dr. Emil Coccaro|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
22268102|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468||
22268103|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351||
22268104|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22268105|NCT01917682|Corindus, Inc.|John Van Vleet, VP of Clinical and Regulatory Affairs|(260)615-8892|john.van_vleet@siemens-healthineers.com|
22268106|NCT02521415|Carolinas Medical Center|Dr. Stacy Reynolds|704-355-3181|stacy.reynolds@carolinashealthcare.org|
22268107|NCT02439216|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
22268108|NCT00200902|Laboratory of Brain, Behavior, and Pharmacology at the University of California Los Angeles|Andrew Leuchter, MD|310-825-0207|jpv@brain.ucla.edu|
22268109|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22268110|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268111|NCT04505969|Barau Dikko Teaching Hospital, Kaduna State University|Study Principal investigator|+2348066664042|abubakarabdulkareem8@gmail.com|
22268112|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22268113|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22296627|NCT04608500|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22278955|NCT05318287|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22278956|NCT05185453|University of Pittsburgh|Dr. Alison Culyba|412-692-6056|alison.culyba@chp.edu|
22278957|NCT02516813|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22278958|NCT03537508|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22278959|NCT04652765|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Cathy Handy Marshall|4109550231|chm@jhmi.edu|
22278960|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu|
22278961|NCT05251805|UZ Brussel|Head of the anesthesiology department|024776001|anesthesiology.clinicaltrials@uzbrussel.be|+32
22278962|NCT03814044|Smith + Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.Horner@smith-nephew.com|
22278963|NCT05218434|Simbec Orion|Dr Annelize Koch|01443694313|gabrielle.brill@simbecorion.com|
22278964|NCT02495883|UCSD|Fatta Nahab, MD|858-822-5871|fnahab@health.ucsd.edu|
22278965|NCT04632030|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
22278966|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org|
22278967|NCT03359395|Wake Forest Health Science|T. Quinn McCutchen, MD|336.716.4498|tmccutch@wakehealth.edu|
22278968|NCT04494971|Pennington Biomedical Research Center|Dr. Hanim Ecem Diktas|(225) 763-2832|hanim.diktas@pbrc.edu|
22278969|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509||
22278970|NCT03552029|Daiichi Sankyo|Contact for Clinical Trial Disclosure Information|908-992-6400|CTRinfo@dsi.com|
22278971|NCT01212900|National Heart Lung and Blood Institute|Mehta, Nehal|+1 301 827 0483|mehtann@mail.nih.gov|
22278972|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu|
22278973|NCT01276704|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
22278974|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22278975|NCT04490278|Washington University|Chris Palmer|314-215-7384|cmpalmer@wustl.edu|
22278976|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org|
22278977|NCT03302767|Institut Bergonié|Véronique GERAT-MULLER|0556337839|v.gerat-muller@bordeaux.unicancer.fr|
22278978|NCT01999530|Centre for Addiction and Mental Health|Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|34772
22278979|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org|
22278980|NCT03359161|St. Elizabeth's Medical Center|Dr. Lana Tsao|617-789-3036|lana.tsao@steward.org|
22278981|NCT01681147|Joslin Diabetes Center|Dr. Florence Brown|617-309-2675|Florence.Brown@joslin.harvard.edu|
22278982|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu|
22278983|NCT03801525|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22278984|NCT03309202|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22278985|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413|polosa@unict.it, p.caponnetto@unict.it|0039
22278986|NCT03243084|UNC Chapel Hill|Julianna Prim|919-962-5271|jhprim@email.unc.edu|
22278987|NCT03641287|University of Washington Medical Center|Kathryn Pennington, MD|206-598-8300|katypenn@uw.edu|
22278988|NCT05870345|University of CHicago|Alisa Brennan, Pediatric Emergency Medicine Fellow, Physician, Co-PI|9787585263|Brennanak@gmail.com|
22278989|NCT03130569|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay|646-888-0039|hayj@mskcc.org|
22278990|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22278991|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu|
22278992|NCT04562116|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
22278993|NCT01559935|Weill Cornell Medicine|Ruben Niesvizky, MD|6469626500|run9001@med.cornell.edu|
22278994|NCT05078437|University of Kentucky|Daniela Moga, Associate Professor|8593239682|daniela.moga@uky.edu|
22278995|NCT03078868|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
22278996|NCT03817580|Eurofins EVIC|Commercial Manager|40 213357090|luciachirita@eurofins.com|
22278997|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov|
22278998|NCT02908178|Yale University|Shi-Yi Wang, MD, PhD|2037852886|shiyi.wang@yale.edu|
22278999|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
22279000|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com|
22279001|NCT02231580|Ipsen|Vice President Early Development & Clinical Pharmacology||clinical.trials@ipsen.com|
22279002|NCT03861338|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
22279003|NCT04079738|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22279004|NCT04554836|Evangelisches Krankenhaus Hamm Werler Str. 110, 59063 Hamm|Prof. Dr. Alexander Baraniskin|+49 (0) 2381 / 589 1863|Alexander.Baraniskin@ruhr-uni-bochum.de|
22279005|NCT05552859|Sanofi|Trial Transparency email recommended (Toll free for US & Canada)|800-633-1610|Contact-us@sanofi.com|Option 6
22279006|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22279007|NCT05634538|Corindus|Alison Lord|617-943-5472|alison.lord@siemens-healthineers.com|
22279008|NCT02303821|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22279009|NCT00210132|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22279010|NCT04341012|Mayo Clinic|Tushar Patel|9049532000|patel.tushar@mayo.edu|
22279011|NCT02711202|Institute for Clinical and Experimental Medicine|Prof. Ondřej Viklický, M.D., Ph.D.|+420 2 6136 4110|ondrej.viklicky@ikem.cz|
22279012|NCT04261985|UCLA DGSOM|Dr. Alma Guerrero|3102672789|aguerrero@mednet.ucla.edu|
22279013|NCT05216380|UMass Chan Medical School|Jamie Faro|7744553744|Jamie.faro@umassmed.edu|
22279014|NCT04312022|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22279015|NCT02927964|Stanford University|Dr. Ronald Levy|(650) 725-6452|levy@stanford.edu|
22279016|NCT02255656|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22279017|NCT03734536|Smith+Nephew|Samantha Andrews|9789718990|samantha.andrews@smith-nephew.com|
22279018|NCT03448393|National Cancer Institute|Dr. Nirali N. Shah|240-760-6970|shahnn@mail.nih.gov|
22279019|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu|
22279020|NCT03826472|California Health Sciences University College of Osteopathic Medicine|Emily Johnston|9737685888|eajohnst@gmail.com|
22279021|NCT03207347|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22279022|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org|
22279023|NCT02096107|Medical University of South Carolina|David Taber|843-792-3368|taberd@musc.edu|
22279024|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
22279025|NCT04983979|Queen Mary University of London|Emily Kirkpatrick|02078825673|cvctu@qmul.ac.uk|
22279026|NCT04144517|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
22279027|NCT04308512|Baylor College of Medicine|Dr. Bijan Najafi|(424) 467-7127|najafi.bijan@gmail.com|
22279028|NCT03176173|Stanford University|Clinical Associate Professor, Radiation Oncology - Radiation Therapy|(650) 723-6171|mgens@stanford.edu|
22279029|NCT05929326|Hung Vuong Hospital|Dr. Huan N Pham|+84906884435|huanpmd@gmail.com|
22279030|NCT05700422|Scheie Eye Institute|Ophthalmology Clinical Research|215-662-8038|ophth.clinicalresearch@pennmedicine.upenn.edu|
22279031|NCT02625428|Mayo Clinic|J. Scott Kriegshauser|480-342-5664|skriegshauser@mayo.edu|
22279032|NCT04093453|Imperial College London|Dr. Edward Chambers|+44 20 7594 0959|e.chambers@imperial.ac.uk|
22279033|NCT05212168|Vaxart|Maria Apkarian|+1 (650) 779-4560|mapkarian@vaxart.com|
22279034|NCT03549507|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
22279035|NCT03941093|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1337|lapis@fibrogen.com|
22279036|NCT03048682|Wake Forest Baptist Health|Dr. Catherine Matthews|336-716-4131|camatthe@wakehealth.edu|
22279037|NCT02333799|Global Alliance for TB Drug Development|Eugene Sun, MD|212-227-7540|eugene.sun@tballiance.org|
22279038|NCT05847686|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
22279039|NCT05484895|Emory University|Dr. Don Operario|404-727-0503|don.operario@emory.edu|
22279040|NCT05395936|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Adam Katz|336-716-4171|akatz@wakehealth.edu|
22279041|NCT04795531|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22279042|NCT03698279|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22279043|NCT02552225|Boson Medical Center|Pieter Noordzij, MD|(617) 414-1756|pieter.noordzij@bmc.org|
22279044|NCT03122184|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
22279045|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com|
22279046|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22279047|NCT00567502|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22279048|NCT02297516|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
22279049|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu|
22279050|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il|
22279051|NCT02538614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22279052|NCT03835078|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22279053|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org|
22279054|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com|
22279055|NCT00415636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279056|NCT01263119|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279057|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22279058|NCT03014635|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
22268114|NCT00942357|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD. and Helen Huang, MS.|716-845-1169|lgedeon@gogstats.org|
22268115|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268116|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov|
22268117|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560|roudiz@labiomed.org|310
22268118|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268119|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22268120|NCT01545648|University of California, San Francisco|Hope Rugo, MD|877-827-3222|cancertrials@ucsf.edu|
22268121|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov|
22268122|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu|
22279059|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601|algallinaro@gmail.com|8022
22279060|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279061|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org|
22296628|NCT01925404|RAND|Deborah Cohen|310 3930411|dcohen@rand.org|
22296629|NCT01030523|Dentsply Sirona Implants|Manager of Global Clinical Research|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
22296630|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org|
22296631|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22279062|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22279063|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22279064|NCT00030264|Children's Hospital of Philadelphia|Ratnakar Patti|267-426-5503||
22279065|NCT01822925|NeuroBo Pharmaceuticals, Inc.|Vice President Clinical Operations|617-313-7331|nikki.shannon@neurobopharma.com|
22279066|NCT03594500|VA NY Harbor Healthcare System|Dr. Joshua Chodosh|212-686-7500|joshua.chodosh@va.gov|5043
22279067|NCT03847519|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
22279068|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
22279069|NCT01650402|UConn Health|William White, MD|860-679-4556|wwhite@uchc.edu|
22279070|NCT02300233|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22279071|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org|
22279072|NCT00744861|Bioventus LLC|Manager Clinical Affairs|1-800-396-4325||
22279073|NCT04856527|University of Cincinnati|Sarah Schwab|5135587477|schwabsr@mail.uc.edu|
22279074|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk|
22279075|NCT03605693|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Dr. Ian Kronish|212-342-1335|ik2293@columbia.edu|
22279076|NCT04752566|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22279077|NCT05134649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22279078|NCT04618276|University Hospital Zurich|PD Dr. med. Yvonne Achermann|+41 44 396 74 18|yvonne.achermann@usz.ch|
22279079|NCT04392154|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22279080|NCT04198012|DEKA Research|Regulatory Affairs Manager|603-669-6491|psmolenski@dekaresearch.com|
22279081|NCT02038647|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22279082|NCT02757430|Abbott|Clinical Research Scientist|6517562885|amber.miller@abbott.com|
22279083|NCT04116684|Cleveland Clinic|Venu Menon, M. D.|216-445-5390|menonv@ccf.org|
22279084|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr|
22279085|NCT03502200|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22279086|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
22279087|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com|
22279088|NCT03097289|Terumo BCT, Inc.|Ned Cosgriff, MD|+1 303-239-2316|ned.cosgriff@TerumoBCT.com|
22279089|NCT05126303|Guard Therapeutics|Sara Thuresson, Head of Clinical Operations|+46733319438|sara.thuresson@guardtherapeutics.com|
22279090|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22279091|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22279092|NCT02082977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279093|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000|king@ctg.queensu.ca|77705
22279094|NCT05036343|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
22279095|NCT02733757|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
22279096|NCT06203717|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|mascha_vant_wout@brown.edu|
22279097|NCT01275300|Upenn|Wenliang Song, MD|215-662-4652.|wenliangsong@gmail.com|
22279098|NCT02402647|VA San Diego|Catherine Ayers|858-220-4041|catherine.ayers1@va.gov|
22279099|NCT02784587|Maine Medical Center|Research coordinator|2076622862|richaj3@mmc.org|
22279100|NCT02371187|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22279101|NCT03557502|University of Oregon|Dr. Christopher Minson|541-953-2231|minson@uoregon.edu|
22279102|NCT00543127|Department of Medical Oncology, Hospital Universitario Gregorio Marañón|Dr. Miguel Martin||miguel.martin@salud.madrid.org|
22279103|NCT02513641|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
22279104|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com|
22279105|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com|
22279106|NCT05819398|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279107|NCT02520154|University of Texas M D Anderson Cancer Center|Dr. Amir Jazaeri MD|(713) 745-1613|aajazaeri@mdanderson.org|
22279108|NCT06022107|Yale University|Li Yan McCurdy, PhD|2037372912|liyan.mccurdy@yale.edu|
22279109|NCT03716830|Massachusetts General Hospital|Jian Kong, PI of the clinical trial|6177267893|kongj@nmr.mgh.harvard.edu|
22279110|NCT04887831|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22279111|NCT03326245|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Dardo Tomasi|+1 301 496 1589|tomasidg@mail.nih.gov|
22279112|NCT02180828|Peking University|Shangrong Fan|860755-83923333|fanshangrong@163.com|5502
22279113|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
22279114|NCT02835690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279115|NCT03728933|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22279116|NCT03674281|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22279117|NCT02323048|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
22279118|NCT04622592|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22279119|NCT01752049|St. Michael's Hospital|Dr. Marie Faughnan|416-864-6060|marie.faughnan@unityhealth.to|5412
22279120|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279121|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu|
22296632|NCT00697515|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22296633|NCT05954052|University of Chicago|Karam Radwan, MD|7738346686|radwan@uchicago.edu|
22296634|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com|
22296635|NCT03102918|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
22296636|NCT04765358|Jaeb Center for Health Research|Robin Gal|813-975-8690|rgal@jaeb.org|
22296637|NCT02419742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22296638|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu|
22296639|NCT04519645|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22296640|NCT02422745|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|COSMOS Study Director|1-800-633-6913|cosmostrial@partners.org|
22296641|NCT01335581|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22296642|NCT01899300|Asian Institute of Gastroenterology|Rajesh Gupta, MD|+91 4023378888|drrajeshgupta98@gmail.com|
22296643|NCT05517382|Yale University|Claudia-Santi Fernandes|203-785-2885|Claudiasanti.fernandes@yale.edu|
22296644|NCT03886220|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22296645|NCT02591147|University of Iowa College of Dentistry|Dr. Justine Kolker|(319) 335-7583|justine-kolker@uiowa.edu|
22296646|NCT02155647|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22296647|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org|
22296648|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov|
22296649|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com|
22296650|NCT04418999|Illinois College of Optometry|Jennifer Harthan|3129497249|JHarthan@ico.edu|
22296651|NCT02461225|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22296652|NCT03526458|University of Wisconsin, School of Medicine and Public Health, Department of Urology|Shuang Li|6082638336|lis@urology.wisc.edu|
22296653|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
22296654|NCT00735878|Dartmouth-Hitchcock Medical Center (DHMC)|Konstantin H. Dragnev, MD|(603) 650-6344|konstantin.h.dragnev@hitchcock.org|
22296655|NCT04404855|UT Health San Antonio|Michael Liss, MD|210-567-5676|liss@uthscsa.edu|
22296656|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org|
22296657|NCT01120756|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@va.gov|
22296658|NCT04026048|Memorial University of Newfoundland|Dr. Sheila Garland|(709) 864-4897|sheila.garland@mun.ca|
22296659|NCT03098173|Tokyo University|Dr. Ryota Niikura|+81-3-3815-5411|niikura-dky@umin.ac.jp|
22296660|NCT00698581|UCB|UCB Cares|+1 877 822 9493||
22296661|NCT03760146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296662|NCT00449644|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
22296663|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com|
22296664|NCT01997515|Rhode Island Hospital|Director of Research|401-444-4933|mark.kendall@lifesapn.org|
22296665|NCT03616899|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results011@kalarx.com|
22296666|NCT00445965|Memorial Sloan Kettering Cancer Center|Dr. Kim Kramer MD|212-639-6410|kramerk@MSKCC.ORG|
22296667|NCT03448185|University of Texas Southwestern Medical Center|Eriko Iwatate|214-648-3680|Eriko.Iwatate@UTSouthwestern.edu|
22296668|NCT05778786|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22296669|NCT02075658|UCI Health Department of Urology|Clinical Research Coordinator|714-456-8176|yoonrh@uci.edu|
22296670|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be|
22296671|NCT02406651|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
22296672|NCT04595513|Cincinnati Children's Hospital Medical Center|Darcy A. Krueger, MD., PhD|513-636-4222|krueger_darcy@cchmc.org|
22296673|NCT01395329|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
22296674|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com|
22296675|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296676|NCT00496756|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
22296677|NCT02946047|Mayo Clinic|Dr. Nathan Cummins|507-284-3747|Cummins.Nathan@mayo.edu|
22296678|NCT03615105|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
22296679|NCT05041322|Spaulding Hospital Cambridge|Jason Hamner|6177585501|jhamner@mgb.org|
22296680|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22296681|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22296682|NCT04199117|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy, Ph.D.|6082655949|demccarthy@ctri.wisc.edu|
22296683|NCT04383743|University of Washington|Dr. Petros Grivas|2066061943|pgrivas@uw.edu|
22296684|NCT05230693|Medical University of South Carolina|Ennis James, MD|843-792-3769|jamesw@musc.edu|
22296685|NCT04814433|NYU Langone Health|Thomas Calahan|929-455-5826|Thomas.Calahan@nyulangone.org|
22296686|NCT03939897|Washington University in St. Louis School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22309535|NCT05660018|UTHealth Houston|Dr. Xiaoming Du|4438829717|Xiaoming.Du@uth.tmc.edu|
22309536|NCT05263037|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
22309537|NCT04321395|Washington University in St. Louis|Assistant Professor|314-362-8708|ssfarabi@wustl.edu|
22309538|NCT04987320|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22309539|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
22309540|NCT01824875|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22309541|NCT04195698|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22268123|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931||
22268124|NCT03103438|Biocad|Nadezhda Kravtsova|+7 (812) 380 49 33|kravtsovana@biocad.ru|
22268125|NCT02792517|Amgen Inc.|Study Director|866-572-6436||
22268126|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22268127|NCT03238651|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22268128|NCT03875508|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22268129|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu|
22268130|NCT02137252|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Fremonta Meyer, MD||flmeyer@partners.org|
22268131|NCT04460911|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268132|NCT01958437|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|7347639259|bhampste@med.umich.edu|
22268133|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu|
22268134|NCT02200055|General Surgery, Naval Medical Center Porstmouth|Dr. Christopher Oxner|757-953-2495|christopher.r.oxner.mil@mail.mil|
22268135|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de|
22268136|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com|
22268137|NCT02603887|UT MD Anderson Cancer Center|Dr. Elisabet Manasanch/ Assistant Professor, Lymphoma-Myeloma|713-745-8092|eemanasanch@mdanderson.org|
22268138|NCT04442464|Mayo Clinic|Cherie B. Nau, O.D.|507-284-4152|Nau.Cherie@mayo.edu|
22268139|NCT03535740|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22268140|NCT04481035|Cincinnati Children's Hospital Medical Center|Donald L. Gilbert MD|513-636-4222|donald.gilbert@cchmc.org|
22268141|NCT05198518|Icahn School of Medicine at Mount Sinai|Alfred Marc C Iloreta Jr, MD|(212) 241-9410|alfred-marc.iloreta@mountsinai.org|
22268142|NCT01223378|Bausch & Lomb|H DeCory, PhD|585-338-8161|heleen.decory@bausch.com|
22268143|NCT05317312|Viatris|Susanne Vogt|004906172|susanne.vogt@viatris.com|88801
22309542|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900||
22309543|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp|
22268144|NCT00124917|National Cancer Institute|Dr. Deborah Citrin|301-496-5457|Debra_Citrin@nih.gov|
22309544|NCT04502888|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22309545|NCT05256017|Drugs for Neglected Disease initiative (DNDi)|Dr Junior Matanglia|+243 970 756 890|jmatangila@dndi.org|
22309546|NCT05082025|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
22268145|NCT02015611|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8217|dhouston@wakehealth.edu|
22268146|NCT00613171|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22268147|NCT04941131|King Abdulaziz University|Dr Zuhair Natto|9666943899|znatto@kau.edu.sa|
22268148|NCT00951496|NRG Oncology|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22268149|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900|ddalury@gmail.com|1221
22268150|NCT02473926|University of Colorado - Anschutz Medical Campus|Dr. Amy Huebschmann|3037242268|amy.huebschmann@cuanschutz.edu|
22268151|NCT00202930|UPMC Children's Hospital of Pittsburgh|Jean M. Tersak, M.D.|412-692-8570|jean.tersak@chp.edu|
22268152|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu|
22268153|NCT04359797|Vanderbilt University Medical Center|Dr. Edward T. Qian|615-322-2386|edward.t.qian@vumc.org|
22268154|NCT03447743|University of Kentucky|Dr. Michele Staton|859-312-8245|mstaton@uky.edu|
22268155|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu|
22268156|NCT03672227|REGENTS OF THE UNIVERSITY OF MICHIGAN|Dr. Katherine Bauer|(734)763-2546|kwbauer@umich.edu|
22268157|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268158|NCT02575833|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22268159|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com|
22268160|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com|
22268161|NCT00768248|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
22268162|NCT04211831|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22268163|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268164|NCT00610428|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22268165|NCT04927845|Strive Weekly Inc|Dr. Leslie Rith-Najarian, Principal Investigator|3108002143|leslie@striveweekly.com|
22279122|NCT01117779|Boston Scientific|Chantal Laframboise, Clinical Research Manager|613-882-0876|chantal.laframboise@bsci.com|
22279123|NCT02448381|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22279124|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
22279125|NCT04617860|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22279126|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com|
22279127|NCT02621892|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22279128|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa|
22279129|NCT00998010|University of California at Los Angeles|Mark Glover|(310) 794-8742|mglover@mednet.ucla.edu|
22279130|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu|
22279131|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279132|NCT04403919|NYU Langone Health|Ran Schwarzkopf, MD|646-501-7070|Ran.Schwarzkopf@nyulangone.org|
22279133|NCT01838226|Durham VAHCS HSR&D|Dr. David Edelman|919-286-6936|david.edelman@va.gov|
22279134|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu|
22279135|NCT04486677|VA San Diego|Dr. Emily Treichler|6192288075|emily.treichler@va.gov|
22279136|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22279137|NCT03815344|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
22279138|NCT02878785|University of Maryland Greenebaum Cancer Center|Maria Baer, M.D.|410-328-8708|mbaer@umm.edu|
22279139|NCT00619866|AbbVie|Global Medical Services|800-633-9110||
22279140|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com|
22279141|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu|
22279142|NCT03949517|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22279143|NCT03510273|PATH|Dr. Silvia de Sanjose|2062853500|sdesanjose@path.org|
22279144|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
22279145|NCT02589938|Wake Forest NCORP Research Base|Lead Biostatistician (Dr. Emily Dressler)|336-716-0891|NCORP@wakehealth.edu|
22279146|NCT04716894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22279147|NCT00608062|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau. PI|303-724-1914|kerrie.moreau@cuanschutz.edu|
22279148|NCT05205616|University of Califronia, San Francisco|Sepehr Hashemi, DMD|4133674736|sepehr.hashemi@ucsf.edu|
22279149|NCT03648892|NIH|Dr. Kevin Hall|301-402-8248|kevinh@niddk.nih.gov|
22279150|NCT01467466|MAVERIC, VA Boston|Christopher Donnelly, Chief of Data Management|857-364-2332|christopher.donnelly2@va.gov|
22279151|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279152|NCT02268656|Gil hospital|Dr. Hyun Jeong Kwak|82324603636|hyun615@gilhospital.com|
22279153|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com|
22279154|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551|Peter.Reaven@va.gov|5817
22279155|NCT02347410|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|6512568503|Rgriffith@spineology.com|
22279156|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com|
22279157|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu|
22279158|NCT01979185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22279159|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu|
22279160|NCT03112902|University of Colorado|Brice McConnell|303-724-3897|brice.mcconnell@cuanschutz.edu|
22279161|NCT03620981|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|06-6943-7722|CL_OPCJ_RDA_Team@otsuka.jp|
22279162|NCT05705375|University of Texas at Arlington|Ziyad Ben Taleb|817-272-8297|ziyad.bentaleb@uta.edu|
22279163|NCT05852470|Alcon Research, LLC|Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22279164|NCT06071104|Alcon Research LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22279165|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
22279166|NCT04118764|Columbia University|Elisa Konofagou, PhD, Robert and Margaret Hariri Professor in Biomedical Engineering and Radiology|212-342-0863|ek2191@columbia.edu|
22279167|NCT04716725|University of California, San Francisco|Dr. Ivan de Kouchkovsky, MD|(415) 221-4810|ivan.dekouchkovsky@ucsf.edu|2129
22279168|NCT04116489|UMass Chan Medical School; Tan Chingfen Graduate School of Nursing|Donna Perry, PhD, RN|508-856-3621|DonnaJ.Perry@umassmed.edu|
22279169|NCT03781570|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
22279170|NCT03229057|University of Pennsylvania|Dr Anuja Dokras|215-615-0085|adokras@pennmedicine.upenn.edu|
22279171|NCT06028464|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279172|NCT03636022|Minnesota HealthSolutions|Sara Seifert|6128036998|sara@minnhealth.com|
22279173|NCT03330847|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22279174|NCT03532256|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
22279175|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22279176|NCT05943990|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279177|NCT04696146|Cedars-Sinai Medical Center|Noriko Ammerman|3102488186|noriko.ammerman@cshs.org|
22279178|NCT04164277|Michigan State University|Jiying Ling|5173538591|lingjiyi@msu.edu|
22279179|NCT02481414|University of Arkansas for Medical Sciences|Matthew Kovak, Director of Clinical Trials|501-686-8274|MRKovak@uams.edu|
22279180|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu|
22279181|NCT03493958|Clinical Center|Wallen, Gwenyth|+1 301 496 0596|gwallen@cc.nih.gov|
22279182|NCT02367456|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279183|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22279184|NCT02300545|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
22279185|NCT02243358|Henry Ford Cancer Institute|Dr. Gazala Khan, MD|313-598-2860|gkhan1@hfhs.org|
22279186|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu|
22279187|NCT02569853|Dr. Reddy's|Director, Clinical Development|609-375-9900|ebrandschieber@drreddys.com|
22279188|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22279189|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279190|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
22279191|NCT02468583|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22279192|NCT01493414|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22279193|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu|
22279194|NCT04319809|Minnesota HealthSolutions|Sara Seifert, President|6128036998|sara@minnhealth.com|
22279195|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil|
22279196|NCT03057704|Wake Forest University School of Medcine|Timothy N. Harwood MD|3367164498|tharwood@wakehealth.edu|
22279197|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
22279198|NCT02329587|Butler Hospital|Sarah Garnaat|401-455-6659|sgarnaat@butler.og|
22279199|NCT01734525|Federal University of Rio de Janeiro|Marcio Nucci|5521-39382463|mnucci@hucff.ufrj.br|
22279200|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363||
22279201|NCT04442893|National Yang Ming University|Chiu-Yueh Yang, Professor|886-2-28267388|cyyang3@ym.edu.tw|8862282673
22279202|NCT02421094|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
22279203|NCT01483560|University of Glasgow|Prof John Petrie|+44 141 330|John.Petrie@glasgow.ac.uk|3325
22279204|NCT03338920|Currax Pharmaceuticals LLC|Dr. Michael Kyle|708.834.8254|mkyle@curraxpharma.com|
22279205|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu|
22309547|NCT03032107|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
22279206|NCT03199079|Advanced Tactile Imaging, Inc.|Egorov Vladimir, Principal Investigator|609 883-0100|egorov@tactile-imaging.com|
22279207|NCT03773484|University of Southern California|Dr. Jason Doctor|213-821-8142|jdoctor@usc.edu|
22279208|NCT04724837|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94|information.center@astrazeneca.com|79
22279209|NCT04222673|Pittsburgh VA|Matthew Chinman|8184813909|chinman@rand.org|
22279210|NCT01280942|Washington Univ Sch of Medicine|Thomas C. Bailey, MD|314-454-8293|tbailey@dom.wustl.edu|
22279211|NCT04212442|University of Pennsylvania|Dr. Rebecca Brown|215-573-2021|rebecca.brown@pennmedicine.upenn.edu|
22279212|NCT02420717|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain MD./Associate Professor|713-745-6080|njain@mdanderson.org|
22279213|NCT03138564|Emory University|Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
22279214|NCT06517394|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Principal investigator|6177267913|apresciutti@mgh.harvard.edu|
22279215|NCT05177354|Medtronic Neuromodulation|Nancy McClelland|1-800-633-8766|nancy.l.mcclelland@medtronic.com|
22279216|NCT02936323|Tarveda Therapeutics, Inc.|Tarveda Clinical Information Center|(617) 923-4100|clinical.information@tarvedatx.com|
22279217|NCT06272383|University of Manitoba|Dr Alex Aregbesola|2047893957|Alex.Aregbesola@umanitoba.ca|
22279218|NCT05715827|Medtronic|Yewon Lee|1031132023|yewon.lee@medtronic.com|
22279219|NCT04846868|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279220|NCT04398706|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22279221|NCT04890509|BerGenBio ASA|BerGenBio Clinical Team|+ 47 559 61 159|cmo@bergenbio.com|
22279222|NCT04116853|Advocate Aurora Research Institute|Kathryn Ross, PhD MPH|414-647-6312|Kathryn.Ross@aah.org|
22279223|NCT03274466|"KCI | 3M"|Director of Clinical Research|(210) 515-4060|actate@mmm.com|
22279224|NCT06899100|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22279225|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu|
22279226|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com|
22279227|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu|
22279228|NCT04630769|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
22279229|NCT02953457|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
22279230|NCT02445911|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
22279231|NCT02581930|University of North Carolina at Chapel Hill|Dr. Stergios Moschos|919-843-7713|stergios_moschos@med.unc.edu|
22279232|NCT02776735|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22279233|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279234|NCT01576783|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
22279235|NCT05489328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279236|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300||
22279237|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com|
22279238|NCT03021486|UT MD Anderson Cancer Center|David Hui, MD- Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22279239|NCT04043286|Loma Linda University, School of Dentistry|Dr. Sasiya Bhumpattarachai|6267565156|sbhumpattarachai@llu.edu|
22279240|NCT01732536|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22279241|NCT02986074|Abbott|Yagna Pathak|+1-469-243-0088|yagna.pathak@abbott.com|
22279242|NCT03186638|University of Rochester Medical Center, Dept of Surgery, Supportive Care in Cancer|Michelle Janelsins, PhD, MPH|585-276-4656|michelle_janelsins@urmc.rochester.edu|
22279243|NCT04099277|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22279244|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22279245|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu|
22279246|NCT02410772|Centers for Disease Control and Prevention|Dr. Ekaterina Kurbatova, MD, PhD, MPH|4046392017|ies3@cdc.gov|
22279247|NCT04987372|UZ Ghent|dr. Harlinde Peperstraete|+3293325185|harlinde.peperstraete@uzgent.be|
22279248|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279249|NCT04252014|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
22279250|NCT05528770|Center for Diabetes Technology|Manager of Clinical Research|434-982-0602|mc7m@uvahealth.org|
22279251|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22279252|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu|
22279253|NCT02493764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279254|NCT04773665|VBI Vaccines Inc|Francisco Diaz-Mitoma, MD, PhD|613-749-4200|fdiazmitoma@vbivaccines.com|
22279255|NCT04846231|Cleveland Clinic|Luke Laffin, MD|216-372-4315|Laffinl@ccf.org|
22279256|NCT05448950|Phraxis, Inc.|Cindy Setum, PhD|16128016730|csetum@phraxis.com|
22279257|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22279258|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu|
22279259|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org|
22279260|NCT04462471|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22279261|NCT02706392|Fred Hutchinson Cancer Center|Dr. David Maloney|2066675616|dmaloney@fredhutch.org|
22279262|NCT03290027|Dr. Reddys Laboratories Inc.|Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22309548|NCT03854227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
22268166|NCT05120193|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
22268167|NCT04796961|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22268168|NCT03848715|UCLA|Dr. Chloe Boyle|310 794 9383|ccboyle@mednet.ucla.edu|
22268169|NCT05825404|Penn State University|Ying-Ling Jao|8148655634|yuj15@psu.edu|
22309549|NCT04948697|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22268170|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268171|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590||
22268172|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
22268173|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
22309550|NCT04870515|Fred Hutch Cancer Center|Marian L. Neuhouser, PhD|206-667-4797|mneuhous@fredhutch.org|
22268174|NCT01741311|University of Connecticut|Michael Copenhaver|8602083632|michael.copenhaver@uconn.edu|
22268175|NCT02243605|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
22268176|NCT05842967|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22268177|NCT04673149|GeneOne Life Science|Chief Medical Officer|6106576351|dkane@genels.us|
22268178|NCT03514459|University of Washington|Dr. McKenna Eastment|5742101120|mceast@uw.edu|
22268179|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268180|NCT02892955|Abbott|Joyce Chuang|9253535817|joyce.chuang@abbott.com|
22268181|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|
22309551|NCT04032704|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268182|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
22268183|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn|
22268184|NCT00970593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268185|NCT02203357|Peking University Health Science Center|Dr. Hui Zhuang|86-10-82801617|zhuangbmu@126.com|
22268186|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu|
22268187|NCT01866826|NCI|Frank Maldarelli, MD|301-846-5611|fmalli@mail.nih.gov|
22268188|NCT02288312|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22268189|NCT01276041|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
22268190|NCT02968576|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@ucdenver.edu|
22268191|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu|
22268192|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com|
22268193|NCT02222922|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268194|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22268195|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com|
22268196|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil|
22268197|NCT03743051|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
22268198|NCT02550561|University of California, Irvine|Phuong Linh Huynh, CRC|7144566155|plhuynh@hs.uci.edu|
22268199|NCT03411863|James J. Peters VAMC|Dr. Noam Y. Harel|718-584-9000|noam.harel@va.gov|1742
22268200|NCT02766335|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22268201|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu|
22268202|NCT02396511|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
22268203|NCT01651078|Monteris Medical|Nissa Mollema (Clinical Operations Manager)|763-253-4710|nmollema@monteris.com|
22268204|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org|
22268205|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22268206|NCT03164551|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22268207|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22268208|NCT01555697|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
22268209|NCT00950365|Montefiore Medical Center|Roman Perez-Soler, MD|(718) 405-8505|RPEREZSO@montefiore.org|
22268210|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu|
22268211|NCT02513212|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22268212|NCT04277962|University of Texas Medical Branch Galveston|Dr. Antonio Saad Director of Clinical Research Division|409-772-0982|afsaad@utmb.edu|
22268213|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22268214|NCT01998841|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268215|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268216|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com|
22268217|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
22268218|NCT02085447|University Hospitals Cleveland Medical Center|Dr. Martha Sajatovic|2168442808|martha.sajatovic@uhhospitals.org|
22309552|NCT03982459|University of California, San Francisco|Dr. Sue Yom, MD|415-353-7175|sue.yom@ucsf.edu|
22309553|NCT03879863|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22279263|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu|
22279264|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
22279265|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
22279266|NCT03078452|Emory University|Dr. Ajay Nooka|404-778-1900|anooka@emory.edu|
22279267|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
22279268|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22279269|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22279270|NCT04537650|KITE Research Institute - University Health Network|Catriona M. Steele, PhD|14165973422|catriona.steele@uhn.ca|7802
22268219|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
22279271|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279272|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22279273|NCT02274571|Pennington Biomedical Research Center|Dr. Eric Ravussin|2252844345|eric.ravussin@pbrc.edu|
22279274|NCT05047627|Dartmouth College|Nicholas Jacobson|(603) 646-7037|Nicholas.C.Jacobson@dartmouth.edu|
22279275|NCT03374306|HK Polytechnic University|Prof. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
22279276|NCT04251533|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22279277|NCT06378008|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22279278|NCT05322408|Masonic Cancer Center|Melissa Geller, MD, MS|612-626-3111|gelle005@umn.edu|
22309554|NCT03576885|AdventHealth|Hussnain Mirza MD|9736263952|Hussnain.Mirza.MD@adventhealth.com|
22268220|NCT04052620|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22268221|NCT01500473|Children's Hospital Los Angeles|Thomas Keens|3233612101|tkeens@chla.usc.edu|
22268222|NCT03552380|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22268223|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu|
22268224|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu|
22268225|NCT02153983|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
22268226|NCT03567980|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22268227|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org|
22268228|NCT04599075|University of Massachusetts Chan School of Medicine|Dr. Gianna Wilkie|7743642523|Gianna.Wilkie@umassmemorial.org|
22268229|NCT03093259|Abivax|Sharon Skare|+33 (0) 1 53 83 08 41|sharon.skare@abivax.com|
22268230|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585|jbomyea@ucsd.edu|3720
22268231|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com|
22268232|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22268233|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22268234|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil|
22268235|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
22268236|NCT02404805|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Dr. Jennifer Kiser|(303) 724-6131|jennifer.kiser@ucdenver.edu|
22268237|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu|
22268238|NCT03793608|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22268239|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu|
22268240|NCT05493501|EQRx International|EQRx Clinical Trials|(650) 779-2300|clinicalstudies@eqrx.com|
22268241|NCT04004403|University of Illinois Chicago|Krista Varady|3129967897|varady@uic.edu|
22268242|NCT04199104|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22268243|NCT04692103|UWashington|Hannah Linden, MD|206-606-2053|hmlinden@uw.edu|
22268244|NCT04563754|Baylor College of Medicine|Dr. Sharmila Anandasabapathy|713-798-8105|Sharmila.Anandasabapathy@bcm.edu|
22268245|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org|
22268246|NCT04023396|Abivax|Associate Director Clinical Operations|+33630031132|laurence.desroys@abivax.com|
22268247|NCT03150329|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22279279|NCT04583618|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22279280|NCT03584490|Northwestern University|James W. Griffith, PhD|3125035345|j-griffith@northwestern.edu|
22279281|NCT02302222|Acelity|Sr Director, Global Clinical Development|2102555595|jane.hart@acelity.com|
22279282|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu|
22279283|NCT03110562|Karyopharm Therapeutics Inc.|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22309555|NCT04053075|Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Healthcare Institute|Dr. Meghan Baker, MD, ScD|617-867-4946|MBAKER1@BWH.HARVARD.EDU|
22309556|NCT04068181|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22268248|NCT02325973|Abbott Medical Italia|Vanoni Benedetta, Abbott Clinical Site Lead|+39340571064|benedetta.vanoni@abbott.com|
22268249|NCT04075825|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22268250|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22268251|NCT03220204|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
22268252|NCT03241862|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22309557|NCT05658224|USouthDakota|Dr. Kory Zimney|6056586373|kory.zimney@usd.edu|
22268253|NCT04470518|Leuven Unit Health Technology Assessment Research, KU Leuven|Tine De Burghgraeve, PhD|+3216377276|tine.deburghgraeve@kuleuven.be|
22268254|NCT03879135|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22268255|NCT05201794|Janssen Research & Development, LLC|Senior Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22268256|NCT03428958|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
22268257|NCT03874117|VA Palo Alto|Tammy Sirich|6504935000|tsirich@stanford.edu|
22268258|NCT06700512|WSAUDAS|Dr. Veronika Littmann|+4991313080|Veronika.littmann@wsa.com|
22268259|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com|
22309558|NCT03785964|SpringWorks Therapeutics|Head of Clinical Operations|877-279-4870|clinical@springworkstx.com|
22309559|NCT02723591|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22268260|NCT06497699|Ocumension Therapeutics (Shanghai) Co., Ltd|Director of Clinical Trials|2289 3653|clinicalop@ocumension.com|3653
22268261|NCT04510090|Escient Pharmaceuticals|Kristin Taylor, Sr VP, Head of Clinical Development|(858) 617-8220|clinicaltrials@escientpharma.com|
22268262|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22309560|NCT05070728|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
22309561|NCT03905798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309562|NCT05374798|Medical University of South Carolina|Stacey sellers|843-792-5807|sellersst@musc.edu|
22268264|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu|
22268265|NCT03657797|Nicox Ophthalmics Inc.|Doug Hubatsch / Chief Scientific Officer|832-360-3022|hubatsch@nicox.com|
22268266|NCT00711243|Northwestern University|Mary Mulcahy (MD)|312.695.6182|Mary.Mulcahy@nm.org|
22268267|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu|
22268268|NCT04074941|Marcus Institute, Hebrew SeniorLife|Shivani Sahni, PhD|6179715382|shivanisahni@hsl.harvard.edu|
22268269|NCT03642262|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22268270|NCT02572570|University of North Carolina at Chapel Hill|Ricardo Walter, DDS, MS|9195373596|walterr@unc.edu|
22268271|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22268272|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu|
22268273|NCT03861390|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
22268274|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com|
22309563|NCT03334630|Medtronic|Katie Flor, Principal Clinical Research Specialist|+1 763 526 9651|katie.j.flor@medtronic.com|
22309564|NCT04252573|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
22268275|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268276|NCT03192488|Indiana University|Robert Chapman|812-856-2452|rfchapma@indiana.edu|
22268277|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
22268278|NCT00611923|Weill Cornell Medical College and Yale School of Medicine|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
22268279|NCT04144413|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22268280|NCT00572936|University of Nebraska Medical Center|Carol Toris, PhD|402-559-1852|ctoris@unmc.edu|
22268281|NCT02806908|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22268282|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu|
22268283|NCT02302833|The University of Texas MD Anderson Cancer Center|Dr. Camilo Jimenez|(713) 792-2841|cjimenez@mdanderson.org|
22268284|NCT04429503|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22268285|NCT05516108|University of Pittsburgh|Emily K Lindsay, PhD|412-601-0585|emily.lindsay@pitt.edu|
22268286|NCT03664232|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22268287|NCT02717507|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22268288|NCT05017246|Washington University School of Medicine|Dr. Premal H Thaker|314-747-3604|thakerp@wustl.edu|
22268289|NCT02493660|Stryker Company|Colleen Roden, Director, Clinical Operations|1 931 267 2041|colleen.roden@stryker.com|
22279284|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my|
22309565|NCT03404115|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22322989|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22322990|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22322991|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org|
22322992|NCT04137783|Children's Hospital of Chongqing Medical University|Dr. Jianhui Wang|13678428167|wangjh@cqmu.edu.cn|
22322993|NCT03222349|Aquestive Therapeutics|Director of Clinical Operations|908-941-1887|denis.scheper@aquestive.com|
22322994|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu|
22322995|NCT03739528|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
22322996|NCT04303000|University of Alabama at Birmingham|Melinda Clarke|205-975-7809|melindaclarke@uabmc.edu|
22322997|NCT05655377|Flint Rehabilitation Devices|Ian Russell|9496670140|irussell@flintrehab.com|
22322998|NCT01110395|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22322999|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org|
22323000|NCT03118947|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22323001|NCT02769624|Cincinnati Children's Hospital Medical Center|Katy Fischesser|513-803-5191|katy.fischesser@cchmc.org|
22323002|NCT04139122|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
22323003|NCT01987908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22323004|NCT03711604|Rhizen Pharmaceuticals AG|Dr.Prajak Barde|9820503970|pjb@rhizen.com|
22323005|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
22323006|NCT01728779|Johns Hopkins University|Dana Kaplin|410-614-3950|dkaplin1@jhmi.edu|
22323007|NCT02789657|BrUOG|Brown University Oncology Research Group|4018633000|BrUOG@Brown.edu|
22323008|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300||
22323009|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com|
22323010|NCT01299727|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22323011|NCT03882424|Zhejiang Teruisi Pharmaceutical Inc.|Yilin Li, Medical Director|13601247168|yilin.li@teruisipharm.com|
22268290|NCT03073876|City University of New York - Queens College and The Graduate Center|Nancy S. Foldi, PhD; Professor|718.997.3253|nfoldi@qc.cuny.edu|
22268291|NCT00709995|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22268292|NCT00638508|Maimonides Medical Center|Kalpana Tyagaraj, M.D.|718-283-9162|Kalpana_tyagaraj@msn.com|
22268293|NCT03500198|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
22268294|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22268295|NCT04650217|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|brr8@cumc.columbia.edu|
22268296|NCT00595621|Texas Tech|Irene Sarosiek, MD, AGAF, FACG, CCRP|915.215.5254|Irene.sarosiek@ttuhsc.edu|
22268297|NCT02440464|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22268298|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408||
22268299|NCT00268450|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22268300|NCT02568072|St George's, University of London|Dr Andrew D'Silva|020 7188 7188|adsilva@nhs.net|51554
22268301|NCT05263908|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268302|NCT02714218|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22268303|NCT01422200|Cincinnati Children's Hospital Medical Center|Dr. Brenda Wong|5136364222|brenda.wong@cchmc.org|
22268304|NCT00840749|Accuray Inc|study admin|4087164608|ccheung@accuray.com|
22268305|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu|
22268306|NCT01113892|Getinge Group|Elizabeth Bulger|603 880 1433|Elizabeth.Bulger@getinge.com|5368
22268307|NCT01285362|Columbia Universty|Dr Mercedes Martinez|212-305-3438|mm2479@cumc.columbia.edu|
22268308|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22268309|NCT03473925|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268310|NCT05966506|The University of Texas Health Science Center at Houston|Nitha Mathew Joseph, PhD, RN, CNE, CGNC|713-500-2165|Nitha.Mathew@uth.tmc.edu|
22268311|NCT02756611|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22268312|NCT03125798|Wielkoposkie Centrum Pulmonologii i Torakochirurgii|Dr Piotr Gabryel|+48616654249|piotrgabryel@gmail.com|
22268313|NCT03618017|University of Michigan Rogel Cancer Center|Lauren Wallner, Ph.D.|734-232-0788|lwallner@med.umich.edu|
22268314|NCT03490110|Veterans Affairs|Dr. Anthony Chen|925-372-2530|anthony.chen@va.gov|
22268315|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400|cswgamboa@yahoo.com|441
22268316|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22268317|NCT02020278|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22268318|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
22268319|NCT00476190|Dana Farber Cancer Institute|Dr. Dan DeAngelo|6175828410|Daniel_Deangelo@dfci.harvard.edu|
22268320|NCT04782076|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22268321|NCT02577991|Northwestern University Department of Orthopaedic Surgery|Surabhi Bhatt|312-472-6024|surabhi.bhatt@nm.org|
22268322|NCT04665765|City of Hope Medical Center|Dr. Alex Herrera , MD|6263598111|aherrera@coh.org|
22268323|NCT04748510|Perth Hip & Knee|Dr Serene Lee, Orthopaedic Research Officer|64891720|research@hipnknee.com.au|
22268324|NCT04565145|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
22323012|NCT02395991|Seoul National University Hospital|Professor Jeong Min Lee|82-2-2072-3154|jmsh@snu.ac.kr|
22268325|NCT02547428|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22268326|NCT03070236|Dana-Farber Cancer Institute (DFCI)|Ann H. Partridge, MD, MPH|617-632-3800|Ann_Partridge@dfci.harvard.edu|
22268327|NCT01634048|Imperial College|Professor Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
22268328|NCT06192589|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
22268329|NCT04552795|UT Health San Antonio|Bess Frost, PhD|210-562-5037|bfrost@uthscsa.edu|
22268330|NCT01662778|Imperial College London|Dr Omar Usmani||o.usmani@imperial.ac.uk|
22268331|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22268332|NCT02003209|NSABP Foundation|Judy Langer, Director of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22268333|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268334|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22268335|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22268336|NCT02548832|INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA|Esperanza Martinez Abundis|3310585200|esperanzamartnezabundi@yahoo.com|34211
22268337|NCT03565900|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268338|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268339|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com|
22268340|NCT06160609|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268341|NCT03359850|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268342|NCT01280643|Fox Chase Cancer Center|Dr. Crystal Denlinger|215-214-1676|crystal.denlinger@fccc.edu|
22268343|NCT02090088|Amgen Inc.|Study Director|866-572-6436||
22268344|NCT01629511|UT MD Anderson Cancer Center|Dr. Chitra Hosing|713-792-8750|cmhosing@mdanderson.org|
22268345|NCT03290378|Avenue Therapeutics|VP of Clinical Operations and Program Management|781-652-4514|mryan@avenuetx.com|
22268346|NCT03817125|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22268347|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu|
22268348|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22268349|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22268350|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
22268351|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu|
22268352|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411|marx0001@mc.duke.edu|7426
22268353|NCT01949662|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
22268354|NCT02291237|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22268355|NCT07034820|Nimsai Academia|Cem Atabiner, Principal Investigator|05324593292|cem.atabiner@kecioutdoor.com.tr|
22268356|NCT02189837|Amgen Inc.|Study Director|866-572-6436||
22268357|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu|
22268358|NCT04851873|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22268359|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com|
22268360|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408||
22268361|NCT03787134|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
22268362|NCT03281876|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268363|NCT02208089|Moorfields Eye Hospital NHS Foundation Trust|Mr Bruce Allan|02075662320|bruce.allan@ucl.ac.uk|
22268364|NCT00456300|Montefiore Medical College|Rubina Heptulla|832824000|rubhep@gmail.com|
22268365|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300||
22268366|NCT00978874|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
22268367|NCT03098082|Indiana University School of Medicine|Jeffrey J. Easler, MD|3179440980|jjeasler@iu.edu|
22268368|NCT01199380|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
22268369|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22268370|NCT02757326|Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy|Yubin Kang, M.D., Principal Investigator|(919) 668-2331|yubin.kang@duke.edu|
22268371|NCT03008174|Johns Hopkins University|Vinciya Pandian|4436553482|vpandia1@jhu.edu|
22268372|NCT01074944|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22268373|NCT00194779|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22268374|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org|
22268375|NCT03741400|Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
22296687|NCT03482791|Washington University School of Medicine|Gregory Vlacich, M.D., Ph.D.|314-362-8610|gvlacich@wustl.edu|
22268376|NCT03560128|Indiana University|Study Coordinator|317-948-0724|rlahr@iu.edu|
22268377|NCT03423940|Rutgers, The State University of New Jersey|Brian D. Greer, Ph.D., BCBA-D|848-800-8505|brian.greer@rutgers.edu|
22268378|NCT03200717|Novartis Pharmaceuticals|Study director|+1 862-778-8300|novartis.email@novartis.com|
22268379|NCT02586155|Resverlogix Corp.|Sr. Director of Clinical Operations|403.254.9252|clinicaltrials@resverlogix.com|
22296688|NCT01918761|Cecog|MD Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
22268380|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
22268381|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com|
22279285|NCT02876172|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22323013|NCT02772757|Mountain Home VA Medical Center|Sherri L. Smith, Au.D., Ph.D.|423.926.1171|sherri.smith@va.gov|7569
22323014|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu|
22323015|NCT05384041|Climb Technologies, Inc.|Julia Lanoha|(925) 405-5458|julia@climb.care|
22323016|NCT02266108|UCSDMED|Elizabeth Reed, Associate Professor|5082121517|elizared7@gmail.com|
22323017|NCT03329378|Icahn School of Medicine at Mount Sinai|Dr. Aarti Bhardwaj|(212) 824-8578|Aarti.Bhardwaj@mountsinai.org|
22323018|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323019|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu|
22323020|NCT01731678|University of Calgary|Frank MacMaster, PI of the project|403-955-2784|fmacmast@ucalgary.ca|
22323021|NCT03715426|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
22323022|NCT00888355|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22268382|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22268383|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821||
22268384|NCT02899962|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22268385|NCT00258960|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34 916 592 870|geicam@geicam.org|
22268386|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590||
22268387|NCT04778475|Medical University of South Carolina|Sinead Farrelly DPT|843-792-3069|farrelsi@musc.edu|
22268388|NCT04446247|Owlet Baby Care, Inc|Madison Kenley, Clinical Research Director|801-552-8383|mkenley@owletcare.com|
22268389|NCT02601014|University of Minnesota Division of Hematology, Oncology and Transplantation|Emmanuel Antonarakis, MD|612-301-2180|anton401@umn.edu|
22268390|NCT02833337|Centro de Implantologia, Cirugia Oral y Maxilofacial|Alberto Monje|+41798836264|amonjec@umich.edu|
22268391|NCT02623725|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
22268392|NCT03918629|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268393|NCT01243957|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22268394|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com|
22268395|NCT02698163|UCLA School of Dentistry|Dr. Eric Sung|(310) 206-6407|esung@dentistry.ucla.edu|
22268396|NCT01133067|Dept. of Radiation Oncology, Tata Memorial Hospital|Dr. J.P. Agarwal|+91 22 24177000|agarwaljp@tmc.gov.in|7164
22279286|NCT02769481|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22279287|NCT02781558|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22279288|NCT04604431|Northwestern University Feinberg School of Medicine|Lucy Bilaver, Associate Professor of Pediatrics, iREACH Co-Investigator|312-503-5618|l-bilavere@northwestern.edu|
22279289|NCT00643279|Medtronic|Dana Wigert|763-526-2802|dana.wigert@medtronic.com|
22279290|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com|
22323023|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu|
22268397|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356|marianne.wanten@medtronic.com|6815
22323024|NCT05523973|University of Cincinnati|Dr. Brittany Krekeler, PI|5132272759|krekelby@ucmail.uc.edu|
22323025|NCT02010203|Clinical Development|Lori McDermott|9197948950|lmcdermott@heatbio.com|9197948950
22323026|NCT03363633|Duke University Medical Center|Ellen D. Dillavou, MD, FACS||ellen.dillavou@duke.edu|
22323027|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22323028|NCT04051957|The University of Texas Health Science Center at Houston|Jaya Kala, MD|713-500-6868|jaya.kala@uth.tmc.edu|
22323029|NCT01929057|UCSD Dermatology Clinical Trials|Dermatology Clinical Trial Manage|(858)657-8390|dermstudies@ucsd.edu|
22323030|NCT03760484|University of Alberta|Dr. Dina Kao|780-233-6025|dina.kao@ualberta.ca|
22323031|NCT00132041|American College of Radiology Imaging Network|Donna Harfeil, Director of Protocol Management|215-717-2765|Donna Hartfeil <dhartfeil@acr.org>|
22323032|NCT05197803|Sonova AG|Study Manager|519 895 0100|carolina.rubiano@sonova.com|2135
22323033|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
22323034|NCT03969875|Icahn School of Medicine at Mount Sinai|Dr. Poonam Pai|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
22323035|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200|kampman@mail.med.upenn.edu|109
22323036|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com|
22323037|NCT03057366|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323038|NCT02911688|Center for Environmental Medicine Asthma and Lung Biology|Carole Robinette Assistant Director of Clinical Research|919 966-5638|carole_robinette@med.unc.edu|
22323039|NCT04201717|FIrst Hospital of Jilin University|Dr. Quan Wang|+86 ‭15843073207‬|wquan@jlu.edu.cn|
22323040|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323041|NCT01793792|MicroVention, Inc|Anne Hurley|714-247-8000|anne.hurley@microvention.com|
22323042|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com|
22323043|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22309566|NCT04498390|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309567|NCT05487404|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22309568|NCT04068311|The Ohio State University|Dr. Lauren Southerland, Principal Investigator|919-293-8305|lauren.southerland@osumc.edu|
22309569|NCT02068885|Boston Children's Hospital|Cara Ebbeling, PhD, Co-Director, New Balance Foundation Obesity Prevention Center|617-919-3457|Cara.Ebbeling@childrens.harvard.edu|
22309570|NCT04353258|University of Connecticut|Principal Investigator|8604862834|tricia.leahey@uconn.edu|
22309571|NCT04581564|Assistant Professor. Speech, Language and Hearing|Dr. Yune Lee|972-883-5639|yune.lee@utdallas.edu|
22309572|NCT04721977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309573|NCT02670525|Dana-Farber Cancer Institute|Dr. Yana Pikman|6176324754|yana_pikman@dfci.harvard.edu|
22309574|NCT04304820|National Heart, Lung and Blood Institute (NHLBI)|Bhavisha Patel, M.D.|301-402-3477|bhavisha.patel@nih.gov|
22309575|NCT03873818|The University of Texas MD Anderson Cancer Center|Isabella C Glitza, MD,PHD|(713) 792-2921|icglitza@mdanderson.org|
22309576|NCT03474107|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22309577|NCT05171855|Ascendis Pharma|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
22309578|NCT05041257|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22309579|NCT03067480|East Tennessee State University|Rick Hess|423-439-2075|hessr@etsu.edu|
22309580|NCT03946111|Yale School of Medicine|Dr. Carlos M. Grilo|2037857210|carlos.grilo@yale.edu|
22309581|NCT05782816|University of Texas Medical Branch|Amanda Wang, MD|4097728666|amanda.mei.wang@gmail.com|
22309582|NCT04221490|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22296689|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu|
22296690|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22296691|NCT01816893|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
22296692|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com|
22296693|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743||
22296694|NCT01545817|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296695|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org|
22296696|NCT04782856|Uconn Health|Francesco S. Celi, MD, MHSc.|860-679-2715|celi@uchs.edu|
22296697|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300||
22296698|NCT04475588|Biocon Biologics India Limited|Dr. Subramanian Loganathan|0802808|subramanian.l101@biocon.com|5466
22296699|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu|
22296700|NCT05620576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296701|NCT02603432|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296702|NCT02666183|Case Western Reserve University|Sara L. Douglas, PhD, RN, Professor FPB School of Nursing|216-368-0702|sld4@case.edu|
22296703|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22296704|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296705|NCT02130063|Pharmacosmos|Chief Medical Officer|+45 5948 5959|llt@pharmacosmos.com|
22296706|NCT01649375|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22296707|NCT01856790|Yale University School of Medicine|Dr. Jennifer Sherr|203-785-5831|jennifer.sherr@yale.edu|
22296708|NCT04939727|HealthPartners Institute|Dr. Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22296709|NCT04091646|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22296710|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu|
22296711|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu|
22296712|NCT05394025|Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System|Project Manager|503-220-8262|Holly.McCready2@va.gov|51856
22296713|NCT01316276|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
22296714|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300||
22296715|NCT05469100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296716|NCT04098107|Children's Hospital of Philadelphia|Elliot Greenberg|215-590-1527|GREENBERGE@chop.edu|
22296717|NCT03538158|Weill Cornell Medicine|Chelsie Burchett|212-746-1417|cob2014@med.cornell.edu|
22296718|NCT03240679|Mayo Clinic|Dr. Kenneth K. Wang|507-284-2691|wang.kenneth@mayo.edu|
22296719|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com|
22296720|NCT00912990|Rady Children's Hospital San Diego|Dr. Sandeep Khanna|858-966-5863||
22296721|NCT02876900|Noven Pharmaceuticals|George Harb, MD, MPH - Executive Director, Clinical Development|1-551-233-2656|gharb@noven.com|
22296722|NCT04356963|University of Maryland School of Medicine|Dr. Nicholas Morris|410-328-4515|nicholas.morris@som.umaryland.edu|
22296723|NCT02285907|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
22296724|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net|
22296725|NCT02410954|University of California, San Francisco|Andrew Krystal, MD|(415) 476-7702|andrew.krystal@ucsf.edu|
22296726|NCT02653456|Ra Medical Systems, Inc.|Vice President of Regulatory Affairs and Quality Assurance|877-635-1800|vchester@ramed.com|207
22296727|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296728|NCT02488681|Medtronic|Micra CA Study Manager|800-328-2518|rs.micracontinuedaccess@medtronic.com|
22323044|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22323045|NCT06062264|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22323046|NCT05256888|University of Maryland School of Nursing|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
22323047|NCT02487108|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22323048|NCT00469612|The Ohio State University|Dr. Don Mutti|614-247-7057|mutti.2@osu.edu|
22323049|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22323050|NCT01622569|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
22323051|NCT02522767|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22323052|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590||
22268398|NCT00349973|University of Maryland, Baltimore|Dr. Elliot Hong, Prinicipal Investigator|410-402-6828|ehong@som.umaryland.edu|
22296729|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22296730|NCT00006101|University of California, Irvine|Dr. Thomas Ahlering|(714) 456-6068|tahlerin@uci.edu|
22309583|NCT04500613|Hospital for Special Surgery|Marko Popovic|646-797-8948|popovicm@hss.edu|
22309584|NCT05799079|Vanderbilt-Ingram Cancer Center|Sanjay Mohan|615-936-8422|sanjay.mohan@vumc.org|
22309585|NCT02998268|Weill Cornell Medicine|Dr. Manish Shah|646-962-6200|mas9313@med.cornell.edu|
22309586|NCT04225273|QMedAB|Clinical Project Manager|18179615000|aestheticclinicaltrials@galderma.com|
22309587|NCT04192266|The University of Texas Health Science Center at Houston|Mohammed R Milad, PhD|713-486-2754|Mohammed.R.Milad@uth.tmc.edu|
22309588|NCT01501955|Zimmer Biomet|Linda Meijer|+31786292929|linda.meijer@zimmerbiomet.com|
22309589|NCT04298983|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|2059345670|ammcdonald@uabmc.edu|
22309590|NCT02927236|National Institute on Drug Abuse (NIDA)|Yihong Yang, PhD|443-740-2648|yihong.yang@nih.gov|
22309591|NCT05477186|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309592|NCT01767636|Mayo Clinic|Brian Costello MD|507/284-2511|Costello.Brian@mayo.edu|
22309593|NCT01919554|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 20 00|mroux@stallergenes.com|
22309594|NCT04018053|BrighamHospital|Heather Jacene|617-632-3767|hjacene@bwh.harvard.edu|
22309595|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22309596|NCT05533918|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
22309597|NCT02838420|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22309598|NCT03024437|University at Buffalo|Dr. Roberto Pili|(716) 881-8918|rpili@buffalo.edu|
22309599|NCT03621371|Karolinska Institutet|Dr Benjamin Bohman|701713443|benjamin.bohman@ki.se|+46
22309600|NCT03240016|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22268399|NCT04135937|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
22268400|NCT05620082|University of Southampton|Dr Samantha J Meredith|0238120|s.j.meredith@soton.ac.uk|4656
22296731|NCT04147455|Emory University|Dr. Kathryn Yount|404-727-8511|kyount@emory.edu|
22296732|NCT02701647|The Hong Kong Polytechnic University|Chloe Chung|2766|chloe.lh.chung@connect.polyu.hk|7092
22296733|NCT01807897|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6175|daniel.gottlieb@va.gov|
22296734|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121|irb@vghks.gov.tw|1518
22296735|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov|
22296736|NCT03341533|Mayo Clinic|Dr. Tatnai Burnett|507-538-5783|burnett.tatnai@mayo.edu|
22296737|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org|
22296738|NCT04311424|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296739|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296740|NCT04170348|CUIMC|Dr. Margaret T. Lee, Professor of Pediatric|212-305-6290|ml653@cumc.columbia.edu|
22296741|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
22296742|NCT03642717|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296743|NCT02587065|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22296744|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313|amaina@cittadellasalute.to.it|5735
22296745|NCT00946712|SWOG Statistics & Data Management Center|Lung Committee Statistican|2066675712|jmiao@fredhutch.org|
22296746|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu|
22296747|NCT04665050|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296748|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu|
22296749|NCT04248933|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22296750|NCT02517996|Johns Hopkins University School of Medicine|Dr. Tola Fashokun|410-464-6641|bunmi_omo@hotmail.com|
22296751|NCT02642432|AbbVie|Global Medical Services|800-633-9110||
22296752|NCT02447081|Abbott|Ryan Gage, Senior Scientist|651 756 3334|Ryan.Gage@abbott.com|
22296753|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565|Jonathan.Nebeker@hsc.utah.edu|2458
22296754|NCT02867709|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22296755|NCT01722240|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
22296756|NCT03188094|NYU Langone Health|Jennifer Zanowiak|212 263 0485|Jennifer.Zanowiak@nyulangone.org|
22309601|NCT05200403|Boston University School of Medicine|Kevin Thomas, PhD, MBA|617-358-9787|kipthoma@bu.edu|
22309602|NCT05546411|Dana Farber Cancer Institute|Kimberly Perez, MD|617-632-5370|KIMBERLY_PEREZ@DFCI.HARVARD.EDU|
22309603|NCT02606422|Johns Hopkins University School of Medicine|Kyrana Tsapkini|410-614-2646|tsapkini@jhmi.edu|
22309604|NCT04625465|Georgia State University|Dr. Dominic Parrott, Distinguished University Professor of Psychology|+1 (404) 413-6287|parrott@gsu.edu|
22309605|NCT04947397|University of California San Francisco|Daniel Abelson|510 428 3000|daniel.abelson@ucsf.edu|
22309606|NCT03584633|Cleveland Clinic|Dr. Wei F. Chen|319-333-6166|chenw6@ccf.org|
22309607|NCT05566639|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22309608|NCT05166577|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
22268401|NCT03796988|University of Miami|Hadar Lev-Tov, Assistant Professor|305-243-4472|hltevtov@med.miami.edu|
22268402|NCT02141438|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22268403|NCT03296813|Duke University|Robert Mentz, MD|919-668-7121|robert.mentz@duke.edu|
22268404|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22268405|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl|
22268406|NCT04021914|Emory University|Dr. Jeffrey N. Siegelman|4042518868|jsiegelman@emory.edu|
22268407|NCT02059512|First Pavlov State Medical University of St. Petersburg|Vladimir V Komok, Ph.D|8-904-632-19-00|vladimir_komok@mail.ru|
22268408|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22268409|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22268410|NCT04581824|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268411|NCT05012098|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
22268412|NCT03593473|University of North Carollina at Chapel Hill|Alison Stuebe, MD, MSc|919-966-1601|astuebe@med.unc.edu|
22268413|NCT01749826|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
22268414|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22268415|NCT05085834|University Hospitals Cleveland Medical Center|Grace McComsey|216-368-3731|Grace.McComsey@uhhospitals.org|
22268416|NCT04514692|Stanford University|Dr. Elizabeth Kidd|(650) 723-6171|ekidd@stanford.edu|
22268417|NCT01823328|Hennepin Healthcare|Audrey Hendrickson|612-873-9528|Audrey.Hendrickson@hcmed.org|
22268418|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400|ogar@unam.mx|832
22268419|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com|
22268420|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com|
22268421|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
22268422|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com|
22268423|NCT00351468|Novartis|Study Director|862-778-8300||
22268424|NCT03588910|Montefiore Medical Center|Dr. Kari Plewniak|718-920-5157|kplewnia@montefiore.org|
22268425|NCT03096314|Massachusetts General Hospital|Nancy Ringwood, CCC Project Manager|617-724-9836|nringwood@mgh.harvard.edu|
22268426|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268427|NCT03318861|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22268428|NCT02844933|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22268429|NCT01479465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22268430|NCT01892501|Institute Bergonie|Dr. Dominique Bechade, Coordinating Investigator|0556337805|d.bechade@bordeaux.unicancer.fr|
22268431|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
22268432|NCT01129440|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
22268433|NCT04335123|Kansas University Medical Center|Dr Matthias Salathe|9135886000|msalathe@kumc.edu|
22268434|NCT01439802|Albert Einstein College of Medicine|Dr. Erika Levi|718-405-8260|elevi@montefiore.org|
22268435|NCT02562066|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22268436|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch|
22268437|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu|
22268438|NCT01234350|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22268439|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22268440|NCT01839708|Ohio State University|Mei-Wei Chang|(614) 292-4041|chang.1572@osu.edu|
22268441|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org|
22268442|NCT01823861|London School of Hygiene and Tropical Medicine|Dr. Chris Smith|07974562199|christopher.smith@lshtm.ac.uk|
22268443|NCT04784091|Tarsus Pharmaceuticals|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
22268444|NCT03428152|Derince Training and Research Hospital|Dr|+905336515650|handegrbz@gmail.com|
22268445|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300||
22268446|NCT01686373|University of South Carolina|Dr. Julius Fridriksson|1-803-777-5931|jfridrik@sc.edu|
22268447|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268448|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it|
22268449|NCT02285361|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268450|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22268451|NCT02411656|The University of Texas MD Anderson Cancer Center|Bora Lim, MD|(713) 745-0689|blim@mdanderson.org|
22268452|NCT06481709|APR Applied Pharma Research s.a.|Giorgio Reiner Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
22268453|NCT03933904|Center for Cytokine Storm Treatment & Laboratory (CSTL), University of Pennsylvania|Dr. David Fajgenbaum|215-614-0935|davidfa@pennmedicine.upenn.edu|
22268454|NCT05366010|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22268455|NCT02224157|AstraZeneca AB|Stefan Ivanov|000000000|information.center@astrazeneca.com|
22268456|NCT05906628|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22309609|NCT04054193|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22309610|NCT04082143|Virginia Commonwealth University|Lyndon Cooper, Dean|(804) 828-7235|cooperlf@vcu.edu|
22309611|NCT05436262|Johns Hopkins University|Cherie Marvel|410-387-8510|cmarvel1@jhmi.edu|
22309612|NCT05299073|mAbxience Research S.L.U.|Susan Millan PhD|+34 917711500|susana.millan@mabxience.com|
22309613|NCT03952338|University of Calgary|Dr. Dana Lee Olstad|403-210-8673|dana.olstad@ucalgary.ca|
22309614|NCT01456949|Medtronic|Kirsten Rasmussen|763-526-2833|kirsten.l.rasmussen@medtronic.com|
22309615|NCT05124704|Zhejiang Cancer Hospital|Jiangling Wang|15168373331|wangjl@zjcc.org.cn|
22309616|NCT04162665|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
22309617|NCT05875467|dfusion Inc|Chief Executive Officer|8312225103|tamara.kuhn@dfusioninc.com|
22309618|NCT05934942|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309619|NCT03924635|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22309620|NCT05469464|UNION therapeutics A/S|UNION therapeutics A/S|+45 61 77 7435|clinicaltrials@uniontherapeutics.com|
22309621|NCT04421989|Cincinnati Children's Hospital Medical Center|Dr. Claire Aarnio-Peterson|5138037459|claire.aarnio-peterson@cchmc.org|
22309622|NCT04585815|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309623|NCT01854775|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22309624|NCT03100149|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22309625|NCT03697876|Laboratorios Sophia S.A. de C.V.|Alejandra Sanchez-Ríos|3330014500|alejandra.sanchez@sophia.com.mx|1190
22309626|NCT02442349|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+441625231825||
22309627|NCT03936959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309628|NCT03748953|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22309629|NCT04676763|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309630|NCT02296125|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
22309631|NCT04858451|Thirty Respiratory Ltd|Inva Hoti, PhD|+44 (0) 1235 431200|Inva.Hoti@30.technology|
22309632|NCT02966873|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
22309633|NCT05844137|Duke University|Anastasia Alexopoulos|1 919 684 4005|anastasia.alexopoulos@duke.edu|
22309634|NCT03235544|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22309635|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309636|NCT06176963|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22309637|NCT04753697|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22309638|NCT01658930|Canadian Cancer Trials Group|Lois E. Shepherd|6135336430|LShepherd@ctg.queensu.ca|
22309639|NCT04200456|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22309640|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu|
22309641|NCT05002088|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
22309642|NCT05495971|Visioneering Technologies, Inc.|Dr. Douglas P. Benoit|6035459507|dbenoit@vtivision.com|
22309643|NCT04770402|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22309644|NCT03599661|Wake Forest Baptist Comprehensive Cancer Center|Stephanie Bunch|336-716-5180|sbunch@wakeforest.edu|
22309645|NCT04811040|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22309646|NCT05446129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22309647|NCT05446168|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
22309648|NCT03512327|Scripps Clinic|Dr. Gauree Konijeti|8585548880|konijeti.gauree@scrippshealth.org|
22309649|NCT06258174|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22309650|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
22309651|NCT06473662|Diabetology Ltd|Roger New|07818068012|rn@diabetology.co.uk|
22309652|NCT02398656|University of Calgary|Dr. Shelagh Coutts|4039444286|scoutts@ucalgary.ca|
22309653|NCT05602220|University of Southern California|Director of Clinical Trials|213-740-9543|nashiro@usc.edu|
22309654|NCT04471246|Ottawa Hospital Research Institute|Krishan Yadav|613-798-5555|kyadav@toh.ca|19489
22309655|NCT04826471|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
22309656|NCT05764525|Vivozon, Inc.|Chief Medical Officer|609 269 9140|adminus@vivozon.com|
22309657|NCT04079218|Albert Einstein College of Medicine|Dr. Kerry Murphy|718-839-7885|kerry.murphy@einsteinmed.edu|
22309658|NCT03743532|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
22309659|NCT05705518|University of California Berkeley Clinical Research Center|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
22309660|NCT03910478|Fred Hutchinson Cancer Research Center|Michael Boeckh, MD|206-667-6706|mboeckh@fredhutch.org|
22309661|NCT05293171|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
22309662|NCT04066205|University of Washington|Teresa Ward, Professor, Department of Pediatrics|206-884-1439|teresa.ward@seattlechildrens.org|
22279291|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810|kirsten.johansen@ucsf.edu|23598
22279292|NCT03198871|University of Pittsburgh School of Medicine / UPMC|Dr. Kathirvel Subramaniam MD MPH FASE|7247995852|subramaniamk@upmc.edu|
22309663|NCT02052882|Memorial Sloan Kettering Cancer Center|Dr. Cy Wilkins, MD|646-608-3720|wilkinsc@mskcc.org|
22279293|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22279294|NCT02777086|Texas Christian University|Wayne E.K. Lehman, Ph.D.|18172577226|w.lehman@tcu.edu|
22279295|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
22279296|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22279297|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279298|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279299|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
22279300|NCT02359006|Yale University|Dr. Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22279301|NCT03376516|Octapharma AG|Sylvia Werner|604-1149|sylvia.werner@octapharma.com|+1 (201)
22279302|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279303|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu|
22279304|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu|
22279305|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu|
22279306|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
22279307|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300||
22279308|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|janis.daly@neurology.ufl.edu|6603
22279309|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu|
22279310|NCT05201807|Johnson & Johnson Vision Care, Inc.|John R. Buch-Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
22279311|NCT05093621|Yale School of Medicine|Jeffrey Testani, MD, MTR Associate Professor of Medicine|(203) 785-7191|jeffrey.testani@yale.edu|
22309664|NCT05590728|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
22309665|NCT03734679|Surmodics|Thu Huyen Ha|952.500.7261|tha@surmodics.com|
22309666|NCT04036253|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
22309667|NCT04339101|City of Hope Medical Center|Dr. Ali Haris|626-359-8111|aharis@coh.org|
22309668|NCT06201559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22309669|NCT05218096|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22268457|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org|
22268458|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
22268459|NCT02857816|Medtronic Pelvic Health & Gastric Therapies|Beth Michaud / Sr. Principal Clinical Research Specialist|763.526.8102|beth.m.michaud@medtronic.com|
22268460|NCT02443740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268461|NCT02046603|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268462|NCT02461160|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22268463|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
22268464|NCT02431364|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22268465|NCT00061932|Montefiore Medical Center|Rutvi Patel|718-379-6861|rupatel@montefiore.org|
22268466|NCT03367819|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22268467|NCT02624180|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
22268468|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com|
22268469|NCT02456740|Amgen Inc.|Study Director|866-572-6436||
22268470|NCT01615367|Massachusetts General Hospital|Dr. Louisa Sylvia|617-643-4804|lsylvia2@partners.org|
22268471|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22268472|NCT04720105|Icahn School of Medicine at Mount Sinai|Hassan Hamade|212-844-8811|hassan.hamade@mountsinai.org|
22268473|NCT02771977|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
22268474|NCT00619723|Psychoneuroendocrine Research Group|Dr. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22268475|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu|
22268476|NCT02546986|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22268477|NCT02844543|Stanford University|Dr. Jamshid Ghajar, MD, PhD|(650) 725-5562|acrevelt@stanford.edu|
22268478|NCT03349060|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268479|NCT02861586|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268480|NCT04710576|Syndax Pharmaceuticals|Chief Medical Officer|781-419-1400|clinicaltrials@syndax.com|
22268481|NCT04796909|The Hong Kong Polytechnic University|Dr. Chi-Wen Chien, Associate Professor|+85227666703|will.chien@polyu.edu.hk|
22268482|NCT00437021|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
22268483|NCT04162847|Washington University in St. Louis School of Medicine|Dr. Denise Wilfley|3142862079|wilfleyd@wustl.edu|
22268484|NCT03985800|Department of Psychiatry, University of Pittsburgh|Eva Szigethy, Co-Principal Investigator, Adjunct Professor of Psychiatry, Staff Psychiatrist|412-667-0416|szigethye@upmc.edu|
22268485|NCT05258773|Sensorion|Chief Medical Officer|+33 4 67 20 77 30|contact@sensorion-pharma.com|
22268486|NCT05277922|Vicore Pharma AB|Cecilia Ganslandt|+46 705 797075|info@vicorepharma.com|
22268487|NCT03018288|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
22268488|NCT05573464|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22268489|NCT05734157|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
22268490|NCT04815083|photonamic GmbH & Co. KG|Vice President Clinical Development & Regulatory Affairs|+49 (0)4101 78539 09|info@photonamic.de|
22268491|NCT06025721|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22268492|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com|
22268493|NCT01730053|Regeneron Pharmaceuticals|Clinical Trial Management||clinicaltrials@regeneron.com|
22268494|NCT02068508|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22268495|NCT02024607|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
22268496|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com|
22268497|NCT04173507|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22268498|NCT02832687|CHRISTUS St. Vincent Regional Medical Center|Dr. Michal Gajewski, DO|(505) 913-3361|Michal.Gajewski@stvin.org|
22268499|NCT04231825|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
22296757|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu|
22296758|NCT03313804|University of Kentucky|Dr. John Villano|8593234405|jlvillano@uky.edu|
22296759|NCT03795298|Boston Scientific|Anne Cornaille|+1-800-227-3422|anne.cornaille@bsci.com|
22296760|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com|
22296761|NCT00571259|Satellite Healthcare, Inc.|Veronica Legg, MS: Director of Research Business|360-607-6892|leggv@satellitehealth.com|
22296762|NCT03971695|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296763|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu|
22296764|NCT01881230|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22296765|NCT02747420|NYU Langone Health|Dr. Benjamin Brucker|+1 646 825 6300|Benjamin.Brucker@nyulangone.org|
22296766|NCT05129488|Bausch & Lomb|Study Director|15853386399|robert.steffen@bausch.com|
22296767|NCT04307446|Tufts University|Nancy Baker|617 627 5562|nancy.baker@tufts.edu|
22296768|NCT02515942|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22296769|NCT02622828|University of Manitoba|Dr. Jacquie Ripat|204-789-3303|jacquie.ripat@umanitoba.ca|
22296770|NCT03616912|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22296771|NCT01723163|Durham Veterans Affairs Medical Center|Dr. Patrick Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
22296772|NCT02510794|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22296773|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
22296774|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com|
22296775|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu|
22296776|NCT00539838|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22296777|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu|
22296778|NCT03090100|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22296779|NCT03446040|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22296780|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com|
22296781|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
22296782|NCT05853250|Cleveland Clinic|Nancy M. Albert, PhD, Associate Chief Nursing Officer|216-444-7028|albertn@ccf.org|47028
22296783|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296784|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com|
22296785|NCT00390325|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|Manisha.Shah@osumc.edu|
22296786|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000||
22296787|NCT04434131|University of New Mexico Health Sciences Center|Dr. Michelle Harkins|5052724751|mharkins@salud.unm.edu|
22296788|NCT02255981|Escuela Neijing|Researcher|5744211000|lhgut2001@gmail.com|
22296789|NCT02672423|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22296790|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com|
22296791|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
22296792|NCT01454570|James J Peters VA Medical Center|Dr. Ann Spungen - PI|718-584-9000|ann.spungen@va.gov|5420
22296793|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22296794|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu|
22296795|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296796|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
22296797|NCT03836963|Edward Hines Jr. VA Hospital|Sandra Kletzel|708-202-5735|sandra.kletzel@va.gov|
22296798|NCT02625090|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22296799|NCT04649164|Rush University Medical Center|Dr. Jori Fleisher|3125632900|jori_fleisher@rush.edu|
22296800|NCT03168464|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
22296801|NCT02250443|Novartis Pharmaceutical|Study Director|862-778-8300||
22296802|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22279312|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22279313|NCT05077969|Leidos, Inc.|Tilly Lawrence|703-578-7034|tilly.lawrence@leidos.com|
22279314|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22279315|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
22279316|NCT02458235|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
22279317|NCT02369536|IRCCS Neuromed|Dr. Chiara Cerletti, operative responsible of the trial and corresponding author of the data public|0865915246|chiara.cerletti@moli-sani.org|
22279318|NCT01636284|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
22279319|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov|
22279320|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279321|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com|
22279322|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org|
22279323|NCT02164864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279324|NCT01870869|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22279325|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22279327|NCT02131766|UVA|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22279328|NCT01874392|Sansum Diabetes Research Institute|Director of Research and Innovation|8056827640|dkerr@sansum.org|
22279329|NCT02271880|Florida International University|Dr. William Pelham|305-348-0477|wpelham@fiu.edu|
22279330|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22279331|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu|
22279332|NCT02006927|William Beaumont Hospitals|Deborah Hasenau, RN|248 551-0804|deborah.hasenau@beaumont.org|
22279333|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
22279334|NCT00673920|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279335|NCT02519842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279336|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu|
22279337|NCT02639390|Department of Veterans Affairs|Peter Lum|12023195181|lum@cua.edu|
22279338|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279339|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu|
22279340|NCT03443635|Tulane University Goldring Center for Culinary Medicine|Principal Investigator|3373290724|dominique.monlezun@gmail.com|
22279341|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org|
22279342|NCT02980107|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
22279343|NCT03648385|Brown University Health, Center for Advanced Lung Care|Corey Ventetuolo, MD|401-444-2733|corey_ventetuolo@brown.edu|
22279344|NCT02836249|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22279345|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279346|NCT03057548|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
22279347|NCT00934921|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22279348|NCT02943473|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|(212) 241-7873|ajai.chari@mountsinai.org|
22279349|NCT04138056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279350|NCT02481557|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22279351|NCT01098422|UC San Diego|Dr. Tony Reid|8583531942|treid@ucsd.edu|
22279352|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279353|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22279354|NCT02625181|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
22279355|NCT05901636|Janssen Research & Development, LLC|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22279356|NCT03193801|Edwards Lifesciences|Director of Research|949-250-2500|THV_ct.gov@edwards.com|
22279357|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279358|NCT02160808|Dartmouth-Hitchcock Medical Center|Timothy B. Gardner MD MS|603-650-6472|timothy.b.gardner@hitchcock.org|
22279359|NCT05239221|Amolyt Pharma|Senior VP of Clinical Development and Regulatory Affairs|+33 428 01 21 54|contact@amolyt.com|
22279360|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu|
22279361|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22279362|NCT04096417|Mayo Clinic|Tanios Bekaii-Saab M.D.|480-342-2000|Bekaii-Saab.Tanios@mayo.edu|
22279363|NCT01897493|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279364|NCT01658059|Hadassah Medical Organization|Moti Moskovitz||motim@ekmd.huji.ac.il|
22279365|NCT05111145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22279366|NCT02336815|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22279367|NCT01359956|NCI Naples|Paolo A Ascierto, M.D., Ph.D|+39 081 5903431|p.ascierto@istitutotumori.na.it|
22279368|NCT01784029|Children's Hospital at Montefiore|Hina Talib|718-920-6781|htalib@montefiore.org|
22279369|NCT03226418|University of Nebraska Medical Center|Vijaya Bhatt|402-559-5520|IITOffice@unmc.edu|
22279370|NCT03235050|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22279371|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22268500|NCT02392481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296803|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22268501|NCT03207776|Atrium Health|Dr. Jason Roberge|704-898-3855|Jason.Roberge@AtriumHealth.org|
22268502|NCT04341363|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
22268503|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|Francisco.Esteva@nyumc.org|
22268504|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300||
22268505|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
22268506|NCT02570308|Immunocore, Ltd|Nicola McKelvie|484-534-5261|nicola.mckelvie@immunocore.com|
22268507|NCT01960413|Vanderbilt University Medical Center|Michael DeBaun, MD MPH|(615) 875-3040|m.debaun@vumc.org|
22268508|NCT02069015|Wayne State University|Julie Gleason-Comstock|313-577-6681|jgleason@med.wayne.edu|
22268509|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com|
22268510|NCT01275365|Brigham and Women's Hospital|Shalendar Bhasin, MD|617-525-9040|Sbhasin@partners.org|
22268511|NCT05921903|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268512|NCT03305848|Regions Hospital|Benjamin A Willenbring, MD|651-254-3563|benjamin.a.willenbring@healthpartners.com|
22268513|NCT05365451|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
22268514|NCT02301169|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
22268515|NCT03762265|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22268516|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22268517|NCT03440229|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|james.lewis@pennmedicine.upenn.edu|
22268518|NCT02289729|AbbVie|Global Medical Services|800-633-9110||
22268519|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org|
22268520|NCT02641093|University of Cincinnati|Trisha Wise-Draper, MD, PhD|513 558 2826|wiseth@ucmail.uc.edu|
22268521|NCT03123068|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
22268522|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu|
22268523|NCT03207386|University of Nebraska Lincoln|Dr. Katie Edwards|6034223207|katie.edwards@unl.edu|
22268524|NCT02845700|Florida State University|Dr. Wen Li|850-645-1409|wenli@neuro.fsu.edu|
22268525|NCT03420521|Johns Hopkins University|Dr. Christine Hann|410-502-0678|chann1@jh.edu|
22268526|NCT02452476|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+39 0521 2791|clinicaltrials_info@chiesi.com|
22268527|NCT01408043|Case Comprehensive Cancer Center|Navneet Majhail|216-444-2199|majhain@ccf.org|
22268528|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22268529|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345|ssanatani@cw.bc.ca|7955
22268530|NCT05373108|University of California, Los Angeles|Rushi V. Parikh, MD|(310) 825-9011|RParikh@mednet.ucla.edu|
22268531|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268532|NCT02892331|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virgina.edu|
22268533|NCT02483676|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Steven Kittner|410-706-0414|skittner@som.umaryland.edu|
22268534|NCT03717155|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22268535|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
22268536|NCT02654054|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22268537|NCT04871776|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@partners.org|
22268538|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
22268539|NCT02490631|Vanderbilt University Medical Center|Elizabeth Card|615-875-4611|elizabeth.b.card@vumc.org|
22268540|NCT06389487|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268541|NCT05423093|Johns Hopkins University|Rheanna Platt|410-550-8753|rplatt1@jhmi.edu|
22268542|NCT03593525|The Hospital for Sick Children|Dr. Lillian Sung|416 813 5287|lillian.sung@sickkids.ca|
22268543|NCT05537233|Indiana University School of Medicine|Viral N Shah, MD|317-278-6017|shahvi@iu.edu|
22268544|NCT05338489|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22268545|NCT05857488|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
22268546|NCT03851406|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
22268547|NCT00210210|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials' Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22268548|NCT00382200|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal, MD, PhD|646-608-3746|rampalr@mskcc.org|
22268549|NCT02502149|Bioverativ|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
22268550|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu|
22268551|NCT04067050|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
22268552|NCT00659711|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
22268553|NCT02677753|University of Louisville|Dr. Sean Francis|5025617260|sean.francis@louisville.edu|
22268554|NCT03036657|Oregon Health & Science University|Alexandra Dimitrova, PI|503-494-0766|dimitroa@ohsu.edu|
22268555|NCT02383017|Onnit Labs|Vince Kreipke|3176954359|Vkreipke@onnit.com|
22296804|NCT04916795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296805|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov|
22296806|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574||
22296807|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu|
22323053|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
22309670|NCT04901078|Kinoxis Therapeutics Pty Ltd|Director of Clinical Operations|+61434360596|tiina.ahveninen@kinoxistherapeutics.com|
22323054|NCT00364689|University of Miami|Clinical Trial Disclosure Manager|305-243-0494|y.p.davis@med.miami.edu|
22323055|NCT01872338|VA New Jersey Healthcare System|Alejandro Interian, PHD|908-647-0180|alejandro.interian@va.gov|4617
22323056|NCT03683394|The University of California, San Francisco|Dr. Kristine Yaffe|(415) 476-7307|kristine.yaffe@ucsf.edu|
22323057|NCT02239263|cochlear|Lori O'Neill Director of Research|8005235798|loneill@cochlear.com|
22323058|NCT01109940|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22268556|NCT02961595|University of Tampere|Hanna Viskari||hanna.viskari@uta.fi|
22268557|NCT02386319|Herlev Hospital|Dr. Anders Gram-Hanssen|004526225318|anders.gram-hanssen@regionh.dk|
22268558|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov|
22268559|NCT01774760|Turku University Hospital, Turku, Finland|Prof. Heikki Minn|+35823130000|heikki.minn@tyks.fi|30149
22268560|NCT03871543|Johnson & Johnson Vision Care, Inc.|Ross Franklin|1 800-843-2020|RFRANKL1@its.jnj.com|
22268561|NCT01894919|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22268562|NCT03711188|Immodulon Therapeutics Ltd|Clinical Trial Information Desk,|0044 0203137 6346|info@immodulon.com|
22268563|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu|
22268564|NCT03534687|University of Michigan|Jacob Haus|734 647-2790|jmhaus@umich.edu|
22268565|NCT03957200|University of manitoba|Dr Helen Pymar|204-787-4184|hpymar@hsc.mb.ca|
22268566|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu|
22268567|NCT00957801|University of Texas Medical Branch|Randall J Urban, Professor and Chair, Internal Medicine|409-772-1176|rurban@utmb.edu|
22268568|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu|
22279372|NCT03545672|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
22279373|NCT02415556|Beth Israel Deaconess Medical Center (BIDMC)|Dr. Vera Novak, Principal Investigator|6176328680|vnovak@bidmc.harvard.edu|
22279374|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22279375|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279376|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22296808|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22296809|NCT02245841|Cleveland Clinic|Anthony Fernandez, MD, PhD|216-445-8776|fernana6@ccf.org|
22296810|NCT02438722|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
22296811|NCT03343483|University of Rochester Medical Center|Dr. Kim Van Orden (PI)|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
22296812|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com|
22296813|NCT01488097|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|475-230-2596|clinicaltrials@alexion.com|
22296814|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22296815|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov|
22296816|NCT04949165|University of Minnesota|Protocol Manager for BLIS|(612)590-2697|telke001@umn.edu|
22296817|NCT04969224|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22296818|NCT02735551|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22296819|NCT02726074|Eisai Inc.|Eisai Korea Inc. Medical department|+82-2-3451-5539|h3-park@eisaikorea.com|
22296820|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
22296821|NCT04191382|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22296822|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com|
22296823|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296824|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
22296825|NCT03054870|Cyclomedica Australia Pty Ltd|James McBrayer|+61 2 9541 0411|clinicaltrials@cyclomedica.com|
22296826|NCT02009046|PHI|Norman A. Constantine, Ph.D.|925-284-8118|nconstantine@berkeley.edu|
22296827|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732|bolog002@mc.duke.edu|2
22296828|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org|
22296829|NCT03168308|University of Texas Southwestern|Tiffany Moon, MD|4694195790|Tiffany.Moon@UTSouthwestern.edu|
22309671|NCT04386057|Dana-Farber Cancer Institute|Dr. Kimberly Perez, MD|617-632-5370|Kimberly_Perez@DFCI.HARVARD.EDU|
22309672|NCT04032847|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
22309673|NCT03056573|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
22309674|NCT05104463|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
22309675|NCT05321082|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22323059|NCT02769728|Medical University of Graz|Prof. Harald Sourij|0316 385 81310|ha.sourij@medunigraz.at|
22323060|NCT02086331|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22268569|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22296830|NCT04039412|Zagazig University-Faculty of Human Medicine|Dr. Ayman Fathy Elsayed|+201125020593|aymanf28@yahoo.com|
22296831|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22296832|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296833|NCT03022292|Stein Eye Institute of UCLA|Dr. David Sarraf|310-825-7836|DSarraf@ucla.edu|
22268570|NCT03051100|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22323061|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22323062|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu|
22323063|NCT02471716|FivePrime Theraputics|Medical|415-365-5600|nick.mahasuwan@fiveprime.com|
22323064|NCT02981069|University of Texas Health San Antonio|Professor|12103587200|cersosimo@uthscsa.edu|
22323065|NCT01558063|Columbia University|J. John Mann, MD|646-774-7553|jjm@columbia.edu|
22323066|NCT01154933|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
22279377|NCT02465931|RTI International|Dr. Don Bailey|(919) 541-6488|dbailey@rti.org|
22279378|NCT01574144|Medtronic, Inc|Amy Lautenbach|7633609163|amy.a.lautenbach@medtronic.com@medtronic.com|
22279379|NCT03423121|Johns Hopkins University School of Medicine|Dr. Pavan Bhargava|410-614-1522|pbharga2@jhmi.edu|
22279380|NCT04790786|UPMC|Erin McCreary|4845159589|mccrearye3@upmc.edu|
22279381|NCT04102007|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22279382|NCT03289143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279383|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu|
22279384|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279385|NCT04388826|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
22279386|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
22279387|NCT02862574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22296834|NCT05198843|University of Texas M D Anderson Cancer Center|Dr. Rachel Layman|(713) 745-8401|RLayman@mdanderson.org|
22296835|NCT02485912|University of Oxford|Adrian V Hill, DPhil FRCP||vaccinetrials@ndm.ox.ac.uk|
22296836|NCT03722017|Tennessee Valley Healthcare System Nashville Campus|Amanda Mixon, MD MSPH MS|(615) 936-3710|amanda.mixon@va.gov|
22296837|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
22296838|NCT02474199|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22296839|NCT02752191|UCLA|J. Paul Finn|(310) 825-5344|ohrpp@research.ucla.edu|
22296840|NCT04061694|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
22296841|NCT02826681|American Regent, Inc.|Mark Falone|631.772.3544|mfalone@americanregent.com|244
22296842|NCT03314584|VAORD|Dr. Albert Leung|858-552-8585|ayleung@health.ucsd.edu|3331
22296843|NCT06134817|NYU Langone Health|Bedros Taslakian, MD|332-237-9866|Bedros.Taslakian@nyulangone.org|
22296844|NCT04345614|CalciMedica, Inc.|Sudarshan Hebbar, MD|8168387105|sudarshan@calcimedica.com|
22296845|NCT05230082|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
22296846|NCT03406858|Wayne State University/Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
22296847|NCT06027866|Queen's University Belfast/Western Health & Social Care Trust|Carla McClintock|07706482050|cmcclintock02@qub.ac.uk|
22296848|NCT00930579|Columbia University|Dawn Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
22296849|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
22296850|NCT04236804|University of Pittsburgh|Brian O'Connell|3023997506|oconnellb2@upmc.edu|
22296851|NCT04335279|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
22296852|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
22296853|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
22296854|NCT05071183|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22296855|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296856|NCT06002347|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
22296857|NCT03506373|Mayo Clinic Jacksonville|Asher Chanan-Khan, MD|904-953-2708|chanan-khan.asher@mayo.edu|
22296858|NCT04493060|Mayo Clinic|Dr. Robert R McWilliams|507-284-2511|mcwilliams.robert@mayo.edu|
22296859|NCT02939560|Medical University of South Carolina|McLeod F. Gwynette, MD|843-792-9162|gwynette@musc.edu|
22296860|NCT03340025|University of Alabama at Birmingham|Benjamin Greene, MD|205-801-7855|bjgreene@uabmc.edu|
22296861|NCT02420691|UT MD Anderson Cancer Center|Arvind Dasari,MBBS|713-792-2828|adasari@mdanderson.org|
22296862|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296863|NCT02149173|University of Washington|Hannah M Linden|206-606-2053|hmlinden@uw.edu|
22296864|NCT02449174|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
22296865|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629||
22296866|NCT01520363|Hugo W. Moser Research Institute at Kennedy Krieger , Inc.|Dr. Sakkubai Naidu|443 923 2778|naidu@kennedykrieger.org|
22296867|NCT03394768|Changi General Hospital|Serene Yeow, Senior Executive, Clinical Trials and Research Unit|+6581258267|serene_yeow@cgh.com.sg|+656426781
22296868|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu|
22296869|NCT02658136|Rigshospitalet|Dr Kiran Mirza|004535451442|KMIR0003@regionh.dk|
22296870|NCT03165110|Ascensia Diabetes|Jane Wallace|(574) 850-1467|jane.wallace@ascensia.com|
22296871|NCT01498952|MedImmune LLC|Mohammed Dar|+301-398-0000|information.center@astrazeneca.com|
22296872|NCT05533632|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22296873|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov|
22296874|NCT02951338|University Health Network|Avril Mansfield|416-597-3422|avril.mansfield@uhn.ca|7831
22296875|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399||
22323067|NCT03002974|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
22279388|NCT01446874|Washington University School of Medicine|Varun Puri, M.D.|314-362-4191|varunpuri@wustl.edu|
22296876|NCT05075850|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
22279389|NCT05130593|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
22279390|NCT04563767|HealthPartners Neurology|Michael Rosenbloom, MD|651-495-6363|michael.h.rosenbloom@healthpartners.com|
22279391|NCT03639610|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22279392|NCT03136055|University of California, San Francisco|Dr. Emily Bergsland|(415) 353-9888|Emily.Bergsland@ucsf.edu|
22279393|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22279394|NCT05067335|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22279395|NCT03610048|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22279396|NCT02136914|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22279397|NCT05878067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22279398|NCT04136145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279399|NCT02649920|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|02 51 44 61 61|guillaume.ducarme@ght85.fr|
22279400|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22279401|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279402|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22279403|NCT03462745|American University of Beirut Medical Center|Dr. Roland Kaddoum|01350000|rk16@aub.edu.lb|6704
22279404|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu|
22279405|NCT02037529|Mayo Clinic|Minetta Liu|5072930526|Liu.Minetta@mayo.edu|
22279406|NCT02384421|Stanford University|Dr. Helen Bronte-Stewart, MD, MSE|650-723-6709|bronte-stewart-lab@stanford.edu|
22279407|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22279408|NCT00399529|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Leisha Emens|412-623-3239|emensla@upmc.edu|
22279409|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279410|NCT02468830|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
22279411|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com|
22279412|NCT01295710|Neovii|Anne Kuan|781 966 3832|anne.kuan@neovii.com|
22279413|NCT03746015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22279414|NCT03767881|Boston Scientific|Evelyne Ho, Clinical Project Manager|1-978-483-8856|Evelyne.ho@bsci.com|
22279415|NCT05200845|Virginia Tech|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
22279416|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
22279417|NCT02303262|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22279418|NCT02412670|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22279419|NCT02622191|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22279420|NCT03781479|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
22279421|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901||
22279422|NCT05805150|CooperVision|Jose Vega|925-621-3761|jvega2@coopervision.com|
22309676|NCT07147257|Hopeshine-Minsheng Hospital of Xinzheng|Principal Investigator|(+86) 138-4905-6696|chenjinxi6688@126.com|
22309677|NCT04171141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309678|NCT04231149|Coloplast A/S|Medical Affairs Vice President|+45 4911 1111|clinical-studies@coloplast.com|
22309679|NCT03252847|MeiraGTx|Program Manager|+44 (0)20 3866 4320|ocularinfo@meiragtx.com|
22309680|NCT03532282|Stanford University|Rachel Manber, PhD|(650) 498-9111|rmanber@stanford.edu|
22309681|NCT02895464|Karolinska Institutet|Dr Elisabeth Rydwik|+46852488818|elisabeth.rydwik@ki.se|
22309682|NCT04979442|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
22309683|NCT04005794|Vanderbilt University|Dr. Sohee Park, Professor of Psychology and the principal investigator|615 322 3435|sohee.park@vanderbilt.edu|
22309684|NCT03287336|GW University|Homa K. Ahmadzia|2027412500|homa.khorrami@gmail.com|
22309685|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com|
22309686|NCT05671653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309687|NCT04914676|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22309688|NCT02433379|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
22309689|NCT03725384|Sunnybrook Health Sciences Centre|Dr. Yulia Lin|4164804042|yulia.lin@sunnybrook.ca|
22309690|NCT02505984|Massachusetts General Hospital|Dr. Sharon Dekel|617-726-1352|sdekel@mgh.harvard.edu|
22309691|NCT03709121|Aldeyra Therapeutics, Inc.|VP, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22309692|NCT04176601|University of Rochester|Dr. Kim Van Orden|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
22309693|NCT02317887|VegaVect, Inc.|Dr. Rob Lin|412-560-9760|r.lin@avistatx.com|
22309694|NCT04299464|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22309695|NCT04019977|University of Maryland School of Social Work|Dr. Lisa Berlin|410 706 6392|lberlin@ssw.umaryland.edu|
22309696|NCT03617679|University of Colorado Denver|Bradley Robert Corr, MD|303-724-2066|bradley.corr@cuanschutz.edu|
22309697|NCT05299242|University of Oxford|Prof. Sally Hopewell|+441865223458|sally.hopewell@csm.ox.ac.uk|
22309698|NCT05907174|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22309699|NCT04777721|University of Oxford|Professor Helen McShane|01865 617606|helen.mcshane@ndm.ox.ac.uk|
22279423|NCT03139721|Medtronic|Jessica Halverson, Clinical Research Director|763-514-9756|rs.CSHHAMMOCKPAS@medtronic.com|
22279424|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org|
22279425|NCT03189719|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309700|NCT04533737|LEO Pharma A/S|Clinical Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
22309701|NCT05093842|West Virginia University|Bethany Barone Gibbs|304-581-1779|behany.gibbs@hsc.wvu.edu|
22309702|NCT03916276|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
22309703|NCT03953417|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
22309704|NCT03209973|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22309705|NCT02641639|Mateon Therapeutics Inc|CEO|(650) 635-7000|ir@oncotelic.com|
22309706|NCT06415292|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22309707|NCT04089137|Georgia State University|Dr. Amanda Gilmore|(404) 413-2000|agilmore12@gsu.edu|
22309708|NCT04383496|Minneapolis VA Health Care System|Wei Duan-Porter|6124675845|wei.duanporter@va.gov|
22323068|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323069|NCT00330187|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22323070|NCT01751971|Brigham and Women's Hospital|Scott Sands, PhD|6172780911|sasands@bwh.harvard.edu|
22323071|NCT01649947|Rutgers Cancer Institute of New Jersey|Joseph Aisner, MD|732-235-7401|aisnerjo@cinj.rutgers.edu|
22323072|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu|
22268571|NCT02626026|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22268572|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu|
22268573|NCT02479451|Mass General Hospital|Sagar Nigwekar|5857298636|sagarnigs@gmail.com|
22268574|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
22268575|NCT01286467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268576|NCT03335475|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
22268577|NCT04886596|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268578|NCT04973267|Brown University - SPH|Tyler Wray, PhD|4018636659|tyler_wray@brown.edu|
22268579|NCT03751098|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
22268580|NCT00923013|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|kreitmar@mail.nih.gov|
22268581|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
22268582|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22268583|NCT06811155|hospital universitario virgen de la victoria|eva cabrera cesar|646905201|evacabreracesar@gmail.com|
22268584|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu|
22268585|NCT02574598|Instituto Nacional de Cancerología|Dr. Oscar Arrieta|(52) 55-5628-0400|ogar@unam.mx|71101
22268586|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu|
22268587|NCT03326193|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268588|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
22268589|NCT02348112|Coloplast Corp.|Liz Driessen|1-800-258-3476|usedri@coloplast.com|
22268590|NCT03714828|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
22268591|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518|MedtronicCRMtrials@medtronic.com|63277
22268592|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22268593|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu|
22268594|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22268595|NCT02107131|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|
22268596|NCT02286713|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22268597|NCT04314037|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22268598|NCT04707573|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
22268599|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623||
22268600|NCT00955409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268601|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268602|NCT03944668|HealthPartners Neuroscience Research|Amanda Herrmann, PhD|651-495-6356|amanda.a.herrmann@healthpartners.com|
22268603|NCT02445248|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22268604|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268605|NCT02596971|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268606|NCT03190993|Pennington Biomedical Research Center|John Apolzan|225-763-2827|john.apolzan@pbrc.edu|
22268607|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr|
22268608|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22268609|NCT04570670|Banner Life Sciences LLC|Thomas Lategan, PhD|3368990959|thomas.lategan@bannerls.com|
22268610|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22268611|NCT02767011|Charleston Area Medical Center Research Institute|Mike Broce|304-388-9923|mike.broce@camc.org|
22268612|NCT02764762|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22268613|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr|
22309709|NCT04032041|University of Iowa|Jason M Wilken, PT, PhD|319-335-9791|jason-wilken@uiowa.edu|
22309710|NCT01275677|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22279426|NCT03012880|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
22279427|NCT05211596|National Center for Deaf Health Research|Steven Barnett, PhD|585-506-9484|steven_barnett@urmc.rochester.edu|
22279428|NCT02293551|Chief Medical Officer|Eli Lilly and Company|800-545-5979||
22279429|NCT04532749|Janssen Research & Development, LLC|Executive Director CDTL Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22279430|NCT05395338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22279431|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
22279432|NCT00069641|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22279433|NCT02704208|San Diego State University|Keith J. Horvath|619-594-3346|khorvath@sdsu.edu|
22279434|NCT02935192|Institute of Virology, Vaccines and Sera, Torlak|Katarina Ilic|+381 11 3953 700|kilic@torlak.rs|214
22279435|NCT01561833|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
22279436|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279437|NCT00372957|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279438|NCT04778592|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
22279439|NCT02673944|Laborie|Clinical Researcher|905-612-1170|sbitzos@laborie.com|1755
22268614|NCT02954601|Oramed|Chief Scientific Officer|+972-2-566-0001|miriam@oramed.com|
22268615|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com|
22268616|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22268617|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22268618|NCT00471081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268619|NCT02739789|Stony Brook University|Dr. David Hsu, Assistant Professor of Psychiatry|(631) 638-1522|david.hsu@stonybrookmedicine.edu|
22268620|NCT03426124|Boston Scientific|Leslie Cass|206-641-4529|Leslie.Cass@bsci.com|
22268621|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com|
22268622|NCT05486091|Anxiety Disorders Center|Gretchen Diefenbach, Ph.D.|860-545-7396|gretchen.diefenbach@hhchealth.org|
22268623|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22268624|NCT03499067|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22268625|NCT02182492|Department of ENT of Tongji Hospital Tongji Medical College Huazhong University of Science and Technology|Dr. Zheng Liu|86 027 83663807|zhengliuent@hotmail.com|
22268626|NCT03776357|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
22268627|NCT02215369|Angiodynamics|Ariel Bloch|7742453646|abloch@angiodynamics.com|
22268628|NCT02211209|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22279440|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888||151
22279441|NCT03246087|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22279442|NCT05173974|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22268629|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008|cmyers@vertosmed.com|216
22309711|NCT05012683|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
22309712|NCT03478956|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22309713|NCT04800211|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22309714|NCT05170841|A Menarini Industrie Farmaceutiche Riunite SrL|Corporate Medical Affair and Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22309715|NCT05233800|MedStar Health Research Institute|Hannah Arem, Scientific Director, Implementation Science|2028932430|hannah.arem@medstar.net|
22309716|NCT05123586|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309717|NCT03643744|Wright State University|Dr. Jeffrey Travers|(937)-245-7500|Jeffrey.Travers@Wright.edu|
22309718|NCT04487860|Aché Laboratórios Farmacêuticos S.A|Dr. Fabio Ikedo|55 11 26086933|fabio.ikedo@ache.com.br|
22309719|NCT02432261|Health Decisions|Kimberly Myer|9842381297|Kimberly.Myer@premier-research.com|
22309720|NCT06085547|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
22309721|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|dha.belvoir.fbch.mbx.wresp-research@health.mil|
22309722|NCT02733159|Cancer Research UK Clincial Trials Unit, University of Birmingham|PePS2 Trial Coordinator|0121 414 8040|peps2@trials.bham.ac.uk|
22309723|NCT05546385|Rehaler A/S|Troels Johansen|004540977313|tj@rehaler.com|
22309724|NCT06122194|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309725|NCT05841004|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
22309726|NCT05193409|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
22309727|NCT03088878|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
22309728|NCT04726371|The Mongan Institute at Massachusetts General Hospital|Dr. Stephen Bartels|617-726-5213|sjbartels@mgh.harvard.edu|
22309729|NCT04506866|Medtronic|Mylène Champs|612-433-0600|mylene.champs@medtronic.com|
22309730|NCT04690582|The Ohio State University College of Medicine|Dr. Craig Bryan, PsyD, ABPP|614-814-8612|craig.bryan@osumc.edu|
22309731|NCT03125070|Fred Hutchinson Cancer Center|Dr. K. Scott Baker|206-667-5594|ksbaker@fredhutch.org|
22309732|NCT05267470|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22309733|NCT04428203|University of Kentucky|Dr. Zin Myint|8593233964|zin.myint@uky.edu|
22309734|NCT02823145|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22309735|NCT04622046|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22309736|NCT03626766|Columbia University|Dr. Anthony Lin|(917) 628-6522|akl17@cumc.columbia.edu|
22309737|NCT03314454|Northeastern University|Dr. Robert Leeman|6173736501|r.leeman@northeastern.edu|
22309738|NCT04119843|Ascelia Pharma AB|Andreas Norlin|+46 735179119|an@ascelia.com|
22309739|NCT04418232|University of Kansas Medical Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
22309740|NCT01037881|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22309741|NCT02841579|Catalan Institute of Oncology, Institut d'Investigació en Ciències, de la Salut Germans Trias i Pujol|Dr. Rafael Rosell|+34 935 543 050|rrosell@iconcologia.net|
22309742|NCT04563546|Duke University|Julian T. Hertz, MD|919-681-0196|julian.hertz@duke.edu|
22309743|NCT04233216|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309744|NCT03652389|NYU Langone Health|Antoinette M. Schoenthaler|646-501-3434|Antoinette.Schoenthaler@nyulangone.org|
22309745|NCT04506307|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22309746|NCT05622812|Q-Med AB|Head of Development|1-817-961-5000|reception.seupp@galderma.com|
22309747|NCT03916185|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22309748|NCT03766685|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22309749|NCT04676165|McGill University|Bettina Habib, Research Project Manager|514-396-1156|bettina.habib@mcgill.ca|
22309750|NCT05593900|University of California Davis|Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
22309751|NCT02844465|MedtronicNeuro|Clinical Study Manager|(877) 590-7835|rs.slatestudy@medtronic.com|
22309752|NCT05297565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22309753|NCT05029622|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22309754|NCT03812549|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
22309755|NCT01197378|Horizon Pharma USA, Inc.|Evelyn Olson|224-383-3000|clinicaltrials@horizonpharma.com|
22309756|NCT06232590|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
22309757|NCT05299723|Columbia University Irving Medical Center|Ari Shechter|212-342-1335|as4874@cumc.columbia.edu|
22309758|NCT01959607|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|clinicaltrials.pmi@pmi.com|
22309759|NCT03913442|NYU Langone Health|Michael H Pillinger, MD, FACP|646-501-2722|Michael.Pillinger@nyulangone.org|
22309760|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital, University of Milan, Via G. B. Grassi, 74 20157 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it|
22309761|NCT03162783|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22309762|NCT03710603|Stichting European Myeloma Network (EMN)|Sarah Lonergan|+31 10 268 70 65|sarah.lonergan@emn.life|
22268630|NCT01719367|Florida Electrophysiology Associates|Matthew Kolek, MD|(561) 434-0353|info@heartrhythmexperts.com|
22268631|NCT03889418|Ochsner Health|Principal Investigator|504-842-8256|eboni.pricehaywood@ochsner.org|
22268632|NCT01549587|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22268633|NCT03437863|Department of Digital Health Research (previously Center for Shared Decision Making and Collaborative Care Research)|Head of Research and Development|+47 23 03 31 67|elin.borosund@rr-research.no|
22268634|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22268635|NCT01827111|UT MD Anderson Cancer Center|Adi Diab, MD-Associate Professor, Melanoma Medical Oncology|(713) 745-7336|adiab@mdanderson.org|
22268636|NCT03181633|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22268637|NCT02749617|Hematology Research Program (HRP)|Director of HRP|6048754111|alee14@bccancer.bc.ca|22958
22268638|NCT04910100|BLP Management Group LLC|Barry Butler|813-766-9539|bbutler@blpmgmt.com|
22268639|NCT04132973|The University of Sheffield|Elaine Clarke|01142226533|e.n.clarke@shef.ac.uk|
22268640|NCT04383327|NYU Langone Health|Keng-Yen Huang, PhD, MPH|646-501-2879|Keng-Yen.Huang@nyulangone.org|
22268641|NCT04837196|Astellas Pharma Inc|Clinical Transparency|08008887704|astellas.resultsdisclosure@astellas.com|
22268642|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
22268643|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22268644|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22268645|NCT01256879|U of Maryland|James Polli, Professor|410-706-8292|jpolli@rx.umaryland.edu|
22268646|NCT00266279|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|bcccto@louisville.edu|
22268647|NCT02964247|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22268648|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br|
22268649|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu|
22268650|NCT06018129|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
22268651|NCT03832686|Stanford University|Heather Starmer, MD|650-529-5903|hstarmer@stanford.edu|
22268652|NCT02290444|University at Buffalo|Curtis Wojcik, Lab Coordinator|7163230551|cmwojcik@buffalo.edu|
22268653|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu|
22268654|NCT03323398|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22268655|NCT03641469|Green Sun Medical|James A. Arthur|720-202-3621|jarthur@greensunmedical.com|
22268656|NCT05479435|Istanbul Medipol University|Arzu Abalay|+905075891917|arzuabalay@hotmail.com|
22268657|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00|emilie.huchet@guerbet-group.com|7688
22268658|NCT06954493|SCYNEXIS, Inc|David Angulo, MD|(201) 884 - 5471|david.angulo@scynexis.com|
22268659|NCT05207865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268660|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
22309763|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000|JM.Wecht@va.gov|3122
22268661|NCT04170738|Icahn School of Medicine at Mount Sinai|Iliyan Ivanov|(212) 523-1924|iliyan.ivanov@mssm.edu|
22268662|NCT03055338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268663|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22268664|NCT03058705|University of Rochester|Edward Messing, MD|585-275-0998|edward_messing@urmc.rochester.edu|
22268665|NCT01880554|Institut Bergonie|Derek Dinart||d.dinart@bordeaux.unicancer.fr|
22268666|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
22268667|NCT02999269|University of New Mexico|Dr. Chris Abbott, Division Chief Neuromodulaton, Department of Psychiatry|505272223|cabbott@salud.unm.edu|
22268668|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22268669|NCT01754350|JohannWGUH|Johannes Rieger|+4969630187711|j.rieger@uni-tuebingen.de|
22268670|NCT03752970|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323073|NCT01162421|AbbVie|Global Medical Information|800-633-9110||
22323074|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu|
22323075|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co|
22323076|NCT02678429|VUMC|Fenna Phibbs|614-936-0060|fenna.phibbs@vumc.org|
22323077|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
22323078|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th|
22323079|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu|
22323080|NCT00091832|Amgen Inc.|Study Director|866-572-6436||
22323081|NCT02349178|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
22323082|NCT00282841|University of California San Diego|Thilo Hoelscher, MD|619-543-5251|thoelscher@ucsd.edu|
22323083|NCT03434379|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22323084|NCT03122431|Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo|Prof Eloisa Bonfa|551130617490|eloisa.bonfa@hc.fm.usp.br|
22323085|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com|
22323086|NCT00578643|Baylor College of Medicine|Robert Krance, MD|(832) 824-4661|rakrance@txch.org|
22323087|NCT01725750|Icahn School of Medicine at Mount Sinai|Jacob Greisman|212-241-4886|Jacob.greisman@mountsinai.org|
22323088|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com|
22323089|NCT03179436|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323090|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22323091|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22323092|NCT01811147|Cleveland Clinic Foundation|Dr. Amit Anand|216-636-2840|ananda@ccf.org|
22323093|NCT04714372|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|612-624-5109|maaka001@umn.edu|
22323094|NCT04025632|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|Please email|clinicaltrials@ucb.com|
22296877|NCT04256785|Universidad de Granada|Dr. Elena Pita Calandre|+34 958246291|epita@ugr.es|
22296878|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296879|NCT01265849|CEL-SCI Corporation|John Cipriano, Senior VP Regulatory Affairs, Eyal Talor Chief Scientific Officer|(205) 586-6947|jcipriano@cel-sci.com|
22296880|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22296881|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22296882|NCT03194321|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
22296883|NCT02188589|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22296884|NCT01547000|University of South Florida|Tanya K. Murphy, MD, MS|813-974-2201|tmurphy@health.usf.edu|
22296885|NCT03019939|The University of Texas MD Anderson Cancer Center|Prithviraj Bose MD/Associate Porfessor|713-792-7747|PBose@mdanderson.org|
22296886|NCT00731770|Penn State University|Erin Banta|717-531-6525|ebanta@hmc.psu.edu|1
22296887|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org|
22296888|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22296889|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22296890|NCT02068222|AbbVie|Global Medical Information|800-633-9110||
22296891|NCT03525210|KU Leuven / UZ Leuven|Head of Leuven University Vaccinology Center|+32 16 321 078|luvac@kuleuven.be|
22296892|NCT01374087|Ipsen|Medical Director|use email|clinical.trials@ipsen.com|
22296893|NCT03011307|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|eisenach@wakehealth.edu|
22296894|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se|
22296895|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu|
22296896|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov|
22296897|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir|
22296898|NCT04690751|SK Life Science, Inc.|Executive Director and Head, Clinical Pharmacology|862-271-2645|vvashi@sklsi.com|
22296899|NCT04364620|Alethia Biotherapeutics ULC|Dr. Julie Laurin, Vice-President, Drug Development|514-581-8125|julie.laurin@alethiabio.com|
22296900|NCT03181828|Children's National|Dr. Nicholas Ah Mew|2025452513|nahmew@childrensnational.org|
22296901|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk|
22296902|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22296903|NCT01614990|Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System|Jose Garcia, MD, PhD|(206) 764-2984|jg77@uw.edu|
22296904|NCT05630274|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22296905|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22296906|NCT02255500|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22296907|NCT03340337|Universidad Maimónides - Universidad Nacional Arturo Jauretche - Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló|Oscar Ronzio|+54-11-4905-1140|ronzio.oscar@maimonides.edu|
22296908|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22296909|NCT04254978|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296910|NCT02449239|Sesen Bio, Inc.|Dr. Rachelle Dillon|204-296-6579|rachelle.dillon@sesenbio.com|
22296911|NCT03257631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22296912|NCT02310919|UCSF Center for Reproductive Health|Dr. Yanett Anaya, Assistant Professor|832-654-8361|Yanett.anaya2@ucsf.edu|
22296913|NCT03244865|UF Health Department of Anesthesiology|Dr. Tammy Euliano|352-514-7460|teuliano@anest.ufl.edu|
22296914|NCT03509675|University of Washington|Stuart Taylor|206-221-3772|stuartt@uw.edu|
22296915|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22296916|NCT03898349|VA|Vera Yakovchenko|7816873374|vera.yakovchenko@va.gov|
22268671|NCT03976362|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22268672|NCT04767282|Michigan State University|Amy Custack, Associate Professor|8106005656|saxeamym@msu.edu|
22268673|NCT02979587|Medtronic|Lindsey Gustafson, Clinical Study Manager|7635262782|lindsey.m.gustafson@medtronic.com|
22268674|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com|
22268675|NCT04846569|Brown University|Jennifer Pellowski|4018635453|jennifer_pellowski@brown.edu|
22268676|NCT02525783|Stryker|Matt Venegoni|612-297-0939|matthew.venegoni@stryker.com|
22268677|NCT02512302|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22268678|NCT03532425|University of Alberta|Dr. Stephen D. Shafran|780-407-6945|sshafran@ualberta.ca|
22268679|NCT01775813|University of Colorado School of Medicine|Dr. Megan Kelsey|720-777-0991|megan.kelsey@childrenscolorado.org|
22268680|NCT05251337|Indiana University Health|Alyson Keen|3173413060|akeen2@iuhealth.org|
22268681|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com|
22268682|NCT02004366|Emory University|Priyathama Vellanki|404-778-1665|priyathama.vellanki@emory.edu|
22268683|NCT05177484|Royal Wolverhampton NHS Trust|Group Research Sponsorship Manager|01902|rwh-tr.sponsorshipofresearch@nhs.net|695065
22268684|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
22268685|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620|info@valneva.com|0
22268686|NCT03334435|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22268687|NCT03922321|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22296917|NCT03336216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22296918|NCT05005390|The University of Texas Health Science Center at Houston|Travis Markham, MD|713-500-6200|Travis.H.Markham@uth.tmc.edu|
22268688|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
22296919|NCT03239470|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
22296920|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22296921|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296922|NCT03856437|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
22296923|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu|
22296924|NCT03483935|University of Dundee|Prof Charlotte Proby|+44 1382 383289|c.proby@dundee.ac.uk|
22296925|NCT02681549|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
22296926|NCT02658890|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22296927|NCT02404311|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22268689|NCT02342678|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
22296928|NCT00159588|St. Olavs Hospital|Professor Knut Hagen|+47 95401579|knut.hagen@stolav.no|
22296929|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se|
22296930|NCT02098161|The University of Texas MD Anderson Cancer Center|Naveen Pemmaraju MD/ Associate Professor|713-792-4956|NPemmaraju@mdanderson.org|
22309764|NCT04197310|Dana Farber Cancer Institute|Dr. Kimberly Perez|617-632-5960|Kimberly_Perez@DFCI.HARVARD.EDU|
22309765|NCT02589795|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
22309766|NCT02322203|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301.402.0521|mamar@nhlbi.nih.gov|
22309767|NCT03691935|Milton S. Hershey Medical Center|Urology Research Operations Manager|717-531-0003|UrologyResearch@pennstatehealth.psu.edu|287502
22268690|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268691|NCT06188715|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22268692|NCT01651117|Corporal Michael J. Crescenz VA Medical Center|Judith A. Long, MD|215-898-4311|judith.long@va.gov|
22268693|NCT03808948|Charité - Universitätsmedizin Berlin|Prof. Dr. med. Kai Schmidt-Ott|+4930450614671|Kai.schmidt-ott@charite.de|
22268694|NCT02075203|SATVI|Dr. Mark Hatherill|+27214066145|mark.hatherill@uct.ac.za|
22268695|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268696|NCT03802825|Kaiser Permanente Center for Health Research|Dr. Stephanie L. Fitzpatrick, Senior Investigator|502-345-1476|Stephanie.L.Fitzpatrick@kpchr.org|
22268697|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
22268698|NCT03982511|Central Michigan University|Sarah Domoff, PhD|989-774-6461|domof1se@cmich.edu|
22268699|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511|markovic.svetomir@mayo.edu|4-2511
22268700|NCT00777296|Insmed Incorporated|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
22268701|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com|
22268702|NCT03876743|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
22268703|NCT05002790|University Hospitals Coventry &Watwickshire NHS Trust|Cyprian Mendonca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25874
22268704|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22268705|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu|
22268706|NCT01416636|SciPharm SàRL|Bianca Tan||b.tan@scipharm.eu|
22268707|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22268708|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu|
22268709|NCT04030299|The University of Iowa|Dr. Yu-Hsaing Wu|(319) 335-9758|yu-hsiang-wu@uiowa.edu|
22268710|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22268711|NCT03093701|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
22268712|NCT03482973|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|0706
22268713|NCT04616612|Indiana University|Dr. Rebecca Bartlett Ellis|3172740047|rjbartle@iu.edu|
22268714|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu|
22268715|NCT04740918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268716|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22268717|NCT02409927|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22268718|NCT02208362|City of Hope Medical Center|Dr. Christine Brown|626-256-4673|CBrown@coh.org|83977
22268719|NCT05081063|Loma Linda University Health|Kaushik Mukherjee|9096515948|kmukherjee@llu.edu|
22268720|NCT05425927|SyntheticMR|Erik Lange|+46(0)70-331 56 78|erik.lange@syntheticmr.com|
22309768|NCT03511664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22309769|NCT01946789|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22309770|NCT04076618|Wake Forest University School of Medicine|Kristen Beavers, PhD, MPH, RD|336-758-5855|kbeavers@wakehealth.edu|
22309771|NCT01928394|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22309772|NCT00321048|Indiana University|Richard Zellars|3179444505|rzellars@iu.edu|
22279443|NCT04047446|Hospital for Special Surgery|Dr. David H. Kim|212-606-1036|kimd@hss.edu|
22279444|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22279445|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22279446|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu|
22279447|NCT03983421|Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico|Annette Crisanti, PhD|5052726238|acrisanti@salud.unm.edu|
22279448|NCT02660229|Mundipharma Korea Ltd.|Mrs Suyoun Yang/CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
22279449|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677|oberwanger@hcor.com.br|8201
22279450|NCT02727322|University of Pittsburgh|Halina Zyczynski|421-641-1440|hzyczynski@upmc.edu|
22279451|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22279452|NCT03564886|University of Missouri, Department of Orthopaedics|Lasun Oladeji, MD|573-884-7796|OladejiL@health.missouri.edu|
22279453|NCT02724839|Cincinnati Children's Hospital Medical Center|Dr.Kristen Copeland|5136361687|kristen.copeland@cchmc.org|
22279454|NCT01155050|PenningtonBRC|Ronald Horswell|225-763-2931|Ronald.Horswell@pbrc.edu|
22279455|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22279456|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22279457|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu|
22279458|NCT00557193|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22279459|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
22279460|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
22279461|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu|
22279462|NCT04358406|BioAegis Therapeutics Inc.|Mark J. DiNubile, MD|609-706-5866|mdinubile@bioaegistx.com|
22279463|NCT01948427|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
22279464|NCT00256126|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22279465|NCT02434081|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|NICOLAS@etop-eu.org|
22279466|NCT02250417|The Ohio State University|Ulysses J. Magalang|614-292-6563|magalang.1@osu.edu|
22279467|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu|
22279468|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801|xuefei_zhou@biotest.de|1229
22279469|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22268721|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
22268722|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22268723|NCT00858273|Nemours Children's Clinic|Dominique Darmaun, MD|(904) 697 3674|ddarmaun@nemours.org|
22268724|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268725|NCT03760744|Vanderbilt Medical Center|Dr. Manus J. Donahue|615.322.8350|mj.donahue@vumc.org|
22268726|NCT03576326|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
22268727|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu|
22268728|NCT05364931|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22268729|NCT02974686|Washington University|Dr. R. Delos Santos|314-362-8351|delossantos@wustl.edu|
22268730|NCT05266053|Indiana University|Dr. Lisa Mims - Principal Investigator|7733074863|lamims@iupui.edu|
22268731|NCT05344560|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22268732|NCT01837901|Okuvision GmbH|Dr. R. Schippert|+49 7121 15935|ruth.schippert@okuvision.de|50
22268733|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
22268734|NCT01051960|University of California, Los Angeles|Rajan Saggar, MD|(310) 794-9718|rsaggar@mednet.ucla.edu|
22268735|NCT02996968|TriHealth Inc.|Abigail Shatkin-Margolis, MD|513-463-4300|Abigail_Shatkin-margolis@trihealth.com|
22268736|NCT03396653|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
22268737|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu|
22268738|NCT01967862|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22268739|NCT00607620|University of Washington|Douglas Zatzick, MD|206-744-6701|dzatzick@uw.edu|206
22268740|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22268741|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22268742|NCT00031590|Childrens Hospital of Philadelphia|Peter Phillips|215-590-1000|phillipsp@email.chop.edu|
22268743|NCT03124368|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22268744|NCT05506046|Georgia State University|Lyudmila Popova|404-413-9338|lpopova1@gsu.edu|
22268745|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu|
22268746|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22296931|NCT04896658|University of Maryland, Baltimore|Ashraf Badros, MD|410-328-1230|abadros@umm.edu|
22296932|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22296933|NCT03970590|VA Bedford Healthcare System Center for Health Organization and Implementation Research|Sarah Cutrona, MD|781-687-2861|sarah.cutrona@va.gov|
22296934|NCT04196140|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22323095|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22323096|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net|
22323097|NCT02591615|NorthShore Medical Group|Thomas Hensing|847.570.2112|thensing@northshore.org|
22323098|NCT03220412|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22323099|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
22323100|NCT05195528|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22323101|NCT01552902|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22323102|NCT02720757|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323103|NCT03256045|University of Washington|Dr. Andrew Cowan|206-606-7348|ajcowan@seattlecca.org|
22323104|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323105|NCT05210504|VUMC|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
22323106|NCT04173741|Hacettepe University|Dr. Asli Melek|+905376636789|aslimelek121@gmail.com|
22323107|NCT02357420|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22323108|NCT03617705|University of Florida|Dr. Yan Wang|3522945942|ywang48@ufl.edu|
22323109|NCT03502187|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22323110|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22323111|NCT06118385|Benevolent|Judit Molnar, MD, PhD|+44 20 3781 9360|judit.molnar.md@benevolent.ai|
22323112|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com|
22323113|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623||
22323114|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323115|NCT03897751|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
22323116|NCT03072160|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
22323117|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu|
22323118|NCT04426695|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22323119|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268747|NCT03313180|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22296935|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22296936|NCT02836600|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22296937|NCT02532647|PAION UK Ltd|Trial Information||reg_paion@paion.com|
22296938|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu|
22296939|NCT02492269|Nationwide Children's Hosp.|Dr. Aymen Naguib|614-722-4200|Aymen.Naguib@nationwidechildrens.org|
22296940|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746|vigorito@unina.it|2639
22296941|NCT04773158|Indiana University School of Medicine, Pediatrics|William E Bennett, MD|317-944-3774|webjr@iu.edu|
22296942|NCT03897179|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22296943|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22296944|NCT02503332|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22296945|NCT04053101|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22296946|NCT05694546|University of Maryland Baltimore|Cassidy Claassen|316-727-6185|cclaassen@ihv.umaryland.edu|
22296947|NCT02120950|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22296948|NCT02424383|Becton Dickinson|Sharon Christensen|612-757-0750|Sharon.Christensen@bd.com|
22296949|NCT03559179|HealthPartners Institute|Dr. Rebecca C Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22296950|NCT03412084|University of Wisconsin - Madison|Dr. Kelli F Koltyn|608-263-6746|kelli.koltyn@wisc.edu|
22296951|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu|
22296952|NCT02916563|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|3037246713|satish.garg@ucdenver.edu|
22296953|NCT03869450|Q-Med AB|Clinical Project Manager|+4618 474 9000|reception.seupp@galderma.com|
22296954|NCT01928862|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22268748|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu|
22296955|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22296956|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu|
22323120|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com|
22323121|NCT03653390|University of Washington|Dr. Ivan Molton, PhD|2065433602|imolton@uw.edu|
22323122|NCT01261819|Florida Hospital|Katherine Kratz, M.D.||katiegoodrich@gmail.com|
22323123|NCT00849667|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22323124|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org|
22323125|NCT00553163|Barts Health NHS Trust|Prof D S Rampton|+442035943300|d.rampton@qmul.ac.uk|
22323126|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu|
22323127|NCT01262625|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
22323128|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22323129|NCT04398732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323130|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com|
22323131|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
22323132|NCT01727089|City of Hope|Jeff Longmate, Ph.D.|626-218-2478|jlongmate@coh.org|
22323133|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686|martin.westphal@fresenius-kabi.com|7280
22323134|NCT01500057|Brooklyn Urology Research Group|Ivan Grunberger, M.D. Medical Director|718-230-7788|ivg9002@nyp.org|
22323135|NCT01225341|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22323136|NCT02318784|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22323137|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@ottawahospital.on.ca|70175
22323138|NCT01242644|University of South Alabama|Office of Research Compliance|251-460-7573|swhite@southalabama.edu|
22323139|NCT03603652|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22323140|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu|
22323141|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org|
22323142|NCT03213366|Albert Einstein College of Medicine|Dr. Viraj V Patel|718.920-7102|vpatel@montefiore.org|
22323143|NCT02532855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323144|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com|
22323145|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
22323146|NCT01960855|AbbVie|Global Medical Services|800-633-9110||
22323147|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323148|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22323149|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu|
22296957|NCT01478321|Northwestern University|Karan Dixit, MD|312-695-1301|karan.dixit@northwestern.edu|
22296958|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590||
22296959|NCT02053753|Amgen Inc.|Study Director|866-572-6436||
22296960|NCT02439320|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22296961|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
22296962|NCT03342742|"University of Colorado Denver | Anschutz"|Kristen Nowak|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22296963|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22296964|NCT04383210|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
22296965|NCT02404350|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
22296966|NCT05389657|University of California, San Francisco|Erin Accurso|415-476-5139|erin.accurso@ucsf.edu|
22296967|NCT04503564|Capillary BioMedical, Inc.|Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
22296968|NCT05237206|Alloplex Biotherapeutics|Dr. Sharron Gargosky, Chief Development Offier|+1 503-915-1400|sgargosky@alloplexbio.com|
22296969|NCT04962009|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
22296970|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22296971|NCT02154581|UT Health San Antonio|Research Compliance Coordinator-Senior|210-567-8554|NijlandK@uthscsa.edu|
22296972|NCT03221595|Denver Health Medical Center|Research Coordinator|303-602-6213|Kiara.Leasia@dhha.org|
22296973|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296974|NCT04296006|University of Kentucky|Joshua Lile, Ph.D.|859-323-6034|jalile2@uky.edu|
22296975|NCT02855437|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
22296976|NCT02864251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22296977|NCT03760796|Johns Hopkins University School of Medicine|Dr. Seth Martin|(610) 331 - 3842|smart100@jhmi.edu|
22296978|NCT04343521|Emory University|Gonzalo Vazquez-Prokopec, PhD|404-727-4217|gmvazqu@emory.edu|
22296979|NCT02211131|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22296980|NCT05664490|University of California, San Francisco|Dr. Jennifer Velloza|9173923561|Jennifer.Velloza@ucsf.edu|
22296981|NCT03999411|University of Miami|Dr. Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
22296982|NCT03144180|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|9152155103|christina.bracamontes@ttuhsc.edu|
22296983|NCT01142310|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22296984|NCT01272830|Clinic Orthopaedic Center|Thomas Bear, MD|330-375-3906|kovacikm@summahealth.org|
22323150|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22323151|NCT04178772|Johnson & Johnson VIsion Care, Inc.|Thomas Karkkanien - Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22296985|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279470|NCT03435380|Duke University|Kevin Oeffinger, MD|919-668-2122|kevin.oeffinger@duke.edu|
22279471|NCT03218917|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
22279472|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22279473|NCT00427193|Duke University Medical Center|William E. Kraus, Director of Clinical Research, Duke Center for Living|919-681-6733|william.kraus@duke.edu|
22279474|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu|
22279475|NCT02581891|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22279476|NCT01076010|AVEO Pharmaceuticals, Inc.|Cheif Medical officer|857-400-0101|Clinical@aveooncology.com|
22279477|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22279478|NCT03421886|University of Alabama at Birmingham|Chung How Kau, chair and professor|(205) 934-2782|ckau@uab.edu|
22279479|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu|
22279480|NCT02831660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279481|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
22279482|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu|
22279483|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu|
22279484|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22279485|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com|
22279486|NCT00758563|Colgate Palmolive|William DeVizio - DMD|732-878-7901|William_DeVizio@colpal.com|
22279487|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22279488|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu|
22279489|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22279490|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620|info@valneva.com|0
22279491|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org|
22279492|NCT03961308|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22279493|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu|
22279494|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org|
22279495|NCT02297412|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
22279496|NCT02371356|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3749|De-Kun.Li@kp.org|
22279497|NCT04549454|Loyola Marymount University|Dr. Bradley Trager, Research Scientist|3103385238|bradley.trager@lmu.edu|
22279498|NCT05437419|Teijin America, Inc.|President|+1 (415) 887-9742|clinical-trials-contact@teijinpo.com|
22279499|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22279500|NCT01230411|Thomas Jefferson University- Jefferson Headache Center|Dr. Hsiangkuo Yuan|2159552243|Hsiangkuo.Yuan@jefferson.edu|
22279501|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22279502|NCT01405196|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279503|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22279504|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
22309773|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com|
22279505|NCT01649869|University of Alabama at Birmingham|David Kimberlin, MD|(205) 638-2530|DKimberlin@peds.uab.edu|
22279506|NCT01126190|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22279507|NCT01977898|Northwestern University|Feyce Peralta, MD|312-472-3585|f-peralta@northwestern.edu|
22279508|NCT03386773|Colorado School of Public Health|Susan L. Moore, PhD, MSPH|303-724-8858|susan.l.moore@cuanschutz.edu|
22279509|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de|
22296986|NCT03583996|HepQuant LLC|Elyse Handley|3037480524|elyse.handley@hepquant.com|
22296987|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22296988|NCT03261947|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22296989|NCT03969992|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
22296990|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296991|NCT03038815|Institute for Biomechanics ETH Zürich|Silvio Lorenzetti|078 608 14 84|sl@ethz.ch|
22309774|NCT00207636|DFCI, Harvard|Jennifer Allen|617-632-2269||
22309775|NCT04730739|Zimmer Biomet|Octavia Gladden, Clinical Research Speaclist|704.493.0178|octavia.gladden@zimmerbiomet.com|
22309776|NCT03806790|LEO Pharma A/S|Clinical disclosure|+4544945888|disclosure@leo-pharma.com|
22309777|NCT00291525|Artivion|Clinical Project Manager (Yael Goode)|8454800137|Yael.Goode@Artivion.com|
22309778|NCT05646355|NYU Langone Health|Aasma Shaukat|6465012906|Aasma.Shaukat@nyulangone.org|
22309779|NCT03362476|New York University|Ralph J DiClemente|+1 (212) 992-3709|rjd438@nyu.edu|
22309780|NCT05216406|Nova Southeastern University|Dr. Jose Antonio|(954) 262-8140|Jose.Antonio@nova.edu|
22309781|NCT03617445|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
22309782|NCT04270942|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22309783|NCT06081309|Wave Neuroscience, Inc.|Bill Phillips|714-883-7890|bill@waveneuro.com|
22323152|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22296992|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org|
22309784|NCT01236781|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
22279510|NCT04573972|Carnegie Mellon University|Gretchen Chapman, PhD|4122687380|gchapman@andrew.cmu.edu|
22279511|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
22279512|NCT01198587|Boston Children's Hospital|Michelle Niescierenko MD MPH|617-919-4121|michelle.niescierenko@childrens.harvard.edu|
22279513|NCT03807089|Massachusetts General Hospital|Dr. Norman Nishioka|617-726-4422|nnishioka@partners.org|
22279514|NCT03036852|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22279515|NCT03984825|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279516|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu|
22279517|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org|
22279518|NCT01865487|Aeras|Dr. Dereck Tait|27214424991|dtait@aeras.org|
22279519|NCT01627691|Boston Scientific|Anne Cornaille|+33608863659|anne.cornaille@bsci.com|
22279520|NCT01307449|Emory University|Rouphael, Nadine|404-712-1435|nroupha@emory.edu|
22279521|NCT01365793|University of California, Davis (UC Davis Health)|Nathan Kuppermann|916-734-1535|nkuppermann@ucdavis.edu|
22279522|NCT03019887|Okada hospital|Dr. Ryota Ataniya|+81-4-7124-6151|ryotaataniya@pbt.nir.jp|
22279523|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22279524|NCT02927795|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279525|NCT03259295|University of Florida|Juan Carlos Roig|352-273-8985|roigjc@peds.ufl.edu|
22279526|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300||
22279527|NCT02976181|Medtronic|Carina Leone, Latam CVG Trial Leader|+5411 5789 8521|carina.leone@medtronic.com|
22279528|NCT04661033|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22279529|NCT03440008|VA Puget Sound Health Care System|Dr. Joseph Iaquinto|206-277-1738|Joseph.Iaquinto@va.gov|
22279530|NCT02814656|AstraZeneca|Ioannis Psallidas||ClinicalTrialTransparency@astrazeneca.com|
22279531|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
22279532|NCT02135484|UT MD Anderson Cancer Center|John C. Araujo, Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|johna@mdanderson.org|
22279533|NCT01734902|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279534|NCT01465841|Penumbra, Inc.|Michaella Corso|415-815-8904|mcorso@penumbrainc.com|
22279535|NCT02092181|Evergreenhealth|Gowri Rajendran|425-899-5370|grajendran@evergreenhealth.com|
22279536|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
22279537|NCT03383666|Cerenovus|Michael Liao|510-770-5376|mliao7@its.jnj.com|
22279538|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22279539|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279540|NCT02972996|Stratton V.A. Medical Center|Margaret M. Wilson MS, RD, LD/N, CD/N, CNSC, CDE|518 626-6889|margaret.wilson2@va.gov|
22279541|NCT03507127|Brown University|Dr. Jennifer Tidey|4018636418|jennifer_tidey@brown.edu|
22279542|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com|
22279543|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu|
22279544|NCT03050710|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
22279545|NCT02106429|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
22279546|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk|
22279547|NCT04756531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279548|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu|
22279549|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com|
22279550|NCT00253422|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722|aude.espinasse@icr.ac.uk|4349
22279551|NCT04646005|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22279552|NCT02918942|Grace Medical, Inc.|Robert Stroup|901-386-0990|robert.stroup@gracemedical.com|
22279553|NCT04712669|Sumitomo Pharma America|Ravi Grewal|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
22279554|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22279555|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22279556|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279557|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org|
22279558|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22279559|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279560|NCT02286895|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22279561|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org|
22279562|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22279563|NCT01987414|University of Minnesota|Chih-Huang Yu|6126262443|yuxxx648@umn.edu|
22279564|NCT02949011|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22279565|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279566|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279567|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22279568|NCT02746809|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
22279569|NCT02261961|Central Arkansas Veterans Healthcare System|Richard Dennis|501-257-5583|richard.dennis2@va.gov|
22309785|NCT02112526|Acerta Pharma LLC|Study Director|1-888-292-9613|acertamc@dlss.com|
22309786|NCT03808961|VAORD|Chandramohan Wakade|7067211106|cwakade@augusta.edu|
22309787|NCT04862416|Radboud university medical center|Dr. Matthew McCall|+31 24 361 43 56|Matthew.McCall@radboudumc.nl|
22309788|NCT04028284|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
22309789|NCT04059185|Boston College School of Social Work|Catherine Taylor, PhD, LCSW, MPH|(617) 552-4033|catherine.taylor.2@bc.edu|
22309790|NCT04707326|ErasmusMC|Dr. Casper Rokx|+310107040704|c.rokx@erasmusmc.nl|
22309791|NCT02329262|The Ohio State University Martha S. Pitzer Center for Women, Children and Youth|Principal Investigator|16142924578|smith.5764@osu.edu|
22309792|NCT01009788|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-835-2285|SISAKOFF@mgh.harvard.edu|
22309793|NCT06180980|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22309794|NCT04741776|Dartmouth-Hitchcock Clinic|Fallon Cluxton-Keller, Ph.D.|603-650-4724|Fallon.P.Cluxton-Keller@dartmouth.edu|
22309795|NCT04622774|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22309796|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
22309797|NCT02852655|Dana-Farber Cancer Institute|Jose R. McFaline Figueroa, MD, PhD|617-632-2166|jose_mcfalinefigueroa@dfci.harvard.edu|
22309798|NCT04168580|AdventHealth Translational Research Institute|Paul M. coen, PhD., Associate Investigator|765-426-9743|paul.coen@adventhealth.com|
22309799|NCT05809453|University of Texas at Southwestern|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
22309800|NCT00462696|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22309801|NCT05098158|Washington State University|Marian Wilson|509-324-7443|marian.wilson@wsu.edu|
22268749|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22268750|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu|
22268751|NCT05188261|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
22309802|NCT03257410|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22309803|NCT02598388|Janssen Vaccines & Prevention B.V.|MEDICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309804|NCT03069924|Medical University of South Carolina|Dr. Benjamin Toll|843-876-1132|toll@musc.edu|
22309805|NCT03668236|Rigshospitalet, University of Copenhagen|Prof. Anders Perner|+45 35458333|anders.perner@regionh.dk|
22309806|NCT06132282|Texas Christian University|Danica Knight|817-257-4391|d.knight@tcu.edu|
22309807|NCT03526887|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22309808|NCT04499924|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22309809|NCT03011333|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22309810|NCT03663569|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309811|NCT04183283|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22309812|NCT01002235|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22309813|NCT00104676|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
22309814|NCT06214559|Eurofins Dermscan Pharmascan|Project Manager|+33 (0)4 72 82 36 56|manon.laune@cpt.eurofinseu.com|
22309815|NCT03711734|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|1206
22309816|NCT04228042|M D Anderson Cancer Center|Mehrad Adibi, MD|713-563-7458|mllozano@mdanderson.org|
22309817|NCT03828799|Institut régional du Cancer de Montpellier|Representative of sponsor|467612446|aurore.moussion@icm.unicancer.fr|+33
22309818|NCT05196919|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
22309819|NCT00696111|University of Chicago|Karla Temple, Clinical Research Manager|773-702-3334|katemple@uchicago.edu|
22309820|NCT03744182|Hanmi Pharmaceutical Co., Ltd.|GAEUN PARK|+824108746|gaeun.park@hanmi.co.kr|8746
22309821|NCT03687086|University of California, Los Angeles and VA Greater Los Angeles Healthcare System|Dr. Constance Fung|818 891-7711|Constance.Fung@va.gov|39311
22309822|NCT03859635|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|3172740275|yyeap@iu.edu|
22309823|NCT04362254|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22309824|NCT04707625|Wake Forest University Health Sciences|Mark Nelson, MD|336.713.1680|mhnelson@wakehealth.edu|
22309825|NCT02038777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309826|NCT03138603|University of Chicago Medicine|Peter Nagele, MD, MSc|773-795-3544|pnagele@uchicagomedicine.org|
22309827|NCT04731129|Centre hospitalier universitaire de liège|Dr Olivier Bonhomme|003243239580|obonhomme@chuliege.be|
22309828|NCT03386578|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22309829|NCT03841773|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
22309830|NCT05205460|Tri-service general hospital|Chia-Ying Lai|87923311|pokerface165@gmail.com|13606
22309831|NCT04971109|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
22309832|NCT03664700|Oxford University Hospitals|Dr Vassilis Athanassoglou|01865|vassilis.athanassoglou@ouh.nhs.uk|221590
22309833|NCT03987022|Metrohealth System|Dr. Robert Pollard|2167781446|rpollard@metrohealth.org|
22309834|NCT01627574|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-2830|lmurphy@uri.edu|
22309835|NCT03528928|Womens Health|Teresa Brousseau|866-432-4400|tbrousseau@isapin.com|
22309836|NCT05089877|AtriCure|Nfii Ndikintum, VP of Clinical Affairs and Biometerics|5136448192|NNdikintum@atricure.com|
22309837|NCT04314778|University of Pennsylvania|S. Ryan Greysen, MD (Principal Investigator)|215-614-0095|Ryan.Greysen@pennmedicine.upenn.edu|
22309838|NCT02240238|NANO MRNA Co.,Ltd.|NANO MRNA Clinical Info Admin|+81 (0)3-6432-4792|clinical.info@nanomrna.co.jp|
22309839|NCT02657005|Oncternal Therapeutics|Mary Breitmeyer|858-434-1113|clinical@oncternal.com|
22309840|NCT01346540|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309841|NCT05863156|Uskudar Univercity|Tugba YILMAZ ESENCAN|05057084946|tugba.yilmazesencan@uskudar.edu.tr|
22309842|NCT05061069|Ghent University|Prof. Dr. Leen Maes|093324066|leen.maes@ugent.be|+32
22309843|NCT06357169|University of Minnesota|Ronda Farah|(612) 625-8625|rfarah@umn.edu|
22309844|NCT05679908|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
22309845|NCT03625115|Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
22309846|NCT04797195|Massachusetts General Hospital Center for Global Health|Katharine Morley, MD|617-726-2000|kemorley@mgh.harvard.edu|
22309847|NCT05868382|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22309848|NCT03655028|Edward Hines Jr., VA Hospital|Eileen Collins|312-3550118|ecollins@uic.edu|
22309849|NCT03513302|Indiana University Indianapolis|Dr. Andrew Coggan|3172740656|acoggan@iu.edu|
22309850|NCT04577963|HUTCHMED International, Inc.|William Schelman, MD, PhD, Senior Vice President, Clinical Development, US/Europe|+1 9733064490|williams@hutch-med.com|
22309851|NCT05256654|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22309852|NCT00866684|Charité Universitätsmedizin Berlin Augustenburger Platz 1 13353 Berlin|Prof. Dr. Petra Reinke|+49 30 450 653 490|petra.reinke@charite.de|
22309853|NCT02709161|University of Pittsburgh|Kymberly Young|4126486179|youngk@pitt.edu|
22309854|NCT05121441|Aardvark Therapeutics, Inc.|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
22309855|NCT05229822|NJSC KARAGANDA MEDICAL UNIVERSITY|Dr. Yermek Turguov|+77016119655|Turgunov@qmu.kz|
22309856|NCT04089059|UCSF School of Medicine|Liviu Klein|415-476-2143|liviu.klein@ucsf.edu|
22309857|NCT03728608|University of Florida|Leslie Parker|352 273 6384|parkela@ufl.edu|
22309858|NCT04243070|BIOTRONIK SE & Co. KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22309859|NCT04587453|Leo Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22309860|NCT03571581|The Miriam Hospital|Elena Salmoirago-Blotcher|401-793-8325|Elena_Salmoirago_Blotcher@brown.edu|
22309861|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu|
22309862|NCT03283722|Medtronic|Jenell Lorenz, Sr. Clinical Research Specialist|651-269-4768|jenell.m.lorenz@medtronic.com|
22309863|NCT02397954|Ophthotech Corp|Keith Westby||Keith.Westby@ophthotech.com|
22323153|NCT04897867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22323154|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22323155|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
22323156|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com|
22323157|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com|
22323158|NCT03875950|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
22323159|NCT02604940|West Virginia University|Pavithra Ranganathan Ellison, MD|304-598-4929|pavithra.ellison@wvumedicine.org|
22323160|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22323161|NCT01465659|Northwestern University|Sheetal Kircher, MD|312-695-0990|sheetal.kircher@nm.org|
22323162|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com|
22323163|NCT02149810|London Health Sciences Centre|Dr. Akshya Vasudev|519-685-8500|akshya.vasudev@lhsc.on.ca|75504
22323164|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22323165|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org|
22323166|NCT00622895|Fred Hutchinson Cancer Research Center|George E. Georges MD|206-667-6886|ggeorges@fredhutch.org|
22323167|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323168|NCT02385279|European Cardiovascular Research Institute|Dr. E. Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
22323169|NCT03828487|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22323170|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com|
22323171|NCT03404648|Mayo Clinic|Dr. Ming Yang|480-342-0988|Yang.Ming@mayo.edu|
22323172|NCT01784796|Edward Hines VA Hospital|Karen Saban, PhD|708-202-5264|Karen.Saban@va.gov|
22323173|NCT02474329|Radboudumc|Marjan Meinders|+00000000|Marjan.Meinders@radboudumc.nl|
22323174|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323175|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22323176|NCT04320407|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22323177|NCT02863068|Albert Einstein College of Medicine|Dr. Caterina Minniti|240-498-8684|bloodconsultant@gmail.com|
22323178|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
22323179|NCT02663895|Stanford University|Dr. Lorinda Chung|(650) 723-6961|shauwei@stanford.edu|
22323180|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323181|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22323182|NCT00595231|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
22323183|NCT00365989|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22323184|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com|
22268752|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu|
22309864|NCT04141891|University of Colorado|Dr. Marian Betz|303-550-5669|marian.betz@cuanschutz.edu|
22309865|NCT04737330|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22309866|NCT04884308|Johns Hopkins University|Noah Lechtzin|410-502-7044|nlechtz@jhmi.edu|4102994561
22309867|NCT03295721|Heron Therapeutics, Inc.|Vice President, Clinical Operations|855-251-7232|svisonneau@herontx.com|
22279570|NCT03500211|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22279571|NCT02431325|Massachusetts General Hospital|Janet Lo, M.D., M.MSc.|617-724-3425|jlo@mgh.harvard.edu|
22279572|NCT01917318|University of Colorado|Michael H. Allen, M.D.|(303) 724-3300|Michael.Allen@ucdenver.edu|
22279573|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22279574|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu|
22279575|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279576|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22279577|NCT03338400|Cleveland Clinic Florida|Dr. David Ossin|954-659-5559|ossind@ccf.org|
22279578|NCT02941614|Kaiser Permanente Southern California Department of Research and Evaluation|Erin Hahn|626-564-3505|Erin.E.Hahn@kp.org|
22279579|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com|
22279580|NCT00129285|University of Pennsylvania Treatment Research Center|Kyle Kampman|215-746-2764|kampman@mail.med.upenn.edu|
22279581|NCT01213082|University of California Davis|Susanna Park, MD|9167346074|sscpark@ucdavis.edu|
22279582|NCT03758261|University of Pittsburgh Medical Center|Dr. Charles Luke|4127485589|lukecb@upmc.edu|
22279583|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823||
22279584|NCT00698828|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22279585|NCT03500289|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
22279586|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22279587|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279588|NCT03892317|Imperial College Healthcare Trust|Goodall Dawn|+44 (0)20 7589 5111|dawn.goodall1@nhs.net|
22279589|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279590|NCT03886493|Johns Hopkins University School of Medicine|Kenneth Pienta, M.D.|410-502-3137|kpienta1@jhmi.edu|
22279591|NCT02918669|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
22279592|NCT04067011|Emergent Biosolutions|Clinical Development Representative|+1 (204) 275-4196|ctgov@ebsi.com|
22279593|NCT05209386|University of Pittsburgh|Taylor Abel|412-692-9631|abeltj@upmc.edu|
22279594|NCT04436744|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279595|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com|
22279596|NCT03381989|National Heart Lung and Blood Institute|Lederman, Robert|+1 301 402 6769|lederman@nih.gov|
22279597|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22279598|NCT00746811|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
22296993|NCT02457403|The Ohio State University|A James Hanje|614 293 6255|james.hanje@osumc.edu|
22296994|NCT04372602|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8491|jdipersi@wustl.edu|
22296995|NCT01085097|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22296996|NCT04120974|Becton, Dickinson and Company|Sandra van Guldener, Director OUS Clinical Affairs|+31646900840|sandra.vanguldener@bd.com|
22296997|NCT06049043|KDHRC|Andrew Simkus, Research Analyst|7046073567|asimkus@kdhrc.com|
22296998|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343||
22296999|NCT05365750|Kaiser Permanente Colorado|Ingrid A Binswanger, MD, MPH|720-416-7104|ingrid.a.binswanger@kp.org|
22297000|NCT03089606|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22297001|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org|
22297002|NCT00922883|NHLBI|Cynthia E Dunbar|301-496-5093|dunbarc@nhlbi.nih.gov|
22297003|NCT03965962|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22297004|NCT04017936|Virginia Commonwealth University|Dr. Jordana Kron, MD|804-828-7565|jordana.kron@vcuhealth.org|
22297005|NCT00651573|Cleveland Clinic Foundation|Daniel Sessler, MD|216-4444900|ds@or.org|
22297006|NCT03190889|The Ohio State University Wexner Medical Center|Nathaniel A. Bates|614-293-9013|nathaniel.bates@osumc.edu|
22297007|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu|
22297008|NCT02140567|Imperial College Healthcare NHS Trust in London, United Kingdom|Dr. Phang Boon Lim|+44|p.b.lim@imperial.ac.uk|(0)20 3313
22297009|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org|
22297010|NCT02882854|Vanderbilt University Medical Center|Stephen Harvey, MD|(615) 936-3198|stephen.harvey@vumc.org|
22297011|NCT02039674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297012|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22297013|NCT03774433|Dartmouth College|Dr. Lisa Marsch|603-646-7092|Lisa.A.Marsch@dartmouth.edu|
22297014|NCT00368654|Kaiser Permanente (Current), UC Davis (Previous)|Chai Sue Lee||lam.nguyen@ucdmc.ucdavis.edu|
22297015|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820|sbradley@umich.edu|55826
22297016|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22297017|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
22297018|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22279599|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
22279600|NCT03358030|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22279601|NCT03342560|Massachusetts General Hospital|Anthony E. Samir|6176432009|asamir@mgh.harvard.edu|
22279602|NCT02604511|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22268753|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu|
22268754|NCT04177095|Massachusetts General Hospital|Hannah Gilligan, MD|617-726-2000|hgilligan@mgh.harvard.edu|
22268755|NCT03810092|CHD VENDEE|Romain DECOURS|02 51 44 65 72|romain.decours@ght85.fr|+33
22268756|NCT01841047|Institut Bergonié|Pr Guy KANTOR||G.Kantor@bordeaux.unicancer.fr|
22268757|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268758|NCT02816736|Duke Clinical Research Institute|Kevin J. Anstrom, Ph.D., Director of Biostatistics|919-668-8902|kevin.anstrom@duke.edu|
22268759|NCT04535141|University of North Carolina Lineberger Comprehensive Cancer Center|Jonathan Ptachcinski PharmD, BCPS, BCOP|+1 919-966-9786|Jonathan.Ptachcinski@unchealth.unc.edu|
22268760|NCT00806403|Sahlgren's University Hospital/S, Gothenburg|Lars Grip||lars.grip@vgregion.se|
22268761|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
22268762|NCT02280200|University of Minnesota|Ryan Mays PhD, MPH, MS|612-625-0430|rjmays@umn.edu|
22268763|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu|
22268764|NCT04846400|University of Michigan|David A Zopf, MD|734-936-5730|davidzop@med.umich.edu|
22268765|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22268766|NCT04306211|Indiana University|John M. DeWitt, MD|317-944-0980|jodewitt@iu.edu|
22268767|NCT03759392|Cytokinetics, Inc.|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
22268768|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22309868|NCT04231331|Asan Medical Center|Professor Duk-Hyun Kang|821030103166|dhkang@amc.seoul.kr|
22268769|NCT03170544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268770|NCT02387840|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Deborah Runkin Gold|1-800-641-2422|CTUReferral@UHhospitals.org|
22268771|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19|yon@tropmedres.ac|1435
22268772|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
22268773|NCT04143373|Tehran UMS|Dr. Nariman Nikparto|+989124969058|n-nikparto@razi.tums.ac.ir|
22268774|NCT05192239|Colorado State University|Christopher Bell, Associate Professor|(970) 491-7522|christopher.bell@colostate.edu|
22268775|NCT03888469|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22268776|NCT04507464|University of Illinois at Chicago|Dr. Ulf Bronas|3123555886|bronas@uic.edu|
22268777|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000||
22279603|NCT03770286|Children's Hospital Los Angeles|Alexander Alcaraz|323-361-2130|aalcaraz@chla.usc.edu|
22309869|NCT04850898|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sabbio.com|
22309870|NCT03374241|HanmiPharma|khseo@hanmi.co.kr|+82 2 410 9042|khseo@hanmi.co.kr|
22309871|NCT04942613|University of Colorado Denver, Anschutz Medical Campus|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22309872|NCT04909801|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22309873|NCT04550221|University of Washington|Susan M. Graham|206-351-0414|grahamsm@uw.edu|
22309874|NCT05274074|University of Rochester|Dr. Benzi M. Kluger|5852754259|benzi_kluger@urmc.rochester.edu|
22309875|NCT04117347|University of Michigan|Dr. Helen Burgess|734-615-8303|bhelen@med.umich.edu|
22309876|NCT05194956|University Hospitals of Derby and Burton NHS Trust|Mrs Trishna Patel|01332340131|trishnaanil.patel@nhs.net|83556
22309877|NCT05452460|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
22309878|NCT05050149|Palvella Therapeutics, Inc.|Christine Kampf, Vice President of Regulatory Affairs|484-844-0865|christine.kampf@palvellatx.com|
22309879|NCT04447040|Johnson & Johnson Consumer, Inc.|Assoc Dir Med Sci Leader US Self Care Pain|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309880|NCT01208662|Dana-Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
22309881|NCT04433208|Prolacta Bioscience|Dr David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
22309882|NCT03208049|VA Palo Alto Health Care System, Palo Alto, CA|Dr. Andrea Goldstein-Piekarski|(650) 493-5000|Andrea.Goldstein2@va.gov|60584
22309883|NCT05485779|AQILION AB|Anneli Tinnerholm|+46 730 88 14 15|anneli.tinnerholm@aqilion.com|
22309884|NCT02010242|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|+46 556659-9766|richard.philipson@calliditas.com|
22309886|NCT03676192|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22309887|NCT02424617|BerGenBio ASA|BerGenBio Clinical Team|+ 47 55961159|registry.postings@bergenbio.com|
22309888|NCT05133739|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
22309889|NCT04778397|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22309890|NCT03308877|University of Rochester Medical Center|Marc T. Swogger, Associate Professor, Psychiatry and Medicine|585-301-7738|marc_swogger@urmc.rochester.edu|
22309891|NCT03523572|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22309892|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22309893|NCT04685135|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22279604|NCT02505425|The University of Alabama at Birmingham, School of Nursing|Marie A. Bakitas, DNSc, NP-C, FAAN|(205) 934-5277|mbakitas@uab.edu|
22279605|NCT04951193|MUSC|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22279606|NCT01370551|Medinova|Doerthe Bassfeld|+41 44 306 1371|bassfeld.doerthe@medinova.ch|
22279607|NCT05175014|Epicentre|Dr Matthew E Coldiron|+33 1 40 21 55 55|matthew.coldiron@epicentre.msf.org|
22279608|NCT05643495|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22279609|NCT02257528|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
22279610|NCT01729039|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
22279611|NCT03449576|Rehabilitation Research & Development|Dr. Shirley Groer (Scientific Program Manager)|202-553-9899|shirley.groer@va.gov|
22279612|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu|
22279613|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279614|NCT05788991|Medinova|Dr. Anahí Hurtado|+41443061396|hurtado.anahi@medinova.ch|
22279615|NCT04464473|Florida State University|Dr. Derek Nee|8506441963|dnee@fsu.edu|
22279616|NCT03802396|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
22279617|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22279618|NCT04066829|University of Michigan|Kao-Ping Chua|(734) 615-8169|chuak@med.umich.edu|
22279619|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22279620|NCT04133415|Washington University School of Medicine|Matthew Spraker, M.D., Ph.D.|314-362-8567|mspraker@wustl.edu|
22279621|NCT04237584|MANA RBM|Penelope Manasco, CEO|9195566456|pmanasco@manarbm.com|
22279622|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
22279623|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il|
22279624|NCT01150357|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22279625|NCT02661672|Icahn School of Medicine at Mount Sinai|Sydney Edwards|212-241-2524|sydney.edwards@mountsinai.org|
22279626|NCT03549338|Symphogen A/S|Vice President, Global Oncology|+45 8838 2600|info@symphogen.com|
22279627|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22279628|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279629|NCT00652743|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279630|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22279631|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
22279632|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279633|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22279634|NCT04606927|University Medical Center Groningen|Dr. Jozine ter Maaten|0503616161|j.m.ter.maaten@umcg.nl|
22297019|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22297020|NCT01347541|University of Washington School of Medicine|Dr, Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
22297021|NCT02171260|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22297022|NCT05821842|Sound Health Systems, Inc.|Paramesh Gopi|313-509-8237|pgopi@soundhealth.life|
22297023|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
22297024|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com|
22297025|NCT03082599|Carolina Eyecare Physicians, LLC|Dr. Helga P Sandoval, Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22279635|NCT02580877|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8631|cjgreen@benaroyaresearch.org|
22297026|NCT02486042|UC San Diego Health|Sarah Lazar, clinical research manager|(858) 249-1711|slazar@health.ucsd.edu|
22297027|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22297028|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu|
22297029|NCT01724060|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22297030|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu|
22297031|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu|
22297032|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
22297033|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org|
22297034|NCT00281684|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297035|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com|
22297036|NCT03745092|Xuanwu Hospital, Capital Medical University|Pro. Ran Meng|+86-10-83199280|ranmeng2011@pku.org.cn|
22297037|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org|
22297038|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22297039|NCT02586896|NYU School of Medicine|Michael Bogenschutz|646-501-4026|michael.bogenschutz@nyulangone.org|
22297040|NCT01124643|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22297041|NCT04220411|Arjil Pharmaceuticals LLC.|YEH B, WU|+886-3-573-3608|ybw333@arjilbio.com|
22297042|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559||
22297043|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297044|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca|
22297045|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu|
22297046|NCT03256552|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22279636|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu|
22297047|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837||
22297048|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org|
22297049|NCT00380393|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297050|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org|
22297051|NCT03865329|Mayo Clinic|Dr. Roberto Benzo|(507) 284-0561|Benzo.Roberto@mayo.edu|
22297052|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch|
22268778|NCT02696291|Emergent Product Development Gaithersburg, Inc.|Tim Babinchak, MD|(240) 631-3585|tbabinchak@ebsi.com|
22297053|NCT04693585|University of California San Francisco|Nadia Diamond-Smith|415-353-4545|nadia.diamond-smith@ucsf.edu|
22297054|NCT01742338|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey L. Carson|732-235-7122|jeffrey.carson@rutgers.edu|
22297055|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk|
22309894|NCT05987813|Virginia Commonwealth University|Gisela Chelimsky|804-628-5882|gisela.chelimsky@vcuhealth.org|
22268779|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268780|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
22268781|NCT04762160|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22268782|NCT01370629|Correvio International|Head of Clinical Development|+41 (0) 22 907 79 70|info@correvio.com|
22268783|NCT02996227|Cleveland Clinic|Fabio Rodriguez|215 444-9950|rodrigf3@ccf.org|
22268784|NCT00536939|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22268785|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com|
22268786|NCT01174823|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22268787|NCT01611935|University of Pennsylvania|Dr. Carrie Sims|215-588-5154|carrie.sims@uphs.upenn.edu|
22268788|NCT04227197|Massachusetts General Hospital|Brian G Skotko, MD, MPP, Principal Investigator|(617) 643-3196|bskotko@mgh.harvard.edu|
22268789|NCT04547985|Weill Cornell Medicine|Dr. Holly G. Prigerson|646-962-9655|hgp2001@med.cornell.edu|
22268790|NCT02992236|Nephrology University Erlangen Germany|Prof Dr Rroland Schmieder|+49 9131 8536207|roland.schmieder@uk-erlangen.de|
22268791|NCT02549859|University of Chicago|Ms. Lani Leong, Research Coordinator|7738341688|lani@neurology.bsd.uchicago.edu|
22268792|NCT03446027|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
22268793|NCT03097341|Aronora, Inc.|Christina U. Lorentz, PhD, Senior Scientist and Project Manager|503-964-0250|christina.lorentz@aronorabio.com|
22268794|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com|
22268795|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu|
22268796|NCT00708552|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268797|NCT02309411|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22268798|NCT01904526|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
22268799|NCT04878432|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22268800|NCT03971071|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22268801|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22268802|NCT03214224|Penn State College of Medicine|Andrew Geronimo|717-531-0003|geronimo@psu.edu|282576
22268803|NCT03566199|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD.|(415) 502-7301|Sabine.Mueller@ucsf.edu|
22268804|NCT02712320|Foresee Pharmaceuticals Co., Ltd.|Dr. John Mao|+886 2-2655-2658|john.mao@foreseepharma.com|
22268805|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu|
22268806|NCT04537078|Elshatby University Maternity Hospital|Dr. Aly Hussein|002-0119448000|emam_aly@me.com|
22268807|NCT03207815|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22268808|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu|
22268809|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br|
22268810|NCT04268771|Dr. Reddy's Laboratories Ltd.|Head-Clinical Development|91-40-4464-4000|RI-01-007@drreddys.com|
22268811|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300||
22268812|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268813|NCT02962492|State University of NY at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
22268814|NCT00942578|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
22268815|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu|
22268816|NCT01697748|University of South Florida|Dr Sheila Connery, Associate Professor Obstetrics and Gynecology|813-259-8542|sconnery@health.usf.edu|
22268817|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com|
22268818|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22268819|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
22268820|NCT02375971|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22268821|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590||
22268822|NCT02275819|VA Boston Healthcare System|Dr. Jayashri Aragam|617-323-7700|Jayashri.Aragam@va.gov|
22268823|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
22268824|NCT02556775|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22268825|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000|Joel.Trugman@frx.com|8681
22268826|NCT02025725|Evoke|Chief Medical Officer|858-345-1494|mcarlson@evokepharma.com|206
22268827|NCT05697809|Oxular Ltd|Friedrich Asmus, MD, Chief Medical Officer|617 882 7179|friedrich.asmus@ocular-cc.com|
22297056|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
22279637|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu|
22279638|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22279639|NCT02764996|Mike O'Callaghan Miltary Medical Center|Jill Clark, Senior Research Associate/Research Manager|(702) 653-3298|Jill.M.Clark15.ctr@mail.mil|
22279640|NCT04460183|Thirty Respiratory Ltd|Alison Bracchi, MSc|+447763882519|alison.bracchi@30.technology|
22279641|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
22279642|NCT02609425|Henry Ford Health System|Sarah Meehan|313-916-9387|smeehan1@hfhs.org|
22279643|NCT00856609|National Institutes of Health|Dr. Jonathan Krakoff|602-200-5217|jkrakoff@mail.nih.gov|
22279644|NCT01788943|University of Pennsylvania|Jacob Dubroff,M.D., Ph.D., Assistant Professor of Radiology|215-662-3041|jacob.dubroff@uphs.upenn.edu|
22279645|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937||
22279646|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us|
22279647|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu|
22279648|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22297057|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22297058|NCT04415281|University of Florida|Eric Weber|3522737802|ebweber@ufl.edu|
22297059|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com|
22297060|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu|
22297061|NCT00181207|Johns Hopkins University|Gregory Diette|410-955-3497|gdiette@jhmi.edu|
22297062|NCT02418195|University of Alabama at Birmingham|Samantha White/ Clinical Trials Manager|12059349189|swwhite@uabmc.edu|
22297063|NCT02882321|The University of Texas MD Anderson Cancer Center|Marina Konopleva MD./Professor|713-794-1628|mkonople@mdanderson.org|
22297064|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22297065|NCT02932904|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22297066|NCT03095456|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22297067|NCT04128683|University of California San Diego|Dr. Guido Frank|858-246-2053|gfrank@health.ucsd.edu|
22297068|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297069|NCT02918851|Stony Brook Medicine|Dr. Elliott Bennett-Guerrero|6314442979|elliott.bennett-guerrero@stonybrookmedicine.edu|
22297070|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22297071|NCT02590939|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
22297072|NCT02225743|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsosh@musc.edu|
22297073|NCT02664909|UConn Health|Vincent Williams, M.D.|(860) 679-8384|vwilliams@uchc.edu|
22297074|NCT03706794|Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|Elizabeth.Seng@einsteinmed.edu|
22297075|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590||
22297076|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22297077|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu|
22297078|NCT02347189|Medtronic|Megan Mueller, Clinical Research Manager|612-916-4771|megan.d.mueller@medtronic.com|
22297079|NCT02677987|Northwestern University Feinberg School of Medicine|Lisa M. Wu, Ph.D.|(312) 503-7722|lisa.wu1@northwestern.edu|
22297080|NCT03320564|Wake Forest Baptist Health|Katie Holbrook Bingman|336-713-7765|krholbro@wakehealth.edu|
22297081|NCT01527682|ASST Spedali Civili di Brescia|Prof. Luciano Quaranta|+39 030 3995|luciano.quaranta@unibs.it|847
22297082|NCT04668950|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22297083|NCT03979638|Bellus Health Inc|Senior Director Clinical Development|833-703-0708|lharvey@bellushealth.com|
22297084|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22297085|NCT02680639|Philips|Senior Clinical Development Scientist|(724) 733-5835|chuck.cain@philips.com|
22297086|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22297087|NCT03200899|The University of Texas at Austin|Dr. Alexa Stuifbergen|+1 (512) 471-4100|astuifbergen@mail.utexas.edu|
22297088|NCT04646499|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
22297089|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu|
22297090|NCT01001442|Biotest AG|Iris Bobenhausen|+49 6103 801|iris.bobenhausen@biotest.com|4832
22297091|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22297092|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
22297093|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com|
22297094|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org|
22297095|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu|
22297096|NCT01412866|DArtmouth-Hitchcock|Mary F. Brunette|603-27105747|mary.f.brunette@dartmouth.edu|
22297097|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22297098|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org|
22297099|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com|
22297100|NCT05756790|University of California San Francisco|Dr. Amy Conroy|303-522-9439|amy.conroy@ucsf.edu|
22297101|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
22297102|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu|
22297103|NCT00864474|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323185|NCT04647110|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323186|NCT04317690|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22323187|NCT02318095|Regulatory Coordinator|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
22323188|NCT02064764|Medtronic, Inc.|Vanessa DeBruin|6123607687|vanessa.debruin@medtronic.com|
22323189|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323190|NCT02367521|Johns Hopkins University School of Medicine|Vani Rao, MD|4105502288|vrao@jhmi.edu|
22323191|NCT00542191|Leo W. Jenkins Cancer Center|Dr. Paul Walker|252-744-1015|walkerp@ecu.edu|
22323192|NCT02633371|University of Colorado|Dr. Anna Bruckner|720-777-0955|anna.bruckner@ucdenver.edu|
22323193|NCT03990870|Posit Science Corporation|Dr. Kyu Lee|415-528-7235|kyu.lee@positscience.com|
22323194|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22323195|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com|
22323196|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu|
22323197|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr|
22323198|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com|
22323199|NCT02808390|PPM Services|Salvatore Bellinvia|+41916961710|sbellinvia@ppmservices.ch|
22323200|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com|
22323201|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com|
22323202|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov|
22323203|NCT02041962|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
22323204|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu|
22323205|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu|
22323206|NCT03543085|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
22323207|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org|
22323208|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323209|NCT04244370|BD|Heather Vander Ploeg|602-751-3268|heather.vander.ploeg@bd.com|
22323210|NCT03336502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323211|NCT02928952|VAPHS, Center for Heath Equity Research and Promotion|Monica DiNardo PhD, Primary Investigator|412 360-2262|monica.dinardo@va.gov|
22323212|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323213|NCT01850615|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22268828|NCT02172664|Indiana University School of Dentistry|Dr. Jeffrey Platt|3172747229|jplatt2@iu.edu|
22268829|NCT01909934|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22268830|NCT03447639|Beaumont Hospital|Director of Urology Research|248.551.0804|Deborah.Hasenau@Beaumont.org|
22268831|NCT01787292|Health Science Specialist|Dr. Keith McGregor|4043216111|keith.mcgregor2@va.gov|126792
22268832|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064|rizikson@proteinsciences.com|163
22268833|NCT02962648|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22268834|NCT02755285|Fujifilm Medical Systems USA, Inc.|Randy Vader|(360) 356-6821|randy.vader@fujifilm.com|
22268835|NCT01597778|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22268836|NCT03267212|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
22268837|NCT05691712|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22268838|NCT05303194|The University of Texas Medical Branch|Rafael Samper-Ternent|8322057994|rasamper@utmb.edu|
22268839|NCT01210560|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22268840|NCT01289678|Brody School of Medicine|Paul R. Walker, MD|2527441888|walkerp@ecu.edu|2527441888
22268841|NCT00226499|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268842|NCT02723344|Eastern Colorado Health Care System, Rocky Mountain MIRECC|Dr. Lisa A Brenner|720-723-6488|lisa.brenner@va.gov|
22268843|NCT03473184|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
22268844|NCT02524847|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
22268845|NCT04352101|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
22268846|NCT01268527|Eisai Medical Research Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22268847|NCT02794727|Mayo Clinic|Sanjeev Nanda, MD|507-284-2511|nanda.sanjeev@mayo.edu|
22268848|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268849|NCT03223350|Henry Ford Hospital|Dr. Joseph Miller, associate research director|313-916-5419|jmiller6@hfhs.org|
22268850|NCT03539302|InCarda Therapeutics|VP Clinical Operations|510-422-5522|propst.meisa@incardatherapeutics.com|111
22268851|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org|
22268852|NCT04564092|GE Healthcare|Yongqing Tang, MD PhD|189-1820-3986|Yongqing.Tang@ge.com|
22268853|NCT02816346|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22268854|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com|
22279649|NCT05525910|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279650|NCT00107276|SWOG|Study statistician|206-667-4623||
22309895|NCT02315703|Janssen Vaccines & Prevention B.V.|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22279651|NCT02287779|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22279652|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22309896|NCT04134208|The University of Texas M D Anderson Cancer Center|Dr. Gregory Ravizzini|(713) 518-9866|gravizzini@mdanderson.org|
22309897|NCT03476343|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
22309898|NCT02724969|University of Pittsburgh|Jill R. Demirci, PhD, RN, IBCLC|412-648-9236|jvr5@pitt.edu|
22309899|NCT05974501|University of Miami|Dr. Victor H. Hernandez|305-243-4000|vhh1@med.miami.edu|
22309900|NCT04911296|Rani Therapeutics|Sr. Director of Clinical Operations|+1 (408) 457-3700|joshua.myers@ranitherapeutics.com|
22309901|NCT04083170|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206.667.5925|fmilano@fredhutch.org|
22309902|NCT02497950|Rigshospitalet Copenhagen, Denmark|Prof. Finn Gustafsson|+4535459743|finn.gustafsson@regionh.dk|
22309903|NCT04249362|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22309904|NCT03268382|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22309905|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com|
22309906|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22309907|NCT03756662|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22309908|NCT02807545|Scottish Rite for Children|Karina Zapata|214-559-7790|karina.zapata@tsrh.org|
22309909|NCT05207982|University at Buffalo, Department of Psychiatry|Daniel Antonius|7168582792|danielan@buffalo.edu|
22309910|NCT04295512|San Diego State University|Kelsey Dickson|(619) 594-5380|kdickson@sdsu.edu|q
22309911|NCT05207956|University of Pennsylvania|Dr. David Mandell|(215) 573 7494|david.mandell@pennmedicine.upenn.edu|
22309912|NCT02800356|San Raffaele Hospital|Prof. Giuseppe Querques|00390226434004|querques.giuseppe@hsr.it|
22309913|NCT01254864|The University of Texas MD Anderson Cancer Center|Paul Corn, MD|(713) 563-7208|pcorn@mdanderson.org|
22309914|NCT03626220|An Nan Hospital, China Medical University, Tainan, Taiwan|Dr. Chien-Chen Huang|886-6-3553111|chenchinh2013@gmail.com|2231
22309915|NCT02795858|Dana-Farber Cancer Institute|Dr. Jennifer Chan, MD|617-632-6315|jennifer_chan@dfci.harvard.edu|
22309916|NCT02573779|Baylor College of Medicine/Texas Children's Hospital|Dr. Amy B. Hair|832-826-1398|abhair@bcm.tmc.edu|
22309917|NCT03746106|University of California, San Francisco|Dr. Kathleen Giacomini|4155144363|kathy.giacomini@ucsf.edu|
22309918|NCT01651403|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22309919|NCT05090683|University of the Fraser Valley|Dr. Cynthia Thomson|6045047441|cynthia.thomson@ufv.ca|2518
22297104|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu|
22297105|NCT04076644|University of Missouri|Matt Schmidt|573-882-5688|schmidtmw@health.missouri.edu|
22297106|NCT02283814|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22297107|NCT01713868|Boston University|Michael Corwin, MD||mjcorwin@bu.edu|
22297108|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu|
22297109|NCT02268409|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297110|NCT01398566|The Ohio State University|Lise Worthen-Chaudhari|614-304-1421|liseworthen@gmail.com|
22297111|NCT03026257|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Clin Dev Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22297112|NCT02181556|FFCD|Mrs Karine Le Malicot, Head of biostatistics|+33 3 80 39.34.79|karine.le-malicot@u-bourgogne.fr|
22297113|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22297114|NCT02376946|TuftsU|Dr. Archana Viswanath|617-636-3578|Archana.Viswanath@tufts.edu|
22297115|NCT00838201|Amgen Inc.|Study Director|866-572-6436||
22297116|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22297117|NCT05447156|Masonic Cancer Center|Dana Mowls Carroll, Ph.D., M.P.H.|612-624-4511|dcarroll@umn.edu|
22297118|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234|lingchihwu@yahoo.com|1810
22297119|NCT03265249|Duke University|Alisha Mavis, M.D.|919-684-5068|alisha.mavis@duke.edu|
22297120|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu|
22297121|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu|
22297122|NCT02520011|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|+1-210-414-7702|Susan.smith@sdponcology.com|
22297123|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297124|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org|
22297125|NCT02780804|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22297126|NCT02476968|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22297127|NCT01661712|2Guy's and St Thomas' NHS Foundation Trust, Lane Fox Respiratory Unit/Sleep Disorders Centre, London, UK|Dr Joerg Steier|020 7188 3430|joerg.steier@gstt.nhs.uk|
22297128|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297129|NCT04171414|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
22297130|NCT01714310|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22297131|NCT02487394|UTMB|William Calhoun, M.D.|409-772-1176|wjcalhou@utmb.edu|
22279653|NCT03498716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22323214|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca|
22323215|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323216|NCT02921425|University of Miami|Dr. Joseph Sharit|305-284-6472|jsharit@miami.edu|
22323217|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
22323218|NCT03403400|Advent Health|Amie Jasper|407-303-8626|amiemarie.jasper@adventhealth.com|42
22323219|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22323220|NCT01107444|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22323221|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu|
22323222|NCT02266433|New York University School of Medicine - Division of Hand Surgery|Anthony Sapienza, MD / Assistant Professor|212 737 3301|Anthony.Sapienza@nyulangone.org|
22323223|NCT03709602|Duke University|Dr. Lisa Mansfield|919-681-9198|lisa.mansfield@duke.edu|
22323224|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
22323225|NCT03310970|University of Iowa|Nicole Brogden, Associate Professor|319-335-8752|nicole-brogden@uiowa.ed|
22323226|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com|
22323227|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu|
22279654|NCT02284191|NHS Lothian|Prof Alasdair Gray Chief Investigator|0131 242 1284|alasdair.gray@ed.ac.uk|
22279655|NCT04064905|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22279656|NCT04849897|University of Southern California|Steven Richeimer|323-442-6202|steven.richeimer@med.usc.edu|
22279657|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777||
22279658|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu|
22279659|NCT03139448|Vanderbilt University Medical Center|Koffi Kla, MD|615-343-9419|koffi.m.kla@vumc.org|
22279660|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca|
22279661|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu|
22279662|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu|
22279663|NCT03398330|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
22279664|NCT03261830|UMissouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
22279665|NCT01918189|VA Boston Healthcare System|Diana M. Higgins, PhD|857-364-2221|diana.higgins2@va.gov|
22279666|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
22279667|NCT01832727|Amgen, Inc|Study Director|866-572-6436|medinfo@amgen.com|
22297132|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22279668|NCT02160288|Massachusetts General Hospital|Dr Liliana Bordeianou|6176430541|lsavitt@mgh.harvard.edu|
22297133|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22297134|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22297135|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org|
22297136|NCT01969812|Atrium Health|Bradley Hurst, M.D.|704-355-3153|brad.hurst@atriumhealth.org|
22297137|NCT03441633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297138|NCT03161483|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22297139|NCT02767427|Columbia University|Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery|212-932-4410|kr2637@cumc.columbia.edu|
22297140|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
22297141|NCT04753164|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+18566613721|idorsiaclinicaltrials@idorsia.com|
22297142|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22297143|NCT00439556|UT MD Anderson Cancer Center|Dr. Khouri,Issa,M.D. / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
22297144|NCT02871739|Massachusetts General Hospital Health Decision Sciences Center|Karen Sepucha|617-724-3350|ksepucha@partners.org|
22297145|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu|
22297146|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297147|NCT01405963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22297148|NCT03615807|Balgrist University Hospital|Professor Ilker UCKAY|+41 44 386 37 05|ilker.uckay@balgrist.ch|
22297149|NCT03023085|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22297150|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297151|NCT01737047|Imperial College London|Alan Winston|02033121603|a.winston@imperial.ac.uk|1603
22297152|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100||
22297153|NCT04007523|Michigan Medicine|Dr. Phillip Vlisides|734-936-4280|pvliside@med.umich.edu|
22297154|NCT01826487|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22297155|NCT01408030|Cure HHT|James R. Gossage, MD, Medical Director of Cure HHT|706-721-6789|jgossage@augusta.edu|
22297156|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov|
22297157|NCT03608774|University of Washington|Julia C. Dombrowski, MD, MPH|206-744-5640|jdombrow@uw.edu|
22297158|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu|
22297159|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu|
22297160|NCT04837131|Mayo Clinic|Michael Pham, M.D.|480-301-8318|Pham.Michael@mayo.edu|
22323228|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu|
22323229|NCT03497845|BARDA|Silvija Tresnjak-Smith, Regulatory Operations Branch Chief, Regulatory and Quality Affairs Division|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
22323230|NCT01831960|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22323231|NCT05032950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323232|NCT02959814|Skejby University Hospital, Denmark|Niels Ramsing Holm, MD|004526849066|Niels.holm@clin.au.dk|
22323233|NCT05243628|Mannkind Corporation|Jennifer Pleitez, Director of Clinical Operations|818-661-5032|endocrineresearch@mannkindcorp.com|
22323234|NCT04343651|CytoDyn Inc.|Dr. Scott Kelly, Chief Medical Officer|(360) 980-8524|skelly@cytodyn.com|
22323235|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org|
22323236|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22323237|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu|
22323238|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com|
22323239|NCT02307370|Spectranetics, LLC now a part of Philips Image Guided Therapy Devices|Nicolas Aguirre, Senior Manager, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
22323240|NCT04451707|Groupe Hospitalier La Rochelle Ré Aunis|Dr Florence Hoefler|+330546455050|florence.hoefler@ch-troyes.fr|
22323241|NCT02281591|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22323242|NCT03219164|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22323243|NCT04585763|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
22323244|NCT02561897|Electrophysiology Research Foundation|Sanjeev Saksena|7323029990|eprf@aol.com|
22323245|NCT03021577|Columbia University Irving Medical Center|Ziad A. Ali, MD Assistant Professor of Medicine|212-305-7060|zaa2112@cumc.columbia.edu|
22323246|NCT03932799|University of Washington|Andrea Elmore|206-685-7194|aelmore@uw.edu|
22323247|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323248|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu|
22323249|NCT02613208|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22323250|NCT01524991|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22323251|NCT01678976|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22323252|NCT04574999|Italfarmaco|Dr. Concepción Nieto|+34 91 657 23 23|cnieto@itfsp.com|
22323253|NCT03631927|Tata Memorial Hospital|Dr. Jigeeshu Divatia|+919869077435|jdivatia@yahoo.com|
22279669|NCT03323164|Wills Eye Hospital|Dr. Daniel Lee|12159283197|daniellee@willseye.org|
22279670|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279671|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org|
22279672|NCT02394561|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22323254|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22323255|NCT05148884|Neurolixis|Adrian Newman-Tancredi, PhD, DSc, CEO|(+33) 605 14 09 64|contact@neurolixis.com|
22323256|NCT01341457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22279673|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
22279674|NCT03434834|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22279675|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People's Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com|
22279676|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu|
22279677|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22279678|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu|
22279679|NCT02633735|HealthPartners Institute|Elyse Kharbanda|952-967-5038|elyse.o.kharbanda@healthpartners.com|
22279680|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu|
22279681|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu|
22279682|NCT01880957|Stony Brook University|Dr. Christine DeLorenzo|(631) 638-1523|Christine.Delorenzo@stonybrookmedicine.edu|
22279683|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
22279684|NCT01854528|AbbVie|Global Medical Information|800-633-9110||
22279685|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com|
22279686|NCT01368614|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
22279687|NCT03060902|University of Oregon|Maureen Zalewski|541-346-7073|zalewski@uoregon.edu|
22279688|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22279689|NCT03722810|BIHAM, University of Bern|Prof. Michael Harris|+44 1761 241366|michael.harris@biham.unibe.ch|
22279690|NCT02579811|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|1-866-223-8100|TaussigResearch@ccf.org|
22279691|NCT00833521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22279692|NCT04336826|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22279693|NCT02561962|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22279694|NCT03586973|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22289065|NCT04287517|Istanbul University Faculty of Medicine Sports Medicine Department|Dr. Sergen Devran, Residency in Istanbul University Sports Medicine Department|00905377782594|sergendevran@gmail.com|
22289066|NCT04150861|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22289067|NCT03613519|Boston University School of Public Health|Lynn Rosenberg, ScD|617.734.6006|lrosenbe@bu.edu|
22297161|NCT04439318|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22297162|NCT03873987|Melinta Therapeutics, Inc.|Vice President Clinical Operations|9086171319|kfusaro@melinta.com|
22297163|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu|
22297164|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012||
22297165|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org|
22297166|NCT02579265|Fresenius Kabi Deutschland GmbH|Dr. Jean-Marc Lohse, Director Clinical Operations PN NAM & ELAMA|+49 6172 686|Jean-Marc.Lohse@fresenius-kabi.com|4911
22297167|NCT02174848|Chiesi Canada Corp.|Fernando Tricta, MD|416--558-6342|f.tricta@chiesi.com|
22297168|NCT06076694|Clinical Study Center of the First Hospital of Jilin University|TenNor|0512-86861979|info@tennorx.com|
22297169|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com|
22297170|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au|
22309920|NCT03325985|NYU Langone Health|Keith Goldfeld|(212) 263-5550|Keith.Goldfeld@nyulangone.org|
22309921|NCT03213665|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22309922|NCT03034356|VA Eastern Colorado Health Care System|Jason Tregellas, PhD|303-724-6232|jason.tregellas@va.gov|
22309923|NCT02684227|MD Anderson Cancer Center|Shannon Westin, MD|713-794-4314|swestin@mdanderson.org|
22309924|NCT04070573|Weill Cornell Medicine|Dr Line Malha|6469622606|lim9120@med.cornell.edu|
22309925|NCT04571619|University of Pennsylvania|Natalie Kuzla|2155732935|nkuzla@pennmedicine.upenn.edu|
22309926|NCT04580914|Boston Scientific|Claire Dietzsch, Senior Clinical Trials Specialist|9529306745|Claire.Dietzsch@bsci.com|
22309927|NCT05205486|B. Braun Medical Inc.|Director, Scientific Affairs Operations|610-596-2512|kevin.minnich@bbraunusa.com|
22309928|NCT05210569|Image Plus Laser Eye Centre|Dr James Wiens|1-204-943-6287|jamesjwiens@gmail.com|
22309929|NCT00544414|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22309930|NCT04167553|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|+8224100377|jiyeon.kang@hanmi.co.kr|
22309931|NCT04750538|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22309932|NCT04479761|New York University|Prof. Anat Lubetzky|2129989195|anat@nyu.edu|
22309933|NCT05309291|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22309934|NCT05209152|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22309935|NCT02568566|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
22309936|NCT02694822|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
22309937|NCT05370040|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22309938|NCT04294641|National Cancer Institute|Dr. Steven Z. Pavletic|240-760-6174|sp326h@nih.gov|
22309939|NCT04870307|University of Oklahoma Tulsa|Dr. Juell Homco|918-660-3038|juell-homco@ouhsc.edu|
22309940|NCT05906784|University of California, San Francisco|Maria Chao, DrPH, MPA, Principal Investigator|415-353-7749|Maria.Chao@ucsf.edu|
22309941|NCT03397706|Viracta Therapeutics|Medical Director|858-400-8470|ClinicalTrials@Viracta.com|
22309942|NCT04491617|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22309943|NCT03249090|University of North Carolina at Chapel Hill|Principal Investigator|9194456223|symptom_study@unc.edu|
22309944|NCT04200911|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
22309945|NCT05163496|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
22309946|NCT05427253|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc, Global Medical Director|+46 317880560|info@vicorepharma.com|
22309947|NCT05147116|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
22309948|NCT03672916|Zimmer Biomet|Martina Hersberger, Clinical Project Lead|+41 79 535 90 29|martina.hersberger@zimmerbiomet.com|
22309949|NCT04197336|Johns Hopkins University|Clifford Weiss, MD|410-614-1046|cweiss@jhmi.edu|
22309950|NCT03221309|Institute of Human Virology, University of Maryland School of Medicine|Dr. Elana Rosenthal / Associate Professor|2403674157|erosenthal@ihv.umaryland.edu|
22309951|NCT04625725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22309952|NCT02945176|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22309953|NCT05244187|MEDIcept Inc|Adelina Paunescu, VP Clinical Affairs|781-526-8152|apaunescu@medicept.com|
22309954|NCT04308681|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22309955|NCT05086796|Cedars-Sinai Medical Center|Itai Danovitch, MD|310-423-2600|itai.danovitch@cshs.org|
22309956|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com|
22309957|NCT05873556|University of Washington|Dr. Anne Fairlie|2062215896|afairlie@uw.edu|
22309958|NCT04047602|Indiana University Health|Kevin Shiue, MD|317 944 2524|kshiue@iuhealth.org|
22309959|NCT04689256|UMass Chan Medical School/UMass Memorial Health|Dr. Brian Silver|508-334-5989|Brian.Silver@umassmemorial.org|
22309960|NCT04867278|Emory University|Dr. Adam Boissonneault|(404) 616-1000|adam.boissonneault@emory.edu|
22309961|NCT04862234|Emory University|Georgia Davis, MD|404-251-8957|georgia.marie.davis@emory.edu|
22309962|NCT04484428|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22309963|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com|
22309964|NCT05828017|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
22309965|NCT04132518|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22309966|NCT05425420|Duke University|Kanecia Zimmerman|919-668-8651|kanecia.zimmerman@duke.edu|
22309967|NCT03714815|Actelion Pharmaceuticals Ltd|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309968|NCT04999111|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22323257|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr|
22323258|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252||5252
22323259|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22323260|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
22323261|NCT02626338|AROG Pharmaceuticals Inc.|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22323262|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999|aalomair@kfmc.med.sa|8771
22279695|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu|
22279696|NCT02735421|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22279697|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297171|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com|
22297172|NCT01641367|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22297173|NCT02623803|Mayo Clinic|Dr. Elird Bojaxhi|904-956-3327|bojaxhi.elrid@mayo.edu|
22297174|NCT04452331|University of Illinois Chicago|Dr. Alan Schwartz|3129962070|alansz@uic.edu|
22297175|NCT04064294|Portland VA Health Care System|Dr. Kathryn Chung|(503) 721 -1091|Kathryn.Chung@va.gov|
22297176|NCT03137693|Moffitt Cancer Center|Michael Montejo, MD|813-745-8424|Michael.Montejo@moffitt.org|
22297177|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
22297178|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu|
22297179|NCT04534764|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
22297180|NCT03007394|National Institute on Drug Abuse|David McCann, Ph.D.|301-827-5934|dmccann@nida.nih.gov|
22297181|NCT02151448|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22297182|NCT01841151|KIND, KBH, Karolinska Institutet|Prof. Sven Bölte|0046703170105|sven.bolte@ki.se|
22297183|NCT00409617|Abbott|Global Medical Services|800-633-9110||
22279698|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700|wipac@afrims.org|4351
22279699|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279700|NCT01714323|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-4709|nrigotti@partners.org|
22279701|NCT03233828|Nova Scotia Health|Principal Investigator|9024736177|carman.giacomantonio@nshealth.ca|
22297184|NCT02159521|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
22297185|NCT04649775|Duke University|Loretta Que, M.D.|919-681-8551|loretta.que@duke.edu|
22297186|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
22297187|NCT03818516|Emory University|David R. Goldsmith, MD|404-727-3735|drgolds@emory.edu|
22297188|NCT02508571|Department of Pediatrics, Seoul National University College of Medicine|Dr. Ee-Kyung Kim|82-2-2072-3628|kimek@snu.ac.kr|
22297189|NCT01524692|University of Virginia|Dr. Patrick Dillon|4349821495|pmd5b@virginia.edu|
22297190|NCT01709695|Icahn School of Medicine at Mount Sinai|Department of Psychiatry|212-241-6623||
22297191|NCT00788892|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|215-832-3750||
22297192|NCT03065244|Dept. of Pediatrics UCSD School of Medicine|Dr. Jane Burns|858-246-0155|jcburns@health.ucsd.edu|
22297193|NCT01894152|Abbott Vascular|Roy Leong|+65 (6277) 3202|roy.leong@abbott.com|
22297194|NCT03556579|Johnson & Johnson Vision Care Inc.|John Buch, O.D. F.A.A.O - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
22297195|NCT02965703|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22297196|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com|
22297197|NCT03560531|Zeno Alpha Inc.|Head of Regulatory Affairs|(858) 263-4333|RegLeads@zentalis.com|
22297198|NCT02968979|CHUGAI PHARMA FRANCE|Dr Luz BOBADILLA, Medical Affairs Director|+33 1 56 37 05 28|bobadilla@chugai-pharm.fr|
22297199|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu|
22297200|NCT00788827|Imperial College London|Professor Charles Pusey|+44 3313 2308|c.pusey@imperial.ac.uk|
22297201|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000|todd.wagner@va.gov|22048
22297202|NCT04222712|Tarsier Pharma|COO|+972508371319|zohar@tarsierpharma.com|
22297203|NCT00699556|Yale University|Sherry McKee|(203) 737-3529|sherry.mckee@yale.edu|
22297204|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu|
22297205|NCT04993287|NorthShore University HealthSystem|Dr. Nirav Shah|847-657-5959|nshah2@northshore.org|
22297206|NCT04448210|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
22297207|NCT02818777|University of Colorado|Dr. Maureen Anne Leehey|303-724-2194|maureen.leehey@ucdenver.edu|
22297208|NCT02028988|Dana-Farber Cancer Institute|Glenn Bubley MD|617-735-2062|gbubley@bidmc.harvard.edu|
22297209|NCT02803307|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|carlb@tlcbio.com|
22297210|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
22297211|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com|
22297212|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22297213|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu|
22297214|NCT02276612|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230|GileadClinicalTrials@gilead.com|
22323263|NCT03312218|McGill University|Dr. Roland Grad|514-947-3718|roland.grad@mcgill.ca|
22297215|NCT04365556|Cincinnati Children's Hospital Medical Center|Rachelle Ramsey|513-803-0415|rachelle.ramsey@cchmc.org|
22323264|NCT01901224|Brigham and Women's Hospital|Mark A. Creager, MD|603-650-8283|mark.a.creager@hitchcock.org|
22323265|NCT06441877|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22279702|NCT02495285|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
22279703|NCT02094118|Mayo Clinic|Dr. Daryl Kor|507-255-6051|kor.daryl@mayo.edu|
22279704|NCT01585025|Imperial College London|Prof Julian Walters|+442033132361|julian.walters@imperial.ac.uk|
22323266|NCT05742984|Cinclus Pharma|Cinclus Pharma Holding AB|+46 8 13 33 10|gosta.hiller@cincluspharma.com|
22323267|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu|
22323268|NCT03116113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22323269|NCT02159807|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
22323270|NCT00950170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323271|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu|
22323272|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu|
22323273|NCT02104414|Mount Sinai St. Luke's|Dr. Ali Shariat|914-409-5023|alishariatmd@gmail.com|
22323274|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov|
22323275|NCT03051633|Colorado State University|Dr. Meghan Crabtree|2105875584|meghan.crabtree@colostate.edu|
22323276|NCT01834235|Precision Biologics Inc.|Dr. Philip Arlen President and CEO|3015008646|philip.arlen@precision-biologics.com|
22323277|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu|
22323278|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22323279|NCT04271761|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|3105
22323280|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22323281|NCT03902080|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22323282|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22323283|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22323284|NCT03822884|Biosidus S.A.|Clinical Trial Manager - Dr. Roberto A. Diez|+5411 4909 8000|r.diez@biosidus.com.ar|
22323285|NCT02620904|Montefiore Einstein|Jessica Maria Atrio|7184058260|jatrio@montefiore.org|
22323286|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22323287|NCT01279057|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22323288|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu|
22323289|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22323290|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22323291|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323292|NCT02913313|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22323293|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
22323294|NCT01492673|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett, MD|212-639-8267|trippet1@mskcc.org|
22323295|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu|
22323296|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22323297|NCT02908100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22323298|NCT04933123|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22323299|NCT05254418|Vanderbilt University Medical Center|Dr. Talat Alp Ikizler|6159366646|alp.ikizler@vumc.org|
22323300|NCT03118596|University Hospitals Coventry & Warwickshire NHS Trust|Dr Cyprian Mendonca|02476964000|cyprian.mendonca@hotmail.com|25871
22323301|NCT02631538|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22323302|NCT00440726|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22323303|NCT04067518|Institut de Recherches Internationales Servier|Clinical Studies Department|+33 1 55 72 43 66|scientificinformation@servier.com|
22323304|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012||
22323305|NCT00822107|Oregon Health & Science University|Dr. David H. Ellison|5034944465|ellisond@ohsu.edu|
22323306|NCT01577238|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22323307|NCT04276207|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22323308|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com|
22323309|NCT03624946|Emergent BioSolutions Canada Inc.|Jason Richardson, Senior Scientist, Clinical Research|204-275-4266|jrichardson@ebsi.com|
22323310|NCT03501966|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
22279705|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu|
22323311|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323312|NCT02796755|Emory University|Andrew H Miller, MD|404-727-8260|amill02@emory.edu|
22279706|NCT03430349|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
22279707|NCT02122380|Vanderbilt University Medical Center|Dr. Jessica Devin|970-875-2708|jessica.devin@vumc.org|
22297216|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22323313|NCT00675025|Eisai Inc|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22297217|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu|
22323314|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br|
22279708|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com|
22297218|NCT04920123|University of Massachusetts Amherst|Juhyeon Lee|413-404-4732|juhyeonlee@cs.umass.edu|
22323315|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com|
22279709|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279710|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279711|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov|
22279712|NCT03623698|Imperial College London|Mrs. Natalia Galaz Souza|07751842851|natalia.galaz-souza16@imperial.ac.uk|
22279713|NCT03604497|University of Alabama at Birmingham|Dr David Schwebel|2059348745|schwebel@uab.edu|
22279714|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22279715|NCT02604459|University of Missouri|Dr. Quinn Johnson|573-882-2568|johnsonql@health.missouri.edu|
22279716|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org|
22279717|NCT01534481|University of Iowa|Dr. Tarah Colaizy|319-356-3508|tarah-colaizy@uiowa.edu|
22279718|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org|
22279719|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
22279720|NCT00945659|Nemours Foundation: Dept. of Biomedical Research|Tim Wysocki, PhD|904-697-3483|twysocki@nemours.org|
22279721|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22279722|NCT03179761|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
22279723|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279724|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22279725|NCT04828707|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
22279726|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22279727|NCT04700423|Swiss TPH|Prof. Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
22279728|NCT01570387|Boston Medical Center|Vaishali Sanchorawala|617-638-7017|vaishali.sanchorawala@bmc.org|
22279729|NCT01876381|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22279730|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com|
22279731|NCT04211363|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844)692-6729|medinfo@arcutis.com|
22279732|NCT01991860|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|Gabrielfox@acaciapharma.com|
22279733|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com|
22279734|NCT02797821|Alexion Pharmaceuticals|Alexion Pharmaceuticals|475-230-2596|ClinicalTrials@Alexion.com|
22279735|NCT00654732|UT MD Anderson Cancer Center|Dr. Hun Ju Lee, Associate Professor, Lymphoma/Myeloma|713 794-1829|hunlee@mdanderson.org|
22279736|NCT01951391|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
22279737|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu|
22279738|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22279739|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22279740|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org|
22279741|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu|
22279742|NCT01585402|National Heart, Lung, and Blood Institute (NHLBI)|Alessandra Brofferio, M.D.|301.496.2634|alessandra.brofferio@nih.gov|
22279743|NCT03368066|University of Virginia|Dr. Brian Wentworth|9739436781|bw8xz@hscmail.mcc.virginia.edu|
22279744|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22279745|NCT01419119|Umea University, Umeå, Sweden|Dr Margareta Norberg|+46702618614|margareta.norberg@umu.se|
22279746|NCT03783780|Masimo|Tala Harake|1-949-297-7100|studies@masimo.com|
22279747|NCT03768427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279748|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu|
22279749|NCT03710889|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
22279750|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu|
22279751|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com|
22279752|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279753|NCT01061528|University of Texas at Austin|Dr. Richard A. Brown|512-471-8584|brown2@utexas.edu|
22279754|NCT00636181|Stanford Sleep Medicine Center|Clete A. Kushida, MD, PhD|(650) 721-7560|clete@stanford.edu|
22279755|NCT02993263|Cleveland Clinic|Daniel Sessler, MD|216-444-9400|sesslers@ccf.org|
22279756|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu|
22279757|NCT00829998|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22279758|NCT00896012|University at Buffalo|Oleh G. Pankewycz, MD||opankewycz@kaleidahealth.org|
22279759|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org|
22279760|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
22279761|NCT02026011|University of California, Los Angeles|Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22279762|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com|
22279763|NCT03372161|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|(650) 386-6709|cambrose@scilexpharma.com|
22279764|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk|
22323316|NCT01596257|Memorial Sloan Kettering Cancer Center|Dr. Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
22279765|NCT05010070|University of Michigan|Laura Saslow, Associate Professor|(734) 764-7836|saslowl@umich.edu|
22323317|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323318|NCT04258579|Weill Cornell Medical College|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
22279766|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279767|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov|
22323319|NCT04007159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279768|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743||
22323320|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22323321|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22323322|NCT03804684|Wills Eye Hospital|M. Reza Razeghinejad, MD|12159283197|reza@willseye.org|
22323323|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22323324|NCT01375764|Amgen Inc.|Study Director|866-572-6436||
22323325|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22323326|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
22323327|NCT02732951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323328|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu|
22323329|NCT02828267|Duke University Medical Center|Catherine Staton|9196845537|catherine.staton@duke.edu|
22323330|NCT05047523|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22323331|NCT03658889|ChugaiPF|Isabelle Idier, Rheumatology Medical Leader|+33 (0) 1 56 37 44 89|idier@chugai-pharm.fr|
22323332|NCT02923271|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
22323333|NCT04188197|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
22323334|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com|
22279769|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com|
22323335|NCT01922921|University of Washington|Director of Clinical Operations|2066162305|childj@u.washington.edu|
22323336|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il|
22279770|NCT02921789|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22323337|NCT04684420|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151 72 5200|service@emdgroup.com|
22279771|NCT01944020|Columbia University|Ari Shechter|2123424487|as4874@cumc.columbia.edu|
22279772|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279773|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
22279774|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu|
22279775|NCT02554799|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
22279776|NCT02808897|Montreal Heart Institute|Philippe Demers|5143763330|philippe.demers@icm-mhi.org|
22323338|NCT00463476|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22323339|NCT00254410|The University of Texas MD Anderson Cancer Center|Wierda,William G, MD./Professor|713-745-0428|wwierda@mdanderson.org|
22323340|NCT04226469|University of Illinois Chicago|Phimon Atsawasuwan|3124132651|patsawas@uic.edu|
22323341|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323342|NCT00544830|City of Hope|Dr. Cy Stein|626-359-8111||
22323343|NCT04130646|Medical University of South Carolina|Associate Professor-Faculty|(843) 792-6076|badran@musc.edu|
22323344|NCT02690194|Boston Children's Hospital|Greggory Kobelski|7812161093|Greggory.Kobelski@childrens.harvard.edu|
22323345|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu|
22323346|NCT02002702|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22323347|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|
22323348|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org|
22323349|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323350|NCT03176316|Loyola University Medical Center|Russell Nockels, M.D.|847-618-9565|neurocare@nch.org|
22323351|NCT01349140|University California San Diego|Brian Ilfeld, MD, MS|1-858-444-5949|bilfeld@ucsd.edu|
22323352|NCT03062657|Medtronic|Rhys Jones, PhD; Senior Clinical Research Specialist|+44 7826874430|rhys.j.jones@medtronic.com|
22323353|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22323354|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org|
22323355|NCT03183128|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
22323356|NCT02978222|Marker Therapeutics|Gerald Garrett|713.400.6400|ggarrett@markertherapeutics.com|
22323357|NCT03258814|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22323358|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323359|NCT02908516|Yale School of Medicine, Department of Orthopaedics and Rehabilitation|Dr. Michael P. Leslie|(203) 737-6358|michael.leslie@yale.edu|
22323360|NCT03382509|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323361|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323362|NCT03251326|New York State Psychiatric Institute|Margaret Haney, Ph.D.|646-774-6129|meg.haney@nyspi.columbia.edu|
22297219|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297220|NCT03893799|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
22323363|NCT02909153|Rockwell Medical|clinical project manager|248-960-9009|sgrimberg@rockwellmed.com|
22323364|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com|
22323365|NCT04666038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22297221|NCT02212587|Hospital of Sick Children|Dr. Valerie Waters|416-813-1500|valerie.waters@sickkids.ca|
22323366|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu|
22323367|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu|
22323368|NCT02867761|University of Michigan|Meilan K. Han|734 615-9772|mrking@med.umich.edu|
22323369|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711|handan.gunduz-bruce@yale.edu|4130
22297222|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
22323370|NCT02445586|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323371|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu|
22323372|NCT01931059|Northwell Health|Dr. Miklos Argyelan|718-470-8175|margyela@northwell.edu|
22323373|NCT02675075|James A. Haley VA Hospital|Dr. Sam Phillips|813 558 3995|samuel.phillips@va.gov|
22323374|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp|
22323375|NCT01176916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323376|NCT01014403|UT Southwestern Medical Center|Dr. Herb Phelan|214-648-6841|herb.phelan@utsouthwestern.edu|
22323377|NCT03158220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323378|NCT02525549|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22323379|NCT03887130|Pierre Fabre|Gustavo Villanova M.D|+33149108265|gustavo.villanova@pierre-fabre.com|
22323380|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22323381|NCT02899156|University of California Davis Medical Center|Kendra Schomer, PharmD|916-734-2243|kjschomer@ucdavis.edu|
22323382|NCT03135249|UT Southwestern Medical Center|Dr. Olaf Stuve, Principal Investigator|12146484559|olaf.stuve@utsouthwestern.edu|
22323383|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
22323384|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22323385|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323386|NCT01609842|VHA Eastern Colorado Health Care System|Marina McCreight|720-857-2785|marina.mccreight@va.gov|
22323387|NCT04722991|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22323388|NCT03186989|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22323389|NCT03057795|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22323390|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org|
22323391|NCT02246621|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22323392|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov|
22323393|NCT03641560|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22323394|NCT04439279|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22323395|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu|
22323396|NCT00110305|Janssen-Virco BE|Director|32 14 641418||
22323397|NCT01495819|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22323398|NCT01609933|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22323399|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22323400|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
22268855|NCT03817190|DS Biopharma|Study Director|+35312933590|info@dsbiopharma.com|
22268856|NCT04146012|Accidentals Inc. (Formally Artegraft Inc.)|Tony Calandra, President|973.540.1250|arc@mcguggan.com|
22268857|NCT01546025|Brown University|Suzanne Colby|4018636655|Suzanne_Colby@brown.edu|
22268858|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268859|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22268860|NCT05795153|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22268861|NCT03668119|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22268862|NCT03769168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22268863|NCT05142722|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22268864|NCT04541017|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
22268865|NCT03896503|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22268866|NCT05400655|Centers for Disease Control and Prevention|Dr. Laura Steinhardt, PhD, MPH|1 6467641472|LSteinhardt@cdc.gov|
22268867|NCT04495946|Wake Forest University School of Medicine|Marc Kowalkowski, PhD|704-355-9902|marc.kowalkowski@advocatehealth.org|
22268868|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22268869|NCT05161481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22268870|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22309969|NCT05987072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309970|NCT03169972|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22309971|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com|
22309972|NCT04056611|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309973|NCT02946736|Oregon Health & Science University|Dr. Leslie Hammer, PI|503-494-9313|hammerl@ohsu.edu|
22309974|NCT03733925|Johnson & Johnson Private Limited|Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22309975|NCT03213873|Karolinska Institutet|Erika Franzén|08-52488878|erika.franzen@ki.se|
22323401|NCT03340350|VA Nebraska-Western Iowa Health Care System|Sriram Ramaswamy, MD|402-995-4712|Sriram.Ramaswamy@va.gov|
22323402|NCT03275870|Beth Israel Lahey Health|Dr. Elena Gonzalez Brant, PI|6173191221|emgbrant@gmail.com|
22323403|NCT03455673|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, manager of clinical trials|+33546455050|caroline.allix-beguec@ght-atlantique17.fr|
22323404|NCT02924896|Imperial College London|Prof Gary Frost|020 7589 5111|g.frost@imperial.ac.uk|
22323405|NCT04801758|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22323406|NCT05019131|University of California, San Francisco|Dr. Patience Afulani|(415) 476-1000|Patience.Afulani@ucsf.edu|
22323407|NCT02360098|TORONTO WESTERN HOSPITAL/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
22323408|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu|
22323409|NCT02673333|Memorial Sloan Kettering Cancer Center|Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
22323410|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22323411|NCT03486392|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22323412|NCT02347631|UT Southwestern Medical Center|Danielle Robertson|214-648-3416|danielle.robertson@utsouthwestern.edu|
22323413|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com|
22297223|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297224|NCT04066426|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
22297225|NCT03249779|Mayo Clinic|Melissa C. Lipford, M.D.|507-255-9230|Lipford.Melissa@mayo.edu|
22297226|NCT02984384|University of Maryland School of Medicine|Robert O'Toole|410-328-6280|rotoole@som.umaryland.edu|
22297227|NCT01604343|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22297228|NCT00436748|Amgen Inc.|Study Director|866-572-6436||
22297229|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org|
22297230|NCT02711800|Duke University|Nancy Zucker|9196680075|zucke001@mc.duke.edu|
22297231|NCT04133168|Boston Scientific|Stephanie Roelke, Clinical Trial Manager|651-582-4000|Stephanie.Roelke@bsci.com|
22297232|NCT01295515|National Cancer Institute|Dr. Frank Maldarelli|301- 846-5611|frank_maldarelli@nih.gov|
22297233|NCT05442554|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22297234|NCT04938232|Dana-Farber Cancer Institute|Reid Merryman|6176326844|reid_merryman@dfci.harvard.edu|
22297235|NCT02269280|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Mnaero|713-745-3428|ggarciam@mdanderson.org|
22297236|NCT03754959|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297237|NCT01990495|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
22297238|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743||
22297239|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22297240|NCT03167879|RAND Corporation|Dr. Glenn Wagner|310-393-0411|gwagner@rand.org|7698
22297241|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com|
22297242|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co|
22297243|NCT02972632|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22297244|NCT02126969|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
22297245|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
22297246|NCT01828034|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
22297247|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu|
22297248|NCT03450707|BIDMC|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
22297249|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22297250|NCT03592121|Applied Biology, Inc.|Dr. Andy Goren|(949) 387-4526|andyg@appliedbiology.com|
22297251|NCT01988571|Wake Forest NCI Community Oncology Research Program Research Base|Lead Biostatistician|336-716-0891|NCORP@wakehealth.edu|
22297252|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu|
22297253|NCT00337103|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22297254|NCT03387813|Abbott|Fei San Lee, PhD, Sr Clinical Research Scientist|925-694-2109|feisan.lee@abbott.com|
22297255|NCT05876273|Center for Diabetes Technology, University of Virginia School of Medicine|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
22297256|NCT04227236|dFusion, Inc.|Regina Firpo-Triplett|831-222-5094|regina.firpo@dfusioninc.com|
22297257|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22297258|NCT03917420|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
22297259|NCT00591942|University of Iowa|Dr. Clark Stanford|319-335-7381|Clark-Stanford@uiowa.edu|
22297260|NCT02319005|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22279777|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22279778|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
22309976|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu|
22309977|NCT02631746|Duke University - Duke Cancer Institute LAO|Christy Arrowood|919-613-6130|christy.arrowood@duke.edu|
22309978|NCT02361216|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
22309979|NCT04709419|The University of Texas Health Science Center at San Antonio|Lawrence Lavery, DPM|214-399-5381|lavery@uthscsa.edu|
22309980|NCT05683340|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22309981|NCT02437136|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
22309982|NCT04117178|Department of Neurology, Zealand University Hospital|Michael Fischer|+4547322800|mihh@regionsjaelland.dk|
22309983|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com|
22309984|NCT04312841|The Ohio State University Comprehensive Cancer Center|Dr. John Reneau|614-293-3196|John.Reneau@osumc.edu|
22309985|NCT02780700|Boehringer Ingelheim|Boehringer IIngelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22309986|NCT05723575|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
22309987|NCT06397443|IRCCS Istituto Ortopedico Rizzoli|Dr. Manila Boarini|+39 051 63666062|manila.boarini@ior.it|
22309988|NCT03367754|Clinical Center|Kovacs, Joseph|+1 301 496 9907|jkovacs@mail.nih.gov|
22309989|NCT03687762|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
22309990|NCT03149822|University of Colorado Hospital|Dr. Elaine Lam|7208480723|elaine.lam@cuanschutz.edu|
22309991|NCT04560595|Johns Hopkins University|Dr. Dustin C. Lee|410-550-4035|dlee214@jhmi.edu|
22309992|NCT02828358|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22309993|NCT03298945|Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center|Yu-Xiao Yang, MD, MSCE|215-823-5800|yuxiao.yang@va.gov|
22309994|NCT03702270|VANDERBILT UNIVERSITY MEDICAL CENTER|Dr. Cosby A Stone, Jr.|6153223412|Cosby.a.stone@vumc.org|
22309995|NCT05285137|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
22309996|NCT03221426|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22309997|NCT06262477|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22309998|NCT06130410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22309999|NCT05365958|University of Houston|Dr. Chakema Carmack, Ph.D., Associate Professor|713-743-6231|ccarmack@central.uh.edu|
22310000|NCT03397654|Imperial College London|Dr David Pinato|+44 20 7594 2799|david.pinato@imperial.ac.uk|
22310001|NCT03220035|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310002|NCT02593773|Horizon Pharma Ireland, Ltd, Dublin Ireland|Julie Ball, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
22310003|NCT05270876|Cochlear|PRS Specialist|+61294286555|cltd-prs-admin@cochlear.com|
22310004|NCT04432506|The University of Texas MD Anderson Cancer Center|Paolo Strati, MD|(713) 745-1776|pstrati@mdanderson.org|
22310005|NCT04024020|University of Pennsylvania|Philip Gehrman|2157463578|philip.gehrman@pennmedicine.upenn.edu|
22310006|NCT05269966|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22310007|NCT05575219|The University of Texas Health Science Center at Houston|Andrea Leigh Heifner, MD|407-729-2972|andrea.heifner@stjude.org|
22310008|NCT06262347|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
22310009|NCT04304144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22310010|NCT04101357|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22310011|NCT04362085|St. Michael's Hospital|Dr. Michelle Sholzberg|4168606060|michelle.sholzberg@unityhealth.to|
22310012|NCT04660539|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22310013|NCT05618587|University at Buffalo|Thomas Guttuso, Jr., MD|716-932-6080|tguttuso@buffalo.edu|
22310014|NCT05167864|University of Pennsylvania|Dr. Ivona Percec, PhD, MD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
22310015|NCT06007781|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22310016|NCT03852550|McMaster University|Research Coordinator|9055259140|galuppi@mcmaster.ca|27852
22310017|NCT05204654|University at Buffalo|No Dr. Alexandria Newton|716-829-2845|amnewton@buffalo.edu|
22310018|NCT03314688|Yale School of Medicine|Tara Sanft, MD|(203) 200-2328|tara.sanft@yale.edu|
22310019|NCT00179400|Albert Einstein College of Medicine|Prof. Meredith A. Hawkins|718 430 3186|meredith.hawkins@einsteinmed.edu|
22279779|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22279780|NCT02217618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22279781|NCT00003816|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
22279782|NCT04108273|NYU Langone Health|Francisco Castellanos, MD|6467545194|Francisco.Castellanos@nyulangone.org|
22279783|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
22279784|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352||
22279785|NCT02154061|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22279786|NCT01936831|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22279787|NCT03715790|Medtronic Cardiac Rhythm Management|CRM Clinical Research|1-800-328-2518|rs.medtronicCRMtrials@medtronic.com|
22279788|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323414|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es|
22323415|NCT02076165|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|36080
22323416|NCT02429856|UAlberta|Director of NACTRC|780-407-8007|ron.welch@ahs.ca|
22323417|NCT01950819|Novartis Pharma|Study Director|8627788300|Novartis.email@novartis.com|
22323418|NCT04134494|BIDMC|Roger Lefevre|6176674070|rlefevre@bidmc.harvard.edu|
22323419|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com|
22323420|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com|
22323421|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22323422|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346|arockich@uky.edu|247
22323423|NCT04591054|Penn State Hershey Medical Center|Seth Pantanelli MD|717-531-4696|spantanelli@pennstatehealth.psu.edu|
22323424|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
22323425|NCT03371355|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22323426|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323427|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu|
22323428|NCT03357393|Region Östergötland|Lena Nilsson|+46 10 103 00 00|lena.nilsson@regionostergotland.se|1838
22323429|NCT03595280|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
22323430|NCT02658812|UT MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD-Professor Breast Medical Oncology|713-792-8754|nueno@mdanderson.org|
22323431|NCT03400800|Novartis|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
22323432|NCT01512264|Universtiy of Alabama at Birmingham|Dr. Jerzy P. Szaflarski|205.975.5587|jszaflarski@uabmc.edu|
22323433|NCT00854828|Washington University|Keith H. Bridwell, MD|314-747-2655|bridwellk@wustl.edu|
22323434|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22323435|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu|
22323436|NCT04957290|Noxopharm|Lorena, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
22323437|NCT00896532|Amgen Inc.|Study Director|866-572-6436||
22323438|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com|
22323439|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323440|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323441|NCT01959165|Biometrics|Nii Masahiro|+81 6 7711 4571|Masahiro.Nii@astrazeneca.com|4571
22323442|NCT03686969|CRMG|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
22323443|NCT01144598|Abbott|Global Medical Services|1-800-633-9110||
22323444|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323445|NCT02344225|SUNY Downstate Medical Center|Jacob V. Aranda, MD, PhD, FRCPC, Principal Investigator|718-270-1912|jaranda@downstate.edu|
22323446|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu|
22323447|NCT03219073|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22323448|NCT02238847|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
22323449|NCT01988090|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22323450|NCT04870671|Eastern Virginia Medical School|Dr. Terry Jacot|757-446-7056|jacotta@evms.edu|
22323451|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
22268871|NCT04225715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268872|NCT01894841|Providence VAMC|Jennifer Primack|401 273-7100|jennifer.primack@va.gov|6295
22268873|NCT04168112|SightMD|Dr. Alanna Nattis|631-957-2816|anattis@sightmd.com|
22268874|NCT03158038|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
22268875|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268876|NCT02918565|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
22268877|NCT01739231|PATH|Richard Walker|202-822-0033|rwalker@path.org|
22268878|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com|
22268879|NCT00925704|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22268880|NCT00661557|GlaxoSmithKline|GSK Response Center|866-435-7343||
22268881|NCT03817853|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268882|NCT05005507|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22268883|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268884|NCT03866512|University of Exeter|Dr Marlou Dirks|+44 1392 725496|m.dirks@exeter.ac.uk|
22268885|NCT00320710|Novartis|Study Director|862-778-8300||
22268886|NCT04545008|Prisma Health|Dr. Julie Martin - Director, Cancer Research|864-455-3667|julie.martin@prismahealth.org|
22268887|NCT03328507|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
22268888|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu|
22323452|NCT01961115|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
22323453|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu|
22323454|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu|
22268889|NCT04578457|Sonova AG|Juliane Raether|+41 58 928 01 01|juliane.raether@sonova.com|
22268890|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22323455|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
22279789|NCT03085680|University of Florida|Dr. Robert Mankowski|+1 (352) 294-5055|r.mankowski@ufl.edu|
22279790|NCT03848416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22279791|NCT02808429|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22279792|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279793|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca|
22279794|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22310020|NCT03895996|Avotres Inc.|Tuochuan Dong, Director, Business & Operations|7169093370|tuochuan.dong@avotres.com|
22310021|NCT04618315|Northwestern University|Sumitrajit Dhar|847 491 8542|s-dhar@northwestern.edu|
22310022|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
22310023|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22310024|NCT04410328|Rutgers New Jersey Medical School|Dr. Amit Singla|319-512-3558|as3321@njms.rutgers.edu|
22310025|NCT03911141|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
22310026|NCT05565820|Alliance Pharmaceuticals|R&D Director|01249 466966|medaffairs@allianceph.com|+44
22310027|NCT02393885|AtriCure, Inc.|Nfii Ndikintum|1-513-755-4100|nndikintum@atricure.com|
22268891|NCT05209867|University of Florida|Dr. Simone Marini|3522948951|simone.marini@ufl.edu|
22268892|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com|
22268893|NCT02841995|Sanofi ( Kadmon, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22268894|NCT01051596|Georgetown University|Michael Pishvaian, MD, PhD|202-444-2223|pishvaim@georgetown.edu|
22268895|NCT02755103|Medical University of South Carolina|Therese K Killeen PhD, Principal Investigator|843-792-5232|killeent@musc.edu|
22268896|NCT00323453|Santa Barbara Cottage Hospital|Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)|805-324-9255|lisaacs@sbch.org|
22279795|NCT01847092|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22279796|NCT02103127|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22279797|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu|
22279798|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22279799|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279800|NCT03064074|Baylor|dianne Nguyen|7137986694|diannen@bcm.edu|
22279801|NCT00269087|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279802|NCT05018689|Penn State College of Medicine|Dr. Deepa Sekhar|717-531-0003|dsekhar@pennstatehealth.psu.edu|x281334
22279803|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22310028|NCT05176093|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310029|NCT04871529|SWOG|Melissa Plets|206 667 2707|mplets@fredhutch.org|
22310030|NCT05184452|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22310031|NCT05586490|University of Michigan|Chatkaew Pongmala, PhD|734-936-1168|pchatkae@umich.edu|
22310032|NCT04136912|UNC Lineberger Comprehensive Cancer Center|Desma Jones|(919) 843-9463|desma_jones@med.unc.edu|
22310033|NCT03606408|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
22310034|NCT03556293|Dartmouth College|Dr. Jeremiah Brown|(603) 646-5409|jeremiah.r.brown@dartmouth.edu|
22310035|NCT03292484|Aimmune Therapeutics, a Nestlé Health Science Company|Jay Patel|(800) 422-2752|jay.patel@uk.nestle.com|
22310036|NCT05419830|University of Pittsburgh|Shachi Tyagi, MD, MS|4126471274|sht55@pitt.edu|
22310037|NCT05012163|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
22310038|NCT05062330|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22310039|NCT02567409|City of Hope|Paul Frankel. Ph.D.|626-218-5265|pfrankel@coh.org|
22310040|NCT03092453|University of Pennsylvania|Regulatory Lead|215-573-7101|psom-ind-ide@pobox.upenn.edu|
22310041|NCT05524402|Massachusetts General Hospital|Dr. Jonathan Greenberg|617-643-9402|jgreenberg5@mgh.harvard.edu|
22310042|NCT05976334|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22310043|NCT03381586|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22310044|NCT01130519|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
22310045|NCT03703908|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
22310046|NCT05280574|Outcomes Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio|Daniel I. Sessler MD, Professor and Michael Cudahy Chair|216-870-2620|DS@OR.org|
22310047|NCT05363163|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
22310048|NCT04180462|Washington University School of Medicine|Allison King, M.D., Ph.D., MPH|314-454-4291|king_a@wustl.edu|
22310049|NCT03931408|University of Louisville|Dr. Harkema|502-582-7676|lori.clark2@louisville.edu|
22310050|NCT02224144|Columbia University|Thomas Nickolas MD, MS|2123053273|tln2001@cumc.columbia.edu|
22310051|NCT03505008|Keio University School of Medicine|Prof. Y Kaneko|+81-3-5363-3786|ykaneko@z6.keio.jp|
22310052|NCT02827838|Wake Forest Baptist Comprehensive Cancer Center|Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
22310053|NCT03980925|MFAR Clinical Research|Federico Nepote|+34 93 434 44 12|investigacion@mfar.net|
22310054|NCT05130814|Emoled srl|Duccio Rossi Degl'Innocenti|+390550751960|d.rossi@emoled.com|
22310055|NCT03824366|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
22310056|NCT04068831|Memorial Sloan Kettering Cancer Center|Dr. Ritesh Kotecha, MD|646-422-4791|kotechar@mskcc.org|
22310057|NCT00323856|Grifols|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22279804|NCT04207320|University of Chicago|Dr. John Cunningham|773-702-6808|jcunning@bsd.uchicago.edu|
22310058|NCT04538378|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22279805|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org|
22310059|NCT04086121|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310060|NCT03825588|University of Texas Southwestern Medical Center, University of Pittsburgh|Dr. Beth Dohoney Kennard; Dr. David Brent|214.456.4244|beth.kennard@utsouthwestern.edu|
22310061|NCT02834390|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22310062|NCT03118518|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
22310063|NCT04667468|University of Pittsburgh|Dr. Jason Sperry|412-215-7025|sperryjl@upmc.edu|
22310064|NCT06029452|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310065|NCT01726257|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
22310066|NCT04750941|Columbia University|Jennifer E. Amengual, MD|212-326-5720|jea2149@cumc.columbia.edu|
22310067|NCT03106740|Massachusetts General Hospital|Marco Loggia|(617) 643-7267|marco.loggia@mgh.harvard.edu|
22310068|NCT01064440|Helixmith, Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310069|NCT04797858|University of Pennsylvania|Robert Gross|2158982437|grossr@pennmedicine.upenn.edu|
22310070|NCT03426891|Moffitt Cancer Center|Dr. Peter Forsyth|813-745-3063|Peter.Forsyth@moffitt.org|
22310071|NCT01880515|Instituto Nacional de Cancerología de México|Oscar Gerardo Arrieta Rodriguez|+52 1 55 56 28 04 00|ogar@unam.mx|71101
22310072|NCT05361031|Helixmith, Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310073|NCT03505710|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
22310074|NCT04414722|Dept. of Family Medicine, Georgetown University Medical Center|Dan Merenstein, Director of Research Programs|202-687-1600|djm23@georgetown.edu|
22310075|NCT04766892|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22310076|NCT03085719|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-582-8731|Jonathan_Schoenfeld@dfci.harvard.edu|
22310077|NCT02584647|Columbia University|Gulam A. Manji|212 305 0592|gam2140@cumc.columbia.edu|
22310078|NCT05290493|Nobias Therapeutics, Inc.|Patrick Dougherty|(215) 821-4698|dougherty@nobiastx.com|
22310079|NCT04003246|University of Texas Southwestern Medical Center|Dr. Yuanyuan Zhang|2146458525|yuanyuan.zhang@utsouthwestern.edu|
22310080|NCT03914742|Johns Hopkins University|Program Manager Adult Brain Tumor Consortium (ABTC) and Brain Cancer Program|410-955-8837|jfisher@jhmi.edu|
22310081|NCT05735652|Boston Scientific|Taimin.Yue|18911590729|Taimin.yue@bsci.com|
22310082|NCT03154190|Stanford University School of Medicine|Manali Patel|650-723-4000|manalip@stanford.edu|
22310083|NCT03673501|Deciphera Pharmaceuticals, LLC|INTRIGUE Clinical Team|781-209-6400|clinicaltrials@deciphera.com|
22310084|NCT05838027|University of Pennsylvania|Eva Fabian|760-791-2633|eva.fabian@pennmedicine.upenn.edu|
22310085|NCT05237284|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22310086|NCT04599634|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22310087|NCT05776875|Yale University|Wei Cheng|203-737-7005|w.cheng@yale.edu|
22310088|NCT06193070|Fred Hutchinson Cancer Center|Dr. Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
22310089|NCT04526886|Dartmouth Hitchcock Medical Center|Gabriel Brooks|(603) 650-4344|gabriel.a.brooks@hitchcock.org|
22310090|NCT05046639|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22310091|NCT03276676|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
22310092|NCT04753788|LSHTM|Professor Michael Marks|+44020 7636 8636|michael.marks@lshtm.ac.uk|
22310093|NCT05015751|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
22310094|NCT02962076|Mercy Research|Michelle Bryant, MPH|314-251-8827|michelle.bryant@mercy.net|
22310095|NCT05482360|University of Washington|Anjuli Wagner, PI|978 460 2331|anjuliw@uw.edu|
22310096|NCT04723147|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
22310097|NCT03580356|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
22310098|NCT05715528|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22310099|NCT03331835|LEO Pharma AS|Clinical Disclosure|(+1) 877-557-1168|disclosure@leo-pharma.com|
22310100|NCT03485729|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22310101|NCT05035654|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
22310102|NCT05848947|Sirtex Medical|Janet Bell, Director, Clinical Research Operations|978-866-1798|jbell@sirtex.com|
22310103|NCT04204083|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22310104|NCT05533190|The Institute of Cancer Research|Prof Ceire Costelloe|20 3437 6777|ceire.costelloe@icr.ac.uk|
22310105|NCT05552508|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310106|NCT05814211|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
22310107|NCT04451772|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22310108|NCT04311632|ITB-MED LLC|Jesse Scott, MPH|+46 8 410 02 887|KTX@itb-med.com|
22310109|NCT05856435|Cincinnati Children's Hospital Medical Center|Katie Nause|513-803-1506|Katie.Fox@cchmc.org|
22310110|NCT04632225|Helixmith Co, Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310111|NCT03812289|OHSU Knight Cancer Institute|Nima Nabavizadeh, MD|503-418-3685|nabaviza@ohsu.edu|
22310112|NCT02484430|Mayo Clinic|Aref Al-Kali, M.D.|(507) 284-2511|alkali.aref@mayo.edu|
22310113|NCT03421340|Boston Scientific|Pooja Goswamy|15086834335|pooja.goswamy@bsci.com|
22268897|NCT05333601|Nemours Children's Health|Dr. Kimberly Canter|3026514501|kimberly.canter@nemours.org|
22310114|NCT05660434|West Virginia University|Dr. Marian Reven, PhD, RN, AHN-BC, CNE, RA|304-293-3399|marian.reven@hsc.wvu.edu|
22310115|NCT00780494|Stanford University|Pamela Kunz|650-725-8738|pkunz@stanford.edu|
22310116|NCT05664958|Duke Unversity School of Medicine|Ashraf Haib|919-668-2024|ashraf.habib@duke.edu|
22310117|NCT01199133|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 29 70|mroux@stallergenes.com|
22297261|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu|
22297262|NCT03373383|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22297263|NCT02689258|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22297264|NCT03317431|Department of Anesthesia,Xinhua hospital affiliated to Shanghai Jiaotong University School of Medicine|Dr.Lai Jiang|021-25078999|jianglaimz@sina.com|
22297265|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22297266|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22297267|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu|
22297268|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
22297269|NCT00544076|City of Hope|Laura Crocitto, M.D.|626-218-3708|lcrocitto@coh.org|
22297270|NCT02907359|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22297271|NCT03131440|Northwestern University|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
22297272|NCT03892460|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
22297273|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22297274|NCT01805024|Santhera Pharmaceuticals|Roxana Drake|+41 61 906 89 29|roxana.drake@santhera.com|
22297275|NCT00176592|Rutgers New Jersey Medical School|Stuart Cook, MD|973-972-2550|cooksd@njms.rutgers.edu|
22297276|NCT03742141|Icahn School of Medicine at Mount Sinai|Dr. David Steinmetz|646-831-5950|dsteinmetz0@gmail.com|
22297277|NCT01566448|West Virginia University Hospitals|Aaron Cumpston|304-598-4000|cumpstona@wvumedicine.org|73350
22297278|NCT02180412|University of Texas Medical Branch, Galveston|Dr. Karl Anderson, MD|409-772-9092|kanderso@utmb.edu|
22297279|NCT04654117|Department of Psychology, Michigan State University|Dr. Brooke Ingersoll, Professor|517-432-8412|ingers19@msu.edu|
22297280|NCT01354496|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22297281|NCT01209442|University of Colorado|Douglas Ney, M.D.|303-724-2184|Douglas.Ney@ucdenver.edu|
22297282|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297283|NCT03352323|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22297284|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22297285|NCT03717480|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-6256|vincent_ho@dfci.harvard.edu|
22297286|NCT02741700|VA ORD: Birmingham VA Medical Center|Dr. Jasvinder Singh|205-934-3235|jasvinder.md@gmail.com|
22297287|NCT05265260|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22297288|NCT01774786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22297289|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22297290|NCT04544293|Savara Inc.|Raymond D Pratt, MD FACP|512 614 1848|ray.pratt@savarapharma.com|
22297291|NCT05045144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297292|NCT02385084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297293|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22297294|NCT02268786|Illumina|Tasha Kalista|858-202-4500|tkalista@illumina.com|
22297295|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
22297296|NCT04809220|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22297297|NCT02535845|The University of Chicago|Dr. Jasmin Tiro|773-834-4384|jtiro@bsd.uchicago.edu|
22297298|NCT01062555|University of Minenesota|Arthur Matas|612-625-5151|matas001@umn.edu|
22297299|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297300|NCT01218555|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
22297301|NCT03299842|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22297302|NCT04380857|Cleveland Eye Clinic|Kathleen Jee, MD|440-526-1974|kjee@midwestvision.com|
22297303|NCT02558790|Massachusetts General Hospital|Craig Surman, MD|617-726-8422|csurman@partners.org|
22297304|NCT05083442|Mayo Clinic Rochester|Dr. Ivana Croghan|507 284-2511|gimresearchstudies@mayo.edu|
22297305|NCT03878316|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
22297306|NCT03961100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22297307|NCT04865354|Alcon Research, LLC|Sr. Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22297308|NCT02945410|Technical University of Munich|Dr. Karsten Koehler|+49 89 289 24488|karsten.koehler@tum.de|
22297309|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu|
22297310|NCT04200248|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
22297311|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899|jiajp@vip.sina.com|8650
22297312|NCT01886833|CIDRZ|Dr. Roma Chilengi|+2609173724935|Roma.Chilengi@cidrz.org|
22297313|NCT04476030|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22297314|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22297315|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22297316|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org|
22297317|NCT04033003|University of Michigan, School of Nursing|Jody R. Lori PhD, Associate Dean for Global Affairs, Director, PAHO/WHO Collaborating Center|734-763-0097|jrlori@med.umich.edu|
22297318|NCT02919670|DFCI|Kelly Masone|6176324167|kmasone@partners.org|
22297319|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com|
22297320|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com|
22297321|NCT01675882|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
22323456|NCT04082663|Washington University School of Medicine|Dr. Gammon Earhart|314-286-1407|earhartg@wustl.edu|
22323457|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22323458|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22323459|NCT02497001|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|1-877-240-9479|information.center@astrazeneca.com|
22323460|NCT05501119|Medical University of South Carolina|Dr. Diana Layne|(843) 792-8515|layne@musc.edu|
22323461|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
22323462|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22323463|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu|
22323464|NCT03961360|The University of Texas Health Science Center at Houston|Farah Amro, MD|713-500-6421|farah.h.amro@uth.tmc.edu|
22323465|NCT02440581|University of Kentucky|Division Administrator|859-218-4943|daniel.ormond@uky.edu|
22323466|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323467|NCT01468987|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323468|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org|
22323469|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22323470|NCT01245673|University of Pennsylvania|Liz Veloso|215|eveloso@pennmedicine.upenn.edu|
22323471|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323472|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22323473|NCT04152824|Oregon Health & Science University|Dr. Leslie Hammer|503-494-9313|hammerl@ohsu.edu|
22323474|NCT01459614|Sidney Kimmel Comprehensive Cancer Center|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
22323475|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu|
22323476|NCT05391438|Children's Hospital Los Angeles|Alaina Vidmar|3236614606|avidmar@chla.usc.edu|
22323477|NCT01629615|SOLTI|Scientific Manager|(+34) 93 343 63 02|pamela.celiz@gruposolti.org|
22323478|NCT02078219|Study Information Center AstraZeneca|Fredrik Erlandsson, MD|+1 877-240-9479|information.center@astrazeneca.com|
22323479|NCT03639948|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
22323480|NCT03036527|University of Louisville|Charles Hubscher|502-852-3058|charles.hubscher@louisville.edu|
22323481|NCT03283085|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22323482|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22323483|NCT04533711|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22323484|NCT02689492|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323485|NCT01750918|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22268898|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu|
22323486|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
22323487|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22323488|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
22323489|NCT02338843|La Jolla Pharmaceutical Company|George Tidmarsh, MD, PhD|858-207-4264|gtidmarsh@ljpc.com|
22323490|NCT04246554|UH Cleveland Medical Center|Dr. Michael Karns|216-844-7200|srmengers@gmail.com|
22323491|NCT04646148|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
22323492|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu|
22323493|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
22323494|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com|
22323495|NCT03124459|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323496|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012||
22323497|NCT03932812|University of Iowa|Sato Ashida|319-384-1477|sato-ashida@uiowa.edu|
22323498|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22323499|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de|
22323500|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323501|NCT03575104|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
22323502|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu|
22323503|NCT01479348|National Cancer Institute|Dr. Karen Kurdziel|804-897-1207|kurdziek@nih.gov|
22323504|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300||
22323505|NCT03293654|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
22323506|NCT01919307|Denver Health and Hospital Authority|Edward Maa|303-602-5099|Edward.Maa@dhha.org|
22268899|NCT02199964|Baylor College of Medicine|Stephen Pflugfelder, M.D.|713-798-6100|stevenp@bcm.edu|
22268900|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590||
22268901|NCT05267236|Midwest Evaluation and Research|Midwest Evaluation and Research|620-208-6143|mer@midwestevaluation.com|
22268902|NCT02883062|Washington University School of Medicine|Dr. William Gillanders|314-747-0072|gillandersw@wustl.edu|
22268903|NCT04578535|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22323507|NCT03742427|Marmara University|Sinan KARACABEY|+902166254545|karacabeysinan@gmail.com|
22268904|NCT03839628|The University of Utah|Micah Drummond|801-213-2737|micah.drummond@hsc.utah.edu|
22323508|NCT05052723|University of Kentucky|Dr. Joseph Kim|859-257-4490|joseph.kim@uky.edu|
22268905|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22297322|NCT03405142|Stanford Medicine at Stanford University|Roan Courtney Raymundo|650-721-4071|rcraymun@stanford.edu|
22297323|NCT01446965|University of California, San Francisco|Jeffrey Olgin, MD|415-476-1000|jeffrey.olgin@ucsf.edu|
22323509|NCT04526730|Moffitt Cancer Center|Ahmad Tarhini, MD, PhD|813-745-8581|Ahmad.Tarhini@moffitt.org|
22323510|NCT02771522|Calcivis Ltd|Director of Clinical Research|+44 131 658 5152|mwillins@calcivis.com|
22323511|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
22323512|NCT03049449|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22323513|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
22323514|NCT02737163|Johns Hopkins All Children's Hospital|Gerald Tuite, MD|7277678181|gtuite1@jhmi.edu|
22323515|NCT00701714|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22323516|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu|
22323517|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323518|NCT04354428|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
22323519|NCT01963481|NYU Langone Health|Sylvia Adams|212 731 5795|Sylvia.Adams@nyulangone.org|
22268906|NCT03380429|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22268907|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22268908|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22268909|NCT02314026|Exalenz Bioscience|Clinical trial manager|97289737513|avrahamh@exalenz.com|
22268910|NCT01139775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22268911|NCT02774941|Children's Health - Children's Medical Center, Dallas|Clinical Research Coordinator - Respiratory Care Dept|214-456-1367|gerald.moody@childrens.com|
22297324|NCT02719158|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22323520|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net|
22323521|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22310118|NCT02575950|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22310119|NCT05080283|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22310120|NCT03993392|Indivior, Inc|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
22310121|NCT03100760|University of New Mexico Health Sciences Center|Justin Baca|505-272-5062|jtbaca@salud.unm.edu|
22310122|NCT05292391|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|(206)-442-5216|Lisa.A.Jackson@kp.org|
22310123|NCT00636389|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22310124|NCT04857723|CooperVision Inc.|Paul Chamberlain|+19257306754|pchamberlain@coopervision.com|
22310125|NCT04359654|University College London|Ms Donna Basire|+44-2031087748|d.basire@ucl.ac.uk|
22310126|NCT04738591|Health Research Institute of the Balearic Islands (IdISBa)|Dr. Rocío Zamanillo Campos|971175897|rocio.zamanillo@ssib.es|
22310127|NCT03711474|West Virginia University|Scott Daffner, MD|304-293-1172|sdaffner@hsc.wvu.edu|
22310128|NCT02446236|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22310129|NCT03677141|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22310130|NCT03018366|Mayo Clinic|Dr. Chrisandra Shufelt|904-953-7224|shufelt.chrisandra@mayo.edu|
22310131|NCT06038708|BIOTRONIK Italy|Paola Napoli, Clinical Project Manager|3357369277|paola.napoli@biotronik.com|0039
22310132|NCT04417998|Mayo Clinic|Bradley J. Kemp, Ph.D.|507-284-4399|Kemp.Brad@mayo.edu|
22310133|NCT03926130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22310134|NCT03583333|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310135|NCT01569659|Northwestern University|Herbert Meltzer, MD|312-503-9096|h-meltzer@northwestern.edu|
22310136|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22310137|NCT04587024|Johns Hopkins University|Dr. Cozumel S. Pruette|410-955-2467|csouthe1@jhmi.edu|
22310138|NCT05069896|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22310139|NCT05395871|Imperial College London|Amish Acharya|0203312 6666|aa2107@ic.ac.uk|
22310140|NCT04075318|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
22310141|NCT04605159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22310142|NCT02323880|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310143|NCT05599334|Pierre Fabre Médicament|Medical Director (Jeanne Suissa)|+33149108269|jeanne.suissa@pierre-fabre.com|
22310144|NCT04934072|Fresenius Kabi SwissBioSim GmbH|Clinical Development|+41 793075735|medinfo_biosim@fresenius-kabi.com|
22310145|NCT03631290|Duke University Medical Center|Rasheeda Hall, M.D.|919-660-6861|rasheeda.hall@duke.edu|
22310146|NCT05424380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22310147|NCT03204825|University of Stirling|Dr Chris Seenan|+441413318151|christopher.seenan@stir.ac.uk|
22310148|NCT03624465|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22310149|NCT03213678|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310150|NCT04218851|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22310151|NCT03174275|University of North Carolina Lineberger Comprehensive Cancer Center|Dr. Jared Weiss|+1 919-843-7718|jared_weiss@med.unc.edu|
22310152|NCT02413489|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310153|NCT03717935|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
22310154|NCT05970861|Asfendiyarov Kazakh National Medical University|Prof. Abdugani Musayev|+77772509406|musaev.dr56@gmail.com|
22310155|NCT04456296|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22310156|NCT05736458|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22310157|NCT02990338|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22310158|NCT04011644|Dept of Family Medicine and Community Health, UW-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
22310159|NCT05493852|Boston Scientific|Dr Xiuyue Jia|+86 15104673346|xiuyue.jia@bsci.com|
22310160|NCT04874948|Klinikum der Universität München (LMU)|Dr. med. vet. Julia Dreisbach|+49 89 4400|julia.dreisbach@med.uni-muenchen.de|59825
22310161|NCT05100628|Noxopharm|Lorena Figueroa, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
22310162|NCT03914469|UT Southwestern Medical Center|Dr. Makris|214 648 3133|una.makris@utsouthwestern.edu|
22310163|NCT03717753|Hospital for Special Surgery|Dr. Jacques YaDeau, MD PhD|212- 606-1206|yadeauj@hss.edu|
22310164|NCT04588415|University of Ottawa|Dr. James Downar|613 562 6262|jdownar@toh.ca|1502
22310165|NCT03655080|Washington University School of Medicine|Hiram A. Gay, M.D.|314-362-8516|hiramgay@wustl.edu|
22310166|NCT05408663|Extend Biosciences|Laura Hales PhD|(732) 599-8581|lhales@extendbio.com|
22310167|NCT03334695|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310168|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010|dbordley@its.jnj.com|8604
22323522|NCT03700047|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
22310169|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com|
22310170|NCT04984590|OnPoint Vision Inc.|Head of Clinical|949-688-0660|larcher@onpoint-vision.com|
22310171|NCT04614948|Janssen Vaccines & Prevention B.V.|VICE PRESIDENT Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310172|NCT04271046|Kaiser Permanente Washington Health Research Institute|Robert Penfold|206-287-2232|robert.b.penfold@kp.org|
22310173|NCT01570361|Johnson & Johnson Medical N.V., Biosense Webster|Liesbeth Vanderlinden|+32 (0) 2 746 3446|lvanderl@its.jnj.com|
22279806|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu|
22279807|NCT04031729|Massachusetts General Hospital|Dr. Tracey Simon|617-724-2401|tgsimon@partners.org|
22279808|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
22279809|NCT02148588|Washington University School of Medicine|Simon Haroutounian|3142861715|simon.haroutounian@wustl.edu|314
22279810|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org|
22279811|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
22310174|NCT04129554|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310175|NCT05158504|IstanbulSBU|HKARTAL|05378870982|kartal_hilal@yahoo.com|
22310176|NCT03309644|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22310177|NCT03606512|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310178|NCT05513937|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|055 5680459|pfabrizzi@menarini.it|+39
22310179|NCT02846545|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310180|NCT06468982|Atatürk University|Dr. Ümit Arslan|05418209007|kvcumit@gmail.com|
22279812|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
22310181|NCT02326974|Dana-Farber Cancer Institute|Project Manager|617-632-3500|ctopm@dfci.harvard.edu|
22310182|NCT04181736|Stanford University|Laura Hack, MD, PhD|650-724-7478|lhack@stanford.edu|
22310183|NCT04924400|Geisinger|Dr. Thomas Morland|703-593-0088|tmorland@geisinger.edu|
22310184|NCT05215613|Zimmer Biomet|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
22310185|NCT04633538|Oxford University Hospital|Dr Elizabeth Orchard|01865223084|elizabeth.orchard@ouh.nhs.uk|
22310186|NCT04230681|Washington University|Dr. Greg Miller|314-454-6000|g.c.miller@wustl.edu|
22310187|NCT04565990|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22279813|NCT02951780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22279814|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22279815|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22279816|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu|
22279817|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
22279818|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com|
22279819|NCT03508050|Institut universitaire de cardiologie et de pneumologie de Québec|Dr Jean S. Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|
22310188|NCT05507333|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
22310189|NCT03963518|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Carine Bellera|+33556333333|c.bellera@bordeaux.unicancer.fr|
22310190|NCT01960452|University of Wisconsin|Meredith Rumble, PhD|608-232-3171|rumble@wisc.edu|
22310191|NCT03981926|University of California, Los Angeles|April W. Armstrong, MD, MPH; Professor and Chief of Dermatology|424-365-4129|skinstudy@mednet.ucla.edu|
22310192|NCT03804788|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
22310193|NCT05716763|Unither-Pharmaceuticals|Non-clinical & clinical Project Manager|33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22310194|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22310195|NCT04466098|University of Minnesota, Masonic Cancer Center|Dr. David Ingbar|612-624-9452|ingba001@umn.edu|
22310196|NCT04820322|INQUIS Clinical Research|Principal Scientist|4168619177|twolever@inquis.com|
22310197|NCT04209595|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22310198|NCT03156465|University of Iowa|Camille Dunn|319-353-8776|camille-dunn@uiowa.edu|
22310199|NCT04200313|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|kruedy@jaeb.org|
22310200|NCT05524116|Boston University|Dr. Deepak Kumar|3026901455|kumard@bu.edu|
22310201|NCT04380337|Stanford University|Dr. Erqi Pollom|650-498-0484|erqiliu@stanford.edu|
22310202|NCT03181516|Georgetown University Medical Center|Dr. Daniel Merenstein|2026872745|djm23@georgetown.edu|
22310203|NCT04444518|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
22268912|NCT01882985|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
22268913|NCT03197389|University Hospitals Leuven|Prof. Dr. Ann Smeets|003216340903|hanne.vos@uzleuven.be|
22268914|NCT03193853|Baylor Scott and White Health|Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
22268915|NCT04129125|Imperative Care|Didem Aksoy, Senior Director of Clinical Affairs|650-644-8293|daksoy@imperativecare.com|
22268916|NCT06684951|AlNahrain university|Omaima Ismail Khalaf|9647831475217|khokh7871@gmail.com|
22268917|NCT02547012|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22268918|NCT00204490|University of Texas Medical Branch Galveston|Dr. Lee Jane W. Lu|409-772-1730|llu@utmb.edu|
22268919|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org|
22268920|NCT03477006|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
22268921|NCT02174627|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22268922|NCT02166333|Johns Hopkins University|Dr. Lawrence Appel|410-955-4156|lappel@jhmi.edu|
22323523|NCT04340050|University of Chicago|Leila Yazdanbakhsh|773-834-5087|leila.yazdanbakhsh@bsd.uchicago.edu|
22268923|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22268924|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net|
22268925|NCT01766076|Makarere University|Damalie Nakanjako|41407000|dnakanjako@gmail.com|249
22268926|NCT02245516|Kala Pharmaceuticals Inc|VP, Clinical Development||results004@kalarx.com|
22268927|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu|
22268928|NCT03644342|Baylor College of Medicine|Michelle S. Ludwig, MD, MPH, PhD|713-566-3662|Michelle.Ludwig@bcm.edu|
22268929|NCT00762710|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
22268930|NCT02462603|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22268931|NCT01831635|Queen's University Belfast|Dr Lesley Anderson|02890632315|l.anderson@qub.ac.uk|
22268932|NCT02716714|Korea University Ansan Hospital|Ilhwan Kim|+82314125986|kumcihk@korea.ac.kr|
22268933|NCT01991743|Northwestern University|Dr. Robert J McCarthy|312-695-4976|r-mccarthy@northwestern.edu|
22268934|NCT01769573|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
22323524|NCT01295125|University Hosptials Cleveland Medical Center|Dr. Michael Rosen|216-396-9937|rosenm@ccf.org|
22323525|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590||
22323526|NCT01355289|Eisai Call Center|Eisai Inc.|888-422-4743||
22323527|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22323528|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22323529|NCT03773302|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|PROOF301.ct@qedtx.com|
22323530|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
22323531|NCT03954626|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22323532|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22268935|NCT04955691|Yale school of Medicine|Laura Nally|203-785-5831|laura.nally@yale.edu|
22268936|NCT05336227|University of Alabama at Birmingham|Byron Lai|205.638.9790|blai@uabmc.edu|8-9725
22268937|NCT05086744|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22268938|NCT04050462|NYU Langone Health|Nina Beri, MD|212-731-5770|nina.beri@nyulangone.org|
22268939|NCT04042467|Vanderbilt University Medical Center|Filoteia Popescu|615-875-9083|filoteia.popescu@vumc.org|
22268940|NCT05151744|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22268941|NCT04053868|University of California San Francisco|Dr. Neal Benowitz|628-206-8324|neal.benowitz@ucsf.edu|
22268942|NCT05731700|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
22268943|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22268944|NCT01682226|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
22268945|NCT03375918|UMass Chan Medical School|Jennifer Tjia|774-455-3538|jennifer.tjia@umassmed.edu|
22268946|NCT03771898|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22268947|NCT03123120|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268948|NCT03507608|Johns Hopkins SOM, Dept of Radiation Oncology|Dana Kaplin|443-690-7007|dkaplin1@jh.edu|
22268949|NCT03135548|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268950|NCT02632175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22268951|NCT02088554|Medtronic|Jessica Halverson, Director of Clinical Research|(800) 633-8766|rsperigonpivotaltrial@medtronic.com|
22268952|NCT04623216|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
22268953|NCT05022667|University of Michigan Medical Center|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
22268954|NCT03521154|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22268955|NCT05468164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22268956|NCT04632927|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
22268957|NCT03827291|Duke University|Amanda Kumar, MD|919-681-6437|amanda.kumar@duke.edu|
22268958|NCT04795466|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22268959|NCT04286269|University of Minnesota|Sonya Wang|612-301-1454|sgwang@umn.edu|
22268960|NCT04526639|University of Massachusetts Lowell|Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
22268961|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com|
22323533|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu|
22323534|NCT03838484|Vanderbilt University Medical Center|Alan S. Lewis, M.D., Ph.D.|615-875-4027|alan.s.lewis@vumc.org|
22297325|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297326|NCT02016482|AbbVie|Global Medical Services|800-633-9110||
22297327|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22297328|NCT00594061|University of Iowa|Bruce Gantz|319-353-8776|bruce-gantz@uiowa.edu|
22297329|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu|
22297330|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu|
22297331|NCT00537446|Columbia University Irving Medical Center|Robert Basner, MD||rcb42@cumc.columbia.edu|
22297332|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22297333|NCT04960228|Lady Davis Institute for Medical Research|Ben Haward, Research Assistant|514-340-8222|ben.haward@ladydavis.ca|23978
22297334|NCT02547129|Mayo Clinic|Dr. Michael J. Taunton|507-284-7692|Taunton.Michael@mayo.edu|
22297335|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350|aserrano@pssjd.org|12215
22297336|NCT01640366|Smith & Nephew Inc|Rachael Winter, Director of Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
22297337|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22297338|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu|
22297339|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it|
22297340|NCT03745144|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
22297341|NCT04681482|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297342|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22297343|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com|
22297344|NCT04697693|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
22297345|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org|
22297346|NCT02531321|University of Southern California|Dr. Nicole Bender|3234093416|nicole.bender@med.usc.edu|
22297347|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com|
22297348|NCT01113879|The Ohio State University|Stacy Harnish|614-688-1471|harnish.18@osu.edu|
22297349|NCT04151290|Cognoa|Senior Director Clinical Research|4082076659|minda.seal@cognoa.com|
22297350|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
22297351|NCT03007758|Prisma Health|Abby Birrell, Study Coordinator|8645222117|abby.birrell@prismahealth.org|
22297352|NCT00082433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22297353|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr|
22297354|NCT01796197|Dana-Farber Cancer Institute|Beth Overmoyer, MD, FACP|617.632.3800|beth_overmoyer@dfci.harvard.edu|
22297355|NCT04097821|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22297356|NCT02214277|Claret Medical|Director of Clinical Research|707-528-9300|info@claretmedical.com|
22297357|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297358|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22297359|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22297360|NCT02776917|University of California, San Diego|Barbara Parker, MD|(858) 657-6100|baparker@health.ucsd.edu|
22297361|NCT02818218|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
22297362|NCT05965349|University of Washington|Dr. Linda Ko|2066854978|lindako@uw.edu|
22297363|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22297364|NCT02970968|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22297365|NCT03003520|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22297366|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297367|NCT04982029|Brigham and Women's Hospital|Dr. Joji Suzuki|617-455-7981|jsuzuki2@bwh.harvard.edu|
22297368|NCT03264404|Columbia University|Ruth White, MD, PhD|212-342-5162|raw2168@cumc.columbia.edu|
22297369|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu|
22297370|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
22297371|NCT04615949|CardiolRx|Andrea B. Parker, MSc. PhD, Senior Director Clinical Operations|+1 289 9100862|andrea.parker@cardiolRx.com|
22297372|NCT03036566|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
22297373|NCT05458856|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22297374|NCT04625803|The First Affiliated Hospital, Zhejiang University School of Medicine|Weijia Fang|+86 87235147|weijiafang@zju.edu.cn|
22297375|NCT05087875|University of Kentucky|Carolyn Lauckner|8595623335|carolyn.lauckner@uky.edu|
22297376|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297377|NCT03661814|Icahn School of Medicine at Mount Sinai|Dr. Joel Bauer|914-715-4242|jjb.msh@gmail.com|
22297378|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com|
22297379|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774|hila.debby@givenimaging.com|7774
22323535|NCT01900002|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD, Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
22297380|NCT03711162|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22297381|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297382|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com|
22297383|NCT03240133|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22297384|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22297385|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297386|NCT04904185|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
22297387|NCT02061969|Emory University|Saumeth Cardona MD|404-616-4827|scardon@emory.edu|
22297388|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22297389|NCT03567850|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kristopher.Attwood@roswellpark.org|
22297390|NCT01127503|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
22323536|NCT01614964|Tulane University|Jeffrey G Shaffer|504-988-1142|jshaffer@tulane.edu|
22323537|NCT03618030|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|Sailaja.Bhaskar@ImbriumThera.com|
22323538|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu|
22323539|NCT03689192|National Center for Cancer Immune Therapy|Cathrine Lund Lorentzen|004538683868|cathrine.lund.lorentzen@regionh.dk|
22323540|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22323541|NCT03705481|Corindus, Inc.|John Van Vleet, VP Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
22323542|NCT01032629|Janssen- Cilag International NV|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22323543|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66||
22323544|NCT02633540|Fox Chase Cancer Center|Dr. Thomas Galloway|215-728-5536|Thomas.Galloway@fccc.edu|
22323545|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22323546|NCT00723957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22323547|NCT01763164|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297391|NCT02129075|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
22297392|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300||
22297393|NCT00935428|OHSU|Dr. John Mayberry|503-494-5300|mayberrj@ohsu.edu|
22297394|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com|
22297395|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22297396|NCT00735371|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22297397|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
22297398|NCT00112242|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof Olivier Michielin|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
22297399|NCT01987427|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22323548|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590||
22323549|NCT02965378|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22323550|NCT04964258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22323551|NCT03384329|Institute of Physiology and Basic Medicine|Dr. Lyubomir Aftanas|+7-913-912-2228|liaftanas@gmail.com|
22323552|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22323553|NCT03670030|Ochsner Medical Center|Robert Ramirez, DO|504-464-8500|awendt@ochsner.org|
22323554|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010|anna.r.pont@gmail.com|21283
22268962|NCT02955355|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22297400|NCT04630093|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
22323555|NCT01285349|Social Intervention Group|Dr. Nabila El-Bassel|212-851-2391|ne5@columbia.edu|
22268963|NCT02612623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22268964|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22268965|NCT03168711|Massachusetts General Hospital|Dr. Sabrina Paganoni|617-724-3914|spaganoni@mgh.harvard.edu|
22268966|NCT02506868|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22268967|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu|
22268968|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22268969|NCT01671007|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22268970|NCT03877068|Emory University|Guillermo E. Umpierrez, MD|404-778-1665|geumpie@emory.edu|
22268971|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu|
22268972|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
22268973|NCT03252535|Cellavita|Cristiane Valverde Wenceslau|+55 (19) 3829.0849|cristiane.valverde@cellavitabrasil.com.br|
22268974|NCT03922308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22268975|NCT00506415|Novartis|Study Director|862 778 8300||
22268976|NCT02198664|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22268977|NCT02632409|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22268978|NCT04426006|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22268979|NCT06180122|Imperial College Healthcare NHS Trust|Sophie Connolly|02033117322|sophie.connolly1@nhs.net|
22297401|NCT04590547|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
22323556|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu|
22323557|NCT03040024|Emory University|Dr. Amit Prabhakar|404-686-2747|amit.prabhakar@emory.edu|
22323558|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu|
22323559|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org|
22323560|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu|
22323561|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
22323562|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700|mdfatihkilinc@yahoo.com|3724
22323563|NCT03633084|Ribomic USA|Yusuf Ali, Ph.D.|(707) 287-4313|yusuf.ali@ribomic.com|
22323564|NCT02914509|Ocular Therapeutix, Inc.|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22323565|NCT03529409|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22323566|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300||
22323567|NCT03812172|Columbia University Irving Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
22323568|NCT06001307|Illinois Institute of Technology|Arryn Guy|312-567-6467|aguy1@iit.edu|
22323569|NCT02237235|Northwestern University|Herbert Y. meltzer|312-503-0309|h-meltzer@northwestern.edu|
22323570|NCT03532100|CLiMB|Glenn Klute, PhD|206.277.6724|Glenn.Klute@va.gov|
22323571|NCT03896581|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22323572|NCT04544566|Coloplast A/S|Head of Scientific Affairs|+45 4911 1111|clinicaltrialsgovSA@coloplast.com|
22323573|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu|
22323574|NCT03338556|PrEP Biopharm Limited|Chief Medical Officer|8666207176|info@prepbiopharm.com|0
22323575|NCT02660580|Fresenius Kabi SwissBioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
22323576|NCT05415449|Children's Medical Center|Maria Leal|2144560276|Maria.leal@childrens.com|
22323577|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu|
22323578|NCT02185521|Philips Healthcare|Dr. Szymon Bieganski|978-284-3271|szymon.bieganski@philips.com|
22323579|NCT04628936|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22323580|NCT01676831|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|deborah.leahy@uphs.upenn.edu|
22323581|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu|
22323582|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu|
22323583|NCT03062917|Imperial College NHS trust|Study PI Simon Nadel|02033126202|s.nadel@imperial.ac.uk|
22323584|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22323585|NCT04486560|Johns Hopkins University|Dr. Lonny Yarmus|410-502-5224|lyarmus@jhmi.edu|
22323586|NCT02357992|UT MD Anderson Cancer Center|Dr. Jack Roth, MD- Professor, Thoracic & Cardio Surgery-Rsch|(713) 792-7664|jroth@mdanderson.org|
22297402|NCT03799484|The University of Texas Health Science Center at Houston|Karina Richani-Reverol, MD|(713) 559-5200|Karina.RichaniReverol@uth.tmc.edu|
22297403|NCT04120610|Medtronic|Janki Shah|732-266-2503|janki.shah@medtronic.com|
22297404|NCT02129803|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
22297405|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22297406|NCT02356692|CooperVision|Donald Siegel, OD|602 485 3414|dsiegel@coopervision.com|
22297407|NCT03712410|University of Pennsylvania|George Demiris|2158988559|gdemiris@upenn.edu|
22297408|NCT01015586|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
22297409|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437|alberto.restrepo@piramal.com|315
22297410|NCT01465464|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22297411|NCT03395314|Yale School of Medicine|Sarah Fineberg, MD, PhD|(203) 974-7265|sarah.fineberg@yale.edu|
22297412|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com|
22297413|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
22297414|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
22297415|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22297416|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu|
22297417|NCT02739269|The University of Hong Kong|Dr. Raymond Li|+852 22554517|raymondli@hku.hk|
22297418|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de|
22297419|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22297420|NCT02136576|Tufts University School of Dental Medicine|Dr. Britta Magnuson|617-636-3878|britta.magnuson@tufts.edu|
22297421|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300||
22297422|NCT00923559|Dept of Women's and Children's Health, Karolinska Institutet|Björn Salomonsson|+46851777206|bjorn.salomonsson@ki.se|
22297423|NCT02268812|Eisai Europe Ltd.|Eisai Medical Services|+44 (0)20 8600 1400||
22297424|NCT04903249|Dartmouth-Hitchcock Medical Center|Courtney J. Stevens, PhD, Principal Investigator|603-650-9643|courtney.j.stevens@dartmouth.edu|
22297425|NCT01951157|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
22297426|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu|
22297427|NCT05218018|University of Washington|Angela Hanson|206-897-5393|hansonaj@uw.edu|
22268980|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297428|NCT04964128|Medtronic|Roseline Re|+33684520425|roseline.re@medtronic.com|
22323587|NCT00826748|Weill Cornell Medicine|Grace Mammen|646-962-2672|gwm2004@med.cornell.edu|
22323588|NCT03802721|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
22323589|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22323590|NCT01887912|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22323591|NCT04462536|NoNO Inc.|Michael Tymianski|6472932232|mtymianski@nonoinc.ca|
22323592|NCT02747927|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22323593|NCT04033926|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22323594|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323595|NCT06331884|4TEEN4 Pharmaceuticals|Kathleen Richter|0049 1784027078|richter@4teen4.de|
22279820|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22323596|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu|
22323597|NCT02472457|The Children's Hospital of Philadelphia|Ronen Stein, MD|215-590-7801|ibdresearch@email.chop.edu|
22323598|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300||
22323599|NCT03480802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323600|NCT01409928|UTSW|Olga T. Gupta|(214) 648-8718|olga.gupta@utsouthwestern.edu|
22323601|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22323602|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
22323603|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu|
22323604|NCT02557178|Mayo Clinic|Johanna Hoult|507-293-1989|hoult.johanna@mayo.edu|
22323605|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22323606|NCT00893516|Emergent Biosolutions|Clinical Development Representative||ctgov@ebsi.com|
22323607|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22323608|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu|
22323609|NCT00956930|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
22323610|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323611|NCT04355013|University Hospital of Salamanca|Dr. José A. Sastre|+34923291100|jasastre@saludcastillayleon.es|55580
22323612|NCT02348099|Gerontology Research Lab|Mr Boris Feldman, Research Associate|16048755115|boris.feldman@vch.ca|
22323613|NCT03898063|University of Miami|Nick Carcioppolo|3052845633|n.carcioppolo@miami.edu|
22323614|NCT03430986|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22323615|NCT03257189|MC10 Inc|Chief Medical Officer|8572145600|ACombs@mc10inc.com|
22323616|NCT00299988|Weill Cornell Medical College|Norman Relkin, MD, PhD|212-746-9882|nrelkin@med.cornell.edu|
22323617|NCT01889602|University of Minnesota|Dr. Susan Marino|612-624-2964|marin007@umn.edu|
22323618|NCT00961961|UPenn|Dr. Robert J. DeRubeis|215-573-5804|derubeis@psych.upenn.edu|
22323619|NCT01412957|Amgen Inc.|Study Director|866-572-6436||
22323620|NCT03035760|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22323621|NCT03120832|Senseibio|Ramzi Melhem MD Medical Director|9168336928|rmelhem@senseibio.com|
22323622|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000|thyfaultj@health.missouri.edu|53742
22323623|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org|
22323624|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
22323625|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22323626|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu|
22323627|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22323628|NCT03636906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22323629|NCT05070338|RAND Corporation|Katherine E. Watkins|310-393-0411|kwatkins@rand.org|6509
22323630|NCT03431467|The Hospital of the University of Pennsylvania|Dr. Christian Bermudez|2153165151|christian.bermudez@pennmedicine.upenn.edu|
22323631|NCT02292771|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22323632|NCT04596891|New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
22323633|NCT04280081|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22323634|NCT01468311|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|gconlonkc@mail.nih.gov|
22279821|NCT03894891|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
22279822|NCT04389866|Advanced Dermatology|Dr. Amy Forman Taub|8474596400|drtaub@advdermatology.com|
22279823|NCT01730872|Ora|Keith Lane|9786858900|klane@oraclinical.com|
22279824|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu|
22279825|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu|
22279826|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com|
22323635|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu|
22323636|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu|
22279827|NCT04940130|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick Duffy|301.761.5089|patrick.duffy@nih.gov|
22323637|NCT01133639|Mount Auburn|Emily Cook|(617) 354-3131|ecook@mah.harvard.edu|
22297429|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22323638|NCT02511522|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22323639|NCT03890679|Tufts Medical Center|Dr. Jonathan Davis|6176365322|jdavis@tuftsmedicalcenter.org|
22323640|NCT04854499|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22310204|NCT04544007|University of Alabama at Birmingham|Coretta Thomas, Scientist & Data Manager for NF Consortium|205-975-8629|coretta@uab.edu|
22310205|NCT06197360|Yangzhou University|Yueqi Zhao|13390676131|mz120221975@stu.yzu.edu.cn|
22310206|NCT03489434|Georgia State University|Amanda Gilmore|404-413-2000|agilmore12@gsu.edu|
22310207|NCT05791435|Nemours Children Health System|Tariq Rahman|302 651 6831|trahman@nemours.org|
22310208|NCT02874001|Institut Bergonié|S Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22310209|NCT02839265|Montefiore Medical Center|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
22310210|NCT02787031|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22310211|NCT06324344|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22310212|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310213|NCT04601480|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
22310214|NCT04186819|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
22310215|NCT03252288|University of South Carolina|Jan Ostermann|+1803-777-8747|jano@mailbox.sc.edu|
22310216|NCT00677365|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
22310217|NCT05900154|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310218|NCT00758862|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22310219|NCT04102111|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310220|NCT02542631|Johnson & Johnson Diabetes Companies|Brian Levy, MD-Chief Medical Officer|484 328-6128|BLevy1@its.jnj.com|
22310221|NCT02641730|Janssen Pharmaceutical K.K.|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310222|NCT05460871|University of Iowa Hospitals and Clinics|Dr. Lee Kral|(319) 384-6593|lee-kral@uiowa.edu|
22310223|NCT02938923|Washington University in St. Louis School of Medicine|Dr. Ellen F. Binder, Professor of Medicine and Occupational Therapy|314-286-2707|ebinder@wustl.edu|
22310224|NCT03663205|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22310225|NCT05932407|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22310226|NCT03582033|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22310227|NCT06010836|Johns Hopkins|Associate Professor|4109552611|jsampso4@jhmi.edu|
22310228|NCT03812614|University of Pittsburgh School of Medicine|Ann-Marie Rosland, MD, MS|412-648-5660|roslandam@pitt.edu|
22310229|NCT04923776|Columbia University|Brian Henick, MD|212-342-5162|bh2682@cumc.columbia.edu|
22310230|NCT04817176|Florida State University College of Medicine|Dr. Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
22310231|NCT03681912|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|850-644-2334|sylvie.naar@med.fsu.edu|
22310232|NCT03372057|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
22310233|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22310234|NCT05890105|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310235|NCT05117008|Medical College of Wisconsin|Meera Mohan MD, MS|414-805-4600|memohan@mcw.edu|
22310236|NCT04505410|University of Miami Miller School of Medicine|Associate Professor, Director of Translational Studies for the Crohn's and Colitis Center|3057733573|odamas@med.miami.edu|
22310237|NCT05123027|Medical University of South Carolina|Dr. Ralph Ward|843-876-6110|wardrc@musc.edu|
22310238|NCT05654662|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22310239|NCT04330040|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310240|NCT05962814|Bionics Institute|Prof Colette McKay|+61 408698202|cmckay@bionicsinstitute.org|
22310241|NCT03057054|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310242|NCT00696124|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310243|NCT04427007|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
22310244|NCT04998305|Columbia University|Hiroshi Mitsumoto, MD|212-305-1319|hm264@cumc.columbia.edu|
22310245|NCT05311176|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
22310246|NCT05247034|Universidad Anáhuac México Norte|Dr. Carlos Alberto Cuéllar Ramos|5556270210|carlos.cuellarra@anahuac.mx|8736
22310247|NCT03489122|VA Bedford Healthcare System|Administrative Officer/R&D|781-687-2903|karen.smith9@va.gov|
22310248|NCT03972150|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310249|NCT05879991|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310250|NCT02668692|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
22310251|NCT04267120|Washington University School of Medicine|Joel Picus, M.D.|314-362-9115|jpicus@wustl.edu|
22310252|NCT05464069|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
22310253|NCT03442309|New York University|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
22310254|NCT05320406|Emory University|Dr. Sagar Patel|404-778-1900|sagar.patel@emory.edu|
22310255|NCT05512650|Tufts University|Nancy Baker, Professor|617 627 5562|nancy.baker@tufts.edu|
22310256|NCT04615273|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
22310257|NCT05465239|Barron Associates, Inc.|Jason Burkholder|434-973-1215|burkholder@bainet.com|
22310258|NCT04197869|UCLA Health|Dr. Alexandra Goodwin|917-969-1654|zangoodwin@gmail.com|
22310259|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310260|NCT06106022|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22323641|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
22297430|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu|
22323642|NCT04091347|Johns Hopkins School of Nursing|Janiece Taylor|443-287-4503|jwalke90@jhu.edu|
22323643|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org|
22323644|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com|
22323645|NCT02601950|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22323646|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22323647|NCT01701258|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
22323648|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22323649|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu|
22297431|NCT01177540|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22297432|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil|
22297433|NCT04662801|Yale School of Medicine|Dr Valentina Ivezaj, Assistant Professor of Psychiatry|+1 (203) 785-7807|valentina.ivezaj@yale.edu|
22297434|NCT02323854|Medtronic|Dr. Jaime Kean|303-882-6759|Jaime.m.Kean@medtronic.com|
22297435|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net|
22297436|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
22297437|NCT00748215|University of Texas (UT) MD Anderson Cancer Center|Bryan Kee, MD/Assistant Professor, GI Medical Oncology|713-792-2828|bkkee@mdanderson.org|
22297438|NCT02013167|Amgen Inc.|Study Director|866-572-6436||
22297439|NCT03200925|Kettering Health Network|Catherine Caponero, DO|937-723-4124|catherine.caponero@ketteringhealth.org|
22297440|NCT05233566|Washington University School of Medicine|Dr. Bradley Fritz|3142733453|bafritz@wustl.edu|
22297441|NCT02620046|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22297442|NCT04476537|Columbia University|Gulam Manji, MD|212-342-5162|gam2140@cumc.columbia.edu|
22297443|NCT02280941|University of Ottawa Heart Institute|Dr. Terrence Ruddy|6136967000|truddy@ottawaheart.ca|7267
22297444|NCT04866771|University Of Illinois At Chicago|PRS Training Lead|(312) 996-4995|awards@uic.edu|
22323650|NCT05617521|Hospital Central Norte PEMEX|Dr. Antonio Marmolejo|+526142231826|dr.marmolejo.ch@gmail.com|
22323651|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca|
22323652|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323653|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu|
22323654|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22323655|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca|
22323656|NCT00486603|Adult Brain Tumor Consortium|Director of ABTC|410-955-3657|jfisher@jhmi.edu|
22323657|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca|
22323658|NCT03837184|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22323659|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com|
22323660|NCT01670994|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22323661|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu|
22323662|NCT01111604|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979||
22323663|NCT00758784|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22323664|NCT02494570|Aadi Bioscience|Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22323665|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22323666|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500|mjanse12@ITS.JNJ.com|1396
22323667|NCT02547623|Icon Bioscience, Inc.|Vice President, Quality and Compliance|510-933-8381||
22323668|NCT02849639|University of Kentucky|Daniela C Moga MD PhD, Associate Professor|859-323-9682|daniela.moga@uky.edu|
22323669|NCT02706938|Universidad Nacional de Colombia|Dr. Ivan Mauricio Villamil Morales|+573178755369|imvillamilm@unal.edu.co|
22323670|NCT02868892|WRMC|Jessica L. Coats|6233417220|jessica.coats@ctca-hope.com|
22323671|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu|
22323672|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu|
22323673|NCT01007526|Samsung Medical Center|Won Seog Kim|82234106548|wskimsmc@skku.edu|
22323674|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com|
22323675|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22323676|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
22323677|NCT03377634|Wake Forest University School of Medicine|Amber Brooks, MD|336-716-4498|akbrooks@wakehealth.edu|
22323678|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323679|NCT04525703|University of Wisconsin - Madison|Pajarita Charles, PhD|608-263-3834|paja.charles@wisc.edu|
22323680|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22323681|NCT03056443|West Virginia University|Robert Stansbury, MD|304-293-4661|rstansbury@hsc.wvu.edu|
22323682|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com|
22323683|NCT02452762|Children's Hospital of Eastern Ontario|James Dayre McNally, Principal Investigator and Pediatric Intensivist|613-737-7600|dmcnally@cheo.on.ca|3553
22268981|NCT04709562|Vapotherm Inc|Kathy Gerich|(585) 469-6753|kgerich@vtherm.com|
22297445|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu|
22279828|NCT02742129|Duke Clinical Research Institute|Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
22279829|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279830|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
22279831|NCT03175731|Qilu Hospital of Shandong University|Prof. Gao|+86-531-82169386|gaoyanjing@sdu.edu.cn|
22279832|NCT04881760|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22279833|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov|
22279834|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
22279835|NCT01595529|Westat|Dr. Elizabeth Rowley|(919) 941-8325|ElizabethRowley@westat.com|
22279836|NCT04016714|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279837|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279838|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net|
22279839|NCT03801993|Seattle Children's Hospital|Dr. Christopher H. Goss M.D., M.Sc.|(206) 987-5725|cgoss@uw.edu|
22279840|NCT04552041|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22279841|NCT03702179|SOGUG|A contact designated by the Sponsor|+34671422325|secretaria@sogug.es|
22279842|NCT04592341|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22279843|NCT01747915|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279844|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
22279845|NCT02499887|UBMD Emergency Medicine|Heather Lindstrom|716-898-4564|hlindstrom@ecmc.edu|
22279846|NCT02259725|USC / Norris Comprehensive Cancer Center|Victoria Soto|3238653000|soto_v@med.usc.edu|
22279847|NCT06164691|University of Pittsburgh|Dr. Matthew Neal|412-647-1158|nealm2@upmc.edu|
22279848|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
22279849|NCT03046446|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22279850|NCT03183063|Beaumont Health|Joanne Gondert|248 551-0439|joanne.gondert@beaumont.org|
22279851|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22279852|NCT00925002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279853|NCT02163577|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22279854|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279855|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22279856|NCT01990742|University of Rochester|Dr. Helena Temkin-Greener|585-275-8713|Helena_Temkin-Greener@urmc.rochester.edu|
22279857|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590||
22279858|NCT00506142|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
22279859|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com|
22279860|NCT02133573|Children's Hospital of Philadelphia|Dr. J. William Gaynor|215-590-5806|gaynor@chop.edu|
22279861|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22279862|NCT00901303|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
22279863|NCT03273907|Alcon Research, LLC|CDMA Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22279864|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu|
22279865|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22279866|NCT01673646|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22279867|NCT01580410|Wake Forest University Health Sciences|Dr. Edward Levine|336-716-2763|elevine@wakehealth.edu|
22279868|NCT03417466|Medtronic Minimed|Fen Peng, Biostatistician|8185763253|fen.peng@medtronic.com|
22279869|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992|nturjman@regenerx.com|108
22297446|NCT04328207|University of Alabama at Birmingham|Cynthia Owsley|2053258635|cynthiaowsley@uabmc.edu|
22297447|NCT04041869|University of Iowa|Lucas Carr|319-353-5432|lucas-carr@uiowa.edu|
22297448|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu|
22297449|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297450|NCT01083433|Rainbow Babies and Children's Hospital|Sarah A. MacLeish, DO|216-844-3661|sarah.macleish2@uhhospitals.org|
22297451|NCT02383667|The University of Toledo|Saima Karim, DO|419-383-3697|Saima.Karim@utoledo.edu|
22297452|NCT01852292|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22297453|NCT04320940|Hikma Pharmaceuticals|Amy Schutte|440-201-5010|aschutte@Hikma.com|
22297454|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297455|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033|mark.nelson@chelwest.nhs.uk|155610
22297456|NCT02388737|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22297457|NCT03252522|Oregon Health & Science University|Jeanette Johnstone, PhD|5034943700|jojeanet@ohsu.edu|
22297458|NCT03018392|Bone and Joint Clinic of Baton Rouge|Research Projects Director|2254218207|aobrien@bjcbr.com|
22297459|NCT04152447|Massachusetts General Hospital|Dr. Marilyn Heng|617-643-0149|mheng@mgh.harvard.edu|
22297460|NCT03240575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279870|NCT04577781|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22297461|NCT04482179|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
22279871|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22297462|NCT02400723|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.gould@va.gov|68899
22279872|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br|
22279873|NCT01657305|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
22279874|NCT03763747|OrbusNeich|Stephen M. Rowland, PhD - Vice-President, Research and Development|954-730-0711|srowland@orbusneich.com|
22279875|NCT00940602|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22279876|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu|
22279877|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com|
22279878|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279879|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com|
22279880|NCT01227057|VASDHS|Catherine Ayers|8585528585|catherine.ayers1@va.gov|2976
22279881|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
22279882|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu|
22279883|NCT02750930|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279884|NCT02761642|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279885|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu|
22279886|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
22279887|NCT02850978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279888|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
22279889|NCT00421148|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279890|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
22279891|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov|
22279892|NCT03289533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279893|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450|christopher.wendel@va.gov|1824
22279894|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr|
22279895|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com|
22279896|NCT02393339|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972507410935|fuxavia@gmail.com|
22279897|NCT01832610|Medtronic|Thomas Vassiliades, MD - VP MCS Clinical/Medical Affairs|+15085321956|thomas.a.vassiliades@medtronic.com|
22279898|NCT03708367|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan, PhD|+1 408 5335282|skasthur@ITS.JNJ.com|
22279899|NCT02874092|NYU Langone|Dr. Jeffrey Berger|212-263-0855|Jeffrey.Berger@nyulangone.org|
22279900|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu|
22279901|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov|
22279902|NCT01974284|Yale University School of Medicine|Dr. Glenda Callendar|203-737-2036|glenda.callender@yale.edu|
22279903|NCT02629861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@Tevapharm.com|
22279904|NCT02525679|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279905|NCT00271544|Medtronic CRDM Clinical Research|Hang Nguyen|800-328-2518|hang.t.nguyen@medtronic.com|62832
22279906|NCT01685684|Collegium Pharmaceutical|Clinical Scientist|+1.781.232.0764|clinicaltrials@collegiumpharma.com|
22279907|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com|
22279908|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279909|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu|
22279910|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743||
22279911|NCT03571971|The Ohio State University|Stephanie Di Stasi, Principal Investigator|614-293-4220|stephanie.distasi@osumc.edu|
22279912|NCT03096886|University of Pennsylvania|Dr. Yvette Sheline|(215) 573-0082|sheline@pennmedicine.upenn.edu|
22279913|NCT03950856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279914|NCT01816984|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
22279915|NCT03820011|Board of Trustees at University of Illinois|Dr. Mary Khetani, Associate Professor|312-996-0942|mkhetani@uic.edu|
22279916|NCT04422431|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22279917|NCT01174563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22279918|NCT03402841|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22279919|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279920|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300||
22279921|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
22279922|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22279923|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov|
22279924|NCT02896257|VA Puget Sound Health Care System|Dr. David Au|206-764-2504|David.Au@va.gov|
22279925|NCT03793621|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22279926|NCT03423602|Vivasure Medical Ltd|Dr Chris Martin|+353 91 395 442|chris.martin@vsuremed.com|
22310261|NCT03640286|Neurovalens|Head of Clinical and Regulatory|02890991835|sinead.watson@neurovalens.com|
22279927|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
22279928|NCT03257358|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22279929|NCT02332187|University of Kentucky|Gerald Supinski, MD, Professor|859-494-3480|gsupi2@email.uky.edu|
22297463|NCT03034954|University of Michigan|Dr. Annalise Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
22297464|NCT02340299|Charité - Universitätsmedizin Berlin|PD Dr. Christoph Czernik, principal investigator|+49 30 450|christoph.czernik@charite.de|566122
22297465|NCT03568942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297466|NCT01381861|TRACON Pharmaceuticals|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22297467|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|6237
22297468|NCT04145895|Beaumont Hospitals|Diane Studzinski|2485512570|diane.studzinski@corewellhealth.org|
22297469|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com|
22297470|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22297471|NCT01539226|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22297472|NCT00283439|Amgen Inc.|Study Director|866-572-6436||
22297473|NCT01218516|Morphotek (subsidiary of Eisai)|Morphotek (subsidiary of Eisai)|1-888-422-4743|esi_medinfo@eisai.com|
22297474|NCT01632891|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22297475|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu|
22297476|NCT02378844|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
22323684|NCT00584870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323685|NCT00631137|Johns Hopkins|Jaishri Blakeley|410-955-8837|jblakel3@jhmi.edu|
22323686|NCT03682120|St Louis University School of Medicine|Sharon Frey, MD|314-997-5500|sharon.frey@health.slu.edu|
22323687|NCT01015833|Memorial Sloan-Kettering Cancer Center|Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
22268982|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org|
22268983|NCT03193684|UTHSCSA|Dr. Muhammad Abdul-Ghani|210 567 6691|abdulghani@uthscsa.edu|
22268984|NCT01198470|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|1669
22268985|NCT00720213|Sleepcare Diagnostics|Shahrokh Javaheri, MD|513-459-7750|javaheri@snorenomore.com|
22268986|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu|
22268987|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org|
22268988|NCT01924689|BioMed Valley Discoveries, Inc.|Brent Kreider|816-960-4644|bkreider@biomed-valley.com|
22268989|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net|
22268990|NCT05271175|Cyprus rTMS|Georgios Mikellides|0035799430330|george.mikellides@gmail.com|
22268991|NCT02492867|University of Michigan Rogel Cancer Center|ClinicalTrials.gov CC Admin|734-936-9499|clinicaltrialsgov_ccadmin@med.umich.edu|
22268992|NCT03296527|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22268993|NCT01597973|University of Michigan|Jolene Daniel|732 235-7713|jd1557@rwjms.rutgers.edu|
22268994|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300||
22268995|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com|
22268996|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com|
22268997|NCT03807544|Theranova|Director of Clinical Trials|14159268616|clindquist@theranova.com|
22268998|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22268999|NCT01591096|SeattleChildrens|Catherine Amlie-Lefond MD|206-987-2078|calefond@seattlechildrens.org|
22269000|NCT03655405|a. Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
22269001|NCT04704050|Tulane University|Nassir Marrouche|504-988-2025|nmarrouche@tulane.edu|
22269002|NCT05271370|CytoDyn|Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
22269003|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com|
22269004|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu|
22269005|NCT03773172|Columbia University Irving Medical Center|Henry Ginsberg, MD|212-305-9562|hng1@cumc.columbia.edu|
22269006|NCT05088460|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22269007|NCT03100864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269008|NCT04066244|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269009|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300||
22269010|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu|
22269011|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22269012|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535|n939492@mail.hosp.ncku.edu.tw|4733
22269013|NCT02283268|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22269014|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000|susan.conroy@va.gov|3213
22269015|NCT03656068|Pinnacle Clinical Research|Stephen Harrison, MD|210-982-0320|stephenharrison87@gmail.com|
22269016|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu|
22269017|NCT02770170|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269018|NCT03270657|Duke University|Dr. Dennis Turner|919-684-7777|dennis.turner@duke.edu|
22269019|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22323688|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com|
22269020|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu|
22269021|NCT03187301|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22323689|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu|
22323690|NCT02040142|Montefiore Medical Center|Dr. John McAuliffe, Associate Professor Department of Surgery and Department of Pathology|718-379-6865|jomcauli@montefiore.org|
22323691|NCT04752384|Medical College of Wisconsin|Stuart J. Wong, MD|414-805-4600|swong@mcw.edu|
22269022|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu|
22269023|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu|
22269024|NCT02158585|DENT Neurosciences Research Center|Dr. Jennifer Cox|716-250-7002|jcox@dentinstitute.com|
22269025|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com|
22269026|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk|
22269027|NCT02546375|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269028|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu|
22269029|NCT02588612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269030|NCT03809663|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22269031|NCT03376789|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22269032|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22269033|NCT02042014|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22269034|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr|
22269035|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22269036|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu|
22269037|NCT03309943|Duke University School of Medicine|Jason A. Oliver, Ph.D.|(919) 668-0093|Jason.A.Oliver@duke.edu|
22269038|NCT03123393|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22269039|NCT05245526|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
22269040|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22269041|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22269042|NCT03197038|University of Illinois at Chicago|Dr. Ulf Bronas|312-355-5886|bronas@uic.edu|
22269043|NCT02069041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22269044|NCT05047211|UTMB Galveston|Dr Antonio Saad Director of PRD|4097721795|antalar@me.com|
22269045|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300||
22269046|NCT03822468|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22269047|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com|
22269048|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us|
22269049|NCT02949973|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22269050|NCT01420068|Noden Pharma DAC|Ciara Walsh|+ 353 1 9121573|cwalsh@nodenpharma.com|
22269051|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133||
22269052|NCT00365794|University of Southern California|Fred Sattler, MD|323-409-4635|fsattler@usc.edu|
22269053|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22269054|NCT04760626|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22269055|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com|
22269056|NCT02554682|Children's Hospital of Philadelphia|Dr. Carol Ford|267-426-3938|fordc@email.chop.edu|63938
22269057|NCT00758290|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22269058|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269059|NCT02946463|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22279930|NCT02903823|Vanderbilt University Medical Center|Peter Konrad, MD PhD - PI|6153439822|peter.konrad@vumc.org|
22279931|NCT02852967|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
22279932|NCT03886948|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22279933|NCT00339040|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22279934|NCT03341637|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22279935|NCT05547412|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
22279936|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22279937|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
22279938|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu|
22279939|NCT02970136|University of Miami|Olveen Carrasquillo|305-243-5505|ocarrasquillo@miami.edu|
22279940|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu|
22279941|NCT03443687|University of New Mexico, Dept OBGYN|Dr. Gena Dunivan|5052729712|gdunivan@salud.unm.edu|
22279942|NCT02805790|Stealth BioTherapeutics Inc.|Rekha Sathyanarayana, Executive Director, Clinical Operations|617-762-2579|Rekha.Sathyanarayana@stealthbt.com|
22297477|NCT03341052|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
22279943|NCT03420742|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22279944|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22297478|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com|
22269060|NCT02022202|Mayo Clinic|Matthew P. Goetz MD and Judy C. Boughey MD|507-284-2511|Goetz.Matthew@mayo.edu|
22269061|NCT03957473|Penumbra, Inc.|Study Manager|+1 415-601-9561|apascua@penumbrainc.com|
22269062|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
22279945|NCT02078752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22279946|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
22279947|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com|
22279948|NCT03975153|Oregon Health & Science University|Teri Greiling, MD, PhD, FAAD|503-494-3376|PRPStudy@ohsu.edu|
22279949|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
22279950|NCT00570323|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22279951|NCT03856359|Duke University Hospital|Dr. Paul V. Suhocki|919-684-7284|suhoc001@mc.duke.edu|
22279952|NCT01773954|Mid Atlantic Retina|Michele Formoso|215-928-3092|research@midatlanticretina.com|
22279953|NCT02266147|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
22279954|NCT02347605|University of Minnesota|Michael Kotlyar|612-251-8780|kotly001@umn.edu|
22279955|NCT01567722|AMC Statistical Center|Madhu Mazumdar|(212) 659-9558|madhu.mazumdar@mountsinai.org|
22279956|NCT02455167|"University of Colorado Denver | Anschutz"|Amanda Wieland, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22279957|NCT02259114|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22279958|NCT03937479|Verona Pharma Plc|Nancy Herje|+1 646-951-0961|nancy.herje@veronapharma.com|
22279959|NCT02578901|University of Washington|Dr. Susanne May|206-685-1302|sjmay@uw.edu|
22279960|NCT02712788|Indiana University|Heather Cero, RN - research cooordinator|317-396-1398|hcero@iupui.edu|
22279961|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu|
22279962|NCT03789292|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
22279963|NCT04655157|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
22279964|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22279965|NCT03988426|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22279966|NCT00532844|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22279967|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
22279968|NCT03734822|Nationwide Children's Hospital|Anne May, MD|614-722-4766|Anne.May@nationwidechildrens.org|
22279969|NCT00553631|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22279970|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22279971|NCT04005586|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22279972|NCT04089020|Children's Mercy Kansas City|Jordan Carlson, PhD.|816-234-9240|jacarlson@cmh.edu|
22279973|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu|
22279974|NCT02031302|Boston Scientific Corp.|Blessie Concepcion, Director Clinical Trials|408-385-8604|Blessie.Concepcion@bsci.com|
22279975|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343||
22279976|NCT04067492|R-Pharm|D.V. Bukhanova, Medical Adviser|0074959567|bukhanova@rpharm.ru|3838
22279977|NCT06158867|Taipei Medical University Hospital|Dr. Leon Tsung-Ju Lee|+886-2-27372181|TJ.LEE.SKIN@GMAIL.COM|8281
22279978|NCT00956384|University Health Network|Dr. Toni Zhong|4163404800|kbutler@uhnresearch.ca|2343
22279979|NCT01147302|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22279980|NCT05899829|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22279981|NCT05076045|Baycrest Academy for Research & Education|Claude Alain|416-785-2500|calain@research.baycrest.org|3523
22279982|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org|
22279983|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22279984|NCT05270863|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
22279985|NCT03984188|University of Miami|Trishul Siddharthan|305-243-6388|tsiddhar@miami.edu|
22279986|NCT03930771|Weill Cornell Medicine|Rajiv Magge|212-746-6575|ram9116@med.cornell.edu|
22279987|NCT03531814|National Cancer Institute|Staci M Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
22279988|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
22279989|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org|
22279990|NCT03402932|Western Michigan University|Jing Shen|2693878067|jing.shen@wmich.edu|
22279991|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com|
22279992|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22279993|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu|
22279994|NCT03611881|Massachusetts General Hospital|Elyse Park, PhD, Professor of Psychiatry and Medicine, Harvard Medical School|617.724.6836|epark@mgh.harvard.edu|
22297479|NCT04627064|Dana-Farber Cancer Institute|Toni Choueiri, M.D|617-6325456|toni_choueiri@dfci.harvard.edu|
22297480|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297481|NCT02086110|University of California, Davis Health System|Dr. Kathleen Angkustsiri|916-703-0278|kangkustsiri@ucdavis.edu|
22297482|NCT01869192|University of Colorado|Anthony Elias, MD|17208480347|anthony.elias@ucdenver.edu|
22297483|NCT05583903|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
22297484|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org|
22297485|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22297486|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org|
22279995|NCT04472650|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22297487|NCT02667483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22297488|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org|
22297489|NCT00980395|University of Arizona|Amy Selegue, NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22297490|NCT01112293|AbramsonCC|James Robinson|215-662-8758|jamesrobinson2@pennmedicine.upenn.edu|
22310262|NCT04393207|Yale|Antonio Gonzalez|203.785.2802|antonio.gonzalez-fiol@yale.edu|
22310263|NCT05405985|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
22310264|NCT03314740|Istituto di Ricerche Farmacologiche Mario Negri|Elena Biagioli|+39 0239014650|elena.biagioli@marionegri.it|
22269063|NCT02040805|University of California, San Francisco|Dr. Kevin L. Delucchi|415-476-4180|kevin.delucchi@ucsf.edu|
22297491|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22297492|NCT03608488|SultanAbdulhamid|Tugba OZsoy-Unubol|+905074583382|tugbaozsoyy@gmail.com|
22297493|NCT02127632|DorkuzEU|Anaesthesiology and Reanimation|90.505.525.29.01|ozbilginsule@gmail.com|
22297494|NCT02901951|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
22297495|NCT01971853|"University of Colorado Denver | Anschutz"|Director, Clinical Research Administration||clinicalresearchsupportcenter@ucdenver.edu|
22297496|NCT06431061|CooperVision Inc.|Jose A Vega, OD,MSc,PhD|925-621-3761|JVega2@coopervision.com|
22297497|NCT04225923|Nobelpharma Co. Ltd.|Research & Development Divion|81-3-6670-3800|watanabe.tatsuya@nobelpharma.co.jp|
22297498|NCT04964453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297499|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22297500|NCT01585766|MedImmune|Armando Flor, MD, Director, Clinical Development|301-398-1955|information.center@astrazeneca.com|
22297501|NCT01073865|AstraZeneca|Global Clinical Lead|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com|
22297502|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22297503|NCT00696137|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
22297504|NCT04371380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297505|NCT02376166|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|(212) 659-5599|matthew.galsky@mssm.edu|
22297506|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
22297507|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22297508|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22297509|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22297510|NCT00680901|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22297511|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22297512|NCT04251221|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
22297513|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775||
22297514|NCT02120794|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22297515|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300||
22297516|NCT00589316|Fred Hutchinson Cancer Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
22297517|NCT00969553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297518|NCT04243538|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
22297519|NCT04536727|University of Illinois at Chicago|Dr. David Marquez|(312) 996-1209|marquezd@uic.edu|
22297520|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22297521|NCT03369717|Montefiore Medical Center|Nadeem Akbar MD|7189204646|nakbar@montefiore.org|
22297522|NCT05308901|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
22297523|NCT02586012|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
22297524|NCT01816139|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22297525|NCT01572038|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22297526|NCT02554656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297527|NCT01888497|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297528|NCT02488785|Joslin Diabetes Center|Sylvia Rosas|6173092486|sylvia.rosas@joslin.harvard.edu|
22297529|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
22297530|NCT05543928|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22297531|NCT04718870|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22297532|NCT04127786|Sanofi Pasteur|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22297533|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22297534|NCT05124665|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
22297535|NCT04147442|Bernafon AG|Dr Barbara Simon|+41 31 998 1515|bsim@bernafon.com|1684
22297536|NCT02904057|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22269064|NCT00908544|MUC Research GmbH|Dr. phil. Eva Wolf|+49 (0)89-558703-0|Eva.Wolf@MUCResearch.de|
22269065|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu|
22269066|NCT03523520|University of Missouri Health Care|Dr. Kara B. Goddard|5738841605|goddardk@health.missouri.edu|
22269067|NCT02045264|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22269068|NCT02859337|Oregon Health & Science University|Dr. A Edelman|503-418-2585|edelmana@ohsu.edu|
22297537|NCT02821962|University of Ottawa Heart Institute|Dr. Robert Reid|613-696-7393|breid@ottawaheart.ca|
22310265|NCT04227288|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22310266|NCT04951076|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
22310267|NCT01820611|Zimmer Biomet|Linda Meijer|+31 6 57933741|linda.meijer@zimmerbiomet.com|
22310268|NCT03484819|Mayo Clinic|Nora Bennani, M.D.|(507) 284-2511|bennani.nora@mayo.edu|
22269069|NCT00848718|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269070|NCT02389829|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
22269071|NCT00833105|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
22269072|NCT02898597|University of Massachusetts Boston|Dr. Sun Kim|617-287-6831|sun.kim@umb.edu|
22269073|NCT01135329|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Yvette Kasamon|410-955-8839|ykasamo1@jhmi.edu|
22269074|NCT05340764|Washington University School of Medicine GI Division|Dr. Chien-Huan Chen|3143623201|chen330@wustl.edu|
22310269|NCT03015532|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22269075|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300||
22269076|NCT01609296|Medtronic|Kristel Wittebols Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
22269077|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22269078|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22310270|NCT00971087|Hologic|Jennifer Bartoshevich, Sr Manager of Clinical Affairs|781-999-7764|jennifer.bartoshevich@hologic.com|
22310271|NCT06435624|Nanjing Mingzhou Rehabilitation Hospital|Jingzhi Zhang|16677137704|170787717@qq.com|86
22310272|NCT05013385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310273|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22310274|NCT02944968|Johnson and Johnson Medical NV/SA|Nathalie Macours, Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
22310275|NCT03329937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22310276|NCT02874742|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310277|NCT03969563|VA Northern California Health Care System|Dr. Jerry Nadler, Chief of Research|9168432776|Jerry.Nadler@va.gov|
22310278|NCT03691298|Smith+Nephew|Laura Everson|+447718320892|laura.everson@smith-nephew.com|
22310279|NCT05571267|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
22310280|NCT04424316|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310281|NCT05070741|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
22310282|NCT03245840|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22310283|NCT01116895|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22310284|NCT03995979|University of Florida|Dr. Salvatore Scali|(352) 376-1611|salvatore.scali@surgery.ufl.edu|
22310285|NCT05652010|Coloplast A/S|Senior Scientific Manager|+4549113192|dkmbs@coloplast.com|
22310286|NCT05451693|HealthPartners Institute|Bhavani Kashyap, PhD, MBBS|651-495-6363|Bhavani.x.kashyap@healthpartners.com|
22310287|NCT04763772|UH Cleveland Medical Center|Ian Neeland|216-844-5965|ian.neeland@uhhospitals.org|
22310288|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22310289|NCT04206787|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310290|NCT05008055|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310291|NCT03003533|Spark Therapeutics|Spark Therapeutics|Please Email|clinicaltrials@sparktx.com|
22310292|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22310293|NCT03011034|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310294|NCT04564209|University of Colorado College of Nursing|Dr. Samantha Stonbraker, Study PI|720-880-8194|Samantha.Stonbraker@CUAnschutz.edu|
22310295|NCT03419052|Indiana University|Daniel Clark, PhD|317-274-9292|daniclar@iu.edu|
22310296|NCT02361658|Toronto Western Hospital, University Health Network|Emad Al Azazi|4166035800|emad.alazazi@uhnresearch.ca|2508
22310297|NCT03735979|Medical University of South Carolina|Jordan J. Elm, PhD|843-876-1605|elmj@musc.edu|
22310298|NCT03417284|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, MD / Stem Cell Transplantation|713-794-4422|QBashir@mdanderson.org|
22310299|NCT05423730|Beth Israel Deaconess Medical Center|Kenneth J Mukamal|617-754-1401|kmukamal@hsph.harvard.edu|
22310300|NCT04276935|Memorial Sloan Kettering Cancer Center|Dr. Thomas M. Atkinson|646-888-0089|atkinsot@mskcc.org|
22310301|NCT04089865|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD, MBA|(212) 606-1206|memtsoudiss@hss.edu|
22310302|NCT04389957|San Francisco Veterans Affairs Medical Center|Dr. Tonya Kaltenbach|(415) 221-4810|tonya.kaltenbach@va.gov|24406
22310303|NCT01540994|Sharp Healthcare|Dr. Geoffrey Weinstein|858-939-5010|geoffrey.weinstein@sharp.com|
22310304|NCT04881461|ALK-Abelló A/S|Senior Director, Clinical Data Science, Global Clinical Development|+4545747576|clinicaltrials@alk.net|
22310305|NCT03988621|University of Pennsylvania|Barbara Riegel, PhD, RN, Professor|2158989927|briegel@nursing.upenn.edu|
22310306|NCT03235440|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22310307|NCT03318159|Seoul National University Hospital|Dr. Koh|82220727217|go01@snu.ac.kr|
22310308|NCT04574583|National Cancer Institute|Dr. James Gulley|301-480-8870|james.gulley@nih.gov|
22310309|NCT02905331|Janssen Research & Development, LLC|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310310|NCT05007080|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22269079|NCT01464333|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22269080|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org|
22323692|NCT02797470|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22323693|NCT05142826|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
22323694|NCT04439331|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22323695|NCT04828330|VA Puget Sound Health Care System|Dr. Pradeep Suri|207-762-1010|pradeep.suri@va.gov|
22323696|NCT04370509|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|david.oh@ucsf.edu|
22323697|NCT04743856|University of Pittsburgh|Bonny Rockette-Wagner|4126240188|bjr26@pitt.edu|
22323698|NCT04696861|Duke University School of Nursing|Brandon Knettel|1 919 660 1218|brandon.knettel@duke.edu|
22323699|NCT04439188|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22323700|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net|
22323701|NCT01438008|Children's Hospital of Eastern Ontario|Dr. Denise Harrison|6137377600|dharrison@cheo.on.ca|6045
22323702|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22323703|NCT02425098|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323704|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22323705|NCT02029976|George Mason University, College of Health and Human Services|Dr. Martha Y Kubik, Professor and Director School of Nursing|703-993-1971|mkubik@gmu.edu|
22323706|NCT03263806|Beaumont Hospitals|Korana Stakich-Alpirez|248 898 0315|Korana.Stakich-Alpirez@beaumont.org|
22323707|NCT04840667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22323708|NCT01445171|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22323709|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov|
22323710|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG|
22323711|NCT05194345|University of South Florida|Heewon Gray|(813) 974-9881|hlgray@usf.edu|
22310311|NCT04442165|Insitute of Tropical Medicine|Brecht Ingelbeen|+32(0)33455787|bingelbeen@itg.be|
22323712|NCT02612909|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
22323713|NCT04214080|Marmara University|Assoc. Prof Aysel Yıldız Ozer|5334674433|aysel.yildiz@marmara.edu.tr|+90
22323714|NCT02863263|Mundipharma Singapore Holding Pte. Limited|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
22323715|NCT05067127|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22323716|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
22323717|NCT03615222|CTX VA|Suzannah Creech|254-654-7241|suzannah.creech@va.gov|
22323718|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org|
22323719|NCT03304522|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22323720|NCT03367871|University of Miami|Abdulrahman Sinno MD|+1 (305) 243-2233|ak.sinno@med.miami.edu|
22323721|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com|
22269081|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447|kathy.ales@jacobus-pharmaceutical.com|231
22269082|NCT03321968|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22269083|NCT01069510|Oregon Health and Science Univ.|Dr. Craig Broberg|503-494-7400|brobergc@ohsu.edu|
22269084|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22269085|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu|
22269086|NCT06509438|EspadPharmed|Hamidreza Kafi|+989129232594|Kafi.h@orchidpharmed.com|
22310312|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
22310313|NCT04583280|Janssen Research & Development LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310314|NCT02577354|Mainstay Medical|Vice President Clinical Affairs|7637727637|diane.burnside@mainstay-medical.com|
22310315|NCT02561611|Pennington Biomedical Research Center|Corby Martin|225-763-2585|Corby.Martin@pbrc.edu|
22310316|NCT04173247|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
22310317|NCT05985382|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
22310318|NCT06097494|Pfizer Ltd|Ranjit Nagra|01304 616161|ranjit.nagra@pfizer.com|
22310319|NCT04265807|University of Washington|Graham Nichol|206 521 1784|nichol@uw.edu|
22310320|NCT06609486|Hanyang University Seoul Hospital|Jongshill Lee, Ph.D.|+82-10-6209-4260|netlee@hanyang.ac.kr|
22310321|NCT05683158|Department of Physiotherapy, University of Valencia|PI. Jose Casaña Granell|+34 656-437-371|jose.casana@uv.es|
22310322|NCT04109066|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22310323|NCT04099732|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310324|NCT05958927|Usak University Medical Faculty|Suzan Doğruya|05322270732|sdogruya@hotmail.com|
22310325|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457||
22310326|NCT01475786|Helixmith|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310327|NCT06229119|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22310328|NCT03165955|Athenex Inc.|Regional Project Manager|+886-978365735|lmeiying@athenex.com|
22310329|NCT03745716|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22310330|NCT04761198|Mereo BioPharma|Mereo BioPharma|Please Email|enquiries@mereobiopharma.com|
22310331|NCT02994927|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
22310332|NCT03875339|University of Kentucky|Dr. Matthew L. Bush, Professor and Chair of Otolaryngology- Head and Neck Surgery|(859)218-2139|matthew.bush@uky.edu|
22279996|NCT01861665|Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.|Dr. Glenn Schattman, Associate Professor|646-962-3836|glschatt@med.cornell.edu|
22279997|NCT03247829|Abbott_Medical_Devices|Dr. Marie-Elena Brett, PhD; Principal Scientist Clinical Research|17815283613|marieelena.brett@abbott.com|
22279998|NCT01783444|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22279999|NCT02722408|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
22280000|NCT00552071|Cedars-Sinai Medical Center|Vivian Hwe|4224-315-4489|hwev@cshs.org|
22280001|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22280002|NCT01058239|Massachusetts General Hospital|Jeremy Abramson, M.D|617-724-4000|JABRAMSON@mgh.harvard.edu|
22280003|NCT03121144|Masimo Corporation|Vikram Ramakanth|(949) 297-7000|clinicalresearchdept@masimo.com|
22297538|NCT04070833|Brigham and Women's Hospital|Pamela M. Rist|617-278-0835|prist@bwh.harvard.edu|
22297539|NCT02633956|Intercept Pharmaceuticals, Inc|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22297540|NCT04118010|Emory University|Dr. Vin Tangpricha|404-727-7254|vtangpr@emory.edu|
22297541|NCT04206293|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22297542|NCT03863210|University of Split School of Medicine|Dr. Slavica Jurić Petričević||slavica.juric01@gmail.com|
22297543|NCT03325166|Oregon Health and Science University|Gerda Teglassy, MD|503-494-4526|tothg@ohsu.edu|
22297544|NCT02299050|University of Texas Health San Antonio|Mariam Alatrach|210-358-7220|alatrach@uthscsa.edu|
22297545|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297546|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu|
22297547|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu|
22297548|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22297549|NCT05923229|Washington University School of Medicine|Kerri Rawson|314-273-1053|rawson@wustl.edu|
22297550|NCT04304001|Florida A&M University|Dr. Tanise Jackson, Director of Animal Welfare Research Integrity|850-599-3214|tanise.jackson@famu.edu|
22297551|NCT04164901|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22297552|NCT02465528|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22297553|NCT05358821|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
22297554|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu|
22297555|NCT05847153|Massachusetts General Hospital|Dr. Christine Ritchie|4156721780|csritchie@mgh.harvard.edu|
22297556|NCT04609020|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22297557|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22297558|NCT00779103|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22297559|NCT04098458|Medical University of South Carolina|Evan M. Graboyes, MD, MPH (principal investigator)|843-792-0719|graboyes@musc.edu|
22297560|NCT02462967|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
22297561|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22297562|NCT02272413|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297563|NCT04327999|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22297564|NCT02872116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22297565|NCT03552575|University of Glasgow|Professor John McMurray|0141 330 2627|john.mcmurray@glasgow.ac.uk|
22297566|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov|
22297567|NCT03792672|Takeda|Medical Director|1-877-825-3327|medicalinformation@tpna.com|
22297568|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22297569|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu|
22297570|NCT04238728|University of Rochester Medical Center|Julie Ryan, MD|585-276-3862|Julie_Ryan@URMC.Rochester.edu|
22297571|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22297572|NCT01907828|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
22297573|NCT03925324|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
22297574|NCT04414553|University of Colorado|Lisa Ross DeCamp|3037246499|lisa.decamp@cuanschutz.edu|
22297575|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00||
22297576|NCT03458130|Eidos Therapeutics|Mark McGovern, Vice President of Clinical Operations|415-887-1471|medinfo@eidostx.com|
22297577|NCT00167934|Washington University School of Medicine|Michael Yingling|573-579-1412|yinglingm@wustl.edu|
22297578|NCT01845792|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
22297579|NCT03554291|University of Washington|Peter Leary|206-685-2484|learyp@uw.edu|
22297580|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116||
22297581|NCT05544786|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310333|NCT03533257|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
22310334|NCT06412965|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310335|NCT04046094|University of Kansas Medical Center|Faith Rahman|913-588-2502|frahman2@kumc.edu|
22310336|NCT05525104|Erasmus Medical center|I.J. de Heer, MD|+31107040704|i.deheer@erasmusmc.nl|
22310337|NCT02039401|Helixmith, LLC|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22310338|NCT06149338|Saint Andrew's General Hospital of Patras|Dr. Vasileios Boviatsis|+306982925945|billboviatsis@gmail.com|
22310339|NCT02865538|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22310340|NCT06946888|Kaohsiung Veterans General Hospital|Li-Ying Lin|07-3422121|llylin@vghks.gov.tw|71571
22310341|NCT04479514|DFCI|Jennifer Huang|6173558937|jennifer.huang@childrens.harvard.edu|
22310342|NCT06834490|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
22310343|NCT03550170|Case Western Reserve University|Dr. Matthew Plow|216-368-8969|map208@case.edu|
22310344|NCT05850052|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
22310345|NCT04214860|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22310346|NCT04282980|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
22310347|NCT05860114|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 64431|m.caserini@italfarmacogroup.com|
22310348|NCT01917084|New England Research Institutes|Felicia Trachtenberg|617-972-3120|FTrachtenberg@neriscience.com|
22310349|NCT03571386|Vanderbilt University|David Vago|236-516-6530|vago.dave@gmail.com|
22310350|NCT03938246|Sagimet Biosciences Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
22310351|NCT06037668|Sumitomo Pharma America|Director, Frontier Business Office|1-866-503-6351|gazeleh.vakili@us.sumitomo-pharma.com|
22310352|NCT02473445|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
22310353|NCT04247802|Oxford University Hospitals NHS Foundation Trust|Mrs Martha Batting|01865|martha.batting@ouh.nhs.uk|737526
22310354|NCT03778801|Aksaray University training and Research Hospital|Principal Investigator|905555289493|mlk.aykut@gmail.com|
22310355|NCT03165786|University of Illinois Chicago|Pamela Martyn-Nemeth, Professor|(312) 996-7903|pmartyn@uic.edu|
22310356|NCT04629339|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22310357|NCT06356285|Imperial College London|Dr Kate Grailey|07912563290|k.grailey18@imperial.ac.uk|
22310358|NCT05265065|Murdoch Children's Research Institute|Kim Mulholland|+61 3 99366656|kim.mulholland@mcri.edu.au|
22310359|NCT04158739|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22310360|NCT04778410|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22310361|NCT03866837|Columbia University|Gary M. Brittenham, M.D.|212 305 7005|gmb31@cumc.columbia.edu|
22297582|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org|
22297583|NCT01025427|University of California, San Francisco|Hiroyu Hatano|415-476-4082|hhatano@php.ucsf.edu|122
22297584|NCT04258605|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
22297585|NCT02910167|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297586|NCT00181961|Massachusetts General Hospital|Dr. Christina Dording|6177249457|cdording@mgh.harvard.edu|
22297587|NCT05300295|University of Minnesota|Lindsey Weiler, PhD|612-301-9345|lmweiler@umn.edu|
22297588|NCT04944901|Scioto Biosciences|Phoevos Hughes, VP Clinical Operations|866-672-4686|phoevos@sciotobiosciences.com|700
22297589|NCT01951339|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
22297590|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22297591|NCT05516082|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|19256213761|javega@coopervision.com|
22297592|NCT03664752|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22297593|NCT00026793|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
22297594|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
22297595|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com|
22310362|NCT05308979|UC Irvine Medical Center|Dr. Carly Crowder|7144562911|crowderc@hs.uci.edu|
22310363|NCT05422885|Marcus Institute|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22310364|NCT04084574|Duke University|Crystal Tyson, MD, MHS|919-660-6671|crystal.simpson@duke.edu|
22310365|NCT01121588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310366|NCT00942877|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@nih.gov|
22310367|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010|RStagg@its.jnj.com|8611
22310368|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
22310369|NCT04370834|National Cancer Institute|Dr. Richard Little, Principal Investigator|240-276-6093|littler@mail.nih.gov|
22310370|NCT04068792|Janssen Research & Development, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310371|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com|
22310372|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com|
22310373|NCT01146704|Department of Veterans Affairs, VAGLAHS|Dr. Joseph Pisegna|3104783711|Joseph.Pisegna@va.gov|41664
22310374|NCT04072861|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
22310375|NCT04801368|Mayo Clinic|Dr. Matthew Ziegelmann|507-266-3982|Ziegelmann.Matthew@mayo.edu|
22310376|NCT05043064|Aalborg University Hospital|Dr Gennady V Atroshchenko|97 66 46 49|g.atroshchenko@rn.dk|45
22310377|NCT04214834|RTI International|Dr. Abhik Das|3017708214|adas@rti.org|
22310378|NCT04947137|Navidea Biopharmaceuticals|Senior Medical Director|6149737555|mblue@navidea.com|
22310379|NCT04967599|University of Southern California|Susan Luczak, PI of study|2137402203|luczak@usc.edu|
22310380|NCT05864040|Rob Surgical Systems|Jaume Amat, CEO|+34 93 013 08 83|jaume.amat@robsurgical.com|
22310381|NCT04369911|HealthPartners Institute|Amanda Herrmann, PhD|6514956565|amanda.a.herrmann@healthpartners.com|
22310382|NCT05741294|Almirall S.A|Valentina Cappello/Global Medical Operations Manager|+34932913000|valentina.cappello@almirall.com|
22310383|NCT03817983|Addenbrookes Hospital, Cambridge, UK|Dr Deepak Jadon|01223 805000|deepak.jadon@addenbrookes.nhs.uk|
22310384|NCT03744676|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22323722|NCT01824979|Fisher and Paykel Healthcare|Clinical Research Scientist|+ 64 09 574 0100|CPAPtrial@fphcare.co.nz|
22323723|NCT01221857|Gamida Cell|Kelly Myers|+972-2-659-5631|clinicaltrials@gamida-cell.com|
22323724|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
22323725|NCT01756456|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22323726|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323727|NCT03094195|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22323728|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183||
22323729|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org|
22323730|NCT03029832|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22323731|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu|
22323732|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22323733|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
22323734|NCT01557790|University of Pennsylvania|Justin E. Bekelman, MD|(215)662-7292|bekelman@xrt.upenn.edu|
22323735|NCT02116621|University of California, Davis|Richard Kravitz, MD, MSPH|916-734-1248|rlkravitz@ucdavis.edu|
22323736|NCT04223609|Mayo Clinic|Gaurav N. Pradhan, PhD|480-301-5351|Pradhan.Gaurav@mayo.edu|
22323737|NCT03437447|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22323738|NCT02549716|Milton S. Hershey Medical Center|Sprague W. Hazard III, M.D.|717-531-0003|shazard@pennstatehealth.psu.edu|311253
22323739|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22323740|NCT01551745|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22323741|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com|
22323742|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22323743|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu|
22323744|NCT00888511|Odense University Hospital|Olfred Hansen|+45 2424 1588|olfred.hansen@rsyd.dk|
22323745|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com|
22323746|NCT04482647|UT MD Anderson Cancer Center|Santhosshi Narayanan, MD-Assistant Professor, Integrative Medicine Program|(346) 228-6676|snarayanan2@mdanderson.org|
22297596|NCT03913091|NYU Langone Health|Uchenna O. Umeh, MD|(212) 598-6085|Uchenna.Umeh@nyulangone.org|
22297597|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
22297598|NCT02381392|Harbor-UCLA Medical Center|Kelly D. Young, MD|310-222-3506|kyoung@emedharbor.edu|
22297599|NCT02453113|UC Irvine|Kristen Kelly|949 824 5515|kmkelly@uci.edu|
22297600|NCT04013191|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
22297601|NCT04144166|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
22297602|NCT02809430|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
22297603|NCT01236755|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766-6100|pauline.cho@polyu.edu.hk|
22297604|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22297605|NCT03848845|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297606|NCT02547662|Mayo Clinic|Shaji Kumar MD|507 284 2511|Kumar.Shaji@mayo.edu|
22297607|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
22297608|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22297609|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
22297610|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu|
22297611|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22297612|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297613|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu|
22297614|NCT01818804|Aalborg University hospital|Salome Kristensen, MD. PhD|+45 97664015|sakr@rn.dk|
22297615|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
22297616|NCT05028374|Karmanos Cancer Institute|Dr. Jeffery Zonder|313-576-8732|zonderj@karmanos.org|
22297617|NCT00430092|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
22297618|NCT01956110|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22297619|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22297620|NCT01166594|Sunnybrook Health Sciences Centre|Dr Catherine Birt|416 480-5882|catherine.birt@sunnybrook.ca|
22297621|NCT02118428|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|ray.goodrich@terumobct.com|
22297622|NCT04587934|Sharp Healthcare|Dr. Anup Katheria|858-939-4170|Anup.Katheria@sharp.com|
22297623|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22297624|NCT00463060|Good Samaritan Hospital Medical Center|Dr. Johnny Kao|(631) 376-4444|johhny.kao@chsli.org|
22297625|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22297626|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
22323747|NCT03952559|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22297627|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com|
22297628|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu|
22297629|NCT02884089|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323748|NCT01997463|University of Arizona|Clara Ehrman|520-621-5439|csehrman@email.arizona.edu|
22280004|NCT03557125|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsonsh@musc.edu|
22280005|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu|
22280006|NCT02549989|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
22280007|NCT00298389|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
22280008|NCT02628444|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22280009|NCT00288015|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
22280010|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org|
22280011|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22323749|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com|
22280012|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22323750|NCT03538743|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323751|NCT02587338|Universitätsklinikum Würzburg|Prof. Dr. Martin Herrmann|+4993120176650|Herrmann_m@ukw.de|
22323752|NCT01827384|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
22323753|NCT00524537|AbbVie|Global Medical Information|800-633-9110||
22280013|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674||
22280014|NCT02079909|FUJIFILM Toyama Chemical|Project Manager|+81-3-6427-6245|fftc-clinicaltrial-info1@fujifilm.com|
22280015|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu|
22280016|NCT01784367|University Medical Center Hamburg-Eppendorf, Germany|Prof. Dr. Stefan Kluge|+49-40-7410|skluge@uke.de|57011
22323754|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22323755|NCT01302808|UT Southwestern Medical Center|David Gerber, MD|2146484180|david.gerber@utsouthwestern.edu|
22323756|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800|labcel.tronco@gmail.com|5856
22323757|NCT06120530|Indiana University School of Medicine|Jose Lazaro|7274241947|jlazarow@iu.edu|
22323758|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com|
22323759|NCT02761967|University of Granada|Dr. Rodríguez-Blanque|+34644322567|rarobla@gmail.com|
22323760|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22323761|NCT03866200|The University of Texas Health Science Center at Houston|Karen Posey, PhD|713-500-5786|karen.posey@uth.tmc.edu|
22323762|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690|pwchong@inqpharm.com|358
22323763|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323764|NCT01671345|Jesse Brown VA Medical Center|Howard S. Gordon, MD|312-569-7331|howard.gordon2@va.gov|
22323765|NCT04291560|University of North Carolina at Chapel Hill|Jamie Crandell, PhD|919-966-5803|jcrandell@unc.edu|
22323766|NCT02847598|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22323767|NCT03690869|Regeneron Pharmaceuticals Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22323768|NCT04981223|Stanford University|Dr. Geoffrey Sonn|(650) 498-6000|gsonn@stanford.edu|
22323769|NCT03797001|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
22323770|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323771|NCT03804671|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323772|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22323773|NCT03895203|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22323774|NCT04572633|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
22323775|NCT03289416|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
22323776|NCT03155997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22323777|NCT00848744|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
22323778|NCT03514914|University of California San Diego|Dr. Anita Raj|(858) 246-0066|anitaraj@health.ucsd.edu|
22323779|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org|
22323780|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu|
22323781|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
22323782|NCT02507349|UPMC Center for High-Value Health Care|Kelly Williams, Program Administrator|412-454-1198|Williamsk17@upmc.edu|
22323783|NCT02700984|Alcon Research|Sr Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22323784|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk|
22323785|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
22323786|NCT00620061|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
22323787|NCT02949830|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22323788|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22323789|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366||
22323790|NCT04373460|Johns Hopkins University Bloomberg School of Public Health|David J. Sullivan|410-502-2522|dsulliv7@jh.edu|
22323791|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323792|NCT03359902|University of Florida|John Williamson|352-548-6920|john.williamson@ufl.edu|
22323793|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22323794|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
22323795|NCT00151892|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22323796|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl|
22323797|NCT03440944|Boston University School of Medicine|Joseph Pare, MD|6174144925|Joseph.pare@bmc.org|
22323798|NCT04672083|Navigen, Inc.|Alan L. Mueller, VP Research|801-243-9703|amueller@nvgn.com|
22323799|NCT02764541|Dana-Farber Cancer Institute|Otto Metzger|6176323800|otto_metzger@dfci.harvard.edu|
22323800|NCT02536248|Laval university|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
22323801|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323802|NCT04492566|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
22323803|NCT03726268|Duke University|Evan Kharasch, MD, PhD|919-613-1154|evan.kharasch@duke.edu|
22323804|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org|
22323805|NCT02875223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22323806|NCT03136107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22323807|NCT02921386|Clarus Therapeutics Inc.|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22323808|NCT01707992|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
22323809|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu|
22323810|NCT03498521|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22323811|NCT04977037|The University of Texas Health Sciences Center at Houston|Nuray Yozbatiran, PhD, PT|7137975282|Nuray.Yozbatiran@uth.tmc.edu|
22323812|NCT02963376|NuvOx Pharma|Evan Unger, MD|520-624-6688|eunger@nuvoxpharma.com|
22323813|NCT02848833|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323814|NCT04980391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22323815|NCT04167345|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22323816|NCT04375761|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22269087|NCT03331796|Veterans Affairs Palo Alto Health Care System|Joy L Taylor, PhD|650-776-3385|joyt@stanford.edu|
22269088|NCT02092298|UT MD Anderson Cancer Center|Brian Badgwell,Professor, Surgical Oncology|713-745-3715|csentonn@mdanderson.org|
22269089|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269090|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060||2915
22269091|NCT03337087|Accru|Dr. Tanios Bekaii-Saab|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
22269092|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
22269093|NCT05581641|BioNTech SE|BioNTech clinical trials patient information|61319084|patients@biontech.de|+49
22269094|NCT04390763|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22269095|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000|ccohorn@sjm.com|8087
22269096|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22280017|NCT00720356|Northwestern University|Jeffery Raizer, MD|312-503-4724|Jeffrey.Raizer@nm.org|
22280018|NCT01869634|University of California, Davis Health, Department of Internal Medicine|Dr. David Asmuth, Professor of Medicine|916-734-8695|dasmuth@UCDAVIS.EDU|
22280019|NCT02237001|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
22280020|NCT01047007|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280021|NCT04254692|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
22280022|NCT03759600|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22280023|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net|
22297630|NCT01631474|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22323817|NCT04840836|Columbia University|Samantha Garbers, PhD, Principal Investigator|212-305-0123|svg2108@cumc.columbia.edu|
22323818|NCT05105243|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|Michelle.Charles@cerevance.com|
22323819|NCT02251743|Ohio State University|Dr. L Eugene Arnold|614-685-6701|L.Arnold@osumc.edu|
22323820|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323821|NCT02935738|Barz IVF Center for Embryo Research and Infertility Treatment|Dr. Saeeda A. Muhsen-Alanssari|9798201303|barzivfcenter@gmail.com|
22323822|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu|
22323823|NCT02900092|Massachusetts General Hospital|Karen K. Miller, MD|617-726-3870|KKMiller@mgh.harvard.edu|
22323824|NCT01389245|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22323825|NCT05540652|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
22323826|NCT04454489|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336 -713-5440|mporosnicu@wakehealth.edu|
22323827|NCT02073487|Houston Methodist|Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
22323828|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
22323829|NCT02886702|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22323830|NCT01808560|TearScience, Inc.|Manager of Clinical and Medical Affairs|919-459-4842|LJi4@its.jnj.com|
22323831|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450|Steven.Goldman@va.gov|4624
22323832|NCT02991599|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22323833|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu|
22323834|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22323835|NCT01147926|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22323836|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr|
22323837|NCT01365156|UT MD Anderson Cancer Center|Michael Frumovitz,Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
22323838|NCT03926143|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22323839|NCT04485455|University of North Carolina at Chapel Hill|Shahzad Ali, MD|984-974-0033|shali@med.unc.edu|
22323840|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu|
22323841|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22323842|NCT02561156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323843|NCT04579549|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
22323844|NCT00967941|CAMC Health System|Patrick Stone, MD|304-388-8250|pstone0627@yahoo.com|9901
22323845|NCT01071070|Abbott|Global Medical Services|800-633-9110||
22323846|NCT02639351|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
22323847|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269097|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22297631|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu|
22297632|NCT03354429|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22297633|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov|
22297634|NCT01691027|Kansas City VA Medical center|Health Scientist|816-861-4700|George.Timberlake@va.gov|52755
22297635|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297636|NCT00542750|Medical University of South Carolina|Kevin M. Gray, M.D.|8437920135|graykm@musc.edu|
22297637|NCT04883632|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22297638|NCT02981381|VA Providence|Noah S. Philip MD|401-273-7100|noah.philip@va.gov|12369
22297639|NCT05040152|The Ohio State University Comprehensive Cancer Center|Xiaochen Zhang|614-293-9600|xiaochen.zhang@osumc.edu|
22297640|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu|
22297641|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu|
22297642|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297643|NCT02153944|National Institute of Mental Health (NIMH)|Dr Maryland Pao|301-435-5770|paom@mail.nih.gov|
22297644|NCT03029624|Valencia Technologies|Stacy Chambliss, Chief of Clinical Trials|661-775-1414|schambliss@valenciatechnologies.com|1002
22297645|NCT02508636|University of California, San Francisco|Dr. Hao Nguyen|(415) 514-5541|Hao.Nguyen@ucsf.edu|
22297646|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297647|NCT01371656|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22297648|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com|
22297649|NCT03621878|imam abdulrahman bin faisal university|Mohammed Alghamdi|+966556852888|mohdg.ios@gmail.com|
22297650|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu|
22297651|NCT04334460|Blade Therapeutics|SVP, Global Regulatory Affairs, Quality, and Safety|(650) 278 4291|dmody@blademed.com|
22297652|NCT03778931|Stemline Therapeutics, Inc.|Carlos A. Garay, MD, Senior Vice President, Clinical Development & Medical Affairs - Solid Tumors|+1-877-332-7967|clinicaltrials@menarinistemline.com|
22297653|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu|
22297654|NCT00775437|AbbVie|Global Medical Information|800-633-9110||
22297655|NCT04688164|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
22297656|NCT04180020|Yale School of Medicine|Sandra Springer, MD|877-554-3578|sandra.springer@yale.edu|
22297657|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297658|NCT03216850|University Hospital Hradec Kralove|Dr. David Astapenko|+420495833218|astapenko.d@seznam.cz|
22297659|NCT01519453|Johns Hopkins School of Medicine|Dr. Michelle Eakin|410-550-0487|meakin1@jhmi.edu|
22297660|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
22297661|NCT02442778|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22297662|NCT02482025|VA Greater Los Angeles Healthcare System|Steven R. Simon, MD|310.268.3132|steven.simon2@va.gov|
22297663|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22297664|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297665|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov|
22297666|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
22297667|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov|
22297668|NCT01398956|UCB Cares|UCB (Study Director)|+1887822||9493
22297669|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org|
22297670|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu|
22297671|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22297672|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22297673|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu|
22297674|NCT01623596|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
22297675|NCT04059146|University of Iowa|Dr. Ruth Chimenti|319-335-9802|ruth-chimenti@uiowa.edu|
22297676|NCT00451035|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22297677|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com|
22297678|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22297679|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu|
22297680|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297681|NCT03274986|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22297682|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297683|NCT02603835|TherOx, Inc.|Jeffrey L. Creech, Ph.D.|(949) 225-6587|jcreech@therox.com|
22297684|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu|
22297685|NCT05627518|Cinclus Pharma AB|Kristofer Katkits Nilsson, Global Trial Manager|+46 7064955|kristofer.katkits@cincluspharma.com|
22297686|NCT01581593|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
22297687|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22297688|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr|
22310385|NCT02510235|Dompé farmaceutici SpA|Clinical Development & operations|+39583831|clinical.trials@dompe.com|
22310386|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
22310387|NCT05990335|Kansas State|Study Director|(785) 532-6850|external+studydirector@nxtech.co|
22310388|NCT03418740|The Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynchd@pennmedicine.upenn.edu|
22280024|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310389|NCT04108130|Columbia University Medical Center|Dr. Marcos F. Vidal Melo|2123424799|mv2869@cumc.columbia.edu|
22310390|NCT04244175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22310391|NCT05505578|225.763.2500 Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22310392|NCT03636490|Columbia University Irving Medical Center|Daichi Shimbo|‭(646) 317-0305‬|ds2231@cumc.columbia.edu|
22310393|NCT01130883|Abbott|Global Medical Services|1-800-633-9110||
22310394|NCT02585323|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
22310395|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22310396|NCT04536012|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
22310397|NCT03364127|University of Illinois Chicago|Judith M. Schlaeger, PhD, CNM, LAc, FAAN|(312) 413-4469|jschlaeg@uic.edu|
22310398|NCT02278211|University of Edinburgh|Professor Dave Newby|0131 242 6515|D.E.Newby@ed.ac.uk|
22310399|NCT05717400|M D Anderson Cancer Center|Harrys A. Torres, MD|(713) 792-6503|htorres@mdanderson.org|
22269098|NCT04025879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22269099|NCT02174510|Shanghai Xuhui Central Hospital, Drug Clinical Trial Institution|Prof.Hu Chaoying|13816319160|cyhu@shxh-centerlab.com|
22269100|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22269101|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501|benoit_mulsant@camh.net|3655
22269102|NCT01225250|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22269103|NCT01845441|University Hospitals Cleveland Medical Center|Dr. Kristine Blackham|216-403-2705|kristine.blackham@gmail.com|
22269104|NCT02259010|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22269105|NCT03194542|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22269106|NCT02976129|VHsquared|Chief Medical Officer|+44 (0)1223 837650|info@vhsquared.com|
22269107|NCT02188147|ZOLL|Vice President Medical Affairs|412-968-3333|stevens@zoll.com|4400
22269108|NCT02640664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22323848|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu|
22323849|NCT03952286|University of Arizona Asthma & Airway Disease Research Center|Dr. Ashley A. Lowe|5206268814|aaray@email.arizona.edu|
22323850|NCT02589977|Vanderbilt University Medical Center|Marvin Kronenberg, MD|615-322-2318|marvin.w.kronenberg@vumc.org|
22323851|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22323852|NCT02393209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323853|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000|joshua.hobson@va.gov|3129
22323854|NCT03751111|Xiangya Hospital, Central South University|Dr. Minxue Shen|86-15973164022|shenmx1988@csu.edu.cn|
22323855|NCT03545282|University of Washington|India Ornelas|206-685-8887|iornelas@uw.edu|
22323856|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22323857|NCT02582671|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22323858|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu|
22323859|NCT01287104|National Cancer Institute|Dr. Nirali N. Shah|301-451-0390|shahnn@nih.gov|
22269109|NCT03175536|Harvard Medical School and Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|6178674893|alison_galbraith@harvardpilgrim.org|
22323860|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr|
22269110|NCT00722137|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22310400|NCT02909686|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
22310401|NCT03858517|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22310402|NCT05268276|Faculty of nursing /cairo university|Asmaa Abdallah Ahmed Hussein|01006961502|asmaaabdallah.cu@cu.edu.eg|
22310403|NCT04804540|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22310404|NCT05172232|Linköping University|Professor Magnus Falk|+46708106176|magnus.falk@liu.se|
22310405|NCT01828021|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
22310406|NCT04012931|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310407|NCT02997202|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22310408|NCT04938726|University of Alabama at Birmingham|Dr. Eric P. Plaisance|2057090980|plaisep@uab.edu|
22310409|NCT04502186|University of Michigan School of Social Work|Dr. Addie Weaver|734-615-2122|weaverad@umich.edu|
22310410|NCT03681262|Stanford University|Vafi Salmasi, MD. MS.|6507250246|vsalmasi@stanford.edu|
22310411|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22310412|NCT02782676|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head of Clinical Sciences|714-247-8613|kendra.hileman@abbott.com|
22310413|NCT04332211|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi MD|4103288025|Mak.Moayedi@som.umaryland.edu|
22310414|NCT05830799|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc|+46 31788 05 60|info@vicorepharma.com|
22310415|NCT03652272|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22310416|NCT04631016|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22310417|NCT05205161|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310418|NCT04704869|The University of Texas Health Science Center at Houston|Bryan A Cotton, MD|713-500-7313|Bryan.A.Cotton@uth.tmc.edu|
22310419|NCT04325815|University College London|Professor Laurence B Lovat|020-7679-9060|l.lovat@ucl.ac.uk|
22310420|NCT04707768|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
22310421|NCT04490109|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22310422|NCT04163991|Horizon Therapeutics USA, Inc.|Ilias Alevizos, PhD, DMD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22310423|NCT05953740|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310424|NCT05496140|UCSF|Lauren M. Haack|415-502-8060|lauren.haack@ucsf.edu|
22310425|NCT05541484|Washington University School of Medicine|Janet McGill, Professor Medicine|314-273-3929|jmcgill@wustl.edu|
22310426|NCT05698368|Stanford University|Dr. Melissa Boswell|(650) 725-4009|boswellm@stanford.edu|
22310427|NCT02785991|Medtronic Ibérica|Patricia Pascual|636183869|patricia.pascual@medtronic.com|
22310428|NCT00626795|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22310429|NCT03998488|Weill Cornell Medicine|Dr. Randy Longman|646-962-6289|ral2006@med.cornell.edu|
22310430|NCT04499521|University of Virginia|Kara Romano, MD|434-982-6278|ked7c@uvahealth.org|
22310431|NCT05132400|NYU Langone Health|Marco Campello, PT, PhD|212-255-6690|Marco.campello@nyulangone.org|
22310432|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org|
22310433|NCT06024642|Imbrium Therapeutics L.P.|Clinical Leader|1-888-827-0622|Medinfo@imbriumthera.com|
22310434|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com|
22310435|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com|
22310436|NCT04734197|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
22310437|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22310438|NCT04165213|University of Pennsylvania, School of Nursing|Emily Summerhayes, Project Manager|6099233786|esummer@nursing.upenn.edu|
22310439|NCT04464564|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
22323861|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22280025|NCT00756275|Brown University|Damaris Rohsenow, PhD|401-863-6665|Damaris_Rohsenow@brown.edu|
22323862|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297689|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
22297690|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22297691|NCT02674412|Cleveland Clinic|Scott Gabbard, MD|216 444-6523|gabbars@ccf.org|
22297692|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22297693|NCT03641378|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@mgb.org|
22297694|NCT00697346|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22297695|NCT03569371|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
22269111|NCT03757312|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
22297696|NCT01433107|Novartis|Clinical Project leader|+41223633111||
22297697|NCT03643562|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22269112|NCT05514873|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22297698|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com|
22297699|NCT01489969|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
22269113|NCT02729025|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22269114|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu|
22297700|NCT02223767|Universitätsklinikum Würzburg|Prof. Dr. M Herrmann|093120176650|Herrmann_m@ukw.de|
22297701|NCT02789176|University of Michigan|Stephanie Rau|734-232-8474|shatchew@med.umich.edu|
22269115|NCT03525678|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297702|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu|
22269116|NCT05096403|Swedish Orphan Biovitrum AB|Luis López Lazaro|46733319155|luis.lopezlazaro@sobi.com|
22297703|NCT05194020|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
22269117|NCT03208166|Medical University of South Carolina|Marc Chimowitz, MD|843-792-3020|mchimow@musc.edu|
22269118|NCT05343000|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
22297704|NCT02224872|Johns Hopkins University|Amy DeZern|4105027208|Adezern1@jhmi.edu|
22269119|NCT04432831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269120|NCT03782792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269121|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297705|NCT03913078|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
22297706|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
22297707|NCT02412631|Mayo Clinic|Dr. Ryan Hurt|(507) 284-2511|gimresearchstudies@mayo.edu|
22297708|NCT02822508|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22297709|NCT03100825|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22269122|NCT02527746|Evivebiotech|Catrina Wang / Senior Medical Director|021-61760866|catrina.wang@evivebiotech.com|
22269123|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300||
22269124|NCT03417557|CooperVision|Myhanh Nguyen, Sr. Optometrist|19257306716|MNguyen@coopervision.com|
22297710|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu|
22269125|NCT04506463|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|Clinical.Trial@sunpharma.com|5689
22269126|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com|
22269127|NCT01295671|Boston Children's Hospital|Dr. David Ludwig|617-355-4878|david.ludwig@childrens.harvard.edu|
22297711|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22297712|NCT05288556|Cleveland Clinic|Eric Yudelevich Blumrosen, MD|216 445-6914|YUDELEE@ccf.org|56914
22310440|NCT04310423|University of California, Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22269128|NCT02395848|McMaster University|Christine Lee|2505191898|clee@mcmaster.ca|
22269129|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22269130|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu|
22269131|NCT01317095|Thomas Jefferson University|Hitoshi Hirose, Professor of Surgery|2159556925|Hitoshi.Hirose@jefferson.edu|
22269132|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269133|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22269134|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22269135|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca|
22269136|NCT03204786|Stanford University|Antonio Hardan, MD|(650)736-1235|autismdd@stanford.edu|
22269137|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net|
22269138|NCT04541589|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22269139|NCT04376346|Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus|Carol Kaufman|303-880-7795|carol.kaufman@cuanschutz.edu|
22269140|NCT03581123|University of Washington|Eric Meier, Study Biostatistician|206-450-0020|emeier11@uw.edu|
22269141|NCT04195685|VA Pacific Islands Healthcare System|Dr. Judy Carlson|808-433-6677|judy.carlson@va.gov|
22269142|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842|ggould@hoosiercancer.org|10
22297713|NCT02704364|NGM Biopharmaceuticals, Inc|Clinical Trial Information and Disclosure|650-243-5555|ngm282@ngmbio.com|
22269143|NCT03448419|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269144|NCT02348918|Allegro Ophthalmics, LLC|Director of Clinical Research|949-940-8130|info@allegroeye.com|
22310441|NCT03786926|HUTCHMED Limited|Chao Pan|(+86)15215192478|chaop@hutch-med.com|
22269145|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu|
22269146|NCT04548193|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|Chong.Wang@roswellpark.org|
22269147|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22269148|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com|
22269149|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com|
22269150|NCT04557215|Cedars-Sinai Medical Center|Mohamad Rashid|310.423.7302|mastprogram@cshs.org|
22269151|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
22269152|NCT00427648|NorthShore Health|Frank F. Tu|8475702521|ftu@northshore.org|
22269153|NCT02187198|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski, PhD|203-932-5711|elizabeth.ralevski@yale.edu|4282
22269154|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org|
22269155|NCT01532518|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
22269156|NCT01575834|Amgen Inc.|Study Director|866-572-6436||
22297714|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300||
22269157|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org|
22269158|NCT03831932|The Ohio State University Comprehensive Cancer Center|Dr. Dwight Owen|614-685-2039|Dwight.Owen@osumc.edu|
22297715|NCT02108821|Children's Mercy Hospital, Kansas City|Alka Goyal MD|816-302-3069|agoyal4@stanford.edu|
22297716|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22297717|NCT02963493|Oncopeptides|Global Clinical Project Lead|866-596-6626|info@oncopeptides.com|
22297718|NCT04889625|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-904-254-0152|TKarkkai@its.jnj.com|
22297719|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22297720|NCT00699010|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
22297721|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
22297722|NCT03663283|Mayo Clinic|Steven J. Hattrup, M.D.|480-301-8519|hattrup.steven@mayo.edu|
22297723|NCT02308735|University of Oklahoma Health Sciences Center|Douglas Dannaway|405-271-5215|douglas-dannaway@ouhsc.edu|42048
22297724|NCT01271868|Aptevo Therapeutics|Dr. David Schaaf|206-859-6655|schaafd@apvo.com|
22297725|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585|neal.doran@va.gov|2421
22297726|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx|
22297727|NCT02614547|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22297728|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
22323863|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu|
22323864|NCT04552470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323865|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk|
22323866|NCT00629083|Contura International A/S|Ieva Ankorina-Stark, Ph D, Chief Scientific Officer|011 45 8110 0900|ieva.ankorina-stark@contura.com|
22323867|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov|
22323868|NCT03401749|University of Alabama at Birmingham|Ashish Shah|205-930-6722|ashishshah@uabmc.edu|
22323869|NCT05003115|Vanderbilt University Medical Center|Dr. Ebele Umeukeje|615-322-3221|ebele.m.umeukeje@vumc.org|
22323870|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323871|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22323872|NCT03757039|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22323873|NCT03406962|Magenta Therapeutics|Medical Director|(857) 242-0170|clinicaltrials@magentatx.com|
22323874|NCT03853694|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22323875|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
22323876|NCT00805207|Washington University in St Louis|Gordon Smith, PhD|314-362-4375|gsmith@wustl.edu|
22323877|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22297729|NCT02151526|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22297730|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com|
22297731|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu|
22297732|NCT04865432|Boston University Chobanian & Avedisian School of Medicine|Michael F. Holick PhD, MD|617-358-6139|mfholick@bu.edu|
22297733|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297734|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|404-778-5984|zalkadh@emory.edu|
22297735|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
22297736|NCT02036502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297737|NCT04652479|Stanford University|Marilyn Tan, MD, FACE|(650) 721-1300|mjtan@stanford.edu|
22297738|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov|
22297739|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com|
22297740|NCT04011410|University of Kentucky College of Medicine|Patrick Hensley|859-562-3223|patrick.hensley@uky.edu|
22297741|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
22297742|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22269159|NCT01956773|Duke University Medical Center|Dr. Lori A. Orlando, Director Program in Precision Medicine|919-660-6606|orlan002@duke.edu|
22280026|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu|
22280027|NCT03394781|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1829|jill.burns@durect.com|
22280028|NCT00420381|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280029|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu|
22280030|NCT01144143|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
22280031|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu|
22280032|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu|
22280033|NCT01482195|King Faisal Specialist Hospital and Research Center|Dr. Fowzan Al Kuraya|+966 11 442 7875|falkuraya@kfshrc.edu.sa|
22280034|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000|joshua.hobson@va.gov|3129
22280035|NCT01244035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22310442|NCT03967379|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
22310443|NCT04664959|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22280036|NCT02776683|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280037|NCT03389308|Castle Creek Pharmaceuticals|Mary C. Spellman, MD|312-847-1291|mspellman@castlecreekpharma.com|
22280038|NCT03350451|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22297743|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu|
22297744|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297745|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu|
22297746|NCT03483675|FHCRC|Kate Chilson|206-667-6069|kchilson@fredhutch.org|
22297747|NCT04052542|University of Pittsburgh School of Medicine|Timothy D Girard, MD, MSCI|(412) 383-0582|timothy.girard@pitt.edu|
22297748|NCT01162382|Washington University School of Medicine|Kathy Pierce|314-362-5626|jenkerson_m@wustl.edu|
22310444|NCT01950234|University of Minnesota|Sarah Hikbert|612-624-7745|hilbe010@umn.edu|
22310445|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com|
22310446|NCT04055012|The University of Pittsburgh|Study Coordinator|412-692-2084|kesslerl@upmc.edu|
22310447|NCT05960032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22310448|NCT05633147|Cinclus Pharma Holding AB|Kajsa Larsson, CMO|+46 706750128|kajsa.larsson@cincluspharma.com|
22310449|NCT02492711|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
22310450|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
22310451|NCT02163694|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22310452|NCT03884101|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310453|NCT05061017|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22310454|NCT05883345|Konkuk University Medical Center|Sun-Young Lee|82-2-2030-7747|sunyoung1973.lee@gmail.com|7505
22310455|NCT02506673|Hospital for Special Surgey|Danya DeMeo, Research Assistant|2127742678|demeod@hss.edu|
22323878|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
22323879|NCT03308188|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
22323880|NCT01791855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323881|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22323882|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323883|NCT04439344|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22323884|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22310456|NCT03880955|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22310457|NCT05112900|Huntsman Cancer Institute at the University of Utah|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
22310458|NCT05386589|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310459|NCT01438853|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@Immunitybio.com|
22310460|NCT02919917|Icahn School of Medicine at Mount Sinai|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22310461|NCT04743973|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@mayo.edu|
22310462|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22310463|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com|
22310464|NCT02461134|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22310465|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22323885|NCT02630953|Brown University|Dr. Bess Marcus, Principle Investigator|401-863-6950|bess_marcus@brown.edu|
22323886|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu|
22323887|NCT03770403|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22323888|NCT03896295|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22323889|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com|
22310466|NCT04300127|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22310467|NCT05412004|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
22310468|NCT03781089|Duke University Medical Center|Dr. John Middleton|919-684-8111|j.p.middleton@duke.edu|
22310469|NCT04644029|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22310470|NCT02246127|Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)|GETNE Secretary|0034934344412|getne@getne.org|
22310471|NCT05988398|University of Michigan|Dr. Katie M Edwards|734-647-8812|edkatie@umich.edu|
22310472|NCT05891275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310473|NCT03733626|William Beaumont Hospitals|Jad Khalil, MD|(248) 663-1900|jad.khalil@corewellhealth.org|
22310474|NCT05147584|Raydiant Oximetry, Inc.|Laura Kemp|4083751465|laurakemp@raydiantoximetry.com|
22269160|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22269161|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu|
22269162|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269163|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov|
22269164|NCT02169271|UT MD Anderson Cancer Center|Dr. Therese Bevers / Clinical Cancer Prevention Department|713-745-8048|tbevers@mdanderson.org|
22269165|NCT04577807|Istari Oncology|Head of Operations|919-245-7662|info@istarioncology.com|
22269166|NCT03591874|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
22269167|NCT03859427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22269168|NCT04031846|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269169|NCT02431676|Johns Hopkins University|Dr. Jessica Yeh|410-614-4316|hyeh1@jhmi.edu|
22269170|NCT00571727|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22269171|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297749|NCT06021951|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22297750|NCT03323658|UT MD Anderson Cancer Center|Priya Thomas,MD-Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
22297751|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297752|NCT00717769|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22297753|NCT01726738|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22297754|NCT03639766|University of Central Florida|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
22297755|NCT01380184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297756|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
22297757|NCT04327986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
22297758|NCT04010266|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
22297759|NCT03350503|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22297760|NCT04492891|Baylor College of Medicine|Michelle Almarez: Clinical Research Manager|713-798-3680|malmarez@bcm.edu|
22297761|NCT03829046|Icahn School of Medicine at Mount Sinai|Dr. Qinzhong Chen|212-659-8864|qinzhong.chen@mssm.edu|
22297762|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590||
22297763|NCT02679911|Galderma|Farzaneh SIDOU Clinical Project Manager|0493957051|farzaneh.sidou@galderma.com|33
22297764|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu|
22297765|NCT04804813|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22297766|NCT05535777|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22297767|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22297768|NCT03756558|Terumo Medical Corporation|Director of Clinical Operations|9085146154|charis.sugden@terumomedical.com|
22297769|NCT02896400|Yale School of Medicine|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
22297770|NCT02984020|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297771|NCT01700179|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22297772|NCT01207778|University of Utah|Dr. Robin Ohls|505-400-7644|robin.ohls@hsc.utah.edu|
22297773|NCT04015219|BioTissue|Medical Affairs|8882968858|medicalaffairs@biotissue.com|
22297774|NCT05168475|Cambridge University Hospitals NHS Foundation Trust|Professor David Jayne|01223 336816|dj106@cam.ac.uk|
22297775|NCT00646204|Baylor College of Medicine/Houston Methodist|William G. Ondo, MD|713-363-8930|wondo@houstonmethodist.org|
22297776|NCT03662100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22323890|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu|
22323891|NCT03185546|Wake Forest School of Medicine|Eric Donny, PhD|336-713-1520|edonny@wakehealth.edu|
22323892|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com|
22269172|NCT01276860|Arkansas Children's Hospital|Clinical Research Coordinator|501-364-2018|boswelljl@archildrens.org|
22269173|NCT05009602|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
22269174|NCT02573597|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
22297777|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|egartner@seagen.com|
22297778|NCT01302964|Massachusetts General Hospital|Christopher J. McDougle, MD|781-860-1783|cmcdougle@mgh.harvard.edu|
22269175|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu|
22280039|NCT01102738|Imperial College London|Dr. Kathleen Sim|(+44) (0)20 7594 3695|k.sim@imperial.ac.uk|
22269176|NCT02126579|University of Virginia|Craig Slingluff, MD; Professor, Department of Surgery; Program Director, UVA Cancer Center|4349249311|cls8h@virginia.edu|
22269177|NCT04229095|The Scripps Research Institute|Dr. Barbara J. Mason, Ph.D. Professor|(858 784-7324|mason@scripps.edu|
22269178|NCT01780038|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
22269179|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269180|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com|
22269181|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22269182|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
22269183|NCT01323517|Memorial Sloan Kettering Cancer Center|Dr. Charlotte Ariyan, MD|212-639-6280|ariyanc@mskcc.org|
22269184|NCT00455403|Wash. Univ. School of Medicine|Janet McGill, MD|314-362-8681|jmcgill@wustl.edu|
22269185|NCT04509076|San Diego State University|D. Keith Horvath, Professor of Psychology|619-594-3346|khorvath@sdsu.edu|
22269186|NCT03351608|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269187|NCT02877004|Mayo Clinic|Dr. Ivana Croghan|507-266-1944|nicotineresearch@mayo.edu|
22269188|NCT02727478|Karolinska Instituet|Dr Breiffni Leavy|+46852488814|breiffni.leavy@ki.se|
22310475|NCT03370913|BioMarin Pharmaceutical Inc.|Tara Robinson, MD, PhD, Senior Medical Director, Clinical Sciences|415-455-7931|tara.robinson@bmrn.com|
22310476|NCT04560179|Stanford University School of Medicine|Erik Jensen, MD, MSCE|267-648-2720|jensene@stanford.edu|
22310477|NCT04078152|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310478|NCT05292222|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
22310479|NCT05966766|Tufts Medical Center|Dan Drzymalski, MD|617-913-8168‬‬‬‬‬‬‬‬‬‬‬‬‬‬|dan.drzymalski@tuftsmedicine.org|
22269189|NCT04029584|University of California, San Francisco|Leslie Benet, PhD|(415) 476-3853|leslie.benet@ucsf.edu|
22269190|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269191|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
22269192|NCT02509507|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22269193|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22269194|NCT01418378|DePuy Synthes|Dave Whalen|574-372-7028|dwhalen@its.jnj.com|
22269195|NCT01987089|Crescenz VA Medical Center|Subhajit Chakravorty|(215)-823-5800|Subhajit.Chakravorty@va.gov|
22310480|NCT05257603|State University of New York at Buffalo|Dr. Kathleen Parks|(716) 887-3301|kparks@buffalo.edu|
22310481|NCT05454514|HIDO TECHNOLOGIES, INC.|Charles Gellman, CEO|5108137224|charles@hidohealth.com|
22310482|NCT04795245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310483|NCT04807777|Columbia University|Alexander Wei, MD|212-305-7115|aw3056@cumc.columbia.edu|
22310484|NCT03279978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310485|NCT04159519|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310486|NCT05305560|MedinCell|Head of Clinical Development|6 40 38 93 83|caroline.denot@medincell.com|0033
22310487|NCT03493542|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310488|NCT02765412|VA Ann Arbor Healthcare System|Angela Larkin|734-845-3612|angela.larkin@va.gov|
22310489|NCT03734029|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22310490|NCT03697408|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22310491|NCT04595331|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22310492|NCT05207033|University of Massachusetts Chan Medical School|Elise Stevens, Assistant Professor|(774) 455-6684|elise.stevens@umassmed.edu|56684
22310493|NCT05020353|Li Ka Shing Knowledge Institute, St. Michael's Hospital|Sean B. Rourke|(416) 878-2779|sean.rourke@utoronto.ca|
22310494|NCT02611687|Bioprojet Pharma|Clinical Project Manager|+33 (0)1 47 03 66 23|a.viatte@bioprojet.com|
22310495|NCT03934931|University of California Irvine|Professor Adithya Cattamanchi|415-206-5489|adithya.cattamanchi@uci.edu|
22310496|NCT03952520|University of North Carolina at Chapel Hill|Jane Chen, PhD|919-966-2537|janechen@live.unc.edu|
22310497|NCT03635567|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310498|NCT05157841|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22310499|NCT06237686|Medical Consultant|Principal Investigator: Søren Meisner, MD|+4520117378|sm_meisner@hotmail.com|
22310500|NCT02075554|Globus Medical Inc.|Brandon Bucklen|610-930-1800|bbucklen@globusmedical.com|2517
22310501|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
22310502|NCT04282109|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
22310503|NCT01167010|Eurofarma Laboratórios S.A|Sandra Rodrigues (Clinical Research)|1150908600|sandra.rodrigues@eurofarma.com.br|8417
22310504|NCT03340428|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
22310505|NCT04243759|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
22310506|NCT04757753|SEPTODONT|Dr. Farid BENABDALLAH|+33785662179|clinical-operations@septodont.com|
22310507|NCT03944915|University of Chicago|Dr. Ari Rosenberg|855-702-8222|arirosenberg@bsd.uchicago.edu|
22310508|NCT02954809|University at Buffalo|Dr. Carleara Weiss|716-829-2006|carleara@buffalo.edu|
22310509|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org|
22310510|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386||
22269196|NCT01812109|University of Texas Southwestern Medical Center|Dr. Linda Baker|214/456-2480|Linda.baker@childrens.com|
22310511|NCT02765854|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Leon Bernal-Mizrachi, MD|336-716-9253|lbernalm@wakehealth.edu|
22280040|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr|
22280041|NCT02304159|Southern California Research Center|Dr. Tarek Hassanein|619-319-3993|thassanein@livercenters.com|
22297779|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com|
22297780|NCT02281851|University of Birmingham|Mathew Soden|07800549318|matthewsoden33@gmail.com|
22297781|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com|
22297782|NCT01076985|Abbott|Global Medical Services|800-633-9110||
22297783|NCT02347527|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristina.legget@cuanschutz.edu|
22297784|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
22297785|NCT01276314|Chang Gung Memorial Hospital, Linko|Drug Hypersensitivity Clinical and Research Center, Laboratory of Dr. Wen-Hung Chung,|886-3-328-1200|kiruamairo@gmail.com|8494
22297786|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
22297787|NCT03237234|Shepherd Center|Dr. Edelle C. Field-Fote|404-603-4274|edee.field-fote@shepherd.org|
22297788|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu|
22297789|NCT03427658|Bournemouth University|Dr Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22297790|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com|
22297791|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297792|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu|
22297793|NCT03097653|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Paola Mosconi and Dr. Anna Roberto|+390239014503|donnainformata-mammografia@marionegri.it; paola.mosconi@marionegri.it|
22297794|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org|
22297795|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
22280042|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300||
22280043|NCT02216526|Charité Universitätsmedizin Berlin, Germany|PD Dr. Jan Kottner|+49 (0)30 450 518 218|jan.kottner@charite.de|
22280044|NCT02348203|University of Arizona|Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22280045|NCT02478489|Boston University School of Public Health and School of Medicine|Richard Saitz, MD MPH|(617) 358-1343|rsaitz@bu.edu|
22280046|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280047|NCT04103450|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22297796|NCT03364049|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
22297797|NCT01340976|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297798|NCT02953821|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22297799|NCT03064126|Boston Scientific|Cynthia Peterson|763-955-8233|Cynthia.Peterson@bsci.com|
22297800|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu|
22297801|NCT03907683|The Pennsylvania State University|Dr David E Conroy|814-863-3451|conroy@psu.edu|
22297802|NCT03400332|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22297803|NCT00048542|Abbott|Global Medical Services|800-633-9110||
22297804|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
22310512|NCT03816397|F.I. Proctor Foundation, University of California, San Francisco|Nisha Acharya, MD, MS|(415) 476-6687|nisha.acharya@ucsf.edu|
22310513|NCT05757193|Duke University|Senthil Selvaraj, MD|919-660-0730|Senthil.Selvaraj@duke.edu|
22310514|NCT04496752|Linus Health|Dr. Sean Tobyne|(617) 433-1777|stobyne@linus.health|
22310515|NCT03907982|Barts and London NHS trust|Dr Malcolm Finlay, Principal Investigator|+442037658635|malcolm.finlay1@nhs.net|
22310516|NCT04908930|Wake Forest University Health Sciences|Jillian Urban, PhD|336.716.0947|jurban@wakehealth.edu|
22310517|NCT04679389|Mayo Clinic|Eva Morava-Kozicz, M.D., Ph.D.|507-266-9140|Morava-Kozicz.Eva@mayo.edu|
22310518|NCT02777593|W.L. Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
22310519|NCT05954546|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310520|NCT04198701|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
22310521|NCT03904576|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310522|NCT04881110|University of Campania Luigi Vanvitelli|Prof. Katherine Esposito, Head of the Division of Endocrinology and Metabolic Diseases|+390815665031|katherine.esposito@unicampania.it|
22310523|NCT05215054|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
22310524|NCT01897441|Albert Einstein College of Medicine|Dr. Jesus Anampa Mesias|718-405-8505|janampa@montefiore.org|
22310525|NCT02933489|ECOG-ACRIN|Director Clinical Research Administration|800-227-5463|dhartfeil@acr.org|4765
22310526|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
22310527|NCT04780581|IBSAL|Project manager|+34 923 29 11 00|uicec.coordinacion@ibsal.es|55779
22310528|NCT03990883|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
22310529|NCT04678856|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22310530|NCT03801616|Cedars-Sinai Medical Center|Dr. Alice Chung|3104239331|alice.chung@cshs.org|
22310531|NCT04633278|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22310532|NCT03705793|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-362-5296|pawina@wustl.edu|
22310533|NCT05448014|Umeå University|Inga Dennhag, Associate Professor|+46706217414|inga.dennhag@umu.se|
22310534|NCT00447980|Neurotech USA, Inc.|Patricia Davis, Sr. Director of Clinical Operations|401.333.3880|p.davis@neurotechusa.com|
22269197|NCT04630002|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269198|NCT04381728|WOMED|Pauline Chirouze|0785225561|pauline@womedtech.com|+33
22269199|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22269200|NCT04498182|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22269201|NCT01788631|Dana-Farber Cancer Institute|Dr. David G. Nathan|61746322155|David_Nathan@dfci.harvard.edu|
22269202|NCT03291080|Nova Laboratories|Dr Hussain Mulla|+44 (0) 116 223 0100|hussain.mulla@novalabs.co.uk|
22269203|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
22269204|NCT03137160|The Ohio State University- Dermatology|Dr. Benjamin Kaffenberger, MD|6143463399|Benjamin.Kaffenberger@osumc.edu|
22269205|NCT03097757|Montefiore Medical Center|Roger Hicks|718-862-1751|roger.hicks@einsteinmed.org|
22269206|NCT01372618|NYU Langone|David Kleinberg|646 501 7504|david.kleinberg@nyumc.org|
22269207|NCT04610346|Jefferson Moss Rehabilitation Research Institute|Sharon Antonucci, Ph.D CCC-SLP, C-AAIS|215-663-6561|sharon.antonucci@jefferson.edu|
22269208|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269209|NCT00931255|UMaryland|Abdolreza Haririan, MD|410-328-5720|ahariria@medicine.umaryland.edu|
22269210|NCT02019264|Eisai Ltd|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22269211|NCT05028790|University of Houston|David A Berntsen, OD PhD|713-743-5836|dberntsen@uh.edu|
22269212|NCT03038867|Weill Cornell Medical College|Research coordinator|212-746-5385|mac4015@med.cornell.edu|
22269213|NCT01417741|OHSU department of APOM|Dr. Christine Martin, assistant professor|503 494 7641|martich@ohsu.edu|
22269214|NCT03821259|University of Edinburgh/NHS Tayside|Klaudia Suchorab|+44 1738 621151|klaudia.suchorab@nhs.net|
22269215|NCT03858998|Weill Cornell Medicine|Dr. Robert Peck|(646) 962-8140|rnp2002@med.cornell.edu|
22269216|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de|
22269217|NCT04205643|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
22269218|NCT04526288|Fred Hutchinson Cancer Center|Dr. Filippo Milano, Director of FHCC Cord Blood Transplant Program|206.667.5925|fmilano@fredhutch.org|
22269219|NCT02798380|Hallux, Inc.|Thomas M Tremblay, RN BSN, Vice President of Clinical Affairs|(415) 305-3491|ttremblay@halluxinc.com|
22269220|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22269221|NCT04926831|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269222|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
22269223|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
22269224|NCT05286450|Sohag University|dr magdy mohamed amin|(093)- 4602963|portal@med.sohag.edu.eg|
22269225|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu|
22269226|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com|
22269227|NCT00669669|Fred Hutch Cancer Research Center|Hans-Peter Kiem, M.D., Ph.D.|206.667.4425|hkiem@fredhutch.org|
22269228|NCT04390113|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
22269229|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269230|NCT02689154|Children's Hospital of Los Angeles|Dr. Alaina Vidmar|323-361-3385|avidmar@chla.usc.edu|
22269231|NCT03379727|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22269232|NCT00715273|University of Washington|Xue-Qiao Zhao|206-744-8305|xueqiao@uw.edu|
22269233|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623||
22269234|NCT03126968|University of Maryland|Robert M. Reed|4103288141|rreed@som.umaryland.edu|
22269235|NCT02576847|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22269236|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu|
22269237|NCT02757053|Heartland Regional Medical Center dba Mosaic Life Care|Clinical Research Development Manager|816 271 7937|Linda.Schumacher@mymlc.com|
22269238|NCT02418182|University of Alabama at Birmingham|Deidre Gunn, Assistant Professor|205-934-1030|ddowns@uabmc.edu|
22269239|NCT01205776|Abbott Vascular|Rhonda Hensley, Clinical Project Manager|+1 828-559-0080|rhonda.hensley@abbott.com|
22269240|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269241|NCT03503370|Baltimore VA Medical Center|Dr. Mary-Claire Roghmann|(410) 706-0062|Mary-Claire.Roghmann@va.gov|
22269242|NCT03483961|Emergent BioSolutions|Sharmila Rajendran|650-486-0244|rajendras@ebsi.com|
22269243|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22269244|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
22269245|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG|
22269246|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22269247|NCT05253573|University of Oklahoma Stephenson Cancer Center|Thanh Cong Bui, MD, DrPH|1-405-271-8001|thanh-c-bui@ouhsc.edu|50559
22269248|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22269249|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269250|NCT01754129|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22269251|NCT01085630|HealthPartners Cancer Care Center|Arkadiusz Z. Dudek M.D., Ph.D.|651 254-3321|Arkadiusz.Z.Dudek@HealthPartners.Com|
22269252|NCT01237041|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
22269253|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22269254|NCT02609607|University of Pittsburgh Medical Center|Dr. David Levinthal|14123030525|levinthald@upmc.edu|
22269255|NCT03691207|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
22323893|NCT02553135|University of Miami|Byron Lam , MD|305-326-6021|blam@med.miami.edu|
22323894|NCT02901431|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323895|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com|
22323896|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu|
22323897|NCT03832387|HOSPITAL GENERAL UNIVERSITARIO DE CASTELLÓN|Dr. ALBERTO BELENGUER MUNCHARAZ|96472500|belengueralberto8@gmail.com|
22323898|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22323899|NCT00784758|University of California, Los Angeles|Dr. Eric Kleerup|310-794-6593|ekleerup@mednet.ucla.edu|
22323900|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu|
22323901|NCT01871506|Elyse Park|Associate Professor|617-724-6836|epark@mgh.harvard.edu|
22323902|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323903|NCT04439266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22323904|NCT02516657|Jacobs School of Medicine and Biomedical Sciences, Department of Pediatrics|Lucy D. Mastrandrea|716-323-0170|ldm@buffalo.edu|
22323905|NCT05027802|Ipsen Bioscience Inc.|Medical Director|see email|clinical.trials@ipsen.com|
22269256|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org|
22323906|NCT03464045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269257|NCT02027545|VA Ann Arbor Healthcare System|Sameer D. Saini, MD, MS|734-845-5865|sameer.saini@va.gov; sdsaini@med.umich.edu|
22269258|NCT02633293|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22269259|NCT01343043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269260|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22269261|NCT02017210|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
22269262|NCT01953302|Varazdin General Hospital|Alen Pajtak|+38542393053|alen.pajtak@obv.hr|
22269263|NCT01790984|University of Surrey|Professor Bruce A.Griffin|+44 0483 689724|b.griffin@surrey.ac.uk|
22269264|NCT04742400|National Institutes of Health|Daniel Reich, MD|301-496-1801|reichds@ninds.nih.gov|
22269265|NCT01346696|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22269266|NCT02182843|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
22269267|NCT05541003|Robert Wood Johnson|Dr. Keerthana Kesavarapu|6784690425|kk1132@rwjms.rutgers.edu|
22269268|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu|
22269269|NCT01051791|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22269270|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
22269271|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269272|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22269273|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22269274|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com|
22269275|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com|
22323907|NCT00001337|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22323908|NCT06161012|Johnson & Johnson Vision Care, Inc. (JJVC)|David Murakami, OD, MPH, FAAO|1-800-843-2020|dmuraka2@its.jnj.com|
22323909|NCT03878147|Michigan State University|Michael J. Boivin|+15178840281|boivin@msu.edu|
22323910|NCT00408005|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22323911|NCT05817045|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
22323912|NCT01506141|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22323913|NCT04889209|Baylor College of Medicine|Dr. Robert L. Atmar|713-798-6849|ratmar@bcm.edu|
22323914|NCT04607408|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|2066675812|hvtn.covpn.sdmc@hvtn.org|
22323915|NCT02148029|Veterans Administration of Baltimore Maryland|Dr. Brajesh K. Lal|410-328-5840|blal@som.umaryland.edu|
22323916|NCT03905928|Pennsylvania State University College of Medicine|Andrea Hobkirk|717-531-7279|alh98@psu.edu|
22323917|NCT05424276|ABLi Therapeutics|Milton Werner|9174940831|info@ablitherapeutics.com|
22323918|NCT01725165|M D Anderson Cancer Center|Dr, Chad Tang|(713) 745-7179|ctang1@mdanderson.org|
22323919|NCT05039086|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22323920|NCT05113940|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22323921|NCT05023252|Veterans Health Administration, Greater Los Angeles Veterans Healthcare Center|Alexander Young MD|310-478-3711|alexander.young@va.gov|
22323922|NCT03619213|AstraZeneca AB|AstraZeneca Clinical Study Information Center|877-240-9479|Information.center@astrazeneca.com|+1
22323923|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com|
22323924|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu|
22323925|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219||
22323926|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
22323927|NCT02514044|University of Texas Health Science Center at Houston (UTHealth)|Dr. Gerard E. Francisco, Chairman and Professor, Physical Medicine and Rehabilitation|713.797.5246|gerard.e.francisco@uth.tmc.edu|
22323928|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com|
22269276|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
22269277|NCT00470717|UHClevelandMC|Dr. Lydia Furman|216-844-8260|Lydia.Furman@uhhospitals.org|
22269278|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269279|NCT01548040|Theragen Inc.|Richard Pearce|901 634 0544|richard.pearce@theragen.com|
22269280|NCT02744430|Baylor College of Medicine|Perla Ramirez|713-798-8514|Perla.Ramirez@bcm.edu|
22269281|NCT03850496|Imperial College London|Dr Tristan Lane, Clinical Lecturer|02033117317|tristan.lane@imperial.ac.uk|
22269282|NCT03090958|UNC-Chapel Hill|Lisa Hightow Weidman, MD|919 966 2536|lisa_hightow@med.unc.edu|
22269283|NCT05209464|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
22269284|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com|
22269285|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org|
22269286|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com|
22269287|NCT03674112|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269288|NCT04157348|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22269289|NCT00426166|University of Toledo|Dr. Martin Skie|419-383-3515|martin.skie@utoledo.edu|
22269290|NCT03020992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22269291|NCT05000164|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
22269292|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269293|NCT03493854|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269294|NCT02422446|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|Ldjousse@rics.bwh.harvard.edu|
22269295|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623||
22269296|NCT01873846|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
22269297|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com|
22269298|NCT02712554|Charleston Laboratories, Inc.|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
22269299|NCT02503540|Cole Eye Institute Cleveland Clinic Foundation|Dr.Justis P. Ehlers|2166360183|ehlersj@ccf.org|
22269300|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com|
22269301|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
22269302|NCT03218995|Sarepta Therapeutics, Inc.|Medical Director|800-690-2003|clinicaltrials@sarepta.com|
22269303|NCT03830333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269304|NCT01445730|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-4717 1990|marja-riitta.taskinen@helsinki.fi|
22269305|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu|
22269306|NCT03134144|Institute of Occupational and Social Medicine and Health Services Research, University of Tübingen|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
22269307|NCT01938092|University of Missouri-Columibia, Dept. Ob/Gyn|Erma Z. Drobnis, Associate Director, Research Success Center|573-817-3124|drobnise@health.missouri.edu|
22269308|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22269309|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com|
22269310|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4|info@cytos.com|7 47
22269311|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269312|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
22269313|NCT03805412|University of Washington Diabetes Institute|Dr. Nicole Ehrhardt|202-741-3422|nehrhard@uw.edu|
22269314|NCT03711786|University of North Carolina at Chapel Hill|Brian Pence, PhD|919-966-7430|bpence@unc.edu|
22269315|NCT03334344|Ceevra|Russ Yoshinaka|415-926-9434|ryoshinaka@ceevra.com|
22269316|NCT02021929|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
22269317|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu|
22269318|NCT07091916|Medtronic Japan Co., Ltd.|Takuto Yamamoto|+818046716498|takuto.yamamoto@medtronic.com|
22269319|NCT02747108|VA Center for Clinical Management Research|Jeffrey Kullgren, MD, MS, MPH - Principal Investigator|(734) 845-3502|jkullgre@med.umich.edu|
22269320|NCT03103152|Queen Mary University, London.|Professor Jack Cuzick, Director of The Wolfson Institute|+44 (0)207 882 3504|j.cuzick@qmul.ac.uk|
22269321|NCT05966584|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2380|markovaa@mskcc.org|
22269322|NCT05682729|University of Dayton|Mary Wagner|9372292775|mwagner8@udayton.edu|
22269323|NCT03548779|University of North Carolina at Chapel Hill|Jonathan Berg, MD, PhD|919-966-7043|jonathan_berg@med.unc.edu|
22269324|NCT03100903|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269325|NCT04659993|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Katie.Duckworth@advocatehealth.org|
22269326|NCT04850989|National University of Singapore|Nur Hani Zainal|+65 6516 3749|hanizainal@nus.edu.sg|
22269327|NCT06360588|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22269328|NCT04010240|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Antoine Italiano|0556333333|a.italiano@bordeaux.unicancer.fr|
22269329|NCT01481766|Hospital for Sick Children, Toronto, Canada|Dr. Patricia Parkin|416-81307654|patricia.parkin@sickkids.ca|
22269330|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22269331|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
22269332|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22269333|NCT03263936|Therapeutic Advanced in Childhood Leukemia and Lymphoma|Ellynore Florendo|323-361-3022|eflorendo@chla.usc.edu|
22269334|NCT06045325|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22269335|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22297805|NCT06138756|Theranica|Dr Dagan Harris|+972-73-3703649|daganh@theranica.com|
22297806|NCT04033159|Dynacure|Dynacure|+33 3 74 95 20 50|info@dynacure.com|
22297807|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com|
22297808|NCT00548860|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22297809|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22297810|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com|
22297811|NCT04152226|Dermbiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
22297812|NCT01452412|Albert Einstein College of Medicine|Michal Melamed, MD|718-430-2496|michal.melamed@einstein.yu.edu|
22297813|NCT02346136|MGH Biostatistics|Eric Macklin, PhD|617-724-9828|emacklin@mgh.harvard.edu|
22323929|NCT03862027|University of North Carolina at Chapel Hill|Amanda Kovacich, MD|919-966-2532|amanda.kovacich@unchealth.unc.edu|
22323930|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com|
22323931|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323932|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323933|NCT02537678|University of South Florida|Alison Salloum|8139741535|asalloum@usf.edu|
22323934|NCT04348851|North Florida/South Georgia Veterans Health System|Dr. Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
22323935|NCT00195650|Abbott|Global Medical Services|800-633-9110||
22323936|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org|
22323937|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
22323938|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22323939|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
22323940|NCT05775289|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22323941|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
22323942|NCT04336397|Alaska Native Tribal Health Consortium|Dr. Diana Redwood|907-729-3959|dredwood@anthc.org|
22323943|NCT02330419|Department of Community Health Systems, University of California at San Francisco|Glenn-Milo Santos, Associate Professor|(628) 2177-6231|glenn-milo.santos@ucsf.edu|
22323944|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063|EBarnath@ITS.JNJ.COM|6171
22323945|NCT02226965|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22323946|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323947|NCT03313050|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323948|NCT04211337|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22323949|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu|
22323950|NCT05818124|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22269336|NCT01623310|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
22269337|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590||
22269338|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269339|NCT05326529|University Hospital of Derby and Burton|Charlotte Smith|01283 593150|charlotte.smith79@nhs.net|3150
22269340|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu|
22269341|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
22269342|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22269343|NCT02273063|Neuromodulation Research Clinic|Director|401-455-6200|Linda_Carpenter_MD@Brown.edu|
22269344|NCT05125848|Zynex Monitoring Solutions|ZMS Clinical|(800) 495-6670|clinical@zynexmonitoring.com|
22269345|NCT04134767|Rollins School of Public Health at Emory University|Dr. Hannah LF Cooper|404-727-0261|hcoope3@emory.edu|
22269346|NCT02344238|Medical University of South Carolina|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
22269347|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu|
22269348|NCT02403479|St. Joseph's Healthcare London|Dr. Leigh Sowerby|519-646-6143|leigh.sowerby@sjhc.london.on.ca|
22269349|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269350|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com|
22269351|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22269352|NCT01831076|University of Colorado|Anthony Elias|720-848-0347|anthony.elias@ucdenver.edu|
22269353|NCT04994691|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22269354|NCT04244084|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22269355|NCT04332081|NYU Langone|David Lee|212-263-3293|David.lee@nyulanogne.org|
22269356|NCT00999609|Spark Therapeutics|Clinical Director||clinicaltrials@sparktx.com|
22269357|NCT02818946|Duke University|Sujata Ghate, MD|919-684-2711|sujata.ghate@duke.edu|
22269358|NCT04123496|Medical University of South Carolina|Donna Robers, MD|843-792-9343|Robertdr@musc.edu|
22269359|NCT02268916|VA Ann Arbor|Pearl Lee, MD|734-845-3182|Pearl.Lee2@va.gov|
22280048|NCT02411461|Vanderbilt University Medical Center|Ashley Shoemaker, Principal Investigator|6153438116|ashley.h.shoemaker@vanderbilt.edu|
22297814|NCT03047135|Johns Hopkins University|Catherine Handy Marshall, MD|410-955-0231|chm@jhmi.edu|
22323951|NCT07145541|AION Biosystems|Samara Barend|9079024986|sam@aionbiosystems.com|
22269360|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590|Babatunde.Ogunnaike@UTSouthwestern.edu|8536
22269361|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg|
22323952|NCT05404776|University of Texas Medical Branch|Meagan Benson, DO|409-772-0982|meaganbenson88@gmail.com|
22280049|NCT02230189|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
22280050|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22280051|NCT02404168|University of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22280052|NCT05501639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280053|NCT03188263|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
22280054|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu|
22280055|NCT02779777|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|ko-tip-003@kuraoncology.com|
22280056|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280057|NCT04540367|Houston Methodist Hospital|Bradley Lambert|8326872483|bslambert@houstonmethodist.org|
22280058|NCT00730886|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22280059|NCT04344184|Virginia Commonwealth University|Dr. Alpha Fowler|(804) 519-4369|alpha.fowler@vcuhealth.org|
22280060|NCT04021290|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22280061|NCT03391882|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22280062|NCT04683913|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
22280063|NCT03913130|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
22280064|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu|
22280065|NCT04046939|Knopp Biosciences|Vice President, Clinical and Translational Medicine|4124881776|calman@knoppbio.com|
22280066|NCT04704193|Massachusetts General Hospital|Daniel Chung, MD|617-726-8687|chung.daniel@mgh.harvard.edu|
22280067|NCT03384875|Cytosorbents|Darlene Lambert-Christie/ Director, Clinical Operations|732.822.3332|DLambert-Christie@cytosorbents.com|
22280068|NCT04790279|Prisma Health Upstate|Katelyn Pratt|2176223524|katelyn.pratt@prismahealth.org|
22280069|NCT01713582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280070|NCT04551898|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280071|NCT03427814|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280072|NCT03846427|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280073|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu|
22280074|NCT02071901|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Sudipto Mukherjee|1-866-223-8100|TaussigResearch@ccf.org|
22280075|NCT02393859|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22280076|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280077|NCT01979614|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22280078|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280079|NCT01535287|University of Iowa|Martin Mueller|3193562633|martin-mueller@uiowa.edu|
22280080|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012||
22280081|NCT03951610|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22280082|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org|
22280083|NCT04971967|University of North Carolina at Chapel Hill Project - China|Ms. Xumeng Yan|+8615330225941|xumeng_yan@seshglobal.org|
22280084|NCT00052910|Yale Cancer Center|Charles S. Fuchs, MD, MPH|(203) 785-4095|charles.fuchs@yale.edu|
22280085|NCT00682929|UC Davis Health|Janelle Butters, NP|916-734-6276|jbutters@ucdavis.edu|
22280086|NCT00938912|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22280087|NCT03663855|NYU Langone Health|David Goldfarb, MD|(212) 263-7300|David.Goldfarb@nyulangone.org|
22280088|NCT03181971|Stanford University|Anisha Patel, MD|(650) 497-1181|anipatel@stanford.edu|
22280089|NCT04343092|College of Medicine-University of Baghdad|Faiq I. Gorial|009647801730696|faiqig@gmail.com|
22280090|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
22280091|NCT02964273|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22280092|NCT03012334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280093|NCT01823107|DSM Biomedical|Forde Hansell|484-713-2152|forde.hansell@dsm.com|
22280094|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22280095|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280096|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22280097|NCT02178800|Fred Hutch Cancer Research Center|Gordon Chau|2066672118|gchau@fredhutch.org|
22280098|NCT02897115|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22297815|NCT00323414|Cleveland Clinic Foundation|Srinivasan Dasarathy MD|216-444-2766|dasaras@ccf.org|
22297816|NCT01632202|Weill Cornell Medicine|Sr. Research Compliance Specialist|646-962-4065|lao2003@med.cornell.edu|
22297817|NCT06105528|ProMIS Neurosciences, Inc.|Wendy Luca|617-250-0365|promisclinical@promisneurosciences.com|
22297818|NCT05619692|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
22297819|NCT02457598|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22297820|NCT01589302|The Ohio State University Comprehensive Cancer Center|Kami Maddocks, MD|614-293-3507|Kami.Maddocks@osumc.edu|
22297821|NCT02703636|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22280099|NCT04512001|Fresenius Kabi SwissBioSim GmbH|Clinical Development|793075735|clinical.development@fresenius-kabi.com|+41
22280100|NCT00581048|Vanderbilt University Medical Center|Ryszard Dworski|615-322-3412|ryszard.dworski@Vanderbilt.Edu|
22297822|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu|
22323953|NCT05630846|GlaxoSmithKline Biologicals SA|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22323954|NCT03697564|University of California, San Diego|Dr. Hitendra Patel|(858) 822-5354|CancerCTO@health.ucsd.edu|
22323955|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323956|NCT03019549|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22323957|NCT04030195|Precision BioSciences|Michael Karg, Senior Director, Clinical Operations|919-324-5512|michael.karg@precisionbiosciences.com|1574
22323958|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22323959|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22323960|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22280101|NCT04231097|Massachusetts General Hospital|Christina Luberto, PhD|617-643-9453|cluberto@mgh.harvard.edu|
22323961|NCT03783195|University of North Carolina at Chapel Hill|Saroja Voruganti, PhD|704-250-5009|saroja@unc.edu|
22323962|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu|
22323963|NCT02240134|University of Montana|Curtis Noonan, PhD|406-243-4957|curtis.noonan@umontana.edu|
22323964|NCT01380899|Facultad de Medicina, Universidad Autonoma de San Luis Potosi|Ildefonso Rodriguez-Leyva|+52 4442043016|ildefonso.rodriguez@uaslp.mx|
22323965|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org|
22323966|NCT02091440|Osaka University Hospital|Prof. Yoshiki Sawa|+81 668793160|sawa@surg1.med.osaka-u.ac.jp|
22280102|NCT03391986|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@columbia.edu|
22280103|NCT03896477|PATH|Mark Alderson|+ 206.302.4859|malderson@path.org|
22280104|NCT01212471|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22280105|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu|
22280106|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22280107|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu|
22280108|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22280109|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca|
22280110|NCT03824392|aTyR Pharma|Lisa Carey|858 731 8389|clinicaltrials@atyrpharma.com|
22280111|NCT00967616|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22280112|NCT01847755|Jupiter Medical Center|Dr. Barry Miskin|561-263-5791|clinicaltrials@jupitermed.com|
22280113|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
22280114|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
22280115|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com|
22280116|NCT01953211|University Reproductive Associates|Michael Cho|(201) 288-6330|michaelcho@nyc.com|
22280117|NCT01628523|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wusm.wustl.edu|
22280118|NCT00768261|Washington University|John G. Csernansky, MD|(312) 926-2323|jgc@northwestern.edu|
22280119|NCT02651545|UBMD Neurology|Michael Jaworski|716-323-0550|mgjawors@buffalo.edu|
22280120|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585|jill.bormann@va.gov|2378
22280121|NCT03386435|Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea|Jun-Gol Song, MD, PhD|+82-2-3010-3869|jungol.song@amc.seoul.kr|
22280122|NCT04068922|University of Florida|Dr. Emily Bartley|352-273-8934|ebartley@dental.ufl.edu|
22280123|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu|
22280124|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no|
22280125|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br|
22280126|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com|
22280127|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com|
22280128|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu|
22280129|NCT00716274|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280130|NCT01932788|Professor of Pediatrics|Carol,Wagner, MD|843-792-8829|wagnercl@musc.edu|
22280131|NCT04290624|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22280132|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org|
22280133|NCT00656370|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22280134|NCT02421757|University of Maryland School of Medicine|Dr. Peter Rock|410-328-6933|prock@som.umaryland.edu|
22280135|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22280136|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com|
22280137|NCT02806414|UCSD Dermatology|Director of Clinical Trials Unit|8586571697|dermstudies@ucsd.edu|
22280138|NCT03111030|Unviersity of British Columbia|Dr. Kathleen Martin Ginis|250-807-9768|Kathleen_martin.ginis@ubc.ca|
22280139|NCT03198156|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
22280140|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com|
22280141|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net|
22280142|NCT03092479|Geisinger Clinic|Michelle Lent, PhD|5702141004|mrlent1@geisinger.edu|
22280143|NCT05653700|Wake Forest University Health Sciences|Kevin Lobdell, MD|704.355.1585|kevin.lobdell@atriumhealth.org|
22280144|NCT00713193|Ohio State University|Spero R Cataland|6142939441|spero.cataland@osumc.edu|
22280145|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280146|NCT02878382|University of Sao Paulo Medical School Brazil|Dr Luis Torezan Associate Professor Dermatology|+551138491888|torezanluis@uol.com.br|
22269362|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22280147|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu|
22280148|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22297823|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590||
22297824|NCT04707534|University of Oklahoma Health Sciences Center|Manager of Clinical Trials|405-271-6173|Dianne-Belshe@ouhsc.edu|
22297825|NCT03316885|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22297826|NCT01820754|Duke University Medical Center|Neal Ready, MD|919 681-6932|neal.ready@duke.edu|
22297827|NCT00704028|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22297828|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22297829|NCT02196324|Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.)|Iain Stuart, PhD.|1- 800-775-7936|Iain.Stuart@foamix.com|
22297830|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu|
22297831|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22297832|NCT02769702|Washington University School of Medicine|Richard Brasington MD|314-454-7255|rbrasing@wustl.edu|
22297833|NCT04248816|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
22297834|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22297835|NCT04859868|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|480-301-5351|Pradhan.Gaurav@mayo.edu|
22297836|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu|
22297837|NCT02849548|Howard University|Ihori Kobayashi|202-865-7185|ihori.kobayashi@gmail.com|
22297838|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu|
22297839|NCT05226104|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22297840|NCT01012817|Mayo Clinic|Andrea Wahner Hendrickson MD|507-293-0553|WahnerHendrickson.Andrea@mayo.edu|
22297841|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov|
22297842|NCT01896895|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22297843|NCT03277846|University of Pennsylvania|Michael Perlis|215-746-3577|mperlis@upenn.edu|
22297844|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com|
22297845|NCT02582840|AstraZeneca K.K.|Yu Shimizuishi|81 6 7711 4669|Yu.Shimizuishi@astrazeneca.com|
22297846|NCT00773175|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22297847|NCT05723770|Bausch & Lomb|Megan Cavet|5852849474|Megan.Cavet@bausch.com|
22297848|NCT03032796|University of California San Francisco|"Joaquin A. Anguera, Associate Professor, Neuroscape | UCSF"|415-502-7322|joaquin.anguera@ucsf.edu|
22297849|NCT04063761|Attune Medical|Clinical Research Coordinator|888.534.4873|info@attune-medical.com|
22297850|NCT03795610|University of California, San Diego|Dr. Assuntina Sacco|(858) 822-6100|agsacco@health.ucsd.edu|
22297851|NCT02775344|Queen Mary Hospital|Dr Manwa Lui|22554647|ellenlui@hku.hk|
22297852|NCT02650986|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22297853|NCT03817320|TACL|TACL|3233615429|TACL@chla.usc.edu|
22297854|NCT03909165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297855|NCT06034496|Center for Applied Brain and Cognitive Sciences|Research Assistant Professor|617-627-1059|kana.okano@tufts.edu|
22297856|NCT02845752|The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Dr. Harry Rossiter|3102228200|hrossiter@lundquist.org|
22269363|NCT04830969|University at Buffalo|Lu Li|7168296284|lli59@buffalo.edu|
22269364|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com|
22269365|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22269366|NCT02748356|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
22269367|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677||
22269368|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269369|NCT04331067|Washington University School of Medicine|Andrew Davis, M.D.|314-273-3581|aadavis@wustl.edu|
22269370|NCT05236764|Baylor College of Medicine|Dr. Erin Morales|832-826-0860|erin.moralesubico@bcm.edu|
22269371|NCT03527589|Merit Medical|Casey Holland|6178420251|casey.holland@merit.com|
22269372|NCT02147834|North Florida South Georigai Veteran Health System|Anthony A Bavry, M.D.|352-548-6000|anthony.bavry@va.gov|104726
22269373|NCT04873869|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
22269374|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
22269375|NCT01796392|Pulmonx Corporation|Narinder Shargill|650-216-0108|nshargill@pulmonx.com|
22269376|NCT03482635|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269377|NCT04639219|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22269378|NCT04681066|CalciMedica|Sudarshan Hebbar (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
22269379|NCT04495829|Woolfson Eye Institute|R. Doyle Stulting, MD, PhD|(770) 255-3330|dstulting@icloud.com|
22269380|NCT03111940|Oxford Heart Centre, John Radcliffe Hospital|Prof Adrian Banning|01865 228934|Adrian.Banning@ouh.nhs.uk|
22269381|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu|
22297857|NCT02377089|UCLA Semel Insititute|Andrew F. Leuchter|310-825-0207|afl@ucla.edu|
22297858|NCT03277261|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22297859|NCT03762083|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
22280149|NCT03848455|Zhujiang Hospital of Southern Medical University|Xiaoya Gao|18680282869|4356975@qq.com|
22280150|NCT02199041|St. Jude Children's Research Hospital|Brandon Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
22280151|NCT01900665|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280152|NCT02481258|Mayo Clinic|Jordan D. Miller, Ph.D.|507-293-0813|Miller.Jordan@mayo.edu|
22280153|NCT03210701|School of Pharmacy, Memorial University|Dr. Debbie Kelly|709 864 7805|dvkelly@mun.ca|
22280154|NCT02317627|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
22280155|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22280156|NCT04749914|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280157|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
22280158|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu|
22280159|NCT04743011|São Paulo State University (UNESP)|Professor Matheus Bertanha, Ph.D.|+551438801444|matheusbertanha@gmail.com|
22280160|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com|
22280161|NCT04011592|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|713-486-2837|Sudhakar.Selvaraj@uth.tmc.edu|
22280162|NCT01364480|University of Pittsburgh|Debbie Harrington, CCRP, senior research coordinator|4123831355|debbie.harrington@pitt.edu|
22280163|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov|
22280164|NCT04103112|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
22280165|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com|
22280166|NCT04005391|University of Colorado|Margo Harrison|19176555178|margo.harrison@cuanschutz.edu|
22280167|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280168|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu|
22280169|NCT03358355|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22280170|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com|
22280171|NCT02291133|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
22280172|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|anademanee@coh.org|62691
22280173|NCT01815424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280174|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22280175|NCT04723355|Hospital Israelita Albert Einstein|Clinical Trialist|551121515915|karla.santo@einstein.br|
22280176|NCT02469701|Brown University Oncology Research Group|Kristen M. Mitchell, CCRP|4018633000|kristen_mitchell@brown.edu|
22280177|NCT03374358|Helsinki University Hospital|Dr Jussi Sutinen|+358407480437|jussi.sutinen@hus.fi|
22280178|NCT01127633|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280179|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com|
22280180|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280181|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu|
22280182|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22280183|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org|
22280184|NCT00775268|National Cancer Institute|Dr. Esther Mena|240-760-6111|esther.menagonzalez@nih.gov|
22280185|NCT01162551|CHOP|Susan Rheingold, MD|215-590-2801|cancertrials@email.chop.edu|
22280186|NCT03745768|Washington University School of Medicine St. Louis|Pilar Cristancho M.D.|314 362 2413|cristanchopimiento.l@wustl.edu|
22280187|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com|
22280188|NCT03723980|Dow University of Health Sciences|Dr. Juzer Shabbir Saifee|92-333-2352134|dr.juzer.shabbir@gmail.com|
22280189|NCT00506779|University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD|713-745-2565|DGershen@mdanderson.org|
22280190|NCT04263766|Georgia Institute of Technology|Dr. Dobromir Rahnev|6466378219|rahnev@psych.gatech.edu|
22280191|NCT04232943|PATH|Rahsan Erdem, MD, Senior Medical Officer|+1 202 540 4546|rerdem@path.org|
22280192|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22280193|NCT01891396|Anika Therapeutics, Inc.|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
22280194|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22280195|NCT02168101|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANNDLClinicalScience@HCAHealthcare.com|
22280196|NCT00400517|Cleveland Clinic|Dr. Jorge Garcia|2164447774|Garciaj4@ccf.org|
22280197|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
22280198|NCT05518461|University of Wisconsin - Madison|Dr. Rachel Gicquelais|(608) 890-1837|gicquelais@wisc.edu|
22297860|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
22297861|NCT00116558|University of Kentucky|Edward J. Kasarskis, M.D., Ph.D.|859-218-5061|ejkas@uky.edu|
22297862|NCT00235872|Abbott|Global Medical Services|800-633-9110||
22297863|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300||
22297864|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297865|NCT02852265|University of California, Davis|Dr. Melissa Chen|916-734-6670|mejchen@ucdavis.edu|
22280199|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22280200|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org|
22297866|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351||
22297867|NCT02432716|HealthPartners Neuroscience Research|Clinical Trial Manager|651-495-6363|maria.x.pyle@healthpartners.com|
22297868|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com|
22297869|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com|
22297870|NCT00534235|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
22297871|NCT00117143|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22297872|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867||
22297873|NCT05052190|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22297874|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22297875|NCT04370691|Abbott|Vinuta Rau|+ 1 408-834-0621|vinuta.rau@abbott.com|
22297876|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22297877|NCT03013543|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22297878|NCT04087122|Valley Health|Rebekah Smith, RN, BSN|540-536-5547|rsmith3@valleyhealthlink.com|
22297879|NCT02552316|University of Pennsylvania|Junko Takeshita|215-349-5551|Junko.Takeshita@pennmedicine.upenn.edu|
22297880|NCT04382911|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22297881|NCT04521166|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
22297882|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu|
22297883|NCT04116710|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|barana@nighthawkbio.com|203
22297884|NCT01256593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297885|NCT02561130|McMaster University|Natalia McInnes|905-521-2100|natalia.mcinnes@mcmaster.ca|
22297886|NCT04514991|University of Pennsylvania- Endodontic Department|Dr. Bekir Karabucak|2158984927|bekirk@upenn.edu|
22297887|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
22280201|NCT02954887|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22280202|NCT03091361|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
22280203|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com|
22280204|NCT03119168|Texas Tech University Health Sciences Center at El Paso|The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma|915-215-4678|antonio.mendoza-ladd@ttuhsc.edu|
22280205|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu|
22280206|NCT01824290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280207|NCT01490918|The Catholic University of Korea, Seoul St Mary's Hospital|Yoon Hee Choi|82-2-2258-8288|choiyh@catholic.ac.kr|
22280208|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22280209|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com|
22280210|NCT02379195|Center for Cancer Immune Therapy, Herlev Hospital|Dr. Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|
22280211|NCT02706925|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280212|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org|
22280213|NCT02382588|Northwestern Universtiy|Dr. Robert Feder|3126958150|r-feder@northwestern.edu|
22280214|NCT01846702|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280215|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com|
22297888|NCT03985813|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
22297889|NCT02161718|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22297890|NCT03463889|University of California, San Francisco|Dr. Robert Flavell, MD PhD|877-827-3222|Robert.Flavell@ucsf.edu|
22297891|NCT00283933|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22297892|NCT02948842|University of South Florida|Lucas Wiegand, MD|813-844-5972|lwiegand@usf.edu|
22297893|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu|
22297894|NCT05124873|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
22297895|NCT02350309|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22297896|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
22297897|NCT01554618|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22297898|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297899|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
22297900|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com|
22297901|NCT01205165|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297902|NCT04352140|Mayo Clinic|J. Ross Renew, M.D.|904-956-3325|Renew.J@mayo.edu|
22297903|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org|
22297904|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
22297905|NCT00978068|University of California, San Francisco|Tamara Clark|415-206-8790|tamara.clark@ucsf.edu|
22297906|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22297907|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22297908|NCT01393405|University of North Carolina, Chapel Hill, NC|Dr. Hans Herfarth|9199666806|hherf@med.unc.edu|
22297909|NCT02281552|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297910|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22280216|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com|
22280217|NCT03682965|Pharma Initiatives|Mark Shapiro|9193063675|mshapiro@pharmainitiatives.com|
22280218|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22280219|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22280220|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22280221|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22280222|NCT05414175|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22280223|NCT00834197|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22280224|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org|
22280225|NCT04028648|seca gmbh & co. kg|Kristin Klückmann|040200000232|kristin.klueckmann@seca.com|
22280226|NCT04050384|Nationwide Children's Hospital|Dr. Lance M. Relland|614-722-5971|lance.relland@nationwidechildrens.org|
22280227|NCT03559270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280228|NCT00577278|City of Hope Medical Center|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
22280229|NCT04776161|Brigham and Women's Hospital|Candace Feldman, MD, MPH, ScD|617-525-1035|CFELDMAN@BWH.HARVARD.EDU|
22280230|NCT01187095|Aarhus University|Yoon Frederiksen|+4587565871|yoonf@psy.au.dk|
22280231|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
22280232|NCT04567524|Lyndra Therapeutics|Nayana Nagaraj, Senior Medical Director|3023040091|Nnagaraj@lyndra.com|
22280233|NCT02848092|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|513-636-8296|jeff.epstein@cchmc.org|
22280234|NCT02189889|UT Southwestern Medical Center|Philip Greilich -PROFESSOR|214/645-8018|PHILIP.GREILICH@UTSouthwestern.edu|
22280235|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
22280236|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu|
22280237|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22280238|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858|michele@innovativepublichealth.org|1-801#
22280239|NCT03432494|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
22280240|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22280241|NCT02921295|University of Pittsburgh|Dr. Goeran Fiedler|4126246475|gfiedler@pitt.edu|
22280242|NCT01833494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22280243|NCT03068897|Montefiore|Dr. Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
22280244|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342|jsk12@case.edu|216
22280245|NCT02607124|Cincinnati Childrens Hosptial Medical Center|Renee Doughman|513-636-1699|renee.doughman@cchmc.org|
22280246|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com|
22280247|NCT04011735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280248|NCT02831855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280249|NCT03368196|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22280250|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280251|NCT03962855|University of Massachusetts Medical School|Jeffrey J Rade MD|774-441-6310|jeffrey.rade@umassmed.edu|
22280252|NCT03326063|Brigham and Women's Hospital|Tanya Laidlaw, MD|617-525-1034|tlaidlaw@bwh.harvard.edu|
22280253|NCT02750514|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22280254|NCT02020590|Bone Therapeutics|Chief Medical Officer|+32 71 12 10 00|regulatory@bonetherapeutics.com|
22280255|NCT02756403|MedStar Washington Hospital Center|Principal Investigator|202-877-7479|peggy.ye@medstar.net|
22280256|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu|
22280257|NCT03046836|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers|8437925807|sellersst@musc.edu|
22280258|NCT03141255|The University of Chicago|Jonathan D. Paul, MD|(773) 702-9461|jpaul@bsd.uchicago.edu|
22280259|NCT02240121|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
22280260|NCT01151020|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22280261|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org|
22280262|NCT01635998|Icahn School of Medicine at Mount Sinai|Sam Cammack|(212) 824-8931|sam.cammack@mountsinai.org|
22280263|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com|
22297911|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22297912|NCT04656132|NYU Rory Meyers College of Nursing|Margaret M. McCarthy, PhD, RN, FNP-BC|212-992-5796|mmm529@nyu.edu|
22297913|NCT04365699|NYU Langone Health|Stuart Katz, MD|212-263-3946|Stuart.Katz@nyulangone.org|
22297914|NCT03761732|University of Washington|Lori Zoellner|206 685 3617|ContactUWCATS@uw.edu|
22297915|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22297916|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757|ssheftel@sheftelderm.com|7106
22297917|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22297918|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es|
22297919|NCT02357147|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22297920|NCT02365636|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22280264|NCT04419467|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22280265|NCT03511001|California State University San Marcos|Dr. Kim Pulvers|760 750 4127|kpulvers@csusm.edu|
22280266|NCT02967679|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
22280267|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
22280268|NCT02471313|National Institutes of Health Clinical Center|Dr. Elliot Levy, Staff Clinician, Radiology & Imaging Sciences|301-402-5368|levyeb@cc.nih.gov|
22280269|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
22280270|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
22280271|NCT04615624|University of Hawaii and Hawaii Pacific Health|Melanie Maykin|8089836000|mmaykin@hawaii.edu|
22280272|NCT04571060|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22280273|NCT01253369|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
22280274|NCT04410159|UNIVERSITI SAINS ISLAM MALAYSIA|NURUL AZMAWATI MOHAMED|+603 42892400|drnurul@usim.edu.my|2417
22280275|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu|
22280276|NCT01853462|Aristotle University of Thessaloniki|Lazaros Lazarou||lazarosphysiotherapist@gmail.com|
22280277|NCT03139032|Arena Pharmaceuticals, Inc.|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
22280278|NCT02765399|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
22280279|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22280280|NCT03958331|Cincinnati Children's Hospital Medical Center|Dr. Avani Modi|513-636-4864|avani.modi@cchmc.org|
22280281|NCT01991483|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280282|NCT02030821|Duke University|Michael Bolognesi, M.D.|919-668-4732|michael.bolognesi@duke.edu|
22280283|NCT03192137|InSite Vision|Senior Manager, Clinical Sciences|+91 9987096080|manjiri.desai@sparcmail.com|
22280284|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280285|NCT02015039|National Institutes of Health|Dr. Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
22280286|NCT01897532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280287|NCT01352286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22280288|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22310535|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22280290|NCT01074931|Abbott|Global Medical Services|1-800-633-9110||
22280291|NCT03132467|UT MD Anderson Cancer Center|Dr. Jennifer Litton, MD- VP, Clinical Research, Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
22280292|NCT01088906|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
22280293|NCT03670160|University of Tennessee Medical Center|Janet Parkey, Director - Research Compliance|865-305-6194|jparkey@utmck.edu|
22280294|NCT00457626|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22280295|NCT03965403|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|6179526319|pbonato@partners.org|
22280296|NCT03366454|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22280297|NCT02836470|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
22280298|NCT02433496|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
22280299|NCT03460652|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
22280300|NCT00548197|Iran university of medical Sciences|Mehdi Modarres|009888602217|mmodarres51@yahoo.com|
22280301|NCT02364037|Washington University School of Medicine|Rachel Paul|3147478176|paulr@wustl.edu|
22280302|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr|
22280303|NCT04072835|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
22280304|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
22280305|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280306|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org|
22280307|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22280308|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000||
22280309|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280310|NCT02329743|Auven Therapeutics|S Weiss|201 486-0396|sid.weiss@auventx.com|
22280311|NCT05160363|Medicines for Malaria|Senior Director, Program Leadership and Strategy|+41 22 555 03 26|borghinii@mmv.org|
22280312|NCT02462187|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22280313|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu|
22280314|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch|
22280315|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu|
22280316|NCT01694433|UCLA|Dr. Jenny Kim|310-825-5420|jekim@mednet.ucla.edu|
22280317|NCT03071861|University of Utah|Tara DuPont|8015814178|tara.dupont@hsc.utah.edu|
22297921|NCT03912233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22280318|NCT00374595|University of Nebraska Medical Center|Jennifer Larsen|(402) 559-4837|jlarsen@unmc.edu|
22280319|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
22280320|NCT00641108|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22297922|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu|
22310536|NCT02720068|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310537|NCT03094052|University of California, San Francisco|Dr. A. Jo Chien, MD|(415) 885-7577|Jo.Chien@ucsf.edu|
22310538|NCT05002738|University of Colorado Anschutz Medical Campus|Eva Dindinger|3037242019|eva.dindinger@cuanschutz.edu|
22310540|NCT01773993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310541|NCT04664881|Mayo Clinic|Joerg Herrmann, M.D.|507-255-1267|Herrmann.Joerg@mayo.edu|
22310542|NCT05643196|NYU Langone Health|Wei Qi|212-961-4492|wei.qi@nyulangone.org|
22310543|NCT04868656|Durham VA Medical Center|Dr. Susan N. Hastings, MD, M.H.Sc|(919) 286-6936|susan.hastings@va.gov|
22310544|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22310545|NCT02295891|Johns Hopkins University|Kristen Rodgers- Research Program Manager, Dept, of Thoracic Surgery|410-955-9047|kpelosk1@jhmi.edu|
22297923|NCT02583256|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22297924|NCT02530294|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22297925|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn|
22297926|NCT03004534|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|030@trioncology.org|
22297927|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu|
22297928|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|74946
22297929|NCT04537806|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22297930|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu|
22297931|NCT03019627|Dompé|Valeria Motta, PhD|02583831|info@dompe.it|
22297932|NCT01802775|Daiichi Sankyo Development Inc.|Clinical Trial Information|+44 1753482800|info@dsd-eu.com|
22297933|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810|Timothy.Carmody@va.gov|6344
22297934|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343||
22297935|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297936|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
22297937|NCT02103478|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22297938|NCT03219333|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22297939|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297940|NCT02566759|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22297941|NCT01096784|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22297942|NCT00976898|Massachusetts General Hospital|Theodore Sunki Hong, MD|617-724-1159|tshong1@mgh.harvard.edu|
22297943|NCT05107128|Sage Therapeutics|Amy Bullock, PhD|617-949-5151|amy.bullock@sagerx.com|
22269382|NCT02438423|Georgia Tech|Mark Prausnitz, PhD|404-894-5135|prausnitz@gatech.edu|
22297944|NCT03761628|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
22297945|NCT01740596|CHF Solutions|Audrey Singh|9523454217|audrey.singh@chf-solutions.com|
22297946|NCT01470469|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22297947|NCT05459129|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22297948|NCT04508725|Stanford University|Dr. Alice Fan|(650) 498-6000|afan@stanford.edu|
22310546|NCT05441683|Department of Periodontology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China|Dr. Yan-Min Wu|+86-13757119560|wuyanmin@zju.edu.cn|
22310547|NCT05109871|Liverpool University Hospitals NHS Foundation Trust|Richard Norris|0151529 2534|richard.norris2@liverpoolft.nhs.uk|
22310548|NCT04408755|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
22310549|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu|
22310550|NCT05374538|VITRAC Therapeutics, LLC|Linda Paradiso, DVM, Chief Development Officer|713-898-8965|linda.paradiso@vitractherapeutics.com|
22310551|NCT06655818|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22310552|NCT03901534|Columbia University|Sanja Jelic, MD|212-543-8875|sj366@cumc.columbia.edu|
22310553|NCT06603766|faculty of medicine Benha University|Dr. Heba Morsy Saad El Din El Ganady|+201111211367|Heba.Aljanadi21@fmed.bu.edu.eg|
22310554|NCT04214418|Columbia University|Gulam Manji, MD, PhD|212-304-6357|gam2140@cumc.columbia.edu|
22310555|NCT04323397|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
22310556|NCT05334355|Montclair State University|Dr. Evan Matthews, Associate Professor|9736553948|matthewse@montclair.edu|
22310557|NCT05785130|ChangGung Memorial Hospital|Ya-Ching, Nien|+886 913112012|yaching79@cgmh.org.tw|
22310558|NCT03351998|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
22310559|NCT04494958|APICES|Juan Luis Sanz|91 816 68 04|juanluis.sanz@apices.es|112
22310560|NCT02624050|Milton S. Hershey Medical Center|Dr. Anthony Bonavia|717-531-6140|abonavia@pennstatehealth.psu.edu|
22310561|NCT03547271|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22310562|NCT04835363|University of Malaga|Garcia-perez, Patricia|+34 675447206|terapiaocupacional.patricia@gmail.com|
22310563|NCT06065735|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269383|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu|
22297949|NCT02638298|Medical University of South Carolina|Dr. Leddy|843-876-1119|leddyl@musc.edu|
22297950|NCT03307759|Peter MacCallum Cancer Centre|Clinical Research Development and Operations|+61 3 8559 5000|crdo@petermac.org|
22310564|NCT03522298|Kazia|Jeremy Simpson|+61 400 410 974|jeremy.simpson@kaziatherapeutics.com|
22310565|NCT01992913|Corporal Michael J Crescenz VA Medical Center|Steven L. Sayers, Ph.D.|(215) 823-5196|steven.sayers@va.gov|
22310566|NCT05718687|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310567|NCT05933772|CooperVision|Jose A. Vega,OD,MSc,FAAO|925-621-3761|jvega2@coopervision.com|
22310568|NCT05485935|Coloplast A/S|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
22310569|NCT04093869|Duke University|Stephanie K. Mabe, MS|919-668-3555|stephanie.mabe@duke.edu|
22310570|NCT02325154|Hospital for Special Surgery, Anesthesiology|Dr. Sean Garvin|2126061036|GarvinS@hss.edu|
22310571|NCT03662022|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
22310572|NCT05275556|Verily|Dr. Scooter Plowman|650-861-9783|splowman@verily.com|
22310573|NCT05836012|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22310574|NCT03248479|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22310575|NCT06017115|Universitat Internacional de Catalunya|Dr. Jordi Gargallo|+34 935 04 20 00|jgargallo@uic.es|
22280321|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu|
22280322|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
22280323|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca|
22280324|NCT01881009|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
22310576|NCT03076021|University of Washington|Dr. Mary Hebert|206-616-5016|mhebert@u.washington.edu|
22310577|NCT03771612|UCLA|Naomi Eisenberger|3108494330|neisenbe@ucla.edu|
22310578|NCT02360371|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
22310579|NCT04731233|University of Florida|Dr. Charles G. Widmer|352-273-5696|widmer@dental.ufl.edu|
22310580|NCT05129501|University of Nebraska-Lincoln, Nebraska Center for Research on Children, Youth, Families, and Schools/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
22310581|NCT01499368|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
22310582|NCT03092674|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22310583|NCT01527188|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 33 55 59 29 70|mroux@stallergenes.com|
22310584|NCT04626427|Becton Dickinson|Simon Lubek, Clinical Program Manager|+33 6 07 56 66 08|simon.lubek@bd.com|
22310585|NCT01553149|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22310586|NCT01265537|St. Paul's Hospital|Dr. Jagbir Gill|6046822344|JAGill@providencehealth.bc.ca|64706
22310587|NCT06202560|Institute of dermatology, Thailand|Chinmanat Lekhavat|+66 95-207-2870|chinmanat@gmail.com|
22310588|NCT04518943|VA Puget Sound Health Care System|Dr. Paul Hebert|(206) 277-4165|paul.hebert2@va.gov|
22310589|NCT03873805|City of Hope Medical Center|Dr. Tanya Dorff|626 218 8231|tdorff@coh.org|
22310590|NCT06408870|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310591|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22310592|NCT04993677|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310593|NCT04174170|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22310594|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu|
22310595|NCT04772534|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310596|NCT04194450|University of British Columbia|Dr. Jonathan Little|(250) 807-9876|jonathan.little@ubc.ca|
22310597|NCT03718130|GenevaUSA.org|Elissa K. Thomas, Associate Director, Corporate Strategy|248-802-6095|ethomas@genevausa.org|
22310598|NCT05265871|Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University|Kefang Lai|18928868231|klai@vip.163.com|
22310599|NCT05875701|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22310600|NCT02514915|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126233272|stadtermanbm@upmc.edu|
22310601|NCT03910218|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
22310602|NCT05769634|Icahn School of Medicine at Mount Sinai|Allison C.Waters|(212) 523-8832|allison.waters@mssm.edu|
22310603|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22310604|NCT04490356|Duke University Medical Center|Kathryn Starr, Ph.D.|919-660-7571|kathryn.starr@duke.edu|
22310605|NCT06664684|İstanbul Bilgi University|Dr. Tugce Ozlu Karahan|+90 212 311 5042|tugce.karahan@bilgi.edu.tr|
22310606|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
22310607|NCT00503971|Fundación GECP|Eva Pereira|+34 934302006|secretaria@gecp.org|
22310608|NCT04675034|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22310609|NCT03201939|Vanderbilt University Medical Center|C. William Wester|6158750145|william.wester@vumc.org|
22310610|NCT04024059|Johns Hopkins University School of Medicine|Kenneth Silverman, Ph.D.|4436176051|ksilverm@jhmi.edu|
22310611|NCT05886452|Mann Eye Institute|Dr Phillip Brunson|17135802500|Phillip.Brunson@manneye.com|
22310612|NCT04177771|RxSight|Jeffrey Ha, VP Clinical Affairs|949-521-7870|jha@rxsight.com|
22323967|NCT03576144|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22323968|NCT00278629|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22280325|NCT01718522|Kinder- und Jugendkrankenhaus Auf der Bult|Prof. Dr. Thomas Danne|0511-8115-3331|danne@hka.de|
22280326|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22323969|NCT03323749|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22280327|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com|
22323970|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|(713) 792-6503|htorres@mdanderson.org|
22280328|NCT02694601|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22323971|NCT00783289|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
22280329|NCT03502915|University of North Carolina at Chapel Hill|Kathleen A. Smith, MD|9199665136|ksmith@aims.unc.edu|
22280330|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22280331|NCT01361217|University of Washington|Nina Isoherranen|206-5432517|ni2@uw.edu|
22280332|NCT03943290|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22323972|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280333|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22280334|NCT00437268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280335|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300||
22323973|NCT03739619|Emory University|Jonathon Cohen, MD|404-778-2214|jonathon.cohen@emory.edu|
22280336|NCT04417257|Laurent Pharmaceuticals Inc.|Vice president Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
22280337|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
22280338|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22280339|NCT03484429|Central Virginia Veterans Affairs Health Care System|Dr. Denise Lester|804-675-5000|denise.lester@va.gov|
22280340|NCT04466384|Medtronic|Ami Stuart PhD|8017934800|ami.stuart@medtronic.com|
22280341|NCT00553410|International Breast Cancer Study Group (IBCSG)|Meredith M. Regan|+1 617 632 3012|mregan@jimmy.harvard.edu|
22323974|NCT05224258|Medtronic Diabetes|Thomas Troub, Sr Clinical Research Program Manager|8052089091|thomas.troub@medtronic.com|
22323975|NCT04053387|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22280342|NCT01328743|Brown University|Christopher Kahler|4018636651|christopher_kahler@brown.edu|
22297951|NCT04649151|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22297952|NCT03752619|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3623|rwilson@metrohealth.org|
22297953|NCT04476017|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22297954|NCT03362502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22297955|NCT04664998|University of Washington|Dr. Renee Heffron|2065203817|rheffron@uw.edu|
22280343|NCT02751814|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22297956|NCT02018458|Baylor Scott and White Health|Dr. Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
22297957|NCT03909009|Izmir Katip Çelebi University, Faculty of Medicine|Doç.Dr. Ayhan AŞKIN|00902322444444|ayhanaskin@hotmail.com|1529
22297958|NCT00654069|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
22297959|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no|
22297960|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
22297961|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22297962|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22310613|NCT02806726|Johnson & Johnson Surgical Vision, Inc.|Priya Janakiraman|1 714 2478628|djanaki1@its.jnj.com|
22280344|NCT05393245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280345|NCT03508674|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22310614|NCT03250676|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22310615|NCT05073510|BlueDop Medical, Ltd.|Dr. Patrick Kelly|+1 605 521 9831|patrick@bluedopmedical.co.uk|
22310616|NCT05372042|University of Washington|Dr. Kristen Lindgren|206-658-8083|kpl9716@uw.edu|
22310617|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22310618|NCT03512301|Psychology Software Tools, Inc.|Anthony Zuccolotto|412-449-0078|anthony.zuccolotto@pstnet.com|
22310619|NCT03779984|UTexasSouthwestern|David Mercier|214-645-3479|David.Mercier@utsouthwestern.edu|
22310620|NCT03363763|Aucta Pharmaceuticals, Inc.|Dr. Marie Tan|7329129575|Marie.Tan@auctapharma.com|
22310621|NCT05419856|4Moving Biotech|Odile Fleurot|03 20 11 80 30|odile.fleurot@4p-pharma.com|
22310622|NCT06102421|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolicky|+420702088258|jakubkatolicky@gmail.com|
22310623|NCT02945800|Moffitt Cancer Center|Jonathan Metts, MD|813-745-5616|Jonathan.Metts@moffitt.org|
22297963|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000|jejike@llu.edu|44250
22297964|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com|
22297965|NCT04296396|George Washington University Biostatistics Center|MFMU Principal Investigator|301-881-9260|mfmudatasets@bsc.gwu.edu|
22297966|NCT06219915|University of Michigan|Principle Investigator|734-998-8400|pchatkae@umich.edu|
22297967|NCT05320029|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
22297968|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22297969|NCT04049760|Amicus Therapeutics, Inc.|Patient Advocacy|001 609-662-2000|clinicaltrials@amicusrx.com|
22297970|NCT02927457|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297971|NCT03995953|Implenomics|Sujha Subramanian|(302) 200 8310|sujha.subramanian@implenomics.com|
22297972|NCT02130765|Abbott|Senior Clinical Research Scientist|6517562885|amber.miller@abbott.com|
22297973|NCT02388997|University of Virginia|Peter W. Heymann|434-982-3654|pwh5a@virginia.edu|
22297974|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu|
22297975|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
22297976|NCT01256710|Abbott Medical Devices, Structure Heart Valves|Yunlong (Phil) Zhang, MD, MS, Clinical Consultant|669-203-9308|phil.yl.zhang@abbott.com|
22297977|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov|
22297978|NCT04155008|Montefiore Medical Center|Dr. Justin Tang|718-920-4094|jtang@montefiore.org|
22297979|NCT04019041|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22297980|NCT03925727|Mimetogen Pharmaceuticals|VP Clinical Development|514 924 7484|karen.meerovitch@mimetogen.com|
22297981|NCT00213148|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22297982|NCT02581384|Dana-Farber Cancer Institute|Karen Marcus MD|16177328783|karen_marcus@dfci.harvard.edu|
22297983|NCT02321462|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
22297984|NCT04425746|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22297985|NCT01514396|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
22310624|NCT02231749|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22297986|NCT03044197|UTexasGalveston|Lori Simon|409-772-1978|lasimon@utmb.edu|
22297987|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901|nina.stachenfeld@yale.edu|219
22297988|NCT01574352|USouthernDenmark|professor Lars Bo Andersen|+45 60114380|lars.bo.andersen@hvl.no|
22297989|NCT00245765|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22297990|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu|
22297991|NCT02741115|Mezzion Pharmaceuticals, Inc|Director of Clinical Trials|5734342579|kelly.williams@mezzion.com|
22297992|NCT06425458|Unity Health Toronto|Dr. Naomi Thulien|(416) 864-6060|naomi.thulien@unityhealth.to|77476
22297993|NCT05711927|Columbia University Irving Medical Center|Toni Iurcotta, MD|646-532-8196|ti2241@cumc.columbia.edu|
22297994|NCT03945981|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22297995|NCT03750903|Department of Veterans Affairs|Dr. Joe Nocera, PI|404 321 6111|joe.nocera2@va.gov|121662
22297996|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22297997|NCT03548584|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22297998|NCT04346615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22297999|NCT02215070|Duke University|Anthony Sung|919-668-1000|anthony.sung@duke.edu|
22298000|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com|
22298001|NCT01595516|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
22298002|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999|yangxiaoyu@huashan.org.cn|7693
22298003|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu|
22298004|NCT04368429|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22298005|NCT03940508|New York University|Dr. Michael A. Lindsey|212-998-5959|michael.lindsey@nyu.edu|
22298006|NCT03633396|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22298007|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22298008|NCT00110266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22310625|NCT04819191|Johns Hopkins Bloomberg School of Public Health|Jennifer Wolff, PhD|(410) 502-0458|jwolff2@jhu.edu|
22298009|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22298010|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org|
22298011|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298012|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org|
22298013|NCT04016324|Medtronic|Rianna Rapson (Prin. Clinical Research Specialist)|763-526-2170|rianna.k.rapson@medtronic.com|
22298014|NCT04709237|Coopervision|Paul Chamberlain|925-251-6682|PChamberlain@coopervision.com|
22298015|NCT02610192|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
22298016|NCT04048460|University of South Florida Department of Communication Sciences & Disorders|Michelle Arnold, AuD, PhD, CCC-A Assistant Professor|(813) 974-1262|mlarnold@usf.edu|
22310626|NCT04602611|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
22310627|NCT04567316|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280346|NCT03137771|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22280347|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com|
22280348|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22280349|NCT03052608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280350|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22280351|NCT05554146|Montefiore Medical Center|Dr. Deepika Slawek|718-920-3786|dslawek@montefiore.org|
22280352|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu|
22280353|NCT03073525|Gradalis, Inc|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
22280354|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com|
22280355|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
22280356|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280357|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200||
22280358|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
22280359|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500|CColesb@ITS.JNJ.com|3449
22280360|NCT00589797|Aesculap Inc.|Associate Director of Medical and Scientific Affairs|800-258-1946|mikhail.chkolnik@aesculap.com|5173
22280361|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu|
22280362|NCT02141672|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22298017|NCT01359592|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
22298018|NCT02881996|Children's Mercy Hospital|Shawn St. Peter|816-234-3000|sspeter@cmh.edu|3575
22298019|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu|
22298020|NCT00419562|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22298021|NCT00355238|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22298022|NCT01454934|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22298023|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298024|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22298025|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu|
22298026|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw|
22298027|NCT03746522|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22298028|NCT03323099|University of California San Francisco|Dr. Greg Marcus|4154763393|greg.marcus@ucsf.edu|
22298029|NCT02082717|Baptist Health South Florida|Diana D'Orazio-Garcia|786-594-9737|DianaDO@baptisthealth.net|
22298030|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22298031|NCT04135703|The Oho State University|Natasha Slesnick|6142478469|slesnick.5@osu.edu|
22298032|NCT05422053|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
22298033|NCT05132127|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22298034|NCT05220397|Mayo Clinic|Mark Stegall, M.D.|507-266-2812|stegall.mark@mayo.edu|
22298035|NCT02659020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298036|NCT02052739|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22298037|NCT02043015|Emory University|Patrick S Sullivan PhD/DVM|404-727-2038|pssulli@emory.edu|
22298038|NCT00868621|Cleveland Clinic Florida|Gamal M. Ghoniem, MD, FACS|954-659-5188|ghonieg@ccf.org|
22298039|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298040|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298041|NCT02385799|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
22298042|NCT04958109|Massachusetts General Hospital|Margaret Lippincott|6177268434|mlippincott@mgh.harvard.edu|
22298043|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org|
22298044|NCT02346240|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22298045|NCT02681302|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22298046|NCT02942017|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
22298047|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
22298048|NCT00838565|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298049|NCT00458484|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Mitchell Machtay MD|216-844-2530|mitchell.machtay@uhhospitals.org|
22298050|NCT04907032|UAB|Russell Stanley|325-829-8315|russellstanley74@gmail.com|
22298051|NCT02253810|Hospital for Special Surgery|Dr. Ernest Sink|2126061279|Sinke@hss.edu|
22298052|NCT01467999|NYSPI|daniel brooks|6467746171|daniel.brooks@nyspi.columbia.edu|
22298053|NCT00291668|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22298054|NCT01557400|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22298055|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
22298056|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22280363|NCT02688192|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
22298057|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22280364|NCT01773967|Cincinnati Children's Hospital Medical Center|Dr. David Schnadower|5138035526|david.schnadower@cchmc.org|
22280365|NCT03889028|Clinical University Hospital of Valencia|David Navarro|+34961973500|david.navarro@uv.es|
22280366|NCT00579553|University of Oklahoma Health Science Center|Andrew Elimian, MD|19146465194|aelimian@aol.com|
22280367|NCT04345900|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
22280368|NCT04860869|University of Texas Medical Branch|Randall Urban|409-772-5476|rurban@utmb.edu|
22280369|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
22280370|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com|
22280371|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu|
22280372|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu|
22310628|NCT02637609|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
22310629|NCT03884439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310630|NCT03839446|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
22310631|NCT04281498|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
22323976|NCT03095703|Amsterdam UMC, location Academic Medical Center|Prof. dr. Evelien Dekker|+3120-5663534|e.dekker@amsterdamumc.nl|
22310632|NCT04342260|University of North Carolina Lineberger Comprehensive Cancer Center|Amanda Gentry|(336) 655-7743|agentry@email.unc.edu|
22323977|NCT03539432|The Mind Research Network|Dr. Eric Claus|5055151556|eclaus@mrn.org|
22310633|NCT03142009|University of New Mexico College of Population Health|Dr. Nina Wallerstein|404-272-4173|nwallerstein@salud.unm.edu|
22310634|NCT04319887|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
22323978|NCT01381094|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
22323979|NCT03370757|Duke University School of Nursing|Dr. Debra Brandon|919-681-3813|debra.brandon@duke.edu|
22323980|NCT02443402|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22323981|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu|
22323982|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22323983|NCT02665689|Charité University, Berlin|Prof. Dr. Antonia Joussen|+49 30 84452331|antonia.joussen@charite.de|
22323984|NCT03198221|Cleveland Clinic|Dr. Carol Burke|216-444-6864|BurkeC1@ccf.org|
22323985|NCT01035151|University of South Caroina|Jeannette Andrews|803 777 3862|j.andrews@sc.edu|
22323986|NCT04504318|Stanford University|Dr. Arash Momeni|650-723-6189|amomeni@stanford.edu|
22323987|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343||
22323988|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22323989|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
22269384|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22269385|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269386|NCT02571673|Memorial Sloan Kettering Cancer Center|Dr. Talya Salz, PhD|646-227-3646|salzt@mskcc.org|
22269387|NCT04722315|Kennedy Krieger Institute|Dr. Jacqueline Harris|6672054295|harrisjac@kennedykrieger.org|
22269388|NCT03868930|VA Boston Healthcare System|Dr. Catherine B. Fortier|857-364-4361|Catherine.Fortier@va.gov|
22269389|NCT06047366|Indiana University School of Dentistry|Dr. Ken Spolnik|317-274-7280|kspolnik@iu.edu|
22269390|NCT02151851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22269391|NCT02159053|Novartis Pharmaceuticals|Study Director|8627788300||
22269392|NCT02640950|Sheppard Pratt Health System|Director of Clinical Research|4109383125|saaronson@sheppardpratt.org|
22269393|NCT04545489|Durham VA Health Care System|Dr. Hayden Bosworth, PhD|919-286-0411|Hayden.Bosworth@va.gov|177101
22269394|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22269395|NCT04003636|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22269396|NCT03048747|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22269397|NCT05336630|Dartmouth-Hitchcock Medical Center|Dr. Timothy B. Gardner|603-653-9033|timothy.b.gardner@hitchcock.org|
22269398|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22269399|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22269400|NCT02582242|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22310635|NCT03587805|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22310636|NCT03982186|Janssen Sciences Ireland UC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310637|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22310638|NCT03008382|Virginia Commonwealth University|Dr. Thomas Chelimsky|(804) 628-4859|Thomas.Chelimsky@vcuhealth.org|
22310639|NCT06637774|University of Pittsburgh|James Coyle|4123836608|jcoyle@pitt.edu|
22310640|NCT05362474|University of Colorado Denver|Jessica Kendrick|303-724-4837|jessica.kendrick@cuanschutz.edu|
22310641|NCT04039113|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310642|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22269401|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22323990|NCT02988856|Massachusetts Eye and Ear|Kevin Houston|617-573-4177|kevin_houston@meei.harvard.edu|
22323991|NCT02210780|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22323992|NCT01562028|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|belief@etop-eu.org|
22310643|NCT02180867|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22280373|NCT01881789|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22310644|NCT05267639|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
22310645|NCT04732871|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22310646|NCT05787054|Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli|Dr Alessandra Familiari|+393285887422|alessandra.familiari@policlinicogemelli.it|
22310647|NCT03109873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Adam Luginbuhl|215-240-0748|adam.luginbuhl@jefferson.ed|
22310648|NCT00983307|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maria Werner-Wasik|215 955-6702|maria.werner-wasik@jefferson.edu|
22310649|NCT05180539|Lehigh University|Lucy Napper|610 758 4689|lun214@lehigh.edu|
22310650|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22310651|NCT02502266|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22310652|NCT02719574|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22310653|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org|
22310654|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22310655|NCT02467270|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22310656|NCT01969916|University of Chicago|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
22310657|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310658|NCT04632394|St George's University of London|Dr Michael Waight|020 8672 9944|m2110065@citystgeorges.ac.uk|
22310659|NCT02988193|Optima Integrated Health|Gabriela Voskerician|6502233588|gxv4@case.edu|
22310660|NCT02306161|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310661|NCT05377411|University of Florida|Dr. Aprinda Queen|(352) 294-8990|aprinda.indahlas@phhp.ufl.edu|
22310662|NCT05030584|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22269402|NCT00603902|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22269403|NCT02101736|The University of Alabama at Birmingham|Karen Cole-Plourde, Program Director -NFCTC|(205) 514-1317|kplourde@uab.edu|
22269404|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208|samuel.ginja@newcastle.ac.uk|4565
22269405|NCT02453334|American Regent, Inc|Mark A. Falone, MD MPH|631-772-3544|mfalone@americanregent.com|61844
22269406|NCT01841762|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani / Associate Director, Clinical Operations|6508086586|scott.tsurutani@actelion.com|
22269407|NCT02362672|Nektar Therapeutics|Medical Affairs||StudyInquiry@nektar.com|
22269408|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu|
22269409|NCT05483686|ISA Associates, Inc.|Dr. Samantha Leaf|703-739-0880|sleaf@isagroup.com|4
22269410|NCT03981900|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269411|NCT02693106|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22269412|NCT02669901|Univesity of New Mexico School of Medicine|Dr. Joanna Katzman, Principal Investigator|(505) 272-2321|JKatzman@salud.unm.edu|
22269413|NCT03611777|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269414|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22269415|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com|
22269416|NCT06152224|UW School of Medicine and Public Health|Ushma Patel, MD|(608) 287-5898|upatel@uwhealth.org|
22269417|NCT05780983|Wake Forest University Health Sciences|Jaime M Hughes, PhD, MPH, MSW|336-716 -0835|jane.hughes@wfusm.edu|
22269418|NCT03126630|Mayo Clinic|Dr. Aaron Mansfield|(507) 284-2511|mansfield.aaron@mayo.edu|
22269419|NCT06028438|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22269420|NCT05625802|University of Michigan|Christopher Fung|734-763-4091|chfung@med.umich.edu|
22269421|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu|
22269422|NCT00808210|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
22269423|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu|
22269424|NCT03150719|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22269425|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
22269426|NCT01954056|University of New Mexico|Dr. Kristi Watterberg|505-272-8609|KWatterberg@salud.unm.edu|
22269427|NCT04005404|Helios Center for Research and Innovation|Director Prof. Dr. Petra Thürmann|0049 (0)202 896-1851|petra.thuermann@helios-gesundheit.de|
22269428|NCT04938180|AmMax Bio., Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
22269429|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com|
22269430|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
22269431|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581||
22269432|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269433|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
22280374|NCT00920556|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280375|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509||
22269434|NCT00441129|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22310663|NCT00410423|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|Joanne.Filicko@jefferson.edu|
22280376|NCT02834819|Children's Hospital Colorado/University of Colorado|Cortney Braund, MD|4406696880|Cortney.Braund@childrenscolorado.org|
22323993|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22323994|NCT04938648|Johns Hopkins University|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
22280377|NCT03637491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280378|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com|
22280379|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
22323995|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22280380|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673|jlongmat@coh.org|62478
22323996|NCT05127486|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22280381|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22280382|NCT02073162|The Cleveland Clinic Foundation|Dr. Daniel Sessler|216-444-4900|ds@or.org|
22280383|NCT04179305|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
22269435|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22269436|NCT03283787|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
22269437|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org|
22269438|NCT02905981|Rockwell Medical|Ray Pratt, MD|248 960-9009|rpratt@rockwellmed.com|405
22269439|NCT03365635|Penn Presbyterian Medical Center|Michael R. Rudnick, MD|215-662-8738|rudnickm@uphs.upenn.edu|
22269440|NCT04278417|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269441|NCT03146806|Emory University|Vinita Singh, MD|404-686-2410|vinita.singh@emory.edu|
22269442|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269443|NCT05870371|Musculoskeletal Research Laboratory (MRL) of Physiotherapy Department University of West Attica, Athens, Greece|Dr. George Georgoudis|+30-210-5387487|physiolab@uniwa.gr|
22269444|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com|
22269445|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com|
22269446|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269447|NCT03308097|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
22269448|NCT02522884|Intact Vascular, Inc.|Joseph C. Griffin, III|4842531048|JGriffin@intactvascular.com|1043
22269449|NCT04495751|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|hklepin@advocatehealth.org|
22269450|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu|
22269451|NCT02907177|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22269452|NCT02968173|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22269453|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu|
22269454|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu|
22269455|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu|
22269456|NCT03474965|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269457|NCT04033237|University of Vermont|Sarah H. Heil, PhD|802-656-8712|Sarah.Heil@uvm.edu|
22269458|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269459|NCT00638404|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22269460|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22269461|NCT00687271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269462|NCT02829320|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269463|NCT02110758|National Committee for Quality Assurance|Sarah Hudson Scholle|202-955-1726|scholle@ncqa.org|
22269464|NCT04090060|Medical college of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
22269465|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22269466|NCT03337113|Kent State University|William Lechner|814-450-1093|wlechner@kent.edu|
22269467|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269468|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com|
22269469|NCT03892642|OU Health Stephenson Cancer Center|Associate Professor|405-271-6900|kelly-stratton@ouhsc.edu|
22269470|NCT02215200|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8361|cjgreen@benaroyaresearch.org|
22269471|NCT03070600|University of Washington|Grace John-Stewart|206-543-4278|gjohn@uw.edu|
22269472|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com|
22269473|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22269474|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu|
22269475|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22269476|NCT06110494|University of Pennsylvania|Dr. Bekir Karabucak Chair of the Department of Endodontics|215-898-4927|bekirk@upenn.edu|
22269477|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590||
22269478|NCT01464593|Celsion Corporation|Chief Medical Officer|609-896-9100|nborys@celsion.com|
22269479|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu|
22280384|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu|
22323997|NCT02724033|Department of Otolaryngology, Indiana University School of Medicine|Dr. Charles Yates, Primary Investigator|317-278-1286|cwyates@iupui.edu|
22323998|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088||
22323999|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324000|NCT04802837|Summit Therapeutics|Katie Tran|4086776503|Katie.Tran@Summitplc.com|
22324001|NCT03193866|Karolinska Institutet|Professor Fredrik Piehl|+46-(0)8-517 798 40|fredrik.piehl@ki.se|
22280385|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com|
22324002|NCT04586504|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
22324003|NCT01464697|University of British Columbia|Dr. Jerilynn C. Prior, Professor|6048755927|jerilynn.prior@ubc.ca|
22324004|NCT02688647|Kadmon Corporation|Karin Herrera, Vice President, Clinical Operations|1-724-778-6134|karin.herrera@kadmon.com|
22324005|NCT02542267|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
22324006|NCT03093402|DAIT/NIAID|Director, Clinical Research Operations Program|3015947669|DAITClinicalTrialsGov@niaid.nih.gov|
22324007|NCT01276184|University of Maryland School of Medicine|Dr. J. Kathleen Tracy, PhD|410-706-1205|ktracy@som.umaryland.edu|
22324008|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu|
22324009|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu|
22324010|NCT02731742|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324011|NCT04026568|Penn State Hershey Medical Center|Kenneth Taylor, MD, Professor of Orthopaedics and Rehabilitation|717-531-2948|ktaylor3@pennstatehealth.psu.edu|
22324012|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22324013|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22324014|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov|
22324015|NCT02673229|The University of Kansas Health System|Suzanne Mitchell, PhD, ARNP, FNP-BC, CWS|913-588-5000|smitchell3@kumc.edu|6562
22324016|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)||
22324017|NCT03417440|University of Southern California Chan Division of OS-OT|Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
22324018|NCT00355264|BioMarin Pharmaceutical Inc.|Joshua Lilienstein|651-523-0310|MEDINFO@bmrn.com|
22324019|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
22324020|NCT03424161|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22324021|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu|
22324022|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22324023|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324024|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810|Timothy.Carmody@va.gov|6344
22324025|NCT02109029|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324026|NCT03195894|KontigoCare AB|Markku Hämäläinen, Research Director|0769 47 31 32|markku.hamalainen@kontigocare.com|
22324027|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
22324028|NCT02101437|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22324029|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300||
22324030|NCT02718820|Medical University of Vienna|Thorsten Fuereder|+43140400|thorsten.fuereder@meduniwien.ac.at|44450
22324031|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu|
22324032|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300||
22324033|NCT00852644|Boston Medical Center|Minh Tam Truong|617-638-7070|minh-tam.truong@bmc.org|
22324034|NCT03424109|NYU Langone Health|Allison Cuthel|212-263-8631|Allison.Cuthel@nyulangone.org|
22324035|NCT02966314|University of Wisconsin - Madison|Ravi Viswanathan|(608) 263-1081|rviswanathan@medicine.wisc.edu|
22280386|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org|
22280387|NCT00625586|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22324036|NCT02582515|Johns Hopkins University School of Medicine|Assistant Professor|443-287-5143|jfmcguire@jhmi.edu|
22280388|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu|
22280389|NCT02246010|American University of Beirut|Dr. Mona Nabulsi|9611350000|mn04@aub.edu.lb|5523
22324037|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324038|NCT02197377|DorkuzEU|Anaesthesiology and Reanimation|0905055252901|ozbilginsule@gmail.com|
22324039|NCT02786901|Bausch Health|Study Manager|(908) 242-8287|sandra.narain@bauschhealth.com|
22324040|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
22280390|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu|
22280391|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22324041|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300||
22280392|NCT02737501|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22280393|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22280394|NCT04819113|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280395|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22280396|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu|
22324042|NCT00826514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324043|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979||
22280397|NCT01482715|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22280398|NCT01985022|Emory University|Nathan Call, PhD|404-785-9400|nathan.call@choa.org|
22280399|NCT05599100|University of Washington School of Public Health, Department of Health Systems and Population Health|Magaly Ramirez, PhD, MS, MS|206-543-9773|maggiera@uw.edu|
22280400|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22280401|NCT03761056|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22280402|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280403|NCT04749745|Butler Hospital|Dr. Shiwen Yuan|2025783000|shiwen_yuan@brown.edu|
22280404|NCT02161536|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|+972 526145354|ravit@motusgi.com|
22280405|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300||
22324044|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu|
22324045|NCT03663166|Moffitt Cancer Center|Bradford A. Perez, MD|813-745-4380|bradford.perez@moffitt.org|
22280406|NCT04566731|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
22280407|NCT04267926|Department of Veterans Affairs MS Center of Excellence-West and Portland, Oregon Health & Science University|Vijayshree Yadav MBBS, MCR|503-494-3813|yadavv@ohsu.edu|
22298058|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22298059|NCT03962543|SpringWorks Therapeutics, Inc.|Head of Clinical Operations|8772794870|clinical@springworkstx.com|
22298060|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com|
22298061|NCT02917031|AstraZeneca R&D|AstraZeneca R&D|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22298062|NCT03285373|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298063|NCT02871128|Chung Shan Medical University|Dr. You-Cheng Shen|+886-4-24730022|youcheng@csmu.edu.tw|12107
22298064|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298065|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22298066|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu|
22324046|NCT00605826|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22324047|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22324048|NCT02620020|Regeneron Pharmaceuticals|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22298067|NCT01962558|MicroTransponder|VP Clinical Affairs|512-371-4160|studies@microtransponder.com|
22298068|NCT04300296|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22298069|NCT05044234|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22324049|NCT03456115|Johns Hopkins University Hospital|Christopher Razavi, MD|410-955-2307|crazavi1@jhmi.edu|
22298070|NCT02619409|Medical University of South Carolina|Dr. Eric Bolin|8437922322|bolin@musc.edu|
22298071|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov|
22298072|NCT02624284|University of Pennsylvania|Mary Falcone, Ph.D.|215-746-3782|mfalc@pennmedicine.upenn.edu|
22298073|NCT02940691|Kirby Institute|Professor Jason Grebely|+61 2 9385 0957|jgrebely@kirby.unsw.edu.au|
22324050|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22298074|NCT02506816|Medica Scientia Innovation Research (MedSIR)|Director of Operations|0034 932 214 135|alicia.garcia@medsir.org|
22298075|NCT02744846|Harvard Pilgrim Health Care Institute|Dr. Jason Block|6178674841|jblock1@partners.org|
22298076|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu|
22298077|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22298078|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu|
22324051|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22324052|NCT05292755|University of Florida|Dr. Yujia Zhou|3053429166|yzhou1996@ufl.edu|
22324053|NCT04052139|Boston Medical Center|Dr. Jeffrey H. Samet|617-414-7288|jsamet@bu.edu|
22324054|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu|
22324055|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324056|NCT01794780|Novartis Pharmaceutical|Study Director|862-778-8300||
22324057|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu|
22298079|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22298080|NCT03852316|University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
22298081|NCT01049919|Zimmer Biomet|Hillary Overholser|574-373-2042|hillary.overholser@zimmerbiomet.com|
22298082|NCT04354831|Medical College of Wisconsin|Mary Beth Graham, MD|414-955-0500|mbgraham@mcw.edu|
22298083|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298084|NCT06285981|Orthofix|Clinical Program Manager|0456719077|danielacangiano@orthofix.it|
22298085|NCT02504372|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298086|NCT02975934|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22298087|NCT02102256|University of Southern California|Dr. Laurie Eisenberg|213-764-2826|laurie.eisenberg@med.usc.edu|
22298088|NCT02075840|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22324058|NCT03333577|Cochlear|George Cire|303 885 5440|gcire@msn.com|
22324059|NCT01967225|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22310664|NCT04107116|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
22310665|NCT02532621|Phraxis, Inc.|Cindy Setum, PhD|612-801-6730|csetum@phraxis.com|
22310666|NCT05424718|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@columbia.edu|
22269480|NCT00435708|Queen's University Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
22269481|NCT02414243|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
22269482|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22269483|NCT02914613|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
22269484|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
22269485|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22269486|NCT04042623|Aravive|Dr. Reshma Rangwala, Chief Medical Officer|936-355-1910|rrangwala@aravive.com|
22269487|NCT03935425|Flint Rehab|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
22269488|NCT00885664|University of Cincinnati|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
22269489|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu|
22269490|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22269491|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
22269492|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu|
22269493|NCT02993250|Janssen Pharmaceutical K.K., Japan|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22269494|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000|MK143@aub.edu.lb|5350
22269495|NCT02527434|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22269496|NCT02861807|University of New Mexico|Katie Witkiewitz|505-277-4121|katiew@unm.edu|
22269497|NCT02560922|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22269498|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU|
22269499|NCT00568061|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22269500|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565|bmgulluoglu@marmara.edu.tr|4012
22269501|NCT02693002|University of Kentucky|Dr. Gretchen Wells, PI||gretchen.wells@uky.edu|
22269502|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu|
22269503|NCT04666259|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269504|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22269505|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu|
22269506|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22269507|NCT03187730|NYU Langone|Elizabeth Vargas|310-486-9775|elizabeth.varagas@nyulangone.org|
22269508|NCT00504712|Barnsley Hospital NHS Foundation Trust|Professor TH Jones|01226 431684||
22269509|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu|
22269510|NCT05630287|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22269511|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org|
22269512|NCT03289754|restor3d, Inc.|Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
22269513|NCT04873934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269514|NCT03584854|University of Chicago|Dr. Naida Cole|773-702-6700|nmcole@bsd.uchicago.edu|
22269515|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu|
22269516|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
22269517|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|603-650-8283|Mark.A.Creager@hitchcock.org|
22269518|NCT01801865|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
22269519|NCT02915705|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22269520|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269521|NCT02134015|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|DataSharing@dsi.com|
22269522|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob|
22269523|NCT04818034|University of California, San Francisco|Marshall Stoller|415-514-0918|victoria.hogue@ucsf.edu|
22269524|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com|
22269525|NCT03694002|SWOG Statistics and Data Management Center|Study Statistician|2066672894|mhsieh@fredhutch.org|
22269526|NCT01760655|Tevogen Bio|Dolores Grosso|848-256-5751|dolores.grosso@tevogen.com|
22298089|NCT05429203|Stanford University|Subhas Banerjee, MD|(650) 736-5555|subhas.banerjee@stanford.edu|
22298090|NCT03491150|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22298091|NCT02402452|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298092|NCT02644967|Idera Pharmaceuticals, Inc|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
22298093|NCT02287896|LFB Biotechnologies|Clinical trial Information desk|33169825656|supportqcm@lfb.fr|
22298094|NCT05179421|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
22269527|NCT01941745|"Tufts Medical Center | Division of Newborn Medicine"|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
22269528|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012||
22269529|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu|
22298095|NCT00813124|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22298096|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)||
22298097|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0)|istvan.zatik@heel.com|3192
22298098|NCT03837899|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22298099|NCT01403974|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298100|NCT01526889|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|Novartis.email@novartis.com|
22298101|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com|
22298102|NCT03571516|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22298103|NCT02800148|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
22298104|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22298105|NCT03465878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298106|NCT02540954|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22298107|NCT01458327|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
22298108|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
22298109|NCT02448875|Alcon Research|Senior Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22298110|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298111|NCT02434770|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22298112|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk|
22298113|NCT01282424|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298114|NCT03316872|Princess Margaret Cancer Centre|Dr. Jennifer J Knox|+1-416-946-2399|jennifer.knox@uhn.ca|
22298115|NCT04074317|Xeris Pharmaceuticals Inc.|Dawn Harper, VP Clinical Devlopment|(215) 704-7290|dharper@xerispharma.com|
22298116|NCT05677425|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
22298117|NCT04036500|Medical College of Wisconsin|Jenna Sarvaideo, DO|414-955-7069|jsarvaideo@mcw.edu|7069
22298118|NCT02283788|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
22298119|NCT02742103|CSL Behring|Trial Registration Coordinator|6108784000|clinicaltrials@cslbehring.com|
22298120|NCT02533921|University of Colorado|Benzi Kluger, MD, MS, Principal Investigator|303-724-2194|Benzi.kluger@ucdenver.edu|
22298121|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22298122|NCT00727194|Alexion Pharmaceuticals|Alexion Pharmaceuticals|855-752-2356|clinicaltrials@alexion.com|
22298123|NCT02595567|Washington University School of Medicine|Alexander Chen, Director of Interventional Pulmonology|314-454-8764|achen@dom.wustl.edu|
22298124|NCT03853707|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22298125|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490|leslamian@tums.ac.ir|2415
22298126|NCT04269161|University of Missouri|Roger Fales|5738841564|falesr@missouri.edu|
22298127|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298128|NCT04031885|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298129|NCT02995915|Duke University Medical Center|Angela Kirby, MS|(919) 824-7729|angela.kirby@duke.edu|
22298130|NCT02896127|Novartis PharmaAG|Study Lead|+41613241111|novartis.email@novartis.com|
22298131|NCT01782313|Northwestern University|Mark Agulnik, MD|312 695 6182|magulnik@nm.org|
22298132|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22298133|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com|
22298134|NCT04027218|University|Ms. Leticia Carmen Simón López|+34 680721340|leticia.simon25@gmail.com|
22298135|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu|
22298136|NCT00418691|UT MD Anderson Cancer Center|Jeffrey Wefel, PHD/ Associate Professor, Neuropsychology|713-563-0514|jwefel@mdanderson.org|
22298137|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
22298138|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com|
22298139|NCT02984995|Daiichi Sankyo Co., Ltd.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22298140|NCT04182100|PharmaEssentia Japan KK|Hiroaki Kawase|+81-3-6910-5103|hiroaki_kawase@pharmaessentia.com|
22298141|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com|
22298142|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
22298143|NCT02509065|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
22298144|NCT02915029|University of New Mexico|Dr Vallabh Shah|505-272-9615|vshah@salud.unm.edu|
22298145|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22310667|NCT04046549|Horizon Therapeutics USA, Inc.|Todd Wilson, DO|866-479-6742|clinicaltrials@horizontherapeutics.com|
22310668|NCT06059443|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
22310669|NCT03520114|Wake Forest University|Sachin Nalin Vyas, MS,PhD|336-713-4098|svyas@wakehealth.edu|
22269530|NCT00836888|Ono Pharmaceutical Co. Ltd|Ohyama Yukiya||y.ohyama@ono.co.jp|
22269531|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
22310670|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com|
22310671|NCT04079517|Karolinska Institutet|Per Hall|+4670750 2110|per.hall@ki.se|
22280408|NCT03145064|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280409|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de|
22280410|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280411|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
22280412|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463|Steven.Lash@va.gov|2593
22280413|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu|
22280414|NCT04245449|Medical University of South Carolina|Michelle Woodbury, PhD|843-792-0651|woodbuml@musc.edu|
22280415|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com|
22280416|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com|
22280417|NCT03692403|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22280418|NCT02479880|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22280419|NCT02840253|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22280420|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com|
22280421|NCT01349673|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22280422|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu|
22280423|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org|
22280424|NCT02621476|Kaiser Permanente Northern California|Julie Schmittdiel, PhD, MA|5108913872|Julie.A.Schmittdiel@kp.org|
22280425|NCT03198767|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22280426|NCT03462758|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
22280427|NCT02820844|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22280428|NCT04701411|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22280429|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280430|NCT03012191|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
22280431|NCT02817594|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22280432|NCT02010593|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22280433|NCT01135459|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22280434|NCT01803880|Smith & Nephew, Inc|Stephan Mangin, Director, Global Clinical Strategy|M +1 (512) 913-8192|stephan.mangin@smith-nephew.com|
22280435|NCT03703232|University of Washington|Murray Maitland PT, PhD, Associate Professor|425-286-5278|mmaitlan@uw.edu|
22280436|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
22280437|NCT03885154|University of Kentucky|Kimberly Jones, MD|859-218-5011|kimberly.jones@uky.edu|
22280438|NCT02651116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280439|NCT02803203|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-608-3912|YuH@mskcc.org|
22280440|NCT01887717|BTG International Inc.|Manager of Clinical Development|613-801-1844|TheraSphereClinical@btgplc.com|
22280441|NCT02592421|University of Texas Health San Antonio|Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
22280442|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
22280443|NCT02251496|University of Iceland|Dr. Áróra Rós Ingadóttir|8461601|aroraros@landspitali.is|
22280444|NCT02041299|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
22280445|NCT02389465|University of Pennsylvania|Dr. Yvette Sheline, McLure Professor of Radiology, Neurology and Psychiatry|(215) 573-0082|sheline@pennmedicine.upenn.edu|
22310672|NCT04940624|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22310673|NCT04479787|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Udoka.okaro@abbott.com|
22269532|NCT03300505|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22269533|NCT04532619|University of Oregon|Camille C. Cioffi|541-525-4886|ccioffi@uoregon.edu|
22269534|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22269535|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22269536|NCT03187418|Centre Hospitalier de l'Universite de Montreal (CHUM)|Dr. Michael Marchand, MD|514-890-8000|michael.marchand-gareau@umontreal.ca|
22269537|NCT01515865|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22269538|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|david.tolin@hhchealth.org|
22269539|NCT04687137|Shire|Study Director|: +1 866 842 5335|ClinicalTransparency@shire.com|
22269540|NCT02510664|Baylor College of Medicine|Marisa Hilliard PhD, Principal Investigator|832-824-7209|marisa.hilliard@bcm.edu|
22269541|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22269542|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22269543|NCT02490371|QEHHongKong|Dr. Helen LUK|852-9208 5366|clkyz02@ha.org.hk|
22269544|NCT03018080|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22269545|NCT03612596|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
22310674|NCT05648890|Thomas Bata Hospital, Zlin, Czech Republic|Dr. Klára Nekvindová|+420 577 552 280|klara.nekvindova@bnzlin.cz|
22310675|NCT05550636|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22310676|NCT03699163|Imperial College London|Professor George Hanna|02033122124|g.hanna@imperial.ac.uk|
22280446|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22280447|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu|
22280448|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22280449|NCT03542266|Weill Cornell Medical College|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
22280450|NCT02272946|University of California, San Francisco|Priscilla Hsue, MD|628-206-5801|Priscilla.hsue@ucsf.edu|
22280451|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil|
22280452|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280453|NCT04721158|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
22280454|NCT05110781|University of California, Davis|Principal Investigator|916-734-2790|abewley@UCDAVIS.EDU|
22280455|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22280456|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280457|NCT03870048|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22280458|NCT02881775|University of North Carolina at Chapel Hill|Deborah Givens, PhD|919-843-8660|deborah_givens@med.unc.edu|
22280459|NCT03069716|Vanderbilt University Medical Center|Dr. Evan L. Brittain|(615) 322-4382|Evan.brittain@vumc.org|
22280460|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22280461|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be|
22280462|NCT04421404|UCSF|Dr. Annie Luetkemeyer|415-476-4082|annie.luetkemeyer@ucsf.edu|130
22280463|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu|
22280464|NCT03111316|University of Oklahoma Health Sciences Center|Director of Women's Health Research|4052718001|christy-zornes@ouhsc.edu|48137
22280465|NCT02965989|Hospital Universitario 12 de Octubre de Madrid|Ph.D. Ignacio Zaragoza-García|913908000|izaragoz@ucm.es|4646
22280466|NCT01913327|University of California San Francisco|Michael Minzenberg|5104122199|MMinzenberg@mednet.ucla.edu|
22280467|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22280468|NCT02112656|Imunon, Inc.|Chief Medical Officer|(609) 896-9100|clinical@imunon.com|
22280469|NCT04522167|Formycon AG|Public Register Contact|+49 89 864667 100|clinicaltrials@formycon.com|
22280470|NCT01234480|Becton Dickinson|Karen Yanson|410-316-4793|karen_a_yanson@bd.com|
22280471|NCT03370419|Wayen State University|Heather Fritz|313-577-9499|heather.fritz@wayne.edu|
22280472|NCT03844672|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
22280473|NCT02220426|University of North Carolina at Chapel Hill|Rosa Tamara Branca, PhD|9199622229|rtbranca@unc.edu|
22280474|NCT02595879|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22280475|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
22280476|NCT02197572|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22280477|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org|
22280478|NCT03801928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280479|NCT02763059|King Abdulaziz University|Prof. Maha A Bahammam|00966126400000|mbahammam@kau.edu.sa|
22280480|NCT03688919|University of Michigan School of Public Health|Professor Alison Miller|7346157459|alimill@umich.edu|
22280481|NCT00118274|University of Virginia|Dr. Craig Slingluff|4349249311|cls8h@virginia.edu|
22280482|NCT04423939|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
22280483|NCT01692743|University of Maryland School of Medicine|Raymond K. Cross, MD, MS, AGAF|410-706-3387|rcross@som.umaryland.edu|
22280484|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu|
22280485|NCT02933879|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22280486|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22280487|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623||
22280488|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu|
22280489|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk|
22280490|NCT05615220|Emalex Biosciences Inc.|Drug Development and Medical Affairs|773 343 0671|mmiller@emalexbiosciences.com|
22298146|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com|
22298147|NCT04439240|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22298148|NCT02315768|UCSD|Dr. Thomas Kipps|858-534-5400|tkipps@ucsd.edu|
22298149|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu|
22298150|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu|
22298151|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22298152|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu|
22298153|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu|
22298154|NCT01302392|Amgen, Inc.|Study Director|866-572-6436||
22280491|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com|
22280492|NCT00533429|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280493|NCT02655887|Becton Dickinson (BPV)|Megan Hill|480-350-6468|Megan.Hill@bd.com|
22298155|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com|
22280494|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu|
22280495|NCT04245709|Duke University|Dwight Koeberl, MD,PhD|919-681-9919|dwight.koeberl@duke.edu|
22280496|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk|
22280497|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org|
22280498|NCT04339413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22280499|NCT03301779|Hemanext|William Iselin|7813017446|william.iselin@hemanext.com|
22280500|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22280501|NCT01964378|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22280502|NCT02358993|University of Pennsylvania|Dr Uduak Andy|215-662-7709|uduak.andy@pennmedicine.upenn.edu|
22280503|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org|
22280504|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
22280505|NCT03503396|University of Missouri|Dr. Denis McCarthy|573-882-0426|mccarthydm@missouri.edu|
22280506|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
22280507|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca|
22298156|NCT03604692|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
22298157|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298158|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
22298159|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org|
22298160|NCT02471521|Seoul National University Hospital|Jin-Tae Kim|82-2-2072-3661|jintae73@gmail.com|
22298161|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu|
22298162|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343||
22298163|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22298164|NCT01696032|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22298165|NCT02188576|Boston Childrens Hospital|Dr. Susan Goobie, PI|6173557737|susan.goobie@childrens.harvard.edu|
22298166|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488|einata@protalix.com|137
22298167|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu|
22298168|NCT05091528|Silverback Therapeutics, Inc.|Chief Scientific Officer|206-456-2900|info@silverbacktx.com|
22280508|NCT00142792|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
22298169|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu|
22298170|NCT02214121|AstraZeneca|Brilinta Global Clinical Lead|+46 31 776 1000|kontakt@astrazeneca.com|
22298171|NCT02375672|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
22298172|NCT02203591|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
22298173|NCT04115358|Marmara University|Prof. Dr. Ali Mentes|+90 2164140545|alimentes@gmail.com|
22298174|NCT00835497|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22298175|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298176|NCT04399161|JSS Dental College & Hospital, JSS Academy of Higher Education & Research|Dr. Krupa NC|8105064056|kripa_555@yahoo.com|+91
22298177|NCT03417141|Mayo Clinic|Jason C. Sluzevich, M.D.|904-953-6192|Sluzevich.Jason@mayo.edu|
22298178|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22298179|NCT01864291|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
22298180|NCT01282216|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
22298181|NCT05093426|Closed Loop Medicine Ltd.|Nihal Noori|07443603405|nihal.noori@closedloopmedicine.com|
22298182|NCT04174313|Hospital El Cruce|Nestor Pistillo|054 1142109000|npistillo@yahoo.com.ar|5636
22298183|NCT04399928|Smith & Nephew|Fleur Derdeyn, Clinical Study Manager|+32497602032|fleur.derdeyn@smith-nephew.com|
22298184|NCT02239536|Seoul ST. Mary's hospital|Bo-In Lee|821083671055|gidoc4u@gmail.com|
22298185|NCT01038778|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22298186|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu|
22298187|NCT05036642|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
22298188|NCT01379963|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298189|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22298190|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca|
22298191|NCT02143414|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22298192|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu|
22298193|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu|
22298194|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22298195|NCT03366077|BioGaia AB|Jenny Palming Clinical research Director|+46 738299900|jp@biogaia.se|
22298196|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
22298197|NCT02649972|Memorial Sloan Kettering Cancer Center|Dr. Eli Diamond, MD|212-610-0243|diamone1@mskcc.org|
22298198|NCT01428193|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
22298199|NCT03523117|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
22298200|NCT04452188|The University of Michigan Health System|Dr. Nathaniel Sznycer-Taub|734-936-8993|nsznycer@umich.edu|
22298201|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22324060|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu|
22324061|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22324062|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net|
22324063|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22324064|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu|
22324065|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324066|NCT00981526|UMass Medical School|Dr. Xiaoduo Fan|508-856-3881|xiaoduo.fan@umassmed.edu|
22324067|NCT00332202|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22269546|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
22269547|NCT01455597|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22269548|NCT04632069|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
22269549|NCT02573181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324068|NCT00655928|Imperial College LOndon|Mark J Griffiths|+44 (0) 2073518523|m.griffiths@imperial.ac.uk|
22324069|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22324070|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov|
22324071|NCT04551014|Stanford University|Shai Friedland, MD|650-723-4000|shaif@stanford.edu|
22324072|NCT02654002|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22324073|NCT04108429|Northwestern University|Dr. Emily Lattie|312-503-5509|emily.lattie@northwestern.edu|
22324074|NCT02570672|UT Health San Antonio|Sara Espinoza|210 617 5197|Sara.Espinoza@cshs.org|
22324075|NCT05262764|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22324076|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu|
22324077|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
22324078|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de|
22324079|NCT01392183|UT MD Anderson Cancer Center|Amado J. .Zurita-Saavedra, MD/ Associate Professor, Genitourinary Medical Oncology|713- 563-6966|azurita@mdanderson.org|
22324080|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu|
22324081|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324082|NCT03128957|University of Michigan|Dr. Paul Picton|734 615 9864|ppicton@med.umich.edu|
22324083|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324084|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca|
22324085|NCT05654714|Baxter|Jessica Gregory|N/A|jessica_gregory@baxter.com|
22324086|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com|
22324087|NCT01444716|The University of Texas MD Anderson Cancer Center|Allessandra Ferrajoli, MD./Professor|713-792-2063|aferrajo@mdanderson.org|
22324088|NCT03263091|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|082MDSstudy@fibrogen.com|
22324089|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|62478
22324090|NCT02983058|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-8436|marlene.carlson@nyspi.columbia.edu|
22324091|NCT00265941|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22324092|NCT03109951|International St. Mary's Hospital, Catholic Kwandong University|Myong Ki Baeg|82-10-6391-9010|baegmk@gmail.com|
22324093|NCT04092257|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu|919-962-0000|Melahat_Canter@med.unc.edu|
22324094|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu|
22324095|NCT02770521|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324096|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22324097|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it|
22269550|NCT03412734|TriHealth Inc.|Catrina Crisp, MD MSc|513-463-4300|Catrina_Crisp@trihealth.com|
22269551|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22269552|NCT03777436|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22269553|NCT02035202|UCSD|Colin Depp|858 822 4251|cdepp@ucsd.edu|
22269554|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300||
22269555|NCT01998932|Imperial College London|Miss Sarah Onida|: +44 (0) 20 3311 7335|s.onida@imperial.ac.uk|
22269556|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22269557|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu|
22269558|NCT03259425|Huntsman Cancer Institute|Data Manager, Research Compliance Office|8015850601|compliance@hci.utah.edu|
22269559|NCT02892110|MUSC|Amanda Wagner, Program Manager|843-792-0484|wagne@musc.edu|
22269560|NCT04724538|P. Hertsen Moscow Oncology Research Institute|Mariia Sedova, MD|+79253093463|mariya.sedova58@gmail.com|
22269561|NCT03363776|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
22269562|NCT01562782|The Rogosin Institute|Lisa Hudgins, M.D.|646-317-0805|lih2013@nyp.org|
22269563|NCT03451591|University of Edinburgh|Prof Joanna Wardlaw|0131 465 9599|joanna.wardlaw@ed.ac.uk|
22280509|NCT04872569|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
22280510|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22324098|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com|
22269564|NCT02649439|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
22324099|NCT00810797|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22310677|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22310678|NCT01976936|Columbia University|Mitchell S.V. Elkind, MD, MS, MPhil|212-305-1710|mse13@cumc.columbia.edu|
22310679|NCT05595213|BUCA School of Medicine, Endocrinology|Michael F Holick, PhD MD|(617) 358-6139|mfholick@bu.edu|
22310680|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com|
22310681|NCT05162586|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
22310682|NCT04899778|Cedars-Sinai Medical Center|Dr. Melodie Metzger|310-423-7765|Melodie.Metzger@cshs.org|
22310683|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22310684|NCT02989662|Johns Hopkins University School of Medicine|Mary E McCaul, Ph.D.|4437225728|mmccaul1@jhmi.edu|
22310685|NCT06393127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310686|NCT02446600|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
22310687|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org|
22310688|NCT00357682|NICE|Prof Janusz A Z Jankowski|07968 479355|prof.jankowski@outlook.com|
22310689|NCT03660930|University of Washington|Lee Cranmer, MD, PhD|206-606-7439|ldcranme@fredhutch.org|
22310690|NCT03725332|University of Kentucky|Wendy Hansen, MD|859-218-0765|wendy.hansen@uky.edu|
22310691|NCT04098276|Johns Hopkins University|Bushra Sabri|+1 (410) 955-7105|bsabri1@jhu.edu|
22310692|NCT03242915|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22310693|NCT02726386|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director|+33687548073|laurence@neuroderm.com|
22310694|NCT04955431|University of Montana|Dr. John Quindry|406-243-4268|john.quindry@mso.umt.edu|
22310695|NCT02101853|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310696|NCT02752685|NYU Langone Health|Sylvia Adams, MD|212-731-5795|Sylvia.Adams@nyulangone.org|
22310697|NCT02112916|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22310698|NCT03333915|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22310699|NCT04276779|University of Alabama at Birmingham|Dr. Caitlin Clevenger|205-934-7008|cwclev@uab.edu|
22310700|NCT02831283|Columbia University|Patrick Lao|2123421351|PJL2133@CUMC.COLUMBIA.EDU|
22310701|NCT04591080|University at Buffalo|Thikriat Al-Jewair, Program Director|17168296190|thikriat@buffalo.edu|
22310702|NCT04549792|Northwestern University|Principal Investigator|312-503-5944|NUderm-research@northwestern.edu|
22310703|NCT05771467|AkdenizU|Dr. Aslı Cetinkaya Yaprak|+0905069228431|ysf20smt@gmail.com|
22310704|NCT03696433|Vanderbilt University Medical Center|Cassandra Reynolds, BS, CCRC|615-875-9854|cassandra.f.reynolds@vumc.org|
22310705|NCT01220531|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
22310706|NCT05047952|Brain and Cognition Discovery Foundation|Dr. Roger S. McIntyre|416-669-5279|roger.mcintyre@bcdf.org|
22310707|NCT05866926|Ferrer|Clinical Operations Head|649442389|nalbareda@ferrer.com|
22310708|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
22310709|NCT05672017|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
22310710|NCT03027128|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22310711|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu|
22310712|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu|
22310713|NCT04098575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310714|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22310715|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu|
22310716|NCT03653364|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22310717|NCT05186740|ProVerum|"Vice President, Clinical Affairs |"|"+1-720-472-1504|"|diane@proverummedical.com|
22310718|NCT03983382|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-5154|yua3@mskcc.org|
22310719|NCT03694262|Medical College of Wisconsin|William Bradley, MD|414-805-6606|wbradley@mcw.edu|
22310720|NCT02348632|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22310721|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22310722|NCT02757898|Emory University|Dr. John Roback|404-712-1774|jroback@emory.edu|
22310723|NCT03744559|Medical University of South Carolina|Dr Michael Saladin|(843) 792-5306|saladinm@musc.edu|
22310724|NCT02567435|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22310725|NCT02166463|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22310726|NCT04726410|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
22310727|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22310728|NCT03767335|Menarini Ricerche S.p.A.|Clinical Sciences|+39 05556809990|martine.piccart@bordet.be|
22310729|NCT03705390|CRCTU, University of Birmingham|D3B Trial Mangement Team Leader|+44 (0) 121 371 8027|ALS@trials.bham.ac.uk|
22310730|NCT03047213|Yale School of Medicine: Medical Oncology|Joseph Kim, MD, Associate Professor of Internal Medicine|(203) 200-4822|joseph.w.kim@yale.edu|
22310731|NCT05988957|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
22310732|NCT06139302|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310733|NCT05394844|uwashington|Dr nicole ehrhardt|2404479566|nehrhard@uw.edu|
22324100|NCT02432807|Eyevance Pharmaceuticals|Mark Jasek|817-677-6127|mjasek@eyevance.com|
22298202|NCT02665728|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22280511|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org|
22280512|NCT02382991|OTTOBOCK FRANCE|Aurélie LACROIX|0033 (0)7 86 29 52 03|market.access@ottobock.fr|
22298203|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com|
22298204|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22298205|NCT01502644|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
22298206|NCT05435885|Department of Rehabilitation Medicine, Pusan National University Hospital|Dr. Sanghun Kim|82-51-240-7485|kel5504@gmail.com|
22298207|NCT03306264|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22280513|NCT04951622|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22280514|NCT03129464|Cleveland Clinic Florida|Pamela Frazzini Padilla|9546595559f|frazzip@ccf.org|
22280515|NCT02568722|Unity Health Toronto|Dr. Ron Wald|(416) 867-3703|ron.wald@unityhealth.to|
22280516|NCT02891226|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280517|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu|
22280518|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa|
22280519|NCT04570384|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
22280520|NCT03654274|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22280521|NCT02454530|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280522|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com|
22280523|NCT03265145|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280524|NCT02137070|University of Florida|Dr. Ronald Cohen|352-273-6124|roncohen@ufl.edu|
22280525|NCT03640325|Dana-Farber Cancer Institute|Dr Abby Rosenberg|617.632.5286|abbyr_rosenberg@dfci.harvard.edu|
22298208|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no|
22280526|NCT03046927|University of Mass Medical|Benjamin U. Nwosu, MD|5083406936|bnwosu1@northwell.edu|
22280527|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22280528|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
22280529|NCT01032954|Brazilian Center for Studies in Dermatology|Dr Doris Hexsel|555130262633|cientifico@cbed.org.br|
22280530|NCT03718325|University of Michigan|Dr. Scott Lempka|734-647-9052|NeuromodulationLab@med.umich.edu|
22280531|NCT03687957|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
22280532|NCT03132532|Mayo Clinic|Dr. Steven E. Schild|480-342-4800|sschild@mayo.edu|
22280533|NCT02415244|University of Iowa Hosptials and Clinics|Kenichi Ueda|3193562633|kenichi-ueda@uiowa.edu|
22280534|NCT04150913|Massachusetts General Hospital|Director, Cellular Immunotherapy Program|857-367-1486|mghcancercenter@partners.org|
22280535|NCT01147965|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22280536|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu|
22280537|NCT04312932|Nationwide Children's Hospital|Sarah Keim|614-722-2000|sarah.keim@nationwidechildrens.org|
22298209|NCT03078946|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22298210|NCT02722928|The Ohio State University Wexner Medical Center|Juan Fiorda-Diaz Postdoctoral Researcher|6142933559|juan.fiorda@osumc.edu|
22280538|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca|
22280539|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org|
22280540|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org|
22280541|NCT02975804|The Hong Kong Polytechnic University|Dr tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
22280542|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22280543|NCT02956746|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+886 2 2659 0988|achuang@synermore.com|
22298211|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22298212|NCT00330551|University of California, Los Angeles|Keith Nuechterlein, PhD|(310) 825-0036|keithn@ucla.edu|
22298213|NCT05059600|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22298214|NCT02152995|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22298215|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22298216|NCT02353247|University of Louisville|Professor Andrew Scott LaJoie, PhD, statistician on project|502-852-1879|lajoie@louisville.edu|
22298217|NCT06561217|Emory University School of Medicine|Ravi B. Parikh, MD, MPP|(352) 422-4285|ravi.bharat.parikh@emory.edu|
22298218|NCT02940327|University of Leicester|Clinical Trials Co-ordinator|0116 250 2427|ha200@le.ac.uk|
22298219|NCT04552587|Medical University of South Carolina|Katherine R. Sterba, PhD, MPH|843- 876-2419|sterba@musc.edu|
22298220|NCT01822132|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22298221|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
22298222|NCT03900299|Alexandria university|DR. mostafa elsayed|560566541|m_elsayed2009@yahoo.com|+966
22310734|NCT04599296|University of Washington|Dr. Mia Hagen, Associate Professor|206-598-3404|smia@uw.edu|
22310735|NCT06415045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
22298223|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298224|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22298225|NCT05409235|Chief Development Officer|D. Scott Edwards, Ph.D.|(339) 234-1333|sedwards@ocuterratx.com|
22298226|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22298227|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com|
22298228|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298229|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org|
22298230|NCT00678561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298231|NCT03080961|CLJI WORLDWIDE|Ty Cross, President & CEO|305-397-8880|tycross@cljiworldwide.com|
22298232|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu|
22298233|NCT02219815|St. Boniface Hospital|Dr. Rakesh Arora|2042581078|rarora@sbgh.mb.ca|
22324101|NCT03976401|Akero Therapeutics, Inc.|Brittany de Temple, Senior Director Clinical Operations|(650) 868-7935|brittany@akerotx.com|
22324102|NCT00089128|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22324103|NCT04125680|University of Michigan|Emily Feuerherm|810-766-6725|feuerher@umich.edu|
22324104|NCT02872103|Generon|Jianmin Chen|7327100262|jianmin_chen@generonbiomed.com|
22324105|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300||
22324106|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu|
22324107|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22324108|NCT03826875|University of Washington|Professor of Neurological Surgery|2067449330|mlevitt@uw.edu|
22324109|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com|
22324110|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
22324111|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22324112|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324113|NCT03093155|Yale School of Medicine/Yale Cancer Center|Alessandro Santin, MD|(203) 737-4450|alessandro.santin@yale.edu|
22324114|NCT01700829|NY State Psychiatric Institute-Columbia University Medical Center|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
22324115|NCT01075178|Abbott|Global Medical Services|800-633-9110||
22324116|NCT02983604|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22324117|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu|
22298234|NCT04976530|CytoSorbents Corp|Weihong Fan|732-329-8885|wfan@cytosorbents.com|
22298235|NCT03508219|European Cardiovascular Research Institute (ECRI-10)|Ernest Spitzer, MD|0031102062828|e.spitzer@ecri-trials.com|
22298236|NCT04466891|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22298237|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22298238|NCT05114005|The Ohio State University Comprehensive Cancer Center|Dr. Lise Worthen-Chaudhari|614-293-6281|wort08@osumc.edu|
22298239|NCT00590954|Memorial Sloan Kettering Cancer Center|Thomas Kaley, MD|212-639-5122|kaleyt@mskcc.org|
22298240|NCT05063734|Oxurion|Clinical Department|+32 16 75 13 10|info@oxurion.com|
22298241|NCT03107988|New Approaches to Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
22298242|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22298243|NCT00529386|Dept of Urology, Queen's University|J C Nickel|613 548 2497|jcn@queensu.ca|
22298244|NCT04027686|UCLA Periodontics and Implant Surgery|Dr Perry Klokkevold|3108251927|pklokkevold@dentistry.ucla.edu|
22298245|NCT02939404|Obesity & Diabetes Clinical Research Section, NIDDK|Douglas C. Chang, MD|602.200.5312|Douglas.Chang@nih.gov|
22298246|NCT05560932|Yale University|Amy C Justice, MD, PhD|203-932-5711|amy.justice2@va.gov|3541
22298247|NCT04456699|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22298248|NCT02075437|Duke University|Dr. Nancy Zucker|919-668-0075|nancy.zucker@duke.edu|
22298249|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
22298250|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu|
22298251|NCT03921411|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22298252|NCT02114879|Washington University|Emily Lenard|314-747-5706|lenarde@wustl.edu|
22298253|NCT03120013|University of Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
22298254|NCT03697811|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22298255|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu|
22298256|NCT06259331|Supernus|Charlene A. Tucker|(301) 838-2500|ctucker@supernus.com|
22298257|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu|
22310736|NCT06995755|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
22310737|NCT03601897|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
22310738|NCT03598998|City of Hope Medical Center|Dr. Alex Herrera|6263598111|aherrera@coh.org|
22310739|NCT02823327|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22310740|NCT04712903|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22310741|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com|
22310742|NCT03782116|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
22310743|NCT04908514|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22324118|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324119|NCT04336163|University of California, Irvine|Kristen Kelly, MD|949-824-6550|kmkelly@uci.edu|
22324120|NCT04927312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324121|NCT04919564|National Cardiovascular Center Harapan Kita Jakarta|Prieta Adriane, MD|+62 852-2004-0006|prietaadriane@gmail.com|
22324122|NCT02351115|Engage Therapeutics, Inc|Chief Medical Officer||studydirector@engagetherapeutics.com|
22324123|NCT01241786|Hackensack University Medical Center|Dr. Anthony Mato|551-996-2000|AMato@hackensackumc.org|
22324124|NCT03431012|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
22324125|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501|bernard.lefoll@camh.ca|34772
22324126|NCT03624816|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22324127|NCT02904226|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
22324128|NCT03182738|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
22324129|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com|
22324130|NCT03496701|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
22324131|NCT00608140|Duke University|Mary Ann Sellers|919-668-8544|maryann.sellers@duke.edu|
22324132|NCT02886715|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22324133|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324134|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
22324135|NCT01172067|CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices|Clay Cohorn, Program Director|+1 972 309 8087|clay.cohorn@abbott.com|
22324136|NCT01128387|University of Wisconsin Carbone Cancer Center|Dr. Mark Ritter|608-263-8500|ritter@humonc.wisc.edu|
22324137|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu|
22324138|NCT02216136|Washington University School of Medicine|Terence M. Myckatyn, M.D.|314-996-3873|myckatyn@wustl.edu|
22324139|NCT02499952|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22324140|NCT02120417|Incyte Corporation|Study Director|855 463-3463||
22324141|NCT00927485|University of Puerto Rico Medical Sciences Campus|Dr. Marcia Cruz-Correa|787-758-2525|marcia.cruz1@upr.edu|1722
22324142|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22324143|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu|
22324144|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722||
22324145|NCT02305563|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22324146|NCT02107755|The Ohio State University Comprehensive Cancer Center|Dr. Jose Bazan|614-688-7040|Jose.Bazan2@osumc.edu|
22324147|NCT01275222|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22324148|NCT00957853|UT MD Anderson Cancer Center|Dr. Maura Gillison, PHD/Professor, Thoracic-Head & Neck Med Onc|713-792-6363|mgillison@mdanderson.org|
22324149|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu|
22324150|NCT02722044|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
22324151|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324152|NCT00825370|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|7189207464|achang@montefiore.org|
22324153|NCT01237951|UT MD Anderson Cancer Center|Dr. Nieto, Yago, M.D./Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
22324154|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com|
22324155|NCT00682630|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
22324156|NCT03481270|Stanford University|Marcella Alsan, Associate Professor of Medicine|(650) 721-1352|malsan@stanford.edu|
22324157|NCT02970929|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1 866-503-6351|clinicaltrialdisclosure@sunovion.com|
22324158|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324159|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
22324160|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu|
22324161|NCT03285529|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
22324162|NCT03874234|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22324163|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu|
22324164|NCT00430040|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22324165|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22324166|NCT03168867|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
22298258|NCT02600637|VA Northern California|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
22298259|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu|
22298260|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com|
22298261|NCT04043312|Hospital of the University of Pennsylvania|Dr. Timothy Markman|267-593-0103|timothy.markman@uphs.upenn.edu|
22298262|NCT03072134|Northwestern University|Christina Amidei, PhD|13126959124|christina.amidei@nm.org|
22298263|NCT02445027|Massachusetts General Hospital|Anna Gao RN.|617-643-6092|tearneylabtrials@partners.org|
22298264|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu|
22298265|NCT04847674|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22298266|NCT01446731|Center for Cancer ImmuneTherapy|Per Kongsted, M.D.|+45 38689255|per.kongsted@regionh.dk|
22298267|NCT02705820|Bank Of Cyprus Oncology Centre|Dr. Harris Charalambous|+35722847300|haris.charalambous@bococ.org.cy|450
22298268|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu|
22324167|NCT03812510|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22324168|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu|
22324169|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu|
22324170|NCT03502746|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22324171|NCT02700529|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22324172|NCT05421754|Northwestern University|Shuai Xu|312-695-8106|stevexu@northwestern.edu|
22324173|NCT04433117|University of Kentucky|Dr. Mohanad Al-Sabbagh|859-257-3003|malsa2@email.uky.edu|
22324174|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324175|NCT02704104|Arch Therapeutics, Inc|Medical/Scientific Affairs|617 431-2313|jprats@archtherapeutics.com|
22324176|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22324177|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com|
22324178|NCT02469246|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22324179|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165|jhe@tulane.edu|504
22324180|NCT03352245|Yale University|Dr. Brett Bade|203 785 6670|Brett.bade@yale.edu|
22324181|NCT02643095|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|Fogt.78@osu.edu|
22324182|NCT02690701|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|Novartis.email@novartis.com|
22324183|NCT02700451|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@HSS.EDU|
22324184|NCT01578902|Sunnybrook Research Institute|Dr Andrew Loblaw, Director GU Radiation Trials|4164804806|andrew.loblaw@sunnybrook.ca|
22324185|NCT02930174|University of Michigan Health System|Carl Haas|734-936-5234|chaas@med.umich.edu|
22324186|NCT04214652|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22324187|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de|
22324188|NCT03303989|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|2059966086|pjfoster@uabmc.edu|
22324189|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22324190|NCT02344576|University of Colorado School of Medicine|Dr. Larry Allen, Principal Investigator|303-724-4713|larry.allen@ucdenver.edu|
22324191|NCT02823457|GV Sonny Montgomery VAMC|Mary Jane Burton|6013624471|mary.burton2@va.gov|
22324192|NCT04325503|Unversity of Michigan|Nicolaas Bohnen|734-998-8400|nbohnen@umich.edu|
22324193|NCT02337387|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324194|NCT01642212|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22324195|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22269565|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22269566|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000|jm.wecht@va.gov|3122
22324196|NCT01243268|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324197|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22324198|NCT00518349|NorwegianDohsa|Dr. Geir Hoff|+4791866762|hofg@online.no|
22324199|NCT03871491|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
22324200|NCT05202808|RxSight, Inc.|Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|300
22324201|NCT04996797|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22324202|NCT02793544|National Marrow Donor Program/BeTheMatch|Steve Spellman|763-406-8334|sspellma@nmdp.org|
22324203|NCT04174599|Evivebiotech|Catrina Wang|021-61760866|catrina.wang@evivebiotech.com|
22324204|NCT02901314|Cleveland Clinic|Nancy M. Albert, PhD, CCNS, CCHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
22324205|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22324206|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324207|NCT03878485|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
22324208|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu|
22269567|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324209|NCT02747004|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324210|NCT05087030|Gedeon Richter Plc.|Medical Information Scientific Service|+36 1 505 70 32|medinfo@richter.hu|
22324211|NCT03658954|Yale University School of Medicine|Lisa Fucito, PhD|(203) 200-1470|lisa.fucito@yale.edu|
22324212|NCT04885257|Birmingham VA Medical Center|Research Compliance Officer|205-933-8101|latanya.higginbottom@va.gov|336885
22324213|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324214|NCT04640766|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
22324215|NCT01946516|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|karnold@fredhutch.org|
22324216|NCT02108457|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
22324217|NCT03551028|University of Virginia|Emma Mitchell|4342433962|emm6z@virginia.edu|
22324218|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
22324219|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324220|NCT02811744|Univerisity of Pennsylvania|Erin Schubert|215-573-6569|erin.schubert@pennmedicine.upenn.edu|
22269568|NCT05393869|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
22269569|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22324221|NCT04101890|Children's Research Institute|Elena Gibson|(202) 476-6877|egibson@cnmc.org|
22324222|NCT01896232|Amgen Inc.|Study Director|866-572-6436||
22324223|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com|
22269570|NCT05027451|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|misty.stevens@intervexion.com|
22269571|NCT04316104|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
22269572|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269573|NCT02737930|University of Rochester|Bogachan Sahin|(585) 275-2530|bogachan_sahin@urmc.rochester.edu|
22269574|NCT04178122|VA Boston Healthcare System|Morgan Danowski|617-595-5385|morgan.danowski@va.gov|
22269575|NCT03124407|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
22269576|NCT05343364|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22269577|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org|
22269578|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu|
22269579|NCT03546491|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22269580|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com|
22269581|NCT02589639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269582|NCT05868577|Atrium Health Wake Forest Baptist|Michael Jones, DPM|704-355-2000|michael.jones4@advocatehealth.org|
22269583|NCT01934582|United Therapeutics Corp.|Global Medical Information|919-425-8350|clinicaltrials@unither.com|
22269584|NCT02630251|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22269585|NCT02505217|University of Vermont|David J Schneider, MD|802-656-8955|david.schneider@uvm.edu|
22269586|NCT03517540|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22269587|NCT04573322|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
22269588|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com|
22269589|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com|
22269590|NCT02644668|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22269591|NCT04138498|Cingulate Therapeutics|VP of Clinical Operations and Regulatory Affairs|913-942-2304|hmitzel@cingulatetherapeutics.com|
22269592|NCT05763875|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269593|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269594|NCT04015518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269595|NCT02046005|Brigham and Women's Hospital|Dr. Elizabeth Karlson|617-732-5078|ekarlson@bwh.harvard.edu|
22269596|NCT04556084|Medical College of Wisconsin|Michael Burke|4149554198|mmburke@mcw.edu|
22269597|NCT04797611|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22269598|NCT03867409|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
22269599|NCT05864612|Wake Forest University Health Sciences|Heidi Munger-Clary, MD, MPH, FACNS, FAES|336-716-7110|heidi.mungerclary@advocatehealth.org|
22269600|NCT05119595|B.Braun Aesculap|Diana Kupferschmid, Study Manager of B. Braun|0049746195|studies@aesculap.de|0
22269601|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87|francine.santoro@galderma.com|87 20
22269602|NCT03100968|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22269603|NCT04973176|University Hospitals Coventry and Warwickshire NHS Trust|Dr Cyprian Mendonnca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25784
22269604|NCT03960008|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
22269605|NCT03056638|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
22269606|NCT02530125|Northwestern University|Winter, Jane MD|312 695 4033|Jwinter@nm.org|
22269607|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22269608|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269609|NCT01568034|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
22269610|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
22269611|NCT03831113|University of Pittsburgh|Dr Steve Caritis|412 641 4874|scaritis@mail.magee.edu|
22269612|NCT03508726|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
22269613|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22269614|NCT02919423|University of Arkansas for Medical Sciences|Merideth Addicott, Assistant Professor|501-526-8436|maddicott@uams.edu|
22269615|NCT04134429|insel Gruppe AG|Dr. med. Christa König|+41 31 632 21 11|christa.koenig@insel.ch|
22269616|NCT02498444|Stanford University|Jeffrey Feinstein, MD|6507252297|jeff.feinstein@stanford.edu|
22269617|NCT04286581|University of Minnesota|Dr. Jacob Hutchins, MD|612-624-9990|hutc0079@umn.edu|
22269618|NCT04181606|The Pennsylvania State University|Dr. David Proctor|(814)863-0724|dnp3@psu.edu|
22269619|NCT02053766|The University of Texas Health Science Center at Houston|Maria Matuszczak|713 -500-5075|maria.matuszczak@uth.tmc.edu|
22269620|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22269621|NCT03782012|William Jewell College|Dr. Amy Elizabeth Barth|816-415-7622|bartha@william.jewell.edu|
22269622|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269623|NCT03491462|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22269624|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us|
22269625|NCT03431831|University of Nebraska Medical Center|Trina Aguirre|308-632-0410|taguirre@unmc.edu|0412
22298269|NCT02702401|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269626|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22269627|NCT04478695|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22298270|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
22298271|NCT01924169|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22298272|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298273|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org|
22298274|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298275|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298276|NCT03337724|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22298277|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174||
22269628|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22298278|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu|
22298279|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu|
22298280|NCT02026115|University of Florida|Diana J. Wilkie, PhD, RN, FAAN, Professor, Prairieview Trust - Earl and Margo Powers Endowed Profess|352-273-6401|diwilkie@ufl.edu|
22298281|NCT04602624|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22298282|NCT04084769|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22298283|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298284|NCT04477304|University of Southern California|Jason Doctor|(213) 821-8142|jdoctor@usc.edu|
22298285|NCT04413929|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22324224|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
22324225|NCT01697215|Cleveland Clinic Foundation|Adriano Tonelli, MD|216-444-0812|tonella@ccf.org|
22298286|NCT02782949|Mayo Clinic|Dr Paul J. Limburg|507-284-2511|limburg.paul@mayo.edu|
22324226|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu|
22324227|NCT02599402|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22324228|NCT02945657|Medimetriks Pharmaceuticals, Inc.|Director of Clinical Development|973-882-7512|clinicaltrials.gov_inquiries@medimetriks.com|524
22324229|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com|
22324230|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
22324231|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu|
22324232|NCT05340504|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
22324233|NCT03723447|Cedars-Sinai|Dr Karen Zaghiyan|(310) 289-9224|kzaghiyan@yahoo.com|
22324234|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22324235|NCT03068715|Stanford University|Dr. Nolan Williams|(650)800-6920|nolanw@stanford.edu|
22324236|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22324237|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22269629|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
22269630|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220||
22298287|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com|
22269631|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu|
22298288|NCT03238911|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22298289|NCT06893809|Başakşehir Çam and Sakura City Hospital|Dr. Emine Ozcan|05301592856|dr.emine3419@gmail.com|
22298290|NCT03091192|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22269632|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org|
22269633|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca|
22269634|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
22269635|NCT04157296|University of Michigan|Yanni Liu|734-936-9275|yanniliu@med.umich.edu|
22269636|NCT02049905|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22269637|NCT03980145|Indiana University|Peter Altenburger|3172780703|paltenbu@iu.edu|
22269638|NCT02088905|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
22269639|NCT02653144|Montefiore Medical Center|Dr. Amaresh Vydyanathan|7189204316|avydyana@montefiore.org|
22269640|NCT04922255|University of Pittsburgh|Megan Bradley, MD|2487701681|megsbrad2010@gmail.com|
22269641|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22269642|NCT03761030|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
22269643|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov|
22269644|NCT05708976|University of California San Francisco|Ashley E. Mason, PhD|4155146820|ashley.mason@ucsf.edu|
22269645|NCT03004638|MedImmune LLC|Richard George|+1-301-398-5681|information.center@astrazenea.com|
22269646|NCT05653479|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|1 917-499-0789|sumathi.sivapalasingam@upstreambio.com|
22269647|NCT02343939|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298291|NCT05645432|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22324238|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu|
22324239|NCT01588821|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-724-4000|rheist@partners.org|
22269648|NCT02684097|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
22298292|NCT03195478|Bristol-Myers Squibb|Bristol-Myers Squibb Study Directo|1-855-907-3286|Clinical.Trials@bms.com|
22310744|NCT00945724|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
22310745|NCT03485287|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22310746|NCT05039021|Ethicon Endo-Surgery, Inc.|Senior Director Medical Affair-Endomechanical and Trx|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310747|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu|
22310748|NCT02566889|Janssen Scientific Affairs|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310749|NCT02377700|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
22310750|NCT03971539|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298293|NCT02373124|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
22298294|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu|
22298295|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com|
22298296|NCT03370341|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
22298297|NCT02805647|Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok|MichałKarpiński|692224714|gufkarp@gmail.com|+48
22298298|NCT01707004|UW Carbone Cancer Center|Aric Hall|608-262-1604|achall@medicine.wisc.edu|
22298299|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com|
22298300|NCT04318210|Centers for Disease Control and Prevention|Dr. Allan Taylor|404-639-6120|avt0@cdc.gov|
22298301|NCT02573324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22298302|NCT01607905|Karyopharm Therapeutics Inc|Jatin Shah|(617) 658-0600|jshah@karyopharm.com|
22298303|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
22298304|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
22298305|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298306|NCT03892889|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22298307|NCT02517580|Lebanese American University|Dr. Sola Aoun Bahous|+961-1-200-800|sola.bahous@lau.edu.lb|
22298308|NCT02873923|Institut Bergonié|Dr Carine Bellera|33 5 56 33 04 95|c.bellera@brodeaux.unicancer.fr|
22298309|NCT02033005|Imperial College London|Dr Chris Gale|+44 (0) 2033153519|christopher.gale@imperial.ac.uk|
22298310|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298311|NCT02097134|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22298312|NCT02610868|Solstice Neurosciences|Regulatory Affairs Specialist|502-815-8148|regulatoryaffairs@usworldmeds.com|
22298313|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590||
22298314|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com|
22298315|NCT00298896|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
22298316|NCT02880371|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298317|NCT02665481|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22298318|NCT03285646|Regeneron Pharmaceuticals, Inc.|Study Director|844-734-6643|clinicaltrials@regeneron.com|
22298319|NCT02660359|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
22298320|NCT02684591|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
22298321|NCT04101526|Moffitt Cancer Center|Dr. Brian Gonzalez|813-745-3219|Brian.Gonzalez@moffitt.org|
22298322|NCT02944578|Emory University|Dr. Lisa Flowers|404-251-8931|flowe2@emory.edu|
22298323|NCT03854916|Klein Buendel, Inc.|Dr. David Buller|3035654321|dbuller@kleinbuendel.com|
22298324|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298325|NCT00348205|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22298326|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298327|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn|
22298328|NCT04879745|University of Pittsburgh Medical Center|Dr. Mehret Birru Talabi|412-383-8000|birrums@upmc.edu|
22298329|NCT00120042|The University of Western Australia|Dr Jan Dickinson|61-8-93401330|Jan.Dickinson@uwa.edu.au|
22298330|NCT01860417|CITOSPIN|Dr. Javier García-Sancho,|0034 983184827|jgsancho@uva.es|
22298331|NCT04532112|University of Pennsylvania|Dr. Michael Kohanski|2153495766|michael.kohanski@pennmedicine.upenn.edu|
22298332|NCT03592641|Duke University Medical Center|John Strickler, MD|919-668-1861|john.strickler@duke.edu|
22298333|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com|
22298334|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298335|NCT04589559|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
22298336|NCT02942979|VA Bedford Medical Center|David Smelson|781-687-2845|david.smelson@va.gov|
22298337|NCT02664038|VA Connecticut Healthcare System|Morris Bell, Ph.D., Senior Research Career Scientist|203-932-5711|morris.bell@va.gov|2281
22298338|NCT03758040|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
22298339|NCT03738826|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
22298340|NCT03912753|Columbia University|Corina Lelutiu-Weinberger, PhD|212-342-1502|cl4265@cumc.columbia.edu|
22298341|NCT06640829|The University of Kansas Medical Center|Holly Hull|9135881000|hhull@kumc.edu|
22298342|NCT05773287|Duke University|Katherine Collins-Bennett, Ph.D.|919-479-2368|katherine.collins-bennett@duke.edu|
22298343|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
22298344|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324240|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22324241|NCT03932240|Emory University|Laura Downey, MD|404-785-6670|laura.ansley.downey@emory.edu|
22324242|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22324243|NCT03075839|Yale University|Krysten Bold|203-974-7603|Krysten.bold@yale.edu|
22324244|NCT02696083|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
22298345|NCT03025828|Icahn School of Medicine at Mount Sinai|Dr. Kirk Campbell|212-241-6271|kirk.campbell@mssm.edu|
22298346|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov|
22298347|NCT02519712|Memorial Sloan Kettering Cancer Center|Brian Shaffer, MD|212-639-2212|shaffeb1@mskcc.org|
22298348|NCT03029689|Fundació Lluita Contra les Infeccions|Dr. Roger Paredes|(+34) 93 465 7897|rparedes@lluita.org|8209
22298349|NCT03037528|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
22298350|NCT02908529|Brigham and women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22298351|NCT04497987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298352|NCT04099524|Stanford University|Feng Vankee Lin, PI|6082156005|vankee_lin@stanford.edu|
22298353|NCT04733157|University of Zimbabwe|Dr. Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
22298354|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu|
22298355|NCT04973488|"University of Medicine and Pharmacy Victor Babes Timisoara"|Dr. Novacescu Alexandru|+40745064844|novacescu_alex@yahoo.com|
22298356|NCT04579679|HUTCHMED International Corporation|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
22298357|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu|
22298358|NCT02285504|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22310752|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com|
22310753|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu|
22310754|NCT03373916|University of Michigan|Paul Pfeiffer, MD|734-845-3645|ppfeiffe@med.umich.edu|
22310755|NCT01964300|Pediatric Brain Tumor Consortium|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
22310756|NCT02524769|Loyola University Chicago|Dr. Elizabeth Mueller|708-216-2180|EMUELLE@lumc.edu|
22310757|NCT06003075|University of Kentucky|Dr. Ralph Zinner|859-562-2864|ralph.zinner@uky.edu|
22310758|NCT03286114|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22310759|NCT02956642|University of California San Francisco|Dr. Jenise Wong|415-476-3316|jenise.wong@ucsf.edu|
22310760|NCT03053960|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Lionel Gold|215-955-6215|Lionel.Gold@jefferson.edu|
22310761|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22310762|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22310763|NCT02754596|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22310764|NCT04227600|JCR Pharmaceuticals|Study Director|+81 797 32 8582|clinical_development@jp.jcrpharm.com|
22310765|NCT04018495|Medical College of Wisconsin|Rose Franco, MD|414-955-7040|rfranco@mcw.edu|
22310766|NCT02879318|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22324245|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu|
22324246|NCT03527043|Weill Cornell Medicine|Jonathan Gal|646-962-4811|jog4018@med.cornell.edu|
22324247|NCT05089708|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22324248|NCT01697332|Brigham and Women's Hospital|Samuel Patz|6172780616|patz@bwh.harvard.edu|
22324249|NCT02500550|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
22324250|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324251|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22324252|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org|
22324253|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com|
22324254|NCT03322358|University of Pennsylvania|Heather Schofield|617-233-4775|hschof@wharton.upenn.edu|
22324255|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com|
22324256|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no|
22324257|NCT04091217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22324258|NCT01822561|Tufts Medical Center|Andre Witkin|6176367950|awitkin@tuftsmedicalcenter.org|
22324259|NCT01624142|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22324260|NCT04826900|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
22324261|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22324262|NCT02597062|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
22324263|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
22324264|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324265|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu|
22324266|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu|
22324267|NCT04188730|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22324268|NCT03929250|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
22324269|NCT01041248|Childrens Hospital of Eastern Ontario|Dr Johannes Roth|6137377600|jroth@cheo.on.ca|1015
22324270|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
22324271|NCT04984889|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22324272|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22324273|NCT02582658|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22324274|NCT02581995|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22324275|NCT01841632|University Hospital Regensburg|Prof. Dr. Marc-H. Dahlke, Ph. D.|+49941944|marc.dahlke@ukr.de|6809
22324276|NCT06119191|CooperVision, Inc.|Cameron Postnikoff|925-730-6734|postnikoff@coopervision.com|
22324277|NCT01491958|The Ohio State University Comprehensive Cancer Center|Yvonne Efebera, M.D|614-293-3196|Yvonne.Efebera@osumc.edu|
22324278|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu|
22324279|NCT03528681|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22324280|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu|
22324281|NCT03518840|Loyola University Chicago|Colleen Fitzgerald, M.D., M.S.|708-216-3380|CFITZGERALD@lumc.edu|
22324282|NCT01612793|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22324283|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu|
22324284|NCT00473694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324285|NCT02468193|Novartis PharmaCeuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22324286|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324287|NCT03816995|The Cleveland Clinic|Rita Brienza|216-399-9186|brienzr@ccf.org|
22324288|NCT01485614|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324289|NCT03537664|University of Sao Paulo|Dr. Ericka Pinheiro|551126488293|erickapinheiro@usp.br|
22324290|NCT03617926|Oystershell Laboratories|Frank Eertmans|+3293772485|fe@oystershell.be|
22324291|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com|
22324292|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
22324293|NCT03941548|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22324294|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22324295|NCT00870688|Desitin|Lohmueller|0049(0)40-59101|lohmueller@desitin.de|373
22324296|NCT02015819|City of Hope Medical Center|Dr. Jana Portnow|6262189200|jportnow@coh.org|
22324297|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
22324298|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|
22324299|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu|
22324300|NCT01486264|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22324301|NCT01854177|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22324302|NCT03584009|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22324303|NCT04112914|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
22324304|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22324305|NCT02635204|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
22324306|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324307|NCT03102411|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
22324308|NCT02039947|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22324309|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324310|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324311|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
22324312|NCT03830281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324313|NCT03293680|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22324314|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com|
22324315|NCT01491945|Endologix|Sripad Bellary, Director of Clinical Affairs|9257011628|sbellary@endologix.com|
22324316|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22324317|NCT03124069|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
22324318|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG|
22324319|NCT03192904|Ruijin Hospital Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
22324320|NCT00709202|Nathan Kline Institute for Psychiatric Research|Dr. Robert C Principal Investigator. Smith,|845-398-6531|robert.smith@nki.rfmh.org|
22324321|NCT03133767|University of Iowa|Nicholas Mohr|319-384-8285|nicholas-mohr@uiowa.edu|
22324322|NCT03301857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22324323|NCT02319369|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22324324|NCT01856114|UT MD Anderson Cancer Center|Dr. David Hui, MD, Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
22324325|NCT02853760|University of Innsbruck, Department of Sport Science|Martin Niedermeier||martin.niedermeier@uibk.ac.at|
22298359|NCT06023394|Children's Mercy Kansas City|Dr. Emily Weisberg, pediatric anesthesiologist|9136605813|eweisberg@cmh.edu|
22298360|NCT02556710|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22298361|NCT02448303|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22298362|NCT00630877|Abbott|Medical Information Specialist|800-633-9110||
22298363|NCT02284828|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22298364|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu|
22298365|NCT02453594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298366|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de|
22298367|NCT01663272|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
22298368|NCT02506114|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
22298369|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298370|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu|
22298371|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298372|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22298373|NCT00456092|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22298374|NCT04904510|UCLA|Dr. Noah Kojima|(310) 319-4377|nkojima@ucla.edu|
22298375|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
22298376|NCT03058796|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
22298377|NCT01358981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298378|NCT04875520|Nationwide Children's Hospital|Jason G. Newland, MD|614-722-3416|Jason.Newland@nationwidechildrens.org|
22298379|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu|
22310767|NCT02382003|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
22310768|NCT05934292|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310769|NCT02890355|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
22310770|NCT02206828|Medtronic|Djamila Bennat|33474089000|djamila.bennat@medtronic.com|1591
22310771|NCT03391466|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22310772|NCT03140670|Abramson Cancer Center|Pancreas Research Program Manager|2672575567|mazali@pennmedicine.upenn.edu|
22310773|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22310774|NCT02325466|Icahn School of Medicine at Mount Sinai|Dr. Robert S. Rosenson|212-241-9101|robert.rosenson@mssm.edu|
22310775|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22310776|NCT01637402|University of California, San Francisco|Dr. Terry Friedlander, MD|415-514-6380|Terence.Friedlander@ucsf.edu|
22310777|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org|
22310778|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu|
22310779|NCT02111096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22310780|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu|
22310781|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22310782|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com|
22310783|NCT04121546|Indiana University School of Medicine|Dr. Michael Bushey|3179637300|mabushey@iu.edu|
22310784|NCT04129164|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22310785|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310786|NCT06065501|National Cheng Kung University|Professor Miaofen Yen / Professor of Nursing department|886-6-2353535|miaofen@mail.ncku.edu.tw|5823
22310787|NCT06203990|Washington University in St. Louis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
22310788|NCT05288348|University of Pittsburgh|Francis X Guyette|412 651 1077|guyettef@upmc.edu|
22310789|NCT00909649|Mansoura university hospital|Elnakeeb Ayman|0106752021|elnakeebayman@yahoo.com|
22310790|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com|
22310791|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300||
22310792|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu|
22310793|NCT02224729|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Joanne Filicko, O'Hara|215-955-8874|joanne.filicko@jeffersron.edu|
22310794|NCT01313559|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
22310795|NCT02466971|NRG Oncology|Christopher Purdy on behalf of Wei Deng, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22310796|NCT05707351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22310797|NCT01996436|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|Peng.R.Chen@uth.tmc.edu|
22310798|NCT04174560|Cincinnati Children's Hospital|Robert Frenck, Jr., MD|513-636-4463|Robert.Frenck@cchmc.org|
22310799|NCT03872466|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
22310800|NCT01778686|Rigshospitalet and University of Copenhagen|Gitte Moos Knudsen|+4535456720|gmk@nru.dk|
22310801|NCT04012567|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22310802|NCT05856266|Biovitrum|CPL|0795914760|rolf.schlosshauer@sobi.com|
22310803|NCT04261790|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
22280544|NCT03346083|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22280545|NCT02630693|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
22280546|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu|
22280547|NCT00175916|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22280548|NCT04105868|University of Pittsburgh|Mary Woody, PhD Assistant Professor of Psychiatry|4123832143|mlw114@pitt.edu|
22280549|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22280550|NCT00382265|George Washington University|Andrew Meltzer, MD, MS|202-741-2952|ameltzer@mfa.gwu.edu|
22280551|NCT02661997|VA Boston Healthcare System|Barbara L. Niles, Ph.D.|857-364-4128|barbara.niles@va.gov|
22310804|NCT02586974|Città della Salute e della Scienza di Torino - Ospedale Molinette|Dr. Marco Oderda|+393479383465|marco.oderda@libero.it|
22310805|NCT05714059|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
22310806|NCT04899674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310807|NCT05545280|Cleveland Clinic Foundation|Kurt Ruetzler, MD|216 636-0561|RUETZLK@ccf.org|
22310808|NCT03593356|University of California, Irvine|Greg John Duncan|(949) 824-7831|gduncan@uci.edu|
22310809|NCT04305327|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22310810|NCT02379351|University of Utah, Department of Obstetrics & Gynecology|Dr. Erin Clark|801-5818425|erin.clark@hsc.utah.edu|
22310811|NCT05517902|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medinfo@mnk.com|
22310812|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
22310813|NCT05864209|NYU Langone Health|Linda G Kahn, PhD, MPH|(917) 439-8069|linda.kahn@nyulangone.org|
22310814|NCT04530487|M D Anderson Cancer Center|Jeremy S Connors, MD|(713) 792-6624|jsconnors@mdanderson.org|
22310815|NCT04977583|Department of Veterans Affairs|Dr. Grant Huang|(202) 443-5700|CSP@va.gov|
22310816|NCT04207736|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
22310817|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298380|NCT02247349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22298381|NCT02867605|Cleveland Clinic Foundation|Dr. Carol De la Motte|216 444-5374|delamoc@ccf.org|
22298382|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu|
22310818|NCT04974047|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22310819|NCT00655499|GERCOR|Regulatory affairs|00331 40 29 85 00|Regulatory.Affairs@gercor.com.fr|
22310820|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22310821|NCT00146172|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22310822|NCT00210106|Digestive Tumours Unit, Institut Bergonie|Pr Serge Evrard|s.evrard@brdeaux.unicancer.fr||
22310823|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za|
22310824|NCT02422615|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22310825|NCT01288443|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22310826|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org|
22310827|NCT04327843|Case Western Reserve University|Kaylee Sarna|(216) 368-3577|kns17@case.edu|
22310828|NCT01639131|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22324326|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540||
22298383|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
22298384|NCT04936685|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22298385|NCT04646616|Drexel University School of Public Health|Dr. Mariana Lazo|2673596058|ml3629@drexel.edu|
22298386|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22298387|NCT03049813|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
22298388|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
22298389|NCT02144675|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22298390|NCT03075644|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22298391|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298392|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22298393|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu|
22298394|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|190
22298395|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22298396|NCT02270060|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
22298397|NCT01072682|SeaStar Medical, Inc|Eric Schlorff|8444278100|eric@seastarmed.com|
22298398|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450||
22310829|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22324327|NCT05300087|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
22280552|NCT03369665|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22298399|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22310830|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com|
22310831|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu|
22310832|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280553|NCT03230318|Basilea Pharmaceutica International Ltd, Allschwil|Dr Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
22310833|NCT03820544|Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Kowalski, MD|215-955-9396|Thomas.Kowalski@jefferson.edu|
22280554|NCT01531582|University of South Florida, Morsani College of Medicine|Edwin J. Weeber, Ph.D.|(813) 396-9995|eweeber@health.usf.edu|
22280555|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310834|NCT01380743|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
22280556|NCT02959463|The University of Texas MD Anderson Cancer Center|Matthew Stephen Ning, MD, MPH|(832) 710-8779|msning@mdanderson.org|
22280557|NCT02413996|IRCCS Istituto Ortopedico Galeazzi, Milano|Davide Tornese|0266214046|davidzai@tin.it|
22310835|NCT05858905|Shockwave Medical|Josh Popp|1-510-279-4262|jpopp@shockwavemedical.com|
22310836|NCT03248492|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo_us@daiichisankyo.com|
22310837|NCT04495621|Menarini Ricerche S.p.A.|Clinical Sciences|+39 0555680|martine.piccart@bordet.be|9990
22310838|NCT03228719|University of Delaware|Daniel K. White|3028317607|dkw@udel.edu|
22310839|NCT03774472|M D Anderson Cancer Center|Debasish Tripathy|713-794-4385|dtripathy@mdanderson.org|
22310840|NCT04059406|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22310841|NCT05495945|University of Michigan|Zirui Huang|(734) 615-2875|huangzu@med.umich.edu|
22280558|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org|
22280559|NCT00090779|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22280560|NCT01672879|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298400|NCT03022617|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22298401|NCT02143843|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22298402|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000|jeffrey.whittle@va.gov|46444
22298403|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22298404|NCT06017089|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
22298405|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
22298406|NCT03181542|Penn State Hershey Medical Center|Dr Priti Dalal|717-531-6597|pdalal@pennstatehealth.psu.edu|
22298407|NCT04138615|University of Texas Southwestern Medical Center|Dr Craig Crandall|2143454623|craigcrandall@texashealth.org|
22298408|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu|
22298409|NCT00247728|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
22298410|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298411|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
22298412|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298413|NCT03012386|Vanderbilt University Medical Center|Cyndya Shibao MD|6159364584|cyndya.shibao@vumc.org|
22298414|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22298415|NCT04292730|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298416|NCT01527292|University of Louisville, James Graham Brown Cancer Center|Dr. Shiao Woo|502-561-2700|sywoo001@exchange.louisville.edu|
22298417|NCT02549508|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|7044
22298418|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
22298419|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22298420|NCT00556842|The Centre for Evidence-Based Orthopaedics|Paula McKay|905-521-2100|mckayp@mcmaster.ca|44131
22298421|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu|
22298422|NCT03400033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298423|NCT01346267|Wake Forest University School of Medicine|Thomas W. McLean, MD|336-716-4085|tmclean@wfubmc.edu|
22298424|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD|617-835-3789|ag355@columbia.edu|
22298425|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22298426|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22298427|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu|
22298428|NCT02353091|UCL Ear Institute|Mr Georgios Stavrinos|07856067517|georgios.stavrinos.13@ucl.ac.uk|
22298429|NCT02457325|University of Sao Paulo / Bauru School of Dentistry|Carlos Ferreira Santos|+551432358200|cfsantos@fob.usp.br|
22298430|NCT02665975|Anglia Ruskin Univeristy|Eldre Beukes|01223698847|eldre.beukes@anglia.ac.uk|2847
22298431|NCT02367599|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
22298432|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22310842|NCT05155306|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310843|NCT04121741|Medical College of WI|Principal Investigator: Jacquelyn P Kulinski|414-955-6896|jakulinski@mcw.edu|
22310844|NCT01084863|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22324328|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu|
22310845|NCT04056910|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22310846|NCT03473223|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
22310847|NCT04505722|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310848|NCT04755595|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|(718) 270-1229|jared.jagdeo@downstate.edu|
22310849|NCT05501548|Johns Hopkins University|Channing Paller, M.D., principal investigator|410-955-8239|cpaller1@jhmi.edu|
22310850|NCT05365997|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
22310851|NCT02549352|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22310852|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22310853|NCT04129450|Boston Medical Center|Natalia Morone, MD, MS|617-414-6652|natalia.morone@bmc.org|
22310854|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
22310855|NCT02291913|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22310856|NCT04876417|University of Iowa|Thorsten Rudroff, PhD, Associate Professor|(319) 467-0363|thorsten-rudroff@uiowa.edu|
22310857|NCT04334317|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22310858|NCT03621735|University of Michigan|Susan Shore|734-647-2116|sushore@umich.edu|
22310859|NCT03614663|Zynerba Pharmaceuticals|Stephen O'Quinn, PharmD|919-271-1339|oquinns@Zynerba.com|
22310860|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300||
22310861|NCT05274321|University of California, San Francisco|Julius Oatts, MD|(415) 353-2800|Julius.Oatts@ucsf.edu|
22310862|NCT03875313|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22310863|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
22310864|NCT03709706|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22310865|NCT01105975|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22310866|NCT04868617|Coloplast A/S|Pernille Nonboe|+4549113143|dkpen@coloplast.com|
22310867|NCT05441449|Spinal Cord Damage research Center, James J. Peters VA Medical Center|Dr. John Handrakis|(718) 584-9000|john.handrakis@va.gov|5439
22310868|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22310869|NCT04612244|BSC|Allison Anderson|651-582-5077|allison.anderson@bsci.com|
22310870|NCT01315132|Sidney Kimmel Cancer Center at Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|Neal.Flomenberg@jefferson.edu|
22310871|NCT03260569|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
22310872|NCT06199986|University of Chicago|Dr. Ted Skolarus|773 702-0881|tskolarus@bsd.uchicago.edu|
22310873|NCT04158141|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22310874|NCT03850899|Indiana University School of Medicine|Samer Gawrieh|(317) 278-9326|sgawrieh@iu.edu|
22310875|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17||
22310876|NCT03777657|BeiGene|Study Director|877-828-5568|Clinicaltrials@beigene.com|
22310877|NCT06284941|Jiangyan District Hospital of traditional Chinese medicine attached to the Nanjing University of Chinese Medicine|Yang Zhang|15861013918|617405180@qq.com|
22310878|NCT04559698|Yale University School of Public Health|Dr. Zachary Soulliard|646-344-4060|zachary.soulliard@yale.edu|
22280561|NCT04930198|Vanderbilt University Medical Center|Dr. Martin Were|(617) 319-6462|martin.c.were@vumc.org|
22310879|NCT01982682|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Dolores Grosso|215-955-0182|dolores.grosso@jefferson.edu|
22310880|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu|
22310881|NCT01574716|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22310882|NCT03183050|Georgetown University|Suzanne O'Neill|202-687-0869|sco4@georgetown.edu|
22310883|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com|
22310884|NCT02797132|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22310885|NCT02502526|Alcon, A Novartis Division|Dir Surg Instrumentation, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22310886|NCT03304418|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22310887|NCT02964741|University of Michigan|Jacqueline Dobson|734-763-8469|contacthope@umich.edu|
22310888|NCT00610558|University of California, Irvine|Dr. Lydia Su|(949) 824-4925|msu@uci.edu|
22324329|NCT03248128|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22324330|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
22280562|NCT05069649|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22280563|NCT03951766|Massachusetts General Hospital, Psychiatry Department|Dr. Bettina Hoeppner|6176431988|bhoeppner@mgh.harvard.edu|
22280564|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu|
22280565|NCT00515528|Department of Medicine|Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
22298433|NCT03385239|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22298434|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298435|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com|
22298436|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22298437|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824|jason.naramore@ivwatch.com|7019
22298438|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu|
22298439|NCT05559320|University of Connecticut Department of Kinesiology|Dr. Sudha Srinivasan|(860)-486-6192|sudha.srinivasan@uconn.edu|
22280566|NCT02623972|Dana-Farber Cancer Institute|Filipa Lynce, MD|617-632-4056|Filipa_Lynce@DFCI.HARVARD.EDU|
22280567|NCT04158375|Mayo Clinic|Dr. Sreekumaran Nair - Principal Investigator|507-284-2511|nair.sree@mayo.edu|
22280568|NCT04847843|University of Utah|Tanya Halliday, PhD, RD|801-213-1364|tanya.halliday@utah.edu|
22280569|NCT02734004|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22280570|NCT02388880|Advanced Circulatory Systems|Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
22280571|NCT01459666|University Hospitals Cleveland Medical Center|Dr. Kevin Cooper|216-844-3100|Kevin.Cooper@UHhospitals.org|
22280572|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
22280573|NCT03800030|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
22280574|NCT04570371|Mayo Clinic|Dr. Andrea Cheville|(507) 284-2747|cheville.andrea@mayo.edu|
22310889|NCT01074294|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22280575|NCT04828135|Duke University|Loretta Que|919-681-8551|loretta.que@duke.edu|
22310890|NCT01500200|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22280576|NCT02379052|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22310891|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22280577|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343||
22310892|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
22310893|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
22280578|NCT02343302|Johns Hopkins University|Director of Clinical Trials|410-955-7518|sleung7@jhu.edu|
22280579|NCT05089292|Icahn School of Medicine at Mount Sinai|Lina Jandorf|(212) 659-5506|lina.jandorf@mssm.edu|
22280580|NCT04229888|Indiana University School of Optometry|Anna Tichenor|812-855-0520|annatich@iu.edu|
22310894|NCT01218659|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22280581|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com|
22298440|NCT05648565|The University of Texas Health Science Center at Houston|David Z. Allen|713-500-5427|David.Allen@uth.tmc.edu|
22310895|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu|
22310896|NCT03066609|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22310897|NCT02284113|Pacira Pharmaceuticals, Inc.|Medical Information||MedInfo@Pacira.com|
22310898|NCT04191824|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22310899|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315|markku.vaarala@oulu.fi|2840
22298441|NCT05346406|Medical College of Wisconsin|Alina G Burek MD|414-337-7050|aburek@mcw.edu|
22298442|NCT03890367|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22298443|NCT02851108|Heidelberg University|Prof. Dr. Olaf Müller|+49 6221 56 4904|olaf.mueller@urz.uni-heidelberg.de|
22298444|NCT04524403|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
22298445|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22298446|NCT01709318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298447|NCT00273364|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22298448|NCT02258152|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
22298449|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
22298450|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu|
22298451|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22298452|NCT01312909|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298453|NCT02200042|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22298454|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com|
22298455|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22298456|NCT01923181|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22298457|NCT00721526|NYU Grossman School of Medicine|Michael Bogenschutz|505-999-9325|Michael.Bogenschutz@nyulangone.org|
22298458|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22298459|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu|
22298460|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com|
22298461|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu|
22298462|NCT03511521|Northwestern University Feinberg School of Medicine|Dr. Mark Molitch, Principal Investigator|3125034130|molitch@northwestern.edu|
22298463|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu|
22298464|NCT01993108|University of Michigan|Chandra Sripada|734 232 0281|sripada@umich.edu|
22298465|NCT01560624|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
22298466|NCT01733368|Hospital Clinico Universitario Virgen de la Victoria|Dr. Javier Alzueta Rodríguez|951 03 20 00|jalzueta@telefonica.net|
22298467|NCT02167035|Cornerstone Healthcare|Michael Tepedino, MD|336-802-2255|mtepedino@wakehealth.edu|
22310900|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22280582|NCT04834726|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
22280583|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu|
22298468|NCT00796861|Penn State Health|Dr. Leah Cream|717-531-8870|lcream@pennstatehealth.psu.edu|
22310901|NCT03170882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22280584|NCT03542019|University of Jordan|Dr. Ahmad El-Ma'aita|+9626535 5000|a.maaita@ju.edu.jo|
22310902|NCT03213457|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22310903|NCT05116774|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22310904|NCT03150862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22310905|NCT05139992|ASH Research Collaborative|Nicole Mortier|866-828-1231|nmortier@ashrc.org|
22310906|NCT05521516|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|bilfeld@health.ucsd.edu|
22310907|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
22310908|NCT06229106|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22310909|NCT05709860|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
22310910|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
22310911|NCT03437733|Biosense Webster, Inc.|Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22310912|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu|
22310913|NCT03684590|University of Texas Southwestern|Tiffany Moon, MD|2145345456|tiffany.moon@utsouthwestern.edu|
22310914|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363||
22310915|NCT04017611|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22310916|NCT03406325|Hong Kong Sanatorium & Hospital|Prof. Tak Hong Lee|28358430|TakHong.Lee@hksh.com|
22310917|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
22310918|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343||
22310919|NCT01970410|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22310920|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu|
22310921|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22310922|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
22280585|NCT04581785|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22280586|NCT02948582|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22280587|NCT01757301|Richard L. Roudebush VA Medical Center|Erica Evans|317-988-3476|erica.evans2@va.gov|
22280588|NCT02213068|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
22280589|NCT03810014|Duke University|Wendy P O'Meara, PhD|919-681-7711|wpo@duke.edu|
22310923|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org|
22310924|NCT01342367|The University of Chicago|Dr. Stanley Liauw|7737026870|sliauw@radonc.uchicago.edu|
22310925|NCT00640159|Baylor College of Medicine/Houston Methodist|William G. Ondo , MD|713-363-8930|wondo@houstonmethodist.org|
22310926|NCT03355573|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22310927|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22310928|NCT03433794|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
22310929|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com|
22310930|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org|
22310931|NCT01830595|Minneapolis Medical Research Foundation|Jason Baker|612-873-2705|baker@umn.edu|
22310932|NCT03875001|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22310933|NCT03857646|Stanford University|Cody Arnold|(650) 723-8772|codya@stanford.edu|
22310934|NCT04529616|RxSight, Inc.|Associate Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|
22310935|NCT03280030|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22310936|NCT05747599|RTIInternational|Yukiko Washio, PhD|9194852794|ywashio@rti.org|
22310937|NCT01983683|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22310938|NCT03400150|BioProtect|Dafna Carmi Yinon|+972 (9) 7731-929|dafna@bioprotect.com|
22310939|NCT04882917|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22310940|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
22310941|NCT04926740|Lawson Health Research Institute|Kristine Van Aarsen (Research Associate)|5196858500|kristine.vanaarsen@lhsc.on.ca|76089
22310942|NCT04980300|University of Delaware|Daniel White|302-831-7607|dkw@udel.edu|
22310943|NCT04528459|Columbia University|Wakenda K. Tyler, MD, MPH|2123059192|wkt2106@cumc.columbia.edu|
22310944|NCT02278185|University of Colorado School of Medicine|Dr. Elizabeth R Kessler|720-848-0402|elizabeth.kessler@cuanschutz.edu|
22310945|NCT06056310|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22310946|NCT04406272|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|patrick_wen@dfci.harvard.edu|
22310947|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
22310948|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22310949|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22310950|NCT02722434|Mayo Clinic|Charles L Loprinzi MD|507/284-2511|cloprinzi@mayo.edu|
22310951|NCT06336967|University of Pennsylvania|Dr. Heather Nuske, PI|(215) 746-6041|heather.nuske@pennmedicine.upenn.edu|
22310952|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu|
22310953|NCT03876457|University Hospitals Cleveland Medical Center|Dr. Amrou Sarraj|(216)844-0474|Amrou.Sarraj@UHhospitals.org|
22310954|NCT01084694|Northside Hospital|Dr. Dawn Speckhart, PhD|404-255-1930|dawn.speckhart@northside.com|
22310955|NCT02414633|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22310956|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com|
22310957|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov|
22310958|NCT02185794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22310959|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
22310960|NCT03478969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22310961|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu|
22310962|NCT05405244|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|Kyle_burger@unc.edu|
22310963|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22310964|NCT03455985|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
22310965|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22310966|NCT04497727|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
22310967|NCT04353492|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22310968|NCT03893318|University of California, San Diego|Michael Kelly, MD|508-410-9567|mpkelly@ucsd.edu|
22310969|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no|
22310970|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22310971|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343||
22310972|NCT01961609|Novartis Pharmaceuticals|Study Director|862-778-1873||
22310973|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil|
22310974|NCT00647400|Abbott|Global Medical Services|800-633-9110||
22269649|NCT02064816|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22310975|NCT01212744|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
22310976|NCT02167451|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
22269650|NCT01757184|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22269651|NCT01959464|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
22269652|NCT04468347|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22269653|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269654|NCT04339062|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617-632-3090|glenn_hanna@dfci.harvard.edu|
22269655|NCT04586244|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22269656|NCT03564119|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22269657|NCT03896022|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
22269658|NCT02741076|Janssen Pharmaceuticals, Inc.|John Han, Associate Director, Statistics|484-354-3547|jhan9@its.jnj.com|
22310977|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22310978|NCT02555306|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
22310979|NCT01566890|Medical College of Wisconsin Department of Hematology|Joshua Field, MD|414-937-6896|JField@Versiti.org|
22310980|NCT02534285|Technical University Dresden, Dept. of Anaesthesiology|Prof. Dr. Matthias Hübler|+4945814002|matthias.huebler@uniklinikum-dresden.de|
22310981|NCT02397096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22310982|NCT03029286|Georgetown University|Suzanne O'Neill, PhD|202-687-0869|sco4@georgetown.edu|
22310983|NCT00743951|University of Ottawa, Ottawa Hospital Research Institute|Dawn Stacey|613-737-8899|dstacey@uottawa.ca|73817
22310984|NCT03275285|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22310985|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com|
22310986|NCT03789110|Dana-Farber Cancer Institute|Sara Tolaney|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22310987|NCT04032106|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
22310988|NCT03959423|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
22310989|NCT04959812|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|CraigCrandall@texashealth.org|
22310990|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu|
22310991|NCT04440228|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
22310992|NCT05747014|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
22310993|NCT02896907|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. James Posey|215-503-6442|James.Posey@jefferson.edu|
22310994|NCT05802173|Technoderma Medicines|Arthur P. Bertolino MD, PhD, MBA Chief Medical Officer|+1.616.928.1145|arthur.bertolino@innovationderm.com|
22310995|NCT04503681|Cooper University Health Care|Brian Roberts|856-342-2352|roberts-brian-w@cooperhealth.edu|
22310996|NCT03352713|Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine|Dr. Shea Lemley|603-646-7040|behavior.change@dartmouth.edu|
22310997|NCT01812759|UT MD Anderson Cancer Center|Kumar Alagappan,Chair, Emergency Medicine|(713) 745-9911|kalagappan@mdanderson.org|
22310998|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu|
22310999|NCT02351791|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
22324331|NCT03372941|Washington University School of Medicine|Stephen Liang|3017470750|syliang@wustl.edu|
22269659|NCT01779440|Dartmouth-Hitchcock|Mary F. Brunette, MD|603-229-5419|Mary.F.Brunette@hitchcock.org|
22311000|NCT04989816|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22311001|NCT03758638|Washington University in St. Louis|Rachel Tabak|3149350153|rtabak@wustl.edu|
22311002|NCT01184326|Dana-Farber Cancer Institute|Dr. Mark Pomerantz|617-632-4524|mark_pomerantz@dfci.harvard.edu|
22311003|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com|
22311004|NCT02967458|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Ethan Halpern|215-955-5345|ethan.halpern@jefferson.edu|
22311005|NCT02186509|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
22311006|NCT03442777|Belgian Healthcare Knowledge Centre|Jillian Harrison|+32 2 287 33 89|jillian.harrison@kce.fgov.be|
22311007|NCT02866942|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22311008|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311009|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com|
22311010|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
22311011|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org|
22311012|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed|
22311013|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311014|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22311015|NCT01436175|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22311016|NCT01664741|Johns Hopkins School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
22311017|NCT03577106|UPMC|Scott Ward|412-683-7105|wards7@upmc.edu|
22311018|NCT01579318|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
22311019|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu|
22311020|NCT03601715|Federal University of Santa Catarina|Inaihá Benincá|(+55 48) 3721-6255|inaiha.b@gmail.com|
22311021|NCT01929291|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269660|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269661|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402|v.jones@columbiaorthogroup.com|4391
22269662|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311022|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com|
22311023|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr|
22311024|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
22311025|NCT01970007|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22311026|NCT03878979|Johns Hopkins University|Dr. Tanguy Seiwert|443-287-8312|tseiwert@jhmi.edu|
22311027|NCT05230433|Happy Trails Nutrition|Jennifer Meijer|6036505250|jen@htnutrition.com|
22311028|NCT04250194|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-2386|fabien.maldonado@vumc.org|
22311029|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov|
22311030|NCT03500549|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22311031|NCT06456723|Imperial College London|Professor Rohini Sharma|0203 313 3720|r.sharma@imperial.ac.uk|
22311032|NCT02016872|Memorial Sloan Kettering Cancer Center|Dr. Jacob Shin, MD|848-225-6436|shinj2@mskcc.org|
22311033|NCT05018143|University of Pennsylvania|Dr. José A. Bauermeister|215-898-3242|bjose@upenn.edu|
22311034|NCT06688357|University of Florida - Norman Fixel Brain Institute|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
22311035|NCT00545545|HiberCell|Michele A. Gargano, MSC/ VP Clin Ops and Prg Mngt|651.675.0300|mgargano@hibercell.com|
22311036|NCT03399500|University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
22311037|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu|
22311038|NCT05357989|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
22311039|NCT02761187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22311040|NCT05617300|HealthPartners Neuroscience Research|Leah Hanson, PhD|6514956352|Leah.R.Hanson@HealthPartners.com|
22311041|NCT05140902|University of Alabama at Birmingham|Dr. Harrison Kim|205-996-4088|hyunkikim@uabmc.edu|
22311042|NCT05786612|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|004549112057|dkmhla@coloplast.com|
22311043|NCT05890794|AM-Pharma|AM-Pharma Office|31 (0)30 228 92 22|office@am-pharma.com|
22311044|NCT04538352|The Cleveland Clinic Foundation|Research Administrator|(216) 445-4791|jenkink@ccf.org|
22311045|NCT05704725|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22311046|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com|
22311047|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org|
22324332|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com|
22324333|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324334|NCT04109599|play2PREVENT Lab, Yale Center for Health and Learning Games, Department of Internal Medicine|Tyra Pendergrass Boomer, Deputy Director of Programs and Partnerships|+1 (203) 737-6101|tyra.pendergrass@yale.edu|
22324335|NCT01731002|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22324336|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22269663|NCT01190410|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22311048|NCT03301467|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
22324337|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22324338|NCT00924703|BioMarin Pharmaceutical Inc.|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
22324339|NCT03040154|Children's Hospital Los Angeles|Joyce R. Javier, MD, MPH, MS|(323)669-2113|jojavier@chla.usc.edu|
22280590|NCT03606486|University of Washington|Dr. Barbara Norquist|206-543-3669|bnorquis@uw.edu|
22280591|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu|
22280592|NCT01081262|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22280593|NCT04684576|University of Washington Department of Rehabilitation Medicine|Dr. Heather Feldner, Study PI|2065433721|hfeldner@uw.edu|
22280594|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu|
22280595|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22311049|NCT02798471|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22280597|NCT04500457|Florida State University|Jesse Cougle|8506458729|cougle@psy.fsu.edu|
22280598|NCT02752490|The University of Texas Health Science Center at Houston|Nana-Ama E Ankumah, MD|713-500-6421|Nana.Ama.E.Ankumah@uth.tmc.edu|
22280599|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22280600|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org|
22280601|NCT04541667|University of Nebraska Medical Center|Chinenye Dike|402-955-5700|chinenye.dike@unmc.edu|
22280602|NCT02292537|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22280603|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com|
22280604|NCT03300206|Hologic|Hologic Clinical Research Team|508.263.2900|ClinicalResearch@Hologic.com|
22280605|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22280606|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com|
22280607|NCT04357730|Denver Health Medical Center|Dr. Ernest Moore, Director of Surgical Research|3036021820|ernest.moore@dhha.org|
22280608|NCT05265728|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22298469|NCT02099721|Medtronic CRHF|Katy Muckala, Sr. Clinical Research Specialist|(763) 526-1767|katy.a.muckala@medtronic.com|
22298470|NCT00754247|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
22298471|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov|
22298472|NCT04574362|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298473|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
22298474|NCT01060384|University of Nebraska Medical Center|Julie M. Vose|402-559-3848|jmvose@unmc.edu|
22298475|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22298476|NCT02476565|Vanderbilt University Medical Center|Antonio Hernandez, MD|615 322-4650|antonio.hernandez@vanderbilt.edu|
22298477|NCT01600040|Massachusetts General Hospital|Andrea Russo, MD|617-726-7941|alrusso@mgh.harvard.edu|
22298478|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300||
22298479|NCT01401530|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22280609|NCT03493451|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22311050|NCT03668899|CairoU|Dr. Amira Farouk|01007192834|Amirafarouk77@gmail.com|
22311051|NCT04803370|Son Llàtzer University Hospital|Joan Bargay Lleonart|34871202000|khaoulahelhaji@gmail.com|
22311052|NCT03752684|University of Alabama at Birmingham|John Knight|205-996-2295|johnknight@uabmc.edu|
22311053|NCT02677766|University of Modena and Reggio Emilia|Stefania Costi|+390522522441|stefania.costi@unimore.it|
22311054|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22311055|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu|
22311056|NCT04213807|Anthos Therapeutics|Debra Freedholm|609-439-8246|Deb.f@anthostherapeutics.com|
22311057|NCT03418922|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22311058|NCT03451422|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22311059|NCT02347332|Institut de Recherche Pierre Fabre, Toulouse France|Zahida Issiakhem, Clinical Development Physician|+33 5 34 50 61 71|zahida.issiakhem@pierre-fabre.com|
22311060|NCT01816971|University of Chicago Medical Center|Andrzej Jakubowiak, MD, PhD|773-702-4005|ajakubowiak@medicine.bsd.uchicago.edu|
22311061|NCT04384172|University of Michigan|Tim Bruns|734-647-8727|bruns@umich.edu|
22311062|NCT04860505|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22311063|NCT01640951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22311064|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
22311065|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu|
22311066|NCT00293397|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22311067|NCT04124432|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22311068|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311069|NCT00822120|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22311070|NCT01759862|Stanford University|Paul Grimm|6507237903||
22311071|NCT02999763|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
22311072|NCT04060212|University of Rochester|Matthew Rand|585-275-5459|matthew_rand@urmc.rochester.edu|
22311073|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com|
22311074|NCT02646618|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
22311075|NCT03885232|University of Colorado at Anschutz Medical Campus|Sean O'Leary, MD, MPH - Principal Investigator|(303)724-1582|sean.oleary@cuanschutz.edu|
22280610|NCT01693250|University of California San Francisco|Dr. Jyu-Lin Chen|415-502-6015|jyu-lin.chen@ucsf.edu|
22311076|NCT04474496|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
22311077|NCT03333109|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22311078|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22311079|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311080|NCT04066075|University of California Los Angeles|Ava K. Bittner, OD, PhD|310-206-9566|researchatvrc@gmail.com|
22311081|NCT00309166|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311082|NCT06571058|The Ohio State University Comprehensive Cancer Center|Karen Meade|614-366-5060|Karen.Meade@osumc.edu|
22311083|NCT00701701|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22311084|NCT05601882|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22311085|NCT03834740|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
22311086|NCT01208974|University of Miami|Cristiane Takita MD|305-243-4337|ctakita@med.miami.edu|
22311087|NCT03593226|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
22280611|NCT02257242|Brown University Oncology Research Group|BrUOG|4018633000|BrUOG@BROWN.EDU|
22280612|NCT00600106|Cedars-Sinai Medical Center|C. Noel Bairey Merz|310-423-9680|Noel.BaireyMerz@cshs.org|
22280613|NCT02213926|AstraZeneca Clinical -Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22280614|NCT02656836|Queen's University Belfast|Augusto Azuara-Blanco|2890976350|a.azuara-blanco@qub.ac.uk|
22280615|NCT02746406|Laborie|Clinical Researcher|9056121170|sbitzos@laborie.com|1755
22280616|NCT03783962|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
22298480|NCT03670810|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22298481|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu|
22298482|NCT01150838|University of Virginia|George Politis MD|434-924-2283|GDP8A@hscmail.mcc.virginia.edu|
22298483|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298484|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu|
22298485|NCT02003625|Massachusetts General Hospital|Bimalangshu Dey, MD, PhD|617-724-1124|BDEY@mgh.harvard.edu|
22311088|NCT02500576|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
22311089|NCT03691493|Emory University|Dr. Mylin Torres|404-778-1900|matorre@emory.edu|
22311090|NCT05507970|Medicines for Malaria Venture|Project Director|+41 22 555 03 00|info@mmv.org|
22311091|NCT05501600|University of Pittsburgh|Keith Vogt|412-647-3147|vogtkm@upmc.edu|
22311092|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
22311093|NCT03459196|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
22311094|NCT03367156|UT MD Anderson Cancer Center|Dr. David Hui- Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22311095|NCT03762850|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
22311096|NCT02303392|The Ohio State University Comprehensive Cancer Center|Dr. Jennifer Woyach|614-293-8165|Jennifer.Woyach@osumc.edu|
22311097|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311098|NCT03083366|University of Utah|Karena McDonald|801-699-9740|karena.mcdonald@hsc.utah.edu|
22324340|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org|
22324341|NCT04906707|Emory University|Dr. Nadine Matthie|404-712-8449|nadine.matthie@emory.edu|
22298486|NCT00075335|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
22298487|NCT02410811|Cincinnati Children's Hospital Medical Center|Dr. Charles T. Quinn|5138033086|charles.quinn@cchmc.org|
22298488|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298489|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
22298490|NCT05267054|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22298491|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov|
22298492|NCT01552226|St. Joseph Mercy Hospital Ann Arbor|Dr. Robert Cleary|7347128150|Robert.Cleary@trinity-health.org|
22298493|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22298494|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298495|NCT04542070|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298496|NCT05035017|CooperVision Inc.|Lee Hall BSc PhD MCOptom, FBCLA|925-251-6884|lhall@coopervision.com|
22298497|NCT03511560|Columbia University|Amanda Alonso|212-342-0261|aa2974@cumc.columbia.edu|
22298498|NCT03487913|Centessa Pharmaceuticals|Milena Kanova, MD, Vice President, Clinical Operations|+44 7780 430583|Milena.Kanova@centessa.com|
22298499|NCT03993938|Henry Ford Health System|Trevor Szymanski MD|(313) 622-4168|tszyman1@hfhs.org|
22298500|NCT02967367|CHU Saint-pierre|Pr. Marie Bruyneel|00325354219|marie_bruyneel@stpierre-bru.be|
22298501|NCT02751983|Rocky Mountain Mental Illness Research, Education, and Clinical Center|Sean Barnes|720-723-6560|Sean.Barnes2@va.gov|
22298502|NCT02167256|Yale University|Stephen Strittmatter|2037854878|stephen.strittmatter@yale.edu|
22298503|NCT03467425|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298504|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov|
22298505|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22324342|NCT01815957|UNewMexico|Bina Ahmed|505-272-7028|hkhawaja@salud.unm.edu|
22311099|NCT05250115|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324343|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
22324344|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu|
22324345|NCT03971721|The Ohio State University|Dr. Ulysses Magalang|(614) 293-4925|Ulysses.Magalang@osumc.edu|
22324346|NCT04429022|University at Buffalo|Dr Sarah Andres, PI|7163230631|seandres@buffalo.edu|
22324347|NCT04321343|POXEL|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
22324348|NCT03430310|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
22324350|NCT02770807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
22324351|NCT01167712|NRG Oncology|Linda Gedeon for Mark Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
22324352|NCT01084252|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22324353|NCT04909463|CommonSpiritHealth|Trenton Bradbury|7193730213|trenton_b1@yahoo.com|
22324354|NCT00853632|Edwards Lifesciences|Director of Clinical Affairs|949-250-2500|Aya_Westbrook@edwards.com|
22324355|NCT04364854|Medical University of South Carolina|Principal Investigator|843-876-8311|bonilha@musc.edu|
22324356|NCT04933812|Duke University|Dr. Sarahn Wheeler|919-668-5462|sarahn.wheeler@duke.edu|
22324357|NCT04493619|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
22324358|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22324359|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200||
22324360|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu|
22311100|NCT04779177|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|6464409333|ITCIClinicalTrials@itci-inc.com|
22311101|NCT03244800|MedImmune Limited|Victoria Parker|+44 747 1357152|information.center@astrazeneca.com|
22311102|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca|
22311103|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu|
22311104|NCT02803749|University of Rochester|Dr. Ruth Schneider|584-341-7500|ruth_schneider@urmc.rochester.edu|
22311105|NCT00890591|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsus.com|
22311106|NCT03234374|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22311107|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu|
22324361|NCT01232946|Indiana University|Kieren J. Mather MD|317-278-7826|kmather@iu.edu|
22324362|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com|
22324363|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22324364|NCT02342171|Institute of Tropical Medicine|Prof. Dr. Johan van Griensven|+3232476426|jvangriensven@itg.be|
22324365|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it|
22324366|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu|
22324367|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22324368|NCT00914628|AGC Biologics S.p.A|Anna Stornaiuolo|00390221277440|astornaiuolo@agcbio.com|
22324369|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu|
22324370|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22324371|NCT01756157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22324372|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
22324373|NCT02799381|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22324374|NCT03638011|Maimonides Medical Center|Dr Dennis Feierman|718-283-6000|dfeierman@maimonidesmed.org|7703
22324375|NCT02698410|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
22324376|NCT03952130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324377|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22324378|NCT02638012|St. Michael's Hospital|Dr. John Lee|416-864-5306|John.Lee@unityhealth.to|
22324379|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu|
22324380|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com|
22311108|NCT05896267|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22324381|NCT04425850|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
22324382|NCT03199911|University of California, San Francisco|Davin Ashraf MD|415-353-2800|davin.ashraf@ucsf.edu|
22324383|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22324384|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com|
22324385|NCT04331899|Stanford University|Dr. Prasanna Jagannathan, MD|1-650-724-5343|prasj@stanford.edu|
22324386|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|
22324387|NCT01062399|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22324388|NCT02424539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22324389|NCT04178590|Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade|Dr Mila Vuckovic|+381637060694|jovanovic.dr.mila@gmail.com|
22324390|NCT04723537|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
22324391|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300||
22324392|NCT02513940|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@iu.edu|
22324393|NCT00733902|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324394|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22280617|NCT02370368|The University of the West Indies, Mona|Dr. Sharmella Roopchand-Martin|876-927-2235|sharmella.roopchandmartin@uwimona.edu.jm|
22311109|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu|
22311110|NCT03911271|Rigshospitalet-Glostrup|Niklas Cyril Hansen MD-PhD|+45 31433244|niklas.cyril.hansen@regionh.dk|
22311111|NCT02195232|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
22311112|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500|TWilson@ITS.JNJ.com|1834
22311113|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22311114|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22311115|NCT03611556|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22311116|NCT02139436|Spaulding Rehabilitation Hospital|Glen Picard|6177585511|gpicard@partners.org|
22280618|NCT01169337|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22311117|NCT04027439|Verona Pharma|Verona Pharma|+44 (0)203 283 4200|info@veronapharma.com|
22311118|NCT03664011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311119|NCT01693822|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722 4297|apredict-icrctsu@icr.ac.uk|
22311120|NCT02844439|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
22311121|NCT04023175|Atrium Health|Dr. Elizabeth Braxton|8032613377|egwbraxton@gmail.com|
22311122|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22311123|NCT00756574|McMaster University|Dr. Mark Loeb|905-525-9140|loebm@mcmaster.ca|26066
22311124|NCT04035447|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
22311125|NCT04622332|Sironax|Lisa Fitzgerald, Senior Director Clinical Operation|781-201-3892|Lisa.Fitzgerald@sironax.com|
22311126|NCT05966155|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22311127|NCT03950817|Maimonides Medical Center|Dr. Sergey Motov (Director of Emergency Medicine Research)|718-283-8693|smotov@maimo.org|
22280619|NCT01692496|GEIS|Clinical Trial Coordinating Investigator|912866807|secretaria@grupogeis.org|
22311128|NCT03304587|Michigan State University College of Nursing|Dr. Horng-Shiuann Wu, Associate Professor|517-884-4643|wuhorngs@msu.edu|
22311129|NCT04122196|University of Missouri|Eliza DeFroda|573-882-4141|elddmc@health.missouri.edu|
22311130|NCT04614454|Massachusetts General Hospital|Michael Levy|6177267565|mlevy11@mgh.harvard.edu|
22311131|NCT05036278|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22280620|NCT01643408|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22280621|NCT03726658|Gate Neurosciences, Inc|Chief Medical Officer|203-247-3895|ron.burch@gateneuro.com|
22280622|NCT05710640|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22280623|NCT04188509|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280624|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22280625|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu|
22311132|NCT04187573|Cerus Endovascular, part of Stryker Corporation|Vanessa Sarge|5103292048|vanessa.sarge@stryker.com|
22280626|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu|
22280627|NCT03994211|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280628|NCT01107964|Milton S. Hershey Medical Center|Dr. David Liang|717-497-9469|dliang12@yahoo.com|
22311133|NCT01458366|Sidney Kimmel Cancer Center at Thomas Jefferson University|Joanna Filicko-O'Hara, MD|215-503-7787|Joanna.Filicko@jefferson.edu|
22280629|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22311134|NCT06122935|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
22311135|NCT04647487|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280630|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org|
22280631|NCT04342091|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
22280632|NCT02148263|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22280633|NCT03900728|Columbia University Irving Medical Center|Carolyn Westhoff, MD|2123057070|clw3@cumc.columbia.edu|
22280634|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu|
22280635|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1-801#
22280636|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
22280637|NCT01183429|Memorial Sloan Kettering Cancer Center|Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22280638|NCT01272037|SWOG Statistics and Data Management Center|Breast Committee Statistician|206-667-4623|dlew@fredhutch.org|
22280639|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280640|NCT02503085|Reckitt Benckiser Healthcare (UK) Ltd.|Clinical Research Director|+441482 326151||
22280641|NCT01027559|University of Pennsylvania|Dr. Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
22280642|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu|
22311136|NCT02787005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311137|NCT04375072|The University of Arizona|Hyochol Brian Ahn|520.626.1769|hbrian@arizona.edu|
22311138|NCT03498612|University of Washington|Ajay Gopal, MD|206-606-2037|agopal@uw.edu|
22311139|NCT01753999|Rutgers Robert Wood Johnson Medical School|Dr. Jag Sunderram|732-235-7038|sunderja@rwjms.rutgers.edu|
22280643|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22280644|NCT03662282|University of South Florida|Thao Ho|813-844-3437|tho1@usf.edu|
22280645|NCT02534883|St. Louis University|Donald Gregory Ward, MD|314-781-1505|dgreg.ward@health.slu.edu|1
22324395|NCT01829048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280646|NCT03328832|Kaohsiung Chang Gung Memorial Hospital|Dr. Wang JW|+886-7-7317123|wangjw@adm.cgmh.org.tw|8003
22280647|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300||
22324396|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org|
22280648|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu|
22280649|NCT00132301|VA Puget Sound Health Care System|Dr. Bruce Montgomery|206-277-6878|Robert.Montgomery@va.gov|
22280650|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu|
22280651|NCT01890265|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|067study@fibrogen.com|
22280652|NCT03674970|Penn State College of Medicine|Patricia Sue Grigson|717-531-5772|pgrigsonkennedy@pennstatehealth.psu.edu|
22280653|NCT05102383|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
22280654|NCT05119582|Bispebjerg University Hospital|Prof. Joergen Serup|+1 21424888|joergen.vedelskov.serup@regionh.dk|
22280655|NCT03670355|San Francisco Department of Public Health|Dr. Albert Liu|4154377408|albert.liu@sfdph.org|
22280656|NCT03517436|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
22280657|NCT04271540|Brigham and Women's Hospital|Brittany Weber, MD, PhD|6177326291|bweber@bwh.harvard.edu|
22280658|NCT02101788|NRG Oncology|Linda Gedeon for Austin Miller, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22280659|NCT04587869|RAND|Laura Bogart|3103930411|lbogart@rand.org|7281
22280660|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22324397|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org|
22280661|NCT02268383|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324398|NCT02176486|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22280662|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324399|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz|
22280663|NCT04581811|UAB Hospital|David Page - PI|205-975-7387|dpage1@uabmc.edu|
22280664|NCT02708680|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
22280665|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280666|NCT04162470|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22280667|NCT03382912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280668|NCT04687917|The Ohio State University|Dr. Bryan R. Garner|6142573462|bryan.garner@osumc.edu|
22280669|NCT05441527|University of Iowa|Dr. Robert Bowers|(319) 467-3199|robert-bowers@uiowa.edu|
22280670|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu|
22280671|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com|
22280672|NCT02573948|UMR 1058 (Inserm/University of Montpellier/EFS)|NAGOT NICOLAS|+33 4 34 35 91 09|n-nagot@chu-montpellier.fr|
22280673|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22280674|NCT01876212|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
22280675|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
22280676|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com|
22280677|NCT05223673|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22280678|NCT03941483|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22324400|NCT03494647|Children's Hospital Colorado|Emily Sweeney, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22280679|NCT03154476|Mayo Clinic|Dr. Alexander Egbe|507-284-3725|Egbe.Alexander@mayo.edu|
22324401|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com|
22280680|NCT02685826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22280681|NCT03368781|Acutus Medical, Inc.|Steve McQuillan|4422326080|steven.mcquillan@acutus.com|
22280682|NCT05823974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298506|NCT02920983|CooperVision Inc.|Jose Vega, O.D., MSc., FAAO|9256213761|jvega2@coopervision.com|
22298507|NCT00712296|Icahn School of Medicine at Mount Sinai|Xiu-Min Li, MD|212-241-1755|Xiu-min.li@mssm.edu|
22298508|NCT01387607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298509|NCT03665038|Sage Therapeutics|Medical Monitor|(617) 299-8380|medinfo@sagerx.com|
22298510|NCT03013491|CytomX Therapeutics, Inc.|Head of Clinical Operations|(650) 515-3185|clinicaltrials@cytomx.com|
22298511|NCT05445128|Ensoma|Ensoma head of regulatory or head of clinical research & development|6127191200|ddietz@ensoma.com|
22298512|NCT02383758|Emory University|Dr. Nathan Call||nathan.call@choa.org|
22298513|NCT03085927|Indiana University School of Nursing|Dr. Sheri Robb, MT-BC|317-274-3152|shrobb@iu.edu|
22280683|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280684|NCT04956731|University of California, San Diego|Office of Clinical Trials Administration|858-822-2940|octa@ucsd.edu|
22280685|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280686|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22311140|NCT03890289|"Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli"|Lisa Argnani|051 214 3827|lisa.argnani@unibo.it|
22280687|NCT03941873|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22280688|NCT04473950|University of California, San Francisco|David Andrew Tompkins, MD, MHS|628-206-3645|david.tompkins@ucsf.edu|
22311141|NCT05440344|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22280689|NCT03276728|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials|866-572-6436|MedInfoInternational@amgen.com|
22280690|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356|miraida.weldam@medtronic.com|6652
22280691|NCT02222688|University of California, San Diego|Thomas Kipps, MD, PhD|858-534-5400|tkipps@ucsd.edu|
22280692|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov|
22280693|NCT03440463|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
22280694|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu|
22311142|NCT02867059|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
22280695|NCT03323853|University of Arkansas for Medical Sciences|Dr. Michael Wilson|501-686-5515|MPWilson@uams.edu|
22280696|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com|
22280697|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br|
22280698|NCT03458325|scPharmaceuticals|Sr. Vice President, Clinical Development and Medical Affairs|(855) 727 4276|jmohr@scpharma.com|
22280699|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012||
22280700|NCT03279237|Massachusetts General Hospital|Dr. Theodore Hong|(617) 726-2000|TSHONG1@mgh.harvard.edu|
22311143|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22280701|NCT01485796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22298514|NCT02564471|SUNY Upstate Medical University|Dr. Timothy Endy|3154647692|endyt@upstate.edu|
22311144|NCT02744066|Magee Womens, UPMC Hamot Hospital|Dr. Michael J. Balsan|814-877-3190|balsanmj@upmc.edu|
22311145|NCT05509816|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22311146|NCT04144868|Affiliated Hospital of Jiujiang University|Zhiying Chen|+86 13767263459|zychenjj@jju.edu.cn|
22311147|NCT05051982|Indiana University School of Medicine (Dept of Anesthesia)|Dr. Timothy Webb|2196893636|ttwebb@iu.edu|
22311148|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu|
22311149|NCT02107261|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|2122418748|david.simpson@mssm.edu|
22311150|NCT01913314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311151|NCT02431273|Auritec Pharmaceuticals|Sarjan Shah|909-210-9715|sshah@auritecpharma.com|
22311152|NCT04337931|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
22311153|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU|
22311154|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu|
22311155|NCT02130557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311156|NCT02928172|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|310-423-1682|loani.elvir-lazo@cshs.org|
22311157|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|
22311158|NCT02408887|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@mail.nih.gov|
22311159|NCT00589875|Candel Therapeutics|Garrett Nichols (CMO)|617-916-5445|Gnichols@candeltx.com|
22311160|NCT03598907|Department of anesthesiology and intensive care medicine, Charles University and Motol Hospital|prof. Miroslav Durila|+420224435440|miroslav.durila@fnmotol.cz|
22311161|NCT02678689|BioMarin Pharmaceutical Inc|Pascal Reisewitz, Global Medical Director, PhD|1-800-983-4587|medinfo@bmrn.com|
22298515|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr|
22298516|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282|jjoo1@jhmi.edu|410
22298517|NCT02033889|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298518|NCT01640301|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22298519|NCT00659646|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22298520|NCT02842060|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22298521|NCT02717949|UT Southwestern Medical Center|Mamta K.Jain, MD|214-648-9914|mamta.jain@utsouthwestern.edu|
22298522|NCT02391948|University of Washington|Sarah Westcott McCoy PT, PhD, FAPTA|206-616-8601|westcs@uw.edu|
22298523|NCT02348489|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22298524|NCT01969838|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298525|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22298526|NCT04193202|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298527|NCT01777997|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22298528|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn|
22298529|NCT02488629|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
22298530|NCT02932891|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22298531|NCT04622254|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22280702|NCT02440139|Virginia Tech|Dr. ShihChung Benedict Lo|301-9215754|benlo@vt.edu|
22269664|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311162|NCT05019742|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
22311163|NCT05071430|HB Biotech|Tomer Seifan|917-685-7351|tomer.seifan@hbbio.com|
22269665|NCT05127330|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|bgaudiano@butler.org|
22269666|NCT04981470|neuroloop|Clinical Affairs|+497611543390|study@neuroloop.de|
22269667|NCT04402138|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
22269668|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804||
22269669|NCT04325568|New York University|Dr. Lawrence Yang|(212) 992-6334|lawrence.yang@nyu.edu|
22269670|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org|
22269671|NCT06098339|CooperVision Inc.|José A. Vega, O.D., MSc., PhD, FAAO|925-621-3761|JVega2@coopervision.com|
22269672|NCT04392375|The Ohio State University|Kara Rood, MD|440-321-0264|Kara.Rood@osumc.edu|
22269673|NCT03656692|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22269674|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com|
22269675|NCT02448537|Massachusetts General Hospital|Gregory Cote, M.D., Ph.D|617-724-4000|gcote@partners.org|
22311164|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22269676|NCT03528369|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
22269677|NCT05778851|PAVmed Inc., Lucid Diagnostics Inc.|Victoria T. Lee, MD CMO, SVM Clinical Affairs|425.218.6535|VTL@PAVmed.com|
22269678|NCT05656534|The Ohio State University|Dr. Stephanie Gorka|614-366-1027|stephanie.gorka@osumc.edu|
22269679|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
22269680|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov|
22269681|NCT02801617|Laboratorios Sophia|Dr. Oscar Olvera|(33) 3001 4200|oscar.olvera@sophia.com.mx|1074
22311165|NCT00490139|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22311166|NCT04640974|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22311167|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22311168|NCT03738228|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
22311169|NCT03801148|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22311170|NCT06212752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22311171|NCT04162210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311172|NCT02941549|Afimmune|Study Director|+3532946380|info@afimmune.com|
22311173|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300||
22269682|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk|
22269683|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca|
22269684|NCT02476578|CLALIT HEALTH SERVICES|Dr. Nir Tsabar|+97246049512|NIR.TSABAR@CLALIT.ORG.IL|
22269685|NCT03421210|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
22269686|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22269687|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399||
22269688|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu|
22269689|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu|
22269690|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de|
22269691|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269692|NCT00942890|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22269693|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269694|NCT02308540|PATH|Dr. Steve Lamola|1-206-285-3500|slamola@path.org|
22269695|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
22269696|NCT04109391|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
22269697|NCT02285166|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22269698|NCT00443079|UCSDMED|Dr. Heather Patton|619-543-2470|hpatton@ucsd.edu|
22269699|NCT01421225|Boston Children's Hospital|Garry Steil (Assistant Prof. of Pediatrics)|617-355-7504|garry.steil@childrens.harvard.edu|
22269700|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu|
22269701|NCT03728348|Exact Sciences|Alexandra Massoud, Sr. Director of Clinical Affairs|608.284.5700|clinicaltrials@exactsciences.com|
22269702|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org|
22269703|NCT02730403|NYU Grossman School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyulangone.org|
22269704|NCT05310071|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22269705|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269706|NCT02418949|Shirley Ryan AbilityLab|Alexander Barry|3122381435|abarry@sralab.org|
22269707|NCT02755467|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22269708|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300||
22269709|NCT01303172|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0) 20 3137 6346|info@immodulon.com|
22269710|NCT00462709|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22269711|NCT03635515|University of Minnesota|Ronald Ordinola Zapata DDS, MS, PhD|(612) 624-9900|rordinol@umn.edu|
22311174|NCT01567605|Simon Fraser University|Dr Victoria Claydon (Principal Investigator)|7787828513|victoria_claydon@sfu.ca|
22324402|NCT00500071|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22324403|NCT05614011|QuantuMDx|Alice Toomey-Smith|4408708031234|alice.toomey-smith@quantumdx.com|
22324404|NCT04898166|Jinnah postgraduate medical centre|Syeda Mahanum Ali|03033901112|mahanumsyed8@gmail.com|
22324405|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22324406|NCT01023789|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
22269712|NCT03278223|Visioncare Research Ltd.|Mr Thomas Boyes, Clinical Project Manager|+441252 718719|t.boyes@visioncare.co.uk|223
22269713|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269714|NCT01435304|Maine Medical Center|Dr. Robert S Kramer|207-662-1486|Kramer@mmc.com|
22269715|NCT02293512|VA Portland Healthcare System|Erin Martz, PhD|503.220.8262|erin.martz@va.gov|56006
22269716|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22269717|NCT05107492|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269718|NCT03218826|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22269719|NCT02683928|Ichnos Sciences SA|Study Director|2013314000|clinicaltrialsdisclosuredesk@ichnossciences.com|
22324408|NCT02698189|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269720|NCT02858583|University of Alberta|Georg Schmölzer|780-735-4647|schmolze@ualberta.ca|
22269721|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu|
22269722|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu|
22269723|NCT01453088|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22269724|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu|
22269725|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
22269726|NCT03867201|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22269727|NCT02260869|Lumbrera LLC|David Cedeno|3098266974|dclumbrera@gmail.com|
22269728|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828|jlewandowski@wum.edu.pl|+48 22
22269729|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu|
22324409|NCT02240706|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324410|NCT03664726|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22324411|NCT05502289|Johnson & Johnson Vision Care, Inc. (JJVC) 7500 Centurion|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22324412|NCT03119649|Galapagos NV|Evelyn Fox|0032 15 34 29 00|evelyn.fox@glpg.com|
22269730|NCT03467217|Johns Hopkins Bloomberg School of Public Health|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
22269731|NCT04390503|Columbia University|Jessica Justman, MD|212-342-0537|jj2158@cumc.columbia.edu|
22269732|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org|
22269733|NCT03233529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269734|NCT03260244|Abbott|Associate Director, Clinical Research, Electrophysiology|651-756-3813|anne.sarver@abbott.com|
22269735|NCT02497040|uludag university|Dr.Banu Otlar Can|+905323827044|botlar@hotmail.com|
22269736|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269737|NCT04725812|Cedars-Sinai Medical Center|Professor of Medicine, Cedars-Sinai Medical Center|310-423-7608|sananth.karumanchi@csmc.edu|
22269738|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22269739|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22269740|NCT03915587|University of Colorado|Sarkis Chris Derderian|720-777-6163|sarkis.derderian@childrenscolorado.org|
22269741|NCT02417142|UMass Medical School|Xiaoduo Fan, MD, MPH|(508) 856 -3881|xiaoduo.fan@umassmed.edu|
22269742|NCT04511520|National medical research center for therapy and preventive medicine|Dr. Maria Makhinova|+79104803524|longtimeaftertomorrow@gmail.com|
22269743|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com|
22269744|NCT04747886|Cedars-Sinai Medical Center|Dr. Sarah-Jeanne Salvy|310-423-6423|sarah.salvy@cshs.org|
22269745|NCT02973503|CHU Clermont-Ferrand|Armand Abergel|+33473750523|aabergel@chu-clermontferrand.fr|
22269746|NCT02237196|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22269747|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu|
22269748|NCT02901067|Denver Health Medical Center|Study Coordinator, James Chandler|303-602-3798|james.chandler@dhha.org|
22269749|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
22269750|NCT02907918|Washington University School of Medicine|Foluso O. Ademuyiwa, M.D., MPH|314-454-8313|bisiademuyiwa@wustl.edu|
22269751|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu|
22269752|NCT02156908|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|josh.kantrowitz@nki.rfmh.org|
22269753|NCT02049814|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22269754|NCT02714595|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22269755|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22269756|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com|
22269757|NCT02307279|Gelesis|Harry Leider, MD, MBA|(443)934-4906|hleider@gelesis.com|
22269758|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|
22311175|NCT03983434|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
22311176|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr|
22311177|NCT02169869|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22311178|NCT03631407|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311179|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743||
22311180|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22311181|NCT03496545|Weill Cornell Medicine|Judy Ch'ang, MD|(212) 746-2596|jhc9010@med.cornell.edu|
22311182|NCT03802994|Ralph H. Johnson VA Medical Center|ACOS/R, R. Amanda C. LaRue|843-789-6707|Rutha.LaRue@va.gov|
22311183|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22311184|NCT03938337|O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham|Eddy S. Yang|12059960780|eyang@uab.edu|
22311185|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22311186|NCT04230941|University of Rochester|Allison Magnuson, (Principal Investigator), Associate Professor of Medicine|585-276-7155|allison_magnuson@urmc.rochester.edu|
22311187|NCT04795167|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
22311188|NCT02029235|Penn State Health Milton S. Hershey Medical Center|Alexander Payatakes, MD|717-531-4805|apayatakes@pennstatehealth.psu.edu|
22311189|NCT03660618|University of Iowa Healthcare|Dr. Randy Kardon|319-356-8299|randy-karon@uiowa.edu|
22311190|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org|
22311191|NCT04436289|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
22311192|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22311193|NCT03224481|Queen Mary University of London|Professor Padhraig Fleming|02073777397|padhraig.fleming@qmul.ac.uk|
22311194|NCT03357952|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311195|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com|
22311196|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com|
22311197|NCT04057820|University of Arkansas for Medical Sciences|Dr. Songthip Ounpraseuth|5016867233|stounpraseuth@uams.edu|
22311198|NCT04517435|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223 8100|TaussigResearch@ccf.org|
22311199|NCT03656718|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22311200|NCT06191679|Children's Hospital of Philadelphia|Shannon Hammer|2678878580|bresslers@chop.edu|
22311201|NCT03211247|DBV Technologies|Pharis Mohideen, MD, Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
22311202|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com|
22311203|NCT05827068|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22311204|NCT05120856|Monash University|Dr Joshua B. B. Garfield|+61 3 8413 8711|joshuag@turningpoint.org.au|
22311205|NCT05464732|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
22311206|NCT04153890|West Virginia University School of Nursing|Dr. Ubolrat Piamjariyakul, PhD, RN|3042936729|ubolrat.piamjariyakul@hsc.wvu.edu|
22311207|NCT03610581|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311208|NCT02868970|Canadian Center for Vaccinology, Dalhousie University|Dr. Jennifer Isenor|902-494-2378|jennifer.isenor@dal.ca|
22311209|NCT05637970|UCLA|David Tehrani|8583360666|davidmtehrani@gmail.com|
22311210|NCT05630833|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311211|NCT04306367|Lombardi Comprehensive Cancer Center|Aiwu Ruth He, MD|202-444-2223|Aiwu.R.He@gunet.georgetown.edu|
22311212|NCT03044158|University of California Irvine|Adithya Cattamanchi|714-456-2959|Adithya.Cattamanchi@uci.edu|
22311213|NCT04660721|Sealantium Medical Ltd.|Prof. Orgad Laub, Chief Executive Officer|+972 0544434387|orgad@sealantium-med.com|
22311214|NCT05483517|Tri-service general hospital|Lai Chia-Ying|87923311|pokerface165@gmail.com|18792
22311215|NCT02751528|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22269759|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711|gihyun.yoon@va.gov|7421
22269760|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22269761|NCT04972110|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22269762|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
22269763|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com|
22269764|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22269765|NCT02821754|Principal Investigator|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
22269766|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu|
22269767|NCT03515811|Medtronic|Andrea DiScipio, Senior Clinical Research Specialist|781-491-5350|andrea.l.discipio@medtronic.com|
22269768|NCT01355575|Imperial College London|Dr Jeremy Cobbold|+44 1865228756|jeremy.cobbold@ndm.ox.ac.uk|
22269769|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
22269770|NCT04321356|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
22269771|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22269772|NCT03723850|University of Chicago|Dr. David Gallo|773-702-8829|dgallo@uchicago.edu|
22269773|NCT03147690|Boston Children's Hospital|Dr. David Mooney, MD MPH|617-355-7800|david.mooney@childrens.harvard.edu|
22311216|NCT05485805|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22311217|NCT04218357|Brown University|Carolina Haass-Koffler, PharmD, PhD|4155191385|carolina_haass-koffler@brown.edu|
22311218|NCT05349838|Research Organisation (KC) Ltd|Clinical Project Manager|07376618244|WISARD@rokcservices.com|
22311219|NCT05075395|University of Nebraska Medical Center|Breanna Hetland|402-559-5460|breanna.hetland@unmc.edu|
22311220|NCT05048394|Point Designs|Becca Connolly|720-600-4753|becca@pointdesigns.com|
22311221|NCT00085982|NIDDK|Rebecca Brown, MD|301-594-0609|brownrebecca@mail.nih.gov|
22311222|NCT05037513|University of Kentucky|Dr. Hilary Surratt|8595622458|hilary.surratt@uky.edu|
22311223|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22311224|NCT03664804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22311225|NCT05529992|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22311226|NCT06140290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311227|NCT03850379|Henry Ford Health|Shatha Farhan|3137133910|sfarhan1@hfhs.org|
22311228|NCT02036970|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22311229|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22311230|NCT02386098|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311231|NCT02702843|Cleveland Clinic Florida|Lo Menzo, M.D.,Emanuele|9546595000|lomenze@ccf.org|
22311232|NCT02986789|Masimo Corporation|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
22311233|NCT05029284|University of Minnesota|Dr. Emily Kringle|(612) 624-8994|ekringle@umn.edu|
22311234|NCT01779141|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22311235|NCT03002194|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22311236|NCT02232737|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
22311237|NCT03849937|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588 1673|kwilliams1@kumc.edu|
22311238|NCT02200705|IceCure Medical|Clinical Trial Manager|+972-4-623-0333|ronitl@icecure-medical.com|
22311239|NCT03987581|Duke University School of Medicine|Angela Kirby|9198247729|angela.caison.kirby@gmail.com|
22311240|NCT03116464|VA New York Harbor Healthcare System|Dr. Cory K. Chen|212-686-7500|cory.chen@va.gov|4002
22311241|NCT02261805|Lombardi Comprehensive Cancer Center|Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
22311242|NCT03284359|University of Pennsylvania|Dr. Katherine Courtright|267-978-5083|Katherine.Courtright@pennmedicine.upenn.edu|
22311243|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22311244|NCT00065182|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311245|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
22311246|NCT02568215|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22311247|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu|
22311248|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu|
22311249|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392||
22311250|NCT03712371|Medical University of South Carolina, Hollings Cancer Center, Clinical Trials|Alan Brisendine, CCRP, Manager, Sponsor-Investigator Support Unit|843-792-9007|brisend@musc.edu|
22311251|NCT05579600|Butler Hospital|Sarah Arias|909-753-9444|sarias@butler.org|
22311252|NCT04732000|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
22311253|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670|robert.hahn@sodertaljesjukhus.se|4670
22311254|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22311255|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu|
22311256|NCT05580003|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311257|NCT03516812|University of Washington|Michael Schweizer|206-606-6252|schweize@uw.edu|
22311258|NCT03840902|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22311259|NCT02392234|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22311260|NCT02313675|University of Pittsbur|John R Fowler, MD|412-605-3245|fowlerjr@upmc.edu|
22311261|NCT02816398|Avenu Medical - Sponsor|Gene Reu|949 276 2483|greu@avenumedical.com|102
22324413|NCT02333227|Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine|Dr. Kjersti Aagaard|7137988467|aagaardt@bcm.edu|
22324414|NCT03459040|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
22269774|NCT02593097|Mayo Clinic|Amaal J. Starling, M.D.|480-301-6574|Starling.Amaal@mayo.edu|
22269775|NCT03759587|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22269776|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org|
22269777|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
22269778|NCT00454363|UT MD Anderson Cancer Center|Dr. James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|jyao@mdanderson.org|
22269779|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu|
22269780|NCT01554527|University of Michigan|Dr. Ronald Chervin|734-647-9064|chervin@med.umich.edu|
22269781|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu|
22311262|NCT01387516|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
22311263|NCT03582475|UCLA / Department of Radiology|Sara Rodriguez|310-794-2877|SaraRodriguez@mednet.ucla.edu|
22311264|NCT02972424|Hospital for Special Surgery|Dr. Jeri W. Nieves|2126061604|nievesje@hss.edu|
22311265|NCT01273610|City of Hope|Dr. Daneng Li|626-359-8111|danli@coh.org|
22311266|NCT03736564|Mayo Clinic|Dr. Stephen Broski|507-293-6155|broski.stephen@mayo.edu|
22298532|NCT02652624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298533|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
22298534|NCT03228680|Ferring Pharmaceuticals|Clinical Development Support|-|DK0-Disclosure@ferring.com|
22298535|NCT02252081|Nashville Campus TVHS|Dr. Adriana Hung|6153274751|adriana.hung@va.goc|6731
22298536|NCT04805983|Associate Director of the Yale Alzheimer's Disease Research Unit|Adam Mecca, MD, PhD|(203) 785-4736|adam.mecca@yale.edu|
22298537|NCT03732638|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22298538|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298539|NCT03192150|Sun Pharma Global FZE|Head, Clinical development|91 2266455645|Clinical.Trials@sparcmail.com|
22298540|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
22324415|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
22324416|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu|
22324417|NCT05369806|University of Washington|Keshet Ronen|2065854363|keshet@uw.edu|
22324418|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22324419|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22324420|NCT05198713|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22324421|NCT03277196|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22324422|NCT05738486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324423|NCT03063385|University of Pennsylvania School of Nursing|Dr. Antonia M. Villarruel|2158988283|amvillar@nursing.upenn.edu|
22324424|NCT04442581|University of Washington|Madeline Jacoby|2026068246|mjacoby@seattlecca.org|
22324425|NCT02017444|University of Birmingham|Professor Alex Sinclair|+44 121 415 9125|a.b.sinclair@bham.ac.uk|
22324426|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324427|NCT03716726|Boston Medical Center|Patricia Kavanagh, MD|617-414-3573|Patricia.Kavanagh@bmc.org|
22324428|NCT02579603|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324429|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22324430|NCT00942162|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324431|NCT03818815|Novus Therapeutics|Clinical Director|949-679-1110|study006@novustherapeutics.com|
22324432|NCT04419506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324433|NCT04329949|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22324434|NCT04645797|Apros Therapeutics|Tom Wu, PhD|+1-858-284-8839|tom_wu@aprostx.com|
22324435|NCT03102736|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-1640|james.murrough@mssm.edu|
22280703|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com|
22324436|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu|
22324437|NCT00817414|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22324438|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com|
22324439|NCT03717922|UCLA Psychiatry & Biobehavioral Sciences|Dr. Taylor P. Kuhn, PhD|‭(310) 829-5968‬|tkuhn@mednet.ucla.edu|
22324440|NCT03126227|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22324441|NCT01126619|Abbott|Global Medical Services|800-633-9110||
22324442|NCT04876391|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22324443|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
22324444|NCT03981029|Ottawa Hospital Research Institute|Alysha Harvey|613-737-8899|alyharvey@ohri.ca|73838
22298541|NCT01420302|Department and Laboratory of Intensive Care Medicine KULeuven/UZLeuven|Professor Greet Van den Berghe|003216344017|greet.vandenberghe@kuleuven.be|
22298542|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com|
22298543|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca|
22298544|NCT02722668|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|612-626-2961|macmi002@umn.edu|
22298545|NCT02214147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22298546|NCT03204942|National Cancer Institute|Director of Ethical Committee|+201224276580|drsherryfanous@yahoo.com|
22298547|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu|
22298548|NCT03226652|Imperial College London|Professor M Cowie|+44 (0)207 3518856|m.cowie@imperial.ac.uk|
22298549|NCT05446909|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
22298550|NCT03759223|VA Center for Integrated Healthcare|Dr. Paul King, Clinical Research Psychologist|716-862-6038|paul.king2@va.gov|
22298551|NCT05421078|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22298552|NCT02606136|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-079DMDStudy@fibrogen.com|
22298553|NCT03296696|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22324445|NCT01859403|VA San Diego Health Sciences|Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology|858-246-1665|azarrinpar@health.ucsd.edu|
22324446|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22324447|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
22324448|NCT03014648|UPMC Hillman Cancer Center|Barbara M Stadterman, Regulatory Supervisor, Clinical Research Services|412-647-5554|stadtermanbm@upmc.edu|
22298554|NCT02713321|Icahn School of Medicine at Mount Sinai|Dr. Victoria Mayer|(212) 659-9194|victoria.mayer@mountsinai.org|
22298555|NCT04694131|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@nih.gov|
22324449|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu|
22324450|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
22280704|NCT03697161|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|8027525168|tbaumgartner@ovidrx.com|
22280705|NCT00292045|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22280706|NCT02236572|Yale Cancer Center|Lajos Pusztai, MD, DPhil|(203) 200-2328|lajos.pusztai@yale.edu|
22280707|NCT00606411|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
22280708|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
22280709|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22280710|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22280711|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org|
22280712|NCT04767061|Weill Cornell Medicine|Princess Osma|646-962-5910|pro4001@med.cornell.edu|
22280713|NCT03465722|Blueprint Medicines|Medical Information Call Center|1-888-258-7768|medinfo@blueprintmedicines.com|
22280714|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com|
22280715|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com|
22280716|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22280717|NCT03205358|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22280718|NCT03579693|University of Washington|Bryan Kestenbaum, MD|206-685-7343|brk@uw.edu|
22280719|NCT04970069|Cleveland Clinic|Dr. Alparslan Turan|2162172312|turana@ccf.org|
22280720|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22280721|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280722|NCT02100930|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22280723|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu|
22280724|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
22280725|NCT03364231|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22280726|NCT02622295|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
22280727|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk|
22280728|NCT00414076|UT MD Anderson Cancer Center|Coleman,Robert,M.D. / Gyn Onc & Reproductive Medicine|7137923203|RColeman@mdanderson.org|
22280729|NCT04373421|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
22280730|NCT02720523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22280731|NCT03146663|NuCana Plc|Medical and Scientific Affairs Department|01313571116|info@nucana.com|
22280732|NCT05526521|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22280733|NCT03929913|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
22280734|NCT04792190|University of Rochester|Mehmet Aktas, MD|585-275-4775|mehmet_aktas@urmc.rochester.edu|
22280735|NCT03919929|University of Colorado Anschutz Medical Campus|Melanie Cree, MD, PhD|720-777-5743|melanie.cree@childrenscolorado.org|
22280736|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com|
22280737|NCT05069012|Beth Israel Deaconess Medical Center|Philip Hess|617-667-3112|phess@bidmc.harvard.edu|
22280738|NCT00125788|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
22280739|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
22280740|NCT03008070|Inventiva S.A.|Dr Michael Cooreman, Chief Medical Officer|+33380447616|native.public@inventivapharma.com|
22280741|NCT05005273|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
22280742|NCT04409834|Brigham and Women's Hospital|COVID-PACT Project Manager|(617) 278-0145|covid-pact@bwh.harvard.edu|
22280743|NCT03081689|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22311267|NCT03509909|VA San Diego Healthcare System|Ariel J Lang|858-552-8585|ariel.lang@va.gov|5359
22311268|NCT04041219|Mayo Clinic|Heather P. May, Pharm.D.|507-266-7405|May.Heather@mayo.edu|
22311269|NCT03683576|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|Gossamer Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22311270|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu|
22311271|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22311272|NCT02350634|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|AVD_Clinical_Ops@lists.lilly.com|
22311273|NCT04205487|Florida International University|Adam W. Carrico, PhD|305-348-7887|acarrico@fiu.edu|
22311274|NCT01939288|Imperial College London|Miss Katherine Williams|020 3311 7335|k.williams@imperial.ac.uk|
22311275|NCT04724759|Massachusetts General Hospital|Jingping Wang - Principal Investigator|617-643-2729|jwang23@mgh.harvard.edu|
22311276|NCT02823028|University of California Irvine|Professor Cornelia Pechmann|3108920619|cpechman@uci.edu|
22311277|NCT00859781|Weill Cornell Medicine|Sarah Yuan|6469626040|say7008@med.cornell.edu|
22311278|NCT02307682|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
22311279|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com|
22280744|NCT03960684|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22311280|NCT03997474|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
22311281|NCT03905694|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22311282|NCT03277989|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
22311283|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22311284|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22311285|NCT00442104|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
22311286|NCT04545619|Biosense Webster, Inc.|Associate Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311287|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754||
22311288|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com|
22311289|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311290|NCT04053270|CLINUVEL PHARMACEUTICAL LIMITED|Dr. Dennis Wright|+ 61 3 9660 4900|mail@clinuvel.com|
22311291|NCT00205179|University of Wisconsin|Dr. Carey Gleason|608-280-7000|ceg@medicine.wisc.edu|
22311292|NCT04941703|University of Maryland School of Medicine|Wonder Drake|410-710-1412|WDrake@som.umaryland.edu|
22311293|NCT03542305|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311294|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762484
22311295|NCT03578965|Washington University School of Medicine|Mary M. Mullen, M.D.|314-655-8750|marymullen@wustl.edu|
22311296|NCT04949542|University of Washington (affiliate) / University of North Carolina at Chapel Hill|Dr. Benjamin Buck, Associate Professor|(919) 445-4330|buckbe@uw.edu|
22311297|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu|
22311298|NCT03021993|Medical University of South Carolina|Alan Brisendine, Sponsor-Investigator Support Unit Manager|843-792-9007|brisend@musc.edu|
22311299|NCT04033315|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22311300|NCT02101775|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
22311301|NCT00909324|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22311302|NCT03502447|Sight Sciences, Inc.|VP Medical & Clinical Affairs|877-266-1144|info@sightsciences.com|
22311303|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov|
22311304|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200||
22311305|NCT03170648|Dana-Farber Cancer Institute|Weidong Lu, MB, MPH, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
22311306|NCT02707198|Whiteside Institute for Clinical Research/St. Luke's Hospital Duluth|Lynsie Radovich, PhD|216-726-7940|lradovic@d.umn.edu|
22311307|NCT04241848|James J. Peters VA Medical Center, Spinal Cord Damage Research Center|Dr. Ann Spungen|(718) 584-9000|Ann.Spungen@va.gov|5814
22311308|NCT02499328|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22311309|NCT02766517|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22311310|NCT03611075|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22311311|NCT02972359|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22311312|NCT03488719|Saniona A/S|Janus Schreiber Larsen|+45 7070 5225|janus.larsen@saniona.com|
22311313|NCT02962102|Brigham and Women's Hospital|Dr. David Leaf|617-525-7612|deleaf@bwh.harvard.edu|
22311314|NCT05807074|University of California, San Francisco|Dr. Merisa Piper, MD|(415) 353-4320|Merisa.Piper@ucsf.edu|
22311315|NCT04801420|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|0
22311316|NCT03414684|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22311317|NCT04038580|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
22311318|NCT03477175|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22311319|NCT02078648|Stemline Therapeutics, Inc.|Clinical Development & Medical Affairs - Solid Tumors|1-973-775-2845|clinicaltrials@menarinistemline.com|
22311320|NCT04088227|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
22311321|NCT04021862|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311322|NCT01855750|Janssen Research & Development, LLC|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311323|NCT05379270|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
22311324|NCT05025384|Vanderbilt University Medical Center|Krista Vermillion|615-875-1921|krista.k.vermillion@vumc.org|
22311325|NCT03160885|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
22311326|NCT03425682|Aziyo Biologics, Inc.|Associate Director, Clinical Operations|678-492-4712|srichardson@aziyo.com|
22311327|NCT03835754|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
22311328|NCT05810285|Permedicaspa|Lorenzo Banci, study coordinator - clinical affairs|0399514811|lorenzo.banci@permedica.it|
22269782|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269783|NCT03627546|Weill Cornell Medicine|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
22269784|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
22269785|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu|
22269786|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22269787|NCT02837731|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22269788|NCT02965573|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22269789|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485||
22280745|NCT04266912|M.D. Anderson Cancer Center|Timothy A. Yap|713-563-1930|tyap@mdanderson.org|
22311329|NCT04257994|St George's, University of London|Dr Angeliki Asimaki|+447484764641|aasimaki@sgul.ac.uk|
22269790|NCT01329380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22311330|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com|
22311331|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu|
22311332|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22311333|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu|
22311334|NCT02683174|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
22311335|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu|
22311336|NCT02522104|Addmedica|Medical director|+33 1 72 69 01 86|corinne.duguet@addmedica.com|
22311337|NCT04497415|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
22311338|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu|
22311339|NCT02463448|Beaumont Hospitals|Jennifer Giordano|248-551-3517|jennifer.geiordano@beaumont.org|
22324451|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324452|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22269791|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
22269792|NCT02508077|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22269793|NCT06868654|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269794|NCT05908526|University of Maryland, Baltimore|Emerson Wickwire, PhD|410-706-4771|ewickwire@som.umaryland.edu|
22269795|NCT03232931|Emory University|Dr. Nathalie Maitre|404-712-8920|nathalie.linda.maitre@emory.edu|
22269796|NCT04925557|State University of New York at Buffalo|Dr. Robert Zivadinov|716-248-2140|rzivadinov@bnac.net|
22269797|NCT02989246|Children's Hospital Los Angeles|Dr Robinder Khemani, Associate Director of Research ACCM|323-361-2376|rkhemani@chla.usc.edu|
22269798|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu|
22269799|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22269800|NCT01620190|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
22269801|NCT01750697|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22269802|NCT00744965|UT Southwestern Medical Center|Kenneth J. Leveno, MD|214-648-2316|kenneth.leveno@utsouthwestern.edu|
22269803|NCT00384839|Texas Oncology, P.A|Dr. Guru Sonpavde|(281) 332-7505|Guru.Sonpavde@USOncology.com|
22269804|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522|dmertz@mesoscale.com|2809
22269805|NCT01322490|Bavarian Nordic A/S|Program Lead, Clinical Operations|+ 45 3326|info@bavarian-nordic.com|8383
22269806|NCT02484456|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22269807|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269808|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
22269809|NCT02792192|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269810|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22269811|NCT03522714|Northwestern University|Peter Ullrich, Clinical Research Coordinator|3129267037|peter.ullrich@nm.org|
22269812|NCT02677922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22269813|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
22269814|NCT03660189|The MetroHealth System|Dr. Chloe Castro|2167784527|ccastro@metrohealth.org|
22269815|NCT04513080|Talkspace|Aarthi Padmanabhan|240-273-6191|aarthi.padmanabhan@talkspace.com|
22269816|NCT05753904|University of Missouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
22269817|NCT00183885|USC/Norris Comprehensive Cancer Center|Victoria Soto|(323) 865-0451|victoria.soto@med.usc.edu|
22269818|NCT03620643|The Royal Marsden NHS Foundation Trust|Clinical Trial Manager|02078082887|rolo.trial@rmh.nhs.uk|
22269819|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org|
22269820|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
22269821|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com|
22269822|NCT02091089|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22269823|NCT02929589|MOMMC|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
22269824|NCT01537926|UTHealth Science Center at Houston|Dr. Ali J. Marian|713-500-2310|Ali.J.marian@uth.tmc.edu|
22269825|NCT04668248|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
22269826|NCT03480542|Hackensack Meriden Health|Cole McCoy|551-204-5529|cole.mccoy@hmhn.org|
22269827|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
22269828|NCT02324504|Boston Children's Hospital|Dr. Michael Agus|617 355-5849|michael.agus@childrens.harvard.edu|
22269829|NCT04002115|Penn State Health|Dr. Seema Naik|7175310003|snaik@pennstatehealth.psu.edu|289626
22269830|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
22269831|NCT00461773|The Christ Hospital|Gina G. Chung, MD|(513) 564-7771|gina.chung@thechristhospital.com|
22269832|NCT02477332|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22269833|NCT04657198|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22269834|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu|
22269835|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com|
22269836|NCT04571645|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22311340|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280746|NCT02234713|Hospital for Sick Children|Dr. Ann Yeh|416-813-7353|ann.yeh@sickkids.ca|207353
22280747|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000|uiec@prodigy.net.mx|31494
22280748|NCT03573206|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
22280749|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
22280750|NCT02574078|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22280751|NCT06219967|SUNY Upstate Department of Emergency Medicine|Michael Keenan, MD|315-416-4457|keenanm@upstate.edu|
22280752|NCT05875727|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280753|NCT01530178|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22280754|NCT05935878|University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences|Professor David W Murray|+44 01865 27457|david.murray@ndorms.ox.ac.uk|
22280755|NCT03980743|Washington University School of Medicine|Dr. Ginger E. Nicol|314-747-1862|nicolg@wustl.edu|
22280756|NCT02709512|Polaris Pharmaceuitcals Inc|Dr. Mirla Langlois|858-452-6688|mlanglois@polarispharma.com|161
22280757|NCT02155101|University of Liverpool|Professor Anna Maria Geretti|+44(0)151 795 9625|Geretti@liverpool.ac.uk|
22280758|NCT01834287|Brown University|Bess Marcus|4018636850|bess_marcus@brown.edu|
22280759|NCT05327660|Consumer Wellness Solutions/RVO Health|Dr. Kristina Mullis|765-265-9169|kmullis@rvohealth.com|
22280760|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu|
22280761|NCT04248712|Mayo Clinic|Dawn Francis, M.D.|904-953-2254|Francis.Dawn@mayo.edu|
22280762|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu|
22280763|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280764|NCT02346903|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
22280765|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280766|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280767|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22280768|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu|
22280769|NCT00293813|Amgen Inc.|Study Director|866-572-6436||
22280770|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22280771|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22311341|NCT01351376|Rehabilitation Medicine, New York University School of Medicine|Tara Denham, MD|212 263 8240|Tara.Denham@nyumc.org|
22311342|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311343|NCT00388726|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22311344|NCT02406092|Hoffman-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22311345|NCT03041233|Abbott|Clinical Scientist|7639541350|emily.jesser@abbott.com|
22269837|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269838|NCT03502070|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22269839|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com|
22269840|NCT01294241|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
22269841|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22269842|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de|
22269843|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org|
22269844|NCT00489918|Zosano Pharma Inc.|Don Kellerman, VP of Clinical Development and Medical Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
22269845|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269846|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi|
22269847|NCT02461433|Johns Hopkins University|Mahmoud Malas|410-550-4546|bmalas1@jhmi.edu|
22269848|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu|
22269849|NCT03291431|Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences|Dr. Timothy C. Durazzo/Project PI|650-493-5000|tdurazzo@stanford.edu|62982
22269850|NCT03850483|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269851|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov|
22269852|NCT01288937|Columbia University|Thomas H. Brannagan, MD|(212) 305-0405|tb2325@cumc.columbia.edu|
22269853|NCT01517763|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|
22269854|NCT02875613|UC San Diego - Moores Cancer Center|Dr. Assuntina Sacco|858-822-5210|agsacco@ucsd.edu|
22269855|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22269856|NCT00288366|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
22269857|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269858|NCT03219840|The University of Texas Health Science Center at Houston|Flavia S. Lakschevitz, DDS, PhD, MSc|604-822-3863|flavia.lakschevitz@dentistry.ubc.ca|
22269859|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22269860|NCT04081610|Laboratorios Sophia|Dr. Alejandra Sanchez-Rios|+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22269861|NCT02257489|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311346|NCT05783843|Wake Forest University School of Medicine|Erin L. Sutfin, PhD|336-713-5282|esutfin@wakehealth.edu|
22298556|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22298557|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net|
22298558|NCT02399085|MorphoSys AG|Lisa Walz|+49 89 89927 26240|Lisa.Walz@morphosys.com|
22298559|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu|
22298560|NCT05944250|Stanford University|Dr. Yuri Ikeda|650-647-3485|yurikeda@stanford.edu|
22298561|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22298562|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu|
22298563|NCT03296163|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
22269862|NCT00497289|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
22269863|NCT04606394|PRISM|Gary T Ferguson, M.D.|248-514-6063|garytferguson@msn.com|
22298564|NCT00821626|Infectious Disease Service, and Travel Clinic, University Hospital of Lausanne, Switzerland|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
22298565|NCT02978690|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298566|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
22298567|NCT01922024|Curetis USA, Inc.|Clinical Operations|800-659-1221|neil.mucci@curetis.com|
22298568|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298569|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776|bpowers@cytokinepharmasciences.com|214
22269864|NCT01896128|Burke Rehabilitation Hospital|Pasquale Fonzetti MD|(914) 597-2502|pfonzett@burke.org|
22269865|NCT01996254|SPR Therapeutics, Inc.|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22269866|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22269867|NCT02920008|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22269868|NCT04594070|University of Texas Medical Branch Galveston|Dr. Melody Safarzadeh|9082854962|mesafarz@utmb.edu|
22269869|NCT03533114|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22269870|NCT01862250|University of Toronto|Estelle B. Gauda|416-813-4908|estelle.gauda@sickkids.ca|
22298570|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org|
22311347|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62808
22311348|NCT03805672|Oregon Health & Science University|Samantha Underwood|503-494-8481|underwos@ohsu.edu|
22311349|NCT00641537|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22311350|NCT03229408|University of Illinois at Chicago|Frank González|(312) 413-1984|frgz12@uic.edu|
22311351|NCT06193590|Indiana University Health|Dr. Alissa M Conklin|317.944.8231|alconkli@iu.edu|
22311352|NCT03745313|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22311353|NCT03304639|University of Pittsburgh Medical Center|Dr. Jason Luke|412-647-2811|lukejj@upmc.edu|
22311354|NCT03292133|Massachusetts General Hospital|Zofia Piotrowska, MD|6176439707|Zofia.Piotrowska@MGH.HARVARD.EDU|
22311355|NCT02052440|Denver Veterans Administration Medical Center|Daniel Heppe MD|303 399 8020|daniel.heppe@ucdenver.edu|3940
22311356|NCT01367236|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22311357|NCT02235298|University of Miami|Gianluca Iacobellis, MD|305-243-3636|giacobellis@miami.edu|
22311358|NCT01595282|PPLM|Principal Investigator|617-616-1600||
22311359|NCT02227706|ETHICON Inc|Patricia Schleckser|9082182244|pschleck@its.jnj.com|
22311360|NCT02628626|Mayo Clinic|Dr. Adil Bharucha|507-284-2687|bharucha.adil@mayo.edu|
22311361|NCT01593020|UT MD Anderson Cancer Center|Dr. Valero Vicente, Professor, Breast Medical Oncology|(713) 563-0751|vvalero@mdanderson.org|
22311362|NCT02990858|CytoDyn|Vice President, Clinical Operations|36009808524|jmeidling@cytodyn.com|
22311363|NCT06211530|GE HealthCare|Principal Engineer|+358 (40) 7755194|100012917@gehealthcare.com|
22311364|NCT05525572|University of Miami, Miller School of Medicine|Thomas A Masterson, III|(305) 243 - 6260|TMasterson@med.miami.edu|
22311365|NCT05116163|Brigham and Women's Hospital|Dr. Candace Feldman|617-525-1035|chfeldman@partners.org|
22311366|NCT00489307|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22311367|NCT03436992|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
22311368|NCT03227861|Janssen Scientific Affairs, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311369|NCT05613907|Leeds Vascular Institute|Dr Assad Khan|0113|assad.khan3@nhs.net|
22311370|NCT05080777|University of Connecticut Center on Aging|Dr. Richard Fortinsky|860-679-8069|fortinsky@uchc.edu|
22311371|NCT04705415|NeurobBo|Sr. Vice President Clinical Operations|8572991035|crinfo@neurobopharma.com|
22311372|NCT03789656|Crinetics Pharmaceuticals, Inc|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
22311373|NCT02473276|Columbia University|Richard Smiley|212 305 5006|rms7@cumc.columbia.edu|
22311374|NCT05256797|Brigham and Women's Hospital|Shirley Wang|617-525-8376|swang1@bwh.harvard.edu|
22311375|NCT04484623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311376|NCT05886777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311377|NCT03773107|Levine Cancer Institute|Jim Symanowski, PhD|9804422371|james.symanowski@atriumhealth.org|
22311378|NCT05961995|The Ohio State University Hospital|Dr. Thangam Venkatesan|614-293-6255|thangam.venkatesan@osumc.edu|
22311379|NCT07204444|University of Florida|Laura R. Shannonhouse, PhD|352-273-4332|lshannonhouse@coe.ufl.edu|
22311380|NCT04172675|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311381|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu|
22311382|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu|
22311383|NCT01429454|University of California San Diego|Dr. Kristin Cadenhead|(619) 543-6445|kcadenhead@ucsd.edu|
22311384|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com|
22311385|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz|
22311386|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu|
22311387|NCT02357966|XBiotech USA, Inc.|Haritha Pallapotu|512-386-2992|hpallapotu@xbiotech.com|
22311388|NCT01779700|Indiana University|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
22311389|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
22311390|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
22311391|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343|john@interlacemedical.com|112
22311392|NCT04608409|University of Kentucky|Dr. Frederick Ueland|859-257-1613|frederick.ueland@uky.edu|
22311393|NCT03819543|University of Manitoba|Dr. Marcus Ng|204-787-2684|marcus.ng@umanitoba.ca|
22311394|NCT00918333|Mayo Clinic Cancer Center|Shaji Kumar, MD|507-284-2511|Kumar.shaji@mayo.edu|
22311395|NCT03392194|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|SREDLINE@BWH.HARVARD.EDU|
22311396|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com|
22311397|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com|
22311398|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311399|NCT03447912|George Washington University|Carla Berg, PhD, MBA, LP|202-994-0168|carlaberg@email.gwu.edu|
22311400|NCT02927249|Dana Farber Cancer Institute|Wendy Chen|617-632-3800|Wendy_chen@dfci.harvard.edu|
22311401|NCT02723929|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
22311402|NCT01477177|Mayo Clinic|Herbert C. Wolfsen, M.D.|904-953-6319|Wolfsen.Herbert@mayo.edu|
22311403|NCT04566861|Johns Hopkins Bloomberg School of Public Health|Dr. Pamela Surkan|4105027396|psurkan@jhu.edu|
22311404|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140|mreid@mcmaster.ca|22306
22311405|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
22280772|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu|
22280773|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22311406|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311407|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
22311408|NCT03113409|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22311409|NCT02040870|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22311410|NCT02483468|Ralph H. Johnson VA Medical Center, Charleston, SC & Medical University of South Carolina|Jeffrey J Borckardt, PhD|843.792.3295|borckard@musc.edu|
22311411|NCT03552276|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22311412|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org|
22311413|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22311414|NCT03371017|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22324453|NCT03185130|University Medical Center of Southern Nevada|Tony Zitek, MD|7023837885|zitek10@gmail.com|4
22311415|NCT04057131|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22311416|NCT02830204|Baylor Scott and White Research Institute|Walter Cerqueira|469-814-3393|walter.cerqueira@bswhealth.org|
22324454|NCT02286960|NYU Langone Health|Milan Amin|646-754-1206|Milan.Amin@nyulangone.org|
22324455|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org|
22324456|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743||
22324457|NCT03596164|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22324458|NCT03427073|Almac Discovery|Professor Richard Kennedy, Medical Director|+44 28 3833 2200|richard.kennedy@almacgroup.com|
22324459|NCT02955329|University of California, San Francisco|Dr. Gideon St. Helen|628-206-2687|gideon.sthelen@ucsf.edu|
22324460|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
22324461|NCT02835495|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolinn@wakehealth.edu|
22324462|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
22324463|NCT02580058|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324464|NCT04283461|Kaiser Permanente Washington|Lisa Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
22324465|NCT05490771|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22324466|NCT02481505|Sintetica SA, via Penate 5 Mendrisio|Elisabetta Donati Clinical Project Leader|+41.91.640.42.50|edonati@sintetica.com|
22324467|NCT01852084|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22324468|NCT01523821|Fred Hutchinson Cancer Research Center|H. Joachim Deeg, MD|206-667-5985|jdeeg@fredhutch.org|
22324469|NCT02533089|Li Ka Shing knowledge institute|Dr. L M Puchalski Ritchie|416 864 6060|lisa.puchalskiritchie@utoronto.ca|
22324470|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
22324471|NCT02115308|Cardiovascular Imaging Technologies, LLC|Joseph Soltys, PhD|816-531-2842|jsoltys@cvit.com|103
22324472|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269871|NCT03852264|University of Arizona|Dr. Evan MacLean|520-621-0386|evanmaclean@arizona.edu|
22269872|NCT05478135|Prova Health|Dr Jack Halligan|07742161980|jack.halligan@provahealth.com|
22269873|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org|
22269874|NCT02411396|Johns Hopkins University School of Medicine|Sophie Lanzkron, MD, MHS, Associate Professor of Medicine and Oncology|410-502-8642|slanzkr@jhmi.edu|
22269875|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl|
22269876|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu|
22269877|NCT00436475|Tufts Medical Center|Dr. Anastassios G. Pittas|617-636-5689|apittas@tuftsmedicalcenter.org|
22311417|NCT05162261|Novoxel Ltd|Dr. Ifat Klein|+972-52-6009860|ifat@novoxel.com|
22269879|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
22269880|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu|
22269881|NCT00179777|University of Helsinki|Professor Mikael Knip|+3582941 25222|mikael.knip@helsinki.fi|
22269882|NCT02865499|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
22269883|NCT02320058|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22269884|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22269885|NCT03521115|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
22269886|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu|
22269887|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800|piergiuseppe.agostoni@ccfm.it|2772
22269888|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22269889|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu|
22269890|NCT02196688|Hutchison Medipharma Ltd|Dr. Songhua Fan|+86 21 2067 3058|songhuaf@hmplglobal.com|5058
22269891|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269892|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu|
22269893|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269894|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com|
22269895|NCT01855243|Cairo University|Eman Said Sayed|01001186079|gaviota_3011@hotmail.com|002
22311418|NCT02517268|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Harish Lavu|215-955-6888|Harish.Lavu@jefferson.edu|
22269896|NCT03615144|Memorial Sloan Kettering Cancer Center|Maria Cancio, MD|212-639-7196|canciom@mskcc.org|
22280774|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311419|NCT03024866|Xoft Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
22269897|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22269898|NCT02587598|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
22269899|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|jessica.coats@ctca-hope.com|
22311420|NCT04686266|University of Pennsylvania|Lauren Massimo, PhD, CRNP|215-349-5863|lmassimo@upenn.edu|
22280775|NCT04024436|Taiho Oncology, Inc|Taiho Oncology, Inc|+1 844-878-2446|medicalinformation@taihooncology.com|
22280776|NCT02553928|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22280777|NCT05507567|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
22280778|NCT04830215|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22311421|NCT05579730|Bausch & Lomb|Daniel Donatello|585-338-5306|Daniel.Donatello@bausch.com|
22311422|NCT02401815|Cogent Biosciences, Inc.|VP, Head of Clinical Development Operations|617-945-5576|clinops@cogentbio.com|
22311423|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311424|NCT01586104|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. David Walterhouse|3122274000|d-walterhouse@northwestern.edu|
22311425|NCT05470114|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22269900|NCT00679289|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22311426|NCT06214052|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311427|NCT05325294|Medtronic Diabetes|Fang Niu, Sr Statistician|8185763319|fang.niu@medtronic.com|
22311428|NCT04649047|Ohio State University College of Nursing|Dr. Mei-Wei Chang|614-247-7211|chang.1572@osu.edu|
22269901|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
22269902|NCT02477826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22269903|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com|
22269904|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu|
22269905|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com|
22269906|NCT00305084|Clinical Operations|MolMed S.p.A.|0039 02212771|clinical.operations@molmed.com|
22269907|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com|
22269908|NCT00853645|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
22269909|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov|
22269910|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
22269911|NCT03170362|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
22269912|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr|
22269913|NCT03340454|NYU Langone Health|Yi-Ling Tan|646-501-3489|yi-ling.tan@nyulangone.org|
22269914|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov|
22269915|NCT02171234|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22280779|NCT03569878|Department of Psychiatry, University of Washington School of Medicine|Douglas Zatzick|206 744-6701|dzatzick@uw.edu|
22280780|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22280781|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22280782|NCT05338710|OHSU|Allison Lindauer, PhD, APRN|5034944347|lindauer@ohsu.edu|
22280783|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22280784|NCT03377816|University of Haifa|Johanna Czamanski-Cohen|+97246146234|jczamansk@univ.haifa.ac.il|
22280785|NCT05226598|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22280786|NCT04503551|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22280787|NCT02569476|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22311429|NCT02488408|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
22311430|NCT00719888|Fred Hutchinson Cancer Center|Dr. Ann Dahlberg|206-667-1959|adahlber@fredhutch.org|
22311431|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22280788|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca|
22280789|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
22280790|NCT04585269|Rutgers Cancer Institute|Dr. Katie Devine (PI)|7322357549|katie.devine@rutgers.edu|
22311432|NCT04837937|Northwestern University- Feinberg School of Medicine- Division of Geriatrics|Vanessa Ramirez-Zohfeld|+1 312 503 3916|vanessa-ramirez-0@northwestern.edu|
22311433|NCT05422339|MapHabit|Matt Golden|9143301776|mgolden@maphabit.com|
22311434|NCT06072170|Altasciences|Senior Regulatory Affairs Associate|450 973 3155|mgalarza@altasciences.com|112084
22311435|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com|
22311436|NCT06307457|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311437|NCT04456413|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
22311438|NCT03706261|Columbia University|Adam M. Brickman, PhD|212-342-1348|amb2139@cumc.columbia.edu|
22311439|NCT05815342|Insulet Corporation|Dr. Trang Ly|9786007628|Tly@insulet.com|
22298571|NCT03139916|Massachusetts General Hospital|Elizabeth R. Gerstner, MD|617-724-8770|egerstner@mgh.harvard.edu|
22298572|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com|
22324473|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com|
22324474|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu|
22324475|NCT00749203|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-241-1563|adriana.feder@mssm.edu|
22324476|NCT02034123|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22324477|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
22324478|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu|
22324479|NCT04454411|University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
22324480|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com|
22324481|NCT01564784|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324482|NCT02272790|AstraZeneca|Pejvack Motlagh, MD|+44 (0) 7384 799 850|pejvack.motlagh@astrazeneca.com|
22324483|NCT03022461|Abbott|Poornima Sood|+17818528334|poornima.sood@abbott.com|
22324484|NCT01982630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324485|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22324486|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
22324487|NCT02299934|University of Colorado, Denver|Dr. Samuel Chang|720-848-1875|SAMUEL.CHANG@UCDENVER.EDU|
22324488|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22324489|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com|
22324490|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324491|NCT03934684|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22324492|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22324493|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
22324494|NCT05662332|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22324495|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324496|NCT00538681|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324497|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br|
22324498|NCT01446809|University of Washington|Dr Darin Davidson|206-543-3690|djdavi@uw.edu|
22324499|NCT03395210|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22298573|NCT02469610|CarmelMC|Dr LEVY FABER Dan|97248250289|DANLf@clalit.org.il|
22298574|NCT04590495|West Virginia University|Toni Marie Rudisill, MS, PhD|304-293-0687|trudisill@hsc.wvu.edu|
22298575|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net|
22298576|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298577|NCT03591575|Chiesi Canada Corp.|Caroline Fradette, PhD|1-(800) 854-3534|c.fradette@chiesi.com|7014
22298578|NCT02915744|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22298579|NCT00813358|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22298580|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU|
22298581|NCT03265119|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22298582|NCT04740034|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22298583|NCT04011475|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298584|NCT01010984|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
22298585|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298586|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
22298587|NCT02602288|Temple University|Dr. Stephen Lepore|215-204-9422|slepore@temple.edu|
22298588|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298589|NCT01621373|UZ Leuven, NICU|Liesbeth Thewissen, MD, PhD|003216343211|liesbeth.thewissen@uzleuven.be|
22298590|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298591|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu|
22298592|NCT02066298|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
22298593|NCT01643473|NYU School of Medicine|Antoinette Schoenthaler|212-263-4205|antoinette.schoenthaler@nyumc.org|
22298594|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616|rod.stables@lhch.nhs.uk|1489
22298595|NCT03894449|University of Veterinary & Animal Sciences, Lahore, Pakistan|Dr. Waqas Ahmed|0092-42-99211449|waqas.niaz@uvas.edu.pk|296
22298596|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu|
22324500|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518||
22324501|NCT02833311|Case Western Reserve University|Matthew Plow, Ph.D.|216-368-8969|map208@case.edu|
22324502|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu|
22324503|NCT02189382|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22324504|NCT03368859|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22324505|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22298597|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623||
22324506|NCT01498991|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
22298598|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
22311440|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298599|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu|
22298600|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca|
22298601|NCT02148003|Cleveland Clinic|Nagy Mekhail, MD|216 444-9114|mekhain@ccf.org|
22311441|NCT04612868|AEYE Health Inc.|Zack Dvey-Aharon, PhD|8662627343|info@aeyehealth.com|
22298602|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
22311442|NCT03376659|Georgetown University|Benjamin Weinberg, MD|202-444-2223|benjamin.a.weinberg@gunet.georgetown.edu|
22298603|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22311443|NCT03220724|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22311444|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
22311445|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov|
22311446|NCT03865732|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22311447|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org|
22311448|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
22311449|NCT02095145|University of Wisconsin Carbone Cancer Center|David Jarrard|608-262-0759|jarrard@urology.wisc.edu|
22311450|NCT01703598|Oregon Health & Science University|Matthew Brodsky MD|503-494-9054|brodskym@ohsu.edu|
22311451|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
22311452|NCT02085941|Brigham & Women's Hospital/Dana-Farber Cancer Institute|Thomas C. Lee, MD|617-732-7260|tchlee@bwh.harvard.edu|
22311453|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu|
22311454|NCT05462912|UC Davis Orthopaedic Surgery|Eric Giza, MD|916-734-6805|egiza@ucdavis.edu|
22311455|NCT00504023|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@mskcc.org|
22311456|NCT02639637|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153644022|nancy.j.brown@vanderbilt.edu|
22311457|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22311458|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu|
22311459|NCT01953224|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
22311460|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
22324507|NCT02907944|Yale School of Medicine|David Fiellin, MD|(203) 688-5555|david.fiellin@yale.edu|
22324508|NCT02559505|University Of Rochester|Dr. Jennifer Nayak|5852767404|Jennifer_Nayak@URMC.Rochester.edu|
22324509|NCT03523585|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22324510|NCT03451825|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22324511|NCT02874794|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22324512|NCT01473004|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
22298604|NCT03160703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298605|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22311461|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311462|NCT01979276|Weill Cornell Medical College|Jennifer Hess|646-962-9440|jmh2004@med.cornell.edu|
22311463|NCT03205566|Guy's & St. Thomas' NHS Foundation Trust|Dr Julie Fox|020 7188 7188|julie.fox@gstt.nhs.uk|
22311464|NCT03184987|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311465|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311466|NCT00853580|The University of Alabama at Birmingham|Bruce R. Korf|205.934.9411|bkorf@uabmc.edu|
22324513|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343||
22269916|NCT00697463|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
22269917|NCT02568189|Icahn School of Medicine at Mount Sinai|James W Tsung MD, MPH|212 241 6272|james.tsung@mountsinai.org|
22311467|NCT01700205|Monell Chemical Senses Center|Julia A. Mennella, PhD|267-519-4880|mennella@monell.org|
22269918|NCT00529373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development,|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269919|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu|
22269920|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22269921|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org|
22269922|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623||
22269923|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22269924|NCT00691444|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
22269925|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269926|NCT03225105|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22269927|NCT05488470|Division of Cardiology at the Rhode Island and Miriam Hospital, Warren Alpert School of Medicine, Brown University|Antony Chu, M.D., FACC, FAHA, FHRS, FACP, Director of Complex Ablation - Arrhythmia Services Section|401-444-8689|antony_chu@brown.edu|
22269928|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22311468|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com|
22324514|NCT05882890|Rahbek FYS|Cathrine Rahbek|0045 30645390|cathrinerahbek@outlook.dk|
22269929|NCT01868438|Medicines for Malaria Venture|Stephan Duparc|+41 22 799 4070|duparcs@mmv.org|351
22269930|NCT01284348|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269931|NCT02347774|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22269932|NCT00181285|University of Illinois at Chicago|Jerry A. Krishnan|312-413-0637|jakris@uic.edu|
22269933|NCT04075682|University of South Carolina|Dr. James F. Thrasher|803.777.4862|thrasher@sc.edu|
22269934|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org|
22269935|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org|
22269936|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com|
22269937|NCT02023411|PGIMER|Dr Ashu Rastogi|9781001046|ashuendo@gmail.com|
22269938|NCT03423173|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22269939|NCT02071706|GE Healthcare|Yvonne Celestial|+33625023857|MarieYvonne.CELESTIAL@ge.com|
22269940|NCT02247440|Institut de Recherche pour le Developpement|Gonzague Jourdain|+66818830065|Gonzague.Jourdain@ird.fr|
22269941|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
22269942|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22269943|NCT03499899|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22269944|NCT03655470|Brown University|Anthony Spirito, PI|4014441929|anthony_spirito@brown.edu|
22269945|NCT03063086|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22269946|NCT01316211|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
22269947|NCT03879525|Wake Forest School of Medicine|Heidi Munger Clary, MD, MPH|336-716-7110|hmungerc@wakehealth.edu|
22269948|NCT02244463|Dana-Farber Cancer Institute|Kartik Sehgal, MD|(617) 632-3090|Kartik_Sehgal@dfci.harvard.edu|
22269949|NCT05481125|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22269950|NCT03834766|Tris Pharma, Inc.|Antonio Pardo|19175149058|apardo@trispharma.com|
22269951|NCT03702010|Hospital Universitario de Salamanca|Dr. Francisco José Sánchez Montero|923291100|fjsmontero@saludcastillayleon.es|
22269952|NCT03457116|NYU Langone Health|Judy Lee, MD|(646) 501-7906|Judy.Lee@nyulangone.org|
22269953|NCT04791319|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22269954|NCT04709692|University of Kentucky|R. Kiplin Guy|859-257-5290|kip.guy@uky.edu|
22269955|NCT02726906|UC San Diego|Judy Pa, PhD|858-246-1333|jpa@ucsd.edu|
22269956|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu|
22269957|NCT01931995|Massachusetts General Hospital|Dr. Mark Eldaief|6177261728|MELDAIEF@PARTNERS.ORG|
22269958|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22269959|NCT01131169|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
22269960|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22269961|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu|
22269962|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110||
22269963|NCT02685358|VA Palo Alto Health Care System|Eric Kuhn, PhD|650-493-5000|eric.kuhn@va.gov|23160
22269964|NCT00520533|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22269965|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu|
22269966|NCT02948751|Columbia University|Kevin Kalinsky, MD|212-305-0170|kk2693@columbia.edu|
22269967|NCT01464164|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|516-562-1506|avlachos@northwell.edu|
22269968|NCT03307252|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22269969|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
22269970|NCT01578239|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22269971|NCT03000010|University of Michigan|G. Ying Li|734-936-5715|yingyuli@med.umich.edu|
22269972|NCT02347813|University of Rochester|Alice Pentland, MD|585-275-1998|alice_pentland@urmc.rochester.edu|
22269973|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590||
22269974|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se|
22269975|NCT01523782|ERYTECH Pharma|Denise Tilton, Global Head Clinical Operations & Program Management|+1 857-706-1587|dtilton@erytech.com|
22269976|NCT04185220|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
22269977|NCT01029782|Interior Health|Dawn Dalen|250-862-4449|dawn.dalen@interiorhealth.ca|
22269978|NCT01030289|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
22269979|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22269980|NCT02195869|Pharmacyclics LLC, An AbbVie Company|Manuela Juretic, Associate Director, Clinical Operations|(408) 215.3628|mjuretic@pcyc.com|
22269981|NCT03456804|Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8717|heathe@karmanos.org|
22269982|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com|
22269983|NCT02981082|University of Pittsburgh|Dr. Robert Lafyatis|412-648-7040|lafyatis@pitt.edu|
22269984|NCT04892706|Bausch Health Americas, Inc|Study Director|908-541-8664|alison.magnotti-nagel@bauschhealth.com|
22324515|NCT03549520|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
22324516|NCT02939300|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
22324517|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324518|NCT03090191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324519|NCT02494141|"University of Colorado Denver | Anschutz"|Kristen Nowak, Ph.D.|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22324520|NCT01324830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280791|NCT06006078|Cleveland Clinic Foundation|Dr. John Vargo|2164455012|vargoj@ccf.org|
22298606|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu|
22298607|NCT03728582|Johns Hopkins University|Dr. Argye Hillis|(443) 287-4610|argye@jhmi.edu|
22298608|NCT02992899|Emory University|Dr. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
22298609|NCT02738775|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22298610|NCT02370888|Univeristy of Florida Health Cancer Center|Archana Narasanna, Project Manager|(352) 273-6772|PMO@cancer.ufl.edu|
22298611|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu|
22298612|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu|
22298613|NCT03054909|University of Minnesota, Masonic Cancer Center|Dr. Melissa Geller|+1 612-626-3111|gelle005@umn.edu|
22298614|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22298615|NCT03235024|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22298616|NCT02357576|University of Michigan|Meghan Arnold|734-936-8978|meghanar@umich.edu|
22298617|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu|
22298618|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu|
22298619|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298620|NCT02047110|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22298621|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300||
22298622|NCT00354224|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22298623|NCT01000051|MD Anderson Cancer Center|Dr. Popat, Uday / Professor, Stem Cell Transplantation|713-745-3055|upopat@mdanderson.org|
22298624|NCT02170727|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22298625|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
22298626|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
22298627|NCT05051241|Zhejiang GenFleet Therapeutics Inc.|Yuting Peng|+86 21 6882 1388|ytpeng@genfleet.com|
22298628|NCT03304379|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22298629|NCT03402243|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22298630|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22298631|NCT03097068|Vitreo-Retinal Associates, P.C.|Louis C. Glazer, MD|1-616-285-1200|glazerlc@vrapc.com|
22298632|NCT02802345|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298633|NCT03969212|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22298634|NCT01397695|UCSD|Research Compliance and Integrity|(858) 822-4939|ctgov@ucsd.edu|
22298635|NCT02075320|UNC School of Medicine Department of Radiology|Dr. Yueh Lee|(919) 537-3730|yueh_lee@med.unc.edu|
22298636|NCT03773757|Indiana University|Dr. Greg Sachs|317-278-5570|sachsg@iu.edu|
22298637|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
22298638|NCT02660918|Christiana Care Health System|Dr. Matthew Hoffman Chair Department of OB/GYN|302 733 3350|mhoffman@christianacare.org|
22298639|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu|
22298640|NCT02985736|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
22298641|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu|
22298642|NCT01856543|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum|914-367-7273|gelblumd@mskcc.org|
22298643|NCT04545515|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22298644|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22298645|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298646|NCT01848990|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22298647|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com|
22298648|NCT00004031|SWOG Statistics and Data Management Center|Study Statistician|2066674623||
22298649|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893||
22298650|NCT03090256|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22298651|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org|
22298652|NCT02489227|Coherus BioSciences, Inc.|Barbara K. Finck, MD|650-649-3530|bfinck@coherus.com|
22298653|NCT03212963|Sun Pharma Advanced Research Company Ltd.|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
22298654|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch|
22298655|NCT00298038|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22298656|NCT02696096|Butler Hospital|Dr. Michael Stein|401-455-6652|michael_stein@brown.edu|
22298657|NCT01940705|VA RR&D National Center for Rehabilitative Auditory Research|Gabrielle Saunders, PhD|503-220-8262|Gabrielle.Saunders@va.gov|56210
22298658|NCT02447991|Mayo Clnic|Jeffrey Staab, MD|507-293-9438|staab.jeffrey@mayo.edu|
22280792|NCT03666988|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22298659|NCT03551210|R-Pharm|Aleksandr Chernavin, Regional Medical Director|0074959567937|chernavin@rpharm.ru|
22298660|NCT04953442|Baylor College of Medicine|Erica Soltero, PhD|4029100832|soltero@bcm.edu|
22298661|NCT04260191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22298662|NCT02343458|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|650-305-2600|creisner@pearltherapeutics.com|
22298663|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn|
22298664|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22298665|NCT02564198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298666|NCT03843502|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
22298667|NCT02866682|University of California, Los Angeles (UCLA)|Dr. Suphamai Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
22298668|NCT01750268|San Francisco VA Health Care System/University of California, San Francisco|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22298669|NCT03738904|Cedars-Sinai Medical Center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
22298670|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu|
22298671|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22298672|NCT01326780|Valeant|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
22298673|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298674|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22298675|NCT03394391|Babcock University|Dr. Olumide ABIODUN|07038569725|olumiabiodun@gmail.com|7038569725
22298676|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22298677|NCT02514252|UT MD Anderson Cancer Center|Suresh K. Reddy, MD/Professor, Palliative Care Med|(713) 794-5362|sreddy@mdanderson.org|
22298678|NCT01268644|UT Southwestern Medical Center|Dr. Abhimanyu Garg|2146482895|abhimanyu.garg@utsouthwestern.edu|
22298679|NCT03358576|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22298680|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
22298681|NCT01222494|Washington University|Dr. Ginger Nicol|314-362-2461|nicolg@wustl.edu|
22298682|NCT02489981|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298683|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22298684|NCT05022810|HALEON|Marc Renard|+44 7880 182593|marc.m.renard@haleon.com|
22298685|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000|elviramquintanilla@hotmail.com|8326
22298686|NCT03779997|University of Washington|Judith I. Tsui|206-744-1835|tsuij@uw.edu|
22298687|NCT04086472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298688|NCT03348904|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22298689|NCT01241734|Hackensack Meridan Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22298690|NCT00436280|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298691|NCT01663259|University of Michigan Rogel Cancer Center|Michelle Mierzwa|734-936-7810|mmierzwa@umich.edu|
22298692|NCT05165121|MDHearing|Dr. Sandra Porps|7346572209|slp@mdhearingaid.com|
22298693|NCT01532687|OHSU Knight Cancer Institute|Dr. Christopher Ryan|503-494-9000|ryanc@ohsu.edu|
22298694|NCT04116229|Washington University School of Medicine|Sarah Eisenstein, Associate Professor in Psychiatry|3143627107|seisens@wustl.edu|
22298695|NCT02595684|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22298696|NCT02809976|Tufts Medical Center|David Romarin, MD Prinicpal Investigator|617 636 7462|drosmarin@tuftsmedicalcenter.org|
22298697|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298698|NCT01734746|MaastrichtUMC|R.F.P.M. Kruitwagen|+31433874767|r.kruitwagen@mumc.nl|
22298699|NCT01163682|Columbia University Irving Medical Center|Dawn Hershman|212-342-5162|dlh23@cumc.columbia.edu|
22298700|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298701|NCT02002767|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311469|NCT03335488|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
22311470|NCT04971733|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22311471|NCT01160354|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jan Burger, Associate Professor, Leukemia|7137927734|CR_Study_Registration@mdanderson.org|
22311472|NCT01006538|King's College Hospital, London|Mr Tim Jackson|+44 2032999000|t.jackson1@nhs.net|1297
22311473|NCT03849066|University of Colorado Denver|James Feinstein, MD, MPH, Principal Investigator|303-724-4186|james.feinstein@cuanschutz.edu|
22311474|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu|
22311475|NCT04941482|Hanoi Medical University|Dr. Thao Thi Phuong Nguyen|+84916911897|dr.nguyenthiphuongthao.hmu@gmail.com|
22311476|NCT02743819|University of Chicago|Daniel Olson, Clinical Instructor|773-834-4183|daniel.olson2@uchospitals.edu|
22311477|NCT04200664|Ear Institute, University College London|Dr N Kharytaniuk (Clinical Research Fellow)|02076792000|n.kharytaniuk@ucl.ac.uk|
22311478|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu|
22311479|NCT03362190|IVERIC bio, Inc|Hersh Patel, OD / Zimura Medical Director|609-474-6755|clinicaltrials@ivericbio.com|
22311480|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22311481|NCT02940249|King's College London|Dr Wendy Hall|020 7836 5454|wendy.hall@kcl.ac.uk|
22280793|NCT02517398|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
22280794|NCT01166347|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
22280795|NCT03541499|Vanderbilt Vaccine Research Program|Dr. C Buddy Creech|615-3430332|buddy.creech@vanderbilt.edu|
22280796|NCT05588440|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
22298702|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu|
22324521|NCT01973283|New York State Psychiatric Institute|Patrick J Brown|646-774-8666|patrick.brown@nyspi.columbia.edu|
22324522|NCT02081963|Department of Respiratory Medicine, Qilu Hospital of Shandong University|Dr.Yu Li|13791122770|qlliyu@163.com|
22324523|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com|
22324524|NCT03047005|Yale University|Dr. Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
22324525|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov|
22324526|NCT02586805|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22324527|NCT01961531|BrUOG- Brown University Oncology Research Group|Jaroslaw Hepel, MD|401-863-3000|BrUOG@brown.edu|
22324528|NCT04249882|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
22324529|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
22324530|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22324531|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22324532|NCT03348514|University of Kansas Medical Center|Dr. John A Taylor III|913-588-8170|Jtaylor27@kumc.edu|
22324533|NCT01773395|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-5938|Vincent_Ho@dfci.harvard.edu|
22324534|NCT03577990|The University of North Carolina at Charlotte|Willie M. Abel, Associate Professor of Nursing|704-687-7949|wmabel@uncc.edu|
22324535|NCT00803114|University of Toronto|Dr. Alison Macarthur|416 586 4800|alison.macarthur@uhn.on.ca|6632
22324536|NCT01696461|National Marrow Donor Program/BeTheMatch|Dr. Steven Devine|7634068239|sdevine2@nmdp.org|
22269985|NCT02835625|Cancer Registry of Norway|Prof. Solveig Hofvind|+47 22928828|solveig.hofvind@kreftregisteret.no|
22269986|NCT03652636|Indiana University|Jordan Swensson, MD|317-944-1837|jswensso@iu.edu|
22269987|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov|
22269988|NCT00679029|University of Nebraska|Elizabeth Reed|(402) 559-5388|ereed@unmc.edu|
22269989|NCT04019613|Mayo Clinic|Dr. Brandon M. Wiley|507-255-1051|Wiley.Brandon@mayo.edu|
22269990|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
22269991|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22269992|NCT03806933|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22269993|NCT05088603|Atrium Health Wake Forest Baptist Health Department of Neurosurgery|Dr. Kyle Fargen|336-716-6702|kfargen@wakehealth.edu|
22269994|NCT03396315|Columbia University|Mariana Bucovsky|12123057225|mb3523@cumc.columbia.edu|
22269995|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
22269996|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu|
22269997|NCT02162719|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22269998|NCT01694069|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22269999|NCT03555565|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22270000|NCT01070095|St. Michael's Hospital|Dr. Samir Gupta|(416) 864-6060|guptas@smh.ca|2252
22270001|NCT03138252|University Hospitals Cleveland Medical Center|Dr. Alison Bauer|216-844-3787|alison.bauer@uhhospitals.org|
22270002|NCT03854370|Wright State University|Dr. Geoffrey Towers|937-208-2850|geoffrey.towers@wright.edu|
22270003|NCT02656290|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Aya_Westbrook@edwards.com|
22270004|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270005|NCT03692325|Dana-Farber Cancer Institute|Glenn Hanna, MD|617-632-3090|gjhanna@partners.org|
22270006|NCT02817516|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22270007|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu|
22270008|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org|
22270009|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270010|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com|
22270011|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270012|NCT03325816|Georgetown University|Chul Kim, MD|202-444-2223|Chul.Kim@gunet.georgetown.edu|
22270013|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
22270014|NCT00083759|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22270015|NCT04306965|Tufts Medical Center|Study Coordinator|617-636-1579|courtney.donovan@tuftsmedicine.org|
22270016|NCT04112043|University of Florida|Dr. Robert Mankowski|352-294-5055|r.mankowski@ufl.edu|
22270017|NCT03567005|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22270018|NCT02799667|Tufts Medical Center|Ashley T. Peterson, MD, Study Coordinator|617-636-5000|apeterson@tuftsmedicalcenter.org|2382
22270019|NCT04292912|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270020|NCT03348930|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
22270021|NCT05338502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324537|NCT03072602|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|12059754720|parora@uabmc.edu|
22324538|NCT03912584|Optos|Michael Sinai, PhD|+1 800 854 3039|MSinai@optos.com|1495
22324539|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
22324540|NCT01097044|Clinuvel Pharmaceuticals Limited|Dr. Dennis Wright, Acting Chief Scientific Officer|646 527 7310|Dennis.Wright@clinuvel.com|
22324541|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22324542|NCT02730546|Mayo Clinic|Harry H Yoon MD MHS|507-284-2511|yoon.harry@mayo.edu|
22324543|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com|
22324544|NCT02452359|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22324545|NCT03414359|UAMS|Nadir El Sharawi|5016866114|nelsharawi@uams.edu|
22324546|NCT02043574|South Texas Veterans Health Care System|Monica Serra|210-617-5300|monica.serra@va.gov|15313
22324547|NCT04865731|University of Texas Health Science Center at San Antonio|Dr. Shraddha Dalwadi|210-567-1203|dalwadi@uthscsa.edu|
22324548|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356|chenweili@ntu.edu.tw|5206
22324549|NCT04907045|Kaiser Permanente Washington Health Research Institute|Joseph E Glass, PhD|206-287-4266|joseph.e.glass@kp.org|
22324550|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu|
22324551|NCT04068103|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22324552|NCT01672892|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22324553|NCT00468715|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
22324554|NCT00934895|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
22324555|NCT04745832|MEI Pharma|Richard Ghalie, MD CMO|858.898-0956|rghalie@meipharma.om|
22324556|NCT02981472|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22324557|NCT03815292|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22324558|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com|
22324559|NCT01584024|University of Michigan|Dr. Mathilde Peters (PI)|734-925-2750|mcpete@umich.edu|
22324560|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org|
22324561|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324562|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
22324563|NCT03453060|Aronora, Inc.|Norah G. Verbout, Senior Scientist and Project Manager|503-964-0250|norah.verbout@aronorabio.com|
22324564|NCT04106492|Shasqi Inc|Jose M. Mejia Oneto, MD, PhD|415-800-1376|clinicalstudies@shasqi.com|
22324565|NCT00450463|National Cancer Institute|Dr. Ravi Madan|301-480-7168|ravi_madan@nih.gov|
22270022|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
22270023|NCT04903496|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270024|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22270025|NCT04431908|Yale School of Medicine|Dr. R. Peter Manes|(203) 785-5430|rpeter.manes@yale.edu|
22270026|NCT02793674|Presbyterian Hospital|Thomas Weiler, MD|505-724-7044|tweiler@gmail.com|
22270027|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com|
22270028|NCT02209519|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|jschwebk@uabmc.edu|
22270029|NCT02401048|Pharmacyclics|Emily Liu|(669) 224-1899|aliu@pcyc.com|
22270030|NCT03474731|University of Kentucky|Dr. Nancy Schoenberg|(859) 323-8175|nesch@uky.edu|
22270031|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu|
22270032|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
22270033|NCT03139578|Johnson & Johnson Vision|Anna Sulley BSc MCOptom FAAO|+44 1344864043|asulley1@its.jnj.com|
22270034|NCT03793842|Michigan Medicine|Robert Hyzy, MD|734-936-5201|rhyzy@med.umich.edu|
22270035|NCT02549287|Georgia State University|Dr. Daniel Whitaker|404-413-1282|dwhitaker@gsu.edu|
22270036|NCT04087720|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22270037|NCT02880475|Mundipharma (China) Pharmaceutical Co. , Ltd|Junjiao Ma|01065636711|Junjiao.Ma@mundipharma.com.cn|
22270038|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu|
22270039|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com|
22270040|NCT01377922|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22270041|NCT04615403|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22270042|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com|
22270043|NCT02547220|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22270044|NCT03817229|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|5136364864|avani.modi@cchmc.org|
22270045|NCT03771560|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
22270046|NCT02887183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22270047|NCT03634033|Grand Valley State University|Dr. Sandra Spoelstra|616-331-5905|spoelsts@gvsu.edu|
22270048|NCT06366087|BARDA|Michael D. Schwartz, MD MPH/Division of CBRN Countermeasures|(202)-260-0849|Michael.Schwartz@hhs.gov|
22270049|NCT00199797|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22270050|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com|
22270051|NCT03717051|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
22324566|NCT04893265|University of California San Francisco|Janice Tsoh, PhD, Professor/ Principal Investigator|4155028438|janice.tsoh@ucsf.edu|
22324567|NCT02523586|Oregon Health and Science University|Jeffrey Kirsch|503-494-9000|kirschje@ohsu.edu|
22324568|NCT02465034|Emory University|Dr. Michael Borich|404-712-0612|michael.borich@emory.edu|
22298703|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu|
22311482|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu|
22311483|NCT06110546|The University of Texas Health Science Center at Houston|Pascal Kingah, MD,MPH|713-500-6828|Pascal.L.Kingah@uth.tmc.edu|
22311485|NCT01732120|Washington University School of Medicine|Manager of Clinical Trials|3147479781|klima@wustl.edu|
22311486|NCT03102034|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22311487|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com|
22311488|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311489|NCT03160521|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
22311490|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu|
22311491|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com|
22311492|NCT02788019|UT Southwestern Medical Center|Anthony Machi, MD, Assistant Professor|214-648-6400|Anthony.Machi@UTSouthwestern.edu|
22311493|NCT04300023|University of Wisconsin - Madison|Kristen Pickett, PhD|(608) 890-2103|Kristen.pickett@wisc.edu|
22311494|NCT05251363|BIOTRONIK, Inc.|Crystal Miller|(503) 475-4984|crystal.miller@biotronik.com|
22311495|NCT03070392|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
22311496|NCT02972034|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311497|NCT03861052|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22311498|NCT03009344|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22311499|NCT03678688|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22311500|NCT02794428|Vanderbilt-Ingram Cancer Center|Douglas Morgan|615-936-7423|drmorgan@uabmc.edu|
22311501|NCT02534233|Johns Hopkins Hospital|Dr Marcia Canto, Director of Clinical Research|443-287-8083|mcanto1@jhmi.edu|
22311502|NCT03560323|University of Texas Health -San Antonio|Yuejuan Qin, Assistant Professor|210-358-7200|qiny@uthscsa.edu|
22311503|NCT02271906|UT MD Anderson Cancer Center|George Simon, MD|713-792-7734|GSimon@mdanderson.org|
22311504|NCT03136159|Loyola University Medical Center|Dr Jean Goodman|7082165459|Jrgoodman@lumc.edu|
22311505|NCT03823703|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
22311506|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
22311507|NCT04323800|The Johns Hopkins University School of Medicine|Shmuel Shoham|410-614-6431|sshoham1@jhmi.edu|
22311508|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311509|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22311510|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22311511|NCT02949297|Endologix, LLC|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
22311512|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22311513|NCT00458783|Cleveland Clinic|Andra Duncan, MD|216-445-2372|duncana@ccf.org|
22311514|NCT01737398|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22311515|NCT02372799|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22324569|NCT00573131|Boston Scientific Corporation|Jessie Stockwell|1-612-618-1136|jessie.stockwell@bsci.com|
22298704|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22298705|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu|
22298706|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22298707|NCT03915548|MGH Institute of Health Professions|Dr. Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
22298708|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
22298709|NCT02074735|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
22298710|NCT03217136|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298711|NCT03755765|Department of Family Medicine, Georgetown University Medical Center|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
22298712|NCT02104557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298713|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22298714|NCT04455893|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
22298715|NCT01158222|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22298716|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se|
22298717|NCT00111228|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22298718|NCT02579616|Eisai Co.,Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22298719|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298720|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
22298721|NCT00962429|Oregon Health and Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
22298722|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org|
22311516|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov|
22298723|NCT02464969|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22298724|NCT02863354|Retina Consultants of Houston|Dr. Charles C. Wykoff|713-524-3434|ccwmd@houstonretina.com|
22298725|NCT01591746|Mayo Clinic|Dr. Valerie Lemaine, MD, MPH|507-284-2736|lemaine.valerie17@gmail.com|
22311517|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22311518|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22311519|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311520|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org|
22311521|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22311522|NCT01655563|Hospital for Sick Children|Dr. Seema Mital|416-813-7418|seema.mital@sickkids.ca|207418
22311523|NCT01354444|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
22311524|NCT00982072|Imperial College NHS Trust|Dr Megan Griffith|02033137309|m.e.griffith@imperial.ac.uk|
22311525|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22311526|NCT03559205|Keele University|Jonathan Hill|01782 733900|j.hill@keele.ac.uk|
22311527|NCT01833455|University of Wisconsin|Stephen Wasmund, PhD|801-587-3740|stephen.wasmund@carma.utah.edu|
22311528|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie|
22298726|NCT02409615|Nemours/A I duPont Hospital for Children|Karen Sacks, MSN PNP|302-651-5649|ksacks@nemours.org|
22298727|NCT00720876|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
22298728|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov|
22298729|NCT03495908|The University of Texas Southwestern Medical Center|Dr Pablo F Mora|469-585-0000|pf_mora@yahoo.com|
22311529|NCT03689946|Cedars-Sinai Medical Center|Daniel Berman|310-423-4224|daniel.berman@cshs.org|
22311530|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|215 746 2764|kampman@pennmedicine.upenn.edu|
22311531|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22311532|NCT02203799|Baylor College of Medicine|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
22311533|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com|
22311534|NCT02384382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311535|NCT01953692|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311536|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu|
22311537|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810|john.mcquaid@va.gov|4106
22311538|NCT05313412|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
22311539|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463||
22311540|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22311541|NCT02157948|Amgen Inc.|Study Director|866-572-6436||
22311542|NCT01801007|MicroVention, Inc., A TERUMO Group Company|Senior Manager, Clinical Quality Compliance and Clinical Operations|714-247-8000|jennifer.jelf@microvention.com|
22311543|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311544|NCT05350501|Enterome|Dr Jan Fagerberg|+33175772785|info@enterome.com|
22311545|NCT04816955|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
22311546|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
22311547|NCT04119063|Northern Arizona University|Zach Lerner, Associate Professor|928-523-1787|Zachary.Lerner@nau.edu|
22311548|NCT03637296|New York State Psychiatric Institute|Thomas Smith, MD|(646)774-8442|thomas.smith@nyspi.columbia.edu|
22311549|NCT04960813|Columbia University|Kate D. Fitzgerald|646-774-5681|kf2688@cumc.columbia.edu|
22311550|NCT01536366|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com|
22311551|NCT00145470|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311552|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22311553|NCT04762277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311554|NCT02556918|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
22311555|NCT00768716|Washington State University|Dr Michael H. Court|5093350817|michael.court@wsu.edu|
22311556|NCT06134089|University of Utah|Andy King|801-646-4274|andy.king@utah.edu|
22311557|NCT05643885|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311558|NCT03954106|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22311559|NCT04511702|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22311560|NCT05349721|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22311561|NCT06006455|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
22311562|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711|guadalupe.garcia-tsao@yale.edu|2210
22311563|NCT01583166|UMass Worcester|Michael Flynn, MD|508-334-9840|michael.flynn@umassmemorial.org|
22311564|NCT03150875|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
22311565|NCT04652869|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
22311566|NCT01372085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311567|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22311568|NCT03960645|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311569|NCT03903692|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
22311570|NCT00790699|Texas Diabetes & Endocrinology|Thomas Blevins,MD|5812.334.3505|blevins@texasdiabetes.com|
22311571|NCT03732807|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311572|NCT03345979|Alkermes, Inc|Eva Stroynowski|7816097000|eva.stroynowski@alkermes.com|
22311573|NCT04689932|Rockwell Medical|Raymond D Pratt, MD|2489609009|rpratt@rockwellmed.com|
22311574|NCT00734578|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22311575|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com|
22311576|NCT03883724|UPittsburgh|Shachi Tyagi|4126471274|sht55@pitt.edu|
22311577|NCT02304757|Tenth People's Hospital of Tongji University|Chao Ma|02125078593|mc_7419@hotmail.com|86
22311578|NCT03389802|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
22311579|NCT02426138|University of North Carolina at Chapel Hill|Dr. Seth A. Berkowitz|919-966-2276|seth__berkowitz@med.unc.edu|
22311580|NCT04677738|Morinaga Milk Industry Co., Ltd.|Director of Clinical Trials|+81-46-252-3067|izen-ri138@morinagamilk.co.jp|
22311581|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22311582|NCT02502461|Dept. of Anesthesia, University of Saskatchewan|Dr. William P. McKay|306 655 1202|bill.mckay@usask.ca|
22311583|NCT03340415|CUHK|Dr Samuel Ling|35052010|samuel-kk-ling@alumni.cuhk.net|
22311584|NCT00467272|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|iraad@mdanderson.org|
22311585|NCT00914966|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22311586|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22311587|NCT03975400|northwell|Michael Birnbaum|718-470-8305|mbirnbaum@northwell.edu|
22311588|NCT02409680|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
22311589|NCT04827732|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
22311590|NCT05366751|Sage Therapeutics|Carrie Vaudreuil|+1-857-259-4766|carrie.vaudreuil@sagerx.com|
22311591|NCT05785832|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|18583666900|clinicalaffairs@tandemdiabetes.com|
22311592|NCT02921555|Grupo Español de Trabajo en Enfermedad de Crohn y colitis Ulcerosa|Dr. Eugeni Domènech|635899553|soporte@geteccu.org|
22311593|NCT01690624|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311594|NCT05885763|CSL Vifor|Milica Enoiu|+41 58 851 82 64|milica.enoiu@viforpharma.com|
22311595|NCT05986617|University of Iowa|Victoria Tappa|3193846136|victoria-tappa@uiowa.edu|
22311596|NCT02842749|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22311597|NCT05293717|University of Rochester|Anna De Benedetto, MD|(585) 275-7546|anna_debenedetto@urmc.rochester.edu|
22311598|NCT05246709|Columbia University|Seon Mi Jeong|646-317-5238|smj9007@nyp.org|
22311599|NCT04202133|University of Pennsylvanai|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
22311600|NCT05395351|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311601|NCT03377049|UW School of Medicine and Public Health|Azam Ahmed, MD, FAANS, FACS|608-263-0485|azam.ahmed@neurosurgery.wisc.edu|
22311602|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov|
22311603|NCT02489357|Johns Hopkins University/Sidney Kimmel Cancer Center|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
22311604|NCT04693637|AlloVir, Inc|Michelle Matzko, MD, PhD|617-433-2605|mmatzko@allovir.com|
22311605|NCT03052517|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22311606|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu|
22311607|NCT04885998|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22311608|NCT04263714|McMaster University|Dr. Stuart Phillips|9055259140|phillis@mcmaster.ca|24465
22311609|NCT05260437|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22311610|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311611|NCT00195819|Abbott|Global Medical Services|800-633-9110||
22311612|NCT00787176|Northwerstern University|Paloma Toledo|312-472-3585|p-toledo@northwestern.edu|
22311613|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22311614|NCT05794191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311615|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22311616|NCT02486939|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
22311617|NCT03298087|West LA VAMC|Nathanael Kane|3104783711|nathanael.kane@va.gov|46735
22311618|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22311619|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
22311620|NCT04228952|Masonic Cancer Center|Susan Murphy, PhD|612-624-7633|murph062@umn.edu|
22311621|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000|alan.hatfield@piramal.com|5002
22311622|NCT03739866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311623|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22311624|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22270052|NCT02195622|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
22311625|NCT03057600|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22311626|NCT02091752|Novartis|Study Director|862-778-8300||
22311627|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu|
22324570|NCT03033108|Kubota Vision Inc.|Clinical Trials Helpdesk|(206) 805-8310|clinicaltrials@kubotavision.com|
22324571|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu|
22324572|NCT01959204|PPSI|Study Director|8139279302|mgoodhead@pharmaprojectsolutions.com|
22324573|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu|
22324574|NCT01251575|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22324575|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22324576|NCT02024464|Alcon Research, LLC|Director, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22324577|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu|
22324578|NCT03767738|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22324579|NCT01575548|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22324580|NCT03806452|THERAVIA|Clinical Operation Manager|+330149709583|laura.thomas-bourgneuf@theravia.com|
22324581|NCT03872180|Emory University Hospital/Winship Cancer Institute|Dr. Jonathon Cohen|4047781900|jonathon.cohen@emory.edu|
22324582|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com|
22324583|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22324584|NCT02750410|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324585|NCT02504541|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22324586|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be|
22324587|NCT03215277|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22324588|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com|
22324589|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22324590|NCT01244737|Children's Hospital of Philadelphia|Dr. Frederick Grant|267-600-1542|grantf@chop.edu|
22324591|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org|
22324592|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com|
22324593|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298730|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298731|NCT01936259|Zimmer Biomet, Inc.|Director of Clinical Operations|800-613-6131|clinicaldirector@zimmerbiomet.com|
22298732|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com|
22298733|NCT03027466|National Cancer Institute|William Klein|2402766972|kleinwm@mail.nih.gov|
22298734|NCT03286140|Imperial College London|Professor Alun Davies|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
22298735|NCT01826825|Brigham and Women's Hospital|Deborah J. Culley, M.D., Principal Investigator|6177327330|dculley@bwh.harvard.edu|
22298736|NCT01858194|Icahn School of Medicine at Mo|Betsy Ellsworth, Research Program Director|212 824 8902|betsy.ellsworth@mountsinai.org|
22298737|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu|
22298738|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511|nthomas@acufocus.com|129
22298739|NCT02563028|Hospital for Special Surgery|Valeria Rotundo|212-774-7885|rotundov@hss.edu|
22298740|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org|
22298741|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22298742|NCT01856140|Seoul National University College of Medicine|Dr. Sang Yoon Lee|028702673|rehabilee@gmail.com|
22298743|NCT02293005|UT MD Anderson Cancer Center|Dr. Anne Tsao, MD- VP, Academic Affairs, CAO Office|(713) 792-6363|astsao@mdanderson.org|
22298744|NCT02766608|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
22298745|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
22298746|NCT02648698|Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing, China|Dr. Dongmei Song|13651294056|echosdm@163.com|86
22298747|NCT03574129|University of Washington|Dr. Irene Njuguna|2065191275|irenen@uw.edu|
22298748|NCT03143829|University of Central Floroda|Victoria Loerzel|407-823-0762|victoria.loerzel@ucf.edu|
22298749|NCT00672477|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22298750|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22324594|NCT02371629|Novartis Pharmaceuticals|Study Director|862-778-8300||
22324595|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270053|NCT03190668|University of Florida|Christoph Seubert, MD|352-273-8960|cseubert@anest.ufl.edu|
22270054|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu|
22270055|NCT01435018|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22270056|NCT03937908|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
22298751|NCT02837744|Axio Biosolutions Pvt. Ltd.|Shailee Mehta, Clinical Research Manager|9879009940|shailee.m@axiobio.com|
22298752|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22298753|NCT00938431|UCB|Study Director|+1877 822 9493||
22298754|NCT01353339|St Paul's Hospital|Dr. John S. Gill|604-806-8970|jgill@providencehealth.bc.ca|
22298755|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org|
22298756|NCT03738865|Xeris Pharmaceuticals, Inc.|Chelsea Boundy|312-517-1466|cboundy@xerispharma.com|
22298757|NCT03455855|Boston Scientific|Dr Haotian Zhang|+8617621154031|haotian.zhang@bsci.com|
22298758|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com|
22298759|NCT01602315|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298760|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu|
22298761|NCT02212730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298762|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22298763|NCT05711069|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
22298764|NCT02691455|The University of Texas Health Science Center at Houston|Robert M. Feldman, MD|(713) 559-5239|Robert.M.Feldman@uth.tmc.edu|
22298765|NCT02057757|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. John Beigel|301-451-9881|jbeigel@niaid.nih.gov|
22298766|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298767|NCT01416194|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298768|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22298769|NCT03586869|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22298770|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu|
22298771|NCT02732847|Memorial University|Reza Tabrizchi|706-864-3381|rtabrizc@mun.ca|
22298772|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22298773|NCT03835260|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
22298774|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com|
22298775|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22298776|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22298777|NCT04378933|Mayo Clinic|R. Robert Auger, M.D.|507-266-1066|Auger.Raymond1@mayo.edu|
22298778|NCT00515827|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22298779|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com|
22298780|NCT03254134|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298781|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu|
22298782|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
22298783|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22298784|NCT02188485|University of Rochester|Kim Van Orden, PhD|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
22298785|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu|
22298786|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22298787|NCT00685932|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbank, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
22298788|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22298789|NCT03149237|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
22298790|NCT02442830|UMass Medical School|Principal Investigator|(774) 442-4098|David.Cave@umassmemorial.org|
22298791|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22298792|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu|
22298793|NCT03851016|University of Houston|Dr. Theresa C. Chrisman|713-447-3334|tkchrisman@comcast.net|
22298794|NCT03878134|NIH Clinical Center|Dr. Elizabeth Jones Chief, Radiology and Imaging Sciences|3012634853|ejones@cc.nih.gov|
22298795|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298796|NCT02553746|424 Army General Hospital|Georgios Kotsovolis|+306948182743|gskotsos@gmail.com|
22298797|NCT04055116|Geisinger|Gayatri Malik, MD|15702716355|gmalik1@geisinger.edu|
22298798|NCT02710526|Braeburn Inc|Sonnie Kim|6104678718|sonnie@braeburnrx.com|
22298799|NCT01003418|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298800|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu|
22298801|NCT04356716|Columbia University|Suzanne Daly, RN, BSN|212 305 9535|sd2798@cumc.columbia.edu|
22298802|NCT04258839|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22298803|NCT03328897|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22298804|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com|
22298805|NCT03189914|Rexahn|Doug Swirsky/ Chief Executive Officer|12402685300|swirskyd@rexahn.com|
22324596|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com|
22324597|NCT03486314|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22324598|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com|
22324599|NCT01364467|Virginia Commonwealth University|Kelley M. Dodson, MD, FACS|804-828-3965|kelley.dodson@vcuhealth.org|
22324600|NCT03228186|Rogel Cancer Center|Gregory Kalemkerian, MD|734-647-8921|kalemker@med.umich.edu|
22324601|NCT03953118|University of California San Francisco CA|Julie Schallhorn, MD|415-514-1922|julie.schallhorn@ucsf.edu|
22324602|NCT03655444|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
22324603|NCT02502864|H. Lee Moffitt Cancer Center and Research Institute|Christine M. Walko, Pharm.D., BCOP|813-745-1519|christine.walko@moffitt.org|
22270057|NCT03875092|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22270058|NCT03205761|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22298806|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com|
22298807|NCT04331366|Emory University|Jeffery Miller, MD|404-778-7200|jeffrey.miller@emory.edu|
22298808|NCT03019536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22298809|NCT03223298|Weill Cornell Medicine|Dr. Gwendolyn S. Reeve|(212) 746-5175|gsr9001@med.cornell.edu|
22298810|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111|heather.bloom@emory.edu|6391
22298811|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298812|NCT00317772|UT MD Anderson Cancer Center|Diane C Bodurka,Chief Education & Training Ofc, Education & Training|(713) 745-3358|dcbodurka@mdanderson.org|
22298813|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22298814|NCT03151265|dorsaVi Ltd|Sangeeth Wanasinghage|+61 1800 367 728|support@dorsavi.com|
22298815|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
22298816|NCT02886572|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
22298817|NCT03087591|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-5772|ptriozzi@wakehealth.edu|
22298818|NCT02621606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298819|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298820|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
22324604|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu|
22298821|NCT00982319|Sidney Kimmel Comprehensive Cancer Center|Dr. Kala Visvanathan|410-614-1112|kvisvan1@jhu.edu|
22298822|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298823|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu|
22298824|NCT00843791|OREGON HEALTH & SCIENCE UNIVERSITY|Dr. Jonathan Q Purnell|5034941056|purnellj@ohsu.edu|
22298825|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org|
22298826|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22298827|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com|
22298828|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22298829|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501|nigel.turner@camh.ca|36063
22298830|NCT03603964|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22298831|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
22298832|NCT03264157|Bio Products Laboratory|Head of Medical Affairs|1-844-4BPLUSA|MedInfo@bpl-us.com|
22298833|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22298834|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com|
22298835|NCT00003498|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22298836|NCT04188041|Kent Hospital|Daria Szkwarko, PI|401-921-7981|szkwarkd@gmail.com|77981
22298837|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22298838|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu|
22298839|NCT02821104|Nationwide Children's Hospi|Robert Hoffman|614-722-4425|robert.hoffman@nationwidechildrens.org|
22298840|NCT02248922|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22298841|NCT01416805|University of South Florida|Dr. Eric Storch|727-767-8230|Eric.Storch@bcm.edu|
22298842|NCT02873104|Cutera|Lourdes Moldre, NP|415-971-5118|lmoldre@cutera.com|
22298843|NCT02708745|Seattle Children's Hospital|Dr. Doug Opel|206-987-2000|douglas.opel@seattlechildrens.org|
22298844|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
22298845|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22298846|NCT02418546|Massachusetts General Hospital|Dr. Anne-Marie Wills|6177265532|awills@mgh.harvard.edu|
22298847|NCT04632940|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-094DMDStudy@fibrogen.com|
22298848|NCT02709395|Wellspect HealthCare|Head of Medical Affairs, Markus Wittebo|+46 31 376 40 00|markus.wittebo@wellspect.com|
22298849|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org|
22298850|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com|
22298851|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300||
22324605|NCT04375878|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589 7020|info@firstwavebio.com|
22324606|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581|david-katz@uiowa.edu|7598
22324607|NCT01624194|Stanford University|Antonio Y. Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
22324608|NCT04322708|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22324609|NCT03212261|Massachusetts General Hospital/Harvard Medical School|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
22324610|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
22324611|NCT03815175|Abbott|Lijuan Jenn Wang|01-408-8453133|Lijuan.wang1@abbott.com|
22324612|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr|
22324613|NCT03679494|Taipei MU|MS. Po-Yao Chiu|+886-2-27361661|m437106006@tmu.edu.tw|6311
22324614|NCT02296840|Emory University|Roy Rajan, MD|404-778-2400|royrajan@yahoo.com|
22324615|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
22324616|NCT02485717|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
22324617|NCT02827877|City of Hope Medical Center|Dr. Joanne Mortimer|626-359-8111|jmortimer@coh.org|
22324618|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org|
22324619|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493||
22324620|NCT03914300|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-293-9779|bhavana.konda@osumc.edu|
22324621|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324622|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov|
22324623|NCT01450540|Philips|Senior Data Scientist|+14125423651||
22324624|NCT00140855|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22324625|NCT03542682|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
22324626|NCT01586091|University of Charité Berlin; Dpt. of Dermatology and Allergy|Professor Marcus Maurer|+49 30 450 518 043|marcus.maurer@charite.de|
22324627|NCT02871479|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@satalispharma.com|101
22324628|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324629|NCT04090164|Mansoura University|Osama Hussein|00201099815110|osamahussein@mans.edu.eg|
22324630|NCT03439345|Nuffield Department of Population Health, University of Oxford|Associate Professor David Preiss|01865 743 743|lens@ndph.ox.ac.uk|
22324631|NCT05405166|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22324632|NCT03746080|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
22324633|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com|
22324634|NCT03665155|Memorial Sloan Kettering Cancer Center|Jason Lewis, PhD|314-276-1830|lewisj2@mskcc.org|
22324635|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
22324636|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22324637|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22324638|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288|Xia.Zhang@astrazeneca.com|2035
22324639|NCT00918723|Fred Hutchinson Cancer Research Center|Dr. Mazyar Shadman|2066675467|mshadman@fredhutch.org|206
22324640|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270059|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com|
22270060|NCT03470012|cyberDERM|Danielle Fendrick|610-325-0881|dfendrick@cyberderm-inc.com|
22270061|NCT04114357|Indiana University|Heba M Ismail|317-278-8326|heismail@iu.edu|
22270062|NCT02163226|UT MD Anderson Cancer Center|Dr. Quynh-Nhu Nguyen, MD,Associate Professor, Radiation Oncology Department|(713) 563-2450|qnnguyen@mdanderson.org|
22311628|NCT01604824|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22311629|NCT02630966|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22311630|NCT03758742|University of Alabama at Birmingham|Dr. Courtney M. Peterson|205-934-0122|cpeterso@uab.edu|
22311631|NCT03617835|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311632|NCT04111510|Yale School of Medicine|Michael Hurwitz, MD, PhD|(877) 925-3637|michael.hurwitz@yale.edu|
22311633|NCT02422524|Duke University|Julius Wilder, MD, PhD|919-668-3063|julius.wilder@duke.edu|
22311634|NCT04205903|The Ohio State University Comprehensive Cancer Center|Dr. Nicole Williams|(614) 293-0066|Nicole.Williams@osumc.edu|
22311635|NCT00544115|City of Hope|Dr. Monzr Al Malki, MD|626359811|malmalki@coh.org|
22311636|NCT03395080|Leap Therapeutics, Inc.|Cynthia Sirard, MD, Chief Medical Officer|+1-617-714-0360|csirard@leaptx.com|
22311637|NCT04233567|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.Roychowdhury@osumc.edu|
22311638|NCT02060487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311639|NCT03387189|HealthPartners|Kamalini Das|651-293-8233|Kamalini.X.Das@HealthPartners.Com|
22311640|NCT03697603|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22311641|NCT04218864|Women & Infants Hospital|Dr. Caron Zlotnick|4014743332|czlotnick@butler.org|
22311642|NCT03683030|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311643|NCT04502472|Inova Health Systems|Anne Whitney Brown, MD|7037763067|anne.brown@inova.org|
22311644|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311645|NCT03132298|Stony Brook University|Jessica Schleider|631-632-4131|jessica.schleider@stonybrook.edu|
22324641|NCT03704051|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
22324642|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov|
22311646|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
22311647|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311648|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru|
22311649|NCT05824559|MEI Pharma|Richard Ghalie, MD CMO|619 990-1153|rghalie@meipharma.com|
22311650|NCT04728711|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22311651|NCT03110575|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
22311652|NCT04701203|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22311653|NCT01804166|Janssen Scientific Affairs, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311654|NCT05001139|Relife Srl|Prof. Giuseppe Micali|05556809528|lfabbri@relifecompany.it|
22311655|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com|
22311656|NCT04577651|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22311657|NCT03427463|Medical University of South Carolina|Katherine Hatter, M.D.|(843) 792-5454|herbertk@musc.edu|
22311658|NCT00647387|Abbott Structural Heart|Ryan Palmer, Director of Clinical Programs|+1 651-202-8362|ryan.palmer@abbott.com|
22311659|NCT03147287|Dana-Farber Cancer Institute|Project Manager|617-632-3800|ctopm@dfci.harvard.edu|
22311660|NCT00302211|Actelion Pharmaceuticals US, Inc.|Gary Palmer SVP, US Medical Affairs|650-624-6900||
22311661|NCT03137459|Yale School of Medicine|Dr. Terri Fried|203-932-5711|terri.fried@yale.edu|5412
22311662|NCT06571695|Loyola University Medical Center|Dr. Dane H. Salazar|773-562-0456|dsalazar@lumc.edu|
22311663|NCT04921358|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22311664|NCT02278796|Inselspital University Hospital Bern|Thomas Pabst, Prof Dr. med|+41 31 632 84 30|thomas.pabst@insel.ch|
22311665|NCT04926857|Medtronic|Nirav Patel|1 (800) 633-8766|nirav.a.patel@medtronic.com|
22311666|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227|abirney@orcasinc.com|541
22311667|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu|
22311668|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu|
22311669|NCT01380145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22311670|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu|
22311671|NCT01256359|University of Oxford|Professor Mark Middleton|+44 (0)1865 617331|mark.middleton@oncology.ox.ac.uk|
22311672|NCT01005615|Kennedy Krieger institute|Cristina Sadowsky|443-923-9232|sadowsky@kennedykrieger.org|
22311673|NCT01583868|Bausch Health|Study Director||robert.steffen@bausch.com|
22311674|NCT03737110|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22311675|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
22311676|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22311677|NCT00252382|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
22324643|NCT03311126|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|(608) 263-9823|jc2@medicine.wisc.edu|
22324644|NCT03113500|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22324645|NCT01348919|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22280797|NCT03533660|University of Pittsburgh|Andrea DiMartini|14122164550|dimartiniaf@upmc.edu|
22280798|NCT01671956|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22280799|NCT04685213|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22280800|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com|
22280801|NCT04446312|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
22280802|NCT02610972|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
22311678|NCT01509183|Propeller Health|Research Team at Propeller Health|9545369563|leanne.kaye@propellerhealth.com|
22270063|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org|
22270064|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270065|NCT03625466|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22270066|NCT04082572|M.D. Anderson Cancer Center|Michael J. Overman, MD|(713) 792-2828|moverman@mdanderson.org|
22270067|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu|
22270068|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200||
22270069|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22270070|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22270071|NCT03448575|Kaiser Permanente Washington Health Research Institute|Robert Penfold, PhD|206-316-7544|robert.b.penfold@kp.org|
22270072|NCT05318092|AngioDynamics, Inc.|Elizabeth Manning|339-237-2765|liz.manning@angiodynamics.com|
22270073|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
22270074|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22270075|NCT03214380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22270076|NCT02230696|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22311679|NCT03783936|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22270077|NCT00614523|Amgen Inc.|Study Director|866-572-6436||
22280803|NCT03816176|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22311680|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu|
22324646|NCT06470087|Adichunchanagiri Institute of Medical Sciences, BG Nagara|Dr Naveen N|9980023372|drnaveenn@bgsaims.edu.in|+91
22324647|NCT02517515|AbbVie|Global Medical Services|800-633-9110||
22324648|NCT04191668|Ectosense|Frederik Massie|+1 786 305 8547|frederik.massie@ectosense.com|
22324649|NCT03839524|TRANSGENE|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
22324650|NCT01568944|Dental College of Georgia|chairman|706-7212442|chcutler@augusta.edu|
22324651|NCT04902885|Jiangsu Simcere Pharmaceutical Co., Ltd.|Study Director|86-025-85566666|simcere@simcere.com|
22324652|NCT02037919|Family Planning Associates Medical Group , Ltd.|Allison A. Cowett, MD MPH|312-707-8988|aacowett@gmail.com|
22324653|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu|
22324654|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324655|NCT04586712|University of Florida|Dr. Paul Borsa|352-294-1726|pborsa@ufl.edu|
22324656|NCT01458340|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22324657|NCT02417415|Vanderbilt University Medical Center|Italo Biaggioni|(615) 322-2318|italo.biaggioni@vumc.org|
22324658|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22324659|NCT03669133|Indiana University|Regina Weber|317-278-3584|reginaw@iu.edu|
22324660|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu|
22324661|NCT01330446|University of Texas M D Anderson Cancer Center|Dr. Gary B. Gunn|(713) 563-2562|gbgunn@mdanderson.org|
22324662|NCT03293030|University of California San Francisco|Wilson Liao|415-476-8364|wilson.liao@ucsf.edu|
22324663|NCT04899271|Dompé Farmaceutici SpA|Clinical Development and Operations|+39 (0) 583831|clinical.trials@dompe.com|
22324664|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324665|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu|
22280804|NCT03581292|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22324666|NCT03652454|IzmirKCU|dr.dt.mücahid faik şahin|+902323254040|m.faiksahin@hotmail.com|
22324667|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu|
22324668|NCT04312997|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
22324669|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22324670|NCT03842137|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|aabrantes@carene.org|
22324671|NCT01472276|Queen's University, Belfast|Michelle McKinley, Professor|02890978936|m.mckinley@qub.ac.uk|
22324672|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org|
22324673|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu|
22324674|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se|
22324675|NCT05480514|Johnson & Johnson Vision Care, Inc. (JJVC)|Brian Pall|1-800-843-2020|bpall@its.jnj.com|
22324676|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es|
22324677|NCT03195140|Tandem Diabetes Care, Inc|Jordan Pinsker, MD|858-366-6900|clinicalaffairs@tandemdiabetes.com|
22324678|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
22324679|NCT02527304|Montefiore Medical Center|Dr. Madhur Garg, Clinical Director, Department of Radiation Oncology|718-920-4361|mgarg@montefiore.org|
22324680|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
22324681|NCT00457639|UT Southwestern Medical Center|Zahid Ahmad, M.D.|214-648-2377|zahid.ahmad@utsouthwestern.edu|
22324682|NCT03885284|Georgetown University|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
22324683|NCT00484354|Wake Forest School of Medicine|Michael Rocco, MD|3367164650|mrocco@wakehealth.edu|
22324684|NCT02932267|Galderma|Rajeev Chavda|0033|rajeev.chavda@galderma.com|492382928
22324685|NCT02625402|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@partners.org|
22324686|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org|
22324687|NCT00840463|UT Southwestern|Kelly Chin|214-645-1825|kelly.chin@utsouthwestern.edu|
22324688|NCT01887210|Rhode Island Hospital|Dr. Larry Brown|401-793-8808|lkbrown@lifespan.org|
22324689|NCT04884243|Cloudbreak Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
22324690|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22324691|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
22324692|NCT02515669|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22324693|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
22324694|NCT04278573|Mayo Clinic|Dr. Stephen P. Merry|507-284-5180|merry.stephen@mayo.edu|
22324695|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com|
22324696|NCT03750838|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
22324697|NCT02985801|Mayo Clinic|Dr. Massimo Raimondo|904-953-6982|Raimondo.Massimo@mayo.edu|
22280805|NCT05200572|University of Rochester|Lee Kehoe, Ph.D.|(585) 276-7686|leekehoephd@gmail.com|
22280806|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
22280807|NCT02524145|University of Texas Southwestern Medical Center|Dr. Satyam Sarma|214-345-7111|SatyamSarma2@texashealth.org|
22280808|NCT01682356|Washington University School of Medicine|Linda R. Peterson, MD|314-362-4577|lpeterso@wustl.edu|
22298852|NCT05013905|Prometheus Biosciences, Inc.|Study Director|858-422-4300|mm@prometheusbiosciences.com|
22324698|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com|
22324699|NCT02656472|Advocate Children's Hospital|Andrew VanBergen|7086848758|andrew.vanbergen@advocatehealth.com|
22311681|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
22311682|NCT04237792|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311683|NCT01218048|University of Pittsburgh Cancer Institute|Robert Ferris, MD, PhD|412-623-3205|ferrrl@upmc.edu|
22311684|NCT02788981|University of Chicago|Dr. Nan Chen|773-702-6149|nchen@bsd.uchicago.edu|
22311685|NCT05553366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22311686|NCT00249769|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22311687|NCT01505166|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22311688|NCT03187678|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22311689|NCT02022657|Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora|Dr. Peter Anderson|3037246821|peter.anderson@ucdenver.edu|
22311690|NCT03274076|University of Michigan|Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
22311691|NCT01786876|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22311692|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com|
22311693|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22311694|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com|
22311695|NCT03781375|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22324700|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22324701|NCT04060277|City of Hope Medical Center|Dr. Ryotaro Nakamura|6263598111|rnakamura@coh.org|
22324702|NCT01093612|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22324703|NCT03191786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22324704|NCT05847881|Back & Pain Center Clinical Research|Afton L. Hassett, PsyD|734-763-5226|afton@med.umich.edu|
22324705|NCT05781542|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22324706|NCT04974307|National Institute of Child Health and Human Development (NICHD)|Dr. An Ngoc Dang Do|301-496-8849|an.dangdo@nih.gov|
22324707|NCT05110300|Gaylord Specialty Healthcare|John Corbett|2032943224|jcorbett@gaylord.org|
22324708|NCT01386385|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
22324709|NCT05768789|University of Pittsburgh, UPMC|Harikesh Subramanian, MBBS, MS, D.ABA, ABPM-CI|412-647-9085|subramanianh4@upmc.edu|
22324710|NCT03348683|Icahn School of Medicine at Mount Sinai|Dr. Catherine A Bigelow|651-206-9069|cassie.bigelow@gmail.com|
22324711|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
22324712|NCT04573777|UCaliforniaLA|David Liebeskind|‭(310) 963-5539‬|dliebeskind@mednet.ucla.edu|
22270078|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22270079|NCT01450826|Duke University Medical Center|Mary Lou Affronti, DNP, RN, MHSc, ANP|9196845301|mary.affronti@duke.edu|
22270080|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca|
22270081|NCT03966924|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
22270082|NCT02153671|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22270083|NCT00655707|ImperialC|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
22270084|NCT02796352|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|(412) 647-5554|stadtermanbm@upmc.edu|
22270085|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22270086|NCT04638881|Stanford University School of Medicine|Dr. Richard K. Kim|3475869661|rkwkim@stanford.edu|
22270087|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22270088|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
22270089|NCT04481191|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270090|NCT02593526|UNewMexico|Mark Unruh|5052728800|MLUnruh@salud.unm.edu|
22270091|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu|
22270092|NCT01598090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22270093|NCT03628339|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22270094|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov|
22270095|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
22270096|NCT03557931|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22270097|NCT02394340|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
22270098|NCT01985932|University of Pennsylvania|Curtiland Deville, MD|215-662-2428|deville@uphs.upenn.edu|
22270099|NCT01707108|Rambam Health Care Campus|Director of Trial|+97247772983|j_horwitz@rambam.health.gov.il|
22270100|NCT02805179|University of Michigan|Michelle Kim, MD|734-936-4300|michekim@med.umich.edu|
22270101|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270102|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22311696|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22324713|NCT03167619|Duke Clinical Research Institute|Senior Biostatistician|919-668-8052|lilin.she@duke.edu|
22324714|NCT00678496|University of Sheffield|Daniel Hind, Assistant Director, Sheffield CTRU|+441142220707|d.hind@sheffield.ac.uk|
22324715|NCT02927223|Vanderbilt University Medical Center|Dr. Prince Kannankeril|615-322-7447|prince.kannankeril@vumc.org|
22324716|NCT06400238|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22270103|NCT02145260|Brigham and Women's Hospital|Finnian Mc Causland|6177326432|fmccausland@bwh.harvard.edu|
22324717|NCT02123329|Qatar University College of Pharmacy|Dr. Maguy El Hajj|0097444035577|maguyh@qu.edu.qa|
22324718|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324719|NCT04430348|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
22324720|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
22324721|NCT03847337|Vanderbilt University Medical Center|Zachary Warren|615-875-3085|zachary.e.warren@vumc.org|
22324722|NCT05408858|Massey University|Dr. Ilana Seager van Dyk|+64 4 979 3625|i.seagervandyk@massey.ac.nz|
22324723|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22324724|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu|
22324725|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324726|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov|
22324727|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300||
22324728|NCT02888626|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22324729|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at|
22324730|NCT02318602|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22324731|NCT04871815|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
22324732|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com|
22324733|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
22324734|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22324735|NCT02379858|Medical College of Wisconsin|Matthew Goldblatt, MD|414-955-5751|mgoldbla@mcw.edu|
22324736|NCT00609128|University of Wisconsin-Madison|Jim Stahl, PhD|608-263-6177|jlstahl@wisc.edu|
22324737|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
22324738|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22324739|NCT05139030|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22324740|NCT02814721|Henry Ford Hospital|Dr. Lalathaksha Kumbar|3136271761|lkumbar1@hfhs.org|
22324741|NCT04378426|Palo Alto VA|Carolyn Rodriguez, MD, PhD|650-493-5000|carolyn.rodriguez@va.gov|60067
22324742|NCT00820040|Medtronic|Heather McManus|2038213323|heather.mcmanus@medtronic.com|
22324743|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com|
22324744|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22324745|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu|
22324746|NCT02192359|City of Hope Medical Center|Dr. Jana Portnow|626-546-8293|JPortnow@coh.org|
22324747|NCT05036785|Royal Devon and Exeter NHS Trust|Dr Ellen Richards|01392 411611|ellen.richards6@nhs.net|
22324748|NCT03721328|Nor Consult, LLC|Nor Consult|206-607-6861|regulatory@nor-consult.com|
22324749|NCT03429075|Imperial College London|Dr Robin Carhart-Harris|02075947992|r.carhart-harris@imperial.ac.uk|
22324750|NCT04333966|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
22324751|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22324752|NCT04037085|UPMC|Grace Lim, MD, MSc|412-641-1110|limkg2@upmc.edu|
22324753|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22324754|NCT02006576|University of Nebraska Medical Center|Amy Nelson|402-559-5536|amyjnelson@unmc.edu|
22324755|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22324756|NCT01919411|Massachusetts Eye & Ear Infirmary|Dr. Eric Holbrook|617-573-3209|Eric_Holbrook@meei.harvard.edu|
22324757|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
22324758|NCT05175170|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Diane Chen|312-227-2939|DiChen@luriechildrens.org|
22324759|NCT03294304|Masonic Cancer Center, University of Minnesota|Dr. Konety Badrinath|612-625-1655|brkonety@umn.edu|
22324760|NCT00630032|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
22324761|NCT02798523|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Luis Franco|+1 240 220 4366|luis.franco@nih.gov|
22324762|NCT02332915|University of Utah|Julie Wambaugh|8015846164|julie.wambaugh@health.utah.edu|
22324763|NCT01909492|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22324764|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22324765|NCT03232073|Actelion Pharmaceuticals Ltd|Associate Director Clinical Sciences Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22324766|NCT04358458|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
22270104|NCT01726270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270105|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com|
22270106|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22270107|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com|
22324767|NCT06046560|Mass General Brigham|Alexander Blood, MD|617-732-7144|ablood3@mgb.org|
22324768|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org|
22324769|NCT03440112|University of Michigan|Stiven Roytman|7349988424|stivenr@med.umich.edu|
22324770|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
22324771|NCT04352660|UCSD Shiley Eye Institute|Dr. Jiun Do|8585346290|jiundo@ucsd.edu|
22324772|NCT01362322|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311697|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22311698|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22311699|NCT02909959|University of North Carolina at Chapel Hill|Laura Politte, MD|919-350-1726|lpolitte@wakemed.org|
22311700|NCT03760913|OliPass Corporation|OliPass Call Center|82-2-6488-2200|clinicaltrials.inquiries@olipass.com|
22311701|NCT04278755|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-974-3929|jhbaker@med.unc.edu|
22311702|NCT01932970|Amgen Inc.|Study Director|866-572-6436||
22311703|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu|
22311704|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311705|NCT03489369|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
22311706|NCT01868230|UMass Amherst|Dr. Lisa Chasan-Taber, Principal Investigator|4135451664|lct@umass.edu|
22311707|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu|
22311708|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311709|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22311710|NCT02208843|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311711|NCT03067948|Johns Hopkins University SOM (Adjunct)|Anne Monroe MD|202-994-0251|amonroe@gwu.edu|
22311712|NCT00665392|GERCOR|Regulatory Affairs|+33 (0)1 40 29 85 00|regulatory.affairs@gercor.com.fr|
22311713|NCT00243867|American Regent Inc.|Manager Medical Writing|631-772-3555|HRathfon@americanregent.com|
22311714|NCT04399837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311715|NCT03088800|Maimonides Medical Center|Sergey Motov, MD|7182836000|smotov@maimonidesmed.org|
22311716|NCT02831816|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
22311717|NCT02954432|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
22311718|NCT04224272|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22311719|NCT02609048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311720|NCT04445831|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
22311721|NCT03268421|Cincinnati Children's Hospital|Susmita Kashikar-Zuck, PhD|513-636-6337|susmita.kashikar-zuck@cchmc.org|
22311722|NCT04912856|Xenon Pharmaceuticals|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
22324773|NCT02413398|Global Clinical Leader-Dapagliflozin AstraZeneca|Anna Maria Langkilde, MD PhD|Tel: + 46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22324774|NCT04168203|BWH|Physician|6177326984|gpiazza@bwh.harvard.edu|
22324775|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu|
22324776|NCT00058370|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
22324777|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov|
22324778|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com|
22324779|NCT02498652|Study Information Center AstraZeneca|Jesse Hall, MD|(877) 240-9479|information.center@astrazeneca.com|
22324780|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22324781|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
22324782|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324783|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
22324784|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
22324785|NCT00482001|Sunnybrook Health Sciences Centre|Dr. Mark Rapoport|416-480-4085|Mark.Rapoport@sunnybrook.ca|
22324786|NCT04786210|NYU Langone Health|Nayoung Lee, MD|212-263-7019|nayoung.lee@nyulangone.org|
22324787|NCT03826914|University of Manitoba|Dr. Semone Myrie|(204) 474-7290|semone.myrie@umanitoba.ca|
22324788|NCT01754688|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher, MD|612-624-4586|tslusher@umn.edu|
22324789|NCT04334148|Duke University|Dr. Susanna Naggie|919-684-2584|susanna.naggie@duke.edu|
22324790|NCT05370157|University of Pittsburgh|Dr. Elizabeth McGuier|412-246-5895|millerea3@upmc.edu|
22324791|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
22324792|NCT06129487|University of Connecticut|Zexin Ma, Ph.D.|(860) 486-6871|zexin.ma@uconn.edu|
22324793|NCT03772327|Weill Cornell Medicine|Dr. Grant Ellsworth|212-746-7204|gre9006@med.cornell.edu|
22324794|NCT04689828|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22324795|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22324796|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
22324797|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22324798|NCT03959189|Expansion Therapeutics, Inc.|Chief Medical Officer|858-764-4290|info@expansionrx.com|
22324799|NCT04332419|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ram Gurajala, MD|1-866-223-8100|TaussigResearch@ccf.org|
22324800|NCT02493751|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324801|NCT01480180|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22324802|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com|
22324803|NCT02513446|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324804|NCT04222725|Tarsier Pharma|Zohar Milman|+972-50-8371319|Zohar Milman <zohar@Tarsierpharma.com>|
22324805|NCT03819140|University of California, San Francisco|Heather Huddleston|(415) 353-7475|Heather.Huddleston@ucsf.edu|
22324806|NCT00104871|UT MD Anderson Cancer Center|Steven Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
22324807|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300||
22324808|NCT04323488|Stanford University|Jason Yeatman, PhD|(650) 321-7553|jyeatman@stanford.edu|
22324809|NCT00828451|Washington University|Aaron Hamvas, MD|314-454-6148|hamvas@kids.wustl.edu|
22324810|NCT03256539|University of California, San Francisco|Dr. Yue Leng|415 502 2949|yue.leng@ucsf.edu|
22324811|NCT04045912|University of California, San Francisco|Dr. Jenny Liu|1-415-502-5200|Jenny.Liu2@ucsf.edu|
22324812|NCT05755438|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22324813|NCT01885689|City of Hope|Dr. Monzi M.Al Malki, MD|626-359-8111|malmalki@coh.org|
22324814|NCT06027593|Children's Hospital of Philadelphia|Kathleen Chiotos|267-426-7729|chiotosk@chop.edu|
22324815|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
22324816|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu|
22324817|NCT05917288|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22324818|NCT01476787|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22324819|NCT03291379|Biocompatibles UK Ltd|Sarah Cooper|07805354224|Sarah-Jane.Cooper@bsci.com|
22324820|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
22324821|NCT04002167|Stanford University|Hadi Hosseini|6507235798|hosseiny@stanford.edu|
22324822|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org|
22324823|NCT01687673|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|Katie.Kelley@ucsf.edu|
22324824|NCT02234622|Roudebush VA Medical Center|Louanne Davis Psy.D.|317-710-1338|louannedavis52@gmail.com|
22324825|NCT03476239|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22324826|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com|
22324827|NCT03598777|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22324828|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com|
22324829|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22324830|NCT02462889|Ophthalmic Consultants of Boston|Jeffrey S. Heier, MD|617-314-2694|jsheier@eyeboston.com|
22311724|NCT02434328|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
22324831|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu|
22324832|NCT04636177|Stanford University School of Medicine|Laura E Simons|(650) 736-0838|lesimons@stanford.edu|
22324833|NCT07215806|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22324834|NCT02770287|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22324835|NCT01981187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324836|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
22324837|NCT01197573|Cleveland Clinic|Bijan Eghtesad, MD|216 444-9898|eghtesb@ccf.org|
22324838|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com|
22324839|NCT03187379|Cleveland Clinic Foundation|Dr. Matthew Kroh|12164457410|krohm@ccf.org|
22324840|NCT01494038|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22324841|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324842|NCT04260607|Naval Medical Center Camp Lejeune|Naval Medical Center Camp Lejeune|317-691-1718|nathan.butler@usmc.mil|
22324843|NCT03215914|University of Pennsylvania|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
22324844|NCT03715465|University of Michigan|Leslie Swanson|734-764-2242|lmswan@med.umich.edu|
22324845|NCT05665335|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22324846|NCT02138110|InVivo Therapeutics Corporation|Dr. Rich Toselli|(617) 863-5540|rtoselli@invivotherapeutics.com|
22324847|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324848|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr|
22270108|NCT04200651|New York Eye Surgery Center; University of Colorado|Dr. Nicholas Tan|3476175971|tannicholas97@gmail.com|
22270109|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu|
22270110|NCT04471194|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
22311725|NCT03496766|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22311726|NCT01850355|Massachusetts General Hospital|Dr. Gagan Joshi|617-724-1541|joshi.gagan@mgh.harvard.edu|
22311727|NCT01276509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22311728|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
22311729|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311730|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
22311731|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22311732|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22311733|NCT00279409|USSF|Laurence Greenhill||larrylgreenhill@gmail.com|
22270111|NCT03649932|University of Texas Medical Branch|Dr. Sunil Jain|4097722815|amnahqasim@gmail.com|
22270112|NCT02703467|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22270113|NCT03319732|RVL Pharmaceuticals, Inc.|Vice President Regulatory Affairs and Quality|908-809-1300|regulatory@rvlpharma.com|
22270114|NCT00757042|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22270115|NCT02934698|MUSC|Patrick Flume|843-792-3167|flumepa@musc.edu|
22270116|NCT02654977|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@umich.edu|
22270117|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu|
22270118|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br|
22270119|NCT02729051|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270120|NCT02702388|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22270121|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22270122|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov|
22270123|NCT04138953|Emory University|Michael Borich, DPT, PhD|404-712-0612|michael.borich@emory.edu|
22311734|NCT02542202|UChicago|Rohan Katipally|773-702-0137|Rohan.Katipally@bsd.uchicago.edu|
22311735|NCT04992273|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22311736|NCT01364597|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22311737|NCT03214081|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22311738|NCT02962284|Sun Pharma Global FZE|Harin Mehta|97145520096, 912266455645|clinicaltrials@sparcmail.com, harin.mehta@sparcmail.com|
22311739|NCT03774849|Candela|Dr. Konika Patel Schallen|5083580357|cie.studyinfo@candelamedical.com|
22311740|NCT03493282|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
22311741|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300||
22311742|NCT02634307|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22311743|NCT03926026|Nicox Ophthalmics, inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
22311744|NCT00413283|Amgen Inc.|Study Director|866-572-6436||
22311745|NCT00667017|University of Texas Southwestern Medical Center|Larry Andeson, MD|214-648-7097||
22311746|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com|
22311747|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu|
22311748|NCT05741450|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22311749|NCT01303796|Cyclacel Ltd|Mark H. Kirschbaum MD|+1 908 517 7330|mkirschbaum@cyclacel.com|
22311750|NCT01532648|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22311751|NCT02148705|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
22311752|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com|
22311753|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk|
22311754|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu|
22311755|NCT02824198|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
22311756|NCT03883828|Montefiore Medical Center|Dr. Beth McLellan|718.862.8840|bmclella@montefiore.org|
22311757|NCT02575365|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22311758|NCT01738698|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22270124|NCT03063437|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|majdi@openbiome.org|
22270125|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
22270126|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270127|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22270128|NCT04432090|AdventHealth, Orlando|Richard Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
22311759|NCT01545583|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311760|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu|
22311761|NCT02736188|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22311762|NCT01698918|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22311763|NCT03176407|Ovesco Endoscopy AG|Prof. Dr. T. Gottwald|0049707196528||160
22311764|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com|
22311765|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311766|NCT05197452|Research Manager|Dr. Yolanda Cartwright|224-420-0323|yolanda_cartwright@rush.edu|
22311767|NCT01817491|Cleveland Clinic|Michael Macknin, MD|216 444-5512|macknim@ccf.org|
22311768|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311769|NCT00670488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311770|NCT00878189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311771|NCT02708498|Department of Health Sciences, Lund University|Professor Gerd Ahlström|+46702747767|gerd.ahlstrom@med.lu.se|
22311772|NCT01829711|MedImmune, LLC|Priti Patel|+1-650-264-9079|information.center@astrazeneca.com|
22311773|NCT01480258|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311774|NCT02108171|Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com|
22311775|NCT02785159|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22311776|NCT04273672|University of Massachusetts Medical School|Kara Smith, MD|5083342527|kara.smith@umassmed.edu|
22311777|NCT04864834|Sandoz|Clinical Disclosure Representative|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
22311778|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22311779|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756|chris.harder@spartanbio.com|778
22311780|NCT02106884|UZ Leuven|Prof. Dr. Eric Van Cutsem|0032 16 344418|eric.vancutsem@uzleuven.be|
22311781|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu|
22311782|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22311783|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org|
22311784|NCT03042767|Emory University|Dr. Miriam Vos|404-727-5383|mvos@emory.edu|
22311785|NCT03784898|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22311786|NCT01543204|Amgen Inc.|Study Director|866-572-6436||
22311787|NCT04638816|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
22311788|NCT00087022|Heidelberg Pharma AG (previously Wilex AG)|Head of R&D||info@hdpharma.com|
22311789|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org|
22311790|NCT03960957|QMedAB|Clinical Project Manager|8179615000|aestheticclinicaltrials@galderma.com|
22311791|NCT02686658|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
22311792|NCT01695291|New York State Psychiatric Institute|Kelsey Hill, Research Coordinator|646-774-5793|Kelsey.Hill@nyspi.columbia.edu|
22311793|NCT02581137|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
22311794|NCT03476798|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
22311795|NCT06269003|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
22311796|NCT06677203|Asceneuron S.A.|Asceneuron Clinical Research|+41213538245|clinicaltrials.gov@asceneuron.com|
22311797|NCT01534052|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|800-888-7704 Ext:5473|astellas.resultsdisclosure@astellas.com|
22311798|NCT03964974|University of Michigan|Mark Ilgen|734-845-3646|marki@med.umich.edu|
22311799|NCT03062488|Nemours Children's Healthcare System|Carlos A. Archilla, MD|4076507646|carlos.archilla@nemours.org|
22311800|NCT02698475|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311801|NCT02038049|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22311802|NCT01363128|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD/ Professor|7137924764|ejabbour@mdanderson.org|
22311803|NCT02660086|Massachusetts General Hospital|Dr. Anne Thorndike, Prinicipal Investigator|6177244608|athorndike@mgh.harvard.edu|
22311804|NCT01377844|Theracos Sub, LLC|Albert Collinson, Ph.D.|(508) 688-4221|acollinson@theracos.com|
22311805|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311806|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu|
22311807|NCT01214200|Temple University School of Medicine|Mark Weir, MBChB|215-707-5864|mark.weir@tuhs.temple.edu|
22311808|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org|
22311809|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22311810|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22311811|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311812|NCT03510195|Universiti Putra Malaysia|Dr. Aneesa Abdul Rashid|03-86092956|aneesa@upm.edu.my|
22311813|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590||
22311814|NCT00403494|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22311815|NCT05005247|MinervaX|CMO|004553883002|LIO@minervax.com|
22311816|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV|
22311817|NCT03648541|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22311818|NCT03490032|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22311819|NCT05005351|Swing Therapeutics, Inc.|Clinical Project Manager|1 (415) 662-0415|research@swingtherapeutics.com|
22311820|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311821|NCT01858688|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Neil Martin, MD|(617) 632-3000|NEMARTIN@PARTNERS.ORG|
22311822|NCT04248868|Eminence Clinical Research, Inc.|Christopher A. Schultz|9715067552|cschultz@ecr-inc.com|
22311823|NCT03672032|University of Iowa Hospitals and Clinics|Dr. Henning Gerke|319-384-6582|henning-gerke@uiowa.edu|
22311824|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu|
22311825|NCT02684136|HenryFordHS|Timothy Roehrs PhD Study Investigator|313-916-5177|troehrs1@hfhs.org|
22311826|NCT01989793|Johns Hopkins University|Dr. Jeremy D. Walston, M.D. , Raymond and Anna Lublin Professor of Geriatric Medicine|410-550-1003|jwalston@jhmi.edu|
22311827|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22324849|NCT02158533|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22270129|NCT04250350|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22270130|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu|
22270131|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
22270132|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu|
22270133|NCT02836236|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311828|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311829|NCT04899999|University of Rochester|Dr. Francisco Cartujano Barrera, M.D|(585) 273-1646|francisco_cartujano@urmc.rochester.edu|
22311830|NCT03822832|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324850|NCT03851744|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
22324851|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com|
22324852|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il|
22270134|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|kevan.herold@yale.edu|
22324853|NCT01389128|University of São Paulo|Dr. Silvana Maria Quintana|+55(16)36022813|quintana@fmrp.usp.br|
22324854|NCT01451515|St. Jude Children's Research Hospital|Hiroto Inaba, MD, PhD|(901) 595-3144|hiroto.inaba@stjude.org|
22324855|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu|
22324856|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22324857|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87|Francine.santoro@galderma.com|87 20
22311831|NCT01668719|SWOG Statistics and Data Management Center|Myeloma Committee Statistician|2066674623|rachaels@crab.org|
22311832|NCT03539055|Vanderbilt Cardiovascular Research Enterprise|Terry Weyand, MS., CCRP|6153229349|terry.l.weyand@vumc.org|
22311833|NCT04939233|Departments of Mechanical Engineering and Electrical and Computer Engineering, Virginia Tech|Dr. Pinhas Ben-Tzvi|NA|bentzvi@vt.edu|
22311834|NCT01321073|The University of Alabama at Birmingham|Robert Bourge, M.D., Professor of Medicine, Radiology, and Surgery|(205)934-7400|bbourge@uab.edu|
22311835|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com|
22311836|NCT04248803|TamilNadu MU|Dr Geeth Deepika|9952331820|geethdeepika@gmail.com|
22311837|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22311838|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22311839|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22311840|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22311841|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22311842|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311843|NCT04162873|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22311844|NCT03343704|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311845|NCT03715946|UPMC Hillman Cancer Center|Barbara Stadterman, MPH|4126475554|stadtermanbm@upmc.edu|
22311846|NCT02969356|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22311847|NCT02678455|University of Vermont|Beth Kirkpatrick MD|802-656-5822|beth.kirkpatrick@med.uvm.edu|
22311848|NCT03187223|Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland|Prof Dr. Thomas Pabst|+41 31 63 2 84 30|Thomas.Pabst@insel.ch|
22311849|NCT04700904|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
22311850|NCT03508700|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
22311851|NCT02808468|University of Washington|Dr. Michele Bedard-Gilligan|206-616-4215|mab29@uw.edu|
22311852|NCT04906057|Cleveland Clinic|Donayja Harris|2164454125|harrisD47@ccf.org|
22311853|NCT05432986|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
22311854|NCT02470312|Abbott|Kristin Ruffner, Clinical Program Director|+1 651 756 6717|Kristin.Ruffner@abbott.com|
22311855|NCT02786966|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22311856|NCT02830893|University of California Irvine|Dr. Steven Cramer|(949) 824-8423|SCCramer@mednet.ucla.edu|
22311857|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590||
22311858|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org|
22311859|NCT02710669|Vanderbilt University Medical Center|Benjamin Shoemaker, MD|615-322-2318|moore.b.shoemaker@vumc.org|
22311860|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu|
22311861|NCT03332589|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
22311862|NCT03627299|Johns Hopkins University|Christine Durand, MD|410-955-5684|ChristineDurand@jhmi.edu|
22311863|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt|
22311864|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com|
22311865|NCT05062161|Columbia University Medical Center|Marwah Abdalla|212 342 1275|ma2947@cumc.columbia.edu|
22311866|NCT03469258|Beth Israel Deaconess Medical Center|A. James Moser, MD|(617) 632-1032|ajmoser@bidmc.harvard.edu|
22311867|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov|
22311868|NCT02005172|University at Buffalo|Deepika Narasimha||deepikan@buffalo.edu|
22311869|NCT01711294|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
22311870|NCT02605174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22324858|NCT03230097|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324859|NCT05980416|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
22324860|NCT05740813|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22311871|NCT00770874|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22324861|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu|
22270135|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu|
22270136|NCT01323153|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22270137|NCT02579343|Counseling and Psychological Services|Adam McCabe|239-590-7950|amccabe@fgcu.edu|
22324862|NCT00609271|Tulane University|Dr. Lydia Bazzano|5049887323|lbazzano@tulane.edu|
22270138|NCT04984278|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22311872|NCT04250636|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
22311873|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22311874|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com|
22311875|NCT01682928|Mednax|Ana Braescu|480-969-5999|ana_braescu@mednax.com|
22311876|NCT04938453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311877|NCT04053699|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22311878|NCT03292406|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22311879|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22311880|NCT03068312|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
22311881|NCT01852045|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22311882|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com|
22311883|NCT02827201|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22311884|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22311885|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311886|NCT02630186|Clovis Oncology, Inc.|Elizabeth Bradley|1-415-409-5495|ebradley@clovisoncology.com|
22311887|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
22311888|NCT03142932|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|(443) 287-2969|jgolub@jhmi.edu|
22311889|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
22311890|NCT01021748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311891|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org|
22311892|NCT01640288|Duke University School of Medicine, Department of Radiology|H. Cecil Charles, Ph.D.|919-684-7921|cecil.charles@duke.edu|
22311893|NCT03775915|University of Oxford|Dr Melanie Fleming, Research Associate|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
22311894|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311895|NCT02234141|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311896|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu|
22311897|NCT01972776|Novartis|Study Director|862-778-8300||
22311898|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22311899|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu|
22311900|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22311901|NCT01220999|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22311902|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net|
22311903|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com|
22311904|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com|
22311905|NCT03326856|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
22311906|NCT03162614|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
22311907|NCT03861234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311908|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
22311909|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org|
22311910|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu|
22311911|NCT05169684|Bristol Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22311912|NCT05352230|UAB|Orlando Gutierrez|2059962736|ogutierrez@uabmc.edu|
22311913|NCT05414682|University of Kansas Medical Center|Dr. Ashley Shaw|913-945-5023|ashaw10@kumc.edu|
22311914|NCT03212638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22311915|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
22311916|NCT03775213|Duke University|Dr. Marc D. Ryser|(919) 684 8294|marc.ryser@duke.edu|
22311917|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22311918|NCT00326183|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22311919|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com|
22311920|NCT03787628|UCLA David Geffen School of Medicine|Dr. Edythe London|3106142150|elondon@mednet.ucla.edu|
22311921|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311922|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com|
22311923|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311924|NCT05426109|Virginia Tech|Dr. Larson-Meyer|540-231-1025|enette@vt.edu|
22311925|NCT05212285|Huadong hospital,Shanghai ,China|Dr.Yinggang Zhu,Dr Ting Zhao|1374321007|robinzyg-zhu@vip.sina.com;vivianzaza@163.com|+86
22311926|NCT01341301|Thomas Jefferson University|Dr. Neal Flomenberg|215-955-8874|neal.flomenberg@jefferson.edu|
22311927|NCT04069247|Chinese University of Hong Kong|Dr. Yun Kwok Wing|+852 39197593|ykwing@cuhk.edu.hk|
22311928|NCT04118894|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
22311929|NCT00604890|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
22311930|NCT04493424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311931|NCT06149416|Stryker Sustainability Solutions|Senior Principal Regulatory Affairs|5602-410-0204|moira.barton@stryker.com|
22270139|NCT04696055|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22270140|NCT03969901|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22311932|NCT03769090|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22311933|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22311934|NCT03690219|Rehabilitation Research Laboratory, University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Ron Clijsen|0041 81 300 01 78|ron.clijsen@supsi.ch|
22311935|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
22311936|NCT02771366|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
22311937|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22311938|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311939|NCT01928732|Palo Alto CSPCC|Lisa Zehm|(650) 493-5000|Lisa.Zehm@va.gov|28805
22311940|NCT01185340|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22311941|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22311942|NCT00246129|imperial College Kidney & Transplant Centre|Dr Adam McLean|+44 (0) 208 383 5164|adam.mclean@imperial.nhs.uk|356164
22311943|NCT01779050|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
22311944|NCT03403036|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
22311945|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311946|NCT02125292|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22311947|NCT02392507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22311948|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311949|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22311950|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org|
22311951|NCT04220983|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
22311952|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
22311953|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org|
22311954|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300||
22311955|NCT03316170|University of Kentucky|Dr. Jessica Burris|+1 859-257-9612|jessica.burris@uky.edu|
22311956|NCT02935673|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22311957|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22311958|NCT02095678|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Vikas Gulani|+1 216-844-3312|Vikas.Gulani@UHhospitals.org|
22311959|NCT03418545|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22311960|NCT02706483|Bausch Health|Matt Markovich|908-541-1341|Matthew.Markovich@bauschhealth.com|
22311961|NCT04660799|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22311962|NCT02764970|Medical University of Graz|Assoc. Prof. Dr. Dirk von Lewinski|31638580684|dirk.von-lewinski@medunigraz.at|316
22311963|NCT03131713|Tufts Medical Center|Bichchau Nguyen, Principal Investigato|617-636-1286|bnguyen2@tuftsmedicalcenter.org|
22311964|NCT02144597|Imperial College London|Prof Gary Frost|07872850308|g.frost@imperial.ac.uk|
22311965|NCT02356198|Mayo Clinic|Dr. Dorin T. Colibaseanu, MD|904-953-2596|colibaseanu.dorin@mayo.edu|
22311966|NCT02397707|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22311967|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu|
22311968|NCT04748341|Lahore school of nursing, University of lahore, Pakistan|Ms. Mishal Liaqat (Principal Investigator)|+923441481666|mishee861@gmail.com|
22311969|NCT05250206|Indizen Optical Technologies (Madrid), Universidad Complutense de Madrid|Director of Clinical Trials|+34 (91) 833 37 86|evachamorro@iot.es|
22311970|NCT02334215|Friends Research Institute|Robert P. Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
22311971|NCT03016871|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22311972|NCT05865392|University of Colorado|Dr. Danielle M. Ostendorf|3037249203|danielle.ostendorf@cuanschutz.edu|
22311973|NCT02159989|MD Anderson Cancer Center|Aung Naing|713-563-3885|anaing@mdanderson.org|
22311974|NCT04889989|Ethicon, Inc.|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22311975|NCT02485925|Biosense Webster, Inc.|Kendra McInnis|949-450-7783|kmcinnis@its.jnj.com|
22311976|NCT05995977|Karaman Provincial Health Directorate|Handan Altunkan|05367443152|handanaltunkan@gmail.com|
22311977|NCT04181788|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311978|NCT04937504|Boston Medical Center, Psychiatry Department|Sarah Valentine, PhD|(617) 414-1989|sarah.valentine@bmc.org|
22311979|NCT04535414|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|andrew.blakely@nih.gov|
22311980|NCT03662659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22298853|NCT00832429|M D Anderson Cancer Center|Sara Hull|713-563-4598|sehull@mdanderson.org|
22298854|NCT04942938|Centura Health|Dr. Courtney Ellerbusch|3039058272|courtneyellerbusch@centura.org|
22298855|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org|
22298856|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com|
22298857|NCT03383588|Montefiore Medical Center|Dr Catherine Igel|718-405-8200|cigel@montefiore.org|
22298858|NCT04524962|Cartesian Therapeutics, Inc.|Hafsa Kamboh|4127585340|hafsa@cartesiantx.com|
22298859|NCT02550652|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22298860|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298861|NCT02486406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22311981|NCT06922643|Nanogen Biopharmaceutical JSC|Dr. Thuy Phuong Nguyen|+84 903 754 559|phuongthuy@nanogenpharma.com|
22311982|NCT04104022|University of Vermont|Dr. Kelly R. Peck, Ph.D.|8026569610|Kelly.Peck@uvm.edu|
22311983|NCT04369664|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
22311984|NCT03840200|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22311985|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com|
22311986|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu|
22311987|NCT03851094|ResMed|Clinical Research Team|800-424-0737|clinicaltrials@resmed.com.au|
22311988|NCT00484198|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22311989|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311990|NCT04658784|Ascension Saint Thomas Medical Group|Dr. Amanda Merriman|615-397-6919|amanda.yacko@gmail.com|
22311991|NCT02958553|Ottobock Healthcare|Russ Lundstrom|512-806-2606|russ.lundstrom@ottobock.com|
22311992|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
22311993|NCT04311983|Washington University School of Medicine|Matthew Kreuter, Ph.D.|314-935-3701|mkreuter@wustl.edu|
22311994|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22311995|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22311996|NCT04070105|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
22298862|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk|
22298863|NCT01196871|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22298864|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu|
22298865|NCT00333606|Ernst Moritz Arndt University of Greifswald|Taras Usichenko, director of the trial|+493834865828|taras@uni-greifswald.de|
22298866|NCT01037790|University of Pennsylvania|Jennifer Louie, Program Manager|267-414-6179|Jennifer.Louie2@pennmedicine.upenn.edu|
22298867|NCT01485601|Medytox Inc.|Young Ryu|+82-2-6901-5890|young.ryu@medytox.com|
22298868|NCT03509948|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22298869|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298870|NCT04587193|Virginia Commonwealth University|Brian Berman|800-762-6161|brian.berman@vcuhealth.org|
22298871|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298872|NCT02501096|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22298873|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22298874|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org|
22298875|NCT02927691|Teachers College, Columbia University|Michelle Troche|212-678-3953|mst2139@tc.columbia.edu|
22298876|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com|
22298877|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org|
22298878|NCT03042312|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22298879|NCT02283528|Emory University|Dr. Gary Francis Bouloux|404-778-4500|gfboulo@emory.edu|
22298880|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22298881|NCT03422003|Dana-Farber Cancer Institute|Dr. Rinaa Punglia|617-632-3591|rpunglia@mgb.org|
22298882|NCT04175262|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298883|NCT03103282|3-D Matrix Europe SAS|Florian REBECA|+33617587769|frebeca@puramatrix.com|
22298884|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu|
22298885|NCT02312310|Columbia University Medical Center|Scott A. Small, MD|212-305-1269|sas68@columbia.edu|
22298886|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22311997|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22311998|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22311999|NCT05228834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312000|NCT05012462|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
22312001|NCT04884191|CTI BioPharma, Inc.|John Volpone SVP, Strategic Operations|+1 (206) 272-4652|jvolpone@ctibiopharma.com|
22312002|NCT06631313|Becton, Dickinson and Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
22312003|NCT00089791|Amgen Inc.|Study Director|866-572-6436||
22312004|NCT02161458|University of Pennsylvania|Yvette Sheline, Principal Investigator|215-746-2637|cndslab@pennmedicine.upenn.edu|
22312005|NCT02941692|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
22312006|NCT02527694|Seoul National University Hospital|So Yeon Kong|82220724412|soyeon.kong@gmail.com|
22312007|NCT02070276|Hôpitaux Universitaires de Genève|Dr. med. Samuele Ceruti|0765661181|samuele.ceruti@me.com|
22312008|NCT02362789|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22312009|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu|
22312010|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22312011|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org|
22312012|NCT05353296|Columbia University|Carmela Alcantara, PhD|212-851-2187|ca2543@cumc.columbia.edu|
22312013|NCT05074433|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22312014|NCT04397263|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22312015|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu|
22312016|NCT02066636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22312017|NCT04806100|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22270141|NCT00348595|Johns Hopkins University School of Medicine|Mario Eisenberger|(410) 614-3511|eisenma@jhmi.edu|
22298887|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
22298888|NCT02061345|Imperial College, London|Prof Pat Price|02075895111|p.price@imperial.ac.uk|
22298889|NCT04023695|Vanderbilt University|Brian Drolet, MD|(615) 322-2350|brian.c.drolet@vumc.org|
22298890|NCT02178475|Amgen Inc.|Study Director|866-572-6436||
22298891|NCT04327934|John B. Pierce Laboratory/Yale School of Medicine|Nina Stachenfeld|203 562 9901|nina.stachenfeld@yale.edu|219
22298892|NCT02443298|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22298893|NCT03095417|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
22298894|NCT02571452|San Francisco VA Healthcare System|Dr. Shira Maguen|415-221-4810|Shira.Maguen@va.gov|22511
22298895|NCT03161314|Physical Therapy Faculty, Mahidol University|Asst.Prof.Dr. Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|20804
22298896|NCT04847050|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
22298897|NCT03698773|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|hsc-anesthesiology@salud.unm.edu|
22298898|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22298899|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu|
22298900|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22298901|NCT04165291|Yale University Child Study Center|Carla Stover|12037853486|carla.stover@yale.edu|
22298902|NCT03732248|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
22298903|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22298904|NCT01731171|Sheppard Pratt Health System|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22298905|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711|morris.bell@yale.edu|2281
22298906|NCT01700946|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
22298907|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22298908|NCT05580575|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
22298909|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298910|NCT00835406|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22312018|NCT00391170|National Heart Lung and Blood Institute|Clara, Joseph|+1 301 402 2399|joseph.clara@nih.gov|
22270142|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22270143|NCT05406479|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
22270144|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22270145|NCT03192306|Benu BioPharma, Inc.|Dr. Eric Morrel, VP Clinical Research|5082085634|emorrel@benubio.com|
22270146|NCT04932655|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD|512-501-2444|eschoen@cassavasciences.com|
22270147|NCT02589626|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270148|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
22270149|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
22270150|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252||5252
22270151|NCT06175026|Stanford University|Dr. Anna H. Grummon, PhD|(650) 644-7366|agrummon@stanford.edu|
22270152|NCT04347564|Augenheilkunde Lindenthal|Daniela Claessens|017229227962|daniela.claessens@gmx.de|
22270153|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu|
22270154|NCT01127451|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22270155|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270156|NCT02111577|SOTIO a.s.|Prof. Radek Spisek, M.D., Ph.D.|+420 2241 75101|spisek@sotio.com|
22270157|NCT03055897|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
22270158|NCT02429778|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.Gould@va.gov|68899
22270159|NCT04501640|Astellas Pharma China, Inc.|Clinical Trial Disclosure|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
22270160|NCT02274870|Northwell Health|Director of Research, Anesthesiology|718-470-7630|odowling@northwell.edu|
22270161|NCT04590586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22270162|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270163|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270164|NCT00910208|Albert Einstein College of Medicine|Polly Bijur, PhD|718-430-4217|polly.bijur@einstein.yu.edu|
22270165|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu|
22270166|NCT03990571|The University of Texas M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
22280809|NCT07214935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22312019|NCT03567616|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22312020|NCT01235936|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
22312021|NCT00380250|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22312022|NCT01989104|Pennington Biomedical Research Center|Dr. William Johnson|225-763-2932|William.Johnson@pbrc.edu|
22312023|NCT02833948|The Heart Center - Rigshospitalet, Copenhagen, Denmark|Ole De Backer, MD, PhD|+45-35457086|ole.debacker@gmail.com|
22312024|NCT03897699|University of Minnesota|Dr. Kathryn Cullen|612-273-9732|rega0026@umn.edu|
22312025|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu|
22312026|NCT02691702|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312027|NCT05613088|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22312028|NCT03796767|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22280810|NCT02744612|City of Hope Medical Center|Dr. Alex Herrera, MD|6263598111|aherrera@coh.org|
22280811|NCT00283803|University of Washington|Dr. Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
22280812|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu|
22280813|NCT03419897|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22280814|NCT05112679|University of Pittsburgh|Sashwati Roy, PI|412 6240422|sar453@pitt.edu|
22280815|NCT05730725|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22280816|NCT03574610|Houston Methodist Hospital|Rose Khavari, MD|7134419118|rkhavari@houstonmethodist.org|
22280817|NCT01945216|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22280818|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22280819|NCT02982772|Florida International University|Maria Jose Miguez|561-839-0223|mjmiguez@fiu.edu|
22280820|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com|
22280821|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es|
22280822|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu|
22280823|NCT03107052|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22280824|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov|
22280825|NCT03015363|CardioVascular Research New Brunswick (CVR-NB)|Sohrab Lutchmedial, MD, FRCP(C)|506-648-6101|sohrab.lutchmedial@horizonnb.ca|
22280826|NCT02263326|Northwestern University|Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
22280827|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22280828|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22280829|NCT03292874|Cedars Sinai Medical Center|Dr. Hyung L Kim|310-423-4700|kimhl@cshs.org|
22280830|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00||
22280831|NCT00960401|Winthrop-University Hospital, Division of Hematology and Oncology|Dr. Alexander Hindenburg|516-663-9500|AHindenburg@winthrop.org|
22280832|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22280833|NCT03592771|Emory University|Ilana Graetz, PhD|404-727-1483|ilana.graetz@emory.edu|
22280834|NCT01642901|MetroHealth Rehabilitation Institute|Christina V Oleson, MD|216-778-4414|coleson@metrohealth.org|
22280835|NCT00348946|Thomas Jefferson University|Judith L. Ross, M.D.|215-955-1648|judith.ross@jefferson.edu|
22280836|NCT05069597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22280837|NCT03650413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22280838|NCT03093207|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
22280839|NCT03332173|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280840|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280841|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22280842|NCT04908683|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22280843|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22280844|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22280845|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22280846|NCT03754556|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22280847|NCT02509936|"Wuqu' Kawoq | Maya Health Alliance"|Dr Peter Rohloff|6174473034|peter@wuqukawoq.org|
22280848|NCT01794312|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
22280849|NCT05384834|Emory University|Dr. Holly Gooding|404-778-1429|holly.gooding@emory.edu|
22280850|NCT01871545|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
22280851|NCT01071954|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials||MedInfoInternational@amgen.com|
22280852|NCT01926444|PCC INC.|Patrick Colin|514-586 9297|PCOLIN@VIDEOTRON.CA|
22312029|NCT04603586|Changhai Hospital|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
22312030|NCT02506283|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr. Erich Hohenauer|+41813000175|erich.hohenauer@supsi.ch|
22312031|NCT05484661|UT Health San Antonio|Monica Serra|210-949-9759|serram@Uthscsa.edu|
22312032|NCT03652610|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312033|NCT05615363|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22312034|NCT03905642|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
22280853|NCT01653587|Santa Casa de Marília|Dr. Pedro Beraldo de Andrade|+551434025561|pedroberaldo@gmail.com|
22280854|NCT03786224|Massachusetts General Hospital|Randi Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
22312035|NCT04278833|Stanford University|Clinical Research Coordinator|(650) 723-0003|jessn16@stanford.edu|
22312036|NCT04447027|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22312037|NCT05200416|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
22312038|NCT06943638|"General Oncology Hospital of Kifissia Agioi Anargyroi"|Christine Mavrogiannopoulou, Physiotherapist and Study coordinator|+30 6941464095|x.mavrogiannopoulou@gmail.com|
22312039|NCT05992350|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
22312040|NCT02421679|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
22312041|NCT01458015|Universitätsklinikum Schleswig-Holstein, Campus Kiel; Sektion neurologische Schmerzforschung und -therapie|Prof. Ralf Baron|+4943123911|r.baron@neurologie.uni-kiel.de|
22312042|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org|
22312043|NCT02354417|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
22312044|NCT01848483|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
22312045|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000|aesi105@yahoo.co.th|4489
22312046|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312047|NCT03041090|Saint Louis University|Medhat Osman, MD, PhD - Professor of Radiology, Director of Nuclear Medicine and PET/CT|314-577-8047|medhat.osman@health.slu.edu|
22312048|NCT02202317|University of Miami Miller School of Medicine|Dr Jason Salsamendi|305-585-7500|jsalsamendi@miami.edu|
22312049|NCT02338999|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Kaplan, Mariana|+1 301 496 0517|mariana.kaplan@nih.gov|
22312050|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net|
22312051|NCT01332266|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22312052|NCT03302091|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312053|NCT01686152|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22312054|NCT01802333|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|206-667-4623|amoseley@fredhutch.org|
22312055|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22312056|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
22312057|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22312058|NCT02224755|Abbott|Joyce Chuang/Principal scientist|925-353-5817|joyce.chuang@abbott.com|
22312059|NCT02067663|Stanford University School of Medicine|Lisa Goldthwaite|541-515-1825|lgoldthw@stanford.edu|
22312060|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;||
22312061|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22312062|NCT03054506|Massachusetts General Hospital|Dr. Kyle Staller|617-726-3080|kstaller@mgh.harvard.edu|
22312063|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312064|NCT00923078|VA Connecticut Healthcare System|Dr Jason K. Johannesen|2039325711|jason.johannesen@va.gov|2224
22312065|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312066|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22312067|NCT04264156|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|2154889300|psimmons@windtreetx.com|
22312068|NCT04766996|Emory University|Kelly Wiltse Nicely, MD|404-727-6946|kelly.wiltse.nicely@emory.edu|
22312069|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org|
22312070|NCT01102426|Pharma Mar, S.A.|Pharma Mar, S.A.|0034918466000|clinicaltrials@pharmamar.com|
22312071|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312072|NCT02637999|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
22312073|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com|
22312074|NCT03265132|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
22312075|NCT03259568|Dept of Neurology, Duke University School of Medicine|Simon W Davis|9195991927|simon.davis@duke.edu|
22312076|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu|
22312077|NCT04347941|National University of Ireland, Galway|Dr Bairbre McNicholas|+35391893063|bmcnicholas@nuigalway.ie|
22312078|NCT03128099|Vanderbilt University|Dr. Sohee Park, Project Director|6153223435|sohee.park@vanderbilt.edu|
22312079|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
22312080|NCT00721734|Amgen, Inc.|Study Director|866-572-6436||
22312081|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com|
22312082|NCT04492475|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22270167|NCT03605862|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
22312083|NCT02494336|Johns Hopkins All Children's Hospital|Nicole Chandler, MD|7277674170|nicole.chandler@jhmi.edu|
22312084|NCT02696200|Cincinnati Childrens Hospital|Kim Foss|513-636-5971|kim.foss@cchmc.org|
22312085|NCT03035942|Pontificia Catholic University of Sao Paulo|Dr. Eduardo Toshiyuki Moro|+5515997728015|edumoro85@gmail.com|
22312086|NCT05270460|Processa Pharmaceuticals Inc.|Dr. Sian Bigora|410-693-6844|sbigora@processapharmaceuticals.com|
22312087|NCT03205488|Northwestern University|Dr. Tanya Simuni|312-503-2970|Tatyana.Simuni@nm.org|
22312088|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22312089|NCT05163353|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22270168|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22312090|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22312091|NCT06086028|Tulane University|Leia Y. Saltzman Associate Professor|504-247-1452|lsaltzman@tulane.edu|
22312092|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312093|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312094|NCT05640167|University of Rhode Island|Dr Christine Clarkin, Principal Investigator|4018742998|chrisclarkin@uri.edu|
22312095|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu|
22312096|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22312097|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn|
22280855|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22280856|NCT02626156|Medical University of South Carolina|Teresa J. Kelechi|843-792-4602|kelechtj@musc.edu|
22280857|NCT02243371|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22280858|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com|
22280859|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu|
22280860|NCT04599803|Verily Life Sciences LLC|Gabriel Kowalsky|9709011616|gabekowalsky@verily.com|
22280861|NCT02544750|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22280862|NCT03751371|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
22280863|NCT03307785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22280864|NCT05111613|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@stryker.com|
22280865|NCT04209387|VA Bedford Healthcare System|Mo Modarres, PhD|2164966169|mmodarres@verizon.net|
22280866|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org|
22280867|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22280868|NCT04704713|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
22280869|NCT03079531|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
22280870|NCT01941927|University of California, San Francisco|Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
22280871|NCT00648648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280872|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu|
22280873|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22280874|NCT03896750|Alliance for Multispecialty Research|William Smith, MD|(865) 305-9100|william.smith@amrllc.com|
22280875|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111|Cbehrendt@coh.org|61148
22280876|NCT02220855|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
22280877|NCT04105738|University of Massachusetts|Arlene Williams|508-856-5584|arlene.williams@umassmed.edu|
22280878|NCT03501992|Mayo Clinic|Robert M Jacobson, MD|507-250-4576|jacobson.robert@mayo.edu|
22280879|NCT02974140|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22280880|NCT01905943|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22280881|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22280882|NCT05516797|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
22280883|NCT05959447|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22280884|NCT02522429|UCLA|Principal Investigator|3108258546|monti@ucla.edu|
22280885|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu|
22280886|NCT02200757|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22280887|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu|
22280888|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu|
22280889|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov|
22280890|NCT03053440|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280891|NCT01675297|Hanlim Pharma|Clinical Trial Unit|82-2-3489-6297|yrsong@hanlim.com|
22280892|NCT01432145|University of Oxford Clinical Trials & Research Governance|Ms Heather House|01865 572245|heather.house@admin.ox.ac.uk|
22280893|NCT02998684|Medical University of South Carolina|Dr. Jane Joseph|843-792-7683|josep@musc.edu|
22280894|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22280895|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
22280896|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22280897|NCT02140970|University of Colorado|Dr. Kyle Rove|720 777 5893|kyle.rove@childrenscolorado.org|
22280898|NCT02440204|Severance|Dr. Jae Chul Koh|82-010-8702-3931|jaykoh82@gmail.com|
22312098|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22324863|NCT02439775|Medtronic|Elishea Argent, Sr. Clinical Research Specialist|(763)505-9584|elishea.n.argent@medtronic.com|
22324864|NCT01588197|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
22324865|NCT03968965|Hospital for Special Surgery|Celeste Abjornson|2127742126|AbjornsonC@HSS.edu|
22324866|NCT01120639|Stanford University|Dr. Scott Soltys (Associate Professor of Radiation Oncology)|650-724-1569|sgsoltys@stanford.edu|
22324867|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk|
22280900|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280901|NCT03050450|Johns Hopkins All Children's Hospital (St. Petersburg, FL)|Dr Stacie Stapleton|17274701017|stacie.stapleton@jhmi.edu|
22280902|NCT00590122|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
22280903|NCT04077424|Vanderbilt University Medical Center|Spyros Kalams, MD|6153222035|Joan.e.eason@vumc.org|
22280904|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22280905|NCT02705105|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22280906|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com|
22280907|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280908|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu|
22324868|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
22280909|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org|
22280910|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
22280911|NCT02253433|Environmental Health, Baylor College of Medicine|Dr. Winifred J. Hamilton|713-798-1052|hamilton@bcm.edu|
22280912|NCT03809078|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22280913|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22324869|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org|
22324870|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu|
22324871|NCT02437669|Columbia University College of Physicians and Surgeons|Daniel S. Tsze, MD, MPH|212-305-9825|dst2141@columbia.edu|
22324872|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324873|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com|
22324874|NCT01938625|Janssen Research & Development|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
22324875|NCT02088034|Northwestern University|Matthew J. O'Brien, MD|312-503-5046|matthew.obrien1@northwestern.edu|
22324876|NCT05780281|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22324877|NCT00091793|Amgen Inc.|Study Director|866-572-6436||
22324878|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu|
22324879|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org|
22324880|NCT05309083|Washington University School of Medicine|Dr. Kerri Rawson|813-468-8900|rawson@wustl.edu|
22324881|NCT01238120|University of Rochester Medical Center|Michelle C. Janelsins, PhD, MPH|(585) 276-4656|Michelle_Janelsins@urmc.rochester.edu|
22324882|NCT02388776|Weill Cornell Medicine|Christine Lennon, M.D.|212-746-2621|chl9083@med.cornell.edu|
22324883|NCT02796144|University of North Carolina at Chapel Hill|Lars Fredrik Jarskog, MD|919-843-7683|lars_jarskog@med.unc.edu|
22324884|NCT01889810|Queen's University, Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
22324885|NCT06105138|Colorado State University|Dr. Hollis Karoly|970-491-3677|hollis.karoly@colostate.edu|
22324886|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22324887|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22324888|NCT00213239|The Hospital for Sick Children, Department of Anesthesia and Pain Medicine|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
22324889|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com|
22324890|NCT03519178|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324891|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
22324892|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu|
22324893|NCT03872427|The University of Texas MD Anderson Cancer Center|Dr. Funda Meric-Bernstam|(713) 794-1226|fmeric@mdanderson.org|
22324894|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324895|NCT02628223|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
22324896|NCT04070378|The Feinstein Institutes for Medical Research|Marc L Gordon, MD|(516) 562-3492|mlgordon@northwell.edu|
22324897|NCT04067661|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22324898|NCT03590457|Rush University|Dr. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
22324899|NCT03412630|ECOG-ACRIN Statistical Office|Study Statistician|4018639181|ecog-acrin@stat.brown.edu|
22324900|NCT05165394|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22324901|NCT03705494|The University of Hong Kong|Dr Kris LOK|39176690|krislok@hku.hk|
22324902|NCT02495077|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22324903|NCT02742649|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22324904|NCT03937986|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
22280914|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22280915|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr|
22324905|NCT02839746|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22324906|NCT02333331|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22324907|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu|
22324908|NCT03952546|Northwell Health System|Nancy Dengler, RN, MS Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
22324909|NCT00416351|Memorial Sloan Kettering Cancer Center|Dr. Steven Horowitz MD|646-608-2680|horwitzs@mskcc.org|
22280916|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111|b.brew@unsw.edu.au|4100
22280917|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343||
22280918|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org|
22312099|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu|
22312100|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22280919|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu|
22312101|NCT01836445|Northwestern University|Dr. Brian Mustanski|312-503-5421|brian@northwestern.edu|
22312102|NCT05289037|The Hope Clinic of Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22312103|NCT04186247|Amsterdam University Medical Center|Johan Van Limbergen, MD, PhD|+31-20 566 9111|j.e.vanlimbergen@amsterdamumc.nl|
22312104|NCT04852978|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|18447346643|clinicaltrials@regeneron.com|
22312105|NCT03565640|Atrium Wake Forest Baptist Health|Sachin Vyas|7865564412|svyas@wakehealth.edu|
22312106|NCT03854734|Penn State College of Medicine|Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
22312107|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu|
22280920|NCT01103440|Icahn School of Medicine at Mount Sinai|Dr. Annapoorna S Kini|(212) 241-4181|Annapoorna.Kini@mountsinai.org|
22280921|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775||
22312108|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22312109|NCT04173000|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22280922|NCT03232827|UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR|Dr. Theodore Wagener|405-271-4407|theodore-wagener@ouhsc.edu|50486
22312110|NCT01668355|VA|Alexander Young|310-794-7219|alexander.young@va.gov|
22312111|NCT02659059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22312112|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
22280923|NCT01823198|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation Department|713-792-3618|rchampli@mdanderson.org|
22312113|NCT04633200|Environment and Health Group|Patricia Flynn Weitzman|617-455-5976|pat.weitzman@gmail.com|
22280924|NCT02441101|University of Iowa|Barry London|319-356-2750|barry-london@uiowa.edu|
22312114|NCT04809623|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22280925|NCT02528942|Thomas Jefferson University|Yevgeniy Vinogradskiy PhD|2159553605|yevgeniy.vinogradskiy@Jefferson.edu|
22312115|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu|
22280926|NCT03035864|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22312116|NCT02822599|Nicklaus Children's Hospital|Jenny Esteves|786-624-2854|jenny.esteves@nicklaushealth.org|
22312117|NCT00638456|Univeristy of California, San Diego|Dr. Ranjan Dohil|(858) 966-4003|rdohil@ucsd.edu|
22280927|NCT02371785|Corindus Vascular Robotics|Vice President, Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
22312118|NCT03236779|Head of iPhysio Research Group. Editor-in-Chief Journal of Invasive Techniques in Physical Therapy|Dr. Pablo Herrero Gallego. PT, PhD.|(+34) 646168248|pherrero@usj.es|
22312119|NCT03070548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22312120|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324910|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
22324911|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22324912|NCT03163342|Altimmune|Stephanie Holland, Clinical Project Manager|240|Sholland@altimmune.com|40
22324913|NCT01538615|University of Minnesota School of Nursing|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
22324914|NCT04329923|UPenn|Amelia Anderson|215-509-5690|amelia.anderson@pennmedicine.upenn.edu|
22324915|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22324916|NCT03695276|UCSF|Rachel Willard-Grace|415-476-5248|Rachel.Willard@ucsf.edu|
22324917|NCT01702805|Emeritus Professor U Pennsylvania at CHOP and Emeritus Professor McMaster University, Dept Pediatrics|Haresh Kirpalani|267-844-3233|kirpalan@mcmaster.ca|
22270169|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22270170|NCT04105218|University of Colorado Anschutz Medical Campus|Clinical Research Support Center|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22324918|NCT03056287|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
22324919|NCT01844076|Fox Chase Cancer Center|Crystal Denlinger MD, FACP|215-214-1676|Crystal.Denlinger@fccc.edu|
22324920|NCT05483127|Alcon Research, LLC|Associate Director, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22270171|NCT03388645|National Institute of Allergy and Infectious Diseases|Lesia Dropulic|+1 301 496 7675|dropulicl@niaid.nih.gov|
22324921|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501|david.hogg@uhn.ca|4521
22324922|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22270172|NCT00482677|Canadian Cancer Trials Group|Keyue Ding|613-5336430|kding@ctg.queensu.ca|
22270173|NCT02553499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270174|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633|faltprem@centrum.cz|205
22324923|NCT03002506|Texas Tech UHSC|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
22324924|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270175|NCT00570063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324925|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
22324926|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470|Corina.SchoenMD@baystatehealth.org|413
22324927|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22324928|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com|
22324929|NCT03043365|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
22324930|NCT02723630|Eisai Inc.|Eisai Medical Services|1-888-247-2378|esi-medinfo@eisai.com|
22270176|NCT02819973|Duke Clinical Research Institute|Kevin Thomas, MD|919-668-8700|kevin.thomas@duke.edu|
22324931|NCT02255838|University of Louisville|Rainer Lenhardt|5028523122|rainer.lenhardt@louisville.edu|
22324932|NCT04207710|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
22324933|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu|
22270177|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463||
22324934|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu|
22270178|NCT04201574|Allysta Pharmaceuticals, Inc.|Clinical Trial Admin|(510) 560-6592|clinicaltrial.admin@allysta.com|
22324935|NCT03291197|Physical Medicine and Rehabilitation Ottawa Resident|Dr. Marc Monsour|6137377350|mmonsour051@gmail.com|
22270179|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22270180|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com|
22324936|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324937|NCT04246047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270181|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
22324938|NCT03643692|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
22270182|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu|
22324939|NCT02495779|University of Pittsburgh, Graduate School of Public Health|James Egan|4126242255|jee48@pitt.edu|
22270183|NCT00150488|Queen Unviersity|J. Curtis Nickel|613 548 2497|jcn@queensu.ca|
22324940|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
22324941|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22324942|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839||
22324943|NCT06081283|University of North Carollina at Chapel Hill|Meitra Kazemi|919-914-9579|meitra_kazemi@med.unc.edu|
22324944|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22324945|NCT03476850|Medical University of South Carolina|Eric Bolin, MD|8437921869|bolin@musc.edu|
22270184|NCT02428309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22324946|NCT02912364|Stanford University|Kimford Meador|650-725-6648|kmeador@stanford.edu|
22324947|NCT04170621|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
22324948|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com|
22270185|NCT05129293|Trinity Health Of New England|Mandell Center Research Team|860-714-3005|MSResearch@TrinityHealthOfNE.org|
22270186|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu|
22324949|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673|CCCP@coh.org|60094
22270187|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu|
22270188|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22270189|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu|
22324950|NCT04125745|University of California San Francisco|Marc Simon, MD, Director of Pulmonary Vascular Disease and Pulmonary Hypertension Comprehensive Care|415-476-1325|Marc.Simon@ucsf.edu|
22270190|NCT01953874|ResMed|Adam Benjafield|(858)836-6782|adam.benjafield@resmed.com|
22324951|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270191|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu|
22270192|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22324952|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343||
22324953|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu|
22270193|NCT01168908|Kennedy Krieger Institute|Kathryn Wagner, MD, PhD|443-923-9525|wagnerk@kennedykrieger.org|
22270194|NCT03653351|Washington University in Saint Louis|Eric Lenze MD|314-362-5154|lenzee@wustl.edu|
22270195|NCT04420585|Montefiore Medical Center|Dr. Kerry Morrone|718-741-2342|kmorrone@montefiore.org|
22324954|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com|
22270196|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com|
22270197|NCT03693612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270198|NCT04364802|University of Kentucky|Alexandra Kejner|859-323-6741|aeke234@uky.edu|
22270199|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300||
22270200|NCT03788434|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
22270201|NCT01953601|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270202|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654|bwalpole@uoguelph.ca|328363
22270203|NCT02991729|UNC School of Medicine Maternal Fetal Medicine|Laura Carlson, MD|8643503140|lauramosbycarlson@gmail.com|
22270204|NCT05537441|Yale University|Daniella Meeker|(213)926-2658|daniella.meeker@yale.edu|
22270205|NCT01905553|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22270206|NCT04310397|The University of Texas MD Anderson Cancer Center|Rodabe Amaria, MD|(713) 792-2921|rnamaria@mdanderson.org|
22270207|NCT05225298|Stanford University|Shuchi Anand, MD, MS|650-725-2207|sanand2@stanford.edu|
22270208|NCT03962790|Johnson & Johnson Vision Care|Brian Pall, Director Clinical Science, Vision Care|1-800-843-2020|bpall@its.jnj.com|
22270209|NCT02877095|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-309-5544|rachel.e.olson@duke.edu|
22270210|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
22270211|NCT05167370|Cincinnati Children's Hospital Medical Center|Dr. Sonata Jodele|(513) 636-5917|Sonata.Jodele@cchmc.org|
22270212|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22270213|NCT01608087|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270214|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com|
22270215|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu|
22270216|NCT00908791|Norris Cotton Cancer Center|Burton Eisenberg, MD, Deputy Director, Norris Cotton Cancer Center|603-653-3613|Burton.L.Eisenberg@Dartmouth.edu|
22270217|NCT00664859|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
22270218|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372|alexrp@butantan.gov.br|9372
22270219|NCT01943851|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270220|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu|
22270221|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM|
22270222|NCT00401544|Amgen Inc.|Study Director|866-572-6436||
22270223|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com|
22270224|NCT03645395|Molecular Templates, Inc.|Study Director|862-204-7184|trials@mtem.com|
22270225|NCT02317276|UCSF Dermatology|Sarah Arron, MD, PhD|415-353-9684|Sarah.Arron@ucsf.edu|
22270226|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568|kutzschn@u.washington.edu|6-3568
22270227|NCT02780713|AstraZeneca AB|AZD9496 Global clinical leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22270228|NCT03461952|Canadian Cancer Trials Group|Janet Dancey|613-533-6430|jdancey@ctg.queensu.ca|
22270229|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270230|NCT02821338|US Food and Drug Administration|Office of Generic Drugs, Center for Drug Evaluation and Research|240-402-7920|genericdrugs@fda.hhs.gov|
22270231|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org|
22270232|NCT01250873|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270233|NCT00887783|Dept. Oncology, Odense University Hospital|Dr. Olfred Hansen, Professor, Ph.D.|+4524241588|olfred.hansen@rsyd.dk|
22270234|NCT01975571|University of Iowa|Dr. Camille Dunn|3193538776|camille-dunn@uiowa.edu|
22270235|NCT03341143|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22270236|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270237|NCT03933618|Albany Medical Center|Dr. Charles Welliver|518-262-3341|wellivr@amc.edu|
22270238|NCT01137110|Washington University|Dr Theresa Human|314-747-8799|theresa.human@bjc.org|
22270239|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu|
22270240|NCT02828124|Bristol Myers-Squibb|Phase 1/2 Study of BMS-986183 in Subjects with Advanced Hepatocellular Carcinoma|Please email|Clinical.Trials@bms.com|
22270241|NCT06586788|Indiana School of Medicine|Dr. Rebecca McNally Keehn|(317) 274-2121|mcnallyr@iu.edu|
22270242|NCT03613909|Cochlear Ltd|Marian Jones, Principal Investigator|+61498008181|mjones@cochlear.com|
22270243|NCT03514485|Children's Hospital of Philadelphia|Tyra Bryant-Stephens, MD|215-590-5261|stephenst@chop.edu|
22270244|NCT03075891|Galderma|Rajeev Chavda|0033492382928|rajeev.chavda@galderma.com|
22270245|NCT05229952|University of Alabama at Birmingham|Dr Sonia Fargue|2059756932|sfargue@uab.edu|
22270246|NCT00634803|Yale University|Richard S. Schottenfeld, M.D.|203-974-7349|richard.schottenfeld@yale.edu|
22270247|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com|
22270248|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu|
22270249|NCT02461524|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
22270250|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu|
22270251|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22270252|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270253|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org|
22270254|NCT00843037|University Health Network|Dr. Jennifer Knox, PI|(416) 946-2000|jennifer.knox@uhn.ca|5131
22270255|NCT02564900|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22270256|NCT03991299|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
22270257|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu|
22270258|NCT02278939|University of California San Francisco, School of Nursing|Dr. Melinda Sarmiento Bender and Dr. Yoshimi Fukuoka|(415) 514-3151|melinda.bender@ucsf.edu; yoshimi.fukuoka@ucsf.edu|
22270259|NCT02669836|Washington University|David D. Limbrick MD|314-454-3212|T.Meehan@wustl.edu|
22270260|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
22270261|NCT02423343|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22270262|NCT04826965|Duke University|Suhail Mithani, MD|919-681-8390|suhail.mithani@duke.edu|
22324955|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu|
22324956|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org|
22324957|NCT01877655|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22324958|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com|
22324959|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com|
22324960|NCT03567187|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
22280928|NCT02340169|Taro Pharmaceuticals|Senior Director, Clinical Research|+1 914-345-9001|natalie.yantovskiy@taro.com|
22324961|NCT03497689|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22324962|NCT02928289|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
22324963|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
22324964|NCT05176847|University of South Carolina|Brie Turner-McGrievy|8037773932|brie@sc.edu|
22324965|NCT02562235|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22280929|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
22324966|NCT05369208|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
22324967|NCT05441670|Medical University of South Carolina|Cynthia Dodds, PT, PhD|8437925731|doddscb@musc.edu|
22324968|NCT03943667|Institut Paoli Calmettes|Dr Christelle DE LA FOUCHARDIERE|+33(0)491223333|DELAFOUCHARDIEREC@ipc.unicancer.fr|
22324969|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
22324970|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
22280930|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22280931|NCT03063606|Yale University|Dr. Carlos Grilo|203-785-7210|carlos.grilo@yale.edu|
22280932|NCT06590441|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
22280933|NCT02683980|Boston Scientific|Clinical Program Manager|612-322-1189|teri.bird@bsci.com|
22280934|NCT03744910|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
22280935|NCT01321216|American University of Beirut|Dr Ghassan Dbaibo|961-1-350000|gdbaibo@aub.edu.lb|4819
22280936|NCT03430843|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22280937|NCT03866538|Mayo Clinic|Joseph A. Murray, M.D.|507-284-2631|Murray.Joseph@mayo.edu|
22280938|NCT03608371|Neumora Therapeutics|Study Contact|8577600900|clinicaltrials@neumoratx.com|
22280939|NCT03452033|D. Western Therapeutics Institute|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
22280940|NCT05360966|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22280941|NCT05396014|UNC Chapel Hill|Matthew Mauck, MD, PhD|(919) 966-5136|Matt_Mauck@med.unc.edu|
22280942|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu|
22280943|NCT05258890|Brigham and Women's Hospital|Amar Dhand, MD, PhD|617-732-7432|adhand@bwh.harvard.edu|
22280944|NCT02351063|Alere, Inc.|William Arnold, PhD|8588053177|william.arnold@alere.com|
22280945|NCT03372434|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|EThoma39@its.jnj.com|
22280946|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22280947|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22280948|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22280949|NCT01947283|Disparities Research Unit, Department of Medicine, Massachusetts General Hospital|Margarita Alegria|617-724-4987|malegria@mgh.harvard.edu|
22280950|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22280951|NCT04729972|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22280952|NCT05002985|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
22280953|NCT03782259|University of Washington|Francis Kim, MD|206-744-8305|fkim@uw.edu|
22280954|NCT00603941|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22298911|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
22280955|NCT02707965|University of Maryland, School of Pharmacy|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22280956|NCT00249808|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22324971|NCT05248945|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22324972|NCT05525975|University of Iowa Health Care|Brendan Patterson|319 678-8451|brendan-patterson@uiowa.edu|
22324973|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu|
22324974|NCT05090423|National Yang Ming Chiao Tung University|Chen Hsin-I, Physical Therapist|+886-982-641-541|hsini0329@gmail.com|
22324975|NCT05733286|Duke University|Michael Devinney, MD, PhD|919-668-6266|michael.devinney@duke.edu|
22324976|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu|
22324977|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
22324978|NCT02836886|Columbia University|Larisa Geskin, MD|2123055550|ljg2145@cumc.columbia.edu|
22324979|NCT05134974|Ocuphire|Drey Coleman, VP of Clinical Operations|813-404-1993|dcoleman@ocuphire.com|
22324980|NCT05098015|RAND|Glenn Wagner|310-393-0411|gwagner@rand.org|
22324981|NCT03618641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22312121|NCT00578344|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
22312122|NCT02169414|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22312123|NCT00321971|Duquesne University School of Nursing|Linda Garand PhD|412-396-6543|garandl@duq.edu|
22312124|NCT03374254|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22312125|NCT00667953|Penn|Tara C Mitchell|215-662-4000|Tara.Mitchell@pennmedicine.upenn.edu|
22312126|NCT02309515|Mayo Clinic|Tait D. Shanafelt, MD|507.284.2511|shanafelt.tait@mayo.edu|
22312127|NCT02395692|ABTC|Sr. Research Program Manager|410-955-8837|ABTC@jhmi.edu|
22312128|NCT02547974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312129|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com|
22312130|NCT02784834|UC San Diego|Dr. Michael Choi|(858) 534-1765|mychoi@ucsd.edu|
22312131|NCT02245620|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22312132|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org|
22312133|NCT00949234|UCLA CARE Center|Dr. Raphael Landovitz|310-557-1891|rlandovitz@mednet.ucla.edu|
22312134|NCT00508183|Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|74700
22312135|NCT03785756|Reckitt Benckiser (Health) Limited|Clinical Project Manager|+44 1482 326151|clinicaldatacontroller@reckitt.com|
22312136|NCT03879538|Cleveland Clinic|Alparslan Turan|2162172312|turana@ccf.org|
22312137|NCT02988713|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
22312138|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com|
22312139|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22312140|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu|
22312141|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
22312142|NCT01029704|Theracos, Inc.|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22312143|NCT03845517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312144|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org|
22312145|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312146|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu|
22312147|NCT03136861|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22312148|NCT03390166|Mahidol|Punnee Pitisuttithum|6626435599|punnee.pit@mahidol.ac.th|
22312149|NCT03125148|Medical College of Wisconsin|Kulwinder Dua, MD|4149556896|kdua@mcw.edu|
22312150|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22312151|NCT01934452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312152|NCT01328756|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22312153|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200|hbueno@cnic.es|4110
22312154|NCT00849485|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-3848-5525|clinicaltrialqueries@tevausa.com|
22312155|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu|
22312156|NCT02359916|Rush University Medical Center|Brad Appelhans, PhD (PI)|312-942-3477|brad_appelhans@rush.edu|
22312157|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk|
22312158|NCT03200574|Corcym S.r.l.|Elisa Cerutti|+393459182413|elisa.cerutti@corcym.com|
22312159|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22312160|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22312161|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov|
22312162|NCT03026166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22312163|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com|
22312164|NCT03292692|University of Miami|Dr. Brian Doss|305-284-1101|bdoss@miami.edu|
22312165|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu|
22312166|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312167|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu|
22312168|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu|
22312169|NCT07016568|LLC UkrMedGroup|Yevheniia Poliakova|+380502818399|jenyapolyakova@gmail.com|
22312170|NCT00210236|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Palissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22312171|NCT04025125|Duke University|Gerald Bloomfield|919-668-8702|gerald.bloomfield@duke.edu|
22312172|NCT03786471|University of California Los Angeles|Jenny Summapund|3233660667|jsummapund@mednet.ucla.edu|
22312173|NCT03346200|KARMA project, Karolinska Institute|PI Professor MD Per Hall|+46 8 524 85000|Per.hall@ki.se|
22312174|NCT04995601|Recovery Force Health, University of Massachusetts Amherst|Jeff Schwegman (PI), Dr. Karen Giuliano (PI, clinical trial subaward)|317-605-4696; 224-725-0270|kschwegman@recoveryforceusa.com; kkgiuliano@umass.edu|
22312175|NCT05006703|University Hospital Southampton|Professor Graham Roberts|02381 204335|g.c.roberts@soton.ac.uk|
22312176|NCT03924193|Yale University School of Medicine|Dr. Valentina Ivezaj|2037857807|valentina.ivezaj@yale.edu|
22312177|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu|
22312178|NCT04371471|NumaHealth international|Dr. Kamyar Hedayat|+33660404192|khedayat@numahealth.com|
22312179|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu|
22312180|NCT05139615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312181|NCT03462966|Cedars-Sinai medical center|Mohamad Rashid|310-423-0617|mohamad.rashid@cshs.org|
22312182|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22312183|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org|
22312184|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
22312185|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22280957|NCT02978157|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22312186|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com|
22280958|NCT03286829|Saniona A/S|Dr.Kim Krogsgaard, MD, DMSc, CMO|+45 20 14 83 84|kim.krogsgaard@saniona.com|
22280959|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22280960|NCT04556591|University of Michigan|Dr. Noelle E. Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
22280961|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu|
22280962|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22280963|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200||
22280964|NCT04381052|Columbia University|David J. Cohen, MD|212-305-3273|djc5@cumc.columbia.edu|
22312187|NCT01212822|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22280965|NCT00807586|Minneapolis Heart Institute Foundation|Dr. Daniel Melby|612-863-3900|daniel.melby@allina.com|
22280966|NCT02229825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22280967|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
22280968|NCT01532921|Medtronic, Bakken Research Center Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen|+3143356 6566|ber.kleijnen@medtronic.com|
22280969|NCT02526212|Montefiore Medical Center-Albert Einstein College of Medicine|Aaron Fox, Principal Investigator|718-920-7173|adfox@montefiore.org|
22280970|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
22280971|NCT02443337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22280972|NCT03645096|UT Southwestern Medical Center|Dr. Sherwood Brown|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
22280973|NCT02096952|Massachusetts General Hospital|Dr. Gahan Joshi|617-726-8392|joshi.gagan@mgh.harvard.edu|
22280974|NCT03520920|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22280975|NCT04169529|Medtronic|Andy St. Martin|(952) 220-4009|andy.stmartin@medtronic.com|
22280976|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org|
22280977|NCT04904744|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22280978|NCT04998318|Duke University Medical Center|Megan Huchko, MD, MPH|(919) 684-8111|megan.huchko@duke.edu|
22280979|NCT05398159|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22280980|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu|
22280981|NCT05420961|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22280982|NCT04283656|Thomas Jefferson University|Dr. Walter K. Kraft|(215) 955-9077|Walter.Kraft@jefferson.edu|
22312188|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623|sood.amit@mayo.edu|8-7623
22312189|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22312190|NCT01759459|Allina Health|David Gurda|612-863-6566|david.gurda@allina.com|
22312191|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100|sgrace@yorku.ca|22364
22312192|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312193|NCT05124210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22280983|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22280984|NCT04445519|Nicox Ophthalmics, Inc.|Doug Hubatsch/Chief Scientific Officer|984-710-5354|hubatsch@nicox.com|
22270263|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22280985|NCT03782064|Beth Israel Deaconess Medical Center|Emma Logan, Director of Research Nursing|6176675984|eklogan@bidmc.harvard.edu|
22280986|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22280987|NCT02446769|Philips|Chuck Cain|412-542-3605|chuck.cain@philips.com|
22280988|NCT04482439|Newsom Eye and Laser Center|T. Hunter Newsom, MD|813-908-2020|hunter@newsomeye.net|
22280989|NCT03072043|Moffitt Cancer Center|David Sallman, MD|813-745-6841|David.Sallman@moffitt.org|
22280990|NCT00645840|UT Southwestern Medical Center|Perrin White|214 648 6875|perrin.white@utsouthwestern.edu|
22280991|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500|Bstraker@ITS.JNJ.com|1380
22280992|NCT04677543|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
22280993|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com|
22280994|NCT01740258|Duke University|Annick Desjardins, MD, FRCPC|919-681-1691|annick.desjardins@duke.edu|
22312194|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312195|NCT02143713|AbbVie|Global Medical Services|800-633-9110||
22280995|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
22280996|NCT02727816|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22312196|NCT01999335|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22312197|NCT01215253|University of Rochester|Wojciech Zareba|585-275-5391|wojciech.zareba@heart.rochester.edu|
22312198|NCT00080119|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22312199|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
22324982|NCT03019055|Froedtert Hospital and the Medical College of Wisconsin|Dr. Nirav Shah, MD|414-805-8900|cccto@mcw.edu|
22324983|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com|
22324984|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22270264|NCT04429555|Medicinova Inc|Malath Makhay|8582468680|makhay@medicinova.com|
22270265|NCT01949844|Cedars-Sinai Medical Center|Dr. Behzad Sharif, Assistant Professor|310-423-7758||
22270266|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262|gabrielle.saunders@va.gov|56210
22270267|NCT02703272|Janssen Research & Development, LLC|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22270268|NCT00712881|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22270269|NCT03200704|Novadaq Technologies ULC, now a part of Stryker|Colleen Roden, Director of Clinical Sciences and Operations|931-267-2041|colleen.roden@stryker.com|
22270270|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu|
22270271|NCT04967885|Dartmouth College|Elizabeth Saunders|6036467006|elizabeth.c.saunders@dartmouth.edu|
22270272|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu|
22270273|NCT03921840|Johns Hopkins University|Junxin Li|4105022608|jli248@jhu.edu|
22270274|NCT02042950|UT MD Anderson Cancer Center|Dr. Hun Ju Lee/ Assistant Professor, Lymphoma/Myeloma|(713) 794-1829|hunlee@mdanderson.org|
22270275|NCT02935179|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
22270276|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu|
22270277|NCT01940887|Ophthotech Corp.|Keith Westby|212-845-8200|Keith.Westby@ophthotech.com|
22270278|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816|shuchi@tlcbio.com|102
22270279|NCT01590121|Imperial College London|Dr. Claire Shovlin, Principal Investigator|+44 208 383 1178|c.shovlin@imperial.ac.uk|
22270280|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu|
22270281|NCT00256854|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270282|NCT02410798|Synapse Biomedical|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
22270283|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270284|NCT03047720|Indiana University|Dr Benjamin Whittam|317.944.8896|bwhittam@iupui.edu|
22270285|NCT05093530|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
22312200|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300||
22312201|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu|
22312202|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com|
22312203|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org|
22312204|NCT04410445|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22312205|NCT02291861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22312206|NCT04332991|Mass General Hopsital (PETAL Network Coordinating Center)|B.Taylor Thompson, MD|617-726-8854|TTHOMPSON1@mgh.harvard.edu|
22312207|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312208|NCT03082313|University of Southern California|Beth Smith|13234424072|beth.smith@usc.edu|
22324985|NCT05299892|Hearts For Hearing|Sara Neumann, AuD|405-548-4300|sara.neumann@heartsforhearing.org|
22312209|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de|
22312210|NCT03547154|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312211|NCT02404441|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22324986|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22312212|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu|
22270286|NCT04603482|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
22280997|NCT00407602|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director of Clinical and Scientific Affiars|8188335089|jdorn@secondsight.com|
22312213|NCT03909100|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22280998|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com|
22312214|NCT02671266|Massachusetts General Hospital/Harvard Medical School|Dr. Angela Fang|617-643-7717|afang@mgh.harvard.edu|
22280999|NCT04188834|Georgia Institute of Technology Atlanta|Dr. Annabelle Singer|404.385.4936|annabelle.singer@bme.gatech.edu|
22312215|NCT02065609|Washington University School of Medicine in St. Louis|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
22281000|NCT02455336|James J. Peters VA Medical Center|Michael F. La Fountaine, EdD, ATC, FACSM|718-584-9000|michael.lafountaine@va.gov|3121
22281001|NCT00391430|NYU Langone|Marylene Cloitre|2122632471|marylene.cloitre@nyulangone.org|
22281002|NCT01158820|Department of Anesthesiology & Critical Care|Jeff E Mandel MD MS|2156150553|mandelj@uphs.upenn.edu|
22281003|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22312216|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281004|NCT03299244|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281005|NCT02561481|Univ of Massachusetts Medical School|Andrew Zimmerman, MD|4109350488|andrew.zimmerman@umassmemorial.org|
22281006|NCT01574287|Emory University|Schuster, David|404-712-4859|dschust@emory.edu|
22281007|NCT01667250|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22281008|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22281009|NCT03706430|Masimo|Dr. William C. Wilson, CMO, SVP|949-297-7000|william.wilson@masimo.com|
22312217|NCT01794299|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
22281010|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de|
22281011|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
22281012|NCT00766116|University of California, San Diego|Edward D. Ball, MD|858-822-6600|tball@ucsd.edu|
22281013|NCT03381287|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
22281014|NCT02709720|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22281015|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22281016|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com|
22312218|NCT03006393|Emory University|Dr. Michael Treadway|(404) 727-3166|mtreadway@emory.edu|
22281017|NCT02712983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22281018|NCT03280303|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281019|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-405-8404|jsparano@montefiore.org|
22281020|NCT02953093|Albert Einstein College of Medicine|Dr. Nir Barzilai|718-430-3144|nir.barzilai@einsteinmed.edu|
22281021|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22281022|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com|
22281023|NCT04439539|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22281024|NCT02013778|University of Pennsylvania|Gregory Nadolski, MD, Principal Investigator|215-662-7892|gregory.nadolski@pennmedicine.upenn.edu|
22281025|NCT02719691|University of Colorado|Jennifer Diamond, MD|303-724-5499|jennifer.diamond@cuanschutz.edu|
22281026|NCT03308968|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22281027|NCT04397939|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
22281028|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu|
22281029|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22281030|NCT03037476|University of Washington|Jason Kilmer, Ph.D.|206-685-4512|jkilmer@uw.edu|
22281031|NCT02403817|University of California, San Diego|Jeanne Townsend, PhD, Professor of Neurosciences|858-246-1931|jtownsend@ucsd.edu|
22281032|NCT02414607|University of Missouri|Dr. David Beversdorf|(573) 882-6081|beversdorfd@health.missouri.edu|
22281033|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com|
22281034|NCT01208324|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
22281035|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
22281036|NCT04474197|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22281037|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
22281038|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org|
22312219|NCT03500406|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
22281039|NCT01390298|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
22312220|NCT00807599|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun, MD|212-639-3228|hassounh@mskcc.org|
22312221|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22312222|NCT03938272|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
22281040|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu|
22281041|NCT02346643|St. Jude Medical|Roni Diaz|+1 972 309 8601|RDiaz@sjm.com|
22312223|NCT02102724|Rush University College of Nursing|Barbara Swanson|3129428977|BARBARA_A_SWANSON@RUSH.EDU|
22312224|NCT04821271|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22312225|NCT03241810|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
22324987|NCT03334214|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22324988|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu|
22324989|NCT04063215|UTHealth, McGovern Medical School at Houston|Carmen Duron|7135007395|maria.carmen.duron@uth.tmc.edu|
22324990|NCT05655832|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22324991|NCT04281537|Amicus Therapeutics, Inc.|Patient Advocacy|001 6096622000|clinicaltrials@amicusrx.com|
22324992|NCT04516967|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
22324993|NCT05916170|Wake Forest University Health Sciences|Dr. Erin Sutfin|336-713-5282|erin.sutfin@wfusm.edu|
22324994|NCT04576949|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22324995|NCT06001398|Children's Mercy Kansas City|Dana Bakula, PhD|(816) 302-3069|dmbakula@cmh.edu|
22324996|NCT03556904|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22324997|NCT05243680|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281042|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22324998|NCT05642442|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22324999|NCT03794986|Yale University, School of Medicine|Dr. Joan Cook|203-856-2782|joan.cook@yale.edu|
22325000|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu|
22325001|NCT00550238|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22325002|NCT04448886|DFCI|Se Eun Kim|9196228080|seeunk@ds.dfci.harvard.edu|
22325003|NCT05270265|University of Oxford|Dr. Angela M Minassian|1865 611424|angela.minassian@bioch.ox.ac.uk|
22325004|NCT05338268|VA Finger Lakes Healthcare System|Lisham Ashrafioun|585-430-2026|Lisham.ashrafioun@va.gov|
22325005|NCT02296684|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
22325006|NCT05063591|Brown University|Roxanne Wood|401-863-3000|roxanne_wood@brown.edu|
22325007|NCT00254423|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Associate Professor|832-750-4211|LMasarova@mdanderson.org|
22325008|NCT03734666|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
22325009|NCT05866185|University of South Florida|Brian Bunnell|8139748607|bbunnell@usf.edu|
22325010|NCT03246529|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
22325011|NCT05302908|Wake Forest School of Medicine|Scott Rhodes, Ph.D|336-713-5080|srhodes@wakehealth.edu|
22325012|NCT05561673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325013|NCT00001259|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22325014|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com|
22325015|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
22325016|NCT04426630|Yale University School of Medicine|Dr. Jeremy Schwartz|2036801598|jeremy.schwartz@yale.edu|
22325017|NCT02786537|UF Hepatology Research at CTRB|Lauren Morelli|352-273-9508|lauren.morelli@medicine.ufl.edu|
22325018|NCT01466751|Stanford University|Amit Etkin|650-725-5736|amitetkin@stanford.edu|
22325019|NCT02413255|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22325020|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22325021|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org|
22325022|NCT02412644|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
22325023|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22325024|NCT04901026|Faculty of Medicine, Prince of Songkla University|Dr Pittayapon Pitathawatchai|+6674451390|pittayapon.p@psu.ac.th|
22281043|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
22281044|NCT05141708|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281045|NCT02888691|Steno Diabetes Center Copenhagen|Dr Signe Schmidt|+4551174785|signe.schmidt@regionh.dk|
22281046|NCT01524224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312226|NCT02521493|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22312227|NCT02008916|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22312228|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22312229|NCT04063124|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
22312230|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
22312231|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312232|NCT00145145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22312233|NCT00428714|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22312234|NCT03530631|University of Alabama, Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uabmc.edu|
22312235|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22312236|NCT01213940|University of South Alabama, Department of Surgery|William O. Richards, MD|251-471-7993|brichards@health.southalabama.edu|
22312237|NCT02106325|New York University School of Medicine|Stephen Ross, MD/ Principal Investigator|212 562 4097|Stephen.Ross@nyumc.org|
22312238|NCT02656199|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
22312239|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu|
22325025|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325026|NCT02584634|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270287|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
22270288|NCT02521051|Massachusetts General Hospital|Justin Gainor, MD|617-724-4000|jgainor@partners.org|
22270289|NCT05819086|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Regulatory Manager|608-262-7568|mark.zehner@ctri.wisc.edu|
22270290|NCT00926848|University of Nebraska Medical Center|Bernice Yates|402-861-1713|bcyates@unmc.edu|
22270291|NCT01551264|Washington University School of Medicine|Matthew Dobbs MD|561-844-5255|mdobbs@paleyinstitute.org|
22270292|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk|
22270293|NCT03831360|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|LUebelacker@butler.org|
22325027|NCT04243369|Philips|T.J. Battisti|(425) 205-3515|t.j.battisti@philips.com|
22325028|NCT04075604|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22325029|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu|
22325030|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu|
22325031|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325032|NCT03894540|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22325033|NCT03000452|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22325034|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org|
22325035|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
22325036|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org|
22325037|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22325038|NCT03700892|University of North Carolina at Chapel Hill, Center for Environmental Medicine Asthma and Lung Biology|Assistant Director of Clinical Research|919 966-5638|robinet@med.unc.edu|
22325039|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org|
22325040|NCT02532543|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidgetta_jenkins@unc.edu|
22325041|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743||
22325042|NCT02640612|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325043|NCT03583424|The Ohio State University Comprehensive Cancer Center|Dr. Kami Maddocks|614-293-9165|Kami.Maddocks@osumc.edu|
22325044|NCT05207436|VA San Diego Healthcare System|Leslie Morland|858-226-5765|leslie.morland@va.gov|
22325045|NCT01144637|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22325046|NCT03472534|Castle Creek Pharmaceuticals|Dr. Mary Spellman/Chief Medical Officer|862-286-0400|mspellman@castlecreekpharma.com|
22325047|NCT02614794|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22325048|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
22325049|NCT03756012|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
22325050|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com|
22325051|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22325052|NCT00491530|Abbott|Medical Information Specialist|800-633-9110||
22325053|NCT01591330|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325054|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22325055|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325056|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu|
22325057|NCT03368404|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
22325058|NCT04725682|FDA/CDER/OGD|Wei-Jhe Sun, Ph.D.|301-796-6176|ORSHSR@fda.hhs.gov|
22325059|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com|
22325060|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
22325061|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
22270294|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org|
22270295|NCT03482453|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22270296|NCT03478644|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270297|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
22270298|NCT03763929|Diffusion Pharmaceuticals Inc|Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
22270299|NCT02504827|University of Southern California|Paul Beringer|323-442-1402|beringer@usc.edu|
22270300|NCT00686829|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270301|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com|
22270302|NCT04740827|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22270303|NCT00940823|Prism Eye Institute|Dr. Iqbal Ike K. Ahmed|905-456-3937|ike.ahmed@utoronto.ca|
22270304|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270305|NCT02715700|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298912|NCT00733343|Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom|Martin R. Cowie, MD|+44 (0)20 7589 0|m.cowie@imperial.ac.uk|5111
22270306|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu|
22325062|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22325063|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300||
22325064|NCT02973815|School of Nursing, University of Minnesota|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
22325065|NCT03478683|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325066|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org|
22325067|NCT03661541|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
22325068|NCT04095416|Henry Ford Hospital|Raef Ali Fadel|3139321347|rfadel2@hfhs.org|
22325069|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org|
22325070|NCT01607892|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22325071|NCT03983941|Nationwide Children's Hospital|Julie Rice-Weimer, RN|614-355-3142|julie.rice-weimer@nationwidechildren.org|
22325072|NCT02273973|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22325073|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22325074|NCT02104180|Mylan Medical SAS|Benoit LA ROCHE|+33 1 46 25 86 76|benoit.la-roche@mylan.com|
22325075|NCT01676116|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22325076|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn|
22325077|NCT01769404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22325078|NCT01821677|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
22325079|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22325080|NCT02768129|Butler Hospital|Benjamin Greenberg|(401) 455-6200|bgreenberg@butler.org|
22325081|NCT03461965|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Margaret Mann, MD|1-800-641-2422|CTUReferral@uhhospitals.org|
22325082|NCT02680301|Seton Family of Hospitals/Ascension|Katherine Sebastian|801-598-2484|krsebastian@ascension.org|
22325083|NCT02677740|University of Minnesota|Silvia Mangia, Associate Professor|6126254920|mangia@umn.edu|
22325084|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu|
22325085|NCT01810757|The Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Emma Hall (Co-Director of ICR-CTSU)|+44 (0)208 722|Emma.Hall@icr.ac.uk|4292
22325086|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
22270307|NCT03558152|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325087|NCT04513158|Norton Healthcare|Joseph M. Flynn, DO, MPH|502-272-5001|joseph.flynn@nortonhealthcare.org|
22325088|NCT05278104|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325089|NCT04957498|Stanford University School of Medicine|Dr. James Lock|(650) 723-6643|jimlock@stanford.edu|
22325090|NCT02629393|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
22325091|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com|
22325092|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu|
22325093|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu|
22270308|NCT04166591|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
22325094|NCT01283581|Melinta Therapeutics|Dr. Sue Cammarata|312-724-9401|scammarata@melinta.com|
22325095|NCT05523362|University Hospitals Cleveland Medical Center|Dr. Ian Neeland|(216)844-5965|Ian.Neeland@UHhospitals.org|
22325096|NCT02760602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22325097|NCT03159754|University of Michigan|Steven Bruch, MD|7349368464|sbruch@umich.edu|
22325098|NCT01260181|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22325099|NCT03351244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325100|NCT03063255|Department of Anesthesiology, NF/SG Veterans Health System|Dr. Jose R. Soberon, Jr.|352-413-2317|jsoberon@anest.ufl.edu|
22325101|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325102|NCT00474253|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325103|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300||
22325104|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu|
22325105|NCT03133481|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22325106|NCT02102230|VA Palo Alto Health Care System|Kimberly Babson, PhD|831-325-1540|kimberly.babson@gmail.com|
22325107|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
22270309|NCT03960021|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22270310|NCT03535194|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22270311|NCT04411810|NYU Langone Health|David Polsky, MD, PhD|212-263-9087|David.Polsky@nyulangone.org|
22270312|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw|
22270313|NCT04304235|The University of British Columbia|J Mark Ansermino|1 604 875 2711|anserminos@yahoo.ca|
22270314|NCT04470544|Mayo Clinic|Alan Haruo Bryce, M.D.|(480)301-8335|Bryce.Alan@mayo.edu|
22270315|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
22270316|NCT02217410|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22270317|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com|
22270318|NCT02655510|Mayo Clinic|Vijay Shah, M.D.|507-284-3917|Shah.Vijay@mayo.edu|
22270319|NCT01471340|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325108|NCT00325572|Milton S. Hershey Medical Center|Jeanette C. Ramer MD|717 531-8414|jramer2@hmc.psu.edu|
22281047|NCT05371054|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
22281048|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281049|NCT01119066|Memorial Sloan Kettering Cancer Center|Richard O'Reilly, MD|646-888-2157|oreillyr@MSKCC.ORG|
22281050|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738||
22281051|NCT00295646|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
22281052|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org|
22281053|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22281054|NCT02880228|Mayo Clinic|Shaji K Kumar MD|5072842511|kumar.shaji@mayo.edu|
22281055|NCT03506412|Mayo Clinic|Naveen L. Pereira, M.D.|507-284-8612|Pereira.Naveen@mayo.edu|
22281056|NCT03162796|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22281057|NCT02623205|Department of Psychiatry, Renaissance School of Medicine at Stony Brook University|Kathryn Hill|904-252-3449|kathryn.hill@stonybrookmedicine.edu|
22281058|NCT01176617|Hospital of the University of Pennsylvania|Dr. Sanjay Dixit|215-615-4337|sanjay.dixit@uphs.upenn.edu|
22281059|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu|
22281060|NCT02725476|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|114
22281061|NCT02749201|maimonides medical center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22312240|NCT03242863|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22312241|NCT05940688|University of Alabama at Birmingham|Dr. Rachel Sinkey|(205) 934-5612|rsinkey@uabmc.edu|
22312242|NCT04602728|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
22312243|NCT03365622|University of Rochester Medical Center|Joseph Dooley, MD|5852752141|joseph_dooley@urmc.rochester.edu|
22312244|NCT05376449|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
22312245|NCT05338476|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22312246|NCT06716632|Gulab Devi Hospital, Lahore|Dr. Zain Himayoun|03043862033|Zain.1080@gmail.com|
22312247|NCT02831049|National Institute on Drug Abuse (NIDA)|Dr David Epstein|1-667-312-5092|david.epstein@nih.gov|
22312248|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22312249|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu|
22312250|NCT03141177|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22312251|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu|
22312252|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312253|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
22312254|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300||
22312255|NCT02121808|Laval University|Jean S. Bussières|418 656-8711|jbuss@criucpq.ulaval.ca|
22312256|NCT04721600|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22312257|NCT01304940|VA ORD|Suzanne Pineles|857-364-5906|suzanne.pineles@va.gov|
22312258|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
22312259|NCT01448447|Mercy|Dr. Robert Frazier|314-251-6844|Robert.Frazier@mercy.net|
22312260|NCT02065895|Boston Children's Hospital|Garry M. Steil, PhD|617-355-7504|garry.steil@childrens.harvard.edu|
22312261|NCT03740737|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22312262|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com|
22312263|NCT00759798|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
22312264|NCT03137784|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22312265|NCT01773707|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@Yale.edu|
22312266|NCT04803734|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
22312267|NCT00239642|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|601-650-4200|mfalone@luitpold.com|
22312268|NCT03835416|Durham VA Medical Center|Dr. Connie Bales, Assoc. Director, GRECC|919-286-0411|connie.bales@va.gov|6780
22312269|NCT04026256|Massachusetts General Hospital|Benjamin Leder|617-724-2039|bzleder@mgh.harvard.edu|
22312270|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300|Jeneen.shell-boyd@va.gov|5831
22312271|NCT04471805|University of Iowa, Department of Health and Human Physiology|Thorsten Rudroff, PhD|(319)467-0363|thorsten-rudroff@uiowa.edu|
22312272|NCT04540952|Atrium Health|Dr. Paul Marshburn|704-619-2537|Paul.Marshburn@atriumhealth.org|
22312273|NCT01799993|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22312274|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
22312275|NCT04361617|Wake Forest University Health Sciences|Lindsay Reynolds, PhD|336.713.1134|lireynol@wakehealth.edu|
22312276|NCT01263223|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312277|NCT03695185|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22312278|NCT05919732|Nemours|Dr. Gohalem Felema|904-416-5430|gohalem.felema@nemours.org|
22312279|NCT04183491|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22312280|NCT02538094|Johns Hopkins University SOM|Dr. Tracy Vannorsdall|4105023701|TVannor1@jhmi.edu|
22312281|NCT03288506|Queen's University Belfast|Dr Paul Best|0289097|p.best@qub.ac.uk|3256
22281062|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com|
22312282|NCT03692871|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312283|NCT03400579|University of North Carolina at Chapel Hill|Mehul Patel, PhD|919-843-7307|mehul_patel@med.unc.edu|
22312284|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov|
22312285|NCT02852824|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281063|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22270320|NCT02475265|Massachusetts General Hospital|Dr. Pouneh Fazeli|617-726-3870|pkfazeli@partners.org|
22270321|NCT05875025|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22270322|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270323|NCT02218736|Duke Clnical Research Institute|Kathy Hijek, Associate Director of Clinical Operations|919-668-8700|kathy.hijek@duke.edu|
22270324|NCT03452488|Biophytis S.A.|Cendrine Tourette|+331 44 27 33 00|cendrine.tourette@biophytis.com|
22270325|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org|
22270326|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
22270327|NCT03315286|Weill Cornell Medicine|Dr. George Varghese, Principal Investigator|646-962-3376|giv9006@med.cornell.edu|
22270328|NCT02829723|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22270329|NCT02989649|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22281064|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281065|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org|
22281066|NCT06875284|RTI International|Marni Kan, PhD|919-248-1836|mkan@rti.org|
22281067|NCT06631274|Florida State University|Dr. Lyndsay Jenkins|(850) 644-4592|lnjenkins@fsu.edu|
22281068|NCT00980460|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22281069|NCT02842086|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22281070|NCT05696444|Medtronic|Michele Masters, Sr. Clinical Research Program Manager|4848948925|michele.masters@medtronic.com|
22281071|NCT03054805|Chang Gung Memorial Hospital|Dr. Hsun-Chin Chao|88633281200|chaohero@yahoo.com|8969
22281072|NCT03759639|IntraBio Ltd|Taylor Fields, Chief Product Development Officer|+44 8081 641283|tfields@intrabio.com|
22281073|NCT01461499|Shiga University of Medical Science|Steering Committee: Takashi Uzu|81-77-548-2222|takuzu@belle.shiga-med.ac.jp|
22281074|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu|
22281075|NCT00078806|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281076|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22281077|NCT01658709|University of Kentucky|Phillip Gribble|8592180885|phillip.gribble@uky.edu|
22281078|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281079|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu|
22281080|NCT04908384|University of Washington|Jennifer Sonney|206-685-2161|jsonney@uw.edu|
22281081|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22312286|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312287|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444|sevket5@yahoo.com|4123
22312288|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
22312289|NCT02114515|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|partner@uic.edu|
22312290|NCT02144285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312291|NCT02759575|University of Cincinnati|Vinita Takiar, MD, PhD, Associate Professor|(513)584-8956|Vinita.Takiar@UCHealth.com|
22312292|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu|
22312293|NCT05522777|Yakult U.S.A. Inc|Hideyuki Shibata|714-434-6500|hideyuki.shibata@yakultusa.com|
22312294|NCT05487300|University of Utah|Dr. Guillaume Lamotte|801-585-7575|guillaume.lamotte@hsc.utah.edu|
22312295|NCT00112827|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22312296|NCT02507297|University of Michigan|Leslie Swanson|734-764-2242|lmswan@umich.edu|
22312297|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312298|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22312299|NCT00070707|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22312300|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
22312301|NCT04909593|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22312302|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu|
22312303|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu|
22312304|NCT03029585|US Biotest, Inc.|Gere S. diZerega, MD, Responsible Medical Officer|1-805-595-1300|gere.dizerega@usbiotest.com|
22312305|NCT04669366|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312306|NCT01241448|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312307|NCT02400749|Innovaderm Research Inc.|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
22312308|NCT01825785|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22312309|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22325109|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
22270330|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270331|NCT01813214|Lombardi Comprehensive Cancer Center|Dr Michael Atkins|202-687-2795|mba41@georgetown.edu|
22281082|NCT02943070|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22281083|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325110|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
22281084|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281085|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com|
22270332|NCT01878084|Alexandria University|Prof. Mona K. Marei|002-03-4858353|mona.marei@gmail.com|
22270333|NCT01876784|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22270334|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281086|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu|
22281087|NCT01014767|Tufts Medical Center|Research Administration|617-636-1142|mcoughlin@tuftsmedicalcenter.org|
22281088|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22281089|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
22281090|NCT00405392|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281091|NCT04301934|Mayo Clinic|Johnny Yi, M.D.|480-342-0612|Yi.Johnny@mayo.edu|
22281092|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281093|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281094|NCT00988052|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22281095|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281096|NCT03352141|Zeltiq Aesthetics|Lori Brandt, Director Cinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
22281097|NCT05312697|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22281098|NCT02858440|GlaxoSmithKline|GSK Response Center|866-435-7343|lrs54533@gsk.com|
22281099|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22281100|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281101|NCT00997984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22281102|NCT01569737|HRA Pharma|Christine Adelbrecht, Clinical Trial Coordinator|+33 1 40 33 32 74|c.adelbrecht@hra-pharma.com|
22281103|NCT01945996|University of Southern California|Elizabeth Burner|3232266667|eburner@usc.edu|
22281104|NCT01736267|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
22281105|NCT04396795|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr Ranjith Ramasamy|305-243-4562|ramasamy@miami.edu|
22281106|NCT02484443|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22281107|NCT01970241|HCMC|Lisa Fish MD|612-873-2705|lisa.fish@hcmed.org|
22281108|NCT02595866|HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute|Kathryn Lurain, M.D.|240-858-3257|kathryn.lurain@nih.gov|
22281109|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22281110|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu|
22281111|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862|gloria_olivam@hotmail.com|21075
22281112|NCT02689206|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281113|NCT02520388|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22281114|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
22281115|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22281116|NCT03020004|Ascletis Pharmaceuticals Co., Ltd|Clinical Trial Disclosures|+86057185389732|yicheng.zhao@ascletis.com|
22281117|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22281118|NCT03711370|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
22281119|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621|joachim.wolf@diakonissen.de|4200
22281120|NCT05007899|Nationwide Children's Hospital|Chelsea Kebodeaux|(614) 722-2250|Chelsea.Kebodeaux@nationwidechildrens.org|
22281121|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281122|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org|
22281123|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
22281124|NCT01740687|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22270335|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu|
22270336|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270337|NCT01552915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22270338|NCT01777568|Cleveland Clinic|Kurz, M.D., Andrea|(216) 445-9924|KURZA@ccf.org|
22270339|NCT00492648|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270340|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu|
22270341|NCT03382834|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|3016283313|ACTGCT.Gov@s-3.com|
22312310|NCT04205669|CERMEL|Julian Matthewman|00241 07-98-91-91|julianmatthewman@gmail.com|
22312311|NCT04025762|University of Cambridge|Dr Charlotte Boughton|+441223769066|cb2000@medschl.cam.ac.uk|
22312312|NCT02132520|University of Minnesota|Bin He|612-626-1115|binhe@umn.edu|
22312313|NCT03340961|Dr. Reddy's Lab, INC|Dr. Srinivas Sidgiddi, Senior Director|908-458-5362|Srinivassidgiddi@drreddys.com|
22312314|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org|
22312315|NCT03034863|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
22270342|NCT02387957|Ophthotech Corp.|Denise Teuber|646-753-8461|denise.teuber@ophthotech.com|
22281125|NCT04201639|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22312316|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22281126|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
22270343|NCT02887248|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22281127|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr|
22281128|NCT03062280|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
22281129|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com|
22281130|NCT04123093|OhioHealth|Dr. Mitch Silver|614-566-1250|mitch.silver@ohiohealth.com|
22281131|NCT01756573|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
22281132|NCT03462641|University of Michigan|Stiven Roytman|734 998-8400|stivenr@med.umich.edu|
22281133|NCT03938103|University of North Carolina at Chapel Hill|Derek Hales, PhD|919-966-6089|derekh@email.unc.edu|
22281134|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu|
22270344|NCT02294396|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
22281135|NCT02579421|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
22281136|NCT03660865|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22281137|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22281138|NCT03248531|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22281139|NCT02923531|X4 Pharmacueticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
22281140|NCT02201329|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281141|NCT02997865|Washington University School of Medicine in St. Louis|Kenneth E. Freedland, PhD|314-286-1311|freedlak@wustl.edu|
22281142|NCT04660552|JelikaLite Corp|Katya Sverdlov, Chief Executive Officer|9175668151|katya@jelikalite.com|
22270345|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com|
22281143|NCT03012828|Medicines Development Limited|Sally Kinrade, Vice President (Clinical Development)|+613 9629 6111|sally.kinrade@medicinesdevelopment.com|
22298913|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22270346|NCT02397122|Kirikkale University|Dr. H. Gencay Keceli|+905326714377|monsieur_gencay@yahoo.com|
22270347|NCT02438826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22270348|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com|
22270349|NCT03429244|Indianan University School of Medicine|Jennifer Lehman|3179489575|jgeck@iu.edu|
22270350|NCT01500187|University of Health Science Center|Franklin Garcia-Godoy DDDS, MS PhD||fgarciagodoy@gmail.com|
22270351|NCT02784613|San Diego Sexual Medicine|Irwin Goldstein|619-265-8865|dr.irwingoldstein@gmail.com|
22270352|NCT04192071|University of Florida|Melissa Vilaro, Assistant Professor|352-2733525|mgraveley@ufl.edu|
22270353|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu|
22270354|NCT02073929|Center of Endocrinology and Metabolism, Dept. of Internal Medicine, Herlev Gentofte Hospital, Denmark|Professor Jens Faber|+4538689016|jens.faber@regionh.dk|
22270355|NCT00430573|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
22270356|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu|
22270357|NCT01483027|Boston Scientific|Chantal Laframboise|+1 613 882 0876|chantal.laframboise@bsci.com|
22270358|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu|
22270359|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu|
22270360|NCT04463251|R-Pharm|Sergey Grishin, Director, Dep. of Clinical Development and Medical Expertise in Autoimmune Diseases|0074959567937|sa.grishin@rpharm.ru|1506
22270361|NCT05020665|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
22270362|NCT03318497|UT Southwestern Medical Center|Kelli Key, PhD|214-648-8152|Kelli.Key@UTSouthwestern.edu|
22270363|NCT03297645|Virginia Commonwealth University|Robin S. Everhart, PhD|(804) 828-7249|reverhart@vcu.edu|
22270364|NCT01743560|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22270365|NCT02842580|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22270366|NCT02965729|Pennington Biomedical Research Center|Dr. Amanda Staiano|225-763-2729|amanda.staiano@pbrc.edu|
22270367|NCT01732640|Johns Hopkins University|Hao Wang|410-614-3426|hwang76@jhmi.edu|
22270368|NCT04574908|Wake Forest University Health Sciences|Portable Hemodynamic Monitoring on Hosp Units|336.716.4498|akhanna@wakehealth.edu|
22270369|NCT00877487|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22270370|NCT03070002|Northwestern University|MASSIMO CRISTOFANILLI, MD|312-503-1114|massimo.cristofanilli@nm.org|
22270371|NCT03687684|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22270372|NCT02118727|University of Missouri Health Care|Richard Barohn, MD|573-882-3693|rbarohn@health.missouri.edu|
22270373|NCT03425396|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22281144|NCT01509846|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22298914|NCT04519658|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
22298915|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu|
22298916|NCT00183872|USC/Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
22298917|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org|
22298918|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298919|NCT02797262|University of California, Los Angeles|Research Scientist|3105917541|statue22@gmail.com|
22298920|NCT01600586|Vanderbilt University|Olena Chorna|850-508-5571|olena.chorna@vanderbilt.edu|
22312317|NCT03331978|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
22281145|NCT03115411|Stanford University School of Medicine|Dr. Subhas Banerjee, MD|650-723-2623|sbanerje@stanford.edu|
22281146|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu|
22281147|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22281148|NCT02110485|Nationwide Children's Hospital|Beth Fischer|614-355-0338|beth.fischer@nationwidechildrens.org|
22281149|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu|
22281150|NCT00295334|Ben-Gurion University of the Negev|Iris Shai|+972086477443|irish@bgu.ac.il|
22312318|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281151|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
22281152|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22312319|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu|
22312320|NCT02605876|University of North Carolina at Chapel Hill|Troy Blackburn|9198432021|troyb@email.unc.edu|
22281153|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
22281154|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270374|NCT02863445|Oregon Health and Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
22270375|NCT00601172|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270376|NCT02219581|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
22270377|NCT04434469|Genetech|Medical Communications|800-821-8590|genentech@druginfo.com|
22270378|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22270379|NCT04184362|SFVA|Joannalyn Delacruz, Ph.D.|415-375-5748|Joannalyn.Delacruz@va.gov|
22270380|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
22270381|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu|
22270382|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu|
22312321|NCT02152384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312322|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22270383|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22312323|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22270384|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu|
22270385|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com|
22270386|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300||
22270387|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil|
22270388|NCT02879617|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22270389|NCT05896527|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22270390|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350|afarreny@pssjd.org|2373
22270391|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22270392|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312324|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
22312325|NCT03800563|Alma Lasers|Dr Meital Grafi-Cohen|+972-523708780|meital.grafi@almalasers.co.il|
22312326|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu|
22312327|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com|
22312328|NCT02964234|University of Illinois at Chicago|Dr. Yamile Molina|312-355-2679|ymolin2@uic.edu|
22312329|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu|
22312330|NCT03015961|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22312331|NCT02067000|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|7044
22312332|NCT02246647|Mayo Clinic|Madhusudan Grover, MBBS|507-253-5384|Grover.Madhusudan@mayo.edu|
22312333|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com|
22312334|NCT04387773|Oregon Health & Science University|Dr. Amie Hiller|503-494-7772|peterami@ohsu.edu|
22312335|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312336|NCT04405180|University of Pittsburgh|Dr. Daniel Forman|412-864-2507|formand@pitt.edu|
22312337|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22312338|NCT02132676|VA Ann Arbor Healthcare System Center for Clinical Management & Research|Dr. Michele Heisler|734-845-3502|mheisler@umich.edu|
22312339|NCT02424968|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
22312340|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
22312341|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com|
22312342|NCT02525744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22312343|NCT02069379|University of Michigan|Alison Berent-Spillson|(734) 936-4400|berent@umich.edu|
22270393|NCT05835011|Taiho Oncology, Inc.|Taiho Central|844-878-2446|medicalinformation@taihooncology.com|
22281155|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo|
22270394|NCT03766165|Johns Hopkins University; Indiana University|Dr. Larissa Jennings Mayo-Wilson|1-812-856-0902|ljmayowi@iu.edu|
22312344|NCT03195127|University of Maryland, Baltimore|Avelino C. Verceles, M.D., M.S.|4103288141|avercele@medicine.umaryland.edu|
22270395|NCT01683266|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
22312345|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
22312346|NCT04617847|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22312347|NCT01525875|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
22312348|NCT03150758|Cleveland Clinic|Dr. Eric Klein|1-800-223-2273|CancerCenterResearch@ccf.org|
22312349|NCT04144088|Chung Shan Medical University Hospital|Dr. Cheng Chung Wei|+886-4-24739595|wei3228@gmail.com|34718
22312350|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at|
22312351|NCT03031782|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22312352|NCT04867382|HealthPartners Institute|Stephanie Hooker, PhD, MPH, MS, Principal Investigator|(952) 967-5056|Stephanie.A.HookerShowalter@HealthPartners.com|
22312353|NCT05445557|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
22312354|NCT03803475|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
22312355|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
22312356|NCT05011292|Emory University|Dr. Jean Welsh|404-375-1165|jwelsh1@emory.edu|
22312357|NCT00046475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22312358|NCT02915783|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22312359|NCT02950961|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Alison B Hamilton, PhD MPH|(310) 478-3711|alison.hamilton@va.gov|44157
22312360|NCT02432274|Eisai Ltd.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22312361|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com|
22312362|NCT01736475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22312363|NCT02807857|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22312364|NCT04197713|University of M D Anderson Cancer Center|Dr. Timothy Yap|713) 563-1784|tyap@mdanderson.org|
22312365|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22312366|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300||
22312367|NCT05184062|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22312368|NCT06164743|VivaVisionBio|Dr. Joanne Li|(86) 021-58598290|joanne.li@vivavisionbio.com|
22312369|NCT00711555|University of Illinois|Sandra Cuellar|312-996-6985|scuell1@uic.edu|
22312370|NCT01298219|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22312371|NCT05489770|EKHUFT|Dr Jane Povey- Research Facilitator|01227766877|jane.povey2@nhs.net|
22312372|NCT04914897|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22312373|NCT02713217|Central Arkansas Veterans Healthcare System|Richard R. Owen, MD|5012574802|richard.owen2@va.gov|
22312374|NCT01921166|AtriumHealth|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|brad.hurst@atriumhealth.org|
22312375|NCT04555694|Cleveland Eye Clinic|Dr. Thomas Chester, OD|440-526-1974|tchester@midwestvision.com|
22312376|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu|
22312377|NCT04783389|Connect Biopharma|Dr. Malinda Longphre, PhD, Head of Clinical Operations|+1 510 520 3361|mlongphre@connectpharm.com|
22312378|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu|
22312379|NCT02164578|Medical Clinic III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Dr. Frank Pistrosch|0049 351 458|frank.pistrosch@uniklinikum-dresden.de|5955
22312380|NCT01975701|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novatis.com|
22312381|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300||
22312382|NCT03734588|Spark Therapeutics|Tiffany Chang, MD, MAS Clinical Development Lead, Hematology|Please Email|Tiffany.chang@sparktx.com|
22312383|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr|
22312384|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
22312385|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399||
22312386|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22312387|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312388|NCT04679675|Kaiser Permanente Washington Health Research Institute|Dr. Beverly Green|206-220-2997|bev.b.green@kp.org|
22325111|NCT05372315|Iworks Laser and Vision Center|Dr. Patrick L. Spencer|937-226-7870|iworkeye@gmail.com|
22312389|NCT01338506|Medical University of South Carolina|Dr. Sudie Back|843-792-9383|backs@musc.edu|
22312390|NCT02802111|Children's Hospital Los Angeles|Dr. Patrick Ross|323-361-7864|pross@chla.usc.edu|
22312391|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
22312392|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
22312393|NCT03711279|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|+86-18036618962|qianna.zhan@hengrui.com|
22312394|NCT04534738|University of Maryland Baltimore|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
22312395|NCT02721147|Fox Chase Cancer Center|Dr. Jennifer Reese, Assistant Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22312396|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk|
22312397|NCT01535261|Novartis|Study Director|862-778-8300||
22312398|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22312399|NCT02009332|Aadi Bioscience|Berta Grigorian|818-416-8378|bgrigorian@aadibio.com|
22312400|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu|
22325112|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312401|NCT03798756|Keele University|Mrs Sarah Lawton|01782 734887|s.a.lawton@keele.ac.uk|
22312402|NCT01757288|UT Southwestern Medical Center|Dr. Yuanyuan Zhang|214-648-6764|Yuanyuan.Zhang@UTSouthwestern.edu|
22312403|NCT02825550|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|3624/5603
22312404|NCT03386344|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22312405|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22312406|NCT02791308|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22312407|NCT05188248|NYU Langone|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
22312408|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012||
22312409|NCT03349476|Icahn School of Medicine at Mount Sinai|Stephanie Harcum|(212) 824-8927|stephanie.harcum@mountsinai.org|
22312410|NCT01182285|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22312411|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22312412|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu|
22312413|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
22312414|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov|
22312415|NCT02379078|St. Michael's Hospital (Unity Health Toronto)|Dr. Catherine Yu|(416) 360-4000|catherine.yu@unityhealth.to|
22312416|NCT03481725|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|m1medeiros@health.ucsd.edu|
22312417|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312418|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22312419|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22312420|NCT04604652|HighTide Therapeutics|VP Clinical Operations|760-809-3523|cbennett@hightidetx.com|
22312421|NCT03936699|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513.236.6799|samlung@elira.com|
22312422|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu|
22312423|NCT03989232|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22312424|NCT01930188|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22312425|NCT03576118|Ajou University Hospital|Dr. Jong Yeop Kim|+82312195574|kjyeop@ajou.ac.kr|
22312426|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22312427|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22312428|NCT03122860|Biosplice Therapeutics, Inc.|Christopher Swearingen, PhD, VP of Biometrics|858.926.2952|chris.swearingen@biosplice.com|
22312429|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22312430|NCT02574286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22312431|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu|
22312432|NCT02399449|University of Maryland Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
22312433|NCT01020435|Palmer College of Chiropractic|Christine M Goertz, DC, PhD (Study Principal Investigator)|563-884-5150|christine.goertz@palmer.edu|
22312434|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22312435|NCT02607956|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22312436|NCT02773732|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22312437|NCT01888484|Clinical Research Management Group|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
22312438|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
22312439|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22312440|NCT04000399|University of Pittsburgh|Stephanie D. Stepp, PhD|4127155447|steppsd@upmc.edu|
22312441|NCT02725372|Bellerophon Therapeutics Inc|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
22312442|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov|
22312443|NCT02548585|MedImmune, LLC|Philip Ambery|+44 (0) 1223 895997|information.center@astrazeneca.com|
22312444|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|coat.trial@gmail.com|
22312445|NCT01840722|University of Kentucky|Michele Staton, Associate Professor|859-257-2483|mstaton@uky.edu|
22312446|NCT01818063|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edith Mitchell|215-955-8874|edith.mitchell@jefferson.edu|
22312447|NCT04445337|University of Nebraska Medical Center|Michael Lankhorst|402-559-4081|michael.lankhorst@unmc.edu|
22312448|NCT03659136|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22312449|NCT05066230|Kodiak Sciences Inc|Chief Medical Officer|1 (650) 281-0850|ClinOps@kodiak.com|
22312450|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com|
22312451|NCT04425252|Clear Creek Bio, Inc.|Vice President Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
22312452|NCT02981953|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22312453|NCT02556606|Michael E. DeBakey VA Medical Center|Marijn Lijffijt, PhD|3618274395|marijn.lijffijt@bcm.edu|
22312454|NCT02165202|PATH|Heather Kelly|650-392-2510|hkelly@path.org|
22312455|NCT01689740|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22312456|NCT01420328|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Husam Ghanim|7169574325|ghanim@buffalo.edu|
22312457|NCT04328467|University of Minnesota|Radha Rajasingham, MD|612-626-8171|radha@umn.edu|
22312458|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu|
22312459|NCT01655498|Pelvalon|Director of Clinical|650-276-0130||
22312460|NCT01301183|Massachusetts General Hospital|Madhu Misra|6177265790|mmisra@mgh.harvard.edu|
22312461|NCT01714947|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22312462|NCT06182631|SUNY Buffalo|Jill Fenenll|716-323-0220|jillfenn@buffalo.edu|
22312463|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312464|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825||
22312465|NCT00930644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22312466|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net|
22312467|NCT02410278|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22312468|NCT02584257|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
22325113|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900|shiverqks@hotmail.com|2407
22325114|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
22325115|NCT01570491|Cleveland Clinic|Daniel Sessler, MD|2164444900|sessled@ccf.org|
22325116|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu|
22325117|NCT02648230|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
22325118|NCT02048878|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
22325119|NCT01720667|University of California San Diego, School of Medicine|Dr. Richard Haas|(858) 822-6700|rhaas@ucsd.edu|
22270396|NCT02222545|Omeros Corporation|Clinical Trial Manager|(206) 676-5000|ctinfo@omeros.com|
22270397|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270398|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22270399|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557||
22270400|NCT02651155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22270401|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com|
22270402|NCT05113979|OnPointVision|Lynne Archer|949-749-4170|larcher@onpoint-vision.com|
22270403|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270404|NCT02048826|University of California at Irvine|Prof. David Reinkensmeyer|949-824-5218|dreinken@uci.edu|
22270405|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270406|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270407|NCT02233296|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270408|NCT04259424|Medical University of South Caroina|Ryan Ross|843-792-3477|rossre@musc.edu|
22270409|NCT00784303|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22270410|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu|
22312469|NCT01670877|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22312470|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312471|NCT02309892|Helix BioPharma Corp.|Brenda Lee, Director, Clinical Operations|416 642 1807|blee@helixbiopharma.com|
22312472|NCT01672242|University of Maryland School of Medicine|Carl Shanholtz, MD|410.328.8141|cshanhol@som.umaryland.edu|
22312473|NCT05376397|Rutgers School of Public Health|Dr. Devin English, Prinicipal Investigator|19739727212|devin.english@rutgers.edu|
22312474|NCT01516710|Oslo University Hospital|Dr. Aasmund A. Fretland|004723070100|aafret@ous-hf.no|
22312475|NCT01280721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
22312476|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22270411|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com|
22270412|NCT01981954|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
22270413|NCT00489086|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
22270414|NCT04016779|Supernus|Joseph Hull, Ph.D., Director Clinical research|240-403-5324|jhull@supernus.com|
22270415|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
22270416|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com|
22270417|NCT02738879|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270418|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270419|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22270420|NCT00205868|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22270421|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu|
22270422|NCT03089697|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
22270423|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu|
22270424|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu|
22270425|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u-tokyo.ac.jp|
22270426|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22270427|NCT03861871|NYU Langone Health|Latoya King|646 558 083|latoya.king@nyulangone.org|
22270428|NCT03613649|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
22270429|NCT02783729|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22270430|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22270431|NCT03421145|3M Health Care Business Group|Manager of Biostatistics|6518152737|swalters@mmm.com|
22270432|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov|
22270433|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22270434|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514||
22270435|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743||
22270436|NCT02258373|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
22270437|NCT00153543|CDC/Arctic Investigations Program|Karen Miernyk|9077293453|kmiernyk@cdc.gov|
22270438|NCT04678232|Case Western Reserve University|Norah Feeny, PhD|(216) 368-2695|ncf2@case.edu|
22270439|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl|
22270440|NCT00604591|Columbia University|Edward D. Huey, MD|212-305-1134|edh2126@cumc.columbia.edu|
22270441|NCT01965366|Emory University|Dr. Barbara Rothbaum|404-712-8866|brothba@emory.edu|
22270442|NCT04152837|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
22312477|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312478|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov|
22312479|NCT03449979|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
22312480|NCT01125436|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
22312481|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com|
22312482|NCT03444155|Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria|Dr. Willibald Wonisch|00436505299540|willibald.wonisch@medunigraz.at|
22312483|NCT02877680|Baylor College of Medicine|Marisa Hilliard, Associate Professor of Pediatrics|832-824-7209|marisa.hilliard@bcm.edu|
22312484|NCT01133678|University of Chicago|Everett Vokes, MD|(773) 702-6227|evokes@medicine.bsd.uchicago.edu|
22312485|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312486|NCT03424187|Imperial College London|Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
22312487|NCT00761267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312488|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com|
22312489|NCT03398798|University of North Carolina at Chapel Hill|Christian Piers, DDS, MS, MFA|(828) 433-1242|christian.piers@gmail.com|
22312490|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com|
22312491|NCT02466958|UCLA|Helen Lavretsky, MD|310-794-4619|HLavretsky@mednet.ucla.edu|
22312492|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org|
22312493|NCT03014726|Urotronic, Inc.|Ian Schorn, Vice President of Clinical Affairs|320.282.6312|schorni@urotronic.com|
22312494|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22312495|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
22270443|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22270444|NCT04999163|Procyrion, Inc.|Sr. Director, Clinical Affairs|650-208-1118|tami@procyrion.com|
22270445|NCT06229132|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
22270446|NCT03527264|Brown Oncology Research Group|Don S. Dizon, MD|4018633000|BrUOG@Brown.edu|
22270447|NCT05903924|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
22270448|NCT04338269|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22270449|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22270450|NCT03030989|University of Chicago|Randee Estes, Study Coordinator|773-702-1209|restes@medicine.bsd.uchicago.edu|
22270451|NCT02730377|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22270452|NCT02706886|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22270453|NCT03917472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22270454|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu|
22270455|NCT02203851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22270456|NCT04934189|Hunter College of the City University of New York|Danielle S. Berke, Ph.D.|212-772-5550|db2800@hunter.cuny.edu|
22312496|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312497|NCT04658888|Penn State Health Milton S Hershey Medical Center|Dr. Christina Scartozzi|484-650-0885|Cscartozzi@pennstatehealth.psu.edu|
22270457|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com|
22270458|NCT03834974|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
22270459|NCT03781583|University of Michigan Medical School|James Weiland|734-764-9793|weiland@umich.edu|
22270460|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22270461|NCT01883817|University of Cincinnati|Director Clinical Research Management|513-558-8621|gayathri.kavikondala@uc.edu|
22270462|NCT03330262|Barron Associates|Principal Research Scientist|434-973-1215|barron@barronassociates.com|125
22270463|NCT02980341|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22270464|NCT01647516|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
22270465|NCT03886519|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
22270466|NCT04964544|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22270467|NCT03875274|BPKIHS|Dr. Pankaj Baral|9856037077|pankajbaral7@gmail.com|
22270468|NCT01613222|GEHealthcare|Jeffrey Conner|414-477-8374|Jeffrey.Conner@ge.com|
22270469|NCT04748458|IRCCS Istituto Ortopedico Rizzoli|Dr Francesco Castagnini|+390516366418|francescocastagnini@hotmail.it|
22270470|NCT02691936|Cleveland Clinic Foundation|Dr. Marie Fidela Paraiso|216-444-3428|PARAISM@ccf.org|
22270471|NCT03829618|Penn State Hershey Medical Center|Zoulfira Nisnevitch-Savarese, M.D.|717-531-6597|znisnevitchsavarese@pennstatehealth.psu.edu|
22270472|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22270473|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com|
22270474|NCT04798989|Tisento Therapeutics|Clinical Research|1-857-259-5371|hello@tisentotx.com|
22270475|NCT04143594|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22270476|NCT00405522|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
22312498|NCT02644122|University of California, San Diego|Ezra Cohen, MD|(858)822-5800|ecohen@ucsd.edu|
22312499|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312500|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312501|NCT02514824|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
22312502|NCT05303324|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22312503|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22312504|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300||
22312505|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22312506|NCT03979040|VA Finger Lakes Health Care System|Dr. Nik Allan - Study Statistician|(850) 274-0567|Nicholas.Allan@osumc.edu|
22312507|NCT02354144|Division of Cancer Epidemiology, Department of Oncology, McGill University|Dr. Eduardo Franco|514-398-6032|eduardo.franco@mcgill.ca|
22312508|NCT04012970|Edinburgh Napier Univerisity|Rebecca Hamilton, PhD student|0131 455|rebeccaisabel.hamilton@napier.ac.uk|2350
22312509|NCT02978183|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
22312510|NCT02279732|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22312511|NCT01605435|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
22312512|NCT03020914|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
22312514|NCT04620733|CymaBay Therapeutics, Inc.|CymaBay Study Director|1-510-293-8800|medinfo@cymabay.com|
22312515|NCT02221934|Neuros Medical, Inc.|Nick Hargus, PhD. Vice President of Clinical and Medical Affairs|440-951-2565|nhargus@neurosmedical.com|
22312516|NCT03976102|Dr. Reddy's Laboratories Ltd.|Head - Clinical Development|91-40-4464-4000|RI-01-006@drreddys.com|
22312517|NCT03624023|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
22312518|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22312519|NCT01578278|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22312520|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu|
22312521|NCT02889900|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazenca.com|
22281156|NCT03082677|Memorial Sloan Kettering Cancer Center|Dr. Doris Ponce, MD|646-608-3739|ponced@mskcc.org|
22281157|NCT01667133|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22281158|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22281159|NCT00626886|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22281160|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu|
22281161|NCT02057640|Cleveland Clinic Taussig Cancer Center|Jason Valent, MD|216-445-7238|valentj3@ccf.org|
22281162|NCT03835481|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281163|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22281164|NCT02063984|Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health|Alan J. Budney, Ph.D|603-646-7088|alan.budney@dartmouth.edu|
22281165|NCT04175340|Bausch + Lomb Incorporated|Senior Manager, Clinical Trials|(585) 623-9588|Margaret.Swartzenberg@bausch.com|
22281166|NCT02901249|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|51999185180|afbslima@gmail.com.br|
22281167|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281168|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668||
22281169|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525|dychen@vghtc.gov.tw|3354
22281170|NCT02008149|Department of Veterans Affairs|Dr. Gary S. Beaupre|(650) 493-5000|Gary.Beaupre@va.gov|64272
22281171|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281172|NCT03497039|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281173|NCT02781571|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22281174|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22281175|NCT03554018|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22281176|NCT01925040|Kulzer GmbH|Global Scientific Affairs Management|+4915116891006|andrea.leyer@kulzer-dental.com|
22281177|NCT03148379|Medacta USA|Rena Mandino, Director of Clinical Research|352-359-3581|rmandino@medacta.us.com|
22281178|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
22281179|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22281180|NCT02953561|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|ndaver@mdanderson.org|
22281181|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com|
22281182|NCT00556439|Cleveland Clinic|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
22281183|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
22281184|NCT02100423|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Paolo Caimi|1-800-641-2422|paolo.caimi@uhhospitals.org|
22281185|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281186|NCT02195700|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22281187|NCT04601532|University of Pittsburgh|Eleanor Shirley, MA CCRC|412-383-7712|shirleye@upmc.edu|
22312522|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu|
22312523|NCT04351243|Kinevant Sciences, Inc. on behalf of Kinevant Sciences GmbH|Simon Lowry, MD, Chief Medical Officer|(646) 495-5368|simon.lowry@roivant.com|
22312524|NCT01416285|Chang Gung Memorial Hospital|CHAO-HUNG WANG, MD|+886-2-24313131|bearty54@gmail.com|2923
22312525|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com|
22312526|NCT04785794|FluGen|Pamuk Bilsel, CSO|608-442-6562|pbilsel@flugen.com|
22312527|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu|
22312528|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22312529|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu|
22312530|NCT01540474|Walter Reed Institute of Research|Jason W. Bennett|3013199477|jason.w.bennett.mil@mail.mil|
22312531|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22312532|NCT01587703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312533|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22312534|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
22312535|NCT03029156|Tufts Medical Center|Nicholas S. Hill|617-636-0688|nhill@tuftsmedicalcenter.org|
22325120|NCT04407507|Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V|Carmen de la Rocha|523320028697|carmen.delarocha@investigacionbiomedica.com.mx|306
22325121|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr|
22325122|NCT01731691|Institute for Human Genetics and Biochemistry|Dr. Cynthia L. Bristow|631-444-6238|cynthia.bristow@stonybrook.edu|
22325123|NCT04109443|Boston University School of Public Health|Kimberly M Nelson, PhD|617-358-1482|knel@bu.edu|
22325124|NCT02984878|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
22325125|NCT03396471|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22325126|NCT01319929|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325127|NCT03237845|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22270477|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927|Roman.Korolkiewicz@morphosys.com|208
22325128|NCT01221233|University of Delaware, Department of Physical Therapy|Dr. Jaclyn Megan Sions, PhD, DPT, PT|302-831-7231|megsions@udel.edu|
22325129|NCT04355117|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22270478|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
22270479|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22325130|NCT03865407|Virginia Commonwealth University|Cristin Kaspar, MD|804-628-3866|cristin.kaspar@vcuhealth.org|
22270480|NCT01154088|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270481|NCT05129137|Unither Pharmaceuticals|Non-Clinical and Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22270482|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22281188|NCT01352221|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22281189|NCT02949024|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22281190|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22281191|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu|
22281192|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
22281193|NCT02159898|Merit Medical, Inc|Casey Holland|7816817983|casey.holland@merit.com|
22281194|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22281195|NCT03206970|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281196|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu|
22281197|NCT04136548|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
22281198|NCT03654040|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22312536|NCT04812977|Hayatabad Medical Complex, Peshawar|Yousaf Jamal Mahsood|091921714047|yousaf82@hotmail.com|
22281199|NCT02377752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281200|NCT01709110|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281201|NCT01951586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281202|NCT02789345|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281203|NCT02802293|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
22281204|NCT01222091|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
22281205|NCT03286543|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
22281206|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249|ron.zimmerman@plxpharma.com|205
22281207|NCT01204905|University of Maryland, Baltimore, IHV|Gregory Brogden|410-706-1660|gbrogden@ihv.umaryland.edu|
22281208|NCT02836717|Department of Surgery, Cantonal Hospital St. Gallen|Dr Lukas Marti|+41 71 494 11 11|lukas.marti@kssg.ch|
22281209|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22281210|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281211|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281212|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22281213|NCT02767869|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
22281214|NCT03125031|Masimo|Tala Harake||studies@masimo.com|
22281215|NCT02544035|National Institute of Child Health and Human Development|Dr. Diane Putnick|301-496-6291|putnickd@mail.nih.gov|
22281216|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22325131|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
22270483|NCT02949843|Wake Forest Baptist Comprehensive Cancer Center|William Petty|3367163313|wpetty@wakehealth.edu|
22281217|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org|
22312537|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22270484|NCT05831644|Vicore Pharma AB|Director Clincial Operations|+46 (0) 31 788 05 60|info@vicorepharma.com|
22270485|NCT02693171|United Therapeutics Corp.|Odette Jordan, MD, PMP|919-425-5606|ojordan@unither.com|
22270486|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22312538|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22312539|NCT04626128|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
22312540|NCT03209492|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22312541|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22312542|NCT04908488|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22312543|NCT02432183|KU Leuven|Dominique MA Bullens|3216341338|dominique.bullens@kuleuven.be|
22312544|NCT01894620|University of Manitoba|Dr Zahra Moussavi|204 474-7023|Zahra.Moussavi@umanitoba.ca|
22312545|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
22312546|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu|
22312547|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22312548|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22312549|NCT02707952|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22312550|NCT01141075|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22312551|NCT01326455|UAlberta|Jennifer Fech||jennifer.fech@albertahealthservices.ca|
22312552|NCT03072862|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22312553|NCT02203513|National Cancer Institute|Dr. Jung-min Lee|240-760-6128|leej6@mail.nih.gov|
22312554|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312555|NCT01331408|Galderma Uppsala|Head of Medical Affairs|+46 (0)18 474 9000|receptionen.SEUPP@galderma.com|
22312556|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com|
22312557|NCT03015220|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22312558|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov|
22312559|NCT03055988|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312560|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22312561|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn|
22312562|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com|
22312563|NCT01156675|Globus Medical|Director, Clinical Affairs|610-930-1800|jmyer@globusmedical.com|1669
22312564|NCT01970527|University of Washington Medical Center|Dr. Ramesh Rengan|206-598-4100|rengan@uw.edu|
22312565|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com|
22312566|NCT01974102|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
22312567|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com|
22312568|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22312569|NCT00845520|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
22312570|NCT02613403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312571|NCT02934932|Duke University|Dr. Steven Szabo|919-681-8742|steven.szabo@duke.edu|
22312572|NCT02067819|Weill Cornell Medicine|Shannon Bennett, PhD|646-962-2820|smb9017@med.cornell.edu|
22312573|NCT00800176|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312574|NCT00779194|STATE UNIVERSITY OF NEW YORK|Andras Perl|3154644194|perla@upstate.edu|
22312575|NCT02326220|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22312576|NCT02699099|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312577|NCT01094106|Kuopio University Hospital|Matti Reinikainen|+358447176681|matti.reinikainen@kuh.fi|
22312578|NCT02659540|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22312579|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312580|NCT00882050|University of Pennsylvania|Kim Lacy, RN BSN|215-893-7234|kim.lacy@uphs.upenn.edu|
22312581|NCT01782209|University of Alabama at Birmingham|Richard J. Whitley, MD|205.638.2530|rwhitley@peds.uab.edu|
22312582|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22325132|NCT02723162|Medical University of South Carolina|Dr. Kevin Gray|843-792-9162|graykm@musc.edu|
22270487|NCT01512446|Ruhr-Universität Bochum|Johannes Pfeilschifter, MD||Johannes.Pfeilschifter@rub.de|
22270488|NCT03085238|MTrap|Vice President, RA/QA/CA|3013258537|cmitchell@m-trap.com|
22270489|NCT01992653|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22270490|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com|
22270491|NCT01706939|Icahn School of Medicine at Mount Sinai|Dr. Marshall R Posner|(212) 659-5461|marshall.posner@mssm.edu|
22270492|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270493|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com|
22270494|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22270495|NCT02344251|MUSC|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
22270496|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu|
22281218|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22281219|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu|
22281220|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181|hctsai.anes@gmail.com|8310
22281221|NCT04908865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281222|NCT05286658|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
22281223|NCT01959178|Bausch Health|Study Director||robert.steffen@bausch.com|
22312583|NCT02739100|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22312584|NCT04820491|Virginia Commonwealth University|Jordan Tozer|804-828-5250|jordan.tozer@vcuhealth.org|
22312585|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22312586|NCT02024477|The George Washington University|Dr Saby Sen|202-994-8560|ssen1@gwu.edu|
22312587|NCT03072238|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22312588|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca|
22312589|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com|
22312590|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu|
22312591|NCT02416102|University of Miami|Matthias Salathe, MD|913-588-6000|msalathe@kumc.edu|
22312592|NCT02958826|University of Missouri|Dr. Hope Gole|573-882-8030|golehk@health.missouri.edu|
22312593|NCT01919489|Emory University|Dr. Francisco Pasquel|404-778-1695|fpasque@emory.edu|
22312594|NCT03884478|Loyola Marymount University|Dr. Sarah C. Boyle, Senior Research Scientist|3105686681|sarah.boyle@lmu.edu|
22312595|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
22312596|NCT04271254|University of North Carolina Lineberger Comprehensive Cancer Center|David Lalush|9195137671|dlalush@email.unc.edu|
22312597|NCT04751929|Dana-Farber Cancer Institute|Atish Choudhury, MD PhD|6176326328|atish_choudhury@dfci.harvard.edu|
22312598|NCT02962609|Istanbul University|Duygu Gözen (Associate Professor)|+902124400000|dgozen@istanbul.edu.tr|27082
22312599|NCT01732419|Maxima Medical Center|Dr. J. Kraal|+31612520944|j.kraal@mmc.nl|
22312600|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040||2917
22312601|NCT02662023|University of California, San Diego|Brian M. Ilfeld, MD, MS||bilfeld@ucsd.edu|
22312602|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com|
22312603|NCT03557307|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
22312604|NCT03745651|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22312605|NCT04175834|Providence Health & Services|Chiayi Chen, Director of WC/PBSI Clinical Research Program|503-216-1012|Chiayi.Chen@providence.org|
22312606|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu|
22312607|NCT03490942|Xeris Pharmaceuticals|B J. Witkin|919-412-6483|bwitkin@xerispharma.com|
22312608|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com|
22312609|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
22312610|NCT04239911|Weill Cornell Medicine|Dr. Madeline Sterling|646-962-5029|mrs9012@med.cornell.edu|
22281224|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281225|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020|neda.rasouli@ucdenver.edu|4314
22281226|NCT03248167|NYU Langone Health|Charles Marmar, MD|646-754-4855|Charles.marmar@nyumc.org|
22281227|NCT02122146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281228|NCT03472495|Virginia Commonwealth University|Tammy Nguyen, PharmD|8046630969|Tammy.Nguyen@vcuhealth.org|
22281229|NCT03578926|CooperVision Inc.|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22281230|NCT02584452|Vanderbilt University Medical Center|Christopher Sobey, MD|615-322-4311|christopher.m.sobey@vumc.org|
22281231|NCT02998671|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22281232|NCT04560686|UT MD Anderson Cancer Center|Dr. Tina Cascone,MD- Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|tcascone@mdanderson.org|
22281233|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov|
22281234|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com|
22281235|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu|
22281236|NCT02846792|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
22281237|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com|
22281238|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
22281239|NCT04222699|VA Maryland Healthcare System|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
22281240|NCT01958580|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio - Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
22281241|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu|
22281242|NCT01763333|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281243|NCT03583359|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22281244|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu|
22312611|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
22312612|NCT03823794|Guy's & St Thomas' NHS Foundation Trust|Carsten Flohr|020 7188 8884|carsten.flohr@kcl.ac.uk|
22312613|NCT03345407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312614|NCT01584648|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22270497|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br|
22270498|NCT00135512|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270499|NCT01094301|SPRTherapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22270500|NCT03600194|Philips|Jeff Jasko|412-542-3836|jeff.jasko@philips.com|
22270501|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com|
22270502|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22270503|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com|
22270504|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22270505|NCT02119455|University of Connecticut- Division of Orthodontics|Dr. Flavio Uribe|8606792550|furibe@uchc.edu|
22270506|NCT02439814|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22270507|NCT02754427|University of British Columbia|Dr. Kristin Campbell|604-827-4704|kristin.campbell@ubc.ca|
22270508|NCT02147158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22270509|NCT04520997|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22270510|NCT03689374|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22270511|NCT05367973|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22270512|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org|
22270513|NCT01758731|University of Colorado, Denver|Dr. David Raben|303-724-3027|david.raben@ucdenver.edu|
22270514|NCT04445714|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22270515|NCT06137131|Ghent University|Dr. Iris Meerschman|+32499294636|iris.meerschman@ugent.be|
22312615|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
22312616|NCT03693989|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22312617|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22312618|NCT03146845|Smith & Nephew, Inc.|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
22312619|NCT03403153|Department of Veterans Affairs|Dr, Suzannah Creech Ph.D|254-297-3025|suzannah.creech@va.gov|
22312620|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
22270516|NCT02396420|South Florida Medical Imaging|Cynthia Toot ARNP|954-267-6626|cynthia.toot@holy-cross.com|
22270517|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22270518|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com|
22270519|NCT01640379|Johns Hopkins University|Dr. Maria Trent|4109552910|mtrent2@jhmi.edu|
22270520|NCT04223635|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22270521|NCT04965311|OHSU Knight Cancer Institute|Dr. Brett Sheppard|503-494-9169|sheppard@ohsu.edu|
22270522|NCT02551770|GWD Consult|Dr. Manfred Klasser|+49 6108 825 65 20|manfred.klasser@gwd-consult.de|
22270523|NCT02122887|Bar Ilan University|Moran Influs|972-35317943|moran.influs@gmail.com|
22270524|NCT03320850|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22270525|NCT06207149|Vanderbilt University|Meghan Burke|6153431014|meghan.burke@vanderbilt.edu|
22270526|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu|
22270527|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
22270528|NCT03796442|Seoul National University Hospital|Prof. Ho Young Hwang|00-82-2-2072-3020|scalpel@snu.ac.kr|
22270529|NCT02893553|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22270530|NCT02086448|University of Pittsburgh|Dr. Francesca Facco|412-641-1220|Faccof@upmc.edu|
22270531|NCT01968356|3M Health Care|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
22270532|NCT02031640|Teva Branded Pharmaceutical Products, R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22270533|NCT02161484|University of Pittsburgh|Dr. Rita Merman, P.I.|41256322137|MermanRB@upmc.edu|
22270534|NCT02173522|University of Miami|Shivank Bhatia|305-243-7500|sbhatia1@med.miami.edu|
22270535|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22270536|NCT00635453|Universidade Federal de Ciências da Saúde de Porto Alegre|Dr. Marcia Vitolo|+555133038798|marciavitolo@hotmail.com|
22270537|NCT02091375|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22270538|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org|
22270539|NCT04720911|UMass Chan Medical School|Dr. Celine Larkin|5084211436|celine.larkin@umassmed.edu|
22270540|NCT04807205|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22270541|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22270542|NCT00949403|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22270543|NCT04533412|Icahn School of Medicine at Mount Sinai|Alex D. Federman, MD, MPH|(212) 824-7565|alex.federman@mountsinai.org|
22270544|NCT03261674|VA Palo Alto|Dr Ansgar Furst; Rayma Williams|(650) 339-4015|ansgar.furst@va.gov; rayma.williams@va.gov|
22270545|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270546|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com|
22270547|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org|
22270548|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com|
22270549|NCT01730534|AstraZeneca|Global Study Leader|+49 4103 708 3792|Sandra.ranft@astrazeneca.com|
22270550|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu|
22270551|NCT03614078|PRCL Research Inc|Caroline Fortier|1-514-708-4417|caroline.fortier@prclresearch.com|
22270552|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
22270553|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
22270554|NCT02050919|OHSU Knight Cancer Institute|Christopher Ryan, MD|503-494-8487|ryanc@ohsu.edu|
22270555|NCT03696108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270556|NCT02643849|SRS Medical|Director of Clinical Trials|800-345-5642|info@srsmedical.com|
22270557|NCT03505593|ENvizion Medical|Clinical Director|+972-72-2288240|anath@envizionmed.com|
22312621|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU|
22312622|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22270558|NCT03891862|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22270559|NCT01053962|Synergy Pharmaceuticals Inc|Dr. Laura Barrow/Senior Vice President Clinical Development|212-297-0020|lbarrow@synergypharma.com|
22312623|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
22270560|NCT02833844|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22270561|NCT02809859|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|7044
22270562|NCT01646021|Janssen-Cilag International NV|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22270563|NCT02347891|Northwell Health|Principal Investigator|5167082550|gmarder@northwell.edu|
22270564|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
22270565|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22270566|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov|
22270567|NCT04439214|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22270568|NCT02964208|Abbott|Ryan Gage|+1 612 805 6398|ryan.gage@abbott.com|
22270569|NCT05476250|Masimo Coporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22270570|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22270571|NCT04013672|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
22270572|NCT04257032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270573|NCT02847494|Montefiore Health|Benjamin W. Friedman, MD|17189206626|befriedm@montefiore.org|
22270574|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
22270575|NCT03887442|TTCC Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Carmen Montalbán, Manager|+34676154172|ttccmanager@yahoo.com|
22270576|NCT06343467|TRIA Orthopedic Center|Megan Reams; Director of Orthopaedic Research|(952) 806-5329|megan.reams@tria.com|
22270577|NCT01628198|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22270578|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22270579|NCT03386994|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270580|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu|
22270581|NCT04553471|Washington University School of Medicine|Pamela Samson, M.D.|314-747-1786|psamson@wustl.edu|
22270582|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu|
22270583|NCT03129945|University of California, Irvine|Judith Chung|714-456-8695|judithc@hs.uci.edu|
22270584|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22270585|NCT03699280|Imperial College London|Ms Nandita Deo|07939360357|nandita.deo@gmail.com|
22270586|NCT01684943|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
22270587|NCT01493284|St Jude Medical|Sr Clinical Scientist|4159179696|alicia.kimber@abbott.com|
22312624|NCT04184271|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22312625|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262|dennis.bourdette@va.gov|54594
22312626|NCT02632747|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312627|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312628|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com|
22325133|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22325134|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22270588|NCT03395184|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270589|NCT02060058|Kaohsiung Medical University Hospital|Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine|+886-7-3121101|hsmonyan@gmail.com|6770
22270590|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
22270591|NCT05033262|The University of Pennsylvania School of Nursing|Emily Summerhayes|6099233786|esummer@nursing.upenn.edu|
22270592|NCT03197467|AIO-Studien-gGmbH|AIO-Studien-gGmbH Help Desk|0049-30-8145344|info@aio-studien-ggmbh.de|31
22270593|NCT03666533|Department of Veterans Affairs Northeast Ohio Healthcare system|Dr. Svetlana Pundik|216-791-3800|svetlana.pundik@va.gov|63732
22270594|NCT02017717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22325135|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22270595|NCT01515462|Fondazione Telethon ETS|Sean Russell|+39 02 2022 17210|srussell@telethon.it|
22281245|NCT00508105|Ottawa Hospital Research Institute|Peter Lapner|613-737-8899|plapner@toh.ca|74700
22312629|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu|
22281246|NCT02299141|Washington University School of Medicine|Ramaswamy Govindan|314-362-5654|rgovindan@wustl.edu|
22312630|NCT03875729|Sanofi|Clinical and Translational Medicine Lead|1-703-344-2992|laura.knecht@sanofi.com|
22312631|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22312632|NCT04085614|Philips Medical Systems Nederland B.V.|Peter Eshuis|+31628739280|peter.g.eshuis@philips.com|
22312633|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu|
22281247|NCT02567799|Humanetics Corporation|Michael D. Kaytor|952-400-0406|mkaytor@humaneticscorp.com|
22312634|NCT05265247|HALEON|Haleon Response Center|+4407880182593|ww.clinical-trial-register@haleon.com|
22312635|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com|
22312636|NCT02516202|Fred Hutchinson Cancer Research Center|Dr. Katherine A. Guthrie|2066675595|kguthrie@fredhutch.org|
22281248|NCT02870985|Fuwai Hospital|Prof. Yuejin Yang|008613701151408|yangyjfw@126.com|
22281249|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918||
22281250|NCT03913013|UCLA Semel Institute for Neuroscience and Behavior|David J. Miklowitz, Ph.D., Principal Investigator|(310) 267-2659|dmiklowitz@mednet.ucla.edu|
22281251|NCT03693144|University of Michigan|Dr. Susan Woolford|734 615-8214|swoolfor@med.umich.edu|
22281252|NCT04068948|University of Washington|Travis Nelson|206-543-0980|tmnelson@uw.edu|
22281253|NCT00790582|Forbes Norris MDA/ALS Center|Giovanna Kushner|415-600-3983|kushneg@cpmcri.org|
22281254|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22281255|NCT02566785|University of Nebraska Medical Center College of Nursing|Dr. Rita McGuire|402-472-4712|rita.mcguire@unmc.edu|
22281256|NCT01597908|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22281257|NCT02384044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22281258|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22281259|NCT02521974|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
22281260|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22281261|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281262|NCT02025634|AdventHealth|Brad Homan|407-303-4270|Brad.Homan.MD@AdventHealth.com|
22281263|NCT00936663|University of Nebraska Medical Center|Vijay Shivaswamy|402-559-6208|vshivaswamy@unmc.edu|
22281264|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com|
22281265|NCT05244603|Utah State University|Dr. Sarah Yoho Leopold|6145708258|sarah.leopold@usu.edu|
22281266|NCT05897242|Fred Hutchinson Cancer Center|Jaimee Heffner, Associate Professor|2066677314|jheffner@fredhutch.org|
22281267|NCT03522246|pharmaand GmbH|Medical Information Department|1-800-506-8501|medinfo@pharmaand.com|
22281268|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com|
22281269|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281270|NCT04309370|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
22281271|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486|kathleen.carroll@yale.edu|7403
22281272|NCT02547038|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22281273|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22281274|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
22281275|NCT05160415|Edgewise Therapeutics, Inc.|Joanne Donovan MD PhD, Chief Medical Officer|720-262-7002|studies@edgewisetx.com|
22281276|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org|
22281277|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
22281278|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org|
22281279|NCT02058511|UCSF|Matthias Behrends|415 476 3761|matthias.behrends@ucsf.edu|
22281280|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22281281|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281282|NCT00559845|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22281283|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22281284|NCT01525862|Stryker ENT|Principal Clinical Research & Publications Manager|764-463-1598|ellen.omalley@stryker.com|
22281285|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu|
22281286|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com|
22281287|NCT01475643|Valeant Pharmaceuticals NA|Denise Raimondo|9089721885|denise.raimondo@valeant.com|
22281288|NCT03645421|AstraZeneca|Global Clinical Lead|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
22281289|NCT02120781|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
22281290|NCT02685566|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22281291|NCT00694577|Massachusetts General Hospital|Alphonse Taghian|6177261160|ataghian@mgh.harvard.edu|
22281292|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu|
22281293|NCT05332392|Masimo|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
22281294|NCT01268046|Massachusetts General Hospital|Janet Hall, MD|617-877-1112|janet.hall@nih.gov|
22312637|NCT02841449|University of Bath|Dr Harriet Carroll|+447706548573|hac38@bath.ac.uk|
22281295|NCT03850093|faculty of medicine- Zagazig university|assistant professor Abeer M. Elnakera|00201005720754|nakera35@hotmail.com|
22281296|NCT03636893|RUIJIN HOSPITAL|Dr BIRENDRA KUMAR SAH|0086-64370045|rjsurgeon@hotmail.com|671302
22281297|NCT02314156|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22281298|NCT03415581|New York State Psychiatric Institute|Jermaine Jones PhD|6467746113|jermaine.jones@nyspi.columbia.edu|
22281299|NCT04918381|Pulse Biosciences, Inc.|William Knape / VP, Clinical, Regulatory and Quality Affairs|919-757-2033|bknape@pulsebiosciences.com|
22281300|NCT02455804|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22281301|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22312638|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22281302|NCT04560816|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22281303|NCT03226249|Northwestern University, Feinberg School of Medicine|Jane N. Winter, M.D.|(312) 695-4538|j-winter@northwestern.edu|
22281304|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22281305|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22281306|NCT02846389|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22281307|NCT04343534|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22281308|NCT01804049|VAORD - Portland VA Health Care System|Dr Robert Klein|503-220-8268|kleinro@ohsu.edu|57496
22281309|NCT03985943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22281310|NCT01858545|Integra LifeSciences|Manager, Clinical Research|443-766-3869|allison.matthews@integralife.com|
22281311|NCT04075513|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22281312|NCT05730335|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22281313|NCT03629223|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22281314|NCT01122446|LundU|Helena Elding Larsson, PI|+4640337676|helena.elding_larsson@med.lu.se|
22281315|NCT01369199|University of Pittsburgh|Dr. Steven Belle|412-624-5419|belle@edc.pitt.edu|
22281316|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu|
22281317|NCT03902392|University of Bari|Thea TM Magrone, BD|+39 080 5478584|thea.magrone@uniba.it|
22281318|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22281319|NCT02038946|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22281320|NCT02548910|Ottawa Hospital Research Institute|Dr. Guillaume Martel|6137378899|gumartel@toh.ca|71053
22281321|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22281322|NCT01267864|Albert Einstein College of Medicine, Montefiore Medical Center|Benjamin Friedman, MD|718-920-6626|befriedm@montefiore.org|
22281323|NCT02467192|Hopitaux Universitaires de Geneve|Dr Jerome Stirnemann|+41223729101|jerome.stirnemann@hcuge.ch|
22281324|NCT03213938|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22281325|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu|
22281326|NCT01814046|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
22281327|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22281328|NCT04552288|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
22281329|NCT00375505|Novartis|Study Director|862-778-8300||
22281330|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
22281331|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org|
22281332|NCT03335150|VASDHS|Dr. Dawn Schiehser|858-552-8585|Dawn.Schiehser@va.gov|2664
22281333|NCT02991898|Masonic Cancer Center, University of Minnesota|Claudio Brunstein|612-625-3918|bruns072@umn.edu|
22281334|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu|
22281335|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281336|NCT02122666|Washington University School of Medicine|Samantha Adamson, MD, PhD|314-362-3500|sadamson@wustl.edu|
22281337|NCT02142803|Dana Farber Cancer Institute|Christine Sceppa McCluskey|617-632-5394|christine_sceppa@dfci.harvard.edu|
22281338|NCT02591472|University of Florida|MaryBeth Horodyski, EdD|352-273-7074|horodmb@ortho.ufl.edu|
22281339|NCT05111002|University of Washington|Lisa E Manhart|206-744-3646|lmanhart@uw.edu|
22281340|NCT04380753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281341|NCT04776720|University of California, San Francisco|Alison Huang, MD, MAS, MPhil|415-353-7900|alison.huang@ucsf.edu|
22281342|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281343|NCT03306433|University of Colorado, SoDM|Clifton Carey|3037241046|clifton.carey@cuanschutz.edu|
22281344|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu|
22281345|NCT01575808|Toyko Jikei University Hospital|Dr. Takao Ohki|81-090-2478-8304|takohki@msn.com|
22281346|NCT01527045|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fredhutch.org|
22281347|NCT03224403|JNJWorldwide|Andrew Myers, MD|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
22281348|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281349|NCT01271010|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22312639|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22281350|NCT01631747|Northwestern University|Mary J. Kwasny|312-503-2294|m-kwasny@northwestern.edu|
22312640|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22281351|NCT02908685|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22312641|NCT02951702|St. Luke's Hospital|Ryan Medas, Pharm.D.|314-205-6053|ryan.medas@stlukes-stl.com|
22281352|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281353|NCT04308239|Virginia Tech|Michael Madigan|(540) 231-3543|mlm@vt.edu|
22281354|NCT03713398|University of North Carolina at Chapel Hill|Amy Wilson, PhD|919-962-3598|amyblank@email.unc.edu|
22281355|NCT05791565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281356|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281357|NCT02516982|Imperial College London|Dr Josip Car|+44(0)2075940799|josip.car@imperial.ac.uk|
22281358|NCT03487588|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
22281359|NCT03379259|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281360|NCT03195660|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
22281361|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281362|NCT00924612|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
22281363|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22281364|NCT03818607|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281365|NCT03560102|Kantonsspital Winterthur|Christoph A Binkert (Sponsor-Investigator)|+41 52 266 2602|christoph.binkert@ksw.ch|
22281366|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22281367|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com|
22312642|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org|
22281368|NCT03588806|University of Pittsburgh|Dr. Ajay D. Wasan|4126658030|wasanad@upmc.edu|
22312643|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com|
22281369|NCT02249091|GSO mbH|Dr Anne L. Kranich|+494044195460|kranich@gsoglobal.com|
22325136|NCT02052960|Glycotope GmbH|Senior Director Clinical Department|0049309489|contact@glycotope.com|2600
22325137|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu|
22281370|NCT02342691|Forsyth|Hatice Hasturk|617-892-8499|hhasturk@forsyth.org|
22281371|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr|
22281372|NCT03249909|Mölnlycke Health Care|Andrea Marie Picchietti|260 2583879|andrea.picchietti@molnlycke.com|
22281373|NCT03517371|Center for Neurorehabilitation, College of Health & Rehabilitation, Sargent College, Boston University|Terry Ellis|617-353-2724|tellis@bu.edu|
22281374|NCT05411822|Icahn School of Medicine at Mount Sinai|Mariana Figueiro, PhD|(518) 366-9306|Mariana.Figueiro@mountsinai.org|
22281375|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22281376|NCT02819297|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22281377|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22281378|NCT02318368|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|(857) 400-0101|Clinical@aveooncology.com|
22281379|NCT01901614|Oregon Health & Science University|David Huang, MD, PhD|503-494-3000|huangd@ohsu.edu|
22281380|NCT02702609|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22281381|NCT02674464|Johns Hopkins University School of Medicine|Dr. Lisa Cooper, Principal Investigator|4106143659|lisa.cooper@jhmi.edu|
22281382|NCT04153981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281383|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu|
22281384|NCT01262638|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22281385|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281386|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu|
22281387|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu|
22281388|NCT00260832|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22281389|NCT01104545|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281390|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov|
22281391|NCT02723916|The Ohio State University, College of Nursing|Dr. Susie Breitenstein|6146884614|breitenstein.5@osu.edu|
22281392|NCT04532294|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281393|NCT03089047|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
22281394|NCT02146131|Medical University of South Carolina|Kate Taylor|843-792-2297|Talykat@musc.edu|
22281395|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22281396|NCT02285023|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Prof. Kanokvalai Kulthanan|(662)419-4333|kanokvalai.kul@mahidol.ac.th|
22281397|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281398|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
22281399|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org|
22312644|NCT03065400|Icahn School of Medicine at Mount Sinai|Mikaela Dougherty|212-241-8839|Mikaela.dougherty@mssm.edu|
22312645|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312646|NCT03347396|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22312647|NCT02312258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22325138|NCT04045613|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 76 302 53 10|manuel.haeckl@basilea.com|
22281400|NCT05356910|University of California, San Diego|Heather Pines|619-594-2481|hpines@health.ucsd.edu|
22325139|NCT02228499|The George Washington University|Dr. Seema Agrawal|202 699 1648|seema300@yahoo.com|
22281401|NCT03321071|University of South Carolina|R. Glenn Weaver|803-777-5606|weaverrg@email.edu|
22281402|NCT02712996|Vanderbilt University Medical Center|Michael Tramontana,PhD|615-327-7144|michael.tramontana@vumc.org|
22312648|NCT04182217|Université d'État d'Haïti|Axler JEAN PAUL, Author|+50943776900|jeanpaulaxler@hotmail.com|
22312649|NCT04343716|University of Alabama at Birmingham|Dr. Robert Sorge|2059348563|rsorge@uab.edu|
22312650|NCT00946998|University of Texas Southwestern Medical Center|Susan Hedayati, MD, Professor of Medicine|214-645-6106|susan.hedayati@utsouthwestern.edu|
22312651|NCT01945593|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22281403|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800|yhchen@mail.cgu.edu.tw|5233
22281404|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com|
22270596|NCT04488419|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
22270597|NCT03309657|University of Queensland Center for Clinical Research|Prof. Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
22270598|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
22270599|NCT01470781|McLean Hospital/Harvard Medical School|Dr. Kathryn Lewandowski|617-855-2886|klewandowski@mclean.harvard.edu|
22270600|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270601|NCT03192995|University of California at San Francisco|Dr. Glenn-Milo Santos, Associate Professor|415-867-1151|glenn-milo.santos@ucsf.edu|
22270602|NCT03506568|Devers Eye Institute|Dr. Robert Kinast|503-413-8202|robertkinast@gmail.com|
22270603|NCT05210101|Brigham and Women's Hospital|Sophia Koo, MD|6175258418|skoo@bwh.harvard.edu|
22270604|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu|
22270605|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu|
22270606|NCT04630249|The Medical University of South Carolina|Constance Guille|843-792-6489|guille@musc.edu|
22270607|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
22270608|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22270609|NCT04594941|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
22270610|NCT03408444|Johnson & Johnson Vision Care, Inc.|Xu Cheng - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
22270611|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu|
22270612|NCT03728426|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Dr. Amy Sherman|6175253575|acsherman@bwh.harvard.edu|
22270613|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100||
22270614|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com|
22270615|NCT02682823|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270616|NCT01995175|GlaxoSmithKline|GSK Response Center|866-435-7343|lr24921@gsk.com|
22270617|NCT01741792|Amgen, Inc.|Study Director|866-572-6436||
22270618|NCT02045862|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
22270619|NCT03961061|Wake Forest Health Sciences|Justin B. Moore, PhD|336-716-3702|jusmoore@wakehealth.edu|
22270620|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu|
22270621|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com|
22270622|NCT02360631|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
22270623|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat|
22270624|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
22270625|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270626|NCT02822573|Wake Forest NCORP Research Base|Lead Biostatistician (Emily Dressler, PhD)|336-716-0891|NCORP@wakehealth.edu|
22281405|NCT00972517|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270627|NCT02319174|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22270628|NCT02892422|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22312652|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu|
22312653|NCT02232009|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
22312654|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22312655|NCT01131325|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22312656|NCT03761849|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22312657|NCT01272388|Washington University School of Medicine|Brian R. Lindman, MD|314-747-3617|brlindman@wustl.edu|
22312658|NCT02213094|UNC at Chapel Hill|Kim Boggess MD Principal Investigator|919-966-1601|kboggess@med.unc.edu|
22312659|NCT02163499|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22312660|NCT01107717|University of Texas Health Science Center at San Antonio|Muhammad Abdul-Ghani, MD|210-557-1157|abdulghani@uthscsa.edu|
22312661|NCT02301299|Northwestern University|Erin Wymore|3125033243|erin.wymore@northwestern.edu|
22312662|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312663|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com|
22312664|NCT02068352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22312665|NCT01286870|Mentor Worldwide, LLC|Laura Vellucci|(805) 879-6000|lvelucci@its.jnj.com|
22312666|NCT02740517|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
22312667|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312668|NCT04883541|Üsküdar Üniversitesi|Assistant Professor Tuğba YILMAZ ESENCAN|+905057084946|tugba.yilmazesencan@uskudar.edu.tr|
22312669|NCT01369147|Emory University|Thomas Ziegler, MD|404-727-7351|tzieg01@emory.edu|
22312670|NCT03456856|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22312671|NCT02043652|CDC|Alexande Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
22312672|NCT02542696|Sumitomo Pharma America, Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22312673|NCT03262389|Mayo Clinic|Michael C. Roarke, M.D.|480-342-0988|Roarke.Michael@mayo.edu|
22312674|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu|
22312675|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312676|NCT02955225|Rush University Medical Center|Dr. Markus Wimmer, Director Motion Analysis Laboratory|(312) 942 2789|markus_a_wimmer@rush.edu|
22312677|NCT04417907|Stanford University|Kimford Meador|650-721-5552|kmeador@stanford.edu|
22312678|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu|
22312679|NCT04421456|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22312680|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu|
22312681|NCT03651271|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22312682|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300||
22312683|NCT05104242|University Hospitals of Derby & Burton NHS Foundation Trust, Royal Derby Hospital|Catherine Johnson|01332 789354|catherine.johnson16@nhs.net|
22312684|NCT05756647|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo, MD|314-362-8641|piccirj@wustl.edu|
22312685|NCT02469155|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22312686|NCT02991118|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22312687|NCT02562521|Yale University School of Medicine|Dr. Krysten Bold|2039747603|krysten.bold@yale.edu|
22312688|NCT03400748|Spiration, Inc.|Lauri DeVore|425-636-5464|lauri.devore@olympus.com|
22312689|NCT01469585|University of Hawaii|Investigator|808-203-6500|blissk@hawaii.edu|
22312690|NCT02428595|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
22312691|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com|
22312692|NCT02764320|Mayo Clinic|Dr. Todd J. Schwedt|480-301-9443|Schwedt.Todd@mayo.edu|
22312693|NCT04765046|Medtronic|Ami Stuart|8017934800|ami.stuart@medtronic.com|
22312694|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
22312695|NCT03150589|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22312696|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22312697|NCT03529942|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22312698|NCT02314000|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
22312699|NCT00999336|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22312700|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312701|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov|
22312702|NCT03132571|Yale School of Medicine, Department of Psychiatry|Dr. Cenk Tek|(203) 974-7500|cenk.tek@yale.edu|
22312703|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22312704|NCT03839355|Mayo Clinic|Dr. Malini Madhavan|507-255-4152|Madhavan.Malini@mayo.edu|
22325140|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22312705|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312706|NCT01794689|Johns Hopkins University|Dr. Michael T. Smith, PhD|410-550-7000|msmith62@jhmi.edu|
22312707|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22312708|NCT03060525|University of Rochester|Dr. Steven Barnett|585-273-2548|steven_barnett@urmc.rochester.edu|
22270629|NCT04323306|MMV|Benoit Bestgen|+41 79 765 18 68|bestgenb@mmv.org|
22270630|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312709|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22270631|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
22270632|NCT04712019|3M|Biostatistics Manager|651-382-2876|swalters@mmm.com|
22312710|NCT01115309|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22312711|NCT04447287|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22312712|NCT05700851|University of Nottingham|Prof. Maarten Taal|01332224618|m.taal@nottingham.ac.uk|
22312713|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
22312714|NCT03246724|Boston Medical Center|Marissa Fiorello, Clinical Research Manager|617-414-8848|Marissa.Fiorello@bmc.org|
22270633|NCT04525079|Celltrion Inc|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
22312715|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312716|NCT02978716|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
22312717|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu|
22270634|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn|
22270635|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
22270636|NCT01084668|Abbott|Global Medical Services|800-633-9110||
22270637|NCT04789291|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270638|NCT03729570|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
22270639|NCT02447497|3M|Nancy Klinger|651 491 9433|nmklinger@mmm.com|
22270640|NCT02017912|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
22270641|NCT04569968|Bolu Abant İzzet Baysal University|Tamer ÇANKAYA|5335519171|tamercankaya@hotmail.com|+90
22312718|NCT00234832|Abbott|Global Medical Services|800-633-9110||
22312719|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312720|NCT04454125|University of Pittsburgh|Dr. Franziska Rosser|412-692-8429|franziska.rosser2@chp.edu|
22312721|NCT01922102|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22312722|NCT05203822|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22312723|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org|
22312724|NCT04343989|NYU Langone Health|Bonnie Lonze, MD, PhD|212-263-3865|bonnie.lonze@nyulangone.org|
22312725|NCT04077437|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22312726|NCT01816165|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicaresearchsupportcenter@ucdenver.edu|
22312727|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com|
22312728|NCT05087849|UCSF|Ayan Kusari|4153537800|ayan.kusari@ucsf.edu|
22312729|NCT02092909|Idera Pharmaceuticals|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22312730|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22312731|NCT02865083|Saint Louis University|Jennifer Goldkamp, MD|314-977-2574|jgolka2@slu.edu|
22312732|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312733|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com|
22325141|NCT04276558|Recordati Rare Diseases Sarl|Beatrice Martin, Clinical study Manager|+33 1 47 73 64 58|martin.be@recordati.com|
22325142|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com|
22325143|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22325144|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000|DKBIR@coloplast.com|1395
22325145|NCT03233048|Mayo Clinic|Dr. Imad Absah|507-266-0114|absah.imad@mayo.edu|
22325146|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206|maria.gutierrez@correounivalle.edu.co|103
22325147|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325148|NCT00691574|Oregon Health & Science University|Alfred Lewy, MD, PhD|(503) 494-7746|lewy@ohsu.edu|
22270642|NCT06191393|Aptitude Medical Systems, Inc|Brad Killingsworth|2814674855|brad.killingsworth@aptitudemedical.com|
22270643|NCT03912818|Stanford University|Sandy Srinivas|650-725-2078|sandysri@stanford.edu|
22270644|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
22270645|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270646|NCT04676451|Penn State Hershey Medical Center|Amy Longenecker|717-531-1513|alongenecker@pennstatehealth.psu.edu|
22270647|NCT02107859|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22270648|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu|
22281406|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22270649|NCT03852628|RTI International|PASA Core Leadership|919-541-6002|shirsch@rti.org|
22270650|NCT03767153|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
22270651|NCT04679311|Washington University School of Medicine|Steven Weintraub MD|314-652-4100|weintraub@wustl.edu|55298
22281407|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
22312734|NCT02010021|Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
22312735|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu|
22312736|NCT05866887|Dana-Farber Cancer Institute|Maimouna Oumar|617-632-3000|maimouna_sy@dfci.harvard.edu|
22312737|NCT03541369|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22312738|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312739|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22312740|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312741|NCT01107795|University of Alabama at Birmingham|Dr. Kirk Withrow|(205) 801-7874|kwithrow@uabmc.edu|
22312742|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22312743|NCT01894503|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22312744|NCT04749797|University of Pennsylvania|Timothy Lucas|(215) 662-3487|Timothy.Lucas@pennmedicine.upenn.edu|
22312745|NCT02513667|UT Southwestern Medical Center|Dr. Sawsan Rashdan|214-648-4180|Sawsan.Rashdan@UTSouthwestern.edu|
22312746|NCT02429115|Penn State College of Medicine - Penn State Health|Nasrollah Ghahramani|7175318156|nghahramani@pennstatehealth.psu.edu|
22312747|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com|
22312748|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu|
22312749|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu|
22312750|NCT02291549|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22312751|NCT00537914|Sandoz|Clinical Disclosure Representative|+4980249080|sandoz.disclosure@sandoz.com|
22312752|NCT01180959|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD- Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
22312753|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu|
22312754|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se|
22312755|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org|
22312756|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu|
22312757|NCT01502813|University of Utah, Diagnostic Neuroimaging Lab|Deborah Yurgelun-Todd, Ph.D.|801-587-1538|Deborah.Yurgelun-Todd@hsc.utah.edu|
22312758|NCT02302157|Lineage|Avi Ben Shabat, MD|+972-509105205|avi@cellcure.co.il|
22312759|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238||
22312760|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu|
22312761|NCT03032198|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
22312762|NCT02470806|Smith & Nephew, Inc.|Natasha Schappell, CCRP|817-302-3949|natasha.schappell@smith-nephew.com|
22312763|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu|
22312764|NCT00866619|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312765|NCT02579915|McLean Hospital|Courtney Beard|16178553557|CBEARD@MCLEAN.HARVARD.EDU|
22312766|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
22312767|NCT05062343|Brigham and Women's Hospital|Sarah Little|6174557372|selittle@bwh.harvard.edu|
22312768|NCT01307800|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312769|NCT02892019|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22270652|NCT01923298|The University of Arizona Cancer Center|Dr. Pavani Chalasani|520-626-0191|pchalasani@uacc.arizona.edu|
22270653|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270654|NCT04064411|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
22270655|NCT01188876|Massachusetts General Hospital|Marcela del Carmen, MD, MPH|617-724-4800|MDELCARMEN@mgh.harvard.edu|
22270656|NCT03512210|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|301-628-3348|ACTGCT.gov@fstrf.org|
22270657|NCT01672710|Institute for Health and the Environment, University at Albany|David O. Carpenter MD|518-525-2660|dcarpenter@albany.edu|
22270658|NCT03725761|Wisconsin Institutes for Medical Research|Joshua M Lang, MD, MS|(608) 265-8131|jmlang@medicine.wisc.edu|
22270659|NCT05239494|University of Alabama at Birmingham|Andrew Pucker, OD, PhD|920-579-2900|andrewpucker@hotmail.com|
22270660|NCT02855359|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22270661|NCT03155178|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
22270662|NCT04874233|Prism Clinical Research|Amy Eastenson, MD|1-651-641-2900|aeastenson@prismresearchinc.com|
22270663|NCT02677038|M D Anderson Cancer Center|Dr. Milind Javle|713-792-5434|mjavle@mdanderson.org|
22270664|NCT02523924|Johns Hopkins University|Steven Rowe, MD|4105028052|srowe8@jhmi.edu|
22270665|NCT01460654|Massachusetts General Hospital|Dr. Benjamin Leder|6177266723|bzleder@partners.org|
22270666|NCT02777970|Menarini Ricerche|Dr. Angela Capriati (Clinical Sciences Director)|+39 055 5680|acapriati@menarini-ricerche.it|9933
22270667|NCT02319967|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|chicagotrial@uic.edu|
22270668|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb|
22270669|NCT02195310|KCI Europe Holding B.V.|Daniela Weichert, PhD|+353 (0) 860436155|daniela.weichert@acelity.com|
22270670|NCT02541669|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22270671|NCT00834639|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22270672|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu|
22270673|NCT04739722|Geneoscopy Inc.|Chief Medical and Science Officer|314-887-7777|contact@geneoscopy.com|
22270674|NCT05010512|Alcon Research, LLC|Associate Director, Clinical Projects - CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22270675|NCT01968707|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
22312770|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22312771|NCT01766206|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
22312772|NCT01662505|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312773|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343||
22312774|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22270676|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com|
22270677|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu|
22270678|NCT01576276|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|jkong2@mgh.harvard.edu|
22270679|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270680|NCT03998163|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22270681|NCT02083185|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22270682|NCT03419598|University of Bath|Professor Richie Gill|01225 383627|r.gill@bath.ac.uk|
22270683|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com|
22270684|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com|
22270685|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333||
22270686|NCT02231879|LMI/NIAID/NIH|Dr. David H. McDermott|301-761-6647|dmcdermott@niaid.nih.gov|
22270687|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com|
22270688|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270689|NCT03640481|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22270690|NCT01322035|University of South Alabama, Department of Surgery|Dr. William O. Richards|251-471-7993|brichards@health.southalabama.edu|
22270691|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22270692|NCT04889157|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270693|NCT01546168|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22270694|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu|
22270695|NCT02850016|The Rockefeller University|Marina Caskey|212-327-7396|mcaskey@rockefeller.edu|
22270696|NCT00715728|Vienna General Hospital/University of Vienna|Olga Plattner, Medical Doctor|43-1-40-400-4103|olga.plattner@meduniwien.ac.at|
22270697|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623||
22270698|NCT02939716|University of Nottingham|Robin Spiller|01158231090|robin.spiller@nottingham.ac.uk|
22312775|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22312776|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22312777|NCT03890484|University of Washington|Dr. Jessica Canning|206.221.4430|jrcannin@uw.edu|
22312778|NCT00518206|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22312779|NCT03075878|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22312780|NCT02188459|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@pennmedicine.upenn.edu|
22312781|NCT04348357|Texas Tech University Health and Science Center El Paso|Dr Steven Radtke|2177254940|dr.radtke@gmail.com|
22312782|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22312783|NCT02367794|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312784|NCT02612285|Esanex Inc|Eric Orlemans PhD||eorlemans@esanexpharma.com|
22312785|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu|
22312786|NCT01986348|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22312787|NCT00805441|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22312788|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu|
22312789|NCT05379400|NYU Langone Health|Sharine Wittkopp|646-501-7733|Sharine.Wittkopp@nyulangone.org|
22312790|NCT05356130|Kaiser Permanente Center for Health Research|Greg Clarke, PhD|503-335-2400|greg.clarke@kpchr.org|
22312791|NCT02680314|Montefiore Medical Center|Peter Bernstein, MD|718-904-2767|pbernste@montefiore.org|
22312792|NCT04820023|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|+82-31-8092-3280|Clinicaltrials.gov_inquiries@bridgebiorx.com|
22312793|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22312794|NCT02240810|Boston Scientific|Director, Clinical Trials|508-683-6678|peter.maurer@bsci.com|
22312795|NCT02802176|University of California, San Francisco|Marcelle Cedars, MD, Director, Division of Reproductive Endocrinology|(415) 353-7475|Marcelle.Cedars@ucsf.edu|
22312796|NCT04714359|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22312797|NCT01330953|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312798|NCT02109172|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22312799|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com|
22312800|NCT03360071|John Hopkins University School of Medicine|Jody Tversky, MD|410-550-2300|hoddin1@jhmi.edu|
22312801|NCT00830284|Boston Children's Hospital|John Kheir|6179194712|john.kheir@childrens.harvard.edu|
22312802|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu|
22312803|NCT00896389|University of Maryland, Baltimore|Dr. Yen Pei Christy Chang|410-706-6737|cchang@som.umaryland.edu|
22312804|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22270699|NCT02747849|UPittsburgh|Rajeev Chaudhry, MD|412-692-7932|rajeev.chaudhry@chp.edu|
22312805|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org|
22312806|NCT03184519|IVIValencia|LAURA CARACENA (STUDY COORDINATOR)|034 963050900|laura.caracena@ivirma.com|
22312807|NCT02755948|Imperial College London|Professor Christopher Chiu|(0)20 8383 2301|c.chiu@imperial.ac.uk|
22312808|NCT02823574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.gov|
22312809|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com|
22312810|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312811|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu|
22312812|NCT01597856|VA Connecticut/ Yale University|Christina Lazar|203-932-5711|Christina.Lazar@Yale.edu|4833
22312813|NCT02959866|St. Michael's Hospital|Anne Rucchetto, Research Coordinator|416-864-6060|rucchettoa@smh.ca|76155
22312814|NCT04463004|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-628-1215|antonio.abbate@vcuhealth.org|
22312815|NCT01532830|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
22312816|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22312817|NCT04791917|University of Florida Department of Clinical and Health Psychology|Jeff Boissoneault, PhD|352-273-6200|jboissoneault@phhp.ufl.edu|
22312818|NCT00910871|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
22312819|NCT00850993|Mallinckrodt Pharmaceuticals|Medical Information Call Center|1-800-844-2830|clinicaltrials@mnk.com|5
22312820|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org|
22312821|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu|
22312822|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22312823|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
22312824|NCT03816202|Integra LifeSciences|Andrew Tummon, Director, Global Clinical Trials|609-936-5490|andrew.tummon@integralife.com|
22312825|NCT04501614|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22312826|NCT04374435|University of California, Irvine|Anand Ganesan, MD, Professor|949-824-0606|aganesan@uci.edu|
22312827|NCT02555397|Henry Ford Health System|Shyam Nyati|734-272-1751|snyati1@hfhs.org|
22312828|NCT01842360|Inmunotek S.L|Miguel Casanovas|34691490175|mcasanovas@inmunotek.com|
22312829|NCT04529941|Cedars-Sinai Medical Center|Dr. Peng-Sheng Chen|310-967-2707|Peng-Sheng.Chen@cshs.org|
22312830|NCT03800602|Emory University|Olumide B. Gbolahan MBBS, MSc|404-778-0032|ogbolah@emory.edu|
22312831|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu|
22312832|NCT02066389|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22312833|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312834|NCT04520321|Trefoil Therapeutics.com|Thomas M Tremblay, RN, BSN|4153053491|ttremblay@trefoiltherapeutics.com|
22281408|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22281409|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch|
22281410|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
22281411|NCT02175277|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281412|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281413|NCT03159468|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
22281414|NCT02954406|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22281415|NCT04812028|University of Minnesota|Gwenyth Fischer|612-625-9950|fisch662@umn.edu|
22281416|NCT05924165|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|(212) 241-1272|Mantu.Gupta@mountsinai.org|
22281417|NCT01681186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281418|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu|
22281419|NCT03806556|University of Pittsburgh Medical Center|Meghan McCormick, MD MS|412-692-6938|meghan.mccormick3@chp.edu|
22281420|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404|mountaindiabetes@msn.com|314
22281421|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094||4518
22281422|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com|
22281423|NCT03177512|Bridge HIV, San Francisco Department of Public Health|Albert Liu|628-217-7408|albert.liu@sfdph.org|
22281424|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com|
22281425|NCT02565147|The Medicines Company|Global Health Science Center|1.888.977.6326|medical.information@themedco.com|
22281426|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov|
22281427|NCT04855240|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
22281428|NCT02812238|NHLBI|Dr. Michael N. Sack|301-402-9259|sackm@nih.gov|
22281429|NCT01994746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281430|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281431|NCT02688270|Covis Pharma|Clinical Trial Interest|18773744177|CTInterest@covispharma.com|
22312835|NCT02935894|USDA, ARS Western Human Nutrition Research Center|Dr. John W. Newman|530-752-1009|john.newman@ars.usda.gov|
22281432|NCT04004221|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281433|NCT03423238|Wake Forest School of Medicine|Tina Brinkley|336-713-8534|tbrinkle@wakehealth.edu|
22281434|NCT02688829|Microport Medical, Shanghai, China|Dr Zhang Haotian|8621-38954600|zhanght@microport.com|8552
22281435|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com|
22312836|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org|
22312837|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300||
22312838|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu|
22312839|NCT01175980|Barbara Ann Karmanos Cancer Institute|Dr. Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
22312840|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
22312841|NCT01186809|Asst Papa Giovanni XXIII|Prof Alessandro Rambaldi|+390352673681|arambaldi@asst-pg23.it|
22312842|NCT04895085|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
22281436|NCT03745638|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22281437|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281438|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
22281439|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
22281440|NCT02993822|NeRRe Therapeutics Limited|Dr. Stephen Pawsey|+44 (0)1438906960|steve.pawsey@nerretherapeutics.com|
22281441|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
22281442|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu|
22281443|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
22281444|NCT01939977|Hospital Universitari de Bellvitge|Dr. Josep M. Cruzado|0034932607602|jmcruzado@bellvitgehospital.cat|
22281445|NCT02959853|Baylor College of Medicine|Rui Chen|812-239-1855|rui.chen2@bcm.edu|
22281446|NCT03641716|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
22281447|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22281448|NCT01917929|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|kevin.barga@stryker.com|
22281449|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22281450|NCT03599518|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22281451|NCT01962428|General Hospital of Chinese People's Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com|
22281452|NCT02798315|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22312843|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com|
22312844|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22312845|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312846|NCT04919499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312847|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
22312848|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com|
22312849|NCT00090064|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22312850|NCT03833934|Addario Lung Cancer Medical Institute (ALCMI)|Ericka Izzo, Clinical Project Manager|941-713-1225|eizzo@alcmi.org|
22312851|NCT04851587|University of Florida|Emily Bartley|352-273-8934|EBartley@dental.ufl.edu|
22312852|NCT05878990|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
22312853|NCT03605745|Boston Scientific|Kaitlyn Rainbow, Clinical Research Associate|952-930-6627|kat.rainbow@bsci.com|
22312854|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
22312855|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu|
22312856|NCT03436797|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22312857|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
22312858|NCT01951105|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
22312859|NCT02727998|Yale School of Medicine|Dr. Ilan Harpaz-Rotem|(203) 937-4760|ilan.harpaz-rotem@yale.edu|
22312860|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu|
22312861|NCT05072795|Medical University of South Carolina|Dr. Andreana Benitez|843-876-8479|benitez@musc.edu|
22312862|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com|
22312863|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312864|NCT05274906|Fred Hutchinson Cancer Center|Marian L. Neuhouser, Principal Investigator|206-667-4797|mneuhous@fredhutch.org|
22312865|NCT00963105|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22312866|NCT01622088|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22312867|NCT02971683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22312868|NCT04206501|University of Rochester Medical Center|Spencer Z. Rosero, M.D.|5852752756|spencer_rosero@urmc.rochester.edu|
22312869|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi|
22312870|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711|deepak.dsouza@yale.edu|2594
22312871|NCT02006641|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22312872|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com|
22312873|NCT02132195|Emory University|Dr. Greenbaum|404-712-6374|LGREEN6@emory.edu|
22312874|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com|
22312875|NCT00321555|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|robert_kreitman@nih.gov|
22312876|NCT02907489|Cairo university|Mohamed Omaia Ahmed|00201224474609|mohamed.omaia@dentistry.cu.edu.eg|
22312877|NCT01468597|Medical University of Graz|Elisabeth Mahla, MD|0043 316 385 13027|elisabeth.mahla@medunigraz.at|
22312878|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22312879|NCT02684435|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22312880|NCT02561195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312881|NCT03905512|Selecta Biosciences, Inc.|Study Director|617-923-1400|ptraber@selectabio.com|
22312882|NCT04990388|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22312883|NCT03293238|Andrews Research & Education Foundation|Dr. Joshua Hackel|850-916-8796|jghackelmd@yahoo.com|
22312884|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
22312885|NCT02502019|Biom'Up|Dr. William Spotnitz, Chief Medical Officer|352-514-5009|wspotnitz@gmail.com|
22312886|NCT03987074|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22312887|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org|
22312888|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu|
22312889|NCT01084772|Smith & Nephew, Inc.|Stuart Pratt|+1 (901) 497-0365|stuart.pratt@smith-nephew.com|
22312890|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com|
22281453|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
22281454|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu|
22281455|NCT03292640|Dr. Reddy's Laboratoris, Inc|Srinivas Sidgiddi, Senior Director, Clinical Development|9084585362|srinivassidgiddi@drreddys.com|
22281456|NCT02530476|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/Associate Professor|713-794-4392|NDaver@mdanderson.org|
22281457|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22281458|NCT03135431|Mayo Clinic|Vanessa Torbenson, M.D.|507-266-9873|Torbenson.Vanessa@mayo.edu|
22281459|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com|
22281460|NCT05253755|Dermbiont Inc|Joanna Jay|415.819.4816|joanna.j@dermbiont.com|
22281461|NCT03122145|Holy Cross Hospital|Lauren Tabor Gray|954 542 3429|lauren.tabor@holy-cross.com|
22281462|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov|
22281463|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com|
22281464|NCT03206918|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281465|NCT02701764|University of Miami|Dr. Anat Galor|305-450-6050|agalor@med.miami.edu|
22281466|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu|
22281467|NCT01059357|Wake Forest University Health Sciences|Dr. Joshua Waltonen|3367169068|jwaltone@wakehealth.edu|
22281468|NCT06899737|KDH Research & Communication|Kristen D. Holtz, PhD|4043958711|kholtz@kdhrc.com|
22281469|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov|
22281470|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718|ClinicalTrials.gov_Inquiries@pfizer.com|1021
22281471|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu|
22281472|NCT05280158|University of California, Los Angeles|Yusaku Michael Shino, MD|(310) 866-6327|MShino@mednet.ucla.edu|
22281473|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281474|NCT00301262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22281475|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr|
22281476|NCT01716039|Alimentiv (Formerly Robarts Clinical Trails)|Dr.Jenny Jeyarajah (Sr. Biostatistician)||jenny.jeyarajah@alimentiv.com|
22298921|NCT04160260|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22298922|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22298923|NCT01978184|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
22298924|NCT04409041|Washington University|Dr. Caroline Mann|(314) 996-8010|cmann@wustl.edu|
22298925|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22298926|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22298927|NCT02517905|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22298928|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov|
22298929|NCT05789875|UCSF|Dr. Parya Saberi|415-502-1000|parya.saberi@ucsf.edu|17171
22298930|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22298931|NCT02287415|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22298932|NCT04551105|Virginia Tech|Study Director of Clinical Trials|+1 (301) 820-5225|dcben0@gmail.com|
22298933|NCT01693601|Icahn School of Medicine at Mount Sinai|John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
22298934|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22298935|NCT02770391|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Moshe Ornstein,|18662238100|taussigresearch@ccf.org|
22298936|NCT03333486|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22298937|NCT03995758|Indiana University School of Medicine|Dr. Marcelino Rivera|3179622485|maeriver@iu.edu|
22298938|NCT02276495|UC Irvine Health Department of Anesthesiology & Perioperative Care|Dr. Joseph Rinehart|714-456-7415|jrinehar@hs.uci.edu|
22298939|NCT01755416|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22298940|NCT04176796|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
22312891|NCT03444298|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
22312892|NCT02942771|University of Kentucky|Dr. Linda Van Eldik|(859) 257-5566|linda.vaneldik@uky.edu|
22312893|NCT02158806|University of Auckland|Professor Andrew Jull|+64 9 923 4259|a.jull@auckland.ac.nz|
22312894|NCT02383043|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
22312895|NCT01898299|New York State Psychiatric Institute|Joshua Kantrowitz|6467746738|jk3380@cumc.columbia.edu|
22312896|NCT02340806|Northwestern University|Elizabeth Lange, MD|312-472-3585|elizabeth.lange@northwestern.edu|
22312897|NCT04520256|The Miriam Hospital|Dr. J. Graham Thomas|(401) 793-8154|jthomas4@brownhealth.org|
22312898|NCT00760877|Novartis|Study Director|862-778-8300||
22312899|NCT04413149|Peking Union Medical College Hospital|Dr. Shi Juhong|+86-13701178492|Shijh@pumch.cn|
22312900|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
22312901|NCT02878590|InnoMed Healthscience|Javier Collazo|9547739656|jcollazo@innomedhs.com|
22312902|NCT01730118|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22312903|NCT03154827|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
22312904|NCT04206397|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
22312905|NCT05480410|Fundación Universitaria María Cano|Physiotherapy professor|+573206728934|catalinaloperamuneton@fumc.edu.co|
22312906|NCT03978130|NYU Langone Health|John Dodson, MD|6465012714|john.dodson@nyulangone.org|
22281477|NCT03530995|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
22281478|NCT01842035|University of Alabama at Birmingham|Fadi Hage|2059757123|fadihage@uab.edu|
22281479|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822||9493
22281480|NCT02650804|BPGbio Inc|Head of Clinical Operations|6175880083|clinicaltrials.connect@berghealth.com|
22281481|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu|
22281482|NCT00801723|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22281483|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
22281484|NCT02150057|Andrews Institute for Orthopaedics & Sports Medicine|Dr. Roger Ostrander|850-916-3700|rostrander@flboneandjoint.com|3725
22298941|NCT03704376|The University of Texas Health Science Center at Houston|Lane Bailey, PhD, PT|713-704-6794|lane.bailey@uth.tmc.edu|
22312907|NCT03523897|Virtua Health|Dr. Jeremy Reid|8008967326|jreid@reconstructiveortho.com|
22312908|NCT05349123|Mayo Clinic|Roberto P Benzo|507-284-0561|benzo.roberto@mayo.edu|
22312909|NCT03239899|National Institutes of Health|Avindra Nath, MD|301-496-1561|avindra.nath@nih.gov|
22312910|NCT04049578|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312911|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
22312912|NCT03409276|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22312913|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
22312914|NCT02169089|University Hospitals Cleveland Medical Center|Dr. Sanjay Rajagopalan|216-844-5191|Sanjay.Rajagopalan@uhhospitals.org|
22312915|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu|
22312916|NCT05361304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, OD, MS, FAAO|800-843-2020|jbuch@its.jnj.com|
22312917|NCT03320941|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22312918|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
22312919|NCT02368691|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22312920|NCT02069366|Wayne State University|Dr. Christine Rabinak|(313) 577-9875|rabinak@wayne.edu|
22312921|NCT03314233|Childrens Hospital of Philadelphia|Dr. Elizabeth Foglia|215-590-1653|foglia@email.chop.edu|
22312922|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com|
22312923|NCT01838447|Children's Hospital of Eastern Ontario|Katie O'Hearn, PICU Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
22312924|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu|
22312925|NCT02030847|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
22312926|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312927|NCT01114217|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22312928|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22312929|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22312930|NCT06247488|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|(913) 389-7961|david.sequeira@azurity.com|
22312931|NCT02995733|Brigham and Women's Hospital|Dr. Elliot Israel|617-732-8110|eisrael@bwh.harvard.edu|
22312932|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu|
22312933|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312934|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu|
22312935|NCT04468633|Duke University|Andrew Gross, MD|919-684-8656|andrew.gross@duke.edu|
22312936|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
22312937|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22312938|NCT01498445|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22312939|NCT04739306|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4190|keumyoung.ahn@celltrion.com|
22281485|NCT02388165|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312940|NCT00641797|Lehigh Valley Health Network|Regina Sacco, DPT, BA, BHSC|610-969-0300|Regina_R.Sacco@lvhn.org|
22281486|NCT03230890|Atrium Health Wake Forest Baptist|Charles H. Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
22281487|NCT02926027|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
22312941|NCT02722278|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22281488|NCT04551963|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281489|NCT02974855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281490|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281491|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281492|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22281493|NCT00748618|University of Nebraska Medical Center|Fang Yu|(402) 559-9436|fangyu@unmc.edu|
22281494|NCT06004895|Aston University|Professor James S Wolffsohn|07833049245|j.s.w.wolffsohn@aston.ac.uk|
22281495|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281496|NCT00878254|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
22281497|NCT01995526|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281498|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
22281499|NCT05445921|Washington University School of Medicine, Dept. of Otolaryngology - Head and Neck Surgery|Dr. Andrew Peterson, Resident Physician|314-362-5626|pandrew@wustl.edu|
22281500|NCT03367403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281501|NCT04928885|The University of Illinois at Chicago|Dr. Julie Bobitt, PhD|312.355.0247|jbobitt@uic.edu|
22281502|NCT02363972|Avenu Medical|Gene Reu EVP and General Manager|9492762483|greu@avenumedical.com|
22281503|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net|
22281504|NCT02321319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22281505|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552|stmdowns@iu.edu|317
22281506|NCT03497975|Trevi Therapeutics, Inc.|Chief Development Officer|203-304-2499|info@trevitherapeutics.com|
22281507|NCT02141399|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22281508|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com|
22281509|NCT01407952|Mayo Clinic|Bernard Bendok, MD|3129269441|bendok.bernard@mayo.edu|
22312942|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
22281510|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu|
22281511|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
22281512|NCT02593903|Medical College of Wisconsin|Clinical Research Coordinator|414-337-3441|ebedjeti@mcw.edu|
22281513|NCT03087604|Wake Forest University Health Sciences|Dr. Sean Dobson|3367168834|sdobson@wakehealth.edu|
22281514|NCT03799952|University of New Brunswick|Dr. Danielle Bouchard|1 (506) 443-3908|danielle.bouchard@unb.ca|
22281515|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com|
22281516|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263|l_bentur@rambam.health.gov.il|0502062400
22281517|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx|
22281518|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu|
22281519|NCT02016716|Amgen Inc.|Study Director|866-572-6436||
22281520|NCT02931838|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22281521|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org|
22312943|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu|
22281522|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu|
22312944|NCT02023099|AbbVie|Global Medical Services|800-633-9110||
22312945|NCT04175392|Beaumont Hospitals|Kirsten Gage, CRM|947-521-8519|kirsten.gage@beaumont.org|
22312946|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu|
22281523|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22281524|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
22281525|NCT03823287|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22281526|NCT00978419|Vanderbilt University Medical Center|Burn Unit Director|(615) 322-4590||
22281527|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312947|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org|
22312948|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp|
22312949|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
22281528|NCT03108521|Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital|Dr. Xingwei Wu and Professor Enwu Long|+8615928017367|wuxw1988@126.com|
22281529|NCT05629312|UZLeuven|Prof. Maria Cadenas|+3216332017|maria.cadenas@uzleuven.be|
22281530|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu|
22281531|NCT03281629|Maryland Psychiatric Research Center, University of Maryland School of Medicine|Dr. Xiaoming Du|410 402 6036|xdu@som.umaryland.edu|
22281532|NCT03974932|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22325149|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
22325150|NCT03114969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325151|NCT00971321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325152|NCT02282332|MedStar Health Research Institute|Scientific Center Adminstrator|(301) 560-7300|Research@medstar.net|
22325153|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com|
22325154|NCT02436239|Allergan|Armin Szegedi, MD, PhD, Vice President CNS Clinical Development|714-246-4500|IR-CTRegistration@allergan.com|
22325155|NCT02168946|Rempex Pharmaceuticals, A Wholly Owned Subsidiary of Melinta Therapeutics, Inc.|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
22325156|NCT01852344|University of Michigan|Dr. Chandra Sripada, MD PhD||csripada@umich.edu|
22325157|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22325158|NCT02675517|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325159|NCT02772783|Boston Children's Hospital|Belinda Lennerz|617 355 7476|belinda.lennerz@childrens.harvard.edu|
22325160|NCT03443024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22270700|NCT00570349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22270701|NCT01054196|Weill Cornell Medicine|Roger Pearse, M.D. PhD|646-962-6500|rnp2001@med.cornell.edu|
22270702|NCT02223546|Medical University of Graz|Gerald Seidel, MD|+43 316 385 12394|gerald.seidel@medunigraz.at|
22270703|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com|
22270704|NCT01820572|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22270705|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22270706|NCT02105246|San Francisco VA Healthcare System|Dr. Mary Whooley|415-221-4810|mary.whooley@va.gov|
22270707|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22270708|NCT05356533|University of Washington|Jennifer Cadigan|206-543-5689|cadiganj@uw.edu|
22270709|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org|
22270710|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270711|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
22270712|NCT02294175|James A. Haley Veterans Hospital and Clinics|Dr. Linda Cowan|813-558-3932|linda.cowan@va.gov|
22270713|NCT02548351|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22270714|NCT01901653|AbbVie Stemcentrx|Senior Director, Clinical Operations|(650) 827-4879|isobel.lakatos@abbvie.com|
22270715|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu|
22270716|NCT01295827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270717|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org|
22270718|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org|
22270719|NCT01868022|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270720|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270721|NCT03226769|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22270722|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22270723|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
22270724|NCT03033602|VA Boston Healthcare System & Boston University School of Medicine|Dr. Denise Sloan, Professor of Psychiatry|857-364-6333|dsloan@bu.edu|
22270725|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org|
22270726|NCT02805660|Mirati Therapeutics|Tavette Neskorik, Senior Director, Clinical Science|858-332-3552|neskorikt@mirati.com|
22270727|NCT02572076|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
22270728|NCT02778074|Linkoping University|Dr Peter Johansson|0460700896548|peter.b.johansson@liu.se|
22270729|NCT03489707|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
22270730|NCT03963232|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22270731|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270732|NCT03617770|University of Illinois at Chicago|Dr. Pamela Martyn-Nemeth|3129967903|pmartyn@uic.edu|
22270733|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu|
22298942|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com|
22298943|NCT02805257|University of California, San Francisco|Ying Han, MD, PhD|415-476-3321|ying.han@ucsf.edu|
22298944|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
22298945|NCT01946711|Pari Pharma|Friedrich gruber|+4989742846|friedrich.gruber@pari.com|76
22298946|NCT02669329|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22298947|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300||
22298948|NCT01337089|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22298949|NCT01404312|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22298950|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298951|NCT02627677|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22298952|NCT02487563|Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University|Yaqiong Tang|+86 18896588075|tangyaqiong@suda.edu.cn|
22281533|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu|
22281534|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22312950|NCT03082196|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-251-6831|drmilgrom@silverarrest.com|
22281535|NCT02109432|Pennington Biomedical Research Center|Corby Martin, Associate Professor|225-763-2585|corby.martin@pbrc.edu|
22281536|NCT03304054|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22281537|NCT03372551|Coopervision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|mnguyen@coopervision.com|
22281538|NCT04523454|Imperial College London|Dr Rochan Agha-Jaffar|0203 311 3000|Rochan.Agha-Jaffar@nhs.net|21253
22281539|NCT04500171|American Samoa Community Cancer Coalition|Va'atausili Tofaeono|648-699-0110|vtofaeono@cancercoalition.as|
22281540|NCT03179982|American University|Caroline Kuo|2028853054|ckuo@american.edu|
22281541|NCT04148482|Massachusetts General Hospital|Sara Cromer|6177247303|scromer@mgh.harvard.edu|
22312951|NCT01695993|University of Rochester Medical Center|Joseph A. Roscoe, PhD Associate Research Professor|585 275-9962|joseph_roscoe@urmc.rochester.edu|
22281542|NCT04683029|Janssen Pharmaceutical K.K.|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22281543|NCT04299308|University of Kansas Medical Center|Dr. Jill Morris|9139457675|jmorris2@kumc.edu|
22281544|NCT02551094|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
22281545|NCT02920528|Lundquist Institute|David Tanen|310-222-3624|dtanen@emedharbor.edu|
22281546|NCT05422365|Biopharma Plasma LLC|Igor Rudenko, Clinical Research Physician|+380503300865|i.rudenko@biopharma.ua|
22281547|NCT03596047|Boston Medical Group|Carolina Sandoval - Director Research|+57 3133920816|csandoval@bostonmedical.com.co|
22281548|NCT00066703|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, PhD Head Trial Activities / Deputy Director|41 31 511 94 00|Heidi.Roschitzki@etop.ibcsg.org|
22281549|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22281550|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22312952|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281551|NCT02199314|Cincinnati Children's Hospital Medical Center|John J McAuliffe, MD|1513-636-4408|john.mcauliffe@cchmc.org|
22281552|NCT04848220|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22281553|NCT02222909|Johns Hopkins School of Public Health|Christine Weston|443-287-8039|cweston1@jhu.edu|
22312953|NCT01540071|Io Therapeutics, Inc.|Martin E. Sanders, M.D.|(650) 219-5973|msanders@io-therapeutics.com|
22281554|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org|
22281555|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu|
22281556|NCT02557100|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22281557|NCT03289910|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22281558|NCT01460875|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
22312954|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
22281559|NCT02513485|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
22281560|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil|
22281561|NCT03811847|Massachusetts General Hospital|Steven Arnold, MD|617-643-5607|searnold@mgh.harvard.edu|
22312955|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281562|NCT02034175|Somnarus Inc|Maria Merchant|4087610884|somnarus@gmail.com|
22281563|NCT01511614|NIH/NIDA|Dr. Amy Janes|667.312.5164|amy.janes@nih.gov|
22281564|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22312956|NCT00212888|OHRI|Dr. Jonathan B Angel|613-737-8442|JANGEL@toh.ca|
22281565|NCT03462927|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22281566|NCT01576146|Amgen, Inc|Study Director|866-572-6436||
22281567|NCT03454399|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
22281568|NCT03654404|Dana-Farber Cancer Institute|Hermioni L. Amonoo, Director of Well-Being and Cancer Research Program|617-525-7472|Hermioni_Amonoo@dfci.harvard.edu|
22281569|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com|
22281570|NCT03086408|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
22312957|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660||
22281571|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
22281572|NCT03470194|U Mass Memorial|Dr Danielle Taylor|508-334-9840|danielle.taylor@umassmemorial.org|
22281573|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281574|NCT02628405|Accru|Dr Grzegorz S. Nowakowski|507-422-6553|Nowakowski.Grzegorz@mayo.edu|
22312958|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu|
22281575|NCT00759876|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22281576|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22312959|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com|
22312960|NCT02062827|The University of Alabama at Birmingham|James Markert, MD|(205) 934-7171|jmarkert@uabmc.edu|
22281577|NCT02570152|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupport@gsk.com|
22325161|NCT02782715|University of Wisconsin School of Medicine and Public Health|Michael Bassetti, MD, PhD|608-263-8500|bassetti@humonc.wisc.edu|
22281578|NCT02684617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281579|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22325162|NCT04429932|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
22325163|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn|
22325164|NCT00968344|University of Texas Medical Branch|Douglas Paddon-Jones, Professor|409-772-3073|djpaddon@utmb.edu|
22325165|NCT05439928|Columbia University|Magdalena Bogun, MD|2128515494|mmb2263@cumc.columbia.edu|
22325166|NCT03949673|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22325167|NCT02453841|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
22325168|NCT01751646|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22325169|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22325170|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
22325171|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050|hasanari03@yahoo.com|1739
22325172|NCT02277444|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22325173|NCT02858193|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22325174|NCT02031146|University of Washington|Christina Marra, MD|206-744-3251|cmarra@uw.edu|
22270734|NCT05270395|University of Kentucky|Dr. McLouth|859-562-2526|laurie.mclouth@uky.edu|
22270735|NCT03055494|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22270736|NCT01296542|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
22270737|NCT04743804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22270738|NCT04598451|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
22270739|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22270740|NCT05027048|Stanford|Dr. Jessica Ansari|650-723-5349|jansari@stanford.edu|
22270741|NCT02879994|Jonsson Comprehensieve Cancer Center|Dr. Edward Garon|(310)586-2098|egaron@mednet.ucla.edu|
22270742|NCT02143791|Abbott|Devyani Nanduri|+1 510 561 4328|devyani.nanduri@abbott.com|
22270743|NCT04112160|UT Southwestern Dept of Urology|Dr. Brett Johnson|214-645-3526|brett.johnson@utsouthwestern.edu|
22270744|NCT03051516|Fred Hutchinson Cancer Center|Margaret M. Madeleine, PhD|206-667-4630|mmadelei@fredhutch.org|
22270745|NCT04984681|University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
22270746|NCT04327661|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
22270747|NCT02091960|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22270748|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22270749|NCT01942486|University of Utah|Bradley Katz|8015871079|bradley.katz@hsc.utah.edu|
22270750|NCT02064270|University of Missouri, Department of Orthopaedic Surgery|Stacee Clawson, Research Manager|5738849017|clawsons@health.missouri.edu|
22270751|NCT02424630|Chuncheon Sacred Heart Hospital|Dr Jung-Taek Hwang|82 33 240 5197|drakehjt@hanmail.net|
22270752|NCT02637895|University of Miami Miller School of Medicine|Dr. Philip Harvey|305 243 4094|pharvey@med.miami.edu|
22270753|NCT04810247|The Miriam Hospital|Dr. KayLoni Olson|401-793-8971|kayloni.olson@lifespan.org|
22270754|NCT03794661|Abbott Medical Devices Neuromodulation|Binith Cheeran|+15122864262|binith.cheeran@abbott.com|
22270755|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22270756|NCT05139303|University of Kentucky College of Dentistry Division of Orofacial Pain|Dr. Isabel Moreno Hay|8593233440|imo226@uky.edu|
22270757|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590||
22270758|NCT04507256|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22270759|NCT04240457|ChicagoArbor Eye Care|David Lubeck, MD|708-798-6633|david.lubeck@chicagoarboreye.com|
22270760|NCT04756128|Methodist Hospital|Daniel Delaney, PharmD|952-993-5442|daniel.delaney@parknicollet.com|
22270761|NCT02858180|Duke University|Andrew Muir, MD|919-684-2052|muir0002@duke.edu|
22270762|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22270763|NCT03488849|InnoVital Systems|Chief Medical Officer|2022862328|amit@innovitalsystems.com|
22270764|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
22270765|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110||
22270766|NCT03197870|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
22270767|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com|
22270768|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
22270769|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22270770|NCT02612610|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270771|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com|
22270772|NCT01546571|Polynoma|Clinical Program Director|5418405451|karihatten@polynoma.com|
22270773|NCT03845491|Stryker Neurovascular|Sr. Clinical Project Manger|510-413-2500|lisa.park@stryker.com|
22270774|NCT04060199|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
22270775|NCT00478699|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
22270776|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22270777|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com|
22270778|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu|
22270779|NCT05600270|Lahey Hospital and Medical Center|Neev Mehta|781-744-1933|neev.n.mehta@lahey.org|
22270780|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
22270781|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com|
22312961|NCT03708744|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
22312962|NCT04930263|National Yang Ming Chiao Tung University|Mrs Cheng-Chen Chou|28267176|chou8278@gmail.com|
22312963|NCT03075449|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22312964|NCT02812706|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22312965|NCT02342275|Sichuan University|Yi jJi|+86 02885423453|jijiyuanyuan@163.com|
22312966|NCT04588207|University of Pittsburgh School of Medicine|Dr. Helbert Rondon Berrios, Professor of Medicine|4126473120|rondonberriosh@upmc.edu|
22312967|NCT02138838|Amgen Inc.|Study Director|866-572-6436||
22312968|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Bruce D. Cheson|202-444-7932|bdc4@georgetown.edu|
22312969|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu|
22312970|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22312971|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com|
22312972|NCT04433091|Vanderbilt University Medical Center|M.Benjamin Shoemaker,MD MSCI|615-322-2318|moore.b.shoemaker@vumc.org|
22312973|NCT02880293|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
22312974|NCT02101554|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22312975|NCT04385849|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22312976|NCT02011568|University of Ottawa Heart Institute|Dr Michel Le May|613-696-7000|mlemay@ottawaheart.ca|14646
22312977|NCT04179799|University of Florida|Emily Fox|352-273-6500|ejfox@phhp.ufl.edu|
22312978|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
22312979|NCT03512041|Washington University School of Medicine|Catherine E Lang|314-286-1945|langc@wustl.edu|
22312980|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300||
22312981|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
22312982|NCT02889809|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22312983|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22312984|NCT03785210|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
22312985|NCT02213458|University of California, San Francisco|Dr. Katherine Possin|(415) 476-1889|katherine.possin@ucsf.edu|
22312986|NCT04043806|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22312987|NCT02499497|Brigham and Women's hospital|Dr. Shalender Bhasin, Principal Investigator|617 525 9150|sbhasin@bwh.harvard.edu|
22312988|NCT03166215|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22312989|NCT01357564|Center of Innovation on Disability and Rehabilitation Research, Department of Veterans Affairs; St. Catherine University, Department of Occupational Therapy|Dr. Paul Arthur|3176881499|pbarthur824@stkate.edu|
22312990|NCT04362176|Vanderbilt University Medical Center|Todd Rice, M.D., MSc|615-343-8010|vcc@vumc.org|
22312991|NCT04985604|Day One Biopharmaceuticals, Inc.|Study Director|1-650-484-0899|clinicaltrials@dayonebio.com|
22312992|NCT04598776|CeraRoot CLINIC|Dr. Josep Oliva-Ochoa. Director of Clinical Trials|+34 935950247|josep.oliva@cerarootclinic.com|
22312993|NCT02282761|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22312994|NCT00515281|University of Chicago|Michael D. Schreiber, MD|773-702-6205|mschreiber@bsd.uchicago.edu|
22312995|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743||
22312996|NCT06312566|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22312997|NCT02632045|Columbia University|Melissa Accordino, MD|212-342-5162|mkg2134@cumc.columbia.edu|
22312998|NCT04551053|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22312999|NCT03861078|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
22313000|NCT03503188|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313001|NCT01699178|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22313002|NCT04407442|University of California, San Francisco|Dr. Alfred Chung|(415) 353-2421|Alfred.Chung@ucsf.edu|
22313003|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu|
22313004|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu|
22313005|NCT03547167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313006|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22313007|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com|
22281580|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu|
22281581|NCT03915574|UAMS|Nadir Sharawi|5016866119|nelsharawi@uams.edu|
22281582|NCT04027803|BIOCAD|Morozova Maria|+7 (495) 992 66 28|morozovama@biocad.ru|8436
22281583|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
22281584|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313008|NCT03100370|Rice University|Marcia O'Malley, PhD|713-348-3545|omalleym@rice.edu|
22313009|NCT02674399|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
22281585|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313010|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313011|NCT00835328|The Children's Hospital of Philadelphia|Diva D. Deleon, MD,MSCE|215-590-3420|deleon@email.chop.edu|
22313012|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22313013|NCT02168855|University of Arkansas|Dr. Brian Primack|479-575-3208|bprimack@uark.edu|
22313014|NCT03000829|Intermountain Health|Dr. Ithan Peltan|801-507-6556|ithan.peltan@imail.org|
22313015|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22298953|NCT02451748|University of Illinois at Chicago|Shiva Shahrara, PhD|312-413-7529|shahrara@uic.edu|
22313016|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu|
22313017|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu|
22313018|NCT03122548|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
22313019|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22313020|NCT03677986|Johns Hopkins University School of Medicine|Kenneth Silverman, Professor|4105502694|ksilverm@jhmi.edu|
22325175|NCT01486316|Medtronic, Inc|Rachael Rose, Clinical Research Specialist|763-526-2332|rachael.k.rose@medtronic.com|
22325176|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu|
22325177|NCT02452970|EpicentRx, Inc.|Study Director: Bryan Oronsky, Chief Medical Officer|408-569-3202|boronsky@epicentrx.com|
22325178|NCT02100657|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
22325179|NCT02531035|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22325180|NCT00403117|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
22325181|NCT01543490|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22325182|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu|
22325183|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl|
22325184|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325185|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22325186|NCT01712438|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22325187|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu|
22325188|NCT03849560|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
22325189|NCT01243593|Sick Kids Hospital|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
22325190|NCT01633060|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22325191|NCT02859415|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@mail.nih.gov|
22325192|NCT00414440|Novartis|Study Director|+1 (862) 778-8300||
22325193|NCT04634162|Division of Cardiology University of Florida College of Medicine - Jacksonville|Francesco Franchi, MD|1-904-244-2060|francesco.franchi@jax.ufl.edu|
22325194|NCT02457897|NIDDK|Dr. Rebecca Brown|301-594-0609|Rebecca.Brown@NIH.gov|
22325195|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22325196|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22325197|NCT02624700|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|(804) 828-0450|AskMassey@vcu.edu|
22325198|NCT04925570|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
22325199|NCT01088412|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22325200|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com|
22325201|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
22325202|NCT03494725|DuPont Nutrition and Biosciences|Elaine Patterson, Ph. D.|+358-40-4827-626|elaine.patterson@dupont.com|
22325203|NCT02619253|IndianaU|Dr. Nabil Adra|317-278-7728|nadra@iu.edu|
22325204|NCT02111811|Crescenz VA Medical Center|David Oslin, MD|215-823-8594|dave.oslin@va.gov|
22325205|NCT01359982|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|8582291062|boronsky@epicentrx.com|
22325206|NCT05593432|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22325207|NCT03529214|Ariadne Labs|Dr. Amber Weiseth|206-786-0282|aweiseth@ariadnelabs.org|
22325208|NCT01450137|Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland|Prof Peter M Villiger||peter.villiger@insel.ch|
22325209|NCT01926886|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325210|NCT00069121|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298954|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343||
22298955|NCT02391402|Portland VA|Megan Callahan|503-220-8262|megan.callahan@va.gov|50525
22298956|NCT02696850|WashingtonU|Dr. Jay F. Piccirillo, Principal Investigator|(314) 362-8641|piccirij@wustl.edu|
22298957|NCT03041415|Stanford University|Principal Investigator|6507235082|king@stanford.edu|
22298958|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22298959|NCT03226067|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|Desk: +46 556659-9766|richard.philipson@calliditas.com|
22298960|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298961|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu|
22298962|NCT04265755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313021|NCT01199302|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22298963|NCT01531959|Beth Israel Deaconess Medical Center|Matthias Eikermann|6176327034|meikerma@bidmc.harvard.edu|
22298964|NCT01863446|Mass General Hospital|Elizabeth Klerman|617-643-2424|ebklerman@hms.harvard.edu|
22298965|NCT02554773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22298966|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@ohri.ca|82534
22298967|NCT02652780|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
22313022|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22313023|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313024|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22313025|NCT04097535|Imperial College London|Professor Eric Aboagye|02083833759|eric.aboagye@imperial.ac.uk|
22313026|NCT03070301|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
22313027|NCT03820024|UNC Lineberger|Leslie Clark|919-966-5996|leslie_Clark@med.unc.edu|
22313028|NCT03016091|Davidoff Cancer Center at Rabin Medical Center|Shlomit Yust-Katz MD|92739378002|shlomit2@clalit.org.il|
22313029|NCT01044901|The University of Chicago|Dr. Amit Patel, MD|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
22313030|NCT03322514|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22313031|NCT00088452|Cincinnati Children's Hospital Medical Center|Tracy Glauser, MD|513-636-8854|tracy.glauser@cchmc.org|
22313032|NCT02629419|Matinas BioPharma|Theresa Matkovits, PhD|862-812-1436|tmatkovits@matinasbiopharma.com|
22313033|NCT02081196|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22325211|NCT02986373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22325212|NCT04800315|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22298968|NCT02956629|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298969|NCT04177693|Yale University|Dr. Heping Zhang|2037855185|heping.zhang@yale.edu|
22298970|NCT03224468|Massachusetts General Hospital|Jodi Gilman, PhD|617-643-7293|jgilman1@mgh.harvard.edu|
22298971|NCT04713748|Duke Clinical and Translational Science Institute|Douglas Wixted|919-668-0515|douglas.wixted@duke.edu|
22298972|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22298973|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
22298974|NCT04067141|CooperVision, Inc.|Jose A. Vega, O.D., MSC., FAAO|9256213761|javega@coopervision.com|
22298975|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu|
22298976|NCT02639884|Masimo Corporation|Vikram Ramakanth|9492977416|vramakanth@masimo.com|
22298977|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22298978|NCT02832674|ThermiGen LLC|Toni Fournier, Sr. VP New Products|214-888-0634|TFournier@Thermi.com|
22298979|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
22298980|NCT02822794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22298981|NCT04788147|RefleXion|Debradenise Brooks|16504828435|dbrooks@reflexion.com|
22298982|NCT05101252|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|(904)254-0152|TKarkkai@its.jnj.com|
22298983|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com|
22298984|NCT01504438|Duke University|James Nunley II, M.D.|919-684-4033|james.nunley@duke.edu|
22298985|NCT02737566|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
22298986|NCT02181231|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
22298987|NCT02520531|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
22298988|NCT01159067|City of Hope National Medical Center|Dr. Vinod Pullarkat|626-256-4673|vpullarkat@coh.org|82405
22298989|NCT03282955|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
22298990|NCT02138214|University of Wisconsin, Madison|Dr. Rebecca Sippel|608-263-1387|sippel@surgery.wisc.edu|
22298991|NCT02185768|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22298992|NCT03221257|University of California, Los Angeles|Dr. Michael D. Roth|3102067389|mroth@mednet.ucla.edu|
22298993|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
22298994|NCT03367312|Duke University School of Medicine|Dr. Sudarshan Rajagopal|919-684-6237|sudarshan.rajagopal@duke.edu|
22298995|NCT05267171|Universidad de Oviedo|Claudia Leirós Díaz|663571819|claudia_leiros@hotmail.com|
22298996|NCT01971346|University of Michigan|Heather Chubb|734-936-6394|hdchubb@med.umich.edu|
22298997|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com|
22298998|NCT04187196|Atrium Health|Elijah Beaty, MD, MPH, FACC|704-403-6100|Elijah.Beaty@atriumhealth.org|
22298999|NCT01687166|Boston Scientific|Clinical Trial Manager|617-218-3849|weismanm@bsci.com|
22299000|NCT02755831|Naval Medical Center San Diego|CAPTAIN Dennis Spence, NC, USN, PhD, CRNA|6199161680|dennis.l.spence.mil@mail.mil|
22299001|NCT02316717|Immuron|Neta Tobis, Clinical Director|+972549277334|neta@immuron.com|2549277334
22299002|NCT00236938|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
22299003|NCT02460198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299004|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22299005|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554|lw@gidoctor.net|102
22313034|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org|
22299006|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200||
22299007|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com|
22313035|NCT02515656|Laboratoire Innotech International|Director of Medical Affairs|+33 (0)1 46 15 29 00||
22313036|NCT04044352|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-4946|kneuzil@som.umaryland.edu|
22313037|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777||
22313038|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
22313039|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313040|NCT00729053|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22313041|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu|
22313042|NCT02514577|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
22313043|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22313044|NCT06091982|National Cardivascular Center Harapan Kita|Prieta Adriane MD|+62 21 5684093|prietaadriane@gmail.com|7406
22313045|NCT02136797|Memorial Sloan Kettering Cancer Center|Dr. Kevin Curran, MD|212-639-5836|currank@mskcc.org|
22313046|NCT04523571|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22313047|NCT04198428|HealthPartners Institute|Dr. Rebecca Rossom, Co-Principal Investigator|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22313048|NCT03473665|Columbia University|Runsheng Wang|212-305-4308|rw2646@cumc.columbia.edu|
22313049|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313050|NCT05030467|Brigham and Women's Hospial|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
22313051|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22313052|NCT05129592|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|3017128357|cweiger2@jhmi.edu|
22313053|NCT03344458|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
22313054|NCT04694300|University of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD. Professor of Oral Surgery and Pharmacology|215-898-9686|evhersh@upenn.edu|
22313055|NCT04203199|Wake Forest University Health Sciences|Colleen Hanlon, PhD|844-386-7001|DeepTMS@brainsway.com|
22313056|NCT03960437|Columbia University|Thomas L.Nickolas, MD, MS|212-305-9847|tln2001@cumc.columbia.edu|
22313057|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com|
22313058|NCT02630147|University of Sherbrooke Hospital Research Center, QC, Canada|Dr Jean-Paul Praud|819-346-1110|jean-paul.praud@usherbrooke.ca|14851
22313059|NCT01136733|Eisai Medical Inc.|Eisai Medical Services|1-888-422-4743||
22313060|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org|
22313061|NCT01882088|Federal research Center of Nutrition and Biotechnology|Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology|+74996131091|morosoffsv@mail.ru|
22313062|NCT02186015|Loyola University Chicago|Patricia Sheean|708-216-0344|psheean1@luc.edu|
22313063|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|patten@phhp.ufl.edu|4160
22313064|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org|
22313065|NCT02720198|Duke University Medical Center|Dr. Narei Hong|984-215-8493|narei.hong@duke.edu|
22313066|NCT03897075|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22313067|NCT02592434|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313068|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com|
22313069|NCT01757171|Weill Cornell Medical College|Navjot Kaur, GI Program Manager|646-962-9350|nak2028@med.cornell.edu|
22313070|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu|
22313071|NCT00105521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22313072|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de|
22313073|NCT03912298|University of Pennsylvania|Peggy Compton|2158986679|pcompton@nursing.upenn.edu|
22313074|NCT00385697|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
22313075|NCT00427297|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
22313076|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu|
22313077|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com|
22313078|NCT01979211|University of Cincinnati Cancer Center|Vinita Takiar, Associate Professor, MD|513-584-4775|vinita.takiar@uc.edu|
22313079|NCT02741297|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
22325213|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
22325214|NCT02049502|Emory University|Dr. Shaffer|404-778-5033|virginia.o.shaffer@emory.edu|
22325215|NCT01526356|The University of Texas Health Science Center at Houston|Mary Kay Koenig, MD|713-500-7142|mary.k.koenig@uth.tmc.edu|
22325216|NCT02983292|Senior Specialist-Clinical Study Management|Dr. Manvendra Saxena|+61 455 870 175|manvendra.saxena@smith-nephew.com|
22325217|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
22325218|NCT03851510|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22270782|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965|michael.hotze@straumann.com|1235
22325219|NCT02426086|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
22270783|NCT02773212|University of Illinois at Chicago|Dr. Margaret Wardle|(312)413-5564|mwardle@uic.edu|
22270784|NCT03843632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270785|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
22270786|NCT03403751|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
22313080|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22281586|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313081|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu|
22313082|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org|
22313083|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313084|NCT02732899|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22313085|NCT02790788|National and Kapodistrian University of Athens|Associate Professor in Intensive Care Medicine|00302132043307|sdmentzelopoulos@yahoo.com|
22313086|NCT05607147|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|7328247241|subramga@sdm.rutgers.edu|
22313087|NCT01721109|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22313088|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu|
22313089|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu|
22313090|NCT00742560|AbbVie|Global Medical Services|800-633-9110||
22313091|NCT02438410|Mayo Clinic|Dr. Darrell Pardi|(507) 538-1827|pardi.darrell@mayo.edu|
22313092|NCT01536795|Institut Pasteur, Tunisia|Afif Ben Salah, MD|011-216-71-792-429|afif.bensalah@pateur.rns.tn|
22313093|NCT02267746|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22313094|NCT05008224|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22313095|NCT00348283|Abbott|Medical Information Specialist|800-633-9110||
22313096|NCT02051972|Abbott Medical|Nicole Harbert|1-972-526-4841|nicole.harbert@abbott.com|
22325220|NCT04542291|Washington University School of Medicine|Kian-Huat Lim, M.D.|314-362-6157|kian-huat.lim@wustl.edu|
22325221|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590||
22281587|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
22281588|NCT01205061|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22281589|NCT04026009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281590|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281591|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu|
22281592|NCT02300558|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22281593|NCT01471028|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
22281594|NCT02957747|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Suzannah Creech, Ph.D.|254-297-3025|Suzannah.Creech@va.gov|
22281595|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu|
22281596|NCT04405999|Almazov National Medical Research Centre|Evgeny Mikhaylov|+7(812)7023764|e.mikhaylov@almazovcentre.ru|
22281597|NCT03115827|Vanderbilt University Medical Center|Dr. Katherine McDonell|615-875-7987|katherine.mcdonell@vumc.org|
22281598|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org|
22281599|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com|
22281600|NCT00964002|Department of Medical Oncology, Institut bergonié|Pr Nadine Houede, oncologist||nadine.HOUEDE@chu-nimes.fr|
22281601|NCT03768089|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22281602|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu|
22281603|NCT01825512|Consorzio per Valutazioni Biologiche e Farmacologiche|Donato Bonifazi|+393936698076|ceo@cvbf.net|
22281604|NCT02091362|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281605|NCT00286091|Amgen Inc.|Study Director|866-572-6436||
22281606|NCT02936869|World Bank|Dr. Adanna Chukwuma|9173712931|adc785@mail.harvard.edu|
22281607|NCT00335738|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22281608|NCT05066750|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
22281609|NCT05141175|Duke University|Dr. Anthony Viera|919 681 3178|anthony.viera@duke.edu|
22281610|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22281611|NCT02445014|Mass General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
22281612|NCT03800537|University of North Carolina at Chapel Hill|Desma Jones|919-843-9463|desma_jones@med.unc.edu|
22281613|NCT01928290|Washington University School of Medicine|Haeseong Park, M.D.|314-747-6268|haeseongpark@wustl.edu|
22281614|NCT01032603|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22281615|NCT04470050|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22281616|NCT03098433|Virginia Commonwealth University|Francesco S. Celi, MD, MHSc.|804-828-9696|francesco.celi@vcuhealth.org|
22281617|NCT01813058|Boston Children's Hospital|susan Goobie, MD, FRCPC|6173667737|susan.goobie@childrens.harvard.edu|
22281618|NCT03585764|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22281619|NCT02777203|The Advanced Gyn Surgery Institute|Mary Johnston|6303641112|mjohnston@drcharlesmiller.com|
22281620|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu|
22281621|NCT03604172|University of Pennsylvania|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
22325222|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22313097|NCT02091102|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22313098|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov|
22325223|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu|
22325224|NCT02862912|Columbia University|Dr. Allison Lee|212-305-6494|al3196@cumc.columbia.edu|
22325225|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu|
22299008|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu|
22299009|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
22270787|NCT01623037|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulaory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22270788|NCT02071810|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22270789|NCT00520481|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22270790|NCT04586634|Coloplast|Director of Clinical Strategy|+4549111111|clinical-studies@coloplast.com|
22270791|NCT04442269|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22270792|NCT03559868|Yale University, Yale School of Medicine|Mehal Wajahat MD, DPhil|877.925.3637|wajahat.mehal@yale.edu|
22270793|NCT03802565|Neurana Pharmaceuticals, Inc.|Randall Kaye, MD - Chief Medical Officer|858-732-0708|rkaye@neuranapharma.com|
22270794|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270795|NCT03099694|Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing|Prof. Shi Yuan|13508300283|15084335697@163.com|
22270796|NCT04326439|Emory University|Dr. Himalee Sabnis|404-727-3285|hsabnis@emory.edu|
22270797|NCT01892709|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
22270798|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
22270799|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270800|NCT03492398|Seoul National University Hospital|Inseung Jeon|82-2-2072-1920|isjeon0127@snu.ac.kr|
22270801|NCT03951064|University of North Carolina at Chapel Hill|Jackson Pettee|984-215-6872|jackson_pettee@med.unc.edu|
22270802|NCT02640677|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22270803|NCT00537576|University of California, San Francisco|Anke Hemmerling, Project Director|415-597-4963|ahemmerling@globalhealth.ucsf.edu|
22270804|NCT02255305|NorthShore UH|Jennifer Grant|847-570-2420|jgrant@northshore.org|
22270805|NCT05685264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270806|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112||
22270807|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060|nawaram@kasrelaini.edu.eg|002
22270808|NCT01746420|Wright Medical|Justin Moss|615-236-4984|justin.moss@wright.com|
22270809|NCT01817582|Bausch & Lomb Incorporated|Director of Clinical Operations||Jon.Williams@bauschhealth.com|
22270810|NCT03053063|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22270811|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22270812|NCT02341495|Loyola University Medical Center|Dr. Elizabeth Henry|708-327-3153|ehenry@lumc.edu|
22270813|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270814|NCT02345265|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|Joyce_Liu@dfci.harvard.edu|
22270815|NCT03569293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22270816|NCT04843761|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
22270817|NCT05072106|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit,|0034918466000|AEincoming@pharmamar.com|
22270818|NCT03839459|University of Rochester Medical Center|Brea Lipe, MD|(585) 275-4099|Brea_Lipe@URMC.Rochester.edu|
22270819|NCT05376241|University of Colorado|Laura Scherer|303-724-5749|laura.scherer@cuanschutz.edu|
22270820|NCT04240886|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22270821|NCT02276053|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22270822|NCT02059434|AstraZeneca|AstraZeneca Clinical Study Information Center||ClinicalTrialTransparency@astrazeneca.com|
22270823|NCT02956447|Massachusetts General Hospital|Dr. Stephanie Seminara|617-724-5390|MGHKisspeptinResearch@partners.org|
22270824|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com|
22270825|NCT02928770|Stanford University|Clete A. Kushida, M.D., Ph.D.|6507217560|clete@stanford.edu|
22270826|NCT03201874|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
22270827|NCT02210247|Pacira Pharmaceuticals Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22270828|NCT02759055|HealthPartners Institute|Patrick J O'Connor|952-967-5034|Patrick.J.OConnor@HealthPartners.Com|
22270829|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com|
22270830|NCT02210286|Stanford University|Alison Myoraku|6507244559|myoraku@stanford.edu|
22270831|NCT01424514|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270832|NCT02653170|Michigan State University|Dr. Mathew Reeves|517-353-8623|reevesm@msu.edu|
22270833|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000||
22270834|NCT03391232|Treos Bio|Chef Scientific Officer|+3615500826|eniko.toke@treosbio.com|
22270835|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831|info@isarna-therapeutics.com|0
22270836|NCT03875482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22270837|NCT04777201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270838|NCT02355821|RGNKC|Ekaterina Dudinskaya, head of age-related metabolic and endocrine disorders laboratory|+79031914690|katharina.gin@gmail.com|
22270839|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu|
22270840|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
22270841|NCT02691013|University of California San Diego|Dr. Robert Owens|858-657-5258|rowens@ucsd.edu|
22270842|NCT02357706|Charite Department of Sleepmedizin|Prof Dr med Ingo Fietze|+49 30 450 513 122|ingo.fietze@charite.de|
22313099|NCT04016415|Milton S. Hershey Medical Center, Penn State Hershey College of Medicine|Dr. Nazia T Raja-Khan, M.D., M.S., Associate Prof, Dept of Medicine, Div. of Endocrin & Diabetes|717-531-8395|nrajakhan@pennstatehealth.psu.edu|
22281622|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org|
22281623|NCT01642056|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
22281624|NCT03028129|Federal University of Mato Grosso do Sul|Julio Croda|+5567981229959|julio.croda@ufms.br|
22313100|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu|
22313101|NCT05777772|University of Washington|Dr. Elizabeth Phelan|(206) 520-5000|phelane@uw.edu|
22313102|NCT01613807|Sansum Diabetes Research Institute|Dr. Kristin Castorino|8056827640|kcastorino@sansum.org|256
22313103|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313104|NCT02661490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313105|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590||
22313106|NCT02388932|Cleveland Clinic, Case Comprehensive Cancer Center|Shlomo Koyfman, MD|216-444-7552|koyfmas@ccf.org|
22313107|NCT04588246|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22313108|NCT05335005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313109|NCT05927753|Bruno Vision|Richard E Lippman|301-580-3931|richard.lippman@gmail.com|
22325226|NCT00003270|Roswell Park Comprehensive Cancer Center|Dr. Theresa Hahn|716-845-5819|theresa.hahn@roswellpark.org|
22325227|NCT02378753|Centers for Disease Control and Prevention|Dr. Barbara Mahon|404-718-1157|bdm3@cdc.gov|
22325228|NCT03572634|Sr. Director Drug Development/Clinical Operations|Susan Smith|210-414-7702|s.smith@toleropharma.com|
22325229|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
22325230|NCT02606877|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325231|NCT04952389|Mayo Clinic|Janalee K. Stokken, M.D.|507-284-1482|Stokken.Janalee@mayo.edu|
22325232|NCT02293954|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22325233|NCT03165981|Duke University|Dr. Emmanuel B. Walter|919-620-5346|chip.walter@duke.edu|
22281625|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov|
22281626|NCT03657134|NYU Langone Health|Lior Jankelson, MD, PhD|212-263-7149|Lior.Jankelson@nyulangone.org|
22281627|NCT02597452|Penn Medicine|Dr. Ari D Brooks|215-829-8461|ari.brooks@pennmedicine.upenn.edu|
22281628|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
22281629|NCT01380535|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22313110|NCT02123797|Baptist Cancer Center|Dr. Raymond Osarogiagbon|901-752-6131|Raymond.Osarogiagbon@bmg.md|
22313111|NCT02132598|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
22325234|NCT06384989|The Ohio State University|Julie Mansfield|614-366-2101|julie.mansfield@osumc.edu|
22325235|NCT05635838|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22325236|NCT05287893|Medicines for Malaria Venture|Joerg Moehrle|+41 22 555 03 00|info@mmv.org|
22325237|NCT02699515|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|+49
22325238|NCT05243550|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
22325239|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22325240|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22325241|NCT05094154|Vanderbilt University Medical Center|Edward T Qian, MD|615-322-2386|edward.t.qian@vumc.org|
22325242|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325243|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300||
22325244|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22325245|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
22325246|NCT00970203|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22325247|NCT02767570|Stanford University|Julie Kolesar, PhD|614-561-1563|julie14@stanford.edu|
22325248|NCT04510922|University of Cincinnati|Alberto Espay, MD, MSc|5135584050|espayaj@ucmail.uc.edu|
22325249|NCT03774745|University of California, Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
22325250|NCT01981122|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
22325251|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org|
22325252|NCT01330381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22270843|NCT02111785|Department of Neurosurgery, University of Virginia Health System|Dr. Daniel Raper|4349823244|raper@virginia.edu|
22270844|NCT02327403|Massachusetts General Hospital|Dr. Leonardo V Riella, MD, PhD|6176436266|LRIELLA@MGH.HARVARD.EDU|
22270845|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org|
22270846|NCT02275780|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22270847|NCT03960866|Ocuphire Pharma, Inc.|Mina Sooch|248-681-9815|msooch@ocuphire.com|
22270848|NCT03369067|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22270849|NCT01054300|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270850|NCT00981045|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22270851|NCT05129475|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313112|NCT01375777|Amgen Inc.|Study Director|866-572-6436||
22325253|NCT03846947|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22325254|NCT03060577|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22325255|NCT03216265|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325256|NCT01306058|Principal Investigator|Dr. Tim Greten|301-451-4723|tim.greten@nih.hhs.gov|
22325257|NCT01539837|Imperial College London|David Dexter|+44 (0)20 7594 6665|d.dexter@imperial.ac.uk|
22325258|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325259|NCT02889510|Dynamic Science S.L|Anna Royo|+34680603119|a.royo@dynasolutions.com|
22325260|NCT01978912|Teijin America, Inc.|President|+1-212-308-8744|clinical-trials-safety@teijinpo.com|
22325261|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22325262|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu|
22325263|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th|
22325264|NCT01878006|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
22325265|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
22325266|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22325267|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com|
22325268|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22325269|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
22325270|NCT03707977|Harvard T.H. Chan School of Public Health|Molly Pretorius Holme|617-432-4377|mpretori@hsph.harvard.edu|
22325271|NCT03069690|University of Pittsburgh Medical Center|Dr. Michele Levine|(412) 647-0703|levinem@upmc.edu|
22325272|NCT02564120|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
22325273|NCT03842709|University of New Mexico-Dept of Neurosciences|ERIN MILLIGAN,|505-272-4411|EMilligan@salud.unm.edu|
22325274|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu|
22325275|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com|
22325276|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22325277|NCT00553059|University of Texas (UT) MD Anderson Cancer Center|Michael J. Fisch, MD/Department of General Oncology|713-563-9905|mfisch@mdanderson.org|
22270852|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325278|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325279|NCT01966731|Cincinnati Children's Hospital Medical Center|Russell Ware, MD, PhD|(513) 803-1108|russell.ware@cchmc.org|
22325280|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
22325281|NCT02757547|Philips|Pat Olsen|(303) 475-3417|pat.olsen@philips.com|
22325282|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
22325283|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com|
22325284|NCT04901897|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22325285|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22325286|NCT00577590|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22325287|NCT01673061|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Medicine|2154562313|mohiuddk@einstein.edu|
22325288|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22325289|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu|
22325290|NCT03455543|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
22325291|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584||
22325292|NCT01505062|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22325293|NCT02717546|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574.527.7934|ryan.boylan@zimmerbiomet.com|
22325294|NCT00909090|University of Georgia|Dr. Billy Hammond, Principal Investigator|(706) 54204812|bhammond@uga.edu|
22325295|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu|
22325296|NCT02926573|Washington University School of Medicine|Melanie Townsend, M.D.|314-362-4470|townsendm@wustl.edu|
22325297|NCT03099369|University of North Carolina at Chapel Hill|David Lee, MD|347-882-8010|dave.lee0530@gmail.com|
22325298|NCT04460027|Stanford Prevention Research Center, Department of Medicine, Stanford University|Judith J. Prochaska, PhD|650-724-3608|jpro@stanford.edu|
22325299|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
22325300|NCT03633331|City of Hope Comprehensive Cancer Center|Mina S. Sedrak MD, MS|626-218-4173|msedrak@coh.org|
22325301|NCT01009294|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22325302|NCT03240081|OHSU|Dr. Martha Goetsch|503-494-3666|goetsch@ohsu.edu|
22325303|NCT00949650|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325304|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164|Karen.Devries@lshtm.ac.uk|8164
22325305|NCT04601272|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
22325306|NCT03322657|Cleveland Clinic Foundation|Dr. Ehab Farag|216 444-7550|FARAGE@ccf.org|
22325307|NCT00940342|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22325308|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn|
22270853|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu|
22270854|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org|
22325309|NCT03249350|Oregon Social Learning Center|Dr. Mike McCart|541-485-2711|MikeM@oslc.org|
22313113|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu|
22299010|NCT02047604|Valeant Pharmaceuticals|VP Clinical Services|9089271162|christine.hnatko@valeant.com|
22299011|NCT00983814|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22299012|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299013|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr|
22299014|NCT05419947|Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Luis Muñoz Bellvís|0034 923 29 11 00|luismb@usal.es|
22299015|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org|
22299016|NCT03136068|UCSF|Director of Clinical Trials|414-206-8715|abby.sokoloff@ucsf.edu|
22299017|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299018|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu|
22299019|NCT04419493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281630|NCT03045406|FadoiFoundation|Giorgio Vescovo|00390685355188|irenezaratti@fadoi.org|
22299020|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22299021|NCT03794089|VA Center for Integrated Healthcare|Dr. Robyn L. Shepardson|315-425-4400|Robyn.Shepardson@va.gov|53956
22299022|NCT03985423|Sobi|Radmila Kanceva, MD|+4686972000|radmila.kanceva@sobi.com|
22299023|NCT03119766|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22299024|NCT02562755|SillaJen Biotherapeutics Inc.|Kyoung Soo Ha, Senior Medical Director|+1-415-281-8886|ksha@kr.sillajen.com|
22299025|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22299026|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22299027|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu|
22299028|NCT01782131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299029|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org|
22299030|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22299031|NCT03266588|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22299032|NCT01176591|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
22299033|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299034|NCT02044510|Lawson Research Institute|Mary McKibbon|5196466367|mary.mckibbon@sjhc.london.on.ca|
22299035|NCT03971617|Stony Brook University Medical Center|Sandra Skinner|631-444-7513|sandra.skinner@stonybrookmedicine.edu|
22299036|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22313114|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22313115|NCT00376935|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22313116|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu|
22281631|NCT03804021|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
22281632|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281633|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22281634|NCT01436656|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281635|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu|
22281636|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr|
22281637|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281638|NCT03350035|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22281639|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22281640|NCT01545934|Cal Poly|Suzanne Phelan|805-756-2087|sphelan@calpoly.edu|
22281641|NCT02710981|OB-GYN department, Assiut University, Egypt|Essam R. Othman|+201006607801|essamrash@yahoo.com|
22281642|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu|
22281643|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu|
22281644|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
22281645|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354|jimeneznavarro@secardiologia.es|0034
22281646|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22281647|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu|
22281648|NCT01812213|Navidea Biopharmaceuticals|Chief Medical Officer|6149737555|mblue@navidea.com|
22281649|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu|
22281650|NCT04826094|Henry M Jackson Foundation for the Advancement of Military Medicine|David Fetterer, MS (Programmer Analyst)|301.500.3818|dfetterer@global-id.org|
22281651|NCT03549572|Spaulding Rehabilitation Hospital|Yelena Bodien|(617) 643-3956|ybodien@mgh.harvard.edu|
22281652|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu|
22281653|NCT03928418|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
22281654|NCT05319600|University of Vermont|Amy Hughes Lansing, PhD|(802) 656-3801|amy.hughes.lansing@uvm.edu|
22299037|NCT02039505|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22299038|NCT01722331|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22325310|NCT03026504|Mayo Clinic|Matthew Koster, M.D.|507-284-5800|koster.matthew@mayo.edu|
22325311|NCT04168645|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
22325312|NCT01853228|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22325313|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325314|NCT01518699|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22325315|NCT02110108|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22325316|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu|
22325317|NCT03635190|Cardio Flow, Inc.|Michael J Kallok, PhD|16512531754|mjkallok@cardioflow.net|
22325318|NCT03692910|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22325319|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu|
22325320|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov|
22325321|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300||
22325322|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com|
22325323|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325324|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org|
22325325|NCT03454048|Radboud university medical center|Prof. dr. Teun Bousema|+3124 3614306|teun.bousema@radboudumc.nl|
22325326|NCT00631319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22325327|NCT02267577|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22325328|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu|
22325329|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325330|NCT03671369|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281655|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313117|NCT03602053|PATH|Dr Niraj Rathi, MD; Senior Medical Officer|+91 11 4064 0000|nrathi@path.org|
22313118|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
22313119|NCT04203225|Harbor-UCLA Medical Center|Kelly D. Young, MD|424-306-5431|kyoung3@dhs.lacounty.gov|
22313120|NCT03672188|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22313121|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com|
22313122|NCT03997409|Vanderbilt University Medical Center|Dr. Sara Duffus|+1 (615)322-7427|sara.duffus@vumc.org|
22313123|NCT03696342|Medical Affairs Operations Chief|Dr. Alejandra Sanchez-Rios|33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22313124|NCT02409732|Dartmouth-Hitchcock Medical Center|Dr. Michael Shane Chapman Section Chief of Dermatology|603-650-3106|Michael.Shane.Chapman@hitchcock.org|
22325331|NCT04382651|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22325332|NCT02732912|Oxford Brookes University|Dr Derick Wade|+447818452133|derick.wade@ntlworld.com|
22325333|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com|
22325334|NCT03134963|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
22325335|NCT01507545|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22325336|NCT03739983|University of Wisconsin Carbone Cancer Center|Ryan Spencer, MD, MS|608-265-1700|rjspencer2@wisc.edu|
22325337|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu|
22325338|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22325339|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu|
22325340|NCT01971476|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325341|NCT04901507|Virginia Commonwealth University School of Dentistry|Dr. Caroline Carrico|804-828-8328|ckcarrico@vcu.edu|
22325342|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu|
22325343|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com|
22325344|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu|
22325345|NCT05121103|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22325346|NCT00514449|Western Psychiatric Institute and Clinic|Dr. Konasale Prasad|412-586-9014|prasadkm@upmc.edu|
22325347|NCT04083144|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|4165358501|bernard.lefoll@camh.ca|33111
22325348|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu|
22325349|NCT02830165|University of California at Los Angeles, David Geffin School of Medicine, Radiation Oncology|Nicholas Nickols, MD|310 825-8278|nnickols@mednet.ucla.edu|50472
22325350|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu|
22325351|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|
22325352|NCT02694029|UT Southwestern Medical Center|Asal Rahimi, MD|214/645-8556|Asal.Rahimi@UTSouthwestern.edu|
22325353|NCT00301067|Northwestern University|Clinical Trials Office|312-695-1301||
22325354|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu|
22325355|NCT05897853|Hospital of Ludwig Maximilians University, Munich|Prof. Dr. Michael Strupp|+49 894400|Michael.Strupp@med.uni-muenchen.de|76980
22325356|NCT03246074|SKCCC at Johns Hopkins|Stephanie Gaillard, MD PhD|410-955-3774|stephanie.gaillard@jhmi.edu|
22325357|NCT04458857|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22325358|NCT02609399|Johns Hopkins University|Dr. Richard Rothman|410-735-6428|rrothma1@jhmi.edu|
22325359|NCT01811030|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22325360|NCT00853905|Wills Eye Hospital Glaucoma Research Center|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org|
22325361|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org|
22325362|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu|
22325363|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu|
22325364|NCT02312986|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
22325365|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com|
22325366|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu|
22325367|NCT02725177|Cleveland Clinic Foundation|Daniel Culver, DO|216-444-6508|culverd@ccf.org|
22325368|NCT02088216|Qilu Hospital of Shandong University|Yu Li|13791122770|qlliyu@163.com|
22325369|NCT04661813|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
22325370|NCT04285723|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22325371|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22325372|NCT02032524|Sanofi-Aventis Recherche & Developpement|Trial Transparency Team|800-633-1610|contact-us@sanofi.com|6#
22325373|NCT04224987|UCSF Proctor foundation|Dr Thomas Lietman|4154761442|tom.lietman@ucsf.edu|
22325374|NCT02903511|"University of Colorado Denver | Anschutz"|Godela Brosnahan, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22325375|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325376|NCT01089725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325377|NCT01894516|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
22325378|NCT05652660|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325379|NCT02605863|University of Rochester|Edward Messing, ND|585-275-0998|edward_messing@urmc.rochester.edu|
22325380|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be|
22325381|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
22325382|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
22325383|NCT03191396|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22325384|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md|
22325385|NCT02133235|NTUH|YJ Cheng|886-2-23123456|chengyj@ntu.edu.tw|62158
22325386|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu|
22325387|NCT02898207|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
22325388|NCT03990766|Washington University School of Medicine|Dr. Jake Lee|3143937248|jakejlee@wustl.edu|
22325389|NCT03726671|University of North Carolina at Chapel Hill|Julie M. Stegall, MSW|704-250-5048|julie_stegall@unc.edu|
22325390|NCT04192448|Eastern Michigan University|Elizabeth Neilson|734-487-4988|eneilso1@emich.edu|
22325391|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
22325392|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com|
22325393|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com|
22325394|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22325395|NCT00500149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22325396|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22325397|NCT02940886|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22325398|NCT03042611|Elevar Therapeutics, Inc|Elevar Clinical Trials|(801) 303-7440|info-clinicalstudy@elevartherapeutics.com|
22325399|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22325400|NCT02740153|Children's National Medical Center|Dr. Nicholas Ah Mew|202-476-5863|nahmew@childrensnational.org|
22325401|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
22325402|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22325403|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com|
22325404|NCT03321617|New York State Psychiatric Institute|Ragy Girgis, MD|646-774-5553|ragy.girgis@nyspi.columbia.edu|
22325405|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu|
22325406|NCT03735095|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22325407|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu|
22325408|NCT02345369|Bassett Medical Center|clinical research nurse supervisor|6075476965|jennifer.victory@bassett.org|
22325409|NCT03897712|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
22325410|NCT00545818|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22325411|NCT02623361|UCSF|Matthias Behrends, PI|415 476 3761|matthias.behrends@ucsf.edu|
22325412|NCT01873742|Modum Bad Research Institute|Dr. Terje Tilden|+4732749869|tilden@modum-bad.no|
22325413|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com|
22325414|NCT01417286|Cancer Institute of New Jersey Rutgers|Dr. Haffty|732-235-8675|hafftybg@cinj.rutgers.edu|
22325415|NCT03368898|bakirkoy dr sadi konuk training and research hospital|İsmail Alay|+905462375638|dr_ismailalay@hotmail.com|
22325416|NCT00942708|UT Southwestern|Kelly Chin|214-645-5989|kelly.chin@utsouthwestern.edu|
22325417|NCT01457339|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22325418|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com|
22325419|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22281656|NCT02771574|Stanford University School of Medicine|Cindy Lamendola|650-723-3141|clamendola@stanford.edu|
22281657|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300||
22281658|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22281659|NCT03231917|White River Junction VAMC|Dr Joseph Anderson|8022959363|joseph.anderson@dartmouth.edu|
22281660|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org|
22281661|NCT03587428|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281662|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org|
22281663|NCT01076205|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22281664|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
22281665|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281666|NCT00313144|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22281667|NCT03403361|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
22281668|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org|
22281669|NCT02487654|Imperial College London|Professor Prapa Kanagaratnam|+44 20 3313 1000|p.kanagaratnam@imperial.ac.uk|
22281670|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
22281671|NCT02443116|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
22281672|NCT01932372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281673|NCT05352412|Washington University School of Medicine|Dr. Michael J. Durkin, Principal Investigator|314-454-8225|mdurkin@wustl.edu|
22281674|NCT03594747|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22281675|NCT04382586|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281676|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com|
22281677|NCT05818956|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22281678|NCT02265536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281679|NCT03869385|University Hospital of Jena|Prof. Dr. Yasser Sakr|01742191538|yasser.sakr@med.uni-jena.de|0049
22281680|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281681|NCT02907216|GlaxoSmithKline|GSK Response Center|866-435-7343|kap69137@gsk.com|
22281682|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org|
22281683|NCT02485639|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
22281684|NCT03763656|Nova Laboratories Ltd|Dr Hussain Mulla, Head of Clinical Development|0116 223 0101|hussain.mulla@novalabs.co.uk|
22299039|NCT04088097|Yale University|Dr Janet Lydecker|2037374299|janet.lydecker@yale.edu|
22299040|NCT03556761|University of Pennsylvania|Dr Lisa Levine|215-662-6913|lisa.levine@pennmedicine.upenn.edu|
22299041|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
22299042|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299043|NCT03614793|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
22299044|NCT02840877|Boston Medical Center|Karen Jacobson, MD MPH|617-414-5213|karen.jacobson@bmc.org|
22299045|NCT04317586|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
22299046|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456|jacque_liu@mail2000.com.tw|63572
22299047|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299048|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22299049|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu|
22299050|NCT03003676|Targovax|Dr. Lone H. Ottesen, Chief Development Officer|+44 7920567911|lone.ottesen@targovax.com|
22299051|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
22299052|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org|
22299053|NCT01807585|Medtronic Endovascular|Melissa Hasenbank, Clinical Research Director|707-525-0111|melissa.hasenbank@medtronic.com|
22299054|NCT03021759|University of Pennsylvania|Rebecca Pepe|215-360-0951|peper@pennmedicine.upenn.edu|
22299055|NCT04279925|Plastic Surgery Division of Surgery Department of Cipto Mangunkusumo Hospital Jakarta / Faculty of Medicine Universitas Indonesia|Prasetyanugraheni Kreshanti, MD|08158732424|pras_md@yahoo.com|
22299056|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com|
22299057|NCT02617589|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22299058|NCT03062891|University of Notre Dame|Dan Denis|6178066484|ddenis@nd.edu|
22299059|NCT03678181|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22299060|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262|james.henry@va.gov|57466
22299061|NCT00495716|University of Washington Virology Research Clinic|Clinic Director|206-520-4340|vrc@uw.edu|
22299062|NCT02076412|Rigel|Anne-Marie Duliege, MD|6506241100|clinicaltrials@rigel.com|6506241100
22299063|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu|
22299064|NCT00298831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299065|NCT01516879|Amgen Inc.|Study Director|866-572-6436||
22299066|NCT04568122|Stanford University BioEngineering|Manu Prakash, PhD|(650) 725-3731|manup@stanford.edu|
22299067|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se|
22299068|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu|
22299069|NCT02460224|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22325420|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu|
22325421|NCT02514070|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
22325422|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325423|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu|
22325424|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu|
22325425|NCT04538950|Mayo Clinic|John P. Bois, M.D.|507 284-4072|Bois.John@mayo.edu|
22325426|NCT05610969|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@pennmedicine.upenn.edu|
22325427|NCT04579393|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Jeffrey Strich, MD|301.496.9320|jeffrey.strich@nih.gov|
22325428|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu|
22325429|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22325430|NCT01535937|NYSPI|Elias Dakwar, MD|646.774.8728|elias.dakwar@nyspi.columbia.edu|
22325431|NCT02519231|University of Washington|Dr. Emily Godfrey|206.685.4895|godfreye@uw.edu|
22325432|NCT02704429|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22325433|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300||
22325434|NCT03557372|Dana Farber Cancer Institute|Dr. Shyam Tanguturi|617-632-0000|stanguturi@partners.org|
22325435|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325436|NCT01707147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325437|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
22325438|NCT04435769|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325439|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22325440|NCT02053246|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
22325441|NCT02707757|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
22325442|NCT01318902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22325443|NCT01783522|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Beth Faiman|216-444-3705|faimanb@ccf.org|
22325444|NCT02420652|Rutgers Cancer Institute of New Jersey|Biren Saraiya, MD|732-235-3360|saraiybi@cinj.rutgers.edu|
22325445|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com|
22325446|NCT02778880|Cincinnati Children's Hospital Medical Center|Theresa Frey, MD|513-636-7966|theresa.frey@cchmc.org|
22325447|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22325448|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22325449|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325450|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22325451|NCT03152136|Cala Health|Paula Chidester|650-273-7436|paula@calahealth.com|
22325452|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu|
22325453|NCT05099991|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
22325454|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com|
22325455|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325456|NCT00915005|UT MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
22325457|NCT01848821|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|617-724-8604|dyeh2@partners.org|
22325458|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org|
22325459|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325460|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325461|NCT03952650|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Dave Cook|240.627.3066|david.cook@nih.gov|
22325462|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325463|NCT04084392|Vanderbilt University Medical Center|Dr. Dave Marcovitz|615-936-3555|david.marcovitz@vumc.org|
22325464|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
22325465|NCT02441803|University of Texas MD Anderson Cancer Center|Dr. Richard Champlin, MD/Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22325466|NCT02873221|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22325467|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org|
22325468|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil|
22325469|NCT01834144|University of Manitoba|Dr. Jonathan McGavock|204-480-1359|jmcgavock@chrim.ca|
22325470|NCT02234583|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22325471|NCT01849250|The University of Texas MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention|713-792-7734|PHBrown@mdanderson.org|
22325472|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu|
22325473|NCT00771030|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22325474|NCT00114114|Massachusetts General Hospital|Dr. Ben Leder|617-726-6723|bzleder@partners.org|
22325475|NCT01022853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325476|NCT01651052|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
22325477|NCT03503773|Ablative Solutions Inc|Kate Rumrill, CEO|1 650-688-9743|krumrill@ablativesolutions.com|
22325478|NCT00607828|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
22325479|NCT05341466|University of Colorado, Boulder|Andrew Q. Tan|303-735-0259|andrew.tan@colorado.edu|
22325480|NCT04156646|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22325481|NCT03511638|Bausch & Lomb|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22325482|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325483|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22325484|NCT02730247|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22325485|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22325486|NCT01645930|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22325487|NCT03245814|The University of Arizona|Dr. Maggie O'Haire|520-621-6767|maggieohaire@arizona.edu|
22325488|NCT00946270|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD./Professor|713-745-3429|sverstov@mdanderson.org|
22325489|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325490|NCT02263365|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
22325491|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22325492|NCT02335450|Oakland University|Beth Black|248-364-8694|bblack@oakland.edu|
22325493|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325494|NCT01004107|Merz North America|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
22325495|NCT02613572|Scheie Eye Institute; Perelman School of Medicine; University of Pennsylvania|Benjamin J. Kim, MD|215-662-8675|benjamin.kim@uphs.upenn.edu|
22325496|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu|
22325497|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611|nikolaj.rongsted.milandt@rsyd.dk|0045
22325498|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22325499|NCT05258058|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22325500|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300||
22325501|NCT02509546|City of Hope Medical Center|Dr. Vinod Pullarkat, MD|626-359-8111|vpullarkat@coh.org|
22325502|NCT01524289|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325503|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222|sarit.assouline@mcgill.ca|8434
22325504|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn|
22325505|NCT03425656|Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.|Dr. Reza Safaei, M.D|0098-9124548684|safaiino@sina.tums.ac.ir|
22325506|NCT03429556|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22325507|NCT01399827|Massachusetts General Hospital|Craig Surman, MD|617-726-8392|csurman@partners.org|
22325508|NCT02209597|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22325509|NCT04441931|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22325510|NCT04799782|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
22325511|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org|
22325512|NCT03465735|Mayo Clinic|Waldemar E. Wysokinski, M.D., Ph.D.|507-266-6717|Wysokinski.Waldemar@mayo.edu|
22325513|NCT04902950|Reading Hospital|Amir Behnam, MD|610-988-9127|amir.behnam@towerhealth.org|
22325514|NCT01589094|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
22325515|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325516|NCT05363293|Alzamend Inc.|Eve Del Rio, MD, PhD|9736993847|Eve@RioPharma.com|
22325517|NCT04773041|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|bhavani.x.kashyap@healthpartners.com|
22325518|NCT02747628|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22325519|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620|info@valneva.com|0
22325520|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325521|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22325522|NCT01058369|Universitätsklinikum Erlangen, Medizinische Klinik 5|Prof. Dr. med. Stefan Krause||stefan.krause@uk-erlangen.de|
22325523|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu|
22325524|NCT01666444|Vice President, Clinical Affairs|Kristi Manjarrez|206-689-2256|kmanjarrez@ventirx.com|
22325525|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org|
22325526|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
22325527|NCT02988986|Houston Methodist Hospital|Dr. Jenny Chang, Director of Houston Methodist Cancer Center|713-441-0681|jcchang@houstonmethodist.org|
22325528|NCT02901262|UNIMIB, ASST-MONZA San Gerardo Hospital|Prof. Giuseppe Citerio|0039 039 233 4316|giuseppe.citerio@unimib.it|
22325529|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
22281685|NCT03479541|Oregon Health and Science University|Dr. Laurie King|5034182602|kingla@ohsu.edu|
22281686|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu|
22281687|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22270855|NCT02662764|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22270856|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
22270857|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22270858|NCT02416193|Loyola University Chicago|Mary Byrn, R.N., Ph.D.|(773) 508-8973|mbyrn@luc.edu|
22270859|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org|
22270860|NCT04521621|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22281688|NCT00334737|University of New Mexico|Dr. Robin K Ohls|505-272-6753|rohls@salud.unm.edu|
22313125|NCT00553800|Hossein.Borghaei@fccc.edu|Hossein Borghaei|215-214-4297|Hossein.Borghaei@fccc.edu|
22313126|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313127|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974||
22313128|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org|
22313129|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com|
22313130|NCT03614923|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22313131|NCT03416335|Sumitomo Pharma America|Reyna Bishop|617-674-6800|reyna.bishop@us.sumitomo-pharma.com|
22313132|NCT00116584|ULouisville|Dr. In Kim|502-629-7212|in.kim@louisville.edu|
22313133|NCT03034772|Wills Eye Physicians, Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
22313134|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu|
22313135|NCT02660034|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22313136|NCT02333071|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
22313137|NCT03863184|Weill Cornell Medicine|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
22313138|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br|
22313139|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22313140|NCT01318356|Radboud university medical center|S.P. Keijmel, MD PhD|0031243611111|stephan.keijmel@radboudumc.nl|
22313141|NCT03045302|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
22313142|NCT04453709|University of Massachusetts Amherst|Kalpana Poudel-Tandukar, Associate Professor|413-545-5095|kalpana@umass.edu|
22313143|NCT03590847|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
22313144|NCT05878522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313145|NCT05263492|Virginia Commonwealth University Massey Cancer Center|Massey IIT Research Operations|804-628-6430|masseyepd@vcu.edu|
22313146|NCT03747575|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22313147|NCT02916745|on behalf of Concordia Laboratories Inc./Advanz Pharma|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
22313148|NCT03953079|Graybug Vision|Executive Director, Biostatistics|650-459-4235|pdinh@graybug.vision|
22313149|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313150|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com|
22313151|NCT02228889|The Ohio State University Wexner Medical Center|Dr. Jeffrey Janis|(614) 297-2913|jeffrey.janis@osumc.edu|
22313152|NCT02260154|Abbott|Tatiana V. Vladimirova MD, PhD|+7 495-258-4280|tatiana.vladimirova@abbott.com|
22313153|NCT03560206|University of Kentucky|Misook Chung, PhD|(859) 323-8024|misook.chung@uky.edu|
22313154|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22313155|NCT03266419|Asan Medical Center|Dr. Byung-Moon Choi|82-2-3010-1704|byungmoonchoi7@gmail.com|
22313156|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22313157|NCT02255474|The Ohio State University|Dr. Jeffrey Walline|614-247-6840|walline.1@osu.edu|
22313158|NCT02394912|Volcano|VP Clinical Trials|858-720-8731|jonathan.batiller@philips.com|
22313159|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
22313160|NCT02993926|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22313161|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008|cmyers@vertosmed.com|216
22313162|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu|
22313163|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
22313164|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk|
22313165|NCT03584282|University of Washington|Dr. Joanne Stekler, Primary Investigator|(206) 744-8312|jstekler@uw.edu|
22313166|NCT00732498|University of Arizona|NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22313167|NCT03394508|Karolinska Institutet|Jon Konradsen|+46704242058|jon.konradsen@ki.se|
22313168|NCT04295499|Unicon Optical Co., Ltd.|Dr. Jimmy Chou|+88635775586|ra@uniconvision.com.tw|1307
22313169|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu|
22313170|NCT01892007|NIHR Nottingham Biomedical Research Centre, University of Nottingham|Dr Helen Henshaw|+44 (0)115 8232606|helen.henshaw@nottingham.ac.uk|
22313171|NCT03556891|Valencia Technologies|Jackie Dister|7604294787|jdister@valenciatechnologies.com|
22313172|NCT03868735|Rush University|Dr. J. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
22313173|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com|
22313174|NCT01002547|Malcom Randall VA Medical Center|Dr. Kenneth Cusi|352-273-8662|Kenneth.Cusi@va.gov; Kenneth.Cusi@medicine.ufl.edu|
22313175|NCT03273283|Hospital Clínic de Barcelona|Pol Bruguera Soler|628162567|pbruguer@clinic.cat|
22313176|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu|
22313177|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22313178|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22313179|NCT02055053|Lahey Clinic|dmitry nepomnayshy MD|781 744 8576|dmitry.nepomnayshy@lahey.org|
22313180|NCT00434577|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313181|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu|
22313182|NCT01921114|AngioDynamics|Alicia Conway|774-249-8707|aconway@angiodynamics.com|
22313183|NCT02956122|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22313184|NCT02652390|Hässleholm Hospital, Hässleholm, Sweden|Dr. Isam Atroshi|+46443091260|Isam.Atroshi@skane.se|
22313185|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313186|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22313187|NCT01410084|Wake Forest School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
22313188|NCT00958711|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22313189|NCT03722485|3M|Sher-ree Beekman|262-409-5112|sbeekman@mmm.com|
22313190|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313191|NCT00612716|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
22313192|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313193|NCT03087851|Dep. of Endocrinology and Internal Medicine, Aarhus University Hospital|MD Anne Sophie Sølling|78 45 54 75|annesoel@rm.dk|
22313194|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com|
22313195|NCT03782545|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22313196|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313197|NCT03050372|Medical University of South Carolina|Thomas W. Uhde, M.D.|843-792-0028|uhde@musc.edu|
22313198|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
22313199|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu|
22281689|NCT02316353|CSL Behring|Michelle Hellstern|6102907515|michelle.hellstern@cslbehring.com|
22281690|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22299070|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22299071|NCT04150224|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
22299072|NCT03837496|Massachusetts General Hospital|Jamie Jacobs, PhD|617-643-1777|jjacobs@mgh.harvard.edu|
22299073|NCT02774681|Northwestern University|Massimo Cristofanilli, MD|312-503-5488|Massimo.cristofanilli@nm.org|
22299074|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com|
22299075|NCT01974050|Columbia University|Melissa S. Stockwell|212-342-5732|mss2112@cumc.columbia.edu|
22299076|NCT03146650|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
22299077|NCT04666441|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22299078|NCT01443442|SCCO at MBKU|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
22299079|NCT03077165|IlkosTherapeutic Inc.|Monique Champagne|450-680-3381|mchampagne@ilkostherapeutic.com|2910
22299080|NCT03362515|Thomas Jefferson University|Dr. Mindy Rabinowitz|215-955-6784|mindy.rabinowitz@jefferson.edu|
22299081|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22299082|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu|
22299083|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov|
22299084|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299085|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299086|NCT02755935|Cochlear Americas|Ginger Grant, AuD|410-375-0883|ggrant@cochlear.com|
22299087|NCT02758236|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22299088|NCT01612546|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22299089|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com|
22299090|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22299091|NCT03655236|Sun Pharma Advanced Research Company Limited|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
22299092|NCT06748040|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22299093|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22299094|NCT01800877|Centre de Recherche du CHUS|Marie-Hélène Masse|819-346-1110|marie-helene.masse3@usherbrooke.ca|14173
22299095|NCT02855060|Atrium Health|Rachel Seymour|74-355-6969|rachel.seymour@atriumhealth.org|
22299096|NCT02807948|Abbott|Adam M.Cline, MD, MSc.- Principal Scientist|818-493-2025|adam.cline@abbott.com|
22299097|NCT03727750|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299098|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22299099|NCT02082522|At the request of Concordia Laboratories Inc.|Dr. Michelle Depot||michelle.depot@advanzpharma.com|
22299100|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu|
22299101|NCT02496884|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22299102|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu|
22313200|NCT02775214|Riley Hospital for Children at Indiana University Health|Dr Nicole Horn|3179449981|nhorn@iuhealth.org|
22281691|NCT02374060|Johns Hopkins University|Elizabeth Sugar, PhD|(410) 614-7837|esugar2@jhu.edu|
22299103|NCT03766646|University Hospital Southampton|Dr Patrick Butler|81205662|patrick.butler@uhs.nhs.uk|+44 (0)23
22313201|NCT02706834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313202|NCT01896921|University of Maryland|Gregg Brogden|4107061660|gbrogden@ihv.umaryland.edu|
22313203|NCT01862614|The Ohio State University College of Dentistry|Dr. John Nusstein, Professor|614-292-3596|nusstein.1@osu.edu|
22313204|NCT04441996|Emory University|Cheryl Maier MD, PhD|404-712-2795|cheryl.maier@emory.edu|
22313205|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com|
22313206|NCT02543294|UT MD Anderson Cancer Center|Dr. Anecita P. Fadol,PHD/Associate Professor, Department of Nursing|713-792-8397|afadol@mdanderson.org|
22313207|NCT05065918|The University of Arkansas for Medical Sciences|Jocelyn Anderson|501-686-7712|andersonjocelyn@uams.edu|
22313208|NCT03149887|UPittsburgh|Dr. Steven L. Orebaugh|412-877-5832|orebaughsl@anes.upmc.edu|
22313209|NCT02115542|Moffitt Cancer Center|Richard Kim, MD|813-745-1432|Richard.Kim@moffitt.org|
22313210|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com|
22313211|NCT03327051|Stanford University|Aida Habtezion|650-736-5555|aidah@stanford.edu|
22313212|NCT02798861|University of Pittsburgh|Andres Duarte-Rojo|412-647-7922|duarterojoa@pitt.edu|
22313213|NCT02795819|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|877-462-7739|AskMassey@vcu.edu|
22313214|NCT04879823|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
22313215|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313216|NCT02137239|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22313217|NCT04057937|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313218|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org|
22313219|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313220|NCT02446912|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22313221|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com|
22313222|NCT05216952|University of North Carolina at Chapel Hill|Jill Hagey, MD, MPH|919-966-5280|jmhagey1@ad.unc.edu|
22313223|NCT04864236|UCLA Anesthesiology|John Shin MD, Associate Clinical Professor|310-267-6629|JShin@mednet.ucla.edu|
22313224|NCT03680092|University of California, San Diego|Dr. Dimitrios Tzachanis|(858) 822-6600|dtzachanis@health.ucsd.edu|
22313225|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313226|NCT02991456|Duke University|James Herndon II, Ph.D.|919-668-8145|james.herndon@duke.edu|
22313227|NCT04604899|jCyte, Inc.|Chief Strategy Officer|9492430687|media@jcyte.com|
22313228|NCT03689452|Icahn School of Medicine at Mount Sinai|Dr. Danielle P. Dubin|212-731-3311|DPDubin121@gmail.com|
22313229|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
22313230|NCT04992494|NYU Langone Health|Amanda Shallcross|646-501-3426|Amanda.Shallcross@nyulangone.org|
22281692|NCT05455580|Hunter-Bellevue School of Nursing, Hunter College, The City University of New York|Tara Heagele, PhD, RN|212-396-7206|th1591@hunter.cuny.edu|
22281693|NCT02640625|Oslo University Hospital|Dr. Dag Henrik Reikvam|+4722119881|dagrei@ous-hf.no|
22281694|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22281695|NCT05425732|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22281696|NCT02582814|AstraZeneca|A clinical pharmacology and long-term safety study|+819039706431|Yu.Shimizuishi@astrazeneca.com|4669
22281697|NCT03990415|University of Missouri|Dr. Dana Duren|(573) 884-7023|durendl@health.missouri.edu|
22281698|NCT01558115|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
22281699|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22281700|NCT04644276|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22281701|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org|
22281702|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281703|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518||
22281704|NCT01280058|The Ohio State University Comprehensive Cancer Center|Anne Noonan, MD|614-685-6912|Anne.Noonan@osumc.edu|
22281705|NCT01200407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281706|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841|indfli@uks.eu|1623526
22281707|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
22281708|NCT02209545|Northwestern Medicine|Dr. Magdy Milad|3126946447|mmilad@nm.org|
22281709|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu|
22281710|NCT03503591|Preceptis Medical|Steve Anderson, CEO|612-327-4795|steve@preceptismedical.com|
22313231|NCT00267865|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|yarchoar@nih.gov|
22281711|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com|
22281712|NCT03831191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281713|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
22281714|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22281715|NCT02151903|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
22281716|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22281717|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
22281718|NCT03490292|UW Carbone Cancer Center|Nataliya Uboha, MD, PhD|(608) 265-9966|nvuboha@medicine.wisc.edu|
22313232|NCT03458416|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22313233|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu|
22313234|NCT01755598|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313235|NCT02332889|University of Louisville|Nancy Alsip|5028522905|nancy.alsip@louisville.edu|502
22313236|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313237|NCT02819141|Mayo Clinic|Dr. Linda L. Chlan, Professor of Nursing|507-255-7859|chlan.linda@mayo.edu|
22313238|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu|
22313239|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22313240|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
22313241|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22313242|NCT02255435|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22313243|NCT01809691|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
22313244|NCT03694210|Interscope, Inc.|Alexis James Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
22313245|NCT01742949|Hopital Bichat-Claude Bernard|Dr Marie-Pia D'Ortho|+33140258080|marie-pia.dortho@bch.aphp.fr|
22313246|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
22313247|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313248|NCT04117711|Applied Therapeutics, Inc|Riccardo Perfetti, MD|2122209226|rperfetti@appliedtherapeutics.com|
22313249|NCT02475733|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313250|NCT02131155|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313251|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020|jjaffe@antarespharma.com|324
22313252|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
22313253|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22313254|NCT05319756|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
22313255|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313256|NCT03906240|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Adam McGuire|254-297-5173|adam.mcguire@va.gov|
22313257|NCT03575572|University of Utah|Stephanie Goldstein|801 587-7572|stephanie.goldstein@hsc.utah.edu|
22313258|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com|
22313259|NCT03647709|St Elizabeth Medical Center|Dr Andrew Wickline|315-735-4496|awickline23@gmail.com|
22313260|NCT05287178|University of Oregon|Yoel Everett|541-346-7054|yeverett@uoregon.edu|
22313261|NCT01426217|Dartmouth-Hitchcock Medical Center|Randy Loftus, MD|(603) 650-6177|Randy.W.Loftus@hitchcock.org|
22313262|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org|
22313263|NCT03023878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313264|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu|
22313265|NCT03720717|University of Alabama at Birmingham|Timothy J Ness MD PhD, Professor Emeritus|2059079743|tness@uabmc.edu|
22313266|NCT00288353|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
22313267|NCT05234632|Smith & Nephew, Inc.|Dr Rochelle O'Hara|+44 1923 477218|Rochelle.OHara@smith-nephew.com|
22313268|NCT04799587|Northwestern University|Paul Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22313269|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22313270|NCT03613363|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22313271|NCT05216835|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22313272|NCT02849509|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313273|NCT00617708|SWOG|Study Statistician|206-667-4623||
22313274|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22313275|NCT03867396|University of Colorado Anschutz SOM|Dr. Melinda Anderson|303-724-9316|melinda.anderson@cuanschutz.edu|
22325530|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501|laurie_zawertailo@camh.net|7422
22325531|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22325532|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org|
22325533|NCT03567291|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22325534|NCT01103349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325535|NCT02284399|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
22325536|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu|
22325537|NCT01736683|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325538|NCT04021472|VA Bedford Healthcare System|Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
22325539|NCT04978376|University of Illinois Chicago|Kelsey Gabel|312-413-8911|kdipma2@uic.edu|
22325540|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22281719|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281720|NCT00435227|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22313276|NCT03941769|The University of Texas MD Anderson Cancer Center|Gheath Al-Atrash, M.D. / Stem Cell Transplantation|713-792-7734|galatras@mdanderson.org|
22313277|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
22325541|NCT04635735|Memorial Sloan Kettering Cancer Center|Dr. Gunjan Shah, MD|646-608-3734|shahg@mskcc.org|
22325542|NCT00090285|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325543|NCT00915967|Oregon Health & Science University|Director of Clinical Trials|503-494-4314|nsgclinicalresearch@ohsu.edu|
22325544|NCT00907478|Amgen Inc.|Study Director|866-572-6436||
22325545|NCT02747043|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22325546|NCT02046564|Otsuka Pharmaceutical Co. Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22281721|NCT05319899|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22325547|NCT04146272|Bernafon AG|Barbara Simon|+41 31 998 15 15|bsim@bernafon.com|1664
22325548|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com|
22325549|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com|
22325550|NCT03904446|University of Iowa|Cynthia A. Wong, MD|13193563868|cynthia-wong@uiowa.edu|
22325551|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn|
22325552|NCT03554005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325553|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325554|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012||
22325555|NCT03136705|Northwestern University Feinberg School of Medicine|Doctor|312-503-6921|tamara.isakova@northwestern.edu|
22325556|NCT02855411|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22325557|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22325558|NCT03988751|Wake Forest University School of Medicine|Dr. Clancy Clark|335-480-8064|cjclark@wakehealth.edu|
22325559|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22325560|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu|
22325561|NCT00824538|University of California San Francisco|Hope S Rugo|877-827-3222|clinicaltrials@ucsf.edu|
22325562|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648|adir@hospitech.co.il|5
22325563|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org|
22325564|NCT02927171|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22325565|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu|
22325566|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
22325567|NCT04530825|Washington University School of Medicine|Maura Kepper, Ph.D.|314-935-0142|kepperm@wustl.edu|
22325568|NCT03870022|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
22325569|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM|
22325570|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22325571|NCT01834326|University of Michigan|Stephen E. Feinberg|734 763 5963|sefein@med.umich.edu|
22325572|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300||
22325573|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
22325574|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com|
22325575|NCT04230486|Wake Forest School of Medicine|Huai Jiang, PhD|336-695-6460|jianghuai.ws@gmail.com|
22325576|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
22325577|NCT04504032|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22325578|NCT01839188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325579|NCT04983901|The University of M.D. Anderson Cancer Center|Dr. Issam I Raad|713-792-6237|iraad@mdanderson.org|
22325580|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22325581|NCT02416908|Washington University School of Medicine|Geoffrey Uy, M.D.|314-747-8439|guy@wustl.edu|
22325582|NCT02285010|Mahidol University|Dr.Taniga Kiatchai|+66-2-419-7990|taniga@gmail.com|
22325583|NCT01832961|Imperial College|Ada Clarice Gastaldi|55 020 7351 8051|ada@fmrp.usp.br|
22325584|NCT03489291|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
22325585|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325586|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590||
22325587|NCT04940598|UAB|Gordon Fisher|2059964114|grdnfs@uab.edu|
22325588|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22325589|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch|
22325590|NCT03896425|University of Minnesota|Rebecca Kazinka|612-626-6772|kazin003@umn.edu|
22299104|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl|
22325591|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org|
22325592|NCT03004846|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325593|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk|
22325594|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu|
22325595|NCT01435512|BVARI|Dr. Casey Taft|857-364-6261|casey.taft@va.gov|
22325596|NCT02489630|Virginia Tech SOM / Carilion Clinic (prior)|Dr Karen J Bowers, co-PI|678-591-7280|bowerskj@gmail.com|
22325597|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
22325598|NCT01596595|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
22325599|NCT02262130|CHU de Reims|Pr Manuelle Viguier|00333 26 78 43 43|mviguier@chu-reims.fr|
22325600|NCT02029430|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22325601|NCT04963179|Womed|Director of Clinical Affairs|0785225561|pauline@womedtech.com|+33
22325602|NCT05270694|MaineHealth Institute for Research|Dr. Kathleen Fairfield|207-661-7614|kathleen.fairfield@mainehealth.org|
22325603|NCT03624101|University of Alabama at Birmingham Child Health Research Unit|Heather Hathorne|2055032829|hyhathorne@uabmc.edu|
22325604|NCT04267562|MicroCube, LLC|Dinesh Mody|(510) 651-5000|m@minitouch.us|
22325605|NCT02026908|Northwestern University/Northwestern Memorial Hospital|Samdeep Mouli MD|312-926-5200|s-mouli@northwestern.edu|
22325606|NCT03729869|Medical University of South Carolina|Lisa Nunn, Program Manager|843-792-0476|jenkinli@musc.edu|
22325607|NCT03270085|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22325608|NCT03825042|A.Menarini Industrie Farmaceutiche Riunite Srl|Director of Clinical Operations|0039 055 5680459|pfabrizzi@menarini.it|
22325609|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22325610|NCT05085392|Montana State University|Dr. Lauren Davis|8287736328|laure.davis6@montana.edu|
22325611|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22325612|NCT03314519|Mahidol University|Kasana Raksamanee|66967841010|kasana@gmail.com|
22325613|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325614|NCT04003155|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22325615|NCT01912872|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22325616|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu|
22325617|NCT01277289|Erydel|Angelo Andriulli, MD|+39 882 410784|aandriulli@operapadrepio.it|
22325618|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu|
22299105|NCT02530619|Northwestern University, Feinberg School of Medicine|Brady L. Stein, MD|312-695-6832|bstein@nmff.org|
22299106|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
22299107|NCT02504645|ImmuPharma|CEO|+33 6 18 22 16 50|robert.zimmer@immupharma.com|
22325619|NCT04760314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22325620|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br|
22325621|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100|drrsdogra@yahoo.com|3444
22325622|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com|
22289068|NCT01869764|Wake Forest University Health Sciences|Edward Levine, MD|336-716-5440|elevine@wakehealth.edu|
22289069|NCT02175030|University of Utah|David Turok, MD, PI|801-581-5160|david.turok@hsc.utah.edu|
22289070|NCT02037230|University of Michigan Rogel Cancer Center|Theodore Lawrence, M.D., Ph.D.|734-647-9955|tsl@umich.edu|
22289071|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22289072|NCT03519711|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22289073|NCT01974635|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
22289074|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi|
22289075|NCT04717336|The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|Georg Aue, MD|301.451.7141|aueg@nhlbi.nih.gov|
22289076|NCT02039843|Tennesse Valley HCS|Joan Richerson|615-574-8198|joan.richerson@va.gov|
22325623|NCT04315363|Northeastern University|Meishan Ai|858-265-7288|ai.me@northeastern.edu|
22325624|NCT02241512|UT Southwestern|Dr. David Troendle|214456-8000|david.troendle@utsouthwestern.edu|
22325625|NCT04013737|Health Protection Research Unit in HCAI and AMR, Imperial College London|Head of Operations|020 3313 2732|head.ops@imperial.ac.uk|
22325626|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325627|NCT04275310|Virginia Commonwealth University|Eric Benotsch|804-828-0133|ebenotsch@vcu.edu|
22325628|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22325629|NCT03648476|Indiana University|Dawn Neumann|3173292188|dmneuman@iupui.edu|
22325630|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325631|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325632|NCT02677701|Seattle Children's Hospital|Arthur Baines|2068841431|arthur.baines@seattlechildrens.org|
22325633|NCT04101422|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
22325634|NCT01174784|Avinger Inc.|Thomas Lawson, PhD|650.241.7900|tlawson@avinger.com|
22325635|NCT02487745|Johns Hopkins University School of Medicine|Kenneth Silverman|4105502694|ksilverm@jhmi.edu|
22325636|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864||
22325637|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com|
22325638|NCT03100435|Tufts University|Robert Gyurko|6176366531|robert.gyurko@tufts.edu|
22325639|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22325640|NCT03792750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22325641|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
22325642|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325643|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22325644|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@toh.on.ca|70175
22325645|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22325646|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22325647|NCT02099799|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
22325648|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de|
22325649|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu|
22325650|NCT01863758|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22325651|NCT02961764|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22325652|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org|
22325653|NCT03118843|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22325654|NCT03067311|University of North Carolina at Chapel Hill|David Penn, PhD|(919) 843-7514|dpenn@email.unc.edu|
22325655|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com|
22325656|NCT02975349|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22325657|NCT01663740|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325658|NCT03551522|CymaBay Therapeutics, Inc.|Barry Crittenden, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
22325659|NCT05136885|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257|healeyalsplatform@mgh.harvard.edu|(HALT ALS)
22325660|NCT02653092|University of Colorado School of Medicine|Dr. Nanette Santoro|303-724-2041|Nanette.Santoro@uanschutz.edu|
22325661|NCT02658656|James J Peters VA Medical Center|Dr. Ann Spungen, Study Chairperson|7185849000|ann.spungen@va.gov|5814
22325662|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com|
22325663|NCT01842061|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
22325664|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu|
22325665|NCT04220489|UPMC|Jacques E. Chelly, MD, PhD, MBA|412-623-6904|chelje@anes.upmc.edu|
22325666|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu|
22325667|NCT00912158|Chest Department, Faculty of Medicine, Assiut University- EGYPT|Dr. Maha K Ghanem, MD, FCCP|+ 2 0127694434|mahaghanem@hotmail.com|
22325668|NCT03459131|Alcon, A Novartis Division|Sr Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22325669|NCT03032068|Cleveland Clinic|Jayson Zadzilka|216-445-8023|zadzilj@ccf.org|
22325670|NCT01597622|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22325671|NCT05047640|University of Miami|Giselle Guerra|3053555803|gguerra@med.miami.edu|
22325672|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22325673|NCT02772965|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-966-1343|michael_kappelman@med.unc.edu|
22325674|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22325675|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22325676|NCT02435173|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22325677|NCT02024711|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22325678|NCT06001372|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22325679|NCT03463265|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22325680|NCT03515538|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
22325681|NCT04410783|Washington Univeristy|Brian M Fuller|3147475368|fullerb@wustl.edu|
22270861|NCT03671564|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
22313278|NCT02374476|Icahn School of Medicine at Mount Sinai|Dr. Srinivas R Dukkipati|(212) 241-7114|srinivas.dukkipati@mountsinai.org|
22313279|NCT03010878|Colorado State University|Dr. Arlene Schmid|9704917562|arlene.schmid@colostate.edu|
22313280|NCT05431543|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
22313281|NCT02924051|University of Kentucky|Dr. Frances Hardin-Fanning|(859) 257-4866|fdbowe2@uky.edu|
22313282|NCT02784535|Vanderbilt University Medical center|Dr Cyndya Shibao|615-322-2318|cyndya.shibao@vumc.org|
22313283|NCT00914732|Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
22313284|NCT02130401|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|bacllc@earthlink.net|
22313285|NCT03005106|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
22313286|NCT03163472|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
22313287|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com|
22313288|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu|
22313289|NCT02389894|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
22313290|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22313291|NCT06392464|Complejo Hospitalario Universitario de Santiago de Compostela, Spain|Violeta Gonzalez Salvado|+34981955913|vgonzalezsalvado@gmail.com|
22313292|NCT05957198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313293|NCT04617574|Holyoke Medical Center Weight Management Program|Bariatric Clinical Administrator|(413) 535 - 4759|davidson_elana@holyokehealth.com|
22313294|NCT01429285|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22313295|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org|
22313296|NCT00990314|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
22313297|NCT04623996|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
22313298|NCT02676778|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22313299|NCT01430299|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
22313300|NCT06466655|University of Delaware|Jody Greaney, PhD|3028312193|jgreaney@udel.edu|
22313301|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu|
22313302|NCT02151643|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com|
22313303|NCT04307134|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313304|NCT02527083|VA Pittsburgh Healthcare System|James Ibinson, MD, PhD|412-360-1484|james.ibinson@va.gov|
22313305|NCT03541200|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22313306|NCT03508830|University of California, San Francisco|Dr. Greg J. Haro|415-353-7502|greg.haro@ucsf.edu|
22313307|NCT02522299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313308|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu|
22313309|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com|
22313310|NCT04908800|Kyorin Pharmaceutical Co.,Ltd|Yoji Mimaki|+81-3-3525-4788|ml-kyorin_clinicaltrials.gov@mb.kyorin-pharm.co.jp|
22313311|NCT03751280|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22313312|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343||
22313313|NCT02162771|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
22313314|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu|
22313315|NCT01078571|Abbott|Global Medical Services|1-800-633-9110||
22313316|NCT03317288|UT Southwestern Medical Center|Dr. Yi-Ting Tzen|2146481786|Yi-Ting.Tzen@UTSouthwestern.edu|
22313317|NCT01047306|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22325682|NCT03088605|Topivert Pharma Ltd|Director of Clinical Trials|+44 203 763 9469|info@topivert.com|
22270862|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu|
22270863|NCT02609100|Washington University School of Medicine in St. Louis|Dr. Vladimir M. Kushnir|314-362-3685|vkushnir@wustl.edu|
22270864|NCT05845567|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
22270865|NCT02946073|Braeburn|Susan Franks, SVP, Head of Regulatory Affaires|6104678719|sfranks@braeburnrx.com|
22270866|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22270867|NCT05178641|Procter & Gamble Co.|Dr. Susanna Brink, Clinical Scientist|+49 6196 89 4474|brink.s@pg.com|
22270868|NCT05803096|Beth Israel Medical Center|Dr. Heidi Rayala|16176673739|hrayala@bidmc.harvard.edu|
22270869|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu|
22270870|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166|Vardit@Gardiamedical.com|106
22270871|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22270872|NCT05028075|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
22270873|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org|
22270874|NCT03783130|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22270875|NCT01867294|Mayo Clinic|Aminah Jatoi, M.D.|507.284.1623|jatoi.aminah@mayo.edu|
22281722|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu|
22325683|NCT02345161|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325684|NCT03323307|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22325685|NCT02225223|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
22325686|NCT03666143|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22325687|NCT03090620|UColorado|Dr. George Sam Wang|303-724-9967|george.wang@childrenscolorado.org|
22325688|NCT02834052|AUGUSTA UNIVERSITY MEDICAL CENTER|Dr Asha Nayak|7067216748|anayak@augusta.edu|
22325689|NCT02639182|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22325690|NCT02546856|Servicio de Cardiologıa, Hospital Universitario Galdakao-Usansolo, OSI Barrualde-Galdakao-Osakidetza, Servicio Vasco de Salud, Galdakao, Bizkaia, Spain .BIOCRUCES, Instituto de Investigacion Sanitaria, Bizkaia, Spain|Juana Oyanguren, Nursing graduate, Master in Heart Failure, CV Pathology and Thrombosis Specialist|34 656780945|juanaoy@hotmail.com|
22325691|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu|
22325692|NCT01215318|University Hospital of Zurich|Irene A Burger|+41 44 255 11 11|irene.burger@usz.ch|
22325693|NCT04655586|Arca biopharma Inc.|Dr. Michael Bristow|720-940-2100|Michael.Bristow@arcabio.com|
22313318|NCT01878253|Zimmer Biomet Inc|Clinical Operation Director|574-371-9823|Bill.Bourdeau@zimmerbiomet.com|
22270876|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22313319|NCT01818245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313320|NCT04393779|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22313321|NCT03802513|VA RR&D National Center for Rehabilitative Auditory Research|Principal Investigator|503-220-8262|sarah.theodoroff@va.gov|
22313322|NCT05045638|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313323|NCT01591655|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22313324|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22313325|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
22313326|NCT03869541|Imperial College London|Huw Woodbridge|+44 (0)20 7594 3192|h.woodbridge@imperial.ac.uk|
22313327|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
22270877|NCT01740128|James J. Peters VAMC|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
22270878|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov|
22270879|NCT02658734|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22325694|NCT03132246|University of Maryland School of Medicine|Dr. Aaron Johnson|410-328-1868|ajohnson1@som.umaryland.edu|
22325695|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894|ravit.peled@givenimaging.com|7894
22325696|NCT05057988|Stanford University|Dr. Dokyoung Sophia You|650-724-9320|dsyou@stanford.edu|
22325697|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22325698|NCT02616029|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22325699|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325700|NCT02383719|Convergent Engineering|Study Coordinator|3523784899|carl@conveng.com|113
22325701|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com|
22325702|NCT03626415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325703|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il|
22325704|NCT02544984|The University of Texas Health Science Center at Houston|Ricardo A. Mosquera, MD|(713) 500-5650|Ricardo.A.Mosquera@uth.tmc.edu|
22325705|NCT02519244|The University of Texas Health Science Center at Houston|Shuo-Hsiu Chang, PT, PhD|713-799-7016|shuo-hsiu.chang@uth.tmc.edu|
22325706|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov|
22325707|NCT01469013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325708|NCT05232097|Helsinki University Hospital|Dr. Jari Punkkinen|+358 50 427 9864|jari.punkkinen@hus.fi|
22325709|NCT05748925|mansoura urology and nephrology center|Nourelsabah Mohamed Elbialy , consaltant nephrology|01065619243|nourelsabah@mans.edu.eg|
22325710|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325711|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu|
22325712|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325713|NCT02134314|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|310-248-8186|noriko.ammerman@cshs.org|
22313328|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935||
22313329|NCT06072196|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22313330|NCT04930445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22313331|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22313332|NCT01261793|Care|UCB|+1844599|UCBCares@ucb.com|2273
22313333|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu|
22313334|NCT03219216|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22313335|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
22313336|NCT03305458|Medical University of South Carolina|Dr. Tatiana Davidson|8437921866|davidst@musc.edu|
22313337|NCT03844750|University of California, San Francisco|Dr. Chloe Atreya, MD|(415) 476-1000|Chloe.Atreya@ucsf.edu|
22313338|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it|
22313339|NCT05615870|University of Arkansas for Medical Sciences|Jing Jin|501-214-2236|JJin@UAMS.edu|
22313340|NCT02214017|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
22313341|NCT03520036|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22313342|NCT01855399|VA HSRD: CCMR Ann Arbor and University of Michigan Medical School|Dr. Michele Heisler|(734) 845-3614|mheisler@umich.edu|
22313343|NCT03019289|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22313344|NCT04743999|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
22313345|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22313346|NCT03926117|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22313347|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com|
22313348|NCT02312245|Mayo Clinic|S. John Weroha, M.D., Ph.D.|(507) 284-2511|weroha.saravut@mayo.edu|
22313349|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22313350|NCT00924833|Istituto Auxologico Italiano|Gianfranco Parati, Professor|+3961911|gianfranco.parati@unimib.it|2949
22325714|NCT02902809|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22325715|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com|
22325716|NCT00871858|Institut Bergonié, Medical Oncology department|Dr. Nathalie Quenel-Tueux|05.56.33.33.33|N.Quenel-Tueux@bordeaux.unicancer.fr|
22325717|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325718|NCT04392011|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
22325719|NCT02795767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325720|NCT04983940|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr. Ranjth Ramasamy|305-243-6596|Ramasamy@miami.edu|
22325721|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu|
22325722|NCT04337138|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325723|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu|
22270880|NCT01890226|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
22270881|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22270882|NCT01252563|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313351|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org|
22313352|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu|
22325724|NCT01269034|Albert Einstein College of Medicine|Roger Hicks, Administrative Director for Research - Department of Pediatrics|718-920-7386|roger.hicks@einsteinmed.org|
22325725|NCT04286867|Kent State University|William Lechner|8144501093|wlechner@kent.edu|
22325726|NCT03863496|Ilizarov centre|Sergey Raybukh|+79226716007|rso_@mail.ru|
22325727|NCT03534271|Rush University|Dr. Jonathan Brady Scott|3129426389|jonathan_b_scott@rush.edu|
22325728|NCT01855789|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325729|NCT04331730|Alkahest, Inc.|Head of Communications|(650) 801-0474|trials@alkahest.com|
22313353|NCT03214198|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313354|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313355|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu|
22313356|NCT03686176|Johns Hopkins University|Therese Canares|4109964711|tcanare1@jhmi.edu|
22313357|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu|
22313358|NCT01846988|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani, Assistant Professor|(513) 736-1814|Neepa.Gurbani@cchmc.org|
22313359|NCT03530345|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22325730|NCT03625986|Penn State College of Medicine|Dr. Jonathan Foulds|(717) 531-3504|jfoulds@pennstatehealth.psu.edu|
22325731|NCT01850563|Dartmouth-Hitchcock Medical Center|Alan Hartford, MD, PhD, FACR, Professor of Medicine (RadOnc) Director, Radiation Oncology|603-650-6600|Alan.C.Hartford@Hitchcock.org|
22325732|NCT04359823|MUSC|Gabriella Santa Lucia|724-413-8833|santaluc@musc.edu|
22325733|NCT03132805|Johns Hopkins University|Nicholas S. Ialongo, Principal Investigator|410-493-1252|nialong1@jhu.edu|
22325734|NCT03009539|University of Miami|Guillermo Prado|305-284-2002|gprado@miami.edu|
22325735|NCT03151148|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22325736|NCT04543955|University of Kentucky|Dr. Lowell Anthony|859-323-8043|lowell.anthony@uky.edu|
22325737|NCT03918642|VA Greater Los Angeles Healthcare System|Brandon C. Yarns|310-478-3711|brandon.yarns@va.gov|
22325738|NCT03046472|Maccabi Health services and Wingate college|Neta Vitman|0508955529|vitmanan@gmail.com|
22325739|NCT03823937|Sultan.abdulhamid|Tugbaozsoy|+905074583382|tugbaozsoyy@gmail.com|
22325740|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22325741|NCT04439838|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325742|NCT04985799|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
22325743|NCT02073435|Northwestern University|Donna Woods, MD|312-503-5550|woods@northwestern.edu|
22325744|NCT00130208|Keryx Biopharmaceuticals|Medical Information|1-844-44-KERYX|medicalinfo@keryx.com|
22325745|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
22325746|NCT03268746|Alcon Research|Clinical/Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22325747|NCT00986258|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
22325748|NCT03332667|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
22325749|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
22325750|NCT04734873|Corvus Pharmaceuticals|Study Director|650-900-4520|clinicaltrials@corvuspharma.com|
22325751|NCT02296346|Huntsman Cancer Institute, University of Utah|Dr. Daniel Couriel|801-213-3082|dan.couriel@hci.utah.edu|
22325752|NCT00609609|The University of Texas (UT) MD Anderson Cancer Center|Dr. Amin Majid Alousi, Associate Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
22325753|NCT03065530|The First Affiliated Hospital of Nanjing Medical University|Dr. Shijiang Liu, Dr. Mei Gao|+862568303569|liushijiang1983@hotmail.com|
22325754|NCT03811951|University of Illinois at Chicago - College of Pharmacy|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22325755|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu|
22325756|NCT01070303|Abbott|Global Medical Services|800-633-9110||
22325757|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325758|NCT03881163|Zambon S.p.A|Valentina Vaja|+390266524497|Valentina.Vaja@ZambonGroup.com|
22325759|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
22313360|NCT02442622|NYU Langone Health|Steve Vanlew, PhD|646-501-7707|Steve.Vanlew@nyulangone.org|
22313361|NCT02938520|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313362|NCT05022472|UCSD|Dr. Britt Skaathun|619-543-5011|bskaathun@health.ucsd.edu|
22313363|NCT01732627|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22313364|NCT02305797|Cardinal Health Regulatory Sciences|Director of Regulatory Affairs and Product Development|913.451.3955|david.rhein@cardinalhealth.com|
22313365|NCT03287947|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
22313366|NCT03594266|BiotronikUS|Crystal Miller|503-475-4984|crystal.miller@biotronik.com|
22313367|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu|
22313368|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org|
22313369|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22313370|NCT04115319|Otsuka|Clinical Transparency|1-800-441-6763|smb_clinicaltranspa@otsuka-us.co,|1
22313371|NCT06029712|Stanford University|Colette DeJong|650-229-2482|cdejong@stanford.edu|
22313372|NCT04803214|Mainstay Medical|Jennifer Tinsley, Director of Clinical Affairs|(877) 702-8488|info@mainstaymedical.com|
22313373|NCT00581009|University of California Irvine|Dr. Joseph Wu|7142252212|jcwu@uci.edu|
22313374|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22313375|NCT03562117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313376|NCT03928821|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22313377|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com|
22313378|NCT03138499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22313379|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313380|NCT01245699|Maricopa Integrated Health System|Bentley J Bobrow, MD|602-364-0580|bentley.bobrow@azdhs.gov|
22313381|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313382|NCT04150250|PATH|Gwen Ambler|206-285-3500|gambler@path.org|
22313383|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com|
22313384|NCT03282071|The University of Hong Kong|Dr. Yuying Sun|(852)39179144|gyysun@hku.hk|
22313385|NCT01391234|University of Virginia Department of Radiation Oncology|Dr. Paul Read|(434) 924-5191|PWR3U@hscmail.mcc.virginia.edu|
22313386|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300||
22313387|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22313388|NCT03537014|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22313389|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
22313390|NCT04448561|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22313392|NCT06597747|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
22313393|NCT01819233|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Nicole Simone|215-955-6702|nicole.simone@jefferson.edu|
22313394|NCT05579769|St. Jude Children's Research Hospital|Dr. Ashok Srinivasan|8662785833|referralinfo@stjude.org|
22313395|NCT03602859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313396|NCT05492786|Geisinger health|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
22313397|NCT00383630|Columbia University|Yoshifumi Naka, MD, PhD|(212) 305-0828|yn33@columbia.edu|
22313398|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org|
22313399|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru|
22313400|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org|
22313401|NCT04816708|Duke University|Christopher E. Cox, MD|919-681-7232|christopher.cox@duke.edu|
22313402|NCT03596905|Bausch Health|Angela Moore|843-877-2756|angela.moore@bauschhealth.com|
22313403|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22313404|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313405|NCT02640807|Revimmune|Dr Michel Morre, DVM, Chief Scientific Officer|+33(0)603357060|m.morre@revimmune.com|
22313406|NCT02531126|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22313407|NCT00111839|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
22313408|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu|
22313409|NCT01654445|University of Calgary, Department of Clinical Neurosciences|Shelagh B Coutts and Michael D Hill|4039448065|michael.hill@ucalgary.ca|
22313410|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
22313411|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
22313412|NCT02794441|Children's Hospital of Eastern Ontario Research Institute|Dr. Roger Zemek|6137377600|rzemek@cheo.on.ca|3931
22313413|NCT01572493|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22313414|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu|
22313415|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu|
22313416|NCT03643705|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
22313417|NCT03132753|Chestnut Health's Lighthouse Institute; Chicago, Illinois|Dennis Watson|224-534-0114|dpwatson@chestnut.org|
22313418|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu|
22313419|NCT01614899|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22313420|NCT01446042|Trimel Pharmaceuticals Corp.|Natalia Tkachenko, MD Director Clinical Affairs|9054641755|ntkachenko@trimelpharmaceuticals.com|
22313421|NCT02724423|Neurelis, Inc.|Sunita Misra, M.D. Medical Director|(832) 257-1975|smisra@neurelis.com|
22313422|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org|
22313423|NCT02713698|Centro Hospitalar do Porto|Ana Maria Araujo|22 2077549|amfariaaraujo@gmail.com|1280
22313424|NCT03152409|Brigham and Women's Hospital|Dr. Jessica Harder|6177326753|jaharder@bwh.harvard.edu|
22313425|NCT05714345|Allogene Therapeutics, Inc|Medical Information|(+1) 415-604-5696|clinicaltrials@allogene.com|
22313426|NCT02815709|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22313427|NCT01323309|Memorial Sloan Kettering Cancer Center|Dr. William Breitbart, MD|646-888-0020|breitbaw@MSKCC.ORG|
22313428|NCT00310050|Wake Forest University Health Sciences|Dr. William Blackstock|3367136501|ablackst@wakehealth.edu|
22313429|NCT03048058|Wake Forest University Health Sciences|Irma M. RIchardson, MHA;|336-716-2903|irichard@wakehealth.edu|
22313430|NCT04422210|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22313431|NCT01257698|Mid Atlantic Retina|Jason Hsu MD|215-928-3092|jhsu@midatlanticretina.com|
22313432|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu|
22313433|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu|
22313434|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
22313435|NCT04601857|Taiho Oncology, Inc|Taiho|844-878-2446|medicalinformation@taihooncology.com|
22313436|NCT00980954|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22313437|NCT04736472|University of Pennsylvania|Sony Tuteja, PI|215-573-7834|Sony.Tuteja@PennMedicine.upenn.edu|
22313438|NCT02268526|Novartis Pharmaceuticals|Study Director|8627788300||
22313439|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org|
22313440|NCT02332824|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313441|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22313442|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu|
22313443|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
22313444|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040|wolfgang.senker@aon.at|6611
22313445|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com|
22313446|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu|
22325760|NCT02191917|BioMarin Pharmacuetical Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
22299108|NCT01854554|UT MD Anderson Cancer Center|Dr. Caroline Chung, MD- VP, Chief Data Officer, Data Impact & Governance|(713) 745-5422|cchung3@mdanderson.org|
22299109|NCT02819726|Archigen Biotech Ltd|Medical Director|+44(0)20 3749 5000|info@archigenbio.com|
22299110|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22299111|NCT02829034|University of Pennsylvania|Yuchi Han, PI of the study|215-615-3417|yuchi.han@uphs.upenn.edu|
22299112|NCT02647658|University of Pittsburgh|Dr. Charity Patterson|412-383-4812|cgp22@pitt.edu|4123834812
22299113|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777||
22299114|NCT02461589|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22299115|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
22299116|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299117|NCT04695691|Cutera|Director Clinical Research|415-657-5518|mdoucette@cutera.com|
22299118|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org|
22299119|NCT03295201|Marmara University|Dr. Kardelen Gencer Atalay|5324404887|kardelengencer@gmail.com|532
22299120|NCT02519504|Emory University|Judith Fridovich-Keil, PhD|404-727-3924|jfridov@emory.edu|
22299121|NCT02548962|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
22299122|NCT03963895|Aronora, Inc.|Norah Verbout, Ph.D.|503-964-0250|norah.verbout@aronorabio.com|
22299123|NCT01958918|Novartis Pharma AG|Study Director|+41613241111|Novartis.email@novartis.com|
22299124|NCT01597687|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299125|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu|
22299126|NCT04627727|BIDMC|Judy Nee, mD|617-667-2193|jnee@bidmc.harvard.edu|
22299127|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
22299128|NCT02401672|Medical University of South Carolina|Xingbao Li, MD|843-792-5729|lixi@musc.edu|
22299129|NCT01736852|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22299130|NCT03653429|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
22299131|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org|
22299132|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299133|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil|
22299134|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299135|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu|
22299136|NCT03634579|Emory University|Sherif Nour|404-778-3800|sherif.nour@emoryhealthcare.org|
22299137|NCT05061446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299138|NCT04111497|Fred Hutchinson Cancer Center|Dr. Stephanie Lee|206-667-6190|sjlee@fredhutch.org|
22299139|NCT05468398|University of California, Irvine|Navid Alem, MD / Principal Investigator|(949) 413-4950|alemn@hs.uci.edu|
22299140|NCT01993719|National Cancer Institute|Dr. Stephanie L. Goff|240-760-6214|stephanie.goff@nih.gov|
22313447|NCT04212299|University of Illinois Chicago|Andrew Sawers|312-996-1427|asawers@uic.edu|
22313448|NCT05379023|Department of Neurology, University of Colorado Anschutz Medical Campus (CU-AMC)|Brianne Bettcher, PhD, ABPP-CN|(303) 724-3941|brianne.bettcher@cuanschutz.edu|
22313449|NCT02675998|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22313450|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com|
22313451|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22313452|NCT02137499|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22313453|NCT02561078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22313454|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
22313455|NCT01194271|The University of Texas (UT) MD Anderson Cancer Center|Padmanee Sharma, Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22313456|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313457|NCT00043186|Amgen Inc.|Study Director|866-572-6436||
22313458|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
22313459|NCT04483791|EVP, Clinical Research|Candace Elek, M.S.|408-913-5468|celek@elixirmedical.com|
22313460|NCT04050722|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313461|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313462|NCT03924947|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22313463|NCT03085433|UCSF CRH|Clinical Research Team|4153534305|CRH.Research@ucsf.edu|
22313464|NCT03809039|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please e-mail|information.US@mb.tanabe-pharma.com|
22313465|NCT03451292|Instituto Grifols, S.A.|Mireia Torres|+34 93 5710500|approach_preciosa@grifols.com|
22313466|NCT05271552|BioXcel Therapeutics|SVP Clinical and Medical Affairs|(203) 530-5000|DKostic@Bioxceltherapeutics.com|
22313467|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313468|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020|robert.keith@ucdenver.edu|3182
22313469|NCT03840993|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22313470|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg|
22313471|NCT02176018|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22313472|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
22313473|NCT03022045|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22313474|NCT03275402|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
22313475|NCT02253147|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
22313476|NCT02986659|Atrium Health Wake Forest Baptist|Jingzhong Ding, PhD|336-713-8601|jding@wakehealth.edu|
22313477|NCT02223871|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure desk||clinical-trials-disclosure@idorsia.com|
22313478|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22313479|NCT02469077|Vanderbilt University Medical Center|Stephen Bruehl, Ph.D.|615-936-1821|stephen.bruehl@vumc.org|
22313480|NCT02973477|University of Michigan|Lynn Ang|734-232-8058|angly@med.umich.edu|
22313481|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700|jshuang@ucsd.edu|7322
22313482|NCT02402465|University of Chicago|Fuad Baroody, MD|773-702-4790|fbaroody@surgery.bsd.uchicago.edu|
22313483|NCT01284634|GW Research Ltd|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22313484|NCT03807700|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313485|NCT01059526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22313486|NCT02720081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313487|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060|macintyref@mmv.org|4078
22313488|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org|
22313489|NCT02143310|FontemVentures|Tanvir Walele|01779337589|tanvir.walele@fontemventures.com|
22313490|NCT05012397|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
22313491|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22313492|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313493|NCT03334747|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22313494|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313495|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu|
22313496|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu|
22270883|NCT01866657|University Hospitals Cleveland Medical Center|Dr. Edwin Avery|440-391-0690|Edwin.avery@uhhospitals.org|
22313497|NCT03042559|Loma Linda University|Dr. Everett Lohman III|9095584632|elohman@llu.edu|83171
22313498|NCT01994538|Minneapolis VA Health Care System|Dimitri Drekonja, MD, MS|612 467 4183|dimitri.drekonja@va.gov|
22270884|NCT01421186|MorphoSys AG|Dr Winrich Rauschning, Clinical Project Lead (external)|+4989 89927|winrich.rauschning@external.morphosys.com|0
22270885|NCT00978250|National Cancer Institute|Dr. James Doroshow|240-781-3320|jim_doroshow@nih.gov|
22313499|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22270886|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu|
22313500|NCT01536535|Connecticut Childrens|Dr. Jeffrey Hyams|8605459532|jhyams@connecticutchildrens.org|
22270887|NCT03036098|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22313501|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com|
22281723|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22281724|NCT03640507|Beth Israel Deaconess Medical Center|Cassandra R. Duffy, MD, MPH|617-667-2636|cduffy3@bidmc.harvard.edu|
22281725|NCT03525600|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22313502|NCT01475370|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22281726|NCT02676895|GlaxoSmithKline|GSK Response Center|866-435-7343|antonella.s.scire@gsk.com|
22281727|NCT02168062|University of California, San Francisco|Li Zhang, PhD|(415) 476-5339|Li.Zhang@ucsf.edu|
22281728|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org|
22313503|NCT04203160|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22325761|NCT03215264|University of Pennsylvania/ Abramson Cancer Center|Thomas Karasic, MD|2156141858|thomas.karasic@pennmedicine.upenn.edu|
22281729|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935||
22281730|NCT00344318|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281731|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu|
22281732|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590||
22281733|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22281734|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22281735|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
22270888|NCT05773781|University of Liverpool|Mr Jason Fleming|0151 529 5259|Jason.Fleming@liverpool.ac.uk|
22270889|NCT01089933|OHRI|Dr Michelle Chiu|613-798-5555|mchiu@toh.ca|14169
22270890|NCT01632904|Incyte Corporation|Study Director|855 463-3463||
22270891|NCT01004406|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
22281736|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300||
22270892|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com|
22281737|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov|
22281738|NCT04154293|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
22270893|NCT04769466|LifeBio|Lisbeth Sanders|937-303-4574|beth@lifebio.com|
22281739|NCT04731298|Sobi|Emmanuel Monnet|+41225519156|Emmanuel.Monnet@sobi.com|
22281740|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22281741|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22281742|NCT06423456|afyonkarahisar health sciences university hospital|Dr. Betül Ahat|05467240341|drbetula@gmail.com|
22281743|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486|kathleen.carroll@yale.edu|7403
22281744|NCT05079347|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
22281745|NCT02091531|Memorial Sloan Kettering Cancer Center|Dr. Dana Rathkopf, MD|646-422-4379|rathkopd@mskcc.org|
22281746|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk|
22270894|NCT04542499|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22299141|NCT05857527|Medical University of South Carolina|Kelly McGloon|8437926443|mcgloon@musc.edu|
22299142|NCT03473886|Massachusetts General Hospital|Rachel A. Millstein|617-724-2047|RAMILLSTEIN@mgh.harvard.edu|
22299143|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
22299144|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu|
22270895|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es|
22270896|NCT05906836|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22270897|NCT04281784|University of Washington|Janaki Torrence, Research Coordinator|206-402-7357|jtorrenc@uw.edu|
22270898|NCT04035434|CRISPR Therapeutics AG|Annie Weaver, PhD: Study Director|+1 617-315-4600|info@crisprtx.com|
22270899|NCT04488497|Weill Cornell Medicine|Dr. Iris Navarro Millan|646-962-7875|vam4007@med.cornell.edu|
22270900|NCT04322539|HUTCHMED International|William Schelman, MD, PhD|+1-973-306-4490|williams@hutch-med.com|
22270901|NCT02111746|The University of Texas Health Science Center at Houston|Dr. Kristofer M Charlton-Ouw|(713) 486-5100|Kristofer.CharltonOuw@uth.tmc.edu|
22270902|NCT04161079|Medtentia International Ltd Oy|Olli Keränen / Chief Executive Officer|+358 50 3567090|ok@medtentia.com|
22270903|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281747|NCT00945529|Nemours Cardiac Center at A. I. duPont Hospital for Children|Ellen Spurrier, MD|302-651-6600|ellen.spurrier@nemours.org|
22299145|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov|
22299146|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com|
22299147|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22299148|NCT00752908|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22299149|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov|
22299150|NCT02610140|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22299151|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22299152|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155|greg.sullivan@tonixpharma.com|117
22299153|NCT01752933|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22270904|NCT03617861|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22281748|NCT03009162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281749|NCT02791516|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22281750|NCT02524275|University of Nebraska Medical Center|Dr. Apar Ganti|402-559-8121|aganti@unmc.edu|
22281751|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com|
22313504|NCT03410953|UICEC, Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Plataforma SCReN, Salamanca, Spain|Ricardo López-Pérez, PhD. Study Coordinator and Manager of Clinical Trial|923 291100|ricardo.lopez@scren.es|55779
22281752|NCT02628600|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
22313505|NCT00679549|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
22281753|NCT03236909|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
22313506|NCT01093183|University of Nebraska Medical Center|James Schwarz, MD|402-559-5166|jkschwarz@unmc.edu|
22281754|NCT04912089|UC San Diego|Jessica Bomyea|858-822-1470|jbomyea@health.ucsd.edu|
22281755|NCT03110029|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
22281756|NCT02453750|SickKids|Dr Theo Moraes|416 813 2196|theo.moraes@sickkids.ca|
22313507|NCT02744898|NYU Langone Health|Franco Muggia, MD|212 263 2172|Franco.Muggia@nyulangone.org|
22313508|NCT04474691|New York University|Tara McAllister|212-992-9445|tkm214@nyu.edu|
22313509|NCT04372186|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genetech@druginfo.com|
22313510|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313511|NCT04964297|Weill Cornell Medical Center|Dr. Mehraneh Jafari|+1 646 962 2270|mdj9003@med.cornell.edu|
22313512|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu|
22313513|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org|
22313514|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
22313515|NCT02951052|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313516|NCT02924350|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313517|NCT01904019|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22313518|NCT00509821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313519|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu|
22313520|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22313521|NCT01589523|Cincinnati Children's Hospital Medical Center|Ken Setchell, PhD|5136364548|kenneth.setchell@cchmc.org|
22313522|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22313523|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22313524|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov|
22313525|NCT03721978|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22313526|NCT05244226|Duke University|Lisa Einhorn, MD|919-681-4877|lisa.einhorn@duke.edu|
22313527|NCT00917462|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, MD, PhD|646-888-4183|ilsond@mskcc.org|
22313528|NCT01441583|Boston Scientific|Clinical Trial Manager|+18002273422|jens.goetzke@bsci.com|
22270905|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22281757|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de|
22281758|NCT03088930|University of Colorado Cancer Center|Dr. Tejas Patil|7208489264|tajas.patil@cuanschutz.edu|
22281759|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22270906|NCT01451164|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
22270907|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
22270908|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
22270909|NCT04045132|The Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
22270910|NCT02963558|Wake Forest University School of Medicine|D Clark Files, MD|336-716-8898|dfiles@wakehealth.edu|
22270911|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu|
22270912|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu|
22270913|NCT04063657|University of California, Davis|Dr. Christopher Kreulen|(916) 734-6805|ckreulen@ucdavis.edu|
22270914|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com|
22270915|NCT02817698|Yale University|Marc Grasso|2037377074|marc.grasso@yale.edu|
22270916|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu|
22270917|NCT05932225|Alcon Research, LLC|Clinical Trial Lead, CDMA Trial Management Operations|1-888-451-3937|alcon.medinfo@alcon.com|
22270918|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22270919|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343||
22270920|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22270921|NCT04178824|Icahn School of Medicine at Mount Sinai|Allan Geliebter PhD|212-523-4574|Allan.Geliebter@mountsinai.org|
22270922|NCT01877551|Washington University School of Medicine|Dr. Dominic Reeds|3143628430|dreeds@wustl.edu|
22270923|NCT06017752|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
22281760|NCT00197145|ViiV Healthcare|GSK Response Center|866-435-7343||
22281761|NCT00790868|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
22281762|NCT02867813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313529|NCT03341312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22281763|NCT03040011|Magee-Womens Hospital of UPMC|Dr. Lauren Giugale, PI|412-641-1498|giugalele@upmc.edu|
22281764|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com|
22281765|NCT02578680|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22281766|NCT02964559|Emory University|Dr. Michael Lowe|404-778-7215|mlowe3@emory.edu|
22281767|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22281768|NCT01559259|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281769|NCT01995669|University of Texas M D Anderson Cancer Center|Dr. Loretta Nastoupil|(713) 792-2860|lnastoupil@mdanderson.org|
22281770|NCT03727646|University of Washington|Dr. Kevin Douglas O'Brien|2065984300|cardiac@uw.edu|
22281771|NCT05659719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281772|NCT06523010|Bitlis Eren University|Asst. Prof. Ömer Dursun|5426088687|fztomrdrsn@gmail.com|+90
22281773|NCT02150551|Children's National Hospital|Catherine Bollard, MD|202-476-4776|cbollard@childrensnational.org|
22281774|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
22281775|NCT04324541|University of North Texas Health Science Center|Leigh Johnson, PhD|817-735-2938|Thanhtruc.Truong@unthsc.edu|
22281776|NCT00306293|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281777|NCT05081167|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
22281778|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22281779|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org|
22299154|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org|
22299155|NCT03333746|The Ohio State University Comprehensive Cancer Center|Dr. Yvonne Efebera|614-293-7243|Yvonne.Efebera@osumc.edu|1278
22299156|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22299157|NCT05402995|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22299158|NCT01427296|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
22299159|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
22299160|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com|
22299161|NCT02002494|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22299162|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22299163|NCT01767792|The University of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.4010|bkorf@uabmc.edu|
22299164|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299165|NCT02780349|Gardia Medical|Vardit Segal Ph.D|972-4-6277166|vardit@gardiamedical.com|
22299166|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov|
22299167|NCT04028388|Modra Pharmaceuticals|M. Keessen|+31202050188|info@modrapharmaceuticals.com|
22299168|NCT02841644|Atrium Health|Vice Chair of Research|7043552000|Rachel.Seymour@atriumhealth.org|
22299169|NCT04114058|Cedar Sinai -Kerlan Jobe|Dr. Michael Banffy|(310) 665-7200|Michael.Banffy@cskerlanjobe.org|
22299170|NCT02430077|UT Southwestern Medical Center|Abhimanyu Garg|2146482895|Abhimanyu.garg@utsouthwestern.edu|
22299171|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22299172|NCT01609556|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22299173|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
22299174|NCT01632579|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299175|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org|
22299176|NCT01539291|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22299177|NCT01543256|Boston Scientific|Evelyne Ho|+1 508-683-4140|Evelyne.Ho@bsci.com|
22299178|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu|
22299179|NCT00129987|Imperial College London|Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
22299180|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22299181|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299182|NCT02744534|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
22299183|NCT02105116|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22299184|NCT03821376|Indiana University|Jordan Swensson, MD|317-944-1831|jswensso@iu.edu|
22299185|NCT02318329|Five Prime Therapeutics|Medical Lead|415-365-5600|FPA144@fiveprime.com|
22299186|NCT04837482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22299187|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300||
22299188|NCT02979535|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22299189|NCT04820673|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22299190|NCT02621983|Atlanta VA Medical Center|Dr. Erica Duncan|404-321-6111|erica.duncan@va.gov|207532
22299191|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
22299192|NCT01162005|Seoul National University Children's Hospital|Hee Gyung Kang|+82-2-2072-0658|pedneph@snuh.org|
22299193|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22299194|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333||
22299195|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com|
22299196|NCT03057119|Florida State University|Katie Kloss|9045716395|katie.kloss@med.fsu.edu|
22299197|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22299198|NCT04495374|Universidade Federal de Alfenas|Profa. Dra. Larissa Helena Lobos Torres Pacheco|3537011805|larissa.torres@unifal-mg.edu.br|55
22281780|NCT02589665|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281781|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu|
22281782|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22281783|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22281784|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22281785|NCT02242435|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22281786|NCT04925076|University of Minnesota|Jeff Boissoneault, PhD|612-624-7357|jboisson@umn.edu|
22281787|NCT00510718|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281788|NCT03258281|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kpbliden@gmail.com|
22281789|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22281790|NCT04051710|Aurobindo Pharma|Dr. Joseph Marialouis|9196150585|jmarialouis@aurobindousa.com|4013
22281791|NCT01971463|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
22281792|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov|
22281793|NCT05096247|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22281794|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu|
22313530|NCT01212952|Mayo Clinic|Martha Q. Lacy, M.D.|(507) 284-8430|lacy.martha@mayo.edu|
22313531|NCT05372913|Woebot Health|Dr. Athena Robinson|(415) 209-5642|athena@woebothealth.com|
22313532|NCT03303521|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22313533|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313534|NCT01654289|University of Wisconsin|Bruce Barrett MD PhD|608-263-2220|bruce.barrett@fammed.wisc.edu|
22313535|NCT02103816|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22313536|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov|
22313537|NCT04086576|University of Pennsylvania|Jessie Hemmons|215-746-8255|jhemmons@pennmedicine.upenn.edu|
22313538|NCT04748445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313539|NCT04736602|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22313540|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22313541|NCT04362111|University of Alabama at Birmingham|Walter Winn Chatham MD|205-612-7402|wchatham@uabmc.edu|
22313542|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
22313543|NCT02538471|Weill Cornell Medicine|Dr. Silvia Formenti|212-746-3608|formenti@med.cornell.edu|
22313544|NCT02350127|San Francisco VA|Dr. Deborah Barnes, PI|415-221-4810|deborah.barnes4@va.gov|24221
22313545|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22313546|NCT01348763|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
22313547|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com|
22313548|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com|
22313549|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com|
22313550|NCT03418701|University of Florida|Dr. Lori Bilello, Project Manager|904-244-9202|Lori.bilello@jax.ufl.edu|
22313551|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com|
22313552|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu|
22313553|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu|
22313554|NCT04593641|Celltrion Inc.|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
22313555|NCT01370564|Medtronic|Todd Fonseca, VP Clinical|763-526-8151|todd.fonseca@medtronic.com|
22313556|NCT00440037|Kyowa Kirin Co., Ltd.|Research & Development Planning Department , Research & Development Division||clinical.info.jp@kyowakirin.com|
22313557|NCT00794573|Jewish General Hospital / McGill University|Mark Eisenberg, MD MPH|5143408222|mark.eisenberg@ladydavis.ca|
22313558|NCT03740919|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22313559|NCT03479502|Vanderbilt_University MC|Rosemary Sanders, Research Coordinator|16155930171|Rosemary.a.sanders@vumc.org|
22313560|NCT02406859|James J. Peters VAMC|Dr. Mark Korsten|718-741-4675|mark.korsten@va.gov|6753
22313561|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org|
22313562|NCT04374253|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22313563|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu|
22313564|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov|
22313565|NCT04313985|Stanford University|Geoffrey Gurtner|(520) 626-2222|gurtner@surgery.arizona.edu|
22313566|NCT02680145|Mayo Clinic|Dr. John A. Occhino|(507) 538-5883|Occhino.John@mayo.edu|
22313567|NCT04382053|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@novartis.com|
22313568|NCT02704156|Changhai Hospital affiliated to Naval Medical University|Huojun Zhang|86-021-31162207|chyyzhj@163.com|
22313569|NCT01399905|Oregon Health and Science University|John G. Nutt, MD|503-494-9054|nuttj@ohsu.edu|
22313570|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22313571|NCT01808144|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22313572|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com|
22313573|NCT02548754|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|4052714742|stavros-stavrakis@ouhsc.edu|
22325762|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu|
22325763|NCT02404155|Maryland Psychiatric Research Center|Dr. Deanna L. Kelly, Pharm.D., BCPP|410-402-6860|dlkelly@som.umaryland.edu|
22325764|NCT02064439|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22325765|NCT02433288|AstraZeneca|Traxler, Barry M|+1 301 398 0657|barry.traxler@astrazeneca.com|
22325766|NCT02615535|Spaulding Rehabilitation Hospital|Dr. Ginger Polich|617 952 5000|ginger.polich@mgh.harvard.edu|
22325767|NCT00858702|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22325768|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu|
22325769|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie|
22325770|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22281795|NCT04115748|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22281796|NCT02752633|Landspitali - The National University Hospital of Iceland|Vidar Orn Edvardsson|+3545431000|vidare@landspitali.is|3452
22281797|NCT06053541|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281798|NCT00152477|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22281799|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu|
22281800|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com|
22281801|NCT02292082|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
22281802|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org|
22281803|NCT01296711|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|001-844-599-2273|clinicaltrials@ucb.com|
22281804|NCT01328535|Mayo Clinic|Roxana S. Dronca, M.D.|507/284-2511|Dronca.Roxana@mayo.edu|
22281805|NCT01035463|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
22281806|NCT04528017|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22281807|NCT03425006|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22281808|NCT02972606|King's College London|Dr Whitney Scott|02071885421|whitney.scott@kcl.ac.uk|
22281809|NCT02126553|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD./Professor|713-563-3534|tkadia@mdanderson.org|
22299199|NCT02473614|University of California at Irvine|Dr. Kelli Sharp|9495107968|ksharp@uci.edu|
22299200|NCT02525133|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22299201|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22299202|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
22299203|NCT01576536|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|mike.stein@vanderbilt.edu|
22299204|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22299205|NCT05209191|REAL Prevention LLC|Dr. Michael L. Hecht|18143601893|HECHTPSU@GMAIL.COM|
22299206|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com|
22299207|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300||
22299208|NCT02613481|Yardley Dermatology Associates, PC|Director of Clinical Trials|2155796155|rfried@yardleyderm.com|
22299209|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299210|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299211|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu|
22299212|NCT05282004|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22299213|NCT04808609|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
22299214|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
22299215|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22299216|NCT02256111|Duke University|Michael Harrison, MD|919-668-4615|michael.harrison@duke.edu|
22299217|NCT04382326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299218|NCT00618657|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22299219|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043||
22299220|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299221|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu|
22299222|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22299223|NCT05734846|CooperVision Inc.|Percy Lazon de la Jara BOptom PhD|+1-925-251-6682|PLazon@coopervision.com|
22299224|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu|
22299225|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu|
22299226|NCT04408963|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22299227|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org|
22299228|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org|
22299229|NCT01748994|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
22299230|NCT03105362|Boston Children's Hospital|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
22299231|NCT02749903|Memorial Sloan Kettering Cancer Center|Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
22299232|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu|
22299233|NCT01440946|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22299234|NCT01975389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299235|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
22299236|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22299237|NCT03735862|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
22299238|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com|
22299239|NCT02296112|Vanderbilt University Medical Center|Douglas Johnson, MD|(615) 936-8422|douglas.b.johnson@vumc.org|
22299240|NCT02778204|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22299241|NCT01720069|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
22313574|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22313575|NCT02972242|WRNMMC Cardiology|Hampton Crimm|301-295-4500|hampton.a.crimm.mil@mail.mil|
22313576|NCT03480919|Hospital for Special Surgery|Jonathan Kirschner|6467146327|kirschnerj@hss.edu|
22313577|NCT04572997|Prof. Dr. Kristian Reich|Prof. Dr. Kristian Reich|+49 1722701941|kreich@jerucon.com|
22313578|NCT03098797|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22313579|NCT02329223|Novartis|Study Director|862-778-8300||
22313580|NCT00651937|The University of Texas (UT) MD Anderson Cancer Center|Dr. Richard E Champlin,MD/Chair, Stem Cell Transplantation|713- 203-8632|rchampli@mdanderson.org|
22313581|NCT03067610|University of Texas Southwestern Medical Center|Dr. David Sher|214/645-7607|david.sher@utsouthwestern.edu|
22313582|NCT02628964|NYU Langone Health|Donna Shelley, MD MPH|917-494-4210|donna.shelley@nyulangone.org|
22313583|NCT03443063|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22313584|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca|
22313585|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22313586|NCT02720185|University of Wisconsin Carbone Cancer Center|Kari Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
22313587|NCT04397614|University of Oklahoma Health Sciences Center|Krista Kezbers|405-271-8001|krista-kezbers@ouhsc.edu|45042
22313588|NCT02507687|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22313589|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
22313590|NCT04357964|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|(615) 343-7592|alp.ikizler@vumc.org|
22313591|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000|cemrazi2@gmail.com|1139
22313592|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net|
22313593|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu|
22325771|NCT02417233|University of California San Francisco|Dr. Sheri Lippman|415-476-6319|sheri.lippman@ucsf.edu|
22325772|NCT01063751|Stryker - Joint Replacement|Filesha Haniff / Clinical Study Manager|1 470.528.9214|filesha.haniff@stryker.com|
22325773|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com|
22325774|NCT02046135|Cohen Children's Medical Center|Dr. James Schneider|7184703330|jschneide2@northwell.edu|
22313594|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu|
22313595|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org|
22313596|NCT03619889|Universidad Complutense de Madrid|Dra. Gema Serrano-Hernanz|669332986|gema.serrano.hernanz@gmail.com, gemase01@ucm.es|
22313597|NCT03296566|University of British Columbia|Dr. Marette Lee|604.875.5608|Marette.Lee@vch.ca|
22313598|NCT03065205|University of Colorado|Heather Hoch MD|720-777-4108|heather.hoch@childrenscolorado.org|
22313599|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100|jmeneses@elogica.com.br|4135
22313600|NCT03511378|Lupin Ltd. (Lupin Research Park), Pune, India|Dr. Chirag Shah, Director|91-20-67917368|chiragshah@lupin.com|
22313601|NCT05012280|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
22313602|NCT01503515|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22313603|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu|
22313604|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it|
22313605|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22313606|NCT00082641|University of Nebraska|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
22313607|NCT03022578|UT MD Anderson Cancer Center|Dr. Barbara O'Brien, MD/Associate Professor, Neuro-Oncology|(713) 794-4380|bjobrien@mdanderson.org|
22313608|NCT03681353|Duke University Medical Center|Angela Kirby, MS|919-286-0411|angela.kirby@duke.edu|175526
22313609|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com|
22313610|NCT00726388|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313611|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551|Yi.Xia@ge.com|500-3045
22299242|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22299243|NCT01898793|Washington University School of Medicine|Amanda Cashen, M.D.|314-434-8323|acashen@wustl.edu|
22299244|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
22299245|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu|
22281810|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934|caroline.quach@mcgill.ca|24485
22281811|NCT03748706|Cassava Sciences|Lindsay Burns, SVP of Neuroscience|512-501-2484|lburns@cassavasciences.com|
22281812|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu|
22281813|NCT03070171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281814|NCT03374683|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
22281815|NCT01059682|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22281816|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu|
22281817|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22281818|NCT03655054|Valencia Technologies|Jacqueline Dister|7604294787|jdister@valenciatechnologies.com|
22281819|NCT03931382|Senior Director|John Jacob|604-875-2393|john.jacob@cw.bc.ca|
22281820|NCT03316118|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
22281821|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca|
22281822|NCT06003777|Pfizer Inc.|Name or Official Title: Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281823|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com|
22281824|NCT02466425|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22281825|NCT04181593|OmegaD LLC|Dr. Gregory Smith, MD|3023833948|SGSmith@omegad.com|
22281826|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281827|NCT01901289|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
22281828|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299246|NCT00162136|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22299247|NCT04450264|Icahn School of Medicine at Mount Sinai|Dr. Jamilia Sly|212-824-7813|jamilia.sly@mssm.edu|
22299248|NCT03809182|Pontificia Universidad Católica de Chile|Mauricio Ibacache MD|+56984421425|mibacach@med.puc.cl|
22299249|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com|
22299250|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu|
22299251|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22299252|NCT03017508|Yale University|Angeli Landeros|203-737-4809|angeli.landeros@yale.edu|
22299253|NCT02162810|UPMC Children's Hospital of Pittsburgh|Karen Kenyon, research coordinator|4126923058|kenyonkl@upmc.edu|
22299254|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
22299255|NCT01831089|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology Business Unit.|+34 91 846 60 00|clinicaltrials@pharmamar.com|
22299256|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
22299257|NCT04729803|palo alto university|Dr. Mikael Rubin|650-433-3805|mrubin@paloaltou.edu|
22299258|NCT00652457|University of California, San Diego|Jody Corey-Bloom, MD, PhD|858-249-0574|jcoreybloom@ucsd.edu|
22299259|NCT03936244|Hospital Universitario Fuenlabrada|Dr. Hugo Otaola Arca|+56 9 4108 9452|hugotaolarca@hotmail.com|
22299260|NCT03551938|University of Michigan|Dr. Rob Stephenson|734-763-1188|rbsteph@med.umich.edu|
22299261|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400|markus.peck@meduniwien.ac.at|47440
22299262|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22299263|NCT01114646|Hartford Hostpial|Arben Ademi, CCRP|860-972-3561|arben.ademi@hhcealth.org|
22299264|NCT01381172|Impulse Dynamics (USA) Inc|Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
22299265|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
22299266|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com|
22299267|NCT02753751|Yale University|Francis P. Wilson|2037376095|francis.p.wilson@yale.edu|
22299268|NCT02667912|Tomsk National Research Medical Center of the Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
22299269|NCT04443218|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22299270|NCT01047683|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
22299271|NCT03447769|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22299272|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
22299273|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu|
22299274|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22299275|NCT01166984|AtoxBio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
22299276|NCT01351740|British Columbia Centre for Excellence in HIV/AIDS|Dr Marianne Harris|1-604-806-8771|mharris@cfenet.ubc.ca|
22299277|NCT01525082|Stanford University|Shaheen Shagufta, Clinical Assistant Professor|650-725-6454|sshaheen@stanford.edu|
22299278|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com|
22299279|NCT01385059|City of Hope Medical Center|Dr. Sumanta Kumar Pal|626-359-8111|SPal@coh.org|
22299280|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22299281|NCT03895853|UT MD Anderson Cancer Center|Joseph L. Nates, Professor, Critical Care& RespiratoryCare|(713) 792-5040|jlnates@mdanderson.org|
22313612|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk|
22313613|NCT01797562|Allerderm(dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|
22313614|NCT03930238|University of Iowa|Jacob Simmering|319-384-1107|jacob-simmering@uiowa.edu|
22313615|NCT01116440|Mereo BioPharma Group Plc.|William Moore|+44333023300|WM@mereobiopharma.com|
22313616|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org|
22313617|NCT01126879|Northwestern University|William Catalona, MD|312-695-1301|WCatalona@nm.org|
22313618|NCT03861429|University of Utah|Dr. Gail Towsley|801-585-9085|gail.towsley@nurs.utah.edu|
22313619|NCT01763346|University or Southern California|Dr. Thomas Buchanan|3234794319|buchanan@usc.edu|
22313620|NCT01797822|Baylor College of Medicine|Stephen Pflugfelder|713-798-6100|stevenp@bcm.edu|
22313621|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu|
22313622|NCT03441789|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22313623|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842|hcrndm@hoosiercancer.org|41
22313624|NCT04318587|University of Pittsburgh|Naomi Ryssel|412-335-9688|agostinonr@upmc.edu|
22313625|NCT00744796|University of Texas Southwestern Medical Center|Dr. Vinod Mootha|214-648-3837|peter.chen@utsouthwestern.edu|
22313626|NCT02581189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22313627|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22313628|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu|
22313629|NCT05135156|University of Washington|Dr. Kathleen J. Ramos|2065430393|ramoskj@uw.edu|
22313630|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu|
22313631|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313632|NCT02389725|Mayo Clinic|Dr. Tobias Kummer|507-255-4399|kummer.tobias@mayo.edu|
22313633|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22313634|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313635|NCT01187407|Eli Lilly and Company|Chief Medical Officer|800-545-597||
22313636|NCT01136798|The University of Chicago|Eve Van Cauter, PhD|773-834-4001|evcauter@bsd.uchicago.edu|
22313637|NCT02382406|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22313638|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22313639|NCT00125853|Imperial College London|Professor Neil Poulter|+44 2075943445|n.poulter@imperial.ac.uk|
22313640|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22313641|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22313642|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org|
22325775|NCT01933984|Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital|Dr. Shin-Hwar Wu|886-4-7238595|126366@cch.org.tw|3971
22325776|NCT03408873|Case Western Reserve University and University Hospitals Cleveland Medical Center|Joy Yala, MPH|216-368-0783|jxy790@case.edu|
22325777|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
22325778|NCT01600131|Veterans Health Administration|Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
22325779|NCT01264965|University of Chicago|Theodore Karrison|773-702-9326|karr@health.bsd.uchicago.edu|
22325780|NCT02844582|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22325781|NCT03799718|Brainstorm Cell therapeutics|Chief Medical Officer|201-488-0460|Clinical.Trial@brainstorm-cell.com|
22325782|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088||
22325783|NCT03662334|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22325784|NCT01097330|Population Health Research Institute|Dr. Carlos Morillo|905-527-4322|Carlos.Morillo@phri.ca|40311
22325785|NCT05848245|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
22325786|NCT03303339|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
22325787|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org|
22325788|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com|
22325789|NCT02116972|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22325790|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
22325791|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
22325792|NCT02428140|University of Alberta|Dr. Brian Buck|78024819227|bbuck@Ualberta.ca|
22325793|NCT03176966|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
22325794|NCT02989727|Univeristy of Saskatchewan|Dr. Evyn Peters|13062904493|evyn.peters@usask.ca|
22325795|NCT01903434|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325796|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325797|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no|
22325798|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22325799|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
22325800|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325801|NCT04011436|Universidad Nacional de Colombia|Pt. Luisa Prieto|+57 3202082723|lfprietog@unal.edu.co|
22325802|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313643|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313644|NCT02038803|Rush University Medical Center|Dr. Robert Balk|3129426744|Robert_Balk@rush.edu|
22313645|NCT04754594|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22313646|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
22313647|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313648|NCT03356145|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22313649|NCT04763863|Coloplast AB|Catarina Sternhufvud|+46 (0)705 56 10 97|secast@coloplast.com|
22313650|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu|
22313651|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org|
22313652|NCT02135419|University of California, San Francisco|Dr. Joel Palefsky|(415) 476-1574|joel.palefsky@ucsf.edu|
22313653|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258||
22313654|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org|
22313655|NCT01524887|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22313656|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com|
22313657|NCT03993054|University of Miami|Sara St. George|305-243-0726|s.stgeorge@med.miami.edu|
22313658|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu|
22313659|NCT02648282|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng MD, PhD|410-502-6241|lzheng6@jhmi.edu|
22313660|NCT02956278|University of California San Francisco|Kathy Giacomini, PhD|415-514-4363|kathy.giacomini@ucsf.edu|
22313661|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22313662|NCT04588519|Spark Biomedical, Inc.|Navid Khodaparast, PhD|832-280-4756|navid.khodaparast@sparkbiomedical.com|
22313663|NCT01226485|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22313664|NCT00961896|Novartis|Study Director|862-778-8300||
22313665|NCT00848393|Nationwide Children's Hospital|Aymen Naguib, MD|6147220596|Aymen.Naguib@nationwidechildrens.org|
22313666|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com|
22313667|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
22313668|NCT02229396|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22313669|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com|
22313670|NCT02679079|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22313671|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22313672|NCT03009019|BioDelivery Sciences (a subsidiary of Collegium Pharmaceutical)|Director, Scientific Communications|913-940-1789|tkunkel@collegiumpharma.com|
22313673|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu|
22313674|NCT03939793|Penn Center for Community Health Workers|Director of Evaluation|267-624-5465|molly.knowles@pennmedicine.upenn.edu|
22313675|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743||
22313676|NCT01812707|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22313677|NCT05376787|F2 Labs|Wendy Fuster|3013682586|wfuster@f2labs.com|
22313678|NCT05060237|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
22313679|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
22313680|NCT01763645|BIOCAD|Feder Krykov|+7 (812) 380 4933|kryukov@biocad.ru|8552
22313681|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313682|NCT02396758|Boston Scientific|Nancy O'Connell|763-494-2706|nancy.oconnell@bsci.com|
22313683|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22313684|NCT02110225|Dompé farmaceutici s.p.a.|Flavio Mantelli, MD, PhD|+39 02 583831|clinical.trials@dompe.com|
22313685|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
22313686|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu|
22313687|NCT03436433|Duke Neurosugery|Claudia E. Pamanes, MPH, CCRP|9196680897|claudia.pamanes@duke.edu|
22313688|NCT03568708|CIncinnati Children's Hospital Medical Center|Dr. Halley Wasserman|513-803-3815|halley.wasserman@cchmc.org|
22313689|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22313690|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com|
22313691|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313692|NCT00809783|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313693|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Head & Neck Surgery|7137927734|rsweber@mdanderson.org|
22313694|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com|
22313695|NCT01443546|Weill Cornell Medical College|Ina Cholst, MD|646-962-3025|icholst@med.cornell.edu|
22313696|NCT03229356|Johns Hopkins University|Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
22313697|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu|
22313698|NCT01956071|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
22313699|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22313700|NCT02254681|Allina Health|Srinevas K. Reddy|612-863-8716|laura.rockwell@allina.com|
22313701|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313702|NCT03461211|Horizon Pharma USA, Inc.|Roxann Becco|866-479-6742|clinicaltrials@horizontherapeutics.com|
22313703|NCT03209050|mmc medical international services|Clinical Research Organization and Trial Manager|9492805700|laura22@mmc-medical.com|
22313704|NCT02316847|SK Bio-pharmaceuticals Co, Ltd|MinJae Lee, Associate Manager||minj.lee@sk.com|
22313705|NCT01370018|Institute for Human Genetics and Biochemistry|Cynthia L. Bristow, MS, PhD|6314446238|cynthia.bristow@alpha1biologics.com|
22313706|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313707|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org|
22313708|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
22313709|NCT04970381|Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Prof. Yan Liang|+8618801287180|fwyy2803@163.com|
22313710|NCT02959177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22313711|NCT03544229|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22313712|NCT02460562|Faculty of Dentistry, Thammasat University|Dr. Kritirat Kiatsirirote|662-9869213-5|kkritirat@yahoo.com|7150
22313713|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org|
22313714|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org|
22313715|NCT02642159|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22325803|NCT03504774|Stanford University School of Medicine|Sayantani B. Sindher, MD|650-521-7237|tina.sindher@stanford.edu|
22325804|NCT02344628|London School of Hygiene and Tropical Medicine|Dr Michael Marks|+447984643424|michael.marks@lshtm.ac.uk|
22325805|NCT01781429|BioMed Valley Discoveries|Brent Kreider, PhD|816-960-4644|bkreider@biomed-valley.com|
22325806|NCT03238248|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22325807|NCT03864237|Brown University School of Public Health|Kate B. Carey|4018636558|kate_carey@brown.edu|
22325808|NCT02385123|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
22325809|NCT04498910|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22325810|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501|anthony.joshua@uhn.ca|2520
22325811|NCT02345434|Columbia University|Adam Sacarny|212 305 7084|ajs2102@columbia.edu|
22325812|NCT03121352|University Hospitals|Joseph Baar|216-844-8683|joseph.baar@uhhospitals.org|
22325813|NCT02409784|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22325814|NCT02688842|Shanghai Microport Medical (Company) Co.,Ltd.|Haotian Zhang|+86-21-38954600|zhanght@microport.com|8552
22325815|NCT00614666|University of Arizona|Dr. John Galgiani|(520) 626-4968|spherule@email.arizona.edu|
22325816|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org|
22325817|NCT01765647|University of Alberta|Dory Sample|780-248-5599|dory.sample@ahs.ca|
22325818|NCT02553915|Massachusetts General Hospital|Dr David Mischoulon, Director, Depression Clinical and Research Program, MGH|617-724-5198|dmischoulon@mgh.harvard.edu|
22325819|NCT03964415|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22325820|NCT01302769|99MDG Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22325821|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
22325822|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22325823|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com|
22325824|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22325825|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
22325826|NCT00733356|University of California Irvine Child Development Center|Kinberley Lakes|949-824-3009|klakes@uci.edu|
22325827|NCT03078608|Kaiser Permanente Northern California|Elaine Kurtovich|510-891-3118|elaine.m.kurtovich@kp.org|
22325828|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22325829|NCT03036592|University of Murcia|Prof. Marta Garaulet Aza|868884030|garaulet@um.es|
22325830|NCT02760407|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
22325831|NCT02522377|CLEVELAND CLINIC FOUNDATION|MURAT ALTINAY, MD|2164453359|altinam@ccf.org|
22325832|NCT01158950|University of California, San Francisco|Dr. Jennifer Mitchell|510-985-3522|jennifer.mitchell@ucsf.edu|
22325833|NCT00945191|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22325834|NCT01858428|Spectranetics|Julie Wolfram Smith|763-955-1072|julie.wolframsmith@spnc.com|
22325835|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22325836|NCT01765712|Nicholas Institute of Sports Medicine and Athletic Trauma|Malachy McHugh Director of Research|2124342714|mchugh@nismat.org|
22325837|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu|
22325838|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov|
22325839|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu|
22313716|NCT02222337|Lombardi Comprehensive Cancer Center, Georgetown University|Kristi Graves, PhD|202-687-1591|Kristi.Graves@georgetown.edu|
22325840|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22270924|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22313717|NCT03746483|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589-7020|info@firstwavebio.com|
22313718|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
22281829|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22313719|NCT02864147|Clinical Research Team Leader, Gynecologic Oncology, Yale Cancer Center|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
22313720|NCT02269917|Janssen Research & Development|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22313721|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il|
22313722|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu|
22313723|NCT02865135|Dana Farber Cancer Institute (DFCI)|Kartik Sehgal, MD|617-632-3090|Kartik_Sehgal@dfci.harvard.edu|
22313724|NCT00985621|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313725|NCT01732406|Massachusetts General Hospital|Dr. Karen Miller|617-726-3870|kkmiller@partners.org|
22313726|NCT04394624|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22313727|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22313728|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
22313729|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu|
22313730|NCT02418819|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313731|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22313732|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org|
22313733|NCT00676663|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|+1-858-888-3798|kmadigan@syndax.com|
22313734|NCT02363933|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
22313735|NCT02168153|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|Long_C@palmer.edu|
22313736|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313737|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313738|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
22313739|NCT00993798|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22313740|NCT02983877|Case Western Reserve University|Dr. Jennifer Levin|2168445057|jennifer.levin@uhhospitals.org|
22313741|NCT01983462|University of Iowa|Gary Pierce, PhD|3193359487|gary-pierce@uiowa.edu|
22313742|NCT01902381|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|bpowell@wakehealth.edu|
22313743|NCT02762500|Lycera Corp.|H. Jeffrey Wilkins, MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
22313744|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771||
22313745|NCT02754310|iLumens|Dr David Drummond|+0033144494848|david.drummond@ilumens.org|6
22313746|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com|
22313747|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22313748|NCT01093222|SWOG|Study Statistician|206-667-4623||
22313749|NCT04194541|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
22313750|NCT02567227|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
22313751|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org|
22313752|NCT04349124|Duke University|Brenna Hughes, M.D.|919-668-0843|brenna.hughes@duke.edu|
22313753|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov|
22313754|NCT01924806|Smith & Nephew|Henry Jaimes|01923-477-164|henry.jaimes@smith-nephew.com|
22313755|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com|
22313756|NCT02886234|The Miriam Hospital|Dr. Michael Carey|401793-8218|michael_carey@brown.edu|
22281830|NCT00700882|ECOG-ACRIN Statistical Office|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
22313757|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net|
22313758|NCT02498418|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22313759|NCT00957671|University of Texas Medical Branch|Randall Urban, MD|409-772-1176|rurban@utmb.edu|
22313760|NCT03635775|University of Wisconsin Madison|Bernadette Gillick|612-625-3645|bgillick@wisc.edu|
22313761|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
22313762|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com|
22313763|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22313764|NCT05562583|Northwestern University|Judith Tedlie Moskowitz|312-503-7712|judith.moskowitz@northwestern.edu|
22313765|NCT03866434|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22313766|NCT02046941|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
22313767|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com|
22313768|NCT00745121|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22281831|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22313769|NCT01961921|Alnylam Pharmaceuticals Inc|Chief Medical Officer|1-877-256-9526|Clinicaltrials@alnylam.com|
22313770|NCT03327571|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313771|NCT03280108|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22313772|NCT02996097|Johns Hopkins School of Medicine|Dr. Ginette Okoye|9142158980|ginette.okoye@howard.edu|
22299282|NCT01568047|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
22299283|NCT03783923|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22299284|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu|
22299285|NCT02255110|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22299286|NCT02328326|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Dr. Ann-Marie Rosland|4123602259|Ann-Marie.rosland@va.gov|
22299287|NCT02543346|Kingston General Hospital|Dr. Anne Ellis|6135482336|ellisa@kgh.kari.net|
22299288|NCT04289753|Northwestern University|Stephen D. Persell, MD, MPH, FACP|3125036464|spersell@nm.org|
22299289|NCT02209324|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22299290|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22299291|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu|
22313773|NCT01820637|Boston Scientific|Lieve Cornelis, Clinical Trial Manager|+ 32 476-840-183|Lieve.Cornelis@bsci.com|
22299292|NCT03433456|University of Alabama at Birmingham|Dr. Gareth Dutton|205.934.6876|gdutton@uabmc.edu|
22299293|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22299294|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629||
22299295|NCT01785602|Novartis|Study Director|862-778-8300||
22299296|NCT03127228|University of Michigan|Dr. Chin-Wei Wang|734-763-2105|jeffwa@umich.edu|
22299297|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22299298|NCT03074734|TobaccoFree Research Institute Ireland|Professor Luke Clancy|+353868364337|lclancy@tri.ie|
22299299|NCT03251924|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22299300|NCT00006411|JCHR|Roy W. Beck, MD, PhD|813-975-8690|cds@jaeb.org|
22299301|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com|
22299302|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com|
22299303|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22299304|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu|
22299305|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
22299306|NCT00983580|Mayo Clinic|Frank A. Sinicrope, M.D.||sinicrope.frank@mayo.edu|
22299307|NCT04382612|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22299308|NCT01328002|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22299309|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299310|NCT02331992|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 5740123|cpaptrial@fphcare.co.nz|
22299311|NCT00234884|Abbott|Global Medical Services|1-800-633-9110||
22299312|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299313|NCT02969928|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
22299314|NCT04286594|McLean Hospital|Dr. Staci Gruber|617-855-2762|gruber@mclean.harvard.edu|
22299315|NCT02143518|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
22299316|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com|
22299317|NCT03964454|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
22299318|NCT05955560|Becton, Dickinson & Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
22299319|NCT04621500|Medical University of South Carolina|Stephen J. Savage, MD|18437925787|savages@musc.edu|
22299320|NCT01787604|MeshalkinRI|Dmitry|+79069090505|dmhvan@mail.ru|
22299321|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org|
22299322|NCT00074282|ECOG-ACRIN Statistical Office|Study Statistician|617 632 3012|eatrials@jimmy.harvard.edu|
22299323|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu|
22299324|NCT01319396|ResMed|Paul Phillips|+353 1 716 3755|paul.phillips@resmed.com|
22299325|NCT04745169|Baylor College of Medicine|Elizabeth Lorenz, MD|713-798-2694|elizabeth.lorenz@bcm.edu|
22299326|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300||
22299327|NCT01760954|AbbVie|Global Medical Services|800-633-9110||
22299328|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299329|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22299330|NCT02352493|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|Clinicaltrials@alnylam.com|
22299331|NCT02317575|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299332|NCT01465334|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
22299333|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
22299334|NCT04479618|BenskinL|Linda Benskin, PhD, RN, Independent Researcher|+1 (512) 659-0812|lindabenskin@utexas.edu|
22299335|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
22299336|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299337|NCT01485861|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22299338|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444||
22299339|NCT01986829|Washington University School of Medicine|Brian Van Tine, M.D.|314-362-5817|bvantine@wustl.edu|
22299340|NCT03795922|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22313774|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22313775|NCT03794609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281832|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22281833|NCT03158740|Connecting Health Innovations|Senior Scientist|8649154636|admin@chi-llc.net|
22281834|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu|
22281835|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu|
22281836|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
22281837|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn|
22281838|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22281839|NCT01818258|Organization: Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22281840|NCT02839720|UAB Heersink School of Medicine|Bruce R. Korf, MD, PhD|205-996-9487|bkorf@uabmc.edu|
22281841|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu|
22281842|NCT03927482|The Miriam Hospital|Beth Bock, PhD|4017938020|Beth_Bock@Brown.edu|
22281843|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu|
22281844|NCT00792740|Italfarmaco SpA|Tiziano Oldoni, MD|+39 0264432540|t.oldoni@italfarmaco.com|
22281845|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com|
22281846|NCT03407053|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
22281847|NCT03724981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281848|NCT03284333|Cutera|Margot Doucette|415-357-5518|mdoucette@cutera.com|
22281849|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22281850|NCT03703310|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
22281851|NCT02791191|Eli Lilly and Company|Chief Medical Officer|800-545-5079|Clinicaltrials.gov@lilly.com|
22281852|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
22281853|NCT03614416|Bioserenity|Eléonore CAILLET|01 57 27 40 00.|eleonore.caillet@bioserenity.com|
22281854|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu|
22281855|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
22281856|NCT01022359|Imperial College London|Neill Duncan|+44 (0 )207 594 7243|n.duncan@imperial.ac.uk|
22281857|NCT04178993|University of Kentucky|Dr. Craig Rush, Ph.D.|8592575388|crush2@uky.edu|
22281858|NCT03100539|Richard L Roudebush VA Medical Center|Dr. Matthew Bair, Director of Center for Health Information and Communication|317-988-2058|Matthew.Bair@va.gov|
22281859|NCT03817463|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281860|NCT04140695|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22281861|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22281862|NCT04753658|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281863|NCT01892436|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|novartis.email@novartis.com|
22281864|NCT02918396|Johns Hopkins University|Dr. Tarek Zghaib|410-955-5000|tzghaib1@jhmi.edu|
22281865|NCT02923830|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22313776|NCT03638258|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22313777|NCT04543942|The Ohio State University|Dr. Jessica Weafer|859-533-9878|jessica.weafer@osumc.edu|
22313778|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22313779|NCT03840278|Massachusetts General Hospital Diabetes Research Center|Courtney A Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22313780|NCT03805698|Cedars-Sinai Medical Center|David Kulber, MD, PI|3104235900|david.kulber@cshs.org|
22313781|NCT04405089|Minneapolis VA Medical Center|Dr. Shalamar Sibley, MD, MPH|612-467-1727|Shalamar.Sibley@va.gov|
22313782|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu|
22313783|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22313784|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22313785|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22313786|NCT01919398|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22313787|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com|
22313788|NCT03722836|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
22313789|NCT05021757|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
22313790|NCT03799289|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
22313791|NCT02391545|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22313792|NCT02016690|AbbVie|Global Medical Services|800-633-9110||
22313793|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313794|NCT04089332|University of Wisconsin - Madison|Dr. William Schrage|608-262-7715|william.schrage@wisc.edu|
22313795|NCT05756348|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
22325841|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu|
22313796|NCT05401149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313797|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
22313798|NCT04281875|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
22313799|NCT02656745|Click Therapeutics|Director of Scientific Affairs|646-844-2158|brian@clicktherapeutics.com|
22313800|NCT02588027|University of California, San Francisco|Dr. Jennifer Tangtiphaiboontana|5622095440|Jennifer.Tangtiphaiboontana@ucsf.edu|
22313801|NCT03847389|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|4073231887|nini.ramirez@hillderm.com|
22313802|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313803|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313804|NCT04853394|University of Illinois Chicago|Mary E. Mackesy-Amiti|312-355-4892|mmamiti@uic.edu|
22313805|NCT04890158|Montefiore Medical Center|Dr. Alecia Thompson-Branch|718-904-4105|alethomp@montefiore.org|
22313806|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov|
22313807|NCT04853238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313808|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22313809|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313810|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
22313811|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22313812|NCT04517877|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
22313813|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com|
22313814|NCT03245762|University of Florida|Jennifer Miller, MD|352-265-7337|millejl@peds.ufl.edu|
22313815|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu|
22313816|NCT01982786|Canadian cancer trials group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
22313817|NCT02312622|Stanford University|Joel W. Neal, MD PhD, Assistant Professor of Medicine (Oncology)|(650) 498-4696|jwneal@stanford.edu|
22313818|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313819|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22313820|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22313821|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu|
22313822|NCT02499835|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD|608-263-4198|dm3@medicine.wisc.edu|
22313823|NCT01751451|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher, MD|646-888-4878|scherh@MSKCC.ORG|
22313824|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22313825|NCT03319719|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22313826|NCT03193216|Medical University of South Carolina|Dr. Puja Elias, Associate Professor, PI for study|8438764269|eliasps@musc.edu|
22313827|NCT02490878|MD Anderson Cancer Center|Caroline Chung, MD|(713) 745-5422|cchung3@mdanderson.org|
22313828|NCT00922441|Boryung Pharmaceutical|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
22313829|NCT00991029|Medical University of South Carolina|Dr. Jordan Elm|843-876-1605|elmj@musc.edu|
22313830|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313831|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300||
22313832|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org|
22313833|NCT03371485|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22313834|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569|clinical-trials@grunenthal.com|3223
22313835|NCT03389451|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
22313836|NCT01860807|UCLA|Keith Heinzerling MD|310-319-4700|kheinzerling@mednet.ucla.edu|
22313837|NCT02853305|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313838|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov|
22313839|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org|
22313840|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org|
22313841|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22313842|NCT02381652|Anika|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
22270925|NCT02659514|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|9497886700|shanta.chawla@sppirx.com|
22270926|NCT03409107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22313843|NCT04772313|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22313844|NCT01836198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22313845|NCT03187353|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
22313846|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22313847|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22313848|NCT00924209|National Cancer Institute, National Institutes of Health|Caryn Steakley, Deputy Clinical Director|240-858-3749|steaklec@nih.gov|
22313849|NCT02943109|Ohio State University College of Medicine|Prof. Ann Scheck McAlearney|614-293-8973|Ann.McAlearney@osumc.edu|
22270927|NCT01588457|UT Health San Antonio|Charles Bowden, MD|2105675393|bowdenc@uthscsa.edu|
22270928|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
22313850|NCT02625922|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22313851|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
22313852|NCT02359552|Cleveland Clinic Lou Ruvo Center for Brain Health|Dr. Aaron Ritter|702-483-6049|rittera@ccf.org|
22313853|NCT01209936|University of Southern California|Dr. David Erceg|(323) 442-2900|erceg@usc.edu|
22313854|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22313855|NCT02391116|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22313856|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22313857|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com|
22313858|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22313859|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org|
22313860|NCT06016127|Albany Saratoga Centers for Pain Management|Kasandra Cliff|518-371-6772|khopkins@northwayspc.com|
22313861|NCT03340766|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313862|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
22313863|NCT01294358|National Cancer Institute|Dr. Udo Rudloff|301-496-3098|udo_rudloff@nih.gov|
22313864|NCT03613454|University of Alabama at Birmingham|Dr. AJ Gunn|205-975-4850|agunn@uabmc.edu|
22313865|NCT02963922|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22313866|NCT02181400|Sydney Eye Hospital|Maria Willilams|02 9382 7309|maria.williams@sydney.edu.au|
22313867|NCT04374019|University of Kentucky|Susanne Arnold MD|8592579568|smarno0@uky.edu|
22313868|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22313869|NCT03873038|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313870|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
22313871|NCT04222088|Research Institute for Tropical Medicine|Dr. Fe Esperanza Caridad J. Espino|63288072628|fe.espino2019@gmail.com|343
22313872|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22313873|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281866|NCT00837265|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22281867|NCT00583414|Massachusetts General Hospital|Matthew Eagleton, MD|617-726-8279|meagleton@mgh.harvard.edu|
22281868|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22281869|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22281870|NCT01751906|Abbott Vascular|Latania Chura / Project Manager|503.935.3002|latania.chura@abbott.com|
22281871|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu|
22281872|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
22281873|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477||
22281874|NCT02759107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22281875|NCT02390414|Dana-Farber Cancer Institute|Dr. Gregory A. Abel|6176322304|gaabel@partners.org|
22281876|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com|
22281877|NCT00420004|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281878|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu|
22281879|NCT03002818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22281880|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22313874|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk|
22313875|NCT00884793|UCSF|Steven Yukl|415-221-4810|steven.yukl@ucsf.edu|3930
22313876|NCT04783519|University of Washington|Mary Larimer|(206) 543-3513|larimer@uw.edu|
22313877|NCT03169530|Beth Israel Deaconess Medical Center|Kenneth Mukamal, MD, MPH|617 754-1401|kmukamal@bidmc.harvard.edu|
22313878|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22313879|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026||
22313880|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu|
22313881|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org|
22313882|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22313883|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22313884|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il|
22313885|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no|
22313886|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313887|NCT01709123|Louisiana State University Health Science Shreveport|Sushil K. Jain, PhD|318.675.6086|sushil.jain@lsuhs.edu|
22313888|NCT02685007|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22313889|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu|
22313890|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com|
22313891|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org|
22313892|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22281881|NCT01606787|Memorial Sloan Kettering Cancer Center|Dr. Jonathan Coleman, MD|646-422-4432|colemanj@mskcc.org|
22313893|NCT00317603|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
22313894|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22313895|NCT02621047|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22313896|NCT03690921|M D Anderson Cancer Center|Dr. Emma Holliday|713-563-2340|EBHolliday@mdanderson.org|
22313897|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22313898|NCT03772041|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22313899|NCT05110014|Wake Forest Baptist Health Sciences|Study Coordinator|336-713-3103|eswright@wakehealth.edu|
22313900|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org|
22313901|NCT03927222|Duke University|Mustafa Khasraw, MD|919-684-5301|mustafa.khasraw@duke.edu|
22313902|NCT03690284|University of Texas Southwestern|Clinical Research Coordinator|3106127741|matthew.oh@utsouthwestern.edu|
22313903|NCT02201771|Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Yunpeng Zhu|008613816819346|zypB1014@rjh.com.cn|
22313904|NCT00549042|Covidien|Alfredo Bozzini, MD|314-654-2000|Alfredo.Bozzini@covidien.com|
22313905|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca|
22313906|NCT03697083|University of Pennsylvania|Katherine K. Milkman Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
22313907|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22313908|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590||
22313909|NCT00006099|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22313910|NCT02264353|University of California, San Diego|Atul Malhotra, MD|(858) 657-6159|amalhotra@ucsd.edu|
22313911|NCT04896502|Arkansas Children's Hospital|Robbie Pesek, MD|501-364-3149|rdpesek@uams.edu|
22313912|NCT02383927|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-001@kuraoncology.com|
22313913|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
22313914|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22313915|NCT01518517|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
22313916|NCT00981578|InSightec|Nadir Alikacem|214.360.2000|nadira@insightec.com|
22313917|NCT01393314|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
22313918|NCT03427177|Fox Chase Cancer Center|Dr. Linda Fleisher|215-214-3757|Linda.Fleisher@fccc.edu|
22313919|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com|
22313920|NCT01180790|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22313921|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22313922|NCT02335242|Stanford University|Jean Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
22313923|NCT04167085|David Geffen School of Medicine at UCLA|Justin P. McWilliams, MD, FSIR|(310) 267-8773|jumcwilliams@mednet.ucla.edu|
22313924|NCT03840148|Venatorx Pharmaceuticals, Inc.|Paul McGovern, MD|484-329-8615|mcgovern@venatorx.com|
22313925|NCT03615404|Duke University Medical Center|Principal Investigator|919-684-0000|pedsneuronc@duke.edu|
22313926|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22313927|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
22313928|NCT03849300|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22313929|NCT04839289|Sonova USCS|Lisa Standaert|331-702-0173|lisa.standaert@phonak.com|
22313930|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org|
22313931|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22313932|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
22313933|NCT00580047|University of Nebraska Medical Center|Lynn Mack|402-559-6208|lmack@unmc.edu|
22313934|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org|
22313935|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085|evamarwali@yahoo.com|2807
22313936|NCT02825849|UCSF|Heather Huddleston|415-353-3040|heather.huddleston@ucsf.edu|
22313937|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu|
22313938|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org|
22313939|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu|
22313940|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313941|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
22281882|NCT03015649|Envision Healthcare Scientific Intelligence, Inc.|Women's Imaging Director|9549397729|clinicaltrials@shcr.com|
22281883|NCT01942668|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|smirkin@therapeuticsmd.com|1952
22281884|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22281885|NCT03299881|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513-236-6799|samlung@elira.com|
22313942|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com|
22313943|NCT02273180|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22281886|NCT01289353|NYU Langone Health - PCC CTO|Carmen Perez, MD, PhD|212-731-5003|carmen.perez@nyulangone.org|
22313944|NCT04531813|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22313945|NCT04387201|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|713-500-6641|absalon.d.gutierrez@uth.tmc.edu|
22299341|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov|
22299342|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000|steven.prior@va.gov|4129
22299343|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22299344|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com|
22313946|NCT04341584|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|:+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
22313947|NCT04320602|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22313948|NCT03051984|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
22313949|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org|
22313950|NCT01318317|City of Hope|Dr. Lwaliw Popplewell|626-359-8111|lpopplewell@coh.org|
22313951|NCT01990313|Stanford University|Chioma Anidi|6507236709|chioma.anidi@stanford.edu|
22313952|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com|
22313953|NCT00837096|Acelity|VP, Global Clinical Affairs|210-255-5595|jane.hart@acelity.com|
22313954|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu|
22313955|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22313956|NCT01169636|UT MD Anderson Cancer Center|Dr. Christopher Flowers, MD/ Chair, Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
22313957|NCT02396953|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
22313958|NCT00510198|Medtronic CRDM Clinical Research and Reimbursement|Clinical Trial leader|7635262788|ming.duanmu@medtronic.com|
22313959|NCT03018223|Moffitt Cancer Center|Nelli Bejanyan, MD|813-745-7208|Nellie.Bejanyan@moffitt.org|
22313960|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313961|NCT02466243|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
22313962|NCT02149524|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
22313963|NCT00307164|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22313964|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
22313965|NCT03712449|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22313966|NCT05786521|University of Texas Health Science Center San Antonio|TIffany M Cortes, MD|210-450-3333|cortest@uthscsa.edu|
22313967|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218|kolb@dhm.mhn.de|2020
22313968|NCT03972137|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
22313969|NCT03226353|CooperVision|Jose A. Vega OD MSc FAAO|(925) 621- 3761|javega@coopervision.com|
22313970|NCT03168425|Vanderbilt University Medical Center|Sarah Osmundson, MD|+1 (615) 343-5700|sarah.osmundson@vumc.org|
22313971|NCT02747121|Helsetilsynet|Dr Einar Hovlid|+4721529900|eho@helsetilsynet.no|
22313972|NCT03029234|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22313973|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300||
22313974|NCT01176435|University of Minnesota|C. Gail Summers, MD|612-625-6469|summe001@umn.edu|
22313975|NCT00902226|H. Lundbeck A/S|Study Director|email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
22313976|NCT04765553|Swedish Orphan Biovitrum AB|Veronica Asnaghi|+41 61 508 72 13|Veronica.Asnaghi@Sobi.com|
22313977|NCT01885936|Duke University|Dwight Koeberl, M.D., Ph.D.|919-681-9919|dwight.koeberl@duke.edu|
22313978|NCT03214250|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22313979|NCT02487251|Michigan State University|Holly E. Brophy-Herb, PI|517-355-3397|hbrophy@msu.edu|
22313980|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk|
22313981|NCT02845375|Leiden University Medical Center|Dr Albert Dahan|+31715262301|a.dahan@lumc.nl|
22313982|NCT00397020|UCSD Medical Center|Dr. David Feifel|619-543-2485|dfeifel@ucsd.edu|
22313983|NCT02171130|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22313984|NCT01951261|Hospital Puerta de Hierro|Dra Patricia Mínguez Clemente|911916859|drapat3@gmail.com|
22313985|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
22313986|NCT04098497|University of Wisconsin - Madison|Amy Cochran|(608) 262-0772|cochran4@wisc.edu|
22313987|NCT03455218|Medical College of Wisconsin|Robert Niebler, MD|4142663360|rniebler@mcw.edu|
22313988|NCT03723915|Northwestern University, Feinberg School of Medicine|Devalingam Mahalingam MD, PhD Associate Professor, Division of Hematology and Oncology|312-695-6929|mahalingam@nm.org|
22270929|NCT02062944|Northwestern University|Josh Levitsky|312 695 4413|josh.levitsky@nm.org|
22299345|NCT03029208|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22299346|NCT01863017|University of Kansas Medical Center|Merlin G Butler|9135881800|mbutler4@kumc.edu|
22299347|NCT03054844|Columbia University|Dr. Daniel Tsze|212-305-9825|dst2141@columbia.edu|
22299348|NCT02673697|Corcym|Elisa Cerutti|+39 3459182413|elisa.cerutti@corcym.com|
22299349|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22299350|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu|
22299351|NCT03893448|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299352|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299353|NCT03321981|Merus N.V.|Executive Director Clinical Trials|+16174014499|USenquiries@merus.nl|
22299354|NCT04689737|Fundació de Lluita contra la SIDA, les Malalties Infeccioses i la Promoció de la Salut i La Ciència|Dr. Jose Molto Marhuenda|+34 934657897|jmolto@lluita.org|
22299355|NCT03321019|University of Florida|Dr. Karen Hegland|3522948366|kwheeler@ufl.edu|
22299356|NCT03880578|Klinikum Lüdenscheid|Professor Rolf Larisch, Director|‭+49 2351 46|rolf.larisch@klinikum-luedenscheid.de|3311
22313989|NCT03569475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22313990|NCT02630706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313991|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu|
22313992|NCT03039088|Rheumatology department, Cochin Hospital, APHP|Doctor Anna MOLTO|0158412617|anna.molto@aphp.fr|
22313993|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org|
22313994|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22313995|NCT00789399|Prairie Education and Research Cooperative|Chief Operating Officer|217 492 9104|jchambers@prairieresearch.com|
22313996|NCT02820298|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22313997|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com|
22313998|NCT03249272|Duke Cardiovascular Magnetic Resonance Center|Han Kim, MD|9196683539|han.kim@duke.edu|
22313999|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com|
22314000|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
22314001|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22314002|NCT02154516|Smith and Nephew|Clinical Study Manager|0499905851|stephanie.rufo@smith-nephew.com|+61
22314003|NCT03406507|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
22314004|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com|
22314005|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
22314006|NCT02319304|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
22314007|NCT03859622|Karl Landsteiner Institute of General Medicine|Dr.med.Gustav Kamenski|+4322832226|kamenski@aon.at|
22314008|NCT02316171|Viralytics|Mark Grose|+1 905 593 2891|Mark.Grose@viralytics.com|
22314009|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314010|NCT01596699|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
22314011|NCT02785900|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22314012|NCT00547300|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22314013|NCT04435522|Rhode Island Hospital|Philip Chan, M.D.|401-793-4859|philip_chan@brown.edu|
22314014|NCT02270463|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|1-877-332-7967|clinicaltrials@menarinistemline.com|
22314015|NCT04990973|Columbia University Irving Medical Center|Dr. Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
22314016|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314017|NCT01878383|University of Alabama at Birmingham|David Kimberlin, MD|205.638.2530|DKimberlin@peds.uab.edu|
22314018|NCT03464383|Wake Forest University School of Medicine|Heidi M. Munger Clary, MD, MPH Associate Professor of Neurology|336-716-7110|hmungerc@wakehealth.edu|
22314019|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22314020|NCT00605566|Princess Margaret Cancer Centre|Dr. Lillian Siu||lillian.siu@uhn.ca|
22314021|NCT03449134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314022|NCT03475056|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22314023|NCT02542410|BOSTON CHILDREN'S HOSPITAL|DR. AMY DIVASTA|6173556000|amy.divasta@childrens.harvard.edu|
22314024|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
22314025|NCT00837590|Indiana University|Dr. Kieren Mather|317-278-2187|kmather@iupui.edu|
22314026|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
22314027|NCT03864341|NYU Langone Health|Kelly Doran, MD, MHS|(212) 263-5850|Kelly.doran@nyulangone.org|
22314028|NCT01066936|Smith & Nephew|Tracey Brengola|978-319-2702|tracey.brengola@smith-nephew.com|
22314029|NCT01904136|Samer Srour, MD / Stem Cellular Transplantation Department|UT MD Anderson Cancer Center|713-794-4354|ssrour@mdanderson.org|
22314030|NCT01502306|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
22314031|NCT00356993|Addictions Program|Dr. Peter Selby|416-535-8501|peter_selby@camh.net|77432
22314032|NCT01960348|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|medinfo@alnylam.com|
22314033|NCT00853372|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22314034|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|
22314035|NCT01821729|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
22314036|NCT01811498|Northwell Health|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
22314037|NCT02517528|AbbVie|Global Medical Services|800-633-9110||
22314038|NCT02668198|Mayo Clinic|Dr. Michael B. Wallace|904-953-2221|wallace.michael@mayo.edu|
22314039|NCT04298099|Baylor College of Medicine|Karla Wyatt-Thompson|8328245800|karla.wyatt@bcm.edu|
22270930|NCT00278148|Case Comprehensive Cancer Center|Dr. Nathan Pennell|21684459281|penneln@ccf.org|
22270931|NCT02262000|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22270932|NCT01459718|Novartis Pharmaceuticals|Study Director|862-778-1873||
22270933|NCT03826628|AFT Pharmaceuticals Ltd.|Ioana Stanescu|+64 9 488 0232|ioana.stanescu@aftpharm.com|712
22270934|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
22270935|NCT05174949|University of Oklahoma Health Sciences Center|Dr. Yuan Yang (Principal Investigator) C/o Dr. Shirley James (Project Biostatistician)|4052712131|shirley-james@ouhsc.edu|46812
22314040|NCT02202109|University of Miami|Dr. Erin Kobetz|3052436185|ekobetz@med.miami.edu|
22314041|NCT00467298|VA Puget Sound Health Care System-Seattle|Cynthia M. Dougherty|206 764 2205|cynthia.dougherty@va.gov|
22314042|NCT01268098|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22314043|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
22314044|NCT04334668|Cleveland Clinic|Dr. W. H. Wilson Tang|216-444-2121|tangw@ccf.org|
22314045|NCT02416713|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
22314046|NCT04156399|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
22314047|NCT03339271|Mayo Clinic|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
22314048|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
22314049|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314050|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22314051|NCT03756168|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22314052|NCT04333732|Washington University School of Medicine in Saint Louis|Professor Michael S. Avidan|+1-(314)-273-2456|avidanm@wustl.edu|
22314053|NCT01845649|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22314054|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp|
22314055|NCT03418493|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314056|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org|
22314057|NCT02028247|Baylor College of Medicine|Dr. Eric Storch|7137983579|eric.storch@bcm.edu|
22314058|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
22314059|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314060|NCT00966979|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
22314061|NCT04140266|Hans Rosling Center for Population Health|Jen Balkus|260 616 6614|jbalkus@uw.edu|
22314062|NCT00943618|UT MD Anderson Cancer Center|Paul M. Cinciripini, BS,MS,PHD/Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
22314063|NCT06142578|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
22314064|NCT03713281|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22314065|NCT02412111|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22314066|NCT02624869|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22314067|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22314068|NCT02994784|Boston Medical Center and BU School of Medicine|John M Sloan, MD|617-638-7519|mark.sloan@bmc.org|
22314069|NCT04867707|University of Missouri|Dr. Luis Martinez|(573) 882-3244.|martinezlemusl@umsystem.edu|
22314070|NCT03935932|University of Pittsburgh|Tim Corcoran, Associate Professor|4126922210|corcorante@upmc.edu|
22314071|NCT02637856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22314072|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22314073|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22314074|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22314075|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22281887|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22314076|NCT02435381|Baylor College of Medicine|Christopher D. Verrico Ph.D.|713-791-1414|Cverrico@bcm.edu|26020
22314077|NCT01490359|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
22314078|NCT04150341|Theravance Biopharma US, Inc|Nathan Pfeifer|001 (650) 808-3711|npfeifer@theravance.com|
22314079|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu|
22314080|NCT03713073|The University of Texas Health Science Center at Houston|Chun-Teh Lee, DDS, DMSc, MS|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
22314081|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
22314082|NCT03730662|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314083|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu|
22314084|NCT03993457|UTexasSouthwestern|Maria Monastirsky|214-648-0174|maria.monastirsky@utsouthwestern.edu|
22314085|NCT02209610|VAORD|Dr Markus Amann|801-582-1565|markus.amann@hsc.utah.edu|4358
22314086|NCT03082898|Vanderbilt University|Dr. Michael Goldfarb|615 343 6924|michael.goldfarb@vanderbilt.edu|
22314087|NCT02895360|Basilea Pharmaceutica International Ltd.|Thomas Kaindl, MD, Global Medical Director, Oncology|+41615671505|Thomas.Kaindl@basilea.com|
22314088|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314089|NCT05153499|Finch Therapeutics|CEO|617-229-6499|info@finchtherapeutics.com|
22314090|NCT04151706|Stanford University|Dr. Robert Lowsky|(650) 723-0822|rlowsky@stanford.edu|
22314091|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com|
22314092|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca|
22314093|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22314094|NCT03432650|Hospital for Special Surgery, Anesthesiology|Dr. Stephen Haskins|212-606-1036|haskinss@hss.edu|
22314095|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
22281888|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314096|NCT00591409|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314097|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
22314098|NCT01542398|Queen's University, Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
22314099|NCT00248534|North American Brain Tumor Consortium|Lauren Abrey, MD|410-955-3657|jfisher@jhmi.edu|
22314100|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314101|NCT03834623|Moffitt Cancer Center|Nikhil Khushalani, MD|813-745-3437|Nikhil.Khushalani@moffitt.org|
22314102|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com|
22314103|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314104|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
22314105|NCT01936324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314106|NCT05566886|Corsano Health B.V.|Clinical Research Manager|+31 61 640 7778|info@corsano.com|
22314107|NCT03226106|Eastern Colorado VA Medical Center|Cory Christiansen, PT, PhD|303-724-9101|cory.christiansen@cuanschutz.edu|
22314108|NCT04349644|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|(615) 936-0280|blythe.corbett@vumc.org|
22314109|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314110|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22314111|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458||
22314112|NCT00943722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314113|NCT01772823|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22314114|NCT02176382|Massachusetts General Hospital|Dr. Joy Tsai|6177266723|jntsai@mgh.harvard.edu|
22314115|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22314116|NCT03897049|dfusion, Inc|Tamara Kuhn, Vice President & Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
22314117|NCT05109117|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22314118|NCT03220776|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
22314119|NCT04491006|Athira Pharma|Hans Moebius, CMO|1-866-725-0930|clinicaltrials@athira.com|
22314120|NCT02166047|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22314121|NCT03192202|Columbia University Irving Medical Center (CUIMC)|Ahmed Sawas, MD|212-305-0591|as4386@cumc.columbia.edu|
22314122|NCT02541942|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22314123|NCT00451555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314124|NCT03430050|MUSC|Dr. Sherman|843-792-8174|shermanb@musc.edu|
22314125|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22314126|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22314127|NCT02154477|SLU|sandeep dhindsa|314-977-4911|dhindsa@slu.edu|
22314128|NCT01388478|University of Kansas Medical Center|Jeffrey Burns, M.D., M.S.|913-588-0555|KUAMP@kumc.edu|
22314129|NCT01037413|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314130|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com|
22314131|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22314132|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu|
22314133|NCT01177137|Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health|Roberta W. Scherer, Director Data Coordinating Center|410 502 4636|rschere1@jhu.edu|
22314134|NCT04731675|AmMax Bio, Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
22314135|NCT02367105|Michael E DeBakey VA Medical Center|Dennis T Villareal, MD|713-794-7156|dennis.villareal@va.gov|
22314136|NCT02560389|University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison|Josh Cisler|608-263-6100|jcisler2@wisc.edu|
22314137|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
22314138|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22314139|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123|a540520@adm.cgmh.org.tw|8753
22314140|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org|
22314141|NCT00827775|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
22314142|NCT03041701|National Cancer Institute|Dr. Christine Heske|240-760-6197|christine.heske@nih.gov|
22314143|NCT00812838|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
22314144|NCT01723514|Amgen Inc.|Study Director|866-572-6436||
22314145|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314146|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu|
22314147|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
22314148|NCT02569632|Children's Hospital Oakland Research Institute (CHORI)|Dan Granoff, MD (Principal Investigator)|510-428-3000|dgranoff@chori.org|7640
22270936|NCT02951533|Janssen-Cilag GmbH|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22270937|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu|
22270938|NCT04351373|Mayo Clinic|Dr. Matthew Carlson|507-284-8532|Carlson.Matthew@mayo.edu|
22299357|NCT04934670|Xenikos BV (no longer in business)|Ypke van Oosterhout, custodian of Sponsor|+31 611 0177 611|ypke@me.com|
22299358|NCT03259035|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22299359|NCT03056690|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22299360|NCT02661828|Emory University|Boadie Dunlop, MD|404-727-8474|vcruz@emory.edu|
22299361|NCT02921412|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|JVega2@coopervision.com|
22299362|NCT01528228|A.T. Still University|Corey Luebbering|660.626.2147|coreyluebbering@atsu.edu|
22314149|NCT01678898|Protalix Ltd|Raul Chertkoff|+972-4-9028100|raul@protalix.com|
22314150|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it|
22314151|NCT03083093|LUMC|F.A. Klok, MD PhD|003171 526 9111|f.a.klok@LUMC.nl|
22314152|NCT02551692|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
22314153|NCT02965599|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314154|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22314155|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22314156|NCT01431105|UC San Diego|Adriana Tremoulet|858-246-0012|atremoulet@ucsd.edu|
22314157|NCT04130061|University of Utah|Vikas Sharma, MD|801-581-5311|vikas.sharma@hsc.utah.edu|
22314158|NCT03579680|University of Michigan|Ted Skolarus|Ph: (734) 845-3506|tskolarus@uchicago.edu|
22314159|NCT04267393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22314160|NCT04396847|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
22314161|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314162|NCT03469492|Yale School Of Medicine|Elizabeth Sanchez Rangel, MD|203-737-6067|elizabeth.sanchezrangel@yale.edu|
22314163|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl|
22314164|NCT02161406|University of Michigan DCC (SABER)|Dr. Cathie Spino|734-615-5469|spino@umich.edu|
22314165|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net|
22314166|NCT06178718|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
22314167|NCT00320398|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314168|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800||
22314169|NCT02179853|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
22314170|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645||
22314171|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543|stlewis@taimedbiologics.com|108
22314172|NCT03677245|University of Mississippi Medical Center|Dr. Meredith Flowers|662-386-5926|mmflowers@umc.edu|
22314173|NCT03596242|Wake Forest School of Medicine|Claudia L. Campos, MD|ccampos@wakehealth.edu|ccampos@wakehealth.edu|
22314174|NCT04912700|Beaumont Hospitals|Ahmit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
22314175|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu|
22314176|NCT02973802|Apitope International|CEO|+44(0)1291 635511|info@apitope.com|
22314177|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22314178|NCT01850823|Teva Pharmaceuticals Inc., USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22314179|NCT02601105|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
22314180|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22281889|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343||
22281890|NCT04569136|National Cheng Kung University|Dr. Kuan-Yin Lin|+886-6-2353535|10802003@gs.ncku.edu.tw|6737
22281891|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22314181|NCT04458181|University of Minnesota|Amy R. Krentzman|612-625-2312|akrentzm@umn.edu|
22281892|NCT03257202|Keck Medical Center of USC|Dr. George Hatch|323-442-5860|ghatch.md@gmail.com|
22281893|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281894|NCT03576066|Assembly Biosciences|Linda Bahr, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
22314182|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22281895|NCT00129701|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
22281896|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22281897|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov|
22314183|NCT00809341|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Lode Swinnen|410-955-8603|lswinne1@jhmi.edu|
22281898|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov|
22314184|NCT02975297|The University of Texas Health Science Center at Houston|Luba Yammine, PhD, APRN, FNP-C, Associate Professor|(713) 500-2005|Luba.Yammine@uth.tmc.edu|
22281899|NCT00635739|Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
22281900|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22314185|NCT03247738|University of Florida College of Medicine, Jacksonville|Dominick J. Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
22281901|NCT00608023|Theratechnologies|Marilyn de Chantal, Global Senior Medical Director|1 438-315-6624|Mdechantal@theratech.com|
22314186|NCT04081389|Roswell Park Comprehensive Cancer Center|Kristopher Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
22314187|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22314188|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com|
22314189|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599|Linda-Gail.Bekker@hiv-research.org.za|21
22314190|NCT04148521|Atrium Health|Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
22314191|NCT01530659|Neurotech USA, Inc.|Neurotech, Sr. Director of Clinical Operations|629-333-5804|p.davis@neurotechusa.com|
22314192|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu|
22314193|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu|
22314194|NCT03416621|Duke Cancer Institute|Dr. Kathryn I Pollak|919-681-4757|kathryn.pollak@duke.edu|
22314195|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz|
22314196|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu|
22314197|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu|
22314198|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com|
22314199|NCT04016805|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22314200|NCT04491084|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-405-8550|nitin.ohri@einsteinmed.edu|
22314201|NCT02101268|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314202|NCT00740870|Medtronic|Karla Mezera|612-306-4325|karla.p.mezera@medtronic.com|
22270939|NCT00896181|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
22270940|NCT04537910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22270941|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com|
22270942|NCT05036668|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22270943|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu|
22270944|NCT06011161|VISN 2 Center of Excellence for Suicide Prevention|Dev Crasta|585-364-8119|Dev.Crasta@va.gov|
22270945|NCT02291601|Bioscience Labs|C Beausoleil|460-782-5498|cbeausoleil@biosciencelabs.com|
22270946|NCT03724877|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270947|NCT04017832|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22270948|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com|
22270949|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694|cristiana.forni@ior.it|0039
22270950|NCT01744184|University Hospitals Dorset NHS Foundation Trust|Dr Simon McLaughlin|01202303626|Simon.McLaughlin@uhd.nhs.uk|
22270951|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22270952|NCT02841280|Indiana University|Dr. Rajiv Agarwal|3179882241|ragarwal@iu.edu|
22270953|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@health.utah.edu|1363
22270954|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22270955|NCT04654754|Rush University|Dr. Jie Li|3125634643|jie_li@rush.edu|
22270956|NCT04616573|Sight Sciences, Inc.|Kavita Dhamdhere, MD, PhD|877-266-1144|kdhamdhere@sightsciences.com|
22270957|NCT03641326|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
22270958|NCT02727777|UT MD Anderson Cancer Center|Dr. Jason R. Westin/Lymphoma/Myeloma|713-792-3750|jwestin@mdanderson.org|
22270959|NCT03003494|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22270960|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22270961|NCT01738503|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22270962|NCT05152966|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
22270963|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com|
22270964|NCT03005327|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
22270965|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22270966|NCT03518619|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|Ana_Abrantes@Brown.edu|
22270967|NCT01794793|RECORDATIGROUP|Mario Maldonado, MD / Head of Clinical Development Global Endocrinology|+41798030344|maldonado.m@recordati.com|
22270968|NCT02234596|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,|646-888-4186|janjigiy@mskcc.org|
22270969|NCT04852679|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22270970|NCT02907593|Oregon Health & Science University|Dr. Cindy McEvoy|5034945598|mcevoyc@ohsu.edu|
22270971|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com|
22270972|NCT03050541|University of Chicago|Office of Clinical Research|(773) 834-1238|tkyeo@bsd.uchicago.edu|
22270973|NCT01752634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22270974|NCT06474078|Chang Gung Memorial Hospital|Dr. Chun Bing Chen|03-3281200|chunbing.chen@gmail.com|8494
22270975|NCT00962949|Vanderbilt University Medical Center|Hossam Mustafa|615-343-6499|adcresearch@vanderbilt.edu|
22270976|NCT05409131|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22270977|NCT04644185|Sinocelltech Ltd.|Dr.|13522038372|yuanxin_chen@sinocelltech.com|
22270978|NCT05128773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22270979|NCT04250714|Boston Scientific|Nele Cielen - Clinical Trial Manager|0032470991143|nele.cielen@bsci.com|
22270980|NCT04697056|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22270981|NCT03339726|JNJWorldwide|Steven Sacavage, PharmD, Associate Director, Global Pain & Allergy Clinical Research|215 273-8568|ssacavag@its.jnj.com|8568
22270982|NCT03681990|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
22270983|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il|
22270984|NCT00546455|UCSD|MARIO CHOJKIER|858-552-8585|mchojkier@gmail.com|7283
22270985|NCT00308750|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22270986|NCT03719287|3M|Helen Han|651-737-9234|mhan3@mmm.com|
22270987|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu|
22314203|NCT02831998|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
22270988|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22270989|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org|
22270990|NCT01007136|University of Texas Southwestern|Timea Hodics, M.D.||Timea.Hodics@UTSouthwestern.edu|
22270991|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org|
22281902|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
22314204|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22314205|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22314206|NCT00839332|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314207|NCT01200485|UT MD Anderson Cancer Center|Saroj Vadhan, MD/Professor, Cytokine & Supportive Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22314208|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
22314209|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22314210|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com|
22314211|NCT04947436|University of Texas Health San Antonio|Dr. Donna Gardner|210-450-8479|dgardner62001@gmail.com|
22314212|NCT03719378|Colorado Joint Replacement|Rose Johnson, CCRP Research Lead|3032602940|roseannjohnson@centura.org|
22314213|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu|
22314214|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp|
22281903|NCT01231321|Abbott|Global Medical Services|800-633-9110||
22281904|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22314215|NCT03078751|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22281905|NCT04021524|University of Washington|Dr. Jason E. Hsu|(206) 543-3690|jehsu@uw.edu|
22281906|NCT06422364|Indiana University|Dr. Harish Rao, Assistant Professor of Clinical Pediatrics|317-948-7208|harirao@iu.edu|
22281907|NCT03713294|Mayo Clinic|Sikander Ailawadhi|904/953-6468|ailawadhi.sikander@mayo.edu|
22281908|NCT05260073|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22281909|NCT03458910|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
22281910|NCT05275010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22281911|NCT04484649|Columbia University Irving Medical Center|Samantha Garbers-Adams, PhD|212-305-0123|svg2108@cumc.columbia.edu|
22281912|NCT04478071|The University of Texas Health Science Center at Houston|Bentley J. Bobrow, MD|713-500-7863|Bentley.J.Bobrow@uth.tmc.edu|
22281913|NCT05742646|Medical University of South Carolina|Dr. Michelle Nichols|8437928515|nicholmg@musc.edu|
22281914|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu|
22281915|NCT03544476|University of Washington|Sarah Iribarren|2065435211|sjiribar@uw.edu|
22281916|NCT03275246|Zimmer Biomet|Oliver Schaetti|0041588548901|oliver.schaetti@zimmerbiomet.com|
22281917|NCT02301546|University of Utah|Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|
22281918|NCT05059301|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22281919|NCT01491789|Kennedy Krieger Institute|Dr. Alberrt Recio|443-923-9227|recio@kennedykrieger.org|
22281920|NCT04952597|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22281921|NCT02925078|University of Michigan|Clinical Research Coordinator|7347633346|aliceou@umich.edu|
22281922|NCT00323960|IRCCS Istituto Giannina Gaslini|Dr. Nicolino Ruperto|+39-010-382854|nicolaruperto@gaslini.org|
22281923|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281924|NCT02661737|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22281925|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22281926|NCT04238481|Astellas Pharma Inc|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22281927|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22281928|NCT01818739|The Ohio State University Comprehensive Cancer Center|Floor Backes, MD|614-730-6968|Floor.Backes@osumc.edu|
22281929|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
22281930|NCT03194568|Children's Hospital of Philadelphia|Dr. Patrick Cahill|2155901000|cahillp1@chop.edu|
22281931|NCT05285644|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22281932|NCT03306979|Sunnybrook Health Sciences Centre|Dr. Krista Lanctôt, Senior Scientist|416-480-6100|krista.lanctot@sunnybrook.ca|62241
22281933|NCT04114071|University of Alabama at Birmingham|Dr. Pamela G. Bowen|12059342778|pbowen@uab.edu|
22281934|NCT00569309|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|Craig.Hofmeister@osumc.edu|
22281935|NCT01301521|MOMH|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
22281936|NCT01448824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22281937|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr|
22281938|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com|
22281939|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu|
22281940|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov|
22281941|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
22281942|NCT04086693|Beaumont Health|Amit Bahl, MD|248-551-1792|Amit.Bahl@beaumont.edu|
22281943|NCT02526524|Elcelyx Therapeutics, Inc|Chief Scientific Officer|858-876-1814|info@elcelyx.com|
22281944|NCT03018418|University of Cincinnati Cancer Center|Jordan Kharofa, MD|513-584 4775|kharofjr@ucmail.uc.edu|
22281945|NCT00966849|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
22281946|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911|dhoffman@retinafoundation.org|125
22281947|NCT03764631|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281948|NCT01549886|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22281949|NCT02039219|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
22281950|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22281951|NCT03333317|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22281952|NCT02975999|LUrie Children's Hospital|Dr. Jamie Penk, co-investigator|7735773782|jpenk@luriechildrens.org|
22281953|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
22299363|NCT01944046|Duke University|Linmarie Sikich, M.D.|919-681-0026|linmarie.sikich@duke.edu|
22299364|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu|
22299365|NCT04496258|University of Denver|Kateri McRae|3038713632|Kateri.McRae@du.edu|
22299366|NCT02041429|Dana-Farber Cancer Institute|Beth Overmoyer, MD|617.632.380|Beth_Overmoyer@DFCI.HARVARD.EDU|
22299367|NCT01427712|Medical affairs|Medical affairs manager|+81-3-5656-0516|takumi.kanzo@viatris.com|
22299368|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299369|NCT03169153|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22299370|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22299371|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM|
22299372|NCT00784043|MED-EL Corporation|Jennifer Bulls|1-888-633-3524|research.us@medel.com|
22299373|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com|
22325842|NCT00863928|Virginia Mason Medical Center|Kathryn Dahl, RN|206-341-0578|kathryn.dahl@vmmc.org|
22325843|NCT03290300|Aerin Medical, Inc.|Scott Wolf, M.D.; Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
22325844|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22325845|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325846|NCT01797432|University of Minnesota|Maria Hordinsky, MD|612-625-6118|hordi001@umn.edu|
22325847|NCT02792777|Thomas Jefferson|Kristin L Rising, MD MS|215-503-5507|kristin.rising@jefferson.edu|
22325848|NCT02795156|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22325849|NCT03320512|University of North Carolina at Chapel Hill|Lisa Hightow-Weidman|919-843-0033|lisa_hightow@med.unc.edu|
22325850|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22325851|NCT03531957|Asana BioSciencxes, LLC|Pablo Jimenez|9086980782|pablo.jimenez@asanabio.com|
22325852|NCT03809546|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22325853|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
22325854|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com|
22325855|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300||
22325856|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22325857|NCT01221298|AbbVie|Global Medical Services|800-633-9110||
22325858|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22325859|NCT00399802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325860|NCT00492921|JHU SKCCC|Dr. Javier Bolanos Meade|410-614-6398|Fbolano2@jhmi.edu|
22325861|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu|
22325862|NCT04946344|Wake Forest University|Dr. Stephen Messier|336-758-3969|messier@wfu.edu|
22325863|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22325864|NCT02213757|MHRI|Dr. Richter|2028776526|Lee.Ann.Richter@medstar.net|
22325865|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325866|NCT04076072|Vanderbilt University Medical Center|Marybeth Carter|615-936-1639|Marybeth.l.carter@vumc.org|
22325867|NCT00469014|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Professor, Chair, Stem Cell Transplantation|713-792-3618|CR_Study_Registration@mdanderson.org|
22325868|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com|
22325869|NCT02722577|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China|Guodong Niu|+86(10)88398866|guodongniu@fuwai.com|
22325870|NCT03461289|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22325871|NCT03418662|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
22325872|NCT03241173|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22325873|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
22325874|NCT00515463|Amgen Inc.|Study Director|866-572-6436||
22325875|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
22325876|NCT03020524|University of Pennsylvania|Regulatory Lead|215.662.4484|psom-ind-ide@pobox.upenn.edu|
22325877|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
22325878|NCT02269319|MicuRx Pharmaceuticals Inc.|John M. Sall, Global Head of Regulatory|919-670-7803|jsall@micurx.com|
22325879|NCT02211495|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22281954|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22281955|NCT04726137|Fondazione Penta ETS|Giorgia Dalla Valle|393783022748|giorgia.dallavalle@pentafoundation.org|
22281956|NCT03883165|University of Michigan Medical School|James T Eckner, MD, MS|734-647-5568|jeckner@med.umich.edu|
22281957|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com|
22325880|NCT03478878|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
22325881|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000||
22325882|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com|
22325883|NCT01989546|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
22325884|NCT02819310|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22325885|NCT04688346|University of Washington|Dr. Travis Nelson|206-290-2899|tmnelson@uw.edu|
22325886|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu|
22325887|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325888|NCT04494633|Clinical Tools, Inc.|Mary Metcalf, PhD, MPH|(919) 960-8118|metcalf@clinicaltools.com|
22325889|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com|
22325890|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325891|NCT03074162|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325892|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22325893|NCT02778867|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
22325894|NCT02948777|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
22299374|NCT03424681|Mind Research Network|Dr. Claire Wilcox|5052725028|cwilcox@mrn.org|
22299375|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
22299376|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org|
22325895|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu|
22325896|NCT02311478|University of Utah|Dr. Dave Turok|8015818160|david.turok@hsc.utah.edu|
22325897|NCT03242928|Novartis Pharma AG|Clinical Disclosure Office|613241111|Novartis.email@Novartis.com|
22325898|NCT03276936|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22325899|NCT00943319|UChicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
22325900|NCT02043301|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325901|NCT03333057|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
22325902|NCT03703375|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22325903|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
22325904|NCT05014776|SKCCC Johns Hopkins Medical Institution|Katherine Bever, MD|443-287-0966|kbever1@jhmi.edu|
22325905|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325906|NCT00931892|Beth Israel Deaconess Medical Center|Dr. Ciaran Kelly|617-667-1272|ckelly2@bidmc.harvard.edu|
22325907|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org|
22325908|NCT02207530|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
22325909|NCT04179968|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
22325910|NCT02045277|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22325911|NCT02440178|seoul national university|Pf. Youngil Koh|82-2-2072-7217|go01@snu.ac.kr|
22325912|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
22325913|NCT03952468|VA Providence Health Care system|Dr. Jennifer Primack|(401) 273-7100|Jennifer.Primack@va.gov|16295
22325914|NCT06094296|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22325915|NCT04964063|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22325916|NCT01397071|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
22325917|NCT03350750|Johns Hopkins|Jessica Wollett|6673068141|jwollet1@jh.edu|
22325918|NCT02221739|Weill Cornell Medical College|Silvia Formenti, M.D.|646-962-4065|formenti@med.cornell.edu|
22325919|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22325920|NCT02202031|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
22325921|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22325922|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22325923|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br|
22325924|NCT04929262|Temple University|Margaret Crane|‭(215) 204-7165‬|margaret.crane@temple.edu|
22325925|NCT01387295|Herlev University Hospital|Dr Dorte Nielsen|+45 38682344|dorte.nielsen.01@regionh.dk|
22325926|NCT02836990|University at Buffalo, SUNY|Dr Linda Harris|7168594207|lmharris@buffalo.edu|
22325927|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325928|NCT05100199|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22325929|NCT01426386|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22325930|NCT03425799|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
22325931|NCT03694522|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
22325932|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22299377|NCT03791398|BrUOG|Brown University Oncology Research Group|401-863-3000|BrUOG@Brown.edu|
22281958|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org|
22299378|NCT04796831|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22314216|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG|
22314217|NCT06135675|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
22314218|NCT02515097|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
22314219|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk|
22314220|NCT03030599|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22314221|NCT01592383|University of Chicago|Hedy Kindler|7737020360|hkindler@medicine.bsd.uchicago.edu|
22314222|NCT04582864|Washington University School of Medicine|Dr. Matthew Christopher|314-273-0286|christopherm@wustl.edu|
22314223|NCT01064856|AbbVie|Global Medical Services|800-633-9110||
22314224|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22314225|NCT05329402|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
22314226|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325933|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22325934|NCT04004507|Ophthalmic Consultants Of Long Island|Dr. Marguerite McDonald|7342501718|margueritemcdmd@aol.com|
22270992|NCT01128218|SIU Medicine|Barbara Lokaitis, BA, CCRP / Senior Clinical Research Coordinator|217.545.9737|blokaitis@siumed.edu|
22270993|NCT05007041|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
22270994|NCT04495816|Icahn School of Medicine at Mount Sinai|Dr. David Lerner|212-241-9410|david.lerner2@mountsinai.org|
22270995|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
22270996|NCT03536949|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
22270997|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com|
22270998|NCT02901275|Johns Hopkins University School of Medicine|Dr. Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
22270999|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu|
22271000|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu|
22271001|NCT01258075|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22271002|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca|
22271003|NCT04360174|Ocular Therapeutix|Chief Medical Officer|7813574000|clinicalaffairs@ocutx.com|
22271004|NCT04021121|University of California, San Francisco|Dr. Felicia Chow|(628) 206-4449|felicia.chow@ucsf.edu|
22271005|NCT05805085|CooperVision Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
22271006|NCT05870956|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271007|NCT01597375|Brigham and Women's Hospital|Tanya Laidlaw|617-525-1034|tlaidlaw@bwh.harvard.edu|
22271008|NCT02375555|Dana Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
22271009|NCT02046395|Tulane University|Vechi Batuman|(504)988-5346|vbatuma@tulane.edu|
22271010|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
22271011|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu|
22271012|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu|
22271013|NCT02782065|Boston Children's Hospital|Leah Abecassis|6173552299|leah.abecassis@childrens.harvard.edu|
22271014|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu|
22271015|NCT01490073|University of Washington|Elizabeth Micks|206-616-4939|emicks@uw.edu|
22299379|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
22299380|NCT03390907|Penn State Milton S. Hershey Medical Center|Dr. John Levenick|717-531-3834|jlevenick@pennstatehealth.psu.edu|
22299381|NCT01578551|Johns Hopkins University|David Ettinger, MD|410-955-8847|ettinda@Jhmi.edu|
22299382|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu|
22299383|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov|
22299384|NCT02752048|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3294-4527|toiawase@taiho.co.jp|
22299385|NCT01092195|National Institutes of Health|Pamela Stratton MD|301-435-4068|strattop@mail.nih.gov|
22314227|NCT03735147|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22314228|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22314229|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122|ablazar@WIHRI.org|8461
22314230|NCT02868788|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22314231|NCT02799745|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22314232|NCT02917421|Weill Medical College|Dr.Silvia Formenti|212-746-3608|shc2043@med.cornell.edu|
22314233|NCT02210208|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22314234|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov|
22314235|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com|
22314236|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314237|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314238|NCT05446714|al-azhar university|dr. mohamed shendy|01223303833|Shendy_ortho@azhar.edu.eg|
22314239|NCT03024996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22314240|NCT02742532|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
22314241|NCT02418845|Lupin Pharmaceuticals Inc|Gregory Kaufman, MD|908.603.6062|gregorykaufman@lupin.com|
22314242|NCT00478647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22299386|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271016|NCT02496091|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22271017|NCT02272842|Innlandet Hospital Trust|Tor Strand|+4790971086|tors@me.com|
22271018|NCT02663102|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271019|NCT01984892|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22271020|NCT04464720|University of California San Francisco|Dr. Stephanie M Holm|415-514-0878|stephanie.holm@ucsf.edu|
22271021|NCT02156895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271022|NCT05723328|Hackensack Meridian Carrier Clinic|Zachary D. Fischer PhD, MT-BC|908-281-1324|Zachary.Fischer@hmhn.org|
22271023|NCT03476174|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
22271024|NCT04089904|University of Chicago|Theodore Karrison (Research Professor)|7737029326|tkarrison@health.bsd.uchicago.edu|
22271025|NCT04383938|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22271026|NCT03728985|W.L. Gore and Associates|Rizwan Afzal|1-623-234-5408|rafzal@wlgore.com|
22271027|NCT02000882|US Oncology Research|Taqi Mohammad|7138702175|taqi.mohammad@mckesson.com|
22271028|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22271029|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271030|NCT05897827|University of Pittsburgh|Robert W. S. Coulter|412-624-0647|robert.ws.coulter@pitt.edu|
22271031|NCT04599933|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22271032|NCT05098067|Women and Infants Hospital|Dr. Lauren Murphy|2107222589|lmmurphy@wihri.org|
22271033|NCT02872857|The University of Texas Health Science Center at Houston|HuiMahn Alex Choi, Associate Professor|713-500-5638|Huimahn.A.Choi@uth.tmc.edu|
22271034|NCT01813734|Massachusetts General Hospital|Dr. Alice Shaw|617-724-4000|ASHAW1@mgh.harvard.edu|
22271035|NCT01358578|Novartis|Study Director|862-778-8300||
22271036|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu|
22271037|NCT03605849|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22271038|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271039|NCT03870529|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
22271040|NCT04516343|Biomotum|Chief Science Officer|(800) 566-2531|zach@biomotum.com|
22271041|NCT03833804|UW School of Medicine and Public Health|Majid Afshar, MD|608-263-1792|mafshar@medicine.wisc.edu|
22271042|NCT06303167|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22271043|NCT02677896|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
22271044|NCT03902522|CytoDyn|Joseph Meidling|13609808524|jmeidling@cytodyn.com|
22271045|NCT02729038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271046|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
22271047|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu|
22271048|NCT03687372|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22271049|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com|
22271050|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22271051|NCT01482962|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22271052|NCT02407457|Endologix, Inc.|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
22271053|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411|william.yancy2@va.gov|7770
22271054|NCT02174913|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
22271055|NCT02954653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271056|NCT02160847|Georgia State University|Dr. Jenelle Shanley Chatham|404-413-1340|jshanley@gsu.edu|
22271057|NCT04329091|UNIVERSITY OF CHICAGO|Al McAuley, Clinical Research Manager|7738343274|amcauley1@bsd.uchicago.edu|
22271058|NCT04106089|Rutgers University Camden|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
22271059|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com|
22271060|NCT03787303|Aultman Hospital|Shruti Trehan MD|3303634162|trehanshruti4@gmail.com|
22271061|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu|
22271062|NCT05028413|University of Pennsylvania|Associate Professor Mucio C. Delgado, MD, MS|215-74-826|mucio.delgado@pennmedicine.upenn.edu|
22271063|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281959|NCT05526781|Eye Consultants of Atlanta|Dr Joseph Christenbury|14043512220|jchristenbury@eyeconsultants.net|
22299387|NCT04523129|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
22299388|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299389|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com|
22299390|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299391|NCT01343160|W.L. Gore & Associates|Rizwan Afzal|623-234-5408|rafzal@wlgore.com|
22299392|NCT02239510|TriHealth Hatton Research Institute|Jenni Steinbrunner|513-862-4033|jenni_steinbrunner@trihealth.com|
22299393|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22299394|NCT02707055|National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Lorenzo Leggio, M.D., PhD|+1 443 740 2801|lorenzo.leggio@nih.gov|
22281960|NCT03905265|Medicines Development for Global Health Limited|Clinical Project Manager|+61 399122400|MDGH-MOX-2001@medicinesdevelopment.com|
22299395|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com|
22299396|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov|
22325935|NCT02062151|USF Pediatrics|Laura Weathers|813/844-3046|lweathers@health.usf.edu|
22281961|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com|
22325936|NCT01905397|Duke University Medical Center|Dan Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
22281962|NCT03632993|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22281963|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22281964|NCT00632827|University of California, San Francisco|Lawrence Kaplan, MD|(415) 353-2661|LKaplan@ucsf.edu|
22281965|NCT00368836|Carolinas Medical Center|Dr. Jeffrey Kline|704-355-3181|jkline@carolinas.org|
22281966|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org|
22281967|NCT03272828|University of Washington|Dr. Mats Kronstrom|425-877-7345|mk33@uw.edu|
22325937|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088||
22325938|NCT02679066|Johns Hopkins Bayview|Erik Hasenboehler MD|4105504190|ehasenb1@jhmi.edu|
22281968|NCT02808052|Melinta Therapeutics|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
22325939|NCT04172831|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22281969|NCT03888235|University of British Columbia Department of Family Practice|Dr. Helene Bertrand|7782277776|dr.hbertrand@gmail.com|
22281970|NCT01054560|Covidien|Director of Clinical Affairs|9498373700||
22281971|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, China|Chun Wang||wangchun2@medmail.com.cn|
22325940|NCT02351037|Pharmacyclics|Priyanka Mandava, Director of Clinical Operations|408-215-3776|psingh@pcyc.com|
22281972|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908||
22281973|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov|
22281974|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org|
22325941|NCT04036136|University of North Carollina at Chapel Hill|Gabriel Dichter, PhD|919-364-4275|dichter@med.unc.edu|
22281975|NCT03703817|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325942|NCT01696877|Johns Hopkins University|Emmanuel S. Antonarakis, M.D., principal investigator|443-287-0553|eantona1@jhmi.edu|
22325943|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281976|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu|
22281977|NCT05129449|OLYMPUS EUROPA SE & CO. KG|Dr. Peter Teichmann|+49 40 23773|peter.teichmann@olympus.com|7835
22299397|NCT02280044|Johns Hopkins Bloomberg School of Public Health|David A Sack|443 287 8795|dsack1@jhu.edu|
22299398|NCT05706506|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22299399|NCT02246998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22299400|NCT03523533|University of New Mexico Health Sciences Center (HSC)|Dr. Tim Petersen|5052722610|timpetersen@salud.unm.edu|
22299401|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu|
22299402|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com|
22299403|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu|
22299404|NCT02590354|Institute of Tropical Medicine Antwerp|Dr. Eric Florence|+32 3 247 66 42|eflorence@itg.be|
22299405|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299406|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299407|NCT02203019|Texas Tech University|Dr Kenneth Nugent|18067436847|kenneth.nugent@ttuhsc.edu|
22299408|NCT02377986|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22299409|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu|
22299410|NCT03326999|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-6426|christina.jeng@mountsinai.org|
22299411|NCT04831736|NYU Langone Health|Lisa Doan, MD|212-201-1004|Lisa.Doan@nyulangone.org|
22299412|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22299413|NCT01659021|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22299414|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu|
22299415|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299416|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org|
22299417|NCT00840970|Intersect ENT|Chris Lewis, VP Clinical Affairs|423-598-6681|clewis@intersectent.com|
22299418|NCT03465540|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22299419|NCT00504829|Life Cycle Pharma|H. Eugene Griffin, MS, DVM|646-200-8505|ggr@lcpharma.com|
22299420|NCT01854827|University of Michigan|DCC PI|734-936-3585|mageej@med.umich.edu|
22299421|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu|
22299422|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22299423|NCT04000165|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Dr. Swee Lay Thein, Chief of Sickle Cell Branch|301.402.6699|sweelay.thein@nih.gov|
22299424|NCT01984398|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22325944|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com|
22314243|NCT04333147|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314244|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com|
22314245|NCT03119688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314246|NCT00630552|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22314247|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org|
22314248|NCT05006417|UW School of Medicine and Public Health|Michael Suer, MD|(608) 265-3207|suer@rehab.wisc.edu|
22314249|NCT02705625|Medivir|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
22314250|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314251|NCT04238520|The Ohio State University|Dr. Xi Chen, Associate Professor|614-2920474|chen.13047@osu.edu|
22314252|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314253|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314254|NCT01917006|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22314255|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com|
22314256|NCT02190552|Neuravi Limited|Mairsil Claffey|0035391394123|mclaffey@neuravi.com|
22314257|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|manfred.stapff@frx.com|8686
22314258|NCT02509312|Beth Israel Deaconess Medical Center|John J. Kowalczyk, MD|617-667-3112|jkowalcz@bidmc.harvard.edu|
22314259|NCT04544865|Ethicon Endo-Surgery|SENIOR DIRECTOR OF CLINICAL AFFAIRS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22314260|NCT03357471|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22314261|NCT01202409|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-745-4317|moverman@mdanderson.org|
22314262|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu|
22314263|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22314264|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com|
22314265|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu|
22314266|NCT02482935|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314267|NCT03503162|Motus GI|Director of Clinical Operations|954-541-8000|anniec@motusgi.com|
22314268|NCT02835092|Medifast|Linda Arterburn, VP Scientific & Clinical Affairs|443-379-5191|linda.arterburn@medifastinc.com|
22314269|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22314270|NCT02856490|Joylux|Colette Courtion|206.219.6444|sophia@joylux.com|
22314271|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu|
22314272|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22314273|NCT04074343|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
22314274|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org|
22314275|NCT04672798|University of Pittsburgh|Dr. Stephanie Stepp|412-715-5447|steppsd@upmc.edu|
22314276|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil|
22314277|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu|
22314278|NCT03891641|University of North Carolina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
22314279|NCT01585298|Novartis Pharmaceuticals|Study Director|862-778-8300||
22314280|NCT01670188|Mayo Clinic|Dr. Alejandro Rabinstein|507-284-4741|Rabinstein.Alejandro@mayo.edu|
22314281|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500|TWilson@ITS.JNJ.com|1834
22314282|NCT00241969|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
22314283|NCT00413634|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22314284|NCT02427958|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22314285|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu|
22314286|NCT02025985|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22314287|NCT03628456|International Biophysics Corporation|VP of Engineering and Quality|512-804-0046|quality@biophysicscorp.com|
22314288|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
22314289|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov|
22314290|NCT03175198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314291|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314292|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22314293|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22314294|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
22314295|NCT03811834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22314296|NCT00372255|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314297|NCT03790878|Duke University|Katherine (Kibby) McMahon|917-880-1551|Kibby.McMahon@duke.edu|
22314298|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281978|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181||
22314299|NCT00661466|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22314300|NCT04414397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22314301|NCT00356759|McMaster University|Dr. Sam Schulman|19055270271|schulms@mcmaster.ca|44810
22314302|NCT03640754|MenoGeniX|Debra Duke|303-995-7979|debra.duke@menogenix.com|
22314303|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22314304|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22314305|NCT04380688|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22325945|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu|
22325946|NCT03519308|Abramson Cancer Center, University of Pennsylvania|Liudmila Mazaleuskaya/Pancreas Research Program Manager|2674559141|mazali@pennmedicine.upenn.edu|
22325947|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590||
22325948|NCT00798967|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22325949|NCT01354691|Bar Ilan University|Jonathan Rabinowitz, PhD||jonathan.rabinowitz@biu.ac.il|
22325950|NCT00633139|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22325951|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr|
22325952|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com|
22325953|NCT04083222|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22325954|NCT03340805|The Children's Hospital of Philadelphia|Dr. Scott L. Weiss, study co-PI|215-590-5505|WeissS@email.chop.edu|
22325955|NCT03575468|Consumer Wellness Solutions|Dr. Katrina Vickerman|469-608-4208|katrina.vickerman@optum.com|
22325956|NCT01522651|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22325957|NCT04400318|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22325958|NCT02078713|University of California, San Francisco|Dr. Christine Dehlendorf, Principal Investigator|415-206-8712|christine.dehlendorf.@ucsf.edu|
22325959|NCT02096861|Celltrion, Inc.|BoYoung Choi / Clinical Operation Team Leader|+82-32-850-6594|BoYoung.Choi@celltrion.com|
22325960|NCT03960138|University of Missouri|Dr. Brett Froeliger|5738824785|froeligerb@health.missouri.edu|
22325961|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu|
22325962|NCT01793051|UT MD Anderson Cancer Center|Dr. Robert Orlowski, Professor, Lymphoma-Myeloma|(713) 794-3234|rorlowski@mdanderson.org|
22325963|NCT05730829|McMaster University|Dr Lisa Carlesso|2896805640|carlesl@mcmaster.ca|
22325964|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org|
22325965|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl|
22325966|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22325967|NCT02597673|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22325968|NCT03691623|Enanta Pharmaceuticals, Inc.|Guy De La Rosa, MD, Senior Medical Director, Infectious Diseases|+1 857 760 0548|gdelarosa@enanta.com|
22299425|NCT01751568|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 544-7040|mallen@fhi360.org|11246
22299426|NCT03834194|University of Virginia, School of Medicine|Dr. Rebecca Krukowski|9014482426|wae4mq@virginia.edu|
22299427|NCT02660944|Resolve Therapeutics LLC|James Posada|(208)7277010|jp@resolvebio.com|
22299428|NCT02843568|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
22299429|NCT03586999|University of Colorado|Brad Haverkos, MD|7208488698|brad.haverkos@cuanschutz.edu|
22299430|NCT04096560|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22299431|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu|
22299432|NCT03526900|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22299433|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
22299434|NCT03735420|National University of Natural Medicine|Ryan Bradley, ND, MPH|5035521862|rbradley@nunm.edu|
22299435|NCT03264989|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22299436|NCT02807597|UT Southwestern Medical Center|Dr. Samuel Achilefu|314-362-8599|Samuel.Achilefu@UTSouthwestern.edu|
22299437|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
22299438|NCT02504866|Clinical Center|Damiano, Diane|+1 301 451 7544|damianod@cc.nih.gov|
22299439|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299440|NCT01144338|Astrazaneca Inc.|Peter Ohman|1(301)398-0120|Peter.Ohman@astrazeneca.com|
22299441|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300||
22299442|NCT04796610|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
22299443|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
22299444|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22299445|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu|
22299446|NCT02059148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299447|NCT02073968|Montefiore Medical Center / Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
22299448|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org|
22299449|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu|
22299450|NCT02658851|Apyx Medical|Kari Larson|8012440058|kari.larson@apyxmedical.com|
22299451|NCT03067441|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22314306|NCT02207322|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
22325969|NCT02816710|Department of Ophthalmology, Ruijin Hospital Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.|Dr. Xi Shen|021-64370025|carl_shen2005@126.com|
22325970|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22325971|NCT02232516|Northwestern University, Feinberg School of Medicine|Dr. Jonathan Moreira|312-695-6180|jonathan.moreira@northwestern.edu|
22325972|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
22325973|NCT01258348|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22325974|NCT01084499|Asan Medical Center|Principal Investigator||mdlhs@amc.seoul.kr|
22325975|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
22325976|NCT01505491|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22325977|NCT02759146|Michigan State University|Dr. Gwen Wyatt|517-353-6672|gwyatt@msu.edu|
22325978|NCT04332640|Johnson & Johnson Surgical Vision|Head of Clinical Science|7142478200|LVarga17@ITS.JNJ.com|
22325979|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22325980|NCT02631135|UludagU|Hale Aksu Erdost,MD,spesialist|+905323615722|haleaksu78@yahoo.com|
22325981|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
22325982|NCT03649321|UT Southwestern Medical Center|Dr. Syed Kazmi|214-648-4180|syed.kazmi@utsouthwestern.edu|
22325983|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22325984|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22325985|NCT04860713|Maimonides Medical Center|Research Administration Director|718-283-6896|alikourezos@maimonidesmed.org|
22325986|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com|
22325987|NCT02786355|UBC Department of Anesthesia - BC Women's Hospital|James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
22325988|NCT02184143|Vanderbilt University Medical Center|Kristin Archer|(615) 322-2732|kristin.archer@Vanderbilt.Edu|
22325989|NCT04412954|Ohio State Univeristy|Sandy Solove|6142478366|solove.3@osu.edu|
22325990|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr|
22325991|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|
22325992|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
22325993|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800|Rollin.Gallagher@va.gov|4907
22325994|NCT00339183|Amgen Inc.|Study Director|866-572-6436||
22325995|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22325996|NCT00002663|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
22325997|NCT01351766|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
22325998|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov|
22325999|NCT00446446|Amgen Inc.|Study Director|866-572-6436||
22326000|NCT02142894|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22326001|NCT01488318|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|414-647-5554|stadtermanbm@upmc.edu|
22326002|NCT02560701|Harvard Pilgrim Health Care Institute|Dr. J. Frank Wharam|(617) 867-4948|jwharam@post.harvard.edu|
22326003|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu|
22326004|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522|dwinship@catalystpharma.com|12
22326005|NCT01564654|ConforMIS|Marc Quartulli, VP Clinical Affairs|781-345-9191|marc.quartulli@conformis.com|
22326006|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com|
22326007|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326008|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu|
22326009|NCT01927562|Fractyl|Sarah Hackett|617-596-9522|shackett@fractyl.com|
22326010|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com|
22326011|NCT02955186|Yale School of Medicine|Dana Cavallo, Project Coordinator|203-610-9788|dana.cavallo@yale.edu|
22326012|NCT02234115|Foresee Pharmaceuticals co., Ltd.|Dr. John Mao||john.mao@foreseepharma.com|
22326013|NCT01618656|Yale University School of Medicine|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@yale.edu|2594
22326014|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326015|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22326016|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22326017|NCT04770155|University of Mississippi Medical Center|Director of Clinical Trials|601-815-5000|clinicaltrials@umc.edu|
22326018|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
22326019|NCT00081289|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22326020|NCT03419533|The University of Adelaide|Prof. Helen Marshall|8161 8115|helen.marshall@adelaide.edu.au|
22326021|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
22326022|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22326023|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281979|NCT03814382|Massachusetts General Hospital|Jessica Gerber, DAc.|617-724-1992|jgerber2@mgh.harvard.edu|
22326024|NCT02508701|Purdue University|Stewart Chang Alexander|765-427-9860|alexan90@purdue.edu|
22326025|NCT03648996|University of Missouri, School of Medicine|Dr. Camila Manrique, MD|(573) 882-2554|manriquec@umsystem.edu|
22314307|NCT04831047|Bascom Palmer Eye Institute|Wendy W. Lee MD|305-243-6434|wlee@med.miami.edu|
22314308|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967||
22314309|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk|
22314310|NCT02363998|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22314311|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org|
22314312|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333|stevens@zoll.com|14400
22314313|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22314314|NCT01387815|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22314315|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22314316|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu|
22314317|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314318|NCT01685047|St Jude Medical|Karolien Timmermans|0032 497 51 39 21|ktimmermans@sjm.com|
22314319|NCT02544113|Cleveland Clinic|Dr. Bijan Eghtesad|216 444-9898|eghtesb@ccf.org|
22314320|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org|
22314321|NCT00583050|Massachusetts General Hospital|Matthew Eagleton, M. D.|617-726-8279|MEAGLETON@mgh.harvard.edu|
22314322|NCT02847637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314323|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314324|NCT03036150|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|Information.center@astrazeneca.com|
22314325|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu|
22314326|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
22314327|NCT02741713|Wake Forest Baptist Health|Dr.Jon Wells Reynolds|336-715-9695|jreynold@wakehealth.edu|
22314328|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314329|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu|
22314330|NCT04191148|Medpace|Clinical Trial Manager|513-630-0130|E.Plummer@Medpace.com|
22314331|NCT02647788|University of Pennsylvania|Dr. Benjamin Gray|215-294-9650|Benjamin.Gray@uphs.upenn.edu|
22314332|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314333|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu|
22314334|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314335|NCT03231969|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
22314336|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu|
22314337|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org|
22314338|NCT02561806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314339|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT|
22314340|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22314341|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22314342|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com|
22314343|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22314344|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22314345|NCT05324007|University of Chicago|Dr. Hyesung Grace Hwang|(773) 834-9791|hyesung@uchicago.edu|
22314346|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22314347|NCT03360110|CooperVision|Myhanh Nguyen, OD, Manager of Clinical Research|19257306716|MNguyen@coopervision.com|
22314348|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314349|NCT06080438|University of Miami|Principal investigator|305-326-6434|wlee@med.miami.edu|
22314350|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov|
22314351|NCT03589300|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
22314352|NCT02161185|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
22314353|NCT03029611|UWashington (University of Washington)|Director of Clinical Operations|206-616-2305|childj@u.washington.edu|
22314354|NCT01527500|Novartis Pharmaceuticals|Study Director|862-778-8300||
22314355|NCT02573883|Medstar Health Research Institute|Dr. Cheryl Iglesia|202-877-6526|cheryl.iglesia@medstar.net|
22314356|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu|
22314357|NCT04289714|Royal Brompton Hospital|Sukeshi Makhecha|0207-3528121|s.makhecha@rbht.nhs.uk|4375
22314358|NCT00953212|Maine Medical Center|Dr. Robert Kramer|207-662-2923|KRAMER@mmc.org|
22314359|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|genentech@druginfo.com|
22314360|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org|
22314361|NCT02341599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314362|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22314363|NCT02970305|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22314364|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu|
22314365|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu|
22314366|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org|
22314367|NCT04088500|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22314368|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com|
22299452|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22299453|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu|
22314369|NCT01078584|Abbott|Global Medical Services|800-633-9110||
22314370|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22299454|NCT02056301|Baylor College of Medicine|Chris Glover, MD, MBA|832-824-5800|cdglover@bcm.edu|
22299455|NCT03023891|Vanderbilt University Medical Center|Vivian Kawai|(615) 322-3304|vivian.k.kawai@vumc.org|
22299456|NCT02096055|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
22314371|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu|
22314372|NCT02979613|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22314373|NCT02946788|Timber Pharmaceuticals|Alan Mendelsohn, MD|12673004249|amendelsohn@timberpharma.com|
22314374|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org|
22314375|NCT05294328|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
22314376|NCT02056873|Univeristy of Florida|Dr. Michael Okun|3522945400|okun@neurology.ufl.edu|
22314377|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314378|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk|
22314379|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
22314380|NCT03991988|Emory University|Dr. Ihab Hajjar|4047121763|ihajjar@emory.edu|
22314381|NCT02276638|Nidek|Head, Regulatory Affairs|(800) 223-9044|support@nidek.com|
22314382|NCT02948569|University of Missouri|Dr. Elizabeth Parks|15738825864|parksej@missouri.edu|
22314383|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314384|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
22314385|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314386|NCT04051242|University of Pittsburgh|J. Peter Rubin, MD Principal Investigator and Endowed Chair of Plastic Surgery|412-383-8080|rubipj@UPMC.EDU|
22314387|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
22314388|NCT02262364|Zimmer Biomet|Jennifer Woodell-May, PhD||jennifer.woodell-may@zimmerbiomet.com|
22314389|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22314390|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com|
22314391|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314392|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu|
22314393|NCT03206476|Universidad de Guadalajara|Dra. Gabriela Macedo Ojeda|(+52) 3310585200|gabriela.macedo@cucs.udg.mx|33900
22314394|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314395|NCT05694533|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
22314396|NCT01085812|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22314397|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com|
22314398|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com|
22314399|NCT01874665|Ariad Pharmaceuticals|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
22314400|NCT04582669|Montefiore Medical Center|Haley Heibel, MD|(718) 920-8352|hheibel@montefiore.org|
22314401|NCT03201900|Eisai, Inc.|Inquiry Service.|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22314402|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu|
22314403|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314404|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com|
22314405|NCT02246218|Horizon Therapeutics, LLC|Colleen Canavan, Director|866-479-6742|clinicaltrials@horizonpharma.com|
22314406|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org|
22314407|NCT03700372|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|cschneider@farapulse.com|
22314408|NCT03409731|Abbott medical device|Hajime Kusano|+1 408-845-1626|hajime.kusano@abbott.com|
22314409|NCT02591862|Akari Therapeutics plc|Chief Scientific Officer|02080040261|miles.nunn@akaritx.com|
22314410|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com|
22314411|NCT04358068|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22314412|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314413|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu|
22314414|NCT00665223|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22314415|NCT00363649|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
22326026|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
22326027|NCT02101411|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22326028|NCT03894904|The University of Texas Health Science Center at Houston|Nischal K. Gautam, MD|(713) 500-6200|Nischal.K.Gautam@uth.tmc.edu|
22299457|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org|
22314416|NCT01349036|Daiichi Sankyo Inc.|Study Director|908-992-6400|CTRinfo@dsi.com|
22314417|NCT03796208|University of Kentucky|Kristin Ashford, PhD, Study MPI|859-257-9333|khashf0@uky.edu|
22314418|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
22314419|NCT05127018|Peking University School of Stomatology|Xi Gong|15201304426|gongx31480528@163.com|
22314420|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314421|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22314422|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org|
22314423|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22314424|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com|
22314425|NCT00513461|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
22314426|NCT02230306|University of Pittsburgh Cancer Institute|Melissa Burgess, MD|412-623-7277|burgessma@upmc.edu|
22314427|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM|
22314428|NCT04206384|CAO Group|VP, Quality & Regulatory|801-256-9282|info@caogroup.com|
22314429|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu|
22314430|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu|
22314431|NCT01688895|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-241-7699|hetanshi.naik@mssm.edu|
22314432|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743||
22314433|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com|
22314434|NCT00618917|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22314435|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu|
22314436|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314437|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu|
22314438|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314439|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu|
22314440|NCT04088136|Georgia Institute of Technology|Dr. Christopher Hertzog|404-894-6774|ch18@gatech.edu|
22314441|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu|
22314442|NCT04159805|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22314443|NCT02930837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314444|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22314445|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org|
22314446|NCT04236245|Venclose, Inc.|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
22314447|NCT02998918|University of South Carolina|Mark Sarzynski|8037779510|sarz@mailbox.sc.edu|
22314448|NCT01071317|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
22314449|NCT02592486|Department of Pulmonary Medicine, Kameda Medical Center|Kei Nakashima, Associate Chief|81-4-7092-2211|kei.7.nakashima@gmail.com|8614
22314450|NCT05041439|Massachusetts General Hospital|Dr. Julie H Levison|(617) 724-4698|jlevison@mgb.org|
22314451|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com|
22314452|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
22314453|NCT01101334|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22314454|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu|
22314455|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu|
22326029|NCT03415464|FACULTY OF SPORT|Vedran Hadzic|+38615207700|vedran.hadzic@fsp.uni-lj.si|728
22326030|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu|
22326031|NCT04064684|The University of Texas Health Science Center at Houston|Alvaro Jose Coronado Munoz, MD|713-500-5553|Alvaro.J.CoronadoMunoz@uth.tmc.edu|
22326032|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu|
22326033|NCT01415440|NYSPI|Jonathan Posner, MD|6467745735|jonathan.posner@nyspi.columbia.edu|
22326034|NCT03090737|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22326035|NCT02517047|Boston Children's Hospital|Dr. Wanda Phipatanakul|6173556117|wanda.phipatanakul@childrens.harvard.edu|
22326036|NCT03596177|MedImmune, LLC|Victoria Parker|+44 747 1357172|information.center@astrazeneca.com|
22326037|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22281980|NCT02901054|Washington University School of Medicine|Simon Haroutounian, PhD|3142861715|simon.haroutounian@wustl.edu|
22326038|NCT03103750|Yale School of Medicine|Marc Potenza, PhD, MD|(203) 974-7356|marc.potenza@yale.edu|
22326039|NCT01810991|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22326040|NCT03123939|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22326041|NCT03022032|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harvard.edu|
22326042|NCT06787781|university of messina|Dr Fiammetta Iannuzzo|327 628 4688|fiannuzzo@unime.it|
22326043|NCT04191967|Univerisity of North Carolina (UNC)|Dr. Chemtai Mungo, MD, MPH|(984) 974-1000|cmungo@email.unc.edu|
22326044|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463|Contact@HeidelbergEngineering.com|0
22314456|NCT02820597|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22314457|NCT04606199|University of California San Francisco|Dr. Stefanie Mayer|7345450698|Stefanie.mayer@ucsf.edu|
22314458|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
22314459|NCT05252845|Mahidol-Oxford Tropical Medicine Research Unit (MORU)|Professor Lorenz von Seidlein|+66-(0)2-3549170|Lorenz@tropmedres.ac|
22314460|NCT03468179|Vanderbilt University|Sean S. Davies|6153225049|sean.davies@vanderbilt.edu|
22314461|NCT03752242|BioMimetix|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
22314462|NCT02512861|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
22314463|NCT01774019|Boston Scientific|Andrea Burbage|15086834387|Andrea.Burbage@bsci.com|
22314464|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
22314465|NCT01983553|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
22314466|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu|
22314467|NCT05215418|Vivus LLC|Lan Nguyen|650-934-5246|clinical@vivus.com|
22314468|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu|
22314469|NCT04731142|Imperial College London|Dr Jack Halligan|+447742161980|j.halligan@imperial.ac.uk|
22314470|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123|oolonghu@gmail.com|2334
22314471|NCT02090998|Rutgers/RWJMS|william grubb md|7322357827|grubbwr@rwjms.rutgers.edu|
22314472|NCT03245619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314473|NCT02832284|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412 749 1423|grubbm@bsci.com|
22314474|NCT03470545|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22314475|NCT04752033|Mayo Clinic|Dr. Joseph Pleticha|5073588378|Pleticha.joseph@mayo.edu|
22314476|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314477|NCT02971228|Zealand Pharma A/S|Kim Mark Knudsen|+45 5060 3780|KMKnudsen@zealandpharma.com|
22314478|NCT01664923|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314479|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com|
22314480|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
22314481|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22314482|NCT00129649|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
22314483|NCT04952701|CooperVision|Jose Vega|9256402964|JVega2@coopervision.com|
22314484|NCT02547441|Clinical Development Dept.|Maruho Co., Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22314485|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu|
22314486|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314487|NCT04545476|Vanderbilt University Medical Center|Karen Arnaud|615-322-6485|karen.arnaud@vumc.org|
22314488|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314489|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at|
22314490|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com|
22314491|NCT01978236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314492|NCT04035577|Northwestern University|Dr. Emily Lattie|3125033741|emily.lattie@northwestern.edu|
22314493|NCT02906696|The University of Texas MD Anderson Cancer Center|Philip Thompson, MD/Assistant Professor|713-792-7430|PAThompson2@mdanderson.org|
22314494|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314495|NCT03367910|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
22314496|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22314497|NCT00644878|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22281981|NCT04674111|Boston Scientific Corporation|Amy Maurer, Director of Clinical Trials|800-876-9960|amy.maurer@bsci.com|
22281982|NCT00642434|University of New Mexico Health Sciences Center|Dr. Kathleen Colleran|505-272-4658|KColleran@salud.unm.edu|
22281983|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org|
22281984|NCT05145322|University of Minnesota School of Dentistry|Hooi Pin Chew|6126256975|chew0014@umn.edu|
22314498|NCT04353817|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22281985|NCT06359028|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22281986|NCT04700540|University of Minnesota|Dr. Jude Mikal|385-212-4185|jpmikal@umn.edu|
22314499|NCT00979745|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22281987|NCT05248997|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22281988|NCT03515551|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
22281989|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22281990|NCT02952313|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22314500|NCT02143063|UConn Health|Sheila Alessi, PhD|860-679-1849|salessi@uchc.edu|
22314501|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com|
22314502|NCT03245463|Hospital for Special Surgery|Dr. James Wyss|2126061731|wyssj@hss.edu|
22314503|NCT03517111|Arizona State University|Dr. Sonia Vega-López|602-496-3350|sonia.vega.lopez@asu.edu|
22314504|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22314505|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
22314506|NCT03188536|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22281991|NCT02063867|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
22326045|NCT05141435|Children's Hospital of Chongqing Medical University|Prof. Shi Yuan|+86 15084335697|shiyuan@hospital.cqmu.edu.cn|
22281992|NCT00920387|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
22281993|NCT04470908|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22326046|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu|
22281994|NCT02835313|University of Delaware|Dr. Darcy Reisman, PT, PhD, FAPTA|302-831-0508|dreisman@udel.edu|
22281995|NCT02470585|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22326047|NCT03059810|Johnson & Johnson Vision|Thomas Karkkainen- SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
22326048|NCT03509207|Medical University of Graz|Prof. Edgar Petru|0043 31638581082|edgar.petru@medunigraz.at|
22281996|NCT03028415|Ferring Pharmaceuticals|Global Clinical Compliance|-+1 833-548-1402|DK0-Disclosure@ferring.com|
22281997|NCT03829969|Shanghai Junshi Bioscience Co., Ltd.|Huimei Xie|86-021-50796193|huimei_xie@junshipharma.com|
22281998|NCT05005013|NYU Langone Health|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
22281999|NCT04818216|University of Texas Health San Antonio|Dr. Subrata Debnath, Assistant Professor|210-450-8333|nath@uthscsa.edu|
22282000|NCT04283994|University of Washington|Dr. Erin Kross|206-744-4649|ekross@uw.edu|
22282001|NCT03315793|Shionogi|Shionogi Clinical Trial Administrator|+81-6-6209-7885|shionogiclinicaltrials-admin@shionogi.co.jp|
22282002|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no|
22282003|NCT01461928|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22282004|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
22282005|NCT03086707|Philip Morris Products S.A.|Julia Hoeng, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
22282006|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
22282007|NCT02704702|Celerion|Dr.Laura Sterling|1-402-476-2811|laura.sterling@celerion.com|
22282008|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155||
22282009|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22282010|NCT04085458|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22282011|NCT02447250|OHSU|Cindy McEvoy, MD|5034940223|mcevoyc@ohsu.edu|
22282012|NCT01921218|Emory University|Idelberto R. Badell, MD|404-712-6562|ibadell@emory.edu|
22282013|NCT03389555|Beth Israel Deaconness Medical Center Emergency Department|Michae Donnino|(617) 754-2882|mdonnino@bidmc.harvard.edu|
22282014|NCT01885208|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22282015|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us|
22282016|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282017|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22282018|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965|nisasan@yahoo.com|9
22282019|NCT00960011|The University of Hong Kong|Dr. Joe Fan King Man|852-22553111|drfanj@gmail.com|
22282020|NCT02130687|Yale University|Nancy J. Brown, M.D.|16153644022|nancy.j.brown@yale.edu|
22282021|NCT04417218|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
22326049|NCT02125331|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
22282022|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300||
22282023|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22282024|NCT02449889|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22282025|NCT00758264|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282026|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za|
22282027|NCT02899650|University of Texas at Austin|Koichiro Hayashi|512-471-8594|k-hayashi@kokugakuin.ac.jp|
22282028|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322|philipj@mcmaster.ca|40654
22282029|NCT02163967|Weill Cornell Medical College|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
22282030|NCT03176472|Regenacy Pharmaceuticals Inc.|Dr. David Michelson, CMO|2676639826|dmichelson@regenacy.com|
22282031|NCT01846663|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22282032|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22282033|NCT03570918|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@Macrogenics.com|
22299458|NCT03299192|Kaiser Permanente|Rene Hawkes, Project Manager|206-287-2073|rene.j.hawkes@kp.org|
22282034|NCT04392141|Kermanshah University of Medical Sciences|Prof. Ali Mostafaie|+989188302044|amostafaie@kums.ac.ir|
22282035|NCT04295681|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22299459|NCT03291613|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22299460|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu|
22299461|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org|
22299462|NCT03779841|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22299463|NCT02788175|NIAID|Dr. Michael C. Sneller|301-496-0491|MSNELLER@niaid.nih.gov|
22299464|NCT03117387|LUMC|Maarten Honing|+31715264038|g.h.m.honing@lumc.nl|
22299465|NCT01203189|Saint Louis Univ Hospital|Aibing Mary Guo, M.D., Assistant Professor|3142563430|aguo@slu.edu|
22299466|NCT05349617|Bavarian Nordic A/S|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
22299467|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov|
22299468|NCT03082963|University of Miami|Dr Jeffrey Goldberger|305-243-4356|j-goldberger@miami.edu|
22299469|NCT04401579|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22299470|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299471|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22299472|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359||
22299473|NCT01230593|Icahn School of Medicine at Mount Sinai|Albert Wu MD PhD|2125184524|albert.wu@mssm.edu|
22299474|NCT01075321|Mayo Clinic|Craig B. Reeder MD|480.301.8000|Reeder.Craig@mayo.edu|
22299475|NCT02646423|University of California, San Francisco|Miriam Kupperman, PhD, MPH|415-502-4089|miriam.kupperman@ucsf.edu|
22314507|NCT00859976|Zimmer Biomet|Clinical Project Lead||Maggie.Shen@zimmerbiomet.com|
22314508|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300||
22314509|NCT03352882|University of Pennsylvania|Kimberly A. Forde, MD, PhD - Principal Investigator|(215) 349-8222|kforde@pennmedicine.upenn.edu|
22314510|NCT02864342|AstraZeneca|Medical Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22314511|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22282036|NCT02357472|Ji Ai Genetics & IVF Institute|Dr.Jing Fu|86-021-63459977|fujing_givf@163.com|
22282037|NCT05623475|College of Nursing, Taipei Medical University, Taiwan|Kee-Hsin Chen, R.N., Ph.D.|+886-2-27361661|keehsin@tmu.edu.tw|3613
22314512|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282038|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com|
22282039|NCT02210689|Teva Pharmaceuticals USA. Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22314513|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22314514|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300||
22314515|NCT02344173|Abbott|Principal Clinical Research Scientist|6517564067|eric.grovender@abbott.com|
22314516|NCT02383407|George Washington University|Dr. Mohamad Koubeissi|202-741-2533|mkoubeissi@mfa.gwu.edu|
22314517|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu|
22314518|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822|aoza@sjm.com|3648
22314519|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22314520|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr|
22282040|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org|
22314521|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca|
22314522|NCT01560585|University Hospitals Cleveland Medical Center - Cleveland, OH|Alan J Lerner,MD|1 216 464 6449|alan.lerner@uhhospitals.org|
22314523|NCT03028012|University of Utah Physical Medicine and Rehabilitation Orthopedics|Dr. Daniel Cushman|8015852373|heidi.hansen@hsc.utah.edu|
22314524|NCT02624375|University of Washington|Dr. Christine Johnston, Associate Professor|206 520 4340|cjohnsto@uw.edu|
22314525|NCT00770588|AstraZeneca|Gerard Lynch|52564555|aztrial_results_posting@astrazeneca.com|86 21
22314526|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu|
22314527|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22314528|NCT03458728|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
22314529|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu|
22314530|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com|
22314531|NCT05145439|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
22314532|NCT01114139|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22314533|NCT01951378|Seton Family of Hospital|Director Pediatric Fellowship|512-324-9999|a.a@abc.com|
22314534|NCT03376555|Penn State University|Professor Lacy Alexander|8148671781|lma191@psu.edu|
22314535|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314536|NCT03568812|Tropical and Infectious Disease Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Indonesia|Dr dr. Erni Juwita Nelwan, Ph.D, Sp.PD-KPTI|+62811961229|ejnelwan@yahoo.com|
22314537|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
22314538|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu|
22314539|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22282041|NCT01923363|Loma Linda University Medical Center|Dr. Steven Forland|909-558-4000|sforland@llu.edu|43980
22282042|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22282043|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22282044|NCT02928029|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22299476|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22314540|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu|
22314541|NCT03974100|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22314542|NCT03318783|Oregon Health and Science University|Ross Martini|4013386803|martinir@ohsu.edu|
22314543|NCT03856047|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22314544|NCT03398421|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314545|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu|
22314546|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22314547|NCT00338949|UCSD/VA San Diego|Jonathan Meyer MD|8589640777|jmmeyer@ucsd.edu|
22314548|NCT03579433|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22314549|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22314550|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
22314551|NCT02271230|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|ldjousse@rics.bwh.harvard.edu|
22314552|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22314553|NCT02719743|GlaxoSmithKline|GSK Response Center|866-435-7343|ct427449@gsk.com|
22314554|NCT01930214|Cardiovascular Systems Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
22314555|NCT02601209|Memorial Sloan-Kettering Cancer Center|William D. Tap, MD|646-888-4156|tapw@mskcc.org|
22282045|NCT02959827|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22282046|NCT05427539|Johnson & Johnson Vision Care, Inc. (JJVC)|Ben Straker|1-800-843-2020|bstraker@its.jnj.com|
22282047|NCT03718884|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22282048|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org|
22282049|NCT02708849|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
22282050|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr|
22282051|NCT00404755|New York State Psychiatric Institute|Jonathan W. Stewart, M.D.|646-774-8000|jws6@columbia.edu|
22282052|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528||
22282053|NCT04376684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282054|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com|
22282055|NCT04084366|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
22282056|NCT02713997|University of Minnesota|Melena Bellin|612-625-4686|bell0130@umn.edu|
22282057|NCT05487040|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282058|NCT02602275|Biologische Heilmittel Heel GmbH|Head of Clinical Research|+49 7221 501|info@heel.com|0
22282059|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr|
22282060|NCT02241733|Edward Hines Jr., VA Hospital|Eileen Collins RN, PhD, Research Nurse Scientist|312-413-5621|ecollins@uic.edu|
22282061|NCT03269968|MedStar Health Reseach Institute|Rachael Overcash|202-877-6093|rachael.overcash@medstar.net|
22282062|NCT04570605|University of Utah School of Medicine|Glen Lau, MD|801-213-2700|Glen.Lau@hsc.utah.edu|
22282063|NCT01866111|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
22282064|NCT05549232|Hemanext Inc.|Sr. Director, Clinical Affairs|781-301-7474|jill.bagdasarian@hemanext.com|
22282065|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com|
22282066|NCT01974206|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22282067|NCT04113018|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22282068|NCT03802630|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22282069|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22282070|NCT06099223|Hartford Hospital|Aseel Walker|860-972-1778|aseel.walker@hhchealth.org|
22282071|NCT00583752|University of Iowa, Holden Comprehensive Cancer Center|David Lubaroff, MD|3193561527|david-lubaroff@uiowa.edu|
22282072|NCT00526656|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Jorge Garcia, MD|216-444-7774|garciaj4@ccf.org|
22282073|NCT04091581|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22282074|NCT01795495|Nationwide Children's Hospital|David Martin, MD|6147224200|David.Martin@nationwidechildrens.org|
22282075|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22282076|NCT03345160|Johns Hopkins School of Medicine|Dr. Robert Wood|410-919-7617|RWood@JHMI.edu|
22282077|NCT03711929|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22282078|NCT00309140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282079|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
22282080|NCT02456636|University of Kansas Medical Center|Christie Befort, PhD|913 588-3338|cbefort@kumc.edu|
22282081|NCT02913430|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
22282082|NCT05312632|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-10-7409-5623|s-kwon@eisaikorea.com|
22282083|NCT02379221|Travis AFB OMFS Clinic|Dr. Jason May|707-423-7085|jason.may.11@us.af.mil|
22282084|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282085|NCT01792817|electroCore, LLC|Clinical Affairs|+1 973-355-6683|clinical@electrocorellc.com|
22282086|NCT03812185|Henry Ford Health System|Yoshihisa Morita|3059784358|moritayoshihisa2016@gmail.com|
22282087|NCT01591837|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22282088|NCT03130439|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22282089|NCT02731820|Istituto Ortopedico Rizzoli|Director of Clinical Trials|+39 051.6366392|ctc@ior.it|
22282090|NCT04838054|Stony Brook University|Srinivas Rao Myneni Venkatasatya, DDS, PhD|631-632-8739|srinivas.MyneniVenkatasatya@stonybrookmedicine.edu|
22282091|NCT02743949|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22282092|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU|
22282093|NCT01345513|Ontario Institute for Cancer Research|Janet E. Dancey|1-613-533-6430|janet.dancey@oicr.on.ca|
22282094|NCT02613117|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22282095|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314556|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
22314557|NCT02024750|University of Wisconsin School of Medicine and Public Health|Elizabeth Cox|608-263-9104|ecox@wisc.edu|
22282096|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282097|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
22314558|NCT02261285|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
22314559|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
22282098|NCT01220973|Rutgers Cancer Institute of New Jersey|Susan Goodin PharmD, FCCP, BCOP|732-235-6783|goodin@cinj.rutgers.edu|
22282099|NCT00006046|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22282100|NCT00596154|Memorial Sloan Kettering Cancer Center|Dr. Christian Grommes, MD|212-610-0344|grommesc@mskcc.org|
22282101|NCT03691844|Amzell B.V.|Clinical Trial Manager|+41614864000|amzell-disclosure@amzell.com|
22282102|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
22282103|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com|
22282104|NCT03582553|Pennington Biomedical Research Center|Dr. Candida Rebello|225-763-3159|Candida.Rebello@pbrc.edu|
22282105|NCT02970006|The Ohio State University- Neurological Institute|Vibhor Krishna, MD|6142939274|Vibhor.Krishna@osumc.edu|
22282106|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22282107|NCT02493257|The University of Texas Health Science Center at Houston|Dr. Amber U. Luong, Associate Professor and Director of Research|(713) 500-5410|Amber.U.Luong@uth.tmc.edu|
22282108|NCT05593913|Acer Medical Inc.|Regulator Manager|886-2-26960366|AcerMedicalofficial@gmail.com|
22282109|NCT01453205|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
22282110|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
22282111|NCT04934800|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
22282112|NCT05596734|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
22282113|NCT02187887|RAND|Eric Pedersen|3103930411|ericp@rand.org|6078
22282114|NCT02333396|ChildrensMemorialH|Karen Rychlik, MS|(773) 755-6310|krychlik@luriechildrens.org|
22282115|NCT05413512|Baylor University|Debroah Holland|(254) 710-1438|Deborah_L_Holland@baylor.edu|
22282116|NCT02059499|AMC Statistical Center|Dr Himanshu Joshi, MBBS, MPH, PhD (Assistant Professor)|212-259-9635|himanshu.joshi@mountsinai.org|
22282117|NCT04210245|NGM Biopharmaceuticals|VP, Clinical Operations|(650) 243-5555|ngm282@ngmbio.com|
22282118|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22282119|NCT03645941|Mayo Clinic|Christi A. Patten, MD|507-266-2554|patten.Christi@mayo.edu|
22282120|NCT03989349|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22282121|NCT02684058|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22282122|NCT01802580|Wake Forest University Health Sciences|Dr. Steve Feldman, Professor of Dermatology, Public Health Scienes, and Pathology|336-716-7740|sfeldman@wakehealth.edu|
22282123|NCT03255967|NYU Langone Health|Abraham Brody|2129927341|Abraham.Brody@nyulangone.org|
22282124|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22282125|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu|
22282126|NCT02620878|Università di Padova-Italy|Dr. Daniela Bruttomesso|00390498212183|daniela.bruttomesso@unipd.it|
22282127|NCT03172884|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22282128|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22282129|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22282130|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22282131|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com|
22282132|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk|
22282133|NCT02147197|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22282134|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22282135|NCT01700959|St. Jude Children's Research Hospital|Tara M. Brinkman, PhD|(901) 595-5683|tara.brinkman@stjude.org|
22282136|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com|
22282137|NCT02438384|Department of Emergency Medicine, UNC School of Medicine|Tim Platts-Mills, MD|559-240-6073|tim_platts-mills@med.unc.edu|
22282138|NCT02650128|Shockwave Medical, Inc.|Beaux Alexander, Vice President Clinical Affairs|510-279-4262|balexander@shockwavemedical.com|145
22282139|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282140|NCT05599451|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
22282141|NCT02723006|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22282142|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov|
22282143|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com|
22282144|NCT03116828|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22282145|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org|
22282146|NCT05243745|HALEON|Haleon Response Center|+441932 95 95 00|ww.clinical-trial-register@haleon.com|
22282147|NCT02998203|Cyprus University of Technology|Dr. Konstantinos C. Makris|00357-25-002398|konstantinos.makris@cut.ac.cy|
22282148|NCT05160168|Theseus Pharmaceuticals (a subsidiary of Concentra Biosciences)|Stew Kroll|(650) 576-9679|skroll@concentrabiosciences.com|
22282149|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu|
22282150|NCT04187144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282151|NCT03842969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22314560|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu|
22314561|NCT03181282|Washington University in St. Louis|Ryan Duncan|314-273-1052|duncanr@wustl.edu|
22282152|NCT01044745|University of Nebraska Medical Center|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
22314562|NCT04525456|NUS|Study administrator|+65 6601 7766|lsixtc@nus.edu.sg|
22314563|NCT02484547|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22282153|NCT02890303|Mynosys Cellular Devices, Inc.|Daniel Marinsik|(510) 857-6296|dmarinsik@mynosys.com|
22282154|NCT04388319|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
22282155|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314564|NCT03765164|QURE Healthcare|Director of Clinical Trials|415-321-3388|qureadmin@qurehealthcare.com|
22282156|NCT01962987|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22314565|NCT01813305|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
22282157|NCT02264665|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282158|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
22282159|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110||
22314566|NCT03448536|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22282160|NCT00470093|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Carol Ann Huff|410-955-8842|huffca@jhmi.edu|
22282161|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343||
22282162|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com|
22314567|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22282163|NCT03392883|Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College|Lisa A. Marsch, PhD|603-646-7092|Lisa.a.marsch@dartmouth.edu|
22282164|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282165|NCT02688088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22282166|NCT01247363|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282167|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620|info@valneva.com|0
22282168|NCT04022226|The University of New Mexico|Dr. Jeremy Miller|5052724490|jermiller@salud.unm.edu|
22314568|NCT03120949|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
22282169|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22282170|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com|
22282171|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
22282172|NCT02241655|Washington University|Dr. Michael Avidan, MBBCh|314-332-7265|avidanm@wustl.edu|
22282173|NCT03305419|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282174|NCT03709277|Vanderbilt University Medical Center|Amanda Kibbons|615-875-4745|amanda.m.kibbons@vumc.org|
22282175|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22282176|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
22282177|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22282178|NCT03655301|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22282179|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org|
22282180|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22282181|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282182|NCT02488135|University of Alberta|Scott Murray|587-891-6240|sipmurray@gmail.com|
22282183|NCT02248649|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22282184|NCT05470842|UNiversity of East Anglia|Dr Katharina Mattishent|01603286286|k.mattishent@uea.ac.uk|
22282185|NCT04621240|Center for BrainHealth at the University of Texas at Dallas|Erin Venza|972-883-3208|erin.venza@utdallas.edu|
22282186|NCT00780143|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22282187|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu|
22282188|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000|shari.g.benoit@medtronic.com|9749
22282189|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca|
22282190|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22282191|NCT03319953|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22299477|NCT04564833|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
22299478|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22299479|NCT03489304|Perelman School of Medicine|Dr. Matthew Kayser|215 898 8298|kayser@pennmedicine.upenn.edu|
22299480|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22299481|NCT02624804|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22299482|NCT01148810|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22299483|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
22299484|NCT02165722|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
22299485|NCT05423509|University of New Mexico Health System|Selina Silva, MD|505-272-4107|ssilva@salud.unm.edu|
22314569|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22282192|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000|shane.chanpimol@va.gov|55854
22314570|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu|
22314571|NCT05400226|Vergent Bio|Maggie Neptune|+1-510-410-9124|mneptune@vergentbio.com|
22282193|NCT00845039|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314572|NCT03015181|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22282194|NCT04027049|Johns Hopkins University|Department of Neurology|410-955-2228|ezink1@jhmi.edu|
22282195|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com|
22282196|NCT03895632|Medical Physics & Clinical Engineering, Royal Liverpool Hospital|Dr. Tristan Payne|0151 7064225|tristan.payne@nhs.net|
22314573|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282197|NCT04545047|VA Cooperative Studies Program|Project Manager|2062774780|Sarah.Keithly@va.gov|
22282198|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com|
22282199|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu|
22282200|NCT00871923|UT MD Anderson Cancer Center|James Welsh,MD- Associate Professor, Radiation Oncology Department|(713) 563-2447|jwelsh@mdanderson.org|
22282201|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282202|NCT03020017|Northwestern University|Priya Kumthekar|312 908 5073|p-kumthekar@northwestern.edu|
22282203|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com|
22282204|NCT03571672|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
22282205|NCT04258995|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282206|NCT04580277|Cedars Sinai Inflammatory Bowel Disease Center|Dr. Gil Y. Melmed|310-423-4100|gil.melmed@cshs.org|
22282207|NCT03285958|University of Michigan|Dr. Mary Janevic|734 647 3194|mjanevic@umich.edu|
22282208|NCT04385238|Harvard T.H. Chan School of Public Health|Sonia Hernandez-Diaz|6174323942|shernan@hsph.harvard.edu|
22282209|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314574|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282210|NCT01967823|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
22282211|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22282212|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22282213|NCT04225676|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22282214|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl|
22282215|NCT05289271|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282216|NCT02019108|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
22282217|NCT03440723|Elm Tree Medical Inc.|CEO|2158050862|evamartin@elmtreemedical.com|
22282218|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org|
22314575|NCT03822377|Cardiology Clinic, Sassari University Hospital, Sassari, Italy|Prof. Guido Parodi|0039|parodiguido@gmail.com|792830626
22314576|NCT03927742|University of Minnesota|Rachel Vogel|612-624-6928|isak0023@umn.edu|
22314577|NCT02356484|Lausanne University Hospital|Pr. Nicolas Demartines|0041213142424|demartines@chuv.ch|
22314578|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314579|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu|
22314580|NCT01817712|VA Cooperative Studies Program|Tassos C. Kyriakides, Ph.D, Biostatistician|203-932-5711|tassos.kyriakides@va.gov|3771
22314581|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
22314582|NCT01251887|NIAAA/NIA|Ramsden, Christopher|+1 410 558 8369|ramsdence@mail.nih.gov|
22314583|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu|
22314584|NCT00316589|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22314585|NCT03594045|Massachusetts General Hospital|Dr. Rachel Rosovsky|617-724-4000|RPROSOVSKY@mgh.harvard.edu|
22314586|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590||
22314587|NCT02617667|Novaliq GmbH|Dr Sonja Krösser, VP Preclinical and Clinical Development|+49 6221 50259-0||
22314588|NCT03777553|Durham Veterans Affairs Medical Center|Elizabeth Van Voorhees|919-886-5542|elizabeth.vanvoorhees@va.gov|
22314589|NCT01554371|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
22314590|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22314591|NCT02811302|Medtronic - MITG, RGI|Melanie Crystal, Sr. Clinical Program Manager|720-435-5737|melanie.crystal@medtronic.com|
22314592|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314593|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314594|NCT02154347|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22314595|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612|alejandraleial@gmail.com|4612
22314596|NCT02473913|University of Chicago|Stephanie Valle|773-834-3778|svalle@yoda.bsd.uchicago.edu|
22314597|NCT04013932|University of North Carolina at Chapel Hill|Joy Noel Baumgartner|919.923.8534|joy.baumgartner@unc.edu|
22314598|NCT05399082|Mayo Clinic|Ryan M. Kern, M.D.|507-266-3958|Kern.Ryan@mayo.edu|
22314599|NCT00960505|University of Illinois Chicago|Krista Varady, PhD, Associate Professor|3129967897|varady@uic.edu|
22282219|NCT00484393|Fraser Health|Brandi Newby|604-585-5666|brandi.newby@fraserhealth.ca|774374
22282220|NCT02642393|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
22282221|NCT01846195|Zynex Monitoring Solutions|Donald Gregg|1-800-495-6670|dgregg@zynex.com|
22282222|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282223|NCT04924530|University of Bath|Professor Javier Gonzalez|01225 38|j.t.gonzalez@bath.ac.uk|5518
22282224|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu|
22314600|NCT02250183|Allegheny Health Network-West Penn Hospital Burn Center|Ariel M. Aballay, MD|412-578-1836|Ariel.Aballay@AHN.org|
22282225|NCT00396006|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22282226|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22282227|NCT02851797|Italfarmaco SpA|Dr Paolo Bettica, MD and PhD|+3902 66041503|p.bettica@italfarmacogroup.com|
22282228|NCT03077438|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22282229|NCT00832598|Memorial Sloan Kettering Cancer Center|Dr. Ronald Blasburg, MD|646-888-2211|blasberr@mskcc.org|
22282230|NCT03466099|KalVista Pharmaceuticals|Director Clinical|857-999-0075|clinicalinfo@kalvista.com|
22282231|NCT03622112|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
22282232|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282233|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl|
22282234|NCT03826173|Brown University School of Public Health|David M Williams|4018636248|david_m_williams@brown.edu|
22282235|NCT02075047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314601|NCT03282799|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
22282236|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314602|NCT01879085|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR, Clinical Trials Administrator|412-647-5554|stadtermanbm@upmc.edu|
22282237|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012||
22282238|NCT03552536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282239|NCT03639623|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22282240|NCT04154605|Stryker|Robyn Schacherer, Manager Clinical Affairs|763-463-7054|robyn.schacherer@stryker.com|
22314603|NCT03749616|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22282241|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22282242|NCT02231892|National Institute on Drug Abuse|Dr. Elliott Stein|443-740-2650|estein@mail.nih.gov|
22282243|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
22282244|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu|
22314604|NCT03302559|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22314605|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu|
22326050|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr|
22326051|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22326052|NCT01532700|University Health Network|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
22326053|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326054|NCT04465370|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
22326055|NCT00751101|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
22326056|NCT02535949|Washington University School of Medicine|Dr. Philip Spinella|314-286-0858|pspinella@wustl.edu|
22326057|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com|
22326058|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22326059|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110||
22282245|NCT03119181|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
22282246|NCT03539211|ChristianaCare|Brian Catania|302-838-4700|bcatania@christianacare.org|
22282247|NCT01534260|IndianaU|Dr. Hamid Sayar|(317) 948-7576|ssayar@iu.edu|
22314606|NCT03390933|MetroHealth System|Dr. Ashwini Sehgal|216-778-8484|axs81@case.edu|
22314607|NCT03371706|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
22314608|NCT02080403|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
22314609|NCT01999972|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314610|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22314611|NCT04260464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314612|NCT01004029|Covis Pharma|Clinical Trial Interest|1-877-374-4177|CTInterest@covispharma.com|
22314613|NCT02826798|VBI|Bebi Yassin-Rajkumar|613-749-4200|byassin-rajkumar@vbivaccines.com|151
22314614|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com|
22314615|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com|
22314616|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22314617|NCT03440047|Mayo Clinic|Dr. Nayantara Coelho-Prabhu|(507)284-2407|CoelhoPrabhu.Nayantara@mayo.edu|
22314618|NCT01722045|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator||clinicaltrials@regeneron.com|
22314619|NCT03379545|NYU Langone Health|Joseph Zuckerman, MD|212-598-6674|Joseph.Zuckerman@nyulangone.org|
22314620|NCT03898700|Thomas Jefferson University|Dr. MJ Mulcahey|215-503-2888|maryjane.mulcahey@jefferson.edu|
22282248|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org|
22314621|NCT01788475|Lahey Medical Center|Christine Gould PAC, MS|9785384412|christine.gould@lahey.org|
22314622|NCT00701909|University of California, San Francisco|Dr. Kathleen Puntillo, RN, PhD|415 819 2655|kathleen.puntillo@ucsf.edu|
22314623|NCT01789840|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
22314624|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314625|NCT03006185|Bispebjerg Hospital|Emily Wenande|+4540505590|emilycathrinew@hotmail.com|
22282249|NCT03858335|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
22299486|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22314626|NCT03984513|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
22314627|NCT04843579|Weill Cornell Medicine|Multiple Myeloma Program Manager|646-962-9376|hyk4001@med.cornell.edu|
22314628|NCT04009629|University of Kansas Medical Center|Dr. Eric Vidoni|913-588-0555|kuamp@kumc.edu|
22314629|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com|
22314630|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net|
22314631|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
22314632|NCT02022111|Emory University|Mohammed Kumail Ali, MD|404-727-9776|mkali@emory.edu|
22314633|NCT04398368|Mayo Clinic|Stephen A. Boorjian, M.D.|507 422-5516|Boorjian.Stephen@mayo.edu|
22299487|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22299488|NCT06390098|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
22299489|NCT02509624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22299490|NCT02348216|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22299491|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
22299492|NCT04450823|Global Surgery Amsterdam|Dr Matthijs Botman|0031648073683|matthijsbotman@gmail.com|
22299493|NCT01202773|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299494|NCT03058679|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|lewisjd@pennmedicine.upenn.edu|
22299495|NCT01098006|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299496|NCT04137380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22299497|NCT02334800|Pfizer Inc.|Pfizer ClinicalTrail.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299498|NCT02127164|University of Arizona|Andrew Tang, MD|520-626-5056|traumaresearch@arizona.edu|
22299499|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22299500|NCT02265705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22299501|NCT02703844|University of Kent|David Wilkinson|+44 (0)1227 824772|d.t.wilkinson@kent.ac.uk|
22299502|NCT04030416|seca gmbh & co. kg|Kristin Klückmann|+49(40)200000|kristin.klueckmann@seca.com|232
22299503|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
22299504|NCT02828111|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|clinical@pellepharm.com|
22299505|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22299506|NCT03660683|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|301-461-6676|ssen1@email.gwu.edu|
22299507|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22299508|NCT01753193|MedImmune, LLC|Raj Tummala|+1 301-398-0548|information.center@astrazeneca.com|
22299509|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22299510|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299511|NCT02682264|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22299512|NCT01131312|National Cancer Institute|Dr. Mark Schiffman|240-276-7259|schiffmm@nih.gov|
22299513|NCT02347761|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22299514|NCT01255358|EryDel spa|Clinical Study Coordinator|+39 02 36504470|guenter.janhofer@erydel.com|
22299515|NCT03370887|AstraZeneca|Global Clinical LEad|1-877-240-9479|information.center@astrazeneca.com|
22299516|NCT04079933|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22299517|NCT03207750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22299518|NCT02493361|University of California, San Francisco|Dr. Katy Tsai|(415) 402-5483|katy.tsai@ucsf.edu|
22299519|NCT02785406|The University of Texas Health Science Center at Houston|Scott Lane|713-486-2535|Scott.D.Lane@uth.tmc.edu|
22299520|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org|
22299521|NCT02937545|Duke University School of Medicine|Susanne B Haga|919-684-0325|susanne.haga@duke.edu|
22299522|NCT02626715|UPMC Children's Hospital of Pittsburgh|Dr. Randy Windreich|412-692-5055|randy.windreich@chp.edu|
22299523|NCT02504294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
22299524|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
22299525|NCT02252211|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22299526|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu|
22299527|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu|
22299528|NCT02255175|UNC School of Medicine|Crystal Edler Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
22299529|NCT05799495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22299530|NCT03373591|Montefiore Medical Center|Diego Camacho, MD|718-920-4800|dicamach@montefiore.org|
22299531|NCT03694548|Emory University|Dr. Nitya Bakshi|404-727-3149|nitya.bakshi@emory.edu|
22299532|NCT04177108|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22282250|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22282251|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22282252|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22314634|NCT03602586|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22314635|NCT01479270|MetroHealth Medical Center|Robert Pollard|216-778-4444|rpollard@metrohealth.org|
22314636|NCT01755546|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
22314637|NCT04702893|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314638|NCT03294941|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
22314639|NCT04629443|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22314640|NCT03954223|Children's Hospital Los Angeles|Alaina Vidmar, MD|323-361-3385|avidmar@chla.usc.edu|
22314641|NCT04067843|University Hospital Zurich|Dr. Yvonne Achermann|+41442553402|yvonne.achermann@usz.ch|
22314642|NCT01172639|University Hospitals Leuven|Prof. Dr. Patrick Verschueren|+32 16 34 25 41|patrick.verschueren@uzleuven.be|
22314643|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314644|NCT02172950|CSL Behring|Clinical Trial Disclosure Manager|use email contact|clinicaltrials@cslbehring.com|
22314645|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com|
22314646|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au|
22314647|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com|
22314648|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu|
22314649|NCT00913068|Capital District Health Authority|Dr. Ricardo A. Rendon|9024736604|rrendon@dal.ca|
22314650|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000||
22314651|NCT04269434|Instituut van Tropische Geneeskunde Antwerpen|Dr. Chris Kenyon|+3232470786|ckenyon@itg.be|
22314652|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314653|NCT01196819|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
22314654|NCT03854019|The University of Texas Health Science Center at Houston|Erin Furr Stimming, MD|713-500-7033|Erin.E.Furr@uth.tmc.edu|
22314655|NCT02586415|Stanford University/School of Medicine|Dr. Gregory Albers|650-723-4448|albers@stanford.edu|
22314656|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au|
22314657|NCT02023905|University of California, San Francisco|Dr. Jennifer Clarke, MD MPH|(415) 353-2167|Jennifer.Clarke@ucsf.edu|
22314658|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
22314659|NCT01209286|Amgen Inc.|Study Director|866-572-6436||
22314660|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu|
22314661|NCT03029819|Georgia State University School of Public Health|Claire Spears|4044139335|cspears@gsu.edu|
22314662|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org|
22314663|NCT03605368|Children's Hospital of Philadelphia|Julia Parish-Morris|267-426-7540|parishmorrisj@chop.edu|
22314664|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
22314665|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org|
22314666|NCT02881047|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|leahyd@uphs.upenn.edu|
22314667|NCT02736955|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22314668|NCT05288504|Avalo Therapeutics, Inc.|Garry Neil, MD|610.254.4201|gneil@avalotx.com|
22314669|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314670|NCT02920021|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22314671|NCT05250960|TriHealth|Rachel Baker|513-569-6191|Rachel_Baker2@trihealth.com|
22314672|NCT00514813|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22314673|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org|
22314674|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com|
22314675|NCT00731588|University of Iowa|John A. Widness, M.D.|319-356-8102|john-widness@uiowa.edu|
22314676|NCT02263040|Mount Sinai Hospital, Toronto|Dr. Allison McGeer|416-586-3118|allison.mcgeer@sinaihealthsystem.ca|
22314677|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
22314678|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org|
22314679|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
22314680|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22314681|NCT00891046|Novartis Pharmaceuticals|Study Director|862--778--8300||
22314682|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org|
22314683|NCT02106195|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
22314684|NCT04984239|University of Pittsburgh|William Evans|412-383-6943|will.evans@pitt.edu|
22282253|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org|
22314685|NCT02034019|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
22314686|NCT02438371|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
22314687|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org|
22314688|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com|
22314689|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org|
22314690|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk|
22314691|NCT01379703|Abbott|Global Medical Services|1-800-633-9110||
22314692|NCT03481556|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22314693|NCT03463577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314694|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
22314695|NCT01101997|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22314696|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314697|NCT01777490|HSR&D/COIN, Durham VAHCS|Courtney Van Houtven|(919)286-6936|Courtney.VanHoutven@va.gov|
22314698|NCT01772563|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314699|NCT02767609|Loma Linda University medical Center|Brenda Bartnik Olson|909-558-4000|bbartnik@llu.edu|85216
22282254|NCT00503581|NRG Oncology|Linda Gedeon for James Kauderer|716-845-1169|linda.gedeon@roswellpark.org|
22282255|NCT02780856|Calcivis Ltd|Director of Clinical Research|+ 44 131 658 5152|mwillins@calcivis.com|
22282256|NCT03354546|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22314700|NCT03045809|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
22314701|NCT00255944|University of Colorado|Dr. Sheana Bull|3037241238|sheana.bull@ucdenver.edu|303
22314702|NCT03671239|University of Pennsylvania|Jose A. Bauermeister, PhD|215-898-9993|bjose@nursing.upenn.edu|
22282257|NCT05747209|Allegheny General Hospital|Colin Champ, MD|412-734-7605|colin.champ@ahn.org|
22314703|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314704|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931|kulzer@diabetes-zentrum.de|594151
22314705|NCT02980705|Sun Pharma Advanced Research Company Limited|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
22314706|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22314707|NCT00263575|Strakan Pharmaceuticals Ltd|Fiona Miller|01896 66868|fiona.miller@prostrakan.com|
22314708|NCT03121612|Arnolda Consulting|Dr Gaston Arnolda|+61 2 8068 4963|gaston.arnolda@gmail.com|
22314709|NCT05674292|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|501
22314710|NCT01841112|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314711|NCT03467698|UT Dallas|UT Dallas IRB DIrector|972-883-4506|amanda.boone@utdallas.edu|
22314712|NCT02669615|Medical College of Wisconsin|Parameswaran Hari|4148054600|phari@mcw.edu|
22282258|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com|
22314713|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314714|NCT01209598|Memorial Sloan Kettering Cancer Center|Mark Dickson, MD|646-888-4164|dicksonm@mskcc.org|
22314715|NCT01438840|Eisai Call Center|Eisai Inc.|888-422-4743||
22314716|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com|
22314717|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org|
22314718|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org|
22282259|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org|
22282260|NCT04003207|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
22282261|NCT02802241|BIDMC|Judy Nee|6176672193|jnee@bidmc.harvard.edu|
22282262|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22282263|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282264|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com|
22314719|NCT02604342|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22282265|NCT01739933|Vanderbilt University Medical Center|Dr. Pratik Pandharipande, Vice Chair Faculty Affairs, PI|6153436268|pratik.pandharipande@vumc.org|
22282266|NCT03356977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282267|NCT01728077|Cares|UCB|+1844599||2273
22282268|NCT01366612|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22282269|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22282270|NCT03224507|University of Alabama at Birmingham|Luciano J Costa- Principal Investigator|2059349695|ljcosta@uabmc.edu|
22282271|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22282272|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu|
22282273|NCT03010137|UC Davis Medical Center|Dr. Yunfeng Xue|408-603-0507|yunxue@ucdavis.edu|
22282274|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22282275|NCT01706497|University Hospitals Leuven (UZ Leuven) and KU Leuven|Prof Dr Geert Meyfroidt, Associate Professor|0032 16 344021|geert.meyfroidt@uzleuven.be|
22282276|NCT00322023|Nathan Kline Institute|Dr. Daniel Javitt|845-398-6534|javitt@nki.rfmh.org|
22282277|NCT03327220|Pacira CryoTech, Inc.|Kent Jones/ Sr. Director, Quality and Medical Affairs|510-933-1513|kent.jones@pacira.com|
22314720|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314721|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu|
22299533|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org|
22299534|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614|terapong_tantawichien@hotmail.com|125
22299535|NCT04737538|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22299536|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
22299537|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it|
22299538|NCT04122443|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22299539|NCT05204134|Tandem Diabetes Care|Supervisor Clinical Operations|+18778016901|clinicalaffairs@tandemdiabetes.com|
22314722|NCT04688086|NIRAMAI Health Analytix Private Limited|Dr Sathiakar Collison|+919810823838|sathiakar.collison@niramai.com|
22299540|NCT02584309|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
22299541|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22299542|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299543|NCT03861000|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
22299544|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il|
22299545|NCT02199691|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext 1#|Contact-US@sanofi.com|
22299546|NCT03154710|Weprom|Dr Katell LE DU|241682940|k.ledu@cjb72.org|0033
22299547|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu|
22314723|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22314724|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi|
22314725|NCT03614676|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314726|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu|
22314727|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22314728|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com|
22314729|NCT05155566|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314730|NCT04523207|Janssen Research & Development, LLC|Group Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22314731|NCT03113383|Vanderbilt University Medical Center|Thomas C Naslund, MD|5-322-2343|thomas.naslund@vumc.org|
22314732|NCT04469465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22271064|NCT03141983|University of Pennsylvania|Natalie Kuzla|2672524208|nkuzla@pennmedicine.upenn.edu|
22299548|NCT01736566|Brigham and Women's Hospital|Carrie Blout, Genetic Counselor Project Manager|617-264-5837|carrie.blout@gmail.com|
22299549|NCT01489579|Kaiser Permanente|Alicia Cymbala|303-972-5384|Alicia.A.Cymbala@kp.org|
22299550|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22299551|NCT04827576|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22299552|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com|
22299553|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299554|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu|
22299555|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
22299556|NCT01438411|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
22299557|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22299558|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com|
22299559|NCT01615731|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22314733|NCT02641587|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
22314734|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu|
22314735|NCT01150045|Alliance for Clinical Trials in Oncology|Jeffrey A. Meyerhardt, MD, MPH|617-632-6855|jmeyerhardt@partners.org|
22314736|NCT03194867|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22314737|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22314738|NCT03831854|Cleveland Clinic|Dr Kamal Maheshwari|216-318-7235|maheshk@ccf.org|
22314739|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22314740|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu|
22314741|NCT03520075|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
22314742|NCT01439854|University of Texas Health San Antonio|Muhammad Abdul-Ghani|210-557-1157|abdulghani@uthscsa.edu|
22314743|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu|
22314744|NCT03305809|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314745|NCT05146206|Community and Patient Preference Research (CaPPRe)|Dr Lili Toh|+61 452551409|lili.toh@cappre.com.au|
22314746|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu|
22314747|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999|xiaoyuyangfudan@gmail.com|7693
22314748|NCT01852032|UC Davis|John Brock Staff Research Associate|916-734-3101|jmbrock@ucdavis.edu|
22314749|NCT02536742|International Breast Cancer Study Group|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
22314750|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu|
22314751|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com|
22299560|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22314752|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch|
22314753|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu|
22314754|NCT01547117|Vanderbilt University Medical Center|Alfredo Gamboa, MD|6158751003|alfredo.gamboa@vumc.org|
22299561|NCT00566228|Mayo Clinic|Luis F. Porrata, M.D.|507/284-2511|Porrata.Luis@mayo.edu|
22314755|NCT01844726|Northwestern University|Dr. James Reilly|312-503-4809|james.reilly@northwestern.edu|
22314756|NCT02229578|University of Florida|Brenda Fahy, MD|859-402-4360|bfahy@anest.ufl.edu|
22314757|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
22314758|NCT01496365|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22299562|NCT02740127|UT MD Anderson Cancer Center|Bobby Bellard, Assistant Professor, Anesthesiology & PeriOper Med|(713) 794-1461|bbellard@mdanderson.org|
22299563|NCT03320070|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medInfo@mnk.com|
22299564|NCT03586648|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22314759|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299565|NCT02041195|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22299566|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com|
22299567|NCT02367911|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
22299568|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299569|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300||
22299570|NCT02492100|Massachusetts General Hospital|Areej El-Jawahri|248-763-3912|ael-jawahri@partners.org|
22299571|NCT03832010|Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
22299572|NCT04969783|Masonic Cancer Center|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
22299573|NCT02489500|Boston Medical Center|Vaishali Sanchorawala, MD|6176388261|sfenness@bu.edu|
22299574|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299575|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Esen Akpek, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu|
22299576|NCT00512135|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22299577|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu|
22299578|NCT03422250|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Michela Pievani|+39 030 35011|mpievani@fatebenefratelli.eu|
22299579|NCT03812146|VA Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|Kyle.Possemato@va.gov|53551
22299580|NCT00377819|Amgen Inc.|Study Director|866-572-6436||
22299581|NCT02416791|Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil|Professor Adriana Bastos Conforto|+55 11 2661-7955|adriana.conforto@hc.fm.usp.br|
22299582|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299583|NCT03388619|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22299584|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22299585|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com|
22299586|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
22299587|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com|
22299588|NCT00760929|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
22299589|NCT02880852|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22299590|NCT01614210|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
22299591|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu|
22299592|NCT03535649|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22299593|NCT00317239|Luitpold Pharmaceuticals, Inc.|Mark Falone|610-650-4200|mfalone@luitpold.com|
22299594|NCT04408469|Yale University School of Public Health|Dr. Danielle Chiaramonte|646-429-9407|danielle.chiaramonte@yale.edu|
22299595|NCT04321460|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22299596|NCT04495712|VA Portland Health Care System|Merritt Raitt MD|503-220-8262|merritt.raitt@va.gov|57571
22299597|NCT03669081|University of Utah|Eryberto Martinez|801-581-2563|eddie.martinez@utah.edu|
22299598|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623||
22299599|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu|
22299600|NCT02546544|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
22299601|NCT02223390|Duke University (Currently at Columbia University)|Kathleen Sikkema, PhD|212-305-8236|ks3364@cumc.columbia.edu|
22299602|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU|
22299603|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org|
22299604|NCT01197950|Universty of Skovde|Professor Lena Mårtensson|+46500448000|lena.martensson@his.se|
22299605|NCT02553330|Incyte Organization|Study Director|855-463-3463|medinfo@incyte.com|
22299606|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu|
22314760|NCT01660256|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22314761|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
22314762|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314763|NCT04883060|University of Iowa|Matthew Howard III|(319) 356-8468|matthew-howard@uiowa.edu|
22299607|NCT02511431|NIDDK|Christopher Koh, MD|301-443-9402|christopher.koh@nih.gov|
22299608|NCT05053087|Mayo Clinic|Benjamin K. Wilke, M.D.|904-953-2405|Wilke.Benjamin@mayo.edu|
22299609|NCT04171700|University of Pennsylvania|Kim Reiss Binder|1 215 360 0735|Kim.ReissBinder@uphs.upenn.edu|
22326060|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu|
22326061|NCT02680847|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282278|NCT03920293|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22282279|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu|
22282280|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
22282281|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
22282282|NCT01952444|Elusys Therapeutics Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22282283|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282284|NCT03555981|London School of Hygiene & Tropical Medicine|Dr Helen Brotherton|07481474150|helen.brotherton@lshtm.ac.uk|
22282285|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
22282286|NCT00688324|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@som.umaryland.edu|
22282287|NCT01972308|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
22282288|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com|
22282289|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu|
22282290|NCT01562314|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22282291|NCT01180036|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
22282292|NCT04243577|Purdue University|Georgia Malandraki|7654960206|malandraki@purdue.edu|
22282293|NCT00813865|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
22282294|NCT02512874|Mayo Clinic|Dr. Cassie C. Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
22299610|NCT01452269|University of Rochester|Dr. Steven Barnett||steven_barnett@urmc.rochester.edu|
22299611|NCT02585895|Amgen Inc.|Study Director|866-572-6436||
22282295|NCT01190475|Mereo BioPharma|Jacqueline Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
22282296|NCT02330653|Boston Children's Hospital|Dr. Stacy A. Kahn|617-355-6058|stacy.kahn@childrens.harvard.edu|
22299612|NCT01243333|Huntsman Cancer Institute Research Compliance Officer|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
22299613|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu|
22299614|NCT03108924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299615|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22299616|NCT02100072|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22299617|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu|
22299618|NCT02641080|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
22299619|NCT06281548|University of North Carolina-Chapel Hill|Adams Sibley|423-227-9198|asibley@live.unc.edu|
22299620|NCT03835533|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22299621|NCT03115424|Mayo Clinic|Adrian Vella, M.D.|507-266-1387|vella.adrian@mayo.edu|
22299622|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com|
22299623|NCT05003791|University of Illinois Chicago|Dr. Madison Goodyke|6166446417|mbuurs2@uic.edu|
22299624|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299625|NCT04292301|SpinTech MRI|Rana El Hachem|2487126789|rana@spintechmri.com|
22299626|NCT03285477|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22299627|NCT01343706|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299628|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299629|NCT03283670|Washington University|Ben Palanca, MD PhD|314 273-9076|palancab@wustl.edu|
22299630|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com|
22299631|NCT01307501|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
22299632|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22299633|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov|
22299634|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22299635|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299636|NCT03564496|NYU Langone|Matthew Lustberg|929 455 5090|matthew.lustberg@nyulangone.org|
22299637|NCT00428610|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299638|NCT00791765|Amgen Inc.|Study Director|866-572-6436||
22299639|NCT04295564|OHSU|Dr. Cindy McEvoy|503-494-0223|mcevoyc@ohsu.edu|
22299640|NCT04537923|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22299641|NCT01261611|Ipsen Innovation|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22299642|NCT02527798|Duke University|Leigh Gosnell|919-668-1280|leigh.gosnell@duke.edu|
22299643|NCT04690855|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22299644|NCT03859323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22299645|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org|
22299646|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca|
22326062|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
22326063|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu|
22326064|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326065|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu|
22326066|NCT01319760|Columbia Presbytarian Hospital, NY|Dr. Ajay Kirtane|212-305-7060|akirtane@columbia.edu|
22326067|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com|
22326068|NCT01952015|Novartis Pharmaceuticals|Study Director|862-778-8300||
22326069|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org|
22326070|NCT02167204|University of Washington|Hannah Linden|206-606-2053|hmlinden@uw.edu|
22326071|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22326072|NCT01863563|Children's Hospital of the Kings Daughters|Craig Derkay, MD|757.668. 9327|Craig.Derkay@chkd.org|
22326073|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22326074|NCT02749370|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22326075|NCT00279500|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director, Clinical and Scientific Research|8188335089|jdorn@secondsight.com|
22326076|NCT03242759|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326077|NCT02186795|MUSC|Sylvia Wilson, MD|843-732-2322|wilsosh@musc.edu|
22326078|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
22326079|NCT03117049|Ono Pharmaceutical Co. Ltd|Medical Information Center|---|clinical_trial@ono.co.jp|
22326080|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us|
22326081|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com|
22326082|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov|
22326083|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22326084|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org|
22326085|NCT03028025|VALBHS|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|
22326086|NCT02644525|Laboratory of Parasitic Diseases, NIAID/NIH|Elise O'Connell, MD, Principal Investigator|301-661-0172|oconnellem@mail.nih.gov|
22326087|NCT02986958|Johns Hopkins Bloomberg School of Public Health|Research Program Manager|410-614-7910|dechava1@jhu.edu|
22326088|NCT02399475|University of Pennsylvania|Dr. Anne Cappola|2155375359|acappola@pennmedicine.upenn.edu|
22326089|NCT02260193|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
22326090|NCT01963117|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
22326091|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
22326092|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu|
22326093|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326094|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300||
22326095|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu|
22326096|NCT02518620|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
22326097|NCT03677089|Massachusetts General Hospital - Clinical Coordinating Center|Dr. Karen Kuhlthau|617-724-2842|KKUHLTHAU@PARTNERS.ORG|
22326098|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org|
22326099|NCT03844633|Ohio State University|Maria Gallo|6146882145|gallo.86@osu.edu|
22326100|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch|
22326101|NCT02588248|UHClevelandMC|L-Menthol Injection as a Novel Technique during Colonoscopy: The MINT-C study|216-844-1000|Richard.wong@UHhospitals.org|6172
22299647|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu|
22299648|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu|
22299649|NCT01808690|University of Colorado Denver/Children's Hospital Colorado|Dr. Kristen J Nadeau|720-777-2855|Kristen.Nadeau@childrenscolorado.org|
22299650|NCT03811912|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22299651|NCT02891187|UNewMexico|Dr. Jennifer Thompson|16366790301|jthompson626@gmail.com|
22299652|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590||
22299653|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590||
22299654|NCT04396834|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
22299655|NCT01787617|Pennington Biomedical Research Center|Dr. Robert Newton|225-763-3034|Robert.Newton@pbrc.edu|
22299656|NCT01024569|University of Illinois at Chicago|Judith A Cook|312-355-3921|jcook@uic.edu|
22299657|NCT02053350|UVirginia|Dr. Cirle Warren|(434) 924-5242|CA6T@hscmail.mcc.virginia.edu|
22299658|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299659|NCT03009045|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Loren G. Miller|310-222-5623|lgmiller@ucla.edu|
22299660|NCT01585103|Mayo Clinic|Dr. Jeffrey Alexander|507-284-1825|Alexander.Jeffrey14@mayo.edu|
22299661|NCT03521635|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299662|NCT01349569|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
22299663|NCT03581305|NIH/CC|Dima Hammoud, Senior investigator|3014023041|hammoudd@cc.nih.gov|
22299664|NCT02244944|University of Kentucky|Gregory Graf|8592574749|Gregory.Graf@uky.edu|
22314764|NCT04184349|The University of Texas Health Science Center at Houston|Olga Pewelek, MD|713-500-6227|Olga.I.Lyuksyutova@uth.tmc.edu|
22314765|NCT03603639|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22314766|NCT02440334|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. John Eisenbrey|(215) 503-5188|john.eisenbrey@jefferson.edu|
22282297|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22314767|NCT04585737|Orlando Immunology Center|Wendy Wert, Clinical Research manager|4076473960|wwert@oicorlando.com|
22314768|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu|
22314769|NCT02165397|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
22314770|NCT04205955|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066677685|karnold@fredhutch.org|
22314771|NCT03898960|CERENOVUS|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22314772|NCT02988349|Sichuan University|Dr. Xin Xu|86-28-85503494|xin.xu@scu.edu.cn|
22314773|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu|
22314774|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu|
22314775|NCT02725008|New York Presbyterian - Brooklyn Methodist Hospital|Christopher P Kelly|718.780.5040|chk9064@nyp.org|
22314776|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314777|NCT03783546|Dana-Farber Cancer Institute|Weidong Lu, MB, MPh, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
22314778|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22314779|NCT04562896|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22314780|NCT06124131|Tulane University|Laura Perry|504-988-8906|lperry5@tulane.edu|
22314781|NCT03797989|University of Oxford|Dr. Angela Minassian|07973684040|angela.minassian@bioch.ox.ac.uk|
22314782|NCT01664897|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD./Professor|713-794-5783|jcortes@mdanderson.org|
22314783|NCT04522778|UPMC|Ryan St. Pierre-Hetz|3154369898|stpierrehetzre@upmc.edu|
22314784|NCT04052997|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22314785|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743||
22314786|NCT04594733|MUSC|Research Coordinator|843-792-1869|nitchie@musc.edu|
22314787|NCT02657954|VA San Diego Healthcare System|Dr Elizabeth Twamley|858-642-3848|elizabeth.twamley@va.gov|
22314788|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu|
22314789|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22314790|NCT00361842|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22314791|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22314792|NCT03512288|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314793|NCT00097669|VITATOPS|Clinical Trial Coordinator|+61892247004|julia.o'dea@health.wa.gov.au|
22314794|NCT00934700|Imperial College London|Research Integrity Officer|+44 020 7594 1872|jrco@imperial.ac.uk|
22314795|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300||
22314796|NCT03821064|Medical University of South Carolina|Evan Graboyes (PI)|843-792-0719|graboyes@musc.edu|
22314797|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040||2917
22314798|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu|
22314799|NCT02364609|UC Davis Comprehensive Cancer Center|Leslie Garcia, Data Research Supervisor|916-734-0156|lesgarcia@ucdavis.edu|
22314800|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com|
22314801|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de|
22314802|NCT00942188|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314803|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22314804|NCT04811339|University of Cincinnati|Dr. Bruce Yacyshyn|513-633-8715|yacyshbr@ucmail.uc.edu|
22314805|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222|susan.kahn@mcgill.ca|7587
22314806|NCT04944784|Cytokinetics|Cytokinetics MD|6506242929|medicalaffairs@cytokinetics.com|
22314807|NCT03900715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22314808|NCT04510948|Department of Medicine, Yale School of Medicine|Mary Tinetti, MD|203-688-5238|MARY.TINETTI@yale.edu|
22314809|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211|acantehr@gmail.com|3533
22314810|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585|rrhenry@outlook.com|3648
22314811|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com|
22314812|NCT00760513|University Hospital Southampton|Professor CD Byrne|02381205006|c.d.byrne@soton.ac.uk|
22314813|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu|
22314814|NCT02808975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22314815|NCT03752177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314816|NCT04367480|University of Rochester NCORP Research Base|Jennifer Gewandter, PhD|585-275-2141|Jennifer_Gewandter@urmc.rochester.edu|
22314817|NCT03382561|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22314818|NCT01131104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289140|NCT03306173|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|540 526 2106|rflemos@vtc.vt.edu|
22314819|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net|
22314820|NCT02370251|University of Oklahoma|Kimberly Ernst, MD|405-271-5215|kimberly-ernst@ouhsc.edu|42039
22299665|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org|
22299666|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu|
22299667|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22299668|NCT01928719|Penn State College of Medicine|Nicolle Krebs|717-531-5673|nkrebs@pennstatehealth.psu.edu|
22271065|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com|
22271066|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271067|NCT04416737|Stanford University|Dr. Rayhan Lal|650-725-2908|inforay@stanford.edu|
22299669|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271068|NCT03332628|University of Iowa|Nicole Brogden, Associate Professor|(319) 335-8752|nicole-brogden@uiowa.ed|
22271069|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
22271070|NCT02938949|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
22299670|NCT03725982|Institute of Occupational and Social Medicine and Health Services Research|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
22271071|NCT02543892|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22299671|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299672|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100,|elizabeth.asztalos@sunnybrook.ca|87791
22314821|NCT05499130|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22271072|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271073|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com|
22314822|NCT03427060|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
22314823|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu|
22314824|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314825|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
22314826|NCT02330562|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22314827|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
22314828|NCT01657799|AbbVie|Global Medical Services|800-633-9110||
22314829|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22314830|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org|
22314831|NCT04599855|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22314832|NCT01624298|Johns Hopkins University|Stephanie Skavenski|+260966674841|sskavenski@yahoo.com|
22314833|NCT01588366|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314834|NCT04962698|Georgia Institute of Technology|Prof. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
22314835|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
22314836|NCT03634306|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|David.Levine@Mercy.net|
22314837|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
22314838|NCT04915131|Bloom Technologies NV|Managing Director|+14156038067|julien@bloomlife.com|
22314839|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
22314840|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
22314841|NCT03414047|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314842|NCT04068051|Axsome Therapeutics, Inc.|Caroline Streicher, Vice President, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22314843|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu|
22314844|NCT03124550|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
22314845|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu|
22314846|NCT01747837|Icahn School of Medicine at Mount Sinai|Sam Commack|212-824-8931|sam.cammack@mountsinai.org|
22314847|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22314848|NCT00690378|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22314849|NCT00014222|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
22314850|NCT02019641|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@mail.nih.gov|
22314851|NCT01246050|VA Medical Center Nashville|Henry Ooi|615-8736373|henry.ooi@va.gov|
22314852|NCT03990298|Hospital of the University of Pennsylvania, Dept of Otorhinolaryngology, Head & Neck Surgery|Erica Thaler, MD|215-662-4533|erica.thaler@pennmedicine.upenn.edu|
22314853|NCT03269695|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314854|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu|
22314855|NCT05043883|CathVision|Mads Matthiesen|+4531470730|mem@cathvision.com|
22314856|NCT03849768|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
22314857|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com|
22314858|NCT02447718|IWK Health Centre|Dr. Karina Top|902-470-6343|karina.top@dal.ca|
22314859|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil|
22326102|NCT03403491|patientMpower Ltd|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
22271074|NCT04027075|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
22314860|NCT01818427|University of Pittsburgh|Dr. Jason Sperry|412 6922850|sperryjl@upmc.edu|
22314861|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22271075|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299673|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com|
22271076|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu|
22271077|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de|
22299674|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com|
22271078|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22271079|NCT05020366|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
22299675|NCT04121962|Johns Hopkins Bloomberg School of Public Health|Dr. Karin Tobin|4105025368|ktobin2@jhu.edu|
22299676|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu|
22314862|NCT00468130|Rutgers University|Sherie Novotny, MD|7322354119|novotnsl@ubhc.rutgers.edu|
22314863|NCT03713320|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
22314864|NCT02725528|McMaster University|Dr. Achilles Thoma|905-523-0019|athoma@mcmaster.ca|
22314865|NCT02706847|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22314866|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22314867|NCT03432390|Anesthesiology Unit, Teaching Hospital of the Federal University of Pernambuco, Recife, Pernambuco, Brazil|Dr. Jayme Marques dos Santos Neto|5581996212977|jaymemed@yahoo.com.br|
22314868|NCT05702541|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22314869|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac|
22314870|NCT03850275|Clarkson University|Ali Boolani|3152681663|aboolani@clarkson.edu|
22314871|NCT03772613|Mayo Clinic|Dr. Shahyar M. Gharacholou|904-956-8400|Gharacholou.Shahyar@mayo.edu|
22314872|NCT03536702|MS Hershey Medical Center|Monika Joshi, MD, MRCP|717-531-8678|muj14@psu.edu|
22314873|NCT01185171|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
22314874|NCT03559829|Associate Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
22314875|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br|
22314876|NCT03506347|Mayo Clinic|Dr. Mark Spangehl|480-342-2948|Spangehl.Mark@mayo.edu|
22314877|NCT05275023|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22314878|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu|
22314879|NCT03110692|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
22314880|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314881|NCT03325608|NYU Langone Health|Joshua Chodosh, MD, MSHS, FACP|212-263-6768|Joshua.Chodosh@nyumc.org|
22314882|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu|
22314883|NCT01266018|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22314884|NCT03167151|Oxford University Hospitals NHS Foundation Trust|Dr Andrew S Protheroe|01865 253275|andrew.protheroe@oncology.ox.ac.uk|
22314885|NCT01458522|Duke University|Aatif M. Husain, M.D.|919-668-8700|aatif.husain@duke.edu|
22314886|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314887|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu|
22314888|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22271080|NCT04150705|Washington University School of Medicine|Tyler Fraum, M.D.|314-362-2928|tylerjfraum@wustl.edu|
22271081|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22299677|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net|
22299678|NCT02019719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271082|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil|
22271083|NCT02751879|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271084|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu|
22271085|NCT04065451|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
22271086|NCT03045276|Children's Hospital of Philadelphia|Dr. Sandra Amaral|2678443097|amarals@chop.edu|
22314889|NCT02122172|University of Chicago|Dr. Peter O'Donnell|(773) 702-7564|podonnel@bsd.uchicago.edu|
22299679|NCT04535037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314890|NCT03062449|Dartmouth Health|Aleksandra C. Stark|(603) 650-5104|Aleksandra.C.Stark@hitchcock.org|
22314891|NCT03765398|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
22299680|NCT02031276|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
22314892|NCT04120376|Children's Hospital of Philadelphia|Dr. Cynthia Mollen|2153701217|mollenc@chop.edu|
22314893|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22314894|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22314895|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22314896|NCT00543062|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22314897|NCT02431052|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22314898|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org|
22314899|NCT04014790|REGiMMUNE|Chief Executive Officer|+81-80-7022-7536|kenzo@regimmune.com|
22314900|NCT03546816|Menlo Therapeutics Inc.|Iain Stuart, PhD|1- 800-775-7936|Iain.Stuart@foamix.com|
22314901|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu|
22314902|NCT02270671|University College Dublin|Dr Amanda Fitzgerald|+35317168541|amanda.fitzgerald@ucd.ie|
22314903|NCT03598699|AxeroVision, Inc.|Dr. Achim Krauss|+1 (484) 238-6255|achim.h.krauss@gmail.com|
22314904|NCT03927690|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22314905|NCT04026399|Medical University of South Carolina|Na Jin Seo|8437920084|seon@musc.edu|
22314906|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org|
22314907|NCT03248141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314908|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22314909|NCT04182113|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
22314910|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22314911|NCT03539068|Department of Veterans Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
22314912|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314913|NCT04294667|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22314914|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
22314915|NCT00727415|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22314916|NCT03634839|Yale University|Dr. Suchitra Krishnan-Sarin|(203)974-7595|suchitra.krishnan-sarin@yale.edu|
22314917|NCT04198948|University of Sarajevo|Associate Professor Tanja Dujic, PhD|+38733586194|tanja.dujic@ffsa.unsa.ba|
22314918|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov|
22314919|NCT01809899|Georgetown University Medical Center|Mary Ann Dutton|2026871997|mad27@georgetown.edu|
22314920|NCT02208037|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22314921|NCT02312206|Prothena Biosciences|Wendy Curlin|(650) 837-8550|clinicaltrials@prothena.com|
22314922|NCT03082612|Emory University|Dr. Jill Hamilton|404-727-8749|jill.b.hamilton@emory.edu|
22314923|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314924|NCT03672175|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22314925|NCT04626271|Healthy.io|Dr. Danielle Jeddah (Director of Clinical Development) OR Jennifer Kachel Acobas (Director of RA)|0543111050, 0528345562|danielle.jeddah@healthy.io, jennifer.acobas@healthy.io|
22314926|NCT03410108|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22314927|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22314928|NCT03599622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22314929|NCT02654132|Bristol Myers-Squibb|Bristol Myers-Squibb Study Director|Please email|Clinical.Trials@bms.com|
22314930|NCT02485899|BioMarin Pharmaceutical, Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
22314931|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu|
22314932|NCT00623363|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22314933|NCT04706793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282298|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org|
22282299|NCT02563860|Montefiore MC|Aleksandra Djukic|7189204378|adjukic@montefiore.org|
22282300|NCT03777709|Mayo Clinic|Dr. LaPrincess Brewer|5072661376|brewer.laprincess@mayo.edu|
22282301|NCT04154345|University of Antwerp|Prof. Filip Struyf|32652783|filip.struyf@uantwerpen.be|0032
22282302|NCT03505788|Ziekenhuis Oost-Limburg|Prof. dr. Wilfried Mullens|+32(0)89327140|wilfried.mullens@zol.be|
22282303|NCT03368053|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
22282304|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22282305|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com|
22282306|NCT03848208|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22282307|NCT01558362|University of Ottawa Heart Institute|Dr. Terrence Ruddy, Principal Investigator|613-696-7267|truddy@ottawaheart.ca|
22282308|NCT00590824|University of Madison Carbone Cancer Center|Paul Sondel, MD, PhD|(608) 263-9069|pmsondel@humonc.wisc.edu|
22282309|NCT00932438|University of Louisville|Robert Martin, Md, PhD|602-629-3355|robert.martin@louisville.edu|
22282310|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282311|NCT03773133|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
22282312|NCT03770728|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22314934|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282313|NCT02778555|Stanford University|Dr. Beth Darnall, Clinical Associate Professor, Division of Pain Medicine|(650) 721-2104|bdarnall@stanford.edu|
22282314|NCT02379988|Peace Health St. Joseph's cancer center|Victor Gonzalez|360-788-8222|vgonzalez1@peachehealth.org|
22282315|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu|
22282316|NCT02089464|Nexstim Plc|Vice President, Medical Affairs||jarmo.laine@nexstim.com|
22282317|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22282318|NCT04262882|University of Texas at San Antonio|Dr. Katelyn Sileo|210-458-7900|katelyn.sileo@utsa.edu|
22282319|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu|
22326103|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326104|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092||
22326105|NCT01593748|MUSC|Cameron Coggins|843-792-4743|cogginca@musc.edu|
22326106|NCT04229446|OsloUH|Primary Investigator Dr. Tone Rustøen|+47 22859229|tone.rustoen@medisin.uio.no|
22326107|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu|
22326108|NCT03141307|University of Utah|Dr. Bob Wong|801-587-9666|bob.wong@nurs.utah.edu|
22326109|NCT00227877|Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research|Sion Kim Harris, PhD|857-218-4304|sion.harris@childrens.harvard.edu|
22326110|NCT03569111|Medtronic|Julie Krzykowski|763-202-3325|Julie.Krzykowski@Medtronic.com|
22326111|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
22326112|NCT02522481|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
22326113|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22326114|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
22326115|NCT01109004|The Emmes Corporation|Adam Mendizabal, PhD||amendizabal@emmes.com|
22326116|NCT03805932|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
22326117|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com|
22326118|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
22326119|NCT01746732|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326120|NCT02817555|Eastern Health|Andrea Woodland|7097778146|andrea.woodland@easternhealth.ca|
22326121|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22326122|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326123|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
22326124|NCT04657016|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22326125|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|
22326126|NCT05291598|University of Miami Department of Orthopedics|Dr. Victor Hernandez|(305) 689-5195|vhh1@miami.edu|
22326127|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22326128|NCT00696657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22326129|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859|aaeemmhh@yahoo.com|400
22326130|NCT03609658|Wake Forest School of Medicine|Jennifer Gabbard, M.D.|336-716-8028|jgabbard@wakehealth.edu|
22326131|NCT00523341|Amgen Inc.|Study Director|866-572-6436||
22326132|NCT05131880|Universidad Europea de Madrid|Alberto Bermejo Franco|+34912115535|alberto.bermejo@universidadeuropea.es|
22326133|NCT02601001|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22326134|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22326135|NCT01790438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326136|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326137|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300||
22326138|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu|
22326139|NCT01701583|University of Colorado|Jenny Stitt|303-724-7205|jenny.stitt@ucdenver.edu|
22326140|NCT05070429|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919-962-3098|lgravens@email.unc.edu|
22326141|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com|
22326142|NCT02653976|Solasia Pharma K.K.|Clinical Development Department|+81358438045|clinicaldev@solasia.co.jp|
22326143|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22326144|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326145|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22326146|NCT02849990|University of Washington|Dr. Michael Schweizer|2066066252|schweize@uw.edu|
22326147|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com|
22282320|NCT02950155|Karolinska Institutet|Prof. Fredrik Piehl|+46 736718101|fredrik.piehl@ki.se|
22326148|NCT03650452|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22326149|NCT02969317|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326150|NCT02678741|LumaBridge|Timothy Vreeland, MD|6363465458|tvreeland@lumabridge.com|
22326151|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901||
22326152|NCT04510194|University of Minnesota|Carolyn Bramante|612-624-0468|jcharles@umn.edu|
22326153|NCT06648161|Kocaeli University|Dr. Resmiye Özdilek|+90 262 303 47 38|resmiyeozdilek@gmail.com|
22326154|NCT02531373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314935|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314936|NCT04354168|Boston University Chobanian & Avedisian School of Medicine, Family Medicine|Brian Jack, MD|617-414-6207|brian.jack@bmc.org|
22282321|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu|
22282322|NCT03569748|University of Catania|Maria Signorelli|095.378.2636/794|maria.signorelli@unict.it|
22282323|NCT02979093|University of Iowa|Lane Strathearn|3193849464|lane-strathearn@uiowa.edu|
22282324|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
22282325|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu|
22282326|NCT02438683|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282327|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282328|NCT01926041|National Taiwan University Hospital & College of Medicine|Dr. Chien-Hsieh Chiang|+88623123456|jiansie@gmail.com|66699
22282329|NCT04319380|London School of Hygiene and Tropical Medicine|Professor Daniel Chandramohan|+447570410351|daniel.chandramohan@lshtm.ac.uk|
22282330|NCT00147017|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
22282331|NCT04432064|Indiana University|Prof. Joshua Brown|812 855-9282|jwmbrown@iu.edu|
22282332|NCT02256384|Cincinnati Children's Hospital Medical Center|Mario Patino|513-636-4200|mario.patino@cchmc.org|
22282333|NCT04448392|UAB|Dr. Nicole Samies|570-271-6440|nsamies2@geisinger.edu|
22282334|NCT04420598|Medica Scientia Innovation Research (Medsir)|Alicia García Sanz PhD|611261467|contact.trials@medsir.org|+34
22282335|NCT05032690|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282336|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22282337|NCT00211757|Montefiore Medical Center|Dr. Eric Hollander|718-920-4287|eholland@montefiore.org|
22282338|NCT05151445|Ohio State University College of Nursing|Tara O'Brien|614-292-8045|obrien.782@osu.edu|
22282339|NCT02298179|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
22282340|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov|
22282341|NCT02320812|jCyte, Inc|Terry O'Neal, Chief Operating Officer|949-243-0688|terry.oneal@jcyte.com|
22282342|NCT02825420|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22282343|NCT04910074|Albert Einstein College of Medicine|Timothy P. Levine, DMD|718-918-5635|timothy.levine@nychhc.org|
22282344|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22282345|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282346|NCT00896363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282347|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282348|NCT03989427|Melaka-Manipal Medical College|Dr. Rajesh Hosadurga|+6062896662|rajesh.hosadurga@manipal.edu.my|3823
22282349|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com|
22282350|NCT04035564|"Hospital del Niño de Saltillo Dr. Federico Gomez Santos"|Carlos Sanchez|+528441757244|sanchez.carlos8516@gmail.com|
22282351|NCT03617536|Cara Therapeutics|Director of Clinical Trials|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22282352|NCT03333252|Weill Medical College of Cornell University|Sara J. Czaja|646-962-7141|sjc7004@med.cornell.edu|
22282353|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
22282354|NCT04686084|UCLA Oral & Maxillofacial Radiology|Sanjay M Mallya|3108251689|smallya@dentistry.ucla.edu|
22282355|NCT01779856|Medtronic, plc|RCS Sr. Director of Medical Affairs|763-505-4566|amy.denise.roettger@medtronic.com|
22282356|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449||
22299681|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu|
22271087|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu|
22271088|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se|
22299682|NCT02417246|UF|Dr. Larisa H Cavallari|352-273-8245|lcavallari@cop.ufl.edu|
22271089|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299683|NCT04483479|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|r.larson@enterininc.com|
22271090|NCT02251106|University of Alberta|Dr. Greg Kawchuk|780-492-6891|greg.kawchuk@ualberta.ca|
22271091|NCT02267772|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD, Associate Professor|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
22271092|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979||
22299684|NCT03907501|UCSD School of Medicine|Dr. Christine Tara Peterson|7033959377|chpeterson@health.ucsd.edu|
22271093|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22271094|NCT01970475|Amgen Inc.|Study Director|866-572-6436||
22271095|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711|elizabeth.ralevski@yale.edu|x4282
22271096|NCT04413552|Indivior, Inc.|Global Director, Clinical Development|804-594-4488|TrialDisclosure@Indivior.com|
22271097|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22271098|NCT03026530|Region Ostergotland|Dr. Kihlstedt Pasquier|0046101041000|ebba.kihlstedt.pasquier@regionostergotland.se|
22299685|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu|
22299686|NCT02824913|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
22299687|NCT02896855|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271099|NCT03955081|OLYMPUS EUROPA SE & CO. KG|Peter Teichmann, PhD|+49 40 23773|peter.teichmann@olympus.com|7835
22299688|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
22271100|NCT03721835|Smith+Nephew, Inc.|Karlie Morgan|+1.512.496.7507|Karlie.Morgan@smith-nephew.com|
22271101|NCT03495154|Medtronic|Alyssa Sutch, Senior Clinical Research Specialist|612-214-9756|alyssa.m.sutch@medtronic.com|
22299689|NCT02169674|Vaccine Evaluation Center|Director of Vaccine Evaluation Center|604-845-2422||
22271102|NCT05013788|The University of Texas Health Science Center at Houston|Monica Kodakandla, MD|713-500-5666|RMonica.Kodakandla@uth.tmc.edu|
22271103|NCT00688935|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
22271104|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299690|NCT04634604|Jaeb Center for Health Research|Ray Kraker|8139758690|rkraker@jaeb.org|
22271105|NCT05633992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22299691|NCT03525834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22271106|NCT05079750|University of Oxford|Dr. Paola Cicconi|01865 611425|paola.cicconi@ndm.ox.ac.uk|
22271107|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590||
22299692|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
22314937|NCT01781832|Cincinnati Children's Hospital Medical Center|Ethan Smith, MD|513 636-4200|Ethan.Smith@cchmc.org|
22314938|NCT02287233|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22314939|NCT03004586|UT MD Anderson Cancer Center|George Eapen,MD/ Professor, Pulmonary Medicine|(713) 563-4256|geapen@mdanderson.org|
22314940|NCT02804399|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001800781021|ClinicalTrials.gov_Inquiries@pfizer.com|
22314941|NCT02058836|Wake Forest University Health Sciences|Dr. Ryan Terlecki|336-716-2011|rterlecki@wakehealth.edu|
22314942|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22314943|NCT00573651|The MetroHealth System|Nora G Singer|216-778-2138|nsinger@metrohealth.org|
22314944|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th|
22271108|NCT05091346|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22271109|NCT02663752|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22314945|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com|
22314946|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com|
22314947|NCT01220856|Dompé SpA|Luisa Daffonchio, PhD|+39 583831|daffonchio@dompe.it|
22314948|NCT04814992|University of Pennsylvania|Dr. Peggy Compton|2158988283|pcompton@nursing.upenn.edu|
22314949|NCT00691678|Columbia University|Dawn L. Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
22314950|NCT00589836|Cleveland Clinic|Zoran Popovic MD|216 444-9242|popoviz@ccf.org|
22314951|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu|
22314952|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314953|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22314954|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922|pverghes@umn.edu|0
22314955|NCT00903760|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|713-745-3428|ggarciam@mdanderson.org|
22314956|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22314957|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271110|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22271111|NCT02339155|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299693|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299694|NCT02942160|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22299695|NCT04040985|Smith and Nephew|Michael Howarth|07540268240|michael.howarth@smith-nephew.com|+44
22314958|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22271112|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
22314959|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22314960|NCT01986114|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22314961|NCT01190644|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22314962|NCT02366143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22299696|NCT03879798|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
22314963|NCT04411186|Medical University of South Carolina|Dr. David Gutman, M.D., MBA, Associate Professor of Anesthesiology|843-792-5454|gutman@musc.edu|
22314964|NCT02172911|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22314965|NCT01589926|Children's Hospital at Montefiore|Kerry Morrone, MD, Asst Prof of Pediatrics|718-741-2342|kmorrone@montefiore.org|
22314966|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu|
22314967|NCT00566813|University of Illinois at Chicago|Jose Oberholzer, MD|312-996-6771|jober@uic.edu|
22314968|NCT04795336|NYU Langone Health|Joshua C Rozell, MD|212-598-6000|Joshua.rozell@nyulangone.org|
22314969|NCT01638390|Carl Zeiss Meditec, Inc.|Todd Otani, Senior Clinical Research Scientist|925-557-4513|todd.otani@zeiss.com|
22314970|NCT04012619|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
22314971|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343||
22314972|NCT02666664|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22314973|NCT03210519|Department of Nutrition, Chung Shan Medical University|Dr. Nae-Cherng Yang|886-0936810214|naeman@csmu.edu.tw|
22314974|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
22314975|NCT02367430|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22314976|NCT00568698|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
22314977|NCT03865953|Lateral Pharma Pty Ltd|Mr David Kenley|+61 (0)400 151 490|dk@lateral-pharma.com|
22314978|NCT01667406|Imperial College London|Professor Waljit Dhillo|442083833242|w.dhillo@imperial.ac.uk|
22314979|NCT03021551|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
22314980|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be|
22314981|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com|
22314982|NCT02232399|University of Gothenburg|Prof. Albert Gyllencreutz Castellheim|+46708979820|albert.castellheim@gu.se|
22314983|NCT03017937|Cincinnati Chidren's Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
22314984|NCT02706951|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22314985|NCT03491215|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
22314986|NCT02489734|Children's Hospital of Fudan University|Dr. Xuan Wang|021-18017591058|13818318679@139.com|
22314987|NCT01951768|Geneva University Hospitals, Balgrist University Hospital|Dr. med. Ilker Uçkay|+41 44 386 11 11|ilker.uckay@balgrist.ch|
22314988|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com|
22314989|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu|
22314990|NCT02720211|Axon Optics|Director of Clinical Trials|8012304851|bradley.katz@hsc.utah.edu|
22314991|NCT04070768|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22314992|NCT04799418|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22314993|NCT03297398|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22299697|NCT01343407|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299698|NCT06027216|Schepens Eye Research Institute, Mass Eye and Ear|Eli Peli|617-912-2597|eli_peli@meei.harvard.edu|
22299699|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu|
22299700|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
22299701|NCT02388321|Maimonides Medical Center|Sergey Motov, MD (Prinicipal Investigator)|718-283-8693|smotov@maimonidesmed.org|
22299702|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu|
22299703|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com|
22314994|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22299704|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22299705|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com|
22271113|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100||503
22299706|NCT03836287|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22314995|NCT04611347|University of Virginia|Brent DeGeorge, MD|434.982.4263|BD6U@uvahealth.org|
22314996|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
22314997|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22314998|NCT02669407|Duke University|Marat Fudim, M.D.|919-684-8111|marat.fudim@duke.edu|
22314999|NCT00345800|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
22315000|NCT01973062|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-444-6145|ahluwam@ccf.org|
22315001|NCT00350298|MassBiologics|Director of Clinical Affairs|617-474-3000|MBLClinicalDirector@umassmed.edu|
22315002|NCT00233389|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22315003|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com|
22315004|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315005|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org|
22315006|NCT04593823|scPharmaceuticals|Dr. John Mohr, PharmD; Sr VP Clinical Development and Medical Affairs|7813017220|jmohr@scpharma.com|
22315007|NCT04974723|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
22315008|NCT02877732|Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine|Dr. Jamshid Ghajar|(650) 725-5562|jghajar@stanford.edu|
22315009|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com|
22299707|NCT01669343|Princess Margaret Hospital|Dr. David Cescon|416-946-2000|dave.cescon@uhn.on.ca|
22299708|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org|
22271114|NCT02176083|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
22299709|NCT02371369|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22299710|NCT01024387|Dana-Farber Cancer Institute|Matthew H. Kulke, MD|617.632.5136|Matthew_Kulke@dfci.harvard.edu|
22299711|NCT03855189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299712|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org|
22299713|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org|
22299714|NCT04307186|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22299715|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org|
22299716|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu|
22299717|NCT01434602|National Cancer Institute|Dr. Mark R. Gilbert|240-760-6023|mark.gilbert@nih.gov|
22299718|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
22299719|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com|
22299720|NCT00754845|Canadian Cancer Trials Group|Senior Biostatistician|6135336430|dtu@ctg.queensu.ca|
22299721|NCT03864900|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
22299722|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630|Jbarak@mcsmed.com|412
22299723|NCT03238001|Digital Cognition Technologies|SVP, Clinical Affairs|6174331777|aholway@digitalcogtech.com|
22299724|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22299725|NCT02582905|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
22299726|NCT00780962|Beth Israel Deaconess Medical Center|Nathan I. Shapiro, MD, MPH|617-754-2323|nshapiro@bidmc.harvard.edu|
22299727|NCT02332720|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299728|NCT05732454|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299729|NCT03846024|University of Vermont|Ethan Jones|802-656-9437|ethan.d.jones@med.uvm.edu|
22299730|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299731|NCT00352365|SWOG|Study Statistician|206-667-4623||
22299732|NCT01262651|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22299733|NCT04743908|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
22299734|NCT03822533|Region Västra Götaland, Närhälsan|Chan-Mei Ho-Henriksson, PhD-student, RPT|+46709892821|chan-mei.ho@vgregion.se|
22299735|NCT01412944|Novartis|Study Director|862-778-8300||
22299736|NCT01990950|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22299737|NCT02863926|Indiana University School of Medicine|Kristen Wanczyk / Certified Clinical Research Nurse Coordinator|317-7988-9548|keevans@iu.edu|
22299738|NCT05356221|Oticon Medical|Dr. Nicole Amichetti|+1 609-366-0424|nitc@oticonmedical.com|
22299739|NCT02061384|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
22299740|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22299741|NCT01286779|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22315010|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu|
22315011|NCT00458393|University of California, San Francisco|David Glidden|415-514-8009|david.glidden@ucsf.edu|
22315012|NCT02725567|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22315013|NCT02625571|Penn State College of Medicine|Dr. Brian Allen|717-531-4100|ballen1@pennstatehealth.psu.edu|323492
22315014|NCT02777242|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22315015|NCT05178979|Boston College|Katelyn Sileo|617-552-3205|sileoka@bc.edu|
22315016|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu|
22315017|NCT03035318|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
22315018|NCT03311269|Vascular Inisights, LLC|Ms. Lorraine Hanley, MBA|617-519-1109|lorraine.hanley@merit.com|
22315019|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22315020|NCT03845075|Saniona A/S|Janus Schreiber Larsen|7070 5225|janus.larsen@saniona.com|+45
22315021|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22315022|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu|
22315023|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22315024|NCT03802617|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
22315025|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov|
22315026|NCT04438382|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22315027|NCT02635386|Woman's Hospital|Dr Karen Elkind-Hirsch|2252315278|karen.elkind-hirsch@womans.org|
22315028|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net|
22315029|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu|
22315030|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com|
22315031|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu|
22315032|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22315033|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
22315034|NCT03561597|KKWCH|Dr Chew Chu Shan Elaine|63946042|elaine.chew.c.s@singhealth.com.sg|
22315035|NCT03972397|The University of Texas Health Science Center at Houston|Anthony L Estrera, MD|713-486-5100|anthony.l.estrera@uth.tmc.edu|
22315036|NCT05347485|Janssen Scientific Affairs, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22315037|NCT05896696|A.Stein Regulatory Affairs Consulting Ltd.|Ahava Stein|+972-9-7670002|ahava@asteinrac.com|
22315038|NCT04978350|UNC Lineberger Comprehensive Cancer Center|Angelo Navas|919-445-1128|angelo_navas@med.unc.edu|
22315039|NCT05923112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315040|NCT04991766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22315041|NCT05781750|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22315042|NCT05621252|Pliant Therapeutics|Pliant Therapeutics Medical Monitor|650-481-6770|clintrials@pliantrx.com|
22315043|NCT00412880|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315044|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
22315045|NCT02309346|Hospital de Clínicas de Porto Alegre|Ricardo Francalacci Savaris|+55 51 33596042|rsavaris@hcpa.edu.br|
22315046|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
22315047|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315048|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22315049|NCT06136897|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22315050|NCT01296555|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22315051|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315052|NCT03197025|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@mail.nih.gov|
22315053|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu|
22315054|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
22315055|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
22315056|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22315057|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22315058|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22315059|NCT01704547|UMGCCC|Elizabeth M. Nichols, MD|410-328-2324|enichols1@umm.edu|
22315060|NCT02564718|Bayer|Therapeutic Area Head|+1-888-84-22937|clinical-trials-contact@bayer.com|
22315061|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu|
22315062|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
22315063|NCT02138253|Conatus Pharmaceuticals, Inc.|Steven Mento, Ph.D., CEO|858-376-2622|smento@conatuspharma.com|
22315064|NCT02085473|MedImmune, LLC|Meena Jain|+44 (0) 1223 895966|jainm@medimmune.com|
22315065|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315066|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315067|NCT04788511|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22315068|NCT03174782|University of California, San Francisco- Fresno|Kamell Eckroth-Bernard|559-431-6226|kamell.eckroth-bernard@ucsf.edu|
22315069|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300||
22315070|NCT03178045|Memorial Sloan Kettering Cancer Center|Robert Allen Jr., MD|646-608-8041|allenr1@mskcc.org|
22315071|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net|
22315072|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252||
22315073|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org|
22315074|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315075|NCT02031536|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22315076|NCT01715883|University of Pittsburgh|Matthew Morrell, MD|412-647-8477|morrellmr@upmc.edu|
22315077|NCT04211389|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22315078|NCT01324700|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD, Professor of Psychiatry|214-645-6950|sherwood.brown@utsouthwestern.edu|
22315079|NCT05479747|Faculty of Dentistry, Ain Shams University|Dr|+11112228724|AlaaMahmoud@dent.asu.edu.eg|
22315080|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22315081|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22315082|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315083|NCT01966978|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22315084|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315085|NCT04522206|NYU LAngone Health - Long Island|Muhammad B. Tariq, M.D|602-363-1134|Muhammad.Tariq2@nyulangone.org|
22315086|NCT02650466|Alfred E. Mann Insitute at the University of Southern California|Cesar E. Blanco,PhD; Sr Director R&D|2138211619|cblanco@usc.edu|2138211619
22315087|NCT01729845|Fred Hutch Cancer Research Center|Dr. Anna Halpern|2066676233|halpern2@uw.edu|206
22315088|NCT01214421|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22315089|NCT03545412|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22315090|NCT02392104|William S. Middleton Memorial Veterans Hospital|Andrea Porter, PharmD|608-890-0742|andrea.porter@wisc.edu|
22315091|NCT04590404|Vanderbilt University Medical Center|Dr. Hilary Tindle|(615) 875-9726|hilary.tindle@vumc.org|
22315092|NCT03912532|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
22315093|NCT03947918|University of California, San Francisco|Suzanna Martinez|415-476-2300|suzanna.martinez@ucsf.edu|
22315094|NCT03783871|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22315095|NCT05990387|Indiana University|Dr. Blair Johnson|8128558699|bj33@iu.edu|
22315096|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu|
22315097|NCT03522389|Mahidol University|Sunee Bovonsunthonchai|66855926144|sunee.bov@mahidol.ac.th|
22315098|NCT04750577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315099|NCT03459612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22315100|NCT02176837|Hope Pharmaceuticals|Craig Sherman, MD|4806071970|sherman@hopepharm.com|
22315101|NCT02473042|The University of Texas MD Anderson Cancer Center|Alicia Kowalski, MD|(713) 563-5614|amkowalsk@mdanderson.org|
22315102|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu|
22315103|NCT04680637|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22315104|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22315105|NCT03780010|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
22315106|NCT01939301|Indiana University|Jeffrey A. Kline, MD|317-880-3900|jefkline@iu.edu|
22315107|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315108|NCT04243512|University of Maryland Baltimore|Amber Kleckner|410-706-5961|amber.kleckner@umaryland.edu|
22315109|NCT00566345|Ology Bioservices|Sr. Manager, Clinical & Regulatory Operations|386-418-8751|angie.kimbler@ologybio.com|
22315110|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com|
22315111|NCT03500835|Children's Hospital Los Angeles|Alaina Vidmar|323-361-4606|avidmar@chla.usc.edu|
22315112|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
22315113|NCT03049306|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
22315114|NCT05093504|CytoSorbents|Weihong Fan|1 732-329-888|wfan@cytosorbents.com|
22315115|NCT03151551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22315116|NCT01190449|Weill Cornell Medicine Cornell University|Cara Rosenbaum, MD|(646) 962-6500|car9156@med.cornell.edu|
22315117|NCT00212992|Ottawa Hospital Research Institute|Dr. Ian G. Stiell, Senior Scientist|613-798-5555|istiell@ohri.ca|18683
22315118|NCT00129935|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22315119|NCT03445793|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|taylorcousarj@njhealth.org|
22315120|NCT02783573|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22315121|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org|
22315122|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org|
22315123|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22315124|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22315125|NCT01367847|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-3995|djjones@email.unc.edu|
22315126|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu|
22315127|NCT02056626|University of Rochester|John Bisognano|585-341-7800|john_bisognano @ urmc.rochester.edu|
22315128|NCT01780454|Massachusetts General Hospital|Dr. David Sachs|617-726-4065|David.Sachs@tbrc.mgh.harvard.edu|
22315129|NCT04916002|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22315130|NCT04836559|Janssen Research & Development, LLC|Executive Medical Director Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22315131|NCT02078726|University of California, San Francisco|John Cello, MD|628-206-4767|John.Cello@ucsf.edu|
22315132|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com|
22315133|NCT05147350|Repare Therapeutics INC|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
22315134|NCT06576674|University of North Carolina at Chapel Hill|Michael Bremmer, PhD|301-827-0566|mbremmer@unc.edu|
22315135|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu|
22315136|NCT02472145|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22315137|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu|
22315138|NCT04919070|University of Rochester|Dr. Sally Norton|5852759814|sally_norton@urmc.rochester.edu|
22315139|NCT02025855|Frederick Health|Thomas Smoot|2405663250|tlsmoot@frederick.health|
22315140|NCT01560871|Texas Woman's University|Dr. Suh-Jen Lin|214-689-7718|slin@twu.edu|
22315141|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22315142|NCT03042299|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22315143|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu|
22315144|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu|
22315145|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22315146|NCT04069585|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
22315147|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org|
22315148|NCT00672451|Wake Forest University Health Sciences|Dr. John Burkart|33671662958|jburkart@wakehealth.edu|
22315149|NCT04206085|Viveve|Vice President, Clinical & Medical Affairs|720-696-8100|clinicalaffairs@viveve.com|
22315150|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu|
22315151|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22315152|NCT03200444|Coloplast A/S|Director of Pre-Clinical Research|49111111|dklfn@coloplast.com|+45
22315153|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com|
22315154|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
22315155|NCT01062971|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22315156|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com|
22315157|NCT05523219|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
22315158|NCT02760485|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22315159|NCT03845023|Apnimed, Inc|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
22315160|NCT03738397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22315161|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22315162|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu|
22315163|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22315164|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22315165|NCT05314374|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
22315166|NCT02658175|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22315167|NCT01743976|Wake Forest School of Medicine|James C. Eisenach|336-716-4182|jimeisenach@gmail.com|
22315168|NCT02526186|MOMH|Amanda Crawford|7025633583|amanda.j.crawford.ctr@health.mil|
22315169|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
22315170|NCT02554383|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
22315171|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22315172|NCT02918292|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22315173|NCT03783689|SPR Therapeutics, Inc|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
22315174|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com|
22315175|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22315176|NCT02581059|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22315177|NCT04887506|Tavanta Therapeutics|Head, Clinical Development|+1 833776 8963|info@tavanta.com|
22315178|NCT01963169|University of Maryland, Baltimore|Eun-Shim Nahm|410-706-4913|enahm@son.umaryland.edu|
22315179|NCT02636608|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22315180|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu|
22315181|NCT04913948|Ottawa Hospital Research Institute|Dr. Darine El-Chaar|(613) 737-8899|delchaar@toh.ca|78797
22315182|NCT06638840|Oticon medical|Director of Clinical Affairs|+46 31 748 61 00|studyinfor@oticonmedical.com|
22315183|NCT05238103|Johns Hopkins University|Lena Mathews, MD MHS|410-502-0469|lmathew6@jhmi.edu|
22315184|NCT05739994|Indiana University Bloomington|Dr. Hannah Block|8128555390|hjblock@iu.edu|
22315185|NCT02911805|Atlanta VA|Jeffrey H. Boatright, PhD|404-321-6111|jeffrey.boatright@va.gov|
22315186|NCT03526679|National Taiwan University Hospital|Dr. Tom Wei-Wu Chen|+886-2-23123456|tomwchen@ntuh.gov.tw|66002
22315187|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu|
22315188|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu|
22315189|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com|
22315190|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu|
22315191|NCT02825251|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22315192|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
22315193|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484|GiselaS@amphastar.com|2016
22315194|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22315195|NCT00624910|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22315196|NCT05064488|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22315197|NCT03023722|Yale University|Stacey Stein, MD|203 737-1600|stacey.stein@yale.edu|
22315198|NCT03616964|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22315199|NCT04596995|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22315200|NCT01952847|UT MD Anderson Cancer Center|Aung Naing, MD-Professor, Invest. Cancer Therapeutics|(713) 563-3885|anaing@mdanderson.org|
22315201|NCT05382039|Loma Linda University|Eric Johnson|9095584632|ejohnson@llu.edu|47471
22315202|NCT04464421|University of Tennessee Health Science Center|Karen Derefinko, PhD|9014482526|kderefin@uthsc.edu|
22315203|NCT02577003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Dvelopment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315204|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com|
22315205|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22315206|NCT01271504|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22315207|NCT02768597|Mayo Clinic|Dr. Mark E. Morrey|507-284-2511|morrey.mark@mayo.edu|
22315208|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org|
22271115|NCT03226678|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22315209|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000|jonathan_deitch@siuh.edu|1278
22315210|NCT03912662|Medtronic|Marion Blanc|+33 4 74 08 90 00|marion.blanc@medtronic.com|
22315211|NCT03845140|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22315212|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com|
22315213|NCT04560374|Marmara University Faculty of Health Sciences Department of Pediatric Nursing|Dr. Çağrı Çövener Özçelik|009-0216-777-57-00|ccovener@gmail.com|5773
22315214|NCT01790295|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
22315215|NCT03721705|Renew Research|Billy Tally, CEO|949-545-8466|bill2@stage2innovations.com|
22315216|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262|Michele.Lewis3@va.gov|51996
22315217|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
22315218|NCT06533527|Cleveland Clinic Florida (Weston Hospital)|Dr. Tilak Shah|954-659-5646|shaht3@ccf.org|
22315219|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu|
22315220|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22315221|NCT05034939|VentureMed Group, Inc.|Vice President, Clinical, Regulatory & Quality|763-296-2021|jschweiger@venturemedgroup.com|
22315222|NCT02599688|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
22315223|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org|
22315224|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|ClinicalTrialsGov@cumc.columbia.edu|
22315225|NCT02113410|Florida Atlantic University|Dr. Juyoung Park|561-297-4537|jpark14@fau.edu|
22315226|NCT02947100|Nemours/AI duPont Hospital|Dr Robin Miller|302-651-5500|rmiller@nemours.org|
22315227|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com|
22315228|NCT02818998|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22315229|NCT00926380|Massachusetts General Hospital|Natalie David||ndavid2@mgh.harvard.edu|
22315230|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
22315231|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315232|NCT01318876|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
22315233|NCT03563313|University of Virginia|Sue Brown, MD|434-962-0602|sab2f@virginia.edu|
22315234|NCT02250534|University of Vermont|Stephen T. Higgins, PhD, Professor, Department of Psychiatry|802-735-6267|stephen.higgins@uvm.edu|
22315235|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22315236|NCT02437071|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
22315237|NCT03101033|Xijing Hospital, the Fourth Military Medical University|Dr yan lu|029-84775337|yanlu001@fmmu.edu.cn|029-847753
22315238|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000|sandra.creel@va.gov|1-2840
22315239|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22315240|NCT02049515|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22271116|NCT04946552|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
22271117|NCT02102100|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehemt.sofuoglu@yale.edu|4809
22299742|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22271118|NCT05014815|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22271119|NCT05185622|Santhera|Dr Shabir Hasham|+41 61 906 89 50|Shabir.Hasham@santhera.com|
22299743|NCT03421197|Dr Reddy's Laboratories|Srinivas Sidgiddi, Sr Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
22271120|NCT05283135|Oregon Medical Research Center, PC|Benjamin Ehst, MD, PhD|5032451525|behst@oregonmedicalresearch.com|
22299744|NCT04118348|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22271121|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905|evelyn.diessel@biotronik.com|1231
22299745|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org|
22271122|NCT03602391|University of Texas at Arlington|JEREMY A FORSBERG|8172722105|ogcs@uta.edu|
22299746|NCT02844946|Baylor College of Medicine|Dr. Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
22271123|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271124|NCT03991013|University of Cape Town|Prof Graeme Meintjes|+27 (0) 21 4066075|Graeme.Meintjes@uct.ac.za|
22299747|NCT02806986|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22299748|NCT01617421|Clinical Center|Middleton, Kimberly|+1 301 496 9083|middletonk@mail.nih.gov|
22271125|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu|
22271126|NCT02725580|Amicus Therapeutics|Amicus Therapeutics Patient Advocacy|+1 609-662-2000|clinicaltrials@amicusrx.com|
22271127|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22271128|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu|
22271129|NCT02634268|VA Puget Sound Health Care System|Margaret Collins|206.764.2085|margaret.collins@va.gov|
22271130|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22271131|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org|
22271132|NCT01575275|Cleveland Clinic|Dr. Michael Vogelbaum|2164448564|vogelbm@ccf.org|
22299749|NCT03646513|Smith+Nephew, Inc.|Andrew Copey|+61.490.503.157|andrew.copley@smith-nephew.com|
22271133|NCT02619396|John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust|Dr Milena Leo|0186522055|milena.leo@ouh.nhs.uk|
22299750|NCT02334748|Novartis Pharma AG|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
22315241|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org|
22315242|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu|
22315243|NCT01653210|Univerisity of Virginia|Sue Brown, MD||sab2f@virginia.edu|
22315244|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22315245|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org|
22315246|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22315247|NCT02569957|Sidney Kimmel Cancer Center at Thomas Jefferson University|Russell Schilder|215-503-3057|russell.schilder@jefferson.edu|
22315248|NCT03513068|ResMed|Maureen Crocker, Sr. Manager Market Access|+65 9815 2195|maureen.crocker@resmed.com|
22315249|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151|nide@sus.no|9455
22315250|NCT03636373|Rutgers, The State University of New Jersey|Naomi Schlesinger, MD|732 235 6117|Naomi.Schlesinger@hsc.utah.edu|
22315251|NCT01575873|Amgen Inc.|Study Director|866-572-6436||
22315252|NCT01850030|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
22315253|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22315254|NCT02688530|Hospital for Special Surgery|Meghan Kirksey, MD, PhD|212-606-1206|Kirkseym@hss.edu|
22315255|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr|
22315256|NCT04996940|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
22315257|NCT03698019|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22315258|NCT04021043|MD Anderson Cancer Center|Joe Chang, MD|(713) 563-2337|jychang@mdanderson.org|
22315259|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
22315260|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22315261|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315262|NCT02852356|Ovation Fertility|Director|5126107474|tex@ovationfertility.com|
22315263|NCT03325790|Sound Pharmaceuticals, Inc.|Dr. Jonathan Kil|206-634-2559|info@soundpharma.com|
22315264|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22315265|NCT04986566|City of Hope Medical Center|Dr, Laleh Melstrom|626-359-8111|lmelstrom@coh.org|
22315266|NCT04546217|University of Alabama at Birmingham|Dr. Sarah dos Anjos|2059347323|smanjos@uab.edu|
22315267|NCT02550938|Align Technology, Inc.|Allison Mossing, Sr. Clinical Research Associate|4084701046|amossing@aligntech.com|
22315268|NCT03415243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315269|NCT03121820|GEROPHARM|GEROPHARM Clinical Leader|+7(812) 703-79-75|inform@geropharm.ru|
22315270|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315271|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22315272|NCT02635360|University of Virginia|Dr. Linda R. Duska|434-944-9135|LRD5D@uvahealth.org|
22315273|NCT04082429|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22299751|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu|
22315274|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22315275|NCT03118050|University of Texas Medical Branch|Elena Volpi, MD, PhD|210-562-6139|volpi@uthscsa.edu|
22315276|NCT02833805|Johns Hopkins University|Dr. Amy DeZern|410-502-7208|adezerb1@jhmi.edu|
22315277|NCT01454739|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
22271134|NCT04489381|Romark, L.C.|Jessica Fulgencio|8132828544|jessica.fulgencio@romark.com|
22299752|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22315278|NCT05765435|Cionic|Rebecca Webster|888-481-3724|rebecca@cionic.com|
22315279|NCT04351269|Aziyo Biologics, Inc.|Associate Director of Clinical Operations|470-514-4085|clinical@aziyo.com|
22315280|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22315281|NCT03182998|Mayo Clinic|Dr. Jon C. Tilburt, MD, MPH|480-301-3401|tilburt.jon@mayo.edu|
22315282|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22315283|NCT02980523|Laboratorios Sophia|Clinical pharmacologist|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22315284|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu|
22315285|NCT00513747|The Arthur James Comprehensive Cancer Center|John Byrd, MD|614-293-9869|john.byrd@osumc.edu|
22315286|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu|
22315287|NCT01236352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22315288|NCT01536197|University of Illinois at Urbana Champaign|M. Yanina Pepino|217-300-2374|ypepino@illinois.edu|
22315289|NCT01999777|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
22315290|NCT05903183|Icosavax Inc.|Icosavax Clinical Operations|206-737-0085|clinops@icosavax.com|
22315291|NCT03149029|Massachusetts General Hospital Cancer Center|Ryan J. Sullivan, MD|617-643-3614|RSULLIVAN7@mgh.harvard.edu|
22315292|NCT03735121|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22315293|NCT02176863|Instituto Grifols, S.A.|Sandra Camprubi, PhD/Senior Director, Clinical Operations|+34 67 0923160|sandra.camprubi@grifols.com|
22315294|NCT02647645|Nova Southeastern University|Raymond L Ownby, MD, PhD|9542621481|ro71@nova.edu|
22315295|NCT02037256|Barbara Ann Karmanos Cancer Institute|Dr. Divaya Bhutani|501-680-9229|db3203@cumc.columbia.edu|
22326155|NCT01623531|Department of Anesthesia, Dalhousie University, Halifax, Canada|Dr. Myron Kwapisz|+1 902 473 4326|myron.kwapisz@nshealth.ca|
22326156|NCT02834403|Houston Methodist Cancer Center|Polly Niravath, MD|713-441-0629|ccresearch@houstonmethodist.org|
22326157|NCT04705597|BioAge Labs, Inc.|Patrick Martin, M.D.|215-260-5134|patrick@bioagelabs.com|
22326158|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com|
22326159|NCT00305006|Teachers College, Columbia University|Dr. Andrew Gordon|212-678-3326|ag275@columbia.edu|
22326160|NCT02606045|University of Pittsburgh|Margaret V. Ragni, MD, PHD|412-209-7480|ragni@pitt.edu|
22326161|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300||
22326162|NCT02758717|Lombardi Comprehensive Cancer Center|Bruce D. Cheson, M.D.|507-266-0800|bdc4@georgetown.edu|
22326163|NCT01671085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326164|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22326165|NCT02853331|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326166|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com|
22326167|NCT02375698|UCT|Dr. Rodney Dawson|27214066850|rodney.dawson@uct.ac.za|
22326168|NCT01595646|Wake Forest School of Medicine|Suzanne Craft, PhD|3366-713-8830|suzcraft@wakehealth.edu|
22326169|NCT02946229|GE Healthcare|Sean Lucas - Research Manager|1-248-533-5575|sean.lucas@ge.com|
22326170|NCT01161524|Eisai Inc.|Eisai Call Center|888-422-4743||
22326171|NCT01088815|Johns Hopkins SKCCC|Dr. Ana De Jesus Acosta|443-287-0411|adejesu1@jhmi.edu|7-0411
22326172|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu|
22326173|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com|
22326174|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch|
22326175|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22326176|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org|
22326177|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000|jm.wecht@va.gov|3122
22326178|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu|
22326179|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
22326180|NCT03008590|VA Boston Healthcare System|Dr Paul Monach, Chief, Rheumatology Section|857-364-5552|Paul.Monach@va.gov|
22326181|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22326182|NCT04436510|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22326183|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326184|NCT03458000|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
22315296|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org|
22326185|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326186|NCT02090114|Johns Hopkins University School of Medicine|Samuel Denmeade, M.D.|410-502-8341|denmesa@jhmi.edu|
22326187|NCT01605071|University of Colorado Denver, Anschutz Medical Campus|Kimberly Cox-York||KIMBERLY.COX-YORK@CUANSCHUTZ.EDU|
22326188|NCT03123354|Masimo Corporation|Vikram Ramakanth|1 (949) 297-7416|clinicalresearchdept@masimo.com|
22326189|NCT02856581|Mayo Clinic|Dr. Ivana T. Croghan|507-284-7313|croghan.ivana@mayo.edu|
22315297|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com|
22315298|NCT04599907|Candesant Biomedical|Erin Tims, VP of Clinical Affairs|19255776863|etims@candesant.com|
22315299|NCT03007732|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|David.Oh@ucsf.edu|
22315300|NCT03371823|University of Delaware|Dr. Megan Wenner|302-831-7343|mwenner@udel.edu|
22315301|NCT00311246|UIC|Nadera J Sweiss|312-996-5723|nsweiss@uic.edu|
22315302|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
22315303|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
22315304|NCT02386839|Shire (Note: This product was divested to Oak Hill Bio in 2022)|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22315305|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com|
22315306|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org|
22315307|NCT02101983|University of Rochester|Deborah Mulford|585-275-5823|deborah_mulford@urmc.rochester.edu|
22315308|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com|
22315309|NCT02634814|University of North Carolina at Chapel Hill|Brian Pietrosimone, PhD|919-962-3617|brian@unc.edu|
22315310|NCT04124471|Children's Hospital of Philadelphia|Ignacio Tapia, MD|(267) 426-5842|tapia@chop.edu|
22315311|NCT03668223|Dana Farber Cancer Institute|Dr. Abby Rosenberg|617-632-5286|abbyr_rosenberg@dfci.harvard.edu|
22315312|NCT05502783|National Heart, Lung, and Blood Institute (NHLBI) at National Institutes of Health (NIH)|Dr. Georg Aue|301.547.9490|aueg@nhlbi.nih.gov|
22271135|NCT02865590|Department MESVA - University of L'Aquila|Enrico Marchetti DDS, PhD|+39862433304|enrico.marchetti@univaq.it|
22271136|NCT03199612|Montefiore Einstein|Omar Saeed|718-920-2626|osaeed@montefiore.org|
22282357|NCT02494518|Cleveland Clinic|Dr. Susan Linder|(216) 445-9815|linders@ccf.org|
22282358|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22282359|NCT03960580|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|265-521-0565|john.messina@optinose.com|
22282360|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu|
22282361|NCT04452435|Vicore Pharma|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
22282362|NCT03397394|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22282363|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282364|NCT03520348|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22282365|NCT02292758|Dana-Farber Cancer Institute|Kimmie Ng, M.D., M.P.H.|(617) 632-4150|Kimmie_Ng@dfci.harvard.edu|
22282366|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu|
22282367|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282368|NCT05898672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282369|NCT03832322|Evergreen General Hospital, Taiwan|Dr. Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
22299753|NCT01310036|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22271137|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov|
22271138|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22271139|NCT02386345|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
22271140|NCT02335749|Zeltiq Aesthetics|Kerrie Jiang, Director Clinical Affairs|925-621-7462|kerrie.jiang@allergan.com|
22271141|NCT03448939|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22271142|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
22271143|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu|
22271144|NCT00628095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271145|NCT03124121|Guy's & St Thomas' Hospital|Dr Mark Samaan|07740637713|mark.samaan@gstt.nhs.uk|
22271146|NCT01005888|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22271147|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com|
22271148|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
22271149|NCT02635542|University of Chicago|Rebecca M Gerlach, MD|773-702-6700|rgerlach@dacc.uchicago.edu|
22271150|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu|
22271151|NCT03526055|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
22271152|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22271153|NCT02787057|Peking University First Hospital|Dr. Jie Dong|+86 010 66551708|jie.dong@bjmu.edu.cn|
22271154|NCT00214149|UW Hospital and Clinics|Diana Trask, research coordinator for study|608-263-9528|trask@humonc.wisc.edu|
22271155|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com|
22271156|NCT04050124|NYU Langone Health|Scott Gorenstein, MD|5166638498|Scott.Gorenstein@nyulangone.org|
22271157|NCT05168878|University of Colorado|Dr. Maya Haasz|7204789231|maya.haasz@childrenscolorado.org|
22271158|NCT05083923|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22271159|NCT03336268|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
22271160|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22315313|NCT04870957|University of Michigan|Afton Hassett, PsyD|734-763-5226|afton@med.umich.edu|
22299754|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org|
22271161|NCT02560324|University of Pennsylvania|Principal Investigator|215-746-5789|rlashare@pennmedicine.upenn.edu|
22271162|NCT01785849|Amgen Inc.|Study Director|866-572-6436||
22271163|NCT02880865|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
22271164|NCT03379753|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
22271165|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu|
22271166|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com|
22299755|NCT00817089|UPENN|David Oslin|215 823 5894|oslin@upenn.edu|
22271167|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299756|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
22299757|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
22299758|NCT04667117|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22271168|NCT01852201|Medical University of SC|Jonathan Lena, MD|843-792-9226|lena@musc.edu|
22271169|NCT02057419|The Miriam Hospital|Dr Kate Guthrie, Principal Investigator, Project WISH Lead Investigator|401-793-8180|kate.guthrie@brownhealth.org|
22271170|NCT05513703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22299759|NCT03359096|University of Pennsylvania|Raj C. Dedhia, MD, MSCR|215-349-5009|Raj.Dedhia@pennmedicine.upenn.edu|
22271171|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org|
22299760|NCT00283504|CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS|MARIPAZ MORALES MD|7576688255|MARIPAZ.MORALES@CHKD.ORG|
22299761|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com|
22315314|NCT05970640|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315315|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
22315316|NCT02272244|Thomas Jefferson Universiy|Ronald Myers(Priniciple Investigator)|215-5034085|ronald.myers@jefferson.edu|
22315317|NCT03670277|Johnson & Johnson Vision Care|Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
22315318|NCT02660112|Mayo Clinic|Ralitza H. Gavrilova, M.D.|507-293-1283|Gavrilova.Ralitza@mayo.edu|
22315319|NCT04340843|Washington University in St. Louis School of Medicine|Dr. Mia Weiss|3147473096|m.c.weiss@wustl.edu|
22315320|NCT06862154|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
22315321|NCT03733899|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22315322|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22315323|NCT04650698|NYU Langone|Arthur Hertling, MD|212-598-6085|Arthur.Hertling@nyulangone.org|
22315324|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk|
22315325|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu|
22315326|NCT02859064|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22315327|NCT04403542|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22315328|NCT01730950|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22315329|NCT02737826|Medical University of South Carolina|Dr. Kelly Barth|843-792-0686|stephen@musc.edu|
22315330|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22315331|NCT02568397|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22315332|NCT02354651|University of Florida|Dr. Barbara Smith|3522945315|bksmith@ufl.edu|
22315333|NCT01317875|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
22315334|NCT00581893|University of Iowa|Erik St. Louis|507-266-7456|StLouis.Erik@mayo.edu|
22315335|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315336|NCT01377389|UT MD Anderson Cancer Center|Aparicio,Ana,M.D. / Genitourinary Medical Oncology|713-792-7734|AAPARICIO@MDANDERSON.ORG|
22315337|NCT04090528|University of Wisconsin - Madison|Douglas G. McNeel, MD PhD|(608) 263-4198|dm3@medicine.wisc.edu|
22315338|NCT03020069|NYU Langone Health|Jeniece Ilkowitz RN, MA, CDE|212-263-9910|Jeniece.ilkowitz@nyulangone.org|
22315339|NCT02684123|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman-Yassky|(212) 241-9728|Emma.Guttman@mountsinai.org|
22315340|NCT05224843|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
22315341|NCT01920932|St. Jude Children's Research Hospital|Matt Ehrhardt, MD|(901) 595-5913|matt.ehrhardt@stjude.org|
22315342|NCT00580489|Metrohealth Medical Center|Charles Emerman|2167783577|cemerman@metrohealth.org|
22315343|NCT01673022|Indiana University School of Medicine|Research Coordinator|317-944-2654|jmvinter@iupui.edu|
22315344|NCT05274750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315345|NCT00283283|Walter Reed National Vaccine Healthcare Center Network|COL Renata J. M. Engler, MD|202-782-9461|renata.engler@na.amedd.army.mil|8819
22315346|NCT04328623|Centre Hospitalier Départemental Vendée|Adeline TROJET-BOSSARD|251446572|adeline.trojet-bossard@ght85.fr|+33
22315347|NCT04340947|University of Oklahoma Health Sciences|Professor of Pediatrics|405-271-1903|heal-lab@ouhsc.edu|
22315348|NCT02312557|Oregon Health & Science University|Rachel Slottke|503-494-6117|slottker@ohsu.edu|
22315349|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu|
22315350|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22315351|NCT02330094|Mayo Clinic|Dr. William D. Freeman|904-953-7103|freeman.william1@mayo.edu|
22271172|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22315352|NCT04486313|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22315353|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
22299762|NCT03452917|University of Washington|Francis Kim|206-897-5264|fkim@u.washington.edu|
22315354|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22315355|NCT01375751|Amgen Inc.|Study Director|866-572-6436||
22282370|NCT04463693|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22315356|NCT00633945|University of Pennsylvania|Dr. Victoria Werth|215-898-0168|werth@mail.med.upenn.edu|
22315357|NCT00882115|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
22315358|NCT02552147|Vanderbilt University Medical Center|Alan Lewis, MD, PhD|(615) 936-4997|alan.s.lewis@vumc.org|
22315359|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22282371|NCT01694121|Center on Gender Equity and Health at UCSD|Dr. Anita Raj|8588220229|anitaraj@ucsd.edu|
22315360|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu|
22315361|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22315362|NCT01573949|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
22315363|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
22315364|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22315365|NCT04071301|Essity Hygiene and Health|Fredrik Agholme, Clinical Trials Manager, Clinical Affairs|+46 73 0323634|Fredrik.AGHOLME@essity.com|
22315366|NCT05186311|Becton, Dickinson and Company|Clinical Program Manager|9292850651|Pierre.Asselin@bd.com|
22315367|NCT02879383|Fractyl Laboratories, Inc.|Sarah Hackett, Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
22282372|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22315368|NCT02125279|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22315369|NCT02018653|University of Texas (UT) MD Anderson Cancer Center|Sai-Ching J. Yeung, MD||CR_Study_Registration@mdanderson.org|
22315370|NCT02677870|UHCMC|Dr. Lori-Anne Schillaci|216-844-3936|lori-anne.schillaci@uhhospitals.org|
22315371|NCT01607879|Froedtert and the Medical college of Wisconsin|Kathryn Bylow, MD|414-805-4600|kbylow@mcw.edu|
22282373|NCT01114971|Cedars Sinai Medical Center|Proffesor Paul F. White|2147703775|paul.white@cshs.org|
22315372|NCT05020145|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282374|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282375|NCT02186652|Duke Clinical Research Institute|Chad Livingston|919-668-1935|chad.livingston@duke.edu|
22282376|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22282377|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu|
22282378|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22282379|NCT01849575|Umea University, Sweden|Dr Margareta Norberg|+46907865544|margareta.norberg@umu.se|
22282380|NCT00945061|University Hospitals Cleveland Medical Center , Case Comprehensive Cancer Center|Dr. Janice A. Lyons, MD|+1 216-844-2536|Janice.Lyons@uhhospitals.org|
22282381|NCT02509039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22282382|NCT03359785|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22282383|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu|
22282384|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org|
22315373|NCT03724253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22315374|NCT01449149|Department of Radiation Oncology, PENN MEDICINE|Michelle Alonso-Basanta, MD PhD|215 615 3782|michelleab@uphs.upenn.edu|
22315375|NCT02224469|University Medical Center Utrecht|Dr E.J. Aarnoutse|+31887555123|e.j.aarnoutse@umcutrecht.nl|
22315376|NCT03721172|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22315377|NCT02417441|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22315378|NCT03080142|UC Davis Medical Center, Department of Anesthesiology|Jon Zhou MD|9167035028|jonzhou@ucdavis.edu|
22315379|NCT05628285|Oticon Medical AB|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
22315380|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com|
22315381|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
22315382|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
22315383|NCT03016598|Portland VA|Delaney.McKechnie@va.gov|360-696-4061|Delaney.McKechnie@va.gov|32017
22315384|NCT05400837|Johns Hopkins University|Nino Isakadze|443-997-0270|nisakad1@jh.edu|
22315385|NCT01101061|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22315386|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22315387|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743||
22315388|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com|
22315389|NCT00133575|Brigham and Women's Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org|
22315390|NCT04016272|Florida State University|Dr. Hyochol Ahn|850-644-2647|hahn@fsu.edu|
22315391|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22315392|NCT03725605|Lytix Biopharma AS|Director Scientific Research Baldur Sweinbjornsson|+47 413 44 682|Baldur.Sveinbjornsson@lytixbiopharma.com|
22315393|NCT01503086|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22315394|NCT06017050|Center for Innovative Public Health Research|Michele Ybarra|8773026858|michele@innovativepublichealth.org|801
22282385|NCT03276026|Jefferson|Dr. Adam Thaler|215-901-0749|thaler.adam@gmail.com|
22315395|NCT01197612|University of Michigan|Garrett Griffin, MD||ggriffin@mw-fp.com|
22315396|NCT02419417|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22326190|NCT04907539|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
22326191|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22326192|NCT04067765|University of Kansas|Dr. Michael Amlung|785-864-0334|mamlung@ku.edu|
22326193|NCT02163993|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326194|NCT01808118|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22326195|NCT03902366|VA Portland Health Care System|Jennifer Loftis, PhD|503-220-8262|jennifer.loftis@va.gov|57155
22326196|NCT02369835|Stanford University|Beth Beadle|650-723-6194|bbeadle@stanford.edu|
22326197|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
22326198|NCT03041116|Retrophin, Inc.|Clinical Trial Information Desk|+1-877-659-5518|medinfo@retrophin.com|
22326199|NCT03097328|Dana Farber Cancer Institute|Bradley McGregor, MD|617-632-6328|Bradley_McGregor@DFCI.harvard.edu|
22326200|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com|
22326201|NCT02023164|TerSera Therapeutics LLC|Executive Director, Clinical Development|888 600 8116|jnorth@tersera.com|
22326202|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com|
22326203|NCT01815333|UT MD Anderson Cancer Center|Haesun Choi, MD/ Professor, Abdominal Imaging Department|713-745-4693|hchoi@mdanderson.org|
22326204|NCT00750555|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
22326205|NCT02880319|DFCI/BWH|Dr. Tracy Balboni|6177327948|tbalboni@bwh.harvard.edu|
22326206|NCT01984346|AtriCure|Medical Director of Clinical Education|513-560-5974|SGaynor@atricure.com|
22326207|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com|
22326208|NCT03100942|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22326209|NCT01523808|Erytech Pharmaceuticals|Director of Clinical Trials|+33 4 78 74 44 38|contact@erytech.com|
22326210|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu|
22326211|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22326212|NCT00718419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326213|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com|
22326214|NCT04184622|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22326215|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov|
22326216|NCT02795988|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
22326217|NCT02341014|Memorial Sloan Kettering Cancer Center|Dr. Steve Horwitz, MD|646-608-2680|horwitzs@MSKCC.ORG|
22326218|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326219|NCT05058664|University of Michigan|Ewa Czyz|734 764-9466|ewac@med.umich.edu|
22326220|NCT02599766|Swiss TPH|Dr. Karin Hediger|0041795197885|karin.hediger@unibas.ch|
22326221|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22326222|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
22326223|NCT03480282|Beth Israel Deaconess Medical Center|Mara Schonberg|16177541414|mschonbe@bidmc.harvard.edu|
22326224|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au|
22326225|NCT03848221|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22326226|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi|
22282386|NCT03650803|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Holly Marshall|216-844-5330|Holly.Marshall@uhhospitals.org|
22326227|NCT03685019|University of Oxford|Thomas Hamilton|01865 227374|thomas.hamilton@ndorms.ox.ac.uk|
22326228|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com|
22326229|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22326230|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu|
22326231|NCT05100316|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326232|NCT05628181|University of Michigan|Donovan Maust|734-845-3649|maustd@med.umich.edu|
22326233|NCT01234402|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326234|NCT03993691|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22326235|NCT02280291|NYU Langone Health|Nirmal Tejwani|212 598 6599|Nirmal.Tejwani@nyulangone.org|
22326236|NCT03508622|Children's Hospital Los Angeles|Brenda Manzanarez|323/361-8245|bmanzanarez@chla.usc.edu|
22326237|NCT05175261|Prolocor, Inc|David J Schneider, MD|8023730071|david.schneider@prolocor.com|
22326238|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326239|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu|
22326240|NCT02243527|University of British Columbia|Dr. Jordan A. Guenette|604.682.2344|Jordan.guenette@hli.ubc.ca|62129
22326241|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22326242|NCT04174638|Akdeniz University|Dr Sefika Tugba Yangoz|+905058039716|tugbayangoz@gmail.com|
22326243|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22326244|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com|
22326245|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577|akausz@allenapharma.com|314
22326246|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326247|NCT01400971|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326248|NCT01729598|University of Kentucky|Dr. Gregory A. Jicha|859-323-5550|gregory.jicha@uky.edu|
22282387|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org|
22282388|NCT01101971|Queen's University|Dr. Robert Reid|6135332898|reidr@queensu.ca|32898
22282389|NCT03664674|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22282390|NCT05082428|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315397|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov|
22315398|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com|
22315399|NCT00159263|Imperial College London|Peter Barnes|+44 (0)20 7594 7959|p.j.barnes@imperial.ac.uk|
22315400|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22315401|NCT04075903|University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology|Lesley Jackson, MD, MSPH|205-934-1779|lejackson@uabmc.edu|
22315402|NCT03617289|Henry Ford Health System|Dr. Jason Muir|517-861-6451|jmuir1@hfhs.org|
22315403|NCT03382769|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22315404|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22315405|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743||
22315406|NCT03053453|NYU Langone Health|Dr. Arthur Hertling|2125986085|Arthur.Hertling@nyulangone.org|
22315407|NCT03332784|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22315408|NCT03306420|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22315409|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22315410|NCT01827046|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
22315411|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu|
22315412|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org|
22315413|NCT05594589|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-2-3451-5533|s-kwon@eisaikorea.com|
22315414|NCT03623373|Washington University School of Medicine|Brad S. Kahl, M.D.|314-273-3591|bkahl@wustl.edu|
22315415|NCT02282917|Mass General Brigham|Matthew E Stenerson, MSc, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
22315416|NCT00115336|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
22315417|NCT02482610|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22315418|NCT03272711|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
22315419|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu|
22315420|NCT01545557|Galderma|Clinical project manager|817-961-5655|aestheticclinicaltrials@galderma.com|
22315421|NCT03180008|University of Illinois at Chicago|Andrew DeMott, MPH|312-355-3174|ademot1@uic.edu|
22315422|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu|
22315423|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22315424|NCT04253119|MSD Pharmaceuticals LLC|Vladimir Achikyan, Medical Affairs Manager|79161981264|vladimir.achikyan@merck.com|
22315425|NCT03566979|Johnson & Johnson Worldwide|Steven Sacavage, Associate Director Clinical Research|215-273-8568|SSacavag@its.jnj.com|
22315426|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22315427|NCT03784820|University of North Carolina at Chapel Hill|Hunna Watson, PhD|984-974-5217|hunna_watson@med.unc.edu|
22315428|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300||
22315429|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu|
22315430|NCT03786744|Samara Medical Center Dinasty|Volchkov Stanislav|+78469564455|quality@cordbank.ru|
22315431|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu|
22282391|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org|
22315432|NCT00569127|SWOG|SWOG Statistician|206-667-4408||
22315433|NCT05147272|Repare Therapeutics|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
22315434|NCT03348631|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22315435|NCT01068210|Memorial Sloan Kettering Cancer Center|Dr. Lee Jones, PhD|646-888-8103|jonesl3@mskcc.org|
22315436|NCT03569891|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22315437|NCT06314438|University of Washington|Principal Investigator|206-221-3595|stonew@uw.edu|
22315438|NCT03299959|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
22315439|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315440|NCT02145169|Albert Einstein Medical Center|Kamran Mohiuddin. Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EISNTEIN.EDU|
22315441|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22315442|NCT01907269|University of Alabama at Birmingham|Dr. Elizabeth J. Rahn|2059966552|rahneli@uab.edu|
22282392|NCT02638207|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22315443|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu|
22315444|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22326249|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
22326250|NCT03634072|Children's Hospital of Philadelphia|Dr Mark Fogel|215-590-7566|fogel@chop.edu|
22315445|NCT03494985|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326251|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22282393|NCT04584346|National Institutes of Health|Dr. Debra Ehrlich|301-443-7888|debra.ehrlich@nih.gov|
22315446|NCT02282059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299763|NCT03198000|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD, MPH|(973) 255-8701|AParikh1@its.jnj.com|
22299764|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
22299765|NCT01953926|Puma Biotechnology, Inc.|Sr Director, Clinical Operations|4242486500|clinicaltrials@pumabiotechnology.com|
22299766|NCT01276587|Columbia University|Margaret Lee, MD|212-305-6290|ml653@cumc.columbia.edu|
22299767|NCT04644328|Massachusetts Institute of Technology|Esther Duflo|617-258-7013|eduflo@mit.edu|
22299768|NCT04102501|Retrotope|Mark G. Midei, MD, VP Medical Affairs|4103715357|mark@retrotope.com|
22299769|NCT03329352|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
22326252|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299770|NCT02338362|Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada|Dr. Graham Trope|1-416-603-5117|graham.trope@uhn.ca|
22299771|NCT03330834|Sun Yat-sen University Cancer Center|Dr.Yuxiang Ma|86 020 87343894|mayx@sysucc.org.cn|
22299772|NCT04798586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299773|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22299774|NCT04433767|Vanderbilt University Medical Cdenter|Warren Taylor, MD, Director of the DIvision of Geriatric Psychiatry|615-322-1073|warren.d.taylor@vumc.org|
22299775|NCT02388633|OregonHSU|Jonathan Lindner, MD|5034949191|lindnerj@ohsu.edu|
22299776|NCT03447782|Boston Children's Hospital|Dr. Alyssa Lebel|7812161960|alyssa.lebel@childrens.harvard.edu|
22299777|NCT02908269|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22299778|NCT03176693|University of California Los Angeles|Masha Livhits, MD|310-206-0585|mlivhits@mednet.ucla.edu|
22299779|NCT03325712|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299780|NCT02265237|AbbVie|Global Medical Information|800-633-9110||
22299781|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil|
22299782|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22299783|NCT03550313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299784|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22299785|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com|
22299786|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22299787|NCT03191903|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
22299788|NCT03149328|University of Alberta|Dr. Kara Schick-Makaroff|1-780-492-9043|kara.schickmakaroff@ualberta.ca|
22299789|NCT02358889|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22299790|NCT00503685|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22299791|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
22299792|NCT01027793|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
22299793|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22299794|NCT01976416|Indiana University|Dr Chandy John|317-274-8940|chjohn@iu.edu|
22299795|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu|
22299796|NCT02897141|Columbia University|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
22299797|NCT02936076|The Miriam Hospital|Dr. Jessica Unick|401-793-8966|junick@lifespan.org|
22299798|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22299799|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743||
22299800|NCT04575896|Johns Hopkins University|Niraj Desai, MD|410-614-8297|ndesai13@jhmi.edu|
22299801|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
22299802|NCT02498483|Columbia University|Jennifer Woo Baidal|212-342-2962|jw3286@cumc.columbia.edu|
22299803|NCT04704375|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
22299804|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22299805|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299806|NCT02395120|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
22299807|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242||
22299808|NCT04546581|University of Minnesota|James Neaton|612-626-9040|neato001@umn.edu|
22299809|NCT02526693|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22299810|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
22299811|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22299812|NCT02250612|Sylentis|Clinical Trials Department||info@sylentis.com|
22299813|NCT02241967|Ralph H. Johnson VA Medical Center|Jeffrey Borckardt, Ph.D|843-792-3295|Jeffrey.Borckardt@va.gov|
22299814|NCT00381966|Johns Hopkins University|Daniel Song|401-502-5875|dsong2@jhmi.edu|
22299815|NCT04579757|HUTCHMED Limited|Nicky Murray|+44 7738 881999|nicolam@hutch-med.com|
22299816|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47||
22326253|NCT00620321|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22299817|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
22326254|NCT05137041|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22299818|NCT05912400|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|IWen@uams.edu|24024
22299819|NCT03319277|Cleveland Clinic|Emily RW Davidson, M.D.|812-272-2380|dr.emily.rose@gmail.com|
22299820|NCT02346383|CCAMP|J Kelby Hutcheson MD|8642956399|khutchesonmd@carolinapain.com|
22315447|NCT03459846|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22282394|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org|
22315448|NCT00001481|National Institute of Mental Health (NIMH)|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
22282395|NCT00534118|Roswell Park Cancer Institute|Theresa Hahn|716-845-2300|theresa.hahn@roswellpark.org|
22315449|NCT04886518|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and Regulatory Writing|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
22315450|NCT03987295|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
22315451|NCT00310180|ECOG-ACRIN Cancer Research Group|ECOG-ACRIN statistician|617-632-3000|eatrials@jimmy.harvard.edu|
22315452|NCT04978129|University of Texas at Arlington|Melissa Lewis|817-272-9833|Melissa.Lewis@uta.edu|
22315453|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22315455|NCT02748889|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
22315456|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315457|NCT03305887|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
22315458|NCT03607422|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22315459|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu|
22315460|NCT03941600|Washington University School of Medicine|Dr. Kerri Morgan|314-286-1659|morgank@wustl.edu|
22315461|NCT03258723|Yale School of Medicine|Marcella Nunez-Smith, MD, MHS|(203) 785-6454|marcella.nunez-smith@yale.edu|
22315462|NCT04832971|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
22315463|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22315464|NCT03584152|Stanford University|Sam P. Most, MD, MBA|(650) 724-8019|smost@stanford.edu|
22315465|NCT04024462|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22315466|NCT01351805|Brigham and Women's Hospital/ Harvard Medical School|Karen Costenbader|16177326088|kcostenbader@bwh.harvard.edu|
22315467|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu|
22315468|NCT04292470|University of California Davis|Dr. Michelle Dossett|916-734-5367|mdossett@ucdavis.edu|
22315469|NCT00867100|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22315470|NCT02906020|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22315471|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
22315472|NCT02701062|AtriCure|Nfii Ndikintum, VP Clinical Affairs and Biometrics|(513) 644-8192|nndikintum@atricure.com|
22315473|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832||
22315474|NCT00399841|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22315475|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com|
22315476|NCT04982588|Medtronic, Inc.|Fairy Liu|+86-02120325765|rs.evolutprochinaclinicalstudy@medtronic.com|
22315477|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu|
22315478|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu|
22315479|NCT03792347|Ruijin Hospital, Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
22315480|NCT02743897|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
22315481|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
22315482|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22315483|NCT02229227|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315484|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315485|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu|
22315486|NCT03934099|LG Chem|Younghwan Jang|02-6987-4154|younghj@lgchem.com|
22315487|NCT02869867|Centre Hospitalier Départemental Vendée|Dr Yves-Marie PLUCHON|251446248|yves-marie.pluchon@chd-vendee.fr|+33
22315488|NCT05555615|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
22315489|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22315490|NCT02872012|University of Michigan Kellogg Eye Center|Dr. Anjali Shah|734-763-8122|arshah@med.umich.edu|
22315491|NCT01728623|Eisai Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22315492|NCT03000348|NovaBiotics Ltd|Dr Deborah O'Neil, CEO|01224 711 377|deborah@novabiotics.co.uk|
22315493|NCT00723125|BrUOG|William Sikov, MD|4018633000|Roxanne_Wood@brown.edu|
22315494|NCT01667549|Monell Chemical Senses Center|Julia A. Mennella, PhD; Study Principal Investigator|267-519-4880|mennella@monell.org|
22315495|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315496|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org|
22315497|NCT04947514|Montefiore Medical Center|Dr. Amy Yao|7189204800|amyao@montefiore.org|123
22315498|NCT01807182|Fred Hutchinson Cancer Center|Dr. Sylvia Lee|206-606-2274|smlee@fredhutch.org|
22315499|NCT04092452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315500|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
22282396|NCT04270682|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22282397|NCT00589056|University of Pennsylvania|Ramesh Rengan, M.D., Ph.D.|(215) 662-2428|Rengan@xrt.upenn.edu|
22315501|NCT01367444|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22315502|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr|
22315503|NCT02127125|San Antonio Geriatric Research, Education, and Clinical Center|Dr. Nicolas Musi|(210) 562-6140|musi@uthscsa.edu|
22315504|NCT03037203|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2159707145|ClinicalTrialDisclosure@JazzPharma.com|
22315505|NCT02498236|University of California, Los Angeles|Dr. Stephen R. Marder|3104783711|SMarder@mednet.ucla.edu|83647
22315506|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493||
22315507|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com|
22315508|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315509|NCT03170518|Janssen Research & Development, LLC|Director Clinical Leader Internal Medicine|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22315510|NCT03842436|Brigham and Women's Hospital|Peter R. Chai, MD, MMS|617-732-5640|pchai@bwh.harvard.edu|
22315511|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org|
22315512|NCT03995225|Yale School of Medicine|Kathleen A Garrison|415-260-8618|kathleen.garrison@yale.edu|
22315513|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu|
22315514|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315515|NCT03766373|Novus Therapeutics|Clinical Director|949-679-1110|study004@novustherapeutics.com|
22315516|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22315517|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com|
22315518|NCT02559310|Nabriva Therapeutics US, Inc.|Jennifer Schranz, MD, Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
22315519|NCT04596540|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
22315520|NCT02950259|Earle A. Chiles Research Institute, Providence Cancer Institute|Dr. David B. Page|503-215-6588|david.page2@providence.org|
22315521|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315522|NCT00433511|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22315523|NCT01375673|WJB Dorn VAMC (VHA)|Andrea M. Boyd, PhD, Asscoaite Nurse Executive, Research/Education|803.776.4000|andrea.boyd@va.gov|5654
22315524|NCT06193967|University of Tennessee, Knoxville|Dr. Hollie Raynor|865-974-9126|hraynor@utk.edu|1
22315525|NCT04698915|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
22315526|NCT02349152|University of Pittsburgh|Dr. Kathirvel Subramaniam, MD, MPH|412-647-5635|subramaniamk@upmc.edu|
22315527|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
22315528|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660||
22315529|NCT01124097|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
22315530|NCT05687032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315531|NCT04829747|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22315532|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
22315533|NCT02367352|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22315534|NCT02866669|University of Alabama at Birmingham|Dr. Andrea Cherrington|205-996-2885|acherrington@uabmc.edu|
22315535|NCT05878873|Colorado State University|Dr. Brett Fling|(970) 491-3451|brett.fling@colostate.edu|
22315536|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu|
22315537|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu|
22315538|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
22315539|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
22315540|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
22315541|NCT02563548|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
22315542|NCT04312256|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22315543|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov|
22315544|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br|
22315545|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315546|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22315547|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22315548|NCT03178344|Department of Psychiatry, UNC Chapel Hill|Jhana Parikh|919-966-9929|jhana_parikh@med.unc.edu|
22315549|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22315550|NCT04468230|Virginia Commonwealth University|Renato Martins, MD|804-828-1965|MasseyCPC@vcu.edu|
22315551|NCT03714659|New Jersey Regenerative Institute|Dr. Gerard Malanga|9739988301|gmalangamd@hotmail.com|
22315552|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315553|NCT03343093|University of Minnesota|Gudrun Kilian|612-626-9568|kilian@umn.edu|
22315554|NCT03994731|Horizon Therapeutics USA, Inc.|Medical Monitor|866-479-6742|clinicaltrials@horizontherapeutics.com|
22315555|NCT06476834|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22315556|NCT05288829|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22315557|NCT03377361|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22315558|NCT03218566|Penumbra, Inc.|Erin Archard, Sr. Clinical Study Manager|+1 510 995 9801|earchard@penumbrainc.com|
22315559|NCT04937920|DermBiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
22315560|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22315561|NCT06733103|University of East Anglia|Sophie Livsey|07947272186|sophie.livsey1@nhs.net|
22315562|NCT03698994|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22315563|NCT03316807|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22315564|NCT03329300|University of Alabama at Birmingham Department of Pediatrics|Marissa Gowey, PhD|2056386618|marissa.gowey.phd@gmail.com|
22315565|NCT02046512|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
22315566|NCT03482752|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22315567|NCT02844777|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
22315568|NCT01776008|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@dom.wustl.edu|
22315569|NCT00150618|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22315570|NCT01162486|Johns Hopkins University School of Medicine|Dr. Kelly E. Dooley|410-955-3100|kdooley1@jhmi.edu|
22315571|NCT03434028|Massachusetts General Hospital|PETAL Clinical Coordinating Center PI|617-872-2882|tthompson1@mgh.harvard.edu|
22315572|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221|in2139@osaka-med.ac.jp|8096
22315573|NCT02296892|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
22315574|NCT03928392|Loma Linda University|Dr. Dragana Krpalek|9095584328|dkrpalek@llu.edu|41340
22315575|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu|
22315576|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315577|NCT04101565|Johns Hopkins Dept of Pediatrics / Division of Adolescent/Young Adult Medicine|Dr. Arik Marcell|4432878946|amarcell@jhu.edu|
22315578|NCT04461158|Medical University of South Carolina|Dr. Jim C. Oates, MD, Rheumatology Division Director|843-792-1991|oatesjc@musc.edu|
22315579|NCT03375320|Dana-Farber Cancer Institute|Jennifer A. Chan, MD, MPH|617-632-6315|jang@partners.org|
22315580|NCT03172975|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
22315581|NCT04556305|University of Illinois Chicago|Dr. Shannon Halloway|(312) 996-7800|sthallow@uic.edu|
22315582|NCT04907357|Medical University of South Carolina|Kathleen Brady, MD, PhD|843-792-5205|bradyk@musc.edu|
22282398|NCT03894969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315583|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22315584|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315585|NCT03512197|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22315586|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
22315587|NCT02121912|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|
22315588|NCT02923193|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
22315589|NCT03358238|University of Wisconsin-Madison|Amy Cochran|608-262-0772|cochran4@wisc.edu|
22315590|NCT02633397|Dean, University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, Baltimore|Mark Gladwin|410-706-7410|mgladwin@som.umaryland.edu|
22315591|NCT03595878|University of North Carolina Lineberger Comprehensive Cancer Center|Colette Shen|+1 984-974-0400|cjshen@email.unc.edu|
22315592|NCT03036124|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
22271173|NCT03376256|University of Miami|Dr. Ralf Gebhard|3055858365|rgebhard@med.miami.edu|
22271174|NCT04450407|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22282399|NCT06107803|Minerva Neurosciences|Joseph Reilly|617-600-7373|JReilly@minervaneurosciences.com|
22282400|NCT03099174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22282401|NCT04173260|University of Pennsylvania|Dr. Andres Deik|2158297049|adeik@upenn.edu|
22282402|NCT04730635|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315593|NCT02774668|University of Missouri|Elizabeth Parks, Professor of Nutrition and Exercise Physiology|573-882-5864|parksej@missouri.edu|
22271175|NCT04542421|u of colorado|Dr Anna Maw|720-848-4289|anna.maw@cuanschutz.edu|
22271176|NCT04696354|Philips|Danielle Op den Kamp, Sr Manager Clinical Operations|+31 (0)627218737|Danielle.op.den.kamp@philips.com|
22271177|NCT03040804|Montefiore Medical Center|Steven R. Cohen, MD, MPH|7189208352|srcohen@montefiore.org|
22271178|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com|
22271179|NCT04216784|Rush University Medical Center|Lance Lineberger|312-942-5126|Lance_Lineberger@rush.edu|
22271180|NCT05741346|BioCryst Pharmaceuticals Inc.|Study Director|+001 919859 1302|clinicaltrials@biocryst.com|
22271181|NCT04439357|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22271182|NCT05573672|Canadian College of Naturopathic Medicine|Monique Aucoin|416 498 1255|maucoin@ccnm.edu|223
22271183|NCT03790618|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22271184|NCT03384784|University of Pennsylvania|Rebecca Ashare|215.746.7143|rlashare@pennmedicine.upenn.edu|
22271185|NCT01668966|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271186|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271187|NCT04247880|University of Washington|Dr. Marissa Baker|206 616 4709|bakermg@uw.edu|
22271188|NCT01701193|University of Saskatchewan|Roger Pierson, PhD|306-884-1059|roger.pierson@usask.ca|
22271189|NCT03054064|Parker Hannifin Corporation|Ryan J. Farris, Ph.D., P.E.|2168963335|ryan.farris@parker.com|
22315595|NCT05752474|Hebrew Rehabilitation Center, Hebrew SeniorLife|Dae Hyun Kim|6179715362|daehyunkim@hsl.harvard.edu|
22271190|NCT02961062|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22315596|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org|
22315597|NCT05454813|Medline Industries, L:P|Julie Miller|630-418-6891|jamiller@medline.com|
22315598|NCT04949802|ViaLase Inc.|Melvin Sarayba, MD|9494662856|melvin.sarayba@vialase.com|
22315599|NCT03778294|Mayo Clinic|Dr Sujay Vora|480-342-1262|Vora.Sujay@mayo.edu|
22315600|NCT01845805|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22315601|NCT00127842|Amgen Inc.|Study Director|866-572-6436||
22315602|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22315603|NCT03595124|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22315604|NCT01888874|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
22315605|NCT02763215|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22315606|NCT00769600|MSKCCC|Charles Rudin, MD|646-888-4336|rudinc@mskcc.edu|
22315607|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22315608|NCT02277054|Filatov Institite of Eye Diseases and Tissue Therapy of the NAMS of Ukraine|Dr. Oleksiy Buznyk|+380487181548|a_buznik@bk.ru|
22315609|NCT02963090|Duke Cancer Institute|Thomas Stinchcombe, MD|(919) 668-6688|thomas.stinchcombe@duke.edu|
22315610|NCT01784523|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
22315611|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22315612|NCT02179177|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
22315613|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22315614|NCT00884650|Children's Hospital Colorado|Dr. Frank Chang|720-777-6900|Chang.Frank@tchden.org|
22315615|NCT04334278|University of Kentucky|Caitlin Conley|8592571939|caitlin.conley2@uky.edu|
22315616|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu|
22315617|NCT00566540|The Ohio State University Comprehensive Cancer Center|Enzer Ozer, MD|614-293-8074|enver.ozer@osumc.edu|
22315618|NCT01908751|McMaster University|Dr. Mohit Bhandari|9055274322|bhandam@mcmaster.ca|
22315619|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
22315620|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov|
22315621|NCT04620369|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
22315622|NCT03635086|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315623|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
22315624|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315625|NCT02977286|Tufts Medical Center|Erik Garpestad, M.D.|617-636-5388|egarpestad@tuftsmedicalcenter.org|
22315626|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22315627|NCT04458818|Combined Military Hospital Kharian, Punjab Pakistan|Dr Muhammad Noman Karim|+923313358884|f9noman@gmail.com|
22315628|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov|
22315629|NCT02493946|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
22315630|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu|
22315631|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22315632|NCT02389764|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
22315633|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com|
22315634|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu|
22315635|NCT04198571|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315636|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315637|NCT01814072|Northwestern University Feinberg School of Medicine|Bonnie Spring, PhD, ABPP|312-908-2293|bspring@northwestern.edu|
22315638|NCT02781311|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22315639|NCT04115189|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315640|NCT02562898|University of California, San Francisco|Dr. Margaret Tempero|415-353-7528|Margaret.Tempero@ucsf.edu|
22315641|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22315642|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315643|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315644|NCT04147858|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22315645|NCT02615938|LMU/ Haunersches Kinderspital|Prof. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
22315646|NCT06173687|Cochlear Limited|PRS Specialist|+612 9428 6555|cltd-prs-admin@cochlear.com|
22315647|NCT04905849|UC San Francisco|Dr. Joaquin A. Anguera, Associate Professor|415 502 7322|joaquin.anguera@ucsf.edu|
22315648|NCT04121897|University of North Carolina at Chapel Hill|Dana McCarty, PT, DPT|919-843-8792|dana_mccarty@med.unc.edu|
22315649|NCT05010850|SafeHeal|Heather Cronin, VP Clinical Affairs|5184289593|hcronin@safeheal.com|
22315650|NCT02810873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Mathew Thakur|215-503-7874|mathew.thakur@jefferson.edu|
22326255|NCT02433210|University of Missouri, Department of Medicine, Division of Nephrology|Dr. Madhukar Misra, MD|573 882-7993|misram@health.missouri.edu|
22271191|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu|
22271192|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com|
22326256|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
22326257|NCT02983981|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
22326258|NCT05936385|Nemours Children's Health|Thao-Ly Phan, Associate Professor of Pediatrics|302-331-7342|tphan@nemours.org|
22326259|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com|
22326260|NCT04126603|George Washington University|Sabyasachi Sen|202-994-8560|ssen1@gwu.edu|
22326261|NCT05374408|UNMC|Margaret Emerson|4025596625|margaret.emerson@unmc.edu|
22326262|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326263|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22326264|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326265|NCT03450369|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
22326266|NCT02641236|Dana-Farber Cancer Institute|Dr. Leslie Lehmann|617-632-4882|Leslie_Lehmann@DFCI.HARVARD.EDU|
22326267|NCT02985450|Carla Coffin|Dr.|403-220-7808|cscoffin@ucalgary.ca|
22326268|NCT00069576|GWU Biostatistics Center|Rebecca Clifton, Ph.D.|(301) 881-9260|rclifton@bsc.gwu.edu|
22326269|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924||
22326270|NCT05590793|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22326271|NCT04060667|Massachusetts General Hospital|Adeline Boatin|617 724 61320|adeline_boatin@mgh.harvard.edu|
22326272|NCT03015610|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
22326273|NCT01603641|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22326274|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com|
22326275|NCT00358917|Abbott|Medical Information Specialist|800-633-9110||
22326276|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22326277|NCT03347617|Oregon Health and Science University|Amy Huddleston|5034942910|huddlesa@ohsu.edu|
22326278|NCT01417780|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
22326279|NCT02086565|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
22326280|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se|
22326281|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
22326282|NCT02890329|Dana Farber Cancer Institute|Dr. Jacqueline Garcia|617-632-1906|Jacqueline_Garcia@dfci.harvard.edu|
22326283|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300||
22326284|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
22326285|NCT01379534|Novartis|Study Director|862-778-8300||
22326286|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org|
22326287|NCT01253460|The University of Texas MD Anderson Cancer Center|William G Wierda, MD/Professor|713-745-0428|wwierda@mdanderson.org|
22326288|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
22315651|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu|
22315652|NCT04683510|University of Tennessee Health Science Center|Principle investigator|(901)448-2383|mmart126@uthsc.edu|
22315653|NCT03771638|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628.217.7479|susan.buchbinder@sfdph.org|
22315654|NCT05190770|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
22315655|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22315656|NCT02884492|Columbia University Medical Center (Taub Institute)|William C. Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
22315657|NCT02706249|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
22315658|NCT05101993|AtriCure|Randall Lee, VP Medical Affairs, Clinical Affairs|650-347-0419|RLee@atricure.com|
22315659|NCT04577573|James J. Peters VA Medical Center|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
22315660|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661|bmasel@tlcgalveston.org|411
22315661|NCT01439867|Amgen Inc.|Study Director|866-572-6436||
22315662|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22315663|NCT01415934|University of Colorado|Carrie Brill|303 808 9708|CARRIE.BRILL@UCDENVER.EDU|
22315664|NCT04042077|Menarini Ricerche S.p.A.|Corporate Director of Clinical Sciences|0555680|acapriati@menarini-ricerche.it|9990
22315665|NCT04530604|University of Michigan|Principal Investigator, Dr. Greg Yanik|734 232-9335|gyanik@med.umich.edu|
22315666|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu|
22315667|NCT02878603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22315668|NCT02689453|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
22315669|NCT00794924|Kaplan-Harzfeld Geriatric Medical Center|Hilla Zaharoni|97288595350|hilla_z@clalit.org.il|
22315670|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu|
22315671|NCT03274895|SIFI SpA|Dr. Jelle Kleijn|+31615643708|jelle.kleijn@sifigroup.com|
22315672|NCT01969851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22326289|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu|
22326290|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326291|NCT01597193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326292|NCT03595215|TheraNova|Clinical Research Associate|415-926-8616|akrajcevska@theranova.com|
22326293|NCT03184701|Albert Einstein Healthcare Netwrok|Manisha Verma|2154561026|vermam@einstein.edu|
22326294|NCT04073823|Tactile Medical|Michelle Wetherby|612.230.4576|mwetherby@tactilemedical.com|
22315673|NCT01754753|The University of Sheffield|Daniel Hind - Assistant Director Sheffield Clinical Trials Research Unit|441142220707|d.hind@sheffield.ac.uk|
22315674|NCT03229486|Pusan National University Yangsan Hospital|Professor|0553602756|anesktk@pusan.ac.kr|
22315675|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu|
22315676|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121|on5083@msn.com|7027
22315677|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu|
22315678|NCT01782690|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22315679|NCT03981939|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22315680|NCT02037620|University of Louisville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
22315681|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501|eric.chen@uhn.ca|2263
22315682|NCT01637077|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-1623|loprinzi.charles@mayo.edu|
22315683|NCT02638103|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22315684|NCT02353312|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|16237
22315685|NCT04199052|University of California San Diego|Dr. Jamila K. Stockman, Professor|(858) 822-4652|jstockman@health.ucsd.edu|
22315686|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu|
22315687|NCT01358331|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure||ClinicalTrialsDisclosure@merck.com|
22315688|NCT04946942|Weill Medical College of Cornell University|Catherine Riffin, PhD|(203) 303-4904|acr2213@med.cornell.edu|
22315689|NCT03342196|University Hospitals, Case Comprehensive Cancer Center|Principle Investigator|216-844-0139|Leland.Metheny@uhhospitals.org|
22315690|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu|
22315691|NCT02325830|Cardiac Dimensions|Vice President of Clinica Affairs|425-605-5922|aswenson@cardiacdimensions.com|
22315692|NCT03023423|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22315693|NCT01151423|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
22315694|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com|
22315695|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22315696|NCT01654068|University of Kentucky|Ronal McGarry|859-323-6486|rcmcga2@email.uky.edu|
22315697|NCT04277507|Aerin Medical|Director of Clinical Operations|650-518-9624|alaborde@aerinmedical.com|
22315698|NCT01227616|AMAG Pharmaceuticals|Medical Information||CTInterest@covispharma.com|
22315699|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu|
22315700|NCT01740154|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22315701|NCT05723263|University of North Carolina at Chapel Hill|Joseph Tucker, MD, PhD|919-966-2536|jdtucker@med.unc.edu|
22315702|NCT02520310|Abbott Structural Heart|Sripad Bellary|650-353-1726|sripad.bellary@abbott.com|
22315703|NCT05032066|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22315704|NCT05564637|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|reddy.yogesh@mayo.edu|
22315705|NCT02065882|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
22315706|NCT06719986|Purdue Pharma|Clinical Leader|1-888-726-7535|Purduemedinfo@pharma.com|
22315707|NCT04581343|PanCAN|Samantha Pedersen, Sr. Director Clinical Operations|310.706.3726|spedersen@pancan.org|
22315708|NCT03213704|Children's Oncology Group|Results Reporting Coordinator|(626) 241-1500|resultsreportingcoordinator@childrensoncologygroup.org|
22315709|NCT03660826|NRG Oncology|Helen Huang on behalf of Danielle Enserro, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
22315710|NCT05609604|UBuffalo|Paresh Dandona|17168818924|ghanim@buffalo.edu|
22315711|NCT00233480|Ahmanson-UCLA Cardiomyopathy Center|Tamara B Horwich, MD|310-825-8676|thorwich@mednet.ucla.edu|
22315712|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com|
22315713|NCT03222505|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22315714|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be|
22315715|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu|
22315716|NCT05302440|University of Hong Kong|Dr. Derek Yee Tak CHEUNG|3917 6652|derekcheung@hku.hk|
22315717|NCT04486625|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315718|NCT01411241|Sanofi Pasteur|Director||Contact-US@sanofi.com|
22315719|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu|
22315720|NCT02980042|University of Colorado Anschutz, Neurology Department|Dr. Timothy Vollmer|3037242187|timothy.vollmer@ucdenver.edu|
22315721|NCT02521363|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina, MD|646-888-4558|trainat@MSKCC.ORG|
22315722|NCT00953771|Mount Sinai Beth Israel|Dr. Ilan Shapira|212-844-8948|Ilan.Shapira@mountsinai.org|
22315723|NCT00974259|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
22315724|NCT03991741|University of California, San Diego|Gregory Daniels, MD, PhD|(858) 822-5354|CancerCTO@health.ucsd.edu|
22315725|NCT06024278|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
22315726|NCT00592293|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
22315727|NCT01933243|Nationwide Children's Hospital|Andrea Bonny|614-722-2458|andrea.bonny@nationwidechildrens.org|
22315728|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326295|NCT00590681|University of Chicago|Amanda Spratt|773-834-4031|aspratt@bsd.uchicago.edu|
22315729|NCT05330988|Department of Veterans Affairs|Dr. John H. Kindred|8437924328|john.kindred1@va.gov|
22315730|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|503-494-7999|trials@ohsu.edu|
22315731|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu|
22315732|NCT02870972|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22315733|NCT04646369|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
22315734|NCT04052425|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22315735|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100|deborah.fritz@va.gov|53692
22315736|NCT00945672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315737|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org|
22315738|NCT01681992|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315739|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
22315740|NCT03880019|Columbia University Medical Center|Matthew Ingham, MD|646-317-7141|mi2337@cumc.columbia.edu|
22315741|NCT04148989|Intermountain Health|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
22315742|NCT03812029|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
22315743|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
22315744|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22315745|NCT02526498|Cancer Institute of New Jersey|Bruce Haffty|732-235-5203|hafftybg@cinj.rutgers.edu|
22315746|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu|
22315747|NCT02694445|Department of Neurology, Xuan Wu Hospital,Beijing,China|Jianping Jia|010-63150669|jiajp@vip.126.com|
22315748|NCT02269423|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315749|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22315750|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315751|NCT04176731|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22315752|NCT04674189|CureVac SE|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22315753|NCT00920647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22315754|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22315755|NCT00691600|Baylor College of Medicine|Andrea T. Cruz, MD, MPH|832-824-5582|acruz@bcm.edu|
22315756|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351||
22315757|NCT01261247|Mayo Clinic Cancer Center|Patrick Johnston, MD, PhD|507-284-2511|johnston.patrick@mayo.edu|
22315758|NCT05226130|VA San Diego Healthcare System, San Diego, CA|Ruth Klaming, PhD|858-552-8585|rklaming@health.ucsd.edu|
22315759|NCT03358472|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22315760|NCT03974022|Dizal Pharmaceuticals|Li Zheng|862161097899|clinicaltrials@dizalpharma.com|
22315761|NCT03811002|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22315762|NCT05853900|Click Therapeutics|Clinical Development|347-460-8607|click_ct_contact@clicktherapeutics.com|
22315763|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22315764|NCT05304117|Western Carolina University|Dr. R Turner Goins|828.227.3515|rtgoins@wcu.edu|
22315765|NCT00217737|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22315766|NCT02259621|Johns Hopkins SKCCC Clinical Research Office Coordinating Center|Jasmine Brooks|6673068335|jbrook54@jhmi.edu|
22315767|NCT04680533|University of Rochester|Jennifer Gewandter|(585) 276-5661|jennifer_gewandter@urmc.rochester.edu|
22315768|NCT03931746|Northwell Health Department of Dermatology|Sr. Clinical Data Analyst|516-321-8508|astrunk1@northwell.edu|
22315769|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22315770|NCT03267810|University of Miami|Elizabeth Felix|305-243-4497|efelix@med.miami.edu|
22315771|NCT04057573|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22315772|NCT04991753|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22315773|NCT01484431|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22315774|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
22315775|NCT02514239|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315776|NCT03299049|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315777|NCT01901419|Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan|Dr. Tso-Chou Lin|+886-2-87927128|tclin@mail.ndmctsgh.edu.tw|
22315778|NCT00475644|Eli Lilly and Company|Cheif Medical Officer|800-545-5979||
22315779|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu|
22315780|NCT03466047|Imperial College London|Carel le Roux|7970719453|c.leroux@imperial.ac.uk|
22315781|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com|
22315782|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com|
22315783|NCT00078338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22315784|NCT02124811|Emory University|Robert Cotes, MD|(404) 616-4752|robert.o.cotes@emory.edu|
22315785|NCT03412916|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
22315786|NCT02356705|Bassett Healthcare|Dr. David Ullman|585-750-7510|doccfi@hotmail.com|
22315787|NCT03430583|Mezzion Pharmaceuticals|Dr. Scott Oglesby|919-260-5782|Oglesby@granzer.biz|
22315788|NCT04201288|Brown University|Ethan Moitra, Associate Professor of Psychiatry and Human Behavior|401-444-1949|ethan_moitra@brown.edu|
22315789|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
22315790|NCT01634269|Medttronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
22315791|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315792|NCT02615509|Philips AB|Daniel Stenströmer|+46 708 303 767|daniel.stenstromer@philips.com|
22271193|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu|
22315793|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu|
22315794|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org|
22315795|NCT02030002|University of Minnesota|Thorsten Gruenheid|612-625-3903|tgruenhe@umn.edu|
22315796|NCT01294397|Amgen Inc.|Study Director|866-572-6436||
22315797|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk|
22315798|NCT02406248|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
22315799|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
22315800|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr|
22315801|NCT04079634|Northwestern University|Nishant Verma, MD|3129262148|nishant.verma@nm.org|
22315802|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315803|NCT03106753|Icahn School of Medicine at Mount Sinai|Dr. Natalie Porat|973-919-6166|poratnat@gmail.com|
22315804|NCT02874014|Mayo Clinic|Dr. C. Richard Choo|507-284-3261|Choo.C@mayo.edu|
22315805|NCT06381986|Sunhawk Vision Biotech|President|+886-72222660|hjuo@shvbiotech.com|
22315806|NCT03149042|University at Buffalo|Dr. Ciprian Ionita|7164004283|cnionita@buffalo.edu|
22315807|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu|
22315808|NCT01434745|Washington State University|Dr. jean-Baptiste Roullet|5093587666|j.roullet@wsu.edu|
22315809|NCT02470780|University of Cincinnati/UC Health|Hilary Perez PhD|5135582577|perezhe@ucmail.uc.edu|
22315810|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315811|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
22315812|NCT02362503|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22315813|NCT03563066|McMaster University|Gail Gauvreau|9055259140|gauvreau@mcmaster.ca|22791
22315814|NCT03017742|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
22315815|NCT04148651|Candela Corporation|Medical Director|+1 949.599.7657|konikap@candelamedical.com|
22315816|NCT03690427|University of California, Los Angeles|Mary Rezk-Hanna, PhD|3102068654|mrhanna@mednet.ucla.edu|
22315817|NCT03519204|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22315818|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
22315819|NCT04591171|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
22315820|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu|
22315821|NCT03392168|Arcutis|Study Inquiry|650-847-4115|studyinquiry@arcutis.com|5
22315822|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu|
22315823|NCT01441635|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22315824|NCT02627118|UConn Health|Andre Kaplan, MD||kaplan@uchc.edu|
22315825|NCT02637323|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22315826|NCT02838134|Radboud University Medical Center|Dr M.C. Warlé|+31-24362415333|Michiel.Warlé@radboudumc.nl|
22315827|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22315828|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org|
22315829|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
22315830|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
22315831|NCT04547023|Stanford University|Yair Blumenfeld, MD|650-498-4069|yairb@stanford.edu|
22315832|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22315833|NCT04529005|University of Illinois Chicago College of Pharmacy|Scott Benken|3123554107|benken@uic.edu|
22315834|NCT04013971|Emory University|Trisha Kesar, PT, PhD|404-712-5803|tkesar@emory.edu|
22315835|NCT04704219|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22315836|NCT02600897|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22315837|NCT02614183|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22315838|NCT03816761|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22315839|NCT02560753|T3DTherapeutics|John Didsbury, PhD|9199490517|didsj919@t3dtherapeutics.com|
22315840|NCT04944290|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
22315841|NCT03388268|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
22315842|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22315843|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576||
22315844|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351||
22315845|NCT03085836|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22315846|NCT03211234|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
22315847|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
22315848|NCT03054051|Emory University|Kate Winskell Enger PhD|404-727-5286|swinske@emory.edu|
22315849|NCT02412735|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
22315850|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590||
22315851|NCT04043143|"University of Colorado Denver | Anschutz"|Karsten Bartels, MD, PhD, MBA|303-724-1111|karsten.bartels@cuanschutz.edu|
22315852|NCT04307940|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22315853|NCT03445533|Idera Pharmaceuticals, Inc.|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
22315854|NCT02153905|National Cancer Institute|Dr. Steven Rosenberg|240-858-3080|sr78a@nih.gov|
22299821|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299822|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22299823|NCT04389762|Professor Lu Neurological Clinic|Professor Lu|+886-3-396-0388|lucs.clinic@gmail.com|
22299824|NCT02692248|MFAR|Responsable person designated by the sponsor|+34934344412|investigacion@mfar.net|
22299825|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org|
22299826|NCT02716974|Johns Hopkins University School of Medicine|Kenneth Pienta|410-502-3137|kpienta1@jh.edu|
22299827|NCT02261363|University of Nevada, Reno|Jennifer Pearson|7756825005|jennipearson@unr.edu|
22299828|NCT01517802|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22299829|NCT02605954|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22299830|NCT02301143|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22299831|NCT03774186|Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus|Dr. Sarit Polsky|303-724-8575|sarit.polsky@cuanschutz.edu|
22315855|NCT03334253|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
22315856|NCT03274453|New York University School of Medicine|Kirsten Boenigk|212 598 6085|Kirsten.Boenigk@nyumc.org|
22315857|NCT00968526|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315858|NCT02493062|St. Louis Fetal Care Institute|Dr. Laura Vricella|3146784488|fetalcare@ssmhealth.com|
22315859|NCT03926195|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22315860|NCT03054337|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
22315861|NCT01327612|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22299832|NCT03214367|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22315862|NCT02838979|University of Washington|Ernest Ayers|206-685-1423|ayerse@uw.edu|
22315863|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59|aaeemmhh@yahoo.com|4644
22315864|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22315865|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com|
22315866|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015||
22315867|NCT05569421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22315868|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com|
22315869|NCT00874731|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315870|NCT01736540|Novartis|Study Director|862-778-8300||
22315871|NCT00581477|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
22315872|NCT03836859|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 513831|clinical.trials@dompe.com|
22315873|NCT04646291|Mosie Baby (Consultant)|Karina Loyo, Ph.D., MBA, CCDM|512-563-1393|karina@drkarina.com|
22315874|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315875|NCT02676843|Columbia University|William Kreisl, MD|212-342-2380|wck2107@cumc.columbia.edu|
22315876|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu|
22315877|NCT02643628|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
22315878|NCT05143138|WL Gore|Cinzia Santin, Clinical Study Mgt, Gore Medical Products|+393463645539|csantin@wlgore.com|
22315879|NCT01993849|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22315880|NCT04245345|Medtronic|Rachel Vasseur, Sr. Clinical Research Specialist|6123550360|rachel.s.vasseur@medtronic.com|
22315881|NCT00980746|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22315882|NCT02335905|Baylor College of Medicine|Sheldon L. Kaplan|832-824-4330|skaplan@bcm.edu|
22315883|NCT04805073|University of Florida Health Gainesville|Adam Wendling, MD, Division Chief Obstetric Anesthesiology|3528707461|Awendling@anest.ufl.edu|
22315884|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315885|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22315886|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315887|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22315888|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22315889|NCT02567708|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315890|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22315891|NCT02097303|Carolina Research Professionals, LLC|Dr. Neal D. Shore, MD, FACS, CPI|843-449-1010|nshore@carolinaresearchprofessionals.com|243
22315892|NCT03937141|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
22315893|NCT05000047|Sonova USCS|Principal Investigator, Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22315894|NCT02975102|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
22315895|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22315896|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com|
22326296|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22326297|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326298|NCT02229864|Abbott Vascular|Latania Chura|503-935-3002|latania.chura@abbott.com|
22282403|NCT04762043|Altec, Inc.|Dr. Joshua Kline|5085458212|jkline@altecresearch.com|
22315897|NCT05262751|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22315898|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org|
22315899|NCT02956837|GlaxoSmithKline|GSK Response Center|866-435-7343|shm60684@gsk.com|
22315900|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
22315901|NCT02614690|Connecticut Children's Medical Center|Dr, Mark Lee|860-837-7421|Mlee01@connecticutchildrens.org|
22315902|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu|
22315903|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315904|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743||
22315905|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
22315906|NCT03327831|UC Irvine|Christopher Zachary|949-824-5515|czachary@uci.edu|
22315907|NCT02595372|IndianaU|Dr. Kathy Miller|(317) 948-3855|kathmill@iu.edu|
22315908|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com|
22315909|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org|
22315910|NCT01661764|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
22315911|NCT02266342|W.L. Gore & Associates|Charee Robe, Biostatistician|928-864-4048|crobe@wlgore.com|
22315912|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
22315913|NCT04297618|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
22315914|NCT02296502|University of Pittsburgh|Benjamin L Handen, PhD|412-235-5445|handenbl@upmc.edu|
22315915|NCT03838731|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22315916|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22315917|NCT03312023|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel V. Chua|1-410-706-5704|jchua@ihv.umaryland.edu|
22315918|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343||
22315919|NCT01483144|Cancer Prevention Pharmaceuticals|Michelle Boytim|520-908-7774|mboytim@canprevent.com|
22315920|NCT02460575|Tulane University|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
22315921|NCT02734498|Wake Forest School of Medicine|James Kimball, MD|336-716-9702|jkimball@wakehealth.edu|
22315922|NCT04624243|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22315923|NCT04996004|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315924|NCT05543174|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22315925|NCT03374488|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22315926|NCT03104075|The Jackson Laboratory|Dr. Jacques Banchereau|860-837-2443|jacques.banchereau@jax.org|
22315927|NCT04896008|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
22315928|NCT04595682|University of Kentucky|Dr. Mark Fillmore|8592574728|fillmore@uky.edu|
22315929|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22315930|NCT06456385|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
22315931|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22315932|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com|
22315933|NCT04497389|University of Utah|Joseph Tonna, MD|801-587-6271|joseph.tonna@hsc.utah.edu|
22315934|NCT04400487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22315935|NCT03559062|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22315936|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu|
22315937|NCT05646719|Opus Genetics|Sarah Callahan|984-884-6030|Scallahan@opusgtx.com|
22315938|NCT05890027|Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida|Dr. Sara T. Wester|(305)-243-2020|swester2@med.miami.edu|
22315939|NCT03322540|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22315940|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu|
22315941|NCT01594827|Johns Hopkins Unviversity School of Medicine|Dr. Mark Jennings|410-502-7044|mjenni15@jhmi.edu|
22315942|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22315943|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu|
22315944|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22315945|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com|
22315946|NCT05105087|Thomas Jefferson University|Ji-Bin Liu, MD|215-955-4862|jxl120@jefferson.edu|
22315947|NCT03470740|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
22315948|NCT00755417|Depomed|Head of Research & Development|650-462-5900|msweeney@depomed.com|108
22315949|NCT02803593|Emory University|Dr. Eun Ok Im|404-712-9805|eun.ok.im@emory.edu|
22315950|NCT03443414|Verona Pharma|Brian Maurer, Senior Clinical Operations Director|(914) 767-5037|brian.maurer@veronapharma.com|
22315951|NCT03933462|Philips|Sara Garbin|724-787-8550|sara.garbin@philips.com|
22315952|NCT02522728|Stryker Orthopaedics|Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe|+31 6 467 135 18|Eric.Garling@stryker.com|
22315953|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22315954|NCT01485120|GE Healthcare|Jeff Conner|414-721-2423||
22315955|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu|
22315956|NCT03355209|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22315957|NCT02251236|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
22315958|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
22315959|NCT02597712|Trio Medicines Ltd|Dr Malcolm Boyce|+44 20 8961 4130|mboyce@triomedicines.com|
22315960|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu|
22315961|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22315962|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22315963|NCT02079025|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
22315964|NCT04276051|Emory University|Alexandra Migdal, MD|404-778-3280|alexandra.love.migdal@emory.edu|
22315965|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22315966|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu|
22315967|NCT03285555|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
22315968|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22315969|NCT04916730|University of California, San Diego|Michael J. Wilkinson, MD|(858)246-2510|mjwilkinson@health.ucsd.edu|
22315970|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu|
22315971|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
22315972|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22315973|NCT01228175|University of Colorado Boulder|Dr. Kent Hutchison|303-492-8163|kent.hutchison@colorado.edu|
22315974|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com|
22315975|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22315976|NCT02281500|Instituto Grifols S.A.|Jordi Navarro Puerto|+34 935712200|jordi.navarro@grifols.com|
22315977|NCT03429166|VA HSR&D|Amanda Borsky, PhD|2024435739|amanda.borsky@va.gov|
22315978|NCT01754987|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
22315979|NCT02194829|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22315980|NCT02354820|Indiana University School of Medicine|William E. Bennett, Jr. Principal Investigator|3172786928|webjr@iu.edu|
22315981|NCT02706405|Fred Hutchinson Cancer Center|Dr. Jordan Gauthier|2066672713|jgauthier@fredhutch.org|
22315982|NCT03011567|NYU Langone Health|Christina Penfield, MD, MPH|646-754-2700|christina.penfield@gmail.com|
22315983|NCT03065075|University of Massachusetts|Dr. Tania Sierra|508-334-9840|tania.sierra@umassmemorial.org|
22315984|NCT00789360|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22315985|NCT03057847|University of Pittsburgh|Dr. Elizabeth Krans|412-641-3532|kransee@upmc.edu|
22315986|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300||
22315987|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22315988|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com|
22315989|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu|
22315990|NCT03111095|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|(206) 371-4014|khoppe2@wisc.edu|
22315991|NCT00955708|Boston Scientific|Director of Clinical Trial Management - cRM franchise|1-800-227-3422|elaine.larson@bsci.com|
22315992|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu|
22315993|NCT03165747|Emory University|Roberto Pacifici, MD|404-712-8420|roberto.pacifici@emory.edu|
22315994|NCT02160730|Cedars-Sinai Medical Center|Dr. Ning-Ai Liu|310-423-7382|ning-ai.liu@cshs.org|
22315995|NCT04028921|Children's Mercy Kansas City|Dr. Robin Shook, PhD|(816) 234-9443|rpshook@cmh.edu|
22315996|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
22315997|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu|
22315998|NCT04210843|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22315999|NCT01266161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316000|NCT04692467|Weill Cornell Medicine|Dr. Margaret McNairy|646-962-8140|mam9365@med.cornell.edu|
22316001|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu|
22316002|NCT01427725|Medical affairs|Medical affairs manager|+81-3-5656-0516||
22316003|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu|
22316004|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com|
22316005|NCT01277887|Yale University School of Medicine|Lisa Fucito, PhD|203 974-5759|lisa.fucito@yale.edu|
22326299|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu|
22326300|NCT02650284|Stryker|Alissa Connelly|+61294671000|alissa.connelly@stryker.com|1075
22326301|NCT04525222|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
22326302|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22326303|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22326304|NCT03395340|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
22326305|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com|
22326306|NCT01519570|The Ohio State University College of Pharmacy|Stuart Beatty|6146888466|beatty.52@osu.edu|
22326307|NCT04598165|Women and Infants Hospital of Rhode Island|Jennifer Unger, MD, MPH. Associate Professor, Department of Obstetrics and Gynecology|(401) 274-1122|jennifer_unger@brown.edu|48554
22326308|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271194|NCT03258008|UT MD Anderson Cancer Center|Dr. John Heymach, PHD-Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
22316006|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil|
22316007|NCT04379011|University of Minnesota|Dr. Ricardo Battaglino|612-625-2661|rbattagal@umn.edu|
22316008|NCT05672771|University of Illinois|Dr. Elizabeth A L Stine-Morrow|217-244-2167|eals@illinois.edu|
22316009|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu|
22316010|NCT04160988|Acer Healthcare Inc.|Regulator Manager|886-6-26963131|Johnny.Lu@acer.com|5789
22316011|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com|
22316012|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu|
22316013|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
22316014|NCT03321253|Necip Fazil City Hospital|Dr. Bunyamin Kutluksaman|903442282800|bkutluksaman@gmail.com|
22316015|NCT02781649|Johns Hopkins University|Christine Durand, MD|410-955-5684|cdurand2@jhmi.edu|
22316016|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu|
22316017|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org|
22316018|NCT04263987|Vanderbilt University Medical Center|Nicholas kavoussi|615-322-7401|nicholas.l.kavoussi@vumc.org|
22316019|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu|
22316020|NCT01213524|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
22316021|NCT05415748|UCSF|Dr. Scott Bauer|650-515-2879|scott.bauer@ucsf.edu|
22316022|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22316023|NCT00975676|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director Dr. Heidi Roschitzki-Voser Organization|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
22326309|NCT01721408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326310|NCT04160468|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
22326311|NCT03987620|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
22326312|NCT01770353|Ipsen Bioscience, Inc|Medical Director|See email|clinical.trials@ipsen.com|
22326313|NCT05128162|University of Michigan|Kevin Boehnke, PhD|734-998-6939|kboehnke@med.umich.edu|
22326314|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu|
22326315|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
22326316|NCT03538652|National Institute on Drug Abuse (NIDA)|Dr. David Epstein|667-312-5092|david.epstein@nih.gov|
22326317|NCT06018350|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
22326318|NCT04920084|Memorial Sloan Kettering Cancer Center|Dr. Urvi Shah, MD, MS|646-608-3713|shahu@mskcc.org|
22326319|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org|
22326320|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu|
22326321|NCT02279524|Galmed Research and Development, Ltd.|Medical Director|+972.3.693.8448|clinicaltrial@galmedpharma.com|
22326322|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22326323|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
22326324|NCT01847638|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
22326325|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22326326|NCT03488472|University of Alabama at Birmingham (UAB)|Drexell Hunter Boggs, MD; Principal Investigator|(205) 934-3411|dboggs@uabmc.edu|
22326327|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22326328|NCT02491437|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
22326329|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu|
22326330|NCT04936724|University of Pennsylvania|Andrew Strasser Ph.D.|215-746-5788|strasse3@pennmedicine.upenn.edu|
22326331|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|hkantarjian@mdanderson.org|
22326332|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu|
22326333|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com|
22326334|NCT01993329|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326335|NCT03539458|Abbott Vascular Structural Heart|Reshma Rao, Principal Study Clinical Research Associate|651-756-2542|reshma.rao@abbott.com|
22326336|NCT02528500|W. L. Gore & Associates|Rimma Zakharyan|928 310 6961|rzakhary@wlgore.com|
22326337|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu|
22326338|NCT02750800|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22326339|NCT00972478|SWOG|Study Statistician|206-667-4623||
22326340|NCT00610727|Alexza Pharmaceuticals, Inc.|Dave Hasegawa, VP, Device Development|650.947.7031|dhasegawa@alexza.com|
22326341|NCT04742907|Tsumura USA, Inc.|Yu Tanaka, Ph.D., MBA|609-799-2083|Tanaka_yuu@mail.tsumura.co.jp|
22326342|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22271195|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org|
22271196|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
22271197|NCT03973918|ABTC Consortium|Director of ABTC Consortium|410-955-8837|jfisher@jhmi.edu|
22326343|NCT01259856|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|212-241-2296|ronald.hoffman@mssm.edu|
22326344|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22326345|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com|
22299833|NCT03740490|Stephenson Cancer Center, University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
22299834|NCT03268811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22299835|NCT04726709|University of Idaho|Dr. Rajal Cohen|2088856324|rcohen@uidaho.edu|
22299836|NCT00728819|Penn Medicine|Associate Professor of Radiology|2156627892|ITKINMAX@GMAIL.COM|
22299837|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22299838|NCT02148250|University of Minnesota|Elizabth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
22299839|NCT04447404|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1417|jill.burns@durect.com|
22316024|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com|
22316025|NCT02579772|Queen's University|Dr. J. Alberto Neder|613-548-2255|nederalb@gmail.com|
22316026|NCT03128671|University of Miami|Cindy Munro|305-284-2107|cmunro@miami.edu|
22316027|NCT04072445|Mayo Clinic|Dr. Amit Mahipal|507-293-0487|Mahipal.Amit@mayo.edu|
22316028|NCT04641962|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22316029|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22316030|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org|
22316031|NCT04463680|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22316032|NCT05472740|Duke University|Amelia Scott, Research Program Leader|(919) 613-4584|amelia.lorenzo@duke.edu|
22316033|NCT02998476|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22316034|NCT01769430|University of Maryland, College Park|Professor & Director PHAB Lab|424-246-8358|phablab@umd.edu|
22316035|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316036|NCT05131477|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|contact-us@saonofi.com|6
22316037|NCT06915285|VisionQuest Biomedical Inc|Vinayak Joshi|3054845674|vjoshi@visionquest-bio.com|
22316038|NCT06840769|Helsinn Healthcare SA|Tulla Spinelli|+41.91.985.21.21|Tulla.Spinelli@helsinn.com|
22316039|NCT02726945|GID Bio|Director of Clinical Operations|3039524901|s.samudre@gidbio.com|105
22316040|NCT05992922|Iacta Pharmaceuticals|Chief Operating Officer|714-330-8532|sj@iactapharma.com|
22316041|NCT04427280|The Royal Marsden NHS Foundation Trust|Senior Trial Manager (for the CARDS study)|020 8642 6011|gi.trials@rmh.nhs.uk|3807
22316042|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
22316043|NCT02473965|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22316044|NCT05310201|Medical University of South Carolina|Angela Moreland, PhD|8437928209|moreland@musc.edu|
22316045|NCT01920477|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22316046|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316047|NCT04227145|Children's Mercy Kansas City|Emily Hurley|(816) 731-7093|eahurley@cmh.edu|
22316048|NCT02271984|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22316049|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22316050|NCT02304705|University of Kentucky|Dr. Maya Guglin|859-323-4738|maya.guglin@uky.edu|
22316051|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
22316052|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu|
22316053|NCT05620108|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
22316054|NCT05602727|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316055|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
22316056|NCT02038842|Service d'immunologie clinique - Hôpital Henri Mondor|Pr. Jean-Daniel Lelièvre|+33 1 49 81 24 55|jean-daniel.lelievre@hmn.aphp.fr|
22316057|NCT05504954|Department of Medicine, Center for Dissemination and Implementation Science, University of Illinois Chicago|Dr. Geri Donenberg|312-996-8602|gerid@uic.edu|
22316058|NCT03412773|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22316059|NCT06490302|CooperVision, Inc.|Jose A. Vega,OD,MSc, PhD|9256213761|javega@coopervision.com|
22316060|NCT02484664|Brigham and Women's Hospital|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
22316061|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu|
22316062|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu|
22316063|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22316064|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316065|NCT04191421|Emory University|Dr. Olatunji Alese, MD|404-778-6639|olatunji.alese@emory.edu|
22316066|NCT02476175|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
22316067|NCT02413645|Hospital Clinic-HIVACAT|Dr. Felipe Garcia|932275400|fgarcia@clinic.cat|2844
22316068|NCT01016262|Forest Laboratories|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22316069|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu|
22316070|NCT03738475|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22316071|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu|
22316072|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov|
22316073|NCT04638660|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22316074|NCT04076943|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-092Study@fibrogen.com|
22316075|NCT05138289|HeartFlow|Saba Mirza|650-241-1221|smirza@heartflow.com|
22299840|NCT00563784|UT MD Anderson Cancer Center|Dr. Steven H. Lin/Radiation Oncology|713-563-8490|shlin@mdanderson.org|
22326346|NCT04488822|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
22316076|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316077|NCT03080493|University of California, Davis|Mitchell Creinin, MD|916-734-6670|mdcreinin@ucdavis.edu|
22316078|NCT03325777|The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
22316079|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
22316080|NCT03004404|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316081|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316082|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com|
22316083|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
22316084|NCT02990468|BioMimetix JV LLC|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
22316085|NCT03151746|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22316086|NCT01193010|Massachusetts General Hospital|Rachel Gottlieb, Clinical Research Coordinator|617.724.4985|rgottlieb3@mgh.harvard.edu|
22316087|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316088|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu|
22316089|NCT02378038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316090|NCT03697122|Duke University|Negmeldeen Mamoun, M.D.|919-681-3551|negmeldeen.mamoun@duke.edu|
22316091|NCT04191616|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22316092|NCT04230122|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316093|NCT04910139|Sound Health Systems|Paramesh Gopi|408-316-3631|pgopi@soundhealth.life|
22316094|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22316095|NCT03697551|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22316096|NCT03518567|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
22316097|NCT02670122|Ramon y Cajal University Hospital. Vascular and Interventional Radiology Service|Jose Urbano Garcia, MD, PhD, EBIR, FCIRSE|+ 34 606 31 84 30|jurbano34@gmail.com ; jurbano@salud.madrid.org|
22316098|NCT02762903|Columbia University|William N. Levine, MD|212-305-0998|wnl1@cumc.columbia.edu|
22316099|NCT00108745|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22316100|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
22316101|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com|
22316102|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316103|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880|sshriram@uromedica-inc.com|216
22316104|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
22316105|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550|soonhyun.s.ban@gmail.com|6554
22316106|NCT02548078|GlaxoSmithKline|GSK Response Center|866-435-7343|aal77632@gsk.com|
22316107|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22316108|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu|
22316109|NCT05239598|Penn Dental Medicine|Dr. Pat Corby|215-898-1162|patcorby@upenn.edu|
22316110|NCT02592707|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22316111|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22316112|NCT04855734|Children's National Hospital|Dr. Maureen E. Lyon, Clinical Health Psychologist, Professor of Pediatrics|703-346-2873|mlyon@childrensnational.org|
22316113|NCT03832595|University of Pittsburgh|Dr. Manisha Jhamb|4126477062|jhambm@upmc.edu|
22316114|NCT03277352|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22316115|NCT03790306|Genesee Orthopedic & Hand Surgery Associates, P.C.|Andrew Wickline, MD|315-735-4496|awickline23@gmail.com|
22316116|NCT03746509|University of Minnesota|Juergen Konczak|612-624-4370|jkonczak@umn.edu|
22316117|NCT03939689|Lantheus|June Li, Vice President, Biometrics and Data Sciences|978-671-8107|lij@lantheus.com|
22316118|NCT03554629|Clinical Research Program Manager|Kathleen H. Niebel RN BSN BSME|978-549-9325|kathleen.h.niebel@gmail.com|
22316119|NCT01228318|Emory University|Igho Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
22316120|NCT03140280|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
22316121|NCT03733990|Faron Pharmaceuticals Ltd|Chief Medical Officer|+35824695151|info@faron.com|
22316122|NCT05577715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22316123|NCT04414202|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22316124|NCT03317990|University College London|Professor Greg Shaw|+44 (0)20 7679 2000|ncita.neurosafe@ucl.ac.uk|
22316125|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
22316126|NCT02643303|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
22316127|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org|
22316128|NCT00626197|F. Hoffmann-La Roche Ltd/Genentech Inc.|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22316129|NCT04339959|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
22316130|NCT05332912|University of Alabama, Tuscaloosa|Professor Emeritus|2052002183|emerrill@ua.edu|
22316131|NCT05282121|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316132|NCT05530577|University of Southern California|Christian Hendershot, PhD|323-442-1082|christian.hendershot@usc.edu|
22282404|NCT03070223|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22282405|NCT02308163|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
22282406|NCT05235971|University of Michigan|Lara N. Coughlin, Ph.D.|734-936-3101|laraco@med.umich.edu|
22282407|NCT03478254|Ciudad Real University Hospital. Castilla La Mancha Health Service.|Angela M. Seco Segura RN, Endocrinology and Nutrition Department.|926278000|amsese@live.com|79510
22316133|NCT01174446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22316134|NCT00929253|Virginia Tech|Dr. Warren K. Bickel|540-526-2015|wkbickel@vt.edu|
22316135|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22316136|NCT03301155|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22316137|NCT02769442|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi Md|4103288025|smoayedi@em.umaryland.edu|
22316138|NCT03510455|National Institute of Dental and Craniofacial Research|Rachel I. Gafni|301-594-9924|gafnir@mail.nih.gov|
22316139|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22316140|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22316141|NCT04958642|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22316142|NCT02942004|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
22316143|NCT05627258|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
22316144|NCT04517669|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22316145|NCT02138786|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22316146|NCT01923662|VAORD|Ronald J Triolo|216-791-3800|Ronald.Triolo@va.gov|64138
22316147|NCT01199068|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22316148|NCT05048238|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22316149|NCT03289351|Phoenix Children's|Dr. Justin Lee|6029330016|jlee8@phoenixchildrens.com|
22316150|NCT05214378|Cleveland Department of Veterans Affairs|Dennis Bourbeau|216-791-3800|dennis.bourbeau@va.gov|
22316151|NCT03882177|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
22316152|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22316153|NCT02224703|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
22316154|NCT02057575|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22316155|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300||
22316156|NCT02451176|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
22316157|NCT01476449|Retina Vitreous Associates of Florida|David Eichenbaum, MD|727-323-0077|deichenbaum@retinavitreous.com|
22316158|NCT02922023|University of Florida Colleges of Pharmacy and Medicine|Katherine Vogel Anderson, Pharm.D., BCACP, FCCP|352-273-6240|kvanderson@cop.ufl.edu|
22316159|NCT00863681|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22316160|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22316161|NCT04076787|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316162|NCT02766777|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22316163|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22316164|NCT01445327|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22316165|NCT01371825|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22316166|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316167|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
22316168|NCT03019640|Yago Nieto, PhD / Stem Cell Transplantation Department|UT MD Anderson Cancer Center|713-792-8750|ynieto@mdanderson.org|
22316169|NCT01721954|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
22316170|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se|
22316171|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org|
22316172|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|952
22316173|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu|
22316174|NCT02920970|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
22316175|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316176|NCT03874754|Johns Hopkins School of Nursing|Nada Lukkahatai|2407509867|nada.lukkahatai@jhu.edu|
22316177|NCT01889069|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316178|NCT04978090|University of Kentucky|Dr. Andrew Bernard|859-257-3253|andrew.bernard@uky.edu|
22316179|NCT03745898|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
22316180|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl|
22316181|NCT01509547|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22316182|NCT02227992|Ethicon, Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22316183|NCT01691950|Imperial College London|Mr Richard M Kwasnicki PhD MRCS|+44 (0) 20 759 48904|rmk107@ic.ac.uk|
22316184|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22316185|NCT02514551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22282408|NCT03219034|Texas A&M University College of Dentistry|Dr. Emet Schneiderman|2148288377|eschneiderman@tamu.edu|
22316186|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com|
22316187|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316188|NCT04535544|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22316189|NCT02506933|City of Hope Medical Center|Dr. Ryotaro Nakamura, MD|6263598111|RNakamura@coh.org|
22316190|NCT04193826|Conformal Medical, Inc|Aly Dechert / Manager of Clinical Operations|(603) 718-8742|adechert@conformalmedical.com|
22316191|NCT01123070|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8270|USMedInfo@tevapharm.com|
22326347|NCT03838367|CytoDyn|Joseph Meidling - Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
22326348|NCT03406104|Gensight Biologics|Magali TAIEL Chief Medical Officer|0762891252|mtaiel@gensight-biologics.com|
22326349|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22326350|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu|
22316192|NCT04942366|Ziauddin University|Mubarra Rao|03343088915|mubarrar@gmail.com|
22326351|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com|
22326352|NCT03958201|University of Washington|Research Coordinator|206-744-4634|ajames1@uw.edu|
22326353|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326354|NCT01732263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326355|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com|
22326356|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22326357|NCT03321929|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
22326358|NCT02991820|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
22326359|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu|
22326360|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22326361|NCT03880227|The University of Texas at Dallas|Hans Klein|8304562444|hans.klein@utdallas.edu|
22326362|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu|
22326363|NCT02389946|BIOTRONIK, Inc|Amy Culley, Director of Vascular Intervention Clinical Studies|503-451-8034|amy.culley@biotronik.com|
22326364|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu|
22326365|NCT01605396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326366|NCT00878072|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22326367|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22326368|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org|
22326369|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu|
22326370|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
22326371|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22326372|NCT03288779|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
22326373|NCT03382899|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|www.ClinicalTrials.gov@lilly.com|
22326374|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu|
22326375|NCT02504892|National Cancer Institute|Dr. Ramaprasad Srinivasan|301-451-2298|srinivasanr@mail.nih.gov|
22326376|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500|kneuzil@path.org|4864
22326377|NCT01413178|U.T. MD Anderson Cancer Center|Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy|713-745-3219|mqazilba@mdanderson.org|
22326378|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu|
22326379|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
22326380|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22326381|NCT03283163|VA Boston Healthcare System|Erica R. Checko (Scioli), PhD|857-364-5696|ericarose.scioli@va.gov|
22326382|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
22326383|NCT04238663|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
22326384|NCT02566525|University of Kentucky College of Medicine|Dr. Joseph Zwischenberger, MD|859-323-6013|jzwis2@uky.edu|
22326385|NCT02149836|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
22326386|NCT01745627|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22326387|NCT04430582|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173091966|MaryElizabeth.Patti@Joslin.Harvard.edu|
22326388|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
22326389|NCT02410902|Curemark|William E. Gannon, Jr MD, Medical Director|914-824-9716|william.gannon@curemark.com|
22326390|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org|
22326391|NCT01881620|Institut Bergonié, Medical Imaging Department|Dr. Anne-Laure Cazeaux, Nuclear physician|05.56.33.78.60|A.cazeaux@bordeaux.unicancer.fr|
22326392|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu|
22316193|NCT02525718|Northwestern Memorial Hospital|Dr. Mohammed Alghoul||malghoul@nm.org|
22316194|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
22316195|NCT03284229|Spectranetics Corporation|Spectranetics Corporation|719-447-2211|Ami.Sood@philips.com|
22316196|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22316197|NCT05817383|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22271198|NCT04281901|Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.|Domen Vozel, M.D., Saba Battelino, M.D., PhD.|+386 (0)1 522 83 07|domen.vozel@kclj.si|
22271199|NCT04601103|3M Health Care Business Group|Brenda Coalwell, Clinical Affairs Manager|16517362456|bccoalwell1@mmm.com|
22271200|NCT03338803|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271201|NCT02978859|Columbia University|Benjamin Izar|212 304 5871|bi2175@cumc.columbia.edu|
22316198|NCT01182441|Boston Scientific|WATCHMAN Trial Manager|1-800-227-3422||
22316199|NCT02981108|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
22316200|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22316201|NCT05241314|University of Minnesota|Sarah Hoffman|612-625-0606|hoff0742@umn.edu|
22316202|NCT00387244|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22316203|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316204|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316205|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu|
22316206|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
22316207|NCT04481373|Baylor College of Medicine|Thomas Giordano|7137988918|tpg@bcm.edu|
22316208|NCT03119233|Endologix|Tammy Stiver, Manager, Clinical Affairs|5136731452|tstiver@endologix.com|
22316209|NCT01254552|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
22316210|NCT02979249|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-659-8512|hetanshi.naik@mssm.edu|
22316211|NCT01125046|Northwestern University|Priya Kumthekar, MD||Priya.Kumthekar@nm.org|
22316212|NCT01685229|Acclarent Inc.|Clinical Manager|949-453-6408|PChen126@ITS.JNJ.com|
22316213|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com|
22316214|NCT00558844|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
22316215|NCT02579135|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
22316216|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu|
22316217|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com|
22316218|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org|
22316219|NCT02964325|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
22316220|NCT03596762|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22316221|NCT02510040|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813-975-8690|rkraker@jaeb.org|
22316222|NCT03842228|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
22316223|NCT03085225|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22316224|NCT03632083|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22316225|NCT02195479|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22316226|NCT01834586|EvergreenHealth Multiple Sclerosis Center|Theodore Brown|425-8995350|trbrown@evergreenhealth.com|
22316227|NCT01512797|Columbia University Medical Center|Dr. Blandine Laferrere|212-851-5562|bbl14@columbia.edu|
22316228|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22316229|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22316230|NCT03993210|DFCI|Clare Tempany|617-732-7858|ctempany@bwh.harvard.edu|
22316231|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22316232|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22316233|NCT01818531|Wake Forest University Health Sciences|Dr. Daryl Henshaw|3367166344|dhenshaw@wakehealth.edu|
22316234|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu|
22316235|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22316236|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316237|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316238|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316239|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org|
22316240|NCT02992691|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316241|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu|
22316242|NCT05071586|University of Wisconsin - Madison|Bernadette Gillick|608-381-2699|bgillick@wisc.edu|
22316243|NCT00820170|Memorial Sloan Kettering Cancer Center|Dr. Monica Fornier|646-888-4563|fornierm@mskcc.org|
22316244|NCT02180243|War Related Illness and Injury Study Center|Matthew Reinhard, PsyD|202-745-8000|matthew.reinhard@va.gov|55785
22316245|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22316246|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov|
22316247|NCT03651700|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
22316248|NCT02775071|Temple University|David Sarwer|215-707-8632|dsarwer@temple.edu|
22316249|NCT05479734|University of Oklahoma Health Sciences|David Bard, Director of EmBRACER Center|4052718001|David-Bard@ouhsc.edu|
22316250|NCT01461005|MCRA|Justin Eggleton, Senior Director, Spine Regulatory Affairs|2025525804|jeggleston@mcra.com|
22316251|NCT03168542|Johnson & Johnson Vision Care, Inc.|Tom Karkkainen, OD MS, FAAO - Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
22316252|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu|
22316253|NCT00455741|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
22316254|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu|
22316255|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316256|NCT03197766|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
22316257|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22316258|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu|
22316259|NCT01460225|Dartmouth-Hitchcock Medical Center|Dr. Brian Lacy|603-650-5215|brian.e.lacy@hitchcock.org|
22316260|NCT02755129|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
22316261|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org|
22316262|NCT03564353|UT Dallas|Clinical Trial Manager|972-883-7277|Sarah.McLeod@utdallas.edu|
22316263|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com|
22316264|NCT03633799|Sebela Women's Health|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|Elizabeth.gray@sebelapharma.com|
22316265|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590||
22316266|NCT03551691|Children's Hospital of Philadelphia|Dr. Virginia Stallings|267-425-1633|stallingsv@chop.edu|
22316267|NCT03829501|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22316268|NCT02964013|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316269|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
22316270|NCT06149104|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22316271|NCT04707664|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
22316272|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22316273|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
22316274|NCT03789175|NHLBI, NIH|Dr. Paul Hwang|3014353068|hwangp@mail.nih.gov|
22316275|NCT03425097|Stanford University|Thomas A Zikos, MD|(408) 426-5599|zikosta@stanford.edu|
22316276|NCT03339245|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
22316277|NCT00384774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316278|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22316279|NCT03480932|Johns Hopkins Bloomberg School of Public Health|Dr. Shruti Mehta|4432873837|smehta@jhu.edu|
22316280|NCT03056300|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22316281|NCT05262517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316282|NCT02190903|University of Pennsylvania School of Medicine|Mark D Neuman|2157467468|neumanm@mail.med.upenn.edu|
22316283|NCT02863289|NHS Tayside|Mr Benedict Clift|01382 660111|ben.clift@nhs.net|35160
22316284|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu|
22316285|NCT01939353|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22316286|NCT03573947|Duke Cancer Institute|Dr. Jeffrey Clarke|9196819509|jeffrey.clarke@duke.edu|
22316287|NCT03237377|Johns Hopkins SKCCC CRO Coordinating Center|Jasmine Brooks, Senior Research Program Coordinator|667-306-8335|jbrook54@jhmi.edu|
22271202|NCT02719938|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
22316288|NCT04421950|University of Arkansas for Medical Sciences and Arkansas Children's Nutrition Ce|Eva C. Diaz, Principal Investigator|5013643056|ecdiazfuentes@uams.edu|
22316289|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu|
22316290|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu|
22316291|NCT04546425|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316292|NCT03296800|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
22316293|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316294|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org|
22316295|NCT02687035|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22316296|NCT05000216|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22316297|NCT03435692|Seattle Children's Hospital|David E. Liston, MD, MPH|206-987-3996|david.liston@seattlechildrens.org|
22316298|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
22316299|NCT05071053|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22316300|NCT02593123|Virginia Commonwealth University Massey Cancer Center|Dr. Amir Toor, Principal Investigator|804 828 5116|amir.toor@vcuhealth.org|
22316301|NCT01038427|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316302|NCT03538938|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy|6082655949|demccarthy@ctri.wisc.edu|
22316303|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
22316304|NCT03995316|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22326393|NCT02561000|Tufts Medical Center|Athan Kuliopulos, MD, PhD|617-636-8482|athan.kuliopulos@tufts.edu|
22316305|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22316306|NCT02985840|OhioHealth Research Institutute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
22326394|NCT04889144|Fred Hutchinson Cancer Center|Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
22316307|NCT03398902|Rory Meyers College of Nursing, New York University|Dr. Susan Malone|212-992-7047|sm7760@nyu.edu|
22316308|NCT01229878|VA Providence Healthcare System|Kel Morin|347-346-0380|kel.morin@va.gov|
22316309|NCT03945825|University of Iowa Carver College of Medicine|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22316310|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org|
22282409|NCT00118846|Director, Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
22316311|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316312|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316313|NCT03041792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316314|NCT02623998|McMaster University|Dr. Natalia McInnes|19055212100|natalia.mcinnes@mcmaster.ca|73794
22316315|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22316316|NCT04041037|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
22316317|NCT01399918|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-888-4740|Feldmand@MSKCC.ORG|
22316318|NCT00245960|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316319|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316320|NCT03083665|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22316321|NCT02519348|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22316322|NCT03635099|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316323|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com|
22316324|NCT06285240|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22316325|NCT05380362|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
22316326|NCT04844879|Medacta International SA|Medical Affairs Department|+41 91 696 60 60|myclinicaldata@medacta.ch|
22316327|NCT05985538|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
22316328|NCT04363957|University of California, San Diego|Dr. Jyoti Mayadev|(858) 822-5354|CancerCTO@health.ucsd.edu|
22316329|NCT06534671|Vanderbilt University Medical Center|Prince J. Kannankeril, MD, MSCI|(615) 322-7447|prince.kannankeril@vumc.org|
22316330|NCT04103892|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
22316331|NCT05576662|Stanford University|Linda N. Geng, MD, PhD|650-723-4000|geng@stanford.edu|
22316332|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22316333|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com|
22316334|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu|
22316335|NCT03008005|Wayne State University|Dr. Christine Rabinak, Principal Investigator|(313) 577-9875|rabinak@wayne.edu|
22316336|NCT05292586|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22316337|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu|
22316338|NCT01744704|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22316339|NCT02367040|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22316340|NCT02477618|Sage Therapeutics|Helen Colquhoun, MD - Vice President, Medical Science|(617) 229-5234|Helen@sagerx.com|
22316341|NCT05855967|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316342|NCT02446821|Sebela Women's Health Inc.|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|elizabeth.gray@sebelapharma.com|
22316343|NCT02603328|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|773-702-8996|astadnik@bsd.uchicago.edu|
22316344|NCT07025837|Citruslabs|Patrick Renner|4242450285|hello@citruslabs.com|
22316345|NCT05899413|University of California, San Francisco|Dr. Yoobin Park|6289461325|yoobin.park@ucsf.edu|
22316346|NCT01555489|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
22316347|NCT07149155|Dell Medical School, The University of Texas at Austin|Project Coordinator|NA|SFA@austin.utexas.edu|
22316348|NCT01876082|Department of Medical Oncology, Institut bergonié|Pr Antoine Italiano, coordinating investigator|05.47.30.60.88|a.italiano@bordeaux.unicancer.fr|
22316349|NCT04854850|University of Pittsburgh|Robyn T. Domsic|412-383-8000|rtd4@pitt.edu|
22316350|NCT04092530|University of Illinois at Chicago|Kristin Rankin|708-710-8411|krankin@uic.edu|
22316351|NCT02441985|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22316352|NCT04020185|ImmuneSensor Therapeutics Inc.|Vice President of Clinical Operations and Project Management|210-380-5164|tmooneyham@immunesensor.com|
22316353|NCT04087811|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
22316354|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22316355|NCT02783027|University of Pittsburgh|Dr. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
22316356|NCT04335591|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22282410|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu|
22282411|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316357|NCT04210427|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
22316358|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu|
22316359|NCT03512964|Johns Hopkins University School of Medicine, Division of Infectious Diseases|Joyce Jones, MD|443-287-8530|jjone154@jhmi.edu|
22316360|NCT05467293|Yuyu Pharma, Inc.|Robert Wonsang Yu|+82 2 6972 9062|wsyu@yuyu.co.kr|
22316361|NCT06264128|SleepRes|Bernie Hete|+1 615-921-2406|bhete@sleepres.com|
22316362|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22316363|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
22316364|NCT01706705|UT MD Anderson Cancer Center|Dr. Ann Klopp / Associate Professor, Radiation Oncology|713-563-6930|aklopp@mdanderson.org|
22316365|NCT03417544|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-3800|Nancy_Lin@dfci.harvard.edu|
22316366|NCT02242097|Northwestern University, Feinberg School of Medicine|Dr. Reem Karmali|(312) 695-0990|reem.karmali@northwestern.edu|
22326395|NCT03430245|Candela Corporation|Director of Clinical Marketing|+1 949.246.7983|doranr@candelamedical.com|
22326396|NCT03656926|Zambon S.p.A.|Enrica Bucchioni, M.D., PhD, Global Clinical Development Head|+39 02 665241|clinicaltrials@zambongroup.com|
22326397|NCT02534805|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
22326398|NCT02902172|St. Louis University|Dr. Jennifer Goldkamp|3149772200|jen.goldkamp@health.slu.edu|
22326399|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu|
22326400|NCT03196505|University of California-San Francisco Fresno|Dr. Pearl Ma|5592614500|pma@fresno.ucsf.edu|
22326401|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211|dr.mai_elshahm@yahoo.com|002
22326402|NCT02575079|Emory University|Elizabeth Stenger|404-785-1272|elizabeth.o'brien.stenger@emory.edu|
22326403|NCT02918266|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22326404|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu|
22326405|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org|
22326406|NCT03796091|Green Counseling Services PLLC|Dr. Melinda Green|5154508913|drgreen@greencounselingservice.com|
22326407|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org|
22326408|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu|
22282412|NCT00541866|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
22282413|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu|
22282414|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org|
22282415|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu|
22282416|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22282417|NCT03638908|UTSouthwestern medical center|Kelly Chin, MD|2146456493|kelly.chin@utsouthwestern.edu|
22316367|NCT01562041|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316368|NCT03079284|Maine Medical Center|Dr. Alexa Craig|207-396-7337|craiga@mmc.org|
22316369|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316370|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu|
22316371|NCT04606901|Temple University Hospital|Dr. Ellen Hauck|2674438719|ellen.hauck@tuhs.temple.edu|
22316372|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316373|NCT03514277|Reconstructive Orthopedics|Robert Greenleaf|609-267-9400|bob.greenleaf1@gmail.com|
22316374|NCT04868539|Brigham and Women's Hospital|Dr. Charles Czeisler, Ph.D., M.D.|617-732-4013|cacadmin@partners.org|
22316375|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22316376|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de|
22316377|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22316378|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316379|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22316380|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org|
22316381|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22316382|NCT02523690|Johns Hopkins University|Dr. Dale Needham|410-287-3343|dale.needham@jhmi.edu|
22316383|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316384|NCT00737698|Imperial College London|Dr Samantha Amanda Sathyapala|+442073518029|s.sathyapala@imperial.ac.uk|
22316385|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu|
22316386|NCT02817906|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22316387|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu|
22316388|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com|
22316389|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu|
22316390|NCT02193490|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22316391|NCT02299414|University of Alabama at Birmingham|Dr. Alan Tita|(205) 934-9616|atita@uabmc.edu|
22316392|NCT03686423|NYU Langone Health|Ryan Brown, PhD|2122633396|Ryan.Brown@nyulangone.org|
22316393|NCT04954326|Institut de Recherches Internationales Servier|Therapeutic Area in Oncology|+33155724366|clinicaltrials@servier.com|
22316394|NCT01310231|Mount Sinai Hospital|Pamela Goodwin/PI|416 586-8211|Pamela.goodwin@sinaihealth.ca|
22316395|NCT01495598|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
22316396|NCT06411613|VA Puget Sound Health Care System|Dawn Bates|206-277-3012|dawn.bates@va.gov|
22316397|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22316398|NCT00669877|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, Assistant Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22316399|NCT05140915|University of Massachusetts Chan Medical School|Dr. Rajani Sadasivam|(508) 856-8923|rajani.sadasivam@umassmed.edu|
22282418|NCT03245736|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
22316400|NCT04520659|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(443) 813-0697|swoods12@jhu.edu|
22316401|NCT04430439|University of California, Irvine|Karen Lindsay|949-824-0148|kllindsa@hs.uci.edu|
22316402|NCT04485611|Durham VA Health Care System|Dr. Atilio Barbeito, Chief, Anesthesiology Service|(919) 286-6938|atilio.barbeito@va.gov|177150
22316403|NCT04879849|Takeda|Medical Director|+1-877-825-3327|Trialdisclosures@takeda.com|
22316404|NCT05371665|Montana State University|Brandon Scott|(406) 994-5218|brandon.scott2@montana.edu|
22316405|NCT03007420|Boston Children's Hospital|Pradeep Dinakar, MD|857-218-3556|Pradeep.Dinakar@childrens.harvard.edu|
22316406|NCT01655251|Connecticut Children's Medical Center|Dr. Sharon R. Smith|860-545-9000|srsmith@connecticutchildrens.org|
22316407|NCT02638883|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22316408|NCT02284009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316409|NCT04147195|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22316410|NCT03841526|Xeris Pharmaceuticals|Dawn Harper, VP Clinical Devlopment|1-877-XERIS-37|clinicaltrials@xerispharma.com|
22316411|NCT01435772|BioMarin Pharmaceutical Inc.|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
22316412|NCT03238963|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316413|NCT05823012|Xeris Pharmaceuticals, Inc.|Valentina Conoscenti, MD|1-877-XERIS-37|Clinicaltrials@xerispharma.com|
22316414|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22316415|NCT04683627|Noven Pharmaceutical|Robert Kirshoff|5512332668|clinicaltrials@noven.com|
22316416|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991|wdahl@ufl.edu|224
22316417|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22316418|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr|
22316419|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu|
22316420|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu|
22316421|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org|
22316422|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
22316423|NCT02566044|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22316424|NCT02683772|ResMed|Maureen Crocker, Manager Medical Affairs|8588366653|maureen.crocker@resmed.com|
22316425|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22316426|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu|
22316427|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22316428|NCT01977677|Stanford University School of Medicine|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
22316429|NCT01498887|Novartis Pharmaceuticals|Study Director|862-778-8300||
22316430|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22316431|NCT03079297|University of Texas Southwestern|Maria Monastirsky|214-648-0174|Maria.Monastirsky@utsouthwestern.edu|
22316432|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu|
22316433|NCT02993406|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22316434|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com|
22316435|NCT04079868|Durham VA Geriatric Research Education and Clinical Center|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colon-emeric@va.gov|6932
22316436|NCT04045964|The University of Texas Health Science Center at Houston|Angela Stotts, PhD|(713) 500-7590|Angela.L.Stotts@uth.tmc.edu|
22316437|NCT04325282|Stanford University|Fiona Baumer, MD, MS|(650) 723-0993|fbaumer@stanford.edu|
22316438|NCT05520775|University of North Carolina at Chapel Hill|Christian Hendershot|(213) 821-0769|christian.hendershot@usc.edu|
22316439|NCT02658877|NYU Langone Health|Joan Reibman|212 263 6479|Joan.Reibman@nyulangone.org|
22316440|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com|
22316441|NCT03338296|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22316442|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
22316443|NCT00702962|MSHERSHEY MC|Dr. C. Belani|717-531-1078|cbelani@psu.edu|
22316444|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22316445|NCT02175641|Washington Universtiy in St. Louis|Leopoldo J. Cabassa, Associate Professor|314-935-2829|ljcabassa@wustl.edu|
22316446|NCT02931253|The Donald Guthrie Foundation for Education and Research|Pramod Deshmukh, MD|570 887 2284|Pramod.Deshmukh@guthrie.org|
22316447|NCT01876901|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22316448|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316449|NCT03031496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316450|NCT02339545|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22316451|NCT03868787|Northwestern University Feinberg School of Medicine|Ashley Turner, MD Assistant Professor of Obstetrics and Gynecology|2316200549|ashley.turner1@nm.org|
22316452|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316453|NCT05486728|Sunhawk Vision Biotech|President|+886-7-2222660|hjuo@shvbiotech.com|
22316454|NCT02119442|UCLA|Soraya Sadeghi|3108255950|smsadeghi@mednet.ucla.edu|
22316455|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu|
22282419|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22316456|NCT02807272|Kura Oncology Inc.|Clinical Operations|+1 617 588-3755|KO-TIP-004@kuraoncology.com|
22316457|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com|
22316458|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu|
22326409|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
22326410|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740|hila.debby@givenimaging.com|77740
22326411|NCT03116399|Weill Medical College of Cornell University|Sara J. Czaja, PhD|646-962-7141|sjc7004@med.cornell.edu|
22326412|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
22326413|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22326414|NCT00962000|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22326415|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no|
22326416|NCT04111276|University of Tennessee|Dr. Michael LaCour|865-974-7684|mlacour@utk.edu|
22326417|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326418|NCT02749721|Rush University Medical Center|Dr. John Zajecka|312-942-5592|John_Zajecka@rush.edu|
22326419|NCT02691247|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
22326420|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca|
22326421|NCT02873715|University at Buffalo|Leonard H. Epstein, PhD, SUNY Distinguished Professor|716-829-3400|lhenet@buffalo.edu|
22326422|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com|
22326423|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu|
22326424|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326425|NCT00592501|Massachusetts General Hospital|Annie W. Chan, MD|617-726-5184|AWCHAN@PARTNERS.ORG|
22326426|NCT04590937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326427|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22326428|NCT01544595|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316459|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22316460|NCT03552523|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
22316461|NCT04145700|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316462|NCT00780559|University of Maryland School of Medicine|Clinical Research Coordinator|(410) 328-6583|inmed@som.umaryland.edu|
22316463|NCT02205034|CHU Toulouse|Pr Maithe Tauber|+33534558551|tauber.mt@chu-toulouse.fr|
22316464|NCT01840410|Novartis|Study Director|862-778-8300||
22316465|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org|
22316466|NCT02206061|University of Rochester|Jill Halterman, MD|5852755798|jill_halterman@urmc.rochester.edu|
22316467|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22316468|NCT01868425|University of Wisconsin - Madison|John Shepler|608-263-8100|jashepler@wisc.edu|
22316469|NCT01077518|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22316470|NCT04958200|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
22316471|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
22316472|NCT04662060|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
22316473|NCT04157400|MUSC|Nathan Rowland|843-792-6590|rowlandn@musc.edu|
22316474|NCT03599687|Yorkshire Ambulance Service NHS Trust|Richard Pilbery|+447463734823|r.pilbery@nhs.net|
22316475|NCT02819024|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|3135768735|shieldsa@karmanos.org|
22316476|NCT02902770|Maimonides Medical Center|Antonios Likourezos|7182836896|alikourezos@maimonidesmed.org|
22316477|NCT05217641|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22316478|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
22316479|NCT03548220|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
22316480|NCT02397447|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22316481|NCT04897841|University of Wisconsin - Madison|Sharon Blohowiak|608-417-6957|sblohowiak@wisc.edu|
22316482|NCT02994069|University of Kentucky|Dr. Susanne Arnold|859-323-6522|susanne.arnold@uky.edu|
22316483|NCT06532357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316484|NCT03345576|Richmond VAMC|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.ogv|3386
22316485|NCT05718466|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
22316486|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca|
22316487|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22316488|NCT00833261|UT Southwestern Medical Center|Dr. Lucien Nedzi|214-645-7653|lucien.nedzi@utsouthwestern.edu|
22316489|NCT03149809|Atlanta VA Health Care System|E. Camille Vaughan, MD, MS|404 315 4100|elizabeth.vaughan2@va.gov|373100
22316490|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271|schulms@mcmaster.ca|44479
22316491|NCT02952534|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22316492|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22316493|NCT02815579|University of California, San Francisco|Dr. Sheri Weiser|(628) 206-2427|Sheri.Weiser@ucsf.edu|
22316494|NCT02389452|Sanofi|Trial Transparency Team||Contact --US@Sanofi.com|
22316495|NCT02311673|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22316496|NCT01006252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316497|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com|
22316498|NCT01076153|Abbott|Global Medical Services|1-800-633-9110||
22316499|NCT04165031|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316500|NCT04143945|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22316501|NCT03563157|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22316502|NCT02942277|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
22316503|NCT00565773|Duke University|Allan D. Kirk, MD, PhD|919-681-1400|allan.kirk@duke.edu|
22316504|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316505|NCT04297631|Washington University|Venessa Riegler|3143621721|rieglerv@wustl.edu|
22316506|NCT01720277|Brown University and Providence VA Medical Center|Dr. Stefan Gravenstein|401-863-3172|Stefan_gravenstein@brown.edu|
22316507|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326429|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326430|NCT00554294|Research Institute of Child Nutrition, Dortmund|Dr. Mathilde Kersting|0049 231 79221013|kersting@fke-do.de|
22326431|NCT05022004|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
22326432|NCT01461863|Dartmouth-Hitchcock|Dr. Charles Fordham von Reyn|6036505000|fvr@dartmouth.edu|8840
22326433|NCT02275026|Icahn School of Medicine at Mount Sinai|Dr. Joshua Mincer|(917) 922-9475|joshua.mincer@mountsinai.org|
22326434|NCT02379923|Asahi Intecc USA, Inc.|Robert Ricker|408.429.3749|robertr@asahi-intecc.com|
22326435|NCT03643432|Oxford University Hospitals NHS FT|Jon Room|01865737526|jonathan.room@ouh.nhs.uk|
22326436|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22326437|NCT03638947|UIOWA|Randy W. Loftus|6033066475|randy-loftus@uiowa.edu|
22326438|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu|
22326439|NCT03141086|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22326440|NCT03017924|Cincinnati Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
22326441|NCT02488759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22326442|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326443|NCT03607682|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22326444|NCT02574312|DePuy Ortho Joint US|Kirstin Cosgrove|800-827-7003|kcosgro1@its.jnj.com|
22326445|NCT02326467|Boston Children's Hospital|Celeste Chandonnet|781-216-0050|celeste.chandonnet@childrens.harvard.edu|
22326446|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu|
22326447|NCT04467164|Massachusetts General Hospital, Harvard Medical School|Jill M. Goldstein|617-724-3776|jill_goldstein@hms.harvard.edu|
22326448|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22326449|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111|gophilli@wakehealth.edu|67806
22326450|NCT03463941|Duke School of Nursing|Cherie Conley|2166597128|cherie.conley@duke.edu|
22326451|NCT02273050|AstraZeneca|Eva Johnsson, MD, PhD|46 31 7762484|Eva.Johnsson@astrazeneca.com|
22326452|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu|
22326453|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov|
22326454|NCT05619172|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
22326455|NCT01429792|Hoffman-La Roche|Medical Communications|8008218590|genentech@druginfo.com|
22326456|NCT01380106|Boston VA Research Institute, Inc.|Nikhil C. Munshi, M.D.|6176325607|nikhil.munshi@dfci.harvard.edu|
22326457|NCT01763905|Amgen Inc.|Study Director|866-572-6436||
22326458|NCT04346628|Stanford University|Yvonne A. Maldonado, MD|(650) 723-5682|bonniem@stanford.edu|
22326459|NCT04149899|Bausch & Lomb Incorporated|Clinical Development|949-416-1194|kevin.kerr@bausch.com|
22326460|NCT03165721|National Cancer Institute|Dr. John Glod|240-760-6194|john.glod@nih.gov|
22326461|NCT02078882|University of California Davis|Christopher L Bowlus|9167348696|clbowlus@ucdavis.edu|
22326462|NCT01457118|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
22326463|NCT02324842|University of Texas Health San Antonio|Eugenio Cersosimo, MD|210-358-7220|cersosimo@uthscsa.edu|
22326464|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
22326465|NCT00630812|Pharmaxis|Brett Charlton|02 94547210|Brett.Charlton@pharmaxis.com.au|
22326466|NCT01554956|Kedrion SpA|Clinical Trial Manager|+39 05831969231|a.lotti@kedrion.com|
22326467|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22316508|NCT03151993|Federal Center for Brain and Neurotechnology|Dr. Eugene I. Gusev, President of the Federal Center for Brain and Neurotechnology|495-280-01-74|egusev2339@gmail.com|+7
22326468|NCT05761444|Organon Korea Co. Ltd|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22326469|NCT05610176|BIOTRONIK SE & Co. KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22316509|NCT04313608|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22326470|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org|
22326471|NCT01434472|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
22326472|NCT01842308|Mayo Clinic|Suzanne R. Hayman, M.D|(855) 776-0015|hayman.suzanne@mayo.edu|
22316510|NCT01867333|National Cancer Institute|Ravi A. Madan|301-480-7168|rm480i@nih.gov|
22316511|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu|
22316512|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com|
22316513|NCT02440425|Moffitt Cancer Center|Robert M. Wenham, MD, MS, FACOG, FACS|813-745-5739|Robert.Wenham@moffitt.org|
22316514|NCT03101462|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
22316515|NCT03750786|Isofol|Karin Gedda|+46 (0) 729 9453 37|karin.gedda@isofolmedical.com|
22316516|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br|
22316517|NCT03309813|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs|214-630-9900|NadirA@Insightec.com|
22316518|NCT01327846|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316519|NCT00847522|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu|
22316520|NCT04343976|Massachusetts General Hospital|Sponsor-Investigator|617-724-3836|chung.raymond@mgh.harvard.edu|
22316521|NCT02807883|University of Texas MD Anderson Cancer Center|Partow Kebriaei, MD / Stem Cell Transplantation Department|713-745-0663|pkebriae@mdanderson.org|
22316522|NCT04608773|University of Pittsburgh|Anne Fisher|4126479665|amf91@pitt.edu|
22316523|NCT02833077|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22316524|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316525|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
22316526|NCT00422812|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22316527|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590||
22316528|NCT02671500|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22316529|NCT01807000|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22316530|NCT05235269|Attralus|Scott Stephens, Senior Director Clinical Operations|321-228-7400|sstephens@attralus.com|
22316531|NCT03361865|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22316532|NCT03852719|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22316533|NCT03810235|School of Medicine and Public Health University of Wisconsin-Madison|Kathleen M. Antony, M.D, M.S.C.I|608-417-6099|kantony@wisc.edu|
22316534|NCT04201262|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22316535|NCT05619575|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22316536|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22316537|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org|
22316538|NCT03682185|University of Pennsylvania|Dr. Nancy A. Hodgson|215-573-7387|hodgsonn@nursing.upenn.edu|
22316539|NCT06926673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316540|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22316541|NCT03843554|University of Pittsburgh|Associate Vice Chancelor, Clinical Trials Operations|412-383-2561|pat.corby@pitt.edu|
22316542|NCT01736943|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22316543|NCT02218606|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin, MD, PhD|646-422-4472|slovins@MSKCC.ORG|
22316544|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org|
22316545|NCT04420949|University of Wisconsin - Madison|Dr. Kreg Gruben|608 262 2711|kreg.gruben@wisc.edu|
22316546|NCT04396366|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22316547|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk|
22316548|NCT04512703|ZOLL Medical Corporation|Mike Osz|4129683333|mosz@zoll.com|14104
22316549|NCT02187159|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22316550|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu|
22316551|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
22316552|NCT03433677|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22316553|NCT03330405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316554|NCT03482466|Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic|Ramiro Salas|7137983502|rsalas@bcm.edu|
22316555|NCT04833127|NYS Psychiatric Institute and Columbia University|Dr. Susie Hoffman|718 744 7686|sh51@cumc.columbia.edu|
22316556|NCT01736189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22316557|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com|
22316558|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com|
22316559|NCT02383940|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22316560|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com|
22316561|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316562|NCT03853551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|8772409479
22326473|NCT02868216|Cardiologia (Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology|Dra Marcia Moura Schmidt|5551 32333600|mmoura22@terra.com.br|3765
22326474|NCT03161678|University of Maryland, School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
22326475|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22326476|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316563|NCT05435482|University of California, San Francisco|Ji Won Choi|415.340.1434|jiwon.choi@ucsf.edu|
22316564|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
22316565|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk|
22316566|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org|
22316567|NCT01373580|ReVision Optics|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
22316568|NCT03878277|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
22316569|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org|
22316570|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22316571|NCT01559129|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22316572|NCT03525392|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
22316573|NCT03262662|University at Buffalo|Larry Hawk, PhD|716-829-2323|lhawk@buffalo.edu|
22316574|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
22316575|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316576|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu|
22316577|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com|
22316578|NCT04276415|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22316579|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com|
22316580|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu|
22316581|NCT04662931|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22326477|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326478|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu|
22326479|NCT02552355|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22326480|NCT05309369|Medical University of South Carolina|Professor|843 367 4260|mintzerj@musc.edu|
22326481|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com|
22326482|NCT02773914|Göteborg University|Isabelle Andersson Hammar|+4631 786 5719|isabelle.a-h@neuro.gu.se|
22326483|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22326484|NCT02084134|Washington University School of Medicine|Dr. Julie Silverstein|314-747-7006|jsilverstein@wustl.edu|
22326485|NCT02026271|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22326486|NCT04333433|Santen, Inc.|Edith van Dijkman|+31683667357|edith.vandijkman@santen.com|
22326487|NCT02807454|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22326488|NCT01585129|WashingtonU|Dr. Anthony Shanks|3179448182|ashanks@iupui.edu|
22326489|NCT05468086|Cedars-Sinai Medical Center|Omer Liran, MD, MSHS|31042333754|omer.liran@cshs.org|
22326490|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326491|NCT01293396|Medical University of Graz|Dr. Norbert Tripolt|0316385|norbert.tripolt@medunigraz.at|78038
22326492|NCT04072237|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22326493|NCT04985773|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
22326494|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov|
22326495|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com|
22326496|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
22326497|NCT00748540|MED-EL Corporation|Allison Racey, AuD|888-633-3524|allison.racey@medel.com|
22326498|NCT04743635|Revelle Aesthetics, Inc.|Rachel Walsh, Senior Manager of Clinical Affairs|6509634498|rwalsh@revelleax.com|
22282420|NCT02994953|Merck KGaA, Darmstadt, Germany|Communication Center|6151 72 5200|service@merckgroup.com|
22282421|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22282422|NCT04098367|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22282423|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu|
22282424|NCT02043197|Abbott|Tatiana V. Vladimirova|+74952584280|tatiana.vladimirova@abbott.com|
22282425|NCT00445939|Abbott|Global Medical Services|800-633-9110||
22282426|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22282427|NCT03879044|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
22282428|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333||
22282429|NCT04028765|Thomas Jefferson University Health System|Dr. Whitney Bender|4342948416|whitney.bender@jefferson.edu|
22316582|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
22316583|NCT02406677|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD, VP, CVMD TA|302-886-5526|Naeem.Khan@astrazeneca.com|
22316584|NCT02654652|Universidade Federal de Minas Gerais|Dr. Maria Isabel Correia|+55 31 34098033|isabel_correia@uol.com.br|
22316585|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu|
22326499|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
22316586|NCT04531098|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
22316587|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca|
22326500|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com|
22316588|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
22316589|NCT03603002|Johns Hopkins University, Department of Radiation Oncology|Dr. K. Ranh Voong|410-550-6597|kvoong1@jhmi.edu|
22316590|NCT03746392|University of Washington|Program Coordinator (Elizabeth Nielsen)|206-744-9516|eniels9@uw.edu|
22316591|NCT00095498|Amgen Inc.|Study Director|866-572-6436||
22316592|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu|
22316593|NCT05020327|University Hospitals Cleveland Medical Center|Dr. Ankita Desai|216-844-3645|Ankita.Desai@UHhospitals.org|
22316594|NCT02548845|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
22316595|NCT03002220|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22316596|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623||
22316597|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch|
22316598|NCT03439254|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22316599|NCT03795753|Emory University|Dr. Nancy Collop|404-712-7533|nancy.collop@emory.edu|
22316600|NCT00128102|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316601|NCT02385240|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22316602|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it|
22316603|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu|
22316604|NCT01008410|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22316605|NCT02988050|Menoufia University|Professor Ezzeldin Ibrahim, Professor of Anaesthesia|00201006303178|ezzeldin7@yahoo.com|
22316606|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu|
22316607|NCT01127893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316608|NCT01262677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316609|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316610|NCT02324608|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger|
22316611|NCT03889704|University of Pittsburgh|Dr. Edward Burton|4126924670|eab25@pitt.edu|
22316612|NCT04440839|UNIVERSITY OF CALIFORNIA DAVIS|Misty Humphries|9167342028|mdhumphries@health.ucdavis.edu|
22316613|NCT04552899|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22316614|NCT04786964|Checkpoint Therapeutics|James Oliviero|212-574-2830|jfo@checkpointtx.com|
22316615|NCT02591953|Rush|Dr. Jeremy Alland|3124322434|jeremy.alland@rushortho.com|
22316616|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com|
22316617|NCT02060370|University of Texas MD Anderson Cancer Center|Dr. Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-2830|ejonasch@mdanderson.org|
22316618|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22316619|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22316620|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22316621|NCT03098563|Johns Hopkins University|Claudia Campbell|4105507989|ccampb41@jhmi.edu|
22316622|NCT02672852|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22316623|NCT00626626|Penn State Hershey Medical Center|Dr David Claxton|717-531-8401|dclaxton@hmc.psu.edu|
22316624|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316625|NCT02636725|University of Miami|Jonathan Trent MD|305-243-2581|JTrent@med.miami.edu|
22316626|NCT01249027|Abbott Vascular|Leong Roy|8133 7475|roy.leong@abbott.com|+65
22316627|NCT03478904|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
22316628|NCT02917603|UMissouri|Debra Parker Oliver; PI|573-356-6719|oliverdr@missouri.edu|
22316629|NCT04462289|Minneapolis VA Health Care System|Dr. Anne Melzer|6124674413|anne.melzer2@va.gov|
22316630|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org|
22316631|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu|
22316632|NCT03030859|University of Pennsylvania School of Nursing|Jie Deng, PhD, PI|215-573-2393|jiedeng@nursing.upenn.edu|
22316633|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316634|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316635|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316636|NCT01803282|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22316637|NCT00515723|Washington University School of Medicine and Florida Atlantic University|John Newcomer, M.D.|561-297-0252|jnewcomer@fau.edu|
22316638|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316639|NCT04522921|Department of Clinical Medicine, Aarhus University / Steno Diabetes Center Aarhus, Aarhus University Hospital|Dorthe Dalstrup Pauls|+45 28256406|dorthedalstrup@clin.au.dk|
22282430|NCT04857437|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282431|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590||
22282432|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org|
22316640|NCT01217437|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22316641|NCT04908631|Duke University|Howard W. Francis, MD|919-681-8069|howard.francis@duke.edu|
22316642|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com|
22282433|NCT02545517|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316643|NCT02336451|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22326501|NCT00968253|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22326502|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu|
22326503|NCT03860844|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22326504|NCT04624932|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
22326505|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326506|NCT05281523|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326507|NCT04038255|University of Miami|Dr. Taghrid Asfar|+1 (901)-371-7229|tasfar@miami.edu|
22326508|NCT05183867|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
22326509|NCT05299983|UC San Diego|Andrea LaCroix|(858) 822-0627|alacroix@ucsd.edu|
22326510|NCT05306873|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22326511|NCT01953328|Amgen Inc.|Study Director|866-572-6436||
22326512|NCT03300752|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
22326513|NCT01755195|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
22326514|NCT05113953|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22326515|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org|
22326516|NCT03499808|SWOG Statistics and Data Management Center|Adam Rosenthal|206-652-9711|adamr@crab.org|
22326517|NCT02340819|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326518|NCT01328249|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
22326519|NCT02330549|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22326520|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300||
22326521|NCT03331666|Columbia University Irving Medical Center|Dr. Nan Wang|212-342-1761|nw30@cumc.columbia.edu|
22326522|NCT00434512|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326523|NCT04253834|Emory University|Dr. Jeffrey Miller|404-252-6104|jeffrey.miller@emory.edu|
22326524|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22326525|NCT02245568|TauRx Therapeutics Ltd|Dr. Diane Downie|+44 1224440905|info@taurx.com|
22326526|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326527|NCT02713230|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-397-2467|MedInfo@pacira.com|
22326528|NCT04549597|Ardelyx|David Rosenbaum|6175134929|drosenbaum@ardelyx.com|
22326529|NCT00769704|Amgen, Inc.|Study Director|866-572-6436||
22326530|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326531|NCT03000309|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22326532|NCT04341675|University of Cincinnati|Nishant Gupta, MD|513-558-4861|Nishant.Gupta@uc.edu|
22326533|NCT03298412|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22326534|NCT03226223|New York State Psychiatric Institute|Dr. Jermaine Jones|6467746113|jermaine.jones@nyspi.columbia.edu|
22326535|NCT03456713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326536|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326537|NCT01894477|Fred Hutchinson Cancer Research Center|Eileen J Sickle|206-271-7066|esickle@fredhutch.org|
22326538|NCT02424955|Stanford University|Lucas Kas Vitzthum|(650) 498-6000|ccto-website@stanford.edu|
22326539|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326540|NCT02251704|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326541|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com|
22326542|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22326543|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl|
22326544|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22326545|NCT02389816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22326546|NCT00300469|Abbott|Medical Information Specialist|800-633-9110||
22326547|NCT01217190|Par Pharmaceutical|Medical Affairs|1-800-828-9393|DrugInfo@strativapharma.com|
22326548|NCT01594476|Oregon Health & Science University|Dr. Maureen Baldwin, MD MPH|(503) 494-9762|schaum@ohsu.edu|
22326549|NCT05114590|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22326550|NCT03007953|Department of Veterans Affairs|Dr. Lynn F. Reinke|206-277-4186|Lynn.Reinke1@va.gov|
22326551|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326552|NCT03196297|Novo Nordisk A/S|Clinical Transparency and Medical Writing (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22326553|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com|
22271203|NCT01455181|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326554|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326555|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com|
22326556|NCT04415489|University of North Carolina at Chapel Hill|Sarah Moustafa, MD|919-908-0000|sarah_moustafa@med.unc.edu|
22326557|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov|
22326558|NCT03302416|Univesity of Pittsburgh|Rajesh Narendran|412-647-5176|narendranr@upmc.edu|
22326559|NCT01745393|Temple University|Bradley Collins|215-204-2849|collinsb@temple.edu|
22326560|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov|
22299841|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch|
22299842|NCT04004611|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22299843|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399||
22299844|NCT04844281|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
22326561|NCT05319535|Durham VA Medical Center|Courtney H Van Houtven, PhD|919-286-6936|courtney.vanhoutven@va.gov|
22299845|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com|
22299846|NCT02384759|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22299847|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu|
22299848|NCT03950739|United Therapeutics Corp.|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22299849|NCT03625570|Louisiana State University Health Sciences Center - New Orleans|Dr. Noelle G. Moreau|504-568-4291|nmorea@lsuhsc.edu|
22299850|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299851|NCT01949480|University of Pittsburgh|Dr. Anna Uskova, Principal Investigator|412) 623-2167|UskoAA@anes.upmc.edu|
22299852|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299853|NCT00305058|Montefiore Medical Center|Andrew Chang, MD|718-920-6626|achang3@yahoo.com|
22326562|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
22299854|NCT03538626|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22299855|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org|
22299856|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299857|NCT01835626|University of California, San Francisco|Dr. Sue Yom|(415) 353-9893|Sue.Yom@ucsf.edu|
22299858|NCT02232893|Tsumura USA Inc|Yu Tanaka|609-799-2083|Yu Tanaka <tanaka_yuu@mail.tsumura.co.jp>|
22299859|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299860|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711|nathalie.gagne@criucpq.ulaval.ca|2645
22299861|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
22299862|NCT05077267|Bavarian Nordic A/S|Bavarian Nordic Call Center|+1-844-422-8274|medical.information_us@bavarian-nordic.com|
22299863|NCT02911948|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22299864|NCT04747977|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22299865|NCT02854540|Stanford School of Medicine|Dr. Marlyanne Pol-Rodriguez|650-721-7144|mpr@stanford.edu|
22299866|NCT00690521|University of New Mexico Health Sciences|Joe Anderson|505-272-3664|janderson@salud.unm.edu|
22299867|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22299868|NCT02679690|University of Pittsburgh|Sheryl Ondrejko, DNP||sherylannmarieo@gmail.com|
22299869|NCT02666950|Mayo Clinic|Lisa Sproat, M.D.|480/301-8000|Sproat.Lisa@mayo.edu|
22299870|NCT03819660|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
22299871|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br|
22299872|NCT03965052|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22299873|NCT01286259|University of California, San Francisco|Steven G. Deeks|(415) 476-4082|Steven.Deeks@ucsf.edu|
22299874|NCT00127673|Case Western Reserve University|Dr. Norah C Feeny|2163682695|ncf2@case.edu|
22299875|NCT02545907|Leeds Institute of Clinical Trials Research|Alexandra Pitchford|0113 343 9077|medcatal@leeds.ac.uk|
22299876|NCT01573702|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22299877|NCT02308033|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
22316644|NCT05570630|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
22316645|NCT06655558|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22316646|NCT04839185|UW School of Medicine and Public Health|Dinesh Shah, MD|608-417-6099|dmshah@wisc.edu|
22316647|NCT03468478|Hospital do Rim - Fundação Oswaldo Ramos|Dr. Helio Tedesco Silva Junior|55 11 50878113|heliotedesco@medfarm.com.br|
22316648|NCT03446001|TauRx Therapeutics Management Ltd.|Sotereos Gates, PhD|+44 (0) 7771 570707|s.gates@taurx.com|
22316649|NCT05430815|Emory University|Anne Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
22316650|NCT04893460|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
22316651|NCT03578887|University of Washington|Ellen Schur, MD, MS|206-543-8433|ellschur@uw.edu|
22316652|NCT01099215|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22316653|NCT02896075|University of Texas at Austin|Stephanie Lapierre|512-471-8594|stephlap1116@gmail.com|
22316654|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org|
22316655|NCT03203473|Dana Farber Cancer Institute|Toni K Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
22316656|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
22316657|NCT03333876|Philips Respironics|Noah Papas|4122776436|Noah.Papas@philips.com|
22326563|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779||
22326564|NCT04937816|Boehringer Ingelheim, Call Center|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22316658|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
22271204|NCT00565669|Carolina Eye|Helga Sandoval||hps@cepmd.com|
22271205|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se|
22316659|NCT00979550|University of Kentucky Healthcare|Henry C. Vasconez, MD|8593236328|betsy.fink@uky.edu|
22299878|NCT03165045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299879|NCT04773015|GE Healthcare|Paul Sherwin, MD, PhD|609 510 3686|PaulSherwin@ge.com|
22299880|NCT04964089|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
22299881|NCT03403725|Menarini Ricerche SPA|Corporate Director of Clinical Sciences|+39 055 56809933|acapriati@menarini-ricerche.it|
22299882|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|PettyNathanM@uams.edu|2461
22299883|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22299884|NCT04153409|Lateral Pharma Pty Ltd|Mr David Kenley|+61400151490|dk@lateral-pharma.com|
22299885|NCT00148343|Case Western Reserve University/MetroHealth Medcial Center|Lynne Sheffler, MD|216-957-3570|lsheffler@metrohealth.org|73556
22316660|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org|
22316661|NCT04684394|Gemini Therapeutics, Inc.|Gemini Therapeutics, Inc.|617-401-4401|clinicaltrials@geminitherapeutics.com|
22316662|NCT03986944|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22316663|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316664|NCT01531673|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22316665|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316666|NCT01332630|UT MD Anderson Cancer Center|Ibrahim,Nuhad K.,M.D. / Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22316667|NCT01318018|Dept. of Anesthesiology and Intensive Care Medicine|Prof. Dr.Martin Soehle|++49-228-287-|martin.soehle@ukb.uni-bonn.de|11378
22316668|NCT04476251|National Cancer Institute|Scott M. Norberg D.O.|301-275-9668|scott.norberg@nih.gov|
22316669|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22316670|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316671|NCT02787044|Brigham and Women's Hospital|Dr. Scott Solomon|857-307-1960|ssolomon@bwh.harvard.edu|
22316672|NCT01638429|Cedars-Sinai Medical Center|Dr Ruchi Mathur|310-423-4774|Ruchi.Mathur@cshs.org|
22316673|NCT02040584|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316674|NCT03894618|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22316675|NCT02530970|Aziyo Biologics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
22316676|NCT00795275|University of Colorado Anschutz Medical Campus|Leigh Perreault, MD|303-249-7732|leigh.perreault@ucdenver.edu|
22316677|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22316678|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22316679|NCT03291288|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22316680|NCT04978493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22316681|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316682|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
22316683|NCT02387970|Columbia University|Panos N. Papapanou, DDS, PhD|(212) 342-3008|pp192@cumc.columbia.edu|
22316684|NCT02628028|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316685|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316686|NCT01743989|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22316687|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org|
22316688|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu|
22316689|NCT04655027|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94 79|information.center@astrazeneca.com|
22316690|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22316691|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22316692|NCT02870049|UC San Diego|Samir Gupta, MD|07/09/2018|s1gupta@health.ucsd.edu|
22316693|NCT05543707|Pardes Biosciences|Vice President, Quality|4042815163|jenna.tagliaferri@pardesbio.com|
22316694|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org|
22316695|NCT05511038|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22316696|NCT02108964|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316697|NCT03006848|St Jude Children's Research Hospital|Dr. Michael Bishop|866-278-5833|referralinfo@stjude.org|
22316698|NCT01198067|M.D. Anderson Cancer Center|Sheeba K. Thomas, MD|713-792-2860|sthomas@mdanderson.org|
22316699|NCT03086655|University of California San Francisco|Dr. Maria Ekstrand|+1 (415) 502-1000|Maria.Ekstrand@ucsf.edu|17142
22316700|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22316701|NCT04531982|Acadia Pharmaceuticals Inc.|Senior Director, Medical Information|8444222342|medicalinformation@acadia-pharm.com|
22316702|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org|
22316703|NCT04998812|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22316704|NCT03524092|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316705|NCT04303780|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22316706|NCT03826030|Duke University|Wayne Feng, MD|919-681-1700|wayne.feng@duke.edu|
22326565|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
22299886|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu|
22326566|NCT05513053|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22282434|NCT03334851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316707|NCT06118957|University of Utah Obgyn|Elizabeth Turner, MPH, Senior Regulatory Coordinator|8012018929|elizabeth.e.turner@hsc.utah.edu|
22316708|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
22316709|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
22316710|NCT02314780|Medical University of Vienna|Dr. Martin Andreas|+ 43 1 40400|martin.andreas@meduniwien.ac.at|69660
22316711|NCT01901432|ITALFARMACO S.p.A.|Medical Expert|+39 026443 258|p.bettica@italfarmaco.com|
22316712|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262|steven.dobscha@va.gov|52207
22316713|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047|drmsweed@gmail.com|+2
22316714|NCT01077271|Abbott|Global Medical Services|1-800-633-9110||
22316715|NCT02225132|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
22316716|NCT03283254|Columbia University|Elizabeth Werner, Ph.D.|646-774-8945|ew150@cumc.columbia.edu|
22316717|NCT02055781|CTI BioPharma Corp.|Beth Ziemba||bziemba@ctibiopharma.com|
22316718|NCT05816330|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter D Crompton|301-761-5042|pcrompton@niaid.nih.gov|
22316719|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com|
22316720|NCT03446781|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22316721|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com|
22316722|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr|
22316723|NCT02796300|UCLA Medical Center|Principal Investigator|310-267-8771|EdwardLee@mednet.ucla.edu|
22316724|NCT05141500|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
22316725|NCT02898077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22316726|NCT02885324|Indiana University|Dr. Scott Coven|317-944-8784|scoven@iu.edu|
22316727|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639||
22316728|NCT01802567|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
22316729|NCT01940939|Dr.LIU|ShanghaiMHC|862134773775|erliu110@126.com|
22316730|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu|
22316731|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl|
22316732|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com|
22316733|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com|
22316734|NCT02182947|Children's Mercy Hospital|Nadia Hijaz|3139204958|nmhijaz@cmh.edu|
22316735|NCT02236988|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22316736|NCT04308590|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22316737|NCT02734576|North Shore University Hospital Northwell Health|Dr. Athos Patsalides|516-562-2244|apatsalides@northwell.edu|
22316738|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22316739|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22316740|NCT05775991|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22316741|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22316742|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu|
22316743|NCT02757872|NYU Langone|Dr. Michal Melamed|212-263-0705|michal.melamed@nyulangone.org|
22316744|NCT00939822|University of Wisconsin School of Medicine and Public Health|Dr. Cynthia M. Carlsson|608-256-1901|cmc@medicine.wisc.edu|11691
22316745|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22316746|NCT02683785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316747|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743||
22316748|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22316749|NCT01877239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316750|NCT04368364|The University of Texas Health Science Center at Houston|Sudipta Sen, MD, Assistant Professor|713-500-6200|Sudipta.Sen@uth.tmc.edu|
22316751|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300||
22316752|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
22271206|NCT04424966|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
22316753|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22316754|NCT04187326|UMass Chan School of Medicine|Dr. Elliot Edmiston, Associate Professor of Psychiatry & Behavioral Sciences|5088566480|kale.edmiston@umassmed.edu|
22271207|NCT03932331|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22271208|NCT01032239|Medtronic Clinical Neuromodulation|Alessandra Calabrese, PhD||alessandra.calabrese@medtronic.com|
22271209|NCT00204477|University of Texas Medical Branch Galveston|Leejane W. Lu|(409)772-1011|llu@utmb.edu|
22271210|NCT04535531|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22271211|NCT01940900|Ophthotech Corp.|Denise Teuber||denise.teuber@ophthotech.com|
22271212|NCT04713592|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22271213|NCT03098498|Department of Periodontology, University Hospital Wuerzburg|Dr. Yvonne Jockel-Schneider|49-931-201-72620|jockel_y@ukw.de|
22316755|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22316756|NCT05686122|Duke University School of Medicine|Sarah Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
22316757|NCT05543187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22316758|NCT04777864|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
22316759|NCT06988800|Muvik|Dr. Chelsea Gordon|9063990332|chelsea@muviklabs.io|
22316760|NCT02344290|REPRIEVE Clinical Coordinating Center|REPRIEVE Project Manager|617-724-9109|mghreprievetrial@mgb.org|
22316761|NCT04746846|Virginia Commonwealth University|Ingrid Pretzer-Aboff, Ph.D., RN , FGSA, FAAN|804-828-3340|iaboff@vcu.edu|
22316762|NCT06748729|Össur Iceland ehf.|Laurine Roussillon|+3548221812|lroussillon@ossur.com|
22316763|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22316764|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org|
22316765|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org|
22316766|NCT03232580|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316767|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300||
22316768|NCT01302080|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316769|NCT00837694|University at Buffalo|Jennifer L. Temple|716-829-5593|jltemple@buffalo.edu|
22316770|NCT04370548|Dare Bioscience, Inc.|VP, Clinical Operations|858-926-7655|nzack@darebioscience.com|109
22316771|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22316772|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu|
22316773|NCT02654691|Aarhus University|Nanna Finnerup|0045 78463382|finnerup@clin.au.dk|
22316774|NCT04019990|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
22326567|NCT04491877|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22326568|NCT02614287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326569|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22326570|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com|
22326571|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408||
22326572|NCT03987919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326573|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com|
22326574|NCT01520324|Cosmo Pharmaceuticals NV|Dr. Richard Jones|+353 18170370|RJones@cosmopharma.com|
22326575|NCT03470922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22326576|NCT02626819|Manhattan Campus of the VA NY Harbor Healthcare System|Melanie Jay, MD MS|212-686-7500|melanie.jay@va.gov|5097
22326577|NCT02361762|Boston Children's Hospital|Dr. Susan Faja|617-919-4108|susan.faja@childrens.harvard.edu|
22326578|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com|
22326579|NCT00502307|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22326580|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
22326581|NCT03813719|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
22326582|NCT02094872|Yale University|Manuel Avedissian, M.D.|203-737-3669|manuel.avedissian@yale.edu|
22326583|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu|
22326584|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu|
22326585|NCT04009096|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
22326586|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu|
22326587|NCT03010423|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22326588|NCT03439748|UCLA|Dr. Michelle G. Craske|(310) 825-8403|mcraske@mednet.ucla.edu|
22326589|NCT05131451|Johns Hopkins University|Dr. Risa Wolf|4109556463|rwolf@jhu.edu|
22326590|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov|
22326591|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu|
22326592|NCT01856595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326593|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22326594|NCT04426825|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22326595|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu|
22326596|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu|
22326597|NCT03161938|Rigshospitalet|Kristin steinthorsdottir|31666112|kjs@dadlnet.dk|
22326598|NCT02154750|UC San Diego Health|Gregory Feld, MD|(858) 246-2972|gfeld@health.ucsd.edu|
22326599|NCT01912729|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22326600|NCT01125176|Weill Cornell Medical College|Richard Furman, MD|646-962-2064|rrfurman@med.cornell.edu|
22326601|NCT00988559|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
22316775|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316776|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
22326602|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316777|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22326603|NCT02538666|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22326604|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326605|NCT02492750|Mayo Clinic|John A Lust MD PhD|507/284-2511|lustj@mayo.edu|
22316778|NCT02735577|New York State Psychiatric Institute|Nasir Naqvi, MD|6467748181|nasir.naqvi@nyspi.columbia.edu|
22316779|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22316780|NCT02040259|Stryker Neurovascular|Minyi Ji, Biostatistician, Clinical Evidence|+1 (510) 980-5689|minyi.ji@stryker.com|
22316781|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22316782|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu|
22316783|NCT00316602|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22316784|NCT01142232|IndianaU|Dr. Attaya Suvannasankha|(317) 278-9306|asuvanna@iu.edu|
22316785|NCT00626990|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
22316786|NCT01507987|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
22316787|NCT04138576|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
22316788|NCT00597246|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
22316789|NCT04142359|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22316790|NCT04410523|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22316791|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu|
22316792|NCT03268603|Mayo Clinic|Nathan Staff, M.D., Ph.D.|507-293-1283|Staff.Nathan@mayo.edu|
22316793|NCT04939701|Astellas Pharma Global Development Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22316794|NCT00772330|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22316795|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316796|NCT03199118|Cairo University|Sarah Elbanna, assistant lecturer at the Oral Medicine and Periodontology department|+201000760002|srhelbanna@gmail.com|
22316797|NCT03248882|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316798|NCT01656200|University of Liverpool|Dr Lance Turtle|+44 151 795 9626|lance.turtle@liverpool.ac.uk|
22316799|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22316800|NCT03015129|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
22316801|NCT05032872|Brandeis University|Xin Yao Lin|6462583562|xylin@brandeis.edu|
22316802|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
22316803|NCT03733314|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
22316804|NCT01598662|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
22316805|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22316806|NCT04246021|King Hussein Cancer Center|Dr. Hikmat Abdel-Razeq|0096265300460|habdelrazeq@khcc.jo|1403
22316807|NCT04155047|Sunovion Respiratory Development Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22316808|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
22316809|NCT04514510|National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)|Arun Shet, MD, PhD|301.827.6808|arun.shet@nih.gov|
22316810|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500|firpirj@medicine.ufl.edu|9466
22316811|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org|
22316812|NCT02781090|Montefiore Medical Center|Dr. Jonathan Shuter|718-920-7845|jshuter@montefiore.org|
22316813|NCT00643617|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
22316814|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
22316815|NCT05731999|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
22316816|NCT04481568|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
22316817|NCT01208103|UT MD Anderson Cancer Center|Dr. Michael Overman/Gastrointestinal Medical Oncology|713-745-4317|MOverman@mdanderson.org|
22316818|NCT02551653|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316819|NCT01882764|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
22316820|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
22316821|NCT02770612|Brigham and Women's Hospital|Brian T Bateman|617-278-0930|bbateman@partners.org|
22316822|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343||
22316823|NCT03846453|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
22316824|NCT04561778|Geisinger Health System|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|5444
22316825|NCT01989169|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22316826|NCT01114880|Abbott|Global Medical Services|1-800-633-9110||
22316827|NCT02539459|Fox Chase Cancer Center|Robert Uzzo, M.D.|215-728-3096|robert.uzzo@fccc.edu|
22316828|NCT04531904|CERENOVUS|Cerenovus Clinical Research Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22316829|NCT02839889|Four Seasons Compassion for Life|Janet Bull, MD|8286926178|jbull@fourseasonscfl.org|302
22316830|NCT02738853|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
22316831|NCT03519997|University Texas Southwestern Medical Center|David Hsieh|214/648-4180|David.Hsieh@UTSouthwestern.edu|
22316832|NCT03361605|University of Michigan|Amy McKinney|734-647-8129|adrongo@med.umich.edu|
22282435|NCT03575065|BeiGene|Study Director|+1 - 877-828-5568|clinicaltrials@beigene.com|
22316833|NCT02906007|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22316834|NCT04696653|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22326606|NCT02965534|University of Applied Sciences Jena|Philipp Hessler|+4916097089677|philipp@hessler.de|
22326607|NCT03230175|TissueTech, Inc.|Nick McCoy, Vice President Clinical Operations|7867340023|nmccoy@tissuetechinc.com|
22326608|NCT02582749|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
22326609|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
22326610|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si|
22326611|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22326612|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22326613|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326614|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
22326615|NCT03342469|American University|Dr. Kathleen Holton|(202) 885-3797|holton@american.edu|
22326616|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22326617|NCT05515601|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326618|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326619|NCT02928406|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22326620|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22326621|NCT03929588|EyeQue|VP Science and Technology|5104558168|noam.sapiens@eyeque.com|
22326622|NCT02678780|Kapadi|Start Up Unit|+34961452190|maria.rocasalbas@kapadi.com|
22326623|NCT02100748|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22326624|NCT01064648|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
22326625|NCT05513391|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22326626|NCT02429427|Imperial College London|Prof Charles Coombes|+44 20 7594 2135|c.coombes@imperial.ac.uk|
22326627|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22326628|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu|
22326629|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk|
22326630|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326631|NCT02775760|Boston University Chobanian & Avedisian School of Medicine|Karin Schon, Ph.D.|(617) 358-2118|kschon@bu.edu|
22326632|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org|
22326633|NCT01760993|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326634|NCT05138783|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22326635|NCT03364335|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
22326636|NCT04710862|Syracuse University|Dr. Soren Lowell|315-443-9615|slowell@syr.edu|
22326637|NCT03725202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22326638|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
22326639|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu|
22326640|NCT02364947|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
22326641|NCT02536170|Emory University|Claudia Morris|404-727-5500|claudia.r.morris@emory.edu|
22326642|NCT02702518|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22326643|NCT00853489|Saint Louis University|Dr. Lisa Kaye Cannada|3145778850|LCannada@slu.edu|7
22326644|NCT01392989|Stanford University|Everett Meyer, Assistant Professor of Medicine (Blood and Marrow Transplantation)|650) 725-5816|evmeyer@stanford.edu|
22326645|NCT01251276|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326646|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org|
22326647|NCT02658994|Human Development Research Foundation|Siham Sikander|+923330590373|sihamsikander@gmail.com|
22326648|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr|
22326649|NCT02728258|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|gedeonl@nrgoncology.org|
22326650|NCT01725152|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
22326651|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu|
22326652|NCT01111539|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22326653|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com|
22326654|NCT03580382|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
22326655|NCT02808312|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22326656|NCT03628417|Szeged University|Principal Investigator, Assistant Professor|+36-62-545-259|kis.erika.gabriella@med.u-szeged.hu|
22326657|NCT02420223|Medical College of Wisconsin|Dr. Jennifer Knight|866-680-0505|jknight@mcw.edu|
22326658|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22326659|NCT01826422|IMSS|Dr. Maricela Rodriguez-Cruz|5256276900|maricela.rodriguez.cruz@gmail.com|. 22483
22326660|NCT04263142|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326661|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com|
22326662|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22326663|NCT03568539|Innovent Biologics (Suzhou) Co., Ltd.|YiBo|+8613382419112|jessica.yi@innoventbio.com|
22326664|NCT03484923|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22326665|NCT01863849|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
22326666|NCT02012608|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
22316835|NCT03520712|BioMarin Pharmaceutical (UK) Ltd.|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44207|KonstantiaMaria.Chavele@bmrn.com|4203351
22316836|NCT04372121|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22316837|NCT03921723|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22316838|NCT05187364|Medical University of South Carolina|Dr. Amber Jarnecke|843-876-3115|jarnecka@musc.edu|
22316839|NCT03046121|Penn State University|Marie Boltz PhD|215-962-9712|mpb40@psu.edu|
22316840|NCT03214640|Wake Forest Health Science|Peter Pan, MD|336-716-1228|ppan@wakehealth.edu|
22316841|NCT01143870|University of Pennsylvania|Anjali Gopalan|575-640-3893|agopalan@upenn.edu|
22316842|NCT04091061|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316843|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu|
22316844|NCT04488770|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22316845|NCT03547739|University of Alabama at Birmingham|Janet M. Turan, PhD, MPH|2059757770|jmturan@uab.edu|
22316846|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
22316847|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
22316848|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22316849|NCT05254080|Medical University of South Carolina|Dr. Christopher W. Austelle|843-792-2872|austelle@musc.edu|
22316850|NCT01353118|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22316851|NCT01696955|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22316852|NCT00799981|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
22316853|NCT03192475|University of Pittsburgh|Elizabeth Mary Venditti PhD, Associate Professor of Psychiatry and Epidemiology|(412) 647-1027|vendittiem@upmc.edu|
22316854|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
22316855|NCT03980808|Georgia Institute of Technology|Salimah LaForce, M.S.|404-385-4614|salimah@cacp.gatech.edu|
22316856|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22316857|NCT01681121|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22326667|NCT04402008|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
22326668|NCT00913978|Northwestern University|Meltem Yilmaz, MD|312-695-0061|m-yilmaz@northwestern.edu|
22326669|NCT04716933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22326670|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org|
22326671|NCT03249792|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326672|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800|jyoung@rcbm.net|261
22326673|NCT03909763|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
22326674|NCT01409031|University of Colorado, Denver|John Kinsella, MD|303-724-2853|John.Kinsella@ucdenver.edu|
22326675|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22326676|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com|
22326677|NCT02913222|Washington University School of Medicine|Marcie Harris-Hayes, PT, DPT, MSCI, Professor, Physical Therapy and Orthopaedic Surgery|314-286-1435|harrisma@wustl.edu|
22326678|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu|
22326679|NCT04272216|Clinical Project Manager|Paige Gowen|908-208-3749|paige.gowen@terumomedical.com|
22326680|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22326681|NCT02509598|Cardinal Health 414, LLC|Director, Regulatory & Medical Affairs|6147570226|npsmedicalaffairs@cardinalhealth.com|
22326682|NCT03521687|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
22326683|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com|
22326684|NCT04891770|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22316858|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com|
22316859|NCT03653208|ImmuneMed Inc.|Byoungok Ahn|+82-2-527-8391|ahnbo@immunemed.co.kr|
22316860|NCT05330676|University of Pennsylvania|John C. Greenwood, MD, MS|856-816-7172|john.greenwood@pennmedicine.upenn.edu|
22316861|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu|
22316862|NCT02741323|University of California, San Francisco|Clinical Research Manager|415-595-1226|Rodney.Rogers@ucsf.edu|
22316863|NCT03417570|Washington University School of Medicine|Vladimir M. Kushnir, M.D.|314-454-5960|vkushnir@wustl.edu|
22316864|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
22316865|NCT02416453|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22316866|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org|
22316867|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu|
22316868|NCT02297100|Wake Forest University Health Sciences|Dr. Robert Evans|336-713-0320|revans@wakehealth.edu|
22316869|NCT01204710|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316870|NCT00680992|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22316871|NCT03898167|The University of Texas MD Anderson Cancer Center|Dr. Jane Montealegre|713-792-0919|jrmontealegre@mdanderson.org|
22316872|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu|
22316873|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov|
22316874|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com|
22316875|NCT03898778|Minnesota Medical Technologies Corporation|VP of Regulatory Affairs|507-533-0366|rmanglin@mnmedicaltechnologies.com|
22316876|NCT04348435|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22316877|NCT00848588|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22316878|NCT04047862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22316879|NCT06122870|Johns Hopkins University|Dr. Kawsar Talaat|410-336-9164|ktalaat@jhu.edu|
22316880|NCT02745353|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
22282436|NCT02323126|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22316881|NCT05014568|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22316882|NCT04349631|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22316883|NCT04015869|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|Elizabeth.Ralevski@yale.edu|1-4282
22316884|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-0671|bryantw@ecu.edu|
22316885|NCT00482690|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
22316886|NCT00640133|Butler Hospital|Dr. Benjamin Greenberg|(401) 455-6602|be3ngreenb@gmail.com|26602
22316887|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
22316888|NCT03896152|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22316889|NCT00224887|Stanford University|Dr. Donna Matheson|650-723-5895|donna.matheson@stanford.edu|
22316890|NCT04032613|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|919-445-2656|jflythe@med.unc.edu|
22316891|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
22316892|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov|
22316893|NCT04850794|University of North Carolina at Chapel Hill|Kelsey Thompson, MS|919-966-1007|kelsey_thompson@med.unc.edu|
22316894|NCT04678505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316895|NCT01365481|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22316896|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22316897|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
22316898|NCT02946853|University of Rochester|Dr. Jonathan Steinberg|9734364155|jsteinberg@summithealth.com|
22316899|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org|
22316900|NCT02369068|Beaumont Hospital, Royal Oak|Deborah Hasenau RN, Director, Urology Research|248-551-0804|Deborah.Hasenau@Beaumont.org|
22316901|NCT04664075|Imperial College London|Senior Clinical Research Nurse|02083833231|flu-rsv-study@imperial.ac.uk|
22316902|NCT02033083|Planned Parenthood of New York City|Director of Clinical Training and Research|212-274-7340|ctri@ppnyc.org|
22316903|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767||
22316904|NCT02755818|University of California, Davis|George Kaysen MD - Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
22316905|NCT03014011|Bispebjerg Hospital|MD Malin Nilsson|50595861|mnil0028@regionh.dk|0045
22316906|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22316907|NCT05319912|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22316908|NCT01143181|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22316909|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912|ianhow@monicahealthcare.com|4540
22316910|NCT03284203|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
22316911|NCT02229851|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22316912|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu|
22316913|NCT03682302|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22316914|NCT04535310|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
22271214|NCT00654992|Seoul National University Bundang Hospital|Effect of erythropoietin in kidney after cardiac surgery|82-31-787-7014|kyna@snubh.org|
22271215|NCT02225366|UT MD Anderson Cancer Center|Dr. Rodabe Amaria,MD, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|rnamaria@mdanderson.org|
22271216|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22271217|NCT03782298|Smtih + Nephew, Inc|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
22271218|NCT02431806|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22271219|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271220|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22271221|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22271222|NCT02426749|University of Manitoba|Dr Zahra Moussavi|204 474 7023|Zahra.Moussavi@umanitoba.ca|
22271223|NCT02513498|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22271224|NCT02767492|Hawkins Foundation|Kyle Adams|864 454-7458|kyle.adams@hawkinsfoundation.com|
22271225|NCT03596723|Kala Pharmaceuticals, Inc|VP Clinical Development|781-996-5252|Results010@kalarx.com|
22271226|NCT02484651|Universidade Aberta, Mathematics Section|Prof. Catarina S Nunes|+351 300 001 705|cnunes@bio-mathematics.org|
22271227|NCT01698879|CETLAM|Dr. Jordi Sierra|+34 93 434 44 12|jsierra@santpau.cat|
22271228|NCT04972968|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22271229|NCT00150800|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22271230|NCT03649178|Vanderbilt University Medical Center|C. Michael Stein MD|615-936-3420|michael.stein@vumc.org|
22271231|NCT04120584|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22271232|NCT03619902|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22271233|NCT03660475|Penn State Hershey Medical Center|Joseph Sassani, MD, MHA|717 531 8783|jsassani@pennstatehealth.psu.edu|
22271234|NCT02251548|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
22271235|NCT00794040|Mood, Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health|Dr Argyris Stringaris|(301) 443-8019|argyris.stringaris@nih.gov|
22271236|NCT04687072|Argenx|Regulatory manager|Please email|regulatory@argenx.com|
22271237|NCT01263782|UT MD Anderson Cancer Center|Dr. George Simon, Thoracic/Head & Neck Med Onc|713-794-4740|GSIMON@MDANDERSON.ORG|
22271238|NCT02336360|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22271239|NCT04545567|University of Virginia|Mark DeBoer|1 434 924 0123|mdd5z@virginia.edu|
22271240|NCT03979807|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271241|NCT02754674|Samsung Medical Center|Wang, JoonHo|82-2-3410-3507|mdwang88@gmail.com|
22271242|NCT04009668|University of Michigan|Dr. Zubin Modi|(734) 232-6798|modiz@med.umich.edu|
22271243|NCT03626363|Michigan Technological University|Kelly Kallio, Assistant Vice President of Sponsored Programs|9064872226|kmkallio@mtu.edu|
22271244|NCT00287989|MSKCC|Charles M. Rudin, MD, PhD.|646-888-4527|rudinc@mskcc.org|
22271245|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org|
22271246|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271247|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271248|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
22271249|NCT02776644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271250|NCT01378377|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22271251|NCT02100670|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299887|NCT00574587|Montefiore Medical Center|Markenya Mirander|718-862-8840|MMIRANDE@montefiore.org|
22299888|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu|
22316915|NCT03189745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316916|NCT01276379|GEMCAD|Joan Maurel Santasusana|+ 34 93 434 44 12|JMAUREL@clinic.cat|
22316917|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
22316918|NCT02729831|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
22316919|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
22316920|NCT03358251|Prudentix Ltd.|Head of QA/RA|+972-72-394-22-24|tsipi@prudentix.com|
22316921|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22316922|NCT01747551|Dana-Farber Cancer Institute|Peter Enzinger|617-632-3029||
22316923|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22316924|NCT02245022|University of Liverpool|Catriona Waitt|0778288217|cwaitt@liverpool.ac.uk|
22316925|NCT05907707|University of North Carolina at Chapel Hill|Andrea Seiler, MD|+41 316322111|andrea.seiler@insel.ch|
22316926|NCT03842358|Washington University School of Medicine|Debbie Bennett, M.D.|314-454-7696|debbie.bennett@wustl.edu|
22271252|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22299889|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22316927|NCT05384938|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22326685|NCT01734512|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD|(415) 502-7301|sabine.mueller@ucsf.edu|
22271253|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com|
22271254|NCT05459558|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22299890|NCT03043664|Duke University Medical Center|Michael Morse, MD|919-668-1861|michael.morse@duke.edu|
22316928|NCT02626455|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
22316929|NCT06665919|Tbilisi State Medical University|Konstantine Liluashvili , MD., PH.D.|+995599908899|k.liluashvili@tsmu.edu|
22316930|NCT05148962|Gritstone bio, Inc.|Elizabeth Martin, Vice President, Clinical Development Infectious Disease|+1 (877) 520-2233|clinicalstudies@gritstone.com|
22316931|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316932|NCT01200290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316933|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22316934|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316935|NCT00452023|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Assistant Professor|832-750-4211|LMasarova@mdanderson.org|
22316936|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org|
22316937|NCT02954198|Medical University of South Carolina|Dr. David Taber|843-792-4003|taberd@musc.edu|
22316938|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com|
22316939|NCT01789567|Medtronic Bakken Research Center|Kitty Schapira|+31433566802|kitty.schapira@medtronic.com|
22316940|NCT01994837|AbbVie|Global Medical Services|800-633-9110||
22316941|NCT01951352|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
22316942|NCT03900416|Lawrence University|Dr. Lori Hilt|920-832-7050|lori.m.hilt@lawrence.edu|
22316943|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22326686|NCT05692154|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22326687|NCT03609359|National Cancer Center Hospital East|Dr.Kohei Shitara|(+81)-4-7133-1111|LenvaPembro_core@east.ncc.go.jp|91520
22326688|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22326689|NCT03860311|UAB|Dr. Stephen Ruffenach|5202707665|stephenruffenach@gmail.com|
22326690|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu|
22326691|NCT02432287|Albert Einstein College of Medicine|Erika Brutsaert|7188397961|erika.brutsaert@einstein.yu.edu|
22326692|NCT01975272|Maastricht University Medical Centre|Prof. dr. Roy Kruitwagen|0031-3874764|r.kruitwagen@mumc.nl|
22326693|NCT04058054|KeraNetics, Inc.|Chris Holder, PhD|336-413-3393|cholder@keranetics.com|
22326694|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22326695|NCT03220048|hVIVO|Tim Sharpington|02071480862|t.sharpington@hvivo.com|
22326696|NCT01052012|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22326697|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
22326698|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700|mark-wolraich@ouhsc.edu|45123
22326699|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se|
22326700|NCT04942483|Imperial College London|Professor Andrew Bush|020 7352 8121|a.bush@imperial.ac.uk|2255
22326701|NCT04370028|OOO NPF Materia Medica Holding|Mikhail Putilovskiy, MD, PhD|+74952761575|PutilovskiyMA@materiamedica.ru|302
22326702|NCT02796924|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
22326703|NCT02993224|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22326704|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22326705|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610|timpetersen@salud.unm.edu|505
22326706|NCT01081223|TVAX Biomedical, Inc.|Gary Wood PhD|913-961-1327|gwood@tvaxbiomedical.com|
22326707|NCT02426658|Wake Forest University Health Sciences|Study Nurse|336-716-2121|saverill@wakehealth.edu|
22326708|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22326709|NCT03050359|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22326710|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu|
22326711|NCT01136668|Hospital for Sick Children|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
22326712|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22326713|NCT04047121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326714|NCT00810459|Philips|Jeff Jasko|412-542-3651|Jeff.Jasko@philips.com|
22326715|NCT02604810|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22326716|NCT03754933|GeoVax, Inc.|Kelly T. McKee, Jr., MD, MPH|(678) 384-7220|kmckee@geovax.com|
22326717|NCT00262080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326718|NCT02044159|Children's Hospital of Eastern Ontario|Katie O'Hearn, Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
22326719|NCT03007485|Northwell Health|Dr. Negin Hajizadeh|516-600-1401|Nhajizadeh@northwell.edu|
22326720|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu|
22326721|NCT03696758|UT Southwestern, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
22326722|NCT01597557|University at Buffalo|Dr. Anne Curtis|716-859-4828|abcurtis@buffalo.edu|
22326723|NCT03540134|University of Virginia|Dr. Jeff Elias|(434) 924-0451|FUSbrain@virginia.edu|
22326724|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu|
22271255|NCT03278847|Imperial College London|Dr Chris Gale, Reader in Neonatal Medicine|+44 203 3153519|christopher.gale@imperial.ac.uk|
22326725|NCT02935634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22316944|NCT03207451|Inova Health System|Director of Clinical Trials|443-244-1497|kevin.bliden@inova.org|
22326726|NCT03207022|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
22326727|NCT06150573|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22316945|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22316946|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com|
22316947|NCT03167359|Emory University|Dr. Mylin Torres|404-778-3473|matorre@emory.edu|
22316948|NCT03339583|I.M. Sechenov First Moscow State Medical University|Polina Pchelina|+79036701725|polbox@mail.ru|
22316949|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
22316950|NCT03651622|University of North Carolina at Chapel Hill|Elizabeth Mayer-Davis, PhD|919-966-7218|mayerdav@email.unc.edu|
22316951|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316952|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com|
22316953|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22316954|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22316955|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026|milva.battaglia@ior.it|0039
22316956|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu|
22316957|NCT05487586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316958|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22316959|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
22316960|NCT02638597|University of Texas Southwestern Medical Center|Principal Investigator|2146480188|madhukar.trivedi@UTSouthwestern.edu|
22316961|NCT00299494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22316962|NCT01538966|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
22316963|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu|
22316964|NCT03223662|National Cancer Institute|Caryn Steakley|240-858-3749|steaklec@nih.gov|
22316965|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22316966|NCT00992225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316967|NCT03122223|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22316968|NCT03466073|BioAegis Therapeutics Inc.|Mark DiNubile MD|609-706-5866|mdinubile@bioaegistx.com|
22316969|NCT02285153|Medical University of Vienna|Bernd Jilma|+434040029180|bernd.jilma@meduniwien.ac.at|
22316970|NCT01390077|University of California, San Diego|William Leo Nyhan, M.D., Ph.D.|(619)543-5337|wnyhan@ucsd.edu|
22316971|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com|
22316972|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov|
22316973|NCT05833100|i-SENS, Inc.|Moon Hwan Kim|+82 (0)2 910 0521|mhkim@i-sens.com|
22316974|NCT02045875|Asthma Management Systems|Andrew G Weinstein MD|302 893 5455|agwmd@aol.com|
22316975|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300||
22316976|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com|
22282437|NCT00210353|International Extranodal Lymphoma Study Group (IELSG)|Prof. Emanuele Zucca MD, Scientific and Medical Director|+41 91 811 9040|ielsg@eoc.ch|
22282438|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com|
22282439|NCT04043234|Infinite Biomedical Technologies, LLC|Chief Executive Officer|(443) 451-7177|rahul@i-biomed.com|
22326728|NCT00210158|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22282440|NCT03172325|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|anjidani.n@orchidpharmed.com|
22282441|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282442|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300||
22282443|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22282444|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22282445|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu|
22282446|NCT03943550|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22282447|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
22282448|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu|
22282449|NCT04077996|Instituto Mexicano del Seguro Social|Dr. Jesus Venegas-Ramírez|3143058373|nefrojesusvr@gmail.com, jesus.venegas@imss.gob.mx|
22282450|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22282451|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
22282452|NCT03651856|Medical University of SC|Dr. Gonzalo Revuelta|843-792-7262|revuelta@musc.edu|
22282453|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22282454|NCT05129072|Bausch + Lomb Incorporated|Steffen Robert, Senior Director Clinical Affairs|15853386399|robert.steffen@bauschcloud.com|
22282455|NCT02388490|Seoul National University Hospital|Tae Min Kim|82+2-2072-3559|gabriel9@snu.ac.kr|
22282456|NCT02378298|Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg|Helena Filipsson Nyström|0046-705833398|helena.filipsson@medic.gu.se|
22282457|NCT03609385|Charité-Universitätsmedizin Berlin|Dr. Christian Nolte|+4930450560676|christian.nolte@charite.de|
22316977|NCT03459443|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
22326729|NCT03484533|Makerere University Infectious Diseases Institute|Andrew Mujugira|206 520 3800|mujugira@uw.edu|
22282458|NCT03006458|CooperVision|Myhanh Nguyen|9257306716|MNguyen@coopervision.com|
22299891|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org|
22316978|NCT02153073|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22299892|NCT00325468|Amgen Inc.|Study Director|866-572-6436||
22316979|NCT03702231|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
22299893|NCT03732209|Fralin Biomedical Research Institute at VTC|Jeffrey Stein|540-526-2124|jstein1@vtc.vt.edu|
22299894|NCT05046795|Viatris|Dik WH Ng, PhD|+44 (0)1304 626895|dik.ng@viatris.com|
22316980|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com|
22316981|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu|
22299895|NCT01127178|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22299896|NCT04139317|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22299897|NCT05857163|TenNor Therapeutics (Suzhou) Limited.|Guozhu Geng|0512-86861990|guozhu.geng@tennorx.com|
22316982|NCT05745701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299898|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22299899|NCT02365467|Medtronic|Alexa Glandon, Medtronic Clinical Study Manager|12624087021|alexa.a.glandon@medtronic.com|
22299900|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22299901|NCT01109992|Brigham and Women's Hospital|Sharmila Dorbala|617-732-6215|sdorbala@partners.org|
22299902|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov|
22316983|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com|
22316984|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu|
22299903|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu|
22299904|NCT04287920|Mayo Clinic|Douglas (Doug) A. Simonetto, M.D.|507-284-4824|Simonetto.Douglas@mayo.edu|
22316985|NCT04445987|Arcutis Biotherapeutics|Arcutis Medical Information|+1 844 692-6729|medinfo@arcutis.com|
22316986|NCT02091206|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22299905|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22299906|NCT03085563|Children's Hospital Colorado|Paul Szefler, MD, FAAP|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22316987|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204|jchulay@agtc.com|7205
22316988|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu|
22316989|NCT03772587|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22316990|NCT02297139|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22316991|NCT03367429|Weill Cornell Medicine|Michael O'Dell, M.D.|19175495179|mio2005@med.cornell.edu|
22316992|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22316993|NCT05051462|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
22316994|NCT02425904|Dana-Farber Cancer Institute/Boston Children's Hospital|Barbara Degar, MD|617-632-5186|Barbara_Degar@dfci.harvard.edu|
22316995|NCT05260021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22316996|NCT05597787|University of Delaware|Valerie Earnshaw|(302) 831-6500|earnshaw@udel.edu|
22316997|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22316998|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22316999|NCT01214642|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317000|NCT01241604|Philips Respironics|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
22317001|NCT02980731|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22299907|NCT02952924|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22299908|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223||
22299909|NCT02830594|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22299910|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp|
22299911|NCT02955511|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|3104231682|ofelia.elvir-lazo@cshs.org|
22317002|NCT03037931|American Regent, Inc.|Elizabeth Ernst, Global Executive Director of Regulatory Affairs|631-605-5753|eernst@americanregent.com|3551
22317003|NCT02075476|Hospital Gregorio Marañón|Dr. Carlos Álvarez|0034915868000|calvargon@gmail.com|
22317004|NCT02731690|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22317005|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623||
22317006|NCT02407990|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22317007|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22317008|NCT03241927|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22317009|NCT03573583|University of Florida|Todd Manini|(352) 273-5914|tmanini@ufl.edu|
22317010|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317011|NCT04004936|Atlanta VAHCS|Dr. Elizabeth Camille Vaughan/ Atlanta Site Section Chief Birmingham/Atlanta GRECC|404 315 4100|elizabeth.vaughan2@va.gov|373118
22299912|NCT03273946|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22299913|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594|hermanns@diabetes-zentrum.de|553
22299914|NCT02944877|University of California, Irvine|Dr. Sean Young|714-413-2347|syoung5@hs.uci.edu|
22317012|NCT02915302|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
22317013|NCT02062593|Imperial College London|Rasha Al-Lamee|+447976276923|r.al-lamee13@imperial.ac.uk|
22317014|NCT04343872|University of Alabama at Birmingham|Dr. Andrea L. Cherrington|205-996-2885|acherrington@uabmc.edu|
22317015|NCT01850446|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22317016|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu|
22317017|NCT01119105|Nabriva Therapeutics|Jennifer Schranz, M.D., Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
22317018|NCT01639495|Biosense Webster, Inc.|Robert Stagg, PhD, Manager, Clinical Franchise|(949) 450-7779|rstagg@its.jnj.com|
22317019|NCT05263388|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
22317020|NCT02551718|University Of Washington|Dr. Percival|206-606-1320|mperciva@seattlecca.org|
22317021|NCT02366468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22317022|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22317023|NCT05540717|Allergy Therapeutics (UK) Ltd.|Pieter-Jan De Kam, Clinical Director|+44 (0) 1903 844 700|pieter-jan.dekam@allergytherapeutics.com|
22317024|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch|
22317025|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22317026|NCT03836716|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22317027|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22317028|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu|
22317029|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22317030|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu|
22317031|NCT04343287|BRIM Biotechnology, Inc.|Erin Chang, Vice President of Portfolio Management Department|0226598779|erin.chang@brimbiotech.com|119
22317032|NCT03582943|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
22317033|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org|
22317034|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22317035|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
22317036|NCT03385343|Mayo Clinic|Kevin Buller Clinical Research Coordinator|507-255-4803|Buller.Kevin@mayo.edu|
22317037|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358||
22317038|NCT03527550|McLean Hospital|Dr. Andrew Peckham|617-855-2946|adpeckham@mclean.harvard.edu|
22317039|NCT01841931|Maimonides Medical Center|Director of Research, Department of Psychiatry|718-283-7162|tjacob@maimonidesmed.org|
22317040|NCT03398213|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
22317041|NCT03053518|NYU Langone Health|Mary Sevick, MD|646-501-2621|Mary.Sevick@nyulangone.org|
22317042|NCT02683876|MEBO Research|Maria De la Torre|7862286880|maria.delatorre@meboresearch.org|
22317043|NCT01232738|UKansasMCRI|Yunxia Wang|913-588-6970|ywang@kumc.edu|
22317044|NCT02503852|Kerastem|Eric Daniels, M.D., Chief Medical Officer|858.348.8050|edaniels@puregraft.com|
22317045|NCT03231800|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22317046|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271256|NCT02020837|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
22317047|NCT00942305|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22271257|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300||
22271258|NCT05103176|University of Michigan|Dr. Michael Vesia, Assistant Professor|734 763-3905|mvesia@umich.edu|
22271259|NCT03711058|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|610-614-9169|nazad2@jhmi.edu|
22271260|NCT05175131|Abbott|Suntje Sander-Struckmeier, PhD|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
22271261|NCT05711381|Hanmi Pharmaceutical Co., Ltd.|Moon Hee Lee, MD|+82 2 410 9062|mhlee7@hanmi.co.kr|
22271262|NCT02672332|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22271263|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22271264|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22271265|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com|
22271266|NCT03502018|Maimonides Medical Center|Dr. Kevin Kang|718-283-8805|kkang@maimonidesmed.org|
22271267|NCT01892085|University of Florida|Leslie Parker|352 215 9360|Parkela@ufl.edu|
22271268|NCT01472757|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
22271269|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu|
22271270|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22271271|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
22271272|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu|
22271273|NCT03747302|Norris Cotton Cancer Center|Dr. Ardis Olson|603-643-2385|Ardis.Olson@dartmouth.edu|
22271274|NCT00583375|Wright Medical|Stephen Roach|615-656-7466|Stephen.Roach@wright.com|
22271275|NCT03769675|Mayo Clinic|Narayan R. Kissoon, M.D.|507-284-4961|Kissoon.Narayan@mayo.edu|
22271276|NCT02844907|Durham VAMC|David D'Alessio, MD|919-684-5778|david.dalessio2@va.gov|
22271277|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22271278|NCT03207074|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
22271279|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org|
22271280|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22271281|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22271282|NCT01683422|Loma Linda University Health|Gary Yang|909 558 4000|gyang@llu.edu|88056
22271283|NCT03235115|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22271284|NCT01797159|The SKCCC at Johns Hopkins|The SKCCC at Johns Hopkins|4109556980|kjansen3@jhmi.edu|
22271285|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
22271286|NCT01839799|University of Pennsylvania|Jennifer Louie, Program Manager|215-220-9668|Jennifer.Louie2@pennmedicine.upenn.edu|
22271287|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com|
22271288|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22271289|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22271290|NCT05127304|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271291|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22271292|NCT03584464|Medtronic, plc|Alissa Anderson, Clinical Study Manager|7075912434|alissa.anderson@medtronic.com|
22271293|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu|
22271294|NCT00955968|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22271295|NCT05020899|Boston Medical Center|Lisa Quintiliani, PhD|617-638-2777|lisa.quintiliani@bmc.org|
22271296|NCT02738255|Brigham and Women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
22271297|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov|
22271298|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271299|NCT01419080|Saint Luke's Hospital of Kansas City|John Spertus|816-932-8270|jspertus@saint-lukes.org|
22271300|NCT03083561|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22271301|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22271302|NCT02135107|Eisai Co., Ltd. and EA Pharma Co., Ltd.|Public Relations Group (EA Pharma Co., Ltd.)|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
22271303|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu|
22271304|NCT02278120|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22271305|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22271306|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu|
22271307|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22326730|NCT02284906|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22326731|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com|
22326732|NCT00370695|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22326733|NCT03885726|Vapotherm, Inc.|George C. Dungan, II|(267)347-3305|gdungan@vtherm.com|
22326734|NCT04096326|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22326735|NCT04804033|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326736|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at|
22326737|NCT02496585|Memorial Sloan Kettering Cancer Center|Dr. Zachary Moore, MD, PhD|929-687-0151|moorez@mskcc.org|
22326738|NCT03248947|Duke University|Dr. Li-Tzy Wu|919-889-9369|litzy.wu@duke.edu|
22326739|NCT04490265|US Department of Veterans Affairs|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
22326740|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300||
22326741|NCT05174039|Theranexus|Chief Medical Officer|0688941976|marie.sebille@theranexus.com|+33
22326742|NCT05122650|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22326743|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn|
22326744|NCT03392753|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
22326745|NCT03280550|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22326746|NCT05896761|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326747|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22326748|NCT04747808|MediPrint Ophthalmics, Inc.|Chief Operating Officer|(858) 522-0815|clinical@mediprintlens.com|
22326749|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org|
22326750|NCT02028338|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22326751|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu|
22326752|NCT03552549|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326753|NCT03403504|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
22326754|NCT02094586|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
22326755|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22326756|NCT02761993|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
22326757|NCT00256867|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326758|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
22326759|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu|
22326760|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com|
22326761|NCT01231633|Long Island Vitreoretinal Consultants|Vincent A. Deramo, MD|5164660390|vaderamo@gmail.com|222
22326762|NCT04072146|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22326763|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22326764|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org|
22326765|NCT04286412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326766|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22326767|NCT02915367|Massachusetts General Hospital|Jessica Haberer|617-643-9195|jhaberer@partners.org|
22326768|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com|
22326769|NCT02916498|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
22326770|NCT00875017|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326771|NCT02689219|IndianaU|Dr. Nabil Adra|(317) 944-5349|nadra@iu.edu|
22326772|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr|
22326773|NCT01515176|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
22326774|NCT02932475|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
22326775|NCT01921257|Circassia Ltd|VP Clinical Operations|+44 1864 405560||
22326776|NCT00364845|Amgen Inc.|Study Director|866-572-6436||
22326777|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
22326778|NCT03255291|Washington University School of Medicine|Erika Waters, MPH, Ph.D.|314-286-2757|waterse@wustl.edu|
22326779|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012||
22326780|NCT02335216|St. Jude Medical|Roni Diaz|+19723098601|rdiaz@sjm.com|
22326781|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326782|NCT05345691|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5301
22326783|NCT02891798|VA Pittsburgh Health System, and University of Pittsburgh|Brian A. Williams, MD, MBA|412-360-1602|brian.williams6@va.gov|
22326784|NCT02723604|Barbara Ann Karmanos Cancer Institute|Dr. Harold Kim|313-576-9543|kimh@karmanos.org|
22326785|NCT00111475|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22326786|NCT00050986|University of Texas, M. D. Anderson Cancer Center|W.K. Yung,MD/Clinical Professor, Neuro-Oncology|(713) 794-1285|wyung@mdanderson.org|
22326787|NCT02417870|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
22326788|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22326789|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300|ablight@acorda.com|102
22326790|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu|
22271308|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu|
22271309|NCT03197324|Theracos Sub, LLC|Albert Collinson, Ph.D.|508-688-4221|acollinson@theracos.com|
22271310|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu|
22271311|NCT02807506|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
22317048|NCT00400725|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22317049|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22317050|NCT01717742|Hospital for Sick Children|Dr. Eyal cohen|416-813-7654|eyal.cohen@sickkids.ca|
22317051|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
22317052|NCT04150068|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22317053|NCT05316701|Orca Biosystems, Inc.|Chief Medical Officer|530-414-9743|info@orcabio.com|
22317054|NCT04679935|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22317055|NCT05820295|Weill Cornell Medicine|Lisa Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
22317056|NCT02199743|UT Southwestern Medical Center|Debra Bushong, MS, LPC|214-648-4653|debra.bushong@utsouthwestern.edu|
22317057|NCT02158052|Massachusetts General Hospital|Thomas Spitzer, MD|6177241124|tspitzer@mgh.harvard.edu|
22317058|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22317059|NCT02516332|Duke University|Patrick Smith, Ph.D.|919-681-3006|patrick.j.smith@duke.edu|
22317060|NCT03695237|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22317061|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22317062|NCT02217332|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22317063|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22317064|NCT00127205|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
22317065|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu|
22317066|NCT03784001|University of California, Los Angeles|Tanera van Diggelen|4086231219|tvandiggelen@gmail.com|
22317067|NCT03377699|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22317068|NCT02580305|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
22317069|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317070|NCT05560243|University of Alabama at Birmingham|Isabel Scarinci, Principal Investigator|2059757177|scarinci@uab.edu|
22317071|NCT04587752|Yale University|Dr. Janet Lydecker|2037374299|janet.lydecker@yale.edu|
22317072|NCT05870228|University of Strathclyde|Stephanie McCrory|07538376660|stephanie.mccrory@strath.ac.uk|
22317073|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com|
22317074|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu|
22317075|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du|
22317076|NCT02111187|Associate professor of oncology and urology|Emmanuel Antonarakis|443-287-0553|eantona1@jhmi.edu|
22317077|NCT04075994|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
22317078|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22317079|NCT04073446|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
22317080|NCT00252577|VA San Diego Healthcare System|John Kelsoe|858-552-8585|john.kelsoe@va.gov|5704
22317081|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317082|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22317083|NCT02797080|Horizon Pharma Ireland, Ltd, Dublin, Ireland|Julie Ball, MS, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
22317085|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343||
22317086|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317087|NCT03992131|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22317088|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300||
22317089|NCT03794700|University of Colorado Anschutz Medical Campus|Channing Tate, PHD Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
22317090|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22317091|NCT02535091|SK Life Science, Inc.|Medical Director|402-835-5977|smisra@sklsi.com|
22317092|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317093|NCT02643472|Children's National Health System|Dr. Karen Fratantoni|202-476-4793|kfratant@childrensnational.org|
22317094|NCT01259089|Northwestern University|Clinical Trials Office|312-695-1301||
22317095|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org|
22317096|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22317097|NCT01215188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317098|NCT02310100|Abbott|Lori Rusch, Ph.D.|1-651-756-2668|lori.rusch@abbott.com|
22317099|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch|
22317100|NCT01680640|University of Southampton|Christopher D Byrne|44 (0)23 8120 8818|cdtb@soton.ac.uk|
22317101|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317102|NCT00477659|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22317103|NCT03835351|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
22317104|NCT01151410|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22317105|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000|christopher.bever@va.gov|7130
22317106|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255||
22317107|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
22317108|NCT01712659|National Cancer Institute|Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22317109|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317110|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378|sschulma@jhmi.edu|410
22317111|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
22317112|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu|
22317113|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com|
22317114|NCT00888927|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22317115|NCT03592745|Feinstein Institutes for Medical Research at Northwell Health|Senior Research Coordinator|5165623646|jchang14@northwell.edu|
22317116|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22317117|NCT03568643|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
22317118|NCT03621787|co-PI|Kathleen Sienko|734647249|sienko@umich.edu|
22317119|NCT04362189|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22317120|NCT02111681|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@mskcc.org|
22317121|NCT03981861|ChildrensMHC|Tania Burgert|203 676 4545|tsburgert@cmh.edu|
22317122|NCT05116540|Hope Biosciences Research Foundation|Maureen Gerwin|(346) 900-0340|maureen@hopebio.org|
22317123|NCT03918499|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22317124|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu|
22317125|NCT02914275|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22317126|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com|
22317127|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22317128|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org|
22317129|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com|
22282459|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de|
22317130|NCT01135537|Sickkids|Dr Tal Schechter-Finkelstein|4168136906|tal.schechter-finkelstein@sickkids.ca|
22317131|NCT02295553|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
22317132|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22317133|NCT03828747|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22317134|NCT01658150|Icahn School of Medicine at Mount Sinia|Dr. Katherine Burdick|212-659-8841|katherine.burdick@mssm.edu|
22317135|NCT04187989|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
22317136|NCT03646656|Department of Veterans Administration|Dr. Karen Goldstein|919.826.0411|karen.goldstein@va.gov|1707764
22317137|NCT03507777|Abbott Vascular|Jana Buccola, Director Clinical Programs|+1-408-845-1049|jana.buccola@abbott.com|
22317138|NCT00446043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22317139|NCT02483000|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
22317140|NCT02796625|University of Maryland Baltimore|Dr. David Seminowicz|14107063476|dseminowicz@umaryland.edu|
22317141|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684|arambaldi@asst-pg23.it|+39
22317142|NCT02071290|St. Michael's Hospital|Dr. Ori Rotstein|416-864-6060|rotsteino@smh.ca|5304
22317143|NCT03535506|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
22317144|NCT05126563|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22317145|NCT06612255|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
22317146|NCT04245228|Mayo Clinic|Dr. Cassie Kennedy, PI|1-507-284-2511|kennedy.cassie@mayo.edu|
22317147|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585|joseph.atkinson@va.gov|2568
22317148|NCT02758847|University of Pittsburgh|Dr Rabih Chaer|4128023333|chaerra@upmc.edu|
22317149|NCT04560010|NYU Langone|Arthur Hertling, MD|212-263-5072|Arthur.hertling@nyulangone.org|
22317150|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22317151|NCT02006251|Cleveland Clinic|Wael Barsoum|2164444954|barsouw@ccf.org|
22317152|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
22317153|NCT03500159|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|604-629-9223|clinical@aqxpharma.com|
22317154|NCT03535597|Memorial Healthcare Systerm|Dr. Jianli Niu|954-265-6653|jniu@mhs.net|
22317155|NCT03484273|University of Calgary|Dr. Satish R. Raj|403-210-6152|satish.raj@ucalgary.ca|
22317156|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et|
22317157|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22317158|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com|
22317159|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590||
22317160|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de|
22317161|NCT04928287|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22317162|NCT01941719|TUSPM|Dr. Jinsup Song|2157775872|jsong@temple.edu|
22326791|NCT04131517|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22317163|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22317164|NCT01670760|3M|Terri White|651-733-0228|twhite3@mmm.com|
22317165|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
22317166|NCT03819634|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
22317167|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22317168|NCT02402153|UNEEG medical A/S|Clinical Manager|+45 41414244|lybl@UNEEG.com|
22317169|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300||
22317170|NCT00858364|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22317171|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22317172|NCT01655693|ONXEO|Olivier De Beaumont; Chief Medical Officer|+33 (0) 1 45 58 95 33|o.debeaumont@onxeo.com|
22317173|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu|
22317174|NCT02120287|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
22317175|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu|
22317176|NCT02601300|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22317177|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br|
22317178|NCT02935660|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22317179|NCT00291642|UCB S.A.|UCB|+1844 599|UCBCares@ucb.com|2273
22317180|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22317181|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
22317182|NCT02544451|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22317183|NCT02338973|National Institutes of Health|Wadih Zein, MD, Principal Investigator, NEI|301-496-8118|zeinw@nei.nih.gov|
22317184|NCT01472549|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
22317185|NCT03001076|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22317186|NCT04602221|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22317187|NCT02327351|National Research Center for Pediatric Hematology , Moscow, Russian Federation|Balashov Dmitriy, head of HSCT department|84956647078|Dmitriy.Balashov@fccho-moscow.ru|6534
22317188|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
22317189|NCT02576587|Cleveland Clinic|Dr. Reena Mehra|216-444-4946|mehrar@ccf.org|
22317190|NCT01080716|Vaccine Trial Treatment Center, Mahidol University|Punnee Pitisutithum, MBBS, DTM&H, FRCPT|66-2-643-5599|tmppt@mahidol.ac.th|
22317191|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net|
22317192|NCT03590366|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22317193|NCT00738894|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22317194|NCT05017103|M D Anderson Cancer Center|Neeta Somaiah, MD|713-792-3626|nsomaiah@mdanderson.org|
22317195|NCT02656329|GE Healthcare|Francois Tranquart, M.D., Ph.D.|0-44-1494-543037|francois.tranquart@ge.com|
22317196|NCT03699826|University of Iowa|Aaron Boes|319-353-8587|aaron-boes@uiowa.edu|
22317197|NCT01081665|Abbott|Global Medical Services|1-800-633-9110||
22317198|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu|
22317199|NCT03796962|Xenon Pharmaceuticals Inc.|Medical Affairs|+1-604-484-3300|medicalaffairs@xenon-pharma.com|
22317200|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu|
22317201|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000||
22317202|NCT03541174|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58844 1977|idorsiaclinicaltrials@idorsia.com|
22317203|NCT00605215|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22317204|NCT00275262|Abbott|Global Medical Services|800-633-9110||
22317205|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com|
22317206|NCT04058366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22317207|NCT02738203|Stanford University, Department of OB/GYN|Research Manager|6507211562|familyplanningresearch@stanford.edu|
22317208|NCT05087979|Virginia Commonwealth University|Vishal Yajnik, MD, MS|804-663-3519|vishal.yajnik@vcuhealth.org|
22271312|NCT03589976|NYU Langone Health|Jose-Alberto Palma, MD, PhD|212-263-7225|JoseAlberto.PalmaCarazo@nyulangone.org|
22271313|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271314|NCT04778059|US Biotest, Inc.|Dr. Gere diZerega|8055951300|gere.dizerega@usbiotest.com|
22317209|NCT02699086|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
22271315|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271316|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271317|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22271318|NCT05537792|Georgia Institute of Technology|Dr. Aaron Young|404.385.5306|aaron.young@me.gatech.edu|
22271319|NCT05250102|Medline Industries, LP|Julie J. Finley|(800) 633-5463|jjfinley@medline.com|
22317210|NCT01227577|Novartis|Study Director|862-778-8300||
22317211|NCT03809429|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22326792|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000|craig.rosen@va.gov|22812
22271320|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271321|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au|
22317212|NCT00194987|Weill MC|Dr James Bussel|917-291-5091|jbussel@med.cornell.edu|
22317213|NCT01664598|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22299915|NCT04323436|Novartis|Study Director|862-778-8300|Novartis.email@novartis.com|
22299916|NCT02279641|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22317214|NCT02778932|University Hospital Schleswig-Holstein, Campus Kiel|Priv.-Doz. Dr. med. Axel Fudickar|0049500|axel.fudickar@uksh.de|20801
22299917|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu|
22299918|NCT01664078|Cordis US Corp|Jennifer Lee|+1-669-699-6851|jennifer.lee02@cordis.com|
22299919|NCT04782323|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22299920|NCT02877485|Stanford Facial Plastic and Reconstructive Surgery|Sam P. Most MD|650-736-3223|smost@stanford.edu|
22317215|NCT03182725|University of California - San Diego Health|Dr. Pam Taub|858-246-2342|ptaub@health.ucsd.edu|
22317216|NCT02245737|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22317217|NCT03866798|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22326793|NCT05161351|Imperial College London Faculty of Medicine|Agnese Zicari,Quality Assurance Facilitator|+44(0)2075946615|a.zicari08@imperial.ac.uk|
22326794|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk|
22326795|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk|
22326796|NCT02780765|Tata Memorial Hospital, Mumbai|Dr Vijaya Patil|+91-2224177000|vijayappatil@yahoo.com|7048
22326797|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com|
22326798|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
22326799|NCT02874404|University of Nebraska Medical Center|Dr. Matthew Lunning, DO, Associate Professor|402-559-7164|mlunning@unmc.edu|
22326800|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22326801|NCT01592409|Centre for Addiction and Mental Health|Dr. Robert Mann, Senior Scientist|416-535-8501|robert.mann@camh.ca|34496
22326802|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326803|NCT01842841|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326804|NCT05132569|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22326805|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22326806|NCT04183179|Michigan State University College of Nursing|Jiying Ling|5173538591|lingjiyi@msu.edu|
22326807|NCT02190747|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22326808|NCT02869854|RegionSkane|Mr Peter Nymberg|0705759810|peter.nymberg@med.lu.se|
22326809|NCT04322994|Stanford University|Dr Thomas Caruso, MD, PhD|6507235728|tjcaruso@stanford.edu|
22326810|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu|
22326811|NCT02345252|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22326812|NCT02239770|Penn State College of Medicine|Dr. Patricia Sue Grigson|717-531-5772|psg6@psu.edu|
22326813|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22326814|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org|
22326815|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22326816|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com|
22326817|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu|
22299921|NCT04369469|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22317218|NCT03786042|Dartmouth college|Research Scientist|603-646-5408|john.brand@dartmouth.edu|
22317219|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317220|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org|
22317221|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22317222|NCT01008319|University of Oklahoma|LaTasha Craig, MD|405-271-8787|latasha-craig@ouhsc.edu|
22317223|NCT02929329|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22317224|NCT02121301|Ciurem Pharma Inc|Gosse B. Bruinsma|613-866-9609|gbb@CIUREM.COM|
22317225|NCT01033422|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
22317226|NCT01954966|University of Pennsylvania|Claudia Iannelli|6104424426|Claudia.iannelli@pennmedicine.upenn.edu|
22317227|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
22317228|NCT01699503|Indiana University|Dr. Nicole Fowler|317-274-9021|fowlern@iupui.edu|
22317229|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22317230|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
22317231|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com|
22317232|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22317233|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
22317234|NCT01181323|Cincinnati Children's Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org|
22317235|NCT03020576|Columbia University Medical Center/ Dept. of Rehabilitation & Regenerative Medicine|Lauri Bishop, PT, DPT Research Physical Therapist|212-305-6095|LB2413@cumc.columbia.edu|
22317236|NCT03292432|University of North Carolina at Chapel Hill|Rachel Goolsby - Research Manager|9198430685|rwgoolsby@unc.edu|
22317237|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317238|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326818|NCT04171037|The University of Texas MD Anderson Cancer Center|Gang Zheng, MD|(713) 563-2731|gzheng@mdanderson.org|
22299922|NCT03135522|The Johns Hopkins University School of Medicine|Dr. Robert A. Wise, M.D.|410-905-5688|rwise@jhmi.edu|
22299923|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu|
22299924|NCT03832192|care.coach|Principal Investigator|8554374569|pi@care.coach|2
22299925|NCT01915563|Althaia Xarxa Assistencial Universitaria de Manresa|Dr Rafael Fernandez|34.8732550|rfernandezf@althaia.cat|3730
22299926|NCT00499369|SWOG|Study Statistician|206-667-4623||
22299927|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org|
22299928|NCT01337245|University of Arizona|Senior Regulatory Coordinator|520-621-6417|regulatory@arizona.edu|
22299929|NCT04095858|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22299930|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22317239|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk|
22317240|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
22317241|NCT02057523|Loyola University Medical Center|Sanjeev Akkina|7082166389|sanjeev.akkina@lumc.edu|
22299931|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu|
22299932|NCT02838017|NorthShore University HealthSystem|Lena Braginsky|2245952705|lena.braginsky.mfm@gmail.com|
22317242|NCT03307005|Johns Hopkins University|Rashmi Nisha Aurora, MD, MHS|443-513-6535|rnaurora@jhmi.edu|
22299933|NCT01692197|UT MD Anderson Cancer Center|Borthakur,Gautam MD|713-563-1586|CR_Study_Registration@mdanderson.org|
22317243|NCT03174431|The Ohio State University|Silpa Nekkanti|614-293-4643|silpa.nekkanti@osumc.edu|
22317244|NCT03097484|University of Kentucky|John Bauer, MD|859-218-2927|john.bauer@uky.edu|
22299934|NCT02120924|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22317245|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22299935|NCT03483623|David Grant Medical Center, Clinical Investigation Facility, Travis AFB, CA|Lt Col Laurie Migliore|707-423-7280|laurie.a.migliore.mil@mail.mil|
22299936|NCT01884350|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22299937|NCT03510481|NIAID/LMIV|Dr. Patrick Duffy|301-761-5089|patrick.duffy@nih.gov|
22317246|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov|
22299938|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22299939|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22326819|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
22299940|NCT03151434|Indiana University Department of Anesthesiology|Dr. Yar Luan Yeap|3172740275|yyeap@iupui.edu|
22326820|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299941|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu|
22299942|NCT03403634|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@Roswellpark.org|
22317247|NCT02706899|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22326821|NCT02864940|Rush University Medical Center|Michael Chen, MD|312-563-2817|Michael_Chen@rush.edu|
22317248|NCT03211117|Mayo Clinic|Ashish V. Chintakuntlawar, MBBS, Ph.D.|(855) 776-0015|Chintakuntlawar.Ashish@mayo.edu|
22326822|NCT01864018|Mayo Clinic|Shaji Kumar|507-284-2511|Kumar.Shaji@mayo.edu|
22326823|NCT02702193|University of Miami|Victoria Mitrani|305 284-9139|vmitrani@miami.edu|
22317249|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22326824|NCT04365985|William Beaumont Hospitals|Matthew Sims, MD|248 551-0027|matthew.sims@beaumont.org|
22326825|NCT02439281|U Pittsbutgh, UPMC Children's Hospital|Mihaela Visoiu|4126925260|visoium@upmc.edu|
22326826|NCT03510663|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22326827|NCT03208192|Moscow Clinical Scientific Center|Mikhail Efanov, MD, PhD,|+79161058830|m.efanov@mknc.ru|
22299943|NCT01850004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22299944|NCT04560166|Y-mAbs Therapeutics|Chief Operating Officer|+4570261414|clinicaltrials@ymabs.com|
22326828|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22299945|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
22271322|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22271323|NCT00224406|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22317250|NCT03916458|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317251|NCT01413503|University of California, San Francisco|Paul A. Fitzgerald, MD|415-665-1136|Paul.Fitzgerald2@ucsf.edu|
22317252|NCT02546921|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22317253|NCT01373151|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22317254|NCT02186600|University of Nebraska Medical Center|Laura Bilek|402-559-6923|lbilek@unmc.edu|
22317255|NCT03026075|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
22317256|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100|linda.resnik@va.gov|2368
22317257|NCT03381339|Marquette Univeristy|Associate Dean|4142885944|andrew.dentino@marquette.edu|
22317258|NCT03117998|REMD Biotherapeutics, Inc|"Dung Zung Thai, MD, PhD"|415-225-9338|zungthai@remdbio.com|
22317259|NCT04927247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317260|NCT03970538|LimFlow|Director, Clinical Affairs|559-970-1012|kmccaffrey@limflow.com|
22317261|NCT02001064|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
22317262|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu|
22317263|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317264|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu|
22317265|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com|
22317266|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
22317267|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu|
22317268|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|vvalero@mdanderson.org|
22326829|NCT01167595|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
22326830|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22326831|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22326832|NCT02775864|Columbia University|Dr. Scott Stroup|646-774-8435|Scott.Stroup@nyspi.columbia.edu|
22326833|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
22326834|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22326835|NCT02467387|CardioCell, LLC|Sergey Sikora, President and CEO|760-315-0861|SSIKORA@STEMCARDIOCELL.COM|
22326836|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com|
22326837|NCT02330627|University of California, San Diego|Dr. Charles Taylor|8585349446|c1taylor@ucsd.edu|
22271324|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
22271325|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22326838|NCT04369430|Alkahest, Inc.|Clinical Development|(650) 801-0474|trials@alkahest.com|
22326839|NCT04737031|University of Pennsylvania|Robert Schnoll, PhD|215.746.7143|schnoll@pennmedicine.upenn.edu|
22326840|NCT00962039|The Ohio State University|John V. Campo|614-581-5984|john.campo@hsc.wvu.edu|
22326841|NCT03453151|Duke University|Marat Fudim|(919) 681-5816|marat.fudim@duke.edu|
22326842|NCT00142519|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl, MD|646-888-2681|moryln@mskcc.org|
22326843|NCT01468909|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22326844|NCT02592629|Penn State Hershey Medical Center|Robert Gallo, M.D.|7175310003|rgallo@pennstatehershey.psu.edu|289222
22326845|NCT04574297|Changhai Hospital|Dr. Zhuan Liao|86-21-31161004|liaozhuan@smmu.edu.cn|
22326846|NCT04594239|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22326847|NCT03229759|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
22326848|NCT00762372|Baxter Healthcare|Baxter Clinical Trial Disclosures Call Center|(224)948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22326849|NCT01194804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22326850|NCT02670915|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22326851|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271326|NCT04823130|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22271327|NCT03312595|Acera Surgical, Inc.|Chief Science Officer|844-879-2237|information@acera-surgical.com|
22271328|NCT03315455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271329|NCT02407132|University of Arkansas for Medical Sciences|Dr. Pearl McElfish|479-713-8680|pamcelfish@uams.edu|
22271330|NCT01846221|Columbia University|Allison Lee, MD - Assistant Professor of Anesthesiology|212-342-2028|al3196@cumc.columbia.edu|
22271331|NCT03427268|Pharmamar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology, Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22271332|NCT03327948|Axonics, Inc.|Gita Ghadimi|9497516412|gita.ghadimi@axonics.com|
22271333|NCT02304380|University of North Carolina at Chapel Hill|Renée Ferrari, PhD|(919) 843-1341|rferrari@unc.edu|
22282460|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22282461|NCT01574157|VA Salt Lake City Healthcare System|Dr. Kalani Raphael, Principal Investigator|801-582-1565|kalani.raphael@va.gov|1794
22326852|NCT02616185|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326853|NCT01303380|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22326854|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org|
22326855|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326856|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500||
22326857|NCT00789958|SWOG|SWOG Statistician|206-667-4408||
22326858|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu|
22326859|NCT01062568|UCSD|Dr. R. Jeffery Chang|858-534-8930|rjchang@ucsd.edu|
22326860|NCT03303092|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22326861|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu|
22326862|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com|
22326863|NCT01697267|Cambridge University Hospitals NHS Foundation Trust|Prof David Jayne|01223 748062|dj106@cam.ac.uk|
22326864|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
22326865|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22326866|NCT03496467|Mati Therapeutics|Deepank Utkhede|6046379717|dutkhede@matitherapeutics.com|
22326867|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22326868|NCT02681055|MediciNova, Inc.|Director, Research and Development|8583444535|makhay@medicinova.com|
22326869|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu|
22326870|NCT00377611|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326871|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
22326872|NCT00884052|University od California San Diego|Sponsor and Principal Investigator|8588226700|rhaas@ucsd.edu|
22326873|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22326874|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
22326875|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org|
22326876|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu|
22326877|NCT03377244|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
22326878|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu|
22326879|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu|
22326880|NCT04348656|McMaster University/Hamilton Health Sciences|Dr Donald Arnold|905 525 9140|arnold@mcmaster.ca|28603
22326881|NCT03474406|Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University.|Asist. Prof. Suratsawadee Wangnamthip|6624197842|suratsawadee.wan@mahidol.ac.th|
22326882|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com|
22326883|NCT05142332|University of California San Francsico|Robert Rodriguez|(628) 206-5875|Robert.Rodriguez@ucsf.edu|
22326884|NCT02116660|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22326885|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673|Joseph.Pidala@moffitt.org|2556
22326886|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org|
22326887|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu|
22326888|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743||
22326889|NCT02561299|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clintrials_csi@csi360.com|
22326890|NCT05631548|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
22326891|NCT02232087|Quotient Clinical Ltd|Pui Leung|44(0)115 974 9000|Pui Leung <Pui.Leung@quotientclinical.com>|
22326892|NCT02208024|University of Cincinnati Cancer Center|Jordan Kharofa, Associate Professor, Department of Radiation Oncology|(513)-584-4073|kharofjr@ucmail.uc.edu|
22326893|NCT01958125|electroCore Inc.|Director Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22326894|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
22326895|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
22271334|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu|
22326896|NCT04056455|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22271335|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu|
22271336|NCT00473824|ADMA Biologics, Inc.|Rebecca Avila|561-989-5853|reavila@admabio.com|
22271337|NCT01349322|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22271338|NCT04527003|MSHersheyMC|Dr. Kristin Riley|7175316647|kriley1@pennstatehealth.psu.edu|
22271339|NCT03506945|University of California San Diego|Brent Mausbach|8588227529|bmausbach@ucsd.edu|
22271340|NCT04076059|Astellas Pharma China, Inc|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|China only
22271341|NCT04186806|3M Health Care|Elaine Egging/Project Manger|651-737-0263|eegging@mmm.com|
22271342|NCT05363072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326897|NCT02512068|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22326898|NCT01507584|ucsdmed|Eunice Williams-Steppe|8588221133|emwilliamssteppe@ucsd.edu|
22326899|NCT02458690|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
22326900|NCT04026412|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22326901|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
22326902|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
22282462|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
22282463|NCT02406573|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22282464|NCT02136680|University of Maryland Baltimore, School of Medicine|Dr. Carla Alexander|410-328-7129|calexand@medicine.umaryland.edu|
22317269|NCT03491891|First Hospital of Jilin University|Xiang Wang|+86-13504321434|jdwxiang123@126.com|
22282465|NCT01632241|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22317270|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22282466|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300||
22282467|NCT03111550|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman,OD, FAAO|+1 714-247-8628|djanaki1@its.jnj.com|
22282468|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu|
22282469|NCT04696276|Saint Savvas Hospital of Athens|Maria Bourazani|+302106409000|mbourazani@yahoo.com|
22282470|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com|
22282471|NCT03761394|UMass Chan Medical School|Edith Mensah Otabil|774-455-6574|edith.mensahotabil@umassmed.edu|
22282472|NCT01657344|Lurie Children's Hospital|Elizabeth Alpern|312-227-6080|ealpern@luriechildrens.org|
22282473|NCT01686750|Johns Hopkins University|Dr. Gregory M.Lucas|410-614-0560|glucas@jhmi.edu|
22282474|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271343|NCT02720744|Flamel Ireland Limited|Jennifer Gudeman|+1 (314) 750-2751|jgudeman@avadel.com|
22282475|NCT02956044|Translational Medicine Group|Program Director|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
22282476|NCT03832114|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22282477|NCT00559468|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282478|NCT04274153|Johns Hopkins SOM Department of GYN/OB|Dr. Jenell Coleman|(410)614-9178|colemanj@jhmi.edu|
22282479|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22282480|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22282481|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com|
22282482|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22317271|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783|adrian@melasciences.com|732
22317272|NCT03776539|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
22317273|NCT03014479|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22317274|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
22317275|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
22317276|NCT03419832|Wake Forest School of Medicine|Joseph E. Andrews, Jr., PhD, CIP, CCRP|336-716-7658|jandrews@wakehealth.edu|
22271344|NCT02122770|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22317277|NCT01081132|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22317278|NCT03973931|University of Colorado|Dr. Michael Ho|303-590-5969|michael.ho@cuanschutz.edu; p.michael.x-ho@kp.org|
22317279|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
22271345|NCT06137703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271346|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
22271347|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org|
22271348|NCT02505334|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22271349|NCT02833935|McGill University|Shane Sweet|514-398-4184|shane.sweet@mcgill.ca|09903
22271350|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU|
22271351|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu|
22282483|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22282484|NCT03095027|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22299946|NCT02536508|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22317280|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22317281|NCT01506453|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
22317282|NCT04461483|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22317283|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343||
22317284|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu|
22317285|NCT01076192|AbbVie|Global Medical Information|800-633-9110||
22317286|NCT01290315|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@luitpold.com|811
22317287|NCT03725085|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22317288|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu|
22317289|NCT03527173|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22317290|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
22317291|NCT04214600|Cairo University|Dr. Nadine Mansour|(+2)01001482455- 01001465719|lotfynadine@gmail.com|
22317292|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265||
22282485|NCT02982018|Johnson & Johnson Vision|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
22282486|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
22317293|NCT02935452|University of Southampton|Ms Lindsay Welch|07881205106|lw13e14@soton.ac.uk|
22282487|NCT01783574|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|KKMILLER@MGH.HARVARD.EDU|
22326903|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov|
22282488|NCT01257568|Stryker Orthopaedics|Shaherah Yancy, Director, Clinical Operations|901-650-6601|shaherah.yancy@stryker.com|
22282489|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732|ryan.j.palmer@medtronic.com|49732
22282490|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu|
22282491|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
22282492|NCT00919867|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326904|NCT04285346|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22282493|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu|
22282494|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
22282495|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
22282496|NCT03093636|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|(434) 982-6484|MB6NT@uvahealth.org|
22282497|NCT03361189|UCLA|Dr. Jeremy P. Moore|310-267-7667|RGoldstein@mednet.ucla.edu|
22282498|NCT03344549|University of Colima|Ari Cisneros Hernández|3335762299|aricisneroshernandez@gmail.com|
22282499|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch|
22282500|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
22282501|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22282502|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22282503|NCT03350256|Abbott|Filippo Agnesi|+19725264860|filippo.agnesi@abbott.com|
22282504|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22282505|NCT03106844|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
22282506|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
22282507|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
22282508|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22326905|NCT00610935|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22326906|NCT04360187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326907|NCT02399813|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
22326908|NCT05372575|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326909|NCT03115801|Weill Cornell Medicine|Sharanya Chandrasekhar|6469623110|shc2043@med.cornell.edu|
22326910|NCT02203838|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22326911|NCT03345836|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22326912|NCT02188121|McLean Hospital|Dr. Dost Ongur|617 855 3922|dongur@partners.org|
22326913|NCT05091060|Erchonia Corporation|Travis Sammons|3214731251|tsammons@erchonia.com|
22326914|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22326915|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu|
22326916|NCT00952289|Incyte Corporation|Study Director|855 463-3463||
22326917|NCT03259334|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22326918|NCT03375112|Henry Ford Health System|Dr. Michael Charters|1-800-436-7936|mcharte1@hfhs.org|
22326919|NCT03599141|Indiana University|Heather K. Hardin|317.274.5966|hhardin@iu.edu|
22326920|NCT00777491|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
22282509|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22317294|NCT00210470|University of Michigan Hospital|Gregory T. Wolf||gregwolf@umich.edu|
22317295|NCT01813929|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22317296|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov|
22317297|NCT04433585|Nektar Therapeutics|Study Director|8554828676|StudyInquiry@nektar.com|
22317298|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22317299|NCT03356626|Seoul National University Hospital, Seoul National University College of Medicine|Seong-Ho Kong|+82-2-2072-4199|seongho.kong@snu.ac.kr|
22317300|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com|
22317301|NCT00692276|Vertiflex|Steve Reitzler|442-325-5934|sreitzler@vertiflex.com|
22317302|NCT04513652|American Genomics, LLC|Martin Uram, MD|848-444-0665|martin@amgenomics.net|
22317303|NCT04988867|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22317304|NCT02015455|University of Washington|Dr. Sandra K Johnston, PhD, RN Executive Administrative Director- CLEAR Center|206-221-7444|stonesk@uw.edu|
22317305|NCT01097707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317306|NCT03212989|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
22326921|NCT03591146|Taiwan Liposome Company|Cynthia Lin|+886 2 2655 7377|cynthia_lin@tlcbio.com|
22326922|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu|
22326923|NCT01511419|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22326924|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu|
22326925|NCT04748783|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|919-537-3424|ljacox@live.unc.edu|
22326926|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
22326927|NCT02669862|Aclaris Therapeutics, Inc.|Judy Schnyder, Senior Director of Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22326928|NCT02294318|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
22326929|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu|
22326930|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu|
22326931|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu|
22326932|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD /Professor, Stem Cell Transplantation|713-745-8613|aalousi@mdanderson.org|
22326933|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
22326934|NCT02494778|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22326935|NCT03621943|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
22326936|NCT02174861|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22326937|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
22326938|NCT01346371|Minnesota Eye Consultants, P.A.|Ahmad Fahmy, OD|612-813-3665|amfahmy@mneye.com|
22326939|NCT01716533|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326940|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22326941|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343||
22326942|NCT03196193|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22326943|NCT02709083|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
22326944|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22271352|NCT04093492|Medical College of Wisconsin|Dr. Mir A Basir|414-266-6820|mbasir@mcw.edu|
22271353|NCT02303990|University of Pennsylvania|Dr. Amit Maity|215) 662-3759|maity@uphs.upenn.edu|
22271354|NCT01576003|Cincinnati Children's Hospital Medical Center|Conrad R. Cole, MD|513-636-6155|conrad.cole@cchmc.org|
22271355|NCT02945254|Brigham and women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
22271356|NCT01711619|Medtronic|Global Clinical Study Manager||medtronicneurotrials@medtronic.com|
22271357|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22271358|NCT03422159|Community Medical Center Department of Critical Care, Department of Nephrology|Jose Iglesias, DO|732-557-8070|jiglesias23@gmail.com|
22271359|NCT04631107|Apnimed, Inc.|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
22271360|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22271361|NCT00087126|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22271362|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22271363|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu|
22271364|NCT01935700|Kaohsiung Medical University Hospital|Dr. Zu-Yau Lin|88677317123|linzuyau@yahoo.com.tw|
22271365|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu|
22271366|NCT01935128|University of Toledo Medical Center|Michael A. Rees, MD, PhD|419 383-3961|michael.rees2@utoledo.edu|
22271367|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22271368|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
22282510|NCT00834990|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22282511|NCT01235923|University of Utah|Robin Ohls|801-581-7052|robin.ohls@hsc.utah.edu|
22282512|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282513|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us|
22282514|NCT03405935|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22282515|NCT04979897|Universidad del Desarrollo|Ana Castro-Avila|+56223279648|anacastro@udd.cl|
22282516|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com|
22282517|NCT03828422|University Medical Centre Ljubljana|dr. Aleš Blinc, MD, PhD|+38615227124|ales.blinc@kclj.si|
22282518|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org|
22282519|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu|
22282520|NCT04659174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22282521|NCT02781792|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
22282522|NCT03061721|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22282523|NCT03447314|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282524|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
22282525|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282526|NCT04011826|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
22326945|NCT03222076|MD Anderson Cancer Center|Dr. Ahmed Kaseb|(713) 792-2828|akaseb@mdanderson.org|
22326946|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
22282527|NCT04599959|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282528|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu|
22282529|NCT04049266|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
22282530|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22282531|NCT02309645|Ethicon Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22282532|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org|
22282533|NCT04600076|University of Michigan|Katherine Jo Gold|734 998-2499|ktgold@med.umich.edu|
22282534|NCT01639339|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282535|NCT02891681|Washington University School of Medicine|Quing Zhu, Ph.D.|314-935-7519|zhu.q@wustl.edu|
22282536|NCT01170598|University Health Network|Sara O'Neill|416-597-3422|o'neill.sara@torontorehab.on.ca|7860
22282537|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22282538|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw|
22282539|NCT02685748|CPD Dr Laza Lazarevic, Belgrade, Serbia|Pavicevic Dragana|0652207970|gagapavicevic@yahoo.com|+381
22282540|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com|
22282541|NCT05131971|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282542|NCT04669262|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22282543|NCT01638013|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22282544|NCT02637427|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
22282545|NCT01846299|Novartis|Study Director|862-778-8300||
22282546|NCT03559517|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22282547|NCT01960998|Birmingham VA Medcial Center|Kathryn L. Burgio, PhD|205-999-9537|kburgio@uabmc.edu|
22282548|NCT03088748|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
22282549|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu|
22282550|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
22282551|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22282552|NCT03510468|Clinical Center|Dr. Joseph Kovacs|+1 301 496 9907|jkovacs@mail.nih.gov|
22282553|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu|
22282554|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu|
22282555|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282556|NCT02068846|University of North Carolina at Chapel Hill|Jennifer Webster-Cyriaque, DDS, PhD|(919) 537-3492|jwebster@email.unc.edu|
22282557|NCT03899064|MC2 Therapeutics|Birgitte Vestbjerg|+44 2077 2575|bve@mc2therapeutics.com|
22282558|NCT03283098|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22282559|NCT03515226|University of Washington, Department of Psychiatry & Behavioral Sciences|Dr. Patricia Arean, Director, UW ALACRITY Center|206-221-8692|parean@uw.edu|
22282560|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282561|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|3522730558|resultsreportingcoordinator@childrensoncologygroup.org|
22282562|NCT03397134|Minerva Neurosciences|Senior Vice President and Head of R&D|617-600-7378|rkuchibhatla@minervaneurosciences.com|
22282563|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no|
22282564|NCT03287674|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD|38686467|anders.kverneland@regionh.dk|
22282565|NCT03136497|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22282566|NCT00735826|Dartmouth-Hitchcock Medical Center|Konstnatin Dragnev, MD Professor of Medicine|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
22282567|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282568|NCT02351349|MUHC|Sameena Iqbal|5146302225|sameena.iqbal@mcgill.ca|1841
22282569|NCT02649218|Novartis Pharmaceuticals|Study Lead|+1 (862) 778-8300|novartis.email@novartis.com|
22299947|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org|
22317307|NCT03775434|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22317308|NCT03047395|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22317309|NCT01145209|National Heart Lung and Blood Institute|Wiestner, Adrian MD, PhD|+1.301.594.6855|wiestnea@nhlbi.nih.gov|
22317310|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu|
22317311|NCT04771611|Mayo Clinic|James L. Kirkland, M.D., Ph.D.|507-538-3817|Kirkland.James@mayo.edu|
22317312|NCT04811131|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22317313|NCT04718779|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22317314|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com|
22317315|NCT00003453|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22326947|NCT02059213|University of Michigan Rogel Cancer Center|Phillip Palmbos, M.D., Ph.D.|734-936-3591|ppalmbos@umich.edu|
22326948|NCT02338492|IlluminOss Medical Inc.|Gene DiPoto|401-714-0008|gdipoto@illuminoss.com|202
22326949|NCT00980785|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-256-1901|cmc@medicine.wisc.edu|11691
22282570|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282571|NCT02174523|Phase I Clinical Research Unit , Shanghai Xuihui Central Hospital|Dr.Hu Chaoying|021-54036058|cyhu@shxh-centerlab.com|
22326950|NCT04281030|NYU Langone Health|Mia Minen|9294555130|Mia.Minen@nyulangone.org|
22317316|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22282572|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282573|NCT01509677|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22282574|NCT02701777|Hines VA|Reagan Morehouse|312-238-2993|rmorehouse@sralab.org|
22282575|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu|
22282576|NCT03549871|Sanofi ( Genzyme, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22282577|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
22282578|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282579|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22282580|NCT03349645|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22282581|NCT02910401|University of Virginia|Larry Borish, MD|4342436570|lb4@virginia.edu|
22282582|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu|
22282583|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282584|NCT02240368|University of Foggia|Alberto Sciusco||alberto.sciusco@gmail.com|
22282585|NCT03802344|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
22282586|NCT03372460|Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System|Dr. Noah S Philip, MD|4012737100|noah_philip@brown.edu|16200
22282587|NCT02793817|Kala Pharmaceuticals, Inc.|Head, Clinical Operations|781-996-5252|Results005@kalarx.com|
22282588|NCT01097642|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
22282589|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
22282590|NCT03995680|Swiss Tropical and Public Health Institute|Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
22282591|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282592|NCT00916058|Weill Cornell Medical College|Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
22282593|NCT03222973|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22282594|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org|
22282595|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com|
22282596|NCT02439450|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
22282597|NCT03998670|PEDIG Coordinating Center, Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813 975 8690|rkraker@jaeb.org|
22282598|NCT04644796|Missouri Orthopaedic Institute|Angela Atkinson|573-884-1128|avadd9@umsystem.edu|
22282599|NCT03730961|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22282600|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282601|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22282602|NCT04508751|University of California Los Angeles|Dr. Kara Calkins|3108259330|kcalkins@mednet.ucla.edu|
22282603|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu|
22282604|NCT00901511|Fondazione IRCCS Policlinico San Matteo Pavia|Francesca Mariani|+39 0382 503590|fr.mariani@smatteo.pv.it|
22282605|NCT02880514|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22282606|NCT02436668|Pharmacyclics, An AbbVie Company|George Cole|(408) 990-7340|gcole@pcyc.com|
22282607|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
22282608|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de|
22282609|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu|
22282610|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu|
22282611|NCT03551665|Arizona State University|Daniel Peterson|602-543-9373|daniel.peterson1@asu.edu|
22282612|NCT05538312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282613|NCT03966885|Columbia University|Jeremy Kane, PhD, MPH|7179914098|jk4397@cumc.columbia.edu|
22282614|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22282615|NCT00509093|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|+1 216-445-9354|advania@ccf.org|
22282616|NCT05013424|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22282617|NCT05858450|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22282618|NCT04143217|Supernus Pharmaceuticals Inc.|Jonathan Rubin, MD, MBA, Senior Vice President/Chief Medical Officer|240-403-5710|jrubin@supernus.com|
22282619|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu|
22282620|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu|
22282621|NCT02868034|University of Utah|Julie Fritz|18015872237|julie.fritz@utah.edu|
22282622|NCT03538444|Medical University of South Carolina|Gregory Sahlem MD|843-792-5716|sahlem@musc.edu|
22282623|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu|
22282624|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu|
22282625|NCT03660228|Dana-Farber Cancer Institute|Gregory A. Abel, MD|617-632-2304|GAABEL@PARTNERS.ORG|
22282626|NCT03640052|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22282627|NCT04422561|Zagazig University|Dr. Waheed Shouman|+201114812048|shouman66@gmail.com|
22282628|NCT04283942|Zhongshan Hospital, Fudan University|Dr. Hua Bian|+86 64041990|zhongshan_bh@126.com|
22317317|NCT02217475|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22317318|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu|
22282629|NCT05494736|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282630|NCT05479097|University of Wisconsin School of Medicine and Public Health|Dr. Sean Duffy|608-263-3111|sean.duffy@fammed.wisc.edu|
22282631|NCT04126564|Sadhguru Center for a Conscious Planet, BIDMC|Dr. Balachundar Subramaniam|(617)632-8071|bsubrama@bidmc.harvard.edu|
22282632|NCT04854031|Boys Town National Research Hospital|Adam Bosen|531-355-5030|adam.bosen@boystown.org|
22282633|NCT01638052|Ann & Robert H. Lurie Children's Hospital of Chicago|Santhanam Suresh, MD|312-227-5147|SSuresh@luriechildrens.org|
22282634|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu|
22282635|NCT02540330|Atossa Therapeutics, Inc.|Heather Fraser, VP Clinical, Regulatory & CMC|206-707-3088|heather.fraser@atossainc.com|
22282636|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282637|NCT03941964|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22282638|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com|
22282639|NCT04420572|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
22282640|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22282641|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com|
22282642|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100|Kim.Stote@esc.edu|2873
22282643|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
22282644|NCT02305017|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22271369|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282645|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22282646|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919|ARTESp@phenox.info|0
22282647|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
22282648|NCT03296137|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD, PhD|+4538686467|anders.kverneland@regionh.dk|
22282649|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957|bredlau@musc.edu|62872
22282650|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu|
22282651|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22282652|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22282653|NCT00951080|KCI|VP, Global Clinical Development|12102555595|jkhart@mmm.com|
22282654|NCT02124018|First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens|Professor Konstantinos A. Gatzoulis|6944580369|kgatzoul@med.uoa.gr|0030
22282655|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22282656|NCT02585830|University of Colorado Anschutz Medical Campus|Stacey L. Simon|720-777-5681|stacey.simon@childrenscolorado.org|
22282657|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22282658|NCT00350272|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22282659|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
22282660|NCT00068250|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22282661|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu|
22282662|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300||
22282663|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu|
22282664|NCT02927925|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22282665|NCT03955250|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|BGaudiano@Butler.org|
22282666|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22282667|NCT03352557|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22282668|NCT04677660|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22282669|NCT03242772|Duke Center for Autism and Brain Development|Dr. Geraldine Dawson, PhD, PI of Duke Autism Center of Excellence|919-668-0070|geraldine.dawson@duke.edu|
22282670|NCT02499900|Teva Pharmaceutical Industries Ltd.|Director, Clinical Research|+01 215-591-3000|USMedInfo@tevapharm.com|
22282671|NCT01560637|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22282672|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi|
22271370|NCT01739764|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271371|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22271372|NCT03887429|Promentis Pharmaceuticals|Chad Beyer|(414) 238 2992|cbeyer@promentispharma.com|
22271373|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org|
22271374|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
22271375|NCT05238025|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22271376|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101|jijits@cc.kmu.edu.tw|6358
22282673|NCT02538419|Brigham and Women's Hospital|Dr. Jessie Bakker|617-732-5987|jpbakker@bwh.harvard.edu|
22282674|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22282675|NCT02434354|Abramson Cancer Center|Dr. Tara Mitchell|215-662-7908|tara.mitchell@pennmedicine.upenn.edu|
22282676|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu|
22282677|NCT03410797|University of Pittsburgh|Jacqueline Gartner-Schmidt|412-232-8970|jgs@pitt.edu|
22299948|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783|adrian@eosciences.com|732
22299949|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu|
22299950|NCT04829344|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
22299951|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299952|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22299953|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22299954|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22299955|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444||
22299956|NCT02995967|UAB|Joseph Malek|2059965466|jmalek@uabmc.edu|
22299957|NCT03305016|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22299958|NCT02119416|SUNYBuffalo|Jennifer Temple|716-829-5593|jltemple@buffalo.edu|
22299959|NCT04420689|Alume Biosciences|Chief Medical Officer|858-922-3966|brett.berman@alumebiosciences.com|
22299960|NCT03434119|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22299961|NCT04323852|Shahid Beheshti Medical School|Dr. ََAfshin Zarghi|021-22439781|Mpajouhesh@sbmu.ac.ir|
22299962|NCT04360824|University of Iowa Hospitals & Clinics|Dr. Usha Perepu|1-319-356-2195|usha-perepu@uiowa.edu|
22299963|NCT04022668|Yeditepe University|Emre Aslanger|0216578000|mr_aslanger@hotmail.com|4240
22299964|NCT02278328|Children's Hospital of Philadelphia|Timothy Roberts, Professor|267 426 0307|robertstim@email.chop.edu|
22299965|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com|
22299966|NCT01347333|Mercy Research|Michelle McFarland, MPH, CHRC|314-251-8827|michelle.mcfarland@mercy.net|
22299967|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com|
22299968|NCT03834779|UT Southwestern Medical Center|Dr. Ank Nijhawan|214-648-2777|ank.nijhawan@utsouthwestern.edu|
22299969|NCT03579459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299970|NCT02528214|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22299971|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22299972|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22299973|NCT03593655|Stellenbosch University, Centre for Medical Ethics and Law|Gonasagrie Nair|27-21-938-7050|gnair@sun.ac.za|
22299974|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com|
22299975|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343||
22299976|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22299977|NCT03970109|National Institutes of Health|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
22299978|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu|
22299979|NCT03971643|InflaRx|Prof. Dr. Niels C. Riedemann|+49-(0) 3641-508 180|niels.riedemann@inflarx.de|
22271377|NCT03814720|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Alicia T Widge, M.D.|301-451-8715|alicia.widge@nih.gov|
22299980|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22299981|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com|
22271378|NCT02419612|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22271379|NCT01095978|Abbott|Global Medical Services|1-800-633-9110||
22271380|NCT05523011|Paracrine Therapeutics Private Limited|Lai Ruenn Chai|+6593375977|ruennchai.lai@paracrinetherapeutics.com|
22271381|NCT02009397|University of Louisville, James Graham Brown Cancer Center|Dr. Jason Chesney|502-562-3429|jason.chesney@louisville.edu|
22271382|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22271383|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com|
22271384|NCT04756154|3M|Linda Olson|651-736-3586|lkolson2@mmm.com|
22271385|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271386|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org|
22271387|NCT02089334|Rexahn Pharmaceuticals Inc.|Doug Swirsky/ Chief Executive Officer|240-268-5300|swirskyd@rexahn.com|
22271388|NCT02824562|UAB|Jessica Merlin|2059967894|jmerlin@uabmc.edu|
22271389|NCT02921750|Mölnlycke Health Care|Maria Åberg Håkansson|+46 31722 3000|maria.aberghakansson@molnlycke.com|
22271390|NCT04676412|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22271391|NCT04550832|LigaChem Bioscience, Inc.|Seonghye Cheon|+82)02-6952-0689|scheon@ligachembio.com|
22271392|NCT04765722|McMaster University|Dr. Imran Satia|905 5212100|satiai@mcmaster.ca|76228
22271393|NCT03596671|BlueWind Medical|Medical Affairs|612-203-5739|peter.rodine@bluewindmedical.com|
22271394|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271395|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu|
22271396|NCT04392167|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22271397|NCT03309696|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
22271398|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
22271399|NCT03117881|University of Alabama at Birmingham|Dr. Tapan Mehta|205) 975-9171|tapan@uab.edu|
22299982|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000|Motterso@mcw.edu|4-1619
22271400|NCT05070468|Alborz University of Medical Sciences|Dr. Masoumeh Farahani|09123783823|drfarahani73@yahoo.com|
22299983|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317319|NCT02615002|Neurim Pharmaceuticals|Tali Nir, DVM, VP Clinical and Regulatory Affairs|+972-3-7684902|talin@neurim.com|
22317320|NCT04738292|Froedtert / Medical College of Wisconsin|Sailaja Kamaraju, MD, MS|414-805-4600|skamaraju@mcw.edu|
22317321|NCT02601976|Getz Pharma|Mr. Jaffer Bin Baqar|111111511|jaffer.baqar@getzpharma.com|2710
22317322|NCT03181789|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22317323|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317324|NCT00735475|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22317325|NCT02442336|Fox Chase Cancer Center|Carolyn Fang|215-728-4062|carolyn.fang@fccc.edu|
22317326|NCT05086276|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
22317327|NCT00777088|Medtronic|Darren LaCour|949-680-1274|darren.j.lacour@medtronic.com|
22317328|NCT02101385|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22317329|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org|
22317330|NCT02489968|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317331|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com|
22317332|NCT01982448|Dana-Farber Cancer Institute|Clinical Trials Office|617-632-5313|ctopm@dfci.harvard.edu|
22317333|NCT02594163|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22317334|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu|
22317335|NCT04497142|Brigham and Women's Hospital|Steven Tobochnik, MD|617-732-7432|stobochnik@bwh.harvard.edu|
22317336|NCT01022268|Imperial College London|Dr Jethro Herberg|+44 - 0207 594 3990|j.herberg@imperial.ac.uk|
22317337|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org|
22271401|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
22271402|NCT02667626|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
22282678|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271403|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org|
22282679|NCT05894538|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22282680|NCT02257177|Galecto|Professor Bertil Lindmark|+4570705210|info@galecto.com|
22282681|NCT04962230|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282682|NCT03576755|University of California San Francisco|Principal Investigator: Dr. Monika Sarkar|415-502-2656|monika.sarkar@ucsf.edu|
22282683|NCT01646645|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
22282684|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22282685|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com|
22282686|NCT04209114|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22317338|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu|
22271404|NCT02560623|Mayo Clinic|Dr. Prasad G. Iyer|507-293-7911|iyer.Prasad@mayo.edu|
22271405|NCT02453282|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22271406|NCT01143064|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
22271407|NCT00985426|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
22271408|NCT00323037|CTI Clinical Trial and Consulting Services|Sandy Stagge, RN, BSN|513-619-1837|sstagge@ctifacts.com|
22271409|NCT02327013|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22271410|NCT02380859|Dartmouth-Hitchcock Medical Center|Stephen L. Lee, MD PhD|603-650-5104|stephen.l.lee@hitchcock.org|
22271411|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com|
22271412|NCT03385304|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
22271413|NCT01565668|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22271414|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271415|NCT04258254|University of Delaware|Anjana Bhat, Study PI|4435238680|abhat@udel.edu|
22271416|NCT01120249|SWOG|Melissa Plets|206.667.2707|mplets@fredhutch.org|
22271417|NCT02063178|University of Tennessee Health Science Center|Rebecca Krukowski|9014482426|rkrukows@uthsc.edu|
22271418|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
22271419|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22271420|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov|
22271421|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org|
22271422|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22271423|NCT04472026|University Of Florida|Naykky Singh Ospina|352) 273-8656|naykky.singhospina@medicine.ufl.edu|
22271424|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu|
22271425|NCT02570139|3M Critical and Chronic Care Solutions Division|Anne Swearingen, Manager, Clinical Operations|651 736 7826|aswearingen@mmm.com|
22271426|NCT02772276|MediBeacon|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
22271427|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com|
22271428|NCT02248974|Baylor College of Medicine|Dr. Jennifer Blumenthal-Barby|(713) 798-3785|jennifer.blumenthal-barby@bcm.edu|
22299984|NCT01494051|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
22271429|NCT03488225|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
22299985|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22299986|NCT03021187|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22317339|NCT02704754|Howard University|Thomas A Mellman|12022575961|TMellman@Howard.edu|
22317340|NCT02856828|Duke University Health Systems|Dr. Rachel Reilly|919-668-0291|rachel.reilly@duke.edu|
22317341|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu|
22317342|NCT03730480|Ascensia Diabetes Care|Pragathi Shelat|1 (862) 229-6679|pragathi.shelat@ascensia.com|
22317343|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org|
22317344|NCT04097301|AGC Biologics|Anna Stornaiuolo|0221277440|astornaiuolo@agcbio.com|
22317345|NCT04464954|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026532067|amanda.j.crawford.ctr@health.mil|
22317346|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com|
22317347|NCT02716818|Diurnal Limited|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
22317348|NCT01403610|UT Health San Antonio|Andrew Brenner|210-450-1000|regulatoryaffairs@uthscsa.edu|
22317349|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
22317350|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com|
22317351|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
22317352|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22326951|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu|
22326952|NCT00310388|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22326953|NCT00330863|Medical College of Georgia, Georgia Regents University|Peter F. Buckley, MD|706-721-2231|pbuckley@gru.edu|
22326954|NCT05209932|Family Transitions - PTW, LLC|Michele M Porter, PhD - Co-PI/Partner|4802037550|m.marie.porter@gmail.com|
22326955|NCT00882999|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22326956|NCT02082145|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22326957|NCT01757405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22326958|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22326959|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271430|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU|
22271431|NCT03436199|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22326960|NCT01219959|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22326961|NCT05906732|Thryv Therapeutics Inc.|VP Clinical Research|514-973-0915|admin@thryvtrx.com|
22326962|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu|
22326963|NCT02052778|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22326964|NCT04168593|USaoPauloGH|Andre Wan Wen Tsai|5511981456449|tsai.andre@gmail.com|
22326965|NCT04087343|The University of Texas Health Science Center at Houston|Jessica Lee, MD, MS, Assistant Professor|713-500-5457|Jessica.Lee@uth.tmc.edu|
22326966|NCT01994226|Keele University|Sponsor|01782|research.governance@keele.ac.uk|734882
22326967|NCT02488551|Central Arkansas Veterans Health Care System|Michael Cucciare|501-526-8179|michael.cucciare@va.gov|
22326968|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu|
22326969|NCT02651194|AbbVie|Global Medical Services|800-633-9110||
22326970|NCT01980706|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
22326971|NCT02546674|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22326972|NCT00004418|Kennedy Krieger Institute|Gerald Raymond|443-923-2750|raymond@kennedykrieger.org|
22326973|NCT02918409|National Jewish Health|Dr. Milene Saavedra|303-270-2333|saavedram@njhealth.org|
22326974|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
22326975|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu|
22326976|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu|
22326977|NCT02841787|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22326978|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
22326979|NCT02110121|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22326980|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22326981|NCT01199263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22326982|NCT02963714|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22326983|NCT05818527|Cairo university|mohamed atfy abdelmotaleb ( PhD student )|01222798922|atfy2002@yahoo.com|
22326984|NCT01687413|Washington University School of Medicine|Jason Rich, M.D.|314-747-3742|richj@wustl.edu|
22326985|NCT03047993|The University of Texas MD Anderson Cancer Center|Courtney DiNardo/Professor|713-794-1141|cdinardo@mdanderson.org|
22326986|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22326987|NCT02349789|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
22326988|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22299987|NCT03351049|University of Pittsburgh|David Brienza|412.624.6383|dbrienza@pitt.edu|
22317353|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu|
22317354|NCT00353522|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22317355|NCT04955444|The Methodist Hospital Research Institute|Elsie Rizk|7134412557|erizk@houstonmethodist.org|
22317356|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937||
22317357|NCT03699085|University of Washington|Lauren Whiteside, Primary Investigator|206-744-8464|laurenkw@uw.edu|
22317358|NCT03568331|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22271432|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22282687|NCT02403895|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
22317359|NCT00158860|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317360|NCT04638920|University Hospital Zurich|Prof. Malcolm Kohler, Sponsor-Investigator|+41442551111|malcolm.kohler@usz.ch|
22317361|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com|
22317362|NCT01435616|Eli Lilly and Company|Chief Medical Officer|800 545 5979||
22317363|NCT04080908|NYU Langone Health|Stuart Katz|2122633946|Stuart.Katz@nyulangone.org|
22317364|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22317365|NCT01237587|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22317366|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
22317367|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com|
22317368|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317369|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22326989|NCT02168933|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465||
22271433|NCT03442699|Hartford Hospital/Institute of Living|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
22271434|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu|
22271435|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22271436|NCT05087966|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
22271437|NCT01914159|Dept of Ophthalmology, University of Bonn, Bonn, Germany|Tim U. Krohne, MD, FEBO|+49 228 287|krohne@uni-bonn.de|15505
22271438|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com|
22271439|NCT01312233|Spine Institute for Quality|Christine M Goertz, DC, PhD (Study Principal Investigator)|301-335-0071|cgoertz@spineiq.org|
22271440|NCT06350461|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
22271441|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271442|NCT02584998|CMC VAMC|Emily Carter Paulson, MD MSCA|215-823-5880|emily.paulson@va.gov|
22271443|NCT00456508|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22271444|NCT04814368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22271445|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
22271446|NCT04530591|Hospital of the University of Pennsylvania|Jacob Brenner, Assistant Professor of Medicine|215-662-2222|Jacob.Brenner@pennmedicine.upenn.edu|
22271447|NCT04216589|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22271448|NCT04198584|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-966-6732|donna_evon@med.unc.edu|
22271449|NCT02987972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271450|NCT02342548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271451|NCT01726036|TriHealth|Rachel G. Sinkey MD - PI|513-862-6918|pam_plummer@trihealth.com|
22271452|NCT01047332|Brigham and Women's Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org|
22271453|NCT03521817|Pennington Biomedical Research Center|John W Apolzan|225-763-2827|john.apolzan@pbrc.edu|
22271454|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300||
22271455|NCT05530980|University of South Carolina College of Nursing|Dr. Demetrius Abshire|803-576-6262|abshired@mailbox.sc.edu|
22271456|NCT05685732|Corium, LLC|Ronald Tashjian|6172337474|rtashjian@corium.com|
22271457|NCT02640404|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22271458|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271459|NCT05397171|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22271460|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140|loebm@mcmaster.ca|26679
22271461|NCT03200847|University of Colorado Hospital|Dr. Martin McCarter|13037242725|martin.mccarter@cuanschutz.edu|
22271462|NCT01520519|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
22271463|NCT04643964|The Ohio State University|Dr. Daniel Strunk|6146884891|strunk.20@osu.edu|
22271464|NCT02368210|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
22271465|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000|bechen@ctg.queensu.ca|77703
22271466|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu|
22271467|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch|
22271468|NCT05216991|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
22271469|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22271470|NCT02255552|Sarepta Therapeutics, Inc.|Medical Director|+1-800-690-2003|clinicaltrials@sarepta.com|
22271471|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu|
22317370|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com|
22317371|NCT03208036|Minneapolis VA Health Care System|Tasha Nienow|612-467-1004|tasha.nienow@va.gov|
22317372|NCT00700778|Fox Chase Cancer Center|Dr. Jose Russo|215-728-4782|Jose.Russo@fccc.edu|
22317373|NCT01504477|Georgetown University|Michael Pishvaian|202-444-2223|pishvaim@georgetown.edu|
22326990|NCT03497429|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22326991|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu|
22282688|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu|
22282689|NCT03785587|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22282690|NCT04092907|Harbour Biomed|Nina Shen|18251811067|nina.shen@harbourbiomed.com|
22282691|NCT02210832|University of Vermont|Stephen T. Higgins|802-735-6267|stephen.higgins@uvm.edu|
22282692|NCT02968381|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
22282693|NCT00471887|UCLA|Antoni Ribas, MD|310-206-3928|aribas@mednet.ucla.edu|
22282694|NCT04790812|The University of Texas Health Science Center at Houston|Harry Gilbert, DDS|713-486-4315|Harry.D.Gilbert@uth.tmc.edu|
22282695|NCT03824405|Botanix Pharmaceuticals|Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
22282696|NCT03710876|Ferring Ventures Ltd|Lindsay Caygill Clinical Trial Manager|+44 (0) 74 213 02230|linsdsay.caygill@trizell.com|
22326992|NCT03309787|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
22326993|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com|
22326994|NCT01393171|Kaiser Permanente|Dr John Nguyen|562-657-2642|john.n.nguyen@kp.org|
22326995|NCT02295735|Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy|PD Dr. Jan Kottner|+4930450518218|jan.kottner@charite.de|
22326996|NCT02622724|Faron Pharmaceuticals|Chief Medical Officer|+3584005529411|medical@faron.com|
22326997|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22326998|NCT01290445|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22326999|NCT03544268|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22327000|NCT03583372|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22327001|NCT02796391|Moffitt Cancer Center|Dr. Vani Simmons|813-745-4816|Vani.Simmons@moffitt.org|
22327002|NCT02695524|University of São Paulo|Anamaria Siriani de Oliveira|+551633154415|siriani@fmrp.usp.br|
22327003|NCT02935699|TerSera Therapeutics|Medical Affairs|844-334-4035|tersera@medinfodept.com|
22327004|NCT03913221|University of North Carolina at Chapel Hill|Wesley Jackson, MD, MPH|984-215-3449|wesley.jackson@unc.edu|
22327005|NCT05439460|Stanford University|Chandra Ramamoorthy, MD|(650) 723-5728|chandrar@stanford.edu|
22327006|NCT03446651|Yale School of Medicine|Jeffrey Testani, MD, MTR|(203) 785-7191|jeffrey.testani@yale.edu|
22327007|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU|
22327008|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22327009|NCT04831515|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
22327010|NCT03712345|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
22327011|NCT05250830|The Ohio State University|Kara Rood|440-321-0264|Kara.Rood@osumc.edu|
22327012|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22327013|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
22327014|NCT03837353|NYU Langone Health|David Wise, MD, PhD|(212) 731-5405|David.Wise@nyulangone.org|
22327015|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22282697|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
22282698|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu|
22299988|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22317374|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org|
22317375|NCT03230877|Fisher & Paykel Healthcare Ltd.|Sarah Gunson|+64 9 574 0123|sarah.gunson@fphcare.co.nz|7675
22317376|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il|
22317377|NCT00350103|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22317378|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22317379|NCT02559895|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22317380|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317381|NCT04828837|NTUNHS|Wang Szu-Yi|886-97140315|jachiex@gmail.com|
22317382|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22317383|NCT01030406|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
22317384|NCT04540887|Wake Forest Institute for Regenerative Medicine|Dr. Stephen Walker|33-713-7272|swalker@wakehealth.edu|
22317385|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22317386|NCT04664400|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
22317387|NCT02688218|Oregon Health and Science University|Joseph El Youssef|503-418-5128|elyoussj@ohsu.edu|
22317388|NCT03122691|Johns Hopkins University School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22317389|NCT03762200|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
22317390|NCT03738423|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22317391|NCT01846494|Duke Clinical Research Institute|Allison DeLong|919-668-6855|allison.delong@duke.edu|
22317392|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu|
22317393|NCT04949243|Duke University|Saira Siddiqui, MPH|919-688-8464|saira.siddiqui@duke.edu|
22317394|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br|
22317395|NCT02592876|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22317396|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22317397|NCT00867308|Johns Hopkins University|Amy DeZern, MD|4105027208|adezern1@jhmi.edu|
22317398|NCT01464775|MercyMC|Dr. Fermin Barrueto|410-321-8452|fbarrueto@mdmercy.com|
22317399|NCT00611975|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
22317400|NCT04625413|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
22317401|NCT03960047|University Of Guelph|Professor Barbara A. Morrongiello|5195461637|bmorrong@uoguelph.ca|
22317402|NCT05618912|Indiana University School of Medicine|Dr. Syril Keena T. Que|317-944-7744|ques@iu.edu|
22317403|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22317404|NCT05130047|Mayo Clinic|Michael Camilleri, M.D., D.Sc.|507-284-2687|camilleri.michael@mayo.edu|
22317405|NCT02233543|Novartis Pharmaceuticals|Study Director|862-778-8300||
22317406|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317407|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101|cynthia.brownd44b2@va.gov|7300
22317408|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22317409|NCT02924428|Venus Concept Ltd.|Director, Clinical Affairs|416-222-6144|mgronski@venusconcept.com|517
22317410|NCT02680002|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
22317411|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317412|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu|
22317413|NCT03241225|Weill Cornell Medicine|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
22317414|NCT04390022|Barcelona Institute for Global Health|Carlos Chaccour|0034666293112|carlos.chaccour@isglobal.org|
22317415|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317416|NCT03296033|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-6344|dhenshaw@wakehealth.edu|
22317417|NCT02383056|University of Miami|Dr. Keyvan Nouri|305-243-3380|Knouri@med.miami.edu|
22317418|NCT02550470|Rutgers - New Jersey Medical School|Dr. Eloy, PI|973 972 5007|eloyje@njms.rutgers.edu|
22317419|NCT01775475|AIDS Malignancy Consortium Statistical and Data Analysis Center|Study Statistician|(212) 659-9558|amcpm@emmes.com|
22317420|NCT03076333|Joint UNC/NC State Department of Biomedical Engineering|David S Lalush|919-513-7671|dslalush@ncsu.edu|
22317421|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com|
22317422|NCT02618915|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
22317423|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22317424|NCT02342743|CEFALY Technology|Clinical Trials Department director|+3243676722|info@cefaly.com|
22317425|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22317426|NCT04875676|Vaxart|Vice President Regulatory|(650) 747-6028|mdrayton@vaxart.com|
22317427|NCT03064035|Methodist Hospital|Zachary Stoecker, PharmD|952-977-5520|Zachary.Stoecker@parknicollet.com|
22327016|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22282699|NCT02534935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282700|NCT01460719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282701|NCT02630017|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|maddicott@uams.edu|
22282702|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu|
22282703|NCT03602885|DFCI|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
22282704|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org|
22282705|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com|
22282706|NCT02838901|Wake Forest School of Medicine|Dr. Cheryl Bushnell|336-716-4101|cbushnel@wakehealth.edu|
22282707|NCT04431713|UCL|Professor Foltynie|020 3448 8726|t.foltynie@ucl.ac.uk|
22282708|NCT04114604|KITE Research Institute - Toronto Rehabilitation Institute, University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
22282709|NCT02285114|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22282710|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22282711|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org|
22282712|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22282713|NCT02725879|2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki,|Professor Assimina Galli-Tsinopoulou|+302310994802|agalli@auth.gr|
22282714|NCT04699032|VectivBio AG|Reda Sheik|+41615513030|clinicaltrials@vectivbio.com|
22282715|NCT03022097|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22282716|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu|
22282717|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org|
22282718|NCT05605691|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22282719|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com|
22282720|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com|
22282721|NCT05463744|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22317428|NCT03602066|University of Arizona Cancer Center|Jared Robbins, MD|520-626-6724|jrobbins@arizona.edu|
22317429|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22317430|NCT02454179|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22317431|NCT03103763|Penobscot Bay Medical Center|Caroline Knight, RN, Clinical Research Manager|207-301-8959|cknight@pbmc.org|
22317432|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu|
22317433|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317434|NCT03245151|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22317435|NCT01970345|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
22317436|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
22317437|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
22317438|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22317439|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317440|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu|
22317441|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org|
22317442|NCT00955253|Imperial College London|Dr Paresh Malhotra|0208 846 1234|p.malhotra@imperial.ac.uk|
22317443|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317444|NCT00703937|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22317445|NCT03840915|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22317446|NCT00700258|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317447|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu|
22317448|NCT03250234|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
22317449|NCT02663518|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317450|NCT02470910|DFCI/BWH|Anthony D'Amico|8572151489|adamico@bwh.harvard.edu|
22317451|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317452|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22271472|NCT03181503|Galderma|Clinical Operations|(0) 4 93 95 70 70|Clinical.Studies@galderma.com|+33
22317453|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
22317454|NCT03178643|DCRI|Dr. Steve Taylor|9198245232|steve.taylor@duke.edu|
22317455|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu|
22317456|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu|
22317457|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu|
22317458|NCT02029872|Johns Hopkins University School of Nursing|Dr. Jason Farley|4105027563|jfarley1@jhu.edu|
22317459|NCT01963923|Complejo Hospitalario Universitario A Coruña|Esther Gimenez Moolhuyzen|679336288|raquel.sebio@udc.es|
22317460|NCT03215810|Moffitt Cancer Center|Ben Creelan, MD|813-745-4541|ben.creelan@moffitt.org|
22317461|NCT02318992|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
22317462|NCT05061472|University of Colorado Anschutz Medical Campus|Adnin Zaman, MD|5852761001|adnin.zaman@cuanschutz.edu|
22317463|NCT03670004|Jesse Brown VA Medical Center|Dr. Matthew Major|312-503-5731|matthew.major2@va.gov|
22317464|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123|oolonghu@gmail.com|2334
22317465|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000|Raela.Williford@va.gov|2433
22317466|NCT03310268|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22317467|NCT04797650|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22317468|NCT03480217|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Ian Kronish|212-342-1335|ik2293@columbia.edu|
22317469|NCT04772898|Creighton University|Anastasia Kyvelidou|4022805749|aky61380@creighton.edu|
22317470|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu|
22317471|NCT00309959|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22317472|NCT02937454|Vifor (International) AG.|FER-CARS-06 Clinical Study Team|+41 588 518 000|FER-CARS-06.study@viforpharma.com|
22317473|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271473|NCT02523235|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
22271474|NCT02382796|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271475|NCT03077659|NanOlogy, LLC|Gere S. diZerega, MD|805-595-1300|gere.dizerega@usbiotest.com|
22271476|NCT02570321|UCSF, Proctor Foundation|Sarah Abedelrahman, Research Data Analyst|2135093817|sarah.abdelrahman@ucsf.edu|
22271477|NCT02258542|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
22271478|NCT04068688|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
22271479|NCT04679051|Texas Tech University|Joaquin U Gonzales|806 834 5944|joaquin.gonzales@ttu.edu|
22271480|NCT04742309|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22271481|NCT04812795|University of Pennsylvania|Dr. Andy Tan|2157466546|andy.tan@asc.upenn.edu|
22317474|NCT04601870|University of Wisconsin-Madison School of Medicine and Public Health Center for Tobacco Research and Intervention|Mark Zehner|16082627568|mark.zehner@ctri.wisc.edu|
22327017|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com|
22271482|NCT00980018|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22299989|NCT03099382|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Shiwei Sun; Project Manager|+86-18036618554|shiwei.sun@hengrui.com|
22299990|NCT02939105|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22299991|NCT02259608|Radboud UMC|Rob Arts|0031 24|rob.jw.arts@radboudumc.nl|36 67206
22299992|NCT01802411|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|Pacira Pharmaceuticals, Inc.|MedInfo@pacira.com|
22299993|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu|
22299994|NCT05039268|Macquarie University|Richard Gan|+61 2 9812 3739|richard.gan@mq.edu.au|
22299995|NCT03930745|University of Alabama at Birmingham School of Medicine|Jeanne Marrazzo, MD, MPH|205-975-5500|jmarrazzo@uabmc.edu|
22299996|NCT02670629|"Servicio de Ortopedia y Traumatología . Hospital Universitario José Eleuterio González"|Dr. Adriana Hernández|8112901288|adrianahl@gmail.com|
22299997|NCT02715765|University of Minnesota|Kelvin Lim|612-273-9803|kolim@umn.edu|
22299998|NCT03588572|Guangzhou General Hospital of Guangzhou Military Command|Dr.Yan Liu|0086-02088654756|yanliu@139.com|0086
22299999|NCT02267382|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@mycovia.com|
22327018|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu|
22300000|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509||
22300001|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
22300002|NCT03277313|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22300003|NCT02863991|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22300004|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22317475|NCT01854138|ProMedica|Karl J. Beer, MD|419-578-4260|karl.beer@promedica.org|
22317476|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu|
22317477|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com|
22317478|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov|
22317479|NCT01160289|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317480|NCT03909529|CMP Pharma|Paul Sudhakar|816-507-8249|pauls@ptspharma.com|
22317481|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com|
22317482|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317483|NCT00768079|MedImmune, LLC|Joseph M. Parker, Director, Clinical Development|+1 301-398-4095|information.center@astrazeneca.com|
22317484|NCT03271021|Foamix Pharmaceuticals|Senior Director, Clinical Operations|9089630117|kendra.gulbronson@foamix.com|
22317485|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22317486|NCT02876159|Emory University|Dr. Mark J. Mulligan, M.D., F.I.D.S.A|404-712-1370|mmulli2@emory.edu|
22317487|NCT02207569|Medtronic|Kristin Smith|763-526-3095|kristin.m.smith@medtronic.com|
22317488|NCT02585232|Tuscaloosa VA Medical Center|Dr. Michelle Hilgeman|205-554-2000|Michelle.Hilgeman@va.gov|3278
22317489|NCT04595318|Montefiore Health System|Dr. Shadi Nahvi|718 920 5379|snahvi@montefiore.org|
22317490|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
22317491|NCT00580645|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22317492|NCT01157676|University of Miami|Dipen Parekh, MD|305 243 6591|parekhd@miami.med.edu|
22317493|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22317494|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu|
22317495|NCT03028220|Imperial College London|Prof Nick Oliver|02075942460|nick.oliver@imperial.ac.uk|
22317496|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22317497|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com|
22317498|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
22317499|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22317500|NCT02971761|Department of Medical Oncology, City of Hope|Yuan Yuan, MD, PhD.|626-256-4673|yuyuan@coh.org|89200
22317501|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu|
22317502|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317503|NCT01302860|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22317504|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000|abrown@apnicure.com|122
22317505|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22317506|NCT02478710|Premier Health|Director of Clinical Research|19374747850|jllader@premierhealth.com|
22317507|NCT02842151|Alcon, A Novartis Division|Senior Global Brand Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22317508|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
22317509|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl|
22317510|NCT03965351|Cincinnati Children's Hospital Medical Center|Mary Banks|513-636-2147|mary.banks@cchmc.org|
22317511|NCT01781078|Boston Scientific|Kelly Aspinwall|651-582-4560|Kelly.Aspinwall@bsci.com|
22317512|NCT04887064|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22317513|NCT02217501|UT Southwestern Medical Center|Subhash Banerjee, MD|214-857-1608|Subhash.Banerjee@utsouthwestern.edu|
22317514|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com|
22300005|NCT00363766|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300006|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300||
22317515|NCT02019667|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
22317516|NCT02577822|Northwestern University|David Manning, MD|312-695-6800|david.manning@nm.org|
22317517|NCT03748992|Medical University of South Carolina|Patrick Flume, MD|843-792-3167|flumepa@musc.edu|
22317518|NCT02432196|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22317519|NCT03924765|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
22317520|NCT03691909|Hope Biosciences Stem Cell Research Foundation|Linette Rehkopf RPh|346-900-0340|linette@hopebio.org|102
22317521|NCT03417895|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yuanchao Wang; SPM|86-18036618707|yuanchao.wang@hengrui.com|
22317522|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22317523|NCT05452278|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
22317524|NCT03663257|Philips Medical Systems Nederland B.V.|Joris de Groot|+31621949619|joris.ah.de.groot@philips.com|
22317525|NCT05121246|mAbxience Research S.L.U.|Dr. Susana Millán|+34 682821346|susana.millan@mabxience.com|
22317526|NCT05038163|NBER|Sarah Holmes Berk|617-588-1445|sholmes@nber.org|
22317527|NCT04512430|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22317528|NCT01905150|Hirschfeld Oncology|Dr. Azriel Hirschfeld|718-732-4050|ah@honcology.com|
22317529|NCT05453201|James J. Peters Veterans Affairs Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
22317530|NCT03562975|University Of South Florida|Clinical Research Manager|18139749423|amjackson@usf.edu|
22317531|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22317532|NCT04688320|"LLC SuperGene"|Dr. Sergey Markin|(495) 287-98-07|info@supergene.ru|+7
22282722|NCT02851407|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
22317533|NCT00552929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317534|NCT01147536|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
22317535|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov|
22317536|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
22317537|NCT02631577|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22317538|NCT03136445|NHS Blood and Transplant|A/Prof Lise Estcourt|44 1865 387789|Lise.Estcourt@nhsbt.nhs.uk|
22317539|NCT04577001|Mayo Clinic|Dr. Hilary DuBrock|(507) 284-2957|DuBrock.Hilary@mayo.edu|
22317540|NCT03647488|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22317541|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com|
22317542|NCT03694275|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22317543|NCT01783847|Iran university of Medical Sciences|Mohsen Bahmani Kashkouli|00989121777003|mkashkouli2@gmail.com|
22317544|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317545|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22317546|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com|
22317547|NCT02340767|National Dental PBRN|Dr. Sonia Makhija|2059965298|smakhija@uab.edu|
22317548|NCT01621737|UCSD|David Feifel|(858) 412-4130|dfeifel@kadimanp.com|
22317549|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu|
22317550|NCT03029351|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22317551|NCT01290029|Amgen Inc.|Study Director|866-572-6436||
22317552|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22317553|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
22317554|NCT00616902|Abbott|Global Medical Services|800-633-9110||
22317555|NCT01877837|Hackensack Meridian Health|Elana Smilow|5519965673|Elana.Smilow@hmhn.org|
22317556|NCT00645801|retired|Director of Gastrointestinal Research||anngimd@icloud.com|
22317557|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22317558|NCT04259645|UPMC Department of Anesthesiology and Perioperative Medicine|Anna Uskova, MD|412-623-2167|uskoaa@upmc.edu|
22317559|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
22317560|NCT01143038|Amgen Inc.|Study Director|866-572-6436||
22317561|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282723|NCT01311115|University of California, San Francisco|Justin White|415-476-8045|Justin.White@ucsf.edu|
22317562|NCT01183234|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22317563|NCT02190045|CAVHS/ UAMS|Kalpana Padala, MD|501-257-1000|kppadala@uams.edu|
22317564|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu|
22317565|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317566|NCT02367820|Nektar Therapeutics|Medical Affairs|855-482-8676|StudyInquiry@nektar.com|
22317567|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22317568|NCT01847469|Yale University School of Medicine, VA Connecticut Healthcare System|Dr. Ismene Petrakis|(203) 932-5711|ismene.petrakis@yale.edu|
22317569|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101||
22317570|NCT02095951|Wayne State University School of Medicine - Children's Hosp. of Michigan|Eric McGrath, MD|313-745-5862|emcgrath@med.wayne.edu|
22282724|NCT03416920|Massachusetts General Hospital|Dr. Pradeep Natarajan|617-724-3526|PNATARAJAN@PARTNERS.ORG|
22317571|NCT03618823|UPMC Children's Hospital of Pittsbugh|Senior Research Associate|1412-692-9879|nelsonjl2@upmc.edu|
22317572|NCT05383508|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22317573|NCT03139669|University of Virginia|Dr. Emma Mitchell Associate Professor|4342433962|emm6z@virginia.edu|
22317574|NCT01621568|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@mail.nih.gov|
22327019|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com|
22327020|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327021|NCT01718509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327022|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu|
22327023|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22327024|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu|
22327025|NCT02520518|COLORADO STATE UNIVERSITY|Manager of Research Operations|970-491-2242|Laurie.Biela@colostate.edu|
22327026|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org|
22327027|NCT03364673|Dana-Farber Cancer Institute|Alexi Wright, MD, MPH|617-632-2334|alexi_wright@dfci.harvard.edu|
22327028|NCT00779324|Indiana University School of Medicine|Flora Hammond, MD|3173292106|flora.hammond@rhin.com|
22327029|NCT02207556|Medical College of Wisconsin|Dr. Anita D'Souza|414-805-0637|dsouza@mcw.edu|
22327030|NCT03558555|Icahn School of Medicine at Mount Sinai|Dr. Alopi Patel|(212) 523-6357|Alopi.patel@mountsinai.org|
22327031|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org|
22327032|NCT01202721|Population Health Research Institute|Dr. Tara McCready, Program Director||tara.mccready@phri.ca|
22327033|NCT02740504|ResMed|Paul Phillips|+447789633508|paul.phillips@resmed.com|
22327034|NCT03741725|University of North Carolina, Project-China|Dr. Weiming Tang|+86-15920567132|weiming_tang@med.unc.edu|
22327035|NCT01199055|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22327036|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22327037|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com|
22327038|NCT00718666|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327039|NCT02196038|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
22327040|NCT01580592|Charité - University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
22327041|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22327042|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu|
22327043|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22327044|NCT03029650|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
22327045|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org|
22327046|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com|
22327047|NCT02402218|Johns Hopkins School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
22317575|NCT02930226|University of Cincinnati|Jose A. Cancelas, M.D., Ph.D.|513-558-1324|Jose.Cancelas@cchmc.org|
22317576|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
22317577|NCT03814031|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
22317578|NCT02224690|GW Research Ltd.|Medical Enquires||medinfo.USA@gwpharm.com, medinfo@greenwichbiosciences.com|
22317579|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
22317580|NCT01506609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22317581|NCT01710891|MinneapolisMRF|Brian Driver|6128739528|Brian.Driver@hcmed.org|
22317582|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org|
22317583|NCT02261597|Beth Israel Deaconess Medical Center, Harvard Medical School|Dr. Monika Haack|617-667-5234|mhaack@bidmc.harvard.edu|
22317584|NCT01990560|Ichan School of Medicine at Mount Sinai|Dr. Alice C. Levine|212-241-1500|alice.levine@mountsinai.org|
22317585|NCT02325557|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
22317586|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com|
22317587|NCT02703259|Christiana Care Health Systems|Dr. Terri Huynh|302-623-4410|terri.huynh@christianacare.org|
22317588|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22317589|NCT01856868|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
22317590|NCT00895154|Washington University|Dr. Allison King|314-454-4291|king_a@wustl.edu|
22317591|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org|
22317592|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org|
22317593|NCT03954392|Vanderbilt University|Judy Garber, Ph.D., Professor of Psychology and Human Development|16153305605|judy.garber@vanderbilt.edu; jgarber.vanderbilt@gmail.com|
22317594|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22317595|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
22317596|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu|
22317597|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317598|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
22317599|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317600|NCT03465904|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|ClinicalTrial@cefaly.com|
22317601|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
22327048|NCT03827473|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22317602|NCT05593445|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22317603|NCT05559476|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22317604|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org|
22317605|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca|
22317606|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com|
22327049|NCT04436822|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
22327050|NCT03807739|Genentech, Inc|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22327051|NCT00430625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327052|NCT02774226|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
22327053|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|carolynn.patten@va.gov|4160
22327054|NCT03744780|McGill University|Mallory Frayn, PhD(c)|N/A|mallory.frayn@mail.mcgill.ca|
22327055|NCT03705962|University of Virginia|Eric McVey|434.243.5382|edm9u@hscmail.mcc.virginia.edu|
22327056|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org|
22327057|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu|
22327058|NCT04158908|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
22327059|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com|
22327060|NCT03855137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22327061|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500|JBUCH@its.jnj.com|1707
22327062|NCT02435277|NuSirt Biopharma|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
22282725|NCT03385265|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
22282726|NCT01648296|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22282727|NCT02794844|Nemours Children's Hospital|James P. Franciosi, MD|407-567-3832|jfrancio@nemours.org|
22282728|NCT04465877|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22282729|NCT03440918|Vanderbilt University Medical Center|Dr. Sophie Katz|615-343-6190|sophie.e.katz@vumc.org|
22317607|NCT02349425|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317608|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22317609|NCT00512317|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22317610|NCT03346161|Washington University School of Medicine|Mary C. Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
22317611|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com|
22317612|NCT01035073|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22317613|NCT04101318|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
22317614|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22317615|NCT02090959|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22317616|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22317617|NCT02966301|MEDSENIC|RIEGER François - CEO - Scientific Director|+33671733159|fr@medsenic.org|
22317618|NCT02561754|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-3880|jdonnelly@ku.edu|
22317619|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org|
22317620|NCT02349646|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
22317621|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu|
22317622|NCT01375114|UT MD Anderson Cancer Center|Dr. Sriram Yennu, MD-Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22317623|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22317624|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22317625|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22317626|NCT00635427|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22317627|NCT05753670|Endeavor Health|Dr. Ghazaleh Rostami Nia|847-570-4729|GRostamiNia@northshore.org|
22317628|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu|
22317629|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22317630|NCT02595073|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22317631|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317632|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22327063|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
22317633|NCT02884908|University of Maryland School of Medicine|Dr. Melanie Bennett|4107060892|mbennett@som.umaryland.edu|
22317634|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com|
22317635|NCT01293487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300007|NCT02345512|National Health Service Greater Glasgow & Clyde|Ms Jennifer Crockett|0141 276 4900|jennifer.crockett@ggc.scot.nhs.uk|4912
22317636|NCT04860297|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22317637|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu|
22317638|NCT01642251|ECOG-ACRIN Cancer Research Group|Study Statistician||eatrials@jimmy.harvard.edu|
22317639|NCT00998790|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
22317640|NCT01993927|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22317641|NCT03988920|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22317642|NCT00287690|Imperial College London|Dr Carolyn Webb|+44 3301288121|c.webb@imperial.ac.uk|
22317643|NCT02414932|Trinity College Dublin|Dr Martha Finnegan|0035312493385|mfinneg@tcd.ie|
22317644|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com|
22317645|NCT01588431|UT Health San Antonio|Anand Karnad, MD|210-450-1267|karnad@uthscsa.edu|
22317646|NCT02632526|AstraZeneca AB|A study to assess the safety, tolerability, pharmacokinetics & dynamics of AZD5718 in healthy male||ClinicalTrialTransparency@astrazeneca.com|
22317647|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu|
22317648|NCT02533531|LifeWatch Services, Inc.|Paul Hanneman|1 847 720 2231|Phanneman@gobio.com|
22317649|NCT03814187|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22317650|NCT02047903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317651|NCT03901482|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
22317652|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22317653|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu|
22317654|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300||
22317655|NCT02689518|University of California San Diego|Professor Michael Goldbaum|858 534 3516|mgoldbaum@ucsd.edu|
22317656|NCT01853774|Arizona State University|Professor, College of Nursing and Health Innovation|6024960740|linda.larkey@asu.edu|
22317657|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu|
22317658|NCT02433340|AbbVie|Global Medical Services|800-633-9110||
22317659|NCT01226095|Abbott|Global Medical Services|800-633-9110||
22317660|NCT03032393|Youngstown State University|Associate Professor|330941-2702|wge@ysu.edu|
22317661|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
22317662|NCT04822597|University of Wisconsin School of Medicine and Public Health|Heather B Neuman, MD, MS, FACS|(608) 263-7064|neuman@surgery.wisc.edu|
22317663|NCT03283072|University of Florida|Mark Bishop|3522736112|bish@ufl.edu|
22317664|NCT03797677|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22317665|NCT02552368|Washington University School of Medicine - Department of Neurology|Dr. Thy Huskey|314-362-4503|huskeyt@wustl.edu|
22317666|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr|
22317667|NCT03661762|Norfolk and Norwich University Hospitals NHS Foundation Trust|Mr John Phillips|: +44 1603 593054|john.phillips@mac.com|
22317668|NCT02859324|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22317669|NCT02819557|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22317670|NCT02665338|Medical University of South Carolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
22317671|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu|
22317672|NCT05110690|Washington University School of Medicine|Michael Avidan, MBBCh, FCASA|314-273-4136|avidanm@wustl.edu|
22317673|NCT02502799|Florida International University|Dr. William E. Pelham Jr.|305-348-3002|wpelham@fiu.edu|
22317674|NCT03706313|Duke University|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
22317675|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il|
22317676|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22317677|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov|
22317678|NCT03207009|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
22317679|NCT01491672|Novartis|Study Director|862-778-8300||
22317680|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
22317681|NCT01336803|Stanford University|Heike Daldrup-Link|650-723-8996|heiked@stanford.edu|
22317682|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
22317683|NCT02947087|MUSouthCarolina|Hongjun Wang, PhD|8437921800|wangho@musc.edu|
22317684|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22317685|NCT04193436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317686|NCT01749904|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
22317687|NCT04256629|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22317688|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317689|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300||
22317690|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
22317691|NCT04745026|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22317692|NCT02926898|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22317693|NCT02292927|Imperial Colege London|Colin Bicknell|02033126072|alison.deslandes@imperial.nhs.uk|
22271483|NCT01985958|University of Pennsylvania|Edgar Ben-Josef, M.D.|215-662-3932|Edgar.Ben-Josef@uphs.upenn.edu|
22271484|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
22271485|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855||
22317694|NCT01656733|University of Connecticut School of Medicine|Cheryl Oncken, MD, MPH|860-679-3425|oncken@uchc.edu|
22317695|NCT00116337|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
22317696|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com|
22317697|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
22317698|NCT02962960|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
22317699|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com|
22317700|NCT02054741|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_GAP70@urmc.rochester.edu|
22317701|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22317702|NCT03430531|Penn State Hershey Medical Center|Dr. Verghese Cherian|7175318521|vcherian@pennstatehealth.psu.edu|
22317703|NCT02344004|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
22317704|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317705|NCT01945060|University of Virginia|Marc D Breton|14349826484|mb6nt@virginia.edu|
22317706|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22317707|NCT02534038|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|sdube@avanir.com|
22317708|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu|
22317709|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317710|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22317711|NCT02943226|The University of Texas Health Science Center at Houston|Joseph P. Hasapes, M.D.|(713) 566-5440|Joseph.P.Hasapes@uth.tmc.edu|
22317712|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
22317713|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu|
22317714|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com|
22317715|NCT02354443|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
22317716|NCT02489123|University of Washington|Ajay K. Gopal, MD|206-606-2037|agopal@uw.edu|
22317717|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22317718|NCT01605019|Houston Methodist Research Institute|Raquel R Bunge|713-441-3912|rrbunge2@houstonmethodist.org|
22317719|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu|
22317720|NCT04223830|Boston Scientific|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
22317721|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22317722|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317723|NCT01737827|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22317724|NCT01451827|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22317725|NCT01964924|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
22317726|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22317727|NCT01034163|Novartis|Study Director|862-778-8300||
22317728|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
22317729|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22317730|NCT05332145|HealthPartners Institute|Stephanie Hooker, PhD, MPH|952-967-5056|stephanie.a.hooker@healthpartners.com|
22317731|NCT02734953|Allegheny Health Network|Dr Raymond Benza|412-359-3131|raymond.benza@ahn.org|
22317732|NCT03406078|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22317733|NCT00467350|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343000|mmiller@cmh.edu|
22317734|NCT03538301|Nitto Denko Corporation|Nitto Denko Corporation Study Director|858-255-3010|clinicaltrialinfo005@nitto.com|
22317735|NCT03616977|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22317736|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
22317737|NCT00515853|University of Southampton|Sophie A. Pilkington|+44 (0)23 8059 5058|rgioinfo@soton.ac.uk|
22317738|NCT04041453|Universidad Nacional de Salta|Alejandro J Krolewiecki|+54 911 3183-8673|alekrol@hotmail.com|
22317739|NCT03798691|UW School of Medicine and Public Health|Freddy Caldera, DO|608-628-8201|fcaldera@medicine.wisc.edu|
22317740|NCT04548544|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|Olga.Tymofiyeva@ucsf.edu|
22271486|NCT03280225|Central Arkansas Veterans Healthcare System|Dr. Sara J. Landes|501-257-3385|sara.landes@va.gov|
22271487|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk|
22271488|NCT01273155|National Cancer Institute|Naoko Takebe, M.D., Ph.D.|240-781-3398|Takeben@mail.nih.gov|
22271489|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
22271490|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22317741|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com|
22317742|NCT04807582|Imperial College London|Professor Eric Aboagye|0203 313 3720|eric.aboagye@imperial.ac.uk|
22317743|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu|
22317744|NCT01586910|Medtronic, Inc.|Peggy Yunker|763-514-4000|surtavi@medtronic.com|
22317745|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22317746|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com|
22317747|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
22317748|NCT01111474|Federal University of São Paulo|Dr. Olga Dumont Flecha - PHD student|38 35326082|olgaflecha@gmail.com|
22317749|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22317750|NCT04289051|Sunstar Americas, Inc.|Akane Takemura|18477944276|akane.takemura@us.sunstar.com|
22317751|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
22317752|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22317753|NCT05877508|University of California San Francisco|Michael Peluso|(415) 502-2449|michael.peluso@ucsf.edu|
22317754|NCT04800432|University of South Florida|Tatyana Harris|(813) 974-7454|trharris1@usf.edu|
22317755|NCT05398237|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
22317756|NCT02370810|Anglia Ruskin Univeristy|Eldre Beukes|1223698847|eldre.beukes@anglia.ac.uk|2847
22317757|NCT01312857|Memorial Sloan Kettering Cancer Center|Dr. Nancy Kemeny, MD|646-888-4180|kemenyn@MSKCC.ORG|
22317758|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu|
22317759|NCT02234687|New York University School of Medicine|Charles Marmar, MD|646 754 4855|Charles.Marmar@nyumc.org|
22317760|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp|
22317761|NCT02781844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22317762|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317763|NCT01774487|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
22317764|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu|
22317765|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|104
22317766|NCT02572882|University of Pennsylvania|Natalie Kuzla|215-573-2935|nkuzla@pennmedicine.upenn.edu|
22317767|NCT04275089|Reia, LLC|Kaitlin Maier|2032742886|kaitlin@reiahealth.com|
22317768|NCT02469389|VISN 5 MIRECC|Dr. Melanie Bennett|(410) 637-1850|Melanie.Bennett@va.gov|
22317769|NCT01079663|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
22317770|NCT03606668|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
22317771|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br|
22317772|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22317773|NCT02354508|Novartis Pharmaceuticals|Study Director|826-778-8300|novartis.email@novartis.com|
22317774|NCT01028937|NTK Enterprises, Inc.|Nancy Lockerman|831-869-1384|nlockerman@opti-k.com|
22317775|NCT00760006|Chilsren's Hospital of Pittsburgh of UPMC|Dr. Joseph E. Losee|412-692-6203|joseph.losee@chp.edu|
22317776|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317777|NCT04447846|Kenndey Krieger Institute|Dr. Anne Comi|443-923-9127|comi@kennedykrieger.org|
22317778|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk|
22317779|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22317780|NCT02350777|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|212-639-5987|tamarir@mskcc.org|
22317781|NCT03536143|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
22271491|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu|
22271492|NCT03887117|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22271493|NCT02584959|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22271494|NCT04908475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22271495|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov|
22271496|NCT00492817|The University of Texas MD Anderson Cancer Center|Amol J. Ghia, MD|(832) 628-7357|ajghia@mdanderson.org|
22271497|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271498|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271499|NCT04272606|University of Iowa|Catherine Olinger|319-384-5892|catherine-olinger@uiowa.edu|
22271500|NCT03912428|National Institute of Mental Health|Dr. Robert Innis|+1 301 594 1368|robert.innis@nih.gov|
22271501|NCT02537431|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
22271502|NCT01717482|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-8462|Wigle.Dennis@mayo.edu|
22271503|NCT02345460|Case Comprehensive Cancer Center|Dr. Davendra Sohal|216-444-8258|sohald@ccf.org|
22271504|NCT00655473|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22271505|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org|
22282730|NCT04346108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22282731|NCT01598753|University of Washington|Dennis C. Turk, Ph.D.|(206)616-2626|turkdc@uw.edu|
22317782|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu|
22271506|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282732|NCT02275117|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22317783|NCT03038438|Medtronic|Stephanie Cihlar|763.258.9524|stephanie.a.cihlar@medtronic.com|
22317784|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com|
22317785|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu|
22317786|NCT03406260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22317787|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22282733|NCT01327274|UCSF Benioff Children's Hospital|Jill Imamura-Ching, RN|415-476-3446|Jill.Imamura-Ching@ucsf.edu|
22282734|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu|
22282735|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca|
22282736|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com|
22282737|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com|
22282738|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22282739|NCT02692040|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
22282740|NCT03089879|GlaxoSmithKline|GSK Response Center|866-435-7343|ass77028@gsk.com|
22282741|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300||
22282742|NCT02470754|University of California, San Francisco|Natalie Nardone, PhD|415-514-1450|natalie.nardone@ucsf.edu|
22282743|NCT02836873|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22282744|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu|
22282745|NCT03190265|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22300008|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22300009|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22300010|NCT01538745|SAUSHEC|Josh Miller|210-916-7111|joshmillersr@gmail.com|
22300011|NCT02142049|Pharmacyclics, LLC|Director of Clinical Operations|408-774-0330|Clinical_Directors@pcyc.com|
22300012|NCT03478891|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22300013|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu|
22300014|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22300015|NCT03843788|Rutgers, The State University of New Jersey|Dr. Adrienne Simonds|8565667190|simondad@shp.rutgers.edu|
22300016|NCT03823651|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
22300017|NCT05932290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300018|NCT03864614|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22317788|NCT03098420|University of Alabama at Birmingham|Dr. Joel Feinstein|205-934-4696|jfeinstein@uabmc.edu|
22317789|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300||
22317790|NCT05767021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22317791|NCT03575754|London Health Sciences Centre|Dr. Derek Cool|519-685-8500|derek.cool@lhsc.on.ca|54965
22317792|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
22317793|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22317794|NCT06377488|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
22317795|NCT03476707|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22317796|NCT02399254|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD|860-714-4055|RZuWalla@TrinityHealthOfNE.org|
22317797|NCT02334423|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22317798|NCT02065687|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22317799|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22317800|NCT02765802|Eiger BioPharmaceuticals, Inc|SVP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22317801|NCT03545503|New Hanover Regional Medical Center|William F. Powers, IV, MD, FACS|910-667-9232|william.powers@nhrmc.org|
22317802|NCT04494256|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22317803|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu|
22317804|NCT02483585|Amgen Inc.|Study Director|866-572-6436||
22317805|NCT01485055|Nationwide Childrens Hospital|Rajinder Bajwa|6147222000|rajinder.bajwa@nationwidechildrens.org|
22317806|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362|heiko.pohl@dartmouth.edu|5595
22317807|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520|dlamon@capstonethx.com|5206
22317808|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22317809|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22317810|NCT01000636|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|
22317811|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca|
22317812|NCT00577577|Insmed|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
22317813|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com|
22317814|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu|
22317815|NCT03294148|Weill Cornell Medicine|Dr. Yoni Ashar|(646) 962-2820|joa9188@med.cornell.edu|
22317816|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com|
22317817|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22317818|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com|
22317819|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
22317820|NCT02996474|National Heart Lung and Blood Institute|Christopher Hourigan|+1 301 451 0257|christopher.hourigan@nih.gov|
22317821|NCT02434497|AstraZeneca Plc|Robin Mukherjee|+46317761000|robin.mukherjee@astrazeneca.com|
22317822|NCT01210664|University of California San Francisco Diabetes Center|Jeffrey Bluestone, PhD|415-502-5677|jeff.bluestone@ucsf.edu|
22317823|NCT01853644|Northwestern University|Daniela Matei|312.472.4684|daniela.matei@northwestern.edu|
22317824|NCT02891837|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
22317825|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22317826|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu|
22317827|NCT04155203|Padagis|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
22317828|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu|
22317829|NCT03387137|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(410) 614-1880|swoods12@jhu.edu|
22317830|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu|
22317831|NCT02502097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317832|NCT02874924|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
22300019|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317833|NCT04609306|University of Orthopaedics|Jonathan Wright, MD|(352) 273-7001|wrightjo@ortho.ufl.edu|
22300020|NCT00443547|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22317834|NCT02808143|Northwestern University Feinberg School of Medicine|Joshua Meeks, MD, PhD|312-363-8959|Joshua.meeks@northwestern.edu|
22317835|NCT01874431|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22317836|NCT03834051|Vancouver Island Health Authority|Dr. Christine Lee|250 519 1898|christine.lee@viha.ca|
22317837|NCT03718533|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22317838|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu|
22317839|NCT02257567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22317840|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com|
22317841|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat|
22317842|NCT01590017|AMC Statistical Center|Jeannette Lee, PhD.|501-526-6712|jylee@uams.edu|
22317843|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu|
22317844|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu|
22317845|NCT02647866|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22317846|NCT02527343|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22317847|NCT04426851|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317848|NCT00568802|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
22317849|NCT03625895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22317850|NCT03256851|Wayne State University|Dr. Nora Fritz|(313) 577-1096|nora.fritz@wayne.edu|
22317851|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
22317852|NCT02081417|Department of Psychiatry and Behavioral Sciences, University of New Mexico|Annette Crisanti, PhD|505-850-7430|acrisanti@salud.unm.edu|
22317853|NCT01288521|University of Iowa|Sony Tuteja, Pharmd|215-573-7834|sony.tuteja@gmail.com|
22317854|NCT00801931|Columbia University|Prakash Satwani, MD|212-305-0223|ps2087@cumc.columbia.edu|
22317855|NCT04196101|Enanta Pharmaceuticals, Inc|Guy De La Rosa, MD Senior Director, Infectious Diseases|(617) 607-0800|gdelarosa@enanta.com|
22317856|NCT03086213|Shenzhen Third People,s Hospital|Thoracic surgical department|13823135410|daoren_000113@126.com|
22317857|NCT01502631|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22317858|NCT02939170|Alcon, A Novartis Division|Clinical Project Lead, Clinical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22317859|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317860|NCT02424734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317861|NCT01445301|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317862|NCT00752557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317863|NCT02150343|Circassia Ltd|VP Clinical Operations|+44 1865 405560|kirsten.evans@circassia.com|
22317864|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22317865|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov|
22317866|NCT04493502|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22317867|NCT02891408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22317868|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22317869|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22317870|NCT05249829|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22317871|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317872|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
22317873|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22317874|NCT02009761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317875|NCT02740374|The Ohio State University Wexner Medical Center - Department of Anesthesiology|Alberto Uribe|6142933559|alberto.uribe@osumc.edu|
22317876|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
22317877|NCT00882687|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22317878|NCT04555031|Bausch & Lomb|Study Director|5853386399|robert.steffen@bausch.com|
22317879|NCT02649946|BD/Bard|Heather Lam, Associate Project Manager, Clinical Affairs|(763) 390-8616|heather.lam@bd.com|
22317880|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
22317881|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
22317882|NCT03002753|Christoph-Dornier-Stiftung Münster|Christian Rupp, M. Sc.|00492514183440|rupp@cds-muenster.de|
22317883|NCT05924945|Masimo Corporation|Chelsea Frank|9492977000|clinicalresearchdept@masimo.com|
22317884|NCT04619251|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282746|NCT00853125|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22317885|NCT03103490|Professor of Radiology (Nuclear Medicine)|Andrei Iagaru|(650) 725-4711|aiagaru@stanford.edu|
22317886|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
22317887|NCT02008877|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22317888|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22317889|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22317890|NCT05652647|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317891|NCT05000931|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22317892|NCT05326815|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
22317893|NCT00979134|AstraZeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
22317894|NCT05172050|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22317895|NCT02909764|Monell Chemical Senses Center|Julie A. Mennella|2675194880|mennella@monell.org|
22317896|NCT06298669|Rutgers|Maya Guglin|9085968459|maya.guglin@rutgers.edu|
22317897|NCT04617275|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317898|NCT04227704|Washington University School of Medicine|Dr. David Monks|314-323-1845|dmonks@wustl.edu|
22317899|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu|
22317900|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se|
22317901|NCT01980654|Pharmacyclics|Dr. Jutta Neuenburg|408-215-3735|jneuenburg@pcyc.com|
22317902|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22317903|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22317904|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
22317905|NCT02204176|Wayne State University and Michigan State University|Dr. Phuong Vo|616-634-0566|votrucph@msu.edu|
22317906|NCT02564354|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
22317907|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22317908|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
22317909|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
22317910|NCT03405792|University of Florida|Ashley Ghiaseddin, MD|352-273-9000|ashley.ghiaseddin@neurosurgery.ufl.edu|
22317911|NCT01347762|Beth Israel Deaconess Medical Center|Kevin P. Hill, M.D., M.H.S., Principal Investigator|617 667 1597|khill1@bidmc.harvard.edu|
22317912|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com|
22317913|NCT04299438|University of Pennsylvania|Dr. Jennifer McCoy|215 662 4000|jennifer.mccoy@pennmedicine.upenn.edu|
22317914|NCT02141451|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22282747|NCT02914548|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22282748|NCT02599649|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|ggarciam@mdanderson.org|
22282749|NCT03746600|University of Kentucky College of Medicine|Carolyn Lauckner, PhD|989-928-2359|carolyn.lauckner@uky.edu|
22282750|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22282751|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
22282752|NCT02374814|SUNY Upstate Medical University|Dr. Timothy Endy|315-464-7692|endyt@upstate.edu|
22282753|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
22282754|NCT05291936|Johnson & Johnson Vision Care, Inc.|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22282755|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22282756|NCT03561701|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
22282757|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org|
22282758|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22282759|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282760|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282761|NCT05693922|University of North Carolina at Chapel Hill|Erin Bondy, PhD|919-843-7694|erin_bondy@med.unc.edu|
22282762|NCT03383757|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
22282763|NCT01722292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22282764|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com|
22282765|NCT02754141|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22282766|NCT02680041|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
22282767|NCT02324205|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
22282768|NCT04239222|Ottobock SE & Co. KGaA|Clinical Project Manager|+4955278483054|pawel.maciejasz@ottobock.com|
22282769|NCT04685707|University of Southern Mississippi|Dr. Nuno Oliveira|6012665804|nuno.oliveira@usm.edu|
22282770|NCT00937404|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282771|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22282772|NCT04863248|G1 Therapeutics, Inc|Clinical Trial Info|919-213-9835|clinicalinfo@g1therapeutics.com|
22282773|NCT01779869|Washington University School of Medicine|Pamela K. Woodard, M.D.|314-362-7130|woodardp@wustl.edu|
22282774|NCT02536300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22282775|NCT03760016|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
22282776|NCT04754230|Stanford University|Zara M. Patel, MD|650-723-5651|zmpatel@stanford.edu|
22282777|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org|
22282778|NCT01691105|Yale School of Medicine|Dr. Steven Bernstein|203-737-3574|steven.bernstein@yale.edu|
22282779|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22282780|NCT03232645|Boston Scientific|Clinical Trial Manager|00393421994999|alberto.belligoli@bsci.com|
22300021|NCT00910481|King's College London|Professor Divaka Perera|02071887188|divaka.perera@kcl.ac.uk|
22317915|NCT02729753|C2 Therapeutics|Marcia Wachna, Director of Clinical Research||marcia@c2therapeutics.com|
22317916|NCT02842827|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282781|NCT01482169|Ochsner Clinic Foundation|Dr. Robert Bober|504-842-4135|rbober@ochsner.org|
22327064|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com|
22327065|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623||
22327066|NCT03213626|IndianaU|Dr. Patrick Loehrer|(317) 278-7418|ploehrer@iu.edu|
22327067|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu|
22327068|NCT03302793|UTHealth|Dr. Sheng Li|713-797-7125|Sheng.Li@uth.tmc.edu|
22327069|NCT03566108|University of Alabama at Birmingham|Dr. Maria Geisinger, PI, Professor, Director of Advanced Education in Periodontology|205-934-4984|miagdds@uab.edu|
22327070|NCT03492463|Duke University|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
22327071|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22327072|NCT02198651|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22327073|NCT03522350|Weill Cornell Medical College|Nikica Zaninovic, PhD|212-746-5790|nizanin@med.cornell.edu|
22327074|NCT02389712|Mayo Clinic|Mark A. Frye, M.D.|507-255-7164|MFrye@mayo.edu|
22327075|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov|
22327076|NCT02922634|BWH|Dr. Gregory Crosby|617-732-7330|gcrosby@bwh.harvard.edu|
22327077|NCT02625324|Medtronic|Rianna Rapson - Clinical Study Manager|763-526.2170|rianna.k.rapson@medtronic.com|
22327078|NCT02457182|University of New Mexico|Gregg Kanter, MD|818-599-3456|greggkanter@gmail.com|
22327079|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22327080|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org|
22327081|NCT03534063|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
22327082|NCT02397694|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22327083|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351||
22327084|NCT02115113|Novartis Pharmaceuticals|Study Director|862-778-8300||
22327085|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22327086|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22282782|NCT00803517|Samsung Medical Center|Jiwon Lim|82-10-9933-5596|samnyasa@naver.com|
22282783|NCT01777542|Boston Children's Hospital|Dr. Mustafa Sahin, Director of Translational Neuroscience Center|617-919-6258|ResearchTNC@childrens.harvard.edu|
22282784|NCT02270255|McGill University Health Centre|Louis-Martin boucher|5149341934|lmboucher@yahoo.com|44454
22282785|NCT01030874|VAORD|Mark Helfand, MD|5032203406|mark.helfand@va.gov|
22282786|NCT05257148|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22282787|NCT02299570|Rebiotix|Assoc. Director of Clinical Research|651-705-8778|Sarah.Mische@Ferring.com|
22282788|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
22282789|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com|
22282790|NCT02769338|Department of Veterans Affairs|Dr. Dawn M. Bravata|317-988-2676|Dawn.Bravata2@va.gov|
22282791|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22282792|NCT03298984|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|2104147702|Susan.smith@sdponcology.com|
22282793|NCT01571284|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22282794|NCT03964246|Veterans Affairs San Diego Healthcare System|Barton W. Palmer|8582460765|bpalmer@ucsd.edu|
22282795|NCT03403231|VA Center for Clinical Management Research|Bradley Youles, Project Manager|734-845-5055|Bradley.Youles@va.gov|
22282796|NCT03883113|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
22282797|NCT00395135|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22282798|NCT02323204|University of Iowa/ University of Minnesota|Dr. Marizen R Ramirez|612-624-3143|mramirez@umn.edu|
22282799|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282800|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22282801|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
22282802|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22282803|NCT02752958|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282804|NCT02825966|ZOLL|Director, Clinical Operations|4129683333|mosz@zoll.com|
22282805|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl|
22282806|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
22282807|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov|
22282808|NCT03023826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22282809|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu|
22282810|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu|
22282811|NCT02142283|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
22282812|NCT02460783|National Institute on Aging|Dimitrios Kapogiannis|+1-202-290-0433|kapogiannisd@nih.mail.gov|
22282813|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646||
22327087|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22282814|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500|grandeto@unesc.net|2571
22327088|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu|
22317917|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
22317918|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193|Jacqueline.Vuky@vmmc.org|32246
22317919|NCT00950950|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22317920|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
22317921|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
22317922|NCT02372136|Gerber Foundation, UT Southwestern Med Ctr, Children's Medical Center|National Grant Gerber Foundation) (LPB); George L. MacGregor Professorship (CRR); National Children'|214-648-3903|luc.brion@utsouthwestern.edu|
22317923|NCT02679508|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22317924|NCT01588496|Amgen Inc.|Study Director|866-572-6436||
22317925|NCT03143166|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317926|NCT01986075|New York State Psychiatric Institute|Kenneth Carpenter, PhD|646-774-8181|kenneth.carpenter@nyspi.columbia.edu|
22317927|NCT02003573|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317928|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu|
22317929|NCT03102645|Department of Clinical Pharmacology, University Hospital Bispebjerg and Frederiksberg|Jonatan Kornholt|+4538635604|jonatan.kornholt@regionh.dk|
22317930|NCT01413087|Anchiano Therapeutics Israel Ltd.|Dr. David Kerstein|857-259-4626|david.kerstein@anchiano.com|
22317931|NCT03683823|The University of Texas at Austin|Dr. Michael Telch|512-560-4100|telch@austin.utexas.edu|
22317932|NCT03456427|GE Healthcare|Beth Heckel|1-262-312-7269|beth.heckel@med.ge.com|
22317933|NCT05026710|University of Michigan|Khurshid Ghani, MD|734-763-2797|kghani@med.umich.edu|
22317934|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu|
22317935|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317936|NCT03218397|Duke University|Vance Fowler, MD, MHS|919-613-5678|vance.fowler@duke.edu|
22317937|NCT02677428|VA Connecticut Healthcare System|Marc Rosen|203-932-5711|marc.rosen@va.go|2112
22317938|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
22317939|NCT03539887|The University of Texas Health Science Center at Houston|Rodrigo Machado-Vieira, MD, PhD, MSc|(713) 741-5000|Rodrigo.MachadoVieira@uth.tmc.edu|
22317940|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317941|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
22317942|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22317943|NCT02495792|Brooke Army Medical Center|MAJ Jamie Morris|210-221-3700|jamie.b.morris.mil@mail.mil|
22317944|NCT03519971|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22317945|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324||
22317946|NCT02545933|University of Florida|Dr. Dominick Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
22317947|NCT03149549|CytomX Therapeutics|Monika Vainorius|(650) 515-3185|clinicaltrials@cytomx.com|
22317948|NCT03141905|University of Maryland, Baltimore|Jeffrey C. Fink MD, MS (Principal Investigator)|410-328-4822|jfink@som.umaryland.edu|
22317949|NCT05180500|University of Pittsburgh|Dr. Sharon Hillier, PhD|412-641-6435|hillsl@mwri.magee.edu|
22317950|NCT02760277|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
22317951|NCT04927884|CSSIFM|Chaitali Nangia, MD Oncologist|855-797-9277|Chaitali.nangia@cssifm.org|
22317952|NCT01775124|Novartis|Study Director|862-778-8300||
22317953|NCT05917470|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
22317954|NCT02317432|Disparities Research Unit, MGH|Margarita Alegria, PI|617-724-1237|malegria@mgh.harvard.edu|
22317955|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr|
22317956|NCT03224351|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22317957|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com|
22317958|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317959|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22317960|NCT04487834|Calisia University, Kalisz, Poland|Jacek Piatek|+48883389788|drpiatek@interia.eu|
22317961|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22317962|NCT02831387|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
22317963|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22317964|NCT01828073|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22317965|NCT01592500|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22317966|NCT05220254|Stanford University|Judith Prochaska|(650) 724-3608|jpro@stanford.edu|
22317967|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590||
22317968|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317969|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22317970|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net|
22317971|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343||
22317972|NCT02080221|Brown University Oncology Research Group|Howard Safran, MD|4018633000|BrUOG@BROWN.EDU|
22317973|NCT02394951|Washington University in Saint Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
22317974|NCT04005053|University of Minnesota|Kathryn Cullen|612-273-9732|rega0026@umn.edu|
22317975|NCT03184870|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22317976|NCT05081388|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22327089|NCT03736629|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22327090|NCT02560493|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632869|amanda.staiano@pbrc.edu|
22327091|NCT02860845|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
22327092|NCT03137121|Univ Alabama Birmingham|Rudolph M Navari|574-261-8385|rmnavari@gmail.com|
22327093|NCT04410198|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-097Study@fibrogen.com|
22327094|NCT02871401|Vanderbilt University Medical Center|Jonathan Kropski MD|615-322-3412|jon.kropski@vumc.org|
22327095|NCT02282982|AbbVie|Global Medical Services|800-633-9110||
22327096|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327097|NCT02939937|assistant|dr.alireza gholizade|989112550646|a.gholizade13@yahoo.com|
22327098|NCT02152670|Yale University|Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry|(203) 974-7536|gustavo.angarita@yale.edu|
22327099|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu|
22327100|NCT02607254|Johns Hopkins University|Dr. Mohammad Khoshnoodi|410-955-5406|mkhoshn1@jhmi.edu|
22327101|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu|
22327102|NCT02343276|Instituto de Cardiologia de Santa Catarina|Roberto Léo da Silva|55 48 32719077|robertoleo@hotmail.com|
22327103|NCT02943265|University of Kansas Medical Center|Simon Lee|(913) 588-2689|slee21@kumc.edu|
22327104|NCT03623334|UT Southwestern Medical Center|Sarah Hardee|214-648-1836|sarah.hardee@utsouthwestern.edu|
22327105|NCT02179515|National Cancer Institute|Dr. James Gulley|301-480-8870|James_Gulley@nih.gov|
22327106|NCT01902953|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22282815|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org|
22327107|NCT01911845|AbbVie|Global Medical Information|800-633-9110||
22327108|NCT01774344|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22282816|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu|
22282817|NCT02170363|St. Jude Medical|Poornima Sood|+17818528334|PSood@sjm.com|
22282818|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585|Samuel.Ho2@va.gov|3280
22282819|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11|lucio.robledo@haag-streit.com|209
22282820|NCT02182440|AM-Pharma B.V.|JAcques Arend MD, DiMD, Chief Medical Officer|+31302598836|j.arend@am-pharma.com|
22282821|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22282822|NCT03754582|Eisai Co., Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22282823|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu|
22282824|NCT01561755|Icahn School of Medicine at Mount Sinai|Dr. David Simpson|212-241-8748|david.simpson@mssm.edu|
22317977|NCT03786783|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22317978|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
22317979|NCT04279392|University of Nebraska Medical Center|Laura Bilek|402-690-3524|lbilek@unmc.edu|
22317980|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317981|NCT00738582|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22317982|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22317983|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com|
22317984|NCT00893984|Minneapolis Heart Institute Foundation|Chief Medical Officer|612-863-3900|scott.sharkey@allina.com|
22317985|NCT02725801|University of Kentucky Division of Plastic Surgery|Lesley Wong|859-323-7505|lesley.wong@uky.edu|
22317986|NCT02518490|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22317987|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com|
22317988|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317989|NCT04882995|UMass Chan Medical School|Dr. Deepali Maheshwari|4137948764|deepali.mahesh@gmail.com|
22317990|NCT03587974|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
22317991|NCT03486457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22317992|NCT00372229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22317993|NCT03235284|Federal University of Bahia - FUBA|Dr.Pietro Araújo|71992520519|pietro.araujo@ufba.br|
22317995|NCT01382706|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22317996|NCT04055090|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22317997|NCT01984671|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
22317998|NCT05478499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22317999|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22318000|NCT01944371|University of California, San Francisco|Steven G. Deeks|4156064082|Steven.Deeks@ucsf.edu|404
22318001|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327109|NCT03664193|Weill Cornell Medicine|Josephine Kang|212-746-3607|jok9106@med.cornell.edu|
22327110|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu|
22327111|NCT04866303|University of Washington|Clinical Trial Manager|2066169195|cgregor2@uw.edu|
22300022|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300023|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360|susana.arias@salud.madrid.org|2459
22300024|NCT01461668|University of California Irvine|Raveena Singh|949-824-9285|ravsingh@uci.edu|
22300025|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu|
22318002|NCT02679573|Melinta Therapeutics, Inc.|Sue Cammarata|312-724-9401|scammarata@melinta.com|
22318003|NCT02476279|Division of Gastroenterology & Hepatology, Medical University of South Carolina|Dr. B. Joseph Elmunzer|8437926982|elmunzer@musc.edu|
22318004|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22318005|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu|
22318006|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318007|NCT02684851|CarolinasHS|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
22318008|NCT03451162|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22318009|NCT01952054|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
22318010|NCT01100034|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318011|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767||
22318012|NCT01831856|Institut de Recherche Pierre Fabre|Karim KEDDAD, MD, PhD Head of Medical Unit|+33 5 34 50 61 69|Karim.keddad@pierre-fabre.com|
22318013|NCT04756960|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22318014|NCT05208866|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
22318015|NCT02996565|HealthPartners Institute|Karen Margolis, MD MPH|952-967-7301|Karen.L.Margolis@HealthPartners.com|
22318016|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu|
22318017|NCT03609853|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22318018|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318019|NCT04964414|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
22318020|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22318021|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22318022|NCT01200589|Novartis Pharmaceuticals|Study Director|862-778-8300||
22318023|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu|
22318024|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22318025|NCT01590082|The University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|sppatel@mdanderson.org|
22318026|NCT02549196|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22318027|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu|
22318028|NCT05195489|NYU Langone Health|Kimberly Hoagwood, PhD|240-401-4289|Kimberly.Hoagwood@nyulangone.org|
22318029|NCT05406752|Unither-Pharmaceuticals|Non-Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22318030|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318031|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22318032|NCT01919814|Pennington Biomedical Research Center|Frank Greenway, MD|2257632578|frank.greenway@pbrc.edu|
22318033|NCT02164383|University of Wisconsin Center for Tobacco Research and Intervention|Tanya Schlam, PhD|608-262-4149|trschlam@ctri.wisc.edu|
22318034|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu|
22318035|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22318036|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com|
22318037|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu|
22318038|NCT03572478|University of Chicago|Walter STadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
22318039|NCT03057977|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318040|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
22318041|NCT01350336|Boston Scientific Corp.|G Mark Grubb|(412) 716-0717|grubbm@bsci.com|
22318042|NCT04234425|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
22318043|NCT02795429|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22318044|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu|
22318045|NCT04776148|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22318046|NCT01052103|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318047|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300026|NCT01760239|HealthPartners Institute|Elyse Kharbanda, MD MPH|952-967-5038|Elyse.O.Kharbanda@healthpartners.com|
22300027|NCT01983293|Abbott|Clay Cohorn|1 972 309 8087|clay.cohorn@abbott.com|
22300028|NCT03147248|Celltrion. Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
22300029|NCT03248739|Wake Forest University School of Medicine|Kyle Fargen|336-716-8641|kfargen@wakehealth.edu|
22300030|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org|
22300031|NCT01795833|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
22318048|NCT00211185|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22318049|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
22271507|NCT04325698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271508|NCT04253782|Yale School of Medicine|Daniel Joseph, MD|(203) 785-4404|daniel.joseph@yale.edu|
22271509|NCT01690910|St. Joseph Mercy Hospital|Amy Burghardt|734-712-2027|amy.burghardt@stjoeshealth.org|
22271510|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu|
22271511|NCT02326298|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22271512|NCT02889835|UAB School of Dentistry|Nathaniel Lawson DMD PhD|205-975-8302|nlawson@uab.edu|
22271513|NCT01834716|Mayo Clinic|Neill Graff-Radford|9049537103|graffradford.neill@mayo.edu|
22271514|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271515|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22271516|NCT02697916|Duke University; Duke Clinical Research Institute|W. Schuyler Jones, MD|919-668-8917|schuyler.jones@duke.edu|
22271517|NCT02864316|Sidney Kimmel Comprehensive Cancer Center|Patrick Forde, MBBCh|410-955-3974|pforde1@jhmi.edu|
22271518|NCT01048905|Emory University School of Medicine|Claudia R. Morris MD, FAAP|404-727-5500|claudia.r.morris@emory.edu|
22271519|NCT02607280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22271520|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271521|NCT02052596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271522|NCT02657577|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
22271523|NCT04829331|Acera Surgical|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
22271524|NCT01967641|New York State Psychiatric Institute|Dr. Maria A. Sullivan, M.D., Ph.D|646-774-6152|mas23@columbia.edu|
22271525|NCT03180515|Stanford School of Medicine|Bronte-Stewart Lab|6507236709|hbsmovlab@gmail.com|
22271526|NCT02718248|Ottawa Hospital Research Institute|Sarah MacLean|6137378899|samaclean@ohri.ca|73011
22271527|NCT04526574|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271528|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com|
22271529|NCT02554318|Medical Faculty Wijaya Kusuma Surabaya|Dr. Budhi Setiawan|+6287751644522|nehesa@gmail.com|
22271530|NCT01541839|University of Alberta|Dr. Erin Wright|780-407-7656|erin.wright@me.com|
22271531|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org|
22271532|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com|
22271533|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu|
22271534|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
22271535|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271536|NCT02669914|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovindan@wustl.edu|
22271537|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za|
22271538|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu|
22271539|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22271540|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com|
22271541|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com|
22271542|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22271543|NCT03301844|NTC srl|Alessandro Colombo|+39 02 4385 0490|alessandro.colombo@ntcpharma.com|
22271544|NCT00501059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22271545|NCT02124759|UTHSC San Antonio|Dr. Nicolas Musi|630-5001|musi@uthscsa.edu|210
22271546|NCT04250298|Medical University Graz|Dr. Camilla Drexler-Helmberg|0043316385|camilla.drexler@uniklinikum.kages.at|83066
22271547|NCT02968433|Stanford University|Dr. Helen Bronte-Stewart|650-723-6709|hbsmovlab@gmail.com|
22271548|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327112|NCT04507867|Universidad Anáhuac México Norte|Dr. Fernando Leal Martínez|+52 5521094339|ferman5@hotmail.com|
22327113|NCT01515995|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|mohamed.badawy@utsouthwestern.edu|
22327114|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com|
22327115|NCT02835677|VA Medical Center|Dr. Linda Nichols, Co-Director Caregiver Center|901 523-8990|linda.nichols@va.gov|5082
22327116|NCT04732819|Hebrew SeniorLife|Sarah Berry, MD|617-971-5355|sarahberry@hsl.harvard.edu|
22327117|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com|
22327118|NCT04019275|University of Pittsburgh|Elizabeth Skidmore|412-383-6620|skidmore@pitt.edu|
22327119|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
22327120|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org|
22327121|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu|
22327122|NCT04124536|University of North Carolina at Chapel Hill|Benjamin Chi, MD, MSc|919-445-4174|bchi@med.unc.edu|
22327123|NCT02124707|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22327124|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
22327125|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22327126|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu|
22327127|NCT04544709|University of Utah Orthopaedics Center|Heather Littell, Regulatory Coordinator|801-587-5432|u6041929@utah.edu|
22271549|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22282825|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com|
22282826|NCT01605227|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22318050|NCT03339570|Hospital Gregorio Maranon|Dr. Mikel Aburto|34915868000|mikelaburto@hotmail.com|7007
22318051|NCT03658668|NYU Langone Health|Mathew Lustberg, MA|929 445 5090|Matthew.Lustberg@nyulangone.org|
22318052|NCT03305731|University of Illinois at Chicago|Dr. Emily Kringle|312-996-9665|kringle@uic.edu|
22318053|NCT04634825|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22318054|NCT02777385|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22318055|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu|
22318056|NCT01127139|Abbott|Global Medical Services|1-800-633-9110||
22318057|NCT04578574|University of Miami|Eva Widerstrom-Noga, PhD; Roberta Vastano, PhD|305243-7125; 305243-8847|ewiderstrom-noga@med.miami.edu; Rxv331@med.miami.edu|
22318058|NCT02388646|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
22318059|NCT03881553|University of Pittsburgh School of Medicnie|Elisabeth Salisbury, PhD|412-246-5378|salisburye2@upmc.edu|
22318060|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22318061|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300||
22318062|NCT01366495|Friends Research Institute|Dr. Michael S. Gordon, Senior Research Scientist|410-837-3977|mgordon@friendsresearch.org|251
22318063|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com|
22318064|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com|
22318065|NCT03572387|Icahn School of Medicine at Mount Sinai|Vaibhav Patel, MD|212-659-5511|vaibhav.patel@mountsinai.org|
22318066|NCT02581631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22318067|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi|
22318068|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318069|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
22318070|NCT01959334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22318071|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22318072|NCT01768637|University of Arkansas for Medical Sciences|Nishank Jain, MD|5016865295|njain2@uams.edu|
22318073|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22318074|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22318075|NCT02666846|Futura Medical Developments Limited|Director of Clinical Development|01483685683|tim.holland@futuramedical.com|
22318076|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt|
22318077|NCT02684253|Memorial Sloan Kettering Cancer Center|Dr. Sean McBride, MD, MPH|646-608-2450|mcbrides@mskcc.org|
22318078|NCT03386110|Hunter College|Tyrel J. Starks|212-206-7919|tstarks@hunter.cuny.edu|
22318079|NCT02697292|Mayo Clinic|Sean J. Pittock, M.D.|507-2084-4741|Pittock.Sean@mayo.edu|
22318080|NCT01981772|The Ohio State University College of Dentistry|Sara Fowler|6142923596|fowler.276@osu.edu|
22318081|NCT03426267|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22318082|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
22318083|NCT02094755|University of Southern California|Dr. Leonardo Clavijo|3234426130|lclavijo@usc.edu|
22318084|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
22318085|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111|larrydg@earthlink.net|151
22318086|NCT02054520|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
22318087|NCT02027623|Washington University|Linda van Dillen, PT, PhD, FAPTA; Research Division Director|314-286-1427|vandillenl@wustl.edu|
22318088|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22318089|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318090|NCT03801915|National Cancer Institute|Dr. Jonathan Hernandez|240-760-6072|jonathan.hernandez@nih.gov|
22318091|NCT02308020|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
22318092|NCT03265938|Icahn School of Medicine at Mount Sinai|Dr. Samuel DeMaria|(212) 241-1518|samuel.demaria@mountsinai.org|
22318093|NCT01211288|University of Alabama at Birmingham|Dr. Toni Tien Neumeier|205-934-5459|neumeier@uab.edu|
22318094|NCT01551212|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22318095|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@mail.med.upenn.edu|152
22318096|NCT02471833|Emory University|Whitney Wharton, PhD|404-712-7359|w.wharton@emory.edu|
22318097|NCT02673515|Medical University of Graz|Assoc.-Prof.Dr. Harald Sourij|+43 316 385|norbert.tripolt@medunigraz.at|78038
22318098|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22318099|NCT02523599|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22318100|NCT01892540|University Hospitals|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22318101|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318102|NCT03110224|Zimmer Biomet|Annette Tieu|971-482-9622|annette.tieu@zimmerbiomet.com|
22318103|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com|
22318104|NCT03992846|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22327128|NCT03135028|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22300032|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
22318105|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
22318106|NCT00235547|University of Washington|Dr. Sarah Prager|415-206-8715|pragers@uw.edu|
22318107|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300||
22318108|NCT04812548|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22318109|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu|
22318110|NCT02141984|AbbVie|Global Medical Services|800-633-9110||
22318111|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com|
22318112|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
22318113|NCT01716117|Stryker Neurovascular|Scott Courts, Clinical Program Manager|5104132170|scott.courts@stryker.com|
22318114|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
22318115|NCT03645057|University of Rochester|Julie Ryan|(585) 276-3862|Julie_Ryan@URMC.Rochester.edu|
22318116|NCT04187053|University of Texas Health Science Center at Houston|Srinivas Ayilavarapu, BDS, DSc, MDS|713-486-4390|srinivas.ayilavarapu@uth.tmc.edu|
22318117|NCT02978144|Columbia University|Gebhard Wagener, MD|(212) 305-6494|gw72@cumc.columbia.edu|
22318118|NCT01171807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
22318119|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22318120|NCT04964388|UNIVERSITY OF MISSISSIPPI MEDICAL CENTER|Amy Wigglesworth|6018153164|ajwigglesworth@umc.edu|
22318121|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351||
22318122|NCT01093521|University of Washington|Christopher H. Goss, MD MSc|206-543-3166|goss@u.washington.edu|
22318123|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22318124|NCT03907410|Children's Hospital of Philadelphia|Chen Kenyon|2674266339|kenyonc@chop.edu|
22318125|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
22318126|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22318127|NCT02563522|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22318128|NCT02440451|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
22318129|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu|
22318130|NCT04874415|University of Pittsburgh|Dr. Mary Ellen Vajravelu|412-692-6533|MaryEllen.Vajravelu@pitt.edu|
22318131|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
22318132|NCT00701220|The Ohio State University|Philip F. Binkley, MD, MPH|(614) 293-3956|binkley.2@osu.edu|
22318133|NCT02700945|Medtronic|Carola Alfaro Vives|763-526-1539|carola.alfaro.vives@medtronic.com|
22318134|NCT05559099|National Institute of Allergy and Infectious Diseases|Lori Dodd|2406695247|doddl@niaid.nih.gov|
22318135|NCT04018092|University of Florida - Norman Fixel Brain Institute|Dr. Dawn Bowers|3522220100|dawnbowers@phhp.ufl.edu|
22318136|NCT06469242|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22318137|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22318138|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22318139|NCT02783768|CUIMC|Elizabeth C. Oelsner, MD, MPH|212-305-9056|eco7@cumc.columbia.edu|
22318140|NCT02208999|CEMKA|Stéphane Bouée, Medical director|331.41.87.95.25|stephane.bouee@cemka.fr|
22318141|NCT00319839|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
22318142|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012||
22318143|NCT01853137|Osama AlAli|Dr.|00963992262582|osama-alali@hotmail.com|
22318144|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22318145|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
22318146|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22318147|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu|
22318148|NCT04025580|National Institutes of Health|Rachel Sparks|240-292-4642|rachel.sparks@nih.gov|
22318149|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|250
22318150|NCT04409886|Maimonides Medical Center|Gene Sobol|718-283-6000|gsobol@maimonidesmed.org|
22318151|NCT01790126|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318152|NCT00455325|Washington University School of Medicine|Janet McGill, MD|(314) 362-8688|jmcgill@wustl.edu|
22318153|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com|
22318154|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318155|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
22318156|NCT03311334|Sumitomo Pharma America|Mimi M. Lee, MSW, CCRP|617-674-6800|mimi.lee@oncology.sumitomo-pharma.com|
22318157|NCT02745392|Zosano Pharma Corporation|Dr. Donald Kellerman|(510) 745-4004|dkellerman@zosanopharma.com|
22318158|NCT04129216|Johns Hopkins University|Dr. Mehran Habibi|4105505522|mhabibi2@jhmi.edu|
22318159|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu|
22318160|NCT02004353|Cochlear|Jasmin Kaur|+41612058238|jakaur@cochlear.com|
22318161|NCT04023110|University of Pennsylvania|Bonnie Ky, MD, MSCE|215-573-6606|bonnie.ky@pennmedicine.upenn.edu|
22318162|NCT01651442|National Jewish Health|Bryan Simmons|303-398-1850|simmonsb@njhealth.org|
22318163|NCT02481947|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22318164|NCT01007448|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
22282827|NCT01286987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282828|NCT00624819|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282829|NCT02847858|University of California San Francisco|Dr. Kathleen Tebb|415-514-0941|Kathleen.Tebb@ucsf.edu|
22282830|NCT04151628|Shockwave Medical Inc|Randee Randoll, Director Clinical Affairs|1-408-577-7856|rrandoll@shockwavemedical.com|
22318165|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318166|NCT03426605|OrphAI Therapeutics|Esther Nkrumah|2675121750|enkrumah@orphai-therapeutics.com|
22318167|NCT01886378|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22318168|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
22318169|NCT02292654|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22318170|NCT02411357|University of Vermont|Sarah H. Heil, PhD|802-656-8712|sarah.heil@uvm.edu|
22318171|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov|
22318172|NCT02858349|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
22318173|NCT04217590|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astazeneca.com|
22318174|NCT03324451|College of Nursing,Kaohsiung Medical University|Ruey-Hsia Wang|886-3-3121101|wrhsia@kmu.edu.tw|2641
22318175|NCT02232243|University of Kentucky|Peng Wang|(859) 257-4488|p.wang@uky.edu|
22318176|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318177|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22318178|NCT02457559|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22318179|NCT02412371|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22318180|NCT03169101|University of Pennsylvania|Rebecca Ashare, PhD|7168296273|rlashare@pennmedicine.upenn.edu|
22318181|NCT02641496|Veterans Affairs Palo Alto Health Care System|Lisa Kinoshita, Ph.D. (Principal Investigator)|650-493-5000|Lisa.Kinoshita@va.gov|65633
22318182|NCT02250092|University of Minnesota|Bernadette Gillick|612-626-6415|gillick@umn.edu|
22318183|NCT05590884|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 680249334|frantz.hebert@guerbet.com|
22318184|NCT04308395|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
22318185|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca|
22318186|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org|
22318187|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
22318188|NCT02673151|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|(650) 725-4711|aiagaru@stanford.edu|
22318189|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318190|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu|
22318191|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov|
22318192|NCT02482870|Recep Tayyip Erdogan University School of Medicine|Dr. Başar Erdivanlı|+904642130491|berdivanli@gmail.com|2128
22318193|NCT01620255|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22318194|NCT03794908|University of Michigan|Helen Burgess|734-615-8303|bhelen@umich.edu|
22318195|NCT02730988|Wake Forest University|Kristen Beavers|3367585855|beaverkm@wfu.edu|
22318196|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu|
22318197|NCT01873495|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
22318198|NCT04335812|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
22318199|NCT03890419|Duke University|Padma Gulur|919-681-4660|padma.gulur@duke.edu|
22318200|NCT03864146|Minneapolis VAHCS|Eric Dieperink, MD|612-467-4010|eric.dieperink@va.gov|
22318201|NCT00799513|San Raffaele Hospital IRCCS|Principal Investigator|0226437649|ferreri.andres@hsr.it|
22318202|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22318203|NCT05062759|AstraZeneca Clinical Study Information Center|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
22318204|NCT04981366|University of São Paulo|Prof. Hamilton Roschel|+55 11 30618789|hars@usp.br|
22318205|NCT04371198|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|Joan.Cahill@duke.edu|
22318206|NCT01112306|Actelion Pharmaceuticals Ltd|Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318207|NCT03214094|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22318208|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org|
22318209|NCT02579174|Northwestern University|Melissa Shauver, MPH|312-472-6024|melissa.shauver1@nm.org|
22318210|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22318211|NCT00310037|University of California, San Francisco|Lawrence D. Kaplan, MD||lkaplan@medicine.ucsf.edu|
22318212|NCT02136420|Massachusetts Eye and Ear Infirmary|Faisal Karmali|617-573-5593|faisal_karmali@meei.harvard.edu|
22318213|NCT04218084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318214|NCT05041101|The University of Texas MD Anderson Cancer Center|Sadia Saleem, MD|(281) 566-1900|ssaleem@mdanderson.org|
22318215|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22318216|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318217|NCT02832154|Wake Forest University Health Sciences|Study coordinator|336-713-5061|drlittle@wakehealth.edu|
22318218|NCT04316182|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
22318219|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22318220|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu|
22318221|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318222|NCT04040400|University of Louisville Brown Cancer Center|Shiao Woo, MD Principal Investigator|502-562-4360|shiao.woo@louisville.edu|
22318223|NCT02959450|INCMNSZ|Dr. Aurora Serralde|+52-55-54870900|aurora.serraldez@incmnsz.mx|2193
22318224|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
22318225|NCT03421431|Enanta Pharmaceuticals|Kristin Sanderson|617-607-0775|ksanderson@enanta.com|
22318226|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov|
22318227|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22318228|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
22318229|NCT04147650|Aurinia Pharmaceuticals|Clinical Trial Support|(250) 744-2487|clinicaltrials@auriniapharma.com|
22318230|NCT00235326|McMaster University|John Marshall|9055212100|marshllj@mcmaster.ca|76782
22318231|NCT01849822|California Institute of Technology|Dr. Richard Andersen|16263958336|andersen@vis.caltech.edu|
22318232|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com|
22318233|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
22318234|NCT04620811|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22318235|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com|
22318236|NCT02501538|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22318237|NCT02513303|Vascular Therapies, Inc.|Rakesh Raghubanshi|9176204369|rakesh@vasculartx.com|
22318238|NCT01691768|CAPRISA|Nonhlanhla Yende-Zuma|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
22318239|NCT03362879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22318240|NCT01809002|Axogen|Stacy Arnold, VP of Clinical Research|770-833-2570|sarnold@axogeninc.com|
22318241|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
22318242|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674||
22318243|NCT00419666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22318244|NCT01736865|Tufts Medical Center|Dr. Anastassios Pittas|617-636-5694|apittas@tuftsmedicalcenter.org|
22318245|NCT03513588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318246|NCT03333837|Wake Forest University School of Medicine|Christina Hugenschmidt, PhD|336-713-8116|chugensc@wakehealth.edu|
22318247|NCT01013285|UCLA Neuro-Oncology Program|Albert Lai|310-825-5321|albertlai@mednet.ucla.edu|
22318248|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318249|NCT02374671|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
22318250|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22318251|NCT00979810|Memorial Sloan Kettering Cancer Center|Michelle Bradbury, MD, PhD|646-888-3373|bradburm@mskcc.org|
22318252|NCT02112838|Rigel Pharmaceuticals|Sandra Tong|1-650-624-1207|stong@rigel.com|
22318253|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318254|NCT04134845|Vanderbilt University Medical Center|Dr. William Stevenson|615-322-2318|William.g.stevenson@vumc.org|
22318255|NCT03440320|Colorado State University|Dr Arlene Schmid|970-491-7562|arlene.schmid@colostate.edu|
22318256|NCT01912456|CSL Behring GmbH|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22318257|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318258|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222|ginna.laport@stanford.edu|13911
22318259|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu|
22318260|NCT00709696|University of Minnesota|Dr. Marc Mooney|612-991-6875|moon0078@umn.edu|
22318261|NCT04262947|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
22318262|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com|
22318263|NCT03077360|"University of Colorado Denver | Anschutz"|Bryan Bergman|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22318264|NCT04344600|Johns Hopkins School of Medicine|Mark Sulkowski|410-955-7538|msulkowski@jhmi.edu|
22318265|NCT00605644|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22318266|NCT00440999|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22318267|NCT03401229|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
22318268|NCT05333224|Istanbul Medeniyet University|Ayca Evkaya Acar|+905544263263|ayca.evkaya@gmail.com|
22318269|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22318270|NCT00959166|Imperial College London|Prof Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22318271|NCT01776424|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22318272|NCT02955147|Mass General Hospital|Dr. Sebastian Unizony|(617) 726-7938|sunizony@mgh.harvard.edu|
22318273|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22318274|NCT02294227|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
22318275|NCT00887432|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22318276|NCT00899548|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Antonio C. Wolff, M.D.|410-614-4192|awolff@jhmi.edu|
22318277|NCT00551460|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22318278|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu|
22318279|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu|
22327129|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
22327130|NCT02065869|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384 1100|clinicaltrials@bellicum.com|
22327131|NCT01842620|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327132|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280|brkovic73@yahoo.com|244
22327133|NCT02322320|The Emmes Company|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22327134|NCT03136185|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327135|NCT02876055|Mayo Clinic|Dr. Jason K. Panchamia|507-284-9698|panchamia.jason@mayo.edu|
22318280|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889||
22318281|NCT02464033|Linkoeping University|Johnny Ludvigsson, MD, PhD, Prof Linkoeping University|+46 13 28 68 54|Johnny.Ludvigsson@liu.se|
22318282|NCT06172881|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
22318283|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22318284|NCT02112708|Institut Català de la Salut|Principal Investigator: Carme Rovira Aler|+34686838979|crovira.bcn.ics@gencat.cat|
22318285|NCT00953745|Washington University School of Medicine|Dr. Charles R. Conway, MD|314-362-7566|conwayc@psychiatry.wustl.edu|
22318286|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653||
22318287|NCT03063125|University of Kansas Medical Center|Katie Glavin|913-588-8721|kglavin@kumc.edu|
22318288|NCT01427595|University of Virginia Center for Research in Reproduction|Dr. Christine Burt Solorzano|4342436911|pcos@virginia.edu|
22318289|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37||
22318290|NCT03866473|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22318291|NCT03110185|Washington University School of Medicine Department of Anesthesiology|Dr. Ben Palanca|314-273-9076|palancab@wustl.edu|
22318292|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300||
22318293|NCT02053792|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22318294|NCT03075410|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300033|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com|
22318295|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22327136|NCT05118386|Gates Medical Research Institute|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22327137|NCT00894413|Johns Hopkins University School of Medicine|Zubair Khan, MD|410-955-3157|zkhan@jhmi.edu|
22327138|NCT04019093|University of Florida|Jeff Boissoneault, PhD|352-273-6147|jboissoneault@phhp.ufl.edu|
22327139|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu|
22327140|NCT01067508|UCLA Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
22327141|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
22327142|NCT02635737|UHSM|Mr James Harvey|01612914436|james.harvey@uhsm.nhs.uk|
22327143|NCT01552928|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327144|NCT04030104|Seno Medical Instruments, Inc.|Vice President of Clinical Operations|210-615-6501|sschaeffer@senomedical.com|
22327145|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com|
22327146|NCT02065622|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22327147|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com|
22327148|NCT02366663|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
22327149|NCT04973228|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22327150|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
22327151|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu|
22327152|NCT00296725|New York State Psychiatric Institute|Jonathan W. Stewart, M.D., Principle Investigator|646-774-8070|jws6@cumc.columbia.edu|
22327153|NCT00074724|MedStar Health Research Institute|Scientific Center Administrator|301-560-7300|Research@medstar.net|
22327154|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il|
22327155|NCT04863417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327156|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov|
22327157|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
22327158|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com|
22327159|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu|
22327160|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov|
22327161|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22327162|NCT03303040|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
22327163|NCT03006471|INSITITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22327164|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu|
22327165|NCT05254613|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22327166|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org|
22327167|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22327168|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22327169|NCT02370498|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327170|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988|xinxianliang@hotmail.com|1370
22327171|NCT02387372|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327172|NCT01576016|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
22327173|NCT03546413|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22327174|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22327175|NCT02504268|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22327176|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
22327177|NCT01094717|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465|Kristina.Duffin@hsc.utah.edu|
22327178|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
22327179|NCT00503880|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
22327180|NCT03198754|Icahn School of Medicine at Mount Sinai|Heiðdís B. Valdimarsdottir|(212) 659-5678|heiddis.valdimarsdottir@mssm.edu|
22327181|NCT03247413|Johns Hopkins University School of Medicine|Akhil Chhatre|443-997-5476|achhatr1@jh.edu|
22327182|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300||
22327183|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu|
22327184|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org|
22327185|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327186|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327187|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22327188|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22327189|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
22327190|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
22327191|NCT02569411|St. Michael's Hospital|Dr. Areti Angeliki Veroniki|416-360-4000|averonik@cc.uoi.gr|
22327192|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org|
22327193|NCT01962714|VA Puget Sound Health Care System|David Kearney, MD|206-277-1445|david.kearney@va.gov|
22327194|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org|
22327195|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov|
22327196|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22327197|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu|
22327198|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu|
22327199|NCT02991937|NYU Langone Health|Jason Fisher, MD|212-263-7391|Jason.Fisher@nyulangone.org|
22327200|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327201|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com|
22327202|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327203|NCT02662985|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22327204|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327205|NCT01486784|Abramson Cancer Center at the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
22327206|NCT03491553|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22327207|NCT03633227|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
22327208|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22327209|NCT04836455|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
22327210|NCT03976531|Institut Bergonié|Pr S Mathoulin-Pélissier|33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22327211|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22327212|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com|
22327213|NCT01606761|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22327214|NCT04237207|Advanced Bionics, LLC|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
22327215|NCT04357379|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
22327216|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com|
22327217|NCT03073213|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22327218|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
22282831|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22282832|NCT04899440|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22327219|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org|
22300034|NCT00856856|Abbott Vascular International BVBA|Susan Veldhof|31653428610|susan.veldhof@av.abbott.com|
22300035|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu|
22327220|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br|
22327221|NCT03209440|University of Florida|Dr. Diana Wilkie|352-273-6401|diwilkie@ufl.edu|
22327222|NCT03379506|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327223|NCT05283863|Case Western Reserve University|Jennifer Sweet, MD|216-844-3192|Jennifer.Sweet@UHhospitals.org|
22327224|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
22327225|NCT03162055|AstraZeneca|Vice President, Inhalation and Oral Respiratory|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22327226|NCT04031404|University of North Carolina at Chapel Hill|Rachel B. Force, PhD|9199669929|rachel_force@med.unc.edu|
22327227|NCT02581865|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22327228|NCT01993615|Madigan Army Medical Center|Daniel Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
22327229|NCT02621619|Albany Medical Center|Dr. Andrew Chang|518-262-0042|changa1@amc.edu|
22327230|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl|
22327231|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22327232|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu|
22327233|NCT01354353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22327234|NCT05674344|Masimo Corporation|Chelsea Frank|(949) 297-7000|clinicalresearchdept@masimo.com|
22327235|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org|
22327236|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org|
22327237|NCT02156492|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22327238|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
22327239|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu|
22327240|NCT02600325|Erasmus MC|Dr. B. J. A. Rijnders|0|b.rijnders@erasmusmc.nl|
22327241|NCT03225716|DFCI|Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22327242|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu|
22327243|NCT02883049|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22327244|NCT03421964|Virginia Commonwealth University|Nancy Hsu, PsyD, PI|804-327-1166|nancy.hsu@vcuhealth.org|
22327245|NCT02581111|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@neuro.wustl.edu|
22327246|NCT03654755|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
22327247|NCT01277341|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22327248|NCT05373706|University of Washington|Dr. Anne Fairlie|(206) 221-5896|afairlie@uw.edu|
22327249|NCT05086289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22327250|NCT03150108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327251|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu|
22300036|NCT03073603|University of Colorado School of Medicine|John R. Corboy, MD|13037242187|john.corboy@cuanschutz.edu|
22300037|NCT02473952|Grifols Therapeutics, LLC|Rhonda Griffin, BSN|919-316-6693|Rhonda.Griffin@Grifols.com|
22300038|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de|
22300039|NCT04757649|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
22300040|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com|
22300041|NCT03750487|Partnership to End Addiction|Sarah Dauber, Vice President|212-841-5270|sdauber@toendaddiction.org|
22318296|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
22318297|NCT01321151|UT Southwestern Medical Center|Megan Marks, Ph.D.|214-648-0882|megan.marks@utsouthwestern.edu|
22318298|NCT03801473|Sultan Abdulhamid Han Training and Research Hospital|Tugba Ozsoy|+902165422020|tugbaozsoyy@gmail.com|3876
22318299|NCT02775695|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-805-9720|stsai@mcw.edu|
22318300|NCT04546789|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22327252|NCT03628508|The Hong Kong Polytechnic University|Dr Amy Fu|8522766 6726|amy.fu@polyu.edu.hk|
22318301|NCT03430206|Stanford University|Thomas Caruso, MD, MEd|(626) 275-0341|tjcaruso@stanford.edu|
22318302|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623||
22318303|NCT04877730|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
22318304|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200||
22318305|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
22318306|NCT04443153|UVA Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
22318307|NCT04118374|Vanderbilt University Medical Center|Justin M Gregory, MD, MSCI|(615) 322- 7427|metabolism@vumc.org|
22318308|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com|
22318309|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012||
22318310|NCT04737187|Taiho Oncology, Inc.|Taiho|+1-844-878-2446|medicalinformation@taihooncology.com|
22318311|NCT05227703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22318312|NCT05849103|Vanderbilt University Medical Center|Sarah Osmundson, MD, MS|6158752231|sarah.osmundson@vumc.org|
22318313|NCT03373201|Vanda Pharmaceuticals|Medical Director|202-734-3400|clinicaltrials@vandapharma.com|
22318314|NCT03464097|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22318315|NCT03035201|Wake Forest University School of Medicine|Mark Espeland, PhD; Multiple Principal Investigator|336-716-2826|mespelan@wakehealth.edu|
22318316|NCT02390050|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22318317|NCT01522469|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22318318|NCT03727438|Department of Veteran Affairs ADAPT|Jennifer Zervakis|919 286-0411|jennifer.zervakis@va.gov|17 6174
22318319|NCT06729606|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
22318320|NCT04849507|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
22318322|NCT02491632|UT MD Anderson Cancer Center|Sriram Yennu,MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22318323|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov|
22318324|NCT03660553|The Lundquist Research Institute|Rajesh Garg|310-222-1968|rajesh.garg@lundquist.org|
22318325|NCT00231153|Cadence Pharmaceuticals, Inc.|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|858-436-1439|chardalo@cadencepharm.com|
22318326|NCT04109196|Rush University Medical Center|Dr. Philip Held|312-942-1423|philip_held@rush.edu|
22318327|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213||
22318328|NCT03938545|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22318329|NCT00355056|St. Jude Medical|Director, Global Clinical Affairs|818-493-3648|aoza@sjm.com|
22318330|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411|corrine.voils@va.gov|5196
22318331|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com|
22318332|NCT02647320|Daiichi Sankyo|Daiichi Sankyo Contact for Clinical Trial Information|+81-3-6225-1111(M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
22318333|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525|cbeysen@kinemed.com|123
22318334|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu|
22318335|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com|
22318336|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22318337|NCT02268474|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22318338|NCT03435497|RAND Corporation|Laura Bogart, PhD|3103930411|lbogart@rand.org|7281
22318339|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
22318340|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318341|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22318342|NCT03719170|VA Ann Arbor Healthcare System|Dr. Sameer Saini|734-845-3504|sameer.saini@va.gov|
22318343|NCT04281004|University of Utah|Mark Mifflin, MD|801-583-4152|mark.mifflin@hsc.utah.edu|
22327253|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
22327254|NCT03238235|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
22327255|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu|
22327256|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
22327257|NCT00243230|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327258|NCT02742077|Corindus, Inc.|Clinical Research Manager|(757) 910-4818|tina.ridgeway@corindus.com|
22327259|NCT03011840|Tata Memorial Hospital, Mumbai|Dr. Sumitra Bakshi|+912224177058|sumitrabakshi@yahoo.com|
22327260|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22327261|NCT00321100|Fox Chase Cancer Center|Dr. Steven Cohen|215-214-1676|steven.cohen@fccc.edu|
22327262|NCT03201198|University of Michigan School of Nursing|Dr. Janet Larson|7346470126|janetlar@med.umich.edu|
22327263|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22327264|NCT04715230|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
22327265|NCT03645408|Boston Medical Center/Boston University School of Medicine|Dr. Eric Devine|617-414-1990|eric.devine@bmc.org|
22327266|NCT00654511|Children's National Medical Center|Julia Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
22327267|NCT02596711|UT MD Anderson Cancer Center|Dr. Marcel A. de Dios / Health Disparities Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22327268|NCT00586924|MedImmune, LLC|Nai Shun Yao, MD|1-301-398-5936|information.center@astrazenea.com|
22327269|NCT03185455|UPenn|Dr. Adi Hirshberg|917-553-9643|adi.hirshberg@uphs.upenn.edu|
22327270|NCT01767194|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22327271|NCT02223455|CADRE - Iowa City VAHCS|Heather Reisinger|319-338-0581|heather.reisinger@va.gov|7715
22327272|NCT04191577|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
22327273|NCT06704178|Citruslabs|Patrick Renner|+1 805-876-4484|hello@citruslabs.com|
22327274|NCT00500045|Palo Alto Medical Foundation|Renee Kaneshiro|650-853-4744|kaneshr@pamf.org|
22327275|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22282833|NCT02210221|UZA|Prof. Em. Dr Andrew Maas|0032 3 821 45 37|andrew.maas@uza.be|
22282834|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com|
22282835|NCT01550341|Yale University|Dr. Frederick Altice, Principal Investigator|203-737-2883|frederick.altice@yale.edu|
22282836|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22282837|NCT03271047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282838|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22282839|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22282840|NCT02649855|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|madanr@mail.nih.gov|
22282841|NCT03058666|Ony Biotech|James Cummings, MD|7166369096|jcummings@onybiotech.com|
22282842|NCT05434013|BU School of Public Health|Jennifer Ross, PhD|617 358 1905|jjross@bu.edu|
22282843|NCT02384434|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22282844|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org|
22282845|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
22282846|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22282847|NCT04195438|University of Maryland School of Medicine|Dr. Cherif Boutros (Surgical Oncologist)|410-328-7320|cboutros@som.umaryland.edu|
22282848|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu|
22282849|NCT01156389|Shin Poong Pharmaceutical Co., Ltd.|Jangsik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
22282850|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22282851|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282852|NCT00328653|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
22282853|NCT01893372|The Universtiy of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
22282854|NCT04081961|Kazakhstan Academy of Preventive Medicine|Baurzhan Zhussupov|87774822171|baurzhan.zhussupov@gmail.com|
22282855|NCT01752400|Massachusetts General Hospital|Alice Shaw, MD, PhD|617-724-4000|ashaw1@mgh.harvard.edu|
22327276|NCT00659724|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22327277|NCT01927744|M.D. Anderson Cancer Center|Xiuning Le, MD|713-792-6363|xle1@mdanderson.org|
22327278|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu|
22327279|NCT03713957|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22327280|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu|
22327281|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327282|NCT03235817|Anesthesiology|T. Wesley Templeton, MD|336-716-4498|ttemplet@wakehealth.edu|
22327283|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36|hanouz-jl@chu-caen.fr|33
22327284|NCT00485589|F. Hoffmann-La Roche AG|Medical Communications|41 616878333|global.trial_information@roche.com|
22327285|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov|
22327286|NCT05340322|Duke University|Nimmi Ramanujam, PhD|9196605307|nimmi@duke.edu|
22327287|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351||
22327288|NCT04017442|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
22327289|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22327290|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282856|NCT05740332|Medline Industries LP|Director Clinical Operations|630-418-6891|jamiller@medline.com|
22327291|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk|
22327292|NCT02226146|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22282857|NCT03630198|Vanderbilt Univeristy Medical center|Dr. Brian Drolet|615-322-2918|brian.c.drolet@vumc.org|
22282858|NCT02279719|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
22282859|NCT04706273|W. L. Gore & Associates|Eric Novak|314-440-2110|enovak@wlgore.com|
22282860|NCT03541187|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22318344|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com|
22318345|NCT02245672|Mylan Pharma UK Ltd|Dik Ng, PhD|+44-7467-941703|dik.ng@mylan.co.uk|
22318346|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org|
22318347|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22318348|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22318349|NCT04878731|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318350|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22318351|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu|
22318352|NCT02382016|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22318353|NCT01535014|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22318354|NCT00730171|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
22318355|NCT01729156|Department of Nuclear Medicine & PET Centre, Aarhus University Hospital|Lars C. Gormsen, Consultant|004578456260|lars.christian.gormsen@clin.au.dk|
22318356|NCT03607539|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22318357|NCT01256658|Novartis|Study Director|41 61 324 1111||
22318358|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu|
22318359|NCT02047643|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
22318360|NCT04256603|MetroHealth|c. kim|216 778 7800|ckim3@metrohealth.com|
22318361|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com|
22318362|NCT04363801|Leap Therapeutics, Inc.|Douglas Onsi / President and CEO|617-218-1116|donsi@leaptx.com|
22318363|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu|
22318364|NCT02113241|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22318365|NCT02901041|Boston University|Dr. Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
22318366|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22318367|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22318368|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318369|NCT03249714|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318370|NCT03818204|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
22318371|NCT01996813|Loyola University Medical Center|Douglas Evans, M.D.|708-216-2523|devans@lumc.edu|
22318372|NCT00887250|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22318373|NCT05754333|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22318374|NCT00879762|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
22318375|NCT03008707|University of Pusa|Dario Tartaglia|+393334491229|dario261184@gmail.com|
22318376|NCT04754477|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22318377|NCT02791945|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22318378|NCT02427464|Helixmith Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22318379|NCT04016558|University of California, San Francisco|Danielle Hessler|415-476-6196|danielle.hessler@ucsf.edu|
22318380|NCT02572843|Swiss Cancer Institute|Regulatory Affairs|+41 31 389 91 91|regulatory@swisscancerinstitute.ch|
22318381|NCT03756129|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318382|NCT04469270|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22318383|NCT03432260|DURECT Corporation|Director of Regulatory Affairs|408-777-1418|jill.burns@durect.com|
22318384|NCT04763421|Ethicon Endo-Surgery|Senior Director of Clinical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318385|NCT02186847|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22318386|NCT05328167|Thomas Jefferson University|Dr. John Eisenbrey, Associate Professor|215-503-5188|john.eisenbrey@jefferson.edu|
22318387|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu|
22318388|NCT01307579|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22318389|NCT05370521|Spruce Biosciences|Chief Medical Officer|415-655-4169|clinicaltrials@sprucebio.com|
22318390|NCT03170349|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22318391|NCT05929339|Wake Forest University School of Medicine|James C. Eisenach, MD|336716-4182|jimeisenach@gmail.com|
22318392|NCT02101034|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
22318393|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com|
22318394|NCT01614197|Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)|Roy Leong|323-361-5132|rleong@chla.usc.edu|
22318395|NCT05779397|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22327293|NCT05464836|MD Anderson Cancer Center|Miriam Garcia, DO|(713) 745-4312|mbgarcia@mdanderson.org|
22327294|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org|
22327295|NCT03575884|Seattle Children's Research Institute|Jason Mendoza, MD, MPH|206.884.1261|Jay.Mendoza@seattlechildrens.org|
22327296|NCT02938585|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22327297|NCT03075176|University of Utah John A. Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
22327298|NCT01850745|Liver Section. Hospital del Mar|Professor Ricard Sola|0034932483200|35783@parcdesalutmar.cat|
22327299|NCT02106455|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22327300|NCT00213980|University of Wisconsin Carbone Cancer Center|Dr. Daniel Mulkerin|608-265-8090|dm2@medicine.wisc.edu|
22327301|NCT03607838|Seikagaku Corporation|General Manager, Clinical Development Department|(81)3-5220-8593|reply@seikagaku.co.jp|
22300042|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org|
22300043|NCT02508311|James J Peters VA Medical Center|Gregory Schilero|7185849000|gregory.schilero@va.gov|6701
22327302|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22327303|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu|
22327304|NCT00798694|Wills Eye Hospital|Principal Investigator|215-928-3197|ljaykatz@gmail.com|
22327305|NCT03709810|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327306|NCT05117229|Mayo Clinic|Rafael J. Sierra, M.D.|507-284-2226|Sierra.Rafael@mayo.edu|
22327307|NCT03364608|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
22327308|NCT02351258|Johns Hopkins University|Dr. Aaron Milstone|443-287-8932|amilsto1@jhmi.edu|
22327309|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327310|NCT02665364|Neovacs|Head of Regulatory Affairs|+33153109300|info@neovacs.com|
22327311|NCT03888391|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22327312|NCT00439673|GIMEMA|Alfonso Piciocchi|+39 06.70390521|a.piciocchi@gimema.it|
22327313|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com|
22327314|NCT03025217|Massachusetts General Hospital|Dr. Michelle Dossett|617-643-6034|mdossett@mgh.harvard.edu|
22327315|NCT00838006|Central Arkansas Veterans Healthcare System|Jeff Pyne, MD|501-257-1083|jeffrey.pyne@va.gov|
22327316|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com|
22327317|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327318|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu|
22327319|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu|
22327320|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22327321|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu|
22327322|NCT01952730|Massachusetts General Hospital|Cristina R. Ferrone, MD|617-643-6189|CFERRONE@PARTNERS.ORG|
22327323|NCT02076321|University of Missouri, Department of Orthopaedics|Dr. Daniel Hoernschemeyer|(573)882-1351|hoernschemeyerd@health.missouri.edu|
22327324|NCT01785810|Abramson Cancer Center|Michael Gardo|215-615-2232|michael.gardo@uphs.upenn.edu|
22300044|NCT04862143|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22300045|NCT04955639|Pivot Health Technologies Inc.|Craig Fujii, Sr. Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
22318396|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300||
22318397|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
22318398|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318399|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca|
22318400|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315|hwroblew@iupui.edu|306
22318401|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de|
22318402|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu|
22318403|NCT03290196|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
22318404|NCT06336603|Regulatory Affairs|Head|9122 66455645|Clinical.Trial@sunpharma.com|
22318405|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu|
22318406|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu|
22318407|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org|
22318408|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828||
22318409|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu|
22318410|NCT01990209|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22318411|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
22318412|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22318413|NCT01222273|Children's Hospital of Pittsburgh of UPMC|Joseph M. Pilewski, MD|(412) 692-2164|pilewskijm@upmc.edu|
22318414|NCT02699983|Rutgers Robert Wood Johnson Medical School|Jeanne Ferrante|848-932-5252|jeanne.ferrante@rutgers.edu|
22318415|NCT03575143|University of California San Diego|Robert L. Owens, MD|8586575258|rowens@health.ucsd.edu|
22327325|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu|
22327326|NCT04895605|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22327327|NCT03615469|Indiana University|Dr. Christine Haedtke|317-274-5358|chaedtke@iu.edu|
22327328|NCT01514188|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22327329|NCT03442829|Bournemouth University|Prof. Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
22327330|NCT02724774|University of Washington|Carol Rhodes, Director of Sponsored Programs|206 543-2139|carhodes@uw.edu|
22327331|NCT02605447|Boston Scientific Corp.|Peter Maurer, Director Clinical Trials|+1 (508) 683|Peter.Maurer@bsci.com|6678
22327332|NCT02237157|RenovoRx|Charles Li|(650) 284-4433|charles@renovorx.com|
22327333|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327334|NCT04533815|University of Alabama|Dr. Lynn Snow|205-201-0312|LSNOW@ua.edu|
22327335|NCT02045212|Regenera Pharma Ltd|Dr Konstantin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
22327336|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
22327337|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22327338|NCT05836818|University of California San Francisco|Robert Rodriguez|925-457-2145|robert.rodriguez@ucsf.edu|
22327339|NCT03738566|Mayo Clinic|Dr. Jeffrey A. Alexander|507-538-0474|Alexander.Jeffrey14@mayo.edu|
22327340|NCT03992768|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
22327341|NCT04539249|Federal Medical Centre, Yenagoa|Dr. Olakunle I. Makinde|08032136315|olakunleife@gmail.com|
22327342|NCT00218036|The University of Texas Health Science Center at Houston|Joy M Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22327343|NCT03126539|Johns Hopkins University|Dr. Anna Chien|410-502-7546|CTReP@jhmi.edu|
22327344|NCT01627067|UT MD Anderson Cancer Center|Dr. Vicente Valero, MD/ Professor, Breast Medical Oncology|713- 563-0751|vvalero@mdanderson.org|
22327345|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
22327346|NCT02410707|Einstein Healthcare Network|Joseph Herres, DO, Director of Research|215-456-6666|herresjo@einstein.edu|
22327347|NCT01331239|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22327348|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327349|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327350|NCT02112994|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22327351|NCT04211155|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
22327352|NCT01274338|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22327353|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22327354|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu|
22327355|NCT03508661|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
22327356|NCT02924688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327357|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327358|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com|
22327359|NCT03457103|NYU Langone|Dr. Anna Norweg|646-501-7777|AnnaMaria.Norweg@nyulangone.org|
22327360|NCT03004469|Polichem S.A.|Francesco Scarci|+41 091 9864 005|francesco.scarci@almirall.com|
22327361|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22327362|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com|
22327363|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
22327364|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22327365|NCT03934710|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22327366|NCT02130427|University of Pennsylvania|Dr. Wei Zou|800-789-7366|Wei.Zou@pennmedicine.upenn.edu|
22327367|NCT03150095|Mayo Clinic|Dr. Cassie Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
22327368|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk|
22327369|NCT04032171|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22327370|NCT04570332|Highlight Therapeutics Ltd.|M. Quintero, CEO|+34686219355|mquintero@highlighttherapeutics.com|
22327371|NCT03822871|Cancer Targeted Technology|Dr. Beatrice Langton-Webster, CEO|(206) 617-0699|bealw@cancertargetedtechnology.com|
22327372|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590||
22327373|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com|
22327374|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327375|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
22327376|NCT03337152|PATH|Gonzalo Domingo|206-285-3500|gdomingo@path.org|
22327377|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu|
22327378|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271550|NCT03325894|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327379|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327380|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu|
22318416|NCT02566265|Yale University School of Medicine|Andrew Branagan, MD|617-459-5234|andrew.branagan@yale.edu|
22318417|NCT01259726|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22318418|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
22318419|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318420|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318421|NCT02145247|UCSDMED|R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
22318422|NCT04781387|Crestone, Inc.|Vice President, Clinical Development|(609) 900-5733|lboccumini@crestonepharma.com|
22318423|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318424|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22318425|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu|
22318426|NCT03463161|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
22318427|NCT05007808|Buzzz Pharmaceuticals Limited|Deirdre O'Keefe, PhD, Head of IP and Portfolio Management|+447733104786|deirdre@hotmail.co.uk|
22318428|NCT02318797|University of Pittsburgh Department of Psychiatry|Charles Reynolds, MD|412-246-6414|reynoldscf@upmc.edu|
22318429|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu|
22318430|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
22318431|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
22318432|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743||
22318433|NCT00940108|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22318434|NCT01740323|Emory University|Andrew Miller, MD|404-727-8260|amill02@emory.edu|
22318435|NCT06338462|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
22318436|NCT00928447|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
22318437|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu|
22318438|NCT03581825|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22318439|NCT02953860|University of Colorado|Professor Anthony Elias|720-848-0347|anthony.elias@cuanschutz.edu|
22318440|NCT00585195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318441|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com|
22318442|NCT02739360|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22318443|NCT02533570|Seattle Genetics, Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22318444|NCT03995667|Oregon Health & Science University|Dr. Timur Mitin, MD, PhD|503-494-8756|mitin@ohsu.edu|
22318445|NCT01163916|Abbott|Global Medical Services|800-633-9110||
22318446|NCT00529958|University of Calgary Sport Medicine Centre|ACL RCT Research Coordinator|403-220-8944|aclstudy@ucalgary.ca|
22318447|NCT02337751|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22318448|NCT01340651|Incyte Corporation|Study Director|855 463-3463||
22318449|NCT01315353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22318450|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22318451|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318452|NCT05572021|Atrium Health|Greg Scarola, MS, MBA|704-355-5766|Gregory.Scarola@advocatehealth.org|
22318453|NCT03319849|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22318454|NCT03143816|Barbara Davis Center for Diabetes, University of Colorado|Satish Garg MD|3037246713|satish.garg@ucdenver.edu|
22318455|NCT03045068|The University of Texas Health Science Center at Houston|Nischal K Gautam, MD|713-500-6200|Nischal.K.Gautam@uth.tmc.edu|
22318456|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com|
22318457|NCT02871258|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22300046|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22318458|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov|
22318459|NCT04873232|Helixmith, Co., LTD|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22318460|NCT05677893|Oneness Biotech Co., Ltd.|Director of Clinical Research|+886-2-2703-1098|Jessica.Ho@onenessbio.com.tw|
22318461|NCT03217266|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22318462|NCT01709747|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
22318463|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
22318464|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu|
22318465|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000|arnold.seto@va.gov|5486
22318466|NCT03836989|Oregon Health and Science University|Dr. Myriam Loyo|503-494-8510|loyo@ohsu.edu|
22318467|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu|
22318468|NCT03442985|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22318469|NCT03330457|Portola Pharmaceuticals|Head of Clinical Development|650-246-7000|ClinicalTrials@Portola.com|
22318470|NCT02598557|UT MD Anderson Cancer Center|Parijatham S. Thomas, MD., Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
22327381|NCT02932332|UT MD Anderson Cancer Center|David Hui, MD, Associate Professor/Palliative Care Med|713-792-6258|dhui@mdanderson.org|
22327382|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22327383|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
22327384|NCT01875367|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22327385|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6|vthomas@mrc.gm|2204
22327386|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com|
22327387|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
22327388|NCT02951988|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22327389|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org|
22327390|NCT00626912|Centre de Recherches du Centre Hospitalier de l'Université de Montréal|Ruby Klink, coordinator|(514) 890 8000|ruby.klink@crchum.qc.ca|25245
22327391|NCT04570657|AstraZeneca AB|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22327392|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22282861|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es|
22282862|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu|
22282863|NCT03199053|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22282864|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com|
22327393|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327394|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000|yesavage@stanford.edu|x64330
22327395|NCT04167306|Addiction BIology Unit - Clinical Trials, Inst Neuroecience and Physiology, Gotheburg University/ Dep of Addictions and Dependency, Sahlgrenska University Hostpital|Andrea de Bejczy|+46313424724|andrea.debejczy@neuro.gu.se|
22327396|NCT03731364|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
22327397|NCT04387136|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
22327398|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu|
22327399|NCT02358369|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22327400|NCT03655717|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@mgh.harvard.edu|
22327401|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com|
22327402|NCT01973452|Memorial Sloan Kettering Cancer Center|Dr. Alessia Pedoto, MD|212-639-6840|pedotoa@mskcc.org|
22327403|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327404|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22327405|NCT00115765|Amgen Inc.|Study Director|866-572-6436||
22327406|NCT03019744|Fondazione Don Carlo Gnocchi|Dr Maurizio Ferrarin|+390240308305|mferrarin@dongnocchi.it|
22327407|NCT01683071|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22327408|NCT03707158|Boston University|Donna Pincus|(617) 353-9610|dpincus@bu.edu|
22327409|NCT04614545|The Cleveland Clinic Foundation|Dr. Marcio Griebeler|216.444.6568|jenkink@ccf.org|
22327410|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se|
22327411|NCT01968187|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
22327412|NCT00430521|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327413|NCT02586233|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22327414|NCT02373241|University of Alabama at Birmingham|Jeffrey Lebensbugrer|2056389285|jlebensburger@uabmc.edu|
22327415|NCT01708941|ECOG-ACRIN Statistical Office|Study Statistician|(617) 632-3012|eatrials@jimmy.harvard.edu|
22327416|NCT01397552|Upstate Medical University|William Lavelle|315-464-4472|lavellew@upstate.edu|
22327417|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com|
22327418|NCT04247815|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
22327419|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com|
22327420|NCT02108600|University of California, San Francisco|Sindhu Chandran|4153538374|sindhu.chandran@ucsf.edu|
22327421|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
22327422|NCT01295580|Bioventus, LLC|Director, Regulatory and Clinical Affairs|1-800-396-4325||
22327423|NCT03943953|Oxford University Hospitals NHS Foundation Trust|Dr Matthew Hotton|01865 234714|matthew.hotton@ouh.nhs.uk|
22327424|NCT01742078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22327425|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es|
22282865|NCT03263923|Case Western Reserve University|Dr. Carol M. Musil|216-368-2545|cmm4@case.edu|
22282866|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22282867|NCT01924442|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-724-2798|Frederic.Grover@ucdenver.edu|
22282868|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu|
22282869|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com|
22282870|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282871|NCT02115750|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
22282872|NCT03305081|TulaneU|Resident of OB/GYN|858-499-2702|sjunya@tulane.edu|
22282873|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com|
22318471|NCT02864381|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22318472|NCT02986334|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
22318473|NCT04142450|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22318474|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
22318475|NCT05398016|University of Nevada Las Vegas|Dr. Brenna Renn, PI|7028950569|brenna.renn@unlv.edu|
22318476|NCT00667355|Abbott|Global Medical Services|1-800-633-9110||
22318477|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318478|NCT00795951|Rady Children's Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700|leichenfield@rchsd.org|4825
22318479|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu|
22318480|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22318481|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318482|NCT05093699|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
22318483|NCT05103228|Dunamenti REK IVF Center (former Kaali Institute)|Dr Peter Kovacs|+3612022802|peterkovacs1970@hotmail.com|
22318484|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318485|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22318486|NCT02768870|Edwards Lifesciences, LLC|Sabrina Hundt, Director, Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22318487|NCT02963610|Fox Chase Cancer Center|Hossein Borghaei, DO, MS|215-214-4297|Hossein.Borghaei@fccc.edu|
22318488|NCT02203695|Johns Hopkins University, School of Medicine|Dr. Daniel Song|410-502-5875|dsong2@jh.edu|
22318489|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318490|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov|
22318491|NCT01580969|Huntsman Cancer Institute|Josiah Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
22318492|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22318493|NCT02019927|Will Eye Hopsital|Ann Murchison MD|267-733-9617|Visionresearch@willseye.org|
22318494|NCT03181451|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22318495|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318496|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
22318497|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov|
22318498|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22318499|NCT02453360|University of Wisconsin School of Medicine|Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
22318500|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu|
22318501|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw|
22318502|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612|miguel@restorationrobotics.com|206
22318503|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org|
22318504|NCT01242800|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22318505|NCT03527238|University of Florida|Ali Zarrinpar|352-265-0606|ali.zarrinpar@surgery.ufl.edu|
22318506|NCT03598088|Dare Bioscience, Inc.|Jessica Hatheway VP, Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22282874|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org|
22282875|NCT01118520|Imperial College London|Professor Neil Poulter|+44(0) 20 7594 3446|n.poulter@imperial.ac.uk|
22282876|NCT01170065|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282877|NCT03220581|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
22282878|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22282879|NCT01527513|BIAL - Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com|
22282880|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22282881|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282882|NCT01767493|Invicro|Stephanie Pizarro|203-990-1613|spizarro@invicro.com|
22282883|NCT02446418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282884|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
22282885|NCT03093974|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clincaltrials@zambongroup.com|
22282886|NCT05418153|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22282887|NCT03109262|Stanford University|Andrei Iagaru, PROFESSOR OF RADIOLOGY (NUCLEAR MEDICINE)|1650-725=4711|aiagaru@stanford.edu|
22282888|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net|
22282889|NCT01009346|Johns Hopkins|Ranee Mehra, MD||rmehra1@jhmi.edu|
22282890|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623||
22282891|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
22282892|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318507|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu|
22318508|NCT02447172|Innocoll|Charlene A. Tucker MS, Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22318509|NCT06020118|Duke University|Dr. Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
22282893|NCT02863523|East Carolina University|Dr. Doyle Cummings|252-744-2607|FLOYDS14@ecu.edu|
22318510|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22318511|NCT03525431|University of California, San Francisco|Mary Norton|(415) 476 4080|mary.norton@ucsf.edu|
22318512|NCT01564628|Acarix A/S|Claus Christensen|+45 29724411|dkcbc@acarix.com|
22318513|NCT02409368|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22318514|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000|gillian.chumbley@imperial.nhs.uk|Bleep 5865
22318515|NCT03343301|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
22318516|NCT04633551|University of South Carolina|Abbi Lane-Cordova|8037777568|lanecord@mailbox.sc.edu|
22318517|NCT02668185|Imperial College London|Professor Wajit Dhillo|+44 (0)20 7594 2489|w.dhillo@imperial.ac.uk|
22318518|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu|
22318519|NCT02678247|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
22318520|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com|
22318521|NCT03081052|Duke University|Kamrouz Ghadimi, M.D., M.H.Sc.|919-681-6532|kamrouz.ghadimi@duke.edu|
22318522|NCT00720941|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22318523|NCT03511053|Dallas VA Medical Center|Dr. Thiru M. Annaswamy, Staff Physician, PM&R Service|2148570273|thiru.annaswamy@va.gov|
22318524|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu|
22318525|NCT03628898|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22318526|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318527|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22318528|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov|
22318529|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318530|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov|
22318531|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org|
22318532|NCT03548987|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22318533|NCT04572841|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22318534|NCT04661878|Duke University School of Nursing|Dr. Marta Mulawa|(919) 684-9555|marta.mulawa@duke.edu|
22318535|NCT03603028|UAB|David A. Brown|205-975-2788|dbrownpt@uab.edu|
22318536|NCT01468831|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22318537|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22318538|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318539|NCT02169453|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22318540|NCT02271425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318541|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu|
22318542|NCT03353350|Hanmi Pharmaceutical Co., Ltd.|Sujin Jung|+82-2-410-0473|sujin.jung@hanmi.co.kr|
22318543|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22318544|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22318545|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu|
22318546|NCT01679405|University Medical Center Mainz|Prof. Dr. Markus Moehler|0049613117|Markus.Moehler@unimedizin-mainz.de|7275
22318547|NCT04508023|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318548|NCT04819776|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22318549|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
22318550|NCT04845633|Damascus University|Dr. Line Droubi|00963966896989|droubiline@gmail.com|
22318551|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22318552|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu|
22318553|NCT03562247|Vanderbilt University Medical Center|Lisa Lancaster, MD|615-322-2386|lisa.lancaster@vumc.org|
22318554|NCT04009850|Yale School of Medicine|Dr. Krysten Bold|203-974-7603|krysten.bold@yale.edu|
22318555|NCT01281969|NIMH|Dr. David I. Driver|301.496.1683|david.driver@nih.gov|
22318556|NCT04640077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22318557|NCT02240693|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318558|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800|norma.amador@imss.gob.mx|31315
22318559|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22318560|NCT03087019|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
22318561|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318562|NCT01907360|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22300047|NCT02962687|Durham VA HSR&D|Susan N Hastings|919-286-6986|susan.hastings@va.gov|
22300048|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
22300049|NCT00924885|Vitrolife|Director of clinical investigations|0046708228063|thardarson@vitrolife.com|
22300050|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
22300051|NCT02508480|Boston University|Dr. Zlatka Russinova|617-353-3549|zlatka@bu.edu|
22300052|NCT03966157|Saint Louis University|Dr. Samuel J. Burton|3147500811|s.burton.1818@gmail.com|
22327426|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327427|NCT00986310|University of California, Davis|Lisa Bateman, MD, FRCPC||lb2863@cumc.columbia.edu|
22327428|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu|
22327429|NCT05025787|MGH|Allison Campbell|617-595-8372|acampbell17@mgh.harvard.edu|
22318563|NCT00603720|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22318564|NCT02796560|University of Sherbrooke|Dr Marjorie Carbonneau|819-346-1110|Marjorie.Carbonneau@USherbrooke.ca|22180
22318565|NCT03804502|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22318566|NCT03816332|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22318567|NCT05330312|Vicore Pharma|Director Clinical Operations|+46317880560|info@vicorepharma.com|
22318568|NCT03534284|University of Washington|Dr. Raj Mehrotra|206-221-7138|rmehrotr@uw.edu|
22318569|NCT03316300|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22318570|NCT05462886|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22318571|NCT03164564|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22318572|NCT04002401|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22318573|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
22318574|NCT02618642|Rzeszow University|Jolanta Zwolińska PhD|48 505095199|jolantazwolinska@op.pl|
22318575|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22318576|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu|
22318577|NCT03567434|Baylor University|Dr. Jason Carter|254-710-4499|jason_carter1@baylor.edu|
22318578|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu|
22318579|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22318580|NCT02880540|Children's National Hospital|Janelle Vaughns MD|202-476-2025|jvaughns@childrensnational.org|4165
22318581|NCT02881957|University of Utah|Dr. Michael Karsy|801-581-6908|michael.karsy@hsc.utah.edu|
22318582|NCT04485858|CorNeat Vision|Clinical Research Associate|0586753739|talia@corneat.com|
22318583|NCT03413735|The Ohio State University|Dr. Richard Bruno|614-292-5522|bruno.27@osu.edu|
22318584|NCT05269355|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22318585|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu|
22318586|NCT03705832|Columbia University|Emily DiMango, MD|212-305-0631|ead3@columbia.edu|
22318587|NCT01880528|Mayo Clinic|Terence T Sio, MD, MS|480/301-7050|Sio.Terence@mayo.edu|
22318588|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22318589|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318590|NCT05203068|"Federal State Budgetary Institution National Medical Research Center of Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation"|Dr. Kazakov Aleksey Vladimirovich, principal investigator|+79254666638|alexeykazakov1982@yandex.ru|
22318591|NCT02390245|Wills Eye Hospital|Dr. L. Jay Katz|215-825-4713|jmolineaux@willseye.org|
22318592|NCT01837069|NYU Langone Health|Jeffrey Berger|212 263 4004|Jeffrey.Berger@nyulangone.org|
22318593|NCT04968197|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|(480) 301-5351|Pradhan.Gaurav@mayo.edu|
22318594|NCT02425644|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318595|NCT02720536|Novartis Pharmaceuticals|Study Director|888-778-8300|Novartis.email@novartis.com|
22318596|NCT02525861|Baxalta|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22318597|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318598|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com|
22318599|NCT01607554|University of New Mexico Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
22318600|NCT05580588|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
22318601|NCT05195814|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318602|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
22318603|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
22318604|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22318605|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu|
22318606|NCT02796001|University of Virginia School of Medicine|Ronald Turner, MD|4349819964|rbt2n@virginia.edu|
22318607|NCT02974088|Medical Entomology Centre|Ian Burgess|+44 1223 810070|ian@insectresearch.com|
22318608|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520|dlamon@capstonethx.com|5206
22318609|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu|
22318610|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca|
22318611|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22318612|NCT01630434|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
22318613|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300||
22318614|NCT02269332|Mike O'Callaghan Military Medical Center|Senior Research Associate/Research Manager|7026533583|amanda.j.crawford.ctr@health.mil|
22327430|NCT03471767|Duke University|James Davis, MD|919-668-5055|james.m.davis@duke.edu|
22318615|NCT00610467|University of California Irvine|Professor|949-824-6001|msu@uci.edu|
22327431|NCT05600309|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22300053|NCT04969250|University of Minnesota|Melissa Skeans, Statistician/Protocol Manager|612-626-9011|tico@insight-trials.org|
22300054|NCT03526250|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22300055|NCT04420221|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300056|NCT05348681|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
22300057|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300058|NCT04174521|Vanderbilt University Medical Center|Bryan Shepherd|615-343-3496|bryan.shepherd@vumc.org|
22300059|NCT03009110|Indiana University School of Medicine|Graham Hogg|317-962-0415|gahogg@iu.edu|
22300060|NCT01866410|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22300061|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300062|NCT04389840|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22300063|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com|
22300064|NCT02078284|Pugent Sound Blood Center|Sherrill Slichter|206-292-6541|sjslichter@psbc.org|
22300065|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22300066|NCT01391962|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
22300067|NCT04618718|Protembis GmbH|Karl von Mangoldt|+49 241 9903 3621|kvm@protembis.com|
22300068|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com|
22300069|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300070|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org|
22300071|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22300072|NCT03585244|Foundation for Prader-Willi Research|Theresa Strong, PhD - Director of Research Programs|888-322-5487|theresa.strong@fpwr.org|702
22300073|NCT04575428|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
22300074|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu|
22300075|NCT02199028|Stanford University|Dr Bruce Buckingham|(408) 356-0911|buckingham@stanford.edu|
22318616|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22318617|NCT04465760|OREGON HEALTH & SCIENCE UNIVERSITY|Joseph Shatzel MD MCR|5034948311|shatzel@ohsu.edu|
22318618|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org|
22318619|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318620|NCT01079741|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22318621|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22318622|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu|
22318623|NCT02075541|GlaxoSmithKline|GSK Response Center|866-435-7343|lp542096@gsk.com|
22318624|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22318625|NCT02349360|University of Florida|Wendy Dahl Associate Professor|3522943707|wdahl@ufl.edu|
22318626|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com|
22318627|NCT02618031|Cleveland Clinic Akron General|John Elias|330-344-6176|eliasj@ccf.org|
22318628|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug|
22318629|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22282894|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22282895|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548||
22282896|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org|
22282897|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22282898|NCT03283150|University of Wisconsin-Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
22282899|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
22282900|NCT02981407|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
22282901|NCT02466074|The University of Texas Health Science Center at Houston|John A. Lincoln, MD, PhD|713-500-7016|John.A.Lincoln@uth.tmc.edu|
22282902|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com|
22282903|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es|
22282904|NCT02084238|Peking University People's Hospital|Dr. Jing He|86|hejing1105@126.com|1861170734
22282905|NCT02436408|University of Michigan Rogel Cancer Center|Cagri Besirli, MD, PhD|734-232-8404|cbesirli@med.umich.edu|
22282906|NCT02818036|University of Pittsburgh|Dr. Tristen Inagaki|412-624-4211|inagaki@pitt.edu|
22282907|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org|
22282908|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com|
22282909|NCT03777917|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22282910|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com|
22282911|NCT04063787|University of Chicago|Dr. Mary Hammes|773-702-6134|mhammes@bsd.uchicago.edu|
22300076|NCT00867217|University of Kansas Medical Center|Dr. Bruce Kimler|(913) 588-4523|bkimler@kumc.edu|
22318630|NCT04250987|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
22318631|NCT03586687|Penn State Hershey Medical Center|Cayce Onks, DO|7175317127|conks@pennstatehealth.psu.edu|
22282912|NCT01416441|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22318632|NCT01614743|DeNova Research|Steven H Dayan, MD|312-335-2070|sdayan@drdayan.com|
22318633|NCT01426763|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22318634|NCT02446886|Weill Cornell Medicine|Research Coordinator|6469625736|liz4005@med.cornell.edu|
22318635|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu|
22318636|NCT02335125|University of Washington Harborview Medical Center|Douglas Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
22318637|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com|
22318638|NCT03021954|Dr Cipto Mangunkusumo Hospital|dr. Fernandi Moegni|+62-82298111778|fernandi71@ui.ac.id|
22318639|NCT02917278|Purdue University|Kathleen Hill Gallant|765-494-0101|hillgallant@purdue.edu|
22318640|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22318641|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu|
22318642|NCT02120716|University of Michigan|Golfo Tzilos, PhD|7349987120|gtzilos@med.umich.edu|
22318643|NCT04079803|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD, Chief Medical Officer|512-501-1900|nfriedmann@cassavasciences.com|
22318644|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821||
22318645|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
22318646|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu|
22318647|NCT04677179|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22318648|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22318649|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318650|NCT03261700|National Center for PTSD, located at the VA Boston Healthcare System|Dr. Katherine Iverson, PI|857-364-2066|katherine.iverson@va.gov|
22318651|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318652|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22318653|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
22318654|NCT04262817|Yale School of Medicine|Asti Jackson, Ph.D.|475-241-4904|asti.jackson@yale.edu|
22318655|NCT04947527|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22318656|NCT02656823|DENTSPLY IH AB,|Ulrika Bonander|31 376 30 68|ulrika.bonander@dentsplysirona.com|+46
22318657|NCT03769181|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22318658|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu|
22318659|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
22318660|NCT01195545|University of Washington|Brant Oelschlager, MD|206-543-3518|brant@uw.edu|
22282913|NCT04627675|Providence Portland Medical Center|Dr. Rom Leidner|503-215-5696|rom.leidner@providence.org|
22282914|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22282915|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org|
22282916|NCT04883528|Duke University|Stephen J. Greene, MD|919-684-3854|stephen.greene@duke.edu|
22282917|NCT02191605|Wayne State University, Merrill Palmer Skillman Institute|Dr. Jessica Beatty|3136642518|jbeatty@wayne.edu|
22282918|NCT04948307|Orexo US, Inc.|David Capano|9085079909|david.capano@orexo.com|
22282919|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22282920|NCT03131596|Fuxing Hospital, Capital Medical University, Beijing, China|Dr. Shi Xiaoyu|+86 18618496384|petershi1990@163.com|
22282921|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22282922|NCT03654885|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22282923|NCT05275582|VA Center for Integrated Healthcare|Dr. Julie Gass|716-834-9200|julie.gass@va.gov|25429
22282924|NCT05320393|Evolus, Inc.|Rui Avelar|1-949-284-4689|rui.avelar@evolus.com|
22282925|NCT04411420|Duke University|Leo Brothers|919-668-8322|joseph.l.brothers@duke.edu|
22282926|NCT03187834|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
22282927|NCT03559699|Agios Pharmaceuticals, Inc|Medical Affairs|833-228-8474|medinfo@agios.com|
22282928|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu|
22282929|NCT01401699|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
22282930|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22282931|NCT02209948|MFAR Clinical Research|Pau Doñate|0034934344412|investigacion@mfar.net|
22282932|NCT03911752|University of A Coruña|Thais Pousada García|+34 981 167 000|thais.pousada.garcia@udc.es|5870
22282933|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22282934|NCT00043108|Fox Chase Cancer Center|Dr. Mark Hallman|215-728-2581|Mark.Hallman@fccc.edu|
22282935|NCT01703117|Icahn School of Medicine at Mount Sinai|Dr. Ana Pereira|212-241-6984|ana.pereira@mssm.edu|
22282936|NCT03837665|University of Kansas Medical Center|Hinrich Staecker, MD, PhD|913-588-6701|hstaecker@kumc.edu|
22282937|NCT03315104|Emergent BioSolutions|Dr. Christine Hall|204-275-4200|chall@ebsi.com|4248
22282938|NCT00330928|InfraReDx, Inc|Director Clinical and Regulatory|781-221-0053|pshah@infraredx.com|
22282939|NCT01309906|Bausch Health|Study Director||robert.steffen@bausch.com|
22282940|NCT03028480|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22318661|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org|
22289141|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22300077|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22318662|NCT01028222|Study Director|Novartis|862-778-8300||
22318663|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318664|NCT01717989|Amgen Inc.|Study Director|866-572-6436||
22318665|NCT03224325|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|+1
22318666|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617|richard.jonkers@medtronic.com|3727
22318667|NCT02072434|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@dsi.com|
22318668|NCT03599557|University of California, Los Angeles|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
22318669|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu|
22318670|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22318671|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au|
22318672|NCT02276872|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
22318673|NCT04175808|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22318674|NCT03312348|Sheffield Children's NHS Trust|Dr Shammi Ramlakhan - Chief Investigator|+44 1142262331|shammi.ramlakhan@sch.nhs.uk|
22318675|NCT02544217|Khondrion B.V.|Edwin Spaans, PharmD.|+31654997700|spaans@khondrion.com|
22318676|NCT03278106|Mayo Clinic|Amit Mahipal MBBS|+1 (507) 293-0487|Mahipal.amit@mayo.edu|
22318677|NCT05057923|DreamTec Research Limited|Keith Kwong|+85237052355|keithkwong@dreamtec.hk|
22318678|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de|
22318679|NCT03952806|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
22318680|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22318681|NCT03867175|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367130031|mfarris@wakehealth.edu|
22318682|NCT04823221|Boao Yiling Life Care Center|Dr. Ming Liu|139 1103 6970|liuming9876@yeah.net|+86
22318683|NCT02027701|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22318684|NCT02875977|Loyola University Medical Center|Cynthia Brincat, M.D., Ph.D.|708-216-2180|cbrincat@lumc.edu|
22318685|NCT00820027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318686|NCT02604433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22318687|NCT03285178|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22318688|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318689|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318690|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com|
22318691|NCT01917513|Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany|Prof. Ralf Kiesslich||ralf.kiesslich@hsk-wiesbaden.de|
22318692|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu|
22318693|NCT02683941|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22318694|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22318695|NCT03554954|National University of Singapore|Dr. Kim Jung Eun|65161136|fstkje@nus.edu.sg|+65
22318696|NCT00256451|University of Pennsylvania|David Oslin, MD|2158235894|oslin@upenn.edu|
22318697|NCT02571049|Dr. Reddy's|Director of Clinical Development|609-375-9900|cfritz@drreddys.com|
22318698|NCT03552822|University of Alabama at Birmingham|Dr. Mark Powell|2059346007|mfpowell@uabmc.edu|
22318699|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590||
22318700|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318701|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu|
22318702|NCT02737917|Lincoln Medical Center|Dr. Nicholas Caputo|718-579-6010|ncaputo.md@gmail.com|
22318703|NCT02254278|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@gmail.com|
22318704|NCT06609135|UMASS Chan Medical School|Dr. Lawrence Rhein, Chair of Pediatrics at UMASS Chan Medical School|5083346581|lawrence.rhein@umassmemorial.org|
22318705|NCT06729593|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
22318706|NCT02903368|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
22318707|NCT05437510|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22318708|NCT02788903|Penn State College of Medicine|Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
22318709|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu|
22318710|NCT05199571|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22327432|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318711|NCT02892344|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22318712|NCT03938454|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22318713|NCT04441905|Pharmaceutical Product Development (PPD), part of Thermo Fisher Scientific|Kristie Miller, MD|512-747-1504|kristie.miller@ppd.com|
22318714|NCT03922802|Shirley Ryan AbilityLab|Kelly Mckenzie, Research Physical Therapist|31223872111|kmckenzie@sralab.org|
22318715|NCT04486716|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22318716|NCT05888103|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318717|NCT04987307|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22318718|NCT03650400|Novartis Pharmaceuticals|Study Director|882 778 8300|Novartis.email@Novartis.com|
22318719|NCT06390085|University of Virginia, Systems and Information Engineering|Gregory Gerling|4349240533|gg7h@virginia.edu|
22300078|NCT05045625|Albany Medical College|Clinical Research Coordinator|518-262-2367|khazeno@amc.edu|
22300079|NCT03980470|University Hospital Zurich|Dr Ronny R. Buechel|+41442551059|ronny.buechel@usz.ch|
22300080|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
22300081|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
22300082|NCT01663636|Center for Global Health, University of Colorado|Dr. Edwin J. Asturias|3037246282|edwin.asturias@ucdenver.edu|
22300083|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com|
22300084|NCT02663817|University of Miami|Dr. Ivaylo Mihaylov|305-243-8223|i.mihaylov@med.miami.edu|
22300085|NCT05350449|University of Nevada Las Vegas|Dr. Nirmala Lekhak|702-895-5983|nirmala.lekhak@unlv.edu|
22300086|NCT02358603|Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine|Dr. Zhao, Jianrong||drzjr@126.com|
22300087|NCT03576547|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./Professor|713-745-0394|fravandi@mdanderson.org|
22300088|NCT01912612|University of Michigan Rogel Cancer Center|Lynn Henry, MD, PhD|734-936-9868|norahh@med.umich.edu|
22318720|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300||
22318721|NCT05541861|BioNTech SE|BioNTech clinical trials patient information|061319084|patients@biontech.de|+49
22318723|NCT04452877|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22318724|NCT05678959|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318725|NCT02065336|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22318726|NCT03226392|Novartis pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
22318727|NCT03056755|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22318728|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318729|NCT02090374|Imperial College London|Professor Trevor Hansel|+44 (0)20 3312 5733|t.hansel@imperial.ac.uk|
22318730|NCT00596648|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22318731|NCT04667949|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318732|NCT04504630|UT Southwestern Medical Center|Christian LoBue, PhD|2146484658|Christian.LoBue@utsw.edu|
22318733|NCT00568321|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318734|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318735|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
22318736|NCT04266301|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
22318737|NCT03215758|Novartis Pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
22318738|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org|
22318739|NCT04091048|Medtronic Cardiovascular|Katie Flor, Clinical Research Manager|262 693 6127|katie.j.flor@medtronic.com|
22318740|NCT02175004|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22318741|NCT00162032|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|Cesare.Orlandi@lantheus.com|
22318742|NCT01137955|Celiac Disease Center at Columbia University|Dr. Peter Green|(212) 305-5590|mtm2111@columbia.edu|
22318743|NCT03210662|M.D. Anderson Cancer Center|Chelsea C. Pinnix, MD|713-563-2300|ccpinnix@mdanderson.org|
22318744|NCT02977988|University of Southern California|David Black|8184260733|davidbla@usc.edu|
22318745|NCT05341115|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22318746|NCT03827109|Abigail Wexner Research Institute at Nationwide Children's Hospital|Kelly Boone|614-722-3749|kelly.boone@nationwidechildrens.org|
22318747|NCT04263909|BWH Anesthesia|Linda S. Aglio, MD MS|6177328480|laglio@bwh.harvard.edu|33328
22318748|NCT05630001|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318749|NCT05386680|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318750|NCT03946670|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22318751|NCT03840486|Emory University|Steven Lindsey, MD|913-706-0232|steven.m.lindsey@emory.edu|
22318752|NCT03437278|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318753|NCT05116046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22318754|NCT03136328|Montefiore Medical Center|Charito Love, MD|718-406-8462|clove@montefiore.org|
22318755|NCT04328727|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318756|NCT02019888|NCRAR|M. Patrick Feeney|503-273-5306|Patrick.Feeney@va.gov|
22318757|NCT02311998|The University of Texas MD Anderson Cancer Center|Nitin Jain MD/Associate Professor|713-745-6080|njain@mdanderson.org|
22318758|NCT02604199|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22318759|NCT02604212|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22318760|NCT04659863|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318761|NCT01768520|Hanlim Pharm|Clinical Trial Unit|82234896297|yrsong@hanlim.com|2234896297
22318762|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318763|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu|
22318764|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net|
22318765|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318766|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
22318767|NCT01971203|Icahn School of Medicine at Mount Sinai|Cindy J. Aaronson, MSW, PhD|212-241-3169|cindy.aaronson@mssm.edu|
22318768|NCT03037619|University of South Carolina|Christine Pellegrini|803-777-0911|cpellegrini@sc.edu|
22318769|NCT04318951|Medical School Berlin|Prof. Dr. Benjamin Stahl|+49 30 7668 375 708|benjamin.stahl@medicalschool-berlin.de|
22318770|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
22318771|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22318772|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22318773|NCT00865969|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22318774|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22318775|NCT01596621|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22318776|NCT00421707|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318777|NCT01992393|Case Western Reserve University|Joy Yala, Data & Regulatory Coordinator II|216-368-0783|jxy790@case.edu|
22318778|NCT01898923|Oneness Biotech Co., Ltd.|Henry Chang, Associate Director of Clinical Research|+886 2 2703 1098|henry.chang@onenessbio.com.tw|366
22318779|NCT02739412|Beth Israel Deaconess Medical Center|Michael Curry MD|617-632-9852|mcurry@bidmc.harvard.edu|
22318780|NCT02975700|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22318781|NCT02441686|Dana-Farber Cancer Institute|Emily Benjamin|6176324167|emily_benjamin@dfci.harvard.edu|
22318782|NCT04150029|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
22318783|NCT05497284|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22318784|NCT02264613|Consultant|Allen Annis|617-921-9467|aannis@aileronrx.com|
22318785|NCT04652726|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318786|NCT03780725|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318787|NCT02738008|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22318788|NCT05192382|Crinetics Pharmaceuticals, Inc.|Clinical Research Director|(833) 276-4636|medinfo@crinetics.com|
22318789|NCT02673203|Yale University School of Medicine|Renata Belfort De Aguiar, MD, PhD; Assistant Professor of Medicine (Endocrinology)|(877) 925-3637|renata.aguiar@yale.edu|
22318790|NCT04702776|Laboratorios Sophia|Alejandra Sanchez Ríos|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22318791|NCT01110876|University of Texas (UT) MD Anderson Cancer Center|John de Groot, MD/Associate Professor, NEURO-ONCOLOGY|(713) 745-3072|jdegroot@mdanderson.org|
22318792|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318793|NCT02893930|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22318794|NCT03975595|University of Virginia|Dr. Patrick Finan|(720) 244-1702|tpx4xe@virginia.edu|
22318795|NCT03370471|Atlanta VA Health Care System|Amy D Rodriguez, PhD|404-321-6111|amy.rodridguez@va.gov|204201
22318796|NCT04176848|Canadian Cancer Trials Group|Dr. Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22318797|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com|
22318798|NCT05358717|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22318799|NCT02640157|AbbVie|Global Medical Services|800-633-9110||
22318800|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22318801|NCT05741372|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318802|NCT04837040|Crinetics Pharmaceuticals, Inc.|Clinical Research Director|(833) 276-4636|medinfo@crinetics.com|
22318803|NCT02961218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22318804|NCT00602667|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|amar.gajjar@stjude.org|
22318805|NCT05569759|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22318806|NCT04765059|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22318807|NCT04300309|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22318808|NCT04647526|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22318809|NCT03816891|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22318810|NCT02577029|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22318811|NCT04379518|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|igor.puzanov@roswellpark.org|
22318812|NCT05666505|University of Arkansas for Medical Sciences|Samantha Kleindienst Robler, AuD, PhD|9074340433|skrobler@uams.edu|
22318813|NCT05135000|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318814|NCT04417127|Brown University School of Public Health|Omar Galarraga, PhD (Study Contact PI)|+1 (401) 863-2331|omar_galarraga@brown.edu|
22318815|NCT06060717|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
22318816|NCT06018844|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
22318817|NCT04596384|City of Hope|Virginia Sun, Professor|+16269888652|VSun@coh.org|
22318818|NCT04751656|University of Florida|Megan McVay|352-294-1638|megan.mcvay@ufl.edu|
22318819|NCT03253926|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
22318820|NCT05591274|University of Miami, Miller School of Medicine|Russell Saltzman|3052431152|R.Saltzman@med.miami.edu|
22318821|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
22318822|NCT03566810|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22318823|NCT05640466|Sohag University|Hussien Sedik Mohamed, Orthopedic Surgery Resident, Sohag University|+20-1065840049|hussien_sediek_post@med.sohag.edu.eg|
22318824|NCT00509665|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22318825|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org|
22318826|NCT03338192|Washington University Pain Center in St. Louis|Burel Goodin|3142736403|burel@wustl.edu|
22318827|NCT03874325|Moffit Cancer Center|Hung Khong, MD|813-745-3828|hung.khong@moffitt.org|
22300089|NCT01588184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22300090|NCT03750552|Theravance Biopharma Inc|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22300091|NCT02062632|Mayo Clinic|Terence T. Sio, MD, MS|507/284-2511|sio.terence@mayo.edu|
22300092|NCT02156674|Masonic Cancer Center, University of Minnesota|Elizabeth Braunlin MD, PhD|612 626 2755|braun002@umn.edu|
22300093|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu|
22300094|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22300095|NCT04517396|University of Pennsylvania|Katherine Greene|215-662-7580|katherine.greene@pennmedicine.upenn.edu|
22300096|NCT02008890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22300097|NCT02207816|GlaxoSmithKline|GSK Response Center|866-435-7343|cc781166@gsk.com|
22300098|NCT02522494|Jesse Brown VA Medical Center|Howard S. Gordon, MD|(312) 569-7331|howard.gordon2@va.gov|
22300099|NCT03165526|Abbott Medical Device|Courtney Weiler|224 430 4918|ClinicalTrials.gov_SH_Inquiries@abbott.com|
22300100|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22300101|NCT03240588|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22300102|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com|
22300103|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22300104|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com|
22300105|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu|
22300106|NCT06111742|Boston Children's Hospital, Harvard Medical School|Harrison Pravder|516-426-8166|hpravder@meei.harvard.edu|
22318828|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
22318829|NCT03236246|Keryx|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22318830|NCT02952001|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22318831|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
22318832|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com|
22318833|NCT01794520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22318834|NCT04796896|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22318835|NCT02021292|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
22318836|NCT04356183|Duke University|Kim Huffman, MD, PhD|919-613-7797|kim.huffman@duke.edu|
22318837|NCT01637623|University of Wisconsin School of Pharmacy|John M. Dopp|608-265-9352|john.dopp@wisc.edu|
22318838|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu|
22318839|NCT02824263|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
22318840|NCT01676909|Department of Veterans Affairs, VAMHCS MIRECC|Mary Brighid Walsh|410-637-1860|marybrighid.walsh@va.gov|
22318841|NCT04615247|Principal Investigator|Alison Huang, MD|415-353-7900|alison.huang@ucsf.edu|
22318842|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu|
22318843|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
22318844|NCT01369511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318845|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu|
22318846|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078||
22318847|NCT03478163|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
22318848|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318849|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net|
22318850|NCT00026208|Stanford Univeristy Medical Center|Jessica C Lam, BS|650-723-0437|jclam11@stanford.edu|
22318851|NCT03282240|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22318852|NCT01675479|Abbott Medical Optics|Head of Clinical Science|714-247-8613|khileman@its.jnj.com|
22318853|NCT02910739|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318854|NCT03620890|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD, Assistant Professor|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
22318855|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com|
22318856|NCT01103245|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|james.luther@vanderbilt.edu|
22318857|NCT03219320|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22318858|NCT03078907|Actelion Pharmaceuticals Ltd|Clinical Registry group|844-434-4210|clinical-trials-disclosure@its.jnj.com|
22318859|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl|
22318860|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318861|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu|
22318862|NCT04612036|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
22318863|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318864|NCT03018587|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
22327433|NCT01081873|Abbott|Global Medical Services|800-633-9110||
22327434|NCT02491073|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351||
22300107|NCT03461003|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
22318865|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
22318866|NCT02464228|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-002@kuraoncology.com|
22318867|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com|
22271551|NCT05727306|University of Sheffield|Andrew G. Messenger|+44 114 222 2000|a.g.messenger@sheffield.ac.uk|
22300108|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825|william.sychen@msa.hinet.net|2151
22300109|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org|
22300110|NCT04477187|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22300111|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
22318868|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
22318869|NCT06078579|Cairo university|Dr. Bahaa Mahmoud Fawzy|+201033559646|bahaamust66@gmail.com|
22318870|NCT05972733|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22318871|NCT01177787|Gachon University of Medicine and Science|Dr. Kyu Rae LeeMD.PhD.|8232-770-1215|baria07@daum.net|
22318872|NCT01570036|Cancer Insight|Program Director, Karen Arrington, RN, BSN|210-243-5711|karrington@cancerinsight.com|
22318873|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org|
22318874|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com|
22318875|NCT05193500|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
22318876|NCT03871829|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318877|NCT02993523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22318878|NCT03694418|Montana State University|Dr. Elizabeth Rink|4066000297|elizabeth.rink@montana.edu|
22318879|NCT01806129|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22318880|NCT04288778|Janssen Research & Development, LLC|Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318881|NCT04442737|Janssen Scientific Affairs, LLC|Vice President Medical Affairs Infectious Disease and Vaccines (IDV)|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22318882|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22318883|NCT04092101|University of Vermont|Stacey C. Sigmon, PhD|802-656-9987|stacey.sigmon@uvm.edu|
22318884|NCT05458479|Massachusetts General Hospital Lurie Center for Autism|Dr. Robyn Thom|7818601700|rthom@mgh.harvard.edu|
22318885|NCT00784693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318886|NCT02982187|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22318887|NCT01978262|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22318888|NCT02202551|Adamas Pharmaceuticals, Inc.|Reed Johnson|510-450-3500|rjohnson@adamaspharma.com|
22318889|NCT02888665|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
22318890|NCT02349451|AbbVie|Global Medical Services|800-633-9110||
22318891|NCT02168842|University of Rochester Medical Center, Department of Biostatistics and Computational Biology|David Oakes, PhD|5852752405|david_oakes@urmc.rochester.edu|
22318892|NCT02147353|Icahn School of Medicine at Mount Sinai|Dr. Shelbi C. Jim On|212-241-6500|shelbi.jimon@mountsinai.org|
22318893|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
22318894|NCT02064855|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
22318895|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu|
22318896|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu|
22318897|NCT02121834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22318898|NCT02578862|Ochsner Medical Center|Edward D McCoul, MD, MPH|504-842-4080|edward.mccoul@ochsner.org|
22318899|NCT00759291|UT Southwestern|Dr. Joshua Beckman|214-648-3100|joshua.beckman@utsouthwestern.edu|
22318900|NCT03128008|Duke University Health System|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
22318901|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr|
22318902|NCT04388774|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
22318903|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu|
22318904|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318905|NCT01794923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318906|NCT01881750|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
22318907|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22318908|NCT03318809|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22318909|NCT04668586|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
22318910|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22318911|NCT02513719|Abbott Vascular|Kusano Hajime|408-645-1626|hajime.kusano@av.abbott.com|
22318912|NCT02577601|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|503-494-0757|mccrimmo@ohsu.edu|
22318913|NCT01572922|St. Jude Children's Research Hospital|Jane Hankins, MD|866-278-5833|Jane.Hankins@stjude.org|
22318914|NCT05312151|Compass Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
22318915|NCT05089656|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22318916|NCT02535416|Arrowhead Pharmaceuticals, Inc.|James Hamilton, MD|626-696-3400|jhamilton@arrowheadpharma.com|
22318917|NCT03706417|MaineHealth|Principal Investigator|207-396-6920|alexa.craig@mainehealth.org|
22318918|NCT05938998|University of Kansas Medical Center|Dr. Amy Bodde|913-588-7983|abodde@kumc.edu|
22318919|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22318920|NCT04641299|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22327435|NCT03977727|Texas Diabetes & Endocrinology|Thomas Blevins, MD|512-334-3505|blevins@texasdiabetes.com|1
22327436|NCT01419665|Hexal AG / Novartis Pharmaceuticals|Study Director|+41613241111|novartis.email@novartis.com|
22327437|NCT01655823|Wex Pharmaceuticals|Mehran Kavoosi|6046767900|mehrank@wexpharma.com|
22327438|NCT00711269|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22327439|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com|
22327440|NCT03352414|University of California, San Diego|Raymond Diep, Clinical Research Coordinator|(858) 822-5352|rhdiep@health.ucsd.edu|
22327441|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
22327442|NCT01628016|Hunan Normal University|Dr. Wenhui Yang|+86 731 8873076|yangwh110@163.com|
22327443|NCT03483506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327444|NCT03689504|Wuqu' Kawoq|Peter Rohloff, Chief Medical Officer|011-502-4958-1253|peter@wuqukawoq.org|
22327445|NCT00403559|Dermatology Specialists, PSC|Joseph F. Fowler, Jr., M.D.|502-583-7546|fowlerjoe@msn.com|184
22327446|NCT02768194|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327447|NCT05291949|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
22327448|NCT02278289|Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan, ROC|Dr. Yi-Shiung Horng|+886-2-66289779|d97841001@ntu.edu.tw|64515
22327449|NCT01982773|National Center for Telehealth and Technology|Nigel E. Bush, PhD|253-968-4153|nigel.e.bush.civ@mail.mil|
22327450|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22327451|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu|
22327452|NCT03294681|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
22327453|NCT00242385|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327454|NCT03089216|Federal University of Goias|Dr. Terezinha de Jesus Esteves Barata|+55 62 3209-6325|terezinhabarata@yahoo.com.br|
22327455|NCT02720016|VHASDC|Dr. Leslie A. Morland|858-552-4324|Leslie.Morland@va.gov|
22327456|NCT04501679|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22327457|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu|
22327458|NCT04846348|Mayo Clinic|Dr. Joseph Butterfield|507-284-3783|butterfield.joseph@mayo.edu|
22327459|NCT02121756|University of Pittsburgh Department of Medicine|Sharon Riddler, MD|412-383-1675|riddler@pitt.edu|
22327460|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22327461|NCT05319080|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
22327462|NCT03095521|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
22327463|NCT03259490|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327464|NCT05027516|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
22327465|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org|
22327466|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca|
22327467|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327468|NCT02365584|Ipsen SpA|Medical Director|see email|clinical.trials@ipsen.com|
22327469|NCT03521193|Centro Cardiologico Monzino, IRCCS|Clinical Trials' Office Chief|+390258002|alessandra.terragni@ccfm.it|675
22327470|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327471|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22327472|NCT04597619|Maine Medical Center|David Sobel, MD|207-773-1728|david.sobel@mainehealth.org|
22327473|NCT01935336|U of Colorado, Division of Medical Oncology. Anschutz Medical Campus|Dr. Ross Camidge|7208480300|ross.camidge@cuanschutz.edu|
22327474|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com|
22327475|NCT02773238|University of Washington|Dr. Jing Zeng|206-598-4110|jzeng13@uw.edu|
22327476|NCT03260205|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22318921|NCT03662139|Department of PM&R, Marmara University School of Medicine|Naime Evrim Karadag-Saygi, Prof. Dr.|00902166570606|evrimkaradag4@hotmail.com|1628
22318922|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com|
22318923|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu|
22318924|NCT00530868|UAB|Lisle Nabell|205 934-3061|Lnabell@uabmc.edu|
22318925|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000||
22318926|NCT01566682|ProLung|Michael Garff, Chief Operating Officer|8012049625|mag@prolunginc.com|
22318927|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu|
22318928|NCT04229472|Oxford University Hospitals NHS Foundation Trust|Timothy R Betts|+44 (0)1865 220256|timothy.betts@cardiov.ox.ac.uk|
22318929|NCT04658186|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22318930|NCT04231539|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22318931|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu|
22318932|NCT04384848|Northwestern University|David Cella|312-503-1725|d-cella@northwestern.edu|
22318933|NCT01290601|WRAIR|Shirley Lee-Lecher|301-251-5000|usarmy.detrick.medcom-wrair.mbx.ocid@mail.mil|
22318934|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22318935|NCT04071795|NYU Langone Health|Erin Rogers|6465012544|Erin.Rogers@nyulangone.org|
22318936|NCT03057808|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
22318937|NCT01749540|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318938|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu|
22318939|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22318940|NCT00576836|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
22318941|NCT04329832|Intermountain Healthcare|Naresh Kumar|8013827483|naresh.kumar@imail.org|
22318942|NCT00392327|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22318943|NCT00894686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318944|NCT03267940|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
22318945|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100|artemis.diamantouros@sunnybrook.ca|3654
22318946|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu|
22318947|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
22318948|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318949|NCT05056987|Alcon Research, LLC|Senior Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22318950|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org|
22318951|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22318952|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu|
22318953|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22318954|NCT03291587|Wake Forest NCORP Research Base|Lead Biostatistician|3367160891|NCORP@wakehealth.edu|
22318955|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
22318956|NCT02197767|Mayo Clinic|Dr. Stephen B. Erickson|507-284-4083|Erickson.Stephen@mayo.edu|
22318957|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br|
22318958|NCT01759407|Nationwide Children's Hospital|Nicole Elsey, MD|614-722-4200|Nicole.Elsey@nationwidechildrens.org|
22318959|NCT01477320|University of Louisville|Dr. Mohamed Saad|5028525841|mohamed.saad@louisville.edu|
22318960|NCT04526197|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22318961|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22318962|NCT01136811|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
22318963|NCT02441062|University of Iowa, Holden Comprehensive Cancer Center|M.Sue O'Dorisio|(319) 335-7234|sue-odorisio@uiowa.edu|
22318964|NCT02279394|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
22318965|NCT02740972|NS Pharma, Inc.|Medical Affairs|(201) 986-3860|trialinfo@nspharma.com|
22318966|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
22318967|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu|
22318968|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22318969|NCT03933774|St. Vincent's Hospital|Dr. Jung Min Bae|82-31-881-8982|jminbae@gmail.com|
22318970|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
22318971|NCT03717129|Johns Hopkins University|Dr. Craig Hendrix|4109559707|chendrix@jhmi.edu|
22318972|NCT01783041|Children's Hospital at Montefiore, Albert Einstein College of Medicine|Mamta Fuloria|718-904-4105|mfuloria@montefiore.org|
22318973|NCT03796260|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22318974|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318975|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com|
22318976|NCT01966471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22318977|NCT02265367|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22318978|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
22318979|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22318980|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org|
22318981|NCT03481023|Riverside Medical Center|Dr. Brad Suprenant|(815) 939-9400|blsuprenant@comcast.net|
22318982|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22318983|NCT01030198|Cynosure, Inc.|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22318984|NCT02791737|The Ohio State University Comprehensive Cancer Center|Dr. Ashley Rosko|614-293-3196|Ashley.Rosko@osumc.edu|
22318985|NCT01411839|University of California, San Francisco|Dr. John A. Sauceda|415-460-6045|john.sauceda@ucsf.edu|
22318986|NCT05736211|Wake Forest University School of Medicine|Dr. Parissa Ballard|704-355-2000|parissa.ballard@advocatehealth.org|
22318987|NCT02158520|Mayo Clinic|Svetomir N. Markovic MD, PhD|507/266-0800|markovic.svetomir@mayo.edu|
22318988|NCT05104476|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22318989|NCT03865940|Vanderbilt University Medical Center|Shelby Meier, PhD - Senior Scientific Project Manager|6159369228|shelby.meier@vumc.org|
22318990|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22318991|NCT00992511|GlaxoSmithKline|GSK Response Center|866-435-7343||
22318992|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
22318993|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327477|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu|
22327478|NCT03675737|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22327479|NCT03052842|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
22327480|NCT03422133|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22327481|NCT02180724|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22327482|NCT05195359|Resmed Germany Inc|Susanne Fischer / Sr. Manager Clinical Research|+491707854257|susanne.fischer@resmed.de|
22327483|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743||
22327484|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com|
22327485|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu|
22327486|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22327487|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22327488|NCT03569449|Boston Medical Center, Boston University School of Public Health|Emily Feinberg, ScD, CPNP|617-414-1425|emfeinbe@bu.edu|
22327489|NCT04124692|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22327490|NCT03746808|University of North Texas Health Sciece Center|Scott Walters|817-735-2365|scott.walters@unthsc.edu|
22327491|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu|
22327492|NCT05136170|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22327493|NCT04393038|Abivax|Study Director|+33 1 53 83 09 63|info@abivax.com|
22327494|NCT05168813|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22327495|NCT01010854|University of California, San Francisco|Pamela Munster, MD|877-827-3222|clinicaltrials@ucsf.edu|
22327496|NCT02492997|Venus Concept Ltd.|Dr. Yoni Iger|888-907-0115|yoni@venusconcpet.com|
22282941|NCT05074888|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22327497|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327498|NCT04069156|Abbott|Nourdine Chakouri, PhD|(925) 989-5982|nourdine.chakouri@abbott.com|
22327499|NCT02500602|Medical University of South Carolina|Sudie Back|843-792-9383|backs@musc.edu|
22327500|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300||
22327501|NCT03806179|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
22327502|NCT05822830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22327503|NCT03368664|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22327504|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327505|NCT01025817|Novartis|Study Director|+1 (862) 778-8300||
22327506|NCT02130258|Massachusetts General Hospital|Dr. Yi Zhang|617-724-6102|yzhang20@partners.org|
22327507|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22327508|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22327509|NCT03448718|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22327510|NCT04799405|Hebrew SeniorLife|Dr. Pascual-Leone|6179715372|apleone@hsl.harvard.edu|
22327511|NCT01029002|Albert Einstein College of Medicine|Dr. Michal Melamed|718-430-2304|michal.melamed@einsteinmed.edu|
22327512|NCT02683525|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22327513|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646||
22327514|NCT02856269|University Hospitals Cleveland Medical Center|Dr. Grace McComsey|216-8442739|Grace.McComsey@UHhospitals.org|
22327515|NCT00127062|Imperial College London|Professor Fan Chung|+44 (0)20 7594 7954|f.chung@imperial.ac.uk|
22327516|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu|
22282942|NCT06239441|Hôpital du Sacre Coeur de Montreal|Catherine Lemiere|514 338 2492|catherine.lemiere@umontreal.ca|
22282943|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22282944|NCT02089113|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22282945|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov|
22282946|NCT02403635|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22282947|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351||
22282948|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu|
22282949|NCT02509052|Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA 91010|Michael Rosenzweig, MD|626-218-2405|mrosenzweig@coh.org|
22282950|NCT04942665|University of Florida|Dr. Ali Zarrinpar|(352) 265-0606|ali.zarrinpar@surgery.ufl.edu|
22282951|NCT03554772|Dr Reddy's Laboratories, Inc.|Srinivas Shenoy B.|6099550249|srinivasshenoyb@drreddys.com|
22282952|NCT04600505|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22282953|NCT00241631|Imperial College London|Ian M Adcock|+44 (0)20 7594 7840|ian.adcock@imperial.ac.uk|
22300112|NCT03508843|University of Alabama at Birmingham|Dr David Schwebel|1-205-934-8745|schwebel@uab.edu|
22327517|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr|
22327518|NCT02118610|Maryland Psychiatric Research Center|Ann Kearns, MS|4104066854|akearns@som.umaryland.edu|
22327519|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com|
22327520|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com|
22327521|NCT04863014|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22327522|NCT04633473|Oregon Research Behavioral Intervention Strategies|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
22327523|NCT00426517|National Institute of Allergy and Infectious Diseases|Kang, Elizabeth|+1 301 402 7567|ekang@niaid.nih.gov|
22327524|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
22327525|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300||
22327526|NCT01877382|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
22327527|NCT03423979|Urotronic, Inc|Sr. Clinical Project Manager|612-245-6434|jmoland@laborie.com|
22327528|NCT05149040|Helse Bergen|Dr. G.L. Schwarz|0047-55976850|gabriele.leonie.schwarz@helse-bergen.no|
22327529|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22327530|NCT04552535|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327531|NCT05366413|Dana-Farber Cancer Institute|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
22327532|NCT05108805|Vanderbilt University Medical Center|Dr. Olalekan Oluwole|(615) 936-8422|olalekan.oluwole@vumc.org|
22327533|NCT04095286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327534|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327535|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
22327536|NCT02509494|Janssen Vaccines & Prevention B.V.|Senior Director Clinical Franchise Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22327537|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu|
22327538|NCT05371912|Christiana Care|Mitra Assadi, MD|3026233017|mitra.assadi@christianacare.org|
22327539|NCT04752189|Wayne State University|Dr. Andria Eisman, Principal Investigator|313-649-7477|aeisman@wayne.edu|
22327540|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327541|NCT03003403|Duke University|Gary G. Bennett, PhD|919-808-7821|gary.bennett@duke.edu|
22327542|NCT05084053|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22327543|NCT03906227|University of North Carolina at Chapel Hill|Anne Froment|919-445-2622|anne_froment@med.unc.edu|
22327544|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr|
22327545|NCT00847938|Clinique Jules Verne|Dr Florent CAPRON|0251171775|florent.capron@mla.fr|33
22327546|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327547|NCT03342937|Duke University|Dr. Hope Uronis|919-668-1861|hope.uronis@duke.edu|
22327548|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252||
22327549|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327550|NCT01617655|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
22327551|NCT01175213|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327552|NCT03224585|VCU Health|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
22327553|NCT01921634|The Pennsylvania State University, Hershey Medical Center|Andrea Benton, MD|717-531-5394|abenton@pennstatehealth.psu.edu|
22327554|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22327555|NCT02325687|Hospital for Special Surgery, Anesthesiology Department|Kethy Jules-Elysee|212-606-1206|juleselyseek@hss.edu|
22327556|NCT03027388|National Cancer Institute|Dr. Eric Burton|240-760-6436|eric.burton@nih.gov|
22327557|NCT02263014|The University of Texas (UT) MD Anderson Cancer Center|Dr. Abenaa Brewster, Professor, Clinical Cancer Prevention|713-792-7734|abrewster@mdanderson.org|
22327558|NCT05279898|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-278-8000|bsubrama@bidmc.harvard.edu|
22327559|NCT00258427|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
22327560|NCT04580394|Apnimed, Inc.|Clinical Trials|6175008880|clinicaltrials@apnimed.com|
22327561|NCT04124042|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
22327562|NCT05388656|University of North Carolina at Chapel Hill|Elizabeth Andersen, PhD|(970) 420-4944|elizabeth_andersen@med.unc.edu|
22327563|NCT03201965|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22327564|NCT05441592|University of Michigan|Edwin Wilkins|734-936-6680|ewilkins@med.umich.edu|
22327565|NCT01371981|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22327566|NCT02493426|University of Minnesota|Suma Jacob, MD, PhD|612-624-0018|sjacob@umn.edu|
22327567|NCT02408796|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22327568|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327569|NCT00603980|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22327570|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155||
22327571|NCT01341652|University of Wisconsin Carbone Cancer Center|Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
22327572|NCT02618928|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22327573|NCT04593940|Washington University in St. Louis|William G. Powderly MD|314-454-8276|wpowderly@wustl.edu|
22327574|NCT01096849|Achaogen, Inc.|Clinical Trials Posting Group||clinical-trials@achaogen.com|
22327575|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca|
22327576|NCT04146467|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22327577|NCT01269372|Givenimaging|Hilla Debby/ Director of Clinical Affairs|97299077740|hila.debby@medtronic.com|77740
22327578|NCT03927508|Clinical Reserach Specialist|Pamela Dicamillo|719-400-7463|pdicamillo@ecr-inc.com|
22327579|NCT02953782|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22327580|NCT02128763|University of Pennsylvania|Maureen G. Maguire, PhD|215-615-1501|maguirem@pennmedicine.upenn.edu|
22327581|NCT00665288|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22318994|NCT04098068|Sidney Kimmel Comprehensive Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22318995|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22318996|NCT05057247|Dana-Farber Cancer Institute|Glenn J. Hanna, M.D.|617-632-309|glenn_hanna@dfci.harvard.edu|
22318997|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org|
22318998|NCT03673865|Emory University|Dina Amin|404-251-8895|dina.amin@emory.edu|
22318999|NCT03588728|University of Pittsburgh|Cynthia Conklin, Ph.D.|4125869840|conkca@upmc.edu|
22319000|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22319001|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22319002|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319003|NCT01386658|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22319004|NCT02465463|Emory|Dr. Tanvi Dhere|404-686-1000|tdhere@emory.edu|
22319005|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org|
22319006|NCT01087931|Vanderbilt University|Kevin O'Neill|615-936-5677||
22319007|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu|
22319008|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319009|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
22319010|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu|
22319011|NCT01498289|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
22319012|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org|
22319013|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
22319014|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
22319015|NCT03681886|Alcon, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22319016|NCT03272763|Fisher & Paykel Healthcare Ltd.|Rebecca Thomson|+64 9 574 0123|Rebecca.Thomson@fphcare.co.nz|7675
22319017|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
22319018|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu|
22319019|NCT00986440|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22319020|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org|
22319021|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org|
22319022|NCT02520284|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22319023|NCT03737474|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22319024|NCT02513745|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22319025|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
22319026|NCT01211522|Vanderbilt University Medical Center|E Wesley Ely|‭(615) 936-3395‬|wes.ely@vumc.org|
22319027|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319028|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493||
22319029|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com|
22319030|NCT03349892|University of California, Los Angeles|Robert K. Chin, MD, PhD , Assistant Clinical Professor|(310) 825-9771|rkchin@mednet.ucla.edu|
22319031|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org|
22319032|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22282954|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com|
22282955|NCT03444766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22282956|NCT03114124|UF Health- Jacksonville|Andrea Goosen|904-244-5617|andrea.ggosen@jax.ufl.edu|
22282957|NCT03421743|Savara Inc|Paymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22282958|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300||
22282959|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
22282960|NCT03900923|NYU Langone Health|Francisco X Castellanos, MD|646-754-5194|Francisco.Castellanos@nyulangone.org|
22282961|NCT03373890|SeattleChildrens|Kristie Bjornson, PT, PhD|206-884-2066|kristie.bjornson@seattlechildrens.org|
22282962|NCT02680574|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22282963|NCT02129478|The Hospital for Sick Children|Dr. Laura Lee Dupuis|416-813-7654|lee.dupuis@sickkids.ca|309355
22282964|NCT03468816|Åby vårdcentral, County council of Östergötland|Dr. Fredrik Iredahl|010-103 00 00|fredrik.iredahl@liu.se|
22282965|NCT02078102|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22282966|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
22282967|NCT02185014|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22282968|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
22319033|NCT02370043|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
22319034|NCT01231516|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319035|NCT02460666|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
22319036|NCT05266586|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22319037|NCT02225353|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
22327582|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327583|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
22327584|NCT02357849|Northwell Health|Dr. Christoph Correll|718-470|ccorrell@northwell.edu|7000
22327585|NCT03637699|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
22327586|NCT03105700|Dartmouth Hitchcock Medical Center|Krzysztof Bujarski, MD|6036505000|krzysztof.a.bujarski@hitchcock.org|
22327587|NCT01253421|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
22327588|NCT04105244|Frances Payne Bolton School of Nursing, Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP-PC, FAAN|216-534-5844|vab@case.edu|
22327589|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu|
22327590|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com|
22327591|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com|
22327592|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327593|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi|
22327594|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com|
22327595|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov|
22327596|NCT01364233|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
22327597|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22327598|NCT02034474|NYSPI|Ragy Girgis,MD|6467745553|ragy.girgis@nyspi.columbia.edu|
22327599|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282969|NCT02141490|National Cancer Institute|Dr. Ismail B. Turkbey|240-760-6112|turkbeyi@nih.gov|
22282970|NCT01813721|Amgen Inc.|Study Director|866-572-6436||
22282971|NCT02387164|Skåne University Hospital|Helena Elding Larsson|+4640337676|helena.larsson@med.lu.se|
22282972|NCT03398265|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
22282973|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22282974|NCT03906656|Ottobock|Russ Lundstrom|6127182025|russ.lundstrom@ottobock.com|
22282975|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com|
22282976|NCT01688843|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
22282977|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22282978|NCT02525939|DalCor Pharmaceuticals|Dr. Don Black, Chief Medical Officer|‭+1 (609) 613-6637‬|dblack@dalcorpharma.com|
22282979|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
22282980|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
22282981|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu|
22282982|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22282983|NCT03515941|Baylor College of Medicine|Eunji Jo|713-798-4923|ejo@bcm.edu|
22282984|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22282985|NCT02652416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22282986|NCT03959982|University of Iowa|Dr. Spyridon Fortis|319-356-4419|spyridon-fortis@uiowa.edu|
22282987|NCT04030247|Stanford University|Rajesh Dash, MD|650-725-7087|rdash@stanford.edu|
22319038|NCT03707925|UT MD Anderson Cancer Center|Roberto Casal, MD/ Associate Professor, Pulmonary Medicine|713-745-2645|rfcasal@mdanderson.org|
22319039|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22319040|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319041|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu|
22319042|NCT05245097|ActiveProtective|Dr Rebecca J Tarbert|267-242-6125|Rebecca@activeprotective.com|
22319043|NCT04770493|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
22319044|NCT04683731|Trustees of Indiana University|Dr. Peter H. Schwartz, MD, PhD|317-278-4037|phschwar@iu.edu|
22319045|NCT00883051|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22319046|NCT00692978|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
22319047|NCT03604523|UMass Medical School|Dr. David Cave|508-856-8399|david.cave@umassmemorial.org|
22319048|NCT00458341|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22319049|NCT02083705|University of Alberta|Georg Schmölzer|7807354647|georg.schmoelzer@me.com|
22319050|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22319051|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov|
22319052|NCT03891524|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319053|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu|
22327600|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
22327601|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000|thomas.ebert@va.gov|42429
22327602|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
22319054|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu|
22319055|NCT01598311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22282988|NCT03809910|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22282989|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327603|NCT02006264|Albert Einstein College of Medicine|Marla Keller, MD, Principal Investigator|718-430-3240|marla.keller@einstein.yu.edu|
22319056|NCT03144804|Massachusetts General Hospital|Aparna Parikh, MD|617-339-8452|aparna.parikh@mgh.harvard.edu|
22319057|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22319058|NCT04223856|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22319059|NCT06515483|Loops, LLC|Steven Kayser, President|360-366-3009|stevenkayser@flossloops.com|
22319060|NCT03454828|Yale University School of Medicine: Pediatrics Endocrinology|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
22319061|NCT03722407|Moffitt Cancer Center|Eric Padron, MD|813-745-2864|eric.padron@moffitt.org|
22319062|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu|
22319063|NCT01306890|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22319064|NCT02217436|Rady Children's Hospital San Diego|Dr. Amy Williams Bryl|8589668036|abryl@rchsd.org|
22319065|NCT02656420|JHSPH|Dr. Thomas W. Kensler|410-955-1292|tkensle1@jhu.edu|
22319066|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22319067|NCT04533451|Mayo Clinic|Dr. Aminah Jatoi|507-266-9160|Jatoi.Aminah@mayo.edu|
22319068|NCT05344092|Department of Veterans Affairs|Dr. Erin Reilly|781-687-2000|Erin.Reilly@va.gov|4191
22319069|NCT02634346|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22319070|NCT02170389|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22319071|NCT02743377|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
22319072|NCT03260595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319073|NCT04485104|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22319074|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492||
22319075|NCT03153137|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319076|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22319077|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22319078|NCT02267356|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@viamet.com|
22319079|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu|
22319080|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu|
22319081|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com|
22319082|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se|
22319083|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu|
22319084|NCT03712189|Children's Hospital Los Angeles|Dr Todd P Chang|13233612109|tochang@chla.usc.edu|
22319085|NCT03026127|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
22319086|NCT01182766|University of Virginia School of Medicine|Dr. Nassima Ait-Daoud Tiouririne|(434) 243-0570|NAT7B@uvahealth.org|
22319087|NCT03027557|Aalborg University Hospital|Professor Peter Vestergaard|+45 97 66 36 00|p.vestergaard@rn.dk|
22319088|NCT03270332|University of Miami|Dr. Adam Wanner|3053010563|awanner@miami.edu|
22319089|NCT02430051|University of Southern California|Dr. Leah Stein Duker|(323)442-0371|lstein@chan.usc.edu|
22319090|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com|
22319091|NCT01050907|Fast-Track Drugs and Biologics, LLC|Jonathan D. Berman|301-922-2097|jberman@fasttrackresearch.com|
22319092|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
22319093|NCT00564018|UT Southwestern Medical Center|Soumya Adhikari, MD|214 456 5959|soumya.adhikari@utsouthwestern.edu|
22319094|NCT03482583|University of Florida|Dr. Ramzi Salloum, Assistant Professor|352-294-4997|rsalloum@ufl.edu|3522944994
22319095|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu|
22319096|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org|
22319097|NCT01145755|AstraZeneca|Gerard Lynch|645895|aztrial_results_posting@astrazeneca.com|+44 1509
22319098|NCT01222260|Columbia University Medical Center|Suzanne Lentzsch, M.D., PhD.|212-304-5485|sl3440@cumc.columbia.edu|
22319099|NCT05062083|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
22319100|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22319101|NCT01605253|Rush University Medical Center|Mark Pollack, MD|3129425372|mark_pollack@rush.edu|
22319102|NCT02973048|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
22319103|NCT04427501|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22319104|NCT03170154|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22319105|NCT04974515|University of Miami, Miller School of Medicine|Naresh M. Punjabi, MD, PhD|305-243-6388|npunjabi@miami.edu|
22319106|NCT01906346|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
22319107|NCT04936841|University of Wisconsin School of Medicine and Public Health|Zachary Morris, MD, PhD|(608) 263-2603|zmorris@humonc.wisc.edu|
22319108|NCT02279862|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22319109|NCT01444209|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
22319110|NCT03431857|Zimmer Biomet|Emilie Rohmer, Clinical Ops manager|+41588548210|emilie.rohmer@zimmerbiomet.com|
22319111|NCT03099005|UCSD|Brook Henry|(619) 543-4737|blhenry@ucsd.edu|
22319112|NCT04195958|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22319113|NCT01721603|University of California, San Francisco|Alain Algazi, MD|(415) 353-7552|Alain.Algazi@ucsf.edu|
22327604|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr|
22282990|NCT04787055|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22327605|NCT05092971|National Institute of Mental Health (NIMH)|Dr. Maryland Pao|301-435-5770|paom@mail.nih.gov|
22327606|NCT01208038|Chelsea and Westminster NHS Trust|Dr Kate Maclaran|020 3315 3000|kate.maclaran@nhs.net|
22327607|NCT02487901|Seoul National Unversity College of Medicine|Chun Kee Chung|+82-2-2072-2357|chungc@snu.ac.kr|
22327608|NCT04092816|University of North Carolina at Chapel Hill|Zev Nakamura, MD|984-974-3829|zev_nakamura@med.unc.edu|
22327609|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327610|NCT03833817|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
22282991|NCT03880838|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
22282992|NCT03647267|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22282993|NCT05079477|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
22282994|NCT01798641|Johns Hopkins University|Dr. Daniele Rigamonti, MD FACS|410-955-2259|hydrocephalus@jhmi.edu|
22282995|NCT05264116|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
22282996|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu|
22327611|NCT02097485|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22327612|NCT04172701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327613|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22327614|NCT02757092|Chang Gung Memorial Hospital|Respiratory therapist Nai-Ying Kuo|+886077317123|ellen0605@gmail.com|2648
22327615|NCT03363919|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
22327616|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327617|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327618|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com|
22327619|NCT00574119|Vanderbilt University School of Medicine|Marvin W. Kronenberg,M.D.|615 936-7437|marvin.w.kronenberg@vumc.org|
22327620|NCT03287245|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22327621|NCT02862548|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22327622|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327623|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com|
22327624|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
22327625|NCT03057951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327626|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22327627|NCT05343585|Pennington Biomedical Research Center|Chloe Panizza Lozano|(225) 763-2500|cpanizza@hawaii.edu|
22327628|NCT04241146|Children's Hospital of Nevada at UMC|Prashant Jha|702-383-2420|prashant.jha@umcsn.com|
22327629|NCT05158179|University of California San Francisco|Yue Ma|415-885-7700|yue.ma@ucsf.edu|
22327630|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327631|NCT04807101|Northwestern University|Greg Cohen, MD|312-695-4452|gregcohen@northwestern.edu|
22327632|NCT06170866|University of Connecticut|Dr. Cristina Colon-Semenza, Assistant Professor|8604860019|cristina.colon-semenza@uconn.edu|
22327633|NCT03353753|Deciphera Pharmaceuticals, LLC|INVICTUS Clinical Team|7812096400|clinicaltrials@deciphera.com|
22327634|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu|
22327635|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu|
22327636|NCT01830816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22327637|NCT01753830|Q-Med AB|Clinical Project Manager|+46 18 4749000|reception.seupp@galderma.com|
22327638|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22327639|NCT03624478|Mayo Clinic|Dr. Carlos Vargas|480-342-1267|Vargas.Carlos@mayo.edu|
22327640|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000|Michael.Falvo@va.gov|2423
22327641|NCT03263117|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|peng.r.chen@uth.tmc.edu|
22327642|NCT01885078|Eli Lilly & Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22327643|NCT02680587|Johns Hopkins University|Dr. Phuoc T. Tran|4106143880|ptran12@jhmi.edu|
22327644|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu|
22327645|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu|
22327646|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu|
22327647|NCT03739853|University of Oxford, NDORMS|Laura Coates|+441865737838|laura.coates@ndorms.ox.ac.uk|
22282997|NCT01330966|George Clinical|Lindsey Munn|901-350-8801|lmunn@georgeclinical.com|
22282998|NCT02080260|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22282999|NCT05438602|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22289142|NCT02289157|UTSW Medical Center|Dr. Scott Roberts|214-648-3113|scott.roberts@utsouthwestern.edu|
22327648|NCT00259740|Amgen Inc.|Study Director|866-572-6436||
22289143|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22289144|NCT01388335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289145|NCT01415882|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
22327649|NCT05848323|University of Washington|Lindsey Knowles|2067449640|lmknow@uw.edu|
22327650|NCT01367301|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
22327651|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu|
22327652|NCT02170649|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
22327653|NCT01309867|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
22327654|NCT04735393|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22327655|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu|
22327656|NCT00432094|Masonic Cancer Center, University of Minnesota|Dr. Najla El Jurdi|612-625-8942|neljurdi@umn.edu|
22327657|NCT02769351|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49617260893488|jennifer.braun@fmc-ag.com|
22327658|NCT03224104|UniversitaetsSpital Zurich - Neurology Clinic|Dr Emilie Le Rhun|+41 762847518|emilie.lerhun@usz.ch|
22327659|NCT04397718|Department of Veterans Affairs GLA|Dr. Matthew Rettig|310-478-3711|matthew.rettig@va.gov|44761
22327660|NCT06087328|Medical University of South Carolina|Amanda M. Palmer, PhD|843-792-1413|palmeram@musc.edu|
22327661|NCT03589326|Director|Medical|+1-877-825-3327|trialdisclosures@takeda.com|
22327662|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22327663|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327664|NCT02998554|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327665|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
22327666|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org|
22327667|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
22327668|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil|
22327669|NCT02049749|Children's Hospital of Philadelphia|Dr. Joanne Wood, PI|267-426-3107|woodjo@email.chop.edu|
22327670|NCT03497026|Auris Health|Scott Rehage|925 6832590|srehage@its.jnj.com|
22327671|NCT03615911|University Medical Center Hamburg-Eppendorf|Prof. Marylyn M. Addo|+49 40 7410|m.addo@uke.de|51102
22327672|NCT04511026|Stanford University|Amer Karam, MD|650-498-6004|amkaram@stanford.edu|
22327673|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327674|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629||
22327675|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com|
22327676|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov|
22327677|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22327678|NCT00622544|University of MN|Clifford E. Kashtan|646 692 9309|cassi044@umn.edu|
22327679|NCT01963208|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22327680|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|70 51
22327681|NCT05522673|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
22327682|NCT01283997|UT MD Anderson Cancer Center|Dr. Sheeba Thomas,Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
22327683|NCT02109744|University of Rochester|Jane Liesveld|585 - 275 - 5823|Jane_Liesveld@urmc.rochester.edu|
22327684|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22327685|NCT04095442|Indiana University Indianapolis|Andrew R. Coggan|3172740656|acoggan@iu.edu|
22327686|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
22327687|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22327688|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22289146|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289147|NCT03210337|Aclaris Therapeutics|Executive Director, Clinical Operations|4843292144|jschnyder@aclaristx.com|
22289148|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22289149|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org|
22289150|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22289151|NCT03339219|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22289152|NCT03702283|VANDERBILT UNIVERSITY MEDICAL CENTER|Cosby A Stone, Jr. MD, MPH|6153223412|Cosby.a.stone@vumc.org|
22289153|NCT01243580|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
22289154|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
22289155|NCT05126953|Bausch + Lomb Incorporated|Schafer, Jill|0000000|Jill.Schafer@bausch.com|
22289156|NCT03155841|University of Pennsylvania|Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22289157|NCT04308291|Medtronic Diabetes|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
22289158|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com|
22289159|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com|
22289160|NCT03399552|Memorial Sloan Kettering Cancer Center|Dr. Andreas Rimner, MD|646-608-2449|Rimnera@MSKCC.ORG|
22289161|NCT02357368|Emory University|Lisa Haddad, MD|404-778-1385|lisa.haddad@emory.edu|
22289162|NCT01931566|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22289163|NCT00411684|HRA Pharma|Paul Carter - Chief Scientific Officer|+33 1 40 33 11 30|p.carter@hra-pharma.com|
22289164|NCT04625101|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
22327689|NCT01263093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283000|NCT02091284|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 3335-7337|emnpalacios@gmail.com|
22283001|NCT02853435|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283002|NCT04973696|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ana-Maria Vranceanu|617-724-4977|avranceanu@mgh.harvard.edu|
22283003|NCT03747120|University of Texas Southwestern Medical Center|Dr. Heather McArthur, Professor IM-Hem Onc|214-645-9380|heather.mcarthur@utsouthwestern.edu|
22283004|NCT02418312|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22283005|NCT00803413|Hospital das Clínicas - São Paulo University School of Medicine|Mario Fereira Junior|55 11 3069-7691|mariofj@uol.com.br|
22283006|NCT00308165|Columbia University|Jeffrey N. Bruce, MD|212-305-7346|jnb2@columbia.edu|
22283007|NCT02583230|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22283008|NCT01410812|University of Pennsylvania|Katherine L. Milkman, Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
22283009|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org|
22283010|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22283011|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22283012|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22283013|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu|
22283014|NCT03362931|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22283015|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22283016|NCT03276052|AstraZeneca|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
22283017|NCT02061397|University of Pennsylvania|Dr. Vera Krymskaya|215-573-9861|krymskay@pennmedicine.upenn.edu|
22283018|NCT03404804|Medical College of Wisconsin|Dr. David Vyles, DO|414-266-2625|dvyles@mcw.edu|
22283019|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com|
22283020|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com|
22283021|NCT05136898|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
22283022|NCT05357664|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
22283023|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu|
22283024|NCT03784846|Pacific University|Michael Christopher, Ph.D.|503-352-2498|mchristopher@pacificu.edu|
22283025|NCT03054350|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
22283026|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22283027|NCT01643850|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22283028|NCT01133405|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22283029|NCT02737553|Ege University|Ali Akdemir|+905056748904|md.aliakdemir@gmail.com|
22283030|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283031|NCT03300024|Johns Hopkins University|Thomas Reifsnyder|410-955-7518|treifsn1@jhmi.edu|
22283032|NCT01238835|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22283033|NCT02088073|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22283034|NCT02419131|Massachusetts General Hospital, Harvard Medical School|Dr. Tim Houle|617-724-2111|thoule1@mgh.harvard.edu|
22283035|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu|
22283036|NCT00902018|Weill Cornell Medical College|Dr James Bussel|22-746-3474|jbussel@med.cornell.edu|
22283037|NCT02969590|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22283038|NCT02881112|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
22283039|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com|
22283040|NCT02370641|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
22283041|NCT02342379|University of Texas Health San Antonio|Andrew Brenner, MD, PhD|210-450-5936|brennera@uthscsa.edu|
22283042|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22283043|NCT02370095|University of North Carolina at Chapel Hill|Wayne H Anderson, PhD|919-445-0351|wayne_anderson@med.unc.edu|
22283044|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22283045|NCT01667562|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22283046|NCT02130986|University of Pittsburgh|David T Huang, MD, MPH, Associate Professor|412-647-6818|huangdt@upmc.edu|
22283047|NCT01129882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22283048|NCT01028716|Fred Hutchinson Cancer Center|Rachel Salit|2066671317|rsalit@fredhutch.org|
22283049|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
22283050|NCT03236168|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
22327690|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300||
22327691|NCT00571519|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22327692|NCT01109069|Pharmacyclics|James Dean|669-224-1880|jdean@pcyc.com|
22289165|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com|
22289166|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu|
22327693|NCT03947255|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22327694|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com|
22327695|NCT04857593|King's College London|Professor Carmine Pariante|020 78480807|carmine.pariante@kcl.ac.uk|
22300113|NCT04717596|Abigail Wexner Research Institute|Dr. Elise Berlan|6147222458|elise.berlan@nationwidechildrens.org|
22300114|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu|
22300115|NCT03555396|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
22300116|NCT02460991|Boston Scientific|Kristi Winterfeldt|763-494-1165|kristi.winterfeldt@bsci.com|
22300117|NCT02564523|Janssen Vaccines & Prevention B.V|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22300118|NCT03814889|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
22300119|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22300120|NCT02357836|UT Southwestern Medical Center|Dr. David Gerber|214-648-4180|David.Gerber@UTSouthwestern.edu|
22300121|NCT03701555|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22300122|NCT00448539|Eisai Inc.|Eisai Medical Information|1 8882472378|esi_medinfo@eisai.com|
22300123|NCT03349710|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22300124|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com|
22300125|NCT04256733|University of Montana|Dr. Laurie Slovarp|406-243-2107|laurie.slovarp@umontana.edu|
22300126|NCT01296568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300127|NCT04542343|CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE|DR. MOHSEN BAZARGAN|323-357-3655|mohsenbazargan@cdrewu.edu|
22300128|NCT02539342|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
22300129|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
22300130|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300131|NCT01816594|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22300132|NCT03905655|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
22300133|NCT04723576|RAND|Lisa S. Meredith|310.393.0411|seidel@rand.org|7365
22300134|NCT02727894|Institution for Clinical and Experimental Medicine|Jan Král|+420605273008|jan.kral@centrum.cz|
22300135|NCT04320069|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22300136|NCT03204279|Helsinn Healthcare SA|Edwin de Wit - Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
22300137|NCT04827212|Northeastern University|Dr. Dinesh John|(801) 230-6320|d.john@northeastern.edu|
22300138|NCT03317002|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22300139|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu|
22300140|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com|
22300141|NCT03927950|Department of Psychiatry, University of Tartu|Eduard Maron|+3727318812|eduard.maron@kliinikum.ee|
22300142|NCT03263429|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22300143|NCT04530448|West Virginia University|Ankit Sakhuja, MD|304.598.6092|ankit.sakhuja@hsc.wvu.edu|
22300144|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22327696|NCT00989612|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327697|NCT03434418|Duke University|Thomas Stinchcombe, MD|919-681-9509|thomas.stinchcombe@duke.edu|
22327698|NCT00944216|Wright State University School of Medicine, Dept of Dermatology|Amy Chen, MD|927-224-3345|amy.chen@wright.edu|
22327699|NCT03039738|Medtronic|Anne Kinney|+1-303-876-8904|anne.r.kinney@medtronic.com|
22327700|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22327701|NCT02716194|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22327702|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300||
22327703|NCT02293993|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22327704|NCT00205699|Florida Atlantic University|John W. Newcomer|(561) 297-0252|jnewcomer@health.fau.edu|
22327705|NCT03587584|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
22327706|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22327707|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327708|NCT01207388|Amgen Inc.|Study Director|866-572-6436||
22283051|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283052|NCT02649192|St. Jude Children's Research Hospital|Nehali Patel, MD|866-278-5833|info@stjude.org|
22283053|NCT03849690|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22283054|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn|
22283055|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com|
22283056|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283057|NCT02761694|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283058|NCT03840525|Florida International University|Dr. Gladys Ibanez|305-348-4920|gibanez@fiu.edu|
22283059|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22283060|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu|
22283061|NCT01896271|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
22283062|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300145|NCT02014116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22300146|NCT01491854|Novartis Pharma AG|Study Director|862-778-8300|novartis.email@novartis.com|
22327709|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu|
22327710|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD/Professor, Stem Cell Transplantation|713-745-3458|mqazilba@mdanderson.org|
22327711|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22327712|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org|
22327713|NCT04465396|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22327714|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu|
22327715|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
22327716|NCT05294211|Marani Health, Inc.|Vice President, Clinical Affairs|612-718-9699|mindy@maranihealth.com|
22327717|NCT03334396|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22327718|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
22327719|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327720|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22327721|NCT02159469|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22327722|NCT03629041|Innoture Ltd|Jemma Burridge, Clinical Project Manager|+44 (0)7799 902476|jburridge@innoture.co|
22327723|NCT01519284|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22327724|NCT03488251|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
22327725|NCT03730194|University of Nebraska Medical Center|Alyson E Hanish|402-559-6731|alyson.hanish@unmc.edu|
22327726|NCT04427917|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327727|NCT01766817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22327728|NCT03600714|NIDDK|Dr. Christopher Koh|301-443-9402|kohchris@mail.nih.gov|
22327729|NCT03814590|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327730|NCT03011450|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22327731|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com|
22327732|NCT03519516|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22327733|NCT00592553|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22327734|NCT04914377|Novatek Pharmaceuticals|Ahmed Kaseb MD|877-662-8351|akaseb@novatekpharmaceuticals.com|
22327735|NCT01244191|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22327736|NCT01752842|Washington University School of Medicine|Jean E. Schaffer, MD|314-362-8717|jschaff@wustl.edu|
22327737|NCT02164513|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327738|NCT05301322|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327739|NCT04971785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22327740|NCT03829332|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22327741|NCT05294341|Hershey Medical Center|Dr. Halina Yee; Primary Resident Investigator|7175313503|hyee@pennstatehealth.psu.edu|
22327742|NCT00646113|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22327743|NCT05458011|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22327744|NCT05076370|Yale University, Department of Psychiatry|Joao De Aquino, M.D.|203-932-5711|joao.deaquinolima@yale.edu|12916
22327745|NCT03794752|UT Southwestern Medical Center|Peter Chen|12146283837|peter.chen@utsouthwestern.edu|
22327746|NCT03292952|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
22327747|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu|
22327748|NCT02690207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327749|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22327750|NCT04656418|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22327751|NCT02586077|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
22327752|NCT02701192|Carolinas Healthcare System|Rachel Seymour, PhD|704-355-2000|Rachel.Seymour@carolinas.org|
22327753|NCT02267226|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
22327754|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22327755|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22327756|NCT02667457|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22327757|NCT02475850|Yale University|Erich Greene PhD|203-737-3636|erich.greene@yale.edu|
22327758|NCT03330041|University of California, Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
22327759|NCT03097614|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22327760|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22327761|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp|
22327762|NCT00912340|Emory University|Elisavet Paplomata, Principal Investigator|404-778-1900|elisavet.paplomata@emory.edu|
22327763|NCT00915538|Western Sky Medical Research|Lyndon Mansfield MD|915-544-2557|immunman@westernskymed.com|
22327764|NCT02527187|Inmunotek|Dr. Miguel Casanovas/ Medical Director|91 6510010|mcasanovas@inmunotek.com|
22327765|NCT00436982|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Eric Garling, PhD, Snr. Director Medical & Scientific Affairs Europe|+31 20 219 2660|Eric.Garling@stryker.com|
22327766|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu|
22327767|NCT03864536|UAB|Pariya Wheeler|2052423924|plfazeli@uab.edu|
22327768|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com|
22327769|NCT04058158|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22327770|NCT02215616|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22327771|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22327772|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu|
22327773|NCT00520299|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22327774|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327775|NCT02062463|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22327776|NCT01743872|Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center|Dr. Vikram S. Kashyap|216-844-1631|vikram.kashyap@uhhospitals.org|
22327777|NCT01509872|Queen's University Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
22327778|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22327779|NCT02858154|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani|513-736-1814|Neepa.Gurbani@cchmc.org|
22327780|NCT02979301|Mayo Clinic|Dr. Carrie Hruska|507-293-4719|hruska.carrie@mayo.edu|
22327781|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com|
22327782|NCT00218426|University of Pennsylvania|Dr. George E Woody|215-746-7702|woodg@pennmedicine.upenn.edu|
22327783|NCT03172481|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
22327784|NCT05197140|University of Arkansas for Medical Sciences|Robert Wolfe|501-526-5769|rwolfe2@uams.edu|
22327785|NCT02759562|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22327786|NCT01957709|Fred Hutchinson Cancer Research Center|Seth Pollack, MD|206-667-6629|spollack@fredhutch.org|
22327787|NCT03050216|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612 625 3918|bruns072@umn.edu|
22327788|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22327789|NCT01925612|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22327790|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-2828|ceng@mdanderson.org|
22327791|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu|
22327792|NCT03115112|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22327793|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu|
22327794|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu|
22327795|NCT02168803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22327796|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22327797|NCT01827930|Institut Bergonié|Pr Simone Mathoulin-Pelissier|05 56 33 33 33|S.Mathoulin@bordeaux.unicancer.fr|
22327798|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk|
22327799|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
22327800|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu|
22327801|NCT03060083|University of Vermont|Elias M Klemperer|8026561641|elias.klemperer@med.uvm.edu|
22327802|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
22327803|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com|
22327804|NCT01583985|Minneapolis VA Health Care System|Erin Krebs, MD|612-725-2000|erin.krebs@va.gov|
22327805|NCT01170702|Northwestern University Feinberg School of Medicine|Edward Yaghmour|312-695-0693|edward.yaghmour@nm.org|
22327806|NCT04999969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22327807|NCT06964165|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327808|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327809|NCT04460690|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
22327810|NCT04363437|Maimonides Medical Center|Dr. Felix Yang|7182836000|fyang@maimonidesmed.org|
22327811|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22327812|NCT05584202|ModernaTX, Inc.|Moderna WeCare Team|866-663-3762|WeCareClinicalTrials@modernatx.com|
22327813|NCT03722472|Access to Advanced Health Institute (AAHI)|Christopher Fox PhD|(206) 381-0883|Christopher.Fox@aahi.org|
22327814|NCT03297216|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joan_price@med.unc.edu|
22327815|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov|
22327816|NCT02700919|Mereo BioPharma Group|Ian Hodgson, Head of Clinical Operations|+44 3330237300|enquiries@mereobiopharma.com|
22327817|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org|
22327818|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
22327819|NCT01057134|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22327820|NCT01383109|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
22327821|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|+1-888-727-3782|clinicaltrials@sarepta.com|
22327822|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu|
22327823|NCT01608490|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|Kristi.Winterfeldt@bsci.com|
22327824|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
22327825|NCT02310906|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
22327826|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623||
22327827|NCT02899377|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22327828|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327829|NCT03007719|University of California, San Francisco|Dr. Lawrence Fong|(415) 353-2051|Lawrence.Fong@ucsf.edu|
22327830|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu|
22327831|NCT04026178|Chiesi|Metreleptin Clinical Program Lead|+3905212791|clinicaltrials_info@chiesi.com|
22327832|NCT03779334|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22327833|NCT06533475|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22327834|NCT04321252|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22327835|NCT06245044|University of Michigan|Dr. Corey Lester|734-647-8849|lesterca@umich.edu|
22327836|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu|
22327837|NCT01082367|Novartis|Study Director|862-778-8300||
22327838|NCT00664755|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22327839|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov|
22327840|NCT02823600|University of North Carolina at Chapel Hill|Seema Garg, MD, PhD|919-966-5296|sgarg@med.unc.edu, ashton.madison@alumni.duke.edu|
22327841|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300||
22327842|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22327843|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov|
22327844|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327845|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22327846|NCT01658579|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
22327847|NCT03641547|OCTO, University of Oxford|Dr Ruth Harman, Trial Manager|01865 617018|octo-CHARIOT@oncology.ox.ac.uk|
22327848|NCT02767856|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
22327849|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br|
22327850|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu|
22327851|NCT02513784|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
22327852|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22327853|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu|
22327854|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com|
22327855|NCT05127044|University of Arkansas for Medical Sciences|Rebecca P Sartini, DNP|5015261580|rpsartini@uams.edu|
22327856|NCT05612581|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22327857|NCT02754830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22327858|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca|
22327859|NCT02670330|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22327860|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22327861|NCT05080179|University of Pennsylvania, Perelman School of Medicine|Dr. Erica Dixon|215-573-9987|erica.dixon@pennmedicine.upenn.edu|
22327862|NCT03670641|University of Pittsburgh Medical Center (UPMC)|David Rometo, MD|412-586-9700|rometoda@upmc.edu|
22327863|NCT01662297|Yale University/West Haven VAMC|Dr. Albert Arias|2039325711|albert.arias@va.gov|8155
22327864|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu|
22327865|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22327866|NCT00125190|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22327867|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
22327868|NCT03172520|Mayo Clinic|Eric J. Moore, M.D.|507-284-3853|Moore.Eric@mayo.edu|
22327869|NCT00414960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22327870|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327871|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov|
22327872|NCT00669916|Novartis|Study Director|862-778-8300||
22327873|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300||
22327874|NCT01788306|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
22327875|NCT02756650|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22327876|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22327877|NCT03041909|Global Blood Therapeutics|Margaret Tonda, Sr. Director, Clinical Science|650-741-7761|mtonda@gbt.com|
22327878|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711|Robert.Rosenheck@va.gov|3723
22327879|NCT01009918|University of South Florida|Maya Guglin, MD, PhD|813-259-0600|mguglin@health.usf.edu|
22327880|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu|
22327881|NCT01589263|Baylor College of Medicine|Christopher Smith|713-798-4001|cps@bcm.edu|
22327882|NCT03955055|UMass Chan Medical School|Anne Foley, Senior Clinical Research Coordinator|774-442-4098|anne.foley@umassmed.edu|
22327883|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22327884|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327885|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu|
22327886|NCT03819218|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
22327887|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu|
22327888|NCT04116073|Sidney Kimmel Comprehensive Center at Johns Hopkins|Nilo Azad|410-614-9169|nilo.azad@jhu.edu|
22327889|NCT02892201|Yale School of Medicine|Barbara Burtness, MD|(203) 200-4622|arbara.burtness@yale.edu|
22327890|NCT05814471|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22327891|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327892|NCT05137730|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22327893|NCT01840228|Ohio State University|Dr. Heather Frey|614-688-6798|Heather.Frey@osumc.edu|
22327894|NCT00712933|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327895|NCT02476357|Lausanne University Hospita! and University of Lausanne|Prof. Dr Med. Maurice MATTER|795561071|maurice.matter@chuv.ch|0041
22327896|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org|
22327897|NCT02022033|Brown University Oncology Research Group|Howard Safran, MD|401-863-3000|BrUOG@BROWN.EDU|
22327898|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org|
22327899|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
22327900|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22327901|NCT01148563|Louisiana State Univeristy Health Care Services Division|Dr. Ron Horswell|225-763-2983|rhorsw@lsuhsc.edu|
22327902|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
22327903|NCT01879319|Amgen Inc.|Study Director|866-572-6436||
22327904|NCT05590767|Tri-Service General Hospital, National Defense Medical Center|Dr. Lu Yi-Hsiung|+886933429559|luyihsiung@gmail.com|
22327905|NCT00084929|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
22327906|NCT03930641|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22327907|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu|
22327908|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
22327909|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
22327910|NCT01797965|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22327911|NCT01764256|PATH|Jorge Flores|2028220033|jeflores@path.org|
22327912|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu|
22327913|NCT02029638|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22327914|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu|
22327915|NCT05489081|Children's Hospital of Philadelphia|Dr. Gwendolyn Lawson|2674266612|lawsong@chop.edu|
22327916|NCT03886701|Thomas Jefferson University|Dr. Walter K. Kraft|215 955-9077|walter.kraft@jefferson.edu|
22327917|NCT01887587|Medical College of Wisconsin|Ehab Atallah, MD|414-805-8900|eatallah@mcw.edu|
22327918|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu|
22327919|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
22327920|NCT03371160|ENvizion Medical (Nutriseal)|Clinical Director|+972-72-2288240|anath@envizionmed.com|
22327921|NCT04348591|Duke University|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
22327922|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300||
22327923|NCT03722784|CooperVision, Inc.|Martine Robie|9256604477|mrobie@coopervision.com|
22327924|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu|
22327925|NCT01317615|Novartis|Study Director|862-778-8300||
22327926|NCT01322646|University at Buffalo|Gregory A. Fabiano, Ph.D.|7166451130|fabiano@buffalo.edu|
22327927|NCT02648724|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
22327928|NCT02821455|University of Edinburgh|E Alexandra Page|7938645122|s1305565@sms.ed.ac.uk|
22327929|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov|
22327930|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327931|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
22327932|NCT04398199|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mfarris@wakehealth.edu|
22327933|NCT02927873|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327934|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org|
22327935|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22327936|NCT02902913|University of California, Davis|Roberta R Holt|530-752-4950|rrholt@ucdavis.edu|
22327937|NCT04900038|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327938|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu|
22327939|NCT02300077|Department of Anesthesiology Washington University in St. Louis|Helga Komen|3148527622|komenh@anest.wustl.edu|
22327940|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012||
22327941|NCT05757427|MVG Industries SAS|Luc Duchesne|+33 (0) 6 70 33 91 20|luc.duchesne91@gmail.com|
22327942|NCT02017899|GSK Vaccines Institute for Global Health S.r.l.|Dr. Audino Podda|+39 0577 243496|audino.p.podda@gsk.com|
22327943|NCT01985971|University of Pennsylvania|Lilie Lin, MD|215-662-7267|lin@xrt.upenn.edu|
22327944|NCT02843178|Stanford University|Mandy Murphy Carroll, Study Coordinator|(650) 509-0004|mandyiam@stanford.edu|
22327945|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000|joseph.liao@va.gov|65581
22327946|NCT02762799|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22327947|NCT02420795|UT MD Anderson Cancer Center|Michael Wang, MD, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
22327948|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu|
22327949|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327950|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327951|NCT04578015|The Ohio State University|Kartik Venkatesh, MD, PhD|614-293-2222|kartik.venkatesh@osumc.edu|
22327952|NCT02528253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22327953|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22327954|NCT01624506|Ethicon|Janet DeMarchi|612-867-8727|jdemarch@its.jnj.com|
22327955|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com|
22327956|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
22327957|NCT04019795|Revian, Inc.|John Oakley|919-321-1726|joakley@knowbiollc.com|
22327958|NCT03625141|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22327959|NCT03250377|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22327960|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu|
22283063|NCT03002623|National Cancer Institute|Dr. Naris Nilubol|301- 451-2355|niluboln@nih.gov|
22283064|NCT01540409|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
22283065|NCT03762616|Exact Imaging|Dr. Brian Wodlinger|6475279032|bwodlinger@exactimaging.com|
22283066|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22283067|NCT06034652|Integra LifeSciences Corporation|Andrew Tummon, Director, Global Clinical Operations|609-936-5490|andrew.tummon@integralife.com|
22283068|NCT00583791|Abbott|Maren Wagner|6517565585|maren.wagner@abbott.com|
22283069|NCT00203021|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22283070|NCT04699812|Apple Inc.|Clinical Health Product Clinician|866-905-5303|htclinicalquestions@apple.com|
22283071|NCT03204890|Boston Medical Group|Dr. José Pablo Saffon|+573208899777|jsaffon@bostonmedical.com.co|
22283072|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22283073|NCT04562597|Medical University of South Carolina|Dr. Sylvia Wilson|843-792-2322|wilsosh@musc.edu|
22283074|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
22283075|NCT04524455|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22283076|NCT01688739|Amgen Inc.|Study Director|866-572-6436||
22283077|NCT02406443|Renal Physiology Laboratory|University Health Network|416-340-4800|vesta.lai@uhn.ca|8508
22300147|NCT02212574|Johns Hopkins University|Dr. Kenneth Cohen|(410) 614-5055|kcohen@jhmi.edu|
22283078|NCT00490776|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22283079|NCT03383783|Oral Health Research Institute|Domenick T Zero, DDS, MS|317-274-8822|dzero@iu.edu|
22300148|NCT02162420|Masonic Cancer Center|Christen Ebens, MD, MPH|612-624-4511|ebens012@umn.edu|
22327961|NCT03444870|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22327962|NCT02034552|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22327963|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu|
22327964|NCT02501902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283080|NCT06276881|Dandelion Science|Chief Executive Officer (CEO)|628-777-3477|info@dandelion.science|
22283081|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283082|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012||
22283083|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com|
22283084|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk|
22283085|NCT02119156|GlaxoSmithKline|GlaxoSmithKline|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22283086|NCT01657760|Harbor-UCLA Department of Psychiatry|Todd Zorick|310-781-3400|tzorick@mednet.ucla.edu|
22283087|NCT02469415|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
22283088|NCT02506660|Hospital of Special Surgery|Dr. Richard Kahn|212-774-7274|KahnR@HSS.EDU|
22283089|NCT02124512|University of Kentucky|Philip Kern|859-323-2232|pake222@uky.edu|
22283090|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22283091|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22283092|NCT02961946|Massachusetts General Hospital|Dr. Brian Ghoshhajra|617-726-5954|BGHOSHHAJRA@mgh.harvard.edu|
22283093|NCT05039671|Yale University|Dr. Elizabeth Connors|12038150685|elizabeth.connors@yale.edu|
22283094|NCT04599166|Penn State College of Medicine|Dr. Benjamin Levi|717-531-8778|BHLevi@psu.edu|
22283095|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com|
22283096|NCT02233738|Ralph H. Johnson VA Medical Cneter|Dr. Elizabeth Santa Ana|843-789-7168|Elizabeth.Santaana2@va.gov|
22283097|NCT02435680|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22283098|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22283099|NCT01975519|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22283100|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283101|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
22327965|NCT02267278|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
22327966|NCT02513771|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22327967|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu|
22327968|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
22327969|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr|
22327970|NCT04295356|CELLTRION, Inc.|Sung Hyun Kim, Head of Clinical Planning Department|+82 32 850 5778|SungHyun.Kim@celltrion.com|
22327971|NCT01784588|Boston Scientific|Teresa Takle-Flach|952-930-6000|Teresa.Takle-Flach@bsci.com|
22327972|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
22327973|NCT04655703|Northwell Health System|Eugene S. Krauss|516-496-2637|ekrauss@northwell.edu|
22327974|NCT03807245|MinervaX ApS|Dr Per Fischer|+45 20 25 20 38|pbf@minervax.com|
22327975|NCT04904614|Tufts Medical Center|Dr. Jennifer Chow|617-636-5244|jennifer.chow@tuftsmedicine.org|
22327976|NCT04268004|Nationwide Children's Hospital|Leena Nahata|6147224502|leena.nahata@nationwidechildrens.org|
22327977|NCT03495453|NYU Langone Health|Anvar Babaev, MD, PhD|212-263-5656|Anvar.Babaev@nyulangone.org|
22327978|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu|
22327979|NCT01360762|Institute of Tropical Medicine Antwerp|Johan Van Griensven|+32(0)32476426|jvangriensven@itg.be|
22327980|NCT04724733|Washington State University College of Nursing|Julie Postma, Professor, Associate Dean for Research|509-324-7287|jpostma@wsu.edu|
22327981|NCT03067129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22327982|NCT03372603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22327983|NCT03341923|Alcon Japan, Ltd.|Group Manager, Vision Care|+81.3.6899.5061|alcon.medinfo@alcon.com|
22327984|NCT03986190|University of Miami Miller School of Medicine|Dr. Sara St George|305-243-0726|s.stgeorge@med.miami.edu|
22327985|NCT02806947|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22327986|NCT04511819|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22327987|NCT04929613|West Virginia University|Keith Zullig, PhD|304-293-1091|kzullig@hsc.wvu.edu|
22327988|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327989|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch|
22327990|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22327991|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343||
22327992|NCT03373110|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
22327993|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu|
22327994|NCT03329599|Northern California Institute for Research & Education|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
22283102|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
22327995|NCT00712322|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22327996|NCT04404010|Precision OS Technology|Dr. Danny P Goel|604-345-0401|danny@precisionostech.com|
22327997|NCT04368455|Cincinnati Children's Hospital Medical Center|Dr. Francis Real|5136364200|francis.real@cchmc.org|
22327998|NCT01599754|SFJ Pharmaceuticals|Stewart Hallett|19252011003|stewart.hallett@sfj-pharma.com|
22327999|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300||
22328000|NCT00753935|Vanderbilt_University MC|John A. Oates, MD|615 4343 4847|john.oates@vanderbilt.edu|
22328001|NCT03666858|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22328002|NCT03282357|Merz Pharmaceuticals GmbH.|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22328003|NCT03550131|University of Washington|Dr. Karen Fredriksen-Goldsen|206-543-5722|fredrikk@uw.edu|
22283103|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org|
22328004|NCT01948388|Arthritis & Rheumatic Disease Specialties|Joanne Sagliani|3059324162|drnbg@rheum-care.com|
22328005|NCT02038218|DEKK-TEC, Inc.|Dr. Lee Roy Morgan|504-583-6135|lrm1579@aol.com|
22328006|NCT00910429|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22328007|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22328008|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
22328009|NCT01369212|University of Pittsburgh|Dr. Abdus Wahed|412-624-3053|wahed@pitt.edu|
22328010|NCT04860752|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@Edwards.com|
22328011|NCT06795204|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|856-263-4239|yuling.lai@haisco-usa.com|
22328012|NCT03927911|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22328013|NCT02658968|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
22328014|NCT01149343|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328015|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500|pwinner777@aol.com|102
22328016|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22328017|NCT03472040|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22328018|NCT02769832|University of Iowa, Holden Comprehensive Cancer Center|Muhammad Furqan, MD|319-356-1527|muhammad-furqan@uiowa.edu|
22328019|NCT02197897|Baylor College of Medicine|Dr. Guilherme Godoy|713-798-4001|godoy@bcm.edu|
22328020|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
22328021|NCT01103778|Rogosin Institute|Dr. Choli Hartono|212-746-1578|chh2001@nyp.org|
22328022|NCT03084718|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22328023|NCT01978509|Mayo Clinic|Dr. Francisco Ramirez|(480) 301-6990|Ramirez.Francisco@mayo.edu|
22328024|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
22328025|NCT01594333|Brigham & Women's Hospital|Dr. Paul Ridker and Dr. Robert Glynn|617-732-4965|pridker@bwh.harvard.edu|
22328026|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com|
22328027|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22328028|NCT03428997|Johnson & Johnson Consumer Inc.|Heather Smith|(908) 874-1235|HSmith21@its.jnj.com|
22328029|NCT05506969|Dynavax Technologies|Ouzama Henry, MD|617-686-4796|ohenry@dynavax.com|
22328030|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328031|NCT02120157|Johns Hopkins University|Heather Symons, MD|410-502-9961|hsymons2@jhmi.edu|
22283104|NCT04612842|Oregon Health & Science University|Dr. Hiroko Kiyoshi-Teo (Assistant Professor)|5034943858|kiyoshi@ohsu.edu|
22283105|NCT05426031|University of Miami|Michael Fabbro II, DO|305-689-1106|mxf790@miami.edu|
22283106|NCT03060512|AstraZeneca Pharmaceutical LP|Catherine J. Datto, MD, MS, Movantik Medical Head, USMA|+1 302 885 1180|Information.Center@astrazeneca.com|
22283107|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328032|NCT02553317|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
22328033|NCT00769808|Bausch & Lomb Incorporated|Study Director|9083009926|susan.harris@bauschhealth.com|
22328034|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22328035|NCT03176277|Ono Pharmaceutical Co., Ltd.|Medical Information Center|Please see email|trials.uk-eu@ono-pharma.com|
22328036|NCT02802878|University of Kansas Medical Center|Dr. Neil Segal|913-945-8985|segal-research@kumc.edu|
22328037|NCT00702052|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22328038|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
22328039|NCT03691610|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22328040|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
22328041|NCT03970395|Azienda Ospedaliera Città della Salute e della scienza di Torino _ Italy|Dr Claudio G Priolo|0039 3471403064|claudiog.priolo@gmail.com|
22328042|NCT02921919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328043|NCT04664855|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
22328044|NCT01906866|Neurim Pharmaceuticals|Dr. Tali Nir|972-7684902|talin@neurim.com|
22328045|NCT02235987|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
22328046|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org|
22328047|NCT03180489|Colorado State University|Christopher Bell|9704917522|christopher.bell@colostate.edu|
22328048|NCT01086150|Albany Medical College|Charles E. Argoff, MD|518 262-0034|argoffc@mail.amc.edu|
22328049|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com|
22328050|NCT00870818|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
22328051|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu|
22300149|NCT04738643|University of Pennsylvania|Robert Schnoll, PhD|215-746-7143|schnoll@pennmedicine.upenn.edu|
22300150|NCT05545072|Emory University|Thomas S Edwards, MD Assistant Professor, Rhinology and Skull Base Surgery Division|4045017710|thomas.edwards@emory.edu|
22300151|NCT02395042|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22300152|NCT03638141|Sidney Kimmel Comprehensive Center|Ana De Jesus-Acosta|4432870411|adejesu1@jh.edu|
22300153|NCT03996473|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22300154|NCT03759873|University of Texas Medical Branch, Division of Cardiovascular Medicine|Dr. Diann Gaalema|409-772-1533|digaalem@utmb.edu|
22300155|NCT05725005|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
22300156|NCT03579563|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
22300157|NCT03621696|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
22300158|NCT03867734|University of Washington|Lindley A. Barbee, MD, MPH|206-744-2595|lbarbee@uw.edu|
22328052|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu|
22328053|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351||
22328054|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328055|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu|
22328056|NCT04009213|Advanced Medical Solutions|Tina Warburton, Senior Clinical Research Associate|07791742957|tina.warburton@admedsol.com|
22328057|NCT02921763|Mylan EPD G.K.|Takumi Kanzo|+81-3-5656-0516|takumi.kanzo@viatris.com|
22328058|NCT04142216|Demiroglu bilim University|Assistant Professor Nurten Ozen|+905334509382|ozenurten@yahoo.com.tr|
22328059|NCT01709981|NYU Langone Health|Dr. Binita Shah|212-263-6631|Binita.Shah@nyulangone.org|
22328060|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu|
22328061|NCT03095053|Antalya IVF|Kevin Coetzee|090 530 764 3135|kevincoetzee61@yahoo.co.nz|
22328062|NCT02659605|The University of Texas Health Science Center at Houston|Dr. Pamela D. Berens|(713) 500-6471|Pamela.D.Berens@uth.tmc.edu|
22328063|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537||
22328064|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org|
22328065|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22328066|NCT00475540|MedStar Health Research Institute|Allie Moses, Manager, Clinical Research Systems and Recruitment Center|301-560-7353|Allison.E.Moses@MedStar.net|
22328067|NCT02618343|UT Health San Antonio|David Wampler, PhD, LP|210-414-9548|wamplerd@uthscsa.edu|
22328068|NCT02394795|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22328069|NCT05202223|University of Kentucky|Dr. Elizabeth Rhodus|859-257-5562|elizabeth.rhodus@uky.edu|
22328070|NCT04390568|Boehringer Ingelheimv|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328071|NCT03245723|UT Southwestern Medical Center, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
22328072|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com|
22328073|NCT03784027|University of Cambridge|Prof Roman Hovorka|+44 1223 762 862|rh347@cam.ac.uk|
22328074|NCT03637842|New York State Psychiatric Institute|Christina Brezing, MD|6467748181|christina.brezing@nyspi.columbia.edu|
22328075|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22328076|NCT02373371|CHU de Limoges|Project Manager|0555058616|abdeslam.bentaleb@chu-limoges.fr|+33
22328077|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org|
22328078|NCT03287869|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22328079|NCT04847141|Sr Manager, Clinical Research, Scientific Innovation Office (SIO)|Mireia Torres|+34 93 5710500|mireia.torres@grifols.com|
22328080|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22328081|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu|
22328082|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22328083|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22328084|NCT04507776|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328085|NCT01705964|University of Louisville|Dr. Kerry Caperell|502-629-7212|k0cape01@louisville.edu|
22328086|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com|
22328087|NCT00094835|Amgen Inc.|Study Director|866-572-6436||
22328088|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org|
22328089|NCT03628599|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22328090|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22328091|NCT01766219|Wake Forest University Health Sciences|Caio Max Rocha Lima|336-703-4246|crochali@wakehealth.edu|
22328092|NCT03064568|UTHSCSA|Sally Kabro|210-567-4950|kabro@uthscsa.edu|
22328093|NCT05905601|University of Washington / University of North Carolina at Chapel Hill|Benjamin Buck, Ph.D.|(919) 445-4330|ben.buck@med.unc.edu|
22328094|NCT03024255|Botanix Pharmaceuticals|Anthony Robinson, MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22328095|NCT03532776|Dermax|Chauvel Virginie|+32 488 07 04 18|chauvelvirginie07@gmail.com|
22328096|NCT00868166|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22328097|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328098|NCT01754207|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22328099|NCT01797445|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22328100|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328101|NCT03939637|Baylor College of Medicine/ Texas Children's Hospital|Amanda Grimes|832-822-4217|abgrimes@texaschildrens.org|
22328102|NCT04190186|University of Rochester|David Huang, MD|585 275 5391|david_huang@urmc.rochester.edu|
22328103|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935|hjwilkins@yaupontherapeutics.com|935
22328104|NCT00830804|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22328105|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org|
22328106|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
22328107|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu|
22328108|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com|
22328109|NCT00776555|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22328110|NCT03452891|University of Nebraska Medical Center|Amy C Killeen|402-479-6205|akilleen@unmc.edu|
22328111|NCT03482141|University of California, San Francisco|Mary Norton|(415) 467 4080|mary.norton@ucsf.edu|
22328112|NCT03483116|Murdoch Children's Research Institute|Professor Julie Bines|+61 3 9345 5522|julie.bines@mcri.edu.au|
22328113|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
22328114|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de|
22328115|NCT00400439|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22328116|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu|
22328117|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22328118|NCT04685499|Weill Cornell Medicine|Meyer Cancer Center GI Program Manager|646-962-8189|cdo4001@med.cornell.edu|
22328119|NCT01232894|Novartis|Study Director|41 61 324 1111||
22328120|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com|
22328121|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com|
22328122|NCT02938052|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
22328123|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no|
22328124|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu|
22328125|NCT00121992|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22328126|NCT03076190|Stanford University|Dr. Beth Darnall|6507365494|bdarnall@stanford.edu|
22328127|NCT01441115|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22328128|NCT00094887|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22328129|NCT02260648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328130|NCT04093258|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|tkarkkai@its.jnj.com|
22328131|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com|
22328132|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu|
22328133|NCT03543358|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22328134|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu|
22328135|NCT02379390|Sanofi|Trial Transparency Team|800-633-1610|Us@sanofipasteur.com|1
22328136|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22328137|NCT05128682|Beaumont Hosptials|Jennifer Giordano CRM|248-551-3517|jennifer.giordano@corewellhealth.org|
22328138|NCT02763072|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22328139|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com|
22328140|NCT02702011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328141|NCT02995330|Johns Hopkins University|"Dr. Samuel R. Denmeade Professor of Oncology| Director Genitourinary Oncology"|410-502-8341|DENMESA@jhmi.edu|
22328142|NCT02721251|VA|David Thompson|602-496-0242|david.thompson4@va.gov|
22328143|NCT05515952|University of Arizona|Lisbeth Haaheim|520-626-7755|lhaaheim@arizona.edu|
22328144|NCT03450915|BiondVax Pharmaceuticals ltd.|Chief Scientific Officer & Clinical Management|+97289302529|benyedidia@BiondVax.com|5103
22328145|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22328146|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22328147|NCT06076148|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22328148|NCT06025396|Tempero Bio|Director, Clinical Operations|510-250-4750|TMP-301-HNV-101@Temperobio.com|
22328149|NCT06422377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22328150|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org|
22328151|NCT03380026|Rochester Skin Lymphoma Medical Group|Clinical Research Coordinator|(585)364-1188|scarroll@roclymphoma.com|
22328152|NCT03326869|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
22328153|NCT01874119|Saint Louis University|Dr. John Richart|314-577-8854|richartj@slu.edu|
22328154|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22328155|NCT00562640|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
22328156|NCT05263921|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328157|NCT04327518|Johnson & Johnson Surgical Vision|Director of Clinical Science, Ophthalmic Implants|7142478200|EThoma39@its.jnj.com|
22328158|NCT01666145|Carolinas Healthcare System|Principal Investigator|704-446-2772|john.martinie@carolinashealthcare.org|
22328159|NCT01297309|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22328160|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com|
22328161|NCT01184456|AIDS Healthcare Foundation - Public Health Division|Adam Sukhija-Cohen|(323) 436-8900|adam.cohen@aidshealth.org|
22300159|NCT01827904|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-360-9900|nadira@insightec.com|
22300160|NCT01910519|Emory University|Nadine Rouphael MD|404-712-1435|nroupha@emory.edu|
22300161|NCT04266028|Desentum Oy|Head of Clinical Operations|+358400224892|Info@desentum.fi|
22300162|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300163|NCT02125786|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|8662785833|referralinfo@stjude.org|
22300164|NCT02663128|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22300165|NCT02720484|Northwestern University|Devalingam Mahalingam|312.472.0564|mahalingam@northwestern.edu;|
22300166|NCT05070897|Hôpital Européen Georges Pompidou|Pr Elena Paillaud|0156093310|elena.paillaud@aphp.fr|
22300167|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org|
22300168|NCT03832946|Galecto Biotech aps|Hans Schambye - Chief Executive Officer|+4526373726|info@galecto.com|
22300169|NCT05244525|The University of Texas Health Science Center at Houston|James M. Gregory, MD|(713) 486-7500|James.M.Gregory@uth.tmc.edu|
22300170|NCT01003249|Wake Forest University Health Sciences|Dr. Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
22300171|NCT03394924|Enanta Pharmaceuticals, Inc.|Nathalie Adda|+1 6176070705|nadda@enanta.com|
22300172|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300173|NCT02657226|The University of Pittsburgh|Dr. John Kellum|4123834202|kas287@pitt.edu|
22300174|NCT04198662|University of California, San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22300175|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com|
22300176|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22300177|NCT01949311|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|1-844-734-6643|clinicaltrials@regeneron.com|
22300178|NCT03272633|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD|732-235-4523|strairrk@cinj.rutgers.edu|
22300179|NCT01002872|Northshore University Healthsystem|Dr Stuart Sprague|847-570-1761|ssprague@northshore.org|
22300180|NCT00951041|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300181|NCT02388724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22300182|NCT01925950|Soligenix, Inc.|Dr. Richard Straube|609-538-8200||
22300183|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu|
22300184|NCT03663231|University of Rochester|Ralph Saunders|585-275-1141|ralph_saunders@urmc.rochester.edu|
22300185|NCT02047045|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22300186|NCT04066114|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22300187|NCT02277106|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22300188|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu|
22300189|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22300190|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300191|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300192|NCT04258020|OhioHealth|Dr. Kiran Devulapally|614-566-9143|kiran.devulapally@ohiohealth.com|
22300193|NCT04386096|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22300194|NCT02097472|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22328162|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu|
22328163|NCT00640146|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22328164|NCT00525785|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|jajani@mdanderson.org|
22328165|NCT01807091|University of Washington|Elihu Estey, MD|206-606-6744|eestey@seattlecca.org|
22328166|NCT04624672|Geisinger Medical Center|Project Manager|570-214-2245|kcunningham1@geisinger.edu|
22328167|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no|
22328168|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22328169|NCT04169113|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
22328170|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22328171|NCT03728504|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
22328172|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net|
22328173|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22328174|NCT02236273|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22300195|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com|
22328175|NCT02119026|Medical University Vienna, Internal Med. I, Dep. of Oncology|Werner Scheithauer, MD|+43 1 40400|werner.scheithauer@meduniwien.ac.at|54620
22328176|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu|
22328177|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
22328178|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22328179|NCT02849184|Jichi Medical University School of Medicine|Professor Kazuomi Kario|+81-285-58-7538|kkario@jichi.ac.jp|
22328180|NCT01803854|Department of Veterans Affiairs, Office of Research and Development|Dr. Christina D. Williams, Acting Director of Cooperative Studies Program Epidemiology Center Durham|919-286-0411|christina.williams4@va.gov|175464
22328181|NCT03783442|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22328182|NCT02016898|Duke University Health System|Michael Quist, MD|718-490-7657|michael.quist@duke.edu|
22328183|NCT01381718|Children's Hospital Boston/Harvard Medical School|Nicole J. Ullrich, MD, PhD|617-355-3193|Nicole.Ullrich@childrens.harvard.edu|
22328184|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu|
22328185|NCT03017846|Albert Einstein College of Medicine|Anthony Guzman, MD|7189208352|anguzman@montefiore.org|
22328186|NCT02505542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22328187|NCT04150562|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22328188|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159||
22328189|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
22328190|NCT02451202|Department of Anesthesiology, King Chulalongkorn Memorial Hospital|Dr. Prok Laosuwan|+66 2256 4295|plaospir@yahoo.com|
22328191|NCT02666508|UIC College of Dentistry|Kimberly Fasula RDH, MS, MPH|(312) 996-5513|kfasul1@uic.edu|
22328192|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu|
22328193|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300||
22328194|NCT02378883|Medtronic Neurovascular|Darren Lacour, Sr. Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
22328195|NCT00318565|Biosense Webster|Christine Liu|9098398608|cliu10@its.jnj.com|8608
22328196|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp|
22328197|NCT00493467|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma|713-563-1509|fsamaniego@mdanderson.org|
22328198|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk|
22328199|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu|
22283108|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22283109|NCT04065074|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22283110|NCT02334683|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|(212) 241-8748|david.simpson@mssm.edu|
22283111|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu|
22283112|NCT03958656|National Cancer Institute|Dr. James N. Kochendefer|240-760-6062|kochendj@mail.nih.gov|
22283113|NCT03831880|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300196|NCT05457608|CooperVision|Jose A. Vega,OD,MSc,FAAO|9256213761|jvega2@coopervision.com|
22328200|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
22328201|NCT00425477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
22328202|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
22328203|NCT03074149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328204|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328205|NCT03859960|Fatih Sultan Mehmet Education and Research Hospital|MD. Arzu Atici|+905335621208|arzususinatici@gmail.com|
22328206|NCT02180217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22328207|NCT00134017|Johns Hopkins University|Leo Luznik, MD|4105027732|luznile@jhmi.edu|
22328208|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com|
22328209|NCT02703987|Danone Nutricia Research|Danone Nutricia Research||register.clinicalresearchnutricia@danone.com|
22328210|NCT03438578|St Olavs Hospital|Erlend Johan Skraastad|0047 79829184|Erlend.Johan.Skraastad@stolav.no|
22328211|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
22328212|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246|gsommer@sandstonedx.com|925
22328213|NCT01681576|Novartis|Study Director|862-778-8300||
22328214|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com|
22328215|NCT03448224|University of Kentucky|Dr. Jerod Stapleton|859.562.2802|jerod.stapleton@uky.edu|
22328216|NCT03103906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328217|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328218|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22328219|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp|
22328220|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu|
22328221|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22328222|NCT00750165|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|cpaptrial@fphcare.co.nz|7044
22328223|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com|
22328224|NCT05691829|NYU Langone Health|Fraustina Hsu|646-754-7124|Fraustina.Hsu@nyulangone.org|
22328225|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328226|NCT00547898|Valeant Pharmaceuticals|Johnson Varughese|9089271162|christine.hnatko@valeant.com|
22328227|NCT01966263|Sint Maartenskliniek Nijmegen|Dr Maaike Fenten|31243659111|m.fenten@maartenskliniek.nl|2941
22328228|NCT02670928|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22328229|NCT02678312|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22328230|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com|
22328231|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22328232|NCT04055467|Johns Hopkins School of Medicine|Dr. Elise Weerts, Professor|410-550-2781|eweerts@jhmi.edu|
22328233|NCT02455388|Virginia Tech|Dr. Brenda Davy|540-231-6784|bdavy@vt.edu|
22328234|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328235|NCT03154294|Avera Cancer Institute|Dr. Casey Williams|605-322-3588|Casey.Williams@avera.org|
22328236|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328237|NCT00873288|Northwestern University|Bonnie Spring|312-908-2293|bspring@northwestern.edu|
22328238|NCT03874351|MJHS Institute for Innovation in Palliative Care, New York, NY|Helena Knotkova, PhD, PhilD|646-784-2262|HKnotkov@mjhs.org|
22328239|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu|
22328240|NCT02685995|University of Pennsylvania|Gregory Nadolski, MD|(215) 662-7892|gregory.nadolski@pennmedicine.upenn.edu|
22328241|NCT01188096|Atrium Health|Donald L. Durden, MD, PhD|980-442-2048|donald.durden@atriumhealth.org|
22328242|NCT02384395|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
22328243|NCT03485222|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|(212) 241-8484|juan.badimon@mssm.edu|
22328244|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328245|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu|
22328246|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
22328247|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU|
22328248|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk|
22328249|NCT05859971|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS, FACS|(608) 262-9060|neuman@surgery.wisc.edu|
22328250|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328251|NCT02786836|UT Southwestern Medical Center at Dallas|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
22328252|NCT03617913|Mayo Clinic|Parminder Singh, MD|5072555123|Singh.Parminder@mayo.edu|
22328253|NCT04426890|Celltrion. Inc|Yunju Bae/Head of Clinical Planning 1 Department|+82 32 850 4160|Yunju.bae@celltrion.com|
22328254|NCT02855450|Dompè|Flavio Mantelli, MD, PhD|+39 02583831|info@dompe.com|
22328255|NCT01803711|UConn Health Center|Jayesh Kamath MD PhD|8606796727|jkamath@uchc.edu|
22328256|NCT01519063|Yale University|Dana Cavallo, Assistant Professor|203974-7607|dana.cavallo@yale.edu|
22328257|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328258|NCT05159362|Q2i, LLC|Steven Jenkins, CEO Q2i|646-660-2151|sjenkins@q2i-group.com|
22328259|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328260|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22328261|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|Philippe.Prokocimer@cubist.com|241
22328262|NCT02693691|Abbott|Dr. Marie-Elena Brett|7815283613|marieelena.brett@abbott.com|
22328263|NCT02727660|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
22328264|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743||
22328265|NCT02171819|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
22328266|NCT01567891|Adaptimmune|Clinical Trials Management|215-825-9302|clinicaltrials@adaptimmune.com|6302
22328267|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328268|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu|
22328269|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328270|NCT02940626|X4 Pharmaceuticals (merged with Arsanis)|Vice President, Clinical Operations|(857) 529-8300|rnd@x4pharma.com|
22328271|NCT00756496|Siemens Medical Solutions USA, Inc.|Milind Dhamankar|+1 (610) 448-6467|milind.dhamankar@siemens-healthineers.com|
22328272|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300|jacquelyn.hughes@biomet.com|3075
22328273|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com|
22328274|NCT00878215|Washington University School of Medicine|William C. Chapman, M.D.|314-362-7792|chapmanw@wustl.edu|
22328275|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu|
22328276|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu|
22328277|NCT01912716|Indiana University|Dr. Evan Fogel|317-944-2816|efogel@iu.edu|
22328278|NCT02391350|University of Utah|Dr. Julie Fritz|8015872237|julie.fritz@utah.edu|
22328279|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22328280|NCT02176291|University of Pittsburgh|Dr. Jordan F. Karp|412-246-6048|karpjf@upmc.edu|
22328281|NCT02815293|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
22328282|NCT02431468|Neurotrope BioScience, Inc.|David Crockford, Vice President, Regulatory Affairs|(973)242-0005|dcrockford@neurotropebioscience.com|
22328283|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22328284|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com|
22328285|NCT01361919|St. Michael's Hospital|Dr. Paul Dorian|416-864-5104|dorianp@smh.ca|
22328286|NCT03454412|International Clinic of Rehabilitation|Oleh Kachmar|+380324765200|okachmar@ic.reha.lviv.ua|
22328287|NCT03001843|University of Florida|Joshua Sappenfield, MD|352-273-5259|jsappenfield@anest.ufl.edu|
22328288|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
22328289|NCT03956225|Alcon Research, LLC|Sr. CDMA Project Lead, Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
22328290|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
22328291|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com|
22328292|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
22328293|NCT02157506|Bristol-Myers Squibb International Corporation|EU Study Start-Up Unit||clinical.trials@bms.com|
22328294|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351||
22328295|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22328296|NCT03498287|Pressure Profile Systems|Clinical Trials Manager|310.641.8100|research@wrist-aid.com|
22328297|NCT02486211|University of Pittsburgh|Dr. Jon Rittenberger|4126479489|rittjc@upmc.edu|
22328298|NCT04169061|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
22328299|NCT01763866|Amgen Inc.|Study Director|866-572-6436||
22328300|NCT02396342|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22328301|NCT05055570|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|majun@mail.ccmu.edu.cn|
22328302|NCT02939599|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22328303|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22328304|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu|
22328305|NCT03288493|Poseida Therapeutics|Rajesh Belani, MD, Vice President Clinical Development|858-779-3100|rbelani@poseida.com|
22328306|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260|khirst@bsc.gwu.edu|8025
22328307|NCT02814448|Cleveland Clinic|Dr. Miriam Cremer|216-312-0618|cremerm@ccf.org|
22328308|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
22328309|NCT01019252|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@mgh.harvard.edu|
22328310|NCT02514772|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
22328311|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22328312|NCT04671342|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
22283114|NCT02081638|National Institute of Allergy and Infectious Diseases|Dr. Irini Sereti|301-496-5533|isereti@niaid.nih.gov|
22328313|NCT03583606|Cincinnati Children's Hospital|Paul Spearman, MD|513-636-4509|paul.spearman@cchmc.org|
22328314|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
22328315|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org|
22328316|NCT00793182|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22328317|NCT03728140|Reproductive medcine of Jinan central hospatil|Dr. bin wu|+86 053185695203|wb0538@163.com|
22328318|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
22328319|NCT02273037|The Hospital for Sick Children|Dr. Diego G. Bassani|+14168137654|diego.bassani@sickkids.ca|303033
22328320|NCT00851253|Boston Medical Center|Dr. Minh Tam Truong|617-638-7070|Minh-Tam.Truong@bmc.org|
22328321|NCT03154307|Miami Neuroscience Institute|Clinical Research Administrator|17865961825|starlieb@baptisthealth.net|
22328322|NCT03657810|Charleston Laboratories, Inc.|Bernard P. Schachtel, MD, Chief Scientific Officer|561.379.8726|bschachtel@charlestonlabs.com|
22328323|NCT04547998|AVITA|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
22328324|NCT03554850|Stryker Neurovascular|Fei Qin|+8613524821775|fei.qin@stryker.com|
22283115|NCT03158012|UCSD Dermatology|Teruaki Nakatsuji|8588227814|tnakatsuji@ucsd.edu|
22283116|NCT02788201|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
22283117|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328325|NCT02487277|University of California, San Francisco|Dr. Andrew Ko|(415) 353-7286|Andrew.Ko@ucsf.edu|
22328326|NCT00291499|IBSA Institut biochimique|Project Leader|0041 58360100|rd@ibsa.ch|
22328327|NCT01457924|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328328|NCT03688685|Cadent Therapeutics (A Novartis Company)|Cadent Therapeutics (A Novartis Company)|1-888-669-6682|Novartis.email@novartis.com|
22328329|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org|
22328330|NCT04581863|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
22328331|NCT05053126|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
22328332|NCT04024072|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
22328333|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu|
22328334|NCT00416312|Johns Hopkins University, School of Medicine|George Sgouros, Ph.D.|410 614 0116|gsgouros@jhmi.edu|
22328335|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000|rcastaneda@apu.edu|2744
22328336|NCT00574496|Memorial Sloan Kettering Cancer Center|Dr. Miguel-Angel Perales, MD|646-608-3757|peralesm@mskcc.org|
22328337|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com|
22283118|NCT01166373|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22300197|NCT04402866|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22328338|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
22300198|NCT03667053|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
22328339|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com|
22328340|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328341|NCT01928485|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Lee Ponsky|+1 216-844-4831|lee.ponsky@uhhospitals.org|
22328342|NCT03589885|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22328343|NCT04111107|Tulane University|Stefan Grant, MD|504-988-5800|sgrant6@tulane.edu|
22328344|NCT01825655|Virginia Commonwealth University|Santhosh Kumar, MD|804-628-1605|santhosh.kumar@vcuhealth.org|
22328345|NCT00039741|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22328346|NCT00946881|STEBA Biotech|Bertrand Gaillac International Project Leader|+ 33 974197905|b.gaillac@stebabiotech.com|
22328347|NCT00293423|University of California, Davis|Dr. Orin Bloch||obloch@ucdavis.edu|
22328348|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581|Carolyn-Turvey@uiowa.edu|7714
22328349|NCT04428359|BP Koirala Institute of Health Sciences|Dr. Bibisha Baaniya|9841744777|cul.bibisha@gmail.com|+977
22328350|NCT03571256|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22328351|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu|
22328352|NCT02247401|AbbVie|Global Medical Services|800-633-9110||
22328353|NCT02807363|Enteris Biopharma Inc.|Paul Shields, Ph.D|9734533520|pshields@enterisbiopharma.com|
22328354|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22328355|NCT02188719|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22328356|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22328357|NCT03371732|Institute Bergonie|Dr. Marion Barrault Couchouron, Coordinating Investigator|0556337805|m.barrault@bordeaux.unicancer.fr|
22328358|NCT01861054|Dompé Farmaceutici|Pier Adelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
22328359|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328360|NCT04962503|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager|Tel: +61 3 9660 4900|mail@clinuvel.com|
22328361|NCT02608229|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
22328362|NCT00476996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22328363|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu|
22328364|NCT04218799|University of Maryland School of Medicine|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
22328365|NCT01214317|Isfahan University of medical sciences|Director of clinical trial|+983136202020|etemadifar.m@gmail.com|
22328366|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu|
22328367|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org|
22328368|NCT05351710|Florida State University|Dr. Jesse Cougle|8506458729|cougle@psy.fsu.edu|
22328369|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
22328370|NCT02133742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328371|NCT03479216|Derince Training and Research Hospital|Dr. Hande Aytuluk|00905336515650|handegrbz@gmail.com|
22328372|NCT02031432|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22328373|NCT02148211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328374|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
22328375|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328376|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22328377|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md|
22328378|NCT03828149|Novus Therapeutics|Clinical Director|949-679-1110|study001@novustherapeutics.com|
22328379|NCT03337139|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
22328380|NCT02554253|Mayo Clinic|Erica Wittwer|5072559814|wittwer.erica@mayo.edu|
22328381|NCT04430283|Faraday Pharmaceuticals, Inc.|Clinical Trial Manager|206-492-5310|info@faradaypharma.com|
22328382|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
22328383|NCT03558191|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|0518-82342973|linan.wang@hengrui.com|
22328384|NCT02559206|Ironwood Pharmaceuticals, Inc.|Nick Omniewski, MPH|(617) 621-8454|nomniewski@ironwoodpharma.com|
22328385|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22328386|NCT03862131|Washington University School of Medicine|Dr. Joshua Mitchell|314-362-1291|jdmitchell@wustl.edu|
22328387|NCT02024204|NYU Langone|Joan Reibman, MD|212-263-6479|joan.reibman@nyumc.org|
22328388|NCT01871896|University of California San Francisco|Matthew Lin|415 353 2161|Matthew.Lin@ucsf.edu|
22328389|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com|
22328390|NCT00597935|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22328391|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com|
22328392|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br|
22328393|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu|
22328394|NCT03127852|Centre for Global eHealth Innovation|Dr. Patrick Ware|1 (416) 340 4800|Patrick.Ware@uhn.ca|4765
22300199|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk|
22328395|NCT03621189|Chang Gung Memorial Hospital|Dr. Hsing Chang Ni|886975365663|alanni0918@yahoo.com.tw|
22328396|NCT03382262|Flexion Therapeutics|Scott Kelley MD, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22328397|NCT03518034|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22328398|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328399|NCT03325556|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-|medicalinformation@acadia-pharm.com|2897
22328400|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu|
22328401|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
22328402|NCT04526067|University of Texas Health Science Center in San Antonio|Dawn Velligan, PhD|210-567-5508|velligand@uthscsa.edu|
22328403|NCT05034614|Mayo Clinic|Danielle J. O'Laughlin, P.A.-C., M.S.|507-284-5164|OLaughlin.Danielle@mayo.edu|
22328404|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22328405|NCT03892707|Woerwag Pharma LLC|Anna Shagako, Clinical Trials Manager/ Authorized Person of Pharmacovigilance|+7 (495) 382 85 56|anna.shagako@woerwagpharma.ru|
22328406|NCT03646760|Henry Ford Health|Steven Keteyian, PhD|313-972-1920|sketeyian1@hfhs.org|
22328407|NCT05224076|University of Kansas School of Nursing|Dr. Barbara Polivka|6142049915|bpolivka@kumc.edu|
22328408|NCT04263363|UCLA|Dr. Eilon Gabel, MD|310-267-8693|EGabel@mednet.ucla.edu|
22328409|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22328410|NCT03819764|The Cleveland Clinic Foundation|Dr. Susan Linder, PT, DPT, PhD|216-445-9815|linders@ccf.org|
22328411|NCT04325906|Rush University|Jie Li, PI|3125634643|jie_li@rush.edu|
22328412|NCT00881361|Mayo Clinic|Judy C. Boughey, MD|507-284-3629|boughey.judy@mayo.edu|
22328413|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328414|NCT03515213|University of California, Irvine|Leslie Thompson|9498243990|lmthomps@hs.uci.edu|
22328415|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22328416|NCT01628393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22328417|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com|
22328418|NCT04015440|Walter Reed Army Institute of Research|Jeffrey M Osgood, Ph.D. Associate Director of Military Psychiatry Branch|301-319-7475|jeffrey.m.osgood.mil@mail.mil|
22328419|NCT04603391|University of Florida|John S. Markowitz, Pharm.D.|(352) 273-6262|jmarkowitz@cop.ufl.edu|
22328420|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com|
22328421|NCT02759861|University of Nebraska Medical Center|Mark Mailliard|402-559-8126|mark.mailliard@unmc.edu|
22328422|NCT02151682|Grünenthal GmbH|Clinical Trial Helpdesk|+49-(0)241-569|clinical-trials@grunenthal.com|3223
22328423|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov|
22328424|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com|
22328425|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328426|NCT02186457|Indiana University School of Medicine|Dr. Michael House|3179440113|michouse@iupui.edu|
22328427|NCT01522443|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22328428|NCT03260894|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22328429|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu|
22328430|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov|
22328431|NCT06000501|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
22328432|NCT01700985|Therapeutics Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22328433|NCT02677220|Cochlear|Director of Clinical Research|3032647180|loneill@cochlear.com|
22328434|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
22328435|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000|r.sotudemanesh@gmail.com|82415000
22328436|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356|hanne.gonnissen@medtronic.com|6734
22328437|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu|
22328438|NCT01342952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328439|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22328440|NCT02584868|Centre Hospitalier Universitaire Brugmann|Philippe Van der Linden, MD, PhD|+32 2 477 23 30|philippe.vanderlinden@chu-brugmann.be|
22328441|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22328442|NCT03970824|CELLTRION, Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
22328443|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809-|carlos.gonzalez@abbott.com|7576
22328444|NCT04569799|Penn State Health College of Medicine|Kathryn McGillen, M.D.|717-531-0003|kmcgillen@pennstatehealth.psu.edu|
22328445|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu|
22328446|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu|
22328447|NCT00425100|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22328448|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
22328449|NCT03086317|Emory University|Dr. Wissam Jaber, Assistant Professor|4046861000|wissam.jaber@emory.edu|
22328450|NCT03699631|Froedtert and the Medical College of Wisconsin|William Drobyski, MD|414-805-6700|wdrobyski@mcw.edu|
22328451|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu|
22328452|NCT02219087|OhioHealth|Sara Jordan Clinical Pharmacist for Surgery Services|614-461-8174|sara.jordan@ohiohealth.com|
22328453|NCT05127421|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22328454|NCT01714817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22283119|NCT02498067|University of Chicago|Soo Young Lee|6513430045|sooyoungl@uchicago.edu|
22283120|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com|
22283121|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
22283122|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com|
22283123|NCT03987932|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
22283124|NCT01669421|University of Miami|Michael Campos|305-243-3045|mcampos1@med.miami.edu|
22283125|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
22283126|NCT02740543|NYU Langone Health - Bellevue Hospital|Angeliki Kazeros, MD|212-263-6479|Angeliki.Kazeros@nyulangone.org|
22283127|NCT02813668|Emory University|Dr. Mary Beth Weber|404-712-1902|mbweber@emory.edu|
22283128|NCT02961790|Mayo Clinic|Charles L. Loprinzi, M.D|507/284-4565|loprinzi.charles@mayo.edu|
22283129|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu|
22283130|NCT02594098|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
22283131|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu|
22283132|NCT00300482|Abbott|Medical Information Specialist|800-633-9110||
22283133|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22283134|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu|
22283135|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22283136|NCT04895293|Midwest Eye Institute|Raj K. Maturi, M.D.|317-817-1423|maturi.md@midwesteye.com|
22283137|NCT03597178|Johnson & Johnson|Brian Pall OD, MS, FAAO- Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
22283138|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu|
22283139|NCT03946124|University of Pennsylvania|Dr. Lily Arya|215-662-3230|larya@pennmedicine.upenn.edu|
22283140|NCT02370004|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
22283141|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22328455|NCT01374217|Carolinas HealthCare System|Nilanjan Ghosh, MD|9804422000||
22328456|NCT02555657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328457|NCT03700970|Vanderbilt university medical center|Dr. Galen Perdikis|+1 (615) 936-0198|galen.perdikis@vumc.org|
22328458|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov|
22328459|NCT02372097|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22328460|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22328461|NCT04152642|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22328462|NCT02443571|Blue Earth Diagnostics Ltd.|Chief Medical Officer|+44 (0) 1865 784 186|contact@blueearthdx.com|
22328463|NCT02790463|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
22328464|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22328465|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328466|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com|
22328467|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com|
22328468|NCT05406440|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328469|NCT02979444|Northwestern University Feinberg School of Medicine|Darius Tandon, PhD|410-852-0399|dtandon@northwestern.edu|
22328470|NCT00713284|California Pacific Medical Center|Dr. V. Ram Peddi|415-600-1000|peddir@sutterhealth.org|
22328471|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22328472|NCT01824693|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22328473|NCT02150213|Novartis|Study Director|862-778-8300||
22328474|NCT03488238|Masimo Corporation|Cristina Johnson|949-297-7000|clincalresearchdept@masimo.com|
22328475|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328476|NCT04134728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328477|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu|
22328478|NCT00662389|Apsara Medical Corporation|Eve Conner, Ph.D. Consultant|510 566-2495|eaconner@sbcglobal.net|
22328479|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22328480|NCT02966353|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22328481|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu|
22328482|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com|
22328483|NCT02062398|BlueWind Medical|Amit Korner, VP Clinical Research|+972.74.7218905|amit.korner@bluewindmedical.com|
22328484|NCT01527110|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328485|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu|
22328486|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22283142|NCT01891344|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22328487|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22300200|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com|
22300201|NCT00130533|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22300202|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22300203|NCT02732938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300204|NCT02898974|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22300205|NCT02703350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300206|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22300207|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu|
22300208|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
22300209|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov|
22300210|NCT01981564|Johns Hopkins University School of Medicine, Department of Pediatrics|Dr. Arlene Butz|410-614-5963|abutz@jhmi.edu|
22300211|NCT02864082|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
22300212|NCT04349553|Prokarium|Kristen Albright|+44 (0) 7375 124 275|kristen.albright@prokarium.com|
22300213|NCT03256162|Trinity College Dublin|Dr Bronagh Gallagher|01 249|bgallag@tcd.ie|3200
22300214|NCT01869491|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
22300215|NCT05177770|Coherus BioSciences|Allison Intondi, Vice President, Clinical Operations|800-794-5434|ClinicalTrials@Coherus.com|
22300216|NCT00233493|University Hospitals Cleveland Medical Center Center for Medical Mycology|Dr. Mahmoud Ghannoum|216-844-8580|Mahmoud.Ghannoum@case.edu|
22300217|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu|
22300218|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228||
22300219|NCT02105948|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300220|NCT04558346|University of Kansas Medical Center|Dr. Michael Rippee|913-945-7486|mrippee@kumc.edu|
22300221|NCT01778465|Western University|Clinical Trials Program Coordinator|+15196466100|taciano.rocha@sjhc.london.on.ca|61125
22300222|NCT00724971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300223|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com|
22300224|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com|
22300225|NCT02276482|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300226|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu|
22300227|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22300228|NCT02005471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22300229|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
22300230|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
22300231|NCT03431168|UAB|Dr. Jodie Dionne|2059756530|jdionne@uabmc.edu|
22300232|NCT04697758|AsclepiX Therapeutics|Dr A Shojaei|8005723545|ashojaei@asclepix.com|
22300233|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300234|NCT02535065|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
22300235|NCT01592643|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22300236|NCT03712917|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
22300237|NCT04764396|University of Michigan|Eileen Carpenter|734-615-3948|eicarpen@med.umich.edu|
22300238|NCT03230916|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300239|NCT00383448|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22300240|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com|
22300241|NCT02587351|University of Minnesota|John Connett|612-626-9010|john-c@umn.edu|
22300242|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com|
22300243|NCT02091167|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios, Coordinator of Clinical Trials|+55 27 3335-7337|emnpalacios@gmail.com|
22300244|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22300245|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
22300246|NCT03680755|Temple University Kornberg School of Dentistry|Associate Dean for Research & Chair Department of Oral Health Sciences|215-707-1773|marisol.tellez.merchan@temple.edu|
22300247|NCT02693665|Children's National Medical Center|Dr. Maureen E. Lyon, PhD, Professor of Pediatrics, Principal Investigator|703-346-2873|mlyon@childrensnational.org|
22300248|NCT03096782|University of Texas MD Anderson Cancer Center|Amanda Olson, MD / Stem Cell Transplantation|713-745-1505|alolson@mdanderson.org|
22300249|NCT02075593|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300250|NCT03156023|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22319114|NCT04226833|Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
22319115|NCT02088788|Geisinger|Melissa Troup|570-214-5433|matroup@geisinger.edu|
22319116|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22319117|NCT02876835|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319118|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22319119|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300||
22319120|NCT02979925|VA San Diego Healthcare System|Albert Leung, MD|858-552-8585|albert.leung@va.gov|3866
22319121|NCT04343248|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22328488|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328489|NCT01998958|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22328490|NCT02432703|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22328491|NCT02373163|PREVENCION|Josefina Medina-Lezama|+5154251269|jmedinal2911@gmail.com|
22328492|NCT02137837|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|dlew@fredhutch.org|
22328493|NCT01329341|James A Haley Veterans Hospital|Stephanie McGovern|813-558-3964|stephanie.mcgovern@va.gov|
22328494|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu|
22300251|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com|
22300252|NCT05872035|Apple|Rajiv Kumar, MD|8669055303|htclinicalquestions@apple.com|
22300253|NCT05819749|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22300254|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300255|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU|
22300256|NCT03069482|Duke University Psychiatry & Behavioral Sciences|Dr. Roger Vilardaga|9196813441|roger.vilardaga@duke.edu|
22300257|NCT03910413|The University of Alabama at Birmingham|Andrew Smith|205-934-4080|andrewdennissmith@uabmc.edu|
22300258|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu|
22300259|NCT01096992|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|CR_Study_Registration@mdanderson.org|
22300260|NCT04098939|Aarhus University Hospital|Søren Helbo Skaarup|+4528911869|soeska@rm.dk|
22300261|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de|
22300262|NCT02338154|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22300263|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu|
22300264|NCT03393000|Diffusion Pharmaceuticals Inc|Vice President of Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
22300265|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22300266|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22300267|NCT02181803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300268|NCT00780208|Medical University of South Carolina|Aimee McRae-Clark, Professor|843-792-5216|mcraeal@musc.edu|
22300269|NCT05645354|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD,MSc,DrPH-NHSN|713-500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
22300270|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com|
22300271|NCT04786444|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
22300272|NCT03166618|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22300273|NCT03137303|University of Illinois at Chicago|Min J. Joo, MD MPH|312-996-8039|joo@uic.edu|
22300274|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300275|NCT03561090|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
22300276|NCT00373399|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
22300277|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22300278|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu|
22300279|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22300280|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22300281|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22300282|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu|
22300283|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|jjd17@case.edu|6603
22300284|NCT03117738|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
22300285|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22300286|NCT01426191|xiangbei welman pharmacuticol CO.,LTD|Directer of clinical trials|020-38868707|gap@welman.com.cn|
22300287|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu|
22300288|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22300289|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22300290|NCT04597190|University of Washington|John Fortney|2066856955|fortneyj@uw.edu|
22300291|NCT01715805|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22300292|NCT04936230|Weill Cornell Medicine|Himanshu Nagar, MD|212-746-3704|hnagar@med.cornell.edu|
22300293|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300||
22300294|NCT03726346|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7675
22300295|NCT00214136|University of Wisconsin Carbone Cancer Center|Dr. Mark A. Ritter|608-263-8500|ritter@humonc.wisc.edu|
22300296|NCT04313634|Mayo Clinic|Sundeep Khosla, M.D.|507-255-6663|khosla.sundeep@mayo.edu|
22300297|NCT05219877|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti|+62 816-825-226|harrinaerlianti@gmail.com|
22300298|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328495|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|402-552-6005|ckratoch@unmc.edu|
22328496|NCT01789346|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22328497|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328498|NCT02375984|Saint John's Cancer Institute (formerly John Wayne Cancer Institute)|Lisa van Kreuningen|3105827053|lisa.vankreuningen@providence.org|
22300299|NCT03449030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22328499|NCT00290589|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22328500|NCT06444165|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22328501|NCT03814005|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22328502|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22328503|NCT05067452|University of California San Francisco|Dr. Kartika Palar|415-502-8492|kartika.palar@ucsf.edu|
22328504|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22328505|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com|
22328506|NCT00739960|UIC|Nadera J Sweiss, MD|312-996-5723|nsweiss@uic.edu|
22328507|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu|
22328508|NCT04311177|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
22328509|NCT00964158|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328510|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
22328511|NCT03101514|the first affiliated hospital of Harbin medical university|Dr. Zhi-Ping Liu|+8613936034546|as150001@aliyun.com|
22328512|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com|
22328513|NCT03141372|Cleveland Clinic Florida|Sara Farag, Fellow in Minimally Invasive Gynecologic Surgery|8147691904|faragsara@gmail.com|
22328514|NCT02407041|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
22328515|NCT03418051|University of North Carolina at Chapel Hill|Erik Wikstrom|9199622260|wikstrom@unc.edu|
22328516|NCT03695393|Boston Medical Center and BU School of Medicine|Karsten Lunze, MD|617-638-6933|lunze@bu.edu|
22328517|NCT04585451|PainQx|VP R&D|6179817753|bd@painqx.com|
22328518|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22328519|NCT00966693|UT MD Anderson Cancer Center|Weber,Donna M.,M.D. / Lymphoma/Myeloma|713-792-2860|dmweber@mdanderson.org|
22328520|NCT02581982|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mgoodman@wakehealth.edu|
22328521|NCT01769469|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22328522|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org|
22328523|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu|
22328524|NCT02714504|Univ Fed Rio de Janeiro|Dr Marcio Nucci|552139382463|mnucci@hucff.ufrj.br|
22328525|NCT02392494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328526|NCT02713789|Urovant Sciences GmbH|JP Nicandro, PharmD|833-219-5557|clinicaltrials@urovant.com|
22328527|NCT01664858|University of Leeds|Professor John P Greenwood|+44 (0)113 3925481|j.greenwood@leeds.ac.uk|
22328528|NCT01011218|Stanford University Medical Center|Oxana RG Palesh, MD, PhD; Assistant Professor of Psychiatry and Behavioral Sciences|650-725-7011|oxana.palesh@stanford.edu|
22328529|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22328530|NCT00888615|NRG Oncology|Christopher Purdy on behalf of James Kauderer|(716)845-1300|purdyc@nrgoncology.org|2296
22328531|NCT00861380|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328532|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22328533|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br|
22328534|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu|
22328535|NCT04186663|University of California San Francisco|Dr. Hellene Ellenikiotis|408-313-0166|hellene.ellenikiotis@ucsf.edu|
22328536|NCT01375647|University of Vermont|Dorothy M Dickson, MSc|802 656 9296|dorothy.dickson@med.uvm.edu|
22328537|NCT02354092|Oregon Health & Science University|Ob/Gyn Regulatory Specialist, Women's Health Research Unit|503-494-3666|whru@ohsu.edu|
22328538|NCT03788967|Senior Vice President Clinical Development|Angela Talley|857-242-1575|atalley@sperotherapeutics.com|
22328539|NCT05711862|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
22328540|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328541|NCT02715804|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
22328542|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22328543|NCT03300258|University of Wisconsin, Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
22328544|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk|
22328545|NCT01281189|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22328546|NCT03351478|Lexicon Pharmaceuticals, Inc|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22300300|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590||
22328547|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
22328548|NCT03911869|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328549|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711||
22328550|NCT02657434|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328551|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org|
22328552|NCT01619488|Nemours Childrens Health Delaware|Kirk W Reichard, MD, MBA, Surgical Director|302-651-5999|kreichar@nemours.org|
22328553|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
22328554|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk|
22328555|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328556|NCT02451488|Mayo Clinic|Dr. James Jakub|507-284-3629|Jakub.James@mayo.edu|
22328557|NCT01106391|Cordis Corp.|Brandy Maschhaupt, Clinical Project Manager|847-887-5744|brandy.maschhaupt@cardinalhealth.com|
22328558|NCT01858597|The first Affiliated Hospital of Sun-Yat Sen University|Director of Clinical Trials|86-020-28823388|zsyyyb@mail.sysu.edu.cn|
22328559|NCT04897594|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
22328560|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328561|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22328562|NCT04866823|Wake Forest School of Medicine|Morgana Mongraw-Chaffin|13367133108|mmongraw@wakehealth.edu|
22328563|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
22328564|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org|
22328565|NCT05014542|Family Medicine Practice Svijetlana Perculija Durdevic, MD, Ninska 10, Sesvete|Svijetlana Perculija Durdevic, MD, family medicine specialist, acupuncturist|00385913302507|svijetlana.perculija.durdevic@outlook.com|
22328566|NCT03496662|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
22328567|NCT01467661|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22328568|NCT01707368|LEO Pharma GmbH|Tobias Anger, Medical Advisor|+49 610 220 1258|TANDE@leo-pharma.com|
22328569|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22328570|NCT03123055|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
22328571|NCT03395223|Provepharm SAS|Emilie HUYGHUES|+33 6 20 58 28 27|emilie.huyghues@provepharm.com|
22328572|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org|
22328573|NCT01896856|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Nilofer Azad|410-614-9169|nazad2@jhmi.edu|
22328574|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22328575|NCT04446299|Braintree Laboratories, Inc.|Head of R&D, GI|7819646710|studydirector@sebelapharma.com|
22328576|NCT02563925|Memorial Sloan Kettering Cancer Center|Dr. Shanu Modi, MD|646-888-5243|modis@MSKCC.ORG|
22328577|NCT03819478|Wake Forest University Health Sciences|Ashley Weaver, PhD|336-716-0944|asweaver@wakehealth.edu|
22300301|NCT03595904|Icahn School of Medicine at Mount Sinai|Dr. Sarah Miller|212-824-7783|Sarah.Miller@mssm.edu|
22300302|NCT02187991|Sarah Cannon Development Innovations, LLC|Taqi Mohammad|713-870-2175|taqi.mohammad@scri.com|
22300303|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300304|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22300305|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil|
22300306|NCT02558010|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
22328578|NCT00282867|University of Virginia|Karen C. Johnston, MD, MSc|434 924-5323|kj4v@virginia.edu|
22328579|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu|
22328580|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
22328581|NCT03005041|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328582|NCT02682030|Cedars Sinai Medical Center - 8700|Dr. Ashraf Elsayegh|3105560335|ashraf.elsayegh@cshs.org|
22328583|NCT02293096|"University of Colorado Denver | Anschutz"|Andrew Monte, MD, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22328584|NCT00673894|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
22328585|NCT03258632|Department of Veterans Affairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|23336
22328586|NCT03162458|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761571|PutilovskiyMA@materiamedica.ru|302
22328587|NCT00442767|Montefiore Medical Center|Dr. Rubina Heptulla|718-920-4664|rheptull@montefiore.org|
22328588|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu|
22328589|NCT04491240|MC Dinasty|Tyumina Olga|+78462039808|centr123@bk.ru|201
22328590|NCT02726113|Medical University of South Carolina|Sebastiano Gattoni-Celli, M.D.; Professor of Radiation Oncology|843-876-5103|gattonis@musc.edu|
22328591|NCT03549117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328592|NCT03820726|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328593|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu|
22328594|NCT02259127|MRC CTU at UCL|Prof Diana M Gibb (Chief Investigator)|+44 (0) 207 670 4700|diana.gibb@ucl.ac.uk|
22300307|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22300308|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org|
22300309|NCT04656847|Sevier|Medical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|
22300310|NCT03301051|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22300311|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
22300312|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300313|NCT02073331|Aziyo Biologics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
22300314|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22300315|NCT03006328|NYU Langone Health|Sandra Wittleder, PhD|212-263-4149|sandra.wittleder@nyulangone.org|
22300316|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com|
22300317|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22300318|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300319|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
22300320|NCT01629329|EINSTEIN MEDICAL CENTER|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
22300321|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22300322|NCT03708198|UVA Health|William Manson, MD|4349242283|wcm6m@virginia.edu|
22300323|NCT01781572|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300324|NCT01218438|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22300325|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22300326|NCT06167031|Tzu Chi University|Associate professer Mei-Lin Hsieh|886933513291|shaer@gms.tcu.edu.tw|
22300327|NCT00907153|Penn State Hershey Medical Center|Dr. Nazia Raja-Khan|717-531-8395|nrajakhan@psu.edu|
22300328|NCT02434692|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22300329|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt|
22300330|NCT01552213|Stanford University, School of Medicine|Anna Girsen, Research Operations Manager|(650) 725-5720|agirsen@stanford.edu|
22300331|NCT02566031|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22300332|NCT03031938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300333|NCT05762835|University of California at Davis|Dr. Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
22300334|NCT02007291|Federal University of Minas Gerais|Luís Felipe José Ravic de Miranda|55-31-3225-2337|ravicmiranda@gmail.com|
22300335|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov|
22300336|NCT02647359|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22300337|NCT01470027|Weill Cornell Medicine|Dr. Dikoma C. Shungu, Professor of Physics in Radiology|2127462481|dcs7001@med.cornell.edu|
22300338|NCT01972061|University of Pittsburgh|Dr. Christopher Chermansky|412-6418385|chermanskycj2@upmc.edu|
22300339|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22300340|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
22300341|NCT04642638|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22300342|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov|
22300343|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
22300344|NCT02388386|Scripps Clinic Medical Group|Sanjeev Bhavanni MD|6196601842|bhavnani.sanjeev@scrippshealth.org|
22300345|NCT01672801|Boston IVF|Alan Penzias|781-434-6500|apenzias@bostonivf.com|
22300346|NCT06476366|Department of Dermatology, Emirates Military Hospital|Dr Ahsan Tameez-ud-din|051-9293480|ahsantameezuddinmalik@gmail.com|312
22300347|NCT04159688|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
22300348|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org|
22300349|NCT04313881|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22300350|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22300351|NCT00651664|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22300352|NCT01988246|Cole Eye Institute - Cleveland Clinic|Rishi Singh, MD|216-445-9497|singhr@ccf.org|
22300353|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301|Markus.Rose@kgu.de|5754
22328595|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us|
22283143|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283144|NCT01665430|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22283145|NCT02310230|University of Vermont Medical Center|Alexander Friend, Clinical Research Coordinator|802-847-4259|alexander.friend@uvmhealth.org|4259
22283146|NCT03593681|Boston Scientific|Clinical Trial Project Manager|612-209-9532|blake.hedstrom@bsci.com|
22283147|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca|
22283148|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22283149|NCT04662073|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
22283150|NCT01053013|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
22283151|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777||
22283152|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915||
22283153|NCT04066686|Imperial College Healthcare NHS Trust|Dr Annabelle Lee|02033121077|annabellelee@nhs.net|
22283154|NCT03366103|Johns Hopkins University/SKCCC|Judy Murray|443-927-3568|jmurra33@jhmi.edu|
22283155|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
22283156|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu|
22283157|NCT00048815|Cedars Sinai Medical Center|Mark Hyman Rapaport, M.D.|310-423-2600|mark.rapaport@cshs.org|
22283158|NCT05590000|Abbott|Devyani Nanduri, Senior Director, Clinical & Regulatory Affairs|+16698329450|devyani.nanduri@abbott.com|
22283159|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
22283160|NCT02689076|James J. Peters VA Medical Center|Kimberly M. Judon|718-584-9000|Kimberly.Judon@va.gov|1174
22283161|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu|
22283162|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
22328596|NCT01736254|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328597|NCT00937794|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22328598|NCT04777214|University of Pennsylvania|Samuel Cason|215-573-4336|sacason@pennmedicine.upenn.edu|
22328599|NCT04884945|Indiana University School of Medicine, Pediatrics|Stacy Keller|3172786127|stasulli@iu.edu|
22328600|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
22328601|NCT04268303|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22328602|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328603|NCT04432376|Hill Dermaceuticals|Dr. Rosario G Ramirez, Medical Director|4073231887|nini.ramirez@hillderm.com|
22328604|NCT03706040|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22328605|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com|
22328606|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22328607|NCT03510910|NYU Langone Health|Thomas Youm, MD|212-348-3636|Thomas.Youm@nyulangone.org|
22328608|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328609|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22328610|NCT00110591|CytoDyn, Inc.|Joe Meidling|360-980-8524|jmeidling@cytodyn.com|
22328611|NCT02940860|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22328612|NCT04914819|University of Pennsylvania|Dr. Jennifer Lewey|215-662-7700|jennifer.lewey@pennmedicine.upenn.edu|
22328613|NCT03961295|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22328614|NCT01807611|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|866-278-5833|referralinfo@stjude.org|
22328615|NCT01625611|Yale University|Dr. Krishnan-Sarin|203.974.7595|nicholas.franco@yale.edu|
22328616|NCT00948194|University of Colorado Denver|Nick Naughton|303-724-0833|nick.naughton@cuanschutz.edu|
22328617|NCT02431793|Northwestern University|Dr. Danielle McCarthy|312-926-7532|d-mccarthy2@northwestern.edu|
22328618|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu|
22328619|NCT01818986|University of Texas Southwestern Medical Center Dallas|Dr. Raquibul Hannan|214-645-7696|raquibul.Hannan@UTSouthwestern.edu|
22328620|NCT02286726|The University of Texas MD Anderson Cancer Center|Ghayas Issa C. MD./Assistant Professor|713-745-6798|GCIssa@mdanderson.org|
22328621|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl|
22328622|NCT01711541|Alliance for Clinical Trials in Oncology|Everett E. Vokes, M.D.|773-702-9306|evokes@medicine.bsd.uchicago.edu|
22328623|NCT00728936|Idera Pharmaceuticals, Inc|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22328624|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22328625|NCT03943446|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22300354|NCT01910129|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22300355|NCT03543826|University of Washington|Adrienne James|206-744-4634|ajames1@uw.edu|
22300356|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252||
22300357|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov|
22300358|NCT02415400|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22300359|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22300360|NCT03825380|Laboratoires Théa|Corentin LE CAMUS|0473981414|Corentin.LECAMUS@theapharma.com|
22300361|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590||
22300362|NCT02270450|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066674623|karnold@fredhutch.org|
22300363|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu|
22300364|NCT03369444|University College London|Pratima Chowdary|+44(0)20 7472 6835|p.chowdary@ucl.ac.uk|
22300365|NCT01968213|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22300366|NCT01762046|Massachusetts General Hospital|Jose C. Florez, MD, PhD|6176433308|jcflorez@partners.org|
22300367|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
22300368|NCT04458948|UNM HSC|Cristina Beato|505-272-1734|CBeato@salud.unm.edu|
22300369|NCT02087163|Align Technology|Allison Mossing|4084701056|amossing@aligntech.com|
22300370|NCT02081846|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
22300371|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328626|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn|
22328627|NCT02707601|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22328628|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu|
22328629|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu|
22328630|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22328631|NCT03004976|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
22328632|NCT01665768|Johns Hopkins University|Douglas Gladstone, MD|4109558781|dgladst1@jhmi.edu|
22328633|NCT04406389|Weill Cornell Medicine|Dr. Maria T. DeSancho|646-962-2065|mtd2002@med.cornell.edu|
22328634|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22328635|NCT02781454|University of Washington|Dr. Michael D. Weiss|206-598-7688|mdweiss@uw.edu|
22328636|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu|
22328637|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22328638|NCT00844285|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22328639|NCT03219892|Xuanwu Hospital|Piu Chan|010-83198677|pbchan@hotmail.com|
22328640|NCT03796182|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22328641|NCT04682353|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22328642|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328643|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu|
22328644|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22328645|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com|
22328646|NCT03219567|Duke University|Anthony Kuo, M.D.|919-684-3799|anthony.kuo@duke.edu|
22328647|NCT01313208|Amgen Inc.|Study Director|866-572-6436||
22328648|NCT01829217|Dana-Farber Cancer Institute|Principal Investigator: Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
22328649|NCT01151540|Eisai Co., Ltd.|Customer Joy Department. EJ|8133817-3700|_ML_CLNCL@hhc.eisai.co.jp|
22328650|NCT01412060|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22328651|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu|
22328652|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328653|NCT02674685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328654|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22328655|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22328656|NCT02661464|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22328657|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
22328658|NCT05567393|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22328659|NCT03148756|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22328660|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov|
22328661|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es|
22328662|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328663|NCT02177175|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-7932|yua3@mskcc.org|
22300372|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22300373|NCT01650259|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328664|NCT04199793|Vanderbilt University Medical Center|Sandip Zalawadiya, MBBS|6159368187|sandip.k.zalawadiya@vumc.org|
22328665|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
22328666|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
22328667|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it|
22328668|NCT02983799|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22328669|NCT02025829|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
22328670|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
22328671|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22328672|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22328673|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu|
22328674|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22328675|NCT02293902|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22328676|NCT04021706|Tufts University|Bess Dawson-Hughes|6175563066|bess.dawson-hughes@tufts.edu|
22328677|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu|
22328678|NCT04306900|Trishula Therapeutics, Inc.|Executive Director|1-650-509-5732|info@trishulatx.com|
22328679|NCT01135394|University of Maryland School of Medicine|Soren Snitker, MD, PhD|4107061511|ssnitker@som.umaryland.edu|
22328680|NCT00462488|Sesen Bio|Rachelle Dillon, Ph.D.|204-452-7126|rachelle.dillon@sesenbio.com|308
22328681|NCT03140722|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
22328682|NCT02088541|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22328683|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
22328684|NCT02848313|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22328685|NCT03984812|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328686|NCT03062267|University of Washington|Principal Investigator|(206) 685-9655|dbenzeev@uw.edu|
22328687|NCT02911818|The University of Pennsylvania Center for Weight and Eating Disorders|Dr. Thomas Wadden|215-746-5046|wadden@pennmedicine.upenn.edu|
22328688|NCT02905825|Exalenz Bisocience|Avraham Hershkowitz|972-8-9737513|avrahamh@exalenz.com|
22328689|NCT01563107|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
22328690|NCT05355818|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22328691|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com|
22328692|NCT01333098|Washington University School of Medicine|Eric Lenze, MD|314-362-5154|lenzee@wustl.edu|
22328693|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012||
22328694|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
22328695|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov|
22328696|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22328697|NCT03276572|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
22328698|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com|
22328699|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com|
22328700|NCT01709708|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22328701|NCT00129740|The University of Texas MD Anderson Cancer Center|Cortes,Jorge E, MD./Professor|713-794-5783|jcortes@mdanderson.org|
22328702|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu|
22328703|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22328704|NCT02954952|Masimo Corporation|Director of Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
22328705|NCT02911519|SAMEIN|Dr. Jenny Garcia|+57 4 219 6014|jenny.garcia@udea.edu.co|
22328706|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
22328707|NCT02001688|Kamada Ltd|Head of Clinical Operations|+972-72-2219172|sharonc@kamada.com|
22328708|NCT03744598|patientMpower Ltd|Chief Scientific Officer|353872599131|colin@patientmpower.com|
22328709|NCT02864706|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22328710|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov|
22328711|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com|
22328712|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com|
22328713|NCT00706394|Endologix|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
22328714|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
22328715|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com|
22328716|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22328717|NCT01118715|Athens Orthopedic Clinic|Dr. Michael Shuler|706-549-1663|mshuler@athensorthopedicclinic.com|
22328718|NCT01902004|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Helen Lavretsky|(310)794-4619|hlavretsky@mednet.ucla.edu|
22328719|NCT02157103|Emory University|William L. Read, MD, Principal Investigator|404-778-1900|william.l.read@emory.edu|
22328720|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com|
22328721|NCT00047853|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
22328722|NCT02443805|Stallergenes Greer|Martine Le Gall, Director of Clinical Development|+33 1 55 59 25 56|martine.legall@stallergenesgreer.com|
22328723|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22328724|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22328725|NCT02708966|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22328726|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328727|NCT01981109|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
22328728|NCT03407170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328729|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
22328730|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328731|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu|
22328732|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu|
22328733|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov|
22328734|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu|
22328735|NCT03488914|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
22328736|NCT02559713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22328737|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
22328738|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328739|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com|
22328740|NCT02261883|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22328741|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777||
22328742|NCT01269047|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22328743|NCT01626989|Philips|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
22328744|NCT03366844|Cedars-Sinai Medical Center|Stephen Shiao, MD, PhD|310-423-2836|Stephen.Shiao@cshs.org|
22328745|NCT02480998|The catholic university of Korea, Seoul ST. Marry's Hospital|Dr.Dong-suck Lim, CI|+82-2-2258-7327||
22328746|NCT02332798|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22328747|NCT02688153|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
22328748|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu|
22328749|NCT02687711|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22328750|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328751|NCT01742091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328752|NCT05742841|Wake Forest School of Medicine|Nick Ashburn|336-716-4646|n.ashburn@wakehealth.edu|
22328753|NCT03750240|NYU Langone Health|Guillaume Madelin, PhD|(212) 263-3343|guillaume.madelin@nyulangone.org|
22328754|NCT03030183|Ra Pharmaceutical, Inc|Sponsor Ra Pharmaceutical, Inc|1 617 401 4060|trials@rapharma.com|
22328755|NCT02971007|Matinas Biopharma|Director Clinical Development|9082953235|jjohnson@matinasbiopharma.com|
22328756|NCT02471586|Abbott|Kristina M Gibbens, Senior Clinical Project Manager|+1 651-756-3859|Kristina.gibbens@abbott.com|
22328757|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328758|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu|
22328759|NCT01766986|University Hospital Hamburg-Eppendorf|Dr. Matthias Reeh|+49015222816521|m.reeh@uke.de|
22328760|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22271552|NCT03482167|University of Delaware|Christopher R. Martens, Ph.D.|302-831-7270|cmartens@udel.edu|
22328761|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300||
22328762|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu|
22328763|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328764|NCT03967847|University Hospitals Cleveland Medical Center|John Strony, MD|908-268-3663|john.strony@uhhospitals.org|
22328765|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
22328766|NCT00443846|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328767|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com|
22328768|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov|
22328769|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu|
22328770|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22283163|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de|
22283164|NCT01241344|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22283165|NCT02944565|The Ohio State University Comprehensive Cancer Center|Hallie Barr, PharmD BCOP|614-685-5803|Hallie.Barr@osumc.edu|
22283166|NCT00539617|University of California, San Francisco|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu|
22283167|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov|
22283168|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22283169|NCT02312765|University of Pennsylvania|Dr Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
22283170|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283171|NCT00042432|Amgen Inc.|Study Director|866-572-6436||
22283172|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
22283173|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283174|NCT02989844|University of Minnesota, Masonic Cancer Center|Jeffrey Miller|612-625-7409|mille011@umn.edu|
22283175|NCT02966795|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22283176|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu|
22283177|NCT01735708|Butler Hospital|Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
22283178|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22283179|NCT02513823|Texas Woman's University|Carolyn Moore|713-794-2377|cmoore8@twu.edu|
22300374|NCT00936858|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
22328771|NCT03437044|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
22328772|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br|
22328773|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
22328774|NCT05441540|UNC School of Medicine|Benjamin Succop|8284439726|benjamin_succop@med.unc.edu|
22328775|NCT01359046|Mayo Clinic|Dr. John Gebhart|507-266-7711|gebhart.john@mayo.edu|
22328776|NCT02665468|VA-CHOIR|Dr. Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
22328777|NCT03862495|Skin Disease Hospital of Southern Medical University|Deputy Chief Physician Li Changchang|18585239166|lichch8@mail2.sysu.edu.cn|
22328778|NCT00064077|NRG Oncology|Angela Kuras on behalf of Michael Sill and Helen Huang|716-845-5702|kurasa@nrgoncology.org|
22328779|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328780|NCT04397796|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22328781|NCT03037307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328782|NCT01661946|Queen's University Department of Ophthalmology|Dr. Sanjay Sharma|613-544-3400|sanjay_sharma60@hotmail.com|2227
22328783|NCT04075396|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22328784|NCT04737759|Boston College|Dr. Karen Lyons|6175526379|karen.lyons@bc.edu|
22328785|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov|
22328786|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org|
22328787|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328788|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22328789|NCT01555905|University of Florida|D. Barbara Smith|3522945315|bksmith@ufl.edu|
22328790|NCT03539861|University of Michigan|Lenar Yessayan|734-763-9041|lenar@med.umich.edu|
22328791|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328792|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328793|NCT02849626|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22328794|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com|
22328795|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu|
22328796|NCT04046341|Children's Hospital of Philadelphia|Marsha Wallace|2155900119|wallacem@chop.edu|
22328797|NCT04377672|Johns Hopkins University|Sanjay K. Jain|4105028241|sjain5@jhmi.ed|
22328798|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
22328799|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328800|NCT01637870|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbanks, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
22328801|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
22328802|NCT03505749|VA Portland Health Care System|Dr. Vanessa Somohano, Postdoctoral Research Fellow|503-220-8262|vanessa.somohano@va.gov|
22328803|NCT03096444|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
22328804|NCT03288324|Cincinnati Childrens Hospital Medical Center|Hermine Brunner|(513) 636-6320|hermine.brunner@cchmc.org|
22328805|NCT03846219|Immunic AG|Andreas Muehler, MD|+4917678738359|andreas.muehler@imux.com|
22328806|NCT05109702|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
22328807|NCT03812588|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
22328808|NCT03094832|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328809|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328810|NCT02679807|University of Virginia|Ronald Turner|434-981-9141|rbt2n@virginia.edu|
22328811|NCT00180271|Boston Scientific|Jill Leigh|800 227 3422|jill.leigh@bsci.com|
22328812|NCT02322411|University of Wisconsin - Madison|Dr. Nicole Pulia|6082561901|npulia@wisc.edu|11697
22328813|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
22328814|NCT04350905|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
22328815|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22328816|NCT02248857|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22328817|NCT02671461|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22328818|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
22328819|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22283180|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com|
22283181|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com|
22283182|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu|
22283183|NCT04342689|Yale School of Medicine|Sherry Mansour, MD, MS Assistant Professor|(203) 785-4184|sherry.mansour@yale.edu|
22283184|NCT01460407|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283185|NCT02818114|Minneapolis VA Health Care System|J. Irene Harris|612-467-1654|jeanette.harris2@va.gov|
22283186|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22283187|NCT01287377|UCSD|Dr. Shu-Hong Zhu|8583001056|szhu@ucsd.edu|
22328820|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
22283188|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328821|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22328822|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22328823|NCT05064332|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328824|NCT00089102|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22328825|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
22328826|NCT04532918|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22328827|NCT03788616|Faculty of dentistry, Ain Shams University|Dr. Marina Fakhry assistant lecturer of pediatric dentistry|01273731722|Dr.marina.fakhry@gmail.com|+02
22328828|NCT03537092|University Of Pittsburgh|Leslie Meyn, PhD|412-641-4233|meynla@mwri.magee.edu|
22328829|NCT04209530|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22328830|NCT04839393|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328831|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU|
22328832|NCT05091918|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
22328833|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666|clinicaltrials@nycomed.com|0
22328834|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu|
22328835|NCT02668952|Dept of Anesthesiology, University of New Mexico|Neal Gerstein, MD|5052722610|ngerstein@salud.unm.edu|
22328836|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22328837|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328838|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22328839|NCT02967172|University of Iowa|Michael Willey, MD|319-384-8452|michael-willey@uiowa.edu|
22328840|NCT02025530|University of Manchester|Professor Alexander Heazell|+441612766484|alexander.heazell@manchester.ac.uk|
22328841|NCT05364437|Imperial College London|Gary Frost|07872850308|g.frost@imperial.ac.uk|
22328842|NCT03551626|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22328843|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu|
22328844|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22328845|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu|
22328846|NCT03304262|University of New Mexico|Sarah Pirio Richardson|505-272-3342|spiriorichardson@salud.unm.edu|
22328847|NCT03051217|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22328848|NCT01989754|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22328849|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org|
22328850|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22328851|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu|
22328852|NCT03168841|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
22328853|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328854|NCT03364491|George Washington University Biostatistics Center|Principal Investigator, MFMU|301-881-9260|mfmudatasets@bsc.gwu.edu|
22328855|NCT03043807|Johns Hopkins University|Kenneth Pienta|4105023137|kpienta1@jh.edu|
22328856|NCT04539262|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22328857|NCT02351739|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22328858|NCT02980692|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22328859|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
22328860|NCT01788150|Svelte Medical|Betsy Lowry|19082642181|blowry@sveltemedical.com|
22328861|NCT05507580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22328862|NCT04702984|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22328863|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com|
22328864|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22328865|NCT03363165|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22328866|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22328867|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22328868|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
22328869|NCT02052141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22328870|NCT02156804|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22328871|NCT03000686|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22328872|NCT02291445|Maastricht University (Medical Center)|Z. Weerts||z.weerts@maastrichtuniversity.nl|
22328873|NCT05097157|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22328874|NCT00770224|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
22328875|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328876|NCT01112982|University of South Florida|John Carter, M.D|813-974-2473|mpatelli@health.usf.edu|
22328877|NCT03371251|Boston Pharmaceuticals, Inc.|Etienne Dumont, MD|(484) 986 8699|clinicaltrials@bostonpharmaceuticals.com|
22328878|NCT04206670|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22328879|NCT02260388|University of Kansas Medical Center|Dr. Richard Barohn|9139459943|rbarohn@kumc.edu|
22328880|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com|
22328881|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
22328882|NCT03332303|Prasco LLC|Senior Director, Quality Assurance|513-618-3333|b.inskeep@prasco.com|
22328883|NCT05425719|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
22328884|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com|
22328885|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22328886|NCT00871572|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328887|NCT04176445|Hospital Moinhos de Vento|PT Douglas Neves|(51) 9.98975514|nevesfisioup@gmail.com|
22328888|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu|
22328889|NCT03954444|Teva Pharmaceuticals Development Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22328890|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com|
22328891|NCT04179786|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
22328892|NCT01938001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22271553|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu|
22300375|NCT01289912|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
22300376|NCT00626431|Abbott|Global Medical Services|800-633-9110||
22300377|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300378|NCT01683864|University Clinic of Tübingen|Prof. Alfred Königsrainer|0049 7071 2983290|silvia.wagner@med.uni-tuebingen.de|
22300379|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca|
22300380|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
22300381|NCT04072159|Arizona State University, College of Health Solutions|Dr. Alexis Koskan (Assistant Professor)|602-827-2792|alexis.koskan@asu.edu|
22300382|NCT01177904|IVI Madrid|Dr. Graciela Kohls|91 180 29 00|graciela.kohls@ivi.es|
22300383|NCT02293044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22300384|NCT00989287|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328893|NCT03310580|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director, Global Clinical Operations|(908) 947-3543|nramirez@aeriepharma.com|
22328894|NCT03205982|Columbia University|Rebecca Schnall, PhD, MPH|212-342-6886|rb897@columbia.edu|
22328895|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu|
22328896|NCT01468701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328897|NCT02677623|Columbia University|Nisha Philip, Clinical Research Manager|212-305-4973|np2173@cumc.columbia.edu|
22328898|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu|
22328899|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22328900|NCT01079195|Abbott|Global Medical Services|1-800-633-9110||
22328901|NCT01999946|NYU Langone Health|Joshua Lee, MD MS|646-501-3552|joshua.lee@nyulangone.org|
22328902|NCT03170258|Duke University|R. Alison Adcock, MD, PhD|919-681-7486|alison.adcock@duke.edu|
22328903|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300||
22328904|NCT02252068|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
22328905|NCT02853123|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22328906|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw|
22328907|NCT03669146|The Ohio State University College of Optometry|Ann Morrison|614-570-3416|morrison.421@osu.edu|
22328908|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int|
22328909|NCT06103591|EmStop, Inc.|Phil Ebeling, CEO|763-227-9954|phil.ebeling@emstopeps.com|
22328910|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov|
22328911|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590||
22328912|NCT01510028|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22328913|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22328914|NCT02741310|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22328915|NCT01784211|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328916|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200|mpatz@icadmed.com|7308
22328917|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
22328918|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu|
22328919|NCT03943888|Seoul National University Hospital|Dr. Sang-Hwan Ji|+82-2-2072-3661|taepoongshin@gmail.com|
22328920|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com|
22328921|NCT03167541|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research|+44 (0) 1482326151|clinicalrequests@rb.com|
22328922|NCT03725293|Beaumont Hospitals|Amit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
22328923|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu|
22328924|NCT03673956|Mayo Clinic|Dr. Garret W. Choby|507-284-2533|Choby.Garret@mayo.edu|
22328925|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu|
22328926|NCT02255760|MedImmune LLC|Hasan S. Jafri, MD, Senior Director, Clinical Development|301-398-0000|jafrih@medimmune.com|
22328927|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22328928|NCT00003838|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
22328929|NCT03228394|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22300385|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300386|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22300387|NCT02341417|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22300388|NCT02512575|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22300389|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
22300390|NCT02726451|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22300391|NCT03570619|University of Michigan Rogel Cancer Center|University of Michigan Cancer Center Admin|7349369499|ClinicalTrialsgov_CCAdmin@umich.edu|
22300392|NCT04773587|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22300393|NCT00746603|Weill Cornell Medicine|Jennifer Levine, MD|212-305-9770|jel9022@med.cornell.edu|
22300394|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu|
22300395|NCT00670774|Mayo Clinic|Dr. Mark D. Stegall|507-284-6275|Stegall.Mark@mayo.edu|
22300396|NCT03143218|London School of Hygiene and Tropical Medicine|Professor Brian Greenwood|+442072994707|brian.greenwood@lshtm.ac.uk|
22300397|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
22300398|NCT03034577|The University of Melbourne|Prof Colin Royse|+61408467548|Colin.Royse@unimelb.edu.au|
22300399|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com|
22300400|NCT02625623|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22300401|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300402|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300403|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22300404|NCT01681589|NYU Langone Health|Prin Amorapanth, MD, PhD|212-263-6037|Prin.Amoropanth@nyulangone.org|
22300405|NCT02649868|Clinical Center|Wood, Bradford|+1 301 496 7739|bwood@mail.cc.nih.gov|
22300406|NCT02352948|AstraZeneca|Medical Science Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22300407|NCT01995123|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health; William S Middleton Memorial Veterans Hospital|Jessica Cook, PhD|608-265-9775|jwcook@ctri.wisc.edu|
22300408|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300409|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org|
22300410|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu|
22300411|NCT03762473|University of Alabama at Birmingham|Graham Towns, MD|(205)934-1801|gtowns@uabmc.edu|
22300412|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu|
22300413|NCT05054816|Sonova Canada|Jinyu Qian, PhD; VP Sonova Innovation Centre Toronto|647-262-4826|jinyu.qian@sonova.com|
22300414|NCT03662750|Imperial College London|Prof Roland Veltkamp|020 3311 7296|r.veltkamp@imperial.ac.uk|
22300415|NCT02010060|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
22300416|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110||
22300417|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300418|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22300419|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020|lisa.brenner@va.gov|2571
22300420|NCT04307004|University of Alabama at Birmingham|Emily B. Levitan, Professor and Vice Chair|(205) 975-7680|elevitan@uab.edu|
22300421|NCT02807558|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|tcrowell@syros.com|
22300422|NCT01972841|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
22300423|NCT01360606|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22300424|NCT03317977|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
22300425|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu|
22300426|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22300427|NCT04053764|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22300428|NCT02935062|Federal University of Santa Maria|Márcia Keske-Soares|55 55 999726370|marcia-keske.soares@ufsm.br|
22300429|NCT02384954|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22300430|NCT04732286|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22300431|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu|
22300432|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300433|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu|
22300434|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
22300435|NCT02372396|Veterans Medical Research Foundation|Dr. Ariel Lang|858-552-8585|ajlang@ucsd.edu|5359
22300436|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
22300437|NCT02890381|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22328930|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600|estherl@Pluristem.com|694
22328931|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com|
22328932|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr|
22300438|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22300439|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22271554|NCT00819780|Amgen Inc.|Study Director|866-572-6436||
22300440|NCT01390246|University of Texas Medical Branch|Dr. Tatiana Nanovskaya, PhD|409-772-3908|tnnanovs@utmb.edu|
22300441|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
22328933|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu|
22328934|NCT00126672|Dana-Farber Cancer Institute|Dabora Sandra L MD|(617) 732-5500|sandy.dabora@gmail.com|
22328935|NCT00442260|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22283189|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22283190|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22283191|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
22283192|NCT02726880|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
22283193|NCT04316741|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
22283194|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283195|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22283196|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com|
22283197|NCT01360398|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283198|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283199|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328936|NCT00466661|Medical University of South Carolina|Bryan K. Tolliver, M.D., Ph.D. (Principal Investigator)|(843) 792-4869|tollive@musc.edu|
22328937|NCT00125372|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@hitchcock.org|
22328938|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22328939|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22328940|NCT01614912|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22328941|NCT03495817|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22328942|NCT01957787|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
22328943|NCT03380624|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|fogt.78@osu.edu|
22328944|NCT01078558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22328945|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22328946|NCT04294095|Colorado School of Public Health|Jenn Leiferman|303-724-4386|jenn.leiferman@cuanschutz.edu|
22328947|NCT02629614|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
22328948|NCT02224638|Swedish Covenant Hospital|Nancy Chaiken|847-372-3500|nchaiken@comcast.net|
22283200|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
22283201|NCT01071356|Public Health Institute: Alcohol Research Group|Dr. Douglas Polcin|510-597-3440|dpolcin@arg.org|277
22271555|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
22271556|NCT04612777|New York State Psychiatric Institute|Dr. Michael Compton|4043759231|mtc2176@cumc.columbia.edu|
22271557|NCT00810446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271558|NCT05497960|IMPACTIV (Vivo)|Eric Levitan|770-331-3208|eric@teamvivo.com|
22271559|NCT04148287|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22271560|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com|
22271561|NCT03430895|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4770|funts@mskcc.org|
22328949|NCT00936299|University of Colorado Denver|Paula Riggs, MD|303.724.2235|paula.riggs@ucdenver.edu|
22328950|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br|
22328951|NCT00659126|Oregon Health and Science University|Amy Huddleston|5034945626|huddlesa@ohsu.edu|
22328952|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900|gkaufman@auxilium.com|5920
22328953|NCT02481596|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
22328954|NCT01804114|NSUHS|Michael Ujiki, MD|8475701700|rpulido@northshore.org|
22328955|NCT02762708|Mayo Clinic|Meera Shah, MB, ChB|507-284-0106|Shah.Meera@mayo.edu|
22328956|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com|
22328957|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22328958|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22271562|NCT00754208|University of Nebrasa Medical Center|Joan Daughton|402-552-6006|jdaughton@childrensomaha.org|
22328959|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il|
22328960|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org|
22271563|NCT03597009|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22328961|NCT02437487|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|(617) 945-9626|mtrucksis@serestherapeutics.com|
22328962|NCT03801356|Cleveland Clinic|Dr. Michael Steinmetz|216-445-5754|STEINMM@ccf.org|
22271564|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu|
22283202|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr|
22328963|NCT03726333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
22328964|NCT02947022|UNC Chapel Hill, Department of Radiology|Clinical Research Manager|919-966-4997|rad_research@med.unc.edu|
22328965|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881||
22328966|NCT03906136|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22328967|NCT04772469|University of California San Francisco|Dr. Carol Camlin|5109679558|Carol.Camlin@ucsf.edu|
22283203|NCT02279498|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
22328968|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu|
22328969|NCT01696396|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22328970|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
22328971|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590||
22328972|NCT02371980|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22328973|NCT00547729|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
22328974|NCT01280812|UC San Francisco|Yoshimi Fukuoka, PhD, RN, FAAN|415-476-8419|yoshimi.fukuoka@ucsf.edu|
22328975|NCT01060098|Imperial College London|Sonya Abraham|+44 (0)20 3313 4114|s.abraham@imperial.ac.uk|
22328976|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu|
22328977|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22328978|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu|
22328979|NCT00922974|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22328980|NCT03682055|Cullinan Oncology|Phill Gallacher|+1 617 710 9127|pgallacher@cullinanoncology.com|
22328981|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22328982|NCT03125018|Masimo|Tala Harake||studies@masimo.com|
22328983|NCT03077243|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22328984|NCT02574481|Boston Scientific|Nicole Kilburn|970-294-4082|Nicole.Kilburn@bsci.com|
22328985|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343||
22328986|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22328987|NCT01826448|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22328988|NCT02314598|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
22328989|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com|
22328990|NCT03404219|Boston University|Dr. Daniel Fulford|(617) 358-6723|dfulford@bu.edu|
22328991|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263||
22328992|NCT05302804|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
22328993|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090||
22328994|NCT02935595|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|(713) 486-2500|Sudhakar.Selvaraj@uth.tmc.edu|
22328995|NCT02431702|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22328996|NCT02058706|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
22328997|NCT02650193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271565|NCT01645891|EO2 Concepts|Dr. Mark Q Niederauer|2103387703|m.niederauer@eo2.com|
22271566|NCT00754520|Zimmer Biomet|Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
22271567|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org|
22271568|NCT03301740|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
22271569|NCT02847182|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
22271570|NCT00962091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22271571|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012||
22271572|NCT01306045|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@nih.gov|
22271573|NCT05072964|FARAPULSE|Allison Anderson|651-582-5077|Allison.Anderson@bsci.com|
22271574|NCT03153982|University of California, San Francisco|WIlliam Ryan, MD|(415) 502-1877|William.Ryan@ucsf.edu|
22283204|NCT04765644|Imperial College London|Dr Ricky Vaja|020 7589 5111|r.vaja@imperial.ac.uk|
22283205|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22328998|NCT03689699|Columbia University|Mark N. Stein, MD|212 305 5874|mns2146@cumc.columbia.edu|
22283206|NCT02739321|The Cleveland Clinic|Dr. Thomas Frazier||fraziet2@ccf.org|
22283207|NCT02558400|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22283208|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
22328999|NCT02683707|JohnsHopkinsU|Dr J William McEvoy|4109555000|jmcevoy1@jhmi.edu|
22329000|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329001|NCT02009930|David Grant Medical Center, Travis Air Force Base|Dr. Elijah Burton|707-423-7950|elijah.j.burton2.mil@mail.mil|
22329002|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com|
22329003|NCT03907969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22329004|NCT01419015|Edwards Lifesciences|Aya Saeki||Aya_Saeki@edwards.com|
22329005|NCT05686044|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
22329006|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov|
22329007|NCT00879437|Baylor College of Medicine|Jack Su|8328224306|jmsu@txch.org|
22329008|NCT02920450|University of Florida Heath Cancer Center|Protocol Development Manager|352-273-8128|clh1230@ufl.edu|
22329009|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329010|NCT01363258|UAB School of Nursing|Rita Jablonski|205-975-9019|rjablonski@uabmc.edu|
22329011|NCT03379376|Wake Forest University Health Sciences|Meg O'Mara - Study Coordinator|336-716-5440|megreen@wakehealth.edu|
22329012|NCT02475629|TaiMed Biologics USA Corp.|Manager - Clinical Services|(949) 331-3225|bbell@taimedbio.com|
22329013|NCT01611298|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
22329014|NCT03238352|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329015|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22329016|NCT04153929|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329017|NCT03383614|DNDi|Jean Yves Gillon|+41.22.906.92.32|jygillon@dndi.org|
22329018|NCT01686958|Profound Medical|Mathieu Burtnyk|647-476-1350|mburtnyk@profoundmedical.com|408
22329019|NCT02486367|University Hospitals Cleveland Medical Center|Dr. David Zidar|216-791-3800|daz21@case.edu|
22329020|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu|
22329021|NCT03199638|Nemours Children's Health|Dr Dominique Darmaun, PI|904 6973674|ddarmaun@nemours.org|
22329022|NCT02807844|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22329023|NCT01669642|washington university in st louis|SRI SANKAR CHINTA PI|3144544661|schinta@wustl.edu|
22329024|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22329025|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
22329026|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com|
22329027|NCT03803202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329028|NCT03595384|Emory University|Jennifer K Frediani PhD, RD|404-727-3766|jfredia@emory.edu|
22329029|NCT01125293|Dana-Farber Cancer Institute|Irene Ghobrial|617-632-4101|irene_ghobrial@dfci.harvard.edu|
22329030|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329031|NCT01406652|Geneva University Hospitals|Dr.med Ilker Uçkay|+412237123311|ilker.uckay@hcuge.ch|
22329032|NCT02228564|Becton Dickinson|Spark Yamanoglu|480-597-8604|Spark.yamanoglu@bd.com|
22329033|NCT03383627|Northwell Health|Lubaina Presswala, DO|516-708-2540|lpresswala@northwell.edu|
22329034|NCT02633046|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22329035|NCT02925312|Medstar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
22329036|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22329037|NCT03644108|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22329038|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22271575|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
22271576|NCT01463267|Kent State University|Joel Hughes|3306727721|jhughes1@kent.edu|
22271577|NCT04908202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22283209|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22329039|NCT04114539|Emalex Biosciences, Inc.|Sr. Director of Clinical Operations|1847|dkim@emalexbiosciences.com|7150562
22300442|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
22300443|NCT02571218|IRCCS Policlinico San Donato|Giuseppe Ciconte|+39 02 52 77 42 60|g.ciconte@gmail.com|
22283210|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283211|NCT03052530|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
22283212|NCT04068519|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22283213|NCT00969761|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283214|NCT03081858|LIPAC Oncology|Karl Bean|714-900-4412|karl@lipaconcology.com|
22283215|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu|
22283216|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu|
22283217|NCT01670565|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
22283218|NCT02936284|Children's Mercy Hospital, Kansas University|Kai Ling Kong, PhD|816-731-7239|kkong@cmh.edu|
22283219|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22283220|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu|
22283221|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283222|NCT02098369|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-0637|jakris@uic.edu|
22283223|NCT00908648|Gastroenterology Unit, Valduce Hospital - Como - Italy|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|+39031324009|vterruzzi@valduce.it|
22283224|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22283225|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
22283226|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it|
22283227|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283228|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com|
22283229|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22283230|NCT00545532|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22283231|NCT01479595|Novartis|Study Director|862-778-8300||
22283232|NCT02120365|Virginia Commonwealth University|Albert Arias|8046286777|albert.arias@vcuhealth.org|
22283233|NCT01726673|Feinstein Institute for Medical Research at Northwell Health|Johanna Chang, Senior Research Coordinator|(516) 562-3646|jchang14@northwell.edu|
22283234|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283235|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283236|NCT02305849|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|Astellas.resultsdisclosure@astellas.com|
22283237|NCT00355342|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329040|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22329041|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
22329042|NCT02766907|TissueTech|VP Medical Affairs|8882968858|hsheha@tissuetechinc.com|
22329043|NCT01360229|University of Colorado School of Medicine|Dr. Benzi Kluger|3037242194|benzi.kluger@ucdenver.edu|
22329044|NCT02281344|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
22329045|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22329046|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22329047|NCT00677560|Queen Mary University of London|Dr Harpal Singh Kalsi|07872492181|h.kalsi@qmul.ac.uk|
22329048|NCT03984838|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22329049|NCT03136367|Dartmouth College|Marie-Anne Durand|603-667-8601|marie-anne.durand@dartmouth.edu|
22329050|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
22329051|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329052|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu|
22329053|NCT01461824|The Research Institute at Nationwide Children's Hospital|Dr. Andrea Bonny|614-722-2450|andrea.bonny@nationwidechildrens.org|
22329054|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr|
22329055|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com|
22329056|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu|
22329057|NCT04038385|William Paterson University, Sociology Department|Jennifer Di Noia, PhD, Principal Investigator|19737203714|dinoiaj@wpunj.edu|
22329058|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu|
22329059|NCT02279160|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
22329060|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@hsc.wvu.edu|
22329061|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu|
22329062|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000|shauwai@stanford.edu|6242
22329063|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu|
22329064|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu|
22283238|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov|
22329065|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300444|NCT02834780|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22271578|NCT04149574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22271579|NCT04506905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271580|NCT04703270|St George's, University of London|Dr Sarah Sturrock|020 8672 9944|ssturroc@sgul.ac.uk|
22271581|NCT03030118|Penn State Hershey College of Medicine|Nancy J Olsen MD, Professor of Medicine|717-531-4921|nolsen@pennstatehealth.psu.edu|
22300445|NCT03150056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300446|NCT03335033|Mayo Clinic|Matthew W. Urban|507-284-3703|Urban.Matthew@mayo.edu|
22319122|NCT05629962|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22319123|NCT03951220|University of Oxford|Gaurav Agarwal|07826636655|gaurav.agarwal@medsci.ox.ac.uk|
22319124|NCT05461794|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22319125|NCT02730598|University of Kansas Medical Center|Neil Segal|(913) 945-8985|segal-research@kumc.edu|
22319126|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch|
22319127|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300||
22319128|NCT03019796|University of Castilla-La Mancha|Proffessor|925268800|ricardo.mora@uclm.es|
22319129|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu|
22319130|NCT01389765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22319131|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22319132|NCT03645954|Lithuanian Univrsity of Health Sciences|Principal Investigator Inna Jaremko|+37064857386|inna.jaremko@kaunoklinikos.lt|
22319133|NCT01335009|Eisai Inc.|Eisai Medical Information|18882742378|esi_medinfo@eisai.com|
22319134|NCT04824521|University of Montana|Dr. Sarah Reese|7313940288|Sarah.reese@mso.umt.edu|
22319135|NCT02076113|Lahey Hospital & Medical Center|Zoher Ghogawala, MD|781-744-8984|zoher.ghogawala@lahey.org|
22319136|NCT02431650|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
22319137|NCT03942406|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
22319138|NCT03801902|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22319139|NCT05664763|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
22319140|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319141|NCT05073679|Penn State College of Medicine|Dr. Rosemary Claire Roden|717-531-1383|rroden@pennstatehealth.psu.edu|
22319142|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22319143|NCT04209621|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Sun, Clare, M.D. Principal Investigator, NIH, NHLBI|301.402.1806|clare.sun@nih.gov|
22319144|NCT04044183|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
22319145|NCT05467774|MetroHealth Hospital/Case Western Reserve University|Dr. James Sulzer|5125419036|jss280@case.edu|
22319146|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22319147|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319148|NCT02554903|Actelion Pharmaceuticals US, Inc|Medical Affairs Associate Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319149|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
22319150|NCT02097641|University of California San Francisco|Michael A. Matthay, MD|415-502-7434|michael.matthay@ucsf.edu|
22319151|NCT02340091|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22319152|NCT01244451|GIMEMA|Alfonso Piciocchi|+39 06 70390528|a.piciocchi@gimema.it|
22319153|NCT05640648|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
22319154|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111|wei.huang@va.gov|6517
22319155|NCT05090995|Yale University School of Medicine|Lisa Fucito, PhD|203-200-1470|Lisa.fucito@yale.edu|
22319156|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22319157|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22319158|NCT02958267|OhioHealth|Joseph J Ruane, DO|614-566-3810|joseph.ruane@ohiohealth.com|
22319159|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
22319160|NCT05066724|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22319161|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk|
22319162|NCT04484831|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
22319163|NCT00508352|Ottawa Hospital Research Institute|Dr. Jean-Michel Caudrelier|613-737-8899|jcaudrelier@toh.ca|70216
22319164|NCT02244996|Hong Kong Polytechnic University|Dr. Henry Chan|85227667937|henryhl.chan@polyu.edu.hk|
22319165|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
22319166|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22319167|NCT03231943|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319168|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
22319169|NCT03471871|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22319170|NCT03040622|Inova Heart and Vascular Institute|Kevin Bliden|443-244-1497|kevin.bliden@inova.org|
22319172|NCT02818920|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
22300447|NCT02363738|University Health Network|Dr. Roger McIntyre|416-603-5279|roger.mcintyre@uhn.ca|
22300448|NCT03265600|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6132|zschuman@cha.harvard.edu|
22300449|NCT02372409|Washington University School of Medicine|Andrew Cluster, M.D.|314-454-6018|acluster@wustl.edu|
22300450|NCT02522715|Oregon Health & Science University|Rachel Slottke, Program Manager|503-494-6117|slottker@ohsu.edu|
22300451|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300452|NCT01289067|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|(212) 604-6010|bobby.liaw@mountsinai.org|
22300453|NCT03736434|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
22300454|NCT01548690|University of Texas Southwestern Medical Center|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
22300455|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu|
22300456|NCT03086447|Johnson & Johnson Vision|Kristy Canavan- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1474|KCANAVA2@its.jnj.com|
22300457|NCT00955877|Washington University in St. Louis School of Medicine|Diego Morales|3144544688|d.morales@wustl.edu|
22300458|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu|
22329066|NCT03180294|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22329067|NCT03870893|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
22329068|NCT01951326|RedHill Biopharma|Reza Fathi, Senior VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
22329069|NCT03542149|Medicines for Malaria Venture (MMV)|Dr. Helen Demarest|: +41 22 555 03 24|demaresth@mmv.org|
22271582|NCT02949908|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22271583|NCT05323994|Sevier|Denis Morozov|8-495-93707-00|denis.morozov@servier.com|
22271584|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org|
22271585|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net|
22329070|NCT02959970|Almirall LLC|Ayman Grada|610-840-7107|ayman.grada@almirall.com|
22329071|NCT03300427|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22329072|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com|
22329073|NCT01473355|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22329074|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082|elvin.geng@ucsf.edu|409
22329075|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org|
22329076|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu|
22329077|NCT02603172|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271586|NCT04395391|Exact Sciences|Alexandra Massoud, Vice President of Clinical Affairs|608-284-5700|clinicaltrials@exactsciences.com|
22300459|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com|
22329078|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com|
22271587|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org|
22283239|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448|kathy.ales@jacobus-pharmaceutical.com|238
22283240|NCT02782325|University of North Carolina at Chapel Hill|Hans Herfarth, MD|919-966-6806|hherf@med.unc.edu|
22329079|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22329080|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com|
22329081|NCT03417505|Tangible Science|Dr. Kelly Mabry|650-241-1045|kelly@tangiblescience.com|108
22329082|NCT02133001|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329083|NCT04211961|University of Galway|Dr. Alberto Alvarez-Iglesias|+35391524411|alberto.alvarez-iglesias@universityofgalway.ie|
22329084|NCT03235726|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329085|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22329086|NCT04685538|Sintetica SA|Anna Guaita|+41 (0)91 640 42 50|aguaita@sintetica.com|
22329087|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22329088|NCT04362813|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22329089|NCT04965116|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
22329090|NCT01732107|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22329091|NCT03882723|Rush University Medical Center|Dr. David Vines|3129424408|David_Vines@rush.edu|
22329092|NCT04445688|Apnimed, Inc|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
22329093|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu|
22329094|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi|
22329095|NCT04083794|Spaulding Rehabilitation Hospital Cambridge|Dr. Adina E. Draghici|617-758-5508|adraghici@mgh.harvard.edu|
22329096|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de|
22329097|NCT01511640|University of Kentucky College of Medicine|Joshua Lile, Ph.D., Professor|8593236034|jalile2@uky.edu|
22329098|NCT00224003|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
22329099|NCT03549429|Tufts Medical Center|Dr. Dan Drzymalski|‪617-913-8168|ddrzymalski@tuftsmedicalcenter.org|
22329100|NCT02157168|University of Arizona|Dr. Ada Wilkinson-Lee, Co-Investigator|(520) 626-7766|adaw@email.arizona.edu|
22329101|NCT02971293|AstraZeneca|Dr Ioannis Psallidas, MD, PhD|1-877-240-9479|Information.centre@astrazeneca.com|
22329102|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
22329103|NCT02754661|Medtronic GIH (Given Imaging LTD)|Liron Bar Yaakov, Senior Manager Clinical Affairs|972-526060466|liron.baryaakov@medtronic.com|
22329104|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22329105|NCT03104985|State Scientific Center of Laser Medicine, Russia, Moscow|Sergey Moskvin|+7-905-770-1860|7652612@mail.ru|
22329106|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329107|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
22329108|NCT04423757|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329109|NCT01202760|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329110|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu|
22329111|NCT02810951|Castle Creek Biosciences|Chief Medical Officer|(484) 713-6000|medinfo@castlecreekbio.com|
22329112|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw|
22329113|NCT03097029|Children's Hospital of Philadelphia|Dr. Nina Sainath|267.426.1736|sainathn@email.chop.edu|
22329114|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu|
22329115|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329116|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329117|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329118|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711|ayumu.m76@gmail.com|429
22329119|NCT02999100|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329120|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329121|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329122|NCT00587301|NYU Langone Health|Christine Ren Fielding, MD|2122633166|christine.ren-fielding@nyulangone.org|
22329123|NCT02867163|University of New Mexico|Dr. David Siegel|505-272-2610|dsiegel@salud.unm.edu|
22329124|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu|
22329125|NCT02460978|AstraZeneca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22329126|NCT00994162|Smith+Nephew|Rachael Winter|+44 1482 673475|rachael.winter@smith-nephew.com|
22329127|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com|
22329128|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
22329129|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com|
22329130|NCT01961089|Ziemer Ophthalmic Systems AG|Dr. Gregor Schmid|+41323327154|gregor.schmid@ziemergroup.com|
22329131|NCT01225172|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22329132|NCT01062009|UCSF Benioff Childrens Hospital Oakland|Natalie Cvijanovich, MD|510-428-3784|NCvijanovich@mail.cho.org|
22329133|NCT04034043|IRCSS Istituto Ortopedico Rizzoli|Federico Giardina|+390516366418|federico.giardina@ior.it|
22329134|NCT03175562|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329135|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22271588|NCT04339179|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22271589|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590||
22271590|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
22271591|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
22329136|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com|
22329137|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329138|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp|
22329139|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com|
22329140|NCT02944513|Brigham and Women's Hospital|Dr. Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
22329141|NCT00937326|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329142|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il|
22329143|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org|
22329144|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
22329145|NCT02225925|Johns Hopkins University|Daniel Song|410-502-5875|dsong2@jhmi.edu|
22329146|NCT03424044|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
22329147|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org|
22329148|NCT04402385|Yale School of Medicine|Olga Grechukhina, MD: Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences|(203) 785-3091|olga.grechukhina@yale.edu|
22329149|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
22329150|NCT01308853|Akademikliniken, Stockholm, Sweden|Dr. Per Hedén|+46 8 614 54 00|per.heden@ak.se|
22329151|NCT02468804|University of Colorado Denver|Isabelle Buard, PhD|(303)472-5973|Isabelle.Buard@cuanschutz.edu|
22329152|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408||
22329153|NCT03250624|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22329154|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu|
22329155|NCT01843205|University of Kentucky|Craig R. Rush, Ph.D.|(859) 257-5388|crush2@email.uky.edu|
22329156|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22329157|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort|
22329158|NCT01518309|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22329159|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu|
22329160|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411|christine.marx@va.gov|3626
22329161|NCT01973972|Duke University|William S. Yancy, Jr.|919-681-2863|yancy006@mc.duke.edu|
22329162|NCT01819506|Ralph H Johnson VAMC|Michelle Woodbury|843-792-1671|Woodbuml@musc.edu|
22329163|NCT02420990|Center on Addiction|Dr. Aaron Hogue|212-841-5278|ahogue@centeronaddiction.org|
22329164|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org|
22329165|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca|
22329166|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu|
22329167|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329168|NCT02017704|SKCCC @ Johns Hopkins Medicine|Amol Narang, MD|410-955-7390|anarang2@jhmi.edu|
22329169|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
22329170|NCT01963780|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
22329171|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org|
22329172|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22329173|NCT03639987|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22329174|NCT04354155|Johns Hopkins All Children's Hospital|Anthony Alexander Sochet|17277672912|anthony.sochet@jhmi.edu|
22329175|NCT04197986|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|Proof302.ct@qedtx.com|
22329176|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu|
22271592|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu|
22271593|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271594|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22271595|NCT05765253|Argon Medical Devices|Danyel Carr|469-731-1421|Danyel.Carr@argonmedical.com|
22271596|NCT02348359|Brace Pharma Capital|Vice President, Clinical and Regulatory|240-403-7153|info@Tyrogenex.com|
22271597|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090|fredyariza@hotmail.com|4122
22271598|NCT03329248|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22271599|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch|
22271600|NCT03000530|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22271601|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888|zhengleetau@qq.com|8204
22283241|NCT02481713|VA Connecticut Healthcare System|Joanna Fiszdon, PhD|2039325711|joanna.fiszdon@va.gov|2231
22329177|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu|
22329178|NCT00376246|UCSD Medical Center|Ori Ben-Yehuda, MD|619-543-2814|obenyehuda@ucsd.edu|
22329179|NCT01711658|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22329180|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|art.wallace@va.gov|3732
22271602|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov|
22271603|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22271604|NCT03379792|AdventHealth Translational Research Institute|Richard E. Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
22271605|NCT03646149|VA Greater Los Angeles|Sonya Gabrielian, MD, Investigator|310-478-3711|sonya.gabrielian@va.gov|49853
22271606|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22271607|NCT02649426|ReCor Medical Inc.|Chief Clinical Officer|+1-650-420-8048|hreeve-stoffer@recormedical.com|
22271608|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271609|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
22271610|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271611|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271612|NCT01870297|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
22271613|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
22300460|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
22271614|NCT04249622|Mayo Clinic|Saranya Chumsri, MD|904-953-2000|Chumsri.Saranya@mayo.edu|
22271615|NCT03604705|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22271616|NCT03689543|National Institute of Mental Health|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
22271617|NCT00586508|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22271618|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22271619|NCT05619536|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
22271620|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271621|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
22271622|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu|
22271623|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22271624|NCT02637713|Montefiore Medical Center|Dr. Erin Moran-Atkin|718-920-4800|emoran2@montefiore.org|
22271625|NCT02345889|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
22271626|NCT01768845|West Virginia Universtiy|Michael Craig, MD|304-293-4980|craigm@wvumedicine.org|
22271627|NCT03191864|Ellodi Pharmaceuticals (Formerly Adare Pharmaceuticals)|Senior Director Clinical Operations and Medical Affairs|(609) 450-1312|karol.knoop@ellodipharma.com|
22271628|NCT02086682|Mayo Clinic|Dr. Marie Hogan|507-266 -1963|Hogan.Marie@mayo.edu|
22271629|NCT02044874|Arena Pharmaceuticals, Inc|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
22271630|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
22271631|NCT04231396|BioSpeech|K. Lindaas, Principal Investigator|(503) 522-6276|kirstylindaas@biospeech.com|
22271632|NCT02539654|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22271633|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22271634|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
22271635|NCT04010747|Boston Medical Center & BU Chobanian & Avedisian School of Medicine|Emily R Kline, PhD|401-206-0586|emily.kline@bmc.org|
22271636|NCT03976323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22271637|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22271638|NCT03800836|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271639|NCT05670314|University of Nottingham|Dr Afroditi Kouraki|0115 8231676|afroditi.kouraki1@nottingham.ac.uk|+44
22271640|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com|
22271641|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750||
22271642|NCT03774394|University of Florida|Francesco Franchi, MD|+1-904-244-2060|francesco.franchi@jax.ufl.edu|
22271643|NCT03334422|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22271644|NCT01313221|Amgen Inc.|Study Director|866-572-6436||
22271645|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22271646|NCT03246061|Relievant Medsystems|Chris Hilker, Sr. Director Clinical Affairs|(650) 368-1000|chilker@relievant.com|
22271647|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22271648|NCT04710368|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
22271649|NCT03282591|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
22271650|NCT01777139|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271651|NCT04987931|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271652|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22271653|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
22329181|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org|
22329182|NCT00088972|SWOG|Study Statistician|206-667-4623||
22329183|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu|
22271654|NCT05625477|Zhuhai Trinomab Pharmaceutical Co., Ltd.|Wenxi Xiang|18083065921|xiangwenxi@trinomab.com|
22300461|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu|
22300462|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com|
22329184|NCT02023112|AbbVie|Global Medical Information|800-633-9110||
22271655|NCT01692002|Imperial College London|Prof Gary Frost Head of Section for Nutrition Research|07872850308|g.frost9296@gmail.com|
22329185|NCT02910219|Georgetown University|Sandra M. Swain, MD, FACP, FASCO|202-687-4600|Sandra.Swain@georgetown.edu|
22329186|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net|
22329187|NCT00845507|University of Cincinnati|Dr. DelBello|513-558-2989|Melissa.Delbello@uc.edu|
22329188|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov|
22329189|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com|
22329190|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22329191|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu|
22329192|NCT04644484|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+86-512-87658266|xjli@synermore.cn|8077
22329193|NCT04399980|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
22329194|NCT04366713|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
22329195|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov|
22329196|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
22329197|NCT03001310|MeiraGTx|Program Manager|0044 (0)20 3866 4320|CNGB3@meiragtx.com|
22329198|NCT03404518|Loma Linda University Health System|Khanh Nguyen, MD|909-558-8558|khanguyen@llu.edu|
22329199|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu|
22329200|NCT03693404|NYU Langone Health|Philipp Leucht, MD|646-501-0291|philipp.leucht@nyulangone.org|
22329201|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22329202|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu|
22329203|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329204|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com|
22329205|NCT02146833|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22329206|NCT04374149|Prisma Health|Dr. Julie Martin, Director of Cancer Research|(864) 455-3667|julie.martin@prismahealth.org|
22329207|NCT05569850|DIBINE, University of Bologna|Prof. Lorenzo Breschi|+393482210664|lorenzo.breschi@unibo.it|
22329208|NCT03565991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329209|NCT00948428|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22329210|NCT04241120|HabitAware|Sameer Kumar|2489904720|sameer@habitaware.com|
22329211|NCT02037204|UMC Utrecht|Prof. Daniel Saris|000000000000000000|d.saris@umcutrecht.nl|
22329212|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899|spakhale@ohri.ca|79428
22329213|NCT03008187|Menarini Ricerche|Angela Capriati, MD|+39 055 56 80 9990|acapriati@menarini-ricerche.it|
22329214|NCT05516134|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
22329215|NCT01155193|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22329216|NCT03613818|Boise State Universtiy|Dr. Diana Doumas|2084261219|dianadoumas@boisestate.edu|
22329217|NCT01119963|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
22329218|NCT01952288|VA Puget Sound Health Care System|Rebekah J. Rein, JD|206-764-2711|rebekah.rein@va.gov|
22329219|NCT03962634|Virginia Commonwealth University|Parthasarathy Madurantakam|804-828-4953|madurantakap@vcu.edu|
22329220|NCT01355497|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
22329221|NCT00038142|The University of Texas (UT) MD Anderson Cancer Center|Dr. Eugenie S. Kleinerman, Professor, Pediatrics - Research|713-792-8110|ekleiner@mdanderson.org|
22329222|NCT05935982|University of Alabama at Birmingham (UAB)|Byron Lai, PhD|205-638-9790|byronlai@uab.edu|8-9725
22329223|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22329224|NCT03053401|Akron Children's Hospital|Dr. Rami Karroum|330-543-8823|rkarroum@akronchildrens.org|
22329225|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov|
22329226|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
22329227|NCT03933215|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22329228|NCT04586673|University of Oxford|Dr Paola Cicconi|01865611425|paola.cicconi@ndm.ox.ac.uk|
22329229|NCT04072575|Janssen Research & Development, LLC|Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329230|NCT05784129|Janssen Pharmaceuticals, Inc, US Medical Affairs|Medical Director Gastroenterology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329231|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
22329232|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu|
22329233|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22329234|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
22329235|NCT02873208|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22329236|NCT00415584|Montefiore Medical Center|Dr. Maria Coco|718-920-4136|mcoco@montefiore.org|
22329237|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329238|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
22329239|NCT01831804|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329240|NCT03326583|George Washington Medical Faculty Associates|Dominic Raj|(202) 741-2296|draj@mfa.gwu.edu|
22329241|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu|
22300463|NCT03674177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300464|NCT03387852|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22300465|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
22300466|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu|
22300467|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351||
22300468|NCT00253864|Ottawa Hospital Research Institute|Clinical Research Coordinator|613-737-8899|kmcilquham@ohri.ca|79839
22300469|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com|
22300470|NCT03826667|Smith+Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
22300471|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com|
22300472|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22300473|NCT03166761|Vanderbilt University Medical Center|Byron Schneider|(615)936-7708|byron.j.schneider@vumc.org|
22300474|NCT03969654|Zimmer Biomet, Inc.|Director of Clinical Operations|8006136131|Clinicaloperations@zimmerbiomet.com|
22300475|NCT01864564|University of Texas at Austin|Lorie M. Harper, MD, MSCI|512-324-7036|lorie.harper@austin.utexas.edu|
22300476|NCT03077724|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
22300477|NCT02269670|Emory University|Dr. Suchita Pakkala|404-686-3496|suchita.pakkala@emoryhealthcare.org|
22300478|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722|abems@otsuka.jp|2545
22300479|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22300480|NCT02313428|University of Pittsburgh|Sashwati Roy|412-648-8297|sar543@pitt.edu|
22300481|NCT05672628|The University of Texas Health Science Center at Houston|Seema S Aggarwal, PhD, APRN, AGNP-C|713-500-9946|Seema.S.Aggarwal@uth.tmc.edu|
22300482|NCT04414696|Kaiser Permanente|Lyndsay Avalos|5108210300|lyndsay.a.avalos@kp.org|
22329242|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22329243|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329244|NCT00114218|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|lgedeon@gogstats.org|
22329245|NCT03168555|Zealand University Hospital|Dr. Christian Borup, coordinating investigator|+4523328035|chrbo@regionsjaelland.dk|
22329246|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu|
22329247|NCT02959190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329248|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329249|NCT01522768|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22329250|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22329251|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org|
22329252|NCT02738580|IVIValencia|DR. ERNESTO BOSCH|+34 963050900|Ernesto.Bosch@ivirma.com|
22329253|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com|
22329254|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu|
22329255|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org|
22329256|NCT03380000|Penn State University|David N. Proctor|8145715234|dnp3@psu.edu|
22329257|NCT00588523|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley, MD|212-639-7523|kaleyt@mskcc.org|
22329258|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu|
22329259|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22329260|NCT03406715|Moffitt Cancer Center|Alberto A. Chiappori, MD|813-745-4541|Alberto.Chiappori@moffitt.org|
22329261|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
22329262|NCT03034057|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329263|NCT03339401|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22329264|NCT02690168|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
22329265|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org|
22329266|NCT02679781|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+97226776135|fuxavia@gmail.com|
22329267|NCT02758119|iLumens|David Drummond|0033144494848|david.drummond@ilumens.org|6
22329268|NCT04209400|VBI Vaccines Inc.|Dr Francisco Diaz-Mitoma|613-297-3304|fdiazmitoma@vbivaccines.com|
22329269|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22329270|NCT04128527|Ambu|Signe Toräng|31267089|sito@ambu.com|
22329271|NCT05041062|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22329272|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu|
22329273|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org|
22329274|NCT04968353|Virginia Commonwealth University School of Dentistry, Orthodontics|Steven J Lindauer|8048289326|sjlindau@vcu.edu|
22329275|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
22329276|NCT05200455|Dartmouth-Hitchcock Medical Center|Dr. Barbara Jobst|6036505000|Barbara.C.Jobst@hitchcock.org|
22329277|NCT01760187|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|8572425142|alison.long@aegerion.com|
22300483|NCT06660823|Ain Shams University|Dr.Mohammed Abd Al Jawad,Professor of cardiac surgery|+201111219461|mohammed_abdaljawad@med.asu.edu.eg|
22329278|NCT03307629|Noxopharm|Lorena Figueroa, Director clinical Operations|+612 9144 2223|lorena.figueroa@noxopharm.com|
22329279|NCT03296787|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22283242|NCT01527383|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300484|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
22300485|NCT00593567|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22300486|NCT02993445|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
22300487|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu|
22300488|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu|
22300489|NCT02119260|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300490|NCT05183022|University of Alabama at Birmingham|Andrew D. Pucker, OD, PhD|1-920-579-2900|apucker@uab.edu|
22300491|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com|
22300492|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com|
22300493|NCT03282981|VA Northern California Health Care System|Dr. Sara Dahle and Dr. Rosyln Rivkah Isseroff|916-843-7151|sara.dahle@va.gov|
22300494|NCT03870763|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22300495|NCT04279314|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22300496|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
22300497|NCT00692094|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
22300498|NCT01471054|Oncology Service, Wills Eye Hospital|Arman Mashayekhi, MD|215-928-3105|arman_mash@yahoo.com|
22329280|NCT02853032|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
22300499|NCT00985725|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22300500|NCT00993655|Canadian Cancer Trials Group|Senior Biostatistician|6135336430||
22300501|NCT03151005|Department of Endocrinology, Xinqiao Hospital, Army Military Medical University|Min Long, MD|023-68763255|longmin_casper@163.com|
22300502|NCT03912259|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22300503|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com|
22300504|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743||
22300505|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu|
22300506|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22300507|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22300508|NCT03162224|Global Clinical Lead|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22300509|NCT04162769|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22300510|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu|
22329281|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
22283243|NCT02575118|NORCE|Dr. Trine Lise Lundekvam Berge|+47 56 10 72 12|trbe@norceresearch.no|
22283244|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn|
22283245|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22283246|NCT04240093|Brown University|Jaclyn White Hughto, PhD, MPH|401-863-6580|jaclyn_hughto@brown.edu|
22283247|NCT02839902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22283248|NCT04957758|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|mmacsai@oysterpointrx.com|
22283249|NCT03353922|Neurana Pharmaceuticals|Judy Caron, Chief Operating Officer|(617) 640-5043|jcaron@neuranapharma.com|
22283250|NCT03688555|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
22283251|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22283252|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22283253|NCT02076399|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22283254|NCT05260333|Baylor College of Medicine|Dr. Leah Antoniewicz, MD-PI|832-8267458|leah.antoniewicz@bcm.edu|
22283255|NCT02008357|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22283256|NCT05044104|Mayo Clinic|Dr. Vinay Chandrasekhara|207-284-2687|Chandrasekhara.Vinay@mayo.edu|
22283257|NCT04941807|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
22283258|NCT03553498|Albert Einstein College of Medicine|Polly Bijur|718-430-4217|polly.bijur@einsteinmed.org|
22283259|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22283260|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu|
22283261|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
22283262|NCT00846040|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Kevin Hall, PhD|3014028248|kevinh@niddk.nih.gov|
22283263|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661|rmchen@tmu.edu.tw|3222
22283264|NCT03352453|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22283265|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003|jyingst@phs.psu.edu|289511
22283266|NCT00858897|Nemours Children's Clinic|Dr. Dominique Darmaun|904-697-3863|ddarmaun@nemours.org|
22283267|NCT02827500|Duke Clinical Research Institute|Dr. Robert Mentz|919-668-7121|robert.mentz@duke.edu|
22283268|NCT03343080|Mayo Clinic|Dr. Troy Seelhammer|507-255-6051|seelhammer.troy@mayo.edu|
22283269|NCT03158272|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22283270|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu|
22300511|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22283271|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
22283272|NCT04064346|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
22283273|NCT01667146|ANZIC - RC, Monash University|Prof Carol Hodgson|+61 (3) 99030598|carol.hodgson@monash.edu|
22300512|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr|
22300513|NCT01636882|Viralytics Ltd|Mark Grose|1 647 821 7673|mark.grose@viralytics.com|
22300514|NCT02964416|Aga Khan University|Dr Asma Abdus Salam|+92-21-34864715|asma.salam.azhar@gmail.com|4639
22300515|NCT03280121|Daniel and Daniel Consulting, LLC|Cynthia Harris, Director of Clinical Trials|775-392-2975|cindy@clinregconsult.com|
22300516|NCT04650555|Humanetics Corporation|Michael D Kaytor, PhD|952-400-0405|mkaytor@humaneticscorp.com|
22300517|NCT03806270|Yeditepe U|Dr. Ferda F. Kartufan|+902165784000|ferdasozer@gmail.com|4754
22300518|NCT04460742|University of Rochester|Adam Simning|585-474-9534|adam_simning@urmc.rochester.edu|
22300519|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22300520|NCT02633137|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
22300521|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22300522|NCT06116591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300523|NCT05585307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22300524|NCT04391023|University of Iowa|Dr. Alexandra Courtney Fietsam|N/A|alexandra-fietsam@uiowa.edu|
22300525|NCT03074630|AmsterdamUMC|Erik van Bommel|+31 20 4444444|e.vanbommel@amsterdamumc.nl|
22300526|NCT01270347|Horizon Pharma USA, Inc|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22300527|NCT02085408|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22300528|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com|
22300529|NCT02486328|Ufuk University Faculty of Medicine|Dr Perihan Ekmekçi|+903122044000|erdogduperi@gmail.com|
22300530|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22300531|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu|
22329282|NCT00676208|Louis Stokes VA Medical Center|Michelle Davidson|(216) 791-2300|michelle.davidson@va.gov|2338
22271656|NCT04849416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329283|NCT01379924|Boston Children's Hospital|Dr. Joanne Cox|6173557701|joanne.cox@childrens.harvard.edu|
22329284|NCT03700736|University of Connecticut|Dr. Molly Waring|860-486-1446|molly.waring@uconn.edu|
22329285|NCT00642018|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329286|NCT01410799|University of Pennsylvania|Dr. Anne Cappola|215-573-5359|acappola@upenn.edu|
22329287|NCT00617656|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22329288|NCT02748785|Seoul National University Hospital|Eun Bong Lee|+82-2-2072-4399|leb7616@snu.ac.kr|
22329289|NCT04037462|VA Ann Arbor Healthcare System|Dr. Nithya Ramnath|(734) 845-5800|Nithya.Ramnath@va.gov|
22329290|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com|
22329291|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov|
22329292|NCT02579863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329293|NCT04480749|LSHTM|Michael Marks|020 7636 8636|michael.marks@lshtm.ac.uk|
22329294|NCT02253394|Brigham and Women's Hospital|Dr. Bradley Maron|617-525-4857|bmaron@bwh.harvard.edu|
22329295|NCT00809614|Novartis|Study Director|862-778-8300||
22329296|NCT01224106|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271657|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk|
22300532|NCT01939028|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Chad Michener|216-444-6601|michenc@ccf.org|
22319173|NCT00445068|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22319174|NCT02673619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319175|NCT03444324|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
22319176|NCT03834038|Vancouver Island Health Authority|Dr. Christine Lee|250-519-1898|christine.lee@islandhealth.ca|
22319177|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319178|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251|hideto.kameda@med.toho-u.ac.jp|2326
22319179|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319180|NCT06071754|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22319181|NCT03226275|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22319182|NCT03824639|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
22319183|NCT05959629|University of Pennsylvania School of Dental Medicine|Dr. Bekir Karabucak|215-898-4927|bekirk@upenn.edu|
22319184|NCT04650282|University of Michigan|Michael Popovich|(734) 936-1808|mipopovi@med.umich.edu|
22319185|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319186|NCT04906616|University of California, San Francisco|Dr. Amy Conroy|415-476-6021|Amy.Conroy@ucsf.edu|
22319187|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319188|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu|
22319189|NCT04147234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
22319190|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
22319191|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22271658|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271659|NCT03749499|University of Chicago Illinois|Heather M. Prendergast MD, MS, MPH, Professor, Department of Emergency Medicine|3124131214|hprender@uic.edu|
22271660|NCT02635009|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22271661|NCT05916131|University of Michigan|Yu Kuei Lin, MD|734-232-1573|yuklin@med.umich.edu|
22271662|NCT02278367|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22271663|NCT04105010|Dizal Pharmaceuticals|Rika Chen|862161095875|clinicaltrials@dizalpharma.com|
22271664|NCT01211483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22271665|NCT01675154|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-8295|abhimanyu.garg@utsouthwestern.edu|
22271666|NCT03724084|The Ohio State University Comprehensive Cancer Center|Dr. James Blachly|614-293-7484|James.Blachly@osumc.edu|
22271667|NCT02971800|CHU de Québec|Dr Philippe Laberge|+1(418)525-4444|philippe.laberge@fmed.ulaval.ca|
22271668|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu|
22271669|NCT00676572|Imperial College London|Professor Kian Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22271670|NCT00565916|Washington University School of Medicine|Dr. Robert Gropler MD|314-747-3878|groplerr@mir.wustl.edu|
22271671|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu|
22271672|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408||
22271673|NCT00115037|UPENN|David Oslin, MD|215-823-5894|oslin@upenn.edu|
22271674|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
22271675|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22271676|NCT02631070|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22271677|NCT03515629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22271678|NCT01523704|Fujita Health University School of Medicine|Eiichi Watanabe, MD, PhD|+81-562-93-2312|enwatan@fujita-hu.ac.jp|
22271679|NCT03597022|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22271680|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu|
22271681|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu|
22300533|NCT03282227|Zosano Pharma Corporation|Donald Kellerman, PharmD, Sr. VP, Clin Dev and Med Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
22329297|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22329298|NCT03210220|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82-32-460-3636|jjchoi2@gilhospital.com|
22329299|NCT02580591|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329300|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816||
22329301|NCT01620658|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute, Research and Outcomes|786-596-3505|raulh@baptisthealth.net|
22329302|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329303|NCT03006926|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22329304|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no|
22329305|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk|
22329306|NCT04882072|Janssen Pharmaceutical K.K.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329307|NCT02918318|Janssen Pharmaceutical K.K., Japan|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22300534|NCT02576678|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22300535|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com|
22300536|NCT03282890|UConn|Dr. Michael Copenhaver|860-208-3632|michael.copenhaver@uconn.edu|
22300537|NCT02937168|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22300538|NCT02154763|The Ottawa Hospital|Dr.Joseph Mamazza|613-798-5555|jmamazza@toh.on.ca|
22300539|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22329308|NCT00990249|The University of Texas (UT) MD Anderson Cancer Center|Partow Kebriaei, MD/Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
22329309|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22329310|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
22329311|NCT04583969|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22329312|NCT04080752|Janssen Research & Development, LLC|BE-R and D-Research Physician - Seni|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329313|NCT00444080|University of Virginia|Peter A. Netland, MD, PhD|434-982-1086|pan9c@virginia.edu|
22329314|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590||
22329315|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
22329316|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259|carlobriguori@clinicamediterranea.it|764
22329317|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22329318|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22329319|NCT03297944|University of Kentucky|Marion Coe|859-257-6488|mcoe07@gmail.com|
22329320|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu|
22329321|NCT04285853|Emory University|Dr. John Xerogeanes|404-778-7202|jxeroge@emory.edu|
22329322|NCT02119468|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|62405
22329323|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22329324|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22329325|NCT03179410|Duke University|Andrew Armstrong, M.D.|919-668-8797|andrew.armstrong@duke.edu|
22329326|NCT02562989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329327|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com|
22329328|NCT02343952|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22329329|NCT04018612|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
22329330|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org|
22329331|NCT02671760|Sequential Medicine Ltd|Head of Product Development|617-818-2735|tadahl@outlook.com|
22329332|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu|
22329333|NCT03418064|CooperVision|Jose A. Vega, O.D., MSc., FAAO|19256213761|jvega2@coopervision.com|
22329334|NCT03032250|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-1432|cnightin@wakehealth.edu|
22329335|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22329336|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org|
22329337|NCT01750840|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
22329338|NCT02650440|Coordination of Improvement of Higher Level Personnel - CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br|
22329339|NCT03328624|SALSA@USC|Research Coordinator|323-442-5528|dhuyvett@usc.edu|
22329340|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22329341|NCT02091921|University of Southern California|Leonardo Clavijo, MD|3234426130|lclavijo@usc.edu|
22329342|NCT02483078|CytoDyn|Joseph Meidling Senior Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22329343|NCT04876599|Massachusetts General Hospital|Dr. Daniel Hall|‭+1 (704) 517-7273‬|dhall7@mgh.harvard.edu|
22329344|NCT01962688|Icahn School of Mediine at Mount Sinai|Dr. Jagat Narula|212-241-4122|jagat.narula@mountsinai.org|
22329345|NCT04482244|Dana-Farber Cancer Institute|Dr. Manan Nayak|617-632-5096|manan_nayak@dfci.harvard.edu|
22329346|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com|
22329347|NCT01607073|Gillette Children's Specialty Healthcare|Beverly Wical, MD|(651) 229-3870|BWical@gillettechildrens.com|
22329348|NCT02564029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329349|NCT04126031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329350|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net|
22329351|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu|
22329352|NCT02712008|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22329353|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22329354|NCT01605890|Hopital Bichat-Claude Bernard, AP-HP, Paris, France|Pr Sophie Matheron|+33140257883|sophie.matheron@aphp.fr|
22329355|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org|
22329356|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22329357|NCT02996110|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22329358|NCT02436915|Institute for Aging Research, Hebrew SeniorLife|Brad Manor|617-971-5332|bradmanor@hsl.harvard.edu|
22329359|NCT03805971|Centre hospitalier universitaire de Liège|Dr Olivier Bonhomme|003243667881|obonhomme@chuliege.be|
22300540|NCT02491671|Hospital Universitario de Salamanca|Dr. Marcelo Jiménez|923291100|mfjl@usal.es|
22329360|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
22329361|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22329362|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com|
22329363|NCT05301803|CathVision ApS|Clinical Research Manager|+4531324745|kpf@cathvision.com|
22329364|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu|
22329365|NCT02939976|Duke University Medical Center|David Kong, M.D.|919-668-8946|David.F.Kong@duke.edu|
22329366|NCT03979872|University of Utah|Dr. Yelena Wu|801-213-5653|yelena@utah.edu|
22329367|NCT01585168|Yale University|Dr. Godfrey Pearlson|(860) 545-7757|Godfrey.Pearlson@hhchealth.org|
22329368|NCT01192100|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
22271682|NCT00416793|UT MD Anderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
22271683|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu|
22271684|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22271685|NCT03303391|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
22271686|NCT03019003|Massachusetts General Hospital Cancer Center|Dr. Sara Pai, MD, PhD|6178779118|sara.pai@mgh.harvard.edu|
22300541|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org|
22300542|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300543|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22300544|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22300545|NCT02439710|Institute for Policy Advancement Ltd|Mark W Skinner|+1-202-253-8342|mskinnerdc@gmail.com|
22300546|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22300547|NCT03152552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22300548|NCT01201057|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22300549|NCT04259086|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22300550|NCT03240692|Stanford University|Dr. Nolan Williams|650-800-6920|nolanw@stanford.edu|
22300551|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu|
22300552|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22300553|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300554|NCT02576067|Icahn School of Medicine at Mount Sinai|Zahi Fayad, PhD|212-824-8471|zahi.fayad@mssm.edu|
22300555|NCT04084314|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22300556|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org|
22300557|NCT03858803|Portland State University|Dr. Janet S. St. Lawrence|971-978-7801|janetsstlawrence@gmail.com|
22300558|NCT04631666|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
22300559|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu|
22300560|NCT05374421|Erchonia Corporation|Clinical Affairs Manager|864-531-0064|tsammons@erchonia.com|501
22300561|NCT00003508|Burzynski Research Institute, Inc|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22300562|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
22271687|NCT01593254|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22271688|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271689|NCT03627416|Jagiellonian University Medical College|Dr. Jakub Antczak|+48 795 421 153|jantczak@uj.edu.pl|
22271690|NCT02079636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22271691|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com|
22300563|NCT03576768|Medical University of South Carolina|Colleen Hanlon, PhD|843-792-9888|hanlon@musc.edu|
22300564|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22300565|NCT02057874|Vanderbilt University Medical Center|Professor of Surgery and Cancer Biology|615-936-2956|lee.gorden@vanderbilt.edu|
22300566|NCT02979639|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329369|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu|
22329370|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu|
22329371|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch|
22329372|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22329373|NCT01421069|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329374|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu|
22329375|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
22329376|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org|
22329377|NCT02809846|Scripps TSRI|Lase Ajayi|785.218.1643|tajayi@scripps.edu|
22329378|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329379|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com|
22329380|NCT01928082|The University of Chicago|Murray J. Favus|(773) 702-6138|mfavus@medicine.bsd.uchicago.edu|
22329381|NCT05563714|University of Michigan|Dr. Jacob E. Kurlander, MD, MS|734-660-4883|jkurland@umich.edu|
22329382|NCT02352103|Vattikuti Urology Institute, Henry Ford Hospital|Deepansh Dalela, MD|3139162600|ddalela1@hfhs.org|
22329383|NCT02427100|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor, Associate Professor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
22329384|NCT02120352|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300567|NCT00799292|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|Charles Ascher-Walsh MD, MPH|212-241-2827|charles.ascher-walsh@mssm.edu|
22300568|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu|
22300569|NCT00610116|Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.|Joachim Winter, MD|+49 (0) 2118|joachim.winter@uniklinik-duesseldorf.de|1173
22300570|NCT01760889|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22300571|NCT02621931|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22300572|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343||
22300573|NCT01466985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300574|NCT03100617|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
22300575|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22300576|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
22300577|NCT02985866|University of Virginia Center for Diabetes Technology|Boris Kovatchev, PhD|434-982-0602|mc7m@virginia.edu|
22300578|NCT03224182|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22300579|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200||
22300580|NCT02925455|Case Western Reserve University and MetroHealth System|Michael Fu|215-368-0355|mjf24@case.edu|
22300581|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com|
22300582|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408||
22300583|NCT02314624|Evidence Based Practice Institute|Linda Dimeff, PhD|206-384-7371|linda.dimeff@jasprhealth.com|
22300584|NCT00464815|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300585|NCT02526654|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22300586|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org|
22300587|NCT03643952|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300588|NCT01358968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300589|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22300590|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012|hasan.zeytin@nobel.com.tr|6012
22300591|NCT01992380|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22300592|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
22300593|NCT02071173|Boston Scientific|Kelly Aspinwall|1-800-CARDIAC|kelly.aspinwall@bsci.com|
22300594|NCT03430674|Indiana University|Jamie Renbarger, MD|317-944-8784|jarenbar@iu.edu|
22300595|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283274|NCT03697993|Vaccine Treatment Evaluation Unit (VTEU)|Nadine Rouphael, MD, MSc|(404) 822-1411|nroupha@emory.edu|
22283275|NCT04384107|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283276|NCT02423122|EIP Pharma|John Alam||jalam@eippharma.com|
22283277|NCT03190694|University Medical Center Groningen|Prof.dr.H.J. Lambers-Heerspink|+31 50 361 7859|h.j.lambers.heerspink@umcg.nl|
22283278|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22283279|NCT03582813|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
22283280|NCT00316524|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22283281|NCT02525094|MedImmune, LLC|Rene van der Merwe|301-398-2532|information.center@astrazeneca.com|
22283282|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283283|NCT02789410|Mayo Clinic|Dr. Hans P. Sviggum|507-284-9697|sviggum.hans@mayo.edu|
22283284|NCT01751776|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283285|NCT00160654|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22283286|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch|
22283287|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu|
22283288|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22283289|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org|
22283290|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22283291|NCT00004445|Louis Stokes Cleveland VAMC|Lisa Lombardo, MPT|216-791-3800|lisa.lombardo2@va.gov|4909
22283292|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283293|NCT03435562|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
22283294|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22283295|NCT02867618|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
22283296|NCT06687824|Manipal University College Malaysia|Heng Sy Xuan|+601110752589|hengsyxuan@hotmail.com|
22283297|NCT02046174|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
22283298|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com|
22283299|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
22283300|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22283301|NCT03180398|Henry Ford Health|Dr. Stephen Brown|3135858415|sbrown1@hfhs.org|
22300596|NCT02436265|Indiana University|Aali shah MD|317-944-9981|ashah9@iuhealth.org|
22283302|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il|
22283303|NCT03630302|Abbott neuromodulation|Erika Ross|972-526-8207|erika.ross@abbott.com|
22329385|NCT00444964|Children's Mercy Hospital|Jaylene Weigel|816-701-1359|jweigel@cmh.edu|
22329386|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329387|NCT02918656|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
22329388|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22329389|NCT02186561|Medtronic Neurovascular, Clinical Affairs|Senior Project Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
22329390|NCT03094611|The University of Texas MD Anderson Cancer Center|Elias Jabbour, MD./ Professor, Leukemia|713-792-4764|ejabbour@mdanderson.org|
22329391|NCT02573233|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22329392|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300||
22329393|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22329394|NCT05103475|Veterans Health Administration|Bella Etingen, PhD|214-857-0240|Bella.Etingen@va.gov|
22329395|NCT02228824|University of Pittsburgh|Dr. Saul Shiffman|412-567-1761|shiffman@pinneyassociates.com|
22329396|NCT01814826|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22329397|NCT02917629|UW Carbone Cancer Center|Dr. Howard Bailey|800-622-8922|clinicaltrials@cancer.wisc.edu|
22329398|NCT03271307|University of California Los Angeles|Dr. Kathryn Dovel|7143303416|KDovel@mednet.ucla.edu|
22329399|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu|
22329400|NCT03136484|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22329401|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org|
22329402|NCT03032510|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
22329403|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329404|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU|
22329405|NCT03061812|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22329406|NCT00431496|Amgen Inc.|Study Director|866-572-6436||
22329407|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
22329408|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org|
22329409|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu|
22329410|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22329411|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net|
22329412|NCT04095793|Theravance Biopharma|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
22329413|NCT03619837|University of Southern California|Norah Terrault|323-442-5100|terrault@usc.edu|
22329414|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329415|NCT05151367|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22329416|NCT03627494|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329417|NCT04483544|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
22329418|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22329419|NCT02177786|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22329420|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22329421|NCT04724291|George Washington University|Dr. Andrew C. Meltzer|2027412952|ameltzer@mfa.gwu.edu|
22329422|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu|
22329423|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329424|NCT04697888|Children's Mercy Hospital|Joel Lim, MD - Principal Investigator|(816)234-3000|jlim@cmh.edu|
22329425|NCT02613338|University of Tennessee|Adrija Sharma, Principal Investigator|8659747684|adrija.sharma@utk.edu|
22329426|NCT01977040|Mednax. Inc|Kimberly Maurel|714593-9171|kimberly_maurel@mednax.com|
22329427|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu|
22329428|NCT03597503|Supernus|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
22329429|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu|
22271692|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
22329430|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22329431|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
22329432|NCT00608894|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
22329433|NCT03654560|United Health Products, Inc.|Gerard Abate, MD Chief Medical Officer|(386) 627-1598|G.Abate@unitedhealthproductsinc.com|
22329434|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
22329435|NCT01235338|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22329436|NCT02918721|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22329437|NCT05283499|Rutgers University School of Dental Medicine|Cecile A. Feldman|973-972-4634|feldman@rutgers.edu|
22271693|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271694|NCT02315872|Providence Health & Services|Lynette Currie|503-216-1034|lynette.currie@providence.org|
22329438|NCT02828644|Akili Interactive Labs|Kathryn Jenkins|7742666693|kjenkins@akiliinteractive.com|
22329439|NCT02408484|Octapharma|Sigurd Knaub|55 451 21 41|sigurd.knaub@octapharma.com|+41 (0)
22329440|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com|
22283304|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271695|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22271696|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu|
22329441|NCT04830839|Cincinnati Children's Hospital Medical Center|Professor|+15136363370|shari.wade@cchmc.org|
22329442|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu|
22329443|NCT04083404|Queen Margaret University|Dr Susan Prior|44 (0)131 474 0000|sprior@qmu.ac.uk|
22329444|NCT00179998|Nationwide Children's Hospital|Dr. Robert Castile|614-355-6670|robert.castile@nationwidechildrens.org|
22329445|NCT02933372|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
22329446|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436||
22329447|NCT03012594|Northwell health|Dr.Larry Miller|5165620334|lmiller7@northwell.edu|
22329448|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22271697|NCT02680834|TactileMedical|Clinical Research Director|612-540-5267|astone@tactilemedical.com|
22271698|NCT02520427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22271699|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271700|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271701|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271702|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271703|NCT02681757|Children's Hospital Colorado|Choi Young Mee MD|7207770859|youngmeeyoungmee@gmail.com|
22271704|NCT03467763|Memorial Sloan Kettering Cancer Center|Dr. James Flory|6468883790|floryj@mskcc.org|
22271705|NCT02073565|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
22271706|NCT04102865|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22271707|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
22271708|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22271709|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu|
22271710|NCT02913105|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22271711|NCT02168777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22271712|NCT05243563|USA Health|Catera Duhon|251-415-1598|cduhon@health.southalabama.edu|
22271713|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22271714|NCT02437188|Baylor College of Medicine|Dr. Lilian Dindo, Assistant Professor|713-440-4637|lilian.dindo@bcm.edu|
22271715|NCT01663857|Eli Lilly and Company|Chief Medical Officer|800-575-5979|Clinicaltrials.gov@lilly.com|
22271716|NCT02517021|Helsinn Healthcare SA|Dr. Ruben Giorgino|+41 91 985 2121|ruben.giorgino@helsinn.com|
22271717|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271718|NCT03529799|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
22271719|NCT03315962|UCSF|Gabe Chamie|(415) 476-4082|gabriel.chamie@ucsf.edu|
22271720|NCT02578940|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
22271721|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
22271722|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org|
22271723|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22271724|NCT02217800|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
22271725|NCT03959488|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22271726|NCT03341936|Dana Farber Cancer Institute|Glenn J. Hanna, MD|6176326799|GJHANNA@partners.org|
22271727|NCT02542293|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22271728|NCT04529850|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
22271729|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576||
22271730|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22271731|NCT02397291|"University of Colorado Denver | Anschutz"|Henry Galan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22271732|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22271733|NCT01472939|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22271734|NCT00114738|National Cancer Institute|Dr. Wyndham Wilson|301-435-2415|wyndham_wilson@nih.gov|
22271735|NCT05940077|Tufts University|Dr. Evan Papa|617-636-4056|evan.papa@tufts.edu|
22271736|NCT01492101|Nektar|Alison Hannah, MD||AHannah@nektar.com|
22271737|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com|
22271738|NCT01253668|Merck|Dr. Stephen Keefe|215-220-9693|stephen.keefe@merck.com|
22271739|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271740|NCT04108988|Yale School of Medicine|Dr. Kimberly Hieftje|(203) 737-3301|kimberly.hieftje@yale.edu|
22271741|NCT03738800|Mayne Pharma|Mayne Pharma|1 252 752 3800|us.medicalinformation@maynepharma.com|
22271742|NCT02777944|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22271743|NCT02223819|Columbia University|Shaheer A. Khan, DO|212-342-5162|sk4488@cumc.columbia.edu|
22271744|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22329449|NCT03938636|Navidea Biopharmaceuticals|Chief Medical Officer|614-822-2320|mrosol@navidea.com|
22283305|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch|
22329450|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22329451|NCT03531762|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22329452|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org|
22329453|NCT02019758|University of North Carolina at Chapel Hill|Evan S. Dellon, MD MPH|919-966-2513|edellon@med.unc.edu|
22329454|NCT04989504|Mayo Clinic|Dr. Kimberly Corbin|855-776-0015|corbin.kimberly@mayo.edu|
22329455|NCT00735072|University of California, San Francisco|Peter W. Hunt, MD|(415) 476-4082|phunt@php.ucsf.edu|345
22329456|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329457|NCT01291511|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22329458|NCT02367859|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
22329459|NCT03960658|Minneapolis VA Health Care System|Dr. Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
22329460|NCT01263314|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329461|NCT02640755|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
22329462|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov|
22329463|NCT01188460|OHRI|Dr. Keith Wilson||kewilson@toh.ca|
22329464|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329465|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu|
22329466|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org|
22329467|NCT01587274|Montefiore Health|Benjamin W. Friedman, MD|7189206626|befriedm@montefiore.org|
22329468|NCT02242760|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22329469|NCT03378973|Hospital for Special Surgery|Ronald Emerson, MD|2127742742|emersonr@hss.edu|
22329470|NCT03236506|University of Dundee|Professor John Dillon|01382 383017|j.f.dillon@dundee.ac.uk|
22329471|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu|
22329472|NCT00638274|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-82748|ppan@wakehealth.edu|
22329473|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
22329474|NCT00838383|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329475|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com|
22329476|NCT02709109|Parion Sciences|Alison Church|919-313-1183|achurch@parion.com|
22329477|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329478|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22329479|NCT02565615|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329480|NCT03920865|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22329481|NCT04010370|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
22329482|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu|
22329483|NCT01815580|Fred Hutchinson Cancer Center|Ann Duerr|206 667 7938|aduerr@fredhutch.org|
22329484|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu|
22329485|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
22329486|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu|
22329487|NCT01610206|University of Virginia|Linda Duska, MD|434-982-1719|lrd5d@virginia.edu|
22329488|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22329489|NCT02999191|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329490|NCT04454138|Prism Eye Institute|Ronaldo Santiago|905-456-3937|ronaldo.santiago@prismeye.ca|267
22329491|NCT01883804|Barbara Davis Center for Diabetes, University of Colorado School of Medicine|Dr. Aaron Michels|303-724-1923|aaron.michels@ucdenver.edu|
22329492|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590||
22329493|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu|
22329494|NCT02566109|Wake Forest University Health Sciences|Gregory Hundley, MD|336-716-0607|ghundley@wakehealth.edu|
22329495|NCT04821960|Northwestern University|James W. Griffith|3125035345|j-griffith@northwestern.edu|
22329496|NCT01993667|University of Utah|Dr. Scott McIntosh, MD, MPH|801-581-2730|Scott.McIntosh@hsc.utah.edu|
22329497|NCT03695471|Mayo Clinic|Jason Sluzevich|904-953-6402|Sluzevich.Jason@mayo.edu|
22283306|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org|
22329498|NCT02859558|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22329499|NCT04507360|University of Washington|Tim Althoff|206-543-4243|althoff@cs.washington.edu|
22329500|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu|
22329501|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com|
22329502|NCT03950440|University Hospitals Leuven|Dr. Danny Feike Hoogma|003216344270|danny.hoogma@uzleuven.be|
22329503|NCT02892734|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
22329504|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22329505|NCT02043509|University of East Anglia|Dr Joanne Emery||joanne.emery@uea.ac.uk|
22329506|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si|
22329507|NCT03189563|Dong-A ST|Xiaofei Du|82-2-92-8457|duxiaofeicat@donga.co.kr|
22329508|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
22329509|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
22329510|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22329511|NCT03690674|Seattle Children's Research Institute|Dr. Pooja Tandon|206-884-1130|pooja.tandon@seattlechildrens.org|
22329512|NCT00688623|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22329513|NCT02443155|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22329514|NCT02000219|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
22329515|NCT00464620|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22329516|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22329517|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu|
22329518|NCT05724069|Alfasigma|Sara Manzoni|3473778218|sara.manzoni@alfasigma.com|
22329519|NCT02444936|Cleveland VA|Dr. David Canaday|216-368-8901|dxc44@case.edu|
22329520|NCT03552289|Cook Research Incorporated|Alan Saunders|765-463-7537|Alan.Saunders@CookMedical.com|
22329521|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu|
22329522|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22329523|NCT02809118|Auris Medical|RAM|0041 61 201 13|ra@aurismedical.com|50
22329524|NCT04403802|Cedars-Sinai Medical Center|Dr. Arash Asher|310-423-1218|arash.asher@cshs.org|
22329525|NCT05241470|Stuart Therapeutics|Brian Del Buono, Executive Vice President|7034025866|brian@stuarttherapeutics.com|
22329526|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723|ulrich.duehrsen@uk-essen.de|2417
22329527|NCT06048809|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22329528|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com|
22329529|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu|
22329530|NCT02658149|Beaumont Health|Dr. James Verner|1(248)551-9722|jverner1@aol.com|
22329531|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
22329532|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22329533|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22329534|NCT03135262|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: BH39147|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22329535|NCT03745989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329536|NCT04944758|University of British Columbia|Dr. Raymond Lam|6048227325|r.lam@ubc.ca|
22329537|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org|
22329538|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
22329539|NCT02773368|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22329540|NCT01665872|Yale University|Dr. Megan Smith|2037648655|megan.smith@yale.edu|
22329541|NCT01929018|University of Colorado Denver, Anschutz Medical Campus|Dr. Cory Christiansen|303.724.9101|cory.christiansen@ucdenver.edu|
22329542|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22329543|NCT02748525|The University of Texas Health Science Center at Houston|Isis Gayed, MD|713-704-1787|isis.w.gayed@uth.tmc.edu|
22329544|NCT03436147|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
22329545|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com|
22329546|NCT05784103|University of Pittsburgh|Dr. Surya Gnyawali, PhD|6143712027|scg92@pitt.edu|
22329547|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu|
22329548|NCT02635867|University of Illinois at Chicago|Adriana Semprum-Clavier|312-966-3535|asemprum@uic.edu|
22329549|NCT02128958|Can-Fite BioPharma|Pnina Fishman, PhD, CEO|972-3-924-1114|pnina@canfite.co.il|
22329550|NCT02565576|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22329551|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22329552|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22329553|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|28062
22300597|NCT03252587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22329554|NCT01408732|University of Minnesota|Holly Boyer, MD|612-725-2000|boyer011@umn.edu|
22329555|NCT04904640|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini, MD|+390516366418|francesco.castagnini@ior.it|
22329556|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22329557|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
22329558|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com|
22329559|NCT03185819|Janssen-Cilag International NV|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329560|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22329561|NCT02910089|Astrazeneca Pharmaceuticals|Susan Thomas, MD|302-886-5589|Susan.Thomas2@astrazeneca.com|
22329562|NCT01976975|McLean Hospital|David Crowley|6178554432|djcrowley@mclean.harvard.edu|
22329563|NCT03434041|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329564|NCT03447821|Cosmo Technologies Ltd.|Richard Jones|+353 18170370|RJones@cosmopharma.com|
22329565|NCT02977507|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22271745|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu|
22329566|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329567|NCT03997760|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22329568|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329569|NCT01906476|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
22329570|NCT01248585|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
22329571|NCT00479167|Rush University Medical Center|Stephanie Gregory, MD|312-942-5982|stephanie_gregory@rush.edu|
22329572|NCT03304912|Drexel University|Alexis Roth, PhD, MPH|267.359.6123|alexisroth@drexel.edu|
22329573|NCT01576406|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329574|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22329575|NCT02988401|Johns Hopkins University|Dr. Ellen Mowry|4106141522|Emowry1@jhmi.edu|
22329576|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22329577|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22329578|NCT02481440|The Third Affiliated Hospital of Sun Yat-sen University|Li-Min Rong M.D., Director of Clinical Trials|862085252900|ronglimin@21cn.com, ronglm@mail.sysu.edu.cn|
22329579|NCT03140488|University of Arizona|Meghan Hill|+64273095220|meghan.hill@auckland.ac.nz|
22329580|NCT01199198|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante,MD/Chair, General Internal Med|(713) 745-4516|cescalan@mdanderson.org|
22329581|NCT04315298|Regeneron Pharmaceuticals, Inc.|Clinical Trials Adminstrator|844-734-6643|clinicaltrials@regeneron.com|
22329582|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu|
22329583|NCT03267511|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329584|NCT03050307|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22329585|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com|
22329586|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
22329587|NCT01847560|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329588|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329589|NCT04210232|Johnson & Johnson Surgical Vision|Eugenia K. Thomas|+1 657 2903260|EThoma39@its.jnj.com|
22329590|NCT00711412|Northwestern University|Dr. Mary Mulcahy|312 695 6182|Mary.Mulcahy@nm.org|
22329591|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
22329592|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net|
22329593|NCT02458352|University Hospital Zurich|Dr. Ronny Buechel|0041442551059|ronny.buechel@usz.ch|
22329594|NCT04097028|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22329595|NCT02498392|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329596|NCT02473289|Janssen Research & Development, LLC|ASSOCIATE DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329597|NCT06073054|University of Iowa|Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
22329598|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org|
22329599|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu|
22329600|NCT03285490|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22329601|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu|
22329602|NCT02728206|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22329603|NCT00617162|Abbott|Lyndahl Himes, Sr. Clinical Research Scientist|+1 214 998 1137|lyndahl.himes@abbott.com|
22329604|NCT04521920|Duke University|Dr. Mehri McKellar|(919) 613-6129|mehri.mckellar@duke.edu|
22329605|NCT00424099|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD- Chair, Palliative Care Med|(713) 792-6084|ebruera@mdanderson.org|
22329606|NCT03689972|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22329607|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com|
22329608|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
22329609|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com|
22329610|NCT02417064|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329611|NCT02437162|Johnson&Johnson|SENIOR DIRECTOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329612|NCT03981744|Janssen Pharmaceutical K.K.|PRODUCT DEVELOPMENT PORTFOLIO LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329613|NCT02782104|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329614|NCT04338321|Janssen-Cilag International NV|Europe, Middle East, Africa (EMEA) Medical Advisor Spravato|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329615|NCT03321526|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329616|NCT03097133|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329617|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu|
22329618|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012||
22329619|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu|
22329620|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com|
22283307|NCT00746733|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22283308|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283309|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283310|NCT04432493|Rutgers University|Travis Baker, PhD|18622503351|travis.e.baker@rutgers.edu|
22283311|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
22329621|NCT04159701|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329622|NCT03605836|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22329623|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com|
22329624|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu|
22329625|NCT04146038|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD, PhD|732-235-4523|strairrk@cinj.rutgers.edu|
22329626|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com|
22329627|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org|
22329628|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
22329629|NCT03241589|VHA|Sara Peracca|415-750-2091|sara.peracca@va.gov|
22329630|NCT01452191|University of Nottingham|Professor Denise Kendrick||denise.kendrick@nottingham.ac.uk|
22329631|NCT02348840|Emory University|Gari D. Clifford, DPhil|404-727-0229|gari.clifford@emory.edu|
22329632|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com|
22329633|NCT03011775|Ukrainian Medical Stomatological Academy|Prof. Igor Kaidashev|+380505858953|kaydashevip@gmail.com|
22329634|NCT03748420|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
22329635|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
22329636|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com|
22329637|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu|
22329638|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329639|NCT03634228|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/ Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
22329640|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590||
22329641|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329642|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu|
22329643|NCT00744991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329644|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
22329645|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329646|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com|
22329647|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu|
22329648|NCT01929707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329649|NCT01332097|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
22329650|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22329651|NCT01240304|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
22329652|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se|
22329653|NCT02384993|University of Wisconsin - Madison|Ozioma C. Okonkwo|(608) 265-4479|ozioma@medicine.wisc.edu|
22329654|NCT03209362|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|taku.hosaka@seikagaku.co.jp|
22329655|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329656|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22329657|NCT00981682|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22329658|NCT02358863|Lombardi Comprehensive Cancer Center (LCCC)|John Marshall, MD|202-444-7064|marshalj@georgetown.edu|
22329659|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu|
22329660|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu|
22329661|NCT04852666|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-843-5908|michael_kappelman@med.unc.edu|
22329662|NCT01636453|Penumbra, Inc.|Michaella Corso|(510) 748-3200||
22329663|NCT05426460|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
22329664|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22329665|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu|
22329666|NCT04829734|Multi Radiance Medical|Douglas Johnson, ATC, EES, CLS - Chief Science Officer, Clinical and Scientific Affairs|440-542-0761|info@multiradiance.com|
22329667|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com|
22329668|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329669|NCT05085327|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22329670|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
22283312|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org|
22283313|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22271746|NCT03435224|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22271747|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com|
22271748|NCT01777295|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271749|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271750|NCT02609724|UZ Leuven|Prof. Nele Devoogdt|0032 16 34 25 15|nele.devoogdt@uzleuven.be|
22271751|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu|
22271752|NCT04007107|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22300598|NCT04052204|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
22300599|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22300600|NCT01433354|Novartis Pharmaceuticals|Study Director|862--778--8300||
22300601|NCT05098054|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22300602|NCT01016769|Memorial Sloan Kettering Cancer Center|Dr. David Pfister, MD|646-888-4237|pfisterd@mskcc.org|
22300603|NCT04149405|OndokusMU|Feyza Otan Özden|+905322535106|feyza_otan@yahoo.com|
22300604|NCT04124926|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
22300605|NCT01250977|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|215-746-7173|albeldab@pennmedicine.upenn.edu|
22300606|NCT02167074|Erasmusm MC University Medical Center Rotterdam|Dr. P. van Riet|0031648237608|p.vanriet@erasmusmc.nl|
22300607|NCT03321396|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|6202
22300608|NCT02578238|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22300609|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu|
22300610|NCT00937924|University of California, Irvine|Dr. Kenneth Chang|714-456-6187|kchang@uci.edu|
22300611|NCT04009291|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22300612|NCT03842995|Hudson Alpha Institute for Biotechnology|Greg Cooper, PhD|2563279490|gcooper@hudsonalpha.org|
22300613|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
22300614|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300615|NCT03421691|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22271753|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu|
22300616|NCT01922076|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22300617|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu|
22329671|NCT02734849|Allakos, Inc.|Henrik Rasmussen, MD, PhD, Chief Medical Officer|1 6505975002|hrasmussen@allakos.com|
22329672|NCT05129124|Bausch + Lomb Incorporated|Jill Schafer|0000000|Jill.Schafer@bausch.com|
22329673|NCT02234050|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
22271754|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329674|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com|
22271755|NCT03114657|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22271756|NCT04245202|Ege University Medical Faculty Hospital|Dr. Aykut Eşki|05303009760|aykuteski1984@gmail.com|
22271757|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu|
22271758|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org|
22329675|NCT02438787|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329676|NCT03412565|Janssen Research & Development, LLC|GLOBAL MEDICAL HEAD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329677|NCT02280096|Instituto Mexicano del Seguro Social. Unidad de Investigación Médica en Enfermedades Neurológicas.|Dr. Israel Grijalva|(01152) 5555780240|igrijalvao@yahoo.com|
22329678|NCT06181708|Imperial College Healthcare NHS Trust|Emma Flint|02033117322|e.flint1@nhs.net|
22329679|NCT03733132|Mayo Clinic|K Sreekumaran Nair, M.D., Ph.D.|507-255-2415|Nair@mayo.edu|
22329680|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu|
22329681|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22329682|NCT01872897|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
22329683|NCT04254796|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|olga.tymofiyeva@ucsf.edu|
22329684|NCT02845440|Massachusetts General Hospital, Center for Addiction Medicine|A. Eden Evins|6177333131|aeevins@mgh.harvard.edu|
22329685|NCT01849562|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22329686|NCT01775800|The Rogosin Institute|Dr. Nathaniel Berman|212-746-9766|nab2009@nyp.org|
22329687|NCT03136913|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
22329688|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
22283314|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com|
22283315|NCT00985907|University of California, San Francisco|Dr. Thomas Martin, MD|(415) 353-9365|Tom.Martin@ucsf.edu|
22283316|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org|
22283317|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283318|NCT03464422|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
22271759|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47||
22271760|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu|
22271761|NCT03769194|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
22283319|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl|
22300618|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
22300619|NCT00572234|University of Nebraska Medical Center|Kathleen Grant|402-995-4347|kathleen.grant2@va.gov|
22300620|NCT03738150|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300621|NCT03762135|University of Michigan|Dr. Susan Woolford|734-615-8214|swoolfor@med.umich.edu|
22300622|NCT04598152|The Ohio State University College of Medicine|Jay Fournier, PhD|614-293-9600|jay.fournier@osumc.edu|
22300623|NCT02271386|The Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|2674262304|fiks@email.chop.edu|
22300624|NCT03346759|University of Michigan|Jason Bell, MD|7342323897|jasonbel@med.umich.edu|
22300625|NCT03943095|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300626|NCT04988308|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22300627|NCT03341910|Dr. Reddy's Laboratories, Inc|Dr. Srinivas Sidgiddi, Sr. Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
22300628|NCT02474927|University of Pittsburgh|John McDyer|(412) 624-8915|mcdyerjf@upmc.edu|
22300629|NCT00866840|Rutgers Cancer Institute of New Jersey|James Goydos, MD|(732) 235-7593|goydosjs@cinj.rutgers.edu|
22300630|NCT02599194|Stanford University|Andrei H. Iagaru|(650) 725-4711|aiagaru@stanford.edu|
22329689|NCT04599972|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22329690|NCT02069704|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
22329691|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu|
22329692|NCT02861118|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22329693|NCT02108522|AlloVir|Iain Fraser, MD|833-409-2281|ClinicalTrials@allovir.com|
22329694|NCT01690988|Washington University School of Medicine|Dr. Michael Avidan|314-747-4155|avidanm@wustl.edu|
22329695|NCT03696576|Emory University|Sandeep Shelly|404-686-4206|SSHELLY@emory.edu|
22329696|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu|
22329697|NCT01975376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329698|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com|
22329699|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22329700|NCT04449276|CureVac AG|Clinical Trial Information|+49 6976805870|clinicaltrials@curevac.com|
22329701|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22329702|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329703|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu|
22300631|NCT03919422|Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital|Dr. Junfen Zhang, director of the clinical trial|+8618930173689|zhangjunfeng@sjtu.edu.cn|
22329704|NCT01915095|Hines VA|Audrey Wilson|3122383637|awilson03@sralab.org|
22329705|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
22329706|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329707|NCT00456885|BIDMC|Jody Dushay|6177353343|jdushay@bidmc.harvard.edu|617
22329708|NCT04266158|The Ohio University|College of Medicine Office of Research Compliance Team|6145886811|comresearchcompliance@osumc.edu|
22329709|NCT03242590|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
22329710|NCT03561246|Brooks Rehabilitation Clinical Research Center|Mark G. Bowden - PI|904-345-6626|mark.bowden@brooksrehab.org|
22329711|NCT02896192|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22329712|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org|
22329713|NCT01308294|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof. Olivier Michielin, MD PhD|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
22329714|NCT04857892|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271762|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
22271763|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22271764|NCT05385224|EnteraSense Ltd.|David Collins, Director of Technical Operations|091 750 246|david@enterasense.com|
22271765|NCT01069315|McMaster University|Paula McKay, Manager|9055274322|mckayp@mcmaster.ca|44131
22271766|NCT01688141|University of Leicester|Professor Nigel Brunskill|+44 116 258 8043|njb18@le.ac.uk|
22271767|NCT04521114|CytoDyn Inc.|Joseph Meidling, Senior Director - Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22271768|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22271769|NCT03878875|Imperial|Hemna Santilale|020|hemna.santilale@nhs.net|
22271770|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org|
22271771|NCT02614131|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22271772|NCT03209518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22271773|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il|
22271774|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22271775|NCT04482036|Eskenazi Health|Jessica Broughton|317-903-6276|jessica.broughton@eskenazihealth.edu|
22271776|NCT02292186|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22271777|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com|
22271778|NCT03083769|Southern Medical University|Dr. Liang Li|86 20 61648510|liliang@smu.edu.cn|
22271779|NCT03653091|Fractyl Health, Inc.|Sarah Hackett, Sr. Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
22271780|NCT02028169|AbbVie|Global Medical Services|800-633-9110||
22271781|NCT00737893|Johns Hopkins Brady Urological Institute|Dr. Hiten Patel|410-502-7710|hiten.patel@lumc.edu|
22271782|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz|
22271783|NCT02240069|University of Montana|Curtis Noonan|406-243-4957|curtis.noonan@umontana.edu|
22300632|NCT04177758|Rush University Medical Center|Anne DeBenedetti, MSc|312-432-2468|anne.debenedetti@rushortho.com|
22300633|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300634|NCT02763384|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-747-8439|guy@wustl.edu|
22300635|NCT04657211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300636|NCT02943408|Veterans Affairs Rocky Mountain (VISN 19) Mental Illness Research Education and Clinical Center (MIRECC)|Dr. Samantha Hack|720-234-2017|samantha.hack@va.gov|
22300637|NCT01106833|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22300638|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu|
22300639|NCT03751631|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
22300640|NCT02481310|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@northwestern.edu|
22300641|NCT04953390|Sonova USCS|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
22300642|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22300643|NCT03035292|Cambridge University Hospitals NHS Trust|Dr Stephen Kelleher, Director of R&D|01223 217418|r&denquiries@addenbrookes.nhs.uk|
22300644|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300645|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342|kschafer@wakehealth.edu|336
22300646|NCT02184611|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22329715|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22329716|NCT01311895|Montefiore Medical Center|Dr. Andrew Chang|718-920-6626|achang3@yahoo.com|
22329717|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu|
22329718|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22329719|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
22329720|NCT02650895|OncoImmune, Inc.|Dr. Pan Zheng|2027516823|pzheng@oncoimmune.com|
22283320|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu|
22283321|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu|
22283322|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
22283323|NCT01955434|Mayo Clinic|P. Leif Bergsagel, MD|480/301-8335|Bergsagel.leif@mayo.edu|
22283324|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com|
22283325|NCT03503292|Mayo Clinic|Yvette N. Martin McGrew, M.D., Ph.D.|507-255-7481|martin.yvette@mayo.edu|
22283326|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org|
22283327|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com|
22283328|NCT00462735|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
22283329|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223||
22283330|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
22283331|NCT04070326|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22283332|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov|
22283333|NCT05182580|Orbis International|Dr. Nathan Congdon, Director of Research|646-674-5514|ncongdon1@gmail.com|
22283334|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu|
22283335|NCT05445206|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
22283336|NCT03461406|Instituto Grifols, S.A.|Sandra Camprubi Gimenez|+34670923160|sandra.camprubi@grifols.com|
22283337|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22283338|NCT03077698|Xenetic Biosciences Inc|Dr. Curtis Lockshin|781-778-7720|info@xeneticbio.com|
22283339|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471||
22283340|NCT01140568|UCSD - Moores Cancer Center|Lara Rose|858-822-6575|ljrose@ucsd.edu|
22283341|NCT03618628|Washington University School of Medicine|Dr. Mary Hastings|3142861433|hastingsmk@wustl.edu|
22283342|NCT01969500|University of Washington|Dror Ben-Zeev|(206) 685-9655|dbenzeev@uw.edu|
22283343|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com|
22283344|NCT04096820|Queen's University/Kingston General Health Research Institute|Heather McFarlane, Administrative Assistant|613-549-6666|heather.mcfarlane@kingstonhsc.ca|8171
22283345|NCT02463032|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22283346|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu|
22283347|NCT02312219|Mass General Hospital|Ahmed Tawakol, MD|617-726-0791|atawakol@mgh.harvard.edu|
22283348|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu|
22283349|NCT02741570|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22283350|NCT02953665|Cedars-Sinai|Vicki Manoukian, Neurology Clinical Research Program Manager|310-423-5067|Vicki.Manoukian@cshs.org|
22283351|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov|
22283352|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22283353|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70||
22283354|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl|
22283355|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283356|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300647|NCT01907191|Saint Francis Hospital and Medical Center|Sanjay Sinha, MD|860-714-6654|ssinha3300@gmail.com|
22300648|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300649|NCT01690130|Medical University of South Carolina|TMS in Nicotine Craving|8437925729|lixi@musc.edu|
22300650|NCT05159622|George Washington University|Uriyoan Colon-Ramos|202994 1899|uriyoan@gwu.edu|
22300651|NCT02723864|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
22300652|NCT03232983|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22300653|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com|
22300654|NCT02633800|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|CTRinfo@DSI.com|
22300655|NCT01030861|Benaroya Research Institute|Carla Greenbaum, MD|206-342-6933|cjgreen@benaroyaresearch.org|
22300656|NCT02836418|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22300657|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
22300658|NCT03647501|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22300659|NCT03945188|Arena Pharmaceuticals, a wholly owned subsidiary of Pfizer|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22300660|NCT04794803|Dompé Farmaceutici|Dr Maria De Pizzol, BSc|+39 02 583831|clinops@pec.dompe.it|
22300661|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22300662|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22300663|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22300664|NCT01763931|SKCCC at Johns Hopkins|Vered Stearns, MD|410-614-1361|HopkinsBreastTrials@jhmi.edu|
22300665|NCT02355002|Massachusetts General Hospital|Drs. Joan Camprodon and Sabine Wilhelm|6177265340|jcamprodon@mgh.harvard.edu|
22300666|NCT03644186|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki|+41 31 511 94 00|TOUCH-monitoring@etop.ibcsg.org|
22300667|NCT04235036|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22300668|NCT01640808|Pharmaceutical Division, Clinical Administration Dept.|Administrator of clinical trial information||ctrdinfo@kowa.co.jp|
22300669|NCT02477111|Cordis, A Cardinal Health Company|Jennifer Lee, Clinical Project Manager|669-699-6851|jennifer.lee02@cordis.com|
22300670|NCT02192502|Cleveland Clinic|Dr. Andra Duncan|216-538-6944|duncana@ccf.org|
22300671|NCT01381692|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22300672|NCT02189798|Advanced Bionics|Michelle Caulfield, Senior VP, Global Quality Assurance and Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
22300673|NCT02921997|Vanderbilt Vaccine Research Program|C. Buddy Creech, MD, MPH|615-343-0332|buddy.creech@vanderbilt.edu|
22300674|NCT04818346|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22300675|NCT05553808|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300676|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
22300677|NCT03819491|Consult Med Iasi|Dr. Delia Reurean-Pintilei|+40232233387|drdeliapintilei@gmail.com|
22300678|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22300679|NCT03695172|Duke University Medical Center|Amanda Kumar, MD|919-681-4607|amanda.kumar@duke.edu|
22300680|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300681|NCT02672111|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
22300682|NCT01839110|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
22300683|NCT06242444|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22300684|NCT02076152|Massachusetts General Hospital|Elizabeth Gerstner, MD|617-724-2887|EGERSTNER@PARTNERS.ORG|
22300685|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr|
22300686|NCT04575467|Caliway Biopharmaceuticals Pty Ltd|Candra Chou|886226971355|candra.chou@caliway.com|1317
22300687|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov|
22300688|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22300689|NCT02464449|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
22300690|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22300691|NCT04899349|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22300692|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu|
22300693|NCT03336619|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22300694|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
22300695|NCT02820623|Northwestern University|Rinad Beidas, PhD|312-503-0546|rinad.beidas@northwestern.edu|
22300696|NCT05893992|Sonova|Dr. Jonathan Vaisberg|9057456785|jonathan.vaisberg@sonova.com|
22300697|NCT05207813|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22300698|NCT01954017|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director of Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
22300699|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22300700|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu|
22329721|NCT06436300|Washington State University|Clemma Muller|612-327-7237|clemma.muller@wsu.edu|
22329722|NCT03765736|Duke Cancer Institute|John Strickler, MD|(919) 668-6608|john.strickler@duke.edu|
22329723|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org|
22300701|NCT02653482|Saint Luke's Hospital of Kansas City|Program Manager, Cardiometabolic Research|8166957561|DEFINE-HF@saint-lukes.org|
22300702|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at|
22300703|NCT05132699|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6742|straud@uthscsa.edu|
22329724|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
22329725|NCT02632344|Massachusetts General Hospital|Dr. Sara Pai, Principal Investigator|617-726-5251|sarapaimdphd@gmail.com|
22329726|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22329727|NCT01370499|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329728|NCT04984876|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22329729|NCT02462122|Bausch Health|Study Director||anyaloncaric@bauschhealth.com|
22329730|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
22329731|NCT02784496|The University of MD Anderson Cancer Center|Prithviraj Bose, MD/Professor|713-792-7747|PBose@mdnaderson.org|
22329732|NCT04960202|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329733|NCT02855086|Stanford University Medical Center|Gordon Li, MD, Associate Professor of Neurosurgery|650-721-1020|gordonli@stanford.edu|
22329734|NCT00054756|NIDDK|Dr Joanna Klubo-Gwiezdzinska|301-496-1211|joanna.klubo-gwiezdzinska@nih.gov|
22329735|NCT04358991|University of Pittsburgh|Dr. Ryan Shields, Associate Professor of Medicine|412-864-3745|shieldsrk@upmc.edu|
22329736|NCT03687827|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22329737|NCT03630185|The University of Texas Health Science Center at Houston|Stuart A Harlin, MD|713-486-5131|Stuart.A.Harlin@uth.tmc.edu|
22329738|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22329739|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
22329740|NCT03377452|VA Greater Los Angeles Healthcare System|Jennifer Martin, PhD|818-891-7711|jennifer.martin@va.gov|36080
22329741|NCT03464136|Janssen Scientific Affairs, LLC|DIRECTOR MEDICAL AFFAIRS MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329742|NCT03146403|Genocea|Jennifer LaVin|617-876-8191|jennifer.lavin@genocea.com|
22329743|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu|
22329744|NCT02182999|Department of Orthopedic Surgery, Medical University of Innsbruck|Dr. Matthias Braito|0043 512 504|matthias.braito@gmail.com|81214
22329745|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611|Lewis.radonovich@va.gov|4988
22329746|NCT02252588|University of Minnesota|Christine Wendt, MD|612-624-0999|wendt005@umn.edu|
22329747|NCT00926185|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22329748|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915||
22329749|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org|
22329750|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22329751|NCT01478581|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
22329752|NCT03531710|United Neuroscience|Medical Director|+1 (972) 809-0481|info@unitedneuroscience.com|
22329753|NCT03152110|University of Pittsburgh|Alicia Koontz|412-822-3700|akoontz@pitt.edu|
22329754|NCT02705352|Massachusetts Eye and Ear|Shyana Harper|6173915982|Shyana_harper@meei.harvard.edu|
22329755|NCT01137006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329756|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22329757|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
22329758|NCT04247828|Altec Inc.|Dr. Paola Contessa|508-545-8236|pcontessa@altecresearch.com|
22329759|NCT01620593|UT Health San Antonio Cancer Center|Sukeshi Arora, MD|210-450-1015|aroras@uthscsa.edu|
22329760|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623||
22329761|NCT03536923|Renovia, Inc|Chief Medical Officer, Dr. Samantha Pulliam|866-735-8424|sjpulliam@renoviainc.com|
22329762|NCT03054740|Aultman Health Foundation|Jane Sewell|330 363 0000|Jane.Sewell@aultman.com|3334
22329763|NCT01378299|Michael E. DeBakey VA Medical Center|Reina Villareal, MD|713-794-7534|reina.villareal@va.gov|
22329764|NCT02046382|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
22329765|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com|
22329766|NCT03595449|Mayo Clinic|Shari A. Ochoa, M.D.|480-301-6479|Ochoa.Shari@mayo.edu|
22329767|NCT02667392|VAORD|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov; dkrose@phhp.ufl.edu|105238
22329768|NCT00383708|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
22329769|NCT02033850|'L. Sacco' Department of Biomedical and Clinical Sciences University of Milan|Prof. Leonardo Pantoni, Principal Investigator|0039-02-50319865|leonardo.pantoni@unimi.it|
22329770|NCT02820038|University of North Carolina at Chapel Hill|Susan J. Blalock, PhD|919-962-0080|s_blalock@unc.edu|
22329771|NCT03215667|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22329772|NCT01997281|Seoul National University College of Medicine|Youn Min Cho, M.D, PhD|+82-2-2072-1965|ymchomd@snu.ac.kr|
22329773|NCT03934203|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329774|NCT00946023|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
22329775|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711|joanna.fiszdon@va.gov|2231
22329776|NCT00560794|Amgen Inc.|Study Director|866-572-6436||
22329777|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
22329778|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il|
22329779|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
22329780|NCT02512276|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22329781|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300704|NCT04370054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300705|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu|
22300706|NCT03373604|Columbia University|Patrick Lao, PhD|212-342-1399|pjl2133@cumc.columbia.edu|
22300707|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22300708|NCT06273774|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22300709|NCT04918784|Acera Surgical, Inc.|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
22300710|NCT01712009|Amgen Inc.|Study Director|866-572-6436||
22300711|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300712|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288|jason.emer@mssm.edu|43288
22300713|NCT01986881|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300714|NCT04333420|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
22300715|NCT00265980|Professor of Pediatrics and Medicine at the Columbia University|Michael Rosenbaum, MD|212-305-9949|mr475@cumc.columbia.edu|
22300716|NCT04050865|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22300717|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
22300718|NCT01258608|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300719|NCT04205630|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
22300720|NCT04250727|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
22300721|NCT01393782|George Washington University Medical Faculty Associates|Clinical Trials Unit, Department of Anesthesiology and Critical Care Medicine|202-715-4750|mseneff@mfa.gwu.edu|
22300722|NCT03078270|George Washington University|Daniel Lieberman, M.D.|202-741-2899|dlieberman@mfa.gwu.edu|
22300723|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300724|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22300725|NCT04493216|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300726|NCT02172755|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22300727|NCT04605978|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22300728|NCT02216123|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300729|NCT04977050|University of New Mexico|Dr. Akshay Sood|505-272-4751|ASood@salud.unm.edu|
22300730|NCT03318523|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22300731|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22300732|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org|
22300733|NCT03610464|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
22300734|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu|
22300735|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22300736|NCT01803074|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300737|NCT02081573|University of Pittsburgh School of Nursing|Judith A. Callan|412-383-5321|callanja@pitt.edu|
22300738|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597|christoph.ilies@anaesthesie.uni-kiel.de|2991
22300739|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000|jamalira@tums.ac.ir|411
22300740|NCT03152526|Miltenyi Biotec|Clinical Project Manager|617-218-0055|lorenb@miltenyibiotec.com|
22300741|NCT05554237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300742|NCT05130970|CSL Behring LLC|Trial Registration Coordinator|610 878 4000|clinicaltrials@cslbehring.com|+1
22300743|NCT04969198|University of Wisconsin-Madison|Jesse Kaye|608-262-8885|jtkaye@ctri.wisc.edu|
22300744|NCT02701985|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22300745|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br|
22300746|NCT01362140|Amgen Inc.|Study Director|866-572-6436||
22300747|NCT01556438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300748|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com|
22300749|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com|
22300750|NCT03206203|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22300751|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu|
22300752|NCT03998618|Indiana University|Dr. Catherine Mosher|317-274-6769|cemosher@iu.edu|
22271784|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org|
22271785|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk|
22271786|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu|
22271787|NCT01294007|ATEC Spine|Saba Pasha, Director Clinical Research & Data Science|760-356-6639|spasha@atecspine.com|
22271788|NCT03233204|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22271789|NCT03850691|Masonic Cancer Center, University of Minnesota|Evidio Domingo-Musibay, MD|612-625-9604|musib024@umn.edu|
22271790|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
22271791|NCT03765229|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22300753|NCT03160027|University of California, San Francisco & San Francisco VA Medical Center|Dr. Linda Chao|14152214810|linda.chao@ucsf.edu|24386
22300754|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu|
22300755|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
22300756|NCT01994954|University of Massachusetts Medical School|Dr. Lawrence Rhein|508-334-6206|Lawrence.Rhein@umassmemorial.org|
22300757|NCT00850473|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22300758|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22300759|NCT02472964|Mylan Inc|Clinical Program Manager|412-651-9530|gail.tribble@mylan.com|
22300760|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de|
22300761|NCT04434560|Duke University|Sarah Sammons, MD|919-684-4563|sarah.sammons@duke.edu|
22300762|NCT04330638|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
22300763|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
22300764|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22329782|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22300765|NCT05525494|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22300766|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp|
22300767|NCT01988779|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
22300768|NCT02275065|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22300769|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu|
22300770|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th|
22300771|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com|
22300772|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300773|NCT01178086|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22300774|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
22300775|NCT06675500|Ain Shams University|Dr.Sarah Elghareeb,lecturer of Anesthesia and ICU|+201012434690|Sarahhamdy@med.asu.edu.eg|
22300776|NCT00127608|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300777|NCT06854601|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
22300778|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net|
22300779|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org|
22300780|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov|
22300781|NCT00160680|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22300782|NCT05276830|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22329783|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com|
22329784|NCT00422240|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22329785|NCT00880607|Children's Hospital of Colorado, University of Colorado|Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology||Mindy.cohen@childrenscolorado.org|
22329786|NCT05104749|Sonoran University of Health Sciences|Elizabeth Rice Principal Investigator|4809700000|e.rice@sonoran.edu|
22329787|NCT00901394|University of Chicago|Principal Investigator|7737022544||
22329788|NCT02590640|"University of Colorado Denver | Anschutz"|Director, Research Services|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22329789|NCT04129086|The University of Texas Health Science Center at Houston|John Andrew Harvin, MD|713-500-7292|John.Harvin@uth.tmc.edu|
22329790|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329791|NCT04888507|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22329792|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu|
22329793|NCT00766142|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
22329794|NCT04685408|Case Western Reserve University|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
22329795|NCT05643170|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22329796|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
22329797|NCT01116661|University of California San Francisco|Mitch Berger, MD; Director of Neurosurgery|415-353-7500|Mtich.Berger@ucsf.edu|
22329798|NCT02996305|Ovid Therapeutics|Adera Matthews, MD|570 620 6290|madera@ovidrx.com|
22329799|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22329800|NCT02710422|University of Miami|Sanoj Punnen MD, MAS|305-243-6596|s.punnen@med.miami.edu|
22329801|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22329802|NCT02000622|AstraZeneca|Medical Science Director|1-877-240-9479|clinicaltrialtransparency@astrazeneca.com|
22329803|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com|
22329804|NCT02045979|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329805|NCT01145833|University of CA, San Diego Center for Healthy Eating and Activity Research|Kerri Boutelle, Principal Investigator|858-534-8037|kboutelle@ucsd.edu|
22329806|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org|
22271792|NCT03046056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22329807|NCT04283773|Assiut Univercity|Demonstrator at pathology department|00201033986747|omar011523@med.au.edu.eg|
22300783|NCT03595579|Axsome Therapeutics, Inc.|Amanda Jones, PharmD, Senior Vice President of Clinical Development|212-332-3223|ajones@axsome.com|
22300784|NCT05090709|Edinburgh Napier University|Dr Rebecca Hamilton|0131455|rebeccaisabel.hamilton@napier.ac.uk|2350
22300785|NCT03775200|Compass Pathways|Medical Director|07443136539|info@compasspathways.com|
22300786|NCT02583425|Dr. Reddy's|Director, Clinical Development|609-375-9900||
22300787|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300788|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu|
22300789|NCT02858050|Saint Michael's Medical Center|Jihad Slim, MD|9738772663|jsmdsmmc@gmail.com|
22300790|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com|
22300791|NCT02157779|Providence VA Medical Center|M. Tracie Shea, PhD|401-273-7100|MaryTracie.Shea@va.gov|6248
22300792|NCT02548455|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22300793|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com|
22300794|NCT02525874|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22300795|NCT03901326|People's Liberation Army General Hospital|Dr Junjie Yang|13581662680|fearlessyang@126.com|86
22300796|NCT02794285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22300797|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22271793|NCT03089853|University of Alabama at Birmingham|Surya P Bhatt|205-934-5555|sbhatt@uabmc.edu|
22300798|NCT04535947|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
22300799|NCT02396745|Allegheny Singer Research Institute|Mara Yerk, Administrative Director|412-389-3059|mara.yerk@ahn.org|
22300800|NCT04111757|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
22300801|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
22300802|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu|
22300803|NCT04867369|NYU Langone Health|Arthur Hertling, MD|212-598-6085|arthur.hertling@nyulangone.org|
22300804|NCT04224155|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
22300805|NCT03712891|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22300806|NCT01904448|University of North Carolina at Chapel Hill|Craig A. Buchman, MD, FACS|314-362-7395|buchmanc@wustl.edu|
22300807|NCT03896035|VANTHCS|Una Makris, MD (PI)|2148570240|una.makris2@va.gov|
22300808|NCT01518868|Bausch Health|Study Director||robert.steffen@bausch.com|
22300809|NCT02635880|Cutera|Ginger Pocock|4156575702|gpocock@cutera.com|
22300810|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu|
22300811|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu|
22300812|NCT01570829|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22300813|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711|chinkin@ucla.edu|44214
22300814|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200|mateusdl@gmail.com|9451
22300815|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu|
22300816|NCT02677116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22300817|NCT02958969|BWH|Gregory Piazza|6177326984|gpiazza@bwh.harvard.edu|
22300818|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org|
22300819|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu|
22300820|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu|
22300821|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu|
22300822|NCT03792126|University Hospitals Dorset NHS Foundation Trust|Louise Johnson|0300 019 4473|Louise.Johnson@uhd.nhs.uk|
22300823|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22300824|NCT04184791|Feinstein Institute for Medical Research at Northwell|Dr. Ritesh Ramdhani|516-325-7000|rramdhani@northwell.edu|
22300825|NCT01400503|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22300826|NCT00983073|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22300827|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu|
22300828|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300829|NCT02962908|PepTcell Ltd (trading as SEEK)|Dr Olga Pleguezuelos, Chief Scientific Officer|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
22300830|NCT03543254|St. Olavs Hospital HF|Knut Hagen|+4795401579|knut.hagen@ntnu.no|
22300831|NCT02077166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22300832|NCT01261338|University of Cincinnati|Ronald J. Jandacek, PhD, Principal Investigator|513-558-5492|ronald.jandacek@uc.edu|
22300833|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br|
22300834|NCT05023304|Vance Thompson Vision|Director of Clinical Trials|1-605-371-7075|keeley.boever@vancethompsonvision.com|
22300835|NCT02899728|Dana- Farber Cancer Institute|Jacob Sands, MD|617-632-6049|Jacob_Sands@DFCI.HARVARD.EDU|
22300836|NCT05557942|Aerovate Therapeutics|Toll Free Number|(888) 373-8110|clinicaltrials@aerovatetx.com|
22300837|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300838|NCT01951625|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22300839|NCT01839734|The Ruth M. Rothstein CORE Center|Dr. Gregory Huhn|312-572-4575|ghuhn@cookcountyhhs.org|
22300840|NCT03754803|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300841|NCT05338333|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22300842|NCT04951336|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
22300843|NCT04348604|Case Western Reserve University|Joy Yala, Data Manager|216-368-0783|jxy790@case.edu|
22300844|NCT05745142|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300845|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
22300846|NCT03073148|Tangible Science|Director of Research and Development|650-241-1045|kelly@tangiblescience.com|108
22300847|NCT02822222|RMJ Holdings LLC d/b/a RMJH Rx|Russell Jaffe, M.D., Chief Executive Officer|(703) 840-4440|rjaffe@rmjholdings.com|
22300848|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492||
22300849|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755||
22300850|NCT03382782|Illinois Institute of Technology|Dr. Lindsay Sheehan, Co-Investigator|312-567-7983|lsheehan@iit.edu|
22300851|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org|
22300852|NCT00440531|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22319192|NCT04498169|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs.|+1 908-947-3551|msenchyna@aeriepharma.com|
22319193|NCT01754857|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|800-622-9822|clinicaltrials@cancer.wisc.edu|
22319194|NCT04964960|University of Kentucky|Dr. John Villano|859-323-0405|jlvillano@uky.edu|
22319195|NCT04682977|University of Illinois Chicago|Dr. Mansha Mirza|312-355-5427|mmirza2@uic.edu|
22319196|NCT02960854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22319197|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu|
22319198|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
22319199|NCT01383161|University of California, Los Angeles|Gary Small, MD|310-825-0291|gsmall@mednet.ucla.edu|
22319200|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22329808|NCT04924114|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22329809|NCT04021628|St George's, University of London|Dr Shari Sapuan|02086729944|ssapuan@sgul.ac.uk|5382
22329810|NCT00354484|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22329811|NCT03558828|Rush University College of Nursing|Manju Daniel|312.942.3460|manju_n_daniel@rush.edu|
22329812|NCT00378534|NIH NHLBI OCD DIR ORIC|Sara Hauffe, RN Protocol Liaison|301-827-2720|sara.hauffe@nih.gov|
22329813|NCT03537937|Pragmatic Critical Care Research Group|Chair of the Steering Committee|(615) 322-3412|matthew.w.semler@vumc.org|
22329814|NCT03671148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22329815|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu|
22329816|NCT02209259|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
22329817|NCT03878160|Massachusetts General Hospital|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
22329818|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
22329819|NCT05618808|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22329820|NCT02527564|Stanford University|Po W. Wang|650-723-2483|wangp0@stanford.edu|
22329821|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22329822|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu|
22329823|NCT02365506|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22329824|NCT03774875|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22329825|NCT02352090|Helsinki University Central Hospital|Oskari Heikinheimo|+358 50 4271533|oskari.heikinheimo@helsinki.fi|
22329826|NCT04428580|Stanford University|James Lock, MD, PhD|(650) 498-9111|jimlock@stanford.edu|
22329827|NCT06048367|West China Hospital of Sichuan University|Professor. Yongsheng Wang|18980602258|wangys@wchscu.cn|
22329828|NCT02869451|Duke University Medical Center|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
22329829|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22329830|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22329831|NCT05179057|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
22283357|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu|
22283358|NCT02248740|Virginia Commonwealth Univeristy|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
22283359|NCT02117349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22283360|NCT00579995|University of Nebraska Medical Center|Scott Shurmur, M.D.|402-559-6463|sshurmur@unmc.edu|
22283361|NCT02242981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283362|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com|
22283363|NCT03474081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283364|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com|
22283365|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu|
22283366|NCT00737594|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22283367|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22283368|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300||
22283369|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com|
22283370|NCT04559022|UT Southwestern|Research Coordinator|2146458907|jennifer.barillas@utsouthwestern.edu|
22283371|NCT03172130|University of Utah|Krishna Sundar|801-581-7806|krishna.sundar@hsc.utah.edu|
22283372|NCT03295396|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22283373|NCT00474617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283374|NCT02218593|Nemours Children's Health|Director of Clinical Trials|4076507652|kristen.gibbs@nemours.org|
22283375|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu|
22283376|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22283377|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
22283378|NCT01825941|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
22283379|NCT00528996|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329832|NCT03345342|Janssen Research & Development, LLC|Compound Development Team Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319201|NCT01423812|The Ruth M. Rothstein CORE Center|Gregory Huhn, MD|312-572-4575|ghuhn@cookcountyhhs.org|
22300853|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22300854|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone||
22300855|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22300856|NCT02690974|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22300857|NCT00746122|Imperial College London|Professor Janet Powell|44-2033117312|j.powell@imperial.ac.uk|
22300858|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22300859|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org|
22300860|NCT03148470|University of Fribourg|Prof. Dr. Jean-Marie Annoni|++4126 306 3802|jean-marie.annoni@unifr.ch|
22300861|NCT00464646|NSABP Foundation, Inc.|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
22271794|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300||
22300862|NCT05095272|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick E. Duffy; Lab Chief|240.381.1317|patrick.duffy@nih.gov|
22300863|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org|
22300864|NCT03294330|Penn State College of Medicine|Colette Pameijer|717-531-5272|cpameijer@pennstatehealth.psu.edu|
22300865|NCT04452292|University of Kentucky|Dr. Charles Kunos|859-323-2354|charles.kunos@uky.edu|
22300866|NCT04139564|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
22300867|NCT01782443|DFCI|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
22300868|NCT02249819|Northwell Health|Johanna Chang, Senior Research Coordinator|(516)562-3646|jchang14@northwell.edu|
22300869|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22300870|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300871|NCT00626028|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22300872|NCT05224050|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
22300873|NCT01335204|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22300874|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu|
22300875|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319202|NCT02616614|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22283380|NCT02831933|Houston Methodist Neal Cancer Center|Eric Bernicker|713.790.3333|ccresearch@houstonmethodist.org|
22319203|NCT02748018|Medtronic Diabetes|Colleen Haberman, Sr. Clinical Research Manager|6127503275|colleen.p.haberman@medtronic.com|
22319204|NCT06069778|BioNTech SE|BioNTech clinical trials patient information|+49 61319084|patients@biontech.de|0
22319205|NCT03952585|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22319206|NCT04704336|NYU Langone Health|Olugbenga Ogedegbe, MD|646-501-3435|Olugbenga.Ogedegbe@nyulangone.org|
22319207|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319208|NCT02249767|Spear Pharmaceuticals|Dr. Spear|239-560-2411|spear@spearpharm.com|
22319209|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319210|NCT04585646|CooperVision, Inc|Lee Hall, PhD|(925) 251 6684|lhall@coopervision.com|
22319211|NCT04614662|The Hospital for Sick Children|Lillian Sung|4168135287|lillian.sung@sickkids.ca|
22319212|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22319213|NCT04086433|Regulatory Mark|Alison Sathe|5133047971|alison@regulatorymark.com|
22319214|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu|
22319215|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org|
22319216|NCT01862640|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|DT-inquiry@otsuka.jp|
22319217|NCT02178553|Mayo Clinic Rochester|Dr. James D. Hannon|507-284-7289|hannon.james@mayo.edu|
22319218|NCT05085665|Washington University in St. Louis|Dr. Philip Budge|314-747-5532|pbudge@wustl.edu|
22319219|NCT03294109|university of Californiia|Siamak Rahman, MD|310 2678839|sirahman@mednet.ucla.edu|
22319220|NCT03030235|Saint Luke's Hospital of Kansas City|PRESERVED-HF Study Manager|816-932-9858|PRESERVED-HF@saint-lukes.org|
22319221|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
22319222|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319223|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu|
22319224|NCT02804178|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
22319225|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com|
22319226|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319227|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22319228|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
22319229|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu|
22319230|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu|
22319231|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
22319232|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com|
22319233|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com|
22319234|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
22319235|NCT00633061|Univesity of Oklahoma College of Medicine|Janna Journeycake, MD||janna-journeycake@ouhsc.edu|
22319236|NCT02708095|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22319237|NCT04931836|University of Minnesota|Mark Pereira, PhD|612-624-4173|map@umn.edu|
22319238|NCT06389838|Kranus Health GmbH|Director of Clinical Trials|+491756939818|medical@kranushealth.com|
22319239|NCT06268288|Mayo Clinic|Lytitia Shea, M.D.|507-422-9847|shea.lytitia@mayo.edu|
22319240|NCT03049735|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22319241|NCT03254485|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
22319242|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu|
22319243|NCT03153111|Actelion|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319244|NCT04225221|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-235-0858|jhbaker@med.unc.edu|
22319245|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300||
22319246|NCT02684357|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22319247|NCT00390910|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319248|NCT03221192|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319249|NCT01491893|Istari Oncology|Garrett Nichols, MD|(919) 245.7662|gnichols@istarioncology.com|
22319250|NCT02069353|University of Pittsburgh|Jonathan Elmer|412-647-9489|elmerjp@upmc.edu|
22319251|NCT04821869|Pulmonary Research Institute of Southeast MIchigan|Gary T Ferguson, MD, Director|248-478-6908|garytferguson@msn.com|
22319252|NCT06605391|Emory University|Fayron Epps, PhD, RN|678-723-8188|fepps@emory.edu|
22271795|NCT04542278|University of Wisconsin - Madison School of Medicine and Public Health|Dawn Elfenbein, MD, MPH, FACS|(608) 263-1387|elfenbein@surgery.wisc.edu|
22271796|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com|
22329833|NCT03375203|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329834|NCT03107793|Janssen-Cilag International N.V.|European Medicines Agency (EMEA) Advisor-Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329835|NCT03277105|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329836|NCT02808507|Johns Hopkins Bloomberg School of Public Health|Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
22329837|NCT05180721|Yale|Robin Whittemore|203-432-7000|robin.whittemore@yale.edu|
22329838|NCT02968277|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22329839|NCT02040857|Dana-Farber Cancer Institute|Project Manager|617-632-5313|ctopm@dfci.harvard.edu|
22329840|NCT00976963|University of Washington|Ann Stapleton|‪(206) 880-3464‬|stapl@uw.edu|
22329841|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
22329842|NCT01024920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329843|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
22329844|NCT03039790|Takeda (Note: This product was divested to HilleVax in 2022)|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22329845|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu|
22329846|NCT04246541|University Hospitals Cleveland Medical Center|Dr. Michael Karns|216-844-7200|michael.karns@uhhospitals.org|
22329847|NCT02575300|H. Lee Moffitt Cancer and Research Center|Dr. Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
22329848|NCT02736929|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
22329849|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
22283381|NCT03495102|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329850|NCT02972593|Indiana University School of Medicine Department of Orthopaedic Surgery|Dr. Brian H. Mullis|317-963-1966|bmullis@iupui.edu|
22329851|NCT03003130|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
22329852|NCT03077711|Lehigh Valley Health Network|Dr. Carolyn Botros, DO|4845917480|carolyn.botros@lvhn.org|
22329853|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com|
22329854|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu|
22329855|NCT02963766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329856|NCT04964557|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
22283382|NCT04802187|Massachusetts General Hospital|Madeline Davies|617-726-6653|medavies@mgh.harvard.edu|
22283383|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
22283384|NCT03875664|Atrium Health|Dr. Sarah Evans|704-304-1660|sarah.evans@atriumhealth.org|
22283385|NCT00520910|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
22283386|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22283387|NCT04129411|Mayo Clinic|Dr. Marius Stan|507-284-2463|stan.marius@mayo.edu|
22283388|NCT05065190|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283389|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22283390|NCT00668811|MedStar Washington Hospital Center|Dr Kenneth D. Burman|202-877-8109|kenneth.d.burman@medstar.net|
22283391|NCT03938324|Duke University|Sharron Docherty, PhD|919-668-3836|sharron.docherty@duke.edu|
22283392|NCT02769962|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22283393|NCT05565937|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22283394|NCT04544683|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Aaron Conger, MD|801-587-1493|u6007025@umail.utah.edu|
22283395|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu|
22283396|NCT05160766|University Hospital Cologne|Prof. Dr. med. Oliver A. Cornely|0049 221 478 85523|oliver.cornely@uk-koeln.de|
22283397|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com|
22271797|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com|
22271798|NCT05437640|University of Alabama at Birmingham|Dr. Christine Ferguson|205-934-7773|cfergus2@uab.edu|
22271799|NCT02474355|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22271800|NCT02287688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271801|NCT03015194|National Heart Lung and Blood Institute (NHLBI)|Robert Lederman, M.D. Principal Investigator, NIH, NHLBI|301.402.6769|ledermar@nhlbi.nih.gov|
22271802|NCT05251064|University of Virginia|Dr. Mark Miller|(434) 243-7778|mdm3p@uvahealth.org|
22271803|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org|
22271804|NCT02263729|University of Pittsburgh|James J. Irrgang|412-383-9865|jirrgang@pitt.edu|
22271805|NCT04591015|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
22271806|NCT02509078|Mass General Hospital (PETAL Clinical Coordinating Center)|Katie Oldmixon|617-726-4777|coldmixon@mgh.harvard.edu|
22271807|NCT02598778|MMC - Dentistry|Kakanantadilok, Nuntiya|(888) 700-6623|nkakanan@montefiore.org|
22271808|NCT02370056|Cleveland Clinic|Dr. Emre Gorgun|216 444-1244|GORGUNE@ccf.org|
22271809|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu|
22271810|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu|
22271811|NCT02553798|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22271812|NCT05869864|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
22271813|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271814|NCT02667587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22271815|NCT03933020|The University of Texas Health Science Center at Houston|Rohini D. Samudralwar, MD|(832) 325-7077|Rohini.D.Samudralwar@uth.tmc.edu|
22271816|NCT01463358|Casa di Cura san Pio XI|Massimo Santini MD FESC FACC|+390666494491|m.santini@rmnet.it|
22271817|NCT02696434|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22271818|NCT01586871|University of Minnesota|Aaron Kelly PhD|612-626-3492|kelly105@umn.edu|
22271819|NCT00445744|FHCRC|H. Joachim Deeg MD|206 667 4409|jdeeg@fhcrc.org|
22271820|NCT04566133|National Cancer Institute|Dr. Tim F. Greten|2407606114|gretentf@mail.nih.gov|
22271821|NCT03570554|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22271822|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373|drm@asipp.org|100
22271823|NCT02719353|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22329857|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu|
22283398|NCT02408523|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22283399|NCT02943915|Moss Rehabilitation Research Institute, Elkins Park, PA, USA|Dylan Edwards|215-663-6554|dylan.edwards@jefferson.edu|
22283400|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu|
22283401|NCT03769311|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|608-262-4961|jybruce@medicine.wisc.edu|
22283402|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com|
22283403|NCT00289198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283404|NCT04172467|Hematology Oncology Kaiserslautern|Prof. Hartmut Link|0631|praxis-link@kabelmail.de|3503709
22283405|NCT04332614|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22283406|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org|
22283407|NCT03369431|University College London|Susan Simmons|+44 7952961881|susan.simmons.16@ucl.ac.uk|
22283408|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283409|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22283410|NCT04214639|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22283411|NCT01266317|University of Pittsburgh|Dr. Michael Donahoe|412-383-2049|donahoem@upmc.edu|
22283412|NCT02937766|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22283413|NCT02753127|Sumitomo Dainippon Pharma Oncology|Keiichi Saito|+1 (617)674-6800|keiichi.saito@SDPOncology.com|
22283414|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283415|NCT02151331|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
22283416|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22283417|NCT01352637|Weill Cornell Medical College|Dr. JoAnn Difede|212 746 3079|jdifede@med.cornell.edu|
22283418|NCT02046070|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22283419|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov|
22283420|NCT04619004|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
22283421|NCT00306475|Vanderbilt Psychiatric Hospital|Herbert Meltzer, M.D.|615-327-7049|herbert.meltzer@vanderbilt.edu|
22283422|NCT05991934|Johns Hopkins Bloomberg School of Public Health|Johannes Thrul, PhD|(443) 318-6633‬|jthrul@jhu.edu|
22283423|NCT05601102|University of Stirling|Professor Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
22283424|NCT05621239|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22283425|NCT06504524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283426|NCT04284813|McLean Hospital/Harvard Medical School|Julie M. McCarthy, PhD|6178553521|jmccarthy@mclean.harvard.edu|
22283427|NCT03846531|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
22283428|NCT03859739|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283429|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283430|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283431|NCT02785458|Northwestern University|Dr. Michael S. Wolf, PhD MPH|312-503-5592|mswolf@northwestern.edu|
22283432|NCT01146652|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22283433|NCT03476876|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22283434|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn|
22283435|NCT03523273|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22283436|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
22283437|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22283438|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283439|NCT02963987|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22283440|NCT03351114|Duke University|Dr. Adela R. Cardones|9196843110|adela.cardones@duke.edu|
22283441|NCT02337530|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
22283442|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22283443|NCT03249935|University of Arkansas for Medical Sciences|Jeannette Lee|501-526-6712|jylee@uams.edu|
22283444|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu|
22283445|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450|judith.babcock@va.gov|5698
22283446|NCT04610489|Carilion Clinic|John Epling, MD, MSEd|540-581-0123|jwepling@carilionclinic.org|
22283447|NCT03780959|Amgen Inc.|Study Director|866-572-6436||
22283448|NCT04253587|UCSF Dept of Neurology|Peter Wais, Principal Investigator|415-502-1212|peter.wais@ucsf.edu|
22329858|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329859|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262|bonnie.becker@va.gov|54525
22283449|NCT04732949|Synairgen|Brooke Clarke, SVP, Head of Communications|02380 512 800|info@synairgen.com|
22283450|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu|
22283451|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738||
22283452|NCT02654236|IU School of Medicine|Dr. Suthat Liangpunsakul|(317) 988-3232|sliangpu@iu.edu|
22283453|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org|
22300876|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22300877|NCT04294966|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22300878|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
22300879|NCT05763628|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22300880|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
22300881|NCT02161133|Veterans Affairs New Jersey Healthcare System|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
22300882|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
22300883|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org|
22300884|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22300885|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22300886|NCT04109703|Soovu Labs|Charles Chabal, MD|206-579-4910|Chuck@Soovu.com|
22300887|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300888|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743||
22300889|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu|
22300890|NCT03492281|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22300891|NCT03342638|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22300892|NCT03028974|Stanford University|Cornelia Dekker, MD|650-724-4437|cdekker@stanford.edu|
22300893|NCT02654808|Columbia University|Dr. Timothy Ryntz|212-305-4973|ter2111@cumc.columbia.edu|
22300894|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22300895|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
22300896|NCT02191267|Brigham and Women's Hospital|Dr. Martha Shenton|617-699-6152|shenton@bwh.harvard.edu|
22300897|NCT02186210|Seoul National University Hospital Dept of Anesthesiology|Dr Yunseok Jeon|82-2-2072-2465|jeonyunseok@gmail.com|
22300898|NCT03213158|University of Wisconsin - Madison|Fahid Aziz, MD|(608) 262-5420|faziz@wisc.edu|
22300899|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org|
22300900|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu|
22300901|NCT01569438|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300902|NCT03649230|Purdue Pharma (Canada)|Graeme Donnelly|905.837-6498|graeme.donnelly@purdue.ca|
22300903|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22300904|NCT01693068|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22300905|NCT00579280|University of South Florida College of Medicine|David V. Sheehan, MD, MBA|813-974-4544|dsheehan@health.usf.edu|
22300906|NCT04126408|northwell health|northwell health|5165620100|trebeiz@northwell.edu|
22300907|NCT04302350|The First Affiliated Hospital of Nanjing Medical University|Dr.cunming Liu|13951890866|cunmingliu@njmu.edu.cn|
22300908|NCT03591068|Optinose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
22300909|NCT00617344|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
22300910|NCT02747238|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
22300911|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu|
22300912|NCT05245864|UAMS|Arny A. Ferrando|501-526-5711|AFerrando@uams.edu|
22300913|NCT01475136|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22300914|NCT01323530|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22300915|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300916|NCT01194570|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22300917|NCT04171102|University of Cagliari|Prof. Dr. Giuseppe Amato|337963197|amatomed@gmail.com|
22300918|NCT01751126|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
22300919|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22300920|NCT00915031|University of California, Irvine|Linda Huynh|7144567354|lindamh@uci.edu|
22300921|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu|
22300922|NCT02673398|City of Hope|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
22300923|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22300924|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22283454|NCT02905006|Cares|UCB|+1877 822|UCBCares@ucb.com|9493
22300925|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com|
22300926|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22300927|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com|
22271824|NCT02651415|BC Cancer|Dr. Barbara Melosky|604-877-6000|bmelosky@bccancer.bc.ca|
22271825|NCT00980174|Amgen Inc.|Study Director|866-572-6436||
22300928|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org|
22300929|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu|
22300930|NCT05616962|Primus Pharmaceuticals, Inc.|Director of Clinical Trials|480-483-1410|info@primusrx.com|
22300931|NCT04924283|Medical University of South Carolina|Christine Hahn|843-518-2875|hahnc@musc.edu|
22300932|NCT00857207|Malcom Randall VAMC|Julia Kay Waid-Ebbs, Health Science Specialist|352-871-0282|Julia.Waid-Ebbs@va.gov|
22300933|NCT02030015|University of Minnesota|Jeanine Jarnes, PharmD|612-626-5131|utzx0002@umn.edu|
22300934|NCT04098406|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
22300935|NCT03014674|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300936|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22300937|NCT03764449|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22300938|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com|
22300939|NCT01316510|UC Davis|Mark Underwood|916-734-8672|munderwood@ucdavis.edu|
22300940|NCT01785680|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manary@kids.wustl.edu|
22300941|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343||
22300942|NCT03409666|Zimmer Biomet|Lisette Smid|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
22300943|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org|
22300944|NCT02623322|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
22300945|NCT03104699|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
22300946|NCT02450331|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22300947|NCT02080871|W.L. Gore & Associates|Hector R Novoa|928-864-3867|hnovoa@wlgore.com|
22300948|NCT00234052|Northwestern University|Clinical Trials Office|312-695-1301||
22300949|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22300950|NCT02428296|Children's National Medical Center|Dr. Kim Keppler-Noreuil|2024766287|kkepplerno@childrensnational.org|
22300951|NCT03384173|University of Wisconsin, Madison|Matthew Harer|608-417-6236|mwharer@wisc.edu|
22300952|NCT04493931|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300953|NCT03338894|Atlantic Children's Health/Atlantic Health Outpatient|Dr. Alycia Leiby|973--971-5676|alycia.leiby@atlantichealth.org|
22329860|NCT02493868|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329861|NCT05849441|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
22329862|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org|
22329863|NCT03039569|University of Nebraska-Lincoln|Weiwen Chai|402-472-7822|wchai2@unl.edu|
22329864|NCT02973997|University of Colorado, School of Medicine|Bryan Haugen, M.D.|507-266-0800|bryan.haugen@ucdenver.edu|
22329865|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329866|NCT00424840|University of Massachusetts Medical School|Dr. William Walsh|508-334-5539|William.Walsh@umassmemorial.org|
22329867|NCT01994109|Solstice Neurosciences|Regulatory Affairs Associate||regulatoryaffairs@usworldmeds.com|
22329868|NCT03287830|Columbia University|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22329869|NCT03008889|Emory University|Dr. Lawrence Scahill|404-785-9336|lawrence.scahill@emory.edu|
22329870|NCT03598140|UTexas Southwestern|Dr. Joshua Gaston|817-637-8043|drgaston@outlook.com|
22329871|NCT05674838|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22329872|NCT03137888|Emory University|Dr. Hui-Kuo Shu|4047781900|hgshu@emory.edu|
22300954|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk|
22271826|NCT05873335|Gabi SmartCare|Edouard Carton|472537844|edouard.carton@gabismartcare.com|
22300955|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22300956|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
22319253|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
22319254|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org|
22319255|NCT03602261|OPKO Health|Akhtar Ashfaq|305-575-423|AAshfaq@opko.com|
22319256|NCT03022318|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
22319257|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319258|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn|
22319259|NCT03808688|Aerie Pharmaceuticals|VP, Medical Affairs|949-246-8731|jmwilliams@aeriepharma.com|
22319260|NCT01974089|Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark|Dorte Melgaard|+4526281086|dmk@rn.dk|
22319261|NCT00749879|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22319262|NCT03335163|University of Colorado Anschutz Medical Campus|Dr. Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22319263|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org|
22319264|NCT01215175|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319265|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com|
22319266|NCT03872453|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22319267|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu|
22319268|NCT01678209|Icahn School of Medicine at Mount Sinai|Beth Krone, PhD|212-241-8014|beth.krone@mssm.edu|
22300957|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22300958|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567|cawoods@sciborg.uwaterloo.ca|36547
22300959|NCT04208516|UPMC|Jeremy Kearns, MD|412-623-5296|kearnsjt@upmc.edu|
22300960|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22300961|NCT04020341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300962|NCT04528069|Alcon Research, LLC|Director of Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22300963|NCT02872701|On Target Laboratories|Tim Biro|216-533-3082|tbiro@ontargetlabs.com|
22300964|NCT01814371|Washington University School of Medicine|Stephanie Fritz, MD, MSCI|3144544115|fritz.s@wustl.edu|
22300965|NCT04683926|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
22300966|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22300967|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22300968|NCT04158050|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
22300969|NCT04341116|I-Mab Biopharma US Ltd|Claire Xu|3177558242|Claire.Xu@i-mabbiopharma.com|
22300970|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300971|NCT04321239|University of Michigan|Mary Janevic|734 647 3194|mjanevic@umich.edu|
22300972|NCT05072080|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
22300973|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22300974|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu|
22271827|NCT01546038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271828|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com|
22271829|NCT01832818|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
22271830|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22271831|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com|
22271832|NCT02565706|William Paterson University|Jennifer Di Noia|973.720.3714|dinoiaj@wpunj.edu|
22271833|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343||
22271834|NCT01897571|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22271835|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22271836|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040|jdeese@fhi360.org|11292
22271837|NCT03217968|CEFALY Technology|Clinical Trial Department director|+3243676722|info@cefaly.com|
22271838|NCT03008278|Yale School of Medicine|Michael Cecchini, MD|(203) 200-4422|michael.cecchini@yale.edu|
22271839|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283455|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu|
22283456|NCT03627065|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22283457|NCT02797184|Washington University in St. Louis|Dr. Lauren Park|3143633915|l.park@wustl.edu|
22283458|NCT06250738|Rollins School of Public Health|Dr. Andrea Lopez-Cepero|404-727-3956|andrea.a.lopez-cepero@emory.edu|
22283459|NCT04912895|Emory University|Larry Anderson, MD|404-727-1746|larry.anderson@emory.edu|
22283460|NCT03294135|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283461|NCT02763254|Cell Medica|Dr. Kurt Gunter (Chief Medical Officer)|832-581-4480|Kurt.Gunter@cellmedica.com|
22283462|NCT03684304|University Hospitals|University Hospitals|216-844-1000|info@uhhospitals.org|
22283463|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
22283464|NCT01510184|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|gajanan.Bhat@sppirx.com|
22283465|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
22283466|NCT03458702|Texas Tech University|Dr. Jacalyn McComb|806-834-6306|jacalyn.mccomb@ttu.edu|
22283467|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu|
22283468|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22283469|NCT03446053|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
22283470|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
22283471|NCT01635764|AbbVie|Global Medical Services|800-633-9110||
22283472|NCT02227836|Mayo Clinic|Karthik Ravi, MD|507-284-4824|Ravi.Karthik@mayo.edu|
22283473|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu|
22283474|NCT01816906|Staffordshire University|Professor Nachiappan Chockalingam|+44 1782 295853|n.chockalingam@staffs.ac.uk|
22283475|NCT04375397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22300975|NCT01955954|Palo Alto Health Sciences, Inc|Debra Reisenthel|9255948404|debra@pahealthsciences.com|
22300976|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com|
22271840|NCT01389258|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22283476|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22329873|NCT02155712|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
22329874|NCT02060903|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22329875|NCT02418585|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329876|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu|
22329877|NCT01688999|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
22329878|NCT02768103|VA Palo Alto Health Care System|Dr Johanson|408-250-1982|lisa.johanson29@gmail.com|
22329879|NCT02951455|University of Illinois Urbana Champaign|Liliane Windsor|2173001782|lwindsor@illinois.edu|
22329880|NCT05241288|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22329881|NCT04246489|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22329882|NCT01520688|Allegheny Health Network|Deborah Gentile, MD|412-359-4099|dgentile@ahn.org|
22329883|NCT00058188|Northwestern University|Clinical Trials Office|312-695-1301||
22329884|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu|
22329885|NCT03289052|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22329886|NCT03949621|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22329887|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com|
22329888|NCT01855425|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
22329889|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu|
22329890|NCT01957085|Lewis Katz School of Medicine|Robert L. Bettiker, MD/MGA, Principle Investigator|215.707.1982|robert.bettiker@temple.edu|
22329891|NCT02283840|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22329892|NCT02148952|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
22329893|NCT01600105|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
22329894|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22329895|NCT01764022|BIOCAD|Dr. Mariia Shustova|+7812380 49 33|shustova@biocad.ru|651
22329896|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22329897|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343||
22329898|NCT04043416|The University of Ottawa|Katherine Reilly|613-562-5800|kreilly@uottawa.ca|8238
22329899|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329900|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22329901|NCT02865928|Northwell Health|Louis Ballas|718-470-5827|lballas@northwell.edu|
22329902|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu|
22329903|NCT01925014|The LOCAT Group|Kyoung Ho Lee|82317877607|kholeemail@gmail.com|
22329904|NCT03813199|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
22329905|NCT01196091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329906|NCT03733249|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
22329907|NCT04476108|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329908|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329909|NCT03645811|University of Health Science|Dr. Demet İnangil|+905303021160|demet.inangil@sbu.edu.tr|
22329910|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22329911|NCT04555811|University of Minnesota, Masonic Cancer Center|Veronika Bachanova MD, PhD|612-625-5469|bach0173@umn.edu|
22329912|NCT02324049|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
22329913|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22329914|NCT00655057|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22329915|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22329916|NCT00838695|VAnderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
22329917|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
22329918|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|plynch@mdanderson.org|
22329919|NCT02699125|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
22329920|NCT03787095|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22329921|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com|
22329922|NCT03799627|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
22329923|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org|
22329924|NCT02996994|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22329925|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com|
22329926|NCT01927068|Spectranetics LLC, now part of Philips Image Guided Therapy|Associate Director, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
22329927|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329928|NCT03964493|TenNor Therapeutics Limited|Zhenkun Ma, PhD / CEO|+1(646) 775-1861|zhenkun.ma@tennorx.com|
22329929|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org|
22329930|NCT01947647|Ralph H. Johnson VAMC|Daniel Gros, PHD|843-789-7311|daniel.gros@va.gov|
22329931|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329932|NCT01474889|UPenn|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
22329933|NCT02482389|Duke University Health System|Joan Cahill|(919) 668-5211|joan.cahill@duke.edu|
22271841|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com|
22271842|NCT03313310|UNC Chapel Hill, ATN Coordinating Center|Betty Rupp|919-962-6603|brupp@email.unc.edu|
22271843|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu|
22271844|NCT01281956|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
22271845|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu|
22329934|NCT02290340|MedImmune, LLC|M. Pamela Griffin|301-398-4095|information.center@astrazeneca.com|
22329935|NCT03227224|Janssen Research & Development, LLC|SENIOR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329936|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
22329937|NCT03782376|Janssen-Cilag Ltd.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329938|NCT02659098|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329939|NCT03039192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329940|NCT02407236|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22329941|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu|
22329942|NCT03277794|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22329943|NCT02168660|UT Southwestern Medical Center|Dr Perrin C White, Professor of Pediatrics|2146486875|perrin.white@utsouthwestern.edu|
22329944|NCT02254304|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22329945|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22329946|NCT02266004|University of Miami|Corneliu Luca, MD|305-243-6732|cluca@med.miami.edu|
22329947|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com|
22329948|NCT01744041|Washington University - School of Medicine|Dr. Shannon Lenze|3143622752|slenze@wustl.edu|
22329949|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22329950|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
22329951|NCT02253992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22329952|NCT03198728|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
22329953|NCT04051944|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22329954|NCT03083470|US Biotest, Inc.|Gere diZerega, MD; President & CEO|805-595-1300|gere.dizerega@usbiotest.com|
22329955|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329956|NCT02139280|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603.650.4628|Kenneth.R.Meehan@hitchcock.org|
22271846|NCT03677934|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
22271847|NCT04769739|Evergreen General Hospital|Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
22300977|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22300978|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu|
22271848|NCT05972941|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
22271849|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22271850|NCT04891406|Imperial Tobacco Ltd|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.co|
22271851|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
22271852|NCT02202044|University of Colorado|Tracey MacDermott|303-724-2757|Tracey.MacDermott@ucdenver.edu|
22271853|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu|
22271854|NCT02407054|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22271855|NCT01863498|Children's Mercy Kansas City|Dr. Shawn St. Peter|816-234-3575|sspeter@cmh.edu|
22271856|NCT00932698|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22300979|NCT02300220|Imperial College London|Professor Jadwiga Wedzicha|02075947947|j.wedzicha@imperial.ac.uk|
22300980|NCT04322682|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514 376-3330|jean-claude.tardif@icm-mhi.org|3612
22300981|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu|
22300982|NCT04123067|Penn State Hershey Medical Center|Dr. Kerstin Bettermann|717-531-1803|kbettermann@pennstatehealth.psu.edu|
22300983|NCT03085485|University of Alabama at Birmingham|Bo Liu|(205) 975-7868|boliu@uabmc.edu|
22300984|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22300985|NCT03088826|Maimonides Medical Center|Sergey Motov|718283600|smotov@maimonidesmed.org|
22300986|NCT04365660|Stanford University|Dr. Kristen Ganjoo, MD|650-498-6000|kganjoo@stanford.edu|
22300987|NCT01311674|Emergent Biosolutions|Christine Hall, Sr. Director Clinical Research||chall@ebsi.com|
22300988|NCT02137369|Emory University|Dr. Dunlop|404-727-8969|bdunlop@emory.edu|
22271857|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu|
22300989|NCT02959996|Massachussetts General Hospital|Malavika Prabhu|6177249028|mprabhu@mgh.harvard.edu|
22300990|NCT03036163|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
22300991|NCT02680054|Oxford University Hospitals NHS Trust|Dr Rachel Besser|01865 741741|rachel.besser@ouh.nhs.uk|
22300992|NCT04907942|Click Therapeutics|Shaheen Lakhan, MDPhD, FAAN Study Chair|Not applicable|Science@clicktherapeutics.com|
22300993|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22300994|NCT03962894|University of Florida|Jennifer Fishe|904-244-4046|Jennifer.Fishe@jax.ufl.edu|
22300995|NCT01321554|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22300996|NCT01865708|Children's Healthcare of Atlanta|Dr. Jana Stockwell|404-785-1868|jana.stockwell@choa.org|
22300997|NCT04128293|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22300998|NCT04177680|Matinas BioPharma|Dr. James J Ferguson, MD|(908) 505-0964|jferguson@matinasbiopharma.com|
22300999|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301000|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com|
22301001|NCT05072457|Hearts for Hearing|Lead Investigator|405-548-4335|phonakaudiologyresearch@gmail.com|
22301002|NCT02001194|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
22301003|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22271858|NCT00642954|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271859|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org|
22271860|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22271861|NCT01080976|BIDMC|Charles Safran|617-278-8170|csafran@bidmc.harvard.edu|
22271862|NCT04114656|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271863|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301004|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22301005|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645|shravanti.bhowmik@sparcmail.com|5626
22301006|NCT03284788|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
22301007|NCT02462876|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
22271864|NCT02661061|Trinity College Dublin|Dr Martha Finnegan|0863638264|mfinneg@tcd.ie|
22271865|NCT02732015|UT MD Anderson Cancer Center|Saroj Vadhan,MD-Clinical Professor, Cytokine & Supportive Oncology|713-792-7966|svadhanr@mdanderson.org|
22271866|NCT03052920|Washington University in St. Luis|Jill B Firszt, PI|314-362-4760|FirsztJ@wustl.edu|
22319269|NCT02960113|Rutgers Robert Wood Johnson Medical School|Shaul Cohen, MD|732-235-8717|chohensh@rwjms.rutgers.edu|
22271867|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271868|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu|
22271869|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300||
22271870|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU|
22271871|NCT02030886|Yale School of Medicine|Dr James Liu|+1 203 785 2020|liu.ji@yale.edu|
22271872|NCT00888290|Albert Einstein College of Medicine|Michal Melamed|718-430-2496|michal.melamed@einsteinmed.org|
22271873|NCT03594955|Sanofi-Aventis Research & Development|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22271874|NCT01829997|RTI Surgical|Kristina Shine|386-418-8888|kshine@rtix.com|4404
22271875|NCT03539484|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22271876|NCT06046209|CooperVision, Inc.|Lee Hall|+19252516684|lhall@coopervision.com|
22271877|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22271878|NCT04525131|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
22271879|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22271880|NCT02173379|Abbott Vascular|Kelly A. Stockelman, PhD|720-951-8649|Kelly.Stockelman@abbott.com|
22271881|NCT00674479|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD/Professor|713-745-0394|fravandi@mdanderson.org|
22271882|NCT06226649|National Cheng Kung University|Mr. Chun-Yi Ho|886-6-2353535|eggman0011@gmail.com|5852
22271883|NCT04997265|Vanderbilt University Medical Center|Whitney Gannon|6109095789|whitney.gannon@vumc.org|
22271884|NCT01450072|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
22271885|NCT00631163|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22271886|NCT02290925|Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka|Professor Sisira Siribaddana|+94777326940|sisira.siribaddana@gmail.com|
22271887|NCT01973335|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge, researcher|0473924199|frederik.verbrugge@zol.be|+32
22271888|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711|meika.fang@va.gov|84503
22271889|NCT00810017|MedStar Health Research Institute|Scientific Center Administrator, Oncology Research|(301) 560-7300|Research@MedStar.net|
22271890|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22271891|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu|
22301008|NCT01786512|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22301009|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22301010|NCT03581981|Atlanta VAHCS|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|203122
22301011|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22301012|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com|
22301013|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
22301014|NCT04322604|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22301015|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com|
22301016|NCT04886479|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
22301017|NCT00053989|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716084505819|theresa.hahn@roswellpark.org|
22301018|NCT00382824|Lahey Hospital & Medical Center|Jordan Jara|7817442958|jordan.jara@lahey.org|2958
22301019|NCT03205371|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22301020|NCT02835339|Oregon Health and Science University|Kathleen Brookfield, MD, PhD, MPH|503-494-2101|brookfie@ohsu.edu|
22301021|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
22301022|NCT04273139|Dana-Farber Cancer Institute|Jorge J. Castillo, Md|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22301023|NCT00295022|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22301024|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414|ellen.teng@va.gov|25513
22329957|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271892|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271893|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu|
22271894|NCT00388297|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
22271895|NCT01004718|University of Pennsylvania|Ellen Napier, CRNP|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
22271896|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu|
22329958|NCT00736450|University of Nebraska Medical Center|Julie Vose|402-559-3848|jmvose@unmc.edu|
22271897|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu|
22271898|NCT01810705|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
22271899|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271900|NCT02284568|Teva Pharmaceutical Industries Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22271901|NCT00460265|Amgen Inc.|Study Director|866-572-6436||
22271902|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu|
22329959|NCT00491751|Boston University School of Medicine|Naomi M. Hamburg, MD|617-638-7462|nhamburg@bu.edu|
22329960|NCT04157751|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329961|NCT04731922|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22329962|NCT02564068|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
22271903|NCT02454075|Trio Medicines|Dr Malcolm Boyce|020 8961 4130|mboyce@hmrlondon.com|
22271904|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com|
22271905|NCT01966419|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
22271906|NCT02956057|Tomas Bata Hospital|Kojecky Vladimir|+420577552512|kojecky@bnzlin.cz|
22271907|NCT00985517|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
22271908|NCT01420679|Spectrum Pharmaceuticals, Inc|Gajanan Bhat|949-743-9219|gajanan.Bhat@sppirx.com|
22271909|NCT03956615|Vrije Universiteit Brussel|Dr. Matthias D'Huyvetter|+3224776013|afspraak_nucleaire@uzbrussel.be|
22271910|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493||
22271911|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008|cmyers@vertosmed.com|216
22271912|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22271913|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22271914|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com|
22271915|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271916|NCT04344535|Stony Brook University|Elliott Bennett-Guerrero|6314446026|elliott.bennett-guerrero@stonybrookmedicine.edu|
22271917|NCT02447575|Baylor College of Medicine|Dr. Nicola Hanania|(713) 873-3454|hanania@bcm.edu|
22271918|NCT01904903|MedStar|Allison Moses|301-256-2728|Allison.E.Moses@medstar.net|
22271919|NCT05708703|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
22271920|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22271921|NCT04395274|Ohio State University Comprehensive Cancer Center|Dr. Alayna Tackett|614-558-2679|alayna.tackett@osumc.edu|
22271922|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623||
22271923|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com|
22329963|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
22329964|NCT04401904|UT Health San Antonio|Carolina Solis-Herrera, MD|210-567-4900|solisherrera@uthscsa.edu|
22329965|NCT00981747|University of Iowa|Dr. Alicia Gerke|319-356-1616|alicia-gerke@uiowa.edu|
22329966|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org|
22329967|NCT02939651|Fox Chase Cancer Center|Namrata Vijayvergia|+1 215-214-4283|Namrata.Vijayvergia@fccc.edu|
22329968|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114|jimoon@catholic.ac.kr|1243
22329969|NCT03148795|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329970|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329971|NCT04489940|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center,|+49 6151725200|service@emdgroup.com|
22329972|NCT04498468|Johns Hopkins Wilmer Eye Institute|Michael Lin, BA, Research coordinator|8653851192|mlin60@jhu.edu|
22329973|NCT02092324|OHSU|Dr. Kim-Hien Dao|503-494-5074|daok@ohsu.edu|
22271924|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271925|NCT01043562|Vanderbilt University (current institution)|Dr. Andrew E. Radbill|615-322-7447|andrew.radbill@vanderbilt.edu|
22271926|NCT02908074|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
22271927|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
22271928|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu|
22271929|NCT03364036|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22271930|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22271931|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121|bernhard.dauser@gmail.com|5098
22271932|NCT01955109|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
22319270|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319271|NCT03756350|Venus Concept|Dr. Matthew Gronski|(888) 907-0115|mgronski@venusconcept.com|
22319272|NCT04283981|The University of Texas Health Science Center at Houston|Simon Young|(713) 486-2568|simon.young@uth.tmc.edu|
22319273|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu|
22319274|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
22319275|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22319276|NCT03422172|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319277|NCT02496897|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|SHolland@Altimmune.com|40
22319278|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
22319279|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319280|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835||
22319281|NCT01736085|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
22319282|NCT02310672|Actelion Pharmaceuticals Ltd|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319283|NCT03258554|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22319284|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu|
22319285|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org|
22319286|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu|
22319287|NCT02691260|University of Wisconsin-Madison|Corrine Voils|608-262-9636|voils@surgery.wisc.edu|
22319288|NCT02308007|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
22319289|NCT03118674|Wake Forest School of Medicine|Herbert L. Bonkovsky, MD|3367137341|hbonkovs@wakehealth.edu|
22319290|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319291|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22319292|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
22271933|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
22271934|NCT03003000|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271935|NCT04933617|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
22271936|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900|araya221@gmail.com|662
22271937|NCT02147067|Emory University|Habib Samady, MD|(404) 778-1237|hsamady@emory.edu|
22271938|NCT00089635|Amgen Inc.|Study Director|866-572-6436||
22271939|NCT02943785|Daiichi Sankyo|Contact for Clinical Trial Information|+ 1 908-992-6400|CTRinfo@dsi.com|
22271940|NCT02603107|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22271941|NCT00821015|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22271942|NCT04103515|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
22271943|NCT03170609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271944|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
22271945|NCT05656885|CooperVision Inc.|Dr. Jose A Vega OD, MSc, FAAO|+19256213761|javega@coopervision.com|
22271946|NCT02366403|War Related Illness and Injury Study Center, VA Palo Alto Healthcare System|Peter Bayley, PhD|650 493-5000|peter.bayley@va.gov|68653
22271947|NCT02572856|University of Washington Medical Center|David Flum, MD|206 616-5440|daveflum@uw.edu|
22271948|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com|
22271949|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org|
22271950|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271951|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu|
22271952|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22319293|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se|
22319294|NCT01158651|UAB|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
22283477|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283478|NCT02568449|Karmanos Cancer Instiute|Dr. Dipesh Uprety|313-576-8722|upretyd@karmanos.org|
22283479|NCT05545644|University of New Mexico|Dr. Barbara McCrady|505-925-2388|bmccrady@unm.edu|
22283480|NCT01312389|University of Pennsylvania|Director of Clinical Trial Operations|215-662-3324|tracey.thomas@pennmedicine.upenn.edu|
22283481|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22283482|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111|elham.emami@umontreal.ca|6053
22283483|NCT01945775|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283484|NCT02876328|National Institute of Allergy and Infectious Diseases (NIAID)|John Tierney, Director of Office of the Clinical Research Policy and Regulatory Operations (OCRPRO)|301.451.5136|JTierney@niaid.nih.gov|
22283485|NCT01995552|India Medtronic Pvt. Ltd.|Vinay Rajan Ph.D|+91 22.3307.4700|vinay.rajan@medtronic.com|
22283486|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir|
22283487|NCT02068118|CDM e-Health|Clinical Development Physician|33 (0) 1 39 07 62 86|fralsi-ctpublication@airliquide.com|
22283488|NCT01152515|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine|Dr. Shin Ok Koh|82-2-2228-2420|sokoh@yuhs.ac|
22283489|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283490|NCT01420627|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
22283491|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22283492|NCT03743064|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
22283493|NCT05242354|Biruni University|Dr Mustafa YILMAZ|+90 533 7129952|myilmaz@biruni.edu.tr|
22283494|NCT02759315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283495|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22283496|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu|
22283497|NCT00582738|Pharmaceuticals|Novartis|41613241111||
22283498|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211|M006565@ms.skh.org.tw|2612
22283499|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22283500|NCT01902459|Ethicon, Inc|Richard Kocharian, MD, PhD|+1 908-218-2013|rkochar1@its.jnj.com|
22283501|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu|
22283502|NCT01557881|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22283503|NCT02210091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22283504|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283505|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu|
22283506|NCT01685021|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|004989899270|sumeet.ambarkhane@morphosys.com|
22283507|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu|
22283508|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743||
22283509|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
22283510|NCT02246608|Kettering Health Network|Manager, Research Operation and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
22283511|NCT02440789|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22283512|NCT02410577|Memorial Sloan Kettering Cancer Center|Dr. Joseph Osborne, MD, PhD|212-639-7788|osbornej@mskcc.org|
22283513|NCT01999218|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283514|NCT02382848|Penn State University College of Medicine|Dr. Fauzia Mahr|717 531-8133|fmahr@pennstatehealth.psu.edu|
22283515|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22283516|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700|Thomas-Lock@ouhsc.edu|45167
22283517|NCT02008773|Indiana University Psychotic Disorders Program|Alan Breier, MD|317-880-8495|abreier@iupui.edu|
22283518|NCT04638127|University of Cincinnati|Principal Investigator: Ashley Weber, PhD, RN, RNC-NIC|513-5580132|ashley.weber@uc.edu|
22283519|NCT04435600|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22283520|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22283521|NCT05970120|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22283522|NCT05149313|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
22283523|NCT04243330|VA Rocky Mountain MIRECC|Nazanin Bahraini, PhD|720-723-6490|Nazanin.Bahraini@va.gov|
22283524|NCT04927663|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|rahul.aggarwal@ucsf.edu|
22283525|NCT03826342|University of Michigan|Golfo Tzilos Wernette|734-988-3424|gtzilos@med.umich.edu|
22283526|NCT05251753|Wake Forest School of Medicine|Caleb Suggs|3367164171|csuggs@wakehealth.edu|
22283527|NCT02212678|University of Minnesota|Lisa Coles, MS, PhD|4109264788|durh0016@umn.edu|
22283528|NCT04979910|Icahn School of Medicine at Mount Sinai|Esther Lee|212-585-6133|esther.lee@mssm.edu|
22283529|NCT04030962|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22283530|NCT04424225|University of Minnesota|Jessica Nielson|714-904-7939|jnielson@umn.edu|
22301025|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
22301026|NCT01239030|Rhodes Pharmaceuticals|Akwete Adjei, PhD|401-202-9408|Akwete.Adjei@pharma.com|
22301027|NCT04403698|Study Principal Investigator Ghent Universitary Hospital|Prof. dr. Ruth Wittoek|+329 332 25 20|Ruth.Wittoek@Ugent.be|
22301028|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22301029|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu|
22301030|NCT03084666|University of Alabama at Birmingham|Brant Wagener, MD, PhD|12059346007|bwagener@uabmc.edu|
22301031|NCT00441090|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22301032|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22301033|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22301034|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301035|NCT04891419|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301036|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301037|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
22301038|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
22301039|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301040|NCT02979262|Yale University Child Study Center|Dr. Carla Stover|2037853486|carla.stover@yale.edu|
22301041|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu|
22301042|NCT02291614|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22301043|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22319295|NCT01191541|Department of pediatrics, Institute of Hematology and Blood Diseases Hospital.|xiaofan Zhu|+86 22 23909001|xfzhu@ihcams.ac.cn|
22319296|NCT01601847|Case Western Reserve University|Dr. Anna Maria Hibbs|216-844-3387|annamaria.hibbs@cwru.edu|
22319297|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22319298|NCT04464265|University of Michigan Medical School|Zirui Huang, PhD|734-615-2875|huangzu@med.umich.edu|
22319299|NCT01063829|AiCuris Anti-infective Cures GmbH|Chief Medical Officer|004920231763|info@aicuris.com|0
22319300|NCT00533468|Children's Hospital of Philadelphia|Dr James Reingold|6027516093|reingoldj@email.chop.edu|
22319301|NCT00954174|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
22319302|NCT02234323|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22319303|NCT02644941|Humacyte Global Inc|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
22319304|NCT00867113|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22319305|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu|
22319306|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov|
22319307|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com|
22319308|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com|
22319309|NCT00846885|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22319310|NCT04884763|Indiana University School of Dentistry|Dr. Domenick Zero|3179877507|dzero@iu.edu|
22319311|NCT00695253|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Rodney A. White, M. D.|310 963-5230|rawhite@ucla.edu|
22319312|NCT01641809|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319313|NCT04195581|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
22319314|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com|
22319315|NCT04561765|Yale University|Ondrej Blaha|203.737.4468|ondrej.blaha@yale.edu|
22319316|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu|
22319317|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu|
22319318|NCT02511678|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
22319319|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov|
22319320|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu|
22319321|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu|
22319322|NCT02000427|Amgen Inc.|Study Director|866-572-6436||
22319323|NCT02208297|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22319324|NCT05125679|Janssen-Cilag Limited|Senior EMEA Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319325|NCT03442114|Cincinnati Children's Medical Center|Dr. Lori Crosby|5136365380|Lori.Crosby@cchmc.org|
22319326|NCT04890054|Oregon Rural Practice Research Network|Robert Durr, M.P.H.|503-418-3592|durrr@ohsu.edu|
22319327|NCT04313153|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
22319328|NCT05586269|Boston Children's Hospital|Dr. Allison Wu|6173556058|allison.wu@childrens.harvard.edu|
22319329|NCT03998176|University of Nebraska Medical Center|Josh Havens|402-559-2674|jhavens@unmc.edu|
22319330|NCT02348775|Baylor College of Medicine|R. V. Sekhar M.D.|713-798-3908|rsekhar@bcm.edu|
22319331|NCT03157232|Masimo|Tala Harake||studies@masimo.com|
22319332|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319333|NCT00928564|UC Irvine|Dr. Felicia Lane|17144566155|kbacca@uci.edu|
22319334|NCT04697264|University of Surrey|Miss Irene Ray|07490749704|i.ray@surrey.ac.uk|
22301044|NCT03743038|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22301045|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301046|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660|kzandinejad@partners.org|34769 page
22329974|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
22329975|NCT02224274|UMC Ljubljana|Marko Noc|+386 1 522 22 96|marko.noc@mf.uni-lj.si|
22329976|NCT00887068|UT MD Anderson Cancer Center|Dr. Richard E. Champlin, MD/ Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22329977|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu|
22329978|NCT03190967|National Cancer Institute|Dr. Stanley Lipkowitz, PhD|240-760-6129|lipkowis@navmed.nci.nih.gov|
22329979|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com|
22329980|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22329981|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22329982|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
22329983|NCT03418376|Hasselt University|Dr. Charly Keytsman|+32477611122|charly.keytsman@uhasselt.be|
22329984|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com|
22329985|NCT02774291|Albert Einstein College of Medicine/Montefiore medical center|Braunschweig, Ira|718-798-7474|ibraunsc@montefiore.org|
22329986|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com|
22329987|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300||
22329988|NCT01387594|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22329989|NCT03054298|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22329990|NCT03073200|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22329991|NCT04757376|CELLTRION, Inc.|Head of Clinical Planning Department|+82 32 850 4167|jeehye.suh@celltrion.com|
22329992|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22329993|NCT03898323|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22329994|NCT01547806|National Cancer Institute|Dr. Jennifer Kanakry|301-451-3787|kanakryja@nih.gov|
22329995|NCT01611311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22329996|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu|
22329997|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22329998|NCT02058251|Medical University of South Carolina|Dr. Sudie Back|843-792-5915|backs@musc.edu|
22329999|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22330000|NCT01186003|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22330001|NCT00550290|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
22330002|NCT02569398|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330003|NCT04511338|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|1-781-249-8216|chianghong.ho@fmc-na.com|
22330004|NCT02116361|Allergan, Inc|Arlene Lum, PMP|714-246-5548|lum_arlene@allergan.com|
22330005|NCT02571972|Retina Service of Wills Eye Hospital, Mid Atlantic Retina|Dr. Jason Hsu|215-928-3092|jhsu@midatlanticretina.com|
22330006|NCT04195750|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22330007|NCT02406027|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330008|NCT04363944|University at Buffalo|Dr. Jeanne Langan|17168292905|jlangan@buffalo.edu|
22330009|NCT03559192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330010|NCT03517722|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI.|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330011|NCT06535932|Philips|Sarah Bass|240-278-0838|sarah.bass@philips.com|
22330012|NCT02177812|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330013|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330014|NCT03991468|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
22330015|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22330016|NCT04418427|Adverum Biotechnologies|Study Medical Director|650-656-9323|clinicaltrials@adverum.com|
22330017|NCT00615420|BC Cancer|Dr. Philippa Hawley|(604) 877-6000|phawley@bccancer.bc.ca|67-2752
22330018|NCT01673373|Getinge|Sr. Clinical Trial Manager|603-864-5219|inka.vesela@getinge.com|
22330019|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu|
22330020|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk|
22330021|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330022|NCT03691649|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22330023|NCT03261037|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22330024|NCT04423718|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22330025|NCT04193605|School of Nursing at the University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
22330026|NCT03315702|Department of Anesthesia, Xinhua hospital affiliated to Shanghai Jiaotong University School of medicine|Dr. Lai Jiang|021-25078999|jianglaimz@sina.com|
22330027|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org|
22330028|NCT00533780|Stanford University|Kathy Turner, RN, NP|650-724-6850|kathyt@stanford.edu|
22330029|NCT03825536|University of California, San Francisco|Sulggi A. Lee|415-735-5127|sulggi.lee@ucsf.edu|
22330030|NCT05298774|Yale University|Dr. Ira Leeds|(203)785-2616|ira.leeds@yale.edu|
22330031|NCT04992507|The Ohio State University Comprehensive Cancer Center|Dr. Aslam Ejaz|614-293-7171|aejaz@uic.edu|
22330032|NCT03887052|Kestra Medical Technologies, Inc.|Laura Gustavson, VP Clinical Marketing|14255264759|laura.gustavson@kestramedical.com|
22330033|NCT05379686|Steno Diabetes Center Copenhagen|Dr|+45 39 68 08 00|SDC-FP-Stenoinfo@regionh.dk|
22330034|NCT04517253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22330035|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22330036|NCT01058395|Wayne State University|Dr. Jay Meythaler|(313) 375-7226|jmeythal@med.wayne.edu|
22330037|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22330038|NCT04870099|Indiana University|Prof. Lorenzo Lorenzo-Luaces, Assistant Professor|8123456193|lolorenz@indiana.edu|
22330039|NCT05016037|Vanderbilt University Medical Center|Dr. Stephen Camarata|(615) 579-5608|stephen.camarata@vumc.org|
22330040|NCT00557323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22330041|NCT04007367|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22330042|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu|
22330043|NCT04098016|Duke University|Dr. Melissa Kay|7812493062|melissa.kay@duke.edu|
22330044|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22330045|NCT02213081|Northwestern University|Dr. Serdar Bulun|312-472-3980|Serdar.Bulun@nm.org|
22330046|NCT01836029|VentiRx|Kristi Manjarrez|206 689 2256|kmanjarrez@ventirx.com|
22330047|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22330048|NCT03523715|University of Southern California|Begum Ozel, MD|562-657-2961|ozel@usc.edu|
22330049|NCT01526928|Clovis Oncology|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22330050|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
22330051|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org|
22330052|NCT04238689|Radboudumc, Department of Medical Microbiology|Dr. Matthew B.B. McCall|+31 024 361 1111|matthew.mccall@radboudumc.nl|
22330053|NCT05559203|University of Stirling|Prof Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
22330054|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
22330055|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330056|NCT01947894|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330057|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236|jaycox@rand.org|5118
22330058|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22330059|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22330060|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu|
22330061|NCT03150199|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
22330062|NCT02725268|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22330063|NCT01838304|University of Pennsylvania|Vice-Chair of Research|(215) 662-3766|roderic.eckenhoff@uphs.upenn.edu|
22330064|NCT03674541|Brigham and Women's Hospital|Dr. David Systrom|6175431554|dsystrom@bwh.harvard.edu|
22330065|NCT02104141|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
22330066|NCT03338036|University of Western Ontario|Dr Jim Dickey, Associate Professor|519-661-2111|jdickey@uwo.ca|87834
22330067|NCT00117572|UC San Diego Moores Cancer Center|Dr. Ezra E.W. Cohen||ecohen@ucsd.edu|
22330068|NCT03256136|Massachusetts General Hospital|Dr. Jessica Lin|617-724-1134|jjlin1@partners.org|
22330069|NCT04973085|University of Vermont|Adam Sprouse Blum, MD|8028478050|Adam.Sprouse-Blum@uvmhealth.org|
22330070|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu|
22330071|NCT00654368|Amgen Inc.|Study Director|866-572-6436||
22330072|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com|
22330073|NCT04228445|Provepharm, Inc.|Senior Director of Clinical Operations|6106018605|todd.koch@provepharm.com|
22330074|NCT03028467|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330075|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org|
22330076|NCT02550093|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
22330077|NCT03954704|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22330078|NCT03017040|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
22330079|NCT04035473|Athenex|Regional Project Manager|+886-277039399|lmeiying@athenex.com|
22301047|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu|
22301048|NCT01302847|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|MPAACT.ctgov@fstrf.org|
22301049|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com|
22301050|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22301051|NCT02430194|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22301052|NCT03969719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301053|NCT05608629|Icahn School of Medicine at Mount Sinai|Dr. Benjamin H Natelson|(212) 844-6665|Benjamin.Natelson@mountsinai.org|
22301054|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301055|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22301056|NCT01297959|Excited States/Exoxemis, Inc|Jackson T Stephens, Jr|(402) 884-2316|sstephens@exoxemis.com|
22301057|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
22301058|NCT03519854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301059|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22301060|NCT02925676|UNEEG medical|Clinical Research Associate|+45 25657550|clinical@uneeg.com|
22301061|NCT02460692|University of California, San Diego|Thomas D. Marcotte, PhD|619-543-5044|tmarcotte@health.ucsd.edu|
22301062|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch|
22301063|NCT04304833|University of Arkansas for Medical Sciences|Judith Weber|5012961982|weberjudithl@uams.edu|
22301064|NCT03776136|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22301065|NCT02858895|Medicenna Therapeutics Inc|Rosemina Merchant - Chief Development Officer|604-340-3081|nmerchant@medicenna.com|
22301066|NCT03163758|Peking Union Medical College Hospital|Dr. Weihong Zhang|01069159581|ZhangWeiHong@pumch.cn|
22301067|NCT04133831|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
22301068|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us|
22301069|NCT02543658|First affilitated hospital of Nanchang university|Wenhua He|+8613879182642|hewenhua@ncu.edu.cn|
22301070|NCT02018445|SeaSpine|Sara Tish Mikoczi|760-216-5652|tish.mikoczi@seaspine.com|
22301071|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249|ron.zimmerman@plxpharma.com|205
22301072|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu|
22301073|NCT04539821|VA Connecticut Healthcare System|Dr. Brent Moore|203-435-2243|brent.moore@va.gov|
22301074|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au|
22301075|NCT04635579|University of Washington|Dr Scott Telfer|2062292022|telfers@uw.edu|
22301076|NCT03813238|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22301077|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
22330080|NCT03649815|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22330081|NCT03573804|Dartmouth-Hitchcock|Timothy B Rooney, MD, PI|603-650-5000|timothy.b.rooney@hitchcock.org|
22330082|NCT03186261|Faculty of Dentistry, Cairo University|Ali Mostafa Shamaa|+201005276468|alishamaa@hotmail.com|
22330083|NCT05166603|US Department of Veterans Affairs|Dawn M. Bravata, MD|3179882676|dawn.bravata2@va.gov|
22330084|NCT03637959|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
22330085|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
22330086|NCT03979495|Massachusetts General Hospital|Dr. Jennifer Haas|617-724-1832|jhaas@mgh.harvard.edu|
22330087|NCT03763942|Emory University|Dr. Jeb Jones|404-712-2275|jeb.jones@emory.edu|
22330088|NCT02200510|CincinnatiChildrens|Lori Crosby|5136365380|lori.crosby@cchmc.org|
22330089|NCT03057106|Canadian Cancer Trials Group|Dr. Keyue Ding|1-613-533-6430|kding@ctg.queensu.ca|77705
22330090|NCT04969900|Principal Investigator|Dr. Leanne Free|303-724-8576|leanne.free@cuanschutz.edu|
22330091|NCT02881151|Stanford University School of Medicine|Dr. Jaimie Henderson|+1 (650) 723-5574|henderj@stanford.edu|
22330092|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu|
22330093|NCT04284787|Yale School of Medicine|Amer Zeidan, MBBS Professor of Internal Medicine (Hematology)|(203) 200-4363|amer.zeidan@yale.edu|
22330094|NCT01874353|AstraZeneca|Global Clinical Program Lead|1-877-240-9479|information.center@astrazeneca.com|
22330095|NCT03728881|Division of Cancer Epidemiology and Genetics, NCI|Aimée R. Kreimer, PhD|240.276.7102|kreimera@mail.nih.gov|
22330096|NCT04651777|Western Universtiy|Dr. Grace E Parraga|519-931-5365|gparraga@robarts.ca|
22330097|NCT05505734|Avillion Life Sciences|Chief Medical Officer|+44 (0)203 764 9530|contact@avillionls.com|
22330098|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330099|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg|
22330100|NCT02432690|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
22283531|NCT05288166|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22301078|NCT00152464|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22330101|NCT03575351|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22330102|NCT03715205|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22330103|NCT02623699|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22330104|NCT01426009|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22330105|NCT02283333|Ralph H. Johnson VA Medical Center|Dr. Ron Acierno, PI|843-364-1667|ron.acierno@va.gov|
22330106|NCT01856855|University of Alabama at Birmingham (UAB)|John Fiveash, MD|(205) 975-0224|jfiveash@uabmc.edu|
22330107|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu|
22330108|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22330109|NCT03342404|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22330110|NCT04732780|Imperial College London|Dr Vicky McKechnie|02083830689|vicky.mckechnie@nhs.net|
22330111|NCT01863901|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
22330112|NCT04099836|Duke University Medical Center|Dr. Thomas Stinchcombe|919-681-9509|Thomas.stinchcombe@duke.edu|
22330113|NCT03148899|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
22330114|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com|
22330115|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330116|NCT03323086|The Miriam Hospital|Dr. Michael Carey|401 793 8218|michael_carey@brown.edu|
22330117|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22330118|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu|
22330119|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22330120|NCT03676465|University of Virginia|Dr. Mark DeBoer|(434) 924-5956|deboer@virginia.edu|
22330121|NCT04259346|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22330122|NCT00085644|Abbott|Global Medical Services|800-633-9110||
22330123|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330124|NCT03330106|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22330125|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
22330126|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22330127|NCT03441594|Pennington Biomedical Research Center|Candice A. Myers|12257632849|candice.myers@pbrc.edu|
22330128|NCT00486889|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22330129|NCT02750501|Alcresta Therapeutics, Inc.|"Madhumalli (Molly) Sarkar, MD, PhD, Head of Clinical Development"|617 431 8866|msarkar@alcresta.com|
22330130|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu|
22330131|NCT01738594|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@nm.org|
22330132|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330133|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov|
22330134|NCT04430036|University of Texas Health Science Center at San Antonio|Robert Svatek, MD|210-567-5643|svatek@uthscsa.edu|
22330135|NCT04107935|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
22330136|NCT01842334|Beth Israel Deaconess Medical Center|Dr. Kevin P Hill, Director of the Division of Addiction Psychiatry|617-667-1504|khill1@bidmc.harvard.edu|
22330137|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
22330138|NCT01833026|University of Illinois at Chicago|Min Joo|3129968039||
22330139|NCT03489850|University of California Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22330140|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330141|NCT02901080|Electromedical Products International, Inc.|Science and Education Director|8174583295|josh@epii.com|
22330142|NCT04925947|Weill Cornell Medicine|Barbara Ma|646-962-6444|btm9003@med.cornell.edu|
22330143|NCT04319445|Wake Forest University Health Sciences|Rebecca E Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
22330144|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com|
22330145|NCT01678560|Yale University|Meir Kryger, MD|203-815-0914|meir.kryger@yale.edu|
22330146|NCT02201472|Cincinnati Children's Hospital|Dr. Stephanie Merhar|513-803-5180|stephanie.merhar@cchmc.org|
22330147|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348||
22330148|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629||
22330149|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22330150|NCT03924427|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22330151|NCT02858713|Department of Dermatology, Odense University Hospital|M.D. Mathias Tiedemann Svendsen|+45 61265827|m_tiedemann@hotmail.dk|
22330152|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu|
22330153|NCT00712270|Kettering Health Network|Manager, Research Operations and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
22330154|NCT04412668|aTyR Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22330155|NCT03864627|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22330156|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22330157|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com|
22330158|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com|
22330159|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu|
22330160|NCT04124952|SightTrust Eye Institute|Andrew Shatz, MD|877.878.7890|ashatz@sighttrust.com|
22330161|NCT01267955|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
22330162|NCT04574570|IRCCS Istituto Ortopedico Rizzoli|Dr Stefano Zaffagnini|+3905163665706366111|stefano.zaffagnini@unibo.it|
22330163|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22330164|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu|
22330165|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu|
22330166|NCT02974621|Massachusetts General Hospital|Isabel Arillaga-Romany, MD PhD|877-442-3324|iarrillaga@mgh.harvard.edu|
22330167|NCT02559115|Memorial Sloan Kettering Cancer Center|Dr. Hebert A. Vargas Alvarez , MD|646-888-5410|vargasah@mskcc.org|
22330168|NCT04288089|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22330169|NCT02354690|National Center for Cancer Immune Therapy|Inge Marie Svane|0045386889339|inge.marie.svane@regionh.dk|
22330170|NCT05064007|Johns Hopkins University|Dr. Junxin Li|4105022608|junxin.li@jhu.edu|
22330171|NCT04556175|Northern Arizona University|Dr Julie Baldwin|928-523-6566|Julie.Baldwin@nau.edu|
22330172|NCT05549505|Arvinas Estrogen Receptor, Inc|Arvinas Estrogen Receptor, Inc.|475-345-3366|clinicaltrialsARV-471@arvinas.com|
22330173|NCT06408818|innovation Research and Training|Dr. Tracy Scull|9194937700|tscull@irtinc.us|
22330174|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu|
22330175|NCT00403390|Children's Hospital Boston|Jeremi Carswell, MD|617-355-7476|Jeremi.Carswell@childrens.harvard.edu|
22330176|NCT01796106|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
22330177|NCT02268942|Medtronic Cardiac Rhythm and Heart Failure|Mary Jacoski|+15087390909|mary.v.jacoski@medtronic.com|
22330178|NCT00995215|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
22330179|NCT01332851|Family and Child Nursing, University of Washington|Dr. Monica Oxford|206-685-6107|mloxford@uw.edu|
22330180|NCT03446612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330181|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org|
22330182|NCT03796195|Northwestern University|David Walega, MD|3126952500|d-walega@northwestern.edu|
22330183|NCT04445051|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
22330184|NCT03296280|South Texas Veterans Health Care System / UT Health San Antonio|Nilam Soni|210-949-9454|sonin@uthscsa.edu|
22330185|NCT02392468|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330186|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp|
22330187|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu|
22330188|NCT03630016|Owlet Baby Care, Inc.|Madison Kenley, CCRP, BS|801-552-8383|mkenley@owletcare.com|
22330189|NCT05083949|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330190|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22330191|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il|
22330192|NCT00606294|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
22330193|NCT03887286|University of Miami|Mary Sokoloski|305 585-6683|msokoloski@med.miami.edu|
22330194|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330195|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22330196|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22330197|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330198|NCT01894776|Ottawa Hospital Research Institute|Dr. Bill Cameron|613-737-8899|bcameron@toh.ca|78923
22330199|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com|
22330200|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu|
22330201|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
22330202|NCT02574520|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22330203|NCT00886691|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22330204|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22330205|NCT03398824|Boston Children's Hospital|Akiko Shimamura|617-919-6946|akiko.shimamura@childrens.harvard.edu|
22330206|NCT05307523|University of Washington|Reham A. Abuatiq, Research coordinator and a PhD candidate|6198309638|rabuat@uw.edu|
22330207|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu|
22330208|NCT05116683|Columbia University|Benjamin Izar, MD|212-304-5871|bi2175@cumc.columbia.edu|
22330209|NCT03298048|UTexas_Houston|Dr. Herbert DuPont|713-500-9366|herbert.l.dupont@uth.tmc.edu|
22330210|NCT03935594|Vanderbilt university medical center|Dr. Salam AlKassis|(615)322-2350|salam.al.kassis@vumc.org|
22330211|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org|
22330212|NCT00112840|University of Miami - Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu|
22330213|NCT02875366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22330214|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22330215|NCT03595176|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
22330216|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se|
22330217|NCT02735044|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22330218|NCT02308709|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22330219|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22330220|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org|
22283532|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu|
22271953|NCT00990665|St. Jude Medical|Clay Cohorn: Director, Clinical Study Management|972 309 8087|ccohorn@sjm.com|
22271954|NCT02603562|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22271955|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
22271956|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu|
22271957|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22271958|NCT02638259|Sandoz|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
22271959|NCT04299048|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271960|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22271961|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org|
22271962|NCT02952872|Wayne State University|Dr. Emily Grekin|313-577-2820|grekine@wayne.edu|
22271963|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com|
22271964|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu|
22271965|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300||
22271966|NCT02624388|UVA Health|William Petersen|434-924-8499|wcp3g@uvahealth.org|
22271967|NCT03434249|SOFAR S.p.A|LAURA PATRUCCO|+390202 909 362291|laura.patrucco@sofarfarm.it|
22271968|NCT02918552|University of Pittsburgh|Tara Sheila Stakich|412-864-2082|tss54@pitt.edu|
22271969|NCT01001598|Boston Children's Hospital|Colin A. Sieff|617 919-4241|colin.sieff@childrens.harvard.edu|
22271970|NCT02722837|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22271971|NCT04877535|Washington University School of Medicine|Christopher King|(314) 362-8649|christopherking@wustl.edu|
22271972|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075||
22271973|NCT02920177|University of Michigan|Jordyn Sessel|734-615-0934|jsessel@med.umich.edu|
22271974|NCT03164265|University of Pittsburgh|Dr. Angus Thomson|(412) 624-6392|thomsonaw@upmc.edu|
22271975|NCT04907227|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271976|NCT03673345|University of Rochester|Jennifer Nayak, MD, PI|5852750526|Jennifer_nayak@urmc.rochester.edu|
22271977|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22271978|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22271979|NCT02267135|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|trialandresults.registries@novartis.com|
22271980|NCT03806231|Intermountain Healthcare|Molly Adams, Clinical Research Project Coordinator|(801)507-7030|molly.adams@imail.org|
22271981|NCT02919267|Institut universitaire de cardiologie de de pneumologie de Québec|Dr Jean Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
22271982|NCT04608344|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22271983|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov|
22271984|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
22271985|NCT02429310|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
22271986|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
22271987|NCT03646305|York University|Keisha C. Gobin, MA|416-736-2100|kgobin@yorku.ca|33153
22301079|NCT02565914|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22301080|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
22301081|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300||
22301082|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org|
22301083|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
22301084|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu|
22301085|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com|
22301086|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301087|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu|
22301088|NCT02054806|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301089|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com|
22301090|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810|Timothy.Carmody@ucsf.edu|26344
22301091|NCT05120115|MetroHealth Hospital|James Sulzer|5125419036|jss280@case.edu|
22301092|NCT03871595|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330221|NCT02497287|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330222|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org|
22330223|NCT01226472|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22330224|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu|
22330225|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com|
22330226|NCT01747447|Brigham and Women's Hospital|Meryl S LeBoff, M.D.|1-800-388-3963|vitalstudy@partners.org|
22330227|NCT00740116|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
22330228|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22330229|NCT02499172|Johns Hopkins Bloomberg School of Public Health|Dr. Mohammad Ali|410-502-3154|mali25@jhu.edu|
22330230|NCT01293123|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
22330231|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283533|NCT03007745|Corporal Michael J. Crescenz VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
22283534|NCT03298841|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
22283535|NCT02981524|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22283536|NCT02811913|VA Northeast Ohio Healthcare System|Dr. Svetlana Pundik|(216)791-3800|svetlana.pundik@va.gov|
22283537|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
22283538|NCT02677844|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283539|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
22301093|NCT03616184|University of Nebraska Medical Center|Vijaya Bhatt|402-559-8008|vijaya.bhatt@unmc.edu|
22330232|NCT04495673|University of Minnesota|Kelvin Lim|(612) 626-6772|kolim@umn.edu|
22330233|NCT02386605|Greater Los Angeles VA Healthcare System|Dr. Felice Reddy|3104783711|felice.reddy@gmail.com|
22330234|NCT01842282|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
22330235|NCT03738878|Yale University|Nancy J. Brown|2037854672|nancy.j.brown@yale.edu|
22330236|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu|
22330237|NCT04076579|University of Michigan Rogel Cancer Center|Clinical Trials Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22330238|NCT00186121|Stanford University Medical Center|Melinda Telli, MD|650-724-9533|mtelli@stanford.edu|
22330239|NCT03650387|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22330240|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22330241|NCT05815758|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22330242|NCT03661983|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22330243|NCT02903966|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330244|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu|
22330245|NCT02353806|University of Texas Southwestern Medical Center|Jamie Morgan, MD|214-645-3838|jamie.morgan@utsouthwestern.edu|2147665011
22330246|NCT01320033|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22330247|NCT02425891|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22330248|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330249|NCT00782756|Memorial Sloan Kettering Cancer Center|Dr. Philip Gutin|212-639-8556|gutinp@mskcc.org|
22330250|NCT02145429|University of Pittsburgh|Charles F. Reynolds, MD|(412) 246-6414|reynoldscf@upmc.edu|
22330251|NCT02943577|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22330252|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu|
22330253|NCT03991936|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
22330254|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com|
22330255|NCT03139435|Wake Forest Baptist Comprehensive Cancer Center|Roy Strowd|336-713-5440|rstrowd@wakehealth.edu|
22330256|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
22330257|NCT03502941|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
22330258|NCT01944462|Thomas Jefferson University|Laura T. Pizzi, PharmD, MPH; Principal Investigator|215-955-1159|laura.pizzi@rutgers.edu|
22330259|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330260|NCT01866839|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
22330261|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil|
22330262|NCT02498600|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|linda.gedeon@roswellpark.org|
22330263|NCT06085443|YSLAB|Mélody DUTOT|33 (0)2.98.53.30.03|melody.dutot@yslab.fr|
22330264|NCT05085275|USRC Kidney Research|Stephanie Brillhart, Senior Director Regulatory Compliance|303-881-9451|stephanie.brillhart@usrenalcare.com|
22330265|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu|
22330266|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22330267|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org|
22330268|NCT05706623|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
22330269|NCT02912572|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
22330270|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22330271|NCT01327573|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
22330272|NCT03070119|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22283540|NCT04709484|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
22330273|NCT01996865|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22330274|NCT04571684|University of Kansas Medical Center|Principal Investigator|913-945-7709|skessler2@kumc.edu|
22330275|NCT05304611|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
22330276|NCT03993119|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330277|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22330278|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu|
22330279|NCT04430894|Dana-Farber Cancer Institute|Elizabeth K. O'Donnell, MD|617-632-3000|Elizabeth_ODonnell@DFCI.HARVARD.EDU|
22330280|NCT02756845|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22330281|NCT05333289|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22330282|NCT01550315|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
22330283|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com|
22330284|NCT01917136|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
22330285|NCT04589832|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22330286|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330287|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330288|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263|jeanna.viola@nyumc.org|0667
22330289|NCT03685643|University of Hong Kong|Dr Wong Chi Wai William|(852) 2518-5650|wongwcw@hku.hk|
22330290|NCT02618512|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
22330291|NCT03797144|Medtronic|Clinical Research Specialist|+39 3450225929|francesca.molineris@medtronic.com|
22330292|NCT02661256|NYU-Winthrop Hospital|Nazeeh Hanna, MD|6314211424|nazeehhanna@gmail.com|
22330293|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
22330294|NCT05393570|UTSW - O'Donnell School of Public Health|Sarah E. Messiah|(972) 546-2919|Sarah.Messiah@UTSouthwestern.edu|
22330295|NCT03299166|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22330296|NCT02092168|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22330297|NCT00195624|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
22330298|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459|staci@hemcon.com|103
22330299|NCT03296072|GlaxoSmithKline|GSK Response Center|866-435-7343 Ext:|GSKClinicalSupportHD@gsk.com|
22330300|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22330301|NCT03109418|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22330302|NCT02043704|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
22330303|NCT02972658|AstraZeneca|AstraZeneca Information Center|877-240-9479|information.center@astrazeneca.com|
22330304|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es|
22330305|NCT01054339|Applied Genetic Technologies Corp.|Ellery D. Mangas|386-462-7106|emangas@agtc.com|
22330306|NCT03958149|Imperial College Healthcare NHS Trust|Key investigator|02033121077|annabellelee@nhs.net|
22330307|NCT02785588|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
22330308|NCT03037489|Medivir AB|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
22330309|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu|
22330310|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22330311|NCT03031327|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22330312|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330313|NCT03793010|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22330314|NCT00908050|Baylor College of Medicine/Houston Methodist|William Ondo, MD|713-363-8390|wondo@houstonmethodist.org|
22330315|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org|
22330316|NCT01997892|Amgen Inc.|Study Director|866-572-6436||
22330317|NCT02531633|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330318|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com|
22330319|NCT01562379|Johns Hopkins Bloomberg School of Public Health|Parul Christian|1-410-955-1188|pchrist1@jhu.edu|
22330320|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu|
22330321|NCT04097925|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
22330322|NCT02608099|Baim Institute for Clinical Research|Director of Trial Design and Development|617-307-5200|TrialDesignandDevelopmentStaff@baiminstitute.org|
22330323|NCT03770689|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22330324|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22283541|NCT02231762|Ipsen|Medical Director||clinical.trials@ipsen.com|
22330325|NCT03040479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22330326|NCT01952041|University of Washington School of Medicine|Dror Ben-Zeev, PhD|(206) 685-9655|dbenzeev@uw.edu|
22330327|NCT01736176|AbbVie|Global Medical Services|800-633-9110||
22330328|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org|
22330329|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22330330|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu|
22330331|NCT00290355|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330332|NCT03345849|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22330333|NCT03657576|The University of Alabama at Birmingham|James Markert, MD|2059347171|jmarkert@uabmc.edu|
22330334|NCT04437511|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22330335|NCT05032755|Duke University Medical Center|Maggie Sweitzer|919-668-0094|maggie.sweitzer@duke.edu|
22330336|NCT00911183|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
22330337|NCT04228276|Palo Alto VA|Dr. Jong Yoon|6504935000|jong.yoon@va.gov|
22330338|NCT03093350|Baylor College of Medicine|Shaun Bulsara|713-798-8014|sbulsara@bcm.edu|
22330339|NCT00777036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22330340|NCT04632589|University of Iowa|Anna Stanhewicz, PhD|3194671732|anna-stanhewicz@uiowa.edu|
22330341|NCT05564039|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22330342|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22301094|NCT00708916|New York University School of Medicine|Andrew Franks, MD, Principal Investigator|212-263-5244|andrew.franks@nyumc.org|
22271988|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301095|NCT04270292|Demiroglu Bilim University|Nurten OZEN|+90 (212) 275 75 82|ozenurten@yahoo.com.tr|
22271989|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22271990|NCT02678000|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22271991|NCT03816644|Albert Einstein College of Medicine|Dr. Joe Verghese|7184303808|joe.verghese@einsteinmed.edu|
22271992|NCT00756600|Boston Children's Hospital Anesthesia Foundation|Dr Mary Ellen McCann|6173557737|mary.mccann@childrens.harvard.edu|
22319335|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com|
22271993|NCT02190721|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|USMedInfo@tevapharm.com|
22271994|NCT01760447|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22271995|NCT01214668|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22271996|NCT02907619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22271997|NCT03326518|Lument AB|Dr Thomas Fork|+46 705336996|thomas.fork@lumentab.com|
22330343|NCT03233308|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22330344|NCT03662789|Oslo University Hospital|Dr. Lars Gullestad|0047 97644772|lars.gullestad@medisin.uio.no|
22330345|NCT02136134|Janssen R&D US|Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330346|NCT05245071|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22330347|NCT04916314|University of Oxford|Dr Elizabeth Morris|01865617289|RESULT@phc.ox.ac.uk|
22330348|NCT01602822|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
22330349|NCT03288311|Vanderbilt University Medical Center|Jonathan Casey, Assistant Professor of Medicine|6158754681|Jonathan.d.Casey@vumc.org|
22330350|NCT00854061|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22330351|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330352|NCT01553591|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22330353|NCT02477800|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22330354|NCT01937624|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Kyle Cassas|864-454-7422|kcassas@ghs.org|
22330355|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com|
22330356|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22330357|NCT02005510|University of Washington|Dr. Rachel Winer|2066165081|rlw@uw.edu|
22330358|NCT00002981|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|212-639-7373|LarsonS@MSKCC.ORG|
22330359|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22330360|NCT01300949|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22330361|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com|
22330362|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22330363|NCT02583360|The Research Institute at Nationwide Children's Hospital|Sudarshan Jadcherla MD|614-355-6433|sudarshan.jadcherla@nationwidechildrens.org|
22330364|NCT02415595|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330365|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com|
22330366|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu|
22330367|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330368|NCT03219476|Medical College of Wisconsin|Lubna Chaudhary|414-805-4600|lchaudhary@mcw.edu|
22330369|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330370|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22330371|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252|stephane.pelet.ortho@gmail.com|3165
22330372|NCT03350724|The University of Texas Health Science Center at Houston|Jennifer James, DMD, MS|713-486-4383|Jennifer.D.James@uth.tmc.edu|
22330373|NCT02134912|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
22330374|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu|
22330375|NCT02636049|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22330376|NCT04806165|Washington University in St. Louis School of Medicine|Ellen E. Fitzsimmons-Craft|314-286-2074|fitzsimmonse@wustl.edu|
22330377|NCT03702439|Imperial Prostate|David Eldred-Evans|020 7594 7773|d.eldred-evans@imperial.ac.uk|
22330378|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330379|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300||
22330380|NCT01196936|University of Alabama at Birmingham|Dr. Smita Bhatia|(205) 638-2120|sbhatia@peds.uab.edu|
22330381|NCT03229538|Duke University|Kevin Hill, MD|919-681-6846|kevin.hill@duke.edu|
22330382|NCT02511106|AstraZeneca AB|Global Clinical Leader|+447920183730|ClinicalTrialTransparency@astrazeneca.com|
22330383|NCT04465240|University of Southern California|Daniel A. Hackman, Ph.D.|(213) 821-3112|dhackman@usc.edu|
22330384|NCT01222767|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22330385|NCT02773849|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
22330386|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22283542|NCT03455829|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22301096|NCT02681614|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Bryan Traughber|+1 216-884-2516|bryan.traughber@uhhospitals.org|
22301097|NCT03923959|LancasterGH|Halle Becker|7175441401|halle.becker@pennmedicine.upenn.edu|
22301098|NCT04212091|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22301099|NCT04575051|University of Pittsburgh|Dr. Catherine Palmer|412-383-6565|cvp@pitt.edu|
22330387|NCT03577028|Harpoon Therapeutics|Medical Director|1-650-452-728|HPN4241001@harpoontx.com|
22330388|NCT02274311|Hospital das Clinicas da Faculdade de Medicina da USP|Dr. Felipe Henning Gaia Duarte|+5511987550990|drfelipegaia@outlook.com|
22330389|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22330390|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org|
22330391|NCT01626859|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330392|NCT03277729|Fred Hutchinson Cancer Center|Mazyar Shadman|206-667-4216|mshadman@fredhutch.org|
22330393|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22330394|NCT03725345|Virginia Commonwealth University|David Chester, PhD|804-828-7624|dschester@vcu.edu|
22330395|NCT05184842|Montefiore Medical Center|Mendel Goldfinger, MD|718-920-4826|mgoldfin@montefiore.org|
22330396|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu|
22330397|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191|nturjman@regenerx.com|108
22330398|NCT04995666|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22330399|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
22330400|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581|Carolyn.Turvey@VA.Gov|7714
22330401|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22330402|NCT02943668|Fred Hutch Cancer Research Center|Dr. Bart Scott|206.667.1990|bscott@fredhutch.org|
22330403|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22330404|NCT04048876|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22330405|NCT01828567|Durham VA Center of Innovation in Primary Care|Eugene Z Oddone, MD, MPSc|919-286-0411|eugene.oddone@va.gov|
22330406|NCT02421146|Psychiatry Research, The Zucker Hillside Hospital|Andrea Joanlanne|7184708898|ajoanlanne@northwell.edu|
22330407|NCT01099761|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330408|NCT03325010|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22330409|NCT02614261|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22330410|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330411|NCT03580525|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22330412|NCT04350372|Abbott Structural Heart|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
22330413|NCT02460172|ZipLine Medical|Wendy Winters, Clinical Project Manager|408-506-1866|wwinters0@gmail.com|
22330414|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org|
22330415|NCT03512275|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330416|NCT00113555|Uromedica|Timothy Plouffe|763-999-7048|tplouffe@uromedica-inc.com|
22330417|NCT04474366|University of California, San Francisco|Esther Kim|415-353-9392|Esther.kim@ucsf.edu|
22330418|NCT04063865|Indiana University|Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
22330419|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22330420|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127||
22330421|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835||
22330422|NCT03144089|University of Iowa Hospitals and Clinics|Ron Abrons, MD|(319) 353-8061|ron-abrons@uiowa.edu|
22330423|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330424|NCT02094664|UCLA Mattel Children's Hospital|Dr. Diana Chen|3108255930|dychen@mednet.ucla.edu|
22330425|NCT04330989|University of North Carolina at Chapel Hill|Benjamin Chi|9194454147|bchi@med.unc.edu|
22330426|NCT02299206|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
22330427|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
22330428|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330429|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
22330430|NCT03074318|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
22330431|NCT01625897|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330432|NCT03455530|University of Arizona|Dr. Paloma Beamer|520-626-0006|pbeamer@arizona.edu|
22330433|NCT03929029|Dana Farber Cancer Institute|Dr. Patrick A. Ott|6175829030|patrick_ott@dfci.harvard.edu|
22330434|NCT02314637|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330435|NCT03961672|City of Hope Medical Center|Dr. Alexey Danilov, MD|626-359-8111|adanilov@coh.org|
22330436|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330437|NCT00412867|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330438|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu|
22330439|NCT03595982|Icahn School of Medicine at Mount Sinai|Dr. Melissa Chu Lam|520-360-8807|melissachu.md@gmail.com|
22301100|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu|
22330440|NCT04221945|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330441|NCT03983993|Emory University|Olatunji Alese|404-778-6639|olatunji.alese@emory.edu|
22330442|NCT00974090|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330443|NCT01626872|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330444|NCT05626751|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22330445|NCT01625000|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330446|NCT03912064|Dana-Farber Cancer Institute|John Koreth, MD, PhD, MBBS|617-632-3470|John_Koreth@dfci.harvard.edu|
22330447|NCT01026194|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330448|NCT04295759|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
22330449|NCT05740566|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22330450|NCT02055872|McMaster University|Simon Oczkowski|905 521 2100|oczkowsj@mcmaster.ca|42442
22330451|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330452|NCT06210035|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
22330453|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
22330454|NCT02591511|Taipei medical university|Dr. Chia-Yun Lin|+886919986391|windoct@hotmail.com|
22330455|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org|
22330456|NCT05616221|Armata Pharmaceuticals, Inc.|Jennifer Smith|310-665-2928|jsmith@armatapharma.com|
22330457|NCT04880733|University California-Irvine|Jeffery Dusek|617-519-8082|jdusek@hs.uci.edu|
22330458|NCT00862992|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330459|NCT05492877|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22330460|NCT02871791|Dana-Farber Cancer Institute|Sara Tolaney, MD MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22330461|NCT02782364|University Hospital of South Manchester|Karen Telford|01612916654|karen.telford@uhsm.nhs.uk|
22330462|NCT03369340|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22330463|NCT04240002|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22330464|NCT04209634|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22301101|NCT03565887|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
22330465|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org|
22330466|NCT03737318|New York University|Tara McAllister, Associate Professor|212-992-9445|tkm214@nyu.edu|
22330467|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110||
22330468|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org|
22330469|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22330470|NCT01603628|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22330471|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu|
22330472|NCT02711553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22330473|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu|
22330474|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22330475|NCT03471143|Washington University School of Medicine|Dr. Patricia Dickson|314-273-2943|pdickson@wustl.edu|
22330476|NCT03858686|Foresee Pharmaceuticals|Yisheng Lee, MD, Chief Medical Officer|4088234807|yisheng.lee@foreseepharma.com|
22330477|NCT04673630|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22330478|NCT03374891|"University of Colorado Denver | Anschutz"|Daniel Matlock, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22330479|NCT03399786|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22330480|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu|
22330481|NCT03053180|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22330482|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22330483|NCT04540627|mAbxience Research SL|Director of Clinical Trials|+34917711500|susana.millan@mabxience.com|
22330484|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com|
22330485|NCT06115681|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330486|NCT01493024|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22330487|NCT04022343|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
22330488|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com|
22330489|NCT02583399|Cumberland Pharmaceuticals Inc.|Sr. Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
22330490|NCT01004861|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22330491|NCT03276494|Ohio State University|Thomas Lawson|614-366-7312|thomas.lawson@osumc.edu|
22330492|NCT04610827|Mayo Clinic|Julie M. Baughn, M.D.|507-293-1031|Baughn.Julie@mayo.edu|
22330493|NCT01823991|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nagi Kumar|813-745-6885|nagi.kumar@moffitt.org|
22330494|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22271998|NCT06439095|Van Yuzuncu Yil University Faculty of Dentistry|Dr. Burçin Avcı, Assistant Professor|+90 5359558140|burcinavci@yyu.edu.tr|
22271999|NCT02485418|University of Texas Southwestern|Deryk Walsh, MD|2144566393|deryk.walsh@utsouthwestern.edu|
22301102|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22330495|NCT04334876|Indiana University|Courtney Rowan|317-944-7065|coujohns@iu.edu|
22330496|NCT02184520|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
22272000|NCT03484403|Dallas VA Medical Center|Dr Thiru Annaswamy|214-857-0273|thiru.annaswamy@va.gov|
22272001|NCT01937884|University of Arizona|Dr. Katri Typpo|5206265485|ktyppo@email.arizona.edu|
22272002|NCT03706469|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22272003|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799|lanorton@mail.med.upenn.edu|215
22272004|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@Novartis.com|
22301103|NCT03182868|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
22330497|NCT02185040|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|866-260-1599|ClinicalTrialDisclosure@Celgene.com|
22330498|NCT02385292|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22330499|NCT01792024|University of Chicago|Dr. Aytekin Oto|773-834-7424|aoto@radiology.bsd.uchicago.edu|
22330500|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22272005|NCT01656187|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
22330501|NCT02530281|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22330502|NCT03557801|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615 343 1187|lucy.b.spalluto@vumc.org|
22330503|NCT00535236|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330504|NCT01671176|Oticon Medical LLC|Ravi Sockalingam|9082023524|rsoc@oticomedical.com|
22330505|NCT03558503|UroGen Pharma|Elyse Seltzer, MD|1-646-492-8518|elyse.seltzer@urogen.com|
22330506|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330507|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org|
22330508|NCT04167514|CSL Behring|Clinical Study Disclosure Manager|1- 610-878-4697|clinicaltrials@cslbehring.com|
22330509|NCT02646891|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22330510|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22330511|NCT03225833|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22330512|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091||
22330513|NCT06029127|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22330514|NCT04785144|Kaiser Permanente Washington|Lisa Jackson|206-442-5216|lisa.a.jackson@kp.org|
22330515|NCT00129376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22330516|NCT01766401|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22330517|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com|
22330518|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu|
22330519|NCT01108068|University of Maryland School of Medicine|Elizabeth Streeten, MD|410-328-3335|estreete@som.umaryland.edu|
22330520|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22330521|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330522|NCT04084210|University of Wisconsin- Madison|Megan Piper, PhD, Director of Research Professor|608-265-5472|mep@ctri.wisc.edu|
22330523|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22330524|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org|
22330525|NCT02201251|Janssen Research & Development, LLC|Director - Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330526|NCT05259800|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22330527|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22330528|NCT04055844|University of Minnesota, Masonic Cancer Center|Mark Juckett , MD|612-676-4200|juck0001@umn.edu|
22330529|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com|
22330530|NCT03457636|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22330531|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca|
22330532|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com|
22330533|NCT03231228|B. Braun Medical Inc.|Diana Valencia MD|610-596-2875|diana.valencia@bbraunusa.com|
22330534|NCT04337203|Wake Forest Baptist Comprehensive Cancer Center|Carol Kittel|336-399-3832|c.kittel@wakehealth.edu|
22330535|NCT01579162|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
22330536|NCT05309499|Kazan State medical Universety|Niiaz Khasanov|+79050204407|dilyara_khastieva@mail.ru|
22330537|NCT03049852|Cloudbreak Therapeutics, LLC|Dr, Jinsong Ni|9496789752|Ni-Jinsong@cloudbreaktherapeutics.com|
22330538|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22330539|NCT01868594|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22330540|NCT04490057|Yale University|E. Jennifer Edelman, MD, MHS|203-727-7115|ejennifer.edelman@yale.edu|
22330541|NCT02369211|Brigham and Women's Hospital|James Webber|(617) 732-6877|jwebber1@partners.org|
22330542|NCT02598661|Geron Corp.|Study Director|650-473-7700|mds3001-info@Geron.com|
22330543|NCT00147316|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22330544|NCT04564027|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
22330545|NCT05827978|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22330546|NCT04566445|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22330547|NCT04453722|Cleveland Clinic|Daniel I. Sessler, Professor & Chair|216-445-6500|DS@CCF.org|
22330548|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov|
22330549|NCT01104922|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor; ClinicalTrials.gov Admin|412-647-5554|stadtermanbm@upmc.edu|
22272006|NCT02798120|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
22272007|NCT02854605|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22272008|NCT05268016|Meiji Pharma USA Inc.|Meiji Pharma USA Inc. Study Lead|+1 201-777-7133|mpu.contact@meiji.com|
22272009|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301104|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
22301105|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22301106|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com|
22301107|NCT03923933|Head of Nephrology Hospital General de México|Rafael Vadez-Ortiz M.D. PhD|+52 2789-2000|rafavaldez@gmail.com|1253
22301108|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu|
22301109|NCT02671032|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
22301110|NCT01777854|UH|Carissa Wentland DO|320-392-4737|carissa.wentland@gmail.com|
22301111|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301112|NCT03311373|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22301113|NCT02115633|RxFunction, Inc.|Lars Oddsson, PhD|8572340382|loddsson@rxfunction.com|
22301114|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22301115|NCT01302119|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
22301116|NCT01775904|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301117|NCT03030222|Saint Luke's Hospital of Kansas City|Study Manager|816-932-9858|EMBRACE-HF@saint-lukes.org|
22301118|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22301119|NCT03156660|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
22301120|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com|
22301121|NCT00205348|University of Wisconsin-Madison|Dr. Herbert Chen|608-263-1387|chen@surgery.wisc.edu|
22301122|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22301123|NCT05725317|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22301124|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711|rebecca.czlapinski@va.gov|3357
22301125|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22301126|NCT02085252|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22301127|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu|
22301128|NCT03260868|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22301129|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com|
22301130|NCT03645759|Michael E. Debakey VA Medical Center|Dr. Gina Evans|832-269-3048|gina.evans@va.gov|
22301131|NCT03195010|FHCRC|Dr Bethany Samuelson Bannow|5034949925|samuelsb@ohsu.edu|
22301132|NCT02693743|University of Arkansas for Medical Sciences|Favrin Smith|1 (501) 526-8488|SmithFavrinM@uams.edu|
22301133|NCT02626780|The GID Group|Director of Clinical Affairs|3039524901|GIDAA-01@thegidgroup.com|
22301134|NCT05540522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301135|NCT04427202|University of Chicago Medicine|Mai T. Pho, MD MPH|773-834-3689|mpho@bsd.uchicago.edu|
22301136|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22301137|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
22301138|NCT05520138|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301139|NCT03854461|Queen's University Belfast|Prof. Jayne Woodside|+44 (0)28 9097 8942|j.woodside@qub.ac.uk|8942
22301140|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
22301141|NCT02586025|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22301142|NCT03822117|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22272010|NCT03013985|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
22272011|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272012|NCT02322333|Clinvest Research|Jim Sly MS|4178413673|jsly@clinvest.com|
22272013|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu|
22272014|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272015|NCT05821296|Dermosciences France|Sara Bayo Rodriguez|638966321|clinicaltrials@dermaceutic.com|0033
22272016|NCT01217385|American College of Radiology|Donna Hartfeil, Director Protocol Management|215-717-2765|dhartfeil@acr.org|
22272017|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22272018|NCT05749068|Silicon Valley Gastroenterolgy|Dr. George Triadafilopoulos|(650) 988-7530|info@siliconvalleygi.com|
22272019|NCT04208321|ICON Early Phase Services, LLC|Dr. Cassandra Key, Senior Medical Director|210-283-4120|Cassandra.key@iconplc.com|
22272020|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00|antonio.hupa@gmail.com|2610
22272021|NCT02117713|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22301143|NCT04280653|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
22301144|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com|
22272022|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu|
22272023|NCT03578146|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22272024|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45|krisoebr@rm.dk|78452845
22272025|NCT01094782|Massachusetts General Hospital|Dr. Lucy Chen|6177246102|mghpainresearch@partners.org|
22272026|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com|
22272027|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu|
22272028|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com|
22272029|NCT04292639|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
22272030|NCT02450552|Massachusetts General Hospital - Neurological Clinical Research Institute|Protocol Investigator|617-726-2000|Brian.Wainger@MGH.HARVARD.EDU|
22272031|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22272032|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22272033|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU|
22272034|NCT03723070|Boston Scientific|Clinical Trial Manager|+32 470 991143|nele.cielen@bsci.com|
22272035|NCT02208050|St. Vincent's University Hospital|Professor Christopher McGuigan|+35312214209|C.McGuigan@svhg.ie|
22272036|NCT02770768|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22330550|NCT03501979|University of Alabama at Birmingham|Dr. Erica Stringer-Reasor|205-975-2914|esreasor@uabmc.edu|
22272037|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22272038|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272039|NCT05153148|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22272040|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22272041|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272042|NCT02892513|Medical College of Wisconsin|Carrie Y. Peterson, MD, MS|414-955-5783|cypeterson@mcw.edu|
22272043|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300||
22272044|NCT00131365|InSightec|Nadir Alikacem|214.630.2000|nadira@insightec.com|
22272045|NCT05249127|Clarity Pharmaceuticals|Dr Othon Gervasio, Chief Medical Officer|+61 2 9209 4037|info@claritypharmaceuticals.com|
22272046|NCT03053427|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
22272047|NCT01801241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
22272048|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com|
22272049|NCT02607306|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22272050|NCT03240406|Albert Einstein College of Medicine|Dr. Yasmin Mossavar-Rahmani|718-430-2136|yasmin.mossavar-rahmani@einsteinmed.edu|
22272051|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272052|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org|
22272053|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com|
22272054|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22272055|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330551|NCT02329860|clinical operation|Zexiang.huang/ project manager|13811725417|zexiang.huang@hengrui.com|
22330552|NCT02061540|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22330553|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org|
22330554|NCT04005755|AFT Pharmaceuticals|Jennifer Zhang -Project Leader|+ 64 9 488 0232|jenniferz@aftpharm.com|710
22330555|NCT02599441|University at Buffalo|Research coordinator|7162043209|mk67@buffalo.edu|
22330556|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22330557|NCT04509024|Carnegie Mellon University|Dr. Seth Wiener, Associate Professor|412-268-5669|sethw1@cmu.edu|
22330558|NCT02561273|University of Nebraska Medical Center|Matthew Lunning|402-559-7164|mlunning@unmc.edu|
22330559|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22330560|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22330561|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22330562|NCT01818765|Oxford university hospitals NHS Foundation Trust|Dr James Gamble|+441865221012|drjgamble1@jhpg.net|
22330563|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22330564|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de|
22330565|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu|
22330566|NCT03667573|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
22330567|NCT04554394|Pulse Biosciences, Inc.|William A. Knape|(919) 757-2033|bill.knape@pulsebiosciences.com|
22330568|NCT02795182|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22330569|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330570|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22330571|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
22272056|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22272057|NCT00810498|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
22330572|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com|
22330573|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu|
22330574|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
22330575|NCT01833806|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs & CRO|(214) 630-2000|nadira@insightec.com|
22272058|NCT04316260|Medical University of South Carolina|Noelle Natale|843-876-2426|natalen@musc.edu|
22272059|NCT03307837|Concentric Analgesics|Dr. John Donovan, President and Founder|415-676-8940|JOHN@CONCENTRICANALGESICS.COM|
22330576|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr|
22330577|NCT02996500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330578|NCT02187224|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
22330579|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22330580|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22330581|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
22330582|NCT02332876|University of San Diego, California|Dr. Sheri Hartman|8585349235|sjhartman@ucsd.edu|
22330583|NCT02402881|The Johns Hopkins University|Elliott R Haut, MD PhD|410-502-3122|ehaut1@jhmi.edu|
22330584|NCT00384449|Oregon Health & Science University|Dr. Christina J. Flaxel|(503) 418-3352|flaxelc@ohsu.edu|
22330585|NCT00415623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22330586|NCT01369069|University of Virginia|Karen C. Johnston, MD|434 924-5323|kj4v@virginia.edu|
22330587|NCT02573012|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22330588|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22330589|NCT01268514|Medtronic|Andrea DiScipio, Clinical Research Associate|781-491-5350|andrea.l.discipio@medtronic.com|
22330590|NCT00407420|University of Bristol|Julian Hamilton-Shield|00441173420183|j.p.h.shield@bristol.ac.uk|
22330591|NCT02382276|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22330592|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu|
22330593|NCT04840849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22330594|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu|
22330595|NCT03714256|Permobil|Vice President of Research and Innovation|+46703836763|karin.leire@permobil.com|
22330596|NCT03258762|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330597|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|sebastian.mirkin@therapeuticsmd.com|1952
22330598|NCT05439876|School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan|Shao-Yu Tsai|(02)23123456#288904|stsai@ntu.edu.tw|
22330599|NCT02545049|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22330600|NCT01586962|Novartis|Clinical Project Leader|+41223633111||
22330601|NCT04191096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330602|NCT05954065|Erchonia|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
22330603|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22330604|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330605|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
22330606|NCT01662752|St Mark's Hospital|Professor Robin Kennedy|+44(0)2082354046|robin.kennedy@nhs.net|
22330607|NCT02306148|University of Sao Paulo - School of Medicine|Dr Isabel Sacco|0055 11 996431511|icnsacco@usp.br|
22330608|NCT04397757|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
22330609|NCT01901809|Johns Hopkins University School of Medicine|Kavita Sharma, MD|410-955-7670|ksharma8@jhmi.edu|
22330610|NCT02776904|University of Arkansas for Medical Sciences|Dr. Charlotte Yates|501-450-5542|cyates@uca.edu|
22330611|NCT04657003|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22330612|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org|
22330613|NCT05158244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330614|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com|
22330615|NCT02408016|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22330616|NCT00775138|Insmed|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
22330617|NCT02009501|Mount Sinai St. Luke's|Dr. John C. Lantis II||JLantis@chpnet.org|
22330618|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
22330619|NCT00712712|Institute Bergonie|Dr. Jean Palussière|05 56 33 37 50|j.palussiere@bordeaux.unicancer.fr|
22330620|NCT02723019|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
22330621|NCT03597789|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-5082|djjones@email.unc.edu|
22330622|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711|Ismene.petrakis@yale.edu|2244
22330623|NCT02718625|Smith & Nephew, Inc.|Natasha Schappell, Clinical Study Manager|817-302-3949|Natasha.Schappell@smith-nephew.com|
22330624|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22272060|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu|
22272061|NCT03041467|Medtronic|Phally Roffe, Clinical Study Manager|763.526.0350|phally.s.roffe@medtronic.com|
22272062|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22272063|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net|
22272064|NCT04757805|Nationwide Children's Hospital|Giorgio Veneziano, MD|614-722-4200|Giorgio.Veneziano@nationwidechildrens.org|
22272065|NCT02469168|Walter Reed National Military Medical Center|Jody Richardson, MSN, RN|301-295-7798|jody.richardson.ctr@usuhs.edu|
22272066|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22272067|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22272068|NCT01533688|UOklahoma|Dr. Mohammad Madhoun|405-456-326-|mohammad-madhoun@ouhsc.edu|
22272069|NCT04046263|"University of Colorado Denver | Anschutz"|Jessica Kendrick, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22272070|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272071|NCT02686814|Medtronic|Jessica Halverson, Clinical Research Director|(800) 633-8766|rs.perigonjapantrial@medtronic.com|
22272072|NCT02065518|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22272073|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
22272074|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
22272075|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu|
22272076|NCT02368886|Mayo Clinic Arizona|Tanios Bekaii-Saab, M.D.|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
22272077|NCT04767529|Akero Therapeutics, Inc.|Kitty Yale|(650) 487-6488|harmonystudies@akerotx.com|
22272078|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu|
22272079|NCT00004088|City of Hope|Brenda Williams, Senior Director, Clinical Trials Office|626-218-2702|bwilliams@coh.org|
22272080|NCT02636699|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
22272081|NCT03624569|The Ohio State University|Richard Bruno, Principal Investigator|6142925522|bruno.27@osu.edu|
22272082|NCT02826577|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22272083|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu|
22272084|NCT04103034|Band Therapeutics|Tia DeFeo-Fraulini|7819186561|tia.defeo-fraulini@bandtherapeutics.com|
22272085|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com|
22330625|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22330626|NCT04050540|University of Washington, Department of Global Health|Jenell Stewart|206 520 3866|jenells@uw.edu|
22330627|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com|
22330628|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300||
22330629|NCT00952588|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22330630|NCT03442933|Universidad Europea de Madrid|Gerson Garrosa Martín|+34 663 294 774|g.garrosa@gmail.com|0034
22272086|NCT03004924|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22330631|NCT01469637|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22272087|NCT02867202|the 1st affiliated hospital of Wenzhou Medical University.|the 1st affiliated hospital of Wenzhou Medical University.|0886-0577-88069525|zfy983023@hotmail.com|
22272088|NCT03924505|RTI International|Dr. Barrot H Lambdin|628-200-6707|blambdin@rti.org|
22272089|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com|
22272090|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu|
22272091|NCT02555930|Imperial College London|Dr Harriet Kemp|+44 20 3315 8816|h.kemp@imperial.ac.uk|
22330632|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200|hanitb@syneron.com|581
22330633|NCT03341728|University of North Caroilina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
22330634|NCT03531918|Fred Hutchinson Cancer Center|Roland Walter, Member of Clinical Research Division|206-667-3599|rwalter@fredhutch.org|
22330635|NCT04716010|University of North Carolina at Chapel Hill|Lindsey Smith Taillie, PhD|(919) 445-8313|taillie@unc.edu|
22330636|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22301145|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
22330637|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org|
22330638|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
22330639|NCT03116841|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22330640|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330641|NCT03267576|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22272092|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net|
22301146|NCT01610427|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301147|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com|
22272093|NCT03611101|Exalenz Bioscience|Clinical Trial Manager|+972-8-9737513|avrahamh@exalenz.com|
22301148|NCT05443659|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
22301149|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr|
22301150|NCT03255824|Montefiore Medical Center|Dr. Patrick Nolan|718-405-8195|pnolan@montefiore.org|
22272094|NCT03743402|University of Washington|Dr. Mark Sullivan|2066853184|sullimar@uw.edu|
22301151|NCT03247790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301152|NCT01866943|Hospital for Special Surgery|Research Fellow|917-843-6655|berlinerz@hss.edu|
22301153|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com|
22301154|NCT03432364|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
22301155|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org|
22272095|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org|
22272096|NCT03411902|Wake Forest School of Medicine|Kristen Beavers|336-758-5855|beaverkm@wfu.edu|
22272097|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
22272098|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com|
22272099|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300||
22272100|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu|
22272101|NCT04964986|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
22272102|NCT00803205|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22283543|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com|
22301156|NCT03040713|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22330642|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov|
22330643|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu|
22330644|NCT02313506|Arthritis Research Canada|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
22330645|NCT02168816|Loyola University Medical Center|Michael Pinzur, M.D.|708-216-4993|mpinzu1@lumc.edu|
22330646|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22330647|NCT02746991|EyePoint Pharmaceutical|Flavio Leonin Jr., MD|617-972-6024|fleonin@eyepointpharma.com|
22330648|NCT01987609|UCSD Medicine|Director of Clinical Trials Unit|858-657-8322|dermstudies@Ucsd.edu|
22330649|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22330650|NCT02709889|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22330651|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu|
22330652|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330653|NCT03860181|Medical University of South Carolina|Josef Eichinger, MD|843-876-0111|eichinge@musc.edu|
22330654|NCT03452397|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22330655|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu|
22330656|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com|
22330657|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk|
22330658|NCT02691468|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
22330659|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu|
22330660|NCT01190020|University of Iowa|Robert Summers, MD|319-356-2130|robert-summers@uiowa.edu|
22330661|NCT06853210|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22330662|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22330663|NCT02422186|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330664|NCT05281094|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22330665|NCT04960397|University of Maryland|Dr. James D. Campbell|410-706-5328|jcampbel@som.umaryland.edu|
22330666|NCT03285061|Brigham & Women's Hospital|Dr. Christopher Chiodo|617-983-7363|cchiodo@bwh.harvard.edu|
22330667|NCT02683668|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
22330668|NCT04223778|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22330669|NCT05325333|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
22330670|NCT03893630|University of Kentucky|Dr. John M. O'Brien|8592575158|john.obrien2@uky.edu|
22330671|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22330672|NCT02308839|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22330673|NCT01265719|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330674|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22330675|NCT02442765|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22330676|NCT02554721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22330677|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22330678|NCT04607291|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22330679|NCT01693562|MedImmune, LLC|Ashok Gupta|+13013981287|information.center@astrazeneca.com|
22330680|NCT05466240|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22330681|NCT02759939|Dartmouth College|Rachel Thompson|6036530860|rachel.thompson@dartmouth.edu|
22330682|NCT04735432|argenx BV|Regulatory Manager|+32 9 310 34 00|regulatory@argenx.com|
22330683|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22330684|NCT01273207|National Heart Lung and Blood Institute|Dr Richard Childs|+301-451-7128|childsr@nhlbi.nih.gov|
22330685|NCT03818399|Virginia Commonwealth University|Roy Sabo, PhD|804-828-3047|roy.sabo@vcuhealth.org|
22330686|NCT04880642|Vicore Pharma|CEO Carl-Johan Dalsgaard|+46 (0) 317880560|info@vicorepharma.com|
22330687|NCT02390323|Hospital for Special Surgery|Semih Gungor|212-606-1206|gungors@hss.edu|
22330688|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330689|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
22330690|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com|
22330691|NCT02807376|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22330692|NCT02481986|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
22330693|NCT03228836|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22330694|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
22330695|NCT01619176|CNR IAC|DR. Christine Nardini|+393386947833|christine.nardini.rsrc@gmail.com|
22330696|NCT05306964|University of Pittsburgh|Raghavan Murugan, MD, MS, FRCP, Principal Investigator|412-647-8499|muruganr@ccm.upmc.edu|
22272103|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com|
22272104|NCT02648477|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22272105|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797|gganieva@vrmny.com|6929
22272106|NCT05604794|University of Toronto|Dr Chris Lo|65 6709 3003|chris.lo@utoronto.ca|203
22272107|NCT02735096|Innervo Technology|Dr. Hui Tang|5732896776|htang@innervotech.com|
22330697|NCT03574987|University of Bath|Professor Javier Gonzalez|0122538|j.t.gonzalez@bath.ac.uk|5518
22330698|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22330699|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22330700|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org|
22283544|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
22283545|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee|
22330701|NCT03018340|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22330702|NCT04652102|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22330703|NCT00706264|Hospital Vall d'Hebron|Maria M Goya|934893085|maria.goya@vhir.org|4652
22283546|NCT03532932|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22283547|NCT05268744|UCSF|Dr. Robert Hendren|(415) 476-7500|robert.hendren@ucsf.edu|
22283548|NCT02699450|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22283549|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
22283550|NCT03689712|Galera Therapeutics|Megan Holm|484-615-2036|mholm@galeratx.com|
22283551|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch|
22330704|NCT02192190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330705|NCT01756833|University of Maryland School of Medicine|Michael L. Terrin, MDCM, MPH, Contact Principal Investigator|410-706-6139|mterrin@som.umaryland.edu|
22330706|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330707|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com|
22330708|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330709|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com|
22330710|NCT02152540|DVBIC, VA Palo Alto/Stanford School of Medicine|Dr. Maheen M. Adamson|6502136307|madamson@stanford.edu|
22330711|NCT01846208|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
22330712|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330713|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22330714|NCT01875874|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
22330715|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu|
22330716|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu|
22330717|NCT02871570|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330718|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22330719|NCT02520141|M D Anderson Cancer Center|Milind Javle|(713) 792-5434|mjavle@mdanderson.org|
22330720|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
22330721|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22330722|NCT00945594|University of Oklahoma Health Sciences Center|Lieschen Quiroz, MD|405-271-8787|lieschen-quiroz@ouhsc.edu|
22330723|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu|
22330724|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22330725|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org|
22330726|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com|
22330727|NCT01436357|University of New Mexico and Johns Hopkins University|Kimberly Page, Ph.D., M.P.H. and Andrea Cox, M.D., Ph.D.|505-272-2520, 410-502-2715|pagek@salud.unm.edu, acox@jhmi.edu|
22330728|NCT03300557|University of Minnesota/Masonic Cancer Center|Britt Erickson|612-626-6283|bkeric@umn.edu|
22330729|NCT01394211|University of Arizona Cancer Center|Program Coordinator|5206260301|aselegue@email.arizona.edu|
22330730|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu|
22330731|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330732|NCT04335929|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
22330733|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu|
22330734|NCT02491463|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330735|NCT01491802|Queen's University|Kathy Webb|613-549-6666|kw2@queensu.ca|4950
22330736|NCT03993314|University of Alabama at Birmingham|Dr. Mark Powell|205-934-6007|mfpowell@uabmc.edu|
22330737|NCT01864746|German Breast Group (GBG) Forschungs GmbH|Prof. Dr. Sibylle Loibl|+49 6102 7480|penelope@gbg.de|0
22330738|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330739|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
22330740|NCT03890731|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22330741|NCT01749930|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
22330742|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330743|NCT03502265|University of Southern California|Beth Smith|323-361-4670|beth.smith@usc.edu|
22330744|NCT03347279|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22330745|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
22283552|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363|heiko.pohl@dartmouth.edu|5595
22301157|NCT01490502|The Johns Hopkins University School of Medicine|Sandra D. Cassard, ScD|443-287-4353|scassar1@jhmi.edu|
22301158|NCT04186780|Universidade de Sorocaba|Dr. Luciane Cruz Lopes|+ 55 15 2101-7104|luciane.lopes@prof.uniso.br|
22301159|NCT03509974|Cochlear|George Cire|+13038855440|gcire@cochlear.com|
22301160|NCT02258139|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
22301161|NCT04465357|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22301162|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262|Daniel.Storzbach@va.gov|56497
22272108|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22301163|NCT02606903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301164|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov|
22301165|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22301166|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu|
22301167|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22301168|NCT03039595|Oxford Univeristy Hospitals NHS Foundation Trust|Dr Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
22301169|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22301170|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
22301171|NCT04385368|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22301172|NCT02123108|University of California Los Angeles|Dr. Fady M. Kaldas|310-825-8138|FKaldas@mednet.ucla.edu|
22301173|NCT01982240|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22301174|NCT02219048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301175|NCT04721925|University of Michigan|Erin Bonar|7347647936|erinbona@med.umich.edu|
22301176|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org|
22301177|NCT01274182|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
22301178|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22301179|NCT01146496|University of Edinburgh|Michael Eddleston|01312426776|m.eddleston@ed.ac.uk|
22301180|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org|
22272109|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22272110|NCT01080391|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22272111|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com|
22283553|NCT01221194|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22283554|NCT03119389|University of Maryland|Kerri Thom|410-706-6124|kthom@som.umaryland.edu|
22283555|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov|
22283556|NCT02674425|PolyPhotonix|Dr|00441740625|duncan@polyphotonix.com|557
22283557|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
22283558|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034||
22283559|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com|
22283560|NCT02956850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22283561|NCT01920152|University of Colorado, Denver|Omer Mei-Dan, MD|3033159900|omer.meidan@cuanschutz.edu|
22283562|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov|
22283563|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590||
22283564|NCT03412604|Massachusetts General Hospital|Emiliano Santarnecchi|617-667-0326|esantarnecchi@mgh.harvard.edu|
22283565|NCT02634606|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|x61987
22283566|NCT05810714|The Ohio State University Comprehensive Cancer Center|Dr. Mira Katz|614-293-6603|Mira.katz@osumc.edu|
22283567|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu|
22283568|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org|
22283569|NCT02469714|Illinois Institute of Technology|Patrick Corrigan|(312)567-6751|corrigan@iit.edu|
22283570|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283571|NCT01287195|Brigham and Women's Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org|
22283572|NCT03562793|Richard L. Roudebush VA Medical Center|Dr. Marianne Matthias|317-988-4514|Marianne.Matthias@va.gov|
22283573|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
22283574|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
22283575|NCT00283868|University of California, San Diego|Brett C. Meyer, MD|619-543-7760|bcmeyer@ucsd.edu|
22283576|NCT01515475|Jaeb Center for Health Research|Ray Kraker M.S.P.H.|813-975-8690|rkraker@jaeb.org|
22283577|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272112|NCT01712308|The University of Texas MD Anderson Cancer|Prithviraj Bose MD/Associate Professor|713-792-7747|PBose@mdanderson.org|
22272113|NCT02083653|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22272114|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22272115|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com|
22283578|NCT03558074|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22283579|NCT01996592|Wake Forest School of Medicine|Jessica L. Booth, MD|336-718-8278|jbooth@wakehealth.edu|
22301181|NCT04040751|Emory University|Sarah Blanton, PT, DPT|404-712-2222|sblanto@emory.edu|
22283580|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu|
22301182|NCT02862457|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283581|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22283582|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu|
22283583|NCT02573246|Duke University Health System|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
22283584|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22283585|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com|
22283586|NCT02256267|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283587|NCT01685983|Janssen R&D BE|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22283588|NCT03149003|Sumitomo Pharma Oncology|Sheila Dhaskali|617-674-6800|Sheila.dhaskali@oncology.sumitomo-pharma.com|
22283589|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu|
22289077|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22289078|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com|
22289079|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330746|NCT03442595|MedStar Health|Dr Michelle F Magee, Director MedStar Diabetes Institute|202-877-2383|michelle.f.magee@medstar.net|
22330747|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de|
22330748|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518||
22330749|NCT01836549|University of Tennessee Health Science Center|Dr. Mehmet Kocak|9014482937|mkocak1@uthsc.edu|901
22330750|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu|
22330751|NCT02364999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330752|NCT00550615|University of Nebraska Medical Center|Julie M Vose|402-559-348|jmvose@unmc.edu|
22330753|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22330754|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330755|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22330756|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com|
22330757|NCT02815982|University of South Florida|Dr. Marilyn Stern|8139740966|mstern1@usf.edu|
22330758|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu|
22330759|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu|
22330760|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330761|NCT03514394|University of Washington|Morgan Johnson|17154161493|mjohn23@uw.edu|
22330762|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22330763|NCT02584660|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330764|NCT00461552|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
22330765|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org|
22330766|NCT00374452|VA Palo Alto Health Care System|Mary K. Goldstein, MD|650-493-5000|mary.goldstein@va.gov|1,1,62105
22330767|NCT02877134|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22330768|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300||
22330769|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22330770|NCT04623255|University College London|Prof Marie Scully|+ 44 (0)20 3447 9884|m.scully@ucl.ac.uk|
22330771|NCT04922710|AdventHealth Research Institute|Kirk Erickson, Director of Translational Neuroscience|412-576-3724|kirk.erickson@adventhealth.com|
22330772|NCT02031627|Tactile Medical|Susy Peters, Clinical Trial Manager|612-540-7175|speters@tactilemedical.com|
22330773|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330774|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu|
22330775|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330776|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch|
22330777|NCT02282930|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
22330778|NCT06022224|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22330779|NCT01855867|The Fenway Institute|Dr. Kenneth Mayer, Medical Research Director|6179276374|kmayer@fenwayhealth.org|
22330780|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22330781|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org|
22330782|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22330783|NCT01601873|The University of Texas Health Science Center at Houston|Kristofer Charlton-Ouw, MD|(713) 486-5117|Kristofer.CharltonOuw@uth.tmc.edu|
22330784|NCT02096471|The Univ of Alabama at Birmingham|Gary Cutter, PhD|205.975-5048|cutterg@uab.edu|
22330785|NCT03196973|Laboratorios Salvat, S.A.|Medical Director|933946400|ejimenez@svt.com|
22330786|NCT03344562|University of Texas Southwestern Medical Center|Dr. Amy Mathews - ASSISTANT PROFESSOR|214/645-1719|Amy.Mathews@UTSouthwestern.edu|
22330787|NCT02736474|Shanghai Mental Health Center|Chief Physician Dr Du. Jiang Du|86-21-64387250|dujiangdou@163.com|
22330788|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935|lydiatmf@yahoo.com.br|81
22330789|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000|waynicegarcia@gmail.com|2211
22289080|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22289081|NCT02963506|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22301183|NCT03364751|Philip Morris Products S.A.|Christelle Haziza, Director Clinical Science & Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22330790|NCT02590406|Institut universitaire Cardiologie et Pneumologie de Québec|Dr Jean S Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
22330791|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22272116|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com|
22330792|NCT01084096|NICHDGlobal|Dr. Elizabeth McClure, Data Coordinating Center PI|919-316-3773|mcclure@rti.org|
22330793|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22330794|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu|
22330795|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com|
22330796|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22330797|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com|
22330798|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org|
22330799|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
22330800|NCT03758612|TB Alliance|Majda Benhayoun|347-601-8225|majda.benhayoun@tballiance.org|
22330801|NCT02500901|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22330802|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
22301184|NCT02413580|Grifols Therapeutics LLC|Rhonda Griffin|9193166693|Rhonda.Griffin@grifols.com|
22283590|NCT01266590|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283591|NCT03350906|Mayo Clinic|Ian R. Lanza, Ph.D.|507-255-8147|Lanza.Ian@mayo.edu|
22283592|NCT01806064|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|233
22283593|NCT01733771|Bnai Zion Medical Center|Dr. Samuel Attias|+972524707304|samuel.attias@b-zion.org.il|
22283594|NCT02804750|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22283595|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu|
22283596|NCT04144959|Penumbra, Inc.|Erin Archard, Senior Director of Clinical Research, Vascular|+1 802 377 9715|earchard@penumbrainc.com|
22283597|NCT05501795|Bismarck Lasik|Dr Stephen Wexler|701-222-2020|drwexler@bismarcklasik.com|
22283598|NCT03133221|University of Maryland Greenebaum Comprehensive Cancer Center|Jean Yared, MD|410-328-1230|jyared@umm.edu|
22283599|NCT02337634|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
22283600|NCT03493607|Icahn School of Medicine at Mount Sinai|Christina Layton|212-241-6231|christina.layton@mssm.edu|
22283601|NCT02428205|University of Missouri|Dr David Beversdorf|5738826081|beversdorfd@health.missouri.edu|
22283602|NCT02888743|Department of Data Science, Dana-Farber Cancer Institute|Anita Giobbie-Hurder, MS (Study biostatistician)|617-632-2193|agiohur@ds.dfci.harvard.edu|
22283603|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com|
22283604|NCT05138549|Prisma Health|Harley T. Davis|8032969533|pamela.davis2@prismahealth.org|
22283605|NCT03344172|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22283606|NCT03106415|Mayo Clinic|Saranya Chumsri MD|904-953-2000|Chumsri.Saranya@mayo.edu|
22283607|NCT01804582|University of Maryland, Baltimore|Gloria M. Reeves, M.D.|410-328-3522|greeves@psych.umaryland.edu|
22301185|NCT02342886|TB Alliance|Leandra Lombard, Director, Clinical Operations|+27 87 700 3900|Leandra.Lombard@tballiance.org|
22283608|NCT04495868|Emory University|Brian Bobzien, MD|404-616-4226|brian.patrick.bobzien@emory.edu|
22283609|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
22283610|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22330803|NCT04495166|Medical School of the University of Sao Paulo|Daniel Fatori|5511 96162-6183|daniel.fatori@gmail.com|
22330804|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22330805|NCT04235959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22330806|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22330807|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu|
22330808|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22330809|NCT02911324|Columbia University/New York State Psychiatric Institute|Reilly Kayser, MD|646-774-8118|reilly.kayser@nyspi.columbia.edu|
22330810|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330811|NCT02870348|Instituto Grifols SA|Sandra Camprubi|+34935710049|sandra.camprubi@grifols.com|
22330812|NCT02381795|Clinvest Research|Clinical Data Manager|417-883-7889|jsly@clinvest.com|
22330813|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov|
22330814|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu|
22330815|NCT01488994|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22330816|NCT02908841|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
22330817|NCT03798366|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22330818|NCT01117428|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22330819|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22330820|NCT02195531|Philips Research|Senior Scientist|+31628041122|Joyca.lacroix@philips.com|
22330821|NCT04912297|Finnish Institute for Health and Welfare|Dr. Merit Melin, Research manager||merit.melin@thl.fi|
22330822|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330823|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
22330824|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx|
22330825|NCT01970540|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
22330826|NCT02736149|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
22330827|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330828|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22330829|NCT00579527|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
22330830|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu|
22330831|NCT03727802|Toray Industries, Inc|Clinical Trials Information Desk|+81-3-3245-8576|clinical-trials.toray.mb@mail.toray|
22330832|NCT02177942|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330833|NCT03062605|UCLA|Dr. Vladimir W. Spolsky|310-794-0700|vspolsky@dentistry.ucla.edu|
22330834|NCT04180475|University of Virginia|John Stankovic|434-982-2275|jas9f@virginia.edu|
22330835|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300||
22330836|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22330837|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu|
22330838|NCT01694966|Cosmo Technologies Ltd|R&D Manager|111111111|rjones@cosmopharma.com|11111
22330839|NCT02246309|Center for Human Reproduction|Dr. David Barad, Director of Clinical Research|2129944400|dbarad@theCHR.com|212
22330840|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu|
22330841|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com|
22330842|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411|seidel@rand.org|7365
22330843|NCT01555541|University of California, San Francisco|Charalambos Andreadis, MD, MSCE, Associate Professor of Clinical Medicine|877-827-3222|cancertrials@ucsf.edu|
22330844|NCT01610414|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330845|NCT03726749|MGH|Dr Sebastian Unizony|617-726-7938|sunizony@mgh.harvard.edu|
22283611|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu|
22283612|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se|
22283613|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22283614|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu|
22283615|NCT05432167|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22283616|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it|
22283617|NCT01656629|Johns Hopkins University|Dr. Suzanne Jan De Beur|410-550-0100|sjandebe@jhmi.edu|
22283618|NCT03035773|Johns Hopkins School of Public Health/SKCCC|Dr. Katherine C. Smith|443.927.3350|ksmit103@jhu.edu|
22283619|NCT02758301|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|6123003066|lindsay.k.werder@medtronic.com|
22283620|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780||
22330846|NCT00472043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22330847|NCT04957745|Schepens Eye Research Institute of Massachusetts Eye and Ear|Dr. Jaehyun Jung|6179122525|jaehyun_jung@meei.harvard.edu|
22330848|NCT04009824|University of Maryland School of Medicine - Center for Vaccine Development|Dr. Matthew Laurens|410-706-5328|mlaurens@som.umaryland.edu|
22272117|NCT03423147|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
22272118|NCT01889355|AgaMatrix, Inc|Senior Clinical Research Technician|603-328-6035|krocha@agamatrix.com|
22272119|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22272120|NCT03611582|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22272121|NCT04438499|Laborie Medical Technologies|Adele Campbell|16032558251|ACampbell@laborie.com|
22272122|NCT04284930|Cleveland Clinic|Risal Djohan|216 312-6146|djohanr@ccf.org|
22272123|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu|
22272124|NCT04494425|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22272125|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu|
22272126|NCT01270321|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
22272127|NCT03151083|VA Connecticut Healthcare System|Dr. Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
22272128|NCT04003623|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22272129|NCT02918097|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|5551999185180|afbslima@gmail.com.br|
22272130|NCT04640038|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
22272131|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22272132|NCT01190189|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272133|NCT03525808|Boston Scientific|Ornela Gjata|(508)-683-4155|Ornela.Gjata@bsci.com|
22272134|NCT05206734|Royal Hospital for Children and Young People, Edinburgh|Richard K Russell|0131 312 0431|richard.russell@nhs.scot|
22272135|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272136|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu|
22272137|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22272138|NCT03214679|University School of Medicine, New York|Ben Eckhardt|212-562-1000|benjamin.eckhardt@nyumc.org|
22272139|NCT01601067|VA San Diego|Sonya Norman, PhD|858-552-8585|sonya.norman@va.gov|
22272140|NCT04513899|University of California, Irvine, Sue & Bill Gross School of Nursing|Dr Adeline Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
22272141|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101|e_encourage@yahoo.com|2315
22272142|NCT03083353|The University of Texas at Austin|Sara Reedy|512-232-4319|Sarah.Fella@austin.utexas.edu|
22272143|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22272144|NCT02412878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22272145|NCT04676152|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22272146|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu|
22272147|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com|
22272148|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272149|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22272150|NCT01908582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272151|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272152|NCT01066663|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|l 617-632-4894|Jennifer_Brown@dfci.harvard.edu|
22272153|NCT02232061|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22272154|NCT03297021|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@mountsinai.org|
22272155|NCT02784288|University of Michigan|Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
22272156|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com|
22272157|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
22272158|NCT02339974|Henry Ford Health|Dr. Brian O'Neill|313-970-6483|boneil3@hfhs.org|
22272159|NCT04278924|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22272160|NCT04847232|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22272161|NCT02476916|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
22301186|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
22301187|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300||
22301188|NCT03015402|University of Pittsburgh|Dr. Michael Risbano, Director of Advanced Cardiopulmonary Exercise Testing Program|412-692-2210|risbanomg@upmc.edu|
22301189|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
22301190|NCT03138096|Radboud University Medical Center|Dr. M.B.B. McCall|+31642166480|Matthew.McCall@radboudumc.nl|
22301191|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22330849|NCT03147495|PLA Institute of Orthopaedics, Xijing Hospital, Fourth Military Medical University, No.17, Changle West Road, Xincheng District, Xi'an, Shanxi Province, China|Dr. Cheng Huang|0086-57427754027|jfj113hc@163.com, jfj906hc@163.com|
22330850|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org|
22330851|NCT02608892|Children's Hospital of Eastern Ontario|Dr Denise Harrison|613-737-7600|dharrison@cheo.on.ca|4140
22330852|NCT03032523|Yale University|Laura Nally, MD, Instructor in Pediatrici Endocrinology|9728324734|laura.nally@yale.edu|
22330853|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
22330854|NCT05375838|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22330855|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22330856|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22330857|NCT04396106|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22330858|NCT00928499|University of California, Irvine|Karen Noblett, MD|714-456-8564|knoblett@uci.edu|
22330859|NCT02036476|Dana-Farber Cancer Institute|Dr. Robert Haddad|617.632.3090|ROBERT_HADDAD@DFCI.HARVARD.EDU|
22330860|NCT02698176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22330861|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu|
22330862|NCT02985684|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22330863|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800|blawrence@angiochem.com|205
22330864|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com|
22330865|NCT01967134|IAVI|Dr. Dereck Tait|27214424991|dtait@iavi.org|
22301192|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22330866|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22330867|NCT03479203|University of Pennsylvania|Felix W.Wehrli, PhD|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
22330868|NCT02679222|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22330869|NCT03419741|Medical University of SouthCarolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
22330870|NCT03428230|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22330871|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org|
22330872|NCT02719028|Golden Biotechnology Corp|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
22330873|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
22330874|NCT00303719|Masonic Cancer Center, University of Minnesota|Erica Warlick, MD|612-625-8942|ewarlick@umn.edu|
22330875|NCT04853368|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22330876|NCT03633461|Oyster Point Pharma, Inc.|Jeffery Nau|609-382-9035|jnau@oysterpointrx.com|
22330877|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22330878|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222|mark.eisenberg@mcgill.ca|3564
22330879|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272|lsabin@bu.edu|617
22330880|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu|
22330881|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu|
22330882|NCT02967562|King's College London|Professor Anne Greenough|02032999000|anne.greenough@kcl.ac.uk|
22330883|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22330884|NCT02404792|University of Colorado|Kristine Erlandson (PI)|303-724-4941|kristine.erlandson@ucdenver.edu|
22330885|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org|
22330886|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu|
22330887|NCT04586127|Wake Forest University School of Medicine|Dr. Emily Haines|(336) 716-5170|ehaines@wakehealth.edu|
22330888|NCT00672139|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
22330889|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu|
22330890|NCT02176226|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22330891|NCT03894501|Rutgers Robert Wood Johnson Medical School|Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
22330892|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu|
22330893|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012||
22330894|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22330895|NCT02465957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22330896|NCT01520727|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22272162|NCT06010732|Indiana University School of Dentistry|Domenick T. Zero|3179877507|dzero@iu.edu|
22330897|NCT01245972|ucsdmed|S. Brian Jiang|8586571663|s2jiang@ucsd.edu|
22301193|NCT02216773|Imperial College London|Professor Long Jiao|+44 2033133937|l.jiao@imperial.ac.uk|
22301194|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
22301195|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
22301196|NCT04540874|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301197|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu|
22301198|NCT02510144|University of Maryland Baltimore|Dr. Mohit Gilotra|(301) 502-4102|mgilotra@som.umaryland.edu|
22301199|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu|
22301200|NCT01522417|Medicure|Kyle Brown|204-594-3411|kbrown@medicure.com|
22330898|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22330899|NCT04005885|CooperVision. Inc|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
22330900|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22330901|NCT01227252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330902|NCT04542525|Alcon Research, LLC|Director of Clinical Projects, Surgical|+1-817-909-6199|jessie.hull@alcon.com|
22330903|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com|
22330904|NCT03227692|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22330905|NCT02447952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330906|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22330907|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com|
22330908|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com|
22330909|NCT02405091|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22330910|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com|
22330911|NCT01365195|Cedars Sinai Medical Center|Research project Advisor|310-423-1682|Ofelia.Elvir-Lazo@cshs.org|
22330912|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330913|NCT02237898|Yale School of Medicine|Dr. Megan Smith|(203) 764-8655|megan.smith@yale.edu|
22330914|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu|
22330915|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org|
22330916|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22330917|NCT01646346|Yale University|Dr. Suzanne Evans, MD, MPH|(203) 785-5175|suzanne.evans@yale.edu|
22330918|NCT02802735|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22330919|NCT01166386|Carolinas Healthcare System, Carolinas Medical Center|Dr. Janet Niemeier|704 355 2046|janet.niemeier@carolinashealthcare.org|
22330920|NCT01564485|University of California, Irvine|Ashwini Erande, Clinical Coordinator|714 456 7025|aerande@uci.edu|
22330921|NCT03922711|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22330922|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343||
22330923|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22330924|NCT02390362|The Research Institute at Nationwide Children's Hospital|William E. Smoyer, MD.|6147222683|william.smoyer@nationwidechildrens.org|
22330925|NCT02178592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22330926|NCT03516227|National Defense Medical Center, Taiwan|Dr. Yu-Ju Chen|886-287923100|judychen37@gmail.com|18762
22330927|NCT01628718|Massachusetts Veterans Epidemiological Research and Information Center|Brett T. Litz, PhD|617-584-9314|litzb@bu.edu|
22330928|NCT02067104|University of Arizona|Amy Selegue|520-626-0301|aselegue@email.arizona.edu|
22330929|NCT02610231|Kyowa Kirin|Development Devision - Project Management Department|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22330930|NCT01901679|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
22330931|NCT01279954|Oregon Health & Science University|Eric Suler, MD|503-494-5023|suhlere@ohsu.edu|
22330932|NCT02140762|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22330933|NCT02067806|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22330934|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22330935|NCT01385098|Houston Methodist Hosptial|Sherman Vadim|713-441-5514|vsherman@tmhs.org|
22330936|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu|
22330937|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585|samuel.ho2@va.gov|2631
22330938|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu|
22330939|NCT03999203|Queen's University Belfast|Professor Liam Heaney|02890976376|l.heaney@qub.ac.uk|
22330940|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu|
22330941|NCT00784225|SWOG Statistical Center|SELECT/S0000B Statistician|2066674623|adarke@fredhutch.org|
22330942|NCT02551874|AstraZeneca|Global Clinical Lead|+46 (0)31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22330943|NCT03500302|Johns Hopkins University|Allison Hays|443-287-6827|ahays2@jhmi.edu|
22330944|NCT04067310|Instituto Nacional do Câncer|Director of Clinical Trials|+552132076549|cecilia.silva@inca.gov.br|
22330945|NCT01041027|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8086|dykuo@montefiore.org|
22301201|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
22301202|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com|
22330946|NCT02493712|Holy Stone Healthcare Co., Ltd|YUCHIH, Chen|886287975966|ivychen@hshc.com.tw|272
22330947|NCT02528643|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22283621|NCT02228343|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
22283622|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu|
22283623|NCT02916407|Inje University, Haeundae Paik hospital|Dr Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
22283624|NCT03094286|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22283625|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
22283626|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22283627|NCT00973102|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
22283628|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com|
22283629|NCT02360293|VA ORD|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
22330948|NCT02058940|The University of North Carolina at Chapel Hill|Nicole R. Pinelli|919-962-1641|nickipinelli@unc.edu|
22330949|NCT04144140|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22330950|NCT02146274|Duke University School of Medicine|Vice Dean of Clinical Research|919-684-4979|awindham@duke.edu|
22283630|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22283631|NCT03099148|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22283632|NCT01269385|Mayo Clinic|Stephen M. Ansell MD||Ansell.Stephen@mayo.edu|
22330951|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
22330952|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22330953|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu|
22330954|NCT03384316|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|straussjy@nci.nih.gov|
22330955|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com|
22330956|NCT03891199|West Virginia University|Brock A. Lindsey, MD|304-293-1317|blindsey@hsc.wvu.edu|
22330957|NCT01539720|Planned Parenthood of the St. Louis Region and Southwest Missouri|Director of Research|314-531-7526|research@ppslr.org|384
22330958|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22330959|NCT03287960|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22330960|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22330961|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22330962|NCT02990325|Abivax|Sophie Biguenet|+33 (0) 1 53 83 08 41|sophie.biguenet@abivax.com|
22330963|NCT02176031|Dana-Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|CSCUTLER@PARTNERS.ORG|
22330964|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
22330965|NCT02065479|University of Florida|Dr. Dominick Angiolillo|904-244-3378|dominic.angiolillo@jax.ufl.edu|
22330966|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com|
22330967|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22330968|NCT02607865|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22330969|NCT01783223|Hennepin Healthcare Department of Emergency Medicine|Director of Research|6128733000|james.miner@hmced.org|
22330970|NCT03427528|Northwestern University, CCH|Dr. Darius Tandon|+1 312 503 3398|dtandon@northwestern.edu|
22330971|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com|
22330972|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22330973|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr|
22283633|NCT02945553|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
22301203|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu|
22301204|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
22301205|NCT01648270|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22301206|NCT04969263|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|extension
22330974|NCT03525613|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22330975|NCT03480360|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|(603) 650-4628|Kenneth.R.Meehan@hitchcock.org|
22330976|NCT02365961|Hawkins Foundation|Hawkins Foundation Research Coordinator|864 454 7458|info@hawkinsfoundation.com|
22330977|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org|
22330978|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22330979|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
22330980|NCT03117309|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22330981|NCT02120469|City of Hope|Dr. Yuan Yuan|626-359-8111|yuyuan@coh.org|
22330982|NCT02583711|Imperial College London|Ms Aliza Abeles|07834987667|aliza.abeles@gmail.com|
22330983|NCT01402375|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-6626|achang3@yahoo.com|
22330984|NCT02176005|Da Volterra|Dr. Annie Ducher, Chief Medical Officer|+33 1 58 39 32 20|annie.ducher@davolterra.com|
22330985|NCT01142791|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22330986|NCT05592145|Atrium Health Wake Forest Baptist|Renea Jennings RN,BSN,CCRP|336-716-4417|rjenning@wakehealth.edu|
22330987|NCT02975206|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
22330988|NCT04733664|Richard L. Roudebush VA Medical Center|Dr. Arjun D. Sinha|---|adsinha@iu.edu|
22330989|NCT01981096|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|susmita.kashikar-zuck@cchmc.org|
22330990|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac|
22330991|NCT04129242|The Medical University of SC|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
22330992|NCT03675685|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22330993|NCT02582151|Lawson Health Research|Blayne Welk|5196466000|lawson@lawsonresearch.ca|
22330994|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232||
22330995|NCT01431794|Johns Hopkins University School of Medicine|Dr. Ana De Jesus-Acosta|443-287-0411|adejesu1@jhmi.edu|
22330996|NCT01899729|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22330997|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net|
22301207|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com|
22330998|NCT01066637|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22330999|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22331000|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22331001|NCT03756285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22331002|NCT06334055|Masimo Corporation|Ahmed Alghazi, M.B.Ch.B|949-297-7000|studies@masimo.com|
22331003|NCT04728815|Duke University|Scott Compton, Ph.D.|919-668-0063|compt004@duke.edu|
22331004|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22331005|NCT05315297|Stanford University School of Medicine|Dr. Raymond Chou, MD|650-723-5256|raymond.chou@stanford.edu|
22331006|NCT01503229|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22331007|NCT01354964|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einsteinmed.org|2903
22331008|NCT00711009|Abbott|Global Medical Services|800-633-9110||
22331009|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org|
22331010|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
22331011|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272163|NCT03491397|University of California Los Angeles|Siddharth A. Padia, MD|310-825-2992|SPadia@mednet.ucla.edu|
22272164|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012||
22272165|NCT03699540|University of Kentucky|Shanna Babalonis, Ph.D.|859-257-1881|babalonis@uky.edu|
22272166|NCT02697591|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22272167|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300||
22272168|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
22272169|NCT04379700|NYU Langone Health|Bedros Taslakian, MD|212-263-5898|bedros.taslakian@nyulangone.org|
22301208|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22301209|NCT03360942|Dartmouth-Hitchcock Medical Center|Cristina Ferrazzano Yaussy, MPH, CCRP, Research Regulatory Affairs Specialist|603-650-5333|Cristina.Ferrazzano.Yaussy@hitchcock.org|
22331012|NCT02889861|Immunocore, LLC|Chris Holland, Executive Director Head of Biometrics|1-267-589-9204|chris.holland2@immunocore.com|
22331013|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com|
22331014|NCT00053482|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
22331015|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331016|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331017|NCT05064449|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22331018|NCT04354870|NYU Langone Health - Bellevue Hospital|H. Michael Belmont, MD|646-501-7400|Michael.Belmont@nyulangone.org|
22331019|NCT04450394|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22331020|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22272170|NCT04595279|Johns Hopkins University|Matthew Johnson|410-550-0056|mwj@jhu.edu|
22272171|NCT03943823|The University of Texas Health Science Center at Houston|Sunbola Ashimi, PhD|713-500-6410|Sunbola.S.Ashimi@uth.tmc.edu|
22272172|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu|
22272173|NCT04493151|Center for Anti-Infective Research and Development, Hartford Hospital|Dr. Joseph L. Kuti, PharmD, FIDP, FCCP|(860) 972-3612|Joseph.Kuti@hhchealth.org|
22289082|NCT01724346|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301210|NCT03456700|Mayo Clinic|Aminah Jatoi MD|507/284-2511|Jatoi.Aminah@mayo.edu|
22301211|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22301212|NCT03053050|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22301213|NCT00655980|University of Chicago Medicine|Principal Investigator|7737022544||
22301214|NCT01367262|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301215|NCT00254202|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22301216|NCT02459574|Imperial College London|Prof. Prapa Kanagaratnam|02033123783|p.kanagaratnam@imperial.ac.uk|
22301217|NCT05501860|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
22301218|NCT04508699|San Diego State University|AVP for Research Support Services|619-594-5938|rss@sdsu.edu|
22301219|NCT04866017|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22301220|NCT01266642|UT MD Anderson Cancer Center|Dr. Benjamin Smith, Professor, Radiation Oncology Department|(713) 563-2380|bsmith3@mdanderson.org|
22301221|NCT02355067|Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
22301222|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu|
22301223|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22301224|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22301225|NCT04639193|University of California San Diego|Dr Chris Schmickl|8582462154|cschmickl@health.ucsd.edu|
22301226|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22301227|NCT01106430|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22301228|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22301229|NCT00175825|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22301230|NCT03704584|Emory University|Dr. Charles Daly|404-919-6168|charles.a.daly@emory.edu|
22301231|NCT03412812|University of Alabama at Birmingham|Dr. John Fiveash|205-975-0224|jfiveash@uabmc.edu|
22301232|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu|
22301233|NCT04141774|UW School of Medicine and Public Health|Dr. Vivek Prabhakaran, MD, PhD|(608) 265-5269|vprabhakaran@uwhealth.org|
22301234|NCT03548207|Janssen Research & Development, LLC|Vice President Research and Development, Cellular Therapy|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22301235|NCT01756352|Brigham and Women's Hospital|Marcelo DiCarli, MD|(617) 732-6290|mdicarli@bwh.harvard.edu|
22301236|NCT02281448|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22301237|NCT02641392|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|amcclain@celgene.com|
22301238|NCT03466086|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
22301239|NCT01113502|Abramson Cancer Center of the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
22301240|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
22301241|NCT03802123|ImaginAb|Director, Regulatory Affairs|: +1.310.730.5869|ethomas@imaginab.com|
22301242|NCT01133158|GELTAMO|Francisco Javier Peñalver|91 621 98 24|fjpenalver@fhalcorcon.es|
22301243|NCT04555096|Galera Therapeutics|Judy Schnyder, SVP Clinical Operations and Data Management|2155937119|jschnyder@galeratx.com|
22301244|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22283634|NCT01005212|Houston Methodist Research Institute - Heart Center Research|Bevin Lopez, Clinical Trials Manager|7134413912|balopez@houstonmethodist.org|
22283635|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu|
22283636|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283637|NCT02713529|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22283638|NCT02700165|Zeltiq Aesthetics|Kerrie Jiang, Exective Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22283639|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu|
22283640|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
22283641|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com|
22283642|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org|
22283643|NCT03759041|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
22283644|NCT02449018|Novartis Pharmaceuticals|Study Director|8627781873||
22283645|NCT02378207|Desmond Tutu HIV Foundation, Cape Town, South Africa|Dr. Linda-Gail Bekker|+27214066959|linda-gail.bekker@hiv-research.org.za|
22283646|NCT01985763|Icahn School of Medicine at Mount Sinai|Dr. Sofya Pintova|212-824-8461|Sofya.Pintova@mountsinai.org|
22283647|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22283648|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu|
22283649|NCT02645617|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22283650|NCT00167661|University of Wisconsin - Madison|Dr. Sharon Bartosh|(608) 265-6020|smbartosh@wisc.edu|
22283651|NCT03306641|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
22301245|NCT04475549|Cyclerion Therapeutics, Inc.|Cyclerion Clinical Development|1-857-327-8778|info@cyclerion.com|
22301246|NCT04852055|Brown University|Project Director|(401) 863-7345|ellen_mccreedy@brown.edu|
22272174|NCT04779606|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22272175|NCT03725033|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22272176|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu|
22272177|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22272178|NCT03290547|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22272179|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu|
22272180|NCT04164004|Stanford University|Alexander Sandhu|9097671214|ats114@stanford.edu|
22272181|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22272182|NCT00925652|Dana-Farber Cancer Institute|Erica Mayer MD MPH|617-632-2335|emayer@partners.org|
22272183|NCT05822648|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
22272184|NCT03564795|KeraNetics|Luke Burnett|336.725.0621|lburnett@keranetics.com|
22272185|NCT05079230|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22272186|NCT00770133|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22272187|NCT00564395|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22272188|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
22272189|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu|
22272190|NCT01782352|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
22272191|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
22272192|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22272193|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22272194|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com|
22272195|NCT03260426|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
22331021|NCT02194699|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22331022|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov|
22331023|NCT03812224|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22331024|NCT03927703|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22331025|NCT02600715|University of Kansas School of Medicine-Wichita|Jennifer Duong, MPH, Research Associate|316-962-3126|jduong@kumc.edu|
22283652|NCT05011513|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331026|NCT01753765|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
22331027|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22331028|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22331029|NCT05386368|Atrium Health Wake Forest Baptist|Joseph Molnar MD|336-716-4171|jmolnar@wakehealth.edu|
22331030|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22331031|NCT01822886|"Policlinico S.Orsola-Malpighi - Institute of Hematology L. e A. Seràgnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy"|Zinzani Pier Luigi/Argnani Lisa|+39 0516364042|pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it|
22331032|NCT02516605|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22331033|NCT02643420|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22331034|NCT02127970|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22331035|NCT01710709|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22331036|NCT04446039|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22331037|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991|percival@ufl.edu|201
22331038|NCT01639599|Seoul St.Mary's Hospital,|Young Eun Moon|822-2258-6163|0910momo@naver.com|
22331039|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com|
22331040|NCT04138758|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331041|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov|
22331042|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
22331043|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu|
22331044|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331045|NCT05102734|Perelman School of Medicine at the University of Pennsylvania|Dr. John C. Greenwood|18568167172|john.greenwood@pennmedicine.upenn.edu|
22331046|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
22331047|NCT01143116|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
22331048|NCT03055806|Ixchelsis Limited|Chief Medical Officer|44 (0) 1227-832760|ian.osterloh@ixchelsis.com|
22331049|NCT04601194|Indiana University|Michelle Salyers|317-274-2904|mpsalyer@iu.edu|
22331050|NCT02630459|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22331051|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590||
22331052|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810|Stephen.Bent@ucsf.edu|3457
22331053|NCT04905563|Le Bonheur Children's Hospital|Lindsey Locke, MSN|(901) 287-8931|lindsey.locke@lebonheur.org|
22331054|NCT01797302|University of Pittsburgh School of Medicine|Kumaravel Rajakumar|412-692-5822|kumaravel.rajakumar@chp.edu|
22331055|NCT02418000|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
22331056|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22331057|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com|
22331058|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22331059|NCT04249076|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22331060|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu|
22331061|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000|susmita.chowdhuri@va.gov|3685
22331062|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331063|NCT04335552|Duke University|Jason Stout, MD, MHS|919-668-0826|jason.stout@dm.duke.edu|
22331064|NCT00611351|University of Nebraska Medical Center|Lori Maness-Harris|402-559-3848|lmaness@unmc.edu|
22331065|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu|
22331066|NCT01284127|Johns Hopkins University|Michael Levy|443-287-4612|mlevy@jhmi.edu|
22331067|NCT03243981|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
22331068|NCT00994890|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331069|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743||
22283653|NCT03667690|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
22283654|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk|
22283655|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com|
22283656|NCT01192568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22283657|NCT02593825|Duquesne University|Regina Harbourne, Primary Investigator|4026570538|harbourner@duq.edu|
22301247|NCT03575325|Moffitt Cancer Center|Bijal D. Shah, MD, MS|813-745-4294|Bijal.Shah@moffitt.org|
22331070|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22301248|NCT03440372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22283658|NCT06359080|JelikaLite Corp|Katya Sverdlov, Chief Operating Officer|9175668151|katya@jelikalite.com|
22283659|NCT04558359|University of Kentucky|Alexander Flannery, PharmD, PhD|859-562-2766|alexander.flannery@gmail.com|
22283660|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
22283661|NCT02706197|Program for Clinical Oximetry and Imaging Geisel School of Medicine & Dartmouth Health; Dartmouth College|Periannan (Kupps) Kuppusamy MS, PhD|603-646-5490|Periannan.Kuppusamy@dartmouth.edu|
22283662|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283663|NCT02783170|Duke University|Dr. Geeta Swamy|919-681-5220|geeta.swamy@duke.edu|
22283664|NCT03323736|Smith+Nephew|Laura England, PhD|(650) 223-6909|laura.england@smith-nephew.com|
22319336|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu|
22283666|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com|
22283667|NCT01778426|Medtronic|Neuromodulation, Clinical Study Management||medtronicneurotrials@medtronic.com|
22283668|NCT03046225|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
22283669|NCT00701805|Abbott|Global Medical Services|800-633-9110||
22283670|NCT05063539|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22283671|NCT04256512|Mayo Clinic|Pooja P. Advani, MBBS|904-953-7291|Advani.Pooja@mayo.edu|
22283672|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu|
22331071|NCT05223478|Ocuphire|Drey Coleman VP of Clinical Operations|8134041993|dcoleman@ocuphire.com|
22283673|NCT04692077|HPTN Statistical & Data Management Center|HPTN Statistical Manager|+1 (206) 667-4004|HPTN-Data-Access@scharp.org|
22283674|NCT01751139|GlaxoSmithKline|GSK Response Center|435-7343|GSKClinicalSupportHD@gsk.com|866
22283675|NCT01727011|Centre Antoine Lacassagne|Professeur JM Hannoun-Levi|04.92.03.12.60|jean-michel.hannoun-levi@nice.unicancer.fr|
22319337|NCT03434353|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22319338|NCT03739762|Kaiser Permanente|Dori Rosenberg, Principal Investigator|206-287-2532|dori.e.rosenberg@kp.org|
22319339|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611|Dorian.Rose@va.gov|5238
22319340|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu|
22319341|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22319342|NCT01131351|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22319343|NCT05787782|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22319344|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com|
22319345|NCT02267603|Cancer Immunotherapy Trials Network|Administrative Director|206-667-6609|citn.core.reg@hvtn.org|
22319346|NCT04606771|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22319347|NCT01346488|AbbVie|Global Medical Information|800-633-9110||
22319348|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com|
22319349|NCT03083847|National Institute of Allergy and Infectious Diseases|Patrick Duffy|(301) 761-5089|Patrick.Duffy@nih.gov|
22319350|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22319351|NCT01621230|UTexasSouthwestern|Margaret Craig, MD|2142638919|maggieanes@gmail.com|
22319352|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com|
22319353|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG||office@protaffin.com|
22319354|NCT03155373|Imperial College Healthcare NHS Trust|Jonathan Afoke|02033132026|j.afoke@nhs.net|
22319355|NCT01054144|Moffitt Cancer Center|Rachid Baz, MD|813-745-3163|Rachid.Baz@moffitt.org|
22319356|NCT02856893|EORTC|Yassin Pretzenbacher|+32 2 774 1365|yassin.pretzenbacher@eortc.org|
22319357|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319358|NCT03189862|University of Michigan|Leah E. Robinson|(734) 647-7645|lerobin@umich.edu|
22319359|NCT03326895|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
22319360|NCT00931944|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22319361|NCT05361668|Crinetics Pharmaceuticals, Inc.|Study Director|(858) 450-6464|medinfo@crinetics.com|
22319362|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net|
22319363|NCT01207726|SKCCC|Charlie Rudin, MD|646.888.4527|rudinc@mskcc.org|
22319364|NCT04325308|University of Alabama at Birmingham|Ariel Salas|2059344680|asalas@uab.edu|
22319365|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org|
22319366|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu|
22319367|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org|
22319368|NCT04233164|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Franco, Luis|+1 240 220 4366|luis.franco@nih.gov|
22319369|NCT04201821|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22319370|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
22319371|NCT03510988|Weill Cornell Medicine|Katerina Dodelzon, MD|646 962 9650|kad9090@med.cornell.edu|
22319372|NCT03829319|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22319373|NCT04484259|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904-244-5515|francesco.franchi@jax.ufl.edu|
22319374|NCT04498832|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22319375|NCT05101707|Medical University of South Carolina|Dr Dorothea Jenkins|(843)792-2112|jenkd@musc.edu|
22319376|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272196|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22272197|NCT02664922|University of California, Los Angeles|Jennifer Scovotti|310.206.4484|jscovotti@mednet.ucla.edu|
22331072|NCT02505269|Massachusetts General Hospital|Dr. Jeremy Abramson|617-724-4000|JABRAMSON@mgh.harvard.edu|
22331073|NCT02692560|Kaiser Permanente Washington Health Research Institute|Dori Rosenberg, PhD, MPH|206-287-2532|rosenberg.d@ghc.org|
22331074|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22331075|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22331076|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu|
22331077|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com|
22331078|NCT03701061|Emory University|Nadine Rouphael|404-712-1435|nroupha@emory.edu|
22331079|NCT02274766|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22331080|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331081|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
22331082|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331083|NCT02417935|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22331084|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org|
22331085|NCT01158885|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22331086|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331087|NCT02363322|NIAID/LIR|Dr. Richard T. Davey, Jr.|301-496-8029|rdavey@niaid.nih.gov|
22331088|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
22331089|NCT02909504|University Hospitals Cleveland Medical Center|Dr. Keming Gao, MD, PhD|2168442865|keming.gao@UHhospitals.org|
22331090|NCT02055976|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331091|NCT02504424|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|
22331092|NCT00751335|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAP.trial@fphcare.co.nz|7044
22331093|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229||
22331094|NCT05604781|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22331095|NCT04259749|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
22331096|NCT02885506|Medicines for Malaria Venture|Dr Cristina Donini|0041 22 555 0312|doninic@mmv.org|
22331097|NCT03922945|VIVUS|Sr. Director, Clinical Research|650-934-5200|clinical@vivus.com|
22331098|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
22331099|NCT02399345|AbbVie|Global Medical Information|800-633-9110||
22331100|NCT02873598|University of Colorado Cancer Center|Dr. Sana Karam|7208480141|sana.karam@cuanschutz.edu|
22331101|NCT02377674|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
22331102|NCT03308799|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22331103|NCT02927990|Philips Medical Systems B.V.|Pim van Lochem|+31 (0)634322891|pim.vanlochem@philips.com|
22331104|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22331105|NCT03521089|Mayo Clinic|Dr. Yonas Geda|480-301-6934|geda.yonas@mayo.edu|
22331106|NCT03414372|University of North Carolina at Chapel Hill|Bryce Stamp, MPH|919-966-7430|bstamp@ad.unc.edu|
22331107|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696|stavros-stavrakis@ouhsc.edu|37539
22331108|NCT04492514|University of Cincinnati|Clinical Research Director|513-584-0156|mcmahasn@ucmail.uc.edu|
22331109|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331110|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331111|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161|alindblad@emmes.com|105
22331112|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org|
22331113|NCT01603615|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22331114|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
22331115|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331116|NCT03474380|HSRD ADAPT|Courtney Van Houtven|919-286-6936|courtney.vanhoutven@va.gov|
22331117|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22331118|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu|
22331119|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331120|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
22331121|NCT03339999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22272198|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
22272199|NCT03759366|Alexion Pharmaceuticals Inc.|Alexion Europe SAS European Clinical Trial Information|7 87148158|clinicaltrials.eu@alexion.com|
22272200|NCT03557684|UCLA|Joshua H. Cho, MD, PhD|3104286218|hjcho@mednet.ucla.edu|
22272201|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933||
22272202|NCT00714753|Mayo Clinic|Thomas M. Pisansky, M.D.||Pisansky.Thomas@mayo.edu|
22272203|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22272204|NCT01573754|University of Texas Medical Branch Galveston|Dr. Karl Anderson|409-772-4661|kanderso@utmb.edu|
22331122|NCT01111058|University of Chicago|Everett Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
22272205|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22272206|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
22272207|NCT01533948|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22272208|NCT04228965|Medical University of South Carolina|Erin A. McClure, Principal Investigator|843-792-7192|mccluree@musc.edu|
22272209|NCT02442206|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22272210|NCT01471444|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22272211|NCT03915626|University of Maryland, Baltimore School of Pharmacy|Dr. Audra L. Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22272212|NCT03972501|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
22272213|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899|blemyre@toh.on.ca|71882
22272214|NCT04571385|Acesion Pharma|Birgitte Vestbjerg|+45 20772575|bve@acesionpharma.com|
22272215|NCT01888653|Columbia University Medical Center/New York State Psychiatric Institute|Yuval Neria|6467748092|yuval.neria@nyspi.columbia.edu|
22272216|NCT01928199|Washington University in St. Louis|Rowena Delos Santos|314-362-8351|delossantos@wustl.edu|
22272217|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org|
22272218|NCT03678675|Tufts Medical Center|Jean Hostage|617-636-4549|jeanhostage@gmail.com|
22272219|NCT03300050|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
22272220|NCT02499263|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22272221|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
22272222|NCT03108066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22272223|NCT02734862|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
22272224|NCT02757625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272225|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu|
22272226|NCT02779075|Mayo Clinic|Adrian Vella|507-202-8490|vella.adrian@mayo.edu|
22272227|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272228|NCT03077607|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272229|NCT04400656|Imperial College London|Ms Puja Jadav|0203 311 5473|p.jadav@imperial.ac.uk|
22272230|NCT04401202|King Abdulaziz University|Dr. Abdulrahman Koshak|0543292333|aekoshak@kau.edu.sa|
22272231|NCT02714036|MEDICINOVA, INC|Director, Research and Development|858-373-1500|clinicaltrialinfo@medicinova.com|
22272232|NCT03141034|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
22272233|NCT03688802|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22272234|NCT05697627|University of Michigan|Hannah Becker|(734) 764-2580|hcbecker@umich.edu|
22272235|NCT04122625|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22272236|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu|
22272237|NCT04165135|Hoffmann-La Roche|Medical Communications|800 821 8590|genentech@druginfo.com|
22272238|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272239|NCT03714776|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22272240|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu|
22272241|NCT01618916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272242|NCT03292471|VA Pittsburgh/California State University, East Bay|Dr. Michelle Gravier|510 885-3215|michelle.gravier@csueastbay.edu|
22272243|NCT02865811|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
22272244|NCT03014622|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
22272245|NCT00911586|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
22272246|NCT00849290|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
22272247|NCT00938587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272248|NCT02540161|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
22272249|NCT02819440|Vanderbilt University Medical Center|Evan Brittain|6153224382|evan.brittain@vumc.org|
22272250|NCT03763058|Centre d'Evaluation et Traitement de la Douleur|Dr Guilhem Parlongue|00262262912037|guilhem_parlongue@hotmail.com|
22272251|NCT02759835|National Cancer Institute|Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
22272252|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu|
22272253|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com|
22272254|NCT02334384|Eastern Virginia Medical School|Kenji Cunnion|7574465125|cunniokm@evms.edu|
22272255|NCT00055497|Abbott|Global Medical Services|800-633-9110||
22272256|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22272257|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
22272258|NCT01084538|Abbott|Global Medical Services|1-800-633-9110||
22272259|NCT03742258|Northwestern University|Dr. Reem Karmali, MD|(312) 695-0711|reem.karmali@northwestern.edu|
22272260|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org|
22272261|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com|
22272262|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22272263|NCT01605032|Albert Einstein College of Medicine/Montefiore Medical Center|Ira Braunschweig, MD|718-920-4057|IBRAUNSC@montefiore.org|
22272264|NCT01952080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22272265|NCT02134353|Pharmaxis|Dr Brett Charlton|+61 2 9454 7200|Brett.Charlton@pharmaxis.com.au|210
22272266|NCT01953432|Michael E. DeBakey VA Medical Center|Daryl Shorter, MD|713-798-4870|shorter@bcm.edu|
22272267|NCT00655681|University of New Mexico Carrie Tingley Hospital|Elizabeth A. Szalay MD|505 272-5214|eszalay@salud.unm.edu|
22272268|NCT05362695|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
22272269|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu|
22272270|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu|
22272271|NCT02978885|Columbia University|Gebhard Wagener, MD|212-305-6494|gw72@cumc.columbia.edu|
22272272|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099||
22272273|NCT01653327|Dartmouth-Hitchcock Medical Center|Dr. Thomas Davis|1-603-650-8626|Thomas.H.Davis@hitchcock.org|
22272274|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22272275|NCT02440854|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272276|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com|
22272277|NCT02669082|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22272278|NCT04918355|University of Colorado|Heather Tolle|303-724-9924|heather.tolle@cuanschutz.edu|
22272279|NCT02301039|Sarcoma Alliance for Research Through Collaboration|Research Manager|734-930-7600|sarc@sarctrials.org|
22272280|NCT04683939|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22272281|NCT04852276|National Institute of Allergy and Infectious Diseases (NIAID)|Emily Ricotta, PhD|240-550-3474|emily.ricotta@nih.gov|
22272282|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272283|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22272284|NCT04575584|Merck Sharp & Dohme, LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272285|NCT02634801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22272286|NCT00199849|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22272287|NCT01548768|Columbia University Irving Medical Center|Dr. Joan Bathon, MD|212-305-6327|jmb2311@cumc.columbia.edu|
22272288|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org|
22272289|NCT02178358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22272290|NCT03735407|CheckCap|Clinical Director|972-4-8303401|daniella.bleistein@check-cap.com|
22272291|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com|
22272292|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
22272293|NCT05600036|Alumis Inc.|SVP, Development Operations|(650) 231-6625|clinicaltrials@alumis.com|
22331123|NCT01856920|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@immunitybio.com|
22331124|NCT00816062|Medtronic|Rianna Rapson|7635262170|rianna.k.rapson@medtronic.com|
22331125|NCT02790476|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22331126|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov|
22331127|NCT03287089|Atrium Health|Dina Bastawros, MD|336-718-1970|dina.bastawros@gmail.com|
22331128|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331129|NCT00106626|Merck & Co., Inc.|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22331130|NCT03018028|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22331131|NCT02519777|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22331132|NCT01396486|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
22331133|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com|
22331134|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu|
22331135|NCT02541994|Ochsner Health Services|Dr. Andrew Lawton|504-842-3995|andrew.lawton@ochsner.org|
22331136|NCT03986671|Powell Mansfield Inc.|Chris Studer|6198101000|cstuder@powellmansfield.com|
22331137|NCT02074436|Emory University|Dr. Ana Antun|404-778-1900|ana.antun@emoryhealthcare.org|
22331138|NCT02169466|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
22331139|NCT03490734|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|kyle_burger@unc.edu|
22331140|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
22331141|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22331142|NCT04491591|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
22331143|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org|
22331144|NCT04212221|Zai Lab (Shanghai) Co.,Ltd.|Medical Director|+86 4008201022|medinfo@zailaboratory.com|
22331145|NCT03845504|Stanford University|Director, Research Development, Integrity and Strategy|(650) 736-4559|aimnoe@stanford.edu|
22331146|NCT03810053|University of Arkansas for Medical Sciences|Matthew Henry|5016868274|mhenry3@uams.edu|
22331147|NCT04111185|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
22331148|NCT02850276|Icahn School of Medicine at Mount Sinai|Dr. Jessica Robinson-Papp|212-241-8390|jessica.robinson-papp@mssm.edu|
22331149|NCT04815291|Merit Medical Systems Inc.|Casey Holland|6178420251|casey.holland@merit.com|
22331150|NCT01914510|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
22331151|NCT02994043|University of Colorado Denver|Jamie Laurin|303-724-3183|JAIME.LAURIN@CUANSCHUTZ.EDU|
22331152|NCT02646332|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|williamhsup@yahoo.com.tw|78233
22331153|NCT04098172|First Affiliated Hospital of Xi 'an Jiaotong University|Dr. Ning Guo|13991229101|drnguo@gmail.com|+86
22331154|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu|
22331155|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331156|NCT01869686|Amgen Inc.|Study Director|866-572-6436||
22331157|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331158|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu|
22331159|NCT03474172|Guangdong Provincial Hospital of Chinese Medicine|Director of department of Clinical Epidemiology|+862081887233|darongwu@163.com|35842
22331160|NCT02312934|Vanderbilt University Medical Center|Dr. Paul A. Newhouse|(615) 327-7009|paul.newhouse@vumc.org|
22331161|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
22319377|NCT04029480|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22331162|NCT03395704|La Jolla Pharmaceutical Company|Stew Kroll, MA|650-576-9679|skroll@ljpc.com|
22331163|NCT01801189|Legacy Weight and Diabetes Institute|Dr. Valerie Halpin|503-413-7557|vhalpin@lhs.org|
22331164|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu|
22331165|NCT04524663|Stanford University|Dr. Julie Parsonnet, MD|(650) 725-4561|parsonnt@stanford.edu|
22331166|NCT00911508|Mayo Clinic|Dr. Douglas L. Packer|507-255-6263|CABANA@mayo.edu|
22331167|NCT04308668|University of Minnesota|David Boulware, MD, MPH|6125552020|covid19@umn.edu|
22331168|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331169|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com|
22331170|NCT05111548|University of Michigan|Dr. Cynthia Burton|734-615-9821|czburton@med.umich.edu|
22331171|NCT00103376|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22331172|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
22331173|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22331174|NCT03938857|Duke University|Mara L. Becker, MD, MSCE|919-613-1942|mara.becker@duke.edu|
22331175|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org|
22331176|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
22331177|NCT02452034|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331178|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22331179|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22331180|NCT01453439|Massachusetts General Hospital|Dr. Sabine Wilhelm, Ph.D.|+1(617)724-6146|swilhelm@mgh.harvard.edu|
22331181|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22331182|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|9477
22331183|NCT03520842|Stanford University|Heather Wakelee|(650) 498-6000|ccto-website@stanford.edu|
22331184|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071||
22331185|NCT02195895|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22331186|NCT01508221|University of Cincinnati|Alison Kastl|513-584-0436|Kastla@ucmail.uc.edu|
22331187|NCT04383665|Keck School of Medicine of University of Southern California|Dr Darrin Lee|(323) 442-5720|darrinjl@usc.edu|
22331188|NCT00147082|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
22331189|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331190|NCT03547960|Imperial College London|Gary Frost|2075940959|g.frost@imperial.ac.uk|
22331191|NCT02543801|Kootenai Health|Director of Research Programs|2086254223|salbritton@kh.org|
22331192|NCT01756846|University Medical Center Utrectht|Dr. Judith Poldervaart|008875 55105|j.poldervaart@umcutrecht.nl|
22331193|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl|
22331194|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22331195|NCT02625610|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22331196|NCT03459794|University of Georgia|Dr Adrian Wolstenholme|706 542 2404|adrianw@uga.edu|
22331197|NCT02350660|University of Virginia|Department of Medicine and Pediatrics|434.924.0000|spc7w@virginia.edu|
22331198|NCT00352027|St. Jude Children's Research Hospital|Jamie Flerlage, MD|901-595-0392|jamie.flerlage@stjude.org|
22331199|NCT04118127|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22331200|NCT00636506|American Medical Systems|Men's Health Clinical Affairs|952-930-6328|Karen.Seybold@ammd.com|
22331201|NCT02607735|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22331202|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
22331203|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org|
22331204|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu|
22331205|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742|jose-exaire@ouhsc.edu|44744
22331206|NCT01681836|University of Pittsburgh|Dr. Kara Hughan|412-692-5170|kara.hughan@chp.edu|
22319378|NCT04893577|University of Utah MidValley Dermatology|Christopher Hull, MD|801-213-0375|adrianne.evans@hsc.utah.edu|
22319379|NCT02593786|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22319380|NCT01839487|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
22319381|NCT03714425|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
22319382|NCT03877432|Taipei Medical University|Dr. Chih-Wei Peng|886-2-27361661|cwpeng@tmu.edu.tw|3070
22319383|NCT01377753|National Cancer Institute|Dr. Peter Pinto|240-760-6249|pintop@mail.nih.gov|
22319384|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300||
22319385|NCT01351753|University of Iowa|Gary Pierce, PhD|13193359487|gary-pierce@uiowa.edu|
22319386|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu|
22319387|NCT02038920|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22319388|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22319389|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu|
22319390|NCT02906787|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
22319391|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu|
22331207|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22331208|NCT02394028|Hoffmann La-Roche|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy|800 821-8590|genentech@druginfo.com|
22331209|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu|
22331210|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331211|NCT02599324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22331212|NCT02109939|Assurex Health|Lindsey Burns|5137015068|lindsey.burns@myriad.com|
22331213|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com|
22331214|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu|
22331215|NCT03480841|University of North Carolina at Chapel Hill|Dr. Linda Beeber|(919) 966-8148|beeber@email.unc.edu|
22331216|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22331217|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu|
22331218|NCT03198884|SIHF Healthcare|John Verna|618-337-8153|jverna@sihf.org|
22331219|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
22331220|NCT02910492|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22331221|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331222|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org|
22331223|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000|jm.wecht@va.gov|3122
22331224|NCT02993783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22331225|NCT02886338|TMU|Fat-Moon, Suk|29307930|fmsuk@tmu.edu.tw|7923
22331226|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
22331227|NCT03359811|UT MD Anderson Cancer Center|Dr. Juan Cata, MD, Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
22331228|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu|
22331229|NCT03330275|Johnson & Johnson Vision Care, Inc.|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
22331230|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu|
22331231|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176||
22331232|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331233|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22331234|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it|
22331235|NCT02049476|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Jennifer E. Thorne, MD, PhD; Professor of Ophthalmology & Epidemiology,Director of Ocular Immunology|410-955-2966|jthorne@jhmi.edu|
22331236|NCT03007472|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
22331237|NCT02988115|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22331238|NCT01731951|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
22331239|NCT03306589|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22331240|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de|
22331241|NCT01977651|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22331242|NCT03028324|University of Miami|Joyce Rios Gomes-Osman|305-284-2632|j.gomes@miami.edu|
22331243|NCT03380091|University of California, San Francisco|Heather Huddleston|(415) 353-3040|Heather.Huddleston@ucsf.edu|
22331244|NCT02515890|University of Pittsburgh|Keith M. Vogt, MD., PhD.|412-999-8570|vogtkm@upmc.edu|
22331245|NCT04594213|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22331246|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org|
22331247|NCT01980056|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
22331248|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22331249|NCT02906644|Duke University|Clinical Research Coordinator|(919) 668-5055|al.salley@duke.edu|
22331250|NCT04646668|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
22331251|NCT03672006|Medical College of Wisconsin|Dr. Shelia Hanson|414-266-3728|shanson@mcw.edu|
22331252|NCT03288987|Aryogen|Dr. Nasim Anjidani (Director of Medical- Clinical Trials)|009809125477964|anjidani.n@orchidpharmed.com|
22331253|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov|
22331254|NCT00761891|Department of Pharmacology, School of Medicine, Vanderbilt University|Olivier Boutaud, PhD|615-343-7398|olivier.boutaud@vanderbilt.edu|
22331255|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22331256|NCT02512094|Faculty of Medicine Siriraj Hospital, Mahidol University|Panai Laohaprasitiporn||panailao@gmail.com|
22331257|NCT02764229|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
22331258|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22331259|NCT01973205|Novartis|Clinical Project Leader|9735038000||
22331260|NCT04056325|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22331261|NCT03128372|Medtronic|Julia Katilius|1 303-305-2278|julia.z.katilius@medtronic.com|
22331262|NCT02030067|Processa Pharmaceuticals|Director Drug Development and Regulatory Affairs|443-631-6614|pfranks@processapharmaceuticals.com|
22331263|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22331264|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
22331265|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org|
22331266|NCT02813681|University of Texas Medical Branch|Denise Wilkes|409-772-1221|dwilkes@utmb.edu|
22331267|NCT00529152|ApoPharma|Dian Shaw, Manager Clinical Research|416-401-7283|dshaw@apotex.com|
22331268|NCT01878786|MedStar Georgetown Transplant Institute|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
22331269|NCT04062240|Mayo Clinic|Dr. Matthew Ritter|507-255-5123|Ritter.Matthew@mayo.edu|
22331270|NCT03961529|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22331271|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22331272|NCT03500419|Mayo Clinic|Matthew (Matt) J. Ziegelmann, M.D.|507-266-3982|Ziegelmann.Matthew@mayo.edu|
22331273|NCT00082628|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22331274|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il|
22331275|NCT03481634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22331276|NCT01874288|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
22331277|NCT03099304|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22331278|NCT01624974|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331279|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com|
22331280|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com||
22331281|NCT01854918|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22331282|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22331283|NCT03373006|HALO Diagnostics|Chief Research Officer|760-766-2047|bernadette@halodx.com|
22331284|NCT02828982|University of Michigan|Dr. Deanna Gates|(734) 647-2698|gatesd@umich.edu|
22331285|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br|
22331286|NCT02705755|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22331287|NCT01906489|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
22331288|NCT03458234|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|(205) 934-5670|ammcdonald@uabmc.edu|
22331289|NCT07072962|Baylor College of Medicine|Bijan Najafi|424-467-7127|najafi.bijan@gmail.com|
22331290|NCT01707667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22331291|NCT03802331|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331292|NCT03010358|OHSU Knight Cancer Institute|Bria Thurlow|503-494-4292|thurlow@ohsu.edu|
22331293|NCT03432819|RAND Corporation|Laura Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
22331294|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331295|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22331296|NCT02735382|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Mark Zehner, MS|6082627568|mark.zehner@ctri.wisc.edu|
22331297|NCT01474993|UMass Medical School|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org|
22331298|NCT02996981|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22331299|NCT00760994|VA Puget Sound Health Care System|Tracy Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
22331300|NCT03258710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331301|NCT03451630|UPMC Center for High-Value Health Care|Kelly Williams, PhD, MPH|412-454-1198|williamsk17@upmc.edu|
22331302|NCT03570476|University of Washington|Dr. Bruce Montgomery, PI|206-598-0860|rbmontgo@uw.edu|
22331303|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22331304|NCT00545740|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22331305|NCT02117024|Clinical Development|Lori McDermott|919-794-8950|lmcdermott@heatbio.com|
22331306|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu|
22331307|NCT01646255|UCB|Study Director|+1877 822||9493
22331308|NCT01468844|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22331309|NCT02239562|University of Miami|Christopher O'Brien|305-243-2329|CObrien@med.miami.edu|
22331310|NCT01241318|"Ariadne Labs|BWH & HSPH"|Katherine Semrau (Epidemiologist, co-PI)|6177805311|ksemrau@ariadnelabs.org|
22331311|NCT02355665|JNJWorldwide|Andrew Myers, MD, Director, Clinical Research|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
22331312|NCT03194256|Brown University|Suzanne Colby|4028636621|suzanne_colby@brown.edu|
22331313|NCT02380703|Baylor College of Medicine|Mark Kunik, MD, MPH, Primary Investigator|713-794-8639|mkunik@bcm.edu|
22331314|NCT03607994|Wake Forest Baptist Health|Catherine Tegeler - Project Manager|336-716-9341|categele@wakehealth.edu|
22331315|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org|
22331316|NCT02183792|University of Southern California School of Pharmacy|Tien Ng, Pharm.D.|3234421840|tienng@usc.edu|
22331317|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org|
22331318|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701|cpirola@ciudad.com.ar|167
22331319|NCT01813149|Cleveland Clinic Foundation|Michael Stanton Hicks, MD|216-445-3497|stantom@ccf.org|
22331320|NCT02853318|Roswell Park Comprehensive Cancer Institute|Katy Wang, Statistician, M.A.|7168451300|katy.wang@roswellpark.org|6269
22331321|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org|
22331322|NCT04490499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331323|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org|
22331324|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22331325|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org|
22331326|NCT03125902|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22331327|NCT01997333|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
22331328|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu|
22331329|NCT04411472|AM-Pharma|AM-Pharma Office|+31 (0)30 22 89 222|office@am-pharma.com|
22331330|NCT00890396|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22331331|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu|
22331332|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
22331333|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331334|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132|Jessica.Hamblen@va.gov|5389
22331335|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110||
22331336|NCT02275559|UMass Chan Medical School|Dr James Carmody|5088561205|james.carmody@umassmed.edu|
22331337|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22331338|NCT03769753|Memorial Sloan Kettering Cancer Center|T. Peter Kingham, MD|212-639-5260|kinghamp@mskcc.org|
22331339|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22331340|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22331341|NCT02699632|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
22331342|NCT01259388|Birmingham VA Medical Center|Dr. John Rinker|205-934-2402|John.Rinker@va.gov|
22331343|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22331344|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu|
22331345|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22331346|NCT05414422|Perception Neuroscience|Clinical Trials Group|+49 (0) 89 2153 9035|clinicaltrials@perceptionneuroscience.com|
22331347|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se|
22331348|NCT02728804|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|adarke@fredhutch.org|
22331349|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com|
22331350|NCT00591786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331351|NCT01835964|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22331352|NCT01920061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331353|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu|
22331354|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu|
22331355|NCT03969589|VISN 5 MIRECC|Amy Drapalski|443-421-6273|amy.drapalski@va.gov|
22331356|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22331357|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777||
22331358|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com|
22331359|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331360|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org|
22331361|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22331362|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22331363|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com|
22331364|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp|
22331365|NCT02978339|Mayo Clinic|John E. Eaton, M.D.|507-284-3917|Eaton.John@mayo.edu|
22331366|NCT01665040|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|rjain@bsci.com|
22331367|NCT05453006|University of Minnesota|Christina Bliss Barsness|612-625-7179|blis0015@umn.edu|
22331368|NCT00195702|Abbott|Global Medical Services|800-633-9110||
22331369|NCT03721549|WCCT Global|Erin Flynn, Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
22331370|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43||
22331371|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22272294|NCT04348500|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
22301249|NCT05711641|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|Dr. Tatiane Vacaro Campos|+551126617585|tati_vacaro@hotmail.com|
22331372|NCT04823494|GN|Todd Fortune|763-772-5566|tfortune@gnresound.com|
22331373|NCT03726320|NYU Langone Health|Danil Makarov|212-263-4961|Danil.Makarov@nyulangone.org|
22272295|NCT02722746|University of Florida, College of Medicine|Dr. Terrie Vasilopoulos|3522738910|tvasilopoulos@anest.ufl.edu|
22272296|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org|
22272297|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com|
22272298|NCT02053259|Arizona State University|Dr. Marc Adams|602-827-2470|marc.adams@asu.edu|
22272299|NCT02343380|University of Turin|Dr Simona Bo|0039116335543|simona.bo@unito.it|5541
22272300|NCT02700698|University of Arkansas for Medical Sciences; Arkansas Children's Research Institute|Elisabet Borsheim, PhD|501-364-3053|EBorsheim@uams.edu|
22272301|NCT00703118|Tibotec|Medical Leader|1 609 730-3174||
22272302|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22301250|NCT03574597|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22301251|NCT03804710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301252|NCT04542018|University of Michigan|Prashant Singh, MBBS|734-647-1191|singhpr@med.umich.edu|
22331374|NCT02679560|UC Davis|Dr. Ian Brown|(916)734-1279|iebrown@ucdavis.edu|
22272303|NCT05053035|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
22319392|NCT03823768|Medical University of South Carolina|Professor|8437922724|taberd@musc.edu|
22331375|NCT03691831|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22331376|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
22331377|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399||
22331378|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331379|NCT02361307|Mahidol University|Piyapat Dajpratham|6624197508|piyapat.daj@mahidol.ac.th|
22331380|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu|
22331381|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu|
22331382|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331383|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|fmeric@mdanderson.org|
22331384|NCT03852901|National Institute on Aging|Josephine M. Egan, MD, Clinical Director|410-558-8414|eganj@mail.nih.gov|
22331385|NCT03374982|University of Nebraska Medical Center|Zachary Houser|402-980-9633|zach.houser@unmc.edu|
22331386|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22319393|NCT03901053|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22319394|NCT01786187|Michigan State University|Amy Hoffman, RN, PhD|517 355 8348|amy.hoffman@ht.msu.edu|
22319396|NCT01350453|University of Southampton|Jane Burridge|+44(0)2380 598 885|jhb1@soton.ac.uk|
22319397|NCT05772156|NewYork-Presbyterian Hospital, Columbia University Irving Medical Center|Intramuscular Methylergonovine to Decrease Blood Loss During Cesarean Delivery for Twins: A Triple-B|877-843-2229|hbg2115@cumc.columbia.edu|
22319398|NCT03047551|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
22319399|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu|
22319400|NCT01999569|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
22319401|NCT02462928|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22319402|NCT00395863|Bracco Diagnostics Inc.|Gianpaolo Pirovano, MD, Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
22319403|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu|
22319404|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu|
22319405|NCT03873493|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22319406|NCT04085341|Graybug Vision|Director, Global Clinical Development Operations|5622098872|bpatel@graybug.vision|
22319407|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053||
22319408|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu|
22331387|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com|
22331388|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
22331389|NCT04563845|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331390|NCT04120116|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
22331391|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu|
22331392|NCT02210559|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-069Study@fibrogen.com|
22331393|NCT00792467|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
22331394|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22331395|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com|
22331396|NCT01098266|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
22331397|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331398|NCT02357394|University of Kansas Health System, Dept of OBGYN|Dr. Gene Lee|9135886201|glee@kumc.edu|
22331399|NCT01811004|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22331400|NCT02545270|Department of Anesthesiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev Denmark|MD. G. G. Nervil||gustavnervil@gmail.com|
22331401|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu|
22331402|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22331403|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu|
22331404|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu|
22331405|NCT04805892|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6464001204|jstega@optonline.net|
22331406|NCT01196793|Imperial College London NHS Trust|Dr Hermione Lyall|02033126965|hermione.lyall@nhs.net|
22331407|NCT04382066|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|+34 91 846 60 00|clinicaltrials@pharmamar.com|
22331408|NCT04738123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22331409|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org|
22331410|NCT03970330|MSHersheyMC|Dr. Kristin Riley|717-531-6447|kriley1@pennstatehealth.psu.edu|
22331411|NCT00083616|Amgen Inc.|Study Director|866-572-6436||
22331412|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22331413|NCT03138798|Icahn School of Medicine at Mount Sinai|Dr. Eric Bergh|908-625-8148|eric.bergh@mssm.edu|
22331414|NCT02500706|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22331415|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu|
22331416|NCT03644173|Hackensack meridian Health|Manager, Investigator Initiated Research Program|5519961244|Elli.GournaPaleoudis@hmhn.org|
22331417|NCT03323385|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
22331418|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM|
22331419|NCT04422951|Stanford University|Thomas N. Robinson, MD, MPH|(650) 723-5331|tom.robinson@stanford.edu|
22331420|NCT04269629|Department of Dermatology and Venerology|Assoz.-Prof. Dr. Gunter Sturm|+4331638580318|gunter.sturm@medunigraz.at|
22331421|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22331422|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
22331423|NCT02918006|Vaxart, Inc.|Sean Tucker, PhD, Chief Scientific Officer|650-550-3502|stucker@vaxart.com|
22331424|NCT04227119|Emory University|Anand Shah, MD|404-712-4063|anand.d.shah@emory.edu|
22331425|NCT02510885|Duke Eye Center|Dr. Priyatham Mettu|919-684-9010|priyatham.mettu@duke.edu|
22331426|NCT02936206|Icahn School of Medicine at Mount Sinai|Dr. Amy Tiersten|212-241-3300|amy.tiersten@mssm.edu|
22331427|NCT03091920|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22331428|NCT01682876|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
22331429|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22331430|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331431|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu|
22331432|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za|
22331433|NCT01881867|Cancer Immunotherapy Trials Network|CITN Director|206-667-4141|mcheever@fredhutch.org|
22331434|NCT03044691|Unversity of Florida|Assistant Professor|(352) 294-4997|rsalloum@ufl.edu|
22331435|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22331436|NCT04156802|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
22331437|NCT02818582|National Institute of Allergy and Infectious Diseases|Higgs, Elizabeth|+1 301 768 3947|ehiggs@niaid.nih.gov|
22331438|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22331439|NCT02582216|Hôpital Erasme|Dominique Mouraux|+32/2.555.38.48|dmouraux@ulb.ac.be|
22331440|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272304|NCT00438256|Massachusetts General Hospital|Theodore Hong, MD|617-724-1159|TSHONG1@mgh.harvard.edu|
22272305|NCT01918072|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Donna L. Washington, MD, MPH|310-478-3711|donna.washington@va.gov|49479
22272306|NCT02005627|Imperial College London|Stephen R Durham|+44207-351-8024|s.durham@imperial.ac.uk|
22272307|NCT04000360|The Cleveland Clinic Foundation|Dr. Jay L. Alberts|440-708-3735|albertj@ccf.org|
22272308|NCT03760458|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22301253|NCT03583554|Baylor College of Medicine and Michael E. DeBakey VA Medical Center|Dr. Marijn Lijffijt, Assistant Professorq|713-798-5642|marijn.lijffijt@bcm.edu|
22301254|NCT03178266|ZipLine Medical|Wendy Winters, Clinical Project Manager|4085061866|wwinters0@gmail.com|
22301255|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu|
22301256|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org|
22301257|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
22301258|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov|
22301259|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org|
22331441|NCT02223637|GlaxoSmithKline|GSK Response Center|866-435-7343|geetha.x.kamath@gsk.com|
22331442|NCT04177862|University of Minnesota|Dr. Jonah Pearson|218-280-8348|pears731@umn.edu|1
22331443|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22331444|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
22331445|NCT05637515|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5302
22331446|NCT03233009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331447|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
22331448|NCT04516291|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331449|NCT01855607|Columbia University Irving Medical Center|Dawn L. Hershman, MD, MS, FASCO|212 305-1945|dlh23@columbia.edu|
22331450|NCT02181634|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|pcata@jimmy.harvard.edu|
22331451|NCT04250558|Dartmouth Hitchcock Medical Center|Dr. Ida Leah Gitajn|(603) 650-5133|ida.leah.gitajn@hitchcock.org|
22331452|NCT04812678|FasciaFrance|Dr Bertrand|+33682308609|isa.bertrand.cerap@gmail.com|
22331453|NCT02843282|University of Texas at Dallas, Center for BrainHealth|Erin Venza, Research Clinician|972-883-3208|erin.venza@utdallas.edu|
22331454|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990||
22331455|NCT03824704|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22331456|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov|
22331457|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22331458|NCT02155660|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
22331459|NCT03730987|University of Miami|Dr. Victoria Behar-Zusman|305-2849139|vbehar-zusman@miami.edu|
22331460|NCT02087085|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22331461|NCT02505945|Torax Medical|Adam Ahlstrom|651-361-8900|aahlstro@its.jnj.com|
22331462|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331463|NCT02680158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22331464|NCT03734601|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
22331465|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|9003
22331466|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org|
22331467|NCT02681094|AstraZeneca|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22331468|NCT01072175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22331469|NCT02839330|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22331470|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at|
22331471|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22331472|NCT02615158|University of Maryland School of Medicine|Dr. Maureen Black|410-706-2136|mblack@som.umaryland.edu|
22331473|NCT02257970|Stanford University, School of Medicine|Dr. Stanley Rockson|650-725-7571|rockson@stanford.edu|
22331474|NCT02477215|Medical College of Wisconsin|Parameswaran Hari|414-805-4600|phari@mcw.edu|
22331475|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940||
22331476|NCT00883896|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331477|NCT02546193|Mayo Clinic|VanessaTorbenson, M.D.|507-266-9873|torbenson.vanessa@mayo.edu|
22331478|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com|
22331479|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no|
22331480|NCT04871451|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
22331481|NCT00438815|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22331482|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com|
22331483|NCT04168775|University of North Carolina at Chapel Hill|Michael B. Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22331484|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22331485|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu|
22331486|NCT00859495|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
22331487|NCT02467504|Peking university People's Hospital|Prof. Zhanguo Li|+86-13810001444|13810001444@163.com|
22331488|NCT04225026|Galera Therapeutics|Judy Schnyder, Sr. Vice President, Clinical Operations|484-870-9625|jschnyder@galeratx.com|
22331489|NCT04462731|University of Pennsylvania|Ya-Hsin Yu|215-898-4927|yayu@upenn.edu|
22301260|NCT01846182|Central Texas Veterans Health Care System|Charles J. Foulks, M.D., ACOS/R|254 743 2643|Charles.Foulks@va.gov|
22331490|NCT00026559|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
22331491|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22272309|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272310|NCT04006509|University of Florida|Leslie A. Parker|352 273 6384|parkela@ufl.edu|
22272311|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com|
22331492|NCT03982069|University of Pittsburgh|Dr. Katherine Williams|412-383-1979|kvw3@pitt.edu|
22272312|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22272313|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com|
22272314|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22272315|NCT03304184|University of Michigan|Elizabeth Van Tubergen|2487045640|evantub@umich.edu|
22272316|NCT01505179|UCSD MED CLINICAL TRIALS|Denise Barnard, MD|858 246-2996|dbarnard@ucsd.edu|
22272317|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22272318|NCT04527978|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22272319|NCT02104167|Zimmer Biomet|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
22272320|NCT02112877|Boston Scientific|Nancy O'Connell, Sr. Clinical Research Manager|763-494-2706|nancy.oconnell@bsci.com|
22272321|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22272322|NCT03780972|ONL Therapeutics|Director of Clinical Operations|(734) 412-8787|info@onltherapeutics.com|
22272323|NCT03973697|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22331493|NCT00914940|Fred Hutchinson Cancer Research Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
22331494|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov|
22331495|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22331497|NCT00957827|University of Pennsylvania|Eric Granquist|215 880-7568|eric.granquist@uphs.upenn.edu|
22331498|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22331499|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22331500|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu|
22331501|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu|
22331502|NCT05040295|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331503|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov|
22331504|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
22331505|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu|
22331506|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu|
22331507|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
22331508|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22331509|NCT00444028|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22331510|NCT02946515|University of Minnesota - Division of Epidemiology and Community Health|Dr. Nancy E. Sherwood, Associate Professor|612-625-4567|sherw005@umn.edu|
22331511|NCT01054209|Brighton and Sussex University Hospitals Trust|Dr Mark Harper|01273696955|mark.harper@bsuh.nhs.uk|4307
22331512|NCT02158949|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
22331513|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22331514|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22331515|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22331516|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22331517|NCT05600101|Dana-Farber Cancer Institute|Dr. Gregory Abel|(877) 442-3324|Gregory_Abel@dfci.harvard.edu|
22331518|NCT03947333|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22331519|NCT02898662|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22331520|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com|
22331521|NCT00917553|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
22331522|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com|
22331523|NCT01905241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
22331524|NCT02675933|Dell Children's Medical Center of Central Texas|Dr. Catherine Yee|5123240000|ceyee@ascension.org|86878
22331525|NCT03172026|University of California Los Angeles|Dr. Bruce H. Dobkin|310-206-6500|BDobkin@mednet.ucla.edu|
22331526|NCT04680273|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22331527|NCT01430559|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331528|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331529|NCT01220024|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22331530|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
22272324|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu|
22331531|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272325|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
22272326|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu|
22272327|NCT01578499|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22272328|NCT01987232|Amgen Inc.|Study Director|866-572-6436||
22272329|NCT02791438|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22272330|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272331|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22272332|NCT00687882|Johns Hopkins All Children's Hospital|Dr. Neil A Goldenberg, Associate Dean of Research|727-767-3674|neil@jhmi.edu|
22272333|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu|
22331532|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500|megan.lawson@biomet.com|1183
22331533|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
22331534|NCT04652245|Meda Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+496172888|christine.kolb@viatris.com|2511
22331535|NCT02071823|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22331536|NCT03698370|Stanford University|Dr. Andrei Iagaru, MD|650-728-4711|aiagaru@stanford.edu|
22331537|NCT03137433|University of Minnesota|Aaron Kelly, PhD|612-626-3492|kelly105@umn.edu|
22331538|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com|
22331539|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
22331540|NCT03503617|Flint Rehabilitation Devices|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
22331541|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com|
22331542|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22331543|NCT05489146|University of Pittsburgh|Amit Sethi, Associate Professor, Department of Occupational Therapy,|4123836619|asethi@pitt.edu|
22331544|NCT02347124|Kaiser Permanente Washington Health Research Institute|Dr. Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
22331545|NCT02499380|PneumRx|Jörg Rennecke|+49 211 5422750|medical.services@btgplc.com|
22331546|NCT04241627|University of Southern California Keck School of Medicine Department of Pediatrics|Caitlin Sayegh|13233617748|cssayegh@chla.usc.edu|
22331547|NCT03681808|Bausch & Lomb|Study Director|585-338-6399|Robert.Steffen@bausch.com|
22331548|NCT03742271|Johnson & Johnson Vision Care Inc.|John Buch OD F.A.A.O- Sr. Principal Research Optometrist|+1 904 443-1707|JBUCH@its.jnj.com|
22331549|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu|
22331550|NCT03137173|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
22331551|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331552|NCT05060003|Washington University School of Medicine|George Ansstas, M.D.|314-362-5677|gansstas@wustl.edu|
22272334|NCT03092934|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22272335|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
22283676|NCT02733653|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
22272336|NCT03426436|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
22272337|NCT03168919|St. Jude Children's Reaserch Hospital|Asim K. Bag, MD Bag|9015953347|asim.bag@stjude.org|
22331553|NCT03524664|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie_petrenko@urmc.rochester.edu|241
22331554|NCT02694562|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
22331555|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331556|NCT00515021|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22331557|NCT00807768|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
22331558|NCT03529162|Saint Louis University|Sarah Dawson, Research Nurse|314-977-4106|sarah.dawson@health.slu.edu|
22331559|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com|
22331560|NCT01522391|Pergamum AB|Margit Mahlapuu PhD, Assoc. Prof. in Molecular Medicine|+46 70 631 01 09|margit.mahlapuu@pergamum.com|
22331561|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22331562|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22331563|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331564|NCT03143855|Virginia Commonwealth University|Dr. F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
22331565|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu|
22331566|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu|
22331567|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331568|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22331569|NCT03077646|Children's Hospital at Montefiore|Alyssa Silver, MD|718-741-2304|alysilve@montefiore.org|
22331570|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331571|NCT02993731|Sumitomo Dainippon Pharma Oncology|Cindy Oh|617-674-8628|coh@bostonbiomedical.com|
22331572|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22331573|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
22331574|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru|
22331575|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu|
22331576|NCT03808298|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22331577|NCT02713490|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22331578|NCT02965027|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
22331579|NCT02196025|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
22331580|NCT03039686|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22331581|NCT01793610|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22331582|NCT05981443|University of Kentucky|Dr. Cody Blanchard|859-323-5867|cody.blanchard@uky.edu|
22331583|NCT03868410|Cleveland Clinic|Dr. Ela Plow|216-445-6728|plowe2@ccf.org|
22331584|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu|
22331585|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22331586|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22331587|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22331588|NCT03382639|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22331589|NCT00987558|Bial - Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com|
22331590|NCT02624713|Tel-Hai College|Prof. Moria Golan|972547240330|moria.golan@mail.huji.ac.il|
22331591|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu|
22331592|NCT03927209|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331593|NCT03558230|Medical University of South Carolina|Dr. Na Jin Seo|843-792-0084|seon@musc.edu|
22331594|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu|
22331595|NCT06104423|A.MENARINI I.F.R SrL|Simone Baldini Global Clinical Operations Manager|055 56801|sbaldini@menarini.it|
22331596|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
22331597|NCT00351611|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331598|NCT01589185|Aridis Pharmaceuticals, Inc.|Lynne Deans, M.T.|408-385-1742|deansl@aridispharma.com|
22331599|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com|
22331600|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22272338|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331601|NCT03781167|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22331602|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
22301261|NCT01786967|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
22301262|NCT02012491|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|Courtney.Schreiber@uphs.upenn.edu|
22301263|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22301264|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org|
22301265|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu|
22301266|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org|
22301267|NCT01054768|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|5104283172|ashutosh.lal@ucsf.edu|
22301268|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301269|NCT02471651|California Retina Consultants|Dr. Gabriel Gordon|8059631648|gabe@californiaretina.com|3034
22301270|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22301271|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org|
22301272|NCT01298999|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
22301273|NCT02816138|Vanderbilt University Medical Center|Warren D. Taylor, MD|6153221073|warren.d.taylor@vanderbilt.edu|
22301274|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301275|NCT00902694|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22272339|NCT02655419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301276|NCT04154787|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22301277|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301|eickholz@med.uni-frankfurt.de|5642
22301278|NCT01437449|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
22301279|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu|
22301280|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301281|NCT00695786|UT MD Anderson Cancer Center|Felipe Samaniego,MD/Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
22301282|NCT02542839|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22301283|NCT00791843|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22301284|NCT04244396|Abbott_Medical_Devices|Emily Jesser Clinical Research Scientist II|6514482520|emily.jesser@abbott.com|
22301285|NCT01787097|Imperial College|Dr Omar S Usmani|+44 (0)20 7351 8051|o.usmani@imperial.ac.uk|
22301286|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22301287|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301288|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca|
22301289|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu|
22301290|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300||
22301291|NCT02124889|WakeForest|Dr. Adolfo Fernandez|336-716-6099|afernand@wakehealth.edu|336
22331603|NCT04435431|Integrative Research Laboratories Sweden AB|Joakim Tedroff, Chief Medical Officer|+46707601691|joakim.tedroff@irlab.se|
22331604|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22331605|NCT03554798|FIDEC Corporation|Ricardo Rüttimann, PhD|+5491161188536|rruttimann@fidec-online.org|
22331606|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22331607|NCT01552408|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
22331608|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
22331609|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
22331610|NCT01016912|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
22331611|NCT01199952|University of California, San Francisco|Director for Research Operations|415-206-2476|abby.sokoloff@ucsf.edu|
22331612|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22331613|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331614|NCT00089505|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22331615|NCT02431559|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22331616|NCT03820388|University of California Davis|Dr. Hong Liu|916-734-5031|hualiu@ucdavis.edu|
22331617|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
22331618|NCT05047601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331619|NCT00286234|Sanford School of Medicine, University of South Dakota|Dr. William Harris|16052716917|bill@omegaquant.com|2
22331620|NCT04834375|Northwell Health|Dr. Stella Hahn|516-465-5400|sthahn@northwell.edu|
22331621|NCT02924129|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
22331622|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu|
22331623|NCT03279731|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
22272340|NCT02604173|Stanford University|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22272341|NCT04226495|University of Nebraska Medical Center|Jeffrey Songster|308-520-2847|jeffrey.songster@unmc.edu|
22301292|NCT00989092|Amgen Inc.|Study Director|866-572-6436||
22301293|NCT02713711|UC de Maule|Professor Gabriel Nasri Marzuca Nassr|56 71 203463|gmarzuca@gmail.com|
22301294|NCT03837509|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22301295|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk|
22301296|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu|
22301297|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu|
22301298|NCT03320018|Stony Brook Medicine|Christine Pol|6314449083|christiana.pol@stonybrookmedicine.edu|
22301299|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22301300|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711|marc.rosen@yale.edu|2575
22272342|NCT02993354|Montefiore Medical Center|Dr. Peter Bernstein|718-904-2767|pbernste@montefiore.org|
22301301|NCT03026790|University of Minnesota|Erin Krebs|612-629-7558|Erin.Krebs@va.gov|
22301302|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300||
22301303|NCT02274857|Abbott|Clinical Program Director|651-756-6717|kristin.ruffner@abbott.com|
22301304|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22301305|NCT00952822|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22301306|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
22301307|NCT01965782|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22331624|NCT00302731|University of Kansas Medical Center|Jeanne A Drisko, MD, CNS, FACN|913-588-6208|jdrisko@kumc.edu|
22331625|NCT02780869|Biom'up|Rachel Hoffman, Vice President Clinical Operations North America|404-702-9253|r.hoffman@biomup.com|
22331626|NCT01610752|Pennington Biomedical Research Center|Dr. Leanne M. Redman|2257630947|leanne.redman@pbrc.edu|
22331627|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22331628|NCT04745065|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|401-360-2980|kevers@prochange.com|
22331629|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov|
22331630|NCT01482598|Abbott|Alessandra Denaro, Sr. Director Clinical Site Management||alessandra.denaro@abbott.com|
22331631|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org|
22331632|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22301308|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22301309|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu|
22301310|NCT03786952|Ohio Northern University|Phillip Zoladz|419-772-2142|p-zoladz@onu.edu|
22319409|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22319410|NCT01831544|Medtronic|Methee Schreuder|+31611597388|methee.schreuder@medtronic.com|
22319411|NCT03308942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319412|NCT01281007|EMS|Manager of Clinical Trials|+5501938874176|pesquisa.clinica@ems.com.br|
22319413|NCT01205438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22319414|NCT00786825|University of Minnesota|Elizabeth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
22319415|NCT03632109|University of Washington|Dr. Lindley Barbee, Principal Investigator|206.744.2595|lbarbee@u.washington.edu|
22319416|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319417|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590||
22319418|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov|
22319419|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com|
22319420|NCT05696236|University of Michigan|Charles Schuler|734-232-2154|schulerc@med.umich.edu|
22319421|NCT05341700|Virginia Tech|Dr. Enette Larson-Meyer|5402311025|enette@vt.edu|
22319422|NCT01829360|University of Kansas|Holly Storkel|7858640099|hstorkel@ku.edu|
22319423|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22319424|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385|peter.winkler@medunigraz.at|83193
22319425|NCT00041067|SWOG|Study statistician|206-667-4623||
22319426|NCT04722250|Medtronic Cardiovascular|Myra Fan Director|763 514 4000|rs.smarttrial@medtronic.com|
22319427|NCT04145544|Nurami Medical Ltd|Dr. Amir Bahar (COO & Clinical Director)|+972-747408888|Amir@nurami-medical.com|
22319428|NCT01395316|University of Chicago|Dr. Adil Javed||ajaved@neurology.bsd.uchicago.edu|
22319429|NCT00688181|Boston Scientific Corporation|Director, Clinical Operations|(952) 930-6300|Teresa.Takle-Flach@bsci.com|
22319430|NCT01891721|VA Greater Los Angeles Healthcare System|Dr. Carol Jahchan|310-478-3711|carol.jahchan@va.gov|42953
22319431|NCT02846532|Janssen Research & Development, LLC|SR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319432|NCT05103280|University of Nebraska at Omaha|Sara A. Myers, PhD - Professor|(402) 554-3246|samyers@nebraska.edu; ffallahtafti@unomaha.edu|
22319433|NCT04908189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22319434|NCT00607022|University of Iowa|Clark Stanford|319-335-7381|CStanford@uiowa.edu|
22319435|NCT04786119|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22319436|NCT06132763|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
22319437|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22319438|NCT04585776|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22319439|NCT03622619|Eye Research Group, SOVS, UNSW Sydney|Dr Jacqueline Tan|02 9385 6551|jacqueline.tan@unsw.edu.au|
22319440|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de|
22319441|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org|
22319442|NCT01658826|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22331633|NCT03702166|UT Health San Antonio|John Moring, PhD|(210) 562-6716|moringj@uthscsa.edu|
22331634|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu|
22331635|NCT03512028|Washington University School of Medicine|Catherine Lang|314-286-1945|langc@wustl.edu|
22331636|NCT03245372|Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud|Dr. Alejandro Domínguez-Blanco|0034660762856|aledguez@gmail.com|
22331637|NCT04047342|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
22331638|NCT02720627|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22331639|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22331640|NCT01861587|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
22331641|NCT02127931|CogCubed|Monika Roots, MD|6122509737|monika.d.heller@gmail.com|
22331642|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22331643|NCT00617994|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22331644|NCT02028182|Allerderm(dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smarthealth.com|
22331645|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
22331646|NCT01945866|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
22331647|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au|
22331648|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22331649|NCT02930889|University of Minnesota|Jafar Golzarian, MD|612-626-5566|jafar@umn.edu|
22331650|NCT04398030|Capillary BioMedical, Inc.|Alayne Lehman Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
22331651|NCT05056311|Indiana University|Elaine Cuevas|317-278-7495|elinder@iu.edu|
22331652|NCT01714726|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22331653|NCT03724305|Henry Ford Health|Chaewon Sagong|2483442409|csagong1@hfhs.org|
22331654|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
22331655|NCT02600559|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22331656|NCT01710007|Orient Europharma Co., Ltd.|Vivian Lu|+886-2-2755-4881|Vivian.Lu@oppharma.com|2958
22331657|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22331658|NCT03628781|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|15136368296|jeff.epstein@cchmc.org|
22331659|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22331660|NCT03778021|University of Washington, Department of Epidemiology|Shirley A.A. Beresford, Principal Investigator|206 543 9512|beresfrd@uw.edu|
22331661|NCT00679042|CellTrans Inc.|Jennifer Cook|312-413-7727|jenny@celltransinc.com|
22331662|NCT02392078|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
22331663|NCT01513538|Medtronic|Céline This|33 6 89 71 90 67|celine.this@medtronic.com|
22331664|NCT02079077|University of Manitoba|Keith Fowke|204-789-3296|keith.fowke@umanitoba.ca|
22331665|NCT01928758|Penn State College of Medicine|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
22331666|NCT02718131|University of Alabama at Birmingham|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
22331667|NCT03198559|University of Melbourne|Professor Sharon Lewin|+61 (0)3 8344 3309|sharon.lewin@unimelb.edu.au|
22331668|NCT02816255|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
22331669|NCT04051320|University of North Carolina at Chapel Hill|Crystal Schiller, PhD|919-966-5243|crystal_schiller@med.unc.edu|
22331670|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
22331671|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu|
22331672|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641|jkalinyak@naviscan.com|108
22331673|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov|
22331674|NCT02172820|The University of Vermont|Diann Gaalema, Ph.D., PI|802-656-9874|Diann.Gaalema@med.uvm.edu|
22331675|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22331676|NCT01348828|Endologix|Sripad Bellary, Director Clinical Affairs|9257011628|sbellary@endologix.com|
22331677|NCT04246996|Dell Medical School at The University of Texas at Austin|Mary Rieger, MD, MAS|512-324-7036|mary.rieger@austin.utexas.edu|
22331678|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22331679|NCT02442284|AbbVie|Global Medical Services|800-633-9110||
22331680|NCT02208466|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
22331681|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22331682|NCT03088345|Medical College of Wisconsin/Children's Hospital of Wisconsin|Dr. Amee Bigelow|5136364200|amee.bigelow@cchmc.org|
22331683|NCT01521494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22283677|NCT04271475|Actelion Pharmaceuticals Ltd|Clinical Science Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22283678|NCT04555837|The University of Texas MD Anderson Cancer Center|Faye Johnson, MD|(713) 792-6363|fmjohns@mdanderson.org|
22331684|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331685|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
22301311|NCT04918147|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22301312|NCT03292146|Massachusetts General Hospital|Karen K. Miller, MD|617-724-7388|KKMILLER@mgh.harvard.edu|
22331686|NCT03006276|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
22331687|NCT04126187|Gainesville Eye Associates|Clayton Blehm, MD|17705324444|claytonblehm@gmail.com|
22331688|NCT00689728|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283679|NCT01818284|UT MD Anderson Cancer Center|Chitra Hosing, MD/Professor, Stem Cell Transplantation|713-792-7734|cmhosing@mdanderson.org|
22283680|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22283681|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com|
22283682|NCT03040414|HealthPartners Institute|Amy Becker LaFrance, Sr. Manager, Research Project Management Office|952.967.5079|Amy.B.LaFrance@healthpartners.com|
22331689|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22331690|NCT02155725|LFB Biomédicaments|Medical Director France|33 169827229|zitounis@lfb.fr|
22331691|NCT03417999|Children's Hospital of Philadelphia|Dr. Kelly Grogan|410-279-6994|grogank@chop.edu|
22331692|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22331693|NCT03815006|Manchester University NHS Foundation Trust|Dr Lala Leelarathna|01612766706|lalantha.leelarathna@manchester.ac.uk|
22331694|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu|
22331695|NCT02539160|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
22331696|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com|
22331697|NCT00372905|Northwestern University|Jane Winter, MD|312 695 4033|Jwinter@nm.org|
22331698|NCT01728454|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22331699|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com|
22331700|NCT02218424|Ann & Robert H. Lurie Children's Hospital of Chicago|Hubert Benzon, MD; Primary Investigator|312-227-5122|hbenzon@luriechildrens.org|
22331701|NCT02980211|University of Iowa College of Dentistry|Dr. Gustavo Avila-Ortiz, Professor and Chair, Department of Periodontics|3193357241|gustavo-avila@uiowa.edu|
22331702|NCT01832753|The Children's Hospital of Philadelphia|Andrea Kelly, MD MSCE|215-590-3174|kellya@email.chop.edu|43174
22331703|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22331704|NCT02058966|Veterans Affairs Portland Healthcare System|Dr. William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
22331705|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it|
22331706|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22331707|NCT01272245|UT MD Anderson Cancer Center|Kantarjian,Hagop M|713-792-7026|CR_Study_Registration@mdanderson.org|
22331708|NCT02545504|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22331709|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org|
22331710|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800|Subhajit.Chakravorty@va.gov|3405
22331711|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22331712|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331713|NCT00508820|Amgen Inc.|Study Director|866-572-6436||
22331714|NCT03539900|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
22331715|NCT02926833|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22331716|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331717|NCT01206296|MedStar Health Research Institute|Director of Clinical Trials|301-560-7300|Research@MedStar.Net|
22331718|NCT01520038|University of Pennsylvania|John Christodouleas, MD|215-662-6568|christojo@uphs.upenn.edu|
22331719|NCT03159455|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331720|NCT02641691|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
22331721|NCT02022566|Lunds university|Physical therapist Therese Jönsson|0046703360721|therese.jonsson@med.lu.se|
22331722|NCT03503565|KYUNG HEE UNIVERSITY HOSPITAL AT GANGDONG|Dr Hyungseok Seo|+821029306885|seohyungseok@gmail.com|
22331723|NCT03799198|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22331724|NCT03427931|University of Virginia|Sue Brown, MD|4349820602|sab2f@virginia.edu|
22331725|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
22331726|NCT02501642|James A. Haley VA|Tracy Kretzmer, Ph.D.|813-972-2000|tracy.kretzmer@va.gov|5729
22331727|NCT05959564|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
22331728|NCT03410693|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22331729|NCT00953576|Beth Israel Deaconess Medical Center|Glenn Bubley, MD||gbubley@bidmc.harvard.edu|
22331730|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22331731|NCT02687815|University of Pittsburgh|Dr. Juan Celedón|(412) 692-8429|juan.celedon@chp.edu|
22331732|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22331733|NCT02558634|Vancouver Coastal Health Research Association|Amanda Chisholm, Manager, Internal Awards|6048754111|amanda.chisholm@vch.ca|21696
22331734|NCT03814824|Northwell Health|Dr. Arvind Trindade|516-387-3990|atrindade@northwell.edu|
22331735|NCT03053102|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22331736|NCT01798056|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283683|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22331737|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com|
22272343|NCT02333383|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22272344|NCT04459598|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22272345|NCT00866333|Syndax Pharmaceuticals, Inc.|Michael L. Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
22272346|NCT01854879|Cochlear Americas|Lori O'Neill Director of Research|(303) 790-9010|loneill@cochlear.com|
22272347|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129|sjannas@uoguelph.ca|53907
22272348|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com|
22272349|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22272350|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272351|NCT02232477|Lundquist Institute|Dr. Agnes Chen|424-306-7635|ahchen@lundquist.org|
22272352|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
22272353|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu|
22272354|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu|
22272355|NCT05025332|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
22272356|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
22272357|NCT02830074|John D. Dingell VA Medical Center|Dr. M.Safwan Badr, MD, Ph.D.|3135763548|m.badr@va.gov|
22272358|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707||
22272359|NCT02788188|National Institute of Allergy and Infectious Diseases|Davey, Richard|+1 301 496 8029|rdavey@niaid.nih.gov|
22272360|NCT00582426|Novartis|Study Director|1-800-778-8300||
22272361|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de|
22272362|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu|
22272363|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu|
22272364|NCT04727528|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22272365|NCT04656301|NY State Psychiatric Institute|Dr. Franklin Schneier|6467748041|franklin.schneier@nyspi.columbia.edu|
22272366|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
22272367|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272368|NCT01964989|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22272369|NCT02769312|Providence VA Medical Center, Center for Neurorestoration and Neurotechnology|Dr. Noah S. Philip|401-273-7100|noah.philip@va.gov|6235
22272370|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu|
22272371|NCT01148459|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272372|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22272373|NCT00948922|H. Lee Moffitt Cancer Center and Research Institute|Dr. Melissa Alsina|813-745-7202|melissa.alsina@moffitt.org|
22272374|NCT04854057|Spaulding Rehabilitation|Dr. Randy Trumbower|6179526822|randy.trumbower@mgh.harvard.edu|
22272375|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283684|NCT05824936|Nemours Children's Hospital|Dr. Abigail Strang|3026516400|astrang@nemours.org|
22272376|NCT02693717|UT MD Anderson Cancer Center|Jianjun Gao, MD PHD, Associate Professor, Genitourinary Medical Oncology|(713) 563-4195|jgao1@mdanderson.org|
22272377|NCT05114564|CooperVision|José A. Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
22272378|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za|
22272379|NCT03247322|Medical University of South Carolina|David Taber, PharmD, MS|843-792-3368|taberd@musc.edu|
22272380|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300||
22272381|NCT03798327|Icahn School of Medicine at Mount Sinai|Dr. Nathan Goldstein|212-844-1712|Nathan.goldstein@mssm.edu|
22272382|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu|
22283685|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|2220
22283686|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22272383|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22272384|NCT03332095|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22301313|NCT06134180|Case Western Reserve Unviersity|Kylie Meyer|2163681928|knm77@case.edu|
22301314|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101||
22331738|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22331739|NCT01008059|Washington University|Evan D. Kharasch, MD PhD|314-362-8796|kharasch@wustl.edu|
22331740|NCT02660489|Imperial College London|Professor Sebastian Johnston|+44 (0)20 7594 3764|s.johnston@imperial.ac.uk|
22331741|NCT02322866|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22331742|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111|yamakage@sapmed.ac.jp|3568
22331743|NCT03735680|OncoNano Medicine, Inc.|Vice President, Clinical Operations|682-285-1411|clinicaltrials@onconanomed.com|
22331744|NCT03930524|University of Michigan|Dr. Megan Patrick|734-763-5043|meganpat@umich.edu|
22331745|NCT02145949|University of Oregon|Dr. Hans Dreyer|541-346-3902|hcdreyer@uoregon.edu|
22331746|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
22331747|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
22331748|NCT04602078|Spanish Oncology GenitoUrinary Group (SOGUG)|A responsible person designated by the Sponsor|0034934344412|investigacion@mfar.net|
22331749|NCT03472586|Thomas Jefferson University|Marlana Orloff, MD|215-955-9974|marlana.orloff@jefferson.edu|
22331750|NCT02928900|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
22331751|NCT02452320|Weill Cornell Medicine|Farrell Cooke, Senior Research Assistant|212-746-2774|fac2010@med.cornell.edu|
22331752|NCT03737812|AbbVie|Global Medical Services|800-699-9110|abbvieclinicaltrials@abbvie.com|
22331753|NCT03693846|University of Pennsylvania|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
22331754|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov|
22331755|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22331756|NCT03471507|Duke University Medical Center|Lance Roy, M.D.|919-684-8111|lance.roy@duke.edu|
22331757|NCT02103608|Tennesse clinical research center|Dr. Michael Gold|615-383-2400|drgold@goldskincare.com|
22331758|NCT02557308|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
22331759|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr|
22331760|NCT04337827|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223-8100|TaussigResearch@ccf.org|
22331761|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
22331762|NCT04491955|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22331763|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22331764|NCT05375942|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331765|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301315|NCT03905330|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22331766|NCT03326323|Inova Heart and Vascular Institute|Eric L. Sarin MD|703-776-4138|eric.sarin@inova.org|
22283687|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
22283688|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22283689|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de|
22283690|NCT00875056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283691|NCT02459275|University of Miami|Dr. D. Dante Yeh|305-585-1822|dxy154@med.miami.edu|
22283692|NCT03826199|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
22331767|NCT03360695|Massachusetts General Hospital|Kelly Irwin, MD, MPH|617-643-4453|kirwin1@partners.org|
22331768|NCT00851721|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22331769|NCT04047472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22331770|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22331771|NCT02347345|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
22331772|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331773|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu|
22331774|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22331775|NCT03485976|Oregon Health & Science University, Department of Dermatology|Teri Greiling, MD, PhD|503-494-8452|PRPStudy@ohsu.edu|
22331776|NCT02132312|Omeros Corporation|Omeros Clinical Trial Information|ctinfo@omeros.com|ctinfo@omeros.com|
22331777|NCT00955682|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331778|NCT04034225|Sensei Bio|Alice Drumheller|2404548027|adrumheller@senseibio.com|
22331779|NCT01680835|Medtronic|Jennifer Seamans, M.S., Clinical Research Program Manager|763-398-7455|jennifer.l.seamans@medtronic.com|
22331780|NCT03026556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331781|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
22331782|NCT02612194|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22331783|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu|
22331784|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com|
22331785|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com|
22331786|NCT01922336|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82 31 8061 4534|sbregistry@samsung.com|
22331787|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22331788|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com|
22331789|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com|
22331790|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu|
22331791|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu|
22331792|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu|
22331793|NCT04001790|Virginia Commonwealth University|Carol Schall|8048286979|cmschall@vcu.edu|
22331794|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu|
22331795|NCT04542304|Stanford University|Tammy Lisa Sirich, MD|650-849-1907|tsirich@stanford.edu|
22331796|NCT02652793|Hospital Clinic of Barcelona|Dr. José Luis Blanco|+34 932275400|jlblanco@clinic.cat|
22331797|NCT04963231|Rhythm Clinical Trials|Rhythm Pharmaceuticals, Inc.|857-264-4280|clinicaltrials@rhythmtx.com|
22331798|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
22331799|NCT02957149|Mayo Clinic|Matthew Gettman, MD|507-284-3249|Gettman.Matthew@mayo.edu|
22331800|NCT06045026|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22331801|NCT04550234|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22331802|NCT02702115|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
22331803|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331804|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com|
22331805|NCT03911401|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22331806|NCT05602818|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22331807|NCT03814499|Fondazione Telethon|Head of Clinical Development and Operations|+3902202217224|szancan@telethon.it|
22331808|NCT03417245|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22331809|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22331810|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22331811|NCT04620356|kimberlyClark|Clinical Science Manager|+55 11 45034500|debora.rodrigues@kcc.com|
22331812|NCT00457951|Chimerix|Zahra Masoud|763-300-0559|zmasoud@chimerix.com|
22331813|NCT03740152|Massachusetts General Hospital|Dr. Paolo Cassano, M.D.|617-643-9622|pcassano@mgh.harvard.edu|
22331814|NCT02951143|University of Kentucky|Mikhail Koffarnus|8593236402|koffarnus@uky.edu|
22331815|NCT01590628|Gamida Cell|Kelly Myers, CRA|026595631|kelly@gamida-cell.com|
22331816|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org|
22331817|NCT02992743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283693|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com|
22283694|NCT01012921|Institut Straumann AG|Julia Dorn|0041619651111|julia.dorn@straumann.com|
22331818|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22331819|NCT03290131|RVL Pharmaceuticals, Inc.|Vice President, Regulatory Affairs and Quality|908-809-1300|Regulatory@RVLpharma.com|
22331820|NCT00398476|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331821|NCT03099096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331822|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22331823|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22331824|NCT04899362|the First Hospital of Jilin University|Dr Yi Yang|0431|doctoryangyi@163.com|88782378
22272385|NCT00178646|UTHealth|Gerard E. Francisco|7137975246|Gerard.E.Francisco@uth.tmc.edu|
22331825|NCT03764813|Fondazione Policlinico Gemelli IRCCS|luciana teofilili medical director of the UNICATT cord blood bank|39 06 30154180|luciana.teofili@unicatt.it|
22331826|NCT03045926|Ipsen Pharma SAS|Medical Director|+33 (0)158335000|clinical.trials@ipsen.com|
22272386|NCT04942210|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22272387|NCT02776670|Alcon, A Novartis Division|Head, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22272388|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com|
22272389|NCT05460078|Atrium Health|Dr. Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
22272390|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org|
22272391|NCT01178814|Columbia University Irving Medical Center|Mark Heaney, MD|646-317-5199|mlh2192@cumc.columbia.edu|
22272392|NCT01687387|Innate Pharma|Director Clinical Operations|+33043030|info@innate-pharma.fr|30
22272393|NCT03838510|San Francisco Department of Public Health, University fo California San Francisco|Phillip Coffin, MD, MIA|628-217-6282|phillip.coffin@sfdph.org|
22272394|NCT02612688|Brown University|Jessica A. Ogarek, Senior Biostatistician|401-863-9356|jessica_ogarek@brown.edu|
22272395|NCT03913104|University of California, San Francisco|Natalie Morris|(415) 353-4724|natalie.morris@ucsf.edu|
22272396|NCT01119846|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289083|NCT05720312|Stanford University|Gregory Sahlem, MD|(650) 434-7844|gsahlem@stanford.edu|
22272397|NCT03420222|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22272398|NCT03292614|Dietrich-Bonhoeffer-Klinikum|Ulrike Holland|+49 395 775 3427|aug-st2@dbknb.de|
22272399|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu|
22331827|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org|
22331828|NCT03648073|University of Alabama at Birmingham|Samuel Galgano, Principal Investigator|2059341449|samuelgalgano@uabmc.edu|
22331829|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org|
22331830|NCT00450814|Mayo Clinic|Angela Dispenzieri, M.D., Morie A. Gertz, M.D.|(507) 284-2511|Dispenzieri.Angela@mayo.edu, Gertz.Morie@mayo.edu|
22331831|NCT03724552|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
22331832|NCT03866811|Columbia University|Dr. Lauren Chernick|2123056628|lc2243@columbia.edu|
22331833|NCT03602976|University of Pennsylvania|Dr. Ethan Weinberg|215-349-8222|ethan.weinberg@pennmedicine.upenn.edu|
22331834|NCT04837807|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22331835|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com|
22331836|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu|
22331837|NCT03260699|Department of Orthopaedic Surgery, Cleveland Clinic|Alison Klika, Research Manager|216 444-4954|klikaa@ccf.org|
22272400|NCT00187278|St Jude Medical|Pascale Ducloux, Clinical Manager|+3227746709|pducloux@sjm.com|
22272401|NCT00595101|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22272402|NCT01380691|Eli Lilly Company|Chief Medical Officer|800-545-5979||
22272403|NCT04100590|New York State Psychiatric Institute|Caroline A Arout, PhD|646-774-6167|caroline.arout@nyspi.columbia.edu|
22272404|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22272405|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu|
22272406|NCT03084315|University of Minnesota|Anne Joseph, MD, MPH|612-625-3789|lagre010@umn.edu|
22272407|NCT04424914|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272408|NCT02820181|The First Hospital of Shanxi Medical University|Dr.Jun Tian|+8618612270351|zguotian@126.com|
22272409|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com|
22272410|NCT03260790|Mayo Clinic|Avni Y. Joshi, M.D., M.S.|507-284-3165|Joshi.Avni@mayo.edu|
22272411|NCT02195427|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
22272412|NCT00624650|OHSU|Samantha Ruimy|5034940724|ruimy@ohsu.edu|
22272413|NCT03782974|USANA Health Sciences|Dr. Jeremy Tian|01-801-954-7658|jeremy.tian@usanainc.com|
22272414|NCT00136214|BIDMC|Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
22272415|NCT04985942|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22272416|NCT00171158|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22272417|NCT02757352|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22272418|NCT04750278|Foresee Pharma|Chief Medical Officer|408-823-4807|yisheng.lee@foreseepharma.com|
22272419|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu|
22272420|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu|
22272421|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu|
22272422|NCT01467271|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
22272423|NCT04392219|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
22272424|NCT03738163|Mölnlycke Health Care|Sabrina Chowdhury|+44 (0)7769 907654|sabrina.chowdhury@molnlycke.com|
22272425|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org|
22272426|NCT02085070|Yale Cancer Center|Director, Clinical Trials Office|12037372572|Joyce.Tull@yale.edu|
22272427|NCT01411319|University of Miami|Alan Pollack, MD, PhD|305-243-4916|apollack@med.miami.edu|
22272428|NCT02815267|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22272429|NCT04948827|Camino Pharma|Gonul Velicelebi|858-201-2901|gonul@caminopharma.com|
22272430|NCT04126317|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22272431|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org|
22272432|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22272433|NCT01602679|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342430329|cm2hq@virginia.edu|
22272434|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com|
22272435|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu|
22272436|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
22272437|NCT03610334|Inflectis Bioscience|Dr Anne Visbecq (Chief Medical Officer)|0630632020|annevisbecq@inflectisbioscience.com|33
22272438|NCT01204918|Yale University|Gerard Sanacora, PhD, MD: Professor of Psychiatry; Director, Yale Depression Research Program|(203) 974-7535|gerard.sanacora@yale.edu|
22272439|NCT05835063|University of Michigan|Melissa Cousino|(734) 936-4220|melcousi@med.umich.edu|
22272440|NCT01280682|Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University|Yang Tao|+86-13851498409|dryangtao@sina.com|
22272441|NCT02893423|Maimonides Medical Center|Kalpana Tyagaraj|718-283-1753|KTyagaraj@maimonidesmed.org|
22272442|NCT04677387|University of North Carollina at Chapel Hill|Delesha Carpenter, PhD, MSPH|828-250-3916|dmcarpenter@unc.edu|
22272443|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22272444|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272445|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com|
22272446|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com|
22272447|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu|
22272448|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22272449|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22272450|NCT01404949|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
22272451|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org|
22272452|NCT04475718|Orange Square Designs|Lisa Marceau|4014284197|lisa@orangesquare.com|
22272453|NCT02651688|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22331838|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org|
22331839|NCT00920582|Provention Bio, Inc.|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
22331840|NCT03319160|Zoll|Mike Osz|412-968-3333|mosz@zoll.com|
22331841|NCT03604159|NYU Langone|Dr. Joshua Lee|646-501-3552|Joshua.Lee@nyulangone.org|
22331842|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
22331843|NCT04533204|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
22331844|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22331845|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com|
22272454|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com|
22272455|NCT03409120|University of Alabama at Birmingham|Christopher Gonzalez|2059753732|clg17@uab.edu|
22331846|NCT01411917|University of Wisconsin School of Medicine, Department of Anesthesiology|Kristopher Schroeder|608-232-1542|kmschro1@wisc.edu|
22331847|NCT02791906|University of Pennsylvania|Associate Professor|2152007779|julio.chirinos@uphs.upenn.edu|
22331848|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22331849|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331850|NCT02984228|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
22331851|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu|
22331852|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22331853|NCT03014700|Stanford university School of Medicine|Glyn David Williams|650-723-5728|jumbo@stanford.edu|
22331854|NCT03044730|Northwestern University, Feinberg School of Medicine|William John Gradishar, MD, FACP, FASCO|(312) 695-4541|w-gradishar@northwestern.edu|
22331855|NCT02549040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331856|NCT02195349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331857|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
22331858|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100||
22331859|NCT00198107|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
22331860|NCT02513732|Abbott|Hajime Kusano, Senior Adviser Clinical|+1 4088451626|hajime.kusano@abbott.com|
22331861|NCT00934661|Anesthesiology|Dr. Pamela Nagle Assistant Professor|336-716-7180||
22331862|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22331863|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
22331864|NCT01358266|Santen Inc.|Clinical Operations|+1-415-268-9100|clinicaltrials@santen.com|
22331865|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22331866|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it|
22331867|NCT02777554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22331868|NCT02147132|UC COM Psychiatry Dept. -- Addiction Sciences Division|Jeff Theobald|5135858281|theobajy@ucmail.uc.edu|
22331869|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au|
22331870|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
22331871|NCT04070157|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22331872|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu|
22331873|NCT01966458|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
22331874|NCT01458535|AbbVie|Global Medical Services|800-633-9110||
22331875|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com|
22331876|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org|
22331877|NCT03757585|Massachusetts General Hospital|Janet Wozniak|6176436617|jwozniak@partners.org|
22331878|NCT03342911|Thomas Jefferson University|Jennifer Johnson|215-955-8874|jxj021@jefferson.edu|
22331879|NCT05064436|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22331880|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331881|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com|
22272456|NCT02670382|Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University|Dr. Stefania Lamon-Fava, Scientist I|617-556-3105|stefania.lamon-fava@tufts.edu|
22272457|NCT02910726|Memorial Sloan Kettering Cancer Center|Neeta Pandit-Taskar, MD|1-833-MSK-KIDS|pandit-n@mskcc.org|
22272458|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22272459|NCT03884985|University of Rochester|Martina Poletti|(585) 275-4801|martina_poletti@urmc.rochester.edu|
22331882|NCT04579666|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22331883|NCT05450198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
22272460|NCT02906033|Helsinki University Hospital|MNSc Maria Pulkkinen|+358 50 427 2678|maria.pulkkinen@hus.fi|
22331884|NCT04511533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22331885|NCT01982942|Medicinova Inc|Director, Medical Writing|8582468680|makhay@medicinova.com|
22331886|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22331887|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22272461|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22272462|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org|
22272463|NCT03417024|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
22272464|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272465|NCT01907217|St Patrick's University Hospital|Prof Declan McLoughlin|+353 1 2493343|d.mcloughlin@tcd.ie|
22272466|NCT03704948|University of Iowa|Lisa S. Segre|13193357079|lisa-segre@uiowa.edu|
22272467|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com|
22272468|NCT04504175|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22272469|NCT04607980|Amgen Inc.|Study Director|8665726436|medinfo@amgen.com|
22272470|NCT00448812|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|+1 (412) 716-0717|grubbm@bsci.com|
22272471|NCT02012959|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22272472|NCT03396822|University of Maryland School of Medicine|Daniel Harrison|410-328-5605|dharrison@som.umaryland.edu|
22272473|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu|
22272474|NCT03372382|McGovern Medical School, University of Texas, Health Science Center at Houston|Dr Jenifer Dinis, MD|713 500 6421|jenifer.dinis@uth.tmc.edu|
22272475|NCT03630705|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22272476|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
22272477|NCT04474054|FARAPULSE|Christopher (Kit) Schneider|617-686-7661|christopher.schneider@bsci.com|
22272478|NCT01523834|Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine) - SOC Clinica Ematologica|Dr. Francesco Zaja, Co-Investigator of the Study|+39 0432559604|francesco.zaja@asuiud.sanita.fvg.it|
22272479|NCT05725824|University of Arizona|Dr. Bryan Wong|5206268549|bryanwong@arizona.edu|
22272480|NCT03782571|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|904 443-3402|TKarkkai@its.jnj.com|2126
22272481|NCT03504189|Nuvo Group|VP Clinical|+972-3-6242266|adar.shani@nuvocares.com|1630
22272482|NCT03488563|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22272483|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110|francois.cabana@usherbrooke.ca|14233
22272484|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272485|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22272486|NCT02665741|University of California, Davis|Dr. Sooraj Tejaswi|916-734-7215|stejaswi@ucdavis.edu|
22283695|NCT01842581|Bausch Health Americas, Inc.|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22283696|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu|
22331888|NCT01512758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22331889|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com|
22331890|NCT04384120|Henry Ford Health|Dr. Joseph Tramer|2165362904|jtramer1@hfhs.org|
22331891|NCT06304064|Capricor Inc.|Study Director|858-727-1755|mawadalla@capricor.com|
22331892|NCT04140942|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
22331893|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22331894|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org|
22331895|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22331896|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu|
22331897|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu|
22331898|NCT02918968|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22331899|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net|
22331900|NCT03661346|University of Texas Medical Branch - Galveston|Dr. Mohamad Chaaban|281-338-0829|mrchaaba@UTMB.EDU|
22331901|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331902|NCT01374516|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22283697|NCT03973905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283698|NCT02553538|Massachusetts General Hospital|Dr. Sanja Percac-Lima|617-643-6980|spercaclima@partners.org|
22283699|NCT02648217|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22283700|NCT00357656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22283701|NCT04904809|Abbott Vascular|Sandeep Pingle|858-222-9673|sandeep.pingle1@abbott.com|
22283702|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22331903|NCT04629534|Medical University of South Carolina|Carol Wagner|843-792-5179|wagnercl@musc.edu|
22331904|NCT03732534|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22301316|NCT02712905|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22301317|NCT03624504|Medtronic (Shanghai) Management Co., Ltd.|Weifan Sun, Clinical Study Manager|021-20325267|weifan.sun@medtronic.com|86
22301318|NCT02975973|Baylor College of Medicine|Raymond Cho|713-798-7781|Raymond.Cho@bcm.edu|
22301319|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org|
22301320|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
22301321|NCT04435665|NFlection|Director of Clinical Operations|7078532199|comara@nflectionrx.com|
22301322|NCT02454101|AinShamsU|ahmed kotb|0100868199|ahmedmkotp@hotmail.com|+2
22301323|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302||
22301324|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov|
22301325|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301326|NCT02124265|Johns Hopkins University School of Medicine|Carisa Cooney|443-287-4629|ccooney3@jhmi.edu|
22301327|NCT00058123|North American Brain Tumor Consortium|Susan Chang, MD|410-955-8837|jfisher@jhmi.edu|
22301328|NCT02732366|University of Pittsburgh, Department of Physical Therapy|Christine M. McDonough, Assistant Professor of Physical Therapy|4123834603|cmm295@pitt.edu|
22301329|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu|
22301330|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org|
22301331|NCT04839965|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
22301332|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
22301333|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
22301334|NCT02276222|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22301335|NCT02170025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22301336|NCT01525602|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22301337|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu|
22272487|NCT03543176|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272488|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com|
22272489|NCT02626000|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22272490|NCT03441685|Vanderbilt University Medical Center|Dr. C. Melanie Schuele|615-936-5256|melanie.schuele@vanderbilt.edu|
22272491|NCT01796301|Amgen Inc.|Study Director|866-572-6436||
22301338|NCT02669784|Milton S. Hershey Medical Center|Rekha Cherian, M.D.|717-531-6735|rcherian@pennstatehealth.psu.edu|
22301339|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu|
22301340|NCT03703466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301341|NCT02412137|Texas Scottish Rite Hospital for Children|Dr. Brandon Ramo|2145597755|brandon.ramo@tsrh.org|
22301342|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
22301343|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22301344|NCT02240108|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
22301345|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org|
22301346|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
22301347|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
22319443|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu|
22319444|NCT03610165|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
22319445|NCT03196232|Stanford University|George A Fisher, Colleen Haas Chair in the School of Medicine|650) 725-9057|georgeaf@stanford.edu|
22319446|NCT02383589|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22319447|NCT04752475|Associate Professor of Prenatal Pediatrics at CUIMC|Russell Miller, MD|212-305-3151|rsm20@cumc.columbia.edu|
22319448|NCT04532372|City of Hope Medical Center|Dr. Sanjeet Dadwal|626-359-8111|sdadjeet@coh.org|
22319449|NCT03435003|Stony Brook University|Dr. Konstantinos Spaniolas|631-444-8330|konstantinos.spaniolas@stonybrookmedicine.edu|
22319450|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22331905|NCT02190604|Novartis|Study Director|862-778-8300||
22301348|NCT04233372|Hospital Clínic of Barcelona|Dr. Alexy Inciarte|+34932275400|ajinciar@clinic.cat|
22301349|NCT04958785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|GileadClinicalTrials@gilead.com|GILEAD-0
22319451|NCT03746951|Nationwide Children's Hospital|Dr. Senthil Krishna|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
22319452|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22319453|NCT00789867|Imperial College|Samia Soussi|0207 594 7980|s.soussi@imperial.ac.uk|
22319454|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com|
22319455|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319456|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu|
22319457|NCT02973425|UMass Chan Medical School|Rajani Sadasivam|15088568923|Rajani.Sadasivam@umassmed.edu|
22319458|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22319459|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
22319460|NCT03503513|University of Michigan|Dr. Denise Tate|(734) 647-5195|dgtate@umich.edu|
22319461|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com|
22283703|NCT03412097|Parker University|Dr. Katherine A Pohlman|972 438 6932|kpohlman@parker.edu|7148
22283704|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
22283705|NCT02900170|Albert Einstein Medical Center|Basma Abdulhadi|215456500|abdulhab@einstein.edu|
22283706|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org|
22283707|NCT01741532|ApoPharma Inc.|Caroline Fradette|416-401-7543|cfradett@apopharma.com|
22283708|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
22283709|NCT04983797|Biosense Webster, Inc.|Associate Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22283710|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac|
22283711|NCT01703065|University of Washington|Dr. Celestia Higano, MD|206-606-1152|thigano@u.washington.edu|
22283712|NCT02124772|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22283713|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu|
22283714|NCT01522404|Emory University|Allan I. Levey, MD, PhD|404-727-7220|alevey@emory.edu|
22283715|NCT02698371|University Fernando Pessoa|Prof. Patricia Manarte-Monteiro; Associate Professor|+351 225 071 300|patmon@ufp.edu.pt|
22301350|NCT01090310|Novartis|Study Director|862-778-8300||
22301351|NCT01224925|UiT The Arctic University of Norway (Tromsø university)|Associate professor Rita Kundzina|+4777649118|rita.kundzina@uit.no|
22301352|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22301353|NCT04149925|Lexington Medical Inc.|Annette Dunn|480-313-8505|annette@lexington-med.com|
22301354|NCT02472652|Thomas D Gazda MD PC|Thomas D Gazda MD|480 518 6299|goodgazda@yahoo.com|
22301355|NCT04586569|Boston Children's Hospital|Dr. Linda Bulich|617-355-7737|linda.bulich@childrens.harvard.edu|
22301356|NCT03185832|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
22301357|NCT03675451|Weill Cornell Medicine|Junaid Niaz|212.746.5793|mjn3001@med.cornell.edu|
22301358|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu|
22301359|NCT03439189|Exalenz Bioscience|Clinical trial manager|00 972 546605412|avrahamh@exalenz.com|
22301360|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331906|NCT02797951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22331907|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22331908|NCT04585906|Johns Hopkins Center for Indigenous Health|Emily E. Haroz, PhD, Co-Director of Research|410-960-9503|eharoz1@jhu.edu|
22331909|NCT03125382|IMP|Drª. Milene Fernandes|00351965751328|milenefernandes@hotmail.com|
22331910|NCT04626947|University of Pittsburgh|David G. Binion|412-647-4194|binion@pitt.edu|
22331911|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO|jayne.prats@themedco.com|1510
22331912|NCT06016556|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319462|NCT03823404|Quince Therapeutics, Inc.|Dr. Karen Smith|650 722 9813|ksmith@quincetx.com|
22319463|NCT04621734|University of Texas Health Science Center at San Antonio|Dr. Veronica Armijo-Garcia|210-274-8969|mirelesv@uthscsa.edu|
22319464|NCT01524133|Atlanta VAMC|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|3122
22319465|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us|
22319466|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu|
22319467|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22319468|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com|
22319469|NCT01292447|Women and Infants Hospital|Rebecca Allen|4012741122|rhallen@wihri.org|
22319470|NCT04504357|Boston University School of Public Health, Departments of Global Health and Epidemiology|Jacob Bor, ScD SM|(617) 358-2176|jbor@bu.edu|
22319471|NCT03085758|Adrenomed AG|Jens Zimmermann|+49 (0) 3302 20 77 810|jzimmermann@adrenomed.com|
22319472|NCT03974334|University of Massachusetts Medical School|Dr. Paula Gardiner|7744416716|paula.gardiner@umassmed.edu|
22319473|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org|
22319474|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22319475|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org|
22319476|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22319477|NCT01968070|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22319478|NCT03078595|Johann Wolfgang Goethe-University Frankfurt|Prof. Dr. med. dent. Peter Eickholz|+4915112433230|eickholz@med.uni-frankfurt.de|
22319479|NCT01822522|AMC Operations and Data Management Cener|Kim Mosby-Griffin|301-251-1161|kmosby@emmes.com|10158
22319480|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
22319481|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov|
22319482|NCT04029116|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
22301361|NCT02173548|Virginia Commonwealth University|Antonio Abbate, MD, PhD|(804) 828-0513|antonio.abbate@vcuhealth.org|
22301362|NCT03597568|University of I|Dr. Diana Jalal|319-338-0581|diana-jalal@uiowa.edu|
22301363|NCT03722927|Wake Forest Baptist Health|Dr. Christopher Runyan|336-716-4171|crunyan@wakehealth.edu|
22301364|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22301365|NCT05131165|RAND Corporation|Sebastian Linnemayr|310-393-0411|slinnema@rand.org|6734
22301366|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu|
22301367|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu|
22301368|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22301369|NCT00832767|Covidien|Jessica Carlson|203-821-4734|jessica.carlson@covidien.com|
22301370|NCT03043079|University of Pennsylvania|Dr. John P Fischer|2156627300|john.fischer2@uphs.upenn.edu|
22301371|NCT05674890|University of Iowa Hospitals and Clinics Department of Ophthalmology and Visual Sciences|Dr. Andrew Pouw|3193562928|andrew-pouw@uiowa.edu|
22301372|NCT04647032|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
22301373|NCT03856515|M.D. Anderson Cancer Center|Jason Robinson|713-792-2265|nicotinestudy@mdanderson.org|
22301374|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr|
22301375|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22301376|NCT05906368|UPMC, University of Pittsburgh|Dr. Katherine Grace Lim|412-641-1778|limkg2@upmc.edu|
22301377|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301378|NCT03387579|Indiana University School of Medicine|Dr. Katie Huff|3179449395|huffka@iupui.edu|
22301379|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org|
22301380|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu|
22301381|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301382|NCT01804816|Cleveland Clinic Foundation|Dr. W.H. Wilson Tang, MD|(216) 444-2121||
22301383|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu|
22301384|NCT02360319|Vanguard Research Group|Patrica Marcy|3474398035|pmarcy@northwell.edu|
22301385|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
22301386|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22301387|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301388|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22301389|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22301390|NCT03002610|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
22301391|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22301392|NCT01822587|MUSC|Michael Saladin|843-792-5306|saladinm@musc.edu|
22301393|NCT04225533|Serpin Pharma, LLC|Dr. Cohava Gelber|7033433258|cgelber@serpinpharma.com|
22301394|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
22301395|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301396|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se|
22301397|NCT04860518|Faron|Dr Juho Jalkanen|+358407071046|juho.jalkanen@faron.com|
22301398|NCT03882879|Rush University Medical Center|Dr. Jori Fleisher|13125632900|jori_fleisher@rush.edu|
22301399|NCT04496219|University of Washington|Dr. Sarah Psutka, MD, MS|206-598-4294|spsutka@uw.edu|
22301400|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590||
22331913|NCT00629343|Columbia University|Robert Taub, MD, PhD|(212) 305-4076|rnt1@columbia.edu|
22331914|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com|
22331915|NCT03907072|WAVE Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22331916|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331917|NCT00265109|Weill Cornell Medicine|Katharine A. Phillips MD|646-962-2820|kap9161@med.cornell.edu|
22331918|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com|
22331919|NCT03831282|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22331920|NCT02078557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331921|NCT01830621|The Ottawa Hospital Regional Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
22331922|NCT03556202|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22331923|NCT03223649|National Institutes of Health|Jack A. Yanovski, MD, PhD|3014960858|jy15i@nih.gov|
22331924|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331925|NCT05664672|Altria|Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22331926|NCT01475513|Virginia Commonwealth University|Kai Cheang|8049863269|kicheang@vcu.edu|
22331927|NCT02815670|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301401|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org|
22301402|NCT02151266|Emory University|Dr. Gary|404-727-8360|ragary@emory.edu|
22331928|NCT03164629|University of Miami|Shivank Bhatia, MD|305-585-7500|SBhatia1@miami.edu|
22301403|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22331929|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
22272492|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov|
22272493|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org|
22272494|NCT02829047|Vibrant Gastro|Clinical trials manager|046663322|service@vibrantgastro.com|
22272495|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272496|NCT02570750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283716|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu|
22283717|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22283718|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org|
22331930|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu|
22331931|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22331932|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331933|NCT01441882|Oregon Health & Science University|Stephen Spurgeon|503-494-4606|spurgeos@ohsu.edu|
22331934|NCT03996694|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
22331935|NCT02477319|Seattle Children's Hospital|Umer Khan (Principal Biostatistician)|206-884-7516|umer.khan@seattlechildrens.org|
22331936|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org|
22331937|NCT01678586|Massachusetts General Hospital|Dr. Lucy Chen|617-724-6102|mghpainresearch@partners.org|
22331938|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu|
22331939|NCT00808665|Vanderbilt University Medical Center|James Blair DO|615-343-6082|james.l.blair@vanderbilt.edu|
22331940|NCT02967393|Vanderbilt University Medical Center|Kathryn M. Edwards MD|615-322-8792|kathryn.edwards@vanderbilt.edu|
22331941|NCT01694849|GENFIT|Carol Addy, MD MMSc|+01 6179536469||
22331942|NCT05227404|University of Minnesota|Eileen Denning|612-626-8049|edenning@umn.edu|
22331943|NCT01326312|Oncternal|Mary Breitmeyer|858-434-1113|mbreitmeyer@oncternal.com|
22331944|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil|
22331945|NCT02787655|Atl VA|Joe Nocera|404 321 6111|joe.nocera2@va.gov|206354
22331946|NCT00678652|Clinical Trials Center, WRAIR|Paul B. Keiser, M.D.||noinformation@available.com|
22331947|NCT05146999|Galderma Research & Development, LLC|Felipe Weinberg, MD, MPH|817-961-5000|aestheticclinicaltrials@galderma.com|
22331948|NCT00383292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22331949|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22331950|NCT03570658|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22331951|NCT03301272|University of North Carolina at Chapel Hill|Daniel Roque, MD|919-966-8178|droque@neurology.unc.edu|
22331952|NCT03457701|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331953|NCT02243306|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331954|NCT03329404|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
22331955|NCT02221882|Eli Lilly and Company|Chief Medical Officer|800+545-5979|ClinicalTrials.gov@lilly.com|
22331956|NCT00740129|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22331957|NCT01598831|Asahi Kasei Pharma America Corp.|Director of Clinical Operations|(781) 419-1919|pallton@akpamerica.com|
22331958|NCT02384096|Boston Scientific Neuromodulation|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
22331959|NCT04095039|Duke University School of Medicine|Hrishikesh Chakraborty, DrPH|919-668-1238|hrishikesh.chakraborty@duke.edu|
22331960|NCT04768881|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22331961|NCT02903121|Oregon Health and Science University|Alison Edelman, MD, MPH|5034943666|edelmana@ohsu.edu|
22331962|NCT02370173|University of Arizona|"Dr. William D. Scott Killgore"|(520) 621-0605|killgore@arizona.edu|
22331963|NCT04236986|Yale University|Dr. Kelly Cosgrove Principal Investigator|2037376969|kelly.cosgrove@yale.edu|
22331964|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org|
22331965|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org|
22331966|NCT03523390|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22331967|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu|
22331968|NCT01365182|Case Western Reserve University|Amy Zhang PhD|2163680968|amy.zhang@case.edu|
22331969|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|513
22331970|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22331971|NCT01728194|Well Cornell Medicine|Faith M. Gunning, PhD, Vice Chair for Research, Dept of Psychiatry|212-746-5832|fgd2002@med.cornell.edu|
22331972|NCT02309372|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
22331973|NCT02054572|Amgen Inc.|Study Director|866-572-6436||
22331974|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil|
22331975|NCT02205177|Mayo Clinic|Stephen P Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
22331976|NCT03289676|UNIVERSITY OF MASSACHUSETTS BOSTON|Dr. Sun Kim|6172875372|sun.kim@umb.edu|6172875372
22331977|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
22331978|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22331979|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343||
22331980|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300|juan.toro2@va.gov|16777
22331981|NCT02576652|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22272497|NCT01884545|NYU Rory Meyers College of Nursing|Allison A. Vorderstrasse, DNSc, APRN, FAAN|212-998-5786|allisonvorderstrasse@nyu.edu|
22272498|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com|
22272499|NCT05537428|Yale University|Philip Corlett|2039747866|philip.corlett@yale.edu|
22272500|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22272501|NCT02445859|The Universit yof Leeds|Andrew Kirby|0044 113 3923989|a.kirby@leeds.ac.uk|
22272502|NCT02886884|University of Miami|Dr. Joshua M. Hare, MD|305-243-5579|jhare@med.miami.edu|
22272503|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454||
22272504|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22272505|NCT02279745|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22272506|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272507|NCT02603926|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
22272508|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22272509|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk|
22272510|NCT03244618|Unilever|Dr Jane Matheson|+44 (0)1516413633|jane.matheson@unilever.com|
22272511|NCT03469999|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
22272512|NCT03439462|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22272513|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272514|NCT02787681|Loma Linda University|H. Bryant Nguyen, MD|909-558-4000|hbnguyen@llu.edu|
22272515|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com|
22272516|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22272517|NCT03383692|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22272518|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
22272519|NCT01897766|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272520|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
22272521|NCT05011890|University of North Carolina Lineberger Comprehensive Cancer Center|Gita Mody|+1 919-966-3382|gita_mody@med.unc.edu|
22272522|NCT04776018|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22272523|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272524|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu|
22272525|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22272526|NCT04503668|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22272527|NCT02306694|Oregon Health & Science University|Dr. Jayson Taylor|503-494-8716|taylojas@ohsu.edu|
22272528|NCT01665677|Medical College of Wisconsin|Dr. Medhi Hamadani|414-805-6800|mhamadani@mcw.edu|
22272529|NCT00742027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22272530|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272531|NCT01764659|UMMC MSGCC|Howard Zhang, PhD|(410)706-6510|hzhang@umm.edu|
22272532|NCT01210352|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
22272533|NCT04227405|University of Maryland|Dr. Mariana Falconier, Associate Professor|301-405-4004|marianak@umd.edu|
22272534|NCT03536663|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|781-699-4203|ChiangHong.Ho@fmc-na.com|
22272535|NCT01502956|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22272536|NCT01616758|Oncternal Therapeutics|Mary Bretimeyer|8582092082|mbreitmeyer@oncternal.com|208
22272537|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272538|NCT02985021|VA Puget Sound HCS|Dr. Bruce Montgomery, PI|2062776878|rbmontgo@uw.edu|
22272539|NCT04105842|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22272540|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org|
22272541|NCT02163681|University of Missouri|Talissa Altes, MD|573-882-1026|altest@health.missouri.edu|
22272542|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com|
22272543|NCT01535443|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medial Director|+52 (33)30014200|lbaiza@sophia.com.mx|
22272544|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
22272545|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22272546|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272547|NCT03146741|University of Pennsylvania|Dr. Peter Reese|215-900-3782|peter.reese@uphs.upenn.edu|
22272548|NCT03224624|VA San Diego Healthcare System|Dena Rifkin|8585528585|dena.rifkin@va.gov|2784
22272549|NCT02589847|Rebiotix, Inc.|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
22272550|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org|
22272551|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com|
22272552|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272553|NCT03571607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272554|NCT00592592|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
22272555|NCT01134263|Sanofi Pasteur|Trial Transparency Team||Contact-US@sanofi.com|
22301404|NCT02354664|University of Florida|Barbara Smith, Assistant Professor|352-294-5315|bksmith@phhp.ufl.edu|
22301405|NCT04102579|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22301406|NCT05899686|UCaliforniaSF|Pekka Talke|4153063602|pekka.talke@ucsf.edu|
22301407|NCT00572195|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
22301408|NCT01602536|University of California, Irvine|Cornelia Pechmann|310-892-0619|cpechman@uci.edu|
22301409|NCT03076970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301410|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com|
22301411|NCT02565901|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22301412|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu|
22301413|NCT03701295|Johns Hopkins University|ETCTN Grants Administrative Manager|410-955-4044|jmurra33@jhmi.edu|
22301414|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22301415|NCT03391765|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301416|NCT03896009|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22301417|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22331982|NCT01756209|Pugliese Hospital of Catanzaro|Dr Francesco Peltrone, Responsible of clinical trial|+.39 0961 7123222|gallelli@unicz.it|
22301418|NCT03966053|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|5165623757|avlachos@northwell.edu|
22301419|NCT03586583|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22301420|NCT02832622|Abbott|Kwangdeok Lee, PhD|1-972-526-9673|kwangdeok.lee@abbott.com|
22301421|NCT00998400|University of Bologna|Professor Chiara Rafanelli|0039 051 2091847|chiara.rafanelli@unibo.it|
22301422|NCT03202472|Jonsson Comprehensive Cancer Center|Mark Glover|310 794-8742|mglover@mednet.ucla.edu|
22301423|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22301424|NCT02691182|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
22301425|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22301426|NCT02052310|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1200|063study@fibrogen.com|
22301427|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301428|NCT03708588|Aurora Health Care|Suhail Allaqaband, MD|414-469-3491|suhail.allaqaban@aah.org|
22301429|NCT02563002|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22301430|NCT03518125|BARDA|Susan Hollingsworth/Regulatory Operations Specialist|202-691-2040|Susan.Hollingsworth@hhs.gov|
22301431|NCT02416492|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
22301432|NCT02093663|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22301433|NCT00508404|Amgen Inc.|Study Director|866-572-6436||
22301434|NCT05453110|Baylor University Keller Army Community Hospital Division 1 Sports Physical Therapy Fellowship|Dr. Kelly M. Scott|509-595-7263|kmsid119@gmail.com|
22301435|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com|
22301436|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22301437|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu|
22301438|NCT02629991|Albert Einstein College of Medicine|Bonnie Taylor|7188397530|botaylor@montefiore.org|
22301439|NCT02799784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331983|NCT04806334|Cedars-Sinai Medical Center|Charles J Rosser, MD|310-423-3723|Charles.rosser@cshs.org|
22331984|NCT02811640|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@toh.ca|81620
22301440|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22301441|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22301442|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301443|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net|
22301444|NCT03086330|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22301445|NCT01970462|Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
22301446|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu|
22301447|NCT02740049|Imperial College London|Dr Coen Wiegman|+44(0)2075947846|c.wiegman@imperial.ac.uk|
22301448|NCT00948298|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
22301449|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu|
22301450|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu|
22301451|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301452|NCT04570436|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
22301453|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com|
22301454|NCT03172702|AstraZeneca|Global Clinical Lead|+18772409479|information.center@astrazeneca.com|
22331985|NCT03216499|Adult Brain Tumor Consortium (ABTC)|Roy Strowd, MD|410-955-8837|jfisher@jhmi.edu|
22331986|NCT01633398|National University Health System, Singapore|Carolyn Lam|(65)67048965|carolyn.lam@duke-nus.edu.sg|
22331987|NCT04557189|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22301455|NCT03673306|IRCCS Ospedale Policlinico San Martino, Genoa, Italy|Matteo Lambertini|+39 010 555 4254|matteo.lambertini@unige.it|
22301456|NCT02355743|BloodCenter of Wisconsin, Medical College of Wisconsin|Lynn Malec|414-257-2424|lynn.malec@bcw.edu|
22301457|NCT03678545|Cincinnati Children's Hospital Medical Center|Regina Yearout|513-517-2108|regina.yearout@cchmc.org|
22331988|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com|
22331989|NCT01811693|Keck School of Medicine of USC|Nerses Sanossian, MD|323-442-7793|nsanossi@usc.edu|
22331990|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22331991|NCT03590613|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22331992|NCT04369742|NYU Langone Health|Mark Mulligan, MD|(212) 263-5182|Mark.mulligan@nyulangone.org|
22331993|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300||
22331994|NCT01130831|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22283719|NCT02290938|RAND|Elizabeth D'Amico|310-393-0411|damico@rand.org|6487
22283720|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22283721|NCT04500769|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
22283722|NCT01511562|Massachusetts General Hospital|Tracy Batchelor, MD, MPH|617-643-1938|tbatchelor@partners.org|
22283723|NCT04736199|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22283724|NCT04744831|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22283725|NCT02805725|Institut Bergonie|Pr Antoine Italiano|+ 33 5 47 30 60 88|a.italiano@bordeaux.unicancer.fr|
22283726|NCT05926544|University of North Carolina at Chapel Hill|Abby Gamble, MA|828-513-0636|abigail_gamble@email.unc.edu|
22283727|NCT05111847|UNEEG medical|Clinical Operations, Medical Affairs|+45 41414244|LYBL@uneeg.com|
22283728|NCT06024096|Emory University|Daniel S. Graciaa, MD, MPH, MSc|404-712-1370|dsgraci@emory.edu|
22283729|NCT05818137|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22283730|NCT04938037|ErciyesU|Dr. Isa Cuce|+905056263723|dr.icüce@hotmail.com|
22283731|NCT05925374|Wayne State University|Dr. Erin Madden|2156053230|efmadden@wayne.edu|
22283732|NCT06071884|University of Pittsburgh, UPMC|Steven Orebaugh, MD|412-650-2965|orebaughsl@upmc.edu|
22283733|NCT03320330|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22283734|NCT05206370|Achieve Life Sciences|Roxann Becco, Sr. Director, Clinical Operations|425-686-1500|rbecco@achievelifesciences.com|
22283735|NCT04998851|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22283736|NCT05845398|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
22283737|NCT03028948|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne|7322356759|mannesl@cinj.rutgers.edu|
22283738|NCT06038123|Medtronic|Peter Tang, Principal Clinical Research Specialist|862138986622|peter.tang@medtronic.com|
22283739|NCT05218499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22283740|NCT03199469|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22283741|NCT05048433|The University of Texas Health Science Center at Houston|Timothy J Walker, PhD|713-500-9664|Timothy.J.Walker@uth.tmc.edu|
22283742|NCT04831424|Columbia University|Martin Picard|6467748967|mp3484@columbia.edu|
22283744|NCT05010018|Johns Hopkins University|Joel Gittelsohn|1-410-274-5310|jgittel1@jh.edu|
22283745|NCT05431387|Achieve Life Sciences|Julie Ball, Vice President, Clinical Operations|425-686-1540|jball@achievelifesciences.com|
22283746|NCT03199391|Zimmer Biomet|Madison Murphy|5745262059|madison.murphy@zimmerbiomet.com|
22283747|NCT01867086|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22283748|NCT04257929|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and RegulatoryWriting|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
22283749|NCT06036914|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|Reddy.Yogesh@mayo.edu|
22283750|NCT04697381|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283751|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
22283752|NCT04088331|Boston Scientific|Winnie Chen|952-930-6000|Winnie.Chen@bsci.com|
22283753|NCT06144918|Skye Bioscience|Chief Medical Officer|858-410-0266|info@skyebioscience.com|
22283754|NCT03500172|Johns Hopkins Bloomberg School of Public Health|Dr. Stefan Baral|4105028975|sbaral@jhu.edu|
22283755|NCT06274723|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
22283756|NCT05851937|Texas Christian University|Alison Prahl|8172575962|a.prahl@tcu.edu|
22283757|NCT03298451|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1 8772409479|information.center@astrazeneca.com|
22283758|NCT03824158|University of Pittsburgh|Yael Schenker, MD, MAS, FAAHPM|415-254-9958|yas28@pitt.edu|
22283759|NCT04908280|University of Rochester|Christopher T Richardson MD, PhD|585 - 275 - 7546|crichardson@urmc.rochester.edu|
22283760|NCT02322840|Medtronic|Yetunde Ishola (Clinical Study Manager)|734-221-8182|yetunde.a.ishola@medtronic.com|
22283761|NCT06987201|East Coast Institute for Research at Universal Axon Clinical Research|Rebecca Goldfaden, PharmD, CCRP|904-854-1354|rg@roviaclinical.com|
22283762|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283763|NCT02486718|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22283764|NCT05702918|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolický|+420702088258|jakubkatolicky@gmail.com|
22283765|NCT05910775|Yale University|Sina Nikayin, MD|203-688-9719|sina.nikayin@yale.edu|
22283766|NCT03982420|Boston Scientific|Megan White|(763) 494-1700|Megan.White2@bsci.com|
22283767|NCT03267134|Alcon Research, LLC|Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22283768|NCT02683993|Boston Scientific|Teri Bird|6123221189|teri.bird@bsci.com|
22283769|NCT03171545|University of Michigan|Dr. Tiffany Veinot|734-615-8281|tveinot@umich.edu|
22331995|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com|
22301458|NCT03088267|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
22301459|NCT02652481|Boston Scientific|Clinical Trial Manager|+32479983495|anneleen.viville@bsci.com|
22331996|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766|yanbinye72@163.com|8179
22331997|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu|
22331998|NCT02173158|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
22331999|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22332000|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22332001|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660||
22332002|NCT03747497|MicuRx Pharmaceuticals, Inc.|Study Director|510-782-2022|info@micrux.com|
22332003|NCT04927858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0217|clinicaltriage.rdg@boehringer-ingelheim.com|
22332004|NCT03461705|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
22332005|NCT03377803|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22332006|NCT00940446|OrthoIndy|Dr David A Fisher|(317) 802-2000|dafisher@orthoindy.com|
22332007|NCT03323034|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22332008|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu|
22272556|NCT01557517|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22301460|NCT02279043|University of California, San Francisco|Edith Fox|4152062544|edith.fox@ucsf.edu|
22301461|NCT00490282|The University of Texas (UT) MD Anderson Cancer Center|Adam Garden, MD/Radiation Oncology Department|(713) 563-2300|agarden@mdanderson.org|
22301462|NCT00774579|Imperial College Healthcare London|Prof. Desmond Johnston|020 3312 1253|desmond.johnston@imperial.ac.uk|
22301463|NCT02411565|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hye Sook Chon|813-745-7205|hyesook.chon@moffitt.org|
22301464|NCT02963974|University of North Carolina at Chapel Hill|Lisa Park, AuD, CCC-A|984-215-2871|lisa_park@med.unc.edu|
22301465|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301466|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22301467|NCT04898231|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
22301468|NCT06030414|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
22301469|NCT03184792|University of Washington|Dr. Fatma Inanici|2067872692|finanici@uw.edu|
22301470|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301471|NCT01352598|Mercy|Jaymeson Stroud, MD|314-251-6844|Jaymeson.Stroud@mercy.net|
22301472|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org|
22301473|NCT02495025|University of California Los Angeles|Principal Research Manager, Health Services Research Program|310-825-8624|lindseythompson@mednet.ucla.edu|
22301474|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22301475|NCT02721082|U. Kansas Medical Center|Dr. Kimber Richter|9134490157|krichter@kumc.edu|
22301476|NCT02453685|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22301477|NCT05238233|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
22301478|NCT02778100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301479|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu|
22301480|NCT04120233|University of Kentucky|Dr. Linda J. Van Eldik|1-859-257-5566|linda.vaneldik@uky.edu|
22301481|NCT05809596|Boston Scientific|Nicole Kelly, Clinical Trial Manager|1-800-CARDIAC|Nicole.Kelly2@bsci.com|
22301482|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301483|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301484|NCT04676425|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301485|NCT01410058|University of Zimbabwe College of Health Sciences|Tsitsi G Monera-Penduka|307148|moneratg@yahoo.co.uk|
22301486|NCT03027414|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
22301487|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22301488|NCT05178121|University of Washington|Doyanne Darnell|206-744-9108|darnelld@uw.edu|
22301489|NCT01953003|Institut de Recherche Pierre Fabre, Toulouse France|Karim Keddad, Head of Medical Unit|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
22301490|NCT03717402|Dana-Farber Cancer Institute|Andrea C. Enzinger, MD|617-582-7335|Andrea_Enzinger@DFCI.HARVARD.EDU|
22301491|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org|
22301492|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com|
22301493|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com|
22301494|NCT04672096|Neuronoff, Inc.|Jasmine Wilson|408-858-2612|jasmine@neuronoff.com|
22301495|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com|
22301496|NCT03496974|XBiotech|Ashley Otero, Corporate and Clinical Relations Manager|512-386-2930|aotero@xbiotech.com|
22301497|NCT01422135|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22301498|NCT04044456|Malcom Randall VAMC|Health Science Specialist|352-376-1611|julia.waid-ebbs@va.gov|105224
22301499|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au|
22332009|NCT02646566|Acacia Pharma|Dr Gabriel Fox|01223875919764|GabrielFox@acaciapharma.com|
22272557|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp|
22301500|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu|
22301501|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332010|NCT01905631|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
22332011|NCT03078504|Saint Louis University|Dr.Zafar Jamkhana|314-577-8856|zafar.jamkhana@health.slu.edu|
22332012|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu|
22332013|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu|
22332014|NCT01683331|University of Michigan|Akinlolu Ojo|734 936-4890|aojo@umich.edu|
22332015|NCT04341727|Washington University School of Medicine|Jane O'Halloran|314 454 0058|janeohalloran@wustl.edu|
22332016|NCT00503035|UT MD Anderson Cancer Center|Dr. Imad Shureiqi, MD|713-745-4929|ishureiqi@mdanderson.org|
22332017|NCT04645342|UCSF|Dr. Thomas Dewland|415-476-5706|thomas.dewland@ucsf.edu|
22332018|NCT05028816|UT Southwestern Department of Plastic Surgery Research|Jennifer Barillas, Research Coordinator|214-645-8907|jennifer.bqarillas@utsouthwestern.edu|
22332020|NCT04552769|Stanford University|Saad A. Khan, MD|650-498-6000|saad.a.khan@stanford.edu|
22332021|NCT04961645|Emory University|Daniel Dilks, PhD|404-727-2980|dilks@emory.edu|
22332022|NCT00070070|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22332023|NCT04576702|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22332024|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332025|NCT00003526|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22332026|NCT02059265|NRG Oncology|Christopher Purdy on behalf of Austin Miller|(716)845-1300|purdyc@nrgoncology.org|2296
22332027|NCT00998166|Columbia University|Mark Stoopler, MD|212-305-8230|mbs5@cumc.columbia.edu|
22332028|NCT04548349|Beth Israel Deaconess Medical Center|Jean S. McGee, MD, PhD|(617) 667-5834|jmcgee2@bidmc.harvard.edu|
22332029|NCT02985996|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22332030|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22332031|NCT03948646|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22332032|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org|
22332033|NCT03709342|CalciMedica|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
22332034|NCT03735849|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22332035|NCT05113277|Florida State University|Danielle M. Morabito|850) 645-1766|morabito@psy.fsu.edu|
22332036|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
22332037|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373|drlm@thepainmd.com|101
22332038|NCT04246593|State University of New York at Buffalo|Dr. Lucia Leone|(716) 829-6040|lucialeo@buffalo.edu|
22332039|NCT04278846|Cleveland Clinic|Raymond Isakov, MD|216 445-3765|ISAKOVR@ccf.org|
22332040|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300||
22332041|NCT02223520|Johns Hopkins Medical Institutions|Aaron M. Milstone, M.D., M.H.S.|410-614-3917|amilsto1@jhmi.edu|
22332042|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
22332043|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
22332044|NCT04717466|University of Miami|Dr. Hideki Mochizuki|305-234-4472|hxm414@med.miami.edu|
22332045|NCT04668157|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22332046|NCT03550989|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22332047|NCT02283411|Abbott Diabetes Care|Shridhara A Karinka, PhD|510-749-6393|shridhara.alva@abbott.com|
22332048|NCT05437211|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22332049|NCT02566304|Thomas Jefferson University|Usama Gergis, MD|215-955-8874|usama.gergis@jefferson.edu|
22332050|NCT03282123|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22301502|NCT04209725|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22301503|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
22301504|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22301505|NCT02954354|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22301506|NCT03468933|Tulane University|Dr. Fayez Kheir|504-988-3541|fkheir@tulane.edu|
22301507|NCT03039023|Cleveland Clinic Foundation|Jennifer Wilcox|216-636-6153|kirsopj@ccf.org|
22301508|NCT04026529|Omaha VA Medical Center|Dr. Debra Romberger|4025597539|debra.romberger@va.gov|
22301509|NCT03338829|University of Minnesota|Sarah A. Wernimont MD, PhD|612-301-3408|swernimo@umn.edu|
22301510|NCT05163418|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22301511|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu|
22301512|NCT02340026|The Children's Hospital of Philadelphia|Laura A. Prosser, PT, PhD|215-590-2495|ProsserL@chop.edu|
22301513|NCT02684006|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301514|NCT04642898|University of Kentucky|Dr. Sauer-Zavala|859-562-1571|ssz@uky.edu|
22301515|NCT04495179|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
22301516|NCT04280562|David Putrino|Icahn School of Medicine at Mount Sinai|212-824-8369|david.putrino@mountsinai.org|
22301517|NCT03434678|Memorial Sloan Kettering Cancer Center|Dr. Florence Grant, MD|212-639-8829|moses-gf@mskcc.org|
22301518|NCT02968420|Vaccine Evaluation Center|Dr. Manish Sadarangani|604-875-2422|msadarangani@bcchr.ubc.ca|
22332051|NCT01211405|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22301519|NCT00162370|Lantheus Medical Imaging|Director, Clinical Operations|978-671-8118|Sandra.Monte@lantheus.com|
22301520|NCT02061202|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|212-241-3650|jeffrey.glassberg@mountsinai.org|
22301521|NCT04559568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22332052|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com|
22301522|NCT03628287|City University of New York, School of Public Health|Denis Nash, PhD|347-331-6554|denis.nash@sph.cuny.edu|
22301523|NCT03721965|Incyte Corporation|Incyte Corporation Call Center|(0)330 100 3677|globalmedinfo@incyte.com|
22301524|NCT01895972|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
22301525|NCT04085328|Alcon Research, LLC|Expert CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22301526|NCT05608499|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
22301527|NCT02865720|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22301528|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu|
22301529|NCT02954523|Georgetown University|Chul Kim|12024442223|Chul.Kim@gunet.georgetown.edu|
22301530|NCT02038894|Cincinnati Children's Hospital Medical Center|Dr. Mario Patino|5132538190|mario.patino@cchcm.org|
22301531|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711|Caroline.Schmidt@va.gov|3391
22301532|NCT03124979|Masimo|Tala Harake||studies@masimo.com|
22301533|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu|
22301534|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22301535|NCT03266770|University Hospitals Cleveland Medical Center|Dr. Kyle Scarberry|(216)844-3009|Kyle.Scarberry@UHhospitals.org|
22301536|NCT04274894|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301537|NCT01936857|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22301538|NCT03848403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301539|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com|
22301540|NCT02080468|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
22301541|NCT02386995|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22301542|NCT00101933|Medtronic Neuromodulation|Jim Vollhaber, Clinical Study Manager|763-526-8093|medtronicneurotrials@medtronic.com|
22332053|NCT04081727|ZSX Medical, LLC|Director of Clinical Affairs|617-631-8865|info@zsxmedical.com|
22332054|NCT03572153|Baylor University|Gary Elkins, PhD|254-296-0824|gary_elkins@baylor.edu|
22332055|NCT04604015|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
22332056|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332057|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu|
22332058|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433|lhollins@atriummed.com|5365
22332059|NCT01979003|University of Arkansas for Medical Sciences|Alexander Burnett|5016868274|aburnett@uams.edu|
22332060|NCT03575975|Georgia Institute of Technology|Dr. Young-Hui Chang|404-894-9993|yh.chang@ap.gatech.edu|
22332061|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu|
22332062|NCT02441517|Astellas Pharma Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22301543|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu|
22332063|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332064|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
22332065|NCT01883362|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22332066|NCT01383317|Wake Forest University Health Sciences|Dr. Scott Miller|3367167437|scmiller@wakehealth.edu|
22332067|NCT03740724|Castle Creek Biosciences|Castle Creek Biosciences Clinical Trial Director|484-713-6000|clinicalresearch@castlecreekbio.com|
22332068|NCT01230489|University of Missouri-Columbia|Harold Moore|5738824433|mooreh@health.missouri.edu|
22332069|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22332070|NCT00967343|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@Kiadis.com|
22332071|NCT02032433|NYU School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyumc.org|
22332072|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org|
22332073|NCT02806700|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
22332074|NCT01255865|3M|Terri White|651-733-0228|twhite3@mmm.com|
22332075|NCT04887922|Washington University School of Medicine|Chet Hammill, M.D., MCR|314-273-1809|hamillc@wustl.edu|
22332076|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com|
22332077|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22332078|NCT00721513|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
22332079|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332080|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332081|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca|
22332082|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu|
22332083|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22301544|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301545|NCT04209075|NIDDK|Dr. Stephanie Chung|301-402-2122|Stephanie.Chung@NIH.gov|
22332084|NCT00290511|UT MD Anderson Cancer Center|Dr. Felipe Samaniego, MD-Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
22332085|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22332086|NCT04311411|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22332087|NCT03533829|Duke Vaccine and Trials Unit|Kristen Gunnell|9196848891|kristen.gunnell@duke.edu|
22332088|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22332089|NCT03988049|University of Utah Dermatology|Dr. David Smart, Assistant Professor, Dermatology|8015816465|david.smart@hsc.utah.edu|
22332090|NCT04780776|Boston University School of Medicine|Dr. Michael F. Holick|(617) 358-6139|mfholick@bu.edu|
22332091|NCT05888740|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
22332092|NCT03113760|AB2 Bio Ltd.|Eduardo Schiffrin|+41 21 694 00 40|eduardo.schiffrin@ab2bio.com|
22332093|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com|
22332094|NCT01982539|Depomed|Clinical Operations||clinicaltrials@depomed.com|
22332095|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no|
22332096|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063||
22332097|NCT05059366|University of Miami|Alecia Sabartinelli Stein, MD|305 585 8380|asabartinelli@med.miami.edu|
22332098|NCT04988035|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22332099|NCT03532048|Baylor College of Medicine|Teresia O'Connor|7137986782|teresiao@bcm.edu|
22332100|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22332101|NCT04366258|NYU Langone Health|Dan Iosifescu, MD|646-754-5156|Dan.Iosifescu@nyulangone.org|
22332102|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca|
22332103|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082|dabrams@hemeonc.ucsf.edu|444
22332104|NCT01383759|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
22332105|NCT02694393|University of Pittsburgh|Dr. Joseph Pilewski|(412) 692-2210‬|pilewskijm@upmc.edu|
22332106|NCT02556112|711 Human Performance Wing, U.S. Air Force|Col Nicole Armitage|937-255-3784|nicole.armitage@us.af.mil|
22332107|NCT04113746|Icahn School of Medicine at Mount Sinai|Juan P. Wisnivesky, MD, DrPH|212-824-7567|juan.wisnivesky@mountsinai.org|
22332108|NCT01717521|UWMC|Dr. Laurent Bollag|2063277328|bollag@uw.edu|
22332109|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
22332110|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu|
22332111|NCT00620191|Columbia University Medical Center|Jose Luchsinger|212-3054730|jal94@cumc.columbia.edu|
22332112|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
22332113|NCT03958045|University of Kentucky|Dr. Zhonglin Hao|859-218-6704|zhonglin.hao@uky.edu|
22332114|NCT00674440|Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania|Lisa J. States, MD|267-425-7146|states@chop.edu|
22332115|NCT01463631|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283770|NCT04409457|Icahn School of Medicine at Mount Sinai|Laura Berner|332-243-7259|laura.berner@mssm.edu|
22283771|NCT04865770|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22283772|NCT04763824|The University of Kansas Medical Center|Jennifer Klemp, PhD, Principal Investigator|9135887750|jklemp@kumc.edu|3662
22283773|NCT04539808|Oregon Health & Science University|Dr. Charles Lopez, Professor|503-494-1080|GIResearch@ohsu.edu|
22283774|NCT04522973|Virginia Commonwealth University|Michelle Peace, PhD|804-828-8240|mrpeace@vcu.edu|
22283775|NCT04007796|San Francisco VA Health Care System|Dr. Liz Goldstein|415-694-3443|lizabeth.goldstein2@va.gov|
22283776|NCT03573401|Biofrontera Discovery GmbH|Clinical Trial Management|Not available|ctm@bfinc.com|
22283777|NCT05579249|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22283778|NCT05028517|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
22283779|NCT04514341|Penn State College of Medicine|Karen Kim|7175318326|kkim5@pennstatehealth.psu.edu|
22283780|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com|
22283781|NCT01216683|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22283782|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283783|NCT04327024|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22283784|NCT05101798|Icahn School of Medicine at Mount Sinai|Orli Weiss|9086700847|orli.weiss@icahn.ismms.edu|
22283785|NCT03968159|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22283786|NCT00864851|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22283787|NCT00443781|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22283788|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283789|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283790|NCT02942654|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22283791|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22283792|NCT02006069|Abbott|Kwangdeok Lee PhD|+19725269673|kwangdeok.lee@abbott.com|
22283793|NCT00958932|National Jewish Health|Dr. Bruce Bender|303-398-1697|benderb@njhealth.org|
22332116|NCT04828993|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301546|NCT04639128|The Permanente Medical Group|Dr. Adrian Hinman|510-454-7292|adrian.d.hinman@kp.org|
22301547|NCT01218126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301548|NCT02574910|UT Southwestern Medical Center|Dr Perrin White|2146489246|perrin.white@utsouthwestern.edu|
22301549|NCT05380947|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22301550|NCT01563536|AbbVie|Global Medical Services|800-633-9110||
22301551|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
22301552|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de|
22301553|NCT02532556|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22301554|NCT06213701|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
22301555|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862|thomas.dietlein@uk-koeln.de|4300
22301556|NCT02563496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301557|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org|
22332117|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil|
22332118|NCT00863265|Washington University School of Medicine|Richard E. Ostlund MD|314-362-3516|rostlund@wustl.edu|
22301558|NCT00860379|Shriners Hospitlas for Children|Maggie Dylewski Begis|617-872-8567|mdylewski@shrinenet.org|
22301559|NCT01515748|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22332119|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|BrUOG@brown.edu|
22332120|NCT03679117|Lifespan Hospital|Margaret Bublitz|401-323-3356|mbublitz@lifespan.org|
22332121|NCT05510297|University of Southern California|Dr. Stacey Schepens Niemiec|323-442-2069|schepens@usc.edu|
22332122|NCT04409262|Hoffmann - La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22332123|NCT01738672|University of Pittsburgh|Ya'aqov Abrams, MD||abramsym@upmc.edu|
22332124|NCT02249377|New York Langone Health|Eric Strauss, MD|646 501 7223|Eric.Strauss@nyumc.org|
22332125|NCT04794491|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@jazzpharma.com|
22332126|NCT01326481|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22332127|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
22332128|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408||
22332129|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351|kelly.webber@uky.edu|859
22332130|NCT04553497|Ege University Faculty of Medicine, Physical Medicine and Rehabilitation|Dr. Emine Duran|+905372103145|docemineduran@gmail.com|
22332131|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22332132|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22332133|NCT03241485|University of Chicago Medicine|Richa Dhawan|773-702-1000|rdhawan@dacc.uchicago.edu|
22332134|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu|
22332135|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332136|NCT01466972|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
22332137|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org|
22332138|NCT01143818|Abbott|Global Medical Services|800-633-9110||
22332139|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22332140|NCT01731600|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22332141|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33|biryulin@biocad.ru|925
22332142|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22332143|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com|
22332144|NCT02696980|University of Vermont|Anne Dixon, MD|802 847 2700|anne.dixon@uvm.edu|
22332145|NCT02748096|University of Oxford|Professor Anrew Price|+44 1865 223421|andrew.price@ndorms.ox.ac.uk|
22332146|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org|
22332147|NCT03575806|Tsinghua University|Statistician of Clinical Trials||majunfan2@sina.com|
22332148|NCT03446846|Minerva Neurosciences, Inc.|Head of Research & Development|617.600.7375|jsaoud@minervaneurosciences.com|
22332149|NCT02842736|Channel Medsystems|Clinical and Regulatory Affairs|510-338-9301|clinreg@channelmedsystems.com|
22332150|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu|
22332151|NCT02389621|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22332152|NCT04158466|Bausch Health|Study Director|(585) 338-6399|robert.steffen@bausch.com|
22332153|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329|aritmo@asl4.liguria.it|0039
22332154|NCT02815540|Gillette Children's Specialty Healthcare|Director of Research|651-229-1745|Research@gillettechildrens.com|
22332155|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22332156|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com|
22332157|NCT02526017|Five Prime Therapeutics|Helen Collins, Chief Medical Officer|650-745-9633|helen.collins@fiveprime.com|
22332158|NCT01249625|University of Texas Southwestern|Dr. Trish Perl|214-648-9022|Trish.Perl@UTSouthwestern.edu|
22301560|NCT03221387|Lewis Katz School of Medicine at Temple University|Adam Nester, JD, MS|215-707-1986|coisom@temple.edu|
22332159|NCT03541356|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
22332160|NCT04969653|Momentum Data Ltd|Dr Andrew McGovern|07531221970|andy.mcgovern@momentumdata.co.uk|
22332161|NCT03986216|Northwestern University|Dr. Jun Yao|3129089060|j-yao4@northwestern.edu|
22332162|NCT03413618|Pirogov Russian National Research Medical University|Dr. Kirill Lobastov|+7-985-211-63-31|lobastov_kv@hotmail.com|
22332163|NCT03246152|Cairo University|Dr. Ayman Elnahry|00201224927604|ayman_elnahri@hotmail.com|
22283794|NCT02989805|Emory University|Benjamin Druss, MD, MPH|404-712-9602|bdruss@emory.edu|
22283795|NCT02776033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283796|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283797|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283798|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22283799|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org|
22283800|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22283801|NCT02725593|Study Information Center|Global Clinical Lead|+1-887-240-9479|information.center@astrazeneca.com|
22283802|NCT03689244|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22283803|NCT03283436|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
22283804|NCT01355796|University of Iowa|Janice Launspach|319-356-2047|janice-launspach@uiowa.edu|
22283805|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22283806|NCT03897036|Senhwa Biosciences|Jason Huang, MD / Chief Medical Officer and Acting Chief Executive Officer|(858) 552-6808|jasonhuang@senhwabio.com|112
22283807|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283808|NCT02718040|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
22283809|NCT00475215|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283810|NCT00699218|UC Davis|Guohua Xia|916-734-3574|gxia@ucdavis.edu|
22283811|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283812|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu|
22283813|NCT01672866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22283814|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu|
22283815|NCT05714943|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
22283816|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com|
22283817|NCT02544373|University of Michigan|Tiffany J. Braley, MD, MS, Associate Professor of Neurology|734-936-6267|tbraley@med.umich.edu|
22283818|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu|
22283819|NCT04208087|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8593|722_clinical_project_team@seikagaku.co.jp|
22283820|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org|
22283821|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu|
22283822|NCT02621073|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22283823|NCT01595581|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
22283824|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283825|NCT03028636|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
22283826|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22283827|NCT02920957|CooperVision Inc|Sr.Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22283828|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319483|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528||
22319484|NCT02469896|Barrow Neurological Institute|Shafeeq Ladha, MD|602-406-8989|Shafeeq.Ladha@Barrowneuro.org|
22319485|NCT02019420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319486|NCT02510560|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098626|Miki@elganpharma.com|
22319487|NCT02401412|Hollister Incorporated|Stacy Haddad, Global Clinical Affairs Director|847-680-2837|stacy.haddad@hollister.com|
22319488|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org|
22319489|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se|
22319490|NCT03684642|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22319491|NCT04556396|Loyola University Medical Center|Kristin Baldea|708-216-9000|kbaldea@lumc.edu|
22319492|NCT01843218|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22319493|NCT01431534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319494|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu|
22319495|NCT06154213|University of Connecticut|Sherry Pagoto, PhD|(860) 486-5917|sherry.pagoto@uconn.edu|
22319496|NCT05118204|Albert Einstein College of Medicine|Aaron Fox|718-920-7173|adfox@montefiore.org|
22319497|NCT06263582|UNC Lineberger Comprehensive Cancer Center|Sorgi Kate|919-966-5280|kasorgi@email.unc.edu|
22319498|NCT05393037|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22319499|NCT04409353|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
22319500|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300||
22319501|NCT04540133|UCSF|Dr. Alessandro Villa|415-476-2045|Alessandro.Villa@ucsf.edu|
22319502|NCT04014361|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22283829|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu|
22301561|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22301562|NCT04648150|Hopital fondation Rothschild|Dr Amélie YAVCHITZ|+33148036454|ayavchitz@for.paris|
22332164|NCT00423137|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332165|NCT01005810|Medical University of South Carolina|Dr. Kevin M. Gray, Associate Professor|843-792-6330|graykm@musc.edu|
22332166|NCT04196023|Vanderbilt University Medical Center|Dr. Qi Dai|(615)936-0707|qi.dai@vanderbilt.edu|
22332167|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
22332168|NCT03303144|Rockwell Medical|Dr Ray Pratt|248 960-9009|rpratt@rockwellmed.com|405
22332169|NCT04359758|Georgetown Lombardi Comprehensive Cancer center|Marc D. Schwartz, PhD|2026870185|schwartm@georgetown.edu|
22332170|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de|
22332171|NCT03358407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332172|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22332173|NCT03605758|Albert Einstein College of Medicine|Dr. Christina Coyle|718-430-3525|christina.coyle@einsteinmed.edu|
22332174|NCT04804579|Boston University School of Public Health|Theresa W. Kim MD|(617) 414-6932|therkim@bu.edu|
22332175|NCT04753606|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22332176|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu|
22332177|NCT04389294|Hospital for Special Surgery|Dr. Ellen M. Soffin|(212) 606-1206|SoffinE@HSS.edu|
22332178|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu|
22332179|NCT03841331|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
22332180|NCT03219372|Cedars Sinai Medical Center|Shehnaz K. Hussain, PhD, ScM|310-429-9859|Shehnaz.Hussain@cshs.org|
22332181|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501|laurie.zawertailo@camh.ca|77422
22332182|NCT04640168|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22332183|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
22332184|NCT02866721|University Hospitals, Rainbow Babies and Children's Hospital|Erica Roesch, MD|(216) 844-3267|Erica.Roesch@UHHospitals.org|
22332185|NCT03557775|Medical University of South Carolina|Dr. Heather Shaw Bonilha|843-792-2527|bonilhah@musc.edu|
22332186|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu|
22332187|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332188|NCT04259905|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
22332189|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22332190|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu|
22332191|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
22332192|NCT03455556|Mayo Clinic|Alex A Adjei, MD, PhD|(507) 284-2511|Adjei.Alex@mayo.edu|
22332193|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332194|NCT02304484|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22332195|NCT04338685|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22332196|NCT00234533|Ipsen|Medical Director, Pediatric Endocrinology||clinical.trials@ipsen.com|
22332197|NCT02967055|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22332198|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332199|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22332200|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com|
22332201|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net|
22332202|NCT04930562|BioNova Pharmaceutical Limited Company|Medical Director|+86(21)50901280|yu.wang@bionovapharma.com|
22332203|NCT02279888|Vanderbilt University Medical Center|Dr. Lynne Stevenson|6159368187|lynne.w.stevenson@vanderbilt.edu|
22332204|NCT00752206|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22332205|NCT01484691|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
22332206|NCT03522506|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22332207|NCT05705544|Vanderbilt University Medical Center|Dr. Fabian Maldonado|(615) 322-5000|fabien.maldonado@vumc.org|
22332208|NCT03480243|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22332209|NCT04365387|Galderma Research & Development, LLC|Sponsor|817 961 5000|aestheticclinicaltrials@galderma.com|
22301563|NCT06223373|Wake Forest University Health Sciences|Kristen Faith Nicholson, PhD|704-355-2000|Kristen.Nicholson@advocatehealth.org|
22301564|NCT03770494|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301565|NCT05050578|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22301566|NCT02243280|AbbVie|Global Medical Services|800-633-9110||
22301567|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518|medtronicCRMtrials@medtronic.com|62864
22301568|NCT05377359|Sonova|Bilal Sheikh, Research Audiologist|2268083260|bilal.sheikh@sonova.com|
22301569|NCT04682119|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301570|NCT03386032|The Procter & Gamble Company|Laurie Moulton, M.S., Statistical Group Scientist|+1-513-544-3636|moulton.lt@pg.com|
22332210|NCT05770401|University of Montana|Jane Reynolds Salois|406-243-2138|jane.salois@umontana.edu|
22332211|NCT03449342|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22332212|NCT01683565|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
22301571|NCT03364348|Stanford Medicine at Stanford University|Sinyoung Park|650-721-4485|sinyoung@stanford.edu|
22301572|NCT03276637|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
22301573|NCT04082442|Johns Hopkins University|Thorsten Leucker, MD|410-502-0469|tleucke1@jhmi.edu|
22301574|NCT04525547|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301575|NCT03122119|Star Spine and Sports|Dr. Douglas Hemler, Prinical Investigator|3035701834|dhemler@starcolorado.com|
22301576|NCT01768832|Washington University in St. Louis|Dr. Gammon M. Earhart|314-286-1407|earhartg@wustl.edu|
22301577|NCT04372628|Vanderbilt University Medical Center|Clinical Trials Operations Manager|(615) 875-3080|kelly.walsh@vumc.org|
22301578|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
22301579|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
22301580|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111|catherine.malboeuf-hurtubise@umontreal.ca|4594
22301581|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org|
22301582|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
22301583|NCT00508261|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301584|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com|
22301585|NCT01746095|Savara Inc.|Head of Clinical Development|+45 7930 1414|info@savarapharma.com|
22301586|NCT03315143|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22301587|NCT00840801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301588|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com|
22301589|NCT02736825|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22301590|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
22301591|NCT02901626|Christiana Care Health System, Department of Obstetrics & Gynecology|Matthew Hoffman, MD, MPH|(302) 301-3350|mhoffman@christianacare.org|
22301592|NCT04082884|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
22301593|NCT03724487|Case Western Reserve University|Dr. Carolyn Still, Assistant Professr|216-368-6338|cwh11@case.edu|
22301594|NCT02421666|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|2157078823|grace.ma@temple.edu|
22301595|NCT03662074|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-0230|saverill@wakehealth.edu|
22301596|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22301597|NCT01621880|Sun Yat-sen Memorial Hospital, Sun Yat-sen University|Yamei Tang|08613556001992|yameitang@hotmail.com|
22319503|NCT06308666|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
22319504|NCT05225103|Duke University|David Goldston|919-681-1100|david.goldston@duke.edu|
22332213|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org|
22332214|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
22332215|NCT04524507|University of North Carolina at Chapel Hill|Luther Bartelt, MD|919-966-2537|barteltl@ad.unc.edu|
22332216|NCT02939326|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
22332217|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu|
22332218|NCT03039699|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22332219|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332220|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
22332221|NCT02911285|Medical University of South Carolina|Stacey Sellers, Program Manager|843-792-5807|sellersst@musc.edu|
22332222|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22332223|NCT03418727|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
22332224|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com|
22332225|NCT02451137|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22332226|NCT05981508|Morehouse School of Medicine|Candice L. Alick, PhD|404-752-1009|calick@msm.edu|
22332227|NCT02010359|Children's Hospital of Philadelphia|Dr. Rachana Shah|215-590-3390|shahr@email.chop.edu|
22332228|NCT01740297|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22332229|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu|
22332230|NCT03280628|Vanderbilt University Medical Center|Dr. Holly Hanson|615-936-7317|holly.r.hanson@vumc.org|
22332231|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com|
22332232|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22332233|NCT02047929|Carolinas HealthCare System|Dr. Thomas Ludden|704-608-2390|tom.ludden@carolinashealthcare.org|
22319505|NCT04252287|Janssen Scientific Affairs, LLC|Director CVM Health Equity|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319506|NCT03857321|Atrium Health Wake Forest|Suzanne Craft, PhD|336-713-8846|suzcraft@wakehealth.edu|
22319507|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu|
22319508|NCT02564926|Astrazeneca, Korea|EunYoung Kim / Local Study Specialist|82 2 2188 0946|EunYoung.Kim@astrazeneca.com|0946
22319509|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com|
22319510|NCT01554488|William S. Middleton Memorial VA Hospital|Mihaela Teodorescu, MD-Principle Investigator|(608)2561901|mt3@medicine.wisc.edu|11080
22319511|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22319512|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22332234|NCT02848781|College of Medicine - Phoenix|Rodrick Tung, MD|602-521-3090|rodricktung@arizona.edu|
22301598|NCT01446666|Asan Medical Center, University of Ulsan College of Medicine|Professor Young-Suk Lim|+82-02-3010-5933|limys@amc.seoul.kr|
22301599|NCT00580814|UCaliforniaIrvine|Tim Wigal, Ph.D., director UCI CHild Development Center|949-824-1812|tlwigal@uci.edu|
22301600|NCT04504331|Stanford Medicine at Stanford University|Jennifer Lee Caswell-Jin, MD|1-310-332-6541|caswell@stanford.edu|
22301601|NCT01804101|Fred Hutchinson Cancer Center|Dr. Roland B. Walter|206-667-3599|rwalter@fredhutch.org|
22301602|NCT02202746|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22301603|NCT03701399|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22301604|NCT04179032|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301605|NCT03945292|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
22301606|NCT03033225|Mayo Clinic|Kenneth K. Wang, MD|507-284-2511|wang.kenneth@mayo.edu|
22301607|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org|
22301608|NCT04283448|Montana State University|Mary P Miles|406 994-6678|mmiles@montana.edu|
22301609|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22301610|NCT02618967|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22301611|NCT06060457|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22301612|NCT00673309|University of Texas Medical Branch|Tina Mack-Moshay- ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
22301613|NCT02676375|Department of Psychiatry, University of California San Diego|Dr. Arthur Brody|8585528585|abrody@ucsd.edu|3775
22301614|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22301615|NCT05656040|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22301616|NCT05103384|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
22301617|NCT02612311|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22301618|NCT05288660|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22301619|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com|
22301620|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22332235|NCT02163759|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22332236|NCT02883400|Atrium Health|Dr. Mark Russo,|704-355-6649|mark.russo@atriumhealth.org|
22332237|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu|
22332238|NCT03022526|University of Pittsburgh|Dr. Grace Lim|412-641-2179|limkg2@upmc.edu|
22332239|NCT03315780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22332240|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu|
22332241|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu|
22272558|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com|
22272559|NCT02259699|University of California, Irvine|Dr. Lari Wenzel|949-824-3926|lwenzel@uci.edu|
22272560|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22272561|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272562|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu|
22301621|NCT04751942|Univeristy Hosptials Cleveland Medical Center|Rachael Kilkenny|216-545-4850|Rachael.Kilkenny@UHhosptials.org|
22272563|NCT02548949|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272564|NCT03230838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272565|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org|
22272566|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu|
22272567|NCT02697734|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22301622|NCT04510675|Princeton Consumer Research Corp.|Principal Investigator|727-576-7300|bd@princetonconsumer.com|
22301623|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22332242|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260|khirst@bsc.gwu.edu|8025
22332243|NCT01972282|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Lucas V.A. Boersma||l.boersma@antoniusziekenhuis.nl|
22332244|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net|
22332245|NCT05732610|Medical Group Care|Tomaz Lovse|239 631 1907|tomaz.lovse@mgc.us|
22332246|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920||
22332247|NCT04717323|Altec Inc.|Dr. Paola Contessa|5085458236|pcontessa@altecresearch.com|
22332248|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com|
22332249|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu|
22332250|NCT05461742|Brown University|Dr. Tayla von Ash|401-863-6192|tayla_ash@brown.edu|
22332251|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332252|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332253|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22332254|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu|
22332255|NCT02335229|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
22332256|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu|
22332257|NCT02277665|Dartmouth-Hitchcock|Dr. Alan J. Budney|603-646-7088|alan.j.budney@dartmouth.edu|
22272568|NCT02324699|Icahn School of Medicine at Mount Sinai|Dr. Bruce Sands|212-241-8100|bruce.sands@mssm.edu|
22272569|NCT03970200|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22272570|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272571|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22272572|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300||
22272573|NCT02740335|Clinical Research Management Group|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
22272574|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272575|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk|
22272576|NCT02033200|Vivus Inc|VP of Development|650-934-5200||
22272577|NCT04333225|Baylor Scott & White Research Institute|Peter A. McCullough, MD, MPH|2148412000|peteramccullough@gmail.com|
22272578|NCT04318132|Nidek.co., ltd.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
22332258|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629||
22332259|NCT04854421|Pennington Biomedical Research Center|Dr. Steven Heymsfield|(225) 763-2541|steven.heymsfield@pbrc.edu|
22332260|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu|
22272579|NCT01863732|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22272580|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
22272581|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400|d49311001@ym.edu.tw|5750
22272582|NCT00840034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272583|NCT05811026|Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan|Dr. Chang-Ming Huang|+886-2-23123456|daniel510791@gmail.com|262141
22272584|NCT02870205|Glenmark Pharmaceuticals Ltd|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22272585|NCT02839876|Duke University Medical Center|Dr. Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
22272586|NCT01313351|Rapid Pathogen Screening, Inc|Robert Sambursky, MD|9415581853|rob.sambursky@lumosdiagnostics.com|
22272587|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org|
22272588|NCT03816007|VA San Diego Healthcare System|Dr. Erik Groessl|858-642-6347|erik.groessl@va.gov|
22272589|NCT03628716|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
22272590|NCT02179749|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22272591|NCT02620384|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
22272592|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com|
22272593|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22272594|NCT02526160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22272595|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
22272596|NCT03231397|Washington University School of Medicine|Dr. Sean J. English|(314) 362-5707|sjenglish@wustl.edu|
22272597|NCT04076319|USC Suzanne Dworak-Peck School of Social Work|Dr. Benjamin Henwood|+1 (213) 821-0496|bhenwood@usc.edu|
22272598|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272599|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com|
22272600|NCT03252145|University of California, San Francisco|Betty Smoot, DPTSc, PT|(707) 494-8262|Betty.Smoot@ucsf.edu|
22272601|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22272602|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22272603|NCT01763827|Amgen Inc.|Study Director|866-572-6436||
22272604|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22272605|NCT04446429|Applied Biology|Director of Clinical Trials|+1-949-387-4526|monican@appliedbiology.com|
22272606|NCT05205005|Harry S. Truman Memorial Veterans' Hospital|Harry S. Truman Memorial Veterans' Hospital Research Service|573- 814-6000|Camila.Manrique-Acevedo@va.gov|56550
22272607|NCT01869777|Wake Forest University Health Sciences|Principal investigator|336-716-5440|tpardee@wakehealth.edu|
22272608|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22272609|NCT04399889|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
22272610|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22332261|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
22332262|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22332263|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614||
22332264|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22332265|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
22332266|NCT01600755|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22332267|NCT03464110|Duke University|Dr. Kathryn Pollak|919-681-4757|kathryn.pollak@duke.edu|
22272611|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22272612|NCT02455453|Washington University School of Medicine|Farrokh Dehdashti, M.D.|314-747-1604|dehdashtif@wustl.edu|
22272613|NCT04957212|Cinnagen Co.|Dr.Nasim Anjidani|0989125477964|anjidani.n@orchidpharmed.com|
22272614|NCT02260817|Decatur Memorial Hospital, Decatur, IL|Thomas H. Tarter, M.D., Ph.D - Director, Urologic Oncology, Cancer Care Specialists of Illinois|(217) 876-6600|ttarter@ccsci.net|
22272615|NCT03299101|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
22272616|NCT06363292|Laboratorios Sophia|Alejandra Sanchez Rios|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22332268|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301624|NCT04653766|Bioxodes|Medical Writer|+32 (0)71 239 602|stephanie.demoulin@bioxodes.com|
22301625|NCT04557930|Dartmouth-Hitchcock|Dr. Amber E. Barnato|603-646-5609|Amber.Barnato@dartmouth.edu|
22301626|NCT00500903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22301627|NCT03063294|Veterans Affairs Greater Los Angeles Healthcare System|David Avram Ganz, MD, PhD|310-478-3711|David.Ganz@va.gov|
22301628|NCT03818672|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22301629|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
22301630|NCT00803452|University of Louisville|Professor Douglas Borchman|502 852 7435|borchman@louisville.edu|
22301631|NCT03987841|University of Alabama at Birmingham|Caroline Presley|205-934-7609|capresley@uabmc.edu|
22301632|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
22301633|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu|
22301634|NCT03017079|THE SECOND AFFILIATED HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE|Dr|18817821529|hm198699@126.com|
22301635|NCT04450108|Bosch Healthcare Solutions|Dr. Klaus Müller, Study director|+49 160 90816081|klaush.mueller@de.bosch.com|
22301636|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk|
22301637|NCT04506970|Mayo Clinic|Mauro Schenone|5072840210|schenone.mauro@mayo.edu|
22301638|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22301639|NCT02882282|MD Anderson Cancer Center|Renata Ferrarotto, MD|713-792-6363|rferrarotto@mdanderson.org|
22301640|NCT03928028|Children's Hospital of Philadlephia|C. Alix Timko|2674265467|timkoc@chop.edu|
22301641|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com|
22301642|NCT02802501|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301643|NCT02012192|Medical University of Innsbruck|Prof. Dr. Nicole Concin|+43 512 504|nicole.concin@i-med.ac.at|81433
22301644|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com|
22301645|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu|
22301646|NCT02803125|VA Boston Healthcare System|Anica Pless Kaiser, PhD|857-364-5309|Anica.PlessKaiser@va.gov|
22301647|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
22301648|NCT05067439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301649|NCT03135535|Baylor College of Medicine|Prof.|17137987536|bijan.najafi@bcm.edu|
22301650|NCT02323646|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22301651|NCT00089141|Fred Hutchinson Cancer Research Center (FHCRC)|Paul J. Martin, M.D.|206-667-4798|pmartin@fhcrc.org|
22301652|NCT01559948|Texas Woman's University|Dr. Kelli Brizzolara|214-689-7722|kbrizzolara@twu.edu|
22301653|NCT02459262|MinervaX ApS|Per Fisher DPhil|+45 20 25 20 38|pbf@minervax.com|
22301654|NCT05168579|University of Pittsburgh|Dr. Deepika Mohan|404-375-9325|dem73@pitt.edu|
22301655|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22301656|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu|
22301657|NCT03687190|Changhua Christian Hospital|Chung-Min Chiu|*886-982-506-067|shongdiah@gmail.com|
22301658|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22301659|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301660|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com|
22301661|NCT01750879|Massachusetts General Hospital|Dr. Wayne Shreffler|617-726-6147|WSHREFFLER@mgh.harvard.edu|
22332269|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22332270|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn|
22332271|NCT02354352|Ohio State University|Dr. Subha Raman|614-293-8963|raman.1@osu.edu|
22332272|NCT02696382|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22332273|NCT00494234|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22332274|NCT04446182|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22332275|NCT04436497|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22332276|NCT01335620|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
22332277|NCT04145531|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22332278|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu|
22332279|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22332280|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu|
22332281|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22332282|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22332283|NCT00104858|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
22332284|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22332285|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22332286|NCT02161380|Bascom Palmer Eye Institute.|Dr. Byron Lam.|305 326 6021|blam@med.miami.edu|
22332287|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu|
22272617|NCT04217317|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-5878|dfunes@wakehealth.edu|
22301662|NCT02347657|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22272618|NCT01424241|Columbia University Medical Center|Pamela Freda, MD|212-305-2254|puf1@columbia.edu|
22272619|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org|
22272620|NCT05259917|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
22272621|NCT05050448|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
22272622|NCT05391555|University of California San Francisco|Rachel Eshima McKay|415-476-9035|rachel.eshima@ucsf.edu|
22272623|NCT00303472|Amgen Inc.|Study Director|866-572-6436||
22272624|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620|info@valneva.com|0
22272625|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
22272626|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu|
22272627|NCT03585712|HRA Pharma|Agnes Hemon|0140337092|a.hemon@hra-pharma.com|
22272628|NCT03517449|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22272629|NCT03319810|Sutter Institute for Medical Research|Carol Parise, PhD, Research Scientist|(916) 887-4744|PariseC@sutterhealth.org|
22272630|NCT01090141|Unknown|Tawanda Gumbo||Unknown@utsouthwestern.edu|
22272631|NCT01808222|Emory University|David Schuster MD|404-712-4859|dschust@emory.edu|
22272632|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com|
22283830|NCT03180307|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
22283831|NCT03159104|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22283832|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111|Jan.Hofland@radboudumc.nl|3658
22283833|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283834|NCT04350307|Yale University|Dr. Robin Raju|203-688-8800|robin.raju@yale.edu|
22283835|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr|
22283836|NCT01742065|Kaiser Permanente Center for Health Research|Gloria D. Coronado|503 335 2427|Gloria.D.Coronado@kpchr.org|
22283837|NCT01858753|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
22283838|NCT02675114|Edwards Lifesciences|Research Director|949-250-2500|THV_CT.gov@Edwards.com|
22283839|NCT00582998|University of Alabama at Birmingham|Asya Love, RN|205-996-6781|asyalove@uab.edu|
22283840|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov|
22283841|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283842|NCT02688868|Shanghai Microport Medicine|HT Zhang|+862138954600|zhanght@microport.com|8552
22283843|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com|
22283844|NCT02066129|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
22283845|NCT02616393|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
22283846|NCT02642965|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22283847|NCT04557787|Coloplast A/S|Vice President, Medical Affairs|+454911 1111|clinical-studies@coloplast.com|
22283848|NCT02713867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22283849|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22283850|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu|
22283851|NCT00180297|Boston Scientific|Elisabeth Mouton - Clinical Trial Manager|+33 1 39 30 11 90|elisabeth.mouton@bsci.com|
22283852|NCT02657564|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
22283853|NCT04135859|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
22283854|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net|
22283855|NCT01291836|Alere San Diego|William Arnold|858-505-2000|william.arnold@alere.com|
22283856|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
22283857|NCT00084149|University of California, San Diego|Dr. Florin Vaida|619 543-8045|fvaida@ucsd.edu|
22283858|NCT03230292|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22283859|NCT03123614|University of Utah Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
22272633|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
22272634|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr|
22332288|NCT03655951|innovation Research & Training|Dr. Tracy Scull|919-493--7700|tscull@irtinc.us|118
22332289|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com|
22332290|NCT02486263|Nationwide Children's Hospital|Dr. Sudarshan Jadcherla|614-355-6643|sudarshan.jadcherla@nationwidechildrens.org|
22332291|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22332292|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu|
22332293|NCT02730234|Midwest Cardiovascular Research Foundation|Nicolas W Shammas|5633242828|shammasg@mcrfmd.com|102
22332294|NCT01791543|Vanderbilt University Medical Center|William G Stevenson, MD|1-615-322-2318|william.g.stevenson@vumc.org|
22332295|NCT00963040|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
22332296|NCT06212310|UT Southwestern Medical Center|Sayoni Lahiri|214-645-2563|sayoni.lahiri@utsouthwestern.edu|
22332297|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22332298|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22332299|NCT03839693|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22332300|NCT04524351|Annovis Bio|Maria Maccecchini, PhD, CEO|(610) 727-3710|maccecchini@annovisbio.com|
22332301|NCT00270205|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22332302|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca|
22332303|NCT02464176|Wake Forest Baptist Medical Center|Dr. James D. Turner|3367164998|jturner@wakehealth.edu|
22332304|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu|
22332305|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279||
22332306|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr|
22332307|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332308|NCT02544607|Massachusetts General Hospital|Dr. Cristina Cusin|617-726-6421|ccusin@mgh.harvard.edu|
22332309|NCT00449761|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22332310|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332311|NCT01969201|IBSA Insitut Biochimique|Project Leader|+41 58 360 10 00|rd@ibsa.ch|
22332312|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu|
22332313|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332314|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org|
22332315|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100|sgrace@yorku.ca|22364
22332316|NCT02856282|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332317|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332318|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22332319|NCT03772574|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
22332320|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com|
22332321|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu|
22332322|NCT04983589|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22332323|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si|
22332324|NCT03546270|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22332325|NCT02940392|Boston Scientific|Director, Clinical Operations|9529306000|teresa.takle-flach@bsci.com|
22332326|NCT00762073|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22332327|NCT03176953|National Center for PTSD|Sonya Norman, PhD|858-518-8266|sonya.norman@va.gov|
22332328|NCT02319642|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22332329|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org|
22332330|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
22332331|NCT01958593|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22332332|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22332333|NCT02276274|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22332334|NCT05147311|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭(617) 525-7472‬|hermioni_amonoo@dfci.harvard.edu|
22332335|NCT02504099|AbbVie|Global Medical Services|800-633-9110||
22332336|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu|
22332337|NCT04419558|FibroGen, Inc.|Clinical Trial Information Desk|(415) 978-1427|zephyrus@fibrogen.com|
22332338|NCT05240313|Boston College|Christopher Salas-Wright|617-552-1295|christopher.salas-wright@bc.edu|
22332339|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22332340|NCT02388906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22332341|NCT05934591|University of Illinois Urbana Champaign|Dr. Liliane Windsor|2173001782|lwindsor@illinois.edu|
22332342|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22332343|NCT06288607|The First Affiliated Hospital with Nanjing Medical University|Dr. Yang Xu|+8613851856794|yangxu@njmu.edu.cn|
22332344|NCT02400281|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22332345|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22332346|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org|
22272635|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22272636|NCT03040427|Cleveland Clinic Foundation|Dr. Wael A. Jaber|216.444.8305|jaberw@ccf.org|
22332347|NCT03145207|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22332348|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
22332349|NCT05436067|CFD Research Corporation|Dr. Paulien Roos|256 715 6817|paulien.roos@cfd-research.com|
22332350|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332351|NCT05689554|University of Washington|Dr. Elizabeth Phelan|(206) 744-9112|phelane@uw.edu|
22332352|NCT04678557|Vertex|Medical Information|617-341-6777|medicalinfo@vrtx.com|
22332353|NCT00157157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22332354|NCT01678794|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
22332355|NCT00121251|Weill Cornell Medical College|Cooperative Group Program Manager|646-962-9377|has7003@med.cornell.edu|
22332356|NCT02260804|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
22332357|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332358|NCT04074109|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
22332359|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com|
22332360|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com|
22332361|NCT03965754|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22332362|NCT02983305|University of Michigan|Sara|734-936-7567|weisssar@umich.edu|
22332363|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov|
22332364|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332365|NCT03433482|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332366|NCT00437294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332367|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|jsparano@montefiore.org|
22332368|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22332369|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
22332370|NCT05292248|Case Western Reserve University|Kylie Meyer, Principal Investigator|216-368-1928|knm77@case.edu|
22332371|NCT01339273|Oxford University Hospitals NHS Trust|Dr Nicholas Crabtree|01865 221590|nicholas.crabtree@ouh.nhs.uk|
22332372|NCT04478994|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22332373|NCT00518531|Amgen Inc.|Study Director|866-572-6436||
22332374|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22332375|NCT02192307|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22332376|NCT04621227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332377|NCT02916056|vTv Therapeutics|Ann Gooch PhD, VP Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
22332378|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300||
22332379|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332380|NCT02303977|Abramson Cancer Center, Penn Presbyterian Medical Center|Dr. Christine Ciunci|215-662-9801|christine.ciunci@pennmedicine.upenn.edu|
22332381|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22332382|NCT02411110|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22332383|NCT04293341|Department of Veterans Affairs|Daniel Gros, PhD|843-789-7311|daniel.gros@va.gov|
22332384|NCT03985982|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22332385|NCT05981365|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332386|NCT04199312|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22332387|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se|
22332388|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332389|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com|
22332390|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22332391|NCT00556907|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22332392|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
22332393|NCT03864406|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@niaid.nih.gov|
22332394|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com|
22332395|NCT01012609|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
22332396|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332397|NCT00766727|Neodyne|VP, R&D/OPS|5104564128|jzepeda@neodynebio.com|128
22332398|NCT00924820|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Professor, Neuro-Oncology|(713) 745-3072|jdegroot@mdanderson.org|
22332399|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu|
22332400|NCT03205046|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
22332401|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org|
22332402|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332403|NCT01522755|Medtronic|Foudali Latifa|+33 631992144|latifa.foudali@medtronic.com|
22332404|NCT03414658|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|Adrienne_Waks@dfci.harvard.edu|
22332405|NCT00402298|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22272637|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22272638|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de|
22272639|NCT03172364|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272640|NCT00630747|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22272641|NCT03858894|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
22272642|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com|
22272643|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272644|NCT00583102|University of Iowa|Raymond Hohl, MD|319-356-8110|rhohl@pennstatehealth.psu.edu|
22272645|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22272646|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272647|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
22272648|NCT02798354|Children's Hospital at Montefiore and Albert Einstein College of Medicine|Dr. Michael Rinke|718-741-2597|mrinke@montefiore.org|
22272649|NCT01298141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22332406|NCT00480077|Medtronic Bakken Research Center|Director CRDM|31-43-3566813||
22332407|NCT00147290|Medtronic|Elisabetta Santi|003906328141|elisabetta.santi@medtronic.com|
22332408|NCT02265874|The Ohio State University Wexner Medical Center|Dr. Elliott Crouser|16142934925|elliott.crouser@osumc.edu|
22332409|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22332410|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332411|NCT05966129|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22332412|NCT05182840|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332413|NCT04563039|Avvio Medical, Inc.|VP of RA / QA / CA|4158872037|clinicalaffairs@avviomed.com|
22332414|NCT04242498|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22332415|NCT02478281|American Regent Inc.|Hal Rathfon, RPh|631-772-3555|HRathfon@americanregent.com|
22332416|NCT02396849|Indiana University|Christina Tiller|317-044-4522|ctiller@iu.edu|
22332417|NCT03328325|University of Rochester|Angela Branche, MD, Site Principal Investigator|585-275-5871|angela_branche@urmc.rochester.edu|
22332418|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com|
22332419|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu|
22332420|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
22332421|NCT02950831|St. Jude Medical|Filippo Agnesi|14694184987|filippo.agnesi@abbott.com|
22332422|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu|
22332423|NCT04487886|Emory University|Edmund Waller, MD, PhD|404-727-4995|ewaller@emory.edu|
22332424|NCT00828009|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22332425|NCT01375491|University of California, San Diego|Dr. Karen Louise Herbst|858-552-8585|kaherbst@gmail.com|7384
22332426|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au|
22332427|NCT02985541|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22332428|NCT02383966|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22332429|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22332430|NCT04888377|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
22332431|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
22332432|NCT05279807|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22332433|NCT01169259|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
22332434|NCT05299359|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22332435|NCT04242446|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22332436|NCT03587116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22332437|NCT05993299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332438|NCT05644756|Brown University|Dr. Ruben Martinez|4014441915|ruben_martinez@brown.edu|
22332439|NCT03110107|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22332440|NCT04058990|Boston Scientific Japan K.K.|Sachiyo Sato/Clinical Project Manager|+81-3-6853-7500|Sachiyo.Sato@bsci.com|
22332441|NCT03093480|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22332442|NCT03526549|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
22332443|NCT05471921|Columbia University|Jeremy Kane|212-305-2862|jk4397@cumc.columbia.edu|
22332444|NCT03927989|Medical University of South Carolina|Dr. Alana Rojewski (PI)|843-876-1593|rojewski@musc.edu|
22332445|NCT02593175|MD Anderson Cancer Center|Clinton Yam|832-589-8343|cyam@mdanderson.org|
22332446|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com|
22332447|NCT01363999|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22332448|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu|
22332449|NCT02203305|University of North Carolina at Chapel Hill|Dr. Margaret Dillon|9199665251|mdillon@med.unc.edu|
22332450|NCT03586427|Gate Neurosciences, Inc|Chief Medical Officer|2032473895|ron.burch@gateneuro.com|
22272650|NCT03338569|University of Minnesota|Ronald Reilkoff, MD|612-624-0999|rreilkof@umn.edu|
22332451|NCT02384200|UCSD Medical Center|Paul Zupkas, Ph.D.|6195432628|pzupkas@ucsd.edu|
22332452|NCT03193996|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
22332453|NCT03478982|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
22332454|NCT05125224|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22332455|NCT00593385|Getinge|Elizabeth Bulger, Director of Clinical Affairs|1-603-864-5368|elizabeth.bulger@getinge.com|
22332456|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22332457|NCT02352831|Washington University School of Medicine|Andrea Wang-Gillam, M.D., Ph.D.|314-362-5740|awang-gillam@wustl.edu|
22332458|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov|
22332459|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr|
22332460|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com|
22332461|NCT03253809|Cleveland Clinic|Dr. Mark Neibauer|216-444-3160|niebaum@ccf.org|
22332462|NCT03992456|Duke Cancer Institute|John Strickler, MD|(507) 284-2511|john.strickler@duke.edu|
22332463|NCT00595946|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22332464|NCT04637815|RAND|David P. Kennedy|3104673904|davidk@rand.org|6133
22332465|NCT00326625|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22332466|NCT02594384|OrphAI Therapeutics|Esther Nkrumah|267 512-1750|enkrumah@orphai-therapeutics.com|
22332467|NCT02427568|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22332468|NCT03919669|University of WI Alzheimer's Disease Research Center|Dr. Sterling Johnson|608-262-9549|scj@medicine.wisc.edu|
22332469|NCT00625846|Mayo Clinic|Keith C. Bible, M.D., Ph.D.|507-284-2511|bible.keith@mayo.edu|
22332470|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22332471|NCT04762771|baptist health south florida|Raul Herrera, MD (Director Miami Cardiac & Vascular Institute)|786-596-7609|RaulH@BaptistHealth.net|
22332472|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org|
22332473|NCT02369874|AstraZeneca|Nassim Morsli|+44 7384 520046|nassim.morsli@astrazeneca.com|
22332474|NCT02058849|University of Kentucky|Dr. Travis Thomas, Associate Professor|859-218-0863|dth225@uky.edu|
22332475|NCT02331680|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
22332476|NCT02219477|AbbVie|Global Medical Services|800-633-9110||
22332477|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332478|NCT04505592|Icahn School of Medicine at Mount Sinai|Dr. Hooman Poor|(212) 241-5656|hooman.poor@mountsinai.org|
22332479|NCT02648646|University of North Carolina|Yvonne Golightly PT, PhD, Assistant Professor of Epidemiology|919-966-0566|golight@email.unc.edu|
22332480|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332481|NCT00761085|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22332482|NCT04298229|Vanderbilt University Medical Center|Zachary Cox|615-966-7107|zachary.l.cox@vumc.org|
22332483|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com|
22332484|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
22332485|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332486|NCT03142919|LIBR|Jonathan Savitz|9185025104|jsavitz@laureateinstitute.org|
22332487|NCT05261126|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332488|NCT05939388|Wake Forest University Health Sciences|Michelle Olshan-Perlmutter|704-358-2800|michell.olshanperlmutter@atriumhealth.org|
22332489|NCT03901274|University of South Carolina|Dr. Mark Weist|803-777-8438|weist@mailbox.sc.edu|
22332490|NCT05570604|Ohio State University|Dr. Diane Von Ah|614-688-0722|vonah.1@osu.edu|
22332491|NCT05074303|University of Florida|Dr. Wendy Dahl|3522943707|wdahl@ufl.edu|
22332492|NCT03158532|ISCS|Roberto Léo da Silva|55 48 999099790|robertoleo@hotmail.com|
22332493|NCT04527380|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22332494|NCT06241768|Wake Forest University School of Medicine|Dr. Anna Snavely|336-716-2011|asnavely@wakehealth.edu|
22332495|NCT04957979|HealthPartners Institute|Steven P. Dehmer, PhD|952-967-5216|steven.p.dehmer@healthpartners.com|
22332496|NCT03671746|Massachusetts General Hospital|Dr. Arun Aneja, MD, PhD|617-726-6546|aaneja@mgh.harvard.edu|
22332497|NCT05445466|BIDMC|Dr. Paulo Lizano|201-776-6708|lizanopl@gmail.com|
22332498|NCT01714921|Medtronic GmbH|ProSA clinical research contact|004921598149|rs.dusclinicalcooperation@medtronic.com|0
22332499|NCT05116241|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
22332500|NCT04410991|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22332501|NCT03668379|University of California, San Francisco|John Sauceda, PhD, Associate Professor|415-502-1000|john.sauceda@ucsf.edu|17172
22332502|NCT00953173|Apollo Endosurgery Inc|Director of Clinical Affairs|512-279-5157|jose.naveira@apolloendo.com|
22332503|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22332504|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org|
22332505|NCT01054443|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22332506|NCT03099265|Yale School of Medicine|Kimberly L. Johung, MD, PhD Associate Professor of Therapeutic Radiology|(203) 200-2008|kimberly.johung@yale.edu|
22332507|NCT02284880|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22332508|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590||
22332509|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
22332510|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22332511|NCT03504839|The Ohio State University Medical Center|Clinical Research Coordinator - Adrianne Miller|614-688-8252|adrianne.miller3@osumc.edu|
22272651|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com|
22272652|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
22272653|NCT02006056|Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto|Dr. Edward Chow|416-480-4974|edward.chow@sunnybrook.ca|
22272654|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
22272655|NCT02379273|Cochlear Americas|Aaron J Parkinson, PhD, Principal Clinical Project Manager|3035242563|aparkinson@cochlear.com|
22272656|NCT02432144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22272657|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com|
22272658|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org|
22319513|NCT04600336|Mayo Clinic|Bradley J. Stish, MD|507-538-6120|stish.bradley@mayo.edu|
22272659|NCT00958412|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22272660|NCT01833936|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|6148958747|ofacresearch@orthofootankle.com|
22272661|NCT02552888|Tulane School of Medicine|Dr. Jing Chen|5049886110|jchen@tulane.edu|
22272662|NCT02371668|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
22272663|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
22272664|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu|
22272665|NCT01962948|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22272666|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu|
22272667|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com|
22272668|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272669|NCT02849704|Children's Hospital of Philadelphia|Virginia Stallings, MD|267.425.1633|stallingsv@email.chop.edu|
22272670|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272671|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu|
22272672|NCT02771860|University Gent|Prof. dr. Ruth Wittoek|+3293322522|anuschka.vandenbogaert@uzgent.be|
22272673|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu|
22272674|NCT04304508|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22272675|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
22272676|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22272677|NCT03091738|Virginia Commonwealth University|Jasmohan Bajaj, MD|804-828-4060|jasmohan.bajaj@vcuhealth.org|
22272678|NCT01393522|Mercy Health Research|Timothy R. Smith, MD|314-251-8895|Timothy.Smith@mercy.net|
22272679|NCT03746405|Duke University|Dr Lysianne Beynel|919-681-1157|lysianne.beynel@duke.edu|
22272680|NCT03479008|Unversity of Michigan|Dr. Benjamin Bassin|734 763-2134|bsbassin@med.umich.edu|
22272681|NCT00412932|Daiichi Sankyo|John Raia|973-630-2683|jraia@dsus.com|
22272682|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
22272683|NCT00929994|Toronto Rehab|Dr.|4169781739|dina.brooks@utoronto.ca|
22272684|NCT03258645|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272685|NCT02061813|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22272686|NCT01705080|Abbott|Steven Madej|651-756-2230|smadej@sjm.com|
22301663|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711|elizabeth.ralevski@yale.edu|4282
22332512|NCT03891602|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
22332513|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com|
22332514|NCT03491800|University of North Carolina at Chapel Hill|Crystal Wiley Cené, MD, MPH, FAHA|919-445-6783|crystal_cene@med.unc.edu|
22332515|NCT05604521|Sanaria Inc.|Chief Medical Officer|301-770-3222|sanaria@sanaria.com|
22332516|NCT02875340|ValiSeek Limited|Suzanne Dilly|+442030084416|suzanne.dilly@valirx.com|
22332517|NCT03681769|Medical University of South Carolina|Dr. Jeff Borckardt|843-792-3295|borckard@musc.edu|
22332518|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu|
22332519|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
22332520|NCT05553600|Kimberly-Clark Corporation|Jin Zhang|770-587-8000|jin.zhang@kcc.com|
22332521|NCT05984784|Inmagene LLC|Clinical Trials Lead|(858) 345-6927|ClinicalTrials@imagenebio.com|
22332522|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
22301664|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301665|NCT02182973|University of Louisville|Paula Radmacher|5028525532|paula.radmacher@louisville.edu|
22332523|NCT02980666|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22301666|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22301667|NCT05614089|University of Pittsburgh|Dr. Jing Luo, MD, MPH, Associate Professor of Medicine|412-383-3559|luoj@pitt.edu|
22301668|NCT05417620|Johns Hopkins Bloomberg School of Public Health|Dr. Sheree Schwartz|443-983-2564|sschwartz@jhu.edu|
22301669|NCT03937219|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22301670|NCT04393441|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301671|NCT02782169|University of Hawaii|Family Planning Department|808-983-6000|hawaiimedab@gmail.com|
22301672|NCT04003610|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22301673|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com|
22301674|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
22301675|NCT05198466|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22301676|NCT02660827|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
22301677|NCT02953938|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22301678|NCT03365154|Libra Medical|Phil Zhang, MD|6692039308|pzhang@libramed.com|
22301679|NCT03371082|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
22301680|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
22301681|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no|
22301682|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com|
22301683|NCT04198805|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
22301684|NCT03078816|UCSF Movement Disorders|Aaron Viser|415 353 9453|aaron.viser@ucsf.edu|
22301685|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22301686|NCT03599349|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 865|clinicaltrials@merz.com|
22301687|NCT06821412|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
22301688|NCT00810264|BIOTRONIK|Clinical Studies Engineer Group Manager|800-547-0394|celestial@biotronik.com|
22301689|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040|m.debaun@vanderbilt.edu|5-3040
22301690|NCT01648348|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-1370|galanis.evanthia@mayo.edu|
22301691|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu|
22301692|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org|
22301693|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com|
22301694|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301695|NCT02925611|PGIMER|Dr. Steve Joys|7087617352|stevejoys@gmail.com|91
22301696|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22301697|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22301698|NCT01811212|The Ohio State University Compreshive Cancer Center|Manisha Shah, MD|614-366-6994|manisha.shah@osumc.edu|
22301699|NCT03419364|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
22301700|NCT04913363|University of Virginia|Jennifer Roe|434-982-4567|jjr4b@virginia.edu|
22301701|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
22301702|NCT03355326|Indiana University, School of Medicine|Dr. Alan Ladd, Principle Investigator|317-274-4606|aladd@iupui.edu|
22301703|NCT04574882|University of Pennsylvania|Director of Research|2674280125|digitalhealth@pennmedicine.upenn.edu|
22301704|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22301705|NCT04620681|Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22301706|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu|
22301707|NCT04922554|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22301708|NCT03308825|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
22301709|NCT03559218|KeraNetics|Ryan Clohessy, PhD|4102513940|rclohessy@keranetics.com|
22301710|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org|
22301711|NCT02760056|OHSU|Anna Orban|503-494-3549|orban@ohsu.edu|
22301712|NCT03810534|University of North Carolina at Chapel Hill|Mark Toles, MPH|919-966-5684|mtoles@email.unc.edu|
22301713|NCT04737109|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22301714|NCT03092375|UF Hepatology Research at CTRB|Lauren Morelli|3522739508|LAUREN.MORELLI@MEDICINE.UFL.EDU|
22301715|NCT01679301|Philips Respironics|Chuck Cain|+1 724 7335835|chuck.cain@philips.com|
22301716|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com|
22301717|NCT03328143|Aurora Neuroscience Innovation Institute|Richard A Rovin, MD|4143851922|richard.rovin@aurora.org|
22301718|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22301719|NCT00944658|Imperial College London|Peter Taylor|+44 (0) 2075941872|jrco@imperial.ac.uk|
22301720|NCT02259517|Duke University|Jonathan Posner, MD|1 919 684 2403|jonathan.posner@duke.edu|
22301721|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu|
22301722|NCT00963911|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
22301723|NCT01289418|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
22301724|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22301725|NCT01352585|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22332524|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr|
22332525|NCT05027958|Division of Intramural Research, NHLBI|Kevin P. Fennelly, M.D., MPH, ATSF|301-385-0807|kevin.fennelly@nih.gov|
22332526|NCT03155269|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332527|NCT02871921|MGH|Dr. Hiroko Dodge, Director of Research Analytics|724-494-3605|hdodge@mgh.harvard.edu|
22332528|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org|
22332529|NCT03056456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22332530|NCT04369885|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22332531|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252||
22332532|NCT00455923|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332533|NCT03099655|Medtronic|Erika Pouliot|+17635261270|erika.pouliot@medtronic.com|
22332534|NCT03715335|Cincinnati Children's Hospital Medical Center|Dr. Jennifer Reed|(513) 636-7966|jennifer.reed@cchmc.org|
22332535|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
22332536|NCT02686749|Cleveland Clinic|Oussama Wazni, MD|216-444-2131|waznio@ccf.org|
22283860|NCT04047420|University of Pittsburgh|Sharon Riddler, MD, MPH|4123831741|riddler@pitt.edu|
22283861|NCT02855944|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22283862|NCT03757130|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22283863|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22283864|NCT00966719|Children's Hospital of Eastern Ontario|Dr Catherine Pound|613-737-7600|cpound@cheo.on.ca|
22283865|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com|
22283866|NCT02641522|Benaroya Research Institute|Sarah Robinson/ Administrative Assistant|(206) 342-6931|diabetes@benaroyaresearch.org|
22283867|NCT03242018|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22283868|NCT02282904|NIAID|Elizabeth Kang|3014027567|ekang@niaid.nih.gov|
22283869|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu|
22283870|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
22283871|NCT02365285|Vanderbilt University Medical Center|Cyndya Shibao, MD|615-322-2318|cyndya.shibao@vumc.org|
22283872|NCT03262116|Massachusetts General Hospital|Dr Steven J. Russell, MD, PhD|617.726.1848|sjrussell@mgh.harvard.edu|
22283873|NCT02968914|AstraZeneca Clinical Study Information Center|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22283874|NCT02635347|Rutgers-NJ Medical School|Baburao Koneru, MD, MPH|973-972-9599|koneruba@njms.rutgers.edu|
22332537|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
22332538|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918||
22332539|NCT04409509|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22332540|NCT04668066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332541|NCT04190056|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|pamela.munster@ucsf.edu|
22332542|NCT04479358|University of Chicago|Pankti Reid, MD|7737021220|pankti.reid@bsd.uchicago.edu|
22332543|NCT03810417|University of Maryland|Stephen Gottlieb, MD|410-328-7877|sgottlie@som.umaryland.edu|
22332544|NCT05487625|Fralin Biomedical Research Institute at VTC|Roberta Freitas Lemos|540 526 2106|rflemos@vtc.vt.edu|
22332545|NCT04103645|Weill Cornell Medicine|Joseph Scandura, MD|(212) 746-2072|jms2003@med.cornell.edu|
22332546|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu|
22332547|NCT03795233|Boston Medical Center|Tamar Barlam, MD MSC|617 414 5190|tamar.barlam@bmc.org|
22332548|NCT02756182|Laborie|Clinical Research Manager|9056121170|sgallone@laborie.com|1755
22332549|NCT03225313|Theodor Bilharz Research Institute|Dr Muhammed Hussein|00201001434459|muhamed.hussein@gmail.com|
22332550|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332551|NCT03826771|Medical University of South Carolina|Chris Gregory|843-792-1078|gregoryc@musc.edu|
22332552|NCT05267652|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
22332553|NCT07002632|University of Health Sciences, Gaziosmanpasa Training and Research Hospital|Ethem ilhan, MD|+90 505 591 86 50|ethem.ilhan@sbu.edu.tr|
22332554|NCT02711306|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
22283875|NCT03923582|University of Minnesota|Gudrun Kilian|612-624-0358|kilian@umn.edu|
22283876|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22283877|NCT02144155|UCSD|David Feifel||dfeifel@kadimanp.com|
22283878|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22283879|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22283880|NCT01304407|Baylor College of Medicine|Dr. Steven Abrams|512-495-4700|sabrams@bcm.edu|
22283881|NCT01283542|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22283882|NCT05059977|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22283883|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org|
22332555|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283884|NCT04405245|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
22332556|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399||
22332557|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu|
22332558|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999|liujenfa@mail.cgust.edu.tw|5487
22332559|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301726|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi|
22301727|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr|
22301728|NCT02305381|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22301729|NCT02276066|University of Florida Board of Trustees Contracts & Grants|Mark S. Segal|352-273-5357|segalms@medicine.ufl.edu|
22301730|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org|
22301731|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
22301732|NCT02943941|Medtronic Inc|Verla Laager|(800) 328.2518|verla.l.laager@medtronic.com|
22301733|NCT03642938|Duquesne University (now at University of Texas at Dallas)|Benedict Kolber|972-883-7225|Benedict.kolber@utdallas.edu|
22301734|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22301735|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com|
22301736|NCT03685396|Azienda Ospedaliera San Paolo - Università degli Studi di Milano|Dr.Fulvio Gatti|3396441920|fudy@libero.it|
22301737|NCT03286751|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22301738|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com|
22301739|NCT01301391|CLIOSS S.r.l.|Dr. Davite Cristina|+39 0031 58|regulatory@clioss.com|1482
22301740|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301741|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu|
22301742|NCT01583686|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
22301743|NCT05292534|Sonova|Dr. Ieda Ishida|6472847562|ieda.ishida@sonova.com|
22301744|NCT01532128|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22301745|NCT02573402|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|(713) 797-5007|Argyrios.Stampas@uth.tmc.edu|
22301746|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu|
22301747|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301748|NCT00053495|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
22332560|NCT03724422|University of Louisville|Salwa Rashid|5028526964|salwa.rashid@louisville.edu|
22332561|NCT04476654|Virginia Commonwealth University|Dr. Vanessa Sheppard|804-828-8892|vlbsheppard@vcu.edu|
22332562|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
22332563|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22332564|NCT02511587|Medical University of Vienna|Univ.-Prof. Dr. Ursula Wiedermann|0043 1 40160 38291|ursula.wiedermann@meduniwien.ac.at|
22332565|NCT02060188|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22332566|NCT03107442|FIBAO|Dr José Antonio Vargas-Hitos|625943933|joseantoniovh@hotmail.com|+34
22332567|NCT04456998|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB002, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22332568|NCT02080273|Colgate Palmolive Company|Maria Ryan|732-878-7766|maria_ryan@colpal.com|
22332569|NCT03707145|Aberystwyth University|Dr Marco Arkesteijn|+44(0)1970628559|maa36@aber.ac.uk|
22332570|NCT04221477|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22332571|NCT04784455|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
22332572|NCT04882085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332573|NCT04455620|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22332574|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
22332575|NCT05681715|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22332576|NCT05455684|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22332577|NCT05204563|Evopoint Biosciences USA, Inc.|Evopoint Biosciences|646-750-2661|info@evopointbio.com|
22332578|NCT05643573|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22332579|NCT04678440|University of California Davis|Simon Cherry|(530) 754-9419|srcherry@ucdavis.edu|
22332580|NCT02268214|AstraZenenca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22332581|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22332582|NCT02951130|UC Davis School of Medicine|Satyan Lakshminrusimha|916 734 5178|slakshmi@health.ucdavis.edu|
22332583|NCT04813484|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22332584|NCT02500732|University of Calgary|Dr. Satish R Raj|403-210-6152|satish.raj@ucalgary.ca|
22332585|NCT03378921|Department of Gastrointestinal surgery, Helsinki University Hospital|Dr. Essi Karjalainen|+358504621853|essi.karjalainen@hus.fi|
22332586|NCT03205605|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22332587|NCT03677440|Kessler Foundation|Brian Sandroff, PhD|973-965-6649|bsandroff@kesslerfoundation.org|
22332588|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com|
22332589|NCT02008396|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22332590|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332591|NCT03759340|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22332592|NCT01003691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332593|NCT01652040|Hunter Holmes McGuire VA Medical Center|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.gov|3386
22301749|NCT03581084|UCSF Airway Clinical Research Center|Ariana Lowman|14155141539|ariana.baum@ucsf.edu|
22301750|NCT00409682|Abbott|Global Medical Services|800-633-9110||
22332594|NCT03832907|Emory University|Dr. Umpierrez|404-778-1665|geumpie@emory.edu|
22301751|NCT03319537|Memorial Sloan Kettering Cancer Center|Dr. Marjorie Zauderer, MD|646-608-3790|zauderem@mskcc.org|
22301752|NCT04710927|University Malaya Kuala Lumpur, Malaysia|Dr Tengku Nurfarhana Nadirah Tengku Hamzah|0379674802|tengkunurfarhana@um.edu.my|4865
22301753|NCT03595332|Northern Arizona University|Dr. Hendrik de Heer|9285231499|dirk.deheer@nau.edu|
22301754|NCT02227875|Mylan, Inc.|Keri L. Vaughan, Director Global Clinical Operations, General Medicine||keri.vaughan@mylan.com|
22272687|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu|
22301755|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22301756|NCT02857426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22272688|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu|
22272689|NCT01041274|NYU Langone Medical Center|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
22272690|NCT03130959|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22272691|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272692|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu|
22272693|NCT02384538|AbbVie|Global Medical Services|800-633-9110||
22272694|NCT02872909|University of Dundee|Professor Sally Ibbotson|01382 383499|s.h.ibbotson@dundee.ac.uk|
22272695|NCT03042910|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272696|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22272697|NCT03083808|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
22272698|NCT01491841|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22272699|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com|
22272700|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012||
22272701|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082|phunt@php.ucsf.edu|345
22272702|NCT04472494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22272703|NCT04096001|Stanford Prevention Research Center, School of Medicine, Stanford University|Judith J Prochaska, PhD|650-724-3608|jpro@stanford.edu|
22272704|NCT03519919|CooperVision.Inc|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22272705|NCT03076996|FHI 360|Dr. Lisa Dulli|919-544-7040|ldulli@fhi360.org|11396
22272706|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001|stefan.sacu@meduniwien.ac.at|7937
22272707|NCT00988000|Imperial College|Professor Martyn Partridge|+44 (0)20 7594 7959|m.partridge@imperial.ac.uk|
22332595|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272708|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu|
22272709|NCT02144077|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32 66|ameluz@biofrontera.com|
22272710|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
22272711|NCT01909973|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22272712|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
22272713|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu|
22272714|NCT02620683|University of North Carolina Chapel Hill|Dr Raymond P. White Jr|919-537-3944|ray_white@unc.edu|
22272715|NCT02813473|ECRI|Ron van Amsterdam|+31102062802|RvAmsterdam@cardialysis.nl|
22272716|NCT02438280|University of Washington|Dr. Greg Huang, Professor and Chair of Orthodontics|(206) 616-6996|ghuang@uw.edu|
22272717|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com|
22272718|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
22272719|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22272720|NCT05753735|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Nikola Anusic, Protocol Study Coordinator|216-421-5986|a.nikolau@icloud.com|
22272721|NCT01882803|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22301757|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu|
22301758|NCT02831257|Massachusetts General Hospital|Scott Plotkin|617-724-5369|splotkin@mgh.harvard.edu|
22301759|NCT00611858|Dana-Farber Cancer Institute|Jeffrey Meyerhardt, MD, MPH|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
22301760|NCT01844284|Abbott Vascular|Hajime Kusano|408-845-1626|hajime.kusano@av.abbott.com|+1
22332596|NCT05405218|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
22332597|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555|giovanni.barisione@hsanmartino.it|3367
22332598|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com|
22332599|NCT02996266|Becton, Dickinson and Company|Director, Global Clinical Affairs - Urology and Critical Care|9733077325|kirsten.hammitt@bd.com|
22332600|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu|
22332601|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es|
22332602|NCT01676818|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22272722|NCT02869893|Cincinnati Children's Hospital Medical Center|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
22272723|NCT01563913|VA Portland Health Care System|Kathryn Chung, MD|5037211091|Kathryn.Chung@va.gov|
22272724|NCT03066778|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272725|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22272726|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com|
22272727|NCT02912455|Cleveland Clinic|Dr. Sangeeta Kashyap|(216) 445-2679|kashyas@ccf.org|
22272728|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272729|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com|
22272730|NCT01836185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272731|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
22272732|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu|
22272733|NCT02356107|University of Utah|Brent Kious, MD, PhD|(801) 581-4888|Brent.Kious@hsc.utah.edu|
22272734|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov|
22272735|NCT03337048|Coloplast A/S|Vice President, Medical Affairs|+45 49111111|clinical-studies@coloplast.com|
22272736|NCT02669667|MedImmune|Rene van der Merwe|+44 (0)1223 898263|information.center@astrazeneca.com|
22272737|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org|
22272738|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272739|NCT03557476|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22272740|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300||
22272741|NCT02721017|University of California San Francisco Department of Surgery|Dr. Benjamin Padilla|415-476-3642|Benjamin.Padilla@ucsf.edu|
22272742|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
22272743|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22272744|NCT03755518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22272745|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu|
22272746|NCT03403621|Mayo Clinic|Dr. Alexander Meves|507-284-3668|Meves.Alexander@mayo.edu|
22272747|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com|
22272748|NCT02183909|University of California, San Francisco|Janet Myers, PhD, MPH, MA|415-502-1000|janet.myers@ucsf.edu|14626
22272749|NCT03489941|Bausch & Lomb|Heleen DeCory|(585) 338-8161|heleen.decory@bausch.com|
22272750|NCT00659776|Oregon Health and Science University|Amy Huddleston|503-494-2910|huddlesa@ohsu.edu|
22272751|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org|
22272752|NCT01738191|Medical University of South Carolina|Dr. Vanessa Hinson|843-792-9115|hinsonvk@musc.edu|
22272753|NCT02483572|University of Nebraska Medical Center|Wayne Fisher|4025598863|wfisher@unmc.edu|
22272754|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu|
22272755|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu|
22272756|NCT05346237|University hospital Osijek|Željka Laksar Klarić|+38598666494|zeljka.l.klaric@gmail.com|
22272757|NCT03638466|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22272758|NCT02576977|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332603|NCT06768658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22272759|NCT02957357|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
22272760|NCT04508647|University of Colorado Hospital|Manali Kamdar, MD|720-848-6400|manali.kamdar@cuanschutz.edu|
22272761|NCT02447328|AstraZeneca Korea|Karin Otter, MD, PhD|+82 2 2188 0968|Karin.Otter@astrazeneca.com|
22272762|NCT02362425|National Institute of Nursing|Katherine Meileur Chief, Neuromuscular Symptoms Unit|301-435-1503|meilleurk@mail.nih.gov|
22272763|NCT03417752|VA Center of Excellence for Suicide Prevention|Elizabeth Karras, PhD|585-393-7285|elizabeth.karras-pilato@va.gov|
22272764|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com|
22272765|NCT02688764|Vifor Fresenius Medical Care Renal Pharma France|Milica Enoiu / Clinical Research Manager|+41588518264|milica.enoiu@viforpharma.com|
22272766|NCT02579382|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22272767|NCT03026283|Northwell Health|Pamela Noack|212 434 4926|pnoack@northwell.edu|
22272768|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272769|NCT04560868|Kaiser Permanente Washington Health Research Institute|Director, Investigative Science|206-287-2737|jennifer.b.mcclure@kp.org|
22272770|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com|
22272771|NCT01944644|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
22272772|NCT02906579|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22272773|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22272774|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272775|NCT03457818|Columbia University|Dr. Mishaela Rubin|2019528237|mrr6@cumc.columbia.edu|
22272776|NCT02753816|Spectrum Health|Dr. Betsy Steensma|(616) 391-5701|elizabeth.steensma@spectrumhealth.org|
22272777|NCT03132415|University of Pennsylvania|Jose Bauermeiser|215-898-9993|bjose@upenn.edu|
22272778|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110||
22272779|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343||
22283885|NCT04285489|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|8029
22283886|NCT03443427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283887|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu|
22283888|NCT02576860|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22332604|NCT03548454|Stanford University|Dr. Vafi Salmasi|650-725-0246|vsalmasi@stanford.edu|
22332605|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu|
22332606|NCT02899884|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22332607|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332608|NCT04075656|Emory University|Chia-shi Wang, MD, MS|404-727-5728|chia-shi.wang@emory.edu|
22332609|NCT01519635|Service of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne|Prof Michel Burnier|+41 21 314 11 54|michel.burnier@chuv.ch|
22332610|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22332611|NCT00968539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332612|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300||
22332613|NCT03065517|Evidence-Based Practice Institute, Inc.|Angela Kelley Brimer|253-279-8659|research@jasprhealth.com|
22332614|NCT03305159|Northwestern University Feinberg School of Medicine|Supriya Rastogi|supriya.rastogi@northwestern.e|supriya.rastogi@northwestern.edu|
22332615|NCT02525627|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Doug McGurty|+44 (0) 1635 500690|doug.mcgurty@stryker.com|
22332616|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22332617|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300||
22332618|NCT04305184|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22332619|NCT04928794|Anesthesiology Department, University of New Mexico|Anesthesiology Research Director|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
22332620|NCT02989623|Thomas Jefferson University|Mathew Thakur|215-503-7874|Mathew.Thakur@Jefferson.edu|
22332621|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
22332622|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111|pfrankel@coh.org|65265
22332623|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com|
22332624|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu|
22332625|NCT03292731|University of Pittsburgh|steve caritis|412 641 5256|scaritis@mail.magee.edu|
22332626|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332627|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332628|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
22332629|NCT03710824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22332630|NCT02951182|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22332631|NCT03112720|RWJMS/Rutgers Health|william grubb md|732 235 7827|grubbwr@rwjms.rutgers.edu|
22332632|NCT02525575|Department of Veteran Affairs|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
22332633|NCT01301625|Abbott Vascular|Jeffrey T. Ellis|(408) 845-8184|jeffrey.ellis@av.abbott.com|
22332634|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777|jslaski@ssrehab.com|838
22332635|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22332636|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu|
22332637|NCT05102162|University of Florida College of Pharmacy|Nicole Maranchick|352-273-6803|n.maranchick@cop.ufl.edu|
22301761|NCT01069354|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
22301762|NCT03138733|Basilea Pharmaceutica|Dr Marc Engelhardt, MD|+41 79 701 0551|marc.engelhardt@basilea.com|
22301763|NCT03641313|Vanderbilt-Ingram Cancer Center|Jordan Berlin|6153434128|jordan.berlin@vumc.org|
22301764|NCT05735587|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22301765|NCT05163522|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301766|NCT01712477|Michigan State University|Chet A Morrison, M.D.|9897901001|chet.morrison@cmich.edu|
22301767|NCT02521285|UT MD Anderson Cancer Center|Robert S. Bresalier, MD- Professor, Gastroenterology Hepat & Nutr|(713) 745-4340|rbresali@mdanderson.org|
22301768|NCT02499679|HeartFlow|Sarah Mullen|650-241-1221|smullen@heartflow.com|
22301769|NCT05701995|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22301770|NCT00715429|University of Wisconsin School of Pharmacy|Dr. Mary Elliott|608-695-7501|meelliott@pharmacy.wisc.edu|
22301771|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org|
22301772|NCT04899245|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
22301773|NCT04880395|Fundación Huésped - Buenos Aires|Dr. María Inés Figueroa|+54 11 2120-9999|maria.figueroa@huesped.org.ar|
22301774|NCT04686422|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22301775|NCT04475432|Tarsus Pharmaceuticals, Inc.|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
22301776|NCT04029129|UConnHealth|Dr. Douglas Brugge|860-679-8814|brugge@uchc.edu|
22301777|NCT01714804|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
22301778|NCT06916468|University Hospitals Cleveland Medical Center|Dr. Bryan Carroll|(216)844-8200|Bryan.Carroll@UHhospitals.org|
22283889|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu|
22301779|NCT04295005|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332638|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov|
22332639|NCT02181673|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22332640|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com|
22332641|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com|
22332642|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu|
22332643|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com|
22332644|NCT01293682|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22332645|NCT00491322|Massachusetts General Hospital|Dr. Sherri-Ann M. Burnett-Bowie|6177245594|sburnett-bowie@mgh.harvard.edu|
22332646|NCT00517868|Vaneltix Pharma, Inc.|CEO|732-354-3217|info@vaneltix.com|
22332647|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22332648|NCT06067191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332649|NCT02277548|University of Pennsylvania|Dr. Erin McMenamin|251-662-2428|Erin.McMenamin@pennmedicine.upenn.edu|
22332650|NCT00890409|Children's Hospital, Fudan University|Prof. Xiaomei Shao|86-21-64931913|zhou_wenhao@yahoo.com.cn|
22332651|NCT03733418|Vanderbilt University Medical Center|Dr. Jin Han|16159360253|jin.h.han@vumc.org|
22332652|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22283890|NCT02391961|Louis Stokes VAMC|Alessandro Serra|2167913800|Alessandro.Serra@va.gov|
22283891|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300||
22283892|NCT04498377|Evive Biotech|Jianmin Chen|6095124566|jianmin.chen@evivebiotech.com|
22283893|NCT04807387|Baylor College of Medicine|Dr Julie Hakim|832-826-7464|julie.hakim@bcm.edu|
22283894|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283895|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu|
22283896|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn|
22283897|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu|
22283898|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com|
22283899|NCT03335254|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
22283900|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org|
22283901|NCT04728594|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22283902|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
22283903|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com|
22283904|NCT01497613|University of Miami Miller School of Medicine|Dr. Sara J. Czaja|305-355-9068|sczaja@med.miami.edu|
22283905|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000|hbnguyen@llu.edu|44023
22283906|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
22283907|NCT02528357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22283908|NCT04039867|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22283909|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu|
22283910|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
22283911|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org|
22283912|NCT00720343|Stanford University|Pamela Flood, M.D.|201-370-3933|pflood@stanford.edu|
22283913|NCT01840527|Massachusetts General Hospital Cancer Center|Ryan Sullivan|6177244000|rsullivan7@mgh.harvard.edu|
22283914|NCT03459365|Cleveland Clinic|Carlos Higuera|954 659-5430|higuerc@ccf.org|
22283915|NCT01356628|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Avnish Bhatia|215-955-8874|avnish.Bhatia@jefferson.edu|
22283916|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
22332653|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22332654|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
22332655|NCT02989922|Jiangsu HengRui Pharmaceuticals Co., Ltd|Linna Wang|+862161053363|linna.wang@hengrui.com|
22332656|NCT04035694|innovation Research & Training|Dr. Tracy Scull|(919) 493-7700|tscull@irtinc.us|
22332657|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343||
22332658|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
22332659|NCT03664024|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332660|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com|
22332661|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org|
22332662|NCT03426995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332663|NCT01886105|Johns Hopkins University|Dr. Brian H. Ladle|443-287-3534|bladle@jhmi.edu|
22332664|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se|
22332665|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com|
22283917|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22283918|NCT04037254|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22301780|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu|
22332666|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu|
22283919|NCT02198794|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22283920|NCT01306656|Columbia University|Shonni Silverberg, MD|212-305-6291|sjs7@cumc.columbia.edu|
22332667|NCT03091478|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Rachel Levy, MS, CCRP|410-502-8738|rlevy16@jhmi.edu|
22332668|NCT03075826|Weill Cornell Medical College|Dr.Pinkal Desai|646-962-2700|pid4006@med.cornell.edu|
22332669|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
22332670|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
22332671|NCT02242942|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22332672|NCT05014672|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
22332673|NCT04228107|University of Colorado|Heather De Keyser MD MSCS|720-777-4108|heather.dekeyser@childrenscolorado.org|
22332674|NCT03792633|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22332675|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566||566
22332676|NCT04411641|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22332677|NCT04342390|Arkansas Children's Research Insitute|Emir Tas|4126928688|tase2@upmc.edu|
22332678|NCT04584294|VA Puget Sound Health Care System|Lisa Callegari (Principal Investigator)|206-277-3129|Lisa.Callegari@va.gov|
22332679|NCT03447015|Mutah University|Dr Reham Khresheh|0791425992|rehamkh@mutah.edu.jo|
22332680|NCT00318357|The University of Hull; Department of Cardiology; United Kingdom|John Cleland, Professor|Telephone: 0044 1482 624084||
22332681|NCT01392469|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22332682|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279|hendeles@cop.ufl.edu|6027
22332683|NCT02056431|Kaiser Permanente Division of Research|Dr. Alyce S. Adams|510-891-5921|Alyce.S.Adams@kp.org|
22332684|NCT03443973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22332685|NCT04930536|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22332686|NCT00267020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332687|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22332688|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu|
22332689|NCT04292171|University of Nevada Las Vegas School of Medicine|Adam V. Levy MD|702-671-2300|adam.levy@unlv.edu|
22332690|NCT04465916|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
22332691|NCT04633434|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22332692|NCT02329834|scPharmaceuticals|Sr. Vice President of Clinical Development and Medical Affairs||jmohr@scpharma.com|
22332693|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu|
22332694|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu|
22332695|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22332696|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu|
22332697|NCT01976104|Eisai Call Center|Eisai Inc.|888-422-4743|esi_medinfo@eisai.com|
22332698|NCT01317199|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Channing Paller|410-955-8239|cpaller1@jhmi.edu|
22332699|NCT01353209|University of Cincinnati|Susan McMahan, Clinical Research Manager|513-558-4831|Susan.mcmahan@uc.edu|
22332700|NCT01283009|Memphis VA Medical Center|Dr. Gianfranco U. Meduri|(901) 577-7520|Gianfranco.Meduri@va.gov|
22332701|NCT02920866|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22332702|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au|
22332703|NCT03237325|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22332704|NCT02684370|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22332705|NCT00212446|New York Downtown Hospital (hospital bankrupt/closed)|Dr. Jeffrey Karsdon||JK_MD@yahoo.com|
22332706|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
22332707|NCT03862469|University of Illinois at Chicago|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22332708|NCT00183170|Boston University School of Public Health|Dr. Jonathan Howland, Professor||jhowl@bu.edu|
22332709|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22332710|NCT03952377|SpineThera|Jeff Missling, CEO|+1(612)-508-4795|jmissling@spinethera.com|
22332711|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
22332712|NCT02050373|UFGoias|Daniella Salvador|556235583272|danirnsalvador@gmail.com|
22332713|NCT04342130|University of Rochester|Paul Geha|203-752-8256|paul_geha@urmc.rochester.edu|
22332714|NCT03046966|University of Arkansas for Medical Sciences|Jennifer Rumpel, MD|501-364-2980|Jarumpel@uams.edu|
22332715|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
22332716|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu|
22332717|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332718|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com|
22332719|NCT03992261|Mayne Pharma|Lee Ann McDowell, PharmD - Director of Medical Affairs|4124776681|leeann.mcdowell@maynepharma.com|
22332720|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org|
22332721|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332722|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu|
22332723|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com|
22301781|NCT00278538|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22301782|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu|
22301783|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org|
22283921|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu|
22301784|NCT00847405|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22301785|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com|
22301786|NCT04277455|Mercy Research|Dr. Johnson Thomas|417-888-5660|johnson.thomas@mercy.net|
22301787|NCT02790073|Sanifit|Rekha Garg MD MS|18582815978|rekha.garg@sanifit.com|
22301788|NCT00705133|UC Los Angeles|Rajan Saggar|310-206-6766|rsaggar@mednet.ucla.edu|
22301789|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301790|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com|
22301791|NCT04711356|London School of Hygiene & Tropical Medicine|Dr Daniela Manno, clinical trial coordinator and responsible physician|+44 20 7927|daniela.manno@lshtm.ac.uk|2092
22301792|NCT00643123|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
22301793|NCT05711537|Wake Forest School of Medicine|Heather Columbano, MD|336-716-4498|hcolumba@wakehealth.edu|
22301794|NCT01896869|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
22301795|NCT01691833|Carolinas Healthcare System|Dr. Rachel Seymour|704-355-2000|Rachel.Seymour@carolinas.org|
22301796|NCT03059901|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22301797|NCT00530062|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22301798|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
22301799|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301800|NCT04681729|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22301801|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
22301802|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com|
22301803|NCT02856113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22301804|NCT03494166|University of Arizona College of Nursing|Terry Badger, PhD (MPI) and Alla Sikorskii, PhD (MPI)|520-626-6058|tbadger@arizona.edu|
22301805|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu|
22301806|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com|
22301807|NCT02110901|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
22301808|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com|
22301809|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22301810|NCT00723099|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
22301811|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411|kelli.allen@va.gov|7090
22301812|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22301813|NCT02496767|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22301814|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat|
22301815|NCT03477279|University of North Carolina at Chapel Hill|Nora Rosenberg, PhD, MSPH|919-843-6580|nora_rosenberg@unc.edu|
22283922|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu|
22283923|NCT01085435|Boston Scientific|Jens Goetzke|1-800-227-3422|jens.goetzke@bsci.com|
22283924|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com|
22283925|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22283926|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22283927|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711|cathy.lee2@va.gov|42627
22283928|NCT04736628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283929|NCT04279613|Yale University|Dr. Kevan Herold|203-785-6507|kevan.herold@yale.edu|
22283930|NCT02478164|Dana-Farber Cancer Institute|Eudocia Q. Lee, MD, MPH|617-632-2166|eqlee@partners.org|
22283931|NCT04051827|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22283932|NCT05779007|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22301816|NCT04035200|Imbrium Therapeutics|Medical Information|1-888-726-7535|Purduemedinfo@pharma.com|
22301817|NCT02277990|Medtronic|Daniel Lexcen, Sr. Clinical Program Manager|+17635269702|daniel.lexcen@medtronic.com|
22301818|NCT04581200|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
22301819|NCT04711603|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
22301820|NCT03351738|MedImmune, LLC|Richard George|+1-301-398-5681|information.center@astrazeneca.com|
22301821|NCT03997513|VA Pittsburgh Healthcare System|Dr. Jessica Bon Field|412-360-6823|jessica.field@va.gov|
22301822|NCT03821337|VA Medical Center|Program Manager|843-792-0476|lisa.nunn@va.gov|
22301823|NCT01089374|Dartmouth-Hitchcock Medical Center|Dr. Richard Barth|603-650-9479|Richard.J.Barth.Jr@hitchcock.org|
22301824|NCT02098538|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22301825|NCT05887947|University of Kansas Medical Center|Eleanor Leavens|913-945-7875|eleavens@kumc.edu|
22301826|NCT04723823|University of Pittsburgh|Debbie Harrington, CCRP|412-383-1355|debbie.harrington@pitt.edu|
22301827|NCT05107960|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22301828|NCT03459287|Cerus Corp|Richard Benjamin, M.D., Ph.D.|925 288 6000|rbenjamin@cerus.com|
22301829|NCT04421092|Medical University of South Carolina - Department of Otolaryngology|Shaun A. Nguyen, MD - Director of Clinical Research|8437921356|nguyensh@musc.edu|
22301830|NCT02597036|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22301831|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org|
22301832|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr|
22301833|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu|
22301834|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
22301835|NCT04672941|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22301836|NCT03531320|InnoPharmax Inc.|Staff of Medical Affairs|886-2-8797-7607|yuan.lin@innopharmax.com|
22301837|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
22301838|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366||
22301839|NCT03685591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22301840|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu|
22301841|NCT04188067|Massachusetts General Hospital|Dr. Alexandra Touroutoglou PhD|6176436348|ATOUROUTOGLOU@mgh.harvard.edu|
22301842|NCT03988166|Teleflex|Ricardo De Medeiros, Director Scientific Clinical Affairs|612.812.5008|ricardo.demedeiros@teleflex.com|
22301843|NCT00944047|University of Kansas Cancer Center|Dr. Qamar Khan|(913) 588-6029|ctnursenav@kumc.edu|
22301844|NCT03933826|University of Washington|Dr. John Gore|206-543-9926|cistopm@uw.edu|
22332724|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org|
22332725|NCT03003793|Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen|Lise Gether, MD||lise.gether.01@regionh.dk|
22332726|NCT05275673|Faeth Therapeutics, Inc|Medical Monitor|7084069282|clinicaltrials@Faeththerapeutics.com|
22332727|NCT02325739|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22332728|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012||
22332729|NCT04881149|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22332730|NCT05048875|Johns Hopkins School of Public Health Center for Immunization Research|Dr Anna Durbin|410-955-1622|adurbin1@jhu.edu|
22332731|NCT02255422|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22301845|NCT02638948|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22319514|NCT00977574|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
22319515|NCT04223791|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319516|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com|
22319517|NCT03829241|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22319518|NCT02224599|Kiromic|CMO and Head of Clinical Operations|(832) 968-4888|sdahlbeck@kiromic.com|
22319519|NCT05178134|Scandinavian Biopharma Holding AB|Head of Clinical Development|+4684705600|info@scandinavianbiopharma.se|
22319520|NCT02315898|University of Michigan|Dr. Kathleen Stringer|734-647-4775|stringek@med.umich.edu|
22319521|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810|anne.schafer@va.gov|24895
22319522|NCT04344860|University Of Pittsburgh|Nicoletta Machin|(412) 209-7280|machinnc2@upmc.edu|
22319523|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu|
22319524|NCT03239483|"Fundacio Lluita Contra la Sida, Hospital Universitari Germans Trias | Pujol"|Dr. Ross D. Cranston|34-934-657-897|rdcranston@outlook.com|
22319525|NCT05352048|University of Kentucky|Dr. Francis Farhadi|859-323-5661|francis.farhadi@uky.edu|
22319526|NCT01660607|Stanford University|Dr. Everett Meyer|650-725-5816|evmeyer@stanford.edu|
22319527|NCT03678103|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22319528|NCT04214301|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22319529|NCT03352011|VA Center for Integrated Heathcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
22319530|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22319531|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
22319532|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com|
22319533|NCT03574441|Augusta University|Efrain Riveros Perez|7067217361|eriverosperez@augusta.edu|
22301846|NCT04992546|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22301847|NCT04506775|UMass Chan Medical School|J. Aaron Scott, DO|774-303-4156|jamesaaron.scott@umassmemorial.org|
22301848|NCT05007392|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22301849|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22332732|NCT03222570|University of Minnesota|Meredith Gunlicks-Stoessel|612-624-9249|mgunlick@umn.edu|
22332733|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22332734|NCT03628872|Columbia University College of Dental Medicine|Dr. Philip Y Kang|212-342-5244|pyk2104@cumc.columbia.edu|
22332735|NCT03179462|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
22332736|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
22332737|NCT03741335|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
22332738|NCT04049474|NYU Langone Health|Lira Gutierrez|212-263-6181|Lira.Gutierrez@nyulangone.org|
22332739|NCT02970877|University Health Network|Scientific Associate|416-340-5159|kschweng@uhnresearch.ca|
22332740|NCT04410978|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22332741|NCT05153629|Stanford University|Simon Conti, MD|650-723-3391|sconti@stanford.edu|
22332742|NCT04560088|University of Rochester Medical Center|Autumn Gallegos, PhD|5852752824|autumn_gallegos@urmc.rochester.edu|
22332743|NCT04089566|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22332744|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22332745|NCT05403502|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|+18583666900|clinicalaffairs@tandemdiabetes.com|
22332746|NCT02630992|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
22332747|NCT01593761|CrystalGenomics, Inc.|Seonggu Ro, Ph.D, Chief Technology Officer|82 31 628 2783|sgro@cgxinc.com|
22332748|NCT02576951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22332749|NCT00223990|Kenya Medical Research Institute|Bernhards R. Ogutu, PhD|254-57-22942|bogutu@kisian.mimcom.net|
22332750|NCT04938687|Spaulding Rehabilitation Hospital|Qing Mei Wang, MD, PhD|(617) 952-5299|wang.qingmei@mgh.harvard.edu|
22332751|NCT03505606|Anglia Ruskin University|Mrs Louisa Haine - Lecturer in Vision Sciences|01223695445|louisa.haine@aru.ac.uk|
22332752|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com|
22332753|NCT04020822|Medtronic Diabetes|Kusal Ahangama, Clinical Study Manager|+18185765023|kusal.c.ahangama@medtronic.com|
22332754|NCT02087865|Cleveland Clinic|Dr. Stephen M. Rao|216 312-4168|raos2@ccf.org|
22332755|NCT01319994|Queen Mary University of London|Prof M Korbonits|+442078826197|m.korbonits@qmul.ac.uk|
22332756|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu|
22332757|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu|
22332758|NCT03309072|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
22332759|NCT01568255|Cedars Sinai|Margo Minissian, PhD|310-423-5195|Margo.Minissian@cshs.org|
22332760|NCT00887965|Amgen Inc.|Study Director|866-572-6436||
22332761|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
22332762|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu|
22332763|NCT00640614|Allerderm|Kim Sullivan|602-225-0595||
22332764|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332765|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332766|NCT03354143|IEEM|Dr. Rong Zhang|214-345-4245|rongzhang@texashealth.org|
22332767|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332768|NCT02530320|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
22332769|NCT00297882|University of Yaounde 1, Cameroon|Professor Wilfred Mbacham|+237 677579180|wfmbacham@yahoo.com|
22332770|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
22332771|NCT04242264|Cincinnati Children's Hospital Medical Center|Robert W Frenck, Jr, M.D.|513-636-4463|Robert.Frenck@cchmc.org|
22332772|NCT04221373|Icahn School of Medicine at Mount Sinai|Dr. Chung-Ying Tsai|(212) 241-7073|chung-ying.tsai@mountsinai.org|
22332773|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org|
22332774|NCT02203604|Dana Farber Cancer Institute|Ann Silk, MD|617-632-6571|Ann_Silk@dfci.harvard.edu|
22332775|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu|
22332776|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com|
22332777|NCT00944528|Assistant Research Practice Manager|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
22332778|NCT04139642|The Ohio State University|Dr. Ajit Chaudhari|+1-614-292-0558|chaudhari.2@osu.edu|
22332779|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org|
22332780|NCT02912507|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22332781|NCT03910439|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
22332782|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22332783|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22332784|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
22332785|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332786|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22332787|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332788|NCT01139801|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
22301850|NCT05070416|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22301851|NCT04058353|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22301852|NCT05340855|Mayo Clinic|Christi A Patten, Ph.D.|507-266-2554|patten.Christi@mayo.edu|
22301853|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com|
22301854|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301855|NCT02390531|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
22332789|NCT05168657|University of Colorado|Dr. Sean Oser|3037245828|sean.oser@cuanschutz.edu|
22332790|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22332791|NCT02335411|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332792|NCT03843775|Memorial Sloan Kettering Cancer Center|Dr. Rona Yaeger MD|646-888-5109|yaegerr@mskcc.org|
22332793|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org|
22332794|NCT02222168|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332795|NCT00530621|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332796|NCT02596009|Novartis Pharmaceuticals|Study Director|862-778-8300||
22332797|NCT04611152|Kodiak Sciences Inc|Pablo Velazquez-Martin|6502810850|clinops@kodiak.com|
22332798|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
22332799|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk|
22332800|NCT05444114|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
22332801|NCT01275170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332802|NCT02316002|University of Pennsylvania (Abramson Cancer Center)|Dr. Joshua Bauml|215-662-4000|melissa.volpe@pennmedicine.upenn.edu|
22332803|NCT03917654|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
22332804|NCT05012943|Vinmec Healthcare System|Nguyen Xuan Hung|+84-865438388|v.hungnx1@vinmec.com|
22332805|NCT00400985|Medtronic BRC, The Netherlands, Maastricht|Director CRDM|+31 43 3566||566
22332806|NCT05382637|Children's National Hospital|Andrew Dauber, MD|202-476-2121|adauber@childrensnational.org|
22332807|NCT01883141|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
22332808|NCT04755283|Anthos Therapeutics, a Novartis company|Study Director|+1-888-669-6682|Novartis.email@Novartis.com|
22332809|NCT02851069|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22332810|NCT02684162|The University of Texas MD Anderson Cancer Center|Betul Oran, MD / Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
22332811|NCT05125237|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22332812|NCT03743571|University of Nevada Reno|Cynthia Lancaster|(775) 682-8144|cynthialancaster@unr.edu|
22332813|NCT01489865|Lombardi Comprehensive Cancer Center|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
22332814|NCT04115488|Polpharma Biologics S.A.|Director Clinical Research and Development|+48 607 697 896|clinicaltrials@polpharmabiologics.com|
22332815|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com|
22332816|NCT00972309|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22332817|NCT03884556|Trishula Therapeutics|Trishula Info|(650) 509-5732|info@trishulatx.com|
22332818|NCT00352794|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD., Professor|713-745-3429|sverstov@mdanderson.org|
22332819|NCT01058707|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22332820|NCT02159872|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdaderson.org|
22332821|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu|
22332822|NCT00167414|University of Rochester|Hong Zhang|585-341-6750|hong_zhang@urmc.rochester.edu|
22332823|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu|
22332824|NCT03722459|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22332825|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu|
22332826|NCT05554471|Cordis|Jenny Jimenez|+1 646 483-6846|jenny.jimenez@cordis.com|
22332827|NCT02218619|Columbia University Irving Medical Center|Robin Goland, MD|212-851-5494|rsg2@cumc.columbia.edu|
22332828|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332829|NCT03188991|US Biotest, Inc.|Gere S. diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
22332830|NCT03781817|University of Alabama at Birmingham, Department of Pediatrics|James Statler, MD|(205) 638-6048|jstatler@uabmc.edu|
22332831|NCT02674568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22332832|NCT01939834|University of Virginia|Sue Brown|434-924-1825|sab2f@virginia.edu|
22332833|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu|
22332834|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22332835|NCT03255226|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22332836|NCT00648739|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22332837|NCT02712359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332838|NCT03387423|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332839|NCT03572049|University of Alabama at Birmingham|Dr. Peter G. Pappas|2059347292|ppappas@uabmc.edu|
22301856|NCT03407794|University of North Florida|Andrea Arikawa|9044798995|andrea.arikawa@unf.edu|
22283933|NCT01424566|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22283934|NCT02484950|Rush University Medical Center|Brian Cole|(312) 432-2818|Brian.cole@rushortho.com|
22283935|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084|michael.kashner@va.gov|2853
22283936|NCT03779503|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22283937|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu|
22283938|NCT00875342|Weil Cornell Medical College|Program director|212 821 0783|jdifede@med.cornell.edu|
22283939|NCT02771626|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22283940|NCT02690649|Parkview Health|Julie Hughbanks|260-266-1444|julie.hughbanks@parkview.com|
22283941|NCT02392403|Cochlear|Chris James|+33 534 638 584|cjames@cochlear.com|
22283942|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu|
22283943|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com|
22283944|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
22301857|NCT03764072|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22301858|NCT03657277|University of Iowa|Nicole Brogden|3193358752|nicole-brogden@uiowa.edu|
22283945|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org|
22332840|NCT02195921|Tianjin University of Traditional Chinese Medicine|Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial|+86 13920921016|guoyi_168@163.com|
22283946|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
22283947|NCT02715726|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22283948|NCT02445573|Guang'anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com|
22283949|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
22283950|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu|
22283951|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov|
22332841|NCT03862807|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22332842|NCT04362761|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22332843|NCT01771627|MUSC|Dr. Ben Toll|843-792-9162|toll@musc.edu|
22332844|NCT03486327|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
22332845|NCT03126682|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
22332846|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332847|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332848|NCT02384239|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
22332849|NCT01299272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332850|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com|
22332851|NCT01721200|Yale University|Liana Fraenkel, MD, MPH, Department of Medicine||liana.fraenkel@yale.edu|
22332852|NCT01513759|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
22332853|NCT03606109|NYU Langone Health|Michael J. Alaia, MD|646-501-7223|Michael.Alaia@nyulangone.org|
22332854|NCT03926728|Statens Serum Institut|Per Skallerup|+4532688554|PRSK@SSI.dk|
22332855|NCT02305329|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22332856|NCT03669640|F. Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22332857|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu|
22332858|NCT03722849|The University of Melbourne|Dr Stuart Mazzone|+61383446457|stuart.mazzone@unimelb.edu.au|
22332859|NCT03993288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22332860|NCT02729545|Beijing Hospital of Integrated Traditional Chinese and Western Medicine|Dr. Yu Cao|086|howgreenbreeze@126.com|88223667
22332861|NCT03533608|Center for Clinical Managment Research|Dr. Rebecca Sripada|734-222-7432|rebecca.sripada@va.gov|
22332862|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu|
22332863|NCT01389024|The Johns Hopkins University School of Medicine|Dr. James Casella|410-955-6132|jcasella@jhmi.edu|
22332864|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu|
22332865|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
22332866|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680|acapriati@menarini-ricerche.it|9990
22332867|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22283952|NCT03619135|University of Iowa College of Dentistry|Dr. Kyle Stein|319-384-5105|kyle-stein@uiowa.edu|
22283953|NCT03629912|Western Kentucky University|Dr. Matthew Shake|270-745-3918|matthew.shake@wku.edu|
22283954|NCT02608450|Cassiopea SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22283955|NCT02565810|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
22332868|NCT01900392|UPENN|Catherine Reale|2157464009|catherine.reale@uphs.upenn.edu|
22332869|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org|
22272780|NCT02821416|AstraZeneca|Maria Jison|001-202-577-6213|Maria.Jison@astrazeneca.com|
22272781|NCT05886907|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22272782|NCT01763203|Icahn School of Medicine at Mount Sinai|Dr. Barbara Vickrey; Chair of Neurology|2122415698|barbara.vickrey@mssm.edu|
22272783|NCT02256917|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22272784|NCT02933528|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22272785|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22332870|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
22272786|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
22272787|NCT02982863|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272788|NCT03739710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272789|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com|
22272790|NCT03642067|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22272791|NCT03124160|FHI 360|David Hubacher|+1-919-321-3459|dhubacher@fhi360.org|
22272792|NCT04313400|Amarex Clinical Research, LLC|Dr. Ahmad Bayat, Sr Director II, Regulatory Affairs|301-956-2523|ahmadb@amarexcro.com|
22272793|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22272794|NCT01784926|Oslo University Hospital|Dr. Olav Kristianslund|+4723015168|olav.kristianslund@medisin.uio.no|
22272795|NCT02521792|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22272796|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22272797|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com|
22272798|NCT02937636|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272799|NCT00359294|PharmaMar USA Inc|Responsible medical officer|1 212 201 6770|ccoronado@pharmamar.com|
22272800|NCT04208412|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
22272801|NCT03762681|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22272802|NCT03148067|University of Sao Paulo|Physician|551126616900|priscila.rosalba@hc.fm.usp.br|
22272803|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22272804|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
22272805|NCT01915771|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
22272806|NCT01420016|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
22272807|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu|
22272808|NCT02774005|Santhera Pharmaceuticals (Switzerland) Ltd|Head of Regulatory Affairs EU|+41 6190689|julien.gaudias@santhera.com|50
22272809|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22272810|NCT03275389|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272811|NCT02770846|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
22272812|NCT03402230|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
22272813|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22272814|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com|
22272815|NCT03885999|The Chinese University of Hong Kong, Department of Surgery, Prince of Wales Hospital|Dr. Kaori Futaba|0085264630121|kfutaba@surgery.cuhk.edu.hk|
22332871|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22332872|NCT00740480|ENTrigue Surgical, Inc.|Gabriele Niederauer, PhD|210-298-6398|gabi.niederauer@entriguesurgical.com|6336
22332873|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22332874|NCT04662086|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
22332875|NCT01687400|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
22332876|NCT03079869|Kaiser Permanente|KPSC PRS Administrator|626-720-7463|RE-CTCAT@kp.org|
22332877|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
22332878|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
22332879|NCT04253756|University of Texas Southwestern Medical Center|Sonja Stutzman, Research Programs Manager|214-648-6719|sonja.stutzman@utsouthwestern.edu|
22332880|NCT01372254|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
22332881|NCT03731325|Washington University in St. Louis|Tina Day|314-286-0079|dayt@wustl.edu|
22332882|NCT03506646|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22332883|NCT04484805|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
22272816|NCT02452554|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22272817|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org|
22272818|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com|
22283956|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com|
22272819|NCT01085084|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22272820|NCT02749799|Dr. Reddys Laboratories Inc|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22272821|NCT02070978|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22272822|NCT03749109|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22283957|NCT02636946|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301859|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th|
22301860|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22301861|NCT02286089|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22301862|NCT05460325|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22301863|NCT04791761|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
22301864|NCT04669600|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22301865|NCT01163643|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22301866|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org|
22301867|NCT01564368|American College of Radiology|Senior Director Clinical Research Administration|215-574-3150|info@acr.org|
22301868|NCT01802437|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
22301869|NCT01861574|Medical University of South Carolina|JEFFREY J BORCKARDT|(843)792-3295|borckard@musc.edu|
22301870|NCT04857034|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22301871|NCT04810221|Life Meter Srl|Dr. Fernando De Benedetto/President|+39 391 4334 090|fernando.debenedetto@lifemetersrl.com|
22301872|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br|
22301873|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22301874|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22301875|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com|
22301876|NCT04998604|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22301877|NCT02659787|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22301878|NCT03953898|Yale School of Medicine|Rory Shallis, MD|(203) 200-4363|rory.shallis@yale.edu|
22301879|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com|
22301880|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu|
22301881|NCT02269371|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|7026533298|jill.clark.3.ctr@us.af.mil|
22301882|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu|
22301883|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu|
22283958|NCT03089944|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22283959|NCT02308488|NYU Langone Health - Perlmutter Cancer Center|Carmen A. Perez, M.D., Ph.D.|212-731-5003|Carmen.Perez@nyulangone.org|
22283960|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000|mconnelly1@cmh.edu|3193
22283961|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200|dbregman@lpicrd.com|828
22283962|NCT03544307|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3774|song-youngpark@unomaha.edu|
22283963|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22283964|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22283965|NCT03263780|Cedars-Sinai Medical Center|Timothy Daskivich, M.D.|310-423-4700|timothy.daskivich@cshs.org|
22283966|NCT01504204|Wake Forest University Health Sciences|Irma M Richardsom, MHA|336-716-2903|irichard@wakehealth.edu|
22283967|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22283968|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org|
22283969|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com|
22283970|NCT02356887|Toronto western Hospital/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
22283971|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22283972|NCT00790478|University of Tennessee|Paul Terry|(865) 305-9341|pterry@utmck.edu|
22283973|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22283974|NCT02495454|Fondazione Italiana Linfomi ONLUS|Dr. Luigi Marcheselli - FIL statistician|059 4223873|lmarcheselli@filinf.it|
22283975|NCT00712582|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
22283976|NCT03442296|Johns Hopkins University School of Medicine|Dr. Carrie Nieman|410-502-6965|cnieman1@jhmi.edu|
22283977|NCT00447122|BrUOG|Howard Safran, MD|4018633000|BrUOG@brown.edu|
22283978|NCT02409342|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22283979|NCT00279812|Institute of Food Research|Dr Charlotte Armah|01603 255 000|charlotte.armah@ifr.ac.uk|5360
22283980|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com|
22283981|NCT03907033|Mayo Clinic|Dr. Johnny Yi|480-342-0612|Yi.Johnny@mayo.edu|
22283982|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu|
22283983|NCT04046250|Tosk, Inc.|Emile Youssef, MD, PhD|312.244.0068|eyoussef@tosk.com|
22283984|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org|
22283985|NCT03834220|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22283986|NCT02020408|UCSD Department of Psychiatry|Walter H. Kaye, MD|858-534|wkaye@ucsd.edu|8019
22301884|NCT03086018|Bernafon AG|Julie Tantau|+41 31 998 1646|juta@bernafon.com|
22301885|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org|
22301886|NCT04219618|The University of Texas Health Science Center at Houston|Igor D. Gregoric, MD|713-486-6714|Igor.D.Gregoric@uth.tmc.edu|
22301887|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu|
22301888|NCT02133872|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
22301889|NCT02923739|M D Anderson Cancer Center|Dr. Anil Sood|713-745-5266|asood@mdanderson.org|
22301890|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22301891|NCT02623855|UCSF Benioff Children's Hospital Oaland|Dr. Nooshin Razani, Principal Investigator|415-428-3129|nrazani@mail.cho.org|
22301892|NCT00948974|Drexel University|Evan Forman|215.553.7113|evan.forman@drexel.edu|
22301893|NCT02487810|Fostering Improvement in End-of-Life Decision Science (FIELDS) Program|Beth Cooney, Assistant Director of FIELDS Program|215-573-9461|elcooney@exchange.upenn.edu|
22301894|NCT01972529|Eisai Inc|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
22301895|NCT01889186|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301896|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000|peter.hauser2@va.gov|2629
22301897|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
22301898|NCT00118716|GlaxoSmithKline|GSK Response Center|866-435-7343||
22301899|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu|
22301900|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu|
22301901|NCT02755597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22301902|NCT04252742|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22301903|NCT03759834|Mayo Clinic|Matthew Carlson, M.D., M.B.A.|507-284-8532|Carlson.Matthew@mayo.edu|
22301904|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org|
22301905|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu|
22301906|NCT01685138|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22301907|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu|
22301908|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu|
22301909|NCT03034018|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
22301910|NCT04859660|University of Arizona|Martina Gabra|520-626-6636|mgabra2@gmail.com|
22301911|NCT03996291|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22301912|NCT02703922|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
22301913|NCT03934736|Dynavax Technologies Corporation|Robert Janssen, MD, Senior Vice President & Chief Medical Officer|5106650414|rjanssen@dynavax.com|1414
22301914|NCT05805657|University of California, Berkeley|Dr. Allison Harvey, Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22301915|NCT01951638|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22301916|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
22301917|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22301918|NCT03188055|University of Wisconsin, Madison|Margaret Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
22301919|NCT04349280|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301920|NCT04549363|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301921|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no|
22301922|NCT00657618|WRAIR|Roseanne A. Resnner, MD|301-295-6400|rose.resnner@us.armyh.mil|
22301923|NCT01659151|Moffitt Cancer Center|Amod Sarnaik, M.D.|813-745-8581|Amod.Sarnaik@moffitt.org|
22301924|NCT05774197|Harvard Medical School|Desiree Azizoddin, PsyD|4052718001|desiree_azizoddin@dfci.harvard.edu|50516
22301925|NCT05073133|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22301926|NCT04981678|MaineHealth, Department of Anethesiology|Lead Research Coordinator|207-662-2862|janelle.richard@mainehealth.org|
22301927|NCT02235545|Abbott|Nicole Harbert, Program Director|1 972-526-4841|nicole.harbert@abbott.com|
22301928|NCT05650164|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22301929|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300||
22301930|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk|
22301931|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com|
22301932|NCT05418777|William Beaumont Hospitals|Maureen Cooney, RN Clinical Research Manager|2485510099|maureen.cooney@corewellhealth.org|
22301933|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu|
22283987|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000|Preben.Kjolhede@lio.se|3187
22332884|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org|
22332885|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332886|NCT03733301|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22332887|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22332888|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu|
22332889|NCT04336189|UCSF|Grant Dorsey|415-310-0525|grant.dorsey@ucsf.edu|
22332890|NCT04636437|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22332891|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com|
22332892|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332893|NCT00594009|University of Texas Medical Branch|Victor Cardenas, MD|(409) 772-2436|vcardena@utmb.edu|
22332894|NCT01821391|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
22332895|NCT04479241|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
22332896|NCT03417102|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22332897|NCT03285581|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22332898|NCT00540982|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22332899|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com|
22332900|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22332901|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com|
22332902|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332903|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22332904|NCT00511329|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
22283988|NCT05498467|Department of Dermatology and Allergy - Herlev-Gentofte Hospital|Kelvin Yeung|38673243|kelvin.yeung@sund.ku.dk|0045
22283989|NCT03684694|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22283990|NCT02720692|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
22283991|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu|
22283992|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org|
22283993|NCT02207491|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22283994|NCT05532891|Imperial College London|Dr Emma Rose McGlone|07949565678|e.mcglone@ic.ac.uk|
22283995|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22283996|NCT03221842|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22283997|NCT02504580|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22283998|NCT01939366|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22283999|NCT04909229|Yale University|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
22284000|NCT00231413|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284001|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu|
22284002|NCT03842683|Steno Diabetes Center North Denmark|Dr. Morten Hasselstrøm Jensen|+4522226964|mhj@hst.aau.dk|
22284003|NCT03242252|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22284004|NCT01659255|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22284005|NCT03675516|Momentum Data|Dr Andrew McGovern|+447531221970|andy.mcgovern@momentumdata.co.uk|
22284006|NCT04094584|University of California, San Francisco|Ralph Wang|(415) 353-4890|ralph.wang@ucsf.edu|
22284007|NCT02276547|Neovasc|Lisa Read, Clinical Study Manager|8558025180|lread@neovasc.com|323
22284008|NCT00106691|GTx, Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
22284009|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284010|NCT00907296|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22284011|NCT03208530|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|(617) 732-5640|kei_ouchi@dfci.harvard.edu|
22284012|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu|
22284013|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com|
22284014|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
22284015|NCT03833713|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
22284016|NCT02768753|General Hospital of Jinan Military Area|Dr.Qing Qing He，Dr.Gao Feng Ni|15653853675|m15653853675@163.com|
22284017|NCT03984487|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
22284018|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284019|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca|
22332905|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org|
22332906|NCT02238639|Hospital Ramon y Cajal|David Jimenez|+34913368133|djimenez.hrc@gmail.com|
22332907|NCT01628159|BD|Director of Clinical Affairs|763-445-2385|anna.lovas@bd.com|
22332908|NCT00698009|UT MD Anderson Cancer Center|Eugenie S Kleinerman,MD/Professor, Pediatrics - Research|(713) 497-6226|ekleiner@mdanderson.org|
22332909|NCT02060526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22301934|NCT02882711|The University of Texas Health Science Center at Houston|Salih Selek, M.D.|713-741-3936|salih.selek@uth.tmc.edu|
22301935|NCT02597790|David Geffen School of Medicine at UCLA|Kara Chew, MD, MS|310-825-0796|kchew@mednet.ucla.edu|
22301936|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
22301937|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org|
22301938|NCT04170686|University of Pennsylvania|Dr. Melissa G. Hunt|610-529-8055|mhunt@psych.upenn.edu|
22301939|NCT04389333|National Clinical Research Center for Digestive Diseases Department of Gastroenterology|Dr. Zhuan Liao|21-31161004|liaozhuan@smmu.edu.cn|+86
22301940|NCT04425902|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22301941|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu|
22319534|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu|
22319535|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22319536|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
22319537|NCT03610399|Acre Health State Secretariat|Suiane Negreiros|55 68 9983 1266|omsvalle@hotmail.com|
22319538|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300||
22319539|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com|
22319540|NCT02252536|NIAAA|Megan Ryan|3014434225|mryan1@mail.nih.gov|
22319541|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu|
22319542|NCT02340728|Memorial Sloan Kettering Cancer Center|Mark Schattner, MD|212-639-3148|schattnm@mskcc.org|
22319543|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu|
22319544|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600|jwells@glaukos.com|227
22319545|NCT02822950|Michigan State University|Gary Stein|517-353-5126|steing@msu.edu|
22319546|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623||
22319547|NCT00072358|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|1-833-MSK KIDS|kushnerb@MSKCC.ORG|
22319548|NCT02459769|University of Rochester|Charles Kamen, PhD|585-275-9958|charles_Kamen@urmc.rochester.edu|
22319549|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu|
22319550|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu|
22332910|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22332911|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332912|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov|
22332913|NCT03457727|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332914|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332915|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22332916|NCT03286426|Duke Eye Center|Dr. Grace Prakalapakorn|+1 919 684 7679|grace.prakalapakorn@duke.edu|
22332917|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332918|NCT01956123|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22332919|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732|sophie.jamal@wchospital.ca|2873
22332920|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu|
22332921|NCT00388674|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22332922|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu|
22332923|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu|
22332924|NCT03576131|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
22332925|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22332926|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com|
22332927|NCT01569594|Aziyo Biolgics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
22332928|NCT04635631|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332929|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22332930|NCT04764669|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22332931|NCT00256217|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22332932|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
22332933|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu|
22332934|NCT04054011|UCSD Dermatology|Joyce Yuan, MD|(858) 657-8322|joyce.yuan2@ucsf.edu|
22332935|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org|
22332936|NCT01785472|Novartis|Study Director|862-778-8300||
22332937|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com|
22332938|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com|
22332939|NCT01803464|University of Delaware|Dr. Christopher Modlesky|302-831-4185|modlesky@udel.edu|
22332940|NCT02424851|Oxford University Hospitals NHS Foundation Trust|Richard Brouwer|441865226950|richard.brouwer@ouh.nhs.uk|
22332941|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
22272823|NCT03951753|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22319551|NCT03838198|University of Michigan|Ewa Czyz|734-764-9466|ewac@umich.edu|
22301942|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu|
22301943|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000||
22301944|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org|
22301945|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686|neohca@gmail.com|5310
22332942|NCT02860039|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
22332943|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22332944|NCT01125358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332945|NCT02115373|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22332946|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org|
22332947|NCT04935931|Children's Mercy Kansas City|Dr. Stephani Stancil|816-234-3000|slstancil@cmh.edu|
22332948|NCT01638416|Australian and New Zealand Intensive Care Research Centre|Dr. Cooper|+61 3 9903 0071|anzicrc@monash.edu|30071
22332949|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253|palmira.bernocchi@fsm.it|260
22332950|NCT04007406|DAMIAN Pharma AG|Teresa Gerlock/Chief Operations Officer|+41 79 230 8591|teresa.gerlock@damianpharma.com|
22332951|NCT03159611|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22332952|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22332953|NCT02072174|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22332954|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com|
22332955|NCT04736316|University of Washington|Dr. Kelli O'Laughlin|206-744-2559|kolaugh@uw.edu|
22332956|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
22332957|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084||
22332958|NCT02665273|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
22332959|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com|
22332960|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov|
22332961|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100|torresfernandoadrian@gmail.com|1014
22332962|NCT06212544|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22332963|NCT03222856|MedSIR|Scientific Director|+34 611261467|alicia.garcia@medsir.org|
22301946|NCT02940574|KU Leuven|Prof. Dr. Kaat Alaerts|16 37 64 46|kaat.alaerts@kuleuven.be|+32
22301947|NCT04538144|Institute for Exercise and Environmental Medicine|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
22332964|NCT00359073|University of Wisconsin Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
22332965|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22332966|NCT02682069|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
22332967|NCT02513095|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201 326 5300|medinfo@eagleus.com|
22332968|NCT02786810|University of Tennessee Health Science Center|Dr. David Hains|9012874876|dhains@uthsc.edu|
22332969|NCT01819467|NHRMC|Dr. Henry Easley|910. 667-9238|sandy.easley@seahec.net|
22332970|NCT03514121|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22332971|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22332972|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|marianne.goodman@va.gov|5188
22332973|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332974|NCT02545868|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22332975|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22332976|NCT01932801|University of Washington / Washington State University|Dr. Susan Collins|12068327885|susan.collins@wsu.edu|
22332977|NCT03286400|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
22332978|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22332979|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343||
22332980|NCT03069365|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22332981|NCT02780115|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22332982|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22332983|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
22332984|NCT01257737|Horizon Therapeutics, LLC|Colleen Canavan, Director|1-224-383-3000|clinicaltrials@horizonpharma.com|
22332985|NCT01940276|Duke University|Daniel George, MD|919-668-4615|daniel.george@duke.edu|
22332986|NCT02723786|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332987|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br|
22332988|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22332989|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
22332990|NCT03170271|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22332991|NCT02466776|Kaiser Permanente|Dr. Mary Zaki|503-332-2390|mary.nasry@gmail.com|
22332992|NCT02701049|Brigham and Women's Hospital|Dr. Adil H. Haider|617-525-9280|ahhaider@bwh.harvard.edu|
22332993|NCT02709759|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22332994|NCT01036594|University of California, San Francisco|Dr. Terence Friedlander, MD|(415) 514-6380|Terence.Friedlander@ucsf.edu|
22284020|NCT04468074|University of Colorado, Boulder|Marta Ceko|443-835-6587|Marta.Ceko@colorado.edu|
22284021|NCT02049138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22284022|NCT03995355|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO - Sr. Principal Research Optometrist|1-800-843-2020|MBishop4@its.jnj.com|
22284023|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284024|NCT00860015|Columbia University|Rober Taub, MD - Vivian and Seymour Milstein Family Prof. of Clinical Medicine||rntaubipod@gmail.com|
22284025|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu|
22284026|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu|
22284027|NCT03945019|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
22284028|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu|
22284029|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu|
22284030|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca|
22284031|NCT00199888|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22284032|NCT02030288|VA Boston Healthcare System|Nicholas Livingston|857-364-6360|nicholas.livingston@va.gov|
22284033|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu|
22284034|NCT05219669|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
22284035|NCT05216627|University of Pennsylvania|Daniel Blumenthal|215-746-7155|daniel.blumenthal@pennmedicine.upenn.edu|
22284036|NCT02177838|Rutgers Cancer Institute of New Jersey|Sung Kim, MD|732-235-3986|sk1375@cinj.rutgers.edu|
22284037|NCT03274804|Universitätsklinikum Heidelberg, NCT|Dr. Georg Martin Haag|+49 (0) 6221 56|GeorgMartin.Haag@med.uni-heidelberg.de|4801
22284038|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu|
22284039|NCT04075409|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22284040|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com|
22284041|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
22284042|NCT00330668|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
22284043|NCT01839656|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22284044|NCT01994993|Duke University Medical Center|Michael Cohen-Wolkowiez, M.D|9196688812|michael.cohenwolkowiez@duke.edu|
22284045|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
22284046|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22284047|NCT02273960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22284048|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu|
22284049|NCT03449433|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22284050|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com|
22284051|NCT02145351|Mayo Clinic|Barry A. Borlaug, M.D.|507-255-4152|Borlaug.Barry@mayo.edu|
22284052|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu|
22284053|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu|
22284054|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22284055|NCT03268941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22284056|NCT02069119|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22284057|NCT03878758|Becton Dickinson|Michael Gibney|201-847-6170|michael.gibney@bd.com|
22284058|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22284059|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284060|NCT03614325|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|6177543189|bpogara@bidmc.harvard.edu|
22284061|NCT00321464|Amgen Inc.|Study Director|866-572-6436||
22284062|NCT00119366|Fred Hutchinson Cancer Research Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
22284063|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284064|NCT00652951|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284065|NCT01022424|Otsuka Pharmaceutical Co.,Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22284066|NCT02100969|University of Kansas Medical Center|Dr. Mazen Dimachkie|913-588-6970|mdimachkie@kumc.edu|
22284067|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300||
22284068|NCT02692755|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
22284069|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org|
22301948|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
22301949|NCT01682213|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman, MD|646-888-4162|chapmanp@mskcc.org|
22301950|NCT04382924|Algernon Pharmaceuticals|Dr. Christopher Bryan|2045572308|cbryan@algernonpharmaceuticals.com|
22301951|NCT00530803|Montefiore Medical Center|Associate Professor, Dept of Pediatrics|718-741-2460|cskae@montefiore.org|
22301952|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com|
22301953|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22301954|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org|
22301955|NCT04207840|Amphastar Pharmaceuticals, Inc.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484|info@amphastar.com|
22301956|NCT05383417|University of California San Diego Health|Dr. Andrew Vahabzadeh-Hagh|858-249-4070|avahabz@health.ucsd.edu|
22301957|NCT03243422|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919 962-3098|lgravens@email.unc.edu|
22301958|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
22301959|NCT03420781|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22301960|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140|jrichard@mcmaster.ca|27811
22301961|NCT03525548|Vertex Pharmaceuticals Incorporated|Medical Monitor|617 341 6777|medicalinfo@vrtx.com|
22301962|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22301963|NCT02696564|School of Medicine, Johns Hopkins University|Robert A. Wise, M.D.|410-550-0545|rwise@jhmi.edu|
22301964|NCT05267600|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22301965|NCT04067401|University of Rochester Medical Center, Psychiatry Dept|Dr. Peter Wyman|5852733372|peter_wyman@urmc.rochester.edu|
22301966|NCT02579876|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
22301967|NCT03633929|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
22301968|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu|
22301969|NCT02287584|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22301970|NCT01892345|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22301971|NCT03745222|Celgene Corporation|Anne McClain|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
22301972|NCT02657317|University of Texas Health Science Center at San Antonio|Donald McGeary, PhD|210-567-5454|mcgeary@uthscsa.edu|
22301973|NCT03643224|Medtronic CAS|Josman Suri|7635050262|josman.suri@medtronic.com|
22301974|NCT06289192|Johns Hopkins University|Alejandra Ellison-Barnes|n/a|aelliso6@jhmi.edu|
22301975|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22301976|NCT01784068|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22301977|NCT06351371|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22301978|NCT04359784|Fred Hutchinson Cancer Center|Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
22301979|NCT02063828|Wake Forest NCORP Research Base|Emily Dressler, PhD|336 716-0891|ncorp@wakehealth.edu|
22301980|NCT02753595|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22301981|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au|
22301982|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22301983|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu|
22301984|NCT02257099|UBMD Orthopaedics and Sports Medicine|John Marzo, MD|7168292982|jmmarzo@buffalo.edu|
22301985|NCT04987762|Purdue Pharma L.P.|Clinical Leader|1-800-745-7445|nelson.sessler@imbriumthera.com|
22301986|NCT02068495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22301987|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu|
22301988|NCT01666808|Emory University|Dr. Ashesh Jani|404-778-3827|abjani@emory.edu|
22301989|NCT02220894|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22301990|NCT03217747|M D Anderson Cancer Center|Aung Naing|713-563-1930|anaing@mdanderson.org|
22301991|NCT03248375|Icahn School of Medicine at Mount Sinai|Dr. Edward Kim|(212) 241-7409|Edward.Kim@mountsinai.org|
22301992|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22272824|NCT03178851|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22301993|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu|
22301994|NCT02618616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22272825|NCT04633291|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
22301995|NCT03904043|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
22301996|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org|
22301997|NCT04839354|Emory University|Claudia Morris, MD|404-785-7141|claudia.r.morris@emory.edu|
22301998|NCT05878197|Ghent University|drs. Anke Adriaansen|0471028622|anke.adriaansen@ugent.be|
22301999|NCT05002218|Columbia University Irving Medical Center|Scott Barbuto, MD|518-275-9588|sb3779@cumc.columbia.edu|
22302000|NCT03779906|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director Medical Planning and Management X-ray products|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22302001|NCT03421808|Medical University of South Carolina|Mark S. George, MD|18438765142|georgem@musc.edu|
22302002|NCT07069764|National Institute of Laser Enhanced Sciences (NILES), Cairo University|DR.hala shaaban attiyah|01012894478|std.halashaaban@niles.edu.eg|
22302003|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155||
22302004|NCT03183388|Yale School of Medicine|Dr. Hilary Blumberg|203-785-6180|hilary.blumberg@yale.edu|
22302005|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
22302006|NCT03935217|Lupin Pharmaceuticals|Director of Clinical Operations|443-301-3146|jackieshaw@lupin.com|
22302007|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu|
22332995|NCT01700335|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
22332996|NCT03466060|Johnson & Johnson Vision Care Inc.|Meredith Bishop, OD, MS, FAAO- Senior Principal Research Optometrist|904-443-1396|MBishop4@its.jnj.com|
22272826|NCT01905592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22332997|NCT01612780|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22332998|NCT05005130|University of North Carolina at Chapel Hill|Michael Herce, MD, MPH, MSc|919-966-2537|michael_herce@med.unc.edu|
22332999|NCT03345485|Mundipharma Research Limited|Mónica Araujo - Senior Programmer, Data Management|+447922223436|monica.araujo@mundipharma-rd.eu|
22333000|NCT02985515|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-393-2455|pawina@wustl.edu|
22333001|NCT01610284|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22333002|NCT03020966|Hospital for Special Surgery|Dr. Jacques Yadeau|(212) 774-2224|Yadeauj@hss.edu|
22333003|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22333004|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22333005|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu|
22333006|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22333007|NCT02379442|NHLBI, NIH|Sawa Ito, MD|301-326-5233|itos3@upmc.edu|
22333008|NCT05674721|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22333009|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22333010|NCT00937859|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22333011|NCT04466956|Barts Health NHS Trust|Dr Anna McDougall|02078827272|anna.mcdougall@nhs.net|
22333012|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org|
22333013|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com|
22333014|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu|
22333015|NCT03506425|Duke University|Richard Bedlack, M.D., Ph.D.|919-668-2839|richard.bedlack@duke.edu|
22333016|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org|
22333017|NCT02181075|Oncology Clinical Trials Group|Sarah Pearson, Trial Management Director|01865 227160|sarah.pearson@oncology.ox.ac.uk|
22333018|NCT04150107|Oramed, Ltd.|Miriam Kidron, PhD|+972-2-566-0001|miriam@oramed.com|
22333019|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu|
22333020|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22333021|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22333022|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22333023|NCT03409328|Rosalind Franklin University|Dr. Brian Feinstein|847-578-8736|brian.feinstein@rosalindfranklin.edu|
22333024|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com|
22333025|NCT03930615|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22333026|NCT02864953|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22333027|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22333028|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406|wegwarth@mpib-berlin.mpg.de|695
22333029|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org|
22333030|NCT05083559|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
22333031|NCT02704130|Atrium Health|Blair Stephenson, Research Business Manager|704-446-4845|blair.stephenson@atriumhealth.org|
22333032|NCT03752866|Abbott|Vinny Podichetty, Sr. Director, Global Clinical Affairs|+1 408-845-1639|vinny.podichetty@abbott.com|
22333033|NCT02648152|Smith + Nephew plc|Director Clinical Operations - EU|00441923 477100|annelaine.tomlinson@smith-nephew.com|
22333034|NCT03945773|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22333035|NCT05895461|The Miriam Hospital|Jacqueline Hayes, phD|4017938917|jhayes3@brownhealth.org|
22272827|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org|
22302008|NCT02412501|Medtronic Coronary/Structural Heart|Beth Moe, Clinical Study Manager|763-526-1184|beth.moe@medtronic.com|
22302009|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22302010|NCT02623816|MetroHealth Medical Center|Nisheet Waghray|2167785736|nwaghray@metrohealth.org|
22302011|NCT02026232|Washington University School of Medicine|Dr. Janet McGill|314-273-3929|jmcgill@wustl.edu|
22302012|NCT01529008|Bone Therapeutics|Chief Medical Officer|+32 493 09 73 66|Regulatory@bonetherapeutics.com|
22302013|NCT02487498|Novartis Pharmaceuticals|Study Director|862-778-1873||
22302014|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22302015|NCT03168295|University of Texas Health San Antonio|Carolina Solis-Herrera|(210) 567-6691|solisherrera@uthscsa.edu|
22302016|NCT02228967|San Diego State University Research Foundation|Mark B. Reed/Professor and Interim Associate Dean|619-594-6664|mreed@sdsu.edu|
22302017|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com|
22302018|NCT01995539|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22302019|NCT02466646|Marmara University Faculty of Dentistry, Department of Periodontology|Prof. Dr. Basak Dogan|00905332621170|basak.sdogan@gmail.com|
22302020|NCT03261271|University of Kansas Medical Center|Dr. Jill Hamilton-Reeves|913-588-7650|jhamilton-reeves@kumc.edu|
22302021|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com|
22302022|NCT01932697|Mayo Clinic|Daniel J. Ma, M.D.|507/284-3261|Ma.Daniel@mayo.edu|
22302023|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302024|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
22302025|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu|
22302026|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
22333036|NCT05197335|Orthofix SRL|Clinical Program Manager|+39-045-6719000|danielacangiano@orthofix.it|
22302027|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
22302028|NCT00674570|San Francisco VA Health Care System|Sabra Inslicht, Ph.D.|415-221-4810|sabra.inslicht@ucsf.edu|23341
22272828|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22302029|NCT03430063|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22302030|NCT03124199|Hospital Universitario de la Princesa|Mercedes Ramas|913093911|mercedesramas@gmail.com|
22302031|NCT02798211|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22302032|NCT02167217|Washington University School of Medicine|Anne M. Connolly, MD FAAN|314-362-6981|connollya@wustl.edu|
22302033|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk|
22302034|NCT02080195|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Javier Bolaños Meade, MD|410-614-6398|fbolano2@jhmi.edu|
22302035|NCT03505476|University of Iowa|Dr. Jennifer Hrabe Clinical Associate Professor|319-384-7359|jennifer-hrabe@uiowa.edu|
22302036|NCT03607825|Minnetronix Neuro|Director of Clinical Trials|651-917-4060|info@cerevention.com|
22302037|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com|
22302038|NCT02255357|new york psychiatric institute|wilfrid raby, m.d.|2129233031|wilfrid.raby@nyspi.columbia.edu|
22302039|NCT03357614|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22302040|NCT01856712|University of Wisconsin|Randall Brown|6082636558|rtbrown@wisc.edu|
22302041|NCT01321541|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
22302042|NCT02192970|University of Wisconsin - Madison|Michael M Altaweel, MD|(608) 263-7290|mmaltaweel@wisc.edu|
22302043|NCT04074590|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22302044|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22302045|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302046|NCT06097676|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
22302047|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|BrUOG@brown.edu|
22302048|NCT02709005|University of Iowa Hospitals and Clinics|Patricia Winokur, MD|319-384-4590|patricia-winokur@uiowa.edu|
22302049|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu|
22302050|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22302051|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22302052|NCT01112228|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22302053|NCT02489110|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
22333037|NCT05833035|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22333038|NCT03377491|Novocure|Medical Director|1-877-678-8611|clinicaltrials@novocure.com|
22333039|NCT02878850|Duke University|Miriam Treggiari|9196819933|miriam.treggiari@duke.edu|
22302054|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300||
22333040|NCT04457297|National Cancer Center Hospital East|Takayuki Yoshino|+81-4-7133-1111|prj-altair_core@eps.co.jp|
22333041|NCT03503344|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
22333042|NCT04231669|Washington University in St. Louis|Dr. Ozge Sensoy Bahar|314-935-9403|ozge.sensoybahar@wustl.edu|
22333043|NCT04377932|Baylor College of Medicine|David Steffin, MD|(832) 824-4745|dhsteffi@texaschildrens.org|
22333044|NCT03729830|Boston Scientific|Susan Hampson, Clinical Trial Manager|508-728-5165|susan.hampson@bsci.com|
22333045|NCT03563716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22333046|NCT06492226|Xentria, Inc|Vice President, Clinical Developement|2244434615|tmatthews@xentria.com|
22333047|NCT03285321|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22272829|NCT03884270|Loyola University Chicago|Dr. Sarah Kinsinger|708-216-0464|sarah.kinsinger@lumc.edu|
22272830|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272831|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu|
22272832|NCT01037816|Hisamitsu Pharmaceutical Co., Inc.|Yoshinobu Higashi, Section Manager, International Regulatory Affairs|+81-3-5293-1712|Yoshinobu_Higashi@hisamitsu.co.jp|
22272833|NCT00966355|Korea University College of Medicine|Prof. Soon Ho Um|+82-2-920-5019|umsh@korea.ac.kr|
22272834|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22272835|NCT01142947|Center for Individualized and Genomic Medicine Research, Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|kwillia5@hfhs.org|
22272836|NCT04378569|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22272837|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
22272838|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it|
22272839|NCT04530838|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284070|NCT04473664|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22284071|NCT00007020|Retrophin, Inc.|Retrophin Medical Information|+1 8776595|medinfo@retrophin.com|518
22284072|NCT02708485|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
22333048|NCT05016960|VA San Diego Healthcare System|Dr. Erin Almklov|858-552-8585|erin.almklov@va.gov|3907
22333049|NCT05788965|University of Minnesota|Amir Moheet|612-624-3209|mohee002@umn.edu|
22333050|NCT02668666|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22333051|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org|
22333052|NCT03794349|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22333053|NCT04872998|University of Utah|Principal Investigator Joel Trinity Associate Professor|801-582-1565|joel.trinity@utah.edu|
22333054|NCT00430989|Bayside health|Professor Paul Myles|+61390762000|p.myles@alfred.org.au|3176
22333055|NCT06547814|University of North Carolina at Chapel Hill|Abby Shackley, MA|828-407-2107|abigail_gamble@email.unc.edu|
22333056|NCT05467397|Brigham and Women's Hospital, Boston, MA|Carmen Priolo, MD PhD|857-307-0783|cpriolo@bwh.harvard.edu|
22333057|NCT04673175|Weill Cornell Medicine|Markus Plate, MD|212-746-7587|map9313@med.cornell.edu|
22333058|NCT05297786|Vanderbilt University Medical Center|Dr. Jorge Gamboa|615-343-4176|jorge.gamboa@vanderbilt.edu|
22333059|NCT05402137|University of California, Los Angeles|A. Janet Tomiyama|310.206.6875|janetto@ucla.edu|
22333060|NCT04933474|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
22333061|NCT03701308|Siteman Cancer Center|Geoffrey Uy|314-454-8304|guy@wustl.edu|
22333062|NCT06269484|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22333063|NCT04035499|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
22333064|NCT05990075|James A. Haley Veterans' Hospital|Vanessa Panaite, PhD|813-768-2193|vanessa.panaite2@va.gov|
22333065|NCT05101317|Peking University|Dr. Ruiping Xiao|86-010-62757243|xiaor@pku.edu.cn|
22333066|NCT04338893|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
22333067|NCT06426927|University of North Carolina at Chapel Hill|José Guillem, MD, MPH|717-531-5164|jgguillem41@gmail.com|
22333068|NCT01424150|Alfred Health|Professor Paul Myles|61 3 9076 3176|p.myles@alfred.org.au|
22333069|NCT03994601|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22333070|NCT04221438|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22333071|NCT04566666|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
22333072|NCT06379893|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22333073|NCT02819752|The Royal Marsden NHS Foundation Trust|PEACH Senior Trial Manager|(+44) 02089156666|peach.trial@rmh.nhs.uk|
22333074|NCT02714881|Brigham and Women's Hospital|Katherine P. Liao, MD, MPH|617-732-5000|kliao@bwh.harvard.edu|
22333075|NCT04233424|PolyPid|Eyal Shoshani, VP Clinical Affairs|+972-74-7195700|eyal.s@polypid.com|138
22333076|NCT04518670|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
22333077|NCT06127147|University of Illinois at Chicago|Cemal Ozemek|312-355-3996|ozemek@uic.edu|
22333078|NCT06232018|Hatyai hospital|Pooriwat Lertsurawat|087-6329824|Pooriwat999@gmail.com|
22333079|NCT03575793|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22333080|NCT05339087|Thoraxklinik Heidelberg gGmbH|Prof. Dr. Ekkehard Grünig|+496221396|PH-Studies.THOR@med.uni-heidelberg.de|1230
22333081|NCT04751383|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22333082|NCT03659916|Albireo, An Ipsen Company|Medical Director|see email|clinical.trials@ipsen.com|
22333083|NCT06187909|Department of Anesthesia, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt|Yasser Mohamed Reyad Ahmed El-Mansoury|01000286206|yassermoahmed0102107@med.asu.edu.eg|
22333084|NCT04745676|University of Rochester Medical Center, Wilmot Cancer Institute|Research Project Manager|585 410 5044|cait_fallone@urmc.rochester.edu|
22333085|NCT04322097|University of Pennsylvania|Raj Dedhia, MD|2158293720|raj.dedhia@pennmedicine.upenn.edu|
22333086|NCT03707834|Temple University|Sharon J. Herring, MD, MPH, Principal Investigator|215-707-2234|herris01@temple.edu|
22333087|NCT02617563|Medtronic Cranial and Spinal Technologies|Clinical Study Manager|+31433566584|bart.heijnen@medtronic.com|
22333088|NCT03003468|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22333089|NCT03879577|University of Chicago|Theodore Karrison (Research Professor)|(773) 702-2453|tkarrison@health.bsd.uchicago.edu|
22333090|NCT06286332|Chang Gung University|Principal Investigator|0905126618|k.kathleenwu@gmail.com|
22302055|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov|
22302056|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
22302057|NCT05479604|Mayo Clinic|Amar Miglani, M.D.|4803422929|miglani.amar@mayo.edu|
22302058|NCT01591382|Brigham and Women's Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org|
22302059|NCT02620917|University of Padova|Daniela Bruttomesso|0039 049/8212183|daniela.bruttomesso@unipd.it|
22302060|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu|
22302061|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
22302062|NCT01398280|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
22302063|NCT05099926|Columbia University Irving Medical Center|Dr. Andrea T. Duran|212-342-4491|atd2127@cumc.columbia.edu|
22302064|NCT02362048|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22302065|NCT00227617|UCSF Helen Diller Family Comprehensive Cancer Center|Dr. Emily Bergsland|415-885-7810|Emily.Bergsland@ucsf.edu|
22333091|NCT05272189|Brigham & Women's Hospital|Jeremy M Wolfe, Professor and Principle Investigator|6178511166|jwolfe@bwh.harvard.edu|
22333092|NCT06070987|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
22333093|NCT03972488|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22333094|NCT04526665|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22333095|NCT07004010|EspadPharmed|Hamidreza Kafi|989129232594|Kafi.h@orchidpharmed.com|
22333096|NCT04544995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22333097|NCT06865677|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
22333098|NCT03900754|San Francisco VA Medical Center|Dr. Josh Woolley|415-221-4810|joshua.woolley@va.gov|24117
22333099|NCT02086578|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@MSKCC.ORG|
22333100|NCT02408861|Icahn School of Medicine at Mount Sinai|Dr Himanshu Joshi MBBS MPH PhD|2126599635|Himanshu.Joshi@mountsinai.org|
22333101|NCT04814654|Albert Einstein College of Medicine|Dr. Viraj Patel|718-920-5256|viraj.patel@einsteinmed.edu|
22333102|NCT04505553|University of Washington Medical Center - Montlake|Stacey Cohen, MD|2066066405|sshovitz@fredhutch.org|
22333103|NCT04583670|General Practice Department Sorbonne University|Mariela Skendi Study Coordinator|0033613930736|marielaskendi@gmail.com|
22333104|NCT05147662|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22333105|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu|
22333106|NCT03222609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22333107|NCT00756509|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22333108|NCT05985304|Rayner Intraocular Lenses Limited|Senior Clinical Trial Manager|714-398-9988|EricAlegria@rayner.com|
22333109|NCT07165366|Indiana University|Bruce A. Matis|3172012089|bmatis@iu.edu|
22333110|NCT04799145|Össur ehf.|Lisa Tronicke|+4915155367970|ltronicke@ossur.com|
22302066|NCT03479697|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
22302067|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|fmjohns@mdanderson.org|
22302068|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302069|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr|
22302070|NCT04251884|Ospedale Regionale di Lugano|Dr. Francesco Mongelli|+41764706297|francesco.mongelli@mail.com|
22302071|NCT04108000|Emory University|Professor Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
22302072|NCT03520322|University of Rochester Medical Center|Otolaryngology Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
22302073|NCT03764774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22302074|NCT06027619|Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center|Edward V Maytin|(216) 445-6676|maytine@ccf.org|
22302075|NCT04716413|Montefiore Medical Center|Dr. Naum Shaparin|718-920-4316|nshapari@montefiore.org|
22302076|NCT01493960|Index Pharmaceuticals|Dr Thomas Knittel|0046 8 508 847 31|thomas.knittel@indexpharma.com|
22302077|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
22302078|NCT01382602|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22302079|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com|
22302080|NCT01686165|University of Arizona Cancer Center|Daniel Persky, M.D.|520-626-8908|dpersky@uacc.arizona.edu|
22302081|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302082|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22302083|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22302084|NCT06369779|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22302085|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302086|NCT01337986|Washington Univerisity St. Louis|Robert Naismith, MD|314-747-5576|naismithr@wustl.edu|
22302087|NCT02313909|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22302088|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu|
22302089|NCT04026165|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22272840|NCT02672176|University of California, Davis|Heather M. Young, Principal Investigator|916-734-4745|hmyoung@ucdavis.edu|
22272841|NCT03117634|Singapore National Eye Center|Gemmy Cheung, Principal Investigator|+65 6322 8335|gemmy.cheung.c.m@singhealth.com.sg|
22272842|NCT02155309|Henry Jackson Military Foundation for Naval Medical Research Unit - Dayton|Daniel Geyer, MPH|(937) 938-3922|daniel.geyer.1.ctr@us.af.mil|
22272843|NCT03565874|Department of Child and Adolescent Psychiatry, University Hospital of Lausanne|Dr. Sébastien Urben|+41 21 314 7492|sebastien.urben@chuv.ch|
22302090|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org|
22302091|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22302092|NCT02569437|Icahn School of Medicine at Mount Sinai|Dr. Benjamin Malkin||Benjamin.D.Malkin@kp.org|
22302093|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302094|NCT05028426|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Vivien Fontaine|+33546455050|recherche.clinique@ght-atlantique17.fr|
22302095|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302096|NCT03155932|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22302097|NCT02206217|School of Optometry, The Hong Kong Polytechnic University|Prof. Carly Sin Yin Lam|2766 6091|carly.lam@polyu.edu.hk|
22302098|NCT03532308|Yale University School of Medicine|Michael S. Leapman, MD|(203) 785-2815|michael.leapman@yale.edu|
22302099|NCT03720938|Abant Izzet Baysal University|Dr. Halil Ibrahim Atasoy|90 532 599 89 53|halilibrahimatasoy@gmail.com|
22284073|NCT01100528|Cleveland Clinic, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|866-223-8100|CancerCenterResearch@ccf.org|
22284074|NCT02066415|Amgen Inc.|Study Director|866-572-6436||
22284075|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22284076|NCT02211313|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
22284077|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22284078|NCT03316950|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22284079|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com|
22284080|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org|
22284081|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
22284082|NCT02322190|National Cancer Institute|Dr. Ronald Gress|240-760-6167|rg26g@nih.gov|
22284083|NCT03344640|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22284084|NCT02809053|Archigen Biotech Ltd|Medical Director|+44 (0)20 3749 5000|info@archigenbio.com|
22284085|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302100|NCT02535364|Juno Therapeutics|Dr. Nikolaus Trede|206-566-5886|Nick.Trede@junotherapeutics.com|
22302101|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
22302102|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu|
22302103|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
22302104|NCT03467932|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
22302105|NCT01959347|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22302106|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22302107|NCT02252432|Cedars Sinai Medical Center|Ofelia Loani Elvir Lazo, MD|310-423-1682|Loani.Elvir-Lazo@cshs.org|
22302108|NCT02889133|Columbia University Medical Center|Dr. Eldad Hod|212-305-4109|eh2217@cumc.columbia.edu|
22302109|NCT01673893|Cardiovascular Institute of the South Clinical Research Corporation|Deanna K. Benoit, LPN, CCRC|985-876-0300|deanna.benoit@cardio.com|5613
22302110|NCT01781390|Mesoblast, Inc.|Kenneth Borow, MD (Lead, Global Cardiovascular Development)|(212) 880-2060|Ken.Borow@Mesoblast.com|7951
22302111|NCT01862796|National Institute of Diabetes Digestive and Kidney Diseases/NIH|Dr. Marci E. Gluck|602-200-5317|gmarci@mail.nih.gov|
22302112|NCT04037436|University of Waterloo|The MoveStrong program for promoting balance and functional strength training and adequate protein i|519-888-4567|lmgiangr@uwaterloo.ca|46357
22302113|NCT01375205|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-3968|simpsone@ohsu.edu|
22302114|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu|
22302115|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu|
22302116|NCT04708223|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22302117|NCT01849263|Washington University School of Medicine|Nancy L. Bartlett, M.D.||nbartlet@dom.wustl.edu|
22302118|NCT04130802|Oculis SA|Chief Development Officer|0041 21 711 39 70|info@oculis.com|
22302119|NCT03185481|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302120|NCT02303184|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22302121|NCT03371940|Indiana University School of Medicine|Dr. Mary de Groot|317-278-1965|mdegroot@iu.edu|
22302122|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302123|NCT02003508|Melbourne Sexual Health Centre|A/Prof Marcus Chen|+613 93416260|mchen@mshc.org.au|
22302124|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
22302125|NCT00586170|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
22302126|NCT04278625|Nationwide Children's Hospital|Dr. Peter Winch|614-722-5936|peter.winch@nationwidechildrens.org|
22272844|NCT02501161|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22272845|NCT04336475|Cukurova University|Dr Nihan Cuzdan, MD, principal investigator|05052706846|nihancuzdan@hotmail.com|
22272846|NCT03304106|Cochlear Limited|Laura Chenier, Clinical Project Manager|422-325-4171|lchenier@cochlear.com|
22272847|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it|
22272848|NCT03188523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272849|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
22272850|NCT02179047|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22272851|NCT02096276|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272852|NCT02213380|The second affiliated hospital and Yuying children's hospital of Wenzhou medical university|Ting Li|008613587876896|liting1021@aliyun.com|
22272853|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu|
22272854|NCT03063619|M D Anderson Cancer Center|Dr. Banu Arun|(713) 792-2817|barun@mdanderson.org|
22272855|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com|
22272856|NCT03331263|Medline Industries, Inc.|Senior Regulatory Affairs Specialist|8476433515|aminarcik@medline.com|
22272857|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
22272858|NCT00905567|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22272859|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu|
22272860|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu|
22272861|NCT02362191|University of North Carolina at Chapel Hill|David Rubinow, MD|919-445-0220|drubinow@med.unc.edu|
22272862|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com|
22272863|NCT01473940|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
22272864|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22272865|NCT02849171|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
22272866|NCT02532257|The University of Texas MD Anderson Cancer Center|Loretta Nastoupil, MD|(713) 792-2860|lnastoupil@mdanderson.org|
22272867|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it|
22272868|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
22272869|NCT02224612|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
22272870|NCT03498313|University of Illinois at Chicago|Dr. Tory Eisenlohr-Moul, Assistant Professor of Psychiatry|859-317-0503|temo@uic.edu|
22272871|NCT04026750|High Point Clinical Trials Center|Melanie Fein, MD|1-336-841-0700|mfein@highpointctc.com|2530
22284086|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22284087|NCT05086510|AinShamsU|Dr. Mohammad Gamal|2001114115331|mdgamal92@gmail.com|
22284088|NCT03022981|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22284089|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22284090|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu|
22284091|NCT02337725|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22284092|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu|
22284093|NCT00500760|Amgen Inc.|Study Director|866-572-6436||
22284094|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22284095|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22284096|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
22284097|NCT03294629|Sleep Center, Taoyuan Chang Gung Memorial Hospital|Ning-Hung, Chen|+886-3-3281200|ninghung@yahoo.com.tw|2281
22284098|NCT03691779|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22302127|NCT03538015|University of Utah|Dr. Owen Chan|801-581-7755|ochan@u2m2.utah.edu|
22302128|NCT00511875|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
22302129|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302130|NCT02686034|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
22302131|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22302132|NCT01678131|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302133|NCT04552743|Stanford Medicine at Stanford University|Khanh Nguyen|650-721-2372|khanhpn@stanford.edu|
22302134|NCT03152084|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22302135|NCT00982930|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22302136|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302137|NCT05597722|University of Pittsburgh|Dr. Eva Szigethy|412-667-0416|szigethye@upmc.edu|
22302138|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302139|NCT05361655|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22302140|NCT04411849|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
22302141|NCT03750006|VA Kansas City Healthcare System|Bruce Troen|913-574-4896|bruce.troen@va.gov|
22302142|NCT03538951|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
22302143|NCT01816763|VA Palo Alto|Karl Lorenz MD MSHS, Principal Investigator|6504935000|kalorenz@stanford.edu|
22302144|NCT01147822|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@Novartis.com|
22302145|NCT01916655|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22302146|NCT03010462|Nexstim Plc|Vice President, Medical Affairs|+358927271710|jarmo.laine@nexstim.com|
22302147|NCT01966003|Amgen Inc.|Study Director|866-572-6436||
22302148|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu|
22302149|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu|
22302150|NCT03154281|Avera Cancer Institute|Dr. Casey Williams|6053223588|Casey.Williams@avera.org|
22302151|NCT02748694|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302152|NCT00077064|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22302153|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu|
22302154|NCT03299686|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22272872|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590||
22272873|NCT02372383|UColorado|Dr. Stacey Martiniano|7207776181|stacey.martiniano@childrenscolorado.org|
22302155|NCT02348684|Medical College of Wisconsin|Dr. Carmen Bergom|414-805-4365|cbergom@mcw.edu|
22302156|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000|thomas.findley@va.gov|2713
22272874|NCT04812184|Indiana University School of Medicine|Nicholas Pettit|18653688599|nrpettit@iu.edu|
22302157|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu|
22302158|NCT01991821|Acacia Pharma|Dr Gabriel Fox|01223875130|GabrielFox@acaciapharma.com|149
22302159|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
22302160|NCT03131960|MicroTransponder Inc.|Study Director|8556289375|studies@microtransponder.com|
22302161|NCT04707196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22302162|NCT01625923|University of Michigan|Allen Lee|734-936-9454|allenlee@umich.edu|
22302163|NCT02918500|University of Ottawa Heart Institute|Dr. Andrew Pipe|613-696-7000|apipe@ottawaheart.ca|
22302164|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22302165|NCT03485911|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22302166|NCT03333928|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
22302167|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22302168|NCT04954586|McMaster University|Dr. Lisa Carlesso|9055259140|carlesl@mcmaster.ca|23811
22302169|NCT03899753|Montefiore Medical Center|Konrad Gruson, MD|3475774412|kgruson@montefiore.org|
22302170|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu|
22302171|NCT03210155|Texas A&M University Corpus Christi|Dr. Christina Murphey|316.825.3747|christina.murphey@tamucc.edu|
22302172|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22302173|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu|
22302174|NCT01987817|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22302175|NCT05390970|University of Iowa Healthcare|Dr. Annah J. Vollstedt|712-253-1627|annah-vollstedt@uiowa.edu|
22302176|NCT01802086|SormlandCC|Beatrice Olsson Duse|0704948359|bod257@hotmail.com|
22302177|NCT05918978|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22302178|NCT00622180|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
22302179|NCT02280239|Providence Health Care|Vininder Kour Bains|604-682-2344|VBains@providencehealth.bc.ca|62207
22302180|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302181|NCT00995072|ECIR|Benjamin Epstein, PharmD|904-854-1354|benjamin.epstein@eastcoastresearch.net|
22302182|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302183|NCT00916032|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22302184|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22302185|NCT01995487|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22302186|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com|
22302187|NCT02498834|University of North Carolina at Chapel Hill|Betsy Sleath, PhD|(919) 962-0079|betsy_sleath@unc.edu|
22302188|NCT04204200|Centre Hospitalier de Ham|Dr. Jean-Francois Cazeneuve, Surgeon|06 62 29 24 51|jfc.laon@gmail.com|0033
22302189|NCT03513757|Medical College of Wisconsin|Susan Taylor MD|414-266-3560|sutaylor@mcw.edu|
22302190|NCT04179721|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
22302191|NCT05559866|Mayo Clinic|Dr. Omar Ghanem|507-284-2095|ghanem.omar@mayo.edu|
22302192|NCT06615544|Ivoclar Vivadent AG|Head of Department Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22302193|NCT03444376|Clinical Development|• Project Lead|+82-2-6098-2756|yoonjeong.choi@genexine.com|
22302194|NCT04081220|UT HEALTH MAYS CANCER CENTER|Dr Zohra Nooruddin|2013362409|nooruddinz@uthscsa.edu|
22302195|NCT00856167|University of Arizona|Dr. Cheryl Ritenbaugh, Principal Investigator|520-822-6710|ritenbau@email.arizona.edu|
22302196|NCT03284112|Columbia University|Dr. James M. Noble|212-342-4126|jn2054@columbia.edu|
22302197|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302198|NCT02783820|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
22302199|NCT01186328|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22302200|NCT02128646|University of Kansas Medical Center|Michael Moncure, MD|913-588-1240|mmoncure@kumc.edu|
22302201|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22302202|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302203|NCT01005303|Belfast Health and Social Care Trust|Dr Nick McKeag|02895048487|nick.mckeag@belfasttrust.hscni.net|
22302204|NCT03170375|VA Ann Arbor Health System|Scott Hummel|734-845-5283|scott.hummel@va.gov|
22302205|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22302206|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786|kcropsey@uab.edu|205
22302207|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302208|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com|
22302209|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org|
22272875|NCT03084302|University of Pittsburgh|Bethany Barone Gibbs, Associate Professor, University of Pittsburgh|412-383-4002|bbarone@pitt.edu|
22272876|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu|
22272877|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu|
22272878|NCT01999985|H. Lee Moffitt Cancer Center and Research Institute|Thoracic CRO, attn: Dr. Ben Creelan|813-745-3050|ben.creelan@moffitt.org; thoraciccro@moffitt.org|
22272879|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22284099|NCT04881747|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22284100|NCT02138240|Johns Hopkins University School of Medicine|Kimberly Gudzune|443-287-7238|gudzune@jhu.edu|
22284101|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu|
22284102|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org|
22284103|NCT04054999|Mayo Clinic|Sher-Lu Pai, M.D.|904-956-3327|Pai.SherLu@mayo.edu|
22284104|NCT03869333|PATH|Rahsan Erdem|+1 202 540 4546|rerdem@path.org|
22284105|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
22284106|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com|
22284107|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351||
22284108|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284109|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22284110|NCT03134183|Virginia Commonwealth University|Frances Casey, MD|804-828-5076|frances.casey@vcuhealth.org|
22284111|NCT02504931|UT Health San Antonio|Dr. John Roache|210-562-5406|roache@uthscsa.edu|
22284112|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611|anthony.bavry@va.gov|6325
22284113|NCT02477553|Indiana University|Peter H. Schwartz, M.D., Ph.D.|317-278-4037|phschwar@iu.edu|
22284114|NCT04311463|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284115|NCT04023682|University of Iowa Hospitals and Clinics|Sundara Reddy, MBBS|(319) 356-2108|sundarareddy-durgempuditripura@uiowa.edu|
22284116|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284117|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com|
22289084|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com|
22289085|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu|
22289086|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org|
22302210|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
22302211|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu|
22302212|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302213|NCT04404478|Ohio State University|Dr. Holly Jones|760-415-6147|jones.7935@osu.edu|
22302214|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302215|NCT02299258|The First People's Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com|
22302216|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com|
22302217|NCT04750655|University of California, San Francisco|Ying Han|(415) 353-2020|ying.han@ucsf.edu|
22302218|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu|
22302219|NCT02786264|Yale School of Medicine|Dr. Robert Schonberger|2037852802|robert.schonberger@yale.edu|
22302220|NCT05414318|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
22302221|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com|
22302222|NCT03056534|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22302223|NCT04543188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302224|NCT02583763|Region Östergötland / University of Linköping|Olov Änghagen PhD student|+461047246|olov.anghagen@regionostergotland.se|
22302225|NCT03815019|University of Kansas Medical Center|Ann Davis, PhD, MPH, ABPP, Director, Center for Children's Healthy Lifestyles & Nutrition|(913) 588-1227|adavis6@kumc.edu|
22302226|NCT05398796|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
22302227|NCT06199934|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302228|NCT04270747|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22302229|NCT05004688|Mass General|Kayla McEachern|617 643 5265|kmceachern2@mgh.harvard.edu|
22302230|NCT05960097|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302231|NCT02134925|University of Pittsburgh|Robert E. Schoen, M.D., M.P.H|412-864-7078|rschoen@pitt.edu|
22302232|NCT02158884|Major Extremity Trauma and Rehabilitation Consortium|Susan Collins (Study Manager)|410 502 8966|scolli21@jhu.edu|
22302233|NCT05158296|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
22302234|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com|
22302235|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302236|NCT04098250|Mayo Clinic|Todd Schwedt, M.D.|480-301-9721|Schwedt.Todd@mayo.edu|
22302237|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de|
22302238|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22302239|NCT05096156|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD MS, Principal Investigator|16142928858|OPT-EyeStudies@osu.edu|
22302240|NCT04241094|Center for Care Delivery & Outcomes Research|Laura Meis, PhD|651-467-4516|laura.meis@va.gov|
22302241|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302242|NCT06387472|Mayo Clinic|Matthew Hall, M.D.|904-953-6412|Hall.Matthew@mayo.edu|
22302243|NCT04182880|Cali Biosciences|Chief Medical Officer|12038376500|e.onel@calibiosciences.com|
22302244|NCT02036645|AstraZeneca Pharmaceuticals|Michael Pomfret, Project Director, IMED Neuroscience||Clinicaltrialstransparency@astrazeneca.net|
22302245|NCT03522077|Aurora Health Care|Dr. Muhammad Fuad Jan|414-649-3491|fuad.jan@aah.org|
22284118|NCT02745535|Institute of Human Virology, University of Maryland|Dr. Eleanor Wilson|1(410)706-1710|eleanor.wilson@ihv.umaryland.edu|
22272880|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300||
22272881|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com|
22272882|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu|
22272883|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com|
22272884|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590||
22272885|NCT01534416|Icahn School of Medicine at Mount Sinai|Dr. Rachel L. Barr Grzesh|212-241-2995|rachel.barr@mssm.edu|
22272886|NCT00435461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272887|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
22272888|NCT02782377|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
22284119|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
22284120|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
22284121|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu|
22284122|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com|
22284123|NCT03480009|University of Pittsburgh|Principal Investigator, MD MPH|412-641-5496|fpr@upmc.edu|
22284124|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22284125|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284126|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284127|NCT01181674|McMaster University|Dr. Natalia McInnes (nee Yakubovich)|905-521-2100|natalia.mcinnes@mcmaster.ca|
22284128|NCT02651220|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22284129|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com|
22284130|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22284131|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284132|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov|
22284133|NCT04576897|Indiana University|Samer Gawrieh|317-278-9326|sgawrieh@iu.edu|
22284134|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284135|NCT02593318|University of Kansas Medical Center|Russell H. Swerdlow, MD|9135885000|rswerdlow@kumc.edu|
22284136|NCT02806960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22284137|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22284138|NCT02522325|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
22284139|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284140|NCT01629953|VA North Texas Health Care System|James LePage, Ph.D. Chief Research and Development|214-857-0240|james.lepage@va.gov|
22284141|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu|
22284142|NCT00448747|Aeterna Zentaris|Nicola Ammer|+496942602|nammer@aezsinc.com|3472
22284143|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284144|NCT00568126|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
22272889|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at|
22272890|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272891|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272892|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22272893|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500|scott.sherman@va.gov|7386
22272894|NCT00583011|University of Oklahoma Health Science Center|Andrew Elimian, MD|9142317323|aelimian@aol.com|
22272895|NCT03360214|Columbia University|Sherene Ishtihar|212-342-3681|si2271@cumc.columbia.edu|
22272896|NCT02946021|Tactile Medical|Jill Christensen|(612) 355-5123|jchristensen@tactilemedical.com|
22272897|NCT02588092|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22272898|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300||
22272899|NCT01129804|UConn Health|Mark D. Litt, PhD; Principal Investigator|860-679-4680|litt@uchc.edu|
22272900|NCT03882957|Geisel School of Medicine (Dartmouth College)|Diane Gilbert-Diamond|603-646-5403|diane.gilbert-diamond@dartmouth.edu|
22272901|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22272902|NCT03658642|Yale School of Medicine|Ted Melnick, MD, MHS Associate Professor of Emergency Medicine and of Biostatistics (Health Informat|(203) 785-5174|edward.melnick@yale.edu|
22284145|NCT01387464|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22284146|NCT04724967|University of Miami|Robert Kirsner|305-689-2646|rkirsner@med.miami.edu|
22302246|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22302247|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22302248|NCT03995784|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22302249|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
22302250|NCT00112580|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22302251|NCT02624739|ResMed|Paul Phillips|01 906 8861|paul.phillips@resmed.com|
22302252|NCT06412146|Children's Mercy Research Institute|Sophie MacColl|8166011485|risingT1DE@cmh.edu|
22302253|NCT02584725|Columbia University Irving Medical Center|Robert Maniker, MD|212-305-9876|rm3046@cumc.columbia.edu|
22302254|NCT03881696|DAIT/NIAID|Director, Clinical Research Operations Program|202-604-9855|DAITClinicalTrialsGov@niaid.nih.gov|
22302255|NCT05690776|Zimmer Biomet|Julie Nicoux|+33672613502|julie.nicoux@zimmerbiomet.com|
22302256|NCT02764775|Fort Worth Independent School district|Dr. Julie Brown|214-725-8232|jbrown18@twu.edu|
22302257|NCT00975221|Amgen Inc.|Study Director|866-572-6436||
22302258|NCT04022889|Cerus Corporation|Carol Moore|9258766819|cmoore@cerus.com|
22302259|NCT02202434|Boston Scientific|Amy Maurer|508-683-6647|amy.maurer@bsci.com|
22302260|NCT03237858|Boston Scientific|Joe Hobbs, Clinical Trial Manager|612-206-4703|JOE.HOBBS@BSCI.COM|
22302261|NCT03015116|Landstuhl Regional Medical Center|Dr. Ann Kobiela Ketz|8022656263|annketz@gmail.com|
22302262|NCT01862991|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22302263|NCT04858802|Medtronic plc|Xiaomin Deng|707-566-1311|Xiaomin.deng@medtronic.com|
22302264|NCT00332332|Amgen Inc.|Study Director|866-572-6436||
22302265|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
22302266|NCT03921346|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
22302267|NCT01746043|UT MD Anderson Cancer Center|Lin,Steven H,M.D. Ph.D. / Radiation Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22302268|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
22302269|NCT02670538|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22302270|NCT02337517|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22302271|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com|
22302272|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
22302273|NCT02207725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22302274|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com|
22302275|NCT03395808|Avenue Therapeutics|Micheal Ryan, VP Clinical|781-652-4514|mryan@avenuetx.com|
22302276|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org|
22302277|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
22302278|NCT00058422|Memorial Sloan Kettering Cancer Center|Paul A. Hamlin, M.D.|646-608-1667|hamlinp@mskcc.org|
22302279|NCT03863522|Johns Hopkins University|Dr. Sara Sukumar|4106142479|saras@jhmi.edu|
22302280|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com|
22302281|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22272903|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com|
22272904|NCT03290391|Boston Medical Center and BU Chobanian & Avedisian School of Medicine|Jeffrey Samet, MD MA MPH|(617) 414-7288|jsamet@bu.edu|
22272905|NCT01396551|Varian Medical Systems|Julie Allen|206-330-2605|julie.allen@varian.com|
22272906|NCT02383355|Radboudumc|Wouter van der Heijden|0031 24 3616980|wouter.vanderheijden@radboudumc.nl|
22272907|NCT02801370|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22272908|NCT03852498|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
22272909|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22272910|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com|
22272911|NCT04811664|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22272912|NCT02717442|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22272913|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22272914|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
22272915|NCT03634813|Yale School of Medicine|Robert B. Schonberger, Director of Clinical Scientist Track Program|203-785-3941|robert.schonberger@yale.edu|
22302282|NCT04766086|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22302283|NCT02660801|UQTR|Pr Martin Descarreaux|819-376-5011|martin.descarreaux@uqtr.ca|3791
22302284|NCT02635724|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22302285|NCT03579290|Yale University|Theresa Babuscio Data Manager|203-737-5430|theresa.babuscio@yale.edu|
22302286|NCT02881008|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
22302287|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22302288|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22302289|NCT00094211|Stanford University|Dr. Abby C. King|650-725-5394|king@stanford.edu|
22302290|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319552|NCT01936909|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
22319553|NCT02378220|Harding University College of Pharmacy / Unity Health - White County Medical Center, Searcy, Arkansas, USA|Lindsay Elliott|5012794800|lselliott@harding.edu|
22319554|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com|
22319555|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22284147|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319556|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com|
22319557|NCT02060721|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319558|NCT05105789|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
22319559|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu|
22319560|NCT03690141|Effector Therapeutics|Mark Densel, Vice President Development Operations|8589258215|mdensel@effector.com|
22319561|NCT01505010|University of Leuven|Dr. Jan A. Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
22319562|NCT04744285|Roswell Park Comprehensive Cancer Center|Kris Attwood|877-275-7724|askroswell@roswellpark.org|
22319563|NCT02354781|Nationwide Children's Hospital|Dr. Jerry Mendell|1-614-722-4877|Jerry.Mendell@nationwidechildrens.org|
22319564|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
22319565|NCT04553068|Evofem|Catherine Maher|8585501900|cmaher@evofem.com|
22319566|NCT02080455|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-242-5142|alison.long@aegerion.com|
22319567|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22319568|NCT02403622|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|mosman@openbiome.org|
22319569|NCT02558231|Actelion Pharmaceuticals Ltd.|Principal Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319570|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov|
22319571|NCT03933397|Duke Clinical Research Institute - Duke University Medical Center|Huiman Barnhardt, PhD|919-668-7313|huiman.barnhart@duke.edu|
22319572|NCT03367715|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
22319573|NCT02257957|Universidad Nacional de Colombia|Dr Marcel Y Avila|+5713165000|myavilac@unal.edu.co|15119
22319574|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu|
22319575|NCT04721821|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319576|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22319577|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22319578|NCT03836807|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22319579|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22319580|NCT03531788|University of Pittsburgh|Roxanna M. Bendixen, Principal Investigator|4123836603|bendixen@pitt.edu|
22319581|NCT02218190|Washington University School of Medicine|Michael P. Kelly, MD, MSc|314-747-2511|kellymi@wustl.edu|
22319582|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com|
22319583|NCT03675776|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22319584|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com|
22319585|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22319586|NCT02014740|University of Miami|Prof Gianluca Iacobellis|3052433636|giacobellis@med.miami.edu|
22319587|NCT01621542|Sunovion Pharmaceuticals Inc.|WT2725 Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22319588|NCT02742766|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319589|NCT03739437|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
22319590|NCT01959048|Hadassah-Hebrew University|Jacob Strahilevitz|972508946353|jstrahilevitz@hadassah.org.il|
22319591|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com|
22319592|NCT01868139|University of Maryland School of Medicine|Dr. Bruce Greenwald|4103288731|bgreenwa@medicine.umaryland.edu|
22302291|NCT02914314|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22284148|NCT02615691|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22284149|NCT04201093|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22284150|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu|
22284151|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937||
22284152|NCT02017522|University of Michigan|Venkatesh Murthy, MD||vlmurthy@umich.edu|
22284153|NCT02596230|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284154|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284155|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu|
22284156|NCT02704689|Stryker|Jennifer Warnke|(201) 749-8000|jennifer.warnke@stryker.com|
22284157|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22284158|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284159|NCT03123328|Masimo Corporation|Director, Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
22284160|NCT03270891|University of Michigan|Laurie Buis|734-998-5694|buisl@med.umich.edu|
22284161|NCT02540668|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22284162|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com|
22284163|NCT04394715|Yale University|Nihar Desai|203-767-6399|nihar.desai@yale.edu|
22284164|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284165|NCT03157583|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284166|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284167|NCT01475162|Medical College of Wisconsin|William R. Drobyski|414-456-4941|wdrobysk@mcw.edu|
22284168|NCT00545103|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22284169|NCT05026853|University of Michigan|Dr. Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
22284170|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284171|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22284172|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
22284173|NCT02723175|Medical University of South Carolina|Jeffrey Borckardt|843-792-3295|borckard@musc.edu|
22284174|NCT03233438|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22284175|NCT04596085|Natural Supplements LLC|Dr. Mahir Abduldaim|+966557880299|maherdaim@yahoo.com|
22284176|NCT02219503|AbbVie|Global Medical Services|800-633-9110||
22284177|NCT03249103|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22284178|NCT04109976|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22284179|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
22284180|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
22302292|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22302293|NCT03483038|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22302294|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22302295|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
22302296|NCT04843930|Weill Cornell Medicine|Lindsay Victoria, PhD|646-962-3973|liv3002@med.cornell.edu|
22302297|NCT02552238|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
22302298|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22302299|NCT04631705|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
22302300|NCT05741385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302301|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
22302302|NCT02070484|OhioHealth|Josepha Shehadi, MD|614-220-5648|joseph@drshehadi.com|
22302303|NCT02821819|Instituto Bernabeu|Dr. Juan Carlos Castillo|+34650562634|jcastillo@institutobernabeu.com|
22302304|NCT02332590|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22302305|NCT01949779|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
22302306|NCT04225988|Cedars Sinai Medical Center|Dr. Edmund Huang, MD|310-423-2641|edmund.huang@cshs.org|
22302307|NCT03466918|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22302308|NCT05619003|Coloplast|Senior Scientific Manager|+45 49112880|dkcpov@coloplast.com|
22302309|NCT06238999|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22302310|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com|
22302311|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22302312|NCT07018999|Department of Anaesthesiology & Perioperative Medicine, Hong Kong Children's Hospital|Dr. Vansie Kwok, Consultant|+852-96737367|kv314@ha.org.hk|
22302313|NCT04226365|Penn Medicine / Lancaster General Hospital|Halle Becker, MPH, Research Project Manager|7175441777|Halle.Becker@pennmedicine.upenn.edu|
22302314|NCT04739761|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22302315|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
22302316|NCT03075501|University of Illinois at Chicago|Emma Childs|312-355-2726|echilds@uic.edu|
22302317|NCT03091673|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
22302318|NCT00857805|Loma Linda University Health|David Bush, MD, Professor Radiation Medicine|909 558 1000|DBush@llu.edu|88056
22302319|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302320|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org|
22302321|NCT03610737|Vertos Medical|Angie Lee|949-349-0008|alee@vertosmed.com|
22302322|NCT02357290|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
22302323|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22302324|NCT02714868|Department of Occupational Therapy, Boston University|Dr. Jessica Kramer, Assistant Professor, PI|617-353-2702|kramerj@bu.edu|
22302325|NCT02938169|Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine|Dr. Juseok Ryu|+82-10-4382-2328|jseok337@snu.ac.kr|
22302326|NCT05056870|Johnson & Johnson Vision Care, Inc.|Benjamin Straker-Principal Research Optometrist|1-800-843-2020|bstraker@its.jnj.com|
22302327|NCT03171480|The Ohio State University|Kara Rood, MD|440-321-0264|kara.rood@osumc.edu|
22302328|NCT05044325|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302329|NCT03941015|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|18710168703@163.com|
22302330|NCT01373931|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302331|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302332|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org|
22302333|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
22302334|NCT01751230|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|leanne.redman@pbrc.edu|
22302335|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com|
22302336|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com|
22302337|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060|freemansl@smh.ca|77042
22302338|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu|
22302339|NCT01114204|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22302340|NCT05582304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R Buch|1-800-843-2020|jbuch@its.jnj.com|
22302341|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22302342|NCT03036384|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
22302343|NCT03145766|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22302344|NCT02799472|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302345|NCT02801669|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22302346|NCT04461795|Clinvest Research|Jim Sly|417-841-3673|jsly@clinvest.com|
22302347|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
22302348|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22302349|NCT04836858|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22302350|NCT02884414|Stanford University|Jennifer Hledik|650-493-5000|jerhart@stanford.edu|62388
22302351|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org|
22302352|NCT03954743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302353|NCT03541044|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302354|NCT01153269|Abbott|Global Medical Services|1-800-633-9110||
22302355|NCT03315936|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302356|NCT02281760|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
22302357|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com|
22302358|NCT04048863|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
22302359|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22302360|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743||
22302361|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22302362|NCT00312702|Walter Reed Army Institute of Research|James F. Cummings, MD|301-319-9312|james.cummings@us.army.mil|
22302363|NCT00770432|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22302364|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22302365|NCT02756832|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302366|NCT03160287|University of Washington|Oleg Zaslavsky|2066163242|ozasl@uw.edu|
22302367|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22302368|NCT03592277|Saint Francis Hospital and Medical Center|David Shapiro, MD, MHCM, FACS, FCCM CMO of Saint Francis Hospital and Medical Center|860-833-5673|dshapiro@trinityhealthofne.org|
22302369|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22302370|NCT02917265|Oklahoma Medical Research Foundation|Aikaterini Thanou, MD|405-271-7805|aikaterini-thanou@omrf.org|
22302371|NCT02481375|University of British Columbia|Crystal Karakochuk|604 822 0421|crystal.karakochuk@ubc.ca|
22302372|NCT03982043|University of Pittsburgh|Tina R. Goldstein, Ph.D.|4122465604|goldtr@upmc.edu|
22302373|NCT05436912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22302374|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com|
22302375|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302376|NCT02413463|Faculty of Medicine, Cairo University|Ahmed Awadein, MD|201223911743|ahmedawadein@yahoo.com|
22302377|NCT02002182|Baylor College of Medicine|Dr. Andrew Sikora|7137983909|Andrew.Sikora@bcm.edu|
22302378|NCT04203537|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
22302379|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22302380|NCT02227316|UCLA Department of Radiological Sciences|Director of Clinical Research|310-794-8995|schaabane@mednet.ucla.edu|
22302381|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302382|NCT03635489|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22302383|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22302384|NCT02492854|Boston Medical Center|Jeffrey Siracuse, MD|617-638-8488|Jeffrey.Siracuse@bmc.org|
22302385|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
22302386|NCT04027348|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22302387|NCT02487472|GlaxoSmithKline|GSK Response Center|866-435-7343|lzr30020@gsk.com|
22302388|NCT01313286|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302389|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com|
22302390|NCT02404389|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302391|NCT01669798|Duke University Medical Center|Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
22302392|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22302393|NCT02439749|Medtronic|Pamela McKenna, Sr. Principal Clinical Research Specialist|(773) 597-5241|pamela.m.mckenna@medtronic.com|
22302394|NCT01806584|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22302395|NCT00140205|BIDMC|Dr. Christos mantzoros|6176671656|cmantzor@bidmc.harvard.edu|
22302396|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com|
22302397|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
22302398|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw|
22302399|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org|
22302400|NCT04684641|Yale University|Dr. Jonathan Koff|475-224-8167|jon.koff@yale.edu|
22302401|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org|
22302402|NCT03549234|University of California San Diego|Matthew Swisher, MD|415-314-4099|matthew.swisher@gmail.com|
22302403|NCT03289481|Clinical Research|Caroline Knight|2079218959|CKnight@pbmc.org|
22284181|NCT04897607|Christiana Care Health System|Dr. Scott Siegel|302-623-4500|ssiegel@christianacare.org|
22284182|NCT03781791|Enterin|Richard Larson, MD Chief Medical Officer|505-469-2670|r.larson@enterininc.com|
22284183|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org|
22284184|NCT02025439|Edward Hines VA Hospital|Theresa Bender-Pape|708-202-4953|Theresa.BenderPape@va.gov|
22284185|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com|
22284186|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com|
22284187|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu|
22284188|NCT03615066|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22284189|NCT04079881|Wash Univ School of Medicine|Janet McGill, MD|(314) 362-8681|jmcgill@wustl.edu|
22302404|NCT01265030|Maine Medical Center|Dr. Aaron Weiss, Principal Investigator|2073967565|Aaron.Weiss@mainehealth.org|
22302405|NCT02243631|Zablocki VA Medical Center|Dr. Ann Rosenthal , MD ACOS/Research|414-384-2000|ann.rosenthal@va.gov|41430
22302406|NCT03117517|Khyber Medical University|Dr. Mohsin Shah (Associate Professor)|3429620074|mohsin.ibms@kmu.edu.pk|+92
22302407|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22302408|NCT01992549|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22302409|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302410|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121|d8079@mail.cmuh.org.tw|5035
22302411|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu|
22302412|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager|+49 69 1503 0|clinicaltrials@merz.com|
22302413|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22302414|NCT02169895|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22302415|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22302416|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu|
22302417|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
22302418|NCT03645967|Medline Industries, LP|Keri Jorgenson|2243014670|kajorgenson@medline.com|
22302419|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22302420|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu|
22302421|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu|
22284190|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu|
22284191|NCT04882787|Sonova|Jinyu Qian, Director Innovation Centre Toronto|905-677-1167|jinyu.qian@sonova.com|5873
22284192|NCT03831945|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
22284193|NCT03426631|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22284194|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
22284195|NCT04032080|Baylor Scott & White Health|Joyce O'Shaughnessy, MD|214-818-8472|joyce.oshaughnessy@usoncology.com|
22284196|NCT02096263|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284197|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22284198|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
22284199|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com|
22284200|NCT00521222|Columbia University Irving Medical Center|Marjorie Slankard, MD|212-326-8410|ms53@columbia.edu|
22284201|NCT03109184|NORTHEASTERN UNIVERSITY|DR. CHRISTIE RIZZO|(617) 373-2486|C.RIZZO@NORTHEASTERN.EDU|
22284202|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22284203|NCT01735981|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
22284204|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu|
22284205|NCT02885246|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
22284206|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu|
22284207|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
22284208|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747|ofacresearch@orthofootankle.com|111
22302422|NCT01134601|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citind@mail.nih.gov|
22272916|NCT03251482|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22272917|NCT02823470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22272918|NCT01490840|Novartis|Study Director|862-778-8300||
22272919|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
22272920|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22272921|NCT02756819|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22272922|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
22272923|NCT02700425|The University of Chicago|Dr. Gaurav A. Upadhyay, MD|773-702-5988|gupadhyay@medicine.bsd.uchicago.edu|
22272924|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co|
22272925|NCT00479115|Cincinnati Children's Hospital Medical Center|Stella Davies, MBBS, PhD, MRCP|513-636-1371|Stella.Davies@cchmc.org|
22272926|NCT03117361|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22272927|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22272928|NCT02072941|University of California San Francisco|Dr. Rebecca Sudore|(415) 221-4810|rebecca.sudore@ucsf.edu|23475
22272929|NCT01462305|Philips|Sr. Clinical Development Scientisit|+41 79 460 0622|fatima.sertkuniyoshi@philips.com|
22272930|NCT01247350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272931|NCT00169104|Dartmouth-Hitchcock Medical Center / Norris Cotton Cancer Center|Gary N. Schwartz MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
22272932|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com|
22272933|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu|
22272934|NCT02020889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272935|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu|
22272936|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu|
22272937|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22272938|NCT03476642|Penn State MS Hershey College of Medicine-PennState Health|Dr. Sanjib Adhikary|717-531-6140|sadhikary@pennstatehealth.psu.edu|
22272939|NCT02826161|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
22272940|NCT02457195|The Pennsylvania State University College of Medicine|Dr. Piotr Janicki|7175315680|pjanicki@pennstatehealth.psu.edu|
22272941|NCT05347966|UBC|Dr. Haakon Nygaard|604-827-0600|haakon.nygaard@ubc.ca|
22272942|NCT05980013|Zynex Monitoring Solutions|ZMS Clinical|888-386-4185|clinical@zynex.com|
22272943|NCT04892446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22272944|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com|
22272945|NCT04676724|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22272946|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu|
22272947|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
22272948|NCT00685360|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22272949|NCT04274075|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22272950|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
22272951|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22272952|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org|
22272953|NCT01146561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272954|NCT01096680|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22272955|NCT03092791|Takeda|Senior Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22272956|NCT04485637|University of Southern California|Wandi Bruine de Bruin|4126385875|wandibdb@usc.edu|
22272957|NCT02182830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272958|NCT04399538|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272959|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22272960|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org|
22272961|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com|
22272962|NCT03268005|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22272963|NCT01926197|Stanford Medicine at Stanford University|Samantha Wong|650-498-8495|swong8@stanford.edu|
22272964|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22272965|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272966|NCT04162795|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22272967|NCT03939533|CRMG|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
22272968|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22272969|NCT03078127|University of North Carolina at Chapel Hill|Scott Donaldson, MD|984-974-9198|scott_donaldson@med.unc.edu|
22272970|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com|
22272971|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22272972|NCT05052697|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272973|NCT03796676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272974|NCT02724410|Atrium Health|Dr. B. Todd Heniford|704-355-3168|Todd.Heniford@atriumhealth.org|
22272975|NCT01900899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22272976|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com|
22272977|NCT02860507|Merck Pharmaceuticals|Chadwick Neal / Medical Affairs Director|2056010605|chadwick.neal@merck.com|
22272978|NCT02772809|University of Pennsylvania|Michelle J Johnson|215 893-2665|johnmic@pennmedicine.upenn.edu|
22272979|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org|
22302423|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu|
22302424|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu|
22272980|NCT02226120|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22272981|NCT02946489|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
22272982|NCT03034135|Cantex Pharmaceuticals|Stephen Marcus MD|9543153660|smarcus@cantex.com|
22302425|NCT00304512|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22302426|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302427|NCT01932294|University of Alabama at Birmingham|RongBing Xie|205-975-3624|rongbingxie@uabmc.edu|
22302428|NCT02150837|Medifast|Chris Coleman|410-504-8161|ccoleman@choosemedifast.com|
22302429|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu|
22302430|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
22302431|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
22302432|NCT02608905|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22302433|NCT03075904|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22302434|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22302435|NCT02228395|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22302436|NCT02924324|Memorial Sloan Kettering Cancer Center|Dr. Ellen Basu, MD, PhD|212-639-5204|BasuE@mskcc.org|
22302437|NCT00829686|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
22302438|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org|
22302439|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590||
22302440|NCT04559282|Cochlear|Therese Agat|+46766498562|tagat@cochlear.com|
22302441|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
22302442|NCT03885011|Orasis|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22302443|NCT02712398|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
22302444|NCT01719237|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
22302445|NCT03597035|University Hospitals Cleveland Medical Center|Sanjay Rajagopalan|216-844-5125|Sanjay.Rajagopalan@UHhospitals.org|
22302446|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com|
22302447|NCT03434457|Douglas Mental Health University Institute|Dr Patricia Pelufo Silveira|1514-761-6131|patricia.silveira@mcgill.ca|3928
22302448|NCT02192775|University of Arkansas for Medical Sciences|Brittany Lehman|501-686-8274|blehman@uams.edu|
22302449|NCT01973036|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
22302450|NCT02255032|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22302451|NCT04772053|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302452|NCT06131294|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22302453|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk|
22302454|NCT04146896|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22302455|NCT03107377|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
22302456|NCT01597505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302457|NCT02914379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22302458|NCT02675465|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
22302459|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu|
22302460|NCT05031078|Emory University|Dr. Erin Scherer|404-712-6904|erin.margaret.scherer@emory.edu|
22302461|NCT03728972|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz MD, PhD|646-608-3714|hultcram@mskcc.org|
22302462|NCT03154944|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
22302463|NCT04249219|University of Massachusetts Chan Medical School|Elise Stevens|(774) 455-6684|elise.stevens@umassmed.edu|56684
22302464|NCT03787680|University of Michigan Rogel Cancer Center|Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22302465|NCT05652036|Houston Methodist Hospital Department of Urology|Dr. Rose Khavari|713-441-6455|rkhavari@houstonmethodist.or|
22302466|NCT05454410|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
22302467|NCT00895622|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22302468|NCT01490125|Novartis|Study director|41 61 324 1111||
22302469|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22302470|NCT01919970|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
22302471|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
22302472|NCT04615182|TransMedics Inc.|Laura Damme, VP Clinical Affairs|9785520900|ldamme@transmedics.com|
22302473|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com|
22302474|NCT03565068|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302475|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it|
22302476|NCT03879603|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Julie E. Ledgerwood, DO (Study Chair)|301-594-8502|ledgerwood@mail.nih.gov|
22302477|NCT02239380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302478|NCT03857230|IVFarma LLC|General Manager|+7(499)6455342|info@ivfarma.ru|1
22302479|NCT03047174|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22302480|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk|
22302481|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu|
22302482|NCT02200939|Smith+Nephew, Inc.|Laura England, Sr. Director Global Clinical Strategy|+1 650 223 6941|Laura.England@smith-nephew.com|
22302483|NCT04567693|Montefiore Medical Center|Dr. Jonathan Ross|718-920-7064|joross@montefiore.org|
22302484|NCT02134210|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
22302485|NCT02970032|University of Utah Health|Corinne Bertolaccini, PharmD|801-581-2167|Corinne.Bertolaccini@hsc.utah.edu|
22302486|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org|
22302487|NCT03722264|Virginia Commonwealth University|Eser Tufekci, DDS, PhD|804-828-9326|etufekci@vcu.edu|
22302488|NCT00957931|University of California, San Francisco|Dr. Sandhya Kharbanda, MD||Sandhya.Kharbanda@ucsf.edu|
22302489|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu|
22302490|NCT03926065|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22302491|NCT02392611|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22302492|NCT03463915|University of Louisville|Sean Francis|502-561-7260|Sean.francis@louisville.edu|
22302493|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
22302494|NCT02687412|SichuanCHRI|Dr Cui Ling|+8618181422637|cuiling1985@qq.com|
22302495|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22302496|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu|
22302497|NCT03239873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302498|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200|chautingy@gmail.com|8121
22302499|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov|
22302500|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22302501|NCT02045433|UT Southwestern/Simmons Cancer Center-Dallas|Dr.Kevin Albuquerque|2146458499|Kevin.Albuquerque@UTSouthwestern.edu|
22302502|NCT03270514|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Kathirvel Subramaniam, MD, MPH, FASE|724-799-5852|subramaniamk@upmc.edu|
22302503|NCT02948959|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22302504|NCT01778946|Vanderbilt University Medical Center|Dr. Paul Newhouse|6159360928|paul.newhouse@vanderbilt.edu|
22302505|NCT01800201|University of Pennsylvania|Noora Marcus|215-746-4429|noora.marcus@uphs.upenn.edu|
22302506|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302507|NCT00818363|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22302508|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com|
22302509|NCT02904902|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22302510|NCT03338621|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
22302511|NCT03564782|Istari Oncology|W. Garrett Nichols, MD MS|919-245-7662|info@istarioncology.com|
22302512|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu|
22302513|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302514|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu|
22302515|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu|
22302516|NCT02037438|Stanford University|Dr. Clete Kushida|650-721-7560|clete@stanford.edu|
22302517|NCT05400746|University of Oxford|Dr. Angela M Minassian|01865611424|angela.minassian@bioch.ox.ac.uk|
22302518|NCT05375955|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22302519|NCT05261191|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22302520|NCT03879408|Johnson & Johnson Consumer, Inc.|ASSOCIATE DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22302521|NCT04522180|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionisph.com|
22302522|NCT06334042|Hacettepe University Department of Anesthesiology and Intensive Care|Oguzhan Kahveci, MD|+903123051207|kahveci.oguz@hotmail.com|
22302523|NCT04571099|Philips Clinical & Medical Affairs Global|Marijke van Vlimmeren|+31 6 31042408|marijke.van.vlimmeren@philips.com|
22272983|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
22272984|NCT02919007|Home Skinovations|Dr Liora Levi|+97249097470|LioraL@silkn.com|
22272985|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu|
22272986|NCT02636439|Wake Forest School of Medicine|Dalane W. Kitzman, MD|336-716-3274|dkitzman@wakehealth.edu|
22272987|NCT04679948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22272988|NCT02494401|University of New Mexico|Janet Poole|(505) 272-1753|JPoole@salud.unm.edu|
22272989|NCT05188729|Verrica Pharmaceuticals|Susan Cutler, VP Medical Affairs|484-773-089|scutler@verrica.com|
22272990|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu|
22272991|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
22272992|NCT00803712|Amgen Inc.|Study Director|866-572-6436||
22272993|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com|
22272994|NCT03639857|University of Central Florida College of Medicine|Dr. David Weinstein|407-266-4900|david.weinstein@ucf.edu|
22272995|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22272996|NCT02014519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272997|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu|
22272998|NCT00547248|GlaxoSmithKline|GSK Response Center|866-435-7343||
22272999|NCT04727736|UPMC Hillman Cancer Center|Barbara M Stadterman, Clinical Research Manager - Regulatory|412-647-5554|stadtermanbm@upmc.edu|
22273000|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu|
22273001|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
22273002|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us|
22273003|NCT05133323|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22273004|NCT00909220|Northwestern University|Jackie Gollan, Ph.D. Associate Professor of Psychiatry and Behavioral Sciences|312-695-6121|j-gollan@northwestern.edu|
22273005|NCT01449864|University of Pennsylvania|John Plastaras, MD, PhD|267-972-3539|plastaras@uphs.upenn.edu|
22273006|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com|
22273007|NCT04152083|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22273008|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273009|NCT03318003|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
22273010|NCT00235573|University of Florida|Gail Kauwell|352-392-1991|gkauwell@ufl.edu|227
22273011|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org|
22273012|NCT03549598|Mayo Clinic|John P. Bois, M.D.|507-284-3545|Bois.John@mayo.edu|
22273013|NCT02768792|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22273014|NCT04819438|Zambon S.p.A.|Dr. Mathias Knecht, Chief Medical Officer|+41.91.960.4187|mathias.knecht@zambongroup.com|
22273015|NCT02716506|Kanta-Häme Central Hospital|Dr Nina Mattsson|+358407338307|nina.mattsson@fimnet.fi|
22273016|NCT04607135|Duke University|Kathy Nightingale, Ph.D.|919-660-5175|kathy.nightingale@duke.edu|
22273017|NCT03465709|Apellis Pharmaceuticals. Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22273018|NCT05359952|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22273019|NCT03836209|PrECOG|Li Chen, MS; Statistician|857-284-3670|Li Chen <lic@ds.dfci.harvard.edu>|
22273020|NCT04167189|PhenoSolve|Lynn Feldman|617-879-1670|lynn@phenosolve.com|
22273021|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22273022|NCT04736069|Ufuk University|Nihan Cüzdan|5052706846|nihancuzdan@hotmail.com|
22273023|NCT01737879|Amgen Inc.|Study Director|866-572-6436||
22273024|NCT04978337|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22273025|NCT01504672|Umeå University|Dr. Maria Gustafsson|0046703978717|maria.gustafsson@umu.se|
22273026|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu|
22273027|NCT01436227|M.D. Anderson Cancer Center|Eric Jonasch, MD|713-792-2830|ejonasch@mdanderson.org|
22273028|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22273029|NCT04865419|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22273030|NCT05446142|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273031|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu|
22273032|NCT00547157|Amgen Inc.|Study Director|866-572-6436||
22273033|NCT03853291|Weill Cornell Medicine|Dr. Catherine Riffin, Assistant Professor of Psychology in Medicine|646.962.7160|acr2213@med.cornell.edu|
22273034|NCT03883477|Cedars-Sinai Medical Center, Department of Orthopedic Surgery|Clinical Trial RN|3104235900|rodriquezsv@csmns.org|
22273035|NCT04186221|TransMedics, Inc.|Laura Damme, VP Clinical Affairs|978-552-0900|ldamme@transmedics.com|
22273036|NCT02432209|Yale School of Public Health|Fangbai Sun|2037855185|fangbai.sun@yale.edu|
22273037|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
22273038|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22273039|NCT03124537|Brandeis University|Alycia Bisson|781 736 3284|lifespanlab@brandeis.edu|
22273040|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com|
22273041|NCT00830518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22273042|NCT02348008|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22273043|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl|
22273044|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org|
22273045|NCT02029274|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273046|NCT02756364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22273047|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu|
22273048|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22273049|NCT02984267|Arizona Anesthesia Consultants|Dr. Thomas Vernon|480-570-7082|tvernon@azanesthesia.net|
22284209|NCT02503501|HealthPartners Neuroscience Research|Clinical Research Manager|651-495-6363|aleta.l.svitak@healthpartners.com|
22284210|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22284211|NCT02315560|University of Pittsburgh|Dr. Heidi Stephany|412-692-7932|heidi.stephany@chp.edu|
22284212|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22284213|NCT04599465|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22284214|NCT04566601|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284215|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov|
22284216|NCT04996251|Northwell Health (previously) now at Advocate Aurora Health|Dr. Vini Chopra Konowitz|859-905-8782|vinichopra924@gmail.com|
22284217|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22284218|NCT02702180|Savara Inc|Raymond D. Pratt, MD, PACP - Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22284219|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22284220|NCT03603106|Guerbet|Jing Hao, MD|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22284221|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
22284222|NCT02241343|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22284223|NCT04680975|Sanofi (Kadmon, a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22284224|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
22284225|NCT03858530|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
22284226|NCT01463072|City of Hope|Dr. Mina Sedrak|626-359-8111|msedrak@coh.org|
22284227|NCT05856227|Basilea Pharmaceutica International Ltd, Allschwil|Marc Engelhardt, MD, Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22284228|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com|
22284229|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com|
22284230|NCT02271945|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
22284231|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu|
22284232|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu|
22284233|NCT05375214|Johns Hopkins University|Kevin Li|443-475-0671|kevinli@jhmi.edu|
22284234|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
22284235|NCT02636712|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
22284236|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de|
22284237|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284238|NCT02613169|University of Washington|Dr. Sylvia M. LaCourse|206-616-5978|sylvial2@uw.edu|
22284239|NCT03729245|Nektar Therapeutics|Study Director|4154825300|StudyInquiry@nektar.com|
22273050|NCT02685072|Yale School of Public Health|Kimberly Yonkers, MD|(203) 764-6621|kimberly.yonkers@yale.edu|
22284240|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22284241|NCT03098745|CooperVision Inc.|Dr.Jose A.Vega O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22284242|NCT04971941|Harvard School of Dental Medicine|Dr. Jeffry R Shaefer|(781) 718-6793|jeffry_shaefer@hms.harvard.edu|
22284243|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22284244|NCT01985360|NYU Langone Health|Sripal Bangalore|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
22284245|NCT04598269|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22284246|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22284247|NCT04040621|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284248|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22284249|NCT02383433|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Davendra Sohal|+1 216-444-8258|sohald@ccf.org|
22284250|NCT02208349|St Vincent Hospital|Jestin Carlson|8144525000|jcarlson@svhs.org|
22284251|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
22284252|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990|pettynathanm@uams.edu|2461
22284253|NCT02963701|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284254|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284255|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org|
22284256|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22284257|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284258|NCT03101085|University of Kansas Medical Center|Dr. Russell Swerdlow|913-588-0970|rswerdlow@kumc.edu|
22284259|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
22284260|NCT02986854|GlaxoSmithKline|GSK Response Center|866-435-7343|mb116236@gsk.com|
22284261|NCT02454153|Johns Hopkins University|Naresh M. Punjabi|410-550-6487|npunjabi@jhmi.edu|
22284262|NCT02039856|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|(818) 891-7711|elizabeth.yano@va.gov|36031
22284263|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl|
22284264|NCT02048371|SARC|SARC|734-930-7600|sarc@sarctrials.org|
22302524|NCT03267680|University of Southern California|Tali Homsey|3238650430|tali.homsey@med.usc.edu|
22302525|NCT01224158|Johnson & Johnson Consumer and Personal Products Worldwide|Director Oral Health, Medical Affair & Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22302526|NCT01622010|St. Boniface Hospital|Kelly Codispodi BMR PT|204-237-2138|kcodispodi@sbgh.mb.ca|
22302527|NCT03976466|ISSEMyM Instituto de Seguridad Social del Estado de Mexico y Municipios|Julio Carlos Vélez de Lachica, Head of the orthopedics department at Regional Hospital Tlalnepantla|5526269200|activeknee@gmail.com|2100
22302528|NCT02055157|BioMarin Pharmaceutical Inc.|Alice Hunstman-Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
22302529|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
22302530|NCT02247336|William S Middleton Memorial Veterans Hospital|Corrine Voils, PhD|608-256-1901|corrine.voils@va.gov|12208
22302531|NCT00733499|DePuy Ortho Joint US|Tamiko Magee-Rodgers, PhD||TMageeRo@its.jnj.com|
22302532|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302533|NCT01931735|VA Palo Alto Research|Jessica Asay|650-493-5000|asay@stanford.edu|65971
22302534|NCT01986101|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22302535|NCT02719990|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
22302536|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de|
22302537|NCT03324880|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22302538|NCT03020225|BGU|Prof. Iris Shai|+972 52-579-3040|irish@bgu.ac.il|
22302539|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302540|NCT01769170|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22302541|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com|
22302542|NCT05076149|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22302543|NCT02087501|Endospan|Jessica Kleine||j.Kleine@endospan.com|
22302544|NCT01481545|National Cancer Institute of Naples|Dr. Antonio Avallone|+39 081 5903629|a.avallone@istitutotumori.na.it|
22302545|NCT03682705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22302546|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22302547|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
22302548|NCT02213328|Desmond Tutu HIV Foundation|Dr Katherine Gill|+2721 785 3121|katherine.gill@hiv-research.org.za|
22302549|NCT04043962|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
22302550|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22302551|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22302552|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr|
22302553|NCT02636270|Cincinnati Childrens Hospital Medical Center|Philippe Backeljauw|513-636-8444|philippe.backeljauw@cchmc.org|
22302554|NCT04236258|Brigham and Women's Hospital|Dr. Elizabeth Yoselevsky|314-413-1254|eyoselevsky@bwh.harvard.edu|
22302555|NCT02707692|UC San Diego|David (Davey) Smith|619-300-9638|d13smith@health.ucsd.edu|
22302556|NCT02914132|ExThera Medical Corporation|Sr. Director of Regulatory and Clinical Affairs|9258392079|erdie@extheramedical.com|
22302557|NCT02053077|MUG|Thomas Pieber|004331638512383|thomas.pieber@medunigraz.at|
22302558|NCT04834817|University of California, Irvine|Dr. Kristen Kelly, Professor and Chair, Dept. of Dermatology|949-824-5515|kmkelly@hs.uci.edu|
22302559|NCT01495221|Vitreous Retina Macula Consulatants of New York|Jason S. Slakter, MD|212-861-9797|mail@vrmny.com|
22302560|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca|
22302561|NCT02209636|Rocky Mountain VA Medical Center|Anna Jovanovich, MD|303-724-8677|anna.jovanovich@va.gov|
22302562|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu|
22302563|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22302564|NCT00856934|CHUV - CPR|Dr. Wassim Raffoul|+41 21 314 25 05|Wassim.Raffoul@chuv.ch|
22302565|NCT03285295|Abbott Laboratories|George Chen (Associate Director Clinical Affairs)|224-668-9185|george.chen@abbott.com|
22273051|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com|
22273052|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.galsky@mssme.edu|
22273053|NCT03597139|Aurinia Pharmaceuticals|Mary Palmen|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22273054|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com|
22273055|NCT02427802|Innocoll|Lesley Russell, MBChB, MRCP, Chief Medical Officer|484-406-5206|lrussell@innocoll.com|
22273056|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22273057|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
22273058|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
22273059|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu|
22273060|NCT03859648|MED-EL Corporation|MED-EL Corporation|919-314-1437|research.us@medel.com|
22273061|NCT03159299|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
22273062|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG|
22273063|NCT01990573|Washington University School of Medicine|Dr. Anshuman Sharma|314-457-3147|sharma.a@wustl.edu|
22273064|NCT02511132|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
22273065|NCT03834025|University of North Carolina at Chapel Hill|Marisa Domino, PhD|919-966-3891|domino@unc.edu|
22273066|NCT01983826|University of Iowa|Dr. Darren P. Casey||darren-casey@uiowa.edu|
22273067|NCT04541329|University of California, San Francisco|Raymond Cho, MD, PhD|415 353 7800|rashes@ucsf.edu|
22273068|NCT03335813|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. John Greskovich|1-866-223-8100|taussigresearch@ccf.org|
22273069|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com|
22273070|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22273071|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu|
22273072|NCT02697214|The Cleveland Clinic|Marc Gillinov, MD|216 445-8841|GILLINOM@ccf.org|
22273073|NCT00411450|Amgen Inc.|Study Director|866-572-6436||
22273074|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu|
22273075|NCT03904420|Cochlear Limited|Laura Chenier|+14423254171|lchenier@cochlear.com|
22273076|NCT04435808|The University of New Mexico School of Medicine|Walter Dehority|5052725535|wdehority@salud.unm.edu|
22273077|NCT00807612|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22273078|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu|
22273079|NCT00205660|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
22273080|NCT02959918|Selecta Biosciences, Inc.|Dr. Peter Traber|713-540-9776|ptraber@selectabiosciences.com|
22273081|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22273082|NCT03173456|Department of Emergency Medicine Albert Einstein Coll of Med|Dr. Polly Bijur|914-661-4707|polly.bijur@einsteinmed.org|
22273083|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22273084|NCT03061188|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
22273085|NCT00090870|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22273086|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273087|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu|
22273088|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
22273089|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu|
22273090|NCT01087203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273091|NCT02446847|The Rockefeller University|Dr. Marina Caskey, Associate Professor of Clinical Investigation|212-327-7396|mcaskey@rockefeller.edu|
22273092|NCT01616160|Massachusetts General Hospital|Daniel L. Hamilos, M.D.|617-726-5090|dhamilos@partners.org|
22273093|NCT04074330|Takeda|Medical Director|1-877-825-3327|TrialDisclosures@takeda.com|
22273094|NCT03790865|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
22273095|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273096|NCT01429298|Department of Emergency Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22273097|NCT02903420|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22302566|NCT02762981|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22302567|NCT02796274|Santhera Pharmaceuticals|Vanessa Dos Reis Ferreira|+41 61 906 89 50|office@santhera.com|
22273098|NCT03866278|Massachusetts General Hospital|Principal investigator|6176709739|patrick.purdon@MGH.HARVARD.EDU|
22273099|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
22273100|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
22302568|NCT04867785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22302569|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk|
22302570|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22302571|NCT02494921|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
22302572|NCT00981474|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22319593|NCT03359590|Profil Institut für Stoffwechselforschung GmbH|Dr. Christoph Kapitza|+49 2131 4018|christoph.kapitza@profil.com|157
22319594|NCT02540538|MaastrichtUMC|Astrid ML Oude Lashof, MD, PHD|0031433876644|a.oudelashof@mumc.nl|
22319595|NCT05649657|New Taipei Municipal Tucheng Hospital, Chang Gung Memorial Hospital|Dr. Shu-Chun Huang|0952818169|h0711@ms13.hinet.net|
22319596|NCT04598477|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
22319597|NCT05183360|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319598|NCT03140423|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Susan S. Huang, MD, MPH|(714) 456-5047|sshuang@hs.uci.edu|
22319599|NCT02876302|Dana-Farber Cancer Institute|Dr. Filipa Lynce, MD, Principal Investigator|617-632-3800|Filipa_Lynce@dfci.harvard.edu|
22319600|NCT05579990|University of Alabama at Birmingham|Dr. Camille Worthington|205-975-7274|cschneid@uab.edu|
22319601|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22319602|NCT01876251|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319603|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22319604|NCT00982865|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22319605|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
22319606|NCT02012296|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22319607|NCT03876171|University of Miami|Louis Herns Marcelin, Ph.D.|3052848493|lmarcel2@miami.edu|
22319608|NCT04321980|Orpheris, Inc.|Jeffrey L Cleland, PhD, Executive Chair|650-505-5048|cleland@orpheris.com|
22319609|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101|alayne.markland@va.gov|6365
22319610|NCT01681810|University of Pittsburgh|Dr. Kara Hughan|4126925173|kara.hughan@chp.edu|
22319611|NCT01826851|URochester|Peter A. Knight, MD|(585) 275-6340|Peter_Knight@URMC.Rochester.edu|
22319612|NCT03627767|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319613|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
22319614|NCT02953639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22302573|NCT00605319|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
22302574|NCT02991482|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki|+41 31 511 94 00|Heidi.Roschitzki@etop-eu.org|
22302575|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com|
22284265|NCT00626405|Mayo Clinic|Svetomir Markovic, M.D., Ph.D.|5072840527|markovic.svetomir@mayo.edu|
22284266|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu|
22284267|NCT03335774|Nivagen Pharmaceuticals|Dr Vishal S Narang|+919820020278|vnarang@nivagen.com|
22284268|NCT03828331|VA Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
22284269|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu|
22284270|NCT05126836|University of Minnesota|Dr. Markus Meyer|612.625-9538|meye3249@umn.edu|
22284271|NCT03775512|Biosense Webster, Inc.|Franchise Medical Manager|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22284272|NCT02629822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284273|NCT01610336|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22284274|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22302576|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
22302577|NCT02887989|Cedars-Sinai Health System|Garth Fuller|3236003890|garth.fuller@cshs.org|
22302578|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu|
22302579|NCT05648357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22302580|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414|sjmathew@bcm.edu|5439
22302581|NCT02949921|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22302582|NCT03585296|Aclaris Therapeutics|Executive Director Clinical Operations|4843242144|jschnyder@aclaristx.com|
22302583|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22302584|NCT02002884|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22302585|NCT02110732|Helsinki University Hospital|Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
22273101|NCT05305989|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22273102|NCT03162328|Philips|Gary Garcia|6085129475|gary.garcia@philips.com|
22273103|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu|
22273104|NCT01990768|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
22273105|NCT03479944|Alcon Japan Ltd.|Group Manager, Surgical, Alcon Japan|03-6899-5061|alcon.medinfo@alcon.com|
22273106|NCT00729300|Baylor College of Medicine|Christopher Verrico|713-791-1313|verrico@bcm.edu|26020
22273107|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22273108|NCT00357890|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
22273109|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082|chare@php.ucsf.edu|556
22273110|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu|
22273111|NCT00248833|WRAIR|Paul B. Keiser|866-856-3259|clinical1@na.amedd.army.mil|
22273112|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273113|NCT01941537|Rockefeller University|James Krueger|2123277730|kruegej@rockefeller.edu|
22273114|NCT02634983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22273115|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273116|NCT03646487|University of Illinois Chicago|Mary Dawn Koenig, PhD, RN, FACNM|312-996-7982|marydh@uic.edu|
22284275|NCT03464019|Milestone Pharmaceuticals Inc.|Cameron Szakacs_PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
22284276|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284277|NCT02489942|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0217|clintriage.rdg@boehringer-ingelheim.com|
22284278|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284279|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
22284280|NCT01543776|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22284281|NCT00567359|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|LVSEQUIST@PARTNERS.ORG|
22284282|NCT02352753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22273117|NCT02014051|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
22273118|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273119|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu|
22273120|NCT01220726|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
22273121|NCT04441788|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22273122|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000||
22273123|NCT02315664|Arthritis Research Canada|Dr. Linda Li, Professor, University of British Columbia|604-207-4020|lli@arthritisresearch.ca|
22284283|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu|
22284284|NCT02870101|UCLA David Geffen School of Medicine and Fielding School of Public Health|Jeffrey D. Klausner, MD, MPH|310-557-2273|JDKlausner@mednet.ucla.edu|
22284285|NCT00126776|Minneapolis VAMC|Kathryn Rice MD|612 725 2000|kathryn.rice@va.gov|4400
22284286|NCT03267888|Emory University|Mohammad K Khan|404-778-3473|m.k.khan@emory.edu|
22284287|NCT02893917|Yale School of Medicine: Medical Oncology|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
22284288|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585||
22284289|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|2644
22284290|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590||
22284291|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590||
22284292|NCT04120363|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
22284293|NCT05011058|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
22284294|NCT02455076|Emory University|Guillermo Umpierrez|(404)778-1665|geumpie@emory.edu|
22284295|NCT02917733|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284296|NCT03908476|Abbott|Marie Fahey|+15122864398|Marie.fahey@abbott.com|
22284297|NCT05194267|UCSD|Jean-Phillipe Miron|514-890-8000|jmiron@health.ucsd.edu|26489
22284298|NCT02868229|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22284299|NCT06151288|Vaxcyte, Inc.|Study Director: Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
22284300|NCT00687102|Wake Forest University Health Sciences|Sally A. Shumaker, PhD|336-71696934|sshumake@wakehealth.edu|
22284301|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu|
22284302|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22284303|NCT06225466|University of Texas Southwestern Medical Center|Dr. Proshad Efune|2144566393|proshad.efune@utsouthwestern.edu|
22284304|NCT03445559|VA New York Harbor Healthcare System|Dr. Danil V. Makarov|212-686-7500|Danil.Makarov@Va.gov|
22284305|NCT02466009|University of Rochester|Aram Hezel|585-275-5823|Aram_Hezel@urmc.rochester.edu|
22284306|NCT01646203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22284307|NCT04676867|DalCor Pharmaceuticals|David Kallend|+1 514-508-5099|dkallend@dalcorpharma.com|
22284308|NCT02435706|Columbia University College of Dental Medicine|Elena Sanz Miralles, DDS, PhD|212-342-3008|ecs2181@cumc.columbia.edu|
22284309|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284310|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22284311|NCT04268173|University of Wisconsin-Madison|Dr. Ryan Westergaard|(608) 265-7927|rpw@medicine.wisc.edu|
22284312|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov|
22284313|NCT01953913|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284314|NCT02925741|Cleveland Clinic|Mary Montague|216-444-1878|montagm@ccf.org|
22284315|NCT02437084|Stanford University School of Medicine|Dr Joshua W. Knowles, MD, PhD; Assistant Professor, Cardiovascular Medicine|650-723-1431|knowlej@stanford.edu|
22284316|NCT00906958|ResMed Ltd|Alison Wimms|+44 7901332675|alison.wimms@resmed.com|
22284317|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu|
22284318|NCT02976103|Dana-Farber Cancer Institute|Donna Berry, PhD, RN|617-632-1909|donna_berry@dfci.harvard.edu|
22284319|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22284320|NCT00509171|London Health Sciences Centre|Emil H. Schemitsch, MD, FRCS|5196633349|emil.schemistch@lhsc.on.ca|
22284321|NCT03040986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
22284322|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
22284323|NCT02228096|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22284324|NCT02925728|Centre Hospitalier Départemental Vendée|Sylvie VERBRUGGHE|0251446161|sylvie.verbrugghe@ght85.fr|
22284325|NCT04042727|Stony Brook University|Andreas KAlogeropoulos|4045124463|Andreas.Kalogeropoulos@stonybrookmedicine.edu|
22284326|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com|
22284327|NCT03652675|Columbia University / New York State Psychiatric Institute|Jennifer C Elliott, PhD|646 774 7953|jce2130@cumc.columbia.edu|
22273124|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22273125|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu|
22273126|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22273127|NCT01431313|University of Pittsburgh|Marc A. Simon, MD|4128023131|SIMONMA@UPMC.EDU|
22273128|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
22273129|NCT02489448|Yale School of Medicine|Lajos Pusztai, MD, DPhil Professor of Medicine (Medical Oncology)|(203) 737-8309|lajos.pusztai@yale.edu|
22273130|NCT02748057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273131|NCT02588586|The Rockefeller University|Dr. Marina Caskey, Professor of Clinical Investigation|2123277396|mcaskey@rockefeller.edu|
22273132|NCT02484092|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273133|NCT02793947|University of Iowa Hospitals and Clinics|Dr. Michael Willey|319-384-8452|michael-willey@uiowa.edu|
22273134|NCT02542397|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
22273135|NCT02090283|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22273136|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu|
22273137|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590||
22273138|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22273139|NCT02459197|Tools4Patient|Chief Scientific Officer|+32 71 91|alvaro.pereira@tools4patient.com|94 00
22273140|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu|
22273141|NCT01761643|UC San Diego|Mike Duszynski|6195438080|mduszynski@health.ucsd.edu|
22273142|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com|
22273143|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
22273144|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22273145|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
22273146|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408||
22273147|NCT02258217|OhioHealth Research Institute|Anand Gupta|614-788-3868|anand.gupta@ohiohealth.com|
22273148|NCT01101750|MedStar Health Research Institute|Veronica Gomez-Lobo, MD|202-877-4099|veronica.gomez-lobo@medstar.net|
22273149|NCT01806168|Vancouver Coastal Health / Vancouver General Hospital|Kawai Leong, MD, MSc, FRCPC|604-875-8289|kawai.leong@vch.ca|
22273150|NCT02693262|University of California, San Diego|Jonathan Hsu, MD, MAS|858-246-2972|jonathan.hsu@ucsd.edu|
22273151|NCT02620787|Center for Anti Infective Research and Development|Dr. David P. Nicolau|(860) 972-3941|david.nicolau@hhchealth.org|
22273152|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu|
22284328|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22302586|NCT03215901|Boston University|Jacob Bor, Assistant Professor|617-358-2176|jbor@bu.edu|
22302587|NCT04887948|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302588|NCT02312856|CERENOVUS|Christopher Hendricks|415-656-6565|chendric@its.jnj.com|
22302589|NCT04415151|Yale School of Medicine|Hyung Chun, MD, FAHA|(203) 785-6012|hyung.chun@yale.edu|
22302590|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu|
22302591|NCT01488708|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284329|NCT02539511|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
22284330|NCT03385330|Children's Hospital of Philadelphia|Dr. Sara DeMauro|445-225-6400|demauro@chop.edu|
22284331|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200|gar1iti@mail.med.upenn.edu|0
22284332|NCT02530996|Salt Lake VAMC and University of Utah|Dr. Tracy Frech|801 213 2312|tracy.frech@hsc.utah.edu|
22284333|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
22284334|NCT00375167|Queens University|Dr. Terry Krupa|613-533-6236|terry.krupa@queensu.ca|
22284335|NCT04484207|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
22284336|NCT01624090|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@nih.gov|
22284337|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284338|NCT01403116|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22284339|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
22284340|NCT00042666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284341|NCT04232215|Mayo Clinic|Yvonne S. Butler Tobah, M.D.|507-284-0210|ButlerTobah.Yvonne@mayo.edu|
22284342|NCT01555125|Novartis Pharmaceutical|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22284343|NCT04836247|University of Delaware|Valerie Earnshaw|302-831-4772|earnshaw@udel.edu|
22284344|NCT04268745|New York University|Dr. Anat Lubetzky|2129989195|anat@nyu.edu|
22284345|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk|
22284346|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org|
22284347|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu|
22284348|NCT05327361|University of Miami|Enzo Berardesca|3052434472|exb743@med.miami.edu|
22284349|NCT02107157|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22284350|NCT01078168|Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz|Prof. Dr. Andreas Fellgiebel|+49-6131-17-7363|Andreas.Fellgiebel@unimedizin-mainz.de|
22284351|NCT02147769|Stanford University|Valerie Chock, MD|650-723-5711|vchock@stanford.edu|
22284352|NCT01962870|Stanford University|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
22284353|NCT02467582|SAKK|Regulatory affairs|+41 31 389 91 91|regulatory@sakk.ch|
22284354|NCT05388617|Cynosure|Jamie Trimper|9782564200|jamie.trimper@cynosure.com|
22284355|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500|mireia.torres@grifols.com|12273
22284356|NCT00627367|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22284357|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22284358|NCT00965575|Cincinnti Childrens|Sejal Jain|513-636-4222|sejal.jain@cchmc.org|
22284359|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com|
22284360|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22284361|NCT02397057|American Regent, Inc|Mark A. Falone, MD MPH|6317723544|mfalone@americanregent.com|61844
22284362|NCT00901199|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|510-428-3172|ashutosh.lal@ucsf.edu|
22284363|NCT00704288|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22284364|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22284365|NCT04395690|Aula Dental Avanzada|G. Esteve-Pardo|965215755|guillem@clinicaesteve.com|
22284366|NCT03927144|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22302592|NCT01588990|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22284367|NCT03909152|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
22284368|NCT05346653|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22284369|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300||
22284370|NCT03433417|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
22284371|NCT04532931|Shin Poong Pharm. Co., Ltd.|Shin Poong Pharm. Co., Ltd.|82-2-2189-3478|bwon@shinpoong.co.kr|
22284372|NCT03781505|Aga Khan University|Dr. Muhammad Saad Yousuf|+92213486|saad.yousuf@aku.edu|4253
22284373|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu|
22284374|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu|
22284375|NCT03002311|WASHINGTON UNIVERSITY MEDICAL SCHOOL|Brian F. Gage, MD|3144548697|bgage@wustl.edu|
22284376|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu|
22284377|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com|
22284378|NCT00652080|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
22284379|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu|
22284380|NCT03722524|AO Servier|Natalya LOGUNOVA|+7 495 9370700|Natalya.LOGUNOVA@servier.com|
22284381|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22284382|NCT04369950|The University of Texas Health Science Center at Houston|Linden Lee, MD, Assistant Professor|(713) 500-6200|Linden.O.Lee@uth.tmc.edu|
22284383|NCT00989963|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director||info@lungbiotechnology.com|
22284384|NCT02408263|HSS|Dr. Gungor|212.606.1206|GungorS@hss.edu|
22284385|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22284386|NCT00759408|Brigham and Women's Hospital|Anju Nohria, MD|617-525-6852|ANOHRIA@PARTNERS.ORG|
22284387|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com|
22284388|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org|
22284389|NCT02251938|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
22284390|NCT04071158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284391|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284392|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284393|NCT04816721|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
22284394|NCT06328660|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
22284395|NCT03194438|State University of New York at Buffalo School of Nursing|Tania Von Visger, APRN, PhD, PCCN|7168292201|Taniavon@buffalo.edu|
22284396|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22284397|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
22284398|NCT00997620|Westernsky|Lyndon E Mansfield, MD|915-544-2557|immunman@westernskymed.com|
22284399|NCT02903394|Duke University|Kengyeh Chu|919-681-2093|ken.chu@duke.edu|
22284400|NCT02717130|Thriving Mind South Florida|John W. Newcomer, M.D., President & CEO|305-860-0653|jnewcomer@thrivingmind.org|
22284401|NCT02335424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284402|NCT01141478|Loma Linda University Medical Center|Diane Scavone, research coordinator|909 558-3636|dscavone@llu.edu|33670
22284403|NCT03096873|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22284404|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu|
22284405|NCT00290498|U.T. MD Anderson Cancer Center|Dr. Luis E. Fayad / Lymphoma/Myeloma|7137922860|lefayad@mdanderson.org|
22284406|NCT00599638|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284407|NCT01463202|Center for Family Planning Research|Principal Investigator|412-641-5496|fpr@upmc.edu|
22284408|NCT02825212|Icahn School of Medicine at Mount Sinai|Dr. Peter D. Gorevic|212-241-0968|peter.gorevic@mountsinai.org|
22302593|NCT02367716|Cardiac Rhythm Management, Abbott Medical Devices|Clay Cohorn, Clinical Program Director|+19723098087|clay.cohorn@abbott.com|
22302594|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director - Clinical Development|201 427-8000|suresh.durgam@frx.com|8172
22302595|NCT00539643|Memorial Sloan Kettering Cancer Center|Dr. Anne Covey, MD|212-639-6746|coveya@MSKCC.ORG|
22302596|NCT02508532|Blueprint Medicines|Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
22302597|NCT03802864|Weill Cornell Medicine|Russell Hayden|2127465566|rph9002@med.cornell.edu|
22302598|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302599|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org|
22302600|NCT04399356|Tufts Medical Center|Dorothy Dulko, PhD - Research Project Director|(617) 636-5009|ddulko@Tuftsmedicalcenter.org|
22302601|NCT03812536|Ohio State University|Dr. Syed Husain|6142938772|syed.husain@osumc.edu|
22302602|NCT00152009|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22302603|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com|
22302604|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu|
22302605|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov|
22302606|NCT02118337|MedImmune, LLC|Farzana Walcott|+1 301-398-3063|information.center@astrazeneca.com|
22302607|NCT02835846|Loyola University Chicago|Alan J Wolfe|7082165814|awolfe@luc.edu|
22302608|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302609|NCT00211237|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22302610|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr|
22302611|NCT01003639|University of Iowa Hospitals and Clinics|Dr. Michael Wall|319-353-3942|michael-wall@uiowa.edu|
22302612|NCT05458024|University of North Carolina at Chapel Hill|Sam McLean, MD, MPH|+1 (919) 843-5931|samuel_mclean@med.unc.edu|
22302613|NCT04000594|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22302614|NCT05807919|University of Mihcigan|Prashant Singh|734-647-9252|singhpr@med.umich.edu|
22302615|NCT00747123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22302616|NCT03489057|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan, PhD|+1 919-966-8450|xianming@email.unc.edu|
22302617|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr|
22302618|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22302619|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
22302620|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302621|NCT00943306|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
22302622|NCT02739347|Baylor College of Medicine|Raymond Cho|7137987781|Raymond.Cho@bcm.edu|
22302623|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org|
22302624|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302625|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org|
22302626|NCT00116272|Amgen Inc.|Study Director|866-572-6436||
22302627|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22302628|NCT05096208|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302629|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22302630|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu|
22302631|NCT01833143|Memorial Sloan Kettering Cancer Center|Gregory Riely, MD, PhD|646-608-3913|rielyg@mskcc.org|
22302632|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22302633|NCT03518658|CRHF Clinical|Keith Holloman|763-526-1545|keith.holloman@medtronic.com|
22302634|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22302635|NCT04662671|EmitBio, Inc.|Chief Scientific Officer|(919) 321-1734|nstasko@emitbio.com|
22302636|NCT02746575|Washington University|Principal Investigator|7737022544||
22302637|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it|
22302638|NCT02959671|University of Minnesota|Thorsten Gruenheid, DDS, PhD|612-625-3903|tgruenhe@umn.edu|
22302639|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr|
22302640|NCT03260127|VA San Diego Healthcare System|Laura Crocker|8586426484|laura.crocker@va.gov|
22302641|NCT03800979|Institute of Dermatology|Dr. Chinmanat Lekhavat (My old last name is Tangjaturonrusamee.)|+660847607474|chinmanat@hotmail.com|
22302642|NCT02419547|Brigham and Women's Hospital|Douglas Shook, MD, Chief, Divison of Cardiac Anesthesia|617-732-8219|dshook@bwh.harvard.edu|
22302643|NCT03728153|Massachusetts General Hospital|Farrah Mateen|16177248653|fmateen@mgh.harvard.edu|
22302644|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu|
22302645|NCT04042285|Hull University Teaching Hospitals NHS Trust|Louise Hitchman|01482 311925|l.hitchman@nhs.net|
22302646|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22302647|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22302648|NCT04343586|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
22284409|NCT03006887|Eisai, Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22284410|NCT03836677|AstraZeneca AB|AstraZeneca AB|1-877-240-9479|information.center@astrazeneca.com|
22284411|NCT02895945|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22284412|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22284413|NCT03429543|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22284414|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284415|NCT01561963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22284416|NCT04018313|Celltrion. Inc|Keumyoung Ahn/Head of Clinical Planning 2 Department|+82 32 850 4190|Keumyoung.ahn@celltrion.com|
22284417|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu|
22284418|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22284419|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com|
22284420|NCT04667104|Janssen Research & Development, LLC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22284421|NCT05066165|Intellia Therapeutics|Trial Manager|833-888-0387|clinicalscience@intelliatx.com|
22284422|NCT03210961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284423|NCT03343626|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22284424|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com|
22284425|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
22284426|NCT03592368|University of Colorado, Anschutz Medical Campus|Joel Stoddard|(720) 777-5702|joel.stoddard@cuanschutz.edu|
22284427|NCT01107665|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22284428|NCT02227667|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
22284429|NCT03047031|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284430|NCT02814175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22284431|NCT02170870|Mayo Clinic|Dr. Adil E. Bharucha, Principal Investigator|507-284-2687|bharucha.adil@mayo.edu|
22284432|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000|bmurphy5@partners.org|2297
22284433|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu|
22284434|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu|
22284435|NCT04207749|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22284436|NCT01971008|Innsbruck Medical University|Prof. Dr. Klaus Seppi|004351250481498|klaus.seppi@tirol-kliniken.at|
22284437|NCT03416127|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22284438|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org|
22284439|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22284440|NCT01912339|Boston Scientific Corporation|Kevin Hagelin, Clinical Program Manager|(800) 328-3881|kevin.hagelin@bsci.com|
22284441|NCT03679624|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
22284442|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu|
22284443|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu|
22284444|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu|
22284445|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu|
22289087|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22302649|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org|
22302650|NCT01287520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302651|NCT03587142|Temple University|Dr. Henry Parkman|(215) 707-7579|henry.parkman@temple.edu|
22302652|NCT03673462|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22302653|NCT01581840|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22302654|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com|
22302655|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
22302656|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar.kastner@intercell.com|0
22302657|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu|
22302658|NCT04359771|faculty of medicine, Cairo University|Dr. Ahmed Abdelbaki|00201066642728|a.abdelbaki@kasralainy.edu.eg|
22302659|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
22302660|NCT04041440|Customized Learning Exercises for Aural Rehabilitation|Chief Operating Officer|314 399-9943|chris@amptify.com|
22302661|NCT02306265|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
22302662|NCT02247804|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22302663|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
22302664|NCT01187329|Cleveland Clinic|Andra E. Duncan, M.D|216-445-2372|DUNCANA@ccf.org|
22302665|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov|
22302666|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22302667|NCT01962025|Ottawa HRI|Dr. Deborah Zimmerman|613-722-7000|dzimmerman@toh.ca|
22302668|NCT05737433|Hepion Pharmaceuticals Inc|Jill Greytok|732-902-4000|jgreytok@hepionpharma.com|
22302669|NCT03002038|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
22302670|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174||
22302671|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22302672|NCT02207439|University of Pennsylvania|Alexander Lin, MD|215-662-3198|alexander.lin2@pennmedicine.upenn.edu|
22302673|NCT03148236|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
22302674|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu|
22302675|NCT03452176|Massachusetts General Hospital|Dr. Michael Levy|617-726-0412|mlevy11@mgh.harvard.edu|
22302676|NCT03724396|University of California San Diego|Dr. Dawn Eichen|858-249-1123|deichen@ucsd.edu|
22302677|NCT04616014|Oramed, Ltd.|Chief Scientific Officer|972-2-566-0001|miriam@oramed.com|
22302678|NCT02237508|Zambon SpA|Isabella Salerio, PhD|+39 02665241|clinicaltrials@zambongroup.com|
22302679|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22302680|NCT04986085|Grupo Español de Tumores Neuroendocrinos y Endocrinos|A responsible Person Designated by the Sponsor|0034934344412|investigacion@mfar.net|
22302681|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu|
22302682|NCT03300570|Fox Chase Cancer Center|David Weinberg, M.D., M.Sc.|215-214-1424|david.weinberg@fccc.edu|
22302683|NCT03188120|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302684|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU|
22302685|NCT02296190|Milestone Pharmaceuticals|Francis Plat _MD_Chief Medical Officer|514-336-0444|fplat@milestonepharma.com|225
22302686|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu|
22302687|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22302688|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com|
22302689|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov|
22302690|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302691|NCT01875185|Johns Hopkins University School of Medicine|RhondaLyn McLean|(215) 662-4949|rhondalyn.mclean@uphs.upenn.edu|
22302692|NCT03238300|Medical University of South Carolina|Lindsay M. Squeglia, PhD|843-792-5451|squegli@musc.edu|
22302693|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22302694|NCT01286441|Santalis Pharmaceuticals|Dr. Paul Castella Ph.D.|210-399-2316|paulc@santalispharma.com|101
22302695|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu|
22302696|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org|
22302697|NCT04064242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22302698|NCT03389477|Washington University School of Medicine|Douglas Adkins, M.D.|(314) 362-4471|dadkins@wustl.edu|
22302699|NCT03536546|Department of Veterans Affairs|Paul N Pfeiffer, MD MS|(734) 769-1000|Paul.Pfeiffer@va.gov|
22302700|NCT04512066|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22302701|NCT01044576|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
22302702|NCT03403426|Reflow Medical|Isa Rizk|9494810399|info@reflowmedical.com|
22302703|NCT00626366|University of Nebraska Medical Center|Erin K O'Brien|402-559-6463|irbora@unmc.edu|
22302704|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org|
22302705|NCT01657266|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Clinical trials Director|52+ (33) 30 01 42 00|leopoldo.baiza@sophia.com.mx|
22284446|NCT02702414|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284447|NCT04541628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22284448|NCT02781480|MeiraGTx|Chief Medical Officer|+1 973 609-2156|robert.zeldin@meiragtx.com|
22284449|NCT01452919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284450|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu|
22284451|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22284452|NCT03446456|University of Maryland School of Nursing|Rachel Massalee|4107068244|rmassalee@umaryland.edu|
22284453|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu|
22284454|NCT00658814|SWOG|Study Statistician|206-667-4623||
22284455|NCT02703480|Tufts University School of Dental Medicine|Associate Professor|6176366659|yumi.ogata@tufts.edu|
22284456|NCT00455143|Icahn School of Medicine at Mount Sinai|Department of Anesthesiology|212-241-7473||
22284457|NCT02387294|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
22284458|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300||
22284459|NCT00524017|SKCCC|Dr. Zubair Khan|4109553157|zkhan@jhmi.edu|
22284460|NCT04856904|Galderma R&D, Inc.|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22284461|NCT02712424|Geisel School of Medicine|Dr C Fordham von Reyn|6036505000|fvr@dartmouth.edu|
22284462|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org|
22284463|NCT05236712|Univcersity of Washington|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
22284464|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22284465|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
22284466|NCT02421601|Seikagaku Corporation|Clinical Development Department|(81)3-5220-8948|kyoichi.osano@seikagaku.co.jp|
22289088|NCT01108185|Abbott|Global Medical Services|1-800-633-9110||
22302706|NCT03520400|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
22302707|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22302708|NCT01316770|NIDCR/NIH|Ilias Alevizos|3014966207|alevizosi@mail.nih.gov|
22302709|NCT04366726|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
22302710|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu|
22302711|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com|
22302712|NCT00116844|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302713|NCT01933880|Xi'an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307||
22302714|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22302715|NCT03474549|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
22302716|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22302717|NCT04466215|The Scripps Research Institute|Dr. Barbara J.. Mason, Ph.D.|(858) 784-7324|mason@scripps.edu|
22302718|NCT00926003|Michigan State University|Dr. Michael J. Boivin|5174324204|Michael.Boivin@hc.msu.edu|
22302719|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22302720|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22302721|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu|
22302722|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk|
22302723|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl|
22302724|NCT02769065|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22302725|NCT03017235|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DKO-Disclosure@ferring.com|
22302726|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu|
22302727|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org|
22302728|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302729|NCT02430818|Washington University School of Medicine|Evan Schwarz|3147473690|schwarze@wustl.edu|
22302730|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22302731|NCT02966002|University of Michigan|Adam Lubert|734-764-5177|luberta@med.umich.edu|
22302732|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu|
22302733|NCT02291432|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22302734|NCT02145078|Barbara Ann Karmanos Cancer Institute|Gerold Bepler|(313)576-8670|beplerg@karmanos.org|
22273153|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072|lwchang@taigenbiotech.com|1227
22273154|NCT01462630|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22273155|NCT03665077|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
22302735|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273156|NCT02364388|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
22284467|NCT04122170|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
22284468|NCT03222414|Vanderbilt University Medical Center|Laura Sorabella||laura.sorabella@vumc.org|
22284469|NCT03847909|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22284470|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu|
22284471|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22284472|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22284473|NCT03286283|Apyx Medical (formerly Bovie Medical Corporation)|Shawn Roman/Vice President of Research and Development|1-727-384-2323|shawn.roman@apyxmedical.com|
22284474|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu|
22284475|NCT02345330|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
22284476|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca|
22284477|NCT03322423|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-904-443-3402|TKarkkai@its.jnj.com|
22284478|NCT04891107|Boston University Department of Physical Therapy & Athletic Training|Terry Ellis PT, PhD, FAPTA|617-353-7571|tellis@bu.edu|
22284479|NCT02453555|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284480|NCT03045341|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
22284481|NCT03689855|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-747-7948|danielmorgensztern@wustl.edu|
22284482|NCT03178669|InDex Pharmaceuticals|Karin Arnesson, Clinical Trial Manager|+46 8 122 038 57|karin.arnesson@indexpharma.com|
22284483|NCT02914561|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22284484|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284485|NCT03074682|Yale University|Dr. Marc Auerbach|203-688-3333|marc.auerbach@yale.edu|
22284486|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com|
22284487|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu|
22284488|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu|
22284489|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu|
22284490|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284491|NCT03332160|Tactile Medical|Heather Smith|612.800.5539|HSmith@tactilemedical.com|
22284492|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu|
22284493|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org|
22284494|NCT01008462|Fred Hutchinson Cancer Research Center|Dr. Mohamed L. Sorror|(206) 667-6298|msorror@fredhutch.org|
22284495|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu|
22284496|NCT03445390|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
22284497|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22284498|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu|
22284499|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22284500|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
22284501|NCT04583956|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22273157|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22273158|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com|
22273159|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22273160|NCT02404610|Hennepin Healthcare|Audrey Hendrickson|6128739528|audrey.hendrickson@hcmed.org|
22273161|NCT02497404|Weill Cornell Medical College|Sebastian Mayer, MD|646-962-7950|sam2033@med.cornell.edu|
22273162|NCT01408901|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22273163|NCT05593770|Research Organization (KC) Ltd|Clinical Project Manager|+44 (0) 7494 795 982|nectar@rokcservices.com|
22273164|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22273165|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878|kirtanaa.voralu@drexelmed.edu|7878
22273166|NCT04060797|Zhongda Hospital Affiliated to Southeast University|Dr. Gaojun Teng|13805175100|gjteng@vip.sina.com|
22273167|NCT01861002|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Roy Leong, BA, CCRP|323-361-5132|rleong@chla.usc.edu|
22273168|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273169|NCT05285787|Epizon Pharma|John Rudy|2127551000|jrudey@epizonpharma.com|
22273170|NCT01509612|Medical University of Vienna|Michael Frass, MD|+436645453040|office@ordination-frass.at|
22273171|NCT04004260|Lamar University|Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 821 9443|vmanchaiah@lamar.edu|
22273172|NCT03774888|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
22273173|NCT02360280|Minneapolis VA Medical Center|Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
22273174|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com|
22273175|NCT03021317|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22284502|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu|
22284503|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn|
22273176|NCT04633226|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22273177|NCT02536105|Massachusetts General Hospital|Dr. Thomas Spencer|617-724-5600|spencer@helix.mgh.harvard.edu|
22273178|NCT04585243|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
22273179|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273180|NCT06329687|Oyster Point Pharma Inc|Marian Macsai, MD|3122592477|marian.macsai@viatris.com|
22284504|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org|
22284505|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22284506|NCT02376179|Nationwide Children's Hospital|Kris Jatana, MD|614-722-6032|Kris.Jatana@nationwidechildrens.org|
22284507|NCT01248741|British Columbia Cancer Agency|Dr Juanita Crook|2507123958|jcrook@bccancer.bc.ca|
22284508|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22284509|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu|
22284510|NCT01900054|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284511|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu|
22284512|NCT01959841|Maruho Co.,Ltd. Kyoto R&D Center|linical Development Dept.|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22284513|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
22284514|NCT01450098|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273181|NCT02733341|The Royal Wolverhampton NHS Trust|Professor James Cotton|01902307999|jamescotton@nhs.net|
22273182|NCT05415462|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22273183|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22284515|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu|
22273184|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
22302736|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>|
22273185|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
22273186|NCT02974803|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
22273187|NCT01904032|Loyola University Chicago|Sue Penckofer, Ph.D., F.A.A.N.|773-508-8949|spencko@luc.edu|
22273188|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org|
22284516|NCT05443256|University of New Mexico|Dr. James F. Cavanagh|5052773890|jcavanagh@unm.edu|
22284517|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu|
22284518|NCT03121365|The Children's Hospital of Phiadelphia|Dr. James Guevara|215-590-1130|Guevara@email.chop.edu|
22284519|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22284520|NCT02277925|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
22284521|NCT01835223|Roswell Park Cancer Institute|Katy Wang, Statistician, M.A.|716-845-1300|katy.wang@roswellpark.org|6269
22284522|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814|roger.soll@uvmhealth.org|212
22284523|NCT04097379|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22284524|NCT03387020|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
22302737|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu|
22319615|NCT01667081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273189|NCT02998996|Eurocine Vaccines AB|Anna-Karin Maltais|+46 76 233 81 62|annakarin.maltais@eurocine-vaccines.com|
22273190|NCT04270695|China Medical University|Ms Weng|0975127007|chuyu0608@gmail.com|
22273191|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
22273192|NCT01398358|University of Michigan|Julie Lumeng, MD|jlumeng@umich.edu|jlumeng@umich.edu|
22273193|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623||
22284525|NCT01425632|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284526|NCT03461146|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22319616|NCT03034460|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22319617|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319618|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
22319619|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22319620|NCT02366728|Duke University|Mustafa Khasraw, M.D.|919-668-6688|mustafa.khasraw@duke.edu|
22319621|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov|
22319622|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22319623|NCT03842163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319624|NCT04216251|Massachusetts General Hspital|Andrew T. Chan, MD, MPH|617-726-3212|achan@partners.org|
22319625|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22319626|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22319627|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu|
22319628|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org|
22319629|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu|
22319630|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu|
22319631|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu|
22319632|NCT03568045|Yale School of Medicine|Dr. Melissa Knauert|203-785-4162|melissa.knauert@yale.edu|
22319633|NCT00117507|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22319634|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu|
22319635|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu|
22319636|NCT02797067|Changhai Hospital|Yangyang Qian|13818040017|919835863@qq.com|
22319637|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22319638|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22319639|NCT05211739|Alcon Research, LLC|Clinical Project Lead, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22302738|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu|
22284527|NCT02140047|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284528|NCT04617496|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22284529|NCT06222892|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284530|NCT00200356|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284531|NCT04508530|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22284532|NCT04530552|University of Arizona|Betsy Wertheim|5207771666|betsy@arizona.edu|
22284533|NCT04148352|Sean N Parker Center for Allergy & Asthma Research at Stanford University|Sayantani B. Sindher, MD|650-521-7237|snpcenterallergy_inquiry@stanford.edu|
22284534|NCT03950492|WVU Rockefeller Neuroscience Institute|James Mahoney, PhD|304-293-5323|james.mahoney@hsc.wvu.edu|
22284535|NCT02176161|NYU Langone Health|Aaron Katz, MD|516-535-1900|Aaron.Katz@nyulangone.org|
22284536|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612||
22284537|NCT02250664|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
22284538|NCT03957876|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD, MPH|216-444-0506|mukhers2@ccf.org|
22284539|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu|
22284540|NCT02522442|Sleep Therapy & Research Center|Eric Powell, Ph.D.|(210) 614-6000|powell.eric@sleeptrc.com|
22284541|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840|jchan@cipherpharma.com|326
22284542|NCT01753401|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22284543|NCT03129360|NYU Langone Health|Donald Goff, MD|646.485.4843|Donald.Goff@nyulangone.org|
22284544|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22284545|NCT01729208|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22284546|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com|
22284547|NCT00295932|Memorial Sloan Kettering Cancer Center|Dr. Carol Portlock|212-639-8109|portlocc@mskcc.org|
22284548|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405|dhansen@mabvax.com|301
22284549|NCT02409719|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
22284550|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22284551|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu|
22284552|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu|
22284553|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22284554|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22284555|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us|
22284556|NCT05096312|East Avenue Medical Center|Dr. Monqiue Lianne Lim-Ang|0287100957|moniquelianne.lim@gmail.com|
22284557|NCT03135210|University of Minnesota|Amanda Sharp|(612) 626-4691|sharp@umn.edu|
22284558|NCT03517566|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22284559|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
22284560|NCT04349033|Wayne State University|Dr. Mark A. Lumley, Professor|3135772247|mlumley@wayne.edu|
22284561|NCT02837042|UAB|Gurudatta Naik, Scientist 3|205-996-5530|alkanand@uab.edu|
22284562|NCT00971295|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22302739|NCT03810313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22302740|NCT00584805|USAMRIID Medical Division|Anthony Cardile, D.O.|301-619-8833|anthony.cardile.mil@mail.mil|
22284563|NCT01704456|UBC|Dr Lori Brotto|604-875-4111|lori.brotto@vch.ca|68898
22273194|NCT02373137|Kaiser Permanente / University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|650-299-2111|Jennifer.Rose-Nussbaumer@kp.org|
22273195|NCT01961167|W. L. Gore & Associates|Melissa Zambeck|928-856-4900|mzambeck@wlgore.com|
22273196|NCT02559570|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22273197|NCT02934555|Beth Israel Deaconess Medical Center|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
22273198|NCT01183416|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22273199|NCT02364076|Georgetown University Medical Center -Lomabardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
22273200|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com|
22273201|NCT01680653|Stanford University|Dr. Bruce Buckingham|650-725-6549|bbendo@stanford.edu|
22273202|NCT03373461|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22273203|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
22273204|NCT03020550|University of California, Davis|Michelle Dossett, MD, PhD|916-734-5367|mdossett@ucdavis.edu|
22273205|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de|
22273206|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com|
22273207|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22273208|NCT00215644|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22273209|NCT05554640|Johnson & Johnson Vision Care (JJVC)|John R. Buch, O.D., M.S.|1-800-843-2020|jbuch@its.jnj.com|
22273210|NCT02861664|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284564|NCT00988364|Baylor College of Medicine|Dr. Chu-Huang Chen|832-355-9026|chu-huang.chen@bcm.edu|
22284565|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22284566|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22284567|NCT04390841|Biotronik (Beijing) Medical Device Limited|Senior Clinical Study Project Manager|+86 10 6522 3851-863|lan.chen@biotronik.com|
22284568|NCT02540291|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22284569|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov|
22284570|NCT03831100|Medical University of South Carolina|Evan Graboyes|843-792-0719|graboyes@musc.edu|
22284571|NCT02566590|University of Utah|Micah Drummond|8015877764|micah.drummond@hsc.utah.edu|
22284572|NCT02454478|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22284573|NCT01732770|Amgen Inc.|Study Director|866-572-6436||
22284574|NCT03229109|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
22284575|NCT03653988|University of Iowa Hospitals and Clinics|Melinda Seering, M.D.|(319) 384-8466|melinda-seering@uiowa.edu|
22302741|NCT04048759|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22284576|NCT03329196|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284577|NCT06476548|Moffitt Cancer Center|Dr. Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
22284578|NCT04493281|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284579|NCT04481750|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284580|NCT03176771|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284581|NCT03439137|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284582|NCT00691028|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284583|NCT04776135|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284584|NCT03372252|CHU de Poitiers|Dr RAULT Christophe|0549445348|christophe.rault@chu-poitiers.fr|
22302742|NCT02341456|AstraZeneca|Lone Ottesen|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
22302743|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736||
22302744|NCT02648971|Wake Forest University|Dr. John Hubbard|336-998-1297|jhubbard@wakehealth.edu|
22302745|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22302746|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu|
22302747|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu|
22302748|NCT02768662|Otonomy, Inc.|Otonomy Medical information Center|1-844-686-4636|medinfo@otonomy.com|
22302749|NCT02294630|Wayne State University|Beena G. Sood, MD, MS|313-745-5638|bsood@med.wayne.edu|
22302750|NCT02567825|UPMC Children's Hospital of Pittsburgh|Alejandro Hoberman, MD|412-999-3277|hobermana@upmc.edu|
22302751|NCT02352363|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
22302752|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22302753|NCT03195465|Loma Linda University School of Allied Health Professions|Amy Sadek, PhD Rehabilitation Science|951-212-2104|asadek@llu.edu|
22302754|NCT03097861|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22302755|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
22302756|NCT05061537|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22302757|NCT03502616|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302758|NCT04503096|Medical University of South Carolina|Andreana Benitez PhD|(843) 876-8479|benitez@musc.edu|
22302759|NCT01785563|University of Iowa|Tarah T. Colaizy|3193255640|tarah-colaizy@uiowa.edu|
22273211|NCT03512353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22273212|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343||
22302760|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22273213|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
22302761|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com|
22302762|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu|
22302763|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302764|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22302765|NCT02387216|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
22302766|NCT02091739|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22302767|NCT03528174|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
22302768|NCT04251065|SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - Trieste|Prof. Francesco Zaja|+ 39 040 3992015|francesco.zaja@asugi.sanita.fvg.it|
22302769|NCT01778556|NIDDK|Dr. Rebecca Brown|301-594-0609|brownrebecca@mail.nih.gov|
22302770|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317||
22302771|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22302772|NCT03571737|Brody School of Medicine @ East Carolina University|Dr. Jennifer Stahl|2527442570|stahlj@ecu.edu|
22302773|NCT02139358|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
22302774|NCT04485130|University of California, San Francisco|Dr. Sulggi Lee|415-735-5127|sulggi.lee@ucsf.edu|
22302775|NCT02178566|Inova Health Systems|Christopher King, MD|7037763067|christopher.king@inova.org|
22302776|NCT02658630|VA Pittsburgh Healthcare System|George F. Wittenberg|412-648-4178|GeoWitt@Pitt.edu|
22302777|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org|
22302778|NCT02081950|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22302779|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302780|NCT00110890|Amgen Inc.|Study Director|866-572-6436||
22302781|NCT01686581|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22302782|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302783|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302784|NCT03619590|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
22302785|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302786|NCT01226914|Medical University of South Carolina - Department of Otolaryngology - Head and Neck Surgery|Shaun A. Nguyen, MD, FAPCR|8437921356|nguyensh@musc.edu|
22302787|NCT03245255|Thomas Jefferson University|Jaydev Dave|2158684795|dave.jaydev@mayo.edu|
22302788|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22302789|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
22302790|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302791|NCT02917941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302792|NCT01893827|NYU Langone Health|Mia Malone|646-501-3577|mia.malone@nyulangone.org|
22302793|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu|
22302794|NCT03021668|Johns Hopkins Hospital|Dr. Matthew J. Weiss|4106143368|mweiss5@jhmi.edu|
22302795|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org|
22302796|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
22319640|NCT04178967|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22319641|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com|
22319642|NCT01975428|Scripps Translational Science Institute|Eric J. Topol, M.D.|858-554-5708|etopol@scripps.edu|
22319643|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22319644|NCT00628251|AstraZeneca|Paula del Rosario|+44 7884 735492|ClinicalTrialTransparency@astrazeneca.com|
22319645|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com|
22319646|NCT04513665|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
22319647|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu|
22319648|NCT02608879|NYU Langone Medical Center|Patricia Corby, Principal Investigator|646-501-2615|patricia.corby@nyumc.org|
22319649|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu|
22319650|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org|
22319651|NCT02536755|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22319652|NCT06132425|University of California, Los Angeles|Nora Barnes-Horowitz|(310) 825-2961|nbarneshorowitz@ucla.edu|
22319653|NCT04448756|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22319654|NCT02733185|Mount Sinai Medical Center of Florida|Dr. Gervasio Lamas|305-674-2162|Gervasio.Lamas@msmc.com|
22319655|NCT05315947|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22319656|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22319657|NCT02204566|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
22319658|NCT01093326|Actelion Pharmaceuticals Ltd|Director Clinical Leader Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319659|NCT04435782|Actelion Pharmaceuticals Ltd|Study Responsible Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319660|NCT03672461|University of California, San Francisco|Alison Huang, MD|415-353-7900|Alison.Huang@ucsf.edu|
22319661|NCT04225806|InterVene, Inc|Clinical Affairs|6509957137|ClinSupport@intervene-med.com|
22302797|NCT02444988|Vanderbilt University Medical Center|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22302798|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590||
22302799|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22302800|NCT00720902|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
22302801|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493||
22302802|NCT03366220|The University of Texas Health Science Center at Houston|Dr. Lillian S Kao|(713) 500-6280|Lillian.S.Kao@uth.tmc.edu|
22302803|NCT02341287|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
22302804|NCT02254408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22319662|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
22284585|NCT04512976|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
22284586|NCT04897763|Institut de cancérologie de l'Ouest|Dr Caroline ROUSSEAU|+33 2 40 67 99 31|caroline.rousseau@ico.unicancer.fr|
22284587|NCT03392649|Univerisity of Chicago Medicine|Dr. Gaurav Upadhyay|773-702-9461|gupadhyay@medicine.bsd.uchicago.edu|
22284588|NCT05249569|UT Southwestern Medical Center|Dr. David Hsieh|214/648-4180|david.hsieh@utsouthwestern.edu|
22284589|NCT03703856|UCSD|Neal R. Swerdlow, M.D., Ph.D.|619-471-9455|nswerdlow@health.ucsd.edu|
22284590|NCT01596335|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284591|NCT03402386|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284592|NCT05095935|Medtronic|Jennifer Bell|303-241-2107|jennifer.bell@medtronic.com|
22284593|NCT01585155|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284594|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu|
22284595|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944|LMagee@sgul.ac.uk|52621
22284596|NCT02421588|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
22284597|NCT04103593|Salem VAMC|Dr. Krisann Oursler|5409822463|krisann.oursler@va.gov|4981
22284598|NCT04254913|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284599|NCT01004952|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay, PhD|646-888-0039|hayj@MSKCC.ORG|
22284600|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300||
22284601|NCT01529034|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
22284602|NCT01166412|Premier Research|Clint Dart|948-238-1243|clint.dart@premier-research.com|
22284603|NCT02911142|National Cancer Institute|Dr. Ramya Ramaswami|240-506-1088|ramya.ramaswami@nih.gov|
22284604|NCT03436693|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284605|NCT04481789|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284606|NCT05216224|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22284607|NCT03245008|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284608|NCT01976572|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284609|NCT06649019|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
22284610|NCT04655144|Florida Interventional Institute|Prasoon Mohan, MD|305-204-7276|contact@flinterventionalinstitute.com|
22284611|NCT04317742|St. Jude Children's Research Hospital|Tara Brinkman, PhD|901-595-5683|Tara.Brinkman@STJUDE.ORG|
22302805|NCT01993017|Center for Behavioral Cardiovascular Health|Ian Kronish, MD, MPH, Principal Investigator|212-342-1335|ik2293@columbia.edu|
22302806|NCT00003511|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22302807|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22302808|NCT03638635|Inova Health System|Erica Emery|703-776-7615|erica.emery@inova.org|
22302809|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22302810|NCT03355755|Ekso Bionics|Leslie Van Hiel|4042268017|leslie.vanhiel@gmail.com|
22302811|NCT02406885|The Johns Hopkins University School of Medicine|Dr. Brent Petty|410-955-8181|bpg@jhmi.edu|
22302812|NCT01200030|The Hong Kong Polytechnic University|Dr. Shamay Ng|(852) 2766-4889|Shamay.Ng@polyu.edu.hk|
22302813|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu|
22302814|NCT03327402|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22284612|NCT01580670|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22302815|NCT00872430|Hospital de Clínicas de Porto Alegre|Dr. Paulo Dornelles Picon|55 xx 51 21018752|paulopicon@gmail.com|
22302816|NCT02444663|University of Oxford|Thomas Hamilton, Clinical Research Fellow|01865227696|thomas.hamilton@ndorms.ox.ac.uk|
22302817|NCT03921190|University of Jordan|Dr. Ahmad El-Ma'aita|+9625355000|a.maaita@ju.edu.jo|
22302818|NCT01540565|NRG Oncology|Christopher Purdy on behalf of Mike Sill|(716)845-1300|purdyc@nrgoncology.org|2296
22302819|NCT03469349|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302820|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302821|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351||
22302822|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com|
22302823|NCT04145037|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
22302824|NCT01756560|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
22302825|NCT02307513|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22284613|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
22284614|NCT03266172|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284615|NCT01554514|Washington University|Dr. Elaine Majerus|314-362-8866|emajerus@wustl.edu|
22284616|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22284617|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000|hillel.grossman2@va.gov|5752
22284618|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu|
22284619|NCT02879578|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22302826|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org|
22302827|NCT01458990|Hunter Holmes McGuire VA Medical Center|Jasmohan Bajaj|804 675 5802|jasmohan.bajaj@va.gov|
22302828|NCT02235701|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22302829|NCT05288023|University of California San Francisco|Kieran O'Brien|(415) 476-1442|kieran.obrien@ucsf.edu|
22302830|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22273214|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net|
22273215|NCT02726789|Replicor Inc.|Chief Scientific Officer|514 733 1998|availlant@replicor.com|
22273216|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu|
22273217|NCT03365934|JNJWorldwide|Amisha Parikh-Das|973-255-8701|aparikh1@its.jnj.com|
22273218|NCT02937740|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
22273219|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636|pbaron@llu.edu|36792
22273220|NCT02964338|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22273221|NCT01867515|VA Portland HCS, RR&D National Center for Auditory Rehabilitative Research|Michelle R. Molis, PhD|503-220-8262|michelle.molis@va.gov|55574
22273222|NCT04611542|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Dr. Jeremy Jones|541-484-2123|jeremy.jones@influentsin.com|
22273223|NCT02291029|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22273224|NCT02171429|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273225|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
22273226|NCT01965002|Stanford Univeristy Medical Center|Pejman Ghanouni, MD, PhD|650-498-4485|ghanouni@stanford.edu|
22273227|NCT04147247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273228|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22284620|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu|
22284621|NCT01879072|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22284622|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
22273229|NCT03397121|The Medicines Company|Vice President - Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
22273230|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com|
22273231|NCT04085601|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22273232|NCT03492437|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22273233|NCT01914393|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22273234|NCT00572455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273235|NCT02609386|Eterna Therapeutics|VP of Quality|212-582-1199|info@eternatx.com|
22273236|NCT03280056|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
22273237|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273238|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com|
22273239|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22273240|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
22302831|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302832|NCT02224482|Fox Chase Cancer Center|Dr. Suzanne Miller|215-728-4069|Suzanne.Miller@fccc.edu|
22302833|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302834|NCT01913639|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22273241|NCT02907463|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
22273242|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu|
22273243|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com|
22273244|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22273245|NCT01447407|NovaDigm Therapeutics, Inc.|John P. Hennessey, Jr.|12676405189|john_hennessey@novadigm.net|
22273246|NCT02762071|Johns Hopkins University|Uma Srikumaran|443-546-1550|us@jhmi.edu|
22273247|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22273248|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu|
22273249|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com|
22273250|NCT01001910|Montefiore Medical Center|Clinical Supervisor|718-405-8395|bkhaksari@montefiore.org|
22273251|NCT01468454|Children's Hospital of Philadelphia - Department of Radiology|Lisa J. States, MD|267-245-7146|states@chop.edu|
22273252|NCT02896569|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22273253|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov|
22273254|NCT03060291|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
22273255|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu|
22273256|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu|
22273257|NCT02237989|Eskisehir Osmangazi University|Dr. Fulya Bakılan|+905057737335|fulyabakilan@gmail.com|
22302835|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com|
22284623|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org|
22284624|NCT02933502|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22284625|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22284626|NCT02666105|University of Minnesota|Manish Patel, DO|612-625-2654|patel069@umn.edu|
22284627|NCT00411632|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
22284628|NCT01264419|Silk Road Medical, Inc.|Richard Ruedy, Exec VP Clinical Affairs|408-828-7281|ric@silkroadmed.com|
22284629|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|3819
22284630|NCT05777798|SIFI SpA|Clinical Development|00390957922111|giulia.faraci@sifigroup.com|
22284631|NCT05138419|University of Arkansas for Medical Sciences|Andrea Easom, APRN|5018379556|easomandreak@uams.edu|
22284632|NCT01048853|The University of Texas MD Anderson Cancer Center|Kathleen Schmeler, MD|(713) 854-9150|kschmele@mdanderson.org|
22284633|NCT05342597|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22302836|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu|
22273258|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr|
22273259|NCT02306850|Saint Louis University|John Richart, MD|314-577-8854|john.richart@health.slu.edu|
22273260|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22273261|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22273262|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22273263|NCT03293394|Spedali Civili di Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
22273264|NCT04156906|The Children's Hospital of Philadelphia|Stella Chou, MD|215-590-0947|chous@chop.edu|
22273265|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
22273266|NCT02984644|University of Texas Health Science Center at San Antonio|Dr. Eugenio Cersosimo|210-358-7200|cersosimo@uthscsa.edu|
22273267|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821|genentech@druginfo.com|8590
22273268|NCT03620383|Oregon Health & Science University|Ramsey Al-Hakim, MD|503-494-7660|alhakim@ohsu.edu|
22273269|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
22273270|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org|
22273271|NCT02273362|Mayo Clinic|Kenneth K. Tanabe, M.D.|507-284-2511|ktanabe@partners.org|
22273272|NCT03283930|National Institute of Mental Health (NIMH)|Dr. Daniel Pine|+1 301 594 1318|daniel.pine@nih.gov|
22273273|NCT00805129|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
22273274|NCT00571662|University of Nebraska Medical Center|R Gregory Bociek|402-559-5388|rgbociek@unmc.edu|
22273275|NCT03167255|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
22273276|NCT03681184|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22273277|NCT03338244|UC San Francisco - Proctor Foundation|Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
22273278|NCT04229771|William Beaumont Hospital|Dr. Dianne Schlachter, Staff Physician|248-551-2020|dianne.schlachter@beaumont.org|
22273279|NCT02787083|Philadelphia Urosurgical Associates, PC|Kristene E Whitmore MD|215-704-1457|bladder1@aol.com|
22273280|NCT02710084|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|212-659-9134|alexander.kolevzon@mssm.edu|
22273281|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com|
22273282|NCT04672044|Birmingham VA Medical Center|Research Integrity Officer|2059338101|latanya.higginbottom@va.gov|337436
22273283|NCT02453256|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22273284|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com|
22273285|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22273286|NCT05259163|Evolution Optiks|Raul Mihali|2039815480|raul.mihali@evolutionoptiks.com|
22273287|NCT05251233|Washington University School of Medicine|Natasha Leigh-Matijakovich, M.D.|314-362-7147|leigh@wustl.edu|
22273288|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu|
22273289|NCT03031340|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
22273290|NCT06785090|College of Medicine, University of Baghdad|Enas Sabeeh|09647704294077|inas.abd2206m@comed.uobaghdad.edu.iq|
22273291|NCT02675764|Medical University of South Carolina|Dr. Na Jin Seo|8437920084|seon@musc.edu|
22273292|NCT04780815|ImperialBrands PLC|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.com|
22273293|NCT02245815|Instituto Mexicano del Seguro Social|Dra. Guadalupe Gómez Rodríguez|477 75 23 166|lupitaneonato@gmail.com|
22273294|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu|
22273295|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au|
22273296|NCT03440619|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22273297|NCT03272347|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284634|NCT01532570|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284635|NCT00805766|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284636|NCT02354222|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284637|NCT04300218|IMSechenovMMA|Polina Pchelina|+79036701725|polbox@mail.ru|
22284638|NCT05451940|University of Pittsburgh|Julia Z. Xu, MD|412-648-6466|xujz2@upmc.edu|
22284639|NCT03645863|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22284640|NCT02220907|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284641|NCT00542815|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284642|NCT06726343|GE HealthCare|Product Manager|+44 (7384) 249324|212612107@gehealthcare.com|
22284643|NCT04176224|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22273298|NCT01971567|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
22284644|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu|
22284645|NCT01274520|Columbia University College of Physicians and Surgeons - Center for Liver Disease and Transplantation|James V. Guarrera, MD, FACS|(212)305.3839|jjg46@cumc.columbia.edu|
22284646|NCT01966445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284647|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284648|NCT01716104|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Director of Clinical Research and Medical Information|+74952761571|PutilovskiyMA@materiamedica.ru|302
22284649|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
22284650|NCT02981966|UTexas_SanAntonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
22284651|NCT01818492|Sobi AB|Carl Johan Treutiger|46 76 00 11 815|CarlJohan.Treutiger@sobi.com|
22284652|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it|
22284653|NCT02772978|University of California at San Francisco|Andrew Kayser, MD PhD|415-502-7332|Andrew.Kayser@ucsf.edu|
22284654|NCT02438813|Allergan, Inc|Medical Director/ Epidemiologist|714-246-4500|clinicaltrials@allergan.com|
22284655|NCT04684992|Cairn Diagnostics|Chief Scientist and Compliance Officer|615-376-5464|cwilliams@cairndx.com|
22302837|NCT04078035|University of Pittsburgh|Dr. Anna Marsland|14123705622|marsland@pitt.edu|
22302838|NCT03758118|IRCCS Fondazione Bietti|Dr, Vincenzo Parisi|+390686356727|vmparisi@gmail.com|
22302839|NCT04296890|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22302840|NCT02100722|Stanford University|William Fearon, MD|650-725-2621|wfearon@stanford.edu|
22302841|NCT01782963|Massachusetts General Hospital|Noopur Raje, MD|617-724-4000|NRAJE@mgh.harvard.edu|
22302842|NCT04986982|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
22302843|NCT03500640|University of Pittsburgh School of Medicine|Elizabeth M. Venditti PhD, Associate Professor of Psychiatry and Epidemiology|4123025228|vendittiem@upmc.edu|
22302844|NCT02613221|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302845|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161|amendizabal@emmes.com|221
22302846|NCT01119898|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22302847|NCT01807650|Amryt Pharma|Head of Clinical Development|+353 1 518 0200|medinfo@amrytpharma.com|
22302848|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu|
22302849|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu|
22302850|NCT02907814|Rutgers New Jersey Medical School|Dr. Elliot Crane|973-972-2020|cranees@njms.rutgers.edu|
22302851|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22302852|NCT03573908|Ironwood Pharmaceuticals, Inc.|Vanessa Chong|(617) 374-3923|vchong@ironwoodpharma.com|
22302853|NCT04006925|Stanford University|Emmanuel During|212-844-8888|Emmanuel.During@mountsinai.org|
22302854|NCT01396317|Hospital for Special Surgery|Dr. Robert Spiera|212-774-2048|spierar@hss.edu|
22302855|NCT02906683|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
22302856|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com|
22302857|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov|
22302858|NCT04602494|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|aeevins@mgh.harvard.edu|
22302859|NCT02531295|University of California, San Francisco|Sulggi Lee, MD PhD|415-735-5127|sulggi.lee@ucsf.edu|
22302860|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22302861|NCT01806740|Guerbet|Corinne Dubourdieu, Head of Clinical Projects|+33145915000|corinne.dubourdieu@guerbet.com|
22302862|NCT04666922|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302863|NCT04651114|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
22302864|NCT03661996|Centrexion Therapeutics Corporation|Clinical Operations|617-837-6911|info@centrexion.com|
22302865|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302866|NCT03472287|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman/Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
22302867|NCT03980184|Yale University|Rajita Sinha, PhD, Study PI|203-737-5805|rajita.sinha@yale.edu|
22302868|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22302869|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu|
22302870|NCT02265224|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
22302871|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302872|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu|
22302873|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
22302874|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
22302875|NCT00467142|Institut Bergonié|Pr Yves Becouran||y.becouarn@bordeaux.unicancer.fr|
22302876|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300||
22302877|NCT03771157|University of Rochester|Michael Brady|585-276-3203|michael_brady@urmc.rochester.edu|
22302878|NCT02086162|Dartmouth-Hitchcock|Dr. Mary F. Brunette|603-229-5419|mary.f.brunette@hitchcock.org|
22302879|NCT03447730|Synlogic|Andrew Marsh, Head Clinical Operations|617-401-9975|andrew.marsh@synlogictx.com|9135
22302880|NCT03349268|University of Michigan|Keith Kaye|732 235-9312|kk1116@rwjms.rutgers.edu|
22302881|NCT01248962|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
22302882|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk|
22302883|NCT04848662|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22302884|NCT01350505|VA Palo Alto Health Care System|Dr. Jamie Zeitzer|650-493-5000|jamie.zeitzer@va.gov|62410
22302885|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302886|NCT04702568|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22302887|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org|
22302888|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org|
22273299|NCT04826484|Johns Hopkins University School of Medicine|Andrew T. Gabrielson, MD|410-955-5000|atg@jhmi.edu|
22273300|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org|
22302889|NCT04205929|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
22273301|NCT02239640|Medtronic|Oscar Bolanos|949-527-0822|Oscar.bolanos@medtronic.com|
22319663|NCT04667247|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
22273302|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu|
22273303|NCT05076604|Washington University School of Medicine|Matthew Schill|3147470707|schillm@wustl.edu|
22273304|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org|
22273305|NCT04846270|Essity Hygiene and Health AB|Fredrik Agholme|+4670323634|fredrik.agholme@essity.com|
22273306|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp|
22273307|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu|
22273308|NCT02915159|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22273309|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn|
22302890|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22302891|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu|
22302892|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22302893|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22302894|NCT05644353|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22302895|NCT01535274|University of Michigan|Dr. Paul Picton|734-936-4280|ppicton@umich.edu|
22302896|NCT01737281|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
22302897|NCT02954458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22302898|NCT05777174|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
22302899|NCT02690077|Advocate Aurora Health|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aah.org|
22302900|NCT01845974|Advocate Medical Group Cardiology|Scott M. Miller MD|847-698-5500|scott.miller@advocatehealth.com|
22302901|NCT02667886|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
22302902|NCT01905046|City of Hope|Victoria Seewaldt, M.D.|6262564674|vseewaldt@coh.org|67321
22302903|NCT05672680|Icahn School of Medicine at Mount Sinai|Celia Divino|(212) 241-3348|celia.divino@mountsinai.org|
22302904|NCT03929562|University of Michigan|Anne C. Fernandez|734-232-0521|acfernan@med.umich.edu|
22302905|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22302906|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net|
22302907|NCT02778399|Clinical Operations|Medical Responsible|+41 (0)22 552 1560|clinicaltrials@obseva.ch|
22273310|NCT04534517|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22302908|NCT03501043|MossRehab|Stella Lee|215-663-6665|leest@einstein.edu|6665
22302909|NCT02978443|Georgetown University|Suthee Rapisuwon|202-877-6583|Suthee.Rapisuwon@medstar.net|
22302910|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
22302911|NCT02081456|Cayuga Medical Center|Dr. Michael Costello, PT, DSc, OCS, MTC|607-252-3500|mcostellopt@gmail.com|
22302912|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de|
22302913|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com|
22302914|NCT02101918|UT MD Anderson Cancer Center|Dr. Daniel M. Halperin/ GI Medical Oncology|713-792-2828|DMHalperin@mdanderson.org|
22302915|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu|
22302916|NCT04557826|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
22302917|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn|
22302918|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22302919|NCT03482505|Masimo|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
22302920|NCT01852058|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22302921|NCT01279343|Washington University School of Medicine|Jeanine Carbone MD|314-362-8523|jfcarbone@hotmail.com|
22302922|NCT03287414|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22302923|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu|
22302924|NCT05093049|Apyx Medical|Senior Director of Clinical Affairs|801-244-0058|kari.larson@apyxmedical.com|
22302925|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
22302926|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov|
22302927|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com|
22302928|NCT02395133|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22302929|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22302930|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org|
22302931|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
22302932|NCT03621202|Saranas, Inc.|Zaffer Syed|833-375-9273|zaffer@saranas.com|
22302933|NCT00738101|Baylor College of Medicine|Dr. Muralidhar H Premkumar|8328267980|premkuma@bcm.edu|
22302934|NCT04934137|University of Texas Medical Branch|Dr. Melissa Morrow|409-266-0344|memorrow@utmb.edu|
22302935|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu|
22302936|NCT02781506|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
22302937|NCT02593539|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273311|NCT03872843|Wake Forest|Dr. Jorge Gutierrez|336-716-2011|jgutierrez@wakehealth.edu|
22302938|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302939|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu|
22302940|NCT02248961|R-Pharm|Boris Berezhanskiy, Medical Advisor|0074959567937|berezhanskiy@rpharm.ru|2468
22302941|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu|
22302942|NCT01060020|Washington University School of Medicine|Brian R. Lindman, MD, Assistant Professor of Medicine|314-747-3617|brlindman@wustl.edu|
22302943|NCT02835443|Enspire DBS Therapy, Inc.|Director of Clinical Trials|123-456-7890|info@enspiredbs.com|
22302944|NCT04551196|Washington University School of Medicine|David Leonard, MD, Principal Investigator|314-454-2136|dsleonard@wustl.edu|
22302945|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082|plum@php.ucsf.edu|411
22302946|NCT01517243|Dartmouth College|Lionel Lewis|1-603-650-8685|lionel.d.lewis@dartmouth.edu|
22302947|NCT03462706|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
22302948|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com|
22302949|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu|
22302950|NCT04105972|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22302951|NCT01966796|Far Eastern Memorial hospital|Dr. Ping-huai Wang|886-2-89667000|pinghuaiwang@gmail.com|2816
22302952|NCT03545113|Wake Forest University Health Sciences|Mariana Murea, MD|336-716-5777|mmurea@wakehealth.edu|
22302953|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22302954|NCT02010697|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
22302955|NCT03321513|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
22302956|NCT03029247|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22302957|NCT02757521|Washington University|Ben J Palanca, MD PhD MSC|314-286-0132|palancab@wustl.edu|
22302958|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
22302959|NCT02342314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22302960|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu|
22302961|NCT02912468|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
22302962|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22302963|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300||
22302964|NCT02541383|Intergroupe Francophone du Myélome|Chief Executive Officier|+33 1 40 21 24 02|ifmclinicaltrials@myelome.fr|
22302965|NCT05796518|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0031|mnjenkin@wakehealth.edu|
22302966|NCT00594217|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342436911|cm2hq@virginia.edu|
22302967|NCT02117934|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22302968|NCT05778526|The Hong Kong Polytechnic University.|Dr. Ka Po Wong|64860214|portia.wong@polyu.edu.hk|
22302969|NCT01985828|Advocate Health|Geraldine Lara|8477238239|geraldine.lara@aah.org|
22302970|NCT03108157|ProcreaTec|Dr. Alexandra Izquierdo, Medical and Scientific Director at ProcreaTec|0034651879266|endoscratchtrial@gmail.com|
22302971|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22302972|NCT03557086|Massachusetts General Hospital|Dr. Nneka Ufere|617-643-3408|nneka.ufere@mgh.harvard.edu|
22302973|NCT02839343|Mayo Clinic|Frank Sinicrope|5072664338|Sinicrope.Frank@mayo.edu|
22302974|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500|TKarkkai@its.jnj.com|3402
22302975|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com|
22302976|NCT04395183|University of Utah|Brent Kious, MD, PhD|801-585-1418|brent.kious@hsc.utah.edu|
22302977|NCT02668016|Imperial College London|Professor Darrel Francis|0207 594 9647|d.francis@imperial.ac.uk|
22302978|NCT04472377|Hygeia Touch Inc.|Lance Yang|+886-3-6675616|cyyang@hygeiatouch.com|
22302979|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov|
22302980|NCT04999644|Johns Hopkins University School of Medicine|Justin Strickland|4105501975|jstric14@jhmi.edu|
22302981|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca|
22302982|NCT02234063|Icahn School of Medicine at Mount Sinai|Dr. Carol R. Horowitz|212-659-9564|carol.horowitz@mssm.edu|
22302983|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com|
22302984|NCT00510458|Stryker Orthopaedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
22302985|NCT02569710|Alios BioPharma, Inc|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22302986|NCT02946918|UT Southwestern Medical Center|Dr. Alex Tessnow-ASSOC PROFESSOR|214/648-3685|Alex.Tessnow@UTSouthwestern.edu|
22302987|NCT02654990|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22302988|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu|
22302989|NCT03203694|University of Missouri|Jaume Padilla|(573) 882-7056|padillaja@missouri.edu|
22302990|NCT04686279|Johns Hopkins University|Dr. Craig Hendrix|410-955-9707|chendrix@jhmi.edu|
22302991|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22302992|NCT04255342|University of Iowa|Chris Barwacz|(319) 384-3002|chris-barwacz@uiowa.edu|
22319664|NCT05460273|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22302993|NCT01620567|Tufts University|Elizabeth J. Johnson, PhD|617.556.3204|elizabeth.johnson@tufts.edu|
22302994|NCT03535337|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
22302995|NCT05879198|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
22302996|NCT01598298|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22302997|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com|
22302998|NCT05197257|University of Colorado|Dr. Bennett Chin|720-848-0000|Bennett.Chin@cuanschutz.edu|
22302999|NCT02802319|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22303000|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu|
22303001|NCT01097395|University of Colorado|Jennifer Kiser|3037246131|jennifer.kiser@cuanschutz.edu|
22303002|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22303003|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu|
22303004|NCT02593305|University of Iowa|Dr. Darren P. Casey|3193841009|darren-casey@uiowa.edu|
22303005|NCT00798174|Washington University in St. Louis|Dr. Timothy W. Smith|314-286-1501|tsmith@wustl.edu|
22303006|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk|
22303007|NCT01683994|National Cancer Institute|Dr. William Dahut|240-760-6070|william_dahut@nih.gov|
22303008|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22303009|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch|
22303010|NCT02250521|The University of Texas Health Science Center at Houston|Carin A. Hagberg, MD|713-500-6200|Carin.A.Hagberg@uth.tmc.edu|
22303011|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303012|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org|
22303013|NCT02318719|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22303014|NCT00854295|Zimmer Biomet|Erin Osborn|574-371-9884|erin.osborn@zimmerbiomet.com|
22303015|NCT02440594|University of Pennsylvania|Shahrzad Mavandadi|215-823-5211|shahrzad.mavandadi@va.gov|
22303016|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115|jirvine@yorku.ca|22444
22303017|NCT04668989|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|jvega2@coopervision.com|
22303018|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be|
22303019|NCT02951351|Mayo Clinic|Margaret M. Reynolds, MD|507-284-2733|margaretmmreynolds@gmail.com|
22303020|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22303021|NCT03765762|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22303022|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303023|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu|
22303024|NCT04537897|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303025|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22303026|NCT01532817|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22303027|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303028|NCT03893825|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22303029|NCT02979626|University of Colorado Denver|Dr. Suchitra Rao|7207771234|suchitra.rao@childrenscolorado.org|
22303030|NCT01336959|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com|
22303031|NCT04488003|Biomed Valley Discoveries|Caroline Emery, PhD|816-960-4615|cemery@biomed-valley.com|
22303032|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
22303033|NCT01468922|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
22303034|NCT02551744|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22303035|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov|
22303036|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org|
22303037|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
22303038|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com|
22303039|NCT03000673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22303040|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
22303041|NCT02300285|Boston Children's Hospital|Michael SD Agus, MD|617 355-5849|michael.agus@childrens.harvard..edu|
22303042|NCT04186403|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22303043|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
22303044|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu|
22303045|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303046|NCT00578721|UC Irvine Health - Chao Family Comprehensive Cancer Center|Jason Zell, DO, MPH, MS|714-456-5153|jzell@hs.uci.edu|
22303047|NCT02205801|The University of Chicago Medicine & Biological Sciences|Dr. Raymond H. Grogan|773-702-7125|rgrogan@surgery.bsd.uchicago.edu|
22303048|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22303049|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu|
22303050|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com|
22303051|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22303052|NCT00697190|Vistakon|John Buch OD|904-443-1707||
22303053|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293|iheinzelmann@schoen-kliniken.de|1540
22303054|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22303055|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303056|NCT02281526|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22303057|NCT03443713|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
22303058|NCT01672853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22303059|NCT02969525|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22303060|NCT03445065|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303061|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu|
22303062|NCT03315130|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22303063|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303064|NCT02944656|Emory University|Tiffany Hailstorks, MD, MPH|404-778-1385|tiffany.p.hailstorks@emory.edu|
22303065|NCT04398537|University of Alabama at Birmingham|Stefanie Woodard|205-996-4132|swoodard@uabmc.edu|
22303066|NCT00118898|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22303067|NCT05473000|The University of British Columbia|Dr. Michael Koehle|604-822-3838|michael.koehle@ubc.ca|
22303068|NCT02714205|University of California, San Francisco|Mike Schembri, Data Systems Analyst|415-353-7161|michael.schembri@ucsf.edu|
22303069|NCT02073097|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Brian T. Hill|1-866-223 8100|TaussigResearch@ccf.org|
22303070|NCT00186498|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22303071|NCT03813147|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22303072|NCT01693692|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22303073|NCT02805595|Beth Israel Deaconess Medical Center|Martina Porter - Associate Directory of Dermatology Research|6176675834|mporter3@bidmc.harvard.edu|
22303074|NCT04424290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303075|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu|
22303076|NCT01449240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22303077|NCT02914184|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303078|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu|
22303079|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp|
22303080|NCT03093428|Dana Farber Cancer Institute|Atish Choudhury|617-632-6328|achoudhury@partners.org|
22303081|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu|
22303082|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu|
22303083|NCT01336634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22303084|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22303085|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22303086|NCT01863043|University of Florida|Dr. Leslie Parker|352 215 9360|parkela@ufl.edu|
22303087|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22303088|NCT01987596|Barbara Ann Karmanos Cancer Institute|Dr. Maxim Yankelevich|313-745-5515|myankele@med.wayne.edu|
22303089|NCT01971580|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
22303090|NCT02632786|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
22303091|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu|
22284656|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org|
22284657|NCT01919216|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
22284658|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22284659|NCT05387564|Nemours Children's Health|Corinna Schultz|302-651-5500|corinna.schultz@nemours.org|
22284660|NCT01069705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22284661|NCT03624127|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22284662|NCT01776723|H Lee Moffitt Cancer Center & Research Institute|Eric Padron, MD|813-745-3907|Eric.Padron@Moffitt.org|
22303092|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org|
22303093|NCT00451217|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303094|NCT02674490|Johns Hopkins University School of Medicine|Dr. Argye Hillis, MD|4109552228|argye@jhmi.edu|
22303095|NCT03154359|Children's Mercy Hospital|James Steven Leeder, PharmD, PhD|816-731-7116|sleeder@cmh.edu|
22303096|NCT03664739|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22303097|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22303098|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com|
22303099|NCT02006420|University of Michigan|Dinesh Khanna|734-763-7182|khannad@umich.edu|
22303100|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca|
22303101|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581|mark-vanderweg@uiowa.edu|7717
22303102|NCT00422799|Dana-Farber Cancer Institute|Irene M. Ghobrial|(617) 632-4218|Irene_Ghobrial@DFCI.HARVARD.EDU|
22303103|NCT00453479|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303104|NCT03029780|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22303105|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu|
22303106|NCT03066622|Regions Hospital|Meghan O'Brien|651-254-5303|meghan.e.obrien@healthpartners.com|
22303107|NCT01763788|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303108|NCT03321006|NYP Institute|Dr. Katharine Brewster|646 774 6380|Katharine.Brewster@nyspi.columbia.edu|
22303109|NCT00749125|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
22303110|NCT02006121|Britannia Pharmaceuticals|Medical Director|+44 1189209500|reception@britannia-pharm.com|
22303111|NCT02354859|University of Washington|Christopher H. Goss, Professor of Medicine and Pediatrics|206-543-3166|goss@uw.edu|
22303112|NCT02357043|Remington-Davis Inc.|Dr. Ian Baird|6144872560|hbaird@remdavis.com|
22303113|NCT04498247|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303114|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303115|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22303116|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303117|NCT02765490|Janssen Research & Development, LLC|Trial Physician, Medical Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22303118|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303119|NCT03237013|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
22303120|NCT05266963|Vanderbilt University Medical Center|Dan Moore, M.D., Ph.D.|615-322-7247|daniel.moore@vumc.org|
22303121|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303122|NCT04091360|Verona Pharma|Medical Science Director|6464130307|margot.macdonald-berko@veronapharma.com|
22303123|NCT02597933|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303124|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303125|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it|
22303126|NCT03501693|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22303127|NCT03961009|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
22303128|NCT01336621|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303129|NCT02487095|National Cancer Institute|Dr. Anish Thomas|240-760-7343|thomasa6@nih.gov|
22303130|NCT04534114|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22303131|NCT02759185|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
22303132|NCT04765735|Medtronic|Janelle Blum|262-289-8419|janelle.blum@medtronic.com|
22303133|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org|
22303134|NCT00513786|The Ohio State University Comprehensive Cancer Center|Dr. David O'Malley|614-293-3873|David.O'Malley@osumc.edu|
22303135|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu|
22303136|NCT02875834|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22303137|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303138|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu|
22303139|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585|Steven.Thorp@va.gov|2468
22303140|NCT03221660|Ivoclar Vivadent AG|Dr. med. dent. Lukas Enggist, Dentist internal clinic (Principal Investigator)|+423 235 34 46|lukas.enggist@ivoclarvivadent.com|
22303141|NCT03104647|Shaare Zedek Medical Center|Dr. Yair Barzilay, PI|+972-2-6555166|barzilay@szmc.org.il|
22303142|NCT04235582|Aurora Health Care|Mindy Waite, Behavioral Health Research Scientist|414-773-4323|mindy.waite@aah.org|
22303143|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu|
22303144|NCT02936037|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33180401440|frederic.sedel@medday-pharma.com|
22284663|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
22303145|NCT01267825|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
22303146|NCT04249336|Dow University of Health Sciences|Syed Jaffar Abbas Zaidi|00923412481371|jaffar.zaidi@duhs.edu.pk|
22303147|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in|
22303148|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303149|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22284664|NCT01705106|University of Chicago|Manish R. Sharma, MD|773-834-0312|msharma@bsd.uchicago.edu|
22303150|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22303151|NCT01976364|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303152|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303153|NCT03223272|UAB|Physician|4346545260|dacalhou@sentara.com|
22303154|NCT04250337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303155|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de|
22303156|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303157|NCT03303469|The University of Alabama at Birmingham|Janis O'Malley|205-934-6504|jomalley@uabmc.edu|
22303158|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303159|NCT03560258|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22303160|NCT01460160|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22303161|NCT03101241|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
22303162|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22303163|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22303164|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303165|NCT03283696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303166|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742|suman-rathbun@ouhsc.edu|44773
22303167|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu|
22303168|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn|
22303169|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22303170|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303171|NCT02357810|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
22303172|NCT00562978|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|ANademanee@coh.org|82405
22303173|NCT00258180|Johns Hopkins School of Medicine|Maria Oliva-Hemker MD|410-955-8769|moliva@jhmi.edu|
22303174|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org|
22303175|NCT06173570|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22303176|NCT03820323|University of Washington|Rena C. Patel|206-520-3800|rcpatel@uw.edu|
22303177|NCT03151395|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303178|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org|
22303179|NCT02153359|Johns Hopkins University|Dr. Sonali Bose|410-550-2708|kladson1@jhmi.edu|
22303180|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
22303181|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu|
22273312|NCT02121795|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|ClinicalTrialDisclosures@gilead.com|
22273313|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu|
22303182|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu|
22303183|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org|
22303184|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com|
22303185|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100|choongk@mcmaster.ca|75617
22303186|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22303187|NCT04599101|William Beaumont Hospitals|Christine Batchelder, Research Nurse Manager|2488981075|christine.batchelder@corewellhealth.org|
22303188|NCT05952297|University of Utah|Dr. Kelly Baron|8015857588|kelly.baron@utah.edu|
22303189|NCT03856996|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22303190|NCT03959592|Duke University|Alessandro Jammal, M.D., Ph.D.|919-684-0202|alessandro.jammal@duke.edu|
22303191|NCT04362137|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22303192|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
22303193|NCT02934620|Ohio State University, College of Public Health|Maria Gallo|16146882145|gallo.86@osu.edu|
22303194|NCT03556358|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
22303195|NCT01298921|Geisinger Health System|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
22303196|NCT05067933|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
22303197|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303198|NCT02716038|Columbia University Irving Medical Center|Catherine A. Shu, MD|212-305-3997|cas2145@cumc.columbia.edu|
22303199|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22303200|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu|
22303201|NCT02459093|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
22303202|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org|
22303203|NCT03519243|BIOCAD|Linkova Iuliia|+7 (495) 992 66 28|linkova@biocad.ru|930
22303204|NCT03331185|University of Manitoba|Dr. Jonathan Bouwer|204 898 1132|jfbouwer@gmail.com|
22303205|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303206|NCT04921969|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22303207|NCT04287868|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
22303208|NCT02791490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303209|NCT02960763|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22303210|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303211|NCT05340751|Hospital for Special Surgery|Dr. Friedrich Boettner|2127742127|BoettnerF@hss.edu|
22303212|NCT04502056|JPAL North America|Tristan Loisel|6307476739|tloisel@povertyactionlab.org|
22303213|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
22303214|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22303215|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org|
22303216|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
22303217|NCT02961881|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22303218|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com|
22303219|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729||
22303220|NCT01928225|University of Colorado|Cynthia Frinhaber|720-848-0000|cynthia.firnhaber@cuanschutz.edu|
22303221|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu|
22303222|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565|charlene.weir@utah.edu|5114
22303223|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303224|NCT01381874|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22303225|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22303226|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu|
22303227|NCT03119610|UT Health San Antonio|Sara Espinoza, MD|210-617-5197|espinozas2@uthscsa.edu|
22303228|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov|
22303229|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22303230|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22303231|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
22303232|NCT02991144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22303233|NCT03662997|Molnlycke Health Care|David Pham|678-231-9655|david.pham@molnlycke.com|
22303234|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu|
22303235|NCT02378402|Department of Radiology, Chang Gung Memorial Hospital|Gigin Lin, MD, PhD|886-3-3281200|giginlin@cgmh.org.tw|2575
22303236|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu|
22303237|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22303238|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu|
22303239|NCT01844115|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22303240|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303241|NCT00210119|Institut Bergonie|Dr Gabriel Etienne||g.etienne@bordeaux.unicancer.fr|
22303242|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
22303243|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu|
22303244|NCT03125941|rigshospitalet|kristin steinthorsdottir, md|31666112|kjs@dadlnet.dk|
22303245|NCT00350701|University at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
22303246|NCT02459080|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22303247|NCT00406419|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
22303248|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303249|NCT04394845|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
22303250|NCT01821898|Baylor College of Medicine/Texas Children's Hospital|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
22303251|NCT04112940|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|4165973422|tri-swallowinglab@uhn.ca|7802
22303252|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303253|NCT05415124|NYU Langone Health|Melissa Debordeaux, MD|(212) 263-7300|Melissa.Debordeaux@nyulangone.org|
22303254|NCT06390826|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22303255|NCT03679767|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22303256|NCT03915951|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303257|NCT05408468|University Hospitals Cleveland Medical Center|Dr. Grant Pignatiello|216-368-4480|gap54@case.edu|
22303258|NCT02130453|The University of Texas MD Anderson Cancer Center|Nicolas Palaskas, MD|(713) 745-1942|nlpalaskas@mdanderson.org|
22273314|NCT00856999|Oregon Health & Sciences University|Roger Dailey, MD, FACS|503-494-3020|daileyr@ohsu.edu|
22273315|NCT02465437|Corbus Pharmaceuticals, Inc.|John Skutnik, MS|781-562-9853|jskutnik@corbuspharma.com|
22284665|NCT00006400|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
22284666|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il|
22284667|NCT03521141|Vanderbilt University Medical Center|Stephen King|615-875-9394|stephen.king@vumc.org|
22284668|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu|
22284669|NCT03828617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284670|NCT03354273|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
22284671|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22273316|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22273317|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com|
22273318|NCT01065571|University of Illinois at Chicago|Joanne Tobacman, MD|312-569-7826|jkt@uic.edu|
22273319|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22273320|NCT04391179|University of Michigan|Jason Knight, MD, PhD|734-763-3031|jsknight@med.umich.edu|
22273321|NCT03373760|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22273322|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org|
22273323|NCT02754518|University of Chicago|Sara Kalantari, MD|773-834-6853|skalantari@medicine.bsd.uchicago.edu|
22273324|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22273325|NCT02302846|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
22273326|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
22273327|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369||
22273328|NCT03200548|University of Michigan|Suzanna Zick|734-998-9553|szick@med.umich.edu|
22273329|NCT03929263|Oklahoma State University|Kara Kerr|9186971478|kara.kerr@okstate.edu|
22273330|NCT03407417|University of Florida|Dr. Benjamin Lok|352-214-9829|lok@ufl.edu|
22273331|NCT02134795|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
22273332|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
22273333|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273334|NCT05612217|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
22284672|NCT00971243|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22303259|NCT01960075|Medical University of South Carolina|Jordan Elm, PhD Biostatistician|843-876-1605|elmj@musc.edu|
22303260|NCT02204579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22303261|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22303262|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22303263|NCT02460263|Outset Medical, Inc|Clinical Operations|(669) 231-8200|clinical@outsetmedical.com|
22303264|NCT03916744|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22303265|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500|philip.jones@lhsc.on.ca|36306
22303266|NCT03176238|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22303267|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu|
22303268|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org|
22303269|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
22303270|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992|fidelixtania@gmail.com|11
22303271|NCT00515437|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
22303272|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22303273|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22303274|NCT03697980|Medtronic Cardiac Rhythm and Heart Failure|CRM/MCS Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
22303275|NCT02089230|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
22303276|NCT04591977|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|7175310003|jmoss1@pennstatehealth.psu.edu|323429
22303277|NCT00405353|UCLA|Dr. Rhonda Voskuhl|(310) 206-4636|rvoskuhl@mednet.ucla.edu|
22303278|NCT03469284|UT MD Anderson Cancer Center|Dr. Carlos Roldan, Associate Professor, Pain Medicine|(713) 563-7402|croldan@mdanderson.org|
22303279|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303280|NCT00358215|Amgen Inc.|Study Director|866-572-6436||
22303281|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22319665|NCT04124614|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22273335|NCT02258659|University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
22273336|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu|
22273337|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu|
22273338|NCT03193047|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22273339|NCT05171270|University of Oxford|Professor Laura Coates|07870257823|laura.coates@ndorms.ox.ac.uk|
22273340|NCT02855567|Icahn School of Medicine at Mount Sinai|Dr. Charles Ascher-Walsh|212-241-2827|Charles.ascher-walsh@mssm.edu|
22273341|NCT03743025|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
22273342|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273343|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711|irina.esterlis@yale.edu|3109
22273344|NCT05095311|Indiana University|Curtis Goss, Student Investigator|8178080085|csgoss13@gmail.com|
22273345|NCT02588664|Wake Forest University Health Sciences|Dr. Pamela W. Duncan|(336) 716-5068|pduncan@wakehealth.edu|
22273346|NCT02500719|University of Arkansas for Medical Sciences|Dr. Keith A. Bush|501.526.8347|kabush@uams.edu|
22273347|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273348|NCT00792116|Baylor|Craig Johnston|713-798-2068|caj@bcm.edu|
22273349|NCT04776928|University of Michigan|Jennifer Waljee|(734) 936-8925|filip@med.umich.edu|
22273350|NCT00103285|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22273351|NCT00452439|University of Texas (UT) MD Anderson Cancer Center|Maria Cabanillas, Associate Professor, Endocrine Neoplasia and HD|(713) 563-0764|mcabani@mdanderson.org|
22273352|NCT00395993|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22273353|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu|
22273354|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com|
22273355|NCT03974802|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22273356|NCT02624947|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22273357|NCT01550510|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
22273358|NCT03107182|University of Chicago|Ari Rosenberg|773-702-8222|arirosenberg@bsd.uchicago.edu|
22273359|NCT05787860|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
22273360|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
22273361|NCT03654729|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46732344698|kristina.sjoblom@egetis.com|
22273362|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22273363|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22273364|NCT01476267|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22273365|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273366|NCT03569098|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22273367|NCT03939923|West Virginia University|Director of Research in Department of Anesthesiology|304-598-4122|david.scalzo@hsc.wvu.edu|
22273368|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu|
22273369|NCT02581488|Smith and Nephew|SR. Clinical Study Manager, US Global Clinical Operations|+1 817-302-3959|Darrell.Lange@smith-nephew.com|
22273370|NCT04194489|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie.petrenko@rochester.edu|241
22273371|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273372|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590||
22273373|NCT00522548|University of Pennsylvania|Roy Bloom, MD|215-662-4643|roy.bloom@uphs.upenn.edu|
22273374|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk|
22273375|NCT04254081|University of California, San Diego|UCSD Family Planning Research|(858) 329-4464|familyplanningresearch@health.ucsd.edu|
22273376|NCT02820870|VA Center for Clinical Management Research|Jeremy Sussman, MD, MS - Principal Investigator|(734) 845-5200|jeremysu@med.umich.edu|
22284673|NCT00200343|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284674|NCT04099511|University of Missouri|Dr. Gregory Petroski|(573) 884-2119|petroskig@health.missouri.edu|
22284675|NCT03929224|Michigan Ear Institute|Seilish Babu, MD|(248) 865-4444|sbabu04@gmail.com|
22284676|NCT06581094|Taipei medical university|YiWen Chien, PhD|02-2736-1661|ychien@tmu.edu.tw|6556
22284677|NCT05740618|University of North Carolina at Chapel Hill|Subhashini Sellers, MD, MSCR|919-966-2531|sasellers@med.unc.edu|
22284678|NCT04588389|UMass Chan Medical School|Dr Alexander Chan for Eman Nada, MD|7743030338|alexander.chan@umassmemorial.org|
22284679|NCT04251819|UAB|Karen Cropsey|2059754204|kcropsey@uabmc.edu|
22284680|NCT02354235|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284681|NCT06045507|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22284682|NCT03321552|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
22284683|NCT03688100|Cedars-Sinai Medical Center|Dr. Waguih IsHak|310-423-3515|Waguih.IsHak@cshs.org|
22284684|NCT04783077|University of Minnesota|Susan Telke|6125902697|telke001@umn.edu|
22284685|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
22284686|NCT00084656|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22284687|NCT02128074|Keryx Biopharmaceuticals, Inc|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22273377|NCT05225558|LigaChem Biosciences, Inc.|Seonghye Cheon|+82)2-6952-0689|scheon@ligachembio.com|
22273378|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22273379|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22284688|NCT00439374|Northwestern University Medical School|William Grobman, MD|312-472-4661|w-grobman@northwestern.edu|
22284689|NCT04033068|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284690|NCT01817959|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22284691|NCT03235089|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
22284692|NCT01204216|Research Service, Cincinnati VA Medical Center|Robert M Cohen, MD, Physician,|5136748676|robert.cohen@uc.edu|
22284693|NCT03665688|UTMB Galveston|Antonio Saad Director of Clinical Research Division|409 772 0982|afsaad@utmb.edu|
22284694|NCT03238924|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
22284695|NCT03576716|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22284696|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com|
22284697|NCT02891382|Universidad Peruana Cayetano Heredia|Dr. J Jaime Miranda|+511 241 69 78|Jaime.Miranda@upch.pe|
22284698|NCT02516228|Philips|Sr. Clinical Operations Manager|3034753417|pat.olsen@philips.com|
22273380|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22273381|NCT02592447|H Lee Moffitt Cancer Center and Research Institute|Heather Jim, PhD|813-745-6369|Heather.Jim@moffitt.org|
22273382|NCT03428100|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
22273383|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273384|NCT03990051|Glia, LLC|Wei-wei Chang, PhD; President|(617) 794-8922|chang@gliacell.com|
22273385|NCT01720524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273386|NCT02493452|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
22284699|NCT03916484|University of North Carolina at Chapel Hill|Kate Muessig, PhD|850-644-3299|kmuessig@fsu.edu|
22284700|NCT04943432|University of North Carolina at Chapel Hill|Catherine Paquette, MA, MPS|919-962-5082|cpaq@live.unc.edu|
22303282|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
22303283|NCT02410967|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
22303284|NCT02032173|Novartis Pharmaceuticals|Study Director|862-778-1873||
22303285|NCT05082142|Northwestern University|Nicholas Dean (current fellow)|7806906285|nicholas.dean@northwestern.edu|
22303286|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22303287|NCT02291289|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303288|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
22303289|NCT05033743|Indiana University School of Medicine|Chemen M. Neal, Associate Professor|3172789639|chmtate@iupui.edu|
22303290|NCT01622543|The Ottawa Hospital - Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
22303291|NCT03354325|University of Utah|Eric Coon|801-662-3645|Eric.Coon@hsc.utah.edu|
22273387|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
22273388|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273389|NCT03628378|Columbia University Irving Medical Center|Jeffrey A. Geller, MD|212-305-1120|jg2520@cumc.columbia.edu|
22273390|NCT00883415|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
22273391|NCT02264210|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|86-20-87343439|wangsy@sysucc.org.cn|
22273392|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273393|NCT04501952|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22273394|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
22273395|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu|
22273396|NCT03509181|McLean Hospital|Courtney Beard|617-855-3557|cbeard@mclean.harvard.edu|
22273397|NCT04550364|Universoty of Oslo|Psychologist and PhD Bente Sommerfeldt|004793221280|bsommerfeldt@gmail.com|
22273398|NCT03382418|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22273399|NCT03138577|Weill Cornell Medical College|Dr. Tiffany Tedore|212-746-2725|tft9001@med.cornell.edu|
22273400|NCT02022735|University of Miami|Corneliu Luca, MD, PhD|305-243-6732|cluca@med.miami.edu|
22273401|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273402|NCT04283253|UNIVERSITY OF PITTSBURGH|George Wittenberg|4126484178|GEOWITT@PITT.EDU|
22273403|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com|
22273404|NCT02716584|VA Greater Los Angeles Healthcare System|Dr. Robert Kern|310-478-3711|Robert.Kern2@va.gov|49229
22273405|NCT02497937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273406|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu|
22273407|NCT03301831|Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP|(216) 368-3082|vab@case.edu|
22273408|NCT03538691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22273409|NCT03715452|Osprey Medical, Inc.|Vice President of Clinical Affairs|952.955.8236|kknish@ospreymed.com|
22273410|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273411|NCT00636636|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
22273412|NCT00524173|NIDDK|Marc Ghany, MD|301-402-5115|marcg@intra.niddk.nih.gov|
22273413|NCT03300180|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
22303292|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22273414|NCT04233671|The University of Alabama|Dr. Mercy Mumba|205-348-6317|mnmumba@ua.edu|
22273415|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
22273416|NCT01409915|"University of Colorado Denver | Anschutz Medical Campus"|John O'Shaughnessy, MS, Clinical Research Services Principal Professional|3037247924|john.oshaughnessy@cuanschutz.edu|
22273417|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu|
22273418|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22273419|NCT02922153|AtriCure|Nfii Ndikitum|513-644-8192|nndikintum@atricure.com|
22273420|NCT03506438|Duke|Christopher Cox|9196817232|christopher.cox@duke.edu|
22273421|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
22273422|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com|
22273423|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu|
22273424|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu|
22273425|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu|
22273426|NCT03557918|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22273427|NCT04575090|UTSouthwestern Medical Center|Zahid Ahmand, MD|214-648-2377|zahid.ahmad@utsouthwestern.edu|
22273428|NCT04218279|University of Pittsburgh|P. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
22273429|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22273430|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu|
22303293|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22284701|NCT01123707|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22273431|NCT04668209|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
22303294|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org|
22284702|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org|
22284703|NCT03281304|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284704|NCT00858637|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22284705|NCT02292706|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22284706|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com|
22284707|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu|
22284708|NCT02725866|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22284709|NCT01990612|Northwestern University|Dr. William Grobman|312-472-4661|w-grobman@northwestern.edu|
22284710|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22284711|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl|
22284712|NCT04365452|Indiana Univiersity|Theresa Joyce, Quality Improvement Consultant, Research Complaince|3172921882|tajoyce@iu.edu|
22284713|NCT02980133|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22284714|NCT03968848|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22284715|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443|jakub.honek@gmail.com|4901
22284716|NCT03208088|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen SR Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22284717|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284718|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22284719|NCT02508324|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
22284720|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22284721|NCT02577016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284722|NCT05399290|Michigan State University|Erika Malana|5173038716|malanaer@msu.edu|
22284723|NCT03304119|Hôpital Privé Antony|V Chassaing|+33 1 46 74 37 00|vchassaing92@gmail.com|
22284724|NCT03738891|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
22284725|NCT02942485|University of Helsinki|Dr. Svetlana Vakkilainen|+358407693375|svetlanakostjukovitch@gmail.com|
22284726|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu|
22284727|NCT02004977|University of Minnesota|Dr. Susie Nanney|612-626-6794|msnanney@umn.edu|
22284728|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273432|NCT02958787|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, MD|734-232-5244|sprattda@umich.edu|
22273433|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300||
22273434|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu|
22273435|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
22273436|NCT00059228|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22273437|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu|
22273438|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr|
22273439|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
22273440|NCT03672344|BioStream Technologies, LLC|Michael Farber|856-222-1122|farberm@biostreamtech.com|
22273441|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu|
22273442|NCT03231306|UAB|Coretta Thomas, Scientist & Data Manager for NF Consortium|2059758629|coretta@uab.edu|
22273443|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu|
22273444|NCT02983045|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22273445|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273446|NCT02585713|Mayo Clinic|Robert D. McBane, M.D.|507/284-4565|Mcbane.robert@mayo.edu|
22273447|NCT03956030|Penn State Health, Milton S. Hershey Medical Center|Dr. Christina DeAngelis|717-531-5994|cdeangelis2@pennstatehealth.psu.edu|3763
22273448|NCT02609984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284729|NCT00849862|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22284730|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
22284731|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22284732|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu|
22284733|NCT03776461|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22284734|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22284735|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com|
22284736|NCT02647346|Podimetrics Inc|Brian Petersen|860-558-9204|brian@podimetrics.com|
22284737|NCT01805037|Northwestern University, Feinberg School of Medicine|Barbara Pro, MD|312-695-6180|barbara.pro@northwestern.edu|
22284738|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu|
22284739|NCT04547582|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1326|lef44@pitt.edu|
22284740|NCT02964585|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|202-741-2233|ssen1@email.gwu.edu|
22284741|NCT03040115|University of Cincinnati|Elizabeth Kopras, Senior Research Associate|513-558-7205|koprasej@uc.edu|
22284742|NCT04566692|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
22284743|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22284744|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530||
22284745|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu|
22284746|NCT03927404|University of Pittsburgh|Dr. Sashwati Roy|412-648-8297|sar453@pitt.edu|
22284747|NCT01229449|Reckitt Benckiser Healthcare International|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22284748|NCT02641067|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284749|NCT03203291|Columbia University Irving Medical Center|Sunil Agrawal, PhD|(212) 854-2841|sunil.agrawal@columbia.edu|
22284750|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com|
22284751|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284752|NCT02533726|Stanford University School of Medicine|Dr David Pickham|650 701 6830|dpickham@stanford.edu|
22284753|NCT05098509|Radius Pharmaceuticals, Inc.|Ellie Ratigan|617-444-1800|scout015@radiuspharm.com|
22273449|NCT02080364|vTv Therapeutics LLC|Ann Gooch PhD,RAC,CCRP; Vice President Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
22273450|NCT00991289|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22273451|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org|
22273452|NCT02256839|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22273453|NCT01843803|Department of Veterans Affairs|Frances M Weaver|708-202-5866|frances.weaver@va.gov|
22273454|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com|
22273455|NCT00436826|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22273456|NCT00121719|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22273457|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273458|NCT04533438|Aerin Medical|Sr. Manager of Clinical Operations|312-888-0441|tdang@aerinmedical.com|
22273459|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu|
22273460|NCT05568797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273461|NCT02651337|Alcyone LifeSciences|Director of Clinical Operations|9787091946|jmcguire@alcyonels.com|
22273462|NCT02401035|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284754|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284755|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
22284756|NCT00908466|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
22284757|NCT03157037|Linköping University|Professor Mårten Segelmark|+46 70 287 19 44|marten.segelmark@liu.se|
22284758|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
22284759|NCT01972789|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22284760|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it|
22284761|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22284762|NCT01707381|Bausch + Lomb|Heleen DeCory, Ph.D.|(585) 338-8161|Heleen.DeCory@bausch.com|
22284763|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528||
22284764|NCT03596450|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22284765|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
22284766|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch|
22284767|NCT04016077|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284768|NCT02474407|SK Bio-pharmaceuticals Co, Ltd|Lee Min Jae, Associate Manager||minj.lee@sk.com|
22284769|NCT03036189|Montana State University|Suzanne Held|4069946321|suzanne@montana.edu|
22284770|NCT03262441|Fred Hutchinson Cancer Research Center|Dr. Joshua Schiffer|(206)667-7359|jschiffe@fredhutch.org|
22284771|NCT02607228|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22284772|NCT01860950|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
22284773|NCT04775264|AtriAN Medical Ltd|Barry O'Brien|+353872934292|barry.obrien@atrianmedical.com|
22284774|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22284775|NCT05090852|UPenn|Natasha Mirza, MD|215 662 2979|natasha.mirza@pennmedicine.upenn.edu|
22284776|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu|
22284777|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org|
22284778|NCT00148941|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22284779|NCT02673684|Defense and Veterans Center for Integrative Pain Management|Mary McDuffie|301-400-4242|mmcduffie@dvcipm.org|
22284780|NCT03050320|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
22284781|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525|cbeysen@kinemed.com|123
22284782|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22284783|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu|
22284784|NCT03908970|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22284785|NCT04407234|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22284786|NCT02280317|Valirx plc|Dr Suzanne Dilly|+44 2476796496|suzanne.dilly@valirx.com|
22284787|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com|
22284788|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
22284789|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu|
22284790|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284791|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu|
22284792|NCT04079114|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22284793|NCT02986802|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3755|De-Kun.Li@kp.org|
22303295|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu|
22303296|NCT00452413|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303297|NCT05150587|Alfasigma|Nicola Gargano - Senior Clinical Scientist|0039 (0)6 91395072|nicola.gargano@alfasigma.com|
22303298|NCT01614847|Northeastern State University Oklahoma College of Optometry|Thomas O. Salmon, OD, PhD, Professor|918-444-4011|salmonto@nsuok.edu|
22303299|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22303300|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
22303301|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22303302|NCT01539863|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
22303303|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu|
22303304|NCT02693834|Baylor Institute for Rehabilitation|Priya Karakkattil, PT PhD|469-888-5172|Pjke7991@gmail.com|
22303305|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22303306|NCT02111213|Stanford University|Principal Investigator|6507232880|desparza@stanford.edu|
22303307|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org|
22303308|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu|
22303309|NCT02226172|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303310|NCT01989598|Princess Margaret Cancer Centre|Dr. Suzanna Trudel|4169464501|Suzanne.Trudel@uhn.ca|4566
22273463|NCT00869128|Shoham Geriatric Medical Center, Pardes Hana, Israel|D. Garfinkel , MD|Tel: 972-4-6375667|dorong@shoham.health.gov.il|
22273464|NCT05137002|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
22273465|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022|j.toews@cinim.org|111
22273466|NCT03046953|CRCTU Birmingham|C Morland Cinical Trial Coordinator|+44 121 371 7862|avail-t@trials.bham.ac.uk|
22273467|NCT03828214|College of St. Scholastica|Dr. Alexandra Borstad|614-395-1708|aborstad@css.edu|
22273468|NCT04039204|Wake Forest University School of Medicine|Bruce Lessey, Ph.D., M.D.|336-713-0380|blessey@wakehealth.edu|
22273469|NCT04388176|Vicore Pharma AB|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
22273470|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org|
22273471|NCT02600611|Motif BioSciences|David Huang|936-577-5770|david.huang@motifbio.com|
22273472|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22273473|NCT03471832|CooperVision|Jose A.Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22273474|NCT02385110|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
22273475|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273476|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu|
22273477|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu|
22273478|NCT00585325|University of Wisconsin-Madison|Cindy Schmitz, RN, MS, NP|608-262-2664|CSchmitz@uwhealth.org|
22273479|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu|
22273480|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273481|NCT02557516|Innate Pharma|Dr. Agnes BOYER-CHAMMARD, Medical Director|+33430303030|Agnes.BOYER-CHAMMARD@innate-pharma.fr|
22273482|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu|
22273483|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu|
22273484|NCT01919164|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22273485|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22273486|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu|
22273487|NCT01845597|Rebound Research and Education Foundation.|Pamela Fairchild|3604498728|pfairchild@reboundmd.com|
22273488|NCT03782987|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273489|NCT04403113|Marmara University|Assoc. Prof Gonul Acar|5323778878|gonulacar34@gmail.com|+90
22273490|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org|
22273491|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
22273492|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22273493|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22273494|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22273495|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu|
22273496|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in|
22273497|NCT04155463|Boise State University|Dr. Cynthia Curl|208-426-3924|cynthiacurl@boisestate.edu|
22273498|NCT03799614|Virginia Commonwealth University|Dr. Ingrid Pretzer-Aboff|804-828-3340|iaboff@vcu.edu|
22273499|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
22273500|NCT02806713|University of Massachusetts UMass Memorial|Michael K Flynn|(508) 856-5152|michael.flynn@umassmemorial.org|
22273501|NCT02824224|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22273502|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu|
22273503|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
22303311|NCT04548531|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@mgh.harvard.edu|
22303312|NCT04957732|University of Florida Shands Emergency Department|Richard Petrik, MD, Clinical Assistant Professor|352-265-5911||
22303313|NCT03767634|Imperial College London|Dr Chris Gale|+44 (0)20 3315 3519|christopher.gale@imperial.ac.uk|
22303314|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155||
22303315|NCT04785326|Dong-A ST|Clinical Research Manager|02-920-1111|imspring@donga.co.kr|
22303316|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22303317|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu|
22303318|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org|
22303319|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303320|NCT03487718|University of Kentucky|Ridge Preservation with Leukocyte Platelet Rich Fibrin: A Clinical, Radiographic, and Histomorphomet|8593236193|firasayafi@uky.edu|
22303321|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303322|NCT04071470|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
22303323|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu|
22303324|NCT03306043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303325|NCT01544491|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22303326|NCT02494206|Memorial Sloan Kettering Cancer Center|Dr. Babak Mehrara MD|212-639-3099|mehrarab@mskcc.org|
22303327|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com|
22303328|NCT01234649|Woman's Hospital|Dr Karen Elkind-Hirsch|225 231-5275|karen.elkind-hirsch@womans.org|2
22303329|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
22303330|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu|
22303331|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com|
22303332|NCT03688711|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
22303333|NCT05229653|NYU Langone Health|Kathy Huang, MD|(212) 545-5400|Kathy.Huang@nyulangone.org|
22303334|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303335|NCT03691948|Medical University of South Carolina|Jenna L. McCauley, PhD, Assistant Professor of Psychiatry|8437923922|mccaule@musc.edu|
22273504|NCT04878055|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22273505|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se|
22273506|NCT03868839|University of Massachusetts Medical School|Xiaoduo Fan|5088563881|xiaoduo.fan@umassmed.edu|
22273507|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22273508|NCT01004978|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22273509|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov|
22273510|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu|
22273511|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com|
22273512|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu|
22273513|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22273514|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273515|NCT01719380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273516|NCT00848757|Yale University School of Medicine|Michelle Van Name|203-785-5831|michelle.vanname@yale.edu|
22273517|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22273518|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com|
22273519|NCT02762084|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|Info@Pellepharm.com|
22273520|NCT02659943|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@nih.gov|
22273521|NCT03478371|Procter & Gamble Co|Jan Streicher-Scott, PhD, RPh|513-634-5584|streicherscott.jl@pg.com|
22273522|NCT03861780|Bioscience Laboratories|Principal Investigator II/Training Coordinator|(406) 587-5735|cduley@biosciencelabs.com|110
22273523|NCT01096160|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273524|NCT00627497|Medtrionic spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22273525|NCT02697071|Lewis Gale Medical Center|Corey Heitz, MD|5406322364|coreyheitzmd@gmail.com|
22273526|NCT02028507|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22273527|NCT03361306|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22273528|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu|
22273529|NCT01960465|Jesse Brown VAMC|Dr. Bharati Prasad|312-569-6343|bharati.prasad@va.gov|
22273530|NCT02038179|University of Alabama at Birmingham|Dr. Elizabeth Rahn|205-996-6552|elizabethrahn@uabmc.edu|
22273531|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
22273532|NCT02420119|HaEmek Medical Center|Dr.Frieda Wolf|97246495476|friedawolf@hotmail.com|
22273533|NCT04767373|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22273534|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca|
22273535|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22273536|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org|
22273537|NCT04346199|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22273538|NCT03576924|University of British Columbia|Dr. Mary Jung|1-250-807-9670|mary.jung@ubc.ca|
22273539|NCT00099632|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22273540|NCT03131687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22273541|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303336|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
22303337|NCT03428126|MD Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
22303338|NCT01018563|Eisai Medical Information|Eisai Medical Information|888 422 4743|esi_medinfo@eisai.com|
22303339|NCT02344537|New York State Psychiatric Institute|Brian Fallon, MD|6467748052|brian.fallon@nyspi.columbia.edu|
22284794|NCT00629798|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|646-608-3738|tamarir@mskcc.org|
22284795|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22284796|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22284797|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22284798|NCT03253328|Washington University School of Medicine|Mohamed A Zayed|314-362-5648|zayedm@wustl.edu|
22284799|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22284800|NCT03077919|RTI International|Kristine L. Rae Olmsted, MSPH|919-541-8035|krolmsted@rti.org|
22284801|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu|
22284802|NCT02175979|Catharina Hospital|dr Misha Luyer|+31402399111|misha.luyer@catharinaziekenhuis.nl|
22284803|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
22284804|NCT03043391|Istari Oncology|W. Garret Nichols, MD MS|919-245-7662|info@istarioncology.com|
22284805|NCT00491491|Chaim Sheba Medical Center|Dr Avichai Shimoni|972 3 530 5303|ashimoni@sheba.health.gov.il|
22284806|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22284807|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com|
22284808|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22284809|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22284810|NCT00635167|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edouard Trabulsi|215-955-1000|edouard.trabulsi@jefferson.edu|
22284811|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22284812|NCT02219334|Baylor College of Medicine|Shabana Yusuf/Associate Professor of Pediatrics|832-824-5388|syusuf@bcm.edu|
22284813|NCT03274414|Memorial Sloan Kettering Cancer Center|Dr. Marc Cohen, MD|212-639-3769|cohenm2@mskcc.org|
22284814|NCT02381015|Wake Forest University Health Sciences|Dr. Aubrey R. Turner|336-918-3585|aubreyturner@gmail.com|
22284815|NCT00904488|UNC Eshelman School of Pharmacy|Dr. Jo Ellen Rodgers|(919) 962-2249|jerodgers@unc.edu|
22284816|NCT02688985|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22284817|NCT02445326|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22284818|NCT01964963|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22284819|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22284820|NCT01726582|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-955-1412|stsai@mcw.edu|
22284821|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22284822|NCT02630472|UPenn|Nithin D. Adappa, Principal Investigator|215-662-2360|Nithin.Adappa@uphs.upenn.edu|
22284823|NCT02967510|ITF Research Pharma SLU|Javier Suárez Almarza|+34 916572323|jsuarez@itfsp.com|
22284824|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu|
22303340|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22284825|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22303341|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
22319666|NCT05749952|University of Pittsburgh|Sashwati Roy|412 624 0422|sasr453@pitt.edu|
22284826|NCT01279616|Nationwide Children's Hospital|Kristy Ott|614-722-6313|kristy.ott@nationwidechildrens.org|
22284827|NCT03400163|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22284828|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600|jcanas@nemours.org|3674
22284829|NCT01458418|Children's Mercy Hospital|Corey Schurman|8162343000|crschurman@cmh.edu|
22284830|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22284831|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22284832|NCT03276546|Queen's University, Belfast|Professor Margaret Cupples|07714233204|m.cupples@qub.ac.uk|
22284833|NCT02638168|Penn State Health Milton S Hershey Medical Center|Raman Baweja, MD, MS|7175318134|rbaweja@pennstatehealth.psu.edu|
22284834|NCT01991522|St. Michael's|Dr. Samir C. Grover|416-864-5628|samir.grover@utoronto.ca|
22284835|NCT02227394|Zambon S.p.A.|Luca Raiteri, MD|+39 02 6652461|luca.raiteri@zambongroup.com|
22284836|NCT04047979|Emory University|Dr. Nadine Rouphael|404-712-1435|nroupha@emory.edu|
22284837|NCT04302545|King Edward Medical University, Lahore, Pakistan|Shazia Saaqib|+92-3214708583|shaziasaaqib@gmail.com|
22284838|NCT02516592|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22284839|NCT04921332|University of Pittsburgh|Erica Osborn DNP, CRNP|814-282-9793|elo25@pitt.edu|
22284840|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu|
22284841|NCT03077204|Ascension Texas Spine and Scoliosis|Devender Singh, Research Scientist|512 324 3580|dpsingh@ascension.org|15916
22284842|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
22284843|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
22284844|NCT01727336|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284845|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
22284846|NCT03001778|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22284847|NCT04058886|University of North Carolina at Chapel Hill|Kim Faurot, PhD|919-966-8586|faurot@med.unc.edu|
22284848|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu|
22284849|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22284850|NCT04118595|University of North Carolina at Chapel Hill|Michelle Meyer, PhD|919-966-6539|mlmeyer@unc.edu|
22284851|NCT04534881|Saint Louis University|Sandeep Dhindsa|13149774911|sandeep.dhindsa@health.slu.edu|
22284852|NCT01729494|University of Cincinnati|Rita R. Alloway, Pharm.D., Director of Clinical Trials|513-558-1568|rita.alloway@uc.edu|
22284853|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22284854|NCT01299116|FHI 360|Dr. David Hubacher|919 544 7040|dhubacher@fhi360.org|11223
22284855|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu|
22284856|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654|TOm.Seekins@UMontana.edu|406
22284857|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22284858|NCT03595527|Centre hospitalier de l'Université de Montréal|Valréie Martel-Laferrière, MD|5148908000|valerie.martel-laferriere.med@ssss.gouv.qc.ca|
22284859|NCT02413047|Indiana University|Dr. Matthew Bohm, DO (Principal Investigator)|3179485136|mbohm@iu.edu|
22284860|NCT02974842|nVision Medical|Surbhi Sarna|408 655 3577|surbhi@nvisionmedical.com|
22284861|NCT01959243|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
22284862|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac|
22284863|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com|
22284864|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22284865|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22284866|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743||
22284867|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu|
22284868|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk|
22284869|NCT04978818|Johns Hopkins School of Public Health|Dr. Laura Hammit|4436510000|lhammitt@jhu.edu|
22284870|NCT04517643|Johns Hopkins Medicine|Robert Hobbs|410-502-1229|rhobbs3@jhmi.edu|
22284871|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
22284872|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284873|NCT04699461|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22284874|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
22284875|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22284876|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22284877|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com|
22284878|NCT02301624|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22284879|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu|
22284880|NCT03738618|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22284881|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068|bkaelin@cumberlandpharma.com|250
22284882|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22284883|NCT01271725|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273542|NCT03134911|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273543|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22273544|NCT00768287|Medexus Pharma, Inc.|Clinical Trial Manager|1-312-548-3125|julissa.leon@medexus.com|
22273545|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu|
22273546|NCT02824627|University of Nebraska Medical Center|Soonjo Hwang|402-552-6351|soonjo.hwang@unmc.edu|
22273547|NCT01868165|Imperial College London|Dr Ruth Peters|07950289662|r.peters@imperial.ac.uk|
22273548|NCT03472521|Stanford University|Dr. Pamela Flood, MD, MA|201-370-3933|pflood@stanford.edu|
22273549|NCT01603407|University of Rochester|Robert Griggs|585-275-6072|robert_griggs@urmc.rochester.edu|
22273550|NCT02358031|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22273551|NCT03442725|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
22273552|NCT04980014|Takeda|Study Director|+1 877-825-3327|TrialDisclosures@takeda.com|
22273553|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com|
22273554|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu|
22273555|NCT05122624|Johns Hopkins Bloomberg School of Public Health|Dr. Yeonsoo Baik|410-955-2378|ybaik3@jh.edu|
22273556|NCT02250300|Froedtert and the Medical college of Wisconsin|Mehdi Hamadani, MD|414-805-4600|mhamadani@mcw.edu|
22273557|NCT02603211|Temple University|Chang-hee Won|2152046158|cwon@temple.edu|
22273558|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
22273559|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22273560|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
22273561|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de|
22273562|NCT02781818|UNC Dermatology|Dr. Christopher Sayed|984-974-3900|christopher_sayed@email.unc.edu|
22273563|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22273564|NCT02317991|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22273565|NCT01223404|University of Maryland School of Medicine|Dr. Britta Hahn|4104026112|bhahn@mprc.umaryland.edu|
22273566|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050|sturner@scolr.com|1001
22273567|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22273568|NCT01697800|Johns Hopkins Medicine|Zubair Khan|410-955-3157|zkhan@jhmi.edu|
22273569|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com|
22273570|NCT03782181|University of Balearic Islands|José Mingorance|+34677602465|josea.mingorance@uib.es|
22273571|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org|
22273572|NCT01000987|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22273573|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
22273574|NCT00823134|ResMed Germany Inc|Oliver Munt|0899901|oliver.munt@resmed.de|00
22273575|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22273576|NCT02880254|Baystate Medical Center|Rushika Conroy MD|413 794 5437|rushika.conroy@bhs.org|
22273577|NCT04421040|Mayo Clinic|Dr. Grace Lin|507-255-1267|lin.grace@mayo.edu|
22284884|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746||
22284885|NCT03826186|University of Iowa Hospitals and Clinics|Vice Chair for Research|319-335-9595|donna-hammond@uiowa.edu|
22284886|NCT03032263|Wake Forest University Health Sciences|Dr. Thomas Templeton|336-716-4285|ttemplet@wakehealth.edu|
22284887|NCT02950480|University of California, San Francisco|Dr. Pamela Munster|(415) 885-7810|pamela.munster@ucsf.edu|
22284888|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com|
22284889|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com|
22284890|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22284891|NCT01959139|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
22284892|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
22284893|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000|ss01@aub.edu.lb|6380
22284894|NCT02255461|St. Jude Children's Research Hospital|Jie Huang|9015955750|jie.huang@stjude.org|
22284895|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com|
22284896|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu|
22284897|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411|corrine.voils@va.gov|5196
22284898|NCT04784143|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22284899|NCT06292130|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
22284900|NCT00891228|NICHD|H. Trent MacKay, MD, MPH|301-435-6988|mackayt@mail.nih.gov|
22284901|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590||
22303342|NCT05490329|Florida State University|Lisa Hightow-Weidman, MD, MPH|8506443296|lhightowweidman@fsu.edu|
22273578|NCT03979066|Columbia University|Gulam Manji, MD, PhD|212-305-0592|gam2140@columbia.edu|
22273579|NCT03316586|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-2335|Sara_Tolaney@dfci.harvard.edu|
22284902|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262|james.henry@va.gov|57466
22284903|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu|
22284904|NCT01177189|Salt Lake City VAMC|Van Reese|801 582 1565|van.reese@hsc.utah.edu|
22284905|NCT03606187|SGX Medical|VP of Clinical Affairs|6613108409|wpark@sgxmedical.com|
22303343|NCT04524598|Limbix Health|Janel Shelton-DeMagnus, Research Operations Manager|8885462495|janel@limbix.com|709
22303344|NCT02306122|Brown University|Joanne Michaud|401-863-9317|joanne_michaud@brown.edu|
22303345|NCT00180713|Imperial College London|Professor Martin R Wilkins|+44 (0)20 8383 2049|m.wilkins@imperial.ac.uk|
22303346|NCT05295732|LEO Pharma A/S|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22303347|NCT02322814|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22303348|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu|
22303349|NCT01164228|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22303350|NCT01741454|University of Wisconsin School of Medicine & Public Health|Shuang Li (Linda)|608.263.8336|lis@urology.wisc.edu|
22273580|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org|
22273581|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22273582|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com|
22273583|NCT02999789|University of California, San Francisco|Eddie Cruz-Romero, MD, MPH|(628) 206-2837|Edward.Cruz@ucsf.edu|
22273584|NCT01111565|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22273585|NCT03150082|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273586|NCT02363387|Johns Hopkins University School of Medicine|Kenneth Silverman|443-617-6051|ksilverm@jhmi.edu|
22273587|NCT04131712|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
22273588|NCT02299388|Tulane University|Dr. Tina Thethi|504-988-5044|tthethi@tulane.edu|
22303351|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22273589|NCT03334188|"University of Colorado | School of Medicine | ACCORDS"|Dr. Larry Allen, Professor of Medicine|303-724-4713|larry.allen@cuanschutz.edu|
22273590|NCT01093586|Case Comprehensive Cancer Center|Brenda Cooper MD|216-844-3213|brenda.cooper@uhhospitals.org|
22273591|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org|
22273592|NCT03570047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273593|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22273594|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov|
22273595|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu|
22273596|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22273597|NCT01765296|CrystalGenomics, Inc.|Chief Medical Officer|+82-31-628-2871|sang-yoon.lee@cgxinc.com|
22273598|NCT03257436|BostonScientific|Sharda Mehta|6785967330|sharda.mehta@bsci.com|
22273599|NCT01619852|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
22273600|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu|
22273601|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu|
22273602|NCT03877744|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
22273603|NCT03489343|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
22273604|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914||
22273605|NCT01912950|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22273606|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273607|NCT03242941|Medtronic|Lilian Kornet|+31433566710|lilian.kornet@medtronic.com|
22273608|NCT02658669|VA San Diego Healthcare System|Dr. Henry Orff|(858) 642-6492|Henry.Orff@va.gov|
22273609|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273610|NCT02550743|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD, Principal Investigator|14018633000|kayla_rosati@brown.edu|
22273611|NCT01246895|Piramal Healthcare (Canada) Limited - Bio-Orthopaedics Division|David Castelo, Clinical Research Manager|450-686-2437|david.castelo@piramal.com|313
22273612|NCT00838097|Amgen Inc.|Study Director|866-572-6436||
22273613|NCT03311841|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273614|NCT05464420|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22273615|NCT01383018|Boston Scientific|Amanda Vail, Clinical Project Manager|612-749-5366|amanda.vail@bsci.com|
22273616|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273617|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22273618|NCT03414229|Memorial Sloan Kettering Cancer Center|Dr. Sanda D'Angelo, MD|646-888-4159|dangelos@mskcc.org|
22273619|NCT01715233|Baylor University Medical Center Dallas Texas|Ronan J. Kelly MD MBA|214-820-2828|Ronan.Kelly@bswhealth.org|
22273620|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca|
22273621|NCT02797678|Philips Respironics|Senior Data Manager|7243877949|Jeff.Jasko@philips.com|
22273622|NCT04693078|Shaare Zedek Medical Center|Dr. Dan Meir Livovsky|+34603833576|danlivo@yahoo.com|
22273623|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu|
22273624|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273625|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu|
22273626|NCT04878120|University of Virginia|Dr. Chiara Fabris|4344220240|cf9qe@virginia.edu|
22273627|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov|
22273628|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22273629|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731|njpaik@snu.ac.kr|7731
22273630|NCT02487797|Northwestern University, Yale University|Dr. Moeun Son|475-414-5328|moeun.son@yale.edu|
22273631|NCT01938846|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273632|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22273633|NCT02499120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273634|NCT02282163|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound Programs|1-609-514-2506|Melda.Dolan@diag.bracco.com|
22273635|NCT01839916|University of Chicago|Dr. Hongtao Liu|773-834-1736|hliu2@medicine.bsd.uchicago.edu|
22273636|NCT04789382|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22273637|NCT02100280|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
22273638|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22273639|NCT02692586|Inari Medical|Ashleigh Willson|877-923-4747|ashleigh.willson@inarimedical.com|
22273640|NCT01095497|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22273641|NCT03407313|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
22273642|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22273643|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648||
22273644|NCT02492802|University Medical Center Groningen|Jan-Willem Alffenaar, PhD|+31503614035|j.w.c.alffenaar@umcg.nl|
22273645|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu|
22273646|NCT03234036|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273647|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu|
22273648|NCT02472730|Baylor College of Medicine|Dr. Kalpesh K. Patel|7137980947|kalpeshp@bcm.edu|
22273649|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273650|NCT02537951|Erasmus MC|Joost L.M. Jongen|+31107041415|j.jongen@erasmusmc.nl|
22273651|NCT02683239|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22273652|NCT03846544|Brussels IVF|Dr Liese Boudry|024779857|liese.boudry@uzbrussel.be|
22273653|NCT00521365|AstraZeneca|Gerard Lynch|09645895|ClinicalTrialTransparency@astrazeneca.com|4415
22273654|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743||
22273655|NCT01718483|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22273656|NCT03049501|University of Miami|David Loewenstein|305-355-7016|dloewenstein@miami.edu|
22273657|NCT03180957|University of Oxford|Professor Jagdeep Nanchahal|+44(001865 612633|jagdeep.nanchahal@kennedy.ox.ac.uk|
22273658|NCT03442088|University Hospitals Cleveland Medical Center|Dr. Neil Korman, Director Clinical Trials Unit|216-844-8200|Neil.Korman@UHhospitals.org|
22273659|NCT02541422|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
22273660|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org|
22273661|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu|
22273662|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22273663|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463||
22273664|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303352|NCT03311230|University of Pennsylvania|Joseph Harrison|2157461249|joseph.harrison@uphs.upenn.edu|
22303353|NCT02998021|University of Pittsburgh|Alicia Koontz, PhD|4128223700|akoontz@pitt.edu|
22303354|NCT05200936|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
22303355|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov|
22303356|NCT03713021|Washington University School of Medicine|Ryan Jackson, M.D.|314-362-0365|jackson.ryan@wustl.edu|
22303357|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
22303358|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk|
22303359|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22273665|NCT02948829|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22284906|NCT03704688|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Arbour|646-608-3792|arbourk@mskcc.org|
22303360|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22303361|NCT04399551|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303362|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
22303363|NCT02122341|USC Intitute of Urology|Dr. Matthew Dunn|323-865-3700|mdunn@med.usc.edu|
22303364|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22303365|NCT03384953|Osher Center for Integrative Medicine|Dr. Lindsey C. McKernan|615-320-7770|lindsey.mckernan@vumc.org|
22303366|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22303367|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk|
22303368|NCT03377790|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22303369|NCT01533714|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22303370|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303371|NCT04542226|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|Phone: +7(495) 730-75-45 ext.|DodonovNS@petrovax.ru|125
22303372|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596|sophie_chang@fountainmab.com|556
22273666|NCT02326272|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22273667|NCT02196857|The University of Texas MD Anderson Cancer Center|Ravandi-Kashani,Farhad MD./Professor|713-745-0394|fravandi@mdanderson.org|
22273668|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22273669|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com|
22273670|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu|
22273671|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
22273672|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com|
22273673|NCT04033146|Georgia Insitute of Technology|Dr. Gregory S. Sawicki; Professor Mechanical Engineering|919 448 5099|gregory.sawicki@me.gatech.edu|
22273674|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org|
22273675|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22273676|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu|
22303373|NCT00919893|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|Dr. F.M.E. Wagenlehner|0049 641 9944518|wagenlehner@AOL.com|
22273677|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22273678|NCT03006562|Johns Hopkins Brady Urological Institute|Dr. Mohamad Allaf|410-955-6100|mallaf@jhmi.edu|
22273679|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org|
22273680|NCT00447772|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
22273681|NCT02427841|OHSUKCI|Dr. Gina Vaccaro|503-216-6300|vaccarog@ohsu.edu|
22273682|NCT05417412|San Diego State University|Dr. V. Robin Weersing|619-594-8892|robin.weersing@sdsu.edu|
22273683|NCT01576575|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22273684|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788|lconboy@nesa.edu|145
22273685|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140|john.mariani@nyspi.columbia.edu|646
22273686|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273687|NCT00274742|Amgen Inc.|Study Director|866-572-6436||
22273688|NCT02256696|Vanderbilt University|Dr. Kelly Dooley|(615) 322-8972|kelly.e.dooley@vumc.org|
22303374|NCT01375959|Albert Einstein College of Medicine|Dr. Jill Crandall|718-430-3765|jill.crandall@einstein.yu.edu|
22273689|NCT02778152|The Research Institute at Nationwide Children's Hospital|Dr. Peter Minneci|614-722-3066|peter.minneci@nationwidechildrens.org|
22273690|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu|
22273691|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org|
22273692|NCT01472445|Stanford University|Melinda Telli, Associate Professor of Medicine (Oncology)|650-724-9533|mtelli@stanford.edu|
22273693|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu|
22273694|NCT03742986|NYU Langone Health - Perlmutter Cancer Center|Maryann Kwa, MD|(212) 731-6364|maryann.kwa@nyulangone.org|
22273695|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22273696|NCT02925858|Jewish General Hospital|Dr Matthew Cameron|514-340-8222|matthew.cameron@mcgill.ca|25701
22273697|NCT01951118|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22273698|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il|
22273699|NCT02989402|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22273700|NCT03066830|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
22273701|NCT02288819|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge|0473924199|frederik.verbrugge@zol.be|+32
22273702|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu|
22273703|NCT00765856|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22273704|NCT03505372|Beth Israel Deaconess Medical Center|Dr Jordana Phillips|617 667 1630|jphilli2@bidmc.harvard.edu|
22273705|NCT03065647|University of Michigan|Robert Neumar|734-936-0253|neumar@umich.edu|
22273706|NCT03705286|Duke University|Miriam Treggiari|919-681-9933|miriam.treggiari@duke.edu|
22273707|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu|
22273708|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu|
22273709|NCT01216332|Vanderbilt|Dr. Natasha Halasa|6153223346|natasha.halasa@vanderbilt.edu|
22273710|NCT03677869|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22273711|NCT05219968|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
22273712|NCT03877224|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
22273713|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
22284907|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu|
22303375|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
22303376|NCT03308058|University of Nebraska Medical Center|Jane Meza|402-559-6825|jmeza@unmc.edu|
22303377|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu|
22303378|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303379|NCT04741802|Duke University|Nia S. Mitchell, MD, MPH|919-668-7202|nia.s.mitchell@duke.edu|
22284908|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000||
22303380|NCT03278886|Boston Medical Center|Dr. Jeffrey Samet|617-414-7444|jsamet@bu.edu|
22303381|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com|
22303382|NCT04161807|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical @Regulatory Affairs|0542220121|daganh@theranica.com|
22303383|NCT04229030|Raziel Therapeutics|Racheli Gueta, Director of Clinical trials|97289126941|racheli@raziel-therapy.com|
22303384|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303385|NCT04711460|University of MN|Joan D. Lund|612-273-9115|Lund1687@umn.edu|
22303386|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303387|NCT00535743|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303388|NCT02572817|National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
22303389|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu|
22303390|NCT00299195|Memorial Sloan Kettering Cancer Center|Dr. Jay Boyle, MD|212-639-2906|boylej@mskcc.org|
22303391|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22303392|NCT04192630|Bausch + Lomb Incorporated|Anya Loncaric, Executive Director, Global Clinical Operations|(310) 770-7750|Anya.Loncaric@bauschcloud.com|
22303393|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303394|NCT01448421|keystoneheart|Karen Jaffe, VP RA./QA/CA|97246158005|karen.jaffe@keystoneheart.com|8005
22303395|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu|
22303396|NCT02590068|The Rockefeller University|Dr. Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
22303397|NCT01775930|UT MD Anderson Cancer Center|Dr. Eric Jonasch, MD / Professor, Genitourinary Medical Oncology|713- 563-7232|ejonasch@mdanderson.org|
22284909|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22284910|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu|
22284911|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu|
22284912|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585|erik.groessl@va.gov|6347
22284913|NCT01835158|Harvard|Toni K. Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
22284914|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284915|NCT00887926|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284916|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22284917|NCT04427072|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22284918|NCT04865237|Imperial College London|Professor Christopher Chiu|02083832301|c.chiu@imperial.ac.uk|
22284919|NCT00773773|Memorial Sloan Kettering Cancer Center|Dr. Paul Tempst, PhD|212-639-8923|liljah@mskcc.org|
22284920|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22284921|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22284922|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22284923|NCT04003987|Indiana University School of Medicine|Yar Yeap|(317) 274-0275|yyeap@iupui.edu|
22284924|NCT03550404|Pacific Institute for Research and Evaluation|Cathleen Willging|505-765-2328|cwillging@pire.org|
22284925|NCT02953886|University of Michigan|Emily Yanca|734-763-3988|emthorpe@umich.edu|
22284926|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22284927|NCT02690714|Prometic Biotherapeutics Inc.|Senior Director, Clinical Development|301-549-9761|clinical@prometic.com|
22284928|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com|
22284929|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22284930|NCT04373746|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
22284931|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284932|NCT04496453|Emory University|Lavanya Vasudevan, Ph.D., M.P.H., C.P.H.|404-727-3956|lavanya.vasudevan@emory.edu|
22284933|NCT00767819|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22284934|NCT03916081|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22284935|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
22303398|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
22284936|NCT01545050|CSL behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22284937|NCT02249182|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22284938|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov|
22284939|NCT04450329|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22284940|NCT03244826|Dana-Farber Cancer Institute|Dr. Gregory Abel (Principal Investigator)|617-632-1906|gregory_abel@dfci.harvard.edu|
22284941|NCT04356040|Abbott|Anne Sarver|6517563813|anne.sarver@abbott.com|
22284942|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22284943|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22284944|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com|
22284945|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
22284946|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu|
22284947|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
22284948|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
22284949|NCT03043651|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
22284950|NCT02353728|Weill Cornell Medical College|Dr.Ellen K.Ritchie|646-962-2700|ritchie@med.cornell.edu|
22284951|NCT02566317|Arizona State University|Matthew Buman, PhD|602-827-2289|mbuman@asu.edu|
22284952|NCT02611817|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22284953|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22284954|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22284955|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22284956|NCT02300259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284957|NCT02737475|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22284958|NCT02510001|University of Oxford Clinical Trials and Research Governance (CTRG)|Heather House|01865 572245|heather.house@admin.ox.ac.uk|
22284959|NCT04120402|Eupraxia Pharmaceuticals Ltd.|Chief Scientific Officer|250-590-3968|amalone@eupraxiapharma.com|
22284960|NCT05690555|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22284961|NCT02380443|Mirror Biologics, Inc|Dr. Michael Har-Noy|7602167494|harnoy@mirrorbio.com|
22284962|NCT00921843|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22284963|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu|
22284964|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411|christine.marx@va.gov|3626
22284965|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22284966|NCT04240574|Rosalind Franklin University|Jacque Ortiz|847-578-8423|jacquelyn.ortiz@rosalindfranklin.edu|
22284967|NCT01858740|Fred Hutchinson Cancer Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
22284968|NCT03041896|MCRA|Glenn Stiegman|2025525800|gstiegman@mcra.com|
22273714|NCT04587336|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|Allison.Lewinski@va.gov|174048
22273715|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273716|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov|
22273717|NCT01490892|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Flemming Forsberg|215-955-4870|flemming.forsberg@jefferson.edu|
22273718|NCT03621956|Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
22273719|NCT05664581|AbbVie|Global Medical Services|001 8006339110|abbvieclinicaltrials@abbvie.com|
22273720|NCT03101150|King Fahd Medical City|Consultant Obstetritian and Gynecologist|00966539417217|amali@kfmc.med.sa|
22273721|NCT05541939|Vogenx|Chief Scientific Officer|919-659-5677|info@vogenx.com|
22273722|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com|
22273723|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
22273724|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22273725|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com|
22273726|NCT02749227|Columbia University|Pamela U. Freda, MD|212-305-2254|puf1@cumc.columbia.edu|
22273727|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com|
22273728|NCT02787304|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22273729|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22273730|NCT04771013|GIMUNICAH|Héctor M. Ramos-Zaldívar|+56934988958|hramos@unicah.edu|
22273731|NCT04754646|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
22273732|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com|
22284969|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com|
22284970|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22303399|NCT02340520|UConn Health|Nausherwan Burki, MD||nburki@uchc.edu|
22303400|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303401|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22303402|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People's Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn|
22303403|NCT04475848|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303404|NCT00896454|Amgen Inc.|Study Director|866-572-6436||
22303405|NCT02228525|Memorial Sloan Kettering Cancer Center|Dr. Eytan Stein, MD|646-608-3749|steine@mskcc.org|
22303406|NCT00930943|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
22303407|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com|
22303408|NCT03936777|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22303409|NCT02301156|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22303410|NCT04195880|Providence VAMC|Vincent Mor, Principal Investigator|4012737100|vincent_mor@brown.edu|6259
22303411|NCT01811940|NYSPI|Frances R. Levin, M.D.|646-774-6137|Frances.levin@nyspi.columbia.edu|
22303412|NCT03734991|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
22303413|NCT02638623|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
22303414|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22303415|NCT06536465|Recursion Pharmaceuticals, Inc.|Recursion Pharmaceuticals|385-374-1724|clinicaltrials@recursionpharma.com|
22303416|NCT03797326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22284971|NCT01919801|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22284972|NCT01059994|University of Texas Medical Branch|Melinda Sheffield-Moore|4097728126|melmoore@utmb.edu|
22284973|NCT01677858|Amgen Inc.|Study Director|866-572-6436||
22284974|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22284975|NCT01806675|Stanford University|Sanjiv Sam Gambhir, Professor for Clinical Investigation in Cancer Research and Professor|650-725-6175|sgambhir@stanford.edu|
22284976|NCT03078855|University of Rochester|Michael Brady, PhD|585-275-5830|michael_brady@urmc.rochester.edu|
22284977|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22284978|NCT03194646|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22284979|NCT04869358|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22284980|NCT05232864|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22284981|NCT04493203|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22284982|NCT04067609|Yale School of Medicine|Dr Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
22284983|NCT04765202|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22284984|NCT04929249|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22284985|NCT03068754|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22284986|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262|linda.ganzini@va.gov|56492
22284987|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736||
22284988|NCT01192828|University of Colorado Denver|Dr. Johan Van Hove, Primary Investigator|303-724-2338|johan.vanhove@childrenscolorado.org|
22284989|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544|jecfonseca@gmail.com|47221
22284990|NCT03037983|Palo Alto VA|Jong Yoon|510-220-7086|jhyoon1@stanford.edu|
22284991|NCT02697188|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|212
22303417|NCT03012061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303418|NCT04152343|Dartmouth-Hitchcock Medical Center|Dr. Eric Hoffer, Director of Interventional Radiology|603 650 7417|hoffer@hitchcock.org|
22303419|NCT03342053|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303420|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es|
22303421|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303422|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com|
22303423|NCT02415998|University of Iowa|Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
22303424|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com|
22303425|NCT04635059|Medical College of Wisconsin|Deepak Kilari, MD|414-805-4600|dkilari@mcw.edu|
22303426|NCT01340482|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22303427|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22303428|NCT02543723|East Carolina University|Essie Torres|252-328-1818|torrese@ecu.edu|
22303429|NCT00963989|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
22303430|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com|
22303431|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu|
22303432|NCT02949674|Instituto Mexicano del Seguro Social|Dr. Juan Lopez|+5257473500|juanlopez110@hotmail.com|25538
22303433|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011|martin.descarreaux@uqtr.ca|3791
22303434|NCT04995497|University of Iowa Healthcare|Archit Sharma, M.D.|(319) 384-7911|archit-sharma@uiowa.edu|
22303435|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22303436|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743||
22303437|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52||
22303438|NCT03483077|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22284992|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com|
22284993|NCT01853878|GlaxoSmithKline|GSK Response Center|866-435-7343||
22284994|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com|
22284995|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu|
22284996|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
22284997|NCT04294147|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22284998|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
22284999|NCT03029091|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513 636-7177|marc.rothenberg@cchmc.org|
22285000|NCT03929640|Milton S. Hershey Medical Center|Serdar Ural|717-531-6209|sural@pennstatehealth.psu.edu|
22285001|NCT04146935|Yale School of Medicine|Dr. Karl Insogna|203-785-3272|karl.insogna@yale.edu|
22285002|NCT01371305|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22285003|NCT04038567|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
22285004|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22285005|NCT02999633|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22285006|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com|
22285007|NCT03274518|University of São Paulo|Dr. Bruno Caldin da Silva|+5511997620521|bruno.caldin@hc.fm.usp.br|
22285008|NCT02456857|MD Anderson Cancer Center|Dr. Clinton Yam|(832) 589-8343|cyam@mdanderson.org|
22285009|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
22285010|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22303439|NCT01857934|St. Jude Children's Research Hospital|Sara M. Federico, MD|866-278-5833|referralinfo@stjude.org|
22273733|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com|
22273734|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
22273735|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org|
22273736|NCT01716806|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22273737|NCT03143257|Medtronic Xomed|Sr Manager, Clinical Affairs|904-296-9600|rs.entgm@medtronic.com|
22273738|NCT03477162|Dartmouth Hitchcock Medical Center|Joseph Phillips, MD|603-650-5000|Joseph.D.Phillips@hitchcock.org|
22273739|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com|
22273740|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu|
22273741|NCT04547140|Grifols Therapeutics LLC|Rhonda Griffin, Clinical Program Leader/Director|+1 919 757 1744|Rhonda.griffin@grifols.com|
22303440|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu|
22303441|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com|
22303442|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu|
22303443|NCT01560377|Novadaq Technologies, Inc.|Alicia Wilton|1.905.629.3822|awilton@novadaq.com|209
22303444|NCT04012814|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
22303445|NCT04789577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303446|NCT02441946|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303447|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu|
22303448|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303449|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu|
22303450|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu|
22303451|NCT02038764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303452|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303453|NCT01812005|The Ohio State University James Comprehensive Cancer Center|Kristie Blum, MD|614-293-7807|Kristie.Blum@osumc.edu|
22303454|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com|
22303455|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu|
22303456|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22303457|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org|
22303458|NCT03912220|Johns Hopkins University|Dr. Ahmet Hoke|410-955-2227|ahoke1@jh.edu|
22303459|NCT04719013|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22303460|NCT04175912|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22303461|NCT04654468|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303462|NCT01155661|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303463|NCT05064735|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22303464|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu|
22303465|NCT04694482|ASST Monza|Dr. Alice Caldiroli|+3495009941|a.caldiroli@asst-monza.it|
22303466|NCT04844970|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
22303467|NCT00447954|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22303468|NCT03757234|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22303469|NCT03599986|DataClin|Medical Writer|(+2) 01001566602|mariam.abdalla@dataclin.com|
22303470|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org|
22303471|NCT04908449|Medical College of Wisconsin|Dr. Anne L. Castro|(414) 805-8700|anncastro@mcw.edu|
22303472|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu|
22285011|NCT03696589|Teachers College, Columbia University|Lori Quinn|212-678-3424|lq2165@tc.columbia.edu|
22303473|NCT02401308|St. Joseph's Hospital and Medical Center|Lisa Arnold - Operations Manager Neurosurgery Clinical Research|602-406-9593|lisa.arnold@dignityhealth.org|
22303474|NCT02736968|University of California, San Diego|Sharon Reed, MD|858-822-2808|slreed@ucsd.edu|
22319667|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu|
22285012|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285013|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22285014|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285015|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285016|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org|
22285017|NCT04016844|University of Iowa|Dr.Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22285018|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300||
22285019|NCT01534195|Ora|Keith Lane|9786896500|klane@oraclinical.com|
22285020|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22285021|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
22285022|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu|
22285023|NCT03068767|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Chief of internal medicine department|+886-2-6628-9779|uld888@yahoo.com.tw|2317
22285024|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22285025|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285026|NCT04254666|University of Massachusetts Chan Medical School|Carol Curtin|774-455-6527|carol.curtin@umassmed.edu|
22285027|NCT02798978|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285028|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22285029|NCT01946152|UT MD Anderson Cancer Center|Michael Wang,MD/ Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
22285030|NCT03712787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22285031|NCT01865448|Unidad de Apoyo a la Investigacion. Hospital Rio Hortega|Dr. Daniel de Luis|983420400|dadluis@yahoo.es|83523
22285032|NCT03499314|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
22285033|NCT01618695|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22285034|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu|
22285035|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org|
22285036|NCT00439296|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22285037|NCT00931606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285038|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285039|NCT02391363|Baylor College of Medicine|Melinda A. Stanley, PhD|713-794-8841|mstanley@bcm.edu|
22285040|NCT00799266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22303475|NCT02294474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22303476|NCT02961374|Cancer Prevention Network (CPN) - Mayo Clinic College of Medicine|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
22285041|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22285042|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
22303477|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de|
22303478|NCT02041923|University of Illinois at Chicago|Rosemary White-Traut|312-996-7935|rwt@uic.edu|
22303479|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303480|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22303481|NCT00874432|University of Wisconsin - Madison|Dr. Arjang Djamali|(608) 262-9306|axd@medicine.wisc.edu|
22303482|NCT05256381|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
22303483|NCT01518946|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@shire.com|
22303484|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
22303485|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303486|NCT03864926|University of Wisconsin Hospital and Clinics|Sandesh Parajuli, MD, MBBS|(608) 265-0152|sparajuli@medicine.wisc.edu|
22303487|NCT00445601|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|206-667-2933|ctangen@fredhutch.org|
22303488|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22303489|NCT01091428|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22303490|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de|
22303491|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu|
22303492|NCT02873286|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22303493|NCT03918239|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@takeda.com|
22303494|NCT01439087|Massachusetts General Hospital|Gary Tearney, MD, PhD|617-724-2979|GTEARNEY@PARTNERS.ORG|
22303495|NCT01984424|Amgen Inc.|Study Director|866-572-6436||
22273742|NCT04613739|Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|617-867-4893|alison_galbraith@harvardpilgrim.org|
22273743|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22273744|NCT05137717|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22273745|NCT02619617|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22273746|NCT02946892|UTSW|Ryan Butts|2144565822|ryan.butts@utsouthwestern.edu|
22273747|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22273748|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300|ablight@acorda.com|102
22273749|NCT02644278|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22273750|NCT02862080|The University of Texas Health Science Center at Houston|Marcie Kern, PT, MSPT|713-799-6995|neurorecoveryresearch@memorialhermann.org|
22273751|NCT00891813|Abbott|Global Medical Services|1-800-633-9110||
22273752|NCT05438277|Campbell Foundation|Research Manager|9017595413|mknack@campbell-foundation.org|
22273753|NCT01723072|Novartis Pharmaceuticals|Study Director|1-888-669-6682||
22273754|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028||
22273755|NCT04474483|University at Buffalo, SUNY|Sanjay Sethi MD|7168884864|ssethi@buffalo.edu|
22303496|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw|
22273756|NCT05926648|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22273757|NCT01805895|Augusta University|Dr Jeffrey Switzer|7067211691|jswitzer@augusta.edu|
22273758|NCT03064113|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22273759|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org|
22273760|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com|
22273761|NCT03075267|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22273762|NCT03874013|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22303497|NCT01807221|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22303498|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu|
22303499|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183||
22303500|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303501|NCT01649596|Genesys Regional Medical Center|Surgeon|810-606-6500|twasfie@gmail.com|
22303502|NCT01617083|University of South Florida Rothman Center|Study Coordinator|7277678393|ebrenna1@health.usf.edu|
22303503|NCT01757665|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Program Management|949-250-2500|aya_westbrook@edwards.com|4035
22303504|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
22303505|NCT03632434|University of East London|Professor Cynthia Fu|07563 240193|c.fu@uel.ac.uk|
22303506|NCT04297241|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
22303507|NCT04038346|University of Pittsburgh Children's Hospital of Pittsburgh|Desiree Neville|412-692-7692|desiree.neville@chp.edu|
22303508|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22303509|NCT02836613|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22303510|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025|egarcia@umh.es|2025
22303511|NCT04276090|University of Kentucky|Dr. Michael Cavnar|859-323-8920|michael.cavnar@uky.edu|
22303512|NCT04131959|CytoSorbents|CytoSorbents|732-329-8885|info@cytosorbents.com|
22303513|NCT02874066|National Taiwan University Hospital|Chen-Hua Liu|+886-972651880|jacque_liu@mail2000.com.tw|
22303514|NCT03141528|Inselspital|Dr. Tina Pedersen|+4522125797|tinaheidipedersen@yahoo.dk|
22303515|NCT02667444|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22303516|NCT01597388|AstraZeneca|Julie Charlton|+ 01625-582828|ClinicalTrialTransparancy@astrazeneca.com|
22303517|NCT05407311|Clarity Pharmaceuticals|Dr. Othon Gervasio, Chief Medical Officer|+61 (0)2 9209 4037|info@claritypharmaceuticals.com|
22303518|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22303519|NCT01263106|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303520|NCT05525286|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
22303521|NCT05027074|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22303522|NCT03169881|University of Utah|Robin K Ohls, MD|801-581-7052|robin.ohls@hsc.utah.edu|
22303523|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
22303524|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22303525|NCT02180438|University of Washington|Dr. Geoffrey S Gottlieb. MD PhD (PI)|1-206-616-2631|gottlieb@uw.edu|
22303526|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
22303527|NCT02090634|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
22303528|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no|
22303529|NCT02578914|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22303530|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org|
22303531|NCT03396432|Children Hospital of Philadelphia|Dr. John Fiadjoe, PI|267-426-2961|fiadjoej@email.chop.edu|
22303532|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu|
22303533|NCT01719900|University of Calgary|Dr. Raylene Reimer|14032208218|reimer@ucalgary.ca|
22303534|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu|
22273763|NCT03335800|Associate Professor of Medicine, Stanford University|Minang (Mintu) Turakhia, Associate Professor of Medicine, Stanford University|(650) 493-5000|mintu@stanford.edu|
22273764|NCT02389959|Stanford University|Peter H. Hwang, MD|(650) 723-5281|hwangph@stanford.edu|
22273765|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com|
22273766|NCT01678664|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22273767|NCT01074177|Massachusetts General Hospital|Lecia Van Damn Sequist|617-724-4000|lvsequist@partners.org|
22273768|NCT01401543|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273769|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu|
22273770|NCT01801111|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22273771|NCT01210482|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273772|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22273773|NCT03284853|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. Vice President, Clinical Development & Medical Affairs.|+1 908 947 3551|msenchyna@aeriepharma.com|
22273774|NCT05176717|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
22273775|NCT02058589|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273776|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273777|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22273778|NCT02308228|University of Kentucky|Douglas Long|859-323-5438|DELONG2@UKY.EDU|
22273779|NCT02143024|UC Davis Department of Psychiatry and Behavioral Sciences|Ladson Hinton, MD|(916) 734-3485|lwhinton@ucdavis.edu|
22285043|NCT04794270|Johnson & Johnson VIsion Care, Inc.|Benjamin Straker - Principal Research Optometrist|1-904-312-0604|bstraker@its.jnj.com|
22285044|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285045|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22285046|NCT06831513|UT Southwestern Medical Center - School of Health Professions|Dara Spivey, CPO, LPO|(214) 645-8250|dara.spivey@utsouthwestern.edu|
22285047|NCT05148806|NHS Blood and Transplant|Gillian Powter Trial Manager|44 7590 353091|gillian.powter@nhsbt.nhs.uk|
22285048|NCT04042324|Rockwell Medical, Inc|Raymond Pratt, MD|248 960 9009|rpratt@rockwellmed.com|405
22285049|NCT03251937|Boston Scientific|Director of Clinical Sciences|661 949 4350|roshini.jain@bsci.com|
22285050|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu|
22303535|NCT04536571|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22285051|NCT01504841|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22285052|NCT04756804|Zurex Pharma, Inc.|VP, Reg Affairs|608.203.9090|customercare@zurexpharma.com|
22285053|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com|
22285054|NCT03149055|Memorial Sloan Kettering Cancer Center|Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
22285055|NCT04440813|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
22285056|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
22285057|NCT04648683|Vanderbilt University Medical Center|Carrie Brintz|615-875-9885|carrie.brintz@vumc.org|
22285058|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu|
22285059|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
22285060|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
22303536|NCT01567865|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22303537|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963||
22285061|NCT01504412|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
22285062|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
22285063|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu|
22285064|NCT05362058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22285065|NCT04774926|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285066|NCT01393639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285067|NCT03626545|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22285068|NCT04274556|Demiroglu Bilim University|Nurten OZEN|+90 212 213 64 86|ozenurten@yahoo.com.tr|
22285069|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
22285070|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov|
22285071|NCT05651867|Quantum Surgical|Marion Chassouant|0033781425198|m.chassouant@quantumsurgical.com|
22285072|NCT02462720|BTG International Inc.|Lynn Allen|425-410-3152|lynn.allen@btgplc.com|
22285073|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se|
22285074|NCT03397342|Montefiore Medical Center|Dr. Madhur Garg|718-920-4140|mgarg@montefiore.org|
22285075|NCT05173012|Sage Therapeutics|Carrie Vaudreuil|(857) 259-4766|carrie.vaudreuil@sagerx.com|
22303538|NCT04613882|Coopervision|Jose A. Vega, OD, MSc, FAAO|9256213761|javega@coopervision.com|
22273780|NCT06597084|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
22273781|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil|
22273782|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
22273783|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436||
22273784|NCT06450457|The University of Texas Health Science Center at Houston|Kaitlin Benjamin, PT, DPT|610-639-0431|Kaitlin.Benjamin@memorialhermann.org|
22273785|NCT03999749|NYU Langone Health|Janice Mehnert, M.D.|212-731-5431|janice.mehnert@nyulangone.org|
22273786|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22273787|NCT04570709|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|Melahat_Canter@med.unc.edu|
22273788|NCT02359110|Penn State Milton S. Hershey Medical Center|Timothy Deimling, M.D.|717-531-3503|tdeimling@pennstatehealth.psu.edu|
22273789|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22273790|NCT03045653|Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative innovation center for Cancer Medicine|Zhongyu Yuan|+8613798027658|yuanzhy@sysucc.org.cn|
22273791|NCT02962427|University of Colorado|Cristina Wood, MD|7208483323|cristina.wood@ucdenver.edu|
22273792|NCT02189668|Nationwide Children's Hospital|Peter Minneci|6147223066|peter.minneci@nationwidechildrens.org|
22273793|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu|
22273794|NCT03934216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22273795|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22273796|NCT04735705|Perfect Care Distribution|Mihnea Mihalache, Chief Executive Officer|+40 786 749 087|contact@perfectcare.ro|
22273797|NCT03627832|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
22273798|NCT01950299|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
22273799|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com|
22273800|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22273801|NCT00815997|NPO International TRI Network|Sigeru Saito, MD, Principal Investigator|+81-467-461717|saito@shonankamakura.or.jp|10490
22273802|NCT04110314|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22273803|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273804|NCT04685993|Lipocine Inc|Senior Director of Clinical Development|801.994.7383|admin@lipocine.com|
22273805|NCT04658797|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22273806|NCT01711983|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22273807|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273808|NCT05270980|NYU Langone Health|Dr. Joshua Chodosh|212-263-6768|Joshua.Chodosh@nyulangone.org|
22273809|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273810|NCT00115778|Columbia University Medical Cetner|Selim Arcasoy, MD|212-305-7771|sa2059@columbia.edu|
22273811|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org|
22273812|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22273813|NCT06060496|University of Kentucky|Gopalkumar Rakesh, MD|8592579402|gopalkumar.rakesh@uky.edu|
22273814|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu|
22273815|NCT00149396|Medigene|Associate Director Regulatory Affairs|858-586-2252|p.larson@medigeneusa.com|
22273816|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22273817|NCT00367003|Emory University|Dr. Patricio Riva Posse||privapo@emory.edu|
22273818|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu|
22273819|NCT05225389|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
22273820|NCT03113968|Department of Psychiatry, Mass General Brigham, and Harvard Medical School|Dr. Amit Anand|6177266421|aanand7@bwh.harvard.edu|
22273821|NCT04805671|INVIVYD, Inc.|Study Inquiry|+1 781-819-0080|ClinicalTrials@invivyd.com|
22273822|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22273823|NCT03804268|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22273824|NCT02849587|University of California, San Diego; Center for Medicinal Cannabis Research|Thomas D. Marcotte, Phd|619-543-5044|tmarcotte@ucsd.edu|
22273825|NCT03380377|Cedars Sinai Medical Center|Stan Jordan, MD|3104232641|stan.jordan@cshs.org|
22273826|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu|
22273827|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273828|NCT03421379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22273829|NCT04010461|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
22273830|NCT03771963|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22273831|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702|zarko@liverpool.ac.uk|4100
22273832|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov|
22273833|NCT00826150|BioCancell Ltd.|VP Clinical|+97225486553|monique.ben-am@biocancell.com|
22273834|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22273835|NCT03360019|University of Florida|Glenn Smith|352-273-6556|glennsmith@ufl.edu|
22273836|NCT03801642|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
22273837|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22273838|NCT01462110|Johnson & Johnson Consumer Inc.|Michael Lynch|908-433-6423|mlynch23@ITS.JNJ.com|
22273839|NCT05279131|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22273840|NCT01211756|UCSD|David Feifel||dfeifel@kadimanp.com|
22273841|NCT01242241|Baylor College of Medicine|Dr. Olutoyin A. Olutoye|832-824-5800|oao@bcm.edu|
22273842|NCT02477358|University of Nebraska Medical Center|Elisabeth Easley|530-524-6020|eleasley@gmail.com|
22273843|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343||
22273844|NCT02106351|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22273845|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22273846|NCT02735473|University of Minnesota|Jeffrey R Wozniak|612-273-9741|jwozniak@umn.edu|
22273847|NCT04754542|University of Colorado Denver|Eric Engebretson|3037244518|eric.engebretson@cuanschutz.edu|
22273848|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273849|NCT04428385|Duke University|Wendy Prudhomme - O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
22273850|NCT03713684|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22273851|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22273852|NCT02515630|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22273853|NCT03870334|NImmune|Project Management|(540) 944-4545|pm@nimmun.com|
22273854|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22273855|NCT00974311|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22273856|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com|
22273857|NCT00458003|Northwestern University|Paul Fitzgerald|312-6951064|p-fitzgerald2@northwestern.edu|
22273858|NCT03286218|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
22273859|NCT01164202|FFCD|Mrs Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22273860|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org|
22273861|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22273862|NCT02346708|University of Colorado Denver - Anschutz Medical Campus|Isabelle Buard, PhD|(303)724-5973|Isabelle.Buard@cuanschutz.edu|
22273863|NCT02976519|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273864|NCT03416270|University Health Network|Dr. David Cherney|416.340.4151|david.cherney@uhn.ca|
22273865|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22273866|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu|
22273867|NCT06331507|University of Michigan|Prachi Agarwal|734-232-5132|prachia@med.umich.edu|
22273868|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300||
22273869|NCT03760224|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
22273870|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com|
22273871|NCT02276963|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
22273872|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601||
22273873|NCT00473655|AstraZeneca|Gerard Lynch|09645895|aztrial_results_posting@astrazeneca.com|44 15
22273874|NCT02076100|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22273875|NCT04556760|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
22285076|NCT03668613|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285077|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu|
22285078|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22285079|NCT04776317|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
22285080|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu|
22285081|NCT03100058|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285082|NCT00465088|Abbott|Global Medical Services|800-633-9110||
22285083|NCT03671304|UT Southwestern Medical Center|Dr. Muhammad Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
22285084|NCT01067144|Stanford University|Dr. Ian Carroll|(650) 723-6411|ic38@stanford.edu|
22285085|NCT01871441|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Neal Flomenberg|215 955-0182|dolores.gross@jefferson.edu|
22285086|NCT02718716|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22285087|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285088|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285089|NCT01578577|Northwestern University|Dr. Stephen Persell|312-503-6464|spersell@nm.org|
22285090|NCT04406649|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
22285091|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
22285092|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com|
22285093|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
22285094|NCT04016259|The University of Texas Health Science Center at Houston|"Hyochol Brian Ahn, PhD, RN, MSN, Associate Professor"|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
22273876|NCT02513550|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273877|NCT02849743|The Children's Hospital of Philadelphia|Dr. Shana McCormack|(215) 590-3174|mccormacks1@chop.edu|
22285095|NCT05758402|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22285096|NCT02332291|Vanderbilt University Medical Center|Warren D. Taylor, MD, MHSc|615-322-1073|warren.d.taylor@vumc.org|
22285097|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
22285098|NCT01424228|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285099|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu|
22285100|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
22285101|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22285102|NCT02478255|Duke University|Bastiaan Driehuys, PhD (Professor of Radiology)|919 684-7786|bastiaan.driehuys@duke.edu|
22285103|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
22285104|NCT02813889|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
22285105|NCT05589610|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
22285106|NCT05224453|Prince Sattam bin Abdulaziz University|Dr. Gopal Nambi|0501878382|physio_gopal@rediffmail.com|
22285107|NCT02974257|BIDMC|Dr. Katherine Berg|617-754-2281|kberg@bidmc.harvard.edu|
22285108|NCT00398567|Puma Biotechnology, Inc|Senior Director, Clinical Operations|+1 424 248 6500|clinicaltrials@pumabiotechnology.com|
22285109|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285110|NCT00345865|Masonic Cancer Center, University of Minnesota|Dr.Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22285111|NCT03250182|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22285112|NCT05979922|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
22285113|NCT03472950|University of Kansas Medical Center|Jeffrey Statland, MD|913-945-9933|Jstatland@kumc.edu|
22285114|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
22285115|NCT03386487|Yale University|Dr. Deepak Cyril D'Souza, M.D.|203-932-5711|deepak.dsouza@yale.edu|2594
22285116|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
22285117|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285118|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu|
22285119|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22285120|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
22285121|NCT05234957|Benha University|Dr. Mohamed Farid|00201003354636|mohamed.farid@fmed.bu.edu.eg|
22285122|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu|
22285123|NCT01340053|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
22285124|NCT00894361|PI/study coordinator retired due to personal family health matters and study sponsor then withdrew funding. Study terminated and no data was collected or analyzed from any participant.|Terence J. Gioe, M.D.||tjgioe@gmail.com|
22285125|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu|
22285126|NCT04207060|Mayo Clinic|Dr. Santhi Swaroop Vege|(507) 266-6931|vege.santhi@mayo.edu|
22285127|NCT05438576|Mayo Clinic|Demilade Adedinsewo, M.B, Ch.B.|904-953-0859|adedinsewo.demilade@mayo.edu|
22285128|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu|
22285129|NCT02881762|University of Maryland, Baltimore|Dr Lydia Tang|14107066567|lydiatang@ihv.umaryland.edu|
22285130|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu|
22285131|NCT04054375|Northwestern University School of Medicine|Dr. Senda Ajroud-Driss|(312) 944-0063|s-ajroud@northwestern.edu|
22285132|NCT00296140|Roudebush VA Medical Center|Dr. Linda Williams|317-988-2715|Linda.Williams6@va.gov|
22285133|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
22285134|NCT01843062|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22285135|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22285136|NCT02669212|National Institutes of Health|Dr. Brian Walitt|202-549-7669|brian.walitt@nih.gov|
22285137|NCT02465372|Wake Forest University Health Sciences|Dr. Justin Moore|336-716-3702|jusmoore@wakehealth.edu|
22303539|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu|
22303540|NCT02274649|Shepherd Center|Michael Jones, PhD, Director Research|4043507595|mike_jones@shepherd.org|
22273878|NCT03677635|King's College London|Dr Clementine Edwards|07557866053|clementine.edwards@kcl.ac.uk|
22273879|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400|michael.krebs@meduniwien.ac.at|43120
22273880|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu|
22303541|NCT01051063|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303542|NCT05569954|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22303543|NCT02708433|University of North Carolina at Chapel Hill|Raymond P. White, Jr. DDS, PhD|919-537-3944|ray_white@unc.edu|
22303544|NCT04885530|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22303545|NCT03857841|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22303546|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303547|NCT01774071|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|646-888-2212|LarsonS@MSKCC.ORG|
22303548|NCT04386746|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Max Kates, MD|4105028130|mkates@jhmi.edu|
22285138|NCT03549104|University of Illinois at Chicago|Pamela Martyn-Nemeth|312-996-7903|pmartyn@uic.edu|
22285139|NCT04124705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22285140|NCT04164732|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285141|NCT01716455|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285142|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22285143|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu|
22285144|NCT03197922|Emory University|Nathan Call, PhD|404-785-9428|ncall@emory.edu|
22285145|NCT02540993|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22285146|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22285147|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22285148|NCT03777319|The Abigal Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-722-5615|kevin.flanigan@nationwidechildrens.org|
22285149|NCT02951429|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22285150|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org|
22285151|NCT03997825|Relievant Medsystems|Diane Sahr, VP of Clinical Research|(650) 368-1000|dsahr@relievant.com|
22285152|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22285153|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
22285154|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22285155|NCT02841241|Intermountain Medical Center|Office of Research|8015077000|officeofresearch@imail.org|
22285156|NCT02387008|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidget_jenkins@unc.edu|
22285157|NCT04356352|Wake Forest University Health Sciences|Michael Norton, MD|336-716-8791|mnorton@wakehealth.edu|
22285158|NCT02518191|Shanghai 6th People's Hospital Affiliated to Shanghai Jiao Tong University|Dr. ZONG|86 (21) 24058549|tigerzong@msn.com|
22285159|NCT05546229|Cari Health Inc.|Chief Medical Officer|619 2343725|drcarr@carihealth.com|
22285160|NCT01983774|Columbia University|Emily DiMango, MD|212-305-0631|ead3@cumc.columbia.edu|
22285161|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
22285162|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285163|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com|
22285164|NCT00830180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285165|NCT01832532|Cincinnati Children's Hospital Medical Center|Raouf Amin, MD|(513) 636-7945|Raouf.Amin@cchmc.org|
22285166|NCT01630889|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|059study@fibrogen.com|
22285167|NCT02355210|University of Nebraska-Lincoln|Heather Rasmussen, Assistant Professor|402-472-1373|hrasmussen2@unl.edu|
22285168|NCT03824587|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22285169|NCT01300572|Fred Hutchinson Cancer Research Center|Brenda Sandmaier, MD|(206) 667-4961|bsandmai@fredhtuch.org|
22289089|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com|
22303549|NCT04435795|Research Institute of the McGill University Health Center|Dr Nicole EZER|514-934-1934|nicole.ezer@mcgill.ca|76192
22303550|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org|
22303551|NCT02959138|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22303552|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22303553|NCT04213989|Laser Lipo and Vein Center|Thomas Wright, MD|636-397-4012|info@laserlipoandveins.com|
22303554|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303555|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu|
22303556|NCT03390036|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
22285170|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303557|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu|
22273881|NCT04919317|Temple University Hospital|George Taylor, MD, MS; surgical resident|2678150512|George.Taylor@tuhs.temple.edu|
22273882|NCT01566604|Novartis|Study Director|862-778-8300||
22273883|NCT00972959|"Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens,"|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr|
22273884|NCT02895035|Penn State Hershey Eye Center|Seth Pantanelli|717-531-5690|spantanelli@pennstatehealth.psu.edu|
22273885|NCT02572453|Dana-Farber Cancer Institute|Jillian Foreman|1-877-338-7425|jillianM_foreman@dfci.harvard.edu|
22273886|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22273887|NCT03861091|Wake Forest Baptist Comprehensive Cancer Center|Biostatistician|336-716-5440|blevine@wakehealth.edu|
22273888|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
22273889|NCT03626701|AVITA Medical|Elizabeth Kirshner|661-877-6869|ekirshner@avitamedical.com|
22273890|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273891|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu|
22273892|NCT02899065|UC Davis Medical Center|Larissa May, MD, MSHS, MSPH, Director of Emergency Medicine Innovation and External Partnerships|916-734-1593|lsmay@ucdavis.edu|
22273893|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22273894|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22273895|NCT01922258|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22273896|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov|
22273897|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu|
22273898|NCT00614172|Loma Linda University Health|David Bush, MD, Vice Chair Clinical Affairs Radiation Medicine|909 558 1000|DBush@llu.edu|
22273899|NCT02782741|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22273900|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
22273901|NCT05918406|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|marian.macsai@viatris.com|
22273902|NCT01497067|Alcon Research|Sr. Clinical Trial Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22273903|NCT01275144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22273904|NCT05116202|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22273905|NCT01852513|The University of Chicago|Dr. Jayant Pinto, PI|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
22273906|NCT01871077|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|drricardollamas@gmail.com|1259
22273907|NCT04457362|NYU Langone Health|Nader Paksima|2122632193|Nader.Paksima@nyulangone.org|
22273908|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22273909|NCT02864407|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22273910|NCT02992119|MORU|Lorenz von Seidlein|662036663|Lorenz@tropmedres.ac|
22273911|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org|
22273912|NCT02686164|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22273913|NCT00401518|Globus Medical|Director of Clinical Affairs|610-930-1800|jmyer@globusmedical.com|
22273914|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th|
22273915|NCT02465164|Central Clinical Trials Office|Central Clinical Trials Office|3139537454|smarl1@hfhs.org|
22273916|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22273917|NCT02324361|Partners Healthcare|Study Project Manager|4259856430|szan@mail.harvard.edu|
22273918|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br|
22273919|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu|
22273920|NCT03110133|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
22273921|NCT03030625|Hospital Universitario de La Princesa|Dr. Almudena Zapatero Laborda|+34 915 20 22 00|almudena.zapatero@salud.madrid.org|
22273922|NCT02223351|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22273923|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22273924|NCT03571724|22nd Century Group, Inc.|Karen E. Delaney|716-270-1523|kdelaney@xxiicentury.com|
22273925|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285171|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu|
22285172|NCT02461745|Southern California Permanente Medical Group|Division of Clinical Trials Research|(626) 564-5667|clinical.trials@kp.org|
22285173|NCT02921087|SUNY College of Optometry Clinical Vision Research Center|Danielle Iacono, OD|212-938-5936|diacono@sunyopt.edu|
22285174|NCT05128578|University of Pittsburgh|Shari Rogal|412-360-6177|rogalss@upmc.edu|
22285175|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991|jfgy@ufl.edu|225
22285176|NCT02837029|Northwestern University, Feinberg School of Medicine|Aparna Kalyan, MBBS, FRACP|312 926 4291|Aparna.kalyan@northwestern.edu|
22285177|NCT01363908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285178|NCT05258149|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
22285179|NCT03370042|Kamineni Institute of dental sciences|Dr. Raga Bindu|09849441800|ragha.j16@gmail.com|
22285180|NCT03437577|University of Minnesota|Susan Marino|612-624-2964|marin007@umn.edu|
22285181|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu|
22285182|NCT00526591|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
22285183|NCT02461927|VA CT Healthcare System, Yale University|Dr. Gihyun Yoon|(203) 932-5711|gihyun.yoon@yale.edu|7421
22289090|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285184|NCT04273893|University of Virginia|UVA Radiation Oncology Clinical Research Coordinator|434-243-0008|UVARADONCClinicalTrials@uvahealth.org|
22285185|NCT05613257|Cedars Sinai Medical Center|Joel Arnold|310-423-9839|joel.arnold@cshs.org|
22285186|NCT02159976|Department of Internal Medicine, Seoul National University Bundang Hospital|Nayoung Kim, M.D., Ph.D.|+ 82-31-787-7008|nayoungkim49@empas.com|
22285187|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623||
22285188|NCT02936843|The University of Michigan|Rodica Pop-Busui, MD, PhD|Phone 734-647-9809|rpbusui@med.umich.edu|
22285189|NCT01393821|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-7202|Jatoi.Aminah@mayo.edu|
22285190|NCT05419232|Nationwide Children's Hospital|Jason Newland|6147223416|jason.newland@nationwidechildrens.org|
22285191|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu|
22285192|NCT02608463|University of Arkansas for Medical Sciences|Dr. Shona Ray-Griffith|501-526-8428|slray@uams.edu|
22285193|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu|
22285194|NCT01439594|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
22285195|NCT02932748|University of Kansas Medical Center|Anna M. Gorczyca, PhD|913-588-9077|agorczyca@kumc.edu|
22285196|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com|
22285197|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu|
22285198|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com|
22285199|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
22285200|NCT00773747|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285201|NCT00836186|Johns Hopkins University|Jean Wright, MD PI|410-614-3950|jwrigh71@jhmi.edu|
22285202|NCT04079816|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22285203|NCT03422536|University of Arizona Cancer Center|Rachel Jarrett|5206260375|rjarrett@email.arizona.edu|
22303558|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
22303559|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org|
22303560|NCT03884231|Abbott|Tucker Tomlinson|+1/ 972 526 9646|tucker.tomlinson@abbott.com|
22303561|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
22285204|NCT01973998|Lewis Katz School of Medicine Temple University|Michael R. Jacobs - Director of Research Development|2157072242|michael.jacobs@tuhs.temple.edu|
22285205|NCT01763606|Memorial Sloan Kettering Cancer Center|Dr. Lisa DeAngelis, MD|212-639-8000|deangell@mskcc.org|
22285206|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com|
22285207|NCT03937960|University of Alabama at Birmingham|Dr. Bhuvana Sunil|2056389107|dr.bhuvana.s@gmail.com|
22285208|NCT02160145|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Devlopment|609 524 6788|clinicaltransparency@otsuka-us.com|
22285209|NCT04867733|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
22303562|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com|
22285210|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu|
22303563|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com|
22285211|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca|
22285212|NCT01620528|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22285213|NCT04569357|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22285214|NCT01122849|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285215|NCT03256253|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
22285216|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
22285217|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285218|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285219|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
22285220|NCT05392803|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
22303564|NCT04176133|Mayo Clinic|Robert J. Pignolo, MD, PhD|507-255-8716|Pignolo.Robert@mayo.edu|
22303565|NCT03076359|Vanderbilt University|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
22303566|NCT02040792|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22303567|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303568|NCT03888885|The Chinese University of Hong Kong|Dr. Sum Kim Wai Raymond|+852 39436091|kwsum@cuhk.edu.hk|
22303569|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22303570|NCT01938664|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
22303571|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303572|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu|
22303573|NCT02165904|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
22303574|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net|
22303575|NCT01027364|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22303576|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu|
22303577|NCT02222896|Microbac|Dr. Bashir|703-925-9366|muhammad.bashir@microbac.com|
22303578|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22303579|NCT01865617|Fred Hutchinson Cancer Research Center|Dr. Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
22303580|NCT02500979|AstraZeneca|Dr. Peter Ohman|+1 (301) 398-0120|Peter.Ohman@astrazeneca.com|
22303581|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca|
22303582|NCT03772314|Emory University|Dr. Lynn Marie Trotti|404-712-7240|lbecke2@emory.edu|
22303583|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303584|NCT02354963|IIS La Fe|Dr Cesar Diaz-Garcia|961 24 67 00|cesar.diaz@ivirma.com|
22303585|NCT04267614|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303586|NCT02707523|UAB|Dr. Michele Kong, PI|205-6389387|mkong@peds.uab.edu|
22303587|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22303588|NCT03853317|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22303589|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303590|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22303591|NCT02141659|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22303592|NCT01927731|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
22303593|NCT00886262|Medical University of South Carolina|Dr. Scott Reeves|843-792-5699|reevess@musc.edu|
22303594|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22285221|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22303595|NCT03881059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22303596|NCT02743793|DAIT/NIAID|Director, Clinical Research Operations Program|13015947669|DAITClinicalTrialsGov@niaid.nih.gov|
22303597|NCT02065570|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22303598|NCT02697006|Fresenius MCD|Dr. Anja Derlet-Savoia|+49 6172 608 2801|Anja.Derlet@fmc-ag.com|
22303599|NCT01844193|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
22303600|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350|thomas.ortel@duke.edu|3
22285222|NCT02220712|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22285223|NCT03533244|Allgenesis Biotherapeutics|Tan Nguyen|+886-2-8787-1232|tan.nguyen@allgenesis.com|
22285224|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be|
22285225|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov|
22285226|NCT02561221|Pennington Biomedical Research Center|Dr. Peter T. Katzmarzyk, Associate Executive Director of Population and Public Health Sciences|225-763-2536|doctors@pbrc.edu|
22285227|NCT03368235|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22285228|NCT01743040|UCLA Biomed|Joseph Thomas, MD|310-222-2544|jthomas@labiomed.org|
22285229|NCT04378114|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
22285230|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net|
22285231|NCT00392990|Northwestern University|Leo Gordon, MD||l-gordon@northwestern.edu|
22285232|NCT04331002|University of Kentucky|Dr. Austin Stone|859-218-3131|austin.stone@uky.edu|
22285233|NCT03845738|Dentsply IH AB d.b.a Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 31 376 30 00|annakarin.lundgren@dentsplysirona.com|
22285234|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22285235|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu|
22285236|NCT00991406|Cleveland VAMC|Elizabeth Hardin|216-791-3800|Elizabeth.HardinvandenBogert@va.gov|4698
22285237|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
22285238|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22285239|NCT03755661|Boston University|LaNeia Thomas|617-358-6346|laneia@bu.edu|
22285240|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu|
22285241|NCT04000581|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22285242|NCT02110264|UCLA|David Farabee|3109630009|dfarabee@mednet.ucla.edu|
22285243|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400|armin.witt@meduniwien.ac.at|2821
22285244|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org|
22285245|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22285246|NCT03188510|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22285247|NCT05261009|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-4498|dhenshaw@wakehealth.edu|
22285248|NCT01736618|Boston Scientific - Rhythm Management|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
22285249|NCT02634827|Mayo Clinic|Aref Al-Kali, MD|507-538-0871|AlKali.Aref@mayo.edu|
22285250|NCT04167137|Synlogic|Aoife Brennan, MB, BCh, BAO, MMSc|(857) 999-0767|aoife@synlogictx.com|
22285251|NCT02762331|Virginia Commonwealth University|Donald Brophy, PharmD|(804) 827-1455|dbrophy@vcu.edu|
22285252|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu|
22285253|NCT03621657|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
22285254|NCT03058692|Baylor College of Medicine|Robert L. Atmar, M.D.|713-798-6849|ratmar@bcm.edu|
22285255|NCT04255862|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22285256|NCT05111249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285257|NCT00555880|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285258|NCT02346461|National Human Genome Research Institute|Carrillo, Nuria|+1 301 402 2324|nuria.carrillo@nih.gov|
22285259|NCT03004911|School of Medicine at the University of Sao Paulo|Amélia Pasqual Marques|+55 11 3091 7451|pasqual@usp.br|
22285260|NCT00941915|Assistant Research Practice Manager|Joan Cahill, BSN RN OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
22285261|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
22285262|NCT02679755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285263|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285264|NCT02477124|Duke University|Jennifer Gallagher|9199701551|jennifer.gallagher@duke.edu|
22285265|NCT03038126|University of Maryland Baltimore|Jeffrey C. Fink, MD MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
22285266|NCT02610777|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22285267|NCT01724866|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22285268|NCT02324283|Juntendo University|Dr. Izumi Kawagoe|+81338133111|ikawago@juntendo.ac.jp|
22285269|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22285270|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
22285271|NCT01173601|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285272|NCT04737278|BDL Biochemistry, consultant for Mitosynergy|Dr Barbara Leinweber, PhD|(520)334-5444|barb@bdlbiochem.com|
22285273|NCT03671213|Moximed, Inc.|Rose Weinstein, Director of Clinical Affairs|415-312-0255|rsweinstein@moximed.com|
22285274|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com|
22285275|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22285276|NCT03223337|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285277|NCT03688074|AstraZeneca|Globall Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
22285278|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300||
22285279|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22285280|NCT00721188|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22285281|NCT03928717|Providence College|Dr. Nick Tarantino|4018651612|ntaranti@providence.edu|
22285282|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu|
22285283|NCT04171219|M.D. Anderson Cancer Center|Aung Naing, MD|713-563-3885|anaing@mdanderson.org|
22285284|NCT04809285|Medtronic|Binh Ngo (Clinical Research Director)|9492027218|binh.ngo@medtronic.com|
22285285|NCT03350815|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22285286|NCT03526146|San Francisco Veterans Affairs Health Care System, San Francisco, CA|Linda L. Chao|415-221-4810|linda.chao@ucsf.edu|24386
22285287|NCT03571555|Royal Holloway University of London|Dr. Michael Evangeli|00447801543681|michael.evangeli@rhul.ac.uk|
22285288|NCT02828436|University of Minnesota|Manda Keller-Ross|612-625-3175|kell0529@umn.edu|
22285289|NCT02644343|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
22285290|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285291|NCT01442714|Stanford University|Dr. Bruno Medeiros|650-723-5007|brunom@stanford.edu|
22285292|NCT01703507|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
22285293|NCT06068426|Cincinnati Children's|Dr. David Vitale|(513) 517-7040|David.Vitale@cchmc.org|
22285294|NCT05380505|NYU Langone Health|Marie Bragg, PhD|646-501-2717|Marie.Bragg@nyulangone.org|
22303601|NCT04642469|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22303602|NCT02733042|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22303603|NCT00787722|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22303604|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22303605|NCT03056859|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
22303606|NCT02838628|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22303607|NCT04193293|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22285295|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
22285296|NCT01979952|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285297|NCT01511068|Cincinnati Children's Hospital Medical Center|Dr. Bruce Trapnell|513636-6361|Bruce.Trapnell@cchmc.org|
22285298|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu|
22285299|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285300|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu|
22285301|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300||
22285302|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu|
22285303|NCT01856582|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD/Associate Professor of Pediatrics|513-803-9063|Rebecca.Marsh@cchmc.org|
22285304|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22285305|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200|robert.palmer@frx.com|8218
22285306|NCT04260347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285307|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com|
22285308|NCT03688620|GlaxoSmithKline|Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccines|877-379-3718|GSKClinicalSupportHD@gsk.com|
22285309|NCT02828020|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22285310|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu|
22285311|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org|
22285312|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com|
22285313|NCT03657095|Lung Biotechnology PBC Study Director|Lung Biotechnology PBC|301-608-9292|info@lungbiotechnology.com|
22285314|NCT01894243|AstraZeneca|Anitra Fielding - Senior Research Physician||ClinicalTrialTransparency@astrazeneca.com|
22285315|NCT02713659|The Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
22285316|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303608|NCT02303626|BioCryst Pharmaceuticals, Inc|VP Clinical Development|(+1) 919 859 1302|clinicaltrials@biocryst.com|
22285317|NCT04006392|Erchonia Corporation|Clinical Affiairs|888.242.0571|tsammons@erchonia.com|501
22285318|NCT01067469|UT MD Anderson Cancer Center|Dr. John F de Groot/Chair Ad Interim, Neuro-Oncology|713- 745-3072|jdegroot@mdanderson.org|
22285319|NCT01620944|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22285320|NCT03597061|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
22285321|NCT01748825|National Cancer Institute|Dr. Naoko Takebe|240-781-3320|takeben@nih.gov|
22285322|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu|
22285323|NCT02714283|Oregon Health & Science University|Emily Henkle, PhD, MPH|503-494-6226|henkle@ohsu.edu|
22285324|NCT01730586|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-7734|MOverman@mdanderson.org|
22285325|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com|
22285326|NCT03777059|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22285327|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu|
22285328|NCT02363621|Sierra Eye Associates|Dr. Arshad Khanani|775-329-0286|Arshad.Khanani@gmail.com|
22285329|NCT03056339|The University of Texas MD Anderson Cancer Center|Dr. Loretta Nastoupil, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-792-2860|lnastoupil@mdanderson.org|
22285330|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
22285331|NCT03974945|Rocky Mountain Regional Department of Veterans Affairs|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
22285332|NCT04506502|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22285333|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111|bruce.brew@svha.org.au|4100
22285334|NCT02214290|Texas Tech University|Dr. Arturo Figueroa|8068345587|arturo.figueroa@ttu.edu|
22285335|NCT02517541|Scientific and Regulatory affairs|Zenia M Størling|+45 49111869|dkzenst@coloplast.com|
22285336|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285337|NCT03782701|Bascom Palmer Eye Institute|Dr. Wendy Lee|(305) 243-2020|wlee@med.miami.edu|
22285338|NCT02551822|University of New Mexico Health Sciences Center, Department of Obstetrics & Gynecology, Division of Urogynecology|Dr. Yuko Komesu, MD|505-272-6382|YKomesu@salud.unm.edu|
22285339|NCT03574779|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285340|NCT01898429|Dartmouth Hitchcock Medical Center|Paul E. Holtzheimer, MD|603-650-4914|Paul.E.Holtzheimer@hitchcock.org|
22285341|NCT02553395|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22285342|NCT04846322|Yale University|Ula Hwang, MD|+1 (203) 7371774|ula.hwang@yale.edu|
22303609|NCT05832437|Columbia University School of Nursing|Maureen George|212-305-1175|mg3656@cumc.columbia.edu|
22303610|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22303611|NCT00882921|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22303612|NCT03662360|Clinica Luganese Moncucco|Dr. Med. Pio Fontana|0041919608712|pioeugenio.fontana@moncucco.ch|
22303613|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu|
22303614|NCT01722318|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22285343|NCT03369249|New York State Psychiatric Institute|Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
22285344|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22285345|NCT04112303|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22285346|NCT01685697|Univeristy of Alberta|Georg Schmolzer|7807354660|georg.schmoelzer@me.com|
22285347|NCT02703324|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285348|NCT01854034|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|lvsequist@partners.org|
22285349|NCT02096549|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
22285350|NCT04303572|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
22285351|NCT06312592|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsaystark@wustl.edu|
22285352|NCT04428619|UCLA|Lin Chang|310-206-0192|linchang@mednet.ucla.edu|
22285353|NCT03517228|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
22285354|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu|
22285355|NCT03781414|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285356|NCT03605914|The University of Texas Health Science Center at Houston|Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology|(713) 500-5410|Martin.J.Citardi@uth.tmc.edu|
22285357|NCT01620762|Circassia Ltd|VP Clinical Operations|+44 1865 405560||
22285358|NCT03521479|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
22285359|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org|
22285360|NCT03514433|Boston Medical Center|Tracy A Battaglia, MD, MPH|617 638 7428|Tracy.Battaglia@bmc.org|
22285361|NCT02161757|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22285362|NCT00391625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285363|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22285364|NCT03664765|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
22285365|NCT02275156|Amgen Inc.|Study Director|866-572-6436||
22285366|NCT01130896|Johns Hopkins University|Henry Halperin, MD|410-955-2412|nsaju1@jhmi.edu|
22303615|NCT03391960|3M|Helen Han|651-737-9234|mhan3@mmm.com|
22303616|NCT03677128|Duke University|Kristin Schroeder, MD MPH|919-668-6288|kristin.schroeder@duke.edu|
22285367|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285368|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu|
22303617|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu|
22319668|NCT04163900|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
22285369|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com|
22285370|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu|
22285371|NCT02019875|University of Washington|Kenneth Thummel|206-543-0819|thummel@u.washington|
22285372|NCT03202134|AZSintJanAV|Jan Mulier|003250452490|jan.mulier@azsintjan.be|
22285373|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22285374|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu|
22285375|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285376|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22285377|NCT02467842|SK bioscience|Hayoung Lee|+82-2-2008-2552|haylee@sk.com|
22285378|NCT02873338|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22285379|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
22285380|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net|
22285381|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
22285382|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22285383|NCT02006979|University of Alberta|Dr. Amy Kirkham, Postdoctoral Research Fellow|7804926874|amy.kirkham@ualberta.ca|
22285384|NCT06037408|Emphycorp, Inc.|Dr. Alain Martin|(908) 237-1561|al.martin.hq@emphycorp.com|
22285385|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu|
22285386|NCT03477838|Virginia Commonwealth University|Evan Sisson, PharmD|804-828-8076|emsisson@vcu.edu|
22285387|NCT01931163|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
22285388|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org|
22285389|NCT03139344|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
22285390|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285391|NCT03193736|iSTAR Medical|Zubair Hussain, VP Clinical and Regulatory Affairs|+3210771658|zubair@istarmed.com|
22285392|NCT00852241|Loyola Medicine|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedicine.org|
22285393|NCT02697435|VAPHS|Debra Kaye Weiner, M.D.|412-360-2920|Debra.Weiner@va.gov|
22285394|NCT04230213|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285395|NCT00524472|Cleveland Clinic|Andra Duncan, MD|216 445-2372|DUNCANA@ccf.org|
22285396|NCT02748070|Stanford University|Michael Chang|(650) 725-6500|michael.t.chang@stanford.edu|
22285397|NCT04338971|Neurolutions|Director of Clinical Affairs|831-316-5466|lsouders@neurolutions.com|
22285398|NCT00240500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285399|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22285400|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285401|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org|
22285402|NCT00669383|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
22285403|NCT02069392|University of Maryland School of Medicine|Britta Hahn, Ph.D.|4104026112|bhahn@som.umaryland.edu|
22285404|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu|
22285405|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22285406|NCT04412707|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22285407|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285408|NCT04220554|University of Southern Denmark|Consultant, MD, PhD Mathias Tiedemann Svendsen|0045 61265827|mtsvendsen@health.sdu.dk|
22285409|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743||
22285410|NCT04306510|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22285411|NCT04720417|Thomas Jefferson University|Rino Seedor, MD|215-955-8874|Rino.Seedor@Jefferson.edu|
22285412|NCT03329092|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285413|NCT04878211|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285414|NCT01159015|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22285415|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
22285416|NCT03755882|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO- Director of clinical Sciences|904 443-1290|BPALL@its.jnj.com|
22285417|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533|mesa.ruben@mayo.edu|4-3533
22285418|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu|
22285419|NCT02598297|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22285420|NCT02546492|University of MAryland sSchool of Medicine|A Haririan|410-328-5720|ahariria@som.umaryland.edu|
22285421|NCT03040674|Lung Health Institute|Melissa Rubio, PhD, APRN|2145042117|pidallas@thelunghealthinstitute.com|
22285422|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com|
22285423|NCT02206035|Froedtert and the Medical college of Wisconsin|William Drobyski, MD|414-456-4941|wdrobysk@mcw.edu|
22285424|NCT01934010|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
22285425|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com|
22285426|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285427|NCT02506192|Minneapolis VA Health Care System|Ronald R Bach, PhD, Principal Investigator|(612)467-6315|ronald.bach@va.gov|
22285428|NCT04042909|Brown University|Kate B. Carey|4018636558|kate_carey@brown.edu|
22285429|NCT03785405|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285430|NCT03705559|University of Kentucky|Shanna Babalonis, Ph. D.|859-257-1881|babalonis@uky.edu|
22285431|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu|
22285432|NCT06041919|Thirty Respiratory Ltd|Inva Hoti|+44 (0) 1235 431200|Inva.Hoti@30.technology|
22285433|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285434|NCT02576795|BioMarin (UK) Ltd|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44 207-4203351|KonstantiaMaria.Chavele@bmrn.com|
22285435|NCT03724890|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22285436|NCT04210622|Medtronic, Inc|Clinical Research Specialist|800-328-2518|medtroniccastrials@medtronic.com|
22285437|NCT02362464|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|maengh@mail.nih.gov|
22285438|NCT02123823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285439|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22285440|NCT03254940|Duke University|Dr. Gary G. Bennett (PI/Dean of Trinity College of Arts & Sciences)|(919) 808-7821|gary.bennett@duke.edu|
22285441|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com|
22285442|NCT03190460|University of Washington School of Nursing|Dr. Hilaire Thompson|2066165641|hilairet@uw.edu|
22285443|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285444|NCT01844778|Novartis|Study Director|862-778-8300||
22285445|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22285446|NCT02343406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22285447|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp|
22285448|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com|
22285449|NCT03089541|Yale School of Medicine|Dr. Deepa Camenga, Principal Investigator|12037378310|deepa.camenga@yale.edu|
22285450|NCT05169424|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22285451|NCT02326233|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
22285452|NCT00961714|Alphatec Spine, Inc.|Glen Seidner, Clinical Affairs|760-494-6789|gseidner@alphatecspine.com|
22285453|NCT00639626|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
22285454|NCT02484222|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|18017591058@163.com|
22285455|NCT03301350|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
22285456|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22285457|NCT04698993|Draegerwerk AG & Co. KGaA|Dr Rainer Polzius|+498824514429|rainer.polzius@draeger.com|
22285458|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285459|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu|
22285460|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com|
22285461|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22285462|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285463|NCT03323801|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
22285464|NCT01298765|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
22285465|NCT03565237|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22285466|NCT02021955|VA Puget Sound Health Care Sysem|Margaret Collins|206.764.2085|margaret.collins@va.gov|
22285467|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285468|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300||
22285469|NCT02669121|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22285470|NCT03216746|UFParaná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
22285471|NCT04384523|Wuhan Healthgen Biotechnology Corp.|Daichang Yang|18602708398|dyang@oryzogen.com|
22285472|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn|
22285473|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22285474|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22285475|NCT04551950|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22285476|NCT03301298|Promentis Pharmaceuticals|Dean Brostowin|617-300-6172|dbrostowin@promentispharma.com|
22285477|NCT03170193|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22285478|NCT03637517|Medicines for Malaria Venture|Stephan Chalon, MD|+41 22 555 0369|chalons@mmv.org|
22285479|NCT03848949|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
22285480|NCT03850535|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22285481|NCT00801398|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
22285482|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org|
22285483|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22285484|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu|
22285485|NCT00965419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285486|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22285487|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029|yama@clin.medic.mie-u.ac.jp|5630
22285488|NCT02222610|Retina Consultants of Texas|Dr. Amy C. Schefler|(713) 524-3434|acsmd@retinaconsultantstexas.com|
22285489|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
22285490|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
22285491|NCT02232022|Northwell Health|Jeffrey M. Katz|516-562-3062|jkatz2@northwell.edu|
22285492|NCT04775953|Duke University|Thomas L. Holland, MD|919-613-4268|thomas.holland@duke.edu|
22285493|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22285494|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22285495|NCT04014062|Lambda Therapeutic Research Ltd.|Dr. Anshul Attrey, M.D. Principal Investigator|+91-79-40202020|anshulattrey@lambda-cro.com|
22285496|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285497|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com|
22285498|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu|
22303618|NCT04834362|National Institute of Neurosciences and Hospital, Dhaka|Dr. Mashfiqul Hasan|+8801816268746|mashfiqul.hasan@nins.gov.bd|
22303619|NCT01868789|Orthopedic Foot and Ankle Center|Dr. Gregory Berlet|6148958747|ofacresearch@orthofootankle.com|
22303620|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu|
22285499|NCT02783599|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22285500|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285501|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu|
22303621|NCT06017999|Xgene Pharmaceutical|Director of Clinical Trials|+886-2-2528-0580|emily.chen@xgenepharm.com|
22303622|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22303623|NCT03943589|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
22303624|NCT04329104|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
22303625|NCT01702428|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303626|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538|perrytamarat@uams.edu|41538
22303627|NCT02821832|National Institute of Allergy and Infectious Diseases|Dr. Clif E. Barry 3rd|301-693-4665|cbarry@niaid.nih.gov|
22303628|NCT03685708|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
22303629|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de|
22303630|NCT02771210|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22303631|NCT04397523|Institute for Transfusion Medicine of RNM|Assoc. Prof. Dr. Rada M. Grubovic Rastvorceva, MD MSci PhD, CMO|+38923226923|drgrubovic@gmail.com|
22303632|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300||
22303633|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca|
22303634|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22303635|NCT01284140|University of Iowa|Brian K. Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
22285502|NCT04808141|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
22285503|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com|
22285504|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu|
22285505|NCT03920254|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22285506|NCT05274269|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22285507|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com|
22285508|NCT05636852|GE HealthCare|Paul Sherwin, MD, PhD|+1 (609) 510-3686|PaulSherwin@gehealthcare.com|
22285509|NCT03534141|University of California, San Francisco|Dr. Michael P. Bokoch, Principal Investigator|415-476-8389|Michael.Bokoch@ucsf.edu|
22285510|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285511|NCT03829449|Akari Therapeutics Plc|Dr Wynne Weston-Davies|0208 004 6106|wynne.weston-davies@akaritx.com|
22285512|NCT00795236|Oregon Health & Science University|Alfred Lewy|(503) 494-7746|lewy@ohsu.edu|
22285513|NCT04759157|University of Utah|Dr. Kelly Baron|801-585-7588|kelly.baron@utah.edu|
22285514|NCT04211441|Medtronic, Inc|Director of Clinical Research|800-328-2518|medttroniccastrials@medtronic.com|
22285515|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com|
22285516|NCT02652468|University of Madison Carbone Cancer Center|Vaishalee Kenkre|(608) 263-1699|vpkenkre@medicine.wisc.edu|
22285517|NCT01746225|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
22285518|NCT00595478|Dartmouth College|Catherine Stanger, Ph.D.|603-646-7023|catherine.stanger@dartmouth.edu|
22285519|NCT02713828|ECOG Stats Center|Dr Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
22285520|NCT03302247|Fox Chase Cancer Center|Martin Edelman|215-728-5682|Martin.Edelman@fccc.edu|
22285521|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285522|NCT04090242|Becton Dickinson|Edward Mahoney|978-901-7248|Edward.Mahoney@bd.com|
22285523|NCT02687581|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
22285524|NCT04405076|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22285525|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu|
22285526|NCT02513472|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22285527|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22285528|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu|
22285529|NCT03214406|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22285530|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
22285531|NCT01898013|Durham VA Medical Center|Jennifer C. Naylor, PhD|9192860411|jennifer.naylor2@va.gov|
22285532|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com|
22285533|NCT01100775|University of Maryland Baltimore|Ms. Dawn Detamore|410 402 6820|DDetamore@som.umaryland.edu|
22285534|NCT04310566|Johnson & Johnson Vision Care|Thomas Karkkainen - Sr.Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22285535|NCT02748928|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
22285536|NCT04677504|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22285537|NCT03182907|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285538|NCT03747640|Florida State University|Hyochol Ahn, PhD, MSN, MS-ECE, MS-CTS, APRN, ANP-BC, FAAN|850-644-2647|hahn@fsu.edu|
22285539|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu|
22285540|NCT01041521|Tufts University|Christine Wanke, Principal Investigator||christine.wanke@tufts.edu|
22285541|NCT03691662|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22285542|NCT03771274|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22285543|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300||
22285544|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu|
22285545|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org|
22285546|NCT01771250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285547|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285548|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org|
22285549|NCT00166439|Mayo Clinic|Patrick B. Johnston, M.D., Ph.D.|507/284-5362|johnston.patrick@mayo.edu|
22285550|NCT02560012|The University of Texas Health Science Center, Houston|Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22285551|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22285552|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400|stephan.doering@meduniwien.ac.at|25190
22285553|NCT03052816|UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol|Andrey Petrikovets MD|323 243 9091|andrepetrikovets@yahoo.com|
22285554|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org|
22285555|NCT02248636|Puget Sound VA|William Banks, Associate Chief of Staff for Research|206 764-2701|william.banks4@va.gov|
22285556|NCT03369236|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|1 855-752-2356|clinicaltrials@alexion.com|
22285557|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
22285558|NCT03334812|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22285559|NCT02508428|Anderson Orthopaedic Research Institute|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
22285560|NCT00368641|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22285561|NCT04343755|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22285562|NCT00108862|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22285563|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com|
22285564|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300||
22285565|NCT04390880|VA Greater Los Angeles Healthcare System|Gholam Berenji, M.D.|310-268-3547|Gholam.Berenji@va.gov|
22285566|NCT02557542|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
22285567|NCT00195091|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina MD|646-888-4558|trainat@MSKCC.ORG|
22285568|NCT01028846|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
22285569|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu|
22285570|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com|
22285571|NCT00684775|"Johns Hopkins School of Medicine: Department of Psychiatry"|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22285572|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285573|NCT04526145|Ohio State University|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
22285574|NCT04491539|Florida State University|Henna Budhwani|(850) 644-3296|hbudhwani@fsu.edu|
22285575|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
22285576|NCT02324816|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22285577|NCT03401671|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285578|NCT02305238|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22285579|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
22285580|NCT02815644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285581|NCT02218008|Alkermes, Inc.|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22285582|NCT01718444|UIC|Albert Asante, MD MPH|3123552634|akdasante@yahoo.com|
22285583|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
22285584|NCT00408434|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22285585|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285586|NCT04039217|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22303636|NCT01927718|UT MD Anderson Cancer Center|Qaiser Bashir, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|QBashir@mdanderson.org|
22303637|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com|
22303638|NCT02029040|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|Mohamed.Badawy@UTsouthwestern.edu|
22303639|NCT02649322|Orlando Health|Daryl C. Osbahr, MD|321.843.4800|Daryl.Osbahr@orlandohealth.com|
22285587|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285588|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu|
22285589|NCT03364309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22285590|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
22285591|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu|
22285592|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285593|NCT04182672|The University of Texas Health Science Center at Houston|Pritish Bawa, MD|713-500-7702|Pritish.Bawa@uth.tmc.edu|
22285594|NCT04522141|Lucerne University of Applied Sciences and Arts|Dr. Mirjam Stieger|0041798852810|mirjam.stieger@hslu.ch|
22285595|NCT03052049|Northwestern Medical Group|Jennifer Karp RN|312-926-5289|jkarp@nm.org|
22285596|NCT03508609|Caladrius Biosciences, Inc.|William Sietsema|9495352391|bsietsema@caladrius.com|
22285597|NCT02328027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285598|NCT03304873|NYU Grossman School of Medicine|Jennifer Lighter, MD|212-263-5454|Jennifer.Lighter@nyulangone.org|
22285599|NCT03319212|Johnson & Johnson Vision Care, Inc.|Elizabeth Dow, OD, FAAO - Principal Research Optometrist|904-443-1061|edow1@its.jnj.com|
22285600|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
22285601|NCT01895959|University of California, San Francisco|Xiaojuan Li, PhD|415-353-4909|Xiaojuan.li@ucsf.edu|
22285602|NCT01868477|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285603|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
22285604|NCT02465203|Novartis|Study Director|+41613241111||
22285605|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285606|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr|
22285607|NCT02973516|Guerbet|Jing Hao, MD, Head of Global Medical Affairs and Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22285608|NCT04072887|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285609|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22285610|NCT02022436|University of Pittsburgh Medical Center|Rabih Chaer|4128023025|chaerra@upmc.edu|
22285611|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285612|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285613|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
22285614|NCT00486824|Stanford University|Dr. Deirdre Lyell|6507255720|dlyell@stanford.edu|
22285615|NCT02859441|National Institutes of Health|Henry E Wiley, M.D., Principal Investigator, NEI|301-496-6583|wileyhe@nei.nih.gov|
22285616|NCT04371666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-093DMDStudy@fibrogen.com|
22285617|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285618|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285619|NCT02092025|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22285620|NCT02927938|Levine Cancer Institute|Dr. James Symanowski; Chair, Department of Cancer Biostatistics|9804422371|james.symanowski@atriumhealth.org|
22285621|NCT03274856|GLWL Research Inc|Caroline Fortier|1.514.708.4417|caroline.fortier@glwlresearch.com|
22285622|NCT03228212|Johnson & Johnson Vision Care Inc.|John Buch -SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
22285623|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org|
22285624|NCT02834247|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22303640|NCT01752413|Memorial Blood Centers|Jed B Gorlin MD, MBA|651-332-7284|Jed.Gorlin@innovativeblood.org|
22285625|NCT01704404|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22285626|NCT01807299|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
22285627|NCT02476006|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22285628|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
22285629|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu|
22285630|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285631|NCT02309944|Masonic Cancer Center, University of Minnesota|Deanna GK Teoh|612-626-3111|dkteoh@umn.edu|
22285632|NCT03049917|University of Washington|Dr.|206-422-5564|jsyker@uw.edu|
22285633|NCT03449758|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22285634|NCT01860287|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22285635|NCT02848222|University of Alabama at Birmingham|Dr Jason Nichols|205-975-3497|jjn@uab.edu|
22285636|NCT01606709|UConnHealth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
22285637|NCT00584012|Holden Comprehensive Cancer Center|Cena Jones-Bitterman|319-353-4596|cena-jones@uiowa.edu|
22285638|NCT02607618|Motif BioSciences|Stephanie Noviello|908-432-7802|stephanie.noviello@motifbio.com|
22285639|NCT02451943|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22285640|NCT03937713|VA ORD|Associate Chief of Staff for Research|716-862-6528|ali.el-solh@va.gov|
22303641|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org|
22303642|NCT02512510|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22285641|NCT02871635|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285642|NCT02420379|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
22285643|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu|
22285644|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22285645|NCT03795116|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|347-466-9263|jared.jagdeo@downstate.edu|
22285646|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22285647|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22285648|NCT01410890|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22285649|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com|
22285650|NCT03951077|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22285651|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org|
22285652|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
22285653|NCT03923790|The University of Texas Health Science Center at Houston|Anjail Sharrief, MD, MPH, Associate Professor|713-500-6538|anjail.z.sharrief@uth.tmc.edu|
22285654|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu|
22285655|NCT03579940|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22285656|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300||
22285657|NCT01751984|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22285658|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu|
22285659|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285660|NCT02274792|Amgen Inc.|Study Director|866-572-6436||
22285661|NCT02751580|Sidney Kimmel Cancer Center at Thomas Jefferson University|Nicole Simone, MD|215-955-6702|nicole.simone@jefferson.edu|
22285662|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu|
22285663|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
22285664|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22285665|NCT02947646|Actuated Medical|Director Quality Assurance & Regulatory Affairs|814-355-0003|medical.affairs@actuatedmedical.com|
22285666|NCT04854551|University of Colorado Anschutz Medical Campus|Joshua Gowin|3037243769|joshua.gowin@cuanschutz.edu|
22285667|NCT01664182|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA 96161|Thomas J Semrad, MD, MAS|+1 530 582 6450|tsemrad@tfhd.com|
22285668|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335|Michail.Pankratov@Corindus.com|206
22285669|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22285670|NCT05292131|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22285671|NCT01345188|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633242828|shammas@mchsi.com|
22285672|NCT04752358|Adaptimmune|Clinical Trials Management|+1 (215) 825-9260|clinicaltrials@adaptimmune.com|
22285673|NCT04607837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22285674|NCT01870505|Memorial Sloan Kettering Cancer Center|Dr. Sarat Chandarlapaty, MD, PhD|646-888-4311|ChandarS@MSKCC.ORG|
22285675|NCT02023996|Memorial Sloan Kettering Cancer Center|Dr. Neeta Pandit-Taskar, MD|212-639-3046|pandit-n@MSKCC.ORG|
22285676|NCT00465452|The University of Toledo|Julia Spears|419-383-6728|julia.spears@utoledo.edu|
22285677|NCT02687139|Johns Hopkins University|Mohamad Allaf, MD|410-502-7710|mallaf@jhmi.edu|
22285678|NCT04030520|University of California San Francisco|Dr Rachel King|+256785304516|rachel.king@ucsf.edu|
22285679|NCT05236257|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22285680|NCT05870865|TrialSpark|TrialSpark|Please Email|soothe.info@trialspark.com|
22285681|NCT03427749|University of Ottawa Heart Institute|Dr. Terrence Ruddy|613-696-7267|truddy@ottawaheart.ca|
22285682|NCT03828019|JHSPH Center for Clinical Trials|Elizabeth E. Sugar|410-614-7837|esugar2@jhu.edu|
22285683|NCT05715242|Stanford University School of Medicine|Michele L. Patel, PhD|650-549-7047|michele.patel@stanford.edu|
22285684|NCT03400176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285685|NCT01561053|Grifols|AMBAR clinical manager|+34 935712200|AMBARclinical@grifols.com|
22285686|NCT02211456|Oxford University Hospitals NHS FT|Dr James Gamble|00441865221012|james.gamble@ouh.nhs.uk|
22285687|NCT02910102|Axovant Sciences, Inc.|Director, Clinical Development|1-833-296-8268|clinicaltrials@axovant.com|
22285688|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org|
22285689|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu|
22285690|NCT02863328|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22285691|NCT04560075|University of Pittsburgh|Dr. Tina Goldstein|(412) 246-5604|goldtr@upmc.edu|
22285692|NCT04565951|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|503-220-8262|alan.teo@va.gov|52461
22285693|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu|
22285694|NCT02109809|Wake Forest University Health Sciences|Dr. Gordon Phillips|336-716-0659|gophilli@wakehealth.edu|
22285695|NCT02936635|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22285696|NCT02407223|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22285697|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22319669|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319670|NCT00699803|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22285698|NCT04404556|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|513-636-4864|avani.modi@cchmc.org|
22285699|NCT05561582|University of Central Florida|Abigail Wilson|407-823-1026|Abigail.Wilson@ucf.edu|
22285700|NCT03652181|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|(773) 702-8996|astadnik@bsd.uchicago.edu|
22285701|NCT00988013|University of Illinois at Chicago|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
22285702|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
22285703|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
22285704|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br|
22285705|NCT03796637|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22285706|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu|
22285707|NCT03726489|University of Pennsylvania|Brooke Bishop|215-615-0523|brooke.bishop@pennmedicine.upenn.edu|
22285708|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22285709|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22285710|NCT03078556|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285711|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu|
22285712|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22285713|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
22285714|NCT04421482|NYU Langone Health|Nazeeh Hanna, MD|516-663-3853|Nazeeh.hanna@nyulangone.org|
22285715|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu|
22285716|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
22285717|NCT05786508|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
22285718|NCT04426318|Center for Healthy Minds|Matthew Hirshberg|608-262-0035|hirshberg@wisc.edu|
22285719|NCT04587050|Imperial College london|Dr Tamara Elliott|02075946230|te04@ic.ac.uk|
22285720|NCT02588261|Astellas Pharma Global Development, Inc.|Senior Medical Director|1800 888-7704|astellas.resultsdisclosure@astellas.com|
22285721|NCT03781778|Fred Hutchinson Cancer Research Center|Marian L. Neuhouser, PhD|2066674797|mneuhous@fredhutch.org|
22285722|NCT02287467|NIAID|Dr. Richard Davey|301-496-8029|rdavey@niaid.nih.gov|
22285723|NCT03106636|University of Oregon|Dr. Philip Fisher|541-346-4968|philf@uoregon.edu|
22285724|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22285725|NCT02292446|Novaratis Pharmaceuticals|Study Director|888-669-6682|novartis.email@novartis.com|
22285726|NCT02652156|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
22285727|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu|
22285728|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com|
22285729|NCT02741596|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285730|NCT03329846|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22285731|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22285732|NCT02021643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22303643|NCT02589392|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
22303644|NCT02965144|Rigshospitalet|Karin Piil|0045612078067|Karin.Piil@regionh.dk|
22303645|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22303646|NCT03382600|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303647|NCT02269943|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22303648|NCT02917577|UCalgary|Heinrike Schmeling|4039553194|schmelingresearch@albertahealthservices.ca|
22303649|NCT04396535|Mayo Clinic|Dr. Konstantinos Leventakos|507-284-2511|leventakos.konstantinos@mayo.edu|
22303650|NCT02066532|Columbia University Irving Medical Center|Dawn Hershman, MD|212-305-5098|dlh23@cumc.columbia.edu|
22303651|NCT05033080|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22303652|NCT05376371|University or Wisconsin-Madison|Ryan Westergaard|6082657927|rpw@medicine.wisc.edu|
22303653|NCT04159415|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22303654|NCT03560245|Neurotropebioscience, Inc|Alan J. Tuchman, MD, Acting Chief Medical Officer|973-242-0005|atuchman@neurotrope.com|
22303655|NCT02400437|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22303656|NCT02913521|Egeen|Kalev Kask|16504690600|kalev.kask@egeeninc.com|
22303657|NCT01468532|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
22303658|NCT00960752|UT MD Anderson Cancer Center|Michael Davis, PHD., Chair, Melanoma Medical Oncology|713-792-3454|mdavies@mdanderson.org|
22303659|NCT05259774|Relife Srl|Lia Fabbri|05556809528|lfabbri@relifecompany.it|
22303660|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456|fungronghu@ntuh.gov.tw|2131
22303661|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
22303662|NCT01238549|VAORD|Dr. Ann Spungen|718-584-9000|ann.spungen@va.gov|5814
22303663|NCT03295266|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303664|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu|
22285733|NCT02631551|Glenmark Pharmaceuticals Ltd.|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22303665|NCT02262260|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22285734|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351||
22303666|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
22303667|NCT01794117|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
22303668|NCT03406702|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22303669|NCT00601003|Beat Childhood Cancer|Giselle Sholler, MD|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
22303670|NCT04394247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303671|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org|
22285735|NCT03393494|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22285736|NCT04390243|Cedar Sinai Medical Center|Andrew Hendifar, M.D.|310-423-2217|Andrew.Hendifar@cshs.org|
22285737|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu|
22285738|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com|
22285739|NCT04034004|UC San Diego|Dr. Fadel Zeidan|858-246-8342|zeidanlaboratory@ucsd.edu|
22285740|NCT04317040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285741|NCT03672292|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
22285742|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285743|NCT02518971|Michigan Medicine|Andrew Urquhart|734-936-6636|andrewu@med.umich.edu|
22285744|NCT03088917|Radboudumc|Prof. dr. J.P.H. Drenth|0031243613999|joost.drenth@radboudumc.nl|
22285745|NCT04477759|Medical College of Wisconsin|Musaddiq Awan, MD|414-805-4497|mawan@mcw.edu|
22285746|NCT01514201|St. Jude Children's Research Hospital|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
22285747|NCT02352844|Washington University School of Medicine|Saiama Waqar, M.D.|314-362-5737|saiamawaqar@wustl.edu|
22285748|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22285749|NCT02735343|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22285750|NCT03318016|University of Colorado Hospital|Daniel Pollyea, MD Associate Professor|720-848-8084|daniel.pollyea@cuanschutz.edu|
22285751|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
22285752|NCT01804881|North York Family Health Team|Principal Investigator|4164943003|dsouthgate@nyfht.com|130
22285753|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22303672|NCT04858295|University of Pennsylvania|Dr. Sarah Schrauben|267-324-7588|sarahsch@upenn.edu|
22285754|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
22285755|NCT04531241|Johnson & Johnson Vision Care, Inc.|Meredith Bishop, OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
22285756|NCT02715609|Washington University School of Medicine|Dr. Jiayi Huang|314-362-8516|jiayi.huang@wustl.edu|
22285757|NCT03983304|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
22285758|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org|
22285759|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22285760|NCT01518374|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22285761|NCT03035331|Mayo Clinic|Yi Lin|507-293-5189|Lin.Yi@mayo.edu|
22285762|NCT04209205|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22285763|NCT04649177|BostonSight|Daniel Brocks, MD|(781)726-7337|ecrowley@bostonsight.org|
22285764|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu|
22285765|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22319671|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319672|NCT01950247|American Regent, Inc.|Mark Falone, MD.|631.772.3544|mfalone@americanregent.com|
22285766|NCT04683835|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
22285767|NCT01908530|Imperial College London|Prof Nick Oliver|07957163617|nick.oliver@imperial.ac.uk|
22285768|NCT00950846|Baylor College of Medicine/Texas Children's Hospital|Dr. Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
22285769|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu|
22285770|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu|
22285771|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
22285772|NCT02114606|University of North Carolina at Chapel Hill|Evan Dellon, MD|919-966-2511|evan_dellon@med.unc.edu|
22285773|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com|
22285774|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com|
22285775|NCT03361293|University of Minnesota|Jeffrey Wozniak, PhD, LP|612-273-9741|jwozniak@umn.edu|
22285776|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285777|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22285778|NCT03010319|Integra LifeSciences|Andrew Tummon Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
22285779|NCT02128724|University of Oxford|Stasya Ng|+441865 617083|octo-BKM120@oncology.ox.ac.uk|
22285780|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
22285781|NCT04829916|Guard Therapeutics|Head of Clinical Operations|+46733319438|trials@guardtherapeutics.com|
22285782|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu|
22285783|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu|
22285784|NCT02660853|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22285785|NCT03594773|University of Pittsburgh School of Medicine|Holly Swartz, MD|4122465588|SwartzHA@upmc.edu|
22285786|NCT01822457|Imperial Vascular Unit|Mr Pasha Normahani|+44 (0) 20 759 48904|pnormahani@gmail.com|
22285787|NCT04098809|Benaroya Research Institute at Virginia Mason|Dr. Andrew Stamm|206-223-6772|Andrew.Stamm@virginiamason.org|
22285788|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22285789|NCT03101254|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
22285790|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285791|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285792|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285793|NCT00352001|CCCC|Dr. Mikkael Sekeres|216-445-9353|sekerem@ccf.org|
22285794|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285795|NCT03066193|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
22285796|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22285797|NCT03071887|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
22285798|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org|
22285799|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285800|NCT04498143|University of Denver|Dr. Kathryn Fox|3015202715|Kathryn.Fox@du.edu|
22285801|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22285802|NCT01843023|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
22285803|NCT01022138|Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
22285804|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
22285805|NCT05139927|NYU|Marya Gwadz, PhD|917-863-2125|mg2890@nyu.edu|
22285806|NCT04980612|University of California San Francisco|Wolf Mehling, MD|415|wolf.mehling@ucsf.edu|9021331
22285807|NCT05730387|Institute for Global Health at BC Children's Hospital and BC Women's Hospital + Health Centre|Matthew O. Wiens|6048292562|matthew.wiens@bcchr.ca|
22285808|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22285809|NCT03364738|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22285810|NCT03245398|Swiss Tropical and Public Health Institute|Dr Jennifer Keiser|+41 61 284 8218|jennifer.keiser@swisstph.ch|
22285811|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
22285812|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu|
22285813|NCT03165916|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
22285814|NCT04137731|Joint Replacement Center of Montefiore Medical Center|Clinical Research Director|9292466352|sereffer@montefiore.org|
22285815|NCT02403999|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285816|NCT03830359|Laboratoires Thea|ESTRADE|0635156453|marielle.estrade@theapharma.com|
22285817|NCT02204072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22285818|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22285819|NCT03319134|UT Dallas|Clinical Trial Manager|9723337277|Sarah.McLeod@utdallas.edu|
22285820|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu|
22285821|NCT01587040|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22285822|NCT02314221|VA RR&D National Center for the Medical Consequences of Spinal Cord Injury|Ann M. Spungen, EdD|718-584-9000|ann.spungen@va.gov|5814
22303673|NCT06211296|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
22303674|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu|
22285823|NCT05725746|Washington University in St. Louis|Cindy Schwarz|314-935-3063|cschwarz@wustl.edu|
22285824|NCT00367835|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22285825|NCT03453489|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|313-576-8735|shieldsa@karmanos.org|
22285826|NCT04346654|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22285827|NCT05747027|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
22285828|NCT00999518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285829|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr|
22285830|NCT02268994|Keryx Biopharmaceuticals, Inc.|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22285831|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu|
22285832|NCT01445080|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22285833|NCT03887221|Zambon S.p.A.|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
22285834|NCT02123576|The Pennsylvania State University Division of Gastroenterology and Hepatology Milton S. Herhsey Medical Center|Dr. Jonathan G. Stine|717-531-0003|jstine@pennstatehealth.psu.edu|28-9478
22285835|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
22285836|NCT04864639|Duke University|Leonor Corsino, MD, MHS|919-684-4005|leonor.corsinonunez@duke.edu|
22285837|NCT04050618|CooperVision, Inc.|Jose A. Vega, O.D., MSc, FAAO|925-621-3761|javega@coopervision.com|
22285838|NCT00948753|University of Pennsylvania Abramson Cancer Center|David Porter|215-662-2862|david.porter@pennmedicine.upenn.edu|
22285839|NCT00655538|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22285840|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
22285841|NCT01101035|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22285842|NCT01764711|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
22285843|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com|
22285844|NCT03110471|swansea university|sue jordan|+44 (0) 1792 518541|s.e.jordan@swansea.ac.uk|
22285845|NCT02279667|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22285846|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22285847|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804||
22285848|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456|tjhwang@ntu.edu.tw|66792
22285849|NCT01641601|UCSF|Kirsten Salmeen|628-213-5314|kesalmeen@gmail.com|
22285850|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285851|NCT02640547|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22285852|NCT03618420|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
22285853|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu|
22285854|NCT00080301|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22285855|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
22285856|NCT01965704|Stanford University|David Drover|650-725-0364|ddrover@stanford.edu|
22285857|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org|
22285858|NCT02524171|Center for Innovation to Implementation, VA Palo Alto|Daniel M. Blonigen, PhD|650-493-5000|daniel.blonigen@va.gov|27828
22285859|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu|
22285860|NCT02868554|University of North Carolina at Chapel Hill|Ching-Chang Ko, DDS, PhD|919-537-3763|ching-chang_ko@unc.edu|
22285861|NCT05150990|University of California Santa Barbara|Dr. Nancy Collins|805-568-0042|ncollins@ucsb.edu|
22285862|NCT05282927|Durham VA Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Dr. Kelli Allen|919-286-0411|Kelli.Allen@va.gov|177090
22285863|NCT05447663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22285864|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22285865|NCT04181762|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22285866|NCT04669301|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22285867|NCT02586727|Murray Ocular Oncology & Retina|Dr. Timothy Murray|3054877470|tmurray@murraymd.com|
22285868|NCT05888181|UZ Leuven|Patrick Verschueren|003216342541|patrick.verschueren@uzleuven.be|
22285869|NCT03054649|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22285870|NCT02534909|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22285871|NCT05431478|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22285872|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300||
22285873|NCT05049850|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
22285874|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu|
22285875|NCT00676013|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
22285876|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22285877|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22285878|NCT03375489|Massachusetts General Hospital|Jennifer Temel, MD|617-724-4000|jtemel@mgh.harvard.edu|
22285879|NCT03838978|Moximed, Inc.|Alexandra Kraenzlin, Director of Clinical Affairs|+41 44 515 62 06|akraenzlin@moximed.com|
22319673|NCT01831921|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolin@wakehealth.edu|
22285880|NCT03071393|University of Florida|Emily Fox, Principal Investigator|904-742-2500|ejfox@phhp.ufl.edu|
22285881|NCT04752332|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22285882|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22285883|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22285884|NCT02451514|GlaxoSmithKline|GSK Response Center|866-435-7343||
22285885|NCT03197376|PATH|Dr. Steve Lamola|+ 1 206.302.6067|slamola@path.org|
22285886|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
22285887|NCT01773187|CTI BioPharma Corp.|Beth Ziemba|206-272-4347|bziemba@ctibiopharma.com|
22285888|NCT02978833|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
22285889|NCT00112125|Impulse Dynamics (USA) Inc|Angela Stagg, Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
22285890|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22285891|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org|
22285892|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu|
22285893|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com|
22285894|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu|
22285895|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22285896|NCT01802710|Hospital Galdakao-Usansolo|Dra Miren Orive|0034 944007105|miren.orivecalzada@osakidetza.net|
22285897|NCT02528786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22285898|NCT03294850|AdventHealth Translational Research Institute|Dr. Karen Corbin|(407) 303-7100|Karen.Corbin@AdventHealth.com|
22285899|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
22285900|NCT02696759|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22285901|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22285902|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22285903|NCT03857542|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22285904|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22285905|NCT02395614|Vanderbilt university medical center|Dr. Kent K. Higdon|615-936-0160|kent.hidgon@vumc.org|
22285906|NCT02709330|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
22285907|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322|philipj@mcmaster.ca|40654
22285908|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com|
22285909|NCT03152591|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22285910|NCT03868254|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22285911|NCT03633344|Omnifarma Kyiv LLC|Oleg Kurchenko|+380503319653|Kurchenko@omnifarma.kiev.ua|
22285912|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
22285913|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu|
22285914|NCT02544503|Emory University|Cathrin Buetefisch, MD, PhD|404-712-5507|cathrin.buetefisch@emory.edu|
22285915|NCT04640311|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285916|NCT03906071|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22285917|NCT02152761|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22285918|NCT01797263|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; matthew.bair@va.gov|
22285919|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22285920|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
22285921|NCT02968368|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22285922|NCT02859246|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-4331|Reza_Dana@meei.harvard.edu|
22285923|NCT03315572|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22285924|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
22285925|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu|
22303675|NCT01668147|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22285926|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
22285927|NCT03188432|Wake Forest Baptist Comprehensive Cancer Center|Principal investigator|3367135440|Michael.G.Kelly@advocatehealth.org|
22285929|NCT02562716|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|smcdonou@fredhutch.org|
22303676|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu|
22303677|NCT02662244|UCSD|Dr. Arisa Ortiz|858-657-1697|dermstudies@ucsd.edu|
22303678|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22303679|NCT02802020|Boston Scientific Corporation|Brian Vatcher|+1-508-683-5274|brian.vatcher@bsci.com|
22285930|NCT02753946|Nabriva Therapeutics plc|Chief Medical Officer|(610) 816-6640|officeUS@nabriva.com|
22285931|NCT02175017|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
22285932|NCT04915729|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303680|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu|
22303681|NCT02516579|Addmedica|Medical director|+33172690186|corinne.duguet@addmedica.com|
22285933|NCT04961541|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22285934|NCT00466921|Northwestern University|Clinical Trials Office|312-695-1301||
22285935|NCT03305770|Alcon, A Novartis Division|Sr Director Project Leadership|1-888-451-3937|alcon.medinfo@alcon.com|
22285936|NCT03539601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285937|NCT03710642|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
22285938|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22285939|NCT02727907|BIOCAD|Linkova Yuliya|+7(495)9926628|linkova@biocad.ru|930
22285940|NCT01633541|University of Michigan Rogel Cancer Center|Dr. Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
22285941|NCT01643382|University of California, San Francisco|Justin Parekh, MD, MAS|415-595-3707|justin.parekh@ucsfmedctr.org|
22285942|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351||
22285943|NCT03676972|Peking University Third Hospital|Dr. Lulin Ma|13701010872|malulin@medmail.com.cn|+86
22285944|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285945|NCT02330055|Beth Israel Deaconess Medical Center|Dr. Matthias Eikermann|6176673364|meikerma@bidmc.harvard.edu|
22285946|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu|
22285947|NCT05729568|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22285948|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285949|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu|
22285950|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu|
22285951|NCT01717001|University of Tennessee|Rebecca Robertson|865-974-2093|rrober28@utk.edu|
22285952|NCT02326597|Emory University|Lakshmanan Krishnamurti, MD|4047270710|lkrishn@emory.edu|
22285953|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22285954|NCT03657849|Regions Hospital|Meghan O'Brien / Study Coordinator|612-437-1141|meghan.e.obrien@healthpartners.com|
22285955|NCT03402035|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
22285956|NCT03559933|Stimdia Medical, Inc.|Tim Miller|612.940.3454|tmiller@stimdia.com|
22285957|NCT02119663|Incyte Corporation|Study Director|855 463-3463||
22285958|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com|
22285959|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
22285960|NCT03245775|University of Virginia|Dr. Jamie Zoellner, Professor of Public Health Sciences|4349624488|jz9q@virginia.edu|
22285961|NCT02921490|Mayo Clinic|Vance Lehman|1-507-284-2511|lehman.vance@mayo.edu|
22285962|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu|
22285963|NCT02363959|Duke University|Scott Shofer MD, PhD|919-668-2402|scott.shofer@duke.edu|
22285964|NCT03421106|University of Connecticut|Caitlin Caspi|(860) 486-2834|caitlin.caspi@uconn.edu|
22285965|NCT00950248|National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Bibiana Bielekova|(240) 669-2724|bibi.bielekova@nih.gov|
22285966|NCT02919072|Sintetica SA|Anna Guaita|+41 (0)91640 42 50|aguaita@sintetica.com|
22285967|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu|
22285968|NCT00940498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22285969|NCT02424175|Brigham and Women's Hospital|Dr. Jessica Allegretti|6177325500|jallegretti@bwh.harvard.edu|
22285970|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22285971|NCT01594931|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
22285972|NCT02744092|Dana-Farber Cancer Institute|Dr. Jean Connors|(617) 632-3000|jconnors@bwh.harvard.edu|
22285973|NCT01929226|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22285974|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285975|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012||
22285976|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov|
22285977|NCT01473732|Montefiore Medical Center|Dr. Enver Akalin, Medical Director Kidney Transplant|718-920-4815|eakalin@montefiore.org|
22285978|NCT03271424|University of North Carolina Chapel Hill|Dr. Audrey Pettifor|919-966-7439|apettif@email.unc.edu|
22285979|NCT00330759|Amgen Inc.|Study Director|866-572-6436||
22285980|NCT00671034|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22285981|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22285982|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22303682|NCT00593554|IndianaU|Dr. Sherif Farag|317-278-0460|ssfarag@iu.edu|
22303683|NCT03796689|University of California, San Fransico|Dr. Mark Pletcher, Professor|415-514-8008|mark.pletcher@ucsf.edu|
22303684|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu|
22303685|NCT04764929|Columbia University|Patrick Wilson, MD|212-305-8458|ptw2107@cumc.columbia.edu|
22285983|NCT06083987|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
22285984|NCT04473963|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
22285985|NCT04685798|Washington University School of Medicine|Gloria J. Guzman Pérez-Carrillo, M.D.|314-362-5950|guzman.gloria@wustl.edu|
22303686|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22285986|NCT02123849|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
22285987|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com|
22285988|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743||
22285989|NCT03187119|West Virginia University|Dr. Christina Duncan|304-293-1289|Christina.Duncan@mail.wvu.edu|
22285990|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22285991|NCT01359904|MUHC|Sameena Iqbal|5149341934|sameena.iqbal@mcgill.ca|44034
22285992|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100|thomas.otoole@va.gov|6359
22285993|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com|
22285994|NCT03018691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22285995|NCT03369418|UCLA|Kirsten Tillisch|1 310 208-5400|ktillisch@mednet.ucla.edu|
22285996|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22285997|NCT00040443|RespireRx Pharmaceuticals|Richard Purcell|732-492-1797|rpurcell@respirerx.com|
22285998|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22285999|NCT05280717|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22286000|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com|
22286001|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu|
22286002|NCT03573323|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286003|NCT03869008|UTMC|Bashar Kahaleh, MD|4193834271|bashar.kahaleh@utoledo.edu|
22286004|NCT06260670|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
22286005|NCT04502290|University of Pittsburgh|Amit Sethi|4123836619|asethi@pitt.edu|
22286006|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
22286007|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286008|NCT04912583|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.korupolu@uth.tmc.edu|
22286009|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu|
22286010|NCT02486016|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchomb (PI)|410-706-2646|astinchc@rx.umaryland.edu|
22286011|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk|
22286012|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu|
22286013|NCT02336230|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
22286014|NCT02526277|The Ohio State University|Ariane Park, MD|614.293.4969|Ariane.Park@osumc.edu|
22286015|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu|
22286016|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu|
22286017|NCT01695135|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22286018|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
22286019|NCT05065905|Saint-Petersburg State Medical Academy n.a. I.I.Mechnikov of Ministry of Health, Saint-Petersburg, Russia, 195067|Dr. med. Sc., Prof. Tamara Sologub|+78125439609|mechnik@mail.ru|
22286020|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu|
22286021|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623||
22286022|NCT01775371|Albert Einstein College of Medicine|Dr. Polly Bijur|718-430-4217|polly.bijur@einsteinmed.edu|
22286023|NCT02519439|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22286024|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu|
22286025|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu|
22286026|NCT04400058|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22286027|NCT03030417|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
22286028|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012||
22286029|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
22286030|NCT02714569|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286031|NCT01684202|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22286032|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286033|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22286034|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736||
22286035|NCT01970306|Memorial Sloan Kettering Cancer Center|Dr. Vivian Strong, MD|212-639-5056|strongv@mskcc.org|
22286036|NCT02741635|Fisher & Paykel Healthcare Ltd.|Christine Lambert|+64 9 574 0123|christine.lambert@fphcare.co.nz|7172
22286037|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286038|NCT03472326|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22286039|NCT00773513|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
22286040|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200|fsiller@cucs.udg.mx|33723
22286041|NCT04739436|Duke University Medical Center|Sherri L. Smith, PhD, AuD, CCC-A|(919) 684-2426|sherri.smith@duke.edu|
22286042|NCT05919888|SSMHealth SLUCare Physician Group|Dr. Randall Otto|314-614-2970|randall.otto@slucare.ssmhealth.com|
22286043|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
22286044|NCT02459119|Dana Farber Cancer Institute|Dr. Guru Sonpavde, MD|617-632-2429|gsonpavde@gmail.com|
22286045|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22286046|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286047|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu|
22286048|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
22286049|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com|
22286050|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com|
22286051|NCT01825187|New Hanover Regional medical Center|Dr. William Hope|(910)667-9233|william.hope@nhrmc.org|667
22286052|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk|
22286053|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673|pfrankel@coh.org|65265
22286054|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
22286055|NCT03600740|Mayo Clinic|Erik H. Middlebrooks, M.D.|904-953-6696|Middlebrooks.Erik@mayo.edu|
22286056|NCT03740659|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
22303687|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org|
22303688|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22303689|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com|
22303690|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu|
22303691|NCT04254679|McGill University|Dr. Julio F. Fiore Jr|514 934-1934|julio.fiorejunior@mcgill.ca|35655
22303692|NCT03954158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303693|NCT03875495|Genenta Science|Chief Medical Officer|+39 02 2643 3982|info-trial@genenta.com|
22286057|NCT06309953|Bausch & Lomb|Jason Vittitow, PhD|908-541-3060|jason.vittitow@bausch.com|
22286058|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286059|NCT02721875|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22286060|NCT02888106|Hepatera LLC|Yana Deloveri|+7 495 762 52 53|deloveri@hepatera.ru|42-14
22286061|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu|
22286062|NCT04142034|University of Arkansas for Medical Sciences|Jeannette Lee|5015266712|jylee@uams.edu|
22286063|NCT01425801|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22286064|NCT03386721|Hoffmann-La Roche|Medical Communications|08008218590|genentech@druginfo.com|
22286065|NCT03066596|Montefiore Medical Center|Marina Reznik, MD, MS|718-741-2494|mreznik@montefiore.org|
22286066|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22286067|NCT03797586|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Dr.Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22286068|NCT02959437|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22286069|NCT02864901|Office of Regulated Activities|Emily Badraslioglu, Senior Regulatory Advisor & FDA Sponsor Representative|(301) 619-6828|emily.d.badraslioglu.civ@health.mil|
22286070|NCT00666406|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22286071|NCT02728089|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286072|NCT04544358|University of Illinois at Chicago|Dr. David X Marquez|312.996.1209|marquezd@uic.edu|
22286073|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22286074|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es|
22303694|NCT04800757|The University of Texas Health Science Center at Houston|Maria Eugenia Fernandez-Esquer|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
22286075|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr|
22286076|NCT03359174|Yale Univeristy|Clinical Research Coordinator|203 737 6839|laura.cusack@yale.edu|
22286077|NCT02680665|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286078|NCT02905266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22286079|NCT04871425|University of Washington|Complex Family Planning Division|206.221.9074|uwfp@uw.edu|
22286080|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22286081|NCT03715803|Universidad de Buenos Aires|Dr. Agustín Sampietro|+5491158336327|asampietro@live.com.ar|
22286082|NCT02538042|Duke University|Dr. F. Joseph McClernon|9196682963|joseph.mcclernon@duke.edu|
22286083|NCT04445662|Massachusetts General Hospital|Travis P Baggett MD MPH|617-643-9314|tbaggett@mgh.harvard.edu|
22286084|NCT04089761|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical and Regulatory Affairs|+972723909755|daganh@theranica.com|
22286085|NCT02506634|FirstSunYetSen|Dr. Niandi Tan|+86 15989117039|tanniandi@126.com|
22286086|NCT04896593|Anxiety Disorders Center|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
22286087|NCT02915978|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22286088|NCT02451124|Case Comprehensive Cancer Center|Amitabh Chak|2168443217|axc22@cwru.edu|
22286089|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286090|NCT01870726|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22286091|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22286092|NCT02937558|Xeris Pharmaceuticals, Inc.|Khaled Junaidi|312-517-1461|xerisclintrials@xerispharma.com|
22286093|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300||
22286094|NCT03691571|The Hospital of the University of Pennsylvania|Dr. Cory M. Tschabrunn|215-614-0482|coryt@pennmedicine.upenn.edu|
22286095|NCT01463306|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286096|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22286097|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu|
22286098|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286099|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov|
22286100|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743||
22286101|NCT01135095|Department of Medicine, Cardiology Division, Columbia University Medical Center and New York Presbyterian Hospital, New York|Dr. Andrew J. Einstein|+1 212 305-4275|Andrew.einstein@columbia.edu|
22286102|NCT02781610|Seattle Children's|Michelle Skalland (Biostatistician)|206-884-7519|michelle.skalland@seattlechildrens.org|
22286103|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu|
22286104|NCT03566082|Smith + Nephew|Fleur Derdeyn, Principal Clinical Study Manager|0032 497 60 20 32|fleur.derdeyn@smith-nephew.com|
22286105|NCT00983385|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22286106|NCT02663622|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286107|NCT00857857|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286108|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
22286109|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com|
22286110|NCT03790111|TerSera Therapeutics Inc.|Janine North, Executive Director-Clinical Development|888 600 8116|jnorth@tersera.com|
22286111|NCT03074409|University of Electronic Science and Technology of China|Dr. Shuxia Yao|+8618111297596|yaoshuxia@uestc.edu.cn|
22286112|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286113|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22286114|NCT00531284|Amgen, Inc.|Study Director|866-572-6436||
22286115|NCT03057496|Schepens Eye Research Institute of Massachusetts Eye and Ear|Alex Bowers|617 912 2512|alex_bowers@meei.harvard.edu|
22286116|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22286117|NCT01560286|BioMarin Pharmaceutical Inc|Sr. Medical Director, Clinical Science|415-475-5854|Ari.Gershman@bmrn.com|
22286118|NCT01364584|University of Colorado School of Medicine|Judith G Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
22286119|NCT03310723|BC Women's Hospital, Department of Anesthesia|Research Assistant|604-875-2424|james.taylor1@phsa.ca|6076
22286120|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22286121|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu|
22286122|NCT01508312|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz|212-639-4839|moskowia@mskcc.org|
22286123|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
22286124|NCT02322281|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
22286125|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu|
22286126|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22286127|NCT03456076|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22303695|NCT04076020|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
22303696|NCT05022602|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
22303697|NCT03230864|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22286128|NCT00466440|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286129|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22286130|NCT03187132|CedarsSinaiMC|R. Brennan Spiegel|310-423-6784|Brennan.Spiegel@cshs.org|
22303698|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
22286131|NCT02707146|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|510-891-5993|Richard.W.Grant@kp.org|
22286132|NCT03191630|The Ohio State University|Dr. Tara O'Brien|6142928045|obrien.782@osu.edu|
22286133|NCT02525588|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
22286134|NCT01837277|Federal University of Bahia|Professor Carlos Brites|+5555992329552|crbrites@hotmail.com|
22286135|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
22286136|NCT05413668|Quotient Sciences|Jeffrey Levy|+44 (0)115 974 9000|jeffrey.levy@quotientsciences.com|
22286137|NCT01631994|NYU Winthrop Hospital, Dep't of Gastroenterology|David Friedel, MD|(516) 663-2528|DFriedel@nyuwinthrop.org|
22286138|NCT00714415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286139|NCT03315039|Moleculin Biotech Inc|Chief Scientific Officer|862-273-1432|DPicker@moleculin.com|
22286140|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu|
22286141|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
22286142|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu|
22286143|NCT02794766|Universidade de Passo Fundo|Prof. Fernando Fornari|+555433168395|fernandofornari@gmail.com|
22286144|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu|
22286145|NCT02073682|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22286146|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu|
22286147|NCT03081156|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|William Stringer, MD|424-571-7626|stringer@ucla.edu|
22286148|NCT03767257|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz, MD, PhD|646-608-3714|hultcram@mskcc.org|
22286149|NCT04435366|Astellas Pharma Global Development, Inc|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22286150|NCT01687296|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286151|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286152|NCT04497116|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22286153|NCT04152772|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|Mascha_vant_Wout@brown.edu|
22286154|NCT05963022|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22286155|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il|
22286156|NCT02698826|Cooper University Health Care|Brian Roberts, MD/ REOX Study Director|856-342-2352|roberts-brian-w@cooperhealth.edu|
22286157|NCT02545608|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
22286158|NCT00945282|ViiV Healthcare|GSK Response Center|866-435-7343||
22286159|NCT02915263|Beth Israel Deaconess Medical Center|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
22286160|NCT02478463|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286161|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286162|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22286163|NCT01702558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22286164|NCT03782233|The First Affiliated Hospital of Nanjing Medical University|Dr. He Huang|13852476684|hh19871117@126.com|
22286165|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu|
22286166|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu|
22286167|NCT03259087|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286168|NCT04524858|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
22286169|NCT03571204|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|msneller@niaid.nih.gov|
22286170|NCT02396212|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22286171|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22286172|NCT04950465|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22286173|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu|
22286174|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286175|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
22286176|NCT00857285|Daiichi Sankyo, Inc.|Senior Director, Regulatory Operations|732-590-5000|hmkessler@dsus.com|
22286177|NCT04797780|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
22286178|NCT02940496|MD Anderson Cancer Center|Ahmed Kaseb, MD|(713) 792-2828|akaseb@mdanderson.org|
22286179|NCT05973006|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22286180|NCT05167825|Janssen Pharmaceutical K.K.|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22286181|NCT01807598|Stanford University|Jason R. Gotlib|650-736-1253|jason.gotlib@stanford.edu|
22286182|NCT02440685|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
22286183|NCT02286921|SKCCC at JHU|Dr. Samual Denmeade|410-955-8875|denmesa@jhmi.edu|
22286184|NCT03622814|Medical University of South Carolina|Teresa Kelechi|843-810-3157|kelechtj@musc.edu|
22286185|NCT04417361|UCSF|Jeffrey D. Sharon|4153532757|jeffrey.sharon@ucsf.edu|
22286186|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
22286187|NCT03868943|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7548|rstrowd@wakehealth.edu|
22286188|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301|Justin.Lindemann@astrazeneca.com|+44
22286189|NCT03543137|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286190|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu|
22286191|NCT01900652|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286192|NCT03761810|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22286193|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu|
22286194|NCT04178720|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22286195|NCT03922620|Geisinger Medical Center|Dr. Gerard Cush|5702716700|MSKIresearch@geisinger.edu|
22286196|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
22286197|NCT03678311|Cleveland Clinic|Dr. Reena Mehra|216-444-2165|mehrar@ccf.org|
22286198|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com|
22286199|NCT02986711|Penn State University College of Medicine|Jessica Yingst|7175310003|jmy5048@psu.edu|289511
22286200|NCT02302365|Terumo BCT|Isobelle Galeon, MD, MPH, MSCS, Medical Monitor Clinical Safety|+1 303 542-5166|Isobelle.Galeon@Terumobct.com|
22286201|NCT01848158|Seattle Children's Hospital|Jane Di Gennaro, MD MS|206-987-6988|jane.digennaro@seattlechildrens.org|
22286202|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr|
22286203|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
22286204|NCT03811340|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
22303699|NCT05462652|Big Health, Inc.|Jessica Lake|(510) 244-3753‬|research@bighealth.com|
22303700|NCT03410914|Sunnybrook Health Sciences Centre|Dr. Paul Karanicolas|4164806100|paul.karanicolas@sunnybrook.ca|4774
22303701|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com|
22303702|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
22303703|NCT04241575|The Chinese University of Hong Kong|Dr Vincent Wong|+85235054205|wongv@cuhk.edu.hk|
22303704|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22303705|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22303706|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu|
22286205|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22286206|NCT04662359|University of Pennsylvania|Dr. Michael George|215-662-2454|michael.george@pennmedicine.upenn.edu|
22286207|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22286208|NCT02785185|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22286209|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu|
22286210|NCT02960516|Vanderbilt university medical center|Dr. Wesley Thayer|+1 (615)936-3759|wesley.thayer@vumc.org|
22286211|NCT02372877|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
22286212|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com|
22286213|NCT01982123|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22286214|NCT02471014|University of Florida|Mathew Sebastian, PhD|8644901978|mathewsebastian@ufl.edu|
22286215|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22286216|NCT05098028|Bausch Health Americas, Inc|Varsha Bhatt|7072301712|varsha.bhatt@bauschhealth.com|
22286217|NCT00896298|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
22286218|NCT02532465|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
22286219|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22303707|NCT02368002|University of Minnesota|Nancy Sherwood|612-625-4567|sherw005@umn.edu|
22286220|NCT02493036|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
22286221|NCT02045095|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22286222|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22286223|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22286224|NCT01818596|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22286225|NCT03801174|University of Wisconsin - Madison|Corrine Voils, PhD|608-262-9636|voils@surgery.wisc.edu|
22286226|NCT04112810|Medical College of Wisconsin|William R Drobyski, MD, FACP, FASTCT|414-456-4941|wdrobysk@mcw.edu|
22286227|NCT02293798|Mark Mofid, M.D.|Dr. Mark Mofid|8589099000|drmofid@drmofid.com|
22286228|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com|
22286229|NCT01076959|Abbott|Global Medical Services|800-633-9110||
22286230|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov|
22286231|NCT03967054|Colorado State University|Brian D. Foy, PhD.|970-491-3470|Brian.Foy@colostate.edu|
22286232|NCT04170543|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22286233|NCT00770601|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
22286234|NCT01987102|Isofol Medical AB|Chief Medical Officer|+46 (0)702433750|karin.ganlov@isofolmedical.com|
22286235|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu|
22286236|NCT04378270|University of Pittsburgh|Jeffrey Gusenoff, MD|(412) 641-3960|gusenoffja@upmc.edu|
22286237|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22286238|NCT01236521|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; Matthew.Bair@va.gov|
22286239|NCT03890588|HealthPartners Institute|JoAnn Sperl-Hillen, MD, Senior Clinical Investigator|952-967-5009|joann.m.sperlhillen@healthpartners.com|
22286240|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286241|NCT03201419|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22286242|NCT04854694|FaceView Mask, LLC|Jeanne Hahne, MSN, RN|4155188574|jeannehahne@gmail.com|
22286243|NCT02784171|Canadian Cancer Trials Group|Dr. Lesley Seymour|613533600|lseymour@ctg.queensu.ca|75544
22286244|NCT05864586|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22286245|NCT03635424|Medtronic Coronary and Structural Heart Clinical|Hatice Bilgic Lim, PhD; Principal Clinical Research Specialist|763-526-1018|hatice.bilgic.lim@medtronic.com|
22286246|NCT02701283|Medtronic Structural Heart & Aortic Clinical Research & Medical Science|Kristin Smith, Clinical Research Manager|763-526-3095|kristin.m.smith@medtronic.com|
22286247|NCT04544956|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286248|NCT04266795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22286249|NCT05017701|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22286250|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov|
22303708|NCT02132533|UT Southwestern Medical Center|Chet Edward Wells, MD|214-648-2316|dawn.wilson@utsouthwestern.edu|
22286251|NCT03915470|Destiny Pharma|Clinical Project Manager|+44 (0)1273-704440|info@destinypharma.com|
22286252|NCT03160898|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22286253|NCT02601833|University of Michigan School of Dentistry|Emily Yanca Project and Data Manager|734-763-3988|emthorpe@umich.edu|
22286254|NCT03405818|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286255|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22286256|NCT02315534|Sumitomo Dainippon Pharma Oncology|Connor Marshall|843-364-8039|cmarshall@bostonbiomedical.com|
22286257|NCT04186871|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22286258|NCT02771197|The Blood and Marrow Transplant Group of Georgia/Northside Hospital|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22286259|NCT02155920|University of Texas Southwestern Medical School|Daniel C. Bowers, MD|214-648-3896|Daniel.Bowers@utsouthwestern.edu|
22286260|NCT04408040|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
22286261|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu|
22286262|NCT03932760|University of Utah|Gwen Latendresse|801-587-9636|Gwen.Latendresse@nurs.utah.edu|
22286263|NCT04725500|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22286264|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082|aluetkemeyer@php.ucsf.edu|130
22286265|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22286266|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu|
22286267|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu|
22286268|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu|
22286269|NCT05736874|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22286270|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
22286271|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu|
22286272|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil|
22286273|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22286274|NCT02981368|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
22286275|NCT02544321|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22286276|NCT03529110|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22286277|NCT03493945|National Cancer Institute|Dr. James L. Gulley|301-480-7164|gulleyj@mail.nih.gov|
22286278|NCT05104450|Veterans Health Administration|Dr. Lucas Donovan|206-277-6783|Lucas.Donovan@va.gov|
22286279|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286280|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22286281|NCT03689582|University of Michigan Rogel Cancer Center|Morand Piert, MD|734-936-5388|mpiert@med.umich.edu|
22286282|NCT02735239|Ludwig Institute for Cancer Research|Jonathan Skipper|212-450-1539|jskipper@lcr.org|
22286283|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu|
22286284|NCT00769886|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22286285|NCT02152631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286286|NCT05904470|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22286287|NCT03776747|University of Iowa|Dr. Eric Hoffman|(319) 356-1381|eric-hoffman@uiowa.edu|
22286288|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
22286289|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22286290|NCT03477396|City of Hope|Dr. MIna Sedrak|626-359-8111|msedrak@coh.org|
22286291|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu|
22286292|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353||
22286293|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu|
22286294|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com|
22286295|NCT03922581|Emory University|Abigail Lott, PhD|404-712-0159|abigail.lott@emoryhealthcare.org|
22286296|NCT04472611|Yale University School of Medicine|Dr. Alexandra Lansky|203 737 2142|alexandra.lansky@yale.edu|
22303709|NCT02001974|Dompé Farmaceutici|Pieradelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
22303710|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr|
22303711|NCT01380990|UCL Institute of Child Health|Dr Claire Booth|+44207 905 2198|C.Booth@ucl.ac.uk|
22286297|NCT00764699|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
22286298|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
22286299|NCT01745367|Aveo Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22286300|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22286301|NCT01507688|VA HSRD PRIS-M QUERI and CHIC HSRD Centers|Teresa Damush Ph.D.|317-988-4277|Teresa.Damush@va.gov|
22286302|NCT02107703|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286303|NCT02366312|NYU College of Dentistry|Dr. Brian Schmidt|212-998-8900|brianl.schmidt@nyu.edu|
22286304|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286305|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
22286306|NCT02541812|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
22286307|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286308|NCT04308941|BostonSight|Dr. Daniel Brocks|(781) 726-7506|ecrowley@bostonsight.org|
22289091|NCT01393392|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
22289092|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org|
22289093|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
22289094|NCT03959176|Wake Forest University School of Medicine|Keith Walter, MD|336-716-2144|kwalter@wakehealth.edu|
22286309|NCT02230566|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
22286310|NCT03507036|UT Southwestern|Jennifer Barillas|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22286311|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300||
22286312|NCT05202418|Emory University|Dr. Bonney Reed|404-727-8312|ebreed@emory.edu|
22286313|NCT03435185|University of Health Sciences Dr. Lütfi Kırdar Kartal Training and Research Hospital|Dr. Cem Bölük|+902164413900|cem.boluk@sbu.edu.tr|
22286314|NCT03901144|Perrigo/ACO Hud Nordic|Dr Tina Holm|+46732744113|tina.holm@perrigo.com|
22286315|NCT02491983|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22286316|NCT02021565|Atlanta VA Medical Center|Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
22286317|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com|
22286318|NCT03575403|University of Kentucky|Dr. Craig R. Rush, Ph.D.|8592575388|crush2@uky.edu|
22286319|NCT02292719|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22286320|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22286321|NCT01451385|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22286322|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22286323|NCT02481297|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain/Associate Professor|713-745-6080|njain@mdanderson.org|
22286324|NCT02412098|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22286325|NCT03089580|University of Michigan / Kellogg Eye Center|Sarah Wood|734-615-2479|skwood@med.umich.edu|
22286326|NCT03087513|Toronto Western Hospital/University Health Network|Study Coordinator|416-603-5800|emad.alazazi@uhnresearch.ca|6237
22286327|NCT04628780|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286328|NCT05315479|Baudax Bio|Development|484-395-2440|info@baudaxbio.com|
22286329|NCT03269994|Memorial Sloan Kettering Cancer Center|Dr. Michael D'Angelica, MD|212-639-3226|dangelim@mskcc.org|
22286330|NCT03884790|GreenBone Ortho SpA|Senior Clinical Affairs Manager|+393479747691|sonia.granados@greenbone.it|
22286331|NCT01288989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286332|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22286333|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu|
22286334|NCT04661150|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22286335|NCT04965688|Inova Health System|Adam Cohen, MD|7035767279|adam.cohen@inova.org|
22286336|NCT00369577|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22286337|NCT04618744|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
22286338|NCT04437485|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
22286339|NCT03553758|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22286340|NCT02807623|Defense Health Agency Immunization Healthcare Division South Atlantic Region Vaccine Safety hub|Laurie Housel|910-432-4015|laurie.a.housel.civ@mail.mil|
22286341|NCT02614729|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
22286342|NCT04456634|Medicines for Malaria Venture (MMV)|Jacques Herve|+41 79 370 40 63|hervej@mmv.org|
22286343|NCT04002960|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
22286344|NCT04367831|Columbia University|Sahil A. Parikh, MD|212-305-3617|sap2196@cumc.columbia.edu|
22286345|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu|
22286346|NCT00181363|Maastro Radiation Oncology|J. Buijsen,|+31 (0)88-44-55-666|jeroen.buijsen@maastro.nl|
22286347|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
22286348|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286349|NCT04363879|AtriumHealth|Dr. Brad Hurst, Director of Assisted Reproduction Program|7043553153|Brad.Hurst@atriumhealth.org|
22286350|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org|
22286351|NCT03999515|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
22286352|NCT01132807|Alliance for Clinical Trials in Oncology|David J. Straus, MD|212-639-8365|strausd@mskcc.org|
22286353|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com|
22286354|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu|
22286355|NCT03654690|Brown University|Dr. Tyler Wray|4018636659|tyler_wray@brown.edu|
22286356|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu|
22286357|NCT03170661|LUMC|Drs. Maarten Honing|0715264038|g.h.m.honing@lumc.nl|
22286358|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com|
22286359|NCT04140396|Stanford University|Chi-Ho Ban Tsui|(650) 200-9107|bantsui@stanford.edu|
22286360|NCT02513121|University of California, San Diego|Dr. Jeffrey Schwimmer|858-966-8907|jschwimmer@ucsd.edu|
22286361|NCT01303939|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22286362|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286363|NCT02254473|TRIA Orthopaedic Center|Megan Reams|952-806-5329|megan.reams@tria.com|
22286364|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com|
22286365|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
22286366|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22286367|NCT03609177|Dana Farber Cancer Institute|James Tulsky, MD, Chair of Suppportive Oncology Department|617-582-9201|JamesA_Tulsky@dfci.harvard.edu|
22286368|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22286369|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu|
22286370|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com|
22286371|NCT02446717|AbbVie|Global Medical Services|800-633-9110||
22286372|NCT03149172|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
22286373|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
22286374|NCT04936061|CoolTech|Clinical Trial Manager|570-228-8140|jholland@cooltechcorp.com|
22286375|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu|
22286376|NCT04532034|Temple University|Elizabeth THomas|215-204-1699|tug66715@temple.edu|
22286377|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn|
22286378|NCT01598922|McLean Hospital|Dr.Isabelle Rosso|6178552607|irosso@partners.org|
22286379|NCT02488005|Icahn School of Medicine at Mount Sinai|Becky Phan|212-824-7785|becky.phan@mssm.edu|
22286380|NCT04289311|Medical University of South Carolina|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
22286381|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
22286382|NCT03384940|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22286383|NCT04184297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303712|NCT04422639|University of Arkansas for Medical Sciences|Assistant Director of Cancer Clinical Trials|501-686-8274|bscanlan@uams.edu|
22303713|NCT01964521|The Norfolk & Norwich University Hospitals NHS Foundation Trust|Dr Ketan Dhatariya|+44 1603 286286|ketan.dhatariya@nnuh.nhs.uk|
22286384|NCT03649074|Akili Interactive|Clinical Operations and Research Manager|8572543399|dfarlow@akiliinteractive.com|
22286385|NCT04303559|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
22286386|NCT01862536|VA Boston Healthcare System|Dr. Ronald Goldstein|857-203-6578|Ronald.Goldstein@va.gov|
22286387|NCT01156714|VAORD|Fred Ivey|410-605-7000|Frederick.Ivey@va.gov|6582
22286388|NCT03946748|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22286389|NCT03775486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22286390|NCT00801216|IRCCS Ospedale San Raffaele|Dr. Andrés José Maria Ferreri|022643 7649|ferreri.clinicaltrials@hsr.it|
22286391|NCT05907395|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286392|NCT05214768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22286393|NCT05481359|Cortex, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
22286394|NCT03066063|Barron Associates, Inc.|Richard Adams|434-973-1215|adams@bainet.com|
22286395|NCT03043872|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22286396|NCT03741088|HistoSonics, Inc.|Clinical Affairs Manager|651.398.7586|christine.sullivan@histosonics.com|
22286397|NCT02777827|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22286398|NCT04551066|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22286399|NCT04491136|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22286400|NCT04441255|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22286401|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286402|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
22286403|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
22286404|NCT02452424|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22286405|NCT01059318|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22286406|NCT03790917|National Medical Research Center for Preventive Medicine|professor Sergey Yu. Martsevich|89161643690|sergeymartsevich@mail.ru|
22286407|NCT02267538|Peking University First Hospital|Dr. Dong-Xin Wang,PHD,the director of department of Anesthesiology and Critical Care Medicine|+8613910731903|wangdongxin@hotmail.com|
22286408|NCT02774148|Spectrum Health|Andrea Mantel|616-486-2051|andrea.mantel@spectrumhealth.org|
22286409|NCT02137096|University of Florida|John Fort, MD|352-273-9120|john.fort@ufl.edu|
22286410|NCT01223183|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
22286411|NCT03772665|Acucela, dba Kubota Vision|Dr. Jeff Gregory|2068058310|clinicaltrials@acucela.com|
22286412|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
22286413|NCT02719171|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22286414|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22286415|NCT05298202|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
22286416|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22286417|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
22286418|NCT04481243|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
22286419|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22286420|NCT02467179|University of California San Diego|Dr. Gregory Feld|(858) 246-2972|gfeld@ucsd.edu|
22286421|NCT02796677|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22286422|NCT02752880|Chang Gung Memorial Hospital|Dr. YH Huang|+886975360240|igighuang@gmail.com|
22286423|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270|christoph.hehrlein@uniklinik-freiburg.de|6095
22286424|NCT01777308|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286425|NCT03410628|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22286426|NCT03212326|Weill Cornell Medical College|Dr. Christopher Liu|212-746-2655|chl7001@med.cornell.edu|
22286427|NCT03430791|Miami Cancer Institute at Baptist Health, Inc.|Yazmin Odia|786-596-2000|YazminO@baptisthealth.net|
22286428|NCT02918617|University of Texas Health San Antonio|Bennett Amaechi, DDS|210-567-3185|amaechi@uthscsa.edu|
22286429|NCT03270943|University of North Carolina at Chapel Hill|Christine Lathren, MD, MPH|919-966-8586|lathren@email.unc.edu|
22286430|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22286431|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de|
22286432|NCT01116401|Brigham & Women's Hospital|Hadine Joffe|617-732-4906|hjoffe@partners.org|
22286433|NCT01855412|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22286434|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300|david.aron@va.gov|5836
22286435|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu|
22286436|NCT03714178|Farapulse|Kit Schneider|617-686-7661|kschnieder@farapulse.com|
22286437|NCT05030350|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
22286438|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com|
22286439|NCT04057807|Yale School of Medicine|Adam Mecca|203.764.8100|adam.mecca@yale.edu|
22286440|NCT02843165|University of California, San Diego|Andrew Sharabi|(858) 822-5354|CancerCTO@health.ucsd.edu|
22286441|NCT03985761|Rutgers The State University of NJ|Dr. Gerard G Fluet DPT, PhD|(973) 972-8529|fluetge@shp.rutgers.edu|
22286442|NCT02609308|Universidad Autónoma de Nuevo León|Carlos Acosta-Olivo, PhD|+52 81 8347-3056|dr.carlosacosta@gmail.com|
22286443|NCT01858363|Spectranetics|Nicolas Aguirre|+1-312-297-6655|nicolas.aguirre@philips.com|
22286444|NCT01859923|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22286445|NCT03148613|Carrot Inc.|Director Clinical Affairs|650-906-4255|craig@carrot.co|
22286446|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22286447|NCT02878317|University of Nottingham|Professor Maarten Taal|01332 224618|m.taal@nottingham.ac.uk|
22286448|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663|jabernethy@nanotherapeutics.com|326
22286449|NCT02462148|Wake Forest Baptist Health|Dr. Jimmy Turner|3368064498|jturner@wakehealth.edu|
22286450|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22286451|NCT02520726|University of Utah|Brent Kious, MD|801-585-1418|brent.kious@hsc.utah.edu|
22286452|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22286453|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286454|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286455|NCT02451995|Imperial College Healthcare|Dr Vishal Luther|07828913612|v.luther14@imperial.ac.uk|
22286456|NCT05114473|University of Valencia|Dr. Borja Perez-Dominguez|697464680|f.borja.perez@uv.es|34
22286457|NCT02927392|University of Colorado Anschutz Medical Campus|Edward L. Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
22286458|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300||
22286459|NCT03095248|Cincinnati Children's Hospital Medical Center|Senior Regulatory Specialist|15135350640|andrea.bidwell@cchmc.org|
22286460|NCT03116685|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
22286461|NCT06019728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22286462|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu|
22286463|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov|
22286464|NCT03137225|Virginia Commonwealth University|Henry J. Rozycki, MD|8048289602|henry.rozycki@vcuhealth.org|
22286465|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623||
22286466|NCT02110095|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22286467|NCT00291486|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22286468|NCT01840345|Virginia Commonwealth University|Dr. Dace Svikis|(804) 827-1184|dssvikis@vcu.edu|
22286469|NCT02679170|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286470|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300||
22286471|NCT01408459|University of Illinois at Chicago|Dr. Phyllis E. Bowen|708-524-0586|pbowen@uic.edu|
22286472|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com|
22286473|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
22286474|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu|
22286475|NCT00543387|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286476|NCT02373774|Columbia University Medical Center|Raquel Schrager|(212) 305-4687|rs3823@cumc.columbia.edu|
22286477|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org|
22286478|NCT03145259|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22286479|NCT04177212|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22286480|NCT01792115|NIDDK|Dr. Yaron Rotman|301-451-6553|rotmanyaron@mail.nih.gov|
22286481|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu|
22286482|NCT01943591|Centre hospitalier de l'Université de Montréal Research Centre|Dr. Jean Raymond|514-890-8000|jraymond.nri@gmail.com|27235
22286483|NCT02539797|University of California, Los Angeles|Dr. Yuri Rassovsky|3104783711|yurir@ucla.edu|
22286484|NCT02831764|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286485|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com|
22286486|NCT01609348|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
22286487|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22286488|NCT03347123|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22286489|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590||
22286490|NCT03273673|Virginia Tech|Dr. Robin Queen|(540) 231-3134|rmqueen@vt.edu|
22286491|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286492|NCT03431441|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|904-443-1396|mbishop4@its.jnj.com|
22286493|NCT03788057|The Regional Public Hospital in Lesko, Poland|Dr. Janusz Ciółkowski|+48 134698071|ciolkowski.janusz@gmail.com|
22286494|NCT02163824|Kala Pharmaceuticals, Inc|VP, Clinical Development||Results001@kalarx.com|
22286495|NCT04115384|HealthPartners Institute|Manager Research Operations|651-495-6363|ClinicalTrials@HealthPartners.com|
22286496|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286497|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286498|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu|
22286499|NCT03392935|University of Utah Dermatology|Dr. Karen Stolman, Assistant Professor, Dermatology|8015816465|ks@checkmateproductions.com|
22286500|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org|
22286501|NCT04537793|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22286502|NCT00988598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286503|NCT03367858|University of Rhode Island|Dr. Sarah Feldstein Ewing|401-874-4251|feldsteinewing@uri.edu|
22286504|NCT03831477|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22286505|NCT02197702|StJustineH|Dr Francine Ducharme|5143454931|Francine.m.ducharme@umontreal.ca|4398
22286506|NCT01619839|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
22286507|NCT03822897|Canadian Cancer Trials Group|Dr. Wendy Ranjana Parulekar|613 533 6430|wparulekar@ctg.queensu.ca|
22286508|NCT02485561|Washington University in St. Louis|Amy McQueen|3142862016|amcqueen@wustl.edu|
22286509|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22286510|NCT02090426|Massachusetts Institute of Technology|Amy Finkelstein, PhD|6173246995|jgubb@mit.edu|
22286511|NCT03174366|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
22286512|NCT02079038|Vertiflex|Steve Reitzler|442-325-5934|Stephen.reitzler2@bsci.com|
22286513|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22286514|NCT03480152|National Cancer Institute|Dr. Steven Rosenberg|240-858.3080|steven-rosenberg@nih.gov|
22286515|NCT05350163|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
22286516|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu|
22286517|NCT03634085|Venn Life Sciences|Simone van Broekhoven / Clinical Trial Manager|+310765480625|simone.vanbroekhoven@vennlife.com|
22286518|NCT04276233|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286519|NCT00876200|Hospices Civils de Lyon|Dr Behrouz KASSAI-KOUPAI|472116911|behrouz.kassai-koupai@chu-lyon.fr|+33
22286520|NCT03246789|Weill Cornell Institute of Geriatric Psychiatry|Dr. Patricia Marino|(914) 997-8691|pam2029@med.cornell.edu|
22286521|NCT01946139|Emmes Company, LLC|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
22286522|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22286523|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22286524|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com|
22286525|NCT00985465|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286526|NCT03101566|University of Michigan Rogel Cancer Center|Vaibhav Sahai, MBBS, MS|734-936-4991|vsahai@med.umich.edu|
22286527|NCT01054456|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22286528|NCT04701333|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22286529|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
22286530|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
22286531|NCT03880058|Scarless Labs Inc.|Dr. Elisabeth Leeflang|213-788-2128|Clin_Info@scarlesslabs.com|
22286532|NCT01814527|East Carolina University|Joseph Armen DO|252-744-3212|armenj@ecu.edu|
22286533|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org|
22286534|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
22286535|NCT03948334|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22286536|NCT04332107|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
22286537|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22286538|NCT00214539|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412-716-0717|Mark.Grubb@bsci.com|
22286539|NCT00271102|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
22286540|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286541|NCT05477485|Virginia Commonwealth University|Dr. April D. Kimmel|(804) 628-6273|adkimmel@vcu.edu|
22286542|NCT03061201|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286543|NCT01572480|National Cancer Institute|Dr. Elizabeth Hill|240-760-6183|Elizabeth.Hill@nih.gov|
22286544|NCT05081219|Atrium Health Wake Forest Baptist|Suzanne Craft, PhD|336.713.8846|Suzanne.Craft@advocatehealth.org|
22286545|NCT03446313|University of California, San Francisco|Linda Park, Principle Investigator|415-502-6616|linda.park@ucsf.edu|
22286546|NCT06235905|Navitorpharma|Senior Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
22286547|NCT04894669|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22286548|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
22286549|NCT02756572|University of Washington/Seattle Cancer Care Alliance|Mary-Elizabeth Percival, MD, MS|206-606-1320|mperciva@seattlecca.org|
22286550|NCT05551611|Kocaeli University|Dr. Suzi ÖZDEMİR|05548488674|suzi.ozdemir@gmail.com|
22286551|NCT02711137|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22286552|NCT03956550|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22286553|NCT03400852|Mallinckrodt|Medical Information Call Center|1-800-844-2830|MedInfo@mnk.com|
22286554|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22286555|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22286556|NCT02341235|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
22286557|NCT05200143|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
22286558|NCT03719131|Emory University|Kavita Dhodapkar, MD|404-785-1112|kavita.dhodapkar@emory.edu|
22286559|NCT04244253|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22286560|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286561|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286562|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu|
22286563|NCT03001557|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22286564|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22286565|NCT02159066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-102|ClinicalTrials.gov_Inquiries@pfizer.com|
22286566|NCT02531217|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22286567|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22286568|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu|
22286569|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528||
22286570|NCT05470387|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
22286571|NCT03742973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286572|NCT02366195|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22286573|NCT02119871|Department of Cardiothoracic Surgery, Lund University|Maya Landenhed Smith|+4646173639|maya.landenhed_smith@med.lu.se|
22286574|NCT00434226|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22286575|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org|
22286576|NCT03324802|Mayo Clinic|Carlos E. Vargas, M.D.|4803421262|Vargas.Carlos@mayo.edu|
22286577|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org|
22286578|NCT02021942|Klinik und Poliklinik für Neurologie der Universitaet Regensburg|Prof. Dr. Berthold Schalke|+49 941 941|berthold.schalke@medbo.de|3010
22286579|NCT02673918|University of British Columbia|Bolette Rafn|604-827-1914|bolette.rafn@ubc.ca|
22286580|NCT02946034|Massachusetts General Hospital|Dr. Raymond Chung|617-726-5925|Chung.Raymond@mgh.harvard.edu|
22286581|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu|
22286582|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com|
22286583|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289095|NCT02736578|Stanford University|Eben Rosenthal|650-723-2967|elr@stanford.edu|
22289096|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org|
22286584|NCT03259555|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22286585|NCT02800863|Abbott Vascular|Nicole Harbert|(972) 526-4841|Nicole.harbert@abbott.com|
22286586|NCT03957551|University of Iowa|John Rieth, MD|(319) 356-1616|john-rieth@uiowa.edu|
22286587|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com|
22286588|NCT02021669|Washington University School of Medicine|Robert M. Carney, Ph.D|314-286-1305|carneyr@wustl.edu|
22286589|NCT02717494|Westat|Lauren Laimon, Senior Study Director|240-453-2987|LaurenLaimon@westat.com|
22286590|NCT01887184|The University of Hong Kong|Professor Chi Wai Cheung|22553303|cheucw@hku.hk|
22286591|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es|
22286592|NCT06098937|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
22286593|NCT01774799|Hebrew SeniorLife|Dr. Susan Mitchell|617-971-5326|smitchell@hsl.harvard.edu|
22286594|NCT04037865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286595|NCT01125800|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22286596|NCT05051579|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286597|NCT00066677|Fox Chase Cancer Center|Steven J. Cohen|215-728-2450|s_cohen@fccc.edu|
22286598|NCT01808196|Cincinnati Children's Hospital Medical Center|Pablo Abonia, MD|513-636-|pablo.abonia@cchmc.org|
22286599|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286600|NCT04106609|Maple Tree Cancer Alliance|Dr. Karen Wonders|937-477-8213|karen.wonders@mapletreecanceralliance.org|
22286601|NCT05274958|Carilion Clinic|Director Psychiatry Clinical Research|540-527-4900|askablinger@carilionclinic.org|
22286602|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu|
22286603|NCT04266925|University of Alabama at Birmingham|Dr David Schwebel,|205-934-4068|schwebel@uab.edu|
22286604|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu|
22286605|NCT02682992|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22286606|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
22286607|NCT03274063|University of Edinburgh|Dr Philip Riches|07944625313|priches@staffmail.ed.ac.uk|
22286608|NCT02679287|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22286609|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu|
22286610|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286611|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22286612|NCT00794950|University of Michigan|Alon Z. Weizer, MD, MS|734-615-6662|aweizer@umich.edu|
22286613|NCT02485704|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
22286614|NCT03628976|Georgia Institute of Technology|Dr. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
22286615|NCT00851786|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22286616|NCT03858049|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22286617|NCT02079740|Massachusetts General Hospital|Ryan Corcoran, MD PhD|617-724-4000|rbcorcoran@mgb.org|
22286618|NCT04104256|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
22286619|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu|
22286620|NCT04388111|Houston Methodist Hospital|Research Coordinator|346 238 1603|tsullivan@houstonmethodist.org|
22286621|NCT02777021|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
22286622|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com|
22286623|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22286624|NCT01914003|QOL Medical, LLC|Heather Smith, Director of One Patient Services|919-832-4949|hsmith@onepatientservices.com|
22286625|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286626|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu|
22286627|NCT02719535|The Hong Kong Polytechnic University|Dr. Andrew Lam|85227666109|andrew.kc.lam@polyu.edu.hk|
22286628|NCT03629886|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286629|NCT03052101|University of Cincinnati|Elizabeth Kopras|513-558-4831|koprasej@uc.edu|
22286630|NCT05473026|University of Florida|Lakeshia Cousin, PhD, APRN, AGPCNP-BC|352-273-6318|lakeshiacousin@ufl.edu|
22286631|NCT02038153|Montefiore|Dr. Ira Braunschweig|718 920-4826|ibraunsc@montefiore.org|
22286632|NCT03683173|Washington University School of Medicine|Diana Parra Perez, Ph.D.|314-286-1426|parrad@wustl.edu|
22286633|NCT02647281|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286634|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286635|NCT00496015|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286636|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu|
22286637|NCT02730728|University of Pennsylvania|Dr Nabil Elkassabany|2156628000|nabil.elkassabany@uphs.upenn.edu|
22286638|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org|
22286639|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240||
22303714|NCT03121534|The University of Texas MD Anderson Cancer Center|Philip Thompson MD.|713-745-5732|PAThompson2@mdanderson.org|
22286640|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com|
22286641|NCT05552027|Children's Hospital of Philadelphia|Morgan O'Donald|267-499-4114|ODONALDM@chop.edu|
22286642|NCT03360682|Hospital Clínic/IDIBAPS, University of Barcelona|Jose M. Miro Meda (PI), MD, PhD, Consultant, Infectious Diseases Service|93 227 54 30|JMMIRO@clinic.cat|
22286643|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com|
22286644|NCT02525653|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
22286645|NCT03244917|Hebrew SeniorLife|Susan Mitchell MD, MPH|6172813669|smitchell@hsl.harvard.edu|
22286646|NCT01147666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22286647|NCT02748863|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22286648|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300||
22286649|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22286650|NCT04177706|Medical University of South Carolina|Prinicipal Investigator|8438761199|JONJEN@musc.edu|
22286651|NCT03004365|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
22286652|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
22286653|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
22286654|NCT02111447|GLA|Research Coordinator|7163236570|tgensler@greatlakesanes.com|
22286655|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
22286656|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com|
22286657|NCT03865446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286658|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22286659|NCT02952365|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22286660|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22286661|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
22286662|NCT03081884|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
22286663|NCT02294058|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|AMcClain@celgene.com|
22286664|NCT05006261|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
22286665|NCT02303093|Octapharma Pharmazeutika Produktionsgesm.b.H.,|Dr. Bernhard Rohrbacher|+431610324182|bernhard.rohrbacher@octapharma.com|
22286666|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu|
22286667|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
22286668|NCT02354534|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|CervixDoctor@jhmi.edu|
22286669|NCT02997501|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22286670|NCT00152503|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22286671|NCT02586623|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22286672|NCT04487106|The University of Texas MD Anderson Cancer Center|Nichols Short MD/Associate Professor|713-563-4485|NShort@mdanderson.org|
22286673|NCT04393493|hospital civil de guadalajara|Dr Jonathan Chavez Iñiguez|3313299609|jonarchi_10@hotmail.com|
22286674|NCT02910466|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22286675|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22286676|NCT02537717|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22286677|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
22286678|NCT02093793|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
22286679|NCT03370718|M.D. Anderson Cancer Center|Mouhammed A. Habra, MD|713-792-2841|mahabra@mdanderson.org|
22286680|NCT06172348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286681|NCT04539938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286682|NCT04037891|Akari|Wynne H Weston-Davies|+44(0)7801 281283|wynne.weston-davies@akaritx.com|
22286683|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
22286684|NCT04194944|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22286685|NCT03400475|University of Iowa|Dr. Ahmed Mahrous|3193336517|ahmedmohamed-mahrous@uiowa.edu|
22286686|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286687|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
22286688|NCT03798717|University of Portsmouth|Dr. Ant Shepherd|02392845289|ant.shepherd@port.ac.uk|
22286689|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov|
22286690|NCT04290039|BARDA|Brenda Wolling, Regulatory SME|(202) 692-4763|Brenda.Wolling@hhs.gov|
22286691|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu|
22286692|NCT03439280|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22286693|NCT03096834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22286694|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu|
22286695|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu|
22286696|NCT04617782|Corium, Inc.|Ronald Tashjian, Sr. Director of Clinical Operations|6172337474|rtashjian@coriumintl.com|
22286697|NCT01650298|ABBOTT|Grant Kim|818-493-3147|gkim@sjm.com|
22286698|NCT02849418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286699|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov|
22286700|NCT00915954|Cedars-Sinai Medical Center|Dr. Odelia Cooper|310-423-2830|coopero@cshs.org|
22286701|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu|
22286702|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org|
22286703|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
22286704|NCT03518294|The Penn State College of Medicine|Dr. Jonathan Stine|7175311017|jstine@pennstatehealth.psu.edu|
22286705|NCT02634333|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
22286706|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22286707|NCT03827655|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22286708|NCT02519023|University of Minnesota|Dr. Jacob Hutchins|6122505535|hutc0079@umn.edu|
22286709|NCT03935126|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22286710|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
22286711|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22286712|NCT01454596|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
22286713|NCT02314936|KGK Synergize Inc.|Dr. Tetyana Pelipyagina|5194389374|drtetyana@kgksynergize.com|
22286714|NCT04875806|NextCure, Inc|Senior VP, Clinical and Translational Development|240-399-4900|NCClin@nextcure.com|
22286715|NCT03318549|University of Miami|Vice Chair of Research|305-326-6373|fmedeiros@med.miami.edu|
22286716|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org|
22286717|NCT00104650|Amgen Inc.|Study Director|866-572-6436||
22286718|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22286719|NCT03515824|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286720|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22286721|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu|
22286722|NCT03084796|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22286723|NCT05470985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22286724|NCT01917747|UK Dept. of Otolaryngology Head and Neck Surgery|Dr. Matthew L. Bush|859-218-2168|matthew.bush@uky.edu|
22286725|NCT04388254|Cassava Sciences|Sr. Associate Director|5125013180|bmurray@cassavasciences.com|
22286726|NCT06451965|University of East Anglia|Ercan Hassan (Trainee Clinical Psychologist)|07496337806|nue22cyu@uea.ac.uk|
22286727|NCT02870283|Universidade Federal do Rio Grande do Sul|Dra. Ana Flávia Silva Lima|+5551999185180|afbslima@gmail.com|
22286728|NCT02741245|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286729|NCT02401347|Stanford Medicine at Stanford University|Melinda L Telli, MD|(650) 724-9533|mtelli@stanford.edu|
22286730|NCT03799341|VA Pittsburgh Healthcare System|Sarah Forster, PhD|412-209-9208|sarah.forster2@va.gov|
22286731|NCT01116648|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
22286732|NCT03064490|Duke University Health System (DUHS)|Linda Kaltenbach/Regulatory Coordinator|(919) 668-3726|linda.kaltenbach@duke.edu|
22286733|NCT02647723|University of Chicago|Dr. Kate Keenan|773-702-4449|kekeenan@uchicago.edu|
22286734|NCT05524220|The University of Texas Health Science Center at Houston|Erikka Washington, MD|713-500-6202|Erikka.L.Washington@uth.tmc.edu|
22286735|NCT05579977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286736|NCT00543777|UT MD Anderson Cancer Center|Haesun Choi, MD/Professor, Abdominal Imaging Department|(713) 745-4693|hchoi@mdanderson.org|
22286737|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com|
22286738|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr|
22286739|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu|
22286740|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22286741|NCT04564846|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
22286742|NCT03737123|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22286743|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22286744|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22286745|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22286746|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22286747|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101|John.Anderson@oamichigan.com|797
22286748|NCT01421017|NYU Langone Health|Sylvia Adams|212-731-5795|sylvia.adams@nyumc.org|
22286749|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr|
22286750|NCT04233008|Brigham and Women's Hospital|Sarah Little|617-732-5452|selittle@bwh.harvard.edu|
22286751|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu|
22286752|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22286753|NCT01702844|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22286754|NCT02193776|TB Alliance|Almari Conradie, Director, Clinical Operations|+27 12 991 6328|almari.conradie@tballiance.org|
22286755|NCT02995980|University of Alabama at Birmingahm|Rachael Lancaster, MD|205-934-4080|mvetrano@uabmc.edu|
22286756|NCT01173016|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22286757|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au|
22286758|NCT04245111|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
22286759|NCT06039579|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286760|NCT02792231|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22286761|NCT03309878|Johns Hopkins University|Grants Administrative Manager|443-927-3568|JHCCCRO@jhmi.edu|
22286762|NCT01884077|Washington University School of Medicine - Dept of Orthopaedic Surgery|Dr. Aaron Chamberlain|314-362-9283|chamberlaina@wudosis.wustl.edu|
22286763|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com|
22286764|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu|
22286765|NCT00659802|Hutchison Medipharma|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
22286766|NCT01220167|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
22286767|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
22286768|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org|
22286769|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl|
22286770|NCT03936608|The University of Kansas|Amit Noheria|9135889757|amit.noheria@gmail.com|
22286771|NCT02855203|Peter MacCallum Cancer Centre|Office of Cancer Research|+61 3 85597364|OCR@petermac.org|
22286772|NCT03776864|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
22286773|NCT04864249|University of Pittsburgh Medical Center, Magee-Womens Hospital|Dr. Alisse Hauspurg|412-641-1381|janickia@upmc.edu|
22286774|NCT06237049|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22286775|NCT04678115|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
22286776|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com|
22286777|NCT02552966|Northwestern University|Dr. John Pandolfino, Principal Investigator|3126950182|j-pandolfino@northwestern.edu|
22286778|NCT02643459|Herlev Hospital, Department of Cardiology|Dr. Martin Schultz|004538683868|martin.schultz@regionh.dk|
22286779|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu|
22286780|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
22303715|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com|
22303716|NCT02796963|UNC Project-China|Dr. Weiming Tang|+86-21-83755824|weimingtangscience@gmail.com|
22303717|NCT03192215|Columbia University|Mitchell S.V. Elkind, MD, MS, FAHA/ Randolph S. Marshall, MD, MS (trial investigators)|212-305-1710/ 212-305-8389|mse13@cumc.columbia.edu, rsm2@cumc.columbia.edu|
22303718|NCT04844918|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303719|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com|
22303720|NCT01990820|NorthShore University HealthSystem|Dr. Mark Gerber|847-504-3300|mgerber@northshore.org|
22303721|NCT04110366|Imperial College London|Dr Ryan Thwaites|(0044) 0203 3125730|r.thwaites@imperial.ac.uk|
22303722|NCT03119571|University of Minnesota|Demetri Yannopoulos, MD|6126261382|yanno001@umn.edu|
22303723|NCT04485546|Dompé Farmaceutici S.p.A|Sarah Wilting, OD MS|833-366-7387|usmedinfo@dompe.com|
22303724|NCT02088632|Jefferson Headache Center|Clinical research manager|2159552680|mary.hopkins@jefferson.edu|
22303725|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22303726|NCT00514046|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
22303727|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22303728|NCT00591123|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Zev Wainberg, MD|310-829-5471|zwainberg@mednet.ucla.edu|
22303729|NCT02855164|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22303730|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22303731|NCT02049710|Carnegie Mellon University, Social and Decision Sciences|Mandy Lanyon, Research Associate II|4122683249|mandy@cmu.edu|
22303732|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
22303733|NCT06385483|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22303734|NCT01216293|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22303735|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
22303736|NCT05819619|Hackensack Meridian Health|Melissa M. Figueroa, MD, MPH, FACOG|551-996-8400|melissa.figueroa@hmhn.org|
22303737|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn|
22303738|NCT03681639|Zimmer Biomet|Esther Foo|+41792894930|esther.foo@zimmerbiomet.com|
22303739|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22303740|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org|
22303741|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com|
22303742|NCT00678444|UPittsburgh|Dr. Jerry Lowder|314-747-1402|lowderj@wudosis.wustl.edu|
22286781|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com|
22286782|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu|
22286783|NCT02794207|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
22286784|NCT03483896|University of Southern California|Prof. Kyle Konis, Ph.D|(213) 740-2723|kkonis@usc.edu|
22286785|NCT02365649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22286786|NCT01506271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286787|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286788|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org|
22286789|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22303743|NCT02169830|Saint Louis University|Dr. Anthony A Mikulec|314-977-8884|anthony.mikulec@health.slu.edu|
22303744|NCT03204695|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22303745|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com|
22303746|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org|
22303747|NCT04781647|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
22303748|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503|matthias.zerm@merz.de|865
22303749|NCT01755689|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303750|NCT04448236|Haven of Hope hospital, Hospital Authority|Dr. Lau Chung Wai|27038888|lcw431@ha.org.hk|
22303751|NCT02930122|University of Kentucky|Dr. Cale Jacobs|859-218-3065|cale.jacobs@uky.edu|
22303752|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com|
22303753|NCT02609659|AbbVie|Global Medical Services|800-633-9110||
22303754|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
22303755|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303756|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590||
22303757|NCT02462083|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
22303758|NCT02435511|University of Chicago|Dr. Stacy Lindau|7738348986|slindau@bsd.uchicago.edu|
22303759|NCT02711995|Weill Cornell Medicine|Katerina Andreadis|646-962-9883|kaa2055@med.cornell.edu|
22303760|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22303761|NCT01809210|AstraZeneca|Dr Gabriella Mariani , MD|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
22303762|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu|
22303763|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk|
22303764|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22286790|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303765|NCT03905811|University of Iowa|Jordan Schultz|3193849388|jordan-schultz@uiowa.edu|
22303766|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303767|NCT04975789|University of Wisconsin - Madison, School of Nursing|Maichou Lor, PhD, RN|608-265-4248|mlor2@wisc.edu|
22303768|NCT01489020|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
22303769|NCT03685747|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
22303770|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
22303771|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov|
22286791|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu|
22286792|NCT01857297|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22286793|NCT01611194|Intermountain Healthcare|Lindell Weaver, MD, FACP, UHM|801-408-3623|lindell.weaver@imail.org|
22286794|NCT03492125|MingSight Pharmaceuticals|Kai Zhang|8582055958|kzhang@mingsight.com|
22286795|NCT02464410|Veterans Health Administration|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
22286796|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22286797|NCT01604291|Hoffmann-La Roche|Medical Communications|800-821-8590|Genentech@druginfo.com|
22286798|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22286799|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org|
22286800|NCT02775916|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22286801|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22286802|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com|
22286803|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
22286804|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22286805|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22286806|NCT03692208|The University of Chicago|Dr. Elbert Huang|(773) 834-9143|ehuang@medicine.bsd.uchicago.edu|
22303772|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu|
22286807|NCT00882440|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22286808|NCT02682381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22286809|NCT05482308|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286810|NCT00905450|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22286811|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com|
22286812|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org|
22286813|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu|
22286814|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
22286815|NCT02123134|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
22286816|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org|
22286817|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22286818|NCT04375150|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22286819|NCT02656017|University of Pittsburgh|Dr. Kyongtae Bae|412-647-3500|baek@upmc.edu|
22286820|NCT04755816|University of Michigan College of Pharmacy|Dr. MICHAEL DORSCH|734/647-1452|mdorsch@umich.edu|
22286821|NCT02611479|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
22286822|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com|
22286823|NCT02314052|Dicerna Pharmaceuticals|Ralf Rosskamp|617-621-8097|rrosskamp@dicerna.com|
22286824|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22286825|NCT02422498|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
22286826|NCT02653326|Universidad de Valparaiso|Carla Taramasco|2508306|carla.taramasco@uv.cl|+56 32
22286827|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351||
22286828|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286829|NCT03452540|Afimmune|Study Director|+353 1 2946380|regulatory.afimmune@afimmune.com|
22286830|NCT03388346|UIHC|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
22286831|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com|
22286832|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
22286833|NCT02767271|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
22286834|NCT04551989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22286835|NCT04201431|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
22286836|NCT02726620|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
22286837|NCT04055675|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
22286838|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com|
22286839|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22286840|NCT04571944|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286841|NCT03192826|Patras Medical School|OPHTHALMOLOGY PATRAS|6975801961|cgeorg@upatras.gr|
22286842|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22286843|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org|
22286844|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22286845|NCT00667888|UT MD Anderson Cancer Center|Karen Huffman, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2339|khoffman1@mdanderson.org|
22286846|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22286847|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu|
22286848|NCT00739401|Endologix|Elisa Hebb, VP Clinical Affairs|949-598-4628|ehebb@endologix.com|
22286849|NCT04575155|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22286850|NCT03808090|University of Alabama at Birmingham|Dr Kyle Wood|205-996-2295|kylewood@uabmc.edu|
22286851|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu|
22286852|NCT03748823|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22286853|NCT00890825|AstraZeneca|Tracy Cunningham|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
22286854|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22286855|NCT02920892|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
22286856|NCT03649217|Moterum Technologies, Inc.|Brianne Darcy|(864) 659-3180|brie@moterumtechnologies.com|
22286857|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22286858|NCT01216202|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
22286859|NCT02851303|Brown Family Medicine|Dr. Mary Beth Sutter|401-921-7981|marybeth_sutter@brown.edu|
22286860|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22286861|NCT03476135|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22286862|NCT02570503|Virginia Commonwealth University|Teresa Potter|804-828-6749|teresa.potter@vcuhealth.org|
22286863|NCT04908397|Vanderbilt University Medical Center|Anna R. Hemnes|615-343-8227|anna.r.hemnes@vumc.org|
22286864|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22286865|NCT02221869|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22289097|NCT05615922|NYU Langone Health|Leigh Charvet, PhD|929-455-5141|Leigh.Charvet@nyulangone.org|
22286866|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu|
22286867|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22286868|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286869|NCT02918357|University of California, San Francisco|Dr. Thomas Hope|(415) 221-4810|thomas.hope@ucsf.edu|2264
22286870|NCT03213834|University of Florida|Erin Silverman, Research Coordinator|352-273-5870|erin.silverman@medicine.ufl.edu|
22286871|NCT02926638|SWOG|Lung Committee Statistician|2066677733|kmini@fredhutch.org|
22286872|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
22286873|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
22286874|NCT02360228|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
22286875|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org|
22286876|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu|
22286877|NCT02426580|The Nephrology Department, the Chengdu Second Affiliated Hospital of Chongqing Medical University, the Third Peoples's Hospital of Chengdu|Dr. Gong Rong, Dr. Han Tianzhao, Dr. Leonard Stern|+86 028-61318708|gongr2006@sina.com|
22286878|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22286879|NCT05295849|University of Connecticut|Sherry Pagoto, PhD|860-486-5917|sherry.pagoto@uconn.edu|
22286880|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu|
22286881|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu|
22286882|NCT02764385|Oregon Health & Science University|Sue Flocke|5034946697|flocke@ohsu.edu|
22286883|NCT03598036|Aurinia Pharmaceuticals Inc.|Clinical Trial Support|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22286884|NCT03893396|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
22286885|NCT05801991|Southern California College of Optometry|Erin Rueff, OD, PhD (Principal Investigator)|714-463-7586|erueff@ketchum.edu|
22286886|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
22286887|NCT04235140|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22286888|NCT03016312|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22286889|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
22286890|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu|
22286891|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286892|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
22286893|NCT02780401|University of Washington Medical Center|Jennifer S. Childs|2066162305|childj@u.washington.edu|
22286894|NCT01893801|Cancer Research and Biostatistics|Adam Rosenthal|(206) 839-1797|adamr@crab.org|
22286895|NCT02754570|University of Colorado|Rachel Gerle|720-848-5096|rachel.gerle@ucdenver.edu|
22286896|NCT00904813|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
22286897|NCT01731912|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22286898|NCT02043938|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22286899|NCT03480048|Michigan State University|Jean Kerver, PhD, MSc, RD, Assistant Professor|231-392-8227|jkerver@epi.msu.edu|
22286900|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com|
22286901|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org|
22286902|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu|
22286903|NCT02836652|Abbott|Poornima Sood|7818528334|poornima.sood@abbott.com|
22286904|NCT03812380|UT Southwestern Medical Center|Khashayar Sakhaee, MD|214-648-0324|Khashayar.Sakhaee@UTSouthwestern.edu|
22286905|NCT03679975|Aquestive Therapeutics|Gary Slatko, Chief Medical Officer|908-941-7050|clinicaltrials@aquestive.com|
22286906|NCT02349633|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286907|NCT00667628|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
22286908|NCT05789745|Nucleus Network|Trisha Shamp, Ph.D|651-641-2925|t.shamp@nucleusnetwork.com|
22286909|NCT04663321|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22286910|NCT05108246|SUNY at Buffalo|Nikhil Satchidanand|7168162884|ns1@buffalo.edu|
22286911|NCT00622505|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22286912|NCT00619515|Case Comprehensive Cancer Center|Dr. Lee Ponsky|216-844-4831|lee.ponsky@uhhospitals.org|
22303773|NCT05584657|Iterum Therapeutics|Senior Vice President and Head of Clinical Development|8606614035|saronin@iterumtx.com|
22303774|NCT04747275|Children's Mercy|Max Feldt|816-960-8892|mmfeldt@cmh.edu|
22303775|NCT02360774|Beth Israel Deaconess Medical Center|Jody Dushay|6176671996|jdushay@bidmc.harvard.edu|
22303776|NCT03268590|Case Western Reserve University|Michael John Decker, PhD|216-368-2467|mjd6@case.edu|
22303777|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com|
22303778|NCT05719285|Cleveland Clinic Foundation|Dr. Lauren Gleich|701-330-1669|LAURENGLEICHDO@GMAIL.COM|
22303779|NCT02823964|Anthera Pharmaceuticals|Nicole Ramza|510-856-5600|info@anthera.com|
22303780|NCT03537261|Massachusetts General Hospital Lurie Center|Lisa Nowinski, PhD|781-860-1700|lnowinski@mgh.harvard.edu|
22303781|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr|
22303782|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22303783|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303784|NCT00178620|The University of Texas Health Science Center at Houston|Dr. Richard W. Smalling|713-500-6559|richard.w.smalling@uth.tmc.edu|
22303785|NCT04524104|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
22303786|NCT00983619|MedImmune, LLC|Shahram Rahimian|800-236-9933|information.center@astrazeneca.com|
22303787|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22303788|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu|
22303789|NCT02593032|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@pennmedicine.upenn.edu|
22303790|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436||
22303791|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303792|NCT01716208|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22303793|NCT02443103|IndianaU|Dr. Kathy Miller|317-948-3855|kathmill@iu.edu|
22303794|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu|
22303795|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu|
22303796|NCT02878213|EPD Solutions|Chen Sagy Bross|+972-50-5560073|chensb@epd-medical.com|
22303797|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303798|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22286913|NCT01839058|Western University|Keith McIntosh|519-646-6100|keith.mcintosh@sjhc.london.on.ca|61312
22286914|NCT03294590|Boston University Henry M. Goldman School of Dental Medicine|Belinda Borrelli, PhD|617-358-3358|belindab@bu.edu|
22286915|NCT03232346|NYS Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22286916|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22286917|NCT04862065|Abbott Laboratories|Tuan Bui (Manager Clinical Research)|224-668-4702|tuan.l.bui@abbott.com|
22286918|NCT01453140|Hackensack University Medical Center|Dr. Michele Donato, MD|551-996-2000|MDonato@hackensackumc.org|3524
22286919|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca|
22286920|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu|
22286921|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22286922|NCT01752426|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
22286923|NCT02269124|Massachusetts Eye and Ear|Dr. Michael S. Cohen, MD|6175733190|Michael_Cohen@MEEI.HARVARD.EDU|
22286924|NCT05075746|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
22286925|NCT04664153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286926|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22286927|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22286928|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
22286929|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com|
22286930|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com|
22286931|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300||
22286932|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286933|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov|
22286934|NCT01945021|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286935|NCT05550779|University of Colorado Colorado Springs|Dr. Lori James|7192554172|ljames@uccs.edu|
22286936|NCT03349723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22286937|NCT00399308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22286938|NCT03409796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22286939|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu|
22286940|NCT02539823|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212 824 9314|yasmin.hurd@mssm.edu|
22286941|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com|
22286942|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
22286943|NCT01908426|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22286944|NCT03240601|Shepherd Center|Dr. Edelle Field-Fote|4046034274|edelle.field-fote@shepherd.org|
22286945|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
22286946|NCT02973100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22286947|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org|
22286948|NCT04046328|Pharmascience Inc.|Clinical Study Manager|514-340-9800|researchsupport@pharmascience.com|
22286949|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com|
22286950|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22286951|NCT04456504|University of Wisconsin School of Pharmacy|Mary Hayney, PharmD, MPH, FCCP, BCPS|608-265-4666|mary.hayney@wisc.edu|
22286952|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org|
22286953|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286954|NCT03112681|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22286955|NCT02869633|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22286956|NCT03287791|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22286957|NCT03441477|NIDEK Co., LTD.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
22286958|NCT02891174|University of Michigan|Dr. Elizabeth Langen|734-764-3406|elangen@med.umich.edu|
22286959|NCT01314313|Edwards Lifesciences|Tenley Koepnick||Tenley_Koepnick@edwards.com|
22286960|NCT04319198|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22286961|NCT04494841|MMJ Labs|Dr. Amy Baxter|1 877 805 2899|abaxter@mmjlabs.com|
22286962|NCT04607668|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
22286963|NCT02250326|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22286964|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
22286965|NCT03285724|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22286966|NCT03010527|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22286967|NCT02469623|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|442232608-|steven.mcquillan@acutus.com|
22286968|NCT04073186|Johnson & Johnson Vision Care|Thomas Karkkainen- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22286969|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu|
22286970|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219||
22286971|NCT05757648|University Hospitals Cleveland Medical Center|Dr. Ying An|(216)368-3277|Ying.An@UHhospitals.org|
22286972|NCT06418152|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
22286973|NCT05256901|Emory University|Viola Vaccarino, MD, PhD, Principal Investigator|404-727-8710|lvaccar@emory.edu|
22286974|NCT02529852|M D Anderson Cancer Center|Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
22286975|NCT02055898|Imperial College London|Keith Boland||k.boland@imperial.ac.uk|
22286976|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com|
22286977|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22286978|NCT02646826|Wellesley Pharmaceuticals, LLC|David Dill|2154930168|ddill@wellesleypharma.com|
22286979|NCT03206216|Stanford University Medical Center|Seema Nagpal, MD|650-725-8630|snagpal@stanford.edu|
22286980|NCT03650088|University of North Carolina at Chapel Hill|Deborah F. Tate, PhD|919-966-5851|dtate@unc.edu|
22286981|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22286982|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22286983|NCT00119847|Stony Brook University|Dr. Eric J. Rashba|631-444-3575|eric.rashba@stonybrookmedicine.edu|
22286984|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
22286985|NCT01553084|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22286986|NCT05139680|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22286987|NCT03119259|Indiana University|Dr. Richard Holden|812-586-1965|rjholden@iu.edu|
22286988|NCT00099372|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
22286989|NCT02527681|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
22286990|NCT02972931|AIDS Research Institute IrsiCaixa|Dr. Judith Dalmau|934656374|jdalmau@irsicaixa.es|161
22286991|NCT00756106|Massachusetts General Hospital|Dr. Elizabeth Gerstner||EGERSTNER@mgh.harvard.edu|
22286992|NCT00647296|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22286993|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343||
22286994|NCT03253679|M D Anderson Cancer Center|Dr. Siqing Fu|713-792-4318|siqingfu@mdanderson.org|
22286995|NCT04816214|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22286996|NCT04879628|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22286997|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22286998|NCT02348593|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22286999|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743||
22287000|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22287001|NCT04612725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22287002|NCT03863509|University of Wisconsin-Madison|Dr James H. Stein|608-262-2075|jhs@medicine.wisc.edu|
22287003|NCT03861273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287004|NCT02511379|Alcon, A Novartis Division|Study Director Med Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22287005|NCT01855360|Brigham and WQomen's Hospital|Rodney H Falk|6175257053|rfalk@bwh.harvard.edu|
22287006|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
22287007|NCT01962792|Pharmacyclics LLC|Thorsten Graef, Head of Clinical Development|+1 (408) 215-3127|tgraef@pcyc.com|
22287008|NCT05622734|University of Washington School of Nursing|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
22287009|NCT03270436|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
22287010|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu|
22287011|NCT04416204|University of Alabama at Birmingham|Dr. Rita Basu|2059341200|rbasu@uabmc.edu|
22287012|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
22287013|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu|
22287014|NCT01393158|Oregon Health & Science University|Dr. Eric Simpson,|503-494-2121|simpsone@ohsu.edu|
22287015|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu|
22287016|NCT04233801|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287017|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287018|NCT01391364|Bausch Health|Study Director||robert.steffen@bausch.com|
22303799|NCT01555021|Massachusetts General Hospital, Boston, MA|John D. Matthews, M.D., M.Sc.|617-643-9095|jmatthews@partners.org|
22303800|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu|
22303801|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22303802|NCT02204293|Helios Fachklinik Vogelsang-Gommern GmbH, Germany|Prof. Dr Eugen Feist|+49 30 450 513 192|eugen.feist@charite.de|
22303803|NCT02420327|University of Maryland School of Medicine|Dr. Britta Hahn|410-402-6112|bhahn@som.umaryland.edu|
22303804|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk|
22303805|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22303806|NCT01146574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22303807|NCT01266993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303808|NCT03299062|University of Arkansas for Medical Sciences|Rohit Dhall, MD|6025033193|rdhall@uams.edu|
22287019|NCT02985827|Ora|Senior Director of Research and Development|9786858900|klane@oraclinical.com|
22287020|NCT01977547|Washington University School of Medicine|Dr. Philip C. Spinella|3142860858|pspinella@wustl.edu|
22287021|NCT01841281|UC Davis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
22287022|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22287023|NCT04024891|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22287024|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov|
22287025|NCT03397264|Opthea|Director of Clinical Research|+61 3 9826 0399|info@opthea.com|
22287026|NCT03095651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287027|NCT00851357|UCSD|Principal Investigator|858-300-1056|szhu@ucsd.edu|
22287028|NCT02714400|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|62155
22287029|NCT04124939|Urology Department, Wake Forest University|Sachin N. Vyas, Research Manager|336-713-4098|svyas@wakehealth.edu|
22287030|NCT04346745|Columbia University|Associate Professor|2128512246|jl4658@columbia.edu|
22287031|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
22287032|NCT02152826|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22287033|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022|b.ricki@cinim.org|0
22287034|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22287035|NCT02690181|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287037|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287038|NCT04750824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287039|NCT05196828|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
22287040|NCT02763644|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22287041|NCT02356159|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22287042|NCT03192176|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22287043|NCT05796557|Yale|Oliver Karam|203-785-4651|oliver.karam@yale.edu|
22287044|NCT03631940|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
22287045|NCT00836589|BIOTRONIK, INC|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
22287046|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22287047|NCT03255902|William Beaumont Hospitals|Donna Marvicsin, Nurse Practitioner, Pediatric Endocrinology|248-568-6932|donna.marvicsin@beaumont.org|
22287048|NCT03324607|Duke University Medical Center|Yuh-Chin T. Huang, MD, MHS|9196843069|huang002@mc.duke.edu|
22287049|NCT02914639|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
22287050|NCT01582061|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22287051|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22287052|NCT01045460|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
22287053|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl|
22287054|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org|
22287055|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
22287056|NCT01924845|BioMarin Pharmaceuticals|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
22287057|NCT03780452|UAB Department of Orthopaedic Surgery|Dr. Ashish Shah|(205) 930-8339|ashishshah@uabmc.edu|
22287058|NCT02388269|electroCore LLC|Clinical Affairs Department electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
22287059|NCT01995708|Memorial Sloan Kettering Cancer Center|Dr. David Chung, MD, PhD|646-608-3770|ChungD1@MSKCC.ORG|
22287060|NCT00265564|Office of Mental Health Operation, Veterans Health Administration|Jodie Trafton, Director Program Evaluation and Resource Center|650-493-5000|Jodie.Trafton@va.gov|22474
22287061|NCT04698343|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
22287062|NCT03581279|MDC Associates, Inc.|Manager, Regulatory and Clinical Affairs|9787055012|t2@mdcassoc.com|
22287063|NCT02163902|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
22287064|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22287065|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22287066|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org|
22287067|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287068|NCT02903160|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|212-604-6010|bobby.liaw@mountsinai.org|
22287069|NCT01838317|University of Texas Southwestern Medical Center|Dr. Muhammad Shaalan Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
22287070|NCT01664910|The University of Texas MD Anderson Cancer Center|Dr. Issa Khouri, MD/Stem Cell Transplantation and Cellular Therapy Department|713-745-0049|ikhouri@mdanderson.org|
22287071|NCT02240485|Université du Québec à Trois-Rivières|Dr. Joël Tremblay|4186592170|joel.tremblay@uqtr.ca|2820
22287072|NCT02525471|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
22287073|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22287074|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22287075|NCT00837902|Vanderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
22287076|NCT00539981|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22287077|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil|
22287078|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca|
22287079|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu|
22287080|NCT01991808|University of Pennsylvania|Lilie Lin, MD|215-622-6515|lin@uphs.upenn.edu|
22287081|NCT03069352|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22287082|NCT02621424|VA Palo Alto|Jauhtai Cheng, MD, Staff Neurologist|650-493-5000|jauhtai.cheng2@va.gov|63617
22287083|NCT01697397|G-Tech Medical|Steve Axelrod, PhD, CEO|650-269-1479|steve.axelrod@gtechhealth.com|
22287084|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
22303809|NCT02559609|UConn Health|Sheia Alessi|860-679-1849|salessi@uchc.edu|
22303810|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287085|NCT00289653|Centre for Addiction and Mental Health|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|36859
22287086|NCT04906499|University of North Carolina at Chapel Hill|Caroline Lisee, PhD|919-962-2025|liseecar@email.unc.edu|
22287087|NCT03346434|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22287088|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com|
22287089|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch|
22287090|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
22287091|NCT01751061|Duke University|Dr. Christopher Cox|9196817232|Christopher.cox@duke.edu|
22287092|NCT02412306|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22287093|NCT05635461|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
22287094|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287095|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com|
22287096|NCT00472108|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
22287097|NCT03882021|Abbott|Laura Zitella Verbick|+1-612-961-7336|laura.zitellaverbick@abbott.com|
22287098|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22287099|NCT04309110|Firstkind Ltd|Dr Kieron Day|+44 (0) 1494 572040|kieron.day@firstkindmedical.com|
22287100|NCT03582215|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.strauss@fda.hhs.gov|
22287101|NCT02174731|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22287102|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012||
22287103|NCT04657679|Georgetown University|Sandra Swain, MD,|(202) 687-8487|sandra.swain@georgetown.edu|
22287104|NCT05748275|Multack Eye Care|Dr Sam Multack|815-889-3333|smultack@mecvision.com|
22287105|NCT03915717|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
22303811|NCT02956434|VA Boston Healthcare System|Dr. Johanna Thompson-Hollands|857-364-2311|johanna.thompson-hollands@va.gov|
22303812|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22303813|NCT04714216|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
22303814|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22287106|NCT06047210|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
22303815|NCT02555371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303816|NCT03095599|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
22303817|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303818|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca|
22303819|NCT03615482|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303820|NCT04006795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303821|NCT04212169|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22303822|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22303823|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
22303824|NCT02018861|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22303825|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303826|NCT02466126|Department of Veterans Affairs, Micheal E. DeBakey VAMC|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
22303827|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu|
22303828|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22303829|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300||
22303830|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22303831|NCT02137538|Stanford University|E Kirk Neely|650-723-5791|neely@stanford.edu|
22303832|NCT02451930|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303833|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
22303834|NCT05258747|Sandoz|Sandoz Disclosure Office|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
22303835|NCT05454449|National Yang-Ming Chiao-Tung University|Yi-Fen Shih, Ph.D Department of Physical Therapy and Assistive Technology|+886-2-28267340|yfshih@nycu.edu.tw|
22303836|NCT02701582|NYU School of Medicine|Marc Bloom, MD, PHD|305 689-2388|mbloom@miami.edu|
22303837|NCT03092960|Stanford University|Lisa Goldman Rosas|(650) 721-8415|lgrosas@stanford.edu|
22303838|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu|
22303839|NCT01950273|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303840|NCT02722941|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-8156|Taiga.Nishihori@moffitt.org|
22303841|NCT04430335|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-9055|megreen@wakehealth.edu|
22303842|NCT01080196|University of Utah|Dr Paul LaStayo|8019719298|paul.lastayo@health.utah.edu|
22303843|NCT00179010|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
22303844|NCT03988374|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|6098061200|annhita.ghassemi@churchdwight.com|
22303845|NCT03748979|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22303846|NCT03249376|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22303847|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu|
22303848|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303849|NCT04204772|University of Minnesota, Department of Medicine|Armin Rashidi, MD, PhD|612-624-0123|arashidi@umn.edu|
22303850|NCT02694640|University of South Carolina|Dr. Bernardine Pinto|8037779272|pintob@mailbox.sc.edu|
22303851|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22303852|NCT04496414|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|
22303853|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22303854|NCT00432679|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303855|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org|
22303856|NCT03405662|University of California, San Francisco & San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@ucsf.edu|24386
22303857|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22303858|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303859|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
22303860|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252||5252
22303861|NCT01824082|University of California San Diego|Brian M. Ilfeld|858-822-0776|bilfled@health.ucsd.edu|
22303862|NCT02056119|Rush University Medical Center|David Vines, PhD, RRT|3129424408|david_vines@rush.edu|
22303863|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com|
22303864|NCT03220737|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
22303865|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu|
22303866|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
22303867|NCT04011384|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
22303868|NCT04716881|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
22303869|NCT01630590|UT MD Anderson Cancer Center|Dr. Paul Corn, Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
22303870|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287107|NCT04079296|Astellas Pharma Global Development Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22287108|NCT06133816|University of Pennslyvania|Katharine Rendle, PI|215-349-5442|katharine.rendle@pennmedicine.upenn.edu|
22287109|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287110|NCT03275740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287111|NCT02639494|Mayo Clinic|Dr. Rajiv Gulati|507-538-6325|Gulati.Rajiv@mayo.edu|
22287112|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287113|NCT04368260|University of Virginia|Dr. Amy Mathers|434-924-9678|ajm5b@virginia.edu|
22287114|NCT04621448|University of California, San Francisco|Dr. Deborah Barnes|415-502-2943|deborah.barnes@ucsf.edu|
22287115|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu|
22287116|NCT03550378|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
22287117|NCT04486235|Corporal Michael J. Crescenz VA Medical Center|Jocelyn Remmert, PhD|215-823-5800|jocelyn.remmert@va.gov|
22287118|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
22287119|NCT04999839|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22287120|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287121|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com|
22287122|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22287123|NCT03546621|Hepatera LLC|Dr.Alexander Alexandrov|+7 (495) 726-52-53|alexandrov@myr-pharma.com|42-03
22303871|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22303872|NCT04147260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303873|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22303874|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it|
22303875|NCT02471404|AstraZeneca|Eva Johnsson, MD, PhD|+46 (0)31776 24 84|ClinicalTrialTransparency@astrazeneca.com|
22303876|NCT03051659|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22303877|NCT04779242|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22303878|NCT01757067|University of Maryland Medical Center|Dr. Timm-Michael Dickfeld|410-328-7801|Tdickfel@som.umaryland.edu|
22303879|NCT02643979|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
22303880|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
22287124|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
22287125|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22287126|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287127|NCT03740048|Wake Health|Dr Zhidong Lin|3367138720|zlin@wakehealth.edu|
22287128|NCT03261336|Inova Schar Cancer Institute|Stephanie Van Bebber, Sr. Director Clinical Trials|5714720213|Stephanie.VanBebber@inova.org|
22287129|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com|
22287130|NCT00292942|Uniformed Services University of the Health Sciences|Louis Cantilena, Jr., MD, PhD|301-295-0016|lcantilina@usuhs.mil|
22287131|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com|
22287132|NCT03180385|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
22287133|NCT02732600|VISN 5 Mental Illness Research, Education, and Clinical Center|Richard Goldberg|410-637-1851|Richard.Goldberg@va.gov|
22303881|NCT02207374|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22287134|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711|robert.kerns@va.gov|3841
22287135|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
22287136|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287137|NCT03360903|University of Chicago|Aaron Fox|(773) 702-0021|aaronfox@uchicago.edu|
22287138|NCT01422161|New York University School of Medicine|Preeti Raghavan, MD|212 598 6206|raghap01@nyumc.org|
22287139|NCT02051764|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22287140|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu|
22287141|NCT02898454|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22287142|NCT03040141|Visterra Inc.|Head of Regulatory Affairs|+1 617-498-1070|info@visterrainc.com|
22287143|NCT04731636|LifeTechScientific|Clinical manager|15695219339|Xuwei@lifetechmed.com|
22287144|NCT01384734|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287145|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu|
22287146|NCT03071263|Vifor Pharma Inc.|Clinical Support & Regulatory Intelligence, Regulatory Affairs Director|+1 250 708 4296|Clive.Burge@viforpharma.com|
22287147|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov|
22287148|NCT02922725|University of Utah|Brent M. Kious|801-585-1418|brent.kious@hsc.utah.edu|
22287149|NCT05626673|Pray.com|Breanne Laird|9095574002|breanne.laird@pray.com|
22287150|NCT02856412|San Francisco Veterans Health Care System|Thomas Neylan, MD|415-750-6961|Thomas.Neylan@va.gov|
22287151|NCT05148234|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22287152|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
22287153|NCT04750642|Cochlear|Aaron Parkinson|13039414951|aparkinson@cochlear.com|
22287154|NCT01650194|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22287155|NCT06319898|Atrium Health Wake Forest Baptist|Dr. Erin Franks|7043041160|erin.franks@atriumhealth.org|
22287156|NCT01602224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287157|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22287158|NCT00644423|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
22287159|NCT03525444|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22287160|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
22287161|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu|
22287162|NCT02741128|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22287163|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
22287164|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22287165|NCT03406377|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22287166|NCT01183689|Wake Forest University School of Medicine|Mark Espeland|336-716-2826|mespelan@wakehealth.edu|
22287167|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
22287168|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu|
22287169|NCT02542046|UCaliforniaSF|Dr. Benjamin Yeh|4155149318|ben.yeh@ucsf.edu|
22287170|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287171|NCT04861597|Montefiore Medical Center|Ruby Greywoode M.D. M.S., Assistant Professor of Medicine|347-671-8205|rgreywoode@montefiore.org|
22287172|NCT01317472|Indiana University|Terese Stevens, Dept administrator|317-278-3187|tstevens@iupui.edu|
22287173|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU|
22287174|NCT04682197|Atrium Wake Forest Baptist Health|Dr. Charles H. Tegeler|336-716-9447|BBRP@wakehealth.edu|
22287175|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22287176|NCT05626738|ENDOSTART SRL|Alessandro Tozzi|0571843033|a.tozzi@endostart.com|0039
22287177|NCT04951115|Weill Cornell Medicine|Ashish Saxena|646-962-2066|ahs9018@med.cornell.edu|
22287178|NCT03583099|Weill Cornell Medicine|Fernando J. Martinez, MD, MS|646-962-2370|fjm2003@med.cornell.edu|
22287179|NCT04364386|InPress Technologies Inc|Jan Segnitz, MD|(408) 238-9279|jsegnitz@gmail.com|
22287180|NCT04709068|Current Health|Clinical Research Lead|617-208-4239|study.team@currenthealth.com|
22287181|NCT04019379|University of Minnesota|Kathleen M. Hill Gallant, PhD|612-625-5285|hillkm@umn.edu|
22287182|NCT00807911|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
22287183|NCT03859024|University of Alabama at Birmingham|Dr. Adam Baumgarten|205-996-6769|abaumgarten@uabmc.edu|
22287184|NCT04175730|University of Illinois at Chicago|Dr. Michael Abern|312-996-9330|mabern1@uic.edu|
22287185|NCT02648204|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22287186|NCT04349891|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22287187|NCT04851691|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
22287188|NCT03532542|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
22287189|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287190|NCT03550118|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
22287191|NCT01187017|NIHNHLBI|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
22287192|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22287193|NCT04590014|Vapotherm Inc|Katherine Gerich|5854696753|kgerich@vtherm.com|
22287194|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu|
22287195|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411|angela.kirby@va.gov|5526
22287196|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22287197|NCT03111875|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|sessled@ccf.org|
22287198|NCT03273426|Seoul National University Hospital|Dr. Wonshik Han|+82-2-2072-1958|hanw@snu.ac.kr|
22287199|NCT05083351|Masimo|Director, Clinical Lab Operations|(949) 297-7000|studies@masimo.com|
22287200|NCT05288816|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22287201|NCT04097431|Mount St Mary's University|Dr. Griffin Rooker|(301) 447-5143|g.w.rooker@msmary.edu|
22287202|NCT04326920|UZ Gent|Cedric Bosteels|+3293325909|cedric.bosteels@ugent.be|
22287203|NCT02343263|Indiana University|Bruce H. Matt, MD, MSc|3172781215|bmatt@iupui.edu|
22287204|NCT02228681|GOG Foundation|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
22287205|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu|
22287206|NCT01784991|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
22287207|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com|
22287208|NCT03353675|Transgene|Director of Medical Affairs|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
22287209|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22287210|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu|
22287211|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287212|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu|
22287213|NCT02370420|Universidad Autonoma de Nuevo Leon|Felix Vilchez Cavazos|811 049 80 70|vilchez.doctor@hotmail.com|
22287214|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22287215|NCT03883581|NOVA Southeastern University|Lauren Tabor Gray|954-914-5447|Lauren.taborgray@nova.edu|
22287216|NCT02099864|Oregon Health & Science University|Dr. Alexandra Sokolova, M.D.|(503) 494-4396|sokolova@ohsu.edu|
22287217|NCT03224130|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
22287218|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287219|NCT02660788|BC Cancer|Dr. Alan Nichol|604-877-6046|anichol@bccancer.bc.ca|
22287220|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22287221|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22287222|NCT03115359|Pennsylvania State University|Aleksandra E. Zgierska, MD, PhD|717-531-8187|azgierska@pennstatehealth.psu.edu|
22287223|NCT04673214|MEXICAN SOCIAL SECURITY INSTITUTE|Dr. GILBERTO CRUZ ARTEAGA|55 87 44 22|gilberto.cruz@imss.gob.mx|15320
22287224|NCT04992312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22287225|NCT05546476|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287226|NCT03804840|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22287227|NCT03793751|Tata Main Hospital, Tata Steel|Dr.Deb Sanjay Nag|+91-9431166582|debsanjay@gmail.com|
22287228|NCT02681809|ThromboGenics|Global Clinical Development|+3216751310|info@oxurion.com|
22287229|NCT03585660|Department of Radiology, University of Chicago|Dr. Aytekin Oto, MD, MBA|1-773-702-8553|aoto@bsd.uchicago.edu|
22287230|NCT05120713|University of Southern California|Dr. Andy Kim|213-740-5156|andyk@usc.edu|
22287231|NCT03316196|VA San Diego Healthcare System|Dr. Jessica Bomyea|8585528585|jessica.bomyea@va.gov|1416
22287232|NCT02498925|McLean Hospital|Christian Webb, PhD|6178554429|cwebb@mclean.harvard.edu|
22287233|NCT03661723|Dana-Farber Cancer Institute|David A. Reardon, MD (Clinical Director, Center for Neuro-Oncology)|617-632-2166|david_reardon@dfci.harvard.edu|
22287234|NCT03760029|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287235|NCT00910104|Boston Children's Hospital|Mark Puder MD PhD|617-355-1838|mark.puder@childrens.harvard.edu|
22287236|NCT03137654|UFlorida|Ben Lewis, Assistant Professor, UF Department of Psychiatry|3522948724|benlewis@ufl.edu|
22287237|NCT04890652|Department of Psychiatry, Yale University School of Medicine|Dongju Seo, Associate Professor|475-441-3457|dongju.seo@yale.edu|
22287238|NCT05753449|Allegheny Health Network|Megan Hendricks, regulatory Specialist|412-330-6206|megan.hendricks@ahn.org|
22287239|NCT03789669|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
22287240|NCT04386291|NYS Psychiatric Institute|Dr. Brian A Fallon|646-774-8052|baf1@cumc.columbia.edu|
22287241|NCT02595983|Alnylam Pharmaceuticals Inc|Chief Medical Office|866.330.0326|Clinicaltrials@alnylam.com|
22303882|NCT02087150|Acclarent|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
22287242|NCT02399215|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
22287243|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22303883|NCT00785538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287244|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org|
22287245|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu|
22287246|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22287247|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287248|NCT01903356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287249|NCT04529083|VA North Texas Health Care System|Dr. James Le Page|214-857-1437|james.lepage@va.gov|
22287250|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
22287251|NCT03305666|Denver Health and Hospital Authority|Dr. Fredric Pieracci|(303) 436-4029|Fredric.Pieracci@dhha.org|
22287252|NCT04196686|Lucile Packard Children's Hospital Stanford|Samuel Rodriguez, MD|(650)723-6412|sr1@stanford.edu|
22287253|NCT01048593|Eyepoint Pharmaceuticals, Inc.|Regulatory Affairs Specialist|6179726318|dbauer@eyepointpharma.com|
22303884|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500|matsuda@medicinova.com|132
22303885|NCT03897205|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
22303886|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu|
22303887|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org|
22303888|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743||
22287254|NCT04701814|Pharos university in Alexandria|P.T Moataz Abdelaal|1060081213|moataz.abd.student@pua.edu.eg|+20
22287255|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu|
22303889|NCT00507026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287256|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22287257|NCT05106959|University of New Mexico South West Clinical Trials Network|Cade Arnink|505-918-0341|clarnink@salud.unm.edu|
22287258|NCT03448406|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287259|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
22287260|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org|
22287261|NCT04369404|Massachusetts General Hospital|Karen Sepucha, PhD|617-724-3350|ksepucha@mgh.harvard.edu|
22287262|NCT03130738|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|407-323-1887|nini.ramirez@hillderm.com|
22287263|NCT02689427|The University of Texas MD Anderson Cancer Center|Clinton Yam, MD|(832) 589-8343|cyam@mdanderson.org|
22287264|NCT04602390|Anokion US|Medical Director|+1 857.320.6607|clinicaltrials@anokion.com|
22287265|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com|
22287266|NCT05005260|Mayo Clinic|Johar Paul|5072556804|Paul.Johar@mayo.edu|
22287267|NCT01277744|UT MD Anderson Cancer Center|Andrea Hayes-Jordan M.D. / Surgical Oncology|713-794-4616|AHJORDAN@MDANDERSON.ORG|
22287268|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22287269|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu|
22287270|NCT02358473|Kyowa Kirin Pharmaceutical Development, Inc.|Regional_Program Lead|1-609-919-1000|clinical.info@kyowa-kirin-pharma.com|
22287271|NCT01856270|University of Washington|Dr. Jeanne Hoffman|206-221-6511|jeanneh@uw.edu|
22287272|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287273|NCT04949191|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22287274|NCT00730158|UPMC Hillman Cancer Center|Edward Chu, MD|(412) 648-6589|chue2@upmc.edu|
22287275|NCT02970981|NYU Langone Health - Perlmutter Cancer Center|Jeffrey S. Weber, MD, PhD|212 731 6262|Jeffrey.Weber@nyulangone.org|
22287276|NCT03535974|Fundatia Bio-Forum|Dr. Felician Stancioiu|+40727500402|felicians11@gmail.com|
22287277|NCT04059549|UW Madison|Olivia Vjorn|6084772614|ocody@wisc.edu|
22287278|NCT02678351|Stanford Medicine at Stanford University|Andrea Otte|650-736-4183|anotte@stanford.edu|
22287279|NCT03259230|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
22287280|NCT02913482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22287281|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22287282|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org|
22303890|NCT04230980|Weill Cornell Medical College|Grace Tan, Clinical Research Coordinator|212-746-3208|grt2008@med.cornell.edu|
22303891|NCT04285229|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22303892|NCT02768558|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
22303893|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu|
22303894|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22303895|NCT04129580|Penn State Milton S. Hershey Medical Center|Dr Sarah Kawasaki|7175311000|skawasaki@pennstatehealth.psu.edu|
22303896|NCT00322868|Case Western Reserve University|Michael W Konstan, MD|2168443267|michael.konstan@case.edu|
22303897|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22303898|NCT03248570|University of California, San Francisco|Dr. David Oh, MD|(415) 476-1000|David.Oh@ucsf.edu|
22287283|NCT05468814|Hospital Universitario Reina Sofía|Ms. Irene Calzado Álvarez de Lara|+34618093419|ircaalla@gmail.com|
22287284|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158||
22287285|NCT01983228|Minneapolis Veterans Affairs Health Care System|Dr. Diana Burgess, Principal Investigator|612-467-1591|diana.burgess@va.gov|
22287286|NCT04716426|ELJ Consultancy|Ernesto Cesar Pinto Leal Junior|+55 11 975222856|ceo@eljconsultancy.com|
22287287|NCT04797585|Cleveland Clinic Foundation|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22287288|NCT01650558|University of Maryland School of Medicine|Miriam K. Laufer, M.D., M.P.H.|410-706-5333|mlaufer@som.umaryland.edu|
22287289|NCT02960217|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22287290|NCT02734693|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22287291|NCT03174353|University of Washington|Dr. Venu Pillarisetty|206-616-4924|vgp@uw.edu|
22287292|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org|
22287293|NCT04158583|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22287294|NCT03043885|UCSF|Daniel Clark|415.476.1101|daniel.clark@ucsf.edu|
22287295|NCT02649556|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
22287296|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22287297|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com|
22287298|NCT00812708|University of California Los Angeles|Kevin M. Miller, MD|(310) 206-9951|millerpatients@jsei.ucla.edu|
22287299|NCT02421172|Novartis Pharmaceuticals|Study Director|8627788300||
22287300|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
22287301|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22287302|NCT00755183|Andover Eye|Dr. Mark Abelson|9784750705||
22287303|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400|vallejo@ciad.mx|365
22287304|NCT02587520|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22287305|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch|
22287306|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu|
22287307|NCT04516746|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22287308|NCT03489863|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
22287309|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu|
22287310|NCT00446849|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22287311|NCT01706458|UWCCC|Mary Jane Staab - Program Manager|608-262-4304|mjs@medicine.wisc.edu|
22287312|NCT03547518|William Beaumont Hosptial|Jennifer Giordano, RN BSN Clinical Research Manager|248-551-3517|jennifer.giordano@corewellhealth.org|
22287313|NCT05875532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287314|NCT05164120|MedStar Health Georgetown Transplant Institute|Alexander Kroemer, MD; Khalid Kahn, MD|202-444-3700|Alexander.Kroemer@gunet.georgetown.edu; Khalid.M.Khan@gunet.georgetown.edu|
22287315|NCT03035032|Astellas Pharma Sinagpore Pte Ltd|Clinical Trial Disclosure|+65 6500 9330|astellas.resultsdisclosure@astellas.com|
22287316|NCT02051452|Harvard Medical School|Dr. Ken Solt, MD, Associate Professor of Anaesthesia|6177264359|ksolt@mgh.harvard.edu|
22287317|NCT03098641|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Philippe Ferry|+33 5 46 45 50 50|philippe.ferry@ch-larochelle.fr|
22287318|NCT01546857|Rutgers-New Jersey Medical School|Jean Daniel Eloy|9739721470|eloyje@njms.rutgers.edu|973
22287319|NCT02542865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287320|NCT01339689|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22287321|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22287322|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac|
22287323|NCT03164668|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22287324|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skk@retinacenterspc.com|
22287325|NCT04205240|The Ohio State University Comprehensive Cancer Center|Dr. Srinivas Devarakonda|614-293-3196|Srinivas.Devarakonda@osumc.edu|
22287326|NCT05121766|Hackensack Meridian Health|Arunima Sarkar, MD|5519961140|arunima.sarkar@hmhn.org|
22287327|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu|
22287328|NCT00528957|Gilead Sciences|Clinical Trial Disclosures & Transparency||GileadClinicalTrials@gilead.com|
22287329|NCT02654782|Mayo Clinic|Dr. William C. Oliver, Jr.|507-255-4240|oliver.william@mayo.edu|
22287330|NCT03485924|Johns Hopkins Medical Institute|Dr. Eun Ji Shin|4106140950|eshin3@jhmi.edu|
22287331|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
22287332|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu|
22287333|NCT03416868|Massachusetts General Hospital; Harvard Medical School|Jarrad Van Stan, PhD, CCC-SLP|617-643-8410|jvanstan@mgh.harvard.edu|
22287334|NCT02970799|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22287335|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov|
22287336|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22287337|NCT03624881|Biosense Webster, Inc.|Senior Safety Officer CSS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22287338|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287339|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr|
22287340|NCT03473236|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|R. Aranda M.D. / Senior Vice President of Clinical Development|(858) 684-1300|raranda@gossamerbio.com|
22287341|NCT04264442|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22287342|NCT03138369|Neurovalens Ltd|Paul McGeoch, MD|858-232-3312|paul.mcgeoch@neurovalens.com|+1
22287343|NCT03309020|National Institutes of Health|Teresa Magone, MD, Principal Investigator, NEI|301-435-4562|teresa.magonedequadroscosta@nih.gov|
22287344|NCT03371836|KennedyKrieger|Project Director|443-923-7600|Salpekar@kennedykrieger.org|
22287345|NCT04897711|Utah State University|Stephanie Borrie|435-797-1388|stephanie.borrie@usu.edu|
22287346|NCT02362724|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22287347|NCT01854359|National Institutes of Allergy and Infectious Diseases|Dr. Peter Kosa (Staff Scientist)|(301) 731-6444|peter.kosa@nih.gov|
22287348|NCT03332459|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22287349|NCT05190120|University of California San Francisco|Dr. Pedram Aleshi|(415) 271-1627|pedram.aleshi@ucsf.edu|
22303899|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com|
22303900|NCT02955277|Assuta Hospital Systems|Dr. Zvi Buckman|+97237462520|Bukman_tz@mac.org.il|
22303901|NCT04404257|William Beaumont Hospitals|Dr. Simon Dixon, MD|248-898-4198|simon.dixon@beaumont.edu|
22303902|NCT02176928|University of Miami|Shirin Shafazand, MD, MS|305-243-7888|sshafazand@med.miami.edu|
22287350|NCT03062358|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287351|NCT05893862|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287352|NCT00410956|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-7601|jarnagiw@mskcc.org|
22287353|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22287354|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012||
22287355|NCT00574197|Cedars-Sinai Medical Center|Ernst Schwarz, MD, PhD|(310) 840-7089|Ernst.Schwarz@cshs.org|
22287356|NCT03965130|Yale|Dr. Kitt Falk Petersen|203 737 1942|kitt.petersen@yale.edu|
22287357|NCT04199351|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22287358|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22287359|NCT02464540|Federal University of Pelotas|Dr Noéli Boscato|5553999530000|noeliboscato@gmail.com|
22287360|NCT05941702|University of Manchester|Krishna Panchmatia|07857543272|krishna.panchmatia@postgrad.manchester.ac.uk|
22287361|NCT02814916|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22287362|NCT04392739|SIGA Technologies|Emily Blum, Assoc. Director of Clinical Research|541-224-1305|eblum@siga.com|
22287363|NCT02047032|Gunang'anmen Hospital|Zhishun Liu|86 88002331|liuzhishun@aliyun.com|
22287364|NCT05719311|Entero Therapeutics|VP, Regulatory, QA & Compliance|9194491484|AChandler@Enterothera.com|
22287365|NCT05316597|University of Washington|Dr. Gregory Bratman|2065437591|bratman@uw.edu|
22287366|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22287367|NCT04854135|Washington University in St. Louis|Paulina Cruz Bravo, MD|314-922-8620|pcruz@wustl.edu|
22287368|NCT02766023|University of California San Francisco|Craig Cohen, MD, MPH|(415) 476-5874|Craig.Cohen@ucsf.edu|
22287369|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22287370|NCT03103542|Swedish Orphan Biovitrum AB|Medical Information|+468 6972000|medical.info@sobi.com|
22287371|NCT02953652|Huya Japan G.K.|Huya Japan Clinical Development||japanclinical@huyabio.com|
22287372|NCT00072462|Queen Mary University of London|Professor Jack Cuzick|+442078823504|j.cuzick@qmul.ac.uk|
22287373|NCT02384551|VA ORD|Heidi J Silver|615-875-9355|heidi.j.silver@vumc.org|
22287374|NCT03679247|Brigham and Women's Hospital|Lipika Samal|6177327063|lsamal@bwh.harvard.edu|
22287375|NCT02887820|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
22287376|NCT02927301|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22303903|NCT01642186|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-824-6566|abou-alg@mskcc.org|
22303904|NCT00504348|Tokyo Medical and Dental University|Kazuki Takada, M.D.|81-3-3813-6111|takada.rheu@tmd.ac.jp|
22303905|NCT02254421|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22287377|NCT04742556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287378|NCT02903771|Kazia Therapeutics Ltd|Jeremy Simpson|+61 400410974|Jeremy.simpson@kaziatherapeutics.com|
22287379|NCT04247347|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
22287380|NCT03562195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303906|NCT02774343|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
22303907|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303908|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org|
22303909|NCT03039543|Seoul National University Bundang Hospital|Dr. Junghee Ryu, Associate Professor|82-31-787-7497|jinaryu74@gmail.com|
22303910|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com|
22303911|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303912|NCT03679013|Inova Fairfax Hospital|Ramesh Singh, MD|(703)776-8025|ramesh.singh@inova.org|
22303913|NCT02379117|UNottingham|Dr Gordon Moran|44 [0]115 9249924|Gordon.Moran@nottingham.ac.uk|70608
22303914|NCT01686932|Novartis|Study Director|862-778-8300||
22303915|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303916|NCT04827134|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303917|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000|isabelle.dionne@usherbrooke.ca|63327
22303918|NCT03657264|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
22303919|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917||
22303920|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com|
22303921|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
22303922|NCT03044353|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22303923|NCT03358329|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22303924|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22303925|NCT03875911|UCLA Jules Stein Eye Institute|Dr. Joseph Caprioli|310-825-6323|caprioli@jsei.ucla.edu|
22303926|NCT05284019|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22319674|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu|
22287381|NCT02218372|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22287382|NCT02923726|Boston Scientific|Jacqueline Beaulieu, Sr. Clinical Trial Manager|1-800-227-3422|jacqueline.beaulieu@bsci.com|
22287383|NCT02753283|University of Pittsburgh|Dr. Susan Greenspan|+14126922477|greenspn@pitt.edu|
22287384|NCT03406780|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
22287385|NCT02795117|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22287386|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22287387|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk|
22287388|NCT02546609|Nusirt Biopharma Inc.|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
22287389|NCT02212015|Universität Heidelberg/Universitätsmedizin Mannheim|Prof. Dr. med. Peter Hohenberger|+49 0621 383 2609|peter.hohenberger@umm.de|
22287390|NCT02756338|BIOTRONIK, Inc.|Crystal Miller|800-547-0394|crystal.miller@biotronik.com|
22287391|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22287392|NCT00659061|Aga Khan University|Professor Zulfiqar Ahmed Bhutta|4930051|zulfiqar.bhutta@aku.edu|4782
22287393|NCT05444855|Children's Mercy Hospitals and Clinics|Melissa Miller MD|816234300|mmiller@cmh.edu|
22287394|NCT04038359|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
22287395|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22287396|NCT01500733|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
22287397|NCT02004236|BrainMech Foundation|Moises Domingo president of Brainmech Foundation|+441615312645|moises@bigdata4brain.co.uk|
22287398|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
22287399|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22287400|NCT01033240|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22287401|NCT02955589|Huya Japan G.K.|Huya Japan clinical development||japanclinical@huyabio.com|
22287402|NCT02987231|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@unesp.br|
22287403|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu|
22287404|NCT03207126|Imperial College London|Diana Marcus|07525133957|diana.marcus@nhs.net|
22287405|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org|
22287406|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22287407|NCT03496844|University of Arizona|Phillip Kuo, MD PhD|5206268318|pkuo@arizona.edu|
22287408|NCT02005016|VA Pittsburgh Healthcare System|Dr. Michael Dickey|412-360-6467|michael.dickey@va.gov|
22287409|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
22287410|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com|
22287411|NCT02978417|Duke University|Michele Easter, Ph.D.|919-385-0862|michele.easter@duke.edu|
22287412|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu|
22287413|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22287414|NCT03557970|Oregon Health and Science University|Elie Traer, MD PhD|5034943553|traere@ohsu.edu|
22287415|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351||
22287416|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287417|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688|wthuang@sinphar.com.tw|2190
22287418|NCT01601535|New Approaches to Neuroblastoma Therapy|NANT Medical Director|323-361-5687|nantops@chla.usc.edu|
22287419|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
22287420|NCT03600909|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
22287421|NCT04576988|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22287422|NCT03218384|NYU Langone Health|Stuart Katz, MD|2122633946|Stuart.Katz@nyulangone.org|
22287423|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu|
22287424|NCT05790460|Abramson Cancer Center at the University of Pennsylvania|Charu Aggarwal, MD, MPH|215-662-6318|charu.aggarwal@pennmedicine.upenn.edu|
22287425|NCT02919761|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22287426|NCT03724942|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22289098|NCT04364867|Orthopedic Institute, Norton Healthcare|Ryan Krupp MD|502-394-6341|Ryan.Krupp@nortonhealthcare.org|
22289099|NCT02110069|Boston Children's Hospital|Dr. Denise M. Adans|617-919-6407|adamsdm@chop.edu|
22289100|NCT02587637|Abbott|Robyn Capobianco|+1 512 286 4274|robyn.capobianco@abbott.com|
22289101|NCT04774094|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22289102|NCT02374450|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22289103|NCT06714682|Ain Shams university|Dr. Mohamed Ibrahim , Lecturer of anesthesia|01115560811|T.majestic@hotmail.com|002
22289104|NCT02819011|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
22289105|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22289106|NCT01677377|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22289107|NCT02260180|Aclaris Therapeutics, Inc.|Judith Schnyder, Senior Director of Clinical Operations|1-484-329-2144|jschnyder@aclaristx.com|
22289108|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020|thomas.beresford@ucdenver.edu|3732
22289109|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
22289110|NCT01193257|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22289111|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com|
22289112|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu|
22289113|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu|
22289114|NCT02810509|Ilsan Paik Hospital Inje University|Keun-Sik Hong, MD, PhD, Prof|82-31-910-7680|nrhks@paik.ac.kr|
22289115|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu|
22289116|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289117|NCT01175083|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289118|NCT02881567|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22289119|NCT02950467|UCSF|Michelle Matvey|4152214810|michelle.matvey@ucsf.edu|24117
22289120|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289121|NCT03275350|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22289122|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu|
22289123|NCT00905645|Sientra|Chief Technology Officer|(805) 562-3500|denise.dajles@sientra.com|
22289124|NCT01386970|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
22289125|NCT04439136|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22289126|NCT00578292|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
22289127|NCT04849559|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22289128|NCT03901469|Zenith Epigenetics|Zenith Study Team|587-390-7865|ZEN003694-004@zenithepigenetics.com|
22289129|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22289130|NCT02586207|Sanford Health|Steven F. Powell, MD|605-328-8000|Steven.Powell@sanfordhealth.org|
22289131|NCT02362282|North Florida/South Georgia Gainesville VA Medical Center|Janis J Daly, Ph.D., Director Brain Rehabilitation Research Center|352-548-6000|Janis.Daly@va.gov|6603
22289132|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22289133|NCT04085289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289134|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com|
22289135|NCT02058303|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
22289136|NCT03527732|Swiss Tropical and Public Health Institute|Prof. Dr. Jennifer Keiser|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
22289137|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22289138|NCT02207088|AbbVie|Global Medical Services|800-633-9110||
22289167|NCT02533453|Astrazeneca, Korea|Hyun Jung Kang / Local Study Leader|82 2 2188 0846|hyunjung.kang@astrazeneca.com|0846
22287427|NCT03863795|National Cancer Institute|Annette Kaufman|301-467-8521|kaufmana@mail.nih.gov|
22287428|NCT02994108|Florida State University College of Medicine|Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
22287429|NCT00904969|American Medical System|Laura Olson, Clinical Project Manager|952-930-6000|laura.olson2@bsci.com|
22287430|NCT04396756|Pliant Therapeutics, Inc.|Gregory P. Cosgrove, MD, Vice President, Clinical Development|1-650-481-6770|GCosgrove@pliantrx.com|
22303927|NCT01990300|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22287431|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com|
22287432|NCT03414983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22287433|NCT00558142|University of Edinburgh|Prof M Eddleston|01312426776|m.eddleston@ed.ac.uk|
22287434|NCT04515771|Richard L. Roudebush VA Medical Center|Dr. Johanne Eliacin|317-988-5000|Johanne.Eliacin@va.gov|
22287435|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca|
22287436|NCT02535481|UCL|EPIGRAAFT Trial team|020 7679 2000|epigraaft@gmail.com|
22287437|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
22287438|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22287439|NCT03937570|Division of Cardiac Surgery, Department of Surgery - University of Verona|Marzia Lilliu, MD, PhD|+39 3281383539|marzialilliu@gmail.com|
22287440|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu|
22287441|NCT03623243|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22287442|NCT03007966|Wake Forest University Health Sciences|Christopher Edwards|336-716-4498|chedward@wakehealth.edu|
22287443|NCT03365102|Brown University|Richard Jones|401-444-1943|rich_jones@brown.edu|
22287444|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22287445|NCT03924622|University of Washington|Becky Ostrem CIP Compliance Administrator, Regulatory Affairs|2066858138|bostrem@uw.edu|
22287446|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu|
22287447|NCT00904943|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22287448|NCT03085095|Myovant Sciences GmbH|Clinical Trials at Myovant|650-278-8743|ClinicalTrials@Myovant.com|
22287449|NCT03284710|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22287450|NCT02994238|Northwestern University|Kathy Boon- Clinical Research Associate|312-503-4687|kathy.boon@northwestern.edu|
22287451|NCT05176314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22287452|NCT04441138|Rush University Medical Center|Dr. Gaurav Marwaha|3129424399|Gaurav_Marwaha@Rush.edu|
22287453|NCT05543265|Massachusetts General Hospital|Mark Clapp, MD|617-724-2000|mark.clapp@mgh.harvard.edu|
22287454|NCT02118584|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22287455|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org|
22287456|NCT03359629|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
22287457|NCT03557294|Arizona State University|Scott Leischow, PhD|602-496-3300|scott.leischow@asu.edu|
22287458|NCT04090203|Cleveland Clinic|Dr. Jaclyn Bjelac|216 445-1449|bjelacj2@ccf.org|
22287459|NCT03299556|Purdue Pharma L.P.|Thomas Alfieri, PhD - Director, Medical Affairs Strategic Research|(475) 299-6085|thomas.alfieri@pharma.com|
22287460|NCT01488045|St. Joseph Mercy Hospital|Robert K. Cleary, MD|734.712.8150|Robert.Cleary@trinity-health.org|
22287461|NCT05043363|Imperial College London|Mr James Kinross|02033121947|j.kinross@imperial.ac.uk|
22287462|NCT00671658|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD./ Chair|713-792-7026|eharriso@mdanderson.org|
22287463|NCT02918370|UT Southwestern|E. Sherwood Brown MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
22287464|NCT03617172|Vanderbilt University Medical Center|Sr. Clinical Trials Operations Manager|6159360815|stephanie.anne.smith@vumc.org|
22287465|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22287466|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
22287467|NCT02587221|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22287468|NCT03988400|Ralph H. Johnson VA|Jesse Dean|8437929566|deaje@musc.edu|
22287469|NCT04913610|Drugs for Neglected Diseases initiative|Clinical Trial Data|41 22 906 9230|ctdata@dndi.org|
22287470|NCT03186209|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22287471|NCT03853473|Medical College of Wisconsin|Matthew J. Durand, Ph.D., Principal Investigator|414-955-5619|mdurand@mcw.edu|
22287472|NCT00590187|Cyclacel Pharmaceuticals|Julius, Huang, PhD.|760-877-2708|jhuang@cyclacel.com|
22287473|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
22287474|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012||
22287475|NCT03521570|Emory University|Nabil F. Saba MD, FACP|404-778-0278|nfsaba@emory.edu|
22287476|NCT04076696|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22287477|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
22287478|NCT02296164|Helsinn Therapeutics (U.S.), Inc.|Bill Bailey|+1 732 603 2848|bill.bailey@helsinn.com|
22287479|NCT03324776|MODEL Clinical Research LLC|Philip Levin, MD|4102413438|pal3420@yahoo.com|
22287480|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org|
22287481|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu|
22287482|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org|
22287483|NCT02138890|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
22287484|NCT05435339|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
22287485|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22287486|NCT01446159|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
22287487|NCT03174184|Vanderbilt University Medical Center|Kelly Dooley, MD, PhD|6153228972|kelly.e.dooley@vumc.org|
22287488|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
22287489|NCT01336933|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
22287490|NCT05135871|Shanghai LianBio Development Co., Ltd|Brianna Sun|+862123081188|brianna.sun@lianbio.com|
22287491|NCT04258423|Indiana University|Dr. Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
22287492|NCT03980730|vTv Therapeutics LLC|VP Clinical Operations|3368410300|jfreeman@vtvtherapeutics.com|
22287493|NCT00880620|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|908-307-2234|kaihong.jiang@amneal.com|
22287494|NCT04076540|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22287495|NCT03125226|University of Washington School of Medicine|Dr. Jing Zeng|2065985998|jzeng13@uw.edu|
22287496|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260|N.Stroebele@uni-hohenheim.de|24260
22287497|NCT03902418|University of CApe Town|Landon Myer|0829430578|landon.myer@uct.ac.za|
22287498|NCT04570930|University of Michigan|Dr. Noelle E Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
22287499|NCT03577275|NorthSea Therapeutics BV|Dr Patrick Round|+44(0)7979502770|patrick.round@northseatherapeutics.com|
22287500|NCT02958917|National Jewish Health|Dr. Evans Fernández|303-388-4461|fernandezevans@njheallth.org|
22287501|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
22303928|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343||
22303929|NCT02293837|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22303930|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303931|NCT03285113|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
22303932|NCT03053492|Medical University of South Carolina|Michelle Woodbury|843-792-1671|woodbuml@musc.edu|
22303933|NCT05515679|Hopeful Aging|Michael Skrajner|4404777881|info@hopefulaging.com|
22303934|NCT04267575|Jerome Canady Research Institute for Advanced Biological and Technological Sciences|Jerome Canady, M.D.|301-270-0147|drjcanady@gwu.edu|
22303935|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22303936|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net|
22303937|NCT03018106|Emory University|Gina Northington, MD|(404) 778-5770|gina.northington@emory.edu|
22303938|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00||
22303939|NCT02216422|AbbVie|Global Medical Services|800-633-9110||
22303940|NCT01010217|UT MD Anderson Cancer Center|Dr. Stefan O Ciurea, Associate Profeddor of Stem Cell Transplantation|713-745-0146|sciurea@mdanderson.org|
22303941|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org|
22303942|NCT02061761|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22303943|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com|
22303944|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu|
22303945|NCT04033991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303946|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22303947|NCT03246672|William S Middleton Memorial Veterans Hospital|Dr. Corrine Voils|608-262-9636|corrine.voils@va.gov|
22303948|NCT03260504|University of Washington|Scott Tykodi, MD, PhD|206-606-7763|stykodi@fredhutch.org|
22303949|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22303950|NCT03542175|Memorial Sloan Kettering Cancer Center|Dr. Atif Khan, MD|848-225-6334|khana7@mskcc.org|
22287502|NCT01775501|Massachusetts General Hospital|Dr. Lipika Goyal|617-724-4000|LGOYAL@PARTNERS.ORG|
22287503|NCT03037385|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22287504|NCT02318706|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22287505|NCT04328077|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
22287506|NCT02170376|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22287507|NCT02326155|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
22287508|NCT03629535|NYU Langone Health|Greta Piper, MD|212-263-4778|Greta.Piper@nyulangone.org|
22287509|NCT03649646|Boryung Pharm. CO., LTD|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
22287510|NCT04204447|University at Buffalo|Andrew Talal|7168884737|ahtalal@buffalo.edu|
22287511|NCT02968134|The University of Queensland|Prof. Jason Roberts|+61 7 3646 4108|j.roberts2@uq.edu.au|
22287512|NCT01499940|West Virginia Universtiy|Gerald Higa, PharmD|(304) 293-1461|ghiga@hsc.wvu.edu|
22287513|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22287514|NCT04739982|Stanford University|Kaiti Dunlap, Clinical Research Coordinator|650-497-9214|kdunlap2@stanford.edu|
22287515|NCT01349543|Imperial College London|Prof Peter JM Openshaw|07973820801|p.openshaw@imperial.ac.uk|
22287516|NCT04914364|Duke University|Ashley Poole|919-538-6272|ashley.poole@duke.edu|
22287517|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com|
22287518|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com|
22287519|NCT01969708|The Emmes Corporation|Principal Investigator of the SCORE2 Data Coordinating Center|301-251-1161|score2@emmes.com|
22287520|NCT04267380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287521|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu|
22287522|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300||
22287523|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org|
22287524|NCT01844765|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22287525|NCT02025179|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22287526|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com|
22287527|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22287528|NCT01927497|Academic medical center|prof. dr. P.J. Tanis|0031205669111|g.d.musters@amc.nl|
22287529|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22287530|NCT04528641|Reithera|Medical Director|06 99775|roberto.camerini@reithera.com|352
22287531|NCT03914417|Icahn School of Medicine at Mount Sinai|Dr. Sharon Rose|212-241-3288|sharone.rose@gmail.com|
22287532|NCT02747186|University of North Carolina at Chapel Hill|Raymond P. White Jr., DDS, PhD|919-537-3944|ray_white@unc.edu|
22287533|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg|
22287534|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu|
22287535|NCT03542812|University of Utah|Candice Fike|801-587-7804|candice.fike@hsc.utah.edu|
22287536|NCT04764162|Virginia Tech|Dr. Kevin Davy|(540)231-3487|kdavy@vt.edu|
22287537|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu|
22287538|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org|
22287539|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22287540|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287541|NCT03474588|Yale University Department of Psychiatry|Dr. Brian Kiluk, Ph.D.|203-737-1544|brian.kiluk@yale.edu|
22287542|NCT01607957|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22287543|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22287544|NCT04972786|University of New Mexico|Dr. Jeremy Hogeveen|773-941-2182|jhogeveen@unm.edu|
22287545|NCT03905096|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287546|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com|
22287547|NCT02016781|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22287548|NCT00945009|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22287549|NCT04886154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287550|NCT03919773|UT Southwestern Medical Center|Dr. Steven Vernino|214-648-8816|steven.vernino@utsouthwestern.edu|
22287551|NCT02702492|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22287552|NCT04388683|Tufts Medical Center|Dr. Marvin Konstam|617-636-6293|mkonstam@tuftsmedicalcenter.org|
22287553|NCT05086705|The Ohio State University Comprehensive Cancer Center|Dr. Sagar Sardesai|614-293-6401|sagar.sardesai@osumc.edu|
22287554|NCT04972162|WSAUDAS|Dr. Veronika Littmann|+4991313080|veronika.littmann@wsa.com|
22287555|NCT02429830|Torax Medical, Inc|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22287556|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com|
22287557|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu|
22287558|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287559|NCT02608684|Cedars-Sinai Medical Center|Bobbie J. Rimel, MD|310-423-1126|Bobbie.Rimel@cshs.org|
22287560|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
22287561|NCT01972217|AstraZeneca|Medical Director|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
22289168|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22287562|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22287563|NCT04936945|Soahg University|Dr. Magdy Mohamed Amien|0934602963|portal@med.sohag.edu.eg|
22287564|NCT04273737|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
22287565|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu|
22287566|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
22287567|NCT04106557|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|802-752-5168|tbaumgartner@ovidrx.com|
22287568|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22287569|NCT03714672|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22287570|NCT03081117|Johns Hopkins University|Dr. Leah Rubin, Associate Professor of Neurology, Psychiatry, and Epidemiology|410-955-7311|lrubin@jhu.edu|
22287571|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org|
22287572|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu|
22287573|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22287574|NCT03904017|University of Colorado|Layne Dylla|303-724-1716|layne.dylla@cuanschutz.edu|
22287575|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com|
22287576|NCT02939287|Rush University Medical Center|Danielle Murphy, PharmD, BCOP, BCPS|3129472401|danielle_murphy@rush.edu|
22287577|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu|
22287578|NCT05236270|University of Oklahoma Health Sciences|Dr. Amanda Janitz|405-271-2229|amanda-janitz@ouhsc.edu|48081
22287579|NCT02476617|AbbVie|Global Medical Services|800-633-9110||
22287580|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22287581|NCT03486912|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22287582|NCT02491684|AstraZeneca|Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22287583|NCT01149096|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22287584|NCT01263769|UT MD Anderson Cancer Center|Dr. Jose Karam, MD, Associate Professor, Urology|(713) 745-0374|jakaram@mdanderson.org|
22287585|NCT03267277|National Institute of Environmental Health Sciences|Dr. Adam Schiffenbauer|+1 301 451 6270|adam.schiffenbauer@nih.gov|
22287586|NCT00468169|University of Chicago|Everett E Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
22287587|NCT04372017|Sanford Health|Dr. Susan Hoover|605-328-8120|Susan.Hoover@sanfordhealth.org|
22303951|NCT05868954|Wake Forest University Health Sciences|Julio Mateus Nino, MD, PhD|704-355-8248|julio.mateusnino@advocatehealth.org|
22303952|NCT03216902|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
22303953|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se|
22303954|NCT01850082|VA Boston Healthcare System|Marco Zenati, M.D.|857-203-6815|Marco.Zenati@va.gov|
22303955|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303956|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
22303957|NCT00183443|Stanford University|Dr. Patricia Suppes|6504935000|tsuppes@Stanford.edu|62567
22303958|NCT02302066|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22303959|NCT03777865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303960|NCT04793464|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
22303961|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu|
22303962|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu|
22303963|NCT02696902|MedImmune, LLC|Mark Esser|+1 301 3986849|information.center@astrazeneca.com|
22303964|NCT02452866|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
22303965|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22303966|NCT00845871|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22303967|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
22303968|NCT03729024|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22303969|NCT03380780|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22303970|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org|
22303971|NCT01734434|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22303972|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com|
22303973|NCT03367962|Stanford University|Dr. Robert Negrin|6507230822|negrs@stanford.edu|
22303974|NCT02748564|Cancer Institute of New Jersey|Adam Berger, MD|215-235-8079|ab2047@cinj.rutgers.edu|
22303975|NCT03114995|Cardiovascular Center, Seoul National University Bundang Hospital|Dr. Tae-Jin Youn|+82-31-787-7031|ytjmd@snubh.org|
22303976|NCT04223154|Wake Forest University School of medicine|Colleen A. Hanlon, Ph.D.|336-716-5465|chanlon@wakehealth.edu|
22303977|NCT02819479|Norton Neuroscience Institute|Shervin R. Dashti, MD, PhD, Principal Investigator|502-394-6390|shervin.dashti@nortonhealthcare.org|
22303978|NCT02968940|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
22303979|NCT02718417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22303980|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com|
22303981|NCT01305356|Wright Medical|Justin Moss|615-236-4984|Justin.Moss@wright.com|
22303982|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22303983|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287588|NCT01126749|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22303984|NCT02892409|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22287589|NCT03668873|Cleveland Clinic Foundation|Cynthia R. Johnson, PhD|216 448-6440|johnsoc@ccf.org|
22287590|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22287591|NCT01521117|Oregon Health & Science University|Amie Hiller, MD|503 721 1091|peterami@ohsu.edu|
22287592|NCT01569191|Aston University|Prof James Wolffsohn|+44(0)1212044140|j.s.w.wolffsohn@aston.ac.uk|
22287593|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu|
22287594|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
22287595|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22287596|NCT03896438|University of Minnesota|Melanie Stimac|612-301-2449|stima011@umn.edu|
22287597|NCT02657889|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287598|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu|
22287599|NCT03050801|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
22287600|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22287601|NCT03836625|Vanderbilt University|Kate Clouse|(615) 343-5351|kate.clouse@vanderbilt.edu|
22287602|NCT00310765|retired|Dr. Ann Silverman||anngimd@icloud.com|
22287603|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22287604|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22287605|NCT03413891|University Hospitals Leuven|Mrs. Barbara Debaveye|003216 341463|barbara.debaveye@uzleuven.be|
22287606|NCT05358366|University of North Carolina at Chapel Hill|Natalia Villegas Rodriguez, PhD|919-966-4260|navilleg@email.unc.edu|
22287607|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com|
22287608|NCT03077542|National Heart, Lung, and Blood Institute at National Institutes of Health|Courtney Fitzhugh, M.D.|301.402.6496|fitzhughc@nhlbi.nih.gov|
22287609|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 556-8820|sgadgee1@hfhs.org|
22287610|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com|
22287611|NCT05460754|Montana State University|Dr. Mary P Miles|406 994-6678|mmiles@montana.edu|
22287612|NCT05305443|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
22287613|NCT02977403|Eunice Kennedy Shriver National Institute of Health, NIH|Dr. Jack Yanovski|301-496-0858|jy15i@nih.gov|
22287614|NCT04659044|Perlmutter Cancer Center at NYU Langone Health|Catherine Diefenbach M.D.|(212) 731-5670|Catherine.diefenbach@nyulangone.org|
22287615|NCT02891447|University of M D Anderson Cancer Center|Dr. Brian Badgwell|713-745-7351|bbadgwell@mdanderson.org|
22287616|NCT04966013|EmitBio Inc|Chief Medical Officer|919.321.1734|info@emitbio.com|
22287617|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net|
22287618|NCT04875975|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22287619|NCT01910298|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22287620|NCT03960541|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287621|NCT00781768|Loyola University Medical Center|Patrick Stiff, M.D.|708-327-3148|pstiff@lumc.edu|
22287622|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu|
22287623|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22287624|NCT02458313|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristian.legget@cuanschutz.edu|
22287625|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
22287626|NCT04671017|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
22287627|NCT04295720|University of Arizona|Phillip H. Kuo, MD, PhD|520-626-1957|pkuo@arizona.edu|
22287628|NCT00181168|Johns Hopkins Univ|Paul W. Ladenson, MD, Professor and PI|4109553663|ladenson@jhmi.edu|
22287629|NCT03453164|Fukushima medical university of medicine|Prof. Koji Kono|+81245471259|kojikono@fmu.ac.jp|
22287630|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu|
22287631|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org|
22287632|NCT02770014|Dana-Farber Cancer Institute|Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
22287633|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu|
22287634|NCT03459079|University of Florida|Kenneth Cusi|352-505-9060|kcusi@ufl.edu|
22287635|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
22287636|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287637|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
22287638|NCT00834977|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22287639|NCT04945733|Janssen Pharmaceutical K.K.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22287640|NCT05660577|Bausch & Lomb|Study Director|5102595284|aloncaric@bausch.com|
22287641|NCT04723056|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
22287642|NCT05106894|Children's Hospital Los Angeles|Dr. Beth A. Smith|3233614670|bsmith@chla.usc.edu|
22287643|NCT03363841|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
22287644|NCT01968447|LUMC|Albert Dahan|+31 71 52 62301|a.dahan@lumc.nl|
22287645|NCT00821795|Lexington VAMC|Dennis G Karounos, MD Principal investigator|859 233-4511|dennis.karounos@va.gov|4430
22287646|NCT02156076|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
22287647|NCT03431285|King Fahd University Hospital- Imam Abdulrahman Bin Faisal University|Dr. Muhammed Alshahrani|+966138966666|msshahrani@iau.edu.sa|2002
22287648|NCT01827137|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
22287649|NCT03566511|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
22287650|NCT02878343|UPenn|Dr. Karen Glanz||kglanz@pennmedicine.upenn.edu|
22287651|NCT04196777|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel.livorsi@va.gov|
22287652|NCT00981656|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22287653|NCT04026113|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22287654|NCT00687596|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
22287655|NCT01527149|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22287656|NCT01709721|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
22287657|NCT03402217|Ci3 at the University of Chicago|Ellen McCammon|773-834-8462|emccammon@bsd.uchicago.edu|
22287658|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22287659|NCT02230410|Mayo Clinic|Dr. Kenneth K. Wang|507-293-7911|wang.kenneth@mayo.edu|
22287660|NCT02135861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287661|NCT04614363|Houston Methodist|Dr. Brian Miles|713-441-8113|bjmiles@houstonmethodist.org|
22287662|NCT02558894|AstraZeneca|Global Clinical Lead|+1 301-398-0000|ClinicalTrialTransparency@astrazeneca.com|
22287663|NCT02992288|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22287664|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es|
22287665|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22287666|NCT03288103|Cincinnati Childrens Hospital Medical Center|Dr. Philippe Backeljauw, MD|15136368444|Philippe.backlejauw@cchmc.org|
22287667|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22287668|NCT03796728|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22287669|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590||
22287670|NCT03165617|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22287671|NCT03926208|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
22287672|NCT02199184|The University of Texas MD Andeerson Cancer Center|Elias Joseph Jabbour|713-792-4764|ejabbout@mdanderson.org|
22287673|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22287674|NCT03651765|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22303985|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300||
22287675|NCT05467007|The George Washington University|Dr. Andrew C. Meltzer|202-741-2952|Ameltzer@mfa.gwu.edu|
22287676|NCT04097678|Twin Cities Spine Center|Clinical Research Director|612-775-6222|jmdawson@tcspine.com|
22287677|NCT03694678|Massachusetts General Hospital|Ana-Maria Vranceanu|6178931664|avranceanu@mgh.harvard.edu|
22287678|NCT02435212|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
22287679|NCT01346358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22287680|NCT02839096|University of Missouri School of Medicine|Research Success Core|(573) 817-3386|obgynresearchsuccesscore@health.missouri.edu|
22287681|NCT05058365|The University of Hong Kong|Professor Lam Shui-fong|85239172388|lamsf@hku.hk|
22287682|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22287683|NCT04819945|GATT Technologies B.V.|Dr Stuart Head, MD, PhD, Chief Medical Officer|+31645306042|s.head@gatt-tech.com|
22287684|NCT05379179|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
22287685|NCT02151487|UT Southwestern Medical Center|Dawood Nasir|214-590-5352|Dawood.Nasir@UTSouthwestern.edu|
22287686|NCT04531176|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
22287687|NCT00214045|University of Wisconsin School of Medicine and Public Health|Dr. Stephen Nakada|(608)263-1359|nakada@urology.wisc.edu|
22287688|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov|
22287689|NCT01451606|University of Maryland, Baltimore|Dr. Joel Greenspan|4107067090|jgreenspan@umaryland.edu|
22287690|NCT03025282|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22287691|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22287692|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22287693|NCT03155724|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
22287694|NCT04875013|DR. EYTAN A. DAVID, MD, Otolaryngologist|Dr. Eytan David|(604) 988-0598|dr.david@shaw.ca|
22287695|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org|
22287696|NCT03361137|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22287697|NCT04567628|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22287698|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22287699|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22287700|NCT04944992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287701|NCT05366738|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22287702|NCT02798627|University of Pennsylvania Perelman School of Medicine|Kyle Kampman, MD|2157462764|kampman@pennemdicine.upenn.edu|
22287703|NCT03821402|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22287704|NCT05024032|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22287705|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22287706|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287707|NCT00804908|AbbVie|Global Medical Information|800-633-9110||
22287708|NCT01280903|University of Pittsburgh|Elizabeth A. Schlenk|412-624-4103|els100@pitt.edu|
22287709|NCT03829228|USANA Health Science|Dr. Junqiang Tian|8019547462|jeremy.tian@usanainc.com|
22287710|NCT02177695|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
22287711|NCT02844569|University of North Carolina at Chapel Hill|Dr. Thiago Morelli|919-537-3727|thiago_morelli@unc.edu|
22287712|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22287713|NCT02443688|Celtaxsys, Inc.|Director, Clincal Operations|4702060153|sbirnbaum@celtaxsys.com|123
22287714|NCT04135417|Humacyte Inc.|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
22287715|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22287716|NCT02007096|Division of General Surgery, Department of Surgery, The Mount Sinai Medical Center|Dr. Celia M Divino|212-241-5499|Celia.Divino@mountsinai.org|
22287717|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu|
22287718|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22287719|NCT03044106|University of North Carolina at Chapel Hill|Nicholas Wise, DC|(864) 494-1001|nicholas_wise@med.unc.edu|
22287720|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300||
22287721|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com|
22287722|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22287723|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990|linda.nichols@va.gov|5082
22287724|NCT03199976|Helsinki University Central Hospital|Dr Anne Kotaniemi-Syrjänen|+35894711|anne.kotaniemi-syrjanen@hus.fi|
22287725|NCT03367793|Ohio State University College of Optometry|Dr. Heather Anderson, Study PI|614-247-5825|anderson.3881@osu.edu|
22287726|NCT02967991|University Hospitals Case Western Reserve|Shaffer Mok|4404065500|Shaffer.Mok@UHHospitals.org|
22287727|NCT04218240|University of Pennsylvania|Kyle M. Kampman, MD|2157462764|kampman@pennmedicine.upenn.edu|
22287728|NCT02453737|Mayo Clinic|Dr. Robert W. Mutter|507-284-3191|Mutter.Robert@mayo.edu|
22287729|NCT04711850|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
22287730|NCT04393935|Emory University|Natalie Crawford, PhD|404-712-9445|ndcrawford@emory.edu|
22287731|NCT03844997|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD|866-223-8100|TaussigResearch@ccf.org|
22287732|NCT00135226|Nuffield Department of Population Health|Prof Jane Armitage|+44 (0)1865 743743|ascend@ndph.ox.ac.uk|
22287733|NCT04689139|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
22287734|NCT00965354|Imperial College|Openshaw, Peter J M|07973 820 801|p.openshaw@imperial.ac.uk|
22287735|NCT02380573|University of Texas Health Science Center at San Antonio|Dr. Peter Fox|210-567-8150|fox@uthscsa.edu|
22287736|NCT04552301|Icahn School of Medicine at Mount Sinai|Dr. Juan Wisnivesky|(212) 241-2125|juan.wisnivesky@mountsinai.org|
22287737|NCT02893293|Stanford University|Heike Daldrup-Link, MD|(650) 725-2548|mairead@stanford.edu|
22287738|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
22287739|NCT02738801|Galapagos NV|Evelyn Fox|003215342900|evelyn.fox@glpg.com|3215342900
22287740|NCT03279081|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22287741|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu|
22287742|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com|
22287743|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se|
22287744|NCT02989493|University of Wisconsin|John Curtin|608-262-0387|jjcurtin@wisc.edu|
22303986|NCT02766673|Children's Hospital of Philadelphia|Natalie Napolitano, MPH, RRT-NPS, FAARC|215-590-1708|napolitanon@email.chop.edu|
22303987|NCT02264574|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
22303988|NCT02080520|Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
22303989|NCT02406261|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22303990|NCT01930643|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|+886-975837711|jeff01@mmh.org.tw|
22287745|NCT04643808|Medical Univesristy of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
22287746|NCT04484961|Houston Methodist Hospital|Bradley Lambert, PhD|8326872483|bslambert@houstonmethodist.org|
22287747|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
22287748|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net|
22287749|NCT03656939|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287750|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287751|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org|
22287752|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu|
22287753|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac|
22287754|NCT05328102|Xencor, Inc|Michael Chiarella|858-945-2415|mchiarella@xencor.com|
22287755|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300|roseopiyo@uonbi.ac.ke|43481
22287756|NCT02954536|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
22287757|NCT05498649|Scripps Optometric Group|Dr Keith Wan|858-530-2800|keithmwan@gmail.com|
22287758|NCT02946580|Massachusetts General Hospital|Dr. Kyle Staller|617-724-7556|kstaller@mgh.harvard.edu|
22287759|NCT03094416|IBSA|Claudia Scarsi|+41583601000|claudia.scarsi@ibsa.ch|
22287760|NCT03638453|Dana Farber Cancer Institute/Boston Children's Hospital|Dr. Kira Bona, MD, MPH|617-632-4688|kira.bona@childrens.harvard.edu|
22287761|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411|corrine.voils@va.gov|5196
22287762|NCT00005780|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
22287763|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu|
22287764|NCT02485691|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22287765|NCT04292535|Michigan State University|Matthew B. Pontifex|517-432-5105|pontifex@msu.edu|
22287766|NCT01420861|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
22287767|NCT03341299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22287768|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu|
22287769|NCT03755206|Johns Hopkins Center for Indigenous Health|Dr. Emily E. Haroz, Associate Professor|4109556931|eharoz1@jhu.edu|
22287770|NCT04905134|Duke University|Walter T. Lee, MD, MHS|919-613-6407|walter.lee@duke.edu|
22287771|NCT03009058|Immodulon Therapeutics Ltd|Chief Medical Odfficer|+44 (0)20 3137 6346|info@immodulon.com|
22287772|NCT05556265|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22287773|NCT04359810|Columbia University Irving Medical Center|Max O'Donnell, MD|212-305-5794|mo2130@columbia.edu|
22287774|NCT04760782|University of Vermont|Dr. David Lunardini|(802) 847-2663|david.lunardini@uvmhealth.org|
22287775|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22287776|NCT02392806|Saint Louis University|Noah Hillman|3145779292|noah.hillman@health.slu.edu|
22287777|NCT03518086|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22287778|NCT02336282|St. Jude Children's Research Hospital|Kevin Krull, PhD|(901) 595-5891|kevin.krull@stjude.org|
22287779|NCT04084171|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22287780|NCT04163341|University of Alabama at Birmingham|Dr. Michael Mugavero|202-966-5822|mmugavero@uab.edu|
22287781|NCT03563209|İzmir Katip Çelebi University, Faculty of Medicine|ilker şengül|05337333698|ilkrsngl@gmail.com|
22287782|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu|
22287783|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
22287784|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22287785|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu|
22287786|NCT01084655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22287787|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu|
22287788|NCT01533207|NRG Oncology|Linda Gedeon on behalf of Danielle Enserro, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22287789|NCT03027609|Aridis Pharmaceutical Inc|Lynne Deans|001-925200|deansl@aridispharma.com|3089
22287790|NCT03182374|Zimmer Biomet|Clinical Project Lead|+41791522905|miguelcorreatapia@zimmerbiomet.com|
22287791|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287792|NCT03651479|Eastern Mediterranean University|Asst. Prof. Dr. Gozde Iyigun|+903926303011|gozde.iyigun@emu.edu.tr|
22287793|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu|
22287794|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu|
22287795|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org|
22287796|NCT02177123|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22287797|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287798|NCT06271993|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
22287799|NCT02988466|University of Minnesota, Masonic Cancer Center|Mark Juckett, MD|(612) 626-5654|juck0001@umn.edu|
22287800|NCT01980017|University of Ottawa Heart Institute|Dr. Robert Reid|6136967393|breid@ottawaheart.ca|
22287801|NCT03520998|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22287802|NCT01435382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287803|NCT00910650|University of California at Los Angeles, Jonsson Comprehensive Cancer Center|Ignacio Baselga|310 206-2090|ibaselga@mednet.ucla.edu|
22303991|NCT04102540|University of Colorado College of Nursing|Dr. Samantha Stonbraker|3037248281|Samantha.Stonbraker@CUAnschutz.edu|
22303992|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22303993|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu|
22303994|NCT02571439|Maimonides Medical Center|Dr Kalpana Tyagaraj|7182836000|KTyagaraj@maimonidesmed.org|
22303995|NCT02501135|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
22303996|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
22303997|NCT02019602|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22303998|NCT00780442|Medical University of South Carolina|Dr. Kimber L. Price|843-792-4847|pricekl@musc.edu|
22303999|NCT03207711|University of California, San Francisco|Frederick Hecht, MD|(415) 353-9743|rick.hecht@ucsf.edu|
22304000|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304001|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu|
22304002|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu|
22304003|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org|
22304004|NCT02788006|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22304005|NCT00318149|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304006|NCT00570258|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
22304007|NCT03541642|Temple University|Dr. Sarah Bass|215-204-5110|sbass@temple.edu|
22304008|NCT02682563|AmsterdamUMC|Erik van Bommel|+31 20 444 2264|e.vanbommel@amsterdamumc.nl|
22304009|NCT03088137|IVFarma LLC|Mikhail Polzikov (PhD)|+74996455342|mikhail.polzikov@ivfarma.ru|1
22304010|NCT03050398|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22304011|NCT05108649|University of Pennsylvania|Valentina Goren, MRA Project Manager|215-746-3602|vsoup@pennmedicine.upenn.edu|
22304012|NCT03523871|NYU Langone Health|Luis Angel, MD|646-501-0119|Luis.Angel@nyulangone.org|
22287804|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
22287805|NCT02392637|UT MD Anderson Cancer Center|Dr. Milind Javle, Professor, GI Medical Oncology|(713) 792-5434|mjavle@mdanderson.org|
22287806|NCT01761877|Stony Brook University|Dr. Alison T Stopeck|5206476982|Alison.Stopeck@stonybrookmedicine.edu|
22287807|NCT03913455|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22287808|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22287809|NCT03962491|Virginia Commonwealth University|Kathryn Polak, PhD|(804) 827-1184|polakkm@vcu.edu|
22287810|NCT03020667|Uwatoko Clinic|Kunihiko Uwatoko, MD|+81-52-991-4602|uwatoko.clinic@gmail.com|
22287811|NCT03697252|Karuna Therapeutics, Inc.|Stephen Brannan|857-449-2234|sbrannan@karunatx.com|
22287812|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287813|NCT01780506|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22287814|NCT00643864|CarolinasHS|Dr. Mark Hirsch, Senior Scientist|704 355 7673|mark.hirsch@carolinashealthcare.org|
22287815|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com|
22287816|NCT01867671|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22287817|NCT04852302|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
22287818|NCT05249582|Palo Alto University|Erick Kim|(510) 457-1584|ekim@paloaltou.edu|
22287819|NCT01743469|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22287820|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org|
22287821|NCT03253796|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287822|NCT02285855|UT MD Anderson Cancer Center|Stephen Chun/Assistant Professor, Radiation Oncology|713- 563-9600|sgchun@mdanderson.org|
22287823|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22287824|NCT02516696|Weill Cornell Medicine|Multiple Myeloma Program Manager|646.962.9376|hyk4001@med.cornell.edu|
22287825|NCT02718898|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304013|NCT01083160|Abbott|Global Medical Services|1-800-633-9110||
22304014|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22304015|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org|
22304016|NCT01712789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22304017|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300||
22304018|NCT00972179|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22304019|NCT03055832|TearFilm Innovations, Inc.|Rob Thornhill|844-458-9776|rthornhill@tearfilm.com|
22304020|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22304021|NCT01991197|Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland|Dr Maeve Lynch||maeve.lynch2@hse.ie|
22304022|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22304023|NCT01932996|University of Minnesota|Rebekah Pratt|612-625-1196|rjpratt@umn.edu|
22304024|NCT02923895|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22304025|NCT00846742|St. Jude Children's Research Hospital|Matt Ehrhardt, MD, MS|(901) 595-5913|matt.ehrhardt@stjude.org|
22304026|NCT03051997|Medcial University of South Carolina|Professor|843-876-1840|cunninpb@musc.edu|
22304027|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170|nicole.chandler@jhmi.edu|727
22304028|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
22304029|NCT01586000|Premier Research|Kimberly Myer, Sr. Program Director, NIH|984-238-1297|Kimberly.Myer@premier-research.com|
22304030|NCT03257995|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22304031|NCT03228017|NYU Langone|Dr. Michael Garshick|212-263-0855|michael.garshick@nyulangone.org|
22304032|NCT02969031|Dana-Farber Cancer Institute|Julie Goldman|617-632-5563|Julie_Goldman@dfci.harvard.edu|
22304033|NCT04170296|Endo Pharmaceuticals|David Hernandez, MD|800-462-3636|clinicaltrials@endo.com|
22304034|NCT03567993|UMass Chan Medical School|Dr. Rajani Sadasivam|508-456-8923|rajani.sadasivam@umassmed.edu|
22304035|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22304036|NCT00547105|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
22304037|NCT00903786|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22304038|NCT02285595|Sonendo, Inc.|Director of Clinical Research|9496678036|clinical@sonendo.com|
22304039|NCT01960790|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22304040|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304041|NCT04318093|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22287826|NCT02163538|University Louisville|Dr. Resad Pasic|502-561-7465|resad.pasic@louisville.edu|
22287827|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304042|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304043|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646|dmitry.kireev@pcr.ru|2227
22304044|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304045|NCT02924389|Emory University|Cecile Lahiri, MD|404-616-6306|cdelill@emory.edu|
22304046|NCT05220501|Sunnybrook Health Sciences Centre|Dr. Laurence Klotz|+1. 416 480 4673|Laurence.Klotz@sunnybrook.ca|
22304047|NCT02692235|AWFiS|Robert Olek|+48 58 5547392|robol@awf.gda.pl|
22304048|NCT00802841|Novartis|Study Director|862-778-1873||
22304049|NCT01268059|MedImmune, LLC|Mohammed Dar, MD, Vice President & Head, Clinical Development, Oncology|+1 301-398-0000|information.center@astrazeneca.com|
22287828|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22287829|NCT01259063|Memorial Sloan Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|dalbagng@mskcc.org|
22287830|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287831|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu|
22287832|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com|
22287833|NCT02855281|Hospital Bethanien Solingen, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Solingen, Germany|Dr. Lars Hagmeyer|0212636004|institut@klinik-bethanien.de|
22287834|NCT02651675|Regenxbio Inc.|Clinical Development Lead|240-552-8968|srastogi@regenxbio.com|
22287835|NCT02246530|University of Alabama at Birmingham|Dr. Breanna Willeford, DO|205-934-4131|breannawilleford@uabmc.edu|
22287836|NCT00617734|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287837|NCT05712460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287838|NCT03529669|Oxford University Hospitals NHS Trust|Dr Somnath Mukherjee|01865 617018|Somnath.Mukherjee@ouh.nhs.uk|
22287839|NCT05560425|University of North Carolina at Chapel Hill|Elena Vidrascu, PhD, MSc|919-843-9193|elena91@live.unc.edu|
22287840|NCT05135767|Brown University|Hayley Treloar Padovano, PhD|4018636623|hayley_treloar@brown.edu|
22287841|NCT02694185|Rocky Mountain Regional VA Medical Center|Elizabeth Cheng|720-857-5101|elizabeth.cheng@va.gov|
22287842|NCT05082857|Wake Forest University School of Medicine|Anna Miller-Fitzwater, MD, MPH|336-713-0630|amillerf@wakehealth.edu|
22287843|NCT04366349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287844|NCT05421624|Boston University|Franchino Porciuncula, EdD, PT, DScPT|(617) 353-7525|fporciun@bu.edu|
22287845|NCT05737069|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22287846|NCT02331134|University of Colorado Hospital|Antonio Jimeno, MD, PhD|3037242478|antonio.jimeno@cuanschutz.edu|
22287847|NCT05967260|Oregon Health & Science University|Clara Mosquera-Lopez|503--418-4129|mosquera@ohsu.edu|
22287848|NCT05565742|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22287849|NCT00668148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22287850|NCT01243190|The university of Texas MD Anderson Cancer Center|William Wierda MD./Professor|713-745-0428|wwierda@mdanderson.org|
22287851|NCT05472090|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
22287852|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no|
22287853|NCT01601236|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22287854|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu|
22287855|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu|
22287856|NCT04639245|Fred Hutchinson Cancer Center|Dr. Damian Green|(855) 557-0555|dgreen@fredhutch.org|
22287857|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
22287858|NCT02419001|Synthetic Biologics Inc.|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
22287859|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22287860|NCT01074814|Translational Drug Development|Linda Vocila, Executive Director Clinical Strategy|6023588311|lvocila@td2inc.com|
22287861|NCT02166346|Johns Hopkins University|Michael Levy, Principal Investigator|443-287-4412|mlevy@jhmi.edu|
22287862|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590||
22287863|NCT02231086|Amsterdam UMC|Prof. dr. P.J. Tanis|+31-20-4444444|p.j.tanis@amsterdamumc.nl|
22287864|NCT03780244|QMedAB|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
22287865|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
22287866|NCT03175367|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22287867|NCT02851615|Cincinnati Children's Hospital Medical Center|Dr. Lori Crosby|513-636-5380|Lori.Crosby@cchmc.org|
22287868|NCT01843621|Dept of Pediatrics, Pharmongkutklao Hospital, Bankok, Thailand|Sriluck Simasathien, MD|66-2-644-8971|ssriluck@yahoo.com|
22287869|NCT02345070|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22287870|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22287871|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22287872|NCT00321620|Amgen Inc.|Study Director|866-572-6436||
22287873|NCT03337477|AstraZeneca Clinical|Study Information Center|+1 877 240 9479|information.center@astrazeneca.com|
22287874|NCT01698333|Therapeutics Inc.|Clinical Research|858-571-1800|clinicalresearch@therapeuticsinc.com|
22287875|NCT03198715|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22287876|NCT02379728|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
22287877|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org|
22287878|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com|
22287879|NCT05101122|Apnimed|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
22287880|NCT03131219|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22287881|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com|
22287882|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu|
22287883|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com|
22287884|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287885|NCT03163303|University of California, San Francisco|Dr. Derek Satre|(415) 476-7382|derek.satre@ucsf.edu|
22287886|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com|
22287887|NCT04163952|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger.edu|
22287888|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
22287889|NCT04538989|Rezolute|Chief Medical Officer (Dr. Brian Roberts)|650-206-4507|brian@rezolutebio.com|
22287890|NCT04613362|Richard L. Roudebush VA Medical Center|Dr. Teresa Damush|317-988-4277|teresa.damush@va.gov|
22287891|NCT04225897|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287892|NCT05172128|Duke University Medical Center|Dr. P. Murali Doraiswamy|9196845933|murali.doraiswamy@duke.edu|
22287893|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu|
22287894|NCT03466658|Penn State Health|Dr. Hyunmin Kim|717-531-4826|hkim2@pennstatehealth.psu.edu|
22287895|NCT01921205|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22287896|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
22287897|NCT00886379|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-7929|jr33@partners.org|
22287898|NCT03137381|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22287899|NCT01684917|Imperial College London|Professor Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22287900|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22287901|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300||
22287902|NCT03848325|University of Pittsburgh|Sanjay R. Patel MD, MS|412-383-0607|patelsr2@upmc.edu|
22287903|NCT03379818|University of Birmingham|Dr Andrea Krott|+44 (0)121 414 4903|a.krott@bham.ac.uk|
22287904|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22287905|NCT03542877|University of Colorado|Dr. Wells Messersmith|303-724-0747|wells.messersmith@cuanschutz.edu|
22287906|NCT04004988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22287907|NCT03873116|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22287908|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22287909|NCT04682366|Wake Forest|Majid Mirzazadeh|336-716-4131|mmirzaza@wakehealth.edu|
22287910|NCT03125395|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22287911|NCT02531802|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22287912|NCT00482053|Stanford University Medical Center|Wen-Kai Weng, Assistant Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22287913|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
22287914|NCT03292926|Hospital for Special Surgery, Anesthesiology|Dr. Jonathan Beathe|2126061036|beatheJ@hss.edu|
22287915|NCT04842747|Veru|Gary Barnette PhD CSO|800-606-9382|veruclinicaltrials@verupharma.com|
22287916|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu|
22287917|NCT02559622|Novartis Pharmaceuticals|Study Director|862--778--8300||
22287918|NCT04011540|University of Pennsylvania|Lauren Southwick|267-428-0125|lauren.southwick@pennmedicine.upenn.edu|
22287919|NCT02731469|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22287920|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu|
22287921|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22287922|NCT02761330|Washington Universtiy School of Medicine|Alyssa Labonte|314-273-7338|alabonte@wustl.edu|
22287923|NCT05386329|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
22304050|NCT03660943|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
22287924|NCT03183869|Lawson Health Research Institute|Chantelle Graf, RN|519-685-8500|chantelle.graf@sjhc.london.on.ca|35352
22287925|NCT03043313|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22287926|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com|
22287927|NCT04973449|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22287928|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
22287929|NCT03816696|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22287930|NCT03137992|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
22287931|NCT04609319|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22287932|NCT03221556|Boston Medical Center|Caroline Kistin, MD MSc|(617) 414-3638|caroline_kistin@brown.edu|
22287933|NCT05010707|Washington University in St. Louis, School of Medicine|Thomas Baranski, MD, PhD|314-747-3997|baranski@wustl.edu|
22287934|NCT04825574|Blueprint Medicines|Blueprint Medicines Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
22304051|NCT03699124|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
22304052|NCT03294213|Ambu A/S|Anna Lundgaard|+4529643748|aclu@ambu.com|
22304053|NCT04411940|Cycle Pharmaceuticals|Head of Global Regulatory Affairs & Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
22304054|NCT00472186|Dupage Chidlren's ENT & Allergy|Manali Amin, MD|630-785-0367|manali.amin@gmail.com|
22304055|NCT05641077|Cleveland Clinic|Lannah Lua-Mailland|216-314-2163|lual@ccf.org|
22304056|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu|
22304057|NCT04655313|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22304058|NCT03781960|University of Pennsylvania Hospital|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
22304059|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304060|NCT02444234|University of Southern California|Paul M Beringer, Pharm.D.|323-442-1402|beringer@usc.edu|
22304061|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov|
22304062|NCT03824938|Columbia University Irving Medical Center|Victoria M. Leavitt, MD|212-342-1351|vl3227@cumc.columbia.edu|
22304063|NCT00287469|Armed Forces Research Institute of Medical Services|Mrigendra P. Shrestha MD|662-644-4888|shrestham@afrims.org|
22304064|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22304065|NCT03653416|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
22304066|NCT03190083|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nidhi Sharma|+1 216-444-9014|sharman2@ccf.org|
22304067|NCT01872949|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
22304068|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu|
22304069|NCT03786094|Spexis AG|Christian Zwingelstein|+41 61 567 16 00|info@spexisbio.com|
22304070|NCT05480722|University of Delaware|William B Farquhar|302-831-6168|wbf@udel.edu|
22304071|NCT04759885|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
22304072|NCT00195715|Abbott|Global Medical Services|1-800-633-9110||
22319675|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22287935|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22287936|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com|
22287937|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22287938|NCT01597596|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
22287939|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22287940|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22287941|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22287942|NCT03181932|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22287943|NCT03304626|University of Cincinnati|Khurram Bari|513-558-2898|khurram.bari@uc.edu|
22287944|NCT01887327|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|ClinicalTrials@mnk.com|5
22287945|NCT03298035|The University of Texas Health Science Center at Houston|Catherine C. Beaullieu, MD|(713) 500-6044|Catherine.C.Beaullieu@uth.tmc.edu|
22287946|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22287947|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22287948|NCT01747876|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22287949|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl|
22287950|NCT00853307|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22287951|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com|
22287952|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com|
22287953|NCT03331315|University of Tennessee - West Cancer Center|Michael Ulm|404-281-9480|mulm@westclinic.com|
22287954|NCT00360230|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287955|NCT02703597|University of Florida|Assistant Professor|3526279467|gkhalil@ufl.edu|
22287956|NCT00481832|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22287957|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com|
22287958|NCT03416985|University of California Los Angeles|Joan Pi Anfruns, DMD|310-825-0834|jpianfruns@dentistry.ucla.edu|
22287959|NCT02006472|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22287960|NCT03219723|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22287961|NCT04558125|Cedars-Sinai Medical Center|Victor Tapson, MD|919-971-6441|Victor.Tapson@cshs.org|
22287962|NCT04843007|NanoAlvand|Dr. Hamidreza kafi|9129232594|Kafi.h@orchidpharmed.com|+98
22287963|NCT05179785|University of Pittsburgh|Mary Phillips|4123838206|fmristudies@upmc.edu|
22287964|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22287965|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
22287966|NCT01033019|Novartis|Study Director|862-778-8300||
22287967|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22287968|NCT01052493|Imperial College London|Dr Tricia Tan|020 83838038|t.tan@imperial.ac.uk|
22287969|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com|
22287970|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com|
22287971|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287972|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22287973|NCT00551642|Mallinckrodt|Medical Information Call Center|800-556-3314|medinfo@mnk.com|
22287974|NCT03337308|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22287975|NCT03593902|Northwestern University|Kathleen Quigley|312-695-8192|kathleen.quigley@nm.org|
22287976|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
22287977|NCT03558737|University of Utah|Bradley Yoder|801-581-7052|bradley.yoder@hsc.utah.edu|
22287978|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343||
22287979|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu|
22287980|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu|
22287981|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov|
22287982|NCT01903460|Mirum|Study Physician|+1 650-667-4085|medinfo@mirumpharma.com|
22287983|NCT03104868|Northwestern University|Dr. Michael Wolf|312-503-5592|mswolf@northwestern.edu|
22287984|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu|
22287985|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22287986|NCT01488890|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
22287987|NCT00829426|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22287988|NCT04408989|mabxience Research SL|Susana Millan|+3491771500|susana.millan@mabxience.com|
22287989|NCT04798183|Pusan National University Yangsan Hospital|Sungchul huh, M.D., Ph.D.||dr.huhsc@gmail.com|0553604250
22287990|NCT03475004|University of Colorado|Dr. Christopher Lieu|303-724-6390|christopher.lieu@cuanschutz.edu|
22287991|NCT03645122|VA Pittsburgh Healthcare System|Assistant Director for Clinical and Regulatory Affairs|412-822-3669|Nikitha.Deepak@va.gov|
22287992|NCT04756427|Washington University|Darla Shores|314-454-6173|shores@wustl.edu|
22287993|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com|
22287994|NCT02260934|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22287995|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22287996|NCT02628873|Wright State University|Steven Lindheim|858-740-1083|doclalalindheim@gmail.com|
22287997|NCT00537134|Centre Hospitalier de l'Université de Montréal (CHUM)|Ruby Klink|(514) 890-8000|ruby.klink.chum@ssss.gouv.qc.ca|27235
22304073|NCT03844321|Massachusetts General Hospital|Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
22304074|NCT03421496|Radius Health|Bruce Mitlak, MD; Head of Discovery Science and Chief Medical Officer|617-444-1943|bmitlak@radiuspharm.com|
22304075|NCT05822921|Virginia Tech|Dr. Angela Scarpa|540-231-2615|ascarpa@vt.edu|
22304076|NCT01414426|UChicago|Dr. Alexander Pearson|855-702-8222|apearson5@medicine.bsd.uchicago.edu|
22304077|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org|
22304078|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22304079|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org|
22304080|NCT02468934|SPR Therapeautics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22304081|NCT02397265|Imperial College London|Nick Oliver|020 7594 2460|nick.oliver@imperial.ac.uk|
22304082|NCT01234766|Dartmouth-Hitchcock Medical Center|Frederick Lansigan, MD|603-650-4628|Frederick.Lansigan@hitchcock.org|
22287998|NCT03597347|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22304083|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22287999|NCT04606134|University of Rochester Medical Center|Mara Weinstein MD|(585) 275-7546|Mara_Weinsteinvelez@URMC.Rochester.edu|
22288000|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22288001|NCT02961894|Rex Medical|Colin Valentis|610-629-6051|cvalentis@rexmedical.com|
22288002|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22288003|NCT04986904|University of Virginia|Dr. Kelly Shaffer|434-982-1022|kshaffer@virginia.edu|
22288004|NCT02532517|Cerenovus|Christopher Hendricks|415-656-6565|CHendric@its.jnj.com|
22288005|NCT02234843|Therapeutic Area Head|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22288006|NCT01319981|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
22288007|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
22288008|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22288009|NCT04272242|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22288010|NCT04053036|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22288011|NCT05856422|Clinimark|Associate Researcher|833 373 0998|Carolyn.Cohen@element.com|1
22288012|NCT03204188|National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)|Adrian Wiestner, M.D., Ph.D., Principal Investigator|301-594-6855|wiestnea@nhlbi.nih.gov|
22288013|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu|
22288014|NCT03531112|University of North Carolina at Chapel Hill|Rachel Goode, PhD|919-962-6429|rwgoode@email.unc.edu|
22288015|NCT01256788|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Douglas Wyland|864-454-7422|dwyland@ghs.org|
22288016|NCT05966142|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22288017|NCT04849364|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22288018|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu|
22288019|NCT04006288|University of Florida|Dr. Dominick J Angiolillo. Professor of med University of Florida College of Medicine-Jacksonville|904-244-3378|dominick.angiolillo@jax.ufl.edu|
22288020|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
22288021|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it|
22288022|NCT02673372|Maimonides Medical Center|Sergey Motov, Director of Research|718-283-8693|smotov@maimonidesmed.org|
22288023|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22288024|NCT03431259|Massachusetts General Hospital|Marilyn Heng, Principal Investigator|6176430149|mheng@mgh.harvard.edu|
22288025|NCT03931941|Clinical Development|Clinical Development|651-705-8778|US8-Studyinfo@ferring.com|
22288026|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com|
22288027|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu|
22288028|NCT01217229|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22288029|NCT02323217|Imperial College London|Dr Robin J Tyacke|(0)20 7594 7096|r.tyacke@imperial.ac.uk|+44
22288030|NCT02784548|VA San Diego Healthcare System|Dr. Thomas Rutledge|8585528585|thomas.rutledge@va.gov|7273
22288031|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu|
22288032|NCT03094325|NYU Langone Health|Daniel Swistel, MD|646-754-7217|Daniel.Swistel@nyulangone.org|
22288033|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com|
22288034|NCT03994081|University of North Carolina at Chapel Hill|Tobias Schwippel, MD|919-966-9929|tobias_schwippel@unc.edu|
22288035|NCT03224819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22288036|NCT03783078|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22288037|NCT02620774|Center for Anti-infective Research and Development|David Nicolau|860-972-3941|david.nicolau@hhchealth.org|
22304084|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22304085|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191|guenter.christ@wienkav.at|2508
22304086|NCT02218489|Kala Pharmaceuticals, Inc|VP, Clinical Development|781-996-5252|Results003@kalarx.com|
22288038|NCT02059278|Point Guard Partners LLC|Jeremy Brace|727-458-2823|jbrace@pointguardllc.com|
22288039|NCT03955146|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|zephyrus@fibrogen.com|
22288040|NCT04363320|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|tdmolfenter@wisc.edu|
22288041|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com|
22288042|NCT03605667|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
22288043|NCT05632211|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
22288044|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22288045|NCT03373240|Yale University|Dr. Arielle Baskin-Sommers|203-432-9257|arielle.baskin-sommers@yale.edu|
22288046|NCT02867436|Motol University Hospital|Zdeněk Šumník, PI|+420702000087|zdenek.sumnik@lfmotol.cuni.cz|
22288047|NCT04029883|Cedars-Sinai Medical Center|Dr. Joseph Ebinger|424-315-2284|cda-research@cshs.org|
22288048|NCT04080505|Columbia University|Jennifer Kuo, MD|212-305-6969|jhk2029@cumc.columbia.edu|
22288049|NCT03175679|BeijingYouanH|Dr. LJUN|861366138148|lujun98@ccmu.edu.cn|
22288050|NCT05194124|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22288051|NCT04876521|All India Institute of Medical Sciences|Dr. Biswa Ranjan Mishra|09438884220|psych_biswa@aiimsbhubaneswar.edu.in|
22288052|NCT05494385|Indiana University School of Medicine|Dr. Anna Guanzon|2197651884|amguanzon89@gmail.com|
22288053|NCT05408429|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288054|NCT03642873|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22288055|NCT03108131|The University of Texas MD Anderson Cancer Center|Dr. Kanwal Raghav|(917) 733-0356|kpraghav@mdanderson.org|
22288056|NCT01253291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22288057|NCT02920632|Amsterdam UMC, Vrije Universiteit|Dr. Chris Vriend|+31625694912|c.vriend@amsterdamumc.nl|
22288058|NCT03312231|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
22288059|NCT05178173|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
22288060|NCT03157830|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22288061|NCT02195518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288062|NCT03694353|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr. Director, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
22288063|NCT04370873|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22288064|NCT03804528|University of Miami|Joyce Gomes-Osman|305-284-2632|j.gomes@miami.edu|
22288065|NCT04309396|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22288066|NCT00651742|Taiho Oncology, Inc|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22288067|NCT01074970|Hoosier Cancer Research Network|Director of Clinical Data Management|317-634-5842|jsmith@hoosiercancer.org|41
22288068|NCT02086175|Dana-Farber Cancer Institute|Caron A. Jacobson, MD|617-632-6404|cajacobson@partners.org|
22288069|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu|
22288070|NCT04314284|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
22288071|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22288072|NCT01652235|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22288073|NCT05138653|Cerevel Therapeutics|Cerevel Central Contact|8572500977|info@cerevel.com|
22288074|NCT03205709|Columbia University Medical Center|D.P. Devanand, M.D.|774-8658|dpd3@cumc.columbia.edu|646
22288075|NCT02023086|Université de Montréal|Langis Michaud|5149166312|langis.michaud@umontreal.ca|
22288076|NCT04607005|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288077|NCT03735875|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
22288078|NCT02711891|Rush University Medical Center|Kathleen C. Heneghan, RN, PhD|3123395943|kheneghan@facs.org|
22288079|NCT02786394|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
22288080|NCT04828343|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22288081|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu|
22288082|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22288083|NCT04743778|University of Michigan, School of Social Work|Dr. Jaclynn Hawkins|(734) 615-2817|jachawk@umich.edu|
22288084|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22288085|NCT03252431|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
22288086|NCT02812342|Yale Dermatology - Middlebury|Brett King, MD, PhD, BA, Associate Professor of Dermatology|(203) 737-4825|brett.king@yale.edu|
22288087|NCT03824769|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
22288088|NCT02266888|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22288089|NCT01550224|Stanford University Medical Center|Steven Edward Coutre, MD; Professor of Medicine (Hematology)|650-725-4040|coutre@stanford.edu|
22288090|NCT03611829|McGill University|Mallory Frayn, PhD (c)|514-398-1399|mallory.frayn@mail.mcgill.ca|
22288091|NCT02224560|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22288092|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
22288093|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
22288094|NCT02461758|University of Wisconsin School of Medicine and Public Health|FREDDY CALDERA, ASST PROFESSOR , GASTROENTEROLOGY|(608) 263-1995|fcaldera@medicine.wisc.edu|
22288095|NCT04454918|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22304087|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov|
22304088|NCT02133924|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-3429|john.levine@mssm.edu|
22304089|NCT02413190|Kennedy Krieger Institute|Dr. Kathryn Wagner|443-923-9525|wagnerk@kennedykrieger.org|
22304090|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22304091|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000|sheldon.brown@va.gov|6666
22304092|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com|
22304093|NCT04039503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304094|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590||
22304095|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org|
22304096|NCT02218203|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
22304097|NCT02601937|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22304098|NCT04145349|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304099|NCT05567952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304100|NCT02385721|Boryung Pharmaceutical Co., Ltd|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
22304101|NCT03280563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22304102|NCT03038672|Mayo Clinic|Stephen Ansell|(507)284-5096|ansell.stephen@mayo.edu|
22304103|NCT04423393|Vir Biotechnology, Inc.|Study Inquiry|(415) 906-4324|clinicaltrials@vir.bio|
22304104|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com|
22304105|NCT05160025|Rutgers University|Dr. John Palmieri, Study Coordinator|9733562378|john.palmieri@rutgers.edu|
22304106|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com|
22304107|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623||
22304108|NCT03673098|Massachusetts General Hospital|Dr. Christina Psaros|617-726-7458|cpsaros@mgh.harvard.edu|
22304109|NCT03850444|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304110|NCT03595683|University of Chicago|Dr. Randy Sweis|773-834-3094|rsweis@uchicago.edu|
22304111|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br|
22304112|NCT04569058|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
22304113|NCT03158948|INOTREM SA|Executive VP Research and Medical Sciences|30 62 86 51|jjg@inotrem.com|+33 (0)6
22304114|NCT05876351|European Clinical Trial Information|Alexion Pharmaceuticals Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22304115|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu|
22304116|NCT02472314|Wayne State University School of Medicine and Cleveland Clinic Florida|Vani J. Sabesan, MD|131375138489|sabes001@gmail.com|
22304117|NCT03415022|New York State Psychiatric Institue|Dr. Franklin Schneier|646-774-8041|Franklin.Schneier@nyspi.columbia.edu|
22304118|NCT05794997|Brigham and Women's Hospital|Rishi J Desai, PhD|6172780932|rdesai@bwh.harvard.edu|
22288096|NCT04543279|Washington University School of Medicine|Dr. Amy Zhou|314-362-8814|a.zhou@wustl.edu|
22288097|NCT02871934|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|Dr. Jason Vassy|857-364-2561|jvassy@partners.org|
22288098|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org|
22288099|NCT04030143|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22288100|NCT03216226|Zealand Pharma A/S|Kim Mark Knudsen|+45 50603780|KMKnudsen@zealandpharma.com|
22288101|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org|
22288102|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22288103|NCT02416206|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22288104|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288105|NCT02383576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22288106|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170|acampbell@laborie.com|2274
22288107|NCT01436149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22288108|NCT01690143|University of Alabama at Birmingham|Luciano J Costa, Principal Investigator|205-209-6038|ljcosta@uabmc.edu|
22288109|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG|
22288110|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu|
22288111|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
22288112|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288113|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471|sarahdassati@yahoo.it|471
22288114|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org|
22288115|NCT05810740|Pierre Fabre Médicament|Ana Catarina Pinto, Responsible Medical Officer|5 3450 6059|ana.catarina.pinto@pierre-fabre.com|
22288116|NCT03542487|Office of Evaluation Sciences, General Services Administration|Mattie Toma|859-621-0517|mattie.toma@gsa.gov|
22288117|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com|
22304119|NCT02086552|Mayo Clinic|Francis K Buadi, MD|507/284-2511|Kumar.Shaji@mayo.edu|
22304120|NCT02206152|University of Minenesota|Elizabeth Seaquist, MD|612-624-9176|chape044@umn.edu|
22304121|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22304122|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304123|NCT04963764|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Todd Florin|312-227-6080|edpneumoniaresearch@luriechildrens.org|
22304124|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
22304125|NCT03226457|University of Dundee|Dr Natalie Mordi (Principle Investigator)|+ 44 (0) 1382 383 667|n.a.mordi@dundee.ac.uk|
22304126|NCT03583541|Washington University in St. Louis|Fred Ssewamala|3149358521|fms1@wustl.edu|
22304127|NCT00884286|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22304128|NCT04463615|City of Hope Medical Center|Dr. Christiane Querfeld|6263598111|cquerfeld@coh.org|
22304129|NCT00594932|Oklahoma Medical Research Foundation|Joan T Merrill M.D.|405 271 7805|joan-merrill@omrf.org|
22304130|NCT00088205|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304131|NCT05199233|Mayo Clinic Rochester|Dr. Ivana T. Croghan|507 284-2511|gimresearchstudies@mayo.edu|
22304132|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu|
22304133|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu|
22304134|NCT02162992|H. Germans Trias i Pujol|Dr. Roger Villuendas|+34 4978398|rogervilluendas@hotmail.com|
22304135|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22304136|NCT02982720|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
22304137|NCT02144519|University of South Carolina|Michael W Beets|8037773003|beets@mailbox.sc.edu|
22304138|NCT02343575|Stanford University|Yelizaveta Sher, MD|650-736-0459|ysher@stanford.edu|
22304139|NCT01734850|CSL Behring|Trial Registration Coordinator|484-878-4000|clinicaltrials@cslbehring.com|
22304140|NCT05126459|Loma Linda University Health|Dr. Jung-Wei Chen|909 558 1000|JWChen@llu.edu|
22304141|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22304142|NCT03619174|Viveve|Vice President, Clinical & Medical Affairs|720-696-8173|clinicalaffairs@viveve.com|
22304143|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu|
22304144|NCT03553940|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
22304145|NCT04675242|Nicox Ophthalmics, Inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
22304146|NCT02448719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22304147|NCT02410161|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22304148|NCT04707391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22304149|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
22304150|NCT01406717|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
22304151|NCT02040090|Kamada|Eran Schenker, VP Medical Director|+972-8-9406472|Erans@kamada.com|
22304152|NCT02554435|California State Polytechnic University, Pomona|Dr. Zakkoyya Lewis|5628819950|drkoyyalewis@gmail.com|
22304153|NCT02275533|University of Chicago|Theodore Karrison|708-925-6771|tkarrison@health.bsd.uchicago.edu|
22304154|NCT01570868|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22304155|NCT03370276|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
22304156|NCT01614574|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22304157|NCT02875561|University of Colorado|Dr. Saketh Guntupalli|303-724-2024|saketh.guntupalli@cuanschutz.edu|
22304158|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
22304159|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
22319676|NCT00763971|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22304160|NCT02258464|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22288118|NCT01539824|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
22288119|NCT02735863|ABIVAX|Sharon Skare|+33153830961|sharon.skare@abivax.com|
22288120|NCT05452486|University of Arkansas for Medical Sciences|Dr. Caitlin Price|(501) 686-8125|CEPrice@uams.edu|
22288121|NCT02002598|Columbia University|Suzanne Lentzsch, MD|646-317-4840|sl3440@cumc.columbia.edu|
22288122|NCT02560038|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22288123|NCT02018562|Johns Hopkins University|Vinciya Pandian PhD, MSN, RN, ACNP-BC, FAAN|4436553482|vpandia1@jhu.edu|
22288124|NCT03435211|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22288125|NCT01838395|BioLineRx Ltd.|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
22288126|NCT05972993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288127|NCT00453895|University of Würzburg|Prof. Dr. Martin Fassnacht|+49-931-201-39201|fassnacht_m@medizin.uni-wuerzburg.de|
22288128|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22288129|NCT01723384|San Francisco Department of Public Healt|Dr. Glenn-Milo Santos|415-437-6231|glenn-milo.santos@ucsf.edu|
22288130|NCT05378672|Zealand Pharma A/S|Clinical Operations|+45 88 77 36 00|clinicaltrials@zealandpharma.com|
22288131|NCT05720897|Indiana University|Stuart Schrader|3172781409|sschrade@iu.edu|
22288132|NCT00400179|Taiho Pharma USA, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22288133|NCT04780061|Patterson Institute for Integrative Oncology Research|Clinical Trial Coordinator|6137921222|mlegacy@thechi.ca|1
22288134|NCT02344108|Mass General Brigham|Matthew E Stenerson, MS, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
22288135|NCT04050553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22288136|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22288137|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu|
22288138|NCT03353688|University of Alabama at Birmingham|Program Manger|(205) 934-0683|clg17@uab.edu|
22288139|NCT04760613|NYU Langone health|Stephen Ross, MD|212-263-6289|Stephen.ross@nyulangone.org|
22288140|NCT03589859|VA Northeast Ohio Healthcare System|Dr. Mark Walker|216-791-3800|mark.walker5@va.gov|65229
22288141|NCT03111121|West Virginia University|Pavithra Ranganathan Ellison, MD|3045984122|pavithra.ellison@hsc.wvu.edu|
22288142|NCT03043794|Johns Hopkins University, Department of Radiation Oncology|Dana Baker Kaplin, MPH|410-614-3950|dkaplin1@jhmi.edu|
22288143|NCT04671901|Memorial Sloan Kettering Cancer Center|Dr. Michael Ortiz MD|212-639-6057|ortizm2@mskcc.org|
22288144|NCT00626106|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22288145|NCT03472885|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22288146|NCT05417438|UMass Chan Medical School|Reem Najjar|7742750890|Reem.najjar@umassmed.edu|
22288147|NCT02845297|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivana Gojo|410-502-8775|igojo1@jhmi.edu|
22288148|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com|
22288149|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22288150|NCT03312634|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22288151|NCT04610281|Ullo World|Dr. Brigitte Laurent|+33782096875|brigitte@ullo.fr|
22288152|NCT01942837|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
22288153|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22288154|NCT02648919|University of Hawaii Cancer Center|Stacy Mercado, IIT/ Education Manager|8084404561|smercado@cc.hawaii.edu|
22288155|NCT05887388|University of North Carolina at Chapel Hill|Mark Toles, PhD|919-966-5684|mtoles@email.unc.edu|
22288156|NCT01424215|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22288157|NCT01458392|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288158|NCT00918255|Abbott|Global Medical Services|800-633-9110||
22288159|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22288160|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
22288161|NCT03250273|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22288162|NCT04154904|Oregon Health and Science University|Jessica Castle|1503-494-7072|castleje@ohsu.edu|
22288163|NCT02392624|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288164|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22288165|NCT04441892|Mayo Clinic|Dr. Michael J. Ackerman|507-284-8900|ackerman.michael@mayo.edu|
22288166|NCT03841604|Zambon SpA|Elena Tiberio, BSc|+39 02665241|clinicaltrials@zambongroup.com|
22288167|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov|
22288168|NCT03877510|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
22288169|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org|
22288170|NCT03763877|Poxel|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
22288171|NCT03040336|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
22288172|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com|
22288173|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org|
22288174|NCT02930824|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
22288175|NCT02086500|University of Pittsburgh|Dr. Jason Sperry MD, MPH|4128028270|sperryjl@upmc.edu|
22288176|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288177|NCT03938259|Baylor College of Medicine7|Dr. Adam Adler|832-824-5801|Adam.adler@bcm.edu|
22288178|NCT01213472|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
22288179|NCT02121158|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Michael T. Wininger, Ph.D., Study Biostatistician|203-932-5711|michael.wininger@va.gov|3262
22288180|NCT02435992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22288181|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22288182|NCT05131308|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
22288183|NCT04757766|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
22288184|NCT04771455|Northwestern University|Dr. Andrea Graham|312-503-5266|andrea.graham@northwestern.edu|
22288185|NCT01210313|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
22288186|NCT03982355|IMperial COllege London|Dr SImon Dryden|+447828464949|simon.dryden@imperial.ac.uk|
22288187|NCT02226367|VA Puget Sound Health Care System|Murray Raskind, MD|(206) 277-3797|Murray.Raskind@va.gov|
22288188|NCT03773978|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22288189|NCT03113487|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22288190|NCT03777982|Dana Farber/Mass General Brigham Cancer Care|Anthony D'Amico|857-215-1489|adamico@bwh.harvard.edu|
22288191|NCT01502293|OncoSec Medical Incorporated|Kellie Malloy, Chief Clinical Development Officer|858-375-9989|kmalloy@oncosec.com|
22288192|NCT03710187|University of Tennessee Medical Center|Pharm D, Pharmacist Specialist, Critical Care|865-305-9134|swinters@utmck.edu|
22288193|NCT01318577|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
22288194|NCT03944577|University of Nebraska Medical Center|Douglas Stoller|402-559-0815|douglas.stoller@unmc.edu|
22288195|NCT02596867|TTUHSC-EP|Zeina Nahleh|9152155195|zeina.nahleh@ttuhsc.edu|
22288196|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU|
22288197|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu|
22288198|NCT03011099|UT health PM&R|Chang, Shuo-Hsiu, PT, PhD|713-799-7016|Shuo-Hsiu.Chang@uth.tmc.edu|
22288199|NCT02968758|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
22288200|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com|
22288201|NCT03058146|University of California, San Diego|Dr. Zvinka Zlatar|858-822-7737|zzlatar@health.ucsd.edu|
22288202|NCT03041181|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22288203|NCT02667119|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
22288204|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com|
22288205|NCT04123470|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
22288206|NCT03818256|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
22288207|NCT02749422|NYU Langone Health|Anli Liu|929-455-2340|Anli.Liu@nyulangone.org|
22288208|NCT00911170|Amgen Inc.|Study Director|866-572-6436||
22288209|NCT02681523|Imperial College London|Laura Kenny|+44 (0)20 7594 2806|l.kenny@imperial.ac.uk|
22288210|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316|hlpark@ilyang.co.kr|7316
22288211|NCT03641937|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22288212|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
22288213|NCT02937116|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22288214|NCT02079246|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22288215|NCT03666663|UCSF|Dr.Nina Riggins|7028064831|Nina.Riggins7@gmail.com|
22288216|NCT03591406|Vifor (International) Inc.|VIT-IRON-2011-004 Clinical Study Team|+41 58 851 80 00|VIT-IRON-2011-004.study@viforpharma.com|
22288217|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288218|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com|
22288219|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565||
22288220|NCT04082819|SE Health|SE Research Centre|N/A|research@sehc.com|
22288221|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300||
22288222|NCT02505919|PROCEPT BioRobotics Corporation|Angela Lee|6502327215|a.lee@procept-biorobotics.com|
22288223|NCT03124342|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22288224|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
22288225|NCT02696967|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22288226|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
22288227|NCT01705509|Cardiovascular Institute of the South|Agostino Ingraldi, MD, FACC|337-988-1585|Agostino.Ingraldi@cardio.com|
22288228|NCT00904033|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22288229|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288230|NCT02736890|Icahn School of Medicine at Mount Sinai|Dr. Thomas Bryce|212-241-6321|thomas.bryce@mountsinai.org|
22288231|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu|
22288232|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288233|NCT03077412|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22288234|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22288235|NCT02351856|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288236|NCT04939714|Emory University|Carolyn Clevenger, DMP, APRN|404-712-2394|carolyn.clevenger@emory.edu|
22288237|NCT03762993|Purdue University|Preeti Sivasankar|765-494-3788|preeti@purdue.edu|
22288238|NCT02993107|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22288239|NCT03038100|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288240|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288241|NCT03906448|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
22288242|NCT01774721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288243|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288244|NCT00248040|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22288245|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com|
22304161|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288246|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org|
22288247|NCT02978781|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22288248|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288249|NCT04827680|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22288250|NCT02054104|National Cancer Institute|Dr. David Schrump|240-858-7000|schrumpd@mail.nih.gov|
22288251|NCT03134703|Johns Hopkins All Children's Hospital|Sandra Brooks, MD|727-767-4313|sbrook36@jhmi.edu|
22288252|NCT00084136|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22288253|NCT03543878|Georgia Institute of Technology|Annabelle C. Singer, PhD|510-501-9659|asinger@gatech.edu|
22288254|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
22288255|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com|
22288256|NCT02633306|University of Minenesota|Stephen Haines, MD|612 624-6666|shaines@umn.edu|
22288257|NCT02131259|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288258|NCT02191111|University of Mississippi|Dr. Meagen Rosenthal|662-915-2475|mmrosent@olemiss.edu|
22288259|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu|
22288260|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com|
22288261|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22288262|NCT03879772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288263|NCT02989597|Montefiore Medical Center|Dr. Andrew J. Kobets|718-920-7400|akobets@montefiore.org|
22288264|NCT03856788|Icahn School of Medicine at Mount Sinai|Christina Jeng, MD, FASA|212) 241-6426|christina.jeng@mountsinai.org|
22288265|NCT03415685|Lutronic|Alexander Denis, Global Manager of Clinical Research|9788959206|adenis@lutronic.com|
22288266|NCT01834911|New York Medical College|Dr. Robert Fekete|9143451313|robert_fekete@nymc.edu|
22288267|NCT03941288|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22288268|NCT00389610|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
22288269|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22288270|NCT03131570|ROCKEFELLER UNIVERSITY|Dr. James G. Krueger|2123277409|KRUEGEJ@MAIL.ROCKEFELLER.EDU|
22288271|NCT04596267|Boston Medical Center|Dr. Eric Devine|617-418-7888|eric.devine@bmc.org|
22288272|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
22288273|NCT02698215|University of California Los Angeles|Lara Ray, PhD|310-794-5383|lararay@psych.ucla.edu|
22288274|NCT05261386|ADS Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
22288275|NCT04189952|University of Miami|Craig Moskowitz, MD|305-243-9009|chm78@med.miami.edu|
22288276|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22288277|NCT04916587|University of Colorado, Denver|Dr. Monica Perez Jolles|303-724-0829|monica.jolles@cuanschutz.edu|
22288278|NCT04475081|Louisiana State University Health - New Orleans|Associate Dean for Research|9858693445|pfidel@lsuhsc.edu|
22304162|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu|
22304163|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk|
22288279|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu|
22288280|NCT03536572|VA San Diego Healthcare System|Carl J. Stepnowky, Deputy ACOS R&D|858-642-3269|carl.stepnowsky@va.gov|
22288281|NCT02180100|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86755-83923333|fanshangrong@163.com|5502
22288282|NCT04672239|Recovery Research Institute, Department of Psychiatry, Massachusetts General Hospital|Bettina B. Hoeppner, Ph.D., MS|617-643-1988|bhoeppner@mgh.harvard.edu|
22288283|NCT01551186|Washington University School of Medicine, St. Louis, Missouri|Dr. Erik Dubberke, MD, MSPH|314-454-8354|edubberk@wustl.edu|
22288284|NCT03866577|Momenta Pharmaceuticals, Inc.|Senior Director Clinical Development Head Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22288285|NCT04825678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22288286|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288287|NCT05430854|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22288288|NCT04223479|The University of Jordan|Lana M. Agraib|+962|lanamg2007@yahoo.com|00000
22288289|NCT01824836|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22288290|NCT03253393|University of New South Wales|Dr Jacqueline Tan|+612 9385 6551|jacqueline.tan@unsw.edu.au|
22288291|NCT03593044|The Ohio State University College of Optometry|Dr. Jeffrey Walline|(614) 247-6840|walline.1@osu.edu|
22288292|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
22288293|NCT05291520|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288294|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu|
22288295|NCT01615120|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22288296|NCT05462756|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22288297|NCT04375085|Elixir Medical Corp|Candace Elek, EVP Clinical Research|4086362000|celek@elixirmedical.com|
22288298|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
22288299|NCT02144610|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
22288300|NCT02169427|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22288301|NCT02409277|University of Utah|Flory Nkoy|801-662-3660|flory.nkoy@hsc.utah.edu|
22288302|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com|
22288303|NCT00420771|NYSPI|John J. Mariani, MD|212-543-5987|jm2330@columbia.edu|
22288304|NCT01432730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288305|NCT03881852|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22288306|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22288307|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22288308|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu|
22288309|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
22288310|NCT02653417|Radius Pharmaceuticals, Inc.|Clinical Operations|617-551-4000|clinopsinfo@radiuspharm.com|
22288311|NCT04591353|University of Alabama at Birmingham|Promil Kukreja|205-934-4042|Pkukreja@uab.edu|
22288312|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com|
22288313|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288314|NCT04790916|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22288315|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il|
22288316|NCT03847896|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22288317|NCT02395471|Medtronic MITG Gastrointestinal & Hepatology|Dr.Jaime Kean|303-882-6759|Jaime.M.Kean@medtronic.com|
22288318|NCT02035267|Allergan, Inc|Beta Bowen|1-714-246-4446|Bowen_Beta@allergan.com|
22288319|NCT04803396|Dompé farmaceutici SpA|dr. Mauro P. Ferrari|+39 02 583831|clinops@pec.dompe.it|
22288320|NCT03038880|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288321|NCT02885025|VA Greater Los Angeles Healthcare System|Joseph Yusin Chief division Allergy Immunology|3104783711|joseph.yusin2@va.gov|40230
22288322|NCT03926611|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22288323|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22288324|NCT02612779|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22288325|NCT02004041|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22288326|NCT01657019|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22288327|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
22288328|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22288329|NCT00763035|Wake Forest University Health Sciences|Gregory Hundley|+1 (336) 716-0607|ghundley@wakehealth.edu|336
22288330|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com|
22288331|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com|
22288332|NCT02900378|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22288333|NCT01134055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288334|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu|
22288335|NCT03345784|University Health Network, Princess Margaret Cancer Centre|Dr. Stephanie Lheureux, PI|416-946-2818|stephanie.lheureux@uhnresearch.ca|
22288336|NCT00571493|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
22288337|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
22288338|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22288339|NCT04298697|Emory University|Colleen Kelley, MD, MPH|404-712-1823|colleen.kelley@emory.edu|
22288340|NCT03995368|VA Greater Los Angeles Healthcare System|Dr. Jonathan K. Wynn|3104783711|Jonathan.Wynn@va.gov|44957
22288341|NCT03592186|Brown University School of Public Health|Sara Becker, Ph.D, Principal Investigator|4018636604|sara_becker@brown.edu|
22288342|NCT03755934|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22288343|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70||
22288344|NCT04266717|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
22288345|NCT00361296|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
22288346|NCT02594124|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22288347|NCT05523089|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
22288348|NCT05530252|BeijingSHCMU|Dr.Nannan Han|15701545851|qhddenver@126.com|
22288349|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288350|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org|
22288351|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22288352|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu|
22288353|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca|
22288354|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288355|NCT04040933|Johnson & Johnson Consumer Inc. (J&JCI)|Robin Mathew|908-904-5034|rmathew1@its.jnj.com|
22288356|NCT02066181|Memorial Sloan-Kettering Cancer Center|Mrinal Murugesan Gounder M.D.|646-888-4167|gounderm@mskcc.org|
22288357|NCT02393378|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288358|NCT05764785|University of Massachusetts Boston|Dr. Jean Rhodes|(617) 620-9147‬|jean.rhodes@umb.edu|
22288359|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org|
22288360|NCT02141295|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22288361|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288362|NCT02536976|Struthers Parkinson's Center|Dr. Sotirios Parashos|001-952-993-5495|sotirios.parashos@parknicolet.com|
22288363|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392|genevieve.chene@isped.u-bordeaux2.fr|+33
22288364|NCT01671319|University of Wisconsin Carbone Cancer Center|Dr. Amyé Tevaarwerk|608-262-2837|at4@medicine.wisc.edu|
22288365|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590||
22288366|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050|ataghian@partners.org|24369
22288367|NCT02904954|Weill Cornell Medicine|Cathy Spinelli, RN BSN|212-746-3328|caf2007@med.cornell.edu|
22288368|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu|
22288369|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|58124
22288370|NCT00706238|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288371|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22288372|NCT03819114|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22288373|NCT04226742|University of California, Irvine|Stephen Schueller|949-824-3850|s.schueller@uci.edu|
22288374|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa|
22288375|NCT05097963|Mayo Clinic|Vinay Chandrasekhara, M.D.|507-284-2687|Chandrasekhara.Vinay@mayo.edu|
22288376|NCT02492763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288377|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288378|NCT03848832|GW Research Ltd|Medical Enquiries|1-833-424-6724|medinfo@gbio.com|
22288379|NCT00865566|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22288380|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22288381|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300||
22288382|NCT03252925|The First Affiliated Hospital of Soochow University|Yue Han|13901551669|hanyue@suda.edu.cn|
22288383|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com|
22288384|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22288385|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu|
22288386|NCT00521404|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22288387|NCT04555616|University of Kentucky|Elizabeth Rhodus|859-257-5567|elizabeth.rhodus@uky.edu|
22288388|NCT03089281|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
22288389|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
22288390|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com|
22288391|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288392|NCT02404025|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
22288393|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org|
22304164|NCT03687450|Brigham and Women's Hospital|Julia Loewenthal, MD|6177325500|jloewenthal@bwh.harvard.edu|
22304165|NCT04963062|University of Wisconsin School of Medicine and Public Health|Shuang Li|608.263.8336|lis@urology.wisc.edu|
22304166|NCT03985098|University of Houston|Susan Abughosh|832-842-8395|smabughosh@uh.edu|
22304167|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22304168|NCT02708641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22304169|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629||
22304170|NCT02054247|Eskisehir Osmangazi University|Dr. Onur Armagan|00902222392979|dronurarmagan@hotmail.com|
22304171|NCT05257837|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22304172|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu|
22304173|NCT05675709|Oregon Health & Science University|Susan Flocke|503 494 4404|fmresrch@ohsu.edu|
22304174|NCT04758403|BIDMC|Adnan Majid|617-632-8386|tsipresearchstaff@bidmc.harvard.edu|
22304175|NCT01033773|MedStar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
22304176|NCT01254565|Amgen, Inc|Study Director|866-572-6436||
22304177|NCT02367014|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
22304178|NCT02774265|University of Maryland Medical Center|Dr. Bryce Haac|410-328-3495|bhaac@som.umaryland.edu|
22304179|NCT02726399|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22304180|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu|
22304181|NCT03468426|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304182|NCT03123263|TTUHSC-El Paso|Sumit Gaur|9152155200|sumit.gaur@ttuhsc.edu|
22304183|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304184|NCT02268552|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22304185|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu|
22304186|NCT04168385|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
22304187|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com|
22304188|NCT02971891|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22304189|NCT02748512|Axiom|Kelley Collins-Winters, RTR, BS, MBA|469-667-6655|kelleyc@axiom.cc|
22304190|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu|
22304191|NCT04990687|UAB|Samantha White|205-934-1989|swwhite@uabmc.edu|
22304192|NCT02900781|Texas Tech University Health Sciences Center|Nancy Swinford CCRC|8067432569|nancy.swinford@ttuhsc.edu|
22304193|NCT01754779|UT Southwestern Medical Center|Dr. Naim Maalouf|214/648-2954|naim.maalouf@utsouthwestern.edu|
22304194|NCT05818540|Bleep, LLC|Stuart Heathington|919-619-7170|stuart@bleepsleep.com|
22304195|NCT02339389|Brigham and Women's Hospital|Bhavani Kodali|6175258449|bkodali@partners.org|
22304196|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22304197|NCT01041508|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22304198|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100|wen-chih.wu@va.gov|6237
22304199|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304200|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk|
22304201|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304202|NCT04496167|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22304203|NCT00598481|Fondazione Telethon|Fondazione Telethon||cvezzali@telethon.it|
22304204|NCT04612049|University of Montreal|Dr Danielle Levac|5148639108|danielle.levac@umontreal.ca|
22304205|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com|
22304206|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22304207|NCT02501759|OHSU Knight Cancer Institute|Fegus Coakley|503-494-2333|coakleyf@ohsu.edu|
22304208|NCT02408549|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22304209|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
22304210|NCT02025205|Pulmonx|Narinder Shargill, Vice President, Global Medical and Clinical Affairs|650-216-0108|nshargill@pulmonx.com|
22304211|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22288394|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov|
22288395|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
22288396|NCT01750229|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
22288397|NCT03774576|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288398|NCT01746901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288399|NCT03594110|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288400|NCT03041038|Northwestern University|Dr. Amy Paller|3126953721|NUderm-research@northwestern.edu|
22288401|NCT02796170|Tulane University|Dragana Lovre|(504)988-9928|dlovre@tulane.edu|
22288402|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288403|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22288404|NCT00930046|Boston Children's Hospital|Dr. Navil Sethna|781-216-1650|navil.sethna@childrens.harvard.edu|
22288405|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org|
22288406|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262|chungka@ohsu.edu|51091
22288407|NCT03769519|Duke|Isaretta L. Riley, MD, MPH|919-286-0411|isaretta.riley@duke.edu|
22288408|NCT03429270|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
22288409|NCT04798196|UW-Madison|Gina Landucci|(608) 890-1440|gina.landucci@wisc.edu|
22288410|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22288411|NCT03114683|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22288412|NCT03066947|BriaCell Therapeutics Corporation|Dr. William Williams|1-888-485-6340|williams@briacell.com|
22288413|NCT01615484|University of North Carolina at Chapel Hill|Thomas Egan, MD, MSc, FACS|919-966-3381|thomas_egan@med.unc.edu|
22288414|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org|
22288415|NCT01967940|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22288416|NCT01550003|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22288417|NCT05567783|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22288418|NCT05005182|Mayo Clinic|Abhishek Mangaonkar|507-538-0173|Mangaonkar.Abhishek@mayo.edu|
22288419|NCT03675126|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
22288420|NCT00940771|Bill Holt Clinic, Phoenix Children's Hospital|Janice Piatt, MD, Medical Director|602-933-0955|jpiatt@phoenixchildrens.com|
22288421|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu|
22288422|NCT02593006|Hackensack University Medical Center|Yukiko Kimura MD|551-996-5306|yukiko.kimura@hackensackmeridian.org|
22288423|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22288424|NCT02252666|University of Wisconsin - Madison|Dr. Mitchell Tyler|(608) 262-5112|metyler1@wisc.edu|
22288425|NCT02072668|University of Tennessee Center for the Heath Sciences|Dr. Kenneth Ataga|901.448.3181|kataga@uthsc.edu|
22288426|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288427|NCT02431637|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
22288428|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288429|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22288430|NCT04322526|University of Pittsburgh|Dr. Marta Pecina|734-945-2473|pecinam@upmc.edu|
22288431|NCT03205423|New York State Psychiatric Institute|Jermaine Jones|7577533212|jermaine.jones@NYSPI.Columbia.edu|
22288432|NCT02083354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22288433|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22288434|NCT02453321|University of Pittsburgh Medical Center|Kevin King, DO - Clinical Asst. Professor|412 748-5589|kingkk@upmc.edu|
22288435|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
22288436|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22288437|NCT01943903|HeartFlow|VP, Clinical|408-314-2335|smullen@heartflow.com|
22288438|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22288439|NCT02106390|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288440|NCT02968004|OPKO Health, Inc.|OPKO Health, Inc.|3055754100|contact@opko.com|
22288441|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
22288442|NCT00803569|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22288443|NCT02504151|Yale|Dr. Mohini Ranganathan|(203)932-5711|mohini.ranganathan@yale.edu|2546
22288444|NCT00538902|Abbott|Global Medical Services|800-633-9110||
22288445|NCT01454102|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22288446|NCT02148874|The Ohio State University Wexner Medical Center|Lisa Christian, PhD|614-293-0936|lisa.christian@osumc.edu|
22288447|NCT01782378|VA Boston Healthcare System, Jamaica Plain Campus, Boston, MA|Margaret Naeser, PhD|857-364-4030|Margaret.Naeser@va.gov; mnaeser@bu.edu|
22288448|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22288449|NCT02233517|VAORD|Elizabeth Van Voorhees|(919) 286-0411|elizabeth.vanvoorhees@va.gov|6435
22288450|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22288451|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22288452|NCT04109547|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22288453|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu|
22288454|NCT04008745|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
22288455|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl|
22288456|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22288457|NCT02668653|Daiichi Sankyo Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22288458|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22288459|NCT04119414|University of Miami|Stephen Weiss|7862108684|sweiss2@med.miami.edu|
22288460|NCT02054689|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22288461|NCT00999102|NY Presbyterian Hospital - Weill Cornell Medical Center|Dr. Samuel Mann, PI|212-746-2200|sjmann@med.cornell.edu|
22288462|NCT03678493|University of Minnesota, Masonic Cancer Center|Armin Rashidi, MD, PhD|(612) 273-8383|arashidi@umn.edu|
22288463|NCT01808456|Inova Fairfax Hospital|Dr. Ravinder Wali|7037764001|ravinder.wali@inova.org|
22288464|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288465|NCT03146585|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
22288466|NCT00993967|Santhera Pharmaceuticals|Thomas Meier, PhD|+41 61 906 89 50|thomas.meier@santhera.com <Thomas.Meier@santhera.com>|
22288467|NCT03714880|University of Pittsburgh|Suji Uhm, MD, MPH|412-641-4590|uhms@upmc.edu|
22288468|NCT03352609|MUSC|Dr Friedrich|843-792-9888|friedric@musc.edu|
22288469|NCT03507569|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288470|NCT03815929|Principle Investigator|Dr. Ekta Kapoor|507 538-7103|kapoor.ekta@mayo.edu|
22288471|NCT03313037|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288472|NCT02760498|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22288473|NCT02205736|Levine Cancer Institute at Carolinas Healthcare System|Dr. James Symanowski|9804422371|james.symanowski@carolinashealthcare.org|
22288474|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com|
22288475|NCT04792645|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
22288476|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov|
22288477|NCT00664443|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22288478|NCT01899040|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22288479|NCT03712358|Istari Oncology|Lisa Franklin|919-245-7662|lfranklin@istarioncology.com|
22288480|NCT02638220|Travere Therapeutics, Inc.|Cheryl Wong Po Foo/Director, Clinical Development|8889697879|cheryl.wongpofoo@travere.com|
22288481|NCT04051996|Yale University|Dr. Amer Zeidan|(203) 200-4363|amer.zeidan@yale.edu|
22288482|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
22288483|NCT02153632|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|9088091357|gwagner@osmotica.ccom|
22288484|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il|
22288485|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu|
22288486|NCT04323124|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288487|NCT04586205|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
22288488|NCT06904586|Duzce University|Assistant Professor|+905059313588|gizem123demir@hotmail.com|
22288489|NCT04684836|Vanderrbilt University|Jessica Ancker, MS, PhD|(615) 322-5000|jessica.s.ancker@vumc.org|
22288490|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288491|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971||
22288492|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288493|NCT02113982|Stemline Therapeutics, Inc.|Ira Gupta, MD|877-332-7967|clinicaltrials@menarinistemline.com|
22288494|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288495|NCT01394003|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22288496|NCT03537404|R-Pharm|Emiliya Krasavina, Medical Adviser|0074959567937|krasavina@rpharm.ru|
22288497|NCT00068692|ECOG-ACRIN statistical office|Statistician||eatrials@jimmy.harvard.edu|
22288498|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu|
22288499|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22288500|NCT03481595|Cleveland Clinic Florida|Carlos Higuera|9546595430|higuerc@ccf.org|
22288501|NCT03557034|Cleveland Clinic|Khaldoun Tarakji, MD, MPH|216-445-9225|TARAKJK@ccf.org|
22288502|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
22288503|NCT02301416|Wake Forest School of Medicine|Jamy Ard|336-716-9837|jard@wakehealth.edu|
22288504|NCT04816552|Johns Hopkins School of Public Health|Dr. Christine Marie George|(202) 657-5798|cmgeorge@jhu.edu|
22288505|NCT01938716|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|713-792-2828|gvaradha@mdanderson.org|
22288506|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22288507|NCT02446899|AstraZeneca AB|Global Clinical Lead|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22288508|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es|
22288509|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288510|NCT05488535|Advanced Bionics|Emily Cardenas, Au.D.|16616785405|Emily.Cardenas@advancedbionics.com|
22288511|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu|
22288512|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532|arden.mcallister@uphs.upenn.edu|267
22288513|NCT03910244|Cleveland Clinic|Keith McCrae, MD|216-445-7809|mccraek@ccf.org|
22288514|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22288515|NCT04455815|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22288516|NCT03977818|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
22288517|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
22288518|NCT03219528|University of Michigan|Allen Lee|734-936-4785|allenlee@med.umich.edu|
22288519|NCT03809104|Ci-Shan Hospital, Health and Welfare of Minister, Taiwan|Ms. Chia-Yu Wei|+886-7-6615523|ivywei@chis.mohw.gov.tw|1729
22288520|NCT00790842|PrECOG|PrECOG Statistician|978-835-3516|jbmanola@gmail.com|
22288521|NCT05029362|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD, MSc, DrPH|(713) 500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
22288522|NCT03734692|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22288523|NCT05571605|University of North Texas|Dr. Justin Sprick|940-565-2226|justin.sprick@unt.edu|
22288524|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22288525|NCT05050227|VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine|Lucinda B. Leung, MD, PhD, MPH|310-478-3711|lleung@mednet.ucla.edu|
22288526|NCT04288661|1st Propaedeutic Surgery Department,Hippocration Hospital,University of Athens, Greece|Dr Maria Malvina Eleftheriou|+30 6945176503|malvina_el@hotmail.com|
22288527|NCT03126591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22288528|NCT02115048|Translational Research In Oncology (TRIO)|Director, Project Management|+33 1 58 10 09 09|TRIO020.contact@trioncology.org|
22288529|NCT03722238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288530|NCT02085460|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22288531|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22288532|NCT02606643|Saint Louis University|Gary Furhman|314-977-2090|jathompson@slu.edu|
22288533|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com|
22288534|NCT02158546|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22288535|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it|
22288536|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
22288537|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org|
22288538|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org|
22288539|NCT03418714|Johns Hopkins University|Frederick Barrett|4105509777|fbarret2@jhmi.edu|
22288540|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22288541|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288542|NCT03122509|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
22288543|NCT04041414|University of Southern California|Jeremy Goldbach, PhD, LMSW|(213) 821-6460|goldbach@usc.edu|
22288544|NCT00665652|Dartmouth Hitchcock Medical Center|Elijah Stommel|603-650-5104|elijah.w.stommel@hitchcock.org|
22288545|NCT01526577|LG Life Sciences|Dong Yeop Shin|82 2 6924 3114|dongyeopshin@lgls.com|
22288546|NCT03060096|Wake Forest NCORP Research Base|Dr. Emily Dressler|336-716-0891|NCORP@wakehealth.edu|
22288547|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org|
22288548|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22288549|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu|
22288550|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
22288551|NCT01721044|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22288552|NCT03102437|Impulse Dynamics|Angela Stagg|18453592389|astagg@impulsedynamics.com|
22288553|NCT04351334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288554|NCT04355169|Shionogi Inc.|Shionogi Clinical Trials Administrator Clinical Support Help Line|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22288555|NCT02048670|Mayo Clinic|Dr. Devin L. McCaslin|507-284-3410|mccaslin.devin@mayo.edu|
22288556|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu|
22288557|NCT02420821|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22288558|NCT03129568|Okayama University Hospital|Dr. Hidemasa Oh|086-235-6506|hidemasa@okayama-u.ac.jp|6506
22288559|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22288560|NCT03987503|University of California, San Francisco|Dr. Meghan D. Morris, Associate Professor|415-574-0651|meghan.morris@ucsf.edu|
22288561|NCT03000608|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@santalispharmaceuticals.com|101
22288562|NCT02546388|University of Pennslyvania|Paco Bravo, MD|1-215-220-9494|Paco.Bravo@pennmedicine.upenn.edu|
22288563|NCT03801408|University of Arkansas for Medical Sciences|Sara Jones, Principal Investigator|501-526-7846|sljones@uams.edu|
22288564|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com|
22288565|NCT05069948|The University of Edinburgh and NHS Lothian|Aimun Jamjoom|0131 536 1000|v1ajamjo@ed.ac.uk|
22288566|NCT04410367|Blue Earth Diagnostics, Ltd.|Chief Medical Officer|+44 (0)1865 784 186|contact@blueearthDx.com|
22288567|NCT01899521|Atlanta VA Medical Center|Dr. Ashish Mehta|404-321-6111|Ashish.Mehta@va.gov|207133
22288568|NCT01588522|BPGbio Inc.|Bing Nie|617-588-1002|bing.nie@bpgbio.com|
22288569|NCT04504253|University of Utah|Brent Kious, MD|8015851418|brent.kious@hsc.utah.edu|
22288570|NCT04377659|Memorial Sloan Kettering Cancer Center|Dr. Boglarka Gyurkocza, MD|646-608-3768|gyurkocb@mskcc.org|
22288571|NCT02855125|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
22288572|NCT04467905|Milestone Pharmaceuticals Inc.|Leonid Kokovin-Sher|1 450-912-6783|lkokovin-sher@milestonepharma.com|
22288573|NCT05370495|Seinda|Jing-Feng Huang, Ph.D.|1.858.254.9188|jfhuang@SeindaPharm.com|
22288574|NCT02514083|National Heart Lung and Blood Institute (NHLBI)|Inhye Ahn, M.D.|301-827-1203|inhye.ahn@nih.gov|
22288575|NCT02017405|Entera Health, Inc.|Audrey L. Shaw, Ph.D.|919 971 8000|audrey.shaw@enterahealth.com|
22288576|NCT03894124|Chelsea and Westminster NHS Foundation Trust|Research Operations Manager|+442033156825|chelwest.research@nhs.net|
22288577|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288578|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
22288579|NCT04953728|University of Michigan|Jiande Chen|734-764-3880|cjiande@med.umich.edu|
22288580|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22288581|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288582|NCT00214890|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
22288583|NCT02540629|Seoul National University Hospital|Dr. Jeong Ho Park|+821035426282|timthe@gmail.com|
22288584|NCT03349034|Icahn School of Medicine at Mount Sinai|Dr. Brett Miles|(212) 241-9410|brett.miles@mountsinai.org|
22288585|NCT01759446|Acura Pharma|Dr. Al Brzeczko|847-705-7709|abrzeczko@acurapharm.com|
22288586|NCT01760733|Telemark Hospital Trust|MD, PhD Kristian Heldal|+4790018417|hkri@ous-hf.no|
22288587|NCT03403283|University of Alabama at Birmingham|maria grant|13528714314|mariagrant@uabmc.edu|
22288588|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590||
22288589|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22288590|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
22288591|NCT01908062|Oregon Health & Science University|Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22288592|NCT03584789|HealthPartners Institute|D. Brad Rindal, DDS, Associate Dental Director Research|952-967-5026|donald.b.rindal@healthpartners.com|
22288593|NCT01357525|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22288594|NCT04646044|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22288595|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288596|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22288597|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org|
22288598|NCT01051518|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
22288599|NCT04730271|DePuy Synthes|Ian Leslie|N/A|ileslie1@its.jnj.com|
22288600|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288601|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22288602|NCT02350296|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22288603|NCT04396639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288604|NCT01544335|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|6177240127|cbrunelle@mgh.harvard.edu|
22288605|NCT00124514|cincinnatichildrens|Hermine Brunner|5136367982|hermine.brunner@cchmc.org|
22288606|NCT02488915|Neuravi Ltd|Mairsíl Claffey|0035391394123|mclaffey@neuravi.com|
22288607|NCT01532986|VA Greater Los Angeles Healthcare System|Eric M Cheng|3102067671|echeng@mednet.ucla.edu|
22288608|NCT03408392|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288609|NCT03216512|Duke University|Dr Scott Kollins|919-681-0014|scott.kollins@duke.edu|
22288610|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288611|NCT03771664|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22288612|NCT02120898|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22288613|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288614|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov|
22288615|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
22288616|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22288617|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
22288618|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
22288619|NCT01749215|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki|415-221-4810|steven.batki@ucsf.edu|23671
22288620|NCT02382705|University of British Columbia|Dr. Robert Enns|604 688 6332|cgalorport@gmail.com|
22288621|NCT02556177|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
22288622|NCT04320316|University of Alabama at Birmingham|M.D|12056389107|hdabdullatif@uabmc.edu|
22288623|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com|
22288624|NCT03818321|TriHealth|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22288625|NCT00275509|New York University Langone Transplant Institute|Robert Montgomery, MD|646-501-2418|Robert.Montgomery@nyumc.org|
22288626|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov|
22288627|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288628|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810|shira.maguen@va.gov|22511
22288629|NCT01278212|Medical University of South Carolin|Harriet Eldredge-Hindy|8437926382|eldredge@musc.edu|
22288630|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu|
22288631|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu|
22288632|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com|
22288633|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org|
22288634|NCT00926237|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
22288635|NCT02911844|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
22288636|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22288637|NCT02535806|Children's Mercy Hospital|Dr. Keith August|816-302-6808|kjaugust@cmh.edu|
22288638|NCT00432172|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22288639|NCT02331277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288640|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120|dmutch@uoguelph.ca|53322
22288641|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22288642|NCT01732718|University of North Carolina at Chapel Hill|Kenneth Ataga, MD|901-448-2813|kataga@uthsc.edu|
22288643|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com|
22288644|NCT04050202|University of California, San Francisco|Danielle Roubinov, PhD|919-843-5898|danielle.roubinov@ucsf.edu|
22288645|NCT04287036|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
22288646|NCT04211909|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22288647|NCT02690948|Stanford University|Anne Lynn S. Chang, Associate Professor of Dermatology|650-721-7151|alschang@stanford.edu|
22304212|NCT01232556|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288648|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
22288649|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr|
22288650|NCT03449667|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22288651|NCT03196349|Duke University|Dr. Thomas Ortel|919-684-5350 ext 3|thomas.ortel@duke.edu|
22288652|NCT01963078|MUSC|Dr. Megan Moran-Santa Maria|843-817-6233|moranm@musc.edu|
22288653|NCT03388164|Laureate Institute for Brain Research|Teresa Victor|918-502-5108|tvictor@laureateinstitute.org|
22288654|NCT02210039|Massachusetts General Hospital|Guillermo Tearney, PI|617-724-2979|gtearney@partners.org|
22288655|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu|
22288656|NCT00499083|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
22288657|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu|
22288658|NCT01254422|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
22288659|NCT00643162|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
22288660|NCT04587661|University of Pittsburgh|Dr. Charles Jonassaint|+14125869850|cjonassaint@pitt.edu|
22288661|NCT02415608|Stanford University Medical Center|Jason Robert Gotlib, MD; Professor of Medicine (Hematology)|650-498-6000|C.Langford@stanford.edu|
22288662|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22288663|NCT01812252|Fred Hutch Cancer Center|Bart Lee Scott M.D.|(206)909-0977|bscott@fredhutch.org|
22288664|NCT03023397|University of North Carolina at Chapel Hill|Allison Burbank, MD|919-962-5136|allison_burbank@med.unc.edu|
22288665|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288666|NCT00363480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288667|NCT05465317|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22288668|NCT04634253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22288669|NCT03133793|Sponsored Programs Adminstration (SPA)|Dr. Mario Medina, Director of Sponsored Programs Administration|913-588-5724|mmedina3@kumc.edu|
22288670|NCT03486834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288671|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
22288672|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22288673|NCT02379091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288674|NCT02053376|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22288675|NCT03326713|Rutgers Cancer Institute|Anita Y. Kinney, PhD|(732) 865-3375|anita.kinney@rutgers.edu|
22288676|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465||
22288677|NCT03067077|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22288678|NCT02529072|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
22288679|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov|
22288680|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304213|NCT04172987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304214|NCT03020095|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
22304215|NCT03785340|Ocugen|Vijay Tammara, VP, Strategic regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
22304216|NCT02500316|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22288681|NCT02129699|European Thoracic Oncology Platform|European Thoracic Oncology Platform|+41 31389 93 91|SPLENDOUR@etop-eu.org|
22288682|NCT01394016|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22288683|NCT03534804|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22288684|NCT02530515|UT MD Anderson Cancer Center|Dr. Chitra Hosing / Stem Cell Transplantation|(713) 745-3219|cmhosing@mdanderson.org|
22288685|NCT04161157|University of Kentucky|Dr. Laurie McLouth|859-562-2526|laurie.mclouth@uky.edu|
22288686|NCT03752567|Farmacia La Regina|Dr. Raffaele La Regina|+393389066138|raffaele.laregina@gmail.com|
22288687|NCT04858035|Montclair State University|Elaine R. Hitchcock|9732293797|hitchcocke@montclair.edu|
22288688|NCT06482125|Universitas Pelita Harapan|Dr. Corry Quando Yahya|2181383190900|corry.yahya@lecturer.uph.edu|
22288689|NCT05353777|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22288690|NCT05174416|Peking Union Medical College Hospital|Prof. Shuyang Zhang|+86 13911667211|shuyangzhang103@163.com|
22288691|NCT02833233|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Comen|646-888-4525|comene@mskcc.org|
22288692|NCT02991768|University of Kansas Medical Center|Clinical Research Coordinator|913-588-3520|edelaney2@kumc.edu|
22288693|NCT04701762|Cleveland Clinic|Kurt Ruetzler|216 407-4108|ruetzlk@ccf.org|
22288694|NCT05786651|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
22288695|NCT05030129|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
22288696|NCT02538510|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
22288697|NCT03397966|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|615-343-7592|alp.ikizler@vumc.org|
22288698|NCT01350401|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
22288699|NCT02273596|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22288700|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
22288701|NCT02139592|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288702|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net|
22288703|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com|
22288704|NCT06131476|Johnson & Johnson Vision Care|Principal Research Optometrist, Clinical Sciences|1 800-843-2020|njoshi30@its.jnj.com|
22288705|NCT02873702|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288706|NCT01177397|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22288707|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw|
22288708|NCT03085797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288709|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
22288710|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu|
22288711|NCT05661409|Emory University|Dr. Matthew K. Whalin|404-616-5014|mwhalin@emory.edu|
22288712|NCT03198507|Redhill Biopharma Inc.|June Almenoff, Chief Scientific Officer|(984) 444 7010|jalmenoff@redhillus.com|
22288713|NCT00724698|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22288714|NCT04614974|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
22288715|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu|
22288716|NCT00658359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288717|NCT02560558|Emory University|Dr. Idelberto Badell|404-712-6562|ibadell@emory.edu|
22288718|NCT02819804|Northwestern University|Shira Dinner, MD|312-695-6180|shira.dinner@nm.org|
22288719|NCT02858362|Summit Therapeutics|Clinical Disclosure|Please Email|clinicaltrials@summitplc.com|
22288720|NCT03967444|Galderma Research & Development, Aesthetics|Director of Clinical Operations|817-961-5655|aestheticclinicaltrials@galderma.com|
22288721|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288722|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288723|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22288724|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu|
22288725|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu|
22288726|NCT05038982|Johns Hopkins University|Shawn Kwatra|410-502-7546|skwatra1@jhmi.edu|
22288727|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
22288728|NCT04170608|FARAPULSE|Christopher Schneider|617-686-7661|kschneider@farapulse.com|
22288729|NCT01378871|Albert Einstein College of Medicine|Dr, Amit Verma||amit.verma@einsteinmed.edu|
22288730|NCT04355143|University of California Los Angeles|Reza Ardehali, MD, PhD|310-825-5280|rardehali@mednet.ucla.edu|
22288731|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com|
22288732|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22288733|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
22288734|NCT04032093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288735|NCT01356277|McGill University Health Centre|Dr. Bethany Foster|514-412-4461|bethany.foster@mcgill.ca|
22288736|NCT02565108|GW Research Ltd.|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22288737|NCT01310075|UT MD Anderson Cancer Center|Dr. Mark W Clemens, Associate Professor, Plastic Surgery|713-794-1247|mwclemens@mdanderson.org|
22288738|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com|
22288739|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu|
22288740|NCT02708186|Axovant Sciences GMBH|Senior Director of Clinical Research|1-833-296-8268|clinicaltrials@axovant.com|
22288741|NCT02745119|Hoffmann-La Roche|Medical Communications|616878333|global.trial_information@roche.com|+41
22288742|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu|
22288743|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22288744|NCT02536963|Rebiscan|CEO|857-600-0982|jgshaka@rebiscan.com|
22288745|NCT02425943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22288746|NCT02668393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288747|NCT02141204|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22288748|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
22288749|NCT01209325|University of California, San Francisco|Dr. Joel M. Palefsky|415-476-1574|jpalefsky@medicine.ucsf.edu|
22288750|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288751|NCT01285557|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22288752|NCT02582775|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
22288753|NCT03529422|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22288754|NCT02000115|Abbott Structural Heart|Daniella Corporan|779-220-7309|daniella.corporan@abbott.com|
22288755|NCT04815824|VA Eastern Colorado Health Care System|Dr. Sarah Wherry|303-704-8054|sarah.wherry@va.gov|
22288756|NCT02484391|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7970|bpowell@wakehealth.edu|
22288757|NCT04922216|University of North Carolina at Chapel Hill|Brooke Nezami, PhD|919-966-5852|bnezami@unc.edu|
22288758|NCT03278249|University of Cincinnati Cancer Center|Rekha Chaudhary, MD, Adjunct-Associate Professor of Medicine|513-558-2119|Rekha.chaudhary@uc.edu|
22288759|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
22288760|NCT02064582|UT Southwestern Medical Center|Kevin Courtney, MD|214-648-4180|Kevin.Courtney@utsouthwestern.edu|
22288761|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
22288762|NCT01136980|EndoGastric Solutions|Adrain Lobontiu|+16504749259|alobontiu@endogastricsolutions.com|
22288763|NCT03207763|Emory University|Evan Anderson, MD|404-727-1746|evanderson@emory.edu|
22288764|NCT02102204|Amgen Inc.|Study Director|866-572-6436||
22288765|NCT02605122|Cempra Pharmeuticals, a wholly owned subsidary of Melinta Therapeutics, Inc.|Melissa Allaband|9199140822|mallaband@melinta.com|
22288766|NCT00990704|Abbott|Global Medical Services|800-633-9110||
22288767|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com|
22288768|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491||
22288769|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
22288770|NCT01399372|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22288771|NCT03773796|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
22288772|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu|
22288773|NCT03805659|Medical College of Wisconsin|Peter Kraegel|414-955-0657|pkraegel@mcw.edu|
22288774|NCT03284307|University of Sydney|Robert Sanders, MBBS, PhD, FRCA|02 9036 3136|robert.sanders@sydney.edu.au|
22288775|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
22288776|NCT03249116|Tufts University|Dr. Megan K Mueller|508-887-4543|megan.mueller@tufts.edu|
22288777|NCT03762317|Hennepin County Medical Center|Dr. Kunal Gupta|6128732677|kunal.gupta@hcmed.org|
22288778|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422|milos.popovic@utoronto.ca|6305
22288779|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22288780|NCT02803580|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288781|NCT01358721|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22288782|NCT02636595|AbbVie|Global Medical Services|800-633-9110||
22288783|NCT02223858|Veterans Affairs Pittsburgh Healthcare System|Dr. Leslie R.M. Hausmann|412-360-2112|leslie.hausmann@va.gov|
22288784|NCT02297373|Ottawa Hospital|Dr Gregoire Le Gal|613-737-8899|glegal@toh.ca|
22288785|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu|
22288786|NCT04954833|Johnson & Johnson Vision Care, Inc. (JJVC)|Xu Cheng|1-800-843-2020|xcheng6@its.jnj.com|
22288787|NCT00831181|Beth Israel Medical Center|Dr Peter Kozuch|212 844-8282|pkozuch@chpnet.org|
22288788|NCT04313244|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22288789|NCT02976038|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22288790|NCT04048356|University of New Mexico|Peter Jeppson, site contact for study|505-967-8428|pjeppson@salud.unm.edu|
22288791|NCT05021978|Praxis Precision Medicines|Charmaine Manilay|2243996121|cmanilay@praxismedicines.com|
22288792|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com|
22288793|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
22288794|NCT04069702|Duke University|Sarah Kelleher, PhD|9194163405|sarah.kelleher@duke.edu|
22288795|NCT03096288|University of Florida College of Medicine - Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
22288796|NCT04592887|Varian, a Siemens Healthineers Company|Senior Manager, Clinical Trials|437-991-3496|ClinOps@varian.com|
22288797|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com|
22288798|NCT04639258|Medtronic Structural Heart & Aortic|Robert Waltonen|763-526-0424|robert.waltonen@medtronic.com|
22288799|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22288800|NCT01635153|Dartmouth-Hitchcock|Dr C Fordham von Reyn|6036507167|fvr@dartmouth.edu|
22288801|NCT02754440|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22288802|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu|
22288803|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22288804|NCT03588884|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22288805|NCT01995838|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22288806|NCT01967576|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
22288807|NCT00345358|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288808|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu|
22288809|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22288810|NCT00318643|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
22288811|NCT01942694|Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center|Dr. Anastassios Pittas|617-636-3232|apittas@tuftsmedicalcenter.org|
22288812|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
22288813|NCT03739203|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22288814|NCT02592798|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22288815|NCT01216189|Karolinska Institutet|Professor Anna Martling|+46851770000|anna.martling@ki.se|
22288816|NCT01143246|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22288817|NCT01146795|Columbia University|Jason Wright, MD|212-305-3410|jw2459@cumc.columbia.edu|
22288818|NCT05375760|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22288819|NCT03853109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22288820|NCT03751657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1)866-867-7178|clinicaltrials@novonordisk.com|
22288821|NCT04603027|Evelo Biosciences, Inc.|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22288822|NCT03894813|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86-0755-83923333|fanshangrong@163.com|
22288823|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22288824|NCT02269267|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
22288825|NCT01745822|French National Research Institute for Sustainable Development (IRD)|Gonzague Jourdain|+66818830065|gonzague.jourdain@ird.fr|
22288826|NCT00145158|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22288827|NCT02741518|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
22288828|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu|
22288829|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22288830|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu|
22288831|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com|
22288832|NCT04657094|City of Hope Medical Center|Dr. Alexey Danilov|6263598111|adanilov@coh.org|
22288833|NCT02948634|UT Southwestern|Jason Zafereo|14-648-1002|jason.zafereo@utsouthwestern.edu|2146481002
22288834|NCT03007225|Ain Shams University|Dr Iman Montasser, Assistant professor of Tropical Medicine member of HCC clinic and group , Ain Sha|0020201065065333|imanfawzy2@gmail.com|
22288835|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org|
22288836|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288837|NCT03108469|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22288838|NCT05844007|Montana State University|Dr. Lauren Davis|828-773-6328|lauren.davis6@montana.edu|
22288839|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com|
22288840|NCT03062540|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22288841|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com|
22288842|NCT04816669|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22288843|NCT01229267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288844|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov|
22288845|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu|
22288846|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu|
22288847|NCT01189409|BC Cancer|Dr. Philippa Hawley|607-877-6000|PHawley@bccancer.bc.ca|67-2707
22288848|NCT01837823|Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai|Dr. Annapoorna Kini|212-241-4181|annapoorna.kini@mountsinai.org|
22288849|NCT03052400|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22288850|NCT00867815|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22304217|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304218|NCT02584855|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304219|NCT02337478|Wake Forest University Health Sciences|Timothy Pardee, MD, Ph.D.|336-716-5440|tpardee@wakehealth.edu|
22304220|NCT02611830|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22304221|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
22288851|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov|
22288852|NCT05782179|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
22288853|NCT06170242|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
22288854|NCT02558296|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22288855|NCT02832115|Aultman Hospital|Dr. Prabhakaran Gopalakrishnan|3304548076|prab.gopalakrishnan@aultman.com|
22288856|NCT02919995|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|
22288857|NCT01059435|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22288858|NCT02245217|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
22288859|NCT01263197|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22288860|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org|
22288861|NCT03281200|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22288862|NCT02194985|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22288863|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
22288864|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu|
22288865|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org|
22288866|NCT02557139|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
22288867|NCT02284243|Recro Pharma|Randall Mack|484-395-2470|rmack@recropharma.com|2406
22288868|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
22288869|NCT01932437|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22288870|NCT04269889|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|David J. Young, MD, PhD|301.827.7823|david.young2@nih.gov|
22288871|NCT04987333|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22288872|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590||
22288873|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu|
22288874|NCT01569607|Emory University|Dr. Cathrin Buetefisch|404-712-5507|cathrin.buetefisch@emory.edu|
22288875|NCT02699749|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288876|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk|
22288877|NCT02377817|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
22288878|NCT04139018|Washington University School of Medicine Department of Otolaryngology - Head and Neck Surgery|Jay Piccirillo, M.D., Vice Chair for Research|314-362-8641|piccirij@wustl.edu|
22288879|NCT02364570|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22288880|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org|
22288881|NCT03810105|Memorial Sloan Kettering Cancer Center|Dr. Karen Autio, MD|646-422-4632|autiok@mskcc.org|
22288882|NCT05503823|University of Manitoba|Dr. Zahra Moussavi|204 474-7023|zahra.moussavi@umanitoba.ca|
22288883|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743||
22288884|NCT00357903|Amgen Inc.|Study Director|866-572-6436||
22288885|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300||
22288886|NCT03529695|USC Center for Economic and Social Research|Kayla De La Haye, PhD, Research Scientist|323-442-8228|delahaye@usc.edu|
22288887|NCT01648751|University of PIttsburgh|Pamela Moalli MD PHD|412-641-6052|moalpa@upmc.edu|
22288888|NCT04194437|TransMedics, Inc.|VP Cliinical Affairs|978-552-0900|ldamme@transmedics.com|
22288889|NCT03467750|Emory University|Dr. Laura Gilbertson|404-785-6670|laura.gilbertson@emory.edu|
22288890|NCT05673876|Genentech Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
22288891|NCT03052829|Medical College of Wisconsin|Amberly Anger|414-955-6708|aanger@mcw.edu|
22288892|NCT05006573|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22288893|NCT01967238|Stanford University|Taia Wang|5103873941|taiawang@stanford.edu|
22288894|NCT03123731|University of California, San Diego|Dr. Brook Henry|619-543-4737|blhenry@ucsd.edu|
22319677|NCT02713542|Arthrex|Clinical Affairs Manager|2395984302|INC_ClinicalResearch@arthrex.com|
22288896|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu|
22288897|NCT02864394|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22288898|NCT05358353|Reflow Medical|Carolyn Mascho|949-481-0399|cmascho@reflowmedical.com|
22288899|NCT01284335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22288900|NCT02656693|Brigham and Women's Hospital|Heather J. Baer, ScD|617-525-7503|hbaer@bwh.harvard.edu|
22288901|NCT02565784|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22288902|NCT02604160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22288903|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22288904|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22288905|NCT03180840|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
22288906|NCT02933450|Emergency Department, Baylor College of Medicine|Dr Zubaid Rafiue|7138732626|zubaidrafique@gmail.com|
22288907|NCT01812668|Barbara Ann Karmanos Cancer Institute|Dr. Elisabeth Heath|313-576-8734|heathe@karmanos.org|
22288908|NCT02223702|Kocaeli University|Chair and Associate Professor of Periodontology|+902623442222|esragd@yahoo.com|5102
22288909|NCT01168219|Washington University School of Medicine|Ravi Vij, MD||rvij@im.wustl.edu|
22288910|NCT00859456|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
22288911|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
22288912|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111||
22288913|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov|
22288914|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com|
22288915|NCT02863419|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22288916|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
22288917|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288918|NCT01470326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288919|NCT02561832|AstraZeneca Pharmaceuticals LP|Carsten Goessl MD|+1 2404490654|Carsten.Goessl@astrazeneca.com|
22288920|NCT02839200|Idorsia Pharmaceuticals|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
22288921|NCT03614156|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22288922|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu|
22288923|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca|
22288924|NCT00834093|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617.632.6799|GJHANNA@PARTNERS.ORG|
22288925|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22288926|NCT02453711|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22288927|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288928|NCT01578486|UMass Medical School|Xiaoduo Fan, MD, MPH|508-856-3881|xiaoduo.fan@umassmed.edu|
22288929|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65||
22288930|NCT03181529|Johns Hopkins University|Dr. Roland Griffiths|410-550-0034|rgriff@jhmi.edu|
22288931|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22288932|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu|
22288933|NCT02773576|Braeburn Inc|Christine Kampf|6104678728|ckampf@braeburnrx.com|
22288934|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22288935|NCT04772560|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@uh.edu|
22288936|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com|
22288937|NCT00314795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22288938|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
22288939|NCT04546672|Oregon Health & Science University|Dr. Brandon Togioka|503-494-4572|togioka@ohsu.edu|
22288940|NCT01607255|VA Northern California Healthcare Systems - Mather|Joseph W. Leung, MD, Chief of Gastroenterology|916-366-5339|Joseph.Leung2@va.gov|
22288941|NCT01397968|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
22288942|NCT02908672|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22288943|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br|
22288944|NCT02876601|Medical University of Vienna|Univ.Prof. Dr. Bernd Jilma|+4314040029810|bernd.jilma@meduniwien.ac.at|
22288945|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com|
22288946|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu|
22288947|NCT03863080|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22288948|NCT01781728|Johns Hopkins University, Department of Radiation Oncology|Dr. Amol Narang|410-913-3559|anarang2@jhmi.edu|
22288949|NCT00802945|Nektar|Alison Hannah, MD||AHannah@nektar.com|
22288950|NCT05307692|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22288951|NCT04400643|Hamilton Medical AG|Jean Michel Arnal|+33 1 84 04 97 58|jarnal@hamilton-medical.com|
22288952|NCT03493464|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
22288953|NCT04949490|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22288954|NCT05232682|Brown University|Mollie Monnig, PhD|4018633491|mollie_monnig@brown.edu|
22288955|NCT00905164|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22288956|NCT04730804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22288957|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se|
22288958|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
22288959|NCT02641561|Cooper University Hospital|Shaffer R. S. Mok, M.D., M.B.S.|6099804564|mok.shaffer@gmail.com|
22288960|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22288961|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com|
22288962|NCT05780424|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22288963|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu|
22288964|NCT01934647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22288965|NCT00662298|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22288966|NCT03126344|Shanghai ninth people's hospital|Sun Yu|13611895542|dr_sunyu@163.com|+86
22288967|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22288968|NCT02563067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22288969|NCT03544333|University Hospital of Psychiatry Zurich, Switzerland|Stephanie Homan, PhD|0041 44 384|stephanie.homan@bli.uzh.ch|28 02
22288970|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22288971|NCT00826462|University of Oslo|Professor Morten Lindbaek|+47-22850646|morten.lindbak@medisin.uio.no|
22288972|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org|
22288973|NCT05801341|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
22288974|NCT02405442|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22304222|NCT04374500|Umeå University, Umeå, Sweden|Stefan Söderberg|+46 70 319 38 03|stefan.soderberg@umu.se|
22304223|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304224|NCT01513967|Regenera Pharma Ltd|Dr Konstatin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
22304225|NCT01987830|Massachusetts General Hospital|Dr. Elizabeth Gerstner|(617) 726-2000|EGERSTNER@mgh.harvard.edu|
22304226|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org|
22304227|NCT02076074|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8610|izoberi@wustl.edu|
22304228|NCT03277378|Abbott|Robyn Capobianco, PhD|+1 512 286 4274|robyn.capobianco@abbott.com|
22304229|NCT03997851|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
22304230|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com|
22304231|NCT03251144|University of California Los Angeles|Theodoros Kelesidis|3108257875|tkelesidis@mednet.ucla.edu|
22304232|NCT05305040|AlloVir, Inc.|Kevin Anderson|617-433-2605|kanderson@allovir.com|
22304233|NCT02206685|Baylor College of Medicine|Kim P. Nguyen, MD, Principal Investigator|832-824-5907|kpnguyen@texaschildrens.org|
22304234|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304235|NCT02424344|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22304236|NCT04730947|Mayo Clinic|Dr. Barry A. Borlaug|507-293-2762|borlaug.barry@mayo.edu|
22304237|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu|
22304238|NCT02123966|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
22304239|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304240|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org|
22304241|NCT01460381|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22304242|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22304243|NCT02561455|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22304244|NCT03639675|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22304245|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com|
22304246|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
22304247|NCT04731714|Washington University School of Medicine|Kevin J. Black, M.D.|314-362-5041|kevin@wustl.edu|
22304248|NCT05343455|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
22304249|NCT02307916|Massachusetts Eye and Ear|Dr. Brad Welling|617-573-4075|brad_welling@meei.harvard.edu|
22304250|NCT03354637|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22304251|NCT04006366|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
22304252|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu|
22304253|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu|
22304254|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22304255|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu|
22304256|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu|
22304257|NCT04179461|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
22304258|NCT04374565|University of Virginia|Dr. Jeffrey Sturek|434-284-1776|JMS3HK@hscmail.mcc.virginia.edu|
22304259|NCT02859597|Montefiore Medical Center|Dr.Jay Berger|7189204316|jberger@montefiore.org|
22304260|NCT02916862|Florida International University|Cristina Palacios|3053483235|crpalaci@fiu.edu|
22304261|NCT03160079|University of California, San Diego, Moores Cancer Center|Dr. James Mangan|858-822-6600|jmangan@health.ucsd.edu|
22304262|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr|
22304263|NCT04648891|Mayo Clinic|David G. Lott, M.D.|480-342-2983|Lott.David@mayo.edu|
22304264|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22304265|NCT03259373|Harvard Pilgrim Health Care|Richard Platt, MD|(617) 867-4912|Richard_Platt@harvardpilgrim.org|
22304266|NCT03262701|Loma Linda University School of Dentistry|Yoon Jeong Kim|(909) 558-4610|yjkim02d2@llu.edu|
22304267|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu|
22304268|NCT05764239|Synlogic|Clinical Operations|(617) 401-9975|info@synlogictx.com|
22304269|NCT03698864|Processa Pharmaceuticals|Mary G. Nyberg, VP Clinical Operations|443-776-3133|mnyberg@processapharmaceuticals.com|
22304270|NCT01591161|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22304271|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22304272|NCT00556374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22304273|NCT04131907|Laborie Medical Technologies|Jill Moland|800-522-6743|jmoland@laborie.com|
22304274|NCT05294419|Genomics Ltd|Seamus Harrison|+44 1865 981600|seamus.harrison@genomics.com|
22304275|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22304276|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com|
22304277|NCT00641186|Baylor College of Medicine|Christine Hunter|713-798-3951|chunter@bcm.edu|
22304278|NCT02922985|University of Texas Medical Branch|Emily Hadley|4022028626|ehadley15@gmail.com|
22304279|NCT05221749|Alexandria University|Nour Ammar|4868066|nour.ammar@alexu.edu.eg|201
22304280|NCT03428815|University of Pittsburgh|Dr. Goeran Fiedler|14126246475|gfiedler@pitt.edu|
22304281|NCT01053637|BAYLOR COLLEGE OF MEDICINE|Corrie E. Chumpitazi|832 824-1353|corriec@bcm.edu|
22304282|NCT04140890|Wayne State University|Dr. Yi-Ling Hu|3142039991|ha1124@wayne.edu|
22304283|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com|
22304284|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
22304285|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com|
22304286|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com|
22304287|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Research Coordinator|302-651-6686|cprosper@nemours.org|
22304288|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300||
22304289|NCT03958630|National Institute of Mental Health|Innis, Robert|+1 301 594 1368|robert.innis@nih.gov|
22304290|NCT00950937|Hospital de Clínicas de Porto Alegre|Pedro Dall'Ago|555133038751|pdallago@pq.cnpq.br|
22304291|NCT01736358|Montefiore Medical Center|Dr.David Hoenig||dhoenig@montefiore.org|
22304292|NCT02413684|Duke Asthma, Airway and Allergy Center|Njira Lugogo|919-613-5707|njira.lugogo@duke.edu|
22304293|NCT04701593|Virginia Tech|Dr Vishak John|(540) 855-5100|vishakjohn@vt.edu|
22304294|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com|
22304295|NCT03317379|New York State Psychiatric Institute|Lisa Ranzenhofer, PhD|240 671 9040|lr2840@cumc.columbia.edu|
22304296|NCT04445155|University of South Florida|Dr. Ukamaka Oruche|813-396-2524|orucheu@usf.edu|
22304297|NCT04157686|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22304298|NCT02018315|University of Texas Southwestern Medical Center|Juan Pascual, M.D., Ph.D.|214-648-3550|juan.pascual@utsouthwestern.edu|
22304299|NCT01388543|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
22304300|NCT03363659|Advocate Aurora Health|Manager of Oncology research|414 778 4345|karen.cheek@aah.org|
22304301|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk|
22304302|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk|
22304303|NCT03872388|MD Anderson Cancer Center|Carlos Barcenas, MD|(713) 794-5098|chbarcenas@mdanderson.org|
22304304|NCT04191135|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304305|NCT01781611|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405-822-2336|joan-merrill@omrf.org|
22304306|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
22304307|NCT02033993|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
22304308|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca|
22304309|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org|
22304310|NCT02633891|BVAMC|Dr. Lindsay Zilliox|410-328-3100|lzilliox@som.umaryland.edu|
22304311|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411|william.yancy2@va.gov|7770
22304312|NCT04466618|Mayo Clinic|Dr Adrian Vella|5072843754|vella.adrian@mayo.edu|
22304313|NCT02800928|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22304314|NCT01853163|Navitas Life Sciences GmbH|Managing Director|+49 (0) 69-66 80 30-0|marty.boom@navitaslifesciences.com|
22304315|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22304316|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com|
22304317|NCT02886728|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22304318|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623||
22304319|NCT04830514|University of Arkansas for Medical Sciences|David D. Church, Ph.D., Assistant Professor|5015265709|dchurch@uams.edu|
22304320|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
22304321|NCT01676220|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22304322|NCT02411591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304323|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr|
22304324|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22304325|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu|
22304326|NCT00305682|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
22304327|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu|
22304328|NCT01628874|Children's Hospital Colorado|Dr. Ryan Caltagirone|303-521-8563|ryan.caltagirone@childrenscolorado.org|
22304329|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22304330|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
22304331|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22304332|NCT00146640|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22304333|NCT03486899|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22304334|NCT01439711|Duke University Medical Center|E. Shelley Hwang MD MPH|919-684-6849|shelley.hwang@duke.edu|
22304335|NCT04242875|Carolina Eyecare Physicians|Director of Research|8438813937|hsandoval@cepmd.com|
22304336|NCT02397460|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304337|NCT02511561|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22304338|NCT01723826|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22304339|NCT01767129|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
22304340|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu|
22304341|NCT02225275|The University of Texas MD Anderson Cancer Center|Dr. Alessandra Ferrajoli MD/ Professor|173-792-2063|aferrajo@mdanderson.org|
22304342|NCT00597870|Lundquist Institute of BioMedical Studies|Rodney A. White, MD|3109635230|rawhite@ucla.edu|
22304343|NCT01473420|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304344|NCT02760862|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22304345|NCT03171168|Montefiore Medical Center|Matthew Bartels|(914) 597-2332|MBARTELS@montefiore.org|
22304346|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu|
22304347|NCT02906202|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22304348|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it|
22304349|NCT03990363|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22304350|NCT02406209|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22304351|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu|
22304352|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com|
22304353|NCT04630756|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22304354|NCT04178551|VA Connecticut Healthcare System|William C. Becker, MD|203-932-5711|william.becker4@va.gov|2427
22304355|NCT03796013|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22304356|NCT01824472|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
22304357|NCT01815736|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22304358|NCT04436796|Sansum Diabetes Research Institute|Jordan Pinsker|805-682-7640|jpinsker@sansum.org|
22304359|NCT03387514|UW School of Medicine and Public Health|Steve Cho, MD|608-263-5585|cho85@wisc.edu|
22304360|NCT03040687|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22304361|NCT02846558|Johns Hopkins Department of Neurology|Dr. Ellen Mowry, M.D., M.C.R.|410-502-0675|emowry1@jhmi.edu|
22304362|NCT00107744|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|504-988-5165|jhe@tulane.edu|
22304363|NCT01556243|Mayo Clinic|Judy Boughey|507-266-9997|Boughey.Judy@mayo.edu|
22304364|NCT04684914|Altimmune|Randy Brown|3179003335|rbrown@altimmune.com|
22304365|NCT02353832|University of Texas Southwestern|Michael Folkert, M.D., Ph.D.|214-645-8525|Michael.Folkert@utsouthwestern.edu|
22304366|NCT04471792|Kansas State University|Dr. Judy Delp|3522269535|mullerdelp@vet.k-state.edu|
22304367|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu|
22304368|NCT04213846|University of Washington|Christine Lee, Ph.D.|206-543-6574|leecm@uw.edu|
22304369|NCT05737550|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
22304370|NCT03374072|Boston University|Dr. Gael Orsmond|(617)353-2703|gorsmond@bu.edu|
22304371|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22304372|NCT02174198|Columbia University|Nurit Bittner, DDS, MS, Dip.ABP|212-342-2763|nb2203@cumc.columbia.edu|
22304373|NCT05516342|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
22304374|NCT01866475|Teleflex|Tatiana Puga|2104451794|tatiana.puga@teleflex.com|
22304375|NCT02823990|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22304376|NCT04096365|AtaCor Medical, Inc.|Alan Marcovecchio, Vice President, Clinical Affairs|949 391 2252|alan@atacor.com|
22304377|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343||
22304378|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com|
22304379|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org|
22304380|NCT01939158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304381|NCT05310084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304382|NCT05373901|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22304383|NCT02065245|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305-243-5579|JHare@med.miami.edu|
22304384|NCT00924664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304385|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300||
22304386|NCT03531905|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22304387|NCT01036087|UT MD Anderson Cancer Center|Dr. Naoto Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
22304388|NCT03961256|Mayo Clinic|Mark D. Stegall, M.D.|507-266-2812|Stegall.Mark@mayo.edu|
22304389|NCT01616563|Metabolic Syndrome Canada|Rupinder Dhaliwal|613 484 3830|rupinder.dhaliwal@metsc.ca|
22304390|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu|
22304391|NCT05153174|University of Rochester Medical Center|Dr Thu H. Le, MD, FAHA - Chief of Nephrology|585-273-4259|thu_le@urmc.rochester.edu|
22304392|NCT03303105|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22304393|NCT01824446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22304394|NCT02023944|Bedford Veterans Hospital|Maureen K. O'Connor|781-687-2830|maureen.oconnor@va.gov|
22304395|NCT01033643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304396|NCT03527277|University of California, Davis|Kimber Stanhope|5302190914|klstanhope@ucdavis.edu|
22304397|NCT04351750|National Cheng Kung University|Dr. Kuan-Yin Lin|+88662353535|10802003@gs.ncku.edu.tw|5931
22304398|NCT01333943|Hospital for Special Surgery|David H. Kim, MD|(212) 606-1206|KimD@HSS.EDU|
22304399|NCT01421771|University of New Mexico Health Sciences Center|Samiha Mateen|505-272-6057|smateen@salud.unm.edu|
22304400|NCT02091063|Columbia University|Jennifer Amengual, MD|212-305-0591|jea2149@cumc.columbia.edu|
22304401|NCT02459587|Veterans Health Administration|Dr. Mark Ilgen|7349366266|mark.ilgen@va.gov|
22304402|NCT03861728|University of Miami|Wendy Lee|305-326-6434|wlee@miami.edu|
22304403|NCT02652130|Mesoblast, Inc.|Christopher James, VP, Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
22304404|NCT02028884|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22304405|NCT05176353|University of Michigan|Owen Albin, MD|734.232.1871|oalbin@med.umich.edu|
22304406|NCT05559047|Bleep, LLC|Stuart Heatherington|919-619-7170|stuart@bleepsleep.com|
22304407|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304408|NCT02297503|Galderma|Maria Norberg|+46184891267|maria.norberg@galderma.com|
22304409|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|1323
22304410|NCT02037061|Cleveland Clinic|Dr. Cecile Unger|216-444-0542|ungerc@ccf.org|
22304411|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
22304412|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com|
22304413|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
22304414|NCT01349660|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
22304415|NCT05593211|Anthem Biotechnologies|Jeremy D. Ollerenshaw, Ph.D.|770.337.2390|ollerenj@anthembiotech.com|
22304416|NCT03225846|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22304417|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu|
22304418|NCT01728805|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
22304419|NCT01875861|Central Arkansas Veterans Healthcare System|Dr. Richard Owen|(501) 257-1710|Richard.Owen2@va.gov|
22304420|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr|
22304421|NCT03703206|University of Pennsylvania|Nabil Elkassbany, MD|2158236700|nabil.elkassabany@uphs.upenn.edu|
22304422|NCT02359019|Barbara Ann Karmanos Cancer Institute|Dr. Ammar Sukari|313-576-8778|sukaria@karamanos.org|
22304423|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22304424|NCT02253316|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
22304425|NCT02684903|University of Oregon|Dr. Elizabeth Skowron|541-346-9329|eskowron@uoregon.edu|
22304426|NCT03824535|Stanford University|Dr. Carina Mari Aparici|650-497 9280|drmari@stanford.edu|
22304427|NCT02841267|Hugo W. Moser Research Institute at Kennedy Krieger Inc.|Dr. Kathryn R. Wagner|443-923-9525|wagnerk@kennedykrieger.org|
22304428|NCT06403605|ETS Wound Care, LLC|Donald Buck, MD|410-490-5998|dbuck@etswoundcare.com|
22304429|NCT07083843|OmanMOH|Amal Salim AlSahi|96103040|amalalsahi@gmail.com|968
22288975|NCT01742117|Mayo Clinic|Dr. Naveen L. Pereira|507-284-4441|Pereira.Naveen@mayo.edu|
22288976|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22288977|NCT02015637|Melinta Therapeutics, Inc.|Susan K. Cammarata, M.D. (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
22288978|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu|
22288979|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu|
22288980|NCT01317277|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
22304430|NCT02941146|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22304431|NCT02651103|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
22304432|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu|
22304433|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22304434|NCT02331940|University of Crete|Director of Clinical Trials|2810394824|izolthi@gmail.com|0030
22304435|NCT01450943|VA Northern California Health Care System|Sara Dahle, D.P.M., M.P.H.|916-843-7151|Sara.dahle@va.gov|
22304436|NCT05570747|Bleep, LLC|Stuart Heatherington, Founder and Executive Chairman of Bleep|(919) 619-7170|stuart@bleepsleep.com|
22304437|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG|
22304438|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk|
22304439|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org|
22304440|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
22304441|NCT02724020|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22304442|NCT02179918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22304443|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22304444|NCT02954575|Octapharma AG|Cristina Solomon|+41 (0)55 451 21 89|Cristina.Solomon@octapharma.com|
22304445|NCT03413605|Center for Asian Health, Lewis Katz School of Medicine, TempleUniversity|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
22304446|NCT00570661|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
22304447|NCT01700673|Johns Hopkins University School of Medicine, Division of Hematologic Malignancies|Jonathan Webster, MD|4106149106|jwebst17@jhmi.edu|
22304448|NCT01734382|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22304449|NCT04537949|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22304450|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
22304451|NCT04183192|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
22304452|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
22304453|NCT01347645|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22304454|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu|
22304455|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com|
22304456|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com|
22304457|NCT00209027|Emory University|Erica Duncan|404-321-6111|erica.duncan@va.gov|7532
22304458|NCT02335268|GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH|Dr. Carsta Köhler|+49 351 25933|info@gmiho.de|100
22304459|NCT05049616|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|(713) 500-6421|michal.f.bartal@uth.tmc.edu|
22304460|NCT05893797|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22304461|NCT04770220|Alzheon|Aidan Power|(508) 861-7709|aidan.power@alzheon.com|
22304462|NCT05087095|Virginia Commonwealth University|Ashlee Loughan, PhD, LCP|804-828-9815|ashlee.loughan@vcuhealth.org|
22304463|NCT04894903|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
22304464|NCT01923428|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
22304465|NCT02550873|Promedior Inc.|Renu Gupta, MD, Chief Medical Officer|856-722-9824|rgupta@promedior.com|
22304466|NCT01822353|Helsinki University Hospital, Helsinki, Finland|Paula Kauppi, Chief Specialist|+358504286802|paula.kauppi@hus.fi|
22304467|NCT04320615|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22304468|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org|
22304469|NCT03873246|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22304470|NCT00885495|University of Cincinnati College of Medicine|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
22304471|NCT02107443|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_COACH@URMC.Rochester.edu|
22304472|NCT00946647|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22304473|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk|
22304474|NCT04387162|Atlanta VA Medical Center|Amy Rodriguez|404-321-6111|amy.rodriguez@va.gov|
22304475|NCT02334527|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22304476|NCT04248465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22304477|NCT05708846|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|dheart@humanitcare.com|
22304478|NCT03621982|ADC Therapeutics|Yvan LeBruchec|+41799110551|Yvan.LeBruchec@adctherapeutics.com|
22304479|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22304480|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
22304481|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu|
22304482|NCT04069221|Medicines for Malaria Venture|Dr Myriam El Gaaloul, PharmD|+41 22 555 0377|elgaaloulm@mmv.org|
22304483|NCT02419755|St. Jude Children's Research Hospital|Tanja A. Gruber, MD, PhD|901-595-2252|tanja.gruber@stjude.org|
22304484|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22304485|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22304486|NCT04988477|Hennepin Healthcare Research Institute|Dr. Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
22304487|NCT02699190|The Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
22319678|NCT03631667|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
22319679|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319680|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22319681|NCT01446016|Houston Methodist|Dr. Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
22319682|NCT02525055|hVIVO Services Limeted|Dr Nicolas Noulin|+442077561365|n.noulin@hvivo.com|
22319683|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22319684|NCT02448225|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22319685|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400||
22319686|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351||
22319687|NCT04234672|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22319688|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319689|NCT00601705|Cleveland Clinic|Dr. David Adelstein|216 444-9310|ADELSTD@ccf.org|
22319690|NCT02232282|Loyola University Chicago|Larissa Bresler, MD|7086433827|lbresler@lumc.edu|
22319691|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com|
22319692|NCT04246801|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22319693|NCT02743351|Fate Therapeutics|Executive Director, Clinical Operations|858.875.1800|info@fatetherapeutics.com|
22319694|NCT02101021|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319695|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22319696|NCT03694613|Fundacion Santa Fe, Bogotá, Colombia|Dr. Sergio Lerma|+57 3017752726|serlerma@gmail.com|
22319697|NCT02632721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319698|NCT04207801|Aurigene Discovery Technologies Limited|Divyesh Mandavia|9427181182|divyesh_m@aurigene.com|
22319699|NCT02663271|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
22319700|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319701|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu|
22319702|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com|
22319703|NCT00690235|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
22319704|NCT01326728|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
22319705|NCT02966223|Indiana University|Mark Tann, MD|317- 948-8782|matann@iupui.edu|
22319706|NCT02939989|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22319707|NCT04399122|Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center|Dr. Jose E. Capo-Aponte|(210) 292-2554|Jose.E.CapoAponte.ctr@mail.mil|
22319708|NCT03620019|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
22319709|NCT01416987|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22319710|NCT02322229|Alcon, A Novartis Division|Worldwide Medical Affairs Director, GMA Retina Lucentis|1-888-451-3937|alcon.medinfo@alcon.com|
22319711|NCT03065023|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319712|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22319713|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu|
22319714|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011|wachter@pvct.com|23
22319715|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319716|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22319717|NCT03427125|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22319718|NCT02281357|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22319719|NCT01162239|University of California, San Francisco|Dr. Gary Humfleet, PhD|(415) 476-7674|Gary.Humfleet@ucsf.edu|
22319720|NCT03454308|Medical University of South Carolina|Dr. Jessica Chandler|843-792-1928|chandlje@musc.edu|
22319721|NCT05390580|Washington University School of Medicine - Neurology Department|Dr. Osvaldo J. Laurido-Soto, PI|314-362-7382|ojlaurido-soto@wustl.edu|
22319722|NCT02767128|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22319723|NCT02499770|G1 Therapeutics|Chandra Lovejoy|001 9192991250|clovejoy@g1therapeutics.com|
22319724|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu|
22319725|NCT02129205|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319726|NCT02877927|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
22319727|NCT03747419|Dana-Farber Cancer Institute|Kent Mouw|6176325734|kent_mouw@dfci.harvard.edu|
22319728|NCT04376060|Saint Joseph University|Dr Sarah Khalil|0096170322739|sarahfkhalil2@gmail.com|
22319729|NCT04275297|Osher Center for Integrative Health|A. Gracie Kelly, MS, Research Assistant|6153431554|gracie.kelly@vumc.org|
22319730|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200|fhasan@partners.org|4901
22319731|NCT04572854|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22319732|NCT04115878|University of Arizona|Daniel Combs, MD|520-626-7780|combs89@arizona.edu|
22319733|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu|
22319734|NCT07052682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22319735|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com|
22319736|NCT02899078|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22319737|NCT02060383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22319738|NCT03426787|Washington University in St. Louis School of Medicine|Dr. Mary C Politi|3147471967|mpoliti@wustl.edu|
22319739|NCT01944293|Columbia University Medical Center - NY State Psychiatric Institute|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
22319740|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com|
22319741|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319742|NCT02592551|Baylor College of Medicine|Bryan Burt, MD|713-798-6376|burt@bcm.edu|
22319743|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22319744|NCT05162027|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
22319745|NCT00483561|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
22319746|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca|
22319747|NCT04415658|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@wustl.edu|
22319748|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
22319749|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
22319750|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com|
22319751|NCT04296877|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
22319752|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22319753|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22319754|NCT01628107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319755|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22319756|NCT02251379|Johns Hopkins University|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
22319757|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366||
22319758|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319759|NCT01301456|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319760|NCT03583450|University of California, San Francisco|Dr. Jina Sinskey|857-998-0137|jina.sinskey@ucsf.edu|
22319761|NCT00404066|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
22319762|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com|
22319763|NCT03938038|The University of Texas Health Science Center at Houston|Gabrielle Hatton, MD|713-500-7211|gabrielle.e.hatton@uth.tmc.edu|
22319764|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com|
22319765|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu|
22319766|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu|
22319767|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
22319768|NCT05395104|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22319769|NCT01534013|Imperial College London|Prof Nick Oliver|02075942433|nick.oliver@imperial.ac.uk|
22319770|NCT04422990|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22319771|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu|
22319772|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933||
22319773|NCT05372653|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22319774|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu|
22319775|NCT03740997|GE HealthCare|David Thompson, MD, PhD|+44 7775 543206|david.thompson1@gehealthcare.com|
22319776|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org|
22319777|NCT01849497|Amgen Inc.|Study Director|866-572-6436||
22319778|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22319779|NCT02221349|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22319780|NCT00999713|Penn State College of Medicine|Neal J. Thomas, M.D.|717-531-5337|nthomas@psu.edu|
22319781|NCT03346057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319782|NCT02921269|Johns Hopkins University|ETCTN Grants Administrative Manager|443-927-3568|jmurra33@jhmi.edu|
22319783|NCT01995578|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari MD|646-608-3738|tamarir@mskcc.org|
22319784|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu|
22319785|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319786|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22319787|NCT01083628|University of California, Berkeley|Dr. Adrian Aguilera|510-642-8564|aguila@berkeley.edu|
22319788|NCT01174238|University of California, San Francisco|Adil Daud, MD|415-353-7392|adaud@medicine.ucsf.edu|
22319789|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu|
22319790|NCT04411953|Cycle Pharmaceuticals|Head of Global Regulatory Affairs and Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
22319791|NCT05975840|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319792|NCT05180279|Medical University of South Carolina|Dr Garth Swanson|843-876-2152|swansong@musc.edu|
22319793|NCT00232141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22319794|NCT05564299|Massachusetts General Hospital|Ingrid V Bassett|617-724-3341|ibassett@mgh.harvard.edu|
22319795|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22319796|NCT06950879|Ghent University|Ruth Van der Looven|003293324237|ruth.Vanderlooven@uzgent.be|
22319797|NCT06291831|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319798|NCT00525044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319799|NCT01653288|Children's Hospital of Philadelphia|Dr. Nancy Kassam-Adams|2155903118|adamsn@email.chop.edu|
22319800|NCT02039726|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22319801|NCT02460497|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22319802|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu|
22319803|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22319804|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22319805|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
22319806|NCT02982239|Sleep and Health Research Program - University of Arizona|Dr. Michael Grandner|5206260105|grandner@psychiatry.arizona.edu|
22319807|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319808|NCT02230254|Second Affiliated Hospital of Zhejiang University|Dr. Wang Jian'an|010-85216440|Yuwei.Zhang@bsci.com|
22319809|NCT00621751|Atrium Health; Currently at Indiana University School of Medicine|Flora Hammond, MD|317-292-6781|flora.hammond@rhin.com|
22319810|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org|
22319811|NCT04311697|Applied Pharma Rersearch|Paola Prina|4847169881|paola.prina@apr.ch|
22319812|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
22319813|NCT03498131|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22319814|NCT03383289|Columbia University in the City of New York|Jeanne Teresi, EdD, PhD|212-305-9379|jat61@cumc.columbia.edu|
22319815|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22319816|NCT04439071|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22319817|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu|
22319818|NCT05097716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319819|NCT01011439|CLIOSS S.r.l.|Dr. Cristina Davite|+39 0031 58|regulatory@clioss.com|1482
22319820|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22319821|NCT02066311|The Feinstein Institute for Medical Research|Dr. Meggan Mackay|516-562-3838|mmackay@northwell.edu|
22319822|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu|
22319823|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22319824|NCT02316340|UT Health San Antonio|Dr. Sukeshi Arora|2104502872|ARORAS@UTHSCSA.EDU|
22319825|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
22319826|NCT03781323|University of Rochester|Richard Dunne|585-275-5823|Richard_Dunne@urmc.rochester.edu|
22319827|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com|
22319828|NCT00975715|Novartis|Study Director|41 61 324 1111||
22319829|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22319830|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319831|NCT04004429|SynAct Pharma|Thomas Jonassen, Chief Scientific Officer|+45 4015 6669|tj@SynActpharma.com|
22319832|NCT02606461|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22319833|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
22319834|NCT02764164|Cincinnati Childrens Hospital Medical Center|Dr. Ernest Pedapati|5137361901|ernest.pedapati@cchmc.org|
22319835|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu|
22319836|NCT04060563|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22319837|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org|
22319838|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu|
22319839|NCT01379573|NYU Langone Health|Jill Buyon|+1 212 263 0746|Jill.Buyon@nyulangone.org|
22319840|NCT02224313|Eastern Virginia Medical School|Dr.David Archer|7574467444|archerdf@evms.edu|
22319841|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22319842|NCT02486653|University of Wisconsin - Madison|Dr. Evie Carchman, MD|608-263-2521|carchman@surgery.wisc.edu|
22319843|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22319844|NCT04808622|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
22319845|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com|
22319846|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343||
22319847|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org|
22319848|NCT01829425|University of New Mexico|Dr. Yuko Komesu|5052490726|ykomesu@salud.unm.edu|
22319849|NCT03681951|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22319850|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22319851|NCT01230554|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
22319852|NCT03837379|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22319853|NCT03530917|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22319854|NCT01006265|Actelion Pharmaceuticals Ltd.|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22319855|NCT01390272|Durham VA Medical Center, Durham, NC|Dr. George Lee Jackson, PhD MHA|919-286-0411|George.Jackson3@va.gov|7091
22319856|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22319857|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu|
22319858|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com|
22319859|NCT02729740|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
22319860|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org|
22319861|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu|
22319862|NCT04267770|Imperial College London|Nick Oliver|+44 20 7594 1796|nick.oliver@imperial.ac.uk|
22319863|NCT03044249|Mediti Pharma Inc.|Chief Executive Officer|1-514-993-7207|ivan.shaw@meditipharma.com|
22319864|NCT05426759|AtriAN Medical Ltd|Barry O'Brien PhD|+353872934292|barry.obrien@atrianmedical.com|
22319865|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22319866|NCT02499081|University of Arkansas for Medical Sciences|Maurizio Zangari, MD|501-686-8274|MZangari@uams.edu|
22319867|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu|
22319868|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22319869|NCT01810016|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22319870|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22319871|NCT04263896|University of Chicago|Dr. Sandra Laveaux|773-702-6118|slaveaux@bsd.uchicago.edu|
22256997|NCT05378269|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22256998|NCT01838863|Denver Health Medical Center|Dr. Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
22256999|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu|
22257000|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
22257001|NCT01247974|CorMatrix Cardiovascular|Director, Clinical Development|240-247-1170|clinical@aziyo.com|
22257002|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774|francesco.sacca@unina.it|+39
22257003|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu|
22257004|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu|
22257005|NCT03692078|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22257006|NCT01339858|Indiana University Psychotic Disorders Program|Alan Breier|317-880-8495|abreier@iupui.edu|
22257007|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it|
22257008|NCT06134128|VA Portland Healthcare System|Kate Shirley, PhD|503-220-8262|kate.shirley@va.gov|52470
22257009|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
22257010|NCT02861534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257011|NCT02886494|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
22257012|NCT00194116|Univeristy Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|Keming.Gao@uhhospitals.org|
22257013|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com|
22257014|NCT01211873|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
22257015|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu|
22257016|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org|
22257017|NCT00445458|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22257018|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com|
22257019|NCT00246441|MUSC|Dr. Sarah Book|8437925200|booksw@musc.edu|
22257020|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257021|NCT02426125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257022|NCT01141049|NYSPI|john mariani md|646-774-6140|john.mariani@nyspi.columbia.edu|
22257023|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22257024|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257025|NCT03186794|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@cc.nih.gov|
22257026|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22257027|NCT00118209|Washington University School of Medicine|Nancy Bartlett, M.D.|314-362-5654|nbartlet@wustl.edu|
22257028|NCT01418365|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22257029|NCT03226366|Intermountain Healthcare|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
22257030|NCT02575807|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
22257031|NCT03319368|University of Maryland School of Medicine|Alison Lydecker, MPH|410-706-0065|alydecke@som.umaryland.edu|
22257032|NCT02180659|Titan Pharmaceuticals|Kate Beebe DeVarney|650-244-4990|kdevarney@titanpharm.com|
22257033|NCT00824993|UT MD Anderson Cancer Center|Lu,Huifang,M.D. PH.D. / General Internal Medicine|713-563-4462|HLU@MDANDERSON.ORG|
22257034|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22257035|NCT02998645|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22257036|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22257037|NCT03701516|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Director|1-904-629-2289|BPALL@its.jnj.com|
22257038|NCT02139969|Boston Scientific Corporation|Laura Olson, Clinical Project Manager|9529306428|laura.olson2@bsci.com|
22257039|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257040|NCT03506724|Icahn School of Medicine at Mount Sinai|Dr. Dyese Taylor|973-926-5508|Dyesetaylor@gmail.com|
22257041|NCT03644927|Veterans Administration Boston Healthcare System and BU School of Medicine|Erica R Scioli, PhD|857 364 6293|ericarose.scioli@va.gov|
22257042|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu|
22257043|NCT04797637|Vanderbilt University Medical Center|Lisa C. Zukerwise, MD|9144203838|lisa.zuckerwise@vumc.org|
22257044|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com|
22257045|NCT03083639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22257046|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22257047|NCT02656875|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22257048|NCT02184169|Boston Childrens Hospital|John Kheir|6173556000|john.kheir@childrens.harvard.edu|
22257049|NCT02357173|Medical University of South Carolina|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
22257050|NCT03611751|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22257051|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl|
22257052|NCT04686500|University of Texas Southwestern Medical Center|Dr. David Parsons|214/645-8525|david.parsons@utsouthwestern.edu|
22257053|NCT03128931|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22257054|NCT03151226|Wake Forest School of Medicine|Dr. Peter H. Pan|336-718-8278|ppan@wakehealth.edu|
22257055|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257056|NCT03239340|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22257057|NCT01497860|Children's National Medical Center|Associate Professor|2024765046|ehwang@childrensnational.org|
22257058|NCT03539952|Orphalan SA|Frank Verheggen - Head Clinical Operations|+31625241264|frank.verheggen@orphalan.com|
22257059|NCT02184988|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22257060|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257061|NCT03256526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257062|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org|
22257063|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257064|NCT03291847|Johns Hopkins University School of Medicine|Lauren Jansson|4105504114|ljansson@jhmi.edu|
22257065|NCT01393717|City of Hope National Medical Center|Dr. Robert Chen|626-256-4673|RChen@coh.org|82405
22257066|NCT03515837|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22257067|NCT02325401|University of Cincinnati|Trisha Wise-Draper M.D., Ph.D., Associate Professor of Medicine, Medical Director of the UC Cancer C|(513) 558-2826|wiseth@ucmail.uc.edu|
22257068|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar Domingo|+441615312645|moises@bigdata4brain.co.uk|
22257069|NCT01426828|University of Pennsylvania|CCI @ University of Pennsylvania|(215)662-4000||
22257070|NCT02406742|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22257071|NCT02367729|Medical College of Wisconsin|Dr. Katja Kovacic|4142663915|kkovacic@mcw.edu|
22257072|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257073|NCT01890109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22257074|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257075|NCT03336645|Shire|Study Physician|1 866-842-5335|ClinicalTransparency@takeda.com|
22257076|NCT01092676|LHSC Lawson HRI|Rodrick Lim|5198525496|rod.lim@lhsc.on.ca|
22257077|NCT03029104|CXL Ophthalmics, LLC|Chief Clinical Development Officer|339-234-6020|info@cxlophthalmics.com|
22257078|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257079|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876||
22257080|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22257081|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
22257082|NCT02586909|Axovant Gene Therapies|Yi Mo, PhD|1-929-227-3828|yi.mo@axovant.com|
22257083|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com|
22257084|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22257085|NCT02086968|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
22257086|NCT02822612|Moorfields Eye Hospital NHS Foundation Trust|Pearse Keane|02072533411|pearse.keane@moorfields.nhs.uk|
22257087|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu|
22257088|NCT03359473|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22257089|NCT02953418|Medtronic MITG-RGI|Director of Clinical Affairs|303-882-6759|Tumordirectedtherapiesclinical@Medtronic.com|
22257090|NCT06251154|CooperVision, Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
22257091|NCT04101721|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22257092|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22257093|NCT05013749|Fundación Valle del Lili|Albaro José Nieto Calvache|(+57) 6023319090|albaro.nieto@fvl.org.co|3056 - 305
22257094|NCT02858076|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22257095|NCT02643394|UT Southwestern Medical Center|David McDonagh, MD|214-648-8083|david.mcdonagh@utsouthwestern.edu|
22257096|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com|
22257097|NCT00096200|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org|
22257098|NCT04193033|Michael E DeBakey VAMC|Dr. Natalie Hundt|713-440-4450|Natalie.Hundt@va.gov|
22257099|NCT03265483|Vanderbilt University Medical Center|Martha J. Shrubsole|(615)936-0812|martha.shrubsole@Vanderbilt.Edu|
22257100|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com|
22257101|NCT03509766|Johns Hopkins School of Medicine|Jody Tversky|410-550-5949|jodytversky@jhmi.edu|
22257102|NCT03014570|University of Maryland School of Nursing|Barbara Resnick PhD, CRNP Professor and PI among MPIs of the trial|410 706 5178|resnick@umaryland.edu|
22257103|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com|
22257104|NCT01923961|eXcorLab GmbH|'Dr. Horst-Dieter Lemke|+49-6022-812647|horstdieter.lemke@excorlab.de|
22257105|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22257106|NCT03791619|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@its.jnj.com|
22257107|NCT02666768|The Lundquist Institute at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1961|lpolgreen@lundquist.org|
22257108|NCT03728257|University of Pittsburgh|Annette DeVito Dabbs|4126245314|ajdst42@pitt.edu|
22257109|NCT00621309|University of Washington|Dr. David L. Eaton|206-543-7468|deaton@uw.edu|
22257110|NCT04993339|University of Miami|Dr. Francesco Travascio|3052842371|f.travascio@miami.edu|
22257111|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300||
22257112|NCT01516684|Wake Forest University Health Sciences|Thomas McLean|336-716-5440|tmclean@wakehealth.edu|
22257113|NCT00402779|UT MD Anderson Cancer Center|Dr. John V. Heymach, PHD/Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
22257114|NCT03075215|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
22257115|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu|
22257116|NCT05376293|The Miriam Hospital|Dr. Jessica Unick|401-793-7966|junick@brownhealth.org|
22257117|NCT01121224|VA North Texas Health Care System|Dr. Subhash Banerjee|(214) 857-1608|Subhash.Banerjee@va.gov|
22257118|NCT03712462|Drexel University|Dr. Adrienne Juarascio|215-553-7154|adrienne.s.juarascio@drexel.edu|
22257119|NCT00690573|Abbott|Global Medical Services|800-633-9110||
22257120|NCT00777920|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22257121|NCT02146365|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22257122|NCT02332655|Kennedy Krieger Institute|Dr. Anne Comi|4439239172|comi@kennedykrieger.org|3-9172
22257123|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257124|NCT02500147|Columbia University|Aviva B Sopher, MD, MS|212-305-9362|ahs32@cumc.columbia.edu|
22257125|NCT02547779|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22257126|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu|
22257127|NCT03569020|Beth Israel Deaconess Medical Center|Dr. Stephen Juraschek|617-754-1416|sjurasch@bidmc.harvard.edu|
22257128|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22257129|NCT03151967|University of Washington|Ann Stapleton, MD|2066609981|stapl@uw.edu|
22257130|NCT02957682|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22257131|NCT02953262|Center for Healthcare Organization and Implementation Research (CHOIR) United States Department of Veterans Affairs VA Bedford Healthcare System|Stephanie Shimada, PhD|781-687-2208|Stephanie.Shimada@va.gov|
22257132|NCT03284424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257133|NCT00765999|Allergan, Inc.|Vice President, Clinical Development, Gastrointestinal|1-862-261-7000|IR-CTRegistration@allergan.com|
22257134|NCT03638102|University of Illinois Chicago|Sirimon Reutrakul|3124135357|sreutrak@uic.edu|
22257135|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org|
22257136|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22257137|NCT00722007|Corin USA Limited|Lucinda Gerber|(772) 321 2478|lucinda.gerber@coringroup.com|
22257138|NCT02964910|Shandong Center for Disease Control and Prevention, Jinan, China|Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention|0531-82679606|aqxuepi@163.com|
22257139|NCT03829462|Institut régional du Cancer de Montpellier|Dr Emmanuelle Samalin|467613136|emmanuelle.samalin@icm.unicancer.fr|+33
22257140|NCT02341482|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22257141|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org|
22257142|NCT03597620|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22257143|NCT03000075|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257144|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22257145|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822||9493
22257146|NCT03332212|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257147|NCT02362646|Icahn School of Medicine at Mount Sinai|Annetine Gelijns, PhD|212-659-9567|annetine.gelijns@mssm.edu|
22257148|NCT04141670|ARMGO Pharma, Inc|Eugene Marcantonio MD PhD|2014633634|gmarcantonio@armgo.com|
22257149|NCT03907540|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
22257150|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22257151|NCT03940742|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257152|NCT04176354|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257153|NCT03428217|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22257154|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257155|NCT05246111|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22257156|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
22257157|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil|
22257158|NCT02736695|Mayo Clinic|Keith Josephs, M.D.|507-266-4106|josephs.keith@mayo.edu|
22257159|NCT05794126|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22257160|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com|
22257161|NCT03252015|Eli Lilly and Company|Cheif Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22257162|NCT00061568|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|John Tisdale, M.D.|301.402.6497|johntis@nhlbi.nih.gov|
22257163|NCT01381068|UCSD|Neil Finer||nfiner@ucsd.edu|
22257164|NCT00597883|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
22257165|NCT04933708|Hospital of the University of Pennsylvania|Fei Cai|215-313-0656|feicai90@gmail.com|
22257166|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu|
22257167|NCT02262507|Cincinnati Childrens Hospital Sports Medicine|Dr. Gregory Myer|513-636-0249|greg.myer@cchmc.org|
22257168|NCT01205568|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@childrens.harvard.edu|
22257169|NCT00975000|Amgen Inc.|Study Director|866-572-6436||
22257170|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
22257171|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu|
22257172|NCT00902486|Incyte Corporation|Study Director|855 463-3463||
22257173|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709||
22257174|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743||
22257175|NCT04439110|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22257176|NCT05460832|Modern Biosciences|Chief Scientific Officer|+44 (0) 207 444 0066|IST-06@istesso.co.uk|
22257177|NCT07046403|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22257178|NCT00526227|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
22257179|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org|
22257180|NCT05257109|Yale University|Dr. Danielle Davis|2039747607|danielle.davis@yale.edu|
22257181|NCT00858234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257182|NCT01678924|Allergan plc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22257183|NCT02253654|Amgen Inc.|Study Director|866-572-6436||
22257184|NCT01614925|Straumann|Michel Mallaun||michel.mallaun@straumann.com|
22257185|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com|
22257186|NCT03612713|Yale University School of Medicine|Data Manager|203-737-5430|Theresa.Babuscio@yale.edu|
22257187|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu|
22257188|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22257189|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
22257190|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu|
22257191|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22257192|NCT02706041|The University of Texas Health Science Center at Houston|John A. Harvin, MD, FACS, Associate Professor|(713) 500-7244|John.Harvin@uth.tmc.edu|
22257193|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22257194|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22257195|NCT03349437|Philips|Biostatistician|412-542-3651|jeff.jasko@philips.com|
22257196|NCT00254488|Weill Cornell Medical College|Robert C. Young, MD, Professor of Psychiatry|914-997-5886|ryoung@med.cornell.edu|
22257197|NCT03343054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257198|NCT01316523|University of California, Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
22257199|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org|
22257200|NCT05041803|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
22257201|NCT05723835|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22257202|NCT05226286|Medtronic|Mylene Champs|7635261627|mylene.champs@medtronic.com|
22257203|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012||
22257204|NCT03901339|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22257205|NCT02148835|Preventive Cardiology, University of Munich|Prof. Dr. C. von Schacky|+49 89 44005 2165|clemens.vonschacky@med.uni-muenchen.de|
22257206|NCT01988337|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
22257207|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com|
22257208|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257209|NCT03387735|UW Madison|CHESS Statistician|6084772614|ocody@wisc.edu|
22257210|NCT03099161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257211|NCT00857493|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22257212|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
22257213|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257214|NCT04854707|IVFarma LLC|General Manager|+74996455342|info@ivfarma.ru|
22257215|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257216|NCT01572428|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
22257217|NCT05302414|National Yang Ming Chiao Tung University, Department of Nursing|Hui-Wen Chen Phd candidate|+886939947807|m513102001@gmail.com|
22257218|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22257219|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr|
22257220|NCT00792142|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22257221|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22257222|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000|kchi@bccancer.bc.ca|2746
22257223|NCT02564952|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22257224|NCT03491228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257225|NCT03706209|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|
22257226|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu|
22257227|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org|
22257228|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com|
22257229|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257230|NCT03972709|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22257231|NCT01523301|UCB|Study Director|+1877 822 9493||
22257232|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
22257233|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257234|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu|
22257235|NCT02017535|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
22257236|NCT05511428|Thomas Jefferson University|Adam Binder, MD|215-955-8874|Adam.binder@jefferson.edu|
22257237|NCT04088734|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22257238|NCT03354169|University of Pennsylvania|Kelly C. Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
22257239|NCT02843308|Stanford University School of Medicine|Carolyn Rodriguez, MD, PhD|650-723-4095|ocdresearch@stanford.edu|
22257240|NCT00664066|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22257241|NCT04828551|Massachusetts General Hospital|Anthony Samir|6178523241|asamir@mgh.harvard.edu|
22257242|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com|
22257243|NCT00345969|Washington University School of Medicine|Ellen F. Binder, MD|314-286-2707|ebinder@wustl.edu|
22257244|NCT00609115|AMES Technology, Inc.|Dr. Paul Cordo|503 970 6129|pcordo@amesdevices.com|
22257245|NCT01721369|Hospital Vall hebron|Dr. Angel Moya||amoyamitjans@gmail.com|
22257246|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
22257247|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257248|NCT01211613|University of Pittsburgh, Department of Physical Therapy'|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu|
22257249|NCT03853213|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
22257250|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov|
22257251|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com|
22257252|NCT04470622|Heron Therapeutics, Inc.|Sophie Visonneau|858-251-7232|svisonneau@herontx.com|
22257253|NCT04313023|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
22257254|NCT02576054|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257255|NCT00791154|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22257256|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org|
22257257|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257258|NCT03976076|Bio-Pharm Solutions Co., Ltd.|Bio-Pharm Solutions Medical Information|NA|conference.clinical@b-psol.com|
22257259|NCT02962739|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
22257260|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
22257261|NCT01208922|Dr. Falk Pharma GmbH|Department of Clinical Research|0049 7611514|zentrale@drfalkpharma.de|0
22257262|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu|
22257263|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257264|NCT00450177|Weill Cornell Medical College|Philip S. Barie, MD|646-962-2580|pbarie@med.cornell.edu|
22257265|NCT03361917|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
22257266|NCT00774202|Weill Cornell Medical College|James B. Bussel, M.D. Professor of Pediatrics|212-746-3474|jbussel@med.cornell.edu|
22257267|NCT03869684|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
22257268|NCT04056299|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22257269|NCT03895307|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
22257270|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22257271|NCT02846740|University of Maryland Baltimore|Nithin krishna|4103286661|nkrishna@som.umaryland.edu|
22257272|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22257273|NCT01268683|Biogen|Medical Director|866-633-4636|clinicaltrials@biogen.com|
22257274|NCT04256759|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
22257275|NCT04661540|CalciMedica|Sudarshan Hebbar, MD (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
22257276|NCT03901352|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22257277|NCT05150340|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22257278|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676|Carena@moleculin.com|232
22257279|NCT02742818|Hospital Israelita Albert Einstein|Dr. Nelson Wolosker|+55 11 2151-5423|nwolosker@yahoo.com.br|
22257280|NCT04701658|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257281|NCT00756652|Mentor Worldwide, LLC|Sponsor|949-453-6408|mgpas@its.jnj.com|
22257282|NCT05349188|Northwell Health|Dr. Mark Butler, PhD|908-414-0238|markbutler@northwell.edu|
22257283|NCT02494544|restor3d|Tara Mann - Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
22257284|NCT03889197|Department of Biostatistics and Health Data Science, Indiana University School of Medicine|Kelly Mosesso, MA; Biostatistician II|317-278-5439|kmosesso@iu.edu|
22257285|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu|
22257286|NCT04616768|University of Pennsylvania|Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
22257287|NCT03193190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22257288|NCT03532295|Washington University School of Medicine|Dr. Milan Chheda|314-747-7222|mchheda@wustl.edu|
22257289|NCT06474715|Columbia University Irving Medical Center|Lauren Houghton, PhD Msc|212-342-0246|lh2746@cumc.columbia.edu|
22257290|NCT05004181|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22257291|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com|
22257292|NCT03868059|Lipocine|Shadi Mehraban|801-994-7383|sm@lipocine.com|2191
22257293|NCT04278872|Sojournix, Inc.|Head of Regulatory Affairs|6174758469|clinicaltrials@sojournixpharma.com|
22257294|NCT02392377|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr Jennifer Eads|(216) 844-6031|jennifer.eads@uhhospitals.org|
22257295|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com|
22257296|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22257297|NCT03232749|University of Florida|MaryBeth Horodyski, Ed.D., ATC, LAT, FNATA|352-273-7074|horodmb@ortho.ufl.edu|
22257298|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk|
22257299|NCT01901146|Amgen Inc.|Study Director|866-572-6436||
22257300|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu|
22257301|NCT02675426|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257302|NCT02277639|Children's Hospital of Philadelphia|Nancy Bunin, MD|215-590-2255|buninn@email.chop.edu|
22257303|NCT03724968|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22257304|NCT01784419|University of California, San Francisco|Dennis W. Nielson, MD, PhD||Dennis.Nielson@ucsf.edu|
22257305|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr|
22257306|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22257307|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu|
22257308|NCT03456726|Eisai Co., Ltd|Eisai Inquiry Service|None|eisai-chiken_hotline@hhc.eisai.co.jp|
22257309|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca|
22257310|NCT03978117|Masonic Cancer Center|Dorothy Hatsukami, PhD|(612) 626-2121|hatsu001@umn.edu|
22257311|NCT02923115|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22257312|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22257313|NCT01875991|Amgen Inc.|Study Director|866-572-6436||
22257314|NCT03981614|University of Texas; MD Anderson Cancer Center|Scott Kopetz, M.D.|(507) 266-0800|SKopetz@mdanderson.org|
22257315|NCT04732728|Boston Scientific|Thomas Stoltz, Clinical Trial Manager|1-800-CARDIAC|thomas.stoltz@bsci.com|
22257316|NCT04971226|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22257317|NCT01158976|University of Chicago|Kathry Keenan|773-702-4449|kekeenan@uchicago.edu|
22257318|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com|
22257320|NCT06065176|University of Utah|Sarang Yoon, PI|801-203-0320|sarang.yoon@hsc.utah.edu|
22257321|NCT04521608|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
22257322|NCT05256992|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22257323|NCT04083378|The University of Texas MD Anderson Cancer Center|Dr. Bruno Odisio|(713) 563-1066|bcodisio@mdanderson.org|
22257324|NCT05824273|Hackensack Meridian Health - Center for Discovery and Innovation|Ana Vielma|2018803100|ana.vielma@hmh-cdi.org|
22257325|NCT04050293|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22257326|NCT05711524|Weill Cornell Medicine|Dr. Melissa Cushing|212-746-3527|mec2013@med.cornell.edu|
22257327|NCT04644237|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22257328|NCT03131817|University of California, San Francisco|Dr. Simon Little|4152995650|simon.little@ucsf.edu|
22257329|NCT04824560|University of New Mexico College of Pharmacy|Alexandra Herman|505-272-7630|asible@salud.unm.edu|
22257330|NCT02061293|NYU Langone Health|Samantha Podrebarac, MSc|212-263-0912|Samantha.Podrebarac@nyulangone.org|
22257331|NCT06232408|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22257332|NCT02949219|Mayo Clinic|Robert R. McWilliams, M.D.|507-266-9161|mcwilliams.robert@mayo.edu|
22257333|NCT03494816|University of Cambridge|Prof Grant Stewart|01223 256211|gds35@cam.ac.uk|
22257334|NCT05573113|Children's Mercy Kansas City|Sherwin Chan|816-234-3273|sschan@cmh.edu|
22257335|NCT05734014|Montana State University|Vanessa Simonds|4069947396|vanessa.simonds@montana.edu|
22257336|NCT04024254|Rush University Medical Center|Dr Lydia Usha|312-942-5904|Lydia_Usha@rush.edu|
22257337|NCT02689973|SWPS University of Social Sciences and Humanities|Dr Aleksandra Luszczynska, Principal Investigator|+4877507260|aluszczynska@swps.edu.pl|
22257338|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu|
22257339|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257340|NCT05838755|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22257341|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22257342|NCT04800510|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22257343|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837||
22257344|NCT02044094|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22257345|NCT03515681|Columbia University|Steven J. Shea, MD|212-305-6355|ss35@cumc.columbia.edu|
22257346|NCT03205163|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22257347|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
22257348|NCT01238172|Moores Cancer Center|J. Kellogg Parsons, M.D., MHS|858-822-7874|jkparsons@ucsd.edu|
22257349|NCT05022121|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
22257350|NCT03229941|New York Veterans Affairs Healthcare System, Brooklyn|Panagiotis Kougias|718-836-6600|panagiotis.kougias@va.gov|
22257351|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com|
22257352|NCT03302299|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
22257353|NCT01458132|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257354|NCT00350337|United States Army Medical Materiel Development Activity|Division of Regulated Activities and Compliance Director|301-619-0317|USAMRMCREGULATORYAFFAIRS@amedd.army.mil|
22257355|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca|
22257356|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com|
22257357|NCT03610646|Viatris|Dr. Prasanna Ganapathi, Head of Global Clinical Strategy and Innovation|+91 80 6672800|prasanna.ganapathi@viatris.com|
22257358|NCT02803138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257359|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22257360|NCT04318535|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22257361|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22257362|NCT01733186|MEDIPOST Co., Ltd.|Director of Product Development Department|+82-2-3465-6740|meehyunj@medi-post.co.kr|
22257363|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
22257364|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22257365|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu|
22257366|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22257367|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257368|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22257369|NCT02556931|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Amy Dezern|410-502-7208|adezern1@jhmi.edu|
22257370|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com|
22257371|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012||
22257372|NCT03224234|Emory University|Dr. Umpierrez|404-251-8957|geumpie@emory.edu|
22257373|NCT02610842|Unicamp - University of Campinas|Dr. Eduardo de Paiva Magalhaes|+55 (19) 35217113|dreduardomagalhaes@gmail.com|
22257374|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org|
22257375|NCT02494583|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257376|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257377|NCT03151707|McLean Hospital|Dost Ongur|6178553922|dongur@partners.org|
22257378|NCT04439149|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22257379|NCT02617446|Windtree Therapeutics, Inc.|Phillip D. Simmons, Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
22257380|NCT03030638|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257381|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22257382|NCT03974516|i Cure Biotech Co., Ltd.|David Liu|+886-955-104-105|white06041983a@gmail.com|
22257383|NCT05264506|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22257384|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623||
22257385|NCT06078124|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsay.stark@wustl.edu|
22257386|NCT02843529|Altoida Inc.|Ioannis Tarnanas|+18325975076|Ioannis@altoida.com|
22257387|NCT02925650|Alzheimer's Disease Cooperative Study|Howard Feldman MDCM, FRCP(C)|858-246-1347|hhfeldman@health.ucsd.edu|
22257388|NCT00417859|University Hospital of Lausanne|Prof Brigitte Jolles|0213149629|brigitte.jolles@chuv.ch|
22257389|NCT03252756|NYU Langone Health|Michael Bogenschutz, PhD|646-501-4026|Michael.Bogenschutz@nyulangone.org|
22257390|NCT04223193|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257391|NCT03594175|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22257392|NCT03732677|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22257393|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
22257394|NCT04066894|M D Anderson Cancer Center|Dr. Craig Messick|(713) 745-1544|cmessick@mdanderson.org|
22257395|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22257396|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623||
22257397|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200|dbregman@lpicrd.com|828
22257398|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012||
22257399|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22257400|NCT03878108|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
22257401|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com|
22257402|NCT03353415|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6713092635|MaryElizabeth.Patti@Joslin.Harvard.edu|
22257403|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012||
22257404|NCT05073692|Kaiser Permanente Division of Research|Romain Neugebauer|510-891-3234|Romain.S.Neugebauer@kp.org|
22257405|NCT06873867|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22257406|NCT04647253|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
22257407|NCT01209234|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
22257408|NCT04502862|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22257409|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu|
22257410|NCT03233737|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
22257411|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257412|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22257413|NCT03911960|Hennepin Healthcare|Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
22257414|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp|
22257415|NCT04071366|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22257416|NCT01858558|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Philip Imus, MD|410-955-8873|pimus1@jhmi.edu|
22257417|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257418|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu|
22257419|NCT00786019|University of Colorado|Judith Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
22257420|NCT00399490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257421|NCT02437890|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
22257422|NCT02328547|Montefiore Medical Center|Dr. Olga C. Aroniadis, PI|718-920-4846|oaroniad@montefiore.org|
22257423|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
22257424|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22257425|NCT01422720|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
22257426|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22257427|NCT01557452|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22257428|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu|
22257429|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
22257430|NCT01453101|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22257431|NCT04604496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257432|NCT02533505|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22257433|NCT00647426|Abramson Cancer Center|Tracey Evans MD|215 614 0861|Christine.Bonney@UPHS.upenn.edu|
22257434|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu|
22257435|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
22257436|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu|
22257437|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
22257438|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com|
22257439|NCT03583931|Denver Health and Hospital Authority|Dr Fredric Pieracci|303-602-1863|Fredric.Pieracci@dhha.org|
22257440|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22257441|NCT02866695|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
22257442|NCT05016765|Washington University School of Medicine|Kevin J. Black, M.D.|1-314-362-5041|kevin@wustl.edu|
22257443|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
22257444|NCT03891875|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22257445|NCT02192541|National Cancer Institute|Alice P. Chen, M.D.|(240) 781-3320|chenali@mail.nih.gov|
22257446|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu|
22257447|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607|tbd@hayatpharma.com|225
22257448|NCT04628221|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
22257449|NCT03474640|TopAlliance BioSciences|Dr. Kevin Li|301-640-5166|kevin_li@topalliancebio.com|
22257450|NCT04166851|Rutgers School of Public Health|Cui Yang|1-732-235-9754|cui.yang@rutgers.edu|
22257451|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22257452|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257453|NCT05298345|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22257454|NCT05631093|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
22257455|NCT02873195|Duke University Medical Center|Niharika Bansal Mettu, M.D.|919-681-2954|niharika.mettu@duke.edu|
22257456|NCT03107715|University Hospitals Rainbow Babies and Children's Hospital|Lydia Furman MD, PI|216-844=8260|lydia.furman@uhhospitals.org|
22257457|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov|
22257458|NCT03739684|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
22257459|NCT04822701|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257460|NCT02706353|M.D. Anderson Cancer Center|Adi Diab, MD|713-792-2921|MDADiab@mdanderson.org|
22257461|NCT03560466|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22257462|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org|
22257463|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com|
22257464|NCT04723173|Sonova AG|Bernhard Buschle|+41 58 928 44 21|bernhard.buschle@sonova.com|
22257465|NCT02996448|NIAID, NIH|Alexandra Freeman|301-594-9045|freemaal@mail.nih.gov|
22257466|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22257467|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22257468|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu|
22257469|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu|
22257470|NCT01289431|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22257471|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800|juan.avendano@uclm.es|5014
22257472|NCT02748616|NYU Langone Health|Norman Javitt, MD|212-263-6588|Norman.Javitt@nyulangone.org|
22257473|NCT02018042|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
22257474|NCT03231709|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22257475|NCT02419469|UT MD Anderson Cancer Center|Rytting,Michael E.,M.D. / PEDIATRICS|713-792-7734|CR_Study_Registration@mdanderson.org|
22257476|NCT01785875|Amgen Inc.|Study Director|866-572-6436||
22257477|NCT03112993|University of Missouri|Dr. Boris Mraovic, MD, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
22257478|NCT04840901|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22257479|NCT01414062|Columbia University Irving Medical Center|Dawn Hershman, MD, MS|212-342-4580|dlh23@cumc.columbia.edu|
22257480|NCT04075292|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22257481|NCT05292053|Baylor Scott & White Research Institute|Clinical Research Manager|214-820-1771|Felicia.Padilla@BSWHealth.org|
22257482|NCT01988493|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22257483|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org|
22257484|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22257485|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu|
22257486|NCT03087773|Medical University of Graz|Univ.-Prof. PD Harald Sourij, MD, MBA|+43 316 385 81310|ha.sourij@medunigraz.at|
22257487|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22257488|NCT05144477|Columbia University Irving Medical Center|Dr. Talea Cornelius|(212) 342-5503|tmc2184@cumc.columbia.edu|
22257489|NCT00639158|Abbott|Global Medical Services|800-633-9110||
22257490|NCT03403712|Helsinn SA|Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
22257491|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
22257492|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257493|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22257494|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com|
22257495|NCT02268045|mAbxience|Susana Millan|+34917711500|Susana.Millan@mabxience.com|9284
22257496|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415|orawaneamopas@yahoo.com|3327
22257497|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257498|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com|
22257499|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300||
22257500|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com|
22257501|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu|
22257502|NCT01556490|Boston Scientific|Clinical Research Manager|16138011844|chantal.laframboise@bsci.com|
22257503|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu|
22257504|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22257505|NCT04348292|Emory University|Jennifer Carlisle, MD|404-778-2304|jennifer.w.carlisle@emory.edu|
22257506|NCT01652872|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22257507|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22257508|NCT03690375|Siperstein Dermatology Group|founder/physician|5613647774|info@sipderm.com|
22257509|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22257510|NCT03985293|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257511|NCT02588651|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Study Principal Investigator|1-866-223-8100|TaussigResearch@ccf.org|
22257512|NCT05899218|University of Pennsylvania|Dr. Jennifer Tran|2158983616|jtgtran@nursing.upenn.edu|
22257513|NCT03801369|Oregon Health & Science University - Knight Cancer Institute|Gordon Mills, MD, PhD|503-346-4660|millsg@ohsu.edu|
22257514|NCT02587325|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22257515|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
22257516|NCT04236635|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22257517|NCT02913261|Novartis Pharmaceuticals|Study Directr|862-778-8300|novartis.email@novartis.com|
22257518|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257519|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu|
22257520|NCT02304302|Case Western Reserve University|Melissa Stasko, JD, MA|216-844-7281|Melissa.Stasko@case.edu|
22257521|NCT00391118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257522|NCT02251431|Baylor Scott & White Research Institute|Biostatistician|8033190755|gelareh.rahimighazikalayeh@bswhealth.org|
22257523|NCT03078192|Duke University Medical Center|Bastiaan Driehuys|919-684-7786|bastiaan.driehuys@duke.edu|
22257524|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257525|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22257526|NCT01197456|UC San Diego|Irene Su, MD MSCE|858-822-5986|hisu@ucsd.edu|
22257527|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22257528|NCT02424799|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22257529|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net|
22257530|NCT00689273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257531|NCT02953873|Medical University of South Carolina|Caitlin Schaffner|843-792-7558|schaffne@musc.edu|
22257532|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262|wesley.stoller@va.gov|54931
22257533|NCT03703297|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22257534|NCT03958071|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257535|NCT02414854|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22257536|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk|
22257537|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca|
22257538|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738||
22257539|NCT01586624|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22257540|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov|
22257541|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22257542|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257543|NCT01408576|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22257544|NCT03565666|Mass. General Hospital|Dr. Steven J. Russell|617-726-8722|sjrussell@mgh.harvard.edu|
22257545|NCT02703454|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
22257546|NCT02284373|New York University Langone Medical Center|Todd Berland, MD|212 263 5060|todd.berland@nyumc.org|
22257547|NCT02016755|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
22257548|NCT02476851|Haemonetics Corporation|Jan Hartmann, MD|(781) 348 7396|Jan.Hartmann@haemonetics.com|
22257549|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu|
22257550|NCT02869295|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
22257551|NCT02360397|Brigham and Women's Cardiovascular Associates at Kent Hospital|Chester M. Hedgepeth, MD, PhD|(401) 737-7010|chedgepeth@kentri.org|32880
22257552|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org|
22257553|NCT03543046|Orlando Health|Corporate Director of Compliance and Regulations|3218413687|Tara.Roberts@orlandohealth.com|
22257554|NCT03174925|Stanford University Medical Center|Aya Kamaya, Professor of Radiology|650-725-1812|kamaya@stanford.edu|
22257555|NCT04247594|Global Blood Therapeutics, Inc.|Eleanor Lisbon|+1 913 449 4319|elisbon@gbt.com|
22257556|NCT01093482|VENTILA group|Andres Esteban|34916834982|aesteban@ucigetafe.com|
22257557|NCT04440163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257558|NCT02577900|Queen Elizabeth Hospital|Dr. Tsang Ka-Kit|+852-35062610|kktsang3@netvigator.com|
22257559|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310||
22257560|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22257561|NCT01954082|University of Rochester|Dale Phelps|(585) 275-2972|dale_phelps@urmc.rochester.edu|
22257562|NCT01682512|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257563|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
22257564|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
22257565|NCT03137082|Stony Brook University|Dr Helen C Fox|631 632 0057|helen.fox@stonybrookmedicine.edu|
22257566|NCT02787785|Boston Scientific|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
22257567|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22257568|NCT03250507|Henry Ford Hospital|Christina Fidkowski, MD|313-916-7648|cfidkow1@hfhs.org|
22257569|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257570|NCT03127943|UNC Department of Oral and Maxillofacial Surgery|Raymond P. White Jr DDS, PhD|919-537-3944|ray_white@unc.edu|
22257571|NCT01447628|Imperial College London|Professor Martin Wilkins|0203 313 8078|jacob.bonner@nhs.net|38078
22257572|NCT04671329|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs|(508) 826-7183|ClinicalResearch@Hologic.com|
22257573|NCT01029769|Technische Universitaet Muenchen, Germany|Prof. Dr. Dr. Stefan Leucht|+498941404200|stefan.leucht@tum.de|
22257574|NCT02703779|University of Kansas Cancer Center|Dr. Sid Ganguly|913-588-6030|sganguly@kumc.edu|
22257575|NCT03111407|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22257576|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu|
22257577|NCT03959137|MSD Belgium|Stephanie Coulon|0032 485 461 467|stephanie.coulon@merck.com|
22257578|NCT03496207|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257579|NCT02756078|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan - PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
22257580|NCT00810615|San Antonio Military Medical Center, Wilford Hall Ambulatory Surgical Center|Dr. George Wolf, Associate Investigator|210-292-3483|earl.wolf.ctr@us.af.mil|
22257581|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22257582|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400|jennifer.turnbull@mcgill.ca|23039
22257583|NCT02058368|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22257584|NCT02181842|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22257585|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com|
22257586|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22257587|NCT02139306|PTC Therapeutics, Inc|Joseph McIntosh|908 912-9138|jmcintosh@ptcbio.com|
22257588|NCT04449354|HidraMed Solutions Ltd|Suzanne Moloney|+353873220509|suzanne@hidramedsolutions.com|
22257589|NCT05789420|Philip Morris Products S.A.|Xavier Jaumont, Global Head of Clinical Development and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
22257590|NCT02278952|University of California, San Francisco|Dr. John Greenland|415-476-0789|john.greenland@ucsf.edu|
22257591|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257592|NCT05406596|Seigla Medical|John Schultz|7632133026|jschultz223@gmail.com|
22257593|NCT02787746|Department of Neurology, Xuan Wu Hospital of Capital Medical University; Freindship Hospital of Capital Medical University|Jianping Jia|+86 10 83188730|jjp@ccmu.edu.cn|
22257594|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22257595|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
22257596|NCT04084028|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
22257597|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743||
22257598|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22257599|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org|
22257600|NCT01528878|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22257601|NCT02162511|Stanford University|Erica Goodwin|253-508-3556|egood55@stanford.edu|
22257602|NCT01160198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257603|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525|a.bronstein@imperial.ac.uk|+44
22257604|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com|
22257605|NCT03067506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22257606|NCT00552617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257607|NCT04651218|University of Kentucky|Dr. Kyle Flack|5182574351|kyle.flack@uky.edu|
22257608|NCT03940326|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
22257609|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300||
22257610|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
22257611|NCT00305110|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
22257612|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623||
22257613|NCT03141931|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
22257614|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU|
22257615|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22257616|NCT02661282|UT MD Anderson Cancer Center|Shiao-Pei Weathers, MD, Associate Professor, Neuro-Oncology|(713) 792-3906|sweathers@mdanderson.org|
22257617|NCT03578276|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|hps@cepmd.com|
22257618|NCT02626182|National Jewish Health|Jennifer Taylor-Cousar, MD, MSCS, ATSF|3032702764|Taylor-CousarJ@NJHealth.org|
22257619|NCT02267850|Biolux Research Ltd|Clinical Studies Manager|1-604-669-0674|d.skrenes@bioluxresearch.com|
22257620|NCT03005379|VA Cooperative Studies Program|Yuan Huang, Ph.D., Biostatistician|2039325711|yuanhuang1@va.gov|
22257621|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22257622|NCT02483481|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
22257623|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
22257624|NCT02766088|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
22257625|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu|
22257626|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22257627|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org|
22257628|NCT03870737|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22257629|NCT02613416|Stony Brook University|Caterina Vacchi-Suzzi|631-444-8074|caterina.vacchi-suzzi@stonybrookmedicine.edu|
22257630|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org|
22257631|NCT00390949|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
22257632|NCT02535247|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22257633|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22257634|NCT03061279|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
22257635|NCT01398982|UHN|Kate Butler|416-340-4800|kbutler@uhnresearch.ca|2343
22257636|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647|sreutrakul@yahoo.com|708
22257637|NCT04285983|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22257638|NCT04936334|Indiana University, Department of Urology|Jennifer Lehman, RN, Senior Research Leader|317-948-9575|jgeck@iu.edu|
22257639|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com|
22257640|NCT03747939|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22257641|NCT01850108|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22257642|NCT03273712|University of Iowa|M. Sue O'Dorisio, MD, PhD|(319) 335-7234|sue-odorisio@uiowa.edu|
22257643|NCT01542736|University of Colorado Denver|Jennifer Raybin, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22257644|NCT03674827|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257645|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com|
22257646|NCT00294632|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Wang, Professor, Lymphoma/Myeloma|713-792-2860|miwang@mdanderson.org|
22257647|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu|
22257648|NCT03454672|Novoxel Ltd|Ifat Klein|+972-52-6009860|ifat@novoxel.com|
22257649|NCT05166512|Johns Hopkins Bloomberg School of Public Health|Dr. Julia Wolfson|410-614-4907|jwolfso7@jhu.edu|
22257650|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22257651|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257652|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org|
22257653|NCT05473247|Berry College|Kameron Suire|3373968980|ksuire@berry.edu|
22257654|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU|
22257655|NCT02719639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257656|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22257657|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22257658|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr|
22257659|NCT01831596|KCI|VP, Global Clinical Development|210-255-5595|jkhart@mmm.com|
22257660|NCT03162354|Penn State College of Medicine, Penn State Health Children's Hospital|Kent P. Hymel, MD; Professor of Pediatrics; Study PI|7036748989|kphymel@gmail.com|
22257661|NCT02737072|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257662|NCT02149199|AstraZeneca AB|Stefan Ivanov|000000000000|information.center@astrazeneca.com|
22257663|NCT02762877|Genomic Health, Inc.|Director of Clinical Trials|1.650.569.2042|kgran@genomichealth.com|
22257664|NCT01915498|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22257665|NCT01806259|UoA|Prof Patrice Forget|497 12 28 36|forgetpatrice@yahoo.fr|
22257666|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
22257667|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu|
22257668|NCT01185639|Wake Forest University Health Sciences|Dr. William Blackstock|336-713-6501|ablackst@wakehealth.edu|
22257669|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com|
22257670|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu|
22257671|NCT00804349|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
22257672|NCT00563524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257673|NCT03608696|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
22257674|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl|
22257675|NCT03712137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257676|NCT04221087|University of PIttsburgh|Dr. Allison Williams|4126925135|williamsae2@upmc.edu|
22257677|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22257678|NCT03836729|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22257679|NCT03379246|TriHealth Inc.|Dr. Catrina Crisp|513-463-4300|Catrina_Crisp@trihealth.com|
22257680|NCT00566618|UT MD Anderson Cancer Center|Debu Tripathy, Chair, Breast Medical Oncology|(713) 792-2817|dtripathy@mdanderson.org|
22257681|NCT02177773|Unviersity of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|22648
22257682|NCT03964220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257683|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22257684|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu|
22257685|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257686|NCT00467818|UMDNJ|Sherie Novotny MD|(732) 235-4119|novotnsl@rutgers.edu|
22257687|NCT02135874|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Proffessor|713-792-4764|eajabbour@mdanderson.org|
22257688|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com|
22257689|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22257690|NCT02216214|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22257691|NCT00716586|University of Illinois at Chicago|Emeritus Professor of Ophthalmology|312 997-3646|gerafish@uic.edu|
22257692|NCT05354206|Washington University in St. Louis|Dr. Ismael Seáñez|3149357665|ismaelseanez@wustl.edu|
22257693|NCT04822467|Cleveland Clinic Foundation|Dr. Donald Kirby, MD|216-444-0446|kirbyd@ccf.org|
22257694|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22257695|NCT02209272|Mayo Clinic|Dr. Jacob L. Sellon|507-284-2608|sellon.jacob@mayo.edu|
22257696|NCT04057118|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
22257697|NCT01676311|Spaulding Rehabilitation Hospital|Ross Zafonte, DO|617-952-5227|rzafonte@mgh.harvard.edu|
22257698|NCT03402126|Medtronic Inc|Joy Aso, Clinical Research Specialist|4015454454|joy.a.aso@medtronic.com|
22257699|NCT02261974|Viveve, Inc.|Debbie Wilkerson, PhD, Vice President, Clinical and Medical Affairs|610-209-9980|dwilkerson@viveve.com|
22257700|NCT02030834|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22257701|NCT04440007|Sorrento Therapeutics, Inc.|Mike Royal, MD|858-203-4100|mroyal@sorrentotherapeutics.com|4146
22257702|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
22257703|NCT03398928|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
22257704|NCT05149989|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|+44(0)1517064553|tristan.payne@liverpoolft.nhs.uk|
22257705|NCT04529499|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
22257706|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22257707|NCT02702271|Boston Scientific|Director of Clinical Trials|1-800-CARDIAC|peter.maurer@bsci.com|
22257708|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257709|NCT03091400|Icahn School of Medicine at Mount Sinai|James F Sumowski, PhD|212-241-6854|james.sumowski@mssm.edu|
22257710|NCT00975884|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257711|NCT03707522|University of Nevada, Reno|Martha Zimmermann|7756368067|mzimmermann@nevada.unr.edu|
22257712|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257713|NCT02508649|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22257714|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com|
22257715|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk|
22257716|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300||
22257717|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu|
22257718|NCT02956005|MedStar Georgetown Transplant Institute|Alexander Gilbert|202-444-0621|Alexander.J.Gilbert@gunet.georgetown.edu|
22257719|NCT03125629|Stanford University|Andrei Iagaru|650-725-4711|aiagaru@stanford.edu|
22257720|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu|
22257721|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257722|NCT02989610|Abbott|Tucker Tomlinson, Scientist, Clinical Research|+19725269646|Tucker.Tomlinson@Abbott.com|
22257723|NCT04179474|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22257724|NCT02602080|Hospital for Special Surgery|George Birch|212-774-7377|birchg@hss.edu|
22257725|NCT01407107|University of Texas Southwestern Medical Center|Dr. Jonathan Dowell|214-648-7097|jonathan.dowell@utsouthwestern.edu|
22257726|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu|
22257727|NCT03934437|Johns Hopkins University|Larry Chang|4109551725|lchang8@jh.edu|
22257728|NCT04508621|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|Greg.Sullivan@TonixPharma.com|
22257729|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22257730|NCT02574260|Amgen, Inc.|Study Director|866-572-6436||
22257731|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22257732|NCT03022799|Kainos Medicine, Inc|Dr. JaeMoon Lee|+1 408 202 4017|jlee@kainosmedicine.com|
22257733|NCT04881448|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257734|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
22257735|NCT01966107|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22257736|NCT02200614|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22257737|NCT01898884|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22257738|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300||
22257739|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22257740|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca|
22257741|NCT02175472|PhotoPharmics, Inc.|Dan Adams|801-770-6960|dan.adams@photopharmics.com|
22257742|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22257743|NCT03980561|MUSC|Amanda Wagner|8437920484|wagne@musc.edu|
22257744|NCT02531698|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257745|NCT01861717|JOHN WAYNE CANCER INSTITUTE|Dr. Daniel Kelly|310-582-7450|Daniel.Kelly2@providence.org|
22257746|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com|
22257747|NCT01456494|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
22257748|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
22257749|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22257750|NCT04499391|Penn State College of Medicine|Dr. Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
22257751|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22257752|NCT04633187|Enanta Pharmaceuticals|Study Director|617-607-0800|enquiries@enanta.com|
22257753|NCT01998035|Columbia University Irving Medical Center|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
22257754|NCT04876482|Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan|Yi-Ju, Lai|+886963123117|jasmine19900728@gmail.com|
22257755|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
22257756|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com|
22257757|NCT02464059|University of North Carolina at Chapel Hill|Michael Bradley Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22257758|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22257759|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu|
22257760|NCT02499406|VACHS|Investigator|203 932 5711|suzanne.decker@va.gov|
22257761|NCT01485588|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22257762|NCT03591107|RAND|Lisa Meredith, Senior Behavioral Scientist|310.393.0411|seidel@rand.org|7365
22257763|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
22257764|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464||
22257765|NCT00823459|University of California, San Francisco|Susan Chang, MD|(415) 353-2966|jessica.carlson@ucsf.edu|
22257766|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257767|NCT00948025|AxoGen, Inc|Vice President, Clinical and Translational Sciences|3864626829|edevinney@axogeninc.com|
22257768|NCT01331083|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22257769|NCT04006847|Penn State Health|Seema Naik, MD|7175318678|snaik@pennstatehealth.psu.edu|
22257770|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257771|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
22257772|NCT03555890|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22257773|NCT03372369|University of North Carolina at Chapel Hill|Seri Link Anderson, PhD|919-619-0433|seri.link.a@gmail.com|
22257774|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
22257775|NCT01791127|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
22257776|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
22257777|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org|
22257778|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com|
22257779|NCT03851107|McGill University|Dr. Dana Anaby|15143984400|dana.anaby@mcgill.ca|00394
22257780|NCT04023994|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22257781|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu|
22257782|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300||
22257783|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22257784|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22257785|NCT00663039|MPRC|Elliot Hong|410-402-6828|ehong@mprc.umaryland.edu|
22257786|NCT03216954|University of Kentucky|William W. Stoops, PhD|859-257-5388|william.stoops@uky.edu|
22257787|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711|robert.kerns@va.gov|3841
22257788|NCT04333199|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22257789|NCT03778190|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
22257790|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov|
22257791|NCT02981602|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22257792|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22257793|NCT01032330|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22257794|NCT03304210|Ghent University|Prof|+32(0)93326251|wim.ceelen@ugent.be|
22257795|NCT02567266|University of Miami|Dr. Amanda Jensen-Doss|+1 (305)284-8332|ajensendoss@miami.edu|
22257796|NCT02983227|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22257797|NCT02020785|Geisinger|Alex Chang, MD|570-271-8026|achang@geisinger.edu|
22257798|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257799|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch|
22257800|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22257801|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22257802|NCT00947518|Department of Pediatrics, All India Institute of Medical Sciences, New Delhi|Mari Jeeva Sankar|+91-11-26594372|jeevasankar@gmail.com|
22257803|NCT02065791|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22257804|NCT04529096|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257805|NCT03467971|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22257806|NCT01619085|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257807|NCT02642991|CooperVision, Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22257808|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu|
22257809|NCT03273257|Papworth Hospital NHS Foundation Trust|David Jenkins, MD; Principal Investigator and ICA Board member|+44 1223 638000|david.jenkins1@nhs.net|
22257810|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
22257811|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22257812|NCT02450760|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.edu|
22257813|NCT04071392|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22257814|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu|
22257815|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu|
22257816|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com|
22257817|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22257818|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
22257819|NCT02685956|Global BioClinical|Jennifer Maas|206-240-8632|jen.maas@globalbioclinical.com|
22257820|NCT01222871|SEMC|Dr. Peter catalano|1-617-789-5004|peter.catalano@steward.org|
22257821|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22257822|NCT02239601|CancerCare Manitoba|Marshall Pitz|2044751431|Mpitz@cc.umanitoba.ca|
22257823|NCT04682639|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257824|NCT04388527|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
22257825|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22257826|NCT02773446|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22257827|NCT02513459|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257828|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22257829|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22257830|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
22257831|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu|
22257832|NCT02454972|Pharma Mar S.A.|Clinical Development, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22257833|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net|
22257834|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22257835|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk|
22257836|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22257837|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu|
22257838|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
22257839|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22257840|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr|
22257841|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22257842|NCT01725113|NYU Langone Health|Candace Grant|5166632171|Candace.Grant@nyulangone.org|
22257843|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr|
22257844|NCT02753400|Kubota Vision Inc.|Clinical Trials Helpdesk|2068058310|clinicaltrials@kubotavision.com|
22257845|NCT03989115|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-02@revmed.com|
22257846|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
22257847|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu|
22257848|NCT04980521|University of North Dakota|Dr. Gary Schwartz|701-777-6598|gary.schwartz@und.edu|
22257849|NCT02660385|University of Connecticut/formerly Yale University|Meghan O'Connell, Program Manager|860-634-4152|meghan.oconnell@uconn.edu|
22257850|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257851|NCT03007537|Nanjing First Hospital, Nanjing Medical University|Dr. Xiaobin Ji|13705174622|xbji007@126.com|
22257852|NCT04736576|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257853|NCT00720304|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Min Yao, MD|1-800-641-2422|CTUReferral@UHhospitals.org|
22257854|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com|
22257855|NCT04330482|Rhode Island Hospital|Geoffrey Tremont|401-444-4500|gtremont@lifespan.org|
22257856|NCT05180630|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22257857|NCT01382901|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|601-650-4200|mfalone@luitpold.com|
22257858|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
22257859|NCT01468974|Abbott Vascular|Nadia bouhdi||nadia.bouhdi@av.abbott.com|
22257860|NCT02725671|Johns Hopkins University|Dr. Armin Zadeh|4105020549|arminzadeh@jhu.edu|
22257861|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22257862|NCT02135094|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
22257863|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
22257864|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22257865|NCT02492295|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|215-456-2313|MOHIUDDK@EISNTEIN.EDU|
22257866|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu|
22257867|NCT02354976|AstraZeneca|Torbjörn Lundström|46 317064100|Torbjorn.lundstrom@astrazeneca.com|
22257868|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888||151
22257869|NCT00068445|Mayo Clinic|Charles L. Loprinzi, M.D.|507-284-3731|cloprinzi@mayo.edu|
22257870|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org|
22257871|NCT01896700|Portland VA Health Care System|Andrea Hildebrand|503-220-8262|hildeand@ohsu.edu|52016
22257872|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22257873|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu|
22257874|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org|
22257875|NCT02282111|The Johns Hopkins Hospital|Dr. Mouen A. Khashab|410-502-0064|mkhasha1@jhmi.edu|
22257876|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu|
22257877|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
22257878|NCT02771340|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22257879|NCT05788237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257880|NCT04148508|University of Exeter|Professor Ed Watkins|01392 724692|e.r.watkins@exeter.ac.uk|
22257881|NCT03877484|Smith and Nephew|Clinical Study Manager|1482673917|rebecca.mcdonald@smith-nephew.com|+44
22257882|NCT00918229|BioProtect|Shaul Shohat|+972545423774|Shaul@bioprotect.com|
22257883|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu|
22257884|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com|
22257885|NCT03724916|Takeda|Contact|+1-877-825-3327|medinfoUS@takeda.com|
22257886|NCT04575038|Clear Creek Bio, Inc.|Barbara Powers, Vice President Clinical Operations|16177652252|clinical@clearcreekbio.com|
22257887|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257888|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
22257889|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr|
22257890|NCT04335110|Oregon Health & Science University|Dr. Allison Lindauer|15034946976|lindauer@ohsu.edu|
22257891|NCT05105477|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
22257892|NCT03101293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22257893|NCT02833857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22257894|NCT03182920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22257895|NCT02542150|"University of Colorado Denver | Anschutz"|Jody Tanabe, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22257896|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22257897|NCT03333382|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
22257898|NCT03471182|Yale University School of Medicine|Patrick Worhunsky|203-737-2668|patrick.worhunsky@yale.edu|
22257899|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu|
22257900|NCT03512067|Brigham and Women's Hospital|Dr. Gyorgy Frendl|617-732-5910|gfrendl@bwh.harvard.edu|
22257901|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22257902|NCT03451331|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22257903|NCT00289731|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257904|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu|
22257905|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
22257906|NCT00660790|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
22257907|NCT06118359|University of Wisconsin|Angela Ingraham|513-833-5205|aingraham.md.ms@gmail.com|
22257908|NCT04214951|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
22257909|NCT03202628|Mayo Clinic|Dr. Prashant Kapoor|507-284-2511|Kapoor.Prashant@mayo.edu|
22257910|NCT00686374|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22257911|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22257912|NCT03903640|Washington University School of Medicine|Dr. George Ansstas|314-508-4426|gansstas@wustl.edu|
22257913|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257914|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk|
22257915|NCT02786498|University of Maryland Baltimore, School of Medicine, Department of Orthopaedics|Dr Gerard Slobogean|410-28-6280|gslobogean@som.umaryland.edu|
22257916|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
22257917|NCT04228302|EicOsis|Dr. William Schmidt|650-438-3018|wkschmidt@eicosis.com|
22257918|NCT00685919|Vanderbilt University Medical Center|Alfredo Gamboa, MD|615-875-1003|alfredo.gamboa@vumc.org|
22257919|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22257920|NCT03118765|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22257921|NCT02643966|University of Pittsburgh|Dr. Wendie A. Berg|412-641-1635|bergwa@upmc.edu|
22257922|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22257923|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com|
22257924|NCT03835975|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257925|NCT01362959|Department of Intensive care, Deventer Hospital|Dr. Huub van den Oever|+31 570 535346|h.vandenoever@dz.nl|
22257926|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196|osktk@snubh.org|7200
22257927|NCT03070431|Department of Radiation Oncology, University of Lübeck, Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|rades.dirk@gmx.net|45400
22257928|NCT00370396|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257929|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com|
22257930|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu|
22257931|NCT00051636|Novartis|Study Director|862-778-8300||
22257932|NCT02340078|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22257933|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu|
22257934|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org|
22257935|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257936|NCT03338673|University of Michigan|Dr. Cynthia Burton|7347639259|czburton@umich.edu|
22257937|NCT01551550|TissueTech|Medical Affairs|(888) 296-8858|info@tissuetech.com|
22257938|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu|
22257939|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu|
22257940|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22257941|NCT04248855|Kanyos Bio (A wholly owned subsidiary of Anokion SA)|Medical Director|+1 857-320-6607|clinicaltrials@anokion.com|
22257942|NCT01368276|Amgen, Inc.|Study Director|866-572-6436||
22257943|NCT05483920|Black Hills State University|Dr. Ashley Pfeiffer|(605) 381-5370|ashley.pfeiffer@bhsu.edu|
22257944|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22257945|NCT03341273|Duke University|Ephraim L. Tsalik, MD, MHS, PhD|919-684-3114|e.t@duke.edu|
22257946|NCT01674478|Wake Forest University Health Sciences|Dr. Qing Yang||qyang@wakehealth.edu|
22257947|NCT02281409|Memorial Sloan Kettering Cancer Center|Dr. Jedd Wolchok, MD, PhD|646-888-2315|wolchokj@mskcc.org|
22257948|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu|
22257949|NCT02732561|Wake Forest Health Sciences|James Kimball, MD|1 (336) 716-9702|jkimball@wakehealth.edu|
22257950|NCT05795062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257951|NCT03066440|UBMD Pediatrics|Dr. Amanda B. Hassinger, Medical Director of the UBMD Pediatrics Sleep Center|716-323-0158|albrooks@buffalo.edu|
22257952|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com|
22257953|NCT03723590|Medline Industries|Julie Miller|630-418-6891|jamiller@medline.com|
22257954|NCT04991311|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
22257955|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com|
22257956|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org|
22257957|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
22257958|NCT03944707|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22257959|NCT01878500|Johns Hopkins University|Dr. John P Gearhart|410-955-5358|jgearha2@jhmi.edu|
22257960|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw|
22257961|NCT01959230|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
22257962|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
22257963|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com|
22257964|NCT00123110|University of Pennsylvania, School of Medicine|Anne R. Cappola, M.D., ScM|(215) 573-5359|ACappola@mail.med.upenn.edu|
22257965|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22257966|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200|teresafr@mail.med.upenn.edu|119
22257967|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22257968|NCT04000373|Cleveland Clinic Neurological Institute Mellen Center|Research Nurse Coordinator|216-445-5877|stoughd@ccf.org|
22257969|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
22257970|NCT02525562|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
22257971|NCT00886782|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22257972|NCT01946282|University of Texas Southwestern Medical Center, Moncrief Cancer Institute|Dr. Keith Argenbright, Director, Moncrief Cancer Institute|817-288-0070|keith.argenbright@utsouthwestern.edu|
22257973|NCT03031431|Boston Children's Hospital|Dr. Anne Hansen|(617)-355-6027|Anne.Hansen@childrens.harvard.edu|
22257974|NCT00078819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22257975|NCT04130919|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22257976|NCT03012815|Mayo Clinic|Ruth Bates|507-255-8716|Bates.Ruth@mayo.edu|
22257977|NCT03216200|DeviceFarm|VP Operations|510-295-5293|timgrammer@devicefarmtech.com|
22257978|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22257979|NCT02400905|Veryan Medical|Nick Yeo|+44 1403 258984|nick.yeo@veryanmed.com|
22257980|NCT02964897|Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System|Keith McInnes, Principal Investigator|617-504-1630|donald.mcinnes@va.gov|
22257981|NCT03196791|Korea university Anam Hospital|Dr. Shin Hoo Park|+82-10-6735-1824|bulsajo333@hanmail.net|
22257982|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343||
22257983|NCT02565485|University Hospitals Cleveland Medical Center|Justin R. Lappen MD|216-844-3787|Justin.Lappen@UHhospitals.org|
22257984|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu|
22257985|NCT01749033|Northwerstern University|Ling Hu M.D.|312-695-3428|l-hu2@northwestern.edu|
22257986|NCT05552430|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ryan Mace|617-724-7030|rmace@mgh.harvard.edu|
22257987|NCT01256398|University of California San Diego Moores Cancer Center|Matthew Wieduwilt, MD, PhD|858-822-6848|mwieduwilt@ucsd.edu|
22257988|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22257989|NCT02740660|Pennington Biomedical Research Center|Dr. Daniel Hsia|225-763-3000|clinicaltrials@pbrc.edu|
22257990|NCT01174368|The Rogosin Institute|Angelica Nazarian|212-746-1551||
22257991|NCT00479765|Boston Scientific Corporation|Jessie Stockwell|16126181136|jessie.stockwell@bsci.com|
22257992|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com|
22257993|NCT03550794|Montefiore Medical Center|Dr. Ari Moskowitz|7189202956|amoskowitz@montefiore.org|
22257994|NCT01864525|Syracuse University|Dr. Soren Lowell|315-443-9648|slowell@syr.edu|
22257995|NCT01890785|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22257996|NCT03296553|Instituto Nacional de Cancerología|Dr. Patricia Volkow|01 55 5628 0400|pvolkowf@gmail.com|12120
22257997|NCT00558519|University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
22257998|NCT03001011|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22257999|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be|
22258000|NCT03077828|Northwestern University|Dr. Jane N. Winter, M.D.|3126954538|j-winter@northwestern.edu|
22258001|NCT02392559|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22258002|NCT02820324|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22258003|NCT03125915|Hunter College, CUNY|Tyrel Starks, Associate Professor|212-206-7919|tstarks@hunter.cuny.edu|934
22258004|NCT04816877|Beth Israel Deaconess Medical Center|Dr. Sunil Sheth|6176675576|ssheth@bidmc.harvard.edu|
22258005|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
22258006|NCT02176642|Duke University|Nazema Siddiqui MD||nazema.siddiqui@duke.edu|
22258007|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22258008|NCT00295620|ABCSG|Trial Office Director|+43 1 4089230|info@abcsg.at|
22258009|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu|
22258010|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258011|NCT01397656|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
22258012|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov|
22258013|NCT01625286|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22258014|NCT02936479|NYU Langone Health- Transplant Institute|Cecilia Deterville, MS, CCRC|212.263.3620|Cecilia.Deterville@nyulangone.org|
22258015|NCT03574818|Montefiore Medical Center|Balazs Halmos|7184058404|bahalmos@montefiore.org|
22258016|NCT04523831|Dhaka Medical College|Dr. Reaz Mahmud, Principal investigator|01912270803|reazdmc22@yahoo.com|+88
22258017|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300||
22258018|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
22258019|NCT03627195|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22258020|NCT03254719|Palmer Center for Chiropractic Research|Dr. Anna Walden-Cobb|563-949-0676|anna.waldencobb@palmer.edu|
22258021|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22258022|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22258023|NCT01977352|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat||alishariatmd@gmail.com|
22258024|NCT02580188|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
22258025|NCT02412956|The George Washington University|Dr. Lorien Abroms||lorien@gwu.edu|
22258026|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22258027|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22258028|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
22258029|NCT01681771|Linköping University, Department of social and welfare studies. Linköping University|Prof. RN Peter Johansson|+4613313685|peter.b.johansson@liu.se|
22258030|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
22258031|NCT02879747|Queen Silvia Children´s Hospital and University of Gothenburg|Dr Jovanna Dahlgren, PI and director of Department of Pediatrics|+46702750233|jovanna.dahlgren@gu.se|
22258032|NCT03208933|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22258033|NCT03154333|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
22258034|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu|
22258035|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
22258036|NCT02096029|Medical University of South Carolina|Amy Boatright, Program Coordinator|843-876-2440|boatrigh@musc.edu|
22258037|NCT04242186|Hebrew SeniorLife|Sarah Berry, MD, MPH|617-971-5355|sarahberry@hsl.harvard.edu|
22258038|NCT05319977|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
22258039|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258040|NCT00353938|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
22258041|NCT00478361|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Nizar M Tannir, MDChair Ad Interim, Genitourinary Medical Oncology|713-563-7265|ntannir@mdanderson.org|
22258042|NCT01872689|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258043|NCT01456052|Lexicon Pharmaceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com|
22258044|NCT03094806|New York Methodist Hospital|Jeremy A Weingarten, MD|718-780-5835|jaw9031@nyp.org|
22258045|NCT02762565|University of Pennsylvnia|Robyn Broach|215-662-7300|robyn.broach@uphs.upenn.edu|
22258046|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22258047|NCT03103581|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
22258048|NCT02770716|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
22258049|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22258050|NCT02499354|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
22258051|NCT04303845|Mayo Clinic|Rashmi B. Halker Singh, M.D.|480-301-8100|Halker.Rashmi@mayo.edu|
22258052|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22258053|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it|
22258054|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22258055|NCT04132232|UAB|Christina Blanchard|205-934-7982|ctblanchard@uabmc.edu|
22258056|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22258057|NCT03876873|University of Missouri-Columbia|Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
22258058|NCT03547531|Prince of Songkla University|istiyanti Hapsari|+66980493996|istiyantihapsari@gmail.com|
22258059|NCT02649608|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22258060|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu|
22258061|NCT02117479|Incyte Corporation|Study Director|855 463-3463||
22258062|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu|
22258063|NCT02577042|Fundació Lluita contra la SIDA|Director of Clinical Trials|+34 93 497 84 14|enegredo@flsida.org|
22258064|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
22258065|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu|
22258066|NCT02629133|Womene and Infants Hospital|Caron Zlotnick|401-474-3332|czlotnick@butler.org|
22258067|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org|
22258068|NCT02598193|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22258069|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu|
22258070|NCT00447694|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22258071|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22258072|NCT00657917|Uniformed Services University of the Heralth Sciences|COL Naomi Aronson MC|301-295-3621|naronson@usuhs.mil|
22258073|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258074|NCT02328807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Julio M. Pow-Sang|813-745-2226|julio.powsang@moffitt.org|
22258075|NCT03672396|University of North Carolina at Chapel Hill|Erik Hanson, PhD|19199620816|edhanson@email.unc.edu|
22258076|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org|
22258077|NCT02580201|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
22258078|NCT04380701|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22258079|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
22258080|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org|
22258081|NCT04363736|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22258082|NCT03797222|Children's Hospital of Philadelphia|Lauren Mitteer|215-590-3174|mitteerl@chop.edu|
22258083|NCT02122471|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22258084|NCT02720224|Estetra SPRL|Marie Mawet||mmawet@mithra.com|
22258085|NCT04542330|University of Southern Denmark|Professor Christine Stabell Benn|+45 25883964|cbenn@health.sdu.dk|
22288981|NCT02688777|North Florida/South Georgia Veteran's Health System|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov|105238
22258086|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu|
22258087|NCT06610279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22258088|NCT00928135|University of Iowa|Lakshmi Durairaj|3193537968|lakshmi-durairaj@uiowa.edu|
22258089|NCT04355767|Stanford University|Kevin Schulman, MD|(650) 724-0543|kevin.schulman@stanford.edu|
22258090|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22258091|NCT02033382|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
22258092|NCT01005407|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22258093|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu|
22258094|NCT02432456|Medical College of Wisconsin|Thomas Carver|414-955-1733|tcarver@mcw.edu|
22258095|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu|
22258096|NCT04583592|Sagent Pharmaceuticals, Inc.|Cynthia Tinkoff, Pharm.D. Manager, Medical Affairs|847-908-6913|ctinkoff@sagentpharma.com|
22258097|NCT02517099|Imperial College London|Professor Sejal Saglani|02075943167|s.saglani@imperial.ac.uk|
22258098|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444||
22258099|NCT03053622|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22258100|NCT01246986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22258101|NCT01447329|Mike O'Callaghan Military Medical Center, Clinical Investigation Program|Amanda Crawford|(702) 653-3583|amanda.j.crawford.ctr@health.mil|
22258102|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22258103|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122|ALaptook@WIHRI.org|7404
22258104|NCT04036227|Gesynta Pharma AB|Charlotte Edenius|+46733864246|ctg@gesynta.se|
22258105|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258106|NCT01406873|University of Rochester|Charles Thornton, MD|585-275-2542|Charles_Thornton@urmc.rochester.edu|
22258107|NCT03990389|The University of Chicago|Dr. David Beiser|773-702-0307|dbeiser@medicine.bsd.uchicago.edu|
22258108|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22258109|NCT02595528|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22258110|NCT03202511|Division of Clinical Pharmacology, School of Medicine, Indiana University|Dr. Zeruesenay Desta|317-274-2823|zdesta@iu.edu|
22258111|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22258112|NCT02460874|UAB|Dr. Hunter Boggs|205-934-5670|dboggs@uabmc.edu|
22258113|NCT03862625|Istanbul University|Dr. Merve Damla Korkmaz|+905556297264|mervedml@gmail.com|
22258114|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu|
22258115|NCT02614703|Dostor's Hospital at Renaissance|Dr Ingrid M Chacon|(956) 362-3636|I.chacon@dhr-rgv.com|
22258116|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22258117|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu|
22258118|NCT00782275|Beth Israel Deaconess Medical Center|David F. McDermott MD PhD|617-632-9262|dmcdermo@bidmc.harvard.edu|
22258119|NCT04378010|Enanta Pharmaceuticals, Inc|Alaa Ahmad|1-617-607-0800|aahmad@enanta.com|
22258120|NCT01792284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258121|NCT02019979|Icahn School of Medicine at Mount Sinai|Dr. Anish Parikh|(212) 241-4705|anish.parikh@mountsinai.org|
22258122|NCT02732587|Yale University Dept of Psychiatry|Dr Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
22258123|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu|
22258124|NCT03237611|Albert Einstein College of Medicine|Dr. Richard Gralla|718-918-6235|richard.gralla@nbhn.net|
22258125|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it|
22258126|NCT04636398|University of California San Francisco|Alison El Ayadi|415-659-8367|alison.elayadi@ucsf.edu|
22258127|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org|
22258128|NCT00534092|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22258129|NCT02919475|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22258130|NCT01928446|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
22258131|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org|
22258132|NCT06156969|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|PBONATO@mgh.harvard.edu|
22258133|NCT00628394|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
22258134|NCT02323295|Massachusetts General Hospital|Dr. Joseph Schwab|617-643-0547|JHSCHWAB@PARTNERS.ORG|
22258135|NCT02873481|Virginia Commonwealth University School of Nursing|Dr. Patricia Kinser, Assistant Professor|804-828-9140|kinserpa@vcu.edu|
22258136|NCT02370784|University of Pittsburgh School of Medicine|Robyn T. Domsic, MD MPH|412-383-8000|rtd4@pitt.edu|
22258137|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu|
22258138|NCT04356573|UAMS|Robert Wolfe|501-526-5708|rrwolfe2@uams.edu|
22258139|NCT01577537|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22258140|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258141|NCT01173159|Cincinnati Children's Hospital Medical Center|Crystal Slaughter, BA, CCRC|513-636-0137|crystal.slaughter@cchmc.org|
22258142|NCT02041494|University of California, San Francisco|Dr. Hobart W. Harris, Chief of General Surgery|(415) 514-3891|hobart.harris@ucsf.edu|
22258143|NCT02784925|WanFangH|Ming-Shun Wu|88629307930|mswu@tmu.edu.tw|7923
22258144|NCT05784571|Pennington Biomedical Research Center, Baton Rouge, LA|Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
22258145|NCT02348619|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22258146|NCT02487979|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22258147|NCT02410837|Medtronic|Jennifer Wolvers|763-258-9405|Jennifer.Wolvers@Medtronic.com|
22258148|NCT02523274|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
22258149|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu|
22258150|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov|
22258151|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
22258152|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu|
22258153|NCT01825876|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258154|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
22258155|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be|
22258156|NCT01147016|Barbara Ann Karmanos Cancer Institute|Dr. Amy Weise|248-344-6688|aweise3@hfhs.org|
22258157|NCT03670537|Auerbach Hematology and Oncology|Michael Auerbach|4107804050|mauerbachmd@abhemonc.com|
22258158|NCT03636542|University of Minnesota|Jason Habeck|612-625-7675|habe0073@umn.edu|
22258159|NCT05149287|University of Kentucky|Austin Stone|(859) 323-5533|austin.stone@uky.edu|
22258160|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258161|NCT03751020|Yale University School of Public Health (Social and Behavioral Sciences)|Dr. John Pachankis|(203) 785-3710|john.pachankis@yale.edu|
22258162|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22258163|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com|
22258164|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22258165|NCT02217345|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
22258166|NCT00845026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258167|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org|
22258168|NCT01203774|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22258169|NCT02238977|University of Arkansas for Medical Sciences|Pedro Delgado, M.D.|501-526-8100|pldelgado@uams.edu|
22258170|NCT01428024|Q-Med AB|Head of Medical Affairs|+ 46 (0) 18 4749000|reception.SEUPP@galderma.com|
22258171|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu|
22258172|NCT03712228|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22258173|NCT01964105|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS|TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY|314-362-4263|myckatyn@wustl.edu|
22258174|NCT04080882|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22258175|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu|
22258176|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com|
22258177|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567|cawoods@sciborg.uwaterloo.ca|36547
22258178|NCT02522949|Enzymatica AB|Enzymatica AB|+46 46 286 31 00|info@enzymatica.com|
22258179|NCT01021137|James H. Quillen VA Medical Center|Director of Vestibular Laboratory|423-926-1171|faith.akin@va.gov|7376
22258180|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258181|NCT03536819|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
22258182|NCT04288115|Central Arkansas Veterans Healthcare System|Spyridoula Maraka, MD, MS|(501) 257-5848|Spyridoula.Maraka@va.gov|
22258183|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu|
22258184|NCT04556838|VivaVision Biotech, Inc.|Joanne Li, M.D.|86-02158598290|joanne.li@vivavisionbio.com|
22258185|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov|
22258186|NCT00142454|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22258187|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu|
22258188|NCT01326702|Memorial Sloan Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
22258189|NCT02266706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258190|NCT03615079|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.Edu|
22258191|NCT02270983|Forest Research Institute, Inc., an affiliate of Allergan|Therapeutic Area Head|862-261-7000|IR-CTRegistration@allergan.com|
22258192|NCT02609737|Memorial Sloan Kettering Cancer Center|Dr. Lisa Bodie, MD, PhD|212-639-6650|bodeil@mskcc.org|
22258193|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
22258194|NCT02962882|Molnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22258195|NCT04741503|Washington University School of Medicine|Ashley J. Housten, OTD, MSCI|314-454-7958|ahousten@wustl.edu|
22258196|NCT00674219|UCLA Department of Psychiatry|Alexander Bystritsky MD PhD|(310) 206-5133|abystritsky@mednet.ucla.edu|
22258197|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
22258198|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com|
22258199|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com|
22258200|NCT03840811|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|(919) 843-6893|mmhobbs@med.unc.edu|
22258201|NCT01904383|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258202|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22258203|NCT02062606|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
22258204|NCT04313283|University of Maryland Baltimore|Sarah Dababnah|14107068076|sdababnah@ssw.umaryland.edu|
22258205|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch|
22258206|NCT03211156|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|schwebke@uab.edu|
22258207|NCT03947788|NorthShore University HealthSystem|Emily White VanGompel|224-364-7300|ewhitevangompel@northshore.org|
22258208|NCT02199652|Medical College of Georgia; Augusta University|William Vaughn McCall|7067216719|WMCCALL@augusta.edu|
22258209|NCT02951884|Loyola University Medical Center|William Lack, M.D.|708-216-1175|wlack@luc.edu|
22258210|NCT01202994|University of Utah|Dr. Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|801
22258211|NCT02528318|Windtree Therapeutics, Inc.|Robert Segal, MD, FACP|215-488-9300|rsegal@windtreetx.com|9450
22258212|NCT04126733|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22258213|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258214|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22258215|NCT02624518|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
22258216|NCT02729194|University of Michigan Rogel Cancer Center|Dr. Ajjai Alva, M.D.|734-936-0091|ajjai@umich.edu|
22258217|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258218|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22258219|NCT03652961|NYU Langone Health|Gregg J. Silverman, MD MACR|212 263 9440|Gregg.Silverman@nyulangone.org|
22258220|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com|
22258221|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22258222|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org|
22258223|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099||
22258224|NCT01190202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258225|NCT03276962|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258226|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479|rwinkler@aptalispharma.com|4175
22258227|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org|
22258228|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu|
22258229|NCT03056001|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22258230|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22258231|NCT04974645|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
22258232|NCT06079853|Columbia University School of Nursing|Allison A. Norful|2123057157|aan2139@cumc.columbia.edu|
22258233|NCT00389649|Universitry of Maryland|Stephen Gottlieb, MD|4103288788|sgottlie@medicine.umaryland.edu|
22258234|NCT03567239|Madonna Rehabilitation Hospital|Chase Pfeifer, Ph.D.|402-413-4504|cpfeifer@madonna.org|
22258235|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu|
22258236|NCT02769000|Virginia Commonwealth University|Timothy Harris, MD|804-828-7232|timothy.harris@vcuhealth.org|
22258237|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com|
22258238|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
22258239|NCT04553484|Semler Scientific|Gena Parker|669-230-2729|gparker@semlerscientific.com|
22258240|NCT03593772|James A. Haley Veteran Hospital Research Service|Dr. Jolie Haun|904-377-6796|Jolie.Haun@va.gov|
22258241|NCT03499249|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
22258242|NCT01374906|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22258243|NCT02795780|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22258244|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu|
22258245|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu|
22258246|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net|
22258247|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com|
22258248|NCT01880541|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
22258249|NCT01458119|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22258250|NCT03033069|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22258251|NCT00430638|Daiichi Sankyo|Global Clinical Leader|1-908-992-6400||
22258252|NCT01529749|Hospital Clínic|FELIPE GARCIA ALCAIDE|34619175783|FGARCIA@clinic.cat|
22258253|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300||
22258254|NCT02623426|Johns Hopkins Bloomberg School of Public Health|Douglas A Jabs, MD, MBA|410 -955-1254|djabs1@jhmi.edu|
22258255|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258256|NCT05458895|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22258257|NCT04639310|Xenon Pharmaceuticals Inc|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
22258258|NCT05166421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
22288982|NCT02549365|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22258259|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu|
22258260|NCT03262233|UW-Madison|John Curtin|608-262-0387|jjcurtin@wisc.edu|
22258261|NCT03770000|Rhizen Pharmaceuticals AG|Dr. Ajit Nair|+41 32 580 0113|an@rhizen.com|
22258262|NCT03877237|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
22258263|NCT02464878|Massachusetts General Hospital|James Markmann|617-643-4533|jmarkmann@mgh.harvard.edu|
22258264|NCT02290028|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|1-800-547-0394|crystal.miller@biotronik.com|
22258265|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu|
22258266|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
22258267|NCT00566098|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
22258268|NCT02236754|Columbia University|Dr. Paul Harris|212-305-7363|peh1@cumc.columbia.edu|
22258269|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22258270|NCT01375010|Columbia University|Elizabeth Shane, MD|212-305-6289|es54@cumc.columbia.edu|
22258271|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258272|NCT04364165|Desmond Tutu Health Foundation (DTHF)|Philip Smith|+27 21 650 1895|philip.smith@hiv-research.org.za|
22258273|NCT00830063|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258274|NCT01847313|University College Dublin|Prof Carel le Roux|+353 1 716 6831|carel.leroux@ucd.ie|
22258275|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22258276|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
22258277|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de|
22258278|NCT03763331|Purdue University|Dr. Bruno Roseguini|7654906284|brosegui@purdue.edu|
22258279|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258280|NCT00936884|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
22258281|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258282|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22258283|NCT02280421|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22258284|NCT02797964|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258285|NCT03870997|Evidation Health|Executive Director, Digital Health Outcomes|650-389-9550|results@evidation.com|
22258286|NCT03726437|GEORGIA STATE UNIVERSITY|Dr. Laura Salazar|4044131396|lsalazar1@gsu.edu|
22258287|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org|
22258288|NCT01917188|Intermountain Heart Institute|Patti Spencer|8015074700|patti.spencer@imail.org|
22258289|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org|
22258290|NCT03818919|Henry Ford Health System|Dr. Toufic Jildeh|(517)2308511|touficjildeh@gmail.com|
22258291|NCT01889862|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
22258292|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22258293|NCT00667719|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22258294|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org|
22258295|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22258296|NCT01361607|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22258297|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org|
22258298|NCT03411642|University Medical Center Hamburg-Eppendorf|Prof. Dr. Götz Thomalla|+4940501377410|thomalla@uke.de|
22258299|NCT02273206|Clinical Directors Network|Andrea Cassells, MPH|212-382-0699|acass@cdnetwork.org|227
22258300|NCT03082391|Cleveland Clinic Foundation|Dr. Michael Rosen|2164453441|rosenm@ccf.org|
22258301|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu|
22258302|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu|
22258303|NCT02741271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258304|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258305|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258306|NCT01953783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22258307|NCT01789281|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22258308|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org|
22258309|NCT03029000|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22258310|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu|
22258311|NCT04428502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258312|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu|
22258313|NCT02295280|Saint Louis University|Dorothea Mostello, MD, Maternal Fetal Medicine Faculty|314-977-2090|mostello@slu.edu|
22258314|NCT02875067|NYU Langone Health|Catherine Diefenbach, MD|212-731-5670|Catherine.Diefenbach@nyulangone.org|
22258315|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258316|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
22258317|NCT02713243|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22258318|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258319|NCT03751124|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22258320|NCT04777591|University of Virginia|John T Stranix, MD|434-924-5078|jts3v@uvahealth.org|
22258321|NCT00555399|University of Texas M D Anderson Cancer Center|Dr. Vinay K. Puduvalli|(713) 745-2343|vpuduval@mdanderson.org|
22258322|NCT00343642|Rush University Medical Center|Ece A Mutlu, Principal Investigator|312 942 5861|Ece_Mutlu@rush.edu|
22258323|NCT02462382|Orlando Orthopaedic Center|Randy Schwartzberg, MD|407-254-2500|orlandosportsdoc@yahoo.com|
22258324|NCT00860574|Fred Hutch/University of Washington Cancer Consortium|Joachim Deeg|206.667.5985|jdeeg@fredhutch.org|
22258325|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258326|NCT01335399|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22258327|NCT01893983|San Francisco VA Healthcare System|Dr. Karen Seal|415-2214810|karen.seal@va.gov|24852
22258328|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258329|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu|
22258330|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258331|NCT03372083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22258332|NCT01690520|Deverra Therapeutics|Chief Scientific Officer|206-519-5304|cdelaney@deverratx.com|
22258333|NCT01725815|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
22258334|NCT02544633|Mirati Therapeutics, Inc.|Vanessa Tassell, Vice President, Clinical Science|858-332-3438|tassellv@mirati.com|
22258335|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22258336|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
22258337|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu|
22258338|NCT02468557|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22258339|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258340|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com|
22258341|NCT03322462|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22258342|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org|
22258343|NCT02764489|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22258344|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
22258345|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258346|NCT02853929|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258347|NCT00623623|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258348|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com|
22258349|NCT02265952|Regeneron Pharmaceuticals, Inc.|Clinical Trial Information|844-734-6643|clinicaltrials@regeneron.com|
22258350|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov|
22258351|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
22258352|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu|
22258353|NCT02655354|University of Washington School of Medicine|Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
22258354|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258355|NCT03522584|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
22258356|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu|
22258357|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22258358|NCT02736227|Northwestern University|Josh Levitsky|312-695-4413|j-levitsky@northwestern.edu|
22258359|NCT01205529|Vanderbilt University Medical Center|Dan Roden|6153220067|dan.roden@Vanderbilt.Edu|
22258360|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu|
22258361|NCT03840135|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
22258362|NCT04133519|metaMe Health|Dr. David Recker, Chief Medical Officer|1-888-463-8262|info@metamehealth.com|
22258363|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
22258364|NCT03803085|Brandeis University|Yujun Liu|781-736-3300|lyujun@brandeis.edu|
22258365|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22258366|NCT05288673|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|8557522356|clinicaltrials@alexion.com|
22258367|NCT03056352|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
22258368|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org|
22258369|NCT02971605|Johns Hopkins University School of Medicine|Frederick Barrett, Ph.D., Principal Investigator|4105509777|fbarret2@jhmi.edu|
22258370|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22258371|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22258372|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258373|NCT03439293|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22258374|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22258375|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
22258376|NCT03404206|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22258377|NCT05478603|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258378|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org|
22258379|NCT03634488|Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease|Leshana Saint Jean|6158751992|leshana.saint.jean@vumc.org|
22258380|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org|
22258381|NCT00863369|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22258382|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22258383|NCT01169844|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
22258384|NCT04499235|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22258385|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22258386|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590||
22258387|NCT05003167|Purdue University|Jessica Huber, Professor and PI|765-494-3796|jhuber@purdue.edu|
22258388|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org|
22258389|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk|
22258390|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu|
22258391|NCT02367781|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258392|NCT01393990|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22258393|NCT02060461|Cleveland Clinic|William J Dupps, Jr, MD, PhD|216-444-8396||
22258394|NCT00740727|Massachusetts General Hospital|Stephen H. Thomas MD MPH|6177267622|stephen-thomas@ouhsc.edu|
22258395|NCT05321810|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258396|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk|
22258397|NCT01976390|Division of Transplant Surgery OSUMC|Director of Research Operations|614-293-8021|brenda.cuson@osumc.edu|
22258398|NCT00331630|Northwestern University|Virginia Kaklamani|312-695-1301||
22258399|NCT01014390|Hôpital Erasme|Jacques Devière, MD, PhD|(32) 0-2-555-4697.|Jacques.Deviere@erasme.ulb.ac.be|
22258400|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
22258401|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu|
22258402|NCT02451670|HealthPartnersInstitute|Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22258403|NCT01151813|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
22258404|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22258405|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22258406|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258407|NCT02415166|LaurateInstitute|Jonathan Savitz|918 502 5104|jsavitz@laureateinstitute.org|
22258408|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258409|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258410|NCT03568500|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22258411|NCT00943800|University of Chicago|Hongtao Liu|773-834-8980|hliu2@medicine.bsd.uchicago.edu|
22258412|NCT02967133|Duke University Medical Center|Neal Ready MD PhD|(919) 681-6932|neal.ready@duke.edu|
22258413|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22258414|NCT04895618|Regulatory Insight, Inc.|Elvira Cawthon|Results Point of Contact Name|elvira@reginsight.com|
22258415|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com|
22258416|NCT01828255|The New York Eye and Ear Infirmary|Dr Gustavo De Moraes|+1 212 477 7540|demoraesmd@gmail.com|
22258417|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org|
22258418|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu|
22258419|NCT03377556|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22258420|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22258421|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu|
22258422|NCT04169282|Duke University|Loretta Que, MD|919-681-8551|loretta.que@duke.edu|
22258423|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu|
22258424|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
22258425|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org|
22258426|NCT03818737|Emory University|Kenneth Mautner, MD|404-778-7142|kmautne@emory.edu|
22258427|NCT01907737|HCFMUSP/FFM|Adriana Conforto|551126617955|adriana.conforto@gmail.com|
22258428|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22258429|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org|
22258430|NCT03135379|Brooke Army Medical Center|Benjamin M. Krainin|210-916-0808|Benjamin.M.Krainin.mil@mail.mil|
22258431|NCT04549259|Center for AIDS Intervention Research, Medical College of Wisconsin|Dr. Jennifer Walsh and Dr. Andrew Petroll|414-955-7710|jwalsh@mcw.edu|
22258432|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22258433|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org|
22258434|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
22258435|NCT01630200|Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology|Dr. Matthias Urban|+43(0)6508125980|matthias.urban1@gmx.net|
22258436|NCT02008721|Department of Neurology, Ludwig-Maximilians-University Munich, Munich, Germany|Prof. Dr. Johannes Levin||johannes.levin@med.uni-munechen.de|
22258437|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com|
22258438|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu|
22258439|NCT01967888|Dompé|Mauro P. Ferrari, Pharm D|+3902583831|info@dompe.com|
22258440|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
22258441|NCT04535609|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
22258442|NCT03175120|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22258443|NCT04120194|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22258444|NCT02622074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258445|NCT02114931|Amgen Inc.|Study Director|866-572-6436||
22258446|NCT01859325|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
22258447|NCT03565211|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22258448|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com|
22258449|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464||
22258450|NCT02400073|ResMed|Senior Manager, Medical Affairs|+61 8884 1123|alison.wimms@resmed.com|
22258451|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu|
22258452|NCT02372682|Saint Louis University|Anna Hardy, Research Nurse Coordinator|314-268-5785|anna.hardy@health.slu.edu|
22258453|NCT01684722|University of Washington|Ian de Boer, MD, MS|2066165403|deboer@u.washington.edu|
22258454|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22258455|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258456|NCT03063632|Cancer Immunotherapy Trials Network|Anna Wright|206-667-2541|akwright@fredhutch.org|
22258457|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu|
22258458|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22258459|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22258460|NCT01023269|Medtronic International Trading Sarl|Alexandra Delacour, Clinical Research Manager|0041218027622|alexandra.delacour@medtronic.com|
22258461|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22258462|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22258463|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br|
22258464|NCT05266456|Vaxcyte|Vice President of Clinical Development|(650) 585-0029|clinicaltrialsgov@vaxcyte.com|
22258465|NCT05267574|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
22258466|NCT02995694|Alvogen Pine Brook|Meena Venugopal|973-532-7824|meena.venugopal@alvogen.com|
22258467|NCT00973856|Cleveland Clinic Akron General|Eliot Mostow, MD||emostow@akronderm.com|
22258468|NCT02746705|NYU Langone Health|Leigh Charvet|929 455 5125|leigh.charvet@nyulangone.org|
22258469|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258470|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu|
22258471|NCT02163811|VA Puget Sound Health Care System|Dr. Aaron Turner|(206) 277-6134|Aaron.Turner@va.gov|
22258472|NCT04929522|AinShams University|Director of Clinical Trials in Endodontics|+2022639083|endohashem@gmail.com|
22258473|NCT00378482|AstraZeneca Clinical Study Information Center|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
22258474|NCT02926053|National Center of Cancer Immune Therapy, Department of Oncology|Troels Holz Borch, MD, PhD, principal investigator|004524460492|troels.holz.borch@regionh.dk|
22258475|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22258476|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org|
22258477|NCT02257632|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22258478|NCT04967313|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
22258479|NCT03167099|West Virginia University|Dr. David Hubbard|304-293-3900|dhubbard@hsc.wvu.edu|
22258480|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22258481|NCT04126057|SightGlass Vision, Inc.|Joe Rappon, OD, MS, FAAC|678-642-9117|joe@sightglassvision.com|
22258482|NCT02806232|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22258483|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu|
22258484|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com|
22258485|NCT03342898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22258486|NCT03997448|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
22258487|NCT01312779|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22258488|NCT01621490|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22258489|NCT00506753|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
22258490|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258491|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22258492|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu|
22258493|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu|
22258494|NCT01144663|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258495|NCT03081767|Stanford University|Andrei Iagaru|6507254711|aiagaru@stanford.edu|
22258496|NCT05569148|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258497|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
22258498|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22258499|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258500|NCT02275923|Medtronic|Jennifer Seamans, Principal Clinical Research Specialist|7635262835|jennifer.l.seamans@medtronic.com|
22258501|NCT03549130|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258502|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22258503|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com|
22258504|NCT02883673|Alydia Health|Kathryn Wine, VP Clinical Operations|415-990-4104|kathryn@alydiahealth.com|
22258505|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org|
22258506|NCT03263195|Department of Pediatrics Ribeirão Preto Medical School|Dr. Marisa Mussi-Pinhata|55-16-3602-2807|mmmpinha@fmrp.usp.br|
22258507|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com|
22258508|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu|
22258509|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258510|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
22258511|NCT01797120|PrECOG, LLC|Carolyn Andrews|267-207-4070|candrews@precogllc.org|
22258512|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258513|NCT04634110|University of Colorado Hospital|Dr. Chad Rusthoven|720-516-0150|chad.rusthoven@cuanschutz.edu|
22258514|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
22258515|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22258516|NCT05751629|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258517|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md|
22258518|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22258519|NCT00287287|University of Kentucky|Kenneth Ain|8593236652|kenneth.ain@uky.edu|
22258520|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258521|NCT02491788|Stanford University|Dr. Jamie Zeitzer|16504935000|jzeitzer@stanford.edu|
22258522|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22258523|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300||
22258524|NCT02965820|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
22258525|NCT01567306|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
22258526|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com|
22258527|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
22258528|NCT03051256|Relmada Therapeutics|Chief Medical Officer|646-876-3459|info@relmada.com|
22258529|NCT04272775|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22258530|NCT01578707|Pharmacyclics, LLC|Anita Szoke|(669) 215-7235|aszoke@pcyc.com|
22258531|NCT02063698|Mayo Clinic|Aminah Jatoi, MD|(507) 284-7202|Jatoi.Aminah@mayo.edu|
22258532|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu|
22258533|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22258534|NCT01068873|Lewis Katz School of Medicine at Temple University|Lisa Landsberg|12157077303|lisa.landsberg@temple.edu|
22258535|NCT00575328|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
22258536|NCT02124746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258537|NCT04322968|VA Ann Arbor Healthcare System|Dr. Alisher Dadabayev, Pain POC|734-222-7639|Alisher.Dadabayev@VA.GOV|
22258538|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu|
22258539|NCT03811249|Refocus Group, Inc.|Linda Stewart, Director of Regulatory and Quality|214-368-0200|lstewart@refocus-group.com|431
22258540|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22258541|NCT01712230|University of Colorado Anschutz Medical Campus|Wendy Kohrt, PhD|303-724-1913|Wendy.Kohrt@CUAnschutz.edu|
22258542|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de|
22258543|NCT03124381|Johnson & Johnson Consumer Inc.|Ali Fassih, Ph.D.|908-904-3259|Afassih@its.jnj.com|
22258544|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com|
22258545|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
22258546|NCT03185949|Endobar Solutions LLC|Director, Clinical Affairs|8456800424|nodar@endobarsolutions.com|
22258547|NCT00500656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22258548|NCT02322242|Sunnybrook Health Sciences Centre|Dr. Stephen Choi|4164804864|stephen.choi@sunnybrook.ca|
22258549|NCT01806597|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22258550|NCT04160078|Emory University|Dayna Johnson, PhD, MPH, MSW, MS|404-727-8708|dayna.johnson@emory.edu|
22258551|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22258552|NCT02763579|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258553|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
22258554|NCT00829413|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
22258555|NCT03534986|International Biophysics Corporation|VP of Engineering and Quality|512-814-0046|quailty@biophysicscorp.com|
22258556|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22258557|NCT02145403|University of Michigan Rogel Cancer Center|Attaphol Pawarode, M.D.|734-936-8785|pawarode@med.umich.edu|
22258558|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22258559|NCT02578732|Brown University Oncology Research Group|Howard Safran, MD|401-863-300|BrUOG@BROWN.EDU|
22258560|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com|
22258561|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22258562|NCT03255031|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Gene-Jack Wang|301-496-5012|gene-jack.wang@nih.gov|
22258563|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258564|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu|
22258565|NCT00863057|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22258566|NCT02539563|Wake Forest School of Medicine|Lynnette Harris, BSN|336-716-6049|lcharris@wakehealth.edu|
22258567|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu|
22258568|NCT02974114|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258569|NCT03654898|Baylor College of Medicine Childrens Foundation Malawi|Maria Kim|+26599869090|mkim@tingathe.org|
22258570|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590||
22258571|NCT06371079|Basrah Medical College|Loay Abdulmutalib Almusawi|009647705559205|loay.almusawi@uobasrah.edu.iq|
22258572|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu|
22258573|NCT02868281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22258574|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258575|NCT04525157|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22258576|NCT01741480|WashingtonU|Dr. Marin Kollef|314-454-8764|mkollef@dom.wustl.edu|
22258577|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org|
22258578|NCT02533999|Nemours Children's Specialty Care|Kathryn Blake, PharmD|904-697-3806|kathryn.blake@nemours.org|
22258579|NCT03210259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258580|NCT05017493|Hiwa Hospital - KRG|Dr. Dara Omer|+9647701586707|mailto:danaomar1979@gmail.com|
22258581|NCT01392859|Children's Mercy Hospital|Dr. Bridgette Jones|816-302-3811|bljones@cmh.edu|
22258582|NCT03940586|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22258583|NCT04304950|Rush University Medical Center|Dr. Garth R. Swanson|312-563-3871|Garth_Swanson@rush.edu|33871
22288983|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1 - 801#
22288984|NCT02454517|Fred Hutchinson Cancer Center|Jeannette M. Schenk, PhD|206-667-6860|jschenk@fredhutch.org|
22288985|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22288986|NCT03565497|Boston University|Dr. Michael Otto|617-306-1836|mwotto@bu.edu|
22288987|NCT02999672|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22288988|NCT01166282|AbbVie|Global Medical Information|800-633-9110||
22288989|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com|
22288990|NCT01155518|suny buffalo|sandeep dhindsa||sandhindsa@yahoo.com|
22288991|NCT02892448|The Ottawa Hospital Research Institute|Dr. Paul E Beaule|613-737-8899|pbeaule@toh.ca|73265
22288992|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22288993|NCT03599089|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
22288994|NCT03214666|GT Biopharma, Inc.|Dr. Gregory Berk|925-719-3531|gb@gtbiopharma.com|
22288995|NCT03048578|NYU Langone Health - Weight Management Program|Holly F. Lofton, MD|(212) 263-3166|Holly.Lofton@nyulangone.org|
22288996|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
22288997|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu|
22288998|NCT02500797|Memorial Sloan-Kettering Cancer Center|Sandra P. D'Angelo, M.D.|646-888-4159|dangelos@mskcc.org|
22288999|NCT03511937|University of North Carolina at Chapel Hill|Anna Grummon, PhD|(617) 495-2021|agrummon@hsph.harvard.edu|
22289000|NCT02983552|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22289001|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924|j.kulkarni@alfred.org.au|66924
22289002|NCT03710161|University of Nebraska Medical Center|Dr. Laura Graeff-Armas|402-559-6310|laura.armas@unmc.edu|
22289003|NCT02921841|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
22289004|NCT01497496|Moffitt Cancer Center|Celeste Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
22289005|NCT02902237|Department of Medicine A, University Hospital Muenster, Germany|Prof. Dr. Wolfgang Berdel, Professor of Medicine|+49 251 835|berdel@uni-muenster.de|2672
22289006|NCT02023697|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22289007|NCT00541385|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
22289008|NCT01469377|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22289009|NCT01733680|SUNy Upstate Medical University|Gail P DePalma|3154643260|depalmag@upstate.edu|
22289010|NCT03937999|Montefiore Medical Center|Paul Riska, MD|718-920-6494|priska@montefiore.org|
22289011|NCT04139798|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22289012|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889||
22289013|NCT04539795|University of Alabama at Birmingham (UAB)|Dr. Wells (Study PI)|205-934-5555|LungHealth@uabmc.edu|
22289014|NCT02952820|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22289015|NCT03857867|Stanford|Peter Tass|650-304-8849|ptass@stanford.edu|
22289016|NCT03070964|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22289017|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com|
22289018|NCT01600170|University of Pennsylvania School of Medicine|Ronald G Collman|215-898-0913|collmanr@pennmedicine.upenn.edu|
22289019|NCT02506244|Scripps Research Translational Institute|Steven R. Steinhul, MD, Prinicipal Investigator|858-554-5757|steinhub@scripps.edu|
22289020|NCT03962062|Medicines Development for Global Health|Sally Kinrade, Vice President, Project Leader, Onchocerciasis & Lymphatic Filariasis|+61 3 9912 2400|sally.kinrade@medicinesdevelopment.com|
22289021|NCT02170077|BIAL - Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com|
22289022|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22289023|NCT02970162|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22289024|NCT02447003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22289025|NCT00750438|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22289026|NCT03848728|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
22289027|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22289028|NCT06083506|WestVirginiaU|Arif Salman Abdul Shakore|304-293-5831|arifsalman.abdulshakore@hsc.wvu.edu|
22289029|NCT04500158|Virginia Commonwealth University|Dr. Caroline Carrico|(804) 828-8328|ckcarrico@vcu.edu|
22289030|NCT05475483|SOM Innovation Biotech SA|Chief Medical Officer|+41 79 552 15 78|medori@sombiotech.com|
22289031|NCT03059355|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305 243 5579|JHare@med.miami.edu|
22289032|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
22289033|NCT03830892|Virginia Commonwealth University|Dr. Andrew J. Barnes|804-827-4361|abarnes3@vcu.edu|
22289034|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
22258584|NCT02006147|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
22258585|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org|
22258586|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343||
22258587|NCT03182686|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22258588|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300||
22258589|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22258590|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258591|NCT00003102|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22258592|NCT05037409|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22258593|NCT04643782|Northwestern University|Phyllis Zee, MD|312-503-5944|SleepSensors@northwestern.edu|
22258594|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu|
22258595|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22258596|NCT01559818|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
22258597|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22258598|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22258599|NCT00125359|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
22289180|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22289181|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22289182|NCT04683887|Azienda Unità Sanitaria Locale di Piacenza|Massimo Guasconi|+39-0523-303853|m.guasconi2@ausl.pc.it|
22289183|NCT02173509|University Aveiro|Teresa Herdeiro|+351234370200|teresaherdeiro@ua.pt|
22289184|NCT04661579|PATH|Christian F. Ockenhouse, MD, PhD|1 (206) 285-3500|cockenhouse@path.org|
22289185|NCT03656562|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22289186|NCT04335136|APEIRON Biologics AG|Dr. Romana Gugenberger|+4366488506236|romana.gugenberger@apeiron-biologics.com|
22289187|NCT01396447|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22289188|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr|
22289189|NCT04269265|University of Minnesota|Kevin Escandon, MD MS|612-626-9344|escan012@umn.edu|
22289190|NCT04693234|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22289191|NCT05814367|Johnson & Johnson Vision Care, Inc. (JJVC)|Nabin Joshi|1-800-843-2020|njoshi30@its.jnj.com|
22289192|NCT04838626|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22289193|NCT02578706|Icahn School of Medicine at Mount Sinai|Dr. Meagan O'Brien||Meagan.O'Brien@mssm.edu|
22289194|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu|
22289195|NCT03217058|University of California San Francisco|Dr. Derek Satre, Principal Investigator|415-476-7382|Derek.Satre@ucsf.edu|
22289196|NCT00614432|University of Hawaii|Investigator|808-203-6500|whrc@hawaii.edu|
22289197|NCT04103749|Boston Scientific Corporation|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
22289198|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
22289199|NCT04950816|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
22289200|NCT04939415|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
22289201|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22289202|NCT00523302|Medical University of South Carolina|Edward B. Short|8437923295|shortb@musc.edu|
22289203|NCT00067002|UT MD Anderson Cancer Center|Simrit Parmar, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|SParmar@mdanderson.org|
22289204|NCT03350672|Philadelphia FIGHT Community Health Centers|Linden Lalley-Chareczko|2155258695|lchareczko@fight.org|
22289205|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com|
22289206|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22289207|NCT03895840|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
22289208|NCT01847027|University of North Texas Health Science Center|Meharvan Singh, PhD|8177355429|meharvan.singh@unthsc.edu|
22289209|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300||
22289210|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22289211|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289212|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343||
22289213|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22289214|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|aruna.nathan@gmail.com|
22289215|NCT02817464|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22289216|NCT03008369|Mayo Clinic|Ashish Vitthalrao Chintakuntlawar, MBBS, Ph.D.|5072930504|Chintakuntlawar.Ashish@mayo.edu|
22289217|NCT04292899|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22289218|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu|
22289219|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu|
22289220|NCT04674761|Albireo AB|Albireo AB|medinfo@albireopharma.com|medinfo@albireopharma.com|
22289221|NCT01627288|Duke University Health System|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
22289222|NCT05340478|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|713 791-1414|Ellen.Teng@va.gov|
22289223|NCT01594216|Abramson Cancer Center|Angela DeMichele, MD|215-615-5329|Angela.DeMichele@pennmedicine.upenn.edu|
22289224|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22289225|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22289226|NCT02624986|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22289227|NCT03830307|University of Pittsburgh|Dr. Grace Lim|412-641-4260|limkg2@upmc.edu|
22289228|NCT03532451|ECOG Stats Center|Xiangying Chu|3472770190|xchu@ds.dfci.harvard.edu|
22289229|NCT02116205|WRAIR Clinical Trials Center|Dr. Kristin Mills, Principal Investigator|301-319- 2039|Kristin.t.mills.ctr@mail.mil|
22289230|NCT03710577|Univerisity of Wisconsin-Madison|Dr. Kelli Koltyn|608-262-4234|koltyn@education.wisc.edu|
22289231|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu|
22289232|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
22289233|NCT02561338|Hua Medicine|Yi Zhang|+86-21-58869997|yzhang@huamedicine.com|3269
22289234|NCT02284035|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|ESTEBANM@clinic.cat|
22289235|NCT04845568|Washington University|Ellen Fitzsimmons-Craft|3142862074|fitzsimmonse@wustl.edu|
22289236|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu|
22289237|NCT00928408|Amgen Inc.|Study Director|866-572-6436||
22289238|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22289239|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
22289240|NCT06139887|White River Junction VA Medical Center|Dr. Natalie Riblet|1-802-295-9363|natalie.riblet@va.gov|5893
22289241|NCT02538354|Universy Medical Center Groningen|dr. J.Z.H. von Martels|0031503616161|j.z.h.von.martels@umcg.nl|
22289242|NCT04672655|Stanford University|Molly Tanenbaum, PhD|(650) 725-3955|mollyt@stanford.edu|
22289243|NCT01326104|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
22289244|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22289245|NCT03843541|Zambon S.p.A.|Valentina Zanin|+39026652441|valentina.zanin@zambongroup.com|
22289246|NCT05978713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22289247|NCT02930018|NoNO Inc.|Michael Tymianski, MD PhD|4165831687|mtymianski@nonoinc.ca|
22289248|NCT02807402|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22289249|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22289250|NCT04098237|Cedars-Sinai Medical Center|Dr. Andrew Hendifar, MD|310-423-2217|andrew.hendifar@cshs.org|
